Protein Entry Name Protein names Gene Names Organism Gene Ontology (biological process) Gene Ontology (cellular component) Gene Ontology (GO) Gene Ontology (molecular function) Gene Ontology IDs Peptide ID Score t-test p ANOVA p Mass stdev (Da) MH+ (Da) CL-6_At_IC50_48H_1 Int (Treated) CL-6_At_IC50_48H_2 Int (Treated) CL-6_At_IC50_48H_3 Int (Treated) CL-6_Be_IC50_48H_1 Int (Treated) CL-6_Be_IC50_48H_2 Int (Treated) CL-6_Be_IC50_48H_3 Int (Treated) CL-6_Cis_IC50_48H_1 Int (Treated) CL-6_Cis_IC50_48H_2 Int (Treated) CL-6_Cis_IC50_48H_3 Int (Treated) CL-6_Con_48H_1 Int (Treated) CL-6_Con_48H_2 Int (Treated) CL-6_Con_48H_3 Int (Treated) H1_At_IC50_48H_1 Int (Treated) H1_At_IC50_48H_2 Int (Treated) H1_At_IC50_48H_3 Int (Treated) H1_Be_IC50_48H_1 Int (Treated) H1_Be_IC50_48H_2 Int (Treated) H1_Be_IC50_48H_3 Int (Treated) H1_Cis_IC50_48H_1 Int (Treated) H1_Cis_IC50_48H_2 Int (Treated) H1_Cis_IC50_48H_3 Int (Treated) H1_Con_48H_1 Int (Treated) H1_Con_48H_2 Int (Treated) H1_Con_48H_3 Int (Treated) H28_At_IC50_48H_1 Int (Treated) H28_At_IC50_48H_2 Int (Treated) H28_At_IC50_48H_3 Int (Treated) H28_Be_IC50_48H_1 Int (Treated) H28_Be_IC50_48H_2 Int (Treated) H28_Be_IC50_48H_3 Int (Treated) H28_Cis_IC50_48H_1 Int (Treated) H28_Cis_IC50_48H_2 Int (Treated) H28_Cis_IC50_48H_3 Int (Treated) H28_Con_48H_1 Int (Treated) H28_Con_48H_2 Int (Treated) H28_Con_48H_3 Int (Treated) MM_At_IC50_48H_1 Int (Treated) MM_At_IC50_48H_2 Int (Treated) MM_At_IC50_48H_3 Int (Treated) MM_Be_IC50_48H_1 Int (Treated) MM_Be_IC50_48H_2 Int (Treated) MM_Be_IC50_48H_3 Int (Treated) MM_Cis_IC50_48H_1 Int (Treated) MM_Cis_IC50_48H_2 Int (Treated) MM_Cis_IC50_48H_3 Int (Treated) MM_Con_48H_1 Int (Treated) MM_Con_48H_2 Int (Treated) MM_Con_48H_3 Int (Treated) A0A075B6H8 KVD42_HUMAN Probable non-functional immunoglobulin kappa variable 1D-42 IGKV1D-42 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 LFLYDAK 24.37000084 0.071557552 0.071557552 0.228456734 869.628711 21.64623 20.0522 21.8862 17.6509 21.64098 20.59927 21.4979 20.24441 20.59386 19.01935 19.13633 19.67433 16.47503 19.42245 19.24078 17.90765 19.89952 19.73788 18.94317 20.07795 20.42299 20.69888 21.53416 17.04043 17.87765 16.87661 21.04861 20.56597 16.86357 18.08978 21.01823 21.14725 18.26523 17.66837 22.8144 22.60235 19.49175 20.76726 20.80444 19.19472 19.45126 19.23502 20.65693 17.36163 19.41331 19.1243 20.70876 21.39997 A0A075B6H9 LV469_HUMAN Immunoglobulin lambda variable 4-69 IGLV4-69 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 GDGIPDRFSGSSSGAER 8.390000343 1 1 0.368067067 1694.585779 0 0 0 0 19.73129 16.42811 19.29702 0 16.57303 0 15.04896 0 0 0 0 0 0 0 0 17.46457 0 0 18.53952 0 0 15.55444 0 0 0 0 0 0 0 16.2664 0 0 0 15.58443 0 0 16.72564 0 0 17.83849 13.47725 0 0 0 A0A075B6K6 LV403_HUMAN Immunoglobulin lambda variable 4-3 IGLV4-3 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 FMGSSSGADR 5.050000191 1 1 2.34E-13 1030.769835 13.78132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05894 0 14.75298 0 14.90235 0 0 0 0 A0A075B6N3 TVBX1_HUMAN T cell receptor beta variable 24-1 TRBV24-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 IMLECSQTK 17.89999962 0.475976467 0.475976467 0.168583516 1126.625705 15.17472 17.98288 0 16.10632 17.58204 0 17.12323 16.64281 18.10911 14.98534 16.34451 18.18324 18.24227 16.32366 16.14259 16.98832 0 18.01536 17.72434 18.02401 17.16746 17.0089 15.55462 0 16.20205 14.78658 16.90717 18.90685 17.38889 18.00222 17.75632 16.01003 0 17.30893 0 17.27155 16.64755 16.48514 13.99759 0 14.9818 14.83847 13.23377 15.62104 15.86105 15.18348 16.3019 16.89981 A0A075B6Q5 HV364_HUMAN Immunoglobulin heavy variable 3-64 IGHV3-64 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 NTLYLQMGSLR 1.429999948 0.306500316 0.306500316 0.117978205 1311.459414 9.060524 0 0 12.68666 13.91978 13.37519 0 0 5.87016 0 14.12384 0 0 14.21905 0 0 10.87975 0 0 0 13.48172 0 0 0 0 0 0 11.92087 0 0 0 14.55521 14.68683 14.965 13.67695 0 0 0 0 0 0 0 0 0 0 0 0 14.78059 A0A075B6T8 TVA91_HUMAN T cell receptor alpha variable 9-1 TRAV9-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0006955; GO:0042101 AMKANDK 2.940000057 1 1 1.26E-12 778.4032666 13.26588 15.96695 0 0 0 0 13.42712 13.29259 14.50752 14.5424 0 0 12.70947 16.41684 0 0 12.88537 0 16.26969 15.92024 0 12.95955 0 16.15465 17.59007 12.26218 0 14.26349 0 15.32093 0 0 0 0 0 0 0 0 0 0 14.54537 0 0 0 0 0 0 0 A0A075B734 AQP7B_HUMAN Aquaporin-7B AQP7B Homo sapiens (Human) glycerol transport [GO:0015793]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transport [GO:0015793]; water transport [GO:0006833] glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] GO:0005886; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323 EFLAEFMSTYVMMVFGLGSVAHMVLNK 5.099999905 1 1 9.18E-13 3068.436444 12.22598 15.70933 0 13.2305 0 0 0 14.77114 0 0 14.37452 11.81041 0 13.97769 13.01003 13.50388 0 12.82319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087WT03 TVAZ1_HUMAN T cell receptor alpha variable 26-1 TRAV26-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 KSSTLILPHATLR 15.32999992 0.794895649 0.794895649 0.192997929 1437.017707 0 0 0 16.5432 14.66361 15.54466 0 0 13.14546 0 0 0 0 17.1876 14.71933 18.15221 16.84141 16.32027 15.75632 16.47634 0 0 0 20.6021 12.82784 13.77427 0 0 15.78329 0 0 13.65058 14.79711 16.17391 16.70931 0 0 0 15.9001 15.55293 0 0 0 10.29063 0 13.46677 0 16.6826 A0A087WXM9 MEIKN_HUMAN Meiosis-specific kinetochore protein MEIKIN Homo sapiens (Human) "female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; male meiosis chromosome segregation [GO:0007060]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; meiotic sister chromatid cohesion, centromeric [GO:0051754]" "condensed chromosome, centromeric region [GO:0000779]; kinetochore [GO:0000776]" "condensed chromosome, centromeric region [GO:0000779]; kinetochore [GO:0000776]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; male meiosis chromosome segregation [GO:0007060]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; meiotic sister chromatid cohesion, centromeric [GO:0051754]" GO:0000776; GO:0000779; GO:0007060; GO:0010789; GO:0016321; GO:0045143; GO:0051754 AEAPPGSKR 2.24000001 1 1 0.089292502 913.0437284 0 13.28581 0 15.84056 0 0 0 0 0 0 11.83284 0 0 0 0 0 0 0 14.70615 0 0 0 13.02336 0 0 0 0 0 0 0 0 0 15.55362 0 16.55079 0 0 0 0 16.13371 0 0 15.34299 0 16.37996 0 15.56491 0 A0A096LP49 CC187_HUMAN Coiled-coil domain-containing protein 187 CCDC187 Homo sapiens (Human) microtubule anchoring [GO:0034453] centrosome [GO:0005813] centrosome [GO:0005813]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453] microtubule binding [GO:0008017] GO:0005813; GO:0008017; GO:0034453 KHSSLER 7.019999981 0.437560856 0.437560856 0.119893942 854.9978388 0 13.80211 11.51705 10.52457 0 0 0 15.92488 16.03395 14.20517 13.03014 10.48182 0 13.87414 0 13.96162 15.0809 15.52613 15.15233 0 14.20962 0 0 13.43023 11.77357 0 13.50991 9.805283 15.47985 12.46255 0 0 0 0 0 14.73371 13.95936 16.36157 0 15.26657 16.02102 13.58633 0 14.15129 15.73996 20.74608 15.41332 0 A0A0A0MT70 TJB26_HUMAN T cell receptor beta joining 2-6 TRBJ2-6 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 SGANVLTFGAGSR 5.289999962 1 1 0.399330768 1236.010591 0 15.65499 0 0 0 15.70907 0 13.61583 0 0 0 15.75462 16.49031 15.41873 0 0 14.60952 0 16.93247 17.17634 16.95579 0 18.51935 0 16.10198 0 16.31601 0 15.91788 0 0 15.83686 12.93281 16.31886 13.51013 14.6957 17.67667 0 15.34867 17.14057 15.87983 0 16.77785 16.31483 16.16371 0 14.88011 0 A0A0A0MT76 LJ01_HUMAN Immunoglobulin lambda joining 1 IGLJ1 Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 PSRLLLQPSPQR 10.36999989 1 1 0.291884448 1391.373849 0 17.71631 0 17.97672 16.41693 0 0 15.53742 16.87038 0 0 0 16.55369 18.14617 0 17.07927 17.10059 0 0 17.06502 0 16.55093 0 16.13684 0 0 18.91255 0 0 17.93771 0 17.02039 17.32839 0 0 16.14369 14.47236 16.61056 15.07771 17.02779 0 17.05231 0 0 0 15.47496 0 0 A0A0A6YYG2 TVB66_HUMAN T cell receptor beta variable 6-6 TRBV6-6 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 QDPGMGLK 2.970000029 1 1 0.216532752 862.2232079 15.6796 16.06748 11.94439 15.93913 14.57959 0 15.46225 16.56015 0 16.97581 16.5603 13.17416 11.67649 12.76871 14.95532 17.5487 16.50615 0 15.49118 13.89219 16.08684 15.87949 13.8577 12.7543 16.9733 16.83586 16.76709 16.88589 0 0 0 0 0 0 0 0 0 16.31571 0 0 0 16.0597 12.55345 16.09956 0 0 13.50765 0 A0A0A6YYK1 TVA81_HUMAN T cell receptor alpha variable 8-1 TRAV8-1 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 GFEAEFIK 6.949999809 0.80369705 0.80369705 0.289877739 941.4805857 17.31528 18.95153 17.35146 0 0 18.26528 21.11233 16.9043 0 0 0 20.60886 0 0 0 0 0 0 0 20.35552 0 0 0 0 19.16219 0 20.92017 0 0 0 0 0 0 20.28402 0 22.28551 18.40125 0 19.13448 0 0 0 0 0 0 0 0 21.66039 A0A0A6YYK7 TVA19_HUMAN T cell receptor alpha variable 19 (T-cell receptor alpha chain V region HPB-MLT) TRAV19 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; MHC protein binding [GO:0042287]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; immune response [GO:0006955] MHC protein binding [GO:0042287]; peptide antigen binding [GO:0042605] GO:0002250; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0042101; GO:0042287; GO:0042605 MLTASLLRAVIASICVVSSMAQK 6.380000114 0.740108967 0.740108967 0.160923922 2448.98373 0 14.53004 15.98022 0 0 14.92149 14.73615 14.20071 12.71594 0 14.47454 0 0 0 15.26704 0 0 0 0 0 13.20204 0 0 0 13.73779 14.51525 0 0 16.24695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.85388 13.39319 A0A0B4J244 TVA3_HUMAN T cell receptor alpha variable 3 TRAV3 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 YITGDNLVK 6.119999886 1 1 0.159960829 1023.705375 0 0 14.81592 15.35963 13.74206 14.14707 0 0 0 0 17.98377 14.62292 0 15.97549 12.83415 18.01757 0 0 0 0 13.85087 17.0633 0 0 0 0 0 14.93284 16.35006 16.11487 0 0 0 0 0 0 16.66104 0 0 0 0 0 0 0 14.55986 15.45945 0 0 A0A0B4J245 TVAL1_HUMAN T cell receptor alpha variable 12-1 TRAV12-1 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250] peptide antigen binding [GO:0042605] GO:0002250; GO:0042101; GO:0042605 LSDSATYLCVVN 2.400000095 1 1 0.383234902 1339.099378 8.912585 0 0 0 0 0 0 17.30127 0 0 0 18.39091 0 0 16.66385 0 0 0 0 0 0 0 0 0 0 0 17.33781 0 0 18.39479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J275 TVA17_HUMAN T cell receptor alpha variable 17 TRAV17 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 HSGRLR 3.930000067 1 1 0.167712313 724.634184 12.93529 12.84595 16.0878 0 0 15.19389 0 0 0 16.06493 0 0 15.53406 0 0 0 0 14.33597 15.00068 0 0 0 15.49386 0 0 16.05779 0 15.73878 0 15.21325 0 0 0 0 0 0 0 15.6593 0 0 0 15.80647 0 0 0 0 0 0 A0A0B4J2D5 GAL3B_HUMAN "Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (Keio novel protein-I, KNP-I) (Protein GT335) (Protein HES1)" GATD3B HES1 KNPI Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 ALVASR 3.24000001 1 1 0.279131797 615.8663195 17.25788 0 0 0 0 15.06597 0 0 0 0 0 0 0 0 0 0 0 18.25498 0 0 0 0 0 16.61792 0 0 0 0 16.75659 17.06737 0 0 16.77279 0 0 16.59754 0 0 0 0 0 0 0 17.34511 0 0 0 0 A0A0B4J2F2 SIK1B_HUMAN "Putative serine/threonine-protein kinase SIK1B, EC 2.7.11.1 (Salt-inducible kinase 1B)" SIK1B Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0042149; GO:0106310 DLKTENLLLDGNMDIK 12.46000004 0.184359401 0.184359401 0.157051548 1849.021486 18.47694 18.89428 16.97727 16.6909 19.95492 0 18.96277 17.71387 18.0137 0 15.4078 15.75298 12.72653 14.57564 0 0 15.62177 14.57513 15.91248 18.08393 16.50352 18.87099 19.56444 0 17.6704 16.45832 16.1681 15.96543 17.17275 0 0 17.95897 18.87261 18.98806 15.26113 16.33666 17.91321 13.41667 0 16.32516 16.48319 0 17.88528 13.56879 14.77412 15.223 17.23982 13.52185 A0A0C4DH59 TVB54_HUMAN T cell receptor beta variable 5-4 TRBV5-4 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 MGPGLLCWALLCLLGAGSVETGVTQSPTHLIK 5.639999866 1 1 4.12E-12 3378.661298 0 13.65377 0 0 0 0 0 12.93475 12.07225 0 0 0 0 13.71106 0 10.09464 10.87386 0 12.61771 0 14.19408 0 0 0 0 14.8701 0 0 14.20888 12.88381 0 11.98856 12.35489 0 13.75756 0 0 0 0 0 0 0 0 0 0 0 0 8.104225 A0A0G2JMD5 PRA33_HUMAN PRAME family member 33 PRAMEF33 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 AELMRTLR 2.609999895 0.403098941 0.403098941 0.287418496 1004.541916 18.02785 0 17.98856 15.13338 0 0 0 0 0 0 0 0 17.7372 0 0 0 0 0 0 17.95583 0 0 0 0 17.65693 17.70115 18.78174 0 16.59295 18.00037 0 0 0 17.39633 0 17.38418 17.6647 0 19.14984 0 0 0 17.05396 0 16.99338 0 18.22322 0 A0A0J9YXQ4 PMA6E_HUMAN Paraneoplastic antigen Ma6E PNMA6E Homo sapiens (Human) MALAMLR 7.03000021 1 1 0.146843127 806.5132688 15.10427 14.1663 0 12.38203 0 0 13.78292 15.97199 11.41602 15.62612 0 0 0 13.4484 0 15.14487 13.93498 15.28738 14.18191 15.28018 15.28953 0 0 13.56683 0 14.8507 0 0 0 0 0 0 0 0 0 0 0 16.7679 0 0 0 0 0 16.33879 0 0 0 0 A0A0U1RQE8 GLYLB_HUMAN "Putative glycine N-acyltransferase-like protein 1B, EC 2.3.1.68" GLYATL1B Homo sapiens (Human) glutamine metabolic process [GO:0006541] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; glutamine metabolic process [GO:0006541] glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410] GO:0005739; GO:0006541; GO:0016410; GO:0047946; GO:0047961 GNGTRLIMR 3.079999924 1 1 4.62E-13 1036.307871 14.44042 16.05533 0 0 0 0 0 15.77727 0 0 0 0 0 13.66144 10.8216 16.60048 0 12.79409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0U1RQF7 DP2NB_HUMAN DPEP2 neighbor protein DPEP2NB Homo sapiens (Human) LEHRGR 4.489999771 1 1 0.165763151 768.3250375 16.36869 0 13.89921 13.02439 13.73059 0 0 0 0 0 0 0 0 14.52973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.23235 0 0 0 0 17.21656 15.11909 0 15.38391 0 0 0 0 0 0 A0A1B0GTH6 CS2IP_HUMAN Casein kinase II subunit alpha'-interacting protein CSNKA2IP Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ALNSHLLHSK 8.630000114 1 1 0.105846545 1120.915692 13.95681 0 14.93005 0 12.4981 0 0 0 0 0 0 0 0 0 0 0 0 0 13.65262 0 0 0 0 0 0 0 0 14.31399 0 12.05636 11.25556 14.80235 0 0 0 0 14.55965 0 13.43823 0 0 0 0 0 0 0 0 13.55156 A0A1B0GTL2 CT204_HUMAN Uncharacterized protein C20orf204 C20orf204 PRR17 Homo sapiens (Human) AIIFEDLQAAVK 14.85000038 0.969998598 0.969998598 0.303561576 1316.668053 16.34032 14.50381 13.24805 13.18492 0 0 0 0 0 0 0 13.25496 0 0 16.50522 0 0 0 0 0 0 0 0 0 14.79501 0 0 14.92364 16.80945 13.88101 15.72026 0 0 0 13.29783 0 16.09739 0 15.97492 0 15.58179 0 16.50529 13.87868 0 0 0 0 A0A1B0GTR0 EDD13_HUMAN Epididymal protein 13 EDDM13 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GIIGLMSRLSPDGLR 3.519999981 1 1 0.134866714 1600.533585 13.74989 0 0 12.86152 14.3574 14.86762 0 0 11.80948 0 0 13.84938 0 11.90793 14.131 14.79652 0 0 0 13.24816 0 0 15.95354 0 0 0 0 15.43361 13.42155 0 0 14.53497 0 0 0 0 0 0 0 15.85892 0 0 0 0 0 0 0 12.54606 A0A1B0GTS1 HSFX4_HUMAN "Heat shock transcription factor, X-linked member 4" HSFX4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357 RSGMWSK 10.68000031 1 1 0.288671765 852.0299571 16.50269 0 0 16.23537 15.69562 16.6114 0 0 16.95567 16.57748 16.25927 15.97013 15.10328 15.58161 15.234 15.35272 16.21844 15.22075 15.9055 16.38883 15.68346 16.64479 16.2198 15.40606 15.5218 15.09609 15.33815 0 0 0 15.17863 16.62123 17.10434 0 15.71459 0 0 15.46644 0 15.54253 0 15.80466 15.39208 15.2614 0 0 13.83717 14.92 A0A1B0GTU1 ZC11B_HUMAN Zinc finger CCCH domain-containing protein 11B ZC3H11B ZC3HDC11B Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973] metal ion binding [GO:0046872]; mRNA binding [GO:0003729] GO:0003729; GO:0016973; GO:0046872 FSTGGDSDPPLKR 8.460000038 1 1 0.241422209 1375.894883 16.79601 16.30721 0 17.94261 0 0 15.21251 0 0 15.88601 17.05897 0 0 16.68594 14.9455 0 0 0 0 0 0 0 0 0 17.2684 0 17.10295 16.63487 0 0 0 0 0 0 0 0 0 0 0 0 17.69074 0 0 0 16.08344 0 16.62933 16.99779 A0A1B0GUC4 MYCOS_HUMAN Myocilin opposite strand protein MYOCOS Homo sapiens (Human) KEIITQK 13.47000027 1 1 0.095433744 857.9521838 16.06932 0 15.48274 0 16.24685 15.34732 16.11278 16.54274 0 15.94175 0 0 0 0 0 13.58644 0 15.17897 0 0 0 15.38984 13.59925 16.00799 0 0 0 0 0 0 0 14.65157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUX0 VAFNB_HUMAN Protein ATP6V1FNB (ATP6V1F neighbor gene protein) ATP6V1FNB Homo sapiens (Human) AKAAAR 6.050000191 0.170020953 0.170020953 0.325214289 586.7426216 13.32893 14.4895 0 15.88761 0 0 15.90822 0 14.92009 0 0 0 0 0 16.15252 0 0 15.98613 0 16.5213 0 0 0 0 17.17003 14.52213 15.35852 0 16.73079 15.18489 15.90641 16.35324 0 17.03706 16.31363 17.04911 0 15.97466 18.935 17.99183 18.62687 17.42075 15.59811 0 17.09733 18.46972 15.92778 18.36929 A0A1B0GV03 GG6L7_HUMAN Golgin subfamily A member 6-like protein 7 GOLGA6L7 Homo sapiens (Human) cis-Golgi network [GO:0005801] cis-Golgi network [GO:0005801] GO:0005801 NIITNK 31.07999992 0.483861148 0.483861148 0.131711466 701.5100608 16.83397 15.28703 16.5709 15.91906 17.26972 16.43619 17.18457 17.05134 17.05064 16.71106 16.77982 16.82739 17.50163 17.04063 16.07435 16.40156 16.56947 17.1222 17.05356 16.45135 16.88564 17.02538 17.06313 16.81943 15.96713 17.08744 16.9814 16.63728 16.99631 16.66393 17.10132 16.32806 0 17.06775 16.68924 16.36654 16.62769 17.72159 16.53166 16.86913 16.28298 16.7311 16.48602 0 15.78171 0 16.91994 16.20784 A0A1B0GV85 RELD1_HUMAN Reelin domain-containing protein 1 REELD1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IESSVVSQQTHSSAHSDDRMEPR 4.019999981 0.530567467 0.530567467 0.343308121 2597.360187 14.09089 0 11.94906 11.62811 14.75164 0 0 13.33484 14.29928 0 0 14.65078 0 0 14.94292 0 0 0 0 0 0 0 15.45953 0 11.30305 0 0 0 0 0 0 0 0 17.02591 12.92222 0 0 0 0 0 16.26803 0 0 0 0 0 0 0 A0A1B0GVH7 IQCM_HUMAN IQ domain-containing protein M IQCM Homo sapiens (Human) FMITPK 1.769999981 1 1 0.040733482 751.4879726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GWB2 PRT1B_HUMAN Proline rich transmembrane protein 1B PRRT1B IFITMD8 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 GGGSPATPEDPR 9.479999542 1 1 0.523262455 1140.387652 0 0 0 0 0 0 0 0 16.72113 0 0 0 0 0 0 0 17.49733 0 0 0 0 0 0 0 0 0 17.63986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1W2PQ73 ERFL_HUMAN ETS domain-containing transcription factor ERF-like (ETS repressor factor-like) ERFL Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]" GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565 ILHKTK 6.199999809 1 1 0.23394632 740.2095611 14.11272 14.34604 15.29432 12.60273 15.07954 13.59479 14.01077 15.5678 12.77453 14.09515 0 12.70292 15.21424 14.86155 14.29532 17.48266 14.07623 16.76918 0 17.60127 0 13.94049 16.73026 16.05184 0 0 0 15.82565 15.36662 14.47931 15.28387 17.18574 16.84206 0 16.68138 0 0 0 0 16.4021 14.81617 17.12266 15.66174 0 0 15.27703 0 0 A0A1W2PR19 GSTT4_HUMAN "Glutathione S-transferase theta-4, EC 2.5.1.18 (GST class-theta-4) (Glutathione S-transferase theta pseudogene 1)" GSTT4 GSTTP1 Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749] glutathione transferase activity [GO:0004364] GO:0004364; GO:0005737; GO:0006749 MQVELNIGSGLFREAHDR 7.46999979 1 1 1.16E-05 2087.811421 14.15949 0 13.93417 13.63715 0 14.11008 12.62753 0 0 0 0 0 0 0 15.2983 0 0 11.15787 14.94099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YFK9 SIM38_HUMAN Small integral membrane protein 38 SMIM38 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MTSWPGGSFGPDPLLALLVVILLAR 5.400000095 1 1 4.11E-12 2638.666841 0 0 10.6798 0 14.72484 11.19123 12.88426 0 0 0 0 12.44607 0 0 0 0 0 0 0 0 12.05944 0 0 0 0 0 0 0 0 0 0 0 0 0 8.355204 0 0 0 0 0 0 0 0 0 0 0 13.03106 0 A0A2R8Y4L2 RA1L3_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 3 (Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48) HNRNPA1L3 HNRNPA1P48 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0008380 EDSQRPDAHLTVKK 11.26000023 1 1 0.26104089 1623.882969 0 0 0 0 0 0 0 0 0 0 16.1776 0 0 0 16.75804 16.72734 0 15.77103 0 13.24445 0 0 16.15849 16.29436 15.76981 16.31982 15.38489 0 0 16.44228 0 0 16.50652 0 16.63624 17.0231 0 16.13352 0 16.87136 15.79743 15.95917 0 16.94423 0 0 0 0 A0A2R8YFL7 OSP4A_HUMAN Oocyte-secreted protein 4A OOSP4A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 FPIILVMRGR 14.43999958 1 1 0.337170658 1200.774712 19.42735 18.26384 18.61649 0 18.0808 16.89554 19.49302 19.06624 19.25736 20.84856 19.13237 18.29263 19.47899 0 0 0 0 0 0 0 18.38701 0 0 0 0 0 0 17.73785 0 18.7382 0 20.06343 0 0 20.11976 0 0 18.6093 0 0 0 0 18.37743 19.77451 0 0 0 18.2108 A0A3B3IU63 H2AL3_HUMAN "Histone H2A-like 3, H2A.L.3" H2AL3 H2AL1RP Homo sapiens (Human) nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] GO:0000786; GO:0003677; GO:0005634; GO:0046982 EEEMVVLVVMGGRR 4.650000095 1 1 0.211250511 1635.213693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.49181 0 0 0 0 0 0 15.14701 0 0 12.69366 13.7252 0 0 0 0 13.80559 0 0 17.39083 13.73381 0 0 15.95369 0 13.38857 17.06858 0 0 10.11093 A0A494C0Y3 F246A_HUMAN Protein FAM246A FAM246A Homo sapiens (Human) KMPVPPGAPQGGGD 8.800000191 0.278048038 0.278048038 0.299873158 1323.787819 17.4385 0 13.51969 0 0 15.31807 0 13.16129 0 0 0 0 0 0 0 14.90479 0 13.2731 0 0 0 0 0 0 0 13.68831 14.3947 0 0 0 14.66708 0 0 0 12.9426 15.95532 0 0 15.07131 0 0 0 0 0 0 0 16.91343 0 A0A597 TVB55_HUMAN T cell receptor beta variable 5-5 TRBV5-5 TCRBV5S3A2T Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 CSPISGHK 11.53999996 0.788945615 0.788945615 0.292939921 886.1452753 16.53169 16.35268 16.01501 15.95975 13.76126 14.53726 20.17412 17.96677 0 0 17.71358 16.95346 18.46956 0 16.8812 0 0 17.82322 16.94129 18.76507 0 18.92608 0 0 16.90764 18.32623 0 18.49108 0 0 19.52093 0 18.59827 0 20.18725 16.82437 17.90053 17.7225 19.67634 17.9172 18.70712 18.72974 16.78627 0 17.17003 17.37785 17.37678 0 A0A5B0 TVB14_HUMAN T cell receptor beta variable 14 TRBV14 TCRBV14S1 TCRBV16S1A1N1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 MVSRLLSLVSLCLLGAK 3.029999971 1 1 0.281524603 1876.781226 15.08823 13.57381 13.66719 12.56986 14.12491 0 0 15.35092 17.04025 10.95154 13.07969 14.81857 0 0 0 0 0 0 0 0 0 0 0 0 14.96665 15.8278 0 0 0 15.78165 18.18351 0 0 0 15.53665 0 15.81837 0 0 14.97909 0 0 0 0 0 0 0 0 A0A6I8PU40 TUG1_HUMAN Taurine up-regulated 1 protein TUG1 Homo sapiens (Human) MARPPPLPGLVGR 7.079999924 0.166711196 0.166711196 0.080164934 1360.300755 0 0 12.44546 0 12.87915 0 0 0 14.49553 0 0 0 0 0 0 0 0 0 15.23122 0 15.96805 0 9.430932 0 0 0 6.840987 0 0 0 12.40392 12.4472 0 0 0 0 9.557524 0 0 0 0 0 0 0 0 0 0 16.06664 A0AV96 RBM47_HUMAN RNA-binding protein 47 (RNA-binding motif protein 47) RBM47 Homo sapiens (Human) cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244] nucleus [GO:0005634] nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0002244; GO:0003723; GO:0003729; GO:0005634; GO:0016554 MTAEDSTAAMSSDSAAGSSAK 3.960000038 0.39916116 0.39916116 0.283608123 1993.88282 20.30738 0 0 0 0 17.42152 17.65883 0 0 18.19792 16.97724 0 20.44456 15.30211 15.60723 0 0 0 15.08804 13.00573 0 0 15.36015 16.19187 17.04393 0 17.28209 0 0 0 0 17.09189 0 0 0 0 0 0 0 0 14.44423 15.92008 19.01426 0 0 15.49458 0 14.1361 A0AVF1 IFT56_HUMAN "Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26, TPR repeat protein 26)" TTC26 IFT56 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224] intraciliary transport particle B binding [GO:0120170] GO:0005813; GO:0005929; GO:0007224; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:0097546; GO:0120170; GO:1905198 GACVGIFQMIIAGR 6.570000172 1 1 0.163981689 1508.397049 17.93381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0AVI2 FR1L5_HUMAN Fer-1-like protein 5 FER1L5 Homo sapiens (Human) macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; myoblast fusion [GO:0007520]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; myoblast fusion [GO:0007520]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005544; GO:0006906; GO:0007009; GO:0007520; GO:0016021; GO:0030315; GO:0031410; GO:0033292; GO:0050765; GO:0061025 FKLQSFEPK 3.279999971 1 1 0.104177819 1123.026353 13.67752 13.88709 12.69868 15.90339 15.91791 11.96688 16.43657 15.36925 16.98139 16.07112 14.46484 13.98918 12.9353 13.73331 0 17.54781 13.13434 0 0 0 0 0 0 0 0 0 0 14.40839 0 0 16.67804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0AVI4 TM129_HUMAN "E3 ubiquitin-protein ligase TM129, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TM129)" TMEM129 Homo sapiens (Human) "protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0030970; GO:0046872; GO:0061630 VHVAQQQDVHLTVTESR 4.739999771 1 1 0.306957495 1945.964821 0 0 0 13.87542 0 0 14.14433 15.67191 0 14.17662 0 15.26043 13.80208 0 14.53329 0 0 0 13.59004 0 12.16041 0 0 0 0 15.16094 0 0 0 0 0 0 16.89958 0 0 0 0 0 0 15.19453 12.67785 14.85602 0 0 0 0 0 0 A0AVK6 E2F8_HUMAN "Transcription factor E2F8, E2F-8" E2F8 Homo sapiens (Human) cell cycle comprising mitosis without cytokinesis [GO:0033301]; cell population proliferation [GO:0008283]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell cycle comprising mitosis without cytokinesis [GO:0033301]; cell population proliferation [GO:0008283]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0008283; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837 ASMLEDSGSK 15.35999966 0.139118508 0.139118508 0.384726886 1041.214532 20.53287 19.1913 21.85538 0 0 17.54938 0 0 0 21.13665 17.12039 0 0 19.5743 0 0 0 21.63953 20.79122 20.06883 18.77578 19.93984 18.49837 19.67203 0 15.62886 0 19.8345 20.28217 19.7287 19.26091 0 0 0 19.7812 0 17.63366 18.71237 19.38963 0 0 0 0 19.7995 19.49987 18.52453 0 0 A0AVT1 UBA6_HUMAN "Ubiquitin-like modifier-activating enzyme 6, Ubiquitin-activating enzyme 6, EC 6.2.1.45 (Monocyte protein 4, MOP-4) (Ubiquitin-activating enzyme E1-like protein 2, E1-L2)" UBA6 MOP4 UBE1L2 Homo sapiens (Human) amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839] GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996 LVKPTTEKK 4.96999979 0.8183496 0.8183496 0.214377868 1044.559942 16.16804 16.35231 15.76476 15.21173 15.5418 15.212 16.65087 16.64712 16.58238 0 15.96074 17.30331 16.09184 16.08931 14.85091 16.81007 15.42741 14.79538 17.35321 0 0 17.00586 17.22384 14.56826 0 16.86677 0 15.89811 16.46039 16.23279 17.375 0 0 15.71182 16.34906 16.13327 16.7453 0 0 15.97852 0 0 0 16.43195 0 15.80832 0 0 A0FGR8 ESYT2_HUMAN "Extended synaptotagmin-2, E-Syt2 (Chr2Syt)" ESYT2 FAM62B KIAA1228 Homo sapiens (Human) endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268 NLPSGK 7.760000229 1 1 0.21725766 613.6515677 11.62361 14.12875 14.47861 0 0 0 14.05219 0 0 0 0 15.32149 0 14.98195 14.34821 0 0 0 0 0 0 0 0 0 0 14.41327 0 15.86929 16.11488 11.20796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47516 A0JNW5 UH1BL_HUMAN UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa) UHRF1BP1L KIAA0701 SHIP164 Homo sapiens (Human) cytosol [GO:0005829]; early endosome [GO:0005769] cytosol [GO:0005829]; early endosome [GO:0005769]; GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803] GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803] GO:0005769; GO:0005829; GO:0042803; GO:0062069 GRPISFVDSFPLSIWICQPTRYAESQK 2.019999981 1 1 0 3181.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.98676 0 0 0 0 0 0 0 18.11209 0 A0MZ66 SHOT1_HUMAN Shootin-1 (Shootin1) SHTN1 KIAA1598 Homo sapiens (Human) "actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]" axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] "axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]" actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894] GO:0005737; GO:0005874; GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0019894; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0042802; GO:0043204; GO:0044295; GO:0045296; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224 TKPESSK 2.579999924 1 1 0.207731751 776.5435593 16.17865 0 0 12.99955 0 13.53806 0 15.25147 15.3333 15.66459 14.68516 0 15.55389 0 0 13.05081 14.21447 0 16.69025 16.51513 0 0 0 11.70894 16.37174 0 15.73931 0 15.87999 0 0 0 16.32718 14.84394 14.83057 0 17.57141 16.12551 0 15.55762 0 0 0 16.38338 16.20442 15.45835 15.78212 16.2693 A0PJE2 DHR12_HUMAN "Dehydrogenase/reductase SDR family member 12, EC 1.1.-.- (Short-chain dehydrogenase/reductase family 40C member 1, Protein SDR40C1)" DHRS12 SDR40C1 Homo sapiens (Human) oxidoreductase activity [GO:0016491] oxidoreductase activity [GO:0016491] GO:0016491 GGTVHLVCR 6.239999771 0.141194582 0.141194582 0.073759601 998.7693636 0 14.37627 0 0 10.8982 12.77629 0 16.3408 0 0 14.9335 16.8084 16.6728 0 0 0 0 0 0 0 13.25226 0 15.34347 13.54346 0 13.01444 15.85836 0 11.88207 13.20293 16.98132 0 17.25992 10.48965 17.11856 0 0 16.69226 15.63989 11.76221 0 15.51622 14.99971 0 0 0 16.60812 0 A0PJY2 FEZF1_HUMAN Fez family zinc finger protein 1 (Zinc finger protein 312B) FEZF1 FEZ ZNF312B Homo sapiens (Human) "axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of cell population proliferation [GO:0008285]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of cell population proliferation [GO:0008285]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0001764; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0007411; GO:0008285; GO:0021772; GO:0021797; GO:0043697; GO:0045666; GO:0045893; GO:0046872; GO:0050767 MLATAPARGNMMSTSKPLAFSIER 4.599999905 0.043800537 0.043800537 4.57E-12 2595.987185 0 0 0 0 0 0 14.14896 15.42412 15.27211 0 0 14.70186 0 15.935 15.20076 0 0 14.81726 14.4857 16.23131 0 16.64932 0 0 0 0 0 13.57942 15.15738 13.60692 0 16.11164 15.55439 16.17552 0 14.50152 17.64597 15.24478 0 0 0 16.3608 0 15.82014 0 0 0 0 A1A4S6 RHG10_HUMAN Rho GTPase-activating protein 10 (GTPase regulator associated with focal adhesion kinase 2) (Graf-related protein 2) (Rho-type GTPase-activating protein 10) ARHGAP10 GRAF2 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471; GO:0051056 LPEKNK 8.460000038 1 1 0.069019695 728.3432217 0 0 0 0 15.29021 0 12.56044 15.90259 14.58674 15.08676 17.32024 15.82417 0 0 13.74117 0 0 15.48609 14.9646 0 17.00255 0 0 0 14.97877 0 0 0 15.98325 0 0 0 0 0 0 0 16.17976 0 0 0 15.777 15.65291 15.01882 0 0 0 0 0 A1A4V9 CF119_HUMAN Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189) CFAP119 C16orf93 CCDC189 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] GO:0001669; GO:0005737; GO:0097228 TQWTTAAAAK 8.300000191 1 1 0.216882662 1048.038001 0 0 15.4015 14.1413 15.06614 0 0 0 0 0 15.42415 0 15.61818 0 14.64054 15.67482 16.39258 15.20983 0 0 0 0 0 0 14.77094 0 15.04083 15.48927 0 0 0 12.14623 0 0 15.93377 15.64406 16.09449 16.36305 13.47864 14.43302 0 10.31929 0 0 0 16.05728 0 0 A1A4Y4 IRGM_HUMAN "Immunity-related GTPase family M protein, EC 3.6.5.- (Immunity-related GTPase family M protein 1) (Interferon-inducible protein 1) (LPS-stimulated RAW 264.7 macrophage protein 47 homolog, LRG-47)" IRGM IFI1 IRGM1 LRG47 Homo sapiens (Human) autophagosome assembly [GO:0000045]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein destabilization [GO:0031648]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254] autophagosome membrane [GO:0000421]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670] autophagosome membrane [GO:0000421]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; BH3 domain binding [GO:0051434]; CARD domain binding [GO:0050700]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; autophagosome assembly [GO:0000045]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein destabilization [GO:0031648]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254] BH3 domain binding [GO:0051434]; CARD domain binding [GO:0050700]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] GO:0000045; GO:0000139; GO:0000421; GO:0001891; GO:0001934; GO:0003924; GO:0005525; GO:0005739; GO:0005789; GO:0005794; GO:0005829; GO:0006952; GO:0006954; GO:0010508; GO:0010800; GO:0019901; GO:0030670; GO:0031648; GO:0033138; GO:0035458; GO:0042742; GO:0042995; GO:0043254; GO:0043539; GO:0045087; GO:0050700; GO:0050821; GO:0050829; GO:0051434; GO:0060335; GO:0061635; GO:0061739; GO:0061762; GO:0070431; GO:0071222; GO:0071902; GO:0098586; GO:1901098 ERVCEY 7.019999981 1 1 0.195906937 856.2720582 15.41917 0 0 0 0 0 14.01679 17.26504 14.55412 15.41395 13.9539 14.75052 0 0 0 15.03497 12.05373 0 0 13.40378 0 15.0405 14.33577 14.84498 0 0 0 0 0 0 0 16.21088 15.02711 0 0 0 0 0 0 0 0 16.13582 16.05422 0 15.5595 0 15.63367 0 A1A519 F170A_HUMAN Protein FAM170A (Zinc finger domain-containing protein) (Zinc finger protein ZNFD) FAM170A ZNFD Homo sapiens (Human) "fertilization [GO:0009566]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]" DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0006366; GO:0009566; GO:0045893; GO:0046872 TESDSLPGSPTVEDTPRAK 3.00999999 1 1 0.341590115 1986.948098 12.58829 0 0 0 0 0 14.81105 0 13.02555 14.9859 16.76876 14.41865 0 15.98766 11.02969 15.46556 13.79746 0 0 0 0 0 0 0 0 0 0 0 0 14.88865 15.87484 0 0 0 0 0 16.01026 16.13263 0 0 0 0 0 0 15.79629 0 15.26178 0 A1A5B4 ANO9_HUMAN Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein) ANO9 PIG5 TMEM16J TP53I5 Homo sapiens (Human) calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; lipid metabolic process [GO:0006629]; negative regulation of intracellular calcium activated chloride channel activity [GO:1902939]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; lipid metabolic process [GO:0006629]; negative regulation of intracellular calcium activated chloride channel activity [GO:1902939]; transmembrane transport [GO:0055085] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128] GO:0005229; GO:0005254; GO:0005886; GO:0006629; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476; GO:1902939 ASESGHLPR 9.649999619 0.103742748 0.103742748 0.131948129 952.9971069 14.64713 15.48471 0 16.55801 11.41907 0 15.73203 12.69911 12.38479 17.24275 0 0 0 16.68717 0 13.85273 18.74382 0 13.18059 14.6723 0 0 14.90468 15.03047 0 17.5304 19.48743 0 15.45189 15.82766 0 17.55774 18.16264 17.60257 17.28562 0 16.43819 0 12.03165 15.55299 0 13.71249 0 0 0 17.41799 0 0 A1A5C7 S22AN_HUMAN Solute carrier family 22 member 23 SLC22A23 C6orf85 Homo sapiens (Human) ion transport [GO:0006811] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811] transmembrane transporter activity [GO:0022857] GO:0006811; GO:0016021; GO:0022857 EAAGGGPGR 3.289999962 1 1 0.187726706 772.2212356 17.609 15.26154 15.36445 0 0 0 11.20128 14.43276 15.0811 14.68434 12.1776 16.57094 0 0 0 0 15.69902 0 0 11.7747 17.11883 0 0 0 14.44093 15.86691 15.61179 0 0 15.90651 0 0 0 17.74158 16.25851 16.02075 0 0 0 14.32741 16.41571 0 0 0 0 17.18114 15.41113 0 A1A5D9 BICL2_HUMAN "BICD family-like cargo adapter 2 (Bicaudal D-related protein 2, BICD-related protein 2, BICDR-2) (Coiled-coil domain-containing protein 64B)" BICDL2 BICDR2 CCDC64B Homo sapiens (Human) Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; small GTPase binding [GO:0031267]; Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496] small GTPase binding [GO:0031267] GO:0005737; GO:0031267; GO:0047496; GO:0055107 AAPRFSLR 7.289999962 1 1 0.216361344 916.840243 13.2343 14.34038 16.01102 11.69506 14.6019 15.20889 14.06999 11.23213 13.25799 12.26713 13.95313 13.44678 13.75116 14.83457 13.40174 14.78572 14.37244 13.44248 14.62726 11.97396 16.84541 15.60681 16.5541 16.04742 13.63741 15.29631 16.17095 15.54323 15.97823 14.4657 14.52387 0 0 0 0 15.22314 15.83916 0 0 15.98908 13.4717 14.43016 0 15.71654 0 15.26762 15.35742 0 A1IGU5 ARH37_HUMAN Rho guanine nucleotide exchange factor 37 ARHGEF37 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737 EVASK 3.170000076 1 1 0.221867878 533.9811317 0 0 15.92806 0 0 14.96478 0 0 0 0 0 15.98636 14.50737 0 14.74123 0 0 0 0 14.05705 0 14.07697 0 0 0 15.49493 14.46897 15.74992 14.39499 14.26431 0 0 0 0 0 0 0 0 16.68985 12.16486 15.49042 14.04573 14.96758 15.83628 15.77877 0 0 0 A1KZ92 PXDNL_HUMAN "Probable oxidoreductase PXDNL, EC 1.-.-.- (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1, PRM1) (Vascular peroxidase 2)" PXDNL VPO2 Homo sapiens (Human) hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] GO:0004519; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0042744; GO:0046872 AVTQESQK 5.050000191 0.356054187 0.356054187 0.073954417 890.2437849 14.0408 0 14.92086 14.91299 12.74744 13.9752 0 17.90471 13.72242 16.94635 16.43443 15.30259 15.09041 13.02516 14.49236 12.62373 0 15.85438 17.47575 13.91529 14.73457 14.75422 0 17.80371 17.93377 13.37703 0 0 15.62978 14.92733 13.65912 16.57411 0 0 15.9368 0 16.40602 17.36977 14.96469 15.57284 0 12.95099 12.8469 12.06086 14.67761 16.57378 15.49675 15.67131 A1L020 MEX3A_HUMAN RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4) MEX3A RKHD4 Homo sapiens (Human) cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005634; GO:0005829; GO:0046872 DPVFEITGAPGNVER 3.650000095 0.354120851 0.354120851 0.312956575 1601.994673 10.47255 13.44928 0 14.73938 13.51907 0 15.01794 13.32119 11.44918 13.67868 13.34129 12.90446 0 0 0 0 0 0 15.34689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98869 16.67191 0 16.47955 15.84753 0 13.8876 0 15.90488 0 0 0 A1L168 CT202_HUMAN Uncharacterized protein C20orf202 C20orf202 Homo sapiens (Human) ARAGSEGR 10.46000004 1 1 0.033932582 803.7330177 0 0 12.88437 0 14.81778 0 9.712662 16.74325 0 16.24887 15.87282 14.60371 0 0 14.69112 15.02308 14.50853 13.95179 0 0 0 0 0 15.76247 0 15.56892 0 0 0 0 15.77053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L188 NDUF8_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8 NDUFAF8 C17orf89 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005739; GO:0032981 LAACGAEAAAYGR 14.77000046 1 1 0.992143861 1283.510197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.79205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L190 SYCE3_HUMAN "Synaptonemal complex central element protein 3 (Testis highly expressed gene 2 protein, THEG-2)" SYCE3 C22orf41 THEG2 Homo sapiens (Human) cell division [GO:0051301]; positive regulation of apoptotic process [GO:0043065]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694]; nucleus [GO:0005634] central element [GO:0000801]; chromosome [GO:0005694]; nucleus [GO:0005634]; cell division [GO:0051301]; positive regulation of apoptotic process [GO:0043065]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0000801; GO:0005634; GO:0005694; GO:0007130; GO:0007131; GO:0007283; GO:0043065; GO:0051301 NYDNMLKMLSDLNK 3.950000048 1 1 0.162791612 1731.174911 16.13183 0 0 0 0 14.72727 17.45775 0 13.5606 14.9889 0 16.301 0 0 0 0 0 0 0 0 13.73249 0 0 0 0 17.59337 0 0 0 0 0 0 0 0 0 0 0 0 0 14.38114 0 0 0 0 0 0 0 0 A1L390 PKHG3_HUMAN "Pleckstrin homology domain-containing family G member 3, PH domain-containing family G member 3" PLEKHG3 KIAA0599 Homo sapiens (Human) regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114]; regulation of small GTPase mediated signal transduction [GO:0051056] actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0003779; GO:0005085; GO:0005829; GO:0030334; GO:0051056; GO:2000114 GPLSPFNSRAAAGPAHHK 3.579999924 1 1 0.266146251 1815.352403 0 0 15.31778 0 0 0 0 0 0 0 17.12459 0 0 0 0 0 0 0 0 0 16.11651 0 0 0 0 19.28222 0 17.51709 0 0 0 0 0 0 0 0 16.4879 0 0 0 0 0 0 0 0 0 0 0 A1L4H1 SRCRL_HUMAN "Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (Soluble scavenger protein with 5 SRCR domains, SSc5D)" SSC5D Homo sapiens (Human) defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; negative regulation of interleukin-8 production [GO:0032717] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; negative regulation of interleukin-8 production [GO:0032717] extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044] GO:0001968; GO:0005044; GO:0005615; GO:0005737; GO:0006952; GO:0016020; GO:0031012; GO:0032717; GO:0042494; GO:0043236; GO:0045087; GO:0050829; GO:0050830; GO:0050840; GO:0062023 GNEGQLGLCHHRGWK 6.210000038 0.595434546 0.595434546 0.344433963 1742.580537 0 0 17.62888 0 0 0 0 0 18.0416 18.79328 0 0 16.75109 0 18.56538 18.45011 0 0 0 0 0 0 0 0 0 19.21157 0 0 0 0 17.01679 0 18.41089 0 0 0 0 0 0 0 0 0 0 16.57303 20.50018 0 14.95892 0 A1L4Q6 YK033_HUMAN Putative uncharacterized protein FLJ41423 Homo sapiens (Human) ESANIY 9.619999886 1 1 3.45E-13 696.2469346 16.24293 16.65793 17.27474 0 0 0 15.80423 0 0 15.83362 15.77911 14.25722 0 15.61471 0 0 0 0 0 0 0 0 0 0 0 0 16.65487 0 16.3921 0 0 16.21854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.77762 0 A1X283 SPD2B_HUMAN SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains) SH3PXD2B FAD49 KIAA1295 TKS4 Homo sapiens (Human) adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102] "cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]" "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]" GO:0001501; GO:0001654; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0016176; GO:0022617; GO:0030054; GO:0030154; GO:0032266; GO:0042169; GO:0042554; GO:0042995; GO:0060348; GO:0060612; GO:0071800; GO:0072657; GO:0080025 DMTIPR 12.80000019 0.173970878 0.173970878 0.296247148 747.8044759 13.11675 16.39484 14.64177 0 0 0 0 18.75586 0 18.49334 0 0 0 16.65737 16.93879 0 0 0 0 0 0 17.71305 16.46326 16.96548 18.36288 0 18.01908 0 0 0 19.797 0 0 0 17.06437 0 17.94978 0 0 0 0 16.54335 0 17.20559 0 17.33347 17.74364 0 A1XBS5 CBAR1_HUMAN CBY1-interacting BAR domain-containing protein 1 CIBAR1 FAM92A FAM92A1 Homo sapiens (Human) cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; limb morphogenesis [GO:0035108]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; limb morphogenesis [GO:0035108]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; positive regulation of smoothened signaling pathway [GO:0045880] phospholipid binding [GO:0005543] GO:0005543; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0007007; GO:0019898; GO:0030061; GO:0035108; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0061024; GO:0097546; GO:0097749 AAMDASRTSR 4.800000191 0.223158553 0.223158553 0.081356608 1078.24722 14.72463 15.2528 0 0 13.59716 14.73238 0 0 13.82918 16.22142 13.63335 0 0 16.37616 13.59553 14.29156 17.36684 13.01326 0 0 0 0 16.02608 13.47409 11.90752 16.9252 15.89842 14.83307 15.56887 13.4733 14.39057 14.87474 13.19381 14.53525 13.90917 0 14.61327 12.68223 11.33176 0 14.76627 17.04876 14.39242 16.00519 13.63347 0 12.249 14.4413 A1Z1Q3 MACD2_HUMAN "ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2, EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2, EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2, EC 3.2.2.-)" MACROD2 C20orf133 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]" "ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]" GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293 GHINGSHK 2.25 1 1 0.315675442 849.0555487 0 0 14.69435 14.62041 14.97582 0 0 0 11.30677 14.35029 0 13.05004 14.96369 13.14739 0 0 0 0 0 0 0 0 15.66665 0 0 0 0 0 0 0 0 15.39559 0 0 0 0 0 0 0 0 0 0 0 15.18622 0 0 0 0 A2A288 ZC12D_HUMAN "Probable ribonuclease ZC3H12D, EC 3.1.-.- (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34)" ZC3H12D C6orf95 MCPIP4 TFL Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729] GO:0000932; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0006402; GO:0030308; GO:0036464; GO:0046872; GO:0061158; GO:0090502; GO:2000134 ETFSCR 9.760000229 1 1 0.239426734 799.1964933 0 0 0 0 0 0 0 0 17.63989 0 0 0 16.61049 0 0 0 0 0 0 0 14.94452 0 0 0 0 17.45639 0 0 16.18031 0 0 0 0 0 0 0 20.2841 0 0 0 0 0 0 0 0 0 0 0 A2A2Y4 FRMD3_HUMAN "FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1, 4.1O)" FRMD3 EPB41L4O Homo sapiens (Human) actomyosin structure organization [GO:0031032] cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021] cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032] cytoskeletal protein binding [GO:0008092] GO:0005856; GO:0008092; GO:0016021; GO:0031032 TFYVIGTQK 2.920000076 1 1 0.163749147 1052.790821 14.94924 0 13.07766 0 0 14.89362 16.24947 13.15609 14.95382 0 0 15.0786 0 0 13.29253 0 0 15.34901 0 0 0 15.03237 0 0 0 0 15.86803 0 0 0 0 0 0 0 14.95685 0 0 0 0 0 0 0 0 0 0 0 0 0 A2A2Z9 AN18B_HUMAN Ankyrin repeat domain-containing protein 18B ANKRD18B Homo sapiens (Human) EAVSSK 18.92000008 0.933404326 0.933404326 0.130946108 620.5477314 18.60105 0 14.8748 16.15679 0 16.27979 0 15.82138 0 0 0 15.57333 0 15.91129 0 15.06371 14.98931 0 0 17.02697 15.40057 0 0 15.91025 16.75596 0 0 14.98564 0 0 17.03986 14.55133 16.13035 16.07901 16.49483 16.16995 18.3714 16.92358 16.72208 0 0 0 16.36114 0 14.67857 0 0 0 A2A3K4 PTPC1_HUMAN "Protein tyrosine phosphatase domain-containing protein 1, EC 3.1.3.-" PTPDC1 PTP9Q22 Homo sapiens (Human) cilium assembly [GO:0060271] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271] protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0004725; GO:0005654; GO:0005737; GO:0008138; GO:0060271 MTKDGPKPGL 6.679999828 1 1 0.182569943 1038.447317 0 13.88665 13.60469 15.42124 14.95466 13.03576 0 0 13.08156 0 0 0 12.72188 0 16.59147 0 0 0 0 13.81463 14.20037 0 0 0 16.39108 0 0 0 0 0 0 0 15.60198 0 0 0 0 16.48638 0 0 0 0 0 15.42942 0 0 0 0 A2A3L6 TTC24_HUMAN "Tetratricopeptide repeat protein 24, TPR repeat protein 24" TTC24 Homo sapiens (Human) AGSSTAGVQHR 3.599999905 0.881621897 0.881621897 0.231626609 1071.336022 0 16.4122 9.497762 16.01972 0 0 12.63236 15.56734 14.46931 12.09472 16.59638 14.74228 0 15.14677 0 0 0 17.38365 0 0 0 0 16.04472 15.54009 17.74489 17.17655 15.62541 13.99676 13.15039 15.414 17.60344 15.85631 0 0 0 0 0 0 17.37563 0 0 15.63522 0 0 0 14.06132 13.63074 0 A2A3N6 PIPSL_HUMAN "Putative PIP5K1A and PSMD4-like protein, PIP5K1A-PSMD4" PIPSL PSMD4P2 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308] GO:0005737; GO:0005886; GO:0016308; GO:0046854 ILSKLHTVQPK 4.639999866 1 1 0.295428492 1261.099857 14.57419 0 13.05337 0 17.68271 0 0 0 0 0 14.62811 0 0 0 0 14.06872 15.96474 0 16.92558 0 0 0 0 0 0 0 0 0 0 0 0 0 15.04564 0 0 14.39993 0 0 0 0 0 0 0 0 0 0 0 0 A2AJT9 BCLA3_HUMAN BCLAF1 and THRAP3 family member 3 BCLAF3 CXorf23 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592]; mitochondrion [GO:0005739] mediator complex [GO:0016592]; mitochondrion [GO:0005739]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944] DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712] GO:0003677; GO:0003712; GO:0005739; GO:0016592; GO:0045944 IDMSLAELQSK 4.179999828 1 1 4.63E-13 1250.444382 14.38478 18.85734 16.74693 15.54262 16.83746 16.75899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2CJ06 DYTN_HUMAN Dystrotelin DYTN Homo sapiens (Human) synaptic signaling [GO:0099536] plasma membrane [GO:0005886]; synapse [GO:0045202] plasma membrane [GO:0005886]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536] zinc ion binding [GO:0008270] GO:0005886; GO:0008270; GO:0045202; GO:0099536 HSLSVQQLSQALQELFQK 2.309999943 1 1 0 2085.198735 14.129 15.3726 16.26562 12.38431 0 13.48889 13.85357 0 13.40771 15.64775 15.7579 15.1812 0 0 14.01474 14.64751 14.0282 13.89776 14.30857 0 15.33645 0 13.48514 14.20953 0 0 0 0 0 0 0 0 0 0 15.82677 0 0 0 0 0 0 0 0 0 14.75678 0 0 0 A2PYH4 HFM1_HUMAN "Probable ATP-dependent DNA helicase HFM1, EC 3.6.4.12 (SEC63 domain-containing protein 1)" HFM1 SEC3D1 Homo sapiens (Human) resolution of meiotic recombination intermediates [GO:0000712] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; resolution of meiotic recombination intermediates [GO:0000712] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676] GO:0000712; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0016887 MDEGVNFKPTEAGR 1.169999957 1 1 0.277729485 1567.072827 17.11378 11.68988 15.03869 16.60143 16.06363 0 0 16.30864 0 0 0 0 16.15615 0 0 0 0 0 0 0 0 0 0 0 15.24074 0 0 0 0 0 0 15.00545 0 0 0 0 18.61054 0 0 0 0 0 0 0 0 16.79811 16.60444 16.68566 A2RRH5 WDR27_HUMAN WD repeat-containing protein 27 WDR27 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 GHHQPITAMAFGNK 3.609999895 1 1 0.679789982 1522.988092 0 0 17.25338 0 0 0 17.37022 0 17.70864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.33973 0 0 19.44685 0 0 0 0 0 0 0 0 A2RTX5 SYTC2_HUMAN "Threonine--tRNA ligase 2, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase protein 3)" TARS3 TARSL2 Homo sapiens (Human) threonyl-tRNA aminoacylation [GO:0006435] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435] ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829] GO:0004829; GO:0005524; GO:0005634; GO:0005737; GO:0006435 DTFALKPMNCPGHCLMFAHRPR 2.440000057 1 1 0 2671.164125 17.05153 0 14.25645 15.50331 15.20101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RTY3 HEAT9_HUMAN Protein HEATR9 (HEAT repeat-containing protein 9) HEATR9 C17orf66 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244 AMAPVHLPLSCYQMPK 3.369999886 1 1 0.649516581 1860.785451 0 0 0 0 0 0 0 0 17.35979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.49438 0 0 17.84462 0 0 18.13969 0 0 0 18.22131 0 0 0 17.04865 0 0 0 0 0 16.97823 0 A2RU54 HMX2_HUMAN Homeobox protein HMX2 (Homeobox protein H6 family member 2) HMX2 Homo sapiens (Human) "brain development [GO:0007420]; cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0008284; GO:0030154; GO:0042472; GO:0048026; GO:1990837 GSGGSGPGGLER 7.119999886 0.597261727 0.597261727 0.137885066 1031.433307 0 0 0 0 0 15.25308 0 0 16.02114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RU67 F234B_HUMAN Protein FAM234B FAM234B KIAA1467 Homo sapiens (Human) cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] GO:0005794; GO:0005856; GO:0016021 DVLLSFVMSR 1.220000029 1 1 0.336080741 1165.89294 15.62966 14.25131 15.85483 13.93993 15.99237 16.14038 14.16025 15.06665 15.50449 0 15.48071 15.29204 14.10013 13.48032 14.96067 16.01269 15.82813 0 13.58026 16.49452 0 0 0 0 15.57507 0 0 0 15.21219 0 16.84938 15.61596 0 0 14.25956 0 15.25188 0 0 12.85561 16.90848 16.05303 0 0 16.86896 0 14.58844 0 A2RUB1 MEIOC_HUMAN Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein) MEIOC C17orf104 Homo sapiens (Human) "chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]" GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192 CQDDRDVFALASAIK 3.420000076 1 1 0.040452894 1707.648323 12.58715 13.10491 0 14.18598 0 0 0 0 0 0 0 0 0 0 15.50965 12.30912 0 0 0 0 16.75012 0 0 15.01406 0 0 0 0 0 0 13.90594 0 0 14.90679 0 15.7295 0 0 0 0 0 0 16.41993 0 0 0 0 0 A2RUB6 CCD66_HUMAN Coiled-coil domain-containing protein 66 CCDC66 Homo sapiens (Human) cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] GO:0001578; GO:0001750; GO:0001895; GO:0001917; GO:0005813; GO:0005829; GO:0005874; GO:0005929; GO:0008017; GO:0030054; GO:0034451; GO:0036064; GO:0042803; GO:0050908; GO:0060271; GO:0090543; GO:1903564 NLGVDTIQMEYNASNISNSR 1.450000048 1 1 1.37E-12 2226.33067 14.14869 12.90715 14.09523 0 0 0 0 0 0 0 0 0 9.897771 14.65409 12.8778 13.15175 8.550488 0 0 0 0 13.318 16.03625 15.84624 0 10.65304 0 14.40549 10.57791 14.73013 12.98808 13.83479 0 15.30573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RUR9 C144A_HUMAN Coiled-coil domain-containing protein 144A CCDC144A KIAA0565 Homo sapiens (Human) GKAEWHK 3.789999962 0.876722813 0.876722813 0.232512896 854.9397215 15.04631 15.56561 13.54498 15.56741 14.78235 15.29297 0 12.61272 17.045 16.46 16.76396 15.62321 17.14299 12.7879 0 14.3066 0 15.11341 0 0 0 15.37281 0 15.9348 16.50292 0 16.21767 0 0 0 17.29086 0 16.3486 0 0 0 15.87206 0 15.85531 0 14.72565 0 0 0 15.38492 0 15.6109 0 A2RUS2 DEND3_HUMAN DENN domain-containing protein 3 DENND3 KIAA0870 Homo sapiens (Human) cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]; regulation of Rab protein signal transduction [GO:0032483] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0008333; GO:0031410; GO:0032483; GO:0044257 IAMTQKR 4.070000172 0.09183459 0.09183459 0.176154706 864.4831548 15.71687 15.84959 13.86378 0 0 0 0 14.05564 15.60273 0 14.09729 0 13.86272 14.35436 15.86283 14.8033 16.1027 0 0 17.12431 15.06397 0 15.63677 15.86743 14.30638 16.14124 13.34039 0 16.02427 14.45053 14.81764 15.82389 16.44383 14.22467 15.55572 15.74066 14.38484 0 15.05089 14.52005 13.78495 0 14.90937 14.23931 15.18496 0 13.22106 0 A2VDJ0 T131L_HUMAN Transmembrane protein 131-like TMEM131L KIAA0922 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055] GO:0005737; GO:0005783; GO:0005886; GO:0016020; GO:0016021; GO:0016055; GO:0033088; GO:0090090 LQMSIMVTMENFSK 8.960000038 1 1 0 1673.657861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2VEC9 SSPO_HUMAN SCO-spondin (SCO-spondin pseudogene) SSPOP KIAA2036 SSPO Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] peptidase inhibitor activity [GO:0030414] GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0030414; GO:0031012 GARAGAPCTR 5.239999771 0.638375401 0.638375401 0.20472217 1017.432011 14.55138 14.79624 0 14.89462 0 13.48416 13.86053 14.85557 0 15.5678 14.174 0 10.74764 0 16.62433 14.66051 12.65626 14.61222 0 0 14.78513 0 0 16.39954 0 12.57714 0 12.96221 13.8604 10.1062 17.42828 14.91265 16.05124 0 15.12681 14.27699 0 6.747334 15.3864 0 0 12.29297 14.18039 13.74603 13.33945 15.2736 14.46881 0 A3KMH1 VWA8_HUMAN "von Willebrand factor A domain-containing protein 8 (PEX7-binding protein 2, P7BP2)" VWA8 KIAA0564 Homo sapiens (Human) cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005737; GO:0005739; GO:0005777; GO:0016887 FPTEGLSSVVR 8.539999962 1 1 0.22658992 1195.321136 16.07634 15.09169 0 0 0 0 0 0 12.29649 0 0 0 0 0 0 15.61897 0 0 0 0 16.06481 0 16.82323 0 0 0 0 0 0 0 0 0 0 0 0 0 16.52833 0 0 0 0 0 0 0 0 0 0 15.07829 A3KN83 SBNO1_HUMAN "Protein strawberry notch homolog 1 (Monocyte protein 3, MOP-3)" SBNO1 MOP3 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]" chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] GO:0005634; GO:0006355; GO:0031490; GO:0042393 KTAILVK 1.580000043 1 1 0.198866197 772.1208584 12.42166 14.58728 15.67041 12.49575 14.03249 0 14.79762 0 13.78198 0 14.91012 0 14.73385 15.43872 14.68081 0 0 0 0 17.26287 0 16.05584 0 0 0 0 0 0 0 0 0 16.44856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.12636 0 A4D0V7 CPED1_HUMAN Cadherin-like and PC-esterase domain-containing protein 1 CPED1 C7orf58 UNQ9432/PRO34713 Homo sapiens (Human) endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783] GO:0005783 EAIGK 5.820000172 1 1 0.287236655 517.0019511 17.08821 16.05812 15.20866 0 15.47127 16.41848 16.13487 0 0 0 0 0 0 15.14401 0 16.41259 15.82397 14.76059 15.76425 16.35854 0 17.85095 16.51053 14.81077 15.8417 16.32357 16.10883 15.28972 0 0 15.65664 17.2399 0 15.3346 0 15.68129 0 0 0 16.38108 0 0 16.38554 17.84478 0 16.88498 0 16.84349 A4D1E1 Z804B_HUMAN Zinc finger protein 804B ZNF804B Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005634; GO:0046872 SPIYKTK 1.309999943 1 1 0.105509489 836.0512942 13.82108 0 0 11.48855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.91313 14.28906 0 0 0 0 15.28721 0 0 0 0 15.89584 0 0 0 0 0 0 0 0 0 A4D1E9 GTPBA_HUMAN "GTP-binding protein 10 (Protein obg homolog 2, ObgH2)" GTPBP10 OBGH2 UG0751c10 Homo sapiens (Human) ribosome biogenesis [GO:0042254] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723] GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254 GGSGGMGYPRLGGEGGK 5.849999905 1 1 0.222490103 1553.380233 0 0 14.88856 15.60253 11.63617 0 0 0 16.2739 0 13.59825 0 0 14.58985 12.68711 14.92707 14.42796 0 0 0 0 0 0 0 0 13.07572 0 0 0 0 0 0 0 0 0 0 0 15.88263 0 0 0 12.44697 0 0 14.20335 0 0 0 A4D1F6 LRRD1_HUMAN Leucine-rich repeat and death domain-containing protein 1 LRRD1 Homo sapiens (Human) positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] GO:0007165; GO:0046579 HIPDTLPSLKTLR 5.599999905 1 1 4.59E-13 1492.01281 14.82571 12.33939 0 0 15.20228 0 12.92282 12.74814 0 0 10.40572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.17306 0 0 0 0 0 A4D1P6 WDR91_HUMAN WD repeat-containing protein 91 WDR91 HSPC049 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551] phosphatidylinositol 3-kinase regulator activity [GO:0035014] GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022; GO:1903362 GMNQVPGR 2.529999971 0.417136431 0.417136431 0.273371809 859.4693061 17.87317 0 0 0 0 0 0 0 0 0 0 0 0 0 17.13094 0 0 17.48935 0 0 0 0 16.56307 0 0 0 0 0 17.06807 16.66547 0 18.77993 0 0 16.79729 0 0 17.75278 0 0 17.72512 17.58302 0 0 16.67068 16.69569 0 0 A4D1S5 RAB19_HUMAN Ras-related protein Rab-19 RAB19 RAB19B Homo sapiens (Human) autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886] endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000045; GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0012505; GO:0070062 RHVLFEDACTLAEK 28.59000015 0.404630452 0.404630452 0.291351155 1689.667792 0 0 0 20.14655 0 16.31305 0 16.74882 0 0 0 16.18052 17.9653 17.40619 0 0 16.70611 16.6448 0 15.72795 0 14.67858 0 18.69217 0 17.60491 0 14.53005 0 16.89556 18.20737 20.01436 0 18.22992 18.23231 17.8273 0 17.953 0 16.00717 18.16534 0 17.53359 17.401 0 19.0449 0 18.66321 A4D263 SPT48_HUMAN Spermatogenesis-associated protein 48 SPATA48 C7orf72 Homo sapiens (Human) spermatogenesis [GO:0007283] spermatogenesis [GO:0007283] GO:0007283 DVEIQDTPGKISISK 3.680000067 0.074209221 0.074209221 0.232088804 1628.267272 16.55417 0 0 0 17.49959 0 0 0 0 0 0 17.33026 0 0 0 0 0 0 17.35664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.27582 0 0 0 0 0 0 A4D2B8 PM2P1_HUMAN "Putative postmeiotic segregation increased 2-like protein 1 (PMS2-related protein 2) (Postmeiotic segregation increased 2-like protein 13) (Postmeiotic segregation increased 2-like protein 6) (Postmeiotic segregation increased 2-like protein 8) (Postmeiotic segregation increased protein 3, hPMS3) (Postmeiotic segregation increased protein 8) (Putative postmeiotic segregation increased 2 pseudogene 1)" PMS2P1 PMS2L1 PMS2L13 PMS2L6 PMS2L8 PMS3 PMS8 PMSR2 Homo sapiens (Human) mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446] mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389] mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446] ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301] GO:0006298; GO:0016301; GO:0016446; GO:0016887; GO:0032300; GO:0032389 SEVGGGAPR 2.829999924 0.834037304 0.834037304 0.235532583 829.2687629 15.29897 16.68394 0 0 13.63073 14.87466 15.76802 16.19801 0 0 15.32012 0 16.08125 0 0 14.56449 0 0 15.28524 0 0 0 15.08109 15.07758 0 0 0 0 0 14.54103 0 0 0 15.9169 0 17.14006 0 16.09706 0 14.71037 0 0 0 0 0 16.28759 0 0 A4D2P6 GRD2I_HUMAN "Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)" GRID2IP Homo sapiens (Human) long-term synaptic depression [GO:0060292] postsynaptic membrane [GO:0045211] postsynaptic membrane [GO:0045211]; long-term synaptic depression [GO:0060292] GO:0045211; GO:0060292 ATTSEAFFGIFAEFMSKFER 8.43999958 1 1 2.29E-12 2313.392658 16.07089 15.36391 12.57669 14.33297 15.05175 15.22934 16.13798 14.4837 0 16.67843 11.68079 0 0 13.45268 0 14.85665 9.521667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4FU69 EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 EFCAB5 Homo sapiens (Human) calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509 KISPGSIK 8.579999924 0.385222942 0.385222942 0.03139131 828.7492887 16.15382 16.25993 0 0 14.34909 15.01973 15.93755 0 0 18.20004 17.05896 13.89557 16.34796 0 11.08772 16.33194 0 0 17.48443 12.38068 18.29078 16.24703 15.07605 17.95971 17.9354 12.55374 14.03183 15.03114 12.28202 16.51721 16.1372 12.94692 10.26539 13.62469 15.26642 15.29569 0 0 10.33897 15.68813 15.51547 17.60641 15.30939 17.00941 16.23721 17.18212 15.00304 16.13425 A4GXA9 EME2_HUMAN "Probable crossover junction endonuclease EME2, EC 3.1.22.-" EME2 Homo sapiens (Human) double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596] endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] DNA binding [GO:0003677]; endonuclease activity [GO:0004519] GO:0000712; GO:0003677; GO:0004519; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0048476; GO:1905347 WAAGEPVAR 3.339999914 1 1 0.119815954 954.3025956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4UGR9 XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin) XIRP2 CMYA3 Homo sapiens (Human) actin filament organization [GO:0007015]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281] cell junction [GO:0030054]; Z disc [GO:0030018] cell junction [GO:0030054]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; actin filament organization [GO:0007015]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281] actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393] GO:0003281; GO:0007015; GO:0030018; GO:0030054; GO:0045216; GO:0051015; GO:0051393; GO:0055008 EERLITER 15.11999989 0.418958783 0.418958783 0.498726453 1046.092176 0 13.73549 16.02201 16.21125 14.42351 0 16.20896 0 14.48185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.14392 0 0 15.43065 0 0 0 0 0 16.82963 0 15.52787 0 17.18098 A5A3E0 POTEF_HUMAN POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein) POTEF A26C1B Homo sapiens (Human) retina homeostasis [GO:0001895] blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; retina homeostasis [GO:0001895] GO:0001895; GO:0005615; GO:0005938; GO:0070062; GO:0072562 SNVGTSGDHDDSAMKTLR 5.039999962 1 1 0.453044584 1906.693963 14.78692 0 0 0 0 10.43051 0 14.66862 17.43164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.29663 17.96177 14.42498 15.41258 0 18.94739 0 0 0 0 0 0 18.57545 0 0 0 0 0 0 0 0 17.49229 0 A5D6W6 FITM1_HUMAN Fat storage-inducing transmembrane protein 1 (Fat-inducing protein 1) FITM1 FIT1 Homo sapiens (Human) lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890] diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129] GO:0005789; GO:0008654; GO:0010890; GO:0017129; GO:0019915; GO:0019992; GO:0030176; GO:0034389; GO:0140042 MERGPVVGAGLGAGAR 6.53000021 1 1 9.17E-13 1513.977997 0 16.15307 0 0 15.85686 0 16.07098 0 0 0 15.69206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A5D8T8 CL18A_HUMAN C-type lectin domain family 18 member A (Mannose receptor-like protein 2) CLEC18A MRLP2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; polysaccharide binding [GO:0030247] polysaccharide binding [GO:0030247] GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0030247 TAKDSFR 5.360000134 0.612585425 0.612585425 0.210272245 823.5136237 0 16.88645 13.1903 0 0 0 15.4644 0 0 0 0 0 14.18511 0 0 0 6.391411 0 0 0 0 0 0 0 0 0 0 17.4243 0 0 15.42082 14.13507 0 0 0 0 0 15.92718 0 0 0 0 15.81668 0 16.85639 0 0 14.11484 A5D8W1 CFA69_HUMAN Cilia- and flagella-associated protein 69 CFAP69 C7orf63 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288] cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225] cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288] GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834 IVDAPK 11.28999996 3.28E-06 3.28E-06 0.259212823 642.6028012 19.5391 0 0 0 19.19231 0 18.44085 0 0 0 0 20.1252 0 19.79497 0 0 16.37245 0 0 0 18.00965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8352 0 0 0 0 0 A5LHX3 PSB11_HUMAN "Proteasome subunit beta type-11, EC 3.4.25.1 (Proteasome subunit beta-5t)" PSMB11 Homo sapiens (Human) "CD8-positive, alpha-beta T cell differentiation [GO:0043374]; proteasomal protein catabolic process [GO:0010498]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]" "cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; proteasomal protein catabolic process [GO:0010498]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]" endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298] GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0006508; GO:0008233; GO:0010498; GO:0019774; GO:0033077; GO:0043374 EGQLPSVASAAKLLSAMMSQYR 11.61999989 1 1 0.15259578 2339.109035 0 0 0 14.5877 0 0 0 0 0 0 14.00464 0 0 0 0 0 15.73302 0 0 13.30179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.62385 17.53146 0 0 0 0 0 0 15.75602 0 0 0 A5PKW4 PSD1_HUMAN "PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6, Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)" PSD EFA6 EFA6A KIAA2011 PSD1 TYL Homo sapiens (Human) neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165] "cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]" "cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165]" guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] GO:0005085; GO:0005543; GO:0007165; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092 MAQGAMRFCSEGDCAISPPR 1.950000048 0.129846215 0.129846215 0.08825089 2255.850054 0 0 12.13918 0 0 14.43622 0 0 0 0 0 0 0 0 16.43236 0 0 15.26328 12.11428 0 0 16.32874 0 0 15.87916 15.60594 0 0 0 0 10.00245 0 9.173341 14.76906 0 14.03612 0 16.05043 14.6901 0 0 13.01936 0 14.43223 15.07931 15.7064 16.25441 11.59948 A5PL33 KRBA1_HUMAN Protein KRBA1 KRBA1 KIAA1862 Homo sapiens (Human) DRLPSCKPPVPLSPCPGGTPAGSSGGSPGEDPR 3.970000029 0.327950239 0.327950239 0.20541693 3286.766514 11.97119 11.94875 14.29877 10.70786 14.16468 12.38512 14.9887 0 14.12791 0 0 0 13.84998 15.11408 9.74111 12.75795 0 10.79569 0 0 12.8241 0 14.86454 0 0 0 15.5733 0 0 0 0 0 0 0 0 0 13.10199 0 0 0 0 14.49438 11.64499 0 0 0 0 0 A5PLK6 RGSL_HUMAN Regulator of G-protein signaling protein-like RGSL1 RGSL RGSL2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AYNENDVILMR 18.28000069 1 1 0.276721652 1354.062878 0 15.18328 0 0 14.16842 0 15.02793 16.23873 15.69255 14.86456 0 14.7757 0 16.44631 0 0 0 16.37741 0 0 0 0 0 0 0 0 0 0 16.70001 0 15.74943 14.95686 0 0 0 0 0 0 0 0 0 0 0 14.59141 17.10958 0 16.88474 0 A5PLN7 F149A_HUMAN Protein FAM149A FAM149A MST119 Homo sapiens (Human) GTKLPTGVDHMASPLVQTSR 4.71999979 0.18483229 0.18483229 0.03254032 2112.074792 17.45589 0 0 14.79785 0 12.43161 0 11.6957 0 17.05522 14.44657 14.77157 13.71362 0 0 0 14.13009 0 13.84398 0 9.567242 12.42859 15.09862 13.95151 13.55552 0 0 0 0 0 13.14496 0 13.30974 0 16.92702 14.62048 0 0 12.81207 16.11081 0 0 9.996795 0 0 0 0 0 A5YKK6 CNOT1_HUMAN "CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog, NOT1H, hNOT1)" CNOT1 CDC39 KIAA1007 NOT1 AD-005 Homo sapiens (Human) "gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]" CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778] "CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]" armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723] GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036 EVFNCMLR 13.01000023 0.491984665 0.491984665 0.440207153 1085.375179 0 12.08351 0 0 0 0 0 0 0 15.85774 14.68942 0 0 0 0 15.93413 15.31248 16.70503 0 0 17.37124 15.69591 0 0 0 0 16.59997 12.29599 13.94083 0 16.75309 12.77501 0 0 15.03387 0 16.47886 17.37698 16.90693 15.72329 0 14.94792 14.8309 15.03824 16.0463 0 15.96192 17.35508 A6H8Y1 BDP1_HUMAN "Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150, TFIIIB150) (Transcription factor-like nuclear regulator)" BDP1 KIAA1241 KIAA1689 TFNR Homo sapiens (Human) RNA polymerase III preinitiation complex assembly [GO:0070898] nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126] nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126]; TFIIIC-class transcription factor complex binding [GO:0001156]; RNA polymerase III preinitiation complex assembly [GO:0070898] TFIIIC-class transcription factor complex binding [GO:0001156] GO:0000126; GO:0001156; GO:0005654; GO:0070898 ASKAMLVTLR 2.470000029 1 1 0.118960254 1105.284116 0 0 12.0338 0 0 0 15.38154 0 15.06787 11.67674 13.83973 14.01835 13.7204 14.54226 0 16.34611 0 0 0 14.02608 0 0 0 15.11552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NC05 YD286_HUMAN Glutaredoxin-like protein C5orf63 C5orf63 Homo sapiens (Human) DQKLPGTR 3.74000001 1 1 0.130294261 915.4522733 0 0 15.01904 10.75215 15.7813 0 14.29571 0 0 0 0 15.62305 0 0 15.64885 14.76607 0 0 0 0 15.94289 14.03293 15.52552 0 15.58121 0 15.07873 14.16326 16.21444 0 16.10467 0 12.85656 0 0 14.72432 11.48339 16.63829 0 0 0 13.8671 0 0 0 14.88493 0 14.56554 A6NC86 PINLY_HUMAN phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein PINLYP Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; phospholipase inhibitor activity [GO:0004859] phospholipase inhibitor activity [GO:0004859] GO:0004859; GO:0005576 DTCVLLVGK 8.020000458 1 1 0.416944302 1002.044256 14.19478 15.918 14.76458 15.05698 13.40218 12.11881 15.47089 14.61548 15.51632 15.46164 0 13.89104 14.95157 0 13.02827 15.79583 0 0 15.73341 0 0 0 0 0 0 15.01246 0 0 0 0 0 15.81392 15.67126 16.31782 0 15.68131 17.1546 17.06203 0 0 0 0 16.30454 15.50508 0 0 0 0 A6NC98 CC88B_HUMAN "Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3, HkRP3)" CCDC88B BRLZ Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; defense response to protozoan [GO:0042832]; positive regulation of cytokine production [GO:0001819]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; defense response to protozoan [GO:0042832]; positive regulation of cytokine production [GO:0001819]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102] dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017] GO:0001819; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0008017; GO:0016020; GO:0030705; GO:0031122; GO:0042102; GO:0042832; GO:0050870; GO:0051959 EALQAELEK 14.06000042 0.206523404 0.206523404 0.444928018 1032.124083 16.91401 0 0 0 0 0 0 0 0 0 0 0 0 16.96221 17.85966 17.22795 0 0 0 0 19.98166 0 0 0 0 15.9545 0 0 0 0 0 14.59222 14.34204 0 0 0 20.54925 0 0 20.17632 17.85209 17.04419 20.22662 0 0 18.07341 20.54432 0 A6NCF6 MA13P_HUMAN Putative MAGE domain-containing protein MAGEA13P MAGEA13P Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 KDPGASQALMLEK 6.46999979 1 1 0.584979251 1403.669119 0 0 0 18.35332 0 0 0 17.96779 19.16787 0 0 0 0 0 0 0 0 0 0 0 0 18.55125 0 0 0 18.0632 0 19.35016 0 0 0 0 0 0 0 19.97063 0 0 0 0 0 0 0 0 0 0 18.15805 0 A6NCI4 VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A VWA3A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AAGGRFHWFGDTGIYESDDINSIMSEMEK 4.929999828 1 1 3.65E-12 3264.18067 11.373 15.74816 14.32364 13.75675 13.74549 13.36641 0 11.55239 15.63938 0 0 13.32688 12.9427 14.31734 0 12.69025 12.33285 0 13.57477 14.97295 12.60282 13.44182 0 10.94248 14.82092 12.27582 12.99084 0 10.9224 0 0 0 0 0 0 0 0 0 0 0 14.47289 0 0 0 14.6702 0 0 0 A6NCI8 CB078_HUMAN Uncharacterized protein C2orf78 C2orf78 Homo sapiens (Human) QTIPNMK 6.840000153 1 1 0.205616858 848.1009329 0 16.12711 0 16.72078 0 0 8.892937 0 15.52646 0 15.77313 16.04332 15.81746 13.14435 0 14.20901 15.95267 14.79804 0 0 0 0 14.40567 0 0 14.81934 16.92329 15.72267 0 15.05703 15.80737 15.77765 17.08533 15.4363 0 0 15.50784 11.47069 0 15.2218 16.4729 13.74488 0 0 0 0 0 16.39422 A6NCJ1 CS071_HUMAN Uncharacterized protein C19orf71 C19orf71 Homo sapiens (Human) APASPFR 8.909999847 1 1 0.204184614 745.5926166 0 0 0 0 14.08391 0 0 0 0 0 0 16.31923 0 0 0 0 0 0 16.09463 0 0 0 15.5645 0 0 16.15246 16.20765 0 0 0 15.38224 0 0 0 0 0 15.80857 16.29938 16.69851 15.91622 0 0 0 0 0 0 0 16.54715 A6NCL7 AN33B_HUMAN Ankyrin repeat domain-containing protein 33B ANKRD33B Homo sapiens (Human) GPAAPAPR 6.25 0.001602429 0.001602429 0.274427389 737.2079293 0 0 0 0 0 0 18.04311 18.82317 0 16.84519 0 0 0 17.73303 0 0 17.30227 16.95893 0 17.54138 0 0 0 17.25422 0 0 0 0 0 0 0 0 0 0 0 0 18.52177 0 0 17.51339 17.87036 18.33102 0 0 0 17.23221 17.63046 0 A6NCM1 IQCAL_HUMAN IQ and AAA domain-containing protein 1-like (IQ and AAA domain-containing protein 1 pseudogene 1) IQCA1L IQCA1P1 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0016887 LGSPDIHIMAPLIRSILLVGPSGMGK 10.92000008 0.822773337 0.822773337 2.28E-12 2671.378585 15.22675 0 14.82195 0 0 15.54996 15.6291 0 0 0 0 12.92498 0 0 12.90179 0 0 14.2633 0 11.06259 14.53791 0 17.6562 0 14.1379 0 0 0 14.06245 0 16.34708 14.72296 13.8017 15.84036 11.33865 0 0 0 0 15.18003 15.02554 12.28013 0 13.54225 0 15.73142 0 15.42196 A6NCN8 TEX52_HUMAN Testis-expressed protein 52 TEX52 Homo sapiens (Human) TALPLHHLSKAQASK 1.220000029 1 1 0.34018531 1602.581964 0 16.2457 13.7189 9.963675 0 13.29748 0 11.63246 0 0 0 0 0 15.53591 0 0 15.68023 0 0 14.53962 15.98743 0 0 0 0 15.96838 0 16.96057 16.53927 0 16.86054 16.85925 0 0 0 0 16.08376 17.21077 16.04863 0 0 0 0 0 17.07965 16.28237 17.4778 17.31345 A6ND01 JUNO_HUMAN "Sperm-egg fusion protein Juno (Folate receptor 4) (Folate receptor delta, FR-delta) (IZUMO1 receptor protein JUNO)" IZUMO1R FOLR4 JUNO Homo sapiens (Human) cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] signaling receptor activity [GO:0038023] GO:0005576; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0031362; GO:0035036; GO:0038023 TWSNSFKASPER 3.609999895 1 1 0.305944376 1409.902868 0 16.65598 12.60202 0 0 12.89356 15.70383 0 0 0 17.0282 0 14.5786 0 0 0 0 0 15.41854 0 0 0 0 0 0 0 0 0 0 0 0 17.18018 17.4901 0 0 0 0 0 0 0 0 0 15.56573 0 0 0 0 0 A6NDP7 MADL2_HUMAN Myeloid-associated differentiation marker-like protein 2 MYADML2 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] GO:0005737; GO:0016021 IRFVPSL 10.97000027 0.365692616 0.365692616 0.177152561 834.2530169 0 12.80175 18.35208 0 16.88607 16.70647 14.21293 0 17.35662 17.28076 10.90223 17.82813 15.4791 17.57601 13.14615 0 17.97634 15.98619 15.25202 19.6638 0 18.2796 19.74982 17.72673 17.10288 17.74899 16.72275 0 17.31647 0 0 0 15.47312 0 11.89679 0 17.27362 17.12558 0 14.73199 17.86749 18.5999 18.92771 0 17.32535 16.00061 0 17.87756 A6NDY0 EPAB2_HUMAN "Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein 2, ePABP-2, ePABP2 (Embryonic poly(A)-binding protein type II) (Poly(A)-binding protein nuclear-like 1)" PABPN1L EPABP2 PABPNL1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005737 GKFSPWFSPY 4.630000114 1 1 0.13544601 1218.050193 0 0 0 15.94089 0 0 0 13.00468 0 0 0 0 0 0 0 10.54389 0 0 13.41373 14.23388 0 0 0 0 14.83945 13.75001 0 15.73455 0 0 0 0 0 13.23706 0 15.14742 0 0 15.85877 0 0 0 0 14.71087 15.1961 0 10.56148 0 A6NDY2 F90AA_HUMAN Putative protein FAM90A10 FAM90A10 FAM90A10P Homo sapiens (Human) APVGPR 1.389999986 1 1 0.077519498 596.5026604 0 0 15.41751 15.40924 0 14.26888 0 0 0 0 14.58484 15.6061 15.33858 15.80271 14.28277 0 0 0 16.47534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.91279 0 14.54059 0 0 0 A6NE02 BTBDH_HUMAN BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like) BTBD17 Homo sapiens (Human) negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] GO:0005576; GO:0005886; GO:0009615; GO:0045071 QGNASDVVLR 3.789999962 1 1 0.123455304 1058.123206 15.77696 0 0 0 0 0 15.36907 0 0 13.85662 0 0 15.74419 13.89407 0 14.14404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NE52 WDR97_HUMAN WD repeat-containing protein 97 WDR97 KIAA1875 Homo sapiens (Human) SVAQDPVGGRFVVLDGAGR 4.28000021 1 1 0.085942854 1900.356549 0 0 14.7492 0 0 0 0 0 15.70518 0 0 16.57046 0 15.58225 0 14.90551 14.27936 0 0 0 0 14.86034 14.01698 0 14.83394 0 15.22446 15.84018 0 0 15.74836 14.94934 13.801 14.76654 13.45514 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEC2 PSAL_HUMAN "Puromycin-sensitive aminopeptidase-like protein, EC 3.4.11.-" NPEPPSL1 Homo sapiens (Human) peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] GO:0005737; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062 GFYRSK 6.150000095 1 1 0.29426593 756.2790005 14.64095 0 0 0 0 11.99135 0 0 15.32945 0 17.31767 16.12857 0 15.19267 0 0 16.31633 15.77901 16.91298 0 16.95812 0 0 0 16.84218 17.72844 17.10288 0 16.21663 0 16.69281 15.98157 17.10298 0 16.99549 16.09877 16.68344 18.09039 17.76793 17.19668 16.38612 18.08032 17.61083 17.04924 16.61311 0 17.08447 17.63517 A6NEH8 ZNAS2_HUMAN Putative uncharacterized protein encoded by ZNF503-AS2 (ZNF503 antisense RNA 2) ZNF503-AS2 C10orf41 NCRNA00245 Homo sapiens (Human) FPNRGSR 1.850000024 1 1 0.24809365 834.6639463 18.04011 0 16.76226 17.13018 18.6521 0 12.29274 19.04936 0 13.53337 18.64284 15.91904 0 0 15.55896 0 0 0 14.87118 17.62263 0 0 0 18.94899 0 0 17.60954 18.30499 0 0 0 0 18.83413 0 0 0 0 0 0 17.27114 0 16.31528 0 17.29604 17.07332 0 0 0 A6NEK1 ARRD5_HUMAN Arrestin domain-containing protein 5 ARRDC5 Homo sapiens (Human) protein transport [GO:0015031] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; protein transport [GO:0015031] ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] GO:0005737; GO:0015031; GO:0031625; GO:1990756 MYLLVQGTSTFHK 2.529999971 0.714279592 0.714279592 6.85E-13 1524.451278 15.44876 0 14.94745 14.06031 0 0 13.94384 14.22205 14.56398 0 0 0 16.33589 0 0 0 0 12.19566 14.31923 8.837253 0 0 8.63546 0 15.96303 13.76211 14.75824 0 18.41664 0 12.31331 17.30546 14.84672 0 15.35224 0 16.03471 14.50556 0 14.3132 11.00413 0 0 0 15.44419 15.27116 0 16.48672 A6NES4 MRO2A_HUMAN Maestro heat-like repeat-containing protein family member 2A (HEAT repeat-containing protein 7B1) MROH2A HEATR7B1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ADIWR 13.47000027 1 1 0.224700003 661.3365476 14.45971 16.26855 15.91803 15.5241 14.20146 0 0 0 16.43067 15.28062 14.47005 0 0 0 15.59471 0 0 15.16402 17.00838 17.09415 16.70652 19.8118 0 0 15.76383 16.36767 0 0 15.73824 13.72847 15.92826 14.71594 15.63544 16.32891 14.46961 16.76804 16.99083 17.14587 16.36241 14.48378 15.80377 14.2672 15.69209 16.22974 16.65709 0 16.93547 17.74902 A6NEY8 PRXD1_HUMAN Putative prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1) (Prolyl-tRNA synthetase associated domain-containing protein 1 pseudogene) PRORSD1P NCRNA00117 PRDXDD1P Homo sapiens (Human) aminoacyl-tRNA editing activity [GO:0002161] aminoacyl-tRNA editing activity [GO:0002161] GO:0002161 QLGVGSGNLRFADETAMLEK 4.170000076 0.295171976 0.295171976 3.65E-12 2152.786498 18.48824 12.11593 0 0 13.7569 0 0 13.42914 15.85667 0 14.75455 0 14.19603 10.02973 15.16952 0 0 17.91135 16.00726 15.24328 13.48152 12.34402 14.73591 13.60906 0 0 16.61345 16.8823 14.57272 16.05225 0 16.71804 0 14.56445 0 0 12.1085 14.70731 16.62759 15.62937 17.08555 12.59089 17.5443 13.52262 14.77637 15.76992 13.06477 16.31468 A6NF34 ANTRL_HUMAN Anthrax toxin receptor-like ANTXRL Homo sapiens (Human) toxin transport [GO:1901998] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; toxin transport [GO:1901998] metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0009986; GO:0016021; GO:0046872; GO:1901998 STIDALTSK 2.369999886 0.28905046 0.28905046 0.118465538 935.6743648 12.83895 15.93635 16.7372 12.91868 0 15.40761 14.65209 11.18455 0 17.74857 15.26668 13.79373 0 0 14.25831 0 15.67329 13.77489 13.08568 13.47971 14.17386 16.49714 15.67798 15.57155 15.56739 16.24611 16.7397 0 0 13.04379 15.35431 16.84613 18.95233 17.34822 0 13.19746 15.72761 0 17.84924 0 14.41444 13.39118 11.69344 0 0 16.16286 14.22765 16.4637 A6NF36 CC182_HUMAN Coiled-coil domain-containing protein 182 CCDC182 Homo sapiens (Human) female gonad development [GO:0008585] female gonad development [GO:0008585] GO:0008585 EPLYQAGSILMTVNTLQGKK 4.159999847 1 1 0.157411456 2206.907254 14.08992 0 0 0 0 12.46746 14.9976 13.80173 0 0 11.61125 0 0 0 3.969814 0 0 0 0 0 0 0 0 0 0 15.91614 0 15.26467 0 13.65665 0 0 15.29781 15.63002 13.01653 12.3164 13.80922 0 0 15.72494 12.42688 0 0 0 0 0 0 0 A6NFA1 TIKI2_HUMAN "Metalloprotease TIKI2, EC 3.4.-.- (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B)" TRABD2B HKAT TIKI2 Homo sapiens (Human) negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0031334; GO:0046872; GO:1904808 MHAALAGPLLAALLATAR 4.78000021 0.528041959 0.528041959 0.236187625 1771.917428 13.05035 0 0 0 0 0 0 0 16.2041 0 0 0 15.69674 0 0 0 0 0 0 0 0 16.44401 14.14264 0 0 0 0 14.95897 15.69388 0 0 15.9507 17.43186 15.2919 15.56893 16.02525 16.43519 15.76684 0 0 0 16.49921 16.44267 17.32306 14.74169 16.30256 0 17.34912 A6NFD8 HELT_HUMAN Hairy and enhancer of split-related protein HELT (HES/HEY-like transcription factor) HELT Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; GABAergic neuron differentiation in basal ganglia [GO:0021858]; gene expression [GO:0010467]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; GABAergic neuron differentiation in basal ganglia [GO:0021858]; gene expression [GO:0010467]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005667; GO:0006357; GO:0007417; GO:0009791; GO:0009952; GO:0010259; GO:0010467; GO:0021858; GO:0035264; GO:0042802; GO:0045944; GO:0046983; GO:0050767 TPVSHK 6.28000021 0.271929711 0.271929711 0.326488536 669.1814404 16.34898 15.94027 16.36037 14.92293 16.25465 15.59733 0 15.00673 0 0 16.16191 0 14.81956 15.20446 15.381 0 16.66031 16.20881 17.06271 16.95613 17.54427 0 17.26316 15.79053 16.49491 0 0 17.23001 16.54532 0 16.15997 15.44522 16.70394 17.05841 15.8297 15.88077 17.02942 17.03325 16.91501 15.08615 17.26134 16.94662 17.86375 17.2662 16.51764 16.93951 15.87995 16.10162 A6NFI3 ZN316_HUMAN Zinc finger protein 316 ZNF316 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872 RIHTGERPYR 5.170000076 1 1 0.324888159 1286.062284 0 0 13.8093 0 0 16.48435 16.82043 14.72773 0 16.5219 0 12.92408 0 0 0 0 0 0 15.30971 13.45018 0 0 16.28963 14.51227 16.06119 0 17.77072 0 0 0 15.95783 14.56083 14.93684 0 15.87707 16.32074 0 0 15.21874 16.9892 16.40624 16.88503 16.05961 16.27923 13.77745 15.75341 16.95319 15.62908 A6NFK2 GRCR2_HUMAN Glutaredoxin domain-containing cysteine-rich protein 2 (GRXCR1-like protein) (Glutaredoxin domain-containing cysteine-rich protein 1-like protein) GRXCR2 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; protein localization to organelle [GO:0033365]; sensory perception of sound [GO:0007605] microvillus [GO:0005902]; stereocilium base [GO:0120044]; stereocilium shaft [GO:0120043] microvillus [GO:0005902]; stereocilium base [GO:0120044]; stereocilium shaft [GO:0120043]; auditory receptor cell stereocilium organization [GO:0060088]; protein localization to organelle [GO:0033365]; sensory perception of sound [GO:0007605] GO:0005902; GO:0007605; GO:0033365; GO:0060088; GO:0120043; GO:0120044 FSMLANRFK 4.860000134 0.571826398 0.571826398 0.216078399 1113.387765 15.37451 14.68876 13.94375 15.61799 0 12.86274 14.02938 9.686299 0 0 0 11.44161 0 0 0 0 14.86973 0 14.52177 0 15.24171 18.71258 0 0 15.34633 0 16.72973 13.74075 0 0 0 12.14712 0 0 15.55556 0 17.39617 14.05769 16.54137 0 0 0 15.69469 0 13.72179 14.88262 14.87121 12.26993 A6NFR6 CE060_HUMAN Uncharacterized protein C5orf60 C5orf60 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 APLAPLASMPSSVPK 4.519999981 1 1 0.116591205 1482.449846 14.88427 11.80706 14.73629 8.001613 14.45083 0 14.79213 13.35834 14.536 14.66378 13.22457 12.46414 12.00372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGA9 TM202_HUMAN Transmembrane protein 202 TMEM202 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 SPACDENVTVIPTERSR 5.659999847 1 1 0.630531961 1931.789236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.25862 0 0 0 18.18316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.34107 0 0 0 0 0 0 0 A6NGB9 WIPF3_HUMAN WAS/WASL-interacting protein family member 3 (Corticosteroids and regional expression protein 16 homolog) WIPF3 CR16 Homo sapiens (Human) actin filament-based movement [GO:0030048]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] actin filament [GO:0005884]; cytosol [GO:0005829] actin filament [GO:0005884]; cytosol [GO:0005829]; actin binding [GO:0003779]; SH3 domain binding [GO:0017124]; actin filament-based movement [GO:0030048]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] actin binding [GO:0003779]; SH3 domain binding [GO:0017124] GO:0003779; GO:0005829; GO:0005884; GO:0007283; GO:0017124; GO:0030048; GO:0030154 TGQGPGSR 7.670000076 0.911209524 0.911209524 0.238552464 758.6145102 16.12936 0 15.79226 15.76827 15.89742 14.9133 18.17071 15.40642 0 17.12739 16.48768 0 14.68012 14.65508 14.86737 15.70498 0 15.25219 15.37551 15.47293 14.87803 16.04432 16.50026 17.03013 15.36241 15.6616 15.70412 13.78339 15.52342 15.95978 0 0 15.87071 0 15.41641 16.2577 16.96591 0 0 16.50342 17.45632 16.74347 16.0907 16.87497 15.6168 0 17.40216 16.99838 A6NGD5 ZSA5C_HUMAN Zinc finger and SCAN domain-containing protein 5C (Zinc finger and SCAN domain-containing protein 5C pseudogene) ZSCAN5C ZSCAN5CP Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 RSKPDATSISQEEPQGEATPVGNR 6.139999866 1 1 0.300995852 2555.822121 0 19.78409 0 0 0 0 20.79683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.03997 20.85449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGG3 CI092_HUMAN Putative uncharacterized protein C9orf92 C9orf92 Homo sapiens (Human) EREEDR 11.98999977 0.002033737 0.002033737 0.277018917 834.0424014 0 0 0 0 0 0 0 16.32362 20.24248 0 0 0 16.53023 0 0 0 17.17763 0 0 0 0 0 0 17.43179 0 0 0 0 0 0 0 17.91792 18.48461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.65064 A6NGG8 PCARE_HUMAN Photoreceptor cilium actin regulator PCARE C2orf71 Homo sapiens (Human) photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cilium [GO:0005929]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cilium [GO:0005929]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0005929; GO:0007601; GO:0035845; GO:0050896; GO:1903546 DSEDSQAVIAK 6.639999866 0.036188852 0.036188852 0.116134994 1164.570868 13.68148 15.54298 0 0 0 0 0 0 15.84185 0 0 0 0 0 13.27296 0 14.91443 10.74217 15.15989 0 0 0 0 13.39048 13.97638 9.073506 15.22666 13.84318 12.21849 0 10.01435 12.73564 15.64744 13.87571 14.60523 15.06625 15.09261 15.72502 0 11.14118 0 0 14.55675 0 0 0 13.06005 16.0946 A6NGH8 ANR61_HUMAN Ankyrin repeat domain-containing protein 61 ANKRD61 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 LLYHTYPLRMTNNQGILPAGIMLPEFR 3.920000076 0.390853375 0.390853375 3.20E-12 3174.733031 13.73361 13.08601 0 0 14.33831 0 0 14.3022 13.58686 0 14.16114 13.03666 13.78443 13.37978 9.598159 14.07624 0 15.33109 13.56759 12.01568 0 0 15.68312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.33339 0 0 0 13.94123 0 0 0 A6NGN9 IGLO5_HUMAN IgLON family member 5 IGLON5 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 PPPAPGAR 6.389999866 0.45114249 0.45114249 0.035068712 758.670308 13.40221 11.17871 0 0 0 0 16.18523 16.58502 15.25533 15.77759 0 14.39508 15.29125 16.63178 11.83546 16.58999 13.67679 11.31449 17.41049 16.23677 16.03644 15.40645 15.92556 14.6126 15.9337 0 11.37058 13.64265 12.35784 0 18.39113 15.62112 15.7078 17.4134 16.22804 13.92113 13.88873 15.92842 0 16.41588 14.14283 13.61153 14.33328 0 13.89726 17.56127 13.00661 16.7971 A6NGR9 MROH6_HUMAN Maestro heat-like repeat-containing protein family member 6 MROH6 C8orf73 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AREAPVGALTLTALTEGIR 7.25 1 1 0.056581669 1942.71621 11.43835 14.35524 0 0 0 0 0 0 0 0 0 0 0 0 0 14.65269 0 0 14.12078 0 0 0 15.93973 0 0 0 15.06632 0 0 0 0 0 0 0 0 0 16.83672 0 0 14.50384 10.54106 0 13.66988 0 0 0 0 0 A6NGU5 GGT3_HUMAN "Putative glutathione hydrolase 3 proenzyme, EC 3.4.19.13 (Gamma-glutamyltransferase 3) (Putative gamma-glutamyltranspeptidase 3, GGT 3, EC 2.3.2.2) [Cleaved into: Putative glutathione hydrolase 3 heavy chain; Putative glutathione hydrolase 3 light chain ]" GGT3P GGT3 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727] glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] GO:0002682; GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0031179; GO:0036374; GO:0050727; GO:0070062; GO:0102953; GO:0103068; GO:1901750 LSGPVLALILNILK 6.349999905 1 1 0.18879711 1464.588065 16.07313 16.7072 17.8468 0 14.82757 17.34107 16.84139 0 0 13.90164 9.338567 15.41389 0 0 18.12862 17.61846 0 15.35474 13.82635 0 15.88534 0 19.15617 0 16.2268 0 17.46372 0 14.26591 16.66365 12.74482 0 0 0 16.46486 17.00314 19.8802 15.3933 0 0 0 16.08538 0 15.10053 0 0 0 16.1133 A6NGY3 CE052_HUMAN Uncharacterized protein C5orf52 C5orf52 Homo sapiens (Human) IYEMEVSALEK 1.149999976 1 1 0.183683281 1312.247269 13.4742 0 0 0 20.02426 0 0 0 13.38733 0 0 0 0 0 0 0 15.78272 0 0 0 0 0 0 0 0 0 12.37267 0 0 0 0 14.65098 0 0 0 0 0 14.97173 15.99218 0 0 0 0 0 0 0 0 0 A6NH52 TV23A_HUMAN Golgi apparatus membrane protein TVP23 homolog A TVP23A FAM18A Homo sapiens (Human) protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] GO:0009306; GO:0016192; GO:0030173 MGGNSDIGK 15.81000042 1 1 0.154513165 893.7344673 16.8981 0 12.51318 14.72141 15.46898 15.85311 0 19.04416 0 16.79354 0 0 17.75088 17.37874 16.42198 15.01741 13.90992 14.92272 0 16.40855 19.92155 16.91393 16.89638 8.950906 16.35875 0 15.85625 0 13.69791 0 12.52379 18.24918 16.38276 0 0 0 18.6325 0 16.09311 16.61481 17.22916 0 16.49071 0 17.32894 16.90701 18.46775 12.70372 A6NHC0 CAN8_HUMAN "Calpain-8, EC 3.4.22.53 (New calpain 2, nCL-2) (Stomach-specific M-type calpain)" CAPN8 NCL2 Homo sapiens (Human) digestion [GO:0007586]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] GO:0004198; GO:0005509; GO:0005737; GO:0005794; GO:0006508; GO:0007586 KVEDGEFWMSLSDFVR 3.5 0.531476021 0.531476021 0.280623634 1959.757665 15.39432 9.822526 15.32483 15.976 0 15.97611 15.61058 8.742809 0 12.92667 15.00256 17.86019 0 15.62682 0 16.3649 15.72269 0 0 16.6858 0 15.70775 16.93231 0 0 0 16.7524 13.45183 9.88632 0 0 16.44839 13.01796 16.62976 0 0 17.88303 14.6489 18.135 0 0 17.6972 0 15.29562 16.77663 18.52316 16.29017 18.41441 A6NHJ4 ZN860_HUMAN Zinc finger protein 860 ZNF860 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GKVFS 2.50999999 1 1 0.305932098 536.7341492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.07412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.82202 0 A6NHM9 MOXD2_HUMAN "Putative DBH-like monooxygenase protein 2, EC 1.14.17.- (DBH-like monooxygenase protein 2 pseudogene)" MOXD2P MOXD2 Homo sapiens (Human) dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] extracellular space [GO:0005615]; secretory granule membrane [GO:0030667] extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500] GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421 MAHDLLFR 10.64999962 1 1 0.231167748 1017.579229 0 12.30584 13.95835 13.91008 0 14.97881 0 0 10.50418 15.63346 16.92332 16.69798 16.16687 16.22178 16.1029 0 16.26851 0 0 15.27184 0 14.84738 0 14.40937 16.389 16.25609 0 15.53585 0 0 16.50757 0 16.18898 0 0 16.30519 0 0 17.34331 0 15.96385 0 0 15.72647 0 14.66929 0 15.61595 A6NHQ2 FBLL1_HUMAN "rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1, EC 2.1.1.- (Protein-glutamine methyltransferase)" FBLL1 Homo sapiens (Human) blastocyst hatching [GO:0001835]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; blastocyst hatching [GO:0001835]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167] histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649] GO:0000494; GO:0001650; GO:0001835; GO:0003723; GO:0005654; GO:0005730; GO:0008649; GO:0015030; GO:0031167; GO:0031428; GO:0032040; GO:1990258; GO:1990259 KGAMVVSVEPHR 9.020000458 1 1 0.126883316 1311.46028 0 0 0 0 0 0 0 0 0 16.38245 0 0 13.32291 10.48627 11.4681 0 14.89049 0 0 0 0 15.40073 16.47293 0 12.38953 15.94825 14.86344 13.17969 12.51565 15.2639 0 14.37252 15.05433 15.20625 0 15.18159 5.982559 0 15.49589 0 15.60969 14.63289 0 0 15.19263 0 0 0 A6NHR9 SMHD1_HUMAN "Structural maintenance of chromosomes flexible hinge domain-containing protein 1, SMC hinge domain-containing protein 1, EC 3.6.1.-" SMCHD1 KIAA0650 Homo sapiens (Human) dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034] Barr body [GO:0001740]; site of double-strand break [GO:0035861] Barr body [GO:0001740]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803] GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0060820; GO:2000042; GO:2001034 MAAADGGGPGGASVGTEEDGGGVGHR 3.059999943 1 1 0.295489641 2285.701211 18.0589 0 15.265 14.08399 16.89871 12.6728 0 12.976 0 0 16.0569 12.97826 15.00131 0 0 12.43481 0 0 0 0 0 0 0 0 14.84519 15.05003 14.0864 0 0 0 0 16.60453 17.8031 0 15.33174 15.93141 14.53637 0 0 0 14.02045 13.98691 14.75921 0 15.37379 0 0 0 A6NHX0 CAST2_HUMAN Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) CASTOR2 GATSL1 GATSL2 Homo sapiens (Human) cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] cytosol [GO:0005829] cytosol [GO:0005829]; identical protein binding [GO:0042802]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:1902531; GO:1903577; GO:1904262 DPMATGDDCGHIR 4.309999943 1 1 0.240232947 1447.651637 13.69521 0 0 0 14.50044 0 0 12.5871 0 0 0 0 0 13.10117 0 0 15.41803 0 0 0 12.68604 16.63072 0 0 0 0 0 0 0 14.86612 0 0 16.96027 0 0 0 0 16.10102 0 0 0 0 0 0 0 16.42346 0 0 A6NHZ5 LR14B_HUMAN Leucine-rich repeat-containing protein 14B LRRC14B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 LASLTLPTK 9.100000381 0.874740779 0.874740779 0.305596782 944.0800019 0 0 0 0 0 16.62207 0 16.19434 0 0 0 0 0 0 0 0 15.99189 0 16.95985 0 0 15.94781 0 0 0 0 0 17.13941 0 0 0 0 17.74725 0 0 0 0 19.02107 0 0 0 16.2757 0 0 15.68833 17.1519 0 0 A6NI28 RHG42_HUMAN Rho GTPase-activating protein 42 (Rho GTPase-activating protein 10-like) (Rho-type GTPase-activating protein 42) ARHGAP42 GRAF3 TMEM133 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0003085; GO:0005096; GO:0007165; GO:0035024; GO:0090630; GO:1904694 ASPNPDLPPK 5.110000134 1 1 0.090714886 1035.652778 0 0 0 14.606 17.0122 0 0 15.39291 0 0 0 0 13.83324 0 0 0 0 0 0 0 0 0 0 15.89607 0 0 0 0 0 0 0 0 0 0 18.32725 0 17.43871 0 0 16.62137 17.41533 0 0 0 0 0 0 0 A6NI56 CC154_HUMAN Coiled-coil domain-containing protein 154 CCDC154 C16orf29 Homo sapiens (Human) bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691] early endosome [GO:0005769] early endosome [GO:0005769]; bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691] GO:0005769; GO:0035630; GO:0042475; GO:0044691; GO:0045453 LATFQNQIMKLENCVQANK 1.909999967 1 1 0.079354566 2266.33871 0 12.8706 13.36416 14.21023 0 0 0 14.92997 0 16.0622 0 13.02003 0 0 15.33813 13.44102 0 0 0 0 12.45846 0 0 0 0 0 0 0 0 0 0 15.7362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NI61 MYMK_HUMAN Protein myomaker (Myoblast fusion maker) (Transmembrane protein 226) (Transmembrane protein 8C) MYMK TMEM226 TMEM8C Homo sapiens (Human) muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206] integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206] GO:0005886; GO:0005887; GO:0007517; GO:0007520; GO:0014905; GO:0030173; GO:0045026; GO:1904206 SVYTQQIGPGLCFGALALMLR 5.239999771 1 1 0.182902011 2310.71254 0 0 0 14.21814 0 12.2346 0 10.84514 0 0 0 0 0 0 0 7.346667 11.79947 0 14.79148 12.92949 0 12.01816 0 0 14.75929 9.270823 14.52136 11.78501 0 13.93706 0 0 0 0 0 0 0 13.87559 0 0 0 0 0 0 0 0 0 0 A6NI79 CCD69_HUMAN Coiled-coil domain-containing protein 69 CCDC69 Homo sapiens (Human) spindle midzone assembly [GO:0051255] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; microtubule binding [GO:0008017]; spindle midzone assembly [GO:0051255] microtubule binding [GO:0008017] GO:0005634; GO:0005737; GO:0008017; GO:0030496; GO:0051233; GO:0051255 EELLYR 15.85999966 1 1 0.23614391 822.7514714 17.89351 18.94248 17.91238 0 17.47401 16.95325 18.2537 0 0 0 17.12496 16.95418 17.08039 19.40579 0 0 15.32041 0 17.21929 0 18.05299 15.45737 18.87165 17.25289 17.09713 0 18.55412 16.87146 16.80698 0 0 18.5302 0 17.62026 18.83237 16.50797 0 0 18.47221 18.56132 16.04271 16.9259 0 17.90429 17.25402 17.38867 18.59632 15.55598 A6NI87 CBY3_HUMAN Protein chibby homolog 3 CBY3 Homo sapiens (Human) AGASAGVLMIQPCALDSQ 4.449999809 0.18774645 0.18774645 0.133376444 1804.454566 0 11.72093 13.51187 0 0 0 10.86889 14.38093 0 11.85941 0 15.53413 16.40351 15.64139 0 15.35742 14.26563 13.5071 0 14.67179 0 0 14.18488 0 0 15.49928 0 0 16.83127 15.77624 16.84941 18.44851 17.16267 0 0 0 0 0 0 0 0 0 15.26409 0 15.07863 14.8518 0 16.46106 A6NJ64 NPIB2_HUMAN Putative nuclear pore complex-interacting protein family member B2 NPIPB2 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 LDMKEIHTYMK 2.430000067 1 1 0.244597318 1441.550557 16.47516 0 9.869954 0 0 8.959558 12.76438 13.02058 0 15.58935 0 11.51908 15.83286 13.79803 11.17082 0 0 12.66484 12.83757 0 17.17779 0 15.10731 0 13.73958 14.80863 0 13.92004 0 0 15.20296 14.18719 0 0 0 0 0 0 0 15.86254 14.02498 0 12.64555 13.71625 0 0 15.19798 0 A6NJ69 IGIP_HUMAN IgA-inducing protein homolog IGIP C5orf53 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 SVSGCNITIFAVMFSHLSAGK 4.630000114 0.18778877 0.18778877 3.66E-12 2243.209026 13.45923 14.53396 9.382403 11.94414 16.4428 14.08867 13.98212 0 0 0 15.34062 14.30698 0 0 0 12.45238 0 0 0 0 0 0 0 14.70051 0 13.5036 14.46098 0 0 0 0 0 0 0 0 0 0 0 0 16.21107 0 0 0 0 0 0 0 0 A6NJG2 SWAHD_HUMAN Ankyrin repeat domain-containing protein SOWAHD (Ankyrin repeat domain-containing protein 58) (Protein sosondowah homolog D) SOWAHD ANKRD58 Homo sapiens (Human) VLVGALGADATR 7.730000019 1 1 0.16131224 1142.496361 13.84552 15.41268 0 12.23874 14.61531 11.63215 14.51576 0 11.5712 0 0 10.6287 17.07598 0 0 10.10308 10.90032 12.19395 14.88807 14.45821 11.43402 12.29766 14.38052 14.79756 16.26825 13.72962 0 0 0 0 0 0 0 0 0 0 14.11189 0 0 0 15.85854 0 13.36125 0 0 0 0 0 A6NK02 TRI75_HUMAN Tripartite motif-containing protein 75 TRIM75 TRIM75P Homo sapiens (Human) female meiosis I [GO:0007144]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; female meiosis I [GO:0007144]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005615; GO:0005737; GO:0007144; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 DSLPTK 6.940000057 1 1 0.064887904 657.3279148 15.81705 0 14.96314 14.29372 12.31009 14.3701 15.372 0 14.26968 16.37271 15.66344 16.13566 13.88389 16.2515 14.17327 13.85098 0 0 15.46925 14.64816 15.00218 0 0 0 0 16.76494 0 0 0 0 0 0 0 0 0 17.20242 0 0 0 0 0 15.58654 14.15121 17.32222 0 0 0 0 A6NK53 ZN233_HUMAN Zinc finger protein 233 ZNF233 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GFSKASNLQAHQR 3.50999999 1 1 2.29E-13 1442.999043 14.75001 15.26125 16.00267 13.7021 15.40364 9.542855 13.83283 0 15.90287 14.14163 15.70977 12.73251 15.03004 15.16771 13.80625 0 12.43264 0 13.6561 13.09464 14.71677 0 0 0 13.68413 0 16.06689 0 0 0 0 0 0 0 0 0 16.55699 0 0 0 0 0 0 0 0 0 15.00323 0 A6NK59 ASB14_HUMAN "Ankyrin repeat and SOCS box protein 14, ASB-14" ASB14 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 AYVLYK 9.010000229 0.00958709 0.00958709 0.243274495 756.3443885 17.65928 18.78673 17.6032 18.42449 16.92314 18.63933 17.78305 17.59436 0 17.88108 0 15.66817 16.79411 15.97125 18.73194 17.79313 19.07147 18.65462 17.96469 18.32144 0 19.02752 0 18.9659 0 18.19045 0 18.30632 0 18.39302 0 19.34075 16.29834 19.40165 18.34187 0 0 17.83198 18.2522 18.2335 17.86012 0 16.41648 19.59172 15.98297 17.98932 16.98361 15.33276 A6NK97 S22AK_HUMAN Solute carrier family 22 member 20 (Organic anion transporter 6) (Solute carrier family 22 member 20 pseudogene) SLC22A20P OAT6 SLC22A20 Homo sapiens (Human) ion transport [GO:0006811] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811] transmembrane transporter activity [GO:0022857] GO:0006811; GO:0016021; GO:0022857 MAFTDLLDALGSMGR 1.299999952 0.81335777 0.81335777 0.316861964 1613.920432 0 0 0 0 17.06168 15.00141 0 13.48073 0 0 0 0 0 0 0 15.65891 16.10941 16.30774 0 14.19677 0 0 0 0 0 0 13.10942 0 0 15.34774 0 15.47224 0 16.95781 0 0 0 0 0 0 14.28583 19.48806 0 0 15.78668 0 0 0 A6NKF1 SAC31_HUMAN SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1) SAC3D1 SHD1 Homo sapiens (Human) cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225] GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0051225; GO:0051298; GO:0051301 GAGPHPR 3.599999905 1 1 0.099224093 690.419039 0 0 0 0 0 16.99472 0 0 0 0 17.92665 15.30628 17.22393 15.3583 0 0 0 17.62747 0 0 0 0 17.99965 0 0 0 0 0 0 0 16.21866 17.35087 13.91085 16.78338 17.0745 0 0 15.06979 0 0 13.69418 0 0 17.08568 0 0 16.79895 15.10742 A6NKF2 ARI3C_HUMAN "AT-rich interactive domain-containing protein 3C, ARID domain-containing protein 3C" ARID3C Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; DNA binding [GO:0003677] GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0045121; GO:0045944 RAVLMGPMDPPRPCMPPSFLPR 6.260000229 0.084644638 0.084644638 5.93E-12 2539.10635 17.25344 0 16.94152 0 15.852 11.96586 0 17.6082 0 14.84562 0 0 15.99481 18.33127 0 0 0 15.65329 18.6798 0 0 0 16.49845 0 14.04303 10.80148 10.57835 17.75038 16.96005 0 0 0 0 0 0 14.41663 16.51561 0 8.698325 0 15.16104 0 0 0 0 0 14.78382 14.15725 A6NKF7 TM88B_HUMAN Transmembrane protein 88B TMEM88B Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165] PDZ domain binding [GO:0030165] GO:0005886; GO:0016021; GO:0030165 ETEEEEGGGGASDTAPMLPR 2.900000095 1 1 0.409065196 2032.545097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.128 0 0 0 0 0 0 0 0 0 0 0 0 0 17.71665 0 0 0 0 0 0 0 0 0 A6NKG5 RTL1_HUMAN Retrotransposon-like protein 1 (Mammalian retrotransposon derived protein 1) (Paternally expressed gene 11 protein) (Retrotransposon-derived protein PEG11) RTL1 MAR1 MART1 PEG11 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 HFSGDR 1.529999971 1 1 0.246041306 714.9606654 17.31387 18.19743 17.36012 17.7777 18.55218 18.10135 0 17.79101 0 0 0 0 0 17.85491 0 0 0 0 17.98983 0 0 0 0 0 0 18.91643 0 0 0 0 21.04657 0 20.73985 0 0 0 0 0 0 0 0 0 0 0 16.37695 0 0 0 A6NKL6 T200C_HUMAN Transmembrane protein 200C (Transmembrane protein TTMA) (Two transmembrane domain-containing family member A) TMEM200C TTMA Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GELDLSMTNLRGAEGSMR 7.449999809 1 1 0.19068789 1953.15405 15.4157 14.7561 14.19824 14.00038 11.85997 13.68032 13.86381 0 15.84501 14.73103 14.73619 0 12.15687 14.94042 0 15.31291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKT7 RGPD3_HUMAN RanBP2-like and GRIP domain-containing protein 3 RGPD3 RGP3 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0050790 KAVPGNSAK 14.03999996 1 1 0.28754713 872.4455256 12.28752 13.09536 14.08018 15.23678 14.06549 0 13.42956 15.26099 0 16.06383 0 14.29805 12.63245 15.09175 13.9567 14.75269 15.34001 16.2724 0 0 0 0 0 14.71582 13.94269 13.12376 15.02169 0 0 0 15.95763 0 0 0 0 16.53481 15.53598 0 0 0 0 0 0 16.07529 0 0 0 0 A6NKX1 F223B_HUMAN Protein FAM223B FAM223B CXorf52B LINC00204B Homo sapiens (Human) VQQSTDER 7.889999866 1 1 0.047613185 961.3952435 15.00429 14.55922 0 11.74786 0 0 0 14.62044 14.5274 15.01953 0 0 0 0 0 0 13.03954 12.09249 0 15.66461 0 0 0 0 0 0 0 0 0 14.8748 14.99632 0 0 0 0 0 0 14.9322 0 0 0 0 13.85126 0 0 0 0 0 A6NL08 O6C75_HUMAN Olfactory receptor 6C75 OR6C75 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 TILKIPSMSQR 12.85000038 1 1 9.18E-13 1273.860076 0 15.07517 0 0 14.04234 0 0 0 16.19409 0 0 0 0 0 0 0 14.61438 0 14.72692 0 0 0 0 0 0 0 15.10963 16.78924 17.25897 0 15.17578 0 0 0 0 0 0 0 0 0 17.04756 0 0 0 0 0 0 13.53754 A6NL82 F183A_HUMAN Protein FAM183A FAM183A Homo sapiens (Human) ciliary base [GO:0097546] ciliary base [GO:0097546] GO:0097546 MAGHPKEK 21.60000038 0.543300331 0.543300331 0.151873563 913.7572308 15.80791 0 16.66401 0 15.03921 12.05553 17.1488 0 0 15.23069 0 0 0 0 0 0 0 13.55301 18.88909 0 0 0 14.96313 14.0987 0 16.74742 0 17.32383 0 0 0 0 15.62123 0 0 0 0 0 0 0 0 0 16.72976 0 0 0 0 0 A6NLJ0 C2C4B_HUMAN C2 calcium-dependent domain-containing protein 4B (Nuclear-localized factor 2) (Protein FAM148B) C2CD4B FAM148B NLF2 Homo sapiens (Human) positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528] nucleus [GO:0005634] nucleus [GO:0005634]; positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528] GO:0002528; GO:0002675; GO:0005634; GO:0030155 VPDGLLSR 1.629999995 1 1 0.144104012 860.2533789 0 15.28848 0 14.88824 14.90303 0 0 0 0 0 15.44815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.78901 0 0 0 0 16.67914 0 0 0 0 0 0 0 0 0 16.68928 A6NLU0 RFPLA_HUMAN Ret finger protein-like 4A (RING finger protein 210) RFPL4A RFPL4 RNF210 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription, DNA-templated [GO:0045893]" metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0045893; GO:0046872 SVLTMNPR 8.31000042 1 1 0.294970385 934.1757913 16.08959 0 0 0 0 0 0 0 0 0 0 0 16.62927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NM11 L37A2_HUMAN Leucine-rich repeat-containing protein 37A2 LRRC37A2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GCSSRR 5.960000038 0.418213308 0.418213308 0.154687964 723.4384197 16.95854 20.622 16.5195 18.71738 19.90348 19.95682 18.2445 18.85066 17.67771 19.50007 19.41746 14.78518 19.63395 20.39276 19.82657 18.45323 19.56595 16.23107 16.75886 17.1794 20.12215 17.58594 19.86364 19.26075 16.46077 17.37009 10.7288 18.51233 17.59011 16.84392 0 19.33746 15.35647 14.53152 15.62415 16.19204 18.14552 19.89928 16.3945 16.82336 19.95222 20.56967 15.61308 17.71212 18.8018 17.27912 14.36307 14.53484 A6NM36 LRC30_HUMAN Leucine-rich repeat-containing protein 30 LRRC30 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005737; GO:0007165; GO:0043231 LNLSNNFFAHIPMCVFSLK 5.320000172 1 1 0.127374262 2268.688552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.09947 0 0 0 0 13.39608 12.83401 0 0 0 0 0 0 0 0 0 0 0 14.99349 0 14.01901 0 0 0 13.83962 0 0 0 0 13.1082 0 13.14615 A6NM43 TCPQL_HUMAN Putative T-complex protein 1 subunit theta-like 1 CCT8L1P CCT8L1 Homo sapiens (Human) protein folding [GO:0006457] chaperonin-containing T-complex [GO:0005832] chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; unfolded protein binding [GO:0051082] GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082 KILGMNN 14.55000019 1 1 0.52322678 804.200826 0 0 0 0 17.17464 0 0 0 17.06526 0 0 0 0 0 0 0 0 0 17.61053 0 0 0 0 0 0 0 0 0 0 17.34909 0 0 0 0 0 0 17.30542 17.8775 0 0 0 0 0 19.77905 0 0 0 0 A6NM62 LRC53_HUMAN Leucine-rich repeat-containing protein 53 LRRC53 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 LNLHPFRK 4.489999771 1 1 0.10708995 1024.98504 16.40051 0 0 0 0 15.30961 14.0708 0 16.38584 15.48222 14.51073 15.35266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0237 0 0 0 0 0 0 0 0 0 16.22335 0 0 14.69004 0 15.8463 0 0 A6NMB1 SIG16_HUMAN "Sialic acid-binding Ig-like lectin 16, Siglec-16 (Siglec-P16)" SIGLEC16 SIGLECP16 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of interleukin-6 production [GO:0032755] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of interleukin-6 production [GO:0032755] carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0032755; GO:0033691; GO:1900426 SGPMTGVVLVAVGEVAMK 3.880000114 0.56840682 0.56840682 0.599646451 1741.679141 0 17.69731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NMB9 FIGL2_HUMAN Fidgetin-like protein 2 FIGNL2 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568] GO:0005524; GO:0008568; GO:0016887 LELPPGGRQR 10.61999989 1 1 0.447750943 1121.852224 16.76825 0 0 0 0 17.39561 16.7497 0 0 0 0 0 17.95155 0 0 16.63929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.83438 0 17.41906 0 0 0 0 0 0 0 0 16.1085 0 0 16.5084 A6NMD0 IFM10_HUMAN "Interferon-induced transmembrane protein 10 (Dispanin subfamily A member 3, DSPA3)" IFITM10 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 TDSVRAAGAPPACK 4.329999924 1 1 0.302976525 1401.172611 15.77063 0 0 0 0 0 0 0 15.31268 0 15.13899 0 16.18985 0 16.2371 0 0 0 0 0 0 0 0 0 16.08424 0 0 16.9141 0 0 0 0 15.5675 0 0 0 16.32629 16.6202 0 13.19456 0 0 0 0 0 0 0 0 A6NMK8 INY2B_HUMAN Protein INSYN2B (Inhibitory synaptic factor family member 2B) INSYN2B C5orf57 FAM196B Homo sapiens (Human) AGGFR 5.360000134 1 1 0.108657675 506.5643091 0 0 15.51435 11.41242 0 15.03564 0 0 0 15.52422 0 0 15.98796 16.04812 0 14.90088 0 0 0 0 0 0 0 0 0 17.08421 0 0 0 16.45942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.25703 17.8687 0 A6NMZ5 O4C45_HUMAN Olfactory receptor 4C45 OR4C45 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 LWKQIMTTDDK 7.320000172 1 1 0.315755206 1396.478585 0 0 0 0 0 0 16.82777 0 0 0 0 15.45922 14.40808 0 0 0 0 17.59302 0 0 14.27705 0 0 0 0 14.13585 0 0 0 0 18.18806 0 0 0 0 0 0 0 0 19.4381 0 0 0 16.0326 0 0 16.83124 0 A6NMZ7 CO6A6_HUMAN Collagen alpha-6(VI) chain COL6A6 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0062023 GCYGTKGPK 4.429999828 1 1 0.104956136 967.7027527 13.96528 0 16.15127 0 0 0 0 15.72764 0 0 0 0 0 0 0 15.51285 16.32333 0 0 0 15.84782 0 0 0 16.49474 15.40496 17.35599 14.80566 16.9556 16.46052 0 16.26678 15.24283 0 0 16.44913 14.09943 15.01088 14.86167 15.32024 0 15.66043 0 0 0 0 0 0 A6NN90 CB081_HUMAN Uncharacterized protein C2orf81 C2orf81 Homo sapiens (Human) GSQEQMESWEPSPQLR 5.849999905 1 1 0.159661126 1905.330978 11.22252 16.28034 0 13.16123 0 0 0 0 15.73829 0 0 16.0998 0 0 0 0 16.91754 13.31985 0 0 0 15.28199 0 0 0 12.9214 0 0 11.71268 0 0 0 0 0 0 13.28675 0 0 12.58552 0 0 0 0 12.61761 11.54067 0 0 0 A6NND4 O2AT4_HUMAN Olfactory receptor 2AT4 (Olfactory receptor OR11-265) OR2AT4 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021; GO:0070374 DVKAAITK 5.730000019 1 1 0.236259155 845.4590408 15.69376 0 0 14.51362 0 0 0 15.83445 0 15.41969 16.19569 0 16.45126 0 0 16.05379 0 17.17084 17.35351 17.80995 16.72907 16.14247 16.43472 16.94261 16.50094 16.37276 16.94048 16.70268 17.35402 0 16.57951 17.294 16.61424 16.71093 16.6969 17.88512 18.17544 17.08605 17.53527 16.5612 16.89812 17.0846 17.38247 17.64527 17.33999 17.15705 17.76428 16.35702 A6NNE9 MARHB_HUMAN "E3 ubiquitin-protein ligase MARCHF11, EC 2.3.2.27 (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI, MARCH-XI) (RING-type E3 ubiquitin transferase MARCHF11)" MARCHF11 MARCH11 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] transferase activity [GO:0016740]; zinc ion binding [GO:0008270] GO:0008270; GO:0016021; GO:0016567; GO:0016740; GO:0030659 MSFEGGHGGSRCR 2.140000105 1 1 0.538382063 1437.724722 0 0 0 0 0 0 0 0 0 17.70264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8834 0 0 0 0 0 0 0 0 0 18.80855 0 0 0 0 0 18.5671 0 0 0 0 0 0 A6NNM8 TTL13_HUMAN "Tubulin polyglutamylase TTLL13, EC 6.3.2.- (Tubulin tyrosine ligase like 13) (Tubulin tyrosine ligase-like family member 13 pseudogene) (Tubulin--tyrosine ligase-like protein 13)" TTLL13 TTLL13P Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740 ILGALPSMNAAIPHVPR 1.830000043 1 1 0.101942383 1772.374748 0 16.65584 15.19899 0 0 12.02905 14.27851 10.94272 16.00018 14.13475 0 13.41682 15.12147 16.23115 0 0 0 13.17291 14.96605 0 16.52369 15.19938 17.71478 0 12.84429 0 0 0 0 17.42154 18.2624 17.33619 0 15.34679 16.92451 0 17.79922 18.06819 0 12.46286 14.78644 13.21238 13.85653 13.58379 16.81522 16.20684 14.92436 0 A6NNP5 CC169_HUMAN Coiled-coil domain-containing protein 169 CCDC169 C13orf38 Homo sapiens (Human) NYNFDGVSTNRLK 17.40999985 0.437543631 0.437543631 0.421350162 1527.767572 20.81647 20.19181 18.30093 18.5411 20.28053 19.87323 0 18.0879 18.35152 20.91182 18.11526 18.46912 0 18.76184 0 0 18.41281 0 0 0 17.1276 19.30502 19.42475 18.93844 19.07434 0 19.07977 19.50253 18.69938 19.85841 20.08928 0 0 19.12959 18.01104 20.22437 0 0 18.77674 18.28943 0 0 20.15217 18.5614 0 19.92559 20.15763 0 A6NNV3 SPD16_HUMAN Putative speedy protein E16 SPDYE16 Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901] GO:0019901; GO:0045737 SRIPLVR 8.640000343 0.000847901 0.000847901 0.259489582 840.3028808 0 0 18.62731 0 17.83776 0 0 0 0 0 0 19.44676 0 0 0 0 0 0 18.78464 0 0 0 0 0 0 17.63013 17.05085 0 0 0 19.39608 0 0 16.73845 0 0 0 0 0 0 0 22.86359 0 0 0 0 0 0 A6NNW6 ENO4_HUMAN "Enolase 4, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase)" ENO4 C10orf134 Homo sapiens (Human) cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; glycolytic process [GO:0006096] phosphopyruvate hydratase complex [GO:0000015]; sperm principal piece [GO:0097228] phosphopyruvate hydratase complex [GO:0000015]; sperm principal piece [GO:0097228]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; glycolytic process [GO:0006096] magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634] GO:0000015; GO:0000287; GO:0004634; GO:0006096; GO:0030317; GO:0044782; GO:0097228 GHDGSKR 1.559999943 1 1 0.20516305 756.6520549 0 13.46529 16.87726 0 16.31339 0 14.32914 14.7452 0 0 16.44144 15.09791 0 0 0 0 0 15.8333 0 0 0 14.35175 13.35408 13.95345 15.24392 11.15721 15.6381 13.52946 15.70572 16.33386 0 16.09606 14.93503 0 0 0 0 0 0 0 0 16.30914 0 0 17.7718 0 0 0 A6PVC2 TTLL8_HUMAN "Protein monoglycylase TTLL8, EC 6.3.2.- (Tubulin--tyrosine ligase-like protein 8)" TTLL8 Homo sapiens (Human) cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126] "axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]" "ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]" GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736 GEGTVCSR 3.619999886 1 1 0.007293384 865.7789399 16.46485 15.0116 12.18007 15.59911 0 14.88291 0 0 13.41294 0 10.60265 0 0 0 0 14.80171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.69156 0 0 0 0 0 0 0 0 A6PVS8 LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 (Leucine-rich repeat-containing protein 44) LRRIQ3 LRRC44 Homo sapiens (Human) HLIQKGQESEDEIVDEK 2.650000095 1 1 0.292705129 2001.240873 0 11.75035 14.69561 12.35254 13.93512 14.001 16.90533 12.35384 11.38982 0 0 13.79632 0 0 0 15.44905 15.79553 0 13.89031 13.76812 16.09771 0 14.87069 15.39158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38351 0 0 0 0 0 A6QL64 AN36A_HUMAN Ankyrin repeat domain-containing protein 36A ANKRD36 ANKRD36A KIAA1641 UNQ2430/PRO499 Homo sapiens (Human) SIKDVLPPVEEAVDR 5.460000038 1 1 0.319988904 1667.4768 10.71028 15.57297 13.02551 11.68629 15.1703 0 0 14.58538 0 0 0 0 0 15.3205 16.42032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2125 0 0 0 0 0 0 0 0 0 0 0 0 15.43061 0 0 0 A7E2U8 CD047_HUMAN UPF0602 protein C4orf47 C4orf47 Chr4_1746 Homo sapiens (Human) 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881] GO:0005813; GO:0005881; GO:0097731 KPGGMK 5.170000076 0.557560146 0.557560146 0.137884585 635.4432163 17.35242 13.24976 17.27386 0 14.56081 13.66424 15.78299 16.45925 15.33098 0 0 12.88462 13.85195 16.64273 15.84798 15.88284 0 17.86852 14.31122 15.98867 17.09148 0 16.55734 17.14196 18.53606 16.48217 16.07956 15.76974 16.31755 17.81333 15.74594 16.7124 12.97432 0 18.32071 17.54583 16.82939 14.94774 18.15062 6.274051 12.94092 18.29181 18.29403 0 0 16.91813 16.77324 14.56598 A7E2V4 ZSWM8_HUMAN Zinc finger SWIM domain-containing protein 8 ZSWIM8 KIAA0913 Homo sapiens (Human) positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270]; positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] ubiquitin ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270] GO:0005829; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:1990756; GO:2000627 GDQLFR 9.840000153 1 1 1.15E-13 735.4136993 15.0207 0 0 13.1315 13.89054 0 14.66642 15.08043 15.2382 14.64215 0 0 0 0 13.18597 15.66894 15.72973 15.91786 0 0 16.19953 0 0 0 0 0 0 15.46005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A7E2Y1 MYH7B_HUMAN "Myosin-7B (Antigen MLAA-21) (Myosin cardiac muscle beta chain) (Myosin heavy chain 7B, cardiac muscle beta isoform) (Slow A MYH14)" MYH7B KIAA1512 Homo sapiens (Human) membrane [GO:0016020]; myosin complex [GO:0016459]; myosin filament [GO:0032982] membrane [GO:0016020]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] GO:0003774; GO:0005524; GO:0016020; GO:0016459; GO:0032982; GO:0051015 ATSAAAALDK 1.940000057 1 1 0.14198572 916.1001731 13.18285 0 0 15.66657 12.01038 0 0 0 0 0 0 15.71671 14.57937 0 0 0 0 0 0 0 0 0 0 0 0 0 14.82034 0 12.35989 14.87512 0 15.50171 15.58471 0 0 13.83912 0 0 0 14.6563 0 0 13.10841 0 0 0 0 0 A7KAX9 RHG32_HUMAN Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP) ARHGAP32 GRIT KIAA0712 RICS Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981] GO:0000139; GO:0001650; GO:0005096; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0005938; GO:0007264; GO:0010008; GO:0014069; GO:0015629; GO:0043197; GO:0051056; GO:1901981 RVQSLHAPPSSMIR 5.789999962 0.74778223 0.74778223 0.196696517 1593.673962 16.13587 13.35551 13.18627 13.98538 10.79648 11.57813 13.44561 0 15.42847 0 14.28789 13.49413 0 15.27291 0 15.55762 0 0 0 0 0 0 0 0 0 0 0 0 15.13624 0 0 0 0 0 0 16.18508 0 0 17.18939 0 0 0 0 0 16.69177 0 0 0 A7MCY6 TBKB1_HUMAN "TANK-binding kinase 1-binding protein 1, TBK1-binding protein 1" TBKBP1 KIAA0775 SINTBAD Homo sapiens (Human) defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; type I interferon signaling pathway [GO:0060337] metal ion binding [GO:0046872] GO:0005737; GO:0007249; GO:0046872; GO:0051607; GO:0060337; GO:1902554 EEQLQAECERLQGELK 9.210000038 1 1 0.239569088 1958.123321 0 15.8402 0 14.26083 15.89763 16.05944 15.53707 15.5389 14.86868 16.37477 0 14.39667 14.82089 0 0 15.01126 0 0 13.70334 0 0 0 0 12.8586 0 0 0 0 0 0 0 0 0 15.34401 0 0 15.74612 0 0 16.96669 16.58638 15.58557 0 0 0 0 0 0 A7MD48 SRRM4_HUMAN "Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa, Neural-specific SR-related protein of 100 kDa, nSR100)" SRRM4 KIAA1853 Homo sapiens (Human) "cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]" nucleus [GO:0005634] "nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]" identical protein binding [GO:0042802]; mRNA binding [GO:0003729] GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0042551; GO:0042802; GO:0043484 HSSSSPK 8.68999958 0.199486211 0.199486211 0.190218537 728.4094302 16.19295 13.27843 11.79343 15.28836 16.91274 15.25141 16.99738 0 0 0 16.3388 14.95018 15.65094 0 14.1534 15.48838 15.20038 16.20009 0 15.69318 15.8411 16.49236 0 16.32323 0 0 0 0 15.9259 16.55659 0 15.7179 0 0 0 0 17.12029 16.98295 16.90186 0 16.51771 15.86891 0 14.68594 0 16.7815 16.18382 16.14394 A8CG34 P121C_HUMAN "Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2, POM121-2) (Pore membrane protein of 121 kDa C)" POM121C Homo sapiens (Human) mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] GO:0005635; GO:0005643; GO:0005654; GO:0005789; GO:0006405; GO:0006606; GO:0008139; GO:0016021; GO:0017056; GO:0031965; GO:0051028 TPGAR 4.670000076 0.237445757 0.237445757 0.124288022 503.3057347 17.80769 17.33911 17.773 16.46933 16.69178 17.70774 16.84324 16.31071 17.13358 17.03083 16.99332 17.24191 17.11797 17.24459 16.94855 16.06798 16.39974 16.92832 17.02542 17.67012 18.10725 17.11376 16.51 17.06891 17.18429 16.67183 15.43028 16.36882 17.07314 15.98783 17.51123 17.21975 16.95802 17.91326 17.34354 17.44282 16.9393 18.06917 17.5954 18.41825 17.33569 18.13255 17.65428 18.63677 18.481 17.01978 18.70885 17.749 A8K0R7 ZN839_HUMAN Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50) ZNF839 C14orf131 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 HTEKLK 3.230000019 1 1 0.093593294 757.7809385 14.39316 0 14.5549 15.1861 14.33936 15.68541 14.03152 15.23098 12.29083 16.06975 14.56481 10.7451 17.23968 0 17.98901 14.90902 14.16247 15.42825 0 17.3498 18.00306 0 0 0 15.7255 0 0 15.30432 14.98642 13.75045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K2U0 A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9) A2ML1 CPAMD9 Homo sapiens (Human) regulation of endopeptidase activity [GO:0052548] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of endopeptidase activity [GO:0052548] endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062 HLNSKK 8.039999962 0.411370933 0.411370933 0.098409901 723.7376555 14.49894 0 0 17.88715 0 0 16.58449 11.65512 16.03821 16.51224 17.22616 15.15872 14.93578 13.25026 14.29797 16.37251 16.11913 0 14.58251 15.4264 15.53324 0 15.72644 18.68518 16.83887 15.25827 0 17.178 0 16.59906 0 15.39421 15.19876 14.52864 0 0 11.45699 17.47449 0 16.1383 15.75655 0 0 0 0 0 15.41927 0 A8K7I4 CLCA1_HUMAN "Calcium-activated chloride channel regulator 1, EC 3.4.-.- (Calcium-activated chloride channel family member 1, hCLCA1) (Calcium-activated chloride channel protein 1, CaCC-1, hCaCC-1)" CLCA1 CACC1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006816; GO:0006821; GO:0034220; GO:0042589; GO:0046872; GO:0071456 CQGGSCYTKR 3.460000038 0.413916916 0.413916916 0.214213316 1216.284564 14.9863 13.39219 0 15.36018 11.77154 10.63418 0 0 0 0 0 12.13058 0 0 0 0 0 13.06072 0 15.20882 0 0 0 0 15.99153 14.27294 0 0 14.50792 0 0 0 0 0 14.58481 0 0 0 0 15.41395 15.50573 13.9612 14.9419 0 0 0 15.80916 0 A8K855 EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 EFCAB7 KIAA1799 Homo sapiens (Human) positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944] ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797] ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]; calcium ion binding [GO:0005509]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944] calcium ion binding [GO:0005509] GO:0005509; GO:0005929; GO:0019898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:1903569 TSGEK 5.090000153 1 1 0.246533785 521.2987877 18.01108 19.40057 18.23641 0 0 0 0 0 20.76629 0 18.20618 22.01989 0 0 18.68808 0 0 18.49728 0 0 0 0 18.01624 0 0 20.68946 21.46566 0 0 0 18.26043 0 21.81269 21.04548 0 0 0 0 0 0 0 0 0 0 0 0 0 18.14344 A8K8P3 SFI1_HUMAN "Protein SFI1 homolog, hSFI1" SFI1 KIAA0542 Homo sapiens (Human) centriole [GO:0005814]; cytosol [GO:0005829] centriole [GO:0005814]; cytosol [GO:0005829]; phosphatase binding [GO:0019902] phosphatase binding [GO:0019902] GO:0005814; GO:0005829; GO:0019902 LLRFAASMK 9.010000229 0.170891523 0.170891523 0.164691039 1052.102059 15.86638 15.4623 0 0 15.36777 0 18.54129 0 14.45174 18.43439 0 0 12.96709 0 0 0 11.27018 0 0 13.99021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.37579 0 0 16.29758 0 0 0 15.86384 0 0 0 0 A8K979 ERI2_HUMAN "ERI1 exoribonuclease 2, EC 3.1.-.- (Exonuclease domain-containing protein 1)" ERI2 EXOD1 KIAA1504 Homo sapiens (Human) "exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]" "3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]" 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0000175; GO:0000467; GO:0003676; GO:0008270 NTALLAWK 1.75 0.731054664 0.731054664 0.157303916 914.8871781 14.91747 16.11979 0 0 0 0 0 0 0 15.26614 0 15.92985 0 0 0 17.51879 0 0 0 0 0 0 13.79035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MPP1 D11L8_HUMAN "Putative ATP-dependent RNA helicase DDX11-like protein 8, EC 3.6.4.13 (DEAD/H box protein 11-like 8)" DDX11L8 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139] nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006139; GO:0016887; GO:0032508; GO:0034085 VASGHR 2.019999981 1 1 0.199477385 624.8255099 0 0 0 16.44438 0 0 0 0 0 0 0 15.25508 0 0 15.82826 0 0 0 16.24743 0 0 0 0 0 0 0 0 0 0 0 0 15.56609 0 0 0 0 15.85398 0 0 0 0 16.09612 0 0 0 0 0 15.91863 A8MPS7 YDJC_HUMAN "Carbohydrate deacetylase, EC 3.5.1.-" YDJC Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975] deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005975; GO:0019213 MGFREAVAAGDVDLPQVR 5.730000019 1 1 0.237686944 1930.59664 0 0 0 0 0 0 0 15.09376 0 0 0 14.13453 0 0 0 0 16.16768 0 0 0 0 0 0 14.71513 0 0 13.36004 0 0 0 0 15.05707 15.14271 13.6317 0 0 0 0 0 14.10494 0 0 0 0 0 0 0 11.29742 A8MTJ6 FOXI3_HUMAN Forkhead box protein I3 FOXI3 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 EDLMKMVRPPYSYSALIAMAIQSAPER 6.889999866 1 1 0.134503195 3084.556081 12.48471 13.94353 15.04355 13.15549 0 0 13.60149 0 0 10.79354 11.06572 0 0 11.71951 0 0 0 0 0 0 13.99142 11.91252 0 0 0 14.65503 0 13.84461 0 0 0 0 12.46975 13.45487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MTL0 IQCF5_HUMAN IQ domain-containing protein F5 IQCF5 Homo sapiens (Human) calmodulin binding [GO:0005516] calmodulin binding [GO:0005516] GO:0005516 MVLEFYVQQEWAAVR 3.549999952 1 1 0.340750934 1884.394508 0 15.81152 0 0 0 15.89797 0 15.85795 15.87925 0 0 0 0 12.56013 0 0 0 0 0 0 0 0 0 0 15.82014 0 0 0 0 14.75209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.75876 0 0 A8MU46 SMTL1_HUMAN Smoothelin-like protein 1 SMTNL1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]" contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] "contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]" calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523] GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0005815; GO:0008157; GO:0009410; GO:0014823; GO:0018105; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0042310; GO:0043292; GO:0043621; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718 AINEGPPTESGK 7.610000134 0.057625175 0.057625175 0.080005734 1199.715996 12.99177 14.77913 12.88365 14.29382 0 0 0 0 9.926513 14.2912 15.7684 14.71598 0 13.41463 0 0 0 14.65596 14.76629 13.43552 0 0 0 14.9085 15.30887 18.81731 0 0 0 10.43767 0 15.39849 0 0 0 15.37316 0 15.62709 12.42896 17.0455 0 17.04323 0 0 0 12.08652 18.82562 0 A8MUU9 YV023_HUMAN Putative uncharacterized protein ENSP00000383309 Homo sapiens (Human) TPPGTWLRR 11.72999954 1 1 1.37E-12 1082.494071 13.60544 11.49234 14.90796 0 0 14.17211 0 0 17.46067 0 15.29966 13.70545 14.82764 0 14.24253 11.99125 0 14.36895 0 10.1913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.35722 0 0 0 0 0 0 A8MUV8 ZN727_HUMAN Putative zinc finger protein 727 (Zinc finger protein 727 pseudogene) ZNF727 ZNF727P Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 CCSDLTK 4.650000095 1 1 0.297318338 883.8223496 18.98478 0 18.44737 0 0 17.00334 0 18.26428 18.79536 16.84552 0 17.03394 16.56243 17.7524 0 17.46215 0 16.7175 0 18.01274 0 18.60244 0 0 0 0 0 0 17.60155 16.25384 0 0 0 0 19.20128 0 0 18.15595 0 0 0 16.10552 16.52984 18.98223 0 0 18.44995 18.49893 A8MUZ8 Z705G_HUMAN Putative zinc finger protein 705G ZNF705G Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 HEKTHTGQRPYK 1.769999981 1 1 0.233835679 1482.121349 0 12.77836 0 0 13.59828 13.5919 0 0 0 13.98633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.92844 13.73477 11.82531 0 0 0 0 0 0 0 16.75386 0 0 0 0 0 A8MV57 MPTX_HUMAN Putative mucosal pentraxin homolog MPTX1 MPTX Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 EMCDSCYSGSLLNR 3.569999933 1 1 0.345193123 1706.800046 15.12624 0 17.78162 0 0 0 0 0 0 0 0 18.11386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MV72 YH009_HUMAN Putative UPF0607 protein ENSP00000382826 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 GGSCL 3.230000019 0.523002744 0.523002744 0.080664745 493.2541033 0 12.91605 13.733 0 15.36574 15.13963 13.13298 0 16.3742 0 14.92917 12.19743 10.89658 12.31881 0 15.99285 0 0 13.92837 0 0 14.48902 14.14401 16.17828 16.60992 18.14947 16.2627 14.13033 0 17.46496 15.14753 0 14.826 16.27804 0 14.18262 15.03851 16.14977 0 15.94082 17.3613 17.03944 18.48271 16.76407 17.03022 17.13697 0 16.00483 A8MV81 HIG1C_HUMAN HIG1 domain family member 1C HIGD1C UBIE UBIE2 Homo sapiens (Human) mitochondrial respirasome assembly [GO:0097250] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; mitochondrial respirasome assembly [GO:0097250] GO:0005739; GO:0016021; GO:0097250 DQKMSIHLIHMR 2.089999914 1 1 0.505717926 1524.444022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.21774 0 0 0 0 0 0 A8MVJ9 HPF1L_HUMAN Putative histone PARylation factor 1-like Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835] nucleus [GO:0005634] nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835] histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572] GO:0005634; GO:0006974; GO:0010835; GO:0018312; GO:0042393; GO:0072572 KENIDQFAA 4.400000095 1 1 0.173170815 1036.566674 0 15.18146 14.49693 14.66152 13.35338 12.82789 0 15.06816 13.86872 12.16411 0 0 15.05923 14.18213 14.17702 15.25192 15.24458 0 14.56481 14.86366 14.45016 0 0 14.69137 0 0 15.07993 0 0 16.40134 15.93204 0 0 0 0 0 0 0 0 0 0 15.80039 0 0 0 0 0 0 A8MVM7 YD021_HUMAN Putative uncharacterized protein ENSP00000382790 Homo sapiens (Human) ITEMSTKR 6.980000019 1 1 0.184102011 981.690262 12.99352 9.521925 0 15.03232 13.08499 0 0 0 17.54566 0 0 14.61354 0 13.44337 13.07707 15.26935 14.29796 0 16.69815 0 0 0 14.45055 14.63776 0 14.58797 0 0 0 14.75297 14.5741 0 0 0 14.68057 0 15.52816 0 0 0 14.80938 0 14.72747 0 0 0 0 14.97455 A8MVX0 ARG33_HUMAN Rho guanine nucleotide exchange factor 33 ARHGEF33 Homo sapiens (Human) guanyl-nucleotide exchange factor activity [GO:0005085] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085 CSMEEK 3.25999999 1 1 0.251029482 799.1231893 0 0 0 15.04182 0 0 0 0 15.4764 0 0 0 0 15.63541 0 0 0 0 0 14.60648 0 0 0 0 16.7385 0 17.04939 17.05793 0 0 16.95313 16.95244 17.27767 0 16.4308 0 17.18531 0 17.41784 16.97383 0 16.82131 0 16.36526 0 0 17.11696 0 A8MW92 P20L1_HUMAN PHD finger protein 20-like protein 1 PHF20L1 CGI-72 Homo sapiens (Human) histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357] NSL complex [GO:0044545] NSL complex [GO:0044545]; metal ion binding [GO:0046872]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872] GO:0006357; GO:0016573; GO:0044545; GO:0046872 LATLPMPDDSVEKVSSPSPATDGK 2.339999914 1 1 0.019687844 2441.316662 0 0 0 18.21854 18.73617 0 17.59583 0 0 0 0 0 0 0 16.75614 0 0 0 17.48723 19.49942 0 18.22409 0 18.47176 0 16.67137 0 15.74666 0 0 0 19.34301 0 12.73776 0 0 0 0 0 0 0 0 0 17.33967 0 0 0 0 A8MWE9 EFCB8_HUMAN EF-hand calcium-binding domain-containing protein 8 EFCAB8 Homo sapiens (Human) calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509 KVLSSVSDEMLK 3.289999962 0.003906346 0.003906346 0 1335.509876 0 0 0 0 17.7226 0 0 0 0 0 0 0 0 0 0 15.42758 15.91125 0 0 0 0 0 0 0 0 16.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MWK0 FS2P1_HUMAN "Putative fatty acid desaturase 2-like protein FADS2B (Fatty acid desaturase 2 pseudogene 1) (Fatty acid desaturase 2B, pseudogene)" FADS2B FADS2P1 Homo sapiens (Human) lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]" "metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]" GO:0005789; GO:0006629; GO:0006636; GO:0016021; GO:0016717; GO:0046872 CGDNGSIVGR 5.039999962 1 1 0.152062349 1029.131793 18.9048 14.84278 14.62104 13.28255 14.29578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8116 0 0 15.32494 15.34048 0 0 17.79429 0 0 0 0 0 0 0 0 0 0 0 0 0 14.88599 14.82086 A8MWL7 TM14D_HUMAN Transmembrane protein 14DP TMEM14DP TMEM14D Homo sapiens (Human) regulation of heme biosynthetic process [GO:0070453] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; regulation of heme biosynthetic process [GO:0070453] GO:0016021; GO:0031966; GO:0070453 MLMTSD 23.98999977 0.667627335 0.667627335 0.189767967 695.4342922 17.94663 15.71597 16.89378 0 14.93939 17.43387 19.3083 18.88523 16.88769 18.11197 14.84995 0 18.41329 16.87909 19.74252 14.22065 16.10902 15.36034 16.91725 0 0 17.38791 16.5654 0 16.85278 0 17.64955 17.36786 18.02353 0 0 17.90414 13.50674 18.93943 17.69135 18.14107 19.57856 19.51551 16.61336 0 0 17.70204 18.1297 0 15.99759 0 15.9326 19.51459 A8MWP4 YU008_HUMAN Putative uncharacterized protein ENSP00000401716 Homo sapiens (Human) MQRPHRR 10.10999966 0.310438871 0.310438871 0.145537888 996.6907715 16.9416 0 12.21616 0 0 0 0 0 14.9517 16.20563 0 0 0 0 0 0 14.68292 13.51441 13.81557 0 15.84421 13.18706 0 0 0 0 0 0 0 0 15.7929 0 0 11.73873 0 0 0 0 0 12.56256 0 0 0 15.79223 0 0 0 0 A8MX76 CAN14_HUMAN "Calpain-14, EC 3.4.22.- (Calcium-activated neutral proteinase 14, CANP 14)" CAPN14 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] GO:0004198; GO:0005509; GO:0005737; GO:0006508 STAGGQR 7.179999828 0.473042786 0.473042786 0.25207661 675.2373704 15.81402 0 0 0 15.92972 13.19718 0 0 0 16.31864 15.28395 0 14.44884 14.64218 15.87647 0 15.1606 0 16.29954 0 15.78784 0 0 14.76652 15.66346 15.62674 16.38638 14.05869 15.28673 0 0 17.25929 0 0 15.95568 0 0 16.96168 0 16.08101 15.49342 15.42988 16.30087 16.7546 15.97473 0 0 16.98329 A8MX80 YM017_HUMAN Putative UPF0607 protein ENSP00000383144 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 SSPPKAAGHR 8.81000042 0.069837257 0.069837257 0.221407474 1008.140753 0 14.18547 0 0 0 0 15.34732 0 0 15.90519 13.45665 15.68507 0 15.37497 14.71833 13.79132 15.14171 0 15.7948 15.39859 0 16.03665 15.66323 0 15.75575 15.32588 15.88371 14.85542 14.43918 7.348936 15.41473 15.24427 13.91328 14.10241 14.58752 10.84809 13.28681 0 15.11322 15.17089 0 0 13.89817 13.37588 14.1907 16.63729 12.28941 15.32813 A8MXD5 GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 GRXCR1 DFNB25 Homo sapiens (Human) inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118] kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420] kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420]; glutathione oxidoreductase activity [GO:0097573]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118] glutathione oxidoreductase activity [GO:0097573] GO:0005902; GO:0007605; GO:0032420; GO:0042491; GO:0048563; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0097573 AASEK 2.920000076 1 1 0.293896643 505.5114523 0 0 0 0 0 0 22.25716 0 0 0 0 0 19.47866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MXQ7 IQAK1_HUMAN IQ motif and ankyrin repeat domain-containing protein 1 IQANK1 Homo sapiens (Human) regulation of barbed-end actin filament capping [GO:2000812] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of barbed-end actin filament capping [GO:2000812] GO:0005634; GO:0005737; GO:2000812 VQLPGTGL 3.809999943 0.757439613 0.757439613 0.201993267 784.4663009 16.85389 13.29934 15.58384 0 14.81746 15.27343 0 14.5367 13.91554 15.39001 14.52469 16.02802 16.02366 0 15.25764 14.42069 15.56131 14.30122 14.03847 0 14.99207 0 0 16.12471 16.25089 0 14.14309 14.37893 12.77448 15.26876 17.00437 11.56319 16.51388 15.63001 15.4356 15.01022 14.80868 15.61228 15.62505 15.26303 14.44688 13.53865 0 11.77335 0 16.51418 16.23758 14.12481 A8MXT2 MAGBH_HUMAN Melanoma-associated antigen B17 MAGEB17 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 GQKGESPNSFHGPSSSESTGR 3.809999943 0.872695744 0.872695744 2.75E-12 2130.623872 0 17.41832 0 0 13.27559 14.86854 12.85178 0 12.15191 0 0 0 11.25237 0 0 11.37344 0 0 0 0 0 0 0 0 15.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.13609 0 0 14.8701 0 0 0 A8MXV4 NUD19_HUMAN "Acyl-coenzyme A diphosphatase NUDT19, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 19, Nudix motif 19)" NUDT19 Homo sapiens (Human) butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; fatty acid catabolic process [GO:0009062]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; fatty acid catabolic process [GO:0009062]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005782; GO:0005829; GO:0009062; GO:0010945; GO:0015938; GO:0036114; GO:0044580; GO:0106399; GO:1901289; GO:1902858; GO:2001294 SSSLRPGPSR 19.15999985 1 1 0.276387995 1042.324056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.26333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.8112 A8MXV6 CD15L_HUMAN CMT1A duplicated region transcript 15 protein-like protein CDRT15L2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EGVTSTAPASR 4.829999924 1 1 0.262085685 1076.85537 0 13.99986 0 0 0 14.10885 15.33149 0 0 14.21805 0 0 14.64306 14.95335 0 0 0 0 0 16.48425 15.96589 17.91334 14.45702 13.59291 0 14.91214 0 0 0 0 17.27899 16.18621 0 0 0 0 0 0 0 0 0 0 0 14.55563 0 14.60387 0 0 A8MYA2 CX049_HUMAN Uncharacterized protein CXorf49 CXorf49; CXorf49B Homo sapiens (Human) AQLPTHRPGLPR 1.539999962 1 1 0.451768955 1343.902032 0 0 0 0 0 17.27648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.60457 0 A8MYJ7 TTC34_HUMAN "Tetratricopeptide repeat protein 34, TPR repeat protein 34" TTC34 Homo sapiens (Human) APTARMFLLR 6.019999981 1 1 0.01740053 1190.796033 0 13.90183 0 0 15.7825 0 8.454234 0 12.97187 11.7655 0 0 0 0 14.85208 0 0 0 0 13.75823 0 0 0 0 0 0 0 0 0 10.82461 0 12.01956 0 0 0 0 0 0 0 11.89629 0 0 0 0 0 0 0 0 A8MYU2 KCNU1_HUMAN "Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)" KCNU1 KCNMA3 KCNMC1 SLO3 Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765]; reproductive process [GO:0022414] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765]; reproductive process [GO:0022414] potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244] GO:0005244; GO:0005267; GO:0005886; GO:0016021; GO:0022414; GO:0034765 IIIQILQSHNKVYLPK 2.690000057 1 1 0.306429912 1908.276229 15.96108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.44525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MYZ6 FOXO6_HUMAN Forkhead box protein O6 FOXO6 Homo sapiens (Human) memory [GO:0007613]; positive regulation of dendritic spine development [GO:0060999]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; memory [GO:0007613]; positive regulation of dendritic spine development [GO:0060999]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007613; GO:0060999 ATAPAMAPAPPLGAEVGPLR 6.739999771 1 1 0.325543885 1904.352639 16.14437 14.60539 0 19.72446 0 19.56057 0 0 0 0 0 19.93134 0 0 18.56357 0 20.37325 20.14636 0 0 0 0 0 0 0 0 0 0 0 19.35155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.1719 0 A8MZ25 YQ037_HUMAN Putative uncharacterized protein FLJ38767 Homo sapiens (Human) RRPPGSPCSIR 7.019999981 1 1 0.190244728 1279.087408 15.24026 0 0 13.58455 0 0 0 0 0 0 0 0 0 0 0 15.91809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.76629 0 0 0 16.1937 0 0 0 0 A8MZF0 PRR33_HUMAN Proline-rich protein 33 PRR33 C11orf89 Homo sapiens (Human) MSVAEAQGR 9.460000038 0.488035977 0.488035977 0.28562548 963.0587219 18.66991 0 0 0 16.82452 0 18.36049 0 18.7063 18.47109 0 18.47457 0 0 0 0 0 16.97839 0 18.45128 0 17.15357 0 0 17.52265 18.5714 0 0 17.2479 17.20827 0 0 0 0 0 0 0 0 19.7467 19.0424 0 17.67477 0 0 17.09769 0 16.78261 18.31917 A8MZH6 OOSP1_HUMAN Putative oocyte-secreted protein 1 homolog OOSP1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MKTILGFK 10.27000046 1 1 0.041341096 936.6953839 18.65971 0 14.3452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.86841 0 0 0 0 0 0 16.54938 15.26657 0 A8TX70 CO6A5_HUMAN Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4) COL6A5 COL29A1 VWA4 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0062023 DVGNAMR 2.25999999 1 1 0.2568901 778.941149 12.19299 14.7059 14.18211 0 14.59613 15.24191 13.14065 14.76013 15.83682 0 0 15.14886 14.83881 15.34063 14.13285 14.93702 0 0 0 0 0 0 0 16.01489 0 0 0 0 0 0 15.44378 16.21027 0 0 0 0 0 0 15.68051 14.30122 15.85719 16.18436 0 15.71731 0 0 0 0 A9YTQ3 AHRR_HUMAN "Aryl hydrocarbon receptor repressor, AhR repressor, AhRR (Class E basic helix-loop-helix protein 77, bHLHe77)" AHRR BHLHE77 KIAA1234 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; xenobiotic metabolic process [GO:0006805] aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]; xenobiotic metabolic process [GO:0006805]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000981; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006805; GO:0034751; GO:0046983 AAEAAPVVK 12.98999977 0.187505662 0.187505662 0.272362812 854.586077 16.73652 19.89082 17.6467 19.87631 17.83966 20.64673 0 18.47711 0 0 0 0 17.05109 17.33592 0 0 20.7576 0 19.50392 0 0 0 0 0 18.59581 0 0 18.93509 0 0 0 21.56477 18.18447 0 0 18.02846 18.46255 0 0 19.26715 0 0 0 0 0 0 18.94339 0 A9Z1Z3 FR1L4_HUMAN Fer-1-like protein 4 FER1L4 C20orf124 Homo sapiens (Human) plasma membrane organization [GO:0007009] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; plasma membrane organization [GO:0007009] metal ion binding [GO:0046872] GO:0007009; GO:0016021; GO:0046872 IYNRSLK 4.340000153 0.456995457 0.456995457 0.173029075 894.6971486 15.85351 0 12.14242 0 14.25548 0 0 0 13.77178 15.46727 15.01971 0 15.13906 13.72229 16.07702 16.8821 0 16.34906 15.55648 16.87642 15.20369 16.53872 16.22102 14.34137 17.02489 0 12.08578 13.85684 0 0 15.30282 16.09288 0 0 16.44075 14.44934 16.73228 15.6455 14.85677 14.96471 0 15.80409 15.81621 14.63195 15.46399 16.56046 14.17276 15.32274 B0I1T2 MYO1G_HUMAN "Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2, mHag HA-2 ]" MYO1G HA2 Homo sapiens (Human) actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]" "actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117 VAAMGALQGLR 7.960000038 1 1 0.265829394 1102.084338 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.26256 0 16.57596 0 0 0 0 0 0 17.53608 16.02821 0 0 0 B1AJZ9 FHAD1_HUMAN "Forkhead-associated domain-containing protein 1, FHA domain-containing protein 1" FHAD1 KIAA1937 Homo sapiens (Human) LSDALAMVEETQKTK 1.00999999 1 1 0.291655776 1680.369358 17.0944 0 0 0 0 0 18.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1AK76 SNUFL_HUMAN Putative SNURF-like protein SNURFL CXorf19 Homo sapiens (Human) nuclear speck [GO:0016607] nuclear speck [GO:0016607] GO:0016607 WTTEQHMPEVEVQVK 3.269999981 0.842364252 0.842364252 0.325770371 1856.616119 0 0 0 0 0 0 15.00366 0 0 0 0 0 0 11.67856 0 0 0 0 0 15.80612 16.64711 0 0 13.93713 0 15.07658 0 16.14545 16.64775 0 17.13958 0 0 16.04217 0 16.67458 0 13.91849 0 0 0 0 15.64743 14.38169 13.95515 0 0 16.53022 B1ANS9 WDR64_HUMAN WD repeat-containing protein 64 WDR64 Homo sapiens (Human) INDILFLFR 7.159999847 1 1 0.293556041 1148.367752 0 17.86071 14.44305 0 0 0 0 0 0 0 0 0 0 15.86362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.26401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1ANY3 F220P_HUMAN Putative protein FAM220BP (Protein FAM220B pseudogene) FAM220BP C9orf51 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470] nucleus [GO:0005634] nucleus [GO:0005634]; STAT family protein binding [GO:0097677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470] STAT family protein binding [GO:0097677] GO:0000122; GO:0005634; GO:0006470; GO:0097677 ATHGHRGQCPK 1.909999967 0.671806455 0.671806455 0.160200991 1249.826053 0 0 14.1514 15.24561 11.86856 14.70872 0 0 14.76673 0 13.21822 0 0 14.55689 0 15.54124 0 0 0 0 0 0 0 13.94771 0 0 15.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B2CW77 KILIN_HUMAN Killin KLLN Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; cell cycle [GO:0007049] DNA binding [GO:0003677] GO:0003677; GO:0005654; GO:0005730; GO:0006915; GO:0007049 VSLVGELSK 10.5 0.436375946 0.436375946 0.181742731 932.68241 15.3178 16.93025 15.75559 14.54565 0 0 17.77659 0 0 0 0 15.2254 0 0 15.4476 15.91455 16.36679 15.85377 15.61077 15.6075 0 15.98777 13.83082 14.68492 0 16.8696 0 17.92355 0 0 0 15.8691 0 0 17.79037 15.51885 15.51507 0 16.62531 17.8273 16.41892 0 15.16316 16.6485 0 0 18.02616 0 B2RTY4 MYO9A_HUMAN Unconventional myosin-IXa (Unconventional myosin-9a) MYO9A MYR7 Homo sapiens (Human) cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601] axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461] axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601] actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005829; GO:0007601; GO:0016021; GO:0016461; GO:0034329; GO:0035556; GO:0043547; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0051056; GO:0150011 AHGILTR 10.64999962 1 1 0.0976284 767.3653576 16.58578 0 14.22322 0 0 0 16.74161 0 0 0 0 0 0 0 0 15.38086 16.22908 15.27343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.56169 0 0 0 0 0 0 20.69524 0 0 0 B2RXF0 T229A_HUMAN Transmembrane protein 229A TMEM229A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RPRGPR 6.460000038 1 1 0.276620455 738.0644528 0 0 17.04145 0 0 0 18.70285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.54564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.053 B2RXH4 BTBDI_HUMAN BTB/POZ domain-containing protein 18 BTBD18 Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spermatogenesis [GO:0007283] GO:0005634; GO:0007141; GO:0007283; GO:0010529; GO:0030154; GO:0032968; GO:1990511 CSPASPK 5.130000114 1 1 0.175333501 747.1731265 0 15.09279 0 0 0 0 0 0 16.12498 0 0 0 13.5073 0 0 0 0 0 0 0 0 16.41784 0 0 0 13.26178 0 0 13.52772 14.78118 0 0 0 15.84263 0 0 0 0 0 0 0 16.4385 0 0 0 13.43506 15.87707 16.74372 B3KS81 SRRM5_HUMAN Serine/arginine repetitive matrix protein 5 SRRM5 ZNF576 Homo sapiens (Human) MSSPKR 5.199999809 1 1 0.135178646 706.1818411 13.9629 16.10505 0 14.34635 15.14155 16.03701 0 0 12.32535 14.21977 14.19635 14.20957 0 0 0 0 15.32471 14.30901 0 0 0 0 0 0 0 0 0 15.51764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.97466 13.29814 0 13.51952 B4DJY2 TM233_HUMAN "Transmembrane protein 233 (Dispanin subfamily B member 2, DSPB2) (Interferon-induced transmembrane domain-containing protein D2)" TMEM233 IFITMD2 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 MSQYAPSPDFKR 10.93999958 1 1 2.29E-13 1426.220523 0 0 15.49832 14.55392 10.968 13.82596 13.62546 14.80719 14.82168 15.06226 0 0 13.69789 16.00121 0 13.02658 0 14.11577 15.05195 14.07089 0 12.40761 0 14.27191 0 0 0 16.17018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B4DU55 ZN879_HUMAN Zinc finger protein 879 ZNF879 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 VLVTIKK 1.50999999 1 1 0.006325461 800.5875407 14.3726 15.16742 17.04964 15.91277 0 13.52566 0 15.28849 0 12.96662 0 0 0 0 0 15.06892 0 0 0 0 14.84819 0 0 0 0 0 17.02886 0 0 0 0 0 0 0 0 0 16.46584 0 0 0 0 0 0 0 0 0 0 0 B4DX44 ZN736_HUMAN Zinc finger protein 736 ZNF736 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 MGVLTFR 10.21000004 0.384276152 0.384276152 0.268927203 839.110827 0 19.56952 18.53477 0 0 0 0 19.06967 0 0 0 18.24248 0 0 0 0 0 18.16386 0 0 0 18.16388 0 0 18.70938 0 0 0 0 0 0 0 0 0 0 19.07214 0 0 0 0 18.16676 0 0 0 18.08762 0 0 17.44781 B4DXR9 ZN732_HUMAN Zinc finger protein 732 ZNF732 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 IITSSSNVAK 2.519999981 0.13596414 0.13596414 0.123506802 1020.821691 13.79378 0 17.11325 11.81877 0 0 0 0 0 0 16.10498 18.73048 0 0 17.78038 0 12.4439 15.1705 0 19.17451 15.78848 19.53604 16.57377 0 0 0 14.90598 0 13.58291 0 0 0 0 0 16.00069 15.74075 16.53665 0 13.88408 0 0 17.51488 0 0 16.97536 0 14.7365 0 B4DYI2 S31C2_HUMAN Putative spermatogenesis-associated protein 31C2 (Protein FAM75C2) SPATA31C2 FAM75C2 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 AHMSR 5.329999924 1 1 0.166422401 600.7524371 13.4355 15.08422 0 15.17001 14.82476 0 0 0 0 14.12435 0 0 0 15.91967 16.15942 13.80182 0 0 0 0 0 0 0 0 14.7833 15.75014 16.50393 0 0 0 0 14.13502 0 13.86219 15.1557 17.1139 15.67443 11.97679 0 13.16506 15.47616 12.95512 16.10972 0 0 16.89958 13.2059 0 B5MCN3 S14L6_HUMAN Putative SEC14-like protein 6 SEC14L6 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 KHMEFR 10.18000031 1 1 0.058351916 865.4430573 14.00616 11.20098 14.76248 13.01821 12.90546 13.09848 14.01094 15.38064 13.72469 14.38373 13.65662 0 0 0 15.75547 0 15.07015 15.4594 0 0 16.31496 0 15.67237 0 0 0 0 0 0 0 0 16.37636 14.27115 15.12105 0 0 13.81124 0 0 0 14.69974 0 0 0 0 0 0 0 B5MCY1 TDR15_HUMAN Tudor domain-containing protein 15 TDRD15 Homo sapiens (Human) P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] P granule [GO:0043186] P granule [GO:0043186]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] GO:0030719; GO:0034587; GO:0043186 CVINELLK 13.06000042 1 1 0.160874788 988.5894457 16.54487 15.7683 0 0 14.64146 14.63276 14.10653 0 15.10745 16.01173 13.64132 13.32952 15.83792 0 0 0 14.60814 15.26214 0 16.65845 0 0 13.24661 0 0 15.54405 0 0 14.71586 15.83034 15.73661 15.38184 16.33241 15.79185 14.94894 15.41982 0 14.08519 16.27463 15.26725 13.13932 14.54897 14.34688 13.0474 13.11284 15.94271 14.73252 16.20389 B7Z6K7 ZN814_HUMAN Zinc finger protein 814 ZNF814 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 MAAAATLR 5.320000172 1 1 0.183426706 823.3572443 0 12.62788 0 0 15.85091 0 13.44099 0 14.15202 15.66989 15.71503 0 0 12.97581 0 0 0 0 0 0 15.46989 0 15.48351 0 0 0 0 0 0 0 0 0 15.91633 0 0 0 0 0 0 0 0 15.72369 0 0 0 0 0 0 B8ZZ34 SHSA8_HUMAN Protein shisa-8 (Shisa family member 8) SHISA8 C22orf17 Homo sapiens (Human) regulation of AMPA receptor activity [GO:2000311]; regulation of short-term neuronal synaptic plasticity [GO:0048172] AMPA glutamate receptor complex [GO:0032281]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] AMPA glutamate receptor complex [GO:0032281]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; regulation of AMPA receptor activity [GO:2000311]; regulation of short-term neuronal synaptic plasticity [GO:0048172] GO:0014069; GO:0032281; GO:0032591; GO:0045211; GO:0048172; GO:2000311 RPGHAAR 3.390000105 0.27661851 0.27661851 0.168255487 763.6804049 0 0 0 0 0 0 0 0 0 0 15.96923 0 16.19128 15.15326 0 0 15.38835 14.71342 0 17.60282 17.14236 0 0 0 17.11274 15.11808 15.43625 15.73724 0 16.97348 0 0 15.19088 15.87891 0 17.1264 0 16.13137 0 16.90553 16.27064 0 12.11782 15.08479 12.76208 13.92836 16.77943 15.66102 C9J202 AG1L2_HUMAN "Putative glycosyltransferase ALG1L2, EC 2.4.1.-" ALG1L2 Homo sapiens (Human) protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; mannosyltransferase activity [GO:0000030]; protein glycosylation [GO:0006486] mannosyltransferase activity [GO:0000030] GO:0000030; GO:0005783; GO:0006486 LFMKLGSTHSPFR 16.89999962 1 1 2.29E-12 1521.479804 11.97311 10.54168 12.4099 15.60733 13.69658 13.51182 0 14.14555 15.17073 13.55566 15.08961 0 14.67935 0 15.65353 14.95895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JC47 F157A_HUMAN Putative protein FAM157A FAM157A Homo sapiens (Human) LLHDLHLLAFAMKR 4.110000134 1 1 0.228129663 1689.375362 0 14.63119 18.24395 0 14.44509 13.90382 0 0 0 13.41615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.73071 0 0 0 0 0 0 14.64445 0 0 13.60144 0 0 0 0 15.79546 12.57528 12.92678 0 C9JE40 PATL2_HUMAN "Protein PAT1 homolog 2 (PAT1-like protein 2) (Protein PAT1 homolog a, Pat1a, hPat1a)" PATL2 Homo sapiens (Human) deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962] RNA binding [GO:0003723] GO:0000290; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0017148; GO:0033962 IEGSLGQVAVSTCFSPRR 4.28000021 0.935141027 0.935141027 1.60E-12 1964.609473 11.26358 0 0 0 0 17.2906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.44885 0 0 0 0 0 0 0 0 0 0 13.19535 0 0 0 14.8287 15.70132 0 0 0 0 0 0 0 15.41055 0 C9JFL3 PHGR1_HUMAN "Proline, histidine and glycine-rich protein 1" PHGR1 Homo sapiens (Human) MDPGPK 3.160000086 1 1 0.156651612 659.3036768 0 14.65966 12.30713 15.5944 15.61623 15.3323 15.23091 14.65582 14.94799 0 16.82157 14.32579 0 16.0083 15.94185 0 0 16.5772 0 0 0 15.40507 0 0 0 0 17.16405 0 0 0 0 0 0 0 0 0 18.84476 0 0 16.9135 16.05897 0 0 0 0 0 0 0 C9JG80 NPIB4_HUMAN Nuclear pore complex-interacting protein family member B4 NPIPB4 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 IVLKDVITLR 3.369999886 0.405865312 0.405865312 0.127833311 1170.55398 14.97401 13.50214 14.85151 0 15.60268 12.58023 12.18366 0 0 0 0 0 0 0 15.94745 0 0 0 0 0 0 0 0 0 14.8491 13.31447 0 15.03928 15.94612 0 14.75391 0 0 0 15.89881 12.82713 11.76991 0 15.23426 14.18756 0 0 0 0 0 0 0 15.62924 C9JLR9 ZFTA_HUMAN "Zinc finger translocation-associated protein, ZFTA" ZFTA C11orf95 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" "negative regulation of transcription, DNA-templated [GO:0045892]" GO:0045892 HPGSTR 4.809999943 1 1 0.268273082 654.8169365 0 0 0 0 0 0 0 0 0 0 17.16449 0 0 0 16.10575 0 0 0 0 0 0 0 0 0 0 17.88139 16.23009 0 0 0 17.30219 0 0 17.55269 0 16.93744 0 0 18.40853 17.84645 17.91563 0 17.20213 0 17.91995 0 0 16.52097 C9JLW8 MCRI1_HUMAN Mapk-regulated corepressor-interacting protein 1 (Granulin-2) (Protein FAM195B) MCRIP1 FAM195B GRAN2 Homo sapiens (Human) regulation of epithelial to mesenchymal transition [GO:0010717] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; regulation of epithelial to mesenchymal transition [GO:0010717] GO:0005634; GO:0005737; GO:0010494; GO:0010717 MTSSPVSR 5.909999847 0.109363556 0.109363556 0.256785414 863.5061727 13.76018 0 0 0 0 14.35109 14.85276 16.17062 13.44124 15.4996 16.7567 14.41747 14.64718 0 0 14.84052 16.5381 0 15.62191 15.04944 0 0 0 0 16.82162 0 0 14.96151 17.09737 0 16.23767 15.1698 0 15.63328 0 0 16.06742 0 15.66888 0 16.0302 0 0 15.73091 15.91211 0 15.79828 0 C9JSJ3 MEIOS_HUMAN Meiosis initiator protein (Basic helix-loop-helix and HMG box domain-containing protein 1) MEIOSIN BHMG1 Homo sapiens (Human) activation of meiosis [GO:0090427]; cellular response to retinoic acid [GO:0071300]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; activation of meiosis [GO:0090427]; cellular response to retinoic acid [GO:0071300]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] DNA binding [GO:0003677]; protein dimerization activity [GO:0046983] GO:0003677; GO:0005634; GO:0006357; GO:0007283; GO:0046983; GO:0048477; GO:0051321; GO:0071300; GO:0090427 LVAPSPDQK 12.07999992 0.592900276 0.592900276 0.253287326 957.2308289 17.17056 15.73532 0 0 14.66075 15.00465 17.17403 12.547 0 17.12938 15.57493 16.59165 0 15.77838 15.222 17.33992 0 15.62588 18.11752 15.28449 15.62919 0 16.53417 0 16.90676 16.04065 0 14.05944 0 15.25313 0 0 0 0 0 15.1596 0 0 16.17325 15.57254 15.78621 16.0896 14.95104 0 13.90638 15.17494 16.14666 15.69114 C9JTQ0 ANR63_HUMAN Ankyrin repeat domain-containing protein 63 ANKRD63 Homo sapiens (Human) AGALMALPNSPQSSGTGRWR 4.170000076 1 1 0.212185938 2072.162804 15.43412 0 15.09516 14.92042 14.19509 11.75319 13.7991 13.19721 15.19233 0 0 0 18.62179 13.5849 13.63235 14.57738 12.68504 13.83023 0 0 0 0 0 0 0 0 0 15.47923 14.23777 0 0 18.99227 0 0 0 0 0 0 0 0 0 14.76614 0 0 0 0 0 0 D6REC4 CFA99_HUMAN Cilia- and flagella-associated protein 99 CFAP99 Homo sapiens (Human) motile cilium [GO:0031514] motile cilium [GO:0031514] GO:0031514 SQELQNMVEQISLCRAAMGR 4.760000229 1 1 4.75E-13 2337.182431 15.69101 16.08255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.17039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 D6RIA3 CD054_HUMAN Uncharacterized protein C4orf54 (Familial obliterative portal venopathy) C4orf54 FOPV Homo sapiens (Human) CGGVGARVEQSLLR 8.760000229 1 1 0.10242558 1501.413041 16.13451 14.5952 15.16457 14.42826 14.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.71698 0 0 18.17782 17.78126 0 0 0 0 0 0 0 0 0 15.35457 15.6635 16.27022 13.13527 0 0 14.08662 14.16387 0 0 0 0 0 0 0 E0CX11 STMP1_HUMAN Short transmembrane mitochondrial protein 1 STMP1 C7orf73 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227] integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrial respirasome [GO:0005746] integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrial respirasome [GO:0005746]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227] GO:0005741; GO:0005746; GO:0005758; GO:0016021; GO:0032731; GO:0045087; GO:1900227 KKPPSA 7.090000153 1 1 0.1784212 625.5715836 0 0 0 0 0 0 16.19776 0 0 0 0 15.54981 0 0 0 0 0 15.48446 0 0 0 0 14.63723 0 0 0 0 0 0 16.6974 11.45936 0 15.3932 0 0 14.72408 16.78817 0 16.89448 16.03211 15.71869 15.17562 0 0 14.52774 15.3164 0 17.22509 E2RYF7 PBMU2_HUMAN Protein PBMUCL2 (HLA complex group 22) (Panbronchiolitis-related mucin-like protein 2) HCG22 G2 PBMUCL2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 HPETSPKDSR 2.609999895 0.555025756 0.555025756 0.194692481 1155.009894 0 15.76507 16.38496 13.4113 12.77634 0 17.36287 13.10346 0 6.495792 13.91647 0 13.99342 0 0 13.37587 15.28735 0 0 0 0 0 0 0 13.82242 0 0 0 0 0 16.27202 16.24246 0 16.00317 0 0 14.40765 16.35238 0 0 0 0 0 0 15.56781 0 0 0 E7EW31 PROB1_HUMAN Proline-rich basic protein 1 PROB1 C5orf65 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 QTPNGAVR 13.67000008 1 1 0.180065555 841.7534231 0 0 0 13.60468 13.44915 15.16678 0 0 15.42231 0 0 14.39487 0 13.65544 0 15.05477 0 0 0 0 0 0 0 0 16.06685 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74075 0 14.83423 0 0 0 0 0 0 0 E9PAV3 NACAM_HUMAN "Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form, skNAC)" NACA Homo sapiens (Human) protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; DNA binding [GO:0003677]; unfolded protein binding [GO:0051082]; protein targeting to membrane [GO:0006612] DNA binding [GO:0003677]; unfolded protein binding [GO:0051082] GO:0003677; GO:0005634; GO:0005737; GO:0005854; GO:0006612; GO:0051082 ATPAPK 1.159999967 1 1 2.32E-13 582.3201276 0 0 15.16197 0 15.22248 14.0537 0 0 0 0 0 0 0 0 0 0 0 16.21466 0 0 14.36129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F2Z333 FND10_HUMAN Fibronectin type III domain-containing protein 10 FNDC10 C1orf233 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CQAPGCVLHAPAGR 4.820000172 1 1 0.046617951 1493.359918 0 15.33988 16.80939 0 0 0 13.04389 14.77962 16.55042 0 16.27346 0 0 16.78884 0 14.43437 0 0 0 0 16.37748 0 15.80502 0 14.09096 0 0 0 0 0 0 16.48192 0 0 0 16.29908 0 0 0 0 0 0 0 0 0 0 14.81933 0 F5H4B4 F227A_HUMAN Protein FAM227A FAM227A Homo sapiens (Human) NTMVKTVR 4.78000021 0.261385798 0.261385798 0.07866374 949.5580959 13.82972 18.52146 16.22859 12.00903 15.80268 0 16.15348 0 15.05668 17.32737 11.45792 13.16015 15.90287 18.65122 0 0 0 0 17.18691 0 0 0 0 18.06952 0 12.18245 11.23981 0 16.65186 0 18.03011 17.68431 15.99675 16.66761 19.11968 0 17.26723 0 18.60828 0 0 0 16.85963 0 0 0 17.18904 16.39004 H3BQB6 STMD1_HUMAN Stathmin domain-containing protein 1 STMND1 Homo sapiens (Human) microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110] tubulin binding [GO:0015631] GO:0005737; GO:0007019; GO:0015631; GO:0031110; GO:0031175; GO:0043005 NESDESFGVVESDMSYNQADDIVY 3.00999999 0.461228997 0.461228997 0.144947031 2713.611212 0 14.22546 0 0 0 15.30017 16.55318 0 15.75674 0 15.4102 0 0 0 0 17.97049 0 15.94576 0 0 0 0 13.29068 0 0 13.29333 0 0 16.01608 0 0 0 13.4585 0 15.4236 16.47642 10.69549 0 15.2029 0 13.25891 0 16.82322 17.64703 15.27399 14.78876 0 0 H3BUK9 POTB2_HUMAN POTE ankyrin domain family member B2 POTEB2 Homo sapiens (Human) SKMGK 5.440000057 0.67397511 0.67397511 0.187879964 569.5609078 15.02011 16.02617 16.46111 14.96296 0 13.56588 15.78342 0 16.60354 15.50198 0 15.89301 0 18.37539 15.9451 0 16.88955 0 0 15.44577 0 15.51237 0 0 0 0 15.58035 16.7799 17.01105 15.44389 16.2094 16.65302 16.92114 17.98758 0 17.11936 16.92123 15.85303 13.37079 16.61022 14.96972 13.99649 14.74653 17.1727 17.53562 14.09396 16.43849 16.47058 H7BZ55 CRCC2_HUMAN Ciliary rootlet coiled-coil protein 2 CROCC2 Homo sapiens (Human) LQDLTAQHQR 8.43999958 0.26390481 0.26390481 0.03616398 1212.288969 0 12.1494 0 0 15.82233 18.37015 0 18.02109 15.00543 0 0 16.10084 16.13262 0 13.51447 0 0 15.81538 14.10064 0 0 0 0 0 0 0 16.18358 0 0 0 15.14713 15.87723 14.24022 0 0 0 15.7796 0 14.67104 15.11001 0 0 0 0 16.07507 0 0 11.16306 I3L1E1 CS084_HUMAN Uncharacterized protein C19orf84 C19orf84 Homo sapiens (Human) AGGPGAGPR 9.550000191 1 1 0.224585676 740.8715107 14.99526 0 14.50825 14.58784 15.01895 12.2464 11.2677 15.43714 16.15465 0 16.1449 15.31467 0 15.27868 14.52283 0 15.68758 16.28709 15.78174 15.6452 16.01669 14.95722 0 15.32359 15.15784 15.13752 15.17118 0 0 0 0 0 0 0 0 0 0 0 0 14.70569 0 0 0 0 16.04534 16.0254 12.76351 0 I3L273 GFY_HUMAN "Golgi-associated olfactory signaling regulator (Golgi protein in olfactory neurons, Goofy)" GFY Homo sapiens (Human) non-motile cilium assembly [GO:1905515]; protein localization to non-motile cilium [GO:0097499]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; non-motile cilium assembly [GO:1905515]; protein localization to non-motile cilium [GO:0097499]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] GO:0007608; GO:0030173; GO:0050896; GO:0097499; GO:1905515 ILFLVFLLAGLRSK 6.550000191 1 1 0.743956847 1591.132336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0183 0 0 18.77842 0 0 19.238 21.15271 0 0 0 0 0 0 0 0 17.78506 0 0 0 18.77407 0 I3L3R5 CCER2_HUMAN Coiled-coil domain-containing glutamate-rich protein 2 CCER2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GLLLGDFKK 9.550000191 1 1 0.243610897 991.2066748 18.03013 16.54506 16.70194 12.20334 0 0 14.30926 12.32254 0 16.52388 18.51251 13.18514 0 15.87422 0 15.46406 15.93573 16.49964 0 0 14.6188 15.59449 0 17.41984 12.90324 15.53857 17.61341 0 0 13.47192 16.39197 0 16.96868 15.42562 15.95778 15.78057 16.26863 16.18563 14.1242 0 14.61005 15.3356 16.14559 0 0 11.70432 0 0 K9M1U5 IFNL4_HUMAN "Interferon lambda-4, IFN-lambda-4" IFNL4 Homo sapiens (Human) cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260] cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007260; GO:0038196; GO:0045087; GO:0050778; GO:0051607; GO:0098586 HVARGIADAQAVLSGLHR 1.5 1 1 0.205335605 1869.900972 16.32093 0 13.60682 0 14.79958 0 0 0 0 0 0 0 0 0 0 7.780131 0 0 0 14.43861 14.35328 0 0 0 13.01668 0 0 0 0 0 0 0 0 0 14.19002 0 0 0 0 0 0 0 0 0 0 0 0 15.35789 M0R2J8 DCDC1_HUMAN Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) DCDC1 DCDC5 KIAA1493 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] GO:0005737; GO:0005874; GO:0007049; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 IIAYKNGDGYR 5.889999866 0.587402761 0.587402761 0.073720577 1269.370324 15.98518 16.08079 14.11898 0 14.33364 0 0 0 14.43592 0 15.91024 0 11.79772 0 0 14.24109 16.96497 0 16.70971 15.60536 0 12.9879 13.69315 0 16.71145 16.4177 0 0 17.36575 14.59879 15.56874 0 0 16.19205 16.07223 0 0 16.56917 0 14.67477 0 16.56323 0 13.67088 16.23017 0 0 13.70578 O00139 KIF2A_HUMAN "Kinesin-like protein KIF2A (Kinesin-2, hK2)" KIF2A KIF2 KNS2 Homo sapiens (Human) cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0120103 VFDLLNR 11.68000031 0.353221893 0.353221893 0.171822066 875.4033168 12.00262 16.96215 17.03913 14.1857 14.79123 15.77995 17.22705 17.0036 15.69772 16.95921 16.61612 17.01002 16.23724 0 17.1967 15.94943 16.69982 17.65473 15.80037 17.3301 18.24539 0 17.04747 0 17.51823 11.34901 16.74074 16.85944 15.29171 17.02824 0 18.71826 17.43613 0 0 15.53623 12.17228 16.73928 17.67039 0 11.32285 0 17.82804 0 16.79438 17.38323 14.43795 16.70051 O00141 SGK1_HUMAN "Serine/threonine-protein kinase Sgk1, EC 2.7.11.1 (Serum/glucocorticoid-regulated kinase 1)" SGK1 SGK Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814] ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080] GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045 GMVAILIAFMK 5.619999886 1 1 2.29E-13 1210.326062 15.56125 13.70375 0 0 12.95663 0 0 0 0 0 0 0 15.19882 0 0 0 0 0 0 0 0 0 10.86526 0 11.78705 0 14.34595 13.86566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00148 DX39A_HUMAN "ATP-dependent RNA helicase DDX39A, EC 3.6.4.13 (DEAD box protein 39) (Nuclear RNA helicase URH49)" DDX39A DDX39 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]" cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0042802 FSKYMPSVK 7.989999771 1 1 6.94E-13 1085.703507 15.30521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.13482 0 0 0 0 0 0 14.78332 16.05974 0 16.68917 15.87128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00154 BACH_HUMAN "Cytosolic acyl coenzyme A thioester hydrolase, EC 3.1.2.2 (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase, BACH, hBACH) (CTE-IIa, CTE-II) (Long chain acyl-CoA thioester hydrolase)" ACOT7 BACH Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; protein homodimerization activity [GO:0042803]; acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535] acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; protein homodimerization activity [GO:0042803] GO:0000062; GO:0005654; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0015937; GO:0016290; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0047617; GO:0051792; GO:0052689; GO:0070062; GO:0102991; GO:1900535 QGHAEPQP 4.829999924 1 1 0.270068385 864.2105595 0 0 0 16.6787 0 0 18.65662 0 15.1373 17.42157 15.31814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.55472 0 0 0 0 18.44734 0 0 0 18.01311 0 19.0041 0 14.12701 0 0 0 0 0 0 0 0 0 O00159 MYO1C_HUMAN "Unconventional myosin-Ic (Myosin I beta, MMI-beta, MMIb)" MYO1C Homo sapiens (Human) actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; chromatin remodeling [GO:0006338]; mRNA transport [GO:0051028]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of histone acetylation [GO:0035066]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; B-WICH complex [GO:0110016]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; B-WICH complex [GO:0110016]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; chromatin remodeling [GO:0006338]; mRNA transport [GO:0051028]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of histone acetylation [GO:0035066]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] GO:0000146; GO:0001726; GO:0005102; GO:0005516; GO:0005524; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0006338; GO:0006612; GO:0007015; GO:0008022; GO:0009925; GO:0015629; GO:0016020; GO:0016328; GO:0016461; GO:0016604; GO:0030050; GO:0030335; GO:0030659; GO:0031267; GO:0031941; GO:0031982; GO:0035066; GO:0038089; GO:0045121; GO:0045335; GO:0045943; GO:0045944; GO:0045945; GO:0051015; GO:0051028; GO:0060171; GO:0070062; GO:0071346; GO:0090314; GO:0110016; GO:1900078; GO:1900748; GO:2000810 GAPVGGHILSYLLEKSR 3.670000076 1 1 0.20229813 1796.027518 10.31167 11.79446 0 12.98747 14.02982 13.37939 14.33855 14.19945 14.37288 15.54213 14.3027 15.10774 0 0 14.69662 15.30165 0 0 14.92089 0 0 0 14.14142 0 0 14.85226 0 0 0 0 0 0 0 0 0 0 15.30347 0 0 0 16.02224 15.24746 14.50504 0 10.06779 0 0 0 O00160 MYO1F_HUMAN Unconventional myosin-If (Myosin-Ie) MYO1F Homo sapiens (Human) actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0031982; GO:0051015 GGPLPLEIMSGGGTHRPPR 6.869999886 1 1 0.267892072 1944.00158 0 0 16.54501 0 0 0 0 0 9.53164 0 13.9374 0 0 0 0 0 0 0 0 0 17.36544 0 0 0 18.1479 0 0 0 0 0 18.65173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00170 AIP_HUMAN "AH receptor-interacting protein, AIP (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2, XAP-2) (Immunophilin homolog ARA9)" AIP XAP2 Homo sapiens (Human) negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805] aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805] aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082] GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0036004; GO:0051082; GO:0051344 YYDAIACLK 5.289999962 0.180140346 0.180140346 1.60E-12 1113.519601 15.53857 0 0 0 0 16.41619 0 0 0 0 0 15.47803 16.03232 13.25015 0 16.57086 15.58734 0 0 0 14.07214 0 14.78222 0 15.38083 0 12.17991 0 15.40477 0 0 13.11879 0 0 0 9.065432 0 12.01885 0 0 14.51038 16.53358 0 0 0 0 0 0 O00178 GTPB1_HUMAN "GTP-binding protein 1, G-protein 1, GP-1, GP1" GTPBP1 Homo sapiens (Human) GTP metabolic process [GO:0046039]; immune response [GO:0006955]; positive regulation of mRNA catabolic process [GO:0061014]; signal transduction [GO:0007165]; translational elongation [GO:0006414] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; immune response [GO:0006955]; positive regulation of mRNA catabolic process [GO:0061014]; signal transduction [GO:0007165]; translational elongation [GO:0006414] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] GO:0000177; GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0006955; GO:0007165; GO:0016020; GO:0046039; GO:0061014 AVGTITK 14.81000042 0.621101618 0.621101618 0.24882573 688.6110051 14.8488 12.22919 14.90923 16.3656 0 13.04049 14.39971 14.39275 14.67741 14.42249 15.53763 16.17966 0 14.84977 15.78349 13.98285 15.61504 0 15.90352 15.36883 16.60002 16.86668 15.67124 0 0 15.81663 16.01344 0 16.12266 0 15.83236 0 0 16.05366 0 0 16.95642 16.52689 16.96212 16.11931 16.15039 16.41503 17.12693 16.86363 16.17174 15.90956 0 0 O00180 KCNK1_HUMAN Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1) KCNK1 HOHO1 KCNO1 TWIK1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322] identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272] GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0016324; GO:0022841; GO:0030322; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0055037; GO:0060075; GO:0071805; GO:0097060; GO:1902937 MLQSLAGSSCVRLVER 4.739999771 1 1 0.126163133 1807.046199 15.55945 0 15.79765 0 0 16.13103 14.83358 10.58854 0 13.95426 0 0 0 0 0 15.55377 0 14.22851 0 0 0 0 0 0 16.77666 0 0 0 0 0 0 0 0 15.79691 0 0 0 14.60153 15.25317 0 0 0 0 0 14.90511 15.48416 0 0 O00186 STXB3_HUMAN "Syntaxin-binding protein 3 (Platelet Sec1 protein, PSP) (Protein unc-18 homolog 3, Unc18-3) (Protein unc-18 homolog C, Unc-18C)" STXBP3 Homo sapiens (Human) brain development [GO:0007420]; cellular glucose homeostasis [GO:0001678]; cellular response to interferon-gamma [GO:0071346]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; brain development [GO:0007420]; cellular glucose homeostasis [GO:0001678]; cellular response to interferon-gamma [GO:0071346]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] GO:0001678; GO:0005829; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007420; GO:0016192; GO:0016323; GO:0016324; GO:0017075; GO:0019905; GO:0022615; GO:0030073; GO:0030141; GO:0031091; GO:0032868; GO:0042581; GO:0043312; GO:0044877; GO:0045335; GO:0045955; GO:0046325; GO:0070062; GO:0070527; GO:0070820; GO:0071346; GO:0098793 DSMRVLLPVLLNK 8.569999695 1 1 0.031778517 1497.023737 0 13.0824 0 15.56906 11.96084 15.81355 0 14.20982 11.90739 16.46879 14.53099 0 15.09154 0 0 14.66994 15.23671 13.06165 15.06533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.65764 0 0 0 0 0 0 0 0 0 0 13.28499 0 0 0 O00192 ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome ARVCF Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043] cadherin binding [GO:0045296] GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0016339; GO:0045296; GO:0098609 DTDNKSVENCVCIMR 3.970000029 1 1 0.210689713 1841.923712 18.2161 15.43733 15.62473 15.92547 14.06285 0 0 0 0 0 0 0 0 0 0 0 0 0 15.54009 0 0 17.09489 0 0 16.51821 0 0 0 16.40634 0 0 17.65562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00203 AP3B1_HUMAN AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain) AP3B1 ADTB3A Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular protein modification process [GO:0006464]; cellular zinc ion homeostasis [GO:0006882]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular protein modification process [GO:0006464]; cellular zinc ion homeostasis [GO:0006882]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]" GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903] GO:0000902; GO:0002224; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005769; GO:0005794; GO:0006464; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0035654; GO:0042789; GO:0045202; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1903232; GO:1904115 NVASK 4.329999924 0.238989323 0.238989323 0.177553274 517.460424 15.46754 16.2982 15.64047 16.11605 15.89166 15.12562 0 15.83202 15.76381 16.62891 15.32364 14.67647 15.97381 15.31702 15.58163 0 0 15.95313 0 15.67075 17.26936 16.72592 14.13854 0 15.06664 16.74833 13.32704 15.34867 15.45243 16.77488 15.04651 14.36251 15.41927 16.59249 0 17.61842 13.42041 15.79257 16.95919 16.21643 16.23551 15.1652 15.64684 15.78689 17.85021 16.42659 17.00638 14.72944 O00204 ST2B1_HUMAN "Sulfotransferase 2B1, EC 2.8.2.2 (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1, ST2B1)" SULT2B1 HSST2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] GO:0003676; GO:0004027; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0008146; GO:0008202; GO:0008203; GO:0008285; GO:0015485; GO:0043231; GO:0045606; GO:0050294; GO:0050427; GO:0051923; GO:0070062; GO:1990239 SVPIWER 7.579999924 1 1 3.48E-13 887.7126807 0 0 14.75476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.16834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00206 TLR4_HUMAN Toll-like receptor 4 (hToll) (CD antigen CD284) TLR4 Homo sapiens (Human) activation of innate immune response [GO:0002218]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of fungus [GO:0016046]; detection of lipopolysaccharide [GO:0032497]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide production involved in inflammatory response [GO:0002537]; phagocytosis [GO:0006909]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; wound healing involved in inflammatory response [GO:0002246] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; activation of innate immune response [GO:0002218]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of fungus [GO:0016046]; detection of lipopolysaccharide [GO:0032497]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide production involved in inflammatory response [GO:0002537]; phagocytosis [GO:0006909]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; wound healing involved in inflammatory response [GO:0002246]" "amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]" GO:0001530; GO:0001540; GO:0001726; GO:0001875; GO:0001891; GO:0002218; GO:0002224; GO:0002246; GO:0002322; GO:0002537; GO:0002730; GO:0002755; GO:0004888; GO:0005102; GO:0005737; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0006955; GO:0007252; GO:0009897; GO:0009986; GO:0010008; GO:0010572; GO:0010628; GO:0014002; GO:0014911; GO:0016046; GO:0030890; GO:0031226; GO:0031663; GO:0032496; GO:0032497; GO:0032689; GO:0032700; GO:0032707; GO:0032715; GO:0032720; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034142; GO:0035666; GO:0036120; GO:0038023; GO:0042088; GO:0042116; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043406; GO:0045087; GO:0045348; GO:0045429; GO:0045671; GO:0045944; GO:0046330; GO:0046696; GO:0046982; GO:0048471; GO:0048661; GO:0050135; GO:0050729; GO:0050829; GO:0051092; GO:0051770; GO:0060729; GO:0060907; GO:0061809; GO:0070373; GO:0070374; GO:0070430; GO:0070434; GO:0071222; GO:0071223; GO:0071260; GO:0071346; GO:0120163; GO:0140052; GO:1900017; GO:1900227; GO:1901224; GO:1903223; GO:1903428; GO:1903974; GO:1904466; GO:1904646; GO:2000343 QLLVEVERMECATPSDK 8.350000381 8.57E-14 8.57E-14 0.393537204 2020.016843 0 21.19452 0 0 18.87743 0 19.87898 0 20.16467 0 0 0 0 0 0 20.60444 18.33227 19.98153 19.92783 0 0 0 19.76852 0 0 0 0 19.69718 19.34605 18.63577 19.78214 20.37832 0 0 0 20.80347 20.27196 0 17.89494 0 0 0 0 20.21715 0 19.60649 0 0 O00213 APBB1_HUMAN Amyloid beta precursor protein binding family B member 1 (Amyloid-beta A4 precursor protein-binding family B member 1) (Protein Fe65) APBB1 FE65 RIR Homo sapiens (Human) "apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H4 acetylation [GO:0043967]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H4 acetylation [GO:0043967]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] GO:0000122; GO:0001540; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005886; GO:0006325; GO:0006355; GO:0006915; GO:0006939; GO:0006974; GO:0007165; GO:0007409; GO:0016607; GO:0030027; GO:0030426; GO:0031625; GO:0042393; GO:0043065; GO:0043967; GO:0045202; GO:0045893; GO:0045944; GO:0050714; GO:0050750; GO:0070064; GO:1902807 DLRSAMGEGGGPEPGPANAK 7.139999866 1 1 0.131615303 1925.395814 0 0 12.75835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00220 TR10A_HUMAN "Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1, TRAIL receptor 1, TRAIL-R1) (CD antigen CD261)" TNFRSF10A APO2 DR4 TRAILR1 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462] cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462] death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569] GO:0002020; GO:0005035; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0036462; GO:0038023; GO:0042802; GO:0043065; GO:0045121; GO:0045569; GO:0071260; GO:0097191 NASIHTLLDALER 6.989999771 1 1 0.219047378 1452.820862 14.95249 14.27425 13.78795 15.0244 10.83824 13.53856 16.00001 12.52439 0 0 12.72805 13.05299 0 0 14.43874 0 13.10048 0 0 0 14.56362 0 15.11483 0 0 16.37025 0 0 0 0 0 0 0 0 0 0 15.95369 0 0 0 0 15.3258 0 0 0 14.33625 0 0 O00221 IKBE_HUMAN "NF-kappa-B inhibitor epsilon, NF-kappa-BIE (I-kappa-B-epsilon, IkB-E, IkB-epsilon, IkappaBepsilon)" NFKBIE IKBE Homo sapiens (Human) cytoplasmic sequestering of transcription factor [GO:0042994] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; cytoplasmic sequestering of transcription factor [GO:0042994] GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0042994 GLMGISSTLCKAGADSLLR 8.340000153 1 1 0.223541712 1949.631608 16.27453 0 13.1949 0 0 17.52419 0 0 0 9.893821 14.5244 0 0 0 0 0 15.42982 0 0 0 12.39712 0 0 0 12.15371 14.34466 17.00012 14.69992 13.70677 13.58666 15.71591 0 0 0 0 0 0 0 0 17.32947 0 0 0 0 0 0 0 0 O00222 GRM8_HUMAN "Metabotropic glutamate receptor 8, mGluR8" GRM8 GPRC1H MGLUR8 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]" adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] GO:0001640; GO:0001642; GO:0004930; GO:0005886; GO:0005887; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966 GVPCGELK 3.690000057 1 1 0.133856436 859.7695588 15.72345 16.62028 0 13.90034 16.7173 14.40059 14.38456 14.90844 14.3217 12.96192 0 0 0 13.39127 0 14.65187 0 14.26662 15.12826 14.76897 0 0 0 15.65148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18018 0 0 0 O00232 PSD12_HUMAN 26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55) PSMD12 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008541; GO:0016020; GO:0022624; GO:0031595; GO:0034774; GO:0043161; GO:0070062; GO:1904813 ERVEFILEQMR 12.86999989 1 1 0.274400472 1466.772532 16.91719 14.16152 15.80352 15.65745 14.14367 14.77599 16.04349 16.04186 14.19428 15.2393 0 0 0 13.45751 0 0 16.40246 0 0 0 15.01742 0 15.65391 16.5185 0 16.66886 0 13.58035 13.38076 0 16.44703 14.22678 0 17.0756 0 0 0 15.93928 0 0 0 0 0 0 0 0 0 13.93518 O00253 AGRP_HUMAN Agouti-related protein AGRP AGRT ART Homo sapiens (Human) adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868] extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025] extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025]; melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868] melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996] GO:0005102; GO:0005184; GO:0005615; GO:0005796; GO:0007218; GO:0007623; GO:0007631; GO:0008343; GO:0009755; GO:0031779; GO:0032868; GO:0042755; GO:0043025; GO:0048571; GO:0060135; GO:0060259; GO:0070996; GO:2000253 GAQMGLAPMEGIR 10.19999981 1 1 2.07E-12 1330.037154 13.73989 0 0 0 0 0 0 0 14.56726 0 0 0 0 11.93669 11.66777 12.39159 15.85519 13.8901 13.46859 0 0 15.36574 0 0 14.74302 0 0 0 0 13.85157 15.56844 0 16.15585 14.98752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00264 PGRC1_HUMAN "Membrane-associated progesterone receptor component 1, mPR (Dap1) (IZA)" PGRMC1 HPR6.6 PGRMC Homo sapiens (Human) associative learning [GO:0008306]; axon guidance [GO:0007411]; heme biosynthetic process [GO:0006783]; memory [GO:0007613]; modification of synaptic structure [GO:0099563]; negative regulation of synapse organization [GO:1905809]; positive regulation of protein localization to plasma membrane [GO:1903078] cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202] cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; associative learning [GO:0008306]; axon guidance [GO:0007411]; heme biosynthetic process [GO:0006783]; memory [GO:0007613]; modification of synaptic structure [GO:0099563]; negative regulation of synapse organization [GO:1905809]; positive regulation of protein localization to plasma membrane [GO:1903078] amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496] GO:0001540; GO:0005496; GO:0005741; GO:0005783; GO:0005886; GO:0005887; GO:0006783; GO:0007411; GO:0007613; GO:0008306; GO:0012505; GO:0016020; GO:0020037; GO:0030868; GO:0035579; GO:0042803; GO:0043005; GO:0043025; GO:0044297; GO:0045202; GO:0046872; GO:0099563; GO:1903078; GO:1905809 FDGVQDPRILMAINGK 4.21999979 1 1 0.189131468 1773.605649 17.90118 16.86726 0 13.16945 15.21109 0 0 0 0 0 0 12.9439 13.3727 14.01603 0 0 0 0 14.47084 14.34773 8.563233 0 0 0 0 0 0 14.55915 16.7504 0 0 0 0 0 0 0 0 0 0 15.05481 0 0 0 0 0 0 0 0 O00267 SPT5H_HUMAN "Transcription elongation factor SPT5, hSPT5 (DRB sensitivity-inducing factor 160 kDa subunit, DSIF p160) (DRB sensitivity-inducing factor large subunit, DSIF large subunit) (Tat-cotransactivator 1 protein, Tat-CT1 protein)" SUPT5H SPT5 SPT5H Homo sapiens (Human) "negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]" DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]" chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:1900364 EMTDVLKVVK 7.099999905 1 1 0.590780459 1179.539869 18.66715 20.27252 13.83717 19.28534 0 0 18.90516 0 0 0 18.75611 0 0 0 0 0 18.26576 17.15526 17.15665 0 0 0 0 0 19.28597 0 0 20.09959 16.51972 17.15069 0 0 0 0 0 18.925 0 19.67914 20.96885 19.3659 17.00131 0 0 0 18.12925 0 17.9831 16.88346 O00273 DFFA_HUMAN "DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit, DFF-45) (Inhibitor of CAD, ICAD)" DFFA DFF1 DFF45 H13 Homo sapiens (Human) apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; thymocyte apoptotic process [GO:0070242] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; thymocyte apoptotic process [GO:0070242] deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183] GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006309; GO:0019904; GO:0032076; GO:0032991; GO:0042981; GO:0043065; GO:0044183; GO:0060703; GO:0061077; GO:0070242; GO:1900118; GO:1902511 AAFGEEVDAVDTGISR 2.720000029 1 1 1.15E-12 1637.858142 0 15.55841 13.92522 0 0 14.07355 0 0 0 0 0 0 0 0 0 15.08989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92252 17.81608 0 0 16.58418 0 0 0 0 0 0 0 O00287 RFXAP_HUMAN "Regulatory factor X-associated protein, RFX-associated protein (RFX DNA-binding complex 36 kDa subunit)" RFXAP Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0006357; GO:0016607; GO:0045944; GO:0090575 SDQALNCGGTASTGSAGNVK 4.639999866 1 1 1.83E-12 1889.983154 0 0 14.16987 13.9832 0 5.903064 14.7859 14.57366 13.51518 14.7153 13.73996 15.31323 14.25148 12.51711 14.06776 15.38049 0 12.24554 0 16.19258 0 0 15.51787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00291 HIP1_HUMAN "Huntingtin-interacting protein 1, HIP-1 (Huntingtin-interacting protein I, HIP-I)" HIP1 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100] clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] "clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]" "actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]" GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006897; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588 ILGCCTSLMQAIQVLIVASK 2.140000105 0.35182783 0.35182783 1.83E-12 2221.611881 14.42579 0 13.24915 10.5352 13.39967 0 0 14.2919 0 0 0 0 0 0 0 9.196941 0 0 0 16.40598 0 0 0 0 12.71502 15.34119 10.2769 0 0 0 0 0 0 0 0 0 0 12.76293 0 0 0 0 0 0 11.19068 0 11.82181 12.08254 O00294 TULP1_HUMAN Tubby-related protein 1 (Tubby-like protein 1) TULP1 TUBL1 Homo sapiens (Human) "dendrite development [GO:0016358]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" axon terminus [GO:0043679]; cell projection [GO:0042995]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202] "axon terminus [GO:0043679]; cell projection [GO:0042995]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; dendrite development [GO:0016358]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" "actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0001750; GO:0001895; GO:0001917; GO:0005546; GO:0005576; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007601; GO:0016358; GO:0042462; GO:0042995; GO:0043679; GO:0045202; GO:0045494; GO:0050766; GO:0050908; GO:0051015; GO:0060041; GO:0061512; GO:1903546 NASDGLLVR 4.010000229 1 1 0.123490375 942.7301879 13.74056 16.77173 0 12.60009 0 0 12.58529 15.86913 15.25888 0 15.42999 14.86524 0 7.948943 13.79678 14.80486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00295 TULP2_HUMAN "Tubby-related protein 2 (Cancer/testis antigen 65, CT65) (Tubby-like protein 2)" TULP2 TUBL2 Homo sapiens (Human) protein localization to cilium [GO:0061512]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; protein-containing complex binding [GO:0044877]; protein localization to cilium [GO:0061512]; visual perception [GO:0007601] protein-containing complex binding [GO:0044877] GO:0005576; GO:0005737; GO:0005929; GO:0007601; GO:0044877; GO:0061512 SQDNDTLMR 6.429999828 1 1 0 1094.419018 0 19.02418 0 0 0 0 0 0 0 17.6817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00303 EIF3F_HUMAN "Eukaryotic translation initiation factor 3 subunit F, eIF3f (Deubiquitinating enzyme eIF3f, EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)" EIF3F EIF3S5 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; identical protein binding [GO:0042802]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413]" identical protein binding [GO:0042802]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0016579; GO:0031369; GO:0033290; GO:0042802; GO:0070122; GO:0071541; GO:0075522; GO:0140492 MSIKAYVSTLMGVPGR 1.879999995 0.002492317 0.002492317 0.585575333 1726.410851 0 0 0 0 0 0 0 18.81077 0 0 0 0 0 0 0 0 16.41862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00305 CACB4_HUMAN "Voltage-dependent L-type calcium channel subunit beta-4, CAB4 (Calcium channel voltage-dependent subunit beta 4)" CACNB4 CACNLB4 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385] voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005829; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0009898; GO:0045202; GO:1901385 AIIERSNTR 3.180000067 1 1 0.134443859 1058.577251 0 16.96065 0 0 14.65739 14.21253 12.68916 0 0 0 15.78741 0 0 0 0 0 0 0 0 0 10.27071 0 0 0 0 0 15.73367 15.67025 16.56864 15.12177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.64117 0 0 O00311 CDC7_HUMAN "Cell division cycle 7-related protein kinase, CDC7-related kinase, HsCdc7, huCdc7, EC 2.7.11.1" CDC7 CDC7L1 Homo sapiens (Human) cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165] ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0072686; GO:0106310 VMNSAVMRK 7.960000038 1 1 2.35E-13 1048.156484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00327 BMAL1_HUMAN "Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5, bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3)" ARNTL BHLHE5 BMAL1 MOP3 PASD3 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]" "aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016 LTVLRMAVQHMK 5.050000191 1 1 0.305603192 1458.547637 11.36463 0 0 0 0 0 0 0 13.68764 0 0 14.44903 0 12.96122 0 0 15.78781 16.59244 0 17.06462 0 0 0 14.9326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59561 0 0 0 0 0 0 15.87621 O00329 PK3CD_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, PI3-kinase subunit delta, PI3K-delta, PI3Kdelta, PtdIns-3-kinase subunit delta, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta, PtdIns-3-kinase subunit p110-delta, p110delta)" PIK3CD Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]" "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" GO:0001779; GO:0001819; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006468; GO:0006954; GO:0006955; GO:0007165; GO:0010595; GO:0010628; GO:0010818; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030101; GO:0030183; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278 ALANRK 6.179999828 1 1 0.220974081 670.77637 16.80622 16.87674 15.26391 13.63978 11.85134 14.68859 13.31382 13.64626 0 13.6489 15.83321 10.69389 0 0 0 16.65134 14.90107 0 16.38121 15.21662 0 15.91152 0 0 0 0 0 15.25288 0 0 0 0 17.17681 0 0 0 0 16.78572 16.39722 0 16.83366 16.76987 0 0 16.66765 17.00731 0 0 O00337 S28A1_HUMAN "Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1, CNT 1, hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)" SLC28A1 CNT1 Homo sapiens (Human) azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862] brush border membrane [GO:0031526]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862] azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213] GO:0005337; GO:0005345; GO:0005415; GO:0005829; GO:0005886; GO:0005887; GO:0006139; GO:0015212; GO:0015213; GO:0015293; GO:0015389; GO:0015855; GO:0015858; GO:0015861; GO:0015862; GO:0016020; GO:0016607; GO:0031526; GO:0045117; GO:0072531; GO:1901474; GO:1901642; GO:1904823 KSDFSQIVLR 3.25999999 1 1 0.128870576 1193.418573 14.92157 0 15.84768 0 0 11.07438 0 14.79726 0 0 0 14.7531 0 0 15.85818 0 0 0 0 0 0 0 14.48679 0 0 0 0 13.6743 11.97793 13.92096 16.79162 14.20227 14.72992 16.04855 0 0 0 0 0 0 14.01908 0 0 0 0 0 0 0 O00338 ST1C2_HUMAN "Sulfotransferase 1C2, ST1C2, EC 2.8.2.1 (Sulfotransferase 1C1, SULT1C#1) (humSULTC2)" SULT1C2 SULT1C1 Homo sapiens (Human) amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; amine metabolic process [GO:0009308]; sulfation [GO:0051923] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923 AKAMPSPR 2.25999999 0.300388038 0.300388038 0.067967333 858.807776 16.1296 13.37642 0 15.10175 15.81314 17.17315 0 12.85526 0 18.13366 13.25097 15.81587 15.2135 17.23069 15.21337 0 12.84164 0 16.07981 12.79233 0 18.01368 0 0 15.67172 15.97585 13.7564 11.93983 0 0 11.58087 16.97626 0 0 17.41606 15.77401 17.78775 14.73256 0 0 0 14.75142 0 15.82186 16.67002 13.71595 16.3027 16.23866 O00358 FOXE1_HUMAN "Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5, HFKL5) (Thyroid transcription factor 2, TTF-2)" FOXE1 FKHL15 FOXE2 TITF2 TTF2 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cranial skeletal system development [GO:1904888]; embryonic organ morphogenesis [GO:0048562]; hair follicle morphogenesis [GO:0031069]; hard palate development [GO:0060022]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cranial skeletal system development [GO:1904888]; embryonic organ morphogenesis [GO:0048562]; hair follicle morphogenesis [GO:0031069]; hard palate development [GO:0060022]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0006590; GO:0009653; GO:0016477; GO:0030154; GO:0030878; GO:0031069; GO:0043565; GO:0045892; GO:0045893; GO:0048538; GO:0048562; GO:0060022; GO:0060023; GO:0060465; GO:1904888; GO:1990837 HAAAYPGGIDRFVSAM 3.220000029 0.738720834 0.738720834 0.345340219 1662.614775 16.39432 0 0 0 0 0 17.67712 0 12.1154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.70716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00370 LORF2_HUMAN "LINE-1 retrotransposable element ORF2 protein, ORF2p [Includes: Reverse transcriptase, EC 2.7.7.49; Endonuclease, EC 3.1.21.- ]" Homo sapiens (Human) "DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]" "metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]" metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036] GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305 CSSSLAIREMQIK 2.109999895 1 1 0.198138188 1523.018748 0 15.66307 17.6998 0 0 0 0 0 0 0 0 0 0 16.08365 0 0 0 0 0 0 19.32015 0 0 0 0 0 16.46365 0 0 0 0 0 16.50006 0 0 0 0 0 0 16.31507 0 0 0 0 0 0 0 0 O00401 WASL_HUMAN "Neural Wiskott-Aldrich syndrome protein, N-WASP" WASL Homo sapiens (Human) actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] actin binding [GO:0003779]; GTPase regulator activity [GO:0030695] GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0006900; GO:0008154; GO:0009617; GO:0015629; GO:0016050; GO:0030027; GO:0030041; GO:0030048; GO:0030050; GO:0030478; GO:0030666; GO:0030695; GO:0031410; GO:0031503; GO:0032880; GO:0045944; GO:0051301; GO:0051491; GO:0051653; GO:0060997; GO:0065003; GO:0070062; GO:1903526; GO:2000370; GO:2000402; GO:2000601 EGAQLKK 11.23999977 1 1 0.137983569 770.8022828 15.21428 0 0 0 0 0 0 0 0 0 0 10.47215 0 16.63807 0 0 0 0 17.26229 0 0 0 0 0 0 0 16.93019 15.88958 0 0 0 0 15.34296 0 16.07715 0 0 0 0 14.91993 0 0 0 0 0 0 0 0 O00408 PDE2A_HUMAN "cGMP-dependent 3',5'-cyclic phosphodiesterase, EC 3.1.4.17 (Cyclic GMP-stimulated phosphodiesterase, CGS-PDE, cGSPDE)" PDE2A Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004114; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:1904613 MLDLMR 22.03000069 1 1 0.181801022 796.4955852 15.09643 0 0 14.55461 0 0 14.57587 0 0 0 15.36293 0 0 0 0 0 15.97704 0 0 0 0 16.96246 0 0 0 0 16.41795 0 0 0 0 0 0 0 0 0 0 0 0 15.50438 0 0 0 0 0 0 0 0 O00409 FOXN3_HUMAN Forkhead box protein N3 (Checkpoint suppressor 1) FOXN3 C14orf116 CHES1 Homo sapiens (Human) "craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]" GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0008022; GO:0045892; GO:0097094 VPSDTLPLK 10.81000042 0.131710693 0.131710693 0.124980654 970.7043525 0 0 0 0 15.23435 0 0 16.03243 0 0 0 11.17806 0 0 0 0 0 14.72951 15.16589 13.23753 0 0 0 0 0 0 0 0 13.1345 0 0 20.92886 0 0 12.99701 0 0 0 0 0 0 0 15.41562 0 0 0 0 0 O00410 IPO5_HUMAN "Importin-5, Imp5 (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5, RanBP5)" IPO5 KPNB3 RANBP5 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005730; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0042307; GO:0045736; GO:0061608; GO:0071230 MCKILGK 3.799999952 1 1 0.253228742 865.1013475 0 16.71713 15.37008 17.40905 16.66593 0 0 0 16.77967 17.83079 16.59758 0 0 0 14.92259 18.81276 0 0 16.60087 15.4937 0 0 16.58571 0 0 0 0 0 0 0 0 18.71075 0 15.43743 0 0 0 0 16.3037 16.49077 0 0 15.9316 0 0 15.82148 0 0 O00418 EF2K_HUMAN "Eukaryotic elongation factor 2 kinase, eEF-2 kinase, eEF-2K, EC 2.7.11.20 (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)" EEF2K Homo sapiens (Human) cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]" "ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]" GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637 ADEDLIFR 23.90999985 0.55025202 0.55025202 0.098990958 978.9682765 17.20641 17.78405 0 0 17.68943 0 0 0 16.35121 0 0 0 16.4497 14.78074 0 0 0 0 16.15781 0 14.69864 0 0 0 0 0 15.28269 12.82498 15.7629 0 16.32091 0 0 0 15.40284 0 13.44742 15.6 0 0 0 0 0 12.58697 0 0 0 0 O00421 CCRL2_HUMAN C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor) CCRL2 CCR11 CCR6 CKRX CRAM HCR Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204] C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379] GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0042379; GO:0048020; GO:0060326 GQSAQGTSR 7.510000229 0.980207384 0.980207384 0.264790542 891.7929339 0 19.03721 0 17.85033 0 0 18.76422 18.87712 17.95175 16.44546 18.29036 0 0 0 16.89197 0 0 19.04133 0 0 0 0 0 17.69968 0 18.77356 19.66808 0 0 16.79681 20.48009 18.51555 19.92168 18.38333 19.01929 0 17.72373 19.98212 0 0 0 0 0 0 0 0 18.66643 16.84131 O00425 IF2B3_HUMAN "Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IMP-3 (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer, hKOC) (VICKZ family member 3)" IGF2BP3 IMP3 KOC1 VICKZ3 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; translation [GO:0006412] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247 GNVETCAK 3.279999971 0.348270267 0.348270267 0.202484742 878.1930368 17.18781 14.76116 10.96366 15.99415 15.17086 0 0 0 15.32384 0 0 0 0 0 0 0 16.0691 0 0 0 0 17.15408 0 0 0 0 14.68072 0 0 0 0 0 0 0 15.06015 0 0 0 0 16.94036 0 0 0 0 0 0 0 0 O00429 DNM1L_HUMAN "Dynamin-1-like protein, EC 3.6.5.5 (Dnm1p/Vps1p-like protein, DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less, Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV, HdynIV) (Dynamin-related protein 1)" DNM1L DLP1 DRP1 Homo sapiens (Human) calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511] brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672] brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511] GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244 EALIPVINK 14.84000015 1 1 0.444000862 996.8530544 0 18.48539 19.17172 0 18.6218 0 15.70031 0 0 0 0 16.50583 14.99936 17.05371 0 0 0 17.82059 0 0 17.64733 0 0 18.29326 0 0 0 19.39197 0 0 0 18.97317 0 19.09246 0 19.81912 0 0 18.80202 0 19.64375 0 0 18.94032 0 0 17.75221 19.55021 O00442 RTCA_HUMAN "RNA 3'-terminal phosphate cyclase, RNA cyclase, RNA-3'-phosphate cyclase, EC 6.5.1.4 (RNA terminal phosphate cyclase domain-containing protein 1, RTC domain-containing protein 1)" RTCA RPC RPC1 RTC1 RTCD1 Homo sapiens (Human) RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963]; RNA processing [GO:0006396] ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963] GO:0003723; GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396 RGVNADK 2.420000076 0.471393734 0.471393734 0.220627824 760.7028812 15.12769 0 0 14.61098 14.84763 0 0 0 0 0 0 0 0 15.042 0 13.86116 14.20007 10.32174 15.79209 0 0 17.00637 14.47147 0 0 17.62199 12.90962 15.41067 0 0 0 14.8242 0 0 0 0 0 0 0 0 16.21095 0 16.67558 16.68554 0 0 0 14.25653 O00443 P3C2A_HUMAN "Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, PI3K-C2-alpha, PtdIns-3-kinase C2 subunit alpha, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-alpha)" PIK3C2A Homo sapiens (Human) cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] "clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; clathrin binding [GO:0030276]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]" "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; clathrin binding [GO:0030276]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" GO:0005524; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0010508; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016477; GO:0030136; GO:0030276; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0046934; GO:0048008; GO:0048015; GO:0048268; GO:0052742; GO:0052812; GO:0061024; GO:0070062; GO:0090050 GFELSSSTR 6.099999905 0.268018246 0.268018246 0.053368337 982.9327094 0 12.91605 16.43145 0 11.92314 13.54846 0 0 13.76107 0 0 0 0 17.2318 16.72711 0 17.70109 14.63435 0 16.17815 0 0 0 16.94112 0 15.02528 15.8373 0 0 15.58172 0 17.79543 0 0 15.57256 0 0 18.50761 16.31294 15.94082 13.86921 15.91427 16.99833 0 14.2276 16.16514 17.57127 13.41591 O00444 PLK4_HUMAN "Serine/threonine-protein kinase PLK4, EC 2.7.11.21 (Polo-like kinase 4, PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak)" PLK4 SAK STK18 Homo sapiens (Human) centriole replication [GO:0007099]; cilium assembly [GO:0060271]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; trophoblast giant cell differentiation [GO:0060707] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; spindle pole [GO:0000922]; XY body [GO:0001741] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; spindle pole [GO:0000922]; XY body [GO:0001741]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; trophoblast giant cell differentiation [GO:0060707] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000278; GO:0000922; GO:0001741; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007099; GO:0032154; GO:0032465; GO:0042802; GO:0046601; GO:0060271; GO:0060707; GO:0098535; GO:0098536; GO:0106310; GO:0120098; GO:0120099 KPGSTSSPK 1.450000048 1 1 3.47E-13 886.499863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.52293 0 0 0 0 0 0 15.24308 15.89809 14.68089 0 17.91027 0 0 0 17.34912 O00445 SYT5_HUMAN "Synaptotagmin-5 (Synaptotagmin V, SytV)" SYT5 Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672] "axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]" "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0043025; GO:0046982; GO:0048471; GO:0048488; GO:0048791; GO:0055038; GO:0070382; GO:0071277; GO:0099066; GO:1990769 HWADMLANPR 7.340000153 0.574057281 0.574057281 0.431068554 1210.292773 15.25759 0 0 0 0 0 0 14.36854 0 0 0 14.65104 16.09007 16.02043 0 0 16.14711 17.54984 17.4228 0 15.92667 16.56971 0 0 16.71971 0 15.65312 15.01154 0 16.41388 15.1424 0 15.08543 16.15747 15.71206 14.60891 17.81074 0 17.55782 16.58578 0 17.11374 16.63624 12.76895 14.51143 0 8.465112 0 O00458 IFRD1_HUMAN Interferon-related developmental regulator 1 (Nerve growth factor-inducible protein PC4) IFRD1 Homo sapiens (Human) myoblast fate determination [GO:0007518] nucleus [GO:0005634] nucleus [GO:0005634]; myoblast fate determination [GO:0007518] GO:0005634; GO:0007518 RMTLTDSIER 7.03000021 1 1 0.333278672 1222.074045 12.32499 0 0 10.6836 12.97581 14.78909 0 14.73382 14.53857 14.94663 14.62455 10.53535 0 0 0 0 13.85395 14.76491 0 0 15.29026 16.40654 14.03389 0 15.58552 0 0 0 0 0 15.77171 0 0 0 16.59233 15.5068 0 0 15.96403 0 0 0 0 0 16.30803 15.47469 0 0 O00461 GOLI4_HUMAN "Golgi integral membrane protein 4 (Golgi integral membrane protein, cis, GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa, Golgi phosphoprotein of 130 kDa)" GOLIM4 GIMPC GOLPH4 GPP130 Homo sapiens (Human) cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133] cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133] GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580 EMALQR 7.440000057 1 1 0.277744773 764.7540117 19.12728 0 0 0 18.24439 0 18.25914 0 0 14.35629 17.21591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.03095 0 0 0 18.50784 0 0 0 0 20.14166 0 0 0 17.91889 20.33907 0 0 18.12326 0 19.63968 O00463 TRAF5_HUMAN TNF receptor-associated factor 5 (RING finger protein 84) TRAF5 RNF84 Homo sapiens (Human) apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829] CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0046330; GO:0048255; GO:0051091; GO:0051092; GO:0070534; GO:0097400 ITLLENNDQR 5.489999771 1 1 0.18595217 1211.743934 14.64656 0 15.92587 15.55688 12.30967 0 12.81726 0 0 0 12.79794 0 0 12.9633 11.74285 0 0 0 0 0 14.04538 0 0 0 0 15.67109 13.79379 0 14.13107 0 0 0 0 0 0 0 0 0 0 15.88869 0 0 15.97422 0 14.07406 0 15.00443 0 O00469 PLOD2_HUMAN "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, EC 1.14.11.4 (Lysyl hydroxylase 2, LH2)" PLOD2 Homo sapiens (Human) cellular protein modification process [GO:0006464]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; cellular protein modification process [GO:0006464]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475] GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0006464; GO:0008475; GO:0017185; GO:0030867; GO:0031418; GO:0046947; GO:0070062 NMGMDFCR 4.039999962 1 1 0.237481239 1061.749641 15.24443 15.21501 12.71468 13.05494 12.70472 15.62117 14.85188 15.39138 0 15.55735 15.84465 13.21709 0 0 0 0 0 0 0 7.84746 0 16.76136 0 0 0 15.95847 0 0 15.03936 0 0 0 0 0 0 0 0 14.98586 15.82679 0 0 15.4957 14.93036 13.99873 0 0 0 0 O00470 MEIS1_HUMAN Homeobox protein Meis1 MEIS1 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216 APGPMSGMGMNMGMEGQWHYM 16.45000076 1 1 0.637305177 2364.967341 0 0 0 0 0 20.48012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00472 ELL2_HUMAN RNA polymerase II elongation factor ELL2 ELL2 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368] euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368] cis-regulatory region sequence-specific DNA binding [GO:0000987] GO:0000791; GO:0000987; GO:0005654; GO:0006368; GO:0008023; GO:0032968; GO:0042795 EEEIAK 8.510000229 0.319270104 0.319270104 0.09882162 718.8783952 0 15.59639 15.59768 17.48656 0 17.04829 0 17.83943 14.78499 16.99869 16.05657 14.91974 16.55613 0 0 17.41213 16.54585 9.964637 13.55142 0 16.2334 18.46816 0 16.24476 16.20638 0 16.90587 7.340604 16.48461 0 0 17.89515 16.38317 0 0 15.65542 0 15.36171 17.87598 14.43126 13.48153 15.78372 17.35266 0 17.35425 15.71023 12.90194 16.82808 O00476 NPT4_HUMAN Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3) SLC17A3 NPT4 Homo sapiens (Human) anion transport [GO:0006820]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transport [GO:0006820]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005436; GO:0005737; GO:0005764; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0006820; GO:0008308; GO:0008514; GO:0015136; GO:0015143; GO:0015562; GO:0015711; GO:0015739; GO:0015747; GO:0015760; GO:0016021; GO:0016324; GO:0019534; GO:0022857; GO:0031526; GO:0034220; GO:0042910; GO:0046415; GO:0048471; GO:1990961 QPLPIK 3.170000076 1 1 0.273400077 694.6193661 0 0 0 0 0 0 17.87106 17.45217 0 0 0 0 0 17.51714 0 0 0 0 0 17.07123 0 0 0 18.17664 18.66448 0 18.78014 16.81441 18.23767 17.2976 0 18.50764 19.08797 0 0 0 18.76561 0 0 0 0 0 0 0 0 0 18.90076 0 O00499 BIN1_HUMAN Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1) BIN1 AMPHL Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292] actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156] GO:0000122; GO:0002020; GO:0005543; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0006997; GO:0007010; GO:0008021; GO:0008333; GO:0010564; GO:0015629; GO:0016020; GO:0019828; GO:0030018; GO:0030276; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0033268; GO:0033292; GO:0042802; GO:0043065; GO:0043194; GO:0043196; GO:0043547; GO:0043679; GO:0044300; GO:0045664; GO:0045807; GO:0048156; GO:0048488; GO:0048711; GO:0051015; GO:0051020; GO:0051087; GO:0051647; GO:0060987; GO:0060988; GO:0070063; GO:0086091; GO:0090571; GO:0098850; GO:0098978; GO:1901380; GO:1902430; GO:1902960; GO:1903946; GO:1904878 AEMGSK 3.920000076 1 1 0.064303517 637.7694899 0 0 0 0 0 0 0 0 0 0 20.12435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.24329 0 0 0 0 0 0 0 0 19.27542 0 0 0 0 0 0 0 0 0 18.34939 0 0 0 O00507 USP9Y_HUMAN "Probable ubiquitin carboxyl-terminal hydrolase FAF-Y, EC 3.4.19.12 (Deubiquitinating enzyme FAF-Y) (Fat facets protein-related, Y-linked) (Ubiquitin thioesterase FAF-Y) (Ubiquitin-specific protease 9, Y chromosome) (Ubiquitin-specific-processing protease FAF-Y)" USP9Y DFFRY Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; protein deubiquitination [GO:0016579]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843]; BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; protein deubiquitination [GO:0016579]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007283; GO:0008234; GO:0016477; GO:0016579; GO:0030509; GO:0070410 HLSLIVR 15.77999973 1 1 0.236992396 838.4899327 17.58709 15.98254 17.04202 17.16526 17.60547 16.3837 17.76296 17.53493 17.20712 0 18.17069 18.40915 15.61254 0 16.95056 18.31675 17.5645 0 0 0 16.82633 16.04599 19.14421 17.77895 18.88412 18.09822 17.3612 16.13314 0 16.25711 20.15995 17.25145 19.3527 15.82341 19.54708 18.12044 18.43251 18.4158 18.44605 14.549 12.59245 16.43065 14.65666 11.8442 18.35008 18.13763 17.31558 17.73831 O00512 BCL9_HUMAN "B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9 (Protein legless homolog)" BCL9 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019] beta-catenin-TCF complex [GO:1990907]; cis-Golgi network [GO:0005801]; nucleoplasm [GO:0005654] beta-catenin-TCF complex [GO:1990907]; cis-Golgi network [GO:0005801]; nucleoplasm [GO:0005654]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0005654; GO:0005801; GO:0008013; GO:0014908; GO:0035019; GO:0035914; GO:0045944; GO:0060070; GO:1990907 TVASSDDDSPPAR 13.43000031 1 1 0.393072144 1318.442906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00515 LAD1_HUMAN "Ladinin-1, Lad-1 (Linear IgA disease antigen, LADA)" LAD1 LAD Homo sapiens (Human) actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] GO:0005198; GO:0005604; GO:0015629; GO:0045296; GO:0070062 LVSEKASIFEK 5.460000038 0.166837543 0.166837543 0.090654811 1251.168679 16.61339 0 17.32008 0 0 16.36827 0 0 17.51144 15.7724 0 0 0 9.981988 0 0 0 0 0 14.1686 15.52642 14.76182 0 11.97532 0 0 0 0 0 0 0 14.54497 0 0 15.4491 17.56635 17.97546 16.89025 18.02919 0 13.31018 0 17.96703 0 15.2899 16.24993 13.69292 17.24608 O00519 FAAH1_HUMAN "Fatty-acid amide hydrolase 1, EC 3.5.1.99 (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase, EC 3.1.1.-) (Oleamide hydrolase 1)" FAAH FAAH1 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907] cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090] cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; identical protein binding [GO:0042802]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907] acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; identical protein binding [GO:0042802]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543] GO:0004040; GO:0005543; GO:0005789; GO:0005856; GO:0009062; GO:0016021; GO:0017064; GO:0019369; GO:0031090; GO:0042802; GO:0045907; GO:0047372; GO:0052651; GO:0102077; GO:0103073 ALDLDVVLTPMLAPALDLNAPGR 2.50999999 0.677473068 0.677473068 0.123633767 2390.159303 4.331267 0 15.43235 13.84822 17.50803 16.28068 0 16.69623 0 15.04559 14.97692 0 0 0 14.3314 16.76143 0 12.48855 14.86405 0 0 0 0 0 0 16.36421 0 0 14.31696 17.28601 15.57938 0 0 16.04065 16.27653 16.32943 15.19218 17.0165 0 10.87864 11.63906 12.79573 12.36217 0 13.57855 0 0 16.0542 O00534 VMA5A_HUMAN "von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1, BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)" VWA5A BCSC1 LOH11CR2A Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 ALHSDRPPSASQPR 6.610000134 0.628212154 0.628212154 0.253028738 1517.350826 15.43824 12.86225 15.0976 14.5225 11.97785 13.04985 0 6.650084 11.45924 0 0 14.6343 17.16837 10.57242 15.85292 0 0 0 13.70105 0 16.21036 0 0 0 15.97557 0 14.79095 0 0 16.25119 0 0 0 0 0 0 0 0 0 15.8172 0 0 16.00641 0 0 0 14.03588 14.4546 O00555 CAC1A_HUMAN "Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I, BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)" CACNA1A CACH4 CACN3 CACNL1A4 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell death [GO:0008219]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] cell projection [GO:0042995]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] cell projection [GO:0042995]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell death [GO:0008219]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245] GO:0001540; GO:0005245; GO:0005634; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0007204; GO:0007268; GO:0008219; GO:0008331; GO:0016021; GO:0019905; GO:0034765; GO:0042995; GO:0043025; GO:0045202; GO:0046872; GO:0050804; GO:0070509; GO:0070588; GO:1904645; GO:1904646 AATSGPR 10.14000034 0.678128123 0.678128123 0.213759727 658.1012329 16.37658 15.12092 0 0 0 0 14.65313 0 0 0 13.9101 0 0 0 14.55513 0 14.51665 0 0 0 0 0 0 0 0 0 16.30307 16.21686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00560 SDCB1_HUMAN "Syntenin-1 (Melanoma differentiation-associated protein 9, MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18, TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)" SDCBP MDA9 SYCL Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]" adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] "adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]" "cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]" GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0072562; GO:0099054; GO:1903543; GO:1903553; GO:1903561 ITMTIR 15.23999977 0.532063901 0.532063901 0.2527052 734.3027135 18.82103 0 0 18.54863 18.62079 19.53704 19.8826 17.87351 19.23478 17.24596 0 19.69775 0 16.91349 0 19.46084 20.36361 18.21181 17.31793 0 19.12747 19.83228 18.38363 21.00142 18.45802 20.7625 20.40494 0 17.97327 0 21.23631 0 20.36016 19.8766 0 20.37571 0 19.29465 19.093 0 0 0 19.20926 0 19.63758 19.66373 19.71293 19.48073 O00562 PITM1_HUMAN "Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1, PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2, NIR-2)" PITPNM1 DRES9 NIR2 PITPNM Homo sapiens (Human) brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031] cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496] cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031] calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0043231; GO:0044297; GO:0070300 AEEDPR 7.599999905 1 1 0.309649411 716.8634825 10.46046 15.01055 0 0 17.21028 14.76784 0 14.70013 0 14.59589 11.48941 0 0 0 0 0 15.847 0 15.51332 0 13.92382 14.55747 0 15.65259 0 0 0 16.5378 0 16.19636 0 0 0 17.20495 0 0 0 0 15.58903 0 0 16.00454 0 16.0107 0 18.06575 0 0 O00566 MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) "RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]" chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] "chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]" RNA binding [GO:0003723] GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0006396; GO:0008380; GO:0032040; GO:0034457 AGDIKTAAEK 3.74000001 1 1 3.47E-13 1003.324148 0 0 0 0 0 13.14116 0 0 0 0 0 0 15.56334 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41971 0 0 0 0 0 0 0 0 0 10.51722 0 0 0 0 0 0 0 0 0 0 0 O00584 RNT2_HUMAN "Ribonuclease T2, EC 4.6.1.19 (Ribonuclease 6)" RNASET2 RNASE6PL Homo sapiens (Human) innate immune response [GO:0045087]; RNA catabolic process [GO:0006401] azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758] azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; endoribonuclease activity [GO:0004521]; ribonuclease activity [GO:0004540]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401] endoribonuclease activity [GO:0004521]; ribonuclease activity [GO:0004540]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723] GO:0003723; GO:0004521; GO:0004540; GO:0005576; GO:0005615; GO:0005758; GO:0005764; GO:0005788; GO:0006401; GO:0033897; GO:0035578; GO:0043202; GO:0045087; GO:0070062 ELDLNSVLLK 22.98999977 1 1 0.517903374 1142.581489 21.78831 21.20475 18.43661 21.20671 19.53537 21.56603 0 0 22.70964 19.33839 0 19.90462 0 19.98342 0 21.91418 0 21.08686 20.27302 0 0 0 21.35793 21.15285 22.24054 0 22.01954 0 0 19.51396 22.78563 22.8333 22.31785 0 22.6173 21.56785 22.29215 21.56297 22.71542 0 20.84871 21.77607 17.9966 21.11698 21.525 21.03476 21.6212 19.90352 O00585 CCL21_HUMAN "C-C motif chemokine 21 (6Ckine) (Beta-chemokine exodus-2) (Secondary lymphoid-tissue chemokine, SLC) (Small-inducible cytokine A21)" CCL21 SCYA21 UNQ784/PRO1600 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295] CCR chemokine receptor binding [GO:0048020]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379] GO:0001768; GO:0001771; GO:0001954; GO:0002407; GO:0002548; GO:0002606; GO:0005576; GO:0005615; GO:0006954; GO:0006955; GO:0007186; GO:0007267; GO:0008009; GO:0010560; GO:0010820; GO:0030593; GO:0030838; GO:0031274; GO:0031295; GO:0031529; GO:0031640; GO:0031732; GO:0033630; GO:0034695; GO:0035759; GO:0038116; GO:0042379; GO:0043123; GO:0043547; GO:0043552; GO:0045860; GO:0046330; GO:0048020; GO:0048245; GO:0048247; GO:0048260; GO:0048469; GO:0050921; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0090023; GO:0090630; GO:0097026; GO:1903237; GO:1990869; GO:2000147; GO:2000406; GO:2000529; GO:2000548; GO:2000669 GSKGCK 7.409999847 1 1 0.202321686 635.5808985 14.71807 13.21489 0 15.66829 0 0 5.621708 0 0 0 0 0 0 0 0 12.44898 0 0 0 0 15.45571 15.41253 0 0 0 0 0 0 0 15.36848 0 0 0 0 0 0 0 0 16.34992 17.64605 16.02438 0 0 16.74599 0 0 0 0 O00602 FCN1_HUMAN Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) FCN1 FCNM Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370] "collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370 ELSGATMARGLAVLLVLFLHIK 1.899999976 0.28522709 0.28522709 0.223633765 2352.351841 0 0 16.73434 16.52884 0 9.849591 0 0 14.77188 17.20222 0 0 18.4456 0 0 15.08092 12.16146 13.43568 0 0 13.4147 16.91546 0 14.29394 16.91392 16.73373 16.35991 14.35231 14.68512 15.89976 17.29576 0 19.2522 0 0 0 15.53997 0 18.48368 0 0 0 0 16.3546 13.70851 11.17614 16.07465 17.02545 O00635 TRI38_HUMAN "E3 ubiquitin-protein ligase TRIM38, EC 2.3.2.27 (RING finger protein 15) (Tripartite motif-containing protein 38) (Zinc finger protein RoRet)" TRIM38 RNF15 RORET Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of defense response to virus [GO:0050687]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of viral entry into host cell [GO:0046598]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of interferon-beta production [GO:0032648]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of defense response to virus [GO:0050687]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of viral entry into host cell [GO:0046598]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of interferon-beta production [GO:0032648]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0000209; GO:0003713; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032648; GO:0032880; GO:0042803; GO:0043123; GO:0043161; GO:0045070; GO:0045087; GO:0046596; GO:0046598; GO:0050687; GO:0051091; GO:0051092; GO:0061630; GO:0070936 QLGSLIEALK 9.539999962 1 1 0.204084555 1071.962696 0 0 12.28897 14.33201 11.56109 14.43266 0 0 16.30169 0 0 0 13.84788 10.55819 14.63893 16.47319 0 0 0 0 17.83798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.70601 0 0 0 0 0 0 14.89385 0 0 0 O00744 WN10B_HUMAN Protein Wnt-10b (Protein Wnt-12) WNT10B WNT12 Homo sapiens (Human) bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] GO:0000086; GO:0000122; GO:0002062; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0006629; GO:0007224; GO:0008284; GO:0010971; GO:0014835; GO:0030182; GO:0030501; GO:0030858; GO:0032434; GO:0043065; GO:0045165; GO:0045599; GO:0045669; GO:0045899; GO:0048018; GO:0048641; GO:0048741; GO:0050680; GO:0050821; GO:0050909; GO:0051091; GO:0051885; GO:0060070; GO:0060346; GO:0061196; GO:0071300; GO:0071320; GO:0071374; GO:0071425; GO:0090263; GO:0120163 VGRQVVTENLK 7.039999962 1 1 4.59E-13 1236.754629 9.872536 13.68983 13.31028 15.1605 0 13.81369 14.00936 14.95056 11.22524 14.08607 11.13073 12.40613 14.68029 13.04 0 0 0 0 0 0 0 16.24869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00750 P3C2B_HUMAN "Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, PI3K-C2-beta, PtdIns-3-kinase C2 subunit beta, EC 2.7.1.137, EC 2.7.1.154 (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)" PIK3C2B Homo sapiens (Human) cell migration [GO:0016477]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; cell migration [GO:0016477]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742] GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0048015; GO:0052742 NATPGKNR 30.65999985 1.01E-13 1.01E-13 0.303825179 856.5285518 21.13205 21.34426 0 20.77418 21.15561 20.21562 0 20.15542 20.91036 18.33824 20.51941 18.27427 20.91568 21.22787 20.64451 0 21.66576 21.12057 20.72895 20.42331 21.47891 19.86515 0 21.21497 0 21.63684 0 21.80563 19.94615 0 0 20.70724 0 20.65885 21.25259 0 21.74147 0 0 0 20.51766 22.49019 0 20.73426 21.96363 21.47266 0 17.15781 O00755 WNT7A_HUMAN Protein Wnt-7a WNT7A Homo sapiens (Human) "angiogenesis [GO:0001525]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]" cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685] "cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]" cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102] GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007269; GO:0007409; GO:0007548; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030666; GO:0031012; GO:0031133; GO:0032270; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0036465; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048103; GO:0048864; GO:0050768; GO:0051965; GO:0060054; GO:0060066; GO:0060070; GO:0060071; GO:0060997; GO:0061038; GO:0062009; GO:0070062; GO:0070307; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:1904861; GO:1904891; GO:1905386; GO:1905606; GO:2000300; GO:2000463 YNEAVHVEPVR 10.14000034 0.076022513 0.076022513 0.148682737 1312.419709 14.3535 14.138 15.92874 14.55193 0 0 12.79069 0 12.21511 8.345362 12.53487 13.33297 16.98428 13.21966 17.09793 0 0 0 0 18.20607 0 0 15.58489 0 15.06491 0 16.81833 0 0 0 18.1032 16.02301 14.46701 0 0 19.11282 14.89938 12.96476 13.93995 12.37242 16.04395 15.31719 0 16.8769 0 10.31091 0 13.64348 O00763 ACACB_HUMAN "Acetyl-CoA carboxylase 2, EC 6.4.1.2 (ACC-beta)" ACACB ACC2 ACCB Homo sapiens (Human) acetyl-CoA metabolic process [GO:0006084]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of glucose metabolic process [GO:0010906]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; acetyl-CoA metabolic process [GO:0006084]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of glucose metabolic process [GO:0010906]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0003989; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006084; GO:0006633; GO:0009374; GO:0009410; GO:0010629; GO:0010884; GO:0010906; GO:0014070; GO:0031667; GO:0031999; GO:0042802; GO:0043086; GO:0046872; GO:0051289; GO:0060421; GO:0097009; GO:2001295 DTPLFSEAR 7.550000191 1 1 0.194614435 1034.953365 0 15.65044 14.60257 13.68435 0 0 0 0 0 0 0 0 0 0 0 0 14.75838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14487 16.54521 0 0 0 0 0 0 15.96673 0 0 O00767 SCD_HUMAN "Stearoyl-CoA desaturase, hSCD1, EC 1.14.19.1 (Acyl-CoA desaturase) (Delta(9)-desaturase, Delta-9 desaturase) (Fatty acid desaturase)" SCD FADS5 SCD1 SCDOS Homo sapiens (Human) monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636] iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768] GO:0004768; GO:0005506; GO:0005730; GO:0005783; GO:0005789; GO:0006636; GO:0016020; GO:0016021; GO:0016491; GO:0030176; GO:0032896; GO:0070542; GO:0120162; GO:1903966 EGPSPK 4.860000134 0.099383086 0.099383086 0.241622521 614.1540303 0 15.80885 13.47813 0 14.11117 16.41869 0 14.34826 15.22426 17.31198 0 0 16.08559 15.16491 15.74801 0 0 0 0 15.37431 15.29249 16.56586 14.63167 0 15.33795 0 15.6803 0 0 0 0 0 16.04986 15.47443 0 0 0 0 16.27755 15.51446 0 0 16.14615 16.11819 17.39661 0 15.91419 0 O14490 DLGP1_HUMAN "Disks large-associated protein 1, DAP-1 (Guanylate kinase-associated protein, hGKAP) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1, SAPAP1)" DLGAP1 DAP1 GKAP Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877] GO:0005886; GO:0007268; GO:0014069; GO:0044877; GO:0060090; GO:0098962; GO:0098978; GO:0099572 ASVNMDQAMVKSESCQQER 4.590000153 1 1 0.309314307 2214.51873 0 15.02167 0 13.89495 15.40328 10.50352 0 0 14.87685 0 0 0 11.99572 14.59571 14.05578 14.40719 0 0 0 14.87641 0 14.55373 14.70306 14.21396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14493 CLD4_HUMAN "Claudin-4 (Clostridium perfringens enterotoxin receptor, CPE-R, CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein)" CLDN4 CPER CPETR1 WBSCR8 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]; circadian rhythm [GO:0007623]; establishment of skin barrier [GO:0061436]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; renal absorption [GO:0070293]; response to progesterone [GO:0032570] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basal plasma membrane [GO:0009925]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basal plasma membrane [GO:0009925]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]; circadian rhythm [GO:0007623]; establishment of skin barrier [GO:0061436]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; renal absorption [GO:0070293]; response to progesterone [GO:0032570] chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005198; GO:0005254; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0006821; GO:0007155; GO:0007565; GO:0007623; GO:0009925; GO:0016324; GO:0016327; GO:0016328; GO:0016338; GO:0022604; GO:0030335; GO:0032570; GO:0034707; GO:0042802; GO:0061436; GO:0070160; GO:0070293; GO:0070830; GO:0090303; GO:1905050 MASMGLQVMGIALAVLGWLAVMLCCALPMWR 7.769999981 1 1 3.66E-12 3450.089467 16.19439 15.36708 16.85779 16.02741 15.49375 15.7988 0 16.53617 1.099677 0 15.59195 15.83602 0 15.74536 0 14.85373 15.99645 0 16.35057 12.45497 0 14.78439 12.34931 0 0 15.48098 17.40473 17.8353 0 19.16144 0 17.59559 18.04094 0 18.07389 0 0 0 18.87499 0 16.99924 0 18.32379 0 18.2695 0 18.48329 0 O14497 ARI1A_HUMAN "AT-rich interactive domain-containing protein 1A, ARID domain-containing protein 1A (B120) (BRG1-associated factor 250, BAF250) (BRG1-associated factor 250a, BAF250A) (Osa homolog 1, hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)" ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; nucleosome mobilization [GO:0042766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; nucleosome mobilization [GO:0042766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713] GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0030520; GO:0030521; GO:0035060; GO:0042766; GO:0042921; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819 GPADMASQCWGAAAAAAAAAAASGGAQQR 8.829999924 1 1 9.24E-13 2646.389008 0 7.596388 11.73634 14.27954 13.16158 14.95813 14.19263 0 17.08187 14.28903 14.39289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14503 BHE40_HUMAN "Class E basic helix-loop-helix protein 40, bHLHe40 (Class B basic helix-loop-helix protein 2, bHLHb2) (Differentially expressed in chondrocytes protein 1, DEC1) (Enhancer-of-split and hairy-related protein 2, SHARP-2) (Stimulated by retinoic acid gene 13 protein)" BHLHE40 BHLHB2 DEC1 SHARP2 STRA13 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0016604; GO:0019904; GO:0032922; GO:0042752; GO:0042803; GO:0043153; GO:0043425; GO:0043426; GO:0043433; GO:0045892; GO:0046982; GO:0050767; GO:0061629; GO:0070888; GO:1990837 ERIPSAQPPPACLPK 7.090000153 1 1 0.188046467 1659.063828 0 15.45123 14.33004 0 15.78889 13.72799 12.0174 13.53481 15.69904 0 0 15.09085 14.38599 0 11.49308 0 0 14.95923 0 0 0 0 0 0 0 0 16.02803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.82862 0 0 0 O14508 SOCS2_HUMAN "Suppressor of cytokine signaling 2, SOCS-2 (Cytokine-inducible SH2 protein 2, CIS-2) (STAT-induced STAT inhibitor 2, SSI-2)" SOCS2 CIS2 SSI2 STATI2 Homo sapiens (Human) cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355] 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269] GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0040015; GO:0043066; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749 MTLRCLEPSGNGGEGTR 9.539999962 1 1 1.37E-12 1845.467466 14.97112 14.50174 0 0 11.45103 12.75982 14.22014 0 0 0 0 13.96096 0 13.97618 13.12996 0 13.50985 0 0 0 15.59931 13.12874 0 14.64896 15.94505 14.23626 14.63883 12.06101 0 15.40094 14.18449 14.7713 14.80919 0 14.99506 14.15899 14.87656 0 17.28339 15.61452 0 14.46611 0 11.87107 0 0 0 13.75199 O14511 NRG2_HUMAN "Pro-neuregulin-2, membrane-bound isoform, Pro-NRG2 [Cleaved into: Neuregulin-2, NRG-2 (Divergent of neuregulin-1, DON-1) (Neural- and thymus-derived activator for ERBB kinases, NTAK) ]" NRG2 NTAK Homo sapiens (Human) animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165] growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0048513 QDSAPL 10.48999977 0.741565943 0.741565943 0.153002364 631.4374979 14.73052 0 0 15.71772 15.53278 0 15.85785 0 0 15.00972 14.7567 14.62887 14.64569 11.98234 15.08291 0 0 15.07671 15.98388 0 0 0 0 0 0 0 0 0 0 0 0 0 16.72988 0 0 0 0 0 0 0 0 0 0 15.21275 16.6544 0 0 0 O14512 SOCS7_HUMAN "Suppressor of cytokine signaling 7, SOCS-7 (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4, NAP-4)" SOCS7 NAP4 SOCS6 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124] GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935 FSNVK 7.380000114 0.315152705 0.315152705 0.251789452 597.5982384 0 0 11.79148 0 0 13.6045 14.92237 15.39913 0 16.49414 15.51719 0 0 15.40145 15.73659 14.44295 16.20745 13.92628 0 0 15.81333 16.48515 15.34105 0 0 15.70584 0 16.86005 0 0 0 15.36626 15.19846 16.22771 14.75263 0 0 0 16.78482 0 15.74396 16.5165 0 14.97441 15.28129 0 14.75963 0 O14513 NCKP5_HUMAN "Nck-associated protein 5, NAP-5 (Peripheral clock protein)" NCKAP5 ERIH NAP5 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] microtubule plus-end [GO:0035371] microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] GO:0001578; GO:0007019; GO:0035371 DCMNSNEGIYSPGIKSSSLK 4.059999943 1 1 1.83E-12 2187.047358 16.74431 0 0 17.71351 0 16.51908 0 16.20151 10.12877 0 0 0 0 0 0 17.21291 16.75215 0 0 0 16.63006 0 14.59865 0 16.44394 18.18232 16.93465 0 0 0 17.39406 16.27799 0 17.04238 15.72402 0 0 0 13.49144 0 0 0 16.55587 0 0 15.19362 0 0 O14514 AGRB1_HUMAN "Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40, Vstat40; Vasculostatin-120, Vstat120 ]" ADGRB1 BAI1 Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]" cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]" G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786] GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428 ETPAGEVAAVR 10.73999977 0.188160151 0.188160151 0.056514696 1100.320307 0 0 0 0 0 0 16.94914 0 16.41924 0 15.18721 0 0 14.5293 13.14926 16.25913 0 0 0 0 0 0 9.117539 10.25211 0 17.58468 15.36675 14.76282 0 0 0 0 0 0 0 16.3493 0 17.18118 0 12.82377 0 0 15.78805 0 0 11.60869 0 15.23491 O14523 C2C2L_HUMAN "Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like, C2CD2-like) (Transmembrane protein 24)" C2CD2L KIAA0285 TMEM24 DLNB23 Homo sapiens (Human) positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526] GO:0005789; GO:0005886; GO:0008526; GO:0016021; GO:0032541; GO:0035091; GO:0035774; GO:0043559; GO:0140268 ANGNPSPQL 8.590000153 1 1 0.258381927 896.9884376 0 0 0 14.86309 16.30898 15.70769 15.18448 0 0 15.8253 0 16.33657 0 0 0 13.49828 0 0 15.77558 0 0 16.73301 0 0 0 0 17.0057 15.19854 0 15.37036 0 0 0 0 0 0 16.82423 0 0 17.18684 15.57426 0 0 0 0 15.74939 0 0 O14524 NEMP1_HUMAN Nuclear envelope integral membrane protein 1 NEMP1 KIAA0286 TMEM194 TMEM194A Homo sapiens (Human) nuclear membrane organization [GO:0071763] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane organization [GO:0071763] GO:0005635; GO:0005637; GO:0016021; GO:0071763 VNSSR 1.840000033 0.584812105 0.584812105 0.267105849 560.7272584 16.6332 0 14.6605 0 15.13057 0 13.5942 0 0 0 0 0 16.48602 14.60343 15.4315 16.64177 0 12.78146 0 15.2107 16.76204 0 15.91323 0 15.11692 16.33239 0 0 0 0 15.03864 0 0 15.27255 0 0 0 15.21038 16.08548 0 0 0 15.9334 16.26092 0 0 15.70534 0 O14526 FCHO1_HUMAN F-BAR domain only protein 1 FCHO1 KIAA0290 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; AP-2 adaptor complex binding [GO:0035612]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852] AP-2 adaptor complex binding [GO:0035612] GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0035612; GO:0048268; GO:0050852; GO:0050870; GO:0072583 CMDQERLR 6.349999905 0.666711032 0.666711032 0.189825456 1112.645427 15.83818 14.57764 12.81852 11.19155 13.65053 15.81929 5.138642 0 15.09659 13.04326 15.08054 12.27858 0 16.26214 0 0 14.87816 15.21889 0 0 9.304179 14.86781 14.83655 15.68002 0 0 0 0 0 0 0 0 14.43886 13.9545 0 15.47462 0 16.11001 16.51449 14.25609 0 0 0 0 0 14.86856 0 0 O14529 CUX2_HUMAN Homeobox protein cut-like 2 (Homeobox protein cux-2) CUX2 CUTL2 KIAA0293 Homo sapiens (Human) cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614] chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007614; GO:0010628; GO:0043565; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:1990837; GO:2000463 LQAQSDYEEIKTELSILK 12.75 0.490357816 0.490357816 0 2109.02315 17.18218 15.88662 13.35147 17.19756 18.29125 15.50123 15.58334 14.69422 15.77594 13.66889 17.08976 0 14.20916 18.39976 12.92994 16.38107 0 17.61418 0 15.98763 16.3229 15.19886 17.6756 15.35452 17.35814 16.22775 17.61456 0 14.43261 14.73158 0 0 15.46339 11.63719 14.23781 14.52361 10.6352 14.96693 15.16163 16.56287 7.444667 14.6232 14.7164 14.51654 15.24195 9.9153 16.19323 16.68521 O14531 DPYL4_HUMAN "Dihydropyrimidinase-related protein 4, DRP-4 (Collapsin response mediator protein 3, CRMP-3) (UNC33-like phosphoprotein 4, ULIP-4)" DPYSL4 CRMP3 ULIP4 Homo sapiens (Human) nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485] cytosol [GO:0005829] "cytosol [GO:0005829]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485]" "filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]" GO:0005829; GO:0007399; GO:0016810; GO:0031005; GO:0070997; GO:0097485 EELEALVK 6.269999981 1 1 0.233755686 931.330982 0 0 17.72443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14543 SOCS3_HUMAN "Suppressor of cytokine signaling 3, SOCS-3 (Cytokine-inducible SH2 protein 3, CIS-3) (STAT-induced STAT inhibitor 3, SSI-3)" SOCS3 CIS3 SSI3 Homo sapiens (Human) branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; protein kinase inhibitor activity [GO:0004860]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707] 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; protein kinase inhibitor activity [GO:0004860] GO:0001784; GO:0004860; GO:0005829; GO:0005942; GO:0007259; GO:0016567; GO:0035556; GO:0040008; GO:0042532; GO:0043066; GO:0045597; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0050728; GO:0060670; GO:0060674; GO:0060707; GO:0060708; GO:1990830 LKTFSSK 16.23999977 1 1 0.213544426 809.7753874 16.62378 0 16.54188 16.49161 0 16.28907 0 0 15.0118 0 0 0 15.1447 16.5722 15.80611 0 15.52455 15.5157 0 17.57922 0 0 0 16.32943 0 14.60163 0 16.47355 16.40689 15.47446 15.10866 14.62148 17.15661 14.64241 16.84833 14.79926 16.6018 16.32019 0 0 15.96355 15.90591 15.31151 0 0 16.02043 0 16.56499 O14545 TRAD1_HUMAN TRAF-type zinc finger domain-containing protein 1 (Protein FLN29) TRAFD1 FLN29 Homo sapiens (Human) negative regulation of innate immune response [GO:0045824] metal ion binding [GO:0046872]; negative regulation of innate immune response [GO:0045824] metal ion binding [GO:0046872] GO:0045824; GO:0046872 TAKAKPSK 2.730000019 1 1 0.233854712 832.3200889 14.08746 16.19427 16.24651 0 0 13.4864 0 0 0 14.7628 14.24039 0 0 14.62055 0 15.99216 0 0 0 0 0 0 0 0 17.14467 16.13391 0 0 15.14307 15.18414 15.43303 15.95569 14.73758 16.98397 15.49451 0 0 15.40472 15.17507 15.50631 15.79979 0 14.8864 9.218837 12.49239 15.77392 15.62003 16.51428 O14556 G3PT_HUMAN "Glyceraldehyde-3-phosphate dehydrogenase, testis-specific, EC 1.2.1.12 (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2, GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)" GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; positive regulation of glycolytic process [GO:0045821] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; positive regulation of glycolytic process [GO:0045821] glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661] GO:0004365; GO:0005634; GO:0005829; GO:0006006; GO:0006096; GO:0030317; GO:0045821; GO:0050661; GO:0051287 MVSVARELTVGINGFGR 3.049999952 1 1 0.344147555 1806.549238 15.73051 0 0 0 16.4601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.94416 0 0 0 16.32204 0 16.21877 16.13039 0 13.85291 12.11194 14.01633 15.47871 13.36612 16.69628 16.49944 15.24729 0 17.31608 0 0 0 0 0 0 0 0 0 O14561 ACPM_HUMAN "Acyl carrier protein, mitochondrial, ACP (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)" NDUFAB1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]" iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504]; aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]" acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504] GO:0000035; GO:0000036; GO:0005504; GO:0005509; GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006633; GO:0009060; GO:0009249; GO:0016226; GO:0031966; GO:0032981; GO:0042776; GO:1990229 LGTLQPALVLAQVPGR 3.900000095 0.190754563 0.190754563 0.533757724 1632.76371 17.25115 17.81102 17.49161 0 0 0 0 0 0 0 17.07366 0 0 0 0 17.80625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.32694 0 17.35365 0 0 0 0 O14569 C56D2_HUMAN "Transmembrane reductase CYB561D2, EC 7.2.1.3 (Cytochrome b561 domain-containing protein 2) (Putative tumor suppressor protein 101F6)" CYB561D2 101F6 LUCA12.2 Homo sapiens (Human) ascorbate homeostasis [GO:0140576] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]; ascorbate homeostasis [GO:0140576] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575] GO:0005783; GO:0005789; GO:0016021; GO:0016491; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576 AHLVTR 8.920000076 0.498540759 0.498540759 0.12761397 694.7561198 16.06444 14.82243 14.32617 16.23553 14.58881 16.93612 14.96708 16.44998 12.2565 18.29612 15.4993 17.0289 11.19785 16.26379 17.84797 0 13.77124 15.92036 0 14.44485 16.58789 14.72681 18.46108 15.07294 0 14.70388 0 17.93268 12.93933 16.31831 0 18.21164 12.51938 13.71993 17.63481 17.18486 16.80947 15.1131 13.38798 0 17.47549 0 16.43697 17.56435 16.78901 17.88197 14.60775 16.42794 O14578 CTRO_HUMAN "Citron Rho-interacting kinase, CRIK, EC 2.7.11.1 (Serine/threonine-protein kinase 21)" CIT CRIK KIAA0949 STK21 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223]; actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223] GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001889; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0016020; GO:0017124; GO:0018107; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035331; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110; GO:0106310 AMINAMDSK 5.179999828 1 1 0.108241718 997.7710946 0 14.41 13.17558 0 0 0 0 15.91838 0 0 0 0 0 0 0 0 0 0 0 0 15.70533 0 0 0 14.7286 0 12.05618 0 0 0 0 0 0 0 0 0 0 0 16.91538 0 0 0 14.52387 0 16.61561 0 11.92902 0 O14579 COPE_HUMAN "Coatomer subunit epsilon (Epsilon-coat protein, Epsilon-COP)" COPE Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" structural molecule activity [GO:0005198] GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133; GO:0099612 LVLQYAPSA 7.550000191 1 1 0.074011283 961.8429023 16.05608 16.91359 12.51902 0 14.52394 0 14.71446 15.0056 15.54008 0 0 0 14.86924 14.86263 14.16191 0 14.59427 15.42366 0 14.07352 0 14.39466 14.46529 0 15.68591 11.50707 0 0 0 13.39549 16.14316 0 13.77695 0 13.88766 0 16.72019 0 0 0 12.56732 0 0 0 0 0 0 0 O14594 NCAN_HUMAN Neurocan core protein (Chondroitin sulfate proteoglycan 3) NCAN CSPG3 NEUR Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540] GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0043202 SYGRR 7.75 0.736498415 0.736498415 0.210246405 639.5527815 14.34443 14.83541 14.36659 13.70527 12.65812 15.60467 15.63663 0 15.07354 15.77296 0 17.11805 16.4652 15.2395 0 16.81584 16.4497 15.87391 15.58937 15.66906 16.49652 0 16.44688 15.68244 17.15679 0 15.83237 16.58797 17.52175 17.71603 17.50332 17.38059 15.60099 15.20002 17.21203 16.00872 16.7832 17.67135 17.0846 19.49878 17.3592 19.76932 14.72139 16.90001 17.70958 15.30663 19.98994 16.92643 O14595 CTDS2_HUMAN "Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 2, NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2, SCP2)" CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470] metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] GO:0001933; GO:0004721; GO:0005654; GO:0006470; GO:0008420; GO:0046872; GO:2000134 MEHGSIITQARR 9.600000381 1 1 6.85E-13 1398.229145 15.92812 16.03851 0 15.37467 13.24969 0 14.06446 0 15.16101 0 15.61365 15.79934 15.05369 0 0 15.91559 15.33242 15.7869 14.12844 0 14.45596 0 15.37837 0 0 0 0 15.25469 16.83555 15.86154 0 0 0 0 0 0 0 0 0 16.49201 0 16.15591 17.35739 0 17.14277 0 0 0 O14602 IF1AY_HUMAN "Eukaryotic translation initiation factor 1A, Y-chromosomal, eIF-1A Y isoform (Eukaryotic translation initiation factor 4C, eIF-4C)" EIF1AY Homo sapiens (Human) translational initiation [GO:0006413] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413] translation initiation factor activity [GO:0003743] GO:0003743; GO:0005737; GO:0006413 ADVILK 2.910000086 0.247363597 0.247363597 0.194678944 659.4048134 13.41339 14.85454 0 16.43733 0 15.99214 14.99567 0 14.25443 0 0 0 14.89021 16.75944 15.51672 0 0 0 16.22423 14.93724 16.10446 16.45049 0 0 15.59689 16.85415 15.9265 14.6106 12.97475 15.34529 0 16.38632 0 16.77505 0 16.14493 16.28544 17.55239 15.76827 16.26807 16.01315 15.83439 0 14.60109 15.76532 15.76338 0 16.59801 O14604 TYB4Y_HUMAN "Thymosin beta-4, Y-chromosomal" TMSB4Y TB4Y Homo sapiens (Human) actin filament organization [GO:0007015]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989] actin monomer binding [GO:0003785] GO:0003785; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007015; GO:0008064; GO:0030334; GO:0042989 ETIEQERQAGES 8.960000038 1 1 2.06E-12 1378.566415 15.18268 14.49883 14.17547 0 13.82112 15.65028 14.81634 15.0339 0 0 0 13.24004 15.64382 0 0 15.40712 14.21227 0 15.35127 0 13.65303 0 15.05755 13.84364 0 13.35338 14.24041 14.98613 15.70764 0 14.57189 14.96311 0 14.67459 14.89754 15.47638 15.08148 15.32212 0 15.457 15.56655 15.57303 0 0 0 14.38483 0 0 O14607 UTY_HUMAN "Histone demethylase UTY, EC 1.14.11.68 (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase UTY)" UTY KDM6C Homo sapiens (Human) chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; regulation of gene expression [GO:0010468] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; regulation of gene expression [GO:0010468] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0005654; GO:0006325; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0046872; GO:0071557; GO:0071558 QLSNSAQGLHK 4.53000021 0.534331739 0.534331739 0.410600216 1181.23127 0 13.78 0 14.94413 17.18978 14.70121 16.21768 13.64524 15.66832 0 0 0 0 15.90502 0 0 0 16.40574 0 0 16.04032 0 16.53225 0 0 0 0 0 16.83033 16.61719 0 16.39774 0 0 0 17.56789 0 0 0 0 16.69213 15.97689 16.61813 0 0 16.74448 16.38675 17.51823 O14617 AP3D1_HUMAN AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) AP3D1 PRO0039 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1903232; GO:1904115 NLMEIVKK 14.75 1 1 0.482495863 989.4797071 0 0 0 0 0 17.06788 16.87895 0 0 18.35517 17.34106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.62131 0 17.21741 17.71725 0 0 0 18.57602 19.79125 0 20.63439 20.68195 0 0 17.06045 18.04653 17.26596 0 0 0 0 O14641 DVL2_HUMAN "Segment polarity protein dishevelled homolog DVL-2, Dishevelled-2 (DSH homolog 2)" DVL2 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cellular protein localization [GO:0034613]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cellular protein localization [GO:0034613]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] GO:0001843; GO:0001934; GO:0003151; GO:0005109; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007379; GO:0007507; GO:0016235; GO:0016328; GO:0016604; GO:0019901; GO:0019904; GO:0022007; GO:0030674; GO:0031267; GO:0031410; GO:0034613; GO:0035556; GO:0035567; GO:0042802; GO:0043507; GO:0043547; GO:0043621; GO:0044340; GO:0045177; GO:0045334; GO:0045944; GO:0051091; GO:0060070; GO:0060071; GO:0061098; GO:0090103; GO:0090179; GO:0150012 KYASGLLK 3.190000057 0.459020495 0.459020495 0.273110675 880.5444111 16.91153 14.14913 14.22748 17.81083 17.75659 0 18.18117 17.89677 16.55271 16.53329 0 0 0 17.58384 0 18.14618 0 0 16.38423 17.50613 0 0 0 0 0 0 0 18.20872 0 18.09939 0 18.0854 17.97494 0 0 0 17.13878 0 0 18.14507 0 0 16.71308 18.85666 0 0 0 18.16607 O14646 CHD1_HUMAN "Chromodomain-helicase-DNA-binding protein 1, CHD-1, EC 3.6.4.12 (ATP-dependent helicase CHD1)" CHD1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; positive regulation by host of viral transcription [GO:0043923] cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; methylated histone binding [GO:0035064]; chromatin remodeling [GO:0006338]; positive regulation by host of viral transcription [GO:0043923] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; methylated histone binding [GO:0035064] GO:0000228; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0016887; GO:0035064; GO:0043923; GO:0140658 QISFNGSEGR 9.239999771 1 1 0.316061354 1093.808824 15.91791 0 0 0 0 16.17569 0 17.00676 15.81495 0 15.71581 0 0 0 0 16.81934 0 0 0 0 16.05244 0 0 16.92271 0 0 0 0 16.76502 0 0 0 0 17.92571 16.9678 0 0 0 0 16.36063 17.02054 0 0 0 0 16.73927 0 0 O14647 CHD2_HUMAN "Chromodomain-helicase-DNA-binding protein 2, CHD-2, EC 3.6.4.12 (ATP-dependent helicase CHD2)" CHD2 Homo sapiens (Human) muscle organ development [GO:0007517] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; muscle organ development [GO:0007517] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0007517; GO:0016887; GO:0042393; GO:0140658 DHHYGDR 6.099999905 1 1 0.146121551 899.4522938 0 13.41608 12.08743 12.42846 10.98484 9.984545 11.47767 12.48104 14.1619 15.0056 0 15.5046 15.2847 0 0 0 0 0 0 0 0 0 15.47599 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10944 0 0 0 0 0 0 14.27041 0 0 15.30148 0 O14654 IRS4_HUMAN "Insulin receptor substrate 4, IRS-4 (160 kDa phosphotyrosine protein, py160) (Phosphoprotein of 160 kDa, pp160)" IRS4 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165] insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548] GO:0005158; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0043548 GSGSGK 7.409999847 1 1 0.097720325 493.181911 14.91267 0 15.11098 14.82937 0 0 16.65935 0 0 0 0 0 0 0 0 15.64039 0 13.3463 0 0 15.77437 0 0 0 0 0 0 0 0 15.31891 0 10.77242 0 0 13.76133 0 0 0 0 0 0 16.15417 0 0 0 0 0 0 O14656 TOR1A_HUMAN "Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)" TOR1A DQ2 DYT1 TA TORA Homo sapiens (Human) "cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ER-associated misfolded protein catabolic process [GO:0071712]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]" cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021] "cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]; cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ER-associated misfolded protein catabolic process [GO:0071712]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082] GO:0000338; GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0005829; GO:0005856; GO:0006979; GO:0006996; GO:0006998; GO:0007155; GO:0008021; GO:0008092; GO:0016020; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0042406; GO:0042802; GO:0043231; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051082; GO:0051085; GO:0051584; GO:0051787; GO:0061077; GO:0070062; GO:0071712; GO:0071763; GO:0140662; GO:1900244; GO:2000008 VEMQSR 1.049999952 0.823913932 0.823913932 0.10505564 766.013228 14.8981 0 0 15.5287 14.02736 0 15.06763 0 0 0 16.15542 14.01803 16.47037 15.99454 12.22339 0 0 0 0 0 0 0 0 0 14.78174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67011 0 O14672 ADA10_HUMAN "Disintegrin and metalloproteinase domain-containing protein 10, ADAM 10, EC 3.4.24.81 (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)" ADAM10 KUZ MADM Homo sapiens (Human) adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998] endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102] GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0035579; GO:0042117; GO:0042803; GO:0042987; GO:0043231; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070062; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945 LVDADGPLAR 2.049999952 1 1 0.127131666 1028.284462 0 10.71118 14.58636 0 0 0 15.51675 0 0 0 0 17.11749 12.18287 14.77831 0 0 0 14.7805 14.69461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53002 15.71586 0 0 0 0 0 0 0 0 14.53034 0 O14678 ABCD4_HUMAN "Lysosomal cobalamin transporter ABCD4, EC 7.6.2.8 (ATP-binding cassette sub-family D member 4) (PMP70-related protein, P70R) (Peroxisomal membrane protein 1-like, PXMP1-L) (Peroxisomal membrane protein 69, PMP69)" ABCD4 PXMP1L Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760] ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760] ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324] GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016021; GO:0042626; GO:0042760; GO:0043190; GO:0055085; GO:1990830 MAVAGPAPGAGARPRLDLQFLQR 3.950000048 1 1 0.01470092 2407.776016 12.73292 0 10.27198 12.43763 0 13.46728 0 13.57124 0 0 0 0 0 12.34875 0 13.63564 12.46084 12.12621 0 0 13.01749 13.1017 14.11455 0 0 0 6.511513 0 10.47975 0 0 0 0 15.12463 14.01995 0 0 0 0 0 0 0 13.2589 14.75393 0 0 0 0 O14681 EI24_HUMAN Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein) EI24 PIG8 Homo sapiens (Human) apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; importin-alpha family protein binding [GO:0061676]; apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308] importin-alpha family protein binding [GO:0061676] GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0016236; GO:0030308; GO:0031965; GO:0061676 AQSIER 13.55000019 1 1 0.23892343 703.8516949 16.55875 0 18.29505 16.16787 0 0 0 14.93046 0 18.00955 0 0 0 0 0 14.78807 0 16.71262 16.78359 18.12405 0 0 17.30732 14.85532 17.32192 16.26406 17.37097 0 0 0 17.73485 11.32346 16.13949 13.98403 16.41884 17.57546 18.58925 0 16.90417 14.07241 0 16.52768 17.21473 16.85926 16.09399 0 15.92882 0 O14686 KMT2D_HUMAN "Histone-lysine N-methyltransferase 2D, Lysine N-methyltransferase 2D, EC 2.1.1.364 (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)" KMT2D ALR MLL2 MLL4 Homo sapiens (Human) "beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin assembly [GO:0031507]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]" histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin assembly [GO:0031507]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]" DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] GO:0000976; GO:0001555; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0008284; GO:0031507; GO:0033148; GO:0035097; GO:0042393; GO:0042800; GO:0043627; GO:0044648; GO:0044666; GO:0045944; GO:0046872; GO:0048477; GO:0051568; GO:0080182; GO:0097692; GO:1904837 APLTPR 3.25999999 1 1 0.256680516 652.0856389 0 0 0 16.32232 0 15.87137 0 0 0 0 0 0 15.51755 0 17.4717 0 0 0 0 0 17.85078 0 0 14.39079 0 0 18.36729 0 0 0 18.5005 0 19.40975 0 16.60804 0 0 0 0 13.95409 16.56528 17.43292 0 15.1778 0 16.1813 0 15.02058 O14709 ZN197_HUMAN Zinc finger protein 197 (Zinc finger protein with KRAB and SCAN domains 9) (ZnF20) (pVHL-associated KRAB domain-containing protein) ZNF197 ZKSCAN9 ZNF166 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 ADSHK 11.32999992 0.224395275 0.224395275 0.262331231 556.7397133 16.15743 0 15.20981 0 15.76011 0 13.8822 0 16.50813 15.46698 0 15.45143 0 16.08336 16.55807 14.33849 14.73583 0 0 0 16.98545 16.97297 17.72402 16.82592 0 15.57876 0 16.33559 16.03805 0 16.52241 0 0 14.17978 16.56917 18.03635 17.18565 0 16.82826 16.05954 0 18.27845 17.50537 16.43283 17.15276 17.17295 15.40453 15.51558 O14727 APAF_HUMAN "Apoptotic protease-activating factor 1, APAF-1" APAF1 KIAA0413 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584] apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774] apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584] ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166] GO:0000166; GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0006915; GO:0006919; GO:0007399; GO:0007568; GO:0007584; GO:0008635; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0034774; GO:0042802; GO:0042981; GO:0043065; GO:0043293; GO:0043531; GO:0051402; GO:0070059; GO:0070062; GO:0071560; GO:0072432; GO:0097193; GO:0097202; GO:1902510; GO:1904813; GO:2001235 AAMLIK 7.400000095 1 1 0.273234284 646.6082459 15.56982 17.41143 0 0 17.521 0 0 18.16018 16.68698 16.74128 0 0 0 0 17.08842 0 0 0 18.01799 0 16.57631 0 0 0 17.18473 0 18.07068 0 0 17.4736 0 18.26494 18.07485 0 0 0 17.38952 18.68514 0 0 17.92917 0 0 16.84522 0 0 16.42943 0 O14730 RIOK3_HUMAN "Serine/threonine-protein kinase RIO3, EC 2.7.11.1 (RIO kinase 3) (sudD homolog)" RIOK3 SUDD Homo sapiens (Human) cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728] "cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]" ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786 HILVMSFIGHDQVPAPKLK 7.980000019 0.710289776 0.710289776 0.092514785 2141.938464 15.66476 14.45242 14.09308 12.98102 13.65115 0 0 13.83075 0 0 0 0 14.35608 14.06945 14.91813 14.98682 16.66809 15.50206 0 16.44425 0 14.5609 16.09209 0 0 14.22888 13.93171 14.608 13.16695 13.05458 15.5223 0 7.99588 13.88704 14.581 0 14.37463 15.76814 14.6512 0 12.83642 0 13.60604 0 0 0 0 14.83955 O14732 IMPA2_HUMAN "Inositol monophosphatase 2, IMP 2, IMPase 2, EC 3.1.3.25 (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2)" IMPA2 IMP.18P Homo sapiens (Human) inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; response to lithium ion [GO:0010226]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; response to lithium ion [GO:0010226]; signal transduction [GO:0007165] inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006796; GO:0007165; GO:0008934; GO:0010226; GO:0042803; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833 ALVLTEIGPKR 5.019999981 1 1 9.17E-13 1197.858313 0 14.27251 0 0 0 0 14.07657 11.96147 0 0 0 0 0 0 0 14.34935 0 0 0 0 0 0 0 0 0 14.88564 16.58905 0 0 15.56227 16.57823 0 0 0 0 0 0 0 0 0 15.90929 0 14.50808 0 15.33032 0 0 15.82092 O14735 CDIPT_HUMAN "CDP-diacylglycerol--inositol 3-phosphatidyltransferase, EC 2.7.8.11 (Phosphatidylinositol synthase, PI synthase, PtdIns synthase)" CDIPT PIS PIS1 Homo sapiens (Human) CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661] alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145] GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341 MGLWVTAPIALLKSLISVIHLITAAR 2.609999895 1 1 0.308504173 2803.019293 0 15.76748 16.14364 0 0 0 0 0 15.52724 0 0 0 0 0 0 0 0 0 0 14.61567 0 0 0 14.84427 0 0 14.21379 0 0 0 0 16.22663 0 0 0 0 14.71427 0 0 0 0 0 0 0 0 0 0 0 O14737 PDCD5_HUMAN "Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19, Protein TFAR19)" PDCD5 TFAR19 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200] acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201] GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0070062; GO:0071560; GO:0090200; GO:1903638; GO:1903645 KVSQQTEK 10.81999969 1 1 0.251513098 947.3063236 14.07847 0 14.15162 14.24353 15.05492 14.75602 0 15.38773 15.77042 13.73464 13.88741 0 0 14.99366 12.93161 15.38428 15.27858 0 0 0 0 0 0 0 0 0 16.05072 0 15.73148 15.30245 16.39068 14.95815 0 15.13864 0 0 0 0 16.51102 0 14.97339 0 0 0 0 0 0 0 O14744 ANM5_HUMAN "Protein arginine N-methyltransferase 5, PRMT5, EC 2.1.1.320 (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog, SKB1 homolog, SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed ]" PRMT5 HRMT1L5 IBP72 JBP1 SKB1 Homo sapiens (Human) "chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]" E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714] GO:0000387; GO:0000785; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048026; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992 SYTIGL 21.45000076 1 1 0.151916278 654.2614779 0 15.63369 15.60949 0 14.63473 15.13836 0 16.11291 13.61467 16.29671 14.17203 15.21832 15.26619 15.99273 0 13.19631 14.66062 14.72913 0 0 0 0 0 15.23389 16.5117 0 15.47232 0 0 0 0 0 0 0 0 17.00983 17.22531 17.2425 0 0 0 0 14.87825 0 0 0 0 18.698 O14745 NHRF1_HUMAN "Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)" SLC9A3R1 NHERF NHERF1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of protein kinase activity [GO:0045859]; regulation of renal phosphate excretion [GO:1903402]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of protein kinase activity [GO:0045859]; regulation of renal phosphate excretion [GO:1903402]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055] beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800] GO:0001726; GO:0002009; GO:0003096; GO:0005102; GO:0005737; GO:0005902; GO:0007009; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0015185; GO:0015629; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0031799; GO:0031800; GO:0031982; GO:0032415; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0034767; GO:0042802; GO:0043495; GO:0043621; GO:0044782; GO:0044877; GO:0045121; GO:0045159; GO:0045198; GO:0045199; GO:0045859; GO:0045930; GO:0047485; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0051939; GO:0060088; GO:0060158; GO:0065003; GO:0070062; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0090660; GO:0097225; GO:0097291; GO:0098739; GO:0098797; GO:0150104; GO:1903402; GO:2001244 AALNAVR 3.460000038 1 1 0.253389254 713.576045 0 0 0 0 0 0 0 0 0 0 0 0 17.50124 0 0 0 0 16.42406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.92278 0 0 0 0 0 0 0 0 0 0 0 0 0 O14753 OVOL1_HUMAN "Putative transcription factor Ovo-like 1, hOvo1" OVOL1 Homo sapiens (Human) "epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0001227; GO:0001822; GO:0005634; GO:0006357; GO:0007283; GO:0007498; GO:0009913; GO:0043588; GO:0046872; GO:0051729; GO:1901994; GO:1990837; GO:2000647 MLNRHMK 8 1 1 0.214247799 945.348445 14.52173 14.64387 12.56313 13.60828 14.20403 14.03946 14.36775 14.51822 15.28772 16.46427 0 0 14.96816 15.30039 13.18878 0 14.69928 0 14.64285 12.41294 0 15.20694 16.29953 0 15.84531 16.2778 0 0 0 15.05933 0 0 0 0 0 0 14.75454 0 0 15.61066 0 0 0 14.44848 15.25425 13.69957 0 14.90886 O14756 H17B6_HUMAN "17-beta-hydroxysteroid dehydrogenase type 6, 17-beta-HSD 6, 17-beta-HSD6, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.239, EC 1.1.1.53, EC 1.1.1.62 (3-alpha->beta-hydroxysteroid epimerase, 3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 6)" HSD17B6 RODH SDR9C6 Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; brexanolone catabolic process [GO:0062175] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783] "early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; brexanolone catabolic process [GO:0062175]" "17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" GO:0003824; GO:0004745; GO:0005783; GO:0006702; GO:0006710; GO:0009055; GO:0016491; GO:0031901; GO:0044594; GO:0047023; GO:0047024; GO:0047035; GO:0047044; GO:0047045; GO:0062175; GO:0072582 SWPKPAQAV 6.440000057 1 1 0.296335388 982.117266 15.52638 0 17.12376 16.37579 14.85342 0 16.59102 17.61388 15.39293 14.75392 16.60122 16.28309 17.33503 0 15.0816 16.35392 15.92692 16.15844 0 17.54195 0 15.24035 0 16.48307 14.63619 15.28267 15.92862 15.76519 16.38293 15.17145 15.17979 16.73834 14.4114 15.32593 15.84581 16.07182 16.3902 0 15.84058 15.03396 15.95392 17.12095 14.49419 13.68033 15.86601 16.1943 14.80463 14.39173 O14763 TR10B_HUMAN "Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2) (CD antigen CD262)" TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462] signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463] GO:0002357; GO:0005886; GO:0006915; GO:0007166; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0034976; GO:0036462; GO:0036463; GO:0038023; GO:0042981; GO:0043065; GO:0043123; GO:0045569; GO:0070059; GO:0071260 AAPQQKR 9.029999733 0.862503946 0.862503946 0.26045012 798.7604284 12.3848 17.47766 15.92772 14.26651 0 0 16.26054 15.8083 0 0 0 0 15.7987 0 0 16.62406 15.15395 16.29742 0 15.55695 17.34173 16.69758 0 0 17.02263 0 17.594 16.54575 0 14.44403 16.15686 15.09751 15.97108 16.92865 17.53212 15.5894 16.45545 16.87975 16.2366 15.81062 15.56059 17.01416 17.07112 17.21495 14.94681 16.32491 16.79423 0 O14770 MEIS2_HUMAN Homeobox protein Meis2 (Meis1-related protein 1) MEIS2 MRG1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; visual learning [GO:0008542] chromatin [GO:0000785]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "chromatin [GO:0000785]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; visual learning [GO:0008542]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003677; GO:0005634; GO:0006357; GO:0007420; GO:0008134; GO:0008284; GO:0008542; GO:0009612; GO:0009880; GO:0009887; GO:0031016; GO:0043565; GO:0045638; GO:0045931; GO:0045944; GO:0048471; GO:0070848; GO:0110024; GO:1990837 DAIYGHPLFPLLALVFEK 3.289999962 0.137013882 0.137013882 0.026509494 2043.919298 0 16.64523 16.50517 8.217234 0 11.78785 15.32771 14.53004 0 0 15.94037 13.89305 15.40292 16.31079 13.81393 0 15.31633 13.55454 0 0 11.83891 15.53167 15.76831 18.69153 0 15.13154 0 14.48786 0 0 12.59177 12.49111 0 16.31875 0 0 0 13.02229 9.952018 12.20403 0 12.73812 16.51801 13.99798 12.12747 14.91283 0 0 O14773 TPP1_HUMAN "Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)" TPP1 CLN2 GIG1 UNQ267/PRO304 Homo sapiens (Human) "bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lipid metabolic process [GO:0006629]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]" extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; recycling endosome [GO:0055037] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240]; bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lipid metabolic process [GO:0006629]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]" endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240] GO:0004175; GO:0004252; GO:0005764; GO:0005794; GO:0006508; GO:0006629; GO:0007040; GO:0007399; GO:0007417; GO:0008233; GO:0008236; GO:0008240; GO:0030163; GO:0030855; GO:0035727; GO:0042277; GO:0042470; GO:0043171; GO:0043202; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070062; GO:0070198; GO:0120146; GO:1905146 VVGQQGRGR 6.75 0.714219928 0.714219928 0.118268457 957.2572081 0 15.39825 15.1432 12.33672 12.01147 13.46816 0 14.94582 0 0 15.19192 0 0 14.09596 10.9705 0 0 0 0 0 16.13817 13.05629 0 0 0 14.79962 14.88382 15.98084 0 13.20731 0 14.6333 15.75219 0 0 0 18.37387 0 0 0 13.5689 0 14.7839 13.31815 14.40352 0 12.05264 16.11215 O14775 GNB5_HUMAN Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5) GNB5 Homo sapiens (Human) dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; signaling receptor complex adaptor activity [GO:0030159]; dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; signaling receptor complex adaptor activity [GO:0030159] GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007186; GO:0007212; GO:0030159; GO:0031682; GO:0036367; GO:0043547; GO:0051087; GO:0098793; GO:1901386; GO:1902773; GO:1990603 NENMAAKK 5.619999886 1 1 0.215774735 921.1024929 16.8893 0 16.76293 0 0 0 18.58493 0 0 0 0 0 17.17023 0 0 0 0 0 17.18195 0 0 0 0 0 0 0 18.85429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1958 0 0 0 0 0 O14777 NDC80_HUMAN "Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1, HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)" NDC80 HEC HEC1 KNTC2 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057] "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]" "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]" cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483] GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0007094; GO:0008315; GO:0008608; GO:0016020; GO:0030332; GO:0031262; GO:0031617; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483; GO:1905342 LLEMVATHVGSVEK 4.420000076 0.811845005 0.811845005 0.089699055 1530.039451 0 0 11.9941 11.65082 13.59925 15.73089 14.47589 0 14.16175 14.55112 14.72453 14.30738 0 0 0 14.51187 0 0 0 0 15.5964 15.64513 0 15.98587 0 0 0 15.39732 12.50303 13.88547 0 16.28106 12.50425 15.18821 13.71782 0 14.30802 0 15.63455 0 15.69945 0 13.25271 0 0 0 14.44901 0 O14787 TNPO2_HUMAN Transportin-2 (Karyopherin beta-2b) TNPO2 Homo sapiens (Human) protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0031267; GO:0061608 ATIGILITTIASK 5.050000191 1 1 0.147188415 1302.584851 0 0 0 0 0 0 0 0 0 10.10963 14.17883 0 0 14.33995 0 0 14.66319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14788 TNF11_HUMAN "Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor, ODF) (Osteoprotegerin ligand, OPGL) (Receptor activator of nuclear factor kappa-B ligand, RANKL) (TNF-related activation-induced cytokine, TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form ]" TNFSF11 OPGL RANKL TRANCE Homo sapiens (Human) bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813] GO:0001503; GO:0002158; GO:0002548; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0010628; GO:0019221; GO:0019722; GO:0030316; GO:0032813; GO:0033209; GO:0033598; GO:0034112; GO:0036035; GO:0038001; GO:0042802; GO:0043123; GO:0043406; GO:0044691; GO:0045453; GO:0045672; GO:0045780; GO:0045944; GO:0046330; GO:0050870; GO:0051091; GO:0051092; GO:0051466; GO:0051897; GO:0055074; GO:0060749; GO:0070371; GO:0071812; GO:0071847; GO:0071848; GO:1902533; GO:1904616; GO:1990830; GO:2001206 TSIKIPSSHTLMK 13.06000042 1 1 0.113134867 1459.317754 13.25246 0 14.67765 0 0 12.86303 0 0 13.32166 0 0 14.47483 14.89518 14.98804 15.57764 0 16.27612 16.27543 0 0 10.9872 0 17.89247 16.40799 16.02825 0 12.59468 12.89849 14.38302 13.85096 15.04718 14.76745 0 0 12.88588 15.07419 15.54259 10.70666 12.49782 16.04777 0 0 11.96052 0 0 0 0 0 O14793 GDF8_HUMAN "Growth/differentiation factor 8, GDF-8 (Myostatin)" MSTN GDF8 Homo sapiens (Human) "cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" cytoplasm [GO:0005737]; extracellular space [GO:0005615] "cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007179; GO:0007517; GO:0008083; GO:0008201; GO:0009408; GO:0009629; GO:0010592; GO:0010759; GO:0010862; GO:0014732; GO:0014741; GO:0014839; GO:0014850; GO:0022602; GO:0033574; GO:0033673; GO:0042802; GO:0042803; GO:0043627; GO:0045471; GO:0045662; GO:0045893; GO:0046627; GO:0046716; GO:0048632; GO:0051602; GO:0051898; GO:0060395; GO:0071549; GO:1902723; GO:1902725; GO:2000818 DGTRYTGIR 3.549999952 1 1 0.037209828 1039.593742 0 16.18909 0 15.74803 0 0 0 0 0 0 15.81128 0 15.09935 0 14.85325 14.09919 14.97758 15.40808 0 0 0 0 0 14.14932 16.38879 0 13.19778 0 0 0 0 14.18602 14.89528 0 15.19229 0 14.88749 12.08074 0 0 0 0 0 0 0 0 0 0 O14795 UN13B_HUMAN "Protein unc-13 homolog B (Munc13-2, munc13)" UNC13B UNC13 Homo sapiens (Human) "acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075] GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016020; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0030742; GO:0031267; GO:0031594; GO:0035249; GO:0042734; GO:0043065; GO:0043195; GO:0048786; GO:0050714; GO:0060478; GO:0061789; GO:0071333; GO:0097151; GO:0098831; GO:0099011; GO:0099525 QMADILGQVR 12.97999954 1 1 0.416798551 1129.403487 20.08234 0 0 0 0 0 0 0 0 0 19.99046 0 0 0 0 0 0 0 0 0 17.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 20.68077 21.30623 21.90507 0 0 0 0 19.74857 20.40635 0 18.46012 0 0 0 O14802 RPC1_HUMAN "DNA-directed RNA polymerase III subunit RPC1, RNA polymerase III subunit C1, EC 2.7.7.6 (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit, RPC155) (RNA polymerase III subunit C160)" POLR3A Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032728; GO:0045087; GO:0046872; GO:0051607 ENSKSSMYYVLQFLK 4.929999828 1 1 0.067876892 1853.53914 14.2162 16.4998 0 0 12.51702 14.5661 13.81466 15.86137 0 12.88167 0 0 0 13.3084 0 0 0 11.48652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14804 TAAR5_HUMAN "Trace amine-associated receptor 5, TaR-5, Trace amine receptor 5, hTaar5 (Putative neurotransmitter receptor)" TAAR5 PNR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081] GO:0001594; GO:0004930; GO:0005887; GO:0007165; GO:0007186; GO:0007606; GO:1990081 SLAGAAKHER 8.369999886 0.150486007 0.150486007 0.264101688 1039.330414 14.57601 0 13.6401 15.08192 13.77209 14.96989 0 15.79774 13.29054 15.91723 16.06165 15.67505 15.8921 0 0 14.95989 0 0 0 0 15.00502 17.18785 15.89871 16.0067 0 14.45125 16.17043 0 0 0 16.65883 0 15.95022 16.42551 0 14.77654 0 14.55394 16.94916 0 0 0 0 0 0 0 14.87793 16.22854 O14807 RASM_HUMAN "Ras-related protein M-Ras, EC 3.6.5.2 (Ras-related protein R-Ras3)" MRAS RRAS3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830 ATGTHK 4 1 1 0.132529429 613.6280515 0 0 0 0 14.07323 0 0 0 15.02262 0 0 0 0 0 0 13.5927 0 0 0 0 0 13.76043 0 0 0 0 0 0 0 0 16.76812 16.30428 0 0 0 0 16.5757 15.73945 0 13.3941 0 0 0 0 0 0 15.5632 16.51237 O14818 PSA7_HUMAN Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; identical protein binding [GO:0042802]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" identical protein binding [GO:0042802] GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0042802; GO:0043161; GO:0070062; GO:0098794 ANAIGRGAK 5.539999962 1 1 0.094301311 857.7920541 0 14.82851 0 14.12403 13.94206 14.98947 14.67437 13.203 14.71291 9.371721 11.96865 15.47465 0 0 0 14.75323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.33025 0 0 0 17.60322 0 0 14.3322 0 0 0 0 0 0 0 0 O14827 RGRF2_HUMAN "Ras-specific guanine nucleotide-releasing factor 2, Ras-GRF2 (Ras guanine nucleotide exchange factor 2)" RASGRF2 GRF2 Homo sapiens (Human) long-term synaptic potentiation [GO:0060291]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to endoplasmic reticulum stress [GO:0034976] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]; long-term synaptic potentiation [GO:0060291]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to endoplasmic reticulum stress [GO:0034976] calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005516; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0007265; GO:0034976; GO:0035023; GO:0043547; GO:0051056; GO:0060291; GO:2000310 FSSPPPLAVSRTSSPVR 4.929999828 1 1 0.027814471 1784.245324 14.99946 14.16458 0 0 0 0 0 0 0 0 0 16.23359 0 0 0 14.52186 0 0 0 0 0 0 16.75277 0 16.78073 0 0 0 0 0 0 0 0 0 0 0 0 14.56891 0 0 15.34281 15.06284 0 13.06131 14.79854 0 0 0 O14829 PPE1_HUMAN "Serine/threonine-protein phosphatase with EF-hands 1, PPEF-1, EC 3.1.3.16 (Protein phosphatase with EF calcium-binding domain, PPEF) (Serine/threonine-protein phosphatase 7, PP7)" PPEF1 PPEF PPP7C Homo sapiens (Human) detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470] calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0030145; GO:0050906 VLKQMPNFTHIQTSPSK 5.420000076 1 1 0.230072315 1956.110324 15.3809 16.24891 0 0 0 15.338 0 13.48491 0 0 0 0 0 0 0 14.04748 0 15.6711 0 13.02204 0 0 0 16.22666 0 0 0 15.3012 0 15.3995 0 15.61843 16.68613 15.42631 12.92422 14.67202 13.26053 0 15.24528 0 13.73046 0 12.88416 13.3542 0 15.14105 11.84952 15.96208 O14830 PPE2_HUMAN "Serine/threonine-protein phosphatase with EF-hands 2, PPEF-2, EC 3.1.3.16" PPEF2 Homo sapiens (Human) detection of stimulus involved in sensory perception [GO:0050906]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; protein dephosphorylation [GO:0006470]; regulation of JUN kinase activity [GO:0043506]; regulation of MAP kinase activity [GO:0043405]; visual perception [GO:0007601] cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; protein dephosphorylation [GO:0006470]; regulation of JUN kinase activity [GO:0043506]; regulation of MAP kinase activity [GO:0043405]; visual perception [GO:0007601] calcium ion binding [GO:0005509]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine phosphatase activity [GO:0004722] GO:0001750; GO:0001917; GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0007601; GO:0010801; GO:0030145; GO:0030544; GO:0031435; GO:0043405; GO:0043409; GO:0043506; GO:0050906; GO:0051879 DSGCSSPGAH 5.039999962 1 1 0.035858722 971.9613357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6579 15.79092 16.64465 0 0 0 0 0 0 0 0 15.34137 0 0 0 13.57458 14.83089 0 0 0 0 0 0 0 0 0 0 0 0 11.53174 0 0 0 O14841 OPLA_HUMAN "5-oxoprolinase, EC 3.5.2.9 (5-oxo-L-prolinase, 5-OPase) (Pyroglutamase)" OPLAH Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytosol [GO:0005829] cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749] 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802] GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802 FMSIAEQMGR 2.529999971 0.487041175 0.487041175 0.204547604 1200.993218 13.60616 14.83504 0 10.67524 14.40523 14.6316 0 13.54871 13.62349 12.31546 0 15.08242 14.62003 10.95295 13.83935 0 0 0 0 0 0 0 0 14.47564 14.09199 0 0 0 14.05352 0 0 0 0 0 0 14.12132 0 0 0 13.58746 0 0 0 0 0 0 0 0 O14896 IRF6_HUMAN "Interferon regulatory factor 6, IRF-6" IRF6 Homo sapiens (Human) "cell development [GO:0048468]; cranial skeletal system development [GO:1904888]; immune system process [GO:0002376]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; cranial skeletal system development [GO:1904888]; immune system process [GO:0002376]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0008285; GO:0030054; GO:0030216; GO:0043565; GO:0043616; GO:0045893; GO:0045944; GO:0048468; GO:0060021; GO:0060173; GO:0060644; GO:0070062; GO:1904888; GO:1990837 EFNLMYDGTKEVPMNPVK 4.139999866 1 1 0.122324911 2129.107654 16.26299 15.55081 12.44605 14.77227 17.13879 0 14.51726 0 12.65894 14.58414 12.95522 16.20637 0 10.5372 0 0 13.84539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14908 GIPC1_HUMAN "PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2, TIP-2)" GIPC1 C19orf3 GIPC RGS19IP1 Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300] actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102] GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005938; GO:0006605; GO:0007186; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0045296; GO:0048023; GO:0048167; GO:0070062; GO:0098685; GO:0098761; GO:0098978; GO:2000300 LTEPR 14.89999962 0.654231608 0.654231608 0.216719528 615.0803111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.80651 0 0 0 0 0 0 0 0 0 0 18.37616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14910 LIN7A_HUMAN "Protein lin-7 homolog A, Lin-7A, hLin-7 (Mammalian lin-seven protein 1, MALS-1) (Tax interaction protein 33, TIP-33) (Vertebrate lin-7 homolog 1, Veli-1)" LIN7A MALS1 VELI1 Homo sapiens (Human) exocytosis [GO:0006887]; inner ear development [GO:0048839]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; synaptic vesicle transport [GO:0048489] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; exocytosis [GO:0006887]; inner ear development [GO:0048839]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; synaptic vesicle transport [GO:0048489] L27 domain binding [GO:0097016] GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0045199; GO:0045202; GO:0048489; GO:0048839; GO:0065003; GO:0070062; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361 IIPGGVAER 8.06000042 1 1 0.224099153 912.6255108 0 0 0 0 0 0 0 0 0 0 0 0 0 17.90226 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59542 0 0 0 0 0 0 0 0 17.58788 0 0 0 0 0 0 16.22359 0 18.25943 0 0 O14917 PCD17_HUMAN Protocadherin-17 (Protocadherin-68) PCDH17 PCDH68 PCH68 Homo sapiens (Human) adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; calcium ion binding [GO:0005509]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030534; GO:0050805; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099560; GO:1904071; GO:2000807 ASRDSSEMGAVLEQLDHPNR 14.05000019 1 1 0.354164998 2211.12417 10.88674 0 0 18.32255 16.45782 19.17301 19.76255 20.59349 19.91846 18.1769 20.32371 19.80395 0 0 20.26183 18.50306 21.24216 18.75481 17.75026 0 0 0 20.68916 0 21.43045 20.36026 20.88712 18.83979 20.45561 20.07924 0 20.20408 20.39018 0 0 22.13761 20.96746 20.4252 0 20.47426 18.51792 0 0 0 0 18.33467 0 0 O14921 RGS13_HUMAN "Regulator of G-protein signaling 13, RGS13" RGS13 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744] GTPase activity [GO:0003924] GO:0003924; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0045744 EINIDSSTR 17.28000069 1 1 0.042667301 1034.231583 0 0 0 0 0 15.34278 15.10433 0 0 0 0 16.28046 15.14887 15.52357 0 13.77986 12.96741 0 16.00449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4748 0 0 0 16.11532 0 0 0 0 16.59417 0 0 0 O14924 RGS12_HUMAN "Regulator of G-protein signaling 12, RGS12" RGS12 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase regulator activity [GO:0030695]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase regulator activity [GO:0030695] GO:0000794; GO:0003924; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0016363; GO:0030425; GO:0030695; GO:0045202 APHPDMFKEQQLQIFNLMK 9.539999962 0.020274824 0.020274824 0.484114545 2315.94414 16.49572 0 19.91901 0 0 0 20.11088 17.55173 0 0 0 17.33463 16.93879 0 17.14439 16.99377 0 0 17.25721 19.02551 18.67926 18.85091 0 0 19.54158 20.15842 19.32041 19.32259 0 0 0 0 19.88191 18.61206 18.69757 17.14006 0 19.46862 0 18.41794 0 0 0 19.61601 18.34893 0 0 0 O14925 TIM23_HUMAN Mitochondrial import inner membrane translocase subunit Tim23 TIMM23 TIM23 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; protein transmembrane transporter activity [GO:0008320]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] protein transmembrane transporter activity [GO:0008320] GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0006886; GO:0008320; GO:0030150; GO:0031305 NVQILNMVTR 3.380000114 0.093565606 0.093565606 0.070969175 1200.764682 12.5419 11.1987 0 15.21565 0 10.97824 14.74106 0 0 0 13.31653 12.64579 10.66948 0 11.39995 0 0 16.38823 16.38382 0 0 12.79117 14.91397 0 0 0 0 15.68367 0 13.05015 0 15.71258 0 0 16.08694 0 15.05304 13.95735 0 16.44361 0 16.35133 11.59984 0 0 12.65922 14.92057 16.1786 O14926 FSCN2_HUMAN Fascin-2 (Retinal fascin) FSCN2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; anatomical structure morphogenesis [GO:0009653]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; anatomical structure morphogenesis [GO:0009653]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; visual perception [GO:0007601] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674] GO:0003779; GO:0005737; GO:0007163; GO:0007601; GO:0009653; GO:0015629; GO:0016477; GO:0030036; GO:0030674; GO:0032420; GO:0042462; GO:0051015; GO:0051017 ASNGRYVCMK 2.420000076 1 1 0.218781327 1202.288189 16.08325 0 13.03569 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5743 0 0 0 0 0 0 0 16.3052 0 0 0 0 0 0 0 0 0 0 15.14756 0 0 14.85294 0 15.78922 0 0 14.68018 0 13.87926 0 0 O14929 HAT1_HUMAN "Histone acetyltransferase type B catalytic subunit, EC 2.3.1.48 (Histone acetyltransferase 1)" HAT1 KAT1 Homo sapiens (Human) DNA packaging [GO:0006323]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; subtelomeric heterochromatin assembly [GO:0031509] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; DNA packaging [GO:0006323]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; subtelomeric heterochromatin assembly [GO:0031509]" H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393] GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006323; GO:0006335; GO:0006336; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043967 VSQMLILTPFQGQGHGAQLLETVHR 3.690000057 0.234249353 0.234249353 0.02951509 2760.515345 0 0 15.6603 0 0 3.899829 0 0 9.664045 14.27759 14.87811 0 0 12.40782 0 0 0 12.38828 15.24099 15.15021 0 0 15.02537 0 0 16.72958 16.67783 15.06266 16.29073 16.32037 0 18.32627 0 0 0 0 12.69567 0 0 0 0 0 0 0 13.73225 0 0 0 O14936 CSKP_HUMAN "Peripheral plasma membrane protein CASK, hCASK, EC 2.7.11.1 (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog)" CASK LIN2 Homo sapiens (Human) calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102] GO:0001953; GO:0004385; GO:0004674; GO:0004712; GO:0005102; GO:0005516; GO:0005524; GO:0005604; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007155; GO:0010839; GO:0015629; GO:0016323; GO:0016363; GO:0031982; GO:0034613; GO:0042043; GO:0042734; GO:0045944; GO:0046928; GO:0060170; GO:0061045; GO:0070509; GO:0090280; GO:0090288; GO:0098685; GO:0106310; GO:2000300 ERLFEGIIK 2.400000095 1 1 0.194832464 1105.558741 14.2783 0 0 15.97521 14.27017 0 14.3917 15.16362 0 14.7087 0 14.80795 0 14.2647 11.62375 15.52733 0 0 0 0 0 15.09226 0 0 0 15.00028 0 0 0 15.59512 0 0 16.01253 16.33894 0 0 0 0 15.99061 0 0 0 0 0 0 0 0 0 O14939 PLD2_HUMAN "Phospholipase D2, PLD 2, hPLD2, EC 3.1.4.4 (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)" PLD2 Homo sapiens (Human) cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynapse [GO:0098793] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465] N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630] GO:0004630; GO:0005789; GO:0005886; GO:0006654; GO:0007010; GO:0007264; GO:0016042; GO:0035091; GO:0036465; GO:0038096; GO:0048017; GO:0048870; GO:0070290; GO:0098793 AAMGTAWR 2.180000067 1 1 0.093757388 862.2904007 15.98605 14.15337 11.35537 0 0 0 0 0 0 0 0 0 0 0 0 15.56886 16.27518 0 0 0 0 0 0 0 0 15.20647 0 0 0 0 0 0 0 13.69475 0 0 0 0 0 0 0 0 0 0 0 0 14.92425 0 O14948 TFEC_HUMAN "Transcription factor EC, TFE-C (Class E basic helix-loop-helix protein 34, bHLHe34) (Transcription factor EC-like, hTFEC-L)" TFEC BHLHE34 TCFEC TFECL Homo sapiens (Human) cellular response to heat [GO:0034605]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to heat [GO:0034605]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0034605; GO:0045944; GO:0046983; GO:1990837 EITETDTR 7.260000229 1 1 1.03E-12 964.2315849 13.09254 15.1013 0 15.4388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.56267 13.5759 0 0 17.50735 0 0 15.54272 15.34091 0 0 13.8638 0 0 0 0 O14957 QCR10_HUMAN Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 6.4 kDa protein) UQCR11 UQCR Homo sapiens (Human) "cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; electron transfer activity [GO:0009055]; cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" electron transfer activity [GO:0009055] GO:0005743; GO:0005750; GO:0006091; GO:0006122; GO:0009055; GO:0045333 MVTRFLGPR 3.279999971 1 1 4.63E-13 1093.155717 0 0 0 0 0 4.575037 12.90581 0 0 0 0 0 14.06187 0 0 0 0 16.82352 0 0 0 0 0 0 0 0 13.46387 0 0 0 0 0 0 14.87165 17.90262 0 0 0 0 0 0 0 0 0 0 0 13.83382 0 O14960 LECT2_HUMAN "Leukocyte cell-derived chemotaxin-2, LECT-2, hLECT2" LECT2 Homo sapiens (Human) chemotaxis [GO:0006935]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chemotaxis [GO:0006935]; skeletal system development [GO:0001501] identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0001501; GO:0005615; GO:0005737; GO:0005829; GO:0006935; GO:0042802; GO:0043231; GO:0046872 NAINNGVR 6.619999886 1 1 0.452866276 856.6188684 0 14.68327 0 15.18509 0 0 16.60981 15.36063 15.34437 0 0 16.14972 16.06203 0 14.93557 14.92962 14.53424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.86082 0 0 0 0 0 0 16.97565 0 0 O14964 HGS_HUMAN Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110) HGS HRS Homo sapiens (Human) endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; phagocytic vesicle lumen [GO:0097013] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; phagocytic vesicle lumen [GO:0097013]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165] metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389] GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0008285; GO:0010324; GO:0010628; GO:0010642; GO:0016197; GO:0016236; GO:0016525; GO:0019904; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0035091; GO:0036258; GO:0042176; GO:0043130; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0070062; GO:0072657; GO:0097013; GO:1903543 STYTSYPK 1.309999943 1 1 0.252377529 948.3771145 15.23027 13.44882 0 14.84537 0 15.29695 0 17.11102 0 0 0 0 16.30099 15.07889 14.21327 15.86897 15.84552 0 15.68757 0 0 15.03126 0 0 17.15466 0 15.96174 16.08163 0 15.94398 0 16.01071 15.18957 11.3169 12.17071 15.22404 16.4504 14.86102 0 15.66552 15.90314 10.11611 15.45657 15.26217 15.73357 15.59859 15.40114 14.85431 O14965 AURKA_HUMAN "Aurora kinase A, EC 2.7.11.1 (Aurora 2) (Aurora/IPL1-related kinase 1, ARK-1, Aurora-related kinase 1, hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)" AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome localization [GO:0051642]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051] axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616] axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome localization [GO:0051642]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051] ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] GO:0000086; GO:0000278; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005929; GO:0006468; GO:0007051; GO:0007052; GO:0007057; GO:0007100; GO:0009611; GO:0009948; GO:0010389; GO:0010629; GO:0015630; GO:0018105; GO:0019901; GO:0030496; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035174; GO:0042585; GO:0043066; GO:0043203; GO:0045120; GO:0045840; GO:0046605; GO:0046777; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051642; GO:0071539; GO:0072686; GO:0072687; GO:0090141; GO:0097421; GO:0097431; GO:0106310; GO:1900195; GO:1901796; GO:1990138 DIKPENLLLGSAGELK 34.79999924 1 1 0.512305827 1697.662726 0 0 0 17.91612 0 0 0 0 18.88985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93819 0 0 0 0 0 0 0 0 0 17.24558 0 0 16.84555 0 0 17.12123 O14966 RAB7L_HUMAN Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29) RAB29 RAB7L1 Homo sapiens (Human) "cell differentiation [GO:0030154]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]; viral RNA genome replication [GO:0039694]" cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] "cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]; cell differentiation [GO:0030154]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]; viral RNA genome replication [GO:0039694]" dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0032438; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0043231; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1901998; GO:1903441; GO:1905279 ENKNINEAMR 6.829999924 1 1 0.085899029 1220.147281 14.75628 15.47869 14.91887 15.64879 15.02307 0 0 0 0 0 0 0 0 0 15.408 0 0 0 0 0 15.94353 15.52726 14.07133 12.17444 0 0 0 16.41058 0 0 0 0 0 0 0 0 15.73563 0 16.88921 15.56017 0 13.38006 0 0 0 0 0 15.11903 O14974 MYPT1_HUMAN "Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1, Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit)" PPP1R12A MBS MYPT1 Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901] GO:0000278; GO:0000776; GO:0004857; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071466; GO:0071889; GO:0072357 EKDTAGVTR 4.130000114 0.44173345 0.44173345 0.217894376 975.8763651 17.14133 13.61846 0 0 16.44738 0 0 0 0 0 13.68057 0 0 15.37753 0 0 0 0 15.8537 0 0 0 15.92643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97719 13.30627 0 0 0 0 0 0 0 O14976 GAK_HUMAN "Cyclin-G-associated kinase, EC 2.7.11.1" GAK Homo sapiens (Human) cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191] ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:0106310; GO:1905224 TATTPK 2.589999914 1 1 0.168018063 620.9217237 15.86209 16.65461 15.54191 0 15.03029 14.7343 12.5148 0 15.62308 0 0 0 0 15.77511 16.12083 0 16.43155 0 16.21894 0 0 0 0 0 0 0 15.19322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2859 0 0 0 0 0 O14978 ZN263_HUMAN Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12) ZNF263 FPM315 ZKSCAN12 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0045944; GO:0046872; GO:1990837 IHAAER 13.01000023 0.399743289 0.399743289 0.18401473 696.4345212 20.40657 18.3521 19.86172 0 19.25328 18.36985 19.13587 18.14535 18.22901 0 17.16292 18.85079 19.65932 18.42689 18.95686 19.09647 19.8549 17.61267 19.61818 19.74513 17.42346 18.27812 18.1022 18.58487 18.92864 15.25349 18.87081 19.3871 19.03584 17.89489 19.69256 18.99056 0 19.47423 18.35062 19.21671 19.89932 19.00194 19.39216 20.10649 16.53679 20.42799 20.22455 19.77448 18.58436 20.16913 19.34588 19.51196 O14979 HNRDL_HUMAN "Heterogeneous nuclear ribonucleoprotein D-like, hnRNP D-like, hnRNP DL (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)" HNRNPDL HNRPDL JKTBP Homo sapiens (Human) regulation of gene expression [GO:0010468]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; regulation of gene expression [GO:0010468]; RNA processing [GO:0006396] DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008143; GO:0010468; GO:0034046 SLSHWRPRPPRQLAPLLPSLAPSSAR 3.24000001 1 1 2.75E-12 2891.125458 0 0 0 0 15.72757 15.44383 0 0 14.34873 17.60121 0 13.32297 0 0 0 0 0 13.13057 14.27686 0 0 0 0 0 0 16.157 0 0 0 0 0 15.71152 0 0 0 0 14.34612 0 0 12.06478 14.13484 0 0 10.60455 10.65926 0 0 11.10069 O14980 XPO1_HUMAN "Exportin-1, Exp1 (Chromosome region maintenance 1 protein homolog)" XPO1 CRM1 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254] annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254] nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0000054; GO:0000055; GO:0000056; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0010824; GO:0015030; GO:0016020; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0043231; GO:0046825; GO:0051028; GO:1990904 DPETVKQLGSILK 3.25 1 1 0.138893067 1428.058834 14.95856 0 0 15.79084 0 14.17459 14.25481 0 13.57927 15.01702 0 14.92146 0 9.718562 14.65279 0 0 14.2914 0 0 0 0 0 0 0 0 0 0 0 0 15.02999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14981 BTAF1_HUMAN "TATA-binding protein-associated factor 172, EC 3.6.4.- (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172, TAF-172)" BTAF1 TAF172 Homo sapiens (Human) "negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]" intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] "intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; transcription coregulator activity [GO:0003712]" GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0016887; GO:0017025; GO:0035562; GO:0043231; GO:0045892; GO:0140658 ADTSTSGKASMK 1.870000005 1 1 0.022613207 1184.002488 13.90174 12.67956 11.63376 0 0 0 0 0 11.96711 0 0 0 0 0 0 0 0 0 0 15.16772 0 0 12.74799 0 14.64874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14983 AT2A1_HUMAN "Sarcoplasmic/endoplasmic reticulum calcium ATPase 1, SERCA1, SR Ca(2+)-ATPase 1, EC 7.2.2.10 (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)" ATP2A1 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cardiac conduction [GO:1903779]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976] calcium channel complex [GO:0034704]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel complex [GO:0034704]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium-dependent ATPase activity [GO:0030899]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cardiac conduction [GO:1903779]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium-dependent ATPase activity [GO:0030899]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; protein homodimerization activity [GO:0042803] GO:0005388; GO:0005509; GO:0005524; GO:0005739; GO:0005789; GO:0005793; GO:0006816; GO:0006874; GO:0006942; GO:0008637; GO:0015662; GO:0016020; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031095; GO:0031448; GO:0031673; GO:0031674; GO:0032470; GO:0032471; GO:0033017; GO:0034220; GO:0034704; GO:0034976; GO:0042803; GO:0045988; GO:0048471; GO:0051561; GO:0051659; GO:0070059; GO:0070509; GO:0070588; GO:0090076; GO:0106134; GO:1901896; GO:1902082; GO:1903779; GO:1990036 KAEIGIAMGSGTAVAK 5.150000095 1 1 0.120978252 1519.148598 0 0 0 0 0 0 0 0 0 0 0 15.19678 0 0 0 0 0 0 0 17.06404 0 0 0 0 0 15.01392 15.12673 0 16.49026 0 0 0 0 0 14.67861 0 0 15.70406 0 0 0 0 0 0 0 0 0 0 O14986 PI51B_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase type-1 beta, PIP5K1-beta, PtdIns(4)P-5-kinase 1 beta, EC 2.7.1.68 (Phosphatidylinositol 4-phosphate 5-kinase type I beta, PIP5KIbeta) (Protein STM-7) (Type I phosphatidylinositol 4-phosphate 5-kinase beta)" PIP5K1B STM7 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; uropod [GO:0001931] "cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; uropod [GO:0001931]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]" "1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]" GO:0000285; GO:0001931; GO:0005524; GO:0005829; GO:0005886; GO:0006661; GO:0012505; GO:0014066; GO:0016308; GO:0046854; GO:0052810; GO:0052812 IVVMNNVLPRSMR 12.01000023 0.110251285 0.110251285 0.20589355 1547.270294 0 0 0 13.90166 0 0 0 18.05929 0 16.71516 13.66895 0 0 0 13.43253 0 0 13.67882 15.211 19.43177 16.21918 16.29898 14.81477 15.30824 0 0 15.59681 0 0 0 10.30793 0 0 17.36542 0 0 0 0 0 9.865146 0 17.93587 0 0 0 17.0595 0 0 O15013 ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 ARHGEF10 KIAA0294 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] centrosome [GO:0005813]; cytosol [GO:0005829] centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894] GO:0005085; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051056; GO:0051298; GO:0051496; GO:0090307; GO:0090630 HPLLVGHMPVMVAKQQEFK 8.590000153 1 1 0.152183957 2220.1944 0 13.76626 17.82461 0 0 13.12868 0 0 14.76188 0 0 15.40718 0 0 0 12.24699 0 0 12.88645 13.65037 0 13.16159 15.47832 15.30047 13.67518 0 0 12.38763 0 10.3813 0 11.29455 0 0 0 0 16.35453 0 0 0 12.35139 0 0 0 0 0 0 0 O15014 ZN609_HUMAN Zinc finger protein 609 ZNF609 KIAA0295 Homo sapiens (Human) muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841] GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0045944; GO:0046872; GO:1990841; GO:2000291; GO:2001224 ASPSVTCK 6.349999905 0.511219859 0.511219859 0.182614883 851.3584333 15.82966 0 14.85908 15.72448 0 0 0 0 0 0 16.03522 0 0 0 0 0 0 15.36615 0 0 15.54871 0 16.95463 0 16.6934 0 0 15.96716 15.74632 15.09403 16.804 0 0 15.58932 0 16.16356 16.02058 14.11458 15.50374 15.08449 0 16.40375 0 14.78451 0 15.4313 14.78425 16.45681 O15015 ZN646_HUMAN Zinc finger protein 646 ZNF646 KIAA0296 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 EHEETER 2.640000105 1 1 0.270265354 928.4282214 13.30274 14.52949 15.34029 14.45771 0 0 13.8896 0 0 16.15674 16.34854 0 0 15.90684 0 16.55661 15.93313 0 0 13.68897 16.10879 15.13974 0 17.35242 15.96324 15.91466 0 0 0 15.42731 16.63506 13.65837 15.86932 0 16.30872 15.63881 17.55323 15.40808 16.57233 16.63441 16.51008 14.75688 15.55987 0 16.8587 15.9707 16.18678 16.02841 O15018 PDZD2_HUMAN PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2 ] PDZD2 AIPC KIAA0300 PDZK3 Homo sapiens (Human) cell adhesion [GO:0007155] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0007155; GO:0034451; GO:0043231 ACPGGSGPK 5.539999962 1 1 0.029477763 831.5636052 13.80496 0 15.1474 0 0 0 0 0 0 0 0 0 0 0 0 17.1222 0 0 0 0 13.64785 0 0 0 15.61387 0 0 14.78735 0 12.11372 0 0 15.10912 16.61201 14.45176 0 0 0 0 0 0 14.94328 17.70645 0 0 0 0 16.33514 O15020 SPTN2_HUMAN "Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)" SPTBN2 KIAA0302 SCA5 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918] GO:0003779; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0005886; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099173; GO:0099189 ALCQPMR 14.36999989 0.730427384 0.730427384 0.140485877 890.8383907 16.5076 14.78015 15.3996 0 0 0 18.1994 16.98863 18.18948 16.67043 13.74938 16.30929 16.35932 15.10673 17.39946 15.12089 14.76381 14.03816 15.14897 14.70478 15.57601 15.57785 14.591 13.57064 0 17.19437 0 0 16.48693 0 0 13.65349 17.69286 11.69011 0 18.01721 15.32862 17.30468 17.00177 12.21515 15.55137 15.93284 17.19277 0 0 17.45574 14.80062 17.63492 O15021 MAST4_HUMAN "Microtubule-associated serine/threonine-protein kinase 4, EC 2.7.11.1" MAST4 KIAA0303 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0007010; GO:0018105; GO:0035556; GO:0106310 AQPAGEGR 8.170000076 0.040305883 0.040305883 0.171780885 784.5151274 19.27306 19.56392 18.66077 17.55964 18.94114 19.53731 0 19.84323 18.04117 18.43475 18.87459 17.26574 18.08271 18.65037 17.86458 19.75242 17.99412 19.3357 17.15805 17.15957 16.66817 18.69809 18.04125 18.38049 17.88286 17.39596 19.31505 18.4717 17.964 17.64349 18.37429 19.84427 19.38721 19.66305 17.78342 17.97412 18.89061 17.09105 18.35793 19.86039 19.34194 17.5828 19.30997 18.44151 16.89219 19.483 19.13194 19.76852 O15031 PLXB2_HUMAN Plexin-B2 (MM1) PLXNB2 KIAA0315 Homo sapiens (Human) brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] semaphorin receptor activity [GO:0017154] GO:0001843; GO:0001932; GO:0002116; GO:0005887; GO:0007156; GO:0007162; GO:0007405; GO:0007420; GO:0008360; GO:0009986; GO:0010976; GO:0017154; GO:0030334; GO:0043087; GO:0045727; GO:0050772; GO:0070062; GO:0071526; GO:1902287; GO:1904861; GO:2001222 LDFFR 9.920000076 1 1 0.006557438 697.4862361 16.5322 0 13.62463 0 0 0 0 15.80293 0 16.16179 0 0 0 15.48138 14.08938 14.54604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.61618 0 0 0 14.67797 0 0 0 O15033 AREL1_HUMAN "Apoptosis-resistant E3 ubiquitin protein ligase 1, EC 2.3.2.26 (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1)" AREL1 KIAA0317 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0043161; GO:0045732; GO:0050727; GO:0061630; GO:0070979; GO:1990390 NILAATFIR 31.51000023 0.5119735 0.5119735 0.192709528 1018.817472 0 23.25633 23.23368 22.9516 23.42415 0 23.67563 23.63641 23.07737 23.52547 23.41607 23.5331 0 23.21442 23.9377 0 22.79897 23.1791 23.69203 23.57753 22.87979 0 22.62503 0 23.4627 22.77835 22.90751 22.66498 23.33383 23.87338 22.43918 22.95996 22.85394 0 23.49371 22.70958 23.24325 21.5121 22.94946 23.2932 23.33856 0 0 0 23.08609 23.3912 21.85838 23.57824 O15034 RIMB2_HUMAN "RIMS-binding protein 2, RIM-BP2" RIMBP2 KIAA0318 RBP2 Homo sapiens (Human) neuromuscular synaptic transmission [GO:0007274] plasma membrane [GO:0005886]; synapse [GO:0045202] plasma membrane [GO:0005886]; synapse [GO:0045202]; neuromuscular synaptic transmission [GO:0007274] GO:0005886; GO:0007274; GO:0045202 ILPQPQGTPVSTTVAKAMAR 4.190000057 1 1 0.173185559 2082.695074 14.43005 14.77633 0 14.01116 0 14.62606 0 11.67782 14.76643 0 0 15.2964 13.4635 13.6925 0 13.53814 13.76298 11.51079 0 17.91681 0 14.53131 0 12.81088 15.19551 15.22981 15.46284 0 0 14.09722 16.23503 0 0 0 0 0 12.81429 0 0 14.86756 0 0 0 0 0 0 0 0 O15037 KHNYN_HUMAN Protein KHNYN (KH and NYN domain-containing protein) KHNYN KIAA0323 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729] GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0090502 EVALRPQSVGGGARESAPLK 3.480000019 1 1 0.282409054 2022.08197 14.87389 0 14.50207 10.92695 0 0 13.00785 13.40366 0 0 0 12.88212 0 0 0 13.27262 0 12.93414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15040 TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297) TECPR2 KIAA0297 KIAA0329 Homo sapiens (Human) autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527] GO:0005737; GO:0006914; GO:0032527 GSQPLSQR 8.550000191 0.492681742 0.492681742 0.201739662 872.8759932 18.5183 15.9908 16.09661 14.21253 17.99004 15.65198 17.26524 13.81575 17.52423 0 17.44747 16.4316 0 12.93354 0 0 0 15.96965 17.44318 15.48891 0 0 18.2934 16.28062 17.03501 16.00528 17.14004 0 17.20849 14.19515 18.9902 16.22195 0 17.9989 0 0 18.07921 0 0 16.18612 0 0 0 17.05047 0 16.62501 15.76596 17.79618 O15042 SR140_HUMAN U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140) U2SURP KIAA0332 SR140 Homo sapiens (Human) RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0006396 EINNPMFR 6.079999924 1 1 0.118428506 1037.206678 0 0 15.369 0 15.41006 14.22077 0 0 0 16.026 18.44481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93234 0 0 0 0 0 0 0 0 0 O15047 SET1A_HUMAN "Histone-lysine N-methyltransferase SETD1A, EC 2.1.1.364 (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A, hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)" SETD1A KIAA0339 KMT2F SET1 SET1A Homo sapiens (Human) brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; regulation of chromatin organization [GO:1902275]; regulation of hematopoietic stem cell differentiation [GO:1902036] chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; regulation of chromatin organization [GO:1902275]; regulation of hematopoietic stem cell differentiation [GO:1902036] beta-catenin binding [GO:0008013]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0007420; GO:0008013; GO:0016607; GO:0035097; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0061629; GO:0080182; GO:0097692; GO:1902036; GO:1902275 APRGVER 3.339999914 1 1 6.89E-13 782.0435031 0 13.00056 14.01831 0 0 12.45655 15.59822 14.04156 15.27261 0 11.28421 15.26782 0 14.16477 0 0 14.567 11.76493 17.02891 0 0 0 0 16.16926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15049 N4BP3_HUMAN "NEDD4-binding protein 3, N4BP3" N4BP3 KIAA0341 Homo sapiens (Human) nervous system development [GO:0007399] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; nervous system development [GO:0007399] GO:0007399; GO:0030424; GO:0030425; GO:0031410 LHEVTQKAER 1.919999957 0.341590196 0.341590196 0.054564111 1209.869893 0 13.01036 0 0 0 0 11.14948 18.02109 10.14704 0 0 0 0 0 13.03833 17.07924 13.01895 0 14.10064 0 0 0 0 0 0 15.69526 16.1969 0 14.57776 0 15.14713 0 0 14.43515 0 0 15.38099 0 0 0 0 0 0 0 0 0 0 11.16306 O15050 TRNK1_HUMAN TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog) TRANK1 KIAA0342 LBA1 Homo sapiens (Human) EGKDAR 4.090000153 1 1 0.187820609 674.7317765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.85184 0 0 0 0 0 0 0 0 0 0 0 0 0 15.39633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15054 KDM6B_HUMAN "Lysine-specific demethylase 6B, EC 1.14.11.68 (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B) ([histone H3]-trimethyl-L-lysine(27) demethylase 6B)" KDM6B JMJD3 KIAA0346 Homo sapiens (Human) cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; inflammatory response [GO:0006954]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; inflammatory response [GO:0006954]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0006954; GO:0007507; GO:0008013; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0045165; GO:0045446; GO:0045944; GO:0046872; GO:0048333; GO:0055007; GO:0070301; GO:0071557; GO:0071558; GO:0120162 NHHIIK 5.289999962 1 1 0.272921502 762.7751207 12.66769 13.86113 15.58907 15.75794 0 0 0 0 17.25142 14.85414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.741 0 0 0 0 0 0 0 0 0 15.53057 0 0 0 0 0 0 0 O15055 PER2_HUMAN "Period circadian protein homolog 2, hPER2 (Circadian clock protein PERIOD 2)" PER2 KIAA0347 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; glycogen biosynthetic process [GO:0005978]; histone H3 deacetylation [GO:0070932]; lactate biosynthetic process [GO:0019249]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of vasoconstriction [GO:0019229]; response to ischemia [GO:0002931]; white fat cell differentiation [GO:0050872]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; glycogen biosynthetic process [GO:0005978]; histone H3 deacetylation [GO:0070932]; lactate biosynthetic process [GO:0019249]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of vasoconstriction [GO:0019229]; response to ischemia [GO:0002931]; white fat cell differentiation [GO:0050872]" transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222] GO:0000122; GO:0000976; GO:0001222; GO:0002931; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005978; GO:0006094; GO:0006631; GO:0007623; GO:0019229; GO:0019249; GO:0031397; GO:0032922; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0048471; GO:0050767; GO:0050796; GO:0050872; GO:0051726; GO:0051946; GO:0070345; GO:0070932; GO:0097167; GO:0120162; GO:2000678 ATPPSAMGR 3.119999886 1 1 0.064158556 899.7276193 13.00663 15.52344 13.6516 0 12.85944 16.70265 14.08972 14.43258 14.90637 0 16.34136 0 16.36598 0 0 12.63015 0 14.92491 0 16.45518 0 0 0 0 0 0 0 15.10969 0 15.0587 17.2086 0 0 0 0 0 0 0 0 0 15.03738 0 14.48347 0 0 0 0 0 O15061 SYNEM_HUMAN Synemin (Desmuslin) SYNM DMN KIAA0353 SYN Homo sapiens (Human) fast-twitch skeletal muscle fiber contraction [GO:0031443]; intermediate filament cytoskeleton organization [GO:0045104] adherens junction [GO:0005912]; costamere [GO:0043034]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofilament cytoskeleton [GO:0060053]; sarcolemma [GO:0042383] adherens junction [GO:0005912]; costamere [GO:0043034]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofilament cytoskeleton [GO:0060053]; sarcolemma [GO:0042383]; intermediate filament binding [GO:0019215]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; fast-twitch skeletal muscle fiber contraction [GO:0031443]; intermediate filament cytoskeleton organization [GO:0045104] intermediate filament binding [GO:0019215]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166] GO:0005200; GO:0005882; GO:0005912; GO:0008307; GO:0017166; GO:0019215; GO:0031443; GO:0042383; GO:0043034; GO:0045104; GO:0045111; GO:0060053 ATLTLAMADWLR 6.860000134 0.951217413 0.951217413 0.169832797 1377.830335 13.42498 15.56323 15.42476 0 12.6244 13.03525 13.92643 0 14.75829 15.59452 0 0 13.82122 13.54655 14.48781 13.82545 0 0 0 0 0 0 0 0 0 12.46196 16.65806 0 0 0 0 0 0 0 0 0 15.77121 0 0 0 0 0 0 14.44602 0 0 0 0 O15063 GRRE1_HUMAN "Granule associated Rac and RHOG effector protein 1, GARRE1" GARRE1 KIAA0355 Homo sapiens (Human) Rac protein signal transduction [GO:0016601] cytosol [GO:0005829]; P-body [GO:0000932] cytosol [GO:0005829]; P-body [GO:0000932]; CCR4-NOT complex binding [GO:1905762]; small GTPase binding [GO:0031267]; Rac protein signal transduction [GO:0016601] CCR4-NOT complex binding [GO:1905762]; small GTPase binding [GO:0031267] GO:0000932; GO:0005829; GO:0016601; GO:0031267; GO:1905762 AKMPGNIDTR 5.380000114 1 1 0.328841488 1102.730654 13.38451 14.13926 15.76273 15.12584 15.30345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.58665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15068 MCF2L_HUMAN Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) MCF2L KIAA0362 OST Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091] GO:0005085; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0012505; GO:0019898; GO:0031234; GO:0035025; GO:0035091; GO:0035556; GO:0051056 DLASFEEK 1.5 0.593777895 0.593777895 0.295232448 938.1531062 18.18723 16.26214 16.63832 0 17.89246 0 0 0 0 0 0 0 0 17.51221 0 19.97723 0 18.3784 0 0 0 0 0 18.12303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38443 17.62931 0 0 0 0 0 17.27463 0 O15072 ATS3_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 3, ADAM-TS 3, ADAM-TS3, ADAMTS-3, EC 3.4.24.- (Procollagen II N-proteinase, PC II-NP) (Procollagen II amino propeptide-processing enzyme)" ADAMTS3 KIAA0366 Homo sapiens (Human) collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 CHLYCQSKETGDVAYMK 3.779999971 1 1 9.23E-13 2091.098488 15.56141 0 0 0 0 0 0 15.5688 0 0 0 12.75685 0 0 0 12.74372 0 0 0 0 0 0 0 14.88447 0 13.1187 0 14.98378 0 0 0 0 0 15.58511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15078 CE290_HUMAN "Centrosomal protein of 290 kDa, Cep290 (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87, CT87) (Nephrocystin-6) (Tumor antigen se2-2)" CEP290 BBS14 KIAA0373 NPHP6 Homo sapiens (Human) "camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]" centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] "centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]" identical protein binding [GO:0042802] GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515 IEGIR 5.269999981 1 1 0.124045097 586.3354429 0 0 0 0 0 0 0 15.181 0 0 16.07056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.76625 0 0 16.84035 17.37862 0 0 0 17.39472 0 16.79204 17.02076 16.43798 0 0 0 0 0 0 0 0 O15079 SNPH_HUMAN Syntaphilin SNPH KIAA0374 Homo sapiens (Human) neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; presynapse [GO:0098793] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; presynapse [GO:0098793]; syntaxin-1 binding [GO:0017075]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081] syntaxin-1 binding [GO:0017075] GO:0005737; GO:0005739; GO:0005881; GO:0007269; GO:0016021; GO:0016081; GO:0017075; GO:0030182; GO:0043005; GO:0098793 MAMSLPGSR 1.480000019 1 1 0.214467943 982.1843315 0 0 16.43212 15.26607 0 0 0 0 0 0 0 0 0 0 12.74895 15.13484 0 0 0 12.40544 0 15.09181 0 0 14.10425 15.58794 15.37456 0 15.12483 0 0 0 15.91399 0 14.81258 0 16.7423 0 12.18939 11.39345 12.39476 10.8994 0 0 0 0 0 0 O15083 ERC2_HUMAN ERC protein 2 ERC2 KIAA0378 Homo sapiens (Human) maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; regulation of synaptic plasticity [GO:0048167]; synaptic vesicle priming [GO:0016082] cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; structural constituent of presynaptic active zone [GO:0098882]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; regulation of synaptic plasticity [GO:0048167]; synaptic vesicle priming [GO:0016082] structural constituent of presynaptic active zone [GO:0098882] GO:0007274; GO:0016082; GO:0030426; GO:0042734; GO:0048167; GO:0048786; GO:0048788; GO:0048790; GO:0098882; GO:0098978; GO:0098982 DTKIASLER 2.5 1 1 0.211689512 1027.895398 0 16.04982 0 0 15.60961 13.88433 16.30632 0 15.62527 18.57835 0 0 0 0 0 0 15.67217 0 0 0 0 0 15.32574 0 0 0 15.80263 0 0 0 0 17.38624 16.26384 0 0 0 15.41261 16.09188 0 0 0 0 0 0 0 0 0 15.8909 O15084 ANR28_HUMAN "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, PP6-ARS-A, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K, PITK)" ANKRD28 KIAA0379 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 CLEYLLR 7.21999979 1 1 3.46E-13 967.4264294 0 15.77199 0 0 0 0 0 0 13.49343 0 15.31483 0 0 0 0 0 0 0 0 0 0 0 16.41035 0 9.912271 0 0 0 0 0 0 0 13.0878 0 15.57917 0 0 0 0 15.80381 0 0 14.03314 0 0 0 16.50372 0 O15085 ARHGB_HUMAN Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF) ARHGEF11 KIAA0380 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]" G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001558; GO:0001664; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006941; GO:0007186; GO:0007266; GO:0030010; GO:0030036; GO:0045893; GO:0051056 IPEMLQAEIDSRLR 9.670000076 1 1 0.231424653 1687.476607 13.326 14.42645 15.86352 14.70663 0 14.19469 15.87514 14.95053 15.75362 0 16.30752 0 0 0 0 0 0 0 0 14.98315 0 15.73212 0 0 0 0 14.56777 12.49479 0 0 0 0 0 0 0 0 14.94603 0 0 0 0 0 0 0 0 0 0 0 O15091 MRPP3_HUMAN "Mitochondrial ribonuclease P catalytic subunit, EC 3.1.26.5 (Mitochondrial ribonuclease P protein 3, Mitochondrial RNase P protein 3) (Protein only RNase P catalytic subunit)" PRORP KIAA0391 MRPP3 Homo sapiens (Human) mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682] mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]; mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682] metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526] GO:0001682; GO:0004526; GO:0005654; GO:0005739; GO:0005759; GO:0030678; GO:0046872; GO:0097745 ERSQMNSQTEDHALAPVR 1.419999957 1 1 0.461238791 2085.280171 0 13.90985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.27648 0 0 0 0 0 0 0 0 0 17.74255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15117 FYB1_HUMAN "FYN-binding protein 1 (Adhesion and degranulation promoting adaptor protein, ADAP) (FYB-120/130, p120/p130) (FYN-T-binding protein) (SLAP-130) (SLP-76-associated phosphoprotein)" FYB1 FYB SLAP130 Homo sapiens (Human) immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852] lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007229; GO:0008289; GO:0015629; GO:0030054; GO:0032991; GO:0044877; GO:0050852; GO:0072659 FGTPASLTTRDPEAK 6.28000021 0.29077208 0.29077208 0.558846372 1591.43603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.21208 17.19236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15119 TBX3_HUMAN "T-box transcription factor TBX3, T-box protein 3" TBX3 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell fate commitment [GO:0060923]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; semicircular canal morphogenesis [GO:0048752]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell fate commitment [GO:0060923]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; semicircular canal morphogenesis [GO:0048752]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001501; GO:0001568; GO:0001701; GO:0001708; GO:0001947; GO:0003151; GO:0003167; GO:0003205; GO:0003272; GO:0005634; GO:0006357; GO:0007417; GO:0007569; GO:0008284; GO:0008595; GO:0009887; GO:0010159; GO:0019827; GO:0021761; GO:0030539; GO:0030540; GO:0030857; GO:0030879; GO:0032275; GO:0035115; GO:0035116; GO:0035136; GO:0036302; GO:0042733; GO:0043066; GO:0043565; GO:0045662; GO:0045787; GO:0045892; GO:0045944; GO:0046884; GO:0048332; GO:0048752; GO:0051145; GO:0060021; GO:0060317; GO:0060412; GO:0060444; GO:0060596; GO:0060923; GO:0060931; GO:0061629; GO:0072105; GO:0090398; GO:1905072; GO:1905222; GO:1990837; GO:2000137; GO:2000648 ADPEMPKR 11.94999981 1 1 0.180381446 944.4524244 0 13.69415 16.87652 15.93387 16.34293 0 0 0 0 0 15.4762 17.68212 16.89563 0 14.00434 15.24686 0 0 16.7111 0 17.19884 0 18.08763 15.28755 16.31744 0 16.11198 17.50336 12.01231 0 18.79472 18.54361 0 16.96157 14.81526 0 17.36746 18.60876 0 18.22502 15.42233 15.30513 16.36725 15.72515 16.87314 18.07967 0 16.85513 O15123 ANGP2_HUMAN "Angiopoietin-2, ANG-2" ANGPT2 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014] metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007165; GO:0007281; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012 KVLAMEDK 6.820000172 1 1 3.47E-13 950.5852017 13.60481 0 15.53179 13.10936 0 0 0 0 0 15.42643 0 0 0 13.68477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15144 ARPC2_HUMAN "Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit, p34-ARC)" ARPC2 ARC34 PRO2446 Homo sapiens (Human) actin filament polymerization [GO:0030041]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200] GO:0003779; GO:0005200; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0010592; GO:0015629; GO:0030027; GO:0030041; GO:0030838; GO:0034314; GO:0035861; GO:0036195; GO:0043005; GO:0070062; GO:0070358; GO:0098978; GO:1900026 VMVSISLK 8.010000229 0.065821409 0.065821409 0.181142956 892.4345895 14.76668 15.76602 13.96433 16.0195 14.13921 0 15.51017 0 15.85509 16.02126 10.55269 14.79976 0 0 0 14.71897 14.82035 0 0 14.09484 0 15.99235 0 0 0 0 0 0 14.55521 16.19252 0 16.4533 0 0 0 0 0 0 0 17.04487 15.26231 0 0 16.11094 0 14.2478 0 15.49163 O15146 MUSK_HUMAN "Muscle, skeletal receptor tyrosine-protein kinase, EC 2.7.10.1 (Muscle-specific tyrosine-protein kinase receptor, MuSK, Muscle-specific kinase receptor)" MUSK Homo sapiens (Human) cell differentiation [GO:0030154]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005887; GO:0007169; GO:0007528; GO:0007613; GO:0008582; GO:0010628; GO:0030154; GO:0031594; GO:0033674; GO:0038062; GO:0043235; GO:0045211; GO:0046777; GO:0046872; GO:0071340; GO:2000541 ILERMCER 6.460000038 1 1 0.014802533 1107.679023 13.02212 13.9124 0 17.03053 0 15.2605 13.84438 0 15.15203 14.58512 13.23148 14.58086 16.74486 13.44777 0 0 12.93763 0 14.17375 0 0 0 13.19692 15.0714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15151 MDM4_HUMAN Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4) MDM4 MDMX Homo sapiens (Human) "atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular septum development [GO:0003281]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular septum development [GO:0003281]" enzyme binding [GO:0019899]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270] GO:0000122; GO:0002039; GO:0003170; GO:0003181; GO:0003203; GO:0003281; GO:0003283; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0008285; GO:0017053; GO:0019899; GO:0030330; GO:0042177; GO:0043066; GO:0045892; GO:0050821; GO:0051726; GO:0065003; GO:0071456 EVMHYLGQYIMVK 2.220000029 1 1 0.144405311 1642.191192 0 12.97646 15.27389 15.77648 0 0 0 0 14.97755 0 0 0 0 0 0 14.84622 0 0 0 0 0 0 0 0 0 0 15.54428 0 0 14.91056 0 15.9226 0 16.53016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15165 LRAD4_HUMAN Low-density lipoprotein receptor class A domain-containing protein 4 LDLRAD4 C18orf1 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; R-SMAD binding [GO:0070412]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] R-SMAD binding [GO:0070412] GO:0000139; GO:0010719; GO:0010991; GO:0016021; GO:0030336; GO:0030512; GO:0031901; GO:0043231; GO:0060394; GO:0070412 MEGPPPTYSEVMGHHPGASFLHHQR 3.630000114 1 1 3.20E-12 2815.816725 15.01066 13.88473 0 0 0 0 14.15879 0 14.8345 0 0 14.53511 0 0 0 11.53617 0 13.55048 0 0 0 0 14.27415 0 0 13.17532 0 0 15.31962 13.53693 0 16.42554 12.59192 7.436532 15.00756 0 0 13.58964 0 10.69519 0 9.757152 0 13.78483 0 15.8966 0 14.60941 O15169 AXIN1_HUMAN "Axin-1 (Axis inhibition protein 1, hAxin)" AXIN1 AXIN Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; genomic imprinting [GO:0071514]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605]" beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Wnt signalosome [GO:1990909] "beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Wnt signalosome [GO:1990909]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; genomic imprinting [GO:0071514]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605]" armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625] GO:0000209; GO:0001701; GO:0001934; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0008022; GO:0009950; GO:0010800; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030159; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032147; GO:0032436; GO:0033138; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043507; GO:0043621; GO:0045599; GO:0045732; GO:0045893; GO:0046330; GO:0046332; GO:0048320; GO:0048471; GO:0051248; GO:0051443; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071514; GO:0071944; GO:0090090; GO:1990909; GO:2000060 LARAIYR 8.100000381 1 1 0.129891584 861.7952947 14.19942 0 15.19648 0 0 0 0 0 0 0 0 0 0 15.95433 0 0 15.92217 0 0 0 0 0 17.05788 0 0 0 0 16.085 0 16.22511 0 0 15.12866 0 15.35563 16.78781 15.96245 16.15786 0 15.42239 0 14.46353 15.07743 10.44264 15.84524 14.27524 0 15.60615 O15195 VILL_HUMAN Villin-like protein VILL Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]" "actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]" GO:0005200; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0051014; GO:0051015; GO:0051016 MSSLQERK 43.61000061 0.398376167 0.398376167 0.269080466 979.9367401 0 15.61717 15.51733 15.94039 14.53151 15.13476 6.977369 0 0 11.42257 0 16.30615 16.85944 14.16315 14.94703 16.39001 16.47871 0 0 15.0999 0 0 0 18.15993 0 0 0 16.65211 0 14.31684 0 18.26432 0 18.66237 0 0 16.42249 0 16.00071 0 0 18.33766 13.93958 14.91585 0 0 17.61114 18.08381 O15197 EPHB6_HUMAN Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6) EPHB6 Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0021952; GO:0033674; GO:0038023; GO:0043005; GO:0043235 QREGQFSSLQLVAMQR 2.789999962 1 1 0.293152491 1878.638504 14.55719 11.57777 0 0 0 0 0 14.53627 0 0 0 0 11.95311 0 0 14.11458 0 0 11.14618 0 0 0 0 14.65338 14.60921 0 0 15.59267 14.40655 14.56232 16.35879 11.08268 13.2631 14.20315 0 14.44465 0 15.07991 0 0 0 0 0 0 0 0 0 0 O15198 SMAD9_HUMAN "Mothers against decapentaplegic homolog 9, MAD homolog 9, Mothers against DPP homolog 9 (Madh6) (SMAD family member 9, SMAD 9, Smad9)" SMAD9 MADH6 MADH9 SMAD8 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007179; GO:0009653; GO:0030154; GO:0030509; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144; GO:0071773; GO:1901522 ALSCPGQPSK 3.960000038 1 1 0.205644592 1044.033334 0 15.52471 13.62768 15.42512 12.82055 13.86432 15.17439 0 13.74315 14.89982 15.85534 14.54665 14.365 0 0 13.69301 14.7956 0 14.728 0 14.87418 0 0 0 0 0 0 0 0 0 14.5902 0 0 0 13.51087 14.02732 0 0 0 0 0 0 0 0 16.48091 0 14.85788 0 O15212 PFD6_HUMAN Prefoldin subunit 6 (Protein Ke2) PFDN6 HKE2 PFD6 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] GO:0001540; GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:0051131; GO:0101031; GO:1905907; GO:1990062 EELALLDGSNVVFK 1.220000029 1 1 0.324783357 1538.351593 16.65712 0 14.91391 0 0 17.1206 0 0 11.63613 14.68285 12.70016 15.49307 0 10.67757 0 0 14.69653 13.50321 0 0 0 0 0 0 15.85445 0 15.8954 0 0 0 0 15.68131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15226 NKRF_HUMAN "NF-kappa-B-repressing factor, NFkB-repressing factor, NRF (Protein ITBA4)" NKRF ITBA4 NRF Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]" "ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0001671; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944 EDLLDQLKQEGQVGHYELVMPQAN 7.53000021 1 1 0.092992955 2771.231979 17.01507 0 0 0 0 14.58958 10.42568 12.75475 13.90224 0 0 0 0 0 15.60972 0 0 0 0 17.84559 14.91382 0 0 17.8938 17.5346 18.06463 0 17.95293 16.28067 0 14.54827 17.6923 17.498 0 11.01731 0 0 17.40051 18.54894 0 13.08979 15.56948 15.84544 12.28627 14.46452 15.27346 0 15.93092 O15228 GNPAT_HUMAN "Dihydroxyacetone phosphate acyltransferase, DAP-AT, DHAP-AT, EC 2.3.1.42 (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)" GNPAT DAPAT DHAPAT Homo sapiens (Human) cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] glycerone-phosphate O-acyltransferase activity [GO:0016287] GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006631; GO:0006654; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0009410; GO:0016020; GO:0016287; GO:0021587; GO:0030913; GO:0031966; GO:0042594; GO:0061024; GO:0070542 ESTTGLLKAR 5.170000076 0.950046241 0.950046241 0.185555107 1076.885636 0 0 0 0 0 0 6.419886 13.95757 19.20751 0 0 0 15.08895 0 0 0 0 15.57394 0 0 0 0 0 14.3098 0 0 0 0 15.1127 0 0 0 0 16.27362 13.83889 0 0 0 0 0 0 0 15.30527 0 14.30228 0 0 0 O15229 KMO_HUMAN "Kynurenine 3-monooxygenase, EC 1.14.13.9 (Kynurenine 3-hydroxylase)" KMO Homo sapiens (Human) "'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]" cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] "cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]" FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174] GO:0004502; GO:0005615; GO:0005741; GO:0005829; GO:0006569; GO:0007568; GO:0009651; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1901216; GO:1903296 LLVQDFFLLPAQPMISVK 5.110000134 1 1 0.282417276 2076.182065 0 0 14.51062 18.89252 0 0 0 0 0 0 0 0 18.1534 17.28112 0 0 0 0 0 0 0 0 0 0 17.88128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15230 LAMA5_HUMAN Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha) LAMA5 KIAA0533 KIAA1907 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178] GO:0001658; GO:0001738; GO:0001755; GO:0001942; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0005634; GO:0007229; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0016331; GO:0016477; GO:0030155; GO:0030324; GO:0030334; GO:0031594; GO:0034446; GO:0042127; GO:0042475; GO:0043083; GO:0043259; GO:0043260; GO:0045995; GO:0060271; GO:0060445; GO:0062023; GO:0070062; GO:0072659; GO:0098609 FLRTNTLLGHLMGK 3.640000105 0.989015222 0.989015222 0.279300876 1616.265201 15.37906 16.35367 0 0 0 0 16.39669 16.47291 15.2834 0 0 15.04685 0 0 0 0 0 0 0 0 0 0 0 0 0 16.67909 0 0 0 0 0 15.57852 0 0 15.29496 0 15.80204 16.56296 15.8983 15.6715 0 16.19127 13.92624 17.21949 0 0 0 0 O15232 MATN3_HUMAN Matrilin-3 MATN3 Homo sapiens (Human) cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] GO:0001501; GO:0005201; GO:0005509; GO:0005576; GO:0005788; GO:0030198; GO:0031012; GO:0051216; GO:0062023; GO:0120216 MPRPAPARR 2.710000038 1 1 0.261465519 1053.047785 13.15472 16.27057 12.46343 0 0 16.86395 16.07216 15.5123 0 15.39016 14.31798 0 11.7736 0 15.38265 14.6136 15.09474 15.80946 15.31417 15.22546 0 15.30614 16.00441 0 0 15.29121 14.32361 0 15.53333 0 0 16.598 0 0 14.95634 0 0 0 0 0 0 0 16.15832 0 0 0 14.7562 0 O15234 CASC3_HUMAN "Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein, MLN 51) (Protein barentsz, Btz)" CASC3 MLN51 Homo sapiens (Human) "intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]" cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006] "cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]" enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625] GO:0000184; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006406; GO:0006417; GO:0008298; GO:0010494; GO:0016607; GO:0019899; GO:0030425; GO:0031625; GO:0031965; GO:0035145; GO:0042802; GO:0048471; GO:0071006; GO:2000622 LEQTSVR 3.609999895 0.325480223 0.325480223 0.030486707 832.0953045 0 15.2434 14.62916 17.03673 0 16.1223 15.02274 16.87813 16.03407 0 17.4684 0 0 0 0 14.88164 13.96294 13.7803 14.36404 0 16.44811 0 13.24738 0 14.72756 15.08093 14.72714 0 12.32329 0 16.95451 18.17325 16.16393 0 16.16044 9.291677 16.2049 14.98614 0 16.67838 14.13862 14.11161 14.71037 0 13.13335 14.17219 17.10692 12.53042 O15244 S22A2_HUMAN "Solute carrier family 22 member 2 (Organic cation transporter 2, hOCT2)" SLC22A2 OCT2 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amine transport [GO:0015837]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; choline transport [GO:0015871]; dopamine uptake [GO:0090494]; export across plasma membrane [GO:0140115]; histamine uptake [GO:0051615]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic cation transport [GO:0015695]; positive regulation of gene expression [GO:0010628]; purine-containing compound transmembrane transport [GO:0072530]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; choline transmembrane transporter activity [GO:0015220]; efflux transmembrane transporter activity [GO:0015562]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amine transport [GO:0015837]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; choline transport [GO:0015871]; dopamine uptake [GO:0090494]; export across plasma membrane [GO:0140115]; histamine uptake [GO:0051615]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic cation transport [GO:0015695]; positive regulation of gene expression [GO:0010628]; purine-containing compound transmembrane transport [GO:0072530]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] amine transmembrane transporter activity [GO:0005275]; choline transmembrane transporter activity [GO:0015220]; efflux transmembrane transporter activity [GO:0015562]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005275; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0006919; GO:0007589; GO:0008504; GO:0010628; GO:0015101; GO:0015179; GO:0015214; GO:0015220; GO:0015562; GO:0015695; GO:0015837; GO:0015871; GO:0016020; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0061459; GO:0070062; GO:0072530; GO:0089718; GO:0090494; GO:0097638; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1902475; GO:1990962 NAEAMRIIK 10.01000023 1 1 0.203004889 1061.535651 0 0 0 0 0 0 0 0 0 0 0 13.86181 12.52383 11.89957 14.01733 0 15.29246 0 0 13.507 0 16.61526 19.48237 0 15.94681 16.53293 16.09644 0 14.27728 14.04195 15.79534 15.22715 14.54807 0 0 12.24032 16.50097 0 0 16.73567 15.16463 16.65774 0 16.68935 0 0 0 0 O15245 S22A1_HUMAN "Solute carrier family 22 member 1 (Organic cation transporter 1, hOCT1)" SLC22A1 OCT1 Homo sapiens (Human) dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015214; GO:0015651; GO:0015695; GO:0015697; GO:0015874; GO:0016020; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0072530; GO:0090494; GO:0098793; GO:0150104; GO:1901998; GO:1990962 ENTIYLKVQTSEPSGT 2.880000114 1 1 0.384958453 1767.486971 0 0 0 0 0 0 13.24591 0 0 0 0 0 16.80935 0 0 0 15.71542 0 0 17.08609 16.76808 0 0 14.40754 0 0 16.94998 16.28912 0 0 16.07388 17.23083 0 16.41421 16.09392 15.14224 14.16355 16.03527 0 0 16.26232 17.4971 15.27627 0 15.28801 16.95454 0 0 O15254 ACOX3_HUMAN "Peroxisomal acyl-coenzyme A oxidase 3, EC 1.3.3.6 (Branched-chain acyl-CoA oxidase, BRCACox) (Pristanoyl-CoA oxidase)" ACOX3 BRCOX PRCOX Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402] GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949 TLLPMPGVMVGDIGKK 6.71999979 1 1 0.267264016 1687.018587 14.30455 15.9826 13.72539 0 0 14.91615 14.27688 0 13.99604 15.72825 17.59034 11.27848 0 0 0 0 0 15.03248 0 0 0 13.97748 0 0 16.07911 0 0 0 0 0 15.3549 15.73909 14.86115 0 0 15.78427 16.43932 0 0 14.52174 0 0 0 0 13.89024 0 0 15.32149 O15259 NPHP1_HUMAN Nephrocystin-1 (Juvenile nephronophthisis 1 protein) NPHP1 NPH1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632] structural molecule activity [GO:0005198] GO:0005198; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0007165; GO:0007632; GO:0016020; GO:0030030; GO:0030036; GO:0031514; GO:0032391; GO:0048515; GO:0060041; GO:0090251; GO:0098609; GO:1903348 GEILLVIEK 18.64999962 0.40988335 0.40988335 0.138169081 1013.48069 17.89032 15.22677 13.50321 16.24968 0 16.63987 15.16716 16.32401 17.32059 16.71324 15.98803 0 0 0 0 14.728 13.47423 16.86344 15.16333 15.68189 0 18.18492 0 14.67311 18.27066 0 0 0 16.09599 15.54769 15.30102 0 16.86604 16.49009 12.56824 0 17.4556 15.82305 15.36716 17.98871 0 16.45816 14.72075 16.67631 16.70975 16.62947 16.18042 0 O15260 SURF4_HUMAN Surfeit locus protein 4 SURF4 SURF-4 Homo sapiens (Human) Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; cargo receptor activity [GO:0038024]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368] cargo receptor activity [GO:0038024] GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0010638; GO:0016021; GO:0030133; GO:0031965; GO:0032368; GO:0033116; GO:0035577; GO:0038024; GO:0042953; GO:0055088 LCLISTFLEDGIR 17.20999908 0.290019244 0.290019244 0.274752994 1537.975981 20.85109 19.56081 15.87712 20.93118 21.04054 14.35049 0 21.55739 21.1141 22.1853 21.00267 21.32844 19.88191 20.25142 0 0 17.85649 19.2045 18.71032 17.74873 20.36683 20.28699 20.52167 20.56569 0 20.66944 21.28264 0 20.05079 21.52136 0 21.51088 20.47287 20.87705 22.81715 0 0 22.21368 0 18.75314 19.05585 0 21.56248 18.22834 0 21.44294 19.66996 20.53724 O15264 MK13_HUMAN "Mitogen-activated protein kinase 13, MAP kinase 13, MAPK 13, EC 2.7.11.24 (Mitogen-activated protein kinase p38 delta, MAP kinase p38 delta) (Stress-activated protein kinase 4)" MAPK13 PRKM13 SAPK4 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to anisomycin [GO:0072740]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to sodium arsenite [GO:1903936]; cellular response to sorbitol [GO:0072709]; cellular response to UV [GO:0034644]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; response to osmotic stress [GO:0006970]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cellular response to anisomycin [GO:0072740]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to sodium arsenite [GO:1903936]; cellular response to sorbitol [GO:0072709]; cellular response to UV [GO:0034644]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; response to osmotic stress [GO:0006970]; stress-activated MAPK cascade [GO:0051403] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006970; GO:0007049; GO:0018105; GO:0032755; GO:0034644; GO:0035556; GO:0050729; GO:0051403; GO:0070301; GO:0071347; GO:0072709; GO:0072740; GO:0106310; GO:1903936 EIVNFSPIAR 4.239999771 1 1 0.180383516 1146.516919 0 0 18.37134 0 0 0 0 0 0 0 0 0 0 0 18.05322 0 0 0 0 0 12.00581 0 0 0 0 17.59426 0 0 0 0 0 0 19.52696 0 0 0 0 0 0 0 0 0 0 16.51621 0 17.82824 0 0 O15265 ATX7_HUMAN Ataxin-7 (Spinocerebellar ataxia type 7 protein) ATXN7 SCA7 Homo sapiens (Human) "histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of microtubule depolymerization [GO:0007026]; nucleus organization [GO:0006997]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of microtubule depolymerization [GO:0007026]; nucleus organization [GO:0006997]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" GO:0000124; GO:0000226; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006282; GO:0006357; GO:0006997; GO:0007026; GO:0007601; GO:0015630; GO:0016363; GO:0016578; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893 RAVQGR 6.96999979 1 1 0.14517814 686.0599168 0 13.68218 13.36774 15.20522 14.81213 14.50258 0 0 0 15.0655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15270 SPTC2_HUMAN "Serine palmitoyltransferase 2, EC 2.3.1.50 (Long chain base biosynthesis protein 2, LCB 2) (Long chain base biosynthesis protein 2a, LCB2a) (Serine-palmitoyl-CoA transferase 2, SPT 2)" SPTLC2 KIAA0526 LCB2 Homo sapiens (Human) adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] GO:0004758; GO:0005789; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504 EILDTALK 3.109999895 1 1 2.28E-12 903.3923161 14.90944 15.2122 15.51495 15.25806 14.1106 14.1174 14.91585 14.04394 12.40249 15.27536 0 15.3769 15.22239 14.28402 0 14.38975 15.43491 0 15.79963 0 0 15.24235 16.58578 0 0 15.66855 0 13.43151 14.56101 12.58721 0 0 0 0 0 0 0 0 0 0 0 0 15.79662 0 0 0 0 0 O15273 TELT_HUMAN Telethonin (Titin cap protein) TCAP Homo sapiens (Human) adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of mechanical stimulus [GO:0050982]; detection of muscle stretch [GO:0035995]; otic vesicle formation [GO:0030916]; protein-containing complex assembly [GO:0065003]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756] cytosol [GO:0005829]; I band [GO:0031674]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] cytosol [GO:0005829]; I band [GO:0031674]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]; BMP binding [GO:0036122]; FATZ binding [GO:0051373]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325]; adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of mechanical stimulus [GO:0050982]; detection of muscle stretch [GO:0035995]; otic vesicle formation [GO:0030916]; protein-containing complex assembly [GO:0065003]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756] BMP binding [GO:0036122]; FATZ binding [GO:0051373]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325] GO:0001756; GO:0003009; GO:0003300; GO:0005829; GO:0007512; GO:0008307; GO:0014898; GO:0030018; GO:0030240; GO:0030241; GO:0030674; GO:0030916; GO:0031432; GO:0031674; GO:0035994; GO:0035995; GO:0036122; GO:0044325; GO:0045214; GO:0048769; GO:0050982; GO:0051373; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0065003; GO:0070080; GO:1990733 MGILGRGLQEYQLPYQR 2.849999905 1 1 2.06E-12 2038.625218 0 14.04072 14.43222 12.74542 14.30563 12.60112 0 0 13.9158 10.41751 15.11886 15.14162 15.19604 14.301 14.66514 17.11824 0 0 12.85517 13.06451 0 0 13.80727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15294 OGT1_HUMAN "UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, EC 2.4.1.255 (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit, OGT)" OGT Homo sapiens (Human) "apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]" cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580] "cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]" "acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]" GO:0000122; GO:0000123; GO:0000423; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016262; GO:0016485; GO:0016580; GO:0017122; GO:0030097; GO:0030336; GO:0030512; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045862; GO:0045893; GO:0045944; GO:0046626; GO:0048015; GO:0051571; GO:0060544; GO:0061087; GO:0080182; GO:0097363; GO:0120162; GO:1900095; GO:1902455; GO:1902459 DSGNIPEAIASYR 3.619999886 1 1 9.18E-13 1391.852775 13.0995 15.78535 0 13.80502 15.59586 14.21047 15.0211 0 0 15.73612 13.1874 16.11747 0 0 13.73759 0 12.96572 15.75078 15.42447 13.48707 0 15.99859 14.29502 15.11833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15318 RPC7_HUMAN "DNA-directed RNA polymerase III subunit RPC7, RNA polymerase III subunit C7 (DNA-directed RNA polymerase III subunit G) (RNA polymerase III 32 kDa apha subunit, RPC32-alpha) (RNA polymerase III 32 kDa subunit, RPC32)" POLR3G Homo sapiens (Human) cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] chromatin binding [GO:0003682]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0008283; GO:0016604; GO:0032728; GO:0045087; GO:0045089; GO:0051607 GTPLTNTEDVLK 1.809999943 1 1 0.149788205 1288.288636 0 9.289728 0 11.1768 14.11323 0 14.95819 13.5876 0 11.49366 13.27671 0 15.10341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.95478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15327 INP4B_HUMAN "Inositol polyphosphate 4-phosphatase type II (Type II inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)" INPP4B Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165]" "inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]" GO:0005737; GO:0005829; GO:0006661; GO:0007165; GO:0016316; GO:0017161; GO:0034597; GO:0043647; GO:0046855; GO:0046856; GO:0052828 ALDCMR 10.43000031 0.562511384 0.562511384 0.062264609 780.5901605 9.460384 17.05987 10.36178 12.06179 9.711795 12.2591 13.34803 0 0 0 11.58217 15.40659 17.36494 0 0 16.89233 0 0 17.10109 14.27547 0 15.45139 13.83628 14.58164 15.01495 0 19.34117 15.60542 0 19.49568 14.57895 12.19416 18.83585 0 13.94812 14.68251 17.28708 16.31417 16.25655 19.04818 14.7513 14.59849 0 12.1249 17.69719 15.75807 14.82156 0 O15335 CHAD_HUMAN Chondroadherin (Cartilage leucine-rich protein) CHAD SLRR4A Homo sapiens (Human) bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155] GO:0005615; GO:0031012; GO:0060348; GO:1900155 EVAAGAFR 8.380000114 0.490468502 0.490468502 0.221258973 820.5662472 16.52146 0 15.91952 15.59252 15.9735 0 0 15.26036 0 15.39909 16.1157 0 16.61778 15.51689 15.75609 14.86404 0 16.90016 0 0 0 0 0 15.99813 16.48714 15.60543 15.74655 0 14.70039 16.15902 16.82228 16.28 16.60231 16.46761 16.78932 16.37902 17.07673 16.49103 16.03826 0 15.6561 16.1532 17.1778 15.89518 16.06469 15.72091 12.13734 15.87421 O15344 TRI18_HUMAN "E3 ubiquitin-protein ligase Midline-1, EC 2.3.2.27 (Midin) (Putative transcription factor XPRF) (RING finger protein 59) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18)" MID1 FXY RNF59 TRIM18 XPRF Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372] enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0000226; GO:0005794; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0007026; GO:0007389; GO:0008017; GO:0008270; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219 EGKVMR 9.729999542 1 1 0.260133792 733.129236 14.78431 14.92793 15.04932 0 18.04306 15.80956 15.30549 16.37719 15.53503 0 0 0 0 0 0 15.91574 16.10479 15.15448 0 0 16.29637 16.09533 17.42967 17.49795 0 0 15.87487 16.19344 15.46925 14.85437 16.39279 0 14.0479 15.47559 16.72143 15.81553 16.40516 15.94929 16.55217 16.32195 0 0 0 15.8513 16.56915 16.93146 16.97061 15.50327 O15347 HMGB3_HUMAN "High mobility group protein B3 (High mobility group protein 2a, HMG-2a) (High mobility group protein 4, HMG-4)" HMGB3 HMG2A HMG4 Homo sapiens (Human) DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]" GO:0000400; GO:0003690; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0006310; GO:0006357; GO:0008301; GO:0032392; GO:0045087; GO:0045578; GO:0045638 IKSTNPGISIGDVAK 4.460000038 1 1 0.28015276 1500.772838 0 0 15.95876 13.56125 15.73252 0 0 16.85008 15.46811 13.36583 14.9427 0 0 0 14.47517 11.97991 14.3801 13.90476 15.46994 0 0 0 14.79426 16.21254 0 0 16.32355 14.45216 12.97135 0 16.59434 0 0 16.19878 14.55409 0 13.91572 0 0 15.53561 0 0 0 0 13.82742 14.54683 15.28061 14.40596 O15354 GPR37_HUMAN "Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1, ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor, PAELR)" GPR37 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625] GO:0000151; GO:0004930; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007218; GO:0008188; GO:0008528; GO:0009986; GO:0016358; GO:0030165; GO:0030544; GO:0031072; GO:0031625; GO:0031987; GO:0036505; GO:0042277; GO:0042416; GO:0042923; GO:0043235; GO:0043410; GO:0045202; GO:0045964; GO:1903206 GRDAWGPGNSAR 12.31999969 1 1 0.170126538 1244.257031 0 0 0 0 0 14.62771 0 13.39764 0 0 0 0 0 0 14.45882 0 15.53598 15.46216 0 0 0 17.15489 17.24225 16.70264 0 15.48002 0 13.58987 0 14.70662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.15658 0 0 O15357 SHIP2_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2, EC 3.1.3.86 (Inositol polyphosphate phosphatase-like protein 1, INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2, SH2 domain-containing inositol phosphatase 2, SHIP-2)" INPPL1 SHIP2 Homo sapiens (Human) actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178]" "actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]" GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0034485; GO:0042169; GO:0046856; GO:0097178 APSVSRGSQEPR 2.829999924 1 1 0.390669128 1271.065094 0 17.41 0 0 0 20.93386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.21771 0 0 0 0 0 0 18.12141 0 0 0 0 17.40905 0 0 0 0 0 0 0 O15360 FANCA_HUMAN "Fanconi anemia group A protein, Protein FACA" FANCA FAA FACA FANCH Homo sapiens (Human) DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589] GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348 ELLMYK 5.349999905 1 1 0.2105933 796.974895 0 0 0 0 14.31782 0 0 15.41151 0 0 0 0 0 0 16.02747 0 0 0 0 0 17.47943 0 0 0 0 17.00019 17.22852 0 0 0 17.00293 0 16.48207 15.27901 0 0 0 16.53325 16.9737 16.25363 17.09814 16.15314 0 0 0 0 0 0 O15371 EIF3D_HUMAN "Eukaryotic translation initiation factor 3 subunit D, eIF3d (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)" EIF3D EIF3S7 Homo sapiens (Human) cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]" mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416 GDRLGK 1.429999948 1 1 0.229144573 645.6302864 16.1855 17.63164 0 0 17.06564 0 18.06131 0 0 0 0 0 0 16.08117 0 0 17.10004 0 16.99284 0 0 0 0 0 0 0 0 0 16.43432 0 0 0 19.53306 0 18.58422 0 0 0 0 0 0 0 0 0 0 0 17.63459 16.4528 O15372 EIF3H_HUMAN "Eukaryotic translation initiation factor 3 subunit H, eIF3h (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)" EIF3H EIF3S3 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0008237; GO:0016020; GO:0016282; GO:0032435; GO:0033290; GO:0042788; GO:0070062; GO:0070122; GO:0071541; GO:0140492 NLQLLMDR 2.460000038 1 1 0.27798058 1018.70344 16.9471 0 16.1824 0 17.32854 0 16.90108 0 18.33026 0 0 16.30099 18.28776 0 0 0 0 17.28244 17.4924 0 0 0 0 0 17.88433 17.02675 0 0 0 0 0 0 0 0 0 18.58373 0 0 0 0 0 0 0 0 0 0 0 18.41234 O15389 SIGL5_HUMAN "Sialic acid-binding Ig-like lectin 5, Siglec-5 (CD33 antigen-like 2) (Obesity-binding protein 2, OB-BP2, OB-binding protein 2) (CD antigen CD170)" SIGLEC5 CD33L2 OBBP2 Homo sapiens (Human) cell adhesion [GO:0007155] ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0030667; GO:0033691; GO:0070821; GO:0101003 MDDEDPIMGTITSGSRK 3.630000114 1 1 0.424730485 1853.911163 0 15.6898 0 0 0 14.0174 0 16.10291 0 0 16.09023 16.40077 13.6812 0 15.885 16.50189 0 0 15.30954 15.27784 0 0 0 16.64359 15.71471 15.47457 16.07717 0 16.19224 0 0 16.88643 0 0 0 0 16.68714 15.267 17.27769 0 15.87643 16.28296 0 0 15.81431 16.61675 16.02523 16.04427 O15394 NCAM2_HUMAN "Neural cell adhesion molecule 2, N-CAM-2, NCAM-2" NCAM2 NCAM21 Homo sapiens (Human) axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608] identical protein binding [GO:0042802] GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802; GO:0043005 VELSVGESK 5.889999866 1 1 0.121566217 947.3773275 0 0 0 0 0 13.9094 0 0 0 0 0 0 12.68281 0 14.87368 0 0 0 0 0 16.58603 0 13.56981 0 0 0 16.46396 13.81838 13.97117 0 0 0 0 14.92542 0 0 0 0 0 0 0 0 0 0 0 0 0 14.91016 O15397 IPO8_HUMAN "Importin-8, Imp8 (Ran-binding protein 8, RanBP8)" IPO8 RANBP8 Homo sapiens (Human) protein import into nucleus [GO:0006606]; signal transduction [GO:0007165] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165] small GTPase binding [GO:0031267] GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0031267 EMPVKVEAALALQSLISNQIQAK 6.559999943 1 1 7.76E-12 2481.098183 0 15.15928 0 18.5562 0 0 16.42798 0 0 16.1281 15.06062 15.64143 8.897476 18.37145 16.73601 17.48012 16.91705 18.11189 16.05931 0 16.37866 16.62674 0 0 15.16635 14.94517 0 14.79557 15.81492 14.73134 16.84702 17.89305 17.25555 0 15.42924 15.95923 16.77036 0 0 16.16817 15.43726 15.74526 14.35792 0 15.4686 11.88648 8.993093 0 O15399 NMDE4_HUMAN "Glutamate receptor ionotropic, NMDA 2D, GluN2D (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D, NMDAR2D, NR2D)" GRIN2D GluN2D NMDAR2D Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]" endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211] "endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]" glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0001964; GO:0004970; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007420; GO:0008344; GO:0015276; GO:0016595; GO:0017146; GO:0022849; GO:0035249; GO:0038023; GO:0042165; GO:0045211; GO:0048167; GO:0048168; GO:0051930; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098686; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1904062; GO:1904315; GO:2000463 LGPAVAAAVR 6.599999905 0.349992782 0.349992782 0.048853141 921.5918622 16.39797 10.59164 15.65445 0 14.295 0 0 16.17143 15.95562 18.13791 16.95287 0 0 13.84907 16.05552 0 15.50091 0 0 16.09552 13.43762 0 0 17.5227 0 16.40137 15.97326 16.09762 17.71233 15.36506 15.57105 0 0 15.36135 0 17.64529 17.63214 15.31856 0 0 17.77379 14.86863 16.61599 11.5903 17.09178 0 16.01385 18.1824 O15400 STX7_HUMAN Syntaxin-7 STX7 Homo sapiens (Human) intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982] azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076 QLEADIMDINEIFK 15.07999992 1 1 1.15E-12 1700.084647 0 0 0 0 0 0 0 0 16.3852 0 0 0 0 0 0 15.34359 15.48554 13.6844 0 15.50733 14.58149 0 0 0 15.53155 13.18885 0 15.94487 14.12446 0 0 0 14.4806 0 15.51048 0 0 0 0 0 0 0 0 0 0 0 0 0 O15403 MOT7_HUMAN "Monocarboxylate transporter 7, MCT 7 (Monocarboxylate transporter 6, MCT 6) (Solute carrier family 16 member 6)" SLC16A6 MCT6 MCT7 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718] monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016021 ADMQQVLVKTSPRPSEK 9.949999809 1 1 0.021754589 1929.922607 0 0 0 0 0 0 0 15.74327 0 0 0 0 13.24234 13.61582 0 0 12.28725 14.79596 0 0 0 0 0 0 0 0 0 0 0 0 14.57506 14.16022 0 12.57646 15.94074 0 0 0 0 0 0 0 0 0 0 0 0 0 O15405 TOX3_HUMAN TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein) TOX3 CAGF9 TNRC9 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713] GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0031490; GO:0042803; GO:0042981; GO:0043524; GO:0045944; GO:0051219 RAAPDSGK 5.849999905 0.655496955 0.655496955 0.213993935 802.1486457 0 13.19718 0 0 0 0 0 7.83494 0 0 0 0 0 0 0 0 0 0 14.71251 9.828471 0 0 0 0 14.30606 0 0 11.18871 0 14.42998 0 0 0 0 0 13.65304 0 0 15.59849 13.35832 12.87185 0 0 0 0 15.39743 0 13.97411 O15417 TNC18_HUMAN Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein) TNRC18 CAGL79 KIAA1856 Homo sapiens (Human) cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682] chromatin binding [GO:0003682] GO:0003682; GO:0005654; GO:0005739; GO:0005829; GO:0031965 DPERPESAKAFGR 6.010000229 0.530795336 0.530795336 0.19049772 1460.313986 13.98217 16.41012 15.20631 0 17.38882 17.55534 17.12584 16.48061 12.70102 14.21819 16.60321 16.66111 13.37403 15.29584 15.27563 16.16873 12.80828 16.54689 13.81322 0 16.18708 16.35868 16.18598 16.6251 17.1592 16.33305 14.91404 14.09502 16.80513 17.13561 0 16.34776 16.75132 16.87029 15.87041 16.68267 15.19489 0 16.70588 0 16.32676 14.8986 0 14.76365 0 16.30156 14.21209 16.06015 O15438 MRP3_HUMAN "ATP-binding cassette sub-family C member 3, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D, MOAT-D) (Multidrug resistance-associated protein 3)" ABCC3 CMOAT2 MLP2 MRP3 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0150104 IKLMSEILNGIK 12.64999962 1 1 0.352883141 1373.450469 7.923088 0 15.44908 0 0 12.3572 0 0 0 15.98804 0 0 14.98627 0 0 0 0 0 0 0 0 13.86509 0 0 0 0 15.9848 0 0 0 13.33047 15.09522 0 13.35486 14.75531 0 13.15508 0 0 14.97932 0 15.3174 0 0 0 0 16.65029 0 O15439 MRP4_HUMAN "ATP-binding cassette sub-family C member 4, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B, MOAT-B) (Multidrug resistance-associated protein 4)" ABCC4 MOATB MRP4 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747] 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104 KNQILIIDEATANVDPR 6.28000021 0.390462697 0.390462697 0.128763309 1909.151924 0 15.27458 13.61073 14.59124 0 0 14.47397 0 0 14.2864 14.33366 14.34332 15.31404 0 0 13.8259 0 0 0 0 0 0 15.16936 0 15.04821 14.97716 0 14.95943 0 0 0 0 0 0 14.06671 0 0 0 0 17.56853 16.32352 0 0 0 14.34721 0 14.43603 13.63051 O15440 MRP5_HUMAN "ATP-binding cassette sub-family C member 5, EC 7.6.2.-, EC 7.6.2.2 (Multi-specific organic anion transporter C, MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11)" ABCC5 MRP5 Homo sapiens (Human) cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910]; cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005524; GO:0005796; GO:0005886; GO:0005887; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0150104 MKDIDIGK 3.410000086 1 1 0.246491193 919.0410634 18.02553 17.78318 17.15724 15.4206 16.04846 15.82387 13.87733 16.11765 14.05851 14.70566 15.53793 6.88494 16.32781 16.33901 17.68391 15.98952 16.43542 15.11687 15.79309 17.16657 0 0 0 0 16.63121 0 0 17.36452 15.22741 16.57689 0 19.02964 17.67701 0 18.27371 0 0 17.44823 0 17.4908 0 15.93302 0 0 0 16.77122 15.27802 16.51964 O15455 TLR3_HUMAN Toll-like receptor 3 (CD antigen CD283) TLR3 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; signal transduction [GO:0007165]; toll-like receptor 3 signaling pathway [GO:0034138] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; signal transduction [GO:0007165]; toll-like receptor 3 signaling pathway [GO:0034138] double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] GO:0000139; GO:0001774; GO:0002730; GO:0002756; GO:0003725; GO:0003953; GO:0004888; GO:0005615; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005887; GO:0006972; GO:0007165; GO:0007250; GO:0007252; GO:0007254; GO:0008584; GO:0009597; GO:0010008; GO:0010628; GO:0016020; GO:0031012; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034123; GO:0034138; GO:0034346; GO:0035458; GO:0036020; GO:0038023; GO:0042742; GO:0042802; GO:0043065; GO:0043123; GO:0043330; GO:0043331; GO:0045087; GO:0045671; GO:0045766; GO:0045944; GO:0046330; GO:0050729; GO:0051092; GO:0051607; GO:0071260; GO:0071346; GO:0071360; GO:0071466; GO:0097191; GO:0097527; GO:0098586; GO:1901224 EFSPGCFHAIGR 13.21000004 1 1 0.614598072 1376.183751 15.05826 0 18.7995 0 0 0 0 0 18.92323 0 18.61466 19.51524 0 0 0 0 0 17.41449 0 15.57502 0 0 0 0 0 0 0 0 0 0 0 18.74418 0 0 0 17.61377 0 0 0 0 0 0 0 17.78082 0 0 0 0 O15479 MAGB2_HUMAN "Melanoma-associated antigen B2 (Cancer/testis antigen 3.2, CT3.2) (DSS-AHC critical interval MAGE superfamily 6, DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen)" MAGEB2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 NASSSQASTSTK 4.920000076 0.435498178 0.435498178 0.156665257 1167.813663 15.61548 16.58255 0 0 0 15.69035 16.6361 0 14.01378 0 16.21885 0 0 13.01258 16.44201 14.44998 16.06748 14.99491 15.0581 0 15.52042 14.28108 17.05675 16.39079 18.15202 17.38051 13.34619 16.44114 16.6543 11.13592 15.04463 0 15.51369 16.12979 0 0 14.74602 14.63281 0 10.02972 16.01757 14.73983 15.46028 11.00599 19.96908 0 0 0 O15480 MAGB3_HUMAN Melanoma-associated antigen B3 (MAGE-B3 antigen) MAGEB3 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 DSYVLVSK 4.039999962 0.138301611 0.138301611 0.287490675 910.6365814 15.12679 17.94243 0 0 19.02902 0 0 17.82036 0 0 18.84931 0 18.12659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.2903 18.01683 18.69826 0 0 0 0 0 0 0 0 17.79465 0 0 16.72214 18.0348 O15481 MAGB4_HUMAN Melanoma-associated antigen B4 (MAGE-B4 antigen) MAGEB4 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005737 GTTAMTSAYSRATSSSSSQPM 1.870000005 0.338299572 0.338299572 0.03332142 2135.410905 15.49263 0 0 0 14.18037 0 0 0 0 0 11.98514 0 0 0 0 11.46367 0 0 0 11.91852 0 0 0 0 14.27693 0 0 0 0 14.43261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.47049 0 0 0 O15484 CAN5_HUMAN "Calpain-5, EC 3.4.22.- (Calpain htra-3) (New calpain 3, nCL-3)" CAPN5 NCL3 Homo sapiens (Human) proteolysis [GO:0006508]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165] calcium-dependent cysteine-type endopeptidase activity [GO:0004198] GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062 GGLISASIK 10.10999966 0.957497001 0.957497001 0.003040548 846.9974008 15.50256 0 14.75651 17.58642 16.52009 15.35529 12.54468 0 16.04626 16.60254 0 16.33461 16.44858 0 0 10.9018 0 15.14894 15.36497 10.70012 15.84267 0 15.81837 0 0 0 15.82628 0 9.989807 16.32965 15.23645 8.61661 16.71027 16.49691 0 17.47366 17.76639 18.13937 0 0 14.6869 0 14.63735 0 12.16928 15.55894 14.8484 14.13794 O15496 PA2GX_HUMAN "Group 10 secretory phospholipase A2, EC 3.1.1.4 (Group X secretory phospholipase A2, GX sPLA2, sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10)" PLA2G10 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; defense response to virus [GO:0051607]; erythrocyte maturation [GO:0043249]; fertilization [GO:0009566]; hair follicle morphogenesis [GO:0031069]; intestinal stem cell homeostasis [GO:0036335]; low-density lipoprotein particle remodeling [GO:0034374]; lysophospholipid transport [GO:0051977]; macrophage activation [GO:0042116]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of inflammatory response [GO:0050728]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; platelet activating factor catabolic process [GO:0062234]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; prostaglandin biosynthetic process [GO:0001516]; regulation of macrophage activation [GO:0043030] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; defense response to virus [GO:0051607]; erythrocyte maturation [GO:0043249]; fertilization [GO:0009566]; hair follicle morphogenesis [GO:0031069]; intestinal stem cell homeostasis [GO:0036335]; low-density lipoprotein particle remodeling [GO:0034374]; lysophospholipid transport [GO:0051977]; macrophage activation [GO:0042116]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of inflammatory response [GO:0050728]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; platelet activating factor catabolic process [GO:0062234]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; prostaglandin biosynthetic process [GO:0001516]; regulation of macrophage activation [GO:0043030] 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; phospholipid binding [GO:0005543] GO:0001516; GO:0001669; GO:0002532; GO:0003847; GO:0004620; GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0006644; GO:0006658; GO:0007411; GO:0009566; GO:0010744; GO:0010884; GO:0019369; GO:0031069; GO:0032270; GO:0032308; GO:0034374; GO:0034638; GO:0036335; GO:0042116; GO:0042632; GO:0043030; GO:0043249; GO:0043433; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0047498; GO:0050482; GO:0050728; GO:0051607; GO:0051977; GO:0062234; GO:0090238; GO:0090370; GO:1900016; GO:1990830; GO:2000344 TPIAYMK 8.779999733 0.176138163 0.176138163 0.20588811 823.4621112 17.75793 18.13396 17.07589 16.97842 17.10462 0 15.74959 16.01594 0 17.66606 15.45785 17.22174 17.30291 14.36859 15.74728 0 16.67842 16.52042 16.07638 0 0 18.54281 17.14178 16.45478 17.55629 16.17154 17.83739 17.50755 17.10309 16.55093 15.88412 17.77264 17.31207 17.18448 17.28154 16.80043 18.11469 18.75425 18.5656 0 16.83318 0 17.97034 17.86703 17.58498 16.09815 16.60021 17.87598 O15511 ARPC5_HUMAN "Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit, p16-ARC)" ARPC5 ARC16 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909] actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200] GO:0003779; GO:0005200; GO:0005576; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0014909; GO:0015629; GO:0016477; GO:0021769; GO:0030011; GO:0030027; GO:0030036; GO:0030426; GO:0030833; GO:0034314; GO:0034774; GO:0035861; GO:0051639; GO:0061842; GO:0070062; GO:0097581; GO:1904813 NTVSSAR 5.210000038 0.189689785 0.189689785 0.243936931 736.2873669 0 0 15.56444 0 15.38382 15.90054 16.32716 15.79363 15.5886 15.67292 15.56643 15.59099 14.82389 15.42945 13.76572 14.96533 0 0 15.68667 15.18073 0 15.10871 0 15.67142 15.31309 0 0 15.90224 14.18857 0 16.50406 15.44294 0 0 0 16.86691 0 0 0 16.02092 0 0 17.75592 15.87163 0 16.57904 0 15.69392 O15525 MAFG_HUMAN Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF) MAFG Homo sapiens (Human) adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030534; GO:0030641; GO:0042127; GO:0042802; GO:0045604; GO:0046982; GO:0090575; GO:1990837 GNKALK 13.21000004 0.27644974 0.27644974 0.318756006 631.1753904 0 0 15.19633 0 0 0 15.95912 15.0591 0 0 0 14.87547 17.33202 15.02668 16.20948 0 17.0689 16.23608 17.6101 16.64802 18.16687 16.03869 17.27476 0 17.08061 17.14074 16.1111 15.99841 16.31358 0 17.62405 0 16.35506 0 17.297 16.91824 0 17.63564 16.93636 19.00916 0 0 16.87423 17.15308 17.21831 0 15.97399 17.93906 O15533 TPSN_HUMAN "Tapasin, TPN, TPSN (NGS-17) (TAP-associated protein) (TAP-binding protein)" TAPBP NGS17 TAPA Homo sapiens (Human) "antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; immune response [GO:0006955]; MHC class I protein complex assembly [GO:0002397]; MHC class Ib protein complex assembly [GO:0002398]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen stabilization [GO:0050823]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of immune response [GO:0050776]; regulation of protein complex stability [GO:0061635]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; Tapasin-ERp57 complex [GO:0061779] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; Tapasin-ERp57 complex [GO:0061779]; ABC-type peptide antigen transporter activity [GO:0015433]; antigen binding [GO:0003823]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; TAP complex binding [GO:0062061]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; unfolded protein binding [GO:0051082]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; immune response [GO:0006955]; MHC class I protein complex assembly [GO:0002397]; MHC class Ib protein complex assembly [GO:0002398]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen stabilization [GO:0050823]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of immune response [GO:0050776]; regulation of protein complex stability [GO:0061635]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" ABC-type peptide antigen transporter activity [GO:0015433]; antigen binding [GO:0003823]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; TAP complex binding [GO:0062061]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; unfolded protein binding [GO:0051082] GO:0000139; GO:0002397; GO:0002398; GO:0002502; GO:0003823; GO:0005783; GO:0005789; GO:0006890; GO:0006955; GO:0010468; GO:0015433; GO:0016021; GO:0019885; GO:0030670; GO:0033116; GO:0042288; GO:0042605; GO:0042824; GO:0046978; GO:0046979; GO:0050776; GO:0050823; GO:0051082; GO:0061635; GO:0061779; GO:0062061; GO:0065003; GO:0071556 VSLMPATLAR 8.960000038 1 1 0.244319912 1074.254504 0 13.88542 16.84999 15.26627 13.71968 14.16991 0 15.45591 0 0 0 15.78758 0 12.9804 14.93093 0 15.82001 14.53365 0 16.50959 0 0 0 0 0 0 0 0 15.68169 14.94055 0 15.54673 0 14.23879 0 0 0 0 0 0 0 0 0 0 0 14.12334 0 0 O15534 PER1_HUMAN "Period circadian protein homolog 1, hPER1 (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui)" PER1 KIAA0482 PER RIGUI Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; histone H3 acetylation [GO:0043966]; histone H3 deacetylation [GO:0070932]; histone H4 acetylation [GO:0043967]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of circadian rhythm [GO:0042752]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of hair cycle [GO:0042634]; regulation of p38MAPK cascade [GO:1900744]; regulation of sodium ion transport [GO:0002028]; response to cAMP [GO:0051591]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; histone H3 acetylation [GO:0043966]; histone H3 deacetylation [GO:0070932]; histone H4 acetylation [GO:0043967]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of circadian rhythm [GO:0042752]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of hair cycle [GO:0042634]; regulation of p38MAPK cascade [GO:1900744]; regulation of sodium ion transport [GO:0002028]; response to cAMP [GO:0051591]" chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] GO:0000122; GO:0000976; GO:0000978; GO:0001222; GO:0002028; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007623; GO:0009649; GO:0010608; GO:0019900; GO:0031490; GO:0031625; GO:0032922; GO:0042634; GO:0042752; GO:0043124; GO:0043153; GO:0043966; GO:0043967; GO:0045892; GO:0045944; GO:0046329; GO:0051591; GO:0070888; GO:0070932; GO:0097167; GO:0140297; GO:1900015; GO:1900744; GO:2000323 YLESCNLPSTTKR 11.81000042 0.190285146 0.190285146 0.200054147 1568.150003 19.27306 16.96248 0 12.81466 0 17.08595 0 15.15396 15.0528 15.59995 15.54311 14.51448 12.14191 18.56484 0 12.10723 16.43149 0 14.856 17.31697 14.57711 15.4294 16.35432 0 18.27936 14.8522 15.22541 17.03457 16.22421 0 0 16.41118 17.50413 14.21413 17.52607 16.29816 16.55318 0 17.38725 0 14.89523 16.65759 17.91297 0 14.79668 16.64571 0 16.39651 O15535 ZSC9_HUMAN Zinc finger and SCAN domain-containing protein 9 (Cell proliferation-inducing gene 12 protein) (PRD51) (Zinc finger protein 193) ZSCAN9 ZNF193 PIG12 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 IHTVAELV 2.529999971 1 1 1.15E-13 884.0187077 15.93743 0 15.72105 0 14.51162 0 0 0 0 0 14.98305 0 0 15.05406 0 15.23734 0 0 0 0 0 0 0 0 15.55538 0 0 0 0 0 0 0 0 0 0 16.40819 0 0 0 0 0 0 0 0 0 0 14.32078 0 O15550 KDM6A_HUMAN "Lysine-specific demethylase 6A, EC 1.14.11.68 (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)" KDM6A UTX Homo sapiens (Human) chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0051568; GO:0071557; GO:0071558 CYLNATR 11.07999992 1 1 0.272010422 898.0041733 11.39954 19.06863 16.20892 0 18.18879 17.11539 0 0 0 17.27563 0 0 17.69824 18.01666 0 0 0 19.83679 0 0 0 0 0 0 18.06953 0 0 17.39367 0 18.718 19.03572 0 0 0 0 19.13645 0 0 18.57908 0 17.89629 18.11236 17.64997 0 0 0 18.0356 0 O15552 FFAR2_HUMAN Free fatty acid receptor 2 (G-protein coupled receptor 43) FFAR2 FFA2 GPCR43 GPR43 Homo sapiens (Human) cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to fatty acid [GO:0071398]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipid storage [GO:0019915]; mucosal immune response [GO:0002385]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-8 production [GO:0032757]; regulation of acute inflammatory response [GO:0002673]; regulation of peptide hormone secretion [GO:0090276] cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to fatty acid [GO:0071398]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipid storage [GO:0019915]; mucosal immune response [GO:0002385]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-8 production [GO:0032757]; regulation of acute inflammatory response [GO:0002673]; regulation of peptide hormone secretion [GO:0090276] G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289] GO:0002232; GO:0002385; GO:0002673; GO:0002720; GO:0002752; GO:0002879; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008289; GO:0019915; GO:0032722; GO:0032757; GO:0042593; GO:0042995; GO:0045444; GO:0071398; GO:0090276 IIEAASNFR 2.339999914 1 1 0.203980251 1021.078739 9.55902 0 14.41514 12.06795 11.40119 15.03953 14.43544 15.64426 12.84065 0 14.38358 14.78018 0 0 0 14.43023 0 16.42839 0 0 0 0 0 0 0 0 0 0 0 0 0 15.58703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15553 MEFV_HUMAN Pyrin (Marenostrin) MEFV MEF TRIM20 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; regulation of gene expression [GO:0010468]; regulation of interleukin-1 beta production [GO:0032651]; response to interferon-gamma [GO:0034341] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; regulation of gene expression [GO:0010468]; regulation of interleukin-1 beta production [GO:0032651]; response to interferon-gamma [GO:0034341] actin binding [GO:0003779]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0001726; GO:0002221; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0006954; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0030027; GO:0031410; GO:0032651; GO:0032691; GO:0032695; GO:0032731; GO:0034341; GO:0042802; GO:0045087; GO:0050728; GO:0061630; GO:0061702; GO:0070269; GO:0071641; GO:1900016; GO:1900226; GO:1904270; GO:2001056 LPDGPQRFDSCIIVLGSPSFLSGR 1.49000001 1 1 0.129133673 2617.546513 10.85968 0 13.0487 0 0 12.89272 0 0 0 0 0 0 0 0 0 0 12.20822 12.21686 0 0 0 0 0 6.623271 11.22503 0 0 0 10.10219 0 0 13.09904 0 0 0 0 0 0 0 0 0 0 0 0 13.92434 0 0 0 O43143 DHX15_HUMAN "ATP-dependent RNA helicase DHX15, EC 3.6.4.13 (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43, hPrp43)" DHX15 DBP1 DDX15 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0043123; GO:0043279; GO:0051607; GO:0140374 AGRTRPGK 7.929999828 1 1 0.031143526 842.655321 15.89936 14.87512 13.95961 14.80078 15.57828 14.50412 0 0 0 0 0 0 0 18.20011 0 0 16.50632 0 0 0 0 16.99747 0 15.91147 0 0 0 0 0 0 0 0 16.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43147 SGSM2_HUMAN Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1) SGSM2 KIAA0397 RUTBC1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547] cytoplasm [GO:0005737]; melanosome [GO:0042470] cytoplasm [GO:0005737]; melanosome [GO:0042470]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630 GPPTR 9.100000381 1 1 0.006600381 525.376963 0 0 0 0 0 0 0 0 0 0 0 0 14.01114 15.82318 0 0 0 14.81156 0 0 15.44703 14.77709 11.24893 15.80491 0 0 15.34458 0 11.96674 0 14.96245 15.75987 13.50803 0 11.62275 0 0 0 0 0 0 0 0 0 0 0 0 0 O43149 ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 ZZEF1 KIAA0399 Homo sapiens (Human) calcium ion binding [GO:0005509]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] calcium ion binding [GO:0005509]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] GO:0003713; GO:0005509; GO:0008270; GO:0035064; GO:0070577 AHGFEEIR 5.650000095 0.752023458 0.752023458 0.209636774 958.6689645 14.77397 14.9971 0 11.67432 13.80309 15.32496 13.84594 14.19135 14.59759 14.85997 14.75212 15.66865 15.82621 16.53915 0 13.25379 13.71272 0 0 15.56799 16.24747 14.49812 14.93728 13.73161 0 0 0 0 16.55276 0 0 17.16505 0 17.52389 14.71787 0 16.1746 15.90598 0 15.51102 0 0 15.65466 14.9821 0 0 16.56586 0 O43150 ASAP2_HUMAN "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3, PAG3) (Pyk2 C-terminus-associated protein, PAP)" ASAP2 DDEF2 KIAA0400 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547] Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886] Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005886; GO:0032580; GO:0043547; GO:0046872 ASIEIANESGETPLDIAK 6.860000134 1 1 9.18E-13 1858.793339 12.4434 0 0 13.6439 15.59823 0 0 0 0 0 0 15.96949 0 0 0 0 15.29577 0 15.84789 0 0 0 16.45231 16.21203 0 0 0 0 0 0 0 0 0 0 14.15382 16.27563 14.60667 15.95074 0 0 0 0 0 14.14834 0 0 0 0 O43151 TET3_HUMAN "Methylcytosine dioxygenase TET3, EC 1.14.11.n2" TET3 KIAA0401 Homo sapiens (Human) 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-K4 trimethylation [GO:0080182]; oxidative demethylation [GO:0070989]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] chromosome [GO:0005694]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-K4 trimethylation [GO:0080182]; oxidative demethylation [GO:0070989]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270] GO:0001939; GO:0001940; GO:0005634; GO:0005694; GO:0005737; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008327; GO:0044727; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182 RPEALPTKPK 5.929999828 1 1 0.276691385 1137.381639 16.78506 15.11553 14.21703 0 0 0 0 0 0 0 0 0 0 15.75515 0 15.93733 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9421 14.50603 0 0 0 16.1559 15.97853 13.07694 0 15.11524 14.70972 10.00475 0 0 0 0 0 0 0 O43155 FLRT2_HUMAN Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2) FLRT2 KIAA0405 UNQ232/PRO265 Homo sapiens (Human) axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222] cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222] chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674] GO:0003007; GO:0005104; GO:0005615; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0008543; GO:0030674; GO:0031012; GO:0043005; GO:0045202; GO:0045499; GO:0051965; GO:0061343; GO:0070062; GO:0071711; GO:2001222 LKEFSIVR 11.43999958 1 1 0.187238597 990.7875066 16.63689 13.3238 0 15.40168 0 11.52739 0 18.95699 15.29559 0 0 0 0 0 0 0 0 0 0 14.15723 0 0 0 0 15.09721 0 14.62185 0 0 15.48983 16.62974 16.14628 15.80649 16.29312 0 16.36708 16.09037 15.5724 15.39757 13.3133 14.83852 0 0 0 0 0 0 0 O43159 RRP8_HUMAN "Ribosomal RNA-processing protein 8, EC 2.1.1.- (Cerebral protein 1) (Nucleomethylin)" RRP8 KIAA0409 NML hucep-1 Homo sapiens (Human) "cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]" chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553] "chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]" methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] GO:0000183; GO:0003723; GO:0005654; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008757; GO:0031062; GO:0031065; GO:0032259; GO:0033553; GO:0035064; GO:0042149; GO:0045786; GO:0045892; GO:0046015; GO:0061773; GO:0072332; GO:0097009; GO:1903450 KASFASASAEVGK 8.199999809 1 1 0.277471652 1251.597145 16.43885 0 13.06967 12.52042 14.68416 11.71718 14.39573 12.86594 15.34315 14.62581 0 9.938841 0 0 0 0 0 0 0 0 0 0 0 0 16.71288 0 16.01549 0 13.85731 13.6416 15.50067 16.12932 0 0 12.99439 16.67903 16.03171 0 0 0 16.52589 0 16.67426 17.63954 0 14.38759 0 16.76105 O43164 PJA2_HUMAN "E3 ubiquitin-protein ligase Praja-2, Praja2, EC 2.3.2.27 (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)" PJA2 KIAA0438 RNF131 Homo sapiens (Human) hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin-protein transferase activity [GO:0004842]; hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738] metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin-protein transferase activity [GO:0004842] GO:0000139; GO:0004842; GO:0005737; GO:0005789; GO:0005886; GO:0006954; GO:0007616; GO:0010738; GO:0014069; GO:0016567; GO:0034137; GO:0034236; GO:0034237; GO:0035329; GO:0043030; GO:0045087; GO:0045111; GO:0046330; GO:0046872; GO:1900745 SGTCPVCRR 1.419999957 1 1 0.075146389 1093.04468 0 0 0 0 0 0 12.37718 0 0 15.8025 0 15.5826 0 0 0 14.10899 0 0 0 0 0 0 0 0 0 0 0 0 0 13.34452 0 0 0 0 0 0 0 0 0 15.3699 0 0 0 0 0 0 0 0 O43166 SI1L1_HUMAN "Signal-induced proliferation-associated 1-like protein 1, SIPA1-like protein 1 (High-risk human papilloma viruses E6 oncoproteins targeted protein 1, E6-targeted protein 1)" SIPA1L1 E6TP1 KIAA0440 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0031532; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0048814; GO:0050770; GO:0051056; GO:0061001; GO:0090630 GPHSPQVPSQVQSPMTSRLNAGK 3.029999971 1 1 0 2402.725312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43167 ZBT24_HUMAN Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450) ZBTB24 KIAA0441 ZNF450 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0002244; GO:0003700; GO:0005634; GO:0006357; GO:0046872 EESEPTCEPSREEEMPVEK 1.929999948 1 1 0.095038829 2304.755668 0 0 0 0 16.64758 17.13 15.5771 0 0 15.68042 0 0 15.04923 13.85624 14.77445 0 17.73066 0 0 0 0 15.47541 15.81857 16.35167 13.6945 16.20967 0 0 15.60358 16.48184 0 15.77368 0 0 0 0 0 0 18.4057 0 0 0 0 0 0 16.64661 0 15.09409 O43169 CYB5B_HUMAN Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform) CYB5B CYB5M OMB5 Homo sapiens (Human) nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958]; enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805] enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872] GO:0005741; GO:0006805; GO:0006809; GO:0006979; GO:0008047; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872; GO:1903958 EMLKQYYIGDIHPSDLKPESGSK 4.059999943 1 1 2.76E-12 2634.882339 0 0 15.31357 0 0 0 0 14.54497 0 0 0 13.5252 16.3252 0 0 14.81504 0 0 0 15.58403 0 14.95794 16.92627 0 0 0 0 0 14.83452 0 0 0 16.81448 14.13152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43173 SIA8C_HUMAN "Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase, EC 2.4.99.- (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C, SIAT8-C) (Sialyltransferase St8Sia III, ST8SiaIII)" ST8SIA3 SIAT8C Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]" "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]" GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0033691; GO:0042802; GO:1990743 HLSPKR 5.889999866 0.956252396 0.956252396 0.292272527 737.9198591 14.48168 16.52718 15.83705 15.00667 15.00935 0 15.36726 15.44427 15.58404 15.96086 15.84024 15.31009 15.60454 17.062 16.7579 15.5278 14.85311 0 15.87769 17.71569 15.75927 15.88832 15.91684 16.40949 16.6783 0 16.40366 16.40569 0 16.26365 16.87518 16.5648 18.11867 16.29459 16.84838 16.04241 17.07843 17.81235 0 16.43097 17.38752 17.4342 0 16.86926 16.31986 15.63465 18.12861 15.61228 O43175 SERA_HUMAN "D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)" PHGDH PGDH3 Homo sapiens (Human) brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566] electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617] GO:0004617; GO:0005829; GO:0006541; GO:0006544; GO:0006564; GO:0006566; GO:0007420; GO:0009055; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0030060; GO:0031175; GO:0051287; GO:0070062; GO:0070314 EVATRMQSFGMK 2.099999905 1 1 0.204973904 1383.818352 14.29617 13.94989 0 0 13.86537 14.35165 15.12046 13.82404 15.53656 0 0 12.76694 0 0 0 16.00018 0 0 15.6225 0 16.33459 0 14.76761 15.34952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2864 0 0 0 0 0 16.25902 0 O43181 NDUS4_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa, CI-18 kDa) (Complex I-AQDQ, CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)" NDUFS4 Homo sapiens (Human) "aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]" NADH dehydrogenase (ubiquinone) activity [GO:0008137] GO:0001932; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007420; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0048146; GO:0051591; GO:0072593 KVPKPK 5.630000114 1 1 0.159082261 695.7676688 0 0 0 0 14.66166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.87669 0 0 0 0 0 0 0 0 0 0 15.49522 0 0 0 0 0 0 0 0 0 0 17.67031 0 0 0 0 0 O43182 RHG06_HUMAN Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1) ARHGAP6 RHOGAP6 Homo sapiens (Human) actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124] GO:0005096; GO:0005737; GO:0005829; GO:0005884; GO:0007202; GO:0007266; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0030041; GO:0043274; GO:0043547; GO:0048041; GO:0051056; GO:0051497; GO:0051895 MSAQSLLHSVFSCSSPASSSAASAKGFSK 4.349999905 0.843576968 0.843576968 0.214626547 2916.793388 0 0 0 11.93701 12.4088 13.48795 12.18332 12.68999 14.65794 0 14.47567 10.97717 14.27639 0 14.49056 0 0 0 13.59004 10.87872 14.13859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.35231 12.2464 13.95183 0 0 0 0 14.14674 0 O43186 CRX_HUMAN Cone-rod homeobox protein CRX CORD2 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" "DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007399; GO:0007601; GO:0009887; GO:0016922; GO:0030154; GO:0043522; GO:0045944; GO:0050896; GO:0061629; GO:0090575; GO:1990837 DQSAWK 4.019999981 1 1 0.145494182 734.8412575 0 13.05448 14.3373 0 0 0 12.89115 0 0 15.72743 0 15.89223 0 15.19276 0 0 0 0 0 0 15.03907 0 0 0 0 0 0 0 15.2454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47024 0 0 0 O43189 PHF1_HUMAN "PHD finger protein 1, Protein PHF1, hPHF1 (Polycomb-like protein 1, hPCl1)" PHF1 PCL1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription corepressor binding [GO:0001222]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription corepressor binding [GO:0001222] GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006325; GO:0006355; GO:0006974; GO:0035064; GO:0035861; GO:0042802; GO:0046872; GO:0061086; GO:0061087; GO:1990226 GERSSR 7.909999847 0.683127284 0.683127284 0.296742507 689.9184794 17.56576 0 15.82355 0 18.06991 0 18.2412 0 17.12964 0 0 0 16.67228 0 0 17.22844 0 0 0 17.0093 18.60159 0 16.64654 16.50495 0 0 0 16.6772 0 0 0 0 18.40991 0 0 0 0 0 0 17.49708 17.19808 0 0 0 0 0 0 0 O43193 MTLR_HUMAN Motilin receptor (G-protein coupled receptor 38) MLNR GPR38 MTLR MTLR1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562] GO:0004930; GO:0005829; GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0042562 GPAASGR 1.950000048 0.446426451 0.446426451 0.207088377 611.9980808 0 0 9.064896 0 13.24971 15.20622 0 0 0 0 0 13.68223 0 15.11253 15.60433 0 16.82965 0 17.11048 0 15.42619 0 14.2991 0 0 16.53294 0 14.68015 14.07413 0 16.5255 17.09657 0 0 11.92419 0 0 0 0 0 14.75263 16.16658 0 0 0 0 16.30194 17.56593 O43194 GPR39_HUMAN G-protein coupled receptor 39 GPR39 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0046872 IMAAAKPK 5.679999828 1 1 0.240957828 829.7418969 0 16.92216 16.57062 15.64266 16.48235 17.11265 15.945 15.4711 14.30342 0 16.95798 0 0 16.02213 14.87031 0 0 14.87518 16.49274 13.4347 0 0 0 16.77255 17.54611 0 0 15.8699 0 15.44048 16.1048 0 17.99419 0 17.62296 17.64329 15.21535 15.2501 0 15.7906 17.58471 0 14.42084 0 0 0 16.36486 0 O43236 SEPT4_HUMAN "Septin-4 (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2, hCDCREL-2) (Peanut-like protein 2)" SEPTIN4 C17orf47 PNUTL2 SEP4 SEPT4 hucep-7 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515] axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021] axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; apoptotic process [GO:0006915]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198] GO:0000287; GO:0001764; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005940; GO:0006915; GO:0008021; GO:0015630; GO:0017157; GO:0030317; GO:0030424; GO:0030425; GO:0031105; GO:0031398; GO:0032153; GO:0034613; GO:0042802; GO:0042981; GO:0043065; GO:0043204; GO:0048515; GO:0060090; GO:0061484; GO:0061640; GO:0097227; GO:2001244 GFDFTLMVAGESGLGKSTLVNSLFLTDLYR 2.190000057 1 1 9.16E-13 3266.481982 0 0 0 0 13.75262 0 0 0 0 0 0 0 8.916475 13.74577 0 0 0 0 0 0 12.60282 10.41366 0 0 0 12.95335 13.5922 12.29247 12.5867 12.00354 0 0 15.74401 0 0 15.40492 0 0 12.88658 0 0 0 16.06451 0 0 0 0 11.34752 O43237 DC1L2_HUMAN "Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic, LIC-2) (LIC53/55)" DYNC1LI2 DNCLI2 LIC2 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802] GO:0000226; GO:0000776; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0016020; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090 MAPVGVEKK 5.679999828 0.80584538 0.80584538 0.149045483 960.0367042 15.76645 15.07056 16.54185 0 15.55559 14.36673 16.9939 0 14.74192 0 0 15.93342 0 13.32339 0 0 0 0 0 0 0 0 0 16.19798 0 0 16.22311 0 0 0 0 0 0 0 14.68327 0 17.03496 0 0 0 0 0 0 14.77712 0 0 0 0 O43242 PSMD3_HUMAN 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) PSMD3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]" enzyme regulator activity [GO:0030234] GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813 TGNLAK 3.420000076 1 1 0.180982579 603.3458685 0 14.76201 0 16.07053 0 0 0 14.13618 0 15.93445 16.24239 10.85885 0 0 0 16.09306 0 0 16.77454 16.39536 16.93442 14.72345 15.85561 16.10846 0 0 0 0 0 0 0 0 15.23909 0 0 0 17.08734 0 16.11514 15.75771 0 0 0 0 0 16.39724 0 0 O43252 PAPS1_HUMAN "Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1, PAPS synthase 1, PAPSS 1 (Sulfurylase kinase 1, SK 1, SK1) [Includes: Sulfate adenylyltransferase, EC 2.7.7.4 (ATP-sulfurylase) (Sulfate adenylate transferase, SAT); Adenylyl-sulfate kinase, EC 2.7.1.25 (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase) ]" PAPSS1 ATPSK1 PAPSS Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103] cytosol [GO:0005829] cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103] adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781] GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428 DPAGMPHPETGK 8.260000229 0.824322462 0.824322462 0.538179364 1251.841972 0 0 0 0 0 0 0 0 0 0 0 0 0 18.27514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.97697 0 0 0 0 0 0 0 0 0 0 0 0 0 O43280 TREA_HUMAN "Trehalase, EC 3.2.1.28 (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)" TREH TREA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991] anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062] "anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; alpha,alpha-trehalase activity [GO:0004555]; animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991]" "alpha,alpha-trehalase activity [GO:0004555]" GO:0004555; GO:0005991; GO:0005993; GO:0009887; GO:0031225; GO:0046658; GO:0070062 EFYPSNLTPLWAGCFSDPGVADK 3.289999962 1 1 0.360377945 2571.148993 0 0 19.73826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43283 M3K13_HUMAN "Mitogen-activated protein kinase kinase kinase 13, EC 2.7.11.25 (Leucine zipper-bearing kinase) (Mixed lineage kinase, MLK)" MAP3K13 LZK Homo sapiens (Human) JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon extension [GO:0045773]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; IkappaB kinase complex binding [GO:0106137]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon extension [GO:0045773]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; IkappaB kinase complex binding [GO:0106137]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0014042; GO:0016020; GO:0018105; GO:0019899; GO:0019901; GO:0042802; GO:0042803; GO:0043507; GO:0043539; GO:0045773; GO:0046777; GO:0046872; GO:0051092; GO:0051403; GO:0106137; GO:0106310; GO:0150012; GO:1905492 LNMHGQDIATCANNLRYFGPAAALR 2.599999905 1 1 0.050547203 2791.20874 16.64968 0 13.90657 10.32062 0 1.805341 13.15372 0 12.43402 14.06638 15.50931 0 0 0 0 0 0 15.19167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43290 SNUT1_HUMAN "U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog, hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1, SART-1, hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)" SART1 Homo sapiens (Human) "maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]" RNA binding [GO:0003723] GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013 GGERGSGR 4.179999828 1 1 0.157343582 774.7092666 0 16.94056 0 0 0 15.88747 0 0 14.84278 0 0 13.21949 16.4723 0 0 0 0 0 0 15.82402 0 0 17.28893 0 16.78009 15.87741 0 0 0 0 0 0 0 0 16.16662 0 0 16.51187 0 15.43096 0 14.77467 15.80947 15.73367 0 0 0 0 O43292 GPAA1_HUMAN "Glycosylphosphatidylinositol anchor attachment 1 protein, GPI anchor attachment protein 1 (GAA1 protein homolog, hGAA1)" GPAA1 GAA1 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; mitochondrion [GO:0005739] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; tubulin binding [GO:0015631]; attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508] tubulin binding [GO:0015631] GO:0005739; GO:0005783; GO:0005789; GO:0005813; GO:0005829; GO:0006508; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003 MGLLSDPVR 4.980000019 0.349418849 0.349418849 0.133638352 1002.584116 18.25293 21.27072 21.60756 20.72875 20.7508 19.65495 20.12867 20.36335 20.08645 16.36798 17.74001 20.27369 19.71354 20.5412 19.96126 18.19598 20.80067 20.99699 18.29231 19.53103 19.06844 21.17759 21.39273 20.73176 20.89864 21.80748 20.4101 17.81061 19.82444 20.16372 22.03033 17.49508 22.15899 21.58164 21.18248 22.34742 21.16976 20.08389 21.11162 20.11309 20.07507 18.57609 21.2501 16.6614 20.7702 19.91181 21.13827 21.55144 O43293 DAPK3_HUMAN "Death-associated protein kinase 3, DAP kinase 3, EC 2.7.11.1 (DAP-like kinase, Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase, ZIP-kinase)" DAPK3 ZIPK Homo sapiens (Human) "apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]" ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0006468; GO:0006915; GO:0006940; GO:0007088; GO:0007346; GO:0008140; GO:0008360; GO:0010506; GO:0016605; GO:0017148; GO:0030335; GO:0031267; GO:0035556; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043519; GO:0043522; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:0106310; GO:2000145; GO:2000249 GALLGTSGLK 2.589999914 1 1 5.75E-13 916.6167375 14.29449 0 0 0 14.88687 13.51054 0 12.88331 0 0 0 0 0 0 0 15.02951 14.12628 0 0 15.30875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43295 SRGP3_HUMAN "SLIT-ROBO Rho GTPase-activating protein 3, srGAP3 (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein, WRP)" SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0051056 ALSEGHSMR 5.809999943 1 1 0 1001.55653 15.34612 0 0 0 0 15.60965 0 0 0 16.29915 0 0 0 13.55688 13.4957 0 0 0 0 0 19.16941 0 0 0 13.3991 0 0 0 16.28107 0 0 15.08225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.55748 0 O43296 ZN264_HUMAN Zinc finger protein 264 ZNF264 KIAA0412 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KSYLTQHQR 7.059999943 0.272238076 0.272238076 0.093214368 1161.465375 16.97189 11.77663 0 0 17.24657 0 14.48871 11.9567 11.19223 16.23432 15.07542 17.20473 15.36204 0 0 0 14.29126 0 0 15.00933 0 15.17839 0 15.37925 0 16.46021 0 9.820282 0 14.16333 16.7302 14.52782 12.55694 16.44681 0 11.62476 16.40795 0 0 15.90272 14.83889 16.60697 15.45569 15.02003 12.09887 16.71725 0 0 O43299 AP5Z1_HUMAN "AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit, Zeta5)" AP5Z1 KIAA0415 SPG48 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005770; GO:0015031; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0044599 LLPPRER 4.949999809 1 1 0.267560746 879.0995743 0 0 13.04974 0 14.69578 15.93789 15.5597 12.15044 0 0 13.44099 0 15.66321 0 0 15.75332 0 13.15115 0 0 0 0 0 0 0 17.15502 0 0 0 0 13.24556 14.91493 0 0 12.67592 0 0 14.95014 13.66434 14.27819 0 14.67928 0 0 0 15.60666 0 0 O43300 LRRT2_HUMAN Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein) LRRTM2 KIAA0416 LRRN2 Homo sapiens (Human) long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808] excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685] excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685]; neurexin family protein binding [GO:0042043]; long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808] neurexin family protein binding [GO:0042043] GO:0002091; GO:0005615; GO:0042043; GO:0050808; GO:0051965; GO:0060076; GO:0060291; GO:0098685; GO:0098686; GO:0098978; GO:0098982; GO:0099060; GO:0099061; GO:0099151 ELILSSNK 28.45000076 0.560273528 0.560273528 0.093451081 902.0706276 16.62375 15.70439 16.07394 16.81268 0 18.10869 0 0 13.84158 13.0147 10.36847 20.08503 0 15.04723 0 11.30311 0 0 0 0 17.28218 16.90098 16.29694 0 17.53584 15.92702 0 0 0 14.37167 13.75623 16.32254 17.41619 11.91261 11.8635 0 0 16.9794 17.04774 0 16.57686 0 17.22099 13.8505 17.97707 14.51178 14.29744 14.55927 O43301 HS12A_HUMAN Heat shock 70 kDa protein 12A HSPA12A KIAA0417 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524] ATP binding [GO:0005524] GO:0005524; GO:0005634; GO:0005737; GO:0070062 ADKEAGGSDGPR 8.039999962 0.801411986 0.801411986 0.304276496 1159.292244 0 13.54697 14.37933 0 0 0 0 0 0 0 0 0 0 14.02738 0 0 0 11.21848 0 0 0 0 0 0 0 15.99559 16.4919 0 0 0 0 15.0668 0 0 0 16.27467 16.86546 0 0 12.14233 15.63609 0 0 0 16.28171 0 0 16.09657 O43304 S14L5_HUMAN SEC14-like protein 5 SEC14L5 KIAA0420 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 STLGPALEAVSMDGDK 2.130000114 0.276589364 0.276589364 0.180170792 1606.221556 0 14.36848 14.87365 0 0 13.84024 0 0 14.03124 0 0 0 0 10.13429 0 15.00919 0 13.52993 0 0 0 17.01826 15.31023 15.3331 0 0 7.037933 12.34538 0 0 16.3727 12.83023 12.96854 14.25443 0 12.82453 15.52296 0 0 0 0 14.09486 13.93894 0 13.44045 0 0 16.1602 O43306 ADCY6_HUMAN "Adenylate cyclase type 6, EC 4.6.1.1 (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)" ADCY6 KIAA0422 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080] GO:0003091; GO:0004016; GO:0005080; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007193; GO:0007212; GO:0010977; GO:0016020; GO:0019901; GO:0031226; GO:0032420; GO:0035556; GO:0035811; GO:0046872; GO:0071380; GO:0071870; GO:0097746; GO:1904117; GO:1904322 LLLSVLPQHVAMEMKEDINTK 9.43999958 1 1 1.38E-12 2445.886894 16.82049 14.48492 0 0 0 15.83586 15.08384 16.71742 14.44298 0 0 0 0 0 13.01979 16.12863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.53851 0 0 0 0 0 0 0 0 0 0 0 O43307 ARHG9_HUMAN Rho guanine nucleotide exchange factor 9 (Collybistin) (PEM-2 homolog) (Rac/Cdc42 guanine nucleotide exchange factor 9) ARHGEF9 ARHDH9 KIAA0424 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; postsynaptic density [GO:0014069]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0014069; GO:0051056 DDDFNVSMKNAFK 7.059999943 1 1 0.441736102 1547.33403 0 0 16.87155 0 0 0 0 17.29569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.16549 19.30237 19.0436 0 0 20.5246 0 0 19.13106 19.65758 0 0 0 0 0 0 0 0 0 O43309 ZSC12_HUMAN Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 305) (Zinc finger protein 96) ZSCAN12 KIAA0426 ZNF305 ZNF96 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 FENDMSK 3.720000029 1 1 0.175075571 870.8097164 13.69757 0 11.30272 0 0 0 16.30284 15.6389 0 0 0 0 0 0 0 15.96495 0 14.00221 0 0 0 0 16.65493 16.35899 15.33569 0 14.82851 15.32136 0 0 16.25493 14.86732 15.79623 0 14.7231 0 16.23605 0 0 0 0 0 0 0 0 0 0 14.8025 O43310 CTIF_HUMAN CBP80/20-dependent translation initiation factor CTIF KIAA0427 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]" cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] "cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]" RNA binding [GO:0003723]; translation activator activity [GO:0008494] GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471 LCDKMALFMVEGTK 4.659999847 1 1 0.22655611 1658.401777 0 0 16.44906 0 0 0 0 15.11773 16.16238 0 0 0 0 0 15.29875 17.66901 0 15.48073 0 0 0 0 0 0 14.26237 14.64353 0 0 0 0 0 0 0 15.99387 0 15.6424 14.87004 14.03424 0 15.76282 13.86802 14.06125 13.86347 0 0 0 0 0 O43314 VIP2_HUMAN "Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, EC 2.7.4.24 (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2, hsVIP2)" PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605] cytosol [GO:0005829] "cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]" "5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]" GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092 LEQLKTVLEMYGHFSGINR 3.109999895 0.47867918 0.47867918 0.214635746 2249.596451 13.87462 13.73974 0 12.73558 13.67628 0 0 0 0 0 0 0 0 0 0 0 10.87386 0 14.08424 0 0 0 14.99227 0 0 14.46139 0 0 0 0 0 0 0 0 13.94451 12.12573 14.57868 13.19307 0 0 13.06094 16.50627 0 0 0 0 0 0 O43315 AQP9_HUMAN "Aquaporin-9, AQP-9 (Aquaglyceroporin-9) (Small solute channel 1)" AQP9 SSC1 Homo sapiens (Human) amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; glycerol transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; glycerol transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] glycerol channel activity [GO:0015254]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] GO:0005345; GO:0005350; GO:0005886; GO:0005887; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015722; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071918 NLGAPR 2.660000086 1 1 0.125597571 626.6105572 14.38596 15.06512 15.74881 0 0 0 0 0 0 0 0 0 0 0 15.26916 0 0 0 0 16.52904 16.88043 0 0 16.69844 0 0 0 0 0 0 0 0 0 0 0 0 17.73796 0 17.53546 0 0 0 0 16.4991 0 0 0 0 O43318 M3K7_HUMAN "Mitogen-activated protein kinase kinase kinase 7, EC 2.7.11.25 (Transforming growth factor-beta-activated kinase 1, TGF-beta-activated kinase 1)" MAP3K7 TAK1 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; anoikis [GO:0043276]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; histone H3 acetylation [GO:0043966]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; p38MAPK cascade [GO:0038066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179] ATAC complex [GO:0140672]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATAC complex [GO:0140672]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; anoikis [GO:0043276]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; histone H3 acetylation [GO:0043966]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; p38MAPK cascade [GO:0038066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] GO:0000165; GO:0000287; GO:0002223; GO:0002726; GO:0002753; GO:0002755; GO:0004672; GO:0004674; GO:0004707; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007179; GO:0007249; GO:0007250; GO:0007252; GO:0007254; GO:0008349; GO:0010008; GO:0016239; GO:0030971; GO:0032743; GO:0038066; GO:0038095; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0043966; GO:0050852; GO:0051092; GO:0051403; GO:0070423; GO:0070498; GO:0097110; GO:0106310; GO:0140672 LVQEHK 10.38000011 0.55259037 0.55259037 0.058590589 754.1426538 0 13.53596 17.0439 14.15106 0 15.4538 12.60518 12.94899 12.90249 15.19285 15.80867 17.01896 15.79395 14.77338 16.65628 14.14119 11.63637 0 14.51254 0 15.39897 15.22197 0 16.2285 16.65862 16.04081 15.2745 15.95973 12.60035 0 15.63672 13.79841 0 15.88714 0 0 16.74842 0 15.80618 11.41227 0 14.5142 14.38088 0 17.42865 16.7865 17.08179 16.31021 O43323 DHH_HUMAN "Desert hedgehog protein, DHH (HHG-3) [Cleaved into: Desert hedgehog protein N-product; Desert hedgehog protein C-product ]" DHH Homo sapiens (Human) cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270] GO:0001649; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0007286; GO:0008233; GO:0008270; GO:0010468; GO:0016540; GO:0030238; GO:0032355; GO:0033327; GO:0042552; GO:0043627; GO:0050810 VARGSER 5.409999847 1 1 0.113475551 772.0860283 14.35355 14.15082 16.24137 0 0 13.50766 16.09686 13.01793 10.77884 0 0 0 14.34428 0 0 0 0 0 0 0 12.85251 0 0 0 0 0 0 13.56611 0 0 0 0 0 0 15.95913 0 0 0 0 0 0 0 0 0 14.94415 0 0 0 O43324 MCA3_HUMAN Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18) EEF1E1 AIMP3 P18 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]" aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]" GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0008285; GO:0017101; GO:0043065; GO:0043517; GO:1990830; GO:2000774; GO:2001235 AAAAELSLLEKSLGLSK 3.789999962 1 1 2.41E-13 1700.280177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43353 RIPK2_HUMAN "Receptor-interacting serine/threonine-protein kinase 2, EC 2.7.11.1 (CARD-containing interleukin-1 beta-converting enzyme-associated kinase, CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2, RIP-2) (Tyrosine-protein kinase RIPK2, EC 2.7.10.2)" RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation [GO:0033091]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; response to exogenous dsRNA [GO:0043330]; response to interleukin-1 [GO:0070555]; response to interleukin-12 [GO:0070671]; response to interleukin-18 [GO:0070673]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; LIM domain binding [GO:0030274]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity [GO:0097202]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation [GO:0033091]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; response to exogenous dsRNA [GO:0043330]; response to interleukin-1 [GO:0070555]; response to interleukin-12 [GO:0070671]; response to interleukin-18 [GO:0070673]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142] ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; LIM domain binding [GO:0030274]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102] GO:0001961; GO:0002250; GO:0002827; GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006915; GO:0006954; GO:0007165; GO:0007249; GO:0010800; GO:0010942; GO:0030274; GO:0031398; GO:0031663; GO:0031982; GO:0032092; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032735; GO:0032743; GO:0032755; GO:0032760; GO:0032991; GO:0033091; GO:0033138; GO:0034134; GO:0034142; GO:0042098; GO:0042802; GO:0042803; GO:0043065; GO:0043123; GO:0043330; GO:0045087; GO:0045627; GO:0045944; GO:0046330; GO:0046641; GO:0050700; GO:0050731; GO:0050830; GO:0050852; GO:0051092; GO:0070374; GO:0070427; GO:0070431; GO:0070555; GO:0070671; GO:0070673; GO:0071223; GO:0071224; GO:0071225; GO:0089720; GO:0097202; GO:0106310; GO:1904417 MISLIESGWAQNPDERPSFLK 3.579999924 1 1 0.188401847 2433.76513 0 0 0 15.47941 0 0 13.84332 0 0 0 0 0 0 15.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43361 ZN749_HUMAN Zinc finger protein 749 ZNF749 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 FFLDSYK 1.940000057 1 1 0.160215389 919.5298944 13.75977 15.7069 11.77836 0 0 0 0 14.23256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95975 0 0 0 0 0 0 0 0 0 0 14.65647 15.25001 0 15.84064 0 13.62415 0 15.75951 16.75384 0 12.52293 0 0 0 0 O43374 RASL2_HUMAN Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2) RASA4 CAPRI GAPL KIAA0538 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046580; GO:0046872; GO:0071277 FFSPAIMSPK 2.839999914 1 1 0.089314525 1140.147137 17.72078 14.33851 16.74551 0 0 13.96816 0 16.76007 14.63013 17.72182 17.09361 17.40055 11.69083 17.37738 0 0 11.49245 15.54012 0 15.40409 0 16.39508 17.61652 0 17.00144 0 0 13.57748 16.80382 18.24316 0 16.37763 0 15.22887 15.95517 0 17.01688 0 14.98632 0 0 14.75848 15.47054 13.54996 0 17.29334 16.22447 0 O43379 WDR62_HUMAN WD repeat-containing protein 62 WDR62 C19orf14 Homo sapiens (Human) centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; regulation of centrosome cycle [GO:0046605]; regulation of neuron differentiation [GO:0045664] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; regulation of centrosome cycle [GO:0046605]; regulation of neuron differentiation [GO:0045664] GO:0000922; GO:0002052; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007099; GO:0021987; GO:0022008; GO:0034451; GO:0045664; GO:0046605; GO:2001224 GSENGTPMDVK 7.710000038 1 1 0.062119933 1148.521465 0 0 19.00346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43390 HNRPR_HUMAN "Heterogeneous nuclear ribonucleoprotein R, hnRNP R" HNRNPR HNRPR Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0071013; GO:1990904 AMDEMNGK 2.910000086 0.189487889 0.189487889 0.226689839 893.9756294 17.53418 0 0 18.86359 0 0 17.91515 0 0 0 0 0 17.97813 0 0 0 17.1017 16.11665 0 16.84552 0 0 0 17.87862 0 0 0 0 0 0 0 17.28425 0 0 0 0 17.85674 0 0 17.18675 0 16.72569 0 0 0 0 17.45153 0 O43395 PRPF3_HUMAN "U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3, hPrp3) (U4/U6 snRNP 90 kDa protein)" PRPF3 HPRP3 PRP3 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0042802; GO:0046540; GO:0071005 EVFGDDSEISKESSGVK 5.809999943 1 1 0.302609115 1812.281014 0 0 0 0 15.19239 15.59358 0 0 0 0 0 14.28088 0 0 0 16.53739 0 0 0 0 0 0 0 0 0 0 0 0 15.04116 0 0 0 0 0 0 0 0 0 0 0 13.54373 13.57573 0 0 0 0 0 15.24194 O43405 COCH_HUMAN Cochlin (COCH-5B2) COCH COCH5B2 UNQ257/PRO294 Homo sapiens (Human) defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; collagen binding [GO:0005518]; defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605] collagen binding [GO:0005518] GO:0005518; GO:0005576; GO:0007605; GO:0008360; GO:0042742; GO:0045089; GO:0062023 GGNSNTGKALK 8.420000076 0.509843767 0.509843767 0.174470165 1045.731459 15.70554 16.08095 14.99634 0 15.63339 16.21146 0 0 0 0 0 14.93519 0 0 0 0 0 0 15.17583 15.94562 0 0 0 0 0 0 15.51169 14.64747 0 0 14.55503 0 0 0 15.186 13.64054 0 0 16.93161 14.7374 14.1005 15.17469 10.45848 15.72363 14.1818 0 16.7676 16.08975 O43432 IF4G3_HUMAN "Eukaryotic translation initiation factor 4 gamma 3, eIF-4-gamma 3, eIF-4G 3, eIF4G 3 (eIF-4-gamma II, eIF4GII)" EIF4G3 Homo sapiens (Human) regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281] "cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" "mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0008135; GO:0016281 EDVHLK 6.75 1 1 0.307276148 740.1298239 0 0 0 0 0 0 0 0 19.25898 0 0 0 0 16.21784 16.88195 16.97383 0 18.84251 0 19.39536 16.24288 0 17.70071 15.97441 0 0 0 0 0 0 0 0 0 0 19.05836 0 0 18.3603 0 17.73836 16.74288 0 19.36672 0 0 0 0 18.67756 O43439 MTG8R_HUMAN Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85) CBFA2T2 EHT MTGR1 Homo sapiens (Human) "intestinal epithelial cell differentiation [GO:0060575]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron projection development [GO:0010976]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron projection development [GO:0010976]; transcription, DNA-templated [GO:0006351]" metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0005634; GO:0006351; GO:0010976; GO:0010977; GO:0045746; GO:0045892; GO:0046872; GO:0060575 KTGTELVSR 3.319999933 1 1 0.01398252 987.7677825 18.18032 0 13.22972 0 0 14.12597 14.74979 0 14.73609 15.12789 14.48177 0 14.55486 0 0 0 0 14.79576 0 0 0 0 0 13.96218 0 0 0 0 0 0 0 0 0 0 0 16.7381 0 0 0 0 0 0 0 0 14.6966 0 15.24536 16.31724 O43448 KCAB3_HUMAN Voltage-gated potassium channel subunit beta-3 (K(+) channel subunit beta-3) (Kv-beta-3) KCNAB3 KCNA3B Homo sapiens (Human) potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] GO:0004033; GO:0005249; GO:0005737; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0044325; GO:1901379 ESTGRGTGMK 6.96999979 1 1 0.105146634 1038.845301 0 14.47272 0 12.97757 15.25991 15.59932 0 0 15.02752 0 0 0 0 0 0 0 14.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7971 0 15.8834 0 0 0 0 0 16.22038 O43451 MGA_HUMAN "Maltase-glucoamylase (Alpha-1,4-glucosidase, EC 3.2.1.20)" MGAM MGA MGAML Homo sapiens (Human) dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] "apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983]" "alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]" GO:0000025; GO:0003824; GO:0004339; GO:0004553; GO:0004558; GO:0005886; GO:0005983; GO:0016021; GO:0016324; GO:0030246; GO:0032450; GO:0070062; GO:0070821; GO:0101003; GO:1901027 RQDPVSWDVAFVNISR 3.019999981 1 1 0.239306957 1888.301139 0 0 13.55277 12.25347 0 0 0 0 0 0 15.21695 0 14.68147 0 14.74063 0 0 0 0 0 0 0 0 0 0 13.54939 0 0 15.45439 0 0 0 0 0 17.16686 0 14.43144 16.4907 16.26851 14.34995 0 0 0 13.63832 15.33014 0 0 13.9533 O43474 KLF4_HUMAN Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor) KLF4 EZF GKLF Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]" "beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001010; GO:0001228; GO:0002357; GO:0003700; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006357; GO:0007500; GO:0008013; GO:0008270; GO:0008285; GO:0009913; GO:0010628; GO:0010629; GO:0015630; GO:0016525; GO:0019827; GO:0031077; GO:0032088; GO:0032270; GO:0032526; GO:0032717; GO:0034115; GO:0035166; GO:0043154; GO:0045429; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046985; GO:0048679; GO:0048730; GO:0050728; GO:0051247; GO:0051973; GO:0060070; GO:0060761; GO:0061629; GO:0071363; GO:0071499; GO:0090051; GO:0120222; GO:1902895; GO:1903672; GO:1904798; GO:1904998; GO:1990830; GO:1990837; GO:1990841; GO:2000134; GO:2000342 EELSHMK 9.090000153 0.615238547 0.615238547 0.188300882 886.5806855 0 16.3984 15.32354 0 16.01153 0 12.90257 0 0 0 0 0 14.89463 13.81787 0 12.82414 0 14.64256 0 0 0 15.31341 0 15.66037 15.53913 0 0 0 15.05928 0 13.68746 13.8492 12.13611 0 0 0 0 0 14.6891 0 0 0 0 16.61148 16.84556 0 0 0 O43482 MS18B_HUMAN "Protein Mis18-beta (Cancer/testis antigen 86, CT86) (Opa-interacting protein 5, OIP-5)" OIP5 MIS18B Homo sapiens (Human) cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059] "Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]" identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0007049; GO:0007059; GO:0007154; GO:0010369; GO:0015030; GO:0016607; GO:0034080; GO:0042802; GO:0043231; GO:0046872; GO:0051301 SLGAVVFSR 4.130000114 0.648678958 0.648678958 0.198136548 936.7148433 17.03872 16.78867 14.48546 0 0 0 0 15.46214 15.44256 0 16.61874 0 0 15.5626 0 14.99711 0 16.40187 15.89422 15.39092 0 0 0 17.18865 16.74437 0 0 15.1843 16.79996 16.46474 16.5741 16.22759 14.79327 15.39781 15.16852 15.49989 15.33451 15.1262 16.7016 14.51889 15.61566 15.25298 15.03134 15.47668 13.12193 15.79973 0 0 O43491 E41L2_HUMAN "Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1, 4.1G)" EPB41L2 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198] GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007049; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778 GDAEEMAQKK 2.269999981 1 1 0.095727326 1122.97467 0 0 13.00041 9.739493 0 13.71994 0 0 0 7.567513 14.59608 14.90706 0 0 0 0 15.18366 14.96883 14.4831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.24922 14.72495 0 0 0 15.51774 16.70252 0 0 0 0 0 O43493 TGON2_HUMAN "Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46, TGN38 homolog, hTGN46) (Trans-Golgi network glycoprotein 48, hTGN48) (Trans-Golgi network glycoprotein 51, hTGN51) (Trans-Golgi network protein 2)" TGOLN2 TGN46 TGN51 Homo sapiens (Human) clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] GO:0005654; GO:0005768; GO:0005788; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0030133; GO:0030140; GO:0030669 DGSNK 5.75 0.984853864 0.984853864 0.141056055 519.1722332 0 15.76082 16.78333 0 15.89648 0 15.13089 0 16.39194 0 16.2205 16.87377 14.68895 0 0 0 16.83316 0 0 0 0 0 0 0 0 16.80953 16.29868 0 15.46523 16.3495 14.58155 14.21235 0 15.43374 16.63578 0 16.40172 0 0 0 15.73415 0 0 0 17.82989 15.99168 0 0 O43497 CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1) CACNA1G KIAA1123 Homo sapiens (Human) AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; sinoatrial node development [GO:0003163] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; voltage-gated sodium channel activity [GO:0005248]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; sinoatrial node development [GO:0003163] low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0003163; GO:0005248; GO:0005737; GO:0005886; GO:0005891; GO:0007268; GO:0008332; GO:0010045; GO:0019228; GO:0034765; GO:0042391; GO:0043005; GO:0045202; GO:0045956; GO:0060371; GO:0070509; GO:0070588; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091; GO:0097110 DPLASGPPDSMAASPSPKK 8.529999733 1 1 0.127540982 1869.37336 0 14.56829 10.11247 0 15.07613 0 12.29311 15.7609 13.58297 0 15.14386 15.6763 0 0 0 14.04909 14.44954 14.57672 14.66674 0 14.80722 0 0 15.10332 0 15.30925 0 15.06347 13.64647 0 16.44767 13.28425 0 13.29845 11.60527 15.21036 14.11413 16.03647 0 15.03993 0 15.2657 0 11.30381 0 0 0 0 O43506 ADA20_HUMAN "Disintegrin and metalloproteinase domain-containing protein 20, ADAM 20, EC 3.4.24.-" ADAM20 Homo sapiens (Human) male gonad development [GO:0008584]; single fertilization [GO:0007338] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; single fertilization [GO:0007338] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004222; GO:0005886; GO:0007338; GO:0008237; GO:0008584; GO:0009897; GO:0016021; GO:0046872; GO:1990913 NNMEGLNVMGK 6.989999771 0.445103437 0.445103437 0.147465839 1238.218361 11.52253 0 14.61371 0 13.9029 12.65489 0 0 0 14.31536 13.0883 0 17.62201 14.33623 0 0 0 0 17.13858 17.3556 0 12.63511 17.70138 18.52125 0 19.02509 0 14.76426 0 16.56131 0 0 16.54133 16.80179 18.38108 0 17.30192 18.14118 15.86815 0 14.95051 17.75931 18.1471 0 16.09219 16.9364 0 16.94476 O43511 S26A4_HUMAN Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4) SLC26A4 PDS Homo sapiens (Human) inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272] anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] GO:0005886; GO:0005887; GO:0006811; GO:0006885; GO:0007605; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015111; GO:0015116; GO:0015301; GO:0015698; GO:0016021; GO:0016324; GO:0019531; GO:0031526; GO:0032880; GO:0070062 STKNYK 4.28000021 1 1 3.45E-13 741.0128851 10.51452 16.19779 0 0 0 0 14.68788 15.99102 13.20739 14.23024 13.55799 0 14.5931 14.93361 14.72432 0 0 0 0 0 0 0 0 0 15.62073 13.60327 0 0 0 14.07716 0 15.02544 0 0 0 0 0 0 0 0 0 0 16.6221 0 0 0 0 0 O43520 AT8B1_HUMAN "Phospholipid-transporting ATPase IC, EC 7.6.2.1 (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1)" ATP8B1 ATPIC FIC1 PFIC Homo sapiens (Human) "apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855]" apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006855; GO:0007030; GO:0007605; GO:0008206; GO:0015721; GO:0016324; GO:0016604; GO:0016887; GO:0021650; GO:0032420; GO:0032534; GO:0034220; GO:0045176; GO:0045332; GO:0045892; GO:0060119; GO:0090554; GO:0090556; GO:0140326; GO:0140345; GO:0140346; GO:1901612; GO:1903729; GO:1990531; GO:2001225 RGVSTR 7.980000019 1 1 0.203605115 672.5137481 0 0 0 0 0 0 0 0 0 0 19.78334 0 0 0 0 0 0 0 19.18944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.26756 0 0 0 0 0 0 0 0 19.95172 O43525 KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3) KCNQ3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; membrane hyperpolarization [GO:0060081]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] axon initial segment [GO:0043194]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] axon initial segment [GO:0043194]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; membrane hyperpolarization [GO:0060081]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0009986; GO:0016021; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0060081; GO:0071805 DEGQRR 4.400000095 1 1 6.91E-13 759.7326008 9.399611 14.84465 0 12.92709 0 14.10352 13.49276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43526 KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2) KCNQ2 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0071805 DPPPEPSPSKGSPCR 2.50999999 1 1 0.159208969 1607.197717 15.41797 12.91316 13.9165 15.84353 13.8451 0 0 15.31834 12.21897 0 15.4433 0 0 0 0 0 15.45423 14.7923 0 0 0 0 17.95432 0 14.32123 15.01976 0 0 0 0 13.08263 13.77883 14.62951 0 13.42262 0 0 17.81685 0 0 0 0 0 0 16.21626 0 0 0 O43541 SMAD6_HUMAN "Mothers against decapentaplegic homolog 6, MAD homolog 6, Mothers against DPP homolog 6 (SMAD family member 6, SMAD 6, Smad6, hSMAD6)" SMAD6 MADH6 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352] chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625] GO:0000785; GO:0000976; GO:0001657; GO:0003148; GO:0003180; GO:0003183; GO:0003184; GO:0003281; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0007179; GO:0007352; GO:0008285; GO:0009653; GO:0010991; GO:0016604; GO:0030154; GO:0030279; GO:0030509; GO:0030512; GO:0030514; GO:0031589; GO:0031625; GO:0032496; GO:0032991; GO:0034616; GO:0034713; GO:0035904; GO:0042802; GO:0043066; GO:0043627; GO:0045444; GO:0045668; GO:0046872; GO:0060394; GO:0060395; GO:0060976; GO:0070410; GO:0070411; GO:0070412; GO:0070698; GO:0071144; GO:0140416; GO:1902895 SRVVPDR 7.170000076 1 1 5.73E-13 829.3533434 14.19698 13.17544 13.05238 12.88123 13.49196 12.73568 15.86128 14.54033 16.2899 14.679 15.53139 16.19193 0 0 15.58407 0 14.37081 13.60194 0 13.73199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43543 XRCC2_HUMAN DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2) XRCC2 Homo sapiens (Human) centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148]" "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]" GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0008094; GO:0010165; GO:0010332; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:2000269 LVNDYR 10.60000038 0.452554345 0.452554345 0.149075952 778.5647762 0 0 0 0 0 0 0 0 15.81284 16.22133 0 15.45572 0 16.77288 15.90839 16.37576 14.85854 16.67614 16.78732 17.83407 0 14.26119 16.93975 0 16.03938 16.04826 16.06321 0 14.21819 15.67009 12.84926 13.81692 17.1384 16.54808 16.3719 15.09365 15.57459 16.96749 15.88608 14.90227 16.70519 17.55615 14.38346 15.44715 16.06044 16.59012 16.5981 15.29482 O43556 SGCE_HUMAN "Epsilon-sarcoglycan, Epsilon-SG" SGCE ESG UNQ433/PRO840 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517] cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517] GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0007160; GO:0007517; GO:0016010; GO:0016012; GO:0032590; GO:0042383 EGVYVMVGADVPFSSCLR 2.440000057 1 1 0.122795023 2002.045921 0 16.8326 0 0 0 0 0 0 13.88974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88102 0 0 0 0 0 0 0 16.41735 0 0 0 0 0 0 0 0 14.43823 0 0 0 0 0 0 0 O43566 RGS14_HUMAN "Regulator of G-protein signaling 14, RGS14" RGS14 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070] centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070] G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159] GO:0000278; GO:0000922; GO:0001965; GO:0003924; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005886; GO:0006913; GO:0006979; GO:0007051; GO:0007059; GO:0007186; GO:0007612; GO:0007616; GO:0008017; GO:0008277; GO:0008542; GO:0010070; GO:0014069; GO:0016604; GO:0016605; GO:0019901; GO:0030159; GO:0030425; GO:0031914; GO:0032794; GO:0035556; GO:0043197; GO:0043407; GO:0043547; GO:0043620; GO:0045744; GO:0048008; GO:0050769; GO:0051301; GO:0060291; GO:0070373; GO:0098978 EPGSSR 10.43999958 1 1 0.230366347 632.7140715 0 0 0 0 0 0 17.23192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43572 AKA10_HUMAN "A-kinase anchor protein 10, mitochondrial, AKAP-10 (Dual specificity A kinase-anchoring protein 2, D-AKAP-2) (Protein kinase A-anchoring protein 10, PRKA10)" AKAP10 Homo sapiens (Human) protein localization [GO:0008104]; signal transduction [GO:0007165] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase A binding [GO:0051018]; protein localization [GO:0008104]; signal transduction [GO:0007165] protein kinase A binding [GO:0051018] GO:0005739; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0032991; GO:0051018 MRGAGPSPR 4.929999828 1 1 0.075282244 943.4601275 16.02644 0 0 0 0 0 0 14.28841 14.40173 14.15529 0 0 0 0 0 0 0 0 0 0 16.16434 0 12.25083 0 17.79779 0 0 9.834078 0 0 0 16.37372 0 0 13.98802 0 0 0 0 0 0 0 0 0 0 0 0 0 O43581 SYT7_HUMAN "Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII, SytVII)" SYT7 PCANAP7 Homo sapiens (Human) calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] cell projection [GO:0042995]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] "cell projection [GO:0042995]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]" "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042995; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0099056; GO:1990926; GO:1990927 MYRDPEAASPGAPSR 6.710000038 1 1 0.474763716 1620.593987 13.63012 0 0 16.81531 0 15.0532 0 0 0 15.93204 15.63457 0 0 0 0 0 0 0 0 15.70985 0 0 0 0 0 0 16.1026 0 0 15.6322 0 15.90511 16.31437 0 0 0 15.90172 0 0 0 15.25281 0 15.33502 0 0 0 0 16.66991 O43583 DENR_HUMAN "Density-regulated protein, DRP (Protein DRP1) (Smooth muscle cell-associated protein 3, SMAP-3)" DENR DRP1 H14 Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743] GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0032790; GO:0075522 LTVENSPK 19.57999992 1 1 0.0347395 887.6613884 15.26298 15.80224 14.83686 0 15.33896 14.68073 15.13165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.58005 0 0 0 0 0 0 0 0 0 15.76099 14.27789 0 0 0 0 0 14.16365 0 0 15.18673 0 0 0 O43586 PPIP1_HUMAN "Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)" PSTPIP1 CD2BP1 Homo sapiens (Human) actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165] actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931] actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165] actin filament binding [GO:0051015]; identical protein binding [GO:0042802] GO:0001931; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0030041; GO:0032154; GO:0042802; GO:0045087; GO:0048471; GO:0051015 ISANGHQKQVEK 9.329999924 1 1 0.233387477 1337.898766 15.12219 12.23116 15.14882 0 14.78305 0 0 0 0 0 0 11.02356 0 0 0 0 0 0 15.68137 0 15.48345 0 0 0 0 16.75913 15.02224 14.24553 14.06454 14.77127 0 0 16.938 14.36816 16.26421 15.45364 11.70295 0 0 14.85868 0 0 15.09943 12.70808 15.85661 0 0 0 O43592 XPOT_HUMAN Exportin-T (Exportin(tRNA)) (tRNA exportin) XPOT Homo sapiens (Human) intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]; intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528] small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528 TYSDDHVK 10.35000038 0.482737303 0.482737303 0.260012619 965.3155894 0 12.2953 14.64454 0 13.16888 12.97119 14.42924 12.58546 9.607173 13.98454 13.62369 12.97457 14.97588 10.37961 14.17113 15.35649 0 16.77058 0 0 0 0 0 15.61421 0 16.08657 13.95186 0 0 0 0 0 13.9842 0 0 0 0 0 0 0 0 14.78267 14.9954 0 0 0 15.33005 0 O43593 HAIR_HUMAN "Lysine-specific demethylase hairless, EC 1.14.11.65 ([histone H3]-dimethyl-L-lysine(9) demethylase hairless)" HR Homo sapiens (Human) histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0140683 AGPGLR 9.130000114 1 1 0.29456799 571.1489046 19.93326 0 0 0 0 0 20.28047 19.89564 17.91097 19.18279 0 0 0 0 0 0 0 0 0 0 17.85825 0 0 0 0 0 0 0 0 16.63855 0 18.09519 0 0 0 0 0 0 0 0 0 0 0 0 17.74084 0 0 18.38439 O43602 DCX_HUMAN "Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X, Lis-X)" DCX DBCN LISX Homo sapiens (Human) axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041] axoneme [GO:0005930]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005] axoneme [GO:0005930]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041] microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0005930; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0042461; GO:0043005; GO:0060041 GNPSATAGPKASPTPQK 3.700000048 1 1 0.161330856 1607.547792 14.35087 0 0 14.23698 0 13.42505 15.38132 0 0 15.12665 13.23539 12.04555 0 0 0 12.18545 0 0 0 0 0 0 0 0 0 0 0 12.56407 0 0 0 0 0 0 0 0 17.93676 15.9216 0 0 0 0 0 0 0 0 0 0 O43612 OREX_HUMAN "Orexin (Hypocretin, Hcrt) [Cleaved into: Orexin-A (Hypocretin-1, Hcrt1); Orexin-B (Hypocretin-2, Hcrt2) ]" HCRT OX PPORX PPOX Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659] extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021] extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659] neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772] GO:0001659; GO:0005184; GO:0005576; GO:0005791; GO:0007200; GO:0007204; GO:0007205; GO:0007218; GO:0007268; GO:0008021; GO:0008156; GO:0030141; GO:0030431; GO:0031771; GO:0031772; GO:0042594; GO:0042755; GO:0043267; GO:0046928; GO:0048471; GO:0051928; GO:0051970; GO:0051971; GO:0060079; GO:0098794; GO:0120162 RSGPPGLQGR 6.739999771 1 1 0.259440423 1025.739173 13.55964 15.85935 14.75692 0 13.90562 14.80456 12.43056 14.75383 0 15.38311 0 16.46739 0 13.23246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.52866 0 16.54594 0 0 0 0 0 0 0 0 0 0 0 O43615 TIM44_HUMAN Mitochondrial import inner membrane translocase subunit TIM44 TIMM44 MIMT44 TIM44 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] ATP binding [GO:0005524]; chaperone binding [GO:0051087] GO:0001650; GO:0005524; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0006626; GO:0006886; GO:0030150; GO:0051087 QELAKNK 8.369999886 1 1 0.031203162 831.2185433 15.41744 0 15.34326 0 0 14.46327 0 14.67012 0 0 0 0 14.48361 0 14.38122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43660 PLRG1_HUMAN Pleiotropic regulator 1 PLRG1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]" catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]" GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:1900087 MVEEVQK 13.35000038 1 1 0.239810056 879.2736047 15.7889 16.33481 14.66763 16.10019 14.22744 14.1142 14.60601 0 14.35164 14.69936 14.2265 13.98705 15.43825 13.59309 0 0 14.48235 0 0 0 15.24201 0 15.23228 15.52322 15.58165 14.33094 15.48485 15.20219 0 0 13.5252 0 16.78729 0 14.46404 0 0 17.25365 17.55882 16.11183 0 16.01565 0 14.49436 0 15.40236 15.43806 15.54036 O43663 PRC1_HUMAN Protein regulator of cytokinesis 1 PRC1 Homo sapiens (Human) cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] GO:0000022; GO:0000226; GO:0000922; GO:0001578; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023 ELWDR 5.429999828 1 1 0.12295942 718.2810203 0 0 15.24594 0 0 12.78396 12.74424 0 0 0 0 13.58067 0 16.64998 0 0 0 0 0 15.11074 16.23013 0 0 0 16.88216 0 0 0 0 15.08048 0 16.49923 15.08403 13.07125 0 0 0 0 0 15.28959 0 14.47337 0 0 0 0 0 0 O43665 RGS10_HUMAN "Regulator of G-protein signaling 10, RGS10" RGS10 Homo sapiens (Human) G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GO:0001965; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0007213; GO:0008277; GO:0009968; GO:0043547; GO:0045202 AKEIYMTFLSSK 18.47999954 1 1 0.234658376 1434.002174 0 0 0 0 0 0 21.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43670 ZN207_HUMAN "BUB3-interacting and GLEBS motif-containing protein ZNF207, BuGZ, hBuGZ (Zinc finger protein 207)" ZNF207 BUGZ Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983] DNA binding [GO:0003677]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA binding [GO:0003723] GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047 LIHPDEDISLEERR 3.769999981 1 1 0.466503176 1720.464759 18.77962 19.68698 16.9282 0 18.55889 0 17.7321 0 0 0 0 0 0 16.58651 0 0 0 0 0 16.37384 0 0 0 0 0 0 0 18.39087 0 0 0 0 0 0 0 18.62729 0 0 0 0 0 0 0 0 0 0 0 0 O43674 NDUB5_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH, CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)" NDUFB5 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" NADH dehydrogenase (ubiquinone) activity [GO:0008137] GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 ATPDN 1.970000029 1 1 0.023587874 516.2956423 15.07592 14.79257 15.14365 13.97571 14.99534 0 14.39233 0 14.46272 15.88669 0 13.61199 0 15.46542 15.15793 0 0 15.37998 0 16.75373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43678 NDUA2_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8, CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit)" NDUFA2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" NADH dehydrogenase (ubiquinone) activity [GO:0008137] GO:0001835; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776 MAAAAASR 2.400000095 1 1 0.252608389 749.096401 16.27197 15.27644 14.87947 15.13073 15.90474 15.04937 0 16.1595 15.31376 15.02157 14.48252 0 14.23354 15.61362 0 16.00087 15.25235 14.79948 15.42783 15.85784 15.62981 15.29647 15.30779 14.87395 16.7478 0 16.73069 15.79003 0 0 0 15.93653 15.44868 16.09114 15.65822 0 16.3364 0 15.71076 0 0 16.0428 14.74444 15.62738 15.03481 14.37518 15.87192 15.30022 O43681 GET3_HUMAN "ATPase GET3, EC 3.6.-.- (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)" GET3 ARSA ASNA1 TRC40 Homo sapiens (Human) posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872] GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0006620; GO:0015105; GO:0016887; GO:0043529; GO:0045048; GO:0046872; GO:0070062; GO:0071816 LPLLPHEVR 6.260000229 0.121034898 0.121034898 0.094905354 1074.161333 0 12.99607 14.43421 11.14042 14.38557 14.58475 17.36693 0 0 17.55083 14.299 13.94924 0 0 0 17.46437 14.56044 0 16.1258 13.46088 8.496955 0 17.85722 12.71633 0 0 0 0 0 15.84811 16.85827 15.69555 0 0 13.39723 0 14.57083 0 14.91777 16.02111 0 0 0 0 14.35501 15.6046 0 17.76896 O43683 BUB1_HUMAN "Mitotic checkpoint serine/threonine-protein kinase BUB1, hBUB1, EC 2.7.11.1 (BUB1A)" BUB1 BUB1L Homo sapiens (Human) "apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]" ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000776; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007063; GO:0007094; GO:0008283; GO:0016020; GO:0043231; GO:0051301; GO:0051754; GO:0051983; GO:0106310 ESNMER 1.919999957 0.95574218 0.95574218 0.191110174 764.5859854 0 0 0 14.97826 0 0 14.51091 14.28504 16.50333 0 15.53323 0 0 0 14.36929 0 0 0 15.90453 0 15.88176 15.80243 0 0 16.24696 0 15.13498 15.90949 16.38145 15.66694 0 16.31989 16.27239 17.09515 16.93368 0 0 16.00452 15.59942 17.59213 15.15209 16.08491 0 15.57392 16.39655 15.82409 16.00289 15.49445 O43699 SIGL6_HUMAN "Sialic acid-binding Ig-like lectin 6, Siglec-6 (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1, OB-BP1) (CD antigen CD327)" SIGLEC6 CD33L CD33L1 OBBP1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267] carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0016020; GO:0030246; GO:0033691 AAQPVQNTDDVNPVMVSGSR 1.75999999 1 1 0.176792861 2085.884779 0 15.33999 0 0 0 13.70423 13.51879 0 15.31705 0 15.13332 14.73169 0 0 15.25981 0 0 0 0 0 0 0 0 0 14.31629 14.54435 0 0 0 12.82429 0 0 0 0 0 0 14.00887 0 0 0 0 0 13.67139 0 0 0 0 0 O43708 MAAI_HUMAN "Maleylacetoacetate isomerase, MAAI, EC 5.2.1.2 (GSTZ1-1) (Glutathione S-transferase zeta 1, EC 2.5.1.18)" GSTZ1 MAAI Homo sapiens (Human) glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803] GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005829; GO:0006559; GO:0006572; GO:0006749; GO:0016034; GO:0042802; GO:0042803 LLPQDPK 9.68999958 1 1 0.252069332 807.0407794 17.3201 17.18237 16.89688 19.56549 7.418602 16.49338 13.21715 16.17169 16.12848 16.7362 14.24896 14.51323 13.67541 14.89688 15.20047 15.48112 16.8606 14.07115 0 14.39018 16.45779 17.10646 14.5052 0 16.35653 0 0 0 16.46657 15.57635 17.50694 15.52774 17.09216 16.61894 18.00121 0 0 0 0 16.53523 0 17.06675 0 0 15.39717 16.61809 16.67137 16.51484 O43709 BUD23_HUMAN "Probable 18S rRNA (guanine-N(7))-methyltransferase, EC 2.1.1.- (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)" BUD23 MERM1 WBSCR22 HUSSY-03 PP3381 Homo sapiens (Human) chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476] methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435] GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234 MASRGR 3.569999933 1 1 0.277390974 692.839526 0 0 15.93298 0 16.33482 0 0 0 0 0 0 0 0 0 16.82783 17.11085 16.77365 15.03184 16.13738 17.71267 17.0235 15.79024 16.31507 0 0 0 15.74033 16.79233 0 0 0 0 0 0 0 0 0 17.83688 17.79201 17.58083 15.87263 16.9611 17.505 16.78896 16.16827 17.60799 16.94173 18.04252 O43716 GATC_HUMAN "Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial, Glu-AdT subunit C, EC 6.3.5.- (Protein 15E1.2)" GATC 15E1.2 Homo sapiens (Human) glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450] ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567] GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681 APLGGR 14.82999992 1 1 0.289839041 569.99029 17.74956 0 0 0 18.64135 0 0 0 0 0 0 0 17.13118 0 0 0 0 0 0 0 0 0 17.14826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.87115 0 0 O43719 HTSF1_HUMAN "HIV Tat-specific factor 1, Tat-SF1" HTATSF1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0006357; GO:0019079; GO:0032784 ESEEGCPK 11.76000023 1 1 0.17661347 936.4197072 15.58771 0 0 0 0 0 0 0 0 0 11.5025 0 15.07879 0 0 0 0 14.84014 0 0 0 0 0 0 14.80994 0 0 14.26202 0 0 0 15.28999 0 11.60004 0 0 0 0 0 0 0 0 0 0 15.24921 0 0 0 O43734 CIKS_HUMAN "E3 ubiquitin ligase TRAF3IP2, EC 2.3.2.27 (Adapter protein CIKS) (Connection to IKK and SAPK/JNK) (E3 ubiquitin-protein ligase CIKS) (Nuclear factor NF-kappa-B activator 1, ACT1) (TRAF3-interacting protein 2)" TRAF3IP2 C6orf2 C6orf4 C6orf5 C6orf6 Homo sapiens (Human) B cell affinity maturation [GO:0002344]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; CD40 signaling pathway [GO:0023035]; eosinophil homeostasis [GO:1990959]; eosinophil mediated immunity [GO:0002447]; establishment of T cell polarity [GO:0001768]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; leukocyte activation involved in inflammatory response [GO:0002269]; lymph node development [GO:0048535]; mRNA stabilization [GO:0048255]; mucus secretion [GO:0070254]; neutrophil activation [GO:0042119]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein import into nucleus [GO:0006606]; protein K63-linked ubiquitination [GO:0070534]; protein localization to P-body [GO:0110012]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; skin development [GO:0043588]; spleen development [GO:0048536]; T cell differentiation [GO:0030217]; T-helper 17 type immune response [GO:0072538]; transitional two stage B cell differentiation [GO:0002334]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type 2 immune response [GO:0042092] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; B cell affinity maturation [GO:0002344]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; CD40 signaling pathway [GO:0023035]; eosinophil homeostasis [GO:1990959]; eosinophil mediated immunity [GO:0002447]; establishment of T cell polarity [GO:0001768]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; leukocyte activation involved in inflammatory response [GO:0002269]; lymph node development [GO:0048535]; mRNA stabilization [GO:0048255]; mucus secretion [GO:0070254]; neutrophil activation [GO:0042119]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein import into nucleus [GO:0006606]; protein K63-linked ubiquitination [GO:0070534]; protein localization to P-body [GO:0110012]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; skin development [GO:0043588]; spleen development [GO:0048536]; T cell differentiation [GO:0030217]; T-helper 17 type immune response [GO:0072538]; transitional two stage B cell differentiation [GO:0002334]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type 2 immune response [GO:0042092] signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630] GO:0001768; GO:0001782; GO:0001783; GO:0001822; GO:0002230; GO:0002269; GO:0002334; GO:0002344; GO:0002447; GO:0005102; GO:0005634; GO:0006606; GO:0006954; GO:0006959; GO:0007507; GO:0009410; GO:0023019; GO:0023035; GO:0030217; GO:0031410; GO:0033209; GO:0035556; GO:0038173; GO:0042092; GO:0042119; GO:0043123; GO:0043588; GO:0048255; GO:0048535; GO:0048536; GO:0061630; GO:0070254; GO:0070534; GO:0072538; GO:0097400; GO:0110012; GO:1990959 GIDIIKWMER 6.320000172 0.338415802 0.338415802 0.330983528 1261.009151 16.25166 15.74552 14.33695 0 13.75923 0 16.00234 13.35313 0 14.48971 0 0 0 14.45245 0 0 16.83025 0 0 0 0 0 0 0 13.16805 0 14.66177 0 15.71749 16.69736 0 0 0 16.20415 17.07791 0 0 0 0 0 15.55864 0 0 0 17.24908 0 16.24161 0 O43745 CHP2_HUMAN Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520) CHP2 HCA520 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cellular response to calcium ion [GO:0071277]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031] calcium ion binding [GO:0005509] GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0008284; GO:0010922; GO:0015031; GO:0042307; GO:0045944; GO:0070886; GO:0071277 VDFPGFVR 4.869999886 1 1 0.283299221 936.7316094 17.61743 0 16.90977 15.90436 0 0 0 0 0 17.56735 17.12075 0 18.2495 0 0 0 0 0 15.23318 0 0 0 17.27368 0 16.97221 17.6269 17.14702 0 19.37596 15.90232 0 0 0 18.46367 0 18.073 17.25426 18.02 0 0 0 18.44424 0 0 0 0 0 0 O43747 AP1G1_HUMAN AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) AP1G1 ADTG CLAPG1 Homo sapiens (Human) basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]; basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] GO:0000139; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006896; GO:0006898; GO:0016020; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232 LTYNHK 3.630000114 0.859953821 0.859953821 0.208676518 777.1473111 0 0 0 15.94237 14.90492 13.35592 0 14.95434 13.399 16.03943 14.93839 0 14.3291 0 0 0 15.83042 13.6548 12.73079 15.71919 15.71774 15.33337 0 0 0 0 0 0 0 0 0 0 15.96559 0 0 15.46097 15.23774 0 0 0 0 0 15.16861 15.62386 0 0 0 0 O43752 STX6_HUMAN Syntaxin-6 STX6 Homo sapiens (Human) "endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0016189; GO:0019905; GO:0030136; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0090161 AVNTAQGLFQR 4.599999905 1 1 0.145483732 1205.19875 0 0 0 0 0 0 0 0 0 0 0 0 0 15.40184 0 0 0 0 0 0 0 0 0 0 15.85107 0 0 0 13.83343 14.83237 0 16.42737 16.30441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43759 SNG1_HUMAN Synaptogyrin-1 SYNGR1 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; protein targeting [GO:0006605]; regulated exocytosis [GO:0045055]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle membrane organization [GO:0048499] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; cellular response to leukemia inhibitory factor [GO:1990830]; protein targeting [GO:0006605]; regulated exocytosis [GO:0045055]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle membrane organization [GO:0048499] GO:0005886; GO:0006605; GO:0016021; GO:0030285; GO:0030672; GO:0031594; GO:0035577; GO:0042470; GO:0045055; GO:0048169; GO:0048172; GO:0048499; GO:1990830 EGGAYGAGK 7.289999962 0.936530173 0.936530173 0.18410522 808.6963994 0 0 15.33475 0 0 0 14.01228 0 0 0 0 0 0 0 15.3491 15.66115 0 0 0 0 0 0 14.21199 0 17.07828 0 0 0 0 16.25061 0 16.76028 15.0236 16.1848 15.71457 0 16.87255 16.41647 16.87006 16.45956 15.97751 0 17.47375 0 16.15096 14.92489 14.61141 16.71742 O43760 SNG2_HUMAN Synaptogyrin-2 (Cellugyrin) SYNGR2 UNQ352/PRO615 Homo sapiens (Human) regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499] GO:0005811; GO:0016021; GO:0030672; GO:0031594; GO:0045055; GO:0048499; GO:0070062 FLTQPQVVAR 7.050000191 1 1 9.20E-13 1158.713052 0 0 0 0 0 0 0 14.56998 0 0 0 0 15.92401 0 0 0 0 0 0 0 0 0 14.86253 0 0 0 15.5507 0 0 0 17.18118 16.48271 17.49521 18.34474 0 0 0 0 0 0 0 0 0 0 0 0 17.6539 0 O43776 SYNC_HUMAN "Asparagine--tRNA ligase, cytoplasmic, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS) (Asparaginyl-tRNA synthetase 1)" NARS1 NARS NRS Homo sapiens (Human) asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983] GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062 TGLKALMTVGK 6.739999771 0.170800298 0.170800298 0.134713756 1122.617676 15.05499 15.09775 13.00576 0 0 0 0 0 12.24401 0 0 0 0 0 0 15.97831 0 0 0 0 11.99946 0 14.44255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.32948 O43805 SSNA1_HUMAN Sjoegren syndrome nuclear autoantigen 1 (Nuclear autoantigen of 14 kDa) SSNA1 NA14 Homo sapiens (Human) ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073] identical protein binding [GO:0042802] GO:0005634; GO:0005813; GO:0005829; GO:0036064; GO:0042073; GO:0042802; GO:0060830 NEFDRTIAETEAAYLK 3.980000019 0.739904284 0.739904284 0.12645614 1870.652259 0 12.81099 0 0 0 0 0 0 14.16224 16.95899 16.16213 14.22294 0 14.47674 12.948 13.56827 13.31102 11.7283 12.32803 16.1803 14.32951 15.57951 17.93544 14.52419 0 9.942039 14.58248 15.51578 0 0 0 14.88339 0 14.68676 14.78848 0 12.03296 17.84394 0 16.147 0 15.13337 0 15.85122 0 13.8331 14.99833 0 O43815 STRN_HUMAN Striatin STRN Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; Wnt signaling pathway [GO:0016055] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; estrogen receptor binding [GO:0030331]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; bicellular tight junction assembly [GO:0070830]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; Wnt signaling pathway [GO:0016055] armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; estrogen receptor binding [GO:0030331]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877] GO:0005516; GO:0005829; GO:0005923; GO:0007626; GO:0008285; GO:0014069; GO:0016020; GO:0016055; GO:0016358; GO:0030331; GO:0030425; GO:0043025; GO:0043197; GO:0044877; GO:0045211; GO:0051721; GO:0070016; GO:0070830; GO:0090443 ALPDSGEDR 6.679999828 0.790386975 0.790386975 0.219512512 959.6924786 16.27042 16.39691 14.80973 14.18451 16.74428 14.18 9.694174 9.701148 15.34137 0 14.83687 16.32567 12.67557 15.90082 11.62475 14.74027 14.72068 12.56443 14.64737 0 14.98999 15.57944 15.60837 15.89472 16.098 0 15.08633 15.78876 15.76564 15.7216 0 15.62416 14.73366 0 15.61467 16.60618 15.8271 16.50674 0 0 15.37141 15.57044 0 0 15.33 0 0 16.80862 O43823 AKAP8_HUMAN "A-kinase anchor protein 8, AKAP-8 (A-kinase anchor protein 95 kDa, AKAP 95)" AKAP8 AKAP95 Homo sapiens (Human) cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; regulation of histone phosphorylation [GO:0033127]; signal transduction [GO:0007165] condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; regulation of histone phosphorylation [GO:0033127]; signal transduction [GO:0007165] double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0000278; GO:0000793; GO:0001939; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005794; GO:0007076; GO:0007165; GO:0008270; GO:0015031; GO:0016020; GO:0016363; GO:0031065; GO:0032720; GO:0033127; GO:0034237; GO:0042826; GO:0044839; GO:0045087; GO:0051059; GO:0071222; GO:0071380 GSLDGFMR 1.110000014 0.22147581 0.22147581 0.266772985 898.3666127 14.82833 18.62216 17.10785 7.841171 16.7046 0 17.40549 18.14106 18.88984 0 14.32496 0 18.79258 18.05724 0 0 19.40561 19.48734 0 19.20859 17.30047 0 18.48589 17.3151 0 19.18806 0 18.5122 19.64017 17.8916 19.66214 19.19155 0 20.03921 20.30349 19.20468 20.54918 0 19.9728 0 19.09315 0 17.80789 18.5982 18.23128 16.16962 19.1846 0 O43824 GTPB6_HUMAN Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like) GTPBP6 PGPL Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022] GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022] GO:0005525; GO:0005737; GO:0043022; GO:0046872 TTLIKALTGDAAIQPR 4.079999924 0.46577391 0.46577391 0.107714017 1669.014777 0 10.86302 0 0 0 14.41403 0 0 11.25807 8.052399 17.54647 0 15.11094 0 18.47178 0 0 14.60522 0 17.16208 16.0298 15.5079 14.41501 16.72746 15.34827 0 0 13.50337 0 0 16.17753 14.55299 0 0 15.10547 0 0 14.93301 14.96726 0 0 0 15.01726 11.00821 14.30993 16.41375 0 0 O43829 ZBT14_HUMAN "Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog, Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog, ZF5, Zfp-5, hZF5)" ZBTB14 ZFP161 ZNF478 Homo sapiens (Human) "cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001822; GO:0003170; GO:0003279; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0016235; GO:0043565; GO:0045892; GO:0046872; GO:0060976; GO:1990837 GFTTQAHLK 13.38000011 1 1 0.186793566 1001.624275 17.57556 0 18.15132 0 0 0 0 0 0 0 0 0 21.3012 0 0 0 22.05466 0 0 15.44967 0 0 0 0 0 0 0 0 20.68055 0 0 21.10368 20.38503 21.6057 0 0 0 0 0 0 21.69175 0 22.31178 0 0 21.37951 21.90545 0 O43837 IDH3B_HUMAN "Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)" IDH3B Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099] electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0009055; GO:0051287 GKVTAVHK 4.489999771 0.33127889 0.33127889 0.131464071 840.1217765 17.76889 16.08018 16.33555 17.01414 16.50688 0 14.91306 15.00395 17.39401 16.77655 16.65839 17.08999 13.16063 0 13.53871 14.31717 0 16.57442 14.10652 13.88972 8.407882 0 17.01545 0 16.83172 14.84048 16.26383 0 15.66607 15.03509 0 15.74693 15.05686 0 15.34929 15.2345 15.38239 16.36583 0 13.04905 14.92143 15.31649 15.45711 13.30102 16.00698 16.34115 16.2063 15.19503 O43852 CALU_HUMAN Calumenin (Crocalbin) (IEF SSP 9302) CALU Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016020; GO:0033018; GO:0042470 IVSKIDGDK 6.630000114 6.83E-06 6.83E-06 0.19452659 974.3871568 0 0 0 0 0 0 0 0 0 0 0 14.48489 0 0 15.93804 15.43248 0 0 0 0 0 0 0 16.40799 0 0 0 13.37719 0 13.85096 0 13.84098 14.87493 0 0 14.38251 0 0 0 14.64372 0 0 13.35024 0 0 0 0 0 O43861 ATP9B_HUMAN "Probable phospholipid-transporting ATPase IIB, EC 7.6.2.1 (ATPase class II type 9B)" ATP9B ATPIIB NEO1L HUSSY-20 Homo sapiens (Human) "endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] "endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0045332; GO:0048471; GO:0140326 MGVIVRDESTAEITFYMK 8.770000458 0.698103964 0.698103964 0.071467797 2122.485583 16.20293 0 0 14.29011 15.65414 14.14035 0 12.58654 14.17625 0 15.15651 14.27813 16.68008 0 17.31408 0 16.20034 15.21206 16.43699 17.19661 0 0 0 0 0 0 0 15.02088 0 0 14.75254 0 16.17212 0 16.13102 0 17.39771 16.75373 0 0 0 0 17.42174 0 0 0 0 0 O43865 SAHH2_HUMAN "S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3), IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2, AdoHcyase 2)" AHCYL1 DCAL IRBIT XPVKONA Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353] identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0006915; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0044233; GO:0051592; GO:0070062; GO:1990456 QIQFADDMQEFTK 5.139999866 0.568097711 0.568097711 0.326675739 1597.768578 16.28783 0 13.4781 15.52088 13.32338 10.66785 12.27059 9.608549 14.75501 13.68508 16.3181 13.67181 0 15.97171 0 0 0 0 14.96722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.89625 0 17.06232 16.68005 0 0 0 0 15.02041 0 0 0 O43866 CD5L_HUMAN "CD5 antigen-like (Apoptosis inhibitor expressed by macrophages, hAIM) (CT-2) (IgM-associated peptide) (SP-alpha)" CD5L API6 UNQ203/PRO229 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; positive regulation of complement-dependent cytotoxicity [GO:1903661]; regulation of complement activation [GO:0030449]; zymogen activation [GO:0031638] blood microparticle [GO:0072562]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; positive regulation of complement-dependent cytotoxicity [GO:1903661]; regulation of complement activation [GO:0030449]; zymogen activation [GO:0031638] scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] GO:0002376; GO:0004252; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006915; GO:0006954; GO:0006968; GO:0009986; GO:0030449; GO:0031638; GO:0072562; GO:1903661 LEVLHK 2.059999943 0.335885644 0.335885644 0.104349739 737.8116526 17.83818 17.921 15.75116 14.07303 0 15.00176 17.18923 17.90635 0 17.88688 18.70919 0 0 17.92525 0 18.39694 18.2985 0 0 0 15.95187 0 0 18.01166 16.87106 18.21637 15.62543 16.47536 0 0 16.19937 18.69125 0 16.22764 0 0 17.51018 17.885 0 0 17.68965 12.21318 17.61001 17.09331 17.06283 0 0 14.48848 O43869 OR2T1_HUMAN "Olfactory receptor 2T1 (Olfactory receptor 1-25, OR1-25) (Olfactory receptor OR1-61)" OR2T1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 VSGGVF 8.229999542 0.55811888 0.55811888 0.189993688 564.3834467 20.31244 17.43404 20.50848 17.03536 20.01251 18.12029 17.17549 18.12005 19.20762 0 17.47295 19.08419 18.88878 19.35103 19.32191 0 0 17.00667 0 17.06811 18.71906 18.24461 0 20.00667 18.83914 18.66202 19.51464 0 18.02594 17.95066 18.3586 18.32024 17.32155 0 0 0 0 19.88146 17.61951 17.64716 0 19.0651 18.37883 18.68205 17.48996 20.16801 18.53598 18.27534 O43895 XPP2_HUMAN "Xaa-Pro aminopeptidase 2, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P, Membrane-bound APP, Membrane-bound AmP, mAmP) (X-Pro aminopeptidase 2)" XPNPEP2 Homo sapiens (Human) anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] GO:0004177; GO:0005576; GO:0005886; GO:0016020; GO:0031225; GO:0046872; GO:0070006; GO:0070062 GMFTSIEPGYYK 13.11999989 0.883126497 0.883126497 0.020883842 1408.698072 15.06866 16.5865 0 0 15.01208 0 0 13.83673 0 0 0 14.80815 0 16.09813 14.51606 15.58428 0 15.19122 0 15.62647 0 16.30597 0 0 0 16.90318 17.13181 15.59894 15.76029 0 16.92961 0 17.5398 0 0 17.52857 14.52518 14.46431 0 15.0708 0 16.13535 0 16.31459 0 0 0 15.33926 O43896 KIF1C_HUMAN Kinesin-like protein KIF1C KIF1C KIAA0706 Homo sapiens (Human) "anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874] "axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; RNA binding [GO:0003723]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; RNA binding [GO:0003723] GO:0003723; GO:0003774; GO:0003777; GO:0005524; GO:0005783; GO:0005794; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:1904115; GO:1990048; GO:1990049 AHIDK 6.110000134 0.022612879 0.022612879 0.242364898 584.2783374 0 16.99689 0 15.60531 16.39921 0 15.4116 15.1493 0 13.96374 0 15.72891 0 0 17.1249 0 0 0 18.80298 15.87636 16.99926 0 15.87039 17.35667 0 0 18.48751 0 15.56231 0 0 0 0 16.48739 0 0 17.45511 16.90565 16.68958 0 0 17.53075 0 16.31273 16.62114 17.50409 14.08679 16.7629 O43897 TLL1_HUMAN "Tolloid-like protein 1, EC 3.4.24.-" TLL1 TLL Homo sapiens (Human) cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; skeletal system development [GO:0001501] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; skeletal system development [GO:0001501] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0001501; GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0008270; GO:0030154; GO:0030199 AATSRTER 5.320000172 0.964767635 0.964767635 0.208672072 892.5762781 15.5596 16.19352 16.65104 16.02992 0 16.34906 16.5033 15.76219 14.28311 0 13.64804 0 17.28829 0 0 0 14.78285 17.45197 14.60531 0 15.08939 0 0 0 16.788 0 12.40299 15.32829 0 0 0 17.72032 0 16.62109 0 0 16.15633 0 0 0 16.10727 0 15.87029 0 0 0 0 0 O43900 PRIC3_HUMAN "Prickle planar cell polarity protein 3 (LIM domain only protein 6, LMO-6) (Prickle-like protein 3, Pk3) (Triple LIM domain protein 6)" PRICKLE3 LMO6 Homo sapiens (Human) cell projection organization [GO:0030030] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; cell projection organization [GO:0030030] zinc ion binding [GO:0008270] GO:0005739; GO:0005886; GO:0008270; GO:0030030 AGMPR 1.370000005 0.304892719 0.304892719 0.144305379 542.9527476 0 16.38928 14.02383 16.59074 13.71425 12.45979 13.91799 14.85565 13.8751 14.81834 17.02283 15.58301 19.38408 20.22033 20.56129 19.82896 0 0 19.96281 20.61783 19.86742 19.08745 19.16623 18.26249 18.00899 19.85813 19.13448 19.73786 0 18.98204 0 17.25458 19.31006 0 20.39989 16.7571 18.39067 0 0 0 17.34646 18.32274 20.83205 20.52209 19.9887 20.87863 16.48299 0 O43914 TYOBP_HUMAN "TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein, KAR-associated protein)" TYROBP DAP12 KARAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; apoptotic cell clearance [GO:0043277]; apoptotic signaling pathway [GO:0097190]; cellular defense response [GO:0006968]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; microglial cell activation involved in immune response [GO:0002282]; myeloid leukocyte activation [GO:0002274]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of transforming growth factor beta1 production [GO:0032911]; neutrophil activation involved in immune response [GO:0002283]; osteoclast differentiation [GO:0030316]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast development [GO:2001206]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; protein stabilization [GO:0050821]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stimulatory killer cell immunoglobulin-like receptor signaling pathway [GO:0002222] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; apoptotic cell clearance [GO:0043277]; apoptotic signaling pathway [GO:0097190]; cellular defense response [GO:0006968]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; microglial cell activation involved in immune response [GO:0002282]; myeloid leukocyte activation [GO:0002274]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of transforming growth factor beta1 production [GO:0032911]; neutrophil activation involved in immune response [GO:0002283]; osteoclast differentiation [GO:0030316]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast development [GO:2001206]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; protein stabilization [GO:0050821]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stimulatory killer cell immunoglobulin-like receptor signaling pathway [GO:0002222] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] GO:0002222; GO:0002223; GO:0002274; GO:0002282; GO:0002283; GO:0005102; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0010628; GO:0016021; GO:0030036; GO:0030316; GO:0030667; GO:0030889; GO:0030900; GO:0032693; GO:0032731; GO:0032755; GO:0032760; GO:0032816; GO:0032911; GO:0032930; GO:0034241; GO:0035556; GO:0042802; GO:0042803; GO:0043277; GO:0046872; GO:0048678; GO:0050821; GO:0097190; GO:0110090; GO:1900272; GO:1901216; GO:1902685; GO:1904151; GO:2000010; GO:2001206 GAAEAATRK 1.799999952 1 1 0.257903755 875.0795575 21.0717 0 0 0 0 0 0 0 0 17.73616 0 0 0 0 0 18.75222 0 0 0 0 0 0 0 17.89643 0 0 0 16.99938 0 0 0 19.16682 19.91987 0 0 0 19.24199 0 0 18.72393 0 0 0 19.80474 0 0 0 0 O43916 CHST1_HUMAN "Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1, GST-1) (Keratan sulfate Gal-6 sulfotransferase, KS6ST, KSGal6ST, KSST, EC 2.8.2.21)" CHST1 Homo sapiens (Human) galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790] keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130 WIQNNTRGDPTLGK 9.430000305 0.787651539 0.787651539 2.29E-13 1600.043377 14.01777 15.7154 12.42846 16.48348 0 0 0 14.4833 13.31564 0 0 0 14.28503 0 0 12.17921 0 14.96486 0 0 0 0 17.03395 0 16.13615 13.73615 0 15.24824 0 0 13.00745 0 0 0 13.50021 11.48364 0 0 0 0 0 0 0 0 0 18.49314 16.1969 0 O43918 AIRE_HUMAN "Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)" AIRE APECED Homo sapiens (Human) "central tolerance induction to self antigen [GO:0002509]; humoral immune response [GO:0006959]; immune response [GO:0006955]; negative thymic T cell selection [GO:0045060]; peripheral T cell tolerance induction [GO:0002458]; positive regulation of chemokine production [GO:0032722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of thymocyte migration [GO:2000410]; regulation of transcription, DNA-templated [GO:0006355]; thymus epithelium morphogenesis [GO:0097536]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; central tolerance induction to self antigen [GO:0002509]; humoral immune response [GO:0006959]; immune response [GO:0006955]; negative thymic T cell selection [GO:0045060]; peripheral T cell tolerance induction [GO:0002458]; positive regulation of chemokine production [GO:0032722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of thymocyte migration [GO:2000410]; regulation of transcription, DNA-templated [GO:0006355]; thymus epithelium morphogenesis [GO:0097536]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270] GO:0000977; GO:0002458; GO:0002509; GO:0003682; GO:0005634; GO:0005737; GO:0006355; GO:0006955; GO:0006959; GO:0008270; GO:0016604; GO:0032722; GO:0042393; GO:0042802; GO:0045060; GO:0045182; GO:0045893; GO:0045944; GO:0097536; GO:2000410 FQETLHLK 12.46000004 1 1 0.290201779 1016.406292 15.74533 0 0 0 0 0 17.18692 0 0 0 0 0 0 0 0 0 0 0 15.20243 16.07657 0 17.10107 0 18.49527 17.21133 0 18.64407 0 0 0 0 17.99011 0 0 19.04169 0 0 18.26614 0 0 0 0 0 0 0 0 0 0 O43933 PEX1_HUMAN Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1) PEX1 Homo sapiens (Human) microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016887; GO:0044877; GO:0060152; GO:0070062 ADAEYK 7.449999809 1 1 0.205401795 694.3258015 0 15.74242 0 15.76447 0 15.91028 15.9363 15.65662 11.47879 15.39929 14.60654 16.34124 14.17435 15.00838 15.29873 15.97776 15.64039 15.50814 0 13.24864 15.06922 16.90087 0 15.33638 15.18728 0 0 0 15.50143 0 0 0 0 16.1063 0 0 0 16.23539 0 0 15.94455 16.23809 16.28682 0 0 0 16.50467 15.3843 O60218 AK1BA_HUMAN "Aldo-keto reductase family 1 member B10, EC 1.1.1.300, EC 1.1.1.54 (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein, ARP, hARP) (Small intestine reductase, SI reductase)" AKR1B10 AKR1B11 Homo sapiens (Human) cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523] alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758] GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0005576; GO:0005739; GO:0005764; GO:0005829; GO:0008106; GO:0016488; GO:0044597; GO:0044598; GO:0045550; GO:0047655; GO:0047718; GO:0052650; GO:0110095 SPLGKVK 10.64999962 1 1 0.261005655 729.459574 0 0 0 0 0 0 0 0 0 17.73768 0 0 0 0 20.23812 0 18.06125 0 0 0 0 0 0 0 0 18.60815 18.77272 0 0 0 0 17.93153 18.20072 0 0 0 0 0 0 0 0 20.15387 0 0 0 0 0 0 O60224 SSX4_HUMAN "Protein SSX4 (Cancer/testis antigen 5.4, CT5.4)" SSX4 SSX4A; SSX4B Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 MKSSEK 1.659999967 1 1 0.023048042 724.4119122 14.29916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.913 0 0 0 0 12.95245 0 0 0 0 0 0 0 0 0 0 0 0 16.48353 0 0 0 0 0 0 0 O60229 KALRN_HUMAN "Kalirin, EC 2.7.11.1 (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)" KALRN DUET DUO HAPIP TRAD Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0007417; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 SNHDRIR 1.929999948 1 1 0.096210329 896.3277641 15.83262 0 0 9.650012 14.94958 13.74132 15.58596 16.10223 14.31553 14.93037 15.24212 16.75343 15.35526 0 14.79129 14.8038 0 13.20615 15.46735 14.17516 0 0 0 15.82713 14.95613 0 0 13.01309 0 0 0 0 0 14.96852 0 0 0 0 14.9151 0 0 0 14.01562 0 0 0 0 0 O60231 DHX16_HUMAN "Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, EC 3.6.4.13 (ATP-dependent RNA helicase #3) (DEAH-box protein 16)" DHX16 DBP2 DDX16 KIAA0577 PRP2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005 AMVPELRK 4.300000191 1 1 0.064221264 959.299432 10.45708 0 14.64374 13.94714 0 14.50504 14.03227 0 0 15.26488 10.56864 0 0 0 14.00868 9.716218 0 14.68287 0 14.12133 13.76963 0 14.11003 14.67099 0 0 0 0 0 16.50801 15.06682 0 13.75994 14.69456 13.90679 0 0 11.37196 16.34191 0 0 0 0 14.06413 0 0 0 0 O60237 MYPT2_HUMAN "Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2, Myosin phosphatase target subunit 2)" PPP1R12B MYPT2 Homo sapiens (Human) regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165] A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018] A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]; enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165] enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901] GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006937; GO:0007165; GO:0008047; GO:0019208; GO:0019901; GO:0030018; GO:0031672 ESAVNLVR 13.72000027 0.207639173 0.207639173 0.242982138 890.1551948 16.87044 16.38978 17.26982 0 15.01155 15.14776 13.98651 0 14.04904 0 12.27768 14.79823 14.40732 0 0 14.54464 15.09974 16.08262 0 12.71046 15.00783 16.55606 15.91724 16.84187 17.09224 14.87138 16.19681 0 17.39563 16.28883 17.59173 15.66178 16.98611 15.12746 14.69893 15.72535 0 17.77598 17.44364 0 17.7727 0 16.56362 15.38357 17.56139 15.11413 11.40187 15.71522 O60238 BNI3L_HUMAN "BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X, NIP3L)" BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macroautophagy [GO:0016239]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of programmed cell death [GO:0043067]; regulation of protein targeting to mitochondrion [GO:1903214] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macroautophagy [GO:0016239]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of programmed cell death [GO:0043067]; regulation of protein targeting to mitochondrion [GO:1903214] identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803] GO:0005521; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005783; GO:0016021; GO:0016239; GO:0016607; GO:0031224; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0051607; GO:0060548; GO:0071456; GO:0097345; GO:1903146; GO:1903214 SVSLSMR 3.220000029 1 1 0.042954314 795.6380721 0 16.02369 0 13.76736 13.87385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.34846 0 0 0 0 0 0 O60239 3BP5_HUMAN "SH3 domain-binding protein 5, SH3BP-5 (SH3 domain-binding protein that preferentially associates with BTK)" SH3BP5 SAB Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]; signal transduction [GO:0007165] guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124] GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0005739; GO:0007165; GO:0016604; GO:0017124; GO:0030659; GO:0035556; GO:0061099 KTVDDLQAK 5.46999979 0.905980349 0.905980349 0.274126833 1018.15967 14.69395 15.21305 15.98914 15.43342 14.73766 0 0 0 0 0 0 0 14.84958 15.05449 0 0 0 0 0 16.11844 0 0 0 0 16.18736 13.74058 16.23199 14.51627 16.69464 16.84091 13.93678 15.92074 12.51901 15.87371 16.60012 15.57032 16.32975 15.75767 15.66352 0 12.96305 14.34725 12.06827 16.31507 13.79856 15.92564 0 14.17851 O60240 PLIN1_HUMAN Perilipin-1 (Lipid droplet-associated protein) PLIN1 PERI PLIN Homo sapiens (Human) cellular response to cold [GO:0070417]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipid binding [GO:0008289]; cellular response to cold [GO:0070417]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] lipid binding [GO:0008289] GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0008289; GO:0016042; GO:0070417 GLLGGVAHTLQK 4.269999981 1 1 0.127727038 1194.605952 0 0 0 14.31119 0 0 0 14.65109 0 0 15.00254 0 0 0 0 14.61093 0 0 15.90967 0 0 0 0 0 16.13458 0 0 0 14.1449 0 12.50866 0 9.341031 14.09727 11.45599 0 11.10951 11.60085 14.25277 12.9389 0 13.36846 13.90216 13.387 0 0 0 0 O60241 AGRB2_HUMAN Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2) ADGRB2 BAI2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016021; GO:0016525; GO:0033173 QVPEPGERSR 3.190000057 1 1 0.258753044 1154.669616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60242 AGRB3_HUMAN Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3) ADGRB3 BAI3 KIAA0550 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814] G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096] GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558 VPQEQADAAK 4.309999943 0.322763324 0.322763324 0.206161811 1057.58179 0 0 0 18.04933 15.40778 14.85468 0 13.65907 15.18337 16.37898 16.07891 16.49507 0 14.73378 10.7362 14.26782 15.76468 0 15.50795 14.20129 0 0 0 0 0 0 0 0 0 0 14.73382 0 17.7337 0 16.18991 15.76015 15.25433 0 16.52269 0 0 17.52535 0 15.33587 15.17894 0 0 19.14625 O60243 H6ST1_HUMAN "Heparan-sulfate 6-O-sulfotransferase 1, HS6ST-1, EC 2.8.2.-" HS6ST1 HS6ST Homo sapiens (Human) "angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]" Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] "Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146]; angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]" heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001525; GO:0005887; GO:0006024; GO:0008146; GO:0015015; GO:0017095; GO:0048286; GO:0048666; GO:0060716 APPDDLDLFPTPDPHYEKK 2.230000019 1 1 0.315728465 2195.115352 0 12.51659 0 12.67045 14.27713 0 9.751763 7.473829 12.97459 14.11887 15.47773 12.62955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.11606 0 0 0 0 0 0 0 0 O60244 MED14_HUMAN "Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component, ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2, CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog, hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component, Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component, DRIP150)" MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]" nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809] GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0019827; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847 DALVHAR 2.849999905 1 1 0.160598969 781.3165033 14.72286 0 0 13.93951 15.637 11.71323 13.88212 0 15.19011 0 0 0 14.48922 14.243 0 14.36896 13.46894 15.87581 0 0 0 0 0 0 0 21.22992 9.568571 14.33309 0 17.41147 19.96519 18.62308 18.65901 0 4.053926 15.27439 0 0 0 17.91778 0 0 0 16.1635 17.03575 0 0 0 O60245 PCDH7_HUMAN "Protocadherin-7 (Brain-heart protocadherin, BH-Pcdh)" PCDH7 BHPCDH Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0031092 AGAADSAPYPGGGGNGASGGGSGGSK 1.779999971 1 1 0.284436584 2062.701749 12.85704 13.37835 15.34026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60256 KPRB_HUMAN "Phosphoribosyl pyrophosphate synthase-associated protein 2, PRPP synthase-associated protein 2 (41 kDa phosphoribosypyrophosphate synthetase-associated protein, PAP41)" PRPSAP2 Homo sapiens (Human) 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164] enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749] GO:0000287; GO:0002189; GO:0004749; GO:0004857; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0042802; GO:0060348 HSPPMVRSVAAIHPSLEIPMLIPK 2.369999886 0.735162199 0.735162199 0.250675601 2636.026175 0 11.292 14.38057 13.90185 13.88535 13.61073 10.86302 14.91321 0 14.09115 14.48259 10.55045 0 0 14.14503 11.96152 0 0 0 0 0 0 0 0 14.80537 16.32711 0 13.55108 14.2824 13.60607 0 0 0 0 0 0 0 0 0 0 15.03414 0 0 0 0 0 11.84918 0 O60258 FGF17_HUMAN "Fibroblast growth factor 17, FGF-17" FGF17 UNQ161/PRO187 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165] fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] GO:0001934; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0030154; GO:0030334 RPQPLT 4.099999905 1 1 0.285284697 712.3952768 0 0 16.72355 0 0 0 0 0 0 0 0 17.96393 0 0 0 0 0 17.08243 0 15.74167 16.44284 0 17.15719 16.63682 0 0 0 0 0 0 17.50004 0 0 0 16.53244 0 0 0 0 0 0 0 17.53004 0 16.36903 16.77454 0 17.79363 O60260 PRKN_HUMAN "E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)" PRKN PARK2 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; amyloid fibril formation [GO:1990000]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]" aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151] "aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; amyloid fibril formation [GO:1990000]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]" actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270] GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001964; GO:0003714; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0014069; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044257; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990000; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378 NGGCMHMK 2.349999905 0.945734203 0.945734203 0.17175854 966.1416104 18.44514 16.36963 0 14.53996 13.53463 14.58385 0 0 0 13.5286 16.60687 17.44112 17.11793 18.9579 0 0 15.74681 17.5751 14.11408 16.83443 14.92833 14.73752 17.25982 15.49524 0 16.95727 15.52599 15.46789 0 17.17759 0 13.45565 16.36669 16.82151 0 10.47229 0 17.2025 15.94057 13.87146 13.76556 11.77818 15.42112 14.91708 0 17.86073 17.04636 0 O60264 SMCA5_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5, EC 3.6.4.- (Sucrose nonfermenting protein 2 homolog, hSNF2H)" SMARCA5 SNF2H WCRF135 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin assembly [GO:0000183]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; WICH complex [GO:0090535] "ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; WICH complex [GO:0090535]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin assembly [GO:0000183]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]" GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0008094; GO:0008623; GO:0016479; GO:0016584; GO:0016589; GO:0016590; GO:0016887; GO:0031062; GO:0031065; GO:0031213; GO:0031491; GO:0031497; GO:0035066; GO:0042766; GO:0044030; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0110016; GO:0140658; GO:1905213; GO:1990164; GO:1990830; GO:2001020 MDGAPDGRGR 8.729999542 1 1 0.302617361 1031.930148 0 0 16.68752 16.36758 0 0 0 0 0 0 0 0 17.43096 0 0 0 0 15.91652 0 0 0 0 16.62777 0 16.17232 0 17.60766 0 0 0 0 0 0 0 0 15.9574 0 17.07339 0 15.85577 0 0 0 0 0 0 0 15.5444 O60266 ADCY3_HUMAN "Adenylate cyclase type 3, EC 4.6.1.1 (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III, AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3, AC3)" ADCY3 KIAA0511 Homo sapiens (Human) acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0016021; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322 MEAGGIPGR 7.25 1 1 0.153982291 888.4968524 14.1506 14.17878 15.71017 17.67494 15.44779 14.33628 0 0 14.78732 0 15.08121 13.21665 0 0 14.25837 13.90809 12.22533 15.03486 0 0 0 16.27827 0 11.12125 0 0 0 0 0 0 0 16.21524 0 0 0 0 0 0 0 16.03258 14.6638 0 0 0 0 0 14.77881 0 O60269 GRIN2_HUMAN "G protein-regulated inducer of neurite outgrowth 2, GRIN2" GPRIN2 KIAA0514 Homo sapiens (Human) neuron projection development [GO:0031175] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; neuron projection development [GO:0031175] GO:0005886; GO:0031175 ASGPK 1.159999967 0.390263587 0.390263587 0.104373623 459.2231284 0 16.66046 16.94385 15.71316 0 0 0 16.71361 16.12259 15.76031 0 14.91189 0 14.90512 0 0 14.78656 17.10488 0 0 0 17.59696 14.67901 0 15.29928 0 0 16.73352 0 0 15.66517 14.94669 0 16.97107 0 17.78596 16.58032 16.63698 0 0 15.89715 16.68367 0 17.48622 16.76223 17.31313 0 17.10463 O60271 JIP4_HUMAN "C-Jun-amino-terminal kinase-interacting protein 4, JIP-4, JNK-interacting protein 4 (Cancer/testis antigen 89, CT89) (Human lung cancer oncogene 6 protein, HLC-6) (JNK-associated leucine-zipper protein, JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis, PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)" SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 Homo sapiens (Human) "lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]" acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] "acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]" identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] GO:0001669; GO:0001933; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860 NVSTGSAENEEK 4.670000076 1 1 0.099961978 1265.469509 17.02416 0 9.214664 0 13.03149 0 12.94541 10.60781 13.5786 0 0 17.45266 0 0 13.61839 0 0 0 0 0 0 0 0 0 0 0 0 14.49535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60279 SUSD5_HUMAN Sushi domain-containing protein 5 SUSD5 KIAA0527 Homo sapiens (Human) cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219] hyaluronic acid binding [GO:0005540] GO:0005540; GO:0007155; GO:0007219; GO:0016021 LNVGQRQAR 4.389999866 0.522687674 0.522687674 0.225232878 1043.086357 12.88893 14.41576 13.56848 14.0115 14.28381 11.62116 0 16.22293 0 16.55139 15.03475 0 0 14.07328 15.24303 15.39795 10.7377 12.37096 0 14.71212 14.72758 0 0 0 0 15.14115 15.93232 14.8009 15.10949 0 13.79235 0 14.71879 16.9079 0 0 0 0 14.83173 0 0 0 0 14.3941 0 15.29832 13.44578 14.69261 O60281 ZN292_HUMAN Zinc finger protein 292 ZNF292 KIAA0530 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872 ETSEQEGAK 3.019999981 1 1 0.208506701 977.1939563 15.20924 10.33167 12.7505 0 0 14.71691 16.41878 9.88747 16.65426 0 0 0 15.18541 0 0 0 0 13.03473 0 0 0 16.20358 0 0 0 0 0 15.17196 0 0 0 17.51182 0 0 0 16.34579 0 15.85377 0 0 15.72202 16.75607 0 0 0 0 0 14.97904 O60282 KIF5C_HUMAN Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2) KIF5C KIAA0531 NKHC2 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0006996; GO:0007018; GO:0007411; GO:0008017; GO:0008045; GO:0008574; GO:0016887; GO:0030705; GO:0032839; GO:0035253; GO:0043025; GO:0044295; GO:0048489; GO:0051028; GO:0098971; GO:0099641; GO:0150034; GO:1904115 FRPLNEAEILRGDK 9.970000267 0.186404139 0.186404139 0.121854208 1657.296978 0 16.10634 12.91559 16.16386 14.52226 0 16.44418 13.54915 0 0 15.78902 16.93517 0 12.05081 13.62101 16.35295 16.55179 16.15876 15.37861 16.84254 14.31749 15.19529 0 0 14.01444 13.68458 11.81966 17.11671 14.72103 0 17.96137 15.14838 18.83866 17.04593 15.80856 19.62071 18.67973 0 14.50713 16.16817 14.08224 12.05607 14.72201 0 0 17.27669 13.37233 0 O60284 ST18_HUMAN Suppression of tumorigenicity 18 protein (Zinc finger protein 387) ST18 KIAA0535 ZNF387 Homo sapiens (Human) interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tumor necrosis factor-mediated signaling pathway [GO:0033209] chromatin [GO:0000785]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] "chromatin [GO:0000785]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0008285; GO:0032993; GO:0033209; GO:0045944; GO:0070102; GO:0070498; GO:2001269 HSPRPEK 12.11999989 1 1 0.039434466 850.2978293 17.24841 14.21684 16.23031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60285 NUAK1_HUMAN "NUAK family SNF1-like kinase 1, EC 2.7.11.1 (AMPK-related protein kinase 5, ARK5) (Omphalocele kinase 1)" NUAK1 ARK5 KIAA0537 OMPHK1 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001650; GO:0002039; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:0106310; GO:1901796; GO:2000772 EPTQPSDARGLIR 12.13000011 1 1 0.549207365 1439.627314 20.91192 0 18.27113 10.41054 0 18.32878 0 0 21.36036 0 0 0 19.49704 0 17.67868 0 0 20.21341 0 17.59207 0 17.09259 0 0 21.99384 20.47312 19.84313 0 0 0 22.88571 20.86169 20.14859 18.84495 21.19109 22.07874 20.55329 21.42519 0 20.13353 17.8151 18.56993 0 20.89545 19.76327 0 19.46394 17.67647 O60287 NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog) URB1 C21orf108 KIAA0539 NOP254 NPA1 Homo sapiens (Human) "maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" fibrillar center [GO:0001650]; nucleolus [GO:0005730] "fibrillar center [GO:0001650]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" RNA binding [GO:0003723] GO:0000463; GO:0000466; GO:0001650; GO:0003723; GO:0005730 ILLLLR 15.55000019 0.58832109 0.58832109 0.123479173 739.4278739 0 13.51706 18.72025 16.63359 11.05665 0 13.76748 15.10843 15.26462 16.64706 17.28845 0 15.37486 0 17.17155 0 16.38608 0 0 17.4727 15.59998 17.05975 0 18.3353 0 17.60824 0 19.14389 17.90871 0 16.74245 17.11243 17.66873 17.95271 17.43554 17.48564 15.7552 0 19.03471 18.57033 17.71492 0 13.41756 16.93339 16.44833 16.67955 14.82115 16.97845 O60290 ZN862_HUMAN Zinc finger protein 862 ZNF862 KIAA0543 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]" metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983] GO:0005634; GO:0006355; GO:0046872; GO:0046983 ELCGSNK 11.89999962 1 1 0 806.7452555 14.12053 0 15.26426 0 14.74147 0 0 0 15.68282 0 0 0 11.45425 0 0 0 0 0 0 0 0 14.56156 0 0 0 0 12.50245 0 0 13.04139 0 0 0 0 14.79412 0 0 0 0 0 0 0 0 0 0 0 0 0 O60291 MGRN1_HUMAN "E3 ubiquitin-protein ligase MGRN1, EC 2.3.2.27 (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1)" MGRN1 KIAA0544 RNF156 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006513; GO:0008333; GO:0016020; GO:0016567; GO:0043231; GO:0043951; GO:0045744; GO:0045879; GO:0046872; GO:0061630; GO:0070062 MGSILSR 5.389999866 1 1 0.155653817 762.5834749 14.33908 0 15.30936 0 0 15.74456 0 0 0 14.86596 0 14.86185 0 0 14.94874 0 16.30028 13.43823 0 0 0 0 0 0 16.73237 0 0 15.13758 17.02816 0 16.56115 0 17.04488 0 0 16.77103 0 0 16.42523 17.39716 0 14.45715 0 0 0 0 0 0 O60292 SI1L3_HUMAN "Signal-induced proliferation-associated 1-like protein 3, SIPA1-like protein 3 (SPA-1-like protein 3)" SIPA1L3 KIAA0545 SPAL3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cytoskeleton organization [GO:0007010]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell polarity [GO:0090162]; eye development [GO:0001654]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of small GTPase mediated signal transduction [GO:0051056] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; tricellular tight junction [GO:0061689] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; tricellular tight junction [GO:0061689]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cytoskeleton organization [GO:0007010]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell polarity [GO:0090162]; eye development [GO:0001654]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096] GO:0001654; GO:0001725; GO:0002244; GO:0003382; GO:0005096; GO:0005615; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0007010; GO:0016324; GO:0045177; GO:0051056; GO:0061689; GO:0090162; GO:0090630 LGPVAVSIKR 6.440000057 1 1 0.123121443 1040.533321 0 8.037623 0 14.68454 14.09357 14.63361 0 0 15.16169 0 0 14.51543 0 0 0 0 0 0 0 0 0 0 0 15.90231 0 0 0 13.75004 0 0 0 0 0 0 15.85821 14.18948 0 14.1439 14.71256 14.18325 15.84049 15.05086 0 15.18752 0 13.34246 0 0 O60293 ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2) ZFC3H1 CCDC131 KIAA0546 PSRC2 Homo sapiens (Human) RNA processing [GO:0006396] exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634] exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA processing [GO:0006396] metal ion binding [GO:0046872] GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872 GRPYR 1 1 1 0.088157403 650.5976975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38615 17.39412 0 0 0 0 0 16.8225 0 0 0 0 15.09565 0 0 0 15.68856 0 0 0 0 0 0 0 0 0 16.50315 15.31035 15.72869 O60299 LZTS3_HUMAN "Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1, ProSAPiP1)" LZTS3 KIAA0552 PROSAPIP1 Homo sapiens (Human) regulation of dendritic spine morphogenesis [GO:0061001] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; regulation of dendritic spine morphogenesis [GO:0061001] GO:0005737; GO:0005856; GO:0014069; GO:0043197; GO:0045202; GO:0061001 KAWTPSR 5.53000021 1 1 0.112760815 842.5748017 0 0 15.43531 0 0 14.29455 15.09098 14.39333 0 0 0 0 18.44252 0 18.00451 15.70631 0 14.89887 14.54983 0 16.35867 0 0 17.47319 16.08683 0 0 0 14.23189 0 0 14.75163 14.77523 0 12.9827 0 0 0 0 0 0 0 0 0 0 0 0 15.80878 O60303 KATIP_HUMAN Katanin-interacting protein KATNIP KIAA0556 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; cerebrospinal fluid circulation [GO:0090660] GO:0005615; GO:0005737; GO:0005856; GO:0042995; GO:0090660 DPVQLR 8.770000458 0.231413931 0.231413931 0.203013597 728.3957873 16.12498 16.50317 15.21161 13.85765 14.6629 13.50063 0 15.18169 14.93798 15.32606 15.73713 14.36272 15.5768 15.69021 16.37563 16.30102 16.5701 17.13333 17.28348 17.52911 16.07693 16.38355 0 17.58305 0 0 0 16.61689 15.58738 16.15309 16.9521 15.76653 16.17496 0 16.22623 17.15845 17.31274 16.8989 0 16.04983 17.33106 17.61689 16.22507 16.88287 17.49923 0 17.45035 15.95718 O60306 AQR_HUMAN "RNA helicase aquarius, EC 3.6.4.13 (Intron-binding protein of 160 kDa, IBP160)" AQR KIAA0560 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA splicing, via spliceosome [GO:0000398]" 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013 GCEIQGMLDDK 7.170000076 0.545821309 0.545821309 0.130280905 1265.810255 0 0 0 0 0 0 0 14.89685 0 0 0 13.75842 11.88462 0 0 0 0 0 0 12.62842 15.61145 0 0 0 8.946012 0 0 11.63503 0 0 0 10.11199 6.668715 13.3826 0 0 16.12446 15.76057 16.76237 0 12.02031 14.84233 0 12.26306 13.48401 14.56813 15.14453 15.00044 O60307 MAST3_HUMAN "Microtubule-associated serine/threonine-protein kinase 3, EC 2.7.11.1" MAST3 KIAA0561 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0007010; GO:0018105; GO:0035556; GO:0106310 ATGTFDNEIVMMNHVYR 5.579999924 1 1 0 2014.02924 0 13.58938 14.80442 13.60526 14.32813 0 0 0 0 14.58097 14.54384 0 11.02924 0 13.35392 12.89621 16.13214 0 0 9.087442 0 0 0 0 16.2155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60308 CE104_HUMAN "Centrosomal protein of 104 kDa, Cep104" CEP104 KIAA0562 Homo sapiens (Human) centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596] glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596] GO:0000922; GO:0005737; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596 AIKDIVTSVFQASLK 4.260000229 1 1 2.31E-13 1616.837117 0 0 0 0 0 0 0 0 0 0 0 14.9545 0 0 0 0 0 0 0 0 0 16.01457 0 0 0 0 0 0 0 0 17.08253 15.48234 15.42561 0 0 16.92213 0 0 0 0 0 0 0 0 0 0 0 0 O60309 L37A3_HUMAN Leucine-rich repeat-containing protein 37A3 LRRC37A3 KIAA0563 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MTHRTPK 3.779999971 0.44133994 0.44133994 0.25750833 866.6319448 17.04724 16.16383 14.34006 15.07403 13.13991 0 14.90201 14.84222 14.60161 15.76797 16.38921 0 0 12.95277 0 15.95897 14.2222 14.04389 16.05366 0 15.17391 15.62183 15.25848 16.35763 15.32992 0 16.11583 13.83046 16.73883 16.38956 17.02114 17.01679 18.08357 0 16.34982 0 16.21381 15.60756 0 16.54653 15.2346 15.31838 0 15.41349 14.9877 0 0 0 O60312 AT10A_HUMAN "Phospholipid-transporting ATPase VA, EC 7.6.2.1 (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A)" ATP10A ATP10C ATPVA ATPVC KIAA0566 Homo sapiens (Human) ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of membrane tubulation [GO:1903527]; regulation of cell shape [GO:0008360] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of membrane tubulation [GO:1903527]; regulation of cell shape [GO:0008360] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0008360; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:0140351; GO:1903527; GO:1990531 DITPDPK 2.599999905 0.158693731 0.158693731 0.254546216 784.5133254 0 0 0 0 0 0 0 0 17.83199 0 0 0 0 0 0 0 0 18.16626 17.89934 0 15.38526 0 17.19304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.12571 0 0 0 0 10.41656 0 19.14738 0 0 O60315 ZEB2_HUMAN "Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1, SMADIP1) (Zinc finger homeobox protein 1b)" ZEB2 KIAA0569 SIP1 ZFHX1B ZFX1B HRIHFB2411 Homo sapiens (Human) anatomical structure development [GO:0048856]; developmental pigmentation [GO:0048066]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of melanosome organization [GO:1903056]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure development [GO:0048856]; developmental pigmentation [GO:0048066]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of melanosome organization [GO:1903056]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007399; GO:0019208; GO:0030511; GO:0043565; GO:0045636; GO:0045944; GO:0046872; GO:0048023; GO:0048066; GO:0048856; GO:0090263; GO:0097324; GO:1903056 QPIMADGPR 8.630000114 1 1 0.333393285 1000.435016 0 14.46987 0 13.47252 0 13.23377 0 14.48715 10.55099 0 13.49533 14.45949 14.96795 14.32698 14.6066 14.07537 13.77893 13.05316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.87724 16.11135 0 0 0 0 15.3106 0 0 16.34675 0 15.76517 O60318 GANP_HUMAN "Germinal-center associated nuclear protein, GANP, EC 2.3.1.48 (80 kDa MCM3-associated protein) (MCM3 acetylating protein, MCM3AP, EC 2.3.1.-) (MCM3 acetyltransferase)" MCM3AP GANP KIAA0572 MAP80 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676] GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390 MLLFR 21.38999939 0.761482418 0.761482418 0.136589514 679.5454426 17.70897 17.62908 17.36412 18.16676 17.22811 18.85401 18.06977 17.34588 18.50879 17.7063 17.75459 18.0329 18.32584 17.7526 17.69855 17.45062 17.64707 17.82034 18.2979 17.88157 18.19732 18.50655 18.28091 17.91257 17.97695 17.89352 17.99623 17.70146 17.89026 18.46236 18.07596 17.8834 17.58084 18.51115 18.4824 17.98999 18.14032 18.34851 18.1123 18.75905 18.10162 18.03333 17.20244 17.94119 17.80549 18.35632 18.66208 18.27811 O60320 F1891_HUMAN Protein FAM189A1 (Transmembrane protein 228) FAM189A1 KIAA0574 TMEM228 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PPAGGPR 9.130000114 1 1 0.265701618 648.8936631 0 0 0 0 0 0 0 16.10224 15.66937 0 0 0 0 16.7436 0 0 0 0 0 0 0 0 16.90832 17.1454 0 0 0 0 0 16.06814 16.33872 16.7381 16.91138 16.3142 0 16.68245 0 0 0 0 16.62906 0 0 15.15876 15.5918 0 15.92899 0 O60330 PCDGC_HUMAN "Protocadherin gamma-A12, PCDH-gamma-A12 (Cadherin-21) (Fibroblast cadherin-3)" PCDHGA12 CDH21 FIB3 KIAA0588 UNQ371/PRO707 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0005911; GO:0007155; GO:0007156 VGDISRDLGLEPR 17.81999969 1 1 0.416338641 1426.049251 17.46348 15.15136 0 0 0 0 17.47072 0 0 0 0 17.51696 17.24109 16.18274 0 0 0 0 0 0 0 0 0 0 0 17.44557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74809 0 0 0 0 0 0 0 O60331 PI51C_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma, PIP5K1gamma, PtdIns(4)P-5-kinase 1 gamma, EC 2.7.1.68 (Type I phosphatidylinositol 4-phosphate 5-kinase gamma)" PIP5K1C KIAA0589 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079] adherens junction [GO:0005912]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931] "adherens junction [GO:0005912]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]" "1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]" GO:0001891; GO:0001931; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006661; GO:0006909; GO:0010008; GO:0014066; GO:0016079; GO:0016308; GO:0030036; GO:0030593; GO:0032587; GO:0034333; GO:0046854; GO:0048488; GO:0052812; GO:0061024; GO:0072583; GO:0098609; GO:0098793 ALYSTAMESIQGGAAR 2.089999914 1 1 0.409867428 1643.003184 16.0734 0 0 0 0 14.30909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38453 0 0 16.21261 0 0 0 0 0 0 0 0 15.58255 0 0 16.34874 0 0 0 0 0 0 0 0 0 0 0 0 O60333 KIF1B_HUMAN "Kinesin-like protein KIF1B, Klp" KIF1B KIAA0591 KIAA1448 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0005875; GO:0006915; GO:0007018; GO:0007270; GO:0007274; GO:0008017; GO:0008021; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030659; GO:0030705; GO:0031410; GO:0043005; GO:1904115 HRGVLLQALNDK 13.85000038 1 1 2.40E-13 1363.917685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60336 MABP1_HUMAN "Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1, JNKBP-1)" MAPKBP1 JNKBP1 KIAA0596 Homo sapiens (Human) negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717] GO:0005654; GO:0005730; GO:0005737; GO:0032717; GO:0043124; GO:0097431; GO:1900425 SGLVAYPAGCVVVLFNPR 4.480000019 1 1 0.214827433 1919.550691 0 0 0 0 15.09418 15.29874 13.43302 13.19148 0 0 0 0 0 13.32339 0 0 0 0 0 0 0 0 17.00327 0 0 0 0 13.82265 0 0 0 0 0 0 0 0 0 0 0 0 17.88777 0 14.44934 0 0 0 0 0 O60343 TBCD4_HUMAN "TBC1 domain family member 4 (Akt substrate of 160 kDa, AS160)" TBC1D4 AS160 KIAA0603 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; vesicle [GO:0031982] cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869; GO:0090630 AQGVR 1.289999962 1 1 0.198435342 531.2025866 0 15.85342 14.88703 15.79854 15.70372 0 16.21835 16.0367 16.19145 14.94733 15.67666 0 13.43566 16.2746 15.9632 15.70737 0 0 16.52365 15.43022 15.05829 16.77414 0 16.57542 15.05172 0 0 0 0 0 0 16.65959 0 0 0 16.95807 0 15.9729 0 0 0 0 17.00478 0 0 0 14.39096 0 O60346 PHLP1_HUMAN "PH domain leucine-rich repeat-containing protein phosphatase 1, EC 3.1.3.16 (Pleckstrin homology domain-containing family E member 1, PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein, hSCOP)" PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP Homo sapiens (Human) apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] GO:0002667; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0009649; GO:0042981; GO:0043231; GO:0043408; GO:0046328; GO:0046872; GO:0051898; GO:1900744 AGGAGRR 8.359999657 1 1 0.152940891 643.4336534 15.86902 15.37991 0 15.01229 15.10919 0 0 15.09921 15.57454 15.99169 15.48458 15.36482 0 0 13.67786 0 15.65279 16.49781 15.73911 16.09443 15.08927 15.80442 0 15.58251 16.28521 15.35865 14.36119 0 0 15.98232 0 16.12987 0 16.23325 0 16.22107 0 0 0 16.1883 16.07073 15.63276 17.23042 0 16.19312 16.28963 16.18175 16.24923 O60391 NMD3B_HUMAN "Glutamate receptor ionotropic, NMDA 3B, GluN3B (N-methyl-D-aspartate receptor subtype 3B, NMDAR3B, NR3B)" GRIN3B Homo sapiens (Human) ionotropic glutamate receptor signaling pathway [GO:0035235]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924] neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; glycine binding [GO:0016594]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; ionotropic glutamate receptor signaling pathway [GO:0035235]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924] calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; glycine binding [GO:0016594]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023] GO:0004970; GO:0005261; GO:0005262; GO:0005886; GO:0015276; GO:0016594; GO:0017146; GO:0030594; GO:0035235; GO:0038023; GO:0042165; GO:0043025; GO:0045211; GO:0051205; GO:0051924 DPASLTR 8.770000458 1 1 0.140666999 759.8843724 0 16.01496 0 15.92198 0 0 0 13.907 14.15017 0 13.70136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.75 0 0 13.72334 0 0 14.66832 0 0 0 0 0 15.90212 0 0 0 0 15.7875 15.49828 0 14.67717 16.32146 15.58307 O60422 ONEC3_HUMAN "One cut domain family member 3 (One cut homeobox 3) (Transcription factor ONECUT-3, OC-3)" ONECUT3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:1990837 SAAAQHR 16.72999954 0.522123933 0.522123933 0.251473197 740.6808906 0 15.27621 16.90316 15.87054 11.04397 14.97182 0 14.59118 16.18546 15.6043 0 0 0 14.61765 13.0492 13.22625 13.01399 15.45156 0 16.96648 0 17.19681 16.57409 0 0 0 0 14.90231 14.67803 16.20478 17.32618 0 15.98577 0 16.25269 16.61954 15.58902 0 0 15.34128 0 15.11716 16.49322 0 0 0 15.76485 0 O60423 AT8B3_HUMAN "Phospholipid-transporting ATPase IK, EC 7.6.2.1 (ATPase class I type 8B member 3)" ATP8B3 ATP1K FOS37502_2 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] acrosomal membrane [GO:0002080]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] acrosomal membrane [GO:0002080]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]; binding of sperm to zona pellucida [GO:0007339]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556] GO:0000287; GO:0002080; GO:0005524; GO:0005789; GO:0005802; GO:0005886; GO:0007030; GO:0007339; GO:0016020; GO:0016021; GO:0016887; GO:0045332; GO:0090556; GO:0140326; GO:1990531 AGMGDSPGRGAPER 4.360000134 1 1 0.125424541 1366.707691 14.35757 12.44349 12.94516 0 14.53329 14.29779 14.09371 13.25087 0 15.58235 15.35549 12.61947 14.64039 13.82441 0 15.99336 0 0 0 12.59653 0 0 0 0 15.29384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60427 FADS1_HUMAN "Acyl-CoA (8-3)-desaturase, EC 1.14.19.44 (Delta(5) fatty acid desaturase, D5D, Delta(5) desaturase, Delta-5 desaturase) (Fatty acid desaturase 1)" FADS1 FADSD5 Homo sapiens (Human) "alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]" "acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]" GO:0000248; GO:0005739; GO:0005789; GO:0006355; GO:0006629; GO:0006636; GO:0007267; GO:0008654; GO:0009267; GO:0016020; GO:0016021; GO:0016213; GO:0016491; GO:0016717; GO:0036109; GO:0042759; GO:0043231; GO:0043651; GO:0045485; GO:0045595; GO:0046456; GO:0062076 ATVERMGLMK 8.079999924 1 1 0.102063264 1152.245847 14.8468 16.14463 15.92679 0 14.8464 0 0 0 0 14.74288 0 15.23151 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68882 0 0 0 0 0 0 0 0 0 0 13.23566 0 0 0 0 0 0 0 0 0 0 0 O60437 PEPL_HUMAN Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein) PPL KIAA0568 Homo sapiens (Human) intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060] cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] GO:0001533; GO:0005198; GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0009612; GO:0016020; GO:0030057; GO:0031424; GO:0042060; GO:0045104; GO:0045296; GO:0070062 TDPEMEK 2.269999981 1 1 0.244588189 863.7513409 0 13.9395 16.96187 15.7331 15.32365 15.10532 15.35079 12.53404 0 15.99843 15.72562 15.83679 16.22964 12.46217 0 14.88624 14.87367 14.64089 15.63908 14.38785 0 0 15.01109 0 0 16.14483 15.89063 15.49397 17.0788 0 0 16.96365 0 0 15.96861 16.3872 15.71007 0 17.56654 14.30146 15.88774 14.46511 15.44505 0 0 14.61797 15.71469 16.03687 O60443 GSDME_HUMAN "Gasdermin-E (Inversely correlated with estrogen receptor expression 1, ICERE-1) (Non-syndromic hearing impairment protein 5) [Cleaved into: Gasdermin-E, N-terminal, GSDME-NT; Gasdermin-E, C-terminal, GSDME-CT ]" GSDME DFNA5 ICERE1 Homo sapiens (Human) cell death [GO:0008219]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; inner ear receptor cell differentiation [GO:0060113]; necrotic cell death [GO:0070265]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of immune response to tumor cell [GO:0002839]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of MAPK cascade [GO:0043410]; pyroptosis [GO:0070269]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cardiolipin binding [GO:1901612]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; wide pore channel activity [GO:0022829]; cell death [GO:0008219]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; inner ear receptor cell differentiation [GO:0060113]; necrotic cell death [GO:0070265]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of immune response to tumor cell [GO:0002839]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of MAPK cascade [GO:0043410]; pyroptosis [GO:0070269]; sensory perception of sound [GO:0007605]" "cardiolipin binding [GO:1901612]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; wide pore channel activity [GO:0022829]" GO:0002839; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0007605; GO:0008219; GO:0008285; GO:0016020; GO:0016021; GO:0022829; GO:0043410; GO:0060113; GO:0070265; GO:0070269; GO:0071356; GO:0098586; GO:0140507; GO:1901612; GO:2001244 FGIVQRLFASADISLER 7.349999905 0.6743325 0.6743325 0.405745236 1921.559453 11.7796 16.72242 0 11.83307 16.79775 0 13.13766 12.64322 14.06766 0 0 16.14236 0 0 11.78494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.83596 0 0 0 0 0 0 0 15.06649 15.71255 14.78135 0 0 0 0 0 0 O60447 EVI5_HUMAN "Ecotropic viral integration site 5 protein homolog, EVI-5 (Neuroblastoma stage 4S gene protein)" EVI5 NB4S Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819] "cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]" GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0007049; GO:0031267; GO:0042147; GO:0043547; GO:0051301; GO:0090630 SVNGSRR 5.260000229 1 1 0.247575883 775.9609058 15.36504 14.83748 0 14.63541 14.59777 14.80768 14.45245 14.98513 0 15.76093 0 0 15.76866 0 0 0 0 0 16.52027 0 0 0 0 0 0 15.19403 0 0 0 0 0 0 0 0 14.79075 0 0 0 0 0 0 0 0 0 15.12213 0 0 0 O60449 LY75_HUMAN "Lymphocyte antigen 75, Ly-75 (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205)" LY75 CD205 CLEC13B Homo sapiens (Human) endocytosis [GO:0006897]; immune response [GO:0006955]; inflammatory response [GO:0006954] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; endocytosis [GO:0006897]; immune response [GO:0006955]; inflammatory response [GO:0006954] carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023] GO:0005887; GO:0006897; GO:0006954; GO:0006955; GO:0009897; GO:0030246; GO:0038023; GO:0070062 NKIANISGDGQK 13.23999977 1 1 0.393463633 1245.183309 17.27653 0 0 14.65369 15.06248 14.43027 0 0 0 0 15.53436 0 0 0 0 0 0 0 15.61327 14.01029 0 0 14.0968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60469 DSCAM_HUMAN Down syndrome cell adhesion molecule (CHD2) DSCAM Homo sapiens (Human) axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782] GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007162; GO:0007399; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0016020; GO:0030424; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:0098632; GO:1990782; GO:1990890 AAAASASMVFVSWLPPLK 4.949999809 1 1 0.380361069 1846.426426 12.94864 0 0 0 14.93667 16.29964 0 12.59522 0 0 15.75184 18.01704 15.98976 15.8216 12.72793 0 15.26579 13.55974 15.24097 0 0 0 0 0 0 0 0 0 0 0 0 16.60089 0 0 0 0 0 0 0 14.1727 10.15639 14.24526 0 0 0 0 0 0 O60476 MA1A2_HUMAN "Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB, EC 3.2.1.113 (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB, Alpha-1,2-mannosidase IB)" MAN1A2 MAN1B Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]" "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381 ALEEAKEK 8.880000114 0.283158332 0.283158332 0.174996916 918.5623177 17.07905 15.39431 0 16.43839 0 0 0 0 0 0 0 0 0 0 0 0 0 15.86161 17.92239 0 11.76169 16.54592 0 13.94078 0 15.66376 16.34274 15.22262 0 0 16.83555 16.48785 0 0 0 0 16.16978 0 0 13.37924 15.22687 16.13531 0 15.63855 15.70971 0 15.73032 0 O60486 PLXC1_HUMAN Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232) PLXNC1 VESPR Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102] GO:0002116; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:1902287 EAPTNK 2.700000048 0.881744742 0.881744742 0.286712326 659.9285757 0 17.40283 19.64976 0 0 0 19.17943 18.56048 0 19.02888 19.93943 18.11458 0 17.72146 20.04136 17.45821 18.34637 20.18554 0 0 19.71668 0 20.60688 0 19.3079 0 0 0 0 0 20.36438 0 18.45121 0 0 20.14319 18.35943 0 19.2847 19.45278 0 0 18.53109 17.68672 0 19.57014 19.25042 18.94706 O60493 SNX3_HUMAN Sorting nexin-3 (Protein SDP3) SNX3 Homo sapiens (Human) endocytic recycling [GO:0032456]; intralumenal vesicle formation [GO:0070676]; late endosome to Golgi transport [GO:0034499]; membrane invagination [GO:0010324]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein transport [GO:0051224]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; response to bacterium [GO:0009617] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; retromer complex [GO:0030904] "clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; retromer complex [GO:0030904]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein phosphatase binding [GO:0019903]; retromer complex binding [GO:1905394]; endocytic recycling [GO:0032456]; intralumenal vesicle formation [GO:0070676]; late endosome to Golgi transport [GO:0034499]; membrane invagination [GO:0010324]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein transport [GO:0051224]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; response to bacterium [GO:0009617]" "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein phosphatase binding [GO:0019903]; retromer complex binding [GO:1905394]" GO:0005737; GO:0005769; GO:0005829; GO:0009617; GO:0010008; GO:0010314; GO:0010324; GO:0010976; GO:0015031; GO:0019903; GO:0022615; GO:0030111; GO:0030136; GO:0030904; GO:0031901; GO:0032009; GO:0032266; GO:0032456; GO:0034499; GO:0042177; GO:0046597; GO:0050765; GO:0051224; GO:0070062; GO:0070273; GO:0070676; GO:0080025; GO:1905394; GO:2000642 SYTPSK 3.24000001 1 1 0.083133436 683.5035418 15.68916 13.9792 15.79769 14.92684 14.66884 0 0 0 13.02199 16.54226 0 13.98717 15.01997 14.82906 0 14.70625 13.75727 16.08719 15.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.39377 15.76543 15.70986 0 18.11425 0 0 0 0 0 0 16.66623 0 16.31873 0 O60494 CUBN_HUMAN Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) CUBN IFCR Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0070062 EIPGPIRSTGEYMFIR 4.5 0.702266693 0.702266693 5.25E-12 1862.726586 15.46667 14.63396 10.41055 0 14.37886 9.99654 14.15049 0 13.54955 12.70105 0 11.18372 0 14.0308 13.24596 12.20199 0 14.23062 14.69658 13.97566 0 0 0 0 14.73129 15.09837 0 12.37581 12.39298 14.6299 0 0 0 0 0 0 0 15.90724 0 14.52033 16.2522 0 15.49975 15.72801 12.97852 0 14.8556 12.07304 O60500 NPHN_HUMAN Nephrin (Renal glomerulus-specific cell adhesion receptor) NPHS1 NPHN Homo sapiens (Human) cell-cell adhesion [GO:0098609]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060] cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022] GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007254; GO:0007519; GO:0007520; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0036060; GO:0042995; GO:0050839; GO:0070062; GO:0072015; GO:0098609 VTPRSSDNR 6.019999981 0.844905496 0.844905496 0.21452695 1030.335014 0 0 14.45766 0 0 0 15.72089 0 0 0 15.95 0 0 0 0 0 15.38398 14.65753 14.21531 0 0 0 15.63198 17.10379 0 0 0 0 0 0 0 13.64901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60502 OGA_HUMAN "Protein O-GlcNAcase, OGA, EC 3.2.1.169 (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase, NCOAT)" OGA HEXC KIAA0679 MEA5 MGEA5 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493] [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415] GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016231; GO:0102166; GO:0102167; GO:0102571 EIPVESIEEVSK 8.340000153 1 1 0.434330623 1357.581099 0 0 0 15.7106 0 0 0 0 0 0 19.71631 0 0 0 18.07439 0 0 0 0 0 0 0 18.88243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.29278 0 0 0 0 0 0 0 0 0 O60503 ADCY9_HUMAN "Adenylate cyclase type 9, EC 4.6.1.1 (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX, ACIX) (Adenylyl cyclase 9, AC9)" ADCY9 KIAA0520 Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872] GO:0001701; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007165; GO:0007189; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0046872; GO:0071880 GKGQMK 1.809999943 0.190380886 0.190380886 0.082596976 663.5445522 0 0 15.49244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.08104 16.71749 17.54272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60506 HNRPQ_HUMAN "Heterogeneous nuclear ribonucleoprotein Q, hnRNP Q (Glycine- and tyrosine-rich RNA-binding protein, GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)" SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) "cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006396; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0045293; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990904; GO:2000623; GO:2000767 SGKHIGVCISVANNR 3.559999943 1 1 0.125935844 1611.18171 14.38418 0 13.19194 13.48033 13.99633 0 12.44483 13.02727 0 0 0 0 0 0 0 0 12.10294 14.18446 0 0 0 0 0 0 0 0 0 14.25699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60507 TPST1_HUMAN "Protein-tyrosine sulfotransferase 1, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 1, TPST-1)" TPST1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478] protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0005794; GO:0006478; GO:0006954; GO:0008146; GO:0008476; GO:0016020; GO:0030173; GO:0042803; GO:0050427 DMPLIFIGGVPRSGTTLMR 2.859999895 1 1 0.254549278 2077.995272 0 12.42503 0 0 13.7895 0 14.40702 0 0 0 0 0 0 0 13.82531 13.56221 0 0 0 0 14.20657 0 0 0 0 0 0 0 0 0 15.30257 0 0 0 12.91218 0 0 0 0 0 16.13897 0 0 0 0 0 0 0 O60508 PRP17_HUMAN "Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3, Ehb3) (PRP17 homolog, hPRP17)" CDC40 EHB3 PRP17 PRPF17 Homo sapiens (Human) "embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0016607; GO:0071007; GO:0071013; GO:1990403 CPLPAADSLMHLTK 3.700000048 0.570855916 0.570855916 0.190817408 1553.194048 0 15.10069 0 0 14.60929 13.18651 0 0 15.52157 0 0 15.4471 14.5775 15.02001 15.23957 15.20554 0 14.76059 15.86868 0 0 0 0 0 14.61355 0 15.13721 16.08528 12.43744 15.33241 16.1482 0 0 0 0 0 13.74508 16.56169 0 14.86573 14.65246 0 0 15.13434 14.33777 0 0 0 O60518 RNBP6_HUMAN "Ran-binding protein 6, RanBP6" RANBP6 Homo sapiens (Human) protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein import into nucleus [GO:0006606] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0061608 QLALEVIVTLSETATPMLK 1.480000019 0.258883864 0.258883864 0.09749017 2072.859564 0 0 0 15.34391 0 14.67745 0 0 16.27315 0 14.35789 9.802708 0 0 12.24262 15.33237 16.03697 0 0 0 13.64725 17.86237 16.8525 18.57428 12.96189 14.08492 13.56858 16.31085 14.15738 17.00542 0 15.25268 18.89826 0 16.49797 12.47334 14.18101 0 13.90525 12.02703 0 13.74859 15.33298 0 0 0 0 14.87034 O60519 CRBL2_HUMAN cAMP-responsive element-binding protein-like 2 CREBL2 Homo sapiens (Human) "cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0007049; GO:0007165; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821 ALLTGEEQNK 6.170000076 0.420781314 0.420781314 0.171175228 1102.54726 18.0031 16.20366 14.44203 15.8325 0 12.01534 13.70659 0 13.721 0 0 0 14.00553 0 0 13.0538 0 15.66538 12.04747 16.31729 0 0 15.89283 0 0 0 0 14.82687 0 16.10436 0 17.28112 0 0 15.90737 16.45184 14.81942 16.58389 12.89935 14.78832 0 0 0 0 0 15.99037 14.90761 0 O60522 TDRD6_HUMAN "Tudor domain-containing protein 6 (Antigen NY-CO-45) (Cancer/testis antigen 41.2, CT41.2)" TDRD6 Homo sapiens (Human) P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0005737; GO:0007283; GO:0030719; GO:0033391; GO:0034587; GO:0043186 VKAQAFR 5.800000191 1 1 0.162246586 818.3895124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.46239 0 0 0 0 0 0 18.17686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60543 CIDEA_HUMAN Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A) CIDEA Homo sapiens (Human) apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to cold [GO:0070417]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to cold [GO:0070417]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659] protein homodimerization activity [GO:0042803] GO:0001659; GO:0001818; GO:0005634; GO:0005737; GO:0005739; GO:0005740; GO:0005811; GO:0005829; GO:0006629; GO:0006915; GO:0008219; GO:0010890; GO:0019915; GO:0030512; GO:0032720; GO:0035634; GO:0042803; GO:0042981; GO:0050995; GO:0070417; GO:0120163; GO:1900118; GO:1902510 RGVMASSLQELISK 6.559999943 1 1 0.424599811 1532.905369 0 0 0 0 0 0 0 0 0 0 17.83504 0 0 0 0 0 0 0 0 0 0 0 18.49693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.87543 0 0 0 0 0 0 O60547 GMDS_HUMAN "GDP-mannose 4,6 dehydratase, EC 4.2.1.47 (GDP-D-mannose dehydratase, GMD)" GMDS Homo sapiens (Human) 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]" "GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]" GO:0005737; GO:0005829; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070062; GO:0070401 CPSARGSGDGEMGKPR 8.220000267 1 1 0.464911381 1662.233348 16.23016 16.40798 16.80152 15.41889 16.40232 0 14.46809 0 0 16.66509 0 16.85359 0 0 14.14381 0 14.95502 0 0 17.1542 0 16.24874 0 0 0 0 0 0 0 0 0 0 0 0 16.1942 0 0 0 0 0 0 0 0 0 0 0 0 0 O60568 PLOD3_HUMAN "Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3, EC 1.14.11.4 (Lysyl hydroxylase 3, LH3); Procollagen glycosyltransferase, EC 2.4.1.50, EC 2.4.1.66 (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase) ]" PLOD3 Homo sapiens (Human) basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475] GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070062; GO:0070831 FLNSGGFIGFATTIHQIVRQWK 1.299999952 1 1 0.030465749 2519.43039 0 0 0 0 0 12.65356 13.47838 0 0 0 0 8.284667 0 10.57982 0 10.01978 0 0 15.93799 11.78838 0 0 0 17.391 0 0 0 0 0 13.20873 0 0 0 0 13.23029 0 0 13.28764 0 0 13.02637 0 0 0 11.97892 0 16.25151 0 O60583 CCNT2_HUMAN "Cyclin-T2, CycT2" CCNT2 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]" cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]" 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223] GO:0000079; GO:0001223; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0006468; GO:0007049; GO:0007519; GO:0008024; GO:0016538; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0032968; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322 EELKMK 8.069999695 0.23895067 0.23895067 0.223146752 777.2906281 16.31019 17.52926 15.99712 15.265 15.80839 14.64186 0 14.86717 0 15.70638 16.05734 0 0 0 17.04615 16.40504 0 0 0 0 0 16.57802 16.21435 16.20788 0 0 0 14.69739 0 15.63562 16.80952 15.56204 15.73886 15.70304 0 16.97383 16.59743 0 17.56544 16.45221 16.58646 17.31882 16.71512 16.42444 0 16.56488 15.79491 13.0917 O60609 GFRA3_HUMAN "GDNF family receptor alpha-3, GDNF receptor alpha-3, GDNFR-alpha-3, GFR-alpha-3" GFRA3 UNQ339/PRO538/PRO3664 Homo sapiens (Human) nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485] axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102] GO:0001764; GO:0005102; GO:0005829; GO:0005886; GO:0007165; GO:0007399; GO:0007422; GO:0008046; GO:0009897; GO:0016167; GO:0019898; GO:0031225; GO:0038023; GO:0043235; GO:0048485 NSSLIGCMCHRR 6.5 1 1 0.02458107 1507.09936 15.89022 16.85502 15.64046 0 0 0 0 0 0 0 0 0 0 16.9821 0 0 0 0 0 0 17.35478 16.85527 18.30596 0 0 0 0 15.23193 0 16.11408 16.84935 15.13572 16.35583 16.64392 15.36594 0 0 0 0 0 0 0 0 0 0 0 0 0 O60610 DIAP1_HUMAN "Protein diaphanous homolog 1 (Diaphanous-related formin-1, DRF1)" DIAPH1 DIAP1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605] actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] GO:0003723; GO:0003779; GO:0005102; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0007605; GO:0008360; GO:0030036; GO:0030041; GO:0030335; GO:0030667; GO:0031267; GO:0032587; GO:0032886; GO:0035372; GO:0044325; GO:0051279; GO:0051493; GO:0071420; GO:0072686; GO:0101003 DIIIK 2.630000114 1 1 0.26718018 600.7946452 17.89818 17.08964 17.60872 0 0 18.66567 16.97623 0 16.07157 14.77578 16.74756 0 0 17.82316 15.31099 0 0 18.35122 18.36093 18.43656 0 17.77896 0 0 0 18.80688 0 18.35203 17.35749 18.17129 18.74357 18.40247 0 0 0 0 0 0 0 0 17.41481 19.49228 16.88393 0 0 0 16.88752 18.37532 O60613 SEP15_HUMAN Selenoprotein F (15 kDa selenoprotein) SELENOF SEP15 Homo sapiens (Human) 'de novo' posttranslational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; 'de novo' posttranslational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092] oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379] GO:0005788; GO:0008379; GO:0008430; GO:0016491; GO:0035092; GO:0051084 YVRGSDPVLK 5.699999809 0.228814974 0.228814974 0.202293453 1135.019478 0 0 0 9.644976 15.19868 0 0 0 0 0 0 17.18195 0 16.40584 14.62264 0 14.55899 0 0 0 0 0 13.5062 0 16.64129 0 0 14.27658 0 15.56437 0 9.377136 0 16.12958 15.20148 0 11.54583 13.96203 16.13628 15.33953 14.84244 14.92847 14.93687 15.47251 13.6577 0 0 14.91114 O60641 AP180_HUMAN Clathrin coat assembly protein AP180 (91 kDa synaptosomal-associated protein) (Clathrin coat-associated protein AP180) (Phosphoprotein F1-20) SNAP91 KIAA0656 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; protein transport [GO:0015031]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; vesicle budding from membrane [GO:0006900] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; synaptic vesicle [GO:0008021] "clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; protein transport [GO:0015031]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; vesicle budding from membrane [GO:0006900]" "1-phosphatidylinositol binding [GO:0005545]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]" GO:0000149; GO:0005545; GO:0005546; GO:0005905; GO:0006900; GO:0008021; GO:0015031; GO:0016185; GO:0019901; GO:0030136; GO:0032050; GO:0048268; GO:0072583; GO:0098894; GO:2000369 DPLADLNIK 12.02000046 0.093819223 0.093819223 0.080425024 999.0994878 0 0 17.64325 17.03906 16.68241 0 20.10499 17.2747 14.5332 16.87123 0 0 17.41911 0 0 17.2082 0 0 0 0 0 16.89438 0 19.41174 15.2016 12.77352 16.48398 0 16.13371 0 0 0 0 0 0 0 0 15.20822 15.98217 0 17.0246 0 17.10091 0 15.63012 0 17.32868 0 O60645 EXOC3_HUMAN Exocyst complex component 3 (Exocyst complex component Sec6) EXOC3 SEC6 SEC6L1 Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667] cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; cadherin binding [GO:0045296]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cadherin binding [GO:0045296]; SNARE binding [GO:0000149] GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522 ASVEAR 9.130000114 1 1 0.195419851 632.3955852 15.69341 16.03429 16.40523 15.1382 14.18299 15.55101 15.3374 16.01533 15.06921 16.82713 14.86575 16.02097 15.09634 0 15.47547 13.17824 15.83093 14.95545 15.63729 15.80429 15.75506 16.04069 14.68213 15.15714 17.2303 16.87971 16.10449 15.60308 14.7756 16.25193 15.97481 16.49019 16.78343 14.15897 15.27603 16.7485 17.32154 16.09436 17.56102 16.13954 0 16.82864 16.60345 0 16.48893 16.38304 16.68734 0 O60658 PDE8A_HUMAN "High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A, EC 3.1.4.53" PDE8A Homo sapiens (Human) "cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]" GO:0001934; GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0006355; GO:0007165; GO:0019900; GO:0046872; GO:0047555; GO:0060548; GO:0070062; GO:0070374; GO:0071364; GO:1903206 EWQGIYYAKK 3.650000095 0.110413276 0.110413276 2.29E-13 1286.097403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.51252 14.91313 0 12.68237 11.95002 17.69429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60664 PLIN3_HUMAN "Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein, 47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17, PP17)" PLIN3 M6PRBP1 TIP47 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of sequestering of triglyceride [GO:0010890]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of sequestering of triglyceride [GO:0010890]; vesicle-mediated transport [GO:0016192] cadherin binding [GO:0045296] GO:0005737; GO:0005768; GO:0005794; GO:0005811; GO:0005829; GO:0010008; GO:0010890; GO:0016020; GO:0016192; GO:0019915; GO:0030133; GO:0042149; GO:0045296; GO:1905691 QEQSYFVRLGSLSER 5.409999847 1 1 0.331989497 1799.730112 13.47632 13.95704 0 0 0 0 0 0 0 0 0 13.21819 0 0 0 0 0 14.95781 0 0 0 16.32344 16.10839 0 15.99672 0 15.38814 0 0 15.71193 0 15.05306 0 17.28533 0 15.54736 14.32541 14.92833 0 0 0 13.15853 0 0 13.34613 14.86641 14.67205 17.31009 O60673 REV3L_HUMAN "DNA polymerase zeta catalytic subunit, EC 2.7.7.7 (Protein reversionless 3-like, REV3-like, hREV3)" REV3L POLZ REV3 Homo sapiens (Human) DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]" "4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]" GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0016035; GO:0042276; GO:0046872; GO:0051539 EEMELSLVMSQR 5.579999924 0.438681245 0.438681245 1.83E-12 1482.619331 0 0 0 0 0 7.495123 0 0 0 0 0 0 0 0 12.68721 0 0 0 0 0 0 0 0 7.190049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60674 JAK2_HUMAN "Tyrosine-protein kinase JAK2, EC 2.7.10.2 (Janus kinase 2, JAK-2)" JAK2 Homo sapiens (Human) actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chromatin organization [GO:0006325]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histone H3-Y41 phosphorylation [GO:0035409]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; postsynapse to nucleus signaling pathway [GO:0099527]; programmed cell death induced by symbiont [GO:0034050]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]; actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chromatin organization [GO:0006325]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histone H3-Y41 phosphorylation [GO:0035409]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; postsynapse to nucleus signaling pathway [GO:0099527]; programmed cell death induced by symbiont [GO:0034050]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260] acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702] GO:0000791; GO:0001774; GO:0002250; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005131; GO:0005143; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006325; GO:0006468; GO:0006915; GO:0006919; GO:0006955; GO:0007165; GO:0007167; GO:0007186; GO:0007204; GO:0007259; GO:0007260; GO:0007498; GO:0008022; GO:0008285; GO:0008631; GO:0010572; GO:0010667; GO:0010811; GO:0014068; GO:0014075; GO:0018108; GO:0019221; GO:0019901; GO:0020037; GO:0022408; GO:0030041; GO:0030154; GO:0030218; GO:0030335; GO:0030526; GO:0031103; GO:0031702; GO:0031904; GO:0031959; GO:0032024; GO:0032496; GO:0032516; GO:0032729; GO:0032731; GO:0032740; GO:0032760; GO:0032819; GO:0033130; GO:0033194; GO:0033209; GO:0034050; GO:0034612; GO:0035166; GO:0035401; GO:0035409; GO:0035556; GO:0035722; GO:0036016; GO:0038065; GO:0038157; GO:0042022; GO:0042102; GO:0042169; GO:0042307; GO:0042393; GO:0042531; GO:0042802; GO:0042976; GO:0042981; GO:0043388; GO:0043392; GO:0043410; GO:0043524; GO:0043548; GO:0043560; GO:0045121; GO:0045348; GO:0045428; GO:0045429; GO:0045597; GO:0045822; GO:0045944; GO:0046425; GO:0046427; GO:0046677; GO:0046777; GO:0046872; GO:0048008; GO:0050727; GO:0050729; GO:0050731; GO:0050804; GO:0051091; GO:0051142; GO:0051428; GO:0051770; GO:0060333; GO:0060391; GO:0060396; GO:0060397; GO:0060399; GO:0061180; GO:0070102; GO:0070665; GO:0070671; GO:0070757; GO:0071222; GO:0071549; GO:0072536; GO:0097191; GO:0097296; GO:0098586; GO:0098794; GO:0098978; GO:0099527; GO:0120162; GO:1901731; GO:1902728; GO:1904037; GO:1904707; GO:2000273; GO:2000318; GO:2001235 DLALR 4.639999866 1 1 0.053883926 588.4007072 16.1114 0 0 14.67409 0 14.99407 0 0 0 0 12.09486 0 0 15.50304 15.23186 0 14.5294 0 14.77968 0 0 0 0 14.89298 16.19995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.44678 0 0 0 O60675 MAFK_HUMAN Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit) MAFK Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0043565 VATTSVITIVK 13.18000031 1 1 0.39938745 1132.220514 0 0 0 0 0 0 0 0 0 0 20.02843 0 18.17467 0 0 0 0 0 0 0 0 0 19.31355 0 0 0 0 0 0 0 17.92059 0 20.50251 0 0 0 16.28675 0 0 0 0 18.6897 18.15027 18.85387 0 19.13256 0 0 O60682 MUSC_HUMAN "Musculin (Activated B-cell factor 1, ABF-1) (Class A basic helix-loop-helix protein 22, bHLHa22)" MSC ABF1 BHLHA22 Homo sapiens (Human) "branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003161; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007519; GO:0014707; GO:0032502; GO:0046983; GO:0060021; GO:0060539; GO:1990830; GO:1990837 GSAAECK 3.170000076 0.139379069 0.139379069 0.26867383 723.1633507 14.90873 0 15.69194 15.65914 14.0853 0 14.38671 14.14754 16.49289 0 0 0 0 14.11773 14.85201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59223 15.47168 0 16.36963 0 16.09594 16.4212 0 0 16.31489 16.70695 16.14474 0 15.24336 0 16.87694 15.63457 0 O60684 IMA7_HUMAN Importin subunit alpha-7 (Karyopherin subunit alpha-6) KPNA6 IPOA7 Homo sapiens (Human) entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0016020; GO:0019079; GO:0042564; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902 ETMASPGK 10.43000031 0.510888696 0.510888696 0.024864321 819.3127109 0 0 0 12.8696 16.11699 0 18.32564 16.31234 0 16.59958 16.71062 17.28958 15.00282 17.40351 0 14.72446 7.274551 16.4774 15.79682 15.45026 16.39169 17.17505 17.71128 0 15.26839 17.73057 15.64929 14.44348 17.68791 0 18.95992 19.11745 19.7212 16.94252 12.13071 16.08864 0 16.64324 18.25021 17.84248 18.22358 0 15.04654 16.09251 0 17.17299 14.10869 0 O60687 SRPX2_HUMAN Sushi repeat-containing protein SRPX2 (Sushi-repeat protein upregulated in leukemia) SRPX2 SRPUL Homo sapiens (Human) angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; synaptic membrane [GO:0097060] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; synaptic membrane [GO:0097060]; hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625] hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] GO:0001525; GO:0005102; GO:0005615; GO:0005737; GO:0009986; GO:0036458; GO:0042325; GO:0042802; GO:0048870; GO:0051965; GO:0060076; GO:0062023; GO:0071625; GO:0090050; GO:0097060; GO:0098609 SRICMEDGR 4.159999847 1 1 0.176577884 1139.6992 0 15.54374 0 0 0 0 0 0 15.10627 0 0 0 0 0 14.96368 0 0 13.39198 0 0 0 0 0 0 0 0 0 0 0 0 0 12.78985 0 0 0 0 0 16.37015 0 15.84938 0 0 0 0 0 0 0 0 O60688 YPEL1_HUMAN Protein yippee-like 1 YPEL1 FKSG3 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005634; GO:0046872 FIIELAHMIK 27.95999908 0.905953348 0.905953348 0.427351719 1214.054497 0 0 0 0 0 0 0 0 0 17.03094 18.605 18.62664 0 0 0 0 17.45475 0 16.46379 0 0 19.89058 0 0 0 0 0 0 18.15662 0 20.50683 0 19.27645 0 19.32826 0 0 0 18.9558 0 0 0 0 18.4251 18.36935 19.16946 0 17.86136 O60701 UGDH_HUMAN "UDP-glucose 6-dehydrogenase, UDP-Glc dehydrogenase, UDP-GlcDH, UDPGDH, EC 1.1.1.22" UGDH Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065] identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979] GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287; GO:0070062 TYGMGK 7.349999905 0.589581013 0.589581013 0.224931305 672.3732001 0 18.64349 0 0 0 15.63089 0 17.12334 0 16.7827 0 0 0 0 0 17.14176 0 17.87905 16.94726 0 0 16.85476 0 0 0 19.44897 17.6309 18.73806 0 0 19.67859 0 0 0 0 17.92863 0 0 0 0 17.48562 17.1772 0 0 0 17.87509 0 17.60662 O60704 TPST2_HUMAN "Protein-tyrosine sulfotransferase 2, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 2, TPST-2)" TPST2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478] protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0050427 ASVHSMITR 3.789999962 1 1 0.083584228 1018.35213 14.64497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60732 MAGC1_HUMAN "Melanoma-associated antigen C1 (Cancer/testis antigen 7.1, CT7.1) (MAGE-C1 antigen)" MAGEC1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AHSEVIK 3.980000019 0.722587883 0.722587883 0.225355969 783.9697763 0 15.75817 15.09591 14.3432 17.07986 0 15.90127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.91291 0 0 0 0 0 0 0 0 0 15.34444 0 0 16.42739 16.70231 0 0 15.8821 0 0 0 0 0 0 0 0 O60733 PLPL9_HUMAN "85/88 kDa calcium-independent phospholipase A2, CaI-PLA2, EC 3.1.1.4 (2-lysophosphatidylcholine acylhydrolase, EC 3.1.1.5) (Group VI phospholipase A2, GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta, iPLA2-beta) (Palmitoyl-CoA hydrolase, EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9, PNPLA9)" PLA2G6 PLPLA9 Homo sapiens (Human) "antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311]" centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] "centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311]" 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171] GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0016787; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0038096; GO:0042311; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0102545; GO:0102991; GO:1901339; GO:2000304 TWDCVLVNPR 1.889999986 1 1 0.434639338 1259.761122 0 0 0 0 0 16.9854 0 0 0 0 0 17.98562 0 0 0 0 17.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.01704 0 0 0 0 16.84024 0 0 0 0 0 0 0 O60741 HCN1_HUMAN "Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1, BCNG-1)" HCN1 BCNG1 Homo sapiens (Human) "apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]" axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]" cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005267; GO:0005886; GO:0005887; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0045176; GO:0046549; GO:0051289; GO:0051967; GO:0071320; GO:0071805; GO:0086091; GO:0098855; GO:0098907; GO:2001257 ASATGAGPAAAEK 6.980000019 1 1 0.37883801 1102.256649 13.7437 12.4394 13.97256 0 15.31078 14.80099 0 0 0 0 0 0 15.42156 15.86742 16.92643 0 0 0 16.62759 14.9538 17.15545 14.76752 16.18642 0 14.79459 15.63528 17.04463 0 15.19141 0 0 0 15.57989 0 15.64305 15.86841 14.1326 14.53246 13.87477 14.89981 15.4853 15.46393 15.96573 17.39518 15.78032 13.79837 0 16.63667 O60749 SNX2_HUMAN "Sorting nexin-2 (Transformation-related gene 9 protein, TRG-9)" SNX2 TRG9 Homo sapiens (Human) "early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]" cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459] GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460 LIAAVKGVFDHR 11.44999981 0.674729049 0.674729049 0.469971304 1324.160842 0 17.83094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60762 DPM1_HUMAN "Dolichol-phosphate mannosyltransferase subunit 1, EC 2.4.1.83 (Dolichol-phosphate mannose synthase subunit 1, DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1, MPD synthase subunit 1)" DPM1 Homo sapiens (Human) dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]; dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269] alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537] GO:0004169; GO:0004582; GO:0005537; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0019348; GO:0019673; GO:0033185; GO:0035268; GO:0035269; GO:0043178 DVAEQLEK 1.029999971 1 1 0.057486887 931.9816625 15.96916 0 13.62709 14.0098 15.22707 0 0 14.12544 12.88586 15.38647 14.87156 16.02223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60779 S19A2_HUMAN "Thiamine transporter 1, ThTr-1, ThTr1 (Solute carrier family 19 member 2) (Thiamine carrier 1, TC1)" SLC19A2 THT1 TRMA Homo sapiens (Human) thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085] folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234] GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934 AAAAAATVLLR 10.35000038 1 1 0.057030454 1027.206128 12.9896 10.33065 12.55296 15.34327 11.10246 13.72221 15.19011 14.05497 0 17.34326 15.88637 15.35354 0 0 13.712 0 15.46373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.83243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60810 PRAM4_HUMAN PRAME family member 4 PRAMEF4 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 LILSHMDVSR 6.360000134 1 1 0.391405684 1171.021311 13.15458 15.12138 13.67633 0 0 0 0 15.22986 0 15.05995 0 0 0 0 0 0 0 14.60766 0 0 0 0 0 0 16.59107 0 0 15.93739 0 0 15.57243 0 15.49219 0 0 14.84989 16.65669 0 0 0 16.52881 17.47952 15.91368 0 0 0 14.82326 0 O60812 HNRC1_HUMAN "Heterogeneous nuclear ribonucleoprotein C-like 1, hnRNP C-like-1 (hnRNP core protein C-like 1)" HNRNPCL1 HNRPCL1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0042802 NAKSEEEQSSSSMK 5.690000057 1 1 0.119151626 1540.379781 15.42268 0 14.09519 0 0 11.0832 0 14.36855 0 0 0 15.30454 15.94858 0 0 13.44514 0 0 14.78016 13.4189 0 0 0 17.03359 0 12.52805 11.44369 15.63526 0 0 16.03877 15.7264 15.54927 0 12.6187 13.04527 0 17.77517 0 0 14.44881 0 0 0 0 0 0 0 O60825 F262_HUMAN "6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2, 6PF-2-K/Fru-2,6-P2ase 2, PFK/FBPase 2 (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]" PFKFB2 Homo sapiens (Human) "fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]" "6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]" GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006007; GO:0006089; GO:0006096; GO:0009749; GO:0019901; GO:0032024; GO:0033133 GADELPYLR 9.260000229 0.400620341 0.400620341 0.264176592 1035.86165 16.11839 0 16.03614 0 0 0 15.56782 0 0 15.09406 15.53894 15.76505 0 15.17423 0 0 17.44337 0 0 15.2033 0 16.69889 16.28683 15.74537 17.37486 17.0695 15.90988 15.3427 14.76737 0 16.31141 19.547 0 16.06139 15.48633 0 16.8328 0 19.17905 17.53177 17.62906 16.0107 16.17966 15.66902 0 17.62247 0 18.16463 O60826 CCD22_HUMAN Coiled-coil domain-containing protein 22 CCDC22 CXorf37 JM1 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; cullin family protein binding [GO:0097602]; cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031] cullin family protein binding [GO:0097602] GO:0005654; GO:0005768; GO:0005829; GO:0006878; GO:0006893; GO:0007253; GO:0015031; GO:0032456; GO:0043123; GO:0043124; GO:0097602; GO:2000060 DLEEQIETELGK 7.119999886 1 1 0 1404.692385 0 0 0 0 0 12.56321 0 13.33228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60828 PQBP1_HUMAN "Polyglutamine-binding protein 1, PQBP-1 (38 kDa nuclear protein containing a WW domain, Npw38) (Polyglutamine tract-binding protein 1)" PQBP1 NPW38 JM26 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713] GO:0000380; GO:0002218; GO:0002230; GO:0003677; GO:0003690; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598 SHDKSDR 13.13000011 1 1 0 843.2385806 18.69223 16.6876 16.70491 0 17.70698 15.58135 13.96627 17.24774 15.65697 0 17.33406 18.74882 18.03253 16.37938 14.04977 15.84711 0 15.67177 17.07737 0 0 18.72523 17.59243 17.76623 16.80793 17.5395 0 14.73432 0 0 18.92396 0 17.9999 17.25077 0 16.07895 18.59549 18.62514 17.49046 18.05993 16.84643 18.38041 15.47631 0 17.89931 13.27523 16.58856 16.11887 O60829 PAGE4_HUMAN "P antigen family member 4, PAGE-4 (G antigen family C member 1) (PAGE-1)" PAGE4 GAGEC1 JM27 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] GO:0003677; GO:0003713; GO:0005634; GO:0005737; GO:0005739; GO:0006979; GO:0032872; GO:0042594; GO:0043066; GO:1903202; GO:1903427 SERGDGSDVK 9.930000305 1 1 0.284341668 1049.653758 0 16.71794 12.07646 14.59363 0 0 0 16.45786 14.74446 13.67487 15.77074 15.45759 16.093 14.31304 0 0 0 0 17.16703 16.76367 16.35575 0 15.58543 16.47604 14.99255 16.95187 0 0 0 17.17751 0 16.97923 0 0 0 0 0 18.19276 16.45623 13.71319 19.05403 16.21833 15.68831 18.59068 16.35923 18.57075 0 18.41467 O60832 DKC1_HUMAN "H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)" DKC1 NOLA4 Homo sapiens (Human) box H/ACA RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004] box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005737; GO:0006364; GO:0006396; GO:0007004; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0034513; GO:0051973; GO:0070034; GO:0072589; GO:0090661; GO:0090666; GO:0090669; GO:1904851; GO:1904871; GO:1904872; GO:1904874; GO:1990481 IMLPGVLRYEDGIEVNQEIVVITTK 7.010000229 0.194230974 0.194230974 8.21E-12 2846.713675 15.31782 0 0 0 0 0 13.05631 0 14.06205 15.16885 0 0 14.57654 0 0 16.11536 0 0 0 14.25673 0 17.63705 20.58016 0 0 0 17.64059 16.63436 13.40538 0 16.13972 0 15.60945 0 0 15.43784 0 0 0 19.88792 0 0 0 0 0 0 13.32164 0 O60840 CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4) CACNA1F CACNAF1 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601] integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; voltage-gated calcium channel complex [GO:0005891] integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601] high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] GO:0001750; GO:0005245; GO:0005891; GO:0006816; GO:0007601; GO:0008331; GO:0016021; GO:0034765; GO:0043204; GO:0046872; GO:0050908; GO:0070509; GO:1901386 QQMEEDLR 5.610000134 1 1 0.302322747 1049.427662 13.54902 15.57097 15.69514 0 0 16.15471 16.31911 0 0 15.31433 0 12.17576 0 14.76146 0 0 0 0 0 0 0 0 11.24893 0 10.31269 0 14.4422 0 10.98729 0 0 0 13.92736 0 0 0 15.17438 13.3442 0 0 15.78556 14.35785 15.30378 0 15.53778 0 0 0 O60841 IF2P_HUMAN "Eukaryotic translation initiation factor 5B, eIF-5B, EC 3.6.5.3 (Translation initiation factor IF-2)" EIF5B IF2 KIAA0741 Homo sapiens (Human) regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872 EGKLLTK 21.04999924 0.340209901 0.340209901 0.30843131 788.8583196 18.38836 16.80778 0 0 18.87919 17.11241 16.03661 17.15368 0 17.80925 16.96802 18.07917 16.65512 17.81236 16.33648 16.2385 17.18726 17.39054 16.44243 0 0 17.48661 17.70848 18.29991 18.40378 17.6841 18.17021 17.09912 16.63603 0 0 18.67144 0 18.50903 0 16.38588 0 19.91498 0 17.70854 19.37794 0 0 16.4501 0 0 0 17.90057 O60861 GAS7_HUMAN "Growth arrest-specific protein 7, GAS-7" GAS7 KIAA0394 Homo sapiens (Human) actin filament polymerization [GO:0030041]; neuron projection morphogenesis [GO:0048812] actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; neuron projection morphogenesis [GO:0048812] actin filament binding [GO:0051015]; identical protein binding [GO:0042802] GO:0005737; GO:0005884; GO:0005886; GO:0030041; GO:0042802; GO:0048812; GO:0051015 STQAGDDLMR 4.159999847 1 1 0.207666845 1093.993828 14.7831 0 0 0 0 16.42466 0 0 0 0 0 15.17888 0 0 0 17.15382 0 0 0 0 0 0 16.78196 0 0 0 0 14.49679 17.34 16.55689 0 0 0 0 0 0 17.8716 0 0 0 0 0 0 0 0 0 0 0 O60870 KIN17_HUMAN "DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein homolog)" KIN BTCD KIN17 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003677; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0016363; GO:0032991; GO:0043231; GO:0046872 YTAVVK 1.269999981 1 1 0.244909616 680.6997842 21.89902 0 0 0 16.19832 17.92914 0 0 0 17.09465 0 0 0 0 19.47512 0 0 0 0 0 16.30337 0 0 0 0 0 0 16.65055 0 0 0 0 0 0 0 0 0 0 18.34251 0 0 15.18 16.24664 0 16.12589 17.74884 17.20664 0 O60882 MMP20_HUMAN "Matrix metalloproteinase-20, MMP-20, EC 3.4.24.- (Enamel metalloproteinase) (Enamelysin)" MMP20 Homo sapiens (Human) amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of enamel mineralization [GO:0070173] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of enamel mineralization [GO:0070173] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030163; GO:0030198; GO:0030574; GO:0031012; GO:0070173; GO:0097186 MKVLPASGLAVFLIMALK 2.339999914 1 1 0.483109642 1933.046393 0 18.05865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.39401 0 0 0 0 0 0 17.30836 0 0 0 0 0 17.09896 17.80971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60883 G37L1_HUMAN "G-protein coupled receptor 37-like 1 (Endothelin B receptor-like protein 2, ETBR-LP-2)" GPR37L1 ETBRLP2 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505] GO:0003085; GO:0004930; GO:0005886; GO:0007193; GO:0008528; GO:0016021; GO:0021940; GO:0036505; GO:0042277; GO:0043235; GO:0043410; GO:0045665; GO:0045879; GO:0048712; GO:0060170; GO:1903206 GNLTGAPGQR 9.229999542 1 1 0.082549211 971.8080662 14.75955 0 14.07033 13.43573 0 14.18811 0 0 0 0 0 12.81299 0 0 0 14.75882 14.1401 0 0 15.30531 0 0 15.78483 0 0 0 0 0 0 0 0 0 16.26395 0 0 0 0 14.56518 0 0 12.10817 0 0 0 0 14.85816 13.28993 0 O60884 DNJA2_HUMAN "DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3, Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)" DNAJA2 CPR3 HIRIP4 Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408] ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] GO:0001671; GO:0005524; GO:0005829; GO:0008284; GO:0009408; GO:0016020; GO:0030544; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0070062 MANVADTK 4.079999924 1 1 0.100018907 850.1785351 14.5115 15.57427 0 11.9278 14.36881 15.41878 11.90189 0 12.94463 0 14.0742 0 14.69132 15.18984 15.11943 13.40289 15.8111 14.42967 15.64597 13.35052 0 0 0 15.56225 14.35743 0 0 14.94297 14.11997 14.85228 0 0 0 0 0 0 15.24742 15.13925 0 15.90862 0 14.83504 14.79838 0 0 0 0 0 O60885 BRD4_HUMAN Bromodomain-containing protein 4 (Protein HUNK1) BRD4 HUNK1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]" chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0000083; GO:0000785; GO:0000794; GO:0002039; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0006338; GO:0006355; GO:0006974; GO:0008353; GO:0010971; GO:0019899; GO:0032968; GO:0043123; GO:0043922; GO:0045893; GO:0045944; GO:0050727; GO:0070577; GO:0099122; GO:0106140; GO:1901407; GO:2000002; GO:2001255 CKPMSYEEKR 4.429999828 1 1 0.392405526 1342.694276 14.57503 14.82707 0 0 0 0 15.16805 15.16541 0 0 0 0 0 15.8092 0 15.09611 14.97793 0 16.64507 15.8505 17.2021 15.37944 16.05191 0 0 0 14.30381 0 15.47787 0 16.2122 0 0 0 16.64998 16.913 17.11872 17.2944 15.70005 15.70603 16.55825 0 17.10402 16.58277 0 0 17.15546 17.20521 O60890 OPHN1_HUMAN Oligophrenin-1 OPHN1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; terminal bouton [GO:0043195] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; terminal bouton [GO:0043195]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]" actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543] GO:0003779; GO:0005096; GO:0005543; GO:0005737; GO:0006930; GO:0007165; GO:0007399; GO:0007411; GO:0015629; GO:0021707; GO:0021895; GO:0030036; GO:0030100; GO:0030182; GO:0031175; GO:0034329; GO:0035023; GO:0035255; GO:0043195; GO:0043197; GO:0045198; GO:0048488; GO:0048667; GO:0051966; GO:0098880; GO:0098978; GO:0099149; GO:1901799 EQIGFTK 15.27000046 0.441873461 0.441873461 0.157149161 824.8276347 15.61212 17.07833 17.11337 0 14.7989 16.84261 15.58962 0 16.41465 0 0 0 15.84619 12.68274 0 0 14.68063 16.73906 17.21713 0 15.73485 16.32554 15.99221 0 16.90575 0 17.45979 16.33447 16.80698 18.52041 17.12556 0 0 14.88091 0 14.84136 15.79681 15.16083 0 17.84276 17.04896 16.91748 0 0 0 16.57896 17.52863 15.38844 O60895 RAMP2_HUMAN "Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2, CRLR activity-modifying protein 2)" RAMP2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] adrenomedullin receptor complex [GO:1903143]; amylin receptor complex 2 [GO:0150057]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] adrenomedullin receptor complex [GO:1903143]; amylin receptor complex 2 [GO:0150057]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026] GO:0001525; GO:0001570; GO:0001605; GO:0002040; GO:0005737; GO:0005764; GO:0005886; GO:0005887; GO:0005905; GO:0006816; GO:0006886; GO:0007186; GO:0007189; GO:0007507; GO:0008217; GO:0008277; GO:0009986; GO:0010628; GO:0015026; GO:0015031; GO:0031623; GO:0032870; GO:0034333; GO:0035924; GO:0043116; GO:0043235; GO:0045766; GO:0070830; GO:0070831; GO:0072659; GO:0097084; GO:0097647; GO:0150057; GO:1903143; GO:1990409; GO:1990410; GO:2000352; GO:2001214 AGGPR 2.730000019 1.06E-06 1.06E-06 0.284674503 456.4261938 0 0 17.85485 16.52012 18.24219 0 17.93383 0 18.80431 17.48508 0 18.57672 16.12234 0 17.52474 0 0 18.67604 18.02573 0 0 16.44962 18.40317 0 20.47599 0 0 17.93442 0 0 0 0 17.34273 0 0 0 18.75516 0 0 18.458 0 19.07929 16.80759 0 0 17.2596 0 0 O60906 NSMA_HUMAN "Sphingomyelin phosphodiesterase 2, EC 3.1.4.12 (Lyso-platelet-activating factor-phospholipase C, Lyso-PAF-PLC) (Neutral sphingomyelinase, N-SMase, nSMase, nSMase1)" SMPD2 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767] GO:0004620; GO:0004767; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006684; GO:0006685; GO:0008081; GO:0016020; GO:0030149; GO:0046513; GO:0046872; GO:0071944 DFKGSEEGNTMVPK 6.340000153 0.650607526 0.650607526 0.334287078 1554.457594 17.16592 16.84054 0 0 0 0 0 0 14.89245 18.33261 15.02142 0 0 0 0 16.40504 16.3308 14.7519 0 14.81423 0 0 15.66675 15.96956 0 0 0 0 15.21462 0 0 0 0 0 16.01166 0 13.95501 14.18423 16.51502 0 15.98566 0 0 16.69743 15.70929 17.0075 0 0 O60911 CATL2_HUMAN "Cathepsin L2, EC 3.4.22.43 (Cathepsin U) (Cathepsin V)" CTSV CATL2 CTSL2 CTSU UNQ268/PRO305 Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; serine-type endopeptidase activity [GO:0004252] GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005764; GO:0006955; GO:0008234; GO:0019886; GO:0022617; GO:0043202; GO:0051603 AVWEKNMK 6.429999828 1 1 0.000256547 1007.44096 14.70299 14.98465 11.20345 0 0 14.2291 0 14.12308 0 0 0 0 0 14.84182 0 16.39554 8.906175 0 0 0 0 16.75235 0 13.75039 13.36704 0 0 13.2721 0 0 15.32978 0 16.11017 11.8057 15.24962 0 0 0 0 0 16.39411 0 0 0 0 0 0 0 O60934 NBN_HUMAN Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1) NBN NBS NBS1 P95 Homo sapiens (Human) "blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell cycle [GO:0051726]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485]; blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell cycle [GO:0051726]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]" damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485] GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001832; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005730; GO:0005829; GO:0006302; GO:0007095; GO:0008283; GO:0016605; GO:0030174; GO:0030330; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042405; GO:0044818; GO:0045190; GO:0047485; GO:0050885; GO:0051321; GO:0051726; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0098687; GO:0110025; GO:0140297; GO:1904354 MLSQDAPTVKESCK 8.130000114 0.72520262 0.72520262 2.05E-12 1593.200613 15.90597 10.7463 0 0 12.44012 9.253762 14.90588 0 11.23092 14.98129 0 0 16.62964 16.73357 18.52665 0 16.94907 0 0 0 0 17.25167 15.29165 0 17.83782 16.40288 16.23449 16.45026 0 17.03334 15.26878 16.51129 16.99744 17.35136 18.03812 17.88987 0 0 18.64939 18.35637 17.71181 17.38432 0 12.81468 17.79328 0 18.6794 0 O60936 NOL3_HUMAN "Nucleolar protein 3 (Apoptosis repressor with CARD) (Muscle-enriched cytoplasmic protein, Myp) (Nucleolar protein of 30 kDa, Nop30)" NOL3 ARC NOP Homo sapiens (Human) blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; intrinsic apoptotic signaling pathway [GO:0097193]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein complex oligomerization [GO:0051259]; regulation of NIK/NF-kappaB signaling [GO:1901222]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to hypoxia [GO:0001666]; response to injury involved in regulation of muscle adaptation [GO:0014876]; response to ischemia [GO:0002931]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; sarcoplasmic reticulum [GO:0016529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; intrinsic apoptotic signaling pathway [GO:0097193]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein complex oligomerization [GO:0051259]; regulation of NIK/NF-kappaB signaling [GO:1901222]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to hypoxia [GO:0001666]; response to injury involved in regulation of muscle adaptation [GO:0014876]; response to ischemia [GO:0002931]; RNA splicing [GO:0008380] calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0001666; GO:0001974; GO:0002931; GO:0003723; GO:0005123; GO:0005509; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006376; GO:0008380; GO:0010659; GO:0010667; GO:0010804; GO:0014736; GO:0014808; GO:0014876; GO:0016020; GO:0016529; GO:0035877; GO:0042802; GO:0043027; GO:0043066; GO:0051259; GO:0060547; GO:0089720; GO:0090201; GO:0097193; GO:1901222; GO:1902109; GO:1902176; GO:1903298; GO:1990001; GO:2001237; GO:2001243 MGNAQERPSETIDRER 3.529999971 1 1 0.237770501 1904.318112 11.66569 14.25909 13.77642 15.2991 16.14576 15.97582 0 14.29284 13.52453 0 15.5054 0 0 0 0 15.88675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60941 DTNB_HUMAN "Dystrobrevin beta, DTN-B (Beta-dystrobrevin)" DTNB Homo sapiens (Human) neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] zinc ion binding [GO:0008270] GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0099536 IMLNMFLDTMMADPPPQCLVWLPLMHR 3.190000057 0.007895735 0.007895735 0.238115591 3287.464933 0 14.27348 12.40735 10.55271 0 0 12.10709 13.13295 0 0 0 0 0 0 13.27416 0 0 0 0 0 12.02752 0 13.12917 0 13.66192 0 12.20624 0 14.61468 9.242579 19.18259 0 0 0 0 0 0 17.64389 0 0 0 0 0 0 0 0 13.0491 14.69552 O75019 LIRA1_HUMAN "Leukocyte immunoglobulin-like receptor subfamily A member 1 (CD85 antigen-like family member I) (Leukocyte immunoglobulin-like receptor 6, LIR-6) (CD antigen CD85i)" LILRA1 LIR6 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952] antigen binding [GO:0003823]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888] GO:0002250; GO:0003823; GO:0004888; GO:0005886; GO:0006952; GO:0007166; GO:0016021; GO:0019221; GO:0032396 KTAPWITR 16.38999939 0.572959781 0.572959781 0.177844336 971.5802613 14.65675 14.76575 0 0 15.66898 0 14.83569 0 0 0 0 0 16.62265 14.93514 15.015 15.47691 14.25242 15.76063 16.38808 16.46582 15.98887 15.77277 15.84239 17.41365 17.03444 15.26943 15.63185 15.29308 14.03335 15.1322 15.62549 16.10459 17.34195 16.39327 13.77695 15.04092 0 16.44445 12.75815 15.03463 14.87935 14.38707 15.0306 15.29444 16.05441 15.65506 14.28178 16.13442 O75022 LIRB3_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR-3, Leukocyte immunoglobulin-like receptor 3 (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5, ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a)" LILRB3 ILT5 LIR3 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; negative regulation of osteoclast differentiation [GO:0045671] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; negative regulation of osteoclast differentiation [GO:0045671] inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] GO:0002250; GO:0004888; GO:0005886; GO:0005887; GO:0006952; GO:0007166; GO:0019221; GO:0030667; GO:0032396; GO:0038023; GO:0045671 EMASPPSSLSGEFLDTKDR 2.779999971 0.204177871 0.204177871 0.026886521 2067.875034 0 0 15.07869 14.57667 15.58518 0 0 13.06811 0 0 16.21216 14.93014 14.81039 14.66652 0 0 0 0 15.19361 15.7326 13.22408 0 13.53228 0 14.37987 0 15.74856 11.40205 0 0 16.87556 13.45767 0 13.11962 13.58525 0 10.10363 14.44964 12.50205 0 0 0 0 0 0 13.46907 0 15.63128 O75027 ABCB7_HUMAN "Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7, ABC transporter 7 protein)" ABCB7 ABC7 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; protein homodimerization activity [GO:0042803]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085] ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; protein homodimerization activity [GO:0042803] GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016226; GO:0034755; GO:0042626; GO:0042803; GO:0055072; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903331; GO:1903427 GNSGQFLDAAK 10.31999969 1 1 0.468450106 1106.580201 0 0 0 0 0 18.06125 0 0 18.90147 0 18.26979 0 0 0 0 0 0 0 0 0 0 0 18.82068 0 0 19.24386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.68478 0 0 0 0 0 0 O75030 MITF_HUMAN "Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32, bHLHe32)" MITF BHLHE32 Homo sapiens (Human) "bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0010628; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0044336; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141 IKELGTLIPK 6.400000095 1 1 0.234645115 1111.915222 0 0 14.44857 0 0 0 13.8345 13.1812 0 0 0 0 0 12.66696 0 0 0 0 0 0 0 0 0 0 0 0 0 15.06929 16.18709 0 16.21889 0 0 0 0 0 0 15.43586 0 0 0 0 0 0 0 0 0 0 O75031 HSF2B_HUMAN Heat shock factor 2-binding protein HSF2BP MEILB2 Homo sapiens (Human) double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] chromosome [GO:0005694]; cytosol [GO:0005829] chromosome [GO:0005694]; cytosol [GO:0005829]; double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] GO:0005694; GO:0005829; GO:0006366; GO:0007141; GO:0007144; GO:0007283; GO:1990918 SASEFR 8.109999657 1 1 0.198981546 696.8561807 0 0 15.63481 15.57463 14.93282 15.82025 16.47044 0 15.62069 16.18568 15.68188 15.65072 0 0 0 16.16467 0 15.93187 16.22619 15.87156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07438 0 0 15.89213 0 0 16.10799 0 0 0 0 0 0 0 O75037 KI21B_HUMAN Kinesin-like protein KIF21B KIF21B KIAA0449 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030425; GO:0030426; GO:0031410 LLESEAMNESLRR 14.17000008 1 1 0.482684222 1549.089425 15.40997 0 15.30366 13.2381 0 0 11.75362 0 0 15.54522 15.88062 0 0 0 0 0 0 13.82892 0 0 0 16.58295 15.80043 0 0 0 0 0 0 0 16.21822 0 0 0 0 0 0 0 0 19.01976 0 0 0 20.5646 0 19.99013 0 0 O75038 PLCH2_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4, PLC-L4, Phospholipase C-like protein 4) (Phospholipase C-eta-2, PLC-eta2)" PLCH2 KIAA0450 PLCL4 Homo sapiens (Human) lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015] calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435] GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0046488; GO:0048015 VKQMFR 1.600000024 1 1 0.132805704 823.6166636 0 14.12053 14.21042 13.59167 0 13.9795 15.92422 14.75883 14.19804 15.40029 16.13008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2118 0 0 0 0 0 0 0 O75051 PLXA2_HUMAN Plexin-A2 (Semaphorin receptor OCT) PLXNA2 KIAA0463 OCT PLXN2 UNQ209/PRO235 Homo sapiens (Human) centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756] identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154] GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287 DPESSAMLDYELHSDFVSSLIK 7.340000153 1 1 0 2499.240373 13.55673 6.106655 12.80314 0 13.46231 12.34612 0 0 14.09054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75052 CAPON_HUMAN Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein) NOS1AP CAPON KIAA0464 Homo sapiens (Human) positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] caveola [GO:0005901]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018] caveola [GO:0005901]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]; nitric-oxide synthase binding [GO:0050998]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] nitric-oxide synthase binding [GO:0050998] GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0005901; GO:0010628; GO:0010750; GO:0030018; GO:0030315; GO:0033017; GO:0042383; GO:0045428; GO:0045429; GO:0048471; GO:0050998; GO:0050999; GO:0051000; GO:0060307; GO:0098901; GO:0098974; GO:0098978; GO:1901381; GO:1901841; GO:1902261; GO:1902514; GO:1903762; GO:2000170 VSIMVSVDGVKVILK 8.859999657 0.101144798 0.101144798 0.489407461 1586.724875 0 0 0 0 0 0 0 17.29906 0 0 0 0 0 0 0 0 0 16.49227 0 0 0 18.12696 0 0 0 17.93469 0 0 18.63997 0 19.46382 22.06175 21.04115 0 20.24811 0 20.64942 20.82559 0 0 0 0 0 19.13733 0 18.85472 0 0 O75061 AUXI_HUMAN "Putative tyrosine-protein phosphatase auxilin, EC 3.1.3.48 (DnaJ homolog subfamily C member 6)" DNAJC6 KIAA0473 Homo sapiens (Human) clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle uncoating [GO:0016191] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982]; clathrin binding [GO:0030276]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle uncoating [GO:0016191] clathrin binding [GO:0030276]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] GO:0004725; GO:0005737; GO:0005829; GO:0014069; GO:0016191; GO:0017124; GO:0030276; GO:0031982; GO:0043231; GO:0072318; GO:0072583; GO:0098793; GO:2000369 EEMAKEMDPEK 5.590000153 1 1 0.407704478 1352.154638 15.23465 15.32422 0 14.71086 0 14.14453 0 0 0 0 15.63681 0 0 0 14.34121 0 0 0 0 17.33635 0 15.54386 13.28872 16.44112 0 0 15.3813 0 0 0 0 0 0 0 0 0 0 17.1441 16.61028 15.37483 15.94486 0 0 15.74149 0 17.10107 0 0 O75063 XYLK_HUMAN "Glycosaminoglycan xylosylkinase, EC 2.7.1.- (Xylose kinase)" FAM20B KIAA0475 Homo sapiens (Human) proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; proteoglycan biosynthetic process [GO:0030166]" "ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016773; GO:0030166; GO:0046872 ADVGYK 5.800000191 0.856167316 0.856167316 0.066849103 652.7132268 19.40929 15.53854 17.43108 0 15.24298 0 0 17.02175 0 14.85486 12.54847 15.94636 0 17.34727 16.37269 18.6588 15.47414 0 0 15.29025 16.50895 18.18975 0 17.48896 0 16.80971 16.49783 18.51901 16.30078 15.81431 16.60548 15.2147 15.10472 16.12299 13.46004 14.85679 17.53252 17.27414 16.07667 15.58858 17.19739 16.68951 14.63066 13.21281 15.68757 0 16.82948 17.76792 O75064 DEN4B_HUMAN DENN domain-containing protein 4B DENND4B KIAA0476 Homo sapiens (Human) regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Rab protein signal transduction [GO:0032483] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005654; GO:0005794; GO:0005829; GO:0031410; GO:0032483 GRALGGR 14.39000034 0.056610402 0.056610402 0.237549494 686.6699319 16.83968 15.24532 17.86587 0 0 0 0 0 0 17.53036 0 0 17.05742 16.75134 0 0 0 0 0 17.04663 0 0 17.41701 0 0 0 0 15.06985 14.80557 14.23295 15.27149 15.27072 17.14434 0 14.68 0 0 0 0 0 0 0 17.4278 0 16.8929 0 0 0 O75069 TMCC2_HUMAN Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11) TMCC2 KIAA0481 hucep-11 Homo sapiens (Human) amyloid precursor protein metabolic process [GO:0042982] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; amyloid precursor protein metabolic process [GO:0042982] GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0042982 ERSPEMHR 6.329999924 1 1 0.264340872 1058.047663 0 0 0 0 0 16.66243 0 0 0 0 0 0 0 0 17.31417 0 0 0 0 0 0 17.94276 0 0 0 0 0 0 0 0 19.77888 17.80646 0 0 0 0 0 0 0 0 0 0 0 0 0 16.69334 0 0 O75078 ADA11_HUMAN "Disintegrin and metalloproteinase domain-containing protein 11, ADAM 11 (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein, MDC)" ADAM11 MDC Homo sapiens (Human) integrin-mediated signaling pathway [GO:0007229] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; integrin-mediated signaling pathway [GO:0007229] integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004222; GO:0005178; GO:0005886; GO:0007229; GO:0008237; GO:0016021 GRSGGA 6.909999847 0.716748416 0.716748416 0.118454928 503.3132244 14.36887 16.31348 17.21415 16.29049 16.48137 17.374 16.58129 16.94117 16.27256 16.99569 17.10459 15.55225 17.52839 18.23333 18.23784 17.36022 17.78173 18.13273 17.88236 17.09319 18.79352 18.11571 17.35398 16.93536 15.83208 17.86202 18.47631 17.45174 17.28379 16.57258 18.24558 17.30359 17.76282 17.62323 16.79586 16.95381 19.05642 18.92632 17.56816 17.978 17.92596 17.64773 16.61033 17.88148 17.9143 19.26737 0 17.94126 O75081 MTG16_HUMAN "Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein, hMTG16) (Zinc finger MYND domain-containing protein 4)" CBFA2T3 MTG16 MTGR2 ZMYND4 Homo sapiens (Human) "granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]" Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]" metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:0046872; GO:1903715 YSPSNGPPQPTPPPHYRLEDIAMAHHFR 4.639999866 1 1 0.15428583 3211.410425 11.66982 14.09813 13.68123 14.99758 13.23854 13.06419 14.5464 11.86324 0 12.82678 12.14728 12.03318 0 12.74628 13.27057 0 0 13.70524 9.220171 0 13.47402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.61114 14.9185 0 0 0 11.59843 0 0 0 O75083 WDR1_HUMAN "WD repeat-containing protein 1 (Actin-interacting protein 1, AIP1) (NORI-1)" WDR1 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605] cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102] cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605] actin filament binding [GO:0051015] GO:0002102; GO:0002446; GO:0005576; GO:0005829; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:0070062; GO:1990266 KCFSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR 3.50999999 1 1 5.04E-12 3525.514089 14.36521 0 11.91837 11.81644 0 9.428669 14.01875 0 14.08981 15.36654 10.2548 0 0 0 0 14.46554 11.6172 11.93683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07378 0 0 0 0 0 0 0 0 0 0 0 0 O75093 SLIT1_HUMAN "Slit homolog 1 protein, Slit-1 (Multiple epidermal growth factor-like domains protein 4, Multiple EGF-like domains protein 4)" SLIT1 KIAA0813 MEGF4 SLIL1 Homo sapiens (Human) axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028] extracellular space [GO:0005615] extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028] calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495] GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0022028; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048843; GO:0048846; GO:0048853; GO:0050919; GO:0051964 QLRVLQLMENQIGAVER 5.5 0.098338269 0.098338269 0.055900676 1999.224324 0 16.02123 0 0 0 0 16.80529 17.79003 0 16.86737 0 0 0 12.68531 0 0 14.34189 0 15.81589 12.81631 8.954739 0 12.79447 10.28091 0 0 0 15.22144 0 16.50632 0 13.13713 18.0684 0 0 0 13.79185 15.57142 0 0 0 0 0 0 19.8985 16.6331 0 0 O75094 SLIT3_HUMAN "Slit homolog 3 protein, Slit-3 (Multiple epidermal growth factor-like domains protein 5, Multiple EGF-like domains protein 5)" SLIT3 KIAA0814 MEGF5 SLIL2 UNQ691/PRO1336 Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] extracellular space [GO:0005615]; mitochondrion [GO:0005739] extracellular space [GO:0005615]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495] GO:0003180; GO:0003181; GO:0005509; GO:0005615; GO:0005739; GO:0007411; GO:0008201; GO:0008285; GO:0010629; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100 DSYVELASAK 9.829999924 1 1 0.248800473 1082.31692 16.27947 0 18.75583 19.16881 18.34421 0 0 16.49171 0 0 18.44579 19.20362 0 17.30766 0 0 0 17.76439 16.30583 0 17.27966 16.95063 18.98721 17.79003 17.10835 17.84658 16.93543 17.1626 0 0 0 20.28818 0 18.27736 16.42882 0 0 18.92617 0 17.85727 0 17.01554 15.89035 0 0 0 0 18.46743 O75096 LRP4_HUMAN "Low-density lipoprotein receptor-related protein 4, LRP-4 (Multiple epidermal growth factor-like domains 7)" LRP4 KIAA0816 LRP10 MEGF7 Homo sapiens (Human) amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395 IEASSMDGSGR 10.84000015 1 1 0.148001519 1125.666017 0 18.23469 0 14.54139 16.75226 13.88151 16.78622 17.16895 0 0 18.08165 0 12.61971 0 11.305 0 0 0 0 0 0 0 0 0 0 14.86009 0 0 15.93717 0 0 0 0 0 0 0 0 0 0 0 15.19392 0 13.88125 0 15.91799 14.7598 0 0 O75110 ATP9A_HUMAN "Probable phospholipid-transporting ATPase IIA, EC 7.6.2.1 (ATPase class II type 9A)" ATP9A ATPIIA KIAA0611 Homo sapiens (Human) "endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020] GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0031901; GO:0032588; GO:0045332; GO:0048471; GO:0055037; GO:0055038; GO:0140326; GO:1903542; GO:1905279; GO:2001135 NAHLVTR 9.420000076 1 1 0.248690194 810.7656594 16.36317 15.83936 15.06001 14.20308 15.84202 0 15.66094 0 15.58379 17.45351 16.24365 15.82726 15.9666 15.88445 15.62463 15.80304 14.52996 16.85122 0 16.35773 16.17247 15.81154 0 17.08763 16.11394 16.23485 16.87422 15.51101 0 0 16.72371 16.68021 17.08702 0 0 0 16.46431 0 16.18994 14.74712 0 16.40587 0 0 16.12098 15.9135 15.38578 15.69545 O75113 N4BP1_HUMAN "NEDD4-binding protein 1, N4BP1, EC 3.1.-.-" N4BP1 KIAA0615 Homo sapiens (Human) cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ubiquitin binding [GO:0043130]; cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088] mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ubiquitin binding [GO:0043130] GO:0001818; GO:0003729; GO:0004540; GO:0005634; GO:0005730; GO:0005829; GO:0016605; GO:0031397; GO:0032435; GO:0034644; GO:0043130; GO:0045071; GO:0045087; GO:0045088 IFPDSEQRLK 5.150000095 0.153016225 0.153016225 0.128338157 1233.370916 0 15.65272 0 0 16.85955 0 15.3709 12.66955 16.77768 12.33696 0 0 0 0 12.59281 0 17.43623 15.56841 15.35735 16.14155 15.29983 0 0 0 15.65897 0 0 0 14.83292 15.41933 15.12659 16.05618 14.50078 14.47837 0 0 14.91464 0 18.10532 0 0 10.25382 16.08115 11.06628 0 15.06228 0 15.18282 O75116 ROCK2_HUMAN "Rho-associated protein kinase 2, EC 2.7.11.1 (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II, ROCK-II) (p164 ROCK-2)" ROCK2 KIAA0619 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0000281; GO:0001837; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0004712; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0018105; GO:0018107; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145 IYESIEEAKSEAMK 8.710000038 1 1 0.242598322 1641.423414 12.78121 0 0 13.76702 15.94857 0 15.10695 0 0 16.99837 0 0 0 0 0 15.49786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.96564 0 0 0 0 0 0 0 0 O75121 MFA3L_HUMAN Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9) MFAP3L KIAA0626 HSD-39 HSD39 Homo sapiens (Human) cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0016021; GO:0030054 VSVHPQSK 5.130000114 1 1 8.04E-13 880.9131788 16.22906 14.29657 15.3573 0 0 0 0 0 0 0 0 0 0 0 0 16.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.10957 0 0 0 O75122 CLAP2_HUMAN "CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2, hOrbit2)" CLASP2 KIAA0627 Homo sapiens (Human) "cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]" axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802] "axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]" actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782] GO:0000226; GO:0000776; GO:0002162; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:0090307; GO:1903690; GO:1903754; GO:1904261; GO:1990782 AMGDDK 7.739999771 1 1 2.29E-13 653.3120397 15.90991 0 0 0 0 0 14.52596 16.27653 15.05119 0 17.22665 15.24808 0 16.26687 0 0 15.2376 0 0 0 16.05568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.54422 0 O75128 COBL_HUMAN Protein cordon-bleu COBL KIAA0633 Homo sapiens (Human) actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; collateral sprouting in absence of injury [GO:0048669]; digestive tract development [GO:0048565]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; liver development [GO:0001889]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; positive regulation of dendrite development [GO:1900006]; positive regulation of ruffle assembly [GO:1900029]; somite specification [GO:0001757] actin filament [GO:0005884]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; terminal web [GO:1990357] actin filament [GO:0005884]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; terminal web [GO:1990357]; actin monomer binding [GO:0003785]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; collateral sprouting in absence of injury [GO:0048669]; digestive tract development [GO:0048565]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; liver development [GO:0001889]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; positive regulation of dendrite development [GO:1900006]; positive regulation of ruffle assembly [GO:1900029]; somite specification [GO:0001757] actin monomer binding [GO:0003785] GO:0000578; GO:0001726; GO:0001757; GO:0001843; GO:0001889; GO:0003785; GO:0005884; GO:0005886; GO:0005938; GO:0016020; GO:0030041; GO:0030424; GO:0030425; GO:0030903; GO:0033504; GO:0043025; GO:0044294; GO:0044295; GO:0048471; GO:0048565; GO:0048669; GO:0051639; GO:1900006; GO:1900029; GO:1990357 ELVNGSVR 9.119999886 0.282762855 0.282762855 0.527259681 870.1817469 16.22884 15.80824 16.38451 0 16.85126 0 0 12.62605 0 15.70712 14.82412 14.69665 0 0 0 16.90767 0 0 15.51422 0 17.30754 16.90552 0 0 0 0 0 16.93464 0 0 0 16.03289 0 0 0 0 0 17.10111 0 0 0 0 0 16.89686 16.42568 0 0 16.37392 O75129 ASTN2_HUMAN Astrotactin-2 ASTN2 KIAA0634 Homo sapiens (Human) establishment of body hair planar orientation [GO:0048105]; negative regulation of protein localization to cell surface [GO:2000009]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764]; protein transport [GO:0015031] cell cortex [GO:0005938]; cell pole [GO:0060187]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perikaryon [GO:0043204] "cell cortex [GO:0005938]; cell pole [GO:0060187]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perikaryon [GO:0043204]; calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; establishment of body hair planar orientation [GO:0048105]; negative regulation of protein localization to cell surface [GO:2000009]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764]; protein transport [GO:0015031]" "calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]" GO:0001764; GO:0005509; GO:0005768; GO:0005769; GO:0005770; GO:0005938; GO:0007158; GO:0015031; GO:0016021; GO:0030136; GO:0043204; GO:0043533; GO:0048105; GO:0060187; GO:2000009 EQQMAYNTLMEVSASMLFR 3.680000067 1 1 0.775606444 2280.217505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75131 CPNE3_HUMAN Copine-3 (Copine III) CPNE3 CPN3 KIAA0636 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335] azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335] calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723] GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363 LLPPKNPATK 11.55000019 1 1 0.210428257 1079.64239 0 0 0 0 0 0 0 0 0 0 0 0 0 17.66708 0 18.20291 0 0 0 0 17.81949 0 0 0 0 0 0 15.32462 0 0 0 19.87142 0 0 17.39623 0 0 0 0 18.0595 0 0 0 0 0 0 0 0 O75132 ZBED4_HUMAN Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983 EAMVSR 21.20000076 1 1 0.274878514 707.7581776 0 0 0 0 0 0 0 0 22.16389 0 19.27697 0 0 0 19.37695 0 0 0 0 0 19.55424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22.36942 20.27152 0 0 0 0 20.33256 0 0 0 0 0 0 O75140 DEPD5_HUMAN GATOR complex protein DEPDC5 (DEP domain-containing protein 5) DEPDC5 KIAA0645 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877] GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130 FGFVQDK 15.77999973 0.045147039 0.045147039 0.266703833 839.290761 16.8065 16.9962 16.31275 0 16.71148 13.71896 15.94005 15.57646 0 0 14.62791 15.77404 16.9558 0 16.31895 16.23014 15.97851 16.40159 0 0 0 0 17.3728 0 16.47909 0 0 17.42166 0 0 16.88708 17.29625 15.98515 0 0 16.69571 16.71943 15.52996 0 16.36109 0 0 0 16.77852 17.79755 15.30526 16.67554 0 O75145 LIPA3_HUMAN "Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3, PTPRF-interacting protein alpha-3)" PPFIA3 KIAA0654 Homo sapiens (Human) neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synapse organization [GO:0050808]; synaptic vesicle docking [GO:0016081] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; epididymosome [GO:0098875]; glutamatergic synapse [GO:0098978]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; epididymosome [GO:0098875]; glutamatergic synapse [GO:0098978]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synapse organization [GO:0050808]; synaptic vesicle docking [GO:0016081] GO:0001669; GO:0005829; GO:0007269; GO:0016081; GO:0048172; GO:0048786; GO:0050808; GO:0098831; GO:0098875; GO:0098978 DVMVWSNER 1.029999971 0.108114444 0.108114444 0.090443727 1149.741009 0 15.93266 13.28037 0 0 12.97031 15.62061 0 0 10.09088 0 14.14076 0 13.83364 0 0 15.67099 0 0 15.66017 13.78655 15.41275 16.0874 14.1961 0 0 0 0 14.48727 17.31376 13.58473 17.80634 14.88512 17.12564 14.01736 0 15.03227 16.24985 16.42056 15.55859 0 0 16.60821 0 0 0 17.50002 14.92217 O75146 HIP1R_HUMAN "Huntingtin-interacting protein 1-related protein, HIP1-related protein (Huntingtin-interacting protein 12, HIP-12)" HIP1R HIP12 KIAA0655 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein binding [GO:0032092]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060] "apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein binding [GO:0032092]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453]" "actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124]" GO:0005546; GO:0005547; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0006898; GO:0006915; GO:0006919; GO:0007015; GO:0014069; GO:0016324; GO:0017124; GO:0030100; GO:0030136; GO:0030276; GO:0030665; GO:0030837; GO:0032051; GO:0032092; GO:0032587; GO:0032839; GO:0032956; GO:0034316; GO:0035091; GO:0035615; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043066; GO:0043197; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048268; GO:0048471; GO:0050821; GO:0051015; GO:0055123; GO:0060453; GO:0080025; GO:0097060; GO:1901030; GO:1905445; GO:2000369; GO:2000588 GAATQQEFYAK 5.590000153 1 1 0.175421801 1212.781761 12.7187 13.53512 15.09398 0 0 13.17332 13.77588 11.74971 13.28546 15.18786 15.02642 15.87703 14.46354 11.82573 0 9.873562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6305 16.1813 0 0 0 0 0 0 0 0 0 O75147 OBSL1_HUMAN Obscurin-like protein 1 OBSL1 KIAA0657 Homo sapiens (Human) cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Z disc [GO:0030018] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Z disc [GO:0030018]; cytoskeletal anchor activity [GO:0008093]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] cytoskeletal anchor activity [GO:0008093] GO:0000226; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0007010; GO:0007030; GO:0007088; GO:0007156; GO:0007416; GO:0008093; GO:0010842; GO:0014704; GO:0030018; GO:0031430; GO:0034067; GO:0045202; GO:0048471; GO:0050775; GO:0055003; GO:1990393 DRDGGFVLK 4.440000057 1 1 0.277812441 1006.794255 16.2223 0 15.52117 0 0 0 0 0 0 0 14.12826 16.57036 0 0 0 14.50166 0 14.43084 0 0 0 0 0 0 0 0 16.11502 0 0 0 0 0 0 0 0 0 0 0 0 16.33387 0 0 14.11251 0 0 0 0 0 O75150 BRE1B_HUMAN "E3 ubiquitin-protein ligase BRE1B, BRE1-B, EC 2.3.2.27 (95 kDa retinoblastoma-associated protein, RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)" RNF40 BRE1B KIAA0661 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] GO:0000151; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006511; GO:0010390; GO:0016020; GO:0017075; GO:0019898; GO:0031624; GO:0031625; GO:0033503; GO:0033523; GO:0042803; GO:0043005; GO:0043434; GO:0043679; GO:0044877; GO:0046872; GO:0061630; GO:0071894; GO:1900364; GO:1901800; GO:1902916; GO:2001168 MSGPGNK 4.150000095 1 1 0.141956838 689.2754138 15.15077 0 0 0 14.03949 15.59602 13.68901 0 15.01978 16.54569 0 0 0 0 14.92473 14.11301 12.83548 14.01618 0 0 16.16678 0 0 0 0 0 0 0 0 0 0 0 15.15169 0 15.09559 0 0 0 0 0 16.09482 16.95958 0 0 0 0 0 0 O75151 PHF2_HUMAN "Lysine-specific demethylase PHF2, EC 1.14.11.- (GRC5) (PHD finger protein 2)" PHF2 CENP-35 KIAA0662 Homo sapiens (Human) epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone H4-K20 demethylation [GO:0035574]; liver development [GO:0001889]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone H4-K20 demethylation [GO:0035574]; liver development [GO:0001889]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] GO:0000776; GO:0001889; GO:0003712; GO:0003713; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006482; GO:0008270; GO:0032454; GO:0035064; GO:0035574; GO:0035575; GO:0045815; GO:0061188 LDSAAYK 6.739999771 0.248014972 0.248014972 0.169065064 767.5294501 19.13977 20.04452 19.88574 18.70226 19.3258 17.56743 18.45731 17.3619 0 18.19748 18.53473 0 17.96694 18.55863 18.05087 20.53884 19.18867 19.39634 17.93583 18.82862 19.05081 0 19.1946 18.72593 18.52609 18.55873 19.63068 18.13873 18.51433 0 18.36461 18.99847 18.59419 18.71396 19.67306 16.14346 18.51711 18.98315 18.10904 20.04585 19.41124 18.40897 19.82828 18.85723 19.73632 19.26586 19.93555 19.69499 O75152 ZC11A_HUMAN Zinc finger CCCH domain-containing protein 11A ZC3H11A KIAA0663 ZC3HDC11A Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; poly(A)+ mRNA export from nucleus [GO:0016973] metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872 SLAQRLGK 11.80000019 0.59279567 0.59279567 0.276752185 873.109229 16.63112 0 13.73112 0 14.97725 0 14.9312 0 13.87901 15.07329 15.52514 0 14.64631 15.02104 0 15.79352 15.04428 15.32596 0 13.55332 15.32334 16.00526 15.23826 15.43938 0 14.97573 0 0 0 16.27655 15.54402 16.26117 0 16.08318 0 0 0 0 15.04154 0 15.844 0 14.97327 16.72535 16.75541 15.06471 0 15.22837 O75153 CLU_HUMAN Clustered mitochondria protein homolog CLUH KIAA0664 Homo sapiens (Human) intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005] mRNA binding [GO:0003729] GO:0003729; GO:0005737; GO:0007005; GO:0048312 QELVDAFVEHR 2.700000048 0.476546258 0.476546258 0.105335415 1342.513618 0 14.78308 0 0 14.83554 0 0 12.34791 0 0 0 0 0 0 0 14.997 0 0 0 18.41564 16.82857 0 16.45056 0 0 0 0 0 0 0 16.57618 16.52056 0 0 0 0 0 0 0 0 15.43798 16.86391 0 0 0 0 0 0 O75155 CAND2_HUMAN "Cullin-associated NEDD8-dissociated protein 2 (Cullin-associated and neddylation-dissociated protein 2) (Epididymis tissue protein Li 169) (TBP-interacting protein of 120 kDa B, TBP-interacting protein 120B) (p120 CAND2)" CAND2 KIAA0667 TIP120B Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; TBP-class protein binding [GO:0017025]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]" TBP-class protein binding [GO:0017025] GO:0005634; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0045893 DHYDIRMLTFIMVAR 8.479999542 1 1 0.26156773 1896.035345 15.62018 14.78203 14.56481 0 0 15.00069 0 15.29998 12.5645 0 0 0 0 0 0 0 0 0 0 0 16.25913 0 15.32786 0 15.81061 13.85032 0 13.06487 0 0 14.2836 0 15.52505 0 14.89091 15.039 0 16.15977 0 14.57837 0 0 16.0651 0 0 0 0 0 O75161 NPHP4_HUMAN Nephrocystin-4 (Nephroretinin) NPHP4 KIAA0673 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; flagellated sperm motility [GO:0030317]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization to ciliary transition zone [GO:1904491]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual behavior [GO:0007632] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor distal connecting cilium [GO:0120206]; ribbon synapse [GO:0097470] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor distal connecting cilium [GO:0120206]; ribbon synapse [GO:0097470]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; flagellated sperm motility [GO:0030317]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization to ciliary transition zone [GO:1904491]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual behavior [GO:0007632] structural molecule activity [GO:0005198] GO:0005198; GO:0005654; GO:0005813; GO:0005829; GO:0005911; GO:0005923; GO:0007165; GO:0007632; GO:0016604; GO:0030036; GO:0030317; GO:0035845; GO:0035869; GO:0036064; GO:0043231; GO:0045494; GO:0060041; GO:0090090; GO:0097470; GO:0097546; GO:0097730; GO:0098609; GO:0120206; GO:1903348; GO:1904491 ESDATRR 6.360000134 1 1 0.048014502 834.519526 0 17.35629 0 0 15.46716 15.1524 14.99765 0 0 0 14.4009 0 0 0 0 0 0 0 0 0 13.30474 0 12.03702 0 0 0 13.37558 16.26228 0 15.89237 0 0 0 0 0 0 0 0 0 0 0 0 0 15.70243 0 0 0 0 O75164 KDM4A_HUMAN "Lysine-specific demethylase 4A, EC 1.14.11.66, EC 1.14.11.69 (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) ([histone H3]-trimethyl-L-lysine(36) demethylase 4A) ([histone H3]-trimethyl-L-lysine(9) demethylase 4A)" KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) "cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; response to nutrient levels [GO:0031667]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-36 demethylase activity [GO:0140681]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; response to nutrient levels [GO:0031667]" histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-36 demethylase activity [GO:0140681]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0001650; GO:0005634; GO:0005654; GO:0005721; GO:0005829; GO:0006338; GO:0008270; GO:0010507; GO:0010628; GO:0010629; GO:0014898; GO:0016577; GO:0031625; GO:0031667; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0045666; GO:0045892; GO:0048712; GO:0051864; GO:0060548; GO:0070544; GO:0140681; GO:0140684; GO:1900113 MTLISPLMLK 19.5 0.329739243 0.329739243 0.267599423 1163.767617 22.55484 23.43614 22.58543 18.50789 22.28448 21.48652 21.88889 21.958 22.50403 16.94842 17.7779 20.84171 21.58229 18.66158 16.20403 21.36371 22.46336 22.15061 21.67423 16.88223 18.34604 20.53154 21.74886 21.11478 0 0 22.41626 22.64814 0 18.77444 22.91304 20.59428 22.43478 23.19789 20.20256 23.3596 21.99648 21.27112 21.70564 21.09162 22.45425 22.17713 17.35196 21.47238 21.59006 22.41001 22.29437 21.95162 O75165 DJC13_HUMAN "DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8, RME-8)" DNAJC13 KIAA0678 RME8 Homo sapiens (Human) endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641 DNVKIAMDQYGK 5.349999905 1 1 0.252458723 1397.390016 0 13.89209 0 0 0 0 0 0 0 15.23392 0 13.69128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.96511 0 0 0 0 0 0 0 0 0 12.23028 0 0 16.91326 16.21006 15.10913 0 0 0 0 0 0 O75170 PP6R2_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2) PPP6R2 KIAA0685 PP6R2 SAPS2 Homo sapiens (Human) regulation of phosphoprotein phosphatase activity [GO:0043666] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666] protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043231; GO:0043666 EAPPLPTVARTEEAVGR 1.159999967 1 1 0.270731146 1792.001107 0 13.56706 0 15.99591 15.12358 0 13.1504 0 0 15.72495 0 0 14.62866 16.70498 0 0 0 15.33008 0 0 0 0 0 14.95142 0 16.67055 17.67824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.52237 0 0 0 0 0 O75173 ATS4_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 4, ADAM-TS 4, ADAM-TS4, ADAMTS-4, EC 3.4.24.82 (ADMP-1) (Aggrecanase-1)" ADAMTS4 KIAA0688 UNQ769/PRO1563 Homo sapiens (Human) extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020] GO:0001501; GO:0002020; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0016607; GO:0022617; GO:0030198; GO:0031012; GO:0046872; GO:0062023 CMVCGGDGSGCSKQSGSFR 4.760000229 1 1 0.109801292 2053.250254 13.78491 0 0 0 0 11.46987 0 0 14.00966 18.34324 14.52622 14.00817 0 0 0 13.72957 0 12.6633 11.92828 0 0 0 0 0 16.55867 16.71863 0 0 11.91625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.582 0 0 0 0 O75177 CREST_HUMAN Calcium-responsive transactivator (SS18-like protein 1) (SYT homolog 1) SS18L1 CREST KIAA0693 Homo sapiens (Human) "chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" cytosol [GO:0005829]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" transcription coactivator activity [GO:0003713] GO:0000776; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0016358; GO:0045893; GO:0045944; GO:0050775; GO:0071565 SVAFASARPR 5.940000057 0.853987515 0.853987515 0.184999267 1060.429733 0 0 15.08647 0 0 0 0 0 16.15563 0 0 0 0 15.21301 0 13.7447 0 15.87669 0 0 0 15.39677 16.02469 0 0 0 15.86252 16.82736 0 0 0 0 0 0 0 0 0 0 0 0 14.09079 14.24944 15.96335 0 0 0 0 0 O75182 SIN3B_HUMAN Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b) SIN3B KIAA0700 Homo sapiens (Human) histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122] autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806] autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0030336; GO:0030849 KPAPGPHSSPPEEK 4.239999771 0.434092522 0.434092522 0.180279614 1457.160485 17.94113 0 16.36081 17.32984 0 0 17.71251 0 0 0 17.1036 0 0 0 0 0 0 14.63489 0 0 0 0 0 0 16.51177 0 0 16.30741 0 16.87473 0 0 16.06069 0 0 11.96868 0 0 14.94669 0 0 0 0 18.24959 15.4039 16.06795 0 0 O75185 AT2C2_HUMAN "Calcium-transporting ATPase type 2C member 2, ATPase 2C2, EC 7.2.2.10 (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2, SPCA2)" ATP2C2 KIAA0703 SPCA2 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659] basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613] GO:0000139; GO:0005388; GO:0005524; GO:0005783; GO:0005886; GO:0006828; GO:0006874; GO:0009898; GO:0015662; GO:0016021; GO:0016323; GO:0016887; GO:0031410; GO:0032588; GO:0034220; GO:0046872; GO:0048471; GO:0061180; GO:0070588; GO:0072659; GO:0090280; GO:0140613 EVIKEFSNVSVGK 7.5 1 1 0.055331686 1435.765275 0 12.788 0 12.38397 0 11.08672 0 15.24415 0 0 0 0 14.27614 0 12.55923 13.44179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.35558 0 13.86634 0 0 0 0 15.46025 0 0 0 13.79793 0 0 0 0 0 O75190 DNJB6_HUMAN "DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2, HSJ-2) (MRJ) (MSJ-1)" DNAJB6 HSJ2 MRJ MSJ1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]" ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] GO:0001671; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0016020; GO:0030018; GO:0030036; GO:0030198; GO:0031072; GO:0032880; GO:0034504; GO:0042802; GO:0043154; GO:0044183; GO:0045109; GO:0045892; GO:0048471; GO:0051082; GO:0051087; GO:0060710; GO:0060715; GO:0060717; GO:0061077; GO:0090084; GO:1900034 SISTSTKMVNGR 4.480000019 1 1 0.147061564 1297.301201 0 0 0 14.52827 0 0 0 0 0 12.07569 0 0 0 12.75486 0 0 0 0 0 0 0 0 0 0 0 14.08744 0 0 0 0 14.85016 0 0 11.7345 14.97793 0 15.88617 0 0 12.94925 0 0 0 0 14.39482 0 0 0 O75191 XYLB_HUMAN "Xylulose kinase, Xylulokinase, EC 2.7.1.17" XYLB Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997] cytosol [GO:0005829] "cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]" "ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]" GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0016310; GO:0016773; GO:0019640; GO:0042732 VAAFPGDVEVR 1.539999962 1 1 0.116363057 1156.109645 19.62378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71275 0 0 0 0 0 0 0 O75197 LRP5_HUMAN "Low-density lipoprotein receptor-related protein 5, LRP-5 (Low-density lipoprotein receptor-related protein 7, LRP-7)" LRP5 LR3 LRP7 Homo sapiens (Human) "adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]" endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]" coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262; GO:1904928; GO:1990851; GO:1990909 DVIIDQLPDLMGLK 3.349999905 1 1 0.030491528 1569.00252 14.71332 0 0 0 0 0 16.37691 0 0 0 0 0 15.17334 15.61888 0 13.65459 0 12.05898 0 0 0 0 0 0 0 0 15.26511 0 0 0 0 14.18887 19.92914 0 17.65977 16.51477 0 0 0 0 0 0 0 0 0 16.45337 0 0 O75223 GGCT_HUMAN "Gamma-glutamylcyclotransferase, EC 4.3.2.9 (Cytochrome c-releasing factor 21)" GGCT C7orf24 CRF21 Homo sapiens (Human) release of cytochrome c from mitochondria [GO:0001836] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836] gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803] GO:0001836; GO:0003839; GO:0005829; GO:0042803; GO:0070062 KIICMGAK 4.809999943 1 1 0.107384374 919.9351067 0 0 15.46655 15.99645 16.16099 15.78581 15.10031 15.08668 13.7965 11.73639 11.07645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.10492 14.52787 13.02245 0 0 14.81436 0 0 16.89869 15.93604 0 0 0 0 0 0 0 0 0 O75290 Z780A_HUMAN Zinc finger protein 780A ZNF780A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 NIHTGEKAS 5.360000134 1 1 0.24203175 955.9018118 14.93326 0 13.1502 14.7112 14.49074 0 18.44955 13.3364 0 0 16.07107 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81195 16.27797 16.41351 0 0 0 0 0 0 0 0 0 0 17.36758 0 0 16.44089 15.65892 14.44966 15.26865 15.39075 0 15.20761 0 O75298 RTN2_HUMAN "Reticulon-2 (Neuroendocrine-specific protein-like 1, NSP-like protein 1) (Neuroendocrine-specific protein-like I, NSP-like protein I, NSPLI)" RTN2 NSPL1 Homo sapiens (Human) gene expression [GO:0010467]; intracellular protein transmembrane transport [GO:0065002]; negative regulation of amyloid-beta formation [GO:1902430]; regulation of glucose import [GO:0046324] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; intermediate filament [GO:0005882]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; Z disc [GO:0030018] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; intermediate filament [GO:0005882]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; gene expression [GO:0010467]; intracellular protein transmembrane transport [GO:0065002]; negative regulation of amyloid-beta formation [GO:1902430]; regulation of glucose import [GO:0046324] GO:0005783; GO:0005882; GO:0009986; GO:0010467; GO:0014802; GO:0030018; GO:0030176; GO:0030315; GO:0033017; GO:0046324; GO:0065002; GO:1902430 VLLKWAK 5.53000021 1 1 0.173638781 856.2931686 15.32004 14.88736 0 15.20216 0 0 0 15.48659 14.07154 14.70762 15.36339 16.98335 13.77072 11.54817 11.42315 0 0 14.84843 15.81547 15.33402 14.60989 16.29839 16.03044 0 13.07837 0 0 0 16.33372 0 0 0 0 0 0 0 0 0 0 0 15.44601 0 0 0 15.65094 0 0 0 O75312 ZPR1_HUMAN Zinc finger protein ZPR1 (Zinc finger protein 259) ZPR1 ZNF259 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834] axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834] receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270] GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0007165; GO:0008270; GO:0008283; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045787; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672 QQEEMLGLQEEAPAEKPEEEDLR 7.25 1 1 1.84E-12 2713.54641 13.17196 0 0 0 15.27507 14.23811 0 0 16.04095 0 0 0 0 0 15.86808 0 0 0 0 0 0 0 13.31608 0 0 0 16.26554 0 0 15.04984 0 12.59841 0 0 0 0 15.27638 0 0 0 0 0 0 0 0 0 0 0 O75324 SNN_HUMAN Stannin (AG8_1) SNN Homo sapiens (Human) response to toxic substance [GO:0009636] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; response to toxic substance [GO:0009636] metal ion binding [GO:0046872] GO:0005737; GO:0005741; GO:0009636; GO:0016021; GO:0046872 LMTPNGPEVHG 6.190000057 1 1 0.188030204 1153.918994 14.08683 15.92113 15.1525 15.71813 14.83957 0 11.87343 0 13.01755 0 0 0 15.35987 0 0 0 15.61484 0 0 0 0 0 0 0 0 16.68836 0 0 17.27419 0 15.09296 0 0 0 0 14.32109 0 0 0 14.59684 0 0 0 0 0 0 0 0 O75326 SEM7A_HUMAN "Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1, Sema K1) (Semaphorin-L, Sema L) (CD antigen CD108)" SEMA7A CD108 SEMAL Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526] chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215] GO:0001649; GO:0001755; GO:0001934; GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007229; GO:0007411; GO:0009897; GO:0016020; GO:0021988; GO:0030215; GO:0030335; GO:0031225; GO:0045499; GO:0045773; GO:0048675; GO:0048843; GO:0050727; GO:0050919; GO:0060907; GO:0070374; GO:0071526 HPEVAQRVEPMGPLK 6.679999828 0.180612177 0.180612177 0.179716672 1687.113017 0 0 16.80714 15.64219 0 14.74487 9.436291 0 13.71357 0 18.63106 12.55059 0 0 0 0 17.66087 17.75113 15.41227 0 0 16.69915 15.73884 13.5548 0 19.01638 18.39611 13.68729 14.97643 0 12.701 0 0 15.09401 0 0 15.03873 0 15.46617 13.55773 13.27132 0 0 14.6145 18.35264 16.5739 17.94471 0 O75330 HMMR_HUMAN Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168) HMMR IHABP RHAMM Homo sapiens (Human) cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819] cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819]; hyaluronic acid binding [GO:0005540] hyaluronic acid binding [GO:0005540] GO:0005540; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0009986; GO:0015630; GO:0016020 SSESK 4.460000038 0.486471981 0.486471981 0.288027791 535.2746156 17.26205 11.08824 0 0 0 0 0 0 0 0 17.32529 0 0 18.65825 0 0 17.08944 0 0 16.8373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.80834 0 0 15.87142 0 0 17.66399 0 0 0 O75333 TBX10_HUMAN "T-box transcription factor TBX10, T-box protein 10" TBX10 TBX7 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0005634; GO:0006357; GO:0009653 VHFHPDSPAK 5.190000057 1 1 0.108438799 1134.30651 12.99266 16.47058 13.70968 0 12.54606 14.00999 0 0 0 0 0 13.66916 0 0 0 0 14.03884 12.63078 0 12.60105 0 11.07858 0 0 16.35819 0 0 13.86062 13.28804 0 0 0 0 16.07951 0 0 0 0 0 0 0 0 16.14956 0 16.6826 0 0 0 O75343 GCYB2_HUMAN "Guanylate cyclase soluble subunit beta-2, GCS-beta-2, EC 4.6.1.2" GUCY1B2 Homo sapiens (Human) cGMP-mediated signaling [GO:0019934] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; cGMP-mediated signaling [GO:0019934] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872] GO:0004383; GO:0005525; GO:0005737; GO:0019934; GO:0020037; GO:0046872 HLAIEK 2.160000086 9.97E-06 9.97E-06 0.038669427 709.7738753 15.54548 15.53547 16.68589 15.91828 6.682693 16.61292 14.1951 0 15.75063 14.64093 0 14.83593 14.76052 14.95783 0 0 15.61256 0 13.96192 0 16.2773 17.37085 17.93363 14.61214 0 16.70299 14.97299 15.32104 0 14.97991 17.1716 17.36819 16.79343 8.598118 13.55168 14.46637 14.76119 0 16.50701 0 15.14445 15.15113 0 15.3795 15.01265 0 17.2294 13.13783 O75351 VPS4B_HUMAN "Vacuolar protein sorting-associated protein 4B, EC 3.6.4.6 (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1, Protein SKD1)" VPS4B SKD1 VPS42 MIG1 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] GO:0000922; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007080; GO:0008022; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060548; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949 AIDLASK 17.09000015 1.19E-11 1.19E-11 0.293789422 716.6757971 17.75505 17.9043 18.39015 0 0 17.71265 0 18.61774 0 19.23131 18.20793 0 0 17.82423 0 0 0 19.01174 17.62486 19.05074 19.00177 0 18.83012 18.98188 0 0 0 18.82788 15.69094 0 0 0 0 0 19.12037 19.93402 18.37141 19.75829 0 0 0 19.72812 18.82511 18.8516 0 0 19.22292 17.38911 O75352 MPU1_HUMAN "Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog, SL15)" MPDU1 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457] GO:0005789; GO:0006457; GO:0006488; GO:0009312; GO:0016020; GO:0016021 AAEADGPLK 11.5 0.37905848 0.37905848 0.132944264 870.9713396 18.04637 17.84671 0 0 16.02115 0 17.39552 18.39446 14.11185 16.37863 16.58914 18.68475 0 14.87719 0 0 14.07203 17.16545 16.67751 16.55919 15.83423 0 14.84597 17.58722 0 15.79224 0 13.21843 16.81923 17.12063 0 16.66137 18.07632 0 0 18.03657 0 0 0 18.72223 0 12.40819 0 0 0 17.30503 0 0 O75354 ENTP6_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 6, NTPDase 6, EC 3.6.1.6 (CD39 antigen-like 2)" ENTPD6 CD39L2 IL6ST2 Homo sapiens (Human) nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytidine-diphosphatase activity [GO:0036384]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026]" "cytidine-diphosphatase activity [GO:0036384]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]" GO:0000139; GO:0004382; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0008894; GO:0009134; GO:0009986; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0032026; GO:0036384; GO:0045134; GO:0051592; GO:1990003 QKSPAS 2.5 0.554157853 0.554157853 0.19126795 616.3945329 15.76735 14.42173 0 14.66047 0 15.00282 16.71923 0 14.33891 0 0 0 0 15.41153 15.06238 16.01419 0 16.1535 16.71639 14.91217 16.30441 15.5734 16.1521 16.04187 15.06212 15.63777 0 0 15.24968 0 0 0 13.63109 0 0 0 0 0 17.18743 0 17.10624 16.3541 15.96103 0 0 15.1242 16.4355 16.52638 O75363 BCAS1_HUMAN Breast carcinoma-amplified sequence 1 (Amplified and overexpressed in breast cancer) (Novel amplified in breast cancer 1) BCAS1 AIBC1 NABC1 Homo sapiens (Human) myelination [GO:0042552] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myelination [GO:0042552] GO:0005737; GO:0042552; GO:0070062 QQSLGGFFKGLGPK 8.380000114 1 1 2.32E-13 1463.325735 16.66679 18.23072 17.37612 0 0 14.44595 0 0 0 0 0 0 0 0 0 0 0 16.72911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75365 TP4A3_HUMAN "Protein tyrosine phosphatase type IVA 3, EC 3.1.3.48 (PRL-R) (Protein-tyrosine phosphatase 4a3) (Protein-tyrosine phosphatase of regenerating liver 3, PRL-3)" PTP4A3 PRL3 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; endothelial cell migration [GO:0043542]; Notch signaling pathway [GO:0007219]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular permeability [GO:0043117]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]" cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to leukemia inhibitory factor [GO:1990830]; endothelial cell migration [GO:0043542]; Notch signaling pathway [GO:0007219]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular permeability [GO:0043117]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]" prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006355; GO:0007219; GO:0008138; GO:0043117; GO:0043542; GO:1900746; GO:1901224; GO:1904951; GO:1990830 MARMNRPAPVEVSYK 8.109999657 0.787114501 0.787114501 0.278422411 1764.652792 0 0 0 0 0 0 0 13.33355 0 15.05591 0 18.93148 14.33845 14.85778 0 0 14.95083 15.15478 0 0 12.83497 0 0 0 0 0 13.53748 0 0 0 0 0 0 12.31644 13.61844 14.84728 0 0 0 0 0 0 0 0 0 0 0 0 O75366 AVIL_HUMAN Advillin (p92) AVIL Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005] "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]" "actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480 GKGATK 8.300000191 1 1 0.306213735 562.6098595 17.85979 18.08295 0 0 17.37632 17.30751 0 0 18.97585 0 0 0 0 0 16.32713 0 20.31699 0 0 15.4846 0 17.58709 0 0 0 0 17.8677 0 18.53827 0 18.342 18.63624 0 0 19.73487 17.99871 0 17.12615 18.80969 0 18.49708 0 17.39246 0 0 0 0 18.30716 O75367 H2AY_HUMAN "Core histone macro-H2A.1, Histone macroH2A1, mH2A1 (Histone H2A.y, H2A/y) (Medulloblastoma antigen MU-MB-50.205)" MACROH2A1 H2AFY Homo sapiens (Human) "dosage compensation [GO:0007549]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; dosage compensation [GO:0007549]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]" chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976] GO:0000122; GO:0000182; GO:0000228; GO:0000781; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0000979; GO:0001739; GO:0001740; GO:0003677; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0031490; GO:0031492; GO:0033128; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0070062; GO:0071169; GO:0071901; GO:1901837; GO:1902750; GO:1902882; GO:1902883; GO:1902884; GO:1903226; GO:1904815; GO:1990841 AGGKK 4.269999981 1 1 0.146828975 459.3023887 16.76309 18.60271 17.8002 18.36526 15.25355 12.50831 21.24178 0 19.95315 17.27336 21.48941 19.70541 0 0 18.66714 0 20.59755 21.38423 17.61379 17.47882 0 20.68002 0 0 0 0 0 18.93024 20.54028 18.7936 0 0 0 17.415 22.06598 0 0 0 0 0 17.45963 19.59584 20.63992 0 0 17.55938 17.86378 19.06192 O75369 FLNB_HUMAN "Filamin-B, FLN-B (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1, Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein, Truncated ABP)" FLNB FLN1L FLN3 TABP TAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0001725; GO:0003334; GO:0003382; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007165; GO:0007519; GO:0015629; GO:0016021; GO:0030018; GO:0030036; GO:0042802; GO:0045296; GO:0045335; GO:0051015; GO:0070062; GO:0071346 AQGDASKVTAK 5.260000229 0.514814258 0.514814258 0.192109773 1075.740548 14.39399 0 16.27685 13.35949 0 0 15.62932 0 0 15.59563 15.12547 0 0 0 0 0 0 0 0 16.00621 0 14.97168 0 0 0 15.90036 13.90837 13.87183 14.94034 15.70104 14.67722 15.5615 15.82587 0 15.29273 15.07998 0 14.64088 15.41862 0 14.5336 14.90431 12.81486 13.31843 11.83178 16.71805 14.71528 13.62763 O75376 NCOR1_HUMAN "Nuclear receptor corepressor 1, N-CoR, N-CoR1" NCOR1 KIAA1047 Homo sapiens (Human) "chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]" chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]" histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0000122; GO:0000785; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006357; GO:0016020; GO:0016922; GO:0017053; GO:0042826; GO:0045475; GO:0045820; GO:0045892; GO:0045922; GO:0046329; GO:0046966; GO:0051225; GO:0060766; GO:0061629; GO:0072686; GO:1903799 GPPPKSR 6.320000172 1 1 0.130003625 737.7046725 0 0 0 17.65147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.70146 0 0 0 0 17.60299 0 0 0 0 16.19559 15.69722 0 0 0 0 0 0 0 13.90129 0 O75380 NDUS6_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A, CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)" NDUFS6 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]" electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137] GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009055; GO:0009060; GO:0042776 VYINLDK 1.350000024 1 1 0.073954309 863.1876439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.77299 0 0 O75385 ULK1_HUMAN "Serine/threonine-protein kinase ULK1, EC 2.7.11.1 (Autophagy-related protein 1 homolog, ATG1, hATG1) (Unc-51-like kinase 1)" ULK1 KIAA0722 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of protein lipidation [GO:1903059]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of protein lipidation [GO:1903059]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] GO:0000045; GO:0000407; GO:0000422; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005741; GO:0005776; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007165; GO:0008104; GO:0008285; GO:0010508; GO:0016236; GO:0016241; GO:0018105; GO:0018107; GO:0030424; GO:0031102; GO:0031175; GO:0031267; GO:0031333; GO:0031669; GO:0034045; GO:0034727; GO:0042594; GO:0042802; GO:0044805; GO:0044877; GO:0046777; GO:0048671; GO:0048675; GO:0051020; GO:0055037; GO:0061709; GO:0097629; GO:0097632; GO:0097635; GO:0106310; GO:1903059; GO:1990316; GO:2000786 DSGGSK 2.00999999 0.103492633 0.103492633 0.172003993 551.273793 14.87982 14.70627 14.56308 14.68824 13.5393 14.60755 15.03268 0 14.55537 0 16.30686 15.18065 16.16422 15.93013 15.3543 0 14.93084 16.00341 16.60226 15.67166 16.36449 0 0 0 0 0 15.79562 16.27692 15.34039 15.70212 15.39088 15.56206 0 17.44921 17.09468 17.40355 16.52688 16.18668 16.77096 17.08823 15.59487 0 17.33416 16.04713 15.91464 16.18153 0 16.86228 O75387 LAT3_HUMAN Large neutral amino acids transporter small subunit 3 (L-type amino acid transporter 3) (Prostate cancer overexpressed gene 1 protein) (Solute carrier family 43 member 1) SLC43A1 LAT3 PB39 POV1 Homo sapiens (Human) amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804] amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175] GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0051956; GO:0060358 LQQEYAANGMGPLK 11.02999973 1 1 0 1520.170176 15.44963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75388 GPR32_HUMAN Probable G-protein coupled receptor 32 GPR32 Homo sapiens (Human) complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982] GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007200; GO:0007204 MNGVSEGTRGCSDR 4.75 0.030539576 0.030539576 0.184982563 1526.3837 0 0 0 15.29945 0 13.88488 0 0 0 0 15.50367 14.5711 16.05297 0 0 0 0 0 0 15.95291 0 0 0 0 0 0 0 15.52239 0 0 15.88752 16.33999 0 15.52029 17.97088 16.02166 14.58004 14.62049 14.70092 0 0 15.91363 0 0 15.44857 12.56137 0 0 O75390 CISY_HUMAN "Citrate synthase, mitochondrial, EC 2.3.3.1 (Citrate (Si)-synthase)" CS Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099] citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723] GO:0003723; GO:0004108; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0006101; GO:0070062 VVPGYGHAVLR 7.46999979 0.480170876 0.480170876 0.245628694 1172.07978 0 16.72938 14.85317 0 0 0 0 15.181 0 0 0 0 18.09694 14.4713 0 0 0 11.84083 0 0 15.62986 16.09549 0 15.39686 0 0 15.31211 16.52457 16.22173 0 16.46555 0 17.34597 17.13145 0 17.39472 0 0 16.94538 15.31252 15.38142 15.63512 0 15.20208 0 0 0 0 O75400 PR40A_HUMAN "Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10, HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)" PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]" membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0007049; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004 RPGTGAER 7.860000134 1 1 0.14616816 843.4644199 0 0 14.53374 14.98284 15.62495 14.35511 0 0 0 0 15.48816 0 16.6482 15.43225 13.71118 16.88931 0 15.52394 0 17.01187 0 0 0 0 0 0 0 0 0 0 16.44178 0 0 16.58492 0 0 0 0 0 16.49831 15.09889 0 18.32422 0 0 0 0 0 O75410 TACC1_HUMAN Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1) TACC1 KIAA1103 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966] GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0007052; GO:0008283; GO:0016020; GO:0016922; GO:0021987; GO:0030331; GO:0030374; GO:0030496; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301 SRLITSGCK 10.65999985 1 1 0.063268624 1021.282745 16.54311 13.40642 14.09438 0 16.73628 0 14.01739 12.34395 12.36545 12.29031 0 0 0 0 22.04712 0 17.14736 0 0 0 0 0 0 0 0 22.15586 0 0 0 0 22.18514 11.01523 0 0 0 0 0 21.03091 16.43581 0 0 0 0 0 19.98399 0 0 0 O75417 DPOLQ_HUMAN "DNA polymerase theta, EC 2.7.7.7 (DNA polymerase eta)" POLQ POLH Homo sapiens (Human) base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116] GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0017116; GO:0042802; GO:0051260; GO:0051575; GO:0097681; GO:2000042 DGFVQTILGRR 7.800000191 1 1 0.101695865 1260.734579 14.0876 15.28877 14.86125 0 13.13464 0 15.26332 0 0 13.15066 0 0 0 0 15.45279 14.4925 0 14.05106 16.48204 0 0 15.2247 15.31029 0 15.10505 16.38265 0 14.19998 15.43092 15.33961 0 0 0 0 0 0 0 0 0 0 0 0 17.62832 0 0 0 0 0 O75419 CDC45_HUMAN Cell division control protein 45 homolog (PORC-PI-1) CDC45 CDC45L CDC45L2 UNQ374/PRO710 Homo sapiens (Human) DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977] chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] GO:0000076; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006268; GO:0006270; GO:0031261; GO:0036064; GO:0071162; GO:1902977 LVLYQHWSLHDSLCNTSYTAARFK 5.329999924 0.676102519 0.676102519 3.66E-12 2911.103222 0 0 14.3303 15.09947 12.07381 14.06847 13.20282 15.20946 0 0 13.93256 17.3258 13.05474 14.73994 0 14.29707 15.77294 0 0 0 0 0 15.93973 9.693634 0 0 0 0 0 0 0 14.82364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75420 GGYF1_HUMAN GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1) GIGYF1 CDS2 PERQ1 PP3360 Homo sapiens (Human) insulin-like growth factor receptor signaling pathway [GO:0048009] cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009] GO:0005829; GO:0032991; GO:0048009 QFLERR 7.150000095 0.698474646 0.698474646 0.005915449 849.2999003 0 0 0 0 0 16.5198 0 0 15.02597 0 0 0 15.02628 14.72279 0 0 0 12.57279 14.15462 0 13.21487 0 13.74939 0 14.23271 0 12.35973 0 15.00267 14.59023 12.35954 0 15.49384 11.92177 11.56457 15.0105 0 16.18699 0 13.06863 0 0 12.27978 0 13.71058 0 0 14.11435 O75426 FBX24_HUMAN F-box only protein 24 FBXO24 FBX24 Homo sapiens (Human) protein ubiquitination [GO:0016567] ubiquitin ligase complex [GO:0000151] ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567] ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0004842; GO:0016567 ACRYVVLCR 13.43000031 1 1 1.83E-12 1195.779661 0 0 0 0 0 11.02479 15.14078 16.72454 16.43444 0 0 0 0 0 0 0 0 0 0 17.15001 0 0 0 0 14.41481 0 0 0 0 14.33273 15.48144 0 0 0 0 0 13.5399 17.08127 0 0 0 0 16.61886 0 0 0 15.81153 16.73865 O75437 ZN254_HUMAN "Zinc finger protein 254 (Bone marrow zinc finger 5, BMZF-5) (Hematopoietic cell-derived zinc finger protein 1, HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)" ZNF254 BMZF5 ZNF539 ZNF91L Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 HTEKK 1.070000052 1 1 0.212530223 642.6226171 0 0 15.93393 16.71593 0 0 14.57754 0 0 17.48495 15.42025 15.67649 0 0 0 0 0 0 0 0 0 16.61702 0 16.32371 0 13.51831 13.60596 0 16.73313 0 0 16.56711 15.93788 16.17994 15.85656 0 0 0 16.46491 0 0 0 0 0 16.17985 0 0 15.19 O75439 MPPB_HUMAN "Mitochondrial-processing peptidase subunit beta, EC 3.4.24.64 (Beta-MPP) (P-52)" PMPCB MPPB Homo sapiens (Human) mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627] mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0006851; GO:0017087; GO:0046872 TNMLLQLDGSTPICEDIGR 7.25 1 1 0.206147073 2148.417163 14.53383 12.61091 12.98562 0 0 0 0 0 0 0 0 12.77242 13.53239 0 0 0 0 0 7.786512 16.07463 0 0 0 0 0 0 0 0 0 14.94188 0 15.92297 0 14.90113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75443 TECTA_HUMAN Alpha-tectorin TECTA Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605] anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0005886; GO:0007160; GO:0007605; GO:0031225; GO:0062023; GO:0070062 GCFSTK 11.22000027 0.36517325 0.36517325 0.225218671 700.0826168 16.34825 0 14.70474 9.149221 13.93659 14.76069 0 15.74989 15.80034 18.09201 16.43791 14.06832 17.88085 0 0 14.74352 14.45936 16.59694 18.65242 0 0 17.4683 0 14.98205 0 0 0 14.50394 14.93788 13.77059 0 0 15.0633 17.44849 0 0 0 17.15525 17.14553 0 16.98092 0 0 16.74196 14.81991 0 0 0 O75445 USH2A_HUMAN Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) USH2A Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0016477; GO:0017022; GO:0032391; GO:0032421; GO:0034446; GO:0035315; GO:0036064; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060113; GO:0060171; GO:1990075; GO:1990696 GLQCDTCR 6.820000172 1 1 0.246691803 1009.39901 0 15.53631 13.87747 0 13.31125 0 13.14737 0 14.82795 0 0 0 14.661 0 14.88821 0 0 0 16.60585 15.95521 0 0 0 0 0 0 0 0 0 0 0 17.08553 0 0 0 0 0 0 0 16.57508 0 14.95878 0 0 0 0 0 0 O75448 MED24_HUMAN "Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component, ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4, CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component, Trap100, hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component, DRIP100)" MED24 ARC100 CRSP4 DRIP100 KIAA0130 THRAP4 TRAP100 Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; histone acetyltransferase activity [GO:0004402]; nuclear receptor coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]" histone acetyltransferase activity [GO:0004402]; nuclear receptor coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809] GO:0000151; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0044877; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847 QGLLSEASVNNLMAK 3.119999886 1 1 0.479857671 1590.315174 16.00226 16.10704 0 0 0 0 17.20899 0 0 0 0 0 16.65213 0 0 0 0 0 0 0 17.54943 0 0 0 0 0 17.0931 0 0 0 0 0 0 0 0 18.64107 0 0 18.6613 0 0 0 0 0 0 18.21128 0 0 O75449 KTNA1_HUMAN "Katanin p60 ATPase-containing subunit A1, Katanin p60 subunit A1, EC 5.6.1.1 (p60 katanin)" KATNA1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982] GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0030496; GO:0046982; GO:0051013; GO:0051301; GO:0097431 TLESFKLDSTPLK 5.03000021 1 1 0.16671685 1478.307434 0 0 14.07313 0 0 10.07143 0 14.16807 0 0 0 0 0 14.88417 0 0 16.22315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53459 0 0 0 0 0 0 0 O75452 RDH16_HUMAN "Retinol dehydrogenase 16, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.315, EC 1.1.1.53 (Human epidermal retinol dehydrogenase, hRDH-E) (Microsomal NAD(+)-dependent retinol dehydrogenase 4, RoDH-4) (Short chain dehydrogenase/reductase family 9C member 8) (Sterol/retinol dehydrogenase)" RDH16 RODH4 SDR9C8 Homo sapiens (Human) lipid metabolic process [GO:0006629]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NAD-retinol dehydrogenase activity [GO:0004745]; lipid metabolic process [GO:0006629]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]" "androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NAD-retinol dehydrogenase activity [GO:0004745]" GO:0004745; GO:0005789; GO:0006629; GO:0008202; GO:0009055; GO:0016021; GO:0042572; GO:0042802; GO:0043231; GO:0047023; GO:0047044 WLYLAVFVGLYYLLHWYR 13.57999992 1 1 0.362965279 2375.557278 0 0 0 0 0 16.91482 0 17.73854 0 0 0 0 0 0 0 0 0 0 17.60208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.12083 0 0 0 0 0 0 0 17.46638 0 0 0 O75461 E2F6_HUMAN "Transcription factor E2F6, E2F-6" E2F6 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000083; GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0046983; GO:0071339; GO:0090575 KFMDLVR 12.09000015 0.745206118 0.745206118 0.276347708 909.796276 0 14.73585 15.44139 18.48604 13.49326 13.77041 14.45384 15.41718 11.49818 16.57388 16.19751 13.70359 14.17416 0 15.42208 14.24288 0 13.9608 16.36875 0 0 0 17.13084 14.84282 17.20004 17.121 0 0 0 0 0 0 0 14.93777 16.3223 15.88894 0 0 16.75885 0 0 17.10342 14.58368 0 0 0 15.33729 0 O75467 Z324A_HUMAN Zinc finger protein 324A (Zinc finger protein ZF5128) ZNF324 ZNF324A Homo sapiens (Human) cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000082; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008283; GO:0046872 QKPCAQEVPGR 8.079999924 0.928655326 0.928655326 0.375628816 1269.504239 16.97092 15.39416 14.3758 0 0 0 14.42447 0 0 0 0 15.71949 0 0 14.80738 16.89919 0 15.55407 0 0 0 0 0 0 15.64506 0 0 16.1046 0 0 16.42473 15.10797 16.53348 16.49096 15.95477 15.64386 16.78459 16.2033 14.83642 16.15775 14.25127 16.19389 16.05941 17.05794 0 14.76615 16.80913 15.7487 O75494 SRS10_HUMAN "Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein, SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats, TASR, TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein, TLS-associated SR protein)" SRSF10 FUSIP1 FUSIP2 SFRS13A TASR Homo sapiens (Human) "cytosolic transport [GO:0016482]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; cytosolic transport [GO:0016482]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082] GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006376; GO:0016482; GO:0016607; GO:0030425; GO:0043025; GO:0043679; GO:0048024; GO:0048025; GO:0050733; GO:0051082 TPNQMKAK 9.31000042 0.926737785 0.926737785 0.252169309 933.8481022 14.27501 15.18327 15.90442 15.29817 14.50339 14.75615 0 14.24477 14.9974 14.36849 15.35946 0 0 0 0 13.69583 14.94008 14.90089 0 0 14.53834 15.41364 14.3927 15.88016 0 15.989 0 14.23694 0 15.22467 15.67793 15.31714 15.22888 13.23606 0 0 0 0 14.95776 0 0 15.31797 11.00619 13.72161 0 17.79541 0 0 O75496 GEMI_HUMAN Geminin GMNN Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346]" chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006275; GO:0007346; GO:0008156; GO:0009887; GO:0017053; GO:0030174; GO:0035563; GO:0042826; GO:0045786; GO:0045892; GO:0071163; GO:0140297; GO:2000104 NPSMKQK 7.710000038 0.99320209 0.99320209 0.13917565 849.918045 0 15.44195 0 0 0 0 0 0 14.64108 0 0 0 0 0 0 0 0 0 0 15.78068 0 0 0 0 0 17.3329 15.09157 0 0 0 0 0 0 0 0 14.48273 15.21277 0 0 0 0 15.05776 0 16.19703 0 0 0 0 O75508 CLD11_HUMAN Claudin-11 (Oligodendrocyte-specific protein) CLDN11 OSP OTM Homo sapiens (Human) axon ensheathment [GO:0008366]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; spermatogenesis [GO:0007283]; tight junction assembly [GO:0120192] axon [GO:0030424]; basal part of cell [GO:0045178]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; tight junction [GO:0070160] axon [GO:0030424]; basal part of cell [GO:0045178]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axon ensheathment [GO:0008366]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; spermatogenesis [GO:0007283]; tight junction assembly [GO:0120192] identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] GO:0005198; GO:0005811; GO:0005883; GO:0005886; GO:0005923; GO:0007155; GO:0007283; GO:0008366; GO:0016021; GO:0016338; GO:0030054; GO:0030424; GO:0042802; GO:0045178; GO:0070160; GO:0070830; GO:0120192 MGQEPGVAKYR 7.329999924 1 1 0.366408861 1251.68837 0 14.78537 0 0 16.43753 0 0 0 0 0 0 0 0 0 0 0 14.29355 15.94072 0 0 10.56211 0 0 14.67482 0 0 0 0 0 0 0 0 0 16.56233 16.24792 0 0 0 0 0 0 0 0 0 15.24443 0 0 0 O75509 TNR21_HUMAN Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358) TNFRSF21 DR6 UNQ437/PRO868 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852] axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852] GO:0001783; GO:0002250; GO:0005737; GO:0005886; GO:0005887; GO:0006915; GO:0006959; GO:0007413; GO:0030424; GO:0030889; GO:0031226; GO:0031642; GO:0032693; GO:0032696; GO:0032714; GO:0042130; GO:0042552; GO:0048713; GO:0050852; GO:0051402; GO:0071356; GO:0097252 CDSTSSGSSALSR 5.03000021 1 1 0.316306984 1312.434913 0 13.47436 15.10336 0 0 13.51091 0 14.07359 16.27087 14.63152 0 0 0 15.14545 0 14.11201 15.36964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.90777 0 0 0 15.06637 14.15029 0 0 0 0 0 0 O75521 ECI2_HUMAN "Enoyl-CoA delta isomerase 2, EC 5.3.3.8 (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase, D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1, DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase, pECI) (Renal carcinoma antigen NY-REN-1)" ECI2 DRS1 HCA88 PECI Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631] dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062] GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006631; GO:0006635; GO:0009062; GO:0016020; GO:0043231 ATEMLIFGK 7.699999809 0.681174219 0.681174219 0.20743462 1025.617326 15.90824 13.4706 0 0 14.80377 14.39326 0 0 17.02296 15.94495 0 0 0 0 0 13.21812 14.10523 14.90318 14.79267 13.23217 14.61437 16.618 13.99345 14.74667 0 16.45966 13.11436 14.58898 15.41686 0 17.42022 15.73366 15.52082 0 14.93167 0 0 0 0 0 15.75321 0 0 15.65748 0 0 0 0 O75525 KHDR3_HUMAN "KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2, SLM-2) (Sam68-like phosphotyrosine protein)" KHDRBS3 SALP SLM2 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124] GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0017124; GO:0019904; GO:0032991; GO:0042802; GO:0048024 GKPTLR 12.34000015 1 1 0.315127206 671.6368852 0 0 0 0 0 0 0 18.58446 0 0 19.61599 17.97479 0 19.10561 0 0 17.25756 0 0 0 17.77906 19.38694 18.63206 19.02359 0 18.18839 0 17.13811 17.1088 18.75162 18.85109 0 20.70568 18.92662 0 20.59938 0 20.18014 17.90081 0 18.5508 17.68964 0 16.85017 18.23356 0 0 0 O75526 RMXL2_HUMAN "RNA-binding motif protein, X-linked-like-2 (Testis-specific heterogeneous nuclear ribonucleoprotein G-T, hnRNP G-T)" RBMXL2 HNRNPGT Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" U12-type spliceosomal complex [GO:0005689] "U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]" mRNA binding [GO:0003729]; snRNA binding [GO:0017069] GO:0000398; GO:0003729; GO:0005689; GO:0017069 DRDYGDHLSR 5.920000076 1 1 0.284092952 1232.645619 15.61012 0 0 15.80026 17.04103 17.5755 0 15.76133 0 0 13.72139 0 0 0 13.48055 0 0 0 0 15.81442 15.90147 0 0 0 0 14.92466 16.40587 15.70056 16.85978 0 15.62126 16.53781 0 0 0 0 0 16.32813 0 0 16.63944 15.72679 0 13.71815 0 0 12.61062 0 O75528 TADA3_HUMAN "Transcriptional adapter 3 (ADA3 homolog, hADA3) (STAF54) (Transcriptional adapter 3-like, ADA3-like protein)" TADA3 ADA3 TADA3L Homo sapiens (Human) "histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713] GO:0000124; GO:0000278; GO:0001932; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006355; GO:0006357; GO:0010628; GO:0016573; GO:0016922; GO:0019904; GO:0030374; GO:0030520; GO:0031063; GO:0031647; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0044154; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672 EKDQAWK 2.420000076 1 1 0.305666466 904.6900684 0 0 0 0 0 0 0 0 0 0 0 0 0 16.95349 17.28325 17.91667 0 0 0 0 0 0 18.64071 0 0 16.95067 0 0 17.18405 0 18.49435 19.10471 0 0 0 0 0 0 0 0 0 0 0 0 15.72825 0 0 0 O75530 EED_HUMAN "Polycomb protein EED, hEED (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1, WAIT-1)" EED Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; spinal cord development [GO:0021510]" chromosome [GO:0005694]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; transcription corepressor binding [GO:0001222]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; spinal cord development [GO:0021510]" chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; transcription corepressor binding [GO:0001222] GO:0000122; GO:0001222; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0008047; GO:0021510; GO:0035098; GO:0042054; GO:0042802; GO:0045892 MSEREVSTAPAGTDMPAAK 5.590000153 1 1 0.550474017 1947.859749 0 0 0 0 0 0 0 0 0 0 0 0 0 18.83837 0 0 0 0 0 17.33391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.45687 0 0 0 0 18.34487 18.05375 0 0 0 0 0 O75531 BAF_HUMAN "Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed ]" BANF1 BAF BCRG1 Homo sapiens (Human) chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485] GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0007059; GO:0007084; GO:0008022; GO:0009615; GO:0015074; GO:0019899; GO:0030261; GO:0032480; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0047485; GO:0097726 KDEDLFR 6.809999943 1 1 0.11047095 923.1432667 15.73495 0 0 0 15.79132 12.17981 15.23194 15.78109 0 0 0 0 0 0 0 0 0 0 0 0 16.17626 0 0 0 0 0 0 0 15.21767 15.83277 0 0 0 0 0 0 0 18.11824 0 0 0 0 0 0 0 0 0 15.87669 O75533 SF3B1_HUMAN "Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit, SF3b155) (Spliceosome-associated protein 155, SAP 155)" SF3B1 SAP155 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]" B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] "B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]" mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935] GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006338; GO:0008380; GO:0016607; GO:0034693; GO:0035066; GO:0045943; GO:0045944; GO:0045945; GO:0071004; GO:0071005; GO:0071013; GO:0110016; GO:1990935 GDTPGHATPGHGGATSSARK 6.059999943 0.821314454 0.821314454 0.334616197 1861.150616 16.31715 17.76494 14.12879 0 17.23547 15.94943 0 0 13.70013 0 0 0 0 12.87885 0 0 0 0 0 0 0 16.29265 0 0 0 12.11266 0 15.38319 0 14.60747 14.2158 0 0 0 15.07831 0 0 0 0 15.41591 0 0 0 15.18456 0 16.82667 15.38848 0 O75534 CSDE1_HUMAN Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; male gonad development [GO:0008584]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; stress granule assembly [GO:0034063]" CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mCRD-mediated mRNA stability complex [GO:0106002]; P-body [GO:0000932]; plasma membrane [GO:0005886] "CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mCRD-mediated mRNA stability complex [GO:0106002]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; male gonad development [GO:0008584]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; stress granule assembly [GO:0034063]" RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613] GO:0000932; GO:0003723; GO:0005794; GO:0005829; GO:0005886; GO:0006446; GO:0008584; GO:0010494; GO:0034063; GO:0035613; GO:0070934; GO:0070937; GO:0070966; GO:0075522; GO:0106002; GO:1900152; GO:2000767 CVDRDVR 5.25 1 1 0.228546639 918.3918586 0 13.44939 15.75667 0 0 0 0 0 0 16.49751 0 0 0 0 15.2904 0 0 0 0 0 15.14441 0 15.32858 16.35924 14.93233 15.18622 15.81439 0 0 0 0 0 15.41529 16.44811 16.19788 0 0 0 0 15.90151 0 0 14.50343 16.01364 16.27225 0 0 0 O75541 ZN821_HUMAN Zinc finger protein 821 ZNF821 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 LEKMDMMLR 10.73999977 1 1 0.237496005 1181.772101 15.98271 16.47376 0 15.35426 16.79697 0 0 0 15.84571 16.09854 0 15.50493 0 0 0 0 0 0 0 0 16.29895 0 16.48894 14.55411 0 0 0 0 16.90736 0 0 0 0 0 17.59261 0 16.84724 0 17.8201 0 0 18.26807 0 0 0 0 17.42422 0 O75554 WBP4_HUMAN "WW domain-binding protein 4, WBP-4 (Formin-binding protein 21) (WW domain-containing-binding protein 4)" WBP4 FBP21 FNBP21 Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008270; GO:0008380; GO:0016607; GO:0045292; GO:0070064; GO:0071005; GO:0071011 NHKENVAK 8.210000038 0.72847873 0.72847873 0.291617695 938.9946948 15.45652 12.71911 13.85601 14.66137 12.69834 15.00513 0 0 14.578 13.58411 15.10269 7.114909 15.00062 13.6591 15.20099 0 0 16.04408 0 0 0 0 13.67481 16.26094 0 0 15.48708 15.00933 16.25728 15.5662 0 15.73607 0 14.77186 0 15.7637 15.48 0 0 0 15.93995 0 15.41727 0 14.98811 16.25135 0 14.88547 O75558 STX11_HUMAN Syntaxin-11 STX11 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] GO:0000149; GO:0005484; GO:0005794; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0031201; GO:0031629; GO:0048278; GO:0048787; GO:0061025 FLTSMR 1.690000057 1 1 0.256316216 770.6762635 16.06959 17.62424 18.5064 0 0 0 17.03046 0 18.37582 16.79024 0 17.53717 0 0 0 19.22966 17.95499 16.79898 18.26621 0 15.31761 17.22375 0 19.30334 0 0 0 0 16.37977 0 0 18.2361 0 0 19.21598 0 18.39488 0 18.19987 16.64614 0 16.88547 17.65257 17.28824 0 0 16.19687 16.15459 O75564 JERKY_HUMAN Jerky protein homolog JRK JH8 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263] DNA binding [GO:0003677]; mRNA binding [GO:0003729] GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904 CLPNPTPEGGAVPGPKQGK 5.139999866 1 1 2.36E-13 1905.067533 0 0 17.17699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75569 PRKRA_HUMAN "Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)" PRKRA PACT RAX HSD-14 HSD14 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705] double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] GO:0003723; GO:0003725; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008047; GO:0008285; GO:0009615; GO:0016020; GO:0019899; GO:0030422; GO:0031054; GO:0034599; GO:0035196; GO:0035280; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0048471; GO:0048705; GO:0050821; GO:0070578; GO:0070883; GO:2001244 HRAAEAAINILK 12.81999969 4.34E-05 4.34E-05 0.111909196 1305.638633 21.57261 22.39692 20.50685 20.41325 19.96983 18.74008 20.62127 20.43565 21.24311 19.99679 20.4008 19.56234 20.43231 19.55067 19.69092 20.88196 20.49037 20.95728 20.78269 18.3802 17.3743 19.57936 21.79018 20.55344 21.11425 21.828 21.28923 20.66485 20.34644 19.87838 21.18554 21.2976 20.1753 19.78634 21.3209 0 21.92491 21.23256 21.5506 20.54881 20.4982 21.81103 20.02497 20.55005 21.10285 19.18888 19.74501 20.7354 O75581 LRP6_HUMAN "Low-density lipoprotein receptor-related protein 6, LRP-6" LRP6 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] "cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909 AAMDGSER 4.110000134 1 1 0.233462545 837.3655639 16.5918 16.63914 0 16.6211 11.11186 14.05683 15.75117 15.07346 15.68786 15.56567 13.22404 14.88968 15.12693 16.23833 0 14.62295 14.30649 0 15.89334 0 14.90409 0 0 0 14.60838 0 16.23082 0 15.64293 15.51236 0 16.61641 0 0 0 17.11769 15.40703 16.09752 17.61878 0 0 0 15.53818 14.44822 0 0 0 0 O75592 MYCB2_HUMAN "E3 ubiquitin-protein ligase MYCBP2, EC 2.3.2.33 (Myc-binding protein 2) (Protein associated with Myc)" MYCBP2 KIAA0916 PAM Homo sapiens (Human) branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880] axon [GO:0030424]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] axon [GO:0030424]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667 FTKTSQGR 11.14999962 1 1 0.082271221 925.3392538 14.95734 14.6864 15.17385 10.43821 10.74062 11.17559 11.6709 15.51217 15.54761 15.16265 14.06298 14.39936 13.55877 15.44134 11.40126 16.07269 15.11491 0 13.90458 15.0123 0 14.36053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.43023 0 0 0 0 O75593 FOXH1_HUMAN "Forkhead box protein H1 (Forkhead activin signal transducer 1, Fast-1, hFAST-1) (Forkhead activin signal transducer 2, Fast-2)" FOXH1 FAST1 FAST2 Homo sapiens (Human) "aorta morphogenesis [GO:0035909]; axial mesoderm development [GO:0048318]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to cytokine stimulus [GO:0071345]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; heart looping [GO:0001947]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; secondary heart field specification [GO:0003139]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular trabecula myocardium morphogenesis [GO:0003222]" activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; aorta morphogenesis [GO:0035909]; axial mesoderm development [GO:0048318]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to cytokine stimulus [GO:0071345]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; heart looping [GO:0001947]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; secondary heart field specification [GO:0003139]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular trabecula myocardium morphogenesis [GO:0003222]" "androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001228; GO:0001947; GO:0003139; GO:0003151; GO:0003215; GO:0003222; GO:0003700; GO:0005634; GO:0005667; GO:0007179; GO:0019904; GO:0032444; GO:0033147; GO:0035054; GO:0035909; GO:0043425; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0046332; GO:0048318; GO:0050681; GO:0060766; GO:0070410; GO:0070412; GO:0071345; GO:0140297; GO:1900164 GPCSGSR 6.550000191 0.923681259 0.923681259 0 718.4204413 14.4974 10.56202 0 12.38397 0 0 0 15.24415 0 0 0 0 0 0 0 13.44179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.64089 0 13.86634 0 0 0 0 15.46025 0 0 0 0 0 0 0 0 0 O75603 GCM2_HUMAN "Chorion-specific transcription factor GCMb, hGCMb (GCM motif protein 2) (Glial cells missing homolog 2)" GCM2 GCMB Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cellular phosphate ion homeostasis [GO:0030643]; gliogenesis [GO:0042063]; parathyroid gland development [GO:0060017]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular calcium ion homeostasis [GO:0006874]; cellular phosphate ion homeostasis [GO:0030643]; gliogenesis [GO:0042063]; parathyroid gland development [GO:0060017]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0006874; GO:0030643; GO:0042063; GO:0043565; GO:0046872; GO:0060017; GO:1990837 AQRHLSGWAMR 2.710000038 1 1 0.60881388 1328.437553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.86186 0 0 0 0 0 0 0 0 0 0 0 19.04489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.93695 17.96767 0 0 0 0 0 O75604 UBP2_HUMAN "Ubiquitin carboxyl-terminal hydrolase 2, EC 3.4.19.12 (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)" USP2 UBP41 Homo sapiens (Human) cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511] cyclin binding [GO:0030332]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625] GO:0000122; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005813; GO:0006511; GO:0007049; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0050821; GO:1901796 SSSPGRDGMNSK 6.849999905 1 1 0.349597763 1240.128143 14.37969 15.36116 13.23326 15.50564 14.21457 14.16168 0 13.28185 12.69039 14.12646 14.77469 13.29886 14.39796 15.70423 0 0 16.45775 17.149 15.42367 15.44057 0 15.8803 16.66991 0 0 16.96487 0 0 0 15.53071 0 15.36969 0 0 0 0 0 0 0 0 16.97467 0 0 0 0 0 0 17.96788 O75608 LYPA1_HUMAN "Acyl-protein thioesterase 1, APT-1, hAPT1, EC 3.1.2.- (Lysophospholipase 1) (Lysophospholipase I, LPL-I, LysoPLA I) (Palmitoyl-protein hydrolase, EC 3.1.2.22)" LYPLA1 APT1 LPL1 Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0008474; GO:0016298; GO:0031965; GO:0042997; GO:0052689; GO:0070062 SSHIK 2.019999981 0.394021332 0.394021332 0.180688486 571.8169612 0 14.6592 0 16.70234 15.66314 16.71317 0 16.0299 14.47002 15.03596 0 16.36699 0 18.15634 13.12317 14.27311 13.63028 0 15.53154 0 0 16.16183 15.3898 13.49242 17.53462 18.96453 15.42237 16.36109 15.99341 17.90047 14.33972 0 14.84972 18.14945 0 15.31616 15.48786 15.60309 0 16.32123 14.66331 16.9535 14.83042 0 0 16.29559 14.41772 17.66311 O75610 LFTY1_HUMAN Left-right determination factor 1 (Left-right determination factor B) (Protein lefty-1) (Protein lefty-B) LEFTY1 LEFTB LEFTYB UNQ278/PRO317 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160] GO:0000122; GO:0003007; GO:0005125; GO:0005160; GO:0005615; GO:0007179; GO:0007368; GO:0008083; GO:0010862; GO:0030509; GO:0060395 VRDDGSNR 15.77000046 1 1 0.42507944 917.3739664 0 16.71739 17.66615 0 0 16.62914 15.21251 0 0 0 17.15524 16.57744 0 17.0115 16.86458 16.69992 17.91907 16.90035 17.61591 0 0 17.16751 0 16.67349 17.27842 16.31673 17.23227 17.14225 0 16.42667 15.33607 17.64827 16.71638 17.51076 15.10627 0 14.67147 17.02987 17.56966 0 0 16.8924 0 0 16.08344 0 0 17.31539 O75618 DEDD_HUMAN Death effector domain-containing protein (DEDPro1) (Death effector domain-containing testicular molecule) (FLDED-1) DEDD DEDPRO1 DEFT KE05 Homo sapiens (Human) decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283] DNA binding [GO:0003677] GO:0003677; GO:0005730; GO:0005737; GO:0007283; GO:0008625; GO:0042177; GO:0042981; GO:0046697; GO:1901837 NLMLQALP 5.619999886 1 1 0.26215615 914.8350222 16.9915 16.77886 0 17.95818 0 18.00696 19.5794 17.30096 18.29295 0 0 0 0 0 0 0 0 0 0 16.24189 0 0 0 16.37873 0 0 0 0 17.90136 0 0 0 18.37057 18.2306 0 18.77799 0 0 0 0 18.07142 0 18.18363 0 16.31626 0 17.84276 0 O75626 PRDM1_HUMAN "PR domain zinc finger protein 1, EC 2.1.1.- (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1, PRDI-BF1, PRDI-binding factor 1)" PRDM1 BLIMP1 Homo sapiens (Human) adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000978; GO:0001227; GO:0001763; GO:0001822; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0010629; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841 EETGLK 10.51000023 0.299693197 0.299693197 0.228264102 673.5616914 15.20462 0 0 15.69793 16.56689 0 15.36899 14.31648 0 0 16.80177 0 0 15.51814 14.88446 0 16.2406 16.45588 17.28892 16.28436 0 14.00153 16.02143 0 15.57722 14.88404 0 0 16.28769 16.06689 15.05896 16.57239 14.55741 17.14062 17.2195 0 17.44781 17.09808 0 15.96813 17.56398 16.80159 0 15.88639 17.069 17.0459 16.29829 0 O75638 CTAG2_HUMAN "Cancer/testis antigen 2, CT2 (Autoimmunogenic cancer/testis antigen NY-ESO-2) (Cancer/testis antigen 6.2, CT6.2) (L antigen family member 1, LAGE-1)" CTAG2 ESO2 LAGE1 Homo sapiens (Human) tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] GO:0005654; GO:0005813; GO:0016604; GO:0043231; GO:0070525 ASGPRGGAPR 5.489999771 0.932878911 0.932878911 4.60E-13 925.8129763 0 14.17548 14.75333 0 0 11.28788 13.69216 0 0 0 0 0 15.08019 0 0 15.51112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.32135 0 0 0 0 0 0 15.32323 0 0 0 0 0 12.9489 0 0 0 O75643 U520_HUMAN "U5 small nuclear ribonucleoprotein 200 kDa helicase, EC 3.6.4.13 (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein, U5-200KD)" SNRNP200 ASCC3L1 HELIC2 KIAA0788 Homo sapiens (Human) "cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013 DMCLEK 4.800000191 1 1 0.222655514 795.8563301 11.64693 16.29322 0 15.96673 13.65875 15.41958 14.97294 0 14.1166 14.02966 13.91011 0 0 0 14.99591 0 0 0 0 0 0 0 16.80932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75648 MTU1_HUMAN "Mitochondrial tRNA-specific 2-thiouridylase 1, EC 2.8.1.14 (MTO2 homolog)" TRMU MTU1 TRMT1 Homo sapiens (Human) tRNA wobble position uridine thiolation [GO:0002143] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tRNA-5-taurinomethyluridine 2-sulfurtransferase [GO:0061708]; tRNA wobble position uridine thiolation [GO:0002143] ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tRNA-5-taurinomethyluridine 2-sulfurtransferase [GO:0061708] GO:0000049; GO:0002143; GO:0005524; GO:0005739; GO:0061708 NRFEVR 7.130000114 1 1 0.161778692 820.7500761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75663 TIPRL_HUMAN "TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein, TIP)" TIPRL Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; TOR signaling [GO:0031929] cytosol [GO:0005829] cytosol [GO:0005829]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; TOR signaling [GO:0031929] GO:0000077; GO:0005829; GO:0031929; GO:0032515; GO:0043666 IDPNPADSQK 5.559999943 0.014428593 0.014428593 6.84E-13 1082.792149 14.79124 15.4694 15.2382 16.39597 0 15.67961 13.54678 16.01551 0 0 15.37207 0 0 14.49988 14.63125 13.68522 0 0 15.67372 14.41299 13.55656 0 14.3886 0 15.48582 11.37574 14.31597 0 10.70788 0 13.07356 15.97865 17.36901 15.41097 15.98068 12.20741 16.0484 0 0 0 13.73502 12.32564 15.26862 15.3951 14.1143 15.70047 15.63204 0 O75665 OFD1_HUMAN Oral-facial-digital syndrome 1 protein (Protein 71-7A) OFD1 CXorf5 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802] GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015630; GO:0016020; GO:0031514; GO:0034451; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060271; GO:0060287 AEMCQK 18.11000061 1 1 0.268178144 766.3711683 0 0 17.19609 17.37725 0 0 19.07532 18.75241 0 0 0 0 0 0 0 0 0 0 0 18.25879 0 0 18.0634 19.21448 19.81069 0 0 0 0 0 0 18.08478 0 0 0 18.25706 0 0 0 17.76665 0 0 0 0 0 0 16.75823 0 O75676 KS6A4_HUMAN "Ribosomal protein S6 kinase alpha-4, S6K-alpha-4, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B, RSKB)" RPS6KA4 MSK2 Homo sapiens (Human) "histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]" ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0000287; GO:0001818; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006954; GO:0016572; GO:0018105; GO:0032793; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0045944; GO:0051092; GO:0070498; GO:0106310 TPDVLESSGPAVR 13.61999989 1 1 0 1327.246995 9.915491 14.28151 0 0 0 14.51653 13.31391 0 0 15.35639 14.93465 16.11183 13.64208 14.78294 0 0 15.28191 0 15.08914 0 0 0 0 0 9.465178 12.30911 14.78574 0 0 0 0 0 0 0 0 0 17.51546 0 0 0 14.45935 14.82087 0 0 0 0 12.93427 0 O75677 RFPL1_HUMAN Ret finger protein-like 1 (RING finger protein 78) RFPL1 RFPL1L RNF78 Homo sapiens (Human) "cell cycle [GO:0007049]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]" metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0007049; GO:0008285; GO:0010972; GO:0032436; GO:0043065; GO:0045893; GO:0045930; GO:0046872; GO:0051782; GO:2001272 SVLSICPVINPGTTDAPVHPGEAK 6.110000134 1 1 0.042238379 2459.613249 13.38339 12.72434 15.81262 14.35891 0 14.93565 0 14.93101 13.23847 0 0 13.96941 0 0 14.93399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75688 PPM1B_HUMAN "Protein phosphatase 1B, EC 3.1.3.16 (Protein phosphatase 2C isoform beta, PP2C-beta)" PPM1B PP2CB Homo sapiens (Human) N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470] magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] GO:0000287; GO:0004722; GO:0005634; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223 ERIQNAGGSVMIQR 13.30000019 1 1 0.278024635 1574.134154 0 13.71874 0 0 15.20782 12.79656 8.157236 14.36643 0 0 0 0 0 0 0 0 15.95477 12.15299 0 0 16.10992 0 0 0 0 0 0 0 0 0 0 0 0 16.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75689 ADAP1_HUMAN "Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1, Cnt-a1) (Putative MAPK-activating protein PM25)" ADAP1 CENTA1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]" "GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]" GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0043087; GO:0043231; GO:0043533; GO:0043547; GO:0046872; GO:1902936 FLFACETESDQR 4.349999905 1 1 0.321719994 1504.84551 15.00442 15.13755 14.57655 0 14.89391 14.96586 13.06819 14.24041 15.02051 15.62043 15.76397 12.31412 11.15068 14.93457 12.15133 15.88316 14.59207 14.09151 14.95501 0 0 0 0 14.39315 0 0 17.82322 0 0 14.84886 0 16.79095 0 0 0 0 15.90537 0 0 14.68413 0 0 14.7813 15.33946 13.75121 0 0 0 O75691 UTP20_HUMAN "Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73, NNP73) (Protein Key-1A6)" UTP20 DRIM Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]" "90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]" "90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]" RNA binding [GO:0003723] GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040 LGNVNIDIIHRIDR 6.989999771 1 1 0.264918627 1647.613993 0 0 16.07757 0 0 16.49356 14.55868 13.15141 0 0 12.70361 16.22024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.17848 0 0 0 17.00981 0 15.52189 14.28279 0 0 0 0 0 17.60734 0 O75694 NU155_HUMAN Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155) NUP155 KIAA0791 Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] structural constituent of nuclear pore [GO:0017056] GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0036228; GO:0044611; GO:0086014 PSSLLGAAMPASTSAAALQEALENAGR 2.25 1 1 0.142968133 2599.554814 13.8878 0 0 13.72871 12.33954 0 0 0 14.58562 13.69592 14.17287 0 0 11.20859 13.24332 12.21918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75712 CXB3_HUMAN "Gap junction beta-3 protein (Connexin-31, Cx31)" GJB3 CX31 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; skin development [GO:0043588]; spermatogenesis [GO:0007283] cell junction [GO:0030054]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] cell junction [GO:0030054]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; skin development [GO:0043588]; spermatogenesis [GO:0007283] gap junction channel activity [GO:0005243] GO:0001701; GO:0001890; GO:0005243; GO:0005737; GO:0005921; GO:0005922; GO:0007267; GO:0007283; GO:0016021; GO:0030054; GO:0043231; GO:0043588; GO:0071300 DFDCNTK 2.809999943 1 1 3.54E-13 899.3640186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.83401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75747 P3C2G_HUMAN "Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma, PI3K-C2-gamma, PtdIns-3-kinase C2 subunit gamma, EC 2.7.1.137, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-gamma)" PIK3C2G Homo sapiens (Human) cell migration [GO:0016477]; chemotaxis [GO:0006935]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate kinase activity [GO:0016307]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; viral RNA genome replication [GO:0039694] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate kinase activity [GO:0016307] GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006935; GO:0014065; GO:0016020; GO:0016303; GO:0016307; GO:0016477; GO:0019898; GO:0035005; GO:0035091; GO:0036092; GO:0039694; GO:0046854; GO:0048015; GO:0052742 CTDPTYNEIVVYDEVTELQGHVLMLIVK 3.019999981 1 1 0.038894845 3279.550748 0 0 13.55567 0 17.48523 0 10.41497 0 0 15.50958 0 13.74823 13.00614 0 0 0 0 0 0 0 7.041451 0 12.87212 15.53413 16.09879 0 15.94167 0 11.86632 14.83445 0 12.07551 0 0 0 0 0 18.51288 0 15.43971 15.26141 0 0 0 13.34834 0 0 14.61874 O75762 TRPA1_HUMAN "Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120, p120) (Wasabi receptor)" TRPA1 ANKTM1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955] calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604] GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0071310; GO:0097604 HASLKR 5.349999905 0.490917861 0.490917861 0.256611823 710.1968754 0 14.27263 0 15.03725 15.57441 14.37571 0 16.05517 0 0 0 0 14.84139 15.08918 0 16.92018 15.78778 16.65298 14.2638 14.91115 15.902 15.04123 15.49129 14.93633 15.82054 16.28028 15.14711 15.91615 0 16.00365 0 14.94527 0 0 15.71278 0 16.92681 0 16.35312 16.47982 15.71257 0 16.98763 0 15.54767 0 15.66974 0 O75764 TCEA3_HUMAN Transcription elongation factor A protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation factor TFIIS.h) TCEA3 TFIISH Homo sapiens (Human) "transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0006351; GO:0006368; GO:0008270 LLDSPGPPK 18.68000031 0.43023631 0.43023631 0.161318832 920.9652506 0 0 0 0 17.53607 0 0 16.58365 16.11195 0 18.98579 16.25659 16.75567 18.04215 0 18.05974 0 0 17.38017 17.76485 0 18.23262 0 17.88365 18.01268 0 17.3293 0 15.28604 16.17694 0 0 16.78376 0 0 0 18.40907 0 17.13259 16.48937 17.92235 18.46298 16.87959 0 17.47127 0 16.61 15.42968 O75771 RA51D_HUMAN DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD) RAD51D RAD51L3 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]" "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]" GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007131; GO:0008094; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726 VGLCPGLTEEMIQLLR 12.52999973 1 1 0.206137987 1828.694197 14.28581 11.77464 18.72571 14.32215 13.3327 17.16339 15.28765 14.3228 12.31922 13.86921 14.8454 10.54369 15.92108 12.78877 13.08317 18.26846 15.72139 0 0 0 17.55168 16.83323 14.02626 15.82888 0 16.1835 19.49247 19.47881 0 0 16.37254 17.78416 15.53836 18.35591 0 0 17.98567 16.63394 18.95754 15.78273 14.12396 17.36662 15.4198 0 14.64225 0 15.52018 15.9196 O75787 RENR_HUMAN "Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9, ATP6M8-9, V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment ]" ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072 Homo sapiens (Human) angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; vacuolar acidification [GO:0007035] "apical plasma membrane [GO:0016324]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell body [GO:0044297]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "apical plasma membrane [GO:0016324]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell body [GO:0044297]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; signaling receptor activity [GO:0038023]; angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; vacuolar acidification [GO:0007035]" signaling receptor activity [GO:0038023] GO:0000139; GO:0000220; GO:0000421; GO:0002003; GO:0005764; GO:0005765; GO:0005789; GO:0005886; GO:0007035; GO:0007042; GO:0009897; GO:0010008; GO:0016020; GO:0016021; GO:0016324; GO:0016471; GO:0021626; GO:0021903; GO:0030177; GO:0030424; GO:0032591; GO:0032914; GO:0033176; GO:0038023; GO:0043408; GO:0044297; GO:0045211; GO:0048069; GO:0048388; GO:0051452; GO:0060323; GO:0061795; GO:0070062; GO:0070821; GO:0090263; GO:0101003; GO:1902600 VYMVGK 13.10000038 1 1 2.34E-13 713.3879413 0 0 0 12.73739 0 0 0 0 0 13.60587 0 0 0 15.54845 0 0 0 0 0 0 0 0 0 0 0 16.52226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75791 GRAP2_HUMAN "GRB2-related adapter protein 2 (Adapter protein GRID) (GRB-2-like protein, GRB2L) (GRBLG) (GRBX) (Grf40 adapter protein, Grf-40) (Growth factor receptor-binding protein) (Hematopoietic cell-associated adapter protein GrpL) (P38) (Protein GADS) (SH3-SH2-SH3 adapter Mona)" GRAP2 GADS GRB2L GRID Homo sapiens (Human) cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265] GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007265; GO:0007267 TNSISRQK 7.53000021 0.114230849 0.114230849 0.185415443 933.9816988 11.77168 12.9361 15.54654 0 0 15.04394 0 16.31141 12.74117 0 16.45787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.72574 0 0 0 0 14.95089 0 0 0 17.068 0 0 0 0 0 15.42912 13.76184 13.47117 O75792 RNH2A_HUMAN "Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)" RNASEH2A RNASEHI RNHIA Homo sapiens (Human) "DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]" metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523] GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872 ADALYPVVSAASICAK 9.340000153 1 1 0.453309309 1635.851596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.76306 0 0 0 0 0 0 19.55413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.87299 0 O75795 UDB17_HUMAN "UDP-glucuronosyltransferase 2B17, UDPGT 2B17, UGT2B17, EC 2.4.1.17 (C19-steroid-specific UDP-glucuronosyltransferase, C19-steroid-specific UDPGT)" UGT2B17 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202] glucuronosyltransferase activity [GO:0015020] GO:0005789; GO:0008202; GO:0008210; GO:0015020; GO:0016020; GO:0016021; GO:0043231; GO:0052695 SVINDPIYK 4.900000095 0.100830138 0.100830138 0.225736788 1048.840363 14.77495 0 15.44856 0 0 14.57278 15.39956 12.71942 17.47982 12.61661 15.70452 0 0 0 13.5532 0 0 0 14.82744 0 0 0 0 0 0 0 0 0 0 0 0 0 15.37003 15.94418 15.99168 0 14.83025 0 16.77794 0 0 0 0 0 0 0 0 0 O75815 BCAR3_HUMAN Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) BCAR3 NSP2 SH2D3B UNQ271/PRO308 Homo sapiens (Human) endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784] GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007165; GO:0007264; GO:0008286; GO:0009410; GO:0016020; GO:0019900; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0045742; GO:0086100 LPSCAQGSHTELLTAK 1.129999995 0.427252978 0.427252978 0.286130176 1712.95557 16.88096 0 15.54234 0 14.10584 14.88077 0 15.7472 0 0 0 0 0 11.91987 16.31111 0 0 0 0 0 16.28751 0 16.07555 0 0 0 0 0 0 0 0 14.72242 0 16.33035 0 0 0 0 17.07592 12.9784 0 0 0 0 0 0 17.09168 0 O75818 RPP40_HUMAN "Ribonuclease P protein subunit p40, RNaseP protein p40 (RNase P subunit 1)" RPP40 RNASEP1 Homo sapiens (Human) "endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage involved in tRNA processing [GO:1905267]; tRNA 5'-leader removal [GO:0001682]" multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] "multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage involved in tRNA processing [GO:1905267]; tRNA 5'-leader removal [GO:0001682]" ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204] GO:0000172; GO:0000447; GO:0001682; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0030681; GO:0033204; GO:1905267 SNFGNHK 2.150000095 0.368549824 0.368549824 0.236837703 804.9231258 0 15.19104 0 0 14.71457 0 0 0 0 0 14.77631 0 0 15.81383 16.72651 14.20292 0 0 0 16.61014 0 16.364 17.09041 0 0 0 0 0 16.59828 0 0 0 0 17.29977 15.87672 0 15.81639 0 16.15988 15.30688 15.82252 0 0 0 0 0 15.8783 0 O75828 CBR3_HUMAN "Carbonyl reductase [NADPH] 3, EC 1.1.1.184 (NADPH-dependent carbonyl reductase 3) (Quinone reductase CBR3, EC 1.6.5.10) (Short chain dehydrogenase/reductase family 21C member 2)" CBR3 SDR21C2 Homo sapiens (Human) cognition [GO:0050890]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]; cognition [GO:0050890]; xenobiotic metabolic process [GO:0006805] carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491] GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0016491; GO:0050890; GO:0070402 AEMTLK 6.78000021 1 1 0.235728491 692.1761385 16.59879 16.07717 0 14.73432 14.57283 12.94721 14.91511 14.79326 12.61529 10.07032 15.7234 15.2976 15.0212 16.71756 15.13348 16.04276 15.1084 16.19349 0 13.9296 15.84806 0 15.1539 15.18791 14.79737 14.54896 17.28356 0 0 14.2633 14.80789 0 0 16.02529 15.2198 0 15.38774 17.0234 0 0 15.20345 17.6463 15.65611 16.4815 0 15.62113 0 0 O75840 KLF7_HUMAN Krueppel-like factor 7 (Ubiquitous krueppel-like factor) KLF7 UKLF Homo sapiens (Human) axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007409; GO:0007411; GO:0008270; GO:0042593; GO:0045604; GO:0045944; GO:0048813; GO:0061179; GO:1904178 TSQTLSAVDGTVTLKLVAK 4.5 1 1 0.310321487 1931.987245 14.35249 0 13.85964 15.63446 0 0 0 0 0 0 0 14.86658 0 0 15.79779 0 0 14.10638 0 0 19.01205 0 0 0 0 0 0 0 0 14.89862 0 0 0 10.01413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75843 AP1G2_HUMAN "AP-1 complex subunit gamma-like 2 (Gamma2-adaptin, G2ad)" AP1G2 Homo sapiens (Human) Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133] AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615] GO:0000139; GO:0005794; GO:0005798; GO:0006886; GO:0006896; GO:0006898; GO:0010008; GO:0016020; GO:0016192; GO:0030121; GO:0030133; GO:0035615; GO:0140312 RVGYLGAMLLLDER 9.920000076 1 1 0.384071641 1622.960778 0 0 15.21208 0 16.58362 12.36921 0 0 0 0 0 0 15.6338 14.94714 0 0 0 0 15.32018 0 14.77159 0 0 17.05851 16.72242 16.41459 16.35185 16.0033 0 0 15.2671 15.17663 16.85682 17.06739 0 12.01829 16.83321 0 0 0 0 0 16.49511 0 0 0 16.34875 0 O75864 PPR37_HUMAN Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68) PPP1R37 KIAA1986 LRRC68 Homo sapiens (Human) protein phosphatase inhibitor activity [GO:0004864] protein phosphatase inhibitor activity [GO:0004864] GO:0004864 ISVSSPGR 1.309999943 1 1 0.395362863 801.1592169 14.0875 12.9685 0 0 0 0 0 15.42173 14.52838 9.824983 0 14.46335 14.04722 12.83183 13.83191 0 0 15.79339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75865 TPC6A_HUMAN "Trafficking protein particle complex subunit 6A, TRAPP complex subunit 6A" TRAPPC6A HSPC289 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; regulation of GTPase activity [GO:0043087]; vesicle tethering [GO:0099022] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; regulation of GTPase activity [GO:0043087]; vesicle tethering [GO:0099022] GO:0005737; GO:0005783; GO:0005801; GO:0005802; GO:0005829; GO:0006888; GO:0030008; GO:0043087; GO:0048208; GO:0099022; GO:1903232; GO:1990072 GALYTLGIESVVTASVAALPVCK 4.559999943 1 1 4.57E-13 2318.563211 10.88883 0 0 0 15.63482 14.93956 0 14.46624 0 0 0 0 15.34659 15.58645 16.02314 12.78059 15.2147 14.91164 0 16.50685 15.46057 15.65849 0 0 16.52607 0 12.48098 0 15.98666 0 14.48844 0 15.30326 14.06002 15.86586 14.36729 13.58731 15.47026 0 0 16.83999 16.16899 0 16.42824 0 0 0 0 O75874 IDHC_HUMAN "Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, IDH1, EC 1.1.1.42 (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)" IDH1 PICD Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803] GO:0000287; GO:0004450; GO:0005576; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0034774; GO:0042802; GO:0042803; GO:0045296; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0070062; GO:0071071; GO:1904724; GO:1904813 DAAEAIK 5.760000229 1 1 0 714.1211501 15.06736 0 12.89382 15.42605 13.91811 14.17459 0 0 0 15.36875 0 0 14.41536 0 0 0 14.27322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75880 SCO1_HUMAN "Protein SCO1 homolog, mitochondrial" SCO1 SCOD1 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617] copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507] GO:0005507; GO:0005739; GO:0006878; GO:0016531; GO:0030016; GO:0031305; GO:0033617 MAMLVLVPGR 7.800000191 1 1 1.37E-12 1112.258015 12.94839 0 12.67011 14.6989 15.08309 14.80187 14.41242 13.42665 14.93912 15.02543 12.94094 0 14.43227 0 15.02174 14.84373 0 0 15.94665 0 0 16.23546 16.28417 16.10474 15.08867 0 14.42963 14.1201 0 0 0 12.15058 0 0 14.57732 0 0 0 0 0 0 0 0 0 0 0 0 0 O75881 CP7B1_HUMAN "Cytochrome P450 7B1 (24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26) (25/26-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.29) (3-hydroxysteroid 7-alpha hydroxylase) (Oxysterol 7-alpha-hydroxylase)" CYP7B1 Homo sapiens (Human) B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid hydroxylase activity [GO:0008395]; B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125] 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid hydroxylase activity [GO:0008395] GO:0005506; GO:0005789; GO:0006699; GO:0008203; GO:0008395; GO:0008396; GO:0016021; GO:0016125; GO:0020037; GO:0033147; GO:0033782; GO:0033783; GO:0035754; GO:0042632; GO:0047092; GO:0050679; GO:0060740 IIKCFSSEK 2.710000038 0.344521582 0.344521582 0.085534414 1112.319106 0 0 0 15.69372 12.65832 13.23276 14.06231 0 0 11.04418 13.47582 0 0 15.25869 13.55441 15.91617 0 12.0438 0 15.34704 0 0 0 0 14.8541 16.41029 13.66725 15.56724 14.37553 15.27543 14.45067 17.48173 13.30412 12.68286 0 0 0 14.5273 16.36151 13.23577 0 16.52879 14.49869 14.36769 14.96735 0 17.25238 0 O75896 TUSC2_HUMAN "Tumor suppressor candidate 2 (Fusion 1 protein, Fus-1 protein) (PDGFA-associated protein 2)" TUSC2 C3orf11 FUS1 LGCC PDAP2 Homo sapiens (Human) cell cycle [GO:0007049]; cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; cell cycle [GO:0007049]; cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377] GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0007049; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0070945; GO:2000377 MGASGSKAR 9.680000305 0.555243134 0.555243134 0.120386564 880.4361375 17.89635 0 0 0 17.03825 16.3643 0 14.86053 0 17.39235 17.33806 0 16.00421 0 16.23389 0 16.51255 0 0 0 14.95502 17.10447 0 0 0 0 15.54718 0 0 0 0 0 15.33869 0 0 0 0 16.36516 17.69682 16.50788 15.40708 15.89202 16.61973 0 0 0 0 13.84277 O75899 GABR2_HUMAN "Gamma-aminobutyric acid type B receptor subunit 2, GABA-B receptor 2, GABA-B-R2, GABA-BR2, GABABR2, Gb2 (G-protein coupled receptor 51) (HG20)" GABBR2 GPR51 GPRC3B Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]" cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]" G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 GAPRPPPSSPPLSIMGLMPLTK 5.369999886 1 1 0.025387368 2277.316001 0 15.01895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75901 RASF9_HUMAN "Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1, P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor)" RASSF9 PAMCI PCIP1 Homo sapiens (Human) endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]; endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165] GO:0005768; GO:0005829; GO:0006605; GO:0007165; GO:0012510; GO:0016197; GO:0046907; GO:0055037; GO:0070062 MKELDLEIEK 6.28000021 1 1 0.350670128 1245.929413 0 0 0 0 0 0 0 0 0 0 0 0 17.9232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75909 CCNK_HUMAN Cyclin-K CCNK CPR4 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0009966; GO:0016538; GO:0019901; GO:0032786; GO:0032968; GO:0044828; GO:0051301; GO:0061575; GO:0070816; GO:2001165 EENKAAEPPPPK 6.409999847 0.188485235 0.188485235 0.237347961 1303.91696 0 0 13.28045 14.08405 0 12.38861 0 0 0 0 0 0 15.89781 15.89363 15.04665 14.75478 0 0 15.82921 0 0 0 0 0 0 0 0 0 15.75781 0 15.96644 16.85353 0 0 0 0 15.70614 0 0 0 17.24806 0 0 14.9344 0 0 0 0 O75912 DGKI_HUMAN "Diacylglycerol kinase iota, DAG kinase iota, DGK-iota, EC 2.7.1.107" DGKI Homo sapiens (Human) "diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]" ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0014069; GO:0030168; GO:0030424; GO:0030672; GO:0032991; GO:0035556; GO:0043197; GO:0045202; GO:0046339; GO:0046834; GO:0046872; GO:0051966; GO:0097060 LQEDLQSVSSGSQR 19.94000053 0.909792006 0.909792006 0.190156403 1533.207992 9.351282 5.688414 0 0 15.91037 21.87612 22.20199 21.42892 12.36545 0 0 0 0 0 0 20.99565 0 0 0 0 0 0 0 13.10359 21.03778 0 0 0 21.33784 0 17.45081 14.95135 0 15.91234 12.36967 0 0 0 16.98199 0 0 0 0 0 0 0 21.76918 0 O75914 PAK3_HUMAN "Serine/threonine-protein kinase PAK 3, EC 2.7.11.1 (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3, PAK-3)" PAK3 OPHN3 Homo sapiens (Human) axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; synapse organization [GO:0050808] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; synapse organization [GO:0050808] ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] GO:0002223; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006468; GO:0007409; GO:0010763; GO:0014069; GO:0016358; GO:0017124; GO:0030833; GO:0031267; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0048013; GO:0050770; GO:0050808; GO:0060997; GO:0061003; GO:0071407; GO:0098978; GO:0106310; GO:2000573 SIYTRSVVESIASPAVPNK 7.179999828 1 1 0.676699657 2019.345246 0 0 15.57922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.62973 19.78549 0 0 0 0 0 18.20775 0 0 0 17.49567 0 0 0 0 0 0 0 0 0 0 0 O75916 RGS9_HUMAN "Regulator of G-protein signaling 9, RGS9" RGS9 Homo sapiens (Human) dark adaptation [GO:1990603]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; light adaption [GO:0036367]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dark adaptation [GO:1990603]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; light adaption [GO:0036367]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GO:0003924; GO:0005096; GO:0005886; GO:0007186; GO:0007601; GO:0008277; GO:0009968; GO:0035556; GO:0036367; GO:0098839; GO:0098978; GO:1990603 APPKAR 5.659999847 1 1 0.254452253 640.1158153 0 0 0 0 0 0 0 18.287 17.41173 0 17.46329 0 0 0 0 0 19.11569 0 0 0 17.37198 0 0 0 0 18.49308 0 0 0 0 16.18314 0 0 0 19.20506 0 19.0915 0 18.26895 0 0 0 0 16.98292 0 0 0 0 O75923 DYSF_HUMAN Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1) DYSF FER1L1 Homo sapiens (Human) macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543]; macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543] GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006906; GO:0007009; GO:0016021; GO:0030139; GO:0030315; GO:0030659; GO:0031410; GO:0033292; GO:0034451; GO:0042383; GO:0050765; GO:0061025; GO:0070062 ALAEEPQNSLPDIVIWMLQGDKR 5.96999979 1 1 3.66E-12 2624.41366 0 0 0 0 0 0 14.15266 0 0 0 0 0 0 0 0 7.86671 0 0 0 0 0 0 0 0 11.86382 0 12.8084 11.20702 0 13.5771 0 0 0 0 0 0 0 0 0 0 15.16247 0 11.40277 14.35669 0 0 0 0 O75925 PIAS1_HUMAN "E3 SUMO-protein ligase PIAS1, EC 2.3.2.- (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein, GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein)" PIAS1 DDXBP1 Homo sapiens (Human) fat cell differentiation [GO:0045444]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; fat cell differentiation [GO:0045444]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0007259; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0031625; GO:0032436; GO:0033235; GO:0042127; GO:0045444; GO:0061665; GO:0140297 EDGTWAPMR 4.099999905 1 1 0.289152667 1062.413629 0 0 0 0 0 0 0 0 0 16.87505 16.16557 0 16.16084 16.93838 0 17.51777 0 15.95071 17.69881 0 17.19302 0 0 0 0 16.16604 17.12036 17.79292 0 17.28374 0 0 0 0 0 0 0 17.75043 0 18.16643 17.44689 0 17.66125 16.39689 17.38099 17.10809 0 0 O75928 PIAS2_HUMAN "E3 SUMO-protein ligase PIAS2, EC 2.3.2.- (Androgen receptor-interacting protein 3, ARIP3) (DAB2-interacting protein, DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting zinc finger protein, Miz1) (PIAS-NY protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2)" PIAS2 PIASX Homo sapiens (Human) "negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0031625; GO:0043433; GO:0060766; GO:0061629; GO:0061665 SGCSPAVQIK 1.600000024 0.09638375 0.09638375 0.247469201 1047.074557 0 0 0 16.28009 14.71596 0 15.44191 0 0 14.62264 16.48423 14.22905 13.29156 0 0 0 0 15.08027 0 0 0 0 0 0 0 0 0 0 0 0 15.50285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75934 SPF27_HUMAN Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2) (DNA amplified in mammary carcinoma 1 protein) (Spliceosome-associated protein SPF 27) BCAS2 DAM1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005813; GO:0008380; GO:0016607; GO:0071007; GO:0071013 ENIRQDF 15 1 1 0.324121636 922.3013109 0 0 13.67299 17.16858 0 13.87743 0 15.15472 14.60473 0 0 0 0 0 14.32408 13.38473 0 0 0 0 0 13.94086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.50058 0 0 0 0 0 0 0 0 0 0 O75936 BODG_HUMAN "Gamma-butyrobetaine dioxygenase, EC 1.14.11.1 (Gamma-butyrobetaine hydroxylase, Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)" BBOX1 BBH BBOX Homo sapiens (Human) carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 AEALDGAHLMQILWYDEEESLYPAVWLR 2.670000076 0.30265072 0.30265072 7.30E-12 3335.078461 0 0 13.99496 0 12.82514 15.29651 0 16.17106 15.96591 0 15.65413 14.29442 0 0 15.16603 14.10558 13.04548 14.75996 14.80111 0 0 16.26661 11.35871 0 0 0 0 14.44133 12.77921 0 19.21803 0 14.91094 16.6637 0 0 19.41488 0 0 15.87253 16.5983 0 0 12.50035 7.295877 0 0 0 O75943 RAD17_HUMAN "Cell cycle checkpoint protein RAD17, hRad17 (RF-C/activator 1 homolog)" RAD17 R24L Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689] GO:0000076; GO:0000077; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0042325 ATKYNK 7.199999809 0.040384822 0.040384822 0.30457703 725.0936164 16.21668 0 16.02153 20.46189 0 0 17.82329 19.90443 17.29342 0 0 17.05005 17.19504 17.90089 18.2881 0 17.53431 0 0 0 0 18.11954 17.78781 0 0 19.79291 0 0 15.86016 17.85599 0 19.47331 0 0 18.22905 0 19.42632 0 0 0 18.24346 18.18606 19.52679 17.91197 0 0 17.57133 0 O75955 FLOT1_HUMAN Flotillin-1 FLOT1 Homo sapiens (Human) "axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]" adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931] "adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931]; ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]; axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]" ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020] GO:0001819; GO:0001931; GO:0001934; GO:0002020; GO:0002090; GO:0005765; GO:0005768; GO:0005769; GO:0005815; GO:0005886; GO:0005901; GO:0005911; GO:0005912; GO:0005925; GO:0007409; GO:0009897; GO:0016020; GO:0016323; GO:0016600; GO:0022617; GO:0030027; GO:0031410; GO:0032092; GO:0032226; GO:0032728; GO:0033227; GO:0034116; GO:0034141; GO:0034451; GO:0034976; GO:0035023; GO:0035255; GO:0042383; GO:0042470; GO:0044291; GO:0044854; GO:0044857; GO:0045121; GO:0045807; GO:0048643; GO:0048786; GO:0050821; GO:0051092; GO:0051580; GO:0070062; GO:0070528; GO:0071360; GO:0072659; GO:0098691; GO:0098978; GO:0098982; GO:1901741; GO:1901890; GO:2000049 AQADLAYQLQVAKTK 5.170000076 1 1 0.345333315 1648.742684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.93133 0 18.08452 0 0 0 0 0 0 0 0 O75962 TRIO_HUMAN "Triple functional domain protein, EC 2.7.11.1 (PTPRF-interacting protein)" TRIO Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005085; GO:0005524; GO:0005737; GO:0005829; GO:0007185; GO:0007411; GO:0007417; GO:0019898; GO:0042995; GO:0045599; GO:0048812; GO:0051056; GO:0106310 EPIHIPK 2.559999943 0.061974954 0.061974954 0.12793992 834.0815485 0 14.62674 0 0 14.27568 14.55522 0 14.68286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.89242 0 14.85954 14.25839 14.0977 0 0 0 0 0 0 0 0 16.31535 0 16.11971 0 0 0 0 0 0 0 O75964 ATP5L_HUMAN "ATP synthase subunit g, mitochondrial, ATPase subunit g (ATP synthase membrane subunit g)" ATP5MG ATP5L Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]" proton transmembrane transporter activity [GO:0015078] GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776 GIIGYDV 20.01000023 0.950893998 0.950893998 0.168438597 734.2760439 0 16.58336 13.02538 0 0 12.45712 0 0 0 14.57136 16.46757 16.03595 0 14.22974 0 0 0 0 15.84722 0 0 17.12614 16.6214 0 14.5251 0 0 0 0 16.24283 0 0 0 0 14.83058 0 0 0 0 0 0 0 0 16.98632 0 16.0947 0 15.43139 O75969 AKAP3_HUMAN "A-kinase anchor protein 3, AKAP-3 (A-kinase anchor protein 110 kDa, AKAP 110) (Cancer/testis antigen 82, CT82) (Fibrous sheath protein of 95 kDa, FSP95) (Fibrousheathin I) (Fibrousheathin-1) (Protein kinase A-anchoring protein 3, PRKA3) (Sperm oocyte-binding protein)" AKAP3 AKAP110 SOB1 Homo sapiens (Human) acrosome reaction [GO:0007340]; blastocyst hatching [GO:0001835]; protein localization [GO:0008104]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; protein kinase A binding [GO:0051018]; acrosome reaction [GO:0007340]; blastocyst hatching [GO:0001835]; protein localization [GO:0008104]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] protein kinase A binding [GO:0051018] GO:0001669; GO:0001835; GO:0005634; GO:0005737; GO:0007178; GO:0007338; GO:0007340; GO:0008104; GO:0035686; GO:0051018; GO:0097225; GO:0097228 AESYSLISMKGMGDPK 6.380000114 1 1 0.48369242 1728.259562 0 20.68707 0 0 0 0 0 0 0 0 19.40256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.34178 0 0 0 0 0 0 0 21.4212 0 0 0 0 0 0 0 0 0 0 0 0 0 O75970 MPDZ_HUMAN Multiple PDZ domain protein (Multi-PDZ domain protein 1) MPDZ MUPP1 Homo sapiens (Human) microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein C-terminus binding [GO:0008022]; microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192] protein C-terminus binding [GO:0008022] GO:0005737; GO:0005886; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0031023; GO:0045177; GO:0070507; GO:0120192 LSNGEVMR 6.139999866 1 1 0.173144214 922.1836027 15.31056 0 15.97978 14.96133 15.59164 0 14.01046 13.32874 14.87995 0 0 0 0 0 0 0 15.34886 15.09116 0 0 0 0 0 0 15.03271 15.07434 0 0 0 10.25205 14.66865 0 13.89792 15.07842 14.45057 0 0 0 0 0 14.60046 0 0 0 0 0 0 0 O76001 OR2J3_HUMAN "Olfactory receptor 2J3 (Hs6M1-3) (Olfactory receptor OR6-16, OR6-6, Olfactory receptor 6-6)" OR2J3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 MNDDGK 11.21000004 0.057662439 0.057662439 0.253674627 678.3086988 0 16.81705 18.9553 17.74586 17.32284 17.10586 15.27844 17.82261 0 0 17.3532 17.07471 16.65782 16.20592 18.48305 14.25739 16.91628 16.3782 0 17.53382 16.27413 14.96956 0 17.52441 0 17.7019 17.83261 16.274 15.5223 0 0 16.63474 19.66105 0 0 15.47171 18.00701 0 0 0 17.68787 16.88907 17.58853 0 0 16.77269 17.11479 18.30393 O76003 GLRX3_HUMAN "Glutaredoxin-3 (PKC-interacting cousin of thioredoxin, PICOT) (PKC-theta-interacting protein, PKCq-interacting protein) (Thioredoxin-like protein 2)" GLRX3 PICOT TXNL2 HUSSY-22 Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018]; glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026] glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723] GO:0002026; GO:0003723; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006879; GO:0010614; GO:0016226; GO:0030018; GO:0030425; GO:0042802; GO:0044571; GO:0045454; GO:0046872; GO:0051536; GO:0055072; GO:0097428; GO:0097573; GO:1990229 QMVEILHK 31.78000069 0.820335686 0.820335686 0.222393579 997.6606037 19.28768 18.79854 19.14678 0 20.43692 0 0 21.20729 0 20.59742 0 19.78274 16.37023 0 19.23566 19.87398 0 0 0 0 0 0 0 18.89617 17.34852 19.33272 0 0 20.21089 19.37366 0 19.8957 20.2069 0 0 20.68321 19.19604 20.21353 0 20.35655 0 19.80132 0 16.52645 19.91888 18.79209 0 20.0157 O76014 KRT37_HUMAN "Keratin, type I cuticular Ha7 (Hair keratin, type I Ha7) (Keratin-37, K37)" KRT37 HHA7 HKA7 KRTHA7 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109; GO:0070062 CGTQKLLDDATLAK 2.960000038 1 1 0.145121508 1537.300259 14.93949 0 0 0 15.08276 0 0 12.46851 14.529 0 0 0 0 0 0 0 0 0 0 16.94367 0 0 0 0 0 0 0 0 0 15.92539 14.01016 0 0 0 13.57902 0 0 16.3957 14.7857 0 15.49106 0 0 0 0 0 0 0 O76038 SEGN_HUMAN Secretagogin SCGN SECRET Homo sapiens (Human) regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0030425; GO:0030658; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0099509; GO:1900271 LGTDDTVMK 10 1 1 0.359338692 994.3794509 0 15.06336 15.15691 16.43098 15.21877 14.12743 14.64936 14.28166 12.02337 0 0 0 14.67339 13.79224 13.06857 0 0 0 0 0 0 0 0 0 15.85608 0 0 0 0 14.28342 0 0 0 0 15.69481 0 0 16.35336 15.83058 0 15.16907 0 0 0 0 0 0 0 O76039 CDKL5_HUMAN "Cyclin-dependent kinase-like 5, EC 2.7.11.22 (Serine/threonine-protein kinase 9)" CDKL5 STK9 Homo sapiens (Human) neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267] GO:0001764; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0006468; GO:0016301; GO:0031267; GO:0032839; GO:0036064; GO:0043547; GO:0044294; GO:0045773; GO:0046777; GO:0050773; GO:0050775; GO:0097542; GO:0098978; GO:0099175; GO:0106310; GO:1902017 DIKPENLLISHNDVLK 7.860000134 0.067082226 0.067082226 0.597535294 1847.539125 0 16.20507 0 0 0 0 0 17.33088 0 0 0 0 0 0 0 0 0 0 0 0 18.27896 0 0 0 0 0 0 0 0 0 20.28888 0 0 0 19.8633 0 0 0 0 18.31999 0 0 0 0 0 0 0 0 O76050 NEUL1_HUMAN "E3 ubiquitin-protein ligase NEURL1, EC 2.3.2.27 (Neuralized-like protein 1A, h-neu, h-neuralized 1) (RING finger protein 67) (RING-type E3 ubiquitin transferase NEURL1)" NEURL1 NEURL NEURL1A RNF67 Homo sapiens (Human) brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288] apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]" "metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]" GO:0004842; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007399; GO:0007420; GO:0007519; GO:0007595; GO:0008285; GO:0014069; GO:0043065; GO:0043197; GO:0043204; GO:0045183; GO:0045741; GO:0045746; GO:0046872; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0071230; GO:0090129; GO:0097440 FHALRAGAHVR 4.360000134 1 1 0.172301701 1235.194477 15.8249 13.32837 14.07584 13.40626 15.7231 0 0 14.3416 0 0 11.20993 0 14.91442 0 15.24328 0 14.61249 0 15.09622 0 15.90351 0 0 0 0 14.84385 0 0 0 0 15.83425 0 0 0 0 0 0 0 0 14.54449 0 0 16.42615 0 16.23179 0 0 14.42622 O76054 S14L2_HUMAN "SEC14-like protein 2 (Alpha-tocopherol-associated protein, TAP, hTAP) (Squalene transfer protein) (Supernatant protein factor, SPF)" SEC14L2 C22orf6 KIAA1186 KIAA1658 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]" phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431] GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008431; GO:0045540; GO:0045893; GO:0070062 ASEEKMK 4 0.27901423 0.27901423 0.077385353 837.3351865 13.85205 10.86302 0 15.88064 14.65521 15.42168 14.38907 14.00263 14.44259 0 15.92318 15.77688 17.03096 13.66637 11.93936 0 0 0 18.48078 0 17.30015 17.08488 0 16.15043 0 15.45406 13.90025 16.06955 0 15.94852 18.52045 0 0 0 15.10547 0 16.66175 0 16.42746 12.71804 0 16.29112 14.33617 15.67319 14.74873 14.31294 14.15339 16.59657 O76064 RNF8_HUMAN "E3 ubiquitin-protein ligase RNF8, hRNF8, EC 2.3.2.27 (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8)" RNF8 KIAA0646 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0016567; GO:0030496; GO:0031625; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0036297; GO:0042393; GO:0042802; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070535; GO:0070936 ICPLMISR 10.18000031 1 1 0.353944064 1005.317913 16.41308 16.24079 0 16.39139 16.1106 15.57893 16.01295 15.58342 16.57942 0 16.81818 15.79953 0 16.36673 16.10411 0 0 16.65246 0 0 0 0 0 0 16.37163 0 16.85942 0 0 0 0 0 0 17.05824 0 0 0 0 0 0 0 16.95051 0 0 0 0 0 0 O76070 SYUG_HUMAN "Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin, SR)" SNCG BCSG1 PERSYN PRSN Homo sapiens (Human) adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cuprous ion binding [GO:1903136]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488] cuprous ion binding [GO:1903136] GO:0005737; GO:0005815; GO:0005819; GO:0007268; GO:0008344; GO:0009306; GO:0014059; GO:0043025; GO:0043679; GO:0046928; GO:0048471; GO:0048488; GO:0050808; GO:0070062; GO:1901214; GO:1903136 TVEEAENIAVTSGVVR 8.890000343 1 1 0.132947581 1673.766249 0 0 0 13.70135 15.73741 0 0 15.8556 0 0 0 0 15.25972 0 15.18131 0 0 16.02146 15.49788 0 16.35649 0 0 15.78599 16.57621 0 0 0 15.85738 0 0 16.19962 16.8165 0 0 16.65326 0 0 0 0 0 15.82901 0 15.57308 0 16.97787 0 15.14044 O76074 PDE5A_HUMAN "cGMP-specific 3',5'-cyclic phosphodiesterase, EC 3.1.4.35 (cGMP-binding cGMP-specific phosphodiesterase, CGB-PDE)" PDE5A PDE5 Homo sapiens (Human) cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]" "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]" GO:0004114; GO:0005829; GO:0007165; GO:0010613; GO:0010749; GO:0030553; GO:0042130; GO:0043406; GO:0046069; GO:0046872; GO:0047555; GO:0055118; GO:0055119; GO:0060282 KEQMPLTPPR 9.93999958 0.79759866 0.79759866 1.60E-12 1212.690142 0 15.854 0 12.92944 0 0 0 0 0 0 0 15.10892 14.90182 0 13.88761 0 0 15.29905 0 14.98817 14.11143 0 0 0 16.21093 14.58473 0 10.0989 0 13.61909 14.55824 0 0 0 0 0 0 16.34968 0 9.985966 15.76644 0 0 15.5229 0 0 0 15.94313 O76075 DFFB_HUMAN "DNA fragmentation factor subunit beta, EC 3.-.-.- (Caspase-activated deoxyribonuclease, CAD, Caspase-activated DNase) (Caspase-activated nuclease, CPAN) (DNA fragmentation factor 40 kDa subunit, DFF-40)" DFFB CAD DFF2 DFF40 Homo sapiens (Human) apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308] deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] GO:0000785; GO:0003677; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718 VLGSMCQR 7.010000229 0.266001016 0.266001016 0.184344708 949.5436246 0 16.55535 15.19963 0 0 13.99141 0 15.73968 0 0 0 0 15.19489 0 15.54575 15.40518 16.14353 16.02735 16.83704 15.53967 16.82581 16.03396 15.63052 17.48577 17.01892 15.46785 15.37659 15.69649 0 15.54107 17.00936 15.2866 0 15.89312 16.04541 13.3411 17.08436 16.48174 0 15.98875 16.46587 15.70755 15.49249 14.77924 17.8738 15.64097 16.26303 17.51567 O76090 BEST1_HUMAN Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2) BEST1 VMD2 Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601] bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229] GO:0005229; GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0009925; GO:0015106; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924; GO:1902476 QNVRGQEDNK 6.420000076 1 1 0.110002878 1189.152471 14.40098 11.72253 0 14.29212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.95237 13.10874 0 0 0 15.14594 0 0 0 0 0 0 0 0 0 O77932 DXO_HUMAN "Decapping and exoribonuclease protein, DXO, EC 3.6.1.- (5'-3' exoribonuclease DXO, EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO, DeNADding enzyme DXO, EC 3.6.1.-)" DXO DOM3L DOM3Z NG6 Homo sapiens (Human) mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779] 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353] GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090305; GO:0110152; GO:0110155 ELMYMGYK 8.100000381 0.99520427 0.99520427 0.256000865 1050.14881 14.47132 15.32616 12.9647 16.91505 15.63803 15.08627 0 14.52839 13.9071 0 15.39681 15.11653 15.41722 13.48928 14.34026 13.09951 16.58549 14.72191 15.68715 15.65912 14.13657 15.25587 15.51925 0 15.43762 0 0 16.39694 0 0 0 0 0 0 14.9168 0 0 16.34865 15.86983 0 0 0 16.20987 0 0 15.42587 0 0 O94759 TRPM2_HUMAN "Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2, LTrpC-2, LTrpC2) (Transient receptor potential channel 7, TrpC7) (Transient receptor potential melastatin 2)" TRPM2 EREG1 KNP3 LTRPC2 TRPC7 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577] cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272] GO:0001659; GO:0002407; GO:0005261; GO:0005262; GO:0005272; GO:0005384; GO:0005509; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006816; GO:0009408; GO:0014074; GO:0015278; GO:0030659; GO:0032024; GO:0033194; GO:0035579; GO:0035584; GO:0043005; GO:0043204; GO:0044849; GO:0051209; GO:0051289; GO:0051489; GO:0070301; GO:0070588; GO:0070821; GO:0071277; GO:0071415; GO:0071502; GO:0071577; GO:0072571; GO:0097028; GO:0097553; GO:0098655; GO:0098703; GO:0099604; GO:0101003; GO:1903223; GO:2000249 SFHGPYTVQAGLPLNPMGR 2.529999971 0.240164325 0.240164325 0.266719231 2057.417447 13.02105 0 12.73519 14.24989 13.78313 0 17.33137 13.34092 13.60558 11.98988 0 0 9.740167 12.53611 0 0 0 0 0 0 0 0 0 15.50341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94761 RECQ4_HUMAN "ATP-dependent DNA helicase Q4, EC 3.6.4.12 (DNA helicase, RecQ-like type 4, RecQ4) (RTS) (RecQ protein-like 4)" RECQL4 RECQ4 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] "chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]" 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821] GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0032508; GO:0043138; GO:0061820; GO:0061821; GO:1990814 TTAEAYHAGMCSRER 1.159999967 1 1 6.85E-13 1755.138919 0 15.07107 0 0 0 0 0 14.30772 0 16.31283 0 14.5285 0 0 0 13.34151 0 12.87607 0 15.08218 13.62716 0 0 14.48299 0 14.53563 0 10.73019 16.07488 0 0 0 0 11.38442 0 0 17.93745 15.86787 16.70332 0 0 16.24636 0 15.32428 14.79921 0 0 17.07205 O94762 RECQ5_HUMAN "ATP-dependent DNA helicase Q5, EC 3.6.4.12 (DNA helicase, RecQ-like type 5, RecQ5) (RecQ protein-like 5)" RECQL5 RECQ5 Homo sapiens (Human) cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]" "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]" 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993] GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0016887; GO:0032508; GO:0034244; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:1990414; GO:2000042 SSSGGSSLAKGR 10.5 1 1 0.038255716 1094.457941 14.69153 0 0 10.9562 13.25859 0 0 0 0 0 0 0 0 14.79146 14.47176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0489 0 0 0 0 0 0 0 0 0 0 0 0 0 O94768 ST17B_HUMAN "Serine/threonine-protein kinase 17B, EC 2.7.11.1 (DAP kinase-related apoptosis-inducing protein kinase 2)" STK17B DRAK2 Homo sapiens (Human) apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005793; GO:0005886; GO:0006468; GO:0006915; GO:0015629; GO:0035556; GO:0043065; GO:0046777; GO:0106310; GO:2000271 IVDFGMSR 1.549999952 0.721962631 0.721962631 0.110015265 940.6211024 16.44094 0 0 0 0 16.66604 12.28943 0 0 13.67313 14.89637 13.97239 15.57893 0 0 11.61836 0 0 0 0 0 0 0 0 14.74355 0 17.43274 11.76423 0 0 16.92956 14.37082 0 0 0 0 0 0 0 0 0 0 15.94893 17.00786 9.499145 0 12.21761 14.33234 O94769 ECM2_HUMAN Extracellular matrix protein 2 (Matrix glycoprotein SC1/ECM2) ECM2 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; collagen V binding [GO:0070052]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] collagen V binding [GO:0070052]; heparin binding [GO:0008201]; integrin binding [GO:0005178] GO:0005178; GO:0005576; GO:0005614; GO:0007160; GO:0008201; GO:0010811; GO:0030198; GO:0031012; GO:0070052 LAHQQQR 6.880000114 0.746179521 0.746179521 0.227965822 877.0961532 0 15.2123 15.87756 0 0 16.49427 0 0 0 14.17302 0 13.70508 14.80147 0 15.43568 13.02764 16.30192 15.50942 15.82676 0 0 0 0 0 15.58094 15.318 16.51303 12.90135 15.54958 14.06613 12.93466 0 16.38723 15.40193 13.00126 14.84124 13.07093 15.3068 13.63548 13.34601 13.35566 0 13.90782 13.57554 13.55346 15.7364 13.04745 0 O94779 CNTN5_HUMAN "Contactin-5 (Neural recognition molecule NB-2, hNB-2)" CNTN5 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605] anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886] anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605] cell-cell adhesion mediator activity [GO:0098632] GO:0005576; GO:0005886; GO:0007411; GO:0007420; GO:0007605; GO:0030424; GO:0098609; GO:0098632; GO:0098982; GO:0099026; GO:0099054 MVTSSEASKFIYR 1.940000057 1 1 0.209183957 1518.044972 0 10.05914 14.41051 12.95243 0 0 0 15.79605 13.80958 0 12.83496 14.19597 0 0 11.70422 0 14.01854 0 15.24419 15.33656 0 0 13.9937 0 14.20106 13.48682 13.92929 0 15.52459 0 0 0 13.73681 0 14.18255 13.67126 0 0 0 15.67107 11.66277 0 0 0 0 0 0 13.48045 O94782 UBP1_HUMAN "Ubiquitin carboxyl-terminal hydrolase 1, EC 3.4.19.12 (Deubiquitinating enzyme 1, hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment ]" USP1 Homo sapiens (Human) DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843] GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006282; GO:0006511; GO:0008233; GO:0009411; GO:0016579; GO:0035520 NVEAIGLLGGQK 1.74000001 0.151750356 0.151750356 0.053087366 1199.350648 14.09315 14.80043 11.48048 16.28661 7.37565 14.29186 0 0 0 0 0 14.99045 0 0 0 0 0 0 0 0 12.81301 0 0 0 0 11.43985 14.06965 0 0 0 0 16.73679 15.4019 13.86658 16.64585 15.08199 0 13.53775 10.17091 0 0 0 11.48711 12.63556 0 14.8999 0 12.99928 O94811 TPPP_HUMAN "Tubulin polymerization-promoting protein, TPPP, EC 3.6.5.- (25 kDa brain-specific protein) (TPPP/p25) (p24) (p25-alpha)" TPPP TPPP1 Homo sapiens (Human) astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507] GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631] GO:0000287; GO:0001578; GO:0003924; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0008017; GO:0014003; GO:0015631; GO:0030953; GO:0031334; GO:0031643; GO:0032273; GO:0032288; GO:0042803; GO:0046785; GO:0048471; GO:0048709; GO:0051301; GO:0051418; GO:0070507; GO:0072686; GO:0150051; GO:1904428 DCQVIDGR 12.25 0.636034369 0.636034369 0.257836813 963.070404 12.875 16.18546 14.81469 14.86514 14.63646 16.41829 0 14.14405 0 14.59765 0 0 15.43637 13.49718 0 14.26726 0 0 0 16.02656 0 16.01138 15.38058 0 0 18.19908 0 15.53984 0 0 15.57073 15.94643 0 0 14.90426 0 0 0 0 15.94114 14.56131 0 15.40718 15.42735 15.63405 0 15.66347 0 O94812 BAIP3_HUMAN "BAI1-associated protein 3, BAP3 (Brain-specific angiogenesis inhibitor I-associated protein 3)" BAIAP3 KIAA0734 Homo sapiens (Human) "dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]" calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502 EPRAQK 4.679999828 1 1 0.114764882 732.2710243 15.85381 15.64268 14.21953 0 15.85228 15.49592 0 0 0 0 0 0 0 0 0 15.43018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94813 SLIT2_HUMAN "Slit homolog 2 protein, Slit-2 [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product ]" SLIT2 SLIL3 Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0009986; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288 DLEVLTLNNNNITR 11.72000027 1 1 2.32E-13 1625.614693 15.49028 0 0 15.76776 0 0 13.16634 0 0 0 0 14.34159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94817 ATG12_HUMAN "Ubiquitin-like protein ATG12 (Autophagy-related protein 12, APG12-like)" ATG12 APG12 APG12L Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096] GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0006501; GO:0016236; GO:0030670; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0043231; GO:0044804; GO:0045824; GO:0050687; GO:1901096; GO:1904973 AVGDTPIMK 4.800000191 1 1 0.21128719 931.2921452 14.32651 12.70409 14.94165 0 11.93518 14.08235 13.73196 0 13.56857 0 15.06575 0 13.8488 0 13.81312 13.97878 0 12.34736 15.97417 0 16.9046 0 0 15.00207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94819 KBTBB_HUMAN Kelch repeat and BTB domain-containing protein 11 (Chronic myelogenous leukemia-associated protein) (Kelch domain-containing protein 7B) KBTBD11 CMLAP KIAA0711 KLHDC7C Homo sapiens (Human) LPEGAPAR 32.15000153 1 1 0.29156532 810.5830471 17.16811 20.51155 16.0134 19.02399 14.33042 14.1032 20.15166 20.89687 20.77577 14.9787 19.61847 17.39757 0 0 17.42832 20.5262 20.6501 17.27418 20.67662 20.26859 11.91059 19.73469 20.25873 0 0 0 0 0 16.43583 0 17.26906 0 0 0 0 0 17.71212 0 19.43354 0 0 0 19.56662 0 0 0 0 0 O94822 LTN1_HUMAN "E3 ubiquitin-protein ligase listerin, EC 2.3.2.27 (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294)" LTN1 C21orf10 C21orf98 KIAA0714 RNF160 ZNF294 HSPC087 Homo sapiens (Human) protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; RQC complex [GO:1990112] cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005829; GO:0008270; GO:0043023; GO:0051865; GO:0061630; GO:0072344; GO:1990112; GO:1990116 ISLDHDR 11.28999996 2.20E-08 2.20E-08 0.223523909 856.586583 17.4563 19.19633 17.88109 18.77887 16.29186 16.83613 17.55438 17.37544 14.34165 0 16.45 0 17.58231 0 19.07786 0 0 17.40084 15.8298 19.13513 17.11987 18.03585 18.94224 0 0 17.3307 17.7509 19.14998 0 17.38123 18.37844 0 0 0 18.3362 17.98312 0 16.83579 19.23558 19.28624 0 19.54129 0 0 18.71211 19.75687 19.42284 16.66581 O94823 AT10B_HUMAN "Phospholipid-transporting ATPase VB, EC 7.6.2.1 (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B)" ATP10B ATPVB KIAA0715 Homo sapiens (Human) lysosomal membrane organization [GO:0097212]; phospholipid translocation [GO:0045332] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of lysosomal membrane [GO:1905103]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of lysosomal membrane [GO:1905103]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; lysosomal membrane organization [GO:0097212]; phospholipid translocation [GO:0045332] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345] GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0016887; GO:0031902; GO:0045332; GO:0097212; GO:0140326; GO:0140345; GO:0140351; GO:1905103; GO:1990531 AMLNNSGPR 7.619999886 1 1 0.520245543 976.1421568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.32709 0 0 0 0 0 0 0 19.38715 0 0 0 0 0 0 0 19.28533 0 17.91027 0 0 O94827 PKHG5_HUMAN "Pleckstrin homology domain-containing family G member 5, PH domain-containing family G member 5 (Guanine nucleotide exchange factor 720, GEF720)" PLEKHG5 KIAA0720 Homo sapiens (Human) endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043123; GO:0043542; GO:0048471; GO:0051056 EVDKMEQLEGK 1.220000029 1 1 0.269132716 1321.553795 0 13.88539 0 0 0 0 16.36858 12.32623 13.62058 14.29331 0 0 12.20422 0 0 14.65106 0 0 14.83479 0 14.80303 0 15.19495 0 0 14.83309 13.88362 0 0 0 0 0 0 10.19002 15.69713 15.96065 13.57703 0 0 0 0 15.37412 13.21071 0 15.70669 16.61884 16.34036 0 O94832 MYO1D_HUMAN Unconventional myosin-Id MYO1D KIAA0727 Homo sapiens (Human) actin filament organization [GO:0007015]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; actin filament organization [GO:0007015]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904] GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030050; GO:0030424; GO:0030673; GO:0031410; GO:0031982; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0070062; GO:0097440 CRHQVEYLGLLENVR 5.869999886 1 1 0.303796992 1884.840607 0 0 16.84479 0 0 0 0 0 18.11226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.90909 0 0 0 15.4761 0 0 0 0 12.62827 0 0 0 0 O94842 TOX4_HUMAN TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1) TOX4 C14orf92 KIAA0737 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; chromatin DNA binding [GO:0031490]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin DNA binding [GO:0031490] GO:0000785; GO:0005634; GO:0006357; GO:0031490; GO:0072357 NSNTVVFVK 5.559999943 0.641163409 0.641163409 0.293918332 1005.298535 15.9033 14.89698 0 0 0 15.54565 0 0 0 0 16.07155 11.60486 14.938 0 0 0 13.6146 15.24924 0 0 0 0 13.60452 0 0 14.46076 0 0 0 0 0 0 0 16.26969 0 0 0 16.85322 0 0 0 0 0 0 0 0 0 0 O94844 RHBT1_HUMAN Rho-related BTB domain-containing protein 1 RHOBTB1 KIAA0740 Homo sapiens (Human) actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0043652 VQKPLLQAPFLPPK 3.769999981 1 1 0.485008554 1575.62509 0 16.42137 13.25271 0 0 0 17.52416 0 0 0 0 0 0 16.34066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10855 0 0 0 0 0 O94850 DEND_HUMAN Dendrin DDN KIAA0749 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211] "cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0005789; GO:0032591; GO:0042995; GO:0043204; GO:0045211; GO:0045944 GTQQGNRK 9.619999886 1 1 0.214171414 885.3709626 15.41184 13.80271 0 0 16.10785 15.48156 13.36791 13.30272 16.04109 15.36648 0 0 0 14.52213 0 0 0 0 15.18473 0 0 0 0 14.98326 9.465178 12.30911 15.74084 0 0 0 0 0 0 15.48228 0 0 17.82754 0 0 0 0 14.82087 14.16615 0 15.11763 0 0 0 O94851 MICA2_HUMAN "[F-actin]-monooxygenase MICAL2, EC 1.14.13.225 (MICAL C-terminal-like protein, Mical-cL) (Molecule interacting with CasL protein 2, MICAL-2)" MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2 MICALCL Homo sapiens (Human) actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417] nucleus [GO:0005634] "nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]" "actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]" GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0071949 AAHLASMFGHGDFPQNKLLSK 13.46000004 0.250154287 0.250154287 0.578981088 2284.049443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.95512 0 0 0 0 0 0 0 0 20.77465 18.73101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94854 K0754_HUMAN "Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754)" MACF1 KIAA0754 Homo sapiens (Human) GEEEDGYIEDCYVPQRSIYDTMR 8.729999542 0.078024939 0.078024939 0.109778816 2840.253008 0 15.46297 13.41513 0 0 0 0 16.77713 0 12.32702 0 0 0 0 14.06855 14.60461 0 16.00333 15.23116 0 0 11.84867 15.32954 0 0 0 14.33308 12.21272 17.34036 0 0 0 15.21411 0 15.17951 0 17.19806 18.02566 17.76939 0 15.81128 0 0 0 0 0 0 13.70163 O94855 SC24D_HUMAN Protein transport protein Sec24D (SEC24-related protein D) SEC24D KIAA0755 Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0043231; GO:0070971; GO:0090110 EEQEETSAIR 3.319999933 1 1 0.169418463 1192.271892 11.52194 13.18828 0 14.20424 13.87336 0 0 13.83483 0 0 0 0 0 0 0 15.32212 0 0 14.83501 0 0 0 0 0 0 0 0 14.79725 13.84289 14.83384 15.95213 8.028619 11.56851 0 0 16.19476 0 0 0 0 13.03362 0 14.41264 14.21537 0 14.94645 13.07249 11.91361 O94856 NFASC_HUMAN Neurofascin NFASC KIAA0756 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226] axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454] axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904] GO:0005886; GO:0005887; GO:0005925; GO:0007411; GO:0007420; GO:0007422; GO:0019226; GO:0019904; GO:0030424; GO:0030425; GO:0033010; GO:0033268; GO:0042552; GO:0043194; GO:0050808; GO:0072659; GO:0097454; GO:0098609; GO:0098632; GO:0101003 RSGTLVIDFR 6.070000172 1 1 0.019864039 1162.545745 0 15.60856 14.59651 10.01455 0 0 0 13.76195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.71689 14.71565 14.85753 0 15.16963 0 0 0 0 0 11.5265 0 0 0 0 0 0 0 0 0 0 0 0 O94874 UFL1_HUMAN "E3 UFM1-protein ligase 1, EC 2.3.2.- (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)" UFL1 KIAA0776 MAXER NLBP RCAD Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709] protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568] GO:0001649; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0008284; GO:0010508; GO:0016020; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043066; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592 ATEGSGSMR 11.61999989 1 1 0.036219064 894.8331312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.954424 0 0 0 0 0 0 8.754951 0 0 13.04446 0 0 16.24598 0 0 0 17.04049 0 0 16.30682 17.38985 0 17.38222 0 17.72816 17.82895 0 0 0 0 0 0 O94875 SRBS2_HUMAN "Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2, ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin)" SORBS2 ARGBP2 KIAA0777 Homo sapiens (Human) actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Z disc [GO:0030018]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219] cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307] GO:0003723; GO:0005200; GO:0005634; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049 GGDDSK 7.309999943 0.409381747 0.409381747 0.110454563 579.0249295 13.15328 0 15.41287 9.96994 8.80643 0 0 0 16.30157 0 0 13.29156 16.23682 15.16246 13.47941 0 16.49081 0 15.40527 15.14019 0 17.04799 13.81332 15.63165 0 16.48153 15.95077 14.92179 11.66944 0 0 0 16.55881 0 16.17166 13.44625 0 0 16.83792 0 18.86159 0 12.237 0 13.5586 16.14857 15.99675 0 O94885 SASH1_HUMAN SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) SASH1 KIAA0790 PEPE1 Homo sapiens (Human) positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901] GO:0000209; GO:0001965; GO:0005737; GO:0008022; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 CGIPEALVQR 13.43999958 1 1 0 1141.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94888 UBXN7_HUMAN UBX domain-containing protein 7 UBXN7 KIAA0794 UBXD7 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629 QEQELRNGGAIDK 2.950000048 1 1 0.254081198 1456.277461 13.94125 14.05848 16.64098 0 0 11.9322 13.70323 0 12.54459 15.06419 0 16.19833 0 0 0 15.01003 0 0 15.44242 0 0 0 0 0 0 0 0 0 16.4981 0 0 0 0 16.33801 15.98004 16.04214 0 0 16.84195 0 0 0 16.96414 0 0 16.66711 0 16.20377 O94889 KLH18_HUMAN Kelch-like protein 18 KLHL18 KIAA0795 OK/SW-cl.74 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567] cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567] GO:0007049; GO:0016567; GO:0051301; GO:1901992 HGAASLGSK 2.809999943 1 1 8.02E-13 827.0347016 12.47534 15.42029 0 13.4883 16.58136 13.91849 13.93467 0 0 0 0 0 15.76116 0 0 0 13.47759 13.51557 0 14.81755 0 13.91963 0 0 0 0 0 0 13.03404 0 15.31401 0 14.66029 16.11088 14.85835 15.07367 0 0 0 0 0 0 0 0 0 14.28791 0 0 O94892 ZN432_HUMAN Zinc finger protein 432 ZNF432 KIAA0798 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 GFTMKR 11.26000023 0.532623947 0.532623947 0.192609079 756.3570643 0 0 0 0 0 0 15.31599 15.6108 0 0 15.25044 0 17.28466 0 0 0 19.37458 17.74431 18.19042 0 0 14.31772 18.05141 17.52874 16.45192 16.24672 15.78105 16.76922 15.15594 14.96338 0 14.04178 16.15633 15.54176 17.19733 0 16.44915 18.14328 17.51658 16.18621 0 15.30481 0 17.61451 18.31937 19.95675 19.04605 18.06705 O94898 LRIG2_HUMAN "Leucine-rich repeats and immunoglobulin-like domains protein 2, LIG-2" LRIG2 KIAA0806 LIG2 Homo sapiens (Human) innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605] signaling receptor binding [GO:0005102] GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0031012; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222 LTVNEMPSFLK 10.90999985 1 1 0.019795204 1294.470937 0 0 0 0 15.30104 0 0 0 0 0 0 0 16.10262 14.02809 0 14.30783 12.72398 0 0 0 16.80062 0 0 14.52601 14.85437 0 0 14.28017 13.74846 0 15.07085 0 14.1182 15.7715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94901 SUN1_HUMAN SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1) SUN1 KIAA0810 UNC84A Homo sapiens (Human) centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283] cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495] GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090292; GO:0140444 CLRNICK 1.899999976 1 1 0.190943448 963.8075214 14.24521 14.17493 0 0 0 0 0 0 13.67564 0 15.28627 0 0 11.96295 0 0 0 0 15.30191 0 0 0 0 0 0 0 16.60734 0 0 16.14038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94903 PLPHP_HUMAN "Pyridoxal phosphate homeostasis protein, PLP homeostasis protein (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein)" PLPBP PROSC Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; pyridoxal phosphate binding [GO:0030170] pyridoxal phosphate binding [GO:0030170] GO:0005737; GO:0005829; GO:0030170 WRAGSMSAELGVGCALR 2.24000001 1 1 0.386705399 1821.544147 15.01456 16.24496 15.23804 11.30474 0 0 0 0 0 0 15.58809 15.8039 0 0 0 0 0 0 13.18425 0 0 0 0 15.26352 0 0 17.10962 0 16.24953 0 0 0 0 17.07512 0 15.80392 0 0 0 0 0 16.14197 0 0 0 0 0 0 O94906 PRP6_HUMAN "Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1, ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein, U5-102 kDa protein)" PRPF6 C20orf14 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]" androgen receptor binding [GO:0050681]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013 GTEMCPK 3.680000067 0.371773273 0.371773273 0.192362875 839.4072728 16.10647 14.8613 0 0 0 13.68824 0 16.07526 15.11531 15.75462 16.4452 0 14.68861 16.19457 0 15.31208 15.35307 0 15.4747 0 0 0 0 16.76521 14.29311 17.18737 14.71867 0 0 0 15.8703 0 16.75683 0 0 0 0 14.65133 0 16.19861 14.18033 14.81929 17.31655 0 0 15.69814 16.55549 0 O94907 DKK1_HUMAN "Dickkopf-related protein 1, Dickkopf-1, Dkk-1, hDkk-1 (SK)" DKK1 UNQ492/PRO1008 Homo sapiens (Human) "cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019] GO:0000122; GO:0000904; GO:0001706; GO:0001707; GO:0001942; GO:0002090; GO:0005576; GO:0005615; GO:0005886; GO:0007611; GO:0008083; GO:0010628; GO:0010942; GO:0010977; GO:0030178; GO:0030279; GO:0030326; GO:0030514; GO:0030900; GO:0031901; GO:0032091; GO:0032526; GO:0033137; GO:0039706; GO:0042662; GO:0042663; GO:0043066; GO:0043507; GO:0045813; GO:0048019; GO:0050750; GO:0051966; GO:0060173; GO:0060325; GO:0060394; GO:0061743; GO:0090082; GO:0090090; GO:0090244; GO:0090647; GO:0098883; GO:1901216; GO:1901296; GO:1902949; GO:1904338; GO:1904723; GO:1904958; GO:1905607; GO:2000096; GO:2000726 CYCGEGLSCR 7.789999962 1 1 0.172485997 1261.778312 13.66806 0 0 14.78749 13.03788 13.57109 0 13.93002 0 0 0 0 0 16.25313 0 0 0 13.12324 12.89765 0 0 13.55999 0 13.88464 0 0 0 0 0 0 14.17988 0 0 0 0 14.39206 15.7535 0 0 0 0 0 0 0 0 0 0 0 O94910 AGRL1_HUMAN "Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1, CIRL-1) (Latrophilin-1) (Lectomedin-2)" ADGRL1 KIAA0821 LEC2 LPHN1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129] axon [GO:0030424]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] axon [GO:0030424]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524] GO:0004930; GO:0005886; GO:0005887; GO:0007157; GO:0007166; GO:0007186; GO:0007189; GO:0014069; GO:0016021; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0090129 CPGSDVIMVENANYGRTDDK 1.399999976 1 1 1.37E-12 2257.635032 11.61921 12.63423 0 12.66544 15.55301 14.77354 12.74772 0 12.17352 11.37687 13.64783 14.25797 0 0 9.525908 13.47773 13.09453 12.91638 15.96643 13.12857 16.64007 0 0 0 15.56429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.78691 13.99022 0 0 0 0 0 0 0 O94913 PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11) PCF11 KIAA0824 Homo sapiens (Human) mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369] mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993] GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379 FDNPR 8.579999924 1 1 0.239556289 648.7561771 15.94829 15.64724 15.61706 15.75846 15.03605 0 16.63859 14.26298 0 15.8195 0 15.22568 0 0 16.69449 0 0 0 0 0 0 0 0 0 15.79508 0 15.6035 17.14151 16.86271 14.4122 17.4624 15.48456 16.84658 15.10756 15.97208 14.8913 17.68996 0 17.54471 17.77995 17.08158 17.00366 0 0 0 16.62584 19.02499 17.75712 O94915 FRYL_HUMAN Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) FRYL AF4P12 KIAA0826 Homo sapiens (Human) cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] cell cortex [GO:0005938]; site of polarized growth [GO:0030427]; cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] GO:0000902; GO:0005938; GO:0030427; GO:0031175 EFNEPR 8.25 1.35E-05 1.35E-05 0.32090737 791.3414194 17.62293 16.06805 0 0 16.12658 0 16.64143 0 0 0 18.4387 16.96289 0 0 15.32431 0 0 0 16.47833 16.9466 16.66023 0 17.17979 0 17.80722 0 0 0 0 0 17.5433 0 0 0 0 0 19.0828 19.5291 0 18.73024 0 0 0 0 0 0 0 16.83068 O94916 NFAT5_HUMAN "Nuclear factor of activated T-cells 5, NF-AT5 (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein, TonE-binding protein, TonEBP)" NFAT5 KIAA0827 TONEBP Homo sapiens (Human) calcineurin-NFAT signaling cascade [GO:0033173]; cellular hyperosmotic response [GO:0071474]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular hyperosmotic response [GO:0071474]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006366; GO:0007165; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:0071474; GO:1901224; GO:1904996; GO:1990837 AMQVESCSSAVGVSNR 6.659999847 1 1 0.212598263 1681.79441 0 0 14.54441 16.08964 13.29615 14.9894 14.22237 0 12.30065 0 0 0 0 0 0 0 0 0 13.48399 0 0 15.37673 0 15.56545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94923 GLCE_HUMAN "D-glucuronyl C5-epimerase, EC 5.1.3.17 (Heparan sulfate C5-epimerase, Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)" GLCE KIAA0836 Homo sapiens (Human) heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]" "calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]" GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464 SRFTNVK 1.629999995 1 1 5.79E-13 850.8233737 0 0 0 16.64843 0 0 0 0 0 0 0 0 0 9.178016 16.27685 0 0 0 0 0 0 0 0 0 0 14.48147 0 0 0 0 0 0 0 0 0 0 0 0 14.8194 0 0 0 0 0 0 0 0 0 O94925 GLSK_HUMAN "Glutaminase kidney isoform, mitochondrial, GLS, EC 3.5.1.2 (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain ]" GLS GLS1 KIAA0838 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967] glutaminase activity [GO:0004359] GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0045202; GO:0051289; GO:0090461 AQPLVTLCR 5.119999886 1 1 0.296618804 1057.217192 14.92288 0 0 0 0 0 15.39883 0 0 0 0 0 15.21451 15.86595 0 0 15.60802 14.89929 15.9415 15.43349 0 0 0 15.5716 14.49157 16.62012 11.1675 14.35542 15.36456 14.76636 15.54861 0 13.75345 0 15.15529 15.19938 13.84241 14.87205 0 14.48309 0 0 15.30239 14.59062 0 12.6215 12.91934 0 O94927 HAUS5_HUMAN HAUS augmin-like complex subunit 5 HAUS5 KIAA0841 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:1990498 ENLGQALK 5.159999847 0.2903561 0.2903561 0.183147017 872.7222189 17.66218 17.4924 0 14.56593 19.36279 0 0 0 17.51136 0 17.18186 19.27927 0 0 0 0 0 0 0 0 0 0 18.12932 0 0 0 0 0 0 0 0 0 0 0 18.69129 0 19.12464 0 19.34793 18.58121 0 0 17.08563 0 0 0 18.09902 17.26697 O94929 ABLM3_HUMAN "Actin-binding LIM protein 3, abLIM-3 (Actin-binding LIM protein family member 3)" ABLIM3 KIAA0843 HMFN1661 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]" actin filament binding [GO:0051015]; metal ion binding [GO:0046872] GO:0001725; GO:0005737; GO:0006351; GO:0015629; GO:0030027; GO:0030032; GO:0030036; GO:0045944; GO:0046872; GO:0051015; GO:0060271; GO:0098978; GO:1903955 VLEAGGK 8.319999695 1 1 0.279509499 672.7130723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94933 SLIK3_HUMAN SLIT and NTRK-like protein 3 SLITRK3 KIAA0848 Homo sapiens (Human) "axonogenesis [GO:0007409]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; synaptic transmission, GABAergic [GO:0051932]; terminal button organization [GO:0072553]" cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; synaptic transmission, GABAergic [GO:0051932]; terminal button organization [GO:0072553]" GO:0005886; GO:0007409; GO:0009986; GO:0051932; GO:0051965; GO:0072553; GO:0072578; GO:0097116; GO:0098982; GO:0099060; GO:0099560; GO:1905606 ENAWPTKPSSMLSSVHFTASSVEYKSSNK 7.679999828 0.000412888 0.000412888 0.088050434 3199.404457 15.05892 13.92934 15.81327 9.492741 0 0 11.88937 13.39608 14.4539 0 0 0 16.01904 0 0 0 0 0 0 0 14.27786 0 0 0 11.35588 13.59157 11.95425 0 0 0 0 0 0 0 14.25189 0 0 0 0 0 13.81703 0 13.8883 0 0 0 11.69253 13.68025 O94952 FBX21_HUMAN F-box only protein 21 FBXO21 FBX21 KIAA0875 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511] DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0003677; GO:0004842; GO:0005829; GO:0006511 AGLEARK 1.350000024 1 1 0.079878198 743.7300716 18.53696 16.80236 17.8516 0 16.54399 15.94106 17.33922 16.79087 0 16.96013 17.21138 0 11.45996 17.03477 0 0 16.74216 0 16.98263 17.49717 11.86151 16.10197 18.35961 0 17.31844 15.25396 14.47893 11.29307 0 17.02308 0 18.55983 16.01397 18.23566 17.55451 18.56088 16.52296 0 17.28567 17.23196 16.18422 17.46478 16.30309 11.81059 17.21696 0 17.2282 15.1759 O94953 KDM4B_HUMAN "Lysine-specific demethylase 4B, EC 1.14.11.66 (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B) ([histone H3]-trimethyl-L-lysine(9) demethylase 4B)" KDM4B JHDM3B JMJD2B KIAA0876 Homo sapiens (Human) chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169] histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872] GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051864; GO:0070544; GO:0140684 MGSEDHGAQNPSCKIMTFRPTMEEFK 4.53000021 1 1 0.767545968 3029.10611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.88975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94955 RHBT3_HUMAN "Rho-related BTB domain-containing protein 3, EC 3.6.1.-" RHOBTB3 KIAA0878 Homo sapiens (Human) "actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; male gonad development [GO:0008584]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; retrograde transport, endosome to Golgi [GO:0042147]; small GTPase mediated signal transduction [GO:0007264]" cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; male gonad development [GO:0008584]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; retrograde transport, endosome to Golgi [GO:0042147]; small GTPase mediated signal transduction [GO:0007264]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0003924; GO:0005524; GO:0005525; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0008584; GO:0016477; GO:0016887; GO:0019901; GO:0030865; GO:0031267; GO:0031410; GO:0032588; GO:0032956; GO:0042147; GO:0042995; GO:0070062 ELASMNLDIVDLLKK 5.570000172 1 1 0.322655569 1719.882399 0 0 15.59048 0 0 15.21024 0 15.24521 0 0 0 14.07208 16.92071 0 16.64066 0 0 0 0 0 0 0 0 0 15.24959 0 0 16.07434 15.21474 0 14.66031 11.28608 13.43578 0 0 15.048 15.04158 0 0 16.98803 14.21192 0 0 0 0 0 0 16.85515 O94956 SO2B1_HUMAN "Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B, OATP-B) (Organic anion transporter polypeptide-related protein 2, OATP-RP2, OATPRP2) (Solute carrier family 21 member 9)" SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] GO:0005886; GO:0005887; GO:0008514; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016324; GO:0042167; GO:0043252; GO:0055085; GO:0150104 WVGAWWLGFLIAAGAVALAAIPYFFFPKEMPK 4.610000134 1 1 2.74E-12 3583.611742 11.12053 0 0 0 11.17271 0 14.66879 0 0 0 11.63965 0 13.69654 0 0 12.44591 0 0 0 0 0 0 0 0 13.16506 0 0 0 0 16.78461 0 0 0 0 0 0 0 0 0 0 15.46405 12.68548 0 0 0 0 0 0 O94964 SOGA1_HUMAN "Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form, 80-kDa SOGA fragment ]" SOGA1 C20orf117 KIAA0889 SOGA Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506] GO:0005615; GO:0008286; GO:0010506; GO:0045721; GO:0070062 ADAVLGCSVK 10.60999966 1 1 0.191265247 1023.433279 0 0 14.71086 0 0 15.94298 14.39545 14.87899 0 0 14.87401 0 15.96146 0 16.19555 0 0 15.07488 0 0 15.90263 0 16.34573 0 0 0 0 15.36543 0 0 0 16.13195 16.38376 15.95631 0 0 13.54418 12.50988 14.11225 15.05546 16.01529 15.16737 12.06849 15.91851 15.22547 0 0 0 O94966 UBP19_HUMAN "Ubiquitin carboxyl-terminal hydrolase 19, EC 3.4.19.12 (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)" USP19 KIAA0891 ZMYND9 Homo sapiens (Human) negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433] Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625] GO:0004843; GO:0005789; GO:0005829; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380 AVPPGNDPVSPAMVR 6.070000172 1 1 0.298919967 1508.101458 0 16.72966 0 16.40651 0 16.33445 0 0 0 0 15.05244 16.53962 0 16.36223 16.43638 0 16.91441 15.6039 0 0 0 0 0 0 0 16.45965 0 0 0 0 0 0 0 0 0 0 0 0 17.65721 16.67731 16.91099 16.70514 15.33278 0 0 0 16.99473 0 O94972 TRI37_HUMAN "E3 ubiquitin-protein ligase TRIM37, EC 2.3.2.27 (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)" TRIM37 KIAA0898 MUL POB1 Homo sapiens (Human) aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865] chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842 CMKTDVK 5.070000172 1 1 0.19152324 879.77097 0 15.73829 0 0 0 0 0 15.24903 15.01971 14.92702 15.85019 11.6877 0 13.99677 0 12.66343 0 0 15.66536 0 14.8186 0 0 0 0 0 0 0 0 0 16.782 0 0 0 16.87324 0 0 0 0 0 16.42038 0 0 0 0 0 0 0 O94973 AP2A2_HUMAN "AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9, HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)" AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901] GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0008289; GO:0009898; GO:0016192; GO:0019901; GO:0030122; GO:0030666; GO:0030667; GO:0030669; GO:0031410; GO:0035615; GO:0036020; GO:0045334; GO:0072583; GO:0097718; GO:0098884; GO:0101003; GO:0140312 LYRTSPDLVPMGDWTSR 2.359999895 0.093104161 0.093104161 0.330516494 1994.078953 13.46311 14.27246 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53668 13.99116 0 13.81557 0 0 0 0 0 13.49735 11.03064 13.14041 13.11609 13.26766 16.28258 14.65194 14.23454 0 0 13.34244 0 0 0 0 13.05181 0 0 0 0 17.17381 0 0 14.96924 O94983 CMTA2_HUMAN Calmodulin-binding transcription activator 2 CAMTA2 KIAA0909 Homo sapiens (Human) cardiac muscle hypertrophy in response to stress [GO:0014898]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cardiac muscle hypertrophy in response to stress [GO:0014898]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0000785; GO:0003682; GO:0003690; GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0014898; GO:0042826; GO:0043565; GO:0045944 QIIEATPERIK 4.659999847 1 1 2.35E-13 1298.816855 0 0 0 0 0 0 0 0 0 0 16.59983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94985 CSTN1_HUMAN "Calsyntenin-1 (Alcadein-alpha, Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha, SAlc-alpha; CTF1-alpha (C-terminal fragment 1-alpha) ]" CLSTN1 CS1 KIAA0911 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988] GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0042988; GO:0043005; GO:0045211; GO:0050806; GO:0051965; GO:0090128; GO:0098845; GO:0098969; GO:0098978; GO:0099003 LIFLFR 15.18999958 0.014072784 0.014072784 0.25845811 808.6025659 19.21131 17.66228 0 18.83372 17.38361 0 20.59017 18.2932 20.27765 19.1927 19.6217 17.32143 16.64833 18.46679 17.5235 21.88412 19.05927 20.73772 19.93978 18.81689 20.42039 20.31653 0 20.06093 19.64735 0 20.04351 0 17.92034 19.438 0 0 19.62496 19.5573 20.67639 0 21.71114 0 20.72692 20.98789 19.85086 17.22446 0 0 21.45955 20.47965 18.8448 0 O94988 FA13A_HUMAN Protein FAM13A FAM13A FAM13A1 KIAA0914 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0007165; GO:0051056 DMPKPPPKTK 5.769999981 0.264366329 0.264366329 0.198139566 1150.553975 13.96203 13.82053 12.34712 15.61758 0 0 15.3633 16.67415 14.33005 15.17071 15.85157 0 12.45894 12.32674 13.32957 13.53548 13.77809 0 14.41068 0 13.10549 0 16.02696 0 15.32196 15.67384 0 0 15.66672 15.62927 0 16.7396 11.58265 14.09526 15.43229 15.00942 16.36359 0 16.03077 15.05145 14.66564 0 0 0 0 0 0 15.45818 O94991 SLIK5_HUMAN SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11) SLITRK5 KIAA0918 LRRC11 Homo sapiens (Human) axonogenesis [GO:0007409]; regulation of presynapse assembly [GO:1905606] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; axonogenesis [GO:0007409]; regulation of presynapse assembly [GO:1905606] GO:0005886; GO:0007409; GO:0016021; GO:0043235; GO:1905606 GILEPDK 3.079999924 0.723750532 0.723750532 0.11957086 771.1953835 0 13.75394 15.39575 13.16529 0 14.12646 0 0 15.54332 15.11405 0 0 14.73004 0 0 0 15.13612 0 15.74449 0 14.76906 16.33997 16.08682 0 0 0 0 0 0 0 15.85127 0 0 0 0 0 0 0 0 0 15.16206 0 0 0 0 0 13.86282 0 O94993 SOX30_HUMAN Transcription factor SOX-30 SOX30 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286] chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]" "beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837 MQSLLEPSVK 18.94000053 1 1 0.358653986 1131.808457 0 19.66133 17.40363 18.61578 0 0 0 0 0 0 19.20435 19.21061 0 17.94836 17.79293 20.34134 0 0 19.17558 0 0 19.2517 19.28076 18.17122 0 0 0 0 0 0 0 0 20.42834 20.0076 0 0 20.10535 0 0 0 0 0 0 0 0 19.13557 0 0 O95067 CCNB2_HUMAN G2/mitotic-specific cyclin-B2 CCNB2 Homo sapiens (Human) cell division [GO:0051301]; G2/MI transition of meiotic cell cycle [GO:0008315]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; G2/MI transition of meiotic cell cycle [GO:0008315]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538] cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000079; GO:0000307; GO:0001701; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0007057; GO:0008315; GO:0015630; GO:0016020; GO:0016538; GO:0040008; GO:0043029; GO:0044772; GO:0045296; GO:0048538; GO:0051301 KLQLVGITALLLASK 15.19999981 1 1 0.551760286 1567.403097 0 19.58301 0 0 0 0 0 0 0 19.91162 0 0 0 0 0 0 0 17.70762 0 0 0 0 19.91612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.20503 0 18.17787 0 0 18.8226 0 0 0 0 0 O95069 KCNK2_HUMAN Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1) KCNK2 TREK TREK1 Homo sapiens (Human) cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322] apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841]; cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322] outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841] GO:0003231; GO:0005634; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007613; GO:0008076; GO:0009612; GO:0009986; GO:0010942; GO:0015271; GO:0016324; GO:0019870; GO:0022841; GO:0030322; GO:0043025; GO:0044305; GO:0048678; GO:0060044; GO:0071456; GO:0071805; GO:0090102; GO:0097449; GO:1900039; GO:2000279 WNVSQTK 3.279999971 1 1 0.058004156 863.2910399 16.57471 17.55281 13.23041 0 0 0 0 13.3838 15.97404 14.85193 14.77557 0 0 0 0 0 0 0 0 0 0 0 15.65031 0 0 0 0 0 0 0 0 0 0 14.0722 15.48198 16.58194 13.32708 0 0 16.77021 15.88467 0 0 0 0 0 0 0 O95071 UBR5_HUMAN "E3 ubiquitin-protein ligase UBR5, EC 2.3.2.26 (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog, hHYD) (Progestin-induced protein)" UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779] RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779; GO:2000780 AAVIIMAVEK 4.519999981 0.513791203 0.513791203 0.225211202 1061.059381 0 15.86914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95081 AGFG2_HUMAN "Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related, RAB-R)" AGFG2 HRBL RABR Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0016020; GO:0046872 GPGPGGGVSGGK 5.260000229 1 1 3.45E-13 925.5881985 0 0 17.22941 0 0 0 12.05638 0 0 0 17.52227 18.85374 0 0 0 0 0 0 0 0 0 0 15.8828 0 0 0 0 0 0 0 0 0 0 0 0 14.219 18.57976 0 0 0 15.12708 17.29328 0 0 13.78754 0 0 0 O95104 SCAF4_HUMAN "SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15)" SCAF4 KIAA1172 SFRS15 Homo sapiens (Human) "mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]" protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269] GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008022; GO:1990269; GO:2000805 RSPDR 7.789999962 1 1 0.20859683 631.1629617 0 0 0 0 0 0 14.95545 0 13.22326 0 14.24735 0 0 0 0 0 0 12.92475 0 0 0 0 0 0 0 18.17812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95140 MFN2_HUMAN "Mitofusin-2, EC 3.6.5.- (Transmembrane GTPase MFN2)" MFN2 CPRP1 KIAA0214 Homo sapiens (Human) apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625] GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0008053; GO:0015630; GO:0016021; GO:0031306; GO:0031625; GO:0034497; GO:0046580; GO:0048593; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461 LTWTTK 4.699999809 0.369828045 0.369828045 0.228564489 750.3749884 14.46221 15.21791 15.1535 0 15.74957 0 14.0288 0 15.29633 0 0 16.043 15.8892 16.56269 0 17.46918 15.92064 0 0 15.49467 0 0 0 18.44405 0 0 0 15.71855 15.55786 0 16.52274 0 16.33293 15.93428 16.71765 0 16.11595 16.85386 15.85909 0 16.74379 16.33973 0 16.06932 16.94959 15.89521 16.73771 0 O95153 RIMB1_HUMAN "Peripheral-type benzodiazepine receptor-associated protein 1, PRAX-1 (Peripheral benzodiazepine receptor-interacting protein, PBR-IP) (RIMS-binding protein 1, RIM-BP1) (TSPO-associated protein 1)" TSPOAP1 BZRAP1 KIAA0612 RBP1 RIMBP1 Homo sapiens (Human) calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] GO:0005737; GO:0005739; GO:0005829; GO:0030156; GO:0044305; GO:0098978; GO:0099626 EHEGAVQLLESTLDSMQARVR 2.700000048 1 1 0.031051392 2385.280298 13.48974 0 12.21145 0 11.67297 12.31898 13.23788 12.72703 13.81313 0 0 12.40353 12.46944 14.46071 0 13.01063 11.36925 17.85204 0 0 0 0 0 0 14.27527 10.39928 16.05426 0 0 0 0 0 0 0 15.31461 0 13.18053 0 0 12.41182 0 13.19598 0 0 0 0 0 0 O95155 UBE4B_HUMAN "Ubiquitin conjugation factor E4 B, EC 2.3.2.27 (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)" UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) granzyme-mediated apoptotic signaling pathway [GO:0008626]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450] GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0034450; GO:0043161 LLVPSLMK 6.309999943 1 1 0.099159056 901.4984751 14.55632 15.1825 15.62775 16.00388 12.01884 0 0 0 14.95549 15.34287 17.47262 13.02136 0 0 0 13.58183 12.51111 0 15.19981 0 15.46894 0 14.45175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.78442 0 0 0 0 0 O95171 SCEL_HUMAN Sciellin SCEL Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612] metal ion binding [GO:0046872] GO:0001533; GO:0005737; GO:0008544; GO:0009612; GO:0009792; GO:0030216; GO:0046872; GO:0048471; GO:0070062; GO:0090263 MNKTSR 7.630000114 1.07E-05 1.07E-05 0.147499025 752.3744777 0 14.93537 14.3331 16.41783 18.06657 14.30923 11.56185 0 0 14.69351 17.40523 16.95333 17.78633 17.64554 15.10047 0 0 17.60315 0 13.96019 0 17.55538 15.22509 12.4424 13.79018 0 0 0 15.90129 14.17174 15.12617 0 19.73731 0 14.18579 0 17.75187 16.85629 17.28621 0 15.32721 0 13.72335 15.11189 17.68812 13.95462 18.55629 17.91195 O95180 CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) CACNA1H Homo sapiens (Human) aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008332; GO:0016021; GO:0019228; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042391; GO:0043005; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:2000344 TEGARAADEVR 8.050000191 1 1 0.062745499 1177.313865 0 0 0 0 15.40833 12.726 0 0 12.58994 14.60891 0 12.68196 0 11.13263 0 12.2099 0 11.87803 0 0 0 0 0 9.736792 14.45486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.56714 0 O95197 RTN3_HUMAN "Reticulon-3 (Homolog of ASY protein, HAP) (Neuroendocrine-specific protein-like 2, NSP-like protein 2) (Neuroendocrine-specific protein-like II, NSP-like protein II, NSPLII)" RTN3 ASYIP NSPL2 Homo sapiens (Human) apoptotic process [GO:0006915]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; vesicle-mediated transport [GO:0016192] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; apoptotic process [GO:0006915]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005615; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006915; GO:0016021; GO:0016192; GO:0045202; GO:0071786; GO:0071787; GO:1902430 EFKDSYK 3.960000038 0.344505519 0.344505519 0.118196915 916.9516922 17.78113 16.20635 16.18097 15.20245 13.51808 16.10883 0 0 16.10311 16.73683 16.72233 17.04469 15.2304 0 0 0 0 16.21337 0 17.07598 0 16.22158 17.0811 16.47489 19.08641 13.77998 15.43039 17.08866 12.48336 13.38523 17.34259 0 17.43588 18.02341 12.28403 14.76054 17.07106 14.2024 16.09004 16.91729 0 15.19614 15.08685 16.48494 16.50581 0 14.44461 0 O95206 PCDH8_HUMAN Protocadherin-8 (Arcadlin) PCDH8 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; regulation of synaptic membrane adhesion [GO:0099179]; somitogenesis [GO:0001756] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; regulation of synaptic membrane adhesion [GO:0099179]; somitogenesis [GO:0001756] calcium ion binding [GO:0005509] GO:0001756; GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007268; GO:0016331; GO:0030425; GO:0042734; GO:0098978; GO:0099055; GO:0099179 EGDGQLTVGDAGLDR 4.809999943 1 1 0.298861363 1502.125357 0 0 0 0 14.83615 15.29737 14.87025 0 0 14.29632 14.28819 13.84926 13.86171 14.97077 13.39788 0 13.71975 0 14.45836 0 14.47664 15.34187 16.54905 0 0 0 0 0 0 0 0 0 0 0 0 0 16.25907 0 0 14.38706 0 14.946 0 0 12.85244 15.65828 0 0 O95218 ZRAB2_HUMAN "Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)" ZRANB2 ZIS ZNF265 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0001530; GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0046872 SSSSSQSR 12.27000046 1 1 0.426538921 825.4717574 0 0 0 0 0 17.0361 0 0 0 0 0 0 0 19.20469 0 0 0 18.2085 0 0 17.11318 0 19.29464 16.84844 18.79411 0 0 0 17.18979 18.52827 0 0 0 0 19.21564 0 18.79706 0 17.12213 19.74072 0 0 17.22799 19.88811 19.66656 20.00569 17.24561 0 O95219 SNX4_HUMAN Sorting nexin-4 SNX4 Homo sapiens (Human) endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031] epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459] GO:0005154; GO:0005158; GO:0005737; GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0016020; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0032991; GO:0035091; GO:1903595; GO:1990459; GO:1990460; GO:2000786 VKNPDK 5.639999866 1 1 0.217259045 699.8482731 0 0 0 0 18.12345 0 18.99302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42479 0 0 0 0 0 0 0 0 18.05341 0 0 0 0 0 0 0 0 0 0 0 O95221 OR5F1_HUMAN "Olfactory receptor 5F1 (Olfactory receptor 11-10, OR11-10) (Olfactory receptor OR11-167)" OR5F1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007608; GO:0016021 RTSSFL 8.75 1 1 0.183068011 711.4092084 15.3505 0 15.35603 0 0 0 0 0 14.98193 14.6615 0 0 16.56526 14.40646 12.45273 15.03292 15.25062 14.79173 13.5228 16.3156 16.0244 0 12.81763 0 0 14.46406 0 0 15.85322 15.6923 0 16.86955 0 0 14.28746 0 16.98678 15.13866 17.36036 16.01005 15.5636 15.29562 0 0 0 16.28754 15.94148 0 O95222 OR6A2_HUMAN "Olfactory receptor 6A2 (Olfactory receptor 11-55, OR11-55) (Olfactory receptor 6A1) (Olfactory receptor OR11-83) (hP2 olfactory receptor)" OR6A2 OR6A1 OR6A2P Homo sapiens (Human) sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007608; GO:0016021 NQEVKR 18.82999992 1 1 0.223335387 772.2343804 0 14.39268 16.27769 0 15.53235 0 0 15.40941 0 0 0 0 15.36715 18.11714 17.06237 11.74928 17.0323 15.98536 0 0 0 0 15.66644 12.48825 0 0 0 15.35427 0 14.87418 0 0 0 16.29295 18.24002 0 0 0 16.04887 0 16.99086 0 16.48337 0 0 0 16.73166 0 O95229 ZWINT_HUMAN "ZW10 interactor (ZW10-interacting protein 1, Zwint-1)" ZWINT Homo sapiens (Human) cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein N-terminus binding [GO:0047485]; cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094] protein N-terminus binding [GO:0047485] GO:0000070; GO:0000776; GO:0005654; GO:0005737; GO:0005829; GO:0007094; GO:0016604; GO:0030425; GO:0031617; GO:0047485; GO:0051301; GO:0051649 DPGVSFK 3.099999905 1 1 0.012319578 748.8880201 0 14.67204 14.92634 14.18153 0 0 14.13851 13.14845 11.90975 11.17278 0 15.92027 0 0 16.00469 0 0 0 0 0 15.37705 0 0 0 0 0 0 0 13.82149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.96772 0 0 0 0 O95232 LC7L3_HUMAN "Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1, CRE-associated protein 1, CREAP-1)" LUC7L3 CREAP1 CROP O48 Homo sapiens (Human) mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004 QHMGYAK 5.349999905 1 1 6.89E-13 834.0770096 14.55214 0 0 0 11.51802 12.33358 0 13.79305 0 0 0 14.02512 0 11.21696 14.34593 0 6.858786 12.83064 0 0 0 0 0 0 0 0 0 14.76944 0 0 11.70316 0 0 14.86858 0 0 0 0 15.26216 0 0 0 0 0 0 0 0 0 O95237 LRAT_HUMAN "Lecithin retinol acyltransferase, EC 2.3.1.135 (Phosphatidylcholine--retinol O-acyltransferase)" LRAT Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; acyltransferase activity [GO:0016746]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-palmitoyltransferase activity [GO:0016416]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776] acyltransferase activity [GO:0016746]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-palmitoyltransferase activity [GO:0016416]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841] GO:0001523; GO:0001972; GO:0005771; GO:0005783; GO:0005789; GO:0005791; GO:0006776; GO:0007601; GO:0009617; GO:0016021; GO:0016416; GO:0016746; GO:0019841; GO:0032370; GO:0032526; GO:0033189; GO:0042572; GO:0047173; GO:0048471; GO:0102279; GO:1990830 NSFYETSSFHR 6.409999847 1 1 0.113206003 1375.401053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.47882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.70563 0 0 0 0 0 0 0 0 0 O95238 SPDEF_HUMAN "SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor, Prostate-specific Ets) (Prostate-derived Ets factor)" SPDEF PDEF PSE Homo sapiens (Human) cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0010454; GO:0010455; GO:0030154; GO:0043065; GO:0043565; GO:0045944; GO:0060480; GO:0060576; GO:1990837 SAAWMK 9.840000153 1 1 0.235704842 708.8684024 17.1757 18.36908 13.83969 17.56962 0 15.81594 15.24125 18.74941 15.34993 0 0 0 15.45466 15.0319 0 15.50113 16.51878 15.11355 14.14798 0 0 0 16.45162 0 0 0 0 0 16.69664 17.76663 0 0 17.69477 0 0 0 0 18.46489 0 15.79307 0 17.83702 0 16.2931 0 0 0 16.75269 O95243 MBD4_HUMAN "Methyl-CpG-binding domain protein 4, EC 3.2.2.- (Methyl-CpG-binding endonuclease 1) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase)" MBD4 MED1 Homo sapiens (Human) depyrimidination [GO:0045008]; DNA repair [GO:0006281] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281] DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696] GO:0003677; GO:0003696; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0008263; GO:0016607; GO:0019104; GO:0045008 EDVAMELERVGEDEEQMMIK 9.449999809 0.380656064 0.380656064 0.15805646 2412.550923 0 17.59369 16.82084 16.03253 17.10279 18.23702 0 18.80352 19.21604 18.31724 16.99654 17.45902 17.11166 16.3855 0 0 0 18.2578 0 0 17.67142 18.00657 17.47399 0 16.70946 17.18995 0 17.52957 0 18.11828 0 18.41122 16.76201 18.38701 18.59245 18.43717 17.49526 18.52682 17.03505 0 17.15352 17.38118 18.33039 17.81917 18.6608 15.29526 0 17.34332 O95248 MTMR5_HUMAN "Myotubularin-related protein 5 (Inactive phosphatidylinositol 3-phosphatase 5) (SET-binding factor 1, Sbf1)" SBF1 MTMR5 Homo sapiens (Human) protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatid development [GO:0007286] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0005085; GO:0005737; GO:0005789; GO:0005829; GO:0006470; GO:0007286; GO:0008138; GO:0016021; GO:0016604; GO:0019208; GO:0043087; GO:0048471 MTMSSLVER 12.11999989 1 1 0.197667825 1069.72279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95249 GOSR1_HUMAN "Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28, GOS-28)" GOSR1 GS28 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]" SNAP receptor activity [GO:0005484] GO:0000139; GO:0005484; GO:0005794; GO:0005797; GO:0005801; GO:0005829; GO:0006888; GO:0006891; GO:0006906; GO:0015031; GO:0016020; GO:0016021; GO:0030133; GO:0031201; GO:0042147 ENLMGSVR 20.01000023 1 1 0.293039521 910.0421879 0 0 17.68238 0 0 13.96199 0 0 0 0 0 15.707 0 0 14.74637 13.37754 16.29329 0 16.2716 0 0 0 0 0 16.68111 17.09714 0 15.9694 0 0 19.85723 0 0 15.66603 0 16.41302 0 0 0 15.33826 15.69237 0 0 16.64233 0 0 0 0 O95251 KAT7_HUMAN "Histone acetyltransferase KAT7, EC 2.3.1.48 (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2, MYST-2)" KAT7 HBO1 HBOa MYST2 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]" DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] GO:0000123; GO:0000775; GO:0001558; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006275; GO:0006281; GO:0006325; GO:0006355; GO:0008270; GO:0016570; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0051726; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000278; GO:2000819 DMSLKDSGSDLSHRPK 1.700000048 1 1 0.383182467 1788.810613 17.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.07319 0 0 16.29624 0 0 0 O95255 MRP6_HUMAN "ATP-binding cassette sub-family C member 6, EC 7.6.2.-, EC 7.6.2.3 (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E, MOAT-E) (Multidrug resistance-associated protein 6)" ABCC6 ARA MRP6 Homo sapiens (Human) ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; cellular phosphate ion homeostasis [GO:0030643]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; leukotriene transport [GO:0071716]; phosphate ion homeostasis [GO:0055062]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; cellular phosphate ion homeostasis [GO:0030643]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; leukotriene transport [GO:0071716]; phosphate ion homeostasis [GO:0055062]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626] GO:0005524; GO:0005576; GO:0005654; GO:0005789; GO:0005886; GO:0007601; GO:0009410; GO:0010467; GO:0015431; GO:0015867; GO:0016020; GO:0016021; GO:0016323; GO:0030505; GO:0030643; GO:0032026; GO:0042626; GO:0043225; GO:0046034; GO:0055062; GO:0055074; GO:0055085; GO:0071716; GO:0110148; GO:1904383 GGSGMK 4.769999981 0.587293684 0.587293684 0.22225867 553.4783898 15.30953 14.99021 17.02662 14.21694 14.627 15.8136 0 0 13.57329 0 16.34831 16.35523 14.70198 15.69985 15.6251 15.94639 16.05392 0 14.87199 15.27765 15.6243 16.46009 15.75551 14.21219 0 0 16.40532 0 14.63259 13.7217 0 0 0 0 16.39523 0 16.75243 0 0 0 13.5108 15.96226 0 0 0 0 15.06683 0 O95258 UCP5_HUMAN "Brain mitochondrial carrier protein 1, BMCP-1 (Mitochondrial uncoupling protein 5, UCP 5) (Solute carrier family 25 member 14)" SLC25A14 BMCP1 UCP5 UNQ791/PRO1682 Homo sapiens (Human) aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117] GO:0005739; GO:0005743; GO:0005887; GO:0006839; GO:0008272; GO:0009060; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0071422; GO:0071423 GIFPGIILIFLR 35.18000031 0.823441505 0.823441505 0.448124272 1357.984929 0 18.14391 0 18.83305 0 19.09233 18.61359 0 0 0 0 18.38532 19.20262 0 18.73328 18.92178 18.08693 18.68916 18.69314 17.75084 18.91332 18.81315 18.91315 19.09915 18.59063 0 0 0 0 19.02478 17.91822 0 17.9355 18.54943 0 0 0 19.08127 0 18.3962 0 0 0 0 18.91561 0 0 0 O95259 KCNH1_HUMAN "Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1, EAG channel 1, h-eag, hEAG1) (Voltage-gated potassium channel subunit Kv10.1)" KCNH1 EAG EAG1 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; myoblast fusion [GO:0007520]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] axon [GO:0030424]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; phosphatidylinositol bisphosphate binding [GO:1902936]; voltage-gated potassium channel activity [GO:0005249]; cellular response to calcium ion [GO:0071277]; myoblast fusion [GO:0007520]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; phosphatidylinositol bisphosphate binding [GO:1902936]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005516; GO:0005637; GO:0005886; GO:0005887; GO:0006813; GO:0007520; GO:0008076; GO:0030424; GO:0030425; GO:0031901; GO:0034765; GO:0042127; GO:0042391; GO:0042734; GO:0043204; GO:0043231; GO:0048015; GO:0071277; GO:0071805; GO:0098839; GO:1902936 ESQGISSLFSSLKVVR 8.409999847 1 1 0.016867057 1735.852081 0 0 14.28423 0 11.83112 12.04894 0 14.5526 15.10628 0 0 13.19061 0 0 14.22025 14.35086 13.0247 15.50413 0 13.91516 14.36742 16.10558 16.03771 13.3992 14.87984 15.73699 16.27779 12.36313 12.41978 11.53031 15.51658 13.02151 14.91582 15.21298 0 15.20596 15.22333 0 0 14.20305 13.98263 0 0 0 0 0 17.00291 0 O95263 PDE8B_HUMAN "High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B, HsPDE8B, EC 3.1.4.53 (Cell proliferation-inducing gene 22 protein)" PDE8B PIG22 Homo sapiens (Human) cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0046872 ASGPPSVAR 8.43999958 0.892270744 0.892270744 0.274750574 840.9836196 15.88018 14.8455 13.6723 0 0 15.02654 16.01928 15.64613 15.6014 0 16.79493 15.66018 0 0 14.84923 0 15.48935 14.94582 0 15.30025 16.21923 14.64706 16.21435 14.19252 0 0 13.91444 15.07901 0 0 15.39419 0 0 15.69883 15.63753 15.18196 0 14.89043 17.39093 14.72698 16.75428 15.7185 0 15.71218 15.73856 0 0 16.63415 O95271 TNKS1_HUMAN "Poly [ADP-ribose] polymerase tankyrase-1, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 5, ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1, EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1, TANK1)" TNKS PARP5A PARPL TIN1 TINF1 TNKS1 Homo sapiens (Human) "cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]" histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270] GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404 GRTQLCALLLAHGADPTMK 5.630000114 1 1 0.22393652 2069.70416 14.64111 0 14.51488 0 11.53749 11.63343 0 0 0 0 0 0 15.55182 0 13.84185 0 0 14.52172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95292 VAPB_HUMAN "Vesicle-associated membrane protein-associated protein B/C, VAMP-B/VAMP-C, VAMP-associated protein B/C, VAP-B/VAP-C" VAPB UNQ484/PRO983 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular calcium ion homeostasis [GO:0006874]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076] beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0006888; GO:0007029; GO:0008017; GO:0016021; GO:0019076; GO:0019899; GO:0030968; GO:0033149; GO:0036498; GO:0042803; GO:0044790; GO:0044828; GO:0044829; GO:0044830; GO:0045070; GO:0045296; GO:0046725; GO:0046982; GO:0048487; GO:0061817; GO:0090114; GO:0090158 FMVQSMFAPTDTSDMEAVWK 1.690000057 0.095172949 0.095172949 1.00E-11 2368.378854 0 0 15.80339 0 0 15.78047 13.36515 0 0 0 0 0 0 0 0 0 15.63542 0 0 0 13.78765 0 0 16.75773 13.06943 0 0 18.48545 0 0 15.87998 14.58382 0 12.37493 16.21254 16.02463 0 14.43169 0 0 0 0 0 0 0 13.38123 15.03588 15.55999 O95294 RASL1_HUMAN RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) RASAL1 RASAL Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0030154; GO:0035556; GO:0043087; GO:0046580; GO:0046872; GO:0071277; GO:1903861 LFDLRDQHADPQTSR 3.869999886 1 1 0.16104002 1798.681687 0 0 0 0 0 0 0 16.15533 0 0 0 0 0 0 0 0 14.96852 15.80866 0 0 0 0 0 0 0 14.01244 0 0 0 16.40719 0 14.43898 0 0 0 0 0 0 0 0 16.55867 0 0 0 0 0 0 0 O95299 NDUAA_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD, CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)" NDUFA10 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" NADH dehydrogenase (ubiquinone) activity [GO:0008137] GO:0005737; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 VRGIHSSVQCK 2.099999905 1 1 0.266416682 1272.301144 0 0 0 0 0 0 0 0 0 0 0 0 0 15.55236 0 0 0 0 0 17.35388 0 0 0 0 0 15.13785 0 0 15.46331 0 15.87122 16.31893 15.40883 0 0 0 0 0 17.23899 0 0 0 0 0 0 0 0 0 O95342 ABCBB_HUMAN "Bile salt export pump, EC 7.6.2.- (ATP-binding cassette sub-family B member 11)" ABCB11 BSEP Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic export [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; carbohydrate transmembrane transporter activity [GO:0015144]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic export [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855] ABC-type bile acid transporter activity [GO:0015432]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; carbohydrate transmembrane transporter activity [GO:0015144] GO:0000139; GO:0005524; GO:0005768; GO:0005886; GO:0006631; GO:0006699; GO:0006805; GO:0006855; GO:0006979; GO:0008206; GO:0008559; GO:0009986; GO:0010468; GO:0015125; GO:0015126; GO:0015144; GO:0015432; GO:0015721; GO:0015722; GO:0016021; GO:0016324; GO:0016567; GO:0031998; GO:0038183; GO:0042626; GO:0042632; GO:0043627; GO:0045471; GO:0046581; GO:0046618; GO:0046691; GO:0055037; GO:0055038; GO:0055085; GO:0055088; GO:0055091; GO:0070062; GO:0120189; GO:1904251; GO:1904486 GDGVR 2.180000067 1 1 0.267589259 505.8303267 0 0 14.09951 16.11217 15.286 14.58509 14.91297 12.4659 15.5467 17.09755 0 16.41474 15.41685 16.05125 0 0 0 0 15.10743 15.18618 0 16.01247 0 15.72379 15.65441 0 16.44972 0 0 0 0 0 0 0 0 16.61418 0 0 0 15.84124 0 0 14.42619 0 14.4446 0 0 0 O95347 SMC2_HUMAN "Structural maintenance of chromosomes protein 2, SMC protein 2, SMC-2 (Chromosome-associated protein E, hCAP-E) (XCAP-E homolog)" SMC2 CAPE SMC2L1 PRO0324 Homo sapiens (Human) cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697] GO:0000228; GO:0000785; GO:0000793; GO:0000794; GO:0000796; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0016887; GO:0045132; GO:0051301; GO:0051383; GO:0051984; GO:0070062; GO:1905820; GO:1905821 GLVASLISVK 4.199999809 1 1 0.181164704 987.7789492 0 15.03094 0 12.26422 15.39517 0 15.81594 0 14.30268 14.99128 13.71933 14.66066 14.96001 13.59574 15.40078 0 13.93358 0 0 13.19404 0 0 15.71507 0 12.01859 15.65154 0 12.70843 15.48826 15.05129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95352 ATG7_HUMAN "Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7, APG7-like, hAGP7) (Ubiquitin-activating enzyme E1-like protein)" ATG7 APG7L Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521] Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803] GO:0000045; GO:0000407; GO:0000422; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0009267; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0031401; GO:0032446; GO:0034727; GO:0034774; GO:0039521; GO:0042752; GO:0042803; GO:0043065; GO:0044805; GO:0045732; GO:0048511; GO:0051607; GO:0071455; GO:1904813 MVNLSECMDPKR 6.639999866 0.012799527 0.012799527 0.543471699 1510.285622 0 0 0 0 0 0 18.10585 0 0 0 0 0 0 18.59937 0 0 0 0 0 0 16.37887 0 0 0 0 0 0 19.22471 0 0 0 0 18.42877 0 0 0 19.01598 0 0 0 0 0 0 0 0 0 0 0 O95359 TACC2_HUMAN "Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1, AZU-1)" TACC2 Homo sapiens (Human) cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear receptor binding [GO:0016922]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] nuclear receptor binding [GO:0016922] GO:0000226; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007052; GO:0008283; GO:0016922; GO:0021987 APSESARGPPGPTDGAK 9.789999962 0.44055602 0.44055602 0.280743917 1594.399127 0 15.37045 14.99122 15.57936 0 0 0 13.03325 0 14.82458 0 0 17.18326 16.31907 0 0 0 0 0 0 0 0 0 0 15.93744 13.80647 16.52894 0 16.52374 0 16.22183 14.71784 14.64087 13.75066 0 15.72273 15.23073 15.40582 15.03007 12.78309 11.99993 0 0 17.60183 16.14886 0 15.55037 0 O95361 TRI16_HUMAN "Tripartite motif-containing protein 16, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM16) (Estrogen-responsive B box protein)" TRIM16 EBBP Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; response to growth hormone [GO:0060416]; response to organophosphorus [GO:0046683]; response to retinoic acid [GO:0032526]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; PML body [GO:0016605] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; PML body [GO:0016605]; DNA binding [GO:0003677]; interleukin-1 binding [GO:0019966]; NACHT domain binding [GO:0032089]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; response to growth hormone [GO:0060416]; response to organophosphorus [GO:0046683]; response to retinoic acid [GO:0032526]" DNA binding [GO:0003677]; interleukin-1 binding [GO:0019966]; NACHT domain binding [GO:0032089]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] GO:0003677; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0016605; GO:0016740; GO:0019966; GO:0032089; GO:0032526; GO:0032731; GO:0043966; GO:0043967; GO:0045618; GO:0045893; GO:0046683; GO:0048386; GO:0060416 LKLNENAISR 15.81000042 0.173589319 0.173589319 0.381898827 1157.176766 17.29804 0 0 0 0 14.77581 0 0 0 0 0 0 0 0 0 0 16.41964 0 0 16.06468 0 0 0 12.70976 0 0 18.18475 0 0 0 15.37924 0 18.46403 0 16.85245 0 0 17.47955 0 0 0 0 0 16.69989 0 0 0 0 O95363 SYFM_HUMAN "Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)" FARS2 FARS1 HSPC320 Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033] ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049] GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006418; GO:0006432; GO:0008033 FVHPKTHK 11.34000015 1 1 0.190645043 995.6281769 15.59872 16.26418 13.93662 0 0 0 0 15.56878 15.62378 0 0 0 16.54042 0 17.38025 0 0 0 15.48328 0 0 12.07198 0 14.40398 0 0 15.14298 0 0 0 0 15.39402 0 0 0 16.48766 16.90174 0 0 0 0 16.63515 0 0 0 17.48439 0 15.86693 O95365 ZBT7A_HUMAN "Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1, FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor, POK erythroid myeloid ontogenic factor, Pokemon, Pokemon 1) (TTF-I-interacting peptide 21, TIP21) (Zinc finger protein 857A)" ZBTB7A FBI1 LRF ZBTB7 ZNF857A Homo sapiens (Human) "B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]" "androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]" GO:0000122; GO:0000381; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006110; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0030183; GO:0030512; GO:0034504; GO:0035035; GO:0035861; GO:0042981; GO:0043249; GO:0045444; GO:0045746; GO:0045892; GO:0046332; GO:0046872; GO:0050681; GO:0051090; GO:0051092; GO:0060766; GO:0070418; GO:0097680; GO:0140297; GO:1990837; GO:2000677 LNVAGAGGGGDSGGGPGAATDGNFTAGLA 7.159999847 0.463647693 0.463647693 0.099040123 2380.750548 14.40098 0 0 0 0 12.35428 0 0 0 0 0 0 0 0 0 0 10.58476 12.50615 0 0 0 0 14.92535 13.7163 0 9.393777 0 0 0 0 0 12.62308 0 0 0 0 0 0 0 0 0 0 0 0 11.20987 0 0 0 O95371 OR2C1_HUMAN Olfactory receptor 2C1 (OLFmf3) (Olfactory receptor 2C2) (Olfactory receptor OR16-1) (Olfactory receptor OR16-2) OR2C1 OR2C2P Homo sapiens (Human) cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0005938; GO:0016021 SAEGRR 5.039999962 1 1 0.063402055 675.4782793 0 0 0 0 0 0 0 0 15.64418 0 0 0 14.7202 16.38551 0 13.12634 0 0 0 15.85927 0 15.30042 0 0 0 15.64071 16.02315 16.40504 0 15.77782 16.63928 15.07849 0 14.28067 0 0 0 0 0 16.33879 0 0 15.34669 14.96499 17.28834 0 0 0 O95372 LYPA2_HUMAN "Acyl-protein thioesterase 2, APT-2, EC 3.1.2.- (Lysophospholipase II, LPL-II, LysoPLA II) (Palmitoyl-protein hydrolase, EC 3.1.2.22)" LYPLA2 APT2 Homo sapiens (Human) acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084] cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474] GO:0002084; GO:0004622; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0007411; GO:0008474; GO:0045296; GO:0046464; GO:0052689; GO:0070062; GO:1905344 ALIEHEMK 7.400000095 0.277096421 0.277096421 0.243916458 986.8389784 15.67455 15.68423 15.22292 0 15.77719 14.96042 0 16.81825 0 16.02747 0 12.80117 15.54477 0 0 16.42845 0 14.73343 0 0 0 0 0 15.30983 16.25538 11.29567 0 15.8039 0 0 0 15.22482 11.93469 14.27454 15.47806 14.30359 14.98004 15.68684 14.61656 16.27322 16.04503 15.14205 14.25352 0 13.48396 16.49105 15.3512 16.01976 O95373 IPO7_HUMAN "Importin-7, Imp7 (Ran-binding protein 7, RanBP7)" IPO7 RANBP7 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606] GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267] GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0016020; GO:0030695; GO:0031267; GO:0042393; GO:0045087; GO:0045736; GO:0046332 QYMAPR 5.46999979 0.156197295 0.156197295 0.310071114 781.8862102 0 0 0 16.99673 0 0 0 15.99798 16.43686 14.43704 0 0 15.46943 15.18167 16.47878 16.27853 16.4259 16.23578 16.72284 0 0 16.55775 17.32553 15.91335 16.22727 15.7858 0 0 0 15.82772 17.56844 16.68823 0 17.35748 0 0 18.12099 17.01044 16.42334 17.4705 18.59758 0 17.49992 0 17.1267 0 0 17.18834 O95379 TFIP8_HUMAN "Tumor necrosis factor alpha-induced protein 8, TNF alpha-induced protein 8 (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein, NDED) (SCC-S2) (TNF-induced protein GG2-1)" TNFAIP8 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027] GO:0005654; GO:0005737; GO:0043027; GO:0043065; GO:0043066 EAEKIIK 11.57999992 1 1 0.308859573 827.4779717 16.07261 0 18.08409 0 0 0 0 0 0 0 0 19.46121 0 17.74552 0 0 17.06027 17.90232 0 0 0 0 19.43323 18.69017 0 17.89474 0 0 0 0 0 0 0 18.86738 0 19.19641 0 19.2787 0 0 0 0 18.03926 0 0 19.25989 0 0 O95382 M3K6_HUMAN "Mitogen-activated protein kinase kinase kinase 6, EC 2.7.11.25 (Apoptosis signal-regulating kinase 2)" MAP3K6 ASK2 MAPKKK6 MEKK6 Homo sapiens (Human) protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004672; GO:0004709; GO:0004712; GO:0005524; GO:0006468; GO:0007165; GO:0106310 RCLSYGGTSQLR 2.210000038 1 1 2.30E-13 1398.063282 0 0 0 0 0 0 15.90727 16.03425 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17545 0 0 0 0 0 15.40796 15.17683 15.52614 16.09295 0 16.00896 15.7911 0 15.11249 16.40843 0 0 0 0 0 0 0 0 0 0 0 O95389 CCN6_HUMAN "Cellular communication network factor 6 (CCN family member 6) (WNT1-inducible-signaling pathway protein 3, WISP-3)" CCN6 WISP3 UNQ462/PRO790/PRO956 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165] growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178] GO:0005178; GO:0005615; GO:0005739; GO:0007155; GO:0007165; GO:0007267; GO:0008083; GO:0008201; GO:0008285; GO:0016525; GO:0031012; GO:0051881; GO:0060548; GO:1903426 NLPLIWKK 5.579999924 1 1 0.168433384 1014.329749 0 0 0 0 13.52297 0 0 0 0 0 0 13.98488 0 0 12.31661 13.43069 13.9682 15.4753 10.99349 14.79585 0 0 0 0 0 16.85417 0 0 0 0 15.73891 0 16.00963 15.84133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95390 GDF11_HUMAN "Growth/differentiation factor 11, GDF-11 (Bone morphogenetic protein 11, BMP-11)" GDF11 BMP11 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657] extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657] cytokine activity [GO:0005125]; growth factor activity [GO:0008083] GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0005654; GO:0007399; GO:0007498; GO:0008083; GO:0008285; GO:0010862; GO:0021512; GO:0031016; GO:0032991; GO:0043231; GO:0045665; GO:0048469; GO:0048593; GO:0060021; GO:0060395 LKPLTGEGTAGGGGGGRR 7.619999886 1 1 0.385732169 1641.35125 15.39889 14.72343 0 0 0 0 15.87805 0 0 0 0 0 0 0 0 0 0 0 0 0 15.08068 0 17.39039 0 0 16.41201 16.02178 0 15.18548 15.33381 14.98971 15.78116 0 16.15483 15.77937 0 0 14.88181 0 0 0 15.10161 0 0 16.68449 0 16.55904 13.93235 O95391 SLU7_HUMAN "Pre-mRNA-splicing factor SLU7, hSlu7" SLU7 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270] GO:0000375; GO:0000380; GO:0000386; GO:0000389; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006886; GO:0008270; GO:0008380; GO:0016020; GO:0016607; GO:0030532; GO:0030628; GO:0034605; GO:0043231; GO:0071013 KALNAEEAR 11.18999958 0.168940201 0.168940201 0.167164496 1001.623078 17.43443 16.1445 17.74411 0 0 13.38406 13.85181 0 0 0 17.24664 16.25811 16.89744 15.92425 18.22053 14.0452 0 12.89259 16.11757 15.06643 19.12714 18.28426 17.52125 17.43493 17.06709 14.27427 16.80743 0 12.20396 18.36482 17.48854 0 16.47488 16.17971 17.21944 0 16.80078 18.05721 13.48858 18.32786 14.19225 16.5407 18.86903 18.1683 18.00995 12.11915 15.81836 15.90946 O95393 BMP10_HUMAN "Bone morphogenetic protein 10, BMP-10" BMP10 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]; activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]" cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433] GO:0001822; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0010862; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060389; GO:0060395; GO:0061036; GO:1903242; GO:2000138 HAIIQALVHLKNSQK 20.21999931 1 1 0.278103044 1699.607577 0 0 0 0 19.51343 0 14.72253 0 0 0 0 19.02811 0 0 0 0 0 0 0 0 0 20.60263 20.59604 0 20.80595 0 0 0 0 0 0 0 0 0 21.05675 0 21.68832 0 0 0 20.69281 21.30724 0 0 0 0 20.84096 20.55113 O95394 AGM1_HUMAN "Phosphoacetylglucosamine mutase, PAGM, EC 5.4.2.3 (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3, PGM 3)" PGM3 AGM1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829] cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614] GO:0000287; GO:0004610; GO:0004614; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097 MGLLAVLR 1.720000029 1 1 0.304942385 889.2671751 0 17.48978 0 0 0 0 17.31253 16.6014 18.37359 0 0 0 17.1141 0 0 0 0 0 0 0 17.29508 0 0 18.1291 18.71666 18.36693 18.23911 0 0 0 0 17.7037 0 0 0 18.11003 0 20.45976 0 0 0 0 16.96425 18.06878 0 16.09861 17.41773 0 O95405 ZFYV9_HUMAN "Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein, Madh-interacting protein) (Novel serine protease, NSP) (Receptor activation anchor, hSARA) (Smad anchor for receptor activation)" ZFYVE9 MADHIP SARA SMADIP Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904] GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872 SECYSNIYEQRGNEATEGSGLLLNSTGDLMK 5.079999924 0.935394406 0.935394406 0.125646046 3452.151455 0 14.6782 13.64977 16.3353 16.25899 0 14.64466 0 15.30784 14.89923 0 0 0 15.3582 16.47511 16.72436 17.74988 0 0 17.60577 0 0 0 17.05698 17.31916 0 15.09381 16.68068 13.91564 13.05246 13.77028 0 16.49941 0 0 16.21509 0 18.04397 0 18.09125 16.36289 18.71753 0 17.238 14.21155 16.95234 17.99185 15.83444 O95407 TNF6B_HUMAN "Tumor necrosis factor receptor superfamily member 6B (Decoy receptor 3, DcR3) (Decoy receptor for Fas ligand) (M68)" TNFRSF6B DCR3 TR6 UNQ186/PRO212 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; signaling receptor activity [GO:0038023]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066] signaling receptor activity [GO:0038023] GO:0005576; GO:0005615; GO:0006915; GO:0038023; GO:0043066 GVAETPTYPWR 3.279999971 0.621582389 0.621582389 1.15E-12 1276.211321 0 16.31744 11.36148 0 0 14.27065 0 0 0 0 15.71222 14.75702 0 0 0 0 0 0 0 0 0 13.93498 15.32128 0 0 16.21059 15.58416 13.81888 0 0 0 0 0 0 0 0 0 0 0 0 16.76179 0 0 0 0 0 0 0 O95411 TIAF1_HUMAN Putative TGFB1-induced anti-apoptotic factor 1 (12 kDa TGF-beta-1-induced antiapoptotic factor) MYO18A TIAF1 Homo sapiens (Human) apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066] nucleus [GO:0005634] nucleus [GO:0005634]; apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066] GO:0005634; GO:0006915; GO:0007249; GO:0043066 VMCNDLFK 13.23999977 0.517688155 0.517688155 0.127424658 1024.945238 16.5438 15.81213 0 13.99188 16.49854 15.9626 16.29183 0 13.05303 15.93162 0 16.91367 15.5245 16.91833 0 15.1606 14.22359 11.09852 15.39521 0 13.1945 15.61764 14.57444 15.61451 16.85107 0 0 0 16.13678 15.1258 15.33495 0 12.8319 14.84103 15.46496 16.31341 13.23125 12.86423 16.90001 10.56634 14.06159 17.60753 13.46789 12.56162 16.48051 15.56859 10.45245 0 O95425 SVIL_HUMAN Supervillin (Archvillin) (p205/p250) SVIL Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519] actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102] "actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]" "actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016 AAGSTR 1.299999952 1 1 0.040373816 561.2376174 15.81519 0 0 0 0 0 16.81666 15.41575 16.4945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88456 16.18834 15.99314 0 0 0 0 0 0 0 0 0 0 0 0 14.13384 0 0 0 O95428 PPN_HUMAN Papilin PAPLN UNQ2420/PRO4977 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004222; GO:0004867; GO:0005576; GO:0030198; GO:0031012 RSCNLHPCPETK 4.989999771 0.349322796 0.349322796 0.330922275 1498.658503 14.91155 0 0 0 0 0 0 15.72348 0 15.2182 0 12.18215 15.24217 15.72486 16.21842 0 14.80817 0 15.58788 0 14.08727 14.91542 0 0 16.25214 14.92642 16.48571 0 0 0 15.01488 13.32808 16.07946 15.00591 16.16783 12.70779 0 15.84876 0 15.25092 14.2227 0 0 0 14.1816 16.89077 12.5547 0 O95447 LCA5L_HUMAN Lebercilin-like protein (Leber congenital amaurosis 5-like protein) LCA5L C21orf13 Homo sapiens (Human) intraciliary transport [GO:0042073] axoneme [GO:0005930] axoneme [GO:0005930]; intraciliary transport [GO:0042073] GO:0005930; GO:0042073 GTAPYTK 6.429999828 1 1 5.74E-13 737.338493 16.04494 13.18288 16.16422 0 0 0 13.93345 0 0 17.14629 0 15.06937 15.09663 0 0 0 0 0 0 0 0 15.89559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95450 ATS2_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 2, ADAM-TS 2, ADAM-TS2, ADAMTS-2, EC 3.4.24.14 (Procollagen I N-proteinase, PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase, pNPI)" ADAMTS2 PCINP PCPNI Homo sapiens (Human) collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0004222; GO:0005576; GO:0007283; GO:0008237; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588; GO:0062023 AAPVR 4.690000057 0.878085911 0.878085911 0.229997198 514.0596087 0 0 0 0 0 0 0 0 18.37419 0 0 0 0 17.76199 0 17.61468 0 17.16742 0 0 0 0 0 0 0 0 0 0 0 18.7895 17.99697 0 0 18.13646 0 0 0 0 0 17.23987 0 0 0 0 0 0 0 0 O95456 PSMG1_HUMAN "Proteasome assembly chaperone 1, PAC-1 (Chromosome 21 leucine-rich protein, C21-LRP) (Down syndrome critical region protein 2)" PSMG1 C21LRP DSCR2 PAC1 Homo sapiens (Human) cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129] molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0021930; GO:0051131; GO:0060090; GO:0070628; GO:0080129; GO:0101031 KNMQITILTCR 9.729999542 0.352620006 0.352620006 0.332798558 1388.69695 9.542271 15.23393 15.67581 0 12.09003 0 0 0 13.52051 0 0 12.31268 0 0 16.48037 15.36427 0 0 0 0 0 15.56385 0 0 0 0 0 0 0 15.23106 0 16.79925 17.24714 17.74243 17.32445 17.90278 17.88444 16.69399 17.24251 17.57218 0 17.2598 15.79072 0 0 17.31855 17.33987 16.70997 O95460 MATN4_HUMAN Matrilin-4 MATN4 Homo sapiens (Human) extracellular matrix organization [GO:0030198] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix organization [GO:0030198] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0030198; GO:0062023 GLNVGPNATR 4.699999809 0.692750096 0.692750096 0.165288663 999.3529164 18.01334 17.1025 0 15.84905 0 16.94372 17.9213 0 0 0 16.60016 0 0 9.443223 0 0 0 0 0 0 0 15.06355 15.60652 0 15.12358 14.68396 0 18.99745 16.59338 0 17.00982 0 18.66315 16.96814 12.79837 17.78429 17.09179 0 11.81292 14.3644 0 0 0 14.86575 0 0 15.35525 17.282 O95466 FMNL1_HUMAN Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin) FMNL1 C17orf1 C17orf1B FMNL FRL1 Homo sapiens (Human) actin filament severing [GO:0051014]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360] bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267]; actin filament severing [GO:0051014]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360] actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267] GO:0005829; GO:0005886; GO:0005938; GO:0008360; GO:0016020; GO:0016477; GO:0030866; GO:0031267; GO:0032059; GO:0032794; GO:0045335; GO:0051014; GO:0051015; GO:0070062 ANSPTMDKLLADSK 9.399999619 1 1 0.306619504 1493.983392 15.10659 0 14.20012 15.18938 14.07387 0 15.28351 13.36917 13.8044 0 0 14.1207 13.72063 11.00313 0 0 0 15.71168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.25455 14.83537 0 0 0 0 0 0 0 0 14.46242 0 0 15.87566 0 O95473 SNG4_HUMAN Synaptogyrin-4 SYNGR4 Homo sapiens (Human) integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672] integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672] GO:0016021; GO:0030672; GO:0031594 MHIPKSLQELANSEAVQFLR 7.300000191 1 1 0.080092228 2326.239654 13.84566 15.35101 12.97986 15.03086 13.35979 13.8694 0 10.01045 0 0 13.56263 12.96986 13.15819 15.07785 0 12.92724 15.09085 0 14.1706 14.41056 14.82036 13.51581 0 15.25136 14.82267 14.8792 13.02274 14.38558 14.22083 13.28607 15.67512 0 0 0 0 15.85751 14.4305 11.34234 0 14.12274 15.19095 13.52038 0 0 0 0 0 15.51743 O95477 ABCA1_HUMAN "Phospholipid-transporting ATPase ABCA1, EC 7.6.2.1 (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1, ABC-1, ATP-binding cassette 1) (Cholesterol efflux regulatory protein)" ABCA1 ABC1 CERP Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]" endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] "endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]" ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 LKETMR 5.590000153 1 1 0.293293671 792.0245576 0 17.02147 16.4445 0 0 0 0 17.75689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.09831 0 0 0 0 0 0 0 16.9477 0 0 O95478 NSA2_HUMAN Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1) NSA2 TINP1 HUSSY-29 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470] "nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]" RNA binding [GO:0003723] GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0030687 GTVIEVNVSELGLVTQGGKVIWGK 3.450000048 1 1 1.37E-12 2482.819712 12.47796 0 0 0 0 0 0 11.70023 0 0 0 0 0 0 0 0 12.42429 0 12.54496 0 9.182977 0 0 0 6.282274 11.20108 0 0 12.62127 13.06398 0 0 13.16842 10.58043 10.32438 0 0 0 0 0 0 0 0 0 0 0 0 0 O95487 SC24B_HUMAN Protein transport protein Sec24B (SEC24-related protein B) SEC24B Homo sapiens (Human) aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] GO:0000149; GO:0001843; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0021747; GO:0030127; GO:0035909; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301 SQPLVHLMKMIHPNLYR 5.110000134 1 1 0.181361069 2094.129244 0 0 11.52763 0 13.4353 12.25534 14.52335 15.23953 13.53474 15.18186 0 12.62707 0 13.89617 13.72756 12.98553 0 0 0 12.54502 0 0 0 0 13.66477 14.38904 14.98342 14.92486 13.62696 0 0 0 0 0 0 0 0 0 0 15.03574 15.67013 0 0 13.40979 14.71241 0 12.59659 0 O95490 AGRL2_HUMAN "Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2, CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)" ADGRL2 KIAA0786 LEC1 LPHH1 LPHN2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016021; GO:0016524; GO:0030246; GO:0043005 TMMGYWSTQGCKLVDTNK 2.720000029 1 1 0.02897293 2148.416677 10.01925 0 13.83722 0 14.79539 0 11.86413 9.162121 7.907812 0 0 0 0 0 0 0 0 0 0 13.19218 15.40641 0 14.24433 0 0 14.05447 0 13.75077 13.4699 0 0 0 0 0 16.47492 0 0 0 0 0 0 0 0 0 0 0 0 0 O95567 CV031_HUMAN Uncharacterized protein C22orf31 C22orf31 Homo sapiens (Human) YSLELGKAIK 10.86999989 0.096896201 0.096896201 0.111472001 1120.72109 19.16601 17.89662 15.7725 0 0 0 0 0 16.38029 0 16.59715 0 0 0 0 0 0 16.02976 0 16.30497 16.98894 0 18.80052 17.49361 0 16.61846 17.49746 0 0 0 0 16.54852 17.48442 0 0 10.59192 17.82316 15.12942 16.67599 0 17.88964 19.43485 0 0 15.62275 0 17.24505 0 O95571 ETHE1_HUMAN "Persulfide dioxygenase ETHE1, mitochondrial, EC 1.13.11.18 (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)" ETHE1 HSCO Homo sapiens (Human) glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]" "hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]" GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813 CGVQTPTA 12.42000008 1 1 0.128262507 832.6834305 0 11.89832 0 0 0 15.68256 0 17.17836 0 0 0 0 15.52806 13.42217 0 14.50482 0 15.80898 13.96271 16.95274 12.37844 0 15.49571 0 16.15833 12.10743 15.65655 16.73306 12.11657 14.61818 14.11067 18.53773 0 0 0 14.31965 17.22768 17.1501 0 14.72433 17.09004 12.97331 15.99472 13.16874 17.97709 15.30321 14.81146 0 O95613 PCNT_HUMAN Pericentrin (Kendrin) (Pericentrin-B) PCNT KIAA0402 PCNT2 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316 APRPGPRAR 2.420000076 0.494488329 0.494488329 0.111876138 976.9151635 15.42637 16.22843 12.42907 6.313928 15.78006 14.66656 13.87419 14.59741 0 13.40659 14.13661 15.79231 14.53742 15.4381 11.42952 12.30881 0 15.13142 12.75445 0 14.341 0 11.71261 0 0 0 0 0 0 0 0 0 0 0 12.24212 0 0 0 0 0 0 0 13.43312 0 15.56769 0 0 0 O95620 DUS4L_HUMAN "tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like, EC 1.3.1.90 (pp35) (tRNA-dihydrouridine synthase 4-like)" DUS4L Homo sapiens (Human) flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150] flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150] GO:0017150; GO:0050660 VCAPMVR 10.77000046 1 1 0.263853867 848.3126901 0 0 18.6895 17.93208 0 0 0 0 0 18.41544 0 0 0 0 0 0 0 0 17.30455 0 0 0 17.92807 0 0 0 0 0 16.36 0 0 18.44376 18.51367 0 16.92036 19.42142 18.94142 0 0 16.90683 0 0 17.04626 16.86959 15.93141 0 0 0 O95622 ADCY5_HUMAN "Adenylate cyclase type 5, EC 4.6.1.1 (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5, AC5)" ADCY5 Homo sapiens (Human) adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110] GO:0001973; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007626; GO:0008179; GO:0016021; GO:0035556; GO:0045111; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322 HVAMEMK 6.019999981 0.73628217 0.73628217 0.226930822 876.204212 0 13.49653 0 0 0 0 0 12.39251 0 15.29524 18.31275 15.10646 0 0 15.13428 0 0 0 0 0 0 0 15.98044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.34566 0 0 0 0 0 17.57346 O95631 NET1_HUMAN Netrin-1 (Epididymis tissue protein Li 131P) NTN1 NTN1L Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]" actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654] "actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]" GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0008045; GO:0008284; GO:0009887; GO:0009888; GO:0015629; GO:0016358; GO:0030334; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060603; GO:0061643; GO:0098609; GO:2000147 FTVNIISVYK 3.789999962 1 1 0.233183194 1184.024779 0 0 0 0 16.58421 12.21367 0 0 10.59346 0 0 0 16.57572 0 12.52591 0 14.49284 0 0 0 0 0 0 0 15.10171 0 0 0 14.28969 0 11.70418 14.94154 11.24088 0 0 14.2034 0 15.27648 0 13.45613 10.92341 14.12658 0 0 13.31189 0 0 0 O95639 CPSF4_HUMAN "Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit, CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1, Neb-1) (No arches homolog)" CPSF4 CPSF30 NAR NEB1 Homo sapiens (Human) pre-mRNA cleavage required for polyadenylation [GO:0098789] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789] RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] GO:0003723; GO:0005654; GO:0005847; GO:0008270; GO:0043231; GO:0098789; GO:1990837 GGMCPFR 10.72999954 0.00099606 0.00099606 0.045955741 839.4107729 15.80677 15.00348 0 0 15.00605 0 0 0 0 0 0 0 0 0 0 16.24643 0 0 0 0 0 0 16.86176 16.79346 0 0 0 16.48517 0 0 0 0 0 0 0 0 16.9879 16.94227 16.48717 16.31347 0 0 0 0 0 0 0 0 O95665 NTR2_HUMAN "Neurotensin receptor type 2, NT-R-2, NTR2 (Levocabastine-sensitive neurotensin receptor)" NTSR2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600] G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007200; GO:0007218; GO:0007600; GO:0016492; GO:0042391 KLFLEAVSSLCGEHHPMK 11.13000011 1 1 0 2083.519817 17.35415 9.299329 13.24442 0 15.27205 13.90983 13.07182 0 15.22183 0 15.28281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.56412 16.58095 0 0 0 0 11.0439 16.5789 14.75772 14.22301 17.43165 0 15.61163 14.4315 0 0 0 0 0 0 0 15.03136 0 O95670 VATG2_HUMAN "V-type proton ATPase subunit G 2, V-ATPase subunit G 2 (V-ATPase 13 kDa subunit 2) (Vacuolar proton pump subunit G 2)" ATP6V1G2 ATP6G ATP6G2 NG38 Homo sapiens (Human) regulation of macroautophagy [GO:0016241] "cytosol [GO:0005829]; melanosome [GO:0042470]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "cytosol [GO:0005829]; melanosome [GO:0042470]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]" "proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0000221; GO:0005829; GO:0016241; GO:0016471; GO:0042470; GO:0046961 ASQSQGIQQLLQAEK 17.29000092 0.240219593 0.240219593 0.437437952 1628.061106 0 17.06791 0 0 0 16.1378 0 0 17.08804 15.55986 0 17.03329 0 0 0 0 0 0 17.63605 0 0 0 17.52923 0 0 0 0 0 0 0 16.84383 0 0 0 17.27496 0 0 0 16.63802 17.54933 0 0 0 0 0 0 0 0 O95671 ASML_HUMAN "Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase, dTTPase/UTPase, EC 3.6.1.9 (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase, Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein, ASMTL, EC 2.1.1.- ]" ASMTL Homo sapiens (Human) methylation [GO:0032259]; nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117] dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221] GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0036221; GO:0047429 VFDLLKDEAPQK 25.62999916 0.315691948 0.315691948 0.38709386 1401.976355 0 15.34292 0 16.6169 15.57572 15.83995 0 16.45619 0 0 15.78683 0 0 0 16.16046 16.53341 0 0 17.20298 16.99187 16.55043 15.20343 0 0 0 0 16.79875 16.84104 0 16.11959 0 16.7483 16.65237 0 16.15955 0 16.57689 16.41183 16.21773 16.94433 0 0 16.36458 0 0 0 15.67183 16.04681 O95696 BRD1_HUMAN Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2) BRD1 BRL BRPF2 Homo sapiens (Human) chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902] chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204] chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902] histone binding [GO:0042393]; metal ion binding [GO:0046872] GO:0005634; GO:0005694; GO:0006325; GO:0006357; GO:0016607; GO:0030425; GO:0035902; GO:0036409; GO:0042393; GO:0043204; GO:0043249; GO:0043966; GO:0044154; GO:0045648; GO:0046872; GO:0050793; GO:0051602; GO:0070776; GO:1903706 IANQVAIQR 6.510000229 1 1 0.000411781 1012.198209 0 14.37657 0 10.43021 0 12.74056 15.68789 0 13.80889 0 0 13.85207 0 13.9339 0 15.03718 14.26006 0 15.62731 12.24854 0 0 0 10.62911 0 0 0 0 0 0 0 17.64127 0 0 0 0 0 0 0 0 0 0 13.41492 0 0 0 0 0 O95704 APBB3_HUMAN "Amyloid-beta A4 precursor protein-binding family B member 3 (Protein Fe65-like 2, Fe65L2)" APBB3 FE65L2 Homo sapiens (Human) "positive regulation of protein secretion [GO:0050714]; regulation of transcription, DNA-templated [GO:0006355]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750]; positive regulation of protein secretion [GO:0050714]; regulation of transcription, DNA-templated [GO:0006355]" amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750] GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0015629; GO:0016020; GO:0050714; GO:0050750 VWGVGSSK 10.65999985 1 1 6.89E-13 817.0215526 16.73115 15.07446 16.17686 0 0 15.44308 13.90408 0 15.09035 0 14.58272 15.31004 15.22599 0 0 0 0 0 0 0 0 0 15.68574 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81285 0 0 0 0 0 0 0 0 0 0 0 O95714 HERC2_HUMAN "E3 ubiquitin-protein ligase HERC2, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)" HERC2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630 FLRSVVTGDVHGTPATK 2.819999933 1 1 1.14E-12 1784.804651 13.81901 16.05768 11.88219 13.934 0 13.15912 14.24794 0 0 0 14.96706 13.57537 0 0 0 0 0 0 0 0 0 0 0 0 0 10.02056 15.40112 0 13.95241 0 0 0 0 0 0 0 0 0 0 0 15.28145 15.85492 0 0 12.27867 0 0 0 O95715 CXL14_HUMAN C-X-C motif chemokine 14 (Chemokine BRAK) (MIP-2G) (Small-inducible cytokine B14) CXCL14 MIP2G NJAC SCYB14 PSEC0212 UNQ240/PRO273 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of another organism [GO:0031640]; signal transduction [GO:0007165] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of another organism [GO:0031640]; signal transduction [GO:0007165] chemokine activity [GO:0008009] GO:0005615; GO:0005794; GO:0006935; GO:0007165; GO:0007267; GO:0008009; GO:0031640; GO:0061844 KLEMKPK 6.409999847 0.360791773 0.360791773 0.188794257 874.3513387 0 16.84071 0 0 13.38518 13.05828 10.49525 12.81575 17.06733 14.10739 0 0 0 0 0 0 0 17.45147 17.58713 16.6223 14.22745 0 17.47052 18.50286 17.27414 16.26979 0 13.30625 17.34599 17.07505 0 0 0 13.31924 14.70071 17.55906 17.62783 14.22472 13.7977 18.19546 14.1989 15.9687 0 0 17.20699 0 0 14.61614 O95721 SNP29_HUMAN "Synaptosomal-associated protein 29, SNAP-29 (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29)" SNAP29 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905] GO:0000139; GO:0000421; GO:0005484; GO:0005654; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006903; GO:0006906; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031629; GO:0035577; GO:0060271; GO:0061025; GO:0097352; GO:0098793 LDDTDPVPRGAGSAMSTDAYPK 3.400000095 0.015778787 0.015778787 0.198803722 2278.876869 0 14.53815 0 0 0 11.06548 13.33021 12.03867 0 17.90138 13.71526 0 0 0 0 15.26858 0 0 0 0 14.02236 0 0 0 13.74931 12.30435 0 11.85822 0 0 0 17.54543 0 0 8.645548 0 0 0 0 14.83548 12.04424 0 11.3071 13.63766 0 0 0 0 O95727 CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule (Class-I MHC-restricted T-cell-associated molecule) (CD antigen CD355) CRTAM Homo sapiens (Human) "adaptive immune response [GO:0002250]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; detection of tumor cell [GO:0002355]; establishment of T cell polarity [GO:0001768]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of activated T cell proliferation [GO:0046007]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of CD8-positive, alpha-beta T cell activation [GO:2001185]; regulation of T cell activation [GO:0050863]; regulation of T cell differentiation [GO:0045580]" immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; detection of tumor cell [GO:0002355]; establishment of T cell polarity [GO:0001768]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of activated T cell proliferation [GO:0046007]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of CD8-positive, alpha-beta T cell activation [GO:2001185]; regulation of T cell activation [GO:0050863]; regulation of T cell differentiation [GO:0045580]" identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] GO:0001768; GO:0001772; GO:0001819; GO:0002250; GO:0002355; GO:0002860; GO:0005102; GO:0005886; GO:0007157; GO:0008037; GO:0016021; GO:0032729; GO:0042802; GO:0045580; GO:0045954; GO:0046007; GO:0050863; GO:0051606; GO:0097021; GO:2001185 VIVLATPFKPILEASVIRK 1.039999962 0.549749196 0.549749196 1.38E-12 2093.876227 16.36327 0 0 0 14.21309 0 0 0 14.37355 0 15.57599 12.85833 0 0 0 0 0 0 0 0 0 0 0 0 15.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.98559 0 14.71434 15.68647 0 0 14.237 14.96642 O95741 CPNE6_HUMAN "Copine-6 (Copine VI) (Neuronal-copine, N-copine)" CPNE6 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0016020; GO:0030154; GO:0030424; GO:0030425; GO:0043204; GO:0045334; GO:0070062; GO:0071277; GO:1903861 VTKPLLLKNGK 7.619999886 1 1 0.289306358 1210.779917 0 15.98826 0 0 0 0 0 0 0 0 16.03514 0 0 0 0 0 14.92832 0 0 0 0 17.0553 0 17.89413 0 0 0 0 0 0 0 17.97469 0 0 0 18.78285 0 0 0 0 0 0 17.48978 0 0 16.05541 0 0 O95747 OXSR1_HUMAN "Serine/threonine-protein kinase OSR1, EC 2.7.11.1 (Oxidative stress-responsive 1 protein)" OXSR1 KIAA1101 OSR1 Homo sapiens (Human) cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0006468; GO:0006979; GO:0007165; GO:0007231; GO:0010820; GO:0018107; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0046777; GO:0070062; GO:0071476; GO:0106310; GO:1901017; GO:1990869 RPTAAELLR 4.789999962 1 1 0.217205675 1027.230799 0 16.43021 15.39114 14.70062 15.22257 0 0 16.63186 0 0 16.5442 0 0 0 0 0 0 0 0 13.314 0 0 0 15.54025 15.72413 15.45333 16.00417 15.04982 0 0 0 13.90252 12.50297 16.11652 15.40116 14.13636 15.69518 15.09317 0 15.80867 13.58888 14.91125 15.80869 14.5629 13.89724 15.08833 16.0665 12.62763 O95749 GGPPS_HUMAN "Geranylgeranyl pyrophosphate synthase, GGPP synthase, GGPPSase, EC 2.5.1.- ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase, EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase, EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase, EC 2.5.1.10)" GGPS1 Homo sapiens (Human) farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720] dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659] GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005654; GO:0005829; GO:0006720; GO:0008299; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872 NTLKELEAK 3.269999981 1 1 0.073995963 1046.454729 15.69018 0 0 13.1109 0 13.73359 0 15.68977 15.50692 19.12731 15.54225 13.05129 15.49768 0 13.35748 0 15.23447 0 0 14.94406 0 0 0 0 0 0 14.5673 0 0 0 0 0 0 0 0 0 11.47111 0 0 0 0 0 0 0 13.74743 0 0 0 O95750 FGF19_HUMAN "Fibroblast growth factor 19, FGF-19" FGF19 UNQ334/PRO533 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070] fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] GO:0001755; GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007399; GO:0007507; GO:0008083; GO:0008284; GO:0008543; GO:0009617; GO:0009887; GO:0010628; GO:0010629; GO:0014070; GO:0015721; GO:0030154; GO:0030334; GO:0045471; GO:0046326; GO:0046330; GO:0070374; GO:0070858 YLCMGADGK 3.380000114 0.725594223 0.725594223 0.220844976 1015.483198 16.22164 17.04546 15.9027 0 0 15.34825 15.85092 15.49151 15.84276 0 15.38961 15.05004 0 15.9639 0 0 0 15.37517 14.77676 13.59084 0 14.32629 0 16.9576 16.88827 16.01884 12.22908 15.76609 0 0 16.49917 16.32277 0 0 14.62261 0 14.13687 12.4897 15.08439 16.09326 0 13.66245 0 13.51976 15.81059 15.28898 16.19921 14.59513 O95757 HS74L_HUMAN "Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Heat-shock protein family A member 4-like protein, HSPA4-like protein) (Osmotic stress protein 94)" HSPA4L APG1 OSP94 Homo sapiens (Human) protein folding [GO:0006457]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986; GO:0016887 YMEHEERPK 6.360000134 0.049304262 0.049304262 1.37E-12 1218.213766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.48746 0 0 0 0 0 0 0 0 0 16.81952 15.64075 0 0 17.86407 0 0 16.62305 0 0 0 17.50613 0 0 0 0 0 0 0 0 0 0 18.41842 0 O95777 LSM8_HUMAN U6 snRNA-associated Sm-like protein LSm8 LSM8 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]" Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] "Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]" RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0016070; GO:0017070; GO:0046540; GO:0071005; GO:0071011; GO:0120115 TVAVITSDGR 3.660000086 0.638609707 0.638609707 0.131172367 1022.328823 0 0 0 15.80768 13.68336 0 14.52098 18.47568 14.44848 16.57547 0 15.30486 12.3696 16.91614 14.56401 0 14.38242 15.12349 0 0 13.60521 12.88109 13.24192 15.71061 14.1945 9.937032 14.41669 0 0 0 0 19.9114 0 0 0 14.75548 17.69913 0 16.69681 16.26404 15.75556 14.03551 18.53377 8.958298 14.36739 0 17.47774 16.83327 O95782 AP2A1_HUMAN AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886] AP-2 adaptor complex [GO:0030122]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901] GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0006898; GO:0009898; GO:0016020; GO:0016192; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0035615; GO:0036020; GO:0045334; GO:0050750; GO:0072583; GO:0098884; GO:0140312; GO:1900126 THIDTVINALK 5.380000114 0.470431149 0.470431149 0.169591522 1225.461162 14.96789 0 15.84419 14.79577 0 12.9322 0 0 0 0 0 15.53623 14.88281 0 0 0 0 15.38493 0 0 0 0 0 0 15.03667 0 0 0 16.26551 0 0 0 14.44287 15.08168 14.9895 12.67266 15.79028 9.039378 11.16652 15.86702 0 14.01295 0 13.13907 0 10.61438 0 15.69182 O95785 WIZ_HUMAN Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803) WIZ ZNF803 Homo sapiens (Human) positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]" GO:0000978; GO:0000981; GO:0001222; GO:0005634; GO:0005654; GO:0006357; GO:0010571; GO:0030496; GO:0044877; GO:0046872; GO:0050821; GO:0070062; GO:1990226 QKEHLLEHMSQHR 5.119999886 1 1 0.378510116 1687.634677 0 0 0 0 0 0 0 0 0 0 0 0 16.16486 0 0 0 0 0 0 0 16.37542 0 0 0 18.7399 0 0 0 11.34125 14.0061 15.98068 0 15.86599 0 18.60076 18.32221 15.66849 0 12.56223 13.97716 16.41158 15.2702 0 0 12.03339 15.34044 14.63814 0 O95786 DDX58_HUMAN "Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58, EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1, RLR-1) (Retinoic acid-inducible gene 1 protein, RIG-1) (Retinoic acid-inducible gene I protein, RIG-I)" DDX58 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0002230; GO:0002735; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 GMMAGAEK 13.14000034 1 1 4.67E-13 826.7686652 18.40273 16.64095 17.39499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71496 0 0 0 0 0 0 O95800 GPR75_HUMAN Probable G-protein coupled receptor 75 GPR75 Homo sapiens (Human) chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214] C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0016493; GO:0070098; GO:1901214 GNLEVNR 5.909999847 1 1 0.238632401 801.8418719 14.58352 15.24719 16.63137 0 0 15.35899 15.51708 0 0 0 0 0 0 0 0 16.77991 16.04236 16.23359 0 0 17.68694 0 0 0 0 0 0 0 0 15.83466 14.82914 16.42558 16.78363 0 0 14.36992 0 0 16.59563 14.0716 0 0 0 0 15.61686 0 0 0 O95801 TTC4_HUMAN "Tetratricopeptide repeat protein 4, TPR repeat protein 4" TTC4 My044 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; defense response to virus [GO:0051607]; innate immune response [GO:0045087] Hsp90 protein binding [GO:0051879] GO:0005634; GO:0005654; GO:0005737; GO:0045087; GO:0051607; GO:0051879 AIIRGALCHLELK 2.170000076 1 1 0.523010479 1494.137601 0 17.62559 0 0 0 0 0 0 15.38539 0 0 18.26373 18.33935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.09249 0 0 0 0 18.72355 0 0 0 0 0 16.32802 0 0 0 0 0 0 0 O95803 NDST3_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (Glucosaminyl N-deacetylase/N-sulfotransferase 3, NDST-3, hNDST-3) (N-heparan sulfate sulfotransferase 3, N-HSST 3) [Includes: Heparan sulfate N-deacetylase NDST3, EC 3.-.-.-; [heparan sulfate]-glucosamine N-sulfotransferase NDST3, EC 2.8.2.8 ]" NDST3 HSST3 UNQ2544/PRO4998 Homo sapiens (Human) "heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140] GO:0000139; GO:0005794; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0102140 VTKSSK 6.380000114 0.798466742 0.798466742 0.201988298 649.5517474 15.41305 14.15813 15.90545 14.83423 15.94758 15.85931 16.50725 16.14596 15.53406 0 0 15.20306 16.3958 16.71249 0 15.97168 0 0 16.30261 17.44144 17.51073 16.06311 16.73189 16.44427 16.44543 16.00505 17.68645 0 15.78036 16.37335 15.72303 17.6253 16.98124 14.96713 16.81663 17.13678 17.19385 0 17.51149 16.68419 15.98086 16.85462 16.51034 15.64443 16.80472 17.00739 16.39188 17.26626 O95816 BAG2_HUMAN "BAG family molecular chaperone regulator 2, BAG-2 (Bcl-2-associated athanogene 2)" BAG2 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821] axon [GO:0030424]; chaperone complex [GO:0101031]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588] axon [GO:0030424]; chaperone complex [GO:0101031]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821] adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] GO:0000774; GO:0005829; GO:0006457; GO:0010954; GO:0019538; GO:0030424; GO:0030425; GO:0031072; GO:0031397; GO:0031625; GO:0032091; GO:0042802; GO:0044325; GO:0048156; GO:0050821; GO:0051087; GO:0101031; GO:1901588; GO:1901800; GO:1904667 TLTVEVSVETIR 1.149999976 1 1 0.292855068 1347.547208 0 15.76207 13.88576 0 15.38707 17.37663 0 10.19413 14.38353 0 16.95013 15.75029 16.27047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.34865 0 16.02649 0 16.72805 16.48198 0 16.51442 0 0 15.4654 0 0 0 15.89085 0 16.18224 0 0 0 O95817 BAG3_HUMAN "BAG family molecular chaperone regulator 3, BAG-3 (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1)" BAG3 BIS Homo sapiens (Human) aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; spinal cord development [GO:0021510] aggresome [GO:0016235]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] aggresome [GO:0016235]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; spinal cord development [GO:0021510] adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877] GO:0000045; GO:0000774; GO:0001725; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0007420; GO:0008625; GO:0010664; GO:0016020; GO:0016235; GO:0021510; GO:0030018; GO:0034605; GO:0034620; GO:0042307; GO:0043005; GO:0043066; GO:0044877; GO:0045296; GO:0045505; GO:0046716; GO:0046827; GO:0050821; GO:0051087; GO:0061684; GO:0070842; GO:0071260; GO:0097192; GO:0097201; GO:0098840; GO:0101031; GO:0140597; GO:1903215; GO:1905337 DPLPPGWEIK 8.199999809 0.634471059 0.634471059 0.061505493 1152.654318 0 16.27839 0 0 15.68701 0 0 16.48167 0 0 12.17887 16.19303 17.94767 15.82443 15.97171 13.32932 18.46613 0 16.05329 0 16.0354 10.56811 16.85262 15.76556 16.69012 17.09752 15.58501 17.66281 0 16.33786 15.84075 17.51852 16.78209 16.30325 0 0 17.53453 16.5413 0 17.21478 0 19.94797 16.63927 15.5439 17.27301 17.85472 15.76625 0 O95819 M4K4_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 4, EC 2.7.11.1 (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4, MEK kinase kinase 4, MEKKK 4) (Nck-interacting kinase)" MAP4K4 HGK KIAA0687 NIK Homo sapiens (Human) intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; focal adhesion [GO:0005925] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408] ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0030335; GO:0032014; GO:0035556; GO:0043066; GO:0043408; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0106310; GO:0120183 VRSSSK 5 0.739954174 0.739954174 0.200275987 662.2386826 0 0 15.61723 0 0 0 0 15.94348 15.94894 15.5141 15.00472 0 0 15.95086 0 13.03313 0 15.1507 0 15.93171 0 0 17.48491 0 15.35062 16.38103 17.0411 14.87797 15.74826 16.23086 15.92727 0 0 16.32467 16.5582 16.76114 16.31355 17.35603 16.30512 17.14196 16.08722 17.67373 16.88499 14.9499 16.23513 16.03935 0 16.93151 O95822 DCMC_HUMAN "Malonyl-CoA decarboxylase, mitochondrial, MCD, EC 4.1.1.9" MLYCD Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931] identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080] GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006633; GO:0006637; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046321; GO:0050080; GO:2001294 LVRALQTPLMR 7.03000021 0.044998825 0.044998825 0.128066552 1293.080819 0 19.84267 0 14.06545 0 0 0 0 0 0 18.28795 0 0 0 0 0 0 0 14.19416 0 0 16.56736 15.83835 14.87559 0 16.3228 15.06631 0 0 18.09718 0 0 0 17.40295 0 0 16.56974 16.29292 0 0 0 0 0 17.95366 16.53379 0 0 11.5746 O95831 AIFM1_HUMAN "Apoptosis-inducing factor 1, mitochondrial, EC 1.6.99.- (Programmed cell death protein 8)" AIFM1 AIF PDCD8 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]" "DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]" GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0009636; GO:0012501; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045 CLIATGGTPR 4.409999847 1 1 0.181495261 1042.071602 0 0 0 0 0 0 16.01732 0 0 0 14.53945 0 15.08469 0 0 0 0 0 0 0 0 0 0 0 0 0 16.45365 0 0 0 0 0 15.70127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95835 LATS1_HUMAN "Serine/threonine-protein kinase LATS1, EC 2.7.11.1 (Large tumor suppressor homolog 1) (WARTS protein kinase, h-warts)" LATS1 WARTS Homo sapiens (Human) cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819] ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0017015; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:0106310; GO:1900181; GO:2000058 QQSASYIPK 13.88000011 0.808553874 0.808553874 0.000317622 1022.109316 15.95036 14.57415 0 16.80984 15.94857 13.31959 12.14068 16.34452 16.09412 14.82049 17.49029 15.82757 15.63024 16.11421 15.45298 16.37535 13.38564 14.95784 15.63026 11.96448 17.16991 14.72493 13.90095 16.75173 17.57554 15.28106 15.2188 12.84289 15.71525 17.0658 15.07214 17.54424 17.50309 14.75975 16.8576 16.81763 17.27043 15.72154 14.71649 16.72013 16.24851 0 13.70364 0 16.3753 16.94182 12.85777 16.82541 O95837 GNA14_HUMAN "Guanine nucleotide-binding protein subunit alpha-14, G alpha-14, G-protein subunit alpha-14" GNA14 Homo sapiens (Human) action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; signal transduction [GO:0007165] G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0031683; GO:0046872; GO:0060158; GO:0070062 AMDTLRIQYVCEQNK 4.21999979 1 1 0.073852732 1878.196722 0 13.89927 0 0 0 0 14.15879 0 15.01165 0 0 14.53511 14.79129 0 0 0 0 0 0 0 0 0 14.27415 0 0 0 0 12.80354 0 0 0 0 0 0 0 0 13.55181 0 0 10.69519 13.05667 0 0 16.1745 0 0 0 14.7347 O95838 GLP2R_HUMAN "Glucagon-like peptide 2 receptor, GLP-2 receptor, GLP-2-R, GLP-2R" GLP2R Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046] GO:0004930; GO:0004967; GO:0005886; GO:0007166; GO:0007188; GO:0008284; GO:0008528; GO:0016021; GO:0017046 LLISKLK 29.79000092 0.309883833 0.309883833 0.129702063 814.5860129 0 0 0 0 17.14733 16.74262 17.74254 17.00322 17.66695 17.80157 17.33864 0 16.72708 16.81095 0 17.09252 0 0 17.06565 0 0 0 0 0 0 0 17.89421 0 0 0 0 0 0 0 17.37006 0 16.33263 16.89855 0 0 0 0 0 16.94099 0 0 17.49522 0 O95841 ANGL1_HUMAN "Angiopoietin-related protein 1 (Angiopoietin-3, ANG-3) (Angiopoietin-like protein 1)" ANGPTL1 ANG3 ANGPT3 ARP1 PSEC0154 UNQ162/PRO188 Homo sapiens (Human) transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] signaling receptor binding [GO:0005102] GO:0005102; GO:0005615; GO:0007169; GO:0062023; GO:0070062 GGQFKIK 7.980000019 1 1 0.311879665 775.4301705 0 0 0 0 17.55709 18.44908 0 0 17.77337 0 0 0 0 0 0 0 18.73898 0 0 0 0 18.3271 0 0 19.00055 0 0 18.31522 0 0 0 16.8742 0 18.25186 0 19.7296 0 0 0 0 0 0 0 0 0 0 18.55632 17.6586 O95847 UCP4_HUMAN "Mitochondrial uncoupling protein 4, UCP 4 (Solute carrier family 25 member 27)" SLC25A27 UCP4 UNQ772/PRO1566 Homo sapiens (Human) response to cold [GO:0009409] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; response to cold [GO:0009409] GO:0005739; GO:0005743; GO:0009409; GO:0016021; GO:0031966 MVTYEHLR 18 1 1 0.387096532 1044.281849 0 16.70175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.62236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95861 BPNT1_HUMAN "3'(2'),5'-bisphosphate nucleotidase 1, EC 3.1.3.7 (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase, PIP)" BPNT1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829] "cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]" "3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]" GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046855; GO:0046872; GO:0050427 SHSNK 5.150000095 1 1 0.241083869 572.0174553 15.35039 0 0 13.23923 0 0 15.45768 0 0 0 0 14.91589 15.50322 14.04893 0 0 14.26983 0 0 0 16.21442 17.38887 6.087514 0 15.45362 17.28366 17.28305 14.73509 15.88408 16.36284 0 16.75247 15.18846 17.37044 17.11207 16.91549 15.91478 16.08609 13.7157 16.28346 14.95821 15.52802 0 14.75967 16.27157 15.84093 0 16.70075 O95865 DDAH2_HUMAN "N(G),N(G)-dimethylarginine dimethylaminohydrolase 2, DDAH-2, Dimethylarginine dimethylaminohydrolase 2, EC 3.5.3.18 (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)" DDAH2 DDAH G6A NG30 Homo sapiens (Human) arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of apoptotic process [GO:0043066]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of apoptotic process [GO:0043066]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999] amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403] GO:0000052; GO:0003824; GO:0005739; GO:0005829; GO:0006525; GO:0006527; GO:0006809; GO:0007263; GO:0016403; GO:0016597; GO:0043066; GO:0045429; GO:0050999; GO:0070062 AGAGLSSLCLVLSTRPHS 6.079999924 1 1 0.311986504 1826.146116 14.83771 13.48619 0 0 0 0 14.32591 14.77384 0 0 14.20981 17.14364 14.23321 12.63896 13.24988 0 13.85708 12.57608 0 0 0 16.43441 0 15.89381 0 0 0 0 0 0 15.55066 0 0 0 0 15.64236 15.78821 15.81244 16.6547 16.10367 14.27334 13.22347 14.79447 15.69551 0 0 0 0 O95876 FRITZ_HUMAN "WD repeat-containing and planar cell polarity effector protein fritz homolog, hFRTZ (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein)" WDPCP BBS15 C2orf86 FRITZ Homo sapiens (Human) auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; glomerular visceral epithelial cell migration [GO:0090521]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587] axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886] axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886]; auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; glomerular visceral epithelial cell migration [GO:0090521]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587] GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114 MESSDVNKR 18.67000008 1 1 0.195209141 1065.590916 16.48212 14.94889 0 15.11555 0 0 0 15.82733 0 15.04228 15.26185 0 9.789246 15.66847 0 0 0 0 14.61015 12.46377 0 13.15853 16.08866 0 14.7005 14.88608 0 0 9.533054 0 14.89128 15.6442 0 0 15.39183 13.63592 0 0 14.80558 13.93662 0 13.18041 0 0 0 0 0 15.7077 O95886 DLGP3_HUMAN "Disks large-associated protein 3, DAP-3 (PSD-95/SAP90-binding protein 3) (SAP90/PSD-95-associated protein 3, SAPAP3)" DLGAP3 DAP3 Homo sapiens (Human) modification of synaptic structure [GO:0099563]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572] cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090]; modification of synaptic structure [GO:0099563]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090] GO:0001540; GO:0005886; GO:0014069; GO:0023052; GO:0031594; GO:0060090; GO:0098962; GO:0098978; GO:0098981; GO:0099563; GO:0099572 ASPKPPTLIIKTIPGR 8 1 1 0.278350354 1690.135834 0 0 15.36632 0 15.49058 0 16.22827 0 0 13.49407 0 0 0 0 0 15.60993 0 0 0 0 0 0 15.63166 0 0 15.81726 0 0 0 0 0 0 0 0 0 0 15.29086 0 0 14.42096 16.42755 0 0 0 0 0 0 0 O95900 TRUB2_HUMAN "Pseudouridylate synthase TRUB2, mitochondrial, EC 5.4.99.- (TruB pseudouridine synthase homolog 2) (tRNA pseudouridine 55 synthase TRUB2, Psi55 synthase TRUB2, EC 5.4.99.25)" TRUB2 Homo sapiens (Human) mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0009982; GO:0035770; GO:0070131; GO:1990481 GSAGLSRLHGLFAVYKPPGLK 2.130000114 1 1 0.020513209 2167.525338 10.33776 0 11.73155 13.06337 0 13.09083 0 0 12.54711 0 0 13.59439 0 0 0 0 0 0 0 0 0 12.27892 0 0 0 0 0 0 0 0 0 11.84501 16.51939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95907 MOT3_HUMAN "Monocarboxylate transporter 3, MCT 3 (Solute carrier family 16 member 8)" SLC16A8 MCT3 Homo sapiens (Human) lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718] lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0015727; GO:0016020; GO:0016021; GO:0016323; GO:0016324 MGAGGPR 6.409999847 0.029761037 0.029761037 0.236232035 660.8611872 0 15.41947 14.38598 0 14.77939 0 0 0 0 0 15.96387 13.10709 0 0 0 16.19494 13.65635 16.47326 0 0 0 0 0 0 0 14.82606 15.94089 0 0 16.44119 0 12.53014 16.78135 16.6356 0 16.81032 15.8835 17.50904 15.41939 16.43194 0 16.8699 16.84536 0 0 16.10707 16.56726 0 O95926 SYF2_HUMAN Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29) SYF2 CBPIN GCIPIP Homo sapiens (Human) "embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]" RNA binding [GO:0003723] GO:0000398; GO:0000974; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0007095; GO:0007369; GO:0008284; GO:0016607; GO:0048568; GO:0071007; GO:0071013; GO:0071014 KLNHQEVVEEDK 10.60999966 0.977494299 0.977494299 0.586580537 1468.520466 0 19.14101 16.41913 0 18.55845 0 0 19.74071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.43762 18.62581 0 20.35015 17.4681 18.99611 0 0 19.15004 0 0 0 0 0 19.38059 17.05991 20.19192 0 0 0 0 0 0 0 O95932 TGM3L_HUMAN "Protein-glutamine gamma-glutamyltransferase 6, EC 2.3.2.13 (Transglutaminase Y, TGY, TGase Y) (Transglutaminase-3-like, TGase-3-like) (Transglutaminase-6, TG6, TGase-6)" TGM6 TGM3L Homo sapiens (Human) peptide cross-linking [GO:0018149] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149] metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] GO:0003810; GO:0005737; GO:0018149; GO:0046872 AVGSDSR 2.660000086 1 1 0.304429486 691.9130144 0 14.81809 16.11071 15.06834 15.55842 15.6195 0 16.3744 16.70091 14.74343 15.7593 0 0 15.01649 10.79514 16.00987 14.82017 14.82404 15.58749 0 16.34794 0 0 15.061 16.52767 0 16.0109 15.90356 0 15.47695 0 0 0 15.44565 0 0 8.162158 0 0 16.00911 16.24069 16.54907 15.92818 15.01733 15.82501 15.6356 14.98645 15.73149 O95936 EOMES_HUMAN "Eomesodermin homolog (T-box brain protein 2, T-brain-2, TBR-2)" EOMES TBR2 Homo sapiens (Human) "adaptive immune response [GO:0002250]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001706; GO:0001707; GO:0001708; GO:0001714; GO:0001829; GO:0002250; GO:0002302; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007420; GO:0010002; GO:0019827; GO:0021772; GO:0021796; GO:0021895; GO:0035914; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0048382; GO:0060706; GO:0060809; GO:0061629; GO:1990837 VKEEIGSSWIETPPSIK 4.869999886 0.4177773 0.4177773 0.126772741 1894.711582 15.41275 15.3959 17.62996 0 16.77877 7.746377 0 15.46987 15.09443 0 16.69133 17.4604 14.93978 0 13.46154 0 15.30373 14.12297 15.06218 14.37843 15.29746 17.46715 16.78361 0 16.05636 15.72532 15.85507 12.04138 10.37851 15.37088 0 0 0 16.78003 16.68731 14.24017 16.77326 14.98544 0 15.38629 13.02406 0 15.81806 0 0 16.28443 11.07809 16.52376 O95944 NCTR2_HUMAN "Natural cytotoxicity triggering receptor 2 (Lymphocyte antigen 95 homolog) (NK cell-activating receptor) (Natural killer cell p44-related protein, NK-p44, NKp44) (CD antigen CD336)" NCR2 LY95 Homo sapiens (Human) cellular defense response [GO:0006968]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; signal transduction [GO:0007165] signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0038023 LVTSSKPR 7.820000172 1 1 0.281942802 887.1968621 14.46002 14.48709 15.74744 9.049343 13.88776 0 15.64137 14.69142 0 14.94571 15.46509 15.4033 0 0 0 0 15.08828 0 15.63811 0 0 0 16.46232 0 0 0 0 17.10362 14.6463 14.26861 0 0 15.37373 15.88087 14.92375 15.47958 0 14.60453 16.33748 0 0 0 0 0 15.39532 16.19009 15.74287 0 O95965 ITGBL_HUMAN Integrin beta-like protein 1 (Osteoblast-specific cysteine-rich protein) (Ten integrin EGF-like repeat domain-containing protein) ITGBL1 OSCP TIED Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] integrin binding [GO:0005178] GO:0005178; GO:0005576; GO:0005886; GO:0005925; GO:0007155; GO:0007160; GO:0007229; GO:0016477; GO:0033627 GSCHCGK 11.09000015 1 1 0.02722007 805.7588078 13.31949 12.95505 0 18.56709 16.42013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.19669 0 14.63657 0 16.16065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95972 BMP15_HUMAN "Bone morphogenetic protein 15, BMP-15 (Growth/differentiation factor 9B, GDF-9B)" BMP15 GDF9B Homo sapiens (Human) BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]; BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698] GO:0001541; GO:0005125; GO:0005615; GO:0005788; GO:0007292; GO:0008083; GO:0010862; GO:0030509; GO:0060016; GO:0060395; GO:0070698 VLLSILR 10.68000031 0.018590171 0.018590171 0.296527385 814.2671487 0 17.16137 0 0 0 0 17.95605 0 21.38138 0 0 19.01511 16.95337 0 0 17.78555 0 19.91516 0 16.1936 18.54481 16.45071 18.13908 0 16.58642 0 18.15518 16.77624 0 0 0 16.52141 0 0 0 0 0 0 0 0 0 0 0 0 17.14022 16.68848 0 0 O95985 TOP3B_HUMAN "DNA topoisomerase 3-beta-1, EC 5.6.2.1 (DNA topoisomerase III beta-1)" TOP3B TOP3B1 Homo sapiens (Human) chromosome segregation [GO:0007059]; DNA topological change [GO:0006265] condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634] "condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]" "DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]" GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059; GO:0140225 KFHYFVDSIAGMDELMEVSFSPLAATGKPLSR 1.440000057 1 1 0.104287196 3559.55376 0 0 0 0 13.53921 15.00594 0 15.34278 14.21086 0 0 0 0 14.70533 0 12.82042 10.53826 13.48866 7.19164 0 11.52916 0 0 12.9256 12.0344 14.66412 0 0 0 0 13.6032 14.9867 11.18315 9.567358 13.05474 11.66383 12.03897 0 0 0 9.192397 0 0 14.87063 0 13.0924 0 14.63916 O95988 TCL1B_HUMAN "T-cell leukemia/lymphoma protein 1B (Oncogene TCL-1B, Oncogene TCL1B) (SYN-1) (Syncytiotrophoblast-specific protein) (TCL1/MTCP1-like protein 1)" TCL1B TCL1 Homo sapiens (Human) positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902] protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] GO:0019901; GO:0032991; GO:0033138; GO:0043539; GO:0071902 LGVPPGRLWIQRPGIYEDEEGR 4.630000114 1 1 0 2539.031029 0 0 14.9833 0 0 14.63862 0 10.09247 0 0 0 0 13.66513 0 0 0 0 12.45396 11.78562 0 0 0 0 0 11.28968 13.11453 11.85787 0 0 11.89314 0 0 0 11.50501 0 13.50751 0 14.29615 0 0 0 0 0 0 0 0 0 0 O95990 F107A_HUMAN Actin-associated protein FAM107A (Down-regulated in renal cell carcinoma 1) (Protein TU3A) FAM107A DRR1 TU3A Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647] actin binding [GO:0003779] GO:0001558; GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005925; GO:0007049; GO:0015629; GO:0016607; GO:0030041; GO:0030335; GO:0031398; GO:0031647; GO:0031669; GO:0032587; GO:0032956; GO:0043005; GO:0045202; GO:0050890; GO:0051017; GO:0051895; GO:0070507; GO:0071385; GO:1900272; GO:2000134 ELLMNHRR 6.059999943 1 1 6.89E-13 1085.015087 14.06175 0 13.53836 0 13.15033 0 15.67974 12.65292 15.02206 0 0 16.96649 0 15.7948 0 0 0 0 0 0 0 0 15.58123 0 0 0 0 14.92959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95996 APCL_HUMAN "Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like, APC-like)" APC2 APCL Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055] actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794] actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017] GO:0000226; GO:0001708; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0016477; GO:0030496; GO:0030877; GO:0031258; GO:0043161; GO:0045171; GO:0045295; GO:0045595; GO:0045732; GO:0048471; GO:0090090; GO:0090630; GO:0098794 AAPAAPPPAR 6.199999809 1 1 0.445890719 918.8138577 15.79459 13.83802 0 14.89408 14.29891 0 0 0 0 0 16.3126 15.19935 14.75659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.13204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95997 PTTG1_HUMAN "Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein, Tumor-transforming protein 1, hPTTG)" PTTG1 EAP1 PTTG TUTR1 Homo sapiens (Human) cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; SH3 domain binding [GO:0017124]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816]; spermatogenesis [GO:0007283] cysteine-type endopeptidase inhibitor activity [GO:0004869]; SH3 domain binding [GO:0017124] GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0007283; GO:0017124; GO:0045143; GO:0051276; GO:0051301; GO:2000816 ALDGRSQVSTPR 5.5 1 1 0.523816786 1287.389331 0 0 0 0 0 0 0 0 0 17.76223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95999 BCL10_HUMAN "B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10, Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein, hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER) (Cellular homolog of vCARMEN, cCARMEN) (Cellular-E10, c-E10) (Mammalian CARD-containing adapter molecule E10, mE10)" BCL10 CIPER CLAP Homo sapiens (Human) "adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cell death [GO:0008219]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]" CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991] "CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cell death [GO:0008219]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]" CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] GO:0001772; GO:0001783; GO:0001843; GO:0002020; GO:0002096; GO:0002224; GO:0002250; GO:0002906; GO:0003713; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005881; GO:0006968; GO:0007249; GO:0008022; GO:0008219; GO:0016064; GO:0019899; GO:0019900; GO:0019901; GO:0031398; GO:0031625; GO:0031663; GO:0032094; GO:0032449; GO:0032755; GO:0032757; GO:0032761; GO:0032765; GO:0032991; GO:0033674; GO:0042327; GO:0042802; GO:0043065; GO:0043123; GO:0043280; GO:0043422; GO:0043621; GO:0044877; GO:0045087; GO:0045121; GO:0045893; GO:0048471; GO:0050700; GO:0050852; GO:0050862; GO:0050870; GO:0051059; GO:0051092; GO:0051260; GO:0061760; GO:0070231; GO:0071222; GO:0071260; GO:0140296; GO:2001238 SNSDESNFSEK 4.670000076 0.126180768 0.126180768 0.139108239 1244.049423 15.53675 0 13.91001 0 8.843431 0 0 11.99086 0 0 9.687071 0 0 0 0 15.56961 0 0 0 0 0 13.61032 14.7036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96005 CLPT1_HUMAN Cleft lip and palate transmembrane protein 1 CLPTM1 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081] GO:0005887; GO:0009897; GO:0016020; GO:0030154; GO:0033081 TKNLLTGETEADPEMIK 3.99000001 1 1 0.301242539 1888.357992 12.64775 14.43223 0 10.13172 0 0 0 0 13.75959 15.13181 0 14.50384 14.92611 13.19313 15.35512 0 0 0 0 0 15.919 0 0 0 0 14.45625 15.97369 0 0 12.75114 0 15.81905 0 0 0 0 0 0 0 0 0 0 0 14.20556 0 0 15.78245 0 O96006 ZBED1_HUMAN "E3 SUMO-protein ligase ZBED1, EC 2.3.2.- (DNA replication-related element-binding factor) (Putative Ac-like transposable element) (Zinc finger BED domain-containing protein 1) (dREF homolog)" ZBED1 ALTE DREF hDREF KIAA0785 TRAMP Homo sapiens (Human) "negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0016605; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0044828; GO:0045944; GO:0046872; GO:0046983; GO:0061665; GO:1990466; GO:1990837 QQNVAHCMLVSNR 7.130000114 1 1 0.236044818 1572.166839 14.26924 12.29658 11.2416 0 14.01386 14.2438 0 0 11.1823 0 0 14.70225 13.5763 11.81735 12.6792 14.45984 0 14.04109 13.37583 0 0 15.18738 14.59275 12.84836 0 14.2693 0 0 14.0074 0 0 0 15.26368 14.87399 15.28161 14.54386 0 0 0 15.1222 16.04351 12.51557 16.70074 0 0 0 0 0 O96015 DNAL4_HUMAN Dynein axonemal light chain 4 DNAL4 Homo sapiens (Human) microtubule-based movement [GO:0007018] cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886] cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0030286; GO:0042802; GO:0045505; GO:0051959 HSDMPEEMR 1.600000024 0.49560377 0.49560377 0.214951681 1151.394076 12.3102 12.9148 16.03054 14.10201 13.78414 13.64403 12.21355 0 13.75393 0 0 15.79281 0 15.87411 0 15.34383 0 0 0 0 0 0 16.64534 15.72207 13.94171 16.1273 15.56056 0 0 14.41182 17.25233 0 0 0 0 0 0 0 0 0 14.96662 0 0 0 0 14.83315 0 0 O96017 CHK2_HUMAN "Serine/threonine-protein kinase Chk2, EC 2.7.11.1 (CHK2 checkpoint homolog) (Cds1 homolog, Hucds1, hCds1) (Checkpoint kinase 2)" CHEK2 CDS1 CHK2 RAD53 Homo sapiens (Human) "cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]" cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]" ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] GO:0000077; GO:0000086; GO:0001934; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016605; GO:0018105; GO:0019901; GO:0031573; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071466; GO:0071480; GO:0090307; GO:0090399; GO:0106310; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210 EATCK 8.739999771 0.707006812 0.707006812 0.277571203 608.2416099 13.3556 11.49946 16.06059 15.23335 14.51102 0 16.3083 0 0 0 16.89395 16.34989 15.61362 14.25199 17.47262 16.11345 15.71172 16.92599 0 0 16.38233 13.89969 0 15.09315 0 0 14.81942 16.11834 15.7837 0 17.12353 17.30782 16.77774 16.44945 16.53063 16.90333 0 17.74215 17.70793 17.11448 0 16.63233 16.49358 18.18866 17.29434 18.02908 18.79507 17.66537 O96020 CCNE2_HUMAN G1/S-specific cyclin-E2 CCNE2 Homo sapiens (Human) cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723] centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] GO:0000079; GO:0000082; GO:0000307; GO:0000723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006270; GO:0007129; GO:0016538; GO:0019901; GO:0032880; GO:0044772; GO:0051301; GO:0097134; GO:0097135 FMLTQK 16 0.885327697 0.885327697 0.222918117 769.6312672 0 16.91456 15.74623 14.90461 17.114 0 15.83934 14.8943 16.42812 16.43047 16.09135 15.49307 13.07109 0 13.71838 14.2086 13.82942 18.2167 16.17593 0 0 0 15.03119 0 16.81368 0 16.6372 15.85734 0 0 0 0 15.007 0 0 15.36593 16.98142 0 0 15.37969 15.80064 15.77628 0 15.51784 15.78952 0 18.01154 15.11179 O96028 NSD2_HUMAN "Histone-lysine N-methyltransferase NSD2, EC 2.1.1.357 (Multiple myeloma SET domain-containing protein, MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)" NSD2 KIAA1090 MMSET TRX5 WHSC1 Homo sapiens (Human) "atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]" chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565] GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006325; GO:0006355; GO:0018024; GO:0042799; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:2001032 GNYSR 1.600000024 1 1 0.084341105 593.6088819 15.50884 15.20111 11.90899 14.26039 0 13.88243 0 0 16.19829 14.97399 12.4285 0 13.89663 15.31296 12.84019 16.64923 14.61927 0 16.87613 16.44202 0 17.04613 16.12659 16.69713 16.54662 15.25236 0 0 16.47837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.07191 0 P00325 ADH1B_HUMAN "All-trans-retinol dehydrogenase [NAD(+)] ADH1B, EC 1.1.1.105 (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta)" ADH1B ADH2 Homo sapiens (Human) ethanol oxidation [GO:0006069]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]" "alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]" GO:0001523; GO:0004024; GO:0004745; GO:0005654; GO:0005829; GO:0005886; GO:0006069; GO:0008270; GO:0042572; GO:0042573 EGIPKLVADFMAK 8.760000229 1 1 0.231534261 1433.893112 15.87949 14.80612 0 14.98468 14.71394 13.57458 0 16.08062 13.63027 0 11.4483 15.01103 14.84946 0 12.96183 0 0 0 0 0 0 0 0 16.23063 16.32804 15.73832 0 15.42349 0 0 0 0 0 12.25008 0 0 16.99835 0 0 0 0 0 0 0 15.62411 0 15.52006 0 P00352 AL1A1_HUMAN "Aldehyde dehydrogenase 1A1, EC 1.2.1.19, EC 1.2.1.28, EC 1.2.1.3, EC 1.2.1.36 (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1, RALDH 1, RalDH1)" ALDH1A1 ALDC ALDH1 PUMB1 Homo sapiens (Human) cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; 3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]; cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] 3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758] GO:0001523; GO:0001758; GO:0004029; GO:0005096; GO:0005497; GO:0005737; GO:0005829; GO:0006081; GO:0009449; GO:0018479; GO:0019145; GO:0030392; GO:0030424; GO:0036438; GO:0042572; GO:0043878; GO:0045202; GO:0051287; GO:0070062; GO:0106373; GO:0110095; GO:0120163 DRLLLATMESMNGGK 5.610000134 0.309017271 0.309017271 0.43549218 1656.628368 15.79446 14.35974 13.40374 0 15.6033 15.97759 0 15.62756 0 17.46737 13.95096 0 0 0 15.5235 0 15.22248 0 15.44327 0 0 0 0 0 0 0 0 0 0 0 0 15.42291 0 0 0 17.71263 13.08643 0 0 15.79241 16.11129 0 16.95329 0 0 15.33449 0 0 P00374 DYR_HUMAN "Dihydrofolate reductase, EC 1.5.1.3" DHFR Homo sapiens (Human) axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653] cytosol [GO:0005829]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]" "dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]" GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005739; GO:0005829; GO:0006545; GO:0006729; GO:0006730; GO:0017148; GO:0031103; GO:0031427; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661; GO:0051000; GO:0070402; GO:1990825; GO:2000121 VGSLNCIVAVSQNMGIGK 2.430000067 0.043809082 0.043809082 0.53574054 1864.399252 16.85336 0 0 0 15.29065 0 18.68001 0 0 17.61236 0 0 0 18.24322 0 0 0 0 16.42083 0 0 0 0 0 0 0 0 0 0 17.90273 0 0 0 0 0 0 0 0 0 0 0 17.08329 0 0 0 0 0 16.41437 P00450 CERU_HUMAN "Ceruloplasmin, EC 1.16.3.1 (Ferroxidase)" CP Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491] GO:0004322; GO:0005507; GO:0005576; GO:0005615; GO:0005765; GO:0005788; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0016491; GO:0051087; GO:0055072; GO:0070062; GO:0072562 DNEDFQESNR 9.340000153 0.996593177 0.996593177 0.338246075 1253.87013 0 15.47017 13.73197 15.37011 14.8294 15.84739 12.65066 14.19061 13.62177 15.75758 0 14.89973 15.81009 0 13.81502 15.03412 10.76392 15.00744 13.38825 0 0 0 0 0 14.74003 16.84193 14.63614 16.27914 15.30892 16.4542 0 0 16.11819 17.91216 0 0 0 17.31161 0 0 16.73774 0 15.21968 16.7869 0 0 0 15.94927 P00451 FA8_HUMAN "Coagulation factor VIII (Antihemophilic factor, AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain ]" F8 F8C Homo sapiens (Human) "acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370] "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007596; GO:0007597; GO:0016020; GO:0016491; GO:0030134; GO:0031093; GO:0031638; GO:0032991; GO:0033116; GO:1905370 EGPIPPDAQNPDMSFFK 12.10000038 1 1 0.34770198 1904.693699 18.66834 0 0 0 0 0 17.22464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00488 F13A_HUMAN "Coagulation factor XIII A chain, Coagulation factor XIIIa, EC 2.3.2.13 (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)" F13A1 F13A Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; transferase complex [GO:1990234] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]" metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] GO:0003810; GO:0005576; GO:0005615; GO:0007596; GO:0018149; GO:0031093; GO:0046872; GO:0062023; GO:0072378; GO:0072562; GO:1990234 CGPASVQAIK 2.109999895 1 1 0.219729649 1030.324754 18.38947 0 16.96093 0 19.62103 0 17.26704 0 0 0 0 16.9847 0 0 0 0 0 0 0 0 0 17.31578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.28524 0 0 0 0 16.64935 0 0 0 16.78802 17.29694 P00491 PNPH_HUMAN "Purine nucleoside phosphorylase, PNP, EC 2.4.2.1 (Inosine phosphorylase) (Inosine-guanosine phosphorylase)" PNP NP Homo sapiens (Human) allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731] GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813 QMGEQR 5.840000153 1 1 0.022505402 748.371868 10.3404 13.0824 14.84119 15.60275 14.11516 15.57943 0 0 15.03675 16.61737 0 15.25465 13.47726 14.58729 16.48377 0 14.96199 14.74835 0 12.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.34667 0 P00505 AATM_HUMAN "Aspartate aminotransferase, mitochondrial, mAspAT, EC 2.6.1.1, EC 2.6.1.7 (Fatty acid-binding protein, FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein, FABPpm) (Transaminase A)" GOT2 KYAT4 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471] kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723] GO:0003723; GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0015908; GO:0016212; GO:0019470; GO:0019550; GO:0019551; GO:0030170; GO:0045471; GO:0070062 DAGMQLQGYR 10.34000015 0.219042182 0.219042182 0.112618125 1155.510016 0 14.35272 0 14.12096 0 12.78555 14.70073 0 0 14.96473 17.64238 0 12.9916 15.24338 11.12393 15.7804 13.98435 0 13.33961 0 12.24595 14.1215 0 0 15.05827 17.71877 16.21503 0 14.50677 14.08304 0 16.54463 0 0 0 14.82403 0 14.11356 15.07148 13.46128 0 12.49712 15.74435 14.84293 0 0 15.71392 0 P00519 ABL1_HUMAN "Tyrosine-protein kinase ABL1, EC 2.7.10.2 (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)" ABL1 ABL JTK7 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]" actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713] GO:0000278; GO:0000287; GO:0000400; GO:0000405; GO:0001726; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0003677; GO:0003713; GO:0003785; GO:0004515; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006298; GO:0006355; GO:0006464; GO:0006468; GO:0006897; GO:0006914; GO:0006974; GO:0006975; GO:0006979; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008306; GO:0008630; GO:0009410; GO:0009791; GO:0010506; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030041; GO:0030100; GO:0030145; GO:0030155; GO:0030425; GO:0030426; GO:0030514; GO:0030516; GO:0031113; GO:0031965; GO:0032489; GO:0032729; GO:0032743; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0034599; GO:0034976; GO:0035791; GO:0038083; GO:0038096; GO:0038189; GO:0038191; GO:0042169; GO:0042770; GO:0042981; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043525; GO:0043542; GO:0045184; GO:0045580; GO:0045907; GO:0045930; GO:0045931; GO:0045944; GO:0046632; GO:0046777; GO:0046875; GO:0048146; GO:0048471; GO:0048536; GO:0048538; GO:0048668; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051726; GO:0051882; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070097; GO:0070301; GO:0070373; GO:0070374; GO:0071103; GO:0071222; GO:0071560; GO:0071871; GO:0071901; GO:0072359; GO:0090050; GO:0090135; GO:0098794; GO:1900006; GO:1900026; GO:1900272; GO:1900275; GO:1901300; GO:1902036; GO:1903055; GO:1903210; GO:1903351; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000145; GO:2000249; GO:2000251; GO:2000352; GO:2000773; GO:2001020 AGSGAPGGTSKGPAEESR 5.989999771 1 1 0.130345519 1616.864975 15.46117 0 0 13.03084 15.14676 13.32858 13.47115 0 14.91549 0 13.69406 13.84152 0 15.41421 13.04752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.16493 0 0 0 P00533 EGFR_HUMAN "Epidermal growth factor receptor, EC 2.7.10.1 (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)" EGFR ERBB ERBB1 HER1 Homo sapiens (Human) "activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]" "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618] GO:0000139; GO:0000902; GO:0001503; GO:0001618; GO:0001892; GO:0001934; GO:0001942; GO:0003682; GO:0003690; GO:0004709; GO:0004712; GO:0004713; GO:0004714; GO:0004888; GO:0005006; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0007165; GO:0007166; GO:0007169; GO:0007173; GO:0007202; GO:0007435; GO:0007611; GO:0008284; GO:0009925; GO:0009986; GO:0010008; GO:0010750; GO:0014066; GO:0016020; GO:0016323; GO:0018108; GO:0019899; GO:0019900; GO:0019903; GO:0021795; GO:0030054; GO:0030154; GO:0030307; GO:0030335; GO:0030669; GO:0031625; GO:0031901; GO:0031965; GO:0032587; GO:0032991; GO:0033138; GO:0033674; GO:0034614; GO:0038083; GO:0042059; GO:0042177; GO:0042327; GO:0042802; GO:0043006; GO:0043066; GO:0043235; GO:0043406; GO:0045121; GO:0045296; GO:0045737; GO:0045739; GO:0045740; GO:0045893; GO:0045944; GO:0046328; GO:0046777; GO:0048146; GO:0048408; GO:0048471; GO:0048546; GO:0050679; GO:0050730; GO:0050999; GO:0051015; GO:0051117; GO:0051205; GO:0051897; GO:0060571; GO:0061029; GO:0070141; GO:0070372; GO:0070374; GO:0070435; GO:0071230; GO:0071276; GO:0071364; GO:0071392; GO:0090263; GO:0097489; GO:0097708; GO:0098609; GO:1900020; GO:1900087; GO:1901224; GO:1903078; GO:1903800; GO:1905208 GMNYLEDR 3.99000001 0.354091287 0.354091287 0.284624116 1014.005472 16.65443 16.84907 15.44893 15.09824 0 15.92044 0 16.08417 17.66381 16.01744 0 0 14.50589 15.44144 0 0 14.29262 15.86395 0 0 0 0 15.01369 14.83849 16.47785 13.45772 0 0 0 0 0 0 0 17.37873 16.72512 0 0 0 17.59175 15.68133 0 0 17.18006 0 15.82936 0 16.53583 0 P00568 KAD1_HUMAN "Adenylate kinase isoenzyme 1, AK 1, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)" AK1 Homo sapiens (Human) ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550] GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0006172; GO:0009142; GO:0015949; GO:0046033; GO:0046034; GO:0070062 RGETSGR 9.920000076 0.435549438 0.435549438 0.204385873 761.9273154 10.82939 16.06046 0 14.61098 17.87547 0 14.4097 0 13.52161 0 0 0 0 15.57925 0 0 14.37688 15.48763 0 0 15.41719 15.28546 17.37808 0 0 0 16.46365 0 0 0 18.22966 16.98073 16.35473 0 0 15.12523 0 0 15.70564 0 0 0 16.33411 0 16.95558 0 0 0 P00736 C1R_HUMAN "Complement C1r subcomponent, EC 3.4.21.41 (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain ]" C1R Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]" blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]" calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004252; GO:0005509; GO:0005576; GO:0005602; GO:0005615; GO:0006955; GO:0006958; GO:0008236; GO:0031638; GO:0042802; GO:0045087; GO:0070062; GO:0072562 AGGSIPIPQK 1.850000024 1 1 0.129766775 965.3946456 0 12.32622 15.28381 14.96042 0 0 14.93054 0 13.58916 0 0 0 0 0 0 16.51129 14.56343 0 0 0 0 0 11.49149 0 0 0 0 0 0 0 0 0 0 0 13.67482 15.81229 0 0 0 0 0 0 0 0 0 0 0 0 P00748 FA12_HUMAN "Coagulation factor XII, EC 3.4.21.38 (Hageman factor, HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2) ]" F12 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]" collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase complex [GO:1905370] "collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]" calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252] GO:0002353; GO:0002542; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005791; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0010756; GO:0016485; GO:0016540; GO:0030194; GO:0031638; GO:0042730; GO:0045087; GO:0051787; GO:0051788; GO:0051919; GO:0062023; GO:0070062; GO:1905370 NKPGVYTDVAYYLAWIR 2.470000029 1 1 0.258008589 2027.671966 0 17.89402 14.01457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00813 ADA_HUMAN "Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)" ADA ADA1 Homo sapiens (Human) adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; biomineralization [GO:0110148]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111] cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; biomineralization [GO:0110148]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111] 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270] GO:0000255; GO:0001666; GO:0001829; GO:0001889; GO:0001890; GO:0002314; GO:0002636; GO:0002686; GO:0002906; GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0006157; GO:0006196; GO:0007155; GO:0008270; GO:0009897; GO:0009986; GO:0010035; GO:0010460; GO:0014074; GO:0016020; GO:0030054; GO:0030890; GO:0032261; GO:0032263; GO:0033089; GO:0033632; GO:0042110; GO:0043101; GO:0043103; GO:0044209; GO:0045987; GO:0046059; GO:0046061; GO:0046085; GO:0046103; GO:0046111; GO:0046638; GO:0046936; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050862; GO:0060169; GO:0060205; GO:0060407; GO:0070244; GO:0070256; GO:0110148 SSFLPEDEKR 16.17000008 0.626702487 0.626702487 0.381135349 1207.72206 15.53759 14.87597 17.06404 0 0 0 17.91223 16.76676 17.69369 0 15.41112 0 17.72998 13.96482 16.95184 13.24366 15.55764 16.78905 0 16.45059 0 17.89851 0 0 0 0 0 16.34811 0 16.39692 0 0 0 16.47302 0 16.80366 0 0 0 17.14195 0 0 16.9593 0 0 0 16.17708 0 P00918 CAH2_HUMAN "Carbonic anhydrase 2, EC 4.2.1.1 (Carbonate dehydratase II) (Carbonic anhydrase C, CAC) (Carbonic anhydrase II, CA-II) (Cyanamide hydratase CA2, EC 4.2.1.69)" CA2 Homo sapiens (Human) "angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; secretion [GO:0046903]" apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886] "apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; secretion [GO:0046903]" arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070062; GO:2001150; GO:2001225 QSPVDIDTHTAK 3.049999952 1 1 0.455525026 1310.802776 14.24659 0 0 0 0 13.05506 11.96561 15.40796 0 0 14.52683 14.53285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.26355 0 0 0 0 0 16.1596 0 0 16.35474 0 0 0 17.34951 0 0 0 P00966 ASSY_HUMAN "Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)" ASS1 ASS Homo sapiens (Human) acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204] cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]; acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643] GO:0000050; GO:0000052; GO:0000053; GO:0001822; GO:0001889; GO:0003723; GO:0004055; GO:0005524; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005783; GO:0005829; GO:0006526; GO:0006531; GO:0006953; GO:0007494; GO:0007568; GO:0007584; GO:0007623; GO:0009410; GO:0010043; GO:0010046; GO:0015643; GO:0016597; GO:0032355; GO:0042802; GO:0043204; GO:0045429; GO:0060416; GO:0060539; GO:0070062; GO:0070852; GO:0071222; GO:0071230; GO:0071242; GO:0071320; GO:0071346; GO:0071356; GO:0071377; GO:0071400; GO:0071418; GO:0071499; GO:0071549; GO:1903038 LQSKVTAK 14.01000023 1 1 0.090140197 871.8613038 13.89795 13.49735 0 14.21644 0 14.54867 16.2554 0 0 0 0 0 0 0 0 0 0 0 0 0 14.01833 0 0 0 0 14.95953 0 0 0 0 0 0 16.62961 0 0 15.02201 0 0 13.91342 0 15.4318 0 0 0 0 0 0 0 P00973 OAS1_HUMAN "2'-5'-oligoadenylate synthase 1, (2-5')oligo(A) synthase 1, 2-5A synthase 1, EC 2.7.7.84 (E18/E16) (p46/p42 OAS)" OAS1 OIAS Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon signaling pathway [GO:0060337] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0060700; GO:0070106; GO:0071639; GO:0071659; GO:0098586; GO:0140374; GO:1901857; GO:2000342 GGSSGK 3.779999971 0.485300809 0.485300809 0.259985971 489.8129661 14.97758 16.04685 15.93025 11.54774 15.12543 12.61279 16.37668 0 18.29361 18.49728 18.65075 14.78796 0 0 15.71471 16.09726 15.74295 16.7988 15.49883 14.70765 0 15.05342 0 0 16.40928 0 0 15.75937 0 15.12113 15.24311 14.89941 0 15.49983 16.67657 0 14.51475 0 0 15.9568 0 16.63626 15.33932 0 0 15.77323 15.95226 0 P01008 ANT3_HUMAN "Antithrombin-III, ATIII (Serpin C1)" SERPINC1 AT3 PRO0309 Homo sapiens (Human) "blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]" heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008201; GO:0010951; GO:0042802; GO:0062023; GO:0070062; GO:0072562; GO:2000266 IPEATNRR 3.950000048 1 1 0.255582547 956.6938472 0 0 0 17.77888 0 0 0 0 0 0 0 0 0 15.54789 0 0 0 0 14.73507 0 18.21554 0 0 17.39111 0 0 19.77674 0 0 0 0 0 0 17.71552 0 0 17.44225 0 0 0 0 0 0 0 0 0 16.94473 0 P01023 A2MG_HUMAN "Alpha-2-macroglobulin, Alpha-2-M (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)" A2M CPAMD5 FWP007 Homo sapiens (Human) "acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]" brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120] GO:0001553; GO:0001869; GO:0002020; GO:0002438; GO:0004866; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0006953; GO:0007584; GO:0010037; GO:0019838; GO:0019899; GO:0019959; GO:0019966; GO:0031093; GO:0034695; GO:0042802; GO:0043120; GO:0048306; GO:0048403; GO:0048406; GO:0048863; GO:0051384; GO:0062023; GO:0070062; GO:0072562; GO:1990402 DMYSFLEDMGLK 15.31999969 0.682505786 0.682505786 0.119091888 1448.512004 15.1877 14.10036 16.28552 17.73866 17.29068 15.48487 0 0 0 13.10168 0 18.46198 15.41027 0 16.42905 0 15.54988 14.21406 12.45425 16.79742 14.38312 0 14.01925 0 7.02891 13.66681 11.29433 15.37437 13.84486 15.68912 13.88276 0 0 0 0 15.34938 11.45699 15.94485 17.04649 14.36128 0 13.50756 12.60561 13.00217 0 14.64429 15.41927 14.99733 P01024 CO3_HUMAN "Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c, C3bc; Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein, ASP (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2 ]" C3 CPAMD1 Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064]" azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370] "azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102]; amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064]" C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102] GO:0001798; GO:0001934; GO:0001970; GO:0004866; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006508; GO:0006631; GO:0006954; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0007165; GO:0007186; GO:0008228; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0030449; GO:0030451; GO:0031715; GO:0032991; GO:0034774; GO:0035578; GO:0035846; GO:0044533; GO:0045745; GO:0045766; GO:0048260; GO:0050766; GO:0050778; GO:0060100; GO:0070062; GO:0072562; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1903028; GO:1905114; GO:1905370; GO:2000427 HQQTVTIPPK 10.63000011 1 1 0.024556099 1148.326514 0 14.15159 12.741 0 14.47459 14.33075 14.31162 15.54256 15.0996 0 0 15.59277 15.47377 14.36878 13.60842 15.61811 0 15.21023 0 0 14.99534 17.23835 0 0 0 0 0 14.64218 0 0 0 0 0 0 0 0 16.28781 0 0 0 0 0 0 0 0 0 14.74169 0 P01100 FOS_HUMAN "Protein c-Fos (Cellular oncogene fos) (Fos proto-oncogene, AP-1 transcription factor subunit) (G0/G1 switch regulatory protein 7) (Proto-oncogene c-Fos) (Transcription factor AP-1 subunit c-Fos)" FOS G0S7 Homo sapiens (Human) "aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; DNA methylation [GO:0006306]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; nervous system development [GO:0007399]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; DNA methylation [GO:0006306]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; nervous system development [GO:0007399]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001228; GO:0001661; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006306; GO:0006357; GO:0006366; GO:0006954; GO:0007179; GO:0007399; GO:0007565; GO:0007568; GO:0009409; GO:0009410; GO:0009416; GO:0009629; GO:0009636; GO:0016020; GO:0030431; GO:0031668; GO:0032496; GO:0032570; GO:0032870; GO:0032993; GO:0034097; GO:0034614; GO:0035902; GO:0035914; GO:0035976; GO:0035994; GO:0042802; GO:0043005; GO:0044877; GO:0045672; GO:0045893; GO:0045944; GO:0051412; GO:0051591; GO:0060395; GO:0061629; GO:0070412; GO:0071276; GO:0071277; GO:0090575; GO:0140467; GO:1901216; GO:1902895; GO:1990837 SISSMELK 5.239999771 1 1 0.140073328 909.6697061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.74077 0 0 0 0 0 0 0 0 0 19.56149 18.76952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01112 RASH_HUMAN "GTPase HRas, EC 3.6.5.2 (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed ]" HRAS HRAS1 Homo sapiens (Human) adipose tissue development [GO:0060612]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; intrinsic apoptotic signaling pathway [GO:0097193]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAP kinase activity [GO:0043405]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein C-terminus binding [GO:0008022]; adipose tissue development [GO:0060612]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; intrinsic apoptotic signaling pathway [GO:0097193]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAP kinase activity [GO:0043405]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein C-terminus binding [GO:0008022] GO:0000139; GO:0000165; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006357; GO:0006897; GO:0006935; GO:0007165; GO:0007166; GO:0007265; GO:0008022; GO:0008284; GO:0008285; GO:0009887; GO:0010629; GO:0010863; GO:0019003; GO:0030335; GO:0032729; GO:0034260; GO:0042088; GO:0042127; GO:0042832; GO:0043405; GO:0043406; GO:0043410; GO:0043524; GO:0043547; GO:0045944; GO:0046330; GO:0048169; GO:0048471; GO:0050679; GO:0050852; GO:0051726; GO:0060612; GO:0070374; GO:0071480; GO:0090303; GO:0090314; GO:0090398; GO:0097193; GO:0098696; GO:0098978; GO:1900029; GO:1905360; GO:2000251; GO:2000630 LNPPDESGPGCMSCK 5.099999905 1 1 0.339279312 1663.581188 15.43748 17.48706 15.78436 0 16.62161 14.8555 16.61107 0 0 0 0 17.98607 0 0 0 0 0 0 0 15.53671 0 0 0 0 11.32737 0 0 0 0 0 0 15.54256 0 0 14.82613 0 17.85434 0 0 0 0 0 0 16.54252 0 0 15.01006 15.18429 P01116 RASK_HUMAN "GTPase KRas, EC 3.6.5.2 (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed ]" KRAS KRAS2 RASK2 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; striated muscle cell differentiation [GO:0051146]; visual learning [GO:0008542]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; striated muscle cell differentiation [GO:0051146]; visual learning [GO:0008542]" G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] GO:0000139; GO:0000165; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0007265; GO:0008284; GO:0008542; GO:0010628; GO:0016020; GO:0019003; GO:0021897; GO:0030036; GO:0031234; GO:0031647; GO:0032228; GO:0035022; GO:0038002; GO:0042802; GO:0043524; GO:0044877; GO:0045596; GO:0048169; GO:0048873; GO:0051146; GO:0060441 QRVEDAFYTLVR 12.72000027 1 1 0.078438139 1496.753345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.01648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01133 EGF_HUMAN "Pro-epidermal growth factor, EGF [Cleaved into: Epidermal growth factor (Urogastrone) ]" EGF Homo sapiens (Human) "angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]" clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] "clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]" calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] GO:0001525; GO:0001938; GO:0002092; GO:0005085; GO:0005154; GO:0005509; GO:0005576; GO:0005615; GO:0005765; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0010595; GO:0010628; GO:0010800; GO:0014068; GO:0016021; GO:0018108; GO:0021940; GO:0030297; GO:0030335; GO:0030669; GO:0031093; GO:0038029; GO:0042327; GO:0043388; GO:0043406; GO:0043410; GO:0045740; GO:0045741; GO:0045840; GO:0045893; GO:0046425; GO:0048754; GO:0051048; GO:0051897; GO:0060749; GO:0070062; GO:0070371; GO:0090263; GO:0090279; GO:0090370; GO:1900127; GO:1902966; GO:1905278; GO:2000008; GO:2000060 ANMDGSQRER 8.970000267 0.572127402 0.572127402 0.177662557 1180.895591 17.54562 18.6224 16.99342 17.54133 0 16.6062 16.19902 17.35413 17.15378 15.80161 16.31798 13.3515 14.77612 19.277 17.75216 15.89763 14.77274 16.71447 15.84822 0 15.7693 0 17.85322 17.5626 17.22372 17.4136 16.38988 0 0 15.60407 15.70491 17.23005 16.77435 14.16946 15.25734 17.08024 15.81683 15.66085 16.98649 0 0 16.90982 16.31672 0 0 0 13.1579 17.87249 P01160 ANF_HUMAN "Natriuretic peptides A (Atrial natriuretic factor prohormone, proANF) (Atrial natriuretic peptide prohormone, preproANP, proANP) (Atriopeptigen) (Cardiodilatin, CDD) (preproCDD-ANF) [Cleaved into: Long-acting natriuretic peptide, LANP (Long-acting natriuretic hormone, LANH) (Pro atrial natriuretic factor 1-30, proANF 1-30) (Pro atrial natriuretic peptide 1-30, proANP 1-30); Vessel dilator, VSDL (Pro atrial natriuretic factor 31-67, proANF 31-67) (Pro atrial natriuretic peptide 31-67, proANP 31-67); Kaliuretic peptide, KP (Pro atrial natriuretic factor 79-98, proANF 79-98) (Pro atrial natriuretic peptide 79-98, proANP 79-98); Urodilatin, URO (CDD 95-126) (CDD-ANP (95-126)) (Pro atrial natriuretic peptide 95-126, proANP 95-126); Auriculin-C (Atrial natriuretic factor 1-33, ANF 1-33); Auriculin-D (Atrial natriuretic factor 3-33, ANF 3-33); Atrial natriuretic peptide, ANP (Alpha-atrial natriuretic peptide) (Alpha-hANP) (Atrial natriuretic factor, ANF) (CDD-ANF) (CDD-ANP (99-126)) (Cardionatrin) (Pro atrial natriuretic factor 99-126, proANF 99-126); Auriculin-B (Atrial natriuretic factor 8-33, ANF 8-33); Auriculin-A; Atriopeptin-1 (Atriopeptin I); Atriopeptin-2 (Atriopeptin II); Atriopeptin-3 (Atriopeptin III) ]" NPPA ANP PND Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; vasodilation [GO:0042311] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102]; aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; vasodilation [GO:0042311] hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102] GO:0003085; GO:0003161; GO:0003180; GO:0005102; GO:0005179; GO:0005184; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006182; GO:0006457; GO:0007168; GO:0007218; GO:0007565; GO:0008217; GO:0010460; GO:0014898; GO:0019934; GO:0032991; GO:0035994; GO:0036376; GO:0042059; GO:0042311; GO:0042995; GO:0043204; GO:0043508; GO:0051427; GO:0060372; GO:0060452; GO:0062023; GO:0071855; GO:0090090; GO:1901841; GO:1902261; GO:1902514; GO:1903766 ANPMYNAVSNADLMDFK 5.079999924 1 1 0.165857753 1917.823658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01258 CALC_HUMAN "Calcitonin [Cleaved into: Calcitonin; Katacalcin (Calcitonin carboxyl-terminal peptide, CCP) (PDN-21) ]" CALCA CALC1 Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265]" calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802] GO:0001984; GO:0002548; GO:0005179; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0007189; GO:0007190; GO:0007204; GO:0007218; GO:0007566; GO:0007568; GO:0007631; GO:0008016; GO:0009408; GO:0030279; GO:0031716; GO:0032147; GO:0042802; GO:0043025; GO:0043195; GO:0045779; GO:0045892; GO:0045986; GO:0048265; GO:0050965; GO:0051480; GO:0051482; GO:0071356; GO:1990090 CGNLSTCMLGTYTQDFNK 1.539999962 1 1 0.058076004 2126.444047 0 0 0 0 15.77133 14.23674 0 12.63113 0 0 0 0 13.56032 0 14.66382 0 0 14.41311 0 13.71988 0 0 0 0 0 0 13.35742 13.21536 14.98627 0 0 0 10.22237 14.68545 0 15.28305 0 0 0 0 0 0 0 13.35489 0 0 0 0 P01266 THYG_HUMAN "Thyroglobulin, Tg" TG Homo sapiens (Human) hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590] hormone activity [GO:0005179]; identical protein binding [GO:0042802] GO:0005179; GO:0005576; GO:0005615; GO:0006590; GO:0007165; GO:0015705; GO:0030878; GO:0031641; GO:0042446; GO:0042802 ELPGSR 8.770000458 1 1 0.244632574 657.0366137 17.68551 17.32763 0 0 0 0 0 0 0 0 0 16.78307 0 0 0 0 16.00792 0 18.0054 0 0 0 0 17.48993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.97107 0 0 0 0 16.7953 P01270 PTHY_HUMAN "Parathyroid hormone, PTH (Parathormone) (Parathyrin)" PTH Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501] hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857] GO:0001501; GO:0005179; GO:0005576; GO:0005615; GO:0006874; GO:0007186; GO:0007189; GO:0007202; GO:0007266; GO:0007267; GO:0008628; GO:0009410; GO:0009967; GO:0010288; GO:0010468; GO:0010629; GO:0010960; GO:0030282; GO:0030501; GO:0031856; GO:0031857; GO:0032331; GO:0033280; GO:0034645; GO:0045453; GO:0045471; GO:0045725; GO:0045944; GO:0046058; GO:0046326; GO:0046686; GO:0047485; GO:0048018; GO:0048873; GO:0051428; GO:0055062; GO:0060732; GO:0071107; GO:0071774; GO:0071864; GO:0071866; GO:0090290; GO:1900158 VMIVMLAICFLTKSDGK 6.5 0.001971818 0.001971818 0.420870412 1958.428137 24.26401 0 21.32964 0 0 0 20.43041 0 0 0 21.15667 0 23.35026 0 0 0 0 23.54872 0 0 0 0 0 23.5134 0 21.27507 23.4846 0 0 0 20.02189 0 0 0 0 0 0 0 0 0 0 0 0 0 23.56032 0 0 18.28256 P01344 IGF2_HUMAN "Insulin-like growth factor II, IGF-II (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin ]" IGF2 PP1446 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]" growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018] GO:0000122; GO:0001649; GO:0001701; GO:0001892; GO:0001934; GO:0005158; GO:0005159; GO:0005178; GO:0005179; GO:0005576; GO:0005615; GO:0006006; GO:0006349; GO:0006355; GO:0008083; GO:0008284; GO:0008286; GO:0009887; GO:0031017; GO:0031056; GO:0031093; GO:0038028; GO:0040018; GO:0042104; GO:0043085; GO:0043410; GO:0043539; GO:0045725; GO:0045840; GO:0045944; GO:0046622; GO:0046628; GO:0048018; GO:0048633; GO:0050731; GO:0051146; GO:0051147; GO:0051148; GO:0051781; GO:0051897; GO:0060669; GO:0060720; GO:1905564; GO:2000467 GLPALLRAR 16.88999939 0.093224764 0.093224764 0.133424556 966.5464546 13.68653 16.76486 11.61287 0 0 0 13.59775 14.4812 13.30288 0 16.7841 0 0 0 15.31725 0 13.33705 0 12.44792 12.6938 13.04847 0 0 0 0 0 14.99694 9.351836 0 13.01023 11.42883 12.30088 13.12185 0 17.53466 0 0 15.3659 0 11.33905 14.99804 18.82503 13.76405 0 12.72758 0 0 12.90847 P01374 TNFB_HUMAN "Lymphotoxin-alpha, LT-alpha (TNF-beta) (Tumor necrosis factor ligand superfamily member 1)" LTA TNFB TNFSF1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] GO:0001666; GO:0002876; GO:0002925; GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006959; GO:0007165; GO:0007267; GO:0007584; GO:0009410; GO:0032496; GO:0032729; GO:0043065; GO:0048147; GO:0048535; GO:0050830; GO:0060252 MTPPER 2.730000019 0.434452832 0.434452832 0.299805365 745.8146899 0 15.11056 0 12.65266 0 0 15.74877 14.09216 12.87943 0 0 0 0 14.81732 15.23325 0 15.90633 14.68279 0 15.78818 15.29517 15.90857 16.10332 15.63019 15.73778 15.47704 16.67574 15.86302 0 0 0 0 15.62809 0 0 16.19981 0 16.47894 16.97709 0 0 15.6373 15.92969 0 0 0 16.1311 0 P01568 IFN21_HUMAN "Interferon alpha-21, IFN-alpha-21 (Interferon alpha-F, LeIF F)" IFNA21 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 RALILLAQMGR 10.22000027 1 1 0.153244774 1258.512479 16.97757 0 0 0 0 0 0 0 0 0 0 0 0 16.91156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01569 IFNA5_HUMAN "Interferon alpha-5, IFN-alpha-5 (Interferon alpha-61) (Interferon alpha-G, LeIF G)" IFNA5 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 AEIMRSFSLSANLQER 8.140000343 1 1 0.209886755 1867.785093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01583 IL1A_HUMAN "Interleukin-1 alpha, IL-1 alpha (Hematopoietin-1)" IL1A IL1F1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283] copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] GO:0001660; GO:0001666; GO:0001819; GO:0002248; GO:0005125; GO:0005149; GO:0005507; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006883; GO:0006915; GO:0006954; GO:0006955; GO:0007283; GO:0007507; GO:0008285; GO:0009986; GO:0010193; GO:0010243; GO:0010332; GO:0010575; GO:0010628; GO:0010893; GO:0019221; GO:0031424; GO:0032308; GO:0032743; GO:0032755; GO:0032760; GO:0032956; GO:0033092; GO:0033591; GO:0034605; GO:0035234; GO:0043123; GO:0045766; GO:0045840; GO:0045944; GO:0046330; GO:0046688; GO:0050714; GO:0050999; GO:0051781; GO:0051930; GO:0070374; GO:0071222; GO:0097192; GO:1902624; GO:1904445; GO:2001240 SSKDDAK 7.619999886 0.043223541 0.043223541 0.045128911 751.4426273 0 14.49789 15.3017 15.87265 17.63754 17.10123 18.76564 0 15.09307 17.00964 0 17.20083 0 0 14.46362 14.08454 14.68092 14.1789 14.73693 15.62247 0 0 17.27683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01584 IL1B_HUMAN "Interleukin-1 beta, IL-1 beta (Catabolin)" IL1B IL1F2 Homo sapiens (Human) "apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to xenobiotic stimulus [GO:0071466]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; hyaluronan biosynthetic process [GO:0030213]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; monocyte aggregation [GO:0070487]; negative regulation of adiponectin secretion [GO:0070164]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurogenesis [GO:0050768]; negative regulation of synaptic transmission [GO:0050805]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phagocytosis [GO:0050766]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA biosynthetic process [GO:1902680]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; regulation of defense response to virus by host [GO:0050691]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of nitric-oxide synthase activity [GO:0050999]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; sequestering of triglyceride [GO:0030730]; signal transduction [GO:0007165]; smooth muscle adaptation [GO:0014805]; vascular endothelial growth factor production [GO:0010573]" cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory granule [GO:0030141] "cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory granule [GO:0030141]; cytokine activity [GO:0005125]; integrin binding [GO:0005178]; interleukin-1 receptor binding [GO:0005149]; protein domain specific binding [GO:0019904]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to xenobiotic stimulus [GO:0071466]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; hyaluronan biosynthetic process [GO:0030213]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; monocyte aggregation [GO:0070487]; negative regulation of adiponectin secretion [GO:0070164]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurogenesis [GO:0050768]; negative regulation of synaptic transmission [GO:0050805]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phagocytosis [GO:0050766]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA biosynthetic process [GO:1902680]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; regulation of defense response to virus by host [GO:0050691]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of nitric-oxide synthase activity [GO:0050999]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; sequestering of triglyceride [GO:0030730]; signal transduction [GO:0007165]; smooth muscle adaptation [GO:0014805]; vascular endothelial growth factor production [GO:0010573]" cytokine activity [GO:0005125]; integrin binding [GO:0005178]; interleukin-1 receptor binding [GO:0005149]; protein domain specific binding [GO:0019904] GO:0000165; GO:0001660; GO:0001934; GO:0002711; GO:0005125; GO:0005149; GO:0005178; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0006915; GO:0006954; GO:0006955; GO:0007165; GO:0007267; GO:0007566; GO:0008284; GO:0008285; GO:0009743; GO:0010573; GO:0010575; GO:0010628; GO:0010718; GO:0010829; GO:0014805; GO:0019221; GO:0019904; GO:0030141; GO:0030213; GO:0030335; GO:0030593; GO:0030730; GO:0030949; GO:0031394; GO:0031622; GO:0031663; GO:0032308; GO:0032496; GO:0032725; GO:0032729; GO:0032743; GO:0032755; GO:0032757; GO:0033092; GO:0033129; GO:0033198; GO:0034116; GO:0035066; GO:0035234; GO:0035505; GO:0042102; GO:0043122; GO:0043123; GO:0043406; GO:0043407; GO:0043491; GO:0045429; GO:0045766; GO:0045833; GO:0045840; GO:0045893; GO:0045917; GO:0045944; GO:0046330; GO:0046627; GO:0046827; GO:0048143; GO:0050691; GO:0050729; GO:0050766; GO:0050767; GO:0050768; GO:0050796; GO:0050805; GO:0050830; GO:0050995; GO:0050996; GO:0050999; GO:0051044; GO:0051091; GO:0051092; GO:0051781; GO:0060252; GO:0060355; GO:0060559; GO:0070164; GO:0070372; GO:0070487; GO:0070498; GO:0070555; GO:0071222; GO:0071260; GO:0071310; GO:0071407; GO:0071466; GO:0071639; GO:0097192; GO:0150078; GO:1900745; GO:1901224; GO:1902680; GO:1903140; GO:1903597; GO:2000556; GO:2001240 ISDHHYSKGFR 5.590000153 1 1 0.210191203 1345.881432 11.73989 13.69793 13.49995 14.12848 13.58103 14.96543 14.15866 14.73503 14.40846 0 14.20604 14.39588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.14395 0 0 16.44797 0 0 0 0 0 0 0 0 0 P01588 EPO_HUMAN Erythropoietin (Epoetin) EPO Homo sapiens (Human) "acute-phase response [GO:0006953]; aging [GO:0007568]; apoptotic process [GO:0006915]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]" cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295]; acute-phase response [GO:0006953]; aging [GO:0007568]; apoptotic process [GO:0006915]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]" cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295] GO:0000122; GO:0001666; GO:0005125; GO:0005128; GO:0005179; GO:0005576; GO:0005615; GO:0006915; GO:0006953; GO:0007165; GO:0007566; GO:0007568; GO:0008015; GO:0008284; GO:0009651; GO:0009986; GO:0010523; GO:0010976; GO:0018105; GO:0030218; GO:0030295; GO:0032496; GO:0033189; GO:0033574; GO:0038162; GO:0042104; GO:0042531; GO:0042541; GO:0043249; GO:0043627; GO:0044297; GO:0045666; GO:0045893; GO:0046579; GO:0048678; GO:0051602; GO:0055093; GO:0070374; GO:0070555; GO:0071474; GO:0071548; GO:1901215; GO:1902219; GO:1902251; GO:2001258 LICDSRVLER 1.639999986 1 1 0.033562882 1260.245996 12.49458 0 0 0 0 9.52485 0 0 0 0 0 0 0 11.61305 0 0 0 0 0 0 0 0 0 0 0 0 0 9.264068 0 12.82987 0 0 0 0 0 0 0 0 0 0 13.34074 0 0 0 0 0 0 0 P01602 KV105_HUMAN Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue) IGKV1-5 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] antigen binding [GO:0003823] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562 MDMRVPAQLLGLLLLWLPGAK 3.920000076 1 1 0.312575986 2351.114069 0 0 0 0 0 18.93863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.80006 0 0 13.59992 0 18.58883 0 0 18.24128 19.18176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8331 0 0 0 P01730 CD4_HUMAN T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4) CD4 Homo sapiens (Human) "adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; enzyme linked receptor protein signaling pathway [GO:0007167]; helper T cell enhancement of adaptive immune response [GO:0035397]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] "clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; enzyme linked receptor protein signaling pathway [GO:0007167]; helper T cell enhancement of adaptive immune response [GO:0035397]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] GO:0001618; GO:0001934; GO:0002250; GO:0004888; GO:0005201; GO:0005769; GO:0005788; GO:0005789; GO:0005886; GO:0005887; GO:0006955; GO:0007155; GO:0007165; GO:0007166; GO:0007167; GO:0007169; GO:0008270; GO:0009897; GO:0015026; GO:0019899; GO:0019901; GO:0023026; GO:0030217; GO:0030225; GO:0030669; GO:0032507; GO:0032743; GO:0033674; GO:0035397; GO:0035723; GO:0038023; GO:0042011; GO:0042012; GO:0042101; GO:0042110; GO:0042289; GO:0042802; GO:0042803; GO:0043123; GO:0043410; GO:0045058; GO:0045121; GO:0045657; GO:0045860; GO:0045893; GO:0046598; GO:0050731; GO:0050829; GO:0050850; GO:0050863; GO:0050870; GO:0051924; GO:0070374; GO:0097011; GO:1990782 NLTCEVWGPTSPK 3.920000076 0.200523198 0.200523198 0.297716769 1489.611266 11.81268 14.59295 0 10.9696 16.04862 13.44704 0 0 13.45947 0 0 0 0 0 0 14.22393 0 13.48406 0 15.73249 0 0 0 0 12.38288 10.5635 13.51237 0 13.0681 13.15199 0 0 0 14.87549 16.03532 0 0 15.90322 0 9.015884 15.61609 0 13.34074 0 0 0 0 15.52057 P01824 HV439_HUMAN Immunoglobulin heavy variable 4-39 (Ig heavy chain V-II region WAH) IGHV4-39 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GO:0003823; GO:0005576; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 DLMCKK 9.829999924 0.447312862 0.447312862 0.176821744 809.7071962 0 14.16801 15.16282 16.43054 15.09932 15.38345 14.54115 14.7927 14.0971 0 0 16.9361 15.86715 13.10282 0 14.84575 0 13.49331 15.16374 14.82631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01833 PIGR_HUMAN "Polymeric immunoglobulin receptor, PIgR, Poly-Ig receptor (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component ]" PIGR Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc receptor signaling pathway [GO:0038093]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113]; retina homeostasis [GO:0001895] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751]; polymeric immunoglobulin receptor activity [GO:0001792]; transmembrane signaling receptor activity [GO:0004888]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc receptor signaling pathway [GO:0038093]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113]; retina homeostasis [GO:0001895] polymeric immunoglobulin receptor activity [GO:0001792]; transmembrane signaling receptor activity [GO:0004888] GO:0001580; GO:0001792; GO:0001895; GO:0002415; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0007173; GO:0035577; GO:0038093; GO:0043113; GO:0043235; GO:0070062; GO:0071751 YWCLWEGAQNGRCPLLVDSEGWVK 3.950000048 1 1 1.83E-12 2924.272423 0 0 14.19936 12.79287 0 12.83694 0 14.76205 14.11211 0 14.6493 14.52203 0 0 0 11.57931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.23685 0 0 0 12.99599 0 0 0 0 0 16.09884 0 P01854 IGHE_HUMAN Immunoglobulin heavy constant epsilon (Ig epsilon chain C region) (Ig epsilon chain C region ND) IGHE Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgE immunoglobulin complex [GO:0071742]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgE immunoglobulin complex [GO:0071742]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0071742 AAPEVYAFATPEWPGSR 8.619999886 1 1 0.163332062 1854.344717 0 15.87814 0 0 0 0 0 0 12.26836 0 0 0 14.92326 0 0 0 14.60952 14.85705 14.8822 0 0 0 0 0 0 0 0 16.19243 14.60901 17.02578 15.95167 0 0 16.06789 13.51013 14.6957 0 15.11069 0 14.29338 16.24575 15.52711 0 0 12.75821 0 0 0 P01876 IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO) IGHA1 Homo sapiens (Human) "adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; glomerular filtration [GO:0003094]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; positive regulation of respiratory burst [GO:0060267]; protein-chromophore linkage [GO:0018298]; retina homeostasis [GO:0001895]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgG immunoglobulin complex [GO:0071735]; immunoglobulin complex, circulating [GO:0042571]; monomeric IgA immunoglobulin complex [GO:0071748]; plasma membrane [GO:0005886]; secretory dimeric IgA immunoglobulin complex [GO:0071752]; secretory IgA immunoglobulin complex [GO:0071751]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgG immunoglobulin complex [GO:0071735]; immunoglobulin complex, circulating [GO:0042571]; monomeric IgA immunoglobulin complex [GO:0071748]; plasma membrane [GO:0005886]; secretory dimeric IgA immunoglobulin complex [GO:0071752]; secretory IgA immunoglobulin complex [GO:0071751]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; glomerular filtration [GO:0003094]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; positive regulation of respiratory burst [GO:0060267]; protein-chromophore linkage [GO:0018298]; retina homeostasis [GO:0001895]" antigen binding [GO:0003823] GO:0001895; GO:0002250; GO:0003094; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0018298; GO:0019731; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0060267; GO:0070062; GO:0071735; GO:0071745; GO:0071748; GO:0071751; GO:0071752; GO:0072562 SAVQGPPER 6.449999809 0.87243104 0.87243104 0.265603166 939.6026092 13.14805 17.91848 11.76081 14.9597 15.15742 14.46299 16.14104 13.52716 0 17.31195 16.11487 17.03498 14.03138 14.90295 16.05694 0 15.34005 14.43679 0 15.8302 16.52561 0 16.08387 15.92525 17.533 0 0 0 0 15.79684 0 15.2137 17.04829 14.93504 0 18.3823 15.51868 0 0 16.03526 16.25193 14.35453 14.40036 15.94805 15.48232 0 0 15.68614 P01889 HLAB_HUMAN "HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B, HLA-B)" HLA-B HLAB Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; defense response [GO:0006952]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of T cell anergy [GO:0002667]" cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667] "cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; chaperone binding [GO:0051087]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; defense response [GO:0006952]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of T cell anergy [GO:0002667]" chaperone binding [GO:0051087]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977] GO:0000139; GO:0001916; GO:0002250; GO:0002486; GO:0002667; GO:0005102; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006952; GO:0006955; GO:0009986; GO:0012507; GO:0016020; GO:0016045; GO:0030667; GO:0030670; GO:0031901; GO:0032655; GO:0032675; GO:0042270; GO:0042605; GO:0042612; GO:0045087; GO:0046977; GO:0051087; GO:0055038; GO:0070062; GO:0071556; GO:2001198 SSGGK 1 1 1 0.244969077 435.7464338 15.90307 0 15.37351 11.77796 16.01497 0 13.90794 0 15.33055 15.64049 14.19017 13.297 0 15.82657 15.78291 15.74901 0 0 0 0 0 0 0 0 0 0 15.43723 0 15.45605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01903 DRA_HUMAN "HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)" HLA-DRA HLA-DRA1 Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class II [GO:0002491]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002504]; cognition [GO:0050890]; immune response [GO:0006955]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of T-helper cell differentiation [GO:0045622]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; polysaccharide binding [GO:0030247]; T cell receptor binding [GO:0042608]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class II [GO:0002491]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002504]; cognition [GO:0050890]; immune response [GO:0006955]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of T-helper cell differentiation [GO:0045622]" MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; polysaccharide binding [GO:0030247]; T cell receptor binding [GO:0042608] GO:0000139; GO:0001772; GO:0001916; GO:0002250; GO:0002469; GO:0002491; GO:0002503; GO:0002504; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006955; GO:0009986; GO:0012507; GO:0019886; GO:0023026; GO:0030247; GO:0030658; GO:0030666; GO:0030669; GO:0031901; GO:0031902; GO:0032395; GO:0032588; GO:0032831; GO:0042605; GO:0042608; GO:0042613; GO:0043382; GO:0045622; GO:0050870; GO:0050890; GO:0070062; GO:0071556; GO:2000516 EPNVLICFIDK 5.380000114 0.4574669 0.4574669 5.02E-12 1348.855249 15.26988 15.98407 14.85613 0 14.18136 0 13.49291 15.45015 0 0 13.2535 14.81531 13.70702 14.14144 15.92773 14.3275 0 12.38978 15.01518 15.58563 16.85917 16.84103 14.93637 15.28663 14.44913 14.92072 16.165 0 0 0 16.14691 17.04276 12.73256 13.84005 14.96509 0 16.70895 16.78123 12.74274 0 14.11778 15.86333 14.94632 0 15.35043 16.4369 0 16.91908 P02042 HBD_HUMAN Hemoglobin subunit delta (Delta-globin) (Hemoglobin delta chain) HBD Homo sapiens (Human) cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744] blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833] blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744] heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] GO:0005344; GO:0005829; GO:0005833; GO:0019825; GO:0020037; GO:0031721; GO:0031838; GO:0042744; GO:0043177; GO:0046872; GO:0072562; GO:0098869 VLGAFSDGLAHLDNLK 7.510000229 1 1 1.83E-12 1669.629422 16.53255 15.89839 16.14794 0 0 0 18.11521 0 0 0 0 0 13.29064 0 14.165 0 0 0 15.10923 0 0 0 0 0 12.88192 0 14.7285 0 14.91338 14.71711 11.68494 16.33537 17.30822 0 0 0 14.23803 0 0 0 0 0 0 0 0 0 0 0 P02100 HBE_HUMAN Hemoglobin subunit epsilon (Epsilon-globin) (Hemoglobin epsilon chain) HBE1 HBE Homo sapiens (Human) cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; response to organic cyclic compound [GO:0014070] blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833] blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; protein-containing complex binding [GO:0044877]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; response to organic cyclic compound [GO:0014070] heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; protein-containing complex binding [GO:0044877] GO:0005344; GO:0005829; GO:0005833; GO:0014070; GO:0019825; GO:0020037; GO:0031721; GO:0031838; GO:0042744; GO:0043177; GO:0044877; GO:0046872; GO:0072562; GO:0098869 LLVVYPWTQR 24.69000053 1 1 0.465472626 1274.672174 16.24594 0 16.7239 0 16.75123 0 0 0 0 18.42864 0 0 17.1216 0 0 19.06288 0 0 0 0 0 0 0 17.93425 0 0 0 0 0 0 0 0 0 0 0 19.0893 0 0 18.54058 0 0 0 0 0 0 0 0 0 P02144 MYG_HUMAN Myoglobin MB Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; enucleate erythrocyte differentiation [GO:0043353]; heart development [GO:0007507]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; brown fat cell differentiation [GO:0050873]; enucleate erythrocyte differentiation [GO:0043353]; heart development [GO:0007507]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] GO:0001666; GO:0005344; GO:0005829; GO:0007507; GO:0015671; GO:0019825; GO:0020037; GO:0043353; GO:0046872; GO:0050873; GO:0070062 DMASNYK 14.72000027 0.729673684 0.729673684 0.202732063 828.4322677 18.46674 17.83502 18.47093 15.72389 17.00193 18.2105 18.60992 14.80869 18.67311 17.92367 16.58893 16.9007 17.97416 17.83382 18.12886 16.65794 16.45656 17.23481 18.29957 16.76101 16.61716 16.98929 18.5387 15.13477 16.79307 19.15177 17.83072 17.86622 17.51786 17.15408 0 18.61896 19.01543 16.76619 0 17.51484 17.82991 18.55107 18.37719 18.77772 17.51471 18.62028 17.90641 16.18369 0 0 18.1981 17.9039 P02452 CO1A1_HUMAN Collagen alpha-1(I) chain (Alpha-1 type I collagen) COL1A1 Homo sapiens (Human) "blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]" collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141] "collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]" extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020] GO:0001501; GO:0001503; GO:0001568; GO:0001649; GO:0001957; GO:0001958; GO:0002020; GO:0005201; GO:0005576; GO:0005584; GO:0005615; GO:0005737; GO:0005788; GO:0005794; GO:0007601; GO:0007605; GO:0009410; GO:0009612; GO:0010718; GO:0010812; GO:0015031; GO:0030020; GO:0030141; GO:0030198; GO:0030199; GO:0030335; GO:0031012; GO:0031960; GO:0032355; GO:0032964; GO:0034504; GO:0034505; GO:0038063; GO:0042060; GO:0042542; GO:0042802; GO:0043434; GO:0043588; GO:0043589; GO:0044344; GO:0044691; GO:0045893; GO:0046872; GO:0048407; GO:0048706; GO:0051591; GO:0055093; GO:0060325; GO:0060346; GO:0060351; GO:0062023; GO:0071230; GO:0071260; GO:0071300; GO:0071306; GO:0071356; GO:0071364; GO:0071560; GO:0090263; GO:1902618 GGPGSR 14.82999992 0.243084624 0.243084624 0.203523873 531.1677238 15.7587 15.47583 0 14.8173 15.63837 0 16.50504 15.713 0 14.2325 14.25109 15.12236 16.07442 15.44056 0 0 15.03394 16.39512 15.01389 15.96294 16.11217 17.14236 17.13312 17.01166 14.87952 0 16.02602 14.87328 16.11724 15.87396 0 15.38719 0 0 16.97433 0 17.06993 0 0 0 0 0 0 0 0 0 0 0 P02458 CO2A1_HUMAN Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin ] COL2A1 Homo sapiens (Human) anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC class II protein binding [GO:0042289]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC class II protein binding [GO:0042289]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394] GO:0001501; GO:0001502; GO:0001894; GO:0001958; GO:0002062; GO:0003007; GO:0005201; GO:0005576; GO:0005581; GO:0005585; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0006029; GO:0007417; GO:0007601; GO:0007605; GO:0010468; GO:0030020; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0042289; GO:0042472; GO:0042802; GO:0043394; GO:0046872; GO:0048407; GO:0051216; GO:0060021; GO:0060174; GO:0060272; GO:0060351; GO:0062023; GO:0071599; GO:0071773; GO:0097065; GO:2001240 GDSGPPGR 2.839999914 1 1 0.221292506 743.3807948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.96376 0 0 0 0 0 0 0 0 0 P02461 CO3A1_HUMAN Collagen alpha-1(III) chain COL3A1 Homo sapiens (Human) aorta smooth muscle tissue morphogenesis [GO:0060414]; cell-matrix adhesion [GO:0007160]; cellular response to amino acid stimulus [GO:0071230]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; digestive tract development [GO:0048565]; elastic fiber assembly [GO:0048251]; endochondral bone morphogenesis [GO:0060350]; extracellular matrix organization [GO:0030198]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; limb joint morphogenesis [GO:0036022]; lung development [GO:0030324]; multicellular organism growth [GO:0035264]; negative regulation of immune response [GO:0050777]; negative regulation of neuron migration [GO:2001223]; peptide cross-linking [GO:0018149]; platelet activation [GO:0030168]; positive regulation of Rho protein signal transduction [GO:0035025]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to radiation [GO:0009314]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tissue homeostasis [GO:0001894]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 production [GO:0032905]; wound healing [GO:0042060] collagen type III trimer [GO:0005586]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type III trimer [GO:0005586]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; SMAD binding [GO:0046332]; aorta smooth muscle tissue morphogenesis [GO:0060414]; cell-matrix adhesion [GO:0007160]; cellular response to amino acid stimulus [GO:0071230]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; digestive tract development [GO:0048565]; elastic fiber assembly [GO:0048251]; endochondral bone morphogenesis [GO:0060350]; extracellular matrix organization [GO:0030198]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; limb joint morphogenesis [GO:0036022]; lung development [GO:0030324]; multicellular organism growth [GO:0035264]; negative regulation of immune response [GO:0050777]; negative regulation of neuron migration [GO:2001223]; peptide cross-linking [GO:0018149]; platelet activation [GO:0030168]; positive regulation of Rho protein signal transduction [GO:0035025]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to radiation [GO:0009314]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tissue homeostasis [GO:0001894]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 production [GO:0032905]; wound healing [GO:0042060] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; SMAD binding [GO:0046332] GO:0001701; GO:0001894; GO:0002020; GO:0002062; GO:0005178; GO:0005201; GO:0005576; GO:0005586; GO:0005615; GO:0005788; GO:0007160; GO:0007179; GO:0007229; GO:0007507; GO:0009314; GO:0018149; GO:0021987; GO:0030020; GO:0030168; GO:0030198; GO:0030199; GO:0030324; GO:0031012; GO:0032905; GO:0034097; GO:0035025; GO:0035264; GO:0036022; GO:0042060; GO:0043588; GO:0046332; GO:0046872; GO:0048144; GO:0048251; GO:0048407; GO:0048565; GO:0050777; GO:0060350; GO:0060414; GO:0062023; GO:0071230; GO:0097435; GO:1990776; GO:2001223 GFDGR 1.090000033 4.60E-07 4.60E-07 0.277093347 551.8470195 0 0 0 0 0 19.64944 0 0 17.53283 0 0 0 0 0 0 16.46671 18.02292 0 0 0 0 0 0 0 0 0 17.06596 18.50167 16.94663 0 0 0 18.04736 0 0 0 19.36202 0 18.27685 18.76469 0 0 0 16.20935 0 0 0 0 P02462 CO4A1_HUMAN Collagen alpha-1(IV) chain [Cleaved into: Arresten ] COL4A1 Homo sapiens (Human) basement membrane organization [GO:0071711]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; basement membrane organization [GO:0071711]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407] GO:0001569; GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007420; GO:0007528; GO:0030020; GO:0030198; GO:0030855; GO:0031012; GO:0038063; GO:0048407; GO:0048514; GO:0061304; GO:0061333; GO:0062023; GO:0071230; GO:0071711 GDFATK 3.75 1 1 0.160185364 637.6856439 0 0 0 0 0 0 0 0 0 0 0 0 0 15.90152 0 0 0 0 0 0 0 17.32555 0 0 16.82162 0 0 0 0 0 16.18906 15.56302 0 0 0 0 17.29269 16.04559 0 0 14.73595 15.85035 0 17.16028 15.36047 0 0 0 P02489 CRYAA_HUMAN "Alpha-crystallin A chain (Heat shock protein beta-4, HspB4) [Cleaved into: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162) ]" CRYAA CRYA1 HSPB4 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein stabilization [GO:0050821]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein stabilization [GO:0050821]; response to stimulus [GO:0050896]; visual perception [GO:0007601] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082] GO:0005198; GO:0005212; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007601; GO:0032387; GO:0032991; GO:0042802; GO:0043066; GO:0046872; GO:0050821; GO:0050896; GO:0051082 DVTIQHPWFK 6.829999924 0.1188915 0.1188915 0.080693564 1270.858264 14.47769 14.29069 0 0 0 13.21922 16.95527 12.13456 16.10751 0 13.34966 14.78624 0 0 0 0 13.36136 8.30477 0 0 0 0 7.898808 0 0 0 13.37183 0 0 0 0 11.75168 10.39847 14.37825 15.96989 0 0 0 15.9644 14.57054 14.83868 16.90762 14.25083 0 0 14.07205 0 14.4836 P02533 K1C14_HUMAN "Keratin, type I cytoskeletal 14 (Cytokeratin-14, CK-14) (Keratin-14, K14)" KRT14 Homo sapiens (Human) aging [GO:0007568]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; hair cycle [GO:0042633]; intermediate filament bundle assembly [GO:0045110]; intermediate filament organization [GO:0045109] basal part of cell [GO:0045178]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634] basal part of cell [GO:0045178]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634]; keratin filament binding [GO:1990254]; structural constituent of cytoskeleton [GO:0005200]; aging [GO:0007568]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; hair cycle [GO:0042633]; intermediate filament bundle assembly [GO:0045110]; intermediate filament organization [GO:0045109] keratin filament binding [GO:1990254]; structural constituent of cytoskeleton [GO:0005200] GO:0001533; GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0007568; GO:0008544; GO:0030855; GO:0042633; GO:0045095; GO:0045109; GO:0045110; GO:0045178; GO:0070062; GO:1990254 QFTSSSSMK 9.800000191 1 1 0.20115914 1018.610895 0 0 9.10591 14.6433 0 13.47232 0 15.91006 0 0 0 0 15.65694 15.53907 13.73792 15.89596 15.7357 14.01999 15.66355 0 0 14.49057 0 0 0 0 15.2005 0 0 0 12.39238 16.3443 0 13.25932 0 0 0 0 14.5847 0 15.4207 0 16.74818 0 16.65103 0 14.32853 0 P02545 LMNA_HUMAN Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32) ] LMNA LMN1 Homo sapiens (Human) cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015] cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015] identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] GO:0005198; GO:0005634; GO:0005635; GO:0005638; GO:0005652; GO:0005654; GO:0005829; GO:0005882; GO:0006606; GO:0006998; GO:0007517; GO:0008285; GO:0010628; GO:0016363; GO:0016607; GO:0030334; GO:0030951; GO:0031647; GO:0031965; GO:0032204; GO:0034504; GO:0034613; GO:0035861; GO:0042802; GO:0048471; GO:0055015; GO:0071456; GO:0072201; GO:0090201; GO:0090343; GO:1900114; GO:1900180; GO:1903243; GO:1990683; GO:2001237 QSAER 15.23999977 1 1 0.264963932 591.2354274 16.36295 15.27966 15.65103 0 0 15.91927 13.88515 13.71059 0 0 15.77993 15.84656 15.33071 14.55258 15.40483 15.64608 16.16669 16.84598 16.3432 16.02992 15.41401 16.36745 15.97035 16.70411 14.95916 15.34789 0 0 15.27924 15.91824 16.02132 0 0 0 16.66757 15.79149 0 16.75267 0 17.75453 0 0 16.30042 0 15.90258 16.11609 17.03595 16.53146 P02549 SPTA1_HUMAN "Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)" SPTA1 SPTA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200] GO:0002260; GO:0005200; GO:0005509; GO:0005829; GO:0005886; GO:0006779; GO:0007009; GO:0007015; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030097; GO:0030424; GO:0030864; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0042995; GO:0051015; GO:0051693 EPLATR 5.960000038 0.621176422 0.621176422 0.252423193 685.8990993 14.77094 14.5735 0 0 0 14.67521 15.13517 0 14.35089 15.32201 14.15684 14.64672 16.11123 17.10189 17.29273 0 15.24535 0 15.96533 15.46443 0 16.81555 15.95763 0 0 15.25459 0 15.48782 0 0 16.69515 0 0 0 15.23545 0 0 0 0 0 16.28681 0 16.61916 0 16.8458 0 0 0 P02647 APOA1_HUMAN "Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]" APOA1 Homo sapiens (Human) adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180] amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] GO:0001540; GO:0001932; GO:0001935; GO:0002719; GO:0005102; GO:0005543; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005829; GO:0005886; GO:0006656; GO:0006695; GO:0007186; GO:0007229; GO:0008035; GO:0008203; GO:0008211; GO:0010804; GO:0010873; GO:0010875; GO:0010898; GO:0010903; GO:0015485; GO:0018158; GO:0018206; GO:0019899; GO:0019915; GO:0030139; GO:0030300; GO:0030301; GO:0030325; GO:0031072; GO:0031210; GO:0031410; GO:0032489; GO:0032691; GO:0033344; GO:0033700; GO:0034115; GO:0034190; GO:0034191; GO:0034361; GO:0034364; GO:0034366; GO:0034372; GO:0034375; GO:0034380; GO:0034384; GO:0034774; GO:0035025; GO:0042157; GO:0042158; GO:0042627; GO:0042632; GO:0042802; GO:0042803; GO:0043534; GO:0043691; GO:0045499; GO:0045723; GO:0046470; GO:0046889; GO:0050728; GO:0050766; GO:0050821; GO:0050919; GO:0051006; GO:0051180; GO:0051345; GO:0051346; GO:0051496; GO:0055091; GO:0060228; GO:0060354; GO:0060761; GO:0062023; GO:0070062; GO:0070328; GO:0070508; GO:0070653; GO:0071682; GO:0072562; GO:0120020; GO:1900026; GO:1902995; GO:1903561 LSPLGEEMR 2.569999933 1 1 0.098734242 1028.341157 0 0 0 0 0 0 0 0 0 0 0 0 0 14.58436 0 0 0 14.51979 13.56748 15.88694 0 0 0 0 0 0 0 14.34413 12.17406 0 0 0 0 14.86998 0 0 0 0 0 0 15.84756 0 0 0 0 0 0 0 P02671 FIBA_HUMAN Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain ] FGA Homo sapiens (Human) "adaptive immune response [GO:0002250]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] GO:0002250; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0005886; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0042730; GO:0043152; GO:0045087; GO:0045907; GO:0045921; GO:0046872; GO:0050714; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0072377; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000261; GO:2000352 AQLVDMKR 5.559999943 0.707668364 0.707668364 0.2643215 976.8289604 0 0 0 13.34366 0 0 0 0 0 0 0 18.99424 0 0 0 0 16.53735 0 0 0 14.64174 0 0 0 15.30975 0 17.24426 0 13.6381 16.11487 0 0 15.79157 0 0 17.29362 0 0 0 0 13.66881 0 0 0 0 0 0 0 P02675 FIBB_HUMAN Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain ] FGB Homo sapiens (Human) "adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202] "blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202]; chaperone binding [GO:0051087]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" chaperone binding [GO:0051087]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] GO:0002250; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005886; GO:0005938; GO:0007155; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0042730; GO:0043152; GO:0044320; GO:0045087; GO:0045202; GO:0045907; GO:0045921; GO:0050714; GO:0051087; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0071347; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000352 HGTDDGVVWMNWKGSWYSMR 7.920000076 0.718082547 0.718082547 0.077180025 2426.396381 0 0 17.32759 0 16.20427 0 18.0595 0 0 19.20722 17.97351 0 17.28178 0 16.81997 0 16.24279 17.23801 0 0 0 0 0 0 19.14809 15.52093 0 0 0 0 12.10856 16.58451 17.62871 0 0 16.4591 18.62223 17.61236 15.94431 0 0 0 18.24373 0 0 16.68504 17.02542 0 P02686 MBP_HUMAN "Myelin basic protein, MBP (Myelin A1 protein) (Myelin membrane encephalitogenic protein)" MBP Homo sapiens (Human) aging [GO:0007568]; axon ensheathment [GO:0008366]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; immune response [GO:0006955]; maintenance of blood-brain barrier [GO:0035633]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; myelination [GO:0042552]; negative regulation of axonogenesis [GO:0050771]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of metalloendopeptidase activity [GO:1904685]; response to fatty acid [GO:0070542]; response to mercury ion [GO:0046689]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; sensory perception of sound [GO:0007605]; substantia nigra development [GO:0021762] cell periphery [GO:0071944]; cell surface [GO:0009986]; compact myelin [GO:0043218]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] cell periphery [GO:0071944]; cell surface [GO:0009986]; compact myelin [GO:0043218]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; protease binding [GO:0002020]; structural constituent of myelin sheath [GO:0019911]; aging [GO:0007568]; axon ensheathment [GO:0008366]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; immune response [GO:0006955]; maintenance of blood-brain barrier [GO:0035633]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; myelination [GO:0042552]; negative regulation of axonogenesis [GO:0050771]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of metalloendopeptidase activity [GO:1904685]; response to fatty acid [GO:0070542]; response to mercury ion [GO:0046689]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; sensory perception of sound [GO:0007605]; substantia nigra development [GO:0021762] calmodulin binding [GO:0005516]; protease binding [GO:0002020]; structural constituent of myelin sheath [GO:0019911] GO:0000165; GO:0002020; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007268; GO:0007417; GO:0007568; GO:0007605; GO:0008366; GO:0009636; GO:0009986; GO:0019911; GO:0021762; GO:0032570; GO:0032755; GO:0032991; GO:0033269; GO:0034115; GO:0034612; GO:0035633; GO:0042552; GO:0043025; GO:0043209; GO:0043218; GO:0045202; GO:0046689; GO:0050771; GO:0061024; GO:0070542; GO:0071944; GO:1904685; GO:2000343 MGNHAGK 6.079999924 0.201164246 0.201164246 0.172048625 712.4716851 15.17677 14.8061 14.65644 14.65606 14.98375 0 0 13.87737 0 15.50765 14.16415 0 0 14.44897 14.01568 0 13.65997 16.5868 0 15.56484 0 0 0 0 0 0 14.91233 0 17.02231 0 15.88213 16.03034 0 0 0 0 0 17.46883 16.02402 14.44584 15.70859 15.73926 16.42658 15.45039 0 16.06646 0 0 P02730 B3AT_HUMAN "Band 3 anion transport protein (Anion exchange protein 1, AE 1, Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233)" SLC4A1 AE1 DI EPB3 Homo sapiens (Human) anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857] GO:0005452; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0006873; GO:0007596; GO:0008509; GO:0009898; GO:0015106; GO:0015108; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0017121; GO:0022857; GO:0030018; GO:0030492; GO:0030506; GO:0030863; GO:0035811; GO:0042803; GO:0043495; GO:0045852; GO:0048821; GO:0050801; GO:0051354; GO:0051453; GO:0055085; GO:0070062; GO:0072562; GO:0072659; GO:1904539 RVLLPLIFR 24.93000031 1 1 0.151532449 1130.875782 16.80264 15.89133 16.83003 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29959 0 0 0 0 0 0 0 0 0 0 0 15.93498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.95009 P02741 CRP_HUMAN C-reactive protein [Cleaved into: C-reactive protein(1-205) ] CRP PTX1 Homo sapiens (Human) "acute-phase response [GO:0006953]; complement activation, classical pathway [GO:0006958]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation by host of viral process [GO:0044793]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; opsonization [GO:0008228]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; choline binding [GO:0033265]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; acute-phase response [GO:0006953]; complement activation, classical pathway [GO:0006958]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation by host of viral process [GO:0044793]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; opsonization [GO:0008228]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310]" calcium ion binding [GO:0005509]; choline binding [GO:0033265]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750] GO:0001849; GO:0005509; GO:0005576; GO:0005615; GO:0006953; GO:0006954; GO:0006958; GO:0008228; GO:0010628; GO:0010745; GO:0010888; GO:0030169; GO:0032677; GO:0032930; GO:0032945; GO:0033265; GO:0042310; GO:0042802; GO:0044793; GO:0045087; GO:0050750; GO:0050830 ESDTSYVSLKAPLTKPLK 3.309999943 1 1 0.385376116 1977.268418 14.16947 0 0 0 0 0 0 14.87044 0 0 0 0 0 13.11329 14.01746 14.22868 0 0 0 15.29693 0 0 16.35142 0 0 15.39468 0 0 14.40939 0 0 0 0 13.24246 0 0 0 16.15302 0 0 0 0 0 0 15.94082 0 0 0 P02743 SAMP_HUMAN "Serum amyloid P-component, SAP (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203) ]" APCS PTX2 Homo sapiens (Human) "acute-phase response [GO:0006953]; chaperone-mediated protein complex assembly [GO:0051131]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation by host of viral exo-alpha-sialidase activity [GO:0044869]; negative regulation by host of viral glycoprotein metabolic process [GO:0044871]; negative regulation by host of viral process [GO:0044793]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of exo-alpha-sialidase activity [GO:1903016]; negative regulation of glycoprotein metabolic process [GO:1903019]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral process [GO:0048525]; negative regulation of wound healing [GO:0061045]; protein folding [GO:0006457]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; acute-phase response [GO:0006953]; chaperone-mediated protein complex assembly [GO:0051131]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation by host of viral exo-alpha-sialidase activity [GO:0044869]; negative regulation by host of viral glycoprotein metabolic process [GO:0044871]; negative regulation by host of viral process [GO:0044793]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of exo-alpha-sialidase activity [GO:1903016]; negative regulation of glycoprotein metabolic process [GO:1903019]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral process [GO:0048525]; negative regulation of wound healing [GO:0061045]; protein folding [GO:0006457]" calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790] GO:0001849; GO:0002674; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0006457; GO:0006953; GO:0006958; GO:0030169; GO:0030246; GO:0042802; GO:0044793; GO:0044869; GO:0044871; GO:0045087; GO:0045656; GO:0046597; GO:0046790; GO:0048525; GO:0051082; GO:0051131; GO:0061045; GO:0062023; GO:0070062; GO:0072562; GO:1903016; GO:1903019 DNELLVYK 7.769999981 0.312284946 0.312284946 0.287864102 993.2719873 14.30875 0 0 0 0 0 18.27061 19.52189 0 17.16325 0 17.81207 0 0 0 0 0 0 0 0 16.86686 0 0 0 0 21.31824 0 16.34377 0 16.26847 0 0 18.58142 0 17.58187 17.5852 16.83205 0 20.995 0 0 0 0 16.39865 0 0 0 0 P02749 APOH_HUMAN "Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H, Apo-H) (Beta-2-glycoprotein I, B2GPI, Beta(2)GPI)" APOH B2G1 Homo sapiens (Human) "blood coagulation, intrinsic pathway [GO:0007597]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; plasminogen activation [GO:0031639]; positive regulation of blood coagulation [GO:0030194]; positive regulation of lipoprotein lipase activity [GO:0051006]; regulation of fibrinolysis [GO:0051917]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]" cell surface [GO:0009986]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; platelet dense granule lumen [GO:0031089]; very-low-density lipoprotein particle [GO:0034361] "cell surface [GO:0009986]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; platelet dense granule lumen [GO:0031089]; very-low-density lipoprotein particle [GO:0034361]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipid binding [GO:0005543]; blood coagulation, intrinsic pathway [GO:0007597]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; plasminogen activation [GO:0031639]; positive regulation of blood coagulation [GO:0030194]; positive regulation of lipoprotein lipase activity [GO:0051006]; regulation of fibrinolysis [GO:0051917]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]" heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipid binding [GO:0005543] GO:0001937; GO:0005543; GO:0005576; GO:0005615; GO:0006641; GO:0007597; GO:0008201; GO:0008289; GO:0009986; GO:0010596; GO:0016525; GO:0030194; GO:0030195; GO:0031089; GO:0031639; GO:0033033; GO:0034197; GO:0034361; GO:0034364; GO:0034392; GO:0042627; GO:0042802; GO:0051006; GO:0051917; GO:0051918; GO:0060230; GO:0062023; GO:0070062 FKNGMLHGDK 19.02000046 1 1 0.509090771 1163.501589 0 0 21.64854 21.55151 18.468 0 18.91597 0 17.86226 0 22.78751 18.8724 17.56355 0 0 0 0 18.53506 21.4951 21.35763 17.88932 0 0 19.62814 0 0 0 0 0 21.80398 0 0 0 0 22.51414 0 18.77267 23.23482 0 0 0 0 22.47776 0 0 0 21.53797 0 P02751 FINC_HUMAN "Fibronectin, FN (Cold-insoluble globulin, CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3 ]" FN1 FN Homo sapiens (Human) "acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of monocyte activation [GO:0150102]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]" apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] "apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of monocyte activation [GO:0150102]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]" chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] GO:0001525; GO:0001932; GO:0002020; GO:0005102; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005577; GO:0005604; GO:0005615; GO:0005788; GO:0005793; GO:0005886; GO:0006953; GO:0007044; GO:0007155; GO:0007160; GO:0007161; GO:0007229; GO:0007399; GO:0007507; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010628; GO:0014068; GO:0016324; GO:0016504; GO:0018149; GO:0019899; GO:0031012; GO:0031093; GO:0033622; GO:0034446; GO:0035987; GO:0042802; GO:0043394; GO:0045773; GO:0048146; GO:0051087; GO:0051702; GO:0062023; GO:0070062; GO:0070372; GO:0070527; GO:0071635; GO:0072378; GO:0072562; GO:0097718; GO:0150102; GO:1901166; GO:1904237 ARITGYIIK 7.909999847 1 1 0.238828338 1033.948761 15.64535 15.20401 16.05428 15.20325 15.59642 0 15.86494 0 0 15.75096 0 16.27077 0 15.15856 0 16.1463 0 15.00879 0 16.31404 0 16.17673 15.7739 0 0 0 0 0 0 0 0 0 15.97185 0 0 16.49563 0 0 0 0 0 0 0 0 0 0 0 0 P02753 RET4_HUMAN "Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]" RBP4 PRO2222 Homo sapiens (Human) cardiac muscle tissue development [GO:0048738]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to retinoic acid [GO:0032526]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; visual perception [GO:0007601] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; cardiac muscle tissue development [GO:0048738]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to retinoic acid [GO:0032526]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; visual perception [GO:0007601] retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632] GO:0001654; GO:0002639; GO:0005576; GO:0005615; GO:0006094; GO:0007507; GO:0007601; GO:0016918; GO:0019841; GO:0030277; GO:0030324; GO:0032024; GO:0032526; GO:0034632; GO:0034633; GO:0042572; GO:0042593; GO:0048562; GO:0048706; GO:0048738; GO:0048807; GO:0060044; GO:0060059; GO:0060065; GO:0060068; GO:0060157; GO:0060347; GO:0070062 MKWVWALLLLAALGSGR 4.289999962 1 1 0.26401932 1900.7846 0 14.86905 14.71201 0 15.39397 0 0 0 0 0 15.94584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.43903 0 0 0 0 P02768 ALBU_HUMAN Albumin ALB GIG20 GIG42 PRO0903 PRO1708 PRO2044 PRO2619 PRO2675 UNQ696/PRO1341 Homo sapiens (Human) cellular response to starvation [GO:0009267]; maintenance of mitochondrion location [GO:0051659]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; retina homeostasis [GO:0001895] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; antioxidant activity [GO:0016209]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; maintenance of mitochondrion location [GO:0051659]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; retina homeostasis [GO:0001895] antioxidant activity [GO:0016209]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; zinc ion binding [GO:0008270] GO:0001895; GO:0003677; GO:0005504; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0005794; GO:0008270; GO:0009267; GO:0015643; GO:0016209; GO:0030170; GO:0031093; GO:0032991; GO:0042802; GO:0043066; GO:0043069; GO:0051087; GO:0051659; GO:0070062; GO:0072562; GO:0140272; GO:1903981 DVFLGMFLYEYAR 11.34000015 1 1 0.38688134 1624.011723 0 0 0 0 0 0 0 0 0 0 17.47497 0 0 0 0 0 0 0 0 0 0 18.01288 0 17.31087 0 17.30442 17.00025 0 17.09709 0 0 0 0 0 16.17533 0 0 0 0 0 0 0 0 0 0 17.64644 15.82231 0 P02771 FETA_HUMAN Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin) AFP HPAFP Homo sapiens (Human) ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]; SMAD protein signal transduction [GO:0060395] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fatty acid binding [GO:0005504]; zinc ion binding [GO:0008270]; ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]; SMAD protein signal transduction [GO:0060395] fatty acid binding [GO:0005504]; zinc ion binding [GO:0008270] GO:0001542; GO:0005504; GO:0005615; GO:0005737; GO:0005788; GO:0008270; GO:0042448; GO:0060395 LSQKFTK 10.73999977 0.105451599 0.105451599 0.265009791 850.4107068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.17652 0 18.01661 0 0 0 0 0 16.41977 0 14.92288 0 17.28553 16.68025 16.30595 0 0 0 0 0 0 15.7492 0 17.23081 15.32889 18.06121 0 17.76392 0 0 0 0 17.33779 P02786 TFR1_HUMAN "Transferrin receptor protein 1, TR, TfR, TfR1, Trfr (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form, sTfR ]" TFRC Homo sapiens (Human) acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]; acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104] chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618] GO:0001618; GO:0001666; GO:0001934; GO:0003723; GO:0003725; GO:0004998; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0005905; GO:0006826; GO:0006879; GO:0006953; GO:0007568; GO:0007584; GO:0009897; GO:0009986; GO:0010008; GO:0010039; GO:0010042; GO:0010628; GO:0010637; GO:0016020; GO:0016323; GO:0019901; GO:0030316; GO:0030544; GO:0030669; GO:0030890; GO:0031334; GO:0031410; GO:0031623; GO:0032526; GO:0033138; GO:0033572; GO:0035556; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0043066; GO:0043123; GO:0043231; GO:0044877; GO:0045780; GO:0045830; GO:0046688; GO:0048471; GO:0051087; GO:0051092; GO:0055037; GO:0055038; GO:0070062; GO:0071466; GO:0072562; GO:0150104; GO:1900182; GO:1903561; GO:1990712; GO:1990830 LVYLVENPGGYVAYSK 7.170000076 0.450583428 0.450583428 0.091458702 1771.040226 14.13295 0 0 0 0 0 0 0 0 15.11513 0 0 0 0 0 0 0 14.20027 0 0 0 0 16.50488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02787 TRFE_HUMAN "Serotransferrin, Transferrin (Beta-1 metal-binding globulin) (Siderophilin)" TF PRO1400 Homo sapiens (Human) "actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]" apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982] "apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]; actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]" ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459] GO:0001895; GO:0005576; GO:0005615; GO:0005769; GO:0005770; GO:0005788; GO:0005886; GO:0005905; GO:0006826; GO:0006879; GO:0007015; GO:0008198; GO:0008199; GO:0009925; GO:0009986; GO:0010008; GO:0016324; GO:0019731; GO:0030139; GO:0030316; GO:0030669; GO:0031232; GO:0031410; GO:0031647; GO:0031982; GO:0034756; GO:0034774; GO:0034986; GO:0042327; GO:0045178; GO:0045780; GO:0045893; GO:0048260; GO:0048471; GO:0055037; GO:0055072; GO:0060395; GO:0070062; GO:0070371; GO:0071281; GO:0072562; GO:1990459; GO:1990712; GO:2000147 CQSFRDHMK 8.430000305 1 1 0.297216825 1209.865511 0 15.58985 13.65306 0 0 0 0 14.6474 0 0 14.32667 0 0 16.79242 0 15.97163 0 0 16.60203 0 0 12.89966 0 16.23978 16.93279 0 16.90522 0 0 16.30219 0 0 16.49226 15.11431 15.68482 0 17.01353 18.60703 17.13335 16.08615 0 16.58801 15.58641 17.51308 16.96951 17.96209 0 17.21272 P02788 TRFL_HUMAN "Lactotransferrin, Lactoferrin, EC 3.4.21.- (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H, Lfcin-H; Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C ]" LTF GIG12 LF Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of membrane potential [GO:0045837]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680]; retina homeostasis [GO:0001895] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of membrane potential [GO:0045837]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680]; retina homeostasis [GO:0001895] cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252] GO:0001503; GO:0001530; GO:0001817; GO:0001895; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045087; GO:0045669; GO:0045837; GO:0048525; GO:0050829; GO:0050830; GO:0051092; GO:0051673; GO:0055037; GO:0055072; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000117; GO:2000308; GO:2001205 CLAENAGDVAFVK 12.47999954 0.267643929 0.267643929 0.543798173 1393.643016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.98142 17.33526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02794 FRIH_HUMAN "Ferritin heavy chain, Ferritin H subunit, EC 1.16.3.1 (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed ]" FTH1 FTH FTHL6 OK/SW-cl.84 PIG15 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147] autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147] ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506] GO:0004322; GO:0005506; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006826; GO:0006879; GO:0006880; GO:0006955; GO:0008043; GO:0008198; GO:0008199; GO:0008285; GO:0042802; GO:0044754; GO:0048147; GO:0070062; GO:1904724; GO:1904813 EHAEKLMK 3.910000086 0.69223237 0.69223237 0.198757822 1000.489216 0 14.36089 13.63578 0 14.66262 14.52642 0 16.83631 0 0 16.11303 0 0 0 0 0 13.80556 0 0 0 0 0 0 16.57761 16.08495 0 16.15829 15.63923 13.88686 15.47483 15.25402 12.94174 16.02598 15.71073 17.55422 15.88032 15.51087 15.83836 17.35156 15.13317 13.67509 13.90414 13.2715 10.21954 14.77607 0 17.18273 14.03963 P02814 SMR3B_HUMAN Submaxillary gland androgen-regulated protein 3B (Proline-rich peptide P-B) (Proline-rich protein 3) [Cleaved into: Peptide P-A; Peptide D1A ] SMR3B PBII PRL3 PROL3 Homo sapiens (Human) regulation of sensory perception of pain [GO:0051930] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; regulation of sensory perception of pain [GO:0051930] endopeptidase inhibitor activity [GO:0004866] GO:0004866; GO:0005615; GO:0051930; GO:0070062 IPPPPPAPYGPGIFPPPPPQP 1.320000052 1 1 1.38E-12 2124.431845 14.51863 0 13.24382 0 0 0 12.3206 0 12.91801 13.35987 0 0 0 13.61551 14.74492 0 13.84456 12.73244 15.04159 16.58026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P03952 KLKB1_HUMAN "Plasma kallikrein, EC 3.4.21.34 (Fletcher factor) (Kininogenin) (Plasma prekallikrein, PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain ]" KLKB1 KLK3 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" serine-type endopeptidase activity [GO:0004252] GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062; GO:1905370 DIYKGVDMR 1.649999976 1 1 0.290420228 1112.038552 0 0 18.19272 0 0 0 0 0 0 0 17.90966 0 15.82235 0 0 0 16.2301 17.03154 0 0 0 0 0 0 0 0 16.82345 0 19.66991 16.53101 18.53879 0 0 0 0 0 0 17.69953 0 0 0 0 0 16.92774 17.12096 0 0 0 P03973 SLPI_HUMAN "Antileukoproteinase, ALP (BLPI) (HUSI-1) (Mucus proteinase inhibitor, MPI) (Protease inhibitor WAP4) (Secretory leukocyte protease inhibitor) (Seminal proteinase inhibitor) (WAP four-disulfide core domain protein 4)" SLPI WAP4 WFDC4 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; immune response [GO:0006955]; innate immune response [GO:0045087]; modulation of process of another organism [GO:0035821]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; response to lipopolysaccharide [GO:0032496] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; specific granule lumen [GO:0035580] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; specific granule lumen [GO:0035580]; DNA binding [GO:0003677]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; immune response [GO:0006955]; innate immune response [GO:0045087]; modulation of process of another organism [GO:0035821]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; response to lipopolysaccharide [GO:0032496] DNA binding [GO:0003677]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0003677; GO:0003729; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0005794; GO:0006955; GO:0019731; GO:0019899; GO:0032091; GO:0032496; GO:0035580; GO:0035821; GO:0045071; GO:0045087; GO:0062023; GO:0070062 AGVCPPK 8.460000038 0.300249696 0.300249696 0.21269339 730.631172 0 16.23092 0 14.85957 17.81767 0 0 0 18.57343 14.00258 16.54997 17.10642 0 0 0 0 0 0 0 0 0 0 16.96772 0 15.76333 17.72469 0 17.17053 0 15.67344 0 0 0 0 0 0 0 16.42731 0 0 0 16.09012 0 0 0 0 0 0 P04003 C4BPA_HUMAN "C4b-binding protein alpha chain, C4bp (Proline-rich protein, PRP)" C4BPA C4BP Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]" blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]" RNA binding [GO:0003723] GO:0003723; GO:0005576; GO:0005615; GO:0005886; GO:0006958; GO:0009609; GO:0045087; GO:0045732; GO:0045959; GO:0072562; GO:1903027 EDVYVVGTVLR 4.989999771 1 1 0.425975591 1249.73039 15.97274 16.36295 15.02375 14.91976 14.4015 0 15.15846 13.99526 13.9478 11.73898 10.30405 0 0 0 14.72149 0 0 0 0 0 14.63721 16.21278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.59835 0 0 0 16.16773 0 0 16.23311 16.04446 0 0 0 P04035 HMDH_HUMAN "3-hydroxy-3-methylglutaryl-coenzyme A reductase, HMG-CoA reductase, EC 1.1.1.34" HMGCR Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542] coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402] GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0008299; GO:0008542; GO:0015936; GO:0016021; GO:0016126; GO:0042177; GO:0043407; GO:0050709; GO:0070402; GO:0120225; GO:1900222 MIMSLGLVLVHAHSR 3.630000114 0.589628339 0.589628339 0.139403677 1697.867707 14.96356 13.2652 0 14.9214 15.84287 0 12.97828 12.93932 17.44007 0 14.61535 13.89821 12.96465 15.48545 0 14.02151 14.71166 16.96993 16.89194 0 15.40104 13.64441 13.83936 15.05023 16.22686 0 0 10.15825 0 15.22197 0 0 17.93577 0 14.82745 0 17.42137 0 15.67035 0 17.66326 17.94104 0 16.00178 12.38111 0 0 13.79254 P04049 RAF1_HUMAN "RAF proto-oncogene serine/threonine-protein kinase, EC 2.7.11.1 (Proto-oncogene c-RAF, cRaf) (Raf-1)" RAF1 RAF Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; wound healing [GO:0042060] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; wound healing [GO:0042060] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007165; GO:0007190; GO:0008285; GO:0019899; GO:0030154; GO:0030878; GO:0031143; GO:0031333; GO:0033138; GO:0035019; GO:0035023; GO:0035773; GO:0035994; GO:0042060; GO:0042802; GO:0042981; GO:0043066; GO:0043154; GO:0043410; GO:0045104; GO:0045595; GO:0045944; GO:0046872; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:0106310; GO:1902042; GO:2000145 MPVSSQHR 1.049999952 1 1 4.58E-13 941.6328487 13.02791 0 14.93761 15.48782 13.73711 15.46948 14.03029 11.71781 15.25897 15.17048 9.576809 0 0 0 15.61405 0 12.52337 13.42341 12.94569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84702 0 0 0 14.8655 12.7025 0 14.35798 0 15.43478 0 0 0 P04062 GLCM_HUMAN "Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)" GBA GC GLUC Homo sapiens (Human) antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] GO:0004348; GO:0005102; GO:0005124; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0008340; GO:0009267; GO:0009268; GO:0014004; GO:0016241; GO:0019882; GO:0019898; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032436; GO:0032715; GO:0033077; GO:0033561; GO:0033574; GO:0035307; GO:0043161; GO:0043202; GO:0043243; GO:0043407; GO:0043524; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050905; GO:0051247; GO:0051402; GO:0061518; GO:0061744; GO:0070062; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037; GO:1905165 DVPLTIK 3.75999999 0.727228224 0.727228224 0.209113746 786.6154556 15.92838 15.8074 12.52286 13.6941 0 13.47001 15.968 0 0 0 15.47677 0 0 14.94749 0 14.38689 14.31611 14.04109 14.49999 14.09264 0 14.99933 0 0 0 0 0 0 0 15.14661 0 16.92397 0 0 15.75847 14.76055 15.07087 15.9107 17.37949 0 14.27721 0 0 16.5787 0 14.63552 16.44516 14.81667 P04114 APOB_HUMAN "Apolipoprotein B-100, Apo B-100 [Cleaved into: Apolipoprotein B-48, Apo B-48 ]" APOB Homo sapiens (Human) artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379] chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983] chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]; cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379] cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543] GO:0001701; GO:0005543; GO:0005576; GO:0005615; GO:0005737; GO:0005769; GO:0005788; GO:0005789; GO:0005790; GO:0005811; GO:0005829; GO:0005886; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009743; GO:0009791; GO:0010008; GO:0010269; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0019433; GO:0030301; GO:0030317; GO:0030669; GO:0031904; GO:0031983; GO:0032355; GO:0032496; GO:0033344; GO:0034359; GO:0034360; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034374; GO:0034379; GO:0034383; GO:0035473; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0043202; GO:0043231; GO:0045540; GO:0048844; GO:0050750; GO:0070062; GO:0070971; GO:0071356; GO:0071379; GO:0071682; GO:0120020 FVEGSHNSTVSLTTKNMEVSVATTTK 3.029999971 1 1 0 2767.959002 0 0 0 15.46925 15.26747 0 13.01864 15.69996 12.81859 17.59453 18.45324 0 16.79543 11.66231 14.1386 0 0 0 0 0 0 0 0 0 0 0 0 16.28976 0 0 0 17.43836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.09735 0 P04150 GCR_HUMAN "Glucocorticoid receptor, GR (Nuclear receptor subfamily 3 group C member 1)" NR3C1 GRL Homo sapiens (Human) "apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor activity [GO:0004883]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" "core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor activity [GO:0004883]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001227; GO:0001228; GO:0003700; GO:0003723; GO:0004879; GO:0004883; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005815; GO:0005819; GO:0005829; GO:0006325; GO:0006355; GO:0006357; GO:0006915; GO:0007049; GO:0007059; GO:0007165; GO:0008270; GO:0016607; GO:0019901; GO:0030518; GO:0032991; GO:0045892; GO:0045944; GO:0051301; GO:0051879; GO:0071383; GO:0071385; GO:0071549; GO:0071560; GO:1902895; GO:1990239; GO:1990837 MDSKESLTPGR 10.63000011 1 1 0.140368792 1215.915566 0 0 15.46253 0 15.86932 0 0 0 0 0 0 0 0 0 0 0 0 13.95793 0 11.94495 0 13.43215 11.98067 0 13.14427 12.12846 0 0 0 0 0 0 0 0 0 0 0 0 16.36768 15.95968 16.63736 0 0 0 0 0 0 17.80731 P04181 OAT_HUMAN "Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]" OAT Homo sapiens (Human) arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601] identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170] GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0007601; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129 ELCTR 9.579999924 0.750680685 0.750680685 0.297159806 678.0652734 0 18.03375 0 0 0 0 0 19.62502 0 0 0 0 20.01763 0 17.26767 0 18.20048 0 0 0 17.77547 0 18.16243 0 0 18.40976 0 18.54436 17.52336 0 19.07483 0 0 0 0 19.02043 17.99258 19.41105 0 0 0 0 17.78426 0 0 17.42926 0 0 P04234 CD3D_HUMAN T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d) CD3D T3D Homo sapiens (Human) adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; positive thymic T cell selection [GO:0045059]; T cell receptor signaling pathway [GO:0050852] alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; positive thymic T cell selection [GO:0045059]; T cell receptor signaling pathway [GO:0050852] identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] GO:0002250; GO:0004888; GO:0005737; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0030669; GO:0042101; GO:0042105; GO:0042802; GO:0045059; GO:0046631; GO:0050852 DKESTVQVHYR 2.359999895 1 1 0.132245028 1361.117719 14.69304 12.29166 12.97384 14.32664 12.72793 0 0 12.32351 0 0 12.04435 0 0 0 0 0 0 10.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04264 K2C1_HUMAN "Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1, CK-1) (Hair alpha protein) (Keratin-1, K1) (Type-II keratin Kb1)" KRT1 KRTA Homo sapiens (Human) "complement activation, lectin pathway [GO:0001867]; establishment of skin barrier [GO:0061436]; fibrinolysis [GO:0042730]; negative regulation of inflammatory response [GO:0050728]; peptide cross-linking [GO:0018149]; protein heterotetramerization [GO:0051290]; regulation of angiogenesis [GO:0045765]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; structural constituent of skin epidermis [GO:0030280]; complement activation, lectin pathway [GO:0001867]; establishment of skin barrier [GO:0061436]; fibrinolysis [GO:0042730]; negative regulation of inflammatory response [GO:0050728]; peptide cross-linking [GO:0018149]; protein heterotetramerization [GO:0051290]; regulation of angiogenesis [GO:0045765]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]" carbohydrate binding [GO:0030246]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; structural constituent of skin epidermis [GO:0030280] GO:0001533; GO:0001867; GO:0001895; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0006979; GO:0016020; GO:0018149; GO:0030246; GO:0030280; GO:0038023; GO:0042730; GO:0045095; GO:0045765; GO:0046982; GO:0050728; GO:0051290; GO:0061436; GO:0062023; GO:0070062; GO:0072562; GO:1904813 FLEQQNQVLQTKWELLQQVDTSTR 24.29000092 1 1 0.535915731 2933.321284 0 0 0 0 0 0 0 0 0 0 20.30231 0 0 20.41424 0 0 0 0 0 0 0 0 18.97563 20.0874 0 0 19.11958 0 0 20.95913 0 0 0 0 0 0 0 0 0 20.52619 0 0 0 17.23863 0 0 0 0 P04275 VWF_HUMAN "von Willebrand factor, vWF [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II) ]" VWF F8VWF Homo sapiens (Human) blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611] chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485] GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0009611; GO:0019865; GO:0030168; GO:0031012; GO:0031091; GO:0031093; GO:0031589; GO:0033093; GO:0042802; GO:0047485; GO:0051087; GO:0062023; GO:0070062; GO:1902533 HIVTFDGQNFK 9.550000191 1 1 0.399664089 1306.234194 0 15.24716 16.33759 16.10467 0 12.52269 15.71198 0 17.08116 17.3627 0 14.8453 17.20226 16.00943 14.76658 14.10364 16.08062 0 16.10923 16.24019 15.51207 18.22773 15.78836 15.88322 0 15.40122 0 0 14.75896 14.66917 0 0 16.23445 17.41117 0 0 17.1325 0 0 17.22432 16.69505 0 0 15.98895 14.00044 0 0 0 P04279 SEMG1_HUMAN "Semenogelin-1 (Cancer/testis antigen 103) (Semenogelin I, SGI) [Cleaved into: Alpha-inhibin-92; Alpha-inhibin-31; Seminal basic protein ]" SEMG1 SEMG Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; coagulation [GO:0050817]; insemination [GO:0007320]; killing of cells of another organism [GO:0031640]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; zinc ion binding [GO:0008270]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; coagulation [GO:0050817]; insemination [GO:0007320]; killing of cells of another organism [GO:0031640]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240] zinc ion binding [GO:0008270] GO:0005576; GO:0005615; GO:0005634; GO:0007320; GO:0008270; GO:0019731; GO:0031640; GO:0032991; GO:0048240; GO:0050817; GO:0061844; GO:0070062; GO:0090281; GO:1900005; GO:1901318 AQGKSQK 3.720000029 0.110369481 0.110369481 0.265906203 742.8913891 14.28832 15.81728 15.08491 14.95615 0 12.7577 15.87137 0 0 10.8729 16.22962 15.45016 0 15.18696 12.78692 14.96944 14.55262 15.56004 16.26637 15.08363 15.03362 0 15.9748 0 0 0 16.52594 0 15.35714 0 15.23615 0 16.116 15.68558 14.96411 0 0 0 0 16.00301 14.7673 14.66027 0 0 15.8838 0 0 0 P04628 WNT1_HUMAN Proto-oncogene Wnt-1 (Proto-oncogene Int-1 homolog) WNT1 INT1 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell aging [GO:0090344]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell aging [GO:0090344]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018] GO:0000578; GO:0001658; GO:0001934; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0007267; GO:0007520; GO:0008284; GO:0009611; GO:0009986; GO:0010592; GO:0010812; GO:0016015; GO:0019904; GO:0021527; GO:0021536; GO:0021551; GO:0021588; GO:0021797; GO:0022004; GO:0022408; GO:0030182; GO:0030512; GO:0030514; GO:0030579; GO:0030666; GO:0030901; GO:0031100; GO:0033077; GO:0033278; GO:0036520; GO:0042472; GO:0042770; GO:0043066; GO:0043568; GO:0045165; GO:0045599; GO:0045747; GO:0045893; GO:0045944; GO:0048018; GO:0048146; GO:0048664; GO:0051091; GO:0060061; GO:0060070; GO:0060348; GO:0061184; GO:0070062; GO:0070365; GO:0071375; GO:0071425; GO:0090344; GO:1903204; GO:1904953; GO:1904954; GO:1990403; GO:2000059 QNPGILHSVSGGLQSAVRECK 1.210000038 0.276206285 0.276206285 4.58E-13 2238.170872 14.64589 8.299011 0 0 13.24928 0 0 0 13.94382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.85063 0 0 0 0 0 15.05377 0 15.83636 0 0 P04629 NTRK1_HUMAN "High affinity nerve growth factor receptor, EC 2.7.10.1 (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A, Trk-A) (gp140trk) (p140-TrkA)" NTRK1 MTC TRK TRKA Homo sapiens (Human) "aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038] "axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005004; GO:0005030; GO:0005166; GO:0005524; GO:0005769; GO:0005770; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0007411; GO:0007568; GO:0007611; GO:0007623; GO:0008285; GO:0009314; GO:0009410; GO:0009986; GO:0010008; GO:0010465; GO:0010623; GO:0010976; GO:0014068; GO:0018108; GO:0019900; GO:0021553; GO:0030183; GO:0030424; GO:0030425; GO:0031175; GO:0031667; GO:0031901; GO:0031902; GO:0032991; GO:0033674; GO:0038083; GO:0038180; GO:0042490; GO:0042802; GO:0042803; GO:0043025; GO:0043066; GO:0043068; GO:0043121; GO:0043235; GO:0043524; GO:0043547; GO:0045766; GO:0046579; GO:0046777; GO:0048011; GO:0048406; GO:0048485; GO:0048666; GO:0048678; GO:0050965; GO:0050966; GO:0051092; GO:0051599; GO:0051602; GO:0051896; GO:0051965; GO:0051968; GO:0055038; GO:0060009; GO:0060385; GO:0061368; GO:0070374; GO:0071316; GO:1990090 NLTIVKSGLR 14.93999958 1 1 0.375932717 1098.76709 0 0 0 0 0 0 0 0 0 0 0 17.44343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04637 P53_HUMAN Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53) TP53 P53 Homo sapiens (Human) "autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac septum morphogenesis [GO:0060411]; cell aging [GO:0007569]; cellular protein localization [GO:0034613]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; gastrulation [GO:0007369]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell aging [GO:0090343]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cellular senescence [GO:2000772]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac septum morphogenesis [GO:0060411]; cell aging [GO:0007569]; cellular protein localization [GO:0034613]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; gastrulation [GO:0007369]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell aging [GO:0090343]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cellular senescence [GO:2000772]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]" "ATP-dependent DNA/DNA annealing activity [GO:0036310]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001046; GO:0001094; GO:0001227; GO:0001228; GO:0001701; GO:0001756; GO:0001836; GO:0002020; GO:0002039; GO:0002244; GO:0002309; GO:0002326; GO:0002360; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0003730; GO:0005507; GO:0005634; GO:0005654; GO:0005657; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0006357; GO:0006606; GO:0006914; GO:0006974; GO:0006977; GO:0006978; GO:0006983; GO:0007179; GO:0007265; GO:0007369; GO:0007406; GO:0007569; GO:0008104; GO:0008156; GO:0008270; GO:0008285; GO:0008340; GO:0009299; GO:0009303; GO:0009651; GO:0010165; GO:0010332; GO:0010628; GO:0010666; GO:0016032; GO:0016363; GO:0016605; GO:0017053; GO:0019899; GO:0019901; GO:0019903; GO:0021549; GO:0030308; GO:0030330; GO:0030512; GO:0030971; GO:0031065; GO:0031497; GO:0031571; GO:0031625; GO:0032991; GO:0033077; GO:0033209; GO:0034103; GO:0034613; GO:0034644; GO:0035033; GO:0035035; GO:0035264; GO:0035794; GO:0035861; GO:0036003; GO:0036310; GO:0042149; GO:0042771; GO:0042802; GO:0042826; GO:0042981; GO:0043065; GO:0043066; GO:0043153; GO:0043504; GO:0043516; GO:0043525; GO:0043621; GO:0045861; GO:0045892; GO:0045893; GO:0045899; GO:0045944; GO:0046677; GO:0046982; GO:0047485; GO:0048147; GO:0048512; GO:0048539; GO:0048568; GO:0050731; GO:0050821; GO:0051087; GO:0051097; GO:0051262; GO:0051402; GO:0051721; GO:0051726; GO:0051974; GO:0060218; GO:0060333; GO:0060411; GO:0061419; GO:0061629; GO:0062100; GO:0065003; GO:0070059; GO:0070245; GO:0070266; GO:0071456; GO:0071466; GO:0071479; GO:0071480; GO:0071494; GO:0072331; GO:0072332; GO:0072717; GO:0090200; GO:0090343; GO:0090399; GO:0090403; GO:0097193; GO:0097252; GO:0097371; GO:0097718; GO:0140296; GO:1900119; GO:1901525; GO:1902108; GO:1902253; GO:1902749; GO:1902895; GO:1903451; GO:1903799; GO:1903800; GO:1904024; GO:1905856; GO:1990144; GO:1990248; GO:1990440; GO:1990841; GO:2000269; GO:2000378; GO:2000379; GO:2000772; GO:2001244 GQSTSR 2.019999981 1 1 3.48E-13 635.2196325 0 14.40222 0 0 0 0 14.82639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.60654 16.21217 0 15.60463 16.95922 0 0 0 0 0 0 0 P04792 HSPB1_HUMAN "Heat shock protein beta-1, HspB1 (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein, HSP 27) (Stress-responsive protein 27, SRP27)" HSPB1 HSP27 HSP28 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895] axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018] axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895] identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130] GO:0000502; GO:0001533; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005925; GO:0006446; GO:0006469; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0032731; GO:0032760; GO:0035556; GO:0035924; GO:0038033; GO:0042802; GO:0042803; GO:0043066; GO:0043122; GO:0043130; GO:0043536; GO:0044183; GO:0045766; GO:0061077; GO:0061629; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028 AQLGGPEAAK 5.639999866 1 1 0.259843814 941.1462453 17.3541 19.57278 16.29141 0 17.13652 0 0 0 18.38872 0 0 16.57497 18.27049 0 0 0 18.03122 18.5081 0 0 0 0 0 18.58292 18.00386 17.75517 0 0 0 0 13.4335 0 0 0 0 0 18.46095 0 0 0 0 0 0 0 0 0 0 0 P04798 CP1A1_HUMAN "Cytochrome P450 1A1, CYPIA1, EC 1.14.14.1 (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)" CYP1A1 Homo sapiens (Human) 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; DNA methylation [GO:0006306]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743] "endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; DNA methylation [GO:0006306]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]" "arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]" GO:0001666; GO:0001676; GO:0002933; GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006306; GO:0006631; GO:0006694; GO:0006778; GO:0006805; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0009308; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009692; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0017143; GO:0019341; GO:0019373; GO:0019825; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042359; GO:0042572; GO:0042759; GO:0042904; GO:0043010; GO:0043231; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0097267; GO:0101020; GO:0101021; GO:0102033; GO:0106256; GO:0120319; GO:1900087 FLTPDGAIDKVLSEK 6.21999979 1 1 0.314156984 1632.763757 15.20638 14.53004 16.21153 18.41429 0 0 0 0 16.73917 15.83846 0 0 13.11231 14.46008 0 0 0 13.946 0 0 0 0 15.35065 0 0 0 16.721 0 0 13.96624 15.60534 0 0 0 0 0 0 0 0 0 17.83236 0 16.13444 0 0 0 0 0 P04843 RPN1_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I, RPN-I) (Ribophorin-1)" RPN1 Homo sapiens (Human) cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] RNA binding [GO:0003723] GO:0003723; GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006464; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0042470 GPFSR 6.190000057 0.048476871 0.048476871 0.221277414 563.3346403 0 14.04209 0 18.33301 14.68222 0 14.87383 0 0 17.59579 15.49071 0 0 16.06019 0 15.5659 0 0 17.09862 17.65249 15.83778 0 17.27607 0 17.75246 0 0 18.21204 16.72405 14.59263 0 15.95929 18.83696 17.95912 18.18505 19.23235 19.34442 18.1063 16.24612 16.24182 0 17.58478 18.59786 15.5911 12.97756 16.59452 17.18466 0 P04844 RPN2_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II, RPN-II) (Ribophorin-2)" RPN2 Homo sapiens (Human) aging [GO:0007568]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to xenobiotic stimulus [GO:0009410] autophagosome membrane [GO:0000421]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791] autophagosome membrane [GO:0000421]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; ribosome binding [GO:0043022]; aging [GO:0007568]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to xenobiotic stimulus [GO:0009410] ribosome binding [GO:0043022] GO:0000421; GO:0005783; GO:0005789; GO:0005791; GO:0006464; GO:0006487; GO:0007568; GO:0008250; GO:0009410; GO:0016020; GO:0016021; GO:0016604; GO:0018279; GO:0043022 YIANTVELRVK 7.630000114 1 1 0.25754244 1304.136333 0 15.58917 14.64744 15.28581 0 13.96988 0 14.54555 12.98134 0 0 15.52584 12.90968 0 14.98449 14.23265 0 0 13.82483 0 0 0 0 0 14.25504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.74114 0 0 0 0 0 0 P04920 B3A2_HUMAN "Anion exchange protein 2, AE 2, Anion exchanger 2 (Non-erythroid band 3-like protein, BND3L) (Solute carrier family 4 member 2)" SLC4A2 AE2 EPB3L1 HKB3 MPB3L Homo sapiens (Human) amelogenesis [GO:0097186]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; positive regulation of enamel mineralization [GO:0070175]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; amelogenesis [GO:0097186]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; positive regulation of enamel mineralization [GO:0070175]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085] anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857] GO:0005452; GO:0005886; GO:0005925; GO:0006820; GO:0007283; GO:0008509; GO:0015301; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0048565; GO:0050801; GO:0051453; GO:0055085; GO:0070175; GO:0097186 NAKGSTQSGR 6.980000019 1 1 0.272882063 1006.054445 15.43805 0 0 15.22507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.71544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.92798 0 0 0 0 0 0 P05060 SCG1_HUMAN "Secretogranin-1 (Chromogranin-B, CgB) (Secretogranin I, SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide ]" CHGB SCG1 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hormone activity [GO:0005179] hormone activity [GO:0005179] GO:0005179; GO:0005615; GO:0005788; GO:0030141 VQENQMDK 1.899999976 1 1 3.45E-13 1008.370065 0 15.90867 0 0 14.68273 0 12.14779 0 9.782228 0 13.37439 0 0 0 13.42184 0 0 0 0 0 0 0 0 0 17.11844 16.11931 16.21931 0 0 0 0 0 0 0 0 0 0 0 0 12.99797 0 0 0 0 0 0 0 13.08536 P05067 A4_HUMAN "Amyloid-beta precursor protein, APP (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide, CVAP) (PreA4) (Protease nexin-II, PN-II) [Cleaved into: N-APP; Soluble APP-alpha, S-APP-alpha; Soluble APP-beta, S-APP-beta; C99 (Beta-secretase C-terminal fragment, Beta-CTF); Amyloid-beta protein 42, Abeta42 (Beta-APP42); Amyloid-beta protein 40, Abeta40 (Beta-APP40); C83 (Alpha-secretase C-terminal fragment, Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59, AICD-59, AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57, AICD-57, AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50, AICD-50, AID(50)) (Gamma-CTF(50)); C31 ]" APP A4 AD1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of blood circulation [GO:1903523]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of histone acetylation [GO:0035066]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T cell migration [GO:2000406]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid-beta clearance [GO:1900221]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of response to calcium ion [GO:1905945]; regulation of signaling receptor activity [GO:0010469]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542] amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi-associated vesicle [GO:0005798]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi-associated vesicle [GO:0005798]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; RAGE receptor binding [GO:0050786]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of blood circulation [GO:1903523]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of histone acetylation [GO:0035066]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T cell migration [GO:2000406]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid-beta clearance [GO:1900221]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of response to calcium ion [GO:1905945]; regulation of signaling receptor activity [GO:0010469]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542] acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; RAGE receptor binding [GO:0050786]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914] GO:0000122; GO:0000978; GO:0001664; GO:0001774; GO:0001878; GO:0001934; GO:0001967; GO:0002265; GO:0003677; GO:0003682; GO:0004867; GO:0005102; GO:0005109; GO:0005158; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005641; GO:0005737; GO:0005739; GO:0005768; GO:0005769; GO:0005783; GO:0005788; GO:0005790; GO:0005791; GO:0005794; GO:0005796; GO:0005798; GO:0005829; GO:0005886; GO:0005887; GO:0005905; GO:0005911; GO:0006357; GO:0006378; GO:0006417; GO:0006468; GO:0006878; GO:0006897; GO:0006979; GO:0007155; GO:0007176; GO:0007186; GO:0007189; GO:0007193; GO:0007204; GO:0007219; GO:0007409; GO:0007417; GO:0007611; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008021; GO:0008088; GO:0008201; GO:0008203; GO:0008285; GO:0008306; GO:0008344; GO:0008542; GO:0009986; GO:0010288; GO:0010468; GO:0010469; GO:0010628; GO:0010629; GO:0010739; GO:0010800; GO:0010823; GO:0010971; GO:0014005; GO:0016020; GO:0016021; GO:0016199; GO:0016322; GO:0016358; GO:0016504; GO:0019722; GO:0019731; GO:0019732; GO:0019899; GO:0030111; GO:0030134; GO:0030178; GO:0030198; GO:0030424; GO:0030546; GO:0030549; GO:0030900; GO:0031093; GO:0031175; GO:0031594; GO:0031904; GO:0032092; GO:0032588; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032760; GO:0032930; GO:0032991; GO:0033130; GO:0033138; GO:0034121; GO:0034185; GO:0034363; GO:0034364; GO:0035066; GO:0035235; GO:0035253; GO:0040014; GO:0042056; GO:0042157; GO:0042327; GO:0042802; GO:0042803; GO:0043065; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0043280; GO:0043395; GO:0043406; GO:0043408; GO:0043410; GO:0043525; GO:0044304; GO:0045087; GO:0045121; GO:0045177; GO:0045202; GO:0045429; GO:0045665; GO:0045666; GO:0045745; GO:0045821; GO:0045931; GO:0045944; GO:0046330; GO:0046875; GO:0046914; GO:0046982; GO:0046983; GO:0048143; GO:0048169; GO:0048471; GO:0048669; GO:0048786; GO:0050729; GO:0050730; GO:0050750; GO:0050786; GO:0050803; GO:0050808; GO:0050829; GO:0050830; GO:0050867; GO:0050885; GO:0050890; GO:0051044; GO:0051087; GO:0051091; GO:0051092; GO:0051124; GO:0051233; GO:0051247; GO:0051260; GO:0051262; GO:0051402; GO:0051425; GO:0051563; GO:0051897; GO:0055037; GO:0061097; GO:0061098; GO:0061844; GO:0061903; GO:0070062; GO:0070206; GO:0070374; GO:0070381; GO:0070555; GO:0070851; GO:0071280; GO:0071287; GO:0071320; GO:0071874; GO:0090026; GO:0090090; GO:0090647; GO:0097449; GO:0097645; GO:0098815; GO:0106003; GO:0150003; GO:1900122; GO:1900181; GO:1900221; GO:1900272; GO:1900273; GO:1900454; GO:1901215; GO:1901216; GO:1901224; GO:1902894; GO:1902949; GO:1902950; GO:1902951; GO:1902961; GO:1903048; GO:1903223; GO:1903523; GO:1904022; GO:1904399; GO:1904472; GO:1904591; GO:1904646; GO:1905606; GO:1905893; GO:1905896; GO:1905898; GO:1905906; GO:1905908; GO:1905945; GO:1990000; GO:1990090; GO:1990535; GO:1990761; GO:1990777; GO:1990812; GO:2000310; GO:2000406; GO:2000463 MLPGLALLLLAAWTAR 2.650000095 0.518598914 0.518598914 0.009809446 1725.281258 0 0 0 0 0 0 0 0 0 0 0 0 13.35637 0 0 14.5614 0 0 0 0 0 16.11697 0 0 17.01441 0 17.19329 14.86834 12.74901 0 0 0 0 15.91179 0 15.63269 0 0 14.5182 0 0 0 0 13.60792 15.96508 0 0 16.33716 P05089 ARGI1_HUMAN "Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)" ARG1 Homo sapiens (Human) adaptive immune response [GO:0002250]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen biosynthetic process [GO:0032964]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; liver development [GO:0001889]; lung development [GO:0030324]; mammary gland involution [GO:0060056]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; regulation of L-arginine import across plasma membrane [GO:1905541]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to herbicide [GO:0009635]; response to manganese ion [GO:0010042]; response to methylmercury [GO:0051597]; response to selenium ion [GO:0010269]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; arginase activity [GO:0004053]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; adaptive immune response [GO:0002250]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen biosynthetic process [GO:0032964]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; liver development [GO:0001889]; lung development [GO:0030324]; mammary gland involution [GO:0060056]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; regulation of L-arginine import across plasma membrane [GO:1905541]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to herbicide [GO:0009635]; response to manganese ion [GO:0010042]; response to methylmercury [GO:0051597]; response to selenium ion [GO:0010269]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] arginase activity [GO:0004053]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145] GO:0000050; GO:0001889; GO:0001938; GO:0002250; GO:0004053; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005741; GO:0005829; GO:0006527; GO:0007568; GO:0009410; GO:0009635; GO:0010042; GO:0010043; GO:0010269; GO:0014075; GO:0019547; GO:0030145; GO:0030324; GO:0032964; GO:0033189; GO:0033197; GO:0035578; GO:0035580; GO:0042130; GO:0042802; GO:0042832; GO:0043005; GO:0043025; GO:0043200; GO:0045087; GO:0046007; GO:0046686; GO:0048678; GO:0051597; GO:0060056; GO:0060135; GO:0060336; GO:0070301; GO:0070965; GO:0071222; GO:0071353; GO:0071377; GO:0071549; GO:0071560; GO:1905541; GO:2000552 MSAKSR 8.029999733 1 1 0.285157353 696.3225209 0 14.21571 16.13375 16.20845 0 0 16.21206 15.78485 0 0 16.57296 0 15.47543 16.7758 17.62885 15.98289 17.50792 18.12889 16.95927 0 18.70604 0 16.55204 15.46752 18.06864 17.15661 17.85756 17.93166 18.56764 17.3667 17.86692 17.41857 14.83859 18.32436 18.32253 18.4649 19.84402 18.95323 19.41829 0 17.48713 18.7335 19.01868 19.27762 19.09428 0 19.20232 18.7176 P05091 ALDH2_HUMAN "Aldehyde dehydrogenase, mitochondrial, EC 1.2.1.3 (ALDH class 2) (ALDH-E2) (ALDHI)" ALDH2 ALDM Homo sapiens (Human) alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylic ester hydrolase activity [GO:0052689]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylic ester hydrolase activity [GO:0052689]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957] GO:0004029; GO:0004030; GO:0005739; GO:0005759; GO:0005975; GO:0006066; GO:0006068; GO:0008957; GO:0009055; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:0070062; GO:1903179; GO:1905627 MLRAAAR 12.10000038 1 1 0.246294628 805.0008298 14.88928 0 12.77021 0 13.69096 0 0 0 0 0 13.99126 14.13095 13.9422 0 0 0 16.15684 0 0 0 0 15.90091 16.15104 0 0 0 0 0 0 0 0 0 0 0 0 14.17943 0 0 0 14.28382 15.19905 0 0 0 0 13.33051 0 0 P05093 CP17A_HUMAN "Steroid 17-alpha-hydroxylase/17,20 lyase, EC 1.14.14.19 (17-alpha-hydroxyprogesterone aldolase, EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17, Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)" CYP17A1 CYP17 S17AH Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508]; androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202] 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508] GO:0004508; GO:0005506; GO:0005783; GO:0005789; GO:0006694; GO:0006702; GO:0006704; GO:0007548; GO:0008202; GO:0019825; GO:0020037; GO:0030424; GO:0042446; GO:0042448; GO:0043025; GO:0047442 LKSHVK 2.309999943 1 1 0.155192505 711.5299848 15.75453 15.93694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9983 0 0 0 0 0 0 0 0 0 0 P05107 ITB2_HUMAN "Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)" ITGB2 CD18 MFI7 Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]" cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] "cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]" amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] GO:0001540; GO:0001774; GO:0001851; GO:0005178; GO:0005886; GO:0005925; GO:0006898; GO:0006911; GO:0006915; GO:0006954; GO:0007155; GO:0007159; GO:0007160; GO:0007229; GO:0007267; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016020; GO:0016477; GO:0019901; GO:0030369; GO:0030593; GO:0031072; GO:0031623; GO:0032930; GO:0033627; GO:0034113; GO:0034687; GO:0034688; GO:0034689; GO:0035579; GO:0035987; GO:0043113; GO:0043235; GO:0043315; GO:0044853; GO:0045963; GO:0046872; GO:0050730; GO:0050839; GO:0070062; GO:0070821; GO:0071404; GO:0090314; GO:0097242; GO:0098609; GO:0098742; GO:0101003; GO:1901216; GO:1903561; GO:1904996; GO:1990266; GO:2000363 LGGDLLRALNEITESGR 15.60000038 1 1 6.86E-13 1813.903077 14.61625 11.24566 0 0 15.53208 0 0 13.3904 0 13.8054 11.45337 13.35747 0 14.5393 15.03092 13.16608 14.35559 15.01987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07204 16.34442 0 0 0 0 0 0 P05129 KPCG_HUMAN "Protein kinase C gamma type, PKC-gamma, EC 2.7.11.13" PRKCG PKCG Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511] calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060] calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511] ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270] GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007268; GO:0007611; GO:0007635; GO:0008270; GO:0009636; GO:0014069; GO:0016310; GO:0018105; GO:0030425; GO:0031397; GO:0032095; GO:0032425; GO:0035556; GO:0042177; GO:0042752; GO:0043278; GO:0043524; GO:0044305; GO:0046777; GO:0048265; GO:0048471; GO:0048511; GO:0050764; GO:0060291; GO:0060384; GO:0097060; GO:0099171; GO:0099523; GO:0099524; GO:0106310; GO:1901799; GO:1990911; GO:2000300 MAGLGPGVGDSEGGPRPLFCR 4.389999866 1 1 0.167254045 2143.226611 8.450943 14.89953 13.38291 0 0 10.5889 8.367502 15.04598 12.82447 12.47677 14.02932 0 11.89357 9.904887 11.30427 0 0 13.21732 0 13.09219 0 14.3757 0 11.67899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05155 IC1_HUMAN "Plasma protease C1 inhibitor, C1 Inh, C1Inh (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)" SERPING1 C1IN C1NH Homo sapiens (Human) "aging [GO:0007568]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; complement activation, classical pathway [GO:0006958]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of endopeptidase activity [GO:0010951]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; serine-type endopeptidase inhibitor activity [GO:0004867]; aging [GO:0007568]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; complement activation, classical pathway [GO:0006958]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of endopeptidase activity [GO:0010951]" serine-type endopeptidase inhibitor activity [GO:0004867] GO:0001869; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0006958; GO:0007568; GO:0007596; GO:0008015; GO:0010951; GO:0031093; GO:0042730; GO:0045087; GO:0062023; GO:0070062; GO:0072562 LEDMEQALSPSVFKAIMEK 2.190000057 1 1 0.185613695 2181.444469 15.95649 12.18433 8.327921 0 0 0 0 13.37533 0 0 0 13.04023 0 0 12.36695 0 0 16.16309 10.54912 0 0 0 0 0 0 0 12.25033 0 0 0 9.700296 0 15.32236 0 0 13.92392 0 15.8573 0 12.58772 0 14.36892 15.73873 0 12.82387 0 0 0 P05164 PERM_HUMAN "Myeloperoxidase, MPO, EC 1.11.2.2 [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain ]" MPO Homo sapiens (Human) aging [GO:0007568]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878] azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141] azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141]; chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878] chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] GO:0001878; GO:0002149; GO:0002679; GO:0003682; GO:0004601; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0006952; GO:0006979; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0035578; GO:0042582; GO:0042742; GO:0042744; GO:0043066; GO:0043231; GO:0046872; GO:0050832; GO:0070062; GO:0097013; GO:1990268 YLPTYRSYNDSVDPR 3.980000019 1 1 0.273378219 1845.864289 0 12.04664 14.5913 15.72934 14.10921 12.72083 0 12.08202 15.7888 0 0 0 0 15.73474 0 14.92364 14.41302 0 0 0 14.3326 0 0 0 0 0 0 0 13.50466 14.65789 14.95657 15.81841 11.93792 13.99662 12.84924 13.5797 14.25197 13.99091 0 10.9731 13.63999 16.10861 0 0 0 0 0 0 P05186 PPBT_HUMAN "Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, TNS-ALP, TNSALP, EC 3.1.3.1 (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase, EC 3.9.1.1)" ALPL Homo sapiens (Human) bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0010259; GO:0016020; GO:0016311; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031225; GO:0031966; GO:0032496; GO:0033280; GO:0033883; GO:0034516; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071407; GO:0071529; GO:0120162; GO:1904383 GNSIFGLAPMLSDTDK 6.130000114 0.761119485 0.761119485 3.65E-12 1665.97195 0 13.66486 0 15.23316 17.0866 0 0 0 0 11.04418 13.47582 12.65813 14.84858 14.01312 13.55441 15.15756 0 0 14.59792 16.43694 16.22413 13.46684 15.09488 16.99426 0 16.25692 0 14.30472 14.37553 14.86873 0 15.23321 13.30412 13.56043 15.43047 0 0 15.03484 16.36151 0 14.69392 0 14.49869 14.36769 12.87792 15.74997 0 16.39091 P05198 IF2A_HUMAN "Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha, eIF-2-alpha, eIF-2A, eIF-2alpha)" EIF2S1 EIF2A Homo sapiens (Human) aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043558; GO:0043614; GO:0044207; GO:0045202; GO:0046777; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676 EALRAGLNCSTENMPIK 6.590000153 1 1 0.035624975 1920.006344 15.4584 14.06415 13.37564 0 0 11.98083 15.83902 0 0 0 0 14.48741 13.63791 0 0 0 0 0 0 0 0 13.64178 0 13.51523 0 0 0 0 0 13.70411 0 0 15.84177 0 0 15.08809 0 0 0 11.92897 0 0 0 0 0 13.34264 0 0 P05305 EDN1_HUMAN "Endothelin-1 (Preproendothelin-1, PPET1) [Cleaved into: Endothelin-1, ET-1; Big endothelin-1 ]" EDN1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; inositol phosphate-mediated signaling [GO:0048016]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C deactivation [GO:0042313]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093] basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093]; cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; inositol phosphate-mediated signaling [GO:0048016]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C deactivation [GO:0042313]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179] GO:0000122; GO:0001516; GO:0001569; GO:0001701; GO:0001821; GO:0001975; GO:0003100; GO:0003253; GO:0003357; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006366; GO:0006468; GO:0006874; GO:0006885; GO:0007005; GO:0007166; GO:0007186; GO:0007193; GO:0007204; GO:0007205; GO:0007249; GO:0007267; GO:0007585; GO:0007589; GO:0008284; GO:0009953; GO:0010193; GO:0010259; GO:0010460; GO:0010595; GO:0010613; GO:0010629; GO:0010737; GO:0010827; GO:0014034; GO:0014065; GO:0014823; GO:0014824; GO:0014826; GO:0019229; GO:0019233; GO:0019722; GO:0030072; GO:0030133; GO:0030185; GO:0030195; GO:0030335; GO:0030878; GO:0031583; GO:0031707; GO:0031708; GO:0032269; GO:0032308; GO:0032496; GO:0033093; GO:0033574; GO:0034392; GO:0034696; GO:0035050; GO:0035094; GO:0035810; GO:0035815; GO:0035994; GO:0042045; GO:0042310; GO:0042313; GO:0042474; GO:0042482; GO:0042554; GO:0043179; GO:0043200; GO:0043406; GO:0043507; GO:0044321; GO:0044751; GO:0045178; GO:0045321; GO:0045429; GO:0045793; GO:0045840; GO:0045944; GO:0045987; GO:0046887; GO:0046888; GO:0048016; GO:0048237; GO:0048661; GO:0048675; GO:0051091; GO:0051216; GO:0051482; GO:0051771; GO:0051899; GO:0051930; GO:0060070; GO:0060137; GO:0060298; GO:0060385; GO:0060585; GO:0061051; GO:0061626; GO:0070101; GO:0070294; GO:0070301; GO:0070371; GO:0070588; GO:0071277; GO:0071310; GO:0071346; GO:0071347; GO:0071356; GO:0071372; GO:0071373; GO:0071385; GO:0071389; GO:0071398; GO:0071456; GO:0071466; GO:0071548; GO:0071560; GO:0086100; GO:0086101; GO:0090023; GO:0097492; GO:1901224; GO:1902074; GO:1902287; GO:1903537; GO:1904707; GO:2000273; GO:2001259 GKPSRER 13 1 1 0.475300218 829.3586274 0 21.27126 21.4416 0 0 0 0 0 0 0 0 0 0 18.81847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.52253 0 0 0 0 0 0 0 0 17.99474 0 0 0 0 0 0 0 P05362 ICAM1_HUMAN "Intercellular adhesion molecule 1, ICAM-1 (Major group rhinovirus receptor) (CD antigen CD54)" ICAM1 Homo sapiens (Human) adhesion of symbiont to host [GO:0044406]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of leukocyte mediated cytotoxicity [GO:0001910]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adhesion of symbiont to host [GO:0044406]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of leukocyte mediated cytotoxicity [GO:0001910]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683] integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] GO:0001618; GO:0001772; GO:0001910; GO:0002291; GO:0002457; GO:0002693; GO:0004888; GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007157; GO:0007159; GO:0009897; GO:0009986; GO:0016020; GO:0022614; GO:0033627; GO:0038023; GO:0044406; GO:0045121; GO:0046813; GO:0050900; GO:0061028; GO:0062023; GO:0070062; GO:0070374; GO:0071333; GO:0072683; GO:1900027; GO:1902042; GO:1904646; GO:1990830; GO:2000352 ELLLPGNNRK 6.440000057 1 1 0.154319992 1155.533079 13.52659 10.56382 15.45796 0 10.9079 0 9.531847 14.98777 11.97197 15.48215 0 17.64503 12.3056 12.87432 0 13.59006 0 0 0 0 0 0 0 0 0 0 0 14.90837 0 0 0 0 0 0 15.38815 0 0 0 0 0 0 0 0 0 0 0 0 0 P05412 JUN_HUMAN "Transcription factor Jun (Activator protein 1, AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39)" JUN Homo sapiens (Human) "angiogenesis [GO:0001525]; axon regeneration [GO:0031103]; cellular response to anisomycin [GO:0072740]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to reactive oxygen species [GO:0034614]; eyelid development in camera-type eye [GO:0061029]; integrated stress response signaling [GO:0140467]; leading edge cell differentiation [GO:0035026]; liver development [GO:0001889]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; angiogenesis [GO:0001525]; axon regeneration [GO:0031103]; cellular response to anisomycin [GO:0072740]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to reactive oxygen species [GO:0034614]; eyelid development in camera-type eye [GO:0061029]; integrated stress response signaling [GO:0140467]; leading edge cell differentiation [GO:0035026]; liver development [GO:0001889]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]" GO:0000122; GO:0000228; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001774; GO:0001889; GO:0001938; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0003723; GO:0005096; GO:0005634; GO:0005654; GO:0005667; GO:0005886; GO:0006357; GO:0007179; GO:0007265; GO:0008285; GO:0009410; GO:0010634; GO:0017053; GO:0019899; GO:0030224; GO:0031103; GO:0031625; GO:0031953; GO:0034614; GO:0035026; GO:0035497; GO:0035976; GO:0035994; GO:0042127; GO:0042802; GO:0043065; GO:0043392; GO:0043524; GO:0043922; GO:0043923; GO:0044389; GO:0045892; GO:0045893; GO:0045944; GO:0048146; GO:0051726; GO:0060395; GO:0061029; GO:0061629; GO:0070374; GO:0070412; GO:0071276; GO:0071277; GO:0072740; GO:0090575; GO:0140296; GO:0140467; GO:1901522; GO:1902895; GO:1904707; GO:1990441; GO:1990837; GO:2000144 VMNHVNSGCQLMLTQQLQTF 4.96999979 1 1 0.150491889 2365.668492 15.30593 0 0 16.21096 0 11.95969 15.13993 0 14.85243 14.89554 14.77001 13.96575 0 13.24929 0 10.5048 0 0 14.64711 0 0 0 0 15.17907 0 0 0 0 0 0 0 12.89867 0 0 0 0 0 0 0 15.7297 14.32555 0 0 0 0 0 11.4738 0 P05423 RPC4_HUMAN "DNA-directed RNA polymerase III subunit RPC4, RNA polymerase III subunit C4 (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)" POLR3D BN51 BN51T Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607 MKAPPK 4.599999905 1 1 0.106925882 687.3321017 15.43717 0 13.41821 14.13871 0 15.79317 13.41966 0 0 0 15.37878 13.76284 15.13981 15.31639 15.92862 0 0 15.71729 15.76447 14.8785 0 0 15.76819 16.98924 14.72571 14.98416 13.82135 0 15.08294 0 16.50991 0 13.31605 0 0 0 0 0 0 0 0 0 16.51485 0 0 0 0 0 P05543 THBG_HUMAN Thyroxine-binding globulin (Serpin A7) (T4-binding globulin) SERPINA7 TBG Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0070062; GO:0070327 NALALFVLPKEGQMESVEAAMSSK 2.319999933 0.715693831 0.715693831 5.48E-12 2582.148009 0 14.4283 0 0 0 0 14.08933 14.81254 13.00632 0 13.217 14.51068 0 0 0 0 15.4854 0 0 13.7493 0 16.33134 0 0 0 0 15.60499 14.45652 0 14.41392 0 16.97145 15.11792 0 0 15.05588 0 0 0 0 0 0 0 17.42417 0 0 0 16.29197 P05771 KPCB_HUMAN "Protein kinase C beta type, PKC-B, PKC-beta, EC 2.7.11.13" PRKCB PKCB PRKCB1 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; chromatin organization [GO:0006325]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; chromatin organization [GO:0006325]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270] GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006357; GO:0006468; GO:0006816; GO:0006874; GO:0006915; GO:0007077; GO:0007165; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0018105; GO:0030374; GO:0030949; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0042953; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0070062; GO:0071322; GO:0099171; GO:0099523; GO:0106310; GO:2000300 TTNTVSK 2.980000019 0.232961893 0.232961893 0.144241838 749.3400215 10.58972 13.36823 13.21026 0 13.78255 0 14.29954 14.72799 15.66821 15.00124 13.66183 0 0 0 0 0 0 0 15.96194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05783 K1C18_HUMAN "Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18, CK-18) (Keratin-18, K18)" KRT18 CYK18 PIG46 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209] adherens junction [GO:0005912]; cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471] adherens junction [GO:0005912]; cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding involved in cell-cell adhesion [GO:0098641]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]; anatomical structure morphogenesis [GO:0009653]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cadherin binding involved in cell-cell adhesion [GO:0098641]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198] GO:0003723; GO:0005198; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005856; GO:0005882; GO:0005912; GO:0007049; GO:0009653; GO:0033209; GO:0034451; GO:0043000; GO:0043066; GO:0045095; GO:0045104; GO:0048471; GO:0070062; GO:0071944; GO:0097110; GO:0097191; GO:0097284; GO:0098641 ETMQSLNDR 5.889999866 1 1 0.097369705 1092.888158 16.707 16.5993 16.95329 17.09519 0 16.92899 16.89478 15.21746 0 0 16.54449 0 16.06861 0 0 0 0 15.54434 0 16.41743 0 16.50558 0 0 16.33628 16.80792 17.51456 0 15.8865 0 0 0 13.92198 0 0 0 16.62647 15.79263 0 0 17.4412 0 0 0 17.45079 16.68587 17.59998 16.32858 P05787 K2C8_HUMAN "Keratin, type II cytoskeletal 8 (Cytokeratin-8, CK-8) (Keratin-8, K8) (Type-II keratin Kb8)" KRT8 CYK8 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110] scaffold protein binding [GO:0097110] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005882; GO:0016363; GO:0045095; GO:0045111; GO:0070062; GO:0097110 LALDIEIATYR 10.55000019 1 1 0.181504276 1277.572196 8.792447 0 0 0 0 15.53033 0 0 0 0 0 0 0 0 16.94536 0 0 0 0 0 0 0 16.45017 0 0 0 0 16.29118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.99629 0 0 0 P05997 CO5A2_HUMAN Collagen alpha-2(V) chain COL5A2 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; ossification [GO:0001503]; skeletal system development [GO:0001501]; skin development [GO:0043588] collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; ossification [GO:0001503]; skeletal system development [GO:0001501]; skin development [GO:0043588] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332] GO:0001501; GO:0001503; GO:0005201; GO:0005576; GO:0005588; GO:0005592; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0043588; GO:0046332; GO:0046872; GO:0048592; GO:0062023; GO:0071230; GO:1903225 SPDGSKK 4.909999847 0.069618277 0.069618277 0.255445285 717.469816 19.16058 0 0 0 0 21.31725 22.53829 19.63417 18.14373 19.51937 22.28618 17.75579 17.44179 18.5394 0 0 16.70571 18.58261 19.71202 17.83315 0 18.07697 21.14262 0 18.74693 23.07689 21.90406 21.77824 0 19.8804 0 0 23.63797 20.14324 19.12059 22.57525 0 19.84151 18.08786 0 17.80903 0 20.83124 20.8683 20.86425 0 0 0 P06132 DCUP_HUMAN "Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37" UROD Homo sapiens (Human) heme biosynthetic process [GO:0006783]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782] uroporphyrinogen decarboxylase activity [GO:0004853] GO:0004853; GO:0005654; GO:0005829; GO:0006778; GO:0006782; GO:0006783; GO:0006787 MEANGLGPQGFPELKNDTFLR 1.450000048 1 1 0.15344947 2350.140373 0 13.30798 0 0 0 12.21253 18.13063 12.44521 10.50194 15.0987 13.30497 12.95444 0 11.55575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32081 0 0 0 0 0 0 0 0 P06213 INSR_HUMAN "Insulin receptor, IR, EC 2.7.10.1 (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta ]" INSR Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]" axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]" amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001540; GO:0001934; GO:0002092; GO:0003007; GO:0004712; GO:0004713; GO:0004714; GO:0005009; GO:0005159; GO:0005198; GO:0005524; GO:0005525; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0005975; GO:0006355; GO:0006468; GO:0006898; GO:0007169; GO:0007186; GO:0007612; GO:0007613; GO:0008284; GO:0008286; GO:0008544; GO:0008584; GO:0009897; GO:0010008; GO:0014068; GO:0016020; GO:0018108; GO:0019904; GO:0030238; GO:0030325; GO:0030335; GO:0030424; GO:0031017; GO:0031994; GO:0031995; GO:0032147; GO:0032148; GO:0032590; GO:0032809; GO:0032869; GO:0033674; GO:0038024; GO:0038083; GO:0042593; GO:0042802; GO:0043235; GO:0043243; GO:0043406; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044877; GO:0045429; GO:0045725; GO:0045821; GO:0045840; GO:0045893; GO:0045995; GO:0046326; GO:0046718; GO:0046777; GO:0048639; GO:0051425; GO:0051446; GO:0051897; GO:0060267; GO:0070062; GO:0071363; GO:0097062; GO:0097242; GO:0150104; GO:1990535; GO:2000194 LIMITDYLLLFR 15.17000008 1 1 0.049366752 1522.070448 0 0 0 0 13.98377 15.49574 15.5635 0 15.1183 15.30696 15.12236 0 15.52425 0 15.66901 13.15274 0 13.17568 0 0 12.16122 0 15.30535 0 15.40401 0 14.79316 0 0 0 0 0 0 0 0 0 0 0 0 14.52501 13.69082 0 0 0 14.81009 0 0 13.92908 P06239 LCK_HUMAN "Tyrosine-protein kinase Lck, EC 2.7.10.2 (Leukocyte C-terminal Src kinase, LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK)" LCK Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; Fc-gamma receptor signaling pathway [GO:0038094]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; Fc-gamma receptor signaling pathway [GO:0038094]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608] GO:0000242; GO:0001772; GO:0001784; GO:0004712; GO:0004713; GO:0004715; GO:0004722; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0006882; GO:0006919; GO:0007169; GO:0008022; GO:0009410; GO:0016004; GO:0018108; GO:0019901; GO:0019903; GO:0030097; GO:0030154; GO:0030168; GO:0030217; GO:0031234; GO:0031295; GO:0034116; GO:0035556; GO:0038083; GO:0038094; GO:0042169; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043274; GO:0043548; GO:0045087; GO:0045121; GO:0050852; GO:0050853; GO:0050862; GO:0050870; GO:0050900; GO:0051117; GO:0051209; GO:0051249; GO:0070062; GO:1903039; GO:2001244 SLKQGSMSPDAFLAEANLMK 5.679999828 1 1 0.256814873 2155.061978 10.68677 14.43976 12.27713 0 0 15.64723 0 0 0 0 0 16.30666 14.74613 0 0 0 12.0188 0 13.19244 0 0 0 0 13.90884 0 0 0 0 0 11.84409 14.84551 0 0 13.88181 0 0 0 0 0 0 0 0 15.878 0 0 0 0 0 P06276 CHLE_HUMAN "Cholinesterase, EC 3.1.1.8 (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase)" BCHE CHE1 Homo sapiens (Human) acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]" "acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]" GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0007612; GO:0008285; GO:0009410; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0052689; GO:0072562 LTGCSR 1.159999967 1 1 8.05E-13 694.3208762 0 0 14.63805 0 0 14.47685 13.85757 0 15.97894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0439 0 0 0 0 0 0 0 0 13.11809 0 0 0 0 0 0 0 P06312 KV401_HUMAN Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH) IGKV4-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] antigen binding [GO:0003823] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0072562 ATINCKSSQSVLYSSNNK 16.60000038 0.586031199 0.586031199 0.17544397 2001.202833 0 17.27553 0 18.4061 15.63492 0 0 0 15.85731 0 0 16.66673 0 16.01101 0 0 18.84464 0 17.86486 0 0 0 0 18.11025 0 0 0 16.41521 0 0 16.52576 17.88241 16.33334 0 18.08995 0 18.2518 0 0 0 17.04067 0 0 0 0 19.07651 0 17.24707 P06340 DOA_HUMAN "HLA class II histocompatibility antigen, DO alpha chain (MHC DN-alpha) (MHC DZ alpha) (MHC class II antigen DOA)" HLA-DOA HLA-DNA HLA-DZA Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; regulation of T cell differentiation [GO:0045580] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; regulation of T cell differentiation [GO:0045580] MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395] GO:0002250; GO:0002503; GO:0002587; GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0019886; GO:0023026; GO:0032395; GO:0042613; GO:0045580; GO:0050870 FDPQGGLAGIAAIK 16.15999985 1 1 0.420909017 1356.279635 0 0 0 0 0 0 0 16.54195 0 0 0 0 16.48541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.49491 0 0 0 0 0 0 0 0 0 0 0 0 0 17.73164 0 0 0 P06396 GELS_HUMAN "Gelsolin (AGEL) (Actin-depolymerizing factor, ADF) (Brevin)" GSN Homo sapiens (Human) "actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]" actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774] "actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]" "actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0002102; GO:0003779; GO:0005509; GO:0005546; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006911; GO:0007417; GO:0008154; GO:0010628; GO:0014891; GO:0015629; GO:0016528; GO:0030027; GO:0030031; GO:0030041; GO:0030042; GO:0030478; GO:0030864; GO:0031648; GO:0034774; GO:0035994; GO:0036313; GO:0042989; GO:0045010; GO:0045159; GO:0045335; GO:0046597; GO:0051014; GO:0051015; GO:0051016; GO:0051127; GO:0051693; GO:0055119; GO:0060271; GO:0070062; GO:0071346; GO:0071801; GO:0072562; GO:0086003; GO:0090527; GO:0097017; GO:0097284; GO:1902174; GO:1903903; GO:1903906; GO:1903909; GO:1903923; GO:1904813; GO:1990000; GO:2001269 DSQEEEKTEALTSAK 5.659999847 1 1 0.168929459 1666.730535 14.4824 0 12.37397 0 15.11646 0 13.6266 13.85101 12.81543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06400 RB_HUMAN "Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb, Rb) (pp110)" RB1 Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; glial cell apoptotic process [GO:0034349]; hepatocyte apoptotic process [GO:0097284]; heterochromatin assembly [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of cohesin loading [GO:0071922]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]" chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; glial cell apoptotic process [GO:0034349]; hepatocyte apoptotic process [GO:0097284]; heterochromatin assembly [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of cohesin loading [GO:0071922]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]" disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006469; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051301; GO:0051402; GO:0051726; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0071901; GO:0071922; GO:0071930; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1902948; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234 VMESMLK 6.46999979 0.357148558 0.357148558 0.274401103 851.0675827 0 16.08199 0 14.74391 0 15.78734 0 14.73171 15.72152 15.79442 15.46322 15.90505 15.18691 15.0992 13.52425 15.43733 15.40787 0 14.36502 0 13.83746 14.2632 0 16.45504 0 15.84507 15.14257 0 0 0 0 15.26087 15.84692 16.07655 15.90959 15.93366 0 15.73545 0 16.04461 0 16.20161 0 15.9398 0 0 15.29459 0 P06401 PRGR_HUMAN "Progesterone receptor, PR (Nuclear receptor subfamily 3 group C member 3)" PGR NR3C3 Homo sapiens (Human) cell-cell signaling [GO:0007267]; epithelial cell maturation [GO:0002070]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lung alveolus development [GO:0048286]; negative regulation of gene expression [GO:0010629]; ovulation from ovarian follicle [GO:0001542]; paracrine signaling [GO:0038001]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748] chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; epithelial cell maturation [GO:0002070]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lung alveolus development [GO:0048286]; negative regulation of gene expression [GO:0010629]; ovulation from ovarian follicle [GO:0001542]; paracrine signaling [GO:0038001]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]" "ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001542; GO:0002070; GO:0003677; GO:0003707; GO:0004879; GO:0005102; GO:0005496; GO:0005654; GO:0005741; GO:0005829; GO:0006357; GO:0007165; GO:0007267; GO:0008270; GO:0010628; GO:0010629; GO:0019899; GO:0030518; GO:0038001; GO:0042802; GO:0045944; GO:0048286; GO:0050678; GO:0050847; GO:0051117; GO:0060748 GVVSSSQR 9.25 1 1 3.45E-13 819.6462476 16.41669 0 0 15.56452 0 0 0 0 0 0 0 15.56346 0 0 0 0 15.85801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68437 0 0 16.47818 0 0 0 0 0 0 0 0 0 15.12513 P06493 CDK1_HUMAN "Cyclin-dependent kinase 1, CDK1, EC 2.7.11.22, EC 2.7.11.23 (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)" CDK1 CDC2 CDC28A CDKN1 P34CDC2 Homo sapiens (Human) animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]" ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618] GO:0000086; GO:0000226; GO:0000307; GO:0000781; GO:0001618; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005789; GO:0005813; GO:0005829; GO:0005876; GO:0006260; GO:0006281; GO:0006468; GO:0006915; GO:0007095; GO:0007098; GO:0007344; GO:0007569; GO:0008283; GO:0008353; GO:0009410; GO:0009636; GO:0010628; GO:0010629; GO:0010971; GO:0014038; GO:0014070; GO:0014075; GO:0014823; GO:0016020; GO:0016477; GO:0016579; GO:0018105; GO:0018107; GO:0030261; GO:0030332; GO:0030496; GO:0030544; GO:0030855; GO:0031100; GO:0034501; GO:0035173; GO:0042307; GO:0042752; GO:0043066; GO:0045471; GO:0045740; GO:0045995; GO:0046686; GO:0046688; GO:0048511; GO:0048678; GO:0051301; GO:0055015; GO:0060045; GO:0065003; GO:0070062; GO:0070301; GO:0070371; GO:0072686; GO:0090166; GO:0097125; GO:0097472; GO:0106310; GO:1900182; GO:1905448 MLIYDPAK 4.420000076 1 1 0.252398692 949.1766131 0 17.7497 0 0 15.69568 16.48587 0 0 0 0 0 17.73301 16.97733 0 0 0 0 0 17.48963 0 0 17.15826 0 0 16.9535 0 16.91212 0 18.3245 0 0 0 0 0 0 0 0 0 17.88104 0 0 0 0 0 0 0 0 0 P06576 ATPB_HUMAN "ATP synthase subunit beta, mitochondrial, EC 7.1.2.2 (ATP synthase F1 subunit beta)" ATP5F1B ATP5B ATPMB ATPSB Homo sapiens (Human) angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453] "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]" "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]" "angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0001525; GO:0001649; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0009986; GO:0015986; GO:0016020; GO:0031966; GO:0042288; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:0098761; GO:1902600 LGFVGR 1.559999943 1 1 0.022347899 646.3365814 0 14.39395 0 0 15.62411 14.35553 0 14.93949 0 14.32199 16.11624 0 14.64007 15.5842 12.99866 15.80869 15.70415 14.47849 15.02098 12.09289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05874 0 0 0 0 16.425 0 0 15.21165 0 0 0 0 0 P06681 CO2_HUMAN "Complement C2, EC 3.4.21.43 (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment ]" C2 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; response to lipopolysaccharide [GO:0032496]; response to thyroid hormone [GO:0097066]" classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; response to lipopolysaccharide [GO:0032496]; response to thyroid hormone [GO:0097066]" metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005576; GO:0005601; GO:0005615; GO:0005886; GO:0006956; GO:0006958; GO:0032496; GO:0045087; GO:0046872; GO:0050778; GO:0070062; GO:0097066; GO:1903028; GO:2000427 ESLGRK 4.119999886 0.790263355 0.790263355 0.023012705 689.2857189 0 14.24196 15.74219 0 0 0 0 12.33022 0 0 0 14.14018 15.59882 0 0 0 0 0 0 0 0 0 0 15.7013 0 0 0 0 14.07883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.14409 0 P06703 S10A6_HUMAN "Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein, PRA) (S100 calcium-binding protein A6)" S100A6 CACY Homo sapiens (Human) axonogenesis [GO:0007409]; positive regulation of fibroblast proliferation [GO:0048146]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ion transmembrane transporter activity [GO:0015075]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tropomyosin binding [GO:0005523]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; positive regulation of fibroblast proliferation [GO:0048146]; signal transduction [GO:0007165] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ion transmembrane transporter activity [GO:0015075]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tropomyosin binding [GO:0005523]; zinc ion binding [GO:0008270] GO:0001726; GO:0005509; GO:0005523; GO:0005576; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007409; GO:0008270; GO:0015075; GO:0031234; GO:0042803; GO:0044548; GO:0048146; GO:0048306; GO:0048471; GO:0062023; GO:0070062 ELTIGSK 9.140000343 0.398185164 0.398185164 0.127977703 747.5053656 15.56002 0 14.07082 13.58872 14.35683 15.75728 0 15.14426 13.22398 0 0 0 14.67075 11.87936 0 15.09164 13.85621 14.32848 0 0 0 0 0 14.81523 0 0 0 0 0 0 0 0 0 0 14.63648 0 0 0 17.36613 0 15.16821 0 0 16.15556 0 0 0 0 P06732 KCRM_HUMAN "Creatine kinase M-type, EC 2.7.3.2 (Creatine kinase M chain) (Creatine phosphokinase M-type, CPK-M) (M-CK)" CKM CKMM Homo sapiens (Human) phosphocreatine biosynthetic process [GO:0046314] cytosol [GO:0005829]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular space [GO:0005615]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314] ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301] GO:0004111; GO:0005524; GO:0005615; GO:0005829; GO:0016301; GO:0046314 GGVHVK 6.670000076 1 1 0.150984538 596.8671732 14.92782 0 14.85748 0 15.38874 0 0 0 0 0 0 16.27767 0 0 16.66425 0 17.02862 0 0 15.60102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06737 PYGL_HUMAN "Glycogen phosphorylase, liver form, EC 2.4.1.1" PYGL Homo sapiens (Human) 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617] AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842] GO:0002060; GO:0005524; GO:0005536; GO:0005576; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0006015; GO:0008184; GO:0009617; GO:0016208; GO:0019842; GO:0030170; GO:0032052; GO:0034774; GO:0042593; GO:0042802; GO:0070062; GO:0070266; GO:0102250; GO:0102499; GO:1904813 HLDRIVALFPK 3.779999971 1 1 6.90E-13 1309.024202 16.07793 0 0 12.15612 0 12.37228 0 0 13.59614 0 0 13.63748 13.57064 0 0 14.89075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.96656 0 0 0 0 0 0 0 0 P06744 G6PI_HUMAN "Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)" GPI Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574] ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574] cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625] GO:0001701; GO:0001707; GO:0002639; GO:0004347; GO:0005125; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0006959; GO:0007599; GO:0007611; GO:0008083; GO:0010595; GO:0016020; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0034774; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051156; GO:0060170; GO:0070062; GO:1904813 HFVALSTNTTK 11.14999962 1 1 0.112787314 1219.670264 0 0 0 0 14.82951 0 0 0 0 0 0 0 12.53327 0 14.92222 0 0 0 0 0 0 0 0 14.47712 0 12.87201 0 0 0 0 0 13.25765 14.31022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06746 DPOLB_HUMAN "DNA polymerase beta, EC 2.7.7.7, EC 4.2.99.-" POLB Homo sapiens (Human) "aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, base-free sugar-phosphate removal [GO:0006286]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]" cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876] "cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, base-free sugar-phosphate removal [GO:0006286]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]" damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017] GO:0001701; GO:0003684; GO:0003887; GO:0003906; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005876; GO:0006261; GO:0006281; GO:0006284; GO:0006286; GO:0006287; GO:0006290; GO:0006303; GO:0006954; GO:0006974; GO:0007435; GO:0007568; GO:0008017; GO:0008630; GO:0010332; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0055093; GO:0071707 KLPGVGTK 4.75 1 1 0.13081535 801.5370654 0 0 0 0 15.09174 0 0 0 0 0 0 0 17.12761 0 0 0 16.39268 16.1808 0 16.9232 0 0 0 0 16.38605 0 0 0 15.52686 16.87877 16.23252 0 16.63737 16.67505 0 15.74257 0 0 0 14.18707 0 0 0 0 14.98972 0 18.25527 0 P06748 NPM_HUMAN "Nucleophosmin, NPM (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)" NPM1 NPM Homo sapiens (Human) "cell aging [GO:0007569]; cellular response to UV [GO:0034644]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; rRNA export from nucleus [GO:0006407]; signal transduction [GO:0007165]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; spindle pole centrosome [GO:0031616] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; spindle pole centrosome [GO:0031616]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]; cell aging [GO:0007569]; cellular response to UV [GO:0034644]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; rRNA export from nucleus [GO:0006407]; signal transduction [GO:0007165]" chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082] GO:0000055; GO:0000056; GO:0001046; GO:0003682; GO:0003713; GO:0003723; GO:0004860; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005925; GO:0006281; GO:0006334; GO:0006338; GO:0006407; GO:0006886; GO:0006913; GO:0007098; GO:0007165; GO:0007569; GO:0008104; GO:0008284; GO:0008285; GO:0010824; GO:0010826; GO:0016020; GO:0019901; GO:0030957; GO:0031616; GO:0032071; GO:0032991; GO:0032993; GO:0034644; GO:0042255; GO:0042273; GO:0042274; GO:0042393; GO:0042803; GO:0043023; GO:0043024; GO:0043066; GO:0044387; GO:0045727; GO:0045893; GO:0045944; GO:0046599; GO:0051059; GO:0051082; GO:0051092; GO:0060699; GO:0060735; GO:0140297; GO:1902629; GO:1902751; GO:1990904 GPSSVEDIKAK 28.75 1 1 0.374557947 1131.72157 0 19.73075 0 18.74769 0 20.9517 0 0 0 0 19.27312 19.31093 0 0 0 20.35795 0 16.88567 0 0 17.43512 0 0 0 0 0 0 0 0 0 20.26901 20.22763 20.46977 20.03403 20.77296 0 19.28665 19.61457 0 17.46152 19.971 20.03755 19.38639 16.98491 20.10393 18.69711 0 18.47757 P06756 ITAV_HUMAN Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain ] ITGAV MSK8 VNRA VTNR Homo sapiens (Human) angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; regulation of transforming growth factor beta activation [GO:1901388]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; viral entry into host cell [GO:0046718] alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579] alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245]; angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; regulation of transforming growth factor beta activation [GO:1901388]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; viral entry into host cell [GO:0046718] coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245] GO:0001525; GO:0001570; GO:0001618; GO:0001846; GO:0001968; GO:0002020; GO:0005080; GO:0005178; GO:0005245; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007160; GO:0007204; GO:0007229; GO:0008284; GO:0008305; GO:0009897; GO:0009986; GO:0010745; GO:0010888; GO:0015026; GO:0016020; GO:0016477; GO:0030335; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032369; GO:0032587; GO:0033627; GO:0033690; GO:0034113; GO:0034446; GO:0034683; GO:0034684; GO:0034685; GO:0034686; GO:0035579; GO:0035866; GO:0035867; GO:0035868; GO:0035987; GO:0038027; GO:0043277; GO:0045335; GO:0045785; GO:0046718; GO:0046872; GO:0050431; GO:0050748; GO:0050764; GO:0050840; GO:0050919; GO:0051057; GO:0070062; GO:0070371; GO:0070588; GO:0071604; GO:0085017; GO:0097192; GO:0098609; GO:1901388; GO:1902533; GO:1905598; GO:1990430; GO:2000536; GO:2001237 MFLLVGAPK 3.50999999 0.202957124 0.202957124 0.112652064 991.1108875 18.64975 14.16818 0 17.01117 13.78686 0 13.85864 16.74511 16.33407 12.83758 15.76884 15.56679 15.68945 0 15.09009 13.69653 17.59537 13.2686 10.86873 0 17.58973 17.05543 0 14.08533 17.74392 14.34496 15.73651 0 15.52787 0 15.3194 15.79583 15.89812 14.99913 13.3903 10.26354 0 19.68204 0 15.68402 15.20205 0 0 13.40041 12.91889 16.54009 15.50574 0 P07195 LDHB_HUMAN "L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)" LDHB Homo sapiens (Human) lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; oxidoreductase complex [GO:1990204] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; oxidoreductase complex [GO:1990204]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]; lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090] identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459] GO:0004459; GO:0005737; GO:0005743; GO:0005829; GO:0006089; GO:0006090; GO:0016020; GO:0042802; GO:0045121; GO:0070062; GO:1990204 GEMMDLQHGSLFLQTPKIVADK 2.49000001 1 1 0.216250564 2491.133203 0 11.71562 15.34961 0 0 0 14.65795 14.99577 16.25161 0 0 14.8413 0 13.82226 0 0 16.63783 0 13.40287 13.62945 0 0 15.43857 0 0 0 15.27493 0 0 15.19394 0 0 15.33968 0 0 13.92993 0 13.82082 0 0 0 14.73783 0 12.12823 0 0 0 13.11538 P07197 NFM_HUMAN "Neurofilament medium polypeptide, NF-M (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein)" NEFM NEF3 NFM Homo sapiens (Human) neurofilament bundle assembly [GO:0033693] axon [GO:0030424]; intermediate filament cytoskeleton [GO:0045111]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883] axon [GO:0030424]; intermediate filament cytoskeleton [GO:0045111]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]; neurofilament bundle assembly [GO:0033693] microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005883; GO:0008017; GO:0030424; GO:0033693; GO:0045111; GO:0097418 TDISTALK 8.789999962 1 1 0.192434607 846.4724248 14.03161 0 15.60413 0 0 13.76194 15.50795 16.54458 0 0 15.09871 14.23819 15.96131 14.75997 0 15.24099 14.11562 0 16.0718 0 13.47601 0 0 0 0 0 0 0 0 15.60674 15.90196 0 0 0 0 0 0 0 0 0 0 0 14.23805 14.69797 0 0 0 0 P07202 PERT_HUMAN "Thyroid peroxidase, TPO, EC 1.11.1.8" TPO Homo sapiens (Human) embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590] cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590] calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601] GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005886; GO:0005887; GO:0006590; GO:0006979; GO:0009986; GO:0020037; GO:0035162; GO:0042446; GO:0042744 LAAALK 8.859999657 0.940295756 0.940295756 0.219591859 587.2763323 11.96752 14.82441 15.24915 14.85878 15.64728 14.87434 16.1261 16.20025 14.81038 14.60004 0 15.49292 16.46983 16.83352 16.42438 0 16.89605 16.78084 16.84006 15.73528 17.34457 16.36913 15.98982 15.6353 17.10253 15.89887 16.76506 15.17157 0 16.13314 0 15.47287 16.71672 17.83755 0 15.32167 17.59268 18.17392 16.47336 16.38567 16.57688 17.81984 17.18258 17.47434 17.26746 17.46637 17.44181 16.84051 P07203 GPX1_HUMAN "Glutathione peroxidase 1, GPx-1, GSHPx-1, EC 1.11.1.9 (Cellular glutathione peroxidase)" GPX1 Homo sapiens (Human) "aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]" glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124] GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006641; GO:0006749; GO:0007568; GO:0007605; GO:0008631; GO:0009410; GO:0009609; GO:0009650; GO:0009725; GO:0010269; GO:0010332; GO:0017124; GO:0018158; GO:0019369; GO:0019372; GO:0032355; GO:0033194; GO:0033599; GO:0034599; GO:0035094; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045454; GO:0047066; GO:0048741; GO:0051402; GO:0051450; GO:0051593; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:1902042; GO:1902176; GO:1902905 DYTQMNELQR 4.78000021 1 1 0.496251199 1297.624765 17.97674 0 0 0 16.58039 0 0 10.5233 18.64547 18.61095 18.15923 16.84427 0 0 0 0 0 0 0 0 0 0 17.69593 0 0 0 0 18.87796 0 0 18.3375 19.56051 0 0 0 0 19.58493 0 0 0 17.39911 0 0 0 0 0 0 0 P07204 TRBM_HUMAN "Thrombomodulin, TM (Fetomodulin) (CD antigen CD141)" THBD THRM Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; female pregnancy [GO:0007565]; negative regulation of blood coagulation [GO:0030195]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to lipopolysaccharide [GO:0032496]; response to X-ray [GO:0010165]; zymogen activation [GO:0031638]" apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; vacuolar membrane [GO:0005774] "apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; vacuolar membrane [GO:0005774]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; female pregnancy [GO:0007565]; negative regulation of blood coagulation [GO:0030195]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to lipopolysaccharide [GO:0032496]; response to X-ray [GO:0010165]; zymogen activation [GO:0031638]" calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005509; GO:0005615; GO:0005774; GO:0005886; GO:0005887; GO:0006508; GO:0007565; GO:0007596; GO:0009897; GO:0009986; GO:0010165; GO:0010544; GO:0016020; GO:0016327; GO:0030195; GO:0031638; GO:0032496; GO:0038023; GO:0051591; GO:0051918; GO:0072377; GO:1905370 TERTPQR 5.369999886 0.80506587 0.80506587 0.312880545 887.9145216 17.02514 13.42106 14.61223 15.06908 16.46596 15.17549 16.30455 0 0 15.47964 16.65257 0 14.34946 16.11084 0 15.09692 15.1168 15.17132 0 13.98244 0 15.00526 15.62205 16.30721 0 0 15.0501 15.75077 0 0 0 0 16.07195 15.52655 15.21061 15.84927 0 16.04818 14.57051 15.84227 16.27141 0 0 11.20231 15.29945 0 14.72597 0 P07205 PGK2_HUMAN "Phosphoglycerate kinase 2, EC 2.7.2.3 (Phosphoglycerate kinase, testis specific)" PGK2 PGKB Homo sapiens (Human) flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310] ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618] GO:0004618; GO:0005524; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0030317; GO:0035686; GO:0043531; GO:0070062 NHAQVVAQAR 4.440000057 1 1 0.221628928 1096.744873 12.22482 15.39701 0 0 0 15.58386 0 0 0 0 16.46349 0 16.17658 12.39525 0 0 0 0 0 0 16.18882 0 14.85732 0 0 15.77758 13.04753 0 0 0 0 15.77013 0 0 0 0 14.91228 16.19529 16.57371 0 0 0 15.66116 13.26902 0 15.68419 0 14.54206 P07237 PDIA1_HUMAN "Protein disulfide-isomerase, PDI, EC 5.3.4.1 (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)" P4HB ERBA2L PDI PDIA1 PO4DB Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976] actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972] GO:0003723; GO:0003756; GO:0003779; GO:0004656; GO:0005178; GO:0005576; GO:0005783; GO:0005788; GO:0005793; GO:0005829; GO:0005856; GO:0005925; GO:0006457; GO:0009897; GO:0015035; GO:0016222; GO:0016972; GO:0018401; GO:0019899; GO:0030027; GO:0032991; GO:0034663; GO:0034975; GO:0034976; GO:0035722; GO:0038155; GO:0042470; GO:0045785; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:0098761; GO:1900026; GO:1902175 TVIDYNGER 3.75 0.404729575 0.404729575 0.060024513 1066.772226 16.03884 16.40288 0 16.57068 0 0 13.58152 11.53576 0 0 0 0 0 0 14.78303 13.89436 12.64241 0 10.56805 0 0 17.21019 16.69239 0 0 0 0 18.14019 17.90895 17.22645 17.42652 0 17.57821 17.52051 9.895951 0 11.8275 13.7478 15.02117 0 0 9.77811 0 0 12.63397 16.47629 16.9015 0 P07305 H10_HUMAN "Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed ]" H1-0 H1F0 H1FV Homo sapiens (Human) chromosome condensation [GO:0030261]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription regulatory region DNA binding [GO:2000679] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; chromosome condensation [GO:0030261]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription regulatory region DNA binding [GO:2000679] chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723] GO:0000785; GO:0000786; GO:0000791; GO:0003680; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0006334; GO:0015629; GO:0016584; GO:0016604; GO:0017053; GO:0030261; GO:0031490; GO:0031492; GO:0031507; GO:0045910; GO:2000679 AGSSR 5.769999981 0.697394133 0.697394133 0.168505835 476.2894104 16.68996 15.37573 15.88911 16.03163 16.12284 15.62194 14.88586 15.83744 14.16697 16.75135 16.46789 15.90429 15.69551 17.18863 0 15.6821 16.87584 13.64268 16.46025 16.57283 16.75171 16.68747 16.28453 15.17809 17.07743 15.16023 15.9758 16.50639 16.22511 15.35153 16.1655 15.60525 16.58788 15.39733 16.28246 16.17745 16.98363 15.22267 10.81523 0 16.60594 0 16.95989 17.174 16.27874 15.21401 15.01258 15.95158 P07307 ASGR2_HUMAN "Asialoglycoprotein receptor 2, ASGP-R 2, ASGPR 2 (C-type lectin domain family 4 member H2) (Hepatic lectin H2, HL-2)" ASGR2 CLEC4H2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; cell surface receptor signaling pathway [GO:0007166] asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246] GO:0004873; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0030246; GO:0044322; GO:0048471 ADHDALLFHLKHFPVDLR 6.5 1 1 0.122862449 2143.278313 0 0 12.92989 0 0 13.31571 0 0 15.03867 0 0 0 12.86829 0 0 14.05215 14.07914 0 13.7785 0 0 0 14.82688 0 14.77449 6.473016 0 0 0 11.92966 15.00105 13.56698 15.13282 0 0 0 14.65513 0 0 0 15.09216 0 14.60569 0 0 13.79115 15.87809 11.93165 P07339 CATD_HUMAN "Cathepsin D, EC 3.4.23.5 [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain ]" CTSD CPSD Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201] collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201] aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233] GO:0004190; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0019886; GO:0035580; GO:0042159; GO:0042470; GO:0043065; GO:0043202; GO:0043280; GO:0045121; GO:0062023; GO:0070001; GO:0070062; GO:0070201; GO:1904724; GO:1904813 VGFAEAARL 7.269999981 1 1 0.143065453 933.7187713 12.21151 15.36171 0 14.26023 15.03513 15.08703 0 0 0 0 0 13.31307 0 0 0 0 0 0 0 15.20263 0 0 0 0 0 15.00183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.26723 0 0 0 0 0 P07355 ANXA2_HUMAN "Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV, PAP-IV) (Protein I) (p36)" ANXA2 ANX2 ANX2L4 CAL1H LPC2D Homo sapiens (Human) angiogenesis [GO:0001525]; membrane raft assembly [GO:0001765]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of exocytosis [GO:0045921]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; vesicle budding from membrane [GO:0006900] adherens junction [GO:0005912]; AnxA2-p11 complex [GO:1990665]; azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; vesicle [GO:0031982] "adherens junction [GO:0005912]; AnxA2-p11 complex [GO:1990665]; azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; vesicle [GO:0031982]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]; virion binding [GO:0046790]; angiogenesis [GO:0001525]; membrane raft assembly [GO:0001765]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of exocytosis [GO:0045921]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; vesicle budding from membrane [GO:0006900]" "cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]; virion binding [GO:0046790]" GO:0001525; GO:0001765; GO:0001786; GO:0001921; GO:0002020; GO:0002091; GO:0003723; GO:0004867; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005811; GO:0005886; GO:0005912; GO:0006900; GO:0008092; GO:0009986; GO:0010756; GO:0016020; GO:0016323; GO:0016363; GO:0019834; GO:0030496; GO:0031340; GO:0031902; GO:0031982; GO:0032804; GO:0035578; GO:0036035; GO:0042470; GO:0042802; GO:0044090; GO:0044548; GO:0045921; GO:0046790; GO:0048306; GO:0062023; GO:0070062; GO:0090575; GO:0098641; GO:0098797; GO:1905581; GO:1905597; GO:1905599; GO:1905602; GO:1905686; GO:1990665; GO:1990667 DLYDAGVK 3.809999943 0.950794339 0.950794339 0.258452463 879.9051596 0 0 0 0 0 0 0 20.11278 19.49693 0 0 16.75366 0 0 0 0 18.72146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07358 CO8B_HUMAN Complement component C8 beta chain (Complement component 8 subunit beta) C8B Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]" protein-containing complex binding [GO:0044877] GO:0005576; GO:0005579; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0016020; GO:0019835; GO:0044877; GO:0050778; GO:0070062; GO:1903561 GILNEIKDR 15.17000008 1 1 0.149491737 1057.087028 0 0 0 14.09741 14.15948 0 14.83941 0 14.0939 15.44963 14.27433 15.62457 14.65031 0 13.54296 15.15015 13.82591 14.97695 0 14.92909 0 16.20293 0 0 0 16.67062 0 0 0 0 0 0 0 0 0 0 0 0 0 14.69896 0 0 0 0 0 0 0 0 P07360 CO8G_HUMAN Complement component C8 gamma chain C8G Homo sapiens (Human) "complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]" blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement binding [GO:0001848]; retinol binding [GO:0019841]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]" complement binding [GO:0001848]; retinol binding [GO:0019841] GO:0001848; GO:0005576; GO:0005579; GO:0005886; GO:0006957; GO:0006958; GO:0019835; GO:0019841; GO:0050778; GO:0070062; GO:0072562 RPASPISTIQPK 1.870000005 1 1 0.490464154 1294.66278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.77447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07384 CAN1_HUMAN "Calpain-1 catalytic subunit, EC 3.4.22.52 (Calcium-activated neutral proteinase 1, CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain, muCANP)" CAPN1 CANPL1 PIG30 Homo sapiens (Human) mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]; mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233] GO:0001533; GO:0004198; GO:0005509; GO:0005576; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0008233; GO:0008284; GO:0016020; GO:0016241; GO:0032801; GO:0050790; GO:0060056; GO:0070062; GO:0097264; GO:1904813; GO:2000310 ARELGLGR 7.190000057 1 1 0.187515845 870.9674938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.76036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07476 INVO_HUMAN Involucrin IVL Homo sapiens (Human) isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; response to UV-B [GO:0010224] centrosome [GO:0005813]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604] centrosome [GO:0005813]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; response to UV-B [GO:0010224] GO:0001533; GO:0005737; GO:0005813; GO:0005829; GO:0010224; GO:0016604; GO:0018149; GO:0018153; GO:0030216; GO:0031424; GO:0070062 DEQLGMK 10.38000011 0.214226127 0.214226127 0.225640663 835.3181828 15.95152 13.78123 16.15219 15.1334 16.1818 15.206 0 15.40163 0 14.09661 14.83939 0 15.74715 12.29405 0 15.17411 0 15.78167 12.85079 15.74153 14.60188 15.46407 15.68387 16.50977 0 15.82168 15.93972 15.90314 13.36283 14.7764 16.71156 15.49811 11.42776 16.81952 0 13.5448 15.78607 16.27834 16.22145 14.24486 13.9562 16.43311 16.82743 13.77526 14.17579 14.301 16.13894 13.75557 P07478 TRY2_HUMAN "Trypsin-2, EC 3.4.21.4 (Anionic trypsinogen) (Serine protease 2) (Trypsin II)" PRSS2 TRY2 TRYP2 Homo sapiens (Human) antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508] calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785 LSSPAVINSR 3.910000086 1 1 0.244549345 1043.255575 0 0 15.18525 15.73153 15.26946 0 0 0 14.68054 0 16.04538 14.96488 0 0 0 0 0 0 15.3872 15.06291 0 14.7434 0 0 15.83935 0 0 0 0 0 0 15.91555 0 0 0 0 0 0 15.75564 0 0 0 0 0 0 16.64123 0 15.94663 P07585 PGS2_HUMAN Decorin (Bone proteoglycan II) (PG-S2) (PG40) DCN SLRR1B Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723]; animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723] GO:0003723; GO:0005518; GO:0005539; GO:0005576; GO:0005615; GO:0005796; GO:0009887; GO:0010508; GO:0010596; GO:0014068; GO:0016239; GO:0016525; GO:0019800; GO:0030021; GO:0043202; GO:0045944; GO:0050840; GO:0051901; GO:0062023; GO:0090141; GO:1900747 AHENEITK 15.10999966 0.913331211 0.913331211 1.71E-12 941.8494615 0 0 0 0 0 0 14.84293 14.29916 0 0 0 15.00641 0 0 0 13.97622 0 0 15.57692 0 0 16.38673 15.66796 0 14.75931 16.1581 17.34095 15.14664 15.06188 14.74144 12.19736 0 16.37565 15.98927 0 0 13.45749 0 15.79166 14.01064 13.58768 0 0 15.73172 0 16.07483 0 14.8686 P07602 SAP_HUMAN "Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator, CSAct) (Dispersin) (Sphingolipid activator protein 1, SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2, SAP-2); Saposin-D (Component C) (Protein C) ]" PSAP GLBA SAP1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0043231; GO:0060736; GO:0060742; GO:0062023; GO:0070062; GO:0097110; GO:1903771; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577 NLEKNSTK 3.49000001 0.849907994 0.849907994 0.250612624 932.7510722 10.59517 14.52968 13.25555 13.53296 15.2245 15.22312 0 14.95233 12.56552 13.44969 14.74999 0 14.60305 0 0 14.43722 0 0 15.4256 0 0 14.26125 12.37707 0 14.71523 14.55074 0 15.63818 13.87761 13.23435 0 14.91416 16.52846 0 0 0 0 13.60324 0 12.37605 16.87933 16.79164 14.38709 16.34112 0 0 13.60608 0 P07766 CD3E_HUMAN T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e) CD3E T3E Homo sapiens (Human) adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell activation [GO:0046629]; negative regulation of gene expression [GO:0010629]; negative regulation of smoothened signaling pathway [GO:0045879]; negative thymic T cell selection [GO:0045060]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal complex assembly [GO:0007172]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] alpha-beta T cell receptor complex [GO:0042105]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] alpha-beta T cell receptor complex [GO:0042105]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell activation [GO:0046629]; negative regulation of gene expression [GO:0010629]; negative regulation of smoothened signaling pathway [GO:0045879]; negative thymic T cell selection [GO:0045060]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal complex assembly [GO:0007172]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888] GO:0001772; GO:0001954; GO:0002250; GO:0002669; GO:0004888; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0007166; GO:0007169; GO:0007172; GO:0007186; GO:0009897; GO:0010628; GO:0010629; GO:0016358; GO:0017124; GO:0019901; GO:0021549; GO:0030159; GO:0031295; GO:0032729; GO:0032743; GO:0032753; GO:0033634; GO:0042101; GO:0042102; GO:0042105; GO:0042106; GO:0042110; GO:0042608; GO:0042802; GO:0042981; GO:0043197; GO:0044297; GO:0045059; GO:0045060; GO:0045879; GO:0046629; GO:0046631; GO:0046641; GO:0050731; GO:0050850; GO:0050852; GO:0065003; GO:0097190 GAGAGGRQR 3.49000001 1 1 0.14204167 830.3428767 0 15.09166 0 15.44867 15.13451 14.46193 15.72938 14.78674 12.98646 15.1755 14.85965 16.39607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.60798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07814 SYEP_HUMAN "Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase, EC 6.1.1.17 (Glutamyl-tRNA synthetase, GluRS); Proline--tRNA ligase, EC 6.1.1.15 (Prolyl-tRNA synthetase) ]" EPRS1 EPRS GLNS PARS QARS QPRS PIG32 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418] ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270] GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0065003; GO:0071346; GO:0097452; GO:0140212; GO:1990904 AEYKEK 4.820000172 7.06E-09 7.06E-09 0.288728142 767.4451445 0 17.51449 0 0 15.92839 0 0 0 0 0 0 0 0 0 0 0 18.17184 18.47656 17.98288 0 17.61297 0 0 17.34512 18.89197 0 0 0 0 17.16299 19.99267 19.15769 0 18.85761 0 0 0 0 0 0 0 0 0 0 0 19.29715 0 0 P07942 LAMB1_HUMAN Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) LAMB1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0009887; GO:0009888; GO:0016477; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0070831; GO:0098637; GO:0110011; GO:2001046 SNEELRNLIK 6.849999905 1 1 0.445328889 1215.728133 0 0 0 0 0 0 0 0 18.38868 0 19.52842 0 0 0 0 0 0 0 0 0 0 18.64721 0 0 19.36945 0 0 0 16.19522 0 0 0 0 0 0 0 0 0 0 0 0 0 18.07239 0 0 0 0 0 P07947 YES_HUMAN "Tyrosine-protein kinase Yes, EC 2.7.10.2 (Proto-oncogene c-Yes) (p61-Yes)" YES1 YES Homo sapiens (Human) cell differentiation [GO:0030154]; cellular protein modification process [GO:0006464]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cell differentiation [GO:0030154]; cellular protein modification process [GO:0006464]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] GO:0001784; GO:0002862; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005794; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0006464; GO:0007169; GO:0010827; GO:0019899; GO:0030154; GO:0031234; GO:0031295; GO:0036120; GO:0038096; GO:0043114; GO:0044325; GO:0045087; GO:0045944; GO:0048013; GO:0050731; GO:0050900; GO:0070062; GO:0071300; GO:0071560 DWDEIRGDNVK 4.96999979 1 1 0.293518787 1347.243112 14.71701 0 0 8.16358 13.05047 9.322214 0 14.07913 0 13.42897 15.97753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.83633 0 0 0 0 0 0 14.89962 0 0 0 0 0 0 0 17.65906 16.99517 0 0 P07949 RET_HUMAN "Proto-oncogene tyrosine-protein kinase receptor Ret, EC 2.7.10.1 (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment ]" RET CDHF12 CDHR16 PTC RET51 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]" axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] "axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]" ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004712; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241 LLEGEGLPFR 14.53999996 1 1 0.486084253 1129.290184 16.72376 15.90966 0 0 0 16.8848 0 16.43923 0 0 0 0 0 0 0 0 16.0619 16.24109 0 0 17.61425 0 16.92515 0 16.85463 0 0 0 0 0 0 0 0 0 16.31538 0 0 0 0 0 0 0 0 0 17.13935 0 0 16.95918 P07954 FUMH_HUMAN "Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2" FH Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050] fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393] GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0070062; GO:0120162; GO:2001034 AFGILK 11.09000015 1 1 0.244191895 648.2855707 17.95023 18.8976 18.61673 16.11452 17.03864 17.8896 16.66287 15.6364 19.16463 18.91406 0 17.14021 16.59772 17.29584 0 0 0 17.9646 17.20618 0 16.2816 18.31192 0 0 0 0 0 16.54248 17.62046 16.00297 18.20477 19.4259 18.13675 18.57666 18.51138 0 18.39459 0 19.03565 0 17.42211 0 18.29368 0 18.20411 16.11363 0 18.27958 P07996 TSP1_HUMAN Thrombospondin-1 (Glycoprotein G) THBS1 TSP TSP1 Homo sapiens (Human) behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040] calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431] GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032695; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0040037; GO:0042327; GO:0042802; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043394; GO:0043406; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237 GDACDHDDDNDGIPDDK 2.910000086 1 1 3.66E-12 1873.958961 14.08979 0 0 11.69278 15.08741 0 14.9171 13.24294 15.79317 14.93049 0 15.60761 14.55093 0 0 0 0 0 15.04583 15.55768 14.8159 0 13.81528 0 0 0 0 14.84377 0 14.78799 0 15.11237 0 0 0 0 0 0 0 0 14.07155 0 0 0 0 0 0 0 P08034 CXB1_HUMAN "Gap junction beta-1 protein (Connexin-32, Cx32) (GAP junction 28 kDa liver protein)" GJB1 CX32 Homo sapiens (Human) cell-cell signaling [GO:0007267]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399]; purine ribonucleotide transport [GO:0015868] connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328] connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399]; purine ribonucleotide transport [GO:0015868] gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802] GO:0005243; GO:0005789; GO:0005922; GO:0007267; GO:0007399; GO:0015868; GO:0016021; GO:0016264; GO:0016328; GO:0042802; GO:1905867 LLSEQDGSLK 4.449999809 1 1 0.097672861 1087.214998 0 14.759 0 0 0 15.6085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.24704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08047 SP1_HUMAN Transcription factor Sp1 SP1 TSFP1 Homo sapiens (Human) "cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]" "bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" GO:0000785; GO:0000791; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008022; GO:0010628; GO:0017053; GO:0032869; GO:0032993; GO:0033194; GO:0035035; GO:0042802; GO:0042803; GO:0042826; GO:0043425; GO:0043536; GO:0043565; GO:0043923; GO:0045766; GO:0045893; GO:0045944; GO:0046872; GO:0048511; GO:0061629; GO:0071837; GO:0140297; GO:1902004; GO:1904828; GO:1905564; GO:1990837 MSDQDHSMDEMTAVVKIEK 1.299999952 1 1 0.176501601 2226.761515 10.9578 14.66578 13.37922 12.33289 0 0 10.136 9.77927 7.590746 13.59836 0 14.76721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08069 IGF1R_HUMAN "Insulin-like growth factor 1 receptor, EC 2.7.10.1 (Insulin-like growth factor I receptor, IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain ]" IGF1R Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315] alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor-activated receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor-activated receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001965; GO:0003230; GO:0004712; GO:0004713; GO:0004714; GO:0005009; GO:0005010; GO:0005158; GO:0005198; GO:0005520; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0006955; GO:0007165; GO:0007169; GO:0007409; GO:0008284; GO:0008286; GO:0010656; GO:0014065; GO:0014068; GO:0016020; GO:0021549; GO:0021766; GO:0030010; GO:0030315; GO:0030335; GO:0030424; GO:0031994; GO:0032467; GO:0033197; GO:0033674; GO:0033690; GO:0035094; GO:0035867; GO:0038083; GO:0042593; GO:0042802; GO:0043025; GO:0043066; GO:0043231; GO:0043235; GO:0043243; GO:0043409; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044849; GO:0045056; GO:0045471; GO:0046328; GO:0046777; GO:0048009; GO:0048015; GO:0048661; GO:0048680; GO:0051054; GO:0051897; GO:0071260; GO:0071333; GO:0071392; GO:0071393; GO:0071394; GO:0071549; GO:0071560; GO:0090031; GO:0090398; GO:0097062; GO:0097242; GO:0120162; GO:0140318; GO:1902065; GO:1902911; GO:1903944; GO:1904045; GO:1904193; GO:1904385; GO:1904646; GO:1990314 MCPSTCGK 2.680000067 1 1 0.229327511 955.850798 11.7745 0 16.39913 14.4079 0 0 16.22186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.05925 14.32349 14.00356 0 0 0 0 0 0 0 0 0 0 0 16.8976 0 0 16.04057 0 16.01577 0 P08123 CO1A2_HUMAN Collagen alpha-2(I) chain (Alpha-2 type I collagen) COL1A2 Homo sapiens (Human) blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; odontogenesis [GO:0042476]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; odontogenesis [GO:0042476]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] GO:0001501; GO:0001568; GO:0002020; GO:0005201; GO:0005576; GO:0005584; GO:0005615; GO:0005783; GO:0005788; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042476; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070062; GO:0070208; GO:0071230; GO:0085029 GEPGAPGENGTPGQTGAR 8.06000042 0.863149345 0.863149345 0.147901477 1646.288499 14.07041 14.37413 13.72111 0 0 0 0 12.29126 0 0 0 15.21553 11.42148 14.17461 15.05706 0 12.52062 12.00641 16.83083 12.63717 12.31613 15.84726 0 0 14.78777 0 13.89544 14.69099 12.07604 14.55628 15.9892 16.18286 14.51538 11.33971 0 0 0 0 0 16.5959 15.36196 12.24034 16.35554 0 0 0 0 16.14232 P08138 TNR16_HUMAN "Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor, NGF receptor) (p75 ICD) (CD antigen CD271)" NGFR TNFRSF16 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266] amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625] GO:0001540; GO:0001678; GO:0004888; GO:0005035; GO:0005516; GO:0005576; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0006886; GO:0006919; GO:0007266; GO:0007411; GO:0007417; GO:0009986; GO:0014069; GO:0015026; GO:0016021; GO:0016048; GO:0021675; GO:0030336; GO:0030426; GO:0031069; GO:0031267; GO:0031625; GO:0032922; GO:0035907; GO:0038023; GO:0040037; GO:0042488; GO:0042593; GO:0043121; GO:0043197; GO:0043204; GO:0048146; GO:0048406; GO:0051402; GO:0051799; GO:1900182; GO:1902895; GO:1903588; GO:1904646; GO:2001235 ADLVESLCSESTATSPV 4.039999962 1 1 0 1765.14408 18.50038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08151 GLI1_HUMAN Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) GLI1 GLI Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hh target transcription factor activity [GO:1990787]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; spermatogenesis [GO:0007283]; ventral midline development [GO:0007418]" axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hh target transcription factor activity [GO:1990787]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; spermatogenesis [GO:0007283]; ventral midline development [GO:0007418]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005930; GO:0006357; GO:0007224; GO:0007283; GO:0007418; GO:0008017; GO:0008284; GO:0008589; GO:0009611; GO:0009913; GO:0009953; GO:0009954; GO:0021696; GO:0021938; GO:0021983; GO:0030324; GO:0030335; GO:0030850; GO:0043565; GO:0045667; GO:0045740; GO:0045880; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0060032; GO:0060045; GO:0060070; GO:0090090; GO:0097421; GO:0097542; GO:0097546; GO:1902808; GO:1990787; GO:1990788; GO:2000345 GDGPLPR 13.96000004 1 1 0.239891562 711.5485948 19.13028 15.23364 19.05984 0 16.70663 16.6147 16.84564 19.90467 20.00565 0 18.08817 0 19.00642 20.47789 17.86796 0 18.2939 0 17.86319 18.17665 0 16.25385 18.76543 17.57306 18.71954 0 17.25724 15.87718 0 0 0 19.8951 0 0 0 0 17.70488 18.52828 0 19.45015 0 0 17.6329 0 0 0 0 18.42772 P08172 ACM2_HUMAN Muscarinic acetylcholine receptor M2 CHRM2 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615]" clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615]" arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] GO:0004993; GO:0005886; GO:0005887; GO:0006940; GO:0007186; GO:0007187; GO:0007188; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007399; GO:0008016; GO:0009615; GO:0016021; GO:0016907; GO:0030425; GO:0030594; GO:0030669; GO:0045202; GO:0045211; GO:1990763 DENSKQTCIR 4.650000095 0.946824431 0.946824431 0.282231 1249.786241 0 0 0 0 0 0 0 0 16.321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.52269 0 0 0 0 0 0 0 0 0 0 18.86886 18.32788 0 19.03027 0 0 0 0 0 0 0 0 0 P08183 MDR1_HUMAN "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1, EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1, EC 7.6.2.1) (CD antigen CD243)" ABCB1 MDR1 PGY1 Homo sapiens (Human) carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0000086; GO:0005524; GO:0005654; GO:0005886; GO:0008559; GO:0009410; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046865; GO:0046943; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0150104; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225 GLNLKVQSGQTVALVGNSGCGK 2.119999886 1 1 0.161500745 2186.245447 13.8615 0 15.49738 0 17.59687 14.51695 12.30041 11.35907 0 15.50958 14.88675 0 15.31345 14.43065 0 0 0 0 0 0 0 0 0 0 0 0 14.80825 12.2489 12.40758 0 12.31644 12.07551 0 0 8.711535 0 0 0 0 15.43971 15.26141 0 14.92064 0 0 0 15.18919 0 P08195 4F2_HUMAN "4F2 cell-surface antigen heavy chain, 4F2hc (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)" SLC3A2 MDU1 Homo sapiens (Human) amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; phenylalanine transport [GO:0015823]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718] amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; catalytic activity [GO:0003824]; double-stranded RNA binding [GO:0003725]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723]; amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; phenylalanine transport [GO:0015823]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718] aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; catalytic activity [GO:0003824]; double-stranded RNA binding [GO:0003725]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723] GO:0003723; GO:0003725; GO:0003824; GO:0005432; GO:0005654; GO:0005765; GO:0005886; GO:0005975; GO:0006816; GO:0006865; GO:0009925; GO:0009986; GO:0015173; GO:0015175; GO:0015180; GO:0015190; GO:0015820; GO:0015823; GO:0015827; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0042470; GO:0043330; GO:0044225; GO:0045202; GO:0045296; GO:0046718; GO:0070062; GO:0098713; GO:1903801; GO:1904273; GO:1990184 QPMNAASGAAMSLAGAEKNGLVK 1.970000029 1 1 0.409763268 2231.912287 0 0 19.41322 0 0 21.31328 19.69502 0 0 0 0 0 0 19.24814 0 20.19506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.60127 0 20.39891 0 0 0 P08235 MCR_HUMAN "Mineralocorticoid receptor, MR (Nuclear receptor subfamily 3 group C member 2)" NR3C2 MCR MLR Homo sapiens (Human) intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005654; GO:0005789; GO:0005829; GO:0006357; GO:0007165; GO:0008270; GO:0030518; GO:0043235; GO:1901224; GO:1990837 DVVPSPDTQEK 7.139999866 1 1 0.178063241 1211.768389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.85627 11.73301 15.67332 0 0 0 0 0 0 0 0 14.25544 0 0 0 0 15.34917 16.26882 0 11.85512 0 0 0 0 0 0 0 0 0 0 12.993 0 0 0 P08237 PFKAM_HUMAN "ATP-dependent 6-phosphofructokinase, muscle type, ATP-PFK, PFK-M, EC 2.7.1.11 (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A, PFK-A) (Phosphohexokinase)" PFKM PFKX Homo sapiens (Human) "canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]" 6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228] "6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]" 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022] GO:0003872; GO:0005524; GO:0005634; GO:0005829; GO:0005945; GO:0005980; GO:0006002; GO:0006096; GO:0008022; GO:0016020; GO:0016208; GO:0016324; GO:0019900; GO:0030388; GO:0032024; GO:0042593; GO:0042802; GO:0045944; GO:0046716; GO:0046872; GO:0048029; GO:0061615; GO:0061621; GO:0070061; GO:0070095; GO:0093001; GO:0097228 SGSHTVAVMNVGAPAAGMNAAVRSTVR 5.230000019 1 1 0.034299727 2642.864576 0 14.37973 15.92543 0 12.79451 13.72076 15.29273 15.09299 15.0689 13.86488 15.07946 15.22649 15.3112 0 15.1916 14.77491 13.27802 0 0 0 0 0 14.80655 13.61081 0 13.13878 0 0 0 0 0 0 0 0 0 0 0 0 0 13.99139 14.47949 0 0 0 0 0 0 0 P08238 HS90B_HUMAN "Heat shock protein HSP 90-beta, HSP 90 (Heat shock 84 kDa, HSP 84, HSP84)" HSP90AB1 HSP90B HSPC2 HSPCB Homo sapiens (Human) axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062] apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913] apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134] GO:0001890; GO:0002134; GO:0002135; GO:0003723; GO:0003725; GO:0005524; GO:0005525; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007004; GO:0009410; GO:0009651; GO:0009986; GO:0016020; GO:0016234; GO:0016323; GO:0016324; GO:0016887; GO:0017098; GO:0019062; GO:0019887; GO:0019900; GO:0019901; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030511; GO:0030911; GO:0031072; GO:0031396; GO:0031526; GO:0031625; GO:0032092; GO:0032435; GO:0032516; GO:0032564; GO:0032880; GO:0032991; GO:0033138; GO:0034605; GO:0034751; GO:0034774; GO:0042220; GO:0042277; GO:0042307; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0043008; GO:0043025; GO:0043524; GO:0044183; GO:0044294; GO:0044295; GO:0044325; GO:0045296; GO:0045429; GO:0045597; GO:0045793; GO:0046983; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051082; GO:0051131; GO:0051248; GO:0051726; GO:0051897; GO:0051973; GO:0070062; GO:0070182; GO:0071353; GO:0071407; GO:0071902; GO:0097435; GO:0097718; GO:0120293; GO:1901389; GO:1901799; GO:1902949; GO:1903660; GO:1904031; GO:1904813; GO:1905323; GO:1990226; GO:1990565; GO:1990913; GO:1990917; GO:2000010 YHTSQSGDEMTSLSEYVSR 7.800000191 0.643881381 0.643881381 0.038854918 2177.457354 0 8.754793 14.15515 0 0 11.36596 0 0 0 15.45471 0 0 14.53166 0 12.91881 11.47857 14.58582 16.87105 15.83454 15.66111 18.58867 16.10534 16.45493 0 12.62232 13.08835 0 14.07529 17.21195 17.81452 0 0 16.32213 16.17003 0 0 16.39945 16.33333 0 16.20079 15.32237 16.70257 13.78458 15.91405 0 0 15.18538 18.95057 P08240 SRPRA_HUMAN "Signal recognition particle receptor subunit alpha, SR-alpha (Docking protein alpha, DP-alpha)" SRPRA SRPR Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785] "endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; cotranslational protein targeting to membrane [GO:0006613]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047] GO:0003723; GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006613; GO:0006617; GO:0016020; GO:0045047; GO:0070062 EAEESSK 2.410000086 1 1 0 780.4182167 0 0 0 0 0 0 0 16.76318 0 0 0 0 0 0 0 0 13.34067 14.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38577 0 0 0 0 0 0 0 0 0 16.18075 0 0 P08243 ASNS_HUMAN "Asparagine synthetase [glutamine-hydrolyzing], EC 6.3.5.4 (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)" ASNS TS11 Homo sapiens (Human) asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931] cytosol [GO:0005829] cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931] asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524] GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0042149; GO:0043066; GO:0045931; GO:0070981 GLVTLK 7.730000019 0.710885048 0.710885048 0.251096414 631.6006643 0 18.53781 0 0 0 0 0 17.25218 0 0 19.23036 0 0 0 0 0 0 0 0 0 0 20.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08253 MMP2_HUMAN "72 kDa type IV collagenase, EC 3.4.24.24 (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2, MMP-2) (TBE-1) [Cleaved into: PEX ]" MMP2 CLG4A Homo sapiens (Human) aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771] endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0001525; GO:0001541; GO:0001542; GO:0001553; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007162; GO:0007507; GO:0007566; GO:0007567; GO:0007568; GO:0008237; GO:0008270; GO:0009410; GO:0009612; GO:0014012; GO:0014823; GO:0016477; GO:0022617; GO:0030017; GO:0030198; GO:0030335; GO:0030574; GO:0032526; GO:0034614; GO:0035094; GO:0035987; GO:0042542; GO:0043065; GO:0043627; GO:0044267; GO:0045906; GO:0048013; GO:0048771; GO:0051602; GO:0055093; GO:0060325; GO:0060346; GO:0060740; GO:0062023; GO:0071230; GO:0071347; GO:0071392; GO:0071492; GO:0071498; GO:1904645; GO:1904707 KMDPGFPK 7.119999886 1 1 0.271729272 934.6944502 0 0 15.83802 0 0 0 16.67753 0 17.38003 0 0 0 16.63826 0 0 0 16.79267 0 0 0 0 0 19.18429 0 0 0 17.44262 0 17.31639 15.9615 0 0 0 0 0 0 0 20.49655 0 16.81141 0 0 0 0 0 0 0 16.8325 P08254 MMP3_HUMAN "Stromelysin-1, SL-1, EC 3.4.24.17 (Matrix metalloproteinase-3, MMP-3) (Transin-1)" MMP3 STMY1 Homo sapiens (Human) cellular response to nitric oxide [GO:0071732]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; positive regulation of oxidative stress-induced cell death [GO:1903209]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cellular response to nitric oxide [GO:0071732]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; positive regulation of oxidative stress-induced cell death [GO:1903209]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645] endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0010727; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0031334; GO:0071492; GO:0071732; GO:0150077; GO:1903209; GO:1904645 SLPILLLLCVAVCSAYPLDGAAR 11.89000034 1 1 4.63E-13 2471.979717 0 14.93326 13.95218 0 11.67545 0 12.75507 0 13.38441 13.19949 15.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08263 GSTA1_HUMAN "Glutathione S-transferase A1, EC 2.5.1.18 (13-hydroperoxyoctadecadienoate peroxidase, EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase, EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed ]" GSTA1 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805] fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769] GO:0004364; GO:0004602; GO:0004769; GO:0005504; GO:0005829; GO:0006693; GO:0006749; GO:0006805; GO:0030855; GO:0043651; GO:0070062; GO:1901687 KPPMDEK 5.849999905 1 1 6.86E-13 864.4480888 0 0 0 13.69095 10.39571 13.28189 0 13.94107 0 15.19777 15.9223 15.35762 0 0 0 0 7.891293 14.7268 15.58861 0 14.05005 15.34159 15.1872 13.35188 0 14.3036 0 13.59572 13.6554 14.76146 0 0 0 0 0 0 0 0 0 0 0 0 14.72635 0 0 0 0 0 P08311 CATG_HUMAN "Cathepsin G, CG, EC 3.4.21.20 [Cleaved into: Cathepsin G, C-terminal truncated form ]" CTSG Homo sapiens (Human) angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; biofilm matrix disassembly [GO:0098786]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; monocyte chemotaxis [GO:0002548]; negative regulation of T cell activation [GO:0050868]; neutrophil activation [GO:0042119]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; platelet activation [GO:0030168]; positive regulation of immune response [GO:0050778]; positive regulation of platelet aggregation [GO:1901731]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; proteolysis [GO:0006508]; purinergic nucleotide receptor signaling pathway [GO:0035590] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; caspase binding [GO:0089720]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; biofilm matrix disassembly [GO:0098786]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; monocyte chemotaxis [GO:0002548]; negative regulation of T cell activation [GO:0050868]; neutrophil activation [GO:0042119]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; platelet activation [GO:0030168]; positive regulation of immune response [GO:0050778]; positive regulation of platelet aggregation [GO:1901731]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; proteolysis [GO:0006508]; purinergic nucleotide receptor signaling pathway [GO:0035590] caspase binding [GO:0089720]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0002003; GO:0002548; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0006468; GO:0006508; GO:0006955; GO:0008201; GO:0008233; GO:0008236; GO:0009986; GO:0010494; GO:0016020; GO:0016485; GO:0019221; GO:0019731; GO:0022617; GO:0030141; GO:0030168; GO:0035578; GO:0035590; GO:0042119; GO:0043231; GO:0044267; GO:0048018; GO:0050778; GO:0050829; GO:0050830; GO:0050832; GO:0050868; GO:0062023; GO:0070062; GO:0070946; GO:0071222; GO:0089720; GO:0098786; GO:1901731 SFKLLDQMETPL 10.30000019 1 1 0.074124896 1422.111174 13.36092 12.89067 14.6868 11.22182 9.660604 0 0 13.60679 7.773835 15.02376 15.79299 11.1737 0 12.35721 12.46983 0 7.519054 14.09237 15.0019 9.896761 0 0 0 0 15.46355 14.18868 15.82847 0 0 0 0 15.04254 0 0 15.18872 0 0 0 0 14.76933 0 0 0 0 0 0 13.192 0 P08476 INHBA_HUMAN "Inhibin beta A chain (Activin beta-A chain) (Erythroid differentiation protein, EDF)" INHBA Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]" activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471] "activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699]; activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]" cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699] GO:0001541; GO:0001942; GO:0002244; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0006357; GO:0006952; GO:0007166; GO:0007267; GO:0007399; GO:0008083; GO:0008285; GO:0008584; GO:0009410; GO:0010628; GO:0010862; GO:0017046; GO:0021773; GO:0030154; GO:0030218; GO:0030308; GO:0032270; GO:0032689; GO:0032924; GO:0034711; GO:0035987; GO:0042326; GO:0042476; GO:0042541; GO:0042701; GO:0042802; GO:0043509; GO:0043512; GO:0044877; GO:0045578; GO:0045648; GO:0045650; GO:0045893; GO:0045944; GO:0046880; GO:0046881; GO:0046882; GO:0048333; GO:0048471; GO:0060021; GO:0060279; GO:0060395; GO:0061029; GO:0070699; GO:0071372; GO:0071397; GO:0097154; GO:0097191; GO:2000134; GO:2001241 AALLNAIRK 10.05000019 0.482052654 0.482052654 0.255891473 969.0790284 14.24696 15.52963 14.40205 0 0 15.57164 0 0 15.19365 0 0 16.29624 14.51136 12.75626 16.50676 0 0 15.79526 14.5017 15.60507 0 15.28745 15.34572 0 15.06693 15.53763 0 14.26823 13.02122 15.46617 14.47351 15.06565 0 16.85769 14.04296 13.16828 14.50939 14.28758 0 12.67574 13.37279 13.39378 14.38985 13.03209 14.61495 13.88682 15.75937 15.47765 P08581 MET_HUMAN "Hepatocyte growth factor receptor, HGF receptor, EC 2.7.10.1 (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor, SF receptor) (Tyrosine-protein kinase Met)" MET Homo sapiens (Human) branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001886; GO:0001889; GO:0004712; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0006909; GO:0007165; GO:0007166; GO:0007169; GO:0007399; GO:0009925; GO:0009986; GO:0010507; GO:0016021; GO:0016477; GO:0017154; GO:0019903; GO:0030182; GO:0031016; GO:0031116; GO:0033674; GO:0035024; GO:0042802; GO:0043235; GO:0045944; GO:0048754; GO:0050918; GO:0051497; GO:0051897; GO:0061436; GO:0070495; GO:0071526; GO:1901299; GO:1905098; GO:2001028 LPVKWMALESLQTQK 4.760000229 1 1 4.11E-12 1772.030508 14.79079 15.18917 0 0 0 0 0 0 0 0 14.16604 0 15.48089 0 0 13.14293 0 0 15.14744 14.80116 0 17.1438 0 15.95435 0 12.519 15.86739 14.8214 13.09511 0 16.01858 15.90343 0 16.46584 14.67146 16.47482 0 0 0 17.17441 0 15.77411 0 17.69142 0 17.63104 0 16.07411 P08588 ADRB1_HUMAN "Beta-1 adrenergic receptor (Beta-1 adrenoreceptor, Beta-1 adrenoceptor)" ADRB1 ADRB1R B1AR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]" early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] "early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-2A adrenergic receptor binding [GO:0031694]; beta-adrenergic receptor activity [GO:0004939]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled receptor activity [GO:0004930]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]" alpha-2A adrenergic receptor binding [GO:0031694]; beta-adrenergic receptor activity [GO:0004939]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled receptor activity [GO:0004930]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982] GO:0001996; GO:0001997; GO:0002024; GO:0002025; GO:0004930; GO:0004939; GO:0004940; GO:0005085; GO:0005769; GO:0005886; GO:0005887; GO:0007190; GO:0009409; GO:0030165; GO:0031649; GO:0031694; GO:0040015; GO:0042596; GO:0043547; GO:0045187; GO:0046982; GO:0050873; GO:0071880; GO:0098685; GO:0099579; GO:0120162 IDSCER 4.150000095 1 1 0.288237909 778.8460434 17.89565 19.42751 0 0 16.00192 0 0 0 0 0 17.77145 0 0 17.0842 0 0 0 0 16.91508 16.65513 0 0 0 0 17.16306 0 18.41577 0 0 0 18.56823 17.8448 17.83374 0 0 0 0 19.17356 19.34756 18.66875 17.56217 0 17.47506 18.40186 0 0 0 17.93308 P08621 RU17_HUMAN "U1 small nuclear ribonucleoprotein 70 kDa, U1 snRNP 70 kDa, U1-70K, snRNP70" SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]" mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619] GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0016607; GO:0017069; GO:0030619; GO:0043462; GO:0043484; GO:0048026; GO:0061084; GO:0071004; GO:1904715 RSGKPR 4.099999905 0.760947466 0.760947466 0.293449385 696.917349 16.20154 16.12355 16.51302 0 15.94015 15.26552 15.2029 0 14.7399 15.68521 15.18101 15.08169 14.07962 15.93175 16.16763 0 0 15.68903 0 15.57068 15.02079 14.48141 16.18978 0 13.48583 15.08539 16.32256 14.32093 15.365 15.59663 15.05503 16.04969 16.59081 15.49608 15.42481 14.92626 16.52294 17.33824 15.55255 14.26283 15.93868 16.73306 0 15.94473 16.09431 17.22744 0 16.44909 P08648 ITA5_HUMAN Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain ] ITGA5 FNRA Homo sapiens (Human) "angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]" alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202] "alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]" epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618] GO:0001525; GO:0001618; GO:0001726; GO:0005154; GO:0005161; GO:0005178; GO:0005783; GO:0005794; GO:0005886; GO:0005925; GO:0007044; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007565; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0010811; GO:0023035; GO:0030335; GO:0030949; GO:0031410; GO:0031589; GO:0033627; GO:0033631; GO:0034113; GO:0034674; GO:0035313; GO:0035987; GO:0043184; GO:0045202; GO:0046872; GO:0050731; GO:0071062; GO:0098609; GO:1903672; GO:2000811 SLPYGTAMEKAQLKPPATSDA 21.14999962 1 1 0.339881526 2191.686897 0 0 0 0 0 0 14.74936 0 17.44502 0 0 0 0 0 0 0 0 0 0 0 17.65874 0 0 0 0 24.15583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08697 A2AP_HUMAN "Alpha-2-antiplasmin, Alpha-2-AP (Alpha-2-plasmin inhibitor, Alpha-2-PI) (Serpin F2)" SERPINF2 AAP PLI Homo sapiens (Human) acute-phase response [GO:0006953]; blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; fibrinolysis [GO:0042730]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; fibrinolysis [GO:0042730]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636] endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0002034; GO:0004866; GO:0004867; GO:0005576; GO:0005577; GO:0005615; GO:0006953; GO:0009986; GO:0010757; GO:0010951; GO:0030199; GO:0031093; GO:0032967; GO:0042730; GO:0042803; GO:0045597; GO:0045944; GO:0046330; GO:0048514; GO:0048661; GO:0051496; GO:0051918; GO:0062023; GO:0070062; GO:0070374; GO:0071636; GO:0072562; GO:2000049 EQQDSPGNKDFLQSLK 8.600000381 1 1 0.22295463 1834.221765 13.9317 15.49158 0 0 0 0 13.42426 0 0 0 0 0 0 0 0 0 0 0 14.75484 0 0 0 0 0 0 14.83365 15.46037 0 0 13.63859 0 0 0 0 0 0 0 0 16.60253 16.19102 0 0 0 0 0 14.90714 15.67178 15.74626 P08729 K2C7_HUMAN "Keratin, type II cytoskeletal 7 (Cytokeratin-7, CK-7) (Keratin-7, K7) (Sarcolectin) (Type-II keratin Kb7)" KRT7 SCL Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634] GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0045095; GO:0045111; GO:0070062 AQYEEMAK 9.710000038 0.006497107 0.006497107 1.14E-12 969.4062331 10.06834 0 0 16.69201 0 14.22462 0 0 0 10.86832 0 0 15.14209 14.1614 0 12.03451 0 0 0 15.14564 0 0 10.77332 17.98725 17.65318 13.74495 17.07917 15.11252 0 0 0 14.49526 15.14911 0 15.75406 14.00243 14.57252 0 15.71749 13.68158 0 0 14.36698 0 14.70997 0 12.90955 15.31436 P08758 ANXA5_HUMAN "Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I, CPB-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4, PP4) (Placental anticoagulant protein I, PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha, VAC-alpha)" ANXA5 ANX5 ENX2 PP4 Homo sapiens (Human) blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543] GO:0004859; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005737; GO:0005829; GO:0005925; GO:0007165; GO:0007596; GO:0009897; GO:0010033; GO:0016020; GO:0043066; GO:0050819; GO:0062023; GO:0070062; GO:0072563 GAGTDDHTLIRVMVSR 6.070000172 1 1 1.38E-12 1740.140345 0 0 0 0 0 0 16.30284 0 15.01128 0 0 0 0 12.91706 0 15.04259 0 12.75656 0 0 0 0 0 0 0 0 15.12923 0 0 0 0 0 12.44646 0 13.47176 0 0 0 0 0 0 15.85478 0 0 0 0 0 0 P08833 IBP1_HUMAN "Insulin-like growth factor-binding protein 1, IBP-1, IGF-binding protein 1, IGFBP-1 (Placental protein 12, PP12)" IGFBP1 IBP1 Homo sapiens (Human) aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of cell growth [GO:0030307]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; tissue regeneration [GO:0042246] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of cell growth [GO:0030307]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; tissue regeneration [GO:0042246] insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005520; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0007165; GO:0007568; GO:0008286; GO:0030307; GO:0031994; GO:0031995; GO:0042246; GO:0043567; GO:0090090 IELYRVVESLAK 8.539999962 1 1 0.373594059 1419.523226 0 0 15.42522 11.13068 0 14.16462 0 0 0 15.3147 0 0 0 15.57472 0 0 0 0 0 0 0 0 0 0 15.37067 0 15.10255 16.9851 14.13393 16.14609 15.00793 13.28813 0 15.4916 16.67186 17.98105 17.14487 18.16651 15.46189 0 16.32842 15.94252 0 16.54151 0 0 13.02146 16.71116 P08887 IL6RA_HUMAN "Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA (IL-6R 1) (Membrane glycoprotein 80, gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha, sIL6R ]" IL6R Homo sapiens (Human) acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573] apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803]; acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573] ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803] GO:0002384; GO:0002446; GO:0002548; GO:0002690; GO:0004896; GO:0004915; GO:0004921; GO:0005576; GO:0005615; GO:0005886; GO:0005896; GO:0006953; GO:0008284; GO:0009897; GO:0010536; GO:0010573; GO:0016324; GO:0019221; GO:0019899; GO:0019955; GO:0019970; GO:0019981; GO:0031018; GO:0032717; GO:0032722; GO:0032755; GO:0032966; GO:0034097; GO:0042531; GO:0042803; GO:0043235; GO:0043410; GO:0045669; GO:0048661; GO:0050731; GO:0050829; GO:0050830; GO:0070102; GO:0070110; GO:0070119; GO:0070120; GO:0072126; GO:0072540; GO:0097191; GO:1901731 KPAAGSHPSR 4.670000076 1 1 0.290126676 1006.57606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.19439 0 0 0 0 0 0 0 0 0 17.53168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.97167 0 0 P08913 ADA2A_HUMAN "Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR)" ADRA2A ADRA2R ADRAR Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intestinal absorption [GO:0050892]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; Rho protein signal transduction [GO:0007266]; thermoception [GO:0050955]; vasodilation [GO:0042311] axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-1B adrenergic receptor binding [GO:0031692]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; heterotrimeric G-protein binding [GO:0032795]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intestinal absorption [GO:0050892]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; Rho protein signal transduction [GO:0007266]; thermoception [GO:0050955]; vasodilation [GO:0042311] alpha-1B adrenergic receptor binding [GO:0031692]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; heterotrimeric G-protein binding [GO:0032795]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996] GO:0001819; GO:0002526; GO:0004930; GO:0004938; GO:0005737; GO:0005886; GO:0005887; GO:0006260; GO:0007186; GO:0007189; GO:0007193; GO:0007265; GO:0007266; GO:0007565; GO:0008284; GO:0010700; GO:0016323; GO:0019229; GO:0019901; GO:0030036; GO:0030168; GO:0030335; GO:0031692; GO:0031696; GO:0031996; GO:0032147; GO:0032148; GO:0032795; GO:0032811; GO:0032870; GO:0035624; GO:0042311; GO:0042593; GO:0042596; GO:0042803; GO:0043025; GO:0043235; GO:0043268; GO:0043406; GO:0043410; GO:0043679; GO:0045741; GO:0045955; GO:0046676; GO:0046982; GO:0050892; GO:0050955; GO:0050995; GO:0051044; GO:0051379; GO:0051380; GO:0051926; GO:0061179; GO:0070473; GO:0071875; GO:0071880; GO:0071881; GO:0071882; GO:0090303; GO:0098691; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:1901020; GO:2000300 ASQVKPGDSLPR 14.15999985 0.358996183 0.358996183 0.433105807 1254.439389 0 15.04636 0 0 0 0 0 0 14.58635 0 0 15.83424 16.99987 0 0 16.4909 0 16.30253 0 0 17.37546 0 0 16.89672 14.98721 0 16.60517 15.06428 17.00221 13.68845 14.19795 17.28798 16.51792 15.0258 17.94845 17.07309 16.99037 19.12056 0 14.91888 17.4648 17.70894 16.84048 17.27536 15.97848 17.53421 14.03585 18.21865 P08F94 PKHD1_HUMAN Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin) PKHD1 FCYT TIGM1 Homo sapiens (Human) branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; homeostatic process [GO:0042592]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of planar polarity [GO:0090175]; regulation of TOR signaling [GO:0032006] "9+0 non-motile cilium [GO:0097731]; anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]" "9+0 non-motile cilium [GO:0097731]; anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor activity [GO:0038023]; branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; homeostatic process [GO:0042592]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of planar polarity [GO:0090175]; regulation of TOR signaling [GO:0032006]" signaling receptor activity [GO:0038023] GO:0000132; GO:0000775; GO:0001822; GO:0001952; GO:0003382; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005929; GO:0006874; GO:0008284; GO:0010824; GO:0016021; GO:0016324; GO:0022407; GO:0030155; GO:0031362; GO:0032006; GO:0032088; GO:0036064; GO:0038023; GO:0042592; GO:0043066; GO:0045216; GO:0048471; GO:0048754; GO:0050679; GO:0051271; GO:0051660; GO:0051898; GO:0060271; GO:0070062; GO:0070372; GO:0072686; GO:0090175; GO:0097731; GO:0098609; GO:1904036; GO:1904054 GAKPMEEIVTVETVQDTDLYLK 2.230000019 1 1 0.073855388 2495.520905 0 0 13.23922 0 0 0 9.227285 10.38401 11.56867 12.21529 0 12.6981 6.618318 11.68571 12.86072 8.967155 16.51223 0 0 0 0 0 13.89792 13.22414 12.26091 11.75852 0 0 0 0 0 9.569591 0 0 0 0 14.21044 0 0 13.76097 14.7224 0 0 0 14.31635 0 0 0 P09001 RM03_HUMAN "39S ribosomal protein L3, mitochondrial, L3mt, MRP-L3 (Mitochondrial large ribosomal subunit protein uL3m)" MRPL3 MRL3 RPML3 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 MPGKMGNIYR 9.25 1 1 0.355024363 1166.286452 0 16.26962 0 0 0 14.04282 0 0 0 0 16.25641 0 14.56432 0 15.0126 14.71775 0 15.30742 15.78185 17.64939 15.39333 0 0 0 0 15.68699 16.2176 16.86859 15.6488 15.4319 0 16.6765 0 15.82081 0 15.92216 0 17.03138 16.34536 0 15.13944 15.30463 14.08436 16.10613 0 15.05941 17.19808 16.82775 P09012 SNRPA_HUMAN "U1 small nuclear ribonucleoprotein A, U1 snRNP A, U1-A, U1A" SNRPA Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]" nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685] "nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]" identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446] GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005685; GO:0030619; GO:0042802; GO:1900363; GO:1990446 SQETPATKK 2.25 1 1 0.047518219 990.5352494 9.3486 0 12.03723 0 0 0 14.30717 0 14.64036 0 0 12.50598 0 15.5012 0 0 0 13.70678 16.27362 0 16.1505 0 0 0 0 0 0 0 15.82717 14.23847 0 0 0 16.40812 0 14.42794 0 14.66243 0 0 0 15.29799 0 0 0 0 0 15.19557 P09016 HXD4_HUMAN Homeobox protein Hox-D4 (Homeobox protein HHO.C13) (Homeobox protein Hox-4B) (Homeobox protein Hox-5.1) HOXD4 HOX4B Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic organ development [GO:0048568]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic organ development [GO:0048568]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0030054; GO:0045944; GO:0048568; GO:0048704; GO:1990837 AYSQSDPKQPPSGTALK 4.400000095 1 1 0.475496238 1774.544437 18.17311 0 0 0 0 0 0 0 0 0 0 18.34796 0 0 0 0 0 0 0 0 17.04285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.62693 0 0 0 0 P09038 FGF2_HUMAN "Fibroblast growth factor 2, FGF-2 (Basic fibroblast growth factor, bFGF) (Heparin-binding growth factor 2, HBGF-2)" FGF2 FGFB Homo sapiens (Human) "aging [GO:0007568]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inositol phosphate biosynthetic process [GO:0032958]; lung development [GO:0030324]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; organ induction [GO:0001759]; paracrine signaling [GO:0038001]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; wound healing [GO:0042060]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722]; aging [GO:0007568]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inositol phosphate biosynthetic process [GO:0032958]; lung development [GO:0030324]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; organ induction [GO:0001759]; paracrine signaling [GO:0038001]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; wound healing [GO:0042060]" chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722] GO:0001658; GO:0001759; GO:0001934; GO:0001938; GO:0002042; GO:0005104; GO:0005125; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006661; GO:0006935; GO:0007165; GO:0007265; GO:0007399; GO:0007568; GO:0008083; GO:0008201; GO:0008284; GO:0008285; GO:0008543; GO:0009792; GO:0009887; GO:0010001; GO:0010595; GO:0010628; GO:0010629; GO:0010764; GO:0010863; GO:0014068; GO:0014843; GO:0019956; GO:0021762; GO:0021940; GO:0030154; GO:0030214; GO:0030324; GO:0030334; GO:0030374; GO:0032958; GO:0038001; GO:0040037; GO:0042056; GO:0042060; GO:0042660; GO:0042802; GO:0043406; GO:0043410; GO:0043536; GO:0043537; GO:0043552; GO:0045669; GO:0045765; GO:0045766; GO:0045893; GO:0045944; GO:0046668; GO:0048598; GO:0048678; GO:0048864; GO:0050679; GO:0051209; GO:0051726; GO:0051781; GO:0051897; GO:0060045; GO:0060128; GO:0060129; GO:0060548; GO:0060591; GO:0060644; GO:0060978; GO:0061045; GO:0070374; GO:0072089; GO:0090049; GO:0090050; GO:0090263; GO:0090722; GO:1902748; GO:1902895; GO:1903587; GO:1903672; GO:1904707; GO:1905278; GO:1905564; GO:2000544; GO:2000546; GO:2000573; GO:2001028 LGSKTGPGQK 8.359999657 1 1 0.383434418 971.4718319 0 0 0 0 0 0 16.84231 0 17.86458 0 10.34019 18.19821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.95911 0 0 15.43364 0 17.20817 0 0 0 0 17.82903 0 0 0 0 0 0 P09067 HXB5_HUMAN Homeobox protein Hox-B5 (Homeobox protein HHO.C10) (Homeobox protein Hox-2A) (Homeobox protein Hu-1) HOXB5 HOX2A Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell differentiation [GO:0045446]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell differentiation [GO:0045446]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0009653; GO:0009952; GO:0045446; GO:0048704; GO:1990837 LHISHDMTGPDGK 19.37000084 1 1 9.21E-13 1408.858656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53433 0 0 0 15.20779 0 0 14.13648 0 0 15.11364 0 0 0 0 0 16.35922 0 0 0 0 0 0 14.10429 P09086 PO2F2_HUMAN "POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2, Oct-2) (Octamer-binding transcription factor 2, OTF-2)" POU2F2 OCT2 OTF2 Homo sapiens (Human) cellular response to virus [GO:0098586]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to virus [GO:0098586]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006959; GO:0032755; GO:0043231; GO:0043565; GO:0045944; GO:0098586; GO:1990837 MSKPLEAEK 9.079999924 1 1 0.306192578 1028.409381 14.92116 0 0 0 0 0 16.7963 0 14.94925 0 0 0 0 16.42326 0 0 16.28025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.79109 0 0 0 0 0 0 0 0 0 0 0 0 19.16542 19.73247 0 P09210 GSTA2_HUMAN "Glutathione S-transferase A2, EC 2.5.1.18 (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2)" GSTA2 GST2 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805] glutathione transferase activity [GO:0004364] GO:0004364; GO:0005829; GO:0006749; GO:0006805; GO:0030855; GO:0070062 GRMESIR 8.800000191 1 1 0.152586972 865.0028616 16.56969 0 17.88497 15.33759 13.34683 12.8489 14.64876 11.27299 0 14.93951 14.24035 15.86936 0 0 0 14.18151 0 15.84735 15.22431 0 0 0 15.77231 0 15.88633 0 0 0 16.57567 0 0 16.58247 0 0 0 0 0 0 0 0 0 0 15.32334 0 0 16.11586 0 0 P09237 MMP7_HUMAN "Matrilysin, EC 3.4.24.23 (Matrin) (Matrix metalloproteinase-7, MMP-7) (Pump-1 protease) (Uterine metalloproteinase)" MMP7 MPSL1 PUMP1 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508] endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006509; GO:0008237; GO:0008270; GO:0022617; GO:0030198; GO:0030335; GO:0030574; GO:0031012; GO:0031293; GO:0070062 EMQKFFGLPITGMLNSR 1.179999948 0.227779597 0.227779597 0.104526325 1984.382228 14.64569 0 15.59896 17.56249 14.71295 0 0 0 0 16.09197 17.21132 0 13.92826 0 17.91444 0 14.66385 16.32856 15.14311 13.20881 0 0 0 15.49303 0 12.73059 17.92797 0 16.08069 0 15.05972 19.40577 0 0 15.40546 15.42063 0 0 17.89423 0 15.72869 0 0 12.77399 15.87382 0 16.33751 13.44327 P09327 VILI_HUMAN Villin-1 VIL1 VIL Homo sapiens (Human) actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]" "actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]" GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0065003; GO:0070062; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394 LRGMTLAK 2.160000086 0.642530918 0.642530918 0.293685433 905.7840906 0 17.00671 18.13402 0 0 0 16.11362 17.21916 0 0 0 0 0 0 0 16.13462 17.98643 0 0 0 17.43452 16.20716 0 18.0896 17.65751 16.8783 0 0 0 16.4237 17.55909 0 18.52821 0 0 19.48418 0 18.98506 17.39795 16.47015 0 16.26524 0 0 0 17.98466 16.24331 17.01247 P09429 HMGB1_HUMAN "High mobility group protein B1 (High mobility group protein 1, HMG-1)" HMGB1 HMG1 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell chemotaxis [GO:0002407]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; heterochromatin assembly [GO:0031507]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; neutrophil clearance [GO:0097350]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mismatch repair [GO:0032425]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]" alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; transcription repressor complex [GO:0017053] "alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; transcription repressor complex [GO:0017053]; bubble DNA binding [GO:0000405]; C-X-C chemokine binding [GO:0019958]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; phosphatidylserine binding [GO:0001786]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell chemotaxis [GO:0002407]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; heterochromatin assembly [GO:0031507]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; neutrophil clearance [GO:0097350]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mismatch repair [GO:0032425]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]" "bubble DNA binding [GO:0000405]; C-X-C chemokine binding [GO:0019958]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; phosphatidylserine binding [GO:0001786]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]" GO:0000122; GO:0000400; GO:0000405; GO:0000793; GO:0000976; GO:0001530; GO:0001773; GO:0001786; GO:0002218; GO:0002407; GO:0002437; GO:0002643; GO:0002840; GO:0003684; GO:0003690; GO:0003697; GO:0003713; GO:0003714; GO:0003723; GO:0005125; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005768; GO:0005793; GO:0006265; GO:0006303; GO:0006310; GO:0006357; GO:0006914; GO:0006954; GO:0007204; GO:0008301; GO:0009986; GO:0010508; GO:0016829; GO:0017053; GO:0017055; GO:0019958; GO:0031175; GO:0031507; GO:0032072; GO:0032392; GO:0032425; GO:0032689; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0033151; GO:0034165; GO:0034774; GO:0035711; GO:0035868; GO:0042056; GO:0042104; GO:0043065; GO:0043277; GO:0043280; GO:0043371; GO:0043388; GO:0043410; GO:0043536; GO:0043537; GO:0045063; GO:0045087; GO:0045944; GO:0046330; GO:0050786; GO:0051106; GO:0061629; GO:0070182; GO:0070374; GO:0071222; GO:0090026; GO:0097100; GO:0097350; GO:0140297; GO:1904813; GO:1905564; GO:2000343; GO:2000426; GO:2001200 GKPDAAK 1.649999976 1 1 0.300456966 686.9730303 15.86749 14.85247 15.02617 15.42145 0 14.1894 0 14.6064 14.55013 0 0 0 0 15.7461 15.10078 13.43635 15.2683 0 16.52134 15.2159 16.94265 0 0 0 14.38449 0 0 14.64483 15.82803 16.81143 0 15.96709 0 15.67143 16.44983 0 0 15.70094 0 0 15.45874 16.0148 0 15.51797 0 0 16.26378 0 P09467 F16P1_HUMAN "Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)" FBP1 FBP Homo sapiens (Human) "cellular response to insulin stimulus [GO:0032869]; cellular response to magnesium ion [GO:0071286]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cellular response to insulin stimulus [GO:0032869]; cellular response to magnesium ion [GO:0071286]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]" "AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" GO:0000122; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0032869; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0061629; GO:0070062; GO:0071286; GO:0071466 LDVLSNDLVMNMLK 1.809999943 1 1 0.405242735 1613.531923 17.63447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09471 GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit alpha GNAO1 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; muscle contraction [GO:0006936] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; muscle contraction [GO:0006936] corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852] GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0006936; GO:0007188; GO:0007212; GO:0031683; GO:0031821; GO:0031852; GO:0046872; GO:0051430 KDLFGEK 10.52000046 1 1 1.15E-13 837.5391384 0 0 0 0 0 0 0 0 16.181 0 0 0 16.7347 0 0 15.84269 0 0 15.18881 0 0 0 0 0 16.37733 15.68937 0 0 15.2369 14.16814 15.66861 0 13.91184 0 0 0 15.98429 0 0 0 0 16.05459 0 0 0 0 0 15.43685 P09493 TPM1_HUMAN Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1) TPM1 C15orf13 TMSA Homo sapiens (Human) actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307] GO:0001725; GO:0003065; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005862; GO:0005884; GO:0006936; GO:0006937; GO:0007010; GO:0007015; GO:0008016; GO:0008092; GO:0008307; GO:0008360; GO:0015629; GO:0030017; GO:0030049; GO:0030336; GO:0031529; GO:0032059; GO:0032587; GO:0032781; GO:0034614; GO:0042060; GO:0042802; GO:0042803; GO:0045214; GO:0045785; GO:0046982; GO:0051015; GO:0051496; GO:0055010; GO:0060048; GO:1904706; GO:1904753 LKGTEDELDK 8.789999962 0.790153086 0.790153086 0.177959976 1148.082125 16.37974 0 0 12.8537 0 9.360046 0 0 0 0 0 16.11229 0 0 0 17.90522 0 0 0 0 0 0 15.27178 0 0 0 0 0 0 0 0 0 0 10.61657 15.77902 0 0 0 0 0 0 0 0 0 0 0 0 0 P09543 CN37_HUMAN "2',3'-cyclic-nucleotide 3'-phosphodiesterase, CNP, CNPase, EC 3.1.4.37" CNP Homo sapiens (Human) adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762]" "2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]" GO:0000226; GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005874; GO:0005886; GO:0005902; GO:0007268; GO:0007409; GO:0007568; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0021762; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0045202; GO:0046902; GO:0048471; GO:0048709; GO:0070062 MVSADAYK 3.950000048 1 1 0.115748652 898.4887253 12.79378 13.97224 0 0 12.98413 0 0 15.17639 15.2388 15.17372 13.4296 15.98039 14.3842 14.43013 12.43311 14.23789 0 0 0 11.63042 0 0 14.64715 0 0 0 0 0 14.27363 0 0 0 0 14.73208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09544 WNT2_HUMAN "Protein Wnt-2 (Int-1-like protein 1) (Int-1-related protein, IRP)" WNT2 INT1L1 IRP Homo sapiens (Human) atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] GO:0001938; GO:0002053; GO:0002088; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0007267; GO:0008284; GO:0022008; GO:0030182; GO:0030324; GO:0031232; GO:0033278; GO:0045165; GO:0045944; GO:0048018; GO:0048146; GO:0050769; GO:0051091; GO:0055009; GO:0060045; GO:0060070; GO:0060317; GO:0060492; GO:0060501; GO:0060716; GO:0061072; GO:0061180; GO:0062023; GO:0071300; GO:0071560; GO:1904948; GO:1904954; GO:1990909 MGSAKDSK 8.819999695 1 1 0.246439562 840.8521643 18.11128 17.40507 15.79081 16.56078 16.17252 0 15.79916 0 16.43139 15.28049 16.62985 15.71 15.55726 15.16183 16.92221 15.67787 0 0 13.76663 16.40767 15.95085 19.14819 16.10292 17.15392 15.38897 15.49727 17.9777 16.76294 15.72387 14.03855 17.1468 17.31412 18.74373 16.27663 16.43547 13.34373 19.469 16.5672 15.95292 18.22733 15.13828 15.91086 0 14.71749 0 18.24494 16.37763 0 P09601 HMOX1_HUMAN "Heme oxygenase 1, HO-1, EC 1.14.14.18 [Cleaved into: Heme oxygenase 1 soluble form ]" HMOX1 HO HO1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to cisplatin [GO:0072719]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient [GO:0031670]; endothelial cell proliferation [GO:0001935]; erythrocyte homeostasis [GO:0034101]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; iron ion homeostasis [GO:0055072]; liver regeneration [GO:0097421]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of chemokine production [GO:0032722]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; smooth muscle hyperplasia [GO:0014806]; wound healing involved in inflammatory response [GO:0002246] caveola [GO:0005901]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] caveola [GO:0005901]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospholipase D activity [GO:0004630]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to cisplatin [GO:0072719]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient [GO:0031670]; endothelial cell proliferation [GO:0001935]; erythrocyte homeostasis [GO:0034101]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; iron ion homeostasis [GO:0055072]; liver regeneration [GO:0097421]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of chemokine production [GO:0032722]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; smooth muscle hyperplasia [GO:0014806]; wound healing involved in inflammatory response [GO:0002246] enzyme binding [GO:0019899]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospholipase D activity [GO:0004630]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] GO:0001525; GO:0001935; GO:0002246; GO:0002686; GO:0004392; GO:0004630; GO:0005198; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0005901; GO:0006788; GO:0006879; GO:0006979; GO:0007264; GO:0008217; GO:0008219; GO:0008630; GO:0009410; GO:0010656; GO:0014806; GO:0016020; GO:0016239; GO:0016242; GO:0019899; GO:0020037; GO:0031670; GO:0032722; GO:0032764; GO:0034101; GO:0034383; GO:0034395; GO:0034605; GO:0035094; GO:0035556; GO:0042167; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0043123; GO:0043305; GO:0043392; GO:0043433; GO:0043524; GO:0043619; GO:0043627; GO:0045765; GO:0045766; GO:0046872; GO:0048471; GO:0048661; GO:0048662; GO:0051090; GO:0055072; GO:0071243; GO:0071276; GO:0071456; GO:0072719; GO:0090050; GO:0097421; GO:1902042; GO:1903589; GO:1904036; GO:1904706 VQDSAPVETPR 5.389999866 1 1 0.36254662 1197.395261 0 0 15.0158 0 0 0 16.78496 0 0 0 0 0 16.41691 15.18554 0 0 16.29488 15.59268 0 0 0 0 0 0 0 0 0 0 0 12.76198 0 14.77304 13.20412 16.28426 16.33416 15.81074 12.56987 15.15675 17.43379 17.24405 14.47716 0 0 15.57149 0 0 0 0 P09603 CSF1_HUMAN "Macrophage colony-stimulating factor 1, CSF-1, M-CSF, MCSF (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1 ]" CSF1 Homo sapiens (Human) branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; negative regulation of neuron death [GO:1901215]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803]; branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; negative regulation of neuron death [GO:1901215]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803] GO:0001503; GO:0001954; GO:0002158; GO:0002931; GO:0003006; GO:0005125; GO:0005157; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006954; GO:0007169; GO:0008083; GO:0008284; GO:0010628; GO:0010743; GO:0010744; GO:0010759; GO:0016020; GO:0016021; GO:0016604; GO:0030225; GO:0030278; GO:0030316; GO:0030335; GO:0032270; GO:0032946; GO:0038145; GO:0040018; GO:0042117; GO:0042476; GO:0042488; GO:0042802; GO:0042803; GO:0045087; GO:0045651; GO:0045657; GO:0045672; GO:0045860; GO:0046579; GO:0048471; GO:0048873; GO:0060444; GO:0060611; GO:0060763; GO:0061518; GO:1901215; GO:1902228; GO:1904141; GO:1905523; GO:1990682 DYEEHDK 12.10999966 0.014754312 0.014754312 0.257361704 935.7461167 0 0 0 0 17.15406 0 0 17.97257 0 0 0 0 0 17.49622 0 0 0 0 17.7403 0 16.5191 0 0 0 0 0 0 0 0 0 18.73095 20.73864 17.63024 0 0 0 17.98317 0 0 0 15.97788 16.99909 18.46187 0 17.49471 0 0 17.72022 P09619 PGFRB_HUMAN "Platelet-derived growth factor receptor beta, PDGF-R-beta, PDGFR-beta, EC 2.7.10.1 (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1, PDGFR-1) (CD antigen CD140b)" PDGFRB PDGFR PDGFR1 Homo sapiens (Human) aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; platelet-derived growth factor-activated receptor activity [GO:0005017]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; platelet-derived growth factor-activated receptor activity [GO:0005017]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085] GO:0001525; GO:0004712; GO:0004713; GO:0004714; GO:0004992; GO:0005017; GO:0005019; GO:0005102; GO:0005161; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0006024; GO:0007165; GO:0007169; GO:0007568; GO:0008284; GO:0008584; GO:0009636; GO:0009986; GO:0010863; GO:0014068; GO:0014911; GO:0016020; GO:0016324; GO:0016477; GO:0018108; GO:0019838; GO:0019899; GO:0019901; GO:0030335; GO:0031226; GO:0031410; GO:0032355; GO:0032516; GO:0032526; GO:0032956; GO:0032967; GO:0033674; GO:0034405; GO:0035025; GO:0035441; GO:0035789; GO:0035791; GO:0035793; GO:0035909; GO:0038085; GO:0038091; GO:0042060; GO:0042542; GO:0043065; GO:0043066; GO:0043202; GO:0043231; GO:0043235; GO:0043406; GO:0043548; GO:0043552; GO:0043627; GO:0045840; GO:0046488; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048661; GO:0048839; GO:0050921; GO:0055003; GO:0055093; GO:0060326; GO:0060437; GO:0060981; GO:0061298; GO:0070374; GO:0071670; GO:0072075; GO:0072262; GO:0072277; GO:0072278; GO:0072284; GO:0090280; GO:2000379; GO:2000491; GO:2000573 GRGMPQPNIIWSACR 5.21999979 1 1 0.429087889 1756.842634 13.44877 15.06414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.64356 0 18.16613 17.47626 0 0 0 0 16.23944 0 0 0 0 0 0 0 18.56508 0 0 0 0 0 0 0 0 0 0 P09622 DLDH_HUMAN "Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)" DLD GCSL LAD PHE3 Homo sapiens (Human) "acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]" acrosomal matrix [GO:0043159]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254] "acrosomal matrix [GO:0043159]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]" dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660] GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0005947; GO:0005967; GO:0006086; GO:0006120; GO:0006508; GO:0007369; GO:0009083; GO:0031514; GO:0042391; GO:0043159; GO:0045252; GO:0045254; GO:0045454; GO:0048240; GO:0050660; GO:0061732; GO:0106077 ADGGTQVIDTK 24.05999947 1 1 0.30346513 1104.637836 19.57624 17.33271 0 0 0 19.50475 18.07731 0 0 18.95667 19.44438 19.7795 19.56167 0 19.54257 18.75904 0 17.92903 19.08048 0 19.5669 0 0 0 0 18.78901 0 17.12132 19.41037 18.57482 20.94604 19.82836 0 19.09669 19.94548 20.59165 19.30623 0 0 0 0 0 19.89441 0 0 0 19.09348 19.48177 P09651 ROA1_HUMAN "Heterogeneous nuclear ribonucleoprotein A1, hnRNP A1 (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed ]" HNRNPA1 HNRPA1 Homo sapiens (Human) "cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752]; cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]" G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752] GO:0000381; GO:0000398; GO:0003697; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0016020; GO:0019904; GO:0032211; GO:0032212; GO:0035198; GO:0036002; GO:0042149; GO:0042802; GO:0043484; GO:0051028; GO:0051168; GO:0051170; GO:0061752; GO:0070062; GO:0071013; GO:0098505; GO:1903936; GO:1990904 MSKSESPK 4.489999771 0.702185452 0.702185452 0.271289102 910.8152675 11.8565 15.43684 14.83953 14.18776 14.12428 15.70373 15.89583 13.33111 15.16426 15.73259 15.66809 15.88907 0 11.6786 15.32415 0 0 0 15.66319 0 0 0 0 0 16.95915 0 0 16.1562 0 0 0 17.23914 0 16.19578 0 15.87731 17.18396 0 15.34951 0 0 15.04034 17.19681 17.32941 14.99864 0 0 15.27647 P09874 PARP1_HUMAN "Poly [ADP-ribose] polymerase 1, PARP-1, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 1, ARTD1) (DNA ADP-ribosyltransferase PARP1, EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1, ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1, EC 2.4.2.-)" PARP1 ADPRT PPOL Homo sapiens (Human) apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179] "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270] GO:0000122; GO:0000723; GO:0000781; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032880; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0061629; GO:0070212; GO:0070213; GO:0070412; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170 FYTLIPHDFGMK 8.859999657 1 1 0.166903 1469.605669 0 0 10.21965 0 11.73451 0 0 0 15.23308 0 0 0 13.65963 0 0 0 0 14.52991 14.3972 0 0 0 0 10.41351 0 12.1184 0 0 15.02414 0 0 14.55725 13.82104 0 15.84951 0 14.6642 0 0 0 0 0 0 0 0 10.36276 0 0 P09913 IFIT2_HUMAN "Interferon-induced protein with tetratricopeptide repeats 2, IFIT-2 (ISG-54 K) (Interferon-induced 54 kDa protein, IFI-54K, P54)" IFIT2 CIG-42 G10P2 IFI54 ISG54 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; RNA binding [GO:0003723]; apoptotic mitochondrial changes [GO:0008637]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; response to virus [GO:0009615] RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005783; GO:0005829; GO:0008637; GO:0009615; GO:0032091; GO:0035457; GO:0043065; GO:0045087; GO:0051607 ENGMYGKR 7.420000076 1 1 0.187118279 955.0445931 13.16153 0 0 0 0 15.78932 0 0 0 0 0 15.90972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95672 0 12.08902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.18625 0 P09914 IFIT1_HUMAN "Interferon-induced protein with tetratricopeptide repeats 1, IFIT-1 (Interferon-induced 56 kDa protein, IFI-56K, P56)" IFIT1 G10P1 IFI56 IFNAI1 ISG56 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of helicase activity [GO:0051097]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; regulation of defense response to virus [GO:0050688]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657] cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; RNA binding [GO:0003723]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of helicase activity [GO:0051097]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; regulation of defense response to virus [GO:0050688]; response to virus [GO:0009615] RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005829; GO:0009615; GO:0019060; GO:0032091; GO:0043657; GO:0045070; GO:0045071; GO:0050688; GO:0051097; GO:0051607; GO:0071357; GO:0071360; GO:0140374 EATKGQPR 3.839999914 0.331111997 0.331111997 0.271190609 885.7507552 16.90167 14.98061 14.92968 15.42207 15.12253 14.74517 15.65673 15.45669 16.5365 13.15181 16.37129 16.65551 14.01431 15.77649 0 15.03703 0 16.84749 0 15.51873 0 15.63823 0 17.52551 16.25195 16.28203 0 0 0 0 0 0 18.17463 0 18.13413 0 0 0 0 14.9564 15.12824 16.51663 0 0 15.81945 0 0 15.10371 P09923 PPBI_HUMAN "Intestinal-type alkaline phosphatase, IAP, Intestinal alkaline phosphatase, EC 3.1.3.1" ALPI Homo sapiens (Human) dephosphorylation [GO:0016311] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311] alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; zinc ion binding [GO:0008270] GO:0000287; GO:0002020; GO:0004035; GO:0005576; GO:0005886; GO:0008270; GO:0016311; GO:0031225 SVGVVTTTRVQHASPAGTYAHTVNR 1.50999999 1 1 0.554779569 2610.066288 0 0 0 0 0 0 20.45974 19.78831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22.04294 0 0 0 0 0 0 0 0 0 0 0 0 P09972 ALDOC_HUMAN "Fructose-bisphosphate aldolase C, EC 4.1.2.13 (Brain-type aldolase)" ALDOC ALDC Homo sapiens (Human) "epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]" cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]" cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332] GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0070062; GO:1904724; GO:1904813 MPHSYPALSAEQKK 2.410000086 1 1 0.288430566 1601.131626 0 15.47696 0 0 0 14.70832 0 0 0 0 0 0 0 0 0 0 0 0 16.57753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C024 NUDT7_HUMAN "Peroxisomal coenzyme A diphosphatase NUDT7, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 7, Nudix motif 7)" NUDT7 Homo sapiens (Human) acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515]; acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515] GO:0000287; GO:0003986; GO:0005777; GO:0005782; GO:0005829; GO:0009132; GO:0010945; GO:0015938; GO:0030145; GO:0030515; GO:0036114; GO:0044580; GO:0046356; GO:0050873; GO:1901289; GO:1902858; GO:1902859; GO:2001294 APGEVCFPGGKR 1.600000024 1 1 0.191421919 1274.072456 12.6936 15.64714 0 10.97308 14.71528 0 0 0 13.98756 14.96912 0 15.78309 15.31404 14.0347 0 15.53025 0 15.48599 0 0 0 0 0 0 15.6153 0 0 14.21682 15.87095 14.76484 15.22317 14.7313 0 0 14.30376 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C091 FREM3_HUMAN FRAS1-related extracellular matrix protein 3 FREM3 Homo sapiens (Human) cell adhesion [GO:0007155]; cell communication [GO:0007154] basement membrane [GO:0005604]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154] metal ion binding [GO:0046872] GO:0005604; GO:0005615; GO:0007154; GO:0007155; GO:0016021; GO:0046872 GAPALKR 11.15999985 1 1 0.186858435 713.3809636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.37578 0 0 0 0 0 0 0 0 P0C0S8 H2A1_HUMAN "Histone H2A type 1, H2A.1 (Histone H2A/ptl)" H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982] GO:0000786; GO:0003677; GO:0005634; GO:0019899; GO:0046982; GO:0070062 AGLQFPVGR 36.04999924 1 1 0.463348219 945.381695 0 17.41966 0 0 18.491 0 18.74252 0 0 18.30534 0 18.86797 17.86744 0 18.29757 0 0 0 0 0 18.21299 19.60389 0 0 0 0 0 0 0 18.45388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.93262 0 0 0 P0C1S8 WEE2_HUMAN "Wee1-like protein kinase 2, EC 2.7.10.2 (Wee1-like protein kinase 1B) (Wee1B kinase)" WEE2 WEE1B Homo sapiens (Human) female meiotic nuclear division [GO:0007143]; female pronucleus assembly [GO:0035038]; mitotic cell cycle [GO:0000278]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of phosphorylation [GO:0042327]; regulation of fertilization [GO:0080154]; regulation of meiosis I [GO:0060631] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; female meiotic nuclear division [GO:0007143]; female pronucleus assembly [GO:0035038]; mitotic cell cycle [GO:0000278]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of phosphorylation [GO:0042327]; regulation of fertilization [GO:0080154]; regulation of meiosis I [GO:0060631] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0000278; GO:0000287; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007143; GO:0035038; GO:0042327; GO:0045736; GO:0060631; GO:0080154; GO:1900194 NTVLRPSLGK 7.46999979 1 1 0.175990047 1085.19884 0 0 0 0 0 14.62492 0 0 14.02049 0 0 0 0 15.15766 16.33865 14.84593 11.52949 0 0 0 0 0 0 0 0 14.57786 0 13.21877 14.55247 0 14.24972 12.32601 0 0 13.88294 0 0 0 16.60951 0 0 0 15.5257 0 0 14.47195 13.80282 0 P0C221 CC175_HUMAN Coiled-coil domain-containing protein 175 CCDC175 C14orf38 Homo sapiens (Human) ATIDLLEIESMELNK 1.580000043 1 1 0.150506425 1719.029266 0 0 0 16.10718 0 0 0 0 0 0 15.18563 0 13.83174 0 0 0 15.78459 0 0 0 0 15.1729 17.26089 12.87902 18.43405 0 17.30049 0 0 0 14.78529 0 0 0 0 0 0 15.84003 0 0 0 0 0 0 0 16.12207 14.91012 0 P0C2W1 FBSP1_HUMAN "F-box/SPRY domain-containing protein 1 (F-box only protein 45, hFbxo45)" FBXO45 FBX45 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511] cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202] cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202]; anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001764; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0098978; GO:0099523; GO:0099524 AFQHAFSTNDCSR 4.710000038 1 1 0.389999126 1541.415147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C2Y1 NBPF7_HUMAN Putative neuroblastoma breakpoint family member 7 NBPF7P NBPF7 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 VLVHSQERELIQLR 4.670000076 1 1 4.61E-13 1720.24306 0 0 0 0 14.01702 0 14.8651 0 0 0 0 0 0 15.69037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.00058 0 0 0 0 0 0 0 0 0 16.63533 0 0 0 0 17.93546 0 0 P0C604 OR4A8_HUMAN Olfactory receptor 4A8 (Olfactory receptor OR11-110) OR4A8 OR4A8P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 TYSPEGR 2.529999971 1 1 0.100629659 807.6741176 14.74962 0 12.87721 0 0 0 0 15.79294 0 0 0 0 0 13.66026 0 15.4446 0 15.27471 0 15.91105 0 0 0 0 0 0 0 0 14.32919 16.07009 16.47345 0 16.44117 16.42467 0 16.80563 15.43634 16.90682 0 0 0 0 0 0 0 0 0 17.0955 P0C671 BNIP5_HUMAN Protein BNIP5 BNIP5 C6orf222 Homo sapiens (Human) ASEYK 6.980000019 1 1 0.265038332 598.1196782 0 0 0 16.87882 0 16.63546 0 0 16.94353 16.96441 16.80942 0 16.93425 0 15.65654 0 18.48314 0 0 0 0 0 0 0 0 0 0 0 0 17.76198 0 0 0 17.38001 0 0 0 0 0 0 0 0 0 17.4731 0 0 0 0 P0C672 TSN19_HUMAN "Tetraspanin-19, Tspan-19" TSPAN19 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887] GO:0005887 NIIHAEM 5.119999886 1 1 0.252664347 842.3298782 15.84337 0 15.28667 0 0 0 0 0 0 0 15.91928 0 0 0 16.53807 0 15.73392 14.83351 15.91319 15.23492 15.9723 0 16.91844 0 0 15.30401 0 0 14.87653 0 0 14.80518 0 16.28175 0 0 0 0 16.24547 16.81831 15.85889 15.7119 14.14637 15.01105 14.31017 17.4626 18.55535 16.13374 P0C6C1 AN34C_HUMAN Ankyrin repeat domain-containing protein 34C ANKRD34C Homo sapiens (Human) ADPNIQDK 3.00999999 0.409243137 0.409243137 0.219770763 899.6345457 13.30512 16.55762 14.98302 0 15.72704 14.96614 16.05204 15.35806 0 0 15.65347 14.05164 0 0 0 16.61465 15.12189 15.89116 0 16.00093 16.63487 0 17.16692 17.19618 0 0 16.2854 16.0154 0 15.3643 14.85424 11.47691 13.90589 15.77986 15.70237 17.82258 17.09946 15.02623 16.92043 0 0 14.07082 14.03339 14.6916 0 16.79645 0 15.47895 P0C7A2 F153B_HUMAN Protein FAM153B FAM153B Homo sapiens (Human) MPGESTVCHRER 2.49000001 1 1 0.169253322 1458.800575 0 16.19148 14.98546 12.3693 15.71625 10.29575 0 0 15.58565 0 0 0 0 15.01707 0 0 0 0 0 0 0 17.17695 16.5822 17.4033 0 15.29119 0 16.43373 14.94688 0 15.82958 0 0 0 0 0 0 0 0 0 0 0 17.57932 0 0 0 0 14.45606 P0C7H9 U17L7_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7 USP17L7 Homo sapiens (Human) protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0042981 SKGNNK 1.879999995 1 1 0.029818834 644.5126648 0 0 0 0 0 0 0 0 0 0 0 0 0 16.18665 15.89965 15.37046 0 0 0 0 0 16.67674 0 12.00089 0 0 0 0 16.76549 0 0 0 0 16.72492 0 0 0 0 0 15.57147 16.57284 14.99177 0 0 0 0 0 0 P0C7I6 CC159_HUMAN Coiled-coil domain-containing protein 159 CCDC159 Homo sapiens (Human) QGEKEEHK 3.279999971 1 1 8.06E-13 984.8276605 14.57289 11.80863 0 14.11428 15.40299 13.41288 0 14.91389 0 17.11521 16.11016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7P0 CISD3_HUMAN "CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2, Miner2) (Mitochondrial inner NEET protein, MiNT)" CISD3 Homo sapiens (Human) protein maturation by [2Fe-2S] cluster transfer [GO:0106034] mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]" "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]" GO:0005739; GO:0046872; GO:0051537; GO:0106034 WCVCGR 13.11999989 0.181086332 0.181086332 6.87E-13 840.2883249 0 0 0 0 13.24672 15.01321 0 0 0 0 0 0 0 15.31252 0 16.577 0 0 0 0 0 0 18.32162 0 0 0 0 0 0 16.40018 16.52443 0 19.06909 0 0 18.84277 0 0 0 15.06858 0 0 0 14.74983 0 16.22139 0 17.26058 P0C7P4 UCRIL_HUMAN Putative cytochrome b-c1 complex subunit Rieske-like protein 1 (Ubiquinol-cytochrome c reductase Rieske iron-sulfur subunit pseudogene 1) UQCRFS1P1 UQCRFSL1 Homo sapiens (Human) "mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" mitochondrial respiratory chain complex III [GO:0005750] "mitochondrial respiratory chain complex III [GO:0005750]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]" GO:0005750; GO:0006122; GO:0008121; GO:0016491; GO:0046872; GO:0051537 SVAAR 1.210000038 1 1 0.19174174 500.7069737 15.58011 15.44761 0 0 15.7005 16.35495 0 0 0 0 0 0 0 0 15.9263 0 0 0 0 15.28144 0 0 0 0 15.297 15.68789 15.0735 0 16.05939 14.69986 13.75244 0 0 16.65298 15.14073 0 0 0 0 0 0 15.97147 17.55193 15.89661 0 14.52251 0 0 P0C7Q2 ARMS2_HUMAN Age-related maculopathy susceptibility protein 2 ARMS2 Homo sapiens (Human) retina homeostasis [GO:0001895] mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917] mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; retina homeostasis [GO:0001895] GO:0001895; GO:0001917; GO:0005739 ESVLDPGVGGEGASDKQR 5.230000019 1 1 0.363316999 1801.82936 14.13004 14.66356 0 0 0 14.90923 15.30394 0 0 0 0 16.29122 0 0 0 0 0 0 0 17.18525 0 16.64 16.15322 0 16.20161 0 16.42057 0 0 16.52277 14.602 0 15.20755 13.84694 0 0 0 15.75989 0 14.12185 13.93615 0 15.30651 0 0 17.02742 16.4701 0 P0C7T2 OR2T7_HUMAN Olfactory receptor 2T7 (OST723) (olfactory receptor OR1-44) OR2T7 OR2T7P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 CVSSGKVTTF 4.670000076 1 1 0.648059549 1085.429688 0 0 0 0 0 0 0 18.76805 0 0 0 0 20.04783 0 17.57994 0 0 0 0 0 17.68117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.40075 0 0 0 0 0 0 0 0 0 0 P0C7T5 ATX1L_HUMAN "Ataxin-1-like (Brother of ataxin-1, Brother of ATXN1)" ATXN1L BOAT BOAT1 Homo sapiens (Human) "anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]" dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]" DNA binding [GO:0003677]; RNA binding [GO:0003723] GO:0000122; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0035176; GO:0048286; GO:0048856; GO:1902035 GVVVAGQSQAGAR 7.539999962 1 1 2.30E-13 1203.31591 14.58762 0 0 13.01017 0 0 0 13.33643 13.00237 0 0 13.87976 0 14.13747 13.7869 0 0 0 0 15.05966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7T7 FMAS1_HUMAN Putative uncharacterized protein FRMD6-AS1 (FRMD6 antisense RNA 1) (FRMD6 antisense gene protein 1) FRMD6-AS1 C14orf82 Homo sapiens (Human) EGGPRR 1.039999962 1 1 0.11506259 670.3329155 0 0 0 14.92046 0 0 0 0 15.00934 16.48685 15.83599 12.29555 0 0 0 0 0 0 0 0 0 0 0 0 0 15.21789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.66981 P0C7U0 ELFN1_HUMAN Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28) ELFN1 PPP1R28 Homo sapiens (Human) synapse organization [GO:0050808] dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein phosphatase inhibitor activity [GO:0004864]; synapse organization [GO:0050808] protein phosphatase inhibitor activity [GO:0004864] GO:0004864; GO:0005615; GO:0016021; GO:0030425; GO:0031012; GO:0050808; GO:0060076 AFRAEAVGVHK 4.460000038 1 1 0.451596656 1184.829745 0 0 14.67026 11.25935 14.47481 0 0 13.27323 9.825038 16.11889 0 16.27163 13.69925 0 0 0 0 0 0 0 0 15.00702 16.45977 0 0 0 16.3349 13.91689 16.32347 13.25117 15.91329 13.91877 15.43428 0 0 0 0 0 0 0 0 0 0 0 15.57004 0 15.21754 0 P0C7V0 CF217_HUMAN Putative uncharacterized protein encoded by LINC00271 (AHI1 divergent transcript) AHI1-DT C6orf217 LINC00271 NCRNA00271 Homo sapiens (Human) NTRCATR 2.529999971 0.304524481 0.304524481 0.068765479 879.5994955 0 14.40941 13.24576 0 0 13.35676 15.29109 14.99614 16.87249 0 0 0 0 0 15.36673 0 0 13.5162 0 0 15.08335 0 0 0 0 0 0 0 17.31847 16.60616 13.831 0 0 0 18.82142 0 0 0 15.9163 0 0 16.59026 0 0 0 0 0 0 P0C7W0 PRR29_HUMAN Proline-rich protein 29 PRR29 C17orf72 Homo sapiens (Human) EDLLELMMLQNAQMHQLLLSR 6.980000019 1 1 1.024478656 2540.902907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.25383 0 0 19.21467 0 0 0 0 0 0 0 0 P0C854 CECR9_HUMAN Putative cat eye syndrome critical region protein 9 CECR9 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 QDGSEWVVPRSSASSNVLYH 5.420000076 1 1 1.38E-12 2218.951581 13.15693 0 0 0 18.58247 0 0 14.36571 14.10286 15.15639 15.28786 15.66038 15.4222 14.26388 15.7136 14.99945 13.73338 13.52908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C866 F91A2_HUMAN Putative uncharacterized protein encoded by LINC00869 LINC00869 FAM91A2 KIAA0493 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] GO:0005802; GO:0006886; GO:0031410; GO:0099041 SLSLSAGHTK 1.74000001 0.292765796 0.292765796 1.37E-12 1001.160374 12.17581 14.80799 12.98686 17.33811 14.53191 15.56809 17.72293 14.64595 0 14.85137 16.57996 0 17.10688 16.35699 16.19584 13.68627 14.25065 16.60774 15.99523 16.40125 12.73181 13.7223 14.30744 15.12393 16.08886 14.43729 16.69177 15.11118 12.46876 15.98747 9.40635 18.1364 12.08184 0 16.39845 15.26265 0 16.60801 15.57702 16.13849 15.62168 15.99886 0 15.11843 16.47754 15.60805 15.66124 14.70902 P0C8F1 PATE4_HUMAN "Prostate and testis expressed protein 4 (PATE-like protein B, PATE-B)" PATE4 Homo sapiens (Human) regulation of neurotransmitter receptor activity [GO:0099601] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; acetylcholine receptor regulator activity [GO:0030548]; regulation of neurotransmitter receptor activity [GO:0099601] acetylcholine receptor regulator activity [GO:0030548] GO:0001669; GO:0005615; GO:0030548; GO:0099601 EEESSK 9.220000267 0.449613065 0.449613065 0.238216902 708.3865903 15.68156 18.12598 15.03025 0 17.50941 15.18924 16.58791 16.772 16.59481 16.43119 18.35698 16.48656 16.61497 0 16.92426 17.7779 15.47056 17.4994 15.26483 17.61681 17.06215 19.32522 19.05598 18.75181 16.43262 16.66438 16.76229 16.64561 16.70032 15.94043 16.15301 17.03365 16.12611 17.98556 16.78064 17.20016 16.49127 17.77929 0 18.32938 17.07297 0 17.04025 17.56471 17.25449 17.37453 16.91068 17.37588 P0CAP1 MYZAP_HUMAN "Myocardial zonula adherens protein (GRINL1A upstream protein, Gup)" MYZAP MYOZAP Homo sapiens (Human) intracellular signal transduction [GO:0035556] cell junction [GO:0030054]; cytoskeleton [GO:0005856]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; I band [GO:0031674]; Z disc [GO:0030018] cell junction [GO:0030054]; cytoskeleton [GO:0005856]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; I band [GO:0031674]; Z disc [GO:0030018]; intracellular signal transduction [GO:0035556] GO:0005856; GO:0030018; GO:0030054; GO:0031234; GO:0031674; GO:0035556 EMVVYGWSTSQLK 10.10999966 1 1 0.461375777 1527.507355 17.3916 20.35408 13.82983 19.33693 20.32377 17.36205 17.80917 17.39614 0 0 0 17.82645 17.11362 19.80435 0 0 18.53081 0 16.4536 16.54769 0 19.91303 0 0 0 20.22778 0 0 0 0 0 0 0 0 0 0 0 0 0 17.81057 0 0 17.33836 0 0 0 0 0 P0CAP2 GRL1A_HUMAN DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A) POLR2M GRINL1A Homo sapiens (Human) intracellular signal transduction [GO:0035556]; maintenance of ER location [GO:0051685] "neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase II, holoenzyme [GO:0016591]" "neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase II, holoenzyme [GO:0016591]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; intracellular signal transduction [GO:0035556]; maintenance of ER location [GO:0051685]" DNA-directed 5'-3' RNA polymerase activity [GO:0003899] GO:0003899; GO:0005635; GO:0005665; GO:0016591; GO:0035556; GO:0043025; GO:0051685 NLTGLSSGTEK 8.090000153 1 1 0.142763473 1106.151315 16.01606 10.91214 16.89978 12.98303 13.56794 0 8.679336 14.77537 0 0 15.19304 14.37626 17.3342 15.28632 0 0 15.43444 0 16.86435 0 0 0 0 16.7455 18.07649 16.40994 14.63616 0 16.14165 0 0 0 0 20.16621 16.59418 16.38713 0 0 0 0 16.11742 0 0 16.12712 0 0 0 0 P0CB47 UBFL1_HUMAN Upstream-binding factor 1-like protein 1 UBTFL1 C11orf27 Homo sapiens (Human) blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; regulation of gene expression [GO:0010468] DNA binding [GO:0003677] GO:0001832; GO:0003677; GO:0005634; GO:0005737; GO:0007566; GO:0010468 FGTLKELVLEAK 14.56999969 1 1 0.177247438 1347.748438 0 0 0 0 0 15.85202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CF97 F200B_HUMAN Protein FAM200B FAM200B C4orf53 Homo sapiens (Human) IANTAAEK 5.579999924 1 1 0.33788144 816.9788342 12.39545 14.37731 11.92198 15.374 14.04204 15.28668 13.94853 0 0 0 0 0 14.17584 12.98058 0 16.00564 12.84466 0 13.96225 15.07178 15.40984 13.54992 14.589 0 0 0 0 0 0 0 0 0 15.88091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG01 GKN3_HUMAN Gastrokine-3 GKN3P Homo sapiens (Human) regulation of cell population proliferation [GO:0042127] extracellular space [GO:0005615] extracellular space [GO:0005615]; regulation of cell population proliferation [GO:0042127] GO:0005615; GO:0042127 MACVLARMDK 1.159999967 1 1 0.075146755 1211.440083 8.862829 0 0 0 0 12.38475 13.04386 0 0 10.88238 0 11.81284 0 11.9989 13.05251 16.16766 0 0 4.028381 13.22343 13.05707 0 0 0 0 14.41197 13.62004 11.43821 11.51381 0 0 15.20184 0 0 7.84605 0 0 0 0 13.48017 0 0 13.8332 19.01495 0 9.30379 0 0 P0CG12 DERPC_HUMAN Decreased expression in renal and prostate cancer protein DERPC Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] GO:0005654; GO:0070062 MAGPQGLDLAPILR 7.019999981 0.111147925 0.111147925 0.186149951 1467.703525 0 15.06366 15.25686 13.86184 0 0 14.28973 15.75075 0 16.519 0 0 10.9473 14.89244 18.46526 13.93646 0 0 0 15.02297 14.989 16.90113 14.4455 16.48018 18.87838 0 16.02455 15.04595 0 13.3927 0 0 14.9652 14.95722 0 0 13.20827 12.48058 0 14.4834 14.47683 17.47926 16.36967 14.92805 0 16.60204 15.44232 0 P0CG20 PRR35_HUMAN Proline-rich protein 35 (Uncharacterized protein RJD1) PRR35 C16orf11 Homo sapiens (Human) ALGDYAR 4.809999943 0.168047369 0.168047369 0.249232969 762.9305654 0 17.3441 0 0 16.69763 13.09886 0 15.77312 15.61797 16.89459 16.56204 17.53721 0 0 11.83538 0 0 16.81467 0 15.38246 16.95424 14.90647 0 12.10202 15.06213 0 0 15.0482 16.69239 12.84388 0 0 18.26003 17.69112 0 0 0 0 0 15.14646 0 15.6878 15.63257 16.63194 0 0 0 15.98809 P0CG32 ZCC18_HUMAN Zinc finger CCHC domain-containing protein 18 ZCCHC18 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005634; GO:0046872 RSEPIMER 9.649999619 1 1 0.135605345 1017.879422 15.18922 0 0 0 0 0 15.16713 0 10.92546 0 0 14.56167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.86433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CI00 Z705B_HUMAN Putative zinc finger protein 705B ZNF705B Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 NLLSPKPR 11.21000004 1 1 0.27340726 924.4970114 0 0 17.04075 0 18.06013 0 0 0 0 19.41579 0 0 16.08693 17.25107 18.59269 17.84191 0 0 0 16.62413 0 18.57974 0 0 19.62499 18.03377 0 18.32886 17.33243 0 18.8179 19.38634 0 0 19.8633 0 0 19.4786 0 16.11336 18.35978 17.28176 0 16.70928 18.68719 18.17848 18.5438 0 P0CW24 PNM6A_HUMAN Paraneoplastic antigen-like protein 6A PNMA6A PNMA6C Homo sapiens (Human) GTALQLVHALLAENPAR 5.809999943 1 1 0.266122454 1775.009088 0 15.93815 0 0 0 0 0 0 16.38481 0 0 0 0 15.34263 0 0 0 0 0 0 15.72206 0 0 0 0 17.53311 0 0 0 0 0 0 16.32537 0 0 12.9631 0 0 0 0 0 0 0 16.47404 0 0 0 0 P0CW27 CC166_HUMAN Coiled-coil domain-containing protein 166 CCDC166 Homo sapiens (Human) MPSLTASRAGSR 1.320000052 1 1 0.297475919 1247.836121 13.30508 14.35501 0 0 0 0 0 15.69837 0 0 0 0 0 0 0 0 0 0 0 13.86424 0 14.61314 0 15.10332 16.00074 14.88498 15.14073 15.40858 13.92686 14.0967 0 14.90579 14.60922 14.51293 14.46424 16.02172 0 15.8846 15.45098 14.57346 0 15.72536 16.92061 15.69238 15.65458 14.79051 0 15.13219 P0DI83 NARR_HUMAN "Ras-related protein Rab-34, isoform NARR (Nine amino-acid residue-repeats)" RAB34 NARR Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730] GO:0005730 AEGSRPGGAAPVPEEGGR 16.31999969 1 1 0.006518278 1696.956292 20.05135 18.4212 18.78983 19.40816 19.05339 0 17.99776 18.07435 0 18.42195 0 18.11692 18.70895 0 0 0 0 0 0 19.79725 0 0 0 20.15746 18.6717 18.99868 18.14598 18.70505 0 18.28979 0 0 0 18.86081 0 0 19.92434 0 0 18.78527 0 0 19.58912 0 19.07687 18.98369 17.06309 19.06788 P0DJD1 RGPD2_HUMAN "RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2, RanBP2-like 2, RanBP2L2)" RGPD2 RANBP2L2 RGP2 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0050790 YLASVQGSAPSPGKK 13.93000031 1 1 6.99E-13 1488.746354 15.75937 16.6177 0 0 16.34013 0 0 14.57048 17.26053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.01397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.11291 0 0 0 0 0 0 0 P0DJI9 SAA2_HUMAN "Serum amyloid A-2 protein, SAA2 [Cleaved into: Amyloid A2 protein, AA2 ]" SAA2 Homo sapiens (Human) acute-phase response [GO:0006953] extracellular exosome [GO:0070062]; high-density lipoprotein particle [GO:0034364] extracellular exosome [GO:0070062]; high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953] GO:0006953; GO:0034364; GO:0070062 GAEDSLADQAANK 4.96999979 0.449551523 0.449551523 0.393784461 1290.754659 12.30267 15.55246 0 11.96686 14.30772 15.3018 8.546587 13.75929 14.90726 13.78848 0 0 0 15.00459 13.25564 0 0 0 16.04377 14.20615 0 15.83501 0 0 0 0 0 15.10311 0 0 0 0 0 0 0 0 15.95638 16.02792 0 0 0 0 16.81336 0 0 0 0 0 P0DKB6 MPC1L_HUMAN Mitochondrial pyruvate carrier 1-like protein MPC1L Homo sapiens (Human) mitochondrial pyruvate transmembrane transport [GO:0006850] integral component of mitochondrial inner membrane [GO:0031305] integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850] pyruvate transmembrane transporter activity [GO:0050833] GO:0006850; GO:0031305; GO:0050833 ASPEIISGRMTTALILYSAIFMR 4.460000038 1 1 0.271478455 2543.593934 13.81344 0 0 16.75297 18.0325 0 13.4044 0 0 15.43055 16.30692 0 15.61945 0 0 0 0 0 0 0 0 0 0 16.57696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.09015 0 0 0 0 0 P0DKV0 S31C1_HUMAN Putative spermatogenesis-associated protein 31C1 (Protein FAM75C1) SPATA31C1 FAM75C1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 VEVATLLGEPPMASLR 1.330000043 1 1 0.274556246 1697.831282 13.7702 0 0 0 14.01789 13.97302 0 10.05719 0 0 16.02737 0 0 15.63912 8.774094 0 12.76673 0 15.58955 15.30989 0 0 0 0 15.92492 16.30531 0 15.2185 0 0 0 0 14.05209 0 0 0 0 0 12.9706 0 14.50211 15.9594 0 0 0 15.72836 13.96136 0 P0DM35 M1BL1_HUMAN Metallothionein 1H-like protein 1 MT1HL1 Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] metal ion binding [GO:0046872] GO:0005634; GO:0005737; GO:0006882; GO:0010273; GO:0046872; GO:0071276; GO:0071280; GO:0071294 MDPNCSCAAGGSYACAGSCKCK 1.200000048 1 1 0.215517244 2426.80748 0 0 0 0 0 0 15.07719 0 0 0 11.06562 0 0 0 0 0 0 0 0 0 10.49235 0 0 0 0 0 0 0 0 0 15.12648 0 0 0 15.4752 0 17.62856 0 16.77958 0 0 0 0 0 0 0 0 0 P0DMN0 ST1A4_HUMAN "Sulfotransferase 1A4, ST1A4, EC 2.8.2.1 (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)" SULT1A4 Homo sapiens (Human) catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] GO:0004062; GO:0005737; GO:0005829; GO:0006584; GO:0008146; GO:0008202; GO:0051923 DTPPPRLIK 9.75 1 1 0.001548151 1034.606884 0 0 0 0 0 18.64858 0 18.54248 17.97042 16.30255 16.73255 17.61779 18.42985 17.1245 18.34531 17.01452 0 0 17.87994 0 0 0 17.75534 0 17.55147 16.70548 0 17.18611 0 17.18661 0 0 18.88863 0 0 19.05886 17.23946 18.38305 0 16.90367 0 18.72902 17.5039 18.94737 16.62933 0 15.21565 0 P0DMU8 CT455_HUMAN Cancer/testis antigen family 45 member A5 (Cancer/testis antigen 45-5) (Cancer/testis antigen 45A5) CT45A5 CT45-5 Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039] integrator complex [GO:0032039]; snRNA 3'-end processing [GO:0034472] GO:0032039; GO:0034472 IFEMLEGVQGPTAVRK 4.429999828 1 1 2.06E-12 1790.51964 0 0 0 0 14.10834 15.08877 15.37792 13.05053 14.09753 0 0 0 14.48819 14.25174 0 0 0 0 0 0 0 0 0 0 0 13.89904 0 0 0 0 0 14.13523 0 0 0 0 0 0 0 0 14.43455 0 12.15428 0 0 0 0 0 P0DMV9 HS71B_HUMAN "Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2, HSP70-2, HSP70.2)" HSPA1B HSP72 Homo sapiens (Human) ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; vesicle-mediated transport [GO:0016192] aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982] aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein disaggregase activity [GO:0140545]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]; ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein disaggregase activity [GO:0140545]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618] GO:0001618; GO:0001664; GO:0003723; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005925; GO:0006402; GO:0008285; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031396; GO:0031397; GO:0031625; GO:0031982; GO:0032436; GO:0032757; GO:0032991; GO:0034599; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0044183; GO:0045648; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051787; GO:0055131; GO:0060548; GO:0070062; GO:0070370; GO:0070434; GO:0071383; GO:0072562; GO:0090063; GO:0090084; GO:0140545; GO:1901673; GO:1903265; GO:1904813; GO:1990904; GO:2001240 HWPFQVINDGDKPK 3.00999999 1 1 6.86E-13 1680.673417 0 0 13.20975 12.64302 0 14.35554 12.5472 14.07049 13.61911 11.88844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53361 0 15.96821 0 0 0 0 0 0 0 0 0 0 0 0 0 14.11978 10.19223 13.27677 0 15.51552 0 0 0 P0DMW4 SIL2A_HUMAN Small integral membrane protein 10-like protein 2A SMIM10L2A LINC00086 NCRNA00086 Homo sapiens (Human) AASAALSAAAAAAALSGLAVRLSR 4.550000191 0.162845567 0.162845567 0.135138793 2140.832217 14.59248 12.99179 0 0 17.56767 14.94202 0 14.12224 14.88673 0 0 0 0 16.85174 0 0 0 0 14.95859 8.7791 14.6345 18.03049 0 16.32117 14.4886 11.1525 0 0 13.80196 0 14.67816 14.08231 12.5505 8.24349 0 15.05046 13.10007 16.65703 12.5237 16.68271 12.0757 0 13.1545 12.23622 13.95005 14.50244 15.91612 12.19668 P0DN81 O13C7_HUMAN Olfactory receptor 13C7 OR13C7 OR13C7P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 DPLGADK 3.269999981 1 1 0.165656773 715.996698 0 0 0 13.3063 0 15.30295 0 15.40762 0 0 0 14.19391 0 0 0 0 14.46381 0 16.21472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DN87 CGB7_HUMAN Choriogonadotropin subunit beta 7 CGB7 Homo sapiens (Human) apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] hormone activity [GO:0005179] GO:0005179; GO:0005615; GO:0005737; GO:0006915; GO:0007165; GO:0007186; GO:0007267; GO:0007292 FQASSSSK 13.88000011 1 1 0.385234881 841.9108789 16.90856 0 16.85785 16.63388 0 0 15.97416 0 0 15.8504 15.2601 0 0 0 0 13.96266 0 15.50801 15.68669 15.75831 0 0 17.47725 0 15.22764 16.37896 0 13.71318 0 16.4173 17.18489 13.5607 16.09953 15.0322 14.82786 14.9816 12.135 14.95942 14.98404 0 16.42831 15.44362 0 13.87997 15.20588 14.84518 0 12.39447 P0DOX7 IGK_HUMAN Immunoglobulin kappa light chain (Immunoglobulin kappa light chain EU) Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 MFGQGTK 3.410000086 1 1 0.173296932 785.7800179 0 13.18948 0 0 16.16109 0 0 0 0 0 0 0 15.172 0 0 13.04179 15.73637 15.51354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42832 14.29941 14.61118 0 0 0 0 16.16158 16.23869 0 12.67364 0 0 0 0 P0DP25 CALM3_HUMAN Calmodulin-3 CALM3 CALML2 CAM3 CAMC CAMIII Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762] calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762] adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800] GO:0000086; GO:0000922; GO:0001975; GO:0002027; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0005886; GO:0007186; GO:0007190; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019901; GO:0019904; GO:0021762; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0044325; GO:0048306; GO:0050848; GO:0050998; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:1905913; GO:2000300 EAFSLFDKDGDGTITTK 5.809999943 1 1 2.98E-12 1844.021229 15.26172 12.70381 14.02925 15.38403 0 12.28067 13.03384 14.44258 0 0 0 14.36351 13.78874 0 14.84069 14.7163 15.14158 14.13497 0 0 0 0 0 12.89548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DP73 D130B_HUMAN Beta-defensin 130B DEFB130B Homo sapiens (Human) cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742] extracellular space [GO:0005615] extracellular space [GO:0005615]; CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742] CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056] GO:0005615; GO:0031731; GO:0042056; GO:0042742; GO:0060326 LCSTLDDTIGICNEGK 8.270000458 0.926675737 0.926675737 0.566529154 1795.615719 0 19.10139 0 18.53881 0 0 0 0 17.04012 18.2212 19.59564 0 19.0924 18.01666 19.25077 18.84816 0 19.48734 18.36712 0 0 0 18.89954 0 0 0 0 0 0 17.8916 0 0 0 0 0 21.82573 18.7306 18.80972 0 0 19.09315 0 17.96866 0 19.41335 0 17.23538 0 P0DPA3 SNH28_HUMAN "Putative uncharacterized protein SNHG28 (Small nucleolar RNA host gene 2) (VSIG8 overlapping transcript protein, VSIG8-OT1)" SNHG28 C1orf204 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 ALPSPDCPGLRTTGEQMQK 5.579999924 0.923909247 0.923909247 1.38E-12 2102.22503 0 13.98836 0 0 0 0 0 0 0 0 0 13.3755 0 0 0 0 0 0 0 15.45814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.10624 0 0 0 0 0 0 0 14.95383 16.86839 0 0 0 P0DPB3 SCHI1_HUMAN "Schwannomin-interacting protein 1, SCHIP-1" SCHIP1 Homo sapiens (Human) positive regulation of hippo signaling [GO:0035332] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; positive regulation of hippo signaling [GO:0035332] identical protein binding [GO:0042802] GO:0005737; GO:0005886; GO:0030054; GO:0035332; GO:0042802 HMAEKMPAK 5.489999771 1 1 0.200667057 1057.609417 15.32109 0 14.74129 16.27336 0 0 0 16.81969 11.37834 0 0 17.32567 19.72366 0 0 0 15.11007 0 0 0 0 0 15.09744 13.27085 0 0 0 0 0 0 13.24032 15.71193 17.42463 16.7531 0 0 19.28724 0 16.81903 0 0 0 0 0 0 0 0 0 P0DPB5 RPC22_HUMAN "Protein POLR1D, isoform 2" POLR1D Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 GSASYSPPRK 4.21999979 1 1 0.01169742 1049.663896 0 14.72347 6.468819 0 0 16.26482 0 0 0 0 0 14.26921 15.03575 0 0 0 0 0 0 0 0 0 11.84095 14.70548 0 0 0 0 0 0 0 0 14.10971 0 14.38819 0 13.40956 16.12633 0 0 0 0 0 0 0 0 0 15.25804 P0DPD6 ECE2_HUMAN "Endothelin-converting enzyme 2, ECE-2, EC 3.4.24.71" ECE2 KIAA0604 UNQ403/PRO740 Homo sapiens (Human) cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485] cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168] GO:0000139; GO:0004222; GO:0005886; GO:0007186; GO:0007267; GO:0008168; GO:0016021; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872 MNVALQELGAGSNMVEYK 2.069999933 1 1 0.356082522 1985.858524 0 0 0 14.3694 16.26223 0 0 11.00286 0 0 16.82445 13.76501 13.46429 0 17.79497 12.57204 15.88766 0 15.72964 0 0 0 16.62136 0 0 0 0 0 0 15.6271 0 0 0 0 0 0 0 0 0 0 16.32912 17.97216 0 0 0 0 0 0 P0DPE3 TMDD1_HUMAN Transmembrane and death domain protein 1 TMDD1 C12orf81 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; signal transduction [GO:0007165] GO:0007165; GO:0016021 FLPRPGAAAR 4.369999886 0.322689325 0.322689325 0.129061127 1055.893109 0 0 0 0 0 15.30256 0 0 0 0 0 0 0 0 0 0 11.59114 0 9.250324 0 0 0 0 15.42326 0 0 0 0 14.08242 0 0 11.61483 13.45534 14.24656 0 12.74693 5.027496 15.07117 14.66552 0 0 0 12.39386 0 0 0 0 8.606213 P0DPF3 NBPF9_HUMAN Neuroblastoma breakpoint family member 9 NBPF9 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 SSAPREMQK 12.68999958 1 1 0.233267472 1032.879834 0 0 0 0 0 0 0 0 0 0 0 0 0 15.23701 0 0 15.54787 14.65973 0 16.83745 11.29825 0 15.74708 15.7253 15.70663 0 17.26308 0 0 0 16.13312 14.19642 0 0 0 0 15.55532 0 0 0 0 0 0 16.69278 0 0 0 0 P0DPQ3 PR20G_HUMAN Proline-rich protein 20G PRR20G Homo sapiens (Human) REPPAR 6.880000114 1 1 0.162812927 725.2559892 15.64949 0 13.75112 0 15.78115 15.22136 0 0 0 0 0 0 0 0 17.49568 16.18752 16.19193 0 18.28989 0 17.03731 17.2225 16.09268 0 15.97036 15.00042 0 13.92546 15.71882 0 16.91829 15.06011 0 0 15.74984 16.4297 0 0 17.04869 16.57046 14.98185 16.39451 15.96379 15.31203 16.95605 16.34366 16.78957 14.29527 P0DSN7 KVD37_HUMAN Probable non-functional immunoglobulinn kappa variable 1D-37 IGKV1D-37 Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 QKPGKVPK 3.75 1 1 0.164381923 881.232231 0 0 0 0 0 0 0 0 16.687 14.97608 0 0 0 0 0 0 0 0 0 0 0 0 18.00728 0 0 0 0 15.37356 0 0 0 0 0 0 0 15.9562 18.27211 15.41094 0 15.19586 0 0 0 0 0 0 0 0 P0DSO1 F246C_HUMAN Protein FAM246C FAM246C Homo sapiens (Human) GQLRAEAASR 6.659999847 0.499104589 0.499104589 0.248300915 1058.439607 15.55681 0 0 14.59793 0 13.71478 0 12.32264 14.48703 15.30716 11.80334 14.94984 0 12.78508 0 14.18088 15.43939 0 12.10209 14.0394 14.24356 0 0 0 0 15.5556 0 0 0 0 0 0 0 0 14.38628 16.04419 0 0 16.70204 0 15.4332 0 0 0 0 0 0 14.41658 P0DTE5 UD2A2_HUMAN "UDP-glucuronosyltransferase 2A2, UDPGT 2A2, EC 2.4.1.17" UGT2A2 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695] glucuronosyltransferase activity [GO:0015020] GO:0005789; GO:0008206; GO:0015020; GO:0016021; GO:0052695 FSPASTVER 1.870000005 1 1 0.107372646 990.4151096 15.33216 0 14.60231 12.56605 0 0 11.29432 0 14.28954 16.60367 0 13.9688 0 0 15.51135 14.06189 15.02758 14.4002 0 0 0 0 0 0 16.14558 0 16.41849 0 15.88399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DTE7 AMY1B_HUMAN "Alpha-amylase 1B, EC 3.2.1.1" AMY1B AMY1 Homo sapiens (Human) oligosaccharide metabolic process [GO:0009311] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; oligosaccharide metabolic process [GO:0009311] alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404] GO:0004556; GO:0005509; GO:0005615; GO:0009311; GO:0031404; GO:0070062 NWGEGWGFMPSDR 7.71999979 1 1 0.355635107 1538.041061 0 0 15.54281 0 0 0 14.3957 0 0 15.66404 14.8937 14.53563 14.25941 0 0 14.08304 0 0 0 0 0 0 0 15.92169 0 0 17.16858 0 0 0 0 0 0 0 18.18133 0 0 0 0 0 0 0 0 16.01749 0 0 17.98441 0 P0DUQ1 PRA15_HUMAN PRAME family member 15 PRAMEF15 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0008284; GO:0043066; GO:0045596; GO:0045892 KPVQDCPRMR 6.940000057 0.418085814 0.418085814 0.074209017 1286.664355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.35344 0 0 0 0 0 0 0 0 0 0 14.64726 0 0 0 0 0 0 0 14.64358 0 0 0 0 P10070 GLI2_HUMAN Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein) GLI2 THP Homo sapiens (Human) "axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]" ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000978; GO:0000981; GO:0001501; GO:0001649; GO:0001822; GO:0002076; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006357; GO:0007224; GO:0007389; GO:0007411; GO:0007418; GO:0007442; GO:0007507; GO:0008270; GO:0009913; GO:0009954; GO:0021508; GO:0021513; GO:0021517; GO:0021696; GO:0021775; GO:0021965; GO:0021983; GO:0030324; GO:0030879; GO:0030902; GO:0031069; GO:0033089; GO:0035295; GO:0042475; GO:0043565; GO:0045740; GO:0045893; GO:0045944; GO:0048566; GO:0048589; GO:0048666; GO:0048754; GO:0097542; GO:0097546; GO:0098586; GO:1990837; GO:1990841 LALLDAPER 10.56999969 0.75683713 0.75683713 0.258052125 998.1219187 15.33214 12.61762 0 14.62178 15.6243 0 15.61109 0 0 13.4858 0 13.65572 15.38554 15.83828 14.2228 0 0 11.20903 14.30168 14.46087 16.23199 16.79696 14.07248 16.91779 0 16.21651 0 0 0 15.22734 15.55312 0 15.60871 0 0 14.91889 0 0 16.61166 0 0 0 0 0 15.60252 0 0 0 P10071 GLI3_HUMAN "Transcriptional activator GLI3 (GLI3 form of 190 kDa, GLI3-190) (GLI3 full-length protein, GLI3FL) [Cleaved into: Transcriptional repressor GLI3R (GLI3 C-terminally truncated form) (GLI3 form of 83 kDa, GLI3-83) ]" GLI3 Homo sapiens (Human) "anterior semicircular canal development [GO:0060873]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; axon guidance [GO:0007411]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye morphogenesis [GO:0048593]; cell differentiation involved in kidney development [GO:0061005]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain radial glial cell differentiation [GO:0021861]; frontal suture morphogenesis [GO:0060364]; heart development [GO:0007507]; hindgut morphogenesis [GO:0007442]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; lambdoid suture morphogenesis [GO:0060366]; larynx morphogenesis [GO:0120223]; lateral ganglionic eminence cell proliferation [GO:0022018]; lateral semicircular canal development [GO:0060875]; layer formation in cerebral cortex [GO:0021819]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; lung development [GO:0030324]; mammary gland specification [GO:0060594]; melanocyte differentiation [GO:0030318]; metanephros development [GO:0001656]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative thymic T cell selection [GO:0045060]; nose morphogenesis [GO:0043585]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; optic nerve morphogenesis [GO:0021631]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein processing [GO:0016485]; proximal/distal pattern formation [GO:0009954]; regulation of bone development [GO:1903010]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; sagittal suture morphogenesis [GO:0060367]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; T cell differentiation in thymus [GO:0033077]; thymocyte apoptotic process [GO:0070242]; tongue development [GO:0043586]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]" axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior semicircular canal development [GO:0060873]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; axon guidance [GO:0007411]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye morphogenesis [GO:0048593]; cell differentiation involved in kidney development [GO:0061005]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain radial glial cell differentiation [GO:0021861]; frontal suture morphogenesis [GO:0060364]; heart development [GO:0007507]; hindgut morphogenesis [GO:0007442]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; lambdoid suture morphogenesis [GO:0060366]; larynx morphogenesis [GO:0120223]; lateral ganglionic eminence cell proliferation [GO:0022018]; lateral semicircular canal development [GO:0060875]; layer formation in cerebral cortex [GO:0021819]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; lung development [GO:0030324]; mammary gland specification [GO:0060594]; melanocyte differentiation [GO:0030318]; metanephros development [GO:0001656]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative thymic T cell selection [GO:0045060]; nose morphogenesis [GO:0043585]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; optic nerve morphogenesis [GO:0021631]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein processing [GO:0016485]; proximal/distal pattern formation [GO:0009954]; regulation of bone development [GO:1903010]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; sagittal suture morphogenesis [GO:0060367]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; T cell differentiation in thymus [GO:0033077]; thymocyte apoptotic process [GO:0070242]; tongue development [GO:0043586]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]" "beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001656; GO:0001658; GO:0001701; GO:0002052; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005929; GO:0005930; GO:0006357; GO:0007224; GO:0007411; GO:0007442; GO:0007507; GO:0008013; GO:0008285; GO:0009952; GO:0009954; GO:0016485; GO:0016607; GO:0017053; GO:0021631; GO:0021766; GO:0021775; GO:0021776; GO:0021798; GO:0021819; GO:0021861; GO:0022018; GO:0030318; GO:0030324; GO:0030850; GO:0032332; GO:0033077; GO:0035035; GO:0035108; GO:0036033; GO:0042060; GO:0042307; GO:0042475; GO:0042733; GO:0042826; GO:0043066; GO:0043231; GO:0043585; GO:0043586; GO:0043627; GO:0045060; GO:0045665; GO:0045669; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046638; GO:0046639; GO:0046872; GO:0048557; GO:0048566; GO:0048589; GO:0048593; GO:0048702; GO:0048709; GO:0060021; GO:0060364; GO:0060366; GO:0060367; GO:0060594; GO:0060831; GO:0060840; GO:0060873; GO:0060875; GO:0061005; GO:0070242; GO:0071625; GO:0090090; GO:0097421; GO:0097542; GO:0097546; GO:0120223; GO:1901620; GO:1903010; GO:1990787; GO:1990788; GO:1990837 GQQEQPEGTTLVK 1.909999967 1 1 2.06E-12 1414.109635 0 0 10.36153 0 0 10.08491 0 0 16.55214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.33946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10072 ZN875_HUMAN Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1) ZNF875 HKR1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 EDNTVVDIGSSPERR 7.050000191 1 1 0.470660131 1672.619769 0 0 13.2587 0 0 0 0 15.17804 0 0 0 0 0 15.47653 0 0 0 0 0 17.82851 0 15.35566 0 0 0 15.61033 0 0 15.83591 15.87619 0 0 0 0 16.23621 0 0 16.99944 0 0 15.53609 0 0 0 0 0 0 15.49683 P10073 ZSC22_HUMAN Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50) ZSCAN22 HKR2 ZNF50 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KMFQSASALEAHQK 3.160000086 0.640619338 0.640619338 0.241632 1575.779598 14.72362 12.7207 0 15.34684 0 0 0 0 13.80054 0 12.08903 15.79119 0 7.55398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76074 0 0 0 0 14.82014 0 0 14.18215 0 0 0 P10109 ADX_HUMAN "Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)" FDX1 ADX Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; electron transport chain [GO:0022900]; hormone biosynthetic process [GO:0042446]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; electron transport chain [GO:0022900]; hormone biosynthetic process [GO:0042446]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694]" "2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]" GO:0005506; GO:0005739; GO:0005759; GO:0006694; GO:0008203; GO:0009055; GO:0022900; GO:0042446; GO:0051353; GO:0051537; GO:0071320; GO:0140647; GO:1904322 AGSSGLLRNR 5.360000134 0.164695665 0.164695665 0.2298726 1029.056589 0 16.91575 10.93077 0 0 15.55365 13.98101 12.87724 0 14.76297 0 0 0 0 0 0 15.68779 0 0 0 0 0 0 0 0 18.51207 19.15108 14.33544 16.56397 0 16.332 0 0 0 0 0 0 0 0 0 0 0 0 0 13.85084 0 0 0 P10144 GRAB_HUMAN "Granzyme B, EC 3.4.21.79 (C11) (CTLA-1) (Cathepsin G-like 1, CTSGL1) (Cytotoxic T-lymphocyte proteinase 2, Lymphocyte protease) (Fragmentin-2) (Granzyme-2) (Human lymphocyte protein, HLP) (SECT) (T-cell serine protease 1-3E)" GZMB CGL1 CSPB CTLA1 GRB Homo sapiens (Human) apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008236; GO:0016020; GO:0017148; GO:0019835; GO:0042267; GO:0043231; GO:0044194; GO:0051603; GO:0070269; GO:0140507; GO:1900740 ADAGEIIGGHEAKPHSRPYMAYLMIWDQK 8.050000191 0.517922878 0.517922878 4.57E-12 3300.633545 0 13.22796 14.8379 0 0 0 0 13.94656 13.60583 0 0 14.00149 0 14.64634 13.38384 11.65858 0 0 0 12.90576 0 0 16.07871 13.82033 12.32651 8.410801 0 0 0 12.70456 0 14.65195 12.30546 0 12.48487 13.43242 13.2115 0 0 12.52492 13.6485 0 0 10.69638 0 0 0 12.17492 P10153 RNAS2_HUMAN "Non-secretory ribonuclease, EC 4.6.1.18 (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2, RNase 2) (Ribonuclease US)" RNASE2 EDN RNS2 Homo sapiens (Human) chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]; chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501] lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540] GO:0002227; GO:0003676; GO:0004522; GO:0004540; GO:0005576; GO:0005615; GO:0006401; GO:0006935; GO:0016829; GO:0035578; GO:0051607; GO:0070062; GO:0090501 YAQTPANMFYIVACDNR 3.880000114 1 1 0.234605825 2049.288164 8.363194 13.86252 0 0 0 14.33193 0 0 0 0 15.94946 14.67395 13.52845 0 0 0 11.39134 0 8.254732 8.483124 12.59438 15.82075 0 0 0 0 13.70902 0 0 0 0 14.49093 0 14.64044 0 0 0 14.71889 0 0 0 0 15.41718 0 0 0 0 0 P10242 MYB_HUMAN Transcriptional activator Myb (Proto-oncogene c-Myb) MYB Homo sapiens (Human) "chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; myeloid cell development [GO:0061515]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; myeloid cell development [GO:0061515]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006355; GO:0016363; GO:0045624; GO:0045892; GO:0045893; GO:0045944; GO:0051571; GO:0051574; GO:0061515; GO:0090575; GO:1901533 TPTPFK 14.64999962 1 1 0.273683457 690.5549462 18.03048 0 17.46815 0 18.49309 0 17.37327 0 0 0 0 18.38286 17.80281 0 0 0 18.36928 0 0 0 0 0 0 0 18.20572 18.26897 18.53029 17.00326 0 0 18.99545 0 0 0 0 17.70491 0 18.61192 18.06584 0 17.92964 0 18.49882 15.96307 18.16666 0 0 0 P10243 MYBA_HUMAN "Myb-related protein A, A-Myb (Myb-like protein 1)" MYBL1 AMYB Homo sapiens (Human) "cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006355; GO:0007141; GO:0007283; GO:0010529; GO:0030154; GO:0045893; GO:0045944; GO:1990511 QENTASGK 15.92000008 1 1 0.081137446 835.2165395 15.97751 0 0 0 16.25133 0 14.42563 0 0 15.40606 13.63755 0 0 0 0 16.63073 15.64165 16.30318 0 0 0 0 0 0 0 0 15.5488 0 0 0 12.16442 15.29943 0 14.25451 15.79997 15.8215 0 17.20592 0 0 0 0 0 0 15.1924 16.22314 0 0 P10253 LYAG_HUMAN "Lysosomal alpha-glucosidase, EC 3.2.1.20 (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase ]" GAA Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] "azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]" "alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]" GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004553; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043231; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0070062; GO:0070821; GO:0090599; GO:0101003 QQPMALAVALTK 11.75 1 1 0.200092741 1264.267715 15.14737 0 14.70542 0 0 0 0 15.46019 0 0 0 0 0 0 0 0 0 0 0 0 0 15.65068 0 16.28288 15.73481 0 0 0 13.85904 14.28158 0 15.10553 0 15.63948 0 0 0 15.45325 0 0 0 0 0 0 0 16.59155 15.37377 0 P10321 HLAC_HUMAN "HLA class I histocompatibility antigen, C alpha chain, HLA-C (HLA-Cw) (Human leukocyte antigen C)" HLA-C HLAC Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; immune response [GO:0006955]; innate immune response [GO:0045087]" cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667] "cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; peptide antigen binding [GO:0042605]; TAP binding [GO:0046977]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; immune response [GO:0006955]; innate immune response [GO:0045087]" peptide antigen binding [GO:0042605]; TAP binding [GO:0046977] GO:0000139; GO:0002250; GO:0002486; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006955; GO:0009986; GO:0012507; GO:0016020; GO:0030667; GO:0030670; GO:0031901; GO:0042605; GO:0042612; GO:0045087; GO:0046977; GO:0055038; GO:0070062; GO:0071556 MRVMAPR 3.160000086 1 1 0.082344679 875.6111205 0 0 14.62788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.33767 0 15.50145 0 0 0 0 0 0 0 14.21523 0 0 0 0 0 0 12.63486 14.92926 0 0 0 13.45237 15.40314 15.93518 0 0 0 17.03228 0 0 P10412 H14_HUMAN Histone H1.4 (Histone H1b) (Histone H1s-4) H1-4 H1F4 HIST1H1E Homo sapiens (Human) chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584] heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634] heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584] chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723] GO:0000122; GO:0000786; GO:0000792; GO:0003690; GO:0003723; GO:0005634; GO:0006334; GO:0016584; GO:0030261; GO:0031490; GO:0031492; GO:0045910; GO:0080182; GO:0098532 KSAGAAK 4.840000153 1 1 0.220315412 633.3263469 15.24625 16.54756 16.69556 15.79005 0 16.02705 0 0 16.38176 0 16.87251 16.74268 14.85834 16.12409 15.58115 16.94337 15.47821 17.22149 18.09488 16.0479 16.90795 16.7135 0 17.09542 0 0 0 15.9386 0 15.99744 0 0 0 17.3011 0 17.72389 0 0 0 0 17.48432 0 17.45057 17.9372 0 0 0 0 P10415 BCL2_HUMAN Apoptosis regulator Bcl-2 BCL2 Homo sapiens (Human) "actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; B cell homeostasis [GO:0001782]; B cell lineage commitment [GO:0002326]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; behavioral fear response [GO:0001662]; branching involved in ureteric bud morphogenesis [GO:0001658]; CD8-positive, alpha-beta T cell lineage commitment [GO:0043375]; cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to organic substance [GO:0071310]; cochlear nucleus development [GO:0021747]; defense response to virus [GO:0051607]; digestive tract morphogenesis [GO:0048546]; ear development [GO:0043583]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; gland morphogenesis [GO:0022612]; glomerulus development [GO:0032835]; hair follicle morphogenesis [GO:0031069]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; mesenchymal cell development [GO:0014031]; metanephros development [GO:0001656]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular pH reduction [GO:0032848]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of retinal cell programmed cell death [GO:0046671]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; organ growth [GO:0035265]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pigment granule organization [GO:0048753]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron maturation [GO:0014042]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of smooth muscle cell migration [GO:0014911]; post-embryonic development [GO:0009791]; protein dephosphorylation [GO:0006470]; protein polyubiquitination [GO:0000209]; reactive oxygen species metabolic process [GO:0072593]; regulation of calcium ion transport [GO:0051924]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; regulation of transmembrane transporter activity [GO:0022898]; regulation of viral genome replication [GO:0045069]; release of cytochrome c from mitochondria [GO:0001836]; renal system process [GO:0003014]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; response to ischemia [GO:0002931]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pore complex [GO:0046930]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pore complex [GO:0046930]; protein-containing complex [GO:0032991]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; channel inhibitor activity [GO:0016248]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; B cell homeostasis [GO:0001782]; B cell lineage commitment [GO:0002326]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; behavioral fear response [GO:0001662]; branching involved in ureteric bud morphogenesis [GO:0001658]; CD8-positive, alpha-beta T cell lineage commitment [GO:0043375]; cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to organic substance [GO:0071310]; cochlear nucleus development [GO:0021747]; defense response to virus [GO:0051607]; digestive tract morphogenesis [GO:0048546]; ear development [GO:0043583]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; gland morphogenesis [GO:0022612]; glomerulus development [GO:0032835]; hair follicle morphogenesis [GO:0031069]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; mesenchymal cell development [GO:0014031]; metanephros development [GO:0001656]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular pH reduction [GO:0032848]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of retinal cell programmed cell death [GO:0046671]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; organ growth [GO:0035265]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pigment granule organization [GO:0048753]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron maturation [GO:0014042]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of smooth muscle cell migration [GO:0014911]; post-embryonic development [GO:0009791]; protein dephosphorylation [GO:0006470]; protein polyubiquitination [GO:0000209]; reactive oxygen species metabolic process [GO:0072593]; regulation of calcium ion transport [GO:0051924]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; regulation of transmembrane transporter activity [GO:0022898]; regulation of viral genome replication [GO:0045069]; release of cytochrome c from mitochondria [GO:0001836]; renal system process [GO:0003014]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; response to ischemia [GO:0002931]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]" BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; channel inhibitor activity [GO:0016248]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625] GO:0000209; GO:0001503; GO:0001541; GO:0001656; GO:0001658; GO:0001662; GO:0001782; GO:0001836; GO:0001952; GO:0002020; GO:0002320; GO:0002326; GO:0002931; GO:0003014; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0006470; GO:0006582; GO:0006808; GO:0006915; GO:0006959; GO:0006974; GO:0007015; GO:0007409; GO:0007565; GO:0007569; GO:0008284; GO:0008584; GO:0008625; GO:0008630; GO:0008631; GO:0009314; GO:0009410; GO:0009636; GO:0009791; GO:0010039; GO:0010224; GO:0010332; GO:0010468; GO:0010507; GO:0010523; GO:0010559; GO:0014031; GO:0014042; GO:0014911; GO:0015267; GO:0016020; GO:0016248; GO:0018105; GO:0018107; GO:0021747; GO:0022612; GO:0022898; GO:0030279; GO:0030307; GO:0030308; GO:0030318; GO:0030336; GO:0030890; GO:0031069; GO:0031103; GO:0031625; GO:0031647; GO:0031965; GO:0032469; GO:0032835; GO:0032848; GO:0032880; GO:0032991; GO:0033033; GO:0033077; GO:0033138; GO:0033689; GO:0034097; GO:0035094; GO:0035265; GO:0040018; GO:0042100; GO:0042149; GO:0042542; GO:0042802; GO:0042803; GO:0043029; GO:0043066; GO:0043085; GO:0043209; GO:0043375; GO:0043524; GO:0043565; GO:0043583; GO:0045069; GO:0045636; GO:0046671; GO:0046902; GO:0046930; GO:0046982; GO:0048041; GO:0048536; GO:0048538; GO:0048546; GO:0048599; GO:0048743; GO:0048753; GO:0048873; GO:0050853; GO:0051384; GO:0051402; GO:0051434; GO:0051607; GO:0051721; GO:0051881; GO:0051902; GO:0051924; GO:0070059; GO:0071310; GO:0071456; GO:0072593; GO:0097192; GO:0098609; GO:0140297; GO:1902166; GO:2000134; GO:2000378; GO:2000811; GO:2001234; GO:2001240; GO:2001243 RDFAEMSSQLHLTPFTAR 5.869999886 1 1 0.229721573 2123.718471 17.89525 0 18.33822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.56617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10523 ARRS_HUMAN "S-arrestin (48 kDa protein) (Retinal S-antigen, S-AG) (Rod photoreceptor arrestin)" SAG Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor internalization [GO:0002031]; rhodopsin mediated signaling pathway [GO:0016056] cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor internalization [GO:0002031]; rhodopsin mediated signaling pathway [GO:0016056] G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864] GO:0001664; GO:0001750; GO:0001917; GO:0002031; GO:0002046; GO:0004864; GO:0005829; GO:0007166; GO:0016020; GO:0016056; GO:0051219 KVQHAPLEMGPQPR 10.72000027 1 1 0.196844335 1588.813662 10.56273 16.18105 13.67753 14.86196 15.88075 14.24656 14.68322 15.12994 16.30014 14.79304 13.66053 13.86794 0 0 0 15.98649 0 0 0 0 0 0 15.94539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10586 PTPRF_HUMAN "Receptor-type tyrosine-protein phosphatase F, EC 3.1.3.48 (Leukocyte common antigen related, LAR)" PTPRF LAR Homo sapiens (Human) cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121 SAVPFK 6.599999905 1 1 0.036697628 647.5738577 16.24107 13.86199 14.80957 0 0 0 0 0 0 0 0 0 16.55239 0 0 15.04779 0 0 17.32211 18.11 17.98354 15.9275 17.61903 15.87099 16.27713 0 0 0 0 16.12671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10588 NR2F6_HUMAN "Nuclear receptor subfamily 2 group F member 6 (V-erbA-related protein 2, EAR-2)" NR2F6 EAR2 ERBAL2 Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0030154; GO:0043153; GO:0043565; GO:0048666; GO:0048856; GO:0050965; GO:1990837 AGGYPR 8.020000458 1 1 0.102043651 620.9830388 0 0 0 0 0 0 12.00258 0 13.74033 0 14.88325 0 0 0 0 0 0 0 0 0 0 0 13.91802 0 0 14.41531 0 0 0 0 0 14.87461 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88429 16.25425 0 P10636 TAU_HUMAN "Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau, PHF-tau)" MAPT MAPTL MTBT1 TAU Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axon development [GO:0061564]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298] axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298]; actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axon development [GO:0061564]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697] GO:0000226; GO:0001774; GO:0003677; GO:0003680; GO:0003690; GO:0003697; GO:0003723; GO:0003779; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0005886; GO:0006475; GO:0006919; GO:0007267; GO:0007416; GO:0007611; GO:0007613; GO:0008017; GO:0010288; GO:0010506; GO:0010629; GO:0010917; GO:0015630; GO:0016072; GO:0016607; GO:0017124; GO:0019896; GO:0019899; GO:0019901; GO:0021954; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030674; GO:0031110; GO:0031113; GO:0031116; GO:0031122; GO:0031175; GO:0032930; GO:0033044; GO:0033673; GO:0034063; GO:0034185; GO:0034399; GO:0034452; GO:0034605; GO:0034614; GO:0035091; GO:0036464; GO:0036477; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043565; GO:0044297; GO:0044304; GO:0045121; GO:0045298; GO:0045773; GO:0046785; GO:0048143; GO:0048167; GO:0048312; GO:0048699; GO:0050808; GO:0050848; GO:0051087; GO:0051258; GO:0051260; GO:0051721; GO:0051879; GO:0061564; GO:0070507; GO:0071813; GO:0072386; GO:0090140; GO:0090258; GO:0097386; GO:0097418; GO:0097435; GO:0098930; GO:0099077; GO:0099609; GO:1900034; GO:1900452; GO:1901216; GO:1902474; GO:1902936; GO:1902988; GO:1903748; GO:1903829; GO:1904115; GO:1904428; GO:1905689; GO:1990000; GO:1990090; GO:1990416; GO:2001020 TGSSGAKEMK 6.880000114 0.443687707 0.443687707 0.237891639 1011.389786 14.69238 0 11.92965 14.83661 17.15506 11.95106 0 15.03528 15.12036 15.69489 16.8289 0 0 15.25263 15.58892 12.87375 15.04848 0 15.16959 17.12617 11.59855 13.53689 14.93554 15.2776 14.34963 14.83583 16.7895 15.281 14.91703 15.40587 0 0 0 14.91766 15.70875 15.24297 0 15.49766 0 0 0 0 15.55617 15.26922 15.36733 0 0 0 P10645 CMGA_HUMAN "Chromogranin-A, CgA (Pituitary secretory protein I, SP-I) [Cleaved into: Vasostatin-1 (Vasostatin I); Vasostatin-2 (Vasostatin II); EA-92; ES-43; Pancreastatin; SS-18; WA-8; WE-14; LF-19; Catestatin (SL21); AL-11; GV-19; GR-44; ER-37; GE-25; Serpinin-RRG; Serpinin; p-Glu serpinin precursor ]" CHGA Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; protein localization to secretory granule [GO:0033366]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026] chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; protein localization to secretory granule [GO:0033366]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026] GO:0002026; GO:0002551; GO:0005576; GO:0005615; GO:0006996; GO:0008217; GO:0030133; GO:0030141; GO:0031640; GO:0033366; GO:0033604; GO:0042583; GO:0042742; GO:0043303; GO:0045087; GO:0045576; GO:0046676; GO:0048471; GO:0050829; GO:0050830; GO:0050832; GO:0060452; GO:0086030; GO:0098992; GO:1900738; GO:1901215; GO:1901899; GO:2000707 EDSLEAGLPLQVR 8.949999809 1 1 0.174482153 1425.786883 0 13.50196 0 0 0 13.59552 14.02569 14.55906 0 0 0 12.99809 0 0 15.42872 0 0 0 0 0 0 0 0 0 0 0 0 15.59832 0 15.37384 0 15.1531 14.9426 0 0 16.59131 0 0 0 15.37185 0 0 15.2476 14.17586 0 0 0 0 P10721 KIT_HUMAN "Mast/stem cell growth factor receptor Kit, SCFR, EC 2.7.10.1 (Piebald trait protein, PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)" KIT SCFR Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of programmed cell death [GO:0043069]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542] acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of programmed cell death [GO:0043069]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542] ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001541; GO:0001650; GO:0001669; GO:0002020; GO:0002244; GO:0002318; GO:0002320; GO:0002327; GO:0002551; GO:0002732; GO:0004712; GO:0004713; GO:0004714; GO:0005020; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0006687; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007286; GO:0008284; GO:0008354; GO:0008360; GO:0008542; GO:0008584; GO:0009897; GO:0009898; GO:0010863; GO:0014068; GO:0019221; GO:0019827; GO:0019955; GO:0030032; GO:0030097; GO:0030183; GO:0030217; GO:0030218; GO:0030318; GO:0030335; GO:0031274; GO:0031532; GO:0032765; GO:0033674; GO:0035019; GO:0035162; GO:0035234; GO:0035556; GO:0035701; GO:0035855; GO:0038093; GO:0038109; GO:0038162; GO:0042127; GO:0042169; GO:0042531; GO:0042803; GO:0043069; GO:0043235; GO:0043303; GO:0043406; GO:0043410; GO:0043473; GO:0043552; GO:0043586; GO:0045747; GO:0046427; GO:0046686; GO:0046777; GO:0046872; GO:0048103; GO:0048170; GO:0048565; GO:0048863; GO:0050673; GO:0050910; GO:0051091; GO:0060326; GO:0060374; GO:0070662; GO:0097067; GO:0097324; GO:0097326; GO:0120072; GO:1904251; GO:1904343; GO:1904349; GO:1905065 SDAAMTVAVKMLKPSAHLTER 3.079999924 1 1 0.036374977 2272.20054 0 0 0 0 0 0 13.9047 10.68024 14.28503 0 0 0 0 0 14.16193 0 0 10.45831 0 13.50625 0 13.76937 0 0 0 0 0 0 0 0 0 0 0 14.08573 0 13.94875 14.67274 0 0 15.29637 0 0 0 0 0 0 0 0 P10745 RET3_HUMAN "Retinol-binding protein 3 (Interphotoreceptor retinoid-binding protein, IRBP) (Interstitial retinol-binding protein)" RBP3 Homo sapiens (Human) lipid metabolic process [GO:0006629]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601] cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236]; lipid metabolic process [GO:0006629]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601] retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236] GO:0001523; GO:0005501; GO:0005576; GO:0005615; GO:0006629; GO:0007601; GO:0008236; GO:0016918; GO:0019841; GO:0090658; GO:1903561 KIMHTDAMIIDMR 14.39999962 0.686471403 0.686471403 0.150600535 1590.82805 0 0 0 14.17484 0 14.33222 20.20503 0 14.19518 15.93587 0 15.70272 0 16.49006 13.38234 13.88956 14.40809 12.18203 12.96844 0 10.01305 15.99969 0 17.74608 0 18.06303 16.00557 11.50923 12.73655 0 14.51366 0 17.50455 0 0 15.05573 17.89666 0 17.08878 11.7828 15.2601 0 12.85929 0 0 18.20284 0 13.38031 P10809 CH60_HUMAN "60 kDa heat shock protein, mitochondrial, EC 5.6.1.7 (60 kDa chaperonin) (Chaperonin 60, CPN60) (Heat shock protein 60, HSP-60, Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)" HSPD1 HSP60 Homo sapiens (Human) 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110] apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] GO:0001530; GO:0002039; GO:0002755; GO:0002842; GO:0003688; GO:0003697; GO:0003723; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006458; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016020; GO:0016853; GO:0016887; GO:0019899; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0034185; GO:0034186; GO:0034514; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0043032; GO:0043065; GO:0043066; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051082; GO:0051087; GO:0051131; GO:0051604; GO:0051702; GO:0070062; GO:0097225 DDAMLLKGK 6.090000153 0.009834972 0.009834972 0.341629543 1005.013348 0 0 0 0 0 0 0 17.35705 0 0 0 0 0 0 0 0 0 0 17.3134 0 0 0 0 0 0 17.67666 18.2158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10826 RARB_HUMAN "Retinoic acid receptor beta, RAR-beta (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon)" RARB HAP NR1B2 Homo sapiens (Human) cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001657; GO:0002068; GO:0003417; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008270; GO:0008285; GO:0009755; GO:0021756; GO:0022008; GO:0030154; GO:0032331; GO:0035116; GO:0035264; GO:0043065; GO:0045944; GO:0048048; GO:0048384; GO:0048566; GO:0055012; GO:1990837 VRLDLGLWDK 3.170000076 0.627107143 0.627107143 0.182373517 1213.840421 15.27202 0 0 16.07287 0 16.22838 12.65822 10.60441 14.35428 12.5181 11.5861 0 0 0 0 15.78181 0 0 0 0 0 0 0 0 0 0 0 14.41659 0 0 14.84967 0 14.99545 14.04744 0 0 0 15.17018 0 0 0 0 0 0 0 0 14.76947 0 P10827 THA_HUMAN "Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7, EAR-7) (c-erbA-1) (c-erbA-alpha)" THRA EAR7 ERBA1 NR1A1 THRA1 THRA2 Homo sapiens (Human) "cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]" "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001502; GO:0001503; GO:0002154; GO:0002155; GO:0002157; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007611; GO:0008016; GO:0008050; GO:0008270; GO:0009409; GO:0009755; GO:0017025; GO:0017055; GO:0019904; GO:0030154; GO:0030218; GO:0030878; GO:0031490; GO:0033032; GO:0042789; GO:0044877; GO:0045892; GO:0045925; GO:0045944; GO:0050994; GO:0060509; GO:0070324; GO:0090575; GO:0120162; GO:0140296; GO:2000143 NQCQLCR 12.56999969 0.711189926 0.711189926 0.214891363 977.3954822 17.07461 14.44471 0 0 16.40424 0 10.1133 0 15.64041 15.21933 0 15.51546 16.54435 14.31306 15.76258 0 16.26482 0 15.91899 0 0 16.42828 0 0 15.45592 17.67863 0 0 0 0 16.59686 19.89549 16.22246 17.00443 0 18.41832 0 18.48617 0 0 16.19064 16.43872 12.85008 0 0 14.40895 10.42019 17.00657 P10828 THB_HUMAN Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) THRB ERBA2 NR1A2 THR1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to thyroid hormone stimulus [GO:0097067]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of female receptivity [GO:0007621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; sensory perception of sound [GO:0007605]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription, DNA-templated [GO:0006351]; type I pneumocyte differentiation [GO:0060509]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid hormone binding [GO:0070324]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to thyroid hormone stimulus [GO:0097067]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of female receptivity [GO:0007621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; sensory perception of sound [GO:0007605]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription, DNA-templated [GO:0006351]; type I pneumocyte differentiation [GO:0060509]" "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid hormone binding [GO:0070324]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0002154; GO:0002157; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006351; GO:0007605; GO:0007621; GO:0008016; GO:0008050; GO:0008270; GO:0009755; GO:0016604; GO:0019899; GO:0030154; GO:0031490; GO:0042789; GO:0045944; GO:0046549; GO:0060509; GO:0070324; GO:0090575; GO:0097067; GO:0097474; GO:1990837 LLMKVTDLR 15.77000046 0.449489832 0.449489832 0.280770877 1103.848004 0 0 0 17.16027 0 16.9251 18.36456 17.23164 17.2055 0 19.13664 0 0 0 19.49002 0 0 0 0 0 0 0 21.0932 0 0 0 0 18.08519 0 19.97537 0 0 0 0 0 0 0 0 0 0 16.24501 16.7237 0 0 0 0 0 17.59137 P10911 MCF2_HUMAN Proto-oncogene DBL (Proto-oncogene MCF-2) [Cleaved into: MCF2-transforming protein; DBL-transforming protein ] MCF2 DBL Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737; GO:0005829; GO:0005856; GO:0016020; GO:0016358; GO:0035556; GO:0050771; GO:0051056; GO:1990830 NDITAVTK 3.220000029 1 1 4.60E-13 858.8280096 0 13.07404 13.86194 14.62167 16.07124 0 0 0 0 0 0 0 18.26058 0 0 0 16.12852 0 0 0 0 0 0 0 0 0 0 0 13.64458 0 0 0 0 0 0 0 0 0 14.54294 0 0 0 0 0 0 15.52781 14.91012 0 P10915 HPLN1_HUMAN "Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1, Cartilage-link protein) (Proteoglycan link protein)" HAPLN1 CRTL1 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] hyaluronic acid binding [GO:0005540] GO:0001501; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0031012; GO:0045202; GO:0062023 YPISRPRR 9.93999958 1 1 0.304791505 1044.937242 18.64334 0 16.63697 16.45243 0 0 0 0 0 0 18.31953 0 0 16.42987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.21293 0 0 0 P11021 BIP_HUMAN "Endoplasmic reticulum chaperone BiP, EC 3.6.4.10 (78 kDa glucose-regulated protein, GRP-78) (Binding-immunoglobulin protein, BiP) (Heat shock protein 70 family protein 5, HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)" HSPA5 GRP78 Homo sapiens (Human) "cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] GO:0001554; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0005925; GO:0006983; GO:0009986; GO:0010976; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0021589; GO:0021680; GO:0021762; GO:0030176; GO:0030182; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0032991; GO:0034620; GO:0034663; GO:0034975; GO:0035437; GO:0042026; GO:0042149; GO:0042220; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051402; GO:0051787; GO:0060904; GO:0070062; GO:0071236; GO:0071277; GO:0071287; GO:0071320; GO:0071353; GO:0071466; GO:0071480; GO:0097501; GO:1901998; GO:1903891; GO:1903894; GO:1903895; GO:1903897; GO:1904313; GO:1990090; GO:1990440 KLSLVAAMLLLLSAAR 5.730000019 1 1 9.28E-13 1686.035743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.12239 0 0 0 0 0 0 0 0 16.81916 0 16.06645 16.3331 0 0 0 0 0 15.83988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11047 LAMC1_HUMAN "Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma, S-LAM gamma)" LAMC1 LAMB2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005615; GO:0005788; GO:0007155; GO:0007492; GO:0009887; GO:0009888; GO:0016477; GO:0022617; GO:0031581; GO:0034446; GO:0035633; GO:0043259; GO:0043260; GO:0045785; GO:0050679; GO:0051149; GO:0062023; GO:0065003; GO:0070062; GO:0098637; GO:0110011; GO:2001046 AHEAER 3.00999999 1 1 0.137858233 713.0329171 0 14.84001 0 13.77886 16.19128 16.27399 14.2716 15.18995 14.56038 0 0 0 0 0 0 0 0 14.99385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11055 MYH3_HUMAN "Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE)" MYH3 Homo sapiens (Human) actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018] GO:0000146; GO:0003009; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0007517; GO:0016887; GO:0017018; GO:0030017; GO:0030048; GO:0030049; GO:0030326; GO:0032982; GO:0045214; GO:0046034; GO:0051015; GO:0060325; GO:0070062 ELTYQSEEDR 7.639999866 1 1 0.48749444 1264.258338 15.19526 16.44727 15.41131 15.84095 13.91794 11.97837 15.49345 16.0537 0 0 0 15.62947 13.66276 0 0 0 0 16.78023 16.31054 0 16.03799 0 0 0 16.5417 16.67924 15.99822 0 0 0 0 17.6075 17.03868 16.91685 15.63939 0 0 15.21969 0 15.6982 0 0 0 0 16.39025 0 0 0 P11137 MTAP2_HUMAN "Microtubule-associated protein 2, MAP-2" MAP2 Homo sapiens (Human) central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]; regulation of protein localization [GO:0032880] apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769] apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]; regulation of protein localization [GO:0032880] calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156] GO:0000226; GO:0001578; GO:0002162; GO:0005198; GO:0005516; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0008017; GO:0016358; GO:0021954; GO:0030425; GO:0030517; GO:0031113; GO:0031115; GO:0031175; GO:0032839; GO:0032880; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0043203; GO:0044294; GO:0044307; GO:0048156; GO:0048813; GO:0097441; GO:0150001; GO:0150002; GO:0150014; GO:1901953; GO:1902513; GO:1902737; GO:1903744; GO:1904527; GO:1990635; GO:1990769 LDTVLEK 6.090000153 0.001556041 0.001556041 0.233387149 817.2305373 0 0 0 0 0 0 0 0 17.42921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.46464 0 0 0 0 0 P11161 EGR2_HUMAN "E3 SUMO-protein ligase EGR2, EC 2.3.2.- (AT591) (E3 SUMO-protein transferase ERG2) (Early growth response protein 2, EGR-2) (Zinc finger protein Krox-20)" EGR2 KROX20 Homo sapiens (Human) "aorta development [GO:0035904]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cellular response to organic substance [GO:0071310]; facial nerve structural organization [GO:0021612]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; rhombomere 3 formation [GO:0021660]; rhombomere 3 structural organization [GO:0021659]; rhombomere 5 formation [GO:0021666]; rhombomere 5 structural organization [GO:0021665]; rhythmic behavior [GO:0007622]; Schwann cell differentiation [GO:0014037]; skeletal muscle cell differentiation [GO:0035914]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; aorta development [GO:0035904]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cellular response to organic substance [GO:0071310]; facial nerve structural organization [GO:0021612]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; rhombomere 3 formation [GO:0021660]; rhombomere 3 structural organization [GO:0021659]; rhombomere 5 formation [GO:0021666]; rhombomere 5 structural organization [GO:0021665]; rhythmic behavior [GO:0007622]; Schwann cell differentiation [GO:0014037]; skeletal muscle cell differentiation [GO:0035914]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006611; GO:0007420; GO:0007422; GO:0007611; GO:0007622; GO:0008045; GO:0010467; GO:0014037; GO:0014040; GO:0016925; GO:0021612; GO:0021659; GO:0021660; GO:0021665; GO:0021666; GO:0030278; GO:0031625; GO:0031643; GO:0032868; GO:0035284; GO:0035904; GO:0035914; GO:0042552; GO:0043231; GO:0043565; GO:0045444; GO:0045893; GO:0045944; GO:0046872; GO:0048168; GO:0061629; GO:0061665; GO:0071310; GO:0071837; GO:1990837 DLHGTAGPDR 6.730000019 0.252737969 0.252737969 0.160026494 1033.936872 15.73011 0 14.92754 0 0 17.25937 0 0 0 0 15.71287 9.802708 14.81039 14.66652 15.00866 10.22993 14.87682 0 0 0 16.4267 11.9255 15.82467 16.25351 0 0 15.27756 14.31299 16.81703 16.19746 18.26402 14.91132 15.92558 16.58176 15.12089 16.53764 17.71276 0 0 12.02703 0 0 17.43141 18.41877 0 0 0 15.44092 P11169 GTR3_HUMAN "Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain, GLUT-3)" SLC2A3 GLUT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; monosaccharide transmembrane transport [GO:0015749]; transport across blood-brain barrier [GO:0150104] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; monosaccharide transmembrane transport [GO:0015749]; transport across blood-brain barrier [GO:0150104] D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149] GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0015149; GO:0015749; GO:0016020; GO:0016021; GO:0019852; GO:0030667; GO:0033300; GO:0035579; GO:0042995; GO:0043204; GO:0046323; GO:0055056; GO:0070062; GO:0070821; GO:0070837; GO:0098708; GO:0101003; GO:0150104; GO:1904659 DGVMEMNSIEPAKETTTNV 3.700000048 1 1 0.246978007 2065.376088 13.01151 0 0 12.80667 0 13.07349 0 0 0 0 0 15.6089 16.87447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.55647 13.47108 0 0 0 0 0 0 12.18044 0 0 0 0 0 0 P11172 UMPS_HUMAN "Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]" UMPS OK/SW-cl.21 Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UDP biosynthetic process [GO:0006225]; UMP biosynthetic process [GO:0006222] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UDP biosynthetic process [GO:0006225]; UMP biosynthetic process [GO:0006222] identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590] GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006222; GO:0006225; GO:0007565; GO:0007595; GO:0019856; GO:0042802; GO:0044205; GO:0071466 GIVSRPR 1 0.054075073 0.054075073 0.246532049 782.1810778 0 16.92255 16.40084 0 15.46223 0 17.86414 0 0 0 0 0 0 0 0 16.34624 0 0 0 15.98597 0 0 17.62747 0 17.2874 0 0 14.79043 0 17.49779 0 16.73873 15.00926 0 0 17.53749 0 0 19.28787 17.57946 15.10535 0 0 0 0 16.92863 16.19176 0 P11182 ODB2_HUMAN "Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial, EC 2.3.1.168 (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2, BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2, BCKAD-E2, BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)" DBT BCATE2 Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]; branched-chain amino acid catabolic process [GO:0009083] acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625] GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005947; GO:0009083; GO:0015630; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754 GEVYK 7.989999771 0.972556949 0.972556949 0.192322481 595.3835589 14.92085 15.63669 16.66295 0 13.32078 15.68603 16.59172 16.26192 15.83875 12.45166 15.61134 16.60718 0 0 16.54383 15.91622 16.20202 16.13547 16.1033 0 15.82971 17.28779 16.43002 17.09546 0 15.74511 16.33559 15.09118 0 15.72139 17.14894 15.33471 15.35115 15.90974 15.87295 16.84446 16.92706 16.74526 17.21644 15.81244 16.33796 0 16.69158 17.33321 0 15.45387 15.47312 16.2258 P11216 PYGB_HUMAN "Glycogen phosphorylase, brain form, EC 2.4.1.1" PYGB Homo sapiens (Human) glycogen catabolic process [GO:0005980] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980] glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499] GO:0005576; GO:0005737; GO:0005980; GO:0008184; GO:0016020; GO:0030170; GO:0035578; GO:0070062; GO:0102250; GO:0102499 EPDCFK 16.15999985 1 1 0.291129328 796.1421952 0 0 19.8111 0 18.43054 0 0 0 0 0 0 0 0 0 0 0 0 19.18197 0 17.97684 0 0 0 18.74459 0 0 0 0 0 0 0 0 0 0 0 19.87795 0 0 0 0 0 0 0 18.02262 0 0 0 17.18376 P11217 PYGM_HUMAN "Glycogen phosphorylase, muscle form, EC 2.4.1.1 (Myophosphorylase)" PYGM Homo sapiens (Human) glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977] glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499] GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499 TIAQYAR 7.409999847 0.149041995 0.149041995 0.214648064 823.3853938 13.10915 14.31428 14.91808 14.98698 15.18936 12.51512 0 16.49076 15.69441 18.8748 0 15.51941 0 0 15.64923 0 14.72228 15.38546 15.61407 15.46454 15.55407 16.03312 0 14.81998 17.56336 0 0 0 0 0 0 16.53571 0 0 16.15652 0 16.0864 16.16931 17.02902 17.11577 16.63845 14.19613 0 16.18115 15.5062 0 15.74753 0 P11230 ACHB_HUMAN Acetylcholine receptor subunit beta CHRNB1 ACHRB CHRNB Homo sapiens (Human) "acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0001941; GO:0003009; GO:0004888; GO:0005887; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015267; GO:0015276; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0055001; GO:0095500; GO:0099060; GO:1904315 AVALLPELR 8.210000038 1 1 2.97E-12 981.6806557 15.09911 0 13.66867 13.87029 14.91388 14.41778 14.11044 14.93327 11.97094 14.89916 12.92299 13.42947 10.91324 13.89743 0 15.30778 14.75651 12.79654 14.51818 15.78069 15.31182 14.97993 0 13.1432 14.95071 0 13.39102 15.68668 15.83855 0 11.53772 0 0 0 0 0 0 13.10785 0 0 11.92752 0 0 0 0 0 0 0 P11233 RALA_HUMAN "Ras-related protein Ral-A, EC 3.6.5.2" RALA RAL Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165] cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165] ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625] GO:0001843; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007049; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031532; GO:0031625; GO:0031755; GO:0032154; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0070062; GO:0072655; GO:0090141; GO:0090543 ADSYRK 6.920000076 0.647675276 0.647675276 0.279909221 737.9563522 15.96748 15.77202 14.33087 14.1918 16.12496 15.83809 15.95647 15.43218 16.24834 15.85337 15.87706 15.8425 0 14.57468 14.1566 15.36538 15.69923 0 16.31016 16.37434 14.37741 16.04037 15.68632 15.64475 17.26779 0 16.29793 15.85869 0 15.99228 16.79121 0 0 0 0 0 16.6025 16.72609 16.70997 15.6453 16.19624 16.41711 0 0 0 0 16.96443 0 P11245 ARY2_HUMAN "Arylamine N-acetyltransferase 2, EC 2.3.1.5 (Arylamide acetylase 2) (N-acetyltransferase type 2, NAT-2) (Polymorphic arylamine N-acetyltransferase, PNAT)" NAT2 AAC2 Homo sapiens (Human) xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829] cytosol [GO:0005829]; arylamine N-acetyltransferase activity [GO:0004060]; xenobiotic metabolic process [GO:0006805] arylamine N-acetyltransferase activity [GO:0004060] GO:0004060; GO:0005829; GO:0006805 NKLDLETLTDILEHQIR 2.069999933 1 1 0.277975627 2051.101224 16.46861 0 12.1619 11.57856 0 15.30961 12.84338 13.99135 15.38735 9.998976 13.39438 15.06442 0 0 11.38823 14.41337 13.94793 0 14.38687 0 14.73603 0 14.62006 0 0 9.839924 0 0 14.29453 0 0 15.81691 0 0 15.61765 0 16.43528 0 0 11.18439 0 12.27753 0 0 0 0 0 0 P11274 BCR_HUMAN "Breakpoint cluster region protein, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-26)" BCR BCR1 D22S11 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0002692; GO:0003014; GO:0004674; GO:0004712; GO:0004713; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007264; GO:0007420; GO:0014069; GO:0016020; GO:0030036; GO:0030216; GO:0030424; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051056; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0070062; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:2000378 DVSVMMSEMDVNAIAGTLKLYFR 3.269999981 1 1 0.309395399 2606.203847 0 0 14.35771 0 0 0 15.01021 14.65801 12.03475 0 15.85489 0 0 0 0 0 0 0 0 0 0 0 0 14.06444 13.82347 0 15.56658 0 0 0 0 0 0 0 0 0 0 0 0 0 14.32343 14.73877 0 0 0 0 0 0 P11277 SPTB1_HUMAN "Spectrin beta chain, erythrocytic (Beta-I spectrin)" SPTB SPTB1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200] GO:0003779; GO:0005200; GO:0005829; GO:0005886; GO:0008091; GO:0009986; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030506; GO:0030864; GO:0031235; GO:0032991; GO:0042995; GO:0051015; GO:0051693 AITAATLKFTEGK 1.269999981 1 1 0.284219286 1351.203123 0 0 0 0 11.72699 13.25926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11308 ERG_HUMAN Transcriptional regulator ERG (Transforming protein ERG) ERG Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0007165; GO:0030154; GO:0045944; GO:1990837; GO:1990904 HMPPPNMTTNER 10.93999958 3.37E-07 3.37E-07 0.337970874 1440.040951 0 0 17.60086 0 0 0 0 19.1796 21.38416 0 0 0 17.4972 0 0 0 0 19.70896 0 0 0 0 0 0 22.02108 21.49721 21.9451 17.35588 0 0 22.90838 22.95225 21.6214 0 0 0 22.96769 21.46051 22.39134 0 0 18.2606 0 20.88869 19.78422 0 19.49252 0 P11362 FGFR1_HUMAN "Fibroblast growth factor receptor 1, FGFR-1, EC 2.7.10.1 (Basic fibroblast growth factor receptor 1, BFGFR, bFGF-R-1) (Fms-like tyrosine kinase 2, FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)" FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR Homo sapiens (Human) cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0000165; GO:0001501; GO:0001764; GO:0001837; GO:0004712; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010518; GO:0010863; GO:0014068; GO:0016021; GO:0016477; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048705; GO:0051897; GO:0090722; GO:1905564; GO:2000546; GO:2001239 DKPNR 9.199999809 0.621665418 0.621665418 0.218972654 631.3270017 13.98625 15.61786 0 14.48509 0 16.62454 0 0 15.32977 0 0 0 15.81591 0 15.80679 15.72741 16.73527 16.22479 0 0 0 16.29915 0 0 16.10204 0 16.58012 14.81885 15.40769 15.83031 16.83684 15.68534 14.18248 16.40389 16.93172 16.31598 16.66043 18.02356 16.66933 15.4988 18.07601 15.32713 17.2925 16.30086 17.2327 13.81609 0 17.8527 P11388 TOP2A_HUMAN "DNA topoisomerase 2-alpha, EC 5.6.2.2 (DNA topoisomerase II, alpha isozyme)" TOP2A TOP2 Homo sapiens (Human) apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819] "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]" "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]" "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]" GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904 AAIGCGIVESILNWVKFK 8.449999809 1 1 0.248406864 2005.204212 0 14.15415 13.35091 13.57519 16.47119 0 0 0 0 0 0 0 13.55696 15.51669 16.0561 0 0 10.86837 0 0 14.26175 0 0 0 0 0 0 0 0 14.10726 14.37146 0 14.44249 0 0 14.78976 0 16.29907 0 14.92888 0 0 12.42718 0 0 0 0 0 P11413 G6PD_HUMAN "Glucose-6-phosphate 1-dehydrogenase, G6PD, EC 1.1.1.49" G6PD Homo sapiens (Human) "cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]" centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634] "centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]" glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803] GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034451; GO:0034599; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378 LTVADIRK 11.85999966 0.535161793 0.535161793 0.118729823 915.5158789 0 14.0944 16.50196 15.71415 0 11.9778 14.54687 15.92382 18.59821 13.54247 16.76991 17.17195 17.17749 16.66122 17.19865 17.90286 0 0 0 19.18016 0 16.21053 17.17734 17.15451 15.86817 16.06625 15.14259 0 14.74226 15.74314 0 0 15.33102 15.70263 14.54554 0 0 14.76875 18.10202 14.79103 15.70347 0 16.14378 14.75576 18.26336 13.98821 13.51903 17.9071 P11473 VDR_HUMAN "Vitamin D3 receptor, VDR (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)" VDR NR1I1 Homo sapiens (Human) "bile acid signaling pathway [GO:0038183]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; lithocholic acid receptor activity [GO:0038186]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; bile acid signaling pathway [GO:0038183]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561]" "calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; lithocholic acid receptor activity [GO:0038186]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001501; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006816; GO:0006874; GO:0007595; GO:0008270; GO:0008285; GO:0010628; GO:0010839; GO:0010980; GO:0030154; GO:0030501; GO:0038183; GO:0038186; GO:0042789; GO:0043235; GO:0045618; GO:0045892; GO:0045944; GO:0046697; GO:0046965; GO:0050892; GO:0060058; GO:0060558; GO:0060745; GO:0070561; GO:0070564; GO:0090575; GO:1902098; GO:1902121 CLSFQPECSMK 3.430000067 1 1 0.183770812 1387.187735 15.02774 16.35719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.52317 0 0 0 0 0 0 0 0 0 0 0 P11474 ERR1_HUMAN "Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha, ERR-alpha) (Nuclear receptor subfamily 3 group B member 1)" ESRRA ERR1 ESRL1 NR3B1 Homo sapiens (Human) "cartilage development [GO:0051216]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0001650; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008270; GO:0015630; GO:0019904; GO:0030278; GO:0032355; GO:0042127; GO:0043565; GO:0045171; GO:0045667; GO:0045670; GO:0045944; GO:0051216; GO:1900078; GO:1990837 AGPGGGAERR 9.25 0.128983974 0.128983974 0.29234978 927.3456145 16.5508 15.86547 15.90308 10.47604 17.27906 0 0 14.50269 15.64522 14.89608 16.26871 16.13998 0 15.06501 0 16.15571 15.69042 0 0 0 15.4243 0 0 0 17.18322 16.10345 15.98953 15.41811 16.14272 0 15.40796 16.84768 16.4742 16.48138 0 0 15.55883 17.27056 0 17.20229 0 15.9351 0 15.12521 17.00891 0 0 16.46237 P11488 GNAT1_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-1 (Transducin alpha-1 chain) GNAT1 GNATR Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell population proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; phototransduction, visible light [GO:0007603]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; response to light intensity [GO:0009642]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of umami taste [GO:0050917]; signal transduction [GO:0007165]; visual perception [GO:0007601]" apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; acyl binding [GO:0000035]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell population proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; phototransduction, visible light [GO:0007603]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; response to light intensity [GO:0009642]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of umami taste [GO:0050917]; signal transduction [GO:0007165]; visual perception [GO:0007601]" acyl binding [GO:0000035]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] GO:0000035; GO:0001580; GO:0001664; GO:0001750; GO:0001917; GO:0001973; GO:0003924; GO:0005525; GO:0005829; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0007193; GO:0007601; GO:0007603; GO:0008283; GO:0009416; GO:0009642; GO:0016020; GO:0016056; GO:0016324; GO:0019003; GO:0019901; GO:0022400; GO:0031683; GO:0032391; GO:0042462; GO:0042622; GO:0043025; GO:0046872; GO:0050908; GO:0050917; GO:0051343; GO:0051344; GO:0060041; GO:0071257; GO:0097381 EMSDIIQR 6.090000153 0.68122828 0.68122828 0.25226666 1008.327007 0 17.41539 15.79281 0 19.05868 0 16.90337 0 17.42524 0 0 0 0 0 0 17.09541 0 16.97859 16.03306 0 15.85802 17.02267 0 0 17.66945 0 0 0 15.87818 0 0 19.39615 0 18.68954 0 18.48934 17.22458 0 19.13522 17.42023 17.43861 16.7124 0 16.69802 17.42027 0 17.60952 0 P11498 PYC_HUMAN "Pyruvate carboxylase, mitochondrial, EC 6.4.1.1 (Pyruvic carboxylase, PCB)" PC Homo sapiens (Human) gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074] ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736] GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0042802; GO:0044794; GO:0046872 DVKGQIGAPMPGK 5.659999847 0.607494593 0.607494593 0.388723938 1313.351818 0 15.38992 0 0 17.07096 0 0 0 0 0 0 0 16.07808 0 0 0 0 0 0 0 13.31919 12.4682 0 0 0 0 0 16.16822 16.20188 0 16.63296 13.93827 15.45929 15.99146 15.29943 0 0 0 0 12.94287 0 0 0 16.09016 0 15.54235 16.17903 15.94205 P11532 DMD_HUMAN Dystrophin DMD Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein localization [GO:0034613]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519] cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cortical actin cytoskeleton [GO:0030864]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018] cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cortical actin cytoskeleton [GO:0030864]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein localization [GO:0034613]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519] actin binding [GO:0003779]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0007519; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030036; GO:0030054; GO:0030055; GO:0030175; GO:0030864; GO:0031527; GO:0032991; GO:0033137; GO:0034613; GO:0035633; GO:0035994; GO:0042383; GO:0042995; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048666; GO:0050998; GO:0051015; GO:0055001; GO:0060048; GO:0060314; GO:0065003; GO:0086001; GO:0090257; GO:0090287; GO:1901385; GO:1902083; GO:2000651 DLGQLEKK 18.52000046 0.34236449 0.34236449 0.21277197 930.0991831 15.66252 15.62077 16.15004 14.69693 0 0 0 14.95083 0 15.24268 14.96418 12.36775 0 0 0 13.61288 0 0 13.64457 14.92949 14.6282 0 0 0 0 0 0 13.42789 16.43912 0 15.89834 13.78347 14.98565 15.46161 11.65919 0 0 0 15.38275 0 16.06431 0 15.72133 16.0756 15.56225 0 0 0 P11678 PERE_HUMAN "Eosinophil peroxidase, EPO, EC 1.11.1.7 [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain ]" EPX EPER EPO EPP Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979] heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] GO:0002215; GO:0004601; GO:0005576; GO:0005615; GO:0006979; GO:0020037; GO:0032693; GO:0032714; GO:0032753; GO:0034774; GO:0042742; GO:0042744; GO:0046872; GO:0070062; GO:0072677 STETPKLAAMHTLFMR 4.360000134 1 1 6.88E-13 1868.36353 15.09608 15.14441 0 13.01913 14.45682 14.44812 11.48464 14.87265 12.36657 14.00833 14.53173 13.58976 12.42413 14.04791 15.47977 16.50711 11.94572 12.59085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11712 CP2C9_HUMAN "Cytochrome P450 2C9, EC 1.14.14.1 ((R)-limonene 6-monooxygenase, EC 1.14.14.53) ((S)-limonene 6-monooxygenase, EC 1.14.14.51) ((S)-limonene 7-monooxygenase, EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)" CYP2C9 CYP2C10 Homo sapiens (Human) cellular amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; (R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; cellular amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" "(R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0005886; GO:0006082; GO:0006805; GO:0008202; GO:0008203; GO:0008210; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016098; GO:0016491; GO:0016712; GO:0018675; GO:0018676; GO:0019373; GO:0019627; GO:0020037; GO:0032787; GO:0034875; GO:0042178; GO:0042759; GO:0043231; GO:0043603; GO:0046456; GO:0052741; GO:0070330; GO:0070989; GO:0097267 MDSLVVLVLCLSCLLLLSLWR 1.110000014 0.53293705 0.53293705 0.037970604 2519.368481 0 15.44789 0 0 0 0 13.09437 0 0 15.03075 0 13.18742 14.10739 0 0 0 0 0 0 0 14.86085 0 0 19.43904 0 16.82595 12.48961 0 0 0 0 15.81737 0 0 0 0 0 15.67935 0 0 14.72496 0 0 0 0 0 0 13.66233 P11717 MPRI_HUMAN "Cation-independent mannose-6-phosphate receptor, CI Man-6-P receptor, CI-MPR, M6PR (300 kDa mannose 6-phosphate receptor, MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor, IGF-II receptor) (M6P/IGF2 receptor, M6P/IGF2R) (CD antigen CD222)" IGF2R MPRI Homo sapiens (Human) animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 DGSPCPSKSGLSYK 5.070000172 1 1 0.218336875 1481.78694 13.74435 15.04842 13.47388 12.79126 15.1138 14.56801 12.45124 0 9.39849 13.0906 0 8.925361 9.343613 15.81824 11.71504 13.15128 13.39485 12.9319 0 12.08413 0 0 0 14.95683 0 0 13.01144 0 16.08092 0 0 14.0421 0 0 0 0 0 0 0 14.82225 14.16451 12.94686 15.51344 0 12.32497 0 0 0 P11766 ADHX_HUMAN "Alcohol dehydrogenase class-3, EC 1.1.1.1 (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase, FALDH, FDH, GSH-FDH, EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase, EC 1.1.1.284)" ADH5 ADHX FDH Homo sapiens (Human) ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase NAD activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase NADP activity [GO:0106321]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]" "alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase NAD activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase NADP activity [GO:0106321]; zinc ion binding [GO:0008270]" GO:0001523; GO:0003016; GO:0004024; GO:0005504; GO:0005739; GO:0005829; GO:0006069; GO:0008270; GO:0009055; GO:0010430; GO:0018119; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903; GO:0070062; GO:0106321; GO:0106322 LVSEYMSK 5.380000114 0.068696558 0.068696558 0.219587219 957.3340624 16.99941 0 0 14.55053 15.4779 14.7049 11.00628 15.26164 12.54361 12.7429 14.14048 16.47237 14.49456 16.22796 15.41026 14.84751 14.72957 0 14.32154 15.11722 15.39787 16.23055 16.37663 0 0 16.08457 16.51303 15.78363 15.25457 15.66954 14.99245 15.57558 16.38467 15.22983 15.13029 0 0 0 15.16834 15.3573 16.03762 14.76948 15.04226 0 0 0 0 16.08821 P11801 KPSH1_HUMAN "Serine/threonine-protein kinase H1, EC 2.7.11.1 (Protein serine kinase H1, PSK-H1)" PSKH1 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; heart development [GO:0007507] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005789; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0016607; GO:0106310 KGDDCLMK 7.329999924 1 1 0.185276296 981.2206366 0 0 15.04023 0 0 0 0 17.59045 0 18.23224 0 17.03 17.3103 16.73852 14.6962 17.10807 13.07128 18.59606 0 14.92812 18.00048 0 0 0 0 17.33825 0 17.29865 0 14.56272 0 0 0 0 17.89472 17.22166 0 0 17.79897 18.0703 0 0 0 0 0 15.56473 15.74637 0 P11802 CDK4_HUMAN "Cyclin-dependent kinase 4, EC 2.7.11.22 (Cell division protein kinase 4) (PSK-J3)" CDK4 Homo sapiens (Human) adipose tissue development [GO:0060612]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] bicellular tight junction [GO:0005923]; chromatin [GO:0000785]; cyclin D1-CDK4 complex [GO:0097128]; cyclin D2-CDK4 complex [GO:0097129]; cyclin D3-CDK4 complex [GO:0097130]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] bicellular tight junction [GO:0005923]; chromatin [GO:0000785]; cyclin D1-CDK4 complex [GO:0097128]; cyclin D2-CDK4 complex [GO:0097129]; cyclin D3-CDK4 complex [GO:0097130]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; adipose tissue development [GO:0060612]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] GO:0000082; GO:0000307; GO:0000785; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005923; GO:0006468; GO:0007165; GO:0008284; GO:0008353; GO:0009410; GO:0010468; GO:0010971; GO:0016538; GO:0016592; GO:0030332; GO:0031965; GO:0032869; GO:0040014; GO:0046626; GO:0046890; GO:0048146; GO:0050994; GO:0051301; GO:0051726; GO:0060260; GO:0060612; GO:0071222; GO:0071353; GO:0097128; GO:0097129; GO:0097130; GO:0106310; GO:1904628; GO:1904637 DEGNPE 9.659999847 1 1 0.09490792 659.9825374 0 0 0 0 0 0 14.5859 0 0 0 0 15.43691 0 13.77343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.86036 12.79487 0 0 15.3787 0 0 0 0 0 16.04515 0 0 0 0 0 0 0 0 0 P11844 CRGA_HUMAN Gamma-crystallin A (Gamma-A-crystallin) (Gamma-crystallin 5) CRYGA CRYG1 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212] GO:0002088; GO:0005212; GO:0007601 QYLLRPGDYRR 4.570000172 1 1 0.247752854 1437.465689 14.24394 15.57005 14.23799 9.558227 12.4826 0 0 0 13.82623 0 0 0 0 0 15.12588 14.98035 14.40102 13.99809 0 0 0 0 0 0 0 0 0 0 0 0 15.08532 0 0 0 0 0 16.22616 0 0 0 0 9.173209 0 0 0 0 14.32968 0 P11926 DCOR_HUMAN "Ornithine decarboxylase, ODC, EC 4.1.1.17" ODC1 Homo sapiens (Human) kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803] GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803 AACASASINV 7.460000038 0.847302437 0.847302437 0.190150745 963.3257757 0 14.36603 15.00088 0 13.91186 14.82565 10.72909 0 12.75441 15.51327 0 14.86939 14.01689 12.39008 10.58255 15.69713 0 17.28908 14.95331 13.89766 14.57061 15.94821 14.30132 0 0 0 0 15.43143 0 18.36178 0 0 0 0 16.01266 0 0 0 15.62464 0 0 15.93648 0 0 0 14.99398 0 0 P11940 PABP1_HUMAN "Polyadenylate-binding protein 1, PABP-1, Poly(A)-binding protein 1" PABPC1 PAB1 PABP PABP1 PABPC2 Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; gene silencing by RNA [GO:0031047]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]" catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; CRD-mediated mRNA stabilization [GO:0070934]; gene silencing by RNA [GO:0031047]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]" mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494] GO:0000184; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006378; GO:0008022; GO:0008143; GO:0008266; GO:0008494; GO:0010494; GO:0016020; GO:0030027; GO:0031047; GO:0031252; GO:0036464; GO:0045070; GO:0048255; GO:0060213; GO:0070062; GO:0070934; GO:0071013; GO:0106002; GO:1900152; GO:1900153; GO:1990904; GO:2000623; GO:2000767 VDEAVAVLQAHQAKEAAQK 7.03000021 1 1 1.14E-12 2006.779296 14.10932 13.70679 13.72327 13.7894 14.63626 0 13.46913 14.00577 16.18822 13.63419 15.23568 0 11.43806 0 15.4818 11.05566 13.55655 15.27287 0 13.64225 0 15.47126 0 0 0 0 0 15.50255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12018 VPREB_HUMAN "Immunoglobulin iota chain (CD179 antigen-like family member A) (Protein VPreB1) (V(pre)B protein, VpreB protein) (CD antigen CD179a)" VPREB1 VPREB Homo sapiens (Human) immune response [GO:0006955] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immune response [GO:0006955] GO:0005576; GO:0005615; GO:0005783; GO:0006955 GYLSISELQPEDEAMYYCAMGAR 6.610000134 0.543482304 0.543482304 2.28E-12 2682.332075 12.44742 12.14765 0 0 11.46653 14.34404 0 9.281473 0 0 0 10.00218 0 0 0 0 10.91568 11.17129 0 0 13.91329 0 14.69347 13.34161 0 0 7.664812 13.34603 11.96281 0 13.69713 14.56464 0 12.86013 0 2.980586 13.13042 15.15746 0 12.68984 0 10.07072 0 0 0 12.87905 0 0 P12034 FGF5_HUMAN "Fibroblast growth factor 5, FGF-5 (Heparin-binding growth factor 5, HBGF-5) (Smag-82)" FGF5 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019] fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010001; GO:0010628; GO:0023019; GO:0030154; GO:0030334; GO:0051781 MSLSFLLLLFFSHLILSAWAHGEK 4.480000019 0.393643558 0.393643558 0.021605776 2761.561974 13.52792 14.92126 16.65445 0 0 14.35586 17.20115 16.17143 0 18.90758 15.21375 0 0 0 10.08058 16.83525 0 17.05455 0 15.93938 0 17.5266 11.71293 17.12687 0 15.99834 15.74326 0 17.65506 17.54624 15.57105 19.19246 15.06336 0 0 16.18678 0 17.55955 16.30201 19.02417 18.55173 0 0 0 16.26248 0 17.0195 0 P12104 FABPI_HUMAN "Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein, I-FABP)" FABP2 FABPI Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856] apical cortex [GO:0045179]; cytosol [GO:0005829]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical cortex [GO:0045179]; cytosol [GO:0005829]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856] fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324] GO:0005324; GO:0005504; GO:0005634; GO:0005829; GO:0005886; GO:0005902; GO:0006631; GO:0015908; GO:0036041; GO:0045179; GO:0098856 SENYDK 8.609999657 1 1 0.221604526 753.0211116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12107 COBA1_HUMAN Collagen alpha-1(XI) chain COL11A1 COLL6 Homo sapiens (Human) cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601] collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674] GO:0001502; GO:0001503; GO:0002063; GO:0005201; GO:0005576; GO:0005592; GO:0005615; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010; GO:0062023; GO:1904399 GADGVRGLK 11.97000027 1 1 0.258179411 871.8233016 16.12247 15.80718 14.41988 16.82464 0 12.42722 15.23977 16.43072 17.471 17.26116 14.29676 15.28405 0 13.85234 14.97179 0 0 0 0 14.49144 15.32486 0 13.72974 0 0 0 0 14.64866 0 15.10575 0 0 0 0 16.65035 0 0 0 15.63057 0 0 0 0 0 15.97738 0 0 0 P12109 CO6A1_HUMAN Collagen alpha-1(VI) chain COL6A1 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; endodermal cell differentiation [GO:0035987]; osteoblast differentiation [GO:0001649] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; endodermal cell differentiation [GO:0035987]; osteoblast differentiation [GO:0001649] collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407] GO:0001649; GO:0005518; GO:0005576; GO:0005589; GO:0005615; GO:0005765; GO:0005788; GO:0007155; GO:0016020; GO:0030020; GO:0032991; GO:0035987; GO:0042383; GO:0048407; GO:0062023; GO:0070062; GO:0071230 GGPGER 5.210000038 1 1 0.303255797 572.7135734 0 0 0 19.86048 19.55608 0 19.96841 17.80306 0 0 18.38557 19.43684 0 0 17.10431 19.47353 17.1289 0 0 15.80766 19.29796 0 20.95307 0 0 18.606 0 16.20905 0 0 0 0 0 0 20.90983 0 0 18.94617 0 18.85472 0 0 0 0 21.56074 0 0 17.82928 P12110 CO6A2_HUMAN Collagen alpha-2(VI) chain COL6A2 Homo sapiens (Human) cell adhesion [GO:0007155]; response to glucose [GO:0009749] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; response to glucose [GO:0009749] collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005518; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0007155; GO:0009749; GO:0030020; GO:0032991; GO:0042383; GO:0062023; GO:0070062; GO:1903561 GDPGRPGFSYPGPR 13.18999958 1 1 0.554079411 1460.404513 0 16.97917 0 0 0 21.54411 21.77511 0 0 0 0 0 0 0 0 0 0 0 0 0 20.09708 0 0 23.43532 0 18.58976 0 0 0 0 0 0 0 0 0 18.27336 0 0 0 17.63156 18.44954 24.0209 0 0 0 22.77329 0 24.56344 P12111 CO6A3_HUMAN Collagen alpha-3(VI) chain COL6A3 Homo sapiens (Human) cell adhesion [GO:0007155]; muscle organ development [GO:0007517] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; muscle organ development [GO:0007517] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0030020; GO:0031012; GO:0042383; GO:0062023; GO:0070062; GO:1903561 LPIGTQQIR 8.5 1 1 0.497951378 1026.891744 0 16.94935 0 0 17.72252 0 18.24296 17.69477 0 0 0 0 0 0 0 0 19.45873 0 0 0 0 16.52254 0 0 0 0 16.82478 0 0 0 0 17.41918 0 16.58897 0 0 19.55956 20.04629 0 0 0 18.43022 17.61893 0 0 17.90213 16.59196 0 P12236 ADT3_HUMAN "ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2, ANT 2) (Adenine nucleotide translocator 3, ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed ]" SLC25A6 AAC3 ANT3 CDABP0051 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544] ATP:ADP antiporter activity [GO:0005471] GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005744; GO:0006915; GO:0016020; GO:0016021; GO:0140021; GO:1990544 LAADVGK 1.080000043 1 1 0.089922747 672.559439 16.04693 13.72648 0 0 13.05029 0 0 15.93329 0 11.1222 0 0 16.29942 15.32324 16.39879 16.06777 0 0 0 0 0 0 0 0 0 0 15.97942 0 0 0 0 0 0 0 0 0 15.78355 0 0 0 0 16.45334 0 0 0 0 0 0 P12259 FA5_HUMAN "Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain ]" F5 Homo sapiens (Human) "blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]" COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370] "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]" copper ion binding [GO:0005507] GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0006508; GO:0007596; GO:0007598; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0031638; GO:0032571; GO:0032991; GO:0033116; GO:0072377; GO:1903561; GO:1905370 ASEFLGYWEPRLAR 8.909999847 1 1 0.390711134 1695.825084 13.8146 16.18283 15.15662 0 0 15.93441 0 0 0 0 0 0 0 0 14.30672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22805 15.4145 0 0 15.30951 16.84572 17.0234 0 0 0 0 16.18055 0 0 0 0 P12268 IMDH2_HUMAN "Inosine-5'-monophosphate dehydrogenase 2, IMP dehydrogenase 2, IMPD 2, IMPDH 2, EC 1.1.1.205 (Inosine-5'-monophosphate dehydrogenase type II, IMP dehydrogenase II, IMPDH-II)" IMPDH2 IMPD2 Homo sapiens (Human) 'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; retina development in camera-type eye [GO:0060041] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; 'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; retina development in camera-type eye [GO:0060041] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723] GO:0000166; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005778; GO:0005829; GO:0006177; GO:0006183; GO:0007623; GO:0016020; GO:0034774; GO:0042802; GO:0046651; GO:0046872; GO:0060041; GO:0070062; GO:0071353; GO:0097294; GO:1904813 YFSEADKIK 5.340000153 1 1 0.210802772 1101.581661 12.08868 15.27815 9.223608 0 0 15.60463 14.4935 14.3112 15.23648 0 15.07033 13.38659 14.34854 0 10.58509 14.14458 13.5545 6.905028 12.23513 0 0 0 0 0 0 16.51536 0 0 0 15.56126 15.97308 14.84572 15.97237 13.84889 0 0 0 13.86677 14.67369 14.90449 0 0 0 14.99048 16.20594 0 0 15.81953 P12270 TPR_HUMAN Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 APILK 3.279999971 1 1 0.090733195 539.4767764 0 0 15.59367 0 15.75238 15.69107 15.28434 0 0 15.36762 15.7317 14.68656 0 0 0 0 0 0 0 0 0 0 16.69693 0 0 0 0 0 0 0 0 0 16.65944 0 0 0 0 0 0 0 0 0 14.76268 0 0 0 0 0 P12318 FCG2A_HUMAN "Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a (CDw32) (Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a) (CD antigen CD32)" FCGR2A CD32 FCG2 FCGR2A1 IGFR2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of immune response [GO:0050776] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of immune response [GO:0050776] IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888] GO:0002376; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0007166; GO:0019864; GO:0030667; GO:0050776 TMETQMSQNVCPR 10.42000008 1 1 0.54619833 1613.334753 17.998 0 0 0 17.8972 0 0 0 0 18.20217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.84559 0 0 0 0 19.33747 19.11647 0 0 0 18.48601 0 0 0 0 0 19.02268 0 0 0 0 0 P12319 FCERA_HUMAN "High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha, FcERI) (IgE Fc receptor subunit alpha)" FCER1A FCE1A Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; regulation of immune response [GO:0050776] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; IgE binding [GO:0019863]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; regulation of immune response [GO:0050776] IgE binding [GO:0019863]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009986; GO:0019863; GO:0050776 FEDSGEYK 8.020000458 1 1 0.305694988 974.0070236 0 15.96557 0 0 0 0 0 0 0 0 0 0 0 17.58836 0 0 0 0 0 0 0 17.88498 18.81637 0 0 0 0 0 0 0 0 0 19.46383 0 0 0 0 0 17.31904 0 0 0 0 0 0 0 17.19338 0 P12525 MYCP1_HUMAN Putative myc-like protein MYCLP1 (Protein L-Myc-2) (V-myc myelocytomatosis viral oncogene homolog pseudogene 1) MYCLP1 MYCL1P1 MYCL2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0046983 ADLLDPR 9.100000381 0.219426602 0.219426602 0.255259927 800.5260413 0 18.80354 0 18.18 18.39592 0 0 17.57752 18.32884 0 19.1359 0 0 0 17.69492 19.8975 0 0 0 17.84981 0 19.031 19.11187 0 18.07247 18.56649 19.38436 17.32712 17.42199 0 18.77567 0 19.77852 0 19.63329 0 0 0 20.20933 18.67198 19.28217 0 16.28415 17.36861 0 16.92669 18.30139 15.7561 P12532 KCRU_HUMAN "Creatine kinase U-type, mitochondrial, EC 2.7.3.2 (Acidic-type mitochondrial creatine kinase, Mia-CK) (Ubiquitous mitochondrial creatine kinase, U-MtCK)" CKMT1A CKMT; CKMT1B CKMT Homo sapiens (Human) phosphocreatine biosynthetic process [GO:0046314] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314] ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301] GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0016301; GO:0046314 DSRFPK 7.559999943 1 1 0.038849061 750.5507887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.39905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12544 GRAA_HUMAN "Granzyme A, EC 3.4.21.78 (CTL tryptase) (Cytotoxic T-lymphocyte proteinase 1) (Fragmentin-1) (Granzyme-1) (Hanukkah factor, H factor, HF)" GZMA CTLA3 HFSP Homo sapiens (Human) apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617] extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634] extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617] protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0006915; GO:0006955; GO:0009617; GO:0019835; GO:0032078; GO:0042803; GO:0043065; GO:0043392; GO:0051354; GO:0051603; GO:0070269; GO:0140507; GO:1902483 EGDLKLLQLMEK 3.539999962 1 1 0.320177026 1432.223969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.14536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12645 BMP3_HUMAN "Bone morphogenetic protein 3, BMP-3 (Bone morphogenetic protein 3A, BMP-3A) (Osteogenin)" BMP3 BMP3A Homo sapiens (Human) cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102] GO:0001501; GO:0001649; GO:0005102; GO:0005125; GO:0005615; GO:0007267; GO:0008083; GO:0010862; GO:0051216; GO:0060395; GO:0070062; GO:0070700 AVPGDR 10.30000019 0.593963146 0.593963146 0.18808658 613.4189867 15.72646 15.33637 0 15.13165 0 16.02054 14.32344 14.77129 0 13.58833 13.44475 15.73506 15.75081 16.69251 16.43644 17.08534 16.90431 17.5403 16.16583 15.08051 18.10607 15.88016 16.58061 16.34937 14.91453 17.65781 15.27298 16.51513 17.50728 17.41326 16.6972 16.79553 16.83437 17.7261 16.56712 18.61186 15.47031 19.67529 19.9964 19.01913 19.28899 16.56595 16.2547 18.92456 17.89481 19.46667 15.97552 16.54901 P12694 ODBA_HUMAN "2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, EC 1.2.4.4 (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain, BCKDE1A, BCKDH E1-alpha)" BCKDHA Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083] 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872] GO:0003863; GO:0005739; GO:0005759; GO:0005947; GO:0009083; GO:0016831; GO:0046872 SMTLLNTMDR 6.300000191 1 1 0.467436425 1198.051295 0 0 0 0 17.41925 0 0 17.35311 0 0 0 0 0 0 17.66965 19.14234 0 20.24794 0 0 0 0 0 18.81553 0 19.33739 19.44802 0 0 0 0 0 19.41223 0 0 22.23103 0 0 20.25592 0 0 0 0 0 17.65496 18.37139 0 0 P12755 SKI_HUMAN Ski oncogene (Proto-oncogene c-Ski) SKI Homo sapiens (Human) "anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001843; GO:0002089; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006351; GO:0007179; GO:0008270; GO:0008285; GO:0009948; GO:0010626; GO:0014902; GO:0016604; GO:0016605; GO:0017053; GO:0019901; GO:0019904; GO:0021772; GO:0022011; GO:0030177; GO:0030326; GO:0030512; GO:0030514; GO:0031625; GO:0032926; GO:0032991; GO:0035019; GO:0042802; GO:0043010; GO:0043388; GO:0043585; GO:0045668; GO:0045944; GO:0046332; GO:0046811; GO:0048147; GO:0048593; GO:0048741; GO:0048870; GO:0060021; GO:0060041; GO:0060325; GO:0060349; GO:0060395; GO:0140297 QALEGGLDTK 3.549999952 0.706174672 0.706174672 0.223706791 1030.564281 0 0 14.73085 0 15.70652 0 16.47468 0 0 0 0 0 0 0 0 0 0 0 0 16.98699 0 0 16.17232 0 0 0 0 0 0 0 0 0 0 16.79816 13.69286 13.92581 0 0 0 16.27964 0 0 18.83529 0 0 0 16.37616 0 P12757 SKIL_HUMAN Ski-like protein (Ski-related oncogene) (Ski-related protein) SKIL SNO Homo sapiens (Human) blastocyst formation [GO:0001825]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to antibiotic [GO:0046677]; response to cytokine [GO:0034097]; response to growth factor [GO:0070848]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; blastocyst formation [GO:0001825]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to antibiotic [GO:0046677]; response to cytokine [GO:0034097]; response to growth factor [GO:0070848]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001669; GO:0001825; GO:0002260; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0007179; GO:0007283; GO:0007519; GO:0016605; GO:0019904; GO:0030512; GO:0030514; GO:0032991; GO:0034097; GO:0042802; GO:0044877; GO:0045596; GO:0046332; GO:0046677; GO:0050772; GO:0051726; GO:0070306; GO:0070848; GO:1902043; GO:1902231 IMEEVMR 10.23999977 0.493102938 0.493102938 0.234321003 922.4991627 16.98567 18.08422 16.41587 16.71873 9.843862 16.10004 11.58678 16.49992 17.39977 16.26508 17.25677 15.5834 14.82313 15.68764 15.19724 14.64241 17.08391 17.34405 16.01376 15.00571 17.34143 16.76284 16.43702 15.876 19.28653 13.01025 14.13981 16.57871 15.09875 16.26776 17.14149 0 16.01153 15.69097 0 16.33445 16.71676 16.58694 16.96399 16.73291 16.61124 15.9752 17.86456 15.91393 15.85428 16.43323 15.76725 17.03214 P12814 ACTN1_HUMAN Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1) ACTN1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; negative regulation of cellular component movement [GO:0051271]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981] brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018] brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; transmembrane transporter binding [GO:0044325]; vinculin binding [GO:0017166]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; negative regulation of cellular component movement [GO:0051271]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; transmembrane transporter binding [GO:0044325]; vinculin binding [GO:0017166] GO:0001725; GO:0001726; GO:0003725; GO:0005178; GO:0005509; GO:0005519; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005916; GO:0005925; GO:0007015; GO:0017166; GO:0019904; GO:0030018; GO:0030036; GO:0030054; GO:0030220; GO:0030374; GO:0030864; GO:0031093; GO:0031143; GO:0036344; GO:0042803; GO:0042981; GO:0042995; GO:0043197; GO:0044325; GO:0048041; GO:0051015; GO:0051017; GO:0051271; GO:0051639; GO:0055001; GO:0070062; GO:0098978; GO:0099186 NYITMDELRR 1.820000052 1 1 0.124944939 1325.81446 16.83821 0 0 14.0211 17.26755 16.56994 0 0 16.2905 0 12.42773 0 12.4722 15.73106 16.82236 17.65627 15.45835 16.71461 14.0773 0 0 14.06392 0 13.87743 0 0 17.30189 15.06793 0 13.4652 14.12283 15.3242 13.94784 0 14.46739 14.68676 16.91953 16.92978 15.81496 12.76583 0 16.11411 0 0 17.97329 13.01642 0 0 P12821 ACE_HUMAN "Angiotensin-converting enzyme, ACE, EC 3.2.1.-, EC 3.4.15.1 (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form ]" ACE DCP DCP1 Homo sapiens (Human) aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310] basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] GO:0001666; GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0007420; GO:0007565; GO:0007568; GO:0008217; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010815; GO:0014910; GO:0016021; GO:0019229; GO:0019233; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0032091; GO:0032092; GO:0032496; GO:0032943; GO:0034616; GO:0035814; GO:0042310; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045907; GO:0046325; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0090281; GO:0097066; GO:0097225; GO:0097746; GO:1900086; GO:1901363; GO:1902033; GO:1903597; GO:1904045; GO:2000170 GAASGR 1.889999986 1 1 0.266102299 515.8328911 15.15178 15.65399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5935 16.06918 0 0 17.45228 15.69483 0 0 0 0 16.20398 0 15.50019 0 16.77117 0 0 0 0 0 16.94756 16.17552 0 0 15.39838 0 0 0 0 0 P12882 MYH1_HUMAN "Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x, MyHC-2x) (Myosin heavy chain IIx/d, MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1)" MYH1 Homo sapiens (Human) muscle contraction [GO:0006936] A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; intercalated disc [GO:0014704]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982] A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; intercalated disc [GO:0014704]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; muscle contraction [GO:0006936] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774] GO:0003774; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0014704; GO:0031672; GO:0032982; GO:0036464; GO:0051015 GFLARVEYQK 6.900000095 1 1 0.243796362 1210.731596 0 16.04944 0 0 0 0 0 16.02617 0 0 0 0 0 16.04054 0 0 0 0 0 0 0 16.71002 0 0 0 0 0 16.73686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07304 0 0 P12883 MYH7_HUMAN "Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform, MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform, MyHC-beta)" MYH7 MYHCB Homo sapiens (Human) adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0001725; GO:0002026; GO:0002027; GO:0003009; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0014728; GO:0014883; GO:0014898; GO:0016459; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0031449; GO:0032982; GO:0046034; GO:0051015; GO:0055010; GO:0060048 AKLQTENGELSR 11.67000008 0.15638575 0.15638575 0.221812886 1344.818198 14.13157 0 13.60188 0 0 0 0 13.54751 13.3247 0 14.81881 15.27514 13.25741 14.49537 13.43165 11.52277 13.97498 16.86364 0 15.36817 14.72896 11.58539 0 13.14459 14.68264 0 0 0 0 15.9667 0 16.99047 0 0 0 0 0 0 0 0 0 0 0 13.44971 0 0 0 18.33246 P12931 SRC_HUMAN "Proto-oncogene tyrosine-protein kinase Src, EC 2.7.10.2 (Proto-oncogene c-Src) (pp60c-src, p60-Src)" SRC SRC1 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" "actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]" "actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; estrogen receptor binding [GO:0030331]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; estrogen receptor binding [GO:0030331]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] GO:0001545; GO:0001819; GO:0002102; GO:0002223; GO:0002862; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005080; GO:0005102; GO:0005158; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005886; GO:0005901; GO:0005925; GO:0007049; GO:0007155; GO:0007165; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0008022; GO:0008283; GO:0009410; GO:0009612; GO:0009615; GO:0010447; GO:0010632; GO:0010634; GO:0010907; GO:0010954; GO:0014068; GO:0014069; GO:0014911; GO:0016004; GO:0016236; GO:0018105; GO:0018108; GO:0019899; GO:0019900; GO:0020037; GO:0022407; GO:0030054; GO:0030154; GO:0030168; GO:0030331; GO:0030900; GO:0031234; GO:0031295; GO:0031333; GO:0031648; GO:0031667; GO:0031954; GO:0032148; GO:0032211; GO:0032587; GO:0032869; GO:0033146; GO:0033625; GO:0034332; GO:0034446; GO:0035306; GO:0035556; GO:0035635; GO:0036035; GO:0036120; GO:0038083; GO:0038096; GO:0038128; GO:0042169; GO:0042476; GO:0043005; GO:0043065; GO:0043066; GO:0043114; GO:0043149; GO:0043154; GO:0043274; GO:0043393; GO:0043406; GO:0043552; GO:0044325; GO:0045056; GO:0045087; GO:0045121; GO:0045124; GO:0045296; GO:0045453; GO:0045737; GO:0045747; GO:0045892; GO:0045893; GO:0046628; GO:0046777; GO:0046875; GO:0048010; GO:0048011; GO:0048013; GO:0048041; GO:0048471; GO:0048477; GO:0050731; GO:0050847; GO:0050900; GO:0051057; GO:0051117; GO:0051219; GO:0051222; GO:0051385; GO:0051602; GO:0051895; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060444; GO:0060491; GO:0060576; GO:0070062; GO:0070102; GO:0070301; GO:0070374; GO:0070555; GO:0070700; GO:0070851; GO:0071222; GO:0071253; GO:0071375; GO:0071393; GO:0071398; GO:0071456; GO:0071498; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:0097110; GO:0098609; GO:0098962; GO:0098978; GO:0099091; GO:1900182; GO:1903997; GO:2000386; GO:2000394; GO:2000573; GO:2000588; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286 MGSNKSKPK 8.739999771 1 1 0.236192409 995.3329072 16.07785 14.40203 15.39156 15.5903 16.47844 15.45918 14.09555 14.23173 15.74714 14.22993 0 15.34756 14.60731 15.40716 18.06437 0 0 15.34259 13.55314 13.99834 15.21616 17.01111 15.73309 18.2365 15.52867 16.70873 0 15.77836 0 14.56113 15.92759 15.10764 17.15818 16.73523 0 0 17.06649 16.38539 0 13.96254 15.71605 0 12.84016 0 14.52525 0 16.73637 14.61593 P12980 LYL1_HUMAN "Protein lyl-1 (Class A basic helix-loop-helix protein 18, bHLHa18) (Lymphoblastic leukemia-derived sequence 1)" LYL1 BHLHA18 Homo sapiens (Human) "B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001955; GO:0003677; GO:0005654; GO:0006355; GO:0006357; GO:0030183; GO:0045893; GO:0046983; GO:0060216 YIGFLVR 8.819999695 1 1 0.1433622 868.6109248 0 17.24712 15.6019 16.18514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.09293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13010 XRCC5_HUMAN "X-ray repair cross-complementing protein 5, EC 3.6.4.- (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit, CTC85, CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen, TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))" XRCC5 G22P2 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]" "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]" GO:0000723; GO:0000725; GO:0000781; GO:0000783; GO:0000976; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008047; GO:0008094; GO:0008283; GO:0009410; GO:0016020; GO:0016787; GO:0031625; GO:0032040; GO:0032204; GO:0032212; GO:0032991; GO:0032993; GO:0034462; GO:0034511; GO:0034774; GO:0042162; GO:0043085; GO:0043564; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051973; GO:0060218; GO:0070198; GO:0070418; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0090734; GO:1904430; GO:1990830; GO:1990904 HLMLPDFDLLEDIESK 2.789999962 0.154980078 0.154980078 4.56E-12 1930.571097 13.72396 0 13.93259 0 15.8547 16.38943 12.55151 15.71761 0 0 0 0 17.03446 16.04251 14.84245 0 15.00294 14.56955 0 16.16145 0 13.37473 14.56647 0 0 19.4073 0 14.30769 0 0 13.34701 0 0 16.61086 0 13.22577 16.27819 17.41803 15.67263 17.90747 0 14.20344 0 18.0962 14.59834 17.50367 0 0 P13196 HEM1_HUMAN "5-aminolevulinate synthase, non-specific, mitochondrial, ALAS-H, EC 2.3.1.37 (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)" ALAS1 ALAS3 ALASH OK/SW-cl.121 Homo sapiens (Human) erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782] 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170] GO:0003870; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0042802; GO:0048821 QHGAGAGGTR 3.680000067 1 1 0.183683856 910.4722299 0 11.42923 16.16462 16.19666 0 0 0 16.10566 0 0 0 0 14.4703 15.05865 15.61904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18494 0 0 0 0 0 15.57065 15.66138 0 15.78604 15.44567 0 15.62891 15.84408 16.65701 15.05026 13.7355 15.79294 12.62284 P13224 GP1BB_HUMAN "Platelet glycoprotein Ib beta chain, GP-Ib beta, GPIb-beta, GPIbB (Antigen CD42b-beta) (CD antigen CD42c)" GP1BB Homo sapiens (Human) "blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0005887; GO:0007155; GO:0007166; GO:0007597; GO:0010572; GO:0030168; GO:0035855; GO:0042802; GO:0051209; GO:1990779 MGSGPR 1.340000033 0.540464878 0.540464878 0.24308619 603.8620968 0 0 0 14.92061 16.07214 0 0 11.72222 17.16085 0 16.47633 0 0 0 14.82346 13.88964 15.71694 0 0 0 0 0 0 0 0 0 17.47978 15.76155 15.78158 0 0 0 15.98521 17.31313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13232 IL7_HUMAN "Interleukin-7, IL-7" IL7 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell differentiation [GO:0045582]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; T cell lineage commitment [GO:0002360] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-7 receptor binding [GO:0005139]; animal organ morphogenesis [GO:0009887]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell differentiation [GO:0045582]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; T cell lineage commitment [GO:0002360] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-7 receptor binding [GO:0005139] GO:0001961; GO:0002360; GO:0005125; GO:0005139; GO:0005576; GO:0005615; GO:0006959; GO:0007267; GO:0008083; GO:0008284; GO:0009887; GO:0019221; GO:0030890; GO:0032722; GO:0043066; GO:0043086; GO:0045453; GO:0045579; GO:0045582; GO:0046622; GO:0048873; GO:0050730; GO:0062023; GO:2001240 ILMGTK 6.170000076 1 1 0.078727718 660.8359229 12.87719 0 16.9943 16.21235 13.10558 0 0 9.597343 0 0 15.23492 0 11.22187 15.85217 0 15.13725 16.68532 0 0 0 0 14.08414 17.12876 14.9541 0 0 0 0 0 0 12.73713 0 14.70638 0 13.96406 0 0 18.30804 0 0 0 0 16.73489 15.92674 0 20.23965 13.58051 0 P13349 MYF5_HUMAN "Myogenic factor 5, Myf-5 (Class C basic helix-loop-helix protein 2, bHLHc2)" MYF5 BHLHC2 Homo sapiens (Human) camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; embryonic skeletal system morphogenesis [GO:0048704]; extracellular matrix organization [GO:0030198]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle tissue morphogenesis [GO:0060415]; ossification [GO:0001503]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of skeletal muscle fiber development [GO:0048743]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; embryonic skeletal system morphogenesis [GO:0048704]; extracellular matrix organization [GO:0030198]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle tissue morphogenesis [GO:0060415]; ossification [GO:0001503]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of skeletal muscle fiber development [GO:0048743]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001502; GO:0001503; GO:0001756; GO:0001952; GO:0005654; GO:0006357; GO:0007517; GO:0007519; GO:0030198; GO:0035914; GO:0042693; GO:0043010; GO:0045663; GO:0046983; GO:0048704; GO:0048743; GO:0060415; GO:0090575 KSTTMDR 9.479999542 1 1 0.168110064 854.6122666 0 17.94858 0 19.72093 17.31596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.31636 0 P13473 LAMP2_HUMAN "Lysosome-associated membrane glycoprotein 2, LAMP-2, Lysosome-associated membrane protein 2 (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)" LAMP2 Homo sapiens (Human) autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647] autolysosome [GO:0044754]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of autophagosome membrane [GO:0097637]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802] autolysosome [GO:0044754]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of autophagosome membrane [GO:0097637]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647] enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904] GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005802; GO:0005886; GO:0006605; GO:0009267; GO:0016020; GO:0017038; GO:0019899; GO:0019904; GO:0030670; GO:0031088; GO:0031333; GO:0031647; GO:0031902; GO:0035577; GO:0043202; GO:0043231; GO:0044754; GO:0046716; GO:0048471; GO:0050821; GO:0061684; GO:0061740; GO:0061742; GO:0070062; GO:0072594; GO:0097352; GO:0097637; GO:0101003; GO:1905146 SYALELNLTDSENATCLYAK 11.69999981 1 1 0.232196263 2276.820501 13.09011 8.917396 0 0 11.42121 11.15979 0 14.9392 11.47054 0 0 14.42623 15.07405 0 15.93397 12.54122 0 0 12.55189 0 0 0 0 12.36822 0 0 0 14.03872 0 0 0 11.99525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13489 RINI_HUMAN "Ribonuclease inhibitor (Placental ribonuclease inhibitor, Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1, RAI)" RNH1 PRI RNH Homo sapiens (Human) mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765] angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ribonuclease inhibitor activity [GO:0008428]; mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765] ribonuclease inhibitor activity [GO:0008428] GO:0005654; GO:0005829; GO:0006402; GO:0008428; GO:0032311; GO:0045765; GO:0070062 DLCGIVASK 10.69999981 0.706026733 0.706026733 0.231586717 961.4824856 15.03849 16.75363 19.53063 15.14621 0 0 0 0 13.88659 16.22454 0 16.05908 14.93073 14.1469 0 15.02625 0 15.64116 16.42626 15.54258 15.65991 16.68508 15.67155 0 15.08933 16.23522 0 0 15.95787 15.51892 16.61229 15.4533 0 18.27277 16.52648 0 17.01935 17.25845 17.90033 16.14087 0 17.79839 0 16.46607 16.39691 17.37494 0 0 P13497 BMP1_HUMAN "Bone morphogenetic protein 1, BMP-1, EC 3.4.24.19 (Mammalian tolloid protein, mTld) (Procollagen C-proteinase, PCP)" BMP1 PCOLC Homo sapiens (Human) cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0004252; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0007275; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0030154; GO:0030199; GO:0031982; GO:0042802; GO:0061036 KPEPVLATGSR 9.390000343 0.692942858 0.692942858 0.042082232 1155.170291 0 0 19.1804 0 18.22153 0 0 0 0 0 0 18.74011 0 19.43854 0 15.73498 18.4304 0 0 16.79726 18.90874 19.11491 19.55251 0 0 19.80053 18.45627 0 0 0 0 19.41882 0 19.32016 0 18.28719 0 0 18.96215 20.24587 0 0 16.35524 18.05314 18.75849 18.69455 0 0 P13500 CCL2_HUMAN "C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor, MCAF) (Monocyte chemotactic protein 1, MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2)" CCL2 MCP1 SCYA2 Homo sapiens (Human) "angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; astrocyte cell migration [GO:0043615]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular homeostasis [GO:0019725]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; helper T cell extravasation [GO:0035684]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of natural killer cell chemotaxis [GO:2000502]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; neutrophil chemotaxis [GO:0030593]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of calcium ion import [GO:0090280]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; viral genome replication [GO:0019079]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR2 chemokine receptor binding [GO:0031727]; chemokine activity [GO:0008009]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; astrocyte cell migration [GO:0043615]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular homeostasis [GO:0019725]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; helper T cell extravasation [GO:0035684]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of natural killer cell chemotaxis [GO:2000502]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; neutrophil chemotaxis [GO:0030593]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of calcium ion import [GO:0090280]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; viral genome replication [GO:0019079]" CCR chemokine receptor binding [GO:0048020]; CCR2 chemokine receptor binding [GO:0031727]; chemokine activity [GO:0008009]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102] GO:0000165; GO:0001525; GO:0002548; GO:0004672; GO:0005102; GO:0005576; GO:0005615; GO:0006468; GO:0006935; GO:0006954; GO:0006959; GO:0007010; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007187; GO:0007259; GO:0008009; GO:0008360; GO:0009617; GO:0009887; GO:0019079; GO:0019221; GO:0019233; GO:0019725; GO:0030593; GO:0031663; GO:0031727; GO:0034351; GO:0035684; GO:0043491; GO:0043524; GO:0043547; GO:0043615; GO:0044344; GO:0048020; GO:0048245; GO:0048246; GO:0048247; GO:0050870; GO:0051770; GO:0051968; GO:0070098; GO:0070374; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0071407; GO:0090280; GO:1904783; GO:1905563; GO:2000134; GO:2000353; GO:2000427; GO:2000502 RITSSK 7.809999943 0.332642704 0.332642704 0.101247861 691.4514456 0 14.92451 0 15.31593 0 14.84153 14.21645 15.69636 0 13.77932 15.14227 14.78309 15.0632 14.10603 0 15.31918 13.80944 0 15.94069 14.30065 15.10004 15.97261 15.67235 14.94841 0 0 0 0 0 0 0 0 0 16.21984 15.99691 0 0 0 0 0 0 0 0 16.55201 0 0 0 0 P13521 SCG2_HUMAN "Secretogranin-2 (Chromogranin-C) (Secretogranin II, SgII) [Cleaved into: Secretoneurin, SN; Manserin ]" SCG2 CHGC Homo sapiens (Human) angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306] chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125] GO:0000165; GO:0001525; GO:0001937; GO:0001938; GO:0005125; GO:0005615; GO:0005788; GO:0006954; GO:0009306; GO:0030141; GO:0035556; GO:0042056; GO:0043542; GO:0048245; GO:0050918; GO:0050930; GO:0098992; GO:2000352; GO:2001237 LQNGQNGERATR 4.099999905 1 1 0.305254148 1344.36568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88712 0 0 0 16.67243 0 0 0 0 0 0 0 0 0 17.20638 0 0 15.98709 16.00818 16.08985 0 16.17752 0 16.01612 0 0 16.51862 0 15.80396 P13533 MYH6_HUMAN "Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform, MyHC-alpha)" MYH6 MYHCA Homo sapiens (Human) adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; regulation of ATP-dependent activity [GO:0043462]; regulation of blood pressure [GO:0008217]; regulation of heart contraction [GO:0008016]; regulation of heart growth [GO:0060420]; regulation of heart rate [GO:0002027]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral muscle development [GO:0007522] cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018] cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; protein kinase binding [GO:0019901]; adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; regulation of ATP-dependent activity [GO:0043462]; regulation of blood pressure [GO:0008217]; regulation of heart contraction [GO:0008016]; regulation of heart growth [GO:0060420]; regulation of heart rate [GO:0002027]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral muscle development [GO:0007522] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; protein kinase binding [GO:0019901] GO:0000146; GO:0001701; GO:0001725; GO:0002026; GO:0002027; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0007522; GO:0008016; GO:0008217; GO:0014898; GO:0016459; GO:0017018; GO:0019901; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0030239; GO:0032982; GO:0043462; GO:0045214; GO:0046034; GO:0051015; GO:0055009; GO:0055010; GO:0055013; GO:0060048; GO:0060420 MTDAQMADFGAAAQYLRK 12.78999996 1 1 1.38E-12 2019.417455 0 0 0 0 0 0 0 13.17701 14.39116 0 0 16.14706 0 15.53875 0 14.96913 0 0 0 0 16.57436 0 0 0 14.14308 0 14.94739 14.57356 0 0 0 0 16.38806 0 0 0 16.02355 0 0 0 0 0 0 0 0 16.29051 0 0 P13535 MYH8_HUMAN "Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal, MyHC-perinatal)" MYH8 Homo sapiens (Human) ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle contraction [GO:0003009] cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; myosin phosphatase activity [GO:0017018]; structural constituent of muscle [GO:0008307]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle contraction [GO:0003009] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; myosin phosphatase activity [GO:0017018]; structural constituent of muscle [GO:0008307] GO:0000146; GO:0003009; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005859; GO:0006936; GO:0008307; GO:0016887; GO:0017018; GO:0030017; GO:0030049; GO:0032027; GO:0032982; GO:0046034; GO:0051015 LEEAGGATSAQVELNK 3.230000019 1 1 1.84E-12 1616.758004 0 15.36901 0 16.18384 0 12.77654 15.26556 0 0 16.47993 0 16.27042 15.46328 15.41236 0 0 0 0 14.29167 0 0 0 15.45868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13569 CFTR_HUMAN "Cystic fibrosis transmembrane conductance regulator, CFTR (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase, EC 5.6.1.6) (cAMP-dependent chloride channel)" CFTR ABCC7 Homo sapiens (Human) amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138]; amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138] GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006695; GO:0006904; GO:0009986; GO:0010008; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016021; GO:0016324; GO:0016853; GO:0016887; GO:0017081; GO:0019869; GO:0019899; GO:0030165; GO:0030301; GO:0030660; GO:0030669; GO:0031901; GO:0032991; GO:0034707; GO:0034976; GO:0035377; GO:0035774; GO:0042626; GO:0043225; GO:0045921; GO:0048240; GO:0050891; GO:0051087; GO:0051454; GO:0055037; GO:0055038; GO:0055085; GO:0060081; GO:0070175; GO:0071320; GO:0097186; GO:0106138; GO:0140359; GO:1902161; GO:1902476; GO:1902943; GO:1904322 SPLEKASVVSK 2.960000038 1 1 0.185680174 1144.713707 15.64422 0 0 0 0 0 13.26488 13.06898 0 0 0 0 14.95004 0 0 14.74815 0 0 0 0 10.94251 0 15.32317 0 15.36473 16.06022 0 0 15.34028 0 15.53602 0 0 14.12394 0 0 0 16.41869 0 0 0 0 15.99277 0 15.17934 0 0 0 P13584 CP4B1_HUMAN "Cytochrome P450 4B1, EC 1.14.14.1 (CYPIVB1) (Cytochrome P450-HP)" CYP4B1 Homo sapiens (Human) biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631] aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825] GO:0004497; GO:0005506; GO:0005789; GO:0006631; GO:0018879; GO:0019825; GO:0020037; GO:0070330 QTLAKAMDK 6.380000114 1 1 0.232616927 1006.2858 0 15.92311 11.66368 12.62055 15.04934 15.20641 16.06245 15.63195 15.32934 15.86819 15.12019 15.36528 13.62892 0 15.24357 14.58609 15.98414 0 0 0 15.6137 14.29118 0 15.80366 0 0 0 0 0 0 0 0 0 15.83334 15.48589 0 0 15.94646 15.35508 0 13.60205 15.36746 0 0 0 14.30481 0 0 P13611 CSPG2_HUMAN "Versican core protein (Chondroitin sulfate proteoglycan core protein 2, Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein, GHAP) (Large fibroblast proteoglycan) (PG-M)" VCAN CSPG2 Homo sapiens (Human) cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501] calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540] GO:0001501; GO:0001649; GO:0001750; GO:0005509; GO:0005539; GO:0005540; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0007155; GO:0007275; GO:0007417; GO:0008037; GO:0008347; GO:0016020; GO:0030021; GO:0030246; GO:0031012; GO:0033165; GO:0043202; GO:0062023 HLPTIR 2.859999895 1 1 0.228656085 737.5133324 15.19944 16.24537 16.22699 16.48432 16.50246 0 15.36825 14.41114 14.91826 16.15966 15.01829 16.58554 0 15.48331 0 15.40908 0 0 15.15751 16.0318 0 15.03371 15.79993 13.79269 0 0 0 16.56169 0 0 17.07165 0 0 0 17.34191 0 16.14728 0 15.36972 0 15.90025 0 16.31113 0 17.20772 16.53118 15.1678 15.56095 P13645 K1C10_HUMAN "Keratin, type I cytoskeletal 10 (Cytokeratin-10, CK-10) (Keratin-10, K10)" KRT10 KPP Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; keratinocyte differentiation [GO:0030216]; morphogenesis of an epithelium [GO:0002009]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]; protein heterotetramerization [GO:0051290] cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; keratinocyte differentiation [GO:0030216]; morphogenesis of an epithelium [GO:0002009]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]; protein heterotetramerization [GO:0051290] protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280] GO:0001533; GO:0002009; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0009986; GO:0016020; GO:0018149; GO:0030216; GO:0030280; GO:0030855; GO:0045095; GO:0045684; GO:0046982; GO:0051290; GO:0070062 ALEESNYELEGK 79.70999908 1 1 0.386415343 1381.944233 18.2483 17.79395 0 0 18.05818 0 18.40403 0 18.68943 0 17.96967 0 0 18.67007 0 0 0 0 18.36544 0 19.00358 18.3416 0 19.11823 18.30611 0 19.25679 0 0 0 0 0 0 0 17.32948 0 18.97156 0 0 0 0 0 0 18.27715 16.69971 0 17.66531 0 P13671 CO6_HUMAN Complement component C6 C6 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]" GO:0001701; GO:0005576; GO:0005579; GO:0005886; GO:0006956; GO:0006958; GO:0019835; GO:0045087; GO:0050778; GO:0070062 QSPDYK 6.900000095 0.21404089 0.21404089 0.208819209 740.2983247 0 16.46821 16.26677 14.3478 15.60141 15.45888 14.66714 16.64581 0 16.01172 0 14.41985 13.78162 0 16.86863 14.76711 15.11617 14.95195 15.91753 0 16.7351 0 16.6706 0 10.00825 12.11982 15.15521 15.57037 14.89835 15.55468 14.50346 14.04836 15.77488 15.49304 0 14.42701 16.04434 16.28296 16.02512 0 0 14.49238 15.45839 14.80521 15.72978 14.3935 14.7191 14.9838 P13688 CEAM1_HUMAN "Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1, BGP-1) (CD antigen CD66a)" CEACAM1 BGP BGP1 Homo sapiens (Human) "angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; wound healing, spreading of cells [GO:0044319]" adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; wound healing, spreading of cells [GO:0044319]" actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782] GO:0001525; GO:0001558; GO:0001568; GO:0001915; GO:0002859; GO:0003779; GO:0005516; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006469; GO:0007155; GO:0007156; GO:0007229; GO:0009925; GO:0009986; GO:0010594; GO:0014066; GO:0015125; GO:0015721; GO:0016020; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0019900; GO:0019903; GO:0030054; GO:0030334; GO:0030658; GO:0030853; GO:0031005; GO:0031528; GO:0032692; GO:0032869; GO:0035579; GO:0035726; GO:0038016; GO:0038158; GO:0042058; GO:0042802; GO:0042803; GO:0043116; GO:0043318; GO:0044319; GO:0045601; GO:0045717; GO:0046983; GO:0050860; GO:0051055; GO:0060312; GO:0070062; GO:0070372; GO:0070821; GO:0090331; GO:0098742; GO:1901143; GO:1903385; GO:1903670; GO:1990782; GO:2000346; GO:2001214 LSQGNTTLSINPVK 4.269999981 1 1 0.402716124 1471.737905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.92846 0 0 0 0 0 0 0 0 0 17.21578 0 0 0 0 0 0 P13725 ONCM_HUMAN "Oncostatin-M, OSM" OSM Homo sapiens (Human) immune response [GO:0006955]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147] GO:0002675; GO:0005125; GO:0005147; GO:0005576; GO:0005615; GO:0006955; GO:0007275; GO:0008083; GO:0008284; GO:0008285; GO:0014068; GO:0032740; GO:0033138; GO:0038165; GO:0040008; GO:0042531; GO:0043410; GO:0045944; GO:0046888; GO:0050729; GO:0050731; GO:0051781; GO:0051897; GO:1902036 HSPHQALR 14.02999973 0.088571332 0.088571332 0.14367339 946.111105 15.51987 16.76709 13.00736 11.72395 14.97313 13.0942 12.63919 20.01467 0 12.44699 13.78089 0 15.04949 0 0 12.54491 15.56666 0 12.65309 16.75556 15.29693 0 14.25064 14.6816 15.82134 0 0 12.63525 0 0 0 0 18.01155 17.47856 14.22159 16.55825 0 14.55976 11.76692 12.30744 19.48876 10.49745 14.65869 0 0 0 0 18.7139 P13796 PLSL_HUMAN "Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1, LCP-1)" LCP1 PLS2 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286] actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178] GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0030866; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0048471; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0051764; GO:0070062; GO:0071803 EGESLEDLMKLSPEELLLR 9.760000229 1 1 0.153769634 2201.232456 14.24864 0 0 0 0 0 0 0 0 0 0 0 15.58869 0 11.16986 11.65858 0 0 0 15.91805 0 0 0 13.82033 0 0 0 12.47356 0 12.70456 0 0 12.30546 0 0 14.36417 13.26776 0 0 0 0 11.80029 0 10.69638 0 0 0 0 P13797 PLST_HUMAN Plastin-3 (T-plastin) PLS3 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] GO:0005509; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0032432; GO:0051015; GO:0051017; GO:0051639; GO:0060348 LGANMK 11.25 0.240291372 0.240291372 0.224842272 647.6659487 20.43426 17.0231 15.09075 18.74028 18.36981 16.66094 14.32419 12.56326 14.89456 16.72866 17.04955 16.37416 14.5609 16.13199 15.42259 15.41468 17.70995 15.60046 14.87348 14.46536 16.21093 14.78751 15.97602 15.81601 18.77179 0 15.91446 17.34241 16.2936 18.09877 21.26013 15.28309 21.45991 19.19207 19.5903 0 18.88292 16.64204 16.25439 15.35687 20.9149 16.96213 16.10705 17.85911 0 13.58799 15.52394 16.67627 P13798 ACPH_HUMAN "Acylamino-acid-releasing enzyme, AARE, EC 3.4.19.1 (Acyl-peptide hydrolase, APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase, OPH)" APEH D3F15S2 D3S48E DNF15S2 Homo sapiens (Human) amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]; translational termination [GO:0006415] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]; translational termination [GO:0006415] identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252] GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435; GO:0070062; GO:1904813 THLGS 4.559999943 0.296668291 0.296668291 0.154048603 514.7764256 17.36359 10.69761 19.10852 0 19.56621 16.76781 17.0001 0 12.5466 0 0 0 17.10431 15.48477 0 0 0 0 15.50119 0 17.06211 16.42638 14.29138 14.61645 0 0 0 0 17.1543 16.97251 19.075 17.07822 0 16.66922 16.17018 16.76193 18.89164 16.77201 18.28745 0 0 16.93834 17.36738 17.0936 0 14.48323 0 15.54485 P13804 ETFA_HUMAN "Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF" ETFA Homo sapiens (Human) cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660 VVVSGGRGLK 15.15999985 1 1 0.158359419 971.6494386 13.43192 15.65594 15.62842 11.46884 13.40022 12.46851 13.85287 15.37894 0 0 0 7.634297 12.53251 12.79175 14.53629 0 11.36857 13.87194 0 15.4397 0 0 15.7053 15.96327 0 0 0 0 0 0 0 0 16.49117 0 0 0 0 0 17.23252 0 15.3801 0 0 15.8544 0 0 0 0 P13928 ANXA8_HUMAN "Annexin A8 (Annexin VIII) (Annexin-8) (Vascular anticoagulant-beta, VAC-beta)" ANXA8 ANX8 Homo sapiens (Human) blood coagulation [GO:0007596]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of serine-type endopeptidase activity [GO:1900004] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886] "collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; blood coagulation [GO:0007596]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of serine-type endopeptidase activity [GO:1900004]" "actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0005509; GO:0005544; GO:0005546; GO:0005547; GO:0005737; GO:0005829; GO:0005886; GO:0007032; GO:0007596; GO:0016197; GO:0031902; GO:0043325; GO:0051015; GO:0062023; GO:1900004; GO:1900138 LYYAMKGAGTR 3.269999981 1 1 0.368157635 1231.239581 0 0 14.77883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13942 COBA2_HUMAN Collagen alpha-2(XI) chain COL11A2 Homo sapiens (Human) cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023] collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674] GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005592; GO:0005615; GO:0005788; GO:0007605; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0046872; GO:0051216; GO:0060021; GO:0060023; GO:0062023 GAKGATGPGGPK 7.340000153 1 1 5.76E-13 998.6441417 10.53213 14.04172 11.76908 14.64697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.02131 0 0 0 0 16.3434 0 0 0 0 0 0 0 0 0 0 0 P13985 HRES1_HUMAN Putative HTLV-1-related endogenous sequence (p25) HRES1 Homo sapiens (Human) HPQDPR 3.769999981 1 1 0.122954277 748.2769655 0 16.89686 12.87914 12.13341 0 11.52189 14.28992 0 0 11.82578 14.64802 14.52009 0 0 14.39544 0 0 0 0 0 0 0 0 0 0 0 15.857 15.79343 0 14.51364 16.29172 0 0 0 0 0 13.60374 16.7567 0 14.88828 0 15.48285 0 0 17.90107 0 15.12693 0 P13994 YJU2B_HUMAN Probable splicing factor YJU2B (Coiled-coil domain-containing protein 130) YJU2B CCDC130 SB115 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]" post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684] "post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]" GO:0000398; GO:0005684; GO:0008380; GO:0009615; GO:0071014 YNAEKK 8.539999962 1 1 0.257117347 752.9402039 0 0 0 17.49644 0 0 15.86288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.16306 0 0 0 0 P14061 DHB1_HUMAN "17-beta-hydroxysteroid dehydrogenase type 1, 17-beta-HSD 1, EC 1.1.1.51 (20 alpha-hydroxysteroid dehydrogenase, 20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 1, EC 1.1.1.62) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1)" HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 Homo sapiens (Human) bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; estrogen metabolic process [GO:0008210]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; catalytic activity [GO:0003824]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estradiol binding [GO:1903924]; NADP binding [GO:0050661]; NADP+ binding [GO:0070401]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; estrogen metabolic process [GO:0008210]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370] 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; catalytic activity [GO:0003824]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estradiol binding [GO:1903924]; NADP binding [GO:0050661]; NADP+ binding [GO:0070401]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283] GO:0003824; GO:0004303; GO:0005496; GO:0005737; GO:0005829; GO:0006694; GO:0006703; GO:0008210; GO:0030283; GO:0035410; GO:0042803; GO:0044594; GO:0047035; GO:0047045; GO:0050661; GO:0060348; GO:0061370; GO:0070401; GO:0071248; GO:0072582; GO:1903924 VLGSPEEVLDRTDIHTFHR 8.600000381 1 1 0.001037454 2221.203089 13.84844 0 14.03402 0 0 15.55687 0 10.22846 9.427062 0 0 13.72553 12.99735 0 16.0967 12.94275 14.49607 0 0 14.03841 14.79952 0 14.48433 15.74802 0 11.57596 0 14.11499 13.40407 14.04391 14.83829 15.70294 14.18924 15.28463 15.19609 0 12.78864 12.66271 0 0 0 0 0 0 16.04534 0 0 0 P14136 GFAP_HUMAN "Glial fibrillary acidic protein, GFAP" GFAP Homo sapiens (Human) astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; D-aspartate import across plasma membrane [GO:0070779]; extracellular matrix organization [GO:0030198]; gene expression [GO:0010467]; intermediate filament organization [GO:0045109]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron projection development [GO:0010977]; neuron projection regeneration [GO:0031102]; positive regulation of Schwann cell proliferation [GO:0010625]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of neurotransmitter uptake [GO:0051580]; regulation of protein-containing complex assembly [GO:0043254]; response to wounding [GO:0009611] astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111] astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; structural constituent of cytoskeleton [GO:0005200]; astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; D-aspartate import across plasma membrane [GO:0070779]; extracellular matrix organization [GO:0030198]; gene expression [GO:0010467]; intermediate filament organization [GO:0045109]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron projection development [GO:0010977]; neuron projection regeneration [GO:0031102]; positive regulation of Schwann cell proliferation [GO:0010625]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of neurotransmitter uptake [GO:0051580]; regulation of protein-containing complex assembly [GO:0043254]; response to wounding [GO:0009611] identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; structural constituent of cytoskeleton [GO:0005200] GO:0005178; GO:0005200; GO:0005737; GO:0005829; GO:0005882; GO:0006886; GO:0009611; GO:0010467; GO:0010625; GO:0010977; GO:0014002; GO:0019900; GO:0030198; GO:0031102; GO:0042802; GO:0043254; GO:0044297; GO:0045109; GO:0045111; GO:0051580; GO:0060020; GO:0060291; GO:0070779; GO:0097450; GO:0098574; GO:1904714 SYVSSGEMMVGGLAPGR 6.989999771 1 1 0.215947325 1713.603977 0 11.80717 12.33689 0 0 0 0 0 14.29349 0 0 12.66154 15.37587 0 0 0 0 0 0 14.2764 16.5623 0 0 0 0 14.50641 16.7911 13.42965 16.24598 15.58367 14.19082 0 16.06304 0 15.26392 0 13.29187 16.02327 0 0 15.77191 0 0 0 0 15.73749 0 0 P14210 HGF_HUMAN "Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor, SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain ]" HGF HPTA Homo sapiens (Human) animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947] chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] GO:0000278; GO:0000902; GO:0001837; GO:0001889; GO:0001934; GO:0005102; GO:0005576; GO:0005615; GO:0008083; GO:0010507; GO:0014068; GO:0016020; GO:0030335; GO:0031093; GO:0031100; GO:0031643; GO:0032715; GO:0032733; GO:0033137; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043154; GO:0043410; GO:0044877; GO:0045669; GO:0045766; GO:0045944; GO:0048012; GO:0050673; GO:0050728; GO:0050731; GO:0051450; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:1900744; GO:1901299; GO:1902042; GO:1902947; GO:2000573 VVNGIPTR 4.460000038 1 1 0.366565653 854.69662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.58967 0 0 0 0 0 0 0 0 0 0 18.20362 18.76095 0 0 0 0 0 0 0 0 0 0 P14222 PERF_HUMAN "Perforin-1, P1 (Cytolysin) (Lymphocyte pore-forming protein, PFP)" PRF1 PFP Homo sapiens (Human) apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; cytolysis [GO:0019835]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; immune response to tumor cell [GO:0002418]; immunological synapse formation [GO:0001771]; positive regulation of killing of cells of another organism [GO:0051712]; protein homooligomerization [GO:0051260]; T cell mediated cytotoxicity [GO:0001913] cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; wide pore channel activity [GO:0022829]; apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; cytolysis [GO:0019835]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; immune response to tumor cell [GO:0002418]; immunological synapse formation [GO:0001771]; positive regulation of killing of cells of another organism [GO:0051712]; protein homooligomerization [GO:0051260]; T cell mediated cytotoxicity [GO:0001913] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; wide pore channel activity [GO:0022829] GO:0001771; GO:0001913; GO:0002357; GO:0002418; GO:0005509; GO:0005576; GO:0005829; GO:0005886; GO:0006915; GO:0006968; GO:0016020; GO:0016021; GO:0019835; GO:0022829; GO:0031904; GO:0042802; GO:0044194; GO:0051260; GO:0051607; GO:0051712 AVELGGR 6.03000021 1 1 0.22001105 698.8409099 16.26211 0 13.3872 0 0 16.14204 0 0 15.97658 0 0 0 0 0 16.231 16.35708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.01023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14317 HCLS1_HUMAN Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75) HCLS1 HS1 Homo sapiens (Human) "actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]" cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667] "cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]" actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SH3 domain binding [GO:0017124] GO:0000122; GO:0005634; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0008284; GO:0009725; GO:0014068; GO:0017124; GO:0019901; GO:0030041; GO:0030218; GO:0030427; GO:0030833; GO:0030854; GO:0030864; GO:0033138; GO:0035556; GO:0042307; GO:0042531; GO:0045651; GO:0045944; GO:0050731; GO:0051015; GO:0051091; GO:0051897; GO:0061629; GO:0071345; GO:2000107; GO:2000251 FESMAEEKR 10.80000019 1 1 0.137933043 1142.128413 0 14.98887 16.17016 0 0 0 0 0 17.8843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14410 SUIS_HUMAN "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase, EC 3.2.1.48; Isomaltase, EC 3.2.1.10 ]" SI Homo sapiens (Human) polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]" "alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]" GO:0004553; GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062 VTTNPSDSGKCPNVLNDPVNVR 5.860000134 1 1 0.041505772 2383.634914 14.97486 11.87518 14.61186 0 16.89283 16.47707 11.90528 14.27086 17.58855 13.27273 0 0 16.47783 0 14.25865 15.89185 13.59905 15.75185 0 0 14.36018 0 15.85033 0 0 17.31248 13.46823 14.92047 9.277158 0 17.16951 0 14.95997 19.04672 18.09991 16.66699 0 17.88985 0 15.68891 17.73621 14.64213 0 0 15.18457 0 9.939624 13.47311 P14415 AT1B2_HUMAN "Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia, AMOG) (Sodium/potassium-dependent ATPase subunit beta-2)" ATP1B2 Homo sapiens (Human) cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-substrate adhesion [GO:0031589]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; lateral ventricle development [GO:0021670]; membrane repolarization [GO:0086009]; motor behavior [GO:0061744]; negative regulation of glial cell migration [GO:1903976]; neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration [GO:0021944]; photoreceptor cell maintenance [GO:0045494]; plasma membrane bounded cell projection organization [GO:0120036]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein stabilization [GO:0050821]; retina homeostasis [GO:0001895]; sodium ion export across plasma membrane [GO:0036376]; third ventricle development [GO:0021678]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; astrocyte projection [GO:0097449]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; astrocyte projection [GO:0097449]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-substrate adhesion [GO:0031589]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; lateral ventricle development [GO:0021670]; membrane repolarization [GO:0086009]; motor behavior [GO:0061744]; negative regulation of glial cell migration [GO:1903976]; neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration [GO:0021944]; photoreceptor cell maintenance [GO:0045494]; plasma membrane bounded cell projection organization [GO:0120036]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein stabilization [GO:0050821]; retina homeostasis [GO:0001895]; sodium ion export across plasma membrane [GO:0036376]; third ventricle development [GO:0021678]; transport across blood-brain barrier [GO:0150104] ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674] GO:0001671; GO:0001895; GO:0001917; GO:0005737; GO:0005886; GO:0005890; GO:0006883; GO:0009897; GO:0010976; GO:0016020; GO:0016324; GO:0016328; GO:0021670; GO:0021678; GO:0021944; GO:0030007; GO:0030674; GO:0031253; GO:0031589; GO:0032781; GO:0036376; GO:0044298; GO:0045494; GO:0046982; GO:0050821; GO:0051117; GO:0061744; GO:0071944; GO:0086009; GO:0086064; GO:0097449; GO:0097450; GO:0098984; GO:0120036; GO:0150104; GO:1901018; GO:1903278; GO:1903288; GO:1903976; GO:1990573 YQDRLATPGLMIRPK 3.619999886 1 1 0.185362736 1775.353663 0 13.72505 14.93531 14.2764 0 14.80338 15.23331 13.66804 13.5528 0 16.65257 14.12114 12.83046 0 0 12.10906 0 0 0 0 0 0 0 11.12125 0 0 0 0 16.70266 0 0 0 0 0 0 0 0 0 0 15.14679 0 0 0 0 0 0 0 0 P14543 NID1_HUMAN "Nidogen-1, NID-1 (Entactin)" NID1 NID Homo sapiens (Human) basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005886; GO:0007160; GO:0010811; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0051149; GO:0062023; GO:0070062; GO:0071711; GO:0098637; GO:0110011; GO:2001046 ESVENLAK 16.23999977 1 1 0.281199505 889.1500647 13.65478 14.38574 0 17.72152 14.66879 0 15.62574 0 0 16.26463 0 0 0 15.30274 0 15.04883 15.38338 13.77057 15.13753 0 0 0 0 16.08991 16.91676 0 16.27917 15.99199 0 16.02674 0 14.88419 0 0 0 0 0 0 16.79114 0 15.92893 16.28679 14.65332 0 0 14.80277 14.40036 16.25066 P14618 KPYM_HUMAN "Pyruvate kinase PKM, EC 2.7.1.40 (Cytosolic thyroid hormone-binding protein, CTHBP) (Opa-interacting protein 3, OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2, EC 2.7.11.1) (Thyroid hormone-binding protein 1, THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2, EC 2.7.10.2) (p58)" PKM OIP3 PK2 PK3 PKM2 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723] GO:0000287; GO:0003723; GO:0003729; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0012501; GO:0016301; GO:0023026; GO:0030955; GO:0031982; GO:0032869; GO:0034774; GO:0045296; GO:0062023; GO:0070062; GO:1903561; GO:1903672; GO:1904813; GO:2000767 APIIAVTR 4.519999981 1 1 0.202805806 840.6978062 15.0654 14.60759 0 15.78854 14.7333 13.6597 16.39034 15.64857 14.22154 0 16.35725 15.71125 0 15.99761 15.55681 0 0 0 14.42604 0 14.71295 16.61 0 15.20025 15.61885 0 0 16.18617 0 15.0153 14.99417 17.62095 16.22594 0 16.45184 0 0 0 0 0 0 0 0 0 0 0 15.10575 0 P14635 CCNB1_HUMAN G2/mitotic-specific cyclin-B1 CCNB1 CCNB Homo sapiens (Human) cell division [GO:0051301]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922] centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; cell division [GO:0051301]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389] GO:0000079; GO:0000307; GO:0000922; GO:0000940; GO:0001701; GO:0005113; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0006468; GO:0007052; GO:0007080; GO:0010971; GO:0016020; GO:0016538; GO:0019901; GO:0044389; GO:0044772; GO:0045931; GO:0048146; GO:0051301; GO:0051987; GO:0061575; GO:0090266; GO:0097125; GO:1905448 AKINMAGAK 7.650000095 1 1 0.279199091 919.2056103 0 0 0 0 0 17.32446 0 0 0 0 0 0 0 17.8857 0 0 0 0 0 0 0 0 0 0 0 0 0 19.37235 0 0 0 0 18.1042 0 18.63435 18.61949 0 0 0 0 0 0 0 0 0 0 0 0 P14651 HXB3_HUMAN Homeobox protein Hox-B3 (Homeobox protein Hox-2.7) (Homeobox protein Hox-2G) HOXB3 HOX2G Homo sapiens (Human) angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; face development [GO:0060324]; glossopharyngeal nerve morphogenesis [GO:0021615]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere development [GO:0021546]; thyroid gland development [GO:0030878] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; face development [GO:0060324]; glossopharyngeal nerve morphogenesis [GO:0021615]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere development [GO:0021546]; thyroid gland development [GO:0030878]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0002244; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0021546; GO:0021615; GO:0030878; GO:0045944; GO:0048704; GO:0050767; GO:0051216; GO:0060216; GO:0060324 CGPGTNSTLTKQIFPWMK 4.269999981 1 1 0.034922872 2065.296944 13.38255 14.31179 0 0 0 13.04203 15.38691 16.3615 14.59265 14.1923 0 14.03551 0 13.24294 14.03263 11.94281 0 0 0 10.50894 0 0 14.56491 0 11.79201 0 0 14.95719 13.62541 13.23843 14.46992 12.42562 0 0 0 0 15.57328 0 0 0 15.99149 0 14.67095 14.41966 12.95281 0 15.19591 11.3373 P14735 IDE_HUMAN "Insulin-degrading enzyme, EC 3.4.24.56 (Abeta-degrading protease) (Insulin protease, Insulinase) (Insulysin)" IDE Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992] ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0030163; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715 RIGNHITK 6.090000153 1 1 0.169500691 937.9102229 14.35722 12.7797 13.96532 0 0 0 15.69023 0 0 0 0 0 14.36528 0 0 14.12441 15.43042 0 0 0 13.88785 0 0 0 0 0 14.2817 0 15.33372 13.52285 14.56229 0 14.64812 0 0 0 0 0 15.25383 0 13.94805 13.93979 0 0 0 0 0 0 P14867 GBRA1_HUMAN Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) GABRA1 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0030659; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862 GDPGLATIAK 3.309999943 0.34675324 0.34675324 0.15807683 942.0489029 14.30571 0 0 12.10917 0 15.10325 12.88597 16.94847 15.82259 0 0 0 0 0 15.04553 0 0 0 0 0 0 0 0 0 0 0 13.98898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.13081 0 0 0 0 P14920 OXDA_HUMAN "D-amino-acid oxidase, DAAO, DAMOX, DAO, EC 1.4.3.3" DAO DAMOX Homo sapiens (Human) D-alanine catabolic process [GO:0055130]; D-amino acid catabolic process [GO:0019478]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; identical protein binding [GO:0042802]; D-alanine catabolic process [GO:0055130]; D-amino acid catabolic process [GO:0019478]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562] D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; identical protein binding [GO:0042802] GO:0003884; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006562; GO:0019478; GO:0036088; GO:0042416; GO:0042802; GO:0055130; GO:0070178; GO:0071949 DTVLGFRK 10.59000015 0.620060742 0.620060742 0.172721482 936.7408266 16.67354 17.66318 14.42397 18.46426 16.64543 17.36 14.43834 12.60015 0 15.95899 17.31373 17.49605 0 16.89367 12.948 18.36046 15.75777 13.92767 0 17.59023 14.9593 17.90152 0 15.91971 0 16.55886 16.65059 16.5885 14.84335 13.67811 17.70963 17.74196 0 0 13.63496 15.01592 15.85181 18.13865 0 16.94383 0 16.84945 13.91112 0 0 15.57425 17.22351 15.9628 P15036 ETS2_HUMAN Protein C-ets-2 ETS2 Homo sapiens (Human) cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0001712; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007498; GO:0019904; GO:0030154; GO:0045944; GO:0061629; GO:0090009; GO:1990837 AVMSQALKATFSGFK 5.090000153 0.053106867 0.053106867 0.006795641 1600.713047 10.03347 12.67134 14.28063 14.49269 0 13.80353 16.7709 16.79241 0 16.85243 14.27862 13.89714 0 14.72064 0 0 12.98399 14.71296 12.47271 14.42185 15.22915 16.11029 17.83875 0 12.98541 16.48336 0 14.73842 0 14.99571 12.27282 0 0 13.66989 15.79585 12.76352 16.74256 0 13.7038 0 16.117 18.57766 15.8313 0 0 12.97941 0 12.23023 P15056 BRAF_HUMAN "Serine/threonine-protein kinase B-raf, EC 2.7.11.1 (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)" BRAF BRAF1 RAFB1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cellular response to calcium ion [GO:0071277]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to membrane [GO:0090150]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; trehalose metabolism in response to stress [GO:0070413] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; animal organ morphogenesis [GO:0009887]; cellular response to calcium ion [GO:0071277]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to membrane [GO:0090150]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; trehalose metabolism in response to stress [GO:0070413] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110] GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007173; GO:0009887; GO:0010628; GO:0010828; GO:0033138; GO:0042802; GO:0043066; GO:0043231; GO:0070374; GO:0070413; GO:0071277; GO:0090150; GO:0097110; GO:0106310 TPIQAGGYGAFPVH 3.480000019 1 1 0.141734634 1414.138888 17.85282 0 0 0 0 0 14.68836 0 0 0 14.33412 0 13.07781 0 0 17.40973 0 0 0 0 0 0 0 0 17.24239 0 0 0 0 0 13.7317 0 17.14228 16.85957 0 15.2106 0 17.34189 0 0 0 0 0 0 0 0 0 0 P15088 CBPA3_HUMAN "Mast cell carboxypeptidase A, MC-CPA, EC 3.4.17.1 (Carboxypeptidase A3)" CPA3 Homo sapiens (Human) angiotensin maturation [GO:0002003]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; proteolysis [GO:0006508] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0002003; GO:0004181; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0030133; GO:0030141; GO:0062023 VKPQDEK 3.400000095 1 1 0.036797721 842.9938735 16.13415 17.29984 16.90011 0 14.32509 0 0 18.02487 14.22771 0 15.08682 16.47415 15.75587 0 13.95344 0 0 17.43102 0 0 16.32555 17.16372 0 16.5588 14.64336 15.75019 13.9957 0 17.42112 16.2403 16.46915 16.39722 16.42178 18.40287 18.5207 17.35439 13.71807 16.39 16.08326 16.06295 17.93156 15.13568 17.98114 13.20187 15.97539 15.34498 18.42413 0 P15090 FABP4_HUMAN "Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein, ALBP) (Adipocyte-type fatty acid-binding protein, A-FABP, AFABP) (Fatty acid-binding protein 4)" FABP4 Homo sapiens (Human) "brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; fatty acid transport [GO:0015908]; long-chain fatty acid transport [GO:0015909]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of inflammatory response [GO:0050729]; response to bacterium [GO:0009617]; white fat cell differentiation [GO:0050872]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; hormone receptor binding [GO:0051427]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; fatty acid transport [GO:0015908]; long-chain fatty acid transport [GO:0015909]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of inflammatory response [GO:0050729]; response to bacterium [GO:0009617]; white fat cell differentiation [GO:0050872]" fatty acid binding [GO:0005504]; hormone receptor binding [GO:0051427]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324] GO:0005324; GO:0005504; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0006469; GO:0009617; GO:0015908; GO:0015909; GO:0036041; GO:0042632; GO:0045892; GO:0050729; GO:0050872; GO:0050873; GO:0051427; GO:0070062; GO:0071285; GO:0071356; GO:0120162 SESTFK 18.39999962 0.823070586 0.823070586 0.252676275 697.7681996 15.52331 14.53323 15.15488 15.06919 0 0 14.94043 0 0 15.55395 15.14984 15.19723 0 0 0 15.56635 0 0 17.31388 0 0 0 0 0 0 16.5919 0 15.88 0 16.6172 0 0 0 0 0 0 16.86364 0 0 0 15.91817 15.84303 13.58443 14.50961 0 16.11561 0 16.42264 P15144 AMPN_HUMAN "Aminopeptidase N, AP-N, hAPN, EC 3.4.11.2 (Alanyl aminopeptidase) (Aminopeptidase M, AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)" ANPEP APN CD13 PEPN Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062 AALACSKELWILNR 5.170000076 1 1 0.081589482 1643.968962 18.32044 0 0 0 0 0 17.53761 0 0 0 0 0 0 0 0 0 0 0 0 0 16.65061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.32048 0 0 P15169 CBPN_HUMAN "Carboxypeptidase N catalytic chain, CPN, EC 3.4.17.3 (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N, SCPN)" CPN1 ACBP Homo sapiens (Human) bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; response to glucocorticoid [GO:0051384] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; response to glucocorticoid [GO:0051384] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005576; GO:0005615; GO:0006518; GO:0008270; GO:0010815; GO:0016485; GO:0051384 RSIPQVSPVR 15.17000008 1 1 0.572321657 1138.029985 0 0 0 0 0 18.94167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.41846 0 0 0 19.10924 0 0 0 0 0 0 0 17.57111 0 0 0 0 0 0 0 0 P15311 EZRI_HUMAN Ezrin (Cytovillin) (Villin-2) (p81) EZR VIL2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] GO:0000122; GO:0001650; GO:0001726; GO:0001772; GO:0001931; GO:0001951; GO:0003376; GO:0003723; GO:0003779; GO:0005615; GO:0005737; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0005925; GO:0007159; GO:0008017; GO:0008022; GO:0008360; GO:0010628; GO:0010737; GO:0015629; GO:0016020; GO:0016323; GO:0016324; GO:0019898; GO:0019904; GO:0022614; GO:0030033; GO:0030175; GO:0030863; GO:0030953; GO:0031503; GO:0031528; GO:0031532; GO:0031623; GO:0031982; GO:0032532; GO:0032587; GO:0032703; GO:0032991; GO:0034236; GO:0034237; GO:0035088; GO:0036064; GO:0040018; GO:0042802; GO:0042995; GO:0043622; GO:0044548; GO:0044853; GO:0045177; GO:0045296; GO:0046847; GO:0048015; GO:0048471; GO:0050714; GO:0050839; GO:0050860; GO:0051015; GO:0051017; GO:0051018; GO:0051117; GO:0051660; GO:0061028; GO:0070062; GO:0070373; GO:0071320; GO:0071944; GO:0072659; GO:0072697; GO:0097718; GO:0098592; GO:1902115; GO:1902896; GO:1902966; GO:1903078; GO:1903364; GO:1903753; GO:2000643 EAQDDLVKTK 5.960000038 1 1 0.208784738 1146.992206 0 0 14.6764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.55589 0 16.90415 0 0 0 0 0 0 16.42097 0 0 0 16.06508 15.71529 12.67869 16.00848 0 14.70187 0 0 0 0 0 0 0 0 16.90035 0 0 0 P15336 ATF2_HUMAN "Cyclic AMP-dependent transcription factor ATF-2, cAMP-dependent transcription factor ATF-2 (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2, CREB-2, cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1)" ATF2 CREB2 CREBP1 Homo sapiens (Human) "abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872]" CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861] "CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; H2B histone acetyltransferase activity [GO:0044013]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872]" "cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; H2B histone acetyltransferase activity [GO:0044013]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001701; GO:0001865; GO:0001889; GO:0001934; GO:0002244; GO:0003151; GO:0003360; GO:0003418; GO:0003419; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006606; GO:0006970; GO:0006974; GO:0007033; GO:0007254; GO:0008140; GO:0009414; GO:0010485; GO:0010628; GO:0014070; GO:0016525; GO:0016602; GO:0018107; GO:0019901; GO:0021742; GO:0021743; GO:0021754; GO:0030509; GO:0031573; GO:0032915; GO:0034599; GO:0035497; GO:0035861; GO:0038066; GO:0042789; GO:0042802; GO:0042803; GO:0043522; GO:0043525; GO:0043967; GO:0043969; GO:0044013; GO:0044255; GO:0044877; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0050872; GO:0051091; GO:0060052; GO:0060245; GO:0060612; GO:0061629; GO:0072740; GO:0090575; GO:0097049; GO:0097186; GO:0097284; GO:0098586; GO:0110024; GO:1901522; GO:1902110; GO:1902562; GO:1902742; GO:1990144; GO:1990253; GO:1990837; GO:1990841 NEVAQLKQLLLAHK 3.49000001 1 1 0.135332497 1605.097354 0 16.4703 0 0 0 0 0 15.45006 11.29482 0 0 0 0 0 0 0 15.00405 0 0 0 0 15.80735 0 0 0 0 0 0 0 0 0 0 0 16.35389 0 0 0 0 15.41449 0 0 0 0 0 0 16.86945 15.85703 0 P15391 CD19_HUMAN B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19) CD19 Homo sapiens (Human) antigen receptor-mediated signaling pathway [GO:0050851]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell differentiation [GO:0001923]; immunoglobulin mediated immune response [GO:0016064]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of B cell activation [GO:0050864]; regulation of B cell receptor signaling pathway [GO:0050855] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell differentiation [GO:0001923]; immunoglobulin mediated immune response [GO:0016064]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of B cell activation [GO:0050864]; regulation of B cell receptor signaling pathway [GO:0050855] GO:0001923; GO:0002322; GO:0005886; GO:0005887; GO:0009897; GO:0016064; GO:0032991; GO:0043552; GO:0045121; GO:0050851; GO:0050853; GO:0050855; GO:0050864; GO:0051281; GO:0070062 MTDPTR 1.350000024 0.381401271 0.381401271 0.163404875 720.6130063 15.99596 15.53069 15.05434 16.09015 16.58195 0 15.21255 0 16.42769 0 15.63002 0 15.66224 14.86107 0 0 0 0 0 13.82705 15.90071 0 0 0 0 0 15.67315 13.15592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.59819 0 0 15.31454 0 14.56588 P15421 GLPE_HUMAN Glycophorin-E GYPE GPE Homo sapiens (Human) integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] GO:0005886; GO:0005887 VIFEVMLVVVGMIILISYCIR 3.289999962 1 1 0.219370574 2484.429333 0 0 13.94209 13.73173 14.40789 0 0 0 0 0 0 0 0 0 8.843905 14.16782 0 0 0 0 0 0 16.65621 0 13.82078 0 0 0 0 13.74746 0 14.34863 17.55197 0 14.88743 0 0 0 0 15.62299 15.88585 0 16.65109 0 0 0 0 0 P15498 VAV_HUMAN Proto-oncogene vav VAV1 VAV Homo sapiens (Human) Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; reactive oxygen species metabolic process [GO:0072593]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; reactive oxygen species metabolic process [GO:0072593]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784] GO:0001784; GO:0005085; GO:0005829; GO:0005886; GO:0005911; GO:0006955; GO:0007186; GO:0007229; GO:0007264; GO:0008361; GO:0030168; GO:0030217; GO:0030593; GO:0031295; GO:0038095; GO:0038096; GO:0043087; GO:0043547; GO:0045954; GO:0046872; GO:0048010; GO:0051056; GO:0072593; GO:0140031 MTEYDK 13.05000019 0.395824045 0.395824045 0.248829248 784.6633894 0 21.84504 19.32614 0 19.06609 0 0 21.85353 0 19.7939 18.9259 16.7252 18.02124 0 21.81762 18.16906 18.0875 0 0 0 0 20.34839 0 19.54928 21.34356 0 0 21.49378 21.59355 0 18.30663 21.21682 19.37924 0 0 22.74775 0 22.58463 18.40299 17.84862 19.35474 0 19.32137 21.19185 0 21.02371 18.70575 0 P15531 NDKA_HUMAN "Nucleoside diphosphate kinase A, NDK A, NDP kinase A, EC 2.7.4.6 (Granzyme A-activated DNase, GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)" NME1 NDPKA NM23 Homo sapiens (Human) cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228] ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723] GO:0000287; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007399; GO:0007595; GO:0008285; GO:0016020; GO:0030154; GO:0032587; GO:0042802; GO:0042981; GO:0043024; GO:0043388; GO:0050679; GO:0070062 YMHSGPVVAMVWEGLNVVKTGR 5.920000076 1 1 0 2446.088003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15586 GNS_HUMAN "N-acetylglucosamine-6-sulfatase, EC 3.1.6.14 (Glucosamine-6-sulfatase, G6S)" GNS Homo sapiens (Human) glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340] glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484] GO:0005539; GO:0005576; GO:0006027; GO:0008449; GO:0008484; GO:0035578; GO:0042340; GO:0043199; GO:0043202; GO:0046872; GO:0070062; GO:1904813 GASNLTWR 5.309999943 1 1 0.168516331 905.8549776 14.41324 0 0 0 0 0 0 0 20.98875 15.59586 0 0 0 13.79557 0 0 0 0 0 0 11.24756 0 0 0 0 0 0 14.8139 17.01835 0 0 15.39174 0 0 0 14.51689 0 0 0 0 0 0 0 0 0 0 0 0 P15622 ZN250_HUMAN Zinc finger protein 250 (Zinc finger protein 647) ZNF250 ZNF647 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872; GO:1990837 MAAARLLPVPAGPQPLSFQAK 8.640000343 1 1 5.03E-12 2162.242692 11.44547 10.69405 0 13.77168 11.59686 13.4074 13.5928 0 0 11.88991 0 12.02445 0 0 0 12.24455 0 13.26184 13.20756 12.07723 0 15.11365 12.9112 0 0 14.35334 13.30765 9.870798 13.57672 0 0 0 0 0 0 0 0 12.93715 0 15.54993 0 0 13.77635 0 15.80492 0 0 0 P15692 VEGFA_HUMAN "Vascular endothelial growth factor A, VEGF-A (Vascular permeability factor, VPF)" VEGFA VEGF Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cellular component movement [GO:0051272]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172]; activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cellular component movement [GO:0051272]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190] chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172] GO:0000122; GO:0001525; GO:0001541; GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001822; GO:0001934; GO:0001938; GO:0001968; GO:0002040; GO:0002042; GO:0002052; GO:0002092; GO:0002575; GO:0002687; GO:0003007; GO:0003151; GO:0003169; GO:0005125; GO:0005161; GO:0005172; GO:0005576; GO:0005615; GO:0005737; GO:0005912; GO:0006357; GO:0007399; GO:0007498; GO:0007595; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009986; GO:0010595; GO:0010628; GO:0010629; GO:0010749; GO:0014068; GO:0016020; GO:0030141; GO:0030224; GO:0030225; GO:0030324; GO:0030335; GO:0030855; GO:0031012; GO:0031077; GO:0031093; GO:0031334; GO:0031954; GO:0032147; GO:0032793; GO:0033138; GO:0035148; GO:0035767; GO:0035924; GO:0036303; GO:0036324; GO:0038033; GO:0038084; GO:0038089; GO:0038091; GO:0038190; GO:0038191; GO:0042056; GO:0042327; GO:0042462; GO:0042802; GO:0042803; GO:0043066; GO:0043117; GO:0043129; GO:0043154; GO:0043183; GO:0043184; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0045785; GO:0045944; GO:0048010; GO:0048018; GO:0048469; GO:0048593; GO:0048842; GO:0048844; GO:0050679; GO:0050731; GO:0050840; GO:0050918; GO:0050927; GO:0050930; GO:0051272; GO:0051781; GO:0051894; GO:0051897; GO:0055013; GO:0060319; GO:0060749; GO:0060754; GO:0060948; GO:0060982; GO:0061042; GO:0061419; GO:0070374; GO:0071456; GO:0071542; GO:0071679; GO:0090037; GO:0090050; GO:0090190; GO:0090259; GO:0097475; GO:0097533; GO:0120162; GO:1900086; GO:1900745; GO:1901165; GO:1901727; GO:1902336; GO:1902966; GO:1903141; GO:1903392; GO:1903572; GO:1903589; GO:1903672; GO:1905278; GO:1905604; GO:2000048; GO:2000573 CECRPKK 8.920000076 1 1 6.88E-13 977.4326054 13.984 14.02255 14.79265 12.73269 11.48849 8.977355 0 15.7995 7.88237 15.47023 14.18085 15.7798 0 0 0 0 0 0 15.50954 0 0 14.71471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15822 ZEP1_HUMAN "Zinc finger protein 40 (Cirhin interaction protein, CIRIP) (Gate keeper of apoptosis-activating protein, GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1, HIV-EP1) (Major histocompatibility complex-binding protein 1, MBP-1) (Positive regulatory domain II-binding factor 1, PRDII-BF1)" HIVEP1 ZNF40 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0016604; GO:0030509; GO:0045944; GO:0046872; GO:1990837 GPLVR 9.090000153 1 1 0.086287968 543.4449006 15.35148 0 0 0 0 14.06765 13.90918 0 0 12.20738 13.59472 0 15.72367 0 0 16.18967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15848 ARSB_HUMAN "Arylsulfatase B, ASB, EC 3.1.6.12 (N-acetylgalactosamine-4-sulfatase, G4S)" ARSB Homo sapiens (Human) autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943] GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 ATGVWGPWM 8.880000114 1 1 0.09976728 1003.520433 0 0 0 0 13.86872 15.32968 0 0 0 17.9988 0 0 17.21329 15.33686 14.14537 14.59101 0 0 0 0 0 0 0 15.65541 15.48353 12.76367 0 0 0 0 0 0 0 0 0 12.41613 0 0 15.61114 0 0 16.4245 0 0 16.09735 0 0 0 P15863 PAX1_HUMAN Paired box protein Pax-1 (HuP48) PAX1 HUP48 Homo sapiens (Human) anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0048856; GO:1990837 VSWEGAAAAAAGPGAGGSALR 4.659999847 1 1 1.37E-12 1831.251143 11.14623 14.7937 13.91632 0 0 0 15.63934 15.70772 0 0 0 0 0 0 0 14.30272 0 15.5 0 0 0 0 0 10.57163 0 0 14.80181 0 17.62069 15.48992 15.61528 15.42216 0 13.41363 13.84973 16.31514 0 15.80939 0 0 15.94409 0 0 0 0 0 0 0 P15882 CHIN_HUMAN "N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin, NC) (Rho GTPase-activating protein 2)" CHN1 ARHGAP2 CHN Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; positive regulation of GTPase activity [GO:0043547]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; positive regulation of GTPase activity [GO:0043547]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005829; GO:0008045; GO:0043087; GO:0043547; GO:0046872; GO:0046875; GO:0048013; GO:0050770; GO:0051056 LTSLVRR 2.079999924 0.453846276 0.453846276 0.156074019 844.1879879 14.71621 15.19019 14.94928 0 0 0 0 0 15.5293 0 0 0 16.71324 15.71127 0 0 0 0 0 0 17.10112 0 0 0 16.51146 0 15.81645 0 0 0 0 0 0 15.56847 12.9827 0 0 14.70285 0 14.965 15.59299 0 0 14.93611 15.32523 14.1168 13.70387 15.47932 P15918 RAG1_HUMAN "V(D)J recombination-activating protein 1, RAG-1 (RING finger protein 74) [Includes: Endonuclease RAG1, EC 3.1.-.-; E3 ubiquitin-protein ligase RAG1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RAG1) ]" RAG1 RNF74 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542] DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542] DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0002250; GO:0002331; GO:0003677; GO:0004519; GO:0004842; GO:0005634; GO:0005654; GO:0006310; GO:0006325; GO:0006955; GO:0008270; GO:0008542; GO:0010390; GO:0030183; GO:0033077; GO:0033151; GO:0042393; GO:0042803; GO:0043029; GO:0043154; GO:0043565; GO:0045582; GO:0046872; GO:0048538; GO:0051865; GO:0061630; GO:0070244; GO:0097519; GO:1905347; GO:2000822 AFADKEEGGDVK 8.670000076 0.297007918 0.297007918 2.74E-12 1265.279272 12.63001 0 0 0 0 0 0 13.59039 15.23119 13.34428 0 0 0 0 0 15.53465 0 0 13.1353 14.20733 0 0 11.76884 0 0 14.48346 0 0 12.47758 15.10697 0 0 14.17507 14.84296 0 0 0 0 14.02388 8.49655 0 12.75364 13.14605 0 0 0 0 0 P15924 DESP_HUMAN "Desmoplakin, DP (250/210 kDa paraneoplastic pemphigus antigen)" DSP Homo sapiens (Human) adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060] basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; ficolin-1-rich granule membrane [GO:0101003]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; ficolin-1-rich granule membrane [GO:0101003]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060] cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] GO:0001533; GO:0002934; GO:0003223; GO:0003723; GO:0005080; GO:0005198; GO:0005200; GO:0005634; GO:0005737; GO:0005882; GO:0005886; GO:0005916; GO:0008544; GO:0014704; GO:0016020; GO:0016323; GO:0018149; GO:0030057; GO:0030216; GO:0034332; GO:0042060; GO:0043588; GO:0045104; GO:0045109; GO:0070062; GO:0086073; GO:0086083; GO:0086091; GO:0090136; GO:0097110; GO:0098609; GO:0098911; GO:0101003; GO:0150105 EDDSKNLR 5.079999924 0.284780771 0.284780771 0.247028315 976.3109716 14.92463 14.55288 0 18.85769 11.14079 15.58499 15.15109 0 17.04773 16.60365 9.780122 14.62633 16.19275 0 0 15.51148 0 16.05028 0 0 15.21854 0 16.22834 16.64079 16.09124 0 16.86503 0 0 18.33374 0 12.52546 0 16.40579 0 0 0 0 0 0 19.05638 13.87966 0 0 13.76253 0 15.80614 17.04364 P15976 GATA1_HUMAN "Erythroid transcription factor (Eryf1) (GATA-binding factor 1, GATA-1, GF-1) (NF-E1 DNA-binding protein)" GATA1 ERYF1 GF1 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; embryonic hemopoiesis [GO:0035162]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of primitive erythrocyte differentiation [GO:0010725]; Sertoli cell development [GO:0060009]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; animal organ regeneration [GO:0031100]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; embryonic hemopoiesis [GO:0035162]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of primitive erythrocyte differentiation [GO:0010725]; Sertoli cell development [GO:0060009]" "C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001701; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0007204; GO:0007267; GO:0008270; GO:0008285; GO:0008584; GO:0010559; GO:0010724; GO:0010725; GO:0017053; GO:0030218; GO:0030219; GO:0030220; GO:0030221; GO:0030222; GO:0030502; GO:0031100; GO:0031490; GO:0032993; GO:0033690; GO:0035162; GO:0035854; GO:0043066; GO:0043306; GO:0043565; GO:0045165; GO:0045648; GO:0045893; GO:0045944; GO:0048821; GO:0048873; GO:0050731; GO:0060009; GO:0061629; GO:0070527; GO:0070742; GO:0071222; GO:0071320; GO:0071372; GO:0097028; GO:0097067; GO:1990837; GO:2000678; GO:2001240 LHQVNRPLTMRK 13.94999981 1 1 0.509681502 1508.762528 0 20.39921 0 18.21398 19.07066 16.85939 0 0 0 16.67211 18.43862 0 0 0 0 20.27287 0 0 17.36158 0 17.07206 18.50924 19.16523 0 19.06165 19.08005 18.16147 0 0 0 19.98598 0 19.36139 20.60911 0 0 19.04477 21.15723 19.79757 0 0 0 19.78264 20.19123 0 0 19.64235 0 P16070 CD44_HUMAN "CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III, ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1, PGP-1) (Phagocytic glycoprotein I, PGP-I) (CD antigen CD44)" CD44 LHR MDU2 MDU3 MIC4 Homo sapiens (Human) "cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]" apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]" collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005518; GO:0005540; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0005902; GO:0005925; GO:0006954; GO:0007155; GO:0007160; GO:0009986; GO:0016323; GO:0016324; GO:0016477; GO:0019221; GO:0030214; GO:0030667; GO:0031258; GO:0033138; GO:0034116; GO:0035692; GO:0042110; GO:0042995; GO:0043066; GO:0043154; GO:0043518; GO:0044319; GO:0044344; GO:0050731; GO:0051216; GO:0070062; GO:0070374; GO:0070487; GO:0098609; GO:1900625; GO:1902166; GO:2000392 GHQAGRR 3.930000067 1 1 0.104433189 781.0861453 17.07309 0 0 0 0 0 0 0 15.71623 13.64817 0 14.68261 0 0 0 0 0 0 0 0 0 0 0 0 15.07003 0 15.98192 16.36374 0 0 0 0 0 0 17.39378 0 15.86637 0 0 0 0 0 0 0 0 0 0 15.32774 P16104 H2AX_HUMAN "Histone H2AX, H2a/x (Histone H2A.X)" H2AX H2AFX Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; cerebral cortex development [GO:0021987]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleosome assembly [GO:0006334]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; XY body [GO:0001741] centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; XY body [GO:0001741]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; cerebral cortex development [GO:0021987]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleosome assembly [GO:0006334]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982] GO:0000077; GO:0000724; GO:0000786; GO:0000794; GO:0001673; GO:0001741; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005813; GO:0006302; GO:0006334; GO:0006974; GO:0007283; GO:0010212; GO:0016607; GO:0019899; GO:0021987; GO:0035861; GO:0042393; GO:0045739; GO:0046982; GO:0051321; GO:0070062; GO:0071480; GO:0090398; GO:0090734 TGGKAR 5.239999771 1 1 2.34E-13 588.3318245 15.30542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.65662 0 0 0 0 0 0 0 15.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16112 PGCA_HUMAN "Aggrecan core protein (Cartilage-specific proteoglycan core protein, CSPCP) (Chondroitin sulfate proteoglycan core protein 1, Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2 ]" ACAN AGC1 CSPG1 MSK16 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872] GO:0001501; GO:0005201; GO:0005540; GO:0005576; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0043202; GO:0046872; GO:0062023 HMPTIR 5.039999962 0.86012578 0.86012578 0.077635943 753.6436928 0 0 14.31046 15.56879 0 0 0 0 0 15.92118 0 0 0 0 12.67881 0 0 0 0 0 0 0 16.64122 0 0 0 13.64476 0 0 0 0 0 0 0 0 0 0 0 0 14.72611 0 0 0 0 0 0 11.17219 0 P16144 ITB4_HUMAN Integrin beta-4 (GP150) (CD antigen CD104) ITGB4 Homo sapiens (Human) autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450] G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178] GO:0001664; GO:0005178; GO:0005604; GO:0005730; GO:0005886; GO:0005925; GO:0006914; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009611; GO:0009925; GO:0009986; GO:0016477; GO:0030054; GO:0030056; GO:0031252; GO:0031581; GO:0031965; GO:0032290; GO:0033627; GO:0035878; GO:0043235; GO:0043589; GO:0046847; GO:0048333; GO:0048870; GO:0061450; GO:0070062 GRTCEECNFK 11.43000031 1 1 0.061291665 1299.515541 0 0 14.04369 12.93812 13.08401 14.86662 10.92796 13.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.11685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16219 ACADS_HUMAN "Short-chain specific acyl-CoA dehydrogenase, mitochondrial, SCAD, EC 1.3.8.1 (Butyryl-CoA dehydrogenase)" ACADS Homo sapiens (Human) butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660] GO:0003995; GO:0004085; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005813; GO:0006635; GO:0033539; GO:0046359; GO:0050660 DSILGEPGMGFKIAMQTLDMGR 6.730000019 1 1 0.289871679 2397.765969 10.03615 17.01389 15.94276 0 0 13.63868 0 0 0 0 0 0 0 0 0 0 0 0 0 17.19669 0 17.11286 0 0 0 0 14.6814 0 0 0 0 0 0 16.19895 0 16.35322 17.58188 17.40964 0 0 0 16.76763 0 19.69076 0 18.59716 0 0 P16233 LIPP_HUMAN "Pancreatic triacylglycerol lipase, PL, PTL, Pancreatic lipase, EC 3.1.1.3" PNLIP Homo sapiens (Human) intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365] extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]" "all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]" GO:0004806; GO:0005576; GO:0005615; GO:0006629; GO:0016042; GO:0016298; GO:0030299; GO:0046872; GO:0047376; GO:0061365 FIWYNNVINPTLPRVGASK 3.940000057 1 1 0.002796517 2189.263808 0 0 0 0 10.32672 14.49562 0 14.26673 13.1307 0 14.82579 16.25221 14.42795 14.3122 16.00526 15.10184 0 0 16.16781 0 0 0 16.19172 0 15.78032 16.2986 0 0 16.36696 0 0 0 0 0 0 0 15.93694 0 0 0 0 0 0 0 0 0 15.21045 0 P16234 PGFRA_HUMAN "Platelet-derived growth factor receptor alpha, PDGF-R-alpha, PDGFR-alpha, EC 2.7.10.1 (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2, PDGFR-2) (CD antigen CD140a)" PDGFRA PDGFR2 RHEPDGFRA Homo sapiens (Human) adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021] GO:0001553; GO:0001701; GO:0001775; GO:0002244; GO:0004672; GO:0004712; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0009897; GO:0010544; GO:0010863; GO:0014068; GO:0016020; GO:0018108; GO:0019838; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030539; GO:0031226; GO:0032991; GO:0033327; GO:0033674; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043552; GO:0044877; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048704; GO:0050872; GO:0050920; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0061298; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000249; GO:2000739 SQPVMKVAVK 4.690000057 1 1 0.392138321 1102.101043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16298 PP2BB_HUMAN "Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, EC 3.1.3.16 (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform, CNA beta)" PPP3CB CALNA2 CALNB CNA2 Homo sapiens (Human) "axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]" calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018] "calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]" calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722] GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007507; GO:0007612; GO:0007613; GO:0008287; GO:0016311; GO:0017156; GO:0019899; GO:0023057; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035774; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0048741; GO:0050796; GO:0070886; GO:0097720; GO:0098978; GO:1900242; GO:1901386; GO:1901387; GO:1905665; GO:1905949 EKTMIEVEAPITVCGDIHGQFFDLMK 9.390000343 1 1 3.21E-12 3023.928362 0 11.95848 8.395365 0 0 0 0 13.4402 14.70389 13.064 14.4515 0 13.67146 0 13.36747 0 0 10.55255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16333 NCK1_HUMAN "Cytoplasmic protein NCK1 (NCK adaptor protein 1, Nck-1) (SH2/SH3 adaptor protein NCK-alpha)" NCK1 NCK Homo sapiens (Human) "actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]" cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506] "cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]" cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159] GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007165; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0051707; GO:0060548; GO:0070262; GO:0071074; GO:1902237; GO:1903676; GO:1903679; GO:1903898; GO:1903912; GO:1990441 INGMVGLVPK 5.489999771 0.295540839 0.295540839 0.218748338 1040.336322 15.89307 0 14.36255 14.50646 14.44487 14.79122 15.99092 0 12.5208 14.72217 13.79245 0 15.29052 15.28048 15.58806 0 0 9.915851 15.21427 0 15.0302 0 0 0 14.49058 0 15.15793 14.61765 11.00121 15.47578 13.46935 13.4323 0 15.29383 14.02797 14.52394 14.5812 14.03617 14.73775 0 0 16.28871 13.96566 12.35346 0 0 14.59017 6.682618 P16383 GCFC2_HUMAN "Intron Large complex component GCFC2 (GC-rich sequence DNA-binding factor) (GC-rich sequence DNA-binding factor 2) (Transcription factor 9, TCF-9)" GCFC2 C2orf3 GCF TCF9 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type post-mRNA release spliceosomal complex [GO:0071008] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; DNA binding [GO:0003677]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]" DNA binding [GO:0003677] GO:0000245; GO:0000398; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0045892; GO:0071008 ALNQAESFIGEHHLDHLKSLIK 3.589999914 1 1 0.033925888 2499.856349 0 0 0 0 0 0 12.57595 0 0 0 0 0 0 18.2803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16435 NCPR_HUMAN "NADPH--cytochrome P450 reductase, CPR, P450R, EC 1.6.2.4" POR CYPOR Homo sapiens (Human) carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; electron transport chain [GO:0022900]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to dexamethasone [GO:0071548]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; electron transport chain [GO:0022900]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to dexamethasone [GO:0071548]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]" "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]" GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0022900; GO:0032332; GO:0032770; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0071548; GO:0090031; GO:0090346 LMTKGR 5.630000114 1 1 0 720.824981 0 8.526248 15.74719 0 0 0 0 0 0 0 0 0 0 0 0 0 16.11996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16442 BGAT_HUMAN "Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase, EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase, EC 2.4.1.37) (Histo-blood group A transferase, A transferase) (Histo-blood group B transferase, B transferase) (NAGAT) [Cleaved into: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form ]" ABO Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; antigen binding [GO:0003823]; fucosylgalactoside 3-alpha-galactosyltransferase activity [GO:0004381]; glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [GO:0004380]; glycosyltransferase activity [GO:0016757]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486] antigen binding [GO:0003823]; fucosylgalactoside 3-alpha-galactosyltransferase activity [GO:0004381]; glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [GO:0004380]; glycosyltransferase activity [GO:0016757]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166] GO:0000139; GO:0000166; GO:0003823; GO:0004380; GO:0004381; GO:0005576; GO:0005794; GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0030145; GO:0030259; GO:0031982; GO:0032580 FLSEVDYLVCVDVDMEFR 1.070000052 1 1 0.218919687 2251.510755 13.49286 14.90195 0 17.3778 11.4203 0 0 0 11.10445 13.35407 15.83303 0 0 8.022273 14.91194 13.77026 0 0 16.87082 0 14.2783 0 0 0 0 11.56125 12.67125 13.98487 0 0 0 0 0 0 0 0 0 16.12988 0 0 0 0 0 0 0 0 0 0 P16444 DPEP1_HUMAN "Dipeptidase 1, EC 3.4.13.19 (Beta-lactamase, EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase, hRDP)" DPEP1 MDP RDP Homo sapiens (Human) antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154] anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154] beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270] GO:0005615; GO:0005654; GO:0005886; GO:0006629; GO:0006749; GO:0006751; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071466; GO:0071732; GO:0072340; GO:0072341 AGFVGGQFWSVYTPCDTQNK 5.980000019 1 1 0.490761336 2262.39535 18.59659 0 0 16.89558 18.92202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16452 EPB42_HUMAN "Protein 4.2, P4.2 (Erythrocyte membrane protein band 4.2, Erythrocyte protein 4.2)" EPB42 E42P Homo sapiens (Human) cell morphogenesis [GO:0000902]; erythrocyte maturation [GO:0043249]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]; peptide cross-linking [GO:0018149]; regulation of cell shape [GO:0008360]; spleen development [GO:0048536] cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; erythrocyte maturation [GO:0043249]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]; peptide cross-linking [GO:0018149]; regulation of cell shape [GO:0008360]; spleen development [GO:0048536] ATP binding [GO:0005524]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural constituent of cytoskeleton [GO:0005200] GO:0000902; GO:0003810; GO:0005200; GO:0005524; GO:0005856; GO:0005886; GO:0008360; GO:0018149; GO:0020027; GO:0030863; GO:0043249; GO:0048536; GO:0055072 SVWPENTMCAKFQFTPTHVGLQR 6.409999847 1 1 0 2749.668013 0 0 14.24603 15.56353 11.86075 13.75518 12.95404 0 12.14522 0 12.57907 0 0 11.68136 0 0 0 0 0 0 0 0 0 0 15.42903 0 15.56014 15.26492 0 14.54626 0 0 0 0 0 0 0 0 0 0 16.67836 0 14.28776 14.79651 13.37609 0 15.62694 15.73612 P16455 MGMT_HUMAN "Methylated-DNA--protein-cysteine methyltransferase, EC 2.1.1.63 (6-O-methylguanine-DNA methyltransferase, MGMT) (O-6-methylguanine-DNA-alkyltransferase)" MGMT Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168]; cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168] GO:0003677; GO:0003908; GO:0005509; GO:0005634; GO:0005654; GO:0006266; GO:0006281; GO:0006307; GO:0008168; GO:0009008; GO:0009410; GO:0009636; GO:0016020; GO:0034599; GO:0043066; GO:0043281; GO:0045471; GO:0051593; GO:0060644; GO:0071407; GO:0071479; GO:2000781 DCEMKR 3.210000038 1 1 0.117620499 853.7241468 0 16.01556 0 0 15.31728 0 14.90828 15.8949 0 0 0 0 0 0 0 12.52921 0 0 0 0 15.28626 16.12838 0 0 0 0 0 0 0 15.14819 17.75624 0 0 0 0 0 0 0 0 0 0 0 0 0 14.62194 0 12.74606 15.38335 P16471 PRLR_HUMAN "Prolactin receptor, PRL-R" PRLR Homo sapiens (Human) activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694] cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901]; activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694] ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901] GO:0004896; GO:0004923; GO:0004925; GO:0005127; GO:0005576; GO:0005886; GO:0006694; GO:0007171; GO:0007259; GO:0007566; GO:0007595; GO:0008284; GO:0009617; GO:0009897; GO:0009986; GO:0016021; GO:0017046; GO:0019221; GO:0019901; GO:0019955; GO:0030155; GO:0030856; GO:0031904; GO:0038165; GO:0042976; GO:0043066; GO:0043235; GO:0046872; GO:0060644; GO:0060736; GO:0060749; GO:0120162 ENSGKPK 11.68000031 1 1 0.160686016 759.7712906 16.1313 16.12919 15.86091 13.49117 14.39664 15.82394 0 0 0 15.15292 0 15.2654 13.30645 15.95197 16.38154 0 14.59861 0 0 14.12878 0 15.8324 15.45836 15.86463 0 0 0 0 0 0 0 0 0 13.7498 0 15.39332 15.66349 15.52633 0 15.30067 15.48497 16.35947 0 15.06955 16.75321 11.57808 13.79711 0 P16499 PDE6A_HUMAN "Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha, GMP-PDE alpha, EC 3.1.4.35 (PDE V-B1)" PDE6A PDEA Homo sapiens (Human) retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601] photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]" "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0042622; GO:0046872; GO:0047555; GO:0060041; GO:0097381 IVDQSK 1.950000048 1 1 0.172673068 690.6323914 15.97551 14.67525 9.554473 14.04964 12.41552 11.63343 0 0 0 0 15.14693 0 14.65774 16.01002 0 0 16.27758 0 0 0 0 0 0 14.12187 0 0 0 0 0 0 16.93493 0 16.59837 0 15.98311 0 0 15.13435 0 0 0 0 0 0 0 0 0 0 P16519 NEC2_HUMAN "Neuroendocrine convertase 2, NEC 2, EC 3.4.21.94 (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2, PC2)" PCSK2 NEC2 Homo sapiens (Human) enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508] dendrite [GO:0030425]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] dendrite [GO:0030425]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508] serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005615; GO:0005654; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0030425; GO:0034230; GO:0034231; GO:0043005; GO:0043204; GO:0043231 DMQHLTVLTSKR 6.710000038 1 1 0.050826717 1428.778184 0 15.3764 0 0 0 0 0 10.2512 14.44438 0 14.81231 0 15.99723 0 0 0 13.99435 13.38774 0 0 15.50515 0 12.89402 0 15.11857 13.75286 13.72448 0 0 0 0 10.98601 0 0 11.32733 14.07527 0 0 0 14.13756 16.55455 0 0 0 0 0 0 0 P16591 FER_HUMAN "Tyrosine-protein kinase Fer, EC 2.7.10.2 (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer)" FER TYK3 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634] cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; gamma-catenin binding [GO:0045295]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] actin binding [GO:0003779]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; gamma-catenin binding [GO:0045295]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] GO:0000226; GO:0001932; GO:0003779; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0007169; GO:0007260; GO:0008157; GO:0008283; GO:0008284; GO:0008289; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0019901; GO:0030054; GO:0030154; GO:0030335; GO:0030838; GO:0031234; GO:0031267; GO:0031532; GO:0032496; GO:0032869; GO:0033007; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038028; GO:0038095; GO:0038109; GO:0042058; GO:0042995; GO:0043304; GO:0044331; GO:0045087; GO:0045295; GO:0045296; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0070102 EMNSAK 9.880000114 0.886090398 0.886090398 0.305010942 697.9529863 16.99186 0 0 15.81484 16.55579 0 15.42214 15.61544 16.31988 0 0 15.89607 0 15.84924 15.71736 0 16.05674 0 0 17.96214 18.46926 0 0 16.61459 0 14.99975 0 16.92145 0 0 17.33621 16.54197 16.6176 17.48084 17.72688 0 16.58422 16.96882 17.37411 11.59164 16.16574 16.46317 17.55727 15.46691 16.2639 17.14954 16.282 17.19121 P16885 PLCG2_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV, PLC-IV) (Phospholipase C-gamma-2, PLC-gamma-2)" PLCG2 Homo sapiens (Human) "activation of store-operated calcium channel activity [GO:0032237]; antifungal innate immune response [GO:0061760]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; activation of store-operated calcium channel activity [GO:0032237]; antifungal innate immune response [GO:0061760]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]" phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110] GO:0001775; GO:0001784; GO:0001878; GO:0002092; GO:0002223; GO:0002224; GO:0002281; GO:0002316; GO:0002732; GO:0004435; GO:0004629; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0009395; GO:0010628; GO:0010634; GO:0016055; GO:0019216; GO:0019722; GO:0019901; GO:0030168; GO:0030183; GO:0031663; GO:0032237; GO:0032481; GO:0032587; GO:0032733; GO:0032735; GO:0032743; GO:0032747; GO:0032755; GO:0032760; GO:0032959; GO:0035556; GO:0038095; GO:0043069; GO:0043122; GO:0043410; GO:0048471; GO:0048678; GO:0050731; GO:0050850; GO:0050852; GO:0050853; GO:0051091; GO:0051092; GO:0051209; GO:0060100; GO:0060907; GO:0061760; GO:0070062; GO:0070884; GO:0071277; GO:0071396; GO:0097110; GO:0097708; GO:0140031; GO:0150078; GO:1900227; GO:1902808; GO:1903428; GO:1903721; GO:1990782; GO:1990858 NSISLR 12.44999981 0.550050318 0.550050318 0.289535971 686.8929439 0 16.36123 15.41597 14.30648 0 0 0 15.10595 14.90656 16.32937 0 0 0 0 16.33939 16.85816 15.423 15.09912 0 0 17.0617 16.30956 16.75328 0 0 16.39758 16.16902 14.97669 15.72989 0 16.23092 15.81328 15.48423 14.47014 0 0 0 15.54501 16.43177 0 16.12568 17.2493 16.64133 17.21371 15.98292 0 15.98445 16.30148 P17010 ZFX_HUMAN Zinc finger X-chromosomal protein ZFX Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0001228; GO:0005654; GO:0005694; GO:0005730; GO:0006357; GO:0043035; GO:0045944; GO:0046872 KHVAAHK 10.93999958 0.281579852 0.281579852 0.197371567 789.1456545 11.75965 0 14.80729 15.20329 0 0 13.43464 0 17.34838 16.52339 0 0 0 0 0 0 0 0 0 16.00495 0 15.65908 0 0 0 18.17398 15.80415 17.20177 0 17.08218 0 16.01614 16.63461 0 18.35543 14.80413 15.3717 15.88052 0 17.37988 0 0 15.97629 0 0 19.6466 15.41172 16.28973 P17014 ZNF12_HUMAN "Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3, GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)" ZNF12 GIOT3 KOX3 ZNF325 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837 SLGPVSFK 8.890000343 1 1 0.216841983 834.7139708 0 0 0 10.53661 5.787189 11.97547 15.23836 15.68353 12.79804 0 17.10456 12.87322 12.86849 10.94903 15.71306 15.17446 0 14.82649 15.18653 14.6916 16.52529 0 0 15.36748 0 16.45232 17.10422 13.82963 0 0 18.37379 15.76148 0 13.77911 14.82398 14.68529 17.46611 16.89878 16.22079 15.33835 16.89477 18.72282 0 15.84179 15.23289 16.69541 0 15.47566 P17019 ZN708_HUMAN Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8) ZNF708 KOX8 ZNF15 ZNF15L1 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 GLNRCVTTTQSK 8.600000381 1 1 0.318037506 1365.549024 13.63799 14.04388 13.39613 11.75388 14.50489 0 13.24183 0 0 0 13.04806 14.41149 16.83947 12.29711 14.47179 14.61383 0 0 0 16.35815 16.09834 0 0 16.6098 17.14958 0 0 0 0 0 16.31581 0 0 0 15.94435 0 15.42138 0 17.16676 0 0 15.90924 16.05555 0 0 18.52967 0 0 P17022 ZNF18_HUMAN Zinc finger protein 18 (Heart development-specific gene 1 protein) (Zinc finger protein 535) (Zinc finger protein KOX11) (Zinc finger protein with KRAB and SCAN domains 6) ZNF18 HDSG1 KOX11 ZKSCAN6 ZNF535 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 QENDKENLNLENHR 6.769999981 1 1 2.29E-13 1752.832689 0 13.81193 0 10.8859 0 14.34414 0 14.40156 0 0 0 0 0 0 0 12.86572 0 15.65805 0 13.34554 14.50111 0 0 0 0 15.36995 11.07686 0 14.90263 0 13.82882 14.76725 14.01752 15.34269 0 0 0 0 0 14.00986 0 0 0 0 0 0 0 0 P17035 ZNF28_HUMAN Zinc finger protein 28 (Zinc finger protein KOX24) ZNF28 KOX24 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 CKSHLER 11.38000011 1 1 0.218365094 929.8775413 13.93261 13.7005 14.3946 14.48263 0 14.04167 0 0 14.46186 0 0 13.74226 14.98467 13.6064 16.45869 0 0 0 0 16.80256 0 0 15.7962 0 0 0 0 13.26697 13.92145 0 0 0 13.54205 0 0 0 0 0 0 0 0 0 0 0 0 16.28132 15.69085 0 P17040 ZSC20_HUMAN Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29) ZSCAN20 KOX29 ZNF31 ZNF360 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AMGTVR 6.099999905 0.542093396 0.542093396 0.150557629 631.6728619 18.53654 0 0 0 0 0 14.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.40122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1801 0 0 0 0 0 0 16.80658 0 0 0 0 P17096 HMGA1_HUMAN "High mobility group protein HMG-I/HMG-Y, HMG-I(Y) (High mobility group AT-hook protein 1, High mobility group protein A1) (High mobility group protein R)" HMGA1 HMGIY Homo sapiens (Human) "base-excision repair [GO:0006284]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; oncogene-induced cell senescence [GO:0090402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; transcription regulator complex [GO:0005667]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]; base-excision repair [GO:0006284]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; oncogene-induced cell senescence [GO:0090402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221] GO:0000978; GO:0000987; GO:0001221; GO:0003677; GO:0003680; GO:0003682; GO:0003712; GO:0003713; GO:0003906; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005925; GO:0006268; GO:0006284; GO:0006337; GO:0006355; GO:0008285; GO:0019899; GO:0030374; GO:0030527; GO:0035985; GO:0042974; GO:0042975; GO:0045892; GO:0045893; GO:0045944; GO:0046965; GO:0051575; GO:0090402; GO:0090575 KTTTTPGR 10.03999996 1 1 0.207928222 862.761103 16.27711 14.43744 13.12259 13.82967 15.04512 0 15.01604 15.56352 15.54893 0 0 0 13.85407 13.91832 14.47498 16.29611 15.57355 12.75936 16.03039 9.09822 16.52024 15.44415 17.70754 13.56571 0 15.27547 0 0 0 0 15.354 16.54185 0 0 0 16.28087 9.65832 0 0 0 0 0 0 0 0 15.07353 15.70598 0 P17098 ZNF8_HUMAN Zinc finger protein 8 (Zinc finger protein HF.18) ZNF8 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0030509 EQNNLKQLEFGLK 24.5 0.001511431 0.001511431 0.310687539 1560.914602 18.01134 20.21765 21.21584 18.62426 18.25113 20.019 19.21766 0 15.74523 14.53786 16.06715 20.2804 19.10798 18.93338 0 0 19.08444 21.08417 19.8824 19.25642 18.19532 0 0 18.09592 20.41854 21.10638 19.76959 18.38497 20.12361 0 0 0 21.18427 19.94908 20.77322 19.62466 20.51931 21.00008 19.79175 18.23304 0 0 19.56126 19.10603 18.681 0 19.46616 0 P17174 AATC_HUMAN "Aspartate aminotransferase, cytoplasmic, cAspAT, EC 2.6.1.1, EC 2.6.1.3 (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic, cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)" GOT1 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384] L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170] GO:0004069; GO:0004609; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0019550; GO:0019551; GO:0030170; GO:0032869; GO:0047801; GO:0051384; GO:0055089; GO:0070062 QIASVMK 3.49000001 0.737790704 0.737790704 0.044711095 779.3555125 16.55764 14.71046 0 14.49602 12.75173 0 0 0 0 12.69591 0 15.24192 15.5544 0 14.29106 15.08557 14.94354 0 0 0 0 0 0 16.42782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.11529 0 0 0 0 P17181 INAR1_HUMAN "Interferon alpha/beta receptor 1, IFN-R-1, IFN-alpha/beta receptor 1 (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1, CRF2-1) (Type I interferon receptor 1)" IFNAR1 IFNAR Homo sapiens (Human) cellular response to interferon-alpha [GO:0035457]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]; cellular response to interferon-alpha [GO:0035457]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905] GO:0004896; GO:0004905; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0007259; GO:0009615; GO:0019221; GO:0019962; GO:0032496; GO:0035457; GO:0060337; GO:0098586; GO:1901857 TSEELQQDFV 5.050000191 1 1 0.130466389 1195.771366 0 0 0 0 0 0 0 15.20551 12.6974 0 10.81315 0 0 0 0 0 0 0 14.8976 15.49362 0 15.61222 0 0 0 14.33555 14.64224 13.61491 15.93832 14.43832 11.52684 13.85432 0 13.33028 15.78292 14.76981 15.12769 13.81656 0 15.60928 13.75106 13.56518 12.76044 14.8057 14.1552 0 9.064601 0 P17252 KPCA_HUMAN "Protein kinase C alpha type, PKC-A, PKC-alpha, EC 2.7.11.13" PRKCA PKCA PRKACA Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555] alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555] ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270] GO:0001525; GO:0001938; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007077; GO:0007155; GO:0008270; GO:0010595; GO:0010613; GO:0018105; GO:0018107; GO:0019899; GO:0030335; GO:0031666; GO:0031966; GO:0034351; GO:0035403; GO:0035408; GO:0035556; GO:0035866; GO:0043488; GO:0043536; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045931; GO:0048471; GO:0070062; GO:0070374; GO:0070555; GO:0090330; GO:0097190; GO:0106071; GO:0106310; GO:2000707 MPASGWYK 3.400000095 1 1 0.188561105 938.9541231 16.18718 14.93344 14.25759 14.18493 0 0 0 14.63696 0 0 0 0 14.14347 14.68968 0 15.64435 0 0 15.50553 0 15.82538 0 0 0 0 0 0 0 0 0 0 0 0 16.57071 0 15.49161 0 0 0 0 11.35415 0 0 0 0 0 0 0 P17301 ITA2_HUMAN "Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia, GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)" ITGA2 CD49B Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen binding [GO:0033343]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]" axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen binding [GO:0033343]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]" amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618] GO:0001540; GO:0001618; GO:0001666; GO:0002687; GO:0005178; GO:0005518; GO:0005634; GO:0005886; GO:0005925; GO:0006929; GO:0006971; GO:0007155; GO:0007160; GO:0007229; GO:0007565; GO:0007596; GO:0008283; GO:0008305; GO:0009410; GO:0009887; GO:0009897; GO:0009986; GO:0010634; GO:0010694; GO:0014075; GO:0014850; GO:0014911; GO:0030879; GO:0031346; GO:0031589; GO:0032967; GO:0033343; GO:0033591; GO:0033627; GO:0034666; GO:0038064; GO:0038065; GO:0043236; GO:0043388; GO:0043395; GO:0043589; GO:0043679; GO:0044877; GO:0045178; GO:0045184; GO:0045727; GO:0045785; GO:0045987; GO:0046872; GO:0048041; GO:0048333; GO:0048471; GO:0048661; GO:0050729; GO:0050927; GO:0050966; GO:0051971; GO:0060100; GO:0070365; GO:0071107; GO:0071260; GO:0071392; GO:0098609; GO:0098639 EKNPLMYLTGVQTDK 11.27000046 0.603987098 0.603987098 0.22556912 1752.499714 17.51977 13.99761 0 15.25365 0 0 12.95903 0 16.26269 0 0 0 13.94975 0 0 0 0 0 0 0 15.30023 0 0 0 0 13.9142 0 0 0 0 0 0 0 0 0 0 0 0 15.18343 0 0 0 0 0 13.80553 0 0 15.87246 P17342 ANPRC_HUMAN "Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C, ANP-C, ANPR-C, NPR-C)" NPR3 ANPRC C5orf23 NPRC Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]; vasodilation [GO:0042311] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]; vasodilation [GO:0042311] chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803] GO:0001501; GO:0002158; GO:0005887; GO:0007193; GO:0007194; GO:0007200; GO:0008217; GO:0008528; GO:0016941; GO:0017046; GO:0030157; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042311; GO:0042562; GO:0042803; GO:0048015; GO:0048662; GO:0051000; GO:0070062; GO:0120163 EALPPQKIEVLVLLPQDDSYLFSLTR 1.220000029 1 1 0.212539976 2985.735712 0 15.47985 14.97105 12.32946 13.26202 12.42759 12.71231 15.78624 0 0 14.68806 0 14.06409 0 0 0 14.21477 0 0 11.40648 13.05065 0 0 12.59272 0 0 0 0 13.93952 11.66061 0 0 0 12.60163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17480 UBF1_HUMAN "Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1, UBF-1)" UBTF UBF UBF1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361] chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110] GO:0001164; GO:0001165; GO:0001181; GO:0001650; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006360; GO:0006361; GO:0045943; GO:0097110 VLGEEK 10.86999989 1 1 0.261389241 675.3454318 19.43969 18.0969 18.74606 18.71921 17.41735 18.9893 0 19.00856 19.66338 19.93478 19.8021 19.44304 17.08724 17.75579 17.79099 0 18.86854 0 0 17.64302 17.61959 19.24495 18.09249 17.43596 0 18.66104 0 0 0 17.96167 19.04492 17.67555 0 18.29017 18.04154 0 0 0 20.58195 0 0 0 0 18.58683 17.17787 0 0 18.78921 P17483 HXB4_HUMAN Homeobox protein Hox-B4 (Homeobox protein Hox-2.6) (Homeobox protein Hox-2F) HOXB4 HOX2F Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; cell population proliferation [GO:0008283]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell differentiation [GO:0060218]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; spleen development [GO:0048536] centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; cell population proliferation [GO:0008283]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell differentiation [GO:0060218]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; spleen development [GO:0048536]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0002011; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0008283; GO:0009952; GO:0045944; GO:0048103; GO:0048536; GO:0048539; GO:0048704; GO:0060216; GO:0060218; GO:1990837; GO:2000738 AACTVQR 5.400000095 1 1 0.108602097 806.1205148 15.48638 0 14.7137 0 0 0 0 0 0 0 0 0 0 0 15.50264 15.12468 0 0 0 0 0 0 0 0 14.13683 14.71427 0 0 0 16.17878 0 0 0 0 0 0 0 0 15.26108 0 0 0 0 17.47823 0 0 0 0 P17540 KCRS_HUMAN "Creatine kinase S-type, mitochondrial, EC 2.7.3.2 (Basic-type mitochondrial creatine kinase, Mib-CK) (Sarcomeric mitochondrial creatine kinase, S-MtCK)" CKMT2 Homo sapiens (Human) muscle contraction [GO:0006936]; phosphocreatine biosynthetic process [GO:0046314] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; muscle contraction [GO:0006936]; phosphocreatine biosynthetic process [GO:0046314] ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301] GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0006936; GO:0016301; GO:0046314 VPPPLPQFGKK 5.130000114 1 1 0.401995225 1207.855607 0 0 15.14572 0 14.08985 15.75657 12.73028 15.07807 14.4141 13.93484 0 0 12.2734 13.99391 0 0 0 14.95781 0 0 16.65985 0 0 0 0 0 0 0 0 14.04779 16.20793 15.25144 0 0 16.28152 15.39493 0 16.86853 0 0 0 0 0 0 0 16.0597 16.5599 0 P17542 TAL1_HUMAN "T-cell acute lymphocytic leukemia protein 1, TAL-1 (Class A basic helix-loop-helix protein 17, bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5)" TAL1 BHLHA17 SCL TCL5 Homo sapiens (Human) "angiogenesis [GO:0001525]; astrocyte fate commitment [GO:0060018]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet formation [GO:0030220]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin assembly or disassembly [GO:0045799]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell differentiation [GO:0060375]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; astrocyte fate commitment [GO:0060018]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet formation [GO:0030220]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin assembly or disassembly [GO:0045799]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell differentiation [GO:0060375]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001525; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006366; GO:0007626; GO:0019899; GO:0021527; GO:0030097; GO:0030218; GO:0030219; GO:0030220; GO:0030221; GO:0030297; GO:0031334; GO:0035162; GO:0035855; GO:0042127; GO:0042826; GO:0043249; GO:0045165; GO:0045648; GO:0045799; GO:0045893; GO:0045931; GO:0045944; GO:0046983; GO:0051781; GO:0060018; GO:0060216; GO:0060217; GO:0060218; GO:0060375; GO:0061629; GO:0070888; GO:2000036 DAATAEAR 6.03000021 0.00024742 0.00024742 0.036968054 803.0364055 16.42911 16.29334 14.67971 13.92632 13.16481 0 0 16.96928 15.1169 0 12.87863 15.64514 16.78681 14.40982 0 13.74498 16.07041 12.5738 15.67983 0 15.81012 15.55798 15.39897 16.47451 17.38898 0 15.05716 15.46072 13.99496 16.28564 16.87426 18.0509 17.69488 17.46946 17.37236 0 17.88204 15.78074 0 11.75427 0 0 17.62223 0 15.15531 14.18795 11.54499 0 P17568 NDUB7_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18, CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit)" NDUFB7 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]" NADH dehydrogenase (ubiquinone) activity [GO:0008137] GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 DYVMRMK 13.18999958 0.480276525 0.480276525 0.057836655 974.1290505 0 0 12.16862 0 0 0 15.44974 15.67395 0 0 0 0 17.4714 0 0 0 0 0 0 0 0 0 16.11602 0 0 0 0 0 15.69514 0 0 10.37208 17.61639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17612 KAPCA_HUMAN "cAMP-dependent protein kinase catalytic subunit alpha, PKA C-alpha, EC 2.7.11.11" PRKACA PKACA Homo sapiens (Human) calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240] AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005952; GO:0006397; GO:0006468; GO:0010737; GO:0010881; GO:0016020; GO:0016241; GO:0016607; GO:0018105; GO:0018107; GO:0019221; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035584; GO:0036126; GO:0043197; GO:0043393; GO:0044853; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051480; GO:0051726; GO:0055117; GO:0060314; GO:0061136; GO:0070062; GO:0070417; GO:0070613; GO:0071333; GO:0071374; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0106310; GO:1901621; GO:1903779; GO:1990044; GO:2000810 NLLQVDLTK 2.930000067 0.05256249 0.05256249 0.24655334 1043.28227 0 15.56563 15.99614 0 16.56846 15.35573 0 14.55049 14.65085 16.22622 16.56962 15.85353 0 14.84804 0 14.10832 14.76854 14.5082 0 16.45241 16.63257 0 0 0 0 16.34251 0 0 15.35786 14.97519 0 0 16.35696 0 14.5877 15.92645 0 0 16.53304 16.05075 0 16.1464 14.8856 15.03253 0 16.15798 16.46272 0 P17643 TYRP1_HUMAN "5,6-dihydroxyindole-2-carboxylic acid oxidase, DHICA oxidase, EC 1.14.18.- (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1, TRP, TRP-1, TRP1)" TYRP1 CAS2 TYRP TYRRP Homo sapiens (Human) acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; positive regulation of melanin biosynthetic process [GO:0048023] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503]; acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; positive regulation of melanin biosynthetic process [GO:0048023] metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503] GO:0004503; GO:0005737; GO:0010008; GO:0016021; GO:0016491; GO:0030318; GO:0030669; GO:0032438; GO:0033162; GO:0042438; GO:0042470; GO:0042803; GO:0043438; GO:0046872; GO:0048023; GO:0097708 ALDMAK 4.710000038 1 1 0.055267728 663.4078687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.9334 19.02843 19.36766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17655 CAN2_HUMAN "Calpain-2 catalytic subunit, EC 3.4.22.53 (Calcium-activated neutral proteinase 2, CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain, M-calpain)" CAPN2 CANPL2 Homo sapiens (Human) behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666] calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877] GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009897; GO:0010666; GO:0016540; GO:0019899; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:0110158; GO:1901216; GO:1901741; GO:2001247 DGDFCIR 5.679999828 1 1 0.195987963 882.9340588 14.32673 16.04664 13.90605 14.3169 13.16158 0 15.10471 14.38643 17.08187 14.36914 15.20909 0 0 0 0 15.0937 0 0 0 15.91447 0 0 0 0 0 0 0 0 0 0 0 15.75679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17677 NEUM_HUMAN Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46) GAP43 Homo sapiens (Human) axon choice point recognition [GO:0016198]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; glial cell differentiation [GO:0010001]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786]; axon choice point recognition [GO:0016198]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; glial cell differentiation [GO:0010001]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246] calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786] GO:0001786; GO:0005516; GO:0005737; GO:0005886; GO:0007205; GO:0009611; GO:0010001; GO:0014069; GO:0016198; GO:0030425; GO:0031103; GO:0031527; GO:0032584; GO:0035727; GO:0040008; GO:0042246; GO:0043204; GO:0045165; GO:0051489; GO:0098982; GO:0099150; GO:1901981 AHKAATK 5.78000021 1 1 0.272204368 726.7918677 13.80101 15.27591 14.67129 12.31573 14.53529 15.64085 15.98985 0 14.31162 0 16.02539 16.42218 0 13.03659 0 14.24924 14.11714 14.05339 0 15.16312 14.92684 16.0413 14.57983 14.30599 16.66079 0 0 16.21708 14.7773 0 0 15.83436 16.26564 16.93443 16.00216 0 16.18719 16.59009 0 15.95072 15.28799 0 15.75127 0 15.80821 0 0 0 P17706 PTN2_HUMAN "Tyrosine-protein phosphatase non-receptor type 2, EC 3.1.3.48 (T-cell protein-tyrosine phosphatase, TCPTP)" PTPN2 PTPT Homo sapiens (Human) B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217] integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905] GO:0000122; GO:0004725; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587 CTGLSSK 5.789999962 0.879477262 0.879477262 0.181634252 752.5326218 17.19992 17.32751 16.85304 14.46123 14.66403 15.82677 0 0 0 0 0 0 0 16.56737 0 17.79099 16.51669 0 16.34865 16.23039 16.71276 14.85134 0 0 16.43151 16.06465 0 15.41367 16.43709 16.72465 15.47917 16.18735 15.74673 18.15624 15.3447 0 17.67831 17.20407 0 17.79204 15.7736 16.62674 16.12449 0 0 0 17.00513 16.71426 P17735 ATTY_HUMAN "Tyrosine aminotransferase, TAT, EC 2.6.1.5 (L-tyrosine:2-oxoglutarate aminotransferase)" TAT Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572] amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170] GO:0004838; GO:0005739; GO:0005829; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548 AIVDNMKVKPNPNK 4.449999809 1 1 0.306140167 1567.119918 0 15.93185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7272 0 0 0 0 0 0 0 0 0 0 18.69392 0 19.76253 0 0 0 0 0 0 0 0 17.8536 0 0 0 0 0 0 0 18.37204 P17813 EGLN_HUMAN Endoglin (CD antigen CD105) ENG END Homo sapiens (Human) "artery morphogenesis [GO:0048844]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular canal morphogenesis [GO:1905222]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; detection of hypoxia [GO:0070483]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; extracellular matrix constituent secretion [GO:0070278]; extracellular matrix disassembly [GO:0022617]; heart looping [GO:0001947]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of phosphorylation [GO:0042325]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to corticosteroid [GO:0031960]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" cell surface [GO:0009986]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell surface [GO:0009986]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; galactose binding [GO:0005534]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane signaling receptor activity [GO:0004888]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; artery morphogenesis [GO:0048844]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular canal morphogenesis [GO:1905222]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; detection of hypoxia [GO:0070483]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; extracellular matrix constituent secretion [GO:0070278]; extracellular matrix disassembly [GO:0022617]; heart looping [GO:0001947]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of phosphorylation [GO:0042325]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to corticosteroid [GO:0031960]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" activin binding [GO:0048185]; coreceptor activity [GO:0015026]; galactose binding [GO:0005534]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane signaling receptor activity [GO:0004888]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114] GO:0000122; GO:0001569; GO:0001570; GO:0001666; GO:0001837; GO:0001934; GO:0001937; GO:0001947; GO:0003084; GO:0003148; GO:0003198; GO:0003203; GO:0003208; GO:0003209; GO:0003222; GO:0003273; GO:0004888; GO:0005024; GO:0005114; GO:0005534; GO:0005539; GO:0005615; GO:0005886; GO:0005925; GO:0006355; GO:0007155; GO:0007179; GO:0009410; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010862; GO:0015026; GO:0016021; GO:0016477; GO:0016604; GO:0017015; GO:0022009; GO:0022617; GO:0030155; GO:0030336; GO:0030509; GO:0030512; GO:0030513; GO:0031953; GO:0031960; GO:0032967; GO:0034713; GO:0035912; GO:0042060; GO:0042127; GO:0042325; GO:0042802; GO:0042803; GO:0043235; GO:0045766; GO:0045944; GO:0048185; GO:0048745; GO:0048844; GO:0048845; GO:0048870; GO:0050431; GO:0051001; GO:0051897; GO:0055009; GO:0060326; GO:0060348; GO:0060394; GO:0070278; GO:0070483; GO:0071260; GO:0072563; GO:0097084; GO:1905007; GO:1905065; GO:1905222 GDKFVLR 1.149999976 1 1 0.164788907 833.8639717 15.65438 17.70286 0 15.22384 0 0 14.59099 0 0 16.16886 14.23801 15.45336 0 0 0 16.08128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41149 0 0 0 0 0 0 0 15.3958 16.76418 0 0 0 0 0 0 0 P17844 DDX5_HUMAN "Probable ATP-dependent RNA helicase DDX5, EC 3.6.4.13 (DEAD box protein 5) (RNA helicase p68)" DDX5 G17P1 HELR HLR1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]" androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332] GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016887; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045445; GO:0045667; GO:0046332; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014 DRYSAGK 9.039999962 1 1 0.261822194 794.4155506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.50089 0 0 0 0 0 0 0 17.62091 0 0 0 0 0 0 0 17.51837 0 0 0 0 0 0 0 0 0 0 P17927 CR1_HUMAN Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35) CR1 C3BR Homo sapiens (Human) "ATP export [GO:1904669]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; immune complex clearance by erythrocytes [GO:0002435]; negative regulation of activation of membrane attack complex [GO:0001971]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of cytolysis [GO:0045918]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of T cell proliferation [GO:0042130]; plasma membrane organization [GO:0007009]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of serine-type endopeptidase activity [GO:1900005]" cell surface [GO:0009986]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667] "cell surface [GO:0009986]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]; complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618]; ATP export [GO:1904669]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; immune complex clearance by erythrocytes [GO:0002435]; negative regulation of activation of membrane attack complex [GO:0001971]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of cytolysis [GO:0045918]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of T cell proliferation [GO:0042130]; plasma membrane organization [GO:0007009]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of serine-type endopeptidase activity [GO:1900005]" complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618] GO:0001618; GO:0001851; GO:0001855; GO:0001861; GO:0001970; GO:0001971; GO:0002430; GO:0002435; GO:0002638; GO:0004877; GO:0005615; GO:0005856; GO:0005886; GO:0005887; GO:0006957; GO:0006958; GO:0007009; GO:0008284; GO:0009986; GO:0030667; GO:0032689; GO:0032703; GO:0042130; GO:0044853; GO:0045591; GO:0045916; GO:0045918; GO:0045957; GO:0045959; GO:0070062; GO:0101003; GO:1900004; GO:1900005; GO:1900099; GO:1904669 MGASSPR 3.400000095 1 1 0.322662154 721.0300826 0 0 0 0 0 0 20.03923 0 0 0 0 0 0 0 0 16.10988 0 0 0 17.80667 0 0 0 0 17.69972 17.90272 17.58392 16.95329 0 0 0 18.60903 18.07431 0 0 0 18.14639 0 17.69502 0 17.08135 0 0 0 0 18.40079 0 0 P17931 LEG3_HUMAN "Galectin-3, Gal-3 (35 kDa lectin) (Carbohydrate-binding protein 35, CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein, GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)" LGALS3 MAC2 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380] carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723] GO:0001772; GO:0002548; GO:0003723; GO:0004864; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0009986; GO:0016020; GO:0019863; GO:0019903; GO:0030246; GO:0030593; GO:0030667; GO:0030855; GO:0031334; GO:0031640; GO:0042056; GO:0042129; GO:0043236; GO:0045087; GO:0045806; GO:0048245; GO:0048246; GO:0050860; GO:0050918; GO:0061844; GO:0062023; GO:0070062; GO:0070232; GO:0070492; GO:0071674; GO:0071677; GO:0090280; GO:0101003; GO:1902041; GO:1903078; GO:1903614; GO:2000521; GO:2001189; GO:2001237 MLITILGTVKPNANR 2.150000095 1 1 0.373553203 1656.133766 15.29071 0 15.93291 13.73173 15.75317 0 16.20056 15.30312 16.12355 17.41451 0 0 0 0 0 0 0 0 15.60944 0 0 15.37064 16.65621 16.61077 14.51611 0 0 0 16.10424 0 0 0 0 0 0 17.61547 0 0 16.40228 16.93834 0 0 13.83648 0 0 16.52145 16.02477 0 P17947 SPI1_HUMAN Transcription factor PU.1 (31 kDa-transforming protein) SPI1 Homo sapiens (Human) "anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; endothelial to hematopoietic transition [GO:0098508]; erythrocyte differentiation [GO:0030218]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; granulocyte differentiation [GO:0030851]; histone H3 acetylation [GO:0043966]; hypermethylation of CpG island [GO:0044027]; immature B cell differentiation [GO:0002327]; interleukin-6-mediated signaling pathway [GO:0070102]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage differentiation [GO:0030225]; myeloid dendritic cell differentiation [GO:0043011]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; pericyte cell differentiation [GO:1904238]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pro-T cell differentiation [GO:0002572]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of erythrocyte differentiation [GO:0045646]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of myeloid progenitor cell differentiation [GO:1905453]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; transforming growth factor beta receptor signaling pathway [GO:0007179]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; NFAT protein binding [GO:0051525]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; endothelial to hematopoietic transition [GO:0098508]; erythrocyte differentiation [GO:0030218]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; granulocyte differentiation [GO:0030851]; histone H3 acetylation [GO:0043966]; hypermethylation of CpG island [GO:0044027]; immature B cell differentiation [GO:0002327]; interleukin-6-mediated signaling pathway [GO:0070102]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage differentiation [GO:0030225]; myeloid dendritic cell differentiation [GO:0043011]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; pericyte cell differentiation [GO:1904238]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pro-T cell differentiation [GO:0002572]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of erythrocyte differentiation [GO:0045646]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of myeloid progenitor cell differentiation [GO:1905453]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; NFAT protein binding [GO:0051525]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001217; GO:0001227; GO:0001228; GO:0002314; GO:0002316; GO:0002327; GO:0002357; GO:0002572; GO:0002573; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007179; GO:0010628; GO:0010629; GO:0030154; GO:0030218; GO:0030225; GO:0030851; GO:0031663; GO:0032088; GO:0035019; GO:0036462; GO:0042826; GO:0043011; GO:0043314; GO:0043966; GO:0044027; GO:0045347; GO:0045646; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0051525; GO:0060033; GO:0061629; GO:0070102; GO:0090241; GO:0090402; GO:0097677; GO:0098508; GO:0120186; GO:0140297; GO:0140311; GO:1900745; GO:1901223; GO:1901674; GO:1902262; GO:1902895; GO:1904151; GO:1904178; GO:1904238; GO:1905036; GO:1905453; GO:2000529 EALAHR 1.769999981 1 1 0.199040256 695.8661151 0 17.02664 0 0 0 0 18.84513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.42672 19.18019 0 0 0 0 0 0 18.20611 0 0 16.3476 0 P17948 VGFR1_HUMAN "Vascular endothelial growth factor receptor 1, VEGFR-1, EC 2.7.10.1 (Fms-like tyrosine kinase 1, FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT, FLT) (Vascular permeability factor receptor)" FLT1 FLT FRT VEGFR1 Homo sapiens (Human) angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021] GO:0001525; GO:0002244; GO:0002548; GO:0004712; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005886; GO:0005887; GO:0005925; GO:0007169; GO:0008284; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:1905563; GO:1990384 KFPLDTLIPDGK 10.25 1 1 0.455592878 1342.576522 20.26542 18.89669 17.76403 0 0 20.13531 0 0 0 17.73741 0 0 0 0 0 19.74322 19.07281 0 0 0 0 0 0 0 0 0 17.84377 0 0 0 0 20.38396 0 0 19.12823 20.43404 0 0 0 0 19.28409 0 0 0 0 0 0 0 P17980 PRS6A_HUMAN "26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1, TBP-1)" PSMC3 TBP1 Homo sapiens (Human) modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402] GO:0000502; GO:0000932; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0034774; GO:0036402; GO:0042802; GO:0043161; GO:0043921; GO:0045944; GO:1901800; GO:1904813 LAGPQLVQMFIGDGAKLVR 10.52000046 1 1 9.16E-13 2028.733968 17.01319 0 15.17487 0 0 12.23477 13.80981 0 0 18.93749 0 0 0 0 0 0 15.99478 15.33757 0 0 14.52024 0 0 0 17.48461 0 0 15.74237 0 0 0 16.18105 19.13415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18031 PTN1_HUMAN "Tyrosine-protein phosphatase non-receptor type 1, EC 3.1.3.48 (Protein-tyrosine phosphatase 1B, PTP-1B)" PTPN1 PTP1B Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338] cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0006470; GO:0008270; GO:0008286; GO:0009966; GO:0009968; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031532; GO:0032991; GO:0033157; GO:0034620; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0043507; GO:0045296; GO:0046627; GO:0046875; GO:0051721; GO:0060338; GO:0060397; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903896; GO:1903898; GO:1990264; GO:2000646 KVLLEMR 7.989999771 0.688866377 0.688866377 0.047895653 904.8538511 0 13.96825 0 16.18529 0 14.87467 0 14.30892 14.28769 14.59406 14.96504 15.01484 0 0 14.61918 14.06142 16.48102 15.13357 0 0 0 16.7355 0 15.25099 16.49356 0 15.09341 15.76241 17.02984 16.09929 15.05471 16.07047 0 0 15.73501 13.76033 0 15.21987 15.89613 0 16.01252 15.34303 16.10727 0 16.06095 0 15.82905 12.88094 P18054 LOX12_HUMAN "Polyunsaturated fatty acid lipoxygenase ALOX12, EC 1.13.11.- (Arachidonate (12S)-lipoxygenase, 12S-LOX, 12S-lipoxygenase, EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase, EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO, EC 3.3.2.-) (Platelet-type lipoxygenase 12)" ALOX12 12LO LOG12 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559]" "arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" GO:0004052; GO:0005506; GO:0005737; GO:0005829; GO:0005886; GO:0006629; GO:0010656; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019395; GO:0033559; GO:0034440; GO:0042383; GO:0042554; GO:0043651; GO:0047977; GO:0050473; GO:0051122; GO:0061436; GO:0070062; GO:0090331; GO:1901751; GO:2001303; GO:2001306 QACLQMAISWHLSR 3.609999895 1 1 0.331056202 1715.385291 0 0 0 0 15.76972 14.82734 0 0 10.95961 0 16.33741 15.26104 0 0 0 0 0 0 0 0 13.10698 0 0 0 15.65931 0 0 12.03689 14.05145 12.87792 0 0 0 0 0 15.79605 0 12.95863 0 0 0 0 15.89233 0 0 0 0 14.9568 P18084 ITB5_HUMAN Integrin beta-5 ITGB5 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta5 complex [GO:0034684]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta5 complex [GO:0034684]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179] integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] GO:0001618; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0016477; GO:0033627; GO:0034684; GO:0035987; GO:0038023; GO:0043149; GO:0043235; GO:0045335; GO:0070062; GO:0090136 NFTALIPGTTVEILDGDSK 4.789999962 1 1 0.312880657 1990.195558 0 12.64851 0 0 11.85224 16.8809 19.00971 20.13375 0 14.61839 0 0 14.8727 0 0 13.13587 16.74041 0 0 0 10.48192 15.20498 18.96865 19.50511 0 0 0 17.39201 0 16.09461 0 0 0 0 0 0 16.81275 0 0 0 16.65027 0 16.5717 0 16.19354 0 18.28295 15.75559 P18089 ADA2B_HUMAN "Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor, Alpha-2B adrenoceptor, Alpha-2BAR)" ADRA2B ADRA2L1 ADRA2RL1 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056] cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056] alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930] GO:0003056; GO:0004930; GO:0004938; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007267; GO:0007565; GO:0009986; GO:0010700; GO:0030168; GO:0032148; GO:0032811; GO:0035624; GO:0043231; GO:0043410; GO:0045666; GO:0045777; GO:0051379; GO:0070474; GO:0071875; GO:0071880 GGPGQGESK 7.369999886 0.189658865 0.189658865 0.266368229 816.5173233 0 0 0 16.22865 19.72475 0 18.53385 0 0 0 0 0 19.77582 17.19311 0 0 0 18.09334 0 0 0 0 0 0 0 0 0 17.69867 18.28414 17.64807 0 0 17.77636 0 0 0 0 20.20408 0 0 0 0 18.27993 0 0 0 0 16.41425 P18206 VINC_HUMAN "Vinculin (Metavinculin, MV)" VCL Homo sapiens (Human) adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702] adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915] adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702] actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625] GO:0002009; GO:0002102; GO:0002162; GO:0003779; GO:0005198; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0007155; GO:0007160; GO:0008013; GO:0030032; GO:0030055; GO:0030336; GO:0031625; GO:0032991; GO:0034333; GO:0034394; GO:0034774; GO:0035580; GO:0035633; GO:0042383; GO:0043034; GO:0043297; GO:0044291; GO:0045121; GO:0045294; GO:0045296; GO:0048675; GO:0051893; GO:0070062; GO:0070527; GO:0090136; GO:0090636; GO:0090637; GO:1903140; GO:1903561; GO:1904702; GO:1904813; GO:1990357 DIAKASDEVTR 10.02000046 1 1 0.185180519 1204.442872 12.73292 0 10.27198 12.43763 15.48624 0 0 0 0 0 0 0 17.63752 0 0 0 14.34043 13.48746 15.02959 0 0 0 0 0 0 0 14.61677 14.18311 10.99495 0 0 0 0 16.17894 0 12.68552 0 0 0 0 0 0 14.94625 0 0 0 15.04173 0 P18433 PTPRA_HUMAN "Receptor-type tyrosine-protein phosphatase alpha, Protein-tyrosine phosphatase alpha, R-PTP-alpha, EC 3.1.3.48" PTPRA PTPA PTPRL2 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006468; GO:0006470; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0050804; GO:0051893; GO:0070062; GO:0098685; GO:0099699 MRTGNLPANMK 2.039999962 1 1 0.323533879 1248.333689 13.93914 0 14.95008 0 13.01505 0 15.58004 15.27671 16.69305 14.84022 14.65424 15.89943 15.35918 0 14.84183 15.98885 0 15.3024 16.49563 0 16.57014 0 15.78939 0 0 0 0 0 0 0 0 15.83094 0 0 0 0 17.31392 0 17.91507 0 14.54476 15.39657 0 0 15.30017 0 0 0 P18505 GBRB1_HUMAN Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) GABRB1 Homo sapiens (Human) cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005635; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0030594; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0071420; GO:0098982; GO:1902476; GO:1902711; GO:1904315 KSFVHGVTVK 8.329999924 1 1 0.120807613 1100.753639 0 0 0 0 0 13.48349 0 13.24395 0 15.98661 12.53002 0 0 0 0 0 0 0 0 0 0 0 0 16.66974 0 0 13.3921 9.259307 0 0 0 17.25187 0 0 0 0 0 0 0 0 0 0 0 15.75085 14.46091 0 7.898982 14.22099 P18545 CNRG_HUMAN "Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma, GMP-PDE gamma, EC 3.1.4.35" PDE6G PDEG Homo sapiens (Human) positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601] photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; spectrin binding [GO:0030507]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; spectrin binding [GO:0030507]" GO:0004857; GO:0005886; GO:0007601; GO:0030507; GO:0030553; GO:0042622; GO:0043410; GO:0045742; GO:0045745; GO:0047555; GO:0050896; GO:0097381 NLEPPK 15.14000034 0.195002824 0.195002824 0.215409174 696.4242314 19.0093 19.81599 19.15555 19.5963 19.17426 17.8184 18.27 18.92907 19.74088 16.97219 20.1167 18.96585 17.7744 18.91723 19.47013 19.68696 18.85304 20.24701 18.92631 18.78565 18.67536 19.84653 19.22281 19.14584 18.60497 19.22168 19.6899 19.50886 18.02242 19.08613 17.73852 18.13035 0 17.60214 18.11977 17.97568 19.18503 19.40742 18.62186 18.91339 19.84154 19.22202 18.29216 18.26902 18.56573 18.38948 18.16603 19.54143 P18583 SON_HUMAN "Protein SON (Bax antagonist selected in saccharomyces 1, BASS1) (Negative regulatory element-binding protein, NRE-binding protein) (Protein DBP-5) (SON3)" SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 Homo sapiens (Human) "microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607] "nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" DNA binding [GO:0003677]; RNA binding [GO:0003723] GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0051726 ATNIEQIFR 10.39000034 1 1 0.159814993 1092.439103 0 0 0 0 18.42929 0 17.93022 0 0 17.19412 0 0 0 0 0 0 0 0 17.70513 0 0 0 17.98958 17.53556 0 16.89931 0 0 17.34932 0 19.77042 0 0 0 18.30624 0 18.78329 17.92078 0 0 17.91094 0 0 0 18.07927 0 17.06066 0 P18615 NELFE_HUMAN "Negative elongation factor E, NELF-E (RNA-binding protein RD)" NELFE RD RDBP Homo sapiens (Human) negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944] NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin binding [GO:0003682]; RNA binding [GO:0003723] GO:0000122; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005886; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0051571; GO:0070374; GO:1900364 SGAHSSASPPR 8.909999847 0.755031943 0.755031943 0.230133057 1053.307785 0 0 17.38997 16.50688 0 0 0 0 0 0 0 0 15.62607 0 13.81904 15.02223 0 0 0 0 0 0 0 12.85591 0 15.70534 0 14.46936 0 14.75164 14.30405 0 13.03133 0 0 0 16.46803 0 15.92934 0 0 0 0 0 0 0 13.78399 0 P18627 LAG3_HUMAN "Lymphocyte activation gene 3 protein, LAG-3 (CD antigen CD223) [Cleaved into: Secreted lymphocyte activation gene 3 protein, sLAG-3 ]" LAG3 FDC Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of regulatory T cell differentiation [GO:0045590]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; MHC class II protein binding [GO:0042289]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of regulatory T cell differentiation [GO:0045590]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776] antigen binding [GO:0003823]; MHC class II protein binding [GO:0042289]; transmembrane signaling receptor activity [GO:0004888] GO:0002250; GO:0002270; GO:0003823; GO:0004888; GO:0005576; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0032703; GO:0042289; GO:0045590; GO:0045954; GO:0050776 SFLTAK 6.980000019 0.123425685 0.123425685 0.236336525 665.0628298 0 14.34673 14.28277 15.93763 14.71546 14.96283 0 14.18266 14.84573 0 15.27114 0 0 16.737 16.36747 0 15.93801 0 0 0 0 17.22786 0 0 15.62581 0 16.12706 16.29746 0 0 16.54661 0 15.06698 0 16.24133 0 15.91344 15.42654 0 0 0 0 16.89087 16.12218 0 16.54362 0 0 P18754 RCC1_HUMAN Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032] chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199] GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301 AEYGRLGLGEGAEEK 1.019999981 1 1 0.320827106 1578.594219 15.6359 0 14.63991 14.7887 0 0 0 0 0 0 0 13.37418 0 0 0 0 0 0 0 0 0 0 0 14.52309 0 0 0 15.6305 0 0 0 0 0 0 0 0 15.14093 13.53983 0 0 13.12563 0 14.30949 14.37349 14.03771 15.40826 0 11.25104 P19012 K1C15_HUMAN "Keratin, type I cytoskeletal 15 (Cytokeratin-15, CK-15) (Keratin-15, K15)" KRT15 KRTB Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0030855; GO:0045109; GO:0070062; GO:0097110 GGSLLAGGGGFGGGSLSGGGGSR 3.779999971 1 1 0.54899222 1821.548333 0 18.71927 0 0 0 0 0 0 0 0 0 0 17.90564 0 0 0 0 0 0 0 16.72738 0 0 0 19.03678 0 0 0 0 0 0 0 18.97574 0 0 18.13956 0 0 0 0 0 0 0 0 0 0 0 0 P19013 K2C4_HUMAN "Keratin, type II cytoskeletal 4 (Cytokeratin-4, CK-4) (Keratin-4, K4) (Type-II keratin Kb4)" KRT4 CYK4 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell proliferation [GO:0050680] cell surface [GO:0009986]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634] cell surface [GO:0009986]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell proliferation [GO:0050680] GO:0005634; GO:0005829; GO:0005882; GO:0007010; GO:0009986; GO:0030855; GO:0045095; GO:0045111; GO:0050680 TAAENDFVVLK 10.69999981 0.67299664 0.67299664 0.133381483 1207.372311 15.58205 0 9.393642 0 17.44429 0 11.42688 12.15237 0 0 0 11.83621 15.27377 0 14.13208 0 0 0 0 0 0 0 15.06025 16.54045 0 0 0 0 0 14.79813 0 0 0 0 0 0 13.69876 0 0 13.76587 0 0 0 0 0 0 0 0 P19021 AMD_HUMAN "Peptidyl-glycine alpha-amidating monooxygenase, PAM [Includes: Peptidylglycine alpha-hydroxylating monooxygenase, PHM, EC 1.14.17.3; Peptidyl-alpha-hydroxyglycine alpha-amidating lyase, EC 4.3.2.5 (Peptidylamidoglycolate lyase, PAL) ]" PAM Homo sapiens (Human) central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404] calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] GO:0001519; GO:0001666; GO:0001676; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0005576; GO:0005802; GO:0005886; GO:0006357; GO:0007417; GO:0007507; GO:0007595; GO:0008270; GO:0009268; GO:0009404; GO:0009410; GO:0009986; GO:0010043; GO:0016020; GO:0016021; GO:0018032; GO:0019901; GO:0022602; GO:0030658; GO:0030667; GO:0031418; GO:0032355; GO:0032956; GO:0042476; GO:0042802; GO:0043005; GO:0043204; GO:0046688; GO:0048471; GO:0050708; GO:0051384; GO:0060135; GO:0060173; GO:0062112; GO:0070062 GNAILVR 48.40000153 0.840457499 0.840457499 0.252099713 741.533853 0 16.11907 17.6814 0 0 0 0 0 0 0 20.04002 0 0 18.86345 0 17.22007 0 0 17.77993 17.40459 16.41014 0 18.63938 0 0 0 0 0 0 0 0 0 18.44562 0 0 0 0 0 17.48522 0 0 19.97041 0 15.08378 15.69326 17.18712 0 0 P19174 PLCG1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, EC 3.1.4.11 (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II, PLC-II) (Phospholipase C-gamma-1, PLC-gamma-1)" PLCG1 PLC1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; T cell receptor signaling pathway [GO:0050852] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901] GO:0001726; GO:0002862; GO:0004435; GO:0004629; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0008180; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0032587; GO:0038095; GO:0042995; GO:0043536; GO:0045766; GO:0046488; GO:0050429; GO:0050852; GO:0051281; GO:0071364; GO:1905564; GO:2000353 DGAFLVR 10.35999966 1 1 0.11857279 776.6054612 0 13.76748 0 15.85316 14.28632 12.92138 12.18619 13.45609 0 0 15.21312 14.93041 0 0 0 0 14.50079 0 0 16.05966 16.18834 0 0 15.66249 0 0 14.7073 0 0 0 15.07473 14.4763 0 14.66355 15.57225 10.90733 0 0 0 0 0 16.28568 0 0 0 13.71269 12.42202 0 P19237 TNNI1_HUMAN "Troponin I, slow skeletal muscle (Troponin I, slow-twitch isoform)" TNNI1 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; regulation of striated muscle contraction [GO:0006942]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cytosol [GO:0005829]; troponin complex [GO:0005861] cytosol [GO:0005829]; troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; regulation of striated muscle contraction [GO:0006942]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] actin binding [GO:0003779]; metal ion binding [GO:0046872] GO:0003009; GO:0003779; GO:0005829; GO:0005861; GO:0006936; GO:0006942; GO:0014883; GO:0046872; GO:0055010; GO:0060048 HKVSMDLR 6.480000019 1 1 0.176221533 1004.487334 15.71816 0 16.416 14.27142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.28136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19256 LFA3_HUMAN "Lymphocyte function-associated antigen 3, Ag3 (Surface glycoprotein LFA-3) (CD antigen CD58)" CD58 LFA3 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cellular response to interferon-gamma [GO:0071346]; cellular response to tumor necrosis factor [GO:0071356]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; signaling receptor binding [GO:0005102]; cell-cell adhesion [GO:0098609]; cellular response to interferon-gamma [GO:0071346]; cellular response to tumor necrosis factor [GO:0071356]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757] signaling receptor binding [GO:0005102] GO:0005102; GO:0005886; GO:0005887; GO:0009986; GO:0016020; GO:0030667; GO:0032757; GO:0034113; GO:0070062; GO:0071346; GO:0071356; GO:0098609; GO:0101003 VAGSDAGR 5.010000229 0.325730324 0.325730324 0.178966778 732.9556284 17.67907 17.13288 0 13.68799 0 15.28841 11.64523 17.37512 0 0 0 16.61182 0 17.72696 18.78799 16.48368 0 16.47597 15.84407 15.87476 0 18.45922 0 0 18.05788 0 0 0 17.03503 15.73991 0 18.55732 18.2828 0 0 17.47127 17.49578 0 18.05485 0 0 17.1888 17.5934 14.92805 16.72529 0 16.01645 14.67485 P19338 NUCL_HUMAN Nucleolin (Protein C23) NCL Homo sapiens (Human) "angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]" cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; DNA topoisomerase binding [GO:0044547]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]" DNA topoisomerase binding [GO:0044547]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] GO:0001525; GO:0001533; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005694; GO:0005730; GO:0005938; GO:0008022; GO:0016020; GO:0017148; GO:0036464; GO:0042162; GO:0042802; GO:0044547; GO:0045944; GO:0048026; GO:0048027; GO:0070062; GO:0071364; GO:0140297; GO:1901838; GO:1990830; GO:1990904 ALVATPGK 5.590000153 0.162219644 0.162219644 0.230733247 756.9183008 15.07325 11.55915 13.66618 0 13.97775 0 15.86053 0 16.19008 0 15.87103 15.15275 0 0 19.86967 15.77242 16.94238 0 16.74069 0 0 0 0 0 17.06273 14.60756 17.54287 16.02609 0 0 16.53919 15.38993 16.69903 16.07593 16.14676 16.21418 15.54108 15.30295 15.66059 0 0 0 0 14.41892 16.57313 14.42949 0 16.21458 P19367 HXK1_HUMAN "Hexokinase-1, EC 2.7.1.1 (Brain form hexokinase) (Hexokinase type I, HK I) (Hexokinase-A)" HK1 Homo sapiens (Human) canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731] cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731] ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834] GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0047931; GO:0051156; GO:0061621; GO:0072655; GO:0072656 RAAQLCGAGMAAVVDK 10.15999985 1 1 0.297893421 1634.418397 0 0 14.27099 13.96809 16.08879 14.2886 0 0 14.25957 0 16.48931 0 17.88401 0 0 0 0 0 0 0 0 0 20.32018 20.08195 0 0 0 0 0 0 0 0 0 0 0 21.1986 18.51111 0 0 0 0 0 0 0 0 0 0 0 P19388 RPAB1_HUMAN "DNA-directed RNA polymerases I, II, and III subunit RPABC1, RNA polymerases I, II, and III subunit ABC1 (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4)" POLR2E Homo sapiens (Human) protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366]" DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006366; GO:0050821; GO:1990062 YITYR 2.529999971 0.752361655 0.752361655 0.262087893 716.1016856 17.33239 15.09672 15.54881 0 18.22036 19.38368 18.14697 18.15386 0 0 14.79933 18.74157 0 0 0 0 0 0 16.60214 19.19499 0 17.82057 0 0 18.68425 0 0 20.47954 0 0 20.1498 18.6846 0 0 19.15776 0 0 0 0 19.05124 0 0 0 17.01764 0 17.09001 18.26428 16.99068 P19447 ERCC3_HUMAN "General transcription and DNA repair factor IIH helicase subunit XPB, TFIIH subunit XPB, EC 3.6.4.12 (Basic transcription factor 2 89 kDa subunit, BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit, TFIIH 89 kDa subunit, TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)" ERCC3 XPB XPBC Homo sapiens (Human) "apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] "nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485] GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006367; GO:0006368; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841 TGVPDGIMQFIK 11.02000046 1 1 0.235133199 1321.928839 0 0 0 13.38879 0 15.95632 0 0 17.86989 14.70008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.18959 0 0 17.83054 0 0 0 0 17.49006 16.66855 0 0 0 0 15.83314 0 16.32983 0 0 0 0 0 16.25074 0 P19532 TFE3_HUMAN "Transcription factor E3 (Class E basic helix-loop-helix protein 33, bHLHe33)" TFE3 BHLHE33 Homo sapiens (Human) "adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002250; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006959; GO:0045670; GO:0045785; GO:0045893; GO:0045944; GO:0046983; GO:0090336; GO:0120163; GO:1990837 SSDPEMR 9.029999733 0.69196552 0.69196552 0.21376252 837.2591199 0 0 15.23003 13.80481 14.55621 15.07173 13.92081 15.71402 13.99658 13.15874 16.51997 0 16.9064 0 15.43064 0 0 16.37909 0 17.87028 0 16.26233 15.96932 17.5 14.89894 16.50995 16.0567 16.0383 16.33019 16.55736 18.27333 14.88995 14.78877 15.32077 16.66525 15.91625 15.53933 16.53934 17.1414 14.84538 15.46 16.23601 14.24118 15.3377 15.82418 14.39648 16.73426 15.93799 P19544 WT1_HUMAN Wilms tumor protein (WT33) WT1 Homo sapiens (Human) "adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA methylation [GO:1905643]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA methylation [GO:1905643]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]" "C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001657; GO:0001658; GO:0001822; GO:0003156; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007281; GO:0007356; GO:0007507; GO:0007530; GO:0008270; GO:0008285; GO:0008380; GO:0008406; GO:0008584; GO:0009888; GO:0010385; GO:0010628; GO:0016607; GO:0017148; GO:0030308; GO:0030325; GO:0030539; GO:0030855; GO:0032835; GO:0032836; GO:0035802; GO:0043010; GO:0043065; GO:0043066; GO:0043565; GO:0044729; GO:0045892; GO:0045893; GO:0045944; GO:0060231; GO:0060421; GO:0060539; GO:0060923; GO:0061032; GO:0070742; GO:0071320; GO:0071371; GO:0072075; GO:0072112; GO:0072166; GO:0072207; GO:0072284; GO:0072302; GO:1902895; GO:1905643; GO:2000020; GO:2000195; GO:2001076 RHTGVKPFQCK 6.619999886 0.637913525 0.637913525 0.072545382 1357.856681 0 15.88269 0 0 16.42744 15.30017 0 15.94251 0 10.94867 15.47469 0 14.01874 18.83452 0 0 11.19986 15.94576 0 17.2264 0 16.82831 13.29068 0 17.35502 13.29333 16.14614 0 0 18.08219 12.67613 0 13.4585 0 15.4236 17.17763 0 0 15.57708 17.96565 13.25891 0 16.82322 17.64703 15.27399 14.78876 16.23866 0 P19634 SL9A1_HUMAN "Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1, NHE-1) (Solute carrier family 9 member 1)" SLC9A1 APNH1 NHE1 Homo sapiens (Human) cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]" "calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]" GO:0005516; GO:0005546; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006811; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014704; GO:0015299; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0016477; GO:0030011; GO:0030027; GO:0030307; GO:0030315; GO:0030346; GO:0030674; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051492; GO:0051893; GO:0051930; GO:0055007; GO:0060090; GO:0070062; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071260; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086036; GO:0086040; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902600; GO:1903281 DQFIIAYGGLRGAIAFSLGYLLDK 1.919999957 1 1 0.187372722 2600.503507 0 15.50042 0 0 9.632399 13.52694 0 0 0 0 15.77954 16.62801 10.64753 0 13.28561 10.66238 0 0 0 14.38879 0 0 0 0 0 16.54587 15.25139 0 0 0 0 0 0 16.84352 13.71049 0 0 0 0 0 0 0 0 0 0 0 13.77217 14.05326 P19784 CSK22_HUMAN "Casein kinase II subunit alpha', CK II alpha', EC 2.7.11.1" CSNK2A2 CK2A2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956] acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000785; GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005956; GO:0006915; GO:0007049; GO:0007283; GO:0016055; GO:0018105; GO:0018107; GO:0021987; GO:0047485; GO:0051726; GO:0097421; GO:0106310; GO:1903146; GO:1903955; GO:1905818; GO:2000059; GO:2001234 MPGPAAGSR 15.89000034 0.379846632 0.379846632 0.111728109 843.8230624 18.41801 15.24424 0 15.58995 14.14646 13.66886 0 15.31209 17.08315 14.19365 15.19999 17.87786 0 16.9065 0 0 16.51449 15.44641 15.06873 16.23815 0 18.10188 13.23625 17.637 17.15686 15.61509 16.1683 0 13.27357 16.37403 0 18.92581 19.84074 17.84228 14.05624 16.10052 0 0 15.94815 0 15.43664 18.35454 0 0 0 16.34264 10.90204 16.62288 P19801 AOC1_HUMAN "Amiloride-sensitive amine oxidase [copper-containing], DAO, Diamine oxidase, EC 1.4.3.22 (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase, KAO)" AOC1 ABP1 DAO1 Homo sapiens (Human) amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677] bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580] "bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]" "calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]" GO:0005507; GO:0005509; GO:0005576; GO:0005615; GO:0005777; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0008270; GO:0009308; GO:0009445; GO:0035580; GO:0035874; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0070062; GO:0071280; GO:0071420; GO:0071504; GO:0097185 LQPSSTTTMAK 5.300000191 0.086851701 0.086851701 0.09029823 1180.772631 0 10.0166 0 0 17.76792 13.00206 0 11.34817 14.37557 0 15.18632 13.7991 0 14.55076 12.98331 0 9.965039 0 0 0 0 0 0 15.73503 0 14.03565 17.04394 17.34967 15.26692 0 0 16.69905 16.27756 14.19303 0 0 13.78341 11.74944 14.21061 0 0 12.43735 0 14.12069 0 9.861722 0 11.30642 P19823 ITIH2_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H2, ITI heavy chain H2, ITI-HC2, Inter-alpha-inhibitor heavy chain 2 (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein, SHAP)" ITIH2 IGHEP2 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] endopeptidase inhibitor activity [GO:0004866]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004866; GO:0004867; GO:0005540; GO:0005576; GO:0005788; GO:0030212; GO:0062023; GO:0070062; GO:0072562 FYNQVSTPLLR 6.869999886 1 1 0.493680241 1337.775522 19.58867 0 17.78749 17.1098 0 0 0 0 0 0 17.03796 0 0 18.17385 0 18.00154 18.99382 0 0 17.26642 0 0 0 19.27934 0 0 0 16.60856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19878 NCF2_HUMAN "Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)" NCF2 NOXA2 P67PHOX Homo sapiens (Human) cellular defense response [GO:0006968]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; cellular defense response [GO:0006968]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] electron transfer activity [GO:0009055]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activator activity [GO:0016176] GO:0001669; GO:0005829; GO:0005886; GO:0006801; GO:0006909; GO:0006968; GO:0008022; GO:0009055; GO:0016020; GO:0016175; GO:0016176; GO:0031267; GO:0032010; GO:0042554; GO:0043020; GO:0045087; GO:0045730 EALIQLR 7.059999943 1 1 0.181652454 841.4040434 0 0 0 0 17.31179 0 16.22773 17.07026 0 0 0 0 0 16.76971 0 0 0 0 17.18826 0 0 14.52878 0 14.90618 16.61599 16.72708 17.95356 16.05252 17.32154 15.93485 14.17078 10.99515 0 16.28636 0 0 0 0 18.19106 12.93027 15.19297 0 15.94837 15.75059 14.34811 15.62431 0 0 P19971 TYPH_HUMAN "Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)" TYMP ECGF1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969] cytosol [GO:0005829] "cytosol [GO:0005829]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]" "1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]" GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333 QLLPRAR 9.119999886 1 1 0.075111498 853.5548294 0 13.69798 0 16.84548 15.31046 13.5175 17.87845 0 16.65742 11.26132 16.13465 0 0 16.80706 0 0 13.13297 15.19003 14.58588 17.69232 16.8728 0 0 0 15.01231 16.81405 15.33162 17.13233 0 16.12764 0 17.29686 0 15.17528 18.41451 0 0 14.40839 14.82832 0 0 0 16.29623 12.0892 0 17.58778 0 0 P20020 AT2B1_HUMAN "Plasma membrane calcium-transporting ATPase 1, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 1, PMCA1) (Plasma membrane calcium pump isoform 1)" ATP2B1 PMCA1 Homo sapiens (Human) aging [GO:0007568]; brain development [GO:0007420]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; aging [GO:0007568]; brain development [GO:0007420]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165] GO:0001772; GO:0001818; GO:0003056; GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006874; GO:0007420; GO:0007568; GO:0008217; GO:0009409; GO:0009898; GO:0015085; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030285; GO:0030501; GO:0032591; GO:0032809; GO:0034220; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0051481; GO:0051928; GO:0070062; GO:0071305; GO:0071386; GO:0098978; GO:0098982; GO:0099056; GO:0099059; GO:1900076; GO:1903779; GO:1905056; GO:1990034 REAVFGK 5.039999962 1 1 0.239354229 806.037023 14.89126 0 15.36113 0 15.34784 0 0 12.86797 15.14327 0 0 0 0 0 14.85047 0 0 0 0 0 0 15.81855 0 15.27741 16.22681 16.7296 0 0 15.96769 0 0 0 18.05857 16.58276 0 0 0 0 0 14.53053 15.66755 15.31952 0 0 0 0 16.25771 0 P20042 IF2B_HUMAN "Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta, eIF-2-beta)" EIF2S2 EIF2B Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]" "metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]" GO:0001701; GO:0001731; GO:0001732; GO:0002176; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0008135; GO:0008584; GO:0031369; GO:0046872 EVEPEPTEDK 3.980000019 1 1 0.337248534 1172.947411 13.43756 14.00174 13.55915 14.39444 14.77924 12.13958 12.70963 0 13.30718 14.8329 0 0 0 16.13877 0 14.47721 0 0 14.93967 16.05825 0 15.57473 0 13.92494 0 0 0 15.46926 14.80928 0 15.66533 0 0 0 0 0 16.38729 0 0 0 0 0 0 16.11276 0 0 0 0 P20073 ANXA7_HUMAN Annexin A7 (Annexin VII) (Annexin-7) (Synexin) ANXA7 ANX7 SNX OK/SW-cl.95 Homo sapiens (Human) autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723] GO:0003723; GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005789; GO:0006914; GO:0010629; GO:0016020; GO:0030855; GO:0048306; GO:0062023; GO:0070062 LYYAMKGAGTDDSTLVR 1.159999967 1 1 0.092064969 1877.557255 12.01294 14.14432 0 14.71698 0 0 0 0 14.46738 14.78371 14.91358 13.41244 0 0 14.13749 0 0 18.09468 0 0 16.20363 16.20222 15.79288 12.16533 0 0 0 0 0 0 0 0 13.45436 0 0 0 0 0 16.86461 0 0 16.75021 17.1112 15.30437 0 12.84514 0 0 P20155 ISK2_HUMAN Serine protease inhibitor Kazal-type 2 (Acrosin-trypsin inhibitor) (Epididymis tissue protein Li 172) (HUSI-II) SPINK2 Homo sapiens (Human) acrosome assembly [GO:0001675]; negative regulation of serine-type endopeptidase activity [GO:1900004]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acrosome assembly [GO:0001675]; negative regulation of serine-type endopeptidase activity [GO:1900004]; spermatid development [GO:0007286] endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0001669; GO:0001675; GO:0004866; GO:0004867; GO:0005576; GO:0007286; GO:1900004 TPNCSQYRLPGCPR 9.279999733 1 1 0.06904904 1706.178977 14.42016 10.58933 13.45439 15.65639 0 15.58438 10.51178 0 15.51779 13.83249 14.54965 0 0 14.83107 14.45821 0 14.03756 0 15.11944 0 0 0 11.67198 0 13.88351 13.01475 14.86455 0 0 0 0 15.77919 0 0 14.06583 0 8.401255 17.94201 0 15.16063 0 13.47994 12.9414 10.89446 19.26811 0 0 0 P20226 TBP_HUMAN TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit) TBP GTF2D1 TF2D TFIID Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase II promoter [GO:0006367]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976]; DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase II promoter [GO:0006367]" aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976] GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000979; GO:0000995; GO:0001046; GO:0001091; GO:0001093; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005737; GO:0006352; GO:0006366; GO:0006367; GO:0006383; GO:0006468; GO:0016251; GO:0017162; GO:0019899; GO:0032991; GO:0042789; GO:0051123; GO:0060261; GO:0097550; GO:0140223; GO:0140297 VVLTGAKVR 1.179999948 1 1 0.103690162 942.4073732 15.18074 16.54842 14.78716 0 0 0 0 0 0 0 0 0 0 0 14.8383 0 0 0 14.00183 0 15.96571 15.74635 15.96265 0 0 0 15.56009 0 15.48395 0 0 0 0 15.61134 14.25265 0 16.91157 15.1351 0 14.14362 0 14.57998 0 15.34399 0 15.75876 0 15.53835 P20265 PO3F2_HUMAN "POU domain, class 3, transcription factor 2 (Brain-specific homeobox/POU domain protein 2, Brain-2, Brn-2) (Nervous system-specific octamer-binding transcription factor N-Oct-3) (Octamer-binding protein 7, Oct-7) (Octamer-binding transcription factor 7, OTF-7)" POU3F2 BRN2 OCT7 OTF7 Homo sapiens (Human) astrocyte development [GO:0014002]; cellular response to organic substance [GO:0071310]; cerebral cortex radially oriented cell migration [GO:0021799]; epidermis development [GO:0008544]; forebrain ventricular zone progenitor cell division [GO:0021869]; hypothalamus cell differentiation [GO:0021979]; myelination in peripheral nervous system [GO:0022011]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neurohypophysis development [GO:0021985]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axonogenesis [GO:0050770]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; astrocyte development [GO:0014002]; cellular response to organic substance [GO:0071310]; cerebral cortex radially oriented cell migration [GO:0021799]; epidermis development [GO:0008544]; forebrain ventricular zone progenitor cell division [GO:0021869]; hypothalamus cell differentiation [GO:0021979]; myelination in peripheral nervous system [GO:0022011]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neurohypophysis development [GO:0021985]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axonogenesis [GO:0050770]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005654; GO:0005667; GO:0006357; GO:0007399; GO:0008284; GO:0008544; GO:0010629; GO:0014002; GO:0021799; GO:0021869; GO:0021979; GO:0021985; GO:0022011; GO:0030182; GO:0040018; GO:0042802; GO:0045595; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050770; GO:0071310; GO:1990837 RMTPPGGTLPGAEDVYGGSR 2.910000086 1 1 0.403204997 2020.299284 0 14.94762 0 0 0 0 0 0 0 0 0 0 14.96661 0 0 0 0 0 16.67341 0 0 0 0 0 0 0 0 0 0 0 15.89614 0 0 15.16459 0 0 0 0 0 14.67882 15.66662 0 0 0 0 14.51653 0 0 P20336 RAB3A_HUMAN Ras-related protein Rab-3A RAB3A Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; constitutive secretory pathway [GO:0045054]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904] acrosomal vesicle [GO:0001669]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] acrosomal vesicle [GO:0001669]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]; acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; constitutive secretory pathway [GO:0045054]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904] ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022] GO:0001669; GO:0001671; GO:0001778; GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0008022; GO:0009306; GO:0009791; GO:0010807; GO:0014059; GO:0016079; GO:0016188; GO:0017157; GO:0030324; GO:0030424; GO:0030667; GO:0030742; GO:0031489; GO:0031630; GO:0032418; GO:0032991; GO:0036465; GO:0043195; GO:0045054; GO:0045055; GO:0045921; GO:0048172; GO:0048471; GO:0048489; GO:0048786; GO:0048790; GO:0050975; GO:0051021; GO:0051117; GO:0051602; GO:0060201; GO:0060203; GO:0060478; GO:0061202; GO:0061670; GO:0070083; GO:0072659; GO:0097091; GO:0098793; GO:0098794; GO:0098993; GO:1903307; GO:1903561; GO:1905684; GO:2000300 CDMEDER 9.699999809 1 1 1.15E-12 956.5966766 16.57403 14.92637 14.1534 13.24425 15.36987 13.78873 0 15.15368 13.15958 0 0 0 0 0 14.14614 0 0 0 0 0 14.38384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.32019 0 0 0 0 0 0 15.88763 0 0 0 P20338 RAB4A_HUMAN "Ras-related protein Rab-4A, EC 3.6.5.2" RAB4A RAB4 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100] cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0015031; GO:0019003; GO:0019882; GO:0030100; GO:0030659; GO:0031901; GO:0031982; GO:0032482; GO:0032593; GO:0048471; GO:0055038; GO:0070062; GO:0098837 DLDADR 1.879999995 1 1 0.16967475 703.786964 0 0 0 0 0 0 0 13.70734 0 0 0 0 0 0 0 16.35836 14.89254 16.99622 0 0 0 0 17.36741 0 15.06596 0 17.80988 0 0 0 13.74976 0 0 0 0 0 0 0 0 0 0 0 16.42395 0 0 0 0 0 P20472 PRVA_HUMAN Parvalbumin alpha PVALB Homo sapiens (Human) cochlea development [GO:0090102]; excitatory chemical synaptic transmission [GO:0098976]; gene expression [GO:0010467]; inhibitory chemical synaptic transmission [GO:0098977] axon [GO:0030424]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; synapse [GO:0045202] axon [GO:0030424]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; excitatory chemical synaptic transmission [GO:0098976]; gene expression [GO:0010467]; inhibitory chemical synaptic transmission [GO:0098977] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] GO:0005509; GO:0005634; GO:0005737; GO:0010467; GO:0030424; GO:0032420; GO:0032437; GO:0032991; GO:0042802; GO:0043025; GO:0044877; GO:0045202; GO:0090102; GO:0098976; GO:0098977 MLMAAGDK 4.010000229 1 1 0.16493014 851.7876138 0 14.5331 0 7.702677 0 0 14.39725 14.21717 14.4255 16.73908 15.01545 14.44329 0 14.33291 0 0 0 0 0 0 16.37099 0 0 0 0 17.33439 16.04989 13.95668 15.05683 16.29185 0 12.84489 0 0 0 0 16.85018 0 15.39637 0 0 0 0 0 0 0 13.03782 16.37424 P20591 MX1_HUMAN "Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78, IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed ]" MX1 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005874; GO:0006915; GO:0006952; GO:0007165; GO:0008017; GO:0009615; GO:0016020; GO:0031965; GO:0034340; GO:0042802; GO:0045071; GO:0045087; GO:0048471; GO:0051607; GO:0070106; GO:0140374 LARLTQAR 12.63000011 1 1 0.243307949 925.2933359 0 15.44652 0 0 0 15.27916 15.62639 15.99342 15.37786 16.76268 18.42949 0 0 0 0 0 0 14.62576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.69662 0 0 0 15.80562 0 0 0 P20594 ANPRB_HUMAN "Atrial natriuretic peptide receptor 2, EC 4.6.1.2 (Atrial natriuretic peptide receptor type B, ANP-B, ANPR-B, NPR-B) (Guanylate cyclase B, GC-B)" NPR2 ANPRB Homo sapiens (Human) bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; reproductive process [GO:0022414]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; reproductive process [GO:0022414]; signal transduction [GO:0007165] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194 QVLFELKHMR 1.440000057 0.304574162 0.304574162 0.240409329 1315.89542 0 0 16.84423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.76646 0 0 0 18.59183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20618 PSB1_HUMAN Proteasome subunit beta type-1 (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain) PSMB1 PSC5 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298] GO:0000502; GO:0004298; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0008233; GO:0010498; GO:0019774; GO:0034774; GO:0043161; GO:0070062; GO:1904813 FSPYVFNGGTILAIAGEDFAIVASDTR 4.21999979 1 1 3.66E-12 2832.53322 0 0 0 9.051687 0 10.64586 0 0 0 11.6054 0 0 0 0 0 11.36448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20645 MPRD_HUMAN "Cation-dependent mannose-6-phosphate receptor, CD Man-6-P receptor, CD-MPR (46 kDa mannose 6-phosphate receptor, MPR 46)" M6PR MPR46 MPRD Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299] clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]; endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299] protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0005886; GO:0005887; GO:0006622; GO:0006898; GO:0007041; GO:0008333; GO:0016020; GO:0019904; GO:0030133; GO:0030669; GO:0032588; GO:0033299; GO:0048471; GO:1905394 SNGKETVVGR 8.720000267 0.001186251 0.001186251 0.014111354 1049.740715 0 0 15.96525 0 0 10.60041 10.74378 14.42082 15.09474 0 0 0 16.59129 0 0 14.42104 0 7.904917 15.86917 0 16.46863 16.75834 0 0 13.46828 16.38155 17.94919 0 16.529 0 0 0 17.20721 16.47146 16.76557 14.46837 15.68174 0 0 0 0 17.69315 0 0 0 0 15.76944 14.10571 P20648 ATP4A_HUMAN "Potassium-transporting ATPase alpha chain 1, EC 7.2.2.19 (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump)" ATP4A Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376] apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; potassium ion binding [GO:0030955]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; potassium ion binding [GO:0030955] GO:0000287; GO:0005391; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006883; GO:0008900; GO:0016324; GO:0016887; GO:0030007; GO:0030955; GO:0034220; GO:0036376; GO:1902600; GO:1990573 DGDKFQINADQLVVGDLVEMK 3.329999924 1 1 0.016395364 2351.026035 0 0 13.94223 14.51054 12.88537 12.46459 13.69044 0 0 0 12.58127 0 14.92725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20674 COX5A_HUMAN "Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)" COX5A Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872] GO:0004129; GO:0005743; GO:0005751; GO:0006123; GO:0009055; GO:0031966; GO:0045333; GO:0046872 GLLHSAR 5.949999809 1 1 0.122266616 753.9209316 16.74435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.88445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20700 LMNB1_HUMAN Lamin-B1 LMNB1 LMN2 LMNB Homo sapiens (Human) nuclear envelope organization [GO:0006998] lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198]; nuclear envelope organization [GO:0006998] phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198] GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0016020; GO:0016363; GO:0031965; GO:0043274; GO:1990837 DAALATALGDK 11.06000042 1 1 0.276783538 1045.739398 17.76805 18.08528 17.83708 16.53775 0 16.61573 18.76977 17.89675 0 16.42836 18.58145 17.77639 0 17.47311 0 17.50057 0 17.73012 0 16.53949 18.77319 0 0 0 18.04741 0 16.34539 18.52701 18.52351 0 18.55525 0 18.32525 0 18.96818 19.81698 0 0 19.31243 18.0538 16.37909 0 16.8483 0 19.01899 0 16.87247 0 P20701 ITAL_HUMAN "Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)" ITGAL CD11A Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory T cell extravasation [GO:0035683]; phagocytosis [GO:0006909]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integrin alphaL-beta2 complex [GO:0034687]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integrin alphaL-beta2 complex [GO:0034687]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; cell adhesion molecule binding [GO:0050839]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory T cell extravasation [GO:0035683]; phagocytosis [GO:0006909]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cell adhesion molecule binding [GO:0050839]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] GO:0002291; GO:0005178; GO:0005886; GO:0006909; GO:0006954; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007165; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0030369; GO:0033627; GO:0034687; GO:0035579; GO:0035683; GO:0043113; GO:0046872; GO:0050839; GO:0070062; GO:0098609 GLFPGGR 5.25 1 1 0.254710951 704.2679452 0 0 0 0 0 0 0 16.92762 17.38826 0 0 0 0 0 0 0 16.46919 0 15.88572 0 15.92817 0 0 0 0 0 17.08044 0 0 0 0 0 0 0 0 0 18.17974 0 17.03588 18.5015 0 0 0 0 0 18.4348 0 0 P20702 ITAX_HUMAN "Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)" ITGAX CD11C Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643] integrin binding [GO:0005178]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023] GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008284; GO:0008305; GO:0009887; GO:0009897; GO:0009986; GO:0010628; GO:0016020; GO:0030335; GO:0030667; GO:0030971; GO:0031643; GO:0033627; GO:0034113; GO:0034689; GO:0038023; GO:0045766; GO:0046872; GO:0051607; GO:0070821; GO:0098609; GO:0101003; GO:1905956 EGDSLDYKDVIPMADAAGIIR 8.899999619 1 1 0.154691347 2248.5378 12.41898 0 0 0 11.33893 13.54773 13.35346 15.91055 14.10706 0 15.39179 0 0 0 13.78252 12.77852 16.13467 13.1676 14.46257 0 15.07727 0 0 16.99991 14.52549 0 15.04227 15.61055 0 14.4733 0 14.89677 15.01075 13.51024 14.52125 0 14.91703 14.85494 0 13.78562 0 15.8768 0 0 0 0 0 17.21778 P20711 DDC_HUMAN "Aromatic-L-amino-acid decarboxylase, AADC, EC 4.1.1.28 (DOPA decarboxylase, DDC)" DDC AADC Homo sapiens (Human) aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to growth factor stimulus [GO:0071363]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; 5-hydroxy-L-tryptophan decarboxylase activity [GO:0036467]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to growth factor stimulus [GO:0071363]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427] 5-hydroxy-L-tryptophan decarboxylase activity [GO:0036467]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170] GO:0004058; GO:0005737; GO:0005829; GO:0006520; GO:0006584; GO:0007623; GO:0008021; GO:0010259; GO:0015842; GO:0016597; GO:0016831; GO:0019899; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0036467; GO:0036468; GO:0042416; GO:0042427; GO:0043025; GO:0046684; GO:0052314; GO:0070062; GO:0071312; GO:0071363; GO:0071466 AGEGGGVIQGSASEATLVALLAAR 1.129999995 1 1 0.210167717 2199.785024 0 0 14.79779 0 15.87597 0 0 13.34679 0 13.83272 12.53002 11.03738 0 13.63764 12.18844 0 0 0 0 0 0 0 0 0 0 11.2948 11.58356 0 0 0 0 16.65193 0 0 0 0 0 12.8237 0 15.05676 0 0 11.56428 0 0 0 7.898982 0 P20742 PZP_HUMAN Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6) PZP CPAMD6 Homo sapiens (Human) female pregnancy [GO:0007565] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565] endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0007565; GO:0070062; GO:0072562 DLFHCVSFTLPR 12.64999962 0.608530462 0.608530462 0.471014165 1491.847798 0 0 17.36709 0 0 0 0 0 0 0 0 0 0 0 0 17.13412 18.52248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.82902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20749 BCL3_HUMAN "B-cell lymphoma 3 protein, BCL-3 (Proto-oncogene BCL3)" BCL3 BCL4 D19S37 Homo sapiens (Human) "antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]" Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]" DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0140297; GO:1901222 MPRCPAGAMDEGPVDLR 5.28000021 1 1 0.259184436 1903.646153 0 0 13.79969 0 0 0 0 0 0 0 0 0 16.08702 0 0 0 0 14.43728 0 0 0 0 0 0 0 0 0 15.84673 0 0 0 12.25921 15.94302 0 0 0 0 13.35117 0 0 14.64842 0 0 15.2823 9.739427 0 0 0 P20800 EDN2_HUMAN "Endothelin-2, ET-2 (Preproendothelin-2, PPET2)" EDN2 Homo sapiens (Human) angiogenesis [GO:0001525]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cell tip growth [GO:0009932]; cellular calcium ion homeostasis [GO:0006874]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; hormonal regulation of the force of heart contraction [GO:0003058]; inositol phosphate-mediated signaling [GO:0048016]; lung alveolus development [GO:0048286]; macrophage activation [GO:0042116]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by chemical signal [GO:0003099]; prostaglandin biosynthetic process [GO:0001516]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; temperature homeostasis [GO:0001659]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; angiogenesis [GO:0001525]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cell tip growth [GO:0009932]; cellular calcium ion homeostasis [GO:0006874]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; hormonal regulation of the force of heart contraction [GO:0003058]; inositol phosphate-mediated signaling [GO:0048016]; lung alveolus development [GO:0048286]; macrophage activation [GO:0042116]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by chemical signal [GO:0003099]; prostaglandin biosynthetic process [GO:0001516]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; temperature homeostasis [GO:0001659]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179] GO:0001516; GO:0001525; GO:0001659; GO:0002690; GO:0003058; GO:0003099; GO:0003100; GO:0005179; GO:0005576; GO:0005615; GO:0006874; GO:0007166; GO:0007204; GO:0008284; GO:0009932; GO:0010460; GO:0014824; GO:0014826; GO:0019221; GO:0019229; GO:0019722; GO:0030593; GO:0031708; GO:0042116; GO:0042310; GO:0043542; GO:0045987; GO:0048016; GO:0048246; GO:0048286; GO:0048675; GO:0060585; GO:0097009 QQEAMR 11.53999996 0.021119764 0.021119764 0.270683988 762.4397637 17.00355 0 17.52452 0 17.58167 17.15586 18.66693 19.22166 17.87127 19.69727 0 0 17.65874 0 16.81477 17.15963 0 0 0 0 17.9225 17.40971 0 17.97002 0 17.97276 17.33281 0 0 16.95476 17.51209 18.80835 18.36873 0 0 17.87886 0 18.00099 19.3381 18.99549 18.18873 17.27612 0 18.72223 0 0 18.05714 0 P20807 CAN3_HUMAN "Calpain-3, EC 3.4.22.54 (Calcium-activated neutral proteinase 3, CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1, nCL-1)" CAPN3 CANP3 CANPL3 NCL1 Homo sapiens (Human) "apoptotic process [GO:0006915]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; G1 to G0 transition involved in cell differentiation [GO:0070315]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of myoblast differentiation [GO:0045661]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular anatomical structure [GO:0005622]; myofibril [GO:0030016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular anatomical structure [GO:0005622]; myofibril [GO:0030016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; apoptotic process [GO:0006915]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; G1 to G0 transition involved in cell differentiation [GO:0070315]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of myoblast differentiation [GO:0045661]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]" calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432] GO:0003824; GO:0004198; GO:0005509; GO:0005622; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0007517; GO:0008233; GO:0008234; GO:0008307; GO:0014718; GO:0014850; GO:0030016; GO:0030018; GO:0030163; GO:0030239; GO:0030315; GO:0031402; GO:0031432; GO:0031648; GO:0032991; GO:0033234; GO:0042802; GO:0043066; GO:0043122; GO:0045214; GO:0045661; GO:0045862; GO:0045892; GO:0045893; GO:0046716; GO:0050790; GO:0051092; GO:0051281; GO:0051592; GO:0055103; GO:0060090; GO:0061061; GO:0065003; GO:0070315; GO:0071277; GO:0071472; GO:0072657; GO:0097264; GO:1990092 VLNTVVNK 3.140000105 0.490183949 0.490183949 0.215273343 886.2664366 0 17.104 16.44641 15.43114 14.28086 0 15.90599 16.53034 16.42797 0 14.75648 14.9634 13.0499 16.89989 0 15.39591 16.85909 16.18734 0 0 15.40466 0 0 17.5473 15.58779 18.09456 17.77475 0 14.32837 0 15.70711 0 18.23237 0 0 0 0 16.61066 0 0 0 0 15.22823 15.21704 0 0 0 10.83677 P20810 ICAL_HUMAN Calpastatin (Calpain inhibitor) (Sperm BS-17 component) CAST Homo sapiens (Human) inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709] cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723] GO:0003723; GO:0004866; GO:0005737; GO:0005783; GO:0005829; GO:0010859; GO:0016020; GO:0045296; GO:0097340; GO:1990709; GO:2000675 MNPTETKAIPVSQQMEGPHLPNK 5.760000229 1 1 3.22E-12 2579.246637 14.20511 14.14852 0 0 13.10913 11.34715 16.88927 0 0 13.18581 14.49176 13.7275 13.11853 0 13.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20813 CP2B6_HUMAN "Cytochrome P450 2B6, EC 1.14.13.- (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)" CYP2B6 Homo sapiens (Human) cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]; cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" "anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008390; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042178; GO:0042180; GO:0043231; GO:0062184; GO:0062187; GO:0062188; GO:0062189; GO:0101021 AEAFSGRGK 4.260000229 1 1 0.2650428 921.3003514 0 0 0 0 0 0 0 0 0 16.2186 0 0 0 0 0 0 15.42429 0 9.428202 0 0 14.80208 0 0 14.89658 14.24995 16.53676 14.64425 13.76507 0 10.30799 0 0 15.36228 0 12.36156 0 13.67643 0 0 0 14.60037 14.06211 0 0 0 0 0 P20815 CP3A5_HUMAN "Cytochrome P450 3A5, EC 1.14.14.1 (CYPIIIA5) (Cytochrome P450-PCN3)" CYP3A5 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649] GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016491; GO:0019825; GO:0020037; GO:0042178; GO:0042572; GO:0042573; GO:0043231; GO:0046222; GO:0050649; GO:0070330; GO:0070989; GO:0101020 DVEINGVFIPK 4.059999943 1 1 0.233692649 1231.415024 21.49418 0 0 15.50616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20823 HNF1A_HUMAN "Hepatocyte nuclear factor 1-alpha, HNF-1-alpha, HNF-1A (Liver-specific transcription factor LF-B1, LFB1) (Transcription factor 1, TCF-1)" HNF1A TCF1 Homo sapiens (Human) "glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; renal glucose absorption [GO:0035623]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; renal glucose absorption [GO:0035623]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0030073; GO:0031016; GO:0032991; GO:0035623; GO:0042593; GO:0042803; GO:0045893; GO:0045944; GO:0046323; GO:0046982; GO:0046983; GO:0060261 EVVDTTGLNQSHLSQHLNKGTPMK 5.880000114 1 1 0.521382184 2635.666782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20849 CO9A1_HUMAN Collagen alpha-1(IX) chain COL9A1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] GO:0005201; GO:0005576; GO:0005594; GO:0005604; GO:0005615; GO:0005788; GO:0009887; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023 NGRDGER 3.200000048 0.602728009 0.602728009 0.221338776 806.6548099 15.75312 15.16039 14.77615 14.01834 14.22089 15.9746 16.44612 10.78537 14.78186 12.40239 15.13487 0 13.74201 15.07018 0 0 0 14.47178 0 14.78764 0 0 15.64266 15.93037 16.4628 0 15.55547 15.77715 0 0 0 15.62319 16.63743 0 0 15.37911 15.94148 16.13093 0 16.90574 0 15.74516 14.98753 0 0 0 16.04192 0 P20908 CO5A1_HUMAN Collagen alpha-1(V) chain COL5A1 Homo sapiens (Human) "blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]" basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]" extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394] GO:0001568; GO:0003007; GO:0005178; GO:0005201; GO:0005576; GO:0005588; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008201; GO:0016477; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0032964; GO:0035313; GO:0035989; GO:0043394; GO:0043588; GO:0045112; GO:0046872; GO:0048407; GO:0048592; GO:0051128; GO:0062023; GO:0097435; GO:1903225 GGPNGDPGPLGPPGEKGK 10.47999954 1 1 4.67E-13 1631.743391 16.8159 0 15.60294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20916 MAG_HUMAN Myelin-associated glycoprotein (Siglec-4a) MAG GMA Homo sapiens (Human) axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; substantia nigra development [GO:0021762]; transmission of nerve impulse [GO:0019226] compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220] compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; substantia nigra development [GO:0021762]; transmission of nerve impulse [GO:0019226] carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0010977; GO:0019226; GO:0019901; GO:0021762; GO:0030246; GO:0030517; GO:0031103; GO:0031643; GO:0032289; GO:0033270; GO:0033691; GO:0035749; GO:0042803; GO:0043209; GO:0043218; GO:0043220; GO:0043524; GO:0045121; GO:0045665; GO:0048711; GO:0071260; GO:0097453; GO:0098742; GO:1905576 EFVYSER 5.349999905 1 1 0.015897643 927.3355427 15.41153 0 13.80671 0 14.74597 15.45388 0 0 0 0 0 16.54457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.87576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20929 NEBU_HUMAN Nebulin NEB Homo sapiens (Human) cardiac muscle thin filament assembly [GO:0071691]; muscle organ development [GO:0007517]; regulation of actin filament length [GO:0030832]; somatic muscle development [GO:0007525] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; structural constituent of muscle [GO:0008307]; cardiac muscle thin filament assembly [GO:0071691]; muscle organ development [GO:0007517]; regulation of actin filament length [GO:0030832]; somatic muscle development [GO:0007525] actin filament binding [GO:0051015]; structural constituent of muscle [GO:0008307] GO:0005829; GO:0007517; GO:0007525; GO:0008307; GO:0015629; GO:0030018; GO:0030832; GO:0051015; GO:0070062; GO:0071691 AKINIPADMVSVLAAK 4.329999924 1 1 0.220192682 1655.545124 19.27618 14.23835 16.89001 0 17.56437 16.61035 0 15.64071 16.50084 17.14221 17.03007 16.71788 16.08236 20.06069 15.58409 19.22919 15.56875 17.72777 0 19.18937 16.91064 19.07798 15.6425 10.98852 16.05023 19.15177 0 17.21119 0 18.27612 0 18.61896 16.75426 14.32969 17.29437 15.16664 16.38346 16.47176 17.84908 0 16.87471 0 0 15.7994 18.40273 18.0283 0 15.16146 P20930 FILA_HUMAN Filaggrin FLG Homo sapiens (Human) establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149] collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914]; establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149] calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914] GO:0001533; GO:0005509; GO:0005634; GO:0005829; GO:0018149; GO:0030216; GO:0030280; GO:0036457; GO:0036464; GO:0046914; GO:0061436; GO:0062023 GQSGSRSASR 1.629999995 1 1 0 991.9163931 15.19886 0 13.61388 16.24642 0 10.86445 0 14.18708 16.42828 0 15.68753 15.49423 0 14.91963 0 0 0 0 16.6473 0 15.06729 0 0 0 0 0 0 13.47161 0 13.22396 0 0 0 0 0 0 0 0 0 0 0 0 16.79984 0 0 0 0 0 P20936 RASA1_HUMAN "Ras GTPase-activating protein 1, GAP, GTPase-activating protein, RasGAP (Ras p21 protein activator) (p120GAP)" RASA1 GAP RASA Homo sapiens (Human) blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of GTPase activity [GO:0043547]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of GTPase activity [GO:0043547]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102] GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0043547; GO:0046580; GO:0048013; GO:0048514; GO:0051020; GO:0051252 GIEPGSLRVR 3.769999981 1 1 0.166828086 1083.581855 14.01005 16.61711 0 0 0 0 14.63175 0 0 0 0 0 15.94896 0 0 15.55508 15.19454 14.55068 0 0 0 0 15.22579 0 15.34011 12.94292 0 14.75333 15.59928 14.64811 16.43075 15.2396 13.40475 13.92855 15.01582 14.32605 15.45291 15.36015 15.91187 15.93425 14.28174 15.87904 16.02432 14.86368 14.59907 13.63768 12.66373 12.15343 P21281 VATB2_HUMAN "V-type proton ATPase subunit B, brain isoform, V-ATPase subunit B 2 (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)" ATP6V1B2 ATP6B2 VPP3 Homo sapiens (Human) ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]" "ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0000221; GO:0001726; GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0015078; GO:0016021; GO:0016241; GO:0016324; GO:0016787; GO:0042470; GO:0043231; GO:0046034; GO:0046961; GO:0070062; GO:1902600 ALRAMR 6.349999905 0.343120068 0.343120068 0.209240685 717.4055477 14.64421 15.21464 13.19555 13.90432 15.12561 16.10978 13.94603 15.64277 16.23625 15.78545 0 13.4009 11.33164 15.69878 15.22618 14.95169 0 0 15.72477 15.3598 15.36763 15.65941 16.17318 16.0848 15.60746 15.81153 16.15024 0 16.20207 0 16.53697 15.87133 16.68528 0 15.79733 0 16.34268 0 17.34505 16.28358 15.79212 15.06848 0 14.86407 0 14.85355 15.92524 0 P21291 CSRP1_HUMAN "Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1, CRP, CRP1) (Epididymis luminal protein 141, HEL-141)" CSRP1 CSRP CYRP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214] actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270] GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527 GYGYGQGAGTLSTDKGESLGIK 5.349999905 1 1 0.141020464 2158.11063 7.989704 12.67412 13.70794 12.31624 16.09186 13.61321 0 0 13.71909 0 15.79189 0 16.68814 13.67958 0 14.56754 13.00461 12.47733 12.15709 0 0 0 0 0 14.84571 0 0 0 0 0 0 0 0 0 0 0 0 0 15.26074 0 16.94284 14.27806 0 0 0 0 0 0 P21333 FLNA_HUMAN "Filamin-A, FLN-A (Actin-binding protein 280, ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)" FLNA FLN FLN1 Homo sapiens (Human) "actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]" actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] "actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]" actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003723; GO:0005080; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005925; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0030018; GO:0030334; GO:0031267; GO:0031523; GO:0031532; GO:0032231; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0045022; GO:0045184; GO:0045216; GO:0045296; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0140297; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:1990779; GO:2001046 LKPGAPLRPK 4.170000076 0.246697024 0.246697024 0.250623676 1077.036821 0 0 0 0 0 0 0 0 0 0 0 0 16.0986 0 0 0 0 18.30701 0 0 0 18.01509 0 0 0 0 0 0 0 0 0 0 0 0 18.51163 0 18.01767 0 0 0 0 16.66791 0 0 0 0 0 0 P21359 NF1_HUMAN Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated ] NF1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]" GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429] GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241 ALAGHGGSRQLTESAAIACVK 7.920000076 1 1 3.20E-12 2096.289008 12.74083 0 0 0 0 0 0 0 0 0 0 14.01481 0 14.29233 14.60311 13.71478 15.81366 14.91983 14.89565 15.11129 13.11893 15.56295 0 0 0 12.86875 16.5365 13.43087 12.3726 13.09009 14.06349 15.5699 14.65875 0 0 13.49084 13.24291 14.174 0 15.96017 15.26153 15.52385 17.18878 0 16.92609 0 0 0 P21397 AOFA_HUMAN "Amine oxidase [flavin-containing] A, EC 1.4.3.21, EC 1.4.3.4 (Monoamine oxidase type A, MAO-A)" MAOA Homo sapiens (Human) cellular biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; positive regulation of signal transduction [GO:0009967] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131]; cellular biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; positive regulation of signal transduction [GO:0009967] flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131] GO:0005739; GO:0005741; GO:0005829; GO:0006576; GO:0008131; GO:0009967; GO:0016021; GO:0042135; GO:0042420; GO:0050660; GO:0097621 WSGYMEGAVEAGER 4.340000153 1 1 0.168931969 1557.425222 0 15.97319 14.3669 0 0 0 15.61405 0 14.55737 0 0 15.61312 0 0 0 0 0 0 0 15.76137 17.73647 0 0 14.45846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.52925 0 0 P21399 ACOHC_HUMAN "Cytoplasmic aconitate hydratase, Aconitase, EC 4.2.1.3 (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1, IRP1) (Iron-responsive element-binding protein 1, IRE-BP 1)" ACO1 IREB1 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]" "3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]" GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0030350; GO:0046872; GO:0047780; GO:0050892; GO:0051538; GO:0051539; GO:0070062 RADSLQK 1.799999952 1 1 0.303017271 817.3688078 16.56954 0 17.87276 0 0 0 0 0 0 0 17.56892 0 19.78051 0 0 18.30581 0 0 0 0 0 0 0 0 0 0 0 0 0 16.27742 19.16347 0 0 0 19.16229 0 0 0 0 0 0 0 0 0 15.6455 16.41863 0 0 P21439 MDR3_HUMAN "Phosphatidylcholine translocator ABCB4, EC 7.6.2.1 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)" ABCB4 MDR3 PGY3 Homo sapiens (Human) bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140 MDLEAAK 4.840000153 0.394905657 0.394905657 0.198716716 776.7115681 13.84798 0 15.68724 15.65657 0 13.95926 0 0 0 15.05968 0 0 0 0 0 16.6206 0 0 0 14.6346 0 0 16.06075 0 17.6358 0 0 0 15.79586 0 0 0 0 0 0 0 0 16.03543 15.94249 0 0 0 0 0 0 14.59725 0 0 P21453 S1PR1_HUMAN "Sphingosine 1-phosphate receptor 1, S1P receptor 1, S1P1 (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1, S1P receptor Edg-1) (CD antigen CD363)" S1PR1 CHEDG1 EDG1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226] cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226] G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036] GO:0001525; GO:0001664; GO:0001955; GO:0003245; GO:0003376; GO:0004930; GO:0005654; GO:0005737; GO:0005768; GO:0005886; GO:0006935; GO:0007155; GO:0007186; GO:0007189; GO:0007193; GO:0007420; GO:0009897; GO:0016021; GO:0016477; GO:0019222; GO:0019226; GO:0030032; GO:0030155; GO:0030182; GO:0030335; GO:0030500; GO:0030595; GO:0031226; GO:0031532; GO:0038036; GO:0043231; GO:0043547; GO:0045121; GO:0045124; GO:0045446; GO:0045944; GO:0046625; GO:0048661; GO:0050927; GO:0051482; GO:0051497; GO:0061384; GO:0072678 CPSGDSAGK 5.579999924 1 1 0.069280653 880.72389 14.02929 15.83934 14.72091 14.13157 0 0 15.29407 16.57811 0 15.74536 0 15.97042 0 0 0 0 13.76284 0 17.95123 0 14.44716 0 16.25718 0 15.25208 0 0 15.39229 0 0 0 0 0 0 0 0 0 0 0 13.81403 0 0 0 0 0 0 0 0 P21462 FPR1_HUMAN "fMet-Leu-Phe receptor, fMLP receptor (N-formyl peptide receptor, FPR) (N-formylpeptide chemoattractant receptor)" FPR1 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165] azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165] complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124] GO:0001664; GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005124; GO:0005737; GO:0005886; GO:0006935; GO:0006954; GO:0007165; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007263; GO:0016021; GO:0030667; GO:0035577; GO:0050786; GO:0101003 VIIGPWVMALLLTLPVIIR 18.54999924 0.228623599 0.228623599 0.10614877 2132.38204 12.5373 16.24571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21583 SCF_HUMAN "Kit ligand (Mast cell growth factor, MGF) (Stem cell factor, SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand, sKITLG ]" KITLG MGF SCF Homo sapiens (Human) cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; male gonad development [GO:0008584]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]; cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; male gonad development [GO:0008584]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173] GO:0001541; GO:0001755; GO:0002687; GO:0002763; GO:0005125; GO:0005173; GO:0005576; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0007155; GO:0008083; GO:0008284; GO:0008584; GO:0016021; GO:0030027; GO:0030175; GO:0033026; GO:0035162; GO:0035234; GO:0043406; GO:0045636; GO:0046579; GO:0050731; GO:0070668; GO:0097192; GO:1901534; GO:1902035 LFTPEEFFRIFNR 1.870000005 1 1 0.371978438 1716.245321 15.84751 0 0 16.04485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.40878 14.48721 0 15.96514 0 0 0 14.64121 0 P21589 5NTD_HUMAN "5'-nucleotidase, 5'-NT, EC 3.1.3.5 (Ecto-5'-nucleotidase) (CD antigen CD73)" NT5E NT5 NTE Homo sapiens (Human) adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035] 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0006259; GO:0007159; GO:0008253; GO:0009897; GO:0009986; GO:0010035; GO:0016020; GO:0031225; GO:0033198; GO:0046032; GO:0046034; GO:0046086; GO:0046872; GO:0050728; GO:0055074; GO:0070062; GO:0110148 CMGGVARLFTK 8.430000305 1 1 0.226365135 1256.182392 0 16.82064 0 14.64118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.51402 0 0 15.60885 0 0 0 0 14.54386 0 17.21233 P21695 GPDA_HUMAN "Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, GPD-C, GPDH-C, EC 1.1.1.8" GPD1 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821] glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803] GO:0004367; GO:0004368; GO:0005829; GO:0006072; GO:0006094; GO:0006116; GO:0006127; GO:0009331; GO:0042803; GO:0045821; GO:0046168; GO:0046486; GO:0051287; GO:0070062; GO:0071320; GO:0071356 LQGPETAR 2.480000019 0.296699375 0.296699375 0.231578346 868.3507804 15.77687 15.46756 15.30588 14.58353 15.76811 14.74796 14.04675 14.96183 14.5053 15.05052 15.43125 16.15064 0 15.41542 14.50499 16.67941 14.4059 15.02215 0 0 0 16.26267 15.17206 16.33455 15.44832 0 0 0 0 16.1379 16.46526 0 15.69894 16.76537 0 0 16.8681 0 16.13222 0 0 15.96569 0 0 15.52738 16.91916 16.16327 0 P21709 EPHA1_HUMAN "Ephrin type-A receptor 1, hEpha1, EC 2.7.10.1 (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH)" EPHA1 EPH EPHT EPHT1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001525; GO:0001954; GO:0001968; GO:0004672; GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006469; GO:0007166; GO:0007169; GO:0007411; GO:0008284; GO:0018108; GO:0019901; GO:0030335; GO:0030336; GO:0033674; GO:0034446; GO:0043005; GO:0043087; GO:0043235; GO:0045766; GO:0046777; GO:0051496; GO:0090630 LPSLSGSDGIPYR 8.220000267 1 1 1.84E-12 1362.215261 15.98131 16.53781 15.50908 0 0 10.94199 15.92075 11.64145 14.6341 11.26138 16.1883 13.65897 16.01444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.61463 0 0 0 0 0 0 0 0 0 0 0 0 P21757 MSRE_HUMAN Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204) MSR1 SCARA1 Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; cellular response to organic cyclic compound [GO:0071407]; cholesterol transport [GO:0030301]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898]" collagen trimer [GO:0005581]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886] "collagen trimer [GO:0005581]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; amyloid-beta clearance [GO:0097242]; cellular response to organic cyclic compound [GO:0071407]; cholesterol transport [GO:0030301]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898]" amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044] GO:0001540; GO:0005044; GO:0005581; GO:0005829; GO:0005886; GO:0005887; GO:0006898; GO:0006911; GO:0009897; GO:0010629; GO:0010744; GO:0010886; GO:0016021; GO:0030169; GO:0030301; GO:0030666; GO:0034362; GO:0034381; GO:0038024; GO:0042953; GO:0071407; GO:0097242 GPTGESGPR 6.78000021 1 1 0.061070159 856.6323765 0 0 0 0 0 0 16.67239 0 16.40163 0 0 0 18.08916 0 0 15.96555 0 0 0 0 0 0 17.15767 0 0 0 0 15.33529 0 0 0 0 0 0 0 15.09231 18.02559 0 14.97813 0 0 0 0 0 0 0 0 0 P21781 FGF7_HUMAN "Fibroblast growth factor 7, FGF-7 (Heparin-binding growth factor 7, HBGF-7) (Keratinocyte growth factor)" FGF7 KGF Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]; actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]" chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111] GO:0001934; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0005794; GO:0007165; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008544; GO:0009611; GO:0009887; GO:0010463; GO:0010628; GO:0010838; GO:0030154; GO:0030324; GO:0030334; GO:0031069; GO:0031532; GO:0034394; GO:0042056; GO:0045893; GO:0050679; GO:0050731; GO:0050918; GO:0051549; GO:0051781; GO:0060445; GO:0060501; GO:0060665; GO:0061033 GTQEMKNNYNIMEIR 2.589999914 1 1 0.357259954 1871.693016 21.36663 15.83912 16.73738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.43367 0 0 0 0 0 0 0 0 0 0 0 0 0 19.77324 0 0 0 0 0 0 0 0 17.24464 17.46605 P21802 FGFR2_HUMAN "Fibroblast growth factor receptor 2, FGFR-2, EC 2.7.10.1 (K-sam, KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)" FGFR2 BEK KGFR KSAM Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060] cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001837; GO:0002053; GO:0003148; GO:0003149; GO:0003416; GO:0004712; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005938; GO:0006915; GO:0007169; GO:0007267; GO:0007409; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0009986; GO:0010518; GO:0010839; GO:0016020; GO:0016021; GO:0016331; GO:0017134; GO:0018108; GO:0021769; GO:0021847; GO:0021860; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031069; GO:0031410; GO:0032496; GO:0032808; GO:0033674; GO:0033688; GO:0035265; GO:0035602; GO:0035603; GO:0035604; GO:0035607; GO:0042060; GO:0042472; GO:0042476; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0045165; GO:0045471; GO:0045667; GO:0045787; GO:0045944; GO:0046777; GO:0048286; GO:0048333; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048661; GO:0048701; GO:0048705; GO:0048730; GO:0048755; GO:0048762; GO:0050679; GO:0051150; GO:0051781; GO:0055010; GO:0060045; GO:0060076; GO:0060174; GO:0060348; GO:0060349; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060595; GO:0060601; GO:0060615; GO:0060664; GO:0060667; GO:0060670; GO:0060688; GO:0060915; GO:0060916; GO:0070372; GO:0070374; GO:0071300; GO:0071560; GO:0090263 CPAGGNPMPTMR 12.86999989 1 1 0.497870881 1319.053946 17.60336 18.8536 17.72404 18.51737 0 18.62373 0 18.68591 17.94075 19.59601 20.244 17.91227 0 0 19.56845 17.39623 19.46235 20.36172 18.34653 19.33938 18.90147 20.83992 19.52987 17.16319 19.84763 20.74978 19.53228 18.85882 20.27319 0 19.06491 18.36217 20.38514 20.12182 0 0 0 21.72973 18.71072 18.56759 0 19.91101 0 0 20.06905 19.52038 18.35622 0 P21810 PGS1_HUMAN Biglycan (Bone/cartilage proteoglycan I) (PG-S1) BGN SLRR1A Homo sapiens (Human) articular cartilage development [GO:0061975]; bone development [GO:0060348]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539] GO:0005201; GO:0005539; GO:0005576; GO:0005615; GO:0005796; GO:0009986; GO:0019800; GO:0030021; GO:0030133; GO:0031012; GO:0042383; GO:0043202; GO:0050840; GO:0060348; GO:0061975; GO:0062023; GO:0070062 VPKGVFSGLR 7.03000021 0.553973496 0.553973496 0.20084532 1059.501424 15.4751 11.18383 15.87221 14.11606 16.17919 12.42862 12.90718 0 0 15.50494 13.48442 14.41278 14.14682 15.18825 0 15.26832 14.0071 12.20618 0 0 0 0 0 0 0 0 0 15.86887 0 14.24633 0 0 0 0 15.48344 0 0 0 15.95504 14.74949 0 0 14.49421 0 0 0 0 0 P21817 RYR1_HUMAN "Ryanodine receptor 1, RYR-1, RyR1 (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor)" RYR1 RYDR Homo sapiens (Human) calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; muscle contraction [GO:0006936]; ossification involved in bone maturation [GO:0043931]; outflow tract morphogenesis [GO:0003151]; protein homotetramerization [GO:0051289]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; skeletal muscle fiber development [GO:0048741]; skin development [GO:0043588] calcium channel complex [GO:0034704]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; I band [GO:0031674]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; ryanodine receptor complex [GO:1990425]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; terminal cisterna [GO:0014802]; Z disc [GO:0030018] calcium channel complex [GO:0034704]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; I band [GO:0031674]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; ryanodine receptor complex [GO:1990425]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; muscle contraction [GO:0006936]; ossification involved in bone maturation [GO:0043931]; outflow tract morphogenesis [GO:0003151]; protein homotetramerization [GO:0051289]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; skeletal muscle fiber development [GO:0048741]; skin development [GO:0043588] ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; voltage-gated calcium channel activity [GO:0005245] GO:0001666; GO:0003151; GO:0005219; GO:0005245; GO:0005262; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005790; GO:0005886; GO:0005887; GO:0005938; GO:0006816; GO:0006936; GO:0014701; GO:0014802; GO:0014808; GO:0015278; GO:0016529; GO:0030018; GO:0030659; GO:0031000; GO:0031301; GO:0031674; GO:0033017; GO:0034704; GO:0042383; GO:0043588; GO:0043931; GO:0048741; GO:0048763; GO:0051209; GO:0051289; GO:0051480; GO:0070062; GO:0071277; GO:0071313; GO:1990425 DFQKAMDSQK 2.589999914 1 1 0.148748164 1212.615533 11.74376 14.89558 0 14.98933 0 13.62143 12.32771 0 0 0 0 0 0 0 0 12.76658 9.511829 15.60132 10.5316 6.903043 0 0 0 0 0 0 0 0 15.07142 0 15.32608 0 0 0 0 0 0 0 15.09534 15.0027 15.85138 0 0 0 0 0 0 0 P21860 ERBB3_HUMAN "Receptor tyrosine-protein kinase erbB-3, EC 2.7.10.1 (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)" ERBB3 HER3 Homo sapiens (Human) cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625] GO:0003197; GO:0004712; GO:0004714; GO:0004888; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0007162; GO:0007165; GO:0007169; GO:0007399; GO:0007422; GO:0007507; GO:0008284; GO:0009925; GO:0009968; GO:0010628; GO:0014037; GO:0014065; GO:0014068; GO:0016323; GO:0016324; GO:0016328; GO:0019838; GO:0021545; GO:0030296; GO:0031625; GO:0033674; GO:0038131; GO:0038132; GO:0038143; GO:0042060; GO:0042127; GO:0042802; GO:0043125; GO:0043235; GO:0043524; GO:0046982; GO:0051048; GO:0051402; GO:0055025; GO:0061098; GO:0070886; GO:0097192 ANAQRT 10.06999969 1 1 0.235048407 659.5574629 0 15.61524 11.04852 0 0 0 18.45768 0 0 0 0 0 0 17.92562 16.54392 0 0 15.51027 0 0 0 0 0 0 0 0 0 0 18.97047 17.00379 0 19.60155 0 0 0 0 18.38178 17.62019 0 0 0 17.36031 0 0 0 0 0 0 P21917 DRD4_HUMAN D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor) DRD4 Homo sapiens (Human) "adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; social behavior [GO:0035176]" centrosome [GO:0005813]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] "centrosome [GO:0005813]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; social behavior [GO:0035176]" "dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; SH3 domain binding [GO:0017124]" GO:0001591; GO:0001662; GO:0001975; GO:0004952; GO:0004993; GO:0005813; GO:0005886; GO:0005887; GO:0006874; GO:0007187; GO:0007195; GO:0007212; GO:0007268; GO:0008344; GO:0015459; GO:0016020; GO:0017124; GO:0030425; GO:0030594; GO:0032417; GO:0033674; GO:0034776; GO:0035176; GO:0035240; GO:0042053; GO:0042417; GO:0042596; GO:0042752; GO:0042802; GO:0043406; GO:0046872; GO:0048148; GO:0048149; GO:0048511; GO:0050482; GO:0050709; GO:0051379; GO:0051380; GO:0051586; GO:0060080; GO:0098794; GO:0098978; GO:0099149; GO:1901386 RQLLLIGATWLLSAAVAAPVLCGLNDVR 2.289999962 1 1 1.39E-12 2990.218605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.51674 0 0 0 0 0 0 0 0 0 0 0 0 18.77897 0 0 18.03691 0 0 17.32414 0 0 16.81527 18.07957 P21953 ODBB_HUMAN "2-oxoisovalerate dehydrogenase subunit beta, mitochondrial, EC 1.2.4.4 (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain, BCKDE1B, BCKDH E1-beta)" BCKDHB Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; protein-containing complex binding [GO:0044877]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584] 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; protein-containing complex binding [GO:0044877] GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0005947; GO:0006629; GO:0007584; GO:0009083; GO:0044877; GO:0051384; GO:0051591 CTVGLRDK 1.49000001 0.6225245 0.6225245 0.236850734 949.3407232 13.38241 16.17466 17.93187 16.88467 0 0 0 0 0 17.51427 0 0 17.22121 0 0 0 0 17.52175 0 0 0 16.17836 0 0 0 0 0 0 0 0 0 17.96777 0 0 18.25661 0 0 0 0 0 0 16.89883 0 0 0 17.65676 17.10468 0 P22059 OSBP1_HUMAN Oxysterol-binding protein 1 OSBP OSBP1 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918] oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248] GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006686; GO:0006699; GO:0008142; GO:0015248; GO:0015914; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0035627; GO:0035774; GO:0042531; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015; GO:1904411 DFLMLAQTHSK 4.03000021 1 1 0.270871553 1305.981237 0 15.3527 15.56773 14.93061 0 14.34189 14.7952 15.1723 0 0 12.42046 15.77948 0 0 13.15555 0 0 15.28603 0 0 0 0 0 0 15.5092 16.11071 0 0 0 15.26812 0 0 15.636 0 13.90889 15.07804 0 17.32205 0 16.01208 0 15.95188 0 0 0 0 0 0 P22102 PUR2_HUMAN "Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase, EC 6.3.4.13 (Glycinamide ribonucleotide synthetase, GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase, EC 6.3.3.1 (AIR synthase, AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase, EC 2.1.2.2 (5'-phosphoribosylglycinamide transformylase) (GAR transformylase, GART) ]" GART PGFT PRGS Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644] GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0044208; GO:0046084; GO:0046654; GO:0046872; GO:0070062; GO:0097294 VKLAEHK 11.46000004 1 1 0.176735076 824.7419513 0 14.78746 16.33445 14.104 14.8996 0 0 0 14.82568 0 17.079 0 14.98449 0 13.93467 15.36289 0 0 14.91895 15.5857 0 0 17.20217 0 0 16.24382 0 0 0 0 0 0 0 0 0 0 0 17.46332 0 0 0 14.86673 15.77273 0 15.99246 0 0 0 P22105 TENX_HUMAN "Tenascin-X, TN-X (Hexabrachion-like protein)" TNXB HXBL TNX TNXB1 TNXB2 XB Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0043506; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0098609; GO:0098633; GO:1904028; GO:1905935 LGELTVTDR 6.239999771 1 1 0.18435986 1000.85489 17.34765 18.1734 16.60277 10.56632 14.89623 14.61992 0 0 0 0 0 0 17.16063 0 0 0 0 0 0 13.99087 15.9129 0 15.75618 17.66405 0 0 0 0 16.28082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22223 CADH3_HUMAN "Cadherin-3 (Placental cadherin, P-cadherin)" CDH3 CDHP Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta2 production [GO:0032912]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; positive regulation of tyrosinase activity [GO:0032773]; regulation of hair cycle by canonical Wnt signaling pathway [GO:0060901]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]; wound healing [GO:0042060] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta2 production [GO:0032912]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; positive regulation of tyrosinase activity [GO:0032773]; regulation of hair cycle by canonical Wnt signaling pathway [GO:0060901]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]; wound healing [GO:0042060] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007156; GO:0007601; GO:0009410; GO:0010628; GO:0010838; GO:0016021; GO:0016342; GO:0022405; GO:0030054; GO:0031424; GO:0032773; GO:0032912; GO:0042060; GO:0043568; GO:0045296; GO:0048023; GO:0051796; GO:0060901; GO:0090263; GO:0098742; GO:1902910 KLADMYGGGEDD 3.130000114 1 1 0.141396586 1275.017534 13.95029 12.71764 13.32014 10.86541 13.15969 0 0 0 0 0 12.58967 13.06203 12.73599 13.14 12.18758 0 14.40235 0 14.5595 0 0 0 0 16.42974 16.07369 12.09744 15.49824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.66141 0 0 0 0 0 P22303 ACES_HUMAN "Acetylcholinesterase, AChE, EC 3.1.1.7" ACHE Homo sapiens (Human) "acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416]" anchored component of membrane [GO:0031225]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083] "anchored component of membrane [GO:0031225]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine hydrolase activity [GO:0017171]; acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416]" acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine hydrolase activity [GO:0017171] GO:0001507; GO:0001540; GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007399; GO:0007416; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0031225; GO:0031594; GO:0031623; GO:0032223; GO:0042166; GO:0042803; GO:0042982; GO:0043083; GO:0043236; GO:0043621; GO:0045202; GO:0048471; GO:0050714; GO:0060041; GO:0095500; GO:0120162 TGDPNEPR 9.930000305 1 1 0.314016466 884.7318212 19.10099 17.92848 18.11502 15.16556 0 0 17.54884 0 0 17.92892 0 19.08578 0 18.49313 0 20.13799 0 17.80993 0 18.94686 17.87004 0 18.07856 18.34855 0 18.86513 0 0 0 0 0 19.309 0 17.57435 0 20.63708 0 19.17581 0 19.10545 18.60156 19.12061 20.65704 0 17.91248 0 18.42643 17.25718 P22307 SCP2_HUMAN "Sterol carrier protein 2, SCP-2 (Acetyl-CoA C-myristoyltransferase, EC 2.3.1.155) (Non-specific lipid-transfer protein, NSL-TP) (Propanoyl-CoA C-acyltransferase, EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase, EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X, SCP-X)" SCP2 Homo sapiens (Human) alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694] acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934] GO:0000062; GO:0003988; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006694; GO:0006699; GO:0006701; GO:0007031; GO:0008206; GO:0008526; GO:0015485; GO:0015914; GO:0016020; GO:0032367; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033540; GO:0033814; GO:0036042; GO:0036109; GO:0043231; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0071071; GO:0072659; GO:0120019; GO:0120020; GO:1901373 ADCTITMADSDFLALMTGKMNPQSAFFQGK 5.449999809 1 1 3.20E-12 3329.624729 13.39465 0 0 0 0 0 14.15721 10.18603 0 0 12.40461 0 11.82641 0 0 0 0 5.915354 14.46407 0 0 0 14.32099 0 11.63772 0 10.2769 0 16.04687 0 17.45611 0 0 0 0 0 0 0 0 0 13.08972 0 0 0 0 0 11.82181 0 P22413 ENPP1_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, E-NPP 1 (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form ] [Includes: Alkaline phosphodiesterase I, EC 3.1.4.1; Nucleotide pyrophosphatase, NPPase, EC 3.6.1.9 (Nucleotide diphosphatase) ]" ENPP1 M6S1 NPPS PC1 PDNP1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]; sequestering of triglyceride [GO:0030730] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphatase activity [GO:0016791]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]; sequestering of triglyceride [GO:0030730] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphatase activity [GO:0016791]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270] GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0010035; GO:0010467; GO:0016021; GO:0016323; GO:0016791; GO:0030247; GO:0030282; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031953; GO:0032869; GO:0033198; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0055062; GO:0090305; GO:0106177; GO:0110148; GO:1990787 DPNTYK 6.460000038 1 1 0.114075834 735.87712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.32324 0 0 0 0 0 0 0 0 0 0 14.98748 16.73225 0 13.37832 15.10251 0 0 15.87352 0 16.0255 0 0 0 0 15.73313 15.34017 16.62606 P22455 FGFR4_HUMAN "Fibroblast growth factor receptor 4, FGFR-4, EC 2.7.10.1 (CD antigen CD334)" FGFR4 JTK2 TKF Homo sapiens (Human) cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0004712; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010715; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0033674; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0055062; GO:0070374; GO:0070857; GO:2000573 CPAAGNPTPTIR 5.269999981 1 1 0 1254.716563 13.34154 11.79951 0 14.29328 13.7275 14.87176 0 13.07428 0 16.26983 14.72343 14.58542 0 12.88577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22459 KCNA4_HUMAN Potassium voltage-gated channel subfamily A member 4 (HPCN2) (Voltage-gated K(+) channel HuKII) (Voltage-gated potassium channel HBK4) (Voltage-gated potassium channel HK1) (Voltage-gated potassium channel subunit Kv1.4) KCNA4 KCNA4L Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] axon [GO:0030424]; axon initial segment [GO:0043194]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; axon initial segment [GO:0043194]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium ion binding [GO:0030955]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] delayed rectifier potassium channel activity [GO:0005251]; potassium ion binding [GO:0030955]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0030424; GO:0030955; GO:0034765; GO:0043194; GO:0043197; GO:0051260; GO:0071805 HSKGLQILGHTLR 9.18999958 1 1 0.208650119 1459.267803 0 0 0 0 12.85087 0 15.26921 11.40897 13.76201 0 0 0 15.70852 0 14.5301 0 0 14.09381 0 0 0 0 0 0 15.56863 0 0 0 0 0 0 16.05105 0 0 0 0 0 0 0 0 0 0 0 16.01213 0 0 0 0 P22460 KCNA5_HUMAN Potassium voltage-gated channel subfamily A member 5 (HPCN1) (Voltage-gated potassium channel HK2) (Voltage-gated potassium channel subunit Kv1.5) KCNA5 Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]; atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033] alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090] GO:0001666; GO:0005102; GO:0005249; GO:0005251; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006813; GO:0007219; GO:0008076; GO:0009612; GO:0009986; GO:0010033; GO:0014704; GO:0015271; GO:0016021; GO:0019229; GO:0019901; GO:0030018; GO:0034705; GO:0042391; GO:0042542; GO:0043266; GO:0045121; GO:0046691; GO:0048471; GO:0050796; GO:0051260; GO:0051393; GO:0051481; GO:0055075; GO:0055093; GO:0060081; GO:0060372; GO:0071805; GO:0086014; GO:0086050; GO:0086052; GO:0086087; GO:0086089; GO:0086090; GO:0086091; GO:0097110; GO:0097623; GO:0098914; GO:1900087; GO:2000288 GSCPLEK 7.360000134 1 1 0.247521966 790.3215087 14.79014 0 15.6861 0 13.86973 0 16.32837 0 0 19.16473 0 0 16.14626 17.7269 13.04922 0 0 0 0 16.77368 14.62012 0 0 15.18757 15.10989 0 16.59157 0 16.01961 14.40626 0 0 0 16.23323 0 0 0 0 17.86654 17.57152 0 0 0 0 18.88865 17.80909 0 15.30728 P22492 H1T_HUMAN Histone H1t (Testicular H1 histone) H1-6 H1FT H1T HIST1H1T Homo sapiens (Human) cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; spermatogenesis [GO:0007283] nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; spermatogenesis [GO:0007283] double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492] GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0007283; GO:0016584; GO:0030154; GO:0030261; GO:0031492; GO:0045910 SETVPAASASAGVAAMEK 11.55000019 0.852197468 0.852197468 2.75E-12 1677.587212 9.36487 13.8968 11.9323 0 0 17.21857 0 0 0 0 0 0 0 0 0 0 15.54862 16.52372 0 0 0 0 0 0 0 0 0 0 0 0 15.85248 13.15514 0 0 0 0 0 17.33873 0 0 0 0 0 0 0 0 0 0 P22557 HEM0_HUMAN "5-aminolevulinate synthase, erythroid-specific, mitochondrial, ALAS-E, EC 2.3.1.37 (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)" ALAS2 ALASE ASB Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666] 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170] GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0006879; GO:0030170; GO:0030218; GO:0032364; GO:0042541; GO:0048821 DLVDMVR 3.150000095 0.184408203 0.184408203 0.07987018 860.0106993 17.07775 0 16.49077 0 0 12.82977 12.78672 13.39537 10.88059 13.0535 15.4035 0 13.51159 0 14.92704 16.5275 12.83979 0 15.7866 0 12.8139 15.63091 0 14.13727 0 0 15.12878 14.14778 0 0 17.11557 0 15.98885 0 13.80268 0 14.84029 14.67871 0 0 14.10903 0 0 14.03587 0 17.08914 15.77263 16.79306 P22570 ADRO_HUMAN "NADPH:adrenodoxin oxidoreductase, mitochondrial, AR, Adrenodoxin reductase, EC 1.18.1.6 (Ferredoxin--NADP(+) reductase, Ferredoxin reductase)" FDXR ADXR Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744] ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491] GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491 RGPLQVAFTIK 5.71999979 0.027935086 0.027935086 0.147262665 1229.935901 0 17.57015 13.02847 0 12.78219 0 0 0 0 0 0 0 0 0 9.240887 0 0 0 0 0 0 12.03507 0 0 0 0 0 0 15.75224 0 0 16.44725 11.76002 15.5171 13.56798 0 0 0 16.16295 0 0 15.99995 0 0 13.77552 0 0 14.12283 P22607 FGFR3_HUMAN "Fibroblast growth factor receptor 3, FGFR-3, EC 2.7.10.1 (CD antigen CD333)" FGFR3 JTK4 Homo sapiens (Human) bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004712; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0018108; GO:0030133; GO:0030282; GO:0033674; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048640; GO:0060349; GO:0070374; GO:0070977; GO:1902178 AAKPVTVAVK 10.39999962 1 1 0.27916355 983.0644586 0 0 15.64145 11.69553 0 15.01006 0 0 0 16.78367 15.44725 15.23159 14.27207 0 0 12.60975 14.80223 15.3844 0 14.81584 0 0 0 0 0 14.2827 0 0 14.37827 0 0 0 0 0 15.11368 14.67089 15.34665 0 0 0 0 15.94903 15.97041 14.55032 16.51246 0 0 15.52326 P22676 CALB2_HUMAN "Calretinin, CR (29 kDa calbindin)" CALB2 CAB29 Homo sapiens (Human) regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] cytosol [GO:0005829]; dendrite [GO:0030425]; gap junction [GO:0005921]; neuron projection [GO:0043005]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195] cytosol [GO:0005829]; dendrite [GO:0030425]; gap junction [GO:0005921]; neuron projection [GO:0043005]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534] GO:0005509; GO:0005634; GO:0005829; GO:0005921; GO:0030425; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0098688; GO:0099509; GO:0099534; GO:1900271 KSVMSLAEAGK 7.949999809 0.540627837 0.540627837 0.132805887 1117.908567 0 0 10.30764 14.15701 17.20401 13.03393 0 13.39338 0 16.51323 13.71878 10.28533 0 0 11.90985 0 0 0 12.77882 16.00767 13.74332 14.82589 0 14.7613 15.44643 15.42562 0 15.72569 0 15.99154 0 17.46791 15.41847 0 17.91962 13.41365 0 13.19991 17.83333 0 15.45835 15.42705 16.80384 0 0 17.29576 0 0 P22680 CP7A1_HUMAN "Cytochrome P450 7A1 (24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cholesterol 7-alpha-monooxygenase, EC 1.14.14.23)" CYP7A1 CYP7 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125] 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395] GO:0005506; GO:0005789; GO:0006699; GO:0006707; GO:0008123; GO:0008395; GO:0010468; GO:0015721; GO:0016021; GO:0016125; GO:0020037; GO:0032966; GO:0033782; GO:0038183; GO:0042632; GO:0043231; GO:0045471; GO:0045542; GO:0045717; GO:0070857; GO:0071333; GO:0071397 AHILNNLDNFKQFDK 15.53999996 1 1 0.06708826 1816.76543 15.15662 16.0791 0 17.12336 12.64295 12.35656 0 0 0 15.46719 0 0 0 13.69403 15.25167 0 14.54981 0 15.48013 0 14.84911 0 0 17.40956 0 0 17.99832 11.28342 0 12.80259 15.15659 0 0 15.321 16.09739 0 0 0 15.9497 12.40473 0 15.57511 14.858 9.472074 0 0 0 0 P22681 CBL_HUMAN "E3 ubiquitin-protein ligase CBL, EC 2.3.2.27 (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL)" CBL CBL2 RNF55 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0001784; GO:0004842; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0007173; GO:0007175; GO:0008584; GO:0010332; GO:0014068; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019221; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0035635; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045296; GO:0045471; GO:0045742; GO:0046677; GO:0046875; GO:0048260; GO:0048471; GO:0051865; GO:0061630; GO:0070997; GO:0090650; GO:1901215; GO:1990090; GO:2000583 LDLLPQR 10.52000046 0.10676226 0.10676226 0.289530602 853.8941944 0 0 0 19.51251 17.23712 20.22594 0 19.13848 20.89313 18.9184 20.03676 19.71874 0 0 21.22459 21.31147 18.06025 0 19.86093 0 0 20.70121 0 0 19.22543 18.6995 0 17.70804 0 0 20.616 17.47513 20.26875 19.41845 19.68025 0 0 19.24709 18.31259 19.24911 0 18.12317 18.175 19.47002 19.68809 19.89124 0 17.2859 P22692 IBP4_HUMAN "Insulin-like growth factor-binding protein 4, IBP-4, IGF-binding protein 4, IGFBP-4" IGFBP4 IBP4 Homo sapiens (Human) inflammatory response [GO:0006954]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; inflammatory response [GO:0006954]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102] GO:0001558; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0006954; GO:0007165; GO:0010906; GO:0031994; GO:0031995; GO:0043410; GO:0043567; GO:0043568; GO:0044342; GO:0090090 STSGGK 6.309999943 1 1 0.015166158 535.1600932 0 0 0 14.6067 0 0 0 0 15.3499 13.8781 0 15.87488 14.5006 13.70256 15.90755 0 0 0 0 15.57608 0 0 0 14.65139 16.27884 12.32999 0 0 0 0 0 13.77449 0 0 0 0 0 0 0 0 0 15.55108 0 0 0 0 16.90343 0 P22695 QCR2_HUMAN "Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)" UQCRC2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]" metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005654; GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006119; GO:0006122; GO:0009060; GO:0045333; GO:0046872 GASSFK 2.650000095 1 1 0.15617329 596.5458037 15.34938 15.09072 14.00718 0 0 0 0 15.78025 0 15.28447 0 16.3624 0 0 0 0 16.89915 0 0 15.65134 16.59731 0 15.61295 0 0 0 16.76285 0 0 0 15.64901 14.64855 15.43194 0 14.011 14.64614 0 0 0 0 0 0 0 11.79447 17.17838 0 0 0 P22732 GTR5_HUMAN "Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine, GLUT-5)" SLC2A5 GLUT5 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; monosaccharide transmembrane transport [GO:0015749]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; specific granule membrane [GO:0035579] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; specific granule membrane [GO:0035579]; fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; monosaccharide transmembrane transport [GO:0015749]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750] fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149] GO:0003044; GO:0005353; GO:0005355; GO:0005886; GO:0005887; GO:0005975; GO:0009750; GO:0015149; GO:0015749; GO:0015755; GO:0016020; GO:0016324; GO:0035579; GO:0042383; GO:0070061; GO:0070062; GO:0071332; GO:0106001; GO:1904659; GO:1990539 AAGFISVLKLFR 8.420000076 0.337520987 0.337520987 0.144884051 1321.142806 0 0 16.3542 17.07712 16.36892 0 14.56138 0 0 0 0 16.82051 13.08115 16.86899 0 0 18.47407 0 12.66951 0 13.03782 0 0 14.01576 14.18198 12.57298 0 13.81263 8.114845 0 14.13309 18.10905 12.6479 16.15509 0 15.40345 17.12237 19.18883 0 15.67434 12.41842 10.31821 0 0 0 16.68977 0 14.86819 P22830 HEMH_HUMAN "Ferrochelatase, mitochondrial, EC 4.99.1.1 (Heme synthase) (Protoheme ferro-lyase)" FECH Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to light stimulus [GO:0009416] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; protein homodimerization activity [GO:0042803]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to light stimulus [GO:0009416]" "2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; protein homodimerization activity [GO:0042803]" GO:0004325; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006783; GO:0008198; GO:0009416; GO:0042803; GO:0046501; GO:0051537 VGPMPWLGPQTDESIK 3.799999952 1 1 0.42421838 1769.287569 17.36274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.42399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.54985 0 18.81294 0 0 0 0 0 P22888 LSHR_HUMAN "Lutropin-choriogonadotropic hormone receptor, LH/CG-R (Luteinizing hormone receptor, LHR, LSH-R)" LHCGR LCGR LGR2 LHRHR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]" endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]" choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964] GO:0001541; GO:0004964; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007189; GO:0007190; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0030539; GO:0032962; GO:0035472; GO:0038106; GO:0042700; GO:0050890; GO:0071371; GO:0071373 DFSAYTSNCK 10.34000015 1 1 0.307130208 1192.380518 15.49672 0 15.20468 0 0 0 0 0 0 0 13.35415 13.77792 15.17336 0 15.8719 0 0 15.60117 0 0 17.05113 0 0 0 16.82729 14.77473 0 15.41247 14.69229 12.72501 16.62192 14.14447 0 0 0 0 17.21802 0 0 15.99048 0 0 0 15.88815 0 17.36709 0 0 P22897 MRC1_HUMAN "Macrophage mannose receptor 1, MMR (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor, hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)" MRC1 CLEC13D CLEC13DL MRC1L1 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898] cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 QEDCVVMK 8.449999809 0.217628121 0.217628121 0.141904505 1024.466098 0 13.60475 0 0 0 0 16.57195 13.96157 17.18432 14.6535 14.69789 15.7064 0 0 16.13211 0 16.86837 13.55454 0 14.0016 14.88513 0 16.96127 18.05071 13.95205 14.03089 17.69237 0 8.26675 0 14.88016 15.11446 15.56564 15.6655 10.22704 0 0 17.11833 14.45911 0 17.05577 8.319553 15.74961 0 14.83457 15.8143 0 15.00449 P22914 CRYGS_HUMAN Gamma-crystallin S (Beta-crystallin S) (Gamma-S-crystallin) CRYGS CRYG8 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212] GO:0002009; GO:0002088; GO:0005212; GO:0007601 KPIDWGAASPAVQSFR 13.48999977 1 1 0.335279408 1730.404626 13.67649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22173 0 15.84699 0 0 16.82695 0 15.09535 14.74296 15.4832 12.40267 15.9093 15.76267 13.55718 0 0 13.49742 0 0 0 0 0 16.99024 0 0 16.0435 0 18.97322 0 14.99752 0 P23025 XPA_HUMAN DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein) XPA XPAC Homo sapiens (Human) "base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634] "intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837] GO:0000110; GO:0000715; GO:0003684; GO:0005634; GO:0005654; GO:0006281; GO:0006284; GO:0009650; GO:0019904; GO:0033683; GO:0034504; GO:0042803; GO:0045171; GO:0046872; GO:0070914; GO:1901255; GO:1990837 EFMDSYLMNHFDLPTCDNCR 14.13000011 1 1 3.66E-12 2577.687467 14.61718 12.85822 0 16.34755 13.98989 0 15.20115 14.41457 0 12.11796 14.73802 0 14.31261 0 11.39605 0 0 0 0 0 0 0 13.11537 0 0 14.86674 0 0 0 0 0 0 0 0 0 0 13.90683 15.64592 0 0 0 0 0 0 10.57384 0 0 0 P23109 AMPD1_HUMAN "AMP deaminase 1, EC 3.5.4.6 (AMP deaminase isoform M) (Myoadenylate deaminase)" AMPD1 Homo sapiens (Human) AMP metabolic process [GO:0046033]; GMP salvage [GO:0032263]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] cytosol [GO:0005829] cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; GMP salvage [GO:0032263]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0003876; GO:0005829; GO:0006188; GO:0032263; GO:0032264; GO:0042802; GO:0046033; GO:0046872 GEDPFR 16.54999924 0.331667334 0.331667334 0.099656187 721.0396829 0 15.71584 15.10807 0 15.18659 0 11.11392 17.00752 0 0 15.55074 0 14.75447 0 0 14.22032 15.58071 0 0 0 0 15.73277 14.744 13.17816 13.90653 0 16.06175 11.94802 0 15.80831 15.62396 0 0 13.66957 13.9845 0 17.68987 16.21824 0 0 14.90599 0 15.95679 0 17.29523 15.15029 0 16.50531 P23141 EST1_HUMAN "Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase, ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1, CE-1, hCE-1, EC 3.1.1.1) (Cholesteryl ester hydrolase, CEH, EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1, EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase, REH) (Serine esterase 1) (Triacylglycerol hydrolase, TGH)" CES1 CES2 SES1 Homo sapiens (Human) cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]; cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691] carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771] GO:0004771; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0005829; GO:0006695; GO:0008203; GO:0009636; GO:0010875; GO:0010887; GO:0016042; GO:0030855; GO:0042632; GO:0043691; GO:0047374; GO:0051791; GO:0052689; GO:0070857; GO:0071397; GO:0071404; GO:0080030; GO:0090122; GO:0090205; GO:0120188 ENIPLK 7.510000229 0.138861328 0.138861328 0.248788219 713.9410226 0 0 17.83964 19.0055 0 0 19.95247 18.55139 19.23826 18.93607 17.08226 17.04864 0 0 0 19.33765 18.15969 0 0 18.60374 19.00473 17.89532 17.93649 20.09544 0 19.61254 20.20666 18.62848 17.63951 19.44176 19.04761 0 19.38504 19.7271 20.02498 0 20.08945 18.52194 0 0 17.99708 0 18.31898 0 0 18.07349 17.03588 0 P23142 FBLN1_HUMAN "Fibulin-1, FIBL-1" FBLN1 PP213 Homo sapiens (Human) "blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]" basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]" calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070062; GO:0070373; GO:0071635; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647 AITPPHPASQANIIFDITEGNLR 14.59000015 0.909185171 0.909185171 1.37E-12 2475.606403 15.65854 13.15672 0 14.24032 0 14.08503 14.4167 0 0 14.2008 0 0 0 0 0 8.118492 14.90916 0 0 0 0 0 0 0 0 16.55872 14.64535 13.56964 0 0 14.73638 0 0 14.19579 0 9.741462 0 0 10.22167 0 0 0 0 0 13.06068 0 0 0 P23229 ITA6_HUMAN "Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6, Alpha6p ]" ITGA6 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589] cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132] GO:0005178; GO:0005886; GO:0005925; GO:0007044; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0010668; GO:0010976; GO:0030335; GO:0031589; GO:0031994; GO:0033627; GO:0035878; GO:0038132; GO:0042327; GO:0043065; GO:0043547; GO:0043589; GO:0045296; GO:0045944; GO:0046872; GO:0050900; GO:0098609; GO:2001237 QLSCVANQNGSQADCELGNPFKR 4.349999905 1 1 0.00437217 2593.553669 15.71838 15.72124 0 0 0 0 0 0 13.17699 0 0 0 13.88278 15.15072 0 0 14.74224 15.5033 15.30999 0 0 0 0 0 0 13.61478 13.98333 14.29516 0 0 0 15.95572 0 15.28764 11.58883 0 13.81124 12.4991 12.92671 0 14.69974 13.77287 13.64413 0 19.03225 0 0 0 P23246 SFPQ_HUMAN "Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein, hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor, PSF, PTB-associated-splicing factor)" SFPQ PSF Homo sapiens (Human) "activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]" chromatin [GO:0000785]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976] GO:0000122; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0002218; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0016363; GO:0016607; GO:0032839; GO:0042382; GO:0042752; GO:0042754; GO:0042803; GO:0042826; GO:0045087; GO:0045876; GO:0045892; GO:0045944; GO:0048511; GO:0051276; GO:0070932; GO:0090575; GO:0098963; GO:1902177 LAQKNPMYQK 3.75999999 0.055765118 0.055765118 0.358564269 1237.723923 12.5538 13.90906 15.63389 14.58185 14.37209 14.68059 0 0 0 14.72035 0 0 0 13.43125 0 12.6237 0 0 0 14.89382 16.11757 0 17.09496 16.41756 13.12781 0 15.29752 0 15.47961 16.27984 0 0 0 0 14.00124 0 0 0 0 15.20083 15.69856 0 0 15.56156 16.30597 12.55553 16.82995 0 P23276 KELL_HUMAN "Kell blood group glycoprotein, EC 3.4.24.- (CD antigen CD238)" KEL Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; negative regulation of potassium ion transmembrane transport [GO:1901380]; protein processing [GO:0016485]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]; vasoconstriction [GO:0042310] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; negative regulation of potassium ion transmembrane transport [GO:1901380]; protein processing [GO:0016485]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]; vasoconstriction [GO:0042310] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006874; GO:0008361; GO:0010961; GO:0016021; GO:0016485; GO:0031133; GO:0042310; GO:0042552; GO:0046872; GO:0048741; GO:1901380 NLPWMNEETQNMAQDK 1.370000005 0.272544891 0.272544891 0.342420838 1965.433578 15.76724 0 0 0 0 0 0 0 0 0 14.71875 0 15.60157 0 0 0 19.10077 0 0 0 0 0 14.28857 0 0 0 0 0 10.36008 13.83504 12.373 0 0 0 0 0 0 0 0 0 13.69657 0 0 0 0 0 0 0 P23352 KALM_HUMAN Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) ANOS1 ADMLX KAL KAL1 KALIG1 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012 SHKPVGCLGEAGHVLSK 12.11999989 1 1 2.75E-12 1775.226074 14.36282 13.71455 14.15878 15.22364 15.74035 14.03354 0 0 0 0 0 14.72963 0 0 0 0 14.80346 15.17849 14.12691 0 15.5942 17.64818 0 0 13.72758 13.90478 14.11415 15.22836 0 0 0 14.5604 14.1451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23368 MAOM_HUMAN "NAD-dependent malic enzyme, mitochondrial, NAD-ME, EC 1.1.1.38 (Malic enzyme 2)" ME2 Homo sapiens (Human) malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031] electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948] GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0009055; GO:0043231; GO:0046872; GO:0051287; GO:1902031 KMTSPLEK 6.03000021 1 1 0.198582625 948.3058138 0 0 0 13.14983 14.40615 0 0 0 16.07496 0 0 17.77391 16.40004 14.41163 0 0 15.23135 0 0 0 0 0 16.71562 13.24053 0 0 13.12749 0 0 0 0 14.30201 17.1806 0 0 18.41744 0 16.83071 18.0974 16.0852 0 0 0 0 0 0 15.37363 17.24596 P23378 GCSP_HUMAN "Glycine dehydrogenase (decarboxylating), mitochondrial, EC 1.4.4.2 (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))" GLDC GCSP Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170] GO:0004375; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0005960; GO:0006546; GO:0009055; GO:0016594; GO:0016829; GO:0019464; GO:0030170; GO:0036255; GO:0042803; GO:0070280; GO:1903442; GO:1990830 AMVDKHK 12.52000046 0.066276804 0.066276804 0.167275493 842.9388854 17.73817 12.97843 14.23695 0 0 0 18.27209 0 0 0 0 0 19.17917 0 0 0 0 0 0 0 0 0 0 15.2377 0 0 0 0 0 18.39304 0 0 0 0 0 16.8543 0 0 0 14.43372 0 0 0 0 0 0 0 0 P23396 RS3_HUMAN "40S ribosomal protein S3, EC 4.2.99.18 (Small ribosomal subunit protein uS3)" RPS3 OK/SW-cl.26 Homo sapiens (Human) apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413] class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] GO:0002181; GO:0003677; GO:0003684; GO:0003723; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0005783; GO:0005829; GO:0005840; GO:0005844; GO:0005886; GO:0005925; GO:0006281; GO:0006412; GO:0006413; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0010628; GO:0014069; GO:0015631; GO:0016020; GO:0017148; GO:0019899; GO:0019900; GO:0019901; GO:0022626; GO:0022627; GO:0030544; GO:0031116; GO:0031334; GO:0031397; GO:0032079; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0034614; GO:0042104; GO:0042981; GO:0043507; GO:0044390; GO:0044877; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051092; GO:0051225; GO:0051301; GO:0051536; GO:0051879; GO:0061481; GO:0070062; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0140078; GO:0140297; GO:1901224; GO:1902231; GO:1902546; GO:1905053; GO:1990904; GO:2001235; GO:2001272 ELTAVVQKR 1.24000001 0.363488078 0.363488078 0.326482484 1042.64352 0 0 0 0 0 15.34904 16.58707 0 0 0 15.90626 0 0 15.69638 0 0 0 0 0 15.82664 16.74933 0 0 0 0 0 0 16.07406 15.97796 15.66641 0 0 0 15.1854 14.87442 0 16.75751 16.5497 0 0 0 14.77604 16.40664 0 0 16.99568 0 0 P23443 KS6B1_HUMAN "Ribosomal protein S6 kinase beta-1, S6K-beta-1, S6K1, EC 2.7.11.1 (70 kDa ribosomal protein S6 kinase 1, P70S6K1, p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA)" RPS6KB1 STK14A Homo sapiens (Human) aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009410; GO:0009611; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030165; GO:0031667; GO:0031929; GO:0032496; GO:0032869; GO:0033574; GO:0033762; GO:0034612; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043201; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048015; GO:0048471; GO:0048633; GO:0048661; GO:0051721; GO:0071346; GO:0071363; GO:0071549; GO:0106310; GO:2001237 LGAGPGDAGEVQAHPFFR 3.970000029 0.568511486 0.568511486 0.108196836 1823.663533 0 7.651083 15.33721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59962 0 0 0 15.73388 0 16.9607 0 0 0 0 0 P23458 JAK1_HUMAN "Tyrosine-protein kinase JAK1, EC 2.7.10.2 (Janus kinase 1, JAK-1)" JAK1 JAK1A JAK1B Homo sapiens (Human) cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196] ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625] GO:0004712; GO:0004713; GO:0004715; GO:0005131; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007259; GO:0016020; GO:0019221; GO:0019903; GO:0031625; GO:0031730; GO:0034112; GO:0035556; GO:0038110; GO:0038196; GO:0046677; GO:0046872; GO:0060333; GO:0060337; GO:0070102; GO:0098586; GO:0150105; GO:1903672 EGIDSECGPFIK 6.789999962 1 1 0.093474325 1352.179818 11.95301 13.27981 0 0 13.878 0 0 0 0 11.71222 0 0 12.34913 0 0 0 0 0 0 0 0 0 0 0 0 16.08157 0 0 0 0 0 0 14.37955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23467 PTPRB_HUMAN "Receptor-type tyrosine-protein phosphatase beta, Protein-tyrosine phosphatase beta, R-PTP-beta, EC 3.1.3.48 (Vascular endothelial protein tyrosine phosphatase, VE-PTP)" PTPRB PTPB Homo sapiens (Human) angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470] cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0001525; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0016311; GO:0035579; GO:0043235; GO:0045296; GO:0070821; GO:1990264 IISLDEER 8.649999619 0.32276085 0.32276085 0.268110761 974.9829124 16.23165 16.53067 14.94278 0 14.68517 0 16.72988 15.70052 15.22348 15.02132 15.30717 15.71048 14.91276 15.01786 14.46218 14.74868 14.52043 13.66844 0 14.09874 16.12419 0 0 15.00917 0 15.35863 15.30883 0 0 16.17914 16.24616 16.18125 0 0 0 0 0 16.37226 16.07464 0 0 14.16985 14.56908 15.26407 16.73582 0 0 0 P23468 PTPRD_HUMAN "Receptor-type tyrosine-protein phosphatase delta, Protein-tyrosine phosphatase delta, R-PTP-delta, EC 3.1.3.48" PTPRD Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0099151; GO:0099545; GO:0099560; GO:1905606 AHTSKGPGPYSPSVQFR 3.619999886 1 1 0.106405885 1816.21901 13.46863 12.55281 15.42111 0 0 0 14.48983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.68163 0 0 0 0 15.56172 14.80815 0 14.78084 0 16.00017 14.5345 13.93914 0 0 0 0 0 0 15.09011 P23470 PTPRG_HUMAN "Receptor-type tyrosine-protein phosphatase gamma, Protein-tyrosine phosphatase gamma, R-PTP-gamma, EC 3.1.3.48" PTPRG PTPG Homo sapiens (Human) brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005887; GO:0006470; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062 IHACYTVR 9.789999962 3.76E-05 3.76E-05 0.226554502 1022.103913 14.2123 0 14.22254 14.3224 18.41556 15.27343 14.44337 14.75747 14.92136 16.18574 16.54306 14.58776 14.43928 15.19522 0 0 11.74405 0 0 14.39181 13.57466 15.95509 14.41178 15.20698 12.54449 0 13.61062 14.70786 0 0 15.32825 16.60078 0 0 14.17798 0 15.85849 0 16.00587 0 0 14.36641 0 15.89256 0 0 14.59108 0 P23471 PTPRZ_HUMAN "Receptor-type tyrosine-protein phosphatase zeta, R-PTP-zeta, EC 3.1.3.48 (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2)" PTPRZ1 HTPZP2 PTPRZ PTPRZ2 PTPZ Homo sapiens (Human) axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445] integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0002244; GO:0004725; GO:0005001; GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0006470; GO:0007409; GO:0007417; GO:0007611; GO:0031226; GO:0031641; GO:0035335; GO:0043524; GO:0045202; GO:0048709; GO:0048714; GO:0070445; GO:0072534 LIHSDEILTSTK 21.38999939 1 1 0.11676666 1356.367065 0 0 0 17.00661 0 15.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.82352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23497 SP100_HUMAN Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa) SP100 Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; interferon-gamma-mediated signaling pathway [GO:0060333]; maintenance of protein location [GO:0045185]; negative regulation of cellular component movement [GO:0051271]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Fas signaling pathway [GO:1902044]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to retinoic acid [GO:0032526]; response to type I interferon [GO:0034340]; retinoic acid receptor signaling pathway [GO:0048384]; telomere maintenance [GO:0000723]; type I interferon signaling pathway [GO:0060337]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; interferon-gamma-mediated signaling pathway [GO:0060333]; maintenance of protein location [GO:0045185]; negative regulation of cellular component movement [GO:0051271]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Fas signaling pathway [GO:1902044]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to retinoic acid [GO:0032526]; response to type I interferon [GO:0034340]; retinoic acid receptor signaling pathway [GO:0048384]; telomere maintenance [GO:0000723]; type I interferon signaling pathway [GO:0060337]" "chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" GO:0000122; GO:0000723; GO:0000781; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0006978; GO:0010596; GO:0016604; GO:0016605; GO:0019900; GO:0019904; GO:0032526; GO:0032897; GO:0034097; GO:0034340; GO:0034341; GO:0034399; GO:0042802; GO:0042803; GO:0043392; GO:0043433; GO:0045185; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0046826; GO:0046983; GO:0048384; GO:0051091; GO:0051271; GO:0060333; GO:0060337; GO:0061629; GO:0070087; GO:1902041; GO:1902044 ANTRPLKR 8.739999771 0.305004865 0.305004865 0.210638367 956.3522284 12.82498 15.27257 13.75816 15.2307 0 15.79442 0 14.73187 0 14.57121 16.1225 15.19086 0 0 13.85593 13.48988 0 0 0 14.42207 0 0 0 0 14.76235 15.1918 16.73656 0 15.07867 13.48609 15.59391 15.71767 12.18844 14.93491 15.08852 14.94049 0 0 13.89602 16.9204 15.88952 15.62371 15.60115 15.66526 12.36294 13.93859 14.80655 0 P23508 CRCM_HUMAN "Colorectal mutant cancer protein, Protein MCC" MCC Homo sapiens (Human) establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] signaling receptor activity [GO:0038023] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090 LTKSSEIR 5.539999962 1 1 0.106577258 931.9178255 17.16266 0 17.60025 14.96083 15.97357 0 17.34157 0 15.83279 15.1278 0 15.74874 17.46269 16.79502 0 0 17.17076 17.21491 18.1134 16.52947 17.6331 17.04181 0 15.16684 0 16.34619 0 0 16.36938 0 0 18.37738 17.51806 17.41448 13.91165 14.63127 16.31747 18.17679 0 0 16.14291 0 0 15.44479 0 15.5559 17.56473 0 P23526 SAHH_HUMAN "Adenosylhomocysteinase, AdoHcyase, EC 3.3.1.1 (S-adenosyl-L-homocysteine hydrolase)" AHCY SAHH Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] adenosylhomocysteinase activity [GO:0004013] GO:0004013; GO:0005829; GO:0006730; GO:0033353; GO:0042470; GO:0070062 MSDKLPYK 1.629999995 1 1 1.71E-12 981.6471029 14.49056 0 0 0 0 14.28296 11.18347 0 15.03173 0 0 0 0 15.13911 0 12.43467 14.84475 13.98157 0 11.60211 14.95607 0 0 0 13.17421 14.26696 15.35657 11.47818 15.2332 0 0 0 0 12.61375 15.51111 14.64497 14.26544 13.81069 0 14.18502 14.22811 11.8849 0 0 0 0 0 0 P23588 IF4B_HUMAN "Eukaryotic translation initiation factor 4B, eIF-4B" EIF4B Homo sapiens (Human) eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743] GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010 LPREPSNPER 7.849999905 1 1 0.034724364 1194.343974 0 0 0 16.07337 15.81982 0 0 15.0382 14.68224 0 14.37991 14.42007 7.956654 16.76566 0 0 0 15.08293 11.63948 0 15.75207 0 18.6197 13.91731 0 0 0 0 0 0 16.09999 18.1137 0 6.804862 0 0 0 0 16.14268 0 0 0 14.56332 0 0 0 0 12.59336 P23634 AT2B4_HUMAN "Plasma membrane calcium-transporting ATPase 4, PMCA4, EC 7.2.2.10 (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)" ATP2B4 ATP2B2 MXRA1 Homo sapiens (Human) calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080] GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0010751; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019829; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0033138; GO:0034220; GO:0036126; GO:0036487; GO:0043005; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0099059; GO:0140199; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145; GO:2000481 LVPSSSYIK 5.190000057 1 1 0.136233144 995.3394229 14.70808 14.27663 15.01978 0 14.27462 15.46423 0 0 0 0 14.99794 17.00587 14.43917 14.54002 0 0 0 0 0 0 0 0 15.80361 0 15.43362 0 0 0 0 0 17.38815 0 0 15.37954 0 0 14.70964 0 0 0 0 0 0 0 0 0 0 0 P23677 IP3KA_HUMAN "Inositol-trisphosphate 3-kinase A, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase A, IP3 3-kinase A, IP3K A, InsP 3-kinase A)" ITPKA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]" "ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; small GTPase binding [GO:0031267]" GO:0000828; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006020; GO:0007165; GO:0008440; GO:0016301; GO:0030036; GO:0031267; GO:0032958; GO:0043197; GO:0046854; GO:0048167; GO:0061003; GO:0097062 TTPLPDGQILDHR 5.710000038 1 1 0.456750582 1463.7373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.08232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.12136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23743 DGKA_HUMAN "Diacylglycerol kinase alpha, DAG kinase alpha, EC 2.7.1.107 (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha, DGK-alpha)" DGKA DAGK DAGK1 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543] GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834 RPHGDIYGINQALGATAK 2.569999933 1 1 0.186899429 1882.622519 0 16.30376 13.87861 0 0 0 0 11.01243 14.73309 0 0 0 0 0 0 13.27943 0 0 0 0 16.04263 0 0 0 0 0 15.65764 0 0 0 0 15.78603 0 15.44555 0 15.10259 15.756 15.27699 16.04897 12.42833 12.54896 14.87289 0 0 0 0 0 0 P23759 PAX7_HUMAN Paired box protein Pax-7 (HuP1) PAX7 HUP1 Homo sapiens (Human) anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007517; GO:0009653; GO:0043066; GO:0048856; GO:1990837 MAALPGTVPRMMRPAPGQNYPR 4.639999866 1 1 0.061591366 2426.830222 0 0 15.38444 13.08328 16.20675 0 0 12.23479 17.61581 13.36105 14.72508 0 0 0 0 0 14.02237 14.37528 0 0 0 0 15.50645 10.59933 0 0 0 18.59425 0 0 0 0 0 0 15.32126 0 0 18.48992 15.3938 0 0 0 0 0 0 0 0 0 P23769 GATA2_HUMAN Endothelial transcription factor GATA-2 (GATA-binding protein 2) GATA2 Homo sapiens (Human) "cell differentiation in hindbrain [GO:0021533]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; urogenital system development [GO:0001655]; vascular wound healing [GO:0061042]; ventral spinal cord interneuron differentiation [GO:0021514]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; cell differentiation in hindbrain [GO:0021533]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; urogenital system development [GO:0001655]; vascular wound healing [GO:0061042]; ventral spinal cord interneuron differentiation [GO:0021514]" "C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000978; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001655; GO:0001709; GO:0001764; GO:0001892; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006909; GO:0007204; GO:0008270; GO:0010628; GO:0010629; GO:0010725; GO:0021514; GO:0021533; GO:0021902; GO:0021954; GO:0021983; GO:0033993; GO:0035019; GO:0035065; GO:0035854; GO:0042472; GO:0043306; GO:0043536; GO:0045165; GO:0045599; GO:0045648; GO:0045650; GO:0045654; GO:0045666; GO:0045746; GO:0045766; GO:0045944; GO:0048469; GO:0048873; GO:0050766; GO:0060100; GO:0060216; GO:0060872; GO:0061042; GO:0061629; GO:0070345; GO:0070742; GO:0090050; GO:0090102; GO:0097154; GO:1902895; GO:1903589; GO:1990837; GO:2000178; GO:2000352; GO:2000977 MNGQNRPLIKPKR 8.149999619 0.378360212 0.378360212 0.449583388 1569.484469 19.5158 0 0 0 17.18353 0 21.03955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38592 0 0 0 0 0 0 0 18.4264 0 0 0 0 0 0 18.40417 0 0 0 0 18.68584 21.94406 0 0 0 P23771 GATA3_HUMAN Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3) GATA3 Homo sapiens (Human) "anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; defense response [GO:0006952]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; gene expression [GO:0010467]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine production [GO:0001817]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; type IV hypersensitivity [GO:0001806]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud formation [GO:0060676]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; defense response [GO:0006952]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; gene expression [GO:0010467]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine production [GO:0001817]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; type IV hypersensitivity [GO:0001806]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud formation [GO:0060676]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001223; GO:0001227; GO:0001228; GO:0001701; GO:0001709; GO:0001764; GO:0001806; GO:0001817; GO:0001822; GO:0001823; GO:0002088; GO:0002520; GO:0002572; GO:0003180; GO:0003215; GO:0003281; GO:0003677; GO:0003700; GO:0005134; GO:0005634; GO:0005654; GO:0006338; GO:0006952; GO:0006959; GO:0007165; GO:0007411; GO:0008270; GO:0008285; GO:0008584; GO:0009410; GO:0009615; GO:0009653; GO:0009791; GO:0009967; GO:0010332; GO:0010467; GO:0010595; GO:0010719; GO:0010975; GO:0014065; GO:0030217; GO:0030218; GO:0030856; GO:0031929; GO:0032689; GO:0032703; GO:0032736; GO:0032753; GO:0032754; GO:0033600; GO:0035162; GO:0035457; GO:0035799; GO:0035898; GO:0042421; GO:0042472; GO:0042802; GO:0043370; GO:0043523; GO:0043583; GO:0043627; GO:0045061; GO:0045064; GO:0045087; GO:0045165; GO:0045471; GO:0045582; GO:0045599; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0048485; GO:0048538; GO:0048568; GO:0048589; GO:0048646; GO:0050728; GO:0050852; GO:0051569; GO:0051897; GO:0060017; GO:0060037; GO:0060065; GO:0060231; GO:0060374; GO:0060676; GO:0061085; GO:0061290; GO:0061629; GO:0070888; GO:0071353; GO:0071356; GO:0071442; GO:0071599; GO:0071773; GO:0071837; GO:0072107; GO:0072178; GO:0072179; GO:0072182; GO:0072197; GO:0072676; GO:0090102; GO:1901536; GO:1902895; GO:1990837; GO:2000114; GO:2000146; GO:2000352; GO:2000553; GO:2000607; GO:2000611; GO:2000617; GO:2000679; GO:2000683; GO:2000703; GO:2000734 YQVPLPDSMK 7.619999886 0.096987322 0.096987322 0.115419578 1172.245861 0 0 0 0 0 17.48848 0 0 0 0 10.40838 0 0 15.62873 18.79077 0 16.14392 0 0 16.96139 16.69368 15.12187 0 0 14.08293 0 0 18.31003 0 16.58049 9.943246 19.32541 0 17.64933 0 17.61073 16.92243 0 0 0 16.15476 17.00745 0 15.34888 19.69693 14.26749 0 16.27946 P23919 KTHY_HUMAN "Thymidylate kinase, EC 2.7.4.9 (dTMP kinase)" DTYMK CDC8 TMPK TYMK Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; thymidine biosynthetic process [GO:0046105] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; thymidine biosynthetic process [GO:0046105] ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041] GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0046105; GO:0071363 LLSSYLQKK 1.230000019 1 1 0.073025028 1080.103446 0 0 0 15.09966 12.60845 0 0 14.70854 13.05814 0 0 15.28101 0 14.28202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23945 FSHR_HUMAN "Follicle-stimulating hormone receptor, FSH-R (Follitropin receptor)" FSHR LGR1 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283] follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528] GO:0004963; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007190; GO:0007283; GO:0007292; GO:0008406; GO:0008528; GO:0008584; GO:0008585; GO:0009755; GO:0010738; GO:0014068; GO:0016021; GO:0042699; GO:0043235; GO:0070374; GO:0071372 MALLLVSLLAFLSLGSGCHHR 1.590000033 0.652694941 0.652694941 0.197698472 2311.78743 0 0 0 14.66623 14.85221 0 11.14068 0 0 17.12362 0 13.7824 0 15.05056 14.59302 12.57963 0 0 0 0 0 0 15.01375 13.69862 12.75815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.25521 0 0 0 0 0 15.37714 0 P23975 SC6A2_HUMAN "Sodium-dependent noradrenaline transporter (Norepinephrine transporter, NET) (Solute carrier family 6 member 2)" SLC6A2 NAT1 NET1 SLC6A5 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334] GO:0003779; GO:0005326; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0007268; GO:0008504; GO:0009410; GO:0009986; GO:0015844; GO:0015874; GO:0016020; GO:0032809; GO:0035725; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0051620; GO:0070050 NGVQCLLAPR 6.460000038 1 1 0 1128.107423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24043 LAMA2_HUMAN Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) LAMA2 LAMM Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]" basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] "basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]" extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0030334; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0045785; GO:0045995; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046 ADAVR 6.590000153 1 1 0.213908494 531.148643 21.00065 17.71219 16.93293 15.47288 18.94195 19.27722 19.08435 18.79632 19.8485 19.89354 17.5563 18.08605 18.4883 17.53272 17.98589 20.73543 17.59656 18.3007 18.46921 16.71507 18.85563 19.24538 17.19011 19.9161 0 20.29735 20.64292 16.66467 19.51908 19.65993 21.34558 19.52242 17.78222 16.73917 20.0084 0 19.87393 18.59037 18.16333 19.76605 19.4621 18.00175 19.69067 19.78545 19.55984 18.11697 17.67431 20.00587 P24046 GBRR1_HUMAN Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor) GABRR1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; identical protein binding [GO:0042802]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; identical protein binding [GO:0042802]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098978; GO:0098982; GO:0099507; GO:1902476; GO:1902711; GO:1904315 SQRSSYVSMR 5.5 1 1 0.323824405 1218.965539 0 0 0 10.62519 0 10.05176 0 8.968627 0 0 13.00693 0 0 0 0 0 13.42151 0 17.53091 14.71059 0 14.30363 0 0 0 0 16.14436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24278 ZBT25_HUMAN Zinc finger and BTB domain-containing protein 25 (Zinc finger protein 46) (Zinc finger protein KUP) ZBTB25 C14orf51 KUP ZNF46 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0006357; GO:0046872 GPKQIVDHSR 9.649999619 1 1 0.08485826 1136.515627 0 13.5591 15.21127 0 0 15.65896 7.148998 0 0 0 14.84109 0 0 0 0 0 0 0 0 11.81745 0 0 14.29637 0 14.79819 0 0 13.58843 0 0 0 14.37685 0 0 0 0 0 0 0 0 0 0 13.56428 0 0 0 13.14589 0 P24298 ALAT1_HUMAN "Alanine aminotransferase 1, ALT1, EC 2.6.1.2 (Glutamate pyruvate transaminase 1, GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1)" GPT AAT1 GPT1 Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular response to insulin stimulus [GO:0032869]; L-alanine catabolic process [GO:0042853]; positive regulation of gluconeogenesis [GO:0045722]; response to starvation [GO:0042594] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular response to insulin stimulus [GO:0032869]; L-alanine catabolic process [GO:0042853]; positive regulation of gluconeogenesis [GO:0045722]; response to starvation [GO:0042594] L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170] GO:0004021; GO:0005829; GO:0009058; GO:0030170; GO:0032869; GO:0042594; GO:0042853; GO:0045722; GO:0070062 AWALDVAELHRALGQAR 10.03999996 0.2560395 0.2560395 0.139038581 1876.364665 0 0 0 16.22481 0 16.86836 0 0 12.88028 0 0 0 0 9.981988 15.20149 12.36101 0 0 0 0 14.52642 0 0 11.97532 13.83281 0 12.14592 17.03841 0 0 16.28425 13.54497 15.68865 0 15.4491 14.8893 15.00223 16.81449 18.02919 13.39363 0 11.21561 17.44265 14.46825 0 16.24993 15.22804 18.27799 P24386 RAE1_HUMAN "Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1, REP-1) (TCD protein)" CHM REP1 TCD Homo sapiens (Human) protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267] GO:0004663; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005968; GO:0006612; GO:0007264; GO:0007601; GO:0016192; GO:0018344; GO:0031267 FNIDLVSKLLYSR 3.829999924 1 1 0.342063078 1568.104755 14.26739 13.98199 13.94223 15.19837 12.88537 12.40896 14.47559 0 14.14327 14.8826 0 16.45267 0 0 0 14.98107 13.44868 13.92104 0 0 0 0 17.26178 0 0 0 15.46092 0 0 0 0 0 0 0 0 0 16.73038 0 0 0 0 0 0 0 0 0 0 15.25643 P24387 CRHBP_HUMAN "Corticotropin-releasing factor-binding protein, CRF-BP, CRF-binding protein (Corticotropin-releasing hormone-binding protein, CRH-BP)" CRHBP CRFBP Homo sapiens (Human) "behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; negative regulation of corticotropin secretion [GO:0051460]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]" axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196] "axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196]; corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277]; behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; negative regulation of corticotropin secretion [GO:0051460]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]" corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277] GO:0001963; GO:0005576; GO:0005615; GO:0005634; GO:0005767; GO:0005771; GO:0005874; GO:0006954; GO:0007165; GO:0007565; GO:0007611; GO:0009755; GO:0030141; GO:0030425; GO:0031045; GO:0035865; GO:0042277; GO:0043196; GO:0043204; GO:0043679; GO:0045055; GO:0048149; GO:0051424; GO:0051459; GO:0051460; GO:0071277; GO:0071314; GO:0071320; GO:0071356; GO:0071391; GO:0071392; GO:0071466; GO:0080135; GO:0097211; GO:1900011; GO:2000310 NCSFSIIYPVVIK 6.25 1 1 0.154956444 1539.794606 18.20912 13.72815 12.68737 15.49268 14.37537 14.60065 0 0 11.45084 13.3509 14.50595 13.09973 0 0 0 0 0 0 0 0 0 0 0 0 12.33595 16.68666 0 12.68274 13.9905 15.14622 15.64858 0 0 0 0 0 0 0 0 14.41788 0 0 0 0 0 0 0 0 P24394 IL4RA_HUMAN "Interleukin-4 receptor subunit alpha, IL-4 receptor subunit alpha, IL-4R subunit alpha, IL-4R-alpha, IL-4RA (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha, Soluble IL-4 receptor subunit alpha, Soluble IL-4R-alpha, sIL4Ralpha/prot (IL-4-binding protein, IL4-BP) ]" IL4R IL4RA 582J2.1 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165] cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913] GO:0002532; GO:0002639; GO:0004896; GO:0004913; GO:0005615; GO:0005654; GO:0005886; GO:0005887; GO:0006955; GO:0007165; GO:0009897; GO:0016064; GO:0019221; GO:0030728; GO:0032722; GO:0034451; GO:0042127; GO:0042832; GO:0043032; GO:0043235; GO:0043306; GO:0043627; GO:0045626; GO:0045630; GO:0120162; GO:1901741; GO:1990834 IVNFVSVGPTYMRVS 3.519999981 0.089389458 0.089389458 0.146962806 1683.748091 0 16.10092 0 0 0 16.40424 14.98174 18.41749 0 17.73779 0 12.32163 15.99345 0 16.0361 14.27956 14.57645 16.12494 14.82433 12.69557 13.73627 16.28421 0 0 14.35908 0 14.89272 16.71565 15.03328 16.55348 16.69215 15.93955 16.70524 18.28516 15.04309 17.92485 0 0 0 14.92135 16.49061 16.23142 17.13597 0 0 0 16.60525 14.39097 P24462 CP3A7_HUMAN "Cytochrome P450 3A7, EC 1.14.14.1 (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)" CYP3A7 Homo sapiens (Human) estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649] GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006694; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0019825; GO:0020037; GO:0042572; GO:0042573; GO:0050649; GO:0062183; GO:0070330; GO:0070989; GO:0101020; GO:0101021 KVISFLTK 17.52000046 8.97E-06 8.97E-06 0.138998462 935.9057344 17.35969 17.49731 12.13428 14.53071 0 13.55794 15.06165 17.96222 13.06138 16.8205 14.28108 16.26318 15.1478 16.07281 13.44543 13.70844 15.44858 15.7158 15.18454 15.69851 15.48213 15.13129 14.77697 16.23307 16.47157 14.04727 0 15.62881 14.54223 0 18.15408 16.53964 13.44556 15.17184 0 14.7473 0 17.32549 16.14154 15.34062 13.68286 0 15.09768 14.87055 16.53161 13.92199 15.80005 14.22558 P24539 AT5F1_HUMAN "ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b, ATPase subunit b)" ATP5PB ATP5F1 Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762] "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]" "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762]" proton transmembrane transporter activity [GO:0015078] GO:0000276; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0015078; GO:0015986; GO:0016020; GO:0021762; GO:0042776 HVVQSISTQQEKETIAK 2.190000057 1 1 0.147893201 1918.87977 0 0 14.45401 0 0 0 0 0 13.62095 0 0 13.87715 14.56329 0 0 0 0 0 0 14.10552 0 0 0 0 0 16.33907 15.42424 15.66956 0 14.11131 16.37401 0 13.80242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24588 AKAP5_HUMAN "A-kinase anchor protein 5, AKAP-5 (A-kinase anchor protein 79 kDa, AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)" AKAP5 AKAP79 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; calmodulin binding [GO:0005516]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165] adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; calmodulin binding [GO:0005516]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124] GO:0005516; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0007194; GO:0007268; GO:0008179; GO:0008287; GO:0009898; GO:0010738; GO:0014069; GO:0017124; GO:0030346; GO:0031698; GO:0032590; GO:0034237; GO:0035254; GO:0043197; GO:0045121; GO:0045762; GO:0050811; GO:0051018; GO:0060076; GO:0060090; GO:0070886; GO:0097110; GO:0098837; GO:1900273; GO:1901387; GO:1903078; GO:1905665; GO:1905751 MEPIAIIITDTEISEFDVTK 6.460000038 0.31640628 0.31640628 0.212750464 2264.089411 0 0 16.23513 14.25978 15.88858 0 14.59815 0 14.08066 0 0 15.12351 14.31279 0 0 13.98384 0 0 0 0 0 16.63712 17.77605 0 0 14.33823 0 0 0 0 0 16.63431 16.80534 0 0 14.14942 17.85082 0 13.8312 16.89962 17.74926 15.662 0 0 14.88601 13.74969 0 0 P24723 KPCL_HUMAN "Protein kinase C eta type, EC 2.7.11.13 (PKC-L) (nPKC-eta)" PRKCH PKCL PRKCL Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165] ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0010744; GO:0018105; GO:0019899; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:1903078; GO:2000810 MNVHIRCQANVAPNCGVNAVELAK 6.739999771 0.511851668 0.511851668 0.135471713 2680.881628 0 0 14.93232 15.41795 0 15.43245 18.18173 0 0 13.76056 15.29098 12.911 11.48331 0 0 12.98015 0 0 0 0 0 0 13.88831 0 11.80125 12.57778 0 13.87338 0 0 0 16.55133 0 0 14.46109 0 0 0 0 0 0 0 0 13.72501 0 0 0 0 P24752 THIL_HUMAN "Acetyl-CoA acetyltransferase, mitochondrial, EC 2.3.1.9 (Acetoacetyl-CoA thiolase) (T2)" ACAT1 ACAT MAT Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594] acetyl-CoA C-acetyltransferase activity [GO:0003985]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955] GO:0001889; GO:0003985; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0034435; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:0120225; GO:1902224; GO:1902860 VDFSKVPK 2.930000067 0.847869933 0.847869933 0.224483953 920.2939333 16.44088 14.5605 16.44748 15.72379 0 0 0 0 15.06718 16.21119 17.35951 12.95365 15.53929 0 14.60402 14.29624 15.7768 15.78113 15.35523 16.43688 14.32235 0 15.68981 0 16.39249 0 15.30172 15.34774 14.27615 0 16.47588 0 0 14.31914 0 0 0 0 0 0 15.50799 15.38367 0 0 0 15.12138 0 0 P24821 TENA_HUMAN "Tenascin, TN (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C, TN-C)" TNC HXB Homo sapiens (Human) cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]; extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545]; cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611] extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545] GO:0001558; GO:0001649; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007528; GO:0008284; GO:0009611; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0045545; GO:0050727; GO:0060739; GO:0060740; GO:0062023; GO:0090733; GO:0098966 FSVGDAK 3.75999999 1 1 0.181178796 724.2606762 0 0 0 0 0 0 0 0 17.52191 0 0 0 15.17671 17.32697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.42386 0 0 0 0 0 18.25367 0 0 0 0 0 0 17.79541 0 0 16.43069 0 P24903 CP2F1_HUMAN "Cytochrome P450 2F1, EC 1.14.14.1 (CYPIIF1)" CYP2F1 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; organic acid metabolic process [GO:0006082]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; organic acid metabolic process [GO:0006082]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]" "arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0009636; GO:0016712; GO:0019373; GO:0019825; GO:0020037; GO:0043231; GO:0070330; GO:1901170 ARLPALK 5.71999979 1 1 0.117013234 770.3126832 13.14719 16.38742 15.32268 13.98708 14.03561 12.89 14.34024 13.33416 15.31308 15.19768 12.6889 12.86717 0 0 0 0 15.53812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.69408 0 0 0 0 0 0 15.31977 0 15.89312 0 0 0 P24928 RPB1_HUMAN "DNA-directed RNA polymerase II subunit RPB1, RNA polymerase II subunit B1, EC 2.7.7.6 (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1, EC 2.7.7.48)" POLR2A POLR2 Homo sapiens (Human) "DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625] GO:0003677; GO:0003723; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0005694; GO:0005737; GO:0006353; GO:0006355; GO:0006366; GO:0008022; GO:0019900; GO:0031625; GO:0033120; GO:0046872; GO:1990841 AMQKSGRPLK 8.479999542 0.050566699 0.050566699 0.119785985 1114.570668 0 0 16.63104 0 16.72217 0 15.6945 0 0 13.21293 0 14.66397 0 0 0 13.82763 15.31206 0 0 11.88425 13.80678 0 18.23308 12.98427 0 0 8.095345 0 16.21315 0 10.18171 15.60167 16.59043 0 17.37893 0 15.70206 17.3187 15.87233 16.91937 16.2552 0 0 0 15.1605 16.5433 15.42066 14.67483 P25025 CXCR2_HUMAN "C-X-C chemokine receptor type 2, CXC-R2, CXCR-2 (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B, IL-8R B) (IL-8 receptor type 2) (CD antigen CD182)" CXCR2 IL8RB Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918] GO:0002407; GO:0004918; GO:0004930; GO:0005654; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007200; GO:0007204; GO:0008284; GO:0009897; GO:0009986; GO:0015630; GO:0016020; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0019959; GO:0030593; GO:0030667; GO:0031623; GO:0038112; GO:0042119; GO:0042629; GO:0060326; GO:0072686 YLAIVHATRTLTQK 7.53000021 1 1 0.355975647 1610.606665 12.93303 12.8338 13.68809 0 15.61626 0 14.38368 0 15.12922 13.49531 13.89157 16.04709 15.95889 12.92905 13.65231 13.41152 16.06739 0 0 0 0 0 0 0 14.75792 0 0 15.46638 0 0 0 15.82219 0 0 0 0 0 0 0 16.20992 0 0 0 0 16.16865 0 0 0 P25054 APC_HUMAN "Adenomatous polyposis coli protein, Protein APC (Deleted in polyposis 2.5)" APC DP2.5 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell differentiation [GO:0045595]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909] adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909]; beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell differentiation [GO:0045595]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055] beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625] GO:0000281; GO:0000776; GO:0001708; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0006974; GO:0007026; GO:0007094; GO:0007155; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0010942; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019887; GO:0019901; GO:0030027; GO:0030335; GO:0030877; GO:0031274; GO:0031625; GO:0032587; GO:0032886; GO:0043065; GO:0043161; GO:0045295; GO:0045595; GO:0045732; GO:0045736; GO:0048471; GO:0051010; GO:0051988; GO:0065003; GO:0070830; GO:0070840; GO:0090090; GO:0120162; GO:1902807; GO:1904781; GO:1990909; GO:2000134 GQPKPILQK 11.02999973 1 1 2.30E-13 1005.271905 15.93077 0 16.80179 16.56148 0 0 16.59215 15.68456 15.83667 17.4116 16.2515 15.69505 0 16.47388 0 16.59162 0 16.05189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25067 CO8A2_HUMAN Collagen alpha-2(VIII) chain (Endothelial collagen) COL8A2 Homo sapiens (Human) angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674] GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609 GPPGPKGEAGPGGPPGVPGIR 7.46999979 0.839480221 0.839480221 0.266194977 1850.942787 15.57658 14.60454 15.56563 0 0 11.28788 14.28115 14.88224 0 0 0 0 15.03796 0 0 15.51112 0 15.06111 0 0 0 0 16.28075 0 0 0 0 0 0 0 0 13.32135 0 0 0 0 0 0 15.32323 0 0 0 0 0 0 0 0 0 P25090 FPR2_HUMAN "N-formyl peptide receptor 2 (FMLP-related receptor I, FMLP-R-I) (Formyl peptide receptor-like 1) (HM63) (Lipoxin A4 receptor, LXA4 receptor) (RFP)" FPR2 FPRH1 FPRL1 LXA4R Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898] amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023] GO:0001540; GO:0001774; GO:0001934; GO:0002430; GO:0002768; GO:0004875; GO:0004930; GO:0004982; GO:0005124; GO:0005737; GO:0005886; GO:0006898; GO:0006935; GO:0006954; GO:0007155; GO:0007166; GO:0007186; GO:0007193; GO:0007200; GO:0007204; GO:0016021; GO:0019722; GO:0032930; GO:0035579; GO:0038023; GO:0038024; GO:0042742; GO:0045089; GO:0048143; GO:0050728; GO:0050766; GO:0050918; GO:0061903; GO:0070374; GO:0070821; GO:0090026; GO:0101003; GO:1904646 VAITMLTAR 5.690000057 0.776135504 0.776135504 0.206104095 991.0980565 14.31647 16.6524 14.19714 0 0 0 0 18.19661 0 0 0 0 15.7061 15.82093 0 0 14.1686 0 0 0 0 14.45224 0 0 0 0 0 0 15.24349 14.11575 10.93091 0 0 17.30657 0 0 0 0 14.86826 14.31821 15.43982 0 16.83371 0 0 0 0 0 P25092 GUC2C_HUMAN "Guanylyl cyclase C, GC-C, EC 4.6.1.2 (Heat-stable enterotoxin receptor, STA receptor, hSTAR) (Intestinal guanylate cyclase)" GUCY2C GUC2C STAR Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643] GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0009636; GO:0015643; GO:0016021; GO:0016941; GO:0017046; GO:0035556; GO:0042127 NESYMDTLIR 4.75 1 1 1.60E-12 1256.513798 13.00239 0 0 14.3196 12.82854 11.08301 15.43394 0 6.684303 0 14.3062 0 12.71263 0 11.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25098 ARBK1_HUMAN "Beta-adrenergic receptor kinase 1, Beta-ARK-1, EC 2.7.11.15 (G-protein coupled receptor kinase 2)" GRK2 ADRBK1 BARK BARK1 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; regulation of the force of heart contraction [GO:0002026]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; regulation of the force of heart contraction [GO:0002026]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079] alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] GO:0001664; GO:0002026; GO:0002029; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0009966; GO:0016020; GO:0018105; GO:0018107; GO:0019079; GO:0031623; GO:0031694; GO:0031755; GO:0033605; GO:0045202; GO:0045988; GO:0046718; GO:0047696; GO:0060048; GO:1901081 ILLPEPSIR 8.350000381 1 1 0.250521057 1037.986707 15.47177 15.08728 14.87193 16.20667 0 14.87483 14.24553 0 14.5595 0 0 0 15.2912 0 0 0 14.73462 0 16.05243 14.09823 14.08874 0 0 0 16.15906 0 14.60375 0 0 0 15.04421 0 13.77996 0 0 0 0 0 0 0 15.68138 0 0 15.6406 0 15.20836 0 0 P25101 EDNRA_HUMAN "Endothelin-1 receptor (Endothelin receptor type A, ET-A, ETA-R, hET-AR)" EDNRA ETA ETRA Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; glomerular visceral epithelial cell differentiation [GO:0072112]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435]; activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; glomerular visceral epithelial cell differentiation [GO:0072112]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310] endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435] GO:0000278; GO:0001569; GO:0001666; GO:0001701; GO:0001974; GO:0001975; GO:0002027; GO:0003094; GO:0003207; GO:0003220; GO:0003228; GO:0003253; GO:0003357; GO:0004435; GO:0004962; GO:0005886; GO:0005887; GO:0006468; GO:0006874; GO:0006939; GO:0007005; GO:0007165; GO:0007186; GO:0007190; GO:0007193; GO:0007202; GO:0007204; GO:0007249; GO:0007585; GO:0008217; GO:0008283; GO:0009611; GO:0010259; GO:0010467; GO:0010737; GO:0010827; GO:0014034; GO:0014824; GO:0016322; GO:0030202; GO:0030878; GO:0034599; GO:0035050; GO:0035904; GO:0042310; GO:0042415; GO:0042474; GO:0044751; GO:0048484; GO:0048485; GO:0048675; GO:0048706; GO:0050905; GO:0055078; GO:0060070; GO:0060324; GO:0060385; GO:0061028; GO:0061626; GO:0070294; GO:0070588; GO:0071372; GO:0071373; GO:0071806; GO:0072011; GO:0072112; GO:0086101; GO:0097018; GO:0097084; GO:0097152; GO:0097492; GO:1902287; GO:1903210; GO:1903537; GO:1904888; GO:1905144; GO:1905871; GO:2001259 TVYNEMDK 3.970000029 0.911170602 0.911170602 0.244387869 1014.428829 14.17432 16.48572 15.21749 15.92752 14.81888 17.42311 12.39711 16.49562 15.19305 13.7494 15.71513 12.61059 15.307 14.11329 0 16.06696 0 14.73455 0 14.79452 17.1687 0 0 0 0 0 14.903 0 15.4045 0 16.59841 15.57582 16.76636 12.6507 16.69094 15.93012 0 17.01552 0 16.8533 0 0 0 0 0 0 16.5 15.9854 P25205 MCM3_HUMAN "DNA replication licensing factor MCM3, EC 3.6.4.12 (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102)" MCM3 Homo sapiens (Human) DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174] "alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]" "alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] GO:0000727; GO:0000781; GO:0003677; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005658; GO:0005813; GO:0006268; GO:0006270; GO:0006271; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0048471; GO:0071162; GO:1902975 AGIHAR 3.440000057 1 1 0.280803267 621.6574238 17.15264 0 17.70041 0 17.06231 17.68281 0 0 17.42926 0 16.00813 0 0 15.88033 15.30063 0 16.55379 16.55021 0 0 0 0 17.13739 16.40808 17.24649 0 0 0 0 0 0 0 0 0 0 18.12807 17.55942 18.6033 0 0 16.90567 0 18.03805 0 0 0 0 0 P25391 LAMA1_HUMAN "Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha, S-LAM alpha)" LAMA1 LAMA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888] extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102] GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0043010; GO:0043208; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046 QAASIKVAVSADR 12.48999977 1 1 0.062554892 1315.296272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.19983 0 0 0 0 P25440 BRD2_HUMAN Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein) BRD2 KIAA9001 RING3 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674] GO:0000785; GO:0001843; GO:0003682; GO:0004674; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0006468; GO:0007283; GO:0016607; GO:0070577 KPVGKTK 5.78000021 1 1 0.237081701 758.5634154 14.58637 14.95896 15.21087 0 13.33683 0 14.23426 0 15.95137 15.9214 0 15.78777 14.50894 15.39258 14.98831 0 0 0 0 0 15.14731 15.6265 0 15.68712 0 14.71786 16.12012 15.53408 0 0 15.27464 0 0 0 0 0 16.22773 0 0 0 0 0 0 0 0 0 0 0 P25686 DNJB2_HUMAN "DnaJ homolog subfamily B member 2 (Heat shock 40 kDa protein 3) (Heat shock protein J1, HSJ-1)" DNAJB2 HSJ1 HSPF3 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; neuron cellular homeostasis [GO:0070050]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; neuron cellular homeostasis [GO:0070050]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082] GO:0001671; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0008285; GO:0016234; GO:0030308; GO:0030433; GO:0030544; GO:0031227; GO:0031396; GO:0031398; GO:0031593; GO:0031625; GO:0031965; GO:0032091; GO:0032436; GO:0032781; GO:0032880; GO:0042026; GO:0042406; GO:0043130; GO:0043161; GO:0048471; GO:0051082; GO:0051087; GO:0061077; GO:0070050; GO:0070628; GO:0090084; GO:0090086; GO:0098554; GO:0140036; GO:1903644 GEATKR 9.539999962 1 1 0.20574442 660.2248822 14.1396 16.14088 16.40766 13.89842 0 0 11.18259 14.89626 15.46293 0 0 16.23572 0 15.212 15.7101 16.30515 14.65204 15.46004 16.02372 0 16.21169 16.40406 16.94272 12.58326 16.55313 14.39877 0 0 0 0 0 0 0 0 16.22803 0 0 15.59845 17.1533 16.70283 0 14.27833 0 0 0 0 15.88114 0 P25705 ATPA_HUMAN "ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)" ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM Homo sapiens (Human) aging [GO:0007568]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850] "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]" "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; aging [GO:0007568]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850]" "ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]" GO:0001937; GO:0002020; GO:0003723; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0006915; GO:0007568; GO:0009986; GO:0014850; GO:0015986; GO:0016020; GO:0016887; GO:0042288; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0045471; GO:0046933; GO:0070062; GO:0071549; GO:0071732 AMKQVAGTMK 1.799999952 1 1 0.267167879 1080.423914 0 17.9082 0 16.58348 0 0 0 0 0 0 0 0 18.13688 16.47456 0 0 0 0 18.4271 0 16.81205 0 0 0 17.9445 19.48786 0 16.02556 16.16637 16.74331 0 17.52546 0 0 0 17.30521 18.26491 0 0 0 16.72419 0 17.05013 19.01437 17.31923 0 0 0 P25787 PSA2_HUMAN Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3) PSMA2 HC3 PSC3 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]" GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0009615; GO:0010498; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813 AANGVVLATEK 9.25 1 1 0.291948743 1073.962417 0 0 0 0 0 0 0 0 15.82734 0 0 0 18.18179 0 0 18.56139 18.89972 0 0 0 16.04744 0 18.51863 0 0 0 17.71517 18.96008 17.1462 0 0 0 0 18.65877 17.49972 0 0 0 18.14755 17.44604 0 0 0 0 0 0 0 0 P25791 RBTN2_HUMAN "Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2, LMO-2) (T-cell translocation protein 2)" LMO2 RBTN2 RBTNL1 RHOM2 TTG2 Homo sapiens (Human) cellular response to thyroid hormone stimulus [GO:0097067]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; cellular response to thyroid hormone stimulus [GO:0097067]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221] GO:0001221; GO:0003713; GO:0005654; GO:0005667; GO:0007275; GO:0042802; GO:0043425; GO:0045944; GO:0046872; GO:0061629; GO:0097067 CAACQK 4.929999828 0.783069909 0.783069909 2.31E-13 738.5143583 0 0 0 0 0 0 0 0 15.73198 0 0 0 0 16.54991 0 0 0 0 0 0 0 0 0 0 17.81234 0 15.96789 15.75051 0 0 0 15.20358 0 0 12.91619 12.95939 0 0 0 0 0 0 0 0 17.52291 0 0 0 P25800 RBTN1_HUMAN "Rhombotin-1 (Cysteine-rich protein TTG-1) (LIM domain only protein 1, LMO-1) (T-cell translocation protein 1)" LMO1 RBTN1 RHOM1 TTG1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell homeostatic proliferation [GO:0046013] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell homeostatic proliferation [GO:0046013] metal ion binding [GO:0046872] GO:0000122; GO:0005634; GO:0005654; GO:0045944; GO:0046013; GO:0046872 MMVLDKEDGVPMLSVQPK 1.409999967 0.781573236 0.781573236 0.165004097 2064.598669 5.999097 16.35059 0 15.06802 16.82699 15.75039 0 0 15.10415 14.87001 15.49325 15.44906 14.94365 14.26896 0 13.65029 0 16.45696 13.27548 0 14.51553 14.84341 14.02049 16.16496 0 14.92006 0 0 15.23965 0 0 16.8516 16.78782 0 13.37162 14.96864 0 16.70263 0 0 13.91523 13.34618 0 16.23046 14.6859 14.8978 16.37631 0 P25874 UCP1_HUMAN "Mitochondrial brown fat uncoupling protein 1, UCP 1 (Solute carrier family 25 member 7) (Thermogenin)" UCP1 SLC25A7 UCP Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; brown fat cell differentiation [GO:0050873]; cellular response to cold [GO:0070417]; cellular response to dehydroepiandrosterone [GO:1903495]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; diet induced thermogenesis [GO:0002024]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; response to nutrient levels [GO:0031667]; response to temperature stimulus [GO:0009266] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; long-chain fatty acid binding [GO:0036041]; oxidative phosphorylation uncoupler activity [GO:0017077]; purine ribonucleotide binding [GO:0032555]; transmembrane transporter activity [GO:0022857]; adaptive thermogenesis [GO:1990845]; brown fat cell differentiation [GO:0050873]; cellular response to cold [GO:0070417]; cellular response to dehydroepiandrosterone [GO:1903495]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; diet induced thermogenesis [GO:0002024]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; response to nutrient levels [GO:0031667]; response to temperature stimulus [GO:0009266] cardiolipin binding [GO:1901612]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; long-chain fatty acid binding [GO:0036041]; oxidative phosphorylation uncoupler activity [GO:0017077]; purine ribonucleotide binding [GO:0032555]; transmembrane transporter activity [GO:0022857] GO:0002024; GO:0005525; GO:0005739; GO:0005743; GO:0006357; GO:0006839; GO:0009266; GO:0009409; GO:0016021; GO:0017077; GO:0019003; GO:0022857; GO:0031667; GO:0032555; GO:0032870; GO:0034614; GO:0036041; GO:0050873; GO:0070417; GO:0071398; GO:0120162; GO:1901612; GO:1902600; GO:1903426; GO:1903495; GO:1990542; GO:1990845 SVPNCAMK 9.239999771 1 1 0.1003114 920.3933881 17.71431 18.17121 15.72677 14.89067 15.79426 3.899829 15.09572 0 0 0 0 0 17.24568 0 13.78305 11.32341 0 0 0 0 0 0 15.5312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.49726 0 0 0 17.35569 14.91946 0 0 0 P25940 CO5A3_HUMAN Collagen alpha-3(V) chain COL5A3 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; skin development [GO:0043588] collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; skin development [GO:0043588] collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394] GO:0005201; GO:0005518; GO:0005576; GO:0005588; GO:0005615; GO:0005788; GO:0007160; GO:0008201; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0043394; GO:0043588; GO:0062023 GEVGDVGSMGPHGAPGPR 13.75 1 1 7.12E-13 1688.003335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.69364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25942 TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40) CD40 TNFRSF5 Homo sapiens (Human) B cell activation [GO:0042113]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; response to interferon-gamma [GO:0034341]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] CD40 receptor complex [GO:0035631]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] CD40 receptor complex [GO:0035631]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; B cell activation [GO:0042113]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; response to interferon-gamma [GO:0034341]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] antigen binding [GO:0003823]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625] GO:0001934; GO:0002768; GO:0003823; GO:0005886; GO:0005887; GO:0006874; GO:0006954; GO:0009897; GO:0009986; GO:0019724; GO:0019899; GO:0023035; GO:0030168; GO:0030890; GO:0031625; GO:0032735; GO:0034341; GO:0035631; GO:0035666; GO:0038023; GO:0042100; GO:0042113; GO:0042531; GO:0042832; GO:0043123; GO:0043231; GO:0043406; GO:0043491; GO:0043536; GO:0043547; GO:0045766; GO:0045944; GO:0048304; GO:0051092; GO:0051607; GO:0065003; GO:0070062; GO:0071260; GO:0071347; GO:0071356; GO:0090037; GO:2000353 SCSPGFGVK 10.22999954 1 1 0.170155312 936.3140586 0 0 0 0 0 0 18.32744 0 0 0 0 0 0 17.2309 0 0 0 0 0 0 0 0 0 0 0 18.13036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26012 ITB8_HUMAN Integrin beta-8 ITGB8 Homo sapiens (Human) cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ganglioside metabolic process [GO:0001573]; hard palate development [GO:0060022]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ganglioside metabolic process [GO:0001573]; hard palate development [GO:0060022]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570] extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023] GO:0001570; GO:0001573; GO:0005178; GO:0005886; GO:0005925; GO:0006955; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008305; GO:0009615; GO:0009986; GO:0010628; GO:0010629; GO:0016477; GO:0033627; GO:0034686; GO:0038023; GO:0045766; GO:0051216; GO:0060022; GO:0060674; GO:0061520; GO:0070062; GO:1901388; GO:1990430 KPGMEGCR 7.710000038 0.950713754 0.950713754 0.165784747 934.8801635 0 0 13.29152 0 0 0 16.02624 13.98157 9.885447 15.90144 0 0 15.59852 0 0 15.7137 12.43515 0 0 0 0 15.81898 0 0 0 16.76547 0 0 0 0 0 0 0 11.60004 0 16.65443 0 0 0 16.53605 14.25716 0 16.18943 0 14.98936 15.31361 0 0 P26196 DDX6_HUMAN "Probable ATP-dependent RNA helicase DDX6, EC 3.6.4.13 (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)" DDX6 HLR2 RCK Homo sapiens (Human) negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0016442; GO:0016887; GO:0017148; GO:0019074; GO:0019827; GO:0019904; GO:0033962; GO:0034063; GO:0036464; GO:0045296; GO:0045665; GO:1905618 VFHDFR 10.60999966 1 1 0.289170896 821.2030613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.84158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26232 CTNA2_HUMAN Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein) CTNNA2 CAPR Homo sapiens (Human) axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823] actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0016477; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222 EFGKEMVK 7.769999981 1 1 1.26E-12 964.2457325 14.55154 12.90639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.42362 0 0 0 0 0 16.03957 0 16.15708 0 15.44638 0 0 0 0 0 0 0 0 16.97631 17.38558 0 0 0 0 0 0 0 0 0 0 0 P26358 DNMT1_HUMAN "DNA (cytosine-5)-methyltransferase 1, Dnmt1, EC 2.1.1.37 (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI, DNA MTase HsaI, M.HsaI) (MCMT)" DNMT1 AIM CXXC9 DNMT Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265] DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0000122; GO:0003677; GO:0003723; GO:0003886; GO:0005634; GO:0005654; GO:0005657; GO:0005721; GO:0006306; GO:0006346; GO:0007265; GO:0008270; GO:0008327; GO:0009008; GO:0010216; GO:0010628; GO:0010629; GO:0043045; GO:0051571; GO:0051573; GO:0071230; GO:0090309; GO:1903926; GO:1904707; GO:1905460; GO:1905931; GO:1990841 CPNMAMK 3.210000038 0.724348485 0.724348485 0.075384308 883.6809082 14.93659 0 0 11.8141 15.94248 0 0 0 13.11451 13.29259 15.94192 0 16.11118 0 16.46042 0 15.7421 16.32042 0 0 0 0 0 16.03502 0 15.05648 0 0 13.29192 13.8671 16.20539 0 0 0 0 0 13.61609 15.24839 15.23567 13.41393 10.75841 0 0 0 15.774 18.54401 0 0 P26368 U2AF2_HUMAN "Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit, hU2AF(65), hU2AF65) (U2 snRNP auxiliary factor large subunit)" U2AF2 U2AF65 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]" commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701] "commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]" C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723] GO:0000243; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701 FANRVVVTK 4.510000229 0.556852937 0.556852937 0.066323814 1030.598819 0 15.11156 0 15.59356 0 0 14.52276 0 14.6238 0 0 0 0 0 0 15.44248 0 0 15.67824 16.27144 0 15.24577 0 0 14.19724 14.5981 13.52699 0 0 0 0 0 18.88409 0 14.69314 0 0 0 0 16.23028 18.01113 0 15.18145 0 15.48456 13.7117 16.89465 13.08909 P26374 RAE2_HUMAN "Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2, REP-2)" CHML REP2 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0018344; GO:0031267 TCMHTVSDKDGDK 8.81000042 1 1 0.525721389 1509.200344 16.80687 0 0 0 0 0 0 0 16.66564 18.17705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.83112 17.02731 0 17.92121 0 0 19.03835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.81635 0 P26440 IVD_HUMAN "Isovaleryl-CoA dehydrogenase, mitochondrial, IVD, EC 1.3.8.4 (Butyryl-CoA dehydrogenase, EC 1.3.8.1)" IVD Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552] acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470] GO:0003995; GO:0004085; GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0033539; GO:0042802; GO:0050660 MAEMATATRLLGWR 4.929999828 1 1 0.446905945 1639.37617 0 0 0 0 0 15.76558 0 0 0 0 14.95375 15.41982 0 0 16.28207 0 0 0 0 16.27795 0 16.55187 16.21532 0 0 0 15.26144 15.64791 14.66693 15.5967 17.07843 14.22016 16.27891 17.0009 0 0 15.91383 0 0 0 16.52758 15.32802 0 0 0 0 0 0 P26572 MGAT1_HUMAN "Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.101 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I, GNT-I, GlcNAc-T I)" MGAT1 GGNT1 GLCT1 GLYT1 MGAT Homo sapiens (Human) in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082] endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] "endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082]" "acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]" GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0033116; GO:0048471; GO:0070062; GO:1903561 GLLQQIGDALSSQRGR 3.25999999 1 1 0.240771739 1698.287992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26599 PTBP1_HUMAN "Polypyrimidine tract-binding protein 1, PTB (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I, hnRNP I)" PTBP1 PTB Homo sapiens (Human) "IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0008187; GO:0008380; GO:0016020; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522 MALIQMGSVEEAVQALIDLHNHDLGENHHLR 2.200000048 1 1 0.037269464 3507.873561 15.25154 13.4392 0 0 15.59891 0 0 10.94594 12.79427 12.50827 11.876 0 15.13831 0 0 13.23097 13.23972 14.19986 0 0 0 0 0 8.43784 15.22909 11.80609 11.08836 0 0 0 0 0 0 0 0 13.00277 0 14.82665 0 0 0 0 0 0 14.9735 13.91543 0 0 P26639 SYTC_HUMAN "Threonine--tRNA ligase 1, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase 1)" TARS1 TARS Homo sapiens (Human) threonyl-tRNA aminoacylation [GO:0006435] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] GO:0000049; GO:0004829; GO:0005524; GO:0005829; GO:0006435; GO:0008270; GO:0042802; GO:0070062 EGSGDGGR 7.010000229 1 1 0.1972419 733.9091717 15.12753 15.62482 15.61514 13.69611 15.23756 15.10414 0 0 0 0 15.41131 0 14.70187 15.12579 15.41674 15.21754 13.3867 0 0 0 13.15394 14.27654 16.05527 16.53914 0 15.0434 0 15.98338 0 0 0 0 16.0689 0 0 0 0 0 16.85451 0 16.75871 14.99843 0 0 0 0 0 0 P26640 SYVC_HUMAN "Valine--tRNA ligase, EC 6.1.1.9 (Protein G7a) (Valyl-tRNA synthetase, ValRS)" VARS1 G7A VARS VARS2 Homo sapiens (Human) tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438] cytosol [GO:0005829] cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832] GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438 KAVLVALK 8.520000458 1 1 0.076866057 841.5179687 0 0 0 0 0 0 15.67064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.46705 14.85218 0 15.64439 0 16.69695 17.12953 0 15.93672 17.18145 16.35869 17.29018 15.68998 15.22821 17.00523 0 0 0 0 0 0 P26641 EF1G_HUMAN "Elongation factor 1-gamma, EF-1-gamma (eEF-1B gamma)" EEF1G EF1G PRO1608 Homo sapiens (Human) glutathione metabolic process [GO:0006749]; response to virus [GO:0009615]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746]; glutathione metabolic process [GO:0006749]; response to virus [GO:0009615]; translational elongation [GO:0006414] cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746] GO:0003746; GO:0005634; GO:0005737; GO:0005829; GO:0006414; GO:0006749; GO:0009615; GO:0016020; GO:0045296; GO:0070062 TFLVGER 17.84000015 0.586025774 0.586025774 0.266013197 820.4220955 0 18.65949 21.36036 16.32264 18.72488 0 0 16.1839 18.62717 0 0 21.92337 0 0 17.55638 19.62793 16.13141 18.66372 0 0 17.37714 18.72333 19.41184 18.8873 0 0 19.4218 18.65923 0 0 0 18.62302 0 20.09179 20.33241 17.45144 0 0 17.14748 18.14391 0 18.34088 18.27878 17.7247 0 16.37328 16.80261 0 P26718 NKG2D_HUMAN NKG2-D type II integral membrane protein (Killer cell lectin-like receptor subfamily K member 1) (NK cell receptor D) (NKG2-D-activating NK receptor) (CD antigen CD314) KLRK1 D12S2489E NKG2D Homo sapiens (Human) adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of GTPase activity [GO:0034260]; negative regulation of natural killer cell chemotaxis [GO:2000502]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib receptor activity [GO:0032394]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of GTPase activity [GO:0034260]; negative regulation of natural killer cell chemotaxis [GO:2000502]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295] carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib receptor activity [GO:0032394]; signaling receptor activity [GO:0038023] GO:0002223; GO:0002250; GO:0005886; GO:0005887; GO:0007165; GO:0009897; GO:0009986; GO:0016021; GO:0030101; GO:0030154; GO:0030246; GO:0031295; GO:0032394; GO:0032729; GO:0034260; GO:0038023; GO:0042267; GO:0042288; GO:0042802; GO:0045429; GO:0045954; GO:0050830; GO:0071222; GO:2000502 EDQDLLK 11.71000004 1 1 0.093968123 859.5864317 0 0 15.29605 12.83542 16.82565 12.7548 15.4077 15.22274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.02799 0 0 0 0 0 0 0 0 0 15.509 0 0 0 0 0 0 0 16.39343 0 P26885 FKBP2_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP2, PPIase FKBP2, EC 5.2.1.8 (13 kDa FK506-binding protein, 13 kDa FKBP, FKBP-13) (FK506-binding protein 2, FKBP-2) (Immunophilin FKBP13) (Rotamase)" FKBP2 FKBP13 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077] FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0003755; GO:0005528; GO:0005783; GO:0005789; GO:0061077 GAPPK 4.71999979 0.700169265 0.700169265 0.110434824 468.1510252 0 0 15.29174 14.73181 15.20051 0 16.09403 15.55384 15.32625 0 15.82854 0 0 14.26143 0 0 15.98402 17.48414 0 0 0 0 0 0 12.10435 13.92168 0 15.68009 15.62823 14.42848 14.42843 14.79558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26992 CNTFR_HUMAN "Ciliary neurotrophic factor receptor subunit alpha, CNTF receptor subunit alpha, CNTFR-alpha" CNTFR Homo sapiens (Human) brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102]; brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967] ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102] GO:0001967; GO:0003360; GO:0004896; GO:0004897; GO:0005102; GO:0005886; GO:0007165; GO:0007399; GO:0007548; GO:0008284; GO:0009897; GO:0016324; GO:0019221; GO:0019898; GO:0019955; GO:0031225; GO:0043235; GO:0043524; GO:0060538; GO:0070110; GO:0070120; GO:0097059 DSWHLR 7.380000114 1 1 0.275909197 813.4147716 0 18.00033 17.10719 0 0 0 0 0 0 0 0 0 16.86432 15.40506 0 16.55748 0 0 0 0 0 0 0 18.62142 17.78634 0 16.37967 0 0 0 0 18.81357 16.98948 18.4426 0 17.38421 18.05144 0 17.06357 0 0 0 0 0 17.18663 0 16.49035 0 P27169 PON1_HUMAN "Serum paraoxonase/arylesterase 1, PON 1, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1 (Aromatic esterase 1, A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)" PON1 PON Homo sapiens (Human) aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636] acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617 IHVYEKHANWTLTPLK 10.26000023 1 1 2.29E-13 1942.47383 0 0 13.54965 13.1814 12.31812 14.4217 13.89681 0 0 0 0 0 15.00385 0 0 13.65549 0 12.33195 16.11245 0 15.70885 0 0 0 16.6858 15.95978 14.97802 15.55479 15.28497 0 0 0 0 0 0 0 17.24075 15.31448 0 15.65348 0 16.60089 0 0 11.09826 0 0 0 P27348 1433T_HUMAN 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) YWHAQ Homo sapiens (Human) "cellular protein localization [GO:0034613]; negative regulation of transcription, DNA-templated [GO:0045892]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; cellular protein localization [GO:0034613]; negative regulation of transcription, DNA-templated [GO:0045892]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762]" identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485] GO:0005737; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0007264; GO:0016020; GO:0019904; GO:0021762; GO:0032991; GO:0034613; GO:0042802; GO:0045892; GO:0047485; GO:0070062 NVVGGRR 6.679999828 1 1 0.257636319 757.8663552 15.06349 15.73614 13.98706 14.84737 15.44148 15.71161 14.60532 15.4135 0 17.24402 15.53723 14.98785 14.78952 16.17943 12.68564 13.19862 16.23418 15.6052 16.26756 0 15.65515 14.78869 0 0 16.78505 13.868 15.8789 13.31903 0 0 0 16.03615 15.55217 18.27711 0 0 16.59614 0 0 16.92884 15.69354 0 0 14.65211 0 0 16.14051 0 P27352 IF_HUMAN "Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor, IF, INF)" CBLIF GIF IFMH Homo sapiens (Human) cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] apical plasma membrane [GO:0016324]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; microvillus [GO:0005902] apical plasma membrane [GO:0016324]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; microvillus [GO:0005902]; cobalamin binding [GO:0031419]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] cobalamin binding [GO:0031419] GO:0005576; GO:0005615; GO:0005768; GO:0005902; GO:0006824; GO:0009235; GO:0015889; GO:0016324; GO:0031419; GO:0043202 TTDMILNEIK 6.400000095 1 1 0.120559364 1193.092901 10.77246 9.309872 0 13.35634 13.35196 0 8.454234 13.99011 13.361 11.7655 13.85165 0 14.39315 0 0 14.0431 0 16.07258 0 0 0 0 0 16.32641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27540 ARNT_HUMAN "Aryl hydrocarbon receptor nuclear translocator, ARNT protein (Class E basic helix-loop-helix protein 2, bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta, HIF-1-beta, HIF1-beta)" ARNT BHLHE2 Homo sapiens (Human) cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666] aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]" "aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001666; GO:0001892; GO:0001938; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010575; GO:0016604; GO:0017162; GO:0030154; GO:0030949; GO:0033235; GO:0034751; GO:0042803; GO:0043565; GO:0043619; GO:0045648; GO:0045821; GO:0045944; GO:0046886; GO:0046982; GO:0061629; GO:0090575; GO:1990837 SDGLFAQDR 5.139999866 0.307365298 0.307365298 0.18648679 1009.560783 16.33922 0 10.72975 0 14.9255 0 10.60396 0 16.31755 16.77174 13.19368 0 0 13.42458 0 0 17.00205 0 0 0 0 0 17.35905 15.38072 0 0 13.44795 14.57106 0 14.84617 0 13.97698 0 15.85276 0 0 0 0 16.42569 0 0 0 0 16.28206 0 0 0 0 P27544 CERS1_HUMAN "Ceramide synthase 1, CerS1 (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1, EC 2.3.1.299)" CERS1 LAG1 LASS1 UOG1 Homo sapiens (Human) cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0016410; GO:0030148; GO:0036146; GO:0043231; GO:0046513; GO:0050291; GO:0051974; GO:0071466; GO:0071492; GO:0072721; GO:1901526 LNIYFKSR 12.64999962 1 1 0.33898831 1038.839073 0 13.20653 12.40517 0 16.42804 15.57354 0 0 0 16.30595 0 0 14.64607 0 0 17.0308 0 0 0 0 17.59013 0 0 0 0 0 16.12391 0 15.16016 0 0 14.7063 15.36346 17.68171 0 0 0 16.46783 0 15.63688 16.95505 15.98623 0 0 0 0 0 0 P27658 CO8A1_HUMAN Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin ] COL8A1 C3orf7 Homo sapiens (Human) angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] extracellular matrix structural constituent [GO:0005201] GO:0001525; GO:0005201; GO:0005576; GO:0005591; GO:0005615; GO:0005788; GO:0007155; GO:0010811; GO:0030198; GO:0031012; GO:0035987; GO:0048593; GO:0050673; GO:0062023 GDRGPK 1.600000024 1 1 0.011966224 630.4907211 15.30122 0 0 0 15.39143 0 14.74539 0 0 0 0 0 0 14.92717 0 16.43293 0 0 0 0 0 0 0 0 0 0 0 0 17.18805 0 0 0 0 18.33655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27694 RFA1_HUMAN "Replication protein A 70 kDa DNA-binding subunit, RP-A p70 (Replication factor A protein 1, RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed ]" RPA1 REPA1 RPA70 Homo sapiens (Human) base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004] "chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]" "chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]" damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047] GO:0000723; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0046872; GO:0051321; GO:0090734; GO:0098505 VGQLSEGAIAAIMQK 2.25 1 1 0.092137001 1530.433944 0 0 0 0 0 0 0 0 0 0 0 0 15.66704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.15603 0 0 0 0 0 18.9554 0 0 0 0 0 0 17.37106 0 0 0 0 P27695 APEX1_HUMAN "DNA-(apurinic or apyrimidinic site) endonuclease, EC 3.1.11.2 (APEX nuclease, APEN) (Apurinic-apyrimidinic endonuclease 1, AP endonuclease 1, APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial ]" APEX1 APE APE1 APEX APX HAP1 REF1 Homo sapiens (Human) "aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to peptide hormone stimulus [GO:0071375]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA demethylation [GO:0080111]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; transcription regulator complex [GO:0005667]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; transcription regulator complex [GO:0005667]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; chromatin DNA binding [GO:0031490]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands [GO:0090580]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; uracil DNA N-glycosylase activity [GO:0004844]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to peptide hormone stimulus [GO:0071375]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA demethylation [GO:0080111]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]" "3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; chromatin DNA binding [GO:0031490]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands [GO:0090580]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; uracil DNA N-glycosylase activity [GO:0004844]" GO:0000723; GO:0000737; GO:0000781; GO:0003677; GO:0003684; GO:0003691; GO:0003713; GO:0003714; GO:0003723; GO:0003906; GO:0004519; GO:0004520; GO:0004523; GO:0004528; GO:0004844; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005813; GO:0005840; GO:0006281; GO:0006284; GO:0006287; GO:0006310; GO:0007568; GO:0008081; GO:0008296; GO:0008309; GO:0008311; GO:0008408; GO:0009410; GO:0014912; GO:0016491; GO:0016607; GO:0016890; GO:0031490; GO:0042981; GO:0043488; GO:0044877; GO:0045454; GO:0045944; GO:0046872; GO:0048471; GO:0051059; GO:0052720; GO:0070301; GO:0071320; GO:0071375; GO:0080111; GO:0090580; GO:0097698; GO:0140431; GO:1900087 KGLDWVK 12.89999962 1 1 0.29074355 846.0862819 16.06376 15.14544 14.76797 16.35011 16.32797 14.68396 17.5992 17.14577 14.8854 16.43544 15.52599 16.1496 16.23083 14.49797 14.82873 16.89796 14.24389 13.52541 0 12.94643 14.89577 14.97853 0 16.24379 0 0 15.93863 16.19175 0 0 16.36836 16.18168 14.92329 0 0 15.24534 15.51715 0 14.84189 15.12725 0 15.6985 0 14.82988 0 15.75841 15.43767 0 P27708 PYR1_HUMAN "CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase, EC 6.3.5.5; Aspartate carbamoyltransferase, EC 2.1.3.2; Dihydroorotase, EC 3.5.2.3 ]" CAD Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; terminal bouton [GO:0043195] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228] aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270] GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006225; GO:0006228; GO:0006541; GO:0006807; GO:0008270; GO:0016020; GO:0016363; GO:0018107; GO:0019240; GO:0019899; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046777; GO:0070062; GO:0070335 AHWTPFEGQK 5.670000076 1 1 0.176675116 1201.582125 12.39625 12.92208 15.12611 14.08532 8.049208 0 0 0 0 14.93783 0 0 14.10243 13.82524 0 0 10.072 0 0 0 0 13.33002 0 14.25117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.37792 0 13.45495 15.41441 P27815 PDE4A_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 4A, EC 3.1.4.53 (DPDE2) (PDE46)" PDE4A DPDE2 Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cellular response to xenobiotic stimulus [GO:0071466]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to xenobiotic stimulus [GO:0071466]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]" GO:0004114; GO:0004115; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006198; GO:0007165; GO:0007186; GO:0007608; GO:0010738; GO:0016020; GO:0030552; GO:0032587; GO:0046872; GO:0048471; GO:0071466; GO:0106070 SPLDSQASPGLVLHAGAATSQR 1.820000052 1 1 0.097244007 2162.215963 0 14.62019 10.64564 0 11.82762 14.25802 16.51659 10.9062 13.87089 13.65648 15.80849 10.38719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27816 MAP4_HUMAN "Microtubule-associated protein 4, MAP-4" MAP4 Homo sapiens (Human) cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175] axon [GO:0030424]; axoneme [GO:0005930]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005] axon [GO:0030424]; axoneme [GO:0005930]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175] microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] GO:0000226; GO:0003723; GO:0005198; GO:0005815; GO:0005874; GO:0005875; GO:0005930; GO:0007052; GO:0008017; GO:0030424; GO:0031175; GO:0043005; GO:0051012; GO:0051294; GO:0051301; GO:0072686; GO:1902856 DMAQLPETEIAPAKDVAPSTVK 2.829999924 1 1 2.75E-12 2327.20846 13.83916 8.475406 0 12.46649 13.82551 13.58507 8.263049 12.54245 13.91964 0 12.32251 13.92016 8.364546 13.6342 10.96595 10.82794 10.44425 11.64148 0 13.65139 0 5.260672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27918 PROP_HUMAN Properdin (Complement factor P) CFP PFC Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]" endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]" GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0035580; GO:0042742; GO:0050778; GO:1903028; GO:1904724 SGGLCQPCR 1.399999976 0.651835442 0.651835442 0.191989506 1029.477389 15.36747 13.48513 16.0551 14.62899 12.8172 15.86975 0 14.39423 16.11633 0 0 14.88721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.25881 15.49223 0 0 17.04139 16.48244 15.41388 13.46978 15.39528 15.63948 16.59017 15.81262 15.21579 16.18513 13.79215 14.46491 15.85076 14.32007 0 16.03017 13.58264 15.19299 P27986 P85A_HUMAN "Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha)" PIK3R1 GRB1 Homo sapiens (Human) B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217] "cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]" "cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]" 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] GO:0001678; GO:0001784; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0014065; GO:0016020; GO:0019903; GO:0030183; GO:0030217; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0050821; GO:0051491; GO:0051497; GO:0060396; GO:0120183; GO:1900103; GO:1903078; GO:1990578 TQSSSNLAELR 7.289999962 1 1 0.382272856 1205.591707 14.10085 15.50641 0 15.20858 0 14.92506 0 13.18291 0 11.87535 0 10.85885 0 14.01781 0 0 0 0 14.90738 0 0 14.72345 15.85561 0 0 0 0 0 0 0 0 0 0 0 0 16.52508 0 0 0 0 0 0 0 0 0 0 0 0 P27987 IP3KB_HUMAN "Inositol-trisphosphate 3-kinase B, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase B, IP3 3-kinase B, IP3K B, InsP 3-kinase B)" ITPKB Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]" "ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]" GO:0000165; GO:0000828; GO:0001932; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0016301; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0046854; GO:0071277 CGSPTAMEIDKR 13.56000042 1 1 0.298489001 1379.962961 12.96596 0 14.5569 0 0 0 0 0 0 0 0 0 16.64013 0 16.76771 15.62354 0 0 0 16.57861 0 0 0 0 14.25224 0 0 0 0 16.17308 0 0 14.58323 15.31138 12.858 17.41176 0 0 18.09654 14.77015 0 0 0 0 14.69495 0 0 0 P28065 PSB9_HUMAN "Proteasome subunit beta type-9, EC 3.4.25.1 (Low molecular mass protein 2) (Macropain chain 7) (Multicatalytic endopeptidase complex chain 7) (Proteasome chain 7) (Proteasome subunit beta-1i) (Really interesting new gene 12 protein)" PSMB9 LMP2 PSMB6i RING12 Homo sapiens (Human) immune system process [GO:0002376]; proteasomal protein catabolic process [GO:0010498]; regulation of cysteine-type endopeptidase activity [GO:2000116] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; proteasomal protein catabolic process [GO:0010498]; regulation of cysteine-type endopeptidase activity [GO:2000116]" threonine-type endopeptidase activity [GO:0004298] GO:0000502; GO:0002376; GO:0004298; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0070062; GO:1990111; GO:2000116 MLRAGAPTGDLPR 4.880000114 0.119190536 0.119190536 0.09240048 1370.724709 16.32598 0 0 0 0 16.04112 14.59734 17.14468 0 14.59121 0 0 14.8278 0 0 17.16182 0 0 0 0 0 14.74811 12.62743 11.80515 0 0 0 14.78677 0 11.54985 0 0 15.46523 0 0 0 15.23178 0 0 0 0 0 0 0 0 0 0 0 P28070 PSB4_HUMAN "Proteasome subunit beta type-4 (26 kDa prosomal protein, HsBPROS26, PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3, HsN3)" PSMB4 PROS26 Homo sapiens (Human) negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298] GO:0000502; GO:0001530; GO:0002862; GO:0004298; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0036064; GO:0043161; GO:0070062 NISRIMR 22.81999969 0.301447928 0.301447928 0.178971302 906.0230426 16.19034 0 0 14.06707 0 0 0 0 22.69271 16.86632 0 0 17.32859 0 17.78484 17.04353 0 16.41579 0 0 0 16.70211 18.23228 15.86996 22.41624 0 13.19685 0 16.3142 19.79557 18.38465 16.98749 0 0 23.42444 0 13.17715 18.41098 17.24602 0 16.91515 23.35167 0 0 0 15.07843 0 20.86913 P28221 5HT1D_HUMAN "5-hydroxytryptamine receptor 1D, 5-HT-1D, 5-HT1D (Serotonin 1D alpha receptor, 5-HT-1D-alpha) (Serotonin receptor 1D)" HTR1D HTR1DA HTRL Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intestine smooth muscle contraction [GO:0014827]; regulation of behavior [GO:0050795]; regulation of locomotion [GO:0040012]; vasoconstriction [GO:0042310]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intestine smooth muscle contraction [GO:0014827]; regulation of behavior [GO:0050795]; regulation of locomotion [GO:0040012]; vasoconstriction [GO:0042310]" G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0014827; GO:0030425; GO:0030594; GO:0040012; GO:0042310; GO:0045202; GO:0050795; GO:0051378 LADSALERK 6.579999924 1 1 0.051875566 1002.405235 14.19981 16.81581 13.66957 13.45467 14.10984 0 0 0 11.71778 0 0 0 12.67915 15.56106 0 0 14.09804 0 0 0 0 15.45092 15.44235 16.37992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28222 5HT1B_HUMAN "5-hydroxytryptamine receptor 1B, 5-HT-1B, 5-HT1B (S12) (Serotonin 1D beta receptor, 5-HT-1D-beta) (Serotonin receptor 1B)" HTR1B HTR1DB Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]" calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154] "calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]" G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] GO:0002031; GO:0004993; GO:0005783; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007205; GO:0007268; GO:0014053; GO:0014059; GO:0014063; GO:0030425; GO:0030594; GO:0032229; GO:0042220; GO:0042310; GO:0042756; GO:0044305; GO:0045471; GO:0046849; GO:0050795; GO:0051378; GO:0051385; GO:0051967; GO:0071312; GO:0071466; GO:0071502; GO:0098666; GO:0099056; GO:0099154; GO:0099171; GO:0099626; GO:1904707; GO:2000300 VSDALLEK 13.46000004 0.833871782 0.833871782 0.207318591 874.4395414 15.70607 14.49049 14.95833 15.58562 14.08694 14.59037 11.83052 17.865 15.04538 14.33791 17.35931 14.62771 14.87598 14.75158 14.59334 14.46219 14.73609 15.60167 16.32095 15.65186 15.53565 0 16.22731 15.48023 13.94681 15.28786 15.94547 14.80891 16.63351 14.72372 16.54963 15.42748 16.24929 0 0 0 0 0 0 15.6463 15.14219 0 0 14.67568 0 15.0706 15.58328 15.62014 P28288 ABCD3_HUMAN "ATP-binding cassette sub-family D member 3, EC 3.1.2.-, EC 7.6.2.- (70 kDa peroxisomal membrane protein, PMP70)" ABCD3 PMP70 PXMP1 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621] GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0014070; GO:0015721; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621; GO:0047617; GO:0140359; GO:1903512 MLLRMSQALGR 4.630000114 1 1 2.51E-12 1292.884592 11.84071 0 0 7.713251 10.86927 11.99267 9.233284 13.77593 11.55657 12.19429 0 13.85774 11.5564 12.00963 0 13.45387 11.32127 9.602461 11.17879 0 0 12.85065 0 14.86507 0 0 14.12858 13.8035 10.12636 13.9469 0 0 0 0 0 0 11.20452 0 0 13.11506 0 0 12.58754 0 13.44719 0 0 0 P28290 ITPI2_HUMAN "Protein ITPRID2 (Cleavage signal-1 protein, CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2)" ITPRID2 CS1 KIAA1927 KRAP SSFA2 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102] actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005654; GO:0005829; GO:0005886; GO:0051015 ASNSK 5.019999981 1 1 0.191968952 507.0050106 0 15.58846 14.37591 0 13.84359 13.91929 13.92626 0 15.82285 15.15761 14.23512 0 0 0 0 15.93529 14.46521 0 14.52995 13.19257 16.97593 0 0 0 0 16.2775 0 0 0 0 16.35779 0 16.1727 0 16.43782 15.44683 16.32349 0 0 0 0 0 0 0 16.46959 0 15.67861 0 P28300 LYOX_HUMAN "Protein-lysine 6-oxidase, EC 1.4.3.13 (Lysyl oxidase) [Cleaved into: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form ]" LOX Homo sapiens (Human) ascending aorta development [GO:0035905]; blood vessel morphogenesis [GO:0048514]; bone mineralization [GO:0030282]; cell chemotaxis [GO:0060326]; cellular protein modification process [GO:0006464]; cellular response to chemokine [GO:1990869]; collagen fibril organization [GO:0030199]; connective tissue development [GO:0061448]; descending aorta development [GO:0035906]; DNA biosynthetic process [GO:0071897]; elastic fiber assembly [GO:0048251]; heart development [GO:0007507]; lung development [GO:0030324]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; osteoblast differentiation [GO:0001649]; peptidyl-lysine oxidation [GO:0018057]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; protein kinase B signaling [GO:0043491]; regulation of apoptotic process [GO:0042981]; regulation of bone development [GO:1903010]; regulation of gene expression [GO:0010468]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000586]; regulation of protein phosphorylation [GO:0001932]; regulation of receptor binding [GO:1900120]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; collagen binding [GO:0005518]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; ascending aorta development [GO:0035905]; blood vessel morphogenesis [GO:0048514]; bone mineralization [GO:0030282]; cell chemotaxis [GO:0060326]; cellular protein modification process [GO:0006464]; cellular response to chemokine [GO:1990869]; collagen fibril organization [GO:0030199]; connective tissue development [GO:0061448]; descending aorta development [GO:0035906]; DNA biosynthetic process [GO:0071897]; elastic fiber assembly [GO:0048251]; heart development [GO:0007507]; lung development [GO:0030324]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; osteoblast differentiation [GO:0001649]; peptidyl-lysine oxidation [GO:0018057]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; protein kinase B signaling [GO:0043491]; regulation of apoptotic process [GO:0042981]; regulation of bone development [GO:1903010]; regulation of gene expression [GO:0010468]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000586]; regulation of protein phosphorylation [GO:0001932]; regulation of receptor binding [GO:1900120]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060] collagen binding [GO:0005518]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720] GO:0001649; GO:0001932; GO:0004720; GO:0005507; GO:0005518; GO:0005576; GO:0005581; GO:0005615; GO:0005634; GO:0006464; GO:0007507; GO:0009410; GO:0010468; GO:0016202; GO:0017015; GO:0018057; GO:0030199; GO:0030282; GO:0030324; GO:0031012; GO:0035791; GO:0035905; GO:0035906; GO:0042060; GO:0042981; GO:0043491; GO:0045652; GO:0046716; GO:0048251; GO:0048514; GO:0048545; GO:0055001; GO:0060326; GO:0061448; GO:0071897; GO:1900120; GO:1903010; GO:1990869; GO:2000586 EAGASR 3.289999962 1 1 0.080478213 590.4139562 0 17.0072 0 16.60516 16.28313 0 17.05271 0 11.96872 14.82801 16.02978 15.08661 0 15.68913 15.80143 0 0 15.11113 12.18004 0 16.14933 15.48045 11.91047 0 17.33714 0 15.87086 16.70239 17.03622 13.09344 15.87803 12.97743 0 18.05795 15.53317 15.97321 0 0 16.23114 16.35222 16.80686 16.21632 15.32642 10.33003 19.50406 0 0 0 P28329 CLAT_HUMAN "Choline O-acetyltransferase, CHOACTase, ChAT, Choline acetylase, EC 2.3.1.6" CHAT Homo sapiens (Human) acetylcholine biosynthetic process [GO:0008292]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; phosphatidylcholine biosynthetic process [GO:0006656] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; choline O-acetyltransferase activity [GO:0004102]; acetylcholine biosynthetic process [GO:0008292]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; phosphatidylcholine biosynthetic process [GO:0006656] choline O-acetyltransferase activity [GO:0004102] GO:0004102; GO:0005634; GO:0005737; GO:0005829; GO:0006656; GO:0006836; GO:0007274; GO:0008292; GO:0043005; GO:0045202 FDNYGKTFIK 6.059999943 1 1 0.205125474 1232.035105 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7841 0 0 0 0 16.33687 0 0 0 0 0 0 15.85347 17.30688 0 0 0 16.44955 0 13.81069 0 15.52443 0 0 0 0 0 0 0 0 16.30561 0 0 0 0 P28330 ACADL_HUMAN "Long-chain specific acyl-CoA dehydrogenase, mitochondrial, LCAD, EC 1.3.8.8" ACADL Homo sapiens (Human) "carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]" mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]" acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401] GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0090181; GO:0120162 GFYYIMKELPQER 2.579999924 1 1 2.98E-12 1690.443287 0 0 14.7226 12.90394 14.27616 13.81243 13.30454 8.660499 0 13.65764 0 15.5578 15.85082 0 0 0 0 0 0 16.83742 15.64522 15.11355 0 0 0 13.10486 0 0 15.09943 14.0731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28331 NDUS1_HUMAN "NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial, EC 7.1.1.2 (Complex I-75kD, CI-75kD)" NDUFS1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]" mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]" "2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]" GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0005759; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593 MTSGVTGDWKVMNILHR 7.929999828 1 1 0.156497985 1961.728157 0 0 12.71442 14.80806 13.08534 13.88486 13.59078 15.62965 14.13199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28332 ADH6_HUMAN "Alcohol dehydrogenase 6, EC 1.1.1.1" ADH6 Homo sapiens (Human) ethanol oxidation [GO:0006069]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]" "alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]" GO:0004022; GO:0004024; GO:0004745; GO:0005829; GO:0006069; GO:0008270; GO:0042572; GO:0042573; GO:0045471; GO:0070062 INEAVELMKTGK 5.340000153 1 1 0.26874459 1344.888367 0 15.95257 8.445833 13.5844 13.10025 11.89704 14.99225 10.76684 0 0 14.41817 13.39167 0 0 12.96743 0 0 0 13.84569 13.60117 15.80889 13.91758 15.62814 16.59986 12.91372 0 15.33997 14.62553 13.51969 16.12107 16.06528 0 11.30228 0 0 0 17.52748 16.49333 17.08951 0 0 0 0 0 13.38925 0 0 10.47578 P28356 HXD9_HUMAN Homeobox protein Hox-D9 (Homeobox protein Hox-4C) (Homeobox protein Hox-5.2) HOXD9 HOX4C Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; hindlimb morphogenesis [GO:0035137]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; hindlimb morphogenesis [GO:0035137]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006357; GO:0007338; GO:0007519; GO:0008344; GO:0009952; GO:0009954; GO:0030879; GO:0035115; GO:0035137; GO:0045944; GO:0048704; GO:0048935; GO:1990837 MLGGSAGRLK 10.43999958 1 1 0.177474768 989.4338633 0 14.19049 0 0 12.92681 14.60622 0 0 15.08661 0 12.98525 0 15.00722 13.00047 15.3226 15.20406 14.57211 11.47103 0 14.84498 0 0 0 0 0 0 0 0 0 0 0 0 14.86499 0 16.51902 0 0 0 0 0 16.38436 16.45462 0 0 0 0 0 0 P28476 GBRR2_HUMAN Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor) GABRR2 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601] chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601] chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902476; GO:1902711; GO:1904315 SMTFDGR 1.50999999 1 1 0.302920092 812.9572701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9611 17.45947 0 0 0 0 0 0 18.28117 0 0 0 18.48707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.68502 0 P28676 GRAN_HUMAN Grancalcin GCA GCL Homo sapiens (Human) membrane fusion [GO:0061025] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; membrane fusion [GO:0061025] calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0005509; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0035578; GO:0042803; GO:0046982; GO:0061025; GO:0070062 IMIAMLDRDHTGK 7.230000019 1 1 0.257749496 1516.029597 0 0 0 16.29127 13.28905 13.7061 15.61622 14.2441 0 14.56678 11.27157 0 0 0 13.55363 0 0 14.14002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.33268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28698 MZF1_HUMAN "Myeloid zinc finger 1, MZF-1 (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42)" MZF1 MZF ZNF42 ZSCAN6 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0006355; GO:0042803; GO:0045944; GO:0046872 SRGRPSTGGGVVR 7.019999981 0.489197224 0.489197224 0.375856741 1285.425592 0 13.4 0 0 15.30165 15.11392 0 0 15.00019 0 0 0 14.03226 16.47829 16.51415 0 15.76457 15.70331 0 0 16.07557 0 0 0 0 0 13.93624 0 0 0 14.40155 15.21784 0 15.90441 15.64994 15.68271 15.45603 0 0 16.40501 0 16.13216 0 0 0 15.30774 0 0 P28715 ERCC5_HUMAN "DNA excision repair protein ERCC-5, EC 3.1.-.- (DNA repair protein complementing XP-G cells) (Xeroderma pigmentosum group G-complementing protein)" ERCC5 ERCM2 XPG XPGC Homo sapiens (Human) "base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of catalytic activity [GO:0050790]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697]; base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of catalytic activity [GO:0050790]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697] GO:0000109; GO:0000405; GO:0000724; GO:0000993; GO:0003684; GO:0003690; GO:0003697; GO:0004519; GO:0004520; GO:0005634; GO:0005654; GO:0005694; GO:0006283; GO:0006285; GO:0006289; GO:0006295; GO:0006296; GO:0008047; GO:0009411; GO:0009650; GO:0010225; GO:0032991; GO:0042803; GO:0043066; GO:0044877; GO:0046872; GO:0047485; GO:0050790 NGGATTSSSSDSDDDGGK 6.289999962 1 1 0.218769081 1656.476237 0 14.23522 0 0 0 0 13.99952 0 16.37421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54576 0 0 0 0 0 0 0 0 0 0 0 13.78648 0 15.51593 0 0 0 0 0 0 0 P28799 GRN_HUMAN "Progranulin, PGRN (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda, GP88, Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor, PCDGF) (Proepithelin, PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E) ]" GRN Homo sapiens (Human) astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723] GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060266; GO:0070062; GO:0106016; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905247; GO:1905673 AVALSSSVMCPDARSR 6.019999981 1 1 0.19847547 1706.361514 15.22789 15.32817 15.00172 13.63272 0 16.96018 0 0 0 10.82467 0 0 14.64511 0 13.70082 15.60331 0 14.88746 0 0 8.472771 0 0 0 0 17.5009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28827 PTPRM_HUMAN "Receptor-type tyrosine-protein phosphatase mu, Protein-tyrosine phosphatase mu, R-PTP-mu, EC 3.1.3.48" PTPRM PTPRL1 Homo sapiens (Human) homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010842; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0045296; GO:0048471 MVWHENTASIIMVTNLVEVGRVK 5.190000057 1 1 0.085551319 2641.277025 12.83995 0 0 0 0 13.93718 0 0 0 0 14.72546 15.80562 0 16.84452 0 14.41083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28838 AMPL_HUMAN "Cytosol aminopeptidase, EC 3.4.11.1 (Cysteinylglycine-S-conjugate dipeptidase, EC 3.4.13.23) (Leucine aminopeptidase 3, LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase, EC 3.4.11.5) (Prolyl aminopeptidase)" LAP3 LAPEP PEPS Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233] GO:0004177; GO:0004180; GO:0005634; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005925; GO:0006508; GO:0008233; GO:0008235; GO:0030145; GO:0030496; GO:0070006; GO:0070062 SASSK 11.23999977 0.15848574 0.15848574 0.215455766 478.6941709 19.32543 16.54704 20.97867 18.80485 16.45023 20.55668 21.88043 0 17.59224 21.9084 21.18071 16.55543 15.48882 0 20.92155 17.24655 20.34218 0 0 19.52603 19.52759 19.69846 17.43947 18.14172 0 19.22227 18.85203 20.12335 0 20.9118 0 22.28261 22.64803 20.99924 17.26164 21.4671 0 21.85884 17.64931 17.59485 19.75279 21.0281 20.83362 19.29103 19.66465 0 18.23324 20.5869 P28845 DHI1_HUMAN "11-beta-hydroxysteroid dehydrogenase 1, 11-DH, 11-beta-HSD1, EC 1.1.1.146 (7-oxosteroid reductase, EC 1.1.1.201) (Corticosteroid 11-beta-dehydrogenase isozyme 1) (Short chain dehydrogenase/reductase family 26C member 1)" HSD11B1 HSD11 HSD11L SDR26C1 Homo sapiens (Human) lung development [GO:0030324]; steroid catabolic process [GO:0006706] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0070524]; cortisol dehydrogenase activity [GO:0102196]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; lung development [GO:0030324]; steroid catabolic process [GO:0006706] 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0070524]; cortisol dehydrogenase activity [GO:0102196]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496] GO:0005496; GO:0005789; GO:0006706; GO:0016020; GO:0030176; GO:0030324; GO:0042803; GO:0050661; GO:0070524; GO:0102196 MGAHVVVTAR 21.46999931 1 1 9.17E-13 1056.624308 0 0 0 0 0 0 0 0 0 11.04838 0 0 0 14.07048 11.06831 0 0 0 0 0 0 0 0 13.60815 15.4295 0 0 0 0 0 0 0 0 18.77139 0 0 0 0 13.21575 0 0 12.04268 0 0 0 0 0 0 P28908 TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30) TNFRSF8 CD30 D1S166E Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165] transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005737; GO:0005886; GO:0007165; GO:0008285; GO:0016021; GO:0032759; GO:0032760; GO:0043065; GO:0070062; GO:0071260 VCECRPGMFCSTSAVNSCAR 4.53000021 0.465791315 0.465791315 2.75E-12 2349.006306 0 10.88446 13.41485 15.25731 0 0 0 0 0 0 0 0 0 14.56744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.98242 0 0 0 0 0 0 0 12.49941 0 0 0 0 0 0 0 0 P29074 PTN4_HUMAN "Tyrosine-protein phosphatase non-receptor type 4, EC 3.1.3.48 (Protein-tyrosine phosphatase MEG1, MEG, PTPase-MEG1)" PTPN4 Homo sapiens (Human) peptidyl-tyrosine phosphorylation [GO:0018108]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein dephosphorylation [GO:0006470] cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0018108; GO:0035254 TMRDQR 16.11000061 0.142945573 0.142945573 0.158445642 822.61897 16.29128 16.12163 14.44005 14.28837 15.30284 0 14.92646 14.71287 0 15.01451 17.2818 0 0 0 17.35494 15.53198 16.61663 0 0 0 0 0 0 0 0 0 0 0 0 15.92206 17.14001 16.03367 0 16.29123 0 16.63378 0 17.20424 0 16.22723 16.21904 15.93437 15.73754 15.63408 16.50584 15.981 14.5702 15.05702 P29120 NEC1_HUMAN "Neuroendocrine convertase 1, NEC 1, EC 3.4.21.93 (Prohormone convertase 1) (Proprotein convertase 1, PC1)" PCSK1 NEC1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; cell-cell signaling [GO:0007267]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410] identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005615; GO:0005791; GO:0005802; GO:0006508; GO:0007267; GO:0009410; GO:0009749; GO:0010157; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030133; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042802; GO:0043005; GO:0043043; GO:0043204; GO:0043278; GO:0043434; GO:0043679; GO:0048471; GO:0048678; GO:0050714; GO:0051384; GO:0051592; GO:0070542; GO:0070555 CAGEIAMQANNHK 3.5 0.889502227 0.889502227 0.17168235 1460.146502 15.86648 0 0 0 15.46842 0 14.43493 14.43565 14.45138 0 0 0 0 0 0 16.24619 0 15.4211 0 0 0 0 16.38914 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14561 0 0 0 0 0 0 16.21254 0 0 0 0 P29144 TPP2_HUMAN "Tripeptidyl-peptidase 2, TPP-2, EC 3.4.14.10 (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II, TPP-II)" TPP2 Homo sapiens (Human) amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144 IPKGAGPGCYLAGSLTLSK 9.770000458 1 1 0.264786413 1890.438747 0 0 0 5.92349 0 15.64774 12.71516 13.53287 0 0 14.45075 14.63416 10.19043 16.75287 0 0 0 0 0 0 0 0 0 0 15.89241 15.40048 0 0 0 0 0 0 0 0 14.36319 0 16.76491 0 0 16.27343 0 16.42918 16.07544 0 16.98611 0 0 0 P29218 IMPA1_HUMAN "Inositol monophosphatase 1, IMP 1, IMPase 1, EC 3.1.3.25 (D-galactose 1-phosphate phosphatase, EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1)" IMPA1 IMPA Homo sapiens (Human) inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803] GO:0000287; GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006661; GO:0006796; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0042802; GO:0042803; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834 NEMNVMLKSSPVDLVTATDQK 7.449999809 1 1 0.23783294 2336.764125 0 14.41512 14.09782 13.715 0 14.67085 11.42558 16.59395 0 0 0 0 0 0 0 14.42763 12.52976 0 0 0 0 0 13.68148 0 10.68738 0 0 0 0 0 0 0 17.54366 0 0 0 0 0 14.33133 0 0 0 0 0 0 13.66174 19.05039 0 P29279 CCN2_HUMAN "CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8, IBP-8, IGF-binding protein 8, IGFBP-8)" CCN2 CTGF HCS24 IGFBP8 Homo sapiens (Human) aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]; aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022] GO:0001502; GO:0001503; GO:0001525; GO:0001894; GO:0001934; GO:0001968; GO:0005178; GO:0005520; GO:0005576; GO:0005615; GO:0005801; GO:0005829; GO:0005886; GO:0005938; GO:0007155; GO:0007160; GO:0007165; GO:0007229; GO:0007568; GO:0008022; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008544; GO:0009611; GO:0009749; GO:0010628; GO:0010629; GO:0010942; GO:0016477; GO:0030154; GO:0030324; GO:0031012; GO:0032330; GO:0032355; GO:0032967; GO:0034059; GO:0035556; GO:0035988; GO:0043200; GO:0043280; GO:0043434; GO:0045597; GO:0046330; GO:0048471; GO:0050867; GO:0051385; GO:0051496; GO:0060401; GO:0060452; GO:0060548; GO:0070278; GO:0070318; GO:0070374; GO:0070542; GO:0071897; GO:0072593 LCMVRPCEADLEENIKK 3.160000086 1 1 0.273284181 2120.342188 14.81859 0 17.96753 0 11.65921 0 11.54693 16.47728 0 0 14.14193 0 0 11.08185 0 0 0 0 0 0 0 0 15.57849 0 0 0 15.80862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29317 EPHA2_HUMAN "Ephrin type-A receptor 2, EC 2.7.10.1 (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)" EPHA2 ECK Homo sapiens (Human) activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; virus receptor activity [GO:0001618]; activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; virus receptor activity [GO:0001618] GO:0001501; GO:0001570; GO:0001618; GO:0001649; GO:0002043; GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0006954; GO:0007155; GO:0007169; GO:0007275; GO:0007411; GO:0008630; GO:0009986; GO:0010591; GO:0014028; GO:0016477; GO:0016525; GO:0019838; GO:0021915; GO:0030027; GO:0030216; GO:0030316; GO:0030335; GO:0031256; GO:0031258; GO:0032587; GO:0032682; GO:0033598; GO:0033628; GO:0033674; GO:0036342; GO:0043005; GO:0043235; GO:0043491; GO:0043535; GO:0045296; GO:0045765; GO:0046058; GO:0046849; GO:0048013; GO:0048320; GO:0048870; GO:0050830; GO:0051898; GO:0060035; GO:0060326; GO:0060444; GO:0070160; GO:0070309; GO:0070372; GO:0070848; GO:0072659; GO:0090630; GO:1901491; GO:1903078; GO:1903348; GO:1904238 KEVPVAIK 9.399999619 1 1 0.230072407 884.6577865 15.48135 12.24577 0 12.60956 15.44337 13.8555 13.46699 12.9896 0 0 0 0 0 0 15.30523 0 0 0 0 0 0 0 0 0 14.45471 0 14.87477 16.16585 14.78866 0 0 0 0 0 0 0 16.17344 0 0 0 0 0 0 0 0 18.60089 0 14.96746 P29322 EPHA8_HUMAN "Ephrin type-A receptor 8, EC 2.7.10.1 (EPH- and ELK-related kinase) (EPH-like kinase 3, EK3, hEK3) (Tyrosine-protein kinase receptor EEK)" EPHA8 EEK HEK3 KIAA1459 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0004712; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006929; GO:0007155; GO:0007169; GO:0007411; GO:0016322; GO:0019838; GO:0030155; GO:0031175; GO:0031901; GO:0033628; GO:0033674; GO:0043005; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048013; GO:0071372 SVGPLSKR 5.840000153 0.663136244 0.663136244 0.159402766 844.5545414 15.33854 13.8591 0 14.79338 0 13.97962 14.22127 0 15.82923 14.53004 0 0 19.00107 18.21875 18.5932 18.15682 17.64046 18.3114 18.41448 19.94408 18.12976 17.97445 18.09832 18.00736 18.78153 18.47018 18.16777 18.31243 18.85409 18.79133 18.37408 17.78674 16.83314 18.96291 18.60371 18.32221 19.07451 18.80542 19.2129 18.26066 18.17183 19.31953 19.5208 19.45799 18.6526 19.04239 18.32647 18.69653 P29323 EPHB2_HUMAN "Ephrin type-B receptor 2, EC 2.7.10.1 (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5, EK5, hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2 ]" EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 Homo sapiens (Human) "angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]" axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235] "axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]" amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001525; GO:0001540; GO:0001655; GO:0001933; GO:0002639; GO:0004712; GO:0004713; GO:0004714; GO:0005005; GO:0005102; GO:0005524; GO:0005576; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006469; GO:0007162; GO:0007169; GO:0007399; GO:0007411; GO:0007413; GO:0007611; GO:0007612; GO:0008046; GO:0009986; GO:0010628; GO:0016310; GO:0018108; GO:0021631; GO:0021934; GO:0021952; GO:0022038; GO:0030193; GO:0030335; GO:0030424; GO:0030425; GO:0030890; GO:0031290; GO:0031915; GO:0032760; GO:0033674; GO:0042113; GO:0042472; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043235; GO:0044877; GO:0046425; GO:0046580; GO:0048013; GO:0048168; GO:0048170; GO:0048593; GO:0050771; GO:0050878; GO:0051489; GO:0051965; GO:0060021; GO:0060996; GO:0060997; GO:0061003; GO:0070373; GO:0071222; GO:0071679; GO:0097104; GO:0098794; GO:0098978; GO:0099055; GO:0099056; GO:0099557; GO:0106028; GO:0110077; GO:0120192; GO:1900016; GO:1900273; GO:1903078; GO:1904646; GO:1904782; GO:1904783; GO:2000316; GO:2000822 AQMNQIQSVEGQPLARRPR 5.659999847 1 1 0.395093863 2193.997162 18.20913 0 17.15383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.23779 0 0 0 0 0 0 0 0 P29353 SHC1_HUMAN "SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1, SH2 domain protein C1)" SHC1 SHC SHCA Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] GO:0001525; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005543; GO:0005759; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007176; GO:0007507; GO:0008284; GO:0008286; GO:0016525; GO:0019901; GO:0030971; GO:0031532; GO:0035556; GO:0040008; GO:0042742; GO:0043066; GO:0043410; GO:0045892; GO:0045893; GO:0046875; GO:0048408; GO:0070374; GO:0070435; GO:0071363; GO:0071864; GO:0090322; GO:0098609 FAGMPITLTVSTSSLNLMAADCK 3.529999971 0.386979997 0.386979997 0.381955451 2460.812188 13.41752 0 0 0 0 12.93534 0 0 0 0 0 0 0 0 0 0 0 0 16.03381 16.55325 0 0 16.9336 0 15.90546 15.16366 15.85367 0 13.87052 0 0 0 0 0 0 0 14.44511 15.92043 15.53941 0 0 0 15.62928 0 0 13.2733 0 0 P29373 RABP2_HUMAN "Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II, CRABP-II)" CRABP2 Homo sapiens (Human) "embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]" cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841] GO:0001972; GO:0002138; GO:0005501; GO:0005504; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006355; GO:0007165; GO:0008544; GO:0015908; GO:0016918; GO:0019841; GO:0030332; GO:0035115; GO:0048672; GO:0070062 KIAVAAASKPAVEIK 2.50999999 1 1 0.157174214 1497.234241 11.80029 0 0 10.51219 0 12.09374 0 12.54962 15.64636 12.87449 14.03172 13.61165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29374 ARI4A_HUMAN "AT-rich interactive domain-containing protein 4A, ARID domain-containing protein 4A (Retinoblastoma-binding protein 1, RBBP-1)" ARID4A RBBP1 RBP1 Homo sapiens (Human) "erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976] GO:0000122; GO:0000976; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006349; GO:0006357; GO:0007283; GO:0016580; GO:0017053; GO:0030336; GO:0030512; GO:0034773; GO:0036124; GO:0045892; GO:0045944; GO:0048821; GO:0080182; GO:0097368; GO:1902455; GO:1902459 AADEPAYLTVGTDVSAKYR 2.569999933 1 1 1.14E-12 2027.235076 12.42344 12.4446 11.19239 13.84302 13.25548 9.838446 0 14.10398 0 0 12.88528 9.008441 13.00393 0 12.35955 0 0 14.95231 11.57304 0 0 16.28299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29375 KDM5A_HUMAN "Lysine-specific demethylase 5A, EC 1.14.11.67 (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2, RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)" KDM5A JARID1A RBBP2 RBP2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]" chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0008270; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034720; GO:0035064; GO:0042393; GO:0045893; GO:0051090; GO:1901726 MAADPECLDVGLAAMVCK 3.859999895 1 1 0.038011094 1967.425252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29400 CO4A5_HUMAN Collagen alpha-5(IV) chain COL4A5 Homo sapiens (Human) collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0031594; GO:0038063; GO:0062023 GEPGFALPGPPGPPGLPGFK 4.71999979 1 1 0.546192119 1888.280265 17.21894 0 16.81458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3068 0 18.45619 18.94003 0 16.87726 0 0 0 0 18.16415 18.3251 0 0 0 0 0 0 0 0 0 0 0 0 0 P29475 NOS1_HUMAN "Nitric oxide synthase, brain, EC 1.14.13.39 (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS, N-NOS, nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS)" NOS1 Homo sapiens (Human) "arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]" cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synapse [GO:0045202]; vesicle membrane [GO:0012506] "cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]" arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325] GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006527; GO:0006809; GO:0006936; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0012506; GO:0014069; GO:0016491; GO:0016529; GO:0017080; GO:0018119; GO:0020037; GO:0031284; GO:0032496; GO:0032991; GO:0033138; GO:0033555; GO:0034617; GO:0034618; GO:0035066; GO:0042136; GO:0042178; GO:0042311; GO:0042383; GO:0043197; GO:0043267; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0051346; GO:0051612; GO:0051926; GO:0055117; GO:0060314; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0098924; GO:1902307; GO:1902514 LMGQAMAK 14 0.816728294 0.816728294 0.257698001 864.314874 16.6601 16.71007 15.52457 0 17.3624 16.02845 0 15.93385 0 17.07416 0 13.91011 15.67165 13.10608 14.54404 0 0 0 0 15.99899 15.55522 0 0 16.29662 0 15.97343 14.39257 14.35247 13.17515 17.14951 16.92767 16.12725 0 17.61003 0 16.94113 0 17.72084 16.31351 0 17.11151 17.88407 15.9432 16.28778 17.33995 0 15.65985 13.18706 P29558 RBMS1_HUMAN "RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2)" RBMS1 C2orf12 MSSP MSSP1 SCR2 Homo sapiens (Human) DNA replication [GO:0006260]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; RNA processing [GO:0006396] double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904 DSSGTSR 1.299999952 1 1 0.213272139 709.9454986 0 15.45079 14.12371 0 0 0 15.44926 16.04482 0 15.43372 0 0 15.38064 17.37124 0 0 0 0 0 0 16.69347 0 0 0 14.44414 15.71621 16.73209 15.48423 11.95086 14.61512 13.44974 14.60754 0 16.13693 0 0 0 17.02992 0 0 0 0 15.94026 0 0 0 0 0 P29728 OAS2_HUMAN "2'-5'-oligoadenylate synthase 2, (2-5')oligo(A) synthase 2, 2-5A synthase 2, EC 2.7.7.84 (p69 OAS / p71 OAS, p69OAS / p71OAS)" OAS2 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006139; GO:0006401; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0042742; GO:0043231; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:0070106; GO:1903487 LKPKGSLPPK 9.489999771 0.057732765 0.057732765 0.114277921 1065.285226 11.76857 0 15.7309 16.19142 15.80338 16.52613 0 15.38667 0 0 0 16.18928 18.04036 16.59123 14.58454 16.39788 12.80385 0 14.18351 0 0 17.30947 14.0068 0 10.39349 15.14512 16.5913 0 0 0 0 13.0935 12.30093 0 17.55385 17.03705 15.92641 0 0 0 13.56388 14.31431 17.32119 0 0 16.34217 10.1588 16.25957 P29803 ODPAT_HUMAN "Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial, EC 1.2.4.1 (PDHE1-A type II)" PDHA2 PDHAL Homo sapiens (Human) acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099] pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604] GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0034604 GKGGSMHMYTK 9.93999958 1 1 1.37E-12 1212.683181 15.13916 0 10.24819 14.71929 0 13.93652 15.68971 14.98845 13.86016 0 12.96019 14.17751 9.88433 14.57252 0 16.28308 14.28873 15.94241 14.86491 14.8412 0 15.54634 14.73327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29966 MARCS_HUMAN "Myristoylated alanine-rich C-kinase substrate, MARCKS (Protein kinase C substrate, 80 kDa protein, light chain, 80K-L protein, PKCSL)" MARCKS MACS PRKCSL Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; central nervous system development [GO:0007417] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; germinal vesicle [GO:0042585]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; germinal vesicle [GO:0042585]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; central nervous system development [GO:0007417] actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080] GO:0005080; GO:0005516; GO:0005737; GO:0005813; GO:0005886; GO:0005925; GO:0005938; GO:0007015; GO:0007417; GO:0015629; GO:0032432; GO:0042585; GO:0042802; GO:0051015; GO:0051017; GO:0051764; GO:0070062 VNGDASPAAAESGAK 8.350000381 1 1 0.37815471 1345.642808 14.83716 10.99411 0 0 0 17.02748 0 16.40367 14.9741 0 0 16.24998 0 0 0 0 17.1236 0 17.35284 15.77001 16.81402 14.85445 0 16.61786 0 17.70753 0 0 0 0 0 0 0 17.98917 0 17.42343 15.82666 15.59763 0 16.68084 0 16.75707 14.46545 0 0 0 0 0 P30038 AL4A1_HUMAN "Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial, P5C dehydrogenase, EC 1.2.1.88 (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)" ALDH4A1 ALDH4 P5CDH Homo sapiens (Human) 4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; 4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560] 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802] GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802 SSPSLTILAGGK 3.549999952 1 1 6.87E-13 1133.426151 13.19058 14.40011 12.98008 9.692815 13.15419 0 13.21116 15.94937 14.55811 13.52823 14.18401 13.66916 0 0 0 0 0 0 0 0 0 14.45958 14.77194 14.46939 0 0 0 0 12.72147 11.08299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30041 PRDX6_HUMAN "Peroxiredoxin-6, EC 1.11.1.27 (1-Cys peroxiredoxin, 1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2, aiPLA2, EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5, LPC acyltransferase 5, LPCAT-5, Lyso-PC acyltransferase 5, EC 2.3.1.23) (Non-selenium glutathione peroxidase, NSGPx) (Red blood cells page spot 12)" PRDX6 AOP2 KIAA0106 Homo sapiens (Human) "cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]" azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; thioredoxin peroxidase activity [GO:0008379]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]" 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; thioredoxin peroxidase activity [GO:0008379]; ubiquitin protein ligase binding [GO:0031625] GO:0004602; GO:0004623; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0016020; GO:0031625; GO:0035578; GO:0042802; GO:0045296; GO:0045454; GO:0046475; GO:0047184; GO:0047499; GO:0048026; GO:0048471; GO:0070062; GO:0098869 ELAILLGMLDPAEKDEK 3.019999981 1 1 0.147157179 1900.47493 14.6231 0 0 0 15.3303 0 0 0 0 0 0 15.80211 0 0 0 13.6906 0 0 0 15.51219 0 15.62758 0 0 15.97094 15.49044 15.53165 0 0 0 15.38682 0 0 0 0 0 16.15272 16.20018 0 15.0826 0 15.30927 0 15.59789 0 0 0 0 P30048 PRDX3_HUMAN "Thioredoxin-dependent peroxide reductase, mitochondrial, EC 1.11.1.24 (Antioxidant protein 1, AOP-1) (HBC189) (Peroxiredoxin III, Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3)" PRDX3 AOP1 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979] alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379] GO:0001893; GO:0005737; GO:0005739; GO:0005759; GO:0005769; GO:0005829; GO:0006979; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0008785; GO:0018171; GO:0019900; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0045454; GO:0051092; GO:0051881 NGGLGHMNIALLSDLTK 9.930000305 1 1 0.395739602 1771.130834 16.78173 20.32995 16.87026 0 0 0 0 17.77429 0 17.55753 0 0 0 0 0 19.25627 0 0 0 0 0 17.7093 0 18.19289 0 0 18.27629 0 0 17.55788 0 20.26873 0 0 0 0 17.84883 20.98736 0 18.83974 0 0 0 17.2232 0 0 0 0 P30049 ATPD_HUMAN "ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)" ATP5F1D ATP5D Homo sapiens (Human) aerobic respiration [GO:0009060]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to copper ion [GO:0046688] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to copper ion [GO:0046688]" "proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]" GO:0000275; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0009060; GO:0015986; GO:0033615; GO:0042776; GO:0046688; GO:0046933 IEANEALVK 5.590000153 1 1 0.277909003 985.6245987 16.68213 0 0 0 15.88043 0 0 0 0 0 0 17.48955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.21951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30050 RL12_HUMAN 60S ribosomal protein L12 (Large ribosomal subunit protein uL11) RPL12 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0015934; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:0070180 VVYLRCTGGEVGATSALAPK 3.400000095 0.335014582 0.335014582 5.47E-12 2048.402494 13.83052 12.56427 0 0 14.47517 13.65792 0 0 0 14.82149 16.92685 15.38384 13.55464 15.5534 14.6271 13.68649 13.98832 14.34183 16.26883 0 14.87808 0 0 0 0 16.63886 14.98092 15.09471 0 0 14.12989 17.04211 18.76088 0 13.09365 12.44351 14.1129 16.52919 12.17653 14.85995 18.11 0 15.65091 0 14.93333 0 15.25965 0 P30153 2AAA_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha) PPP2R1A Homo sapiens (Human) "apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]" "chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]" "chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]" protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722] GO:0000159; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007143; GO:0008380; GO:0010033; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0043005; GO:0043025; GO:0043409; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0098978; GO:1903538; GO:1990405; GO:2001241 VLELDNVK 21.34000015 1 1 0.180464951 928.1998739 0 0 15.64647 0 0 14.82633 15.23606 0 15.98507 15.16745 0 0 0 16.3628 16.02858 0 14.64156 0 0 17.09291 0 0 0 0 0 0 0 0 0 15.76723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30154 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta) PPP2R1B Homo sapiens (Human) apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470] protein phosphatase regulator activity [GO:0019888] GO:0000159; GO:0005737; GO:0006470; GO:0019888; GO:0045121; GO:0060561; GO:0070062; GO:2001241 LGQDEDMDVK 5.099999905 1 1 0.267597354 1149.251095 11.36827 0 14.21832 15.50526 14.1133 15.0682 0 0 0 15.36344 0 0 0 14.25456 15.00017 0 0 0 0 0 14.36775 15.70773 0 0 0 0 0 0 0 17.06312 0 15.05297 0 0 0 0 0 0 0 0 0 0 0 0 14.68635 0 0 0 P30260 CDC27_HUMAN "Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3, APC3) (CDC27 homolog, CDC27Hs) (H-NUC)" CDC27 ANAPC3 D0S1430E D17S978E Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] protein phosphatase binding [GO:0019903] GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686 NPLCKFHR 1.960000038 1 1 0.01071306 1071.875106 0 0 0 15.98036 0 0 0 0 0 0 0 0 16.79535 0 0 0 0 0 19.00721 0 0 15.98052 0 0 16.46148 0 0 0 0 0 15.88451 16.90351 14.86456 0 14.95664 0 0 16.31942 15.13979 13.68259 15.5135 0 0 0 13.87366 0 0 0 P30305 MPIP2_HUMAN "M-phase inducer phosphatase 2, EC 3.1.3.48 (Dual specificity phosphatase Cdc25B)" CDC25B CDC25HU2 Homo sapiens (Human) cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468] phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] GO:0000086; GO:0000278; GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007144; GO:0008284; GO:0010971; GO:0019901; GO:0032467; GO:0045860; GO:0045931; GO:0051301; GO:0110032 DTPVQNKR 8.970000267 1 1 4.59E-13 958.4109027 0 16.18066 13.32864 13.91826 14.30569 0 0 0 12.92268 0 14.13712 0 13.64433 0 0 0 0 0 0 14.91659 0 0 16.0086 0 0 0 16.26251 0 0 0 0 0 0 0 0 0 0 0 0 15.52468 0 0 0 0 16.0915 0 16.0505 0 P30307 MPIP3_HUMAN "M-phase inducer phosphatase 3, EC 3.1.3.48 (Dual specificity phosphatase Cdc25C)" CDC25C Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283] phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699] GO:0000079; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005758; GO:0005829; GO:0007088; GO:0007283; GO:0008283; GO:0010971; GO:0016607; GO:0019901; GO:0048471; GO:0050699; GO:0051301; GO:0110032 YFSGQGKLR 5.320000172 1 1 0.221980879 1056.644978 14.01408 0 11.51556 13.0265 14.00309 15.38954 0 0 0 0 0 15.58341 16.53215 15.64413 0 14.78902 16.57482 14.67402 14.35203 0 14.7437 15.31498 0 15.58728 0 14.63821 0 14.84477 16.97337 0 16.36143 0 0 0 0 0 15.28915 0 0 0 0 16.08809 0 0 0 0 0 0 P30414 NKTR_HUMAN "NK-tumor recognition protein, NK-TR protein (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR, PPIase, EC 5.2.1.8) (Rotamase)" NKTR Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0016018; GO:0043231 IQEMKAK 2.839999914 0.020012626 0.020012626 0.277843673 864.8304015 15.60784 13.27637 13.01524 15.71124 14.61881 14.8628 15.40902 15.13602 15.81267 15.54619 15.08642 15.14586 14.08658 14.98205 0 15.98351 14.50245 15.20419 16.46195 14.94707 16.68302 16.40234 0 15.99929 14.8458 15.50343 12.71169 0 15.38059 15.35399 15.71881 0 0 16.06091 15.50483 0 14.49807 15.84625 15.67432 8.684264 15.77396 15.52078 0 15.7955 13.74703 0 0 16.78426 P30519 HMOX2_HUMAN "Heme oxygenase 2, HO-2, EC 1.14.14.18 [Cleaved into: Heme oxygenase 2 soluble form ]" HMOX2 HO2 Homo sapiens (Human) heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; iron ion homeostasis [GO:0055072]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; iron ion homeostasis [GO:0055072]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872] GO:0001666; GO:0004392; GO:0005789; GO:0005886; GO:0006788; GO:0006979; GO:0016020; GO:0020037; GO:0035579; GO:0042167; GO:0046872; GO:0055072 DMEYFFGENWEEQVQCPKAAQK 3.450000048 1 1 9.19E-13 2749.178898 0 14.30429 13.80828 14.02761 14.08815 13.16892 0 12.82271 0 0 0 15.28629 11.39692 0 0 0 0 0 0 0 0 0 16.04392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30530 UFO_HUMAN "Tyrosine-protein kinase receptor UFO, EC 2.7.10.1 (AXL oncogene)" AXL UFO Homo sapiens (Human) animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718] ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618] GO:0001618; GO:0001764; GO:0001779; GO:0001786; GO:0001961; GO:0001974; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007399; GO:0009986; GO:0015629; GO:0016477; GO:0021885; GO:0030168; GO:0031100; GO:0031668; GO:0032036; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0033674; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043491; GO:0043524; GO:0043548; GO:0044228; GO:0045087; GO:0046718; GO:0048010; GO:0048469; GO:0048549; GO:0051250; GO:0051897; GO:0060068; GO:0070062; GO:0070301; GO:0071222; GO:0097028; GO:0097350; GO:1903902; GO:2000669 MAWRCPR 7.320000172 1 1 3.49E-13 977.4422231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.90676 0 0 0 0 0 0 0 0 0 0 16.00702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.65414 0 0 0 0 0 0 P30533 AMRP_HUMAN "Alpha-2-macroglobulin receptor-associated protein, Alpha-2-MRAP (Low density lipoprotein receptor-related protein-associated protein 1, RAP)" LRPAP1 A2MRAP Homo sapiens (Human) amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165] cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237] cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165] amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326] GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0007165; GO:0008201; GO:0009986; GO:0010916; GO:0012505; GO:0031904; GO:0032091; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0060548; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223 ELGYTVK 15.80000019 0.421353638 0.421353638 0.186871164 809.7839771 15.77502 15.54391 15.30959 0 17.04225 0 15.76031 15.81629 15.68475 17.05042 17.03868 15.23482 0 15.51443 13.23229 14.96219 14.82333 16.18302 15.1357 14.87432 15.17606 15.88692 15.69119 0 17.26547 15.17601 0 14.55359 0 0 0 0 0 0 0 0 0 0 0 16.07945 0 0 15.9561 16.62621 0 15.55917 0 0 P30559 OXYR_HUMAN "Oxytocin receptor, OT-R" OXTR Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]" adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000]; cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]" G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000] GO:0001967; GO:0001975; GO:0001992; GO:0004930; GO:0004990; GO:0005000; GO:0005886; GO:0005887; GO:0005902; GO:0005912; GO:0006936; GO:0007166; GO:0007186; GO:0007204; GO:0007507; GO:0007565; GO:0007595; GO:0007613; GO:0009410; GO:0010701; GO:0016324; GO:0017046; GO:0021537; GO:0030431; GO:0032230; GO:0032355; GO:0032570; GO:0034059; GO:0034097; GO:0035176; GO:0042220; GO:0042277; GO:0042711; GO:0042713; GO:0042755; GO:0043434; GO:0044849; GO:0045777; GO:0045907; GO:0048565; GO:0051965; GO:0051968; GO:0060137; GO:0060406; GO:0060455; GO:0070371; GO:0070474; GO:0120162 SNSSSFVLSHRSSSQR 10.78999996 0.330198169 0.330198169 0.139816932 1765.83388 19.3426 15.43837 13.90024 11.04575 0 18.50197 0 0 16.57429 0 0 0 0 20.93537 19.1565 19.13198 21.29325 0 19.37889 15.51088 0 19.37313 0 13.18803 19.88796 0 0 18.02341 0 0 18.48937 17.79355 0 0 0 0 0 0 18.66286 20.67951 0 20.23602 0 0 0 0 0 0 P30622 CLIP1_HUMAN "CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2, CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)" CLIP1 CYLN1 RSN Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 LLDLDALR 9.279999733 1 1 0.164722932 928.5593221 0 0 15.07514 15.22426 15.13047 13.71602 0 0 14.51502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30740 ILEU_HUMAN "Leukocyte elastase inhibitor, LEI (Monocyte/neutrophil elastase inhibitor, EI, M/NEI) (Peptidase inhibitor 2, PI-2) (Serpin B1)" SERPINB1 ELANH2 MNEI PI2 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342] collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774] collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342] peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576; GO:0005615; GO:0005769; GO:0010951; GO:0016020; GO:0030414; GO:0032691; GO:0034774; GO:0036464; GO:0044194; GO:0044342; GO:0062023; GO:0070062 GASYILK 1.649999976 1 1 0.280122644 751.8358392 0 0 0 0 0 0 0 0 0 0 18.23445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.04745 0 0 0 0 0 P30793 GCH1_HUMAN "GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)" GCH1 DYT5 GCH Homo sapiens (Human) "7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]" cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]" calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270] GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0006809; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042802; GO:0042803; GO:0044306; GO:0044877; GO:0045776; GO:0046654; GO:0048265; GO:0050884; GO:0051000; GO:0051019; GO:0065003; GO:2000121 EDPKTR 3.299999952 0.672652006 0.672652006 0.212062056 745.6985358 0 14.72472 15.60779 15.94825 0 10.80241 0 0 14.97889 0 14.73238 15.46902 0 13.46917 0 0 0 0 17.10832 16.62129 0 0 0 0 16.43327 0 0 14.57507 14.42513 15.32682 0 14.83057 0 0 17.05207 14.90061 16.4715 0 0 0 16.80774 0 0 0 15.05958 14.49693 0 0 P30837 AL1B1_HUMAN "Aldehyde dehydrogenase X, mitochondrial, EC 1.2.1.3 (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)" ALDH1B1 ALDH5 ALDHX Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287] GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005975; GO:0006068; GO:0043878; GO:0051287 AYTEVK 5.25 1 1 0.051197977 711.5450659 0 0 13.09058 0 0 0 10.66578 0 0 0 0 0 0 0 0 0 15.04172 0 0 0 0 0 0 0 16.91482 0 0 0 0 0 0 16.07069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30876 RPB2_HUMAN "DNA-directed RNA polymerase II subunit RPB2, EC 2.7.7.6 (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)" POLR2B Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] "membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; transcription by RNA polymerase II [GO:0006366]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723] GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0016020; GO:0032549; GO:0046872 DLCELNECPLDPGGYFIINGSEKVLIAQEK 1.720000029 1 1 0.141442571 3420.908527 0 15.55668 0 12.99324 12.46539 0 7.823 14.36472 14.2036 14.50432 13.71526 13.4627 0 0 0 0 0 0 0 0 0 0 11.90963 0 14.74931 0 0 15.1828 0 0 0 0 0 0 0 0 0 13.14517 0 0 0 0 0 13.49096 14.38285 16.92401 0 12.56644 P30926 ACHB4_HUMAN Neuronal acetylcholine receptor subunit beta-4 CHRNB4 Homo sapiens (Human) "action potential [GO:0001508]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of smooth muscle contraction [GO:0006940]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821] "acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; action potential [GO:0001508]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of smooth muscle contraction [GO:0006940]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594] GO:0001508; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006939; GO:0006940; GO:0007165; GO:0007268; GO:0007271; GO:0007626; GO:0015276; GO:0015464; GO:0016021; GO:0022848; GO:0030594; GO:0034220; GO:0035095; GO:0035579; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046928; GO:0050877; GO:0051899; GO:0051971; GO:0060084; GO:0070821; GO:0098981 RPGPDSSPAR 5.099999905 1 1 4.59E-13 1039.858465 15.83608 15.34951 16.03504 0 15.67782 12.7199 0 13.87322 0 0 11.83678 0 0 0 15.72085 0 12.85893 15.22042 0 14.47083 0 0 8.242668 14.91918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.86037 0 0 0 P30954 O10J1_HUMAN Olfactory receptor 10J1 (Olfactory receptor OR1-26) (Olfactory receptor-like protein HGMP07J) OR10J1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; single fertilization [GO:0007338] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; single fertilization [GO:0007338] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005887; GO:0007186; GO:0007338; GO:0007606; GO:0016021; GO:0050911 AVGGK 2.609999895 1 1 0.097229063 429.6957479 15.34717 0 14.97433 0 14.50231 0 15.62829 15.17158 0 0 14.16526 14.1623 0 14.5028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30988 CALCR_HUMAN "Calcitonin receptor, CT-R" CALCR Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384] amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384] amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528] GO:0001540; GO:0001635; GO:0004948; GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0007204; GO:0008528; GO:0010628; GO:0010739; GO:0010942; GO:0030424; GO:0032841; GO:0033138; GO:0038041; GO:0045762; GO:0051384; GO:0051897; GO:0070374; GO:0097643; GO:0097647; GO:0150056; GO:0150057; GO:0150058; GO:1904645; GO:1905665 VLVTKMR 3.130000114 1 1 0.223262962 862.7530645 15.58947 17.45474 14.25517 14.6814 0 15.10597 0 15.82965 15.65336 15.83706 14.73144 14.65559 16.98739 13.75128 16.36475 16.40856 16.2096 16.65781 0 15.04355 0 14.97463 0 17.01176 0 0 15.75372 0 15.537 16.8241 16.04555 14.73323 16.47016 15.84901 16.38949 14.63574 15.73784 17.02841 13.25286 14.77896 15.78112 13.7571 17.23806 15.26613 14.32324 15.79709 17.36787 15.46102 P31040 SDHA_HUMAN "Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial, EC 1.3.5.1 (Flavoprotein subunit of complex II, Fp)" SDHA SDH2 SDHF Homo sapiens (Human) "mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]" "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]" "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]" electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177] GO:0005730; GO:0005739; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0007399; GO:0008177; GO:0009055; GO:0022904; GO:0042776; GO:0050660 SHTVAAQGGINAALGNMEEDNWR 7.679999828 1 1 0.261211265 2442.496476 0 0 0 0 0 0 0 0 17.74515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31153 METK2_HUMAN "S-adenosylmethionine synthase isoform type-2, AdoMet synthase 2, EC 2.5.1.6 (Methionine adenosyltransferase 2, MAT 2) (Methionine adenosyltransferase II, MAT-II)" MAT2A AMS2 MATA2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478] GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830 HIGYDDSSK 2.440000057 1 1 0.113694621 1020.904238 13.92816 14.82083 0 0 0 11.24018 0 14.29481 11.77401 10.56096 14.19364 16.01483 0 13.90713 11.77844 13.61105 15.36032 15.83026 14.72864 14.21737 0 14.68022 13.34382 15.65504 0 0 14.78547 0 0 0 0 0 0 14.38939 14.52973 0 0 0 0 0 0 0 13.81062 15.14881 0 0 0 0 P31249 HXD3_HUMAN Homeobox protein Hox-D3 (Homeobox protein Hox-4A) HOXD3 HOX1D HOX4A Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]" aggresome [GO:0016235]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0007160; GO:0007219; GO:0009952; GO:0010628; GO:0016235; GO:0016604; GO:0030878; GO:0045666; GO:0045944; GO:0048704; GO:0051216; GO:1990837 AKGILHSPASQSPER 6.329999924 1 1 0.41455801 1577.22084 0 0 11.53832 13.7158 13.78868 0 10.94746 0 13.85464 13.51162 14.98858 0 0 16.59167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9971 0 0 0 15.35377 15.19868 0 0 0 P31274 HXC9_HUMAN Homeobox protein Hox-C9 (Homeobox protein Hox-3B) HOXC9 HOX3B Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell cycle [GO:0045786]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" aggresome [GO:0016235]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "aggresome [GO:0016235]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell cycle [GO:0045786]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0009952; GO:0009954; GO:0016235; GO:0017053; GO:0045786; GO:0048704; GO:1990837 SYPDYMYGSPGELRDR 2.289999962 1 1 1.61E-12 1906.359225 0 0 13.51076 0 0 0 0 0 0 0 0 0 16.04954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.23166 0 0 0 P31327 CPSM_HUMAN "Carbamoyl-phosphate synthase [ammonia], mitochondrial, EC 6.3.4.16 (Carbamoyl-phosphate synthetase I, CPSase I)" CPS1 Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0006207; GO:0006541; GO:0006807; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0032094; GO:0032496; GO:0032991; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341 AMLSTGFKIPQK 2.920000076 1 1 0.175264631 1335.823512 12.39229 15.01958 0 14.87634 0 0 14.99766 0 0 0 0 0 0 0 0 13.64872 15.17593 0 0 15.48812 0 14.81087 0 0 0 0 0 0 17.03037 0 0 0 0 15.86916 0 14.40719 16.82516 16.99399 0 0 15.72528 14.93529 0 16.21317 0 0 0 16.21812 P31350 RIR2_HUMAN "Ribonucleoside-diphosphate reductase subunit M2, EC 1.17.4.1 (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)" RRM2 RR2 Homo sapiens (Human) 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971] "cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]" "ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]" GO:0001824; GO:0004748; GO:0005634; GO:0005829; GO:0005971; GO:0006260; GO:0008199; GO:0009185; GO:0009263; GO:0009265; GO:0042803; GO:0051290; GO:1900087 VENPFDFMENISLEGK 9.93999958 0.720016539 0.720016539 0.046185063 1878.746438 13.61057 0 12.66521 15.45555 0 0 15.79458 14.31809 15.80845 12.0586 0 0 14.90357 0 0 15.70224 13.61239 15.05067 0 0 0 0 14.63148 14.51313 0 9.424219 15.66629 0 0 0 0 0 0 0 0 0 0 14.31121 0 15.70924 0 0 0 0 14.11065 13.53141 0 0 P31415 CASQ1_HUMAN "Calsequestrin-1 (Calmitine) (Calsequestrin, skeletal muscle isoform)" CASQ1 CASQ Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to heat [GO:0009408]; response to organic substance [GO:0010033]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; terminal cisterna lumen [GO:0014804]; Z disc [GO:0030018] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; terminal cisterna lumen [GO:0014804]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to heat [GO:0009408]; response to organic substance [GO:0010033]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] GO:0005509; GO:0005739; GO:0005759; GO:0005783; GO:0005790; GO:0005794; GO:0007029; GO:0007519; GO:0009408; GO:0010033; GO:0014804; GO:0014809; GO:0014894; GO:0016529; GO:0030018; GO:0030315; GO:0033017; GO:0033018; GO:0042802; GO:0045214; GO:0051258; GO:0051279; GO:0051281; GO:1901341; GO:2001256 SATDRMGPR 3.319999933 0.804740489 0.804740489 0.221906277 988.3514891 0 15.14279 0 15.11762 14.15429 14.38621 0 0 15.93306 14.71022 0 0 15.35815 0 16.39069 15.02111 15.40149 0 0 0 0 16.50266 0 16.24351 13.28745 15.73392 14.75768 14.88311 14.14704 15.21841 15.08179 14.85777 15.07483 13.2612 14.91956 13.95983 13.75719 15.83616 14.55589 12.6543 14.74549 17.32078 14.9065 13.03689 15.24766 14.9984 14.24029 13.30549 P31483 TIA1_HUMAN "Cytotoxic granule associated RNA binding protein TIA1 (Nucleolysin TIA-1 isoform p40) (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1, TIA-1) (p40-TIA-1)" TIA1 Homo sapiens (Human) "apoptotic process [GO:0006915]; negative regulation of cytokine production [GO:0001818]; negative regulation of translation [GO:0017148]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; stress granule assembly [GO:0034063]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of cytokine production [GO:0001818]; negative regulation of translation [GO:0017148]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; stress granule assembly [GO:0034063]" mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] GO:0000381; GO:0001818; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008143; GO:0010494; GO:0017148; GO:0034063; GO:0035925; GO:0048024; GO:0097165; GO:1903608 AAFAPFGR 3.670000076 1 1 0.252095229 835.3538154 0 0 19.13787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.39626 0 0 0 16.49909 18.4812 0 0 0 0 0 0 0 0 16.7101 17.35946 0 0 0 0 0 0 0 0 0 0 16.35385 0 0 P31629 ZEP2_HUMAN "Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2, HIV-EP2) (MHC-binding protein 2, MBP-2)" HIVEP2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872 ACAKPSVLK 3.390000105 1 1 0.140894058 971.6666188 12.66181 15.01737 12.42766 0 0 0 0 0 9.571422 13.95131 0 0 0 0 0 15.34875 0 0 0 0 0 15.28054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31644 GBRA5_HUMAN Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) GABRA5 Homo sapiens (Human) "associative learning [GO:0008306]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202] "chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; transporter activity [GO:0005215]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; transporter activity [GO:0005215] GO:0001662; GO:0004890; GO:0005215; GO:0005237; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007420; GO:0007605; GO:0008306; GO:0022851; GO:0030594; GO:0032590; GO:0032809; GO:0034220; GO:0034707; GO:0038023; GO:0042391; GO:0043005; GO:0043524; GO:0045202; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0060119; GO:0060384; GO:0090102; GO:0098794; GO:0098982; GO:0099056; GO:0099060; GO:1902476; GO:1902711; GO:1904315 EVILNKSTNAFTTGK 6.670000076 1 1 0.427569239 1622.578469 14.3821 14.69711 0 17.43026 0 15.93455 0 12.21436 16.74065 0 0 12.71421 0 13.95535 0 0 15.10054 0 0 14.49163 0 0 0 0 0 0 0 0 0 0 0 0 17.08015 15.64668 0 0 0 17.68139 0 0 0 0 15.73341 0 15.67614 0 14.41282 15.10634 P31689 DNJA1_HUMAN "DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2, HSJ-2) (Human DnaJ protein 2, hDj-2)" DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986] ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0009408; GO:0015630; GO:0016020; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1903748; GO:1905259 GTGMQIR 8.670000076 0.005675995 0.005675995 0.227256546 779.2533295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.67577 16.65579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.01578 0 0 0 0 0 0 0 0 0 17.74759 0 18.17566 0 0 0 0 P31751 AKT2_HUMAN "RAC-beta serine/threonine-protein kinase, EC 2.7.11.1 (Protein kinase Akt-2) (Protein kinase B beta, PKB beta) (RAC-PK-beta)" AKT2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001934; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0006464; GO:0007165; GO:0008284; GO:0008286; GO:0008643; GO:0010748; GO:0010907; GO:0010918; GO:0018105; GO:0030334; GO:0030335; GO:0031340; GO:0032000; GO:0032287; GO:0032587; GO:0032869; GO:0032991; GO:0035556; GO:0043066; GO:0043231; GO:0045444; GO:0045725; GO:0046326; GO:0046872; GO:0051726; GO:0060644; GO:0065002; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:0106310; GO:2000147 CGSPSDSSTTEEMEVAVSKAR 2.470000029 0.09853588 0.09853588 0.116673975 2244.797846 19.86241 12.08189 17.09597 14.65707 0 0 15.26229 0 11.46877 17.09906 0 16.71559 12.94517 0 10.95577 0 0 17.42413 9.368748 17.28105 0 16.05973 0 17.02787 16.72805 0 13.23329 14.20586 0 0 0 0 16.54447 0 18.79686 0 0 14.47794 15.5737 14.20735 15.84711 0 14.87994 0 13.96235 0 0 16.98802 P31937 3HIDH_HUMAN "3-hydroxyisobutyrate dehydrogenase, mitochondrial, HIBADH, EC 1.1.1.31" HIBADH Homo sapiens (Human) valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574]" "3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287 SVASKTPVGFIGLGNMGNPMAK 13.27000046 0.299686491 0.299686491 0.312750476 2192.39952 17.34487 15.59229 14.05554 14.66611 13.63975 14.17657 12.10709 0 11.26939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.42737 0 0 0 0 0 19.18259 19.02341 17.42842 16.47952 11.43176 0 0 19.40459 0 0 0 0 0 14.04044 0 0 0 0 P31939 PUR9_HUMAN "Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase, ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed ] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase, EC 2.1.2.3 (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase, AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase, IMP cyclohydrolase, EC 3.5.4.10 (IMP synthase) (Inosinicase) ]" ATIC PURH OK/SW-cl.86 Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654] cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803] GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006139; GO:0006177; GO:0006189; GO:0009116; GO:0010035; GO:0016020; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0044208; GO:0045296; GO:0046452; GO:0046654; GO:0070062; GO:0097294; GO:0098761 GVSQMPLR 11.35000038 1 1 6.88E-13 883.7379278 0 16.53341 15.65392 0 0 17.41723 14.87954 15.23831 0 0 0 0 0 0 10.6898 0 0 0 0 0 0 0 0 0 0 12.71094 0 0 0 0 0 0 0 0 12.88514 0 0 0 0 0 14.42802 0 0 12.48739 0 0 0 9.944818 P31948 STIP1_HUMAN "Stress-induced-phosphoprotein 1, STI1 (Hsc70/Hsp90-organizing protein, Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)" STIP1 Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; protein folding [GO:0006457] chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; protein folding [GO:0006457] Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005794; GO:0005829; GO:0006457; GO:0030544; GO:0032991; GO:0051879; GO:0098761; GO:0101031; GO:0120293 KAAALEAMK 2.640000105 0.923701942 0.923701942 0.236643717 935.078134 13.46296 15.69988 0 14.72041 0 15.00213 0 0 0 0 14.86391 0 0 0 13.89784 0 14.56939 14.84703 13.74596 0 13.7408 0 0 16.59318 0 0 0 0 0 0 0 16.37254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.94316 0 P31997 CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b) CEACAM8 CGM6 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955] anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; protein heterodimerization activity [GO:0046982]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955] protein heterodimerization activity [GO:0046982] GO:0005615; GO:0005886; GO:0006955; GO:0007157; GO:0009986; GO:0031225; GO:0035577; GO:0035579; GO:0046982; GO:0070062; GO:0070821 ATVSIMIGVLAR 10.22000027 1 1 0.334986026 1247.712976 0 12.82627 12.89954 0 0 0 0 0 0 0 0 0 16.59638 14.5035 0 0 15.86734 0 0 17.16322 0 0 17.87452 0 0 0 0 0 15.36352 0 0 13.97843 0 14.55794 0 17.24986 0 0 0 15.26431 14.10969 16.45466 0 17.73489 0 13.20672 18.74496 0 P32004 L1CAM_HUMAN "Neural cell adhesion molecule L1, N-CAM-L1, NCAM-L1 (CD antigen CD171)" L1CAM CAML1 MIC5 Homo sapiens (Human) axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808] axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904]; axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808] axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904] GO:0005886; GO:0005925; GO:0006935; GO:0007155; GO:0007156; GO:0007160; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0016021; GO:0016477; GO:0019904; GO:0030424; GO:0030425; GO:0031175; GO:0043025; GO:0044295; GO:0045773; GO:0050808; GO:0061564; GO:0062023 TNGTGRVR 5.150000095 0.780909717 0.780909717 0.260257653 859.1024224 16.63042 15.04756 17.12413 16.32662 0 14.90902 0 16.60287 16.22883 15.59382 16.16397 15.67048 0 0 16.37923 0 14.81382 17.0398 16.24617 0 15.3599 0 0 0 16.46115 0 0 13.7739 16.16849 0 0 16.39326 18.23135 0 15.42044 15.29692 0 0 15.16319 14.31939 18.96354 12.85613 0 0 15.47779 0 15.51207 17.97952 P32019 I5P2_HUMAN "Type II inositol 1,4,5-trisphosphate 5-phosphatase, EC 3.1.3.36 (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase, 5PTase)" INPP5B OCRL2 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]" "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]" GO:0001701; GO:0004439; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0016021; GO:0030317; GO:0030670; GO:0031901; GO:0043647; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0052659; GO:0070613 AVSEGLHPDAK 8.619999886 1 1 0.043671542 1119.888521 0 0 18.05671 0 0 0 0 0 14.91265 0 0 14.89682 0 0 0 0 0 0 0 0 0 0 0 0 15.42754 16.45808 0 0 0 0 0 0 14.61431 14.05477 0 0 0 0 0 0 0 0 0 14.85148 0 0 0 0 P32238 CCKAR_HUMAN "Cholecystokinin receptor type A, CCK-A receptor, CCK-AR (Cholecystokinin-1 receptor, CCK1-R)" CCKAR CCKRA Homo sapiens (Human) axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883] cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046] GO:0001764; GO:0004930; GO:0004951; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007409; GO:0016020; GO:0017046; GO:0030900; GO:0038188; GO:0046883 LELRQLSTGSSSR 7.809999943 0.783611357 0.783611357 0.179292918 1433.649803 14.13095 16.07453 0 0 0 11.35327 15.38188 14.76256 0 0 0 0 0 15.37733 0 0 0 13.95386 0 0 0 0 0 0 0 0 0 13.24746 15.07181 8.982446 0 14.11217 0 0 16.13777 15.13739 14.79983 0 0 14.65809 0 0 0 13.85206 0 0 0 0 P32241 VIPR1_HUMAN "Vasoactive intestinal polypeptide receptor 1, VIP-R-1 (Pituitary adenylate cyclase-activating polypeptide type II receptor, PACAP type II receptor, PACAP-R-2, PACAP-R2) (VPAC1)" VIPR1 Homo sapiens (Human) "adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]" G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] GO:0004999; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007187; GO:0007188; GO:0008284; GO:0008528; GO:0017046; GO:0043235 SSSFQAEVSLV 8.510000229 1 1 0.17427039 1152.628833 0 14.73993 14.94607 14.4579 14.2638 12.89766 15.08214 13.73525 9.172163 15.24465 15.0856 16.08663 14.15061 15.31639 0 0 0 15.0158 0 0 0 0 0 0 0 0 0 15.89319 0 0 0 15.75776 16.37257 0 13.72566 0 14.38809 0 0 0 14.89301 0 0 0 0 0 13.73144 0 P32242 OTX1_HUMAN Homeobox protein OTX1 (Orthodenticle homolog 1) OTX1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030901; GO:0042472; GO:0045944; GO:0048852; GO:1990837 CRQQQQSGSGTK 3.529999971 1 1 0.669120429 1364.393126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32248 CCR7_HUMAN "C-C chemokine receptor type 7, C-C CKR-7, CC-CKR-7, CCR-7 (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1, EBI1, EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197)" CCR7 CMKBR7 EBI1 EVI1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930]; activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529] C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930] GO:0001768; GO:0001954; GO:0002407; GO:0002408; GO:0002606; GO:0002885; GO:0002922; GO:0004930; GO:0005739; GO:0005886; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0009986; GO:0016021; GO:0016493; GO:0019722; GO:0019957; GO:0030838; GO:0031274; GO:0031529; GO:0032496; GO:0032649; GO:0032651; GO:0032695; GO:0032735; GO:0034695; GO:0035757; GO:0035758; GO:0038117; GO:0038121; GO:0043123; GO:0043552; GO:0045060; GO:0045785; GO:0045860; GO:0046330; GO:0048872; GO:0050862; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0070374; GO:0071345; GO:0071731; GO:0090023; GO:0090630; GO:0097022; GO:0097029; GO:2000147; GO:2000510; GO:2000522; GO:2000525; GO:2000526; GO:2000547; GO:2000669 MDLGKPMK 6.769999981 0.91098237 0.91098237 0.103342197 934.7156174 0 0 12.24507 13.48662 0 0 0 0 14.95552 0 0 0 15.33173 0 0 7.780131 15.42387 0 15.29773 0 14.13477 0 0 14.88941 0 0 0 0 0 14.93777 0 0 0 11.75554 13.49058 0 0 0 15.10545 0 0 0 14.01921 0 0 0 0 0 P32249 GP183_HUMAN "G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2, EBI2, EBV-induced G-protein coupled receptor 2, hEBI2)" GPR183 EBI2 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470] G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142] GO:0002250; GO:0002312; GO:0002313; GO:0002407; GO:0004930; GO:0005886; GO:0005887; GO:0006955; GO:0006959; GO:0007186; GO:0008142; GO:0010818; GO:0030316; GO:0030595; GO:0030890; GO:0036145; GO:0061470; GO:0070374; GO:2000458 LFRTAK 8.109999657 1 1 0.121059623 734.5615451 15.71476 12.03742 14.74505 14.8034 16.01896 14.44973 14.81648 16.43636 15.34868 12.22449 14.76235 14.14128 0 0 15.94793 15.36905 0 0 15.57477 0 0 0 0 15.65544 0 0 0 0 0 0 0 0 0 0 0 0 16.5273 0 0 0 0 0 0 0 0 0 15.94241 0 P32298 GRK4_HUMAN "G protein-coupled receptor kinase 4, EC 2.7.11.16 (G protein-coupled receptor kinase GRK4) (ITI1)" GRK4 GPRK2L GPRK4 Homo sapiens (Human) protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254] GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381 MYACKK 2.279999971 1 1 0.282060679 800.5884482 19.467 0 0 16.12736 0 16.41208 0 18.51824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.43785 18.19177 17.77588 0 0 19.06111 0 0 0 0 0 0 18.85913 16.66084 0 0 17.39035 0 0 P32314 FOXN2_HUMAN Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0035914; GO:0043231; GO:1990837 MGPVIGMTPDKR 8.050000191 0.665376902 0.665376902 0.336182411 1317.320571 12.33784 15.95181 0 0 15.21252 0 0 13.01972 13.22465 15.08594 15.2447 13.86196 0 15.70421 0 13.06323 0 0 16.42169 0 16.02439 0 14.74131 13.60663 16.76346 0 0 0 14.69383 0 0 0 0 0 0 0 0 16.16324 0 0 15.04179 14.26992 0 0 0 0 0 0 P32321 DCTD_HUMAN "Deoxycytidylate deaminase, EC 3.5.4.12 (dCMP deaminase)" DCTD Homo sapiens (Human) dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; pyrimidine nucleotide metabolic process [GO:0006220] cytosol [GO:0005829] cytosol [GO:0005829]; dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; pyrimidine nucleotide metabolic process [GO:0006220] dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] GO:0004132; GO:0005829; GO:0006220; GO:0006226; GO:0006231; GO:0008270; GO:0042802 SEVSCKK 3.00999999 1 1 0.209609564 840.7418286 15.13895 15.46295 0 16.81213 0 0 15.17746 16.55529 18.05901 0 15.60595 15.75923 0 14.68914 16.16538 0 0 0 0 0 0 0 0 0 0 0 0 15.8329 14.76708 0 0 16.51697 17.0958 0 0 0 17.5372 15.47713 15.90972 16.71054 0 0 14.80726 15.87741 0 15.20196 0 0 P32418 NAC1_HUMAN Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1) SLC8A1 CNC NCX1 Homo sapiens (Human) calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; cytosolic calcium ion transport [GO:0060401]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; metal ion transport [GO:0030001]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829] axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; transmembrane transporter binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; cytosolic calcium ion transport [GO:0060401]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; metal ion transport [GO:0030001]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829] ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; transmembrane transporter binding [GO:0044325] GO:0002026; GO:0002027; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0006883; GO:0006936; GO:0007584; GO:0008092; GO:0009410; GO:0009749; GO:0010468; GO:0010649; GO:0010763; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0014829; GO:0015491; GO:0016020; GO:0021537; GO:0030001; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030501; GO:0030506; GO:0033198; GO:0034614; GO:0035725; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042542; GO:0043025; GO:0043197; GO:0043198; GO:0043679; GO:0044325; GO:0044557; GO:0045202; GO:0051481; GO:0055013; GO:0055074; GO:0055119; GO:0060048; GO:0060401; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0071456; GO:0071901; GO:0071944; GO:0086012; GO:0086064; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:0099055; GO:0099580; GO:1901660; GO:1903779; GO:1905060 EITIK 10.77000046 1 1 0.36319251 602.081034 0 15.51277 0 16.41039 0 0 15.53092 0 16.40648 0 0 16.28139 0 0 16.45623 0 0 16.71488 16.71406 0 17.12329 17.13085 0 0 15.75047 0 16.69158 0 0 14.70383 0 0 0 15.56396 0 0 16.41121 0 0 0 0 0 17.16035 15.7427 0 15.31151 0 0 P32455 GBP1_HUMAN "Guanylate-binding protein 1, EC 3.6.5.- (GTP-binding protein 1, GBP-1, HuGBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1)" GBP1 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein localization to vacuole [GO:0072665]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein localization to plasma membrane [GO:1903076] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein localization to vacuole [GO:0072665]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein localization to plasma membrane [GO:1903076] actin binding [GO:0003779]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507] GO:0000139; GO:0003779; GO:0003924; GO:0005525; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0012506; GO:0015629; GO:0019003; GO:0019899; GO:0019955; GO:0030507; GO:0031410; GO:0032703; GO:0042802; GO:0042803; GO:0050848; GO:0050860; GO:0051607; GO:0051879; GO:0070373; GO:0071346; GO:0071347; GO:0071356; GO:0072665; GO:1900025; GO:1903076; GO:1903077 KCFVFDRPVHR 14.52999973 0.613608778 0.613608778 0.346804008 1460.914193 24.15809 23.70652 19.17202 24.00822 0 20.81191 18.78517 23.69541 23.57257 21.65736 20.19261 19.8013 24.1816 17.27866 23.28447 19.27511 22.14352 18.73712 23.16518 17.81815 22.38601 15.60749 23.5218 18.76335 19.42748 0 23.67548 18.30952 0 18.40166 17.96951 18.8555 21.25859 24.65096 24.03484 24.38722 21.63239 22.85222 23.75747 19.53605 17.99763 19.58674 23.5098 23.23439 18.48552 18.82818 0 21.56064 P32456 GBP2_HUMAN "Guanylate-binding protein 2, EC 3.6.5.- (GTP-binding protein 2, GBP-2, HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)" GBP2 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; protein localization to nucleus [GO:0034504] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0031410; GO:0034504; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0071346; GO:0071347; GO:0071356 ILSAITQPVVVVAIVGLYRTGK 9.319999695 1 1 0.224726483 2299.026903 15.88145 0 14.07225 0 20.93835 0 14.57548 0 0 14.44313 0 0 0 0 0 0 15.79462 20.99292 0 0 0 0 15.45264 14.05856 0 0 0 0 0 0 0 19.36364 0 0 0 0 0 0 0 0 20.85575 0 0 0 0 0 0 0 P32519 ELF1_HUMAN ETS-related transcription factor Elf-1 (E74-like factor 1) ELF1 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001817; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045893; GO:0045944; GO:0050860; GO:1990837 AAKPK 3.039999962 0.706035733 0.706035733 0.222791083 514.4274588 13.88716 15.04667 14.08838 15.77502 14.82356 0 15.54942 0 12.81894 0 15.6892 14.95569 0 0 14.05746 16.05588 14.90574 0 14.91447 15.48847 14.33319 0 15.6615 0 0 14.90603 0 0 0 0 0 0 15.2233 0 0 0 0 0 0 16.61971 0 0 15.7914 0 15.71672 16.74388 15.17606 15.68407 P32926 DSG3_HUMAN "Desmoglein-3 (130 kDa pemphigus vulgaris antigen, PVA) (Cadherin family member 6)" DSG3 CDHF6 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0001533; GO:0005509; GO:0005829; GO:0005886; GO:0005911; GO:0007156; GO:0016021; GO:0030057; GO:0070062; GO:0098609 TNEGILKVVK 2.029999971 1 1 0.285213053 1100.775735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7381 0 0 0 0 16.90659 0 0 0 0 0 0 17.34679 0 0 17.82435 0 0 18.86126 0 0 0 0 0 0 0 0 0 0 0 0 0 P32971 TNFL8_HUMAN "Tumor necrosis factor ligand superfamily member 8 (CD30 ligand, CD30-L) (CD antigen CD153)" TNFSF8 CD30L CD30LG Homo sapiens (Human) "CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]" extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]" cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0007267; GO:0042129; GO:0043374; GO:0045944; GO:0050830 DGILHGVR 3.700000048 0.891243219 0.891243219 0.242023627 868.2859691 13.29235 15.83342 12.76633 13.62849 0 0 17.59521 0 0 16.00855 16.72816 0 12.27819 0 0 14.88258 0 0 16.73722 0 0 0 0 14.84671 0 17.24056 0 15.92898 14.97303 15.76521 0 15.44644 17.60415 0 0 15.74294 16.58868 15.67549 0 17.1014 0 15.61287 0 0 0 0 0 15.36747 P33121 ACSL1_HUMAN "Long-chain-fatty-acid--CoA ligase 1, EC 6.2.1.3 (Acyl-CoA synthetase 1, ACS1) (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1, LACS 1) (Long-chain acyl-CoA synthetase 2, LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase, EC 6.2.1.24)" ACSL1 FACL1 FACL2 LACS LACS1 LACS2 Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251] GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0007584; GO:0008610; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162 GAMVTHR 3.059999943 0.444636703 0.444636703 0.120170281 788.4624632 17.03327 11.14578 16.12272 15.52839 12.374 0 12.29546 14.30175 14.94466 0 13.76528 0 13.38128 14.50863 0 14.6786 16.08467 15.35315 17.25468 0 0 17.53561 14.11111 15.19232 13.6782 0 16.3126 16.67356 15.71517 10.60936 0 0 17.62555 0 11.45811 0 17.11877 0 15.57034 16.36448 0 0 15.6065 0 15.5245 15.88509 14.44829 0 P33151 CADH5_HUMAN "Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin, VE-cadherin) (CD antigen CD144)" CDH5 Homo sapiens (Human) adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; blood vessel endothelial cell migration [GO:0043534]; blood vessel maturation [GO:0001955]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to bicellular tight junction [GO:1902396]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein phosphorylation [GO:0001932]; regulation of vascular permeability [GO:0043114]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculature development [GO:0001944] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; fibrinogen binding [GO:0070051]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; blood vessel endothelial cell migration [GO:0043534]; blood vessel maturation [GO:0001955]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to bicellular tight junction [GO:1902396]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein phosphorylation [GO:0001932]; regulation of vascular permeability [GO:0043114]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculature development [GO:0001944] beta-catenin binding [GO:0008013]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; fibrinogen binding [GO:0070051]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; vascular endothelial growth factor receptor 2 binding [GO:0043184] GO:0000902; GO:0001932; GO:0001944; GO:0001955; GO:0005102; GO:0005509; GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0006874; GO:0007043; GO:0007156; GO:0007179; GO:0008013; GO:0008285; GO:0009897; GO:0009986; GO:0010628; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0019903; GO:0030054; GO:0030335; GO:0030513; GO:0031115; GO:0031334; GO:0031965; GO:0034332; GO:0035307; GO:0035633; GO:0043114; GO:0043184; GO:0043534; GO:0044325; GO:0044331; GO:0045296; GO:0045766; GO:0050728; GO:0070051; GO:0070700; GO:0070830; GO:0098609; GO:0098742; GO:1902396; GO:1903142; GO:1990782; GO:2000114; GO:2000352 GKEYFAIDNSGR 18.21999931 1 1 0.36458655 1357.768931 16.43885 16.57498 15.53297 16.11377 0 16.92084 16.72491 17.12971 0 16.04331 16.9198 16.38179 0 16.17942 0 0 0 0 16.81629 0 16.92482 0 16.78313 18.52339 0 0 17.51875 16.68847 15.61153 0 0 13.8111 17.07385 15.94279 16.1976 17.06212 16.57844 15.82713 0 0 0 0 16.45255 15.94814 17.09357 0 0 17.04384 P33176 KINH_HUMAN "Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain, UKHC)" KIF5B KNS KNS1 Homo sapiens (Human) "anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]" axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982] "axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003777; GO:0005524; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007028; GO:0007411; GO:0008017; GO:0008574; GO:0016020; GO:0016887; GO:0030705; GO:0031982; GO:0032230; GO:0032418; GO:0032839; GO:0034451; GO:0035253; GO:0035617; GO:0042267; GO:0042391; GO:0042802; GO:0043268; GO:0045296; GO:0045335; GO:0047496; GO:0048471; GO:0048489; GO:0051642; GO:0071346; GO:0072383; GO:0098971; GO:0099641; GO:1903078; GO:1904115; GO:1990048; GO:1990049 AAEMMASLLK 8.470000267 1 1 0.111774686 1095.559293 0 16.2752 15.73716 13.12809 17.10811 0 12.06922 15.47204 0 0 17.10444 16.53126 15.68961 0 0 14.01845 12.74744 16.45202 14.06819 0 15.85982 0 14.38994 14.27898 17.56816 16.63058 0 15.07557 11.15821 0 15.97363 20.53679 16.81482 16.77153 14.32081 16.9137 0 13.23389 15.92925 15.88728 0 16.87916 0 0 0 0 13.71939 0 P33241 LSP1_HUMAN "Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein, pp52) (Lymphocyte-specific antigen WP34)" LSP1 WP34 Homo sapiens (Human) cellular defense response [GO:0006968]; cellular response to interleukin-7 [GO:0098761]; chemotaxis [GO:0006935]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cellular defense response [GO:0006968]; cellular response to interleukin-7 [GO:0098761]; chemotaxis [GO:0006935]; signal transduction [GO:0007165] actin binding [GO:0003779] GO:0003779; GO:0005886; GO:0006935; GO:0006968; GO:0007165; GO:0015629; GO:0016020; GO:0070062; GO:0098761 VLVEGGPAP 5.510000229 1 1 0.281024816 837.9689396 15.42486 0 16.51301 15.395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3053 18.50182 19.42141 0 18.61782 0 18.36986 0 0 0 0 17.71802 0 0 0 0 P33527 MRP1_HUMAN "Multidrug resistance-associated protein 1, EC 7.6.2.2 (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1, EC 7.6.2.3) (Leukotriene C(4) transporter, LTC4 transporter)" ABCC1 MRP MRP1 Homo sapiens (Human) carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; hydrolase activity [GO:0016787]; xenobiotic transmembrane transporter activity [GO:0042910]; carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; hydrolase activity [GO:0016787]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009410; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016787; GO:0034040; GO:0034599; GO:0034634; GO:0034775; GO:0042167; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0045332; GO:0046943; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646; GO:1905039; GO:1990962 VEGHVAIK 1.899999976 1 1 0.211494453 853.6975816 12.58715 0 15.07251 0 0 14.5964 14.95041 13.89047 14.3118 15.32274 0 14.46493 0 0 0 15.45725 0 14.91783 15.10598 16.44697 16.82674 0 0 0 16.34739 0 0 0 14.85047 16.0962 0 14.73666 0 0 0 16.04525 0 0 0 15.65238 0 15.99552 13.4084 15.61384 14.83624 0 15.66546 0 P33763 S10A5_HUMAN Protein S100-A5 (Protein S-100D) (S100 calcium-binding protein A5) S100A5 S100D Homo sapiens (Human) neuronal cell body [GO:0043025]; nucleus [GO:0005634] neuronal cell body [GO:0043025]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0005507; GO:0005509; GO:0005634; GO:0008270; GO:0042803; GO:0043025; GO:0048306 ELCLGEMKESSIDDLMK 2.410000086 1 1 0.321271045 2000.78728 15.90704 0 0 12.06299 0 15.05211 0 0 0 0 17.90049 0 15.02811 0 0 0 0 13.46564 0 0 0 14.27721 0 0 0 0 17.52284 0 15.37464 16.27715 0 0 0 0 0 0 0 16.79458 0 13.86704 15.6957 0 0 14.08494 14.93854 0 0 0 P33981 TTK_HUMAN "Dual specificity protein kinase TTK, EC 2.7.12.1 (Phosphotyrosine picked threonine-protein kinase, PYT)" TTK MPS1 MPS1L1 Homo sapiens (Human) chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; spindle organization [GO:0007051] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; spindle organization [GO:0007051] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0007052; GO:0007059; GO:0007094; GO:0008284; GO:0010862; GO:0016020; GO:0016321; GO:0018105; GO:0018107; GO:0033316; GO:0034501; GO:0042802; GO:0043515; GO:0046777; GO:0051304; GO:0106310; GO:1903096 DYFQMARANCK 9.199999809 1 1 0.473257943 1417.965998 0 0 0 18.8041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.87129 P33991 MCM4_HUMAN "DNA replication licensing factor MCM4, EC 3.6.4.12 (CDC21 homolog) (P1-CDC21)" MCM4 CDC21 Homo sapiens (Human) DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174] "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006268; GO:0006271; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975 DFSHTGRGK 20.75 0.64206928 0.64206928 0.237699888 1007.723073 0 0 14.9242 0 0 16.61162 0 15.37801 0 0 0 0 15.85975 0 15.32319 0 0 15.00051 0 16.56265 0 0 16.72969 0 0 14.43517 17.61842 14.44992 0 15.75815 17.08453 0 13.9243 0 14.42967 0 0 16.7124 0 0 0 0 14.79831 0 0 0 0 15.79594 P33993 MCM7_HUMAN "DNA replication licensing factor MCM7, EC 3.6.4.12 (CDC47 homolog) (P1.1-MCM3)" MCM7 CDC47 MCM2 Homo sapiens (Human) cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] GO:0000727; GO:0000781; GO:0000785; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006268; GO:0006270; GO:0006271; GO:0006974; GO:0007049; GO:0008283; GO:0016020; GO:0016887; GO:0030174; GO:0042325; GO:0042555; GO:0071162; GO:0071364; GO:0071466 SQYTTGR 9.090000153 0.341144562 0.341144562 0.049458748 810.4987717 16.03207 16.35446 17.10339 16.36881 12.34711 0 17.16894 16.25809 14.51498 18.31243 16.82355 14.2849 16.79791 0 0 14.75329 15.12676 16.87949 15.51395 13.35999 13.83496 0 17.88244 18.80441 17.77974 17.21157 16.98516 0 18.70345 17.40975 16.01677 0 17.42756 0 15.74547 0 17.01605 17.11146 0 15.38811 17.93505 17.61136 16.58391 12.77652 17.15562 16.60155 15.22583 15.66098 P34059 GALNS_HUMAN "N-acetylgalactosamine-6-sulfatase, EC 3.1.6.4 (Chondroitinsulfatase, Chondroitinase) (Galactose-6-sulfate sulfatase, GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase, GalNAc6S sulfatase)" GALNS Homo sapiens (Human) azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] GO:0003943; GO:0004065; GO:0005576; GO:0008484; GO:0035578; GO:0043202; GO:0043890; GO:0046872; GO:0070062 GRYGDAVR 2.269999981 0.336799055 0.336799055 0.179127332 894.5432797 0 15.18186 13.39258 0 0 16.62181 16.54004 13.92691 0 0 0 0 0 0 0 0 13.35721 16.05369 0 15.83873 14.75222 0 0 0 0 0 0 13.99815 15.44643 15.37718 15.21338 0 12.10742 10.48007 14.00742 0 0 15.79265 15.48028 13.27641 11.08557 14.97831 0 0 14.49102 15.3222 10.28125 0 P34897 GLYM_HUMAN "Serine hydroxymethyltransferase, mitochondrial, SHMT, EC 2.1.2.1 (Glycine hydroxymethyltransferase) (Serine methylase)" SHMT2 Homo sapiens (Human) folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]" "chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]" GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0008270; GO:0009113; GO:0015630; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715 TGREIPYTFEDR 13.82999992 0.731046259 0.731046259 0.038278594 1483.662269 16.15674 15.5222 13.271 0 13.73878 14.62504 15.92109 15.8372 15.75044 0 0 0 16.48399 14.90581 0 0 0 12.65737 13.84151 0 0 0 0 17.47245 0 12.94777 14.59578 10.70582 15.16499 14.39544 14.83459 14.4403 0 15.53508 0 14.14405 0 12.59274 0 0 13.14016 16.48508 0 13.03209 0 0 0 0 P34903 GBRA3_HUMAN Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) GABRA3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202] "chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315 FDGPMK 15.84000015 0.427481592 0.427481592 0.247526265 710.0315251 14.39392 17.72525 17.48738 0 0 0 0 15.09816 17.09598 0 0 0 17.19892 18.01062 0 0 0 17.82644 14.41169 16.24464 0 0 16.35679 0 16.28691 0 0 0 14.47976 16.24357 18.15187 16.55865 0 0 0 0 18.06473 16.92054 0 0 18.49981 0 14.72763 0 0 0 0 0 P34913 HYES_HUMAN "Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2, CEH, EC 3.3.2.10 (Epoxide hydratase) (Soluble epoxide hydrolase, SEH); Lipid-phosphate phosphatase, EC 3.1.3.76 ]" EPHX2 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272] 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] GO:0000287; GO:0004301; GO:0005777; GO:0005782; GO:0005829; GO:0009636; GO:0010628; GO:0015643; GO:0016311; GO:0016787; GO:0016791; GO:0033885; GO:0042577; GO:0042632; GO:0042803; GO:0046272; GO:0046839; GO:0052642; GO:0070062; GO:0090181; GO:0097176 GLLNDAFQKGGPEGATTR 1.309999943 0.940174758 0.940174758 0.165208354 1832.30081 0 0 0 0 0 0 0 0 14.73522 0 14.59937 0 0 0 0 0 13.31646 0 0 0 0 17.4262 0 15.54394 14.94055 0 0 0 0 0 0 15.18941 0 0 0 0 0 12.70881 0 0 0 0 0 0 0 16.53939 0 0 P34925 RYK_HUMAN "Tyrosine-protein kinase RYK, EC 2.7.10.1" RYK JTK5A Homo sapiens (Human) axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" "ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]" GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016301; GO:0017147; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953 EKQAFVK 14.92000008 0.005167995 0.005167995 0.25686196 848.9361867 0 18.30803 0 15.43806 0 0 0 0 16.74264 0 0 0 0 0 0 0 15.26115 0 0 15.32293 0 17.06051 0 0 0 0 18.47084 16.46911 13.95286 0 16.72163 18.71352 0 14.29584 16.59493 16.8305 17.07869 0 17.56519 0 0 0 0 0 0 15.33955 15.65238 17.31669 P34931 HS71L_HUMAN "Heat shock 70 kDa protein 1-like, Heat shock 70 kDa protein 1L (Heat shock 70 kDa protein 1-Hom, HSP70-Hom)" HSPA1L Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192] blood microparticle [GO:0072562]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199] blood microparticle [GO:0072562]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] GO:0002199; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006986; GO:0007339; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0044297; GO:0051082; GO:0051085; GO:0051787; GO:0072562; GO:1903955 DAKMDK 6.659999847 0.738773048 0.738773048 3.19E-12 724.7631955 15.89464 14.63874 11.90653 12.3748 14.36802 11.2843 14.00188 14.07067 14.66866 14.51804 16.32074 0 16.39539 0 14.61523 16.98964 16.69501 14.35211 14.20608 13.50053 15.00756 16.7883 14.9072 15.74051 12.7714 16.12 16.99414 10.00959 13.68416 14.14942 15.10106 14.55143 14.64201 16.26328 14.21713 15.8807 0 17.09874 11.4407 0 11.9383 13.46287 15.93777 13.88465 17.6327 14.72116 15.38508 14.52849 P34932 HSP74_HUMAN Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2) HSPA4 APG2 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006986; GO:0016887; GO:0045040; GO:0051131; GO:0070062 VEPPLR 18.67000008 0.000350627 0.000350627 0.263276766 710.3050134 0 0 0 17.77026 18.0766 17.48187 18.30046 0 16.86969 0 16.73072 0 17.5856 0 15.94323 0 16.93385 18.28366 0 0 0 18.1386 0 15.87365 0 20.20675 19.38611 17.58371 16.64479 16.10994 0 18.55553 18.70013 18.57315 0 0 0 0 0 17.3091 16.00175 18.0657 0 0 0 15.88797 0 0 P34972 CNR2_HUMAN "Cannabinoid receptor 2, CB-2, CB2, hCB2 (CX5)" CNR2 CB2A CB2B Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; leukocyte chemotaxis [GO:0030595]; negative regulation of action potential [GO:0045759]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation [GO:0033004]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; regulation of metabolic process [GO:0019222]; response to amphetamine [GO:0001975]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; leukocyte chemotaxis [GO:0030595]; negative regulation of action potential [GO:0045759]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation [GO:0033004]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; regulation of metabolic process [GO:0019222]; response to amphetamine [GO:0001975]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]" cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930] GO:0001975; GO:0004930; GO:0004949; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007187; GO:0007189; GO:0019222; GO:0019233; GO:0030425; GO:0030595; GO:0031234; GO:0032229; GO:0032496; GO:0033004; GO:0038171; GO:0043204; GO:0045759; GO:0050728; GO:0051001 SSVTETEADGK 11.97999954 1 1 0.063488867 1127.358841 13.75952 0 0 0 0 0 0 0 0 0 0 0 0 0 15.82614 15.75529 0 0 0 15.65036 0 11.27263 0 13.83111 0 0 0 0 0 0 0 14.39788 15.14739 14.34293 14.43659 0 0 0 0 7.502865 14.26281 0 0 0 10.20111 0 0 0 P35222 CTNB1_HUMAN Catenin beta-1 (Beta-catenin) CTNNB1 CTNNB OK/SW-cl.35 PRO2286 Homo sapiens (Human) "adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]" "adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]" "adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transmembrane transporter binding [GO:0044325]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]" alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transmembrane transporter binding [GO:0044325] GO:0000122; GO:0000209; GO:0000578; GO:0000791; GO:0000904; GO:0000922; GO:0001221; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0008013; GO:0008022; GO:0008285; GO:0009410; GO:0009948; GO:0009950; GO:0009954; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0016922; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035315; GO:0035995; GO:0036023; GO:0036520; GO:0042129; GO:0042475; GO:0042733; GO:0042734; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0044338; GO:0044339; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045597; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0061629; GO:0070062; GO:0070369; GO:0070411; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0072497; GO:0090090; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:0099092; GO:0140297; GO:1903204; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990403; GO:1990711; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2001234 LIILASGGPQALVNIMRTYTYEK 6.159999847 0.515365362 0.515365362 6.84E-12 2552.482186 16.3438 15.19177 0 10.74024 16.8584 15.63275 17.27225 0 15.35626 15.66203 14.94756 0 0 0 0 16.30747 14.87893 0 0 17.50135 0 15.11075 0 16.63379 0 0 15.43413 16.74952 18.21961 0 15.58811 0 16.20784 15.6501 16.75715 0 16.16348 0 14.20119 16.27756 0 0 0 14.52677 14.86472 10.08344 14.29024 12.6998 P35226 BMI1_HUMAN Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51) BMI1 PCGF4 RNF51 Homo sapiens (Human) "hemopoiesis [GO:0030097]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of gene expression [GO:0010468]; segment specification [GO:0007379]" cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] "cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; zinc ion binding [GO:0008270]; hemopoiesis [GO:0030097]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of gene expression [GO:0010468]; segment specification [GO:0007379]" promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; zinc ion binding [GO:0008270] GO:0000122; GO:0000151; GO:0005634; GO:0005654; GO:0005829; GO:0007379; GO:0008270; GO:0010468; GO:0016604; GO:0030097; GO:0031519; GO:0035102; GO:0036353; GO:0045814; GO:0048146; GO:0051443; GO:0071535; GO:1990841 DFYAAHPSADAANGSNEDRGEVADEDK 4.440000057 1 1 3.68E-12 2851.367154 15.02647 15.91141 16.03915 0 15.75916 15.44999 13.74836 0 13.8533 0 0 0 0 0 9.092084 0 0 0 14.79172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35228 NOS2_HUMAN "Nitric oxide synthase, inducible, EC 1.14.13.39 (Hepatocyte NOS, HEP-NOS) (Inducible NO synthase, Inducible NOS, iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)" NOS2 NOS2A Homo sapiens (Human) arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response in mucosa [GO:0002227]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of leukocyte mediated cytotoxicity [GO:0001912]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cellular respiration [GO:0043457]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801] cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tetrahydrobiopterin binding [GO:0034617]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response in mucosa [GO:0002227]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of leukocyte mediated cytotoxicity [GO:0001912]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cellular respiration [GO:0043457]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801] arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tetrahydrobiopterin binding [GO:0034617] GO:0001666; GO:0001912; GO:0002227; GO:0004517; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0006954; GO:0007263; GO:0007623; GO:0009617; GO:0009725; GO:0010181; GO:0010629; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0030863; GO:0031284; GO:0032310; GO:0032496; GO:0032755; GO:0032757; GO:0034617; GO:0034618; GO:0042127; GO:0042177; GO:0042742; GO:0042803; GO:0043457; GO:0045454; GO:0045776; GO:0046872; GO:0048471; GO:0050660; GO:0050661; GO:0050796; GO:0050829; GO:0051712; GO:0071222; GO:0071346; GO:0071466; GO:1900015 LEALCQPSEYSK 3.410000086 1 1 0.242444351 1424.53698 16.41394 0 15.04465 15.48273 0 0 0 0 0 0 14.80628 0 16.24165 15.25707 14.709 0 0 0 0 0 0 0 0 0 0 0 0 15.40053 17.30301 15.98537 0 15.99656 16.66998 0 0 16.72292 0 17.3656 0 0 0 0 0 0 0 0 0 0 P35236 PTN7_HUMAN "Tyrosine-protein phosphatase non-receptor type 7, EC 3.1.3.48 (Hematopoietic protein-tyrosine phosphatase, HEPTP) (Protein-tyrosine phosphatase LC-PTP)" PTPN7 Homo sapiens (Human) MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] GO:0000165; GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0009898; GO:0015630; GO:0072686 QPPSPK 3.279999971 1 1 3.44E-13 650.3255487 10.26213 14.43083 13.67713 12.24557 15.28331 13.48884 0 0 0 14.75034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.64831 16.1045 0 0 0 0 0 0 0 0 0 0 0 0 0 15.24874 0 0 0 P35240 MERL_HUMAN Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin) NF2 SCH Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010] actin binding [GO:0003779]; integrin binding [GO:0005178] GO:0001707; GO:0001953; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006469; GO:0007398; GO:0008285; GO:0014010; GO:0014013; GO:0016020; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030336; GO:0030864; GO:0031527; GO:0031647; GO:0032154; GO:0032587; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177 KLTLQSAK 9.279999733 0.300119907 0.300119907 0.291431751 887.3634892 13.87481 15.834 0 15.71632 14.05053 13.8906 14.49555 12.61591 0 0 0 16.37297 0 0 0 0 16.25882 14.76449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8608 0 15.09145 0 14.88245 0 P35241 RADI_HUMAN Radixin RDX Homo sapiens (Human) apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027] actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723] GO:0003723; GO:0003779; GO:0005615; GO:0005886; GO:0005902; GO:0005912; GO:0005925; GO:0008360; GO:0008361; GO:0010628; GO:0010737; GO:0016324; GO:0030027; GO:0030175; GO:0030315; GO:0030335; GO:0030496; GO:0030864; GO:0032154; GO:0032231; GO:0032487; GO:0034111; GO:0034260; GO:0036120; GO:0043087; GO:0045176; GO:0045177; GO:0045184; GO:0045296; GO:0045792; GO:0050839; GO:0051016; GO:0051018; GO:0051117; GO:0051286; GO:0061028; GO:0070062; GO:0071944; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643 EELMER 5.309999943 1 1 0.050327597 822.7428624 15.40314 15.06281 15.34901 15.5346 15.03284 0 0 16.32776 15.93786 16.28447 14.77271 15.62341 14.8371 16.03724 15.3237 0 0 0 0 0 0 0 0 14.76208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.81318 0 0 0 16.90845 0 0 0 P35247 SFTPD_HUMAN "Pulmonary surfactant-associated protein D, PSP-D, SP-D (Collectin-7) (Lung surfactant protein D)" SFTPD COLEC7 PSPD SFTP4 Homo sapiens (Human) defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129] clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791] clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129] carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802] GO:0001817; GO:0005576; GO:0005581; GO:0005615; GO:0005764; GO:0005771; GO:0005789; GO:0005791; GO:0006898; GO:0007585; GO:0030139; GO:0030246; GO:0032703; GO:0042130; GO:0042742; GO:0042802; GO:0043129; GO:0043152; GO:0045087; GO:0045334; GO:0048246; GO:0048286; GO:0050766; GO:0052403; GO:0072593; GO:1905226 DGREGPR 3.329999924 1 1 0.221079825 786.7175933 0 16.67574 15.68139 15.49705 14.25085 16.02061 14.88115 0 15.23814 16.02844 0 15.50952 0 0 14.31173 15.74899 0 0 15.87613 15.81249 14.94281 0 15.31244 0 14.99597 15.22644 13.36575 0 0 0 0 17.41122 0 0 0 0 0 17.96299 15.02856 15.70133 14.82509 15.66693 0 0 0 15.71974 18.0254 0 P35250 RFC2_HUMAN "Replication factor C subunit 2 (Activator 1 40 kDa subunit, A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit, RF-C 40 kDa subunit, RFC40)" RFC2 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899] GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0032508; GO:1900264 TMAPVAS 6.039999962 1 1 0.200694196 691.3366521 14.54518 0 14.86483 13.89635 15.44738 12.95339 0 14.89028 11.98316 0 0 15.41621 15.82562 0 15.04033 15.34002 13.79812 0 0 15.25651 16.46923 16.3706 14.81038 0 0 0 0 0 0 0 0 0 15.63159 0 0 16.26735 0 15.8513 0 0 0 0 0 0 15.22221 0 15.29778 0 P35251 RFC1_HUMAN "Replication factor C subunit 1 (Activator 1 140 kDa subunit, A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit, RF-C 140 kDa subunit, RFC140) (Replication factor C large subunit)" RFC1 RFC140 Homo sapiens (Human) "DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomerase [GO:0007004]" cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomerase [GO:0007004]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565] GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0005730; GO:0005737; GO:0006261; GO:0006281; GO:0007004; GO:0008047; GO:0016887; GO:0019904; GO:0031391; GO:0043565; GO:0045893; GO:0061860; GO:0070062; GO:0090618 DTEAGETFSSVQANLSKAEK 1.24000001 1 1 0.114967866 2111.657553 11.69499 0 0 0 14.75684 0 0 0 0 0 0 12.13356 0 14.06494 0 0 0 0 0 0 0 14.87456 0 0 0 0 0 0 0 0 0 14.93809 0 9.623371 0 0 0 13.46167 14.3778 14.17301 14.07994 13.7418 11.45103 0 12.52317 0 0 8.606213 P35318 ADML_HUMAN "Pro-adrenomedullin [Cleaved into: Adrenomedullin, AM; Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide, PAMP, ProAM-N20) ]" ADM AM Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102] GO:0001570; GO:0001666; GO:0001843; GO:0002026; GO:0002031; GO:0003073; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0007165; GO:0007189; GO:0007204; GO:0007507; GO:0007565; GO:0007568; GO:0008209; GO:0008284; GO:0008285; GO:0009409; GO:0009611; GO:0010460; GO:0019731; GO:0019933; GO:0031100; GO:0031102; GO:0031623; GO:0031700; GO:0032496; GO:0032868; GO:0035809; GO:0042475; GO:0042594; GO:0043065; GO:0043116; GO:0045766; GO:0045906; GO:0046879; GO:0048589; GO:0050829; GO:0050830; GO:0051384; GO:0060670; GO:0060712; GO:0061844; GO:0097084; GO:0097647; GO:1990410; GO:2000184; GO:2001214 RSLPEAGPGR 15.81000042 0.722483158 0.722483158 0.227860111 1039.605079 16.53131 0 16.59941 13.82741 0 14.51525 15.82398 0 0 0 15.84043 0 0 14.50985 0 15.63825 13.14852 0 15.66771 0 0 0 0 16.26041 0 0 14.57064 0 16.17367 0 16.53425 0 0 15.5781 0 16.72439 15.74988 0 0 0 0 0 16.08494 0 16.25973 17.95992 16.58158 0 P35348 ADA1A_HUMAN "Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor, Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c)" ADRA1A ADRA1C Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; micturition [GO:0060073]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018] "caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; micturition [GO:0060073]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982] GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004930; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006915; GO:0006939; GO:0007165; GO:0007186; GO:0007200; GO:0007202; GO:0007204; GO:0007267; GO:0007512; GO:0007568; GO:0008285; GO:0009410; GO:0009725; GO:0010259; GO:0010507; GO:0010613; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035556; GO:0043231; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300 SGLKTDK 5.960000038 1 1 0.278743268 749.1090209 19.21196 18.13272 17.39554 17.59787 18.42957 15.29064 0 19.07443 0 0 0 0 0 0 0 17.9202 0 17.1347 15.4304 0 17.56937 18.1734 0 0 0 0 17.4063 0 0 0 19.38658 19.06661 0 0 17.57396 0 0 0 18.67458 17.78477 18.73151 18.94588 17.89246 0 0 17.09541 0 16.88465 P35354 PGH2_HUMAN "Prostaglandin G/H synthase 2, EC 1.14.99.1 (Cyclooxygenase-2, COX-2) (PHS II) (Prostaglandin H2 synthase 2, PGH synthase 2, PGHS-2) (Prostaglandin-endoperoxide synthase 2)" PTGS2 COX2 Homo sapiens (Human) "aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]" caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991] "caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]" "enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]" GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008285; GO:0009410; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0016702; GO:0019233; GO:0019371; GO:0019899; GO:0020037; GO:0030282; GO:0030728; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042307; GO:0042633; GO:0042803; GO:0043005; GO:0043065; GO:0043154; GO:0043231; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050727; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0150077; GO:1902219; GO:1990776 NVPPAVQKVSQASIDQSR 4.599999905 1 1 1.14E-12 1923.052324 14.68652 14.97547 13.58909 0 0 0 0 12.1826 0 0 0 12.71858 0 0 14.4311 0 0 14.26089 14.05222 13.45106 0 0 0 11.3683 12.69618 0 15.33926 14.04582 0 15.14729 15.75311 0 0 16.56538 0 17.03003 16.52745 15.53492 0 0 0 13.8838 0 15.94152 0 15.22771 0 13.53049 P35367 HRH1_HUMAN "Histamine H1 receptor, H1R, HH1R" HRH1 Homo sapiens (Human) "cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; inositol phosphate-mediated signaling [GO:0048016]; memory [GO:0007613]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; visual learning [GO:0008542]" cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; inositol phosphate-mediated signaling [GO:0048016]; memory [GO:0007613]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; visual learning [GO:0008542]" G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] GO:0004930; GO:0004969; GO:0004993; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007187; GO:0007200; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0032962; GO:0043114; GO:0045202; GO:0045907; GO:0048016; GO:0048167; GO:0048245; GO:0071420 DYVAVNR 9.920000076 1 1 0.221070652 836.7746932 18.01187 0 13.8635 17.80339 0 0 0 0 0 16.74045 0 18.53539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.34039 P35368 ADA1B_HUMAN "Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor, Alpha-1B adrenoceptor)" ADRA1B Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117] caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117] alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982] GO:0001996; GO:0004930; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0031965; GO:0035556; GO:0043410; GO:0045907; GO:0046982; GO:0055117; GO:0071880; GO:0150099 VYIVAKR 8.609999657 1 1 0.13060354 847.6413013 15.63522 15.27558 0 14.54325 14.81838 10.85104 16.58894 0 0 0 12.64604 0 13.66291 16.05901 0 13.89428 0 14.89095 13.1163 0 0 0 0 14.91558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.73242 0 0 0 P35372 OPRM_HUMAN "Mu-type opioid receptor, M-OR-1, MOR-1 (Mu opiate receptor) (Mu opioid receptor, MOP, hMOP)" OPRM1 MOR1 Homo sapiens (Human) "acute inflammatory response to antigenic stimulus [GO:0002438]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to cocaine [GO:0042220]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]" axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444] "axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444]; beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245]; acute inflammatory response to antigenic stimulus [GO:0002438]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to cocaine [GO:0042220]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]" beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245] GO:0001965; GO:0002438; GO:0004930; GO:0004979; GO:0005245; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0007187; GO:0007197; GO:0007200; GO:0007204; GO:0007218; GO:0007600; GO:0008022; GO:0008285; GO:0009314; GO:0019233; GO:0019904; GO:0030424; GO:0030425; GO:0031005; GO:0031635; GO:0031681; GO:0032094; GO:0032100; GO:0032496; GO:0032590; GO:0032839; GO:0038003; GO:0038047; GO:0042060; GO:0042220; GO:0042277; GO:0042383; GO:0042755; GO:0042923; GO:0043005; GO:0043204; GO:0043950; GO:0043951; GO:0044849; GO:0045019; GO:0045121; GO:0045429; GO:0048149; GO:0050769; GO:0051481; GO:0051930; GO:0060079; GO:0061358; GO:0070374; GO:0070848; GO:0080135; GO:0097444; GO:0099055; GO:0099056; GO:0106072; GO:2000310 SVRMLSGSK 14.80000019 1 1 0.198583391 966.4845713 13.03815 0 14.24991 15.15316 0 0 14.27855 15.79455 13.68108 13.27993 12.94085 0 0 0 0 16.40199 0 0 0 0 0 0 0 0 15.65507 0 0 0 0 0 0 16.63694 0 0 0 0 0 0 0 0 14.72659 0 0 0 0 0 0 0 P35442 TSP2_HUMAN Thrombospondin-2 THBS2 TSP2 Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965] calcium ion binding [GO:0005509]; heparin binding [GO:0008201] GO:0005509; GO:0005576; GO:0005604; GO:0007155; GO:0008201; GO:0016525; GO:0031091; GO:0051965; GO:0062023 KTIGAK 6.869999886 1 1 1.16E-13 614.5101731 0 15.47089 15.27632 12.46426 15.11952 0 0 0 13.897 0 15.39655 13.26902 14.79292 0 0 0 14.71845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35443 TSP4_HUMAN Thrombospondin-4 THBS4 TSP4 Homo sapiens (Human) behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771] calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178] GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023 YLKNDGK 15.57999992 0.855605543 0.855605543 0.099949329 837.5944834 14.78243 0 16.76542 10.51993 14.95755 0 0 13.43949 14.52833 16.94598 14.59381 13.9454 12.57811 14.22984 14.27553 15.03067 13.82661 0 0 14.13567 14.47674 0 14.09863 0 16.12794 0 0 0 13.31045 0 0 0 0 0 0 0 16.70823 16.26994 0 16.51392 0 0 0 0 0 0 0 0 P35498 SCN1A_HUMAN Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) SCN1A NAC1 SCN1 Homo sapiens (Human) adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; axon initial segment [GO:0043194]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] axon [GO:0030424]; axon initial segment [GO:0043194]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005654; GO:0005886; GO:0006814; GO:0007628; GO:0014704; GO:0016604; GO:0019227; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0033268; GO:0034765; GO:0035725; GO:0043025; GO:0043194; GO:0050884; GO:0050966; GO:0086002; GO:0086010 VTKPIVEK 6.789999962 0.117582701 0.117582701 0.266719857 913.7009541 0 0 18.14782 0 0 16.99015 0 0 16.10964 0 17.28975 0 18.40174 17.12722 17.67137 17.58267 18.20687 15.1849 18.56015 18.47091 19.06392 17.15223 18.95362 17.12436 18.54336 0 17.15629 17.64262 17.00224 17.70195 19.20103 0 0 0 17.76374 18.12784 17.40505 19.40658 18.58965 0 17.8781 18.34489 18.56704 18.54014 17.20016 18.42267 18.74565 18.39238 P35499 SCN4A_HUMAN Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4) SCN4A Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006936; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010; GO:0100001 FYYCINTTTSER 1.710000038 0.216668978 0.216668978 2.28E-13 1552.557941 0 17.51038 0 0 0 14.31123 15.82438 15.48728 16.63931 0 15.52062 15.46105 17.33604 15.89983 0 15.23647 15.52907 13.9763 17.15736 17.29074 14.49931 14.91165 14.74026 0 0 15.90378 15.9675 13.76708 0 15.58895 17.98817 18.77323 15.07565 16.86115 10.86665 0 17.04133 0 0 18.31655 0 15.48498 0 0 16.56555 0 0 13.43668 P35520 CBS_HUMAN "Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)" CBS Homo sapiens (Human) cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563] carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625] GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0019343; GO:0019344; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0030170; GO:0031625; GO:0042262; GO:0042802; GO:0042803; GO:0043418; GO:0046872; GO:0050421; GO:0050667; GO:0070025; GO:0070026; GO:0070814; GO:0072341; GO:1904047 TPTNAR 6.699999809 1 1 4.60E-13 659.3121598 13.91256 15.70398 15.38078 15.59226 0 0 0 0 0 0 0 0 13.86102 0 0 14.81571 0 0 0 0 0 0 15.61875 13.83719 14.14925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35523 CLCN1_HUMAN "Chloride channel protein 1, ClC-1 (Chloride channel protein, skeletal muscle)" CLCN1 CLC1 Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; muscle contraction [GO:0006936]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; muscle contraction [GO:0006936]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765] protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0006936; GO:0019227; GO:0034707; GO:0034765; GO:0042383; GO:0042803; GO:1902476 TLPLVDSK 7.420000076 1 1 0.071505378 871.4358522 15.60866 0 13.62144 12.20435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.93947 0 0 0 14.83108 0 0 0 0 0 0 0 0 0 0 13.61087 0 0 0 0 0 0 0 0 P35527 K1C9_HUMAN "Keratin, type I cytoskeletal 9 (Cytokeratin-9, CK-9) (Keratin-9, K9)" KRT9 Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; skin development [GO:0043588]; spermatogenesis [GO:0007283] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; skin development [GO:0043588]; spermatogenesis [GO:0007283] structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0007283; GO:0008544; GO:0016020; GO:0030855; GO:0043588; GO:0045095; GO:0045109; GO:0070062 GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK 41.41999817 1 1 0.009109023 3223.183777 0 0 10.3562 0 16.22086 15.68518 0 0 0 0 14.56312 0 14.52857 0 0 0 0 15.10601 0 0 0 0 18.27425 0 13.90871 15.38919 12.59739 0 0 0 0 17.09306 0 16.82262 16.27458 15.12011 0 0 15.73158 0 0 0 0 0 0 0 15.8467 0 P35556 FBN2_HUMAN Fibrillin-2 [Cleaved into: Placensin ] FBN2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179]; anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163 GMMCKNLIGTFMCICPPGMAR 2.230000019 1 1 2.28E-12 2510.248376 0 14.61461 16.04387 0 0 0 0 15.45472 15.03354 0 0 13.65997 16.5269 0 14.3797 0 12.89238 12.15075 14.78297 0 0 0 13.81557 16.16713 0 0 14.32272 0 0 0 14.14346 15.12096 0 12.94963 0 13.87869 13.09764 14.20217 0 15.94673 15.22218 15.47871 0 15.47438 0 15.26772 0 0 P35557 HXK4_HUMAN "Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)" GCK Homo sapiens (Human) calcium ion import [GO:0070509]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; NADP metabolic process [GO:0006739]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; regulation of glycolytic process [GO:0006110]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; calcium ion import [GO:0070509]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; NADP metabolic process [GO:0006739]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; regulation of glycolytic process [GO:0006110]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266] ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158] GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005654; GO:0005739; GO:0005829; GO:0006096; GO:0006110; GO:0006739; GO:0008865; GO:0019158; GO:0032024; GO:0032869; GO:0042593; GO:0043266; GO:0044320; GO:0045721; GO:0045725; GO:0050796; GO:0051156; GO:0051594; GO:0061621; GO:0070509 GAALVSAVACK 2.099999905 1 1 0.01324984 1045.548862 0 0 16.20282 0 0 0 0 0 15.45372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49577 0 0 0 0 0 0 0 0 14.36288 0 0 0 0 0 0 0 0 0 0 P35558 PCKGC_HUMAN "Phosphoenolpyruvate carboxykinase, cytosolic [GTP], PEPCK-C, EC 4.1.1.32 (Serine-protein kinase PCK1, EC 2.7.11.-)" PCK1 PEPCK1 Homo sapiens (Human) aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to potassium ion starvation [GO:0051365]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; regulation of lipid biosynthetic process [GO:0046890]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]; aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to potassium ion starvation [GO:0051365]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; regulation of lipid biosynthetic process [GO:0046890]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594] carboxylic acid binding [GO:0031406]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264] GO:0000287; GO:0004613; GO:0005525; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006006; GO:0006094; GO:0006107; GO:0007568; GO:0014823; GO:0018105; GO:0019003; GO:0019543; GO:0030145; GO:0031406; GO:0032496; GO:0032868; GO:0032869; GO:0033993; GO:0042593; GO:0042594; GO:0043382; GO:0046327; GO:0046890; GO:0051365; GO:0061402; GO:0070062; GO:0070365; GO:0070741; GO:0071300; GO:0071320; GO:0071332; GO:0071333; GO:0071347; GO:0071356; GO:0071377; GO:0071456; GO:0071549; GO:0106264; GO:1904640 AINPENGFFGVAPGTSVKTNPNAIK 5.480000019 1 1 0.493030531 2543.996343 0 14.19248 0 0 0 0 0 0 0 0 0 19.55729 0 0 0 0 0 0 0 0 0 0 0 20.50883 0 17.99925 0 0 0 18.95021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35568 IRS1_HUMAN "Insulin receptor substrate 1, IRS-1" IRS1 Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165] insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] GO:0001784; GO:0005068; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0005901; GO:0007165; GO:0008284; GO:0008286; GO:0010907; GO:0014065; GO:0030159; GO:0032000; GO:0032868; GO:0032869; GO:0042169; GO:0042593; GO:0043231; GO:0043434; GO:0043548; GO:0043552; GO:0045725; GO:0046326; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0071398 HRGSAR 2.170000076 1 1 0.13760952 684.9289999 0 0 14.84035 0 0 14.17019 15.07663 14.87504 0 15.48892 14.42459 0 0 0 0 0 9.609847 13.34886 0 0 0 0 15.78033 0 0 0 0 13.94186 0 13.95137 0 0 0 0 0 0 0 0 0 15.64661 0 0 0 0 0 0 15.77192 0 P35573 GDE_HUMAN "Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase, EC 2.4.1.25 (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase, Amylo-1,6-glucosidase, EC 3.2.1.33 (Dextrin 6-alpha-D-glucosidase) ]" AGL GDE Homo sapiens (Human) glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]" "4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]" GO:0004133; GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0051384; GO:0102500; GO:1904813 GYDELVPHQISVVSEER 6.239999771 0.322890729 0.322890729 0.137201338 1954.182349 0 17.52385 0 17.99683 0 14.77843 0 15.25991 0 0 0 0 0 15.8058 15.43541 0 14.93113 0 0 14.40935 0 0 17.70776 18.44991 0 14.81535 0 17.62333 15.68744 0 16.2599 0 0 16.89527 0 0 16.02686 18.25759 0 0 15.47169 0 0 0 0 15.46793 0 0 P35579 MYH9_HUMAN "Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A, NMMHC-A) (Non-muscle myosin heavy chain IIa, NMMHC II-a, NMMHC-IIA)" MYH9 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]" actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] "actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]" actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723] GO:0000146; GO:0000212; GO:0001525; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0003723; GO:0003774; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005826; GO:0005829; GO:0005886; GO:0005903; GO:0005912; GO:0005925; GO:0006509; GO:0006911; GO:0007229; GO:0007520; GO:0008360; GO:0009898; GO:0015031; GO:0015629; GO:0016020; GO:0016460; GO:0016604; GO:0019904; GO:0030048; GO:0030220; GO:0030224; GO:0031032; GO:0031252; GO:0031532; GO:0031594; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032991; GO:0042641; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045296; GO:0050900; GO:0051015; GO:0051295; GO:0060471; GO:0060473; GO:0070062; GO:0070527; GO:0097513; GO:1903919; GO:1903923; GO:1905684 ELESQISELQEDLESERASR 2.339999914 1 1 3.20E-12 2348.179039 12.37281 0 13.31705 10.55386 0 14.44732 13.79065 12.1472 0 0 10.95015 13.64246 14.39987 13.32983 0 0 13.21078 12.08474 0 13.13126 13.1569 0 14.71194 0 0 7.627217 0 0 12.81499 0 0 0 0 0 0 0 0 0 0 12.92756 0 15.9087 14.77121 0 0 0 0 0 P35580 MYH10_HUMAN "Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B, NMMHC-B) (Non-muscle myosin heavy chain IIb, NMMHC II-b, NMMHC-IIB)" MYH10 Homo sapiens (Human) actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; positive regulation of protein secretion [GO:0050714]; regulation of cell shape [GO:0008360] actomyosin [GO:0042641]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; polysome [GO:0005844]; stress fiber [GO:0001725] actomyosin [GO:0042641]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; polysome [GO:0005844]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; positive regulation of protein secretion [GO:0050714]; regulation of cell shape [GO:0008360] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613] GO:0000146; GO:0000281; GO:0001725; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005938; GO:0007155; GO:0008360; GO:0016459; GO:0016460; GO:0030027; GO:0030048; GO:0030496; GO:0031032; GO:0032154; GO:0035613; GO:0042641; GO:0043531; GO:0048027; GO:0050714; GO:0051015; GO:0070062; GO:0097513 IVGLDQVTGMTETAFGSAYK 3.730000019 1 1 0.109849268 2104.182482 13.65015 15.7247 0 12.64548 0 0 18.5432 0 0 18.49135 14.03226 13.85629 0 0 0 0 0 0 18.24342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35606 COPB2_HUMAN "Coatomer subunit beta' (Beta'-coat protein, Beta'-COP) (p102)" COPB2 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]" structural molecule activity [GO:0005198] GO:0000139; GO:0005198; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:1901998 IAYQLAVEAESEQK 13.22000027 1 1 0.211115445 1577.733558 0 13.95164 14.96273 0 0 0 0 14.13148 12.60073 0 0 0 15.92664 13.25384 0 14.49508 12.64377 13.49682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35612 ADDB_HUMAN Beta-adducin (Erythrocyte adducin subunit beta) ADD2 ADDB Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; synapse assembly [GO:0007416] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; synapse assembly [GO:0007416] actin binding [GO:0003779]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200] GO:0003779; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007416; GO:0008290; GO:0014069; GO:0019901; GO:0030036; GO:0030097; GO:0030507; GO:0031410; GO:0032092; GO:0042803; GO:0044853; GO:0046982; GO:0050900; GO:0050901; GO:0051015; GO:0051016; GO:0051017; GO:0065003 QDFNLMEQK 3.200000048 1 1 0.122597421 1168.201707 16.52963 0 0 11.54233 17.09461 0 0 0 0 14.56173 0 0 0 0 0 0 0 0 0 13.18243 0 16.41284 13.54319 0 15.89591 0 0 17.32561 15.66144 15.55693 12.00814 0 0 16.12186 0 0 0 6.963031 0 0 0 16.0489 0 7.950767 0 0 0 0 P35626 ARBK2_HUMAN "Beta-adrenergic receptor kinase 2, Beta-ARK-2, EC 2.7.11.15 (G-protein-coupled receptor kinase 3)" GRK3 ADRBK2 BARK2 Homo sapiens (Human) desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007186; GO:0009966; GO:0031623; GO:0047696 ADTGKMYAMK 4.199999809 1 1 0.551322884 1147.618024 14.69812 0 18.93713 0 0 0 0 0 0 18.35854 17.77075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.62963 0 0 0 0 0 0 0 0 16.70548 0 0 0 P35637 FUS_HUMAN RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein) FUS TLS Homo sapiens (Human) "mRNA stabilization [GO:0048255]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein homooligomerization [GO:0051260]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; mRNA stabilization [GO:0048255]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein homooligomerization [GO:0051260]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008380; GO:0042802; GO:0043484; GO:0046872; GO:0048255; GO:0051260; GO:1905168 GGRGGYDR 5.590000153 0.356355637 0.356355637 0.130048005 836.7658053 0 16.52675 15.78129 15.52506 14.60997 16.75208 15.11924 15.41845 15.83231 16.53531 0 15.16951 16.65887 17.1844 15.04568 16.28597 15.03847 12.17722 14.01445 16.71151 15.5692 14.66172 15.91607 15.6974 15.39816 0 0 0 0 10.84249 17.78993 15.14787 0 15.28697 15.09252 13.23997 15.5762 12.74183 0 10.94158 16.2427 12.83538 14.89109 15.35142 12.79287 15.27358 13.95792 13.76769 P35658 NU214_HUMAN Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) NUP214 CAIN CAN KIAA0023 Homo sapiens (Human) mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 DDEAVVQAPR 2.609999895 0.313917398 0.313917398 0.095458091 1099.526279 0 14.74462 14.41018 0 0 0 0 17.099 0 0 0 0 0 0 0 0 0 17.20179 0 0 12.24713 16.6714 13.13533 15.25669 11.74401 15.93403 0 14.78455 17.19767 0 17.20214 18.18288 14.12521 13.76446 17.70095 0 0 0 0 18.8189 17.47071 0 0 0 0 15.34097 15.51243 16.39635 P35659 DEK_HUMAN Protein DEK DEK Homo sapiens (Human) chromatin remodeling [GO:0006338]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] B-WICH complex [GO:0110016]; contractile fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] B-WICH complex [GO:0110016]; contractile fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006357; GO:0006366; GO:0007165; GO:0019079; GO:0035066; GO:0042393; GO:0043292; GO:0045943; GO:0045944; GO:0045945; GO:0110016; GO:2000779; GO:2001032 LLASANLEEVTMKQICK 5.050000191 0.363604248 0.363604248 0.248997385 1963.28866 0 17.60265 0 16.59077 0 19.07198 14.55104 11.8888 9.777299 17.28427 17.40735 16.55449 17.70271 13.616 18.32004 0 13.89908 15.40302 17.0872 0 0 18.51689 15.50641 17.58015 12.86681 12.34451 0 17.76614 16.54314 17.07996 11.42146 19.24255 16.94058 15.42757 17.72093 0 15.06174 16.43529 19.7932 14.79144 17.67649 18.31813 0 0 16.6214 13.70424 0 0 P35663 CYLC1_HUMAN Cylicin-1 (Cylicin I) (Multiple-band polypeptide I) CYLC1 CYL CYL1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] acrosomal matrix [GO:0043159]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634] acrosomal matrix [GO:0043159]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] GO:0005198; GO:0005200; GO:0005634; GO:0007283; GO:0030154; GO:0033150; GO:0043159 QIVEEKTK 10.39999962 1 1 0.31488229 974.471829 16.74672 0 16.32881 0 0 0 0 0 14.66013 0 0 0 0 0 0 0 0 0 0 0 14.24491 0 0 0 0 0 0 19.02744 0 16.28145 0 0 0 0 0 0 0 0 0 18.41569 0 0 0 0 0 0 16.60918 0 P35670 ATP7B_HUMAN "Copper-transporting ATPase 2, EC 7.2.2.8 (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa ]" ATP7B PWD WC1 WND Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0015680; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0055070; GO:0060003; GO:0140581; GO:1990961 RNGLTISSDVSDAMTDHEMK 9.079999924 0.411015481 0.411015481 0.193717344 2240.116434 0 11.6877 13.40451 14.68102 0 0 15.3526 0 10.07511 18.17312 14.05539 11.64565 14.73289 12.48767 0 0 0 0 14.73685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.24718 0 0 0 0 0 P35711 SOX5_HUMAN Transcription factor SOX-5 SOX5 Homo sapiens (Human) asymmetric neuroblast division [GO:0055059]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; asymmetric neuroblast division [GO:0055059]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001502; GO:0002062; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0032332; GO:0045165; GO:0051216; GO:0055059; GO:0061036; GO:0071560; GO:2000741 AMTNLEK 2.069999933 1 1 0.04673244 822.5807234 15.97049 14.99168 16.72566 12.85255 13.25927 14.61568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.34824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35716 SOX11_HUMAN Transcription factor SOX-11 SOX11 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006355; GO:0008284; GO:0009653; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030154; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:2000648; GO:2000678; GO:2001111 VSGSGGGGAGK 6.420000076 1 1 0.120401874 833.5545314 0 0 0 15.53069 13.57279 0 12.82897 13.47216 11.42146 9.33055 0 10.13552 13.02325 0 0 14.03497 0 14.97219 0 13.25754 0 15.4307 13.32916 15.56554 0 0 16.70308 0 0 15.6461 0 0 0 0 0 0 0 0 0 0 15.81743 0 0 0 0 0 0 0 P35749 MYH11_HUMAN "Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)" MYH11 KIAA0866 Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; elastic fiber assembly [GO:0048251]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; cardiac muscle cell development [GO:0055013]; elastic fiber assembly [GO:0048251]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307] GO:0003774; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006939; GO:0008307; GO:0030241; GO:0032982; GO:0042470; GO:0048251; GO:0051015; GO:0055013; GO:0070062 CSDGER 1.870000005 1 1 0.291126475 724.1340443 18.68684 18.20679 17.42946 0 20.14646 17.41597 0 17.34364 0 0 17.51882 0 0 17.0444 0 0 0 0 0 16.36488 0 18.5625 0 0 0 18.23685 17.952 0 0 0 0 19.39701 0 0 0 0 19.59877 18.79705 0 18.37985 18.27936 0 17.32168 16.36719 0 17.64478 0 0 P35789 ZNF93_HUMAN Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34) ZNF93 ZNF505 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895 HNIRHTEK 10.47999954 0.338966399 0.338966399 0.240229789 1035.42797 13.19379 13.41331 16.54251 16.06595 17.5324 0 0 0 0 17.88032 16.75413 15.58186 0 15.45765 16.40314 16.11367 0 0 16.15656 0 0 16.63332 0 0 0 0 17.6771 15.54582 15.51233 0 18.01778 0 0 0 16.8469 17.33695 0 0 16.50175 0 17.55859 15.96276 0 0 0 0 15.87896 0 P35790 CHKA_HUMAN "Choline kinase alpha, CK, EC 2.7.1.32 (CHETK-alpha) (Ethanolamine kinase, EK, EC 2.7.1.82)" CHKA CHK CKI Homo sapiens (Human) CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646] ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713] GO:0004103; GO:0004104; GO:0004305; GO:0004713; GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0006657; GO:0006869; GO:0042149; GO:0042803; GO:1905691 EEMLLEVNR 2.710000038 1 1 6.86E-13 1148.181099 0 0 14.95492 15.07401 0 0 16.65073 0 15.14296 16.72386 17.62967 15.97184 14.93264 14.3842 15.3572 0 0 0 0 15.8278 0 0 16.38827 5.796014 11.72756 14.98626 0 0 0 0 0 13.15893 0 16.92152 0 0 0 0 15.14578 0 15.0801 13.34895 0 0 0 0 15.74916 0 P35908 K22E_HUMAN "Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e, CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e, K2e) (Type-II keratin Kb2)" KRT2 KRT2A KRT2E Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684] cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280] GO:0001533; GO:0003334; GO:0005200; GO:0005615; GO:0005634; GO:0005829; GO:0005882; GO:0008092; GO:0008544; GO:0016020; GO:0018149; GO:0030280; GO:0031424; GO:0032980; GO:0043616; GO:0045095; GO:0045109; GO:0045684; GO:0051546; GO:0070062 GSSSGGGYSSGSSSYGSGGR 7.760000229 1 1 0.594639402 1741.252331 0 18.92305 0 18.71874 0 0 0 0 18.0418 18.78392 0 0 0 0 0 0 0 20.12783 18.7444 0 0 0 0 0 0 18.81131 0 0 0 0 0 0 18.03543 19.65771 0 0 0 0 0 0 0 18.82718 0 0 0 0 0 0 P35913 PDE6B_HUMAN "Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta, GMP-PDE beta, EC 3.1.4.35" PDE6B PDEB Homo sapiens (Human) "entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction, visible light [GO:0007603]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; signal transduction [GO:0007165]; visual perception [GO:0007601]" photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction, visible light [GO:0007603]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; signal transduction [GO:0007165]; visual perception [GO:0007601]" "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0007603; GO:0042622; GO:0043153; GO:0046872; GO:0047555; GO:0060041; GO:0097381; GO:1990009 AAELPKLQVGFIDFVCTFVYK 11.35000038 0.815097868 0.815097868 0.021658277 2444.755688 18.27792 0 0 0 16.55283 0 0 0 0 17.08498 0 16.74653 0 0 17.61228 0 0 17.44882 0 16.92683 18.60364 0 15.77505 17.74022 0 17.75813 0 0 17.44952 0 15.94351 16.15823 0 16.53611 17.74355 17.06074 17.73457 17.7857 16.1484 0 17.44243 16.8527 0 15.51477 0 0 0 16.58205 P35916 VGFR3_HUMAN "Vascular endothelial growth factor receptor 3, VEGFR-3, EC 2.7.10.1 (Fms-like tyrosine kinase 4, FLT-4) (Tyrosine-protein kinase receptor FLT4)" FLT4 VEGFR3 Homo sapiens (Human) blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021] GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004712; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037 RPERGAR 4.840000153 1 1 3.46E-13 840.9107306 14.86007 15.39441 14.25969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6902 0 0 0 0 0 12.48961 0 0 13.43262 0 15.81737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35968 VGFR2_HUMAN "Vascular endothelial growth factor receptor 2, VEGFR-2, EC 2.7.10.1 (Fetal liver kinase 1, FLK-1) (Kinase insert domain receptor, KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)" KDR FLK1 VEGFR2 Homo sapiens (Human) angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570] cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443] cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021] GO:0001525; GO:0001541; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0001945; GO:0002042; GO:0002053; GO:0002244; GO:0003157; GO:0003158; GO:0004712; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0008360; GO:0009897; GO:0010595; GO:0010629; GO:0014068; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030335; GO:0030513; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043129; GO:0043235; GO:0043410; GO:0043491; GO:0043536; GO:0045121; GO:0045165; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0048286; GO:0048469; GO:0048597; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0055074; GO:0061042; GO:0070371; GO:0070374; GO:0090050; GO:0090141; GO:0097443; GO:1901532; GO:1903010; GO:1904881; GO:2000352; GO:2001214 NILLSEK 6.480000019 1 1 0.204638426 816.9916661 0 0 0 0 0 0 0 0 14.36907 0 0 0 0 17.42074 17.62955 0 0 0 18.29225 0 0 0 17.95178 0 0 0 0 0 0 15.70833 16.28625 16.97934 15.51045 0 0 0 0 17.41984 18.20158 0 15.515 0 18.11214 17.7147 0 0 0 0 P35998 PRS7_HUMAN 26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) PSMC2 MSS1 Homo sapiens (Human) osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402] GO:0000502; GO:0000932; GO:0001649; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0034774; GO:0036402; GO:0036464; GO:0043161; GO:1901800; GO:1904813 VGVDRNK 15 0.040627543 0.040627543 0.202242651 786.4657939 15.22894 14.58361 14.37485 17.68303 15.16912 0 0 15.18325 15.59327 15.34606 15.09897 0 15.30019 14.8641 0 14.61494 0 14.23166 15.2215 15.84181 15.25971 15.73116 0 16.75829 16.59138 0 0 14.01707 15.75897 15.92813 15.77229 16.2211 0 14.48373 0 0 0 16.46575 15.20908 0 15.25404 0 0 16.08866 16.87476 15.74021 0 0 P36222 CH3L1_HUMAN "Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39, CGP-39, GP-39, hCGP-39) (YKL-40)" CHI3L1 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; extracellular matrix structural constituent [GO:0005201]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005975; GO:0006032; GO:0006915; GO:0006954; GO:0007250; GO:0008061; GO:0009612; GO:0010800; GO:0030246; GO:0030324; GO:0031012; GO:0032757; GO:0034612; GO:0035580; GO:0045766; GO:0048471; GO:0051216; GO:0051897; GO:0070062; GO:0070374; GO:0070555; GO:0070741; GO:0071356 DALAAT 2.460000038 0.264769107 0.264769107 0.080091345 560.1786355 14.33133 14.5589 14.66758 10.70436 14.3165 18.49831 0 14.02089 16.63073 15.43739 0 16.93703 0 14.46911 0 17.33711 16.77274 0 0 17.0718 19.10678 15.78781 0 0 0 0 17.60447 0 0 0 0 16.93845 16.93789 16.17582 0 15.8115 18.24033 17.59234 0 15.4007 0 17.38668 0 0 18.98388 0 0 16.19535 P36269 GGT5_HUMAN "Glutathione hydrolase 5 proenzyme, EC 3.4.19.13 (Gamma-glutamyl transpeptidase-related enzyme, GGT-rel) (Gamma-glutamyltransferase 5, GGT 5, EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase, EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain ]" GGT5 GGTLA1 Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508] glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] GO:0000048; GO:0002951; GO:0005886; GO:0006508; GO:0006520; GO:0006631; GO:0006750; GO:0006751; GO:0006954; GO:0016021; GO:0031226; GO:0036374; GO:0102953; GO:0103068; GO:1901750 SGEAAGY 6.46999979 1 1 0.077938304 651.5057411 0 14.95729 15.73083 0 13.65157 14.22388 12.99672 15.77847 0 14.14779 16.28491 12.78521 0 15.86411 15.68631 15.5509 15.95558 0 16.53662 0 0 16.23162 14.04989 14.31161 0 15.86357 16.40891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68727 0 P36507 MP2K2_HUMAN "Dual specificity mitogen-activated protein kinase kinase 2, MAP kinase kinase 2, MAPKK 2, EC 2.7.12.2 (ERK activator kinase 2) (MAPK/ERK kinase 2, MEK 2)" MAP2K2 MEK2 MKK2 PRKMK2 Homo sapiens (Human) "ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]" cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778] "cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]" ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110] GO:0000165; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005576; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005911; GO:0005925; GO:0009898; GO:0030165; GO:0032872; GO:0036289; GO:0043539; GO:0045893; GO:0046872; GO:0048471; GO:0070371; GO:0071902; GO:0090170; GO:0097110; GO:0106310; GO:1903800; GO:2000641 DDDFER 6.46999979 0.399946094 0.399946094 0.183136493 795.8242021 0 0 12.76384 0 0 0 0 0 14.85029 0 0 0 12.66704 15.12869 12.34944 16.51562 0 0 0 0 0 0 14.95047 14.5184 0 0 0 0 0 0 15.54987 0 0 18.91138 16.40867 0 0 0 0 16.77132 0 0 0 0 0 0 0 0 P36542 ATPG_HUMAN "ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)" ATP5F1C ATP5C ATP5C1 ATP5CL1 Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119] "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]" "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]" "proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]" GO:0000275; GO:0003723; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006119; GO:0006754; GO:0015986; GO:0016020; GO:0042776; GO:0046933 ADIKGPEDK 10.69999981 1 1 0.357472707 973.257861 0 15.43463 11.72013 16.05252 15.78837 14.4684 0 0 0 13.51978 0 16.65989 11.40234 0 0 14.12836 16.16286 13.67832 14.96245 12.89788 15.23245 0 15.3226 0 0 15.54142 16.69433 15.07918 13.48731 14.72093 15.09788 15.74016 0 0 0 15.33949 0 16.62842 15.59728 17.07027 16.7591 16.93945 15.50222 0 0 0 0 16.81291 P36551 HEM6_HUMAN "Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3" CPOX CPO CPX Homo sapiens (Human) heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597] coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212] GO:0004109; GO:0005212; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006782; GO:0006783; GO:0010039; GO:0010288; GO:0017085; GO:0042803; GO:0046685; GO:0051597 AEMLPK 1.149999976 1 1 0.246950918 703.9203973 16.02111 0 17.5499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4573 0 0 18.09192 0 0 0 0 0 0 P36578 RL4_HUMAN 60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4) RPL4 RPL1 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:1990904 KPVVGKK 14.14000034 0.044555541 0.044555541 0.275330527 755.8345837 16.7345 18.16791 18.32743 0 0 18.74442 18.41505 0 0 0 0 0 18.02641 0 0 0 17.67462 0 0 0 0 0 0 18.99605 0 18.77824 0 0 0 0 0 19.89637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.81915 17.08154 P36888 FLT3_HUMAN "Receptor-type tyrosine-protein kinase FLT3, EC 2.7.10.1 (FL cytokine receptor) (Fetal liver kinase-2, FLK-2) (Fms-like tyrosine kinase 3, FLT-3) (Stem cell tyrosine kinase 1, STK-1) (CD antigen CD135)" FLT3 CD135 FLK2 STK1 Homo sapiens (Human) animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; glucocorticoid receptor binding [GO:0035259]; growth factor binding [GO:0019838]; protein self-association [GO:0043621]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; glucocorticoid receptor binding [GO:0035259]; growth factor binding [GO:0019838]; protein self-association [GO:0043621]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021] GO:0001776; GO:0002318; GO:0002328; GO:0004712; GO:0004713; GO:0004714; GO:0004896; GO:0005021; GO:0005524; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010008; GO:0010243; GO:0014068; GO:0018108; GO:0019221; GO:0019838; GO:0030097; GO:0030183; GO:0031100; GO:0033674; GO:0035259; GO:0035726; GO:0042531; GO:0042981; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0043621; GO:0044877; GO:0046651; GO:0046777; GO:0071345; GO:0071385; GO:0097028 CTWTFSRK 10.38000011 0.096745528 0.096745528 0.324690332 1086.184203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.85144 0 0 0 0 0 0 0 0 0 0 0 0 0 15.73078 0 0 P36896 ACV1B_HUMAN "Activin receptor type-1B, EC 2.7.11.30 (Activin receptor type IB, ACTR-IB) (Activin receptor-like kinase 4, ALK-4) (Serine/threonine-protein kinase receptor R2, SKR2)" ACVR1B ACVRLK4 ALK4 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]" activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]" "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]" GO:0000082; GO:0001701; GO:0001942; GO:0004674; GO:0004675; GO:0005524; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007399; GO:0009986; GO:0010628; GO:0010629; GO:0016361; GO:0018107; GO:0030308; GO:0031625; GO:0032924; GO:0032927; GO:0034711; GO:0038092; GO:0043235; GO:0045648; GO:0046332; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0071363; GO:0097191; GO:1901165 VMGKMMR 8.300000191 0.047738899 0.047738899 0.27255755 852.821864 17.33111 18.33264 0 17.76715 0 17.10046 17.57794 15.71457 17.01588 16.75112 19.25191 0 0 0 17.4801 16.9591 16.24457 0 0 0 0 18.43521 0 0 0 18.85494 18.92229 18.38146 0 0 0 18.90137 17.81704 18.83559 19.59391 0 0 18.43496 0 0 17.44735 15.78999 18.19785 0 17.35597 0 18.48721 0 P36897 TGFR1_HUMAN "TGF-beta receptor type-1, TGFR-1, EC 2.7.11.30 (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5, ALK-5, ALK5) (Serine/threonine-protein kinase receptor R4, SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I, TGF-beta receptor type I, TbetaR-I)" TGFBR1 ALK5 SKR4 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021] "activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]" GO:0001501; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005114; GO:0005524; GO:0005634; GO:0005768; GO:0005886; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007399; GO:0007507; GO:0008284; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0016020; GO:0016361; GO:0018105; GO:0018107; GO:0030199; GO:0030307; GO:0030335; GO:0031396; GO:0032331; GO:0032924; GO:0035556; GO:0042060; GO:0042118; GO:0043062; GO:0043235; GO:0043393; GO:0043410; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051272; GO:0051491; GO:0051496; GO:0051726; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070021; GO:0070411; GO:0070723; GO:0071363; GO:0071560; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237 KNGTCCIADLGLAVR 3.299999952 1 1 0.475553074 1646.863294 16.52308 0 0 0 0 0 0 16.15806 0 0 0 0 10.7086 14.14576 0 0 0 0 0 14.92444 0 0 0 0 0 0 0 0 15.27114 0 0 0 0 0 0 0 0 0 0 0 16.17458 0 0 0 0 0 0 0 P36915 GNL1_HUMAN Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1) GNL1 HSR1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456] extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198]; cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198] GO:0002456; GO:0003924; GO:0005198; GO:0005525; GO:0005615; GO:0005634; GO:0006974; GO:0007165 EQLMSQEER 3.349999905 1 1 0.202371794 1150.638259 15.86839 0 13.99193 14.73501 0 15.42481 15.67595 0 14.56527 15.34938 0 12.13713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18327 0 0 0 0 0 0 15.86567 16.50969 15.59837 15.38017 0 0 0 0 0 P36956 SRBP1_HUMAN "Sterol regulatory element-binding protein 1, SREBP-1 (Class D basic helix-loop-helix protein 1, bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1) ]" SREBF1 BHLHD1 SREBP1 Homo sapiens (Human) aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]" GO:0000122; GO:0000139; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0010867; GO:0010876; GO:0010883; GO:0012507; GO:0016021; GO:0019217; GO:0019901; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0044877; GO:0045444; GO:0045471; GO:0045542; GO:0045944; GO:0046676; GO:0046983; GO:0051591; GO:0071398; GO:1902895; GO:1903146; GO:1903214; GO:1990837 LMAGASPTR 1.879999995 1 1 0.020978883 920.4140648 15.92473 15.5241 0 14.50373 0 0 16.59416 16.17143 0 0 0 16.42401 14.89617 0 0 13.11162 14.82416 0 16.9809 0 17.73829 17.58609 13.32172 0 0 16.61539 15.74326 0 17.62579 17.37772 15.57105 0 17.85096 0 0 0 0 17.55955 0 0 0 16.26884 0 0 0 0 0 0 P36959 GMPR1_HUMAN "GMP reductase 1, GMPR 1, EC 1.7.1.7 (Guanosine 5'-monophosphate oxidoreductase 1, Guanosine monophosphate reductase 1)" GMPR GMPR1 Homo sapiens (Human) purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409] cytosol [GO:0005829]; GMP reductase complex [GO:1902560] cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409] GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872] GO:0003920; GO:0005829; GO:0006144; GO:0006163; GO:0009409; GO:0046872; GO:1902560 IDADLK 6.119999886 0.843445659 0.843445659 0.20962238 674.5520796 0 0 15.98045 17.53611 0 0 15.01291 0 15.4249 16.00544 14.41817 0 0 0 0 0 15.78041 0 15.84861 15.1452 16.37951 15.97557 16.22646 0 14.9697 0 0 15.22461 0 18.50981 0 16.97903 0 0 15.53228 16.73606 0 0 17.26329 0 0 0 17.55081 14.59743 14.5527 15.71413 17.06991 0 P37023 ACVL1_HUMAN "Serine/threonine-protein kinase receptor R3, SKR3, EC 2.7.11.30 (Activin receptor-like kinase 1, ALK-1) (TGF-B superfamily receptor type I, TSR-I)" ACVRL1 ACVRLK1 ALK1 Homo sapiens (Human) "angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]" BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]" "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]" GO:0001525; GO:0001666; GO:0001701; GO:0001936; GO:0001937; GO:0001938; GO:0001946; GO:0001955; GO:0001974; GO:0002043; GO:0003203; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006275; GO:0006355; GO:0006468; GO:0007162; GO:0007165; GO:0007179; GO:0007507; GO:0008015; GO:0008217; GO:0008285; GO:0009953; GO:0009986; GO:0010596; GO:0010629; GO:0010862; GO:0016361; GO:0019901; GO:0030308; GO:0030336; GO:0030425; GO:0030509; GO:0030513; GO:0032332; GO:0035313; GO:0035912; GO:0043025; GO:0043235; GO:0043535; GO:0043537; GO:0045602; GO:0045603; GO:0045766; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048185; GO:0050431; GO:0051895; GO:0060836; GO:0060840; GO:0060841; GO:0061154; GO:0061298; GO:0070724; GO:0071363; GO:0071560; GO:0071773; GO:0098821; GO:2000279 QTLEPHLALR 10.76000023 1 1 0.481330667 1176.799366 0 19.33875 0 0 0 17.9129 0 0 0 0 0 18.46904 0 0 0 0 0 0 17.00016 0 0 0 0 0 0 18.65847 18.7079 0 0 0 0 17.58172 0 0 0 20.60143 0 0 0 17.45099 17.50074 0 0 17.31551 0 0 0 0 P37059 DHB2_HUMAN "17-beta-hydroxysteroid dehydrogenase type 2, 17-beta-HSD 2 (20 alpha-hydroxysteroid dehydrogenase, 20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2, EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase, EC 1.1.1.239)" HSD17B2 EDH17B2 SDR9C2 Homo sapiens (Human) estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]" "17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006703; GO:0016021; GO:0032526; GO:0044594; GO:0047006; GO:0047035; GO:0072582 DFSPVLRDIQHAILAK 6.800000191 0.828461826 0.828461826 0.103895923 1822.166321 13.15779 15.61246 0 11.09169 14.97486 0 14.68234 15.72168 15.46178 12.86231 15.00582 0 0 0 0 14.13933 0 0 14.44466 0 0 0 0 0 0 14.64539 16.72348 0 0 0 0 0 0 0 0 0 16.53788 0 0 0 0 16.63401 0 0 0 0 0 0 P37088 SCNNA_HUMAN "Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha, Alpha-ENaC, ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)" SCNN1A SCNN1 Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699] GO:0001669; GO:0005737; GO:0005886; GO:0005887; GO:0006883; GO:0008217; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725; GO:0036254; GO:0050699; GO:0050891; GO:0050914; GO:0050915; GO:0055078; GO:0060170; GO:0070062; GO:0071468; GO:0097228; GO:0098719; GO:1904045; GO:1904117 ARSVASSLR 3.230000019 0.410047352 0.410047352 0.121425133 947.432514 0 15.00219 14.50709 15.5827 0 14.1943 14.62527 13.69479 12.90307 0 0 14.98407 15.00463 0 15.46619 0 0 15.03478 13.91762 14.93615 0 14.82121 14.06519 0 0 15.38701 0 14.8274 13.71532 13.00102 0 0 0 0 0 0 16.04093 0 0 0 0 0 0 0 0 0 0 0 P37268 FDFT_HUMAN "Squalene synthase, SQS, SS, EC 2.5.1.21 (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase 1)" FDFT1 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694] farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996] GO:0004310; GO:0005783; GO:0005789; GO:0006694; GO:0006695; GO:0016021; GO:0045338; GO:0046872; GO:0051996 ANSMGLFLQKTNIIR 5.679999828 1 1 0.244100249 1705.35618 12.11716 0 0 0 0 13.79795 0 0 0 14.64789 0 0 0 0 0 16.39488 0 14.31019 0 0 0 0 0 0 0 16.09748 0 10.69402 0 0 0 0 13.32182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P37275 ZEB1_HUMAN "Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8, TCF-8)" ZEB1 AREB6 TCF8 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cochlea morphogenesis [GO:0090103]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to activity [GO:0014823]; response to nutrient levels [GO:0031667]; semicircular canal morphogenesis [GO:0048752]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cochlea morphogenesis [GO:0090103]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to activity [GO:0014823]; response to nutrient levels [GO:0031667]; semicircular canal morphogenesis [GO:0048752]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007389; GO:0008270; GO:0008285; GO:0010464; GO:0014823; GO:0017015; GO:0030154; GO:0030900; GO:0031667; GO:0033081; GO:0045602; GO:0045666; GO:0045892; GO:0045944; GO:0048596; GO:0048704; GO:0048752; GO:0048856; GO:0051150; GO:0051216; GO:0070888; GO:0071230; GO:0071560; GO:0090103 HMTSHK 6.400000095 1 1 0.272302794 740.7648516 15.23026 14.15948 13.61182 0 0 0 0 0 15.92188 16.09127 14.49946 0 18.36744 14.13969 18.10731 0 0 17.23489 16.62639 18.29617 0 17.09033 0 0 18.24108 0 16.77978 17.94265 15.47607 16.32275 18.08372 17.30389 0 18.44721 17.89692 16.09371 19.84968 20.02179 19.07007 0 16.8231 16.72702 19.0487 19.77574 0 19.19586 0 16.72601 P37802 TAGL2_HUMAN Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog) TAGLN2 KIAA0120 CDABP0035 Homo sapiens (Human) epithelial cell differentiation [GO:0030855] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855] cadherin binding [GO:0045296] GO:0005576; GO:0005829; GO:0005856; GO:0030855; GO:0031982; GO:0045296; GO:0070062 GASQAGMTGYGMPRQIL 9.649999619 1 1 0.385897341 1737.817072 16.96805 15.21325 0 0 0 0 0 0 15.08887 16.9011 17.00313 15.2353 0 13.58414 0 15.9429 0 0 15.9654 0 0 15.77701 0 17.32243 0 0 16.86936 12.56532 16.48759 0 0 0 17.34847 0 17.3467 16.0918 17.29122 16.34722 0 0 0 0 0 16.182 14.8374 0 14.91648 0 P37837 TALDO_HUMAN "Transaldolase, EC 2.2.1.2" TALDO1 TAL TALDO TALDOR Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]" monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801] GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0006002; GO:0009052; GO:0019682; GO:0048029; GO:0070062 FSYKTIVMGASFR 9.289999962 1 1 0.211446281 1517.140448 15.45681 15.54471 15.56721 14.80621 0 14.57045 16.59299 0 15.65833 14.03302 13.02451 11.06841 0 0 0 15.06785 15.51012 0 16.90372 0 0 0 0 0 0 0 0 0 0 0 0 16.52715 0 0 0 0 18.57074 0 0 16.16396 0 0 17.87834 0 18.35807 0 0 0 P38117 ETFB_HUMAN "Electron transfer flavoprotein subunit beta, Beta-ETF" ETFB FP585 Homo sapiens (Human) cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer activity [GO:0009055] GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251 IEVIKPGDLGVDLTSKLSVISVEDPPQR 1.360000014 1 1 0.004176649 2996.392171 15.26037 0 6.668431 0 0 0 0 15.10983 0 0 0 0 0 0 15.33024 0 10.72084 15.33264 13.52017 0 0 0 0 0 14.58076 0 13.39313 14.37315 13.68655 14.63197 15.28788 0 15.02518 9.619596 11.45368 15.88058 0 16.8381 0 0 14.40001 0 0 0 0 0 0 0 P38159 RBMX_HUMAN "RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G, hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed ]" RBMX HNRPG RBMXP1 Homo sapiens (Human) "cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]" catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530] "catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]" chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0001649; GO:0003682; GO:0003723; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0006366; GO:0006509; GO:0016020; GO:0019904; GO:0032991; GO:0042802; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347; GO:1990904 DAARDMNGK 3.410000086 1 1 0.159834533 992.3908264 15.91829 0 14.78223 11.69514 0 14.65729 11.72316 0 0 0 0 0 13.81247 12.03884 0 0 0 14.32106 15.80779 0 0 0 12.49281 0 13.84616 0 0 0 15.44738 0 17.43404 0 13.64638 16.34404 0 0 15.72237 15.05726 0 0 0 0 16.61167 0 15.48528 0 14.09567 0 P38398 BRCA1_HUMAN "Breast cancer type 1 susceptibility protein, EC 2.3.2.27 (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)" BRCA1 RNF53 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA methylation [GO:0044030]; regulation of DNA repair [GO:0006282]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]" BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin large complex [GO:0000931]; lateral element [GO:0000800]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151] "BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin large complex [GO:0000931]; lateral element [GO:0000800]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA methylation [GO:0044030]; regulation of DNA repair [GO:0006282]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]" damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0000152; GO:0000209; GO:0000724; GO:0000800; GO:0000931; GO:0000976; GO:0003677; GO:0003684; GO:0003713; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005886; GO:0006281; GO:0006282; GO:0006301; GO:0006302; GO:0006349; GO:0006357; GO:0006633; GO:0006974; GO:0007059; GO:0007095; GO:0007098; GO:0008270; GO:0008630; GO:0009048; GO:0010212; GO:0010575; GO:0010628; GO:0015631; GO:0016567; GO:0016604; GO:0019899; GO:0031398; GO:0031436; GO:0031625; GO:0032991; GO:0033147; GO:0035066; GO:0035067; GO:0035518; GO:0035825; GO:0043009; GO:0043627; GO:0044030; GO:0044818; GO:0045717; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0046600; GO:0051571; GO:0051572; GO:0051573; GO:0051574; GO:0051726; GO:0051865; GO:0070063; GO:0070512; GO:0070531; GO:0070532; GO:0070533; GO:0070537; GO:0071356; GO:0071479; GO:0071681; GO:0085020; GO:0110025; GO:1902042; GO:1990391; GO:1990904; GO:2000001; GO:2000378; GO:2000617; GO:2000620 IICAFQLDTGLEYANSYNFAK 7.53000021 1 1 0.204978487 2437.218576 0 15.322 0 0 0 14.85372 0 0 0 0 0 0 0 0 0 16.40094 15.57976 16.00301 0 0 14.67525 0 0 16.74988 0 0 15.97646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P38570 ITAE_HUMAN Integrin alpha-E (HML-1 antigen) (Integrin alpha-IEL) (Mucosal lymphocyte 1 antigen) (CD antigen CD103) [Cleaved into: Integrin alpha-E light chain; Integrin alpha-E heavy chain ] ITGAE Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] integrin binding [GO:0005178]; metal ion binding [GO:0046872] GO:0005178; GO:0005886; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0033627; GO:0046872; GO:0098609 GVTVVR 5.829999924 0.716462433 0.716462433 0.270925981 631.9464749 0 0 0 0 0 14.60493 0 0 0 0 15.50442 0 0 16.84053 0 0 0 0 0 17.45231 0 0 0 17.44035 16.79085 16.81969 0 0 0 16.87676 17.65065 0 0 0 17.96096 16.60195 18.69402 0 17.87761 0 0 17.49984 17.46148 0 0 0 0 0 P38606 VATA_HUMAN "V-type proton ATPase catalytic subunit A, V-ATPase subunit A, EC 7.1.2.2 (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha)" ATP6V1A ATP6A1 ATP6V1A1 VPP2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" "ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0000139; GO:0000221; GO:0005524; GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0006879; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0016324; GO:0016469; GO:0030133; GO:0030141; GO:0033176; GO:0036295; GO:0043231; GO:0046933; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:1902600 IKSDYAQLLEDMQNAFR 1.080000043 1 1 0.414673825 2041.946824 17.41804 0 15.98902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.09694 0 0 0 0 P38646 GRP75_HUMAN "Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein, GRP-75) (Heat shock 70 kDa protein 9) (Mortalin, MOT) (Peptide-binding protein 74, PBP74)" HSPA9 GRP75 HSPA9B mt-HSP70 Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; intracellular protein transport [GO:0006886]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; intracellular protein transport [GO:0006886]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] GO:0001401; GO:0003723; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0005925; GO:0006611; GO:0006886; GO:0007007; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0043066; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0140275; GO:1902037; GO:1903707 ETGVDLTKDNMALQR 5.480000019 1 1 0.540323242 1706.833199 0 0 17.8355 0 0 0 19.73081 0 0 0 0 0 0 0 0 0 18.47109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.69291 0 19.26715 0 19.5931 0 0 0 0 0 0 P38919 IF4A3_HUMAN "Eukaryotic initiation factor 4A-III, eIF-4A-III, eIF4A-III, EC 3.6.4.13 (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic initiation factor 4A-like NUK-34) (Eukaryotic translation initiation factor 4A isoform 3) (Nuclear matrix protein 265, NMP 265, hNMP 265) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed ]" EIF4A3 DDX48 KIAA0111 Homo sapiens (Human) "associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to organic cyclic compound [GO:0014070]; rRNA processing [GO:0006364]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; U2-type catalytic step 1 spliceosome [GO:0071006] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; U2-type catalytic step 1 spliceosome [GO:0071006]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182]; associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to organic cyclic compound [GO:0014070]; rRNA processing [GO:0006364]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182] GO:0000184; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006406; GO:0008143; GO:0008306; GO:0014070; GO:0016020; GO:0016607; GO:0016887; GO:0017148; GO:0030425; GO:0035145; GO:0035368; GO:0035613; GO:0035640; GO:0043021; GO:0043025; GO:0045182; GO:0045727; GO:0048701; GO:0071006; GO:0071013; GO:0072715; GO:0090394; GO:0098978; GO:0099524; GO:0099578; GO:1904570; GO:1904574; GO:1990416; GO:2000622 ATTATMATSGSAR 9.920000076 1 1 0.184642349 1225.49093 15.61026 17.54864 16.00884 15.2785 15.82135 13.52523 14.44588 14.86542 15.03225 15.63908 0 15.36565 9.500751 14.20311 0 15.71432 14.20621 12.87953 13.5978 15.96098 14.91934 0 0 15.99526 14.33321 14.63587 15.6159 15.36835 14.34769 0 16.45911 16.20283 15.73555 15.71409 0 0 15.63166 15.47506 0 0 15.43366 0 0 14.43727 0 14.98655 0 16.01023 P38936 CDN1A_HUMAN "Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6, MDA-6) (p21)" CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 Homo sapiens (Human) "cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]" cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; protein-containing complex [GO:0032991] "cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]" cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] GO:0000079; GO:0000082; GO:0000307; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006606; GO:0006974; GO:0006977; GO:0006978; GO:0007095; GO:0007265; GO:0007507; GO:0008285; GO:0010389; GO:0010629; GO:0016604; GO:0019901; GO:0019912; GO:0030308; GO:0030332; GO:0030890; GO:0031625; GO:0031668; GO:0032091; GO:0032991; GO:0034198; GO:0042060; GO:0042246; GO:0042326; GO:0042771; GO:0043068; GO:0044877; GO:0045860; GO:0046872; GO:0048146; GO:0051726; GO:0070557; GO:0071479; GO:0071480; GO:0071493; GO:0090398; GO:0090399; GO:0090400; GO:0097193; GO:0140311; GO:1902806; GO:1904030; GO:1904706; GO:1905179; GO:2000045; GO:2000134; GO:2000279; GO:2000379 VRGLGLPK 8.970000267 0.737521827 0.737521827 0.277227116 840.824544 16.16827 19.94989 16.95428 0 0 20.39725 18.60201 0 0 0 18.0931 19.86804 0 0 0 0 0 0 16.43746 0 0 17.37691 0 0 0 19.36571 0 0 0 18.35717 0 0 0 0 0 0 0 17.58217 0 0 0 0 0 0 0 0 0 0 P39059 COFA1_HUMAN Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV) ] COL15A1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005582; GO:0005615; GO:0005788; GO:0007155; GO:0007165; GO:0016021; GO:0030020; GO:0030198; GO:0031012; GO:0062023; GO:0070062 EHVGMK 5.900000095 0.575181901 0.575181901 0.271589496 716.2550664 16.6883 0 0 15.19177 0 13.97071 0 0 0 0 0 0 15.2609 0 15.23937 16.99994 0 0 0 0 16.11071 0 17.8227 17.53383 17.38065 17.57635 0 14.85168 0 16.53258 15.35092 15.79238 0 0 16.50559 0 17.3711 15.83704 17.48728 16.68282 0 16.43194 15.87372 0 0 15.6096 16.85218 16.18157 P39060 COIA1_HUMAN "Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1, NC1 ]" COL18A1 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; visual perception [GO:0007601] extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0007601; GO:0008285; GO:0009887; GO:0030198; GO:0031012; GO:0042802; GO:0046872; GO:0062023; GO:0070062 GDPGVGERGPPGPQGPPGPPGPSFR 1.960000038 1 1 1.37E-12 2366.462833 13.76386 13.96818 14.35296 13.02308 12.43392 9.51579 13.46207 12.13718 13.95757 0 12.91554 0 13.05844 10.5538 0 12.85297 14.85028 13.26105 12.84457 13.45651 0 0 0 0 0 0 12.90338 0 0 14.00902 0 0 0 0 16.29263 0 0 0 0 0 0 0 0 0 0 0 0 0 P39687 AN32A_HUMAN "Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32, pp32) (Leucine-rich acidic nuclear protein, LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I, PHAPI)" ANP32A C15orf1 LANP MAPM PHAP1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; nucleocytoplasmic transport [GO:0006913]; regulation of apoptotic process [GO:0042981] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; histone binding [GO:0042393]; RNA binding [GO:0003723]; intracellular signal transduction [GO:0035556]; nucleocytoplasmic transport [GO:0006913]; regulation of apoptotic process [GO:0042981] histone binding [GO:0042393]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006913; GO:0035556; GO:0042393; GO:0042981; GO:0048471 LELSDNR 9.239999771 0.432190657 0.432190657 0.286825354 845.136747 12.7822 16.68593 0 17.58176 0 0 19.73032 0 0 0 0 0 0 0 0 0 0 17.56051 0 0 0 0 0 17.15638 0 17.81487 17.85088 0 0 0 0 0 19.63802 17.61335 16.67837 0 0 0 0 0 0 0 17.58648 0 0 0 18.81672 0 P39748 FEN1_HUMAN "Flap endonuclease 1, FEN-1, EC 3.1.-.- (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1, MF1, hFEN-1)" FEN1 RAD2 Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair, gap-filling [GO:0006287]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]" 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523] GO:0000287; GO:0000724; GO:0000781; GO:0003677; GO:0003684; GO:0003690; GO:0004519; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006281; GO:0006287; GO:0006302; GO:0007613; GO:0008309; GO:0008409; GO:0009650; GO:0016020; GO:0017108; GO:0030145; GO:0032201; GO:0032991; GO:0043137; GO:0045876; GO:0048256; GO:0090305 QLQQAQAAGAEQEVEKFTK 2.00999999 1 1 9.20E-13 2103.919564 14.61167 0 15.31278 0 13.93341 13.69027 14.00632 0 0 0 17.93694 0 0 0 0 0 13.14449 8.138556 16.13827 0 0 0 0 0 0 0 0 0 14.82455 0 0 16.7904 0 0 0 0 0 0 0 16.04643 0 0 9.158997 0 12.91676 0 0 0 P39900 MMP12_HUMAN "Macrophage metalloelastase, MME, EC 3.4.24.65 (Macrophage elastase, ME, hME) (Matrix metalloproteinase-12, MMP-12)" MMP12 HME Homo sapiens (Human) "bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]" cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]" calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0000122; GO:0001046; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1904645; GO:1904905 NFQGIGPK 22.18000031 1 1 0.417937646 861.4382305 0 0 0 18.87777 0 16.90228 0 17.69146 0 0 0 0 0 0 18.04396 0 0 0 18.96446 0 0 0 0 17.45011 0 0 0 19.25212 0 0 0 17.70692 0 0 0 0 0 0 0 0 17.89345 0 0 0 0 0 16.6807 0 P39905 GDNF_HUMAN "Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)" GDNF Homo sapiens (Human) adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676] chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] GO:0001656; GO:0001658; GO:0001755; GO:0001759; GO:0001941; GO:0003337; GO:0005102; GO:0005576; GO:0005615; GO:0005794; GO:0007165; GO:0007399; GO:0007422; GO:0008083; GO:0008284; GO:0008344; GO:0010468; GO:0021516; GO:0021784; GO:0030116; GO:0030432; GO:0030971; GO:0031175; GO:0032770; GO:0033603; GO:0042803; GO:0043066; GO:0043524; GO:0045597; GO:0045944; GO:0048255; GO:0048484; GO:0048485; GO:0048568; GO:0051584; GO:0060676; GO:0060688; GO:0071679; GO:0072107; GO:0072108; GO:0090190; GO:1902379; GO:2000736; GO:2001240; GO:2001260 EELIFR 5.980000019 1 1 0.248153966 806.4396594 0 18.68217 0 0 0 17.60364 0 0 0 0 0 0 0 0 17.27774 0 0 0 0 0 16.89309 0 18.99319 0 0 0 0 0 0 0 0 0 0 0 18.74016 0 0 0 0 0 0 0 16.90273 0 0 0 0 0 P40126 TYRP2_HUMAN "L-dopachrome tautomerase, DCT, DT, EC 5.3.3.12 (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2, TRP-2, TRP2)" DCT TYRP2 Homo sapiens (Human) cell development [GO:0048468]; developmental pigmentation [GO:0048066]; epidermis development [GO:0008544]; melanin biosynthetic process from tyrosine [GO:0006583]; positive regulation of neuroblast proliferation [GO:0002052]; response to blue light [GO:0009637]; ventricular zone neuroblast division [GO:0021847] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; dopachrome isomerase activity [GO:0004167]; oxidoreductase activity [GO:0016491]; cell development [GO:0048468]; developmental pigmentation [GO:0048066]; epidermis development [GO:0008544]; melanin biosynthetic process from tyrosine [GO:0006583]; positive regulation of neuroblast proliferation [GO:0002052]; response to blue light [GO:0009637]; ventricular zone neuroblast division [GO:0021847] copper ion binding [GO:0005507]; dopachrome isomerase activity [GO:0004167]; oxidoreductase activity [GO:0016491] GO:0002052; GO:0004167; GO:0005507; GO:0005829; GO:0005886; GO:0006583; GO:0008544; GO:0009637; GO:0016021; GO:0016491; GO:0021847; GO:0033162; GO:0042470; GO:0043231; GO:0048066; GO:0048468 ILPGAQGQFPR 3.029999971 0.740159988 0.740159988 0.126475898 1183.725997 14.46044 0 15.1141 14.5778 0 14.38694 14.73714 0 0 0 0 0 0 0 0 5.616707 0 0 0 16.65364 15.46918 0 15.49655 15.65984 13.2257 0 12.58537 0 14.65853 0 0 14.60401 13.75525 14.76948 14.51696 9.927031 14.41144 13.45428 16.16864 0 12.80942 14.82702 10.39183 14.84074 14.35864 0 13.67297 14.30447 P40197 GPV_HUMAN "Platelet glycoprotein V, GPV (Glycoprotein 5) (CD antigen CD42d)" GP5 Homo sapiens (Human) "blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" extracellular exosome [GO:0070062]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" GO:0005886; GO:0005887; GO:0007155; GO:0007597; GO:0010572; GO:0035855; GO:0051209; GO:0070062; GO:1990779 MLRGTLLCAVLGLLR 2.470000029 0.444742441 0.444742441 0.10739221 1685.712434 15.85537 0 17.13475 0 0 16.27272 18.15873 0 12.51626 14.26365 0 0 12.73829 17.35601 17.592 0 15.77435 11.63822 0 14.14511 0 14.95839 0 13.02538 14.03956 14.15441 14.35675 16.24057 11.66264 15.78679 11.20309 17.29965 15.90587 17.45548 14.63842 14.15391 17.11105 17.86357 16.37788 12.66536 14.04734 14.42894 15.45504 10.47565 13.48634 14.8777 17.61877 17.38227 P40200 TACT_HUMAN T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96) CD96 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell cytokine production [GO:0002728]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell cytokine production [GO:0002728]; response to lipopolysaccharide [GO:0032496] GO:0002728; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007155; GO:0007160; GO:0032496; GO:0032689 YCAVYYIIQIHFVK 6.679999828 1 1 0.223103882 1816.236428 0 0 0 0 0 0 0 13.89287 8.259936 0 0 0 16.01646 13.95853 14.39601 11.85565 0 14.28571 0 16.03164 16.52544 0 16.28316 0 15.52503 14.2141 16.25867 0 0 0 10.09592 0 13.45282 11.85512 0 0 0 0 14.53695 0 11.85411 15.73244 0 0 12.97298 0 0 13.98984 P40222 TXLNA_HUMAN Alpha-taxilin TXLNA TXLN Homo sapiens (Human) B cell activation [GO:0042113]; exocytosis [GO:0006887] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887] syntaxin binding [GO:0019905] GO:0005576; GO:0005737; GO:0005829; GO:0006887; GO:0016020; GO:0019905; GO:0042113 QQETHLK 6.989999771 0.733694255 0.733694255 0.261425256 885.8929624 13.57946 16.12739 14.63681 0 0 0 0 0 0 15.64335 16.50197 14.10398 0 15.48263 15.57187 0 15.94884 15.94938 0 16.34735 15.92275 0 16.70601 0 15.87711 0 16.77793 12.71028 0 14.87082 16.3128 14.71762 12.03648 17.21234 15.97744 17.14599 15.10353 16.07378 17.26694 12.21836 0 14.25868 14.87602 15.43174 15.13168 13.53093 16.95658 14.32618 P40227 TCPZ_HUMAN "T-complex protein 1 subunit zeta, TCP-1-zeta (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)" CCT6A CCT6 CCTZ Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987] GO:0003723; GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0016887; GO:0032212; GO:0044183; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0071987; GO:1904851; GO:1904871; GO:1904874 TNLGPKGTMK 3.559999943 0.435032576 0.435032576 0.225303682 1061.746643 15.60852 16.53756 16.71461 15.35146 16.48883 15.62342 16.43287 14.46768 0 16.31906 15.89611 15.65906 15.86289 0 14.41218 13.37494 8.657065 16.59475 12.35954 0 0 0 17.26516 0 16.23988 16.14338 17.31905 16.01291 16.23796 16.71605 17.76549 16.96649 0 0 0 16.11316 15.7905 15.77421 15.07191 15.8969 0 16.18885 0 0 16.34903 15.20667 0 0 P40261 NNMT_HUMAN "Nicotinamide N-methyltransferase, EC 2.1.1.1" NNMT Homo sapiens (Human) animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinamide metabolic process [GO:0006769]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein deacetylation [GO:0090312]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone methylation [GO:0031060]; regulation of polyamine biosynthetic process [GO:0010967]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829] cytosol [GO:0005829]; N-methyltransferase activity [GO:0008170]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760]; animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinamide metabolic process [GO:0006769]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein deacetylation [GO:0090312]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone methylation [GO:0031060]; regulation of polyamine biosynthetic process [GO:0010967]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410] N-methyltransferase activity [GO:0008170]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760] GO:0005829; GO:0006769; GO:0008112; GO:0008170; GO:0009410; GO:0010243; GO:0010967; GO:0030760; GO:0031060; GO:0031100; GO:0032259; GO:0034356; GO:0045722; GO:0051569; GO:0090312 GPEKEEK 2.329999924 0.012895986 0.012895986 0.293129403 815.1402217 0 0 0 0 0 0 17.49388 0 0 16.24482 0 0 0 0 16.58021 18.92771 0 0 0 0 15.58942 0 0 0 0 0 0 0 0 0 0 0 16.85048 19.29276 0 0 0 19.11261 0 0 0 19.14519 0 0 0 0 18.30837 18.23711 P40305 IFI27_HUMAN "Interferon alpha-inducible protein 27, mitochondrial, p27 (Interferon alpha-induced 11.5 kDa protein) (Interferon-stimulated gene 12a protein, ISG12(a), ISG12A)" IFI27 Homo sapiens (Human) apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; innate immune response [GO:0045087]; modulation by host of viral genome replication [GO:0044827]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein export from nucleus [GO:0046825]; type I interferon signaling pathway [GO:0060337] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; innate immune response [GO:0045087]; modulation by host of viral genome replication [GO:0044827]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein export from nucleus [GO:0046825]; type I interferon signaling pathway [GO:0060337] identical protein binding [GO:0042802]; lamin binding [GO:0005521]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0000122; GO:0005521; GO:0005635; GO:0005637; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0042802; GO:0043161; GO:0044827; GO:0045087; GO:0046825; GO:0051607; GO:0060337; GO:0061629; GO:0070936; GO:0097190; GO:0097191 MEASALTSSAVTSVAK 12.60999966 1 1 2.98E-12 1567.804607 16.04218 16.16045 15.19956 0 13.17155 15.26841 14.93603 14.86384 0 15.0766 14.15178 12.22171 13.57547 15.17122 15.41633 0 13.34886 0 14.75638 0 0 14.74458 0 0 0 13.53048 0 15.45611 14.4596 15.40026 15.93318 0 0 0 15.12477 0 0 0 0 0 0 0 0 0 0 0 0 0 P40306 PSB10_HUMAN "Proteasome subunit beta type-10, EC 3.4.25.1 (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i)" PSMB10 LMP10 MECL1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; humoral immune response [GO:0006959]; proteasomal protein catabolic process [GO:0010498]; T cell proliferation [GO:0042098] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; threonine-type endopeptidase activity [GO:0004298]; cell morphogenesis [GO:0000902]; humoral immune response [GO:0006959]; proteasomal protein catabolic process [GO:0010498]; T cell proliferation [GO:0042098]" threonine-type endopeptidase activity [GO:0004298] GO:0000502; GO:0000902; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0006959; GO:0010498; GO:0019774; GO:0042098; GO:1990111 LKPALEPR 11.14000034 1 1 0.194278344 922.1040733 0 15.65114 15.4038 0 0 0 0 14.48697 15.32291 0 16.12284 0 15.51746 15.24474 15.52336 14.46018 15.6565 0 0 0 15.71862 0 12.00359 0 16.13958 14.85802 17.0539 13.6617 12.17192 14.85061 15.2436 0 0 14.15825 0 14.75943 0 13.39568 12.28691 0 14.81475 14.28318 13.84099 11.79069 15.04021 14.81857 14.81286 0 P40394 ADH7_HUMAN "All-trans-retinol dehydrogenase [NAD(+)] ADH7, EC 1.1.1.105 (Alcohol dehydrogenase class 4 mu/sigma chain, EC 1.1.1.1) (Alcohol dehydrogenase class IV mu/sigma chain) (Gastric alcohol dehydrogenase) (Omega-hydroxydecanoate dehydrogenase ADH7, EC 1.1.1.66) (Retinol dehydrogenase)" ADH7 Homo sapiens (Human) ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; aldehyde oxidase activity [GO:0004031]; ethanol binding [GO:0035276]; NAD-retinol dehydrogenase activity [GO:0004745]; omega-hydroxydecanoate dehydrogenase activity [GO:0050153]; receptor antagonist activity [GO:0048019]; retinol binding [GO:0019841]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]" "alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; aldehyde oxidase activity [GO:0004031]; ethanol binding [GO:0035276]; NAD-retinol dehydrogenase activity [GO:0004745]; omega-hydroxydecanoate dehydrogenase activity [GO:0050153]; receptor antagonist activity [GO:0048019]; retinol binding [GO:0019841]; zinc ion binding [GO:0008270]" GO:0001523; GO:0004022; GO:0004024; GO:0004031; GO:0004745; GO:0005829; GO:0005886; GO:0006069; GO:0008270; GO:0009617; GO:0010430; GO:0019841; GO:0035276; GO:0042572; GO:0042573; GO:0045471; GO:0048019; GO:0050153 MFAEIQIQDKDR 11.01000023 1 1 0.137327969 1510.569927 14.06023 15.44807 11.76532 0 13.69052 15.64009 13.75569 15.3309 14.19408 0 0 13.0461 0 0 0 15.21229 13.96113 15.06618 0 18.78513 0 19.28446 0 0 0 14.06273 14.38199 16.22409 15.95404 14.05328 15.59924 0 0 0 0 0 14.59056 0 0 14.15717 0 0 0 0 16.34608 0 0 14.28237 P40429 RL13A_HUMAN 60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13) RPL13A Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cytoplasmic translation [GO:0002181]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; cytoplasmic translation [GO:0002181]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0015934; GO:0016020; GO:0017148; GO:0022625; GO:0022626; GO:0071346; GO:0097452; GO:1901194; GO:1990904 CEGINISGNFYR 4.659999847 0.17408675 0.17408675 0.342314204 1426.282743 0 17.23615 18.28396 15.47017 15.60462 12.71182 16.71512 0 13.6853 0 0 0 0 13.2584 0 0 0 0 15.02666 16.48881 0 0 0 0 12.16763 0 16.64468 0 13.37304 14.53586 14.85965 17.77323 14.02909 0 0 15.63278 0 0 16.3076 0 0 0 0 14.27473 0 0 0 0 P40879 S26A3_HUMAN "Chloride anion exchanger (Down-regulated in adenoma, Protein DRA) (Solute carrier family 26 member 3)" SLC26A3 DRA Homo sapiens (Human) anion transport [GO:0006820]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240] anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] GO:0005452; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016020; GO:0016324; GO:0019531; GO:0031526; GO:0048240; GO:0051454; GO:0060081; GO:0071320; GO:0097225 QGLLQVTPK 3.680000067 1 1 0.095238267 984.7320353 0 16.20818 13.88983 0 0 15.15885 0 0 0 0 0 0 0 0 15.22353 12.56332 14.7561 0 0 0 0 0 0 0 0 15.97289 0 15.10958 0 0 14.29527 0 0 0 0 16.59436 0 0 15.72476 14.07712 0 15.57355 0 13.29775 0 12.78586 0 0 P40937 RFC5_HUMAN "Replication factor C subunit 5 (Activator 1 36 kDa subunit, A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit, RF-C 36 kDa subunit, RFC36)" RFC5 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899] GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0032508; GO:1900264 FGPLTPELMVPR 10.89999962 0.744022906 0.744022906 0.096641538 1373.013038 0 0 17.62174 15.13889 16.77954 0 0 0 16.54709 16.58079 0 15.9495 0 0 15.50728 0 0 0 0 0 0 0 16.41169 0 0 0 0 0 0 0 0 16.21291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40939 ECHA_HUMAN "Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase, EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase, EC 4.2.1.17; Long chain 3-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.211 ]" HADHA HADH Homo sapiens (Human) cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877] GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403 HLAILGAGLMGAGIAQVSVDK 13.53999996 1 1 0.153661373 2034.331227 0 0 0 0 15.02372 0 0 0 0 0 0 0 0 0 0 0 0 15.64507 0 13.63337 0 0 16.58872 0 15.09789 0 14.53207 0 0 0 0 0 16.19713 15.67756 0 16.04073 0 16.51701 0 14.60769 17.27371 0 0 0 0 0 0 0 P40967 PMEL_HUMAN "Melanocyte protein PMEL (ME20-M, ME20M) (Melanocyte protein Pmel 17) (Melanocytes lineage-specific antigen GP100) (Melanoma-associated ME20 antigen) (P1) (P100) (Premelanosome protein) (Silver locus protein homolog) [Cleaved into: M-alpha (95 kDa melanocyte-specific secreted glycoprotein) (P26) (Secreted melanoma-associated ME20 antigen, ME20-S, ME20S); M-beta ]" PMEL D12S53E PMEL17 SILV Homo sapiens (Human) melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438] identical protein binding [GO:0042802] GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0032438; GO:0032585; GO:0042438; GO:0042470; GO:0042802 QVPLDCVLYR 16.52000046 1 1 1.83E-12 1262.726229 15.01539 0 14.33815 0 0 0 0 16.30451 16.88182 0 14.30562 0 0 0 0 15.20149 0 0 0 0 0 0 0 0 16.23344 0 13.21649 0 0 0 0 0 0 0 11.59389 13.24671 0 15.21907 16.88374 0 0 0 0 0 13.97772 16.21779 14.46609 0 P41002 CCNF_HUMAN Cyclin-F (F-box only protein 1) CCNF FBX1 FBXO1 Homo sapiens (Human) cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of centrosome duplication [GO:0010826]; placenta development [GO:0001890]; protein ubiquitination [GO:0016567]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005] cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; anaphase-promoting complex binding [GO:0010997]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of centrosome duplication [GO:0010826]; placenta development [GO:0001890]; protein ubiquitination [GO:0016567]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] anaphase-promoting complex binding [GO:0010997]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000079; GO:0000307; GO:0000320; GO:0001890; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010826; GO:0010997; GO:0016538; GO:0016567; GO:0019005; GO:0030054; GO:0031146; GO:0044772; GO:0048471; GO:0051301; GO:0051726 INLCIHSEEEDMNLGLVRL 2.799999952 1 1 0.131034311 2274.555916 12.28208 8.917396 13.17071 9.153482 14.87333 13.63015 0 0 0 0 0 0 14.09449 0 0 0 15.14626 16.47614 12.65143 0 0 0 0 0 0 12.0212 0 0 11.3891 14.10146 0 0 0 14.81688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41182 BCL6_HUMAN "B-cell lymphoma 6 protein, BCL-6 (B-cell lymphoma 5 protein, BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51)" BCL6 BCL5 LAZ3 ZBTB27 ZNF51 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]" Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382] "Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]" "chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]" GO:0000122; GO:0000902; GO:0000978; GO:0001161; GO:0001222; GO:0001227; GO:0001817; GO:0001953; GO:0002467; GO:0002634; GO:0002682; GO:0002903; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006357; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0031065; GO:0031490; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0042382; GO:0042802; GO:0043065; GO:0043087; GO:0043380; GO:0043565; GO:0045591; GO:0045595; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0050776; GO:0051272; GO:0140297; GO:1903464; GO:1990837; GO:2000773 AYTAPPACQPPMEPENLDLQSPTK 3.599999905 1 1 0.325879595 2655.10188 0 0 0 0 0 0 0 0 16.35949 0 16.46231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.65412 0 18.56643 18.6596 0 17.71205 0 0 0 19.33681 0 17.75858 0 17.53621 0 0 0 0 0 0 0 0 0 P41220 RGS2_HUMAN "Regulator of G-protein signaling 2, RGS2 (Cell growth-inhibiting gene 31 protein) (G0/G1 switch regulatory protein 8)" RGS2 G0S8 GIG31 Homo sapiens (Human) brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283] adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GO:0001965; GO:0001975; GO:0003924; GO:0005096; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0007049; GO:0007186; GO:0007283; GO:0007420; GO:0008277; GO:0009898; GO:0010519; GO:0010614; GO:0010855; GO:0010976; GO:0017148; GO:0030728; GO:0043005; GO:0043407; GO:0045471; GO:0045744; GO:0048487; GO:0050873; GO:0055119; GO:0060087; GO:0060135; GO:0060452; GO:0061052; GO:0140194; GO:1900924 SAGSGHK 1.649999976 1 1 0.051792043 642.4623318 15.80597 0 0 0 0 0 0 0 16.20962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47868 0 0 16.07696 0 0 15.44717 15.77576 0 15.95546 17.11504 0 18.33155 16.74666 16.68013 17.92086 16.05849 17.36955 16.72406 0 0 15.33134 0 0 P41221 WNT5A_HUMAN Protein Wnt-5a WNT5A Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115] GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003283; GO:0003323; GO:0003402; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006468; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0033138; GO:0034613; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043507; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090082; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0150012; GO:1900020; GO:1901216; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052 ETAFTYAVSAAGVVNAMSR 3.269999981 1 1 0.322299525 1944.365012 0 0 14.36478 0 16.16375 12.42273 0 16.00208 13.03943 15.04213 0 0 0 0 0 0 0 0 16.34543 0 0 0 12.75397 0 15.00962 0 0 13.98309 0 0 0 16.46864 0 0 0 0 0 0 0 12.90329 10.82842 0 0 13.31606 10.98093 0 0 0 P41225 SOX3_HUMAN Transcription factor SOX-3 SOX3 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0005654; GO:0006355; GO:0007417; GO:0007423; GO:0007530; GO:0009653; GO:0021854; GO:0021983; GO:0030154; GO:0045665; GO:0045944; GO:0060324; GO:1990837 KMALENPK 2.839999914 0.801410735 0.801410735 0.272108632 945.0907006 0 17.752 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32054 0 0 0 0 0 0 18.73675 0 0 0 0 0 0 0 0 0 0 0 17.91622 0 0 0 0 0 0 0 0 0 0 0 0 0 P41226 UBA7_HUMAN "Ubiquitin-like modifier-activating enzyme 7, Ubiquitin-activating enzyme 7 (D8) (Ubiquitin-activating enzyme E1 homolog)" UBA7 UBE1L UBE2 Homo sapiens (Human) cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein modification by small protein conjugation [GO:0032446] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein modification by small protein conjugation [GO:0032446] ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446 AEVAAAAAR 12.59000015 1 1 0.585272981 830.3154954 0 17.78492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.36632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.11123 0 0 0 0 0 0 0 P41229 KDM5C_HUMAN "Lysine-specific demethylase 5C, EC 1.14.11.67 (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)" KDM5C DXS1272E JARID1C SMCX XE169 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]" DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0008270; GO:0009636; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0045892; GO:0048511 EELGGDVK 1.149999976 0.925545633 0.925545633 0.227000847 845.7917112 16.45136 14.11662 0 0 15.46727 13.07177 0 0 14.46719 16.29424 12.73263 0 0 11.71419 14.14129 0 0 0 0 0 0 0 16.0414 15.83236 0 0 0 0 15.4647 0 15.35303 0 0 15.92439 0 0 15.06633 0 0 0 0 0 0 0 0 0 0 0 P41235 HNF4A_HUMAN "Hepatocyte nuclear factor 4-alpha, HNF-4-alpha (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14, TCF-14) (Transcription factor HNF-4)" HNF4A HNF4 NR2A1 TCF14 Homo sapiens (Human) "anatomical structure development [GO:0048856]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; ornithine metabolic process [GO:0006591]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of gastrulation [GO:0010470]; regulation of growth hormone receptor signaling pathway [GO:0060398]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; sex differentiation [GO:0007548]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; triglyceride homeostasis [GO:0070328]; type B pancreatic cell development [GO:0003323]; xenobiotic metabolic process [GO:0006805]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; fatty acid binding [GO:0005504]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; ornithine metabolic process [GO:0006591]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of gastrulation [GO:0010470]; regulation of growth hormone receptor signaling pathway [GO:0060398]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; sex differentiation [GO:0007548]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; triglyceride homeostasis [GO:0070328]; type B pancreatic cell development [GO:0003323]; xenobiotic metabolic process [GO:0006805]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; fatty acid binding [GO:0005504]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003323; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005504; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006591; GO:0006629; GO:0006805; GO:0007548; GO:0007596; GO:0008270; GO:0008285; GO:0009749; GO:0010470; GO:0019216; GO:0023019; GO:0030154; GO:0030308; GO:0042593; GO:0042632; GO:0042752; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048856; GO:0050796; GO:0055088; GO:0055091; GO:0060395; GO:0060398; GO:0061629; GO:0070328; GO:0070365; GO:1990837 GLSDPGK 4.579999924 1 1 0.189289101 673.8683866 0 0 0 18.76492 0 0 0 0 0 0 20.72919 0 0 0 17.56078 0 0 0 0 0 0 0 0 0 0 0 19.76257 20.75463 0 18.14199 0 0 0 0 0 0 0 21.79123 0 0 0 0 0 0 0 0 0 0 P41240 CSK_HUMAN "Tyrosine-protein kinase CSK, EC 2.7.10.2 (C-Src kinase) (Protein-tyrosine kinase CYL)" CSK Homo sapiens (Human) adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0002250; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375 DVVPR 5.929999828 1 1 0.245244261 586.2417895 19.3192 20.05147 17.40082 18.38002 15.80417 16.50706 0 18.44284 18.43357 17.57188 18.84932 0 17.81716 0 0 0 17.94732 17.24786 17.28772 16.33865 0 17.01897 16.62882 0 17.35443 17.70781 0 0 0 0 0 0 0 17.61031 0 0 0 19.50239 18.12068 0 17.1686 0 17.77876 17.61815 0 0 17.97673 17.83817 P41250 GARS_HUMAN "Glycine--tRNA ligase, EC 6.1.1.14 (Diadenosine tetraphosphate synthetase, Ap4A synthetase, EC 2.7.7.-) (Glycyl-tRNA synthetase, GlyRS) (Glycyl-tRNA synthetase 1)" GARS1 GARS Homo sapiens (Human) diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418] ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740] GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150 SSMDGAGAEEVLAPLR 8.899999619 1 1 0.433454516 1618.453369 18.13333 16.31779 18.42829 18.6523 18.07343 18.25989 0 0 18.23044 19.98959 18.52441 0 0 0 0 18.76666 18.38591 0 0 0 0 0 0 0 17.8123 17.16165 0 0 0 0 19.69491 18.36099 19.77109 0 0 17.25898 18.82991 0 20.46226 18.58054 18.98746 0 0 0 0 0 0 18.37161 P41252 SYIC_HUMAN "Isoleucine--tRNA ligase, cytoplasmic, EC 6.1.1.5 (Isoleucyl-tRNA synthetase, IRS, IleRS)" IARS1 IARS Homo sapiens (Human) isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062 GDNRLDLLK 9.300000191 1 1 0.283579155 1042.413695 0 17.17486 0 17.64126 17.68721 0 0 0 0 0 0 0 0 17.44943 0 0 0 0 0 0 16.77466 0 0 15.24101 0 0 0 0 0 16.85706 0 19.19724 0 17.95005 0 0 17.15683 0 0 16.72031 0 15.03757 0 0 0 0 0 0 P41271 NBL1_HUMAN Neuroblastoma suppressor of tumorigenicity 1 (DAN domain family member 1) (Protein N03) (Zinc finger protein DAN) NBL1 DAN DAND1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582] extracellular space [GO:0005615] extracellular space [GO:0005615]; BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582] BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018] GO:0005615; GO:0007399; GO:0009887; GO:0016015; GO:0030514; GO:0035582; GO:0036122; GO:0038098; GO:0042802; GO:0045666; GO:0048018; GO:0048263; GO:0048812; GO:0090027 SAWCEAKNITQIVGHSGCEAK 2.960000038 0.634345174 0.634345174 1.83E-12 2344.906038 0 14.29169 0 14.71239 0 0 0 0 0 11.08725 12.19804 0 14.41526 0 12.96529 0 0 0 0 0 14.10785 0 0 0 0 0 0 0 14.3721 14.62681 0 12.48739 0 0 9.968405 0 0 15.85833 0 0 0 0 0 0 0 0 0 13.36421 P41439 FOLR3_HUMAN "Folate receptor gamma, FR-gamma (Folate receptor 3)" FOLR3 Homo sapiens (Human) cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; folic acid binding [GO:0005542]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] folic acid binding [GO:0005542]; signaling receptor activity [GO:0038023] GO:0005542; GO:0005576; GO:0007155; GO:0007342; GO:0015884; GO:0016020; GO:0019898; GO:0031362; GO:0035036; GO:0035580; GO:0038023; GO:1904724 CIQMWFDSAQGNPNEEVAKFYAAAMNAGAPSR 1.840000033 1 1 5.95E-12 3548.497503 14.45915 12.18768 0 13.31811 11.65049 0 7.999961 0 6.540313 14.0611 15.50743 0 14.58053 10.35672 0 0 0 0 0 0 0 12.39611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41586 PACR_HUMAN "Pituitary adenylate cyclase-activating polypeptide type I receptor, PACAP type I receptor, PACAP-R-1, PACAP-R1" ADCYAP1R1 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283] adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999] GO:0004999; GO:0005768; GO:0005791; GO:0005886; GO:0005887; GO:0005901; GO:0005923; GO:0007166; GO:0007188; GO:0007202; GO:0007283; GO:0008179; GO:0008528; GO:0009410; GO:0009986; GO:0010524; GO:0017046; GO:0019933; GO:0030154; GO:0031267; GO:0032355; GO:0033555; GO:0038023; GO:0042923; GO:0043005; GO:0043231; GO:0043235; GO:0043950; GO:0045471; GO:0046545; GO:0051057; GO:0060548; GO:0060732 EQAMCLEK 2.430000067 1 1 0.226614187 1024.601429 0 0 0 0 0 17.29879 17.04424 0 0 0 16.63216 0 0 14.75195 0 0 0 0 0 0 0 0 0 0 0 16.49015 16.13088 0 0 0 0 17.8206 0 0 0 0 17.37362 17.2694 17.91673 0 0 0 0 0 0 0 0 0 P41587 VIPR2_HUMAN "Vasoactive intestinal polypeptide receptor 2, VIP-R-2 (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor, PACAP type III receptor, PACAP-R-3, PACAP-R3) (VPAC2)" VIPR2 VIP2R Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] GO:0004930; GO:0004999; GO:0005886; GO:0005887; GO:0007165; GO:0007166; GO:0007188; GO:0007190; GO:0007267; GO:0008528; GO:0017046; GO:0048662 SRCPTPSASR 9.800000191 0.023275699 0.023275699 0.112840038 1119.515108 0 18.34216 14.76836 15.59381 0 13.05548 14.36716 0 0 16.52712 13.55085 15.53094 14.62993 14.08931 0 0 0 16.30324 0 0 0 0 0 0 13.23492 0 14.48257 0 10.12903 12.84514 16.22 18.376 0 17.27035 11.49804 15.73283 16.61841 17.71398 16.35037 0 16.67422 0 17.45767 12.74791 15.09314 12.93749 16.26212 14.86314 P41594 GRM5_HUMAN "Metabotropic glutamate receptor 5, mGluR5" GRM5 GPRC1E MGLUR5 Homo sapiens (Human) "calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]" astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] "astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]" A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] GO:0001640; GO:0001932; GO:0002029; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006417; GO:0006448; GO:0006468; GO:0007205; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0030296; GO:0031687; GO:0035584; GO:0040013; GO:0042802; GO:0043197; GO:0043198; GO:0043410; GO:0048170; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0090647; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099170; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782 VVPSDAQQARAMVDIVK 9.75 0.279409349 0.279409349 0.312598123 1825.898807 11.80555 16.75723 0 0 0 0 0 15.38362 0 0 0 0 17.68538 0 0 0 0 0 0 0 15.79302 0 15.57138 0 0 0 0 0 14.18191 0 0 14.22601 17.67824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41732 TSN7_HUMAN "Tetraspanin-7, Tspan-7 (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1, TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231)" TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887] GO:0005887 SRAVDHVQR 4.150000095 1 1 0.181367489 1068.306513 12.81413 15.60257 0 10.36313 13.67472 0 12.79941 0 0 0 15.90653 15.64233 0 0 0 11.47787 0 0 0 0 14.95618 0 0 0 0 0 0 0 0 14.43261 0 15.99889 15.46644 13.6353 16.0836 16.23931 16.32257 16.20676 0 0 0 0 0 0 0 14.71469 13.93228 0 P42025 ACTY_HUMAN "Beta-centractin (Actin-related protein 1B, ARP1B)" ACTR1B CTRN2 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524] ATP binding [GO:0005524] GO:0005524; GO:0005576; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0015630; GO:0016020; GO:0034774; GO:0070062; GO:1904813 VDIAGRDVSR 2.380000114 1 1 0.021744985 1086.023643 12.03901 15.79753 16.61615 13.50919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42126 ECI1_HUMAN "Enoyl-CoA delta isomerase 1, mitochondrial, EC 5.3.3.8 (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase, D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)" ECI1 DCI Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]" "dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]" GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0016863 VLVEPDAGAGVAVMKFK 2.470000029 1 1 0.25539344 1747.049805 0 10.50574 0 0 0 0 14.71523 15.78446 0 0 0 0 14.72687 0 0 0 0 14.36802 0 0 0 0 0 0 0 0 0 0 0 0 0 12.78662 0 0 0 0 0 0 0 0 15.58528 0 0 0 0 0 0 0 P42261 GRIA1_HUMAN "Glutamate receptor 1, GluR-1 (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1, GluA1)" GRIA1 GLUH1 GLUR1 Homo sapiens (Human) cellular response to ammonium ion [GO:0071242]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] AMPA glutamate receptor complex [GO:0032281]; axonal spine [GO:0044308]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672] AMPA glutamate receptor complex [GO:0032281]; axonal spine [GO:0044308]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to ammonium ion [GO:0071242]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0001540; GO:0004971; GO:0005789; GO:0005886; GO:0007165; GO:0007268; GO:0007616; GO:0008066; GO:0009986; GO:0012507; GO:0014069; GO:0015276; GO:0030165; GO:0030425; GO:0030666; GO:0030672; GO:0031623; GO:0031901; GO:0032281; GO:0032591; GO:0033116; GO:0038023; GO:0043025; GO:0043197; GO:0044308; GO:0044309; GO:0055037; GO:0055038; GO:0060076; GO:0060292; GO:0071242; GO:0097060; GO:0098793; GO:0098978; GO:0099061; GO:0099544; GO:0099583; GO:1904315 MVSPIESAEDLAKQTEIAYGTLEAGSTK 6.519999981 1 1 0.16682988 2940.544673 0 0 0 0 0 19.42353 0 0 0 0 0 0 13.82615 14.98576 17.06543 0 0 0 0 0 0 0 10.0504 0 0 0 0 0 0 14.56272 0 0 18.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42262 GRIA2_HUMAN "Glutamate receptor 2, GluR-2 (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2, GluA2)" GRIA2 GLUR2 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]" AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843] "AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]" AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023] GO:0001540; GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0009897; GO:0014069; GO:0015276; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0038023; GO:0043025; GO:0043197; GO:0060076; GO:0098794; GO:0098839; GO:0098843 IGYWSEVDK 2.700000048 1 1 0.142578112 1096.196592 14.23509 0 15.53155 0 14.36941 13.34315 0 0 0 15.00793 0 0 0 16.56765 14.57847 0 0 0 15.278 12.87627 15.67152 0 0 0 0 0 0 14.53686 0 0 0 0 0 0 0 0 0 0 0 0 14.11361 0 0 0 12.33657 0 0 0 P42285 MTREX_HUMAN "Exosome RNA helicase MTR4, EC 3.6.4.13 (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)" MTREX DOB1 KIAA0052 MTR4 SKIV2L2 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0006974; GO:0016076; GO:0016607; GO:0016887; GO:0031499; GO:0071013 DIVFAASLYL 5.699999809 1 1 0.38667306 1108.460264 15.53765 12.15261 13.12836 0 0 0 14.56984 14.61853 14.78982 14.35162 0 13.87651 0 0 0 0 0 0 0 15.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.97824 0 0 16.00549 0 0 0 0 0 0 0 0 0 P42336 PK3CA_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha, PtdIns-3-kinase subunit p110-alpha, p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA, EC 2.7.11.1)" PIK3CA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]" "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]" GO:0001525; GO:0001889; GO:0001944; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0007173; GO:0010592; GO:0010629; GO:0014065; GO:0014704; GO:0014823; GO:0014870; GO:0016020; GO:0016242; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030027; GO:0030036; GO:0030168; GO:0030295; GO:0030835; GO:0031295; GO:0032008; GO:0033138; GO:0035004; GO:0035005; GO:0035994; GO:0036092; GO:0038028; GO:0038084; GO:0040014; GO:0043201; GO:0043276; GO:0043457; GO:0043491; GO:0043524; GO:0043542; GO:0043560; GO:0044029; GO:0046854; GO:0046934; GO:0048015; GO:0048471; GO:0048661; GO:0050852; GO:0051897; GO:0052742; GO:0052812; GO:0055119; GO:0060048; GO:0060612; GO:0071333; GO:0071464; GO:0071548; GO:0086003; GO:0097009; GO:0106310; GO:0110053; GO:1903544; GO:2000270; GO:2000653; GO:2000811 DPEVQDFR 4.949999809 1 1 5.80E-13 1005.723772 0 12.66482 14.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9196 16.18713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.76347 0 P42338 PK3CB_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform, PI3-kinase subunit beta, PI3K-beta, PI3Kbeta, PtdIns-3-kinase subunit beta, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta, PtdIns-3-kinase subunit p110-beta, p110beta) (Serine/threonine protein kinase PIK3CB, EC 2.7.11.1)" PIK3CB PIK3C1 Homo sapiens (Human) angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; chemotaxis [GO:0006935]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of autophagy [GO:0010508]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; regulation of clathrin-dependent endocytosis [GO:2000369]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; chemotaxis [GO:0006935]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of autophagy [GO:0010508]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; regulation of clathrin-dependent endocytosis [GO:2000369]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0006935; GO:0007156; GO:0007165; GO:0007169; GO:0007186; GO:0010508; GO:0010595; GO:0010628; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030168; GO:0030496; GO:0033031; GO:0035004; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0043231; GO:0043407; GO:0043560; GO:0046854; GO:0046934; GO:0048015; GO:0051000; GO:0051897; GO:0051898; GO:0052742; GO:0052812; GO:0060055; GO:0070527; GO:1900747; GO:1903298; GO:1903671; GO:2000369 TGNTEKFGR 8.550000191 2.35E-06 2.35E-06 0.087466249 1010.613871 11.03196 14.32707 16.24487 16.08631 15.66042 12.6563 15.61143 18.7085 14.31269 13.62231 12.6855 15.59262 14.90373 15.61681 0 11.89482 0 0 16.4268 0 15.8796 16.29169 15.78632 14.04781 0 15.55656 15.69624 15.94969 0 16.13458 14.87419 18.00076 17.1911 16.54398 15.79334 14.64404 0 17.0675 0 15.89594 16.11657 18.97243 13.26267 0 16.20131 15.20512 11.95197 11.77896 P42345 MTOR_HUMAN "Serine/threonine-protein kinase mTOR, EC 2.7.11.1 (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin, mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)" MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 Homo sapiens (Human) "'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; lysosome organization [GO:0007040]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; neuronal action potential [GO:0019228]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; voluntary musculoskeletal movement [GO:0050882]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; lysosome organization [GO:0007040]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; neuronal action potential [GO:0019228]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; voluntary musculoskeletal movement [GO:0050882]" ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156] GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0006112; GO:0006207; GO:0006468; GO:0006954; GO:0006974; GO:0007010; GO:0007040; GO:0007281; GO:0007584; GO:0008361; GO:0009267; GO:0009408; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019228; GO:0030163; GO:0030307; GO:0030425; GO:0030838; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035264; GO:0038202; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043087; GO:0043200; GO:0043276; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0046777; GO:0046889; GO:0048266; GO:0048511; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051896; GO:0055013; GO:0060048; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0106310; GO:1900034; GO:1901796; GO:1901838; GO:1903691; GO:1904059; GO:1904690; GO:1905857; GO:1990253 AALETVDR 2.549999952 1 1 0.213473571 874.6899108 0 0 16.71886 0 0 0 16.76404 22.96552 0 0 0 0 0 0 0 0 0 0 0 0 17.13008 0 0 0 0 0 0 0 0 17.00745 0 0 0 0 0 0 0 0 0 0 19.80456 0 0 19.15491 0 0 0 18.96212 P42574 CASP3_HUMAN "Caspase-3, CASP-3, EC 3.4.22.56 (Apopain) (Cysteine protease CPP32, CPP-32) (Protein Yama) (SREBP cleavage activity 1, SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12 ]" CASP3 CPP32 Homo sapiens (Human) anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet formation [GO:0030220]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060] caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet formation [GO:0030220]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060] aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877] GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008303; GO:0008627; GO:0009410; GO:0009411; GO:0009749; GO:0010165; GO:0016005; GO:0016241; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030220; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0034612; GO:0035094; GO:0042060; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043200; GO:0043525; GO:0044877; GO:0045121; GO:0045165; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0071887; GO:0072734; GO:0097153; GO:0097190; GO:0097193; GO:0097194; GO:0097199; GO:0097200; GO:1902004; GO:1902512 EEIVELMR 2.75 1 1 0.223756591 1017.992461 15.18693 0 0 0 0 0 0 0 0 15.48726 13.07239 0 14.35724 0 14.18756 0 15.27236 13.76595 0 0 14.84534 0 0 0 0 0 0 13.71663 0 0 0 13.84822 0 14.52683 15.01989 0 0 0 0 13.50624 14.99056 0 13.95841 14.5123 0 14.01035 15.23032 0 P42658 DPP6_HUMAN "Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI, DPP VI)" DPP6 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379] potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236] GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016021; GO:0072659; GO:1901379 KIESLR 4.329999924 1 1 0.153528389 747.6852912 0 17.25364 0 15.68516 6.498616 0 0 15.46903 14.51994 0 0 0 0 0 0 14.07198 0 0 0 0 15.60895 15.77499 15.99511 0 15.60227 15.52976 0 0 13.7732 0 16.8515 15.90177 0 15.5188 0 13.31997 0 16.48685 0 15.08231 16.34909 15.84084 0 14.29096 0 0 0 0 P42680 TEC_HUMAN "Tyrosine-protein kinase Tec, EC 2.7.10.2" TEC PSCTK4 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0002250; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005543; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007229; GO:0010543; GO:0018108; GO:0035556; GO:0038083; GO:0042246; GO:0046872; GO:0050731; GO:0050852; GO:0050853 VSDFGMAR 15.26000023 1 1 0.15399454 882.4385126 15.39425 0 15.78432 0 0 13.93718 10.15197 0 0 14.55714 14.00034 0 14.51983 14.21214 0 0 0 0 14.70878 0 0 0 14.58654 0 0 0 14.8378 15.76447 16.64649 16.46298 0 0 0 0 16.15672 0 0 0 0 0 0 0 0 0 0 0 0 0 P42684 ABL2_HUMAN "Tyrosine-protein kinase ABL2, EC 2.7.10.2 (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG)" ABL2 ABLL ARG Homo sapiens (Human) cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165] actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0000287; GO:0001784; GO:0003785; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0006464; GO:0007155; GO:0007165; GO:0007204; GO:0010506; GO:0010863; GO:0010976; GO:0015629; GO:0018108; GO:0030100; GO:0030145; GO:0030155; GO:0035024; GO:0035640; GO:0051015; GO:0051353; GO:0071300; GO:2000145; GO:2000249 GATALPLRTPSGDLAITEK 11.07999992 1 1 0.313586236 1910.835077 21.2481 0 21.08735 21.03334 19.46405 19.58027 20.77288 21.66411 19.96332 0 20.62064 20.42925 20.84188 21.47982 21.60142 21.63276 21.17495 0 21.51244 19.75976 19.79983 21.33901 21.46425 20.61762 20.77693 21.27645 21.33505 20.7954 18.78081 21.51509 21.12703 21.17278 20.08316 20.48926 21.87405 0 21.84428 21.58953 21.72039 21.84752 20.35537 20.39256 21.51244 0 21.44255 0 0 0 P42685 FRK_HUMAN "Tyrosine-protein kinase FRK, EC 2.7.10.2 (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5)" FRK PTK5 RAK Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular anatomical structure [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular anatomical structure [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] GO:0000122; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005576; GO:0005622; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0007169; GO:0008285; GO:0030154; GO:0031234; GO:0035578; GO:0035580; GO:0045087; GO:0070062 WTAPEAIR 1.24000001 1 1 0.195659104 943.492953 0 0 0 0 0 0 0 0 0 0 17.34411 0 0 0 0 16.97763 0 0 17.49559 0 0 0 0 0 0 0 0 0 0 0 17.51922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42694 HELZ_HUMAN "Probable helicase with zinc finger domain, EC 3.6.4.- (Down-regulated in human cancers protein)" HELZ DRHC KIAA0054 Homo sapiens (Human) post-transcriptional gene silencing by RNA [GO:0035194] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194] ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0016787; GO:0035194; GO:0043186; GO:0046872 LMASGKQPAHK 3.680000067 1 1 0.248738018 1161.836228 0 0 0 0 0 0 15.41907 0 16.04386 0 0 0 0 14.757 0 13.83097 0 14.97912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.11249 15.11219 0 14.40145 0 0 0 0 0 0 0 0 0 0 0 13.3741 P42695 CNDD3_HUMAN "Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3, hCAP-D3)" NCAPD3 CAPD3 KIAA0056 Homo sapiens (Human) cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076] "condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]" "condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]" histone binding [GO:0042393]; methylated histone binding [GO:0035064] GO:0000779; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0035064; GO:0042393; GO:0051301 APLAVTSQVINCR 5.559999943 1 1 0.007865006 1427.930807 15.57907 0 15.45807 0 0 0 13.92581 12.72201 0 0 0 0 15.75887 14.20867 0 0 0 0 0 15.27479 13.93398 0 0 0 0 13.29193 0 13.37381 15.42176 0 0 0 0 0 0 0 0 0 0 14.76715 16.22727 14.74144 14.17704 14.27195 14.14371 0 0 0 P42701 I12R1_HUMAN "Interleukin-12 receptor subunit beta-1, IL-12 receptor subunit beta-1, IL-12R subunit beta-1, IL-12R-beta-1, IL-12RB1 (IL-12 receptor beta component) (CD antigen CD212)" IL12RB1 IL12R IL12RB Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; signal transduction [GO:0007165] cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896] GO:0001916; GO:0002230; GO:0002827; GO:0004896; GO:0005886; GO:0006955; GO:0007165; GO:0009897; GO:0019221; GO:0019955; GO:0032729; GO:0032740; GO:0032819; GO:0035722; GO:0038155; GO:0042022; GO:0042102; GO:0042104; GO:0043235; GO:0043382; GO:0046427; GO:0051142; GO:0071346; GO:0072536; GO:2000318; GO:2000330 QLGSQGSSWSK 6.380000114 1 1 0.015037682 1164.748105 16.04421 13.92605 15.84513 15.34903 11.61848 0 14.37181 0 15.58358 16.69414 15.79637 0 14.84508 0 16.4563 0 13.52399 0 0 15.15461 16.37616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3064 0 0 0 0 0 0 0 0 P42702 LIFR_HUMAN "Leukemia inhibitory factor receptor, LIF receptor, LIF-R (CD antigen CD118)" LIFR Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]; cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097] ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923] GO:0004896; GO:0004923; GO:0005127; GO:0005886; GO:0005887; GO:0007166; GO:0008284; GO:0009897; GO:0019221; GO:0019838; GO:0019955; GO:0034097; GO:0038165; GO:0043235; GO:0048861; GO:0070062; GO:0070120 NISWIPDSQTKVFPQDK 6.380000114 1 1 0.210343413 2003.911008 0 0 16.00695 12.65003 0 15.21079 12.79291 14.45121 0 0 0 0 0 0 0 14.14195 16.04923 14.40215 0 15.77649 0 0 15.18218 16.58302 15.49815 0 12.25381 11.89864 0 0 0 0 16.21822 15.74828 15.20606 0 14.20408 0 0 15.4018 0 0 0 0 0 0 15.63667 0 P42704 LPPRC_HUMAN "Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein, LRP 130) (GP130)" LRPPRC LRP130 Homo sapiens (Human) mitochondrion transport along microtubule [GO:0047497]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129] condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904] condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; mitochondrion transport along microtubule [GO:0047497]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129] beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] GO:0000794; GO:0000961; GO:0003697; GO:0003723; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005739; GO:0005856; GO:0005874; GO:0008017; GO:0016020; GO:0031625; GO:0042645; GO:0047497; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904 GAYDIFLNAK 6.940000057 0.645694554 0.645694554 0.201062382 1111.480467 14.15459 15.9709 15.41459 14.69745 13.36039 0 12.90543 14.34997 14.90378 0 12.76637 0 16.53008 0 0 0 0 5.915354 14.49453 16.51583 0 15.43243 15.34634 15.4301 0 15.34787 15.54173 0 14.355 0 15.86436 0 0 0 0 0 15.93457 0 0 0 0 0 0 17.04803 0 15.33491 0 0 P42765 THIM_HUMAN "3-ketoacyl-CoA thiolase, mitochondrial, EC 2.3.1.16 (Acetyl-CoA acetyltransferase, EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial, EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)" ACAA2 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723] GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109 VGIPK 6.079999924 0.506393015 0.506393015 0.056552476 513.4267575 9.250315 16.2043 17.1988 16.80984 13.19148 15.64567 0 0 17.28569 18.18407 11.4019 0 16.93309 17.42027 7.67266 15.18308 0 14.32797 17.35661 18.45402 0 9.794936 0 11.48801 17.56468 18.10063 13.57873 15.05467 16.26103 0 16.35156 0 0 15.66048 0 0 17.20048 17.09265 17.10382 0 16.67795 15.70805 14.06987 0 15.99963 17.0708 16.27043 15.34841 P42766 RL35_HUMAN 60S ribosomal protein L35 (Large ribosomal subunit protein uL29) RPL35 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]" mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0000463; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626 VTGGAASKLSK 8.930000305 1 1 0.2349972 1018.768586 12.41575 16.34691 13.9696 0 0 15.38698 16.31401 15.33895 14.08974 13.7976 0 14.22919 15.30224 0 14.61579 0 14.42354 15.22203 14.73921 14.95257 15.07079 0 0 17.71084 15.12121 0 0 14.87961 14.91681 0 15.20346 15.41011 14.74408 0 0 15.39605 0 14.10894 15.01 0 0 0 13.58955 13.16948 0 15.3164 15.31426 0 P42771 CDN2A_HUMAN "Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A, CDK4I) (Multiple tumor suppressor 1, MTS-1) (p16-INK4a, p16-INK4, p16INK4A)" CDKN2A CDKN2 MTS1 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; replicative senescence [GO:0090399]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; replicative senescence [GO:0090399]" cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] GO:0001953; GO:0003723; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007265; GO:0008285; GO:0019901; GO:0030308; GO:0032088; GO:0034393; GO:0035985; GO:0042326; GO:0045736; GO:0045892; GO:0051059; GO:0051726; GO:0090398; GO:0090399; GO:2000045; GO:2000111 EPAAGSSMEPSADWLATAAAR 2.299999952 1 1 0.27196914 2089.791519 14.97787 13.4907 13.77808 0 0 14.19136 0 0 15.71372 0 0 0 14.65361 0 0 0 0 14.44559 13.35706 0 0 16.54818 0 0 14.92363 0 15.17225 0 12.77132 0 0 14.5192 15.80641 16.25387 15.97338 0 0 0 0 0 0 0 0 0 0 0 0 0 P42785 PCP_HUMAN "Lysosomal Pro-X carboxypeptidase, EC 3.4.16.2 (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase, PRCP)" PRCP PCP Homo sapiens (Human) angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155] azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]; angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155] dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185] GO:0002155; GO:0002353; GO:0003085; GO:0004185; GO:0005886; GO:0006508; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377 DITDTLVAVTISEGAHHLDLRTK 2.49000001 1 1 0.109078861 2504.15803 15.41086 0 0 14.66198 15.97925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42858 HD_HUMAN "Huntingtin (Huntington disease protein, HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment ]" HTT HD IT15 Homo sapiens (Human) "apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]" autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991] "autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]" beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325] GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099523; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237 FGGFLR 8.970000267 0.860495508 0.860495508 0.111871852 693.6380089 12.13352 0 11.11048 0 16.70671 17.17319 17.84189 9.900942 17.49606 0 8.761048 12.03685 17.13111 16.59098 12.27157 12.78298 13.53298 16.88111 17.50073 12.85898 14.61978 16.34764 9.733035 17.0568 15.83153 16.43325 16.77448 14.00683 0 12.79663 15.44713 16.1063 16.0007 10.16494 12.79205 6.848244 15.28776 12.9702 16.43867 16.18041 0 16.06297 0 14.59603 16.17606 16.10435 16.60619 0 P42892 ECE1_HUMAN "Endothelin-converting enzyme 1, ECE-1, EC 3.4.24.71" ECE1 Homo sapiens (Human) axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492] early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492] endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007186; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0070062; GO:0097492; GO:1902287 EFSEHFR 11.21000004 1 1 0.32217205 951.3274584 14.84884 0 15.31983 0 15.0738 14.88497 16.60731 0 14.59257 16.96348 15.97856 16.13615 16.02689 0 16.5056 14.77812 16.68155 0 0 17.33 0 0 15.28955 16.16098 14.19509 14.49764 15.01824 0 16.07723 15.84612 14.86214 15.9276 15.64704 13.87096 0 0 14.24286 14.35835 0 0 14.8702 15.25605 0 0 16.46827 17.07418 0 15.07157 P42898 MTHR_HUMAN "Methylenetetrahydrofolate reductase, EC 1.5.1.20" MTHFR Homo sapiens (Human) heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999] cytosol [GO:0005829]; synapse [GO:0045202] cytosol [GO:0005829]; synapse [GO:0045202]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase NADH activity [GO:0106312]; methylenetetrahydrofolate reductase NADPH activity [GO:0106313]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]; heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999] FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase NADH activity [GO:0106312]; methylenetetrahydrofolate reductase NADPH activity [GO:0106313]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877] GO:0001666; GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0009086; GO:0009410; GO:0031060; GO:0033274; GO:0035999; GO:0043200; GO:0044877; GO:0045202; GO:0046500; GO:0050660; GO:0050661; GO:0050667; GO:0051593; GO:0070555; GO:0070828; GO:0071949; GO:0072341; GO:0106312; GO:0106313 DNDAAIR 4.590000153 1 1 0.249297648 775.1043578 16.71505 15.8461 16.92026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.89358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21022 0 0 0 17.16921 0 0 0 0 P43003 EAA1_HUMAN "Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1, GLAST-1) (Solute carrier family 1 member 3)" SLC1A3 EAAT1 GLAST GLAST1 Homo sapiens (Human) auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to cocaine [GO:0071314]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to cocaine [GO:0071314]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104] glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0006836; GO:0006883; GO:0007268; GO:0007605; GO:0009410; GO:0009416; GO:0009449; GO:0009611; GO:0009925; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0016595; GO:0021545; GO:0031223; GO:0031410; GO:0043005; GO:0043025; GO:0045202; GO:0046677; GO:0046872; GO:0048471; GO:0048667; GO:0050806; GO:0050885; GO:0051938; GO:0070633; GO:0070779; GO:0071314; GO:0071805; GO:0098712; GO:0098796; GO:0140009; GO:0150104; GO:1902476 SNGEEPKMGGR 11.72999954 1 1 9.17E-13 1177.829157 0 16.17439 15.62415 15.70278 0 0 0 0 15.3663 0 0 0 0 0 0 0 0 0 0 0 0 15.28017 0 14.63041 14.56678 0 0 0 14.82101 0 15.63257 0 0 0 0 16.19858 16.15032 17.27498 0 0 0 0 0 0 0 0 0 0 P43004 EAA2_HUMAN Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2) SLC1A2 EAAT2 GLT1 Homo sapiens (Human) adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632] astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; vesicle [GO:0031982] astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632] cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006750; GO:0006811; GO:0006836; GO:0007268; GO:0007632; GO:0009410; GO:0009611; GO:0009986; GO:0010259; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0031982; GO:0033229; GO:0035264; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0046326; GO:0046872; GO:0070207; GO:0070633; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0099056; GO:0150104 MGDQAKLMVDFFNILNEIVMK 1.820000052 1 1 1.84E-12 2489.32684 14.44176 14.4302 0 0 12.75466 11.92717 12.6281 0 11.80233 0 15.19482 0 0 14.71536 11.97549 14.23663 0 11.68163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43026 GDF5_HUMAN "Growth/differentiation factor 5, GDF-5 (Bone morphogenetic protein 14, BMP-14) (Cartilage-derived morphogenetic protein 1, CDMP-1) (Lipopolysaccharide-associated protein 4, LAP-4, LPS-associated protein 4) (Radotermin)" GDF5 BMP14 CDMP1 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802] GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0007179; GO:0007267; GO:0008083; GO:0009612; GO:0010862; GO:0030326; GO:0030509; GO:0030513; GO:0032331; GO:0032332; GO:0035136; GO:0035137; GO:0036122; GO:0040014; GO:0042802; GO:0043524; GO:0043932; GO:0045666; GO:0050680; GO:0060390; GO:0060395; GO:0060591; GO:2001054 GGNSSVK 4.659999847 1 1 0.059377273 649.1282207 14.15584 14.47085 0 14.95041 0 13.33282 12.2949 14.20238 0 13.67412 13.91996 0 14.04573 0 14.63205 12.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43119 PI2R_HUMAN "Prostacyclin receptor (Prostaglandin I2 receptor, PGI receptor, PGI2 receptor) (Prostanoid IP receptor)" PTGIR PRIPR Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496]" cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; prostacyclin receptor activity [GO:0016501]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496]" guanyl-nucleotide exchange factor activity [GO:0005085]; prostacyclin receptor activity [GO:0016501] GO:0005085; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007187; GO:0007189; GO:0007204; GO:0007267; GO:0010642; GO:0016501; GO:0032496; GO:0048662 CFTQAVAPDSSSEMGDLLAFR 6.309999943 1 1 0.025825652 2302.941129 0 15.20354 15.10757 12.68858 14.57154 13.82614 0 16.37959 0 14.06128 12.74327 11.84113 14.3373 0 13.98577 0 0 0 0 0 0 0 11.56439 0 13.16258 14.96509 0 0 0 0 0 0 0 0 0 0 0 0 0 14.50733 15.18816 0 0 0 0 0 13.88249 0 P43155 CACP_HUMAN "Carnitine O-acetyltransferase, Carnitine acetylase, EC 2.3.1.137, EC 2.3.1.7 (Carnitine acetyltransferase, CAT, CrAT)" CRAT CAT1 Homo sapiens (Human) "carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]" acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458] GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791 ALLDMR 5.789999962 0.094629638 0.094629638 0.218552519 717.5801258 18.11277 17.45964 13.22443 17.2424 16.76908 0 0 0 0 18.0103 17.17104 16.80779 17.67931 16.36674 0 16.95752 16.57253 18.65675 0 16.67589 0 0 17.99105 18.6487 18.87341 0 19.00439 17.44637 16.97273 0 20.81571 0 18.62573 0 17.97886 18.72087 19.37731 0 0 0 17.62196 0 0 17.91609 18.04705 0 0 17.0549 P43220 GLP1R_HUMAN "Glucagon-like peptide 1 receptor, GLP-1 receptor, GLP-1-R, GLP-1R" GLP1R Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; hormone secretion [GO:0046879]; learning or memory [GO:0007611]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; posttranslational protein targeting to membrane, translocation [GO:0031204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]" integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; glucagon-like peptide 1 receptor activity [GO:0044508]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; hormone secretion [GO:0046879]; learning or memory [GO:0007611]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; posttranslational protein targeting to membrane, translocation [GO:0031204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]" G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; glucagon-like peptide 1 receptor activity [GO:0044508]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0004967; GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007204; GO:0007611; GO:0008016; GO:0008528; GO:0016021; GO:0017046; GO:0019933; GO:0031204; GO:0044508; GO:0045776; GO:0045777; GO:0046879; GO:1990911 ANLMCK 10.40999985 1.49E-05 1.49E-05 0.193266511 752.6078909 16.84062 16.95706 15.72576 17.51375 16.49722 17.0484 15.9108 15.61173 0 17.49513 17.13935 17.60048 16.89987 0 0 17.49294 16.18431 16.47371 0 16.80087 0 18.33896 0 17.94669 17.58169 16.6514 16.31087 0 16.36407 15.2168 14.92363 0 16.59964 17.48306 17.61682 17.43409 18.1123 16.53312 17.40656 17.06391 18.24304 17.83123 18.31876 17.36966 18.40771 0 16.77929 17.47139 P43243 MATR3_HUMAN Matrin-3 MATR3 KIAA0723 Homo sapiens (Human) activation of innate immune response [GO:0002218]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281] membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634] membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281] identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] GO:0002218; GO:0003170; GO:0003281; GO:0003723; GO:0005198; GO:0005634; GO:0005637; GO:0008270; GO:0010608; GO:0016020; GO:0016363; GO:0035198; GO:0042802; GO:0045087 EPSDKAVK 9.300000191 1 1 0.306507614 873.236155 14.60456 0 12.62735 13.58368 13.78315 0 0 11.69448 13.27293 13.26771 14.41807 12.87269 0 13.78205 0 13.99273 14.99231 14.60968 10.63733 14.80291 0 11.86807 0 0 0 0 15.22023 0 0 0 0 0 0 14.64502 0 0 0 0 0 0 14.72853 0 0 0 14.30378 0 0 0 P43246 MSH2_HUMAN "DNA mismatch repair protein Msh2, hMSH2 (MutS protein homolog 2)" MSH2 Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204] "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]" GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168 ENDWYLAYK 7.670000076 1 1 0.037878417 1203.625135 12.03838 0 13.00921 0 11.75572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43353 AL3B1_HUMAN "Aldehyde dehydrogenase family 3 member B1, EC 1.2.1.28, EC 1.2.1.5, EC 1.2.1.7 (Aldehyde dehydrogenase 7)" ALDH3B1 ALDH7 Homo sapiens (Human) alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid biosynthetic process [GO:0030148] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid biosynthetic process [GO:0030148] 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477] GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0006979; GO:0018477; GO:0018479; GO:0030148; GO:0030667; GO:0031982; GO:0034599; GO:0035579; GO:0046185; GO:0070062 DPLGDTLRR 12.27999973 1 1 0.247219213 1041.459205 15.24298 0 0 16.30618 14.61502 0 15.67768 0 0 15.0442 0 0 0 0 0 0 0 0 0 0 0 15.72612 0 0 0 0 0 0 0 0 15.52375 0 0 0 15.40161 0 0 0 0 0 0 0 0 0 0 0 16.50429 0 P43358 MAGA4_HUMAN "Melanoma-associated antigen 4 (Cancer/testis antigen 1.4, CT1.4) (MAGE-4 antigen) (MAGE-41 antigen) (MAGE-X2 antigen)" MAGEA4 MAGE4 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787] nucleus [GO:0005634] nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787] histone deacetylase binding [GO:0042826] GO:0000122; GO:0005634; GO:0042826; GO:0043066; GO:0045787 MSSEQK 8.010000229 0.986952126 0.986952126 0.204819638 724.2688921 16.28748 15.16154 15.82789 15.96393 15.84071 15.75998 0 15.85822 14.53249 15.81069 15.82587 15.49243 14.76402 0 0 15.33932 15.59901 0 0 14.50595 0 14.92002 16.39432 14.8969 0 0 0 0 0 0 16.95711 0 0 0 0 0 16.2268 16.91939 16.35586 16.63448 0 0 0 0 0 0 0 0 P43366 MAGB1_HUMAN "Melanoma-associated antigen B1 (Cancer/testis antigen 3.1, CT3.1) (DSS-AHC critical interval MAGE superfamily 10, DAM10) (MAGE-B1 antigen) (MAGE-XP antigen)" MAGEB1 MAGEL1 MAGEXP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 VLEFLAK 15.53999996 0.838282228 0.838282228 0.120115376 817.3396088 15.20638 0 0 9.348648 0 0 0 14.48373 13.3269 0 15.43457 14.74626 13.60547 0 0 13.56089 0 0 0 0 0 0 0 0 0 0 15.22958 0 0 14.20323 14.58006 0 0 0 0 0 18.25755 0 0 0 0 0 0 0 0 0 0 0 P43403 ZAP70_HUMAN "Tyrosine-protein kinase ZAP-70, EC 2.7.10.2 (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase)" ZAP70 SRK Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] GO:0001772; GO:0001784; GO:0002250; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006955; GO:0007169; GO:0018108; GO:0030154; GO:0030217; GO:0031234; GO:0035556; GO:0042101; GO:0042110; GO:0042113; GO:0043366; GO:0045059; GO:0045060; GO:0045087; GO:0045582; GO:0046638; GO:0046641; GO:0046777; GO:0050850; GO:0050852; GO:0070489; GO:0072678 FLVGKR 5.989999771 0.644873023 0.644873023 0.128599062 719.7442932 14.10708 15.2056 15.96478 14.32199 15.11479 15.19502 0 0 15.73524 0 16.05041 0 15.97363 0 0 15.20044 14.7649 15.66089 12.59508 15.51311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.25998 0 0 16.94927 0 0 15.8243 P43405 KSYK_HUMAN "Tyrosine-protein kinase SYK, EC 2.7.10.2 (Spleen tyrosine kinase) (p72-Syk)" SYK Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101] B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325] GO:0001525; GO:0001775; GO:0001784; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0002862; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006606; GO:0007159; GO:0007169; GO:0007229; GO:0009887; GO:0010543; GO:0010803; GO:0016170; GO:0018105; GO:0018108; GO:0019370; GO:0019815; GO:0019901; GO:0019902; GO:0030154; GO:0030168; GO:0030593; GO:0031234; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032725; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0035556; GO:0038063; GO:0038095; GO:0038096; GO:0038156; GO:0042101; GO:0042169; GO:0042742; GO:0043274; GO:0043280; GO:0043306; GO:0043313; GO:0043366; GO:0043507; GO:0045087; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0046777; GO:0048514; GO:0050731; GO:0050764; GO:0050850; GO:0050853; GO:0051090; GO:0051712; GO:0070372; GO:0071226; GO:0071396; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0097110; GO:0120162; GO:1990858 KSSPAQGNR 4.269999981 0.674909711 0.674909711 0.19589281 945.6453856 13.43104 17.58049 0 0 0 0 17.38078 0 0 14.79217 0 0 0 16.44154 0 0 0 0 17.14996 0 0 0 18.80598 14.00738 0 0 0 16.36284 14.70465 0 0 15.69141 17.11384 0 17.97877 0 0 0 19.26487 15.43024 0 0 0 0 13.3684 0 0 0 P43490 NAMPT_HUMAN "Nicotinamide phosphoribosyltransferase, NAmPRTase, Nampt, EC 2.4.2.12 (Pre-B-cell colony-enhancing factor 1, Pre-B cell-enhancing factor) (Visfatin)" NAMPT PBEF PBEF1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514] GO:0004514; GO:0005125; GO:0005829; GO:0007165; GO:0007267; GO:0008284; GO:0009435; GO:0016607; GO:0030054; GO:0032922; GO:0034356; GO:0042802; GO:0045944; GO:0047280; GO:0051770; GO:0070062 KYYGTK 4.039999962 1 1 0.122928329 759.7811689 13.35166 0 13.83417 14.07136 0 0 0 0 16.34822 0 0 0 0 0 13.77587 0 15.36289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.96605 16.57194 0 0 0 0 0 15.23915 16.21535 0 0 P43626 KI2L1_HUMAN "Killer cell immunoglobulin-like receptor 2DL1 (CD158 antigen-like family member A) (Natural killer-associated transcript 1, NKAT-1) (p58 natural killer cell receptor clones CL-42/47.11, p58 NK receptor CL-42/47.11) (p58.1 MHC class-I-specific NK receptor) (CD antigen CD158a)" KIR2DL1 CD158A NKAT1 Homo sapiens (Human) immune response [GO:0006955]; natural killer cell inhibitory signaling pathway [GO:0002769] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]; natural killer cell inhibitory signaling pathway [GO:0002769] signaling receptor activity [GO:0038023] GO:0002769; GO:0005886; GO:0005887; GO:0006955; GO:0038023 LIGEHHDGVSK 7.510000229 1 1 0.367809614 1191.903543 13.88898 0 0 14.79992 0 0 0 0 0 0 0 0 16.9668 0 0 15.91781 0 0 0 0 17.10237 15.96081 15.10129 16.41348 15.73838 15.11785 0 0 16.40463 14.39277 15.64901 14.58492 15.43194 13.84319 13.38138 14.64614 0 0 15.95756 0 0 0 0 16.45709 0 15.52849 14.22567 15.65541 P43681 ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 CHRNA4 NACRA4 Homo sapiens (Human) "action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594] GO:0001508; GO:0001666; GO:0005886; GO:0005887; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0016021; GO:0019233; GO:0022848; GO:0030425; GO:0030594; GO:0034220; GO:0035094; GO:0035095; GO:0042113; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080 SPSDQLPPQQPLEAEK 4.690000057 0.025167055 0.025167055 0.447323265 1763.816286 0 17.85128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.86998 0 0 0 18.02485 19.17244 0 0 0 0 0 0 17.867 0 0 0 0 0 19.91168 19.50319 20.03139 0 0 18.35971 0 0 0 0 0 0 0 0 P43686 PRS6B_HUMAN "26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7, TBP-7)" PSMC4 MIP224 TBP7 Homo sapiens (Human) blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]" "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402] GO:0000502; GO:0001824; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0036402; GO:0043161 QIGIDPPR 7.949999809 0.425813168 0.425813168 0.154477131 896.4156598 14.44021 19.43012 18.10065 15.37661 17.76851 17.0247 0 16.35093 14.11302 17.19248 0 11.80007 0 0 15.88597 0 16.61468 15.87518 15.76602 15.72269 0 17.05151 15.2967 17.50467 0 16.09409 16.61507 0 0 0 16.53019 0 19.58064 15.95002 0 14.67187 16.66393 17.3743 16.98545 18.35236 0 19.82535 0 17.33698 17.77513 0 19.18749 15.25158 P43694 GATA4_HUMAN Transcription factor GATA-4 (GATA-binding factor 4) GATA4 Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle morphogenesis [GO:0003208]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion development [GO:0003197]; endoderm development [GO:0007492]; heart looping [GO:0001947]; intestinal epithelial cell differentiation [GO:0060575]; male gonad development [GO:0008584]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein kinase B signaling [GO:0051896]; regulation of transcription, DNA-templated [GO:0006355]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; transdifferentiation [GO:0060290]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle morphogenesis [GO:0003208]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion development [GO:0003197]; endoderm development [GO:0007492]; heart looping [GO:0001947]; intestinal epithelial cell differentiation [GO:0060575]; male gonad development [GO:0008584]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein kinase B signaling [GO:0051896]; regulation of transcription, DNA-templated [GO:0006355]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; transdifferentiation [GO:0060290]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]" "co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0001947; GO:0003162; GO:0003180; GO:0003190; GO:0003197; GO:0003208; GO:0003215; GO:0003281; GO:0003289; GO:0003290; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007267; GO:0007492; GO:0008270; GO:0008584; GO:0009410; GO:0009612; GO:0010507; GO:0010575; GO:0010667; GO:0016604; GO:0019901; GO:0030513; GO:0033189; GO:0035054; GO:0036302; GO:0042060; GO:0043565; GO:0045165; GO:0045766; GO:0045893; GO:0045944; GO:0048617; GO:0051525; GO:0051891; GO:0051896; GO:0060290; GO:0060413; GO:0060575; GO:0061026; GO:0061049; GO:0061629; GO:0070374; GO:0070410; GO:0071333; GO:0086004; GO:0090575; GO:1903202; GO:1990837; GO:2001234 EAAAYSSGGGAAGAGLAGREQYGR 6.409999847 1 1 0.163806004 2228.100347 0 12.7316 0 0 0 0 0 0 0 0 0 0 11.83405 15.16312 0 0 14.72147 14.02646 14.58515 0 0 13.4203 0 0 12.52244 11.96911 11.47133 0 13.6617 0 13.34538 0 13.15752 13.68454 0 12.56862 14.02001 0 0 0 0 0 0 0 0 0 15.62715 0 P43699 NKX21_HUMAN "Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1, TTF-1) (Thyroid-specific enhancer-binding protein, T/EBP)" NKX2-1 NKX2A TITF1 TTF1 Homo sapiens (Human) "brain development [GO:0007420]; cell differentiation [GO:0030154]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; globus pallidus development [GO:0021759]; lung development [GO:0030324]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; cell differentiation [GO:0030154]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; globus pallidus development [GO:0021759]; lung development [GO:0030324]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001161; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007420; GO:0009725; GO:0010628; GO:0010719; GO:0019899; GO:0021759; GO:0030154; GO:0030324; GO:0030336; GO:0030512; GO:0030878; GO:0030900; GO:0042753; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0060441; GO:0061629 MSMSPK 2.470000029 1 1 6.90E-13 696.5419585 0 14.77521 13.94257 0 0 0 0 0 0 0 0 0 15.9965 0 0 0 0 0 0 16.02525 0 0 0 0 15.8276 0 0 0 0 0 0 0 0 17.28879 0 0 0 16.84366 0 16.41508 0 0 0 0 0 0 17.1504 0 P45452 MMP13_HUMAN "Collagenase 3, EC 3.4.24.- (Matrix metalloproteinase-13, MMP-13)" MMP13 Homo sapiens (Human) bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0001958; GO:0003417; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0044267; GO:0060349; GO:1904645 CDPSLSLDAITSLR 11.89999962 1 1 4.59E-13 1547.925931 0 12.86708 0 16.56105 13.97457 9.144051 15.73909 13.08253 14.11699 0 0 14.92264 13.37391 14.94259 0 0 0 0 0 12.94505 0 0 0 0 0 0 0 0 0 0 0 0 16.6308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45984 MK09_HUMAN "Mitogen-activated protein kinase 9, MAP kinase 9, MAPK 9, EC 2.7.11.24 (JNK-55) (Stress-activated protein kinase 1a, SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)" MAPK9 JNK2 PRKM9 SAPK1A Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; rhythmic process [GO:0048511] ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004705; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0010628; GO:0010744; GO:0016607; GO:0018105; GO:0031398; GO:0034614; GO:0035556; GO:0038095; GO:0042752; GO:0048511; GO:0051090; GO:0061833; GO:0071276; GO:0071803; GO:0090398; GO:0106310; GO:1901485; GO:2001235 TACTNFMMTPYVVTR 3.319999933 0.132062569 0.132062569 0.341977052 1824.376327 0 16.97224 0 0 0 14.03186 16.8051 0 0 0 15.3581 15.62918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8224 0 0 14.94915 13.07927 16.50842 0 14.0696 0 0 0 0 0 15.63745 0 0 0 0 17.28271 0 0 P46013 KI67_HUMAN "Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67, Antigen KI-67, Antigen Ki67)" MKI67 Homo sapiens (Human) cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0007049; GO:0007088; GO:0008022; GO:0008283; GO:0016020; GO:0016604; GO:0051983; GO:1902275 AMLTPKPAGGDEK 13.21000004 1 1 0.020078667 1313.892902 15.66159 0 14.32349 14.01922 0 13.17359 15.372 0 0 14.6076 0 14.98457 13.66067 0 15.19885 15.07769 15.02871 14.78948 0 0 0 0 0 11.88152 0 14.05967 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8955 18.816 14.43595 18.68974 0 0 0 0 0 P46020 KPB1_HUMAN "Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform, Phosphorylase kinase alpha M subunit" PHKA1 PHKA Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977] calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689] GO:0004689; GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005977; GO:0006091 GGLDRFQAAVQTTCDLMSLVTK 4.630000114 0.387754709 0.387754709 0.07149616 2418.050614 15.59078 0 13.39712 16.97249 0 0 0 16.65956 0 0 18.79285 0 16.65426 0 0 0 17.07747 0 0 0 0 0 0 0 0 0 0 14.77022 0 0 0 17.98959 0 15.61004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46063 RECQ1_HUMAN "ATP-dependent DNA helicase Q1, EC 3.6.4.12 (DNA helicase, RecQ-like type 1, RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)" RECQL RECQ1 RECQL1 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378] GO:0000724; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032508; GO:0036310; GO:0043138; GO:1990814 QLGISATMLNASSSK 1.429999948 1 1 0.173211626 1528.599455 0 0 14.94087 0 0 0 0 0 0 15.05481 0 0 0 0 0 14.81331 0 0 0 0 0 0 16.10332 0 0 0 0 0 0 0 16.57649 0 15.31983 0 0 16.0125 16.70395 14.49635 15.85902 15.63843 15.22046 16.24968 0 0 0 0 0 0 P46087 NOP2_HUMAN "Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase, EC 2.1.1.- (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)" NOP2 NOL1 NSUN1 Homo sapiens (Human) maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383] GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796 SSRPPPAK 4.269999981 1 1 0.076931445 838.7748979 0 14.44281 0 15.25217 13.86294 0 15.10482 13.18047 15.09305 16.22668 15.60707 14.86119 0 11.93364 0 0 15.74933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47137 0 0 0 0 0 0 0 0 0 0 0 P46098 5HT3A_HUMAN "5-hydroxytryptamine receptor 3A, 5-HT3-A, 5-HT3A (5-hydroxytryptamine receptor 3, 5-HT-3, 5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)" HTR3A 5HT3R HTR3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0032154; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051378; GO:0098662; GO:1904602 EFSMESSNYYAEMKFYVVIR 4.809999943 1 1 0.140430634 2493.902968 0 11.89847 13.08952 0 0 0 0 0 0 0 15.04648 0 0 0 0 0 0 13.2006 14.46092 9.444768 13.06319 0 0 12.81861 0 11.32034 0 0 7.550521 12.17518 14.16963 0 0 0 0 0 13.74574 11.06748 0 0 0 0 0 0 11.33204 0 0 0 P46100 ATRX_HUMAN "Transcriptional regulator ATRX, EC 3.6.4.12 (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein, XNP) (Znf-HX)" ATRX RAD54L XH2 Homo sapiens (Human) "cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent chromatin assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]" "chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]" "chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent chromatin assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] GO:0000212; GO:0000228; GO:0000779; GO:0000781; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005721; GO:0006281; GO:0006306; GO:0006334; GO:0006336; GO:0006338; GO:0006355; GO:0007283; GO:0010571; GO:0015616; GO:0016604; GO:0016605; GO:0016887; GO:0030330; GO:0030900; GO:0031297; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0046872; GO:0060009; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:0099115; GO:0140658; GO:1900112; GO:1901581; GO:1901582; GO:1904908 CKLLGK 11.39999962 1 1 0.273037936 718.3147153 18.97087 17.1433 18.5822 0 0 0 16.77532 18.27941 0 0 18.38175 0 18.85032 17.13089 0 0 17.4561 0 0 0 0 0 0 17.72496 0 0 19.62623 18.83665 0 0 0 23.14476 0 18.73639 0 0 0 0 0 0 0 0 18.05347 0 0 18.31393 17.67128 0 P46199 IF2M_HUMAN "Translation initiation factor IF-2, mitochondrial, IF-2(Mt), IF-2Mt, IF2(mt)" MTIF2 Homo sapiens (Human) mitochondrial translational initiation [GO:0070124]; regulation of translational initiation [GO:0006446]; ribosome disassembly [GO:0032790] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; regulation of translational initiation [GO:0006446]; ribosome disassembly [GO:0032790]" "GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0006446; GO:0008135; GO:0032790; GO:0043024; GO:0070124 FHTIYR 5.730000019 0.78430891 0.78430891 0.188869079 833.5283901 15.06717 15.21601 16.60435 0 15.02878 15.34508 16.65987 0 14.26518 0 0 0 12.03021 0 0 15.781 0 0 14.88944 0 0 0 0 0 0 15.90798 0 13.08799 13.96295 14.53336 16.21827 15.66739 15.76288 15.33658 14.08286 14.8072 6.987453 16.68 15.7485 12.67907 16.52566 13.28811 14.23141 14.74921 14.18566 16.04101 15.40525 14.59092 P46379 BAG6_HUMAN "Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6, BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe)" BAG6 BAT3 G3 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030433; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818; GO:1904294; GO:1904378; GO:1904379; GO:1990381 EHIAASVSIPSEKQR 6.440000057 1 1 1.15E-12 1651.427962 14.364 16.02101 16.14286 0 0 0 16.58093 0 0 14.59568 0 0 14.26989 0 0 15.01955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46459 NSF_HUMAN "Vesicle-fusing ATPase, EC 3.6.4.6 (N-ethylmaleimide-sensitive fusion protein, NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)" NSF Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein disaggregase activity [GO:0140545]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein disaggregase activity [GO:0140545]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075] GO:0000149; GO:0001921; GO:0005524; GO:0005765; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0006887; GO:0006891; GO:0014069; GO:0016192; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030165; GO:0035255; GO:0035494; GO:0043001; GO:0043198; GO:0044877; GO:0045026; GO:0045732; GO:0046872; GO:0140545 CQAMKK 1.809999943 1 1 0.107352218 781.5784666 0 15.02011 13.22082 0 14.94819 12.81883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.13406 0 0 15.53366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.96912 0 0 0 P46531 NOTC1_HUMAN "Neurogenic locus notch homolog protein 1, Notch 1, hN1 (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation, NEXT; Notch 1 intracellular domain, NICD ]" NOTCH1 TAN1 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888] GO:0000122; GO:0000139; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010467; GO:0010614; GO:0010628; GO:0010629; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 SDAAK 4.119999886 1 1 0.081585544 490.7267016 16.04057 16.18785 0 14.79546 15.70204 0 0 0 15.55982 13.75556 15.07441 15.01537 13.94836 10.19237 15.26442 14.88513 15.22757 16.1562 16.20173 12.45448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46597 ASMT_HUMAN "Acetylserotonin O-methyltransferase, EC 2.1.1.4 (Hydroxyindole O-methyltransferase, HIOMT)" ASMT Homo sapiens (Human) aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412] cytosol [GO:0005829] cytosol [GO:0005829]; acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172]; aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412] acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172] GO:0005829; GO:0006412; GO:0006629; GO:0008171; GO:0008172; GO:0008757; GO:0017096; GO:0019438; GO:0030187; GO:0032259; GO:0042802; GO:0042803; GO:0046219 MGSSEDQAYR 17.56999969 0.015698219 0.015698219 0.279199293 1158.74289 19.36813 20.1644 20.2628 18.59654 19.03615 18.45171 19.84192 19.51251 19.60135 19.30134 18.93127 19.97608 0 19.69799 0 0 0 17.60062 18.32779 19.08625 0 18.94561 19.74531 18.44012 18.62597 19.19934 19.32041 19.03078 19.05424 19.99658 0 19.58893 0 19.33965 19.88071 21.39491 0 18.15112 19.17857 18.49601 16.60184 17.37129 17.14394 17.80854 16.93619 16.4786 20.07789 19.99842 P46695 IEX1_HUMAN "Radiation-inducible immediate-early gene IEX-1 (Differentiation-dependent gene 2 protein, Protein DIF-2) (Immediate early protein GLY96) (Immediate early response 3 protein) (PACAP-responsive gene 1 protein, Protein PRG1)" IER3 DIF2 IEX1 PRG1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of response to DNA damage stimulus [GO:2001020] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of response to DNA damage stimulus [GO:2001020] GO:0005634; GO:0005829; GO:0006915; GO:0009653; GO:0016021; GO:0043066; GO:2001020 QLPVEEPNPAK 12.97999954 1 1 1.14E-12 1220.585857 0 11.90281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.40163 0 0 0 0 0 10.93806 0 0 0 0 0 0 0 0 0 13.64285 0 0 13.7874 0 0 0 0 0 0 0 0 12.79988 0 0 P46734 MP2K3_HUMAN "Dual specificity mitogen-activated protein kinase kinase 3, MAP kinase kinase 3, MAPKK 3, EC 2.7.12.2 (MAPK/ERK kinase 3, MEK 3) (Stress-activated protein kinase kinase 2, SAPK kinase 2, SAPKK-2, SAPKK2)" MAP2K3 MEK3 MKK3 PRKMK3 SKK2 Homo sapiens (Human) "cardiac muscle contraction [GO:0060048]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular senescence [GO:0090398]; heart development [GO:0007507]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cardiac muscle contraction [GO:0060048]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular senescence [GO:0090398]; heart development [GO:0007507]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]" ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] GO:0000165; GO:0001817; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0006954; GO:0007165; GO:0007507; GO:0016020; GO:0019901; GO:0035331; GO:0035924; GO:0038066; GO:0043410; GO:0043536; GO:0045860; GO:0045893; GO:0051770; GO:0060048; GO:0071222; GO:0072709; GO:0090398; GO:0106310 VRHAQSGTIMAVK 14.82999992 0.323838025 0.323838025 0.564233797 1412.475723 17.60055 0 0 0 0 18.92564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.19235 0 0 19.07385 0 0 0 0 0 0 0 0 0 0 19.02998 0 0 18.77492 0 19.24562 0 0 0 19.47598 0 0 17.70677 P46736 BRCC3_HUMAN "Lys-63-specific deubiquitinase BRCC36, EC 3.4.19.- (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)" BRCC3 BRCC36 C6.1A CXorf53 Homo sapiens (Human) cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165] enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843] GO:0000151; GO:0000152; GO:0000922; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0008237; GO:0010165; GO:0010212; GO:0016579; GO:0030234; GO:0031593; GO:0035518; GO:0044818; GO:0045739; GO:0046872; GO:0051301; GO:0051865; GO:0061578; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0071479; GO:0140492; GO:2000001 RIHSLTHLDSVTK 7.300000191 1 1 0.596232902 1509.502751 0 0 0 0 0 0 0 11.52388 0 0 14.4374 0 0 0 0 0 0 0 0 16.08073 0 0 0 15.12407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.82572 0 0 0 0 0 0 0 0 0 P46779 RL28_HUMAN 60S ribosomal protein L28 (Large ribosomal subunit protein eL28) RPL28 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0030425; GO:0036464; GO:0044297; GO:0070062 YNGLIHR 2.109999895 0.511811316 0.511811316 0.102318151 872.8313573 15.67436 14.79537 14.24209 0 0 0 0 0 0 0 0 12.75476 0 0 0 0 0 0 0 0 0 0 14.87885 0 0 0 0 0 0 0 0 15.80378 0 15.11666 0 15.49811 0 0 0 0 0 0 0 0 16.63479 0 0 0 P46781 RS9_HUMAN 40S ribosomal protein S9 (Small ribosomal subunit protein uS4) RPS9 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412] 5.8S rRNA binding [GO:1990932]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:0070062; GO:1990904; GO:1990932 IGVLDEGK 9.680000305 0.088859603 0.088859603 0.226228562 831.7166875 19.55972 17.21027 16.44655 15.5997 18.19014 15.26655 17.4421 17.75603 16.73529 18.99947 18.10642 18.65896 16.04616 15.06124 18.51532 17.14312 18.02336 0 18.85095 17.24142 0 18.52761 0 18.05575 18.60266 16.9665 17.86912 19.39437 15.50099 16.75206 18.52536 18.80622 16.71927 0 18.69927 0 16.39407 15.048 18.11779 15.22582 0 0 17.95188 0 0 17.19944 16.62004 0 P46783 RS10_HUMAN 40S ribosomal protein S10 (Small ribosomal subunit protein eS10) RPS10 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0016020; GO:0022626; GO:0022627 NVPNLHVMK 2.410000086 0.077198572 0.077198572 0.093842966 1069.040769 13.77055 0 14.27823 12.16347 0 0 0 0 17.06022 0 0 0 13.62253 14.72391 0 0 12.91061 0 10.00215 0 0 17.38972 11.72904 0 12.51245 0 0 17.6494 0 0 0 14.23081 16.51678 0 0 0 0 18.76275 0 18.72251 16.11373 13.77853 14.94083 0 0 0 0 14.82937 P46821 MAP1B_HUMAN "Microtubule-associated protein 1B, MAP-1B [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1 ]" MAP1B Homo sapiens (Human) axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196] apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] GO:0000226; GO:0001578; GO:0001750; GO:0001764; GO:0003779; GO:0005198; GO:0005543; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0007026; GO:0007409; GO:0007416; GO:0008017; GO:0009410; GO:0009612; GO:0009743; GO:0010035; GO:0014012; GO:0014069; GO:0016358; GO:0017085; GO:0021700; GO:0030424; GO:0030425; GO:0030426; GO:0031114; GO:0031116; GO:0032355; GO:0032387; GO:0033189; GO:0036477; GO:0043025; GO:0043196; GO:0043197; GO:0043204; GO:0044877; GO:0045202; GO:0045666; GO:0045773; GO:0047497; GO:0048471; GO:0048675; GO:0051915; GO:0061162; GO:0071363; GO:0071375; GO:0071895; GO:0097440; GO:0097441; GO:0097457 DSGGK 2.200000048 0.700094461 0.700094461 0.177632711 464.3534486 15.87958 15.37977 16.48793 16.54111 15.43235 16.51538 15.53744 15.79317 16.07691 15.3945 16.36295 16.25985 14.62274 15.75281 13.97948 16.84348 16.14178 15.46022 15.5598 15.37875 14.96149 15.91129 16.98864 16.03603 16.83288 15.29456 16.87367 15.86738 15.65512 16.58752 16.65997 16.03356 16.12002 16.41906 16.5558 15.67847 16.36919 16.72781 17.04158 16.57519 16.35781 15.75116 15.04259 16.27902 16.53823 16.02871 16.77803 15.93579 P46934 NEDD4_HUMAN "E3 ubiquitin-protein ligase NEDD4, EC 2.3.2.26 (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4, NEDD-4)" NEDD4 KIAA0093 NEDD4-1 PIG53 Homo sapiens (Human) cellular response to UV [GO:0034644]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; cellular response to UV [GO:0034644]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630] GO:0000151; GO:0000209; GO:0000785; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006622; GO:0007041; GO:0007528; GO:0010766; GO:0010768; GO:0014068; GO:0016241; GO:0016327; GO:0016567; GO:0019871; GO:0019899; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0032991; GO:0034644; GO:0034765; GO:0042391; GO:0042921; GO:0043130; GO:0043161; GO:0043162; GO:0043197; GO:0044111; GO:0045732; GO:0046755; GO:0046824; GO:0048471; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0051592; GO:0061630; GO:0070062; GO:0070063; GO:0070064; GO:0070534; GO:1901016; GO:2000650 ISTSNVVQMK 5.019999981 0.113614954 0.113614954 0.085064914 1124.212827 16.1272 0 16.17823 16.33171 0 15.20006 13.96278 14.04464 17.64342 16.11738 8.4025 0 0 0 0 16.01629 0 12.99125 15.03871 0 0 0 17.25817 0 0 14.39756 0 18.2671 0 0 13.74556 17.74217 11.02235 15.11243 15.88597 0 12.81141 17.31739 0 13.72709 0 13.92524 0 0 13.68405 16.34536 17.42206 14.61931 P46939 UTRN_HUMAN "Utrophin (Dystrophin-related protein 1, DRP-1)" UTRN DMDL DRP1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649] actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006936; GO:0007517; GO:0008270; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030036; GO:0030054; GO:0030175; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0042383; GO:0042995; GO:0045211; GO:0051015; GO:0070062; GO:2000649 DQALILMNAR 8.329999924 0.290454626 0.290454626 0.179072843 1160.718337 9.183744 0 13.28478 0 0 0 0 13.06425 0 14.649 0 0 15.88314 0 13.42389 0 0 0 0 0 0 0 0 0 0 16.33217 0 15.44949 0 0 15.64632 0 16.48233 0 0 0 0 16.26576 0 0 0 0 0 0 0 16.87564 0 0 P46940 IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 (p195) IQGAP1 KIAA0051 Homo sapiens (Human) cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165] actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057] "actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165]" "actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]" GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043087; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0045860; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1990138; GO:1990904 GLQQQNSDWYLK 2.49000001 1 1 1.61E-12 1480.226842 0 14.85942 13.77508 14.94214 0 0 0 0 12.0717 13.57647 15.61352 15.17698 15.49464 14.26388 15.64273 0 14.22596 0 0 0 0 17.57166 13.93566 15.8485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47224 MSS4_HUMAN Guanine nucleotide exchange factor MSS4 (Rab-interacting factor) RABIF MSS4 RASGRF3 Homo sapiens (Human) membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270] GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0015031; GO:0016020; GO:0061025 DVGNIK 3.799999952 1 1 0.019276791 646.3382066 14.0167 16.42446 13.65647 15.67682 16.55693 15.06556 15.11382 15.1466 0 14.23949 0 16.81957 14.02667 0 0 0 14.88196 0 14.76001 0 0 15.57388 0 15.35646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10191 0 0 0 P47712 PA24A_HUMAN "Cytosolic phospholipase A2, cPLA2 (Phospholipase A2 group IVA) [Includes: Phospholipase A2, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase, EC 3.1.1.5 ]" PLA2G4A CPLA2 PLA2G4 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623] GO:0000139; GO:0001516; GO:0002827; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006071; GO:0006640; GO:0006663; GO:0006690; GO:0008374; GO:0010314; GO:0010572; GO:0019369; GO:0019370; GO:0032266; GO:0032308; GO:0034478; GO:0034638; GO:0036151; GO:0042127; GO:0043032; GO:0043231; GO:0046475; GO:0047498; GO:0047499; GO:0050482; GO:0070273; GO:0071236; GO:0102545; GO:1902387 MNTTLSSLK 5.260000229 1 1 0.068084844 1011.564384 0 0 13.47056 0 0 0 15.48967 0 0 0 0 13.59486 0 0 0 15.04278 0 14.61491 0 0 0 0 13.47287 0 0 14.88122 15.39657 13.68285 0 0 0 0 0 0 0 0 15.58262 0 16.47259 0 13.58112 0 0 0 0 0 0 0 P47884 OR1D4_HUMAN "Olfactory receptor 1D4 (Olfactory receptor 17-30, OR17-30)" OR1D4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887; GO:0007186; GO:0007606 DMHGAPGR 7.440000057 1 1 0.157607873 857.3858015 14.45884 15.3076 0 15.56114 14.16504 13.58155 15.42357 15.55486 14.02886 14.60529 14.50197 0 14.40895 14.40568 13.11961 0 0 0 15.64844 0 0 0 0 0 0 0 15.07962 0 0 15.10168 0 0 0 0 0 0 0 0 0 0 0 13.68638 0 0 0 0 0 0 P47895 AL1A3_HUMAN "Aldehyde dehydrogenase family 1 member A3, EC 1.2.1.36 (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3, RALDH-3, RalDH3)" ALDH1A3 ALDH6 Homo sapiens (Human) embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324] GO:0001758; GO:0002072; GO:0002138; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0007626; GO:0021768; GO:0031076; GO:0042472; GO:0042572; GO:0042573; GO:0042574; GO:0042803; GO:0043065; GO:0048048; GO:0050885; GO:0051289; GO:0060013; GO:0060166; GO:0060324; GO:0070062; GO:0070324; GO:0070384; GO:0070403 EGAKLECGGSAMEDK 4.75 1 1 0.293096119 1596.09426 12.66212 15.30991 16.75741 13.76105 0 14.45451 0 13.71386 0 0 0 13.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.68026 13.85703 16.74826 15.78207 0 0 16.7117 0 0 0 0 0 15.14434 0 16.2479 14.11172 14.62236 0 0 17.53215 P47929 LEG7_HUMAN "Galectin-7, Gal-7 (HKL-14) (PI7) (p53-induced gene 1 protein)" LGALS7 PIG1; LGALS7B Homo sapiens (Human) "apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]" carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936] GO:0005615; GO:0005634; GO:0005829; GO:0006915; GO:0007157; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:0070062; GO:2000562 GLVPPNASR 4.300000191 0.421272457 0.421272457 0.28573853 911.7736732 15.37967 15.48147 15.03742 14.25024 14.77378 15.53916 0 0 15.81007 15.59874 0 0 13.70215 16.35296 0 14.46727 12.93514 15.18737 15.48804 16.12289 12.31346 14.63988 0 15.62981 0 15.80772 16.28275 13.78551 0 0 0 0 0 14.71484 0 14.97438 0 0 0 0 16.39911 15.94009 0 0 0 0 0 0 P47972 NPTX2_HUMAN "Neuronal pentraxin-2, NP2 (Neuronal pentraxin II, NP-II)" NPTX2 Homo sapiens (Human) associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] GO:0005576; GO:0007268; GO:0008306; GO:0030246; GO:0046872; GO:0098962; GO:0098978 GNSAFK 7.760000229 1 1 0.232767054 623.0131646 0 16.80519 0 17.83956 15.82772 13.412 17.83496 13.17524 17.60936 16.08442 14.00947 16.24849 16.43789 0 14.54239 16.25287 16.78004 16.15674 0 14.95631 15.43568 17.92053 16.93907 0 15.42144 15.91412 0 0 16.2918 15.85598 0 0 16.17169 0 16.95391 0 0 17.29984 16.39935 0 0 16.49236 0 16.98066 18.29713 17.38311 0 18.03391 P47985 UCRI_HUMAN "Cytochrome b-c1 complex subunit Rieske, mitochondrial, EC 7.1.1.8 (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein, RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9, Su9, Subunit 9 (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence, UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein) ]" UQCRFS1 Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]" "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]" GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0016491; GO:0022904; GO:0034551; GO:0045333; GO:0046872; GO:0051537 SSRESSEAR 4.019999981 0.854323149 0.854323149 0.131279232 1006.574231 0 0 0 0 0 0 0 0 0 0 0 0 16.02015 0 0 0 0 0 0 0 0 0 0 0 15.04233 13.59762 0 0 16.05858 0 0 16.43816 14.55357 0 0 0 0 0 0 0 0 0 0 0 0 12.85391 0 0 P47989 XDH_HUMAN "Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase, XD, EC 1.17.1.4; Xanthine oxidase, XO, EC 1.17.3.2 (Xanthine oxidoreductase, XOR) ]" XDH XDHA Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115] cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529] "cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115]" "2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]" GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007595; GO:0009114; GO:0009115; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213 ETRSTVVSTAVALAAYK 2.849999905 1 1 4.61E-13 1765.051613 0 0 13.58624 0 0 0 0 0 0 0 0 0 0 0 0 14.90733 16.16775 0 0 16.01688 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49677 14.43185 0 0 0 0 0 0 16.11247 0 15.73861 0 0 0 15.0419 P48039 MTR1A_HUMAN "Melatonin receptor type 1A, Mel-1A-R, Mel1a receptor" MTNR1A Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]" G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0097159 KPKLKPQDFR 13.86999989 1 1 4.61E-13 1253.669414 0 0 14.7534 0 12.92755 0 0 0 0 15.30917 0 0 0 0 0 15.44547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.75387 0 0 0 0 17.80119 0 0 0 0 0 0 0 0 0 0 0 P48047 ATPO_HUMAN "ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein, OSCP)" ATP5PO ATP5O ATPO Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]" "proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]" GO:0000274; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006754; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600 YVDMSVKTK 7.210000038 1 1 0.346699351 1086.677046 0 12.77991 0 0 0 0 0 0 14.27127 0 0 0 0 13.63812 0 0 0 0 0 0 16.46431 0 0 0 15.05363 0 14.60393 0 0 16.9042 0 0 0 0 16.53957 0 0 0 0 0 15.55944 0 0 15.60493 0 0 0 0 P48048 KCNJ1_HUMAN "ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)" KCNJ1 ROMK1 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]" "ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0005242; GO:0005524; GO:0005546; GO:0005886; GO:0015272; GO:0016021; GO:0034765; GO:1990573 ARLVSK 12.39999962 1 1 0.28955954 672.6219465 0 18.90489 18.19082 18.44025 18.29711 20.37617 0 0 18.54023 0 17.63449 16.93083 17.64443 0 17.84325 0 0 19.26311 18.00825 18.20887 0 18.84817 0 18.25687 18.22281 19.28543 19.63525 0 0 0 0 19.04263 0 0 18.01874 17.61303 0 0 0 19.73661 0 0 18.8409 0 0 0 0 18.92422 P48052 CBPA2_HUMAN "Carboxypeptidase A2, EC 3.4.17.15" CPA2 Homo sapiens (Human) protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773] extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508] carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270 EWVTQATALWTANK 4.730000019 0.547881484 0.547881484 0.558239482 1618.855884 0 0 0 18.91158 20.50661 0 0 0 0 0 19.75159 0 0 0 0 0 18.15853 0 0 0 0 0 18.35352 0 19.9122 19.11403 0 18.18909 0 0 0 19.49971 20.56816 19.41208 0 0 0 0 0 0 18.7999 0 0 0 18.04373 0 0 0 P48058 GRIA4_HUMAN "Glutamate receptor 4, GluR-4, GluR4 (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4, GluA4)" GRIA4 GLUR4 Homo sapiens (Human) glutamate receptor signaling pathway [GO:0007215]; negative regulation of smooth muscle cell apoptotic process [GO:0034392] AMPA glutamate receptor complex [GO:0032281]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] AMPA glutamate receptor complex [GO:0032281]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of smooth muscle cell apoptotic process [GO:0034392] AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023] GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007215; GO:0015276; GO:0030666; GO:0032281; GO:0034392; GO:0038023; GO:0043025; GO:0043197; GO:0045211; GO:1903561 VGYWNDMDK 6.369999886 1 1 0.012889517 1126.772396 16.26621 13.85065 14.54538 13.40653 0 11.84449 0 0 12.67483 0 0 0 14.18644 0 0 13.77026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48067 SC6A9_HUMAN "Sodium- and chloride-dependent glycine transporter 1, GlyT-1, GlyT1 (Solute carrier family 6 member 9)" SLC6A9 Homo sapiens (Human) glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375] GO:0005768; GO:0005886; GO:0005887; GO:0006836; GO:0009925; GO:0014069; GO:0015187; GO:0015375; GO:0015816; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030285; GO:0031045; GO:0035725; GO:0046985; GO:0070455; GO:0098686; GO:0098688; GO:0099055; GO:0099056; GO:0150104; GO:1903804; GO:1904782 ISPMFK 10.59000015 0.185325891 0.185325891 0.305606041 738.0439392 17.07602 15.65111 15.97191 14.443 0 0 16.14784 16.7446 15.82617 16.0893 15.47974 16.11539 16.90261 0 17.519 15.58809 16.36807 15.43977 17.71171 16.21593 16.99227 16.08273 16.25679 15.91695 17.4895 16.80161 17.05926 16.2956 16.08718 17.00795 16.81698 17.13568 17.63303 16.20824 16.92964 18.1362 18.13017 17.74477 16.51681 0 17.58516 17.51113 17.26836 17.8285 18.21548 18.65331 18.91962 17.40075 P48163 MAOX_HUMAN "NADP-dependent malic enzyme, NADP-ME, EC 1.1.1.40 (Malic enzyme 1)" ME1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; nucleotide biosynthetic process [GO:0009165]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; nucleotide biosynthetic process [GO:0009165]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725] ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948] GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005829; GO:0005975; GO:0006090; GO:0006108; GO:0008948; GO:0009055; GO:0009165; GO:0009725; GO:0009743; GO:0030145; GO:0042802; GO:0043531; GO:0050661; GO:0051287; GO:1902031 DLAFTLEER 5.639999866 1 1 0.047695594 1094.307457 0 0 0 0 0 0 0 0 14.80902 14.93051 0 0 0 0 0 16.21908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48200 IREB2_HUMAN "Iron-responsive element-binding protein 2, IRE-BP 2 (Iron regulatory protein 2, IRP2)" IREB2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; tricarboxylic acid cycle [GO:0006099]" "4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]" GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006782; GO:0006826; GO:0006879; GO:0009791; GO:0030316; GO:0030350; GO:0030371; GO:0034101; GO:0046872; GO:0050892; GO:0051539; GO:0055072 RPQDRVAVTDMK 4.579999924 1 1 0.395868095 1414.636515 0 0 13.70889 3.840729 14.12833 0 0 13.1947 12.86454 14.47363 13.39035 0 0 0 0 15.78551 13.22179 0 16.1899 15.26084 0 0 0 16.21718 0 0 17.12324 0 0 0 0 0 0 16.84198 0 0 0 0 0 0 0 0 0 16.73917 0 0 0 0 P48230 T4S4_HUMAN "Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein, IL-TMP)" TM4SF4 ILTMP Homo sapiens (Human) tissue regeneration [GO:0042246] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; tissue regeneration [GO:0042246] GO:0016021; GO:0042246 CTGGCAR 8.729999542 1 1 0.223008862 781.3776207 15.71748 12.18167 13.31264 12.00015 15.07596 15.10154 15.15155 13.17654 12.57708 14.52222 11.55755 0 16.25455 0 14.69159 0 14.14744 15.41564 14.5701 14.79007 14.4479 13.29896 15.50445 15.7261 0 0 0 0 16.16153 0 15.25048 15.24569 16.40239 16.66804 0 0 15.95675 0 0 0 0 16.23147 14.95442 15.82973 0 0 14.26439 0 P48382 RFX5_HUMAN DNA-binding protein RFX5 (Regulatory factor X 5) RFX5 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045944; GO:0090575; GO:1990837 DPKATPP 7.429999828 0.005704093 0.005704093 0.301889813 724.9982842 0 0 0 0 0 17.02672 17.32599 0 16.55493 19.77218 0 0 17.81569 0 0 0 0 0 0 0 0 17.27406 0 0 0 0 0 0 0 16.26705 0 0 17.83897 0 0 21.08801 18.13789 0 0 16.64049 0 0 0 17.00104 0 18.09323 0 0 P48444 COPD_HUMAN "Coatomer subunit delta (Archain) (Delta-coat protein, Delta-COP)" ARCN1 COPD Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" RNA binding [GO:0003723] GO:0000139; GO:0003723; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0008344; GO:0016020; GO:0021691; GO:0030126; GO:0030133; GO:0043473; GO:0051645 EAKAEMR 10.43000031 1 1 0.106532927 853.3841964 16.09563 0 14.94134 0 15.48423 0 17.32993 12.72704 0 0 16.39867 0 0 0 0 13.92221 0 0 0 0 0 0 0 0 14.30043 0 17.71048 0 0 0 0 0 0 14.85322 0 0 0 0 0 15.44814 0 0 15.67027 0 14.62445 0 0 0 P48448 AL3B2_HUMAN "Aldehyde dehydrogenase family 3 member B2, EC 1.2.1.3 (Aldehyde dehydrogenase 8)" ALDH3B2 ALDH8 Homo sapiens (Human) alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; sphingolipid biosynthetic process [GO:0030148] cytoplasm [GO:0005737]; lipid droplet [GO:0005811] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; sphingolipid biosynthetic process [GO:0030148] 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878] GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005811; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0030148; GO:0043878 LDSVFIWK 17.06999969 1 1 0.14466097 1007.383992 16.34175 17.54528 0 0 0 16.41759 0 15.77456 0 16.1782 0 0 14.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.00561 16.75914 0 0 0 0 0 0 17.68198 0 0 0 0 0 0 0 0 P48449 LSS_HUMAN "Lanosterol synthase, EC 5.4.99.7 (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase, OSC, hOSC)" LSS OSC Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; lanosterol synthase activity [GO:0000250]; cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104] lanosterol synthase activity [GO:0000250] GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016020; GO:0016104; GO:0031647 HPDIEAQERGVR 2.549999952 1 1 0.238817851 1410.777089 12.24374 14.4745 0 0 0 14.59571 0 0 0 0 0 0 0 0 0 0 0 0 16.68012 0 0 0 0 0 12.9021 15.84683 0 0 0 14.19923 0 0 15.7579 0 15.12946 0 15.64864 0 0 0 14.39411 14.31103 16.33491 0 13.62574 16.20144 14.91211 0 P48454 PP2BC_HUMAN "Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform, EC 3.1.3.16 (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)" PPP3CC CALNA3 CNA3 Homo sapiens (Human) brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; protein serine/threonine phosphatase complex [GO:0008287] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; protein serine/threonine phosphatase complex [GO:0008287]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470] calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872] GO:0004723; GO:0005516; GO:0005737; GO:0005829; GO:0005955; GO:0006470; GO:0007420; GO:0008287; GO:0033173; GO:0033192; GO:0046872; GO:0070886; GO:0097720; GO:0098793; GO:0098978; GO:1900244; GO:1901386; GO:1901387; GO:1905665; GO:1905949 EGRLEEEVALK 16.92000008 1 1 0 1272.145119 0 0 12.50264 0 0 14.69264 0 10.68264 0 0 0 0 0 14.45607 0 0 13.23838 0 0 12.61398 11.57588 15.60628 0 0 0 0 14.4016 0 0 0 0 15.2146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48546 GIPR_HUMAN "Gastric inhibitory polypeptide receptor, GIP-R (Glucose-dependent insulinotropic polypeptide receptor)" GIPR Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584] G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888] GO:0002029; GO:0004888; GO:0005886; GO:0006091; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007204; GO:0007584; GO:0008528; GO:0009749; GO:0016021; GO:0016519; GO:0017046; GO:0031018; GO:0032024; GO:0038192; GO:0043950; GO:0048678; GO:0050796; GO:0051592; GO:0070542; GO:0120022 QLPERAFR 21.62999916 1 1 0.250296485 1018.430424 15.53631 15.31723 0 16.33716 0 0 0 0 16.14358 0 0 0 0 0 0 16.08253 16.45207 0 0 0 0 17.16245 0 0 0 0 0 16.31901 0 0 15.20692 15.51065 15.23037 0 0 15.65948 0 0 16.06474 0 0 0 14.43228 16.92644 16.42279 0 0 0 P48551 INAR2_HUMAN "Interferon alpha/beta receptor 2, IFN-R-2, IFN-alpha binding protein, IFN-alpha/beta receptor 2 (Interferon alpha binding protein) (Type I interferon receptor 2)" IFNAR2 IFNABR IFNARB Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]; cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905] GO:0004896; GO:0004905; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0007166; GO:0007259; GO:0009615; GO:0019221; GO:0019901; GO:0019962; GO:0035455; GO:0035456; GO:0051607; GO:0060337; GO:0098586 MLLSQNAFIFR 17.03000069 1 1 0.363898661 1355.58003 17.10367 0 0 0 0 0 0 16.91567 16.00985 0 16.90299 0 0 0 0 0 0 0 0 0 16.62296 0 0 0 16.19458 0 0 0 15.77386 0 16.55559 16.07123 16.697 15.85044 0 16.49685 16.72244 16.04882 0 16.24434 16.34139 15.56427 0 15.02828 0 0 15.28232 16.39562 P48552 NRIP1_HUMAN Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140) NRIP1 Homo sapiens (Human) cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944] estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0000122; GO:0000785; GO:0000978; GO:0001543; GO:0001650; GO:0003713; GO:0003714; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007623; GO:0016607; GO:0016922; GO:0019915; GO:0030331; GO:0032922; GO:0035259; GO:0042826; GO:0045944; GO:0046965; GO:0071392 GGNSVTSR 8.619999886 1 1 0.268089935 776.5582048 0 21.42441 0 0 0 0 22.56304 0 0 0 0 0 0 0 17.53389 17.38414 0 0 0 16.96992 0 0 0 0 18.90318 0 0 0 0 0 0 0 22.52046 21.32101 18.48248 0 19.46584 17.94281 0 17.47121 0 23.112 0 0 0 0 20.25338 0 P48553 TPC10_HUMAN "Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein, EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1, TRAPP subunit TMEM1)" TRAPPC10 EHOC1 TMEM1 Homo sapiens (Human) early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071 EELLPK 8.909999847 1 1 0.148417546 728.122666 15.17627 0 0 0 12.78524 0 0 13.53232 0 0 0 14.95018 0 14.59807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.31337 0 0 0 0 0 0 0 0 0 0 0 P48556 PSMD8_HUMAN 26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31) PSMD8 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0022624; GO:0043161 KSPNLSK 6.599999905 0.027521163 0.027521163 0.162705118 773.0910569 0 0 12.2981 0 0 0 0 0 0 0 16.50685 16.23527 14.52794 0 15.74074 15.18063 0 0 15.00676 14.35494 0 14.42394 0 0 0 0 16.57494 13.87238 15.53764 15.37279 0 0 0 16.0526 0 0 0 16.25862 0 0 14.44812 15.01362 0 0 0 0 16.6292 0 P48594 SPB4_HUMAN "Serpin B4 (Leupin) (Peptidase inhibitor 11, PI-11) (Squamous cell carcinoma antigen 2, SCCA-2)" SERPINB4 PI11 SCCA2 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162] enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0004867; GO:0005615; GO:0005737; GO:0010466; GO:0010951; GO:0019899; GO:0030162; GO:0042270 SVQMMR 3.190000057 1 1 0.242876771 768.1807788 0 0 18.34989 17.58006 0 0 0 19.71088 0 0 0 0 17.70296 0 0 0 0 0 15.78265 0 0 0 0 0 0 0 0 0 0 0 0 18.23704 0 0 0 0 0 0 17.74448 0 0 0 0 13.63093 0 0 0 0 P48595 SPB10_HUMAN "Serpin B10 (Bomapin) (Peptidase inhibitor 10, PI-10)" SERPINB10 PI10 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] cytosol [GO:0005829]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cytosol [GO:0005829]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0010951; GO:0030667; GO:0101003 LEDSYDLKSTLSSMGMSDAFSQSK 7.25 1 1 0 2659.543919 0 14.63851 14.75476 0 0 14.44635 15.02855 0 16.12797 0 0 14.32844 0 0 13.39322 0 0 0 0 14.13094 0 0 0 0 0 14.04377 0 0 0 0 0 0 0 0 15.23307 0 0 0 0 0 0 13.85551 0 0 0 0 0 0 P48634 PRC2A_HUMAN Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2) PRRC2A BAT2 G2 Homo sapiens (Human) cell differentiation [GO:0030154] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062 FTARGGR 2.920000076 0.739350438 0.739350438 0.078566936 763.9573695 0 0 0 14.93698 0 0 0 0 0 15.30964 16.14678 17.62052 16.43544 0 15.55914 0 0 0 0 16.17087 0 0 19.21737 17.45926 14.37875 0 0 0 0 15.20399 17.50447 18.4279 16.98011 17.81095 0 16.36009 18.02652 0 0 0 12.07497 15.5816 0 17.08528 0 0 17.54742 0 P48643 TCPE_HUMAN "T-complex protein 1 subunit epsilon, TCP-1-epsilon (CCT-epsilon)" CCT5 CCTE KIAA0098 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874 LGFAGLVQEISFGTTKDK 5.570000172 1 1 0.167807133 1908.944355 0 0 21.1893 0 0 0 0 0 0 0 20.63477 20.3568 0 0 0 0 0 0 0 0 0 0 0 0 0 18.72664 0 0 0 0 18.25617 0 0 0 20.78612 0 0 0 21.24161 0 0 0 0 18.48227 0 0 0 0 P48664 EAA4_HUMAN Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6) SLC1A6 EAAT4 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504] integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504] glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0006836; GO:0007268; GO:0015175; GO:0015183; GO:0015501; GO:0015810; GO:0015813; GO:0016020; GO:0045111; GO:0045202; GO:0046872; GO:0098712; GO:0098796 GGNESAM 4.260000229 0.117794767 0.117794767 0.306313731 665.9023223 16.66728 15.60071 16.48793 0 0 0 0 0 16.70096 0 0 0 0 0 0 15.61083 17.96878 0 0 0 0 17.86779 0 0 0 0 16.38257 16.47487 0 0 16.05163 15.20357 16.49084 16.80887 15.78863 17.35974 17.00318 16.40104 16.78766 16.28974 16.35229 16.12761 16.0804 16.66091 16.00066 14.96917 16.34354 16.20218 P48668 K2C6C_HUMAN "Keratin, type II cytoskeletal 6C (Cytokeratin-6C, CK-6C) (Cytokeratin-6E, CK-6E) (Keratin K6h) (Keratin-6C, K6C) (Type-II keratin Kb12)" KRT6C KRT6E Homo sapiens (Human) intermediate filament cytoskeleton organization [GO:0045104] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; intermediate filament cytoskeleton organization [GO:0045104] GO:0005829; GO:0005882; GO:0045095; GO:0045104; GO:0070062 NLDLDSIIAEVK 35.97000122 1 1 0.49886175 1330.933123 18.68451 18.39654 15.04518 0 18.31794 17.98781 18.75218 18.75999 0 0 0 0 0 18.24176 0 0 0 18.61377 0 0 0 0 17.88731 0 0 0 0 0 0 0 19.05411 0 0 19.94614 18.91449 0 0 0 0 0 0 16.57355 0 0 18.1065 0 0 18.90485 P48681 NEST_HUMAN Nestin NES Nbla00170 Homo sapiens (Human) brain development [GO:0007420]; cell projection morphogenesis [GO:0048858]; central nervous system development [GO:0007417]; embryonic camera-type eye development [GO:0031076]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; positive regulation of intermediate filament depolymerization [GO:0030844]; positive regulation of neural precursor cell proliferation [GO:2000179]; stem cell proliferation [GO:0072089] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; CCR5 chemokine receptor binding [GO:0031730]; intermediate filament binding [GO:0019215]; brain development [GO:0007420]; cell projection morphogenesis [GO:0048858]; central nervous system development [GO:0007417]; embryonic camera-type eye development [GO:0031076]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; positive regulation of intermediate filament depolymerization [GO:0030844]; positive regulation of neural precursor cell proliferation [GO:2000179]; stem cell proliferation [GO:0072089] CCR5 chemokine receptor binding [GO:0031730]; intermediate filament binding [GO:0019215] GO:0000086; GO:0005737; GO:0005882; GO:0007417; GO:0007420; GO:0019215; GO:0030844; GO:0031076; GO:0031730; GO:0032091; GO:0043086; GO:0043524; GO:0045111; GO:0048858; GO:0072089; GO:2000179 SPTSPR 15.72999954 1 1 0.305645174 643.1767544 16.8695 0 18.29173 17.76147 0 0 18.19915 0 19.47171 0 0 0 18.35073 0 17.98532 0 0 0 0 17.35596 17.74807 0 0 18.20135 0 0 0 0 0 0 19.59162 0 19.88712 16.6517 0 18.31475 0 0 0 19.24353 0 0 16.72333 18.98116 0 0 0 0 P48729 KC1A_HUMAN "Casein kinase I isoform alpha, CKI-alpha, EC 2.7.11.1 (CK1)" CSNK1A1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000776; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007049; GO:0007165; GO:0007166; GO:0016020; GO:0016055; GO:0016607; GO:0018105; GO:0019082; GO:0030877; GO:0032436; GO:0036064; GO:0043161; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1904424 MASSSGSK 18.98999977 1 1 0.097096613 769.8043147 15.50831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48730 KC1D_HUMAN "Casein kinase I isoform delta, CKI-delta, CKId, EC 2.7.11.1 (Tau-protein kinase CSNK1D, EC 2.7.11.26)" CSNK1D HCKID Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; signal transduction [GO:0007165]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; signal transduction [GO:0007165]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321] GO:0001934; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0006468; GO:0007020; GO:0007030; GO:0007165; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0033116; GO:0034067; GO:0036064; GO:0042752; GO:0043005; GO:0045296; GO:0048208; GO:0048471; GO:0050321; GO:0051225; GO:0061512; GO:0071539; GO:0090263; GO:0106310; GO:1905426; GO:1905515; GO:1990090; GO:2000052 FSLKTVLLLADQMISR 4.78000021 0.315631777 0.315631777 0.181695848 1835.682067 0 17.55433 17.12333 0 0 12.75087 0 0 0 0 14.95185 17.20745 13.45244 14.92007 0 15.72003 0 0 0 16.91225 17.1551 18.42368 16.87651 15.30793 0 0 16.97784 16.53596 0 0 17.28538 0 17.48582 16.13692 13.08964 18.40095 17.44351 17.31167 0 0 0 14.46023 0 13.84232 15.04971 12.55426 0 0 P48735 IDHP_HUMAN "Isocitrate dehydrogenase [NADP], mitochondrial, IDH, EC 1.1.1.42 (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)" IDH2 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099] isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] GO:0000287; GO:0004450; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0005975; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287; GO:0070062 AGTFKMVFTPK 6.579999924 1 1 0.37180717 1242.464731 0 15.76427 0 0 0 15.55934 16.26741 14.86082 14.99482 0 13.9864 0 17.17992 14.18368 0 0 0 16.54278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21207 0 0 0 16.20453 0 0 16.69979 0 0 0 0 0 0 0 0 P48736 PK3CG_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, PI3-kinase subunit gamma, PI3K-gamma, PI3Kgamma, PtdIns-3-kinase subunit gamma, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma, PtdIns-3-kinase subunit p110-gamma, p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG, EC 2.7.11.1) (p120-PI3K)" PIK3CG Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098]" "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]" GO:0001525; GO:0001819; GO:0002250; GO:0002407; GO:0002675; GO:0002679; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006897; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0010595; GO:0010818; GO:0010897; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030593; GO:0032252; GO:0033628; GO:0035004; GO:0035005; GO:0035022; GO:0035747; GO:0036092; GO:0042098; GO:0042110; GO:0042802; GO:0043303; GO:0043406; GO:0045087; GO:0046854; GO:0046875; GO:0046934; GO:0048015; GO:0051897; GO:0052742; GO:0052812; GO:0055118; GO:0070527; GO:0071320; GO:0072672; GO:0097284; GO:0106310; GO:1903169; GO:2000270 LFSSVK 1.950000048 0.10599222 0.10599222 0.194656049 680.1827186 0 0 0 0 0 0 10.85496 0 16.00883 0 0 0 0 0 0 0 0 0 0 0 15.48249 0 0 0 0 0 0 0 0 0 0 16.87348 15.30719 0 0 0 0 0 17.50135 16.67311 0 0 0 0 0 0 0 0 P48751 B3A3_HUMAN "Anion exchange protein 3, AE 3, Anion exchanger 3 (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3)" SLC4A3 AE3 Homo sapiens (Human) bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857] GO:0005452; GO:0005886; GO:0005887; GO:0009897; GO:0015106; GO:0015301; GO:0015701; GO:0016020; GO:0022857; GO:0050801; GO:0051453; GO:0055085; GO:0061337; GO:0086001; GO:0150104 LTVPTGLSVTSPDK 1.429999948 1 1 0.57515725 1414.693356 0 0 0 0 0 0 0 0 0 0 20.68279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.39496 0 0 0 0 0 0 0 0 0 18.00862 0 0 0 0 0 0 17.81251 0 P48960 AGRE5_HUMAN Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta ] ADGRE5 CD97 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0007267; GO:0016020; GO:0030667; GO:0070062 DPPAKDVMPGPR 5.880000114 1 1 0.133441067 1294.69027 0 0 0 14.88079 0 13.25806 15.37204 0 0 14.05959 0 0 0 0 15.9713 0 0 17.64869 11.8604 0 15.3672 0 0 15.35658 0 0 19.57505 0 0 0 0 21.90153 0 0 0 0 18.43285 0 0 0 0 18.92819 0 0 0 0 0 17.45496 P49005 DPOD2_HUMAN DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50) POLD2 Homo sapiens (Human) DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035] delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0042575; GO:0043625; GO:0071897 MFSEQAAQR 9.430000305 1 1 0.312660505 1084.345583 0 0 11.41837 15.97196 0 13.83837 13.65967 12.678 0 0 15.51015 0 0 14.64499 0 15.65526 14.92677 0 15.69314 14.94137 0 0 0 14.8734 0 0 0 0 0 0 16.78497 0 0 0 0 16.1767 0 16.20354 0 0 0 0 15.65116 0 16.20381 0 0 0 P49006 MRP_HUMAN "MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate, Mac-MARCKS, MacMARCKS)" MARCKSL1 MLP MRP Homo sapiens (Human) actin filament organization [GO:0007015]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; actin filament organization [GO:0007015]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284] actin filament binding [GO:0051015]; calmodulin binding [GO:0005516] GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0007015; GO:0007417; GO:0008284; GO:0051015; GO:0070062 ANGQENGHVKSNGDLSPK 1.610000014 1 1 4.70E-13 1850.440624 0 0 0 0 0 15.21611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.20903 0 0 0 0 0 0 0 0 P49069 CAMLG_HUMAN Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand) CAMLG CAML GET2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ubiquitin protein ligase binding [GO:0031625]; B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192] ubiquitin protein ligase binding [GO:0031625] GO:0001782; GO:0001881; GO:0005737; GO:0005783; GO:0005789; GO:0006952; GO:0007165; GO:0007173; GO:0016020; GO:0016192; GO:0030176; GO:0031397; GO:0031625; GO:0032435; GO:0043529; GO:0045048; GO:0050821; GO:0071816 MESMAVATDGGERPGVPAGSGLSASQRR 11.56000042 1 1 7.31E-12 2791.509355 0 8.971267 0 0 9.735036 13.41425 0 13.93827 13.24718 15.30583 0 11.45457 14.7081 13.01662 0 13.29079 13.11484 0 0 0 13.33733 14.47991 0 15.40569 0 13.37091 14.70889 0 13.08028 14.71436 12.90199 0 0 0 0 0 0 0 0 9.918921 0 15.53038 15.95489 0 11.24393 0 0 0 P49116 NR2C2_HUMAN Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4) NR2C2 TAK1 TR4 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007399; GO:0008270; GO:0030154; GO:0040019; GO:0043565; GO:0045944; GO:0048856; GO:1990837 TSPSPR 2.140000105 1 1 0.137679902 644.464459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.55232 0 0 0 0 16.39491 0 19.00511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49137 MAPK2_HUMAN "MAP kinase-activated protein kinase 2, MAPK-activated protein kinase 2, MAPKAP kinase 2, MAPKAP-K2, MAPKAPK-2, MK-2, MK2, EC 2.7.11.1" MAPKAPK2 Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0002224; GO:0004672; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006691; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0032760; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0043488; GO:0044351; GO:0046777; GO:0048010; GO:0048839; GO:0051019; GO:0070062; GO:0070935; GO:0106310; GO:1900034 MGQYEFPNPEWSEVSEEVK 2.910000086 0.561289847 0.561289847 0.315508467 2301.876975 17.80699 17.00659 14.64977 16.35867 15.74386 17.28759 17.94175 16.24029 15.30784 14.89923 0 0 17.98816 15.3582 15.5598 0 17.74988 17.77516 16.67278 17.60577 0 0 0 20.31006 17.31916 0 17.40271 18.03987 0 18.95056 16.02647 18.91776 16.87334 17.63815 17.74329 0 18.14932 18.04397 18.11877 18.22666 18.76389 18.71753 18.52293 16.1012 14.21155 17.07256 0 18.06788 P49146 NPY2R_HUMAN "Neuropeptide Y receptor type 2, NPY2-R (NPY-Y2 receptor, Y2 receptor)" NPY2R Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151] calcium channel regulator activity [GO:0005246]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; signaling receptor activity [GO:0038023] GO:0001601; GO:0003151; GO:0003214; GO:0004983; GO:0005246; GO:0005886; GO:0005887; GO:0005929; GO:0007193; GO:0007626; GO:0038023; GO:0097730 GELVPDPEPELIDSTK 11.06000042 1 1 0.640865859 1740.84419 0 20.43828 19.47298 0 0 0 0 0 18.13845 0 0 0 0 18.6473 0 18.95478 0 20.16969 0 0 0 0 0 0 0 18.87914 18.76103 0 0 0 0 0 0 19.76769 0 0 0 19.61745 19.66566 18.57795 0 0 0 0 0 0 17.06151 0 P49189 AL9A1_HUMAN "4-trimethylaminobutyraldehyde dehydrogenase, TMABA-DH, TMABALDH, EC 1.2.1.47 (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1, EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase, EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed ]" ALDH9A1 ALDH4 ALDH7 ALDH9 Homo sapiens (Human) carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; protein homotetramerization [GO:0051289] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; protein homotetramerization [GO:0051289] 1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878] GO:0004029; GO:0005737; GO:0005829; GO:0006081; GO:0019145; GO:0033737; GO:0042136; GO:0042445; GO:0043878; GO:0045329; GO:0047105; GO:0051289; GO:0070062 GIKPVTLELGGK 14.98999977 0.874573648 0.874573648 0.346343713 1214.157999 15.56209 13.50115 12.93104 0 0 0 0 15.54071 0 0 15.83389 0 0 0 0 0 0 0 0 13.41228 0 0 0 0 0 0 0 13.61108 0 0 0 16.59571 0 0 0 0 0 0 15.67694 0 0 0 0 0 17.26531 0 0 0 P49257 LMAN1_HUMAN Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1) LMAN1 ERGIC53 F5F8D Homo sapiens (Human) blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031] mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0051082; GO:0062023; GO:0070062; GO:1903215 EISEKEK 19.73999977 1 1 0.177546523 862.6371299 14.79028 15.37094 0 15.27363 15.26465 0 15.6993 15.95851 0 16.66925 0 14.65342 15.67819 13.51701 15.53833 0 0 15.35277 15.45726 14.59304 0 16.65267 0 16.36337 16.53109 0 15.74879 15.70495 0 16.35635 16.60982 16.61372 15.50792 15.55325 15.31626 15.73845 16.01346 13.99127 16.82591 15.78012 15.6086 13.8024 15.04371 13.85962 16.02188 14.26653 15.47727 15.80328 P49321 NASP_HUMAN "Nuclear autoantigenic sperm protein, NASP" NASP Homo sapiens (Human) blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] histone binding [GO:0042393]; protein-containing complex binding [GO:0044877] GO:0000082; GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0006336; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0043486; GO:0044877 EKGGQEK 5.130000114 1 1 0.317991728 777.0715506 15.97133 0 15.5588 15.33776 15.42007 0 14.82141 13.94581 12.13544 15.60292 0 15.10436 16.06084 15.50777 0 0 15.37615 15.64523 15.49268 15.21113 16.5339 15.74199 15.77138 15.98841 15.05309 16.60199 15.9655 0 15.75262 15.86399 0 0 15.77011 0 16.53864 14.38912 16.62472 16.77567 0 16.15831 15.1704 14.59735 16.92345 0 0 16.51793 18.86146 0 P49327 FAS_HUMAN "Fatty acid synthase, EC 2.3.1.85 (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase, EC 2.3.1.38; [Acyl-carrier-protein] S-malonyltransferase, EC 2.3.1.39; 3-oxoacyl-[acyl-carrier-protein] synthase, EC 2.3.1.41; 3-oxoacyl-[acyl-carrier-protein] reductase, EC 1.1.1.100; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase, EC 4.2.1.59; Enoyl-[acyl-carrier-protein] reductase, EC 1.3.1.39; Acyl-[acyl-carrier-protein] hydrolase, EC 3.1.2.14 ]" FASN FAS Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649]" "(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]" GO:0001649; GO:0002068; GO:0003723; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006631; GO:0006633; GO:0006954; GO:0008611; GO:0008659; GO:0008693; GO:0016020; GO:0016295; GO:0016296; GO:0030223; GO:0030224; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0045296; GO:0047117; GO:0047451; GO:0070062; GO:0071353; GO:0090557 AAAYR 7.940000057 0.017480614 0.017480614 0.193211443 551.3269721 15.13384 0 15.8526 15.58512 15.99129 14.95807 15.59851 15.53635 13.23227 15.6849 16.2148 0 0 15.64056 15.96317 14.32886 0 15.44984 0 15.69338 14.66404 0 17.58921 0 0 0 0 14.1608 15.24138 13.7013 15.35153 15.2316 0 14.41868 0 16.00933 16.31959 16.79436 16.88716 15.33675 15.44453 15.42178 15.50231 12.04421 15.59919 0 14.39638 16.14554 P49335 PO3F4_HUMAN "POU domain, class 3, transcription factor 4 (Brain-specific homeobox/POU domain protein 4, Brain-4, Brn-4) (Octamer-binding protein 9, Oct-9) (Octamer-binding transcription factor 9, OTF-9)" POU3F4 BRN4 OTF9 Homo sapiens (Human) brain development [GO:0007420]; cochlea morphogenesis [GO:0090103]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; cochlea morphogenesis [GO:0090103]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007605; GO:0090103; GO:1990837; GO:2001054 TSIEVSVKGVLETHFLK 10.97000027 1 1 6.84E-13 1887.808832 14.80157 0 13.77662 0 18.34983 0 0 16.48417 15.83886 0 16.53779 0 10.44891 0 17.63298 14.63444 0 15.36305 0 0 13.8903 16.07635 0 15.1858 0 0 15.8035 17.32786 12.97958 0 0 0 0 14.03209 0 0 17.48459 0 15.42522 11.88137 14.18818 14.15638 0 0 0 10.85888 15.49885 0 P49406 RM19_HUMAN "39S ribosomal protein L19, mitochondrial, L19mt, MRP-L19 (39S ribosomal protein L15, mitochondrial, L15mt, MRP-L15) (Mitochondrial large ribosomal subunit protein bL19m)" MRPL19 KIAA0104 MRPL15 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005634; GO:0005739; GO:0005743; GO:0005762; GO:0032543 LDDSLLYLR 6.019999981 1 1 0.002468858 1106.411189 14.69288 14.23449 14.31216 13.02117 0 12.48492 15.11727 9.055379 12.46113 10.79951 0 14.88296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49407 ARRB1_HUMAN Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2) ARRB1 ARR1 Homo sapiens (Human) G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511] angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625] GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0008134; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0035066; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:0090240; GO:1990763 KDLFVANVQSFPPAPEDK 2.400000095 1 1 0.149603802 2002.657456 0 18.90118 0 0 21.26469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49411 EFTU_HUMAN "Elongation factor Tu, mitochondrial, EF-Tu (P43)" TUFM Homo sapiens (Human) mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; synapse [GO:0045202] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0042645; GO:0045202; GO:0045471; GO:0070062; GO:0070125 TVVTGIEMFHK 6.460000038 0.003787601 0.003787601 0.024024455 1278.266107 16.59906 0 0 0 0 0 0 0 15.83541 0 0 0 0 0 0 0 0 0 12.46566 0 0 0 0 0 0 0 13.97077 0 16.02111 0 13.76128 12.69933 11.25941 15.1661 0 0 0 15.71043 0 0 0 0 0 0 0 0 0 0 P49419 AL7A1_HUMAN "Alpha-aminoadipic semialdehyde dehydrogenase, Alpha-AASA dehydrogenase, EC 1.2.1.31 (Aldehyde dehydrogenase family 7 member A1, EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase, EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase, P6c dehydrogenase)" ALDH7A1 ATQ1 Homo sapiens (Human) cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043] GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006081; GO:0007605; GO:0008802; GO:0019285; GO:0042426; GO:0042802; GO:0043878; GO:0070062 HTGGGR 6.489999771 0.258735925 0.258735925 0.253385215 583.6021481 15.53282 15.63867 16.27815 15.2467 16.08066 15.85806 15.64437 15.88746 16.82583 15.99194 15.21709 16.87638 16.6315 0 16.30861 15.7175 14.95747 16.39594 16.52035 16.96335 16.69306 15.72468 17.19534 16.37742 15.86381 16.98718 0 0 0 0 0 15.5696 15.86668 15.72119 15.6987 17.22565 17.25128 17.58161 0 15.95624 16.63616 16.132 16.72974 0 0 0 16.39374 0 P49427 UB2R1_HUMAN "Ubiquitin-conjugating enzyme E2 R1, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme R1, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1)" CDC34 UBCH3 UBE2R1 Homo sapiens (Human) cellular protein modification process [GO:0006464]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] GO:0000082; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006270; GO:0006464; GO:0006511; GO:0016567; GO:0016607; GO:0035458; GO:0043161; GO:0043525; GO:0043951; GO:0061631; GO:0070848; GO:0070936; GO:0090261 ALLLELK 3.599999905 1 1 0.290911781 800.8290204 0 0 0 0 0 0 0 0 18.39124 0 0 0 0 0 17.18021 0 0 0 0 0 0 0 0 0 19.7053 0 0 18.61979 0 0 0 0 0 18.69208 19.47912 0 0 0 0 0 0 0 0 18.23837 0 17.14798 0 19.58303 P49454 CENPF_HUMAN "Centromere protein F, CENP-F (AH antigen) (Kinetochore protein CENPF) (Mitosin)" CENPF Homo sapiens (Human) "cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591]" "axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]" "axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591]" chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803] GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008017; GO:0008022; GO:0009410; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0070840; GO:0071897; GO:0097539; GO:0140297 ALLSALELKK 5.619999886 0.208951995 0.208951995 0.227432605 1086.0721 12.80112 11.18408 12.18836 0 14.97518 13.58138 13.70158 14.63905 13.51821 0 15.03546 10.7962 0 14.12877 14.15478 0 15.32685 0 0 0 15.37425 0 13.77324 0 16.30609 14.68406 0 0 0 15.46023 0 0 15.86924 0 15.3473 0 0 0 0 0 18.27329 0 0 0 16.41875 0 0 0 P49585 PCY1A_HUMAN "Choline-phosphate cytidylyltransferase A, EC 2.7.7.15 (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A, CCT A, CT A) (Phosphorylcholine transferase A)" PCYT1A CTPCT PCYT1 Homo sapiens (Human) CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656] calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803] GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006656; GO:0006657; GO:0031210; GO:0042587; GO:0042802; GO:0042803 MLQAISPK 1.399999976 0.258276552 0.258276552 0.249745281 888.8217374 19.00346 20.71278 11.10868 15.2703 17.24454 17.10128 0 0 18.11054 0 0 0 0 0 0 0 0 0 0 0 16.43887 0 0 0 0 20.05757 0 0 0 0 20.33097 0 0 17.7533 0 0 18.1584 0 18.10364 0 0 18.2475 16.70736 17.55687 17.57073 0 18.00325 18.04474 P49588 SYAC_HUMAN "Alanine--tRNA ligase, cytoplasmic, EC 6.1.1.7 (Alanyl-tRNA synthetase, AlaRS) (Renal carcinoma antigen NY-REN-42)" AARS1 AARS Homo sapiens (Human) alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0070062; GO:0140018 AIQGLR 1.179999948 1 1 0.200917717 658.4194563 0 15.92869 13.7701 0 0 0 0 0 0 0 0 15.49266 0 0 0 0 0 0 0 0 0 0 0 0 15.76573 0 0 15.79005 16.38461 0 0 15.50072 0 0 16.25049 0 16.79208 0 0 0 0 0 0 0 0 16.64283 0 0 P49589 SYCC_HUMAN "Cysteine--tRNA ligase, cytoplasmic, EC 6.1.1.16 (Cysteinyl-tRNA synthetase, CysRS)" CARS1 CARS Homo sapiens (Human) cysteinyl-tRNA aminoacylation [GO:0006423] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423] ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0005829; GO:0006423; GO:0042802; GO:0042803; GO:0046872 MKIPPSEMFLSETDK 2.559999943 1 1 0.276065849 1783.618212 0 0 0 0 0 0 0 15.84206 0 0 16.09333 16.4387 14.15528 0 0 0 14.63836 13.95754 0 0 0 0 0 11.14207 14.51188 15.38843 14.12671 0 0 0 0 16.63707 19.51906 0 0 0 15.8657 0 0 0 0 0 0 0 0 0 13.52686 0 P49593 PPM1F_HUMAN "Protein phosphatase 1F, EC 3.1.3.16 (Ca(2+)/calmodulin-dependent protein kinase phosphatase, CaM-kinase phosphatase, CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog, hFem-2)" PPM1F KIAA0015 POPX2 Homo sapiens (Human) "cellular response to xenobiotic stimulus [GO:0071466]; histone dephosphorylation [GO:0016576]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]; regulation of protein localization [GO:0032880]" cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to xenobiotic stimulus [GO:0071466]; histone dephosphorylation [GO:0016576]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]; regulation of protein localization [GO:0032880]" calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0004722; GO:0005634; GO:0005829; GO:0006469; GO:0006470; GO:0008138; GO:0010628; GO:0010634; GO:0010811; GO:0016576; GO:0030335; GO:0032880; GO:0032991; GO:0033137; GO:0033192; GO:0035970; GO:0043280; GO:0044387; GO:0045892; GO:0045927; GO:0046872; GO:0048471; GO:0050921; GO:0051224; GO:0051496; GO:0051894; GO:0070262; GO:0071466; GO:0097193; GO:2000048 SSGAPQK 2.859999895 1 1 0.300119991 673.8589272 16.87342 0 15.16414 15.55099 15.13484 15.17577 15.2916 15.90517 0 13.9482 17.15177 15.69609 16.05723 0 0 15.73325 15.70257 15.91088 15.9084 0 0 0 16.84737 15.52886 15.97603 14.33851 0 15.48272 0 16.41403 17.3767 0 15.54337 0 15.58268 16.77655 16.39222 17.53204 17.75512 16.72128 0 0 15.39211 0 0 0 16.77747 0 P49619 DGKG_HUMAN "Diacylglycerol kinase gamma, DAG kinase gamma, EC 2.7.1.107 (Diglyceride kinase gamma, DGK-gamma)" DGKG DAGK3 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951] GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005829; GO:0005856; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0048666; GO:0050773; GO:0090038 YTVHERCVSR 8.359999657 1 1 0.025729924 1306.733199 0 16.58093 0 0 0 15.29678 0 0 0 0 0 0 0 0 0 15.85519 0 0 0 0 0 0 0 0 0 15.50083 0 0 0 11.92756 13.74595 0 0 0 0 15.75751 14.16075 0 0 0 0 0 0 13.73778 0 0 0 0 P49639 HXA1_HUMAN Homeobox protein Hox-A1 (Homeobox protein Hox-1F) HOXA1 HOX1F Homo sapiens (Human) abducens nerve formation [GO:0021599]; anatomical structure morphogenesis [GO:0009653]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; abducens nerve formation [GO:0021599]; anatomical structure morphogenesis [GO:0009653]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0007605; GO:0007634; GO:0009653; GO:0021599; GO:0042473; GO:0042802; GO:0043565; GO:0045944; GO:0048702; GO:0048839; GO:0048844; GO:0050795; GO:0050890; GO:0050905; GO:0060840; GO:0060876; GO:0090102; GO:0090103; GO:1990837 NPPKTGK 1.980000019 0.320195377 0.320195377 0.07351725 741.5393552 15.72514 13.78709 13.17941 0 12.56483 16.50126 15.19361 0 15.63092 0 16.88511 0 15.77375 0 13.39984 0 14.43193 0 0 0 13.54057 0 0 0 0 16.77115 15.2435 0 14.13156 16.60693 15.0325 15.91337 0 15.74247 16.08468 15.5783 0 15.24596 13.61169 0 0 17.1658 12.58691 0 0 15.31378 11.48659 13.89045 P49641 MA2A2_HUMAN "Alpha-mannosidase 2x, EC 3.2.1.114 (Alpha-mannosidase IIx, Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)" MAN2A2 MANA2X Homo sapiens (Human) mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]" "alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]" GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872 RTLGLFQHHDAITGTAK 4.690000057 1 1 0.012192353 1865.245383 10.11702 14.49385 12.41719 0 14.35213 0 14.11261 0 16.74252 13.97243 13.47662 0 0 14.31585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49703 ARL4D_HUMAN ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) ARL4D ARF4L Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0009306; GO:0016192 GNHLTEMAPTASSFLPHFQALHVVVIGLDSAGK 4.480000019 1 1 6.86E-12 3459.96953 14.13951 0 10.85804 12.30672 0 13.30061 0 13.09757 13.02542 14.83254 14.439 15.00665 0 0 13.27358 0 13.53423 0 0 0 0 0 12.64082 14.45201 14.18945 12.3463 0 9.890716 0 9.567399 15.21068 10.95296 15.27484 15.06084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49711 CTCF_HUMAN Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) CTCF Homo sapiens (Human) "chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; genomic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; genomic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0001221; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006357; GO:0007059; GO:0008270; GO:0008285; GO:0010216; GO:0010628; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0043035; GO:0043565; GO:0045892; GO:0045893; GO:0070602; GO:0071459; GO:0071514 SNLDRHMK 4.309999943 1 1 0.172773189 1000.110154 0 0 15.01872 14.9187 0 0 12.18374 15.60571 15.85475 10.47291 15.21879 15.50402 13.74346 0 13.84593 13.87095 14.54781 14.27895 15.09199 13.75711 14.61846 15.1613 16.33723 15.10012 0 0 15.50542 0 0 0 0 0 15.28624 0 16.96215 0 0 0 0 14.08871 15.21702 0 0 15.98352 0 0 0 0 P49720 PSB3_HUMAN Proteasome subunit beta type-3 (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain) PSMB3 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" threonine-type endopeptidase activity [GO:0004298] GO:0000502; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0043161; GO:0070062 MSIMSYNGGAVMAMK 1.720000029 1 1 0.194070092 1639.650919 16.21867 14.99582 15.79513 15.62715 0 14.84591 0 16.00542 0 17.59726 0 0 0 0 14.86923 0 0 0 0 15.35331 0 0 0 0 15.76061 16.53528 0 16.35778 0 15.36496 0 0 0 0 0 0 0 0 0 0 15.95345 0 16.14312 15.02344 14.57646 0 15.19714 0 P49736 MCM2_HUMAN DNA replication licensing factor MCM2 (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28) MCM2 BM28 CCNL1 CDCL1 KIAA0030 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-dependent DNA replication initiation [GO:0030174] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-dependent DNA replication initiation [GO:0030174]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697] GO:0000727; GO:0000781; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0016887; GO:0019899; GO:0030174; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775 ERVHPK 7.840000153 0.449966073 0.449966073 0.268832924 766.7921178 0 14.90869 0 0 0 0 17.3625 0 0 0 0 0 0 0 0 0 0 15.82293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.83155 0 12.04887 0 16.83023 0 16.56202 0 14.39007 0 0 0 21.43478 0 0 0 P49746 TSP3_HUMAN Thrombospondin-3 THBS3 TSP3 Homo sapiens (Human) bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931] calcium ion binding [GO:0005509]; heparin binding [GO:0008201] GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023 MQGFVESMKIILGGSMAR 8.18999958 0.354046583 0.354046583 0.084161075 1996.926125 16.91268 0 0 0 14.5581 15.82415 14.15064 12.7455 0 0 0 0 17.03911 12.81567 11.90973 11.06204 15.98703 14.70199 0 0 0 15.28256 14.84817 12.06439 15.50489 14.83148 0 11.35472 12.81272 0 15.00622 0 17.65635 0 0 0 0 14.06144 13.90746 0 0 16.17015 0 0 16.00303 13.98432 0 16.66541 P49750 YLPM1_HUMAN YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113) YLPM1 C14orf170 ZAP3 Homo sapiens (Human) regulation of telomere maintenance [GO:0032204] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; regulation of telomere maintenance [GO:0032204] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0032204 DEPPR 7.929999828 1 1 0.115285495 613.1569638 14.86987 15.31001 14.52318 0 10.21889 14.52729 0 0 15.21746 12.68696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.76019 0 0 17.70991 0 14.61502 0 0 0 0 0 0 P49754 VPS41_HUMAN Vacuolar protein sorting-associated protein 41 homolog (S53) VPS41 Homo sapiens (Human) cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017] GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042802; GO:0046872; GO:0048193; GO:1902501; GO:1902774 ILVADSLSLLK 1.610000014 1 1 0.069857143 1172.706464 12.03502 0 9.342105 12.25472 14.47064 12.69842 0 0 12.09741 0 9.591857 12.9937 9.61278 14.32983 12.80678 16.38993 16.4514 8.264584 12.80208 0 13.22074 0 0 0 8.841568 0 0 0 12.51167 12.53026 0 0 0 0 0 0 16.20332 0 0 12.78072 0 0 0 0 0 0 0 15.07511 P49756 RBM25_HUMAN "RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa, RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)" RBM25 RNPC7 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981 EKEMEADER 8.18999958 1 1 1.83E-12 1137.687028 13.90153 14.12804 14.79593 14.49864 11.3648 15.74406 15.95359 13.12839 10.02912 12.26546 12.45781 0 0 14.48457 11.14463 14.55713 15.34928 13.65084 15.98162 11.0778 14.8966 15.9849 15.38704 11.98545 14.64452 14.98872 13.76956 0 13.81708 0 14.99346 0 0 15.68402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49757 NUMB_HUMAN "Protein numb homolog, h-Numb (Protein S171)" NUMB C14orf41 Homo sapiens (Human) adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0005905; GO:0005925; GO:0007409; GO:0008013; GO:0010008; GO:0016323; GO:0019897; GO:0021670; GO:0021849; GO:0030136; GO:0030335; GO:0034332; GO:0045177; GO:0045294; GO:0045296; GO:0050769; GO:0098978; GO:0099149; GO:1903077 KAETDK 10.38000011 0.587427676 0.587427676 0.288445675 691.1229872 15.31472 0 0 0 16.97963 0 14.19249 15.75066 0 11.31071 15.32302 0 0 14.52041 14.5102 15.98765 15.45749 0 15.73809 15.91132 16.09926 0 15.41191 0 0 14.11756 15.6502 0 0 15.31555 0 15.48907 15.93505 15.889 16.38635 15.79091 0 17.36925 0 15.42107 0 15.2563 16.70431 0 15.97244 0 15.83717 16.39032 P49758 RGS6_HUMAN "Regulator of G-protein signaling 6, RGS6 (S914)" RGS6 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0019898; GO:0035556; GO:0043547 IPSVVTGTDIVQWLMK 1.190000057 1 1 2.06E-12 1785.943431 14.06131 13.90353 13.17122 13.39881 13.34979 14.27052 0 0 0 14.39351 11.97206 15.09172 14.06838 0 14.80559 0 0 0 13.85876 14.68753 0 0 0 0 0 0 0 0 0 0 0 13.53567 0 0 0 0 13.14802 0 0 0 0 0 0 0 0 0 14.59219 0 P49760 CLK2_HUMAN "Dual specificity protein kinase CLK2, EC 2.7.12.1 (CDC-like kinase 2)" CLK2 Homo sapiens (Human) negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0042802; GO:0043484; GO:0045721; GO:0046777; GO:0106310 GGARVALK 8.699999809 1 1 0.150818099 770.2921212 0 16.33956 14.66878 0 0 0 0 0 0 13.35995 15.16465 15.89577 0 0 14.12904 0 0 14.04517 0 0 0 0 0 0 16.69393 0 0 0 0 0 16.10583 0 15.9292 0 16.28645 15.98299 15.99619 14.86339 15.22134 13.32179 0 15.1395 15.43283 0 0 0 0 0 P49761 CLK3_HUMAN "Dual specificity protein kinase CLK3, EC 2.7.12.1 (CDC-like kinase 3)" CLK3 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723] GO:0001669; GO:0003723; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0016020; GO:0016607; GO:0042802; GO:0043484; GO:0045111; GO:0046777; GO:0106310 SQQSSKR 3.890000105 1 1 0.210072627 821.3392595 13.93647 12.74909 15.1281 0 0 15.75975 0 0 0 16.32252 0 0 16.09477 16.5803 0 0 0 15.48723 0 0 0 0 16.01865 0 14.27559 15.02391 14.96354 0 0 0 14.50802 6.408769 14.17546 12.72284 0 12.5924 0 0 0 0 0 0 0 0 16.5249 16.61723 0 0 P49763 PLGF_HUMAN "Placenta growth factor, PlGF" PGF PGFL PLGF Homo sapiens (Human) animal organ regeneration [GO:0031100]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172]; animal organ regeneration [GO:0031100]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172] GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0005172; GO:0005576; GO:0005615; GO:0007165; GO:0007267; GO:0007565; GO:0008083; GO:0008201; GO:0008284; GO:0009410; GO:0016020; GO:0030154; GO:0031100; GO:0032870; GO:0038084; GO:0042056; GO:0042802; GO:0044877; GO:0045766; GO:0048010; GO:0050930; GO:0051781; GO:0060754 EKMKPER 4.050000191 1 1 0.228221887 929.9838556 15.69901 0 15.51233 0 0 14.83089 0 16.09713 0 0 0 16.65006 15.5451 14.36391 0 0 14.9645 0 0 0 0 0 16.45231 0 0 0 0 0 15.34104 14.18133 15.78702 13.60353 0 15.57665 0 16.94254 15.99777 14.85002 16.32109 0 0 17.469 0 15.10344 14.10405 0 11.41137 15.2484 P49792 RBP2_HUMAN "E3 SUMO-protein ligase RanBP2, EC 2.3.2.- (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2, RanBP2) (p270)" RANBP2 NUP358 Homo sapiens (Human) centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; positive regulation of glucokinase activity [GO:0033133]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; positive regulation of glucokinase activity [GO:0033133]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789] GO:0000413; GO:0003723; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0016020; GO:0016925; GO:0019789; GO:0031267; GO:0031965; GO:0033133; GO:0042405; GO:0043231; GO:0044614; GO:0044615; GO:0046872; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068 EVADCFKK 4.170000076 1 1 0.018046783 994.5457831 16.3742 0 13.72737 0 13.48145 15.35255 0 0 12.72991 0 0 0 0 13.3225 0 12.73883 0 0 0 0 0 0 15.63033 14.79804 0 9.759493 0 11.83953 0 0 0 14.34418 0 0 0 0 0 0 0 14.18436 0 0 0 0 0 0 0 0 P49796 RGS3_HUMAN "Regulator of G-protein signaling 3, RGP3, RGS3" RGS3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0008277; GO:0009968 ADKMMK 2.99000001 0.16628854 0.16628854 0.174234514 722.4044718 0 14.38203 15.68244 15.68812 0 14.9036 0 0 15.93996 0 14.51113 14.87556 0 15.14149 13.70829 16.32286 15.73236 17.29005 0 0 13.82045 0 0 0 16.40893 0 15.5786 14.84572 0 14.38625 15.71908 0 0 15.5603 16.15534 16.45721 17.08534 0 0 0 15.49658 17.70088 15.47124 0 0 0 15.32848 15.68095 P49810 PSN2_HUMAN "Presenilin-2, PS-2, EC 3.4.23.- (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit ]" PSEN2 AD4 PS2 PSNL2 STM2 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018] "apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097]" "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]" GO:0000139; GO:0000776; GO:0004175; GO:0005634; GO:0005637; GO:0005743; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005813; GO:0005886; GO:0005887; GO:0005938; GO:0006509; GO:0006816; GO:0007219; GO:0007220; GO:0009986; GO:0016020; GO:0016324; GO:0016485; GO:0030018; GO:0030426; GO:0031594; GO:0032991; GO:0034205; GO:0035253; GO:0035556; GO:0042500; GO:0042987; GO:0043025; GO:0043066; GO:0043085; GO:0043198; GO:0045121; GO:0048471; GO:0050435; GO:0070765; GO:0110097; GO:1990456 YGAKHVIMLFVPVTLCMIVVVATIK 2.720000029 1 1 7.30E-12 2818.310089 0 13.02574 0 0 0 17.08818 14.39664 0 0 0 18.58334 0 0 15.7252 0 0 0 0 0 16.00972 0 0 0 0 0 0 0 15.99239 0 16.41442 12.51901 16.94658 0 0 0 15.04692 0 0 14.65256 19.84721 14.87494 0 0 0 14.81495 16.2048 0 0 P49815 TSC2_HUMAN Tuberin (Tuberous sclerosis 2 protein) TSC2 TSC4 Homo sapiens (Human) anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192] GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0014069; GO:0016020; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0043547; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525 SLRIARPPK 1.279999971 1 1 0.141864355 1038.011554 0 0 0 0 0 0 0 0 16.5804 0 0 13.87286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.77794 0 0 0 0 0 0 14.18137 0 0 14.39824 0 0 0 0 0 0 0 0 P49862 KLK7_HUMAN "Kallikrein-7, hK7, EC 3.4.21.117 (Serine protease 6) (Stratum corneum chymotryptic enzyme, hSCCE)" KLK7 PRSS6 SCCE Homo sapiens (Human) epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803] cornified envelope [GO:0001533]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] cornified envelope [GO:0001533]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803] metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0001533; GO:0002803; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0008233; GO:0008236; GO:0008544; GO:0022617; GO:0030141; GO:0097209 VRLPSR 9.300000191 0.372418612 0.372418612 0.308417661 727.7689079 0 14.26962 14.44479 12.99841 15.316 15.46687 0 16.67917 14.34206 0 14.11879 17.02679 0 14.14653 16.48805 13.08964 15.94854 14.28463 16.14869 16.74277 14.47977 14.17496 15.43899 0 16.2018 15.92021 15.68111 14.99951 0 0 0 16.24307 17.14794 0 15.84408 0 0 17.82189 17.87836 17.10889 17.90138 17.12174 15.56343 0 16.03075 15.80684 17.54222 0 P49863 GRAK_HUMAN "Granzyme K, EC 3.4.21.- (Fragmentin-3) (Granzyme-3) (NK-tryptase-2, NK-Tryp-2)" GZMK TRYP2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004252; GO:0005576; GO:0008236 EVTVTVLSRK 4 1 1 0.197837245 1132.33293 0 0 14.06361 0 10.45888 0 12.73097 0 0 13.46704 11.01736 0 0 13.40449 15.68214 13.90896 0 0 15.83282 13.81439 17.40274 0 0 13.41476 0 14.54527 16.36634 0 0 0 0 16.21899 0 14.86167 16.18371 16.20985 16.78479 18.60282 0 0 15.79421 12.05435 0 16.14905 0 14.89046 0 0 P49888 ST1E1_HUMAN "Sulfotransferase 1E1, ST1E1, EC 2.8.2.4 (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)" SULT1E1 STE Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0006068; GO:0006711; GO:0008146; GO:0008202; GO:0008210; GO:0031965; GO:0045600; GO:0047894; GO:0050294; GO:0050427; GO:0051923 ENLMNGVK 28.29999924 0.357325405 0.357325405 0.185685033 905.7131676 0 18.91262 19.03189 19.26961 18.87896 0 0 18.58674 19.05465 18.74212 18.51397 18.44296 18.48772 19.29705 18.72138 18.41189 18.28701 0 19.01744 18.82463 0 18.4078 18.60606 18.70943 19.26276 0 0 18.62621 18.40404 18.44134 0 18.91056 0 18.34676 18.76949 0 18.55119 18.33238 18.30431 0 0 18.57019 0 18.84868 0 18.49724 0 18.83772 P49902 5NTC_HUMAN "Cytosolic purine 5'-nucleotidase, EC 3.1.3.5, EC 3.1.3.99 (Cytosolic 5'-nucleotidase II, cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N, EC 2.7.1.77) (High Km 5'-nucleotidase)" NT5C2 NT5B NT5CP PNT5 Homo sapiens (Human) adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; nucleotide phosphorylation [GO:0046939] cytosol [GO:0005829] cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; nucleotide phosphorylation [GO:0046939] 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146] GO:0000255; GO:0005524; GO:0005829; GO:0006204; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046085; GO:0046872; GO:0046939; GO:0050146; GO:0050483; GO:0050484 VTHDMDMCYGMMGSLFR 7.489999771 1 1 0.172425289 2066.434252 0 0 0 12.11923 0 13.2796 14.65725 9.425071 0 0 0 14.98968 14.14619 0 0 0 0 14.098 0 16.26787 0 11.16328 0 0 0 0 0 0 0 0 0 0 0 0 15.35805 0 0 15.71159 10.61832 12.67447 14.91566 11.12981 14.32933 0 0 0 0 0 P49913 CAMP_HUMAN "Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein, CAP-18, hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37 ]" CAMP CAP18 FALL39 HSD26 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; modulation of process of another organism [GO:0035821]; neutrophil activation [GO:0042119]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein phosphorylation [GO:0001934]; response to yeast [GO:0001878] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; lipopolysaccharide binding [GO:0001530]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; modulation of process of another organism [GO:0035821]; neutrophil activation [GO:0042119]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein phosphorylation [GO:0001934]; response to yeast [GO:0001878] lipopolysaccharide binding [GO:0001530] GO:0001530; GO:0001878; GO:0001934; GO:0002227; GO:0002544; GO:0005576; GO:0005615; GO:0008284; GO:0019731; GO:0019732; GO:0032757; GO:0035580; GO:0035821; GO:0042119; GO:0042581; GO:0042742; GO:0042995; GO:0045087; GO:0045766; GO:0050829; GO:0050830; GO:0051838; GO:0051873; GO:0061844; GO:0070062; GO:0071222; GO:0071224; GO:0071347; GO:0071354; GO:0071356; GO:1904724 RCMGTVTLNQAR 4.619999886 0.561758339 0.561758339 4.56E-13 1422.540626 11.08924 0 12.5074 16.09953 0 0 0 15.0557 17.36563 0 15.91681 0 0 0 0 0 0 0 0 15.63645 16.0131 13.00794 13.89354 15.9327 16.13909 0 0 0 0 17.08631 0 14.82988 0 0 14.7804 0 15.27119 14.85968 14.7165 17.38776 0 14.5869 15.20232 14.9439 15.35492 0 10.4353 11.68732 P49916 DNLI3_HUMAN "DNA ligase 3, EC 6.5.1.1 (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3)" LIG3 Homo sapiens (Human) "base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]" cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]" ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006287; GO:0006288; GO:0006302; GO:0007005; GO:0007049; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 APSKPSASTKK 1.460000038 1 1 0.117211419 1102.153772 15.40975 0 14.31371 15.67608 15.7061 0 14.07586 0 0 0 0 15.05458 0 0 0 0 0 0 14.33727 13.30349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49917 DNLI4_HUMAN "DNA ligase 4, EC 6.5.1.1 (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)" LIG4 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]" "chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]" ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022] GO:0000012; GO:0000781; GO:0000793; GO:0001701; GO:0002328; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005958; GO:0006260; GO:0006266; GO:0006297; GO:0006302; GO:0006303; GO:0007049; GO:0007417; GO:0008022; GO:0008283; GO:0010165; GO:0010332; GO:0016874; GO:0032807; GO:0033077; GO:0033151; GO:0033152; GO:0033153; GO:0035019; GO:0036464; GO:0043524; GO:0045190; GO:0046872; GO:0048146; GO:0050769; GO:0051102; GO:0051103; GO:0051276; GO:0051301; GO:0051402; GO:0070419; GO:0071285; GO:0071479; GO:0071897; GO:0075713; GO:0097680; GO:2001252 ALELRFHGAK 6.670000076 1 1 0.199976824 1142.390851 13.99116 15.04971 14.06206 0 15.66777 0 0 0 13.40223 0 14.36415 16.40774 14.96251 15.6804 13.75147 9.234618 0 0 0 0 0 0 15.68928 13.62129 14.89425 0 0 0 0 14.33512 0 0 14.09139 0 0 0 15.54742 16.24401 0 0 0 0 15.30604 0 0 0 0 0 P49918 CDN1C_HUMAN Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2) CDKN1C KIP2 Homo sapiens (Human) "adrenal gland development [GO:0030325]; aging [GO:0007568]; camera-type eye development [GO:0043010]; cell cycle [GO:0007049]; digestive system development [GO:0055123]; embryonic placenta morphogenesis [GO:0060669]; genomic imprinting [GO:0071514]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; myeloid cell differentiation [GO:0030099]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of exit from mitosis [GO:0007096]; regulation of lens fiber cell differentiation [GO:1902746]; skeletal system development [GO:0001501]; uterus development [GO:0060065]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; adrenal gland development [GO:0030325]; aging [GO:0007568]; camera-type eye development [GO:0043010]; cell cycle [GO:0007049]; digestive system development [GO:0055123]; embryonic placenta morphogenesis [GO:0060669]; genomic imprinting [GO:0071514]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; myeloid cell differentiation [GO:0030099]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of exit from mitosis [GO:0007096]; regulation of lens fiber cell differentiation [GO:1902746]; skeletal system development [GO:0001501]; uterus development [GO:0060065]" cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877] GO:0000122; GO:0001501; GO:0001822; GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007049; GO:0007096; GO:0007568; GO:0030099; GO:0030325; GO:0030511; GO:0033673; GO:0035264; GO:0042326; GO:0042551; GO:0043010; GO:0044877; GO:0045736; GO:0045892; GO:0045893; GO:0045930; GO:0050680; GO:0055123; GO:0060065; GO:0060669; GO:0071514; GO:1902746; GO:1904030 MSDASLRSTSTMER 8.779999733 1 1 6.87E-13 1586.864401 0 0 0 0 0 14.10325 0 0 13.21515 0 0 0 0 0 14.93295 13.76045 13.38437 11.47819 0 16.83724 14.07803 13.89841 13.8596 15.40365 0 13.50625 0 14.33753 0 0 14.12986 15.50194 0 12.36368 13.43015 0 0 0 0 0 0 0 0 0 0 0 15.5983 0 P49959 MRE11_HUMAN "Double-strand break repair protein MRE11, EC 3.1.-.- (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1, MRE11 homolog 1) (Meiotic recombination 11 homolog A, MRE11 homolog A)" MRE11 HNGS1 MRE11A Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860] "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 5'-3' exonuclease activity [GO:0008409]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]" 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 5'-3' exonuclease activity [GO:0008409]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008022; GO:0008283; GO:0008296; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0070533; GO:0097552; GO:0098687; GO:0110025 LITKPSEGTTLR 2.809999943 1 1 0.003525978 1314.97207 0 12.2051 14.06486 11.19699 0 0 0 13.04136 0 0 0 11.33074 13.23268 12.19771 0 0 0 11.68692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50213 IDH3A_HUMAN "Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial, EC 1.1.1.41 (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)" IDH3A Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005962; GO:0005975; GO:0006099; GO:0006102; GO:0051287 ANIMR 13.39000034 1 1 0.034192112 619.4105314 16.78457 0 0 16.53938 0 0 0 0 0 0 0 15.05193 0 0 0 0 0 0 0 0 0 18.33909 19.16124 17.87462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50219 MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9) MNX1 HLXB9 Homo sapiens (Human) central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; neuron projection morphogenesis [GO:0048812]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; neuron projection morphogenesis [GO:0048812]; spinal cord motor neuron cell fate specification [GO:0021520]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007417; GO:0021520; GO:0031018; GO:0048812; GO:1990837 AESPSPPR 13.13000011 1 1 0 841.1844265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50221 MEOX1_HUMAN Homeobox protein MOX-1 (Mesenchyme homeobox 1) MEOX1 MOX1 Homo sapiens (Human) hematopoietic stem cell differentiation [GO:0060218]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; hematopoietic stem cell differentiation [GO:0060218]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001757; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007275; GO:0043565; GO:0060218; GO:0061053; GO:0061056; GO:0071837; GO:1990837 QVKVWFQNR 8.149999619 1 1 0.107441495 1203.828753 14.21359 13.95458 13.75008 13.43128 10.79489 9.514137 13.25601 0 0 15.42934 12.61792 14.33612 15.70118 0 0 0 0 14.28542 16.03528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50225 ST1A1_HUMAN "Sulfotransferase 1A1, ST1A1, EC 2.8.2.1 (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1, P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase, Ts-PST)" SULT1A1 STP STP1 OK/SW-cl.88 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006584; GO:0006805; GO:0008146; GO:0008210; GO:0009308; GO:0009812; GO:0047894; GO:0050294; GO:0050427; GO:0050656; GO:0051923 NAKDVAVSYYHFYHMAK 2.410000086 1 1 9.24E-13 2062.89343 0 15.26729 14.62653 0 0 0 0 0 17.34301 0 15.87944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.13405 0 P50281 MMP14_HUMAN "Matrix metalloproteinase-14, MMP-14, EC 3.4.24.80 (MMP-X1) (Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1) (Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP)" MMP14 Homo sapiens (Human) angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; cell motility [GO:0048870]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; cell motility [GO:0048870]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638] endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] GO:0001501; GO:0001525; GO:0001541; GO:0001666; GO:0001935; GO:0001958; GO:0004175; GO:0004222; GO:0004252; GO:0005178; GO:0005615; GO:0005634; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006508; GO:0006979; GO:0008270; GO:0008584; GO:0009612; GO:0010831; GO:0010954; GO:0014070; GO:0016485; GO:0022617; GO:0030198; GO:0030307; GO:0030324; GO:0030335; GO:0030574; GO:0031012; GO:0031410; GO:0031638; GO:0035987; GO:0035988; GO:0042470; GO:0043615; GO:0043627; GO:0044354; GO:0045111; GO:0045579; GO:0045746; GO:0048701; GO:0048754; GO:0048771; GO:0048870; GO:0051895; GO:0060322; GO:0070006; GO:0097094; GO:1903076; GO:1905523; GO:1990834 GDKHWVFDEASLEPGYPK 4.230000019 1 1 0.143205159 2073.337068 15.49423 15.42844 0 13.17239 14.83584 0 0 0 0 0 14.97516 0 0 15.39837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.72124 0 19.29975 19.04338 0 0 0 0 16.44308 0 0 0 0 15.3233 15.95576 0 0 0 0 P50336 PPOX_HUMAN "Protoporphyrinogen oxidase, PPO, EC 1.3.3.4" PPOX Homo sapiens (Human) heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782] intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966] intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782] flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729] GO:0004729; GO:0005758; GO:0006779; GO:0006782; GO:0006783; GO:0016491; GO:0031304; GO:0031966; GO:0050660 GVSVLR 12.76000023 0.933712244 0.933712244 0.297827683 631.6467942 0 18.95697 17.63337 0 0 15.07876 0 0 17.55127 16.89049 18.38707 0 17.51476 0 16.98365 0 0 0 0 0 0 17.64557 18.03773 0 17.48554 17.82291 0 19.12818 0 0 0 0 18.53161 0 0 16.89677 0 0 16.93684 0 0 16.47858 0 0 16.60281 0 0 17.67745 P50395 GDIB_HUMAN "Rab GDP dissociation inhibitor beta, Rab GDI beta (Guanosine diphosphate dissociation inhibitor 2, GDI-2)" GDI2 RABGDIB Homo sapiens (Human) negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565 IPGSPPESMGR 1.899999976 1 1 0.235725338 1129.096779 0 17.15849 0 0 0 0 19.56825 0 0 0 0 14.48993 14.07804 0 0 0 0 0 0 0 0 0 0 0 0 15.76651 0 17.45898 0 0 17.14393 0 0 0 18.63406 0 0 0 0 0 0 0 0 15.19831 0 19.6181 16.23252 0 P50416 CPT1A_HUMAN "Carnitine O-palmitoyltransferase 1, liver isoform, CPT1-L, EC 2.3.1.21 (Carnitine O-palmitoyltransferase I, liver isoform, CPT I, CPTI-L) (Carnitine palmitoyltransferase 1A)" CPT1A CPT1 Homo sapiens (Human) carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698] GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031307; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698 ATKIWMGMVK 5.570000172 1 1 4.59E-13 1179.566486 0 0 12.06045 0 0 14.8017 14.45419 0 16.25104 0 14.99222 16.3895 15.47857 0 0 0 0 13.23608 15.99421 0 0 15.78521 0 14.91487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50452 SPB8_HUMAN "Serpin B8 (Cytoplasmic antiproteinase 2, CAP-2, CAP2) (Peptidase inhibitor 8, PI-8)" SERPINB8 PI8 Homo sapiens (Human) epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005615; GO:0005737; GO:0005829; GO:0010951; GO:0062023; GO:0070062; GO:0090136 HINDWVAEK 2.5 1 1 0.242815842 1112.574286 0 0 0 0 16.86478 0 0 0 0 0 16.62864 0 0 16.09462 0 0 0 0 15.99331 0 0 0 0 0 0 0 0 0 0 0 19.15395 0 0 0 0 0 0 17.86113 20.13629 0 0 0 0 17.00942 0 0 0 0 P50453 SPB9_HUMAN "Serpin B9 (Cytoplasmic antiproteinase 3, CAP-3, CAP3) (Peptidase inhibitor 9, PI-9)" SERPINB9 PI9 Homo sapiens (Human) cellular response to estrogen stimulus [GO:0071391]; immune response [GO:0006955]; mast cell mediated immunity [GO:0002448]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endopeptidase activity [GO:0010951]; protection from natural killer cell mediated cytotoxicity [GO:0042270] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cellular response to estrogen stimulus [GO:0071391]; immune response [GO:0006955]; mast cell mediated immunity [GO:0002448]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endopeptidase activity [GO:0010951]; protection from natural killer cell mediated cytotoxicity [GO:0042270] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0002448; GO:0004867; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0010951; GO:0016020; GO:0042270; GO:0043027; GO:0043066; GO:0062023; GO:0070062; GO:0071391 ETLSNASGTFAIRLLK 4.53000021 0.841047227 0.841047227 0.328490657 1719.81653 12.28564 0 0 14.70546 13.42427 0 14.68714 0 13.83763 0 16.5067 0 0 12.96437 0 0 16.54223 0 0 0 0 0 13.7498 0 16.30392 0 0 0 0 14.91144 0 17.88653 0 0 11.76486 0 0 0 0 15.39646 18.57681 0 0 14.77841 0 0 0 0 P50454 SERPH_HUMAN "Serpin H1 (47 kDa heat shock protein) (Arsenic-transactivated protein 3, AsTP3) (Cell proliferation-inducing gene 14 protein) (Collagen-binding protein, Colligin) (Rheumatoid arthritis-related antigen RA-A47)" SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 Homo sapiens (Human) chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; negative regulation of endopeptidase activity [GO:0010951]; protein maturation [GO:0051604]; response to unfolded protein [GO:0006986] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; membrane raft [GO:0045121] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; collagen binding [GO:0005518]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; unfolded protein binding [GO:0051082]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; negative regulation of endopeptidase activity [GO:0010951]; protein maturation [GO:0051604]; response to unfolded protein [GO:0006986] collagen binding [GO:0005518]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; unfolded protein binding [GO:0051082] GO:0003433; GO:0003723; GO:0004867; GO:0005518; GO:0005615; GO:0005783; GO:0005788; GO:0005793; GO:0006986; GO:0010951; GO:0030199; GO:0032964; GO:0045121; GO:0051082; GO:0051604; GO:0062023 DTQSGSLLFIGRLVRPK 1.580000043 0.319030166 0.319030166 0.269252233 1891.022034 15.69541 16.24449 0 0 0 0 0 0 0 0 0 0 0 12.00496 0 15.01006 0 0 0 0 0 14.5382 0 0 15.82383 0 15.90211 0 0 0 15.97693 16.0294 0 0 0 0 0 0 0 0 16.44457 0 15.39881 15.64635 0 0 0 0 P50479 PDLI4_HUMAN PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein) PDLIM4 RIL Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; muscle structure development [GO:0061061] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; muscle structure development [GO:0061061] actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903] GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0005912; GO:0007507; GO:0019903; GO:0030018; GO:0030027; GO:0030036; GO:0031532; GO:0031901; GO:0031905; GO:0031941; GO:0034777; GO:0042803; GO:0043197; GO:0045211; GO:0046872; GO:0048471; GO:0051371; GO:0051393; GO:0055038; GO:0061061; GO:0098976 VHAGSK 7.510000229 0.248028293 0.248028293 0.152059584 599.430596 15.78697 14.9634 0 15.98805 16.94057 15.1129 15.19925 0 15.68341 0 15.88765 0 0 14.41079 0 0 16.34422 15.05716 0 17.42271 0 0 18.08822 15.32367 16.61408 17.23365 17.64629 0 16.1188 15.25039 16.7848 0 15.64526 0 17.3351 0 16.46149 16.59836 17.64042 0 15.76016 16.28461 0 0 0 16.84616 14.83077 15.14052 P50552 VASP_HUMAN "Vasodilator-stimulated phosphoprotein, VASP" VASP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289] actin binding [GO:0003779]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124] GO:0001843; GO:0003779; GO:0005522; GO:0005829; GO:0005886; GO:0005923; GO:0005925; GO:0007411; GO:0008154; GO:0015629; GO:0017124; GO:0030036; GO:0030838; GO:0031258; GO:0031527; GO:0045296; GO:0051289; GO:0070062 AESGRSGGGGLMEEMNAMLAR 2.940000057 1 1 9.16E-13 2156.442726 11.61452 13.62268 0 0 15.25169 0 13.92119 0 17.90582 11.72905 0 0 15.38126 0 0 0 13.95329 12.64283 0 0 0 0 0 13.10217 12.22444 0 17.96341 15.36764 0 0 0 13.96608 0 0 0 0 0 0 12.53826 0 0 0 0 0 15.82718 0 15.46356 0 P50553 ASCL1_HUMAN "Achaete-scute homolog 1, ASH-1, hASH1 (Class A basic helix-loop-helix protein 46, bHLHa46)" ASCL1 ASH1 BHLHA46 HASH1 Homo sapiens (Human) "adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]" chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]" "bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001764; GO:0003358; GO:0003359; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0010226; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:1990837; GO:2000179 SSSPELMR 4.760000229 1 1 1.03E-12 923.4634346 15.6521 13.79667 0 0 0 0 0 12.72604 0 0 0 0 0 15.7519 0 13.8349 13.90293 0 15.9298 0 15.38665 0 0 15.64643 16.20393 0 0 13.92085 0 14.60234 0 0 16.43864 16.18342 14.43308 0 0 0 0 0 0 0 0 0 14.60249 0 0 0 P50613 CDK7_HUMAN "Cyclin-dependent kinase 7, EC 2.7.11.22, EC 2.7.11.23 (39 kDa protein kinase, p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)" CDK7 CAK CAK1 CDKN7 MO15 STK1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] "CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]" GO:0000079; GO:0000439; GO:0001650; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0006468; GO:0007049; GO:0008022; GO:0008094; GO:0008353; GO:0019907; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0051726; GO:0070516; GO:0070816; GO:0070985; GO:0106310; GO:2000045 SFGSPNR 4.610000134 1 1 0.13526671 765.6590285 0 0 0 0 0 0 12.52421 14.62407 0 0 14.64759 15.77186 0 13.28356 14.36119 0 15.48896 15.36321 0 0 0 0 16.89039 0 0 0 0 0 15.44271 0 0 0 0 0 0 0 0 16.63559 0 0 0 0 0 0 0 0 0 15.11259 P50748 KNTC1_HUMAN "Kinetochore-associated protein 1 (Rough deal homolog, HsROD, Rod, hRod)" KNTC1 KIAA0166 Homo sapiens (Human) cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; small GTPase binding [GO:0031267]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096] small GTPase binding [GO:0031267] GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0065003; GO:1903394; GO:1990423 ALEMVPLLTSTK 8.779999733 0.252650887 0.252650887 0.150775031 1317.629466 10.39036 6.674703 15.85952 14.44918 13.96317 12.89821 0 0 15.1306 17.07332 0 15.36271 14.72575 13.52532 0 0 15.73426 0 13.52664 13.93828 15.4653 14.41304 13.34347 10.2185 0 0 12.72052 12.28593 0 15.00924 0 0 15.14542 15.00924 10.4899 11.26959 16.50954 13.63702 15.45738 11.17748 16.07117 18.21642 5.75191 13.40706 0 0 0 0 P50851 LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein) LRBA BGL CDC4L LBA Homo sapiens (Human) mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497] protein kinase binding [GO:0019901] GO:0000423; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0016021; GO:0019901; GO:0034497 LLSQTMK 12.93999958 0.006300548 0.006300548 0.251954175 820.4813427 16.20104 0 0 0 0 0 0 18.40668 0 19.6026 0 16.43886 17.60266 0 18.05159 17.40858 0 0 0 0 0 16.75424 0 0 0 23.88933 20.85461 18.07425 22.27825 19.96266 0 18.30501 0 18.49442 19.22211 0 21.31993 0 0 17.29693 15.51707 0 0 0 0 0 0 0 P50876 R144A_HUMAN "E3 ubiquitin-protein ligase RNF144A, EC 2.3.2.31 (RING finger protein 144A) (UbcM4-interacting protein 4) (Ubiquitin-conjugating enzyme 7-interacting protein 4)" RNF144A KIAA0161 RNF144 UBCE7IP4 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] GO:0000151; GO:0000209; GO:0005737; GO:0005794; GO:0005886; GO:0006511; GO:0010008; GO:0016021; GO:0016567; GO:0031624; GO:0032436; GO:0043231; GO:0046872; GO:0061630 MTTTRYRPTWDLALDPLVSCK 2.809999943 1 1 0.149999572 2541.028296 15.4166 15.18951 13.76629 0 15.85953 14.34941 15.32471 12.42374 13.65065 0 13.46882 11.73211 0 14.14259 0 13.36771 0 16.30619 0 14.97714 13.3322 13.7587 0 0 0 0 15.52333 0 0 0 14.81524 16.59545 0 0 0 13.41589 0 14.04831 0 16.05247 14.88755 0 0 15.1566 0 0 0 0 P50914 RL14_HUMAN 60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14) RPL14 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0042273; GO:0045296; GO:0070062 AAPAPK 3.230000019 1 1 0 553.1466552 0 17.44293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50991 TCPD_HUMAN "T-complex protein 1 subunit delta, TCP-1-delta (CCT-delta) (Stimulator of TAR RNA-binding)" CCT4 CCTD SRB Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199] cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042470; GO:0042995; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874 LTEYSR 17.29999924 1 1 0.29442441 768.2712167 18.44672 17.36542 14.93194 20.85106 17.67994 0 17.91764 18.10455 0 18.52517 0 17.47104 17.70574 0 0 0 20.0958 19.79278 17.52941 16.69356 0 19.97549 0 0 19.72364 19.80593 0 0 0 17.19109 22.73005 20.57466 21.38872 20.55574 19.52614 0 16.93161 20.861 20.70351 18.5569 16.25222 18.4935 18.39226 17.70436 0 19.38926 0 16.44991 P50993 AT1A2_HUMAN "Sodium/potassium-transporting ATPase subunit alpha-2, Na(+)/K(+) ATPase alpha-2 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-2)" ATP1A2 KIAA0778 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]" caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315] "caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239] GO:0001504; GO:0001662; GO:0002026; GO:0002087; GO:0005391; GO:0005496; GO:0005524; GO:0005737; GO:0005768; GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006883; GO:0006937; GO:0006940; GO:0006942; GO:0008217; GO:0008344; GO:0008542; GO:0010881; GO:0010996; GO:0014704; GO:0016020; GO:0016791; GO:0016887; GO:0019229; GO:0019829; GO:0021764; GO:0021989; GO:0030007; GO:0030315; GO:0030955; GO:0031090; GO:0031402; GO:0035094; GO:0035641; GO:0035725; GO:0036376; GO:0040011; GO:0042995; GO:0043025; GO:0043197; GO:0045822; GO:0045823; GO:0045988; GO:0046034; GO:0046982; GO:0051087; GO:0051481; GO:0051946; GO:0051966; GO:0055119; GO:0060048; GO:0071260; GO:0071383; GO:0071805; GO:0086004; GO:0086009; GO:0086012; GO:0086064; GO:0098655; GO:0150104; GO:1902600; GO:1903170; GO:1903280; GO:1903416; GO:1903561; GO:1990239; GO:1990573 VLGFCQLNLPSGKFPR 1.659999967 1 1 2.30E-12 1833.708119 0 15.36718 15.2473 12.15525 0 0 0 0 0 14.01571 14.11612 0 13.12512 0 0 14.51651 0 0 14.12426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.03293 15.89164 14.67792 0 0 0 0 0 P50995 ANX11_HUMAN "Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50, CAP-50)" ANXA11 ANX11 Homo sapiens (Human) cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819] azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006909; GO:0008429; GO:0016020; GO:0023026; GO:0030496; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0062023; GO:0070062 GAGTK 10.19999981 1 1 0.25666332 432.6567568 17.20149 0 14.79039 0 17.00592 0 16.17131 0 0 0 0 0 0 17.81468 17.12517 17.65844 0 18.83824 0 0 0 0 0 15.30379 0 18.72993 0 17.69724 17.13247 0 0 16.59223 17.16056 19.14574 0 0 0 0 0 0 16.82042 17.33916 16.44647 17.09904 0 16.50242 0 0 P51114 FXR1_HUMAN "Fragile X mental retardation syndrome-related protein 1, hFXR1p" FXR1 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]" axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] "axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]" mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182] GO:0000381; GO:0001934; GO:0003723; GO:0003730; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005844; GO:0006915; GO:0007517; GO:0014069; GO:0016020; GO:0017148; GO:0030154; GO:0030424; GO:0030426; GO:0033592; GO:0036464; GO:0042803; GO:0043025; GO:0043034; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0048471; GO:0051489; GO:0060538; GO:0098793; GO:0098978; GO:1902737; GO:2000637; GO:2001022 NLPRETLAK 6.690000057 0.307483464 0.307483464 0.154852669 1041.904304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.15133 0 14.67961 0 0 0 0 0 0 0 15.33348 14.85995 0 14.97973 0 0 0 0 0 0 0 13.58685 15.15005 15.83325 12.10019 14.33558 12.4722 0 0 10.22003 0 0 0 P51116 FXR2_HUMAN Fragile X mental retardation syndrome-related protein 2 FXR2 FMR1L2 Homo sapiens (Human) "negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]" identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] GO:0000381; GO:0001934; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0014069; GO:0016020; GO:0017148; GO:0022625; GO:0030424; GO:0030426; GO:0036464; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0051489; GO:0098793; GO:1902737; GO:2001022 GGLASGGDVEPGLPVEVR 13.86999989 0.816957593 0.816957593 0.12048856 1708.838379 0 18.13283 17.00154 0 0 15.05648 0 0 0 0 17.15071 17.92665 0 0 0 13.75468 0 0 14.96068 0 11.90033 14.49122 0 12.70045 17.60485 15.06195 16.12743 16.84046 15.03533 16.0535 14.16972 19.40909 13.63762 0 19.02135 0 16.92859 17.4278 15.29452 0 16.77789 17.0323 0 0 17.75229 0 15.73233 0 P51124 GRAM_HUMAN "Granzyme M, EC 3.4.21.- (Met-1 serine protease, Hu-Met-1) (Met-ase) (Natural killer cell granular protease)" GZMM MET1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell death [GO:0008219]; cytolysis [GO:0019835]; innate immune response [GO:0045087]; T cell mediated cytotoxicity [GO:0001913] extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytolysis [GO:0019835]; innate immune response [GO:0045087]; T cell mediated cytotoxicity [GO:0001913] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0001913; GO:0004252; GO:0005576; GO:0006915; GO:0008219; GO:0008236; GO:0016020; GO:0019835; GO:0045087 DQAPCK 1.5 0.951138318 0.951138318 0.268559928 717.9179956 14.53081 0 16.0204 0 0 0 14.20838 0 0 0 0 0 0 0 0 15.78782 0 14.3085 0 17.08013 0 0 0 0 16.48297 15.05345 0 0 0 14.58895 15.93242 0 0 0 16.83384 0 17.35191 0 17.2535 16.46088 16.26974 17.30963 16.06609 15.98998 15.20172 0 16.82938 16.06611 P51148 RAB5C_HUMAN "Ras-related protein Rab-5C, EC 3.6.5.2 (L1880) (RAB5L)" RAB5C RABL Homo sapiens (Human) endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0035577; GO:0042470; GO:0048227; GO:0070062 TAMNVNEIFMAIAK 1.809999943 1 1 2.29E-12 1552.682535 0 13.7695 0 0 0 0 0 0 0 0 0 0 14.67579 0 0 10.71174 0 0 0 15.03695 0 0 0 0 0 0 14.23904 0 0 0 0 0 0 0 0 0 0 0 0 16.22417 0 0 0 13.33814 0 0 0 0 P51151 RAB9A_HUMAN Ras-related protein Rab-9A RAB9A RAB9 Homo sapiens (Human) "negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]" GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030133; GO:0030670; GO:0032482; GO:0032588; GO:0032880; GO:0042147; GO:0042470; GO:0045335; GO:0045921; GO:0052403; GO:0070062 SSLFKVILLGDGGVGK 6.630000114 1 1 0.29643146 1588.607689 14.33861 15.42584 0 13.77435 0 0 12.78794 15.21473 15.82836 0 14.99996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41529 0 0 0 0 0 0 0 0 14.34631 0 0 0 0 0 0 0 0 P51157 RAB28_HUMAN Ras-related protein Rab-28 RAB28 Homo sapiens (Human) intracellular protein transport [GO:0006886]; toxin transport [GO:1901998] ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; toxin transport [GO:1901998] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0012505; GO:0019003; GO:0035253; GO:0036064; GO:1901998 IVVLGDGASGK 9.649999619 0.635935605 0.635935605 0.240997111 1012.963947 15.73107 14.02949 15.93784 0 14.28135 15.46495 13.85641 13.24332 13.3612 16.37777 14.4495 15.83539 14.41762 15.81461 14.06229 14.84455 15.22204 0 13.54113 0 0 0 14.98674 0 15.10544 0 16.00615 16.25254 15.13707 15.58342 18.43809 12.44182 13.32821 15.07892 15.50535 14.44137 14.21554 14.36074 14.35842 10.97687 15.18624 14.24543 17.75132 14.00426 13.24517 15.01983 0 11.83592 P51160 PDE6C_HUMAN "Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha', EC 3.1.4.35 (cGMP phosphodiesterase 6C)" PDE6C PDEA2 Homo sapiens (Human) "phototransduction, visible light [GO:0007603]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]" plasma membrane [GO:0005886] "plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; phototransduction, visible light [GO:0007603]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]" "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]" GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0007603; GO:0030553; GO:0046549; GO:0046872; GO:0047555 LAHLLQADR 13.44999981 0.141659871 0.141659871 0.254445064 1036.529587 10.39713 13.807 17.09233 16.0385 0 15.29185 15.51982 0 0 0 16.28635 16.06165 0 0 0 14.70519 0 0 0 15.9901 0 0 0 0 0 15.77979 15.85444 0 0 0 0 17.46945 0 0 0 0 0 15.8101 0 17.52347 16.16014 16.95326 14.88842 0 16.8644 17.32861 0 16.84696 P51172 SCNND_HUMAN "Amiloride-sensitive sodium channel subunit delta (Delta-NaCH) (Epithelial Na(+) channel subunit delta, Delta-ENaC, ENaCD) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED)" SCNN1D DNACH Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] ligand-gated sodium channel activity [GO:0015280] GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0008217; GO:0015280; GO:0015629; GO:0016020; GO:0034706; GO:0035725; GO:0036254; GO:0050914; GO:0050915; GO:0071468; GO:0098719; GO:1904045; GO:1904117 QPHGGALTSR 3.569999933 1 1 0.263754237 1024.253769 15.53767 18.97772 0 0 17.85341 0 0 0 15.17647 0 0 0 0 0 0 0 17.9461 0 0 0 0 0 16.91392 0 0 0 18.27511 0 0 0 0 0 0 19.18668 0 19.44936 0 0 0 15.94406 0 0 0 16.36976 0 0 16.22227 0 P51178 PLCD1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III, PLC-III) (Phospholipase C-delta-1, PLC-delta-1)" PLCD1 Homo sapiens (Human) lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644]" "calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0046488; GO:0048015; GO:0070062 AIRDYAFK 2.269999981 1 1 0.212602244 983.6095384 0 15.56728 10.50305 0 11.03771 17.2906 14.14476 0 0 15.4726 0 0 0 14.15658 15.45822 14.58223 12.32654 0 0 0 0 0 12.44885 14.15931 14.60736 0 0 0 14.30312 0 0 14.34557 0 0 0 16.88631 0 16.22666 19.28532 0 0 0 17.41136 0 0 0 16.86273 0 P51397 DAP1_HUMAN "Death-associated protein 1, DAP-1" DAP DAP1 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]" "death domain binding [GO:0070513]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]" death domain binding [GO:0070513] GO:0006914; GO:0006915; GO:0006919; GO:0010507; GO:0032088; GO:0034198; GO:0045892; GO:0070513; GO:0097190 AGGMR 4.369999886 1 1 0.215696635 509.9400763 0 17.75465 0 17.89462 17.84249 16.22616 18.15151 17.34515 17.47786 17.34118 17.87255 17.98147 0 0 0 17.74621 16.91619 0 0 16.70882 17.83584 17.68483 0 0 0 0 0 17.43826 16.92558 18.11416 0 0 0 16.83822 0 0 18.4679 17.89719 17.97241 0 0 17.29214 0 0 0 0 17.2 0 P51398 RT29_HUMAN "28S ribosomal protein S29, mitochondrial, MRP-S29, S29mt (Death-associated protein 3, DAP-3) (Ionizing radiation resistance conferring protein) (Mitochondrial small ribosomal subunit protein mS29)" DAP3 MRPS29 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543] GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0097190 LISRIHK 6.829999924 1 1 0.32339582 868.1483735 0 0 0 0 0 15.52351 0 10.95126 14.79239 0 0 0 0 12.32896 0 0 0 0 0 16.64231 15.51692 0 14.97068 14.74002 14.74749 0 0 0 15.41961 17.123 12.67958 15.0422 0 12.59952 16.59426 10.9994 0 0 0 0 0 12.41258 0 0 16.99288 0 0 16.56973 P51449 RORG_HUMAN Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) RORC NR1F3 RORG RZRG Homo sapiens (Human) "adipose tissue development [GO:0060612]; cellular response to sterol [GO:0036315]; circadian regulation of gene expression [GO:0032922]; lymph node development [GO:0048535]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Peyer's patch development [GO:0048541]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]; regulation of glucose metabolic process [GO:0010906]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper cell differentiation [GO:0042093]; xenobiotic metabolic process [GO:0006805]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; cellular response to sterol [GO:0036315]; circadian regulation of gene expression [GO:0032922]; lymph node development [GO:0048535]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Peyer's patch development [GO:0048541]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]; regulation of glucose metabolic process [GO:0010906]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper cell differentiation [GO:0042093]; xenobiotic metabolic process [GO:0006805]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006357; GO:0006805; GO:0008142; GO:0008270; GO:0010906; GO:0016604; GO:0019218; GO:0032922; GO:0036315; GO:0042093; GO:0042753; GO:0045598; GO:0045893; GO:0048535; GO:0048541; GO:0060612; GO:0070244; GO:0072539; GO:0098531; GO:1990837 AGLNGASCHLEYSPERGK 11.77000046 1 1 0.252795977 1943.189792 17.1584 0 8.906747 0 0 16.34233 0 17.44945 0 16.64001 0 0 0 0 0 17.73009 16.21185 0 0 0 0 0 16.30826 0 0 0 0 0 0 0 0 0 0 0 0 13.86774 0 16.62348 0 0 0 17.30123 0 0 12.24291 0 0 0 P51530 DNA2_HUMAN "DNA replication ATP-dependent helicase/nuclease DNA2, hDNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2, EC 3.1.-.-; DNA replication ATP-dependent helicase DNA2, EC 3.6.4.12 ]" DNA2 DNA2L KIAA0083 Homo sapiens (Human) "base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]" "4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]" GO:0000076; GO:0000723; GO:0000729; GO:0000781; GO:0003677; GO:0003678; GO:0003723; GO:0004386; GO:0004518; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0032201; GO:0033567; GO:0042645; GO:0043137; GO:0043139; GO:0043504; GO:0044806; GO:0045740; GO:0046872; GO:0051539; GO:0071932; GO:0090305; GO:0090656; GO:1902990 GGVSNVTEAK 7.170000076 1 1 0.25239961 961.1867513 0 14.77777 0 14.34117 14.08974 14.8673 14.23142 14.51866 15.27738 0 0 16.71699 15.33513 13.49785 0 13.33375 0 14.22019 0 0 15.26955 16.00002 15.17353 0 0 0 0 0 0 0 15.95443 0 0 0 0 0 16.45445 17.01882 0 0 0 0 0 15.19925 0 0 0 0 P51531 SMCA2_HUMAN "Probable global transcription activator SNF2L2, EC 3.6.4.- (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B, BAF190B) (Protein brahma homolog, hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)" SMARCA2 BAF190B BRM SNF2A SNF2L2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]" GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0035060; GO:0042393; GO:0043231; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 MDMDRR 4.199999809 0.73310256 0.73310256 0.146954683 841.5325768 17.39839 15.81542 0 14.11461 15.38822 16.33232 0 0 0 14.01066 13.14259 17.01404 14.34087 0 11.72276 0 14.22919 0 0 0 14.98827 15.42013 18.3068 14.85664 15.94003 17.84872 16.28481 17.70932 16.96612 16.54007 17.42872 16.26913 17.85618 0 14.984 14.09862 14.85758 14.35817 17.41281 13.98297 15.82318 15.99485 15.19665 11.79941 16.41321 0 0 0 P51532 SMCA4_HUMAN "Transcription activator BRG1, EC 3.6.4.- (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A, BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)" SMARCA4 BAF190A BRG1 SNF2B SNF2L4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]" bBAF complex [GO:0140092]; chromatin [GO:0000785]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; chromatin [GO:0000785]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]" "androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]" GO:0000122; GO:0000776; GO:0000785; GO:0001188; GO:0001221; GO:0001650; GO:0002039; GO:0003407; GO:0003677; GO:0003713; GO:0003714; GO:0003723; GO:0004386; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008094; GO:0008284; GO:0016020; GO:0016363; GO:0016514; GO:0016586; GO:0016887; GO:0030071; GO:0030177; GO:0030308; GO:0030957; GO:0032991; GO:0043923; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050681; GO:0051091; GO:0060766; GO:0070182; GO:0070316; GO:0070577; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140658; GO:1901838; GO:1902459; GO:1902661; GO:1902895; GO:2000045; GO:2000781; GO:2000819 GKGGTK 10.57999992 0.654559851 0.654559851 0.13578109 547.3961835 15.34884 17.1312 16.63241 16.35367 16.38975 16.13679 16.36152 15.32678 16.54749 16.08618 16.67941 15.34028 17.11764 16.93012 16.16588 17.20557 16.16774 17.10238 16.20425 16.41616 16.82438 16.99118 18.50525 17.0458 17.67469 15.31288 17.39012 16.36291 16.78302 15.78451 17.84731 17.03113 17.12554 16.7859 15.78964 17.12421 17.70461 18.49506 17.3078 17.08506 16.83388 15.95566 17.57384 16.68002 17.40664 17.31799 17.4406 16.91256 P51553 IDH3G_HUMAN "Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)" IDH3G Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0005962; GO:0005975; GO:0006099; GO:0006102; GO:0051287 HTVTMIPGDGIGPELMLHVK 10.89000034 1 1 0.704715535 2160.429636 0 0 0 0 0 0 0 0 0 0 20.38357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51580 TPMT_HUMAN "Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)" TPMT Homo sapiens (Human) methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829] cytosol [GO:0005829]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic metabolic process [GO:0006805] S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119] GO:0005829; GO:0006139; GO:0006805; GO:0008119; GO:0032259; GO:1904047 NQVLTLEEWQDK 10.53999996 1 1 0.491119446 1502.646687 0 0 0 0 0 0 16.27913 0 0 0 0 0 17.21939 0 0 0 0 0 0 0 19.45773 19.70907 0 0 0 0 0 0 0 20.25694 0 0 0 0 0 0 0 0 19.48217 0 0 0 0 0 0 0 0 0 P51589 CP2J2_HUMAN "Cytochrome P450 2J2, EC 1.14.14.- (Albendazole monooxygenase (hydroxylating), EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming), EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase, EC 5.4.4.7)" CYP2J2 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]" "arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043231; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 FTFRPPNNEK 26.38999939 1 1 0.44135767 1250.046821 0 18.72214 0 0 0 0 19.00081 17.05429 0 0 17.47438 0 0 0 0 0 16.86825 0 18.58604 0 0 21.00346 0 0 0 15.03525 17.81551 20.92517 0 0 17.0192 0 0 0 0 0 0 0 0 0 0 0 0 0 17.32294 17.88029 19.62883 0 P51608 MECP2_HUMAN "Methyl-CpG-binding protein 2, MeCp-2 protein, MeCp2" MECP2 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]" centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794] "centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000792; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003714; GO:0003723; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006020; GO:0006349; GO:0006541; GO:0006576; GO:0007052; GO:0007416; GO:0007585; GO:0007616; GO:0008104; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009791; GO:0010385; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019904; GO:0021549; GO:0021591; GO:0031507; GO:0032048; GO:0035176; GO:0035197; GO:0042551; GO:0043524; GO:0043537; GO:0045892; GO:0045944; GO:0046470; GO:0047485; GO:0051151; GO:0051707; GO:0060079; GO:0060291; GO:0090063; GO:0098794; GO:1900114; GO:1905643; GO:1990841; GO:2000820 MVAGMLGLR 12.60000038 1 1 0.201721008 946.9951122 11.53055 15.99174 16.16466 0 19.71838 0 17.52515 17.17419 15.92273 13.41762 16.2688 15.25315 16.45209 0 0 0 0 16.82417 0 14.88164 17.14709 0 15.85256 0 17.47803 0 0 15.02317 14.60626 15.33303 0 18.21982 17.91936 17.48818 16.25765 0 0 17.11568 0 0 0 0 16.37403 0 16.99258 16.81023 15.77034 0 P51610 HCFC1_HUMAN "Host cell factor 1, HCF, HCF-1 (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6 ]" HCFC1 HCF1 HFC1 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]" cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188] "cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]" cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713] GO:0000122; GO:0000123; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007049; GO:0010628; GO:0016020; GO:0019046; GO:0030674; GO:0032991; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0044665; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0051568; GO:0051571; GO:0071339; GO:0140297 SSVGAGEPR 13 0.719359756 0.719359756 0.354038439 860.9471597 15.53941 0 0 16.40024 0 0 0 0 16.0166 0 15.18602 15.58764 17.23277 0 15.76532 16.42381 15.9422 13.57107 0 15.00798 0 0 17.14623 0 0 16.44686 0 16.97189 0 0 0 15.681 16.24669 0 15.88242 0 13.95607 18.30487 0 13.78615 0 0 0 16.92459 0 0 0 0 P51649 SSDH_HUMAN "Succinate-semialdehyde dehydrogenase, mitochondrial, EC 1.2.1.24 (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)" ALDH5A1 SSADH Homo sapiens (Human) central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105] identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777] GO:0004777; GO:0005739; GO:0005759; GO:0006105; GO:0006536; GO:0007417; GO:0009450; GO:0009791; GO:0042135; GO:0042802 QPIGVAAVITPWNFPSAMITRK 3.849999905 1 1 0.605902685 2412.455193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51654 GPC3_HUMAN Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Glypican-3 alpha subunit; Glypican-3 beta subunit ] GPC3 OCI5 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]" anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] "anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; peptidyl-dipeptidase inhibitor activity [GO:0060422]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]" peptidyl-dipeptidase inhibitor activity [GO:0060422] GO:0001658; GO:0005788; GO:0005796; GO:0005886; GO:0009617; GO:0009653; GO:0009948; GO:0009986; GO:0010171; GO:0010466; GO:0016477; GO:0030282; GO:0030316; GO:0030324; GO:0030513; GO:0031226; GO:0035116; GO:0042074; GO:0043202; GO:0045732; GO:0045807; GO:0045879; GO:0045880; GO:0045926; GO:0046326; GO:0046658; GO:0050680; GO:0060422; GO:0060828; GO:0060976; GO:0062023; GO:0072111; GO:0072138; GO:0072180; GO:0072203; GO:0090090; GO:0090263; GO:1905475; GO:2000050; GO:2000096 DLKVFGNFPK 1.940000057 1 1 0.323679495 1163.439486 16.28312 0 0 0 15.83864 16.1032 0 0 0 0 0 16.17126 0 16.07324 0 0 0 0 15.77987 0 0 0 0 0 0 0 15.72918 14.26748 0 16.1202 16.09178 15.64504 0 16.49375 0 0 0 16.21052 14.83372 0 15.02696 16.44524 11.05288 15.51773 0 0 0 16.86902 P51659 DHB4_HUMAN "Peroxisomal multifunctional enzyme type 2, MFE-2 (17-beta-hydroxysteroid dehydrogenase 4, 17-beta-HSD 4) (D-bifunctional protein, DBP) (Multifunctional protein 2, MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.n12; Enoyl-CoA hydratase 2, EC 4.2.1.107, EC 4.2.1.119 (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase) ]" HSD17B4 EDH17B4 SDR8C1 Homo sapiens (Human) androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] "cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]" "(3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]" GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386 VVLVTGAGAGLGR 4.190000057 1 1 0.202803767 1170.09391 0 0 15.84156 0 0 0 0 0 0 0 16.91687 0 0 16.23018 0 0 15.95583 0 0 0 0 0 0 0 0 0 15.74541 0 16.19139 0 17.11707 0 17.13552 17.66329 17.9207 17.9403 17.15279 0 0 0 15.39485 16.5505 0 16.35875 0 0 0 0 P51665 PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40) PSMD7 MOV34L Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; protein homodimerization activity [GO:0042803]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] protein homodimerization activity [GO:0042803] GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813 GLNSKLLDIR 3.269999981 0.648185432 0.648185432 0.139980898 1129.587392 0 0 0 0 0 0 0 13.29287 14.59235 0 0 0 0 0 15.03641 0 0 0 0 0 0 0 0 0 14.63183 16.79865 0 0 0 0 0 0 0 0 0 0 16.4852 0 0 0 0 0 0 0 15.39137 0 0 0 P51671 CCL11_HUMAN Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11) CCL11 SCYA11 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; modulation of age-related behavioral decline [GO:0090647]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; modulation of age-related behavioral decline [GO:0090647]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165] CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018] GO:0001938; GO:0002548; GO:0005576; GO:0005615; GO:0006468; GO:0006874; GO:0006935; GO:0006954; GO:0007010; GO:0007155; GO:0007165; GO:0007186; GO:0007611; GO:0008009; GO:0008360; GO:0009314; GO:0009615; GO:0030335; GO:0030593; GO:0030838; GO:0031640; GO:0031728; GO:0043547; GO:0045766; GO:0046983; GO:0048018; GO:0048020; GO:0048245; GO:0048247; GO:0050768; GO:0060444; GO:0060763; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0090647 SPTPKP 4.480000019 1 1 0.077141393 625.9878798 15.39811 14.22756 0 14.31053 0 14.50822 13.72292 0 12.79469 0 14.70897 0 0 0 13.1495 15.67753 0 0 0 0 0 0 15.89337 0 0 16.7399 16.01143 0 15.17855 16.32798 0 0 0 0 0 0 0 0 0 0 0 0 16.93856 0 0 0 15.35571 0 P51689 ARSD_HUMAN "Arylsulfatase D, ASD, EC 3.1.6.-" ARSD Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; lysosome [GO:0005764] endoplasmic reticulum lumen [GO:0005788]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005764; GO:0005788; GO:0046872 TASLMLK 6.480000019 1 1 0.262429787 763.3043258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9381 0 0 0 0 17.74885 0 19.29838 17.07037 0 0 0 0 0 0 0 0 16.41504 0 0 0 0 0 0 0 18.19669 0 0 0 17.47948 P51692 STA5B_HUMAN Signal transducer and activator of transcription 5B STAT5B Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0042803; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045588; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0090575; GO:0097531 EANNGSSPAGSLADAMSQK 2.460000038 1 1 0.261753344 1835.544569 0 15.84951 13.98707 15.72912 14.81636 13.65036 15.65557 0 9.172726 14.52737 14.07296 13.24494 0 0 13.25796 8.520136 0 0 0 0 0 18.61188 0 0 0 0 0 0 15.04123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.69163 15.72688 P51693 APLP1_HUMAN "Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1, APLP, APLP-1) [Cleaved into: C30 ]" APLP1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399] basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; alpha-2B adrenergic receptor binding [GO:0031695]; alpha-2C adrenergic receptor binding [GO:0031696]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399] alpha-2A adrenergic receptor binding [GO:0031694]; alpha-2B adrenergic receptor binding [GO:0031695]; alpha-2C adrenergic receptor binding [GO:0031696]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914] GO:0005604; GO:0005654; GO:0005794; GO:0005886; GO:0006897; GO:0006915; GO:0007155; GO:0007399; GO:0007409; GO:0007417; GO:0008201; GO:0009887; GO:0016021; GO:0030198; GO:0030900; GO:0031694; GO:0031695; GO:0031696; GO:0042802; GO:0046914; GO:0048471; GO:0071874; GO:0106072 GPASPAARGLSR 5.360000134 1 1 0.192831803 1142.134435 16.16857 16.13287 14.20412 0 0 0 0 14.29669 15.2795 0 10.92595 13.57339 0 0 0 14.16182 0 13.68908 0 14.38106 16.24194 0 0 0 14.6983 0 16.82504 13.42965 0 0 0 0 16.31662 0 15.58188 0 13.37336 0 0 16.48057 15.77191 0 0 0 0 0 0 0 P51786 ZN157_HUMAN Zinc finger protein 157 (Zinc finger protein HZF22) ZNF157 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KAFHEK 16.85000038 1 1 0.195236796 759.8634089 0 0 10.57609 0 0 0 0 0 0 0 14.02553 0 13.98423 14.99434 0 16.0269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51788 CLCN2_HUMAN "Chloride channel protein 2, ClC-2" CLCN2 Homo sapiens (Human) cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041] chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated chloride channel activity [GO:0005247]; cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041] voltage-gated chloride channel activity [GO:0005247] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030324; GO:0030425; GO:0032347; GO:0034707; GO:0034765; GO:0043204; GO:0060041; GO:0060689 HQQYRVR 14.73999977 0.235560209 0.235560209 0.142167342 987.3499289 13.05419 7.274232 16.17768 16.14162 15.47805 15.95321 12.32564 16.62247 0 13.9401 0 15.69015 10.91738 14.79442 16.06095 15.06328 16.1687 15.82453 12.18155 16.27616 15.72149 16.94924 18.16889 16.37837 11.55924 15.94258 17.1862 16.00388 0 13.9403 16.80502 17.24745 16.95637 0 7.800774 16.5622 16.69738 16.16128 18.17344 12.40465 0 0 10.01772 13.1844 0 15.6989 0 13.68165 P51797 CLCN6_HUMAN "H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6, ClC-6) (Chloride transport protein 6)" CLCN6 KIAA0046 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165] antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247] GO:0005247; GO:0005524; GO:0005765; GO:0006821; GO:0006884; GO:0007165; GO:0009612; GO:0010008; GO:0015108; GO:0015297; GO:0016021; GO:0034220; GO:0043231 ASDIMEPNLTYVYPHTR 1.570000052 1 1 0.292671818 2011.517471 14.0786 0 0 0 14.71715 0 11.01034 0 0 0 15.12019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.21428 0 0 0 0 0 16.74743 0 0 0 0 15.93445 0 0 P51798 CLCN7_HUMAN "H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7, ClC-7)" CLCN7 Homo sapiens (Human) response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] chloride channel complex [GO:0034707]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321] antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247] GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0030321; GO:0031410; GO:0034707; GO:0043231 GNIDKFTEK 4.949999809 0.673665226 0.673665226 0.240549057 1052.134366 15.68237 0 15.12658 0 15.76489 0 15.50539 11.81684 0 0 15.3281 12.24069 0 13.97427 0 16.10498 15.21087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51800 CLCKA_HUMAN "Chloride channel protein ClC-Ka, Chloride channel Ka (ClC-K1)" CLCNKA Homo sapiens (Human) chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; transepithelial chloride transport [GO:0030321] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030321; GO:0034707; GO:0034765; GO:0042802; GO:0046872; GO:0070293 AVGCVSWVEMK 1.460000038 0.932888985 0.932888985 0.259690733 1286.278683 14.80743 0 12.97865 0 0 0 0 0 0 0 15.23802 13.14658 0 0 0 16.02841 0 0 0 0 0 0 13.08358 0 14.60558 0 18.09586 0 15.84383 0 15.59939 0 15.45679 0 0 15.45617 0 17.07649 0 15.57303 16.29667 0 0 0 0 0 0 0 P51805 PLXA3_HUMAN Plexin-A3 (Plexin-4) (Semaphorin receptor SEX) PLXNA3 PLXN4 SEX Homo sapiens (Human) axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637] semaphorin receptor activity [GO:0017154] GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008360; GO:0017154; GO:0021612; GO:0021637; GO:0021766; GO:0021785; GO:0021860; GO:0030334; GO:0043087; GO:0048843; GO:0050772; GO:0050919; GO:0051495; GO:0071526; GO:0097485; GO:1902287; GO:1990138 AHVTGPVEDNARCYPPPSMR 5.46999979 1 1 0.122198286 2254.282428 0 13.06569 13.18266 0 0 0 0 0 14.59235 0 12.70889 0 0 0 0 0 0 14.07639 0 0 0 0 0 16.88931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.67366 0 0 0 P51810 GP143_HUMAN G-protein coupled receptor 143 (Ocular albinism type 1 protein) GPR143 OA1 Homo sapiens (Human) calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601] dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545] GO:0004930; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006726; GO:0007165; GO:0007186; GO:0007601; GO:0016020; GO:0016021; GO:0016324; GO:0032400; GO:0032402; GO:0032438; GO:0033162; GO:0035240; GO:0035584; GO:0035643; GO:0042470; GO:0048015; GO:0050848; GO:0072544; GO:0072545; GO:1902908; GO:1903056 ILRAAAACDLLGCLGMVIR 14.93999958 0.272873402 0.272873402 0.094211761 2083.67419 12.72162 0 9.970794 12.46461 0 14.46504 0 0 14.32318 11.86138 0 17.20021 17.52757 15.10854 18.60382 13.22065 0 13.65306 19.43191 16.93025 0 16.38791 15.36761 12.53341 0 16.23414 18.36036 16.40014 18.02353 0 18.24474 0 0 14.91053 0 16.15006 17.33826 17.51439 18.89943 0 0 0 0 0 19.08181 17.42925 18.28277 14.96238 P51811 XK_HUMAN Endoplasmic reticulum membrane adapter protein XK (Kell complex 37 kDa component) (Kx antigen) (Membrane transport protein XK) (XK-related protein 1) XK XKR1 XRG1 Homo sapiens (Human) amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transporter activity [GO:0005215]; amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741] transporter activity [GO:0005215] GO:0005215; GO:0005886; GO:0006865; GO:0006874; GO:0008361; GO:0010961; GO:0016021; GO:0031133; GO:0042552; GO:0048741 CNILAIK 4.269999981 1 1 0.022393491 831.9310466 15.49856 0 0 14.95778 0 14.54167 13.12672 15.56313 12.71519 0 0 0 0 14.59012 13.68027 0 0 14.89643 0 0 0 15.4541 14.44106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.25957 0 0 0 0 0 P51812 KS6A3_HUMAN "Ribosomal protein S6 kinase alpha-3, S6K-alpha-3, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 3, p90-RSK 3, p90RSK3) (Insulin-stimulated protein kinase 1, ISPK-1) (MAP kinase-activated protein kinase 1b, MAPK-activated protein kinase 1b, MAPKAP kinase 1b, MAPKAPK-1b) (Ribosomal S6 kinase 2, RSK-2) (pp90RSK2)" RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) cell cycle [GO:0007049]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224] ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007268; GO:0007417; GO:0018105; GO:0019901; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045202; GO:0045597; GO:0045944; GO:0106310 KISGSDAR 5.25 0.768581629 0.768581629 0.28222634 832.5347261 0 17.45096 0 17.39494 0 0 17.73546 17.47952 0 17.97895 18.24826 0 17.09489 0 0 0 16.50513 0 0 0 0 18.87429 17.12783 0 0 18.06152 18.62469 0 0 17.92089 18.97857 19.38813 18.03345 18.82253 17.7061 17.6666 18.70613 17.67262 0 16.05669 0 0 16.01063 0 0 18.60055 17.68831 0 P51814 ZNF41_HUMAN Zinc finger protein 41 ZNF41 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 MHSGEKR 7.119999886 1 1 0.26873056 861.4625618 14.28188 0 16.92835 14.95737 0 0 16.40825 0 0 0 0 0 0 0 0 15.49546 16.42877 15.9703 15.93954 0 0 0 15.32768 0 0 0 0 0 15.2132 0 0 13.63201 15.94251 15.75701 0 0 17.11658 0 0 16.64554 0 0 0 16.41159 0 0 0 0 P51815 ZN75D_HUMAN Zinc finger protein 75D (Zinc finger protein 75) (Zinc finger protein 82) ZNF75D ZNF75 ZNF82 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 NDTGNDHPISVSTSEIQTSGCEVSKK 6.980000019 0.86424005 0.86424005 3.20E-12 2790.850085 14.1048 15.14267 15.4668 0 0 0 13.62834 16.26116 0 0 0 0 0 11.59891 14.82592 13.55849 14.75681 14.49427 15.36009 0 15.10364 0 13.55938 0 15.48918 12.49333 14.31454 0 14.87335 13.20253 0 16.09238 0 13.376 15.96914 0 0 0 0 15.69958 15.64644 15.25962 0 0 0 0 0 15.61192 P51816 AFF2_HUMAN "AF4/FMR2 family member 2 (Fragile X E mental retardation syndrome protein) (Fragile X mental retardation 2 protein, FMR2P, Protein FMR-2) (Protein Ox19)" AFF2 FMR2 OX19 Homo sapiens (Human) brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nuclear speck [GO:0016607] nuclear speck [GO:0016607]; G-quadruplex RNA binding [GO:0002151]; brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] G-quadruplex RNA binding [GO:0002151] GO:0002151; GO:0006397; GO:0007420; GO:0007611; GO:0008380; GO:0010468; GO:0010629; GO:0016607; GO:0035063; GO:0043484 LAVLCYR 14.22000027 0.553734303 0.553734303 0.52148722 894.5620604 17.96896 0 0 0 0 0 0 0 18.83366 0 16.28478 18.82429 16.16402 0 0 0 0 0 0 0 17.26131 17.79355 0 0 0 17.19319 18.37988 0 0 0 0 0 17.71918 0 0 0 0 0 0 0 0 17.93195 0 0 0 0 0 0 P51817 PRKX_HUMAN "cAMP-dependent protein kinase catalytic subunit PRKX, PrKX, Protein kinase X, Protein kinase X-linked, Serine/threonine-protein kinase PRKX, EC 2.7.11.1 (Protein kinase PKX1)" PRKX PKX1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001525; GO:0001935; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:0106310; GO:2000696 EAPGLAQAAAAESDSRK 1.210000038 1 1 0.616200538 1672.37503 0 0 0 0 17.36213 0 18.69303 0 0 0 0 0 0 17.40325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.22271 17.87449 0 17.86676 0 0 0 0 0 0 P51825 AFF1_HUMAN "AF4/FMR2 family member 1 (ALL1-fused gene from chromosome 4 protein, Protein AF-4) (Protein FEL) (Proto-oncogene AF4)" AFF1 AF4 FEL MLLT2 PBM1 Homo sapiens (Human) regulation of gene expression [GO:0010468] super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468] GO:0008023; GO:0010468; GO:0032783 AAQSSLYNDDR 3.680000067 1 1 0.107675353 1240.692224 12.62517 14.30736 0 14.82135 0 14.32749 10.29907 13.82851 0 13.53726 0 0 13.67732 12.93354 0 0 0 11.74841 15.30677 0 0 0 0 0 10.99791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51841 GUC2F_HUMAN "Retinal guanylyl cyclase 2, RETGC-2, EC 4.6.1.2 (Guanylate cyclase 2F, retinal) (Guanylate cyclase F, GC-F) (Rod outer segment membrane guanylate cyclase 2, ROS-GC2)" GUCY2F GUC2F RETGC2 Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005640; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0019934; GO:0022400; GO:0038023; GO:0042802; GO:0044877; GO:0050908; GO:0097381; GO:0120200 IRIGLHSGPVVAGVVGLTMPR 5.789999962 0.290212572 0.290212572 0.270964175 2128.501934 14.19888 0 15.01422 13.69963 13.17293 0 0 8.987993 0 0 0 0 13.12589 0 14.04263 0 12.24976 0 14.05837 0 16.10458 0 16.23515 0 0 11.08754 0 0 12.3924 0 0 0 13.99189 0 0 14.37583 15.13718 0 0 13.86322 0 0 16.5775 0 0 0 0 0 P51946 CCNH_HUMAN Cyclin-H (MO15-associated protein) (p34) (p37) CCNH Homo sapiens (Human) cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000079; GO:0000439; GO:0005634; GO:0005654; GO:0005675; GO:0006357; GO:0006366; GO:0006367; GO:0007049; GO:0016538; GO:0019907; GO:0050821; GO:0070516; GO:0070816; GO:0070985; GO:2000045 AVANGKVLPNDPVFLEPHEEMTLCK 2.339999914 1 1 9.14E-13 2824.723791 0 16.11746 13.0628 0 0 15.36046 0 16.36017 0 0 0 15.86947 15.00002 12.5492 0 0 12.97615 0 14.00183 13.6078 15.70252 0 13.97268 12.94753 0 0 15.28712 0 0 14.72992 0 0 14.97455 14.93518 0 0 16.91157 14.81731 0 13.56881 0 14.69109 0 15.10849 0 0 0 15.51965 P51959 CCNG1_HUMAN "Cyclin-G1, Cyclin-G" CCNG1 CCNG CYCG1 Homo sapiens (Human) brain development [GO:0007420]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to organonitrogen compound [GO:0010243]; syncytium formation [GO:0006949] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; brain development [GO:0007420]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to organonitrogen compound [GO:0010243]; syncytium formation [GO:0006949] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000079; GO:0000307; GO:0005634; GO:0005654; GO:0005737; GO:0006949; GO:0007095; GO:0007420; GO:0010243; GO:0016538; GO:0030425; GO:0043025; GO:0043066; GO:0044772; GO:0048471; GO:0051301 CSKPNVQK 6.690000057 1 1 0.132784097 959.5842616 0 14.96427 14.40705 14.16507 14.08977 0 12.60882 15.51074 15.50885 16.64237 0 11.26091 12.19411 11.19648 13.00898 0 0 0 0 13.05966 0 14.69472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52179 MYOM1_HUMAN Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1) MYOM1 Homo sapiens (Human) muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737] M band [GO:0031430]; striated muscle myosin thick filament [GO:0005863] M band [GO:0031430]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737] actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307] GO:0005863; GO:0006936; GO:0008307; GO:0010628; GO:0010737; GO:0019900; GO:0031430; GO:0042802; GO:0042803; GO:0050714; GO:0051015 DVRSTVSHYQR 9.199999809 1 1 0.356052034 1348.138063 15.78597 13.87451 15.72514 13.38334 14.85265 13.95163 0 14.26541 15.57468 0 12.55668 13.62263 0 15.01333 15.79966 16.04798 0 15.26812 15.79942 17.75702 15.20491 16.2808 0 0 0 0 0 16.31342 0 0 0 0 15.82594 16.5656 16.55328 0 17.14677 18.20529 0 15.37916 18.4738 16.15379 0 0 16.61391 17.23297 0 16.04733 P52198 RND2_HUMAN Rho-related GTP-binding protein RhoN (Rho family GTPase 2) (Rho-related GTP-binding protein Rho7) (Rnd2) RND2 ARHN RHO7 Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; plasma membrane [GO:0005886] acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485] GO:0002080; GO:0003924; GO:0005525; GO:0005769; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0047485; GO:0048672 GNEGEIHK 8.920000076 1 1 0.482476905 885.0992674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1191 0 0 0 0 P52272 HNRPM_HUMAN "Heterogeneous nuclear ribonucleoprotein M, hnRNP M" HNRNPM HNRPM NAGR1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]" catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]" mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] GO:0000380; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0016020; GO:0016363; GO:0019904; GO:0042382; GO:0062023; GO:0070062; GO:0071013; GO:0071014; GO:1990904; GO:2000815 ACRMMNGMK 5.489999771 1 1 0.156864243 1114.26277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98625 0 0 0 0 0 P52292 IMA1_HUMAN Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha) KPNA2 RCH1 SRP1 Homo sapiens (Human) DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018] histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723] GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0042564; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902 GKDSTEMR 15.53999996 1 1 0.068144716 939.1262855 0 0 0 14.58157 0 0 0 0 0 15.70836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.39484 0 0 0 0 0 14.75866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.78169 15.29937 0 P52294 IMA5_HUMAN "Importin subunit alpha-5 (Karyopherin subunit alpha-1) (Nucleoprotein interactor 1, NPI-1) (RAG cohort protein 2) (SRP1-beta) [Cleaved into: Importin subunit alpha-5, N-terminally processed ]" KPNA1 RCH2 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of apoptotic process [GO:0042981]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA recombination [GO:0000018]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell proliferation [GO:0014841] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of apoptotic process [GO:0042981]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA recombination [GO:0000018]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell proliferation [GO:0014841] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] GO:0000018; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006607; GO:0008139; GO:0014069; GO:0014841; GO:0014901; GO:0030425; GO:0042564; GO:0042981; GO:0060828; GO:0061608; GO:0098978; GO:0099527 SPPPEFAK 1.230000019 0.788121283 0.788121283 0.218725335 873.082874 13.9273 14.22867 15.11069 0 0 15.26185 0 0 16.69286 15.47793 0 0 0 0 0 13.58099 16.52186 16.38421 0 0 0 0 14.76222 16.99361 16.45681 0 0 17.02582 0 0 16.06884 0 15.48003 0 0 17.12616 15.17739 0 16.66483 0 14.05129 13.95738 12.36941 15.33631 16.50147 17.16408 0 15.6179 P52298 NCBP2_HUMAN "Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (Cell proliferation-inducing gene 55 protein) (NCBP 20 kDa subunit, CBP20) (NCBP-interacting protein 1, NIP1)" NCBP2 CBP20 PIG55 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; gene silencing by miRNA [GO:0035195]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; snRNA binding [GO:0017069]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; gene silencing by miRNA [GO:0035195]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]" mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; snRNA binding [GO:0017069] GO:0000184; GO:0000339; GO:0000340; GO:0000380; GO:0000398; GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005845; GO:0005846; GO:0006406; GO:0006408; GO:0006446; GO:0008334; GO:0008380; GO:0016246; GO:0017069; GO:0031053; GO:0031124; GO:0031442; GO:0032968; GO:0034518; GO:0035195; GO:0042789; GO:0045292; GO:0046833; GO:0098789; GO:1901409 GRSGGQVR 1.649999976 1 1 0.021030766 817.6218616 15.43343 14.65613 0 0 13.35225 14.03688 13.40714 14.50024 0 0 15.41436 0 12.09653 13.57433 0 0 0 9.652579 0 0 0 16.08026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52306 GDS1_HUMAN Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein) RAP1GDS1 SMGGDS Homo sapiens (Human) myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829] GTPase activator activity [GO:0005096] GO:0005096; GO:0005739; GO:0005783; GO:0005829; GO:0014829; GO:0031034; GO:0032471; GO:0043547; GO:0051561; GO:0070062 SKDVIK 2.839999914 0.778034627 0.778034627 0.226666743 688.2609777 14.95733 14.43102 14.99213 14.71123 0 0 0 15.88626 0 0 0 0 0 13.71472 0 0 15.89365 14.45849 16.14317 16.1932 0 0 0 0 0 0 0 0 0 0 15.14738 16.11605 0 13.96091 16.73218 16.71215 0 0 0 17.27376 0 0 17.42437 15.81201 14.9479 17.66052 15.10441 16.47554 P52333 JAK3_HUMAN "Tyrosine-protein kinase JAK3, EC 2.7.10.2 (Janus kinase 3, JAK-3) (Leukocyte janus kinase, L-JAK)" JAK3 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; innate immune response [GO:0045087]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; intracellular signal transduction [GO:0035556]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL production [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; innate immune response [GO:0045087]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; intracellular signal transduction [GO:0035556]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL production [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0002250; GO:0002731; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007167; GO:0007204; GO:0007260; GO:0018108; GO:0019221; GO:0019903; GO:0030183; GO:0030218; GO:0032693; GO:0032695; GO:0035556; GO:0035771; GO:0038110; GO:0042102; GO:0042104; GO:0042981; GO:0043029; GO:0045087; GO:0045221; GO:0045626; GO:0046425; GO:0050868; GO:0051770; GO:0051928; GO:0060397; GO:0070232; GO:0070244; GO:0070669; GO:0070670; GO:0070672; GO:0071104 LPAPPACPAEVHELMK 3.369999886 1 1 9.21E-13 1776.027886 13.97643 0 0 0 13.77048 0 0 0 0 0 15.85203 11.44245 15.60352 16.14586 0 0 0 0 15.62985 14.77367 0 0 0 0 0 0 0 0 0 16.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52429 DGKE_HUMAN "Diacylglycerol kinase epsilon, DAG kinase epsilon, EC 2.7.1.107 (Diglyceride kinase epsilon, DGK-epsilon)" DGKE DAGK5 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0006661; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046834; GO:0046872; GO:0050804; GO:0098978 CDFGEFK 3.200000048 0.249682739 0.249682739 0.173378855 903.4571138 14.77048 0 15.14981 0 0 13.62088 11.35868 15.7333 0 0 0 15.46684 15.00949 14.5409 14.66316 0 0 0 0 15.25749 0 0 16.11943 16.43972 0 0 15.88744 15.35054 0 15.06352 0 15.22815 16.54196 15.09452 0 0 16.45242 16.78922 15.63536 0 15.89655 16.00552 0 0 0 0 0 0 P52564 MP2K6_HUMAN "Dual specificity mitogen-activated protein kinase kinase 6, MAP kinase kinase 6, MAPKK 6, EC 2.7.12.2 (MAPK/ERK kinase 6, MEK 6) (Stress-activated protein kinase kinase 3, SAPK kinase 3, SAPKK-3, SAPKK3)" MAP2K6 MEK6 MKK6 PRKMK6 SKK3 Homo sapiens (Human) apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; DNA damage induced protein phosphorylation [GO:0006975]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; phosphatase activator activity [GO:0019211]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; DNA damage induced protein phosphorylation [GO:0006975]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; phosphatase activator activity [GO:0019211]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] GO:0000165; GO:0001649; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0006975; GO:0007165; GO:0009410; GO:0019211; GO:0019901; GO:0022602; GO:0032308; GO:0038066; GO:0042802; GO:0043065; GO:0043406; GO:0043539; GO:0051403; GO:0051726; GO:0051770; GO:0060048; GO:0060348; GO:0070423; GO:0072709; GO:0090398; GO:0106310; GO:0120163; GO:1901796 ERPTYPELMQHPFFTLHESK 21.46999931 1 1 0.298045234 2486.609263 13.89782 13.93018 10.79714 0 17.51942 16.31498 0 0 0 0 15.38534 11.63026 0 0 0 14.3598 14.58913 0 13.30096 0 0 0 15.36402 13.83733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4004 15.96819 13.5807 0 0 0 0 14.63304 0 P52565 GDIR1_HUMAN "Rho GDP-dissociation inhibitor 1, Rho GDI 1 (Rho-GDI alpha)" ARHGDIA GDIA1 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526] GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094] GO:0001772; GO:0005094; GO:0005096; GO:0005634; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0032880; GO:0035023; GO:0043066; GO:0070062; GO:0071526; GO:2000249 EIVSGMK 15.07999992 0.428972721 0.428972721 0.196252878 762.5349322 18.49399 17.85013 0 17.61083 18.01243 16.7911 0 17.66859 15.64754 20.07211 16.50297 16.75486 17.48661 19.6442 0 16.23365 16.89806 17.07257 16.89891 0 15.00252 18.48297 16.53064 16.97302 15.66851 18.00795 17.26521 13.43054 15.96809 18.07042 15.54196 20.21898 15.50424 18.80619 17.56952 17.26583 18.20539 17.44119 19.3614 18.89957 18.01885 15.72673 16.30449 18.11963 15.71569 13.29104 15.3601 17.37235 P52569 CTR2_HUMAN "Cationic amino acid transporter 2, CAT-2, CAT2 (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)" SLC7A2 ATRC2 CAT2 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] GO:0000064; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352 HSLEGHLR 4.059999943 1 1 0.461931487 948.0164578 14.38623 0 0 0 0 17.80651 0 0 0 18.38986 0 18.34975 16.92827 17.28458 0 0 0 17.35807 0 15.29275 16.90046 0 17.5 0 0 0 0 0 16.0916 0 0 0 0 17.59559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52594 AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein) AGFG1 HRB RAB RIP Homo sapiens (Human) cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; spermatogenesis [GO:0007283] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; spermatogenesis [GO:0007283] DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005829; GO:0006406; GO:0007283; GO:0030154; GO:0031410; GO:0043231; GO:0046872 MAASAKR 3.869999886 0.303053617 0.303053617 7.98E-13 750.6206581 17.77005 15.46308 16.34896 10.99802 11.49881 0 0 0 15.10274 15.71587 16.10741 17.72859 12.50299 15.49329 0 11.43106 14.7213 0 14.50432 11.86784 15.56594 0 16.43765 14.51074 16.01392 17.49656 14.09845 16.23909 14.71389 13.94108 17.09905 18.56405 0 15.39019 0 14.87563 15.08943 0 16.87599 0 11.74167 0 13.14369 17.53622 13.35224 14.86901 17.38871 17.47723 P52597 HNRPF_HUMAN "Heterogeneous nuclear ribonucleoprotein F, hnRNP F (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed ]" HNRNPF HNRPF Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]" RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0016020; GO:0043484; GO:0071013; GO:1990904 QSGEAFVELGSEDDVKMALK 1.559999943 0.664443314 0.664443314 0.138908157 2154.001959 14.19402 13.90304 14.6619 16.82177 13.66231 0 14.61661 0 0 0 0 0 0 0 0 12.91773 0 0 0 0 12.61336 14.8844 12.663 0 15.22867 11.98218 15.87737 0 0 15.77783 0 15.80453 0 0 0 0 0 0 0 0 14.98201 0 0 15.53488 13.77875 13.7986 0 14.04469 P52630 STAT2_HUMAN Signal transducer and activator of transcription 2 (p113) STAT2 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337] chromatin [GO:0000785]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]" GO:0000785; GO:0000978; GO:0000981; GO:0001932; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0060339; GO:0070721; GO:0090140; GO:0090575 ILQETLNELDKR 4.840000153 0.642845392 0.642845392 0.258925187 1471.313501 15.83002 14.27888 14.13824 0 0 14.82796 14.91392 0 14.92548 0 12.58487 15.82961 17.82512 13.40067 13.24834 0 0 0 0 0 0 17.53033 0 0 15.79398 15.50721 16.82517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.82635 0 0 0 0 0 12.8281 P52655 TF2AA_HUMAN "Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit, TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit) ]" GTF2A1 TF2A1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025] GO:0000979; GO:0001091; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0016251; GO:0017025; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629; GO:0097550 ANSANTNTVPK 4.059999943 1 1 0.110558258 1114.460588 10.9578 15.03908 12.71124 17.6647 12.69849 13.65479 0 0 0 0 0 0 0 0 0 0 14.49938 0 0 0 0 0 14.254 0 0 0 0 0 0 0 0 0 13.52237 0 0 0 0 0 0 0 0 0 0 14.88158 0 0 0 0 P52701 MSH6_HUMAN "DNA mismatch repair protein Msh6, hMSH6 (G/T mismatch-binding protein, GTBP, GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit, p160)" MSH6 GTBP Homo sapiens (Human) determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283]" "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]" GO:0000710; GO:0000785; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006298; GO:0007283; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032301; GO:0035064; GO:0043231; GO:0045190; GO:0045910; GO:0051096; GO:0097193 EVCLASER 9.470000267 0.361504257 0.361504257 0.118666266 961.1074392 0 0 0 14.31725 17.58903 0 15.4482 0 12.92381 0 0 0 0 0 0 0 0 0 0 0 0 17.9391 0 0 0 0 0 0 0 16.53594 16.67842 15.17126 0 0 0 0 0 0 0 0 0 0 0 0 16.0802 0 15.18141 0 P52732 KIF11_HUMAN "Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5, TR-interacting protein 5, TRIP-5)" KIF11 EG5 KNSL1 TRIP5 Homo sapiens (Human) cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle organization [GO:0007051] cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922] cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle organization [GO:0007051] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901] GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007051; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0016020; GO:0019901; GO:0032991; GO:0046602; GO:0051301; GO:0072686; GO:0090307 DGSSK 2.279999971 1 1 0.098390231 490.6684157 14.23647 14.84312 0 15.47143 0 15.5922 14.41978 0 0 14.52877 14.74673 0 0 0 0 0 0 13.94396 0 0 0 0 0 14.41159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52735 VAV2_HUMAN "Guanine nucleotide exchange factor VAV2, VAV-2" VAV2 Homo sapiens (Human) angiogenesis [GO:0001525]; cell migration [GO:0016477]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784] GO:0001525; GO:0001784; GO:0005085; GO:0005154; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0008361; GO:0016477; GO:0030032; GO:0030168; GO:0038095; GO:0038096; GO:0043087; GO:0043552; GO:0046872; GO:0048010; GO:0051056 MGMTEDDK 4.519999981 0.05974362 0.05974362 0.307075014 942.9298451 0 14.82452 13.30697 15.66693 16.19909 14.03135 0 0 13.84328 15.37375 0 0 14.70495 15.44869 0 0 0 0 0 14.36981 0 16.51382 15.69895 14.99248 0 0 0 0 15.1342 0 0 16.64103 0 15.20233 0 0 0 0 0 0 14.52054 0 0 0 0 0 15.22149 0 P52737 ZN136_HUMAN Zinc finger protein 136 ZNF136 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 DQNIKDHYK 6.440000057 0.259810984 0.259810984 0.011349261 1160.130395 10.34847 15.13797 13.01401 0 0 0 13.47999 0 16.3953 0 14.06628 14.87446 0 19.25463 13.5155 13.75334 0 0 17.76147 17.6111 16.62435 16.49043 17.9059 0 8.937066 15.64651 17.06167 16.64012 13.92924 15.64944 11.01807 14.45768 13.74753 0 14.97595 15.61487 15.17143 15.17648 13.52091 13.38287 15.9272 0 15.76674 16.32095 15.55609 0 0 13.04188 P52739 ZN131_HUMAN Zinc finger protein 131 ZNF131 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654] "intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0045111; GO:0046872 HLIEFTYTAKLMIQGEEEANDVWK 2.289999962 1 1 0.185054741 2881.337943 15.50954 12.28498 9.98414 10.64358 16.69535 12.48581 12.80824 0 0 0 15.91176 15.97418 12.31653 0 0 0 0 0 0 13.66466 14.05122 0 0 0 16.53975 0 14.73716 0 16.20208 0 0 0 0 0 16.23214 0 0 17.14613 0 0 0 0 0 12.63534 0 0 14.35782 15.17167 P52740 ZN132_HUMAN Zinc finger protein 132 ZNF132 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 DALMKSSK 1.019999981 1 1 0.114371493 896.2648574 14.93915 14.27732 0 0 0 12.92535 13.41118 14.76966 13.82904 0 0 14.53759 0 13.52667 0 0 16.9822 0 15.02234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52741 ZN134_HUMAN Zinc finger protein 134 ZNF134 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872 VHNGARPYKCSDCGK 2.819999933 1 1 0.135462644 1749.264733 16.04366 15.60069 0 14.46252 0 14.59925 15.80989 15.06615 14.69287 15.66671 12.5645 0 13.19135 0 15.74579 0 0 0 0 16.25356 0 0 15.91522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52746 ZN142_HUMAN Zinc finger protein 142 ZNF142 KIAA0236 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AVDKGQGAQR 13.65999985 1 1 0.066660752 1025.751058 0 0 16.04016 15.91392 0 13.849 0 14.95638 0 0 0 0 0 0 14.6566 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2638 0 0 0 0 0 0 0 0 0 0 14.87243 14.60584 0 0 0 0 0 0 0 P52747 ZN143_HUMAN "Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor, hStaf)" ZNF143 SBF STAF Homo sapiens (Human) "positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005654; GO:0006355; GO:0006357; GO:0006359; GO:0045944; GO:0045945; GO:0046872; GO:0048661; GO:1905382 CPFEGCGR 9.329999924 1 1 0.017249203 981.4124547 16.1347 12.9218 11.97564 13.75437 13.14642 15.53393 15.12953 0 12.58852 0 15.59012 14.29078 0 0 0 12.41615 0 0 0 0 0 0 16.50709 0 0 14.35182 13.81894 0 0 11.0975 13.95403 16.69555 0 15.46143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52756 RBM5_HUMAN RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9) RBM5 H37 LUCA15 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0006915; GO:0008285; GO:0043065; GO:0046872 ESAAADAGFALFEKK 15.22999954 0.755996644 0.755996644 0.239734795 1554.306889 14.93296 13.10366 16.01489 0 0 14.50068 17.09393 14.99381 0 0 0 13.23839 0 0 0 16.15666 15.11243 13.59758 12.01405 13.45957 12.25113 0 0 0 0 14.56917 0 14.02973 0 12.98817 16.52203 14.92798 16.16815 15.50407 0 15.57628 0 13.64173 0 15.81502 15.44716 13.55569 15.26959 0 0 0 0 15.46508 P52758 RIDA_HUMAN "2-iminobutanoate/2-iminopropanoate deaminase, EC 3.5.99.10 (14.5 kDa translational inhibitor protein, hp14.5, p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog)" RIDA HRSP12 Homo sapiens (Human) brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]" "2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]" GO:0001822; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0006629; GO:0007420; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0030324; GO:0033993; GO:0036041; GO:0042802; GO:0046914; GO:0050680; GO:0061157; GO:0070062; GO:0070314; GO:0120242; GO:0120243; GO:1901565; GO:1902074 GSRIEIEAVAIQGPLTTASL 2.75999999 1 1 0.348226315 2027.866147 0 12.23272 12.67667 0 0 13.36324 15.66007 0 0 0 14.45254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.19754 0 0 0 0 0 0 0 0 0 0 0 0 0 14.62462 0 0 0 P52788 SPSY_HUMAN "Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)" SMS Homo sapiens (Human) methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; spermine synthase activity [GO:0016768]; methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597] spermine synthase activity [GO:0016768] GO:0005829; GO:0006555; GO:0006595; GO:0006597; GO:0016768; GO:0070062 EDYTGK 5.659999847 1 1 0.247423439 714.3391575 0 16.531 16.03113 0 15.56508 0 0 16.34585 14.7935 0 16.24944 15.03032 0 0 0 0 0 0 0 0 15.61298 0 0 0 0 16.31805 16.17697 0 0 15.80484 0 17.31052 16.79478 16.13973 16.18275 17.14406 17.33923 16.81058 14.75386 15.45758 16.05102 16.34821 15.76624 16.28962 0 15.82617 17.11245 15.1252 P52789 HXK2_HUMAN "Hexokinase-2, EC 2.7.1.1 (Hexokinase type II, HK II) (Hexokinase-B) (Muscle form hexokinase)" HK2 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158] GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0005886; GO:0006002; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0019158; GO:0035795; GO:0043231; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1904925; GO:1990830; GO:2000378 GLLFR 18.35000038 1 1 0.159398463 604.376079 12.7083 14.64927 14.83323 12.05239 14.47258 0 0 0 0 15.44219 12.64119 14.4995 0 0 0 0 16.28733 16.92588 17.9537 0 15.76992 0 16.11949 15.80458 0 0 0 0 0 0 0 15.36971 0 0 0 0 0 0 0 0 0 0 15.60831 14.84762 0 0 0 17.07228 P52790 HXK3_HUMAN "Hexokinase-3, EC 2.7.1.1 (Hexokinase type III, HK III) (Hexokinase-C)" HK3 Homo sapiens (Human) canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096] ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158] GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005576; GO:0005739; GO:0005829; GO:0006002; GO:0006096; GO:0008865; GO:0019158; GO:0034774; GO:0051156; GO:0061621; GO:1904813 AMAKGLR 4.929999828 0.308782578 0.308782578 0.200325723 746.8652318 0 13.95535 14.55132 0 0 0 0 0 14.35654 0 0 0 13.93751 0 0 15.69703 0 0 0 0 0 0 16.43528 16.21803 15.06181 0 15.35814 14.92268 11.9528 15.14724 13.97187 0 14.01779 14.74814 0 15.59361 15.75185 15.08171 14.03595 15.04073 17.02055 16.67271 15.51622 16.24954 16.11554 16.8365 16.61349 15.19337 P52823 STC1_HUMAN "Stanniocalcin-1, STC-1" STC1 STC Homo sapiens (Human) bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280] hormone activity [GO:0005179]; identical protein binding [GO:0042802] GO:0001503; GO:0001886; GO:0003421; GO:0005179; GO:0005615; GO:0005634; GO:0005737; GO:0006874; GO:0007566; GO:0010596; GO:0016324; GO:0030336; GO:0033280; GO:0035988; GO:0042802; GO:0044070; GO:0046697; GO:0051926; GO:0060348; GO:0071320; GO:0071385; GO:0071456; GO:0086004; GO:0090280; GO:1903403 CIANGVTSK 7.21999979 0.425121099 0.425121099 0.253049123 950.0578485 14.5987 14.97112 14.87731 11.66671 0 15.01311 0 0 15.58999 0 0 16.05718 0 14.21614 15.57611 16.3234 15.93885 15.97115 15.38267 13.65901 15.77345 16.86238 0 17.8288 15.15722 16.35373 16.94182 0 16.19803 0 15.88197 17.90594 15.20776 16.69883 0 0 15.477 17.02743 0 0 15.42171 14.69783 0 0 0 15.28241 0 0 P52824 DGKQ_HUMAN "Diacylglycerol kinase theta, DAG kinase theta, DGKtheta, EC 2.7.1.107 (Diglyceride kinase theta, DGK-theta)" DGKQ DAGK4 Homo sapiens (Human) cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030168; GO:0030297; GO:0033198; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903432; GO:2000064; GO:2000182 AGTTR 5.420000076 1 1 0.189114777 506.0826306 13.34838 14.98253 0 15.95096 16.38899 13.84928 0 0 13.37636 15.05368 14.8086 15.51769 15.22741 14.93021 16.17925 15.02758 15.36872 16.71662 15.42755 0 15.86426 0 0 0 0 0 16.83899 0 0 0 0 0 0 0 16.83966 0 18.83031 19.25756 19.00043 17.66119 0 0 17.21681 0 0 0 0 0 P52848 NDST1_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1, NDST-1) (N-heparan sulfate sulfotransferase 1, N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1, HSNST 1) [Includes: Heparan sulfate N-deacetylase 1, EC 3.5.1.-; Heparan sulfate N-sulfotransferase 1, EC 2.8.2.8 ]" NDST1 HSST HSST1 Homo sapiens (Human) "aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange by respiratory system [GO:0007585]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange by respiratory system [GO:0007585]" [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119] GO:0000139; GO:0003279; GO:0005794; GO:0006024; GO:0006477; GO:0006954; GO:0007585; GO:0008283; GO:0008543; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0030900; GO:0030901; GO:0032588; GO:0035904; GO:0043410; GO:0045880; GO:0048702; GO:0048703; GO:0050119; GO:0060976; GO:0102140 TEPAKVMDMVQK 1.909999967 0.475386828 0.475386828 0.252892965 1392.055987 0 0 0 0 16.02253 0 14.34526 0 0 0 0 0 0 0 0 16.33544 14.20801 15.13394 0 0 0 0 16.11542 0 15.45797 0 16.2627 10.95218 0 0 16.55902 17.1276 0 16.12984 0 0 0 0 0 0 0 0 0 0 14.00705 0 0 0 P52849 NDST2_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2, EC 2.8.2.8 (Glucosaminyl N-deacetylase/N-sulfotransferase 2, NDST-2) (N-heparan sulfate sulfotransferase 2, N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2, EC 3.-.-.-; Heparan sulfate N-sulfotransferase 2, EC 2.8.2.- ]" NDST2 HSST2 Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; N-acetylglucosamine deacetylase activity [GO:0050119]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; N-acetylglucosamine deacetylase activity [GO:0050119] GO:0000139; GO:0005794; GO:0006024; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0050119 FRYSTELAPGR 11.21000004 0.870581269 0.870581269 0.076326431 1292.319954 0 0 8.62858 0 11.7216 10.87558 0 0 8.906544 0 13.14157 0 10.10185 0 10.60703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.09132 0 0 10.6702 0 9.162917 0 0 0 11.56895 0 0 0 0 0 0 0 P52888 THOP1_HUMAN "Thimet oligopeptidase, EC 3.4.24.15 (Endopeptidase 24.15) (MP78)" THOP1 Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0000209; GO:0004222; GO:0005758; GO:0005829; GO:0006508; GO:0006518; GO:0046872 TASTEADK 13.82999992 0.901486635 0.901486635 0.218639438 822.3800345 0 0 14.1183 14.66191 0 15.33806 14.20059 14.86952 16.86765 17.94751 0 14.41872 15.38676 0 14.52716 0 12.21898 14.61516 14.75478 14.47104 14.87992 14.99544 16.93293 17.65154 0 0 0 0 0 15.89187 15.4415 0 0 0 16.24892 0 0 0 0 15.08699 13.82292 0 0 0 0 15.78344 0 0 P52907 CAZA1_HUMAN F-actin-capping protein subunit alpha-1 (CapZ alpha-1) CAPZA1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]; protein-containing complex assembly [GO:0065003] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]; protein-containing complex assembly [GO:0065003] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296] GO:0003779; GO:0005576; GO:0005829; GO:0005856; GO:0008290; GO:0015629; GO:0030036; GO:0034329; GO:0045296; GO:0051015; GO:0051016; GO:0065003; GO:0070062; GO:0071203 ADFDDR 3.559999943 0.899589777 0.899589777 0.219924802 736.574395 17.48151 0 0 0 0 17.50599 0 0 0 17.38028 17.32001 0 0 0 17.23668 19.05236 17.42686 0 18.82906 17.69935 0 0 0 0 17.69235 0 0 0 17.36482 17.39739 0 19.64647 0 0 0 0 17.74879 19.06187 0 19.21357 0 17.16768 16.94565 17.34678 18.01935 0 16.28738 18.23133 P52945 PDX1_HUMAN "Pancreas/duodenum homeobox protein 1, PDX-1 (Glucose-sensitive factor, GSF) (Insulin promoter factor 1, IPF-1) (Insulin upstream factor 1, IUF-1) (Islet/duodenum homeobox-1, IDX-1) (Somatostatin-transactivating factor 1, STF-1)" PDX1 IPF1 STF1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; animal organ senescence [GO:0010260]; central nervous system development [GO:0007417]; detection of glucose [GO:0051594]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; liver development [GO:0001889]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to cytokine [GO:0034097]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to iron(II) ion [GO:0010040]; response to leucine [GO:0043201]; response to nicotine [GO:0035094]; response to vitamin [GO:0033273]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; animal organ senescence [GO:0010260]; central nervous system development [GO:0007417]; detection of glucose [GO:0051594]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; liver development [GO:0001889]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to cytokine [GO:0034097]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to iron(II) ion [GO:0010040]; response to leucine [GO:0043201]; response to nicotine [GO:0035094]; response to vitamin [GO:0033273]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001889; GO:0003309; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006006; GO:0006091; GO:0006357; GO:0006366; GO:0007224; GO:0007263; GO:0007417; GO:0008284; GO:0008285; GO:0009410; GO:0009611; GO:0009887; GO:0010040; GO:0010157; GO:0010260; GO:0010942; GO:0016331; GO:0016607; GO:0030073; GO:0031017; GO:0031100; GO:0033273; GO:0034097; GO:0035094; GO:0035774; GO:0042593; GO:0043201; GO:0043279; GO:0043388; GO:0044877; GO:0045944; GO:0048565; GO:0048863; GO:0051384; GO:0051594; GO:0060290; GO:0070542; GO:1902236; GO:1990837; GO:1990841; GO:2000675 GPAPEFSASPPACLYMGR 2.549999952 0.649890125 0.649890125 0.254929595 1907.721441 15.30845 16.53416 0 0 13.783 13.39925 13.50167 0 0 0 0 0 0 0 0 14.54778 13.64336 12.39935 0 0 0 0 0 0 15.05191 0 0 0 0 0 17.10053 11.66533 0 0 8.664305 0 0 0 0 0 0 0 0 0 0 15.71363 13.16569 0 P52948 NUP98_HUMAN "Nuclear pore complex protein Nup98-Nup96, EC 3.4.21.- [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98, Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96, Nup96) ]" NUP98 ADAR2 Homo sapiens (Human) "mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]" cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] "cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]" mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215] GO:0003713; GO:0003729; GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904 DRLAQSDMAK 2.430000067 1 1 0.011463868 1135.624846 0 14.87632 0 0 0 0 14.69914 0 15.2568 0 0 0 0 0 0 0 13.73198 0 0 0 0 0 0 0 0 15.26973 0 14.96959 0 0 0 11.5025 0 0 0 0 0 0 0 0 0 13.32714 0 0 0 13.1082 0 0 P53007 TXTP_HUMAN "Tricarboxylate transport protein, mitochondrial (Citrate transport protein, CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)" SLC25A1 SLC20A3 Homo sapiens (Human) fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142]; fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843] citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142] GO:0005634; GO:0005743; GO:0006094; GO:0006843; GO:0015137; GO:0015142; GO:0016021; GO:0046949; GO:0070062; GO:0071913 AKLTHPGK 11 1 1 0.289359927 851.7543008 19.52477 19.58433 0 0 0 0 0 0 19.32091 20.55405 19.00406 0 17.35113 18.77417 0 19.01203 18.75641 17.1012 17.36151 16.48796 0 0 0 0 0 18.97931 17.48457 18.21644 18.80075 18.27091 0 0 0 0 0 17.88445 19.74971 0 20.07658 20.26011 19.17373 17.43637 0 18.49212 19.27831 19.38117 0 15.91384 P53041 PPP5_HUMAN "Serine/threonine-protein phosphatase 5, PP5, EC 3.1.3.16 (Protein phosphatase T, PP-T, PPT)" PPP5C PPP5 Homo sapiens (Human) "double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]" chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]" ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156] GO:0000165; GO:0000278; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006302; GO:0006351; GO:0006470; GO:0008289; GO:0010288; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0101031; GO:1904550 AMAEGER 2.569999933 0.771713257 0.771713257 0.178525011 764.2032945 0 16.01867 14.02845 0 11.91042 18.41219 0 17.22493 0 0 16.12921 0 0 15.26192 0 0 0 0 0 0 0 0 0 0 16.23394 0 0 0 0 0 0 16.65281 0 0 0 0 0 15.48391 0 0 0 0 0 0 11.77328 0 13.97234 14.93403 P53350 PLK1_HUMAN "Serine/threonine-protein kinase PLK1, EC 2.7.11.21 (Polo-like kinase 1, PLK-1) (Serine/threonine-protein kinase 13, STPK13)" PLK1 PLK Homo sapiens (Human) centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194] anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000785; GO:0000795; GO:0000922; GO:0000940; GO:0001578; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006468; GO:0007052; GO:0007062; GO:0007076; GO:0007077; GO:0007094; GO:0007095; GO:0007098; GO:0007346; GO:0008017; GO:0010800; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0051726; GO:0070194; GO:0071168; GO:0090435; GO:0097431; GO:0106310; GO:1900182; GO:1901673; GO:1901990; GO:1904668; GO:1904776; GO:1905784 MSAAVTAGK 10.90999985 0.56186527 0.56186527 0.270853986 836.8881432 0 11.26095 16.60099 14.9719 15.09929 14.99207 14.81709 15.85903 0 0 13.63593 14.74845 12.83243 0 0 0 16.30737 13.82716 17.59414 17.89328 12.06291 14.9509 14.9244 15.98272 17.50543 0 0 0 0 16.50755 18.29716 14.6846 0 16.13302 16.68048 0 16.33278 0 0 0 0 16.2908 0 15.43932 0 0 0 0 P53370 NUDT6_HUMAN "Nucleoside diphosphate-linked moiety X motif 6, Nudix motif 6, EC 3.6.1.- (Antisense basic fibroblast growth factor) (Protein GFG)" NUDT6 FGF2AS Homo sapiens (Human) negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285] ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529] GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287 TYGPGPSAGYRWASGAQGYVR 5.690000057 1 1 0.204999225 2200.904605 0 0 13.82582 0 0 15.10216 0 0 15.37414 0 0 0 0 16.03733 0 14.6947 0 14.62935 16.90746 17.01728 0 0 0 16.32153 13.29386 0 14.95215 15.90748 14.14694 14.69055 13.88566 0 0 15.447 0 0 0 16.57068 16.87136 0 0 0 0 0 0 0 0 0 P53396 ACLY_HUMAN "ATP-citrate synthase, EC 2.3.3.8 (ATP-citrate (pro-S-)-lyase, ACL) (Citrate cleavage enzyme)" ACLY Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0035578; GO:0046872; GO:0070062; GO:1904813 EAYPEEAYIADLDAKSGASLK 7.039999962 1 1 0.041659024 2241.263805 12.05335 15.6203 0 0 0 0 0 0 15.01081 0 0 0 0 12.78199 0 11.49876 0 0 13.93253 0 13.34086 10.69497 0 14.08614 0 0 0 0 0 0 0 0 0 0 0 0 13.82299 0 0 14.97389 0 0 0 0 0 0 0 0 P53420 CO4A4_HUMAN Collagen alpha-4(IV) chain COL4A4 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0032836; GO:0062023 GDKGPTGVPGFPGLDGIPGHPGPPGPR 1.440000057 1 1 0.098978827 2533.545282 0 17.29064 15.37178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53609 PGTB1_HUMAN "Geranylgeranyl transferase type-1 subunit beta, EC 2.5.1.59 (Geranylgeranyl transferase type I subunit beta, GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta)" PGGT1B Homo sapiens (Human) protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342] CAAX-protein geranylgeranyltransferase complex [GO:0005953] CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342] CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270] GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018342; GO:0018344 LLDLHQSWK 9.569999695 1 1 0.287189469 1140.807441 0 0 0 0 0 0 0 0 0 0 0 0 0 16.04587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.98476 0 0 0 18.57434 0 0 16.03125 15.73391 P53618 COPB_HUMAN "Coatomer subunit beta (Beta-coat protein, Beta-COP)" COPB1 COPB MSTP026 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886] structural molecule activity [GO:0005198] GO:0000139; GO:0005198; GO:0005789; GO:0005793; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030667; GO:0043231; GO:0070821; GO:0101003 RNAFMMLIHADQDR 26.04000092 1 1 0.955044384 1749.0372 0 21.65672 0 0 0 0 0 21.73325 0 0 21.81184 0 19.7856 0 0 0 0 0 0 0 0 22.37612 0 0 0 0 19.19144 0 0 0 0 0 0 22.45666 0 0 0 0 0 0 0 0 0 21.77445 0 0 18.38358 0 P53621 COPA_HUMAN "Coatomer subunit alpha (Alpha-coat protein, Alpha-COP) (HEP-COP, HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin ]" COPA Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" hormone activity [GO:0005179]; structural molecule activity [GO:0005198] GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062 GKPVEK 3.950000048 1 1 0.058652846 656.6870288 0 0 7.409853 0 0 0 0 0 14.20928 0 0 0 0 0 0 0 0 0 0 0 0 0 14.14495 14.28219 0 0 13.77525 0 0 0 0 14.65098 0 0 0 0 0 0 17.47379 0 0 0 0 0 0 0 15.93704 0 P53634 CATC_HUMAN "Dipeptidyl peptidase 1, EC 3.4.14.1 (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I, DPP-I, DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain) ]" CTSC CPPI Homo sapiens (Human) aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913] chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252] GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005794; GO:0005813; GO:0006508; GO:0006955; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235 MGAGPSLLLAALLLLLSGDGAVR 21.23999977 1 1 3.67E-12 2204.55394 0 18.1152 17.40345 15.90526 16.6966 15.95255 0 15.48279 13.94681 0 0 14.15796 15.38098 0 13.24834 0 0 0 0 0 0 0 0 0 12.05372 0 0 14.79591 14.43909 0 0 12.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.55661 12.53917 P53671 LIMK2_HUMAN "LIM domain kinase 2, LIMK-2, EC 2.7.11.1" LIMK2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; phosphorylation [GO:0016310]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; phosphorylation [GO:0016310]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001934; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005801; GO:0005813; GO:0006468; GO:0007283; GO:0016310; GO:0030036; GO:0030953; GO:0046872; GO:0048471; GO:0051650; GO:0060322; GO:0061303; GO:0072686; GO:0106310; GO:1900182; GO:1902018 ATGKVMVMK 2.289999962 0.55510956 0.55510956 0.141259933 997.5947437 14.98042 0 14.88594 0 15.60944 0 0 0 0 0 0 0 0 0 0 0 14.32908 0 0 0 0 0 0 0 15.83231 15.24907 0 14.9904 0 0 0 0 13.34356 15.56837 11.25379 15.58689 0 15.10372 14.29918 15.60172 0 0 0 0 0 11.38943 0 0 P53778 MK12_HUMAN "Mitogen-activated protein kinase 12, MAP kinase 12, MAPK 12, EC 2.7.11.24 (Extracellular signal-regulated kinase 6, ERK-6) (Mitogen-activated protein kinase p38 gamma, MAP kinase p38 gamma) (Stress-activated protein kinase 3)" MAPK12 ERK6 SAPK3 Homo sapiens (Human) cell cycle [GO:0007049]; DNA damage induced protein phosphorylation [GO:0006975]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; DNA damage induced protein phosphorylation [GO:0006975]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0000287; GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006975; GO:0007049; GO:0007165; GO:0007517; GO:0010952; GO:0018105; GO:0035556; GO:0045445; GO:0045786; GO:0051149; GO:0051726; GO:0106310 APEVILNWMR 2.799999952 1 1 6.89E-13 1244.294068 14.28873 14.25143 12.88834 0 0 0 0 0 0 0 0 0 0 0 0 13.54966 0 0 0 13.46825 0 0 0 0 15.16774 16.12763 15.02918 0 0 14.28548 0 11.83884 0 14.97602 0 0 16.60443 15.45067 0 15.0108 0 0 0 0 0 0 0 15.74259 P53794 SC5A3_HUMAN "Sodium/myo-inositol cotransporter, Na(+)/myo-inositol cotransporter (Sodium/myo-inositol transporter 1, SMIT1) (Solute carrier family 5 member 3)" SLC5A3 Homo sapiens (Human) fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transporter activity [GO:0032409]; transport across blood-brain barrier [GO:0150104] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transporter activity [GO:0032409]; transport across blood-brain barrier [GO:0150104] fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] GO:0005365; GO:0005367; GO:0005412; GO:0005886; GO:0005887; GO:0006020; GO:0007422; GO:0008076; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016021; GO:0032409; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:0150104; GO:1903428; GO:1904659; GO:1904679; GO:1905477 RFGGHR 5.820000172 0.295105785 0.295105785 0.094565938 730.584906 14.63884 15.77834 0 15.82921 16.18327 16.46231 17.82162 16.7139 0 0 16.21793 15.24997 0 18.01093 17.26914 16.50319 17.72064 0 15.17942 15.66731 16.05093 15.61203 16.04495 15.59828 18.49169 11.53572 17.27862 17.91628 16.67442 14.31705 0 18.08545 17.28716 16.68572 15.95615 16.47588 16.84545 16.31344 17.1109 14.39249 17.43769 16.58061 16.4306 13.65071 0 14.65277 14.37173 16.57251 P53801 PTTG_HUMAN "Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor, PBF, PTTG-binding factor)" PTTG1IP C21orf1 C21orf3 Homo sapiens (Human) "negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; p53 binding [GO:0002039]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]" p53 binding [GO:0002039] GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006606; GO:0016020; GO:0016021; GO:0031398; GO:0043518; GO:0070062; GO:1902254; GO:1903364 APGVAR 4.03000021 0.460382998 0.460382998 0.289944967 571.0065141 16.47922 13.86261 14.23852 14.7788 0 15.48673 0 0 14.66503 14.10684 15.91665 14.47303 0 0 15.63468 17.27781 16.13485 0 0 15.04484 0 0 0 0 15.08776 0 0 0 16.09393 0 0 0 15.86552 17.27567 16.03852 15.938 17.37074 17.3181 0 16.3933 15.68455 15.5423 16.3255 16.51039 0 13.47933 16.32387 13.5002 P53804 TTC3_HUMAN "E3 ubiquitin-protein ligase TTC3, EC 2.3.2.27 (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3, TPR repeat protein 3)" TTC3 DCRR1 RNF105 TPRD Homo sapiens (Human) protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936 IIIFSSGGEVK 12.34000015 1 1 0.29903557 1150.050726 0 0 17.68311 0 17.63647 17.0871 0 0 0 0 17.7366 0 0 0 16.92127 0 0 0 0 0 0 18.70176 15.46897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.40197 0 0 0 0 P53990 IST1_HUMAN "IST1 homolog, hIST1 (Charged multivesicular body protein 8, CHMP8) (Putative MAPK-activating protein PM28)" IST1 KIAA0174 Homo sapiens (Human) abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903 YSKEYGK 9.119999886 0.332827777 0.332827777 0.096589147 873.4580826 16.45924 8.796071 0 18.27293 15.27552 16.28647 15.16974 17.2029 16.82609 17.51544 0 0 17.6782 14.75493 17.90264 12.19697 16.08204 17.65473 0 15.57288 19.35294 17.21754 16.63088 16.28062 18.17068 0 14.98148 15.67552 0 0 17.14949 18.33216 18.78448 0 18.3691 0 11.2674 15.44613 16.64439 0 16.02492 0 0 0 0 0 14.99586 16.7925 P53992 SC24C_HUMAN Protein transport protein Sec24C (SEC24-related protein C) SEC24C KIAA0079 Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110 GQVPPLVTTNFLVK 6.880000114 1 1 0.375517571 1511.181674 0 14.58646 16.98463 0 0 0 17.49971 13.21502 0 0 0 0 11.72018 0 0 10.19415 13.70277 0 0 15.86346 15.79436 0 0 12.73723 14.60964 16.13252 0 12.70873 0 0 0 0 14.8944 16.07661 0 13.55416 17.2445 0 0 0 16.32208 0 16.16764 16.38613 15.25675 17.26357 0 0 P54098 DPOG1_HUMAN "DNA polymerase subunit gamma-1, EC 2.7.7.7 (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)" POLG MDP1 POLG1 POLGA Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]" gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] "gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; base-excision repair, gap-filling [GO:0006287]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]" 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020] GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005759; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0008408; GO:0032991; GO:0042645 GTDLHSK 13.43000031 0.675810397 0.675810397 0.189422877 756.7041425 14.96531 13.88724 12.18771 14.54009 15.13711 0 15.47222 0 0 0 0 0 0 0 0 0 0 16.3504 0 14.1608 15.25144 0 0 17.08738 0 0 0 0 0 15.0839 15.89557 0 0 0 14.37908 0 0 0 0 0 0 0 0 0 12.01522 0 0 0 P54108 CRIS3_HUMAN "Cysteine-rich secretory protein 3, CRISP-3 (Specific granule protein of 28 kDa, SGP28)" CRISP3 Homo sapiens (Human) defense response [GO:0006952]; innate immune response [GO:0045087] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; defense response [GO:0006952]; innate immune response [GO:0045087] GO:0005576; GO:0005615; GO:0006952; GO:0031012; GO:0035580; GO:0042581; GO:0045087; GO:1904724 HSNPK 4.800000191 0.386320442 0.386320442 0.158483007 581.3461242 0 0 0 0 15.4677 0 0 0 0 14.38486 0 19.2412 16.06265 0 17.20645 0 17.45548 15.20959 16.22051 0 15.52192 0 0 16.72186 0 0 15.02669 0 11.6364 0 0 0 15.21907 0 0 17.7195 0 13.86189 16.9815 17.08177 0 17.65226 0 11.90451 0 17.09859 16.04068 0 P54132 BLM_HUMAN "Bloom syndrome protein, EC 3.6.4.12 (DNA helicase, RecQ-like type 2, RecQ2) (RecQ protein-like 3)" BLM RECQ2 RECQL3 Homo sapiens (Human) "cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]" "3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]" GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0031422; GO:0032201; GO:0032508; GO:0032991; GO:0042802; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071139; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1905773; GO:1990814 DLDTSDR 14.73999977 1 1 0.128561517 821.9390193 16.12385 14.66493 0 15.97674 15.29592 15.33943 14.55729 14.36912 14.12722 18.8262 15.12159 13.43481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4373 0 0 0 0 0 0 P54136 SYRC_HUMAN "Arginine--tRNA ligase, cytoplasmic, EC 6.1.1.19 (Arginyl-tRNA synthetase, ArgRS)" RARS1 RARS Homo sapiens (Human) arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418] arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049] GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062 FGDYQCNSAMGISQMLK 2.99000001 1 1 0.075640575 1966.548903 0 13.49561 10.5037 0 14.84472 14.17921 15.9319 13.37011 0 15.79628 16.20092 11.6342 13.41129 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4508 0 0 0 0 0 0 0 0 0 12.60945 0 0 13.34855 14.36866 0 0 0 14.33833 0 0 0 P54252 ATX3_HUMAN "Ataxin-3, EC 3.4.19.12 (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein)" ATXN3 ATX3 MJD MJD1 SCA3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511] ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625] GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006289; GO:0006511; GO:0006515; GO:0007268; GO:0007399; GO:0010810; GO:0016363; GO:0016579; GO:0030036; GO:0031625; GO:0031966; GO:0034605; GO:0035520; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0045202; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904294; GO:1904379; GO:1990380 TEGKK 8.399999619 1 1 0.31847561 560.9606498 0 0 0 0 0 0 17.32536 18.04934 0 0 0 0 18.56812 18.08836 0 0 0 0 0 0 16.10293 0 18.44578 21.44697 0 0 0 17.10448 19.38151 0 17.3299 0 18.05518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54253 ATX1_HUMAN Ataxin-1 (Spinocerebellar ataxia type 1 protein) ATXN1 ATX1 SCA1 Homo sapiens (Human) "anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]" DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621] GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006396; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0016363; GO:0034046; GO:0035176; GO:0042405; GO:0042802; GO:0043621; GO:0045892; GO:0048856; GO:0051168 GHGGGR 6.5 0.404272199 0.404272199 0.240365081 539.1278174 14.48092 15.13802 15.38849 0 15.01661 14.29126 14.94354 14.38943 14.99591 0 0 0 0 0 0 15.32029 0 0 0 0 0 16.58831 16.02111 12.16725 0 0 0 0 15.68837 15.95085 0 0 0 15.74157 0 0 17.00317 0 0 0 0 16.15221 0 0 16.70531 0 16.52975 0 P54257 HAP1_HUMAN "Huntingtin-associated protein 1, HAP-1 (Neuroan 1)" HAP1 HAP2 HLP1 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; autophagy [GO:0006914]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; hypothalamus cell differentiation [GO:0021979]; mitochondrion distribution [GO:0048311]; negative regulation of amyloid-beta formation [GO:1902430]; neurogenesis [GO:0022008]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of exocytosis [GO:0017157]; regulation of organelle transport along microtubule [GO:1902513]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]" actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021] "actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021]; brain-derived neurotrophic factor binding [GO:0048403]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; autophagy [GO:0006914]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; hypothalamus cell differentiation [GO:0021979]; mitochondrion distribution [GO:0048311]; negative regulation of amyloid-beta formation [GO:1902430]; neurogenesis [GO:0022008]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of exocytosis [GO:0017157]; regulation of organelle transport along microtubule [GO:1902513]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]" brain-derived neurotrophic factor binding [GO:0048403]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] GO:0005102; GO:0005730; GO:0005739; GO:0005764; GO:0005769; GO:0005776; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0006605; GO:0006887; GO:0006914; GO:0007268; GO:0007420; GO:0008021; GO:0008089; GO:0008090; GO:0008104; GO:0015629; GO:0016234; GO:0017022; GO:0017157; GO:0021549; GO:0021979; GO:0022008; GO:0030030; GO:0030425; GO:0030426; GO:0031410; GO:0031587; GO:0032230; GO:0032901; GO:0043197; GO:0044325; GO:0045742; GO:0047496; GO:0048011; GO:0048311; GO:0048403; GO:0050769; GO:0098957; GO:1902430; GO:1902513; GO:1902857; GO:1904115 MYGAETEK 2.769999981 0.048424594 0.048424594 0.187331709 925.4939994 0 0 0 0 0 0 18.58569 0 0 0 18.92264 0 0 0 0 0 0 0 0 0 17.76298 0 0 0 0 0 0 18.39082 15.9748 0 19.02217 0 0 0 19.57635 0 0 0 0 0 0 0 0 16.72417 0 0 0 0 P54274 TERF1_HUMAN Telomeric repeat-binding factor 1 (NIMA-interacting protein 2) (TTAGGG repeat-binding factor 1) (Telomeric protein Pin2/TRF1) TERF1 PIN2 TRBF1 TRF TRF1 Homo sapiens (Human) cell division [GO:0051301]; meiotic telomere clustering [GO:0045141]; negative regulation of DNA replication [GO:0008156]; negative regulation of establishment of protein localization to telomere [GO:1904850]; negative regulation of establishment of protein-containing complex localization to telomere [GO:1904914]; negative regulation of establishment of RNA localization to telomere [GO:1904911]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of shelterin complex assembly [GO:1904792]; positive regulation of telomere maintenance [GO:0032206]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; spindle [GO:0005819]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; spindle [GO:0005819]; ankyrin repeat binding [GO:0071532]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomeric DNA binding [GO:0042162]; cell division [GO:0051301]; meiotic telomere clustering [GO:0045141]; negative regulation of DNA replication [GO:0008156]; negative regulation of establishment of protein localization to telomere [GO:1904850]; negative regulation of establishment of protein-containing complex localization to telomere [GO:1904914]; negative regulation of establishment of RNA localization to telomere [GO:1904911]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of shelterin complex assembly [GO:1904792]; positive regulation of telomere maintenance [GO:0032206]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820]" "ankyrin repeat binding [GO:0071532]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomeric DNA binding [GO:0042162]" GO:0000723; GO:0000781; GO:0000783; GO:0001650; GO:0003677; GO:0003691; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0007004; GO:0008017; GO:0008022; GO:0008156; GO:0008301; GO:0009410; GO:0016233; GO:0016604; GO:0032206; GO:0032211; GO:0032214; GO:0042162; GO:0042802; GO:0042803; GO:0045141; GO:0051301; GO:0051974; GO:0061820; GO:0070187; GO:0071532; GO:0090656; GO:0098505; GO:1904357; GO:1904792; GO:1904850; GO:1904911; GO:1904914; GO:1905778; GO:1905839 NSAEAIIHGLSSLTACQLR 2.670000076 1 1 0.185673067 2040.480981 14.50085 10.60307 14.65209 0 13.35267 0 13.41251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14042 17.48378 0 0 0 0 0 17.73061 0 0 18.20323 15.51187 0 0 16.99635 0 0 0 0 17.21278 0 0 0 0 P54284 CACB3_HUMAN "Voltage-dependent L-type calcium channel subunit beta-3, CAB3 (Calcium channel voltage-dependent subunit beta 3)" CACNB3 CACNLB3 Homo sapiens (Human) calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385]; T cell receptor signaling pathway [GO:0050852] calcium channel regulator activity [GO:0005246]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005246; GO:0005829; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0008331; GO:0016020; GO:0045202; GO:0050852; GO:0060402; GO:0061577; GO:0072659; GO:0098903; GO:1901385; GO:1901843; GO:1990454 QAWTGSSQRSSR 8.529999733 1 1 0.279967281 1352.08537 0 0 13.2055 0 0 0 0 0 0 0 0 0 0 0 15.69911 15.79263 0 16.66486 0 16.0514 18.05 0 16.61865 0 13.37222 0 0 16.93376 0 15.38062 15.99963 16.65442 0 0 16.02718 17.84929 17.65692 15.81856 18.18678 17.06367 0 15.13351 15.31785 11.80767 15.31428 17.11534 18.53025 0 P54289 CA2D1_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1 ] CACNA2D1 CACNL2A CCHL2A MHS3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] extracellular exosome [GO:0070062]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891] extracellular exosome [GO:0070062]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005891; GO:0006816; GO:0016529; GO:0045933; GO:0046872; GO:0051924; GO:0060307; GO:0060402; GO:0061577; GO:0070062; GO:0070588; GO:0086002; GO:0086048; GO:0086091; GO:0098703; GO:0098903; GO:1901843; GO:1902514; GO:1904646; GO:1990454 AKLEETITQAR 5.289999962 0.373666167 0.373666167 0.291996873 1259.023672 11.83228 14.85262 13.34895 0 0 0 0 0 11.81213 0 0 0 0 0 0 0 15.87425 0 0 15.75829 15.09938 0 0 0 14.91195 0 16.94788 15.84097 0 14.81696 16.29814 15.06867 15.91659 14.74335 0 0 15.73495 14.79377 17.3821 0 0 16.53523 0 0 0 16.0846 14.58885 0 P54296 MYOM2_HUMAN Myomesin-2 (165 kDa connectin-associated protein) (165 kDa titin-associated protein) (M-protein) (Myomesin family member 2) MYOM2 Homo sapiens (Human) muscle contraction [GO:0006936]; sarcomere organization [GO:0045214] M band [GO:0031430]; mitochondrion [GO:0005739]; myosin filament [GO:0032982] M band [GO:0031430]; mitochondrion [GO:0005739]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; kinase binding [GO:0019900]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214] actin filament binding [GO:0051015]; kinase binding [GO:0019900]; structural constituent of muscle [GO:0008307] GO:0005739; GO:0006936; GO:0008307; GO:0019900; GO:0031430; GO:0032982; GO:0045214; GO:0051015 GDEEPFR 4.96999979 0.21573177 0.21573177 0.151665893 849.5481993 16.64848 0 15.96664 18.61421 0 0 15.54827 15.38976 14.16677 0 0 0 0 0 0 15.15441 0 0 15.41613 0 0 0 0 0 16.72697 18.05971 0 16.51407 0 0 0 0 0 0 0 0 0 0 16.10825 0 0 15.15796 0 0 0 0 0 0 P54577 SYYC_HUMAN "Tyrosine--tRNA ligase, cytoplasmic, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed ]" YARS1 YARS Homo sapiens (Human) apoptotic process [GO:0006915]; tyrosyl-tRNA aminoacylation [GO:0006437] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; apoptotic process [GO:0006915]; tyrosyl-tRNA aminoacylation [GO:0006437] ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831] GO:0000049; GO:0003723; GO:0004831; GO:0005153; GO:0005524; GO:0005615; GO:0005737; GO:0005829; GO:0006437; GO:0006915; GO:0016604 AMLESIGVPLEKLK 11.01000023 1 1 0.249604164 1545.364149 0 0 0 0 15.9757 0 14.57178 12.91221 0 0 0 0 0 0 0 0 7.573669 14.45838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.61115 0 0 0 0 0 0 0 0 0 0 17.75363 0 P54578 UBP14_HUMAN "Ubiquitin carboxyl-terminal hydrolase 14, EC 3.4.19.12 (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)" USP14 TGT Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent deubiquitinase [GO:0004843]; chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136] cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent deubiquitinase [GO:0004843] GO:0000502; GO:0004197; GO:0004843; GO:0004866; GO:0005829; GO:0005886; GO:0007268; GO:0009986; GO:0016579; GO:0031410; GO:0043161; GO:0045087; GO:0045202; GO:0050920; GO:0061136; GO:0070062; GO:0070628; GO:1903070 DLFDSMDK 8.079999924 1 1 0.140684073 969.4149499 15.1697 15.31639 0 13.04071 0 0 0 0 0 0 0 0 12.9389 0 12.44505 0 0 0 0 0 0 15.03049 0 12.98614 0 0 0 14.35587 0 0 0 15.71802 0 15.50468 0 0 14.99868 14.72174 0 0 15.44853 15.54203 0 0 0 16.03559 0 0 P54646 AAPK2_HUMAN "5'-AMP-activated protein kinase catalytic subunit alpha-2, AMPK subunit alpha-2, EC 2.7.11.1 (Acetyl-CoA carboxylase kinase, ACACA kinase, EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase, HMGCR kinase, EC 2.7.11.31)" PRKAA2 AMPK AMPK2 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:1903829; GO:1904428; GO:1905691; GO:1990044; GO:2000758 AMKQLDFEWK 4.349999905 1 1 0.18800355 1311.186128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.86167 0 0 0 0 0 9.316563 0 0 12.36376 0 15.94809 0 0 0 0 0 0 0 14.45812 0 0 0 0 0 0 0 0 P54707 AT12A_HUMAN "Potassium-transporting ATPase alpha chain 2 (HK alpha 2) (Non-gastric H(+)/K(+) ATPase subunit alpha, EC 7.2.2.19) (Non-gastric Na(+)/K(+) ATPase subunit alpha, EC 7.2.2.13) (Proton pump) (Sodium pump)" ATP12A ATP1AL1 Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sodium ion export across plasma membrane [GO:0036376] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; potassium:proton exchanging ATPase complex [GO:0005889] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; potassium:proton exchanging ATPase complex [GO:0005889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sodium ion export across plasma membrane [GO:0036376] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391] GO:0005391; GO:0005524; GO:0005829; GO:0005886; GO:0005889; GO:0006883; GO:0006885; GO:0008900; GO:0015629; GO:0016323; GO:0016324; GO:0016887; GO:0030007; GO:0036376; GO:0046872; GO:1902600; GO:1990573 FLMVMK 4.96999979 0.674874008 0.674874008 0.232071137 768.6370009 15.46529 14.92165 14.6064 15.23947 0 14.93363 15.52016 14.61427 14.5674 0 0 14.10118 16.23237 15.93921 13.20481 14.12811 15.64201 13.8518 15.6858 15.55106 14.93587 0 15.34167 0 15.25204 0 16.93638 0 15.75493 0 15.09766 14.7861 0 15.68566 16.52703 17.00957 15.73868 0 16.69869 0 16.67993 0 0 0 0 0 15.81849 0 P54710 ATNG_HUMAN "Sodium/potassium-transporting ATPase subunit gamma, Na(+)/K(+) ATPase subunit gamma (FXYD domain-containing ion transport regulator 2) (Sodium pump gamma chain)" FXYD2 ATP1C ATP1G1 Homo sapiens (Human) establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; sodium ion export across plasma membrane [GO:0036376]; transmembrane transport [GO:0055085] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; sodium ion export across plasma membrane [GO:0036376]; transmembrane transport [GO:0055085] ATPase activator activity [GO:0001671]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080] GO:0001671; GO:0005886; GO:0005890; GO:0010248; GO:0017080; GO:0030674; GO:0036376; GO:0055085; GO:0070062; GO:1902600; GO:1903408; GO:1990573; GO:2000649 MTGLSMDGGGSPK 16.10000038 1 1 0.303719691 1269.828147 15.59428 15.61083 17.09304 0 0 0 15.8868 16.63935 0 14.73851 13.34414 15.34701 16.15344 0 0 0 0 0 18.57034 18.68082 0 0 0 0 0 0 0 0 0 17.94738 0 0 15.98623 0 0 16.95206 19.69548 18.66263 16.26176 18.67788 19.41348 16.803 17.91267 0 18.32261 17.33155 18.01297 19.28293 P54753 EPHB3_HUMAN "Ephrin type-B receptor 3, EC 2.7.10.1 (EPH-like tyrosine kinase 2, EPH-like kinase 2) (Embryonic kinase 2, EK2, hEK2) (Tyrosine-protein kinase TYRO6)" EPHB3 ETK2 HEK2 TYRO6 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655] cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655] ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001525; GO:0001655; GO:0004712; GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0007413; GO:0008046; GO:0016477; GO:0021952; GO:0022038; GO:0022407; GO:0030425; GO:0031290; GO:0033674; GO:0034446; GO:0043005; GO:0043087; GO:0043235; GO:0046777; GO:0048013; GO:0048538; GO:0048546; GO:0050770; GO:0051965; GO:0060021; GO:0060996; GO:0060997 EIDVSCVKIEEVIGAGEFGEVCR 2.319999933 1 1 0.107080509 2595.24761 0 13.47064 13.95716 13.44659 12.76276 14.25336 0 13.183 12.24994 0 0 11.02627 10.57085 0 12.55096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54756 EPHA5_HUMAN "Ephrin type-A receptor 5, EC 2.7.10.1 (Brain-specific kinase) (EPH homology kinase 1, EHK-1) (EPH-like kinase 7, EK7, hEK7)" EPHA5 BSK EHK1 HEK7 TYRO4 Homo sapiens (Human) axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791] axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0004712; GO:0004714; GO:0005003; GO:0005004; GO:0005005; GO:0005524; GO:0005791; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0009897; GO:0019933; GO:0021766; GO:0030424; GO:0030425; GO:0032793; GO:0032956; GO:0033674; GO:0043005; GO:0043025; GO:0043087; GO:0043235; GO:0048013; GO:0048471; GO:0048666; GO:0061178 IMNSLQEMKVQLVNGMVPL 10.27999973 1 1 0 2185.765361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54760 EPHB4_HUMAN "Ephrin type-B receptor 4, EC 2.7.10.1 (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)" EPHB4 HTK MYK1 TYRO11 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001525; GO:0002042; GO:0003007; GO:0004712; GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007411; GO:0033674; GO:0043005; GO:0043235; GO:0046777; GO:0048013; GO:0070062 QSNGREAEYSDK 7.570000172 0.958838522 0.958838522 0.124211826 1384.21405 15.13563 12.99933 15.31977 0 0 0 17.04079 0 11.44565 15.55541 12.59228 16.59294 14.81829 17.58204 0 14.63451 0 13.76537 14.56542 14.8092 16.20068 11.28774 14.90921 0 11.503 0 18.9576 16.81245 13.56688 8.711724 14.79399 17.1034 17.4598 18.6998 0 11.97885 0 16.05159 0 0 14.01445 16.65879 14.29152 16.20749 13.63958 0 13.5453 0 P54762 EPHB1_HUMAN "Ephrin type-B receptor 1, EC 2.7.10.1 (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6, EK6, hEK6) (Neuronally-expressed EPH-related tyrosine kinase, NET) (Tyrosine-protein kinase receptor EPH-2)" EPHB1 ELK EPHT2 HEK6 NET Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001525; GO:0001771; GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070062; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725 NGFYLAFQDYGACMSLLSVR 4.940000057 0.212792337 0.212792337 0.147619986 2326.904804 14.80291 0 12.33123 0 13.10309 12.20814 0 10.83592 15.07269 0 0 14.34779 15.04206 12.57555 13.41095 0 0 0 0 0 0 0 0 0 15.64347 0 0 0 0 0 0 0 0 0 0 0 0 15.1496 0 0 15.343 0 0 0 0 0 0 0 P54764 EPHA4_HUMAN "Ephrin type-A receptor 4, EC 2.7.10.1 (EPH-like kinase 8, EK8, hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK)" EPHA4 HEK8 SEK TYRO1 Homo sapiens (Human) adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] adherens junction [GO:0005912]; axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] adherens junction [GO:0005912]; axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001540; GO:0004672; GO:0004712; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005741; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005912; GO:0007155; GO:0007162; GO:0007169; GO:0007411; GO:0007628; GO:0008045; GO:0008284; GO:0008347; GO:0009986; GO:0010719; GO:0010977; GO:0016301; GO:0018108; GO:0021957; GO:0030175; GO:0030335; GO:0030336; GO:0030424; GO:0030425; GO:0031594; GO:0031901; GO:0033674; GO:0034332; GO:0042731; GO:0042802; GO:0043005; GO:0043087; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0043507; GO:0043679; GO:0044295; GO:0045785; GO:0046777; GO:0046875; GO:0048013; GO:0048681; GO:0048710; GO:0050770; GO:0050775; GO:0050821; GO:0061001; GO:0061098; GO:0070373; GO:0072178; GO:0090102; GO:0097155; GO:0097156; GO:0097161; GO:0097485; GO:0098685; GO:0098839; GO:0098883; GO:0098978; GO:0099055; GO:0099056; GO:0106030; GO:1900038; GO:1900272; GO:1902004; GO:1902961; GO:1903051; GO:1904646; GO:1905244; GO:1990782; GO:2001108 IDTIAADESFTQVDIGDRIMK 5.329999924 0.262988836 0.262988836 0.106981058 2353.853234 0 0 10.39093 13.0351 0 11.7025 14.60383 0 0 0 0 0 14.35911 0 12.88106 14.05974 0 14.96567 0 0 0 0 13.15359 0 16.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.29137 0 0 0 0 0 11.00607 0 P54793 ARSF_HUMAN "Arylsulfatase F, ASF, EC 3.1.6.1" ARSF Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005788; GO:0046872; GO:0070062 VANALK 4.71999979 1 1 0.226956934 615.2803785 15.16555 15.32144 0 16.0262 14.99555 14.4753 15.87533 15.18495 0 16.03597 16.35844 14.17748 15.93639 0 0 15.43662 15.50315 15.27691 0 0 0 17.04633 16.99103 0 0 16.56468 0 0 13.91029 15.3774 16.55933 16.66987 17.00648 16.47845 16.35463 15.2391 0 16.81966 0 17.14249 16.13552 15.34572 0 0 0 0 16.57661 0 P54826 GAS1_HUMAN "Growth arrest-specific protein 1, GAS-1" GAS1 Homo sapiens (Human) cell cycle [GO:0007049]; cell fate commitment [GO:0045165]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; developmental growth [GO:0048589]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of apoptotic process [GO:0042981]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589] anchored component of plasma membrane [GO:0046658]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell fate commitment [GO:0045165]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; developmental growth [GO:0048589]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of apoptotic process [GO:0042981]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589] GO:0005886; GO:0007049; GO:0008589; GO:0010955; GO:0016021; GO:0035924; GO:0042981; GO:0045165; GO:0045930; GO:0046658; GO:0048589; GO:0060628 RSSGGGGR 3.029999971 1 1 0 734.4438965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54886 P5CS_HUMAN "Delta-1-pyrroline-5-carboxylate synthase, P5CS (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase, GK, EC 2.7.2.11 (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase, GPR, EC 1.2.1.41 (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase) ]" ALDH18A1 GSAS P5CS PYCS Homo sapiens (Human) citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561] ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0019240; GO:0042802; GO:0055129 EMMLVTSGAVAFGK 6.170000076 0.547357678 0.547357678 0.046058723 1457.773031 0 0 14.13883 0 14.98448 0 13.81918 0 0 0 0 11.86026 0 0 0 0 0 0 0 0 0 17.42975 0 0 0 0 0 0 0 0 0 0 15.15802 0 0 16.92385 0 15.34289 16.70142 0 0 0 16.04791 0 16.7163 0 0 0 P54922 ADPRH_HUMAN "ADP-ribosylhydrolase ARH1, EC 3.2.2.19 (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase, ADP-ribosylarginine hydrolase, hARH1)" ADPRH ARH1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; protein de-ADP-ribosylation [GO:0051725]; regulation of autophagosome assembly [GO:2000785] autophagosome [GO:0005776]; cytosol [GO:0005829]; extracellular space [GO:0005615]; recycling endosome [GO:0055037] autophagosome [GO:0005776]; cytosol [GO:0005829]; extracellular space [GO:0005615]; recycling endosome [GO:0055037]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; protein de-ADP-ribosylation [GO:0051725]; regulation of autophagosome assembly [GO:2000785] ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955] GO:0000287; GO:0003875; GO:0005096; GO:0005615; GO:0005776; GO:0005829; GO:0006464; GO:0030955; GO:0051725; GO:0055037; GO:0090630; GO:2000785 ALYSLGSK 3.25 1 1 0.051951075 839.0311143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55008 AIF1_HUMAN "Allograft inflammatory factor 1, AIF-1 (Ionized calcium-binding adapter molecule 1) (Protein G1)" AIF1 G1 IBA1 Homo sapiens (Human) "actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cellular response to oxidative stress [GO:0034599]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178]" actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] "actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cellular response to oxidative stress [GO:0034599]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178]" actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] GO:0001726; GO:0001774; GO:0001891; GO:0001934; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0010629; GO:0014739; GO:0016601; GO:0021549; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0031668; GO:0032587; GO:0032722; GO:0032755; GO:0032870; GO:0034599; GO:0042102; GO:0043066; GO:0043204; GO:0045429; GO:0048471; GO:0048661; GO:0048662; GO:0048678; GO:0050921; GO:0051015; GO:0051017; GO:0051384; GO:0051602; GO:0051764; GO:0071315; GO:0071346; GO:0071447; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:1900087; GO:2000406 MILMYEEKAR 2.670000076 1 1 0.290167027 1302.347182 17.08277 0 15.2185 15.84943 0 15.5902 15.50213 0 0 15.30858 14.65358 11.87961 0 14.92024 0 17.44869 0 16.20908 0 0 0 0 0 0 16.17364 0 14.77163 0 0 14.03044 15.91271 0 15.7578 0 0 0 16.86386 16.44034 0 0 16.78064 16.39557 0 0 14.70204 0 15.92564 0 P55011 S12A2_HUMAN Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) SLC12A2 NKCC1 Homo sapiens (Human) aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; ion transport [GO:0006811]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511]; aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; ion transport [GO:0006811]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104] ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511] GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0007568; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0015379; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869 KDWLQADMR 3.789999962 0.4536919 0.4536919 0.111860126 1179.694872 12.27754 14.88014 0 0 13.02374 13.88027 11.89399 14.94889 12.24087 10.84768 14.83923 0 12.90355 0 0 0 0 0 0 0 0 14.95719 0 0 15.67414 0 0 0 0 0 0 15.20936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55017 S12A3_HUMAN "Solute carrier family 12 member 3 (Na-Cl cotransporter, NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter)" SLC12A3 NCC TSC Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511] GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006814; GO:0006884; GO:0008511; GO:0015081; GO:0015378; GO:0015379; GO:0016020; GO:0016324; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:1902476; GO:1990573 QRMPELQLIANGHTK 3.150000095 0.547539294 0.547539294 0.068097072 1736.965735 0 15.34426 15.65643 16.87302 0 15.67527 0 0 14.71838 15.27422 0 11.87218 16.71309 16.68339 0 16.25728 15.3407 0 0 16.5075 15.83677 0 16.42797 15.96143 0 16.50299 0 0 17.85055 15.60859 13.72674 13.50149 16.31343 0 15.67175 16.22217 17.61217 0 15.02523 16.34109 17.06461 15.9081 0 16.13536 14.99073 0 16.47539 17.14432 P55036 PSMD4_HUMAN "26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1, AF, ASF) (Multiubiquitin chain-binding protein)" PSMD4 MCB1 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723] GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161 QGKNHK 3.680000067 1 1 0.062018189 710.7949773 0 0 16.84025 0 14.2152 0 13.1807 12.09969 15.74613 12.52888 0 0 0 16.33853 15.42934 13.61292 16.70315 16.33587 0 15.9672 15.92366 12.67189 16.67394 0 14.72213 18.28248 0 0 0 14.68004 0 17.18171 17.09234 12.98392 0 12.4 0 16.78999 16.92489 0 0 0 16.73902 15.99812 14.3903 15.08406 0 0 P55039 DRG2_HUMAN "Developmentally-regulated GTP-binding protein 2, DRG-2 (Translation factor GTPase DRG2, TRAFAC GTPase DRG2, EC 3.6.5.-)" DRG2 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872 EIARTQK 7.539999962 1 1 0.201333099 844.6300668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.89075 0 0 0 0 17.81585 18.24983 0 0 0 0 0 0 0 20.16177 0 0 0 0 0 0 0 0 0 18.86451 0 0 0 0 0 0 0 P55040 GEM_HUMAN GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR) GEM KIR Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165] cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233] cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165] calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842 EPHQYSHRNR 5.75 1 1 0.273717765 1323.370799 12.35344 0 0 0 0 0 0 0 0 0 0 0 11.65255 0 0 13.42477 0 15.04785 15.85738 13.72389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38115 0 0 0 0 14.51569 14.89581 0 0 0 0 0 0 0 P55042 RAD_HUMAN GTP-binding protein RAD (RAD1) (Ras associated with diabetes) RRAD RAD Homo sapiens (Human) negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264] calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005829; GO:0005886; GO:0007264; GO:1901842 WLPGHCMAMGDAYVIVYSVTDK 8.5 1 1 0.953887156 2530.128909 13.08135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.99654 0 20.7683 0 0 0 0 0 19.07871 0 0 0 0 0 0 0 0 0 0 0 P55060 XPO2_HUMAN "Exportin-2, Exp2 (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)" CSE1L CAS XPO2 Homo sapiens (Human) protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] GO:0005049; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006611; GO:0016020; GO:0031267; GO:0070062 YGALALQEIFDGIQPK 1.149999976 1 1 0.360104535 1761.593864 14.36925 0 15.92543 14.10694 0 15.00332 12.82528 15.24331 0 14.64727 15.24057 15.41733 15.43098 15.06944 14.93116 14.46526 0 14.09508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.14876 15.24359 0 17.36704 11.29607 0 0 0 0 0 0 16.26564 0 P55061 BI1_HUMAN "Bax inhibitor 1, BI-1 (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6)" TMBIM6 BI1 TEGT Homo sapiens (Human) autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoribonuclease activity [GO:0060702]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of protein binding [GO:0032091]; negative regulation of RNA splicing [GO:0033119]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; response to L-glutamate [GO:1902065] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; endoribonuclease inhibitor activity [GO:0060698]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoribonuclease activity [GO:0060702]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of protein binding [GO:0032091]; negative regulation of RNA splicing [GO:0033119]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; response to L-glutamate [GO:1902065] endoribonuclease inhibitor activity [GO:0060698]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625] GO:0002638; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005887; GO:0006914; GO:0010523; GO:0016020; GO:0016021; GO:0019899; GO:0031625; GO:0031966; GO:0032091; GO:0032469; GO:0033119; GO:0034620; GO:0043066; GO:0060698; GO:0060702; GO:0070059; GO:1902065; GO:1902236; GO:1903298; GO:1990441; GO:2001234 MNIFDRK 19.12000084 1 1 9.19E-13 923.8351542 13.87424 14.5412 14.1581 15.89871 0 14.44396 15.96484 0 0 15.83563 0 0 0 0 0 15.11804 0 13.87082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55157 MTP_HUMAN Microsomal triglyceride transfer protein large subunit MTTP MTP Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; chylomicron assembly [GO:0034378]; circadian rhythm [GO:0007623]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle remodeling [GO:0034374]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle assembly [GO:0034379] basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982] basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982]; apolipoprotein binding [GO:0034185]; ceramide 1-phosphate transfer activity [GO:1902388]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transfer activity [GO:0120014]; phospholipid transporter activity [GO:0005548]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; triglyceride transfer activity [GO:0140344]; cholesterol homeostasis [GO:0042632]; chylomicron assembly [GO:0034378]; circadian rhythm [GO:0007623]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle remodeling [GO:0034374]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle assembly [GO:0034379] apolipoprotein binding [GO:0034185]; ceramide 1-phosphate transfer activity [GO:1902388]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transfer activity [GO:0120014]; phospholipid transporter activity [GO:0005548]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; triglyceride transfer activity [GO:0140344] GO:0005319; GO:0005548; GO:0005783; GO:0005788; GO:0005791; GO:0005794; GO:0005829; GO:0006497; GO:0006629; GO:0006641; GO:0007623; GO:0008289; GO:0009306; GO:0015914; GO:0016323; GO:0031526; GO:0031528; GO:0031982; GO:0034185; GO:0034197; GO:0034374; GO:0034377; GO:0034378; GO:0034379; GO:0042157; GO:0042632; GO:0042953; GO:0043235; GO:0044877; GO:0046982; GO:0051592; GO:0120014; GO:0120019; GO:0120020; GO:0140344; GO:1902388; GO:1904121 LILGGLEKAEK 5.070000172 1 1 0.432460978 1169.024955 14.24029 13.11784 0 0 0 0 0 0 0 0 0 0 0 13.53526 14.73322 0 0 15.40255 0 0 0 0 0 0 0 0 0 0 16.14112 0 0 16.71243 16.63819 0 0 0 0 0 0 0 16.46307 0 0 0 0 0 0 0 P55196 AFAD_HUMAN "Afadin (ALL1-fused gene from chromosome 6 protein, Protein AF-6) (Afadin adherens junction formation factor)" AFDN AF6 MLLT4 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267] GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007155; GO:0007165; GO:0007267; GO:0008022; GO:0010628; GO:0016607; GO:0022409; GO:0030054; GO:0030336; GO:0031267; GO:0032880; GO:0043547; GO:0044291; GO:0044331; GO:0045296; GO:0046930; GO:0046931; GO:0050839; GO:0051015; GO:0061951; GO:0070160; GO:0070830; GO:0090557; GO:2000049 LEKQQQMHIVDMLSK 5.929999828 1 1 0.263573182 1842.873353 0 15.69566 15.28402 13.79205 14.28177 0 16.05872 0 14.89027 0 0 0 0 0 16.64326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55197 AF10_HUMAN Protein AF-10 (ALL1-fused gene from chromosome 10 protein) MLLT10 AF10 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491] GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872 GSLSPR 8.380000114 0.736656785 0.736656785 0.187224268 617.4371217 11.49012 17.40365 15.15821 15.46749 16.94231 17.90914 16.92758 14.49627 14.79374 16.94396 12.85021 15.8128 16.43525 0 14.17697 16.1218 16.63297 14.60446 17.03393 14.44267 16.2469 16.63011 0 16.67248 14.80337 15.31225 16.59394 0 15.50287 0 0 15.79224 0 0 0 0 0 15.9786 0 15.16394 0 0 0 0 15.79748 15.41502 17.29524 16.138 P55201 BRPF1_HUMAN Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) BRPF1 BR140 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006357; GO:0010698; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0050793; GO:0070776; GO:1903706 GWSSEKVK 7.440000057 1 1 0.107883744 922.0681364 0 0 16.01969 0 12.00015 16.18491 0 0 0 16.50458 0 0 0 0 0 0 0 0 0 0 0 0 17.21257 0 0 14.91734 0 0 0 0 0 0 0 14.93705 0 0 0 0 18.17082 0 0 0 0 0 0 0 0 0 P55211 CASP9_HUMAN "Caspase-9, CASP-9, EC 3.4.22.62 (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3, APAF-3) (ICE-like apoptotic protease 6, ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10 ]" CASP9 MCH6 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0007568; GO:0008047; GO:0008233; GO:0008303; GO:0008630; GO:0008635; GO:0017124; GO:0019901; GO:0030220; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0046677; GO:0071549; GO:0071887; GO:0097153; GO:0097193; GO:0097199; GO:0097200; GO:0097202; GO:2001020 FSSLHFMVEVK 13.11999989 0.130947992 0.130947992 0.171013223 1323.781735 15.50791 10.64948 14.02824 13.30874 17.26755 15.78446 15.11166 0 0 19.40303 0 15.01896 0 9.777634 16.82236 13.78352 15.99185 0 0 10.2878 0 0 14.43179 0 0 0 17.44132 0 0 0 0 0 0 0 15.83981 14.48325 0 0 0 0 13.8764 11.27624 13.91194 0 0 14.87883 15.88564 0 P55268 LAMB2_HUMAN "Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta, S-LAM beta)" LAMB2 LAMS Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0043260; GO:0045785; GO:0048677; GO:0051149; GO:0060041; GO:0062023; GO:0070062; GO:0070831; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:2001046 AGFGGR 6.150000095 1 1 0.296107849 565.1939611 18.34848 0 0 0 0 0 0 0 0 0 0 0 15.84965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6777 0 0 P55283 CADH4_HUMAN "Cadherin-4 (Retinal cadherin, R-CAD, R-cadherin)" CDH4 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of axon extension [GO:0045773] catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of axon extension [GO:0045773] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007157; GO:0007411; GO:0016342; GO:0045296; GO:0045773; GO:0098742 APGVR 3.140000105 1 1 0.110324714 497.242226 15.31079 0 0 0 16.2468 15.56313 14.82787 15.62335 0 16.74092 14.19755 0 0 0 0 0 13.10404 15.08436 0 0 0 0 0 0 0 0 0 0 0 0 0 15.57069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55285 CADH6_HUMAN "Cadherin-6 (Kidney cadherin, K-cadherin)" CDH6 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0000902; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0007219; GO:0016021; GO:0016339; GO:0016342; GO:0030054; GO:0034332; GO:0045296; GO:0098742 EPLIISK 8.279999733 1 1 0.253396638 799.9774703 0 0 14.46641 16.60804 0 0 0 0 0 0 0 0 0 0 0 0 0 10.57193 0 15.15888 15.20592 0 0 12.70999 0 0 0 12.94975 15.03498 0 0 13.66415 14.62481 0 9.445889 0 0 0 13.69946 0 0 0 0 0 0 15.55521 0 0 P55286 CADH8_HUMAN Cadherin-8 CDH8 Homo sapiens (Human) "adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]" adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060] "adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]" cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0009409; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0035249; GO:0042802; GO:0043083; GO:0043679; GO:0045296; GO:0050807; GO:0097060; GO:0098742; GO:0098978 LGELYSVGESDKET 6.809999943 1 1 0.570730549 1526.976465 17.57046 14.99858 17.30116 18.33448 0 0 0 0 20.21659 0 0 0 0 0 0 0 0 0 0 0 19.38949 0 19.17293 0 18.9988 0 0 18.83149 18.50285 0 0 0 0 0 0 0 0 0 19.35379 17.67505 0 0 18.58521 0 0 0 17.54944 19.16897 P55287 CAD11_HUMAN "Cadherin-11 (OSF-4) (Osteoblast cadherin, OB-cadherin)" CDH11 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0000902; GO:0001501; GO:0001503; GO:0005509; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0021957; GO:0034332; GO:0045296; GO:0050804; GO:0070062; GO:0098685; GO:0098742; GO:0098978 FISNGPFK 2.75999999 1 1 0.125717434 908.9321082 0 0 14.91607 0 0 14.91142 0 15.21268 0 0 0 0 0 0 0 0 14.22147 0 0 0 15.56013 0 0 0 0 15.10839 0 0 0 15.72262 14.76106 14.64612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55289 CAD12_HUMAN "Cadherin-12 (Brain cadherin, BR-cadherin) (Neural type cadherin 2, N-cadherin 2)" CDH12 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 QQELYFLPVVIEDSSYPVQSSTNTMTIR 2.779999971 0.443344593 0.443344593 0.104611869 3246.17986 0 13.57175 11.25035 0 16.22326 12.31431 14.38055 0 0 14.30008 14.45798 14.78254 13.65509 0 0 0 11.77996 0 0 0 0 0 0 13.10347 0 12.94452 0 0 0 0 0 15.91326 0 0 12.46939 0 16.18086 0 0 0 0 0 0 0 0 0 0 0 P55290 CAD13_HUMAN "Cadherin-13 (Heart cadherin, H-cadherin) (P105) (Truncated cadherin, T-cad, T-cadherin)" CDH13 CDHH Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; endothelial cell migration [GO:0043542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte proliferation [GO:0043616]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rac protein signal transduction [GO:0016601]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040] anchored component of membrane [GO:0031225]; catenin complex [GO:0016342]; caveola [GO:0005901]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; catenin complex [GO:0016342]; caveola [GO:0005901]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; adiponectin binding [GO:0055100]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; protein homodimerization activity [GO:0042803]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; endothelial cell migration [GO:0043542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte proliferation [GO:0043616]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rac protein signal transduction [GO:0016601]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040] adiponectin binding [GO:0055100]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; protein homodimerization activity [GO:0042803] GO:0001938; GO:0001954; GO:0002040; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005901; GO:0005925; GO:0007156; GO:0007162; GO:0007266; GO:0008285; GO:0009897; GO:0016339; GO:0016342; GO:0016601; GO:0030032; GO:0030100; GO:0030169; GO:0030335; GO:0031225; GO:0042058; GO:0042803; GO:0043005; GO:0043542; GO:0043616; GO:0045296; GO:0045944; GO:0048661; GO:0050850; GO:0050927; GO:0051668; GO:0055096; GO:0055100; GO:0062023; GO:0070062; GO:0071813; GO:0098742 FRLTGK 2.349999905 1 1 0.012766722 720.4907271 0 14.43275 12.93909 15.22894 14.15733 14.6527 10.05674 0 0 13.46335 16.32388 13.2812 0 0 0 14.48438 0 0 0 0 0 0 12.73179 13.85256 0 16.45147 16.72025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55291 CAD15_HUMAN "Cadherin-15 (Cadherin-14) (Muscle cadherin, M-cadherin)" CDH15 CDH14 CDH3 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] catenin complex [GO:0016342]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886] catenin complex [GO:0016342]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0005509; GO:0005794; GO:0005886; GO:0005901; GO:0007155; GO:0007156; GO:0016021; GO:0016342; GO:0031594; GO:0045296; GO:0070062; GO:0098742 APALSRVR 1.960000038 1 1 0.175016166 868.4766631 0 13.74587 11.69242 13.14795 15.71865 0 17.52649 0 0 0 15.77578 0 0 0 11.45944 0 0 0 15.07874 0 15.26703 0 0 0 0 14.05777 0 0 0 0 0 13.02279 0 0 0 0 0 0 0 0 0 0 0 15.83433 13.6209 0 0 0 P55316 FOXG1_HUMAN "Forkhead box protein G1 (Brain factor 1, BF-1, BF1) (Brain factor 2, BF-2, BF2, hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1, HFK1) (Forkhead-related protein FKHL2, HFK2) (Forkhead-related protein FKHL3, HFK3)" FOXG1 FKH2 FKHL1 FKHL2 FKHL3 FKHL4 FOXG1A FOXG1B FOXG1C Homo sapiens (Human) "aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000981; GO:0002052; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007346; GO:0007420; GO:0007568; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0045892; GO:0048664; GO:1990837 HYDDPGK 6.650000095 0.083838508 0.083838508 0.258988986 831.6952958 0 14.12935 14.7957 14.65871 14.50438 13.97103 15.2517 14.64971 16.509 15.2721 15.64463 15.41601 16.59264 15.81905 14.72586 16.74903 12.98943 15.7154 15.8639 15.79666 15.12489 16.50934 0 16.76589 14.14215 15.49098 14.47513 14.0515 15.79399 16.40002 15.78696 15.91269 16.27365 0 14.74409 16.5706 0 0 16.71909 16.0089 0 16.34496 0 0 0 0 16.67793 16.62246 P55317 FOXA1_HUMAN "Hepatocyte nuclear factor 3-alpha, HNF-3-alpha, HNF-3A (Forkhead box protein A1) (Transcription factor 3A, TCF-3A)" FOXA1 HNF3A TCF3A Homo sapiens (Human) alveolar secondary septum development [GO:0061144]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell maturation involved in prostate gland development [GO:0060743]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; glucose homeostasis [GO:0042593]; hormone metabolic process [GO:0042445]; lung epithelial cell differentiation [GO:0060487]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland stromal morphogenesis [GO:0060741]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory basal cell differentiation [GO:1902691]; response to estradiol [GO:0032355]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528] chromatin [GO:0000785]; fibrillar center [GO:0001650]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; alveolar secondary septum development [GO:0061144]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell maturation involved in prostate gland development [GO:0060743]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; glucose homeostasis [GO:0042593]; hormone metabolic process [GO:0042445]; lung epithelial cell differentiation [GO:0060487]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland stromal morphogenesis [GO:0060741]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory basal cell differentiation [GO:1902691]; response to estradiol [GO:0032355]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005902; GO:0006338; GO:0006357; GO:0007219; GO:0009653; GO:0010719; GO:0019904; GO:0021904; GO:0030154; GO:0032355; GO:0033148; GO:0042445; GO:0042593; GO:0043065; GO:0045666; GO:0045880; GO:0045931; GO:0045944; GO:0048646; GO:0048665; GO:0051091; GO:0060441; GO:0060487; GO:0060528; GO:0060738; GO:0060740; GO:0060741; GO:0060743; GO:0061144; GO:0071542; GO:1902691; GO:1990837; GO:2000049 KDPSGASNPSADSPLHR 6.150000095 0.575532258 0.575532258 0.437254938 1734.859409 17.43912 14.75449 0 17.69515 16.20185 18.12926 0 18.4011 19.88032 17.6419 0 0 0 0 18.44109 0 0 0 0 18.20014 17.23256 19.05057 0 0 0 0 0 0 0 0 21.11275 20.05754 0 0 0 0 0 0 0 0 17.90803 18.59443 0 0 0 0 0 0 P55318 FOXA3_HUMAN "Hepatocyte nuclear factor 3-gamma, HNF-3-gamma, HNF-3G (Fork head-related protein FKH H3) (Forkhead box protein A3) (Transcription factor 3G, TCF-3G)" FOXA3 HNF3G TCF3G Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0007283; GO:0009267; GO:0009653; GO:0015629; GO:0019904; GO:0030154; GO:0045944; GO:0061484; GO:1990837 GGSGAATTTR 11.94999981 0.179220498 0.179220498 0.258685278 879.2297295 16.39581 19.04329 19.35646 18.54907 16.64985 18.46301 19.09434 19.74566 18.12743 16.55727 17.9194 0 0 0 18.53381 0 0 17.92162 15.91511 17.06656 0 0 0 18.71995 19.54972 0 17.54637 16.83347 18.34478 17.31459 18.57338 18.2757 18.59491 0 18.61165 19.55503 0 20.68924 18.44432 19.33301 17.63851 17.43625 18.86804 16.9281 0 18.17582 17.449 19.11287 P55771 PAX9_HUMAN Paired box protein Pax-9 PAX9 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; face morphogenesis [GO:0060325]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; face morphogenesis [GO:0060325]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0005730; GO:0006357; GO:0007492; GO:0042476; GO:0042481; GO:0045892; GO:0048856; GO:0060325; GO:0071363; GO:1990837 GALEQEAK 11.76000023 1 1 0.169674657 846.1891269 16.404 16.40831 0 12.65336 0 16.39572 16.21364 0 16.8029 17.454 16.78902 16.93912 15.10299 11.29748 14.20023 16.77333 0 15.32126 0 11.10855 18.61987 16.37934 0 15.54832 0 0 0 14.4311 0 16.81696 0 0 0 0 16.28646 0 0 0 0 13.52035 0 0 0 0 0 0 0 0 P55773 CCL23_HUMAN "C-C motif chemokine 23 (CK-beta-8, CKB-8) (Macrophage inflammatory protein 3, MIP-3) (Myeloid progenitor inhibitory factor 1, MPIF-1) (Small-inducible cytokine A23) [Cleaved into: CCL23(19-99); CCL23(22-99); CCL23(27-99); CCL23(30-99) ]" CCL23 MIP3 MPIF1 SCYA23 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; chemokine activity [GO:0008009]; heparin binding [GO:0008201] GO:0002548; GO:0005576; GO:0005615; GO:0006874; GO:0006935; GO:0006954; GO:0006955; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008201; GO:0008285; GO:0030593; GO:0031726; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:2001264 VSVAALSCLMLVTALGSQAR 4.949999809 1 1 0.343623808 2063.235085 0 12.01971 0 0 15.1702 12.88122 0 14.90448 14.83877 13.82801 0 0 11.62377 12.68561 0 0 0 0 0 0 0 0 16.60466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55786 PSA_HUMAN "Puromycin-sensitive aminopeptidase, PSA, EC 3.4.11.14 (Cytosol alanyl aminopeptidase, AAP-S)" NPEPPS PSA Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955 DGVCVR 1.789999962 0.99680531 0.99680531 0.113652861 706.6479425 17.37532 14.23928 15.8168 17.82019 15.38473 12.84841 14.56008 10.77607 17.13355 17.07593 15.6393 15.60369 0 14.4791 6.445952 14.62421 17.60699 0 14.11929 10.19686 0 17.11225 17.34791 17.23329 17.12101 15.26021 17.41661 14.59222 16.20083 14.38986 16.31813 19.16525 12.71138 18.79445 15.22729 16.0492 15.29969 10.56645 12.18166 12.66564 17.46143 14.80652 15.55661 13.44103 15.39679 16.49874 13.50813 14.42048 P55789 ALR_HUMAN "FAD-linked sulfhydryl oxidase ALR, EC 1.8.3.2 (Augmenter of liver regeneration, hERV1) (Hepatopoietin)" GFER ALR HERV1 HPO Homo sapiens (Human) cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035]; cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573] flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035] GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0071222; GO:0071356; GO:0072717; GO:0097237; GO:0097421; GO:1903204; GO:2000573 MAAPGERGR 1.070000052 0.964522481 0.964522481 0.217969659 943.9784943 0 12.68378 11.73563 14.03912 0 0 15.72034 0 0 0 0 15.87185 0 0 15.58062 0 15.69162 0 0 0 0 0 0 15.16048 15.79928 0 0 0 15.16517 0 0 17.06751 15.83824 16.11339 0 0 16.02366 16.19541 15.73539 0 15.65232 15.44347 15.42479 0 0 14.69052 15.97877 0 P55809 SCOT1_HUMAN "Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)" OXCT1 OXCT SCOT Homo sapiens (Human) adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802] GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612 GNAHKIMEK 5.800000191 0.301409006 0.301409006 0.217822097 1044.398263 0 16.18262 15.94956 0 0 13.87238 0 13.85288 13.16085 0 12.11344 0 16.31375 15.54548 15.71288 0 12.10609 16.06211 15.72489 15.61403 0 0 0 15.5365 0 14.94119 15.65316 0 0 14.89507 16.75641 16.17147 16.40398 16.14038 15.77055 14.8178 14.94528 14.53831 15.00908 11.57842 13.95423 15.39535 14.1223 14.52651 0 0 15.7685 15.09864 P55851 UCP2_HUMAN "Mitochondrial uncoupling protein 2, UCP 2 (Solute carrier family 25 member 8) (UCPH)" UCP2 SLC25A8 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303] oxidative phosphorylation uncoupler activity [GO:0017077] GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006839; GO:0007565; GO:0007568; GO:0009409; GO:0010942; GO:0016021; GO:0017077; GO:0032869; GO:0034198; GO:0043066; GO:0051881; GO:0061179; GO:0070542; GO:0071333; GO:0097421; GO:0120162; GO:1902600; GO:1990542; GO:1990845 RALMAACTSR 7.96999979 0.010960368 0.010960368 0.293394902 1152.335296 9.198606 14.55956 14.71666 14.22561 0 13.37722 11.14678 14.20837 0 15.08236 0 0 12.01298 0 12.51858 15.57523 15.58869 0 0 0 0 0 0 0 0 0 16.09105 0 0 0 0 0 0 0 0 0 16.3688 0 18.14846 14.7841 0 0 15.74987 16.13536 0 0 14.44882 17.66197 P55884 EIF3B_HUMAN "Eukaryotic translation initiation factor 3 subunit B, eIF3b (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog, hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)" EIF3B EIF3S9 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]" molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525 AAEAEPR 10.92000008 0.429452658 0.429452658 0.119309704 743.7918088 15.8298 0 17.26027 16.17418 12.08706 0 15.49287 12.48323 0 0 16.24035 16.47086 15.52771 16.24423 14.5949 15.45294 15.47891 11.34542 13.92022 17.57628 15.23912 12.53727 17.21091 15.01338 16.99706 15.9962 0 14.74323 13.84183 16.08002 0 16.96877 0 15.76732 16.69553 17.23319 16.48137 15.35948 17.39163 13.97517 17.17979 15.44915 11.77604 15.92755 0 0 0 18.59544 P55916 UCP3_HUMAN "Mitochondrial uncoupling protein 3, UCP 3 (Solute carrier family 25 member 9)" UCP3 SLC25A9 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; transporter activity [GO:0005215]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303] oxidative phosphorylation uncoupler activity [GO:0017077]; transporter activity [GO:0005215] GO:0000303; GO:0001666; GO:0005215; GO:0005739; GO:0005743; GO:0006629; GO:0006631; GO:0006839; GO:0007568; GO:0007584; GO:0007585; GO:0009409; GO:0014823; GO:0016021; GO:0017077; GO:0032868; GO:0032870; GO:0051384; GO:1902600; GO:1990542; GO:1990845 TIAREEGVR 10.06999969 1 1 0.264690876 1031.963968 16.77022 15.10652 17.91646 15.85232 15.02886 14.09576 0 0 15.82178 15.91022 17.05101 0 0 0 0 16.15759 18.34431 0 15.09053 16.14431 0 17.22886 0 0 0 0 17.16573 0 0 15.74177 16.08552 0 0 17.24147 14.30036 0 0 17.32054 15.48367 0 0 0 0 0 17.22719 0 0 16.11213 P56134 ATPK_HUMAN "ATP synthase subunit f, mitochondrial (ATP synthase membrane subunit f)" ATP5MF ATP5J2 ATP5JL Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]" GO:0005739; GO:0005743; GO:0005753; GO:0015986; GO:0016021; GO:0031965; GO:0042776; GO:0045263; GO:1902600 DFSPSGIFGAFQR 8.600000381 1 1 0.451380851 1428.265674 0 17.47961 17.54454 0 0 0 17.29262 17.36186 0 0 0 0 0 0 0 0 0 0 0 0 0 18.92537 0 0 0 17.19041 0 0 0 0 0 0 20.50217 0 0 0 19.83587 20.41628 0 0 16.23897 0 0 0 0 0 0 0 P56199 ITA1_HUMAN Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a) ITGA1 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; vasodilation [GO:0042311] acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein phosphatase binding [GO:0019903]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; vasodilation [GO:0042311] collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein phosphatase binding [GO:0019903] GO:0001669; GO:0005178; GO:0005518; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008285; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0019903; GO:0030593; GO:0032516; GO:0033627; GO:0034665; GO:0042059; GO:0042311; GO:0043005; GO:0043204; GO:0043410; GO:0043525; GO:0045121; GO:0045123; GO:0045178; GO:0046872; GO:0048812; GO:0070062; GO:0098609; GO:0098639 DSNTDILLVGAPMYMGTEK 10.18000031 0.338006318 0.338006318 2.29E-12 2066.117029 14.54581 13.7532 0 13.93405 0 15.85123 16.34797 0 15.67454 0 14.49024 0 0 0 0 0 0 16.22969 0 0 0 0 0 0 17.76843 16.58701 13.75278 0 0 0 0 12.52395 17.34018 16.31149 0 16.24146 0 18.92094 0 0 0 0 0 0 0 0 0 0 P56202 CATW_HUMAN "Cathepsin W, EC 3.4.22.- (Lymphopain)" CTSW Homo sapiens (Human) immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0006955; GO:0008234; GO:0016020; GO:0031089; GO:0051603 VASAISPIK 3.450000048 0.701552391 0.701552391 0.231289137 885.3997119 17.94172 13.04194 0 11.82659 12.18867 14.35753 4.152008 0 0 0 0 0 0 0 15.61449 16.84937 16.35393 0 15.46624 15.96756 0 15.45903 15.47027 15.47141 15.50735 14.69398 15.33675 15.5277 0 12.9889 11.78272 0 0 0 0 16.98638 0 0 0 0 0 0 16.63947 0 18.51423 0 0 0 P56277 CMC4_HUMAN "Cx9C motif-containing protein 4 (Mature T-cell proliferation 1 neighbor protein) (Mature T-cell proliferation-1 type A, MTCP-1 type A) (Protein p8 MTCP-1, p8MTCP1)" CMC4 C6.1B MTCP1 MTCP1NB Homo sapiens (Human) mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] GO:0005739; GO:0005758 MPQKDPCQK 8.180000305 0.165379256 0.165379256 0.0594234 1130.465237 0 12.59302 0 0 0 0 18.37629 0 10.43123 0 17.94592 0 0 0 0 0 0 9.825944 14.45968 16.69141 0 0 0 0 9.220648 0 10.37258 0 0 0 0 0 0 0 11.67631 0 11.81413 14.70876 0 12.69269 12.77254 0 13.5366 0 13.44457 16.23573 15.67117 0 P56282 DPOE2_HUMAN DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B) POLE2 DPE2 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887] GO:0003677; GO:0003887; GO:0005654; GO:0006260; GO:0006261; GO:0006281; GO:0008622; GO:0016604; GO:0042276; GO:0043231 ALSAFK 5.070000172 0.129544988 0.129544988 0.290287288 633.8426117 15.28478 0 16.63618 15.9084 15.51164 15.86739 0 0 0 0 15.26906 15.59892 15.90531 16.24816 0 15.65576 16.27023 16.16641 0 16.5844 17.24311 13.89484 0 0 15.97389 16.8155 16.85073 16.25026 16.83151 17.10768 0 0 0 0 16.41287 17.81067 0 0 17.35535 16.31543 0 16.80584 0 17.05745 0 0 16.49074 16.54315 P56378 ATP68_HUMAN "ATP synthase subunit ATP5MJ, mitochondrial (6.8 kDa mitochondrial proteolipid protein, MLQ) (ATP synthase membrane subunit 6.8PL)" ATP5MJ ATP5MPL C14orf2 MP68 PRO1574 Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; ATP synthesis coupled proton transport [GO:0015986] GO:0005743; GO:0005753; GO:0015986; GO:0016021 VYQEIWIGMGLMGFIVYKIR 4.389999866 1 1 2.29E-12 2432.400766 12.3794 0 13.19529 0 11.18998 13.39434 11.65093 12.30033 0 0 0 0 12.8984 13.32367 0 13.2589 0 10.94026 13.06878 0 0 0 0 11.88696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56385 ATP5I_HUMAN "ATP synthase subunit e, mitochondrial, ATPase subunit e (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed ]" ATP5ME ATP5I ATP5K Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]" proton transmembrane transporter activity [GO:0015078] GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776 YNYLKPR 9.380000114 1 1 0.002902314 955.6373569 0 0 0 0 0 14.34387 0 11.47258 14.16219 0 0 0 14.30756 0 15.0048 13.91057 0 13.83307 15.10206 0 14.9802 14.83728 0 0 0 13.51645 0 0 0 13.58745 14.37962 14.13609 0 11.88477 15.7122 12.59972 0 0 0 0 0 0 0 0 0 0 0 0 P56524 HDAC4_HUMAN "Histone deacetylase 4, HD4, EC 3.5.1.98" HDAC4 KIAA0288 Homo sapiens (Human) "B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]" DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] GO:0000118; GO:0000122; GO:0000978; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006476; GO:0006954; GO:0007399; GO:0008270; GO:0008284; GO:0010832; GO:0014894; GO:0014898; GO:0016575; GO:0016607; GO:0017053; GO:0019789; GO:0030183; GO:0030955; GO:0033235; GO:0033558; GO:0034983; GO:0040029; GO:0042113; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0051091; GO:0061629; GO:0070555; GO:0070932; GO:0070933; GO:0140297 MSSQSHPDGLSGR 6.940000057 1 1 0.254951557 1375.425594 0 10.62505 10.80485 0 15.005 0 0 13.50025 0 0 0 14.08425 0 0 0 0 0 0 16.14317 14.19529 0 0 0 0 0 0 0 0 0 0 0 0 0 15.09995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56537 IF6_HUMAN "Eukaryotic translation initiation factor 6, eIF-6 (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP))" EIF6 EIF3A ITGB4BP OK/SW-cl.27 Homo sapiens (Human) assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]" ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743] GO:0000054; GO:0000460; GO:0000470; GO:0003743; GO:0005634; GO:0005638; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006110; GO:0030687; GO:0032868; GO:0035195; GO:0035278; GO:0042256; GO:0042304; GO:0043022; GO:0043023; GO:0045652; GO:0045727; GO:0070062; GO:1902626; GO:2000377 LNEAQPSTIATSMRDSLIDSLT 12.82999992 0.622301698 0.622301698 0.575378217 2375.321174 0 0 0 0 0 0 0 0 0 20.8195 19.8529 0 0 0 0 0 0 0 0 24.78999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24.37992 0 0 0 0 0 0 P56696 KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4) KCNQ4 Homo sapiens (Human) inner ear morphogenesis [GO:0042472]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of sound [GO:0007605] basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; inner ear morphogenesis [GO:0042472]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of sound [GO:0007605] calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005267; GO:0005516; GO:0005886; GO:0006813; GO:0007605; GO:0008076; GO:0009925; GO:0016021; GO:0034765; GO:0042472; GO:0071805 GPGDRK 2.809999943 0.331344664 0.331344664 0.134011762 628.9158962 15.5656 0 16.85749 0 17.62005 0 0 0 0 0 15.7413 0 15.95654 15.6696 17.15026 17.68485 16.9477 15.43756 15.75326 0 16.66018 17.89735 13.56337 16.22893 0 17.5347 16.74179 16.9861 17.42725 0 16.68174 16.47388 16.90406 0 17.44344 16.36941 17.08764 18.21051 15.91805 0 15.21922 15.84338 17.44664 15.79295 16.25537 17.91506 17.3866 0 P56703 WNT3_HUMAN Proto-oncogene Wnt-3 (Proto-oncogene Int-4 homolog) WNT3 INT4 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018] GO:0000902; GO:0001707; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007276; GO:0007411; GO:0009948; GO:0009950; GO:0010628; GO:0019904; GO:0030177; GO:0030182; GO:0030666; GO:0031012; GO:0035115; GO:0035116; GO:0044338; GO:0044339; GO:0045165; GO:0048018; GO:0048697; GO:0048843; GO:0050767; GO:0060064; GO:0060070; GO:0060174; GO:0060323; GO:0061180; GO:0070062; GO:0071300; GO:0072089; GO:1904954; GO:1905474; GO:1990909 AIGDFLK 3.519999981 0.407504529 0.407504529 0.19628621 763.7254052 13.62969 0 0 0 16.79716 14.87515 15.17842 0 0 15.3776 0 15.36778 18.33489 15.34576 0 0 0 15.26038 16.13117 0 0 0 0 0 0 0 0 16.19663 0 0 15.73851 0 0 0 0 0 15.24144 0 0 0 0 0 0 0 0 0 0 0 P56715 RP1_HUMAN Oxygen-regulated protein 1 (Retinitis pigmentosa 1 protein) (Retinitis pigmentosa RP1 protein) RP1 ORP1 Homo sapiens (Human) "axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction, visible light [GO:0007603]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]" axoneme [GO:0005930]; ciliary tip [GO:0097542]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] "axoneme [GO:0005930]; ciliary tip [GO:0097542]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; microtubule binding [GO:0008017]; axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction, visible light [GO:0007603]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]" microtubule binding [GO:0008017] GO:0001750; GO:0001917; GO:0005874; GO:0005875; GO:0005930; GO:0007601; GO:0007603; GO:0008017; GO:0032391; GO:0035082; GO:0035556; GO:0035845; GO:0042461; GO:0045494; GO:0046548; GO:0046549; GO:0060041; GO:0071482; GO:0097542; GO:1902857 KISTHMSSSSR 4.980000019 0.20971863 0.20971863 1.38E-12 1235.845993 0 0 14.52301 0 0 14.78333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.03455 15.76236 16.64734 0 16.17535 16.33392 0 16.39792 17.42454 16.99552 0 0 0 0 0 0 0 0 0 0 P56730 NETR_HUMAN "Neurotrypsin, EC 3.4.21.- (Leydin) (Motopsin) (Serine protease 12)" PRSS12 Homo sapiens (Human) exocytosis [GO:0006887]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; exocytosis [GO:0006887]; zymogen activation [GO:0031638] scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0008236; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195 ASGNSNKESLSSVCGLR 1.019999981 0.906421304 0.906421304 0.400126566 1766.02975 0 14.91692 13.91103 15.25717 0 0 0 0 0 0 11.94776 0 0 0 0 15.70854 13.41256 0 0 0 0 0 0 0 0 14.91762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56851 EP3B_HUMAN "Epididymal secretory protein E3-beta (Human epididymis-specific protein 3-beta, HE3-beta)" EDDM3B FAM12B HE3B UNQ6412/PRO21187 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MASSLK 4.519999981 1 1 0.159457618 653.4798627 15.56847 0 0 0 0 0 0 16.41266 0 16.19464 0 0 0 16.26746 0 0 0 0 0 0 0 0 0 16.42374 0 0 0 0 16.3009 0 16.4286 16.99897 17.21223 0 0 0 16.6002 16.6887 17.08946 0 0 0 15.89454 16.58282 17.53999 16.54056 15.79486 16.27464 P56880 CLD20_HUMAN Claudin-20 CLDN20 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tight junction [GO:0070160] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0070160; GO:0070830 LGGDRETK 6.570000172 0.99400574 0.99400574 0.23287717 875.7633556 0 14.64289 0 0 16.51517 0 0 0 14.92908 16.7081 0 0 0 15.98559 13.77761 12.30768 16.41574 15.23208 14.02505 15.85914 0 16.65578 0 16.75303 15.31792 14.85174 15.48346 14.42925 0 0 0 0 15.23985 15.76328 14.26009 16.22972 4.030753 15.66042 15.76826 13.35856 15.82256 16.1617 15.8338 16.14714 15.92531 15.07857 14.40506 15.82164 P56945 BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas) BCAR1 CAS CASS1 CRKAS Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] GO:0001558; GO:0001726; GO:0005737; GO:0005829; GO:0005925; GO:0007015; GO:0007155; GO:0007169; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016020; GO:0016477; GO:0017124; GO:0019901; GO:0030027; GO:0030335; GO:0030424; GO:0035729; GO:0042981; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050852; GO:0050853; GO:0051301; GO:0060326; GO:0086100; GO:0090527 SQLELQQLK 5.769999981 1 1 0.284365871 1086.713221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57052 RBM11_HUMAN Splicing regulator RBM11 (RNA-binding motif protein 11) RBM11 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727] GO:0000381; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0008266; GO:0008380; GO:0016607; GO:0030154; GO:0034599; GO:0042803 DREGKPK 9.710000038 0.191917539 0.191917539 0.299030193 826.9631462 16.98273 0 16.04583 0 16.35973 16.36345 18.37725 0 0 0 17.14368 16.25801 15.72128 0 0 14.03602 0 0 0 16.21416 0 0 16.42737 0 15.78426 0 0 15.45735 16.51309 0 19.68047 16.68545 16.25341 15.79729 16.63834 0 13.28011 16.80238 0 17.46852 0 0 0 16.69255 0 0 0 0 P57053 H2BFS_HUMAN "Histone H2B type F-S (H2B-clustered histone 12 like) (H2B.S histone 1) (Histone H2B.s, H2B/s)" H2BC12L H2BFS H2BS1 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nucleosome assembly [GO:0006334]; substantia nigra development [GO:0021762] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nucleosome assembly [GO:0006334]; substantia nigra development [GO:0021762] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] GO:0000786; GO:0002227; GO:0003677; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0019731; GO:0021762; GO:0046982; GO:0050830; GO:0061844 LLLPGELAK 17.97999954 1 1 0.517211844 953.2943562 0 0 0 0 0 0 0 0 0 0 0 17.23379 0 0 0 0 17.61959 0 0 0 0 0 0 18.17498 0 0 18.9077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.49369 0 0 0 0 P57055 DSCR6_HUMAN Protein ripply3 (Down syndrome critical region protein 6) RIPPLY3 DSCR6 Homo sapiens (Human) embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pharyngeal system development [GO:0060037] nucleus [GO:0005634] nucleus [GO:0005634]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pharyngeal system development [GO:0060037] GO:0000122; GO:0005634; GO:0007507; GO:0008285; GO:0009880; GO:0060037 VYLPMSK 9.039999962 1 1 2.05E-12 853.1693219 0 15.88369 0 0 15.31046 0 13.06612 12.99312 0 11.26132 16.90601 0 0 16.74982 0 14.97231 15.116 15.86246 14.58588 16.32789 0 16.49778 16.18783 16.52724 0 14.72127 15.34299 15.88877 14.31433 12.28583 0 17.02561 0 15.29319 15.93069 16.14919 16.18536 13.30701 0 15.32829 14.99367 0 17.29874 12.07023 17.16563 16.70309 15.70657 16.23383 P57071 PRD15_HUMAN "PR domain zinc finger protein 15, EC 2.1.1.- (PR domain-containing protein 15) (Zinc finger protein 298)" PRDM15 C21orf83 ZNF298 Homo sapiens (Human) methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035 DSFVLSRAR 5.630000114 1 1 0.136760383 1054.582815 0 0 0 15.70682 0 0 0 11.76309 0 0 0 16.76501 0 0 12.23181 0 0 13.93993 0 0 11.96262 17.62689 15.49049 14.56562 0 0 0 0 16.34338 0 18.18344 0 14.87435 19.97561 16.45597 11.46747 18.83409 14.9741 0 17.01299 0 17.14487 16.48587 0 0 16.71136 0 0 P57073 SOX8_HUMAN Transcription factor SOX-8 SOX8 Homo sapiens (Human) "adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone levels [GO:0010817]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone levels [GO:0010817]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837 MLDMSEAR 18.29000092 1 1 0.212964077 968.4374597 12.95834 11.52923 13.69113 0 14.2838 14.82287 13.78403 12.79996 14.39221 14.08435 13.1518 14.10827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57075 UBS3A_HUMAN "Ubiquitin-associated and SH3 domain-containing protein A (Cbl-interacting protein 4, CLIP4) (Suppressor of T-cell receptor signaling 2, STS-2) (T-cell ubiquitin ligand 1, TULA-1)" UBASH3A STS2 Homo sapiens (Human) negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cytokine production [GO:0001817] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cytokine production [GO:0001817] GO:0001817; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0050860; GO:0070062 KSVLVVR 8.699999809 0.005558686 0.005558686 0.045114155 799.5288825 13.01436 0 0 17.73679 12.53417 0 10.93469 0 0 15.16166 15.22125 12.33157 15.79178 0 0 9.892531 16.11937 0 17.39603 0 14.19042 16.85188 0 17.52205 16.71671 0 14.49343 0 13.70149 0 12.49233 0 16.13495 0 0 0 17.91654 15.27731 0 0 15.55729 10.68781 0 10.57974 11.17272 15.95507 14.42599 16.07144 P57087 JAM2_HUMAN "Junctional adhesion molecule B, JAM-B (Junctional adhesion molecule 2, JAM-2) (Vascular endothelial junction-associated molecule, VE-JAM) (CD antigen CD322)" JAM2 C21orf43 VEJAM UNQ219/PRO245 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cellular extravasation [GO:0045123]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte tethering or rolling [GO:0050901]; lymphocyte aggregation [GO:0071593]; maintenance of blood-brain barrier [GO:0035633]; myoblast fusion [GO:0007520]; negative regulation of myelination [GO:0031642]; positive regulation of lymphocyte migration [GO:2000403]; spermatid development [GO:0007286] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; integrin binding [GO:0005178]; cell-cell adhesion [GO:0098609]; cellular extravasation [GO:0045123]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte tethering or rolling [GO:0050901]; lymphocyte aggregation [GO:0071593]; maintenance of blood-brain barrier [GO:0035633]; myoblast fusion [GO:0007520]; negative regulation of myelination [GO:0031642]; positive regulation of lymphocyte migration [GO:2000403]; spermatid development [GO:0007286] integrin binding [GO:0005178] GO:0005178; GO:0005886; GO:0005887; GO:0005923; GO:0007286; GO:0007520; GO:0009986; GO:0031642; GO:0035633; GO:0036477; GO:0044291; GO:0045123; GO:0050901; GO:0070160; GO:0071593; GO:0097241; GO:0098609; GO:0098636; GO:2000403 LLLLLLR 23.97999954 0.801279604 0.801279604 0.282482847 853.6877555 0 0 18.78638 18.91116 0 19.36277 0 0 19.33487 0 0 0 18.89988 0 19.05045 19.09879 14.24944 18.79829 16.11754 18.80874 19.33857 16.88318 0 19.26757 18.64894 18.70389 19.17568 16.95239 18.29045 17.36835 17.71364 18.42615 0 18.25829 0 18.41339 17.67666 18.2523 0 17.61972 17.4924 17.25936 17.98454 18.08103 0 0 18.75033 18.4626 P57103 NAC3_HUMAN Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) SLC8A3 NCX3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202] axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872] GO:0002244; GO:0005432; GO:0005516; GO:0005741; GO:0005789; GO:0005886; GO:0005887; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015491; GO:0016020; GO:0016528; GO:0030001; GO:0030424; GO:0030425; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0070588; GO:0071456; GO:0071901; GO:0098703; GO:0098794; GO:0098815; GO:0099580; GO:1903779 TTVDKLIK 10.64000034 0.490459889 0.490459889 0.215021506 917.4315376 13.9832 0 12.51505 0 14.792 0 17.59099 16.91892 14.73522 0 0 0 7.922195 14.53376 0 14.33124 14.60812 15.92651 0 16.65171 12.25491 16.1112 13.3612 15.51188 0 0 15.80826 0 0 0 0 15.48938 0 12.11912 0 0 0 0 0 0 0 0 0 0 13.15459 0 0 0 P57679 EVC_HUMAN Ellis-van Creveld syndrome protein (DWF-1) EVC Homo sapiens (Human) cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; muscle organ development [GO:0007517]; positive regulation of smoothened signaling pathway [GO:0045880]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224] ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane protein complex [GO:0098797] ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane protein complex [GO:0098797]; cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; muscle organ development [GO:0007517]; positive regulation of smoothened signaling pathway [GO:0045880]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224] GO:0001501; GO:0003416; GO:0005737; GO:0005929; GO:0007224; GO:0007517; GO:0016021; GO:0036064; GO:0045880; GO:0051216; GO:0060170; GO:0098797 QLMMTLTER 3.650000095 1 1 0.133402469 1139.511742 0 0 0 0 0 0 0 16.36353 0 0 13.0796 0 0 0 0 0 0 14.92559 14.61684 0 0 0 0 13.74975 12.96963 0 15.09466 14.10524 0 13.61777 16.86769 0 0 0 0 0 15.93265 0 16.25296 0 0 0 0 0 0 0 0 0 P57682 KLF3_HUMAN Krueppel-like factor 3 (Basic krueppel-like factor) (CACCC-box-binding protein BKLF) (TEF-2) KLF3 BKLF Homo sapiens (Human) cellular response to peptide [GO:1901653]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide [GO:1901653]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0006357; GO:0007275; GO:0046872; GO:1901653; GO:1990837 FPSSHR 4.199999809 1 1 0.108814519 730.8136934 16.11328 0 15.75186 0 0 15.67599 0 16.05383 0 16.1523 16.69672 0 0 15.2287 0 0 0 0 16.9604 0 0 0 0 0 0 16.69107 0 0 0 0 0 0 0 16.02719 0 0 16.63305 0 0 0 0 0 0 0 0 0 0 0 P57721 PCBP3_HUMAN Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1) PCBP3 PCBP3-OT1 PCBP3OT Homo sapiens (Human) mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062 QMSGAQIKIANATEGSSER 4.510000229 1 1 0.37728699 1995.075599 14.08809 14.88601 0 15.91809 13.79409 14.92373 0 0 17.32213 0 12.34279 14.49894 14.40408 0 15.89345 0 0 0 13.94832 0 0 0 0 0 0 0 0 12.03872 15.4664 13.92774 15.16733 0 0 0 0 0 0 0 16.76197 0 0 0 0 0 0 0 0 0 P57737 CORO7_HUMAN "Coronin-7, Crn7 (70 kDa WD repeat tumor rejection antigen homolog)" CORO7 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] actin binding [GO:0003779]; actin filament binding [GO:0051015] GO:0000139; GO:0003779; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007015; GO:0015031; GO:0016020; GO:0016021; GO:0030041; GO:0031410; GO:0051015 DSHITNLK 18.07999992 0.177959993 0.177959993 0.272662234 927.689079 17.63099 16.30408 16.29117 16.19375 15.03226 16.20398 16.63862 0 16.74804 14.88078 15.53721 14.7468 14.87567 16.2584 15.20593 14.9475 0 17.27485 0 15.77511 16.48821 16.25997 16.38827 16.86366 15.38802 15.9697 14.85899 15.34066 16.36769 0 15.95745 15.88877 16.45807 17.52523 0 0 15.30801 0 17.2942 15.41264 0 0 0 0 17.30253 0 15.44895 16.54975 P57740 NU107_HUMAN Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107) NUP107 Homo sapiens (Human) "female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] "cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]" structural constituent of nuclear pore [GO:0017056] GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006355; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0016020; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006 EKMYNVLLFVDGGWMVDVR 1.409999967 1 1 0.10358199 2287.40132 12.23007 0 13.57641 0 11.20906 9.663874 10.85551 0 8.664252 10.3828 11.24213 0 10.0949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.87985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57775 FBXW4_HUMAN F-box/WD repeat-containing protein 4 (Dactylin) (F-box and WD-40 domain-containing protein 4) FBXW4 FBW4 SHFM3 Homo sapiens (Human) embryonic limb morphogenesis [GO:0030326]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; embryonic limb morphogenesis [GO:0030326]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0000151; GO:0005829; GO:0006511; GO:0016055; GO:0019005; GO:0030326; GO:0031146 ACLHAFPLTSTPLSSPVYCLR 13.01000023 1 1 0.045258059 2390.339636 15.63191 0 13.96037 0 0 14.49608 0 0 0 0 13.65736 13.77625 0 15.4896 15.2501 0 0 14.91903 16.63978 9.923644 16.63362 15.60018 0 0 0 0 0 15.00623 17.24457 0 0 0 0 15.83227 15.79324 16.08586 17.55953 0 0 0 0 0 0 17.62199 0 17.40344 0 0 P57789 KCNKA_HUMAN Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit) KCNK10 TREK2 Homo sapiens (Human) memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322] potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244] GO:0005244; GO:0005267; GO:0005886; GO:0005887; GO:0007165; GO:0007613; GO:0022841; GO:0030322; GO:0034765; GO:0071805 EEVGEIKAHAAEWK 5.170000076 1 1 0.10422167 1596.241221 13.97386 14.31819 0 13.9903 0 13.60792 14.21776 0 0 14.35107 0 0 0 0 0 0 0 0 0 0 18.4888 0 0 0 16.09799 0 14.8893 16.08376 0 0 14.7121 13.52065 15.30742 12.95339 13.64068 0 0 0 0 0 0 0 0 0 0 0 0 0 P57796 CABP4_HUMAN "Calcium-binding protein 4, CaBP4" CABP4 Homo sapiens (Human) photoreceptor cell morphogenesis [GO:0008594]; phototransduction [GO:0007602]; retinal bipolar neuron differentiation [GO:0060040]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601] cytosol [GO:0005829]; extracellular region [GO:0005576]; synapse [GO:0045202]; terminal bouton [GO:0043195] cytosol [GO:0005829]; extracellular region [GO:0005576]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325]; photoreceptor cell morphogenesis [GO:0008594]; phototransduction [GO:0007602]; retinal bipolar neuron differentiation [GO:0060040]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325] GO:0005246; GO:0005509; GO:0005576; GO:0005829; GO:0007165; GO:0007601; GO:0007602; GO:0008594; GO:0043195; GO:0044325; GO:0045202; GO:0046549; GO:0060040 DRDGR 6.940000057 1 1 0.230548186 618.1282392 0 14.761 0 0 0 13.54278 14.21078 16.05253 0 14.46857 15.55893 0 0 0 15.72181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.67949 0 0 0 0 14.26628 0 0 0 0 0 0 0 0 0 17.10336 0 0 P58004 SESN2_HUMAN "Sestrin-2, EC 1.11.1.- (Hypoxia-induced gene)" SESN2 Hi95 SEST2 Homo sapiens (Human) "cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]" Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932] "Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]" "GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]" GO:0001932; GO:0005092; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006635; GO:0009749; GO:0016239; GO:0016684; GO:0030308; GO:0030330; GO:0031588; GO:0031932; GO:0032042; GO:0032542; GO:0032868; GO:0034198; GO:0034599; GO:0036091; GO:0042149; GO:0042593; GO:0043491; GO:0044877; GO:0046323; GO:0070328; GO:0070728; GO:0071230; GO:0071233; GO:0072593; GO:0098869; GO:1900182; GO:1901031; GO:1902010; GO:1904262; GO:1904504; GO:1990253; GO:1990316; GO:2000479 GPRGPSAFIPVEEVLR 1.970000029 0.316693574 0.316693574 0.22295378 1723.247166 14.6848 15.23841 14.18506 0 0 15.07743 0 0 0 0 0 14.7285 0 0 0 0 0 0 0 0 0 0 0 16.69405 0 0 0 0 0 15.93668 13.84257 14.27298 15.17491 16.74869 13.56474 15.11251 0 0 0 0 0 0 0 0 13.9231 0 0 0 P58107 EPIPL_HUMAN Epiplakin (450 kDa epidermal antigen) EPPK1 EPIPL Homo sapiens (Human) intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; regulation of epithelium regeneration [GO:1905041]; wound healing [GO:0042060] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; membrane [GO:0016020]; perinucleolar compartment [GO:0097356] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; membrane [GO:0016020]; perinucleolar compartment [GO:0097356]; intermediate filament binding [GO:0019215]; keratin filament binding [GO:1990254]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; regulation of epithelium regeneration [GO:1905041]; wound healing [GO:0042060] intermediate filament binding [GO:0019215]; keratin filament binding [GO:1990254]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] GO:0003723; GO:0005198; GO:0005737; GO:0005856; GO:0005923; GO:0010839; GO:0016020; GO:0016323; GO:0016327; GO:0019215; GO:0030054; GO:0030056; GO:0030336; GO:0042060; GO:0042995; GO:0045095; GO:0045104; GO:0045109; GO:0045110; GO:0045111; GO:0050680; GO:0051548; GO:0061045; GO:0071944; GO:0097356; GO:1905041; GO:1990254 RQDLLSR 6.829999924 1 1 0.246099368 888.3138276 16.81128 14.76501 16.81208 14.56113 14.87941 0 0 14.98646 14.8395 16.04999 15.88452 0 0 0 16.26328 16.63746 16.16982 0 17.1037 14.80627 15.97687 15.47019 17.52239 15.72504 15.59432 15.77829 14.97349 15.38115 16.63034 16.20086 0 15.59338 15.9603 18.38796 0 0 18.27661 16.33402 18.60733 16.42429 14.07155 14.53053 16.02249 17.66843 16.29743 15.77175 15.99045 18.15185 P58215 LOXL3_HUMAN "Lysyl oxidase homolog 3, EC 1.4.3.-, EC 1.4.3.13 (Lysyl oxidase-like protein 3)" LOXL3 LOXL Homo sapiens (Human) "collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]" copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044] GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046 ADFRPK 5.300000191 1 1 0.279887681 733.0212174 15.5636 0 15.09336 15.15908 16.87458 15.17608 14.72313 15.41562 13.47223 13.41014 14.99769 14.63275 16.04936 14.44998 0 15.716 16.10982 14.25176 0 0 16.35586 16.11621 15.37279 0 0 15.6568 0 0 15.99994 0 16.49592 17.40212 0 16.43396 18.22173 0 0 0 0 14.88973 0 0 0 16.27201 0 0 17.07779 15.20653 P58397 ATS12_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 12, ADAM-TS 12, ADAM-TS12, ADAMTS-12, EC 3.4.24.-" ADAMTS12 UNQ1918/PRO4389 Homo sapiens (Human) cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0002062; GO:0004222; GO:0005576; GO:0007160; GO:0016477; GO:0030167; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113 IVHHAEKTLSSFCK 7.739999771 1 1 9.17E-13 1656.044194 12.65104 14.78942 14.76217 15.29819 13.10811 16.00645 0 0 0 0 0 0 15.27394 0 0 0 0 0 0 0 0 0 15.27646 15.59968 0 0 0 0 0 0 16.78666 16.90275 15.17884 14.16339 0 0 13.69326 0 0 0 0 0 0 0 0 0 0 14.79203 P58505 CU058_HUMAN Uncharacterized protein C21orf58 C21orf58 Homo sapiens (Human) AQAWSGPSR 5.090000153 1 1 0.160683669 959.7506068 0 14.29266 13.59452 0 0 10.85574 14.78653 16.76937 15.04573 16.93526 13.43216 0 13.3824 13.78172 14.72858 14.6136 13.73464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92945 0 0 15.0865 0 15.94963 0 0 0 0 0 16.12279 0 0 0 0 P58743 S26A5_HUMAN Prestin (Solute carrier family 26 member 5) SLC26A5 PRES Homo sapiens (Human) cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; lateral wall of outer hair cell [GO:0120249] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; lateral wall of outer hair cell [GO:0120249]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605] anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116] GO:0002931; GO:0005737; GO:0005887; GO:0007605; GO:0008271; GO:0008360; GO:0009410; GO:0009751; GO:0010996; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015755; GO:0016323; GO:0016328; GO:0019531; GO:0030507; GO:0034766; GO:0035864; GO:0042391; GO:0042802; GO:0045793; GO:0090102; GO:0097066; GO:0120249; GO:1902074; GO:2000147 QAFTCTPK 8.220000267 0.060231302 0.060231302 0.25137875 951.7581167 0 15.44255 11.44378 15.28674 15.2375 15.72392 17.54147 0 13.65586 17.46763 16.60873 16.17435 15.32775 15.64014 16.71629 0 14.27191 16.16147 15.62401 14.25293 15.60461 16.18993 14.24617 16.7632 14.47416 0 16.09105 0 14.67642 0 0 16.51911 15.44026 0 14.85971 16.19408 0 16.71994 15.63325 17.03275 16.50259 16.65426 16.36899 15.15083 14.43621 15.58041 15.48494 0 P58872 RHBL3_HUMAN "Rhomboid-related protein 3, EC 3.4.21.105 (Ventrhoid transmembrane protein)" RHBDL3 RHBDL4 VRHO Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005509; GO:0016021 LDPHKR 5.230000019 1 1 0.220336569 766.6185994 0 0 0 0 0 14.92527 0 13.58515 16.32779 14.53166 0 0 7.232177 0 20.24051 11.41759 0 16.70512 0 12.28356 0 16.86795 0 0 17.9077 0 17.09841 0 0 0 17.25651 0 0 17.53925 0 13.69946 16.0683 0 0 0 16.38403 18.84472 16.62074 17.30902 11.91322 18.02431 0 0 P59046 NAL12_HUMAN "NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide)" NLRP12 NALP12 PYPAF7 RNO Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interleukin-18 production [GO:0032661]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interleukin-18 production [GO:0032661]; signal transduction [GO:0007165] ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656] GO:0001818; GO:0005524; GO:0005737; GO:0006919; GO:0007165; GO:0008656; GO:0009968; GO:0031953; GO:0032088; GO:0032661; GO:0032692; GO:0032715; GO:0032731; GO:0036336; GO:0043122; GO:0043124; GO:0043281; GO:0045345; GO:0045751; GO:0050728; GO:0050729; GO:0070373; GO:0071345; GO:1901223; GO:1901224 DINCER 3.75999999 1 1 0.349728103 807.1615883 0 0 16.22425 0 17.93489 0 0 0 0 0 0 0 0 0 17.01428 0 0 0 17.80268 18.19259 0 0 0 0 0 18.71168 0 0 0 19.61469 0 0 0 0 0 0 0 0 0 0 17.23555 0 0 0 0 17.66985 17.72485 17.65951 P59051 BRAS2_HUMAN Putative uncharacterized protein encoded by BRWD1-AS2 (ATP1A1 antisense RNA 1) (ATP1A1 antisense gene protein 1) (BRWD1 intronic transcript 2) BRWD1-AS2 BRWD1-IT2 C21orf87 NCRNA00257 Homo sapiens (Human) GSGRR 6.239999771 1 1 0.138930108 532.479149 13.20234 0 16.85147 14.13984 14.87646 15.79861 15.23487 0 14.09628 14.04807 12.39964 0 0 15.12892 16.04347 0 0 16.52485 0 0 0 0 0 0 0 13.6005 0 15.12615 0 0 0 0 0 15.24637 0 0 0 0 0 0 0 0 16.6079 0 0 0 0 0 P59095 STAR6_HUMAN "StAR-related lipid transfer protein 6 (START domain-containing protein 6, StARD6)" STARD6 Homo sapiens (Human) lipid transport [GO:0006869] lipid binding [GO:0008289]; lipid transport [GO:0006869] lipid binding [GO:0008289] GO:0006869; GO:0008289 LVMFVQTEMR 6.940000057 1 1 0.136289062 1257.455887 14.42829 8.948898 14.43997 0 0 14.34449 0 0 0 0 14.78068 15.98027 0 0 0 0 14.23899 0 0 0 0 14.9952 0 0 0 14.66369 0 0 0 0 14.57216 0 0 0 14.05055 0 16.44083 0 0 0 0 0 0 0 0 0 0 0 P59510 ATS20_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 20, ADAM-TS 20, ADAM-TS20, ADAMTS-20, EC 3.4.24.-" ADAMTS20 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0004222; GO:0005615; GO:0008270; GO:0009967; GO:0030198; GO:0031012; GO:0043066; GO:0045636 GVGQVVEEMCDQSTRPCSQR 1.029999971 1 1 0.173819314 2323.288542 14.08014 14.58257 15.53995 12.30026 0 14.12091 0 0 0 0 0 14.52602 0 14.04021 15.04697 0 13.29087 0 0 0 0 0 0 0 0 12.88303 0 0 0 0 13.33648 0 0 0 0 0 0 0 0 0 0 0 15.14072 0 0 0 0 0 P59551 T2R60_HUMAN "Taste receptor type 2 member 60, T2R60 (Taste receptor type 2 member 56, T2R56)" TAS2R60 Homo sapiens (Human) sensory perception of bitter taste [GO:0050913] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of bitter taste [GO:0050913] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021; GO:0050913 MNGDHMVLGSSVTDKK 12.27000046 1 1 0.459482921 1749.472714 0 18.06564 0 0 0 0 16.76404 0 16.44665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.09212 0 0 0 0 0 0 0 0 0 0 0 0 0 P59780 AP3S2_HUMAN "AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adaptor-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin, Sigma3B-adaptin) (Sigma-adaptin 3b)" AP3S2 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0005769; GO:0005794; GO:0006886; GO:0006896; GO:0008089; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:1903232; GO:1904115 CFENVCELDLIFHMDK 5.78000021 1 1 0.043695496 2069.939747 0 14.74383 0 13.55479 0 12.81476 0 0 0 0 12.92373 14.08015 0 12.31224 0 12.99461 0 0 0 0 0 11.16328 0 16.04329 0 0 0 15.27544 0 0 0 0 0 0 0 0 0 0 0 11.93024 0 0 16.61123 0 0 0 0 16.10751 P59797 SELV_HUMAN "Selenoprotein V, SelV" SELENOV SELV Homo sapiens (Human) response to selenium ion [GO:0010269] cytosol [GO:0005829] cytosol [GO:0005829]; response to selenium ion [GO:0010269] GO:0005829; GO:0010269 ASTPTR 6.079999924 1 1 0.250676999 634.0851604 14.73672 15.7621 0 16.35037 15.14544 0 0 0 0 0 0 0 14.37137 15.32785 0 15.50398 0 16.34993 15.60748 16.36834 14.99355 17.00559 0 16.9164 15.34221 0 16.91083 0 15.27802 0 15.23206 0 15.75919 17.11692 15.61494 16.2797 0 16.41207 17.298 16.10225 16.22392 17.18133 16.40199 0 16.38459 0 15.95997 0 P59817 Z280A_HUMAN Zinc finger protein 280A (3'OY11.1) (Suppressor of hairy wing homolog 1) (Zinc finger protein 636) ZNF280A SUHW1 ZNF280 ZNF636 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 SSSEPGYK 6.519999981 1 1 0.35472443 855.7838083 16.48303 13.99488 16.56106 0 0 0 0 0 17.16352 16.486 13.68912 14.98106 0 0 0 15.50212 0 0 0 15.34312 0 0 15.52913 15.59033 14.47083 15.29219 0 14.76619 16.187 14.38539 0 0 0 16.05093 0 0 14.86346 15.85874 0 0 16.44787 0 0 0 0 16.37001 0 0 P59827 BPIB4_HUMAN "BPI fold-containing family B member 4 (Ligand-binding protein RY2G5) (Long palate, lung and nasal epithelium carcinoma-associated protein 4)" BPIFB4 C20orf186 LPLUNC4 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular region [GO:0005576] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lipid binding [GO:0008289] lipid binding [GO:0008289] GO:0005576; GO:0005829; GO:0008289; GO:0015629 VLATAEVMVSQPK 21.87999916 1 1 0.067802492 1372.281147 14.76698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42465 0 0 0 15.50451 14.89119 17.14632 13.93513 16.23616 0 16.4271 0 17.14453 15.69101 13.76408 17.00968 0 16.09132 16.5438 16.43949 17.35222 P59910 DJB13_HUMAN DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein) DNAJB13 TSARG3 TSARG6 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085] axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085] chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] GO:0005829; GO:0005930; GO:0031514; GO:0036126; GO:0051082; GO:0051085; GO:0051087; GO:0097224; GO:1904158 NSEDAQIK 13.68000031 1 1 0.241775461 904.9098549 0 17.58284 0 0 17.33347 16.81015 16.70788 0 0 0 0 0 0 0 0 17.48018 0 0 0 0 18.36482 0 17.2123 0 0 18.79778 0 0 0 0 0 18.02011 0 0 0 17.22486 0 0 18.37816 0 19.02791 0 0 0 17.36183 0 0 19.2715 P59923 ZN445_HUMAN "Zinc finger protein 445, ZFP445 (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15)" ZNF445 ZFP445 ZKSCAN15 ZNF168 Homo sapiens (Human) maintenance of DNA methylation [GO:0010216]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; maintenance of DNA methylation [GO:0010216]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0010216; GO:0010385; GO:0046872; GO:2000653 CSQCGKAFR 8.569999695 0.988021195 0.988021195 0.175620956 1109.331655 14.97059 15.95605 12.16842 15.18788 0 0 15.28554 0 0 15.04325 9.679208 14.44937 0 0 0 0 15.07945 0 0 14.46936 15.34974 0 0 16.3862 0 13.62699 0 0 0 14.4312 13.80541 0 12.9714 11.34559 14.73064 15.99441 15.24898 13.70386 14.7834 13.28854 12.85824 11.20097 13.14917 0 12.29054 14.351 0 0 P60153 RNAS9_HUMAN Inactive ribonuclease-like protein 9 RNASE9 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; nucleic acid binding [GO:0003676] nucleic acid binding [GO:0003676] GO:0003676; GO:0005576 SFLSEDGVFVISP 5.699999809 0.871983647 0.871983647 0.193512499 1396.3675 0 0 12.44988 0 0 15.71934 0 0 0 15.46258 16.5659 0 0 0 0 0 14.38185 0 0 0 0 0 0 0 15.33585 0 0 0 0 0 0 0 0 15.61282 0 0 0 16.93179 15.04564 16.85195 0 16.35898 0 0 16.86189 0 0 0 P60174 TPIS_HUMAN "Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)" TPI1 TPI Homo sapiens (Human) gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242] methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625] GO:0004807; GO:0005615; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0031625; GO:0042803; GO:0046166; GO:0070062 EAGITEK 6.840000153 1 1 0.145934315 749.2227081 0 16.23354 14.63606 0 16.06709 0 0 14.37643 0 0 15.5582 0 0 15.59307 0 15.40645 0 0 0 0 15.62973 0 15.62707 0 0 0 0 15.23512 0 0 0 0 0 0 0 0 0 15.88609 0 0 0 0 0 14.80546 0 0 15.65436 0 P60228 EIF3E_HUMAN "Eukaryotic translation initiation factor 3 subunit E, eIF3e (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)" EIF3E EIF3S6 INT6 Homo sapiens (Human) "formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0000184; GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0016605; GO:0033290; GO:0045296; GO:0045727; GO:0045947; GO:0047485; GO:0070062; GO:0071540; GO:1902416 DLVKVIQQESYTYK 3.49000001 0.158679485 0.158679485 0.249920075 1710.466604 0 0 0 0 0 15.80331 0 0 0 18.35552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.67761 0 0 0 15.20293 0 0 15.61236 15.84167 0 14.58457 0 0 0 0 0 0 0 0 0 0 0 0 P60321 NANO2_HUMAN "Nanos homolog 2, NOS-2" NANOS2 NOS2 Homo sapiens (Human) "germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]" mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:1900153 NSAGRR 3.650000095 1 1 0.188528358 661.40767 15.72935 16.11358 0 10.88289 16.37495 15.49915 14.7982 16.09454 11.82937 15.82135 13.34527 14.88797 14.67838 14.80839 13.5131 14.59376 0 16.23253 16.46205 16.51723 15.61665 16.69331 0 0 0 15.17158 16.46351 12.40077 14.46814 13.76259 0 16.47246 0 15.3331 0 0 14.01544 0 15.73392 0 0 0 0 0 16.65776 16.98873 0 0 P60323 NANO3_HUMAN "Nanos homolog 3, NOS-3" NANOS3 NOS3 Homo sapiens (Human) "germ cell development [GO:0007281]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]" mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0007281; GO:0007283; GO:0008270; GO:0010494; GO:0017148; GO:0048471; GO:0048477; GO:0051726; GO:1900153; GO:2001234 GGGGGAGFR 9.670000076 1 1 0.224707137 735.6230087 0 0 0 18.45483 0 0 0 0 17.20829 0 0 0 0 16.40394 0 0 0 17.4628 0 0 15.70821 0 0 0 0 0 18.87372 18.76573 0 0 0 17.92738 0 0 0 0 0 0 19.98285 0 0 0 0 0 0 0 0 0 P60411 KR109_HUMAN Keratin-associated protein 10-9 (High sulfur keratin-associated protein 10.9) (Keratin-associated protein 10.9) (Keratin-associated protein 18-9) (Keratin-associated protein 18.9) KRTAP10-9 KAP10.9 KAP18-9 KRTAP10.9 KRTAP18-9 KRTAP18.9 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MAASTMSIR 1.220000029 1 1 0.201566633 999.3417225 0 0 0 0 0 0 17.08192 0 0 18.60071 0 15.99324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.15405 0 0 0 P60468 SC61B_HUMAN Protein transport protein Sec61 subunit beta SEC61B Homo sapiens (Human) "posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]; epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]" epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] GO:0003723; GO:0005783; GO:0005784; GO:0005789; GO:0005829; GO:0006616; GO:0016020; GO:0016021; GO:0030433; GO:0030970; GO:0031204; GO:0031205; GO:0043022; GO:0044322; GO:0048408 NASCGTR 6.389999866 0.307348788 0.307348788 0.155016142 765.3650672 0 14.6148 0 0 15.36402 0 0 16.72976 14.95626 0 14.01576 8.689112 14.23932 15.408 14.95078 15.29855 16.98965 14.63243 17.01766 0 0 0 16.17454 0 0 0 0 0 0 0 16.2632 0 0 17.10807 16.35765 14.72398 15.13419 0 0 16.60293 17.16567 0 0 16.28372 16.16184 13.1562 16.26225 0 P60602 ROMO1_HUMAN "Reactive oxygen species modulator 1, ROS modulator 1 (Epididymis tissue protein Li 175) (Glyrichin) (Mitochondrial targeting GxxxG motif protein, MTGM) (Protein MGR2 homolog)" ROMO1 C20orf52 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; intracellular protein transport [GO:0006886]; killing of cells of another organism [GO:0031640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative senescence [GO:0090399] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; intracellular protein transport [GO:0006886]; killing of cells of another organism [GO:0031640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative senescence [GO:0090399] GO:0005739; GO:0005743; GO:0005744; GO:0006886; GO:0008284; GO:0016021; GO:0030150; GO:0031640; GO:0034614; GO:0042742; GO:0045039; GO:0050829; GO:0050830; GO:0051838; GO:0061844; GO:0090399; GO:2000379 TMMQSGGTFGTFMAIGMGIR 4.320000172 1 1 0.267093329 2127.444466 15.64132 13.65976 0 11.87088 16.10947 0 14.13573 12.70972 12.89519 13.48314 16.31375 17.1439 14.05511 13.70553 0 14.65636 12.94262 0 0 0 0 0 0 0 15.01202 15.56823 0 0 13.15186 0 12.19995 15.29937 0 0 0 0 16.35451 0 15.9143 0 0 0 14.97148 13.16213 0 13.78704 0 16.2217 P60604 UB2G2_HUMAN "Ubiquitin-conjugating enzyme E2 G2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)" UBE2G2 UBC7 Homo sapiens (Human) "cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0030433; GO:0035458; GO:0042802; GO:0044257; GO:0061631; GO:0070936; GO:1904153 QIVQKSLGL 4.630000114 1 1 0.130569735 985.7687661 15.36235 0 12.07876 12.45421 13.31406 15.25403 15.83964 0 0 12.70531 15.01071 15.84327 0 14.30934 13.22456 0 14.32938 0 0 14.40031 14.47786 0 15.98707 15.85112 15.24649 11.83195 15.84704 13.90892 11.81464 14.6725 0 0 0 0 0 0 0 0 0 14.78837 12.94897 0 16.14803 0 16.85699 0 0 0 P60608 EFC2_HUMAN "Endogenous retrovirus group FC1 member 1 Env polyprotein (Envelope polyprotein) (Fc2deltaenv) (HERV-F(c)2_7q36.2 provirus ancestral Env polyprotein) [Includes: Surface protein, SU; Truncated transmembrane protein, TM ]" ERVFC1-1 Homo sapiens (Human) LVATAASPPAGCQAPIAFLGLK 2.349999905 1 1 0.165546865 2149.62789 12.52686 10.09709 15.01879 14.17412 14.4099 13.06649 0 0 0 0 0 0 0 0 0 0 13.61651 0 0 15.27565 0 13.46881 0 16.18459 16.41414 0 13.99005 0 0 12.75101 0 10.92377 11.93299 0 11.28748 0 0 13.94887 0 0 13.11804 15.45005 0 13.8308 0 0 0 0 P60842 IF4A1_HUMAN "Eukaryotic initiation factor 4A-I, eIF-4A-I, eIF4A-I, EC 3.6.4.13 (ATP-dependent RNA helicase eIF4A-1)" EIF4A1 DDX2A EIF4A Homo sapiens (Human) cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" GO:0000339; GO:0002183; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0003743; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016020; GO:0016281; GO:0016887; GO:0070062 FMRDPIR 10.07999992 5.95E-07 5.95E-07 0.232541839 951.5572207 17.62556 18.30836 0 18.07152 19.04095 19.01148 21.26771 0 19.6833 19.52434 0 17.59049 17.62293 0 19.83475 18.42392 0 0 0 0 17.25064 18.23339 0 18.20374 20.5755 0 20.52001 0 20.84458 0 20.54253 0 0 19.25929 18.80609 0 19.84046 0 0 20.83854 20.07613 20.09698 17.57824 17.28568 0 18.72363 18.47586 18.82913 P60866 RS20_HUMAN 40S ribosomal protein S20 (Small ribosomal subunit protein uS10) RPS20 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412] MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016020; GO:0022626; GO:0022627; GO:0045202; GO:0070062; GO:0097371; GO:1901798; GO:1990948 MAFKDTGK 2.279999971 0.673708677 0.673708677 0.247163166 898.0967286 15.04818 0 0 15.70253 0 0 0 0 15.96738 0 15.87911 0 0 0 0 15.67446 15.1389 16.14201 0 15.03488 0 0 0 0 16.38503 14.42518 15.40349 13.95359 14.92088 14.68616 15.26438 16.6976 9.090755 0 11.44591 15.60174 15.81741 15.86424 0 16.06319 0 15.50067 15.01748 16.79125 13.94671 16.72614 11.39379 16.13925 P60903 S10AA_HUMAN Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11) S100A10 ANX2LG CAL1L CLP11 Homo sapiens (Human) membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of binding [GO:0051099]; positive regulation of exocytosis [GO:0045921]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of neurogenesis [GO:0050767]; vesicle budding from membrane [GO:0006900] AnxA2-p11 complex [GO:1990665]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575] AnxA2-p11 complex [GO:1990665]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; transmembrane transporter binding [GO:0044325]; membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of binding [GO:0051099]; positive regulation of exocytosis [GO:0045921]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of neurogenesis [GO:0050767]; vesicle budding from membrane [GO:0006900] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; transmembrane transporter binding [GO:0044325] GO:0001765; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006900; GO:0010756; GO:0016020; GO:0016363; GO:0019897; GO:0042789; GO:0042803; GO:0043547; GO:0044325; GO:0045921; GO:0045944; GO:0048306; GO:0050767; GO:0051099; GO:0051496; GO:0051894; GO:0062023; GO:0070062; GO:0072659; GO:0090575; GO:0098797; GO:1900026; GO:1905686; GO:1990665 IMKDLDQCR 8.390000343 1 1 4.58E-13 1191.941794 0 14.99567 11.70028 0 16.06337 11.04299 0 0 0 12.01748 0 13.1215 0 0 0 0 0 0 16.18728 0 0 0 0 12.11981 0 0 11.15294 15.37431 15.83853 0 0 0 0 0 0 0 0 14.55039 0 0 0 0 16.46102 0 0 0 0 0 P61006 RAB8A_HUMAN "Ras-related protein Rab-8A, EC 3.6.5.2 (Oncogene c-mel)" RAB8A MEL RAB8 Homo sapiens (Human) "autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]" centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140] "centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]" GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030496; GO:0030670; GO:0031267; GO:0031489; GO:0032588; GO:0032869; GO:0036064; GO:0043025; GO:0043197; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055038; GO:0060271; GO:0061512; GO:0070062; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003 TIELDGKR 11.02999973 0.214359015 0.214359015 0.170268218 930.3956238 17.56657 0 0 15.51798 15.52997 16.96204 15.58718 17.83978 13.36388 14.26366 17.44487 17.71535 16.98886 15.99648 16.24178 17.89329 0 16.31066 17.09887 17.28285 17.2001 17.47412 17.32964 15.87819 18.75731 16.70966 17.31416 15.45071 16.61726 0 16.11975 17.92513 16.69981 16.37983 17.07856 18.38408 18.99642 17.16627 19.36782 17.32984 15.30434 17.1562 16.64463 18.5079 16.27174 16.69304 14.02451 17.20805 P61011 SRP54_HUMAN "Signal recognition particle 54 kDa protein, SRP54, EC 3.6.5.-" SRP54 Homo sapiens (Human) "exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0006617; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021; GO:0045047 MGPFSQILGMIPGFGTDFMSK 6.039999962 1 1 0.084512808 2298.517724 0 12.96954 12.34712 12.70595 0 0 13.47108 0 12.53076 12.89814 12.35966 14.84879 0 13.08789 16.06526 13.28444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.76925 12.57289 0 0 0 0 0 0 P61020 RAB5B_HUMAN "Ras-related protein Rab-5B, EC 3.6.5.2" RAB5B Homo sapiens (Human) antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100] anchored component of synaptic vesicle membrane [GO:0098993]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] anchored component of synaptic vesicle membrane [GO:0098993]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0012505; GO:0016020; GO:0019003; GO:0019882; GO:0030100; GO:0030139; GO:0030667; GO:0030742; GO:0031901; GO:0042470; GO:0043231; GO:0048227; GO:0070062; GO:0098993 QASPSIVIALAGNK 7.320000172 0.275028706 0.275028706 0.318933052 1366.147741 13.08796 14.95685 13.61064 0 0 0 0 0 14.20718 0 0 0 0 15.39777 16.11914 0 0 0 0 15.43414 15.59734 17.23539 0 16.64385 17.02167 0 0 16.20992 0 0 0 15.39396 16.43133 12.8786 0 0 17.1196 17.2394 18.94601 16.95949 15.3819 15.67048 0 0 0 0 16.14845 18.09925 P61073 CXCR4_HUMAN "C-X-C chemokine receptor type 4, CXC-R4, CXCR-4 (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor, LESTR) (Lipopolysaccharide-associated protein 3, LAP-3, LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor, SDF-1 receptor) (CD antigen CD184)" CXCR4 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029] cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029] actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618] GO:0001618; GO:0001666; GO:0001764; GO:0002064; GO:0002407; GO:0003779; GO:0004930; GO:0005634; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0006915; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0007420; GO:0008038; GO:0009615; GO:0009897; GO:0009986; GO:0014823; GO:0015026; GO:0016021; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0022008; GO:0022029; GO:0030054; GO:0030155; GO:0031252; GO:0031410; GO:0031625; GO:0032027; GO:0032991; GO:0035470; GO:0036094; GO:0038147; GO:0038160; GO:0043067; GO:0043130; GO:0043217; GO:0043278; GO:0045446; GO:0048714; GO:0050792; GO:0050920; GO:0050921; GO:0050965; GO:0050966; GO:0051924; GO:0060048; GO:0060326; GO:0061154; GO:0070062; GO:0071345; GO:0071466; GO:0120162; GO:1903861; GO:1905322; GO:1990478; GO:2000448 YLAIVHATNSQRPRK 5.349999905 1 1 1.83E-12 1753.774071 15.23585 14.44227 14.61424 13.43171 0 13.1806 14.71682 0 0 0 16.67068 16.13914 14.74955 14.67656 14.28119 15.16971 14.08494 0 15.48434 0 0 14.40836 13.7056 14.87766 14.55848 15.01237 14.50536 0 0 13.39529 0 0 0 0 0 0 14.31815 0 0 0 0 15.1909 0 0 14.21883 0 0 0 P61129 ZC3H6_HUMAN Zinc finger CCCH domain-containing protein 6 ZC3H6 KIAA2035 ZC3HDC6 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]" metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0000785; GO:0003723; GO:0005634; GO:0045892; GO:0046872 EGYLEQFGDSHGSGAKLGDPR 10.19999981 1 1 0.431766711 2219.802367 20.17195 22.10819 18.29768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61163 ACTZ_HUMAN "Alpha-centractin, Centractin (ARP1) (Actin-RPV) (Centrosome-associated actin homolog)" ACTR1A CTRN1 Homo sapiens (Human) vesicle-mediated transport [GO:0016192] cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630] cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524] GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005875; GO:0015630; GO:0016192; GO:0070062; GO:0099738 TLFSNIVLSGGSTLFKGFGDR 2.700000048 0.437011212 0.437011212 0.135762499 2217.26398 0 0 13.62663 0 0 12.78847 0 13.40104 0 0 0 0 0 0 0 0 0 0 13.65106 13.65037 9.292399 0 0 0 0 0 0 0 0 14.56339 15.32007 0 12.77944 0 0 0 15.30232 16.13754 15.08464 0 12.15085 0 12.81324 0 14.18086 14.31452 15.17937 0 P61201 CSN2_HUMAN "COP9 signalosome complex subunit 2, SGN2, Signalosome subunit 2 (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15, TR-interacting protein 15, TRIP-15)" COPS2 CSN2 TRIP15 Homo sapiens (Human) inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366] transcription corepressor activity [GO:0003714] GO:0000122; GO:0000338; GO:0001833; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0006468; GO:0007165; GO:0008180; GO:0030182; GO:0035914; GO:0045116; GO:1903507; GO:2000434 LIKPYTR 4.010000229 1 1 0.059153718 890.7752899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.28129 0 0 0 0 0 0 0 0 13.92666 0 14.10992 0 0 0 16.24621 14.3773 15.31028 0 15.24331 0 0 0 0 0 0 0 0 0 0 0 0 0 P61244 MAX_HUMAN "Protein max (Class D basic helix-loop-helix protein 4, bHLHd4) (Myc-associated factor X)" MAX BHLHD4 Homo sapiens (Human) "cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0009267; GO:0010629; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042802; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070443; GO:0070888; GO:0071339; GO:0071375; GO:0071943; GO:0090575; GO:0140297; GO:1990837 DSFHSLRDSVPSLQGEK 12.68000031 1 1 0.270902077 1900.63509 17.72794 16.50704 17.01423 0 17.29532 16.5927 0 0 0 0 17.70909 0 17.24209 16.80796 15.45485 16.49004 13.24023 0 15.26901 8.203424 0 17.62894 15.78084 0 0 14.27602 17.39834 17.33095 15.61121 0 19.41022 16.86159 18.41092 0 0 15.15089 16.17355 0 18.95889 0 10.66511 16.50875 13.82006 12.42288 9.749958 0 15.44725 0 P61247 RS3A_HUMAN "40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein, Fte-1)" RPS3A FTE1 MFTL Homo sapiens (Human) cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; translation [GO:0006412]; translational initiation [GO:0006413] mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0022626; GO:0022627; GO:0030154; GO:0043066; GO:0045202; GO:0048027; GO:0070062; GO:1990904 ADGYEPPVQESV 8.409999847 1 1 0.069406716 1290.938918 0 14.74291 0 0 0 12.04976 13.0242 16.36042 0 0 0 0 0 0 0 11.06535 0 0 0 0 0 0 13.03507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.38091 0 0 0 0 0 0 10.78271 0 P61353 RL27_HUMAN 60S ribosomal protein L27 (Large ribosomal subunit protein eL27) RPL27 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:0098556; GO:1904044; GO:1990904 KVTAAMGK 7.050000191 0.558614373 0.558614373 0.108410792 806.6292541 17.26147 14.24074 0 16.78574 14.95897 0 0 17.06932 15.89031 13.17008 16.72236 0 17.68881 14.63709 12.6584 15.53977 16.0803 14.09647 15.54113 15.16949 17.25462 17.0257 14.977 14.49234 9.503288 14.48913 0 14.69454 0 15.52198 14.75359 0 17.07886 15.20875 15.16533 15.51533 15.98466 14.0979 16.59282 15.31467 14.8095 13.47116 13.90247 13.3598 15.69307 15.89164 15.7113 17.97311 P61371 ISL1_HUMAN "Insulin gene enhancer protein ISL-1, Islet-1" ISL1 Homo sapiens (Human) atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]" "bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003151; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0005737; GO:0006357; GO:0007409; GO:0007507; GO:0008284; GO:0010575; GO:0010718; GO:0016922; GO:0021520; GO:0021522; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0031333; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042531; GO:0043388; GO:0043425; GO:0043524; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0046872; GO:0048665; GO:0048762; GO:0048880; GO:0048936; GO:0050680; GO:0050728; GO:0055010; GO:0060037; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0060931; GO:0061629; GO:0071385; GO:0071657; GO:0086091; GO:0090090; GO:1901258; GO:1990837; GO:1990841 GDMGDPPK 9.270000458 0.348409742 0.348409742 0.275328333 833.3865978 0 19.02407 17.65172 14.3324 16.79147 16.7478 0 0 18.44608 17.07923 15.44255 17.79753 16.42121 0 0 18.21831 17.64329 18.58777 15.82037 0 17.35375 0 0 0 18.54749 0 19.34115 17.06456 0 18.31031 0 0 0 19.48832 19.71513 0 20.12254 19.46807 21.85934 0 16.3935 16.85104 0 18.35456 19.19306 16.90444 18.16792 17.95912 P61513 RL37A_HUMAN 60S ribosomal protein L37a (Large ribosomal subunit protein eL43) RPL37A Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0046872; GO:0070062 RAVGIWHCGSCMK 2.920000076 0.350984991 0.350984991 0.185271292 1577.774634 15.29668 16.1535 15.48002 0 15.58383 15.75628 19.02723 16.94605 0 15.12767 16.50735 15.78433 0 15.88444 16.70549 0 14.39799 18.05973 16.94299 15.60337 13.38042 0 0 0 15.3623 15.45128 18.25026 14.46656 0 17.15973 13.83227 0 15.7535 17.1947 0 16.32485 18.00377 0 17.53221 0 17.26975 15.85468 17.632 0 17.43632 16.20571 18.58842 0 P61579 ERK25_HUMAN Endogenous retrovirus group K member 25 Rec protein (Endogenous retrovirus group K member 25) (HERV-K_11q22.1 provirus Rec protein) ERVK-25 Homo sapiens (Human) mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; mRNA transport [GO:0051028] RNA binding [GO:0003723] GO:0003723; GO:0005730; GO:0005737; GO:0051028 MNPSEMQR 9.359999657 1 1 0.2501761 991.3764034 0 0 0 15.35571 15.86321 0 14.7604 14.59022 15.1144 13.47237 15.371 16.50225 13.31997 14.93731 14.13466 12.55839 0 15.23374 0 0 15.68135 0 15.98541 14.38985 16.72923 15.49701 0 14.44375 0 13.92139 16.58742 16.38402 16.1684 14.63043 0 0 0 0 0 0 16.72778 0 15.63585 14.49798 14.193 0 0 0 P61647 SIA8F_HUMAN "Alpha-2,8-sialyltransferase 8F, EC 2.4.99.- (Sialyltransferase 8F, SIAT8-F) (Sialyltransferase St8Sia VI, ST8SiaVI)" ST8SIA6 SIAT8F Homo sapiens (Human) blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]" "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]" GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006486; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016021; GO:0016051 ARILVEESR 27.68000031 0.999402642 0.999402642 0.305707961 1072.919176 18.27632 18.81347 0 0 0 16.24295 0 0 0 0 0 0 16.30232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.92376 0 0 18.77012 0 17.73869 0 0 0 0 0 0 0 16.85709 0 0 0 0 0 0 0 P61758 PFD3_HUMAN "Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1, VBP-1, VHL-binding protein 1)" VBP1 PFDN3 Homo sapiens (Human) microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082]; microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; tubulin complex assembly [GO:0007021] amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082] GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231; GO:0050821; GO:0051082; GO:1905907 GQIPEIK 6.75 1 1 0.237207895 783.7253118 16.80408 13.81115 17.56085 17.18659 16.21061 0 0 0 18.73739 0 16.93437 0 19.06334 0 0 0 0 17.3189 16.07871 18.49658 0 0 0 0 0 0 0 0 0 0 0 0 18.93488 0 0 20.21969 17.08991 0 16.8779 17.73617 0 0 17.80548 16.73694 0 18.99746 0 17.91818 P61764 STXB1_HUMAN "Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1, Unc18-1) (Protein unc-18 homolog A, Unc-18A) (p67)" STXBP1 UNC18A Homo sapiens (Human) "axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]" identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] GO:0000149; GO:0002576; GO:0003006; GO:0003723; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007274; GO:0007412; GO:0010807; GO:0016082; GO:0016188; GO:0016192; GO:0017075; GO:0019901; GO:0019904; GO:0019905; GO:0030141; GO:0030424; GO:0031091; GO:0031333; GO:0031630; GO:0032229; GO:0032355; GO:0032991; GO:0035493; GO:0035542; GO:0042802; GO:0043274; GO:0043306; GO:0043524; GO:0045335; GO:0045956; GO:0047485; GO:0048471; GO:0048787; GO:0050821; GO:0060292; GO:0070062; GO:0070527; GO:0071346; GO:0072659; GO:0098794; GO:0098978; GO:0099525; GO:0106022; GO:1903296; GO:2000367 VLVVDQLSMR 9.109999657 0.805649102 0.805649102 0.246289698 1177.698571 19.3426 16.41288 0 0 0 18.50197 0 16.60851 16.94419 0 0 17.80223 19.44275 0 20.87889 20.27939 19.47934 20.17008 20.64961 21.23249 0 19.37313 20.61532 20.00376 0 19.69909 20.06455 0 20.29529 20.4872 19.00351 20.74852 19.37513 21.11993 20.79391 20.50785 21.39771 20.5324 0 19.47315 19.84653 21.17811 20.66276 20.77619 20.75217 20.96748 0 20.10077 P61812 TGFB2_HUMAN "Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor, G-TSF) [Cleaved into: Latency-associated peptide, LAP; Transforming growth factor beta-2, TGF-beta-2 ]" TGFB2 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060] axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126] axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]; activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060] amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714] GO:0000902; GO:0001501; GO:0001540; GO:0001654; GO:0001666; GO:0001822; GO:0001837; GO:0001843; GO:0001942; GO:0003007; GO:0003148; GO:0003149; GO:0003179; GO:0003181; GO:0003184; GO:0003203; GO:0003215; GO:0003222; GO:0003274; GO:0003289; GO:0003407; GO:0005102; GO:0005114; GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0005886; GO:0006468; GO:0007179; GO:0007435; GO:0007507; GO:0008083; GO:0008219; GO:0008284; GO:0008285; GO:0008347; GO:0008584; GO:0009410; GO:0009611; GO:0009792; GO:0010002; GO:0010629; GO:0010634; GO:0010693; GO:0010718; GO:0010862; GO:0010936; GO:0014068; GO:0016477; GO:0016525; GO:0030097; GO:0030199; GO:0030307; GO:0030308; GO:0030326; GO:0030424; GO:0030509; GO:0030593; GO:0031069; GO:0031093; GO:0032147; GO:0032570; GO:0032874; GO:0032909; GO:0033630; GO:0034714; GO:0035910; GO:0042060; GO:0042127; GO:0042416; GO:0042476; GO:0042704; GO:0042803; GO:0043025; GO:0043525; GO:0045216; GO:0045726; GO:0045747; GO:0045778; GO:0045787; GO:0045823; GO:0046580; GO:0048103; GO:0048566; GO:0048666; GO:0048699; GO:0048839; GO:0050680; GO:0050714; GO:0050778; GO:0051781; GO:0051794; GO:0051795; GO:0051891; GO:0060038; GO:0060065; GO:0060317; GO:0060389; GO:0060395; GO:0060412; GO:0060413; GO:0061626; GO:0062009; GO:0062023; GO:0097191; GO:0099126; GO:1902256; GO:1902895; GO:1903701; GO:1904888; GO:1905006; GO:1905007 GQILSKLK 10.57999992 0.357692569 0.357692569 0.190400743 885.0542485 16.87346 0 0 0 15.6776 16.67971 0 0 10.47238 0 18.17506 15.10554 14.33381 15.92828 0 15.95972 14.77444 0 0 0 0 13.78636 17.80945 0 17.1497 0 16.2962 0 0 18.4584 17.8111 15.88247 14.3842 17.27933 18.61825 0 18.60328 14.84589 0 0 0 17.26026 0 0 0 0 0 17.36394 P61916 NPC2_HUMAN "NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)" NPC2 HE1 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934] GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0015485; GO:0015914; GO:0015918; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0032934; GO:0033344; GO:0035578; GO:0042632; GO:0043202; GO:0046836; GO:0070062; GO:0120020 TYSYLNK 6.760000229 0.399758875 0.399758875 0.028845245 889.0592815 15.00363 16.19634 17.3354 15.80115 14.67489 0 10.10945 0 17.62313 0 0 14.26074 12.44512 17.29483 0 0 14.31972 0 14.60329 15.6572 14.16262 15.089 17.09136 17.96355 17.93556 14.55697 16.88331 0 0 13.84806 0 15.25964 16.47277 0 10.12378 14.72219 16.95601 16.80511 16.78062 16.82352 12.38201 16.90943 16.93844 0 13.93016 15.38718 0 0 P61923 COPZ1_HUMAN "Coatomer subunit zeta-1 (Zeta-1-coat protein, Zeta-1 COP)" COPZ1 COPZ CGI-120 HSPC181 Homo sapiens (Human) "intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]" GO:0000139; GO:0005789; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:1901998 AILILDNDGDR 1.549999952 1 1 9.24E-13 1211.882594 11.0971 13.90069 0 0 0 12.06463 13.29102 11.74971 10.69058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.00952 0 19.05616 0 0 0 0 P61962 DCAF7_HUMAN DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog) DCAF7 HAN11 WDR68 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-macromolecule adaptor activity [GO:0030674]; protein ubiquitination [GO:0016567] protein-macromolecule adaptor activity [GO:0030674] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016363; GO:0016567; GO:0016604; GO:0030674; GO:0032991; GO:0080008 QDPNYLATMAMDGMEVVILDVR 11 1 1 3.66E-12 2496.019923 0 13.3188 0 15.73139 8.734538 14.50779 9.74501 0 0 16.03922 0 0 11.88614 0 0 12.24318 11.52548 0 0 0 0 0 16.10292 0 14.43992 14.78461 13.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.61645 0 P62072 TIM10_HUMAN Mitochondrial import inner membrane translocase subunit Tim10 TIMM10 TIM10 Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087 MTSACHRK 3.24000001 1 1 0.106096322 991.360414 0 0 0 17.69032 15.53749 0 13.12465 15.68918 0 15.57117 13.58727 13.99654 15.23953 0 10.57698 0 0 15.91818 13.93851 0 0 0 0 14.81614 16.73969 0 0 15.06065 14.0537 12.12824 15.9375 15.61142 14.17149 0 15.33056 11.44668 0 16.35036 16.17524 14.51002 16.20951 0 0 15.4084 0 16.1622 0 0 P62081 RS7_HUMAN 40S ribosomal protein S7 (Small ribosomal subunit protein eS7) RPS7 Homo sapiens (Human) cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] GO:0001843; GO:0002181; GO:0003723; GO:0003730; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0010628; GO:0016020; GO:0019901; GO:0022626; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059 LIKVHLDK 3.24000001 1 1 1.15E-13 963.707274 0 0 14.70838 12.71924 0 0 0 0 0 16.08955 0 0 14.89406 0 0 9.898818 0 0 0 0 0 0 0 0 0 17.22884 0 0 0 0 0 17.01875 0 13.40938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62140 PP1B_HUMAN "Serine/threonine-protein phosphatase PP1-beta catalytic subunit, PP-1B, PPP1CD, EC 3.1.3.16, EC 3.1.3.53" PPP1CB Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722] GO:0000164; GO:0000165; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005977; GO:0005979; GO:0005981; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042587; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0070062; GO:0072357 FNIKLWK 12.52999973 1 1 0.230373783 948.5178591 0 16.93631 18.18767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.65945 0 0 0 0 17.47104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62191 PRS4_HUMAN "26S proteasome regulatory subunit 4, P26s4 (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)" PSMC1 Homo sapiens (Human) negative regulation of neuron death [GO:1901215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]" "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]; negative regulation of neuron death [GO:1901215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025] GO:0000502; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043161; GO:1901215 MGQSQSGGHGPGGGKK 3.140000105 1 1 0.260925691 1468.161036 0 0 0 0 0 0 12.61802 0 0 0 0 0 0 0 0 0 16.26883 0 0 0 0 0 0 0 0 0 16.59932 0 14.2889 12.6635 15.42267 15.72352 0 0 16.31667 0 0 17.28601 0 17.91127 16.17661 15.31197 14.65599 14.52235 15.96178 0 0 17.07542 P62249 RS16_HUMAN 40S ribosomal protein S16 (Small ribosomal subunit protein uS9) RPS16 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]" RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0015935; GO:0016020; GO:0022626; GO:0022627; GO:0042274; GO:0070062; GO:1990830 GGGHVAQIYAIR 7.860000134 0.261804909 0.261804909 0.051579894 1242.120463 0 11.46271 0 0 12.84164 0 14.36516 0 12.35209 11.41752 0 9.725883 0 13.08104 0 0 0 0 0 10.2862 12.96654 0 0 0 12.15728 0 10.7781 0 12.64234 0 0 0 0 0 0 0 0 0 0 0 0 14.76481 0 14.44518 0 13.80111 11.26174 0 P62253 UB2G1_HUMAN "Ubiquitin-conjugating enzyme E2 G1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed ]" UBE2G1 UBE2G Homo sapiens (Human) cellular protein catabolic process [GO:0044257]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0044257; GO:0061631; GO:0070062; GO:0070534; GO:0070936 MTELQSALLLRR 3.700000048 1 1 4.63E-13 1444.463123 0 0 0 0 16.61692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68757 0 0 0 0 0 0 0 0 0 0 0 0 P62263 RS14_HUMAN 40S ribosomal protein S14 (Small ribosomal subunit protein uS11) RPS14 PRO2640 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182] GO:0000028; GO:0000122; GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022626; GO:0022627; GO:0030218; GO:0030490; GO:0045182; GO:0048027; GO:0070062; GO:0070181 TKTPGPGAQSALR 4.230000019 1 1 0.332956221 1284.641868 15.72281 0 15.19549 15.03942 14.98009 14.14027 0 0 13.7882 14.96733 0 0 0 0 0 0 0 0 16.11832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62266 RS23_HUMAN 40S ribosomal protein S23 (Small ribosomal subunit protein uS12) RPS23 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005840; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0034063; GO:0042788; GO:0045202; GO:1990145 ANPFGGASHAK 2.839999914 1 1 0.240183357 1055.873331 0 14.99058 14.2101 0 0 0 14.76186 16.97686 15.98914 16.84521 0 14.54981 0 0 0 0 0 0 0 0 0 0 15.80278 0 0 15.47655 13.93261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62304 RUXE_HUMAN "Small nuclear ribonucleoprotein E, snRNP-E (Sm protein E, Sm-E, SmE)" SNRPE Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" RNA binding [GO:0003723] GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013 VQKVMVQPINLIFR 17.59000015 1 1 0.172466673 1696.933827 0 0 0 15.65855 0 0 17.26033 0 15.77932 0 0 16.03246 0 17.43492 16.99095 0 0 0 0 0 0 0 16.49808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.14919 0 0 0 0 0 0 0 P62312 LSM6_HUMAN U6 snRNA-associated Sm-like protein LSm6 LSM6 Homo sapiens (Human) "maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]" protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005730; GO:0005732; GO:0005737; GO:0005829; GO:0006402; GO:0008033; GO:0008380; GO:0030490; GO:0030532; GO:0046540; GO:0046982; GO:0071005; GO:0120115 LNSGVDYR 13.43999958 0.65057075 0.65057075 0.249136048 922.4132202 15.89528 14.62244 16.94974 16.78567 15.50045 0 15.48272 11.51796 0 17.76616 0 0 16.48379 15.613 16.54691 16.0669 0 15.39255 13.37689 0 0 16.93709 0 15.38431 17.11794 16.42903 17.28361 0 0 16.57635 15.57691 18.66901 14.39855 15.45613 17.3025 16.35244 0 0 17.47309 0 16.6826 14.55964 0 0 15.65208 0 16.96508 0 P62314 SMD1_HUMAN "Small nuclear ribonucleoprotein Sm D1, Sm-D1 (Sm-D autoantigen) (snRNP core protein D1)" SNRPD1 Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446] GO:0000243; GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526; GO:1990446 MTLKNR 8.960000038 1 1 0.137678744 761.4255694 0 15.713 15.20479 14.50589 0 0 15.82324 15.16524 0 15.09699 0 13.77977 0 0 13.45716 15.37381 0 0 0 0 15.02419 0 0 16.01647 16.1534 15.94038 16.34572 0 0 0 0 0 0 16.48492 15.86452 0 0 0 0 0 15.78171 15.24895 0 0 0 0 16.26159 0 P62316 SMD2_HUMAN "Small nuclear ribonucleoprotein Sm D2, Sm-D2 (snRNP core protein D2)" SNRPD2 SNRPD1 Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" RNA binding [GO:0003723] GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0070062; GO:0071005; GO:0071007; GO:0071011; GO:0071013 KSKPVNK 5.070000172 1 1 0.164062315 799.899837 14.94933 14.52427 15.5707 18.14825 0 0 0 14.96361 11.44918 14.64293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.03816 0 15.04996 0 0 0 0 0 0 0 15.71993 0 0 0 0 0 P62495 ERF1_HUMAN "Eukaryotic peptide chain release factor subunit 1, Eukaryotic release factor 1, eRF1 (Protein Cl1) (TB3-1)" ETF1 ERF1 RF1 SUP45L1 Homo sapiens (Human) "cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]" "ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]" GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0005737; GO:0005829; GO:0006415; GO:0006449; GO:0006479; GO:0008079; GO:0016149; GO:0018444; GO:0043022; GO:1990825 SLEAARGNGTSMISLIIPPK 1.610000014 1 1 0.063206538 2054.305733 13.43222 0 14.88673 11.43059 15.95656 0 0 15.12256 0 0 0 0 0 0 0 12.80817 13.14727 0 10.75036 0 0 0 12.1068 0 0 0 0 0 0 0 11.66459 14.90301 0 15.10764 11.93452 0 0 0 0 0 0 0 0 0 0 0 0 0 P62508 ERR3_HUMAN Estrogen-related receptor gamma (ERR gamma-2) (Estrogen receptor-related protein 3) (Nuclear receptor subfamily 3 group B member 3) ESRRG ERR3 ERRG2 KIAA0832 NR3B3 Homo sapiens (Human) "positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]" "AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003707; GO:0004879; GO:0005496; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0034056; GO:0042802; GO:0045944; GO:0048384; GO:0050682; GO:0120162; GO:1990837 MSNKDR 7.559999943 0.132377043 0.132377043 0.226315628 766.2520159 0 15.02199 12.85774 0 0 14.78592 0 14.80348 0 15.7654 15.67385 0 15.11805 0 0 15.66319 14.45765 15.77142 11.30777 15.31869 0 15.82958 16.68583 16.59477 16.41713 15.57313 16.89854 15.3963 14.03243 15.43801 15.5909 14.75794 15.06096 14.20164 15.13606 0 15.96156 16.56681 17.03652 15.78589 15.11249 0 16.16484 15.6466 0 17.5347 16.45448 13.29746 P62699 YPEL5_HUMAN Protein yippee-like 5 YPEL5 CGI-127 Homo sapiens (Human) cell population proliferation [GO:0008283] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell population proliferation [GO:0008283] metal ion binding [GO:0046872] GO:0000151; GO:0005576; GO:0005634; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431; GO:1904724; GO:1904813 IFLDHIGGTRLFSCANCDTILTNR 3.420000076 1 1 0.257846168 2793.387312 0 0 0 0 13.0979 0 15.77623 12.72061 14.25091 0 15.48024 15.3136 15.01217 0 16.27109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.50731 0 0 15.85072 0 0 13.27119 0 12.32614 0 0 0 P62701 RS4X_HUMAN "40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)" RPS4X CCG2 RPS4 SCAR Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; translation [GO:0006412] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; translation [GO:0006412] RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005829; GO:0005840; GO:0005844; GO:0005925; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0036464; GO:0045202; GO:0045727; GO:0070062; GO:1990904 IFVGTK 3.5 1 1 0.184863866 660.2809816 0 0 0 0 0 0 0 0 0 15.42138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.32588 14.67406 16.19633 0 17.59393 15.11211 0 0 15.66757 16.25126 15.30504 0 17.29513 15.89993 15.30664 16.14176 16.28561 0 14.45216 16.68844 0 16.80134 0 0 P62750 RL23A_HUMAN 60S ribosomal protein L23a (Large ribosomal subunit protein uL23) RPL23A Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841] GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0019843; GO:0022625; GO:0022626; GO:0045296; GO:0070062; GO:1904841 AEAKAK 4.5 1 1 0.272296924 618.5479879 18.02871 0 0 17.98967 16.3672 17.69796 0 16.74787 0 19.64554 0 0 0 0 17.30378 16.50912 0 0 0 0 0 16.4812 0 0 0 0 0 0 0 0 0 19.85608 18.11066 0 17.40999 16.9273 0 0 0 0 0 0 0 0 0 15.83907 17.05518 16.97594 P62760 VISL1_HUMAN "Visinin-like protein 1, VILIP, VLP-1 (Hippocalcin-like protein 3, HLP3)" VSNL1 VISL1 Homo sapiens (Human) negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] calcium ion binding [GO:0005509] GO:0005509; GO:0005829; GO:0016020; GO:0035774; GO:0045921; GO:0046676 ITRVEMLEIIEAIYK 5.920000076 1 1 2.29E-12 1838.026933 14.24954 13.7137 12.63508 16.08727 11.32512 11.58822 13.71248 13.57839 16.10073 15.31514 0 14.49613 14.8768 12.10101 0 9.161159 0 0 0 0 0 0 17.44812 0 0 0 0 11.8529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62805 H4_HUMAN Histone H4 H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4 Homo sapiens (Human) "chromatin assembly or disassembly [GO:0006333]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein localization to CENP-A containing chromatin [GO:0061644]; telomere organization [GO:0032200]" "CENP-A containing nucleosome [GO:0043505]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "CENP-A containing nucleosome [GO:0043505]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; chromatin assembly or disassembly [GO:0006333]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein localization to CENP-A containing chromatin [GO:0061644]; telomere organization [GO:0032200]" DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] GO:0000228; GO:0000781; GO:0000786; GO:0003677; GO:0003723; GO:0005576; GO:0005634; GO:0005654; GO:0006333; GO:0006334; GO:0006335; GO:0006336; GO:0006352; GO:0016020; GO:0019904; GO:0032200; GO:0032991; GO:0043505; GO:0045653; GO:0046982; GO:0061644; GO:0070062 DNIQGITKPAIR 8.270000458 1 1 0.600376309 1325.258649 17.6842 18.69282 18.65944 18.15025 18.03087 0 0 0 18.82685 18.13805 18.04042 0 0 0 0 0 0 0 0 0 0 0 0 0 18.89689 18.53666 18.9112 0 20.62943 0 0 0 0 19.49536 0 0 0 0 0 0 0 0 0 0 19.04379 0 16.71337 18.63189 P62841 RS15_HUMAN 40S ribosomal protein S15 (RIG protein) (Small ribosomal subunit protein uS19) RPS15 RIG Homo sapiens (Human) cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]; osteoblast differentiation [GO:0001649]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]; osteoblast differentiation [GO:0001649]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412] DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] GO:0000028; GO:0000056; GO:0001649; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0042274; GO:0045202; GO:0097371; GO:0097421; GO:1901798; GO:1990948 KEAPPMEKPEVVK 10.46000004 1 1 0.178727415 1497.720369 17.16512 15.96383 13.56403 0 0 0 0 0 14.63402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.60145 0 0 13.78459 12.94157 0 0 0 12.02116 16.13244 14.03191 0 0 0 0 0 0 0 P62851 RS25_HUMAN 40S ribosomal protein S25 (Small ribosomal subunit protein eS25) RPS25 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006364; GO:0006412; GO:0014069; GO:0015935; GO:0022626; GO:0022627; GO:0042274; GO:0070062 GSLAR 27.59000015 0.13446945 0.13446945 0.227925871 503.2931449 0 0 16.67961 16.84442 17.50853 16.01312 0 0 0 16.98872 14.35327 0 14.938 16.0988 15.24763 0 15.27256 16.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 15.25155 0 17.25253 0 0 0 17.11947 0 0 0 0 0 0 0 0 0 0 P62879 GBB2_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2) GNB2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; G protein-coupled receptor signaling pathway [GO:0007186] GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159] GO:0003924; GO:0005615; GO:0005737; GO:0005765; GO:0005829; GO:0005834; GO:0005925; GO:0007186; GO:0016020; GO:0030159; GO:0031982; GO:0044877; GO:0048471; GO:0051020; GO:0070062 AGVLAGHDNR 7.039999962 1 1 0.157611261 1010.521439 0 0 15.78585 11.63188 0 12.95902 0 14.52889 13.33796 0 17.2089 15.07308 14.60708 14.5171 11.74643 12.39805 12.2894 15.26774 0 0 0 0 16.0326 12.2078 14.37364 0 0 0 0 0 0 0 0 0 16.18712 0 17.28576 0 0 15.86362 0 0 0 0 0 14.28014 14.82069 0 P62906 RL10A_HUMAN "60S ribosomal protein L10a (CSA-19) (Large ribosomal subunit protein uL1) (Neural precursor cell expressed developmentally down-regulated protein 6, NEDD-6)" RPL10A NEDD6 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0070062 AGKFPSLLTHNENMVAK 4.420000076 1 1 0.41821146 1856.957441 15.45908 0 0 15.30325 0 13.86132 0 0 0 15.70649 0 16.43372 0 15.69605 13.92162 15.01803 0 0 0 0 0 0 15.64089 0 14.55178 0 0 14.70335 16.99566 0 0 0 0 0 0 0 0 0 17.45941 15.89241 0 0 0 0 0 0 0 0 P62913 RL11_HUMAN 60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5) RPL11 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0006605; GO:0008097; GO:0010628; GO:0016020; GO:0022625; GO:0022626; GO:0031625; GO:0032092; GO:0032435; GO:0032991; GO:0034504; GO:0042273; GO:0042788; GO:0050821; GO:0070062; GO:1901796; GO:1904667; GO:1990948; GO:2000059; GO:2000435 RTGCIGAK 5.480000019 0.97114116 0.97114116 0.193695788 861.8029938 0 0 0 0 0 14.92458 0 0 0 0 0 0 16.63341 0 15.96835 0 0 16.76106 16.90626 0 0 17.04296 16.70572 0 15.99127 15.97047 16.53276 15.5749 17.16523 14.66697 15.89528 14.59376 15.3806 14.76406 0 15.7519 0 18.60434 0 14.81109 15.6129 17.90733 0 0 0 17.77989 16.30108 15.70098 P62917 RL8_HUMAN 60S ribosomal protein L8 (Large ribosomal subunit protein uL2) RPL8 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0019843; GO:0022625; GO:0022626; GO:0042788; GO:0098794 DAPAGR 2.789999962 0.125394166 0.125394166 0.17924101 587.4815874 0 0 0 15.28645 0 0 0 0 0 0 0 14.15033 15.74908 15.73772 15.25952 0 16.51171 16.70033 0 17.66064 0 14.60681 0 16.32406 16.58177 0 15.80728 16.34484 15.70434 16.58496 16.70559 15.7806 16.11666 16.88462 16.59237 16.1292 17.36728 17.44714 0 15.38239 17.84591 17.14762 16.59292 17.54695 16.91042 16.48071 17.63082 17.53618 P62942 FKB1A_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP1A, PPIase FKBP1A, EC 5.2.1.8 (12 kDa FK506-binding protein, 12 kDa FKBP, FKBP-12) (Calstabin-1) (FK506-binding protein 1A, FKBP-1A) (Immunophilin FKBP12) (Rotamase)" FKBP1A FKBP1 FKBP12 Homo sapiens (Human) 'de novo' protein folding [GO:0006458]; amyloid fibril formation [GO:1990000]; calcium ion transmembrane transport [GO:0070588]; chaperone-mediated protein folding [GO:0061077]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell activation [GO:0042110]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; terminal cisterna [GO:0014802]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; FK506 binding [GO:0005528]; macrolide binding [GO:0005527]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; transmembrane transporter binding [GO:0044325]; type I transforming growth factor beta receptor binding [GO:0034713]; 'de novo' protein folding [GO:0006458]; amyloid fibril formation [GO:1990000]; calcium ion transmembrane transport [GO:0070588]; chaperone-mediated protein folding [GO:0061077]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell activation [GO:0042110]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] activin binding [GO:0048185]; FK506 binding [GO:0005528]; macrolide binding [GO:0005527]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; transmembrane transporter binding [GO:0044325]; type I transforming growth factor beta receptor binding [GO:0034713] GO:0000413; GO:0003007; GO:0003755; GO:0005160; GO:0005527; GO:0005528; GO:0005737; GO:0005829; GO:0006457; GO:0006458; GO:0007183; GO:0014802; GO:0016020; GO:0016529; GO:0022417; GO:0030018; GO:0030512; GO:0031312; GO:0031398; GO:0032092; GO:0032515; GO:0032880; GO:0032925; GO:0034713; GO:0042026; GO:0042110; GO:0043123; GO:0044325; GO:0046332; GO:0048185; GO:0050776; GO:0055010; GO:0060314; GO:0060347; GO:0061077; GO:0070588; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425 GVQVETISPGDGRTFPK 2.019999981 1 1 0.355696879 1788.660791 14.9806 0 13.52266 0 15.88729 15.57154 0 14.31106 0 0 15.12129 15.56596 0 15.94261 0 0 0 15.34679 0 0 14.5195 0 0 0 0 0 0 0 0 0 0 0 16.5132 0 0 0 15.73967 0 0 0 0 15.28306 14.31856 15.86095 0 0 16.14652 0 P62979 RS27A_HUMAN Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a (Small ribosomal subunit protein eS31) ] RPS27A UBA80 UBCEP1 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412] metal ion binding [GO:0046872]; protein tag [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625] GO:0002181; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0005886; GO:0006412; GO:0010008; GO:0015935; GO:0016020; GO:0016567; GO:0019941; GO:0022626; GO:0022627; GO:0030666; GO:0031386; GO:0031625; GO:0031982; GO:0046872; GO:0070062 ECPSDECGAGVFMASHFDR 5.090000153 0.737137556 0.737137556 9.17E-13 2187.665899 0 13.68255 0 0 0 0 0 0 0 0 14.37717 0 0 0 0 0 0 0 0 0 0 0 0 0 12.84867 0 0 0 0 0 0 0 13.05967 0 15.16888 0 0 0 0 12.50515 15.41513 0 16.42677 0 0 0 14.12745 0 P62995 TRA2B_HUMAN "Transformer-2 protein homolog beta, TRA-2 beta, TRA2-beta, hTRA2-beta (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)" TRA2B SFRS10 Homo sapiens (Human) "cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]" nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681] "nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]" identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0071333; GO:1990403 RHVGNR 16.65999985 0.188871741 0.188871741 0.252866801 738.0982895 21.35303 21.75138 21.0042 20.67184 21.5294 18.45864 20.90093 17.50442 17.81156 23.66089 22.39239 20.41472 21.64298 21.67666 22.2518 19.09248 21.69338 22.2335 18.52192 22.34629 22.03534 21.39548 21.96998 20.93264 22.2586 21.69568 22.1257 19.02243 22.39345 22.46122 19.27356 22.20298 23.23166 20.07294 18.55356 21.05899 21.07968 20.26331 19.22321 22.68487 0 21.22766 22.47094 17.90149 21.75358 22.14205 22.30303 22.22487 P63010 AP2B1_HUMAN AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit) AP2B1 ADTB2 CLAPB1 Homo sapiens (Human) aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin adaptor complex [GO:0030131]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] AP-2 adaptor complex [GO:0030122]; clathrin adaptor complex [GO:0030131]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; signal sequence binding [GO:0005048]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192] clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; signal sequence binding [GO:0005048] GO:0001822; GO:0003281; GO:0005048; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0016020; GO:0016192; GO:0030122; GO:0030131; GO:0030276; GO:0030666; GO:0030669; GO:0035904; GO:0036020; GO:0044877; GO:0045334; GO:0045807; GO:0048268; GO:0048488; GO:0060976; GO:0072583; GO:0098793; GO:0098794; GO:0098884; GO:0098978; GO:1901215; GO:1905477 AKGLEISGTFTHR 13.89000034 0.72466588 0.72466588 0.562874709 1416.5803 18.38314 15.5886 18.92485 0 16.7352 0 0 0 0 0 0 0 17.31833 0 18.0609 0 17.53606 0 0 0 0 0 0 0 0 0 0 0 16.94509 0 0 0 0 0 0 0 17.53762 21.44996 19.00719 0 0 0 0 0 0 0 0 0 P63208 SKP1_HUMAN "S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19, p19A) (Organ of Corti protein 2, OCP-2) (Organ of Corti protein II, OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1)" SKP1 EMC19 OCP2 SKP1A TCEB1L Homo sapiens (Human) histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0008013; GO:0016567; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0035518; GO:0051457; GO:0070936; GO:0097602; GO:1904668; GO:1990444; GO:1990756 KVIQWCTHHK 2.819999933 1 1 0.182024698 1336.27379 0 0 15.58512 14.19685 0 0 15.27904 0 0 13.56422 0 0 15.0919 16.00498 14.92476 0 0 15.55719 0 0 0 0 0 0 0 0 0 16.33232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63211 GBG1_HUMAN Guanine nucleotide-binding protein G(T) subunit gamma-T1 (Transducin gamma chain) GNGT1 Homo sapiens (Human) cardiac muscle cell apoptotic process [GO:0010659]; cellular response to hypoxia [GO:0071456]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein localization [GO:0008104]; signal transduction [GO:0007165] heterotrimeric G-protein complex [GO:0005834]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917] heterotrimeric G-protein complex [GO:0005834]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to hypoxia [GO:0071456]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein localization [GO:0008104]; signal transduction [GO:0007165] G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924] GO:0001917; GO:0003924; GO:0005834; GO:0007165; GO:0007186; GO:0007602; GO:0008104; GO:0010659; GO:0031681; GO:0042462; GO:0071456; GO:0097381 KEVTLER 6.010000229 0.720902443 0.720902443 0.183641934 874.7345254 0 18.14283 13.22206 14.99033 0 16.32693 0 0 15.21856 0 0 15.93334 10.54984 0 0 13.48968 0 0 15.26335 0 0 0 16.50496 0 13.986 14.34479 13.98558 0 14.40165 14.78197 16.37385 16.11816 14.55875 11.15514 14.8934 14.61258 13.47948 14.2201 13.05504 13.1854 15.68504 15.25999 12.86671 14.93482 15.48123 16.09286 14.88171 0 P63218 GBG5_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 GNG5 GNGT5 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165] GO:0003924; GO:0005834; GO:0005886; GO:0007165; GO:0007186; GO:0016020; GO:0030165; GO:0031681; GO:0070062 SGSSSVAAMKK 5.590000153 1 1 0.052555223 1068.253645 15.01276 0 15.26174 14.71696 13.75192 15.65383 16.98365 14.87683 0 9.820301 0 0 0 15.79417 0 0 0 13.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63261 ACTG_HUMAN "Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed ]" ACTG1 ACTG Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to interferon-gamma [GO:0071346]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of a polarized epithelium [GO:0001738]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of transepithelial transport [GO:0150111]; response to calcium ion [GO:0051592]; response to mechanical stimulus [GO:0009612]; retina homeostasis [GO:0001895]; sarcomere organization [GO:0045214]; synaptic vesicle endocytosis [GO:0048488]; tight junction assembly [GO:0120192] actin filament [GO:0005884]; apical junction complex [GO:0043296]; basal body patch [GO:0120220]; blood microparticle [GO:0072562]; calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane [GO:0016020]; myofibril [GO:0030016]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic actin cytoskeleton [GO:0099143]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament [GO:0005884]; apical junction complex [GO:0043296]; basal body patch [GO:0120220]; blood microparticle [GO:0072562]; calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane [GO:0016020]; myofibril [GO:0030016]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic actin cytoskeleton [GO:0099143]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; cellular response to interferon-gamma [GO:0071346]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of a polarized epithelium [GO:0001738]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of transepithelial transport [GO:0150111]; response to calcium ion [GO:0051592]; response to mechanical stimulus [GO:0009612]; retina homeostasis [GO:0001895]; sarcomere organization [GO:0045214]; synaptic vesicle endocytosis [GO:0048488]; tight junction assembly [GO:0120192] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625] GO:0001525; GO:0001738; GO:0001895; GO:0005200; GO:0005522; GO:0005524; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0009612; GO:0010628; GO:0016020; GO:0030016; GO:0030335; GO:0031625; GO:0031941; GO:0035633; GO:0042802; GO:0043296; GO:0044305; GO:0045214; GO:0045335; GO:0048488; GO:0051492; GO:0051592; GO:0051893; GO:0070062; GO:0070527; GO:0071346; GO:0072562; GO:0090303; GO:0097433; GO:0098685; GO:0098871; GO:0098973; GO:0099143; GO:0120192; GO:0120220; GO:0150111; GO:1902396 EEEIAALVIDNGSGMCK 6.630000114 1 1 0.474297403 1852.5328 18.42013 16.32761 0 18.8229 0 0 0 18.79424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.32844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63302 SELW_HUMAN "Selenoprotein W, SelW" SELENOW SELW SEPW1 Homo sapiens (Human) response to selenium ion [GO:0010269] cytosol [GO:0005829] cytosol [GO:0005829]; antioxidant activity [GO:0016209]; response to selenium ion [GO:0010269] antioxidant activity [GO:0016209] GO:0005829; GO:0010269; GO:0016209 AALAQG 9.31000042 0.041423291 0.041423291 2.31E-13 529.3177399 0 0 0 0 0 0 0 0 14.94238 0 0 0 14.39846 0 0 0 0 0 14.79496 0 0 0 0 0 0 0 0 14.04488 0 0 0 0 0 15.04064 0 0 0 15.76586 0 0 15.64652 0 0 0 0 0 0 0 P63313 TYB10_HUMAN Thymosin beta-10 TMSB10 PTMB10 THYB10 Homo sapiens (Human) actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989] actin monomer binding [GO:0003785] GO:0003785; GO:0005737; GO:0005856; GO:0007015; GO:0030334; GO:0042989 ETIEQEKR 11.75 1 1 0.02755552 1032.316491 13.7033 12.84306 0 15.56684 14.16307 0 0 0 13.00924 15.17639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63316 TNNC1_HUMAN "Troponin C, slow skeletal and cardiac muscles, TN-C" TNNC1 TNNC Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; regulation of ATP-dependent activity [GO:0043462]; regulation of muscle contraction [GO:0006937]; regulation of muscle filament sliding speed [GO:0032972]; response to metal ion [GO:0010038]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; troponin complex [GO:0005861] cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; troponin I binding [GO:0031013]; troponin T binding [GO:0031014]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; regulation of ATP-dependent activity [GO:0043462]; regulation of muscle contraction [GO:0006937]; regulation of muscle filament sliding speed [GO:0032972]; response to metal ion [GO:0010038]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; troponin I binding [GO:0031013]; troponin T binding [GO:0031014] GO:0002086; GO:0003009; GO:0005509; GO:0005829; GO:0005861; GO:0006937; GO:0010038; GO:0014883; GO:0031013; GO:0031014; GO:0032972; GO:0042803; GO:0043462; GO:0048306; GO:0051015; GO:0055010; GO:0060048; GO:1990584 MDDIYK 4.889999866 0.146289662 0.146289662 0.064132952 783.2452695 16.61732 8.454315 16.3296 15.87954 12.56158 16.41373 0 16.84114 15.44235 14.88545 0 0 11.74791 18.23301 11.47377 0 15.41045 14.62039 0 17.41368 14.20629 0 0 0 0 0 15.63671 0 16.47988 0 0 16.8874 16.49655 15.28295 17.49956 14.58214 15.76772 17.36232 16.30096 19.29443 16.65944 16.50573 0 16.41134 0 16.37299 14.51971 13.61186 P67870 CSK2B_HUMAN "Casein kinase II subunit beta, CK II beta (Phosvitin) (Protein G5a)" CSNK2B CK2N G5A Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102] GO:0003682; GO:0004674; GO:0005102; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005956; GO:0006468; GO:0007165; GO:0008285; GO:0010862; GO:0016055; GO:0018107; GO:0019887; GO:0019904; GO:0032927; GO:0033211; GO:0034774; GO:0042802; GO:0043537; GO:0046872; GO:0051101; GO:0061154; GO:0061629; GO:0065003; GO:0070062; GO:0080163; GO:1904813 FNLTGLNEQVPHYR 7.960000038 1 1 0.473899515 1686.918266 0 15.5569 19.28711 17.8104 0 0 0 0 0 0 0 19.89815 0 0 0 0 0 17.88873 0 0 17.63392 0 0 0 0 19.40433 20.39991 0 0 0 0 20.69477 0 0 19.03891 0 0 18.43144 18.3585 0 18.40112 0 17.64387 19.52315 0 0 0 0 P68104 EF1A1_HUMAN "Elongation factor 1-alpha 1, EF-1-alpha-1 (Elongation factor Tu, EF-Tu) (Eukaryotic elongation factor 1 A-1, eEF1A-1) (Leukocyte receptor cluster member 7)" EEF1A1 EEF1A EF1A LENG7 Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414] calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049] GO:0000049; GO:0003723; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005576; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005853; GO:0005886; GO:0006412; GO:0006414; GO:0016020; GO:0019900; GO:0019901; GO:0030864; GO:0032587; GO:0034774; GO:0070062; GO:0071364; GO:0098574; GO:1900022; GO:1904714; GO:1904813 YYVTIIDAPGHRDFIK 7.989999771 1 1 2.29E-13 1906.815646 15.14618 15.23615 0 14.92212 13.89657 0 0 0 0 0 0 0 14.53949 14.79672 0 15.61892 14.65371 0 15.36608 0 15.6158 0 17.59999 0 0 14.30936 0 16.16725 14.43173 0 15.61866 0 15.27784 16.39979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P68133 ACTS_HUMAN "Actin, alpha skeletal muscle (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form ]" ACTA1 ACTA Homo sapiens (Human) cellular response to organonitrogen compound [GO:0071417]; mesenchyme migration [GO:0090131]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; response to extracellular stimulus [GO:0009991]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to steroid hormone [GO:0048545]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; blood microparticle [GO:0072562]; cell body [GO:0044297]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; blood microparticle [GO:0072562]; cell body [GO:0044297]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cellular response to organonitrogen compound [GO:0071417]; mesenchyme migration [GO:0090131]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; response to extracellular stimulus [GO:0009991]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to steroid hormone [GO:0048545]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240] ADP binding [GO:0043531]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200] GO:0001725; GO:0005200; GO:0005524; GO:0005615; GO:0005829; GO:0005865; GO:0005869; GO:0005884; GO:0006936; GO:0009612; GO:0009991; GO:0010226; GO:0010628; GO:0015629; GO:0017022; GO:0030017; GO:0030027; GO:0030175; GO:0030240; GO:0043503; GO:0043531; GO:0044297; GO:0048545; GO:0048741; GO:0070062; GO:0071417; GO:0072562; GO:0090131 IIAPPERK 13.65999985 0.807957172 0.807957172 0.159065372 922.7909802 0 0 16.68257 17.50018 0 0 15.87307 16.45311 15.4604 16.27998 15.1031 18.22038 0 17.00347 0 0 0 14.69863 15.81218 14.56946 16.37766 0 0 0 0 0 0 0 14.41142 18.06801 0 0 0 0 0 0 0 0 0 16.23185 0 0 17.68408 0 15.44619 17.11801 16.91676 16.15209 P69905 HBA_HUMAN Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) HBA1; HBA2 Homo sapiens (Human) carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542] blood microparticle [GO:0072562]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; membrane [GO:0016020] blood microparticle [GO:0072562]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542] heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] GO:0005344; GO:0005506; GO:0005576; GO:0005615; GO:0005829; GO:0005833; GO:0010942; GO:0015670; GO:0015671; GO:0016020; GO:0019825; GO:0020037; GO:0022627; GO:0030185; GO:0031838; GO:0042542; GO:0042744; GO:0043177; GO:0070062; GO:0071682; GO:0072562; GO:0098869 MFLSFPTTK 36.68000031 0.392430454 0.392430454 0.500494597 1072.227802 17.1698 0 18.10488 17.95998 15.86436 0 0 16.78073 19.09537 0 0 0 0 0 0 0 18.42781 15.80583 0 0 17.48314 0 0 0 0 0 0 17.23116 0 0 0 0 0 0 19.44726 17.29887 0 0 0 0 0 0 16.56437 0 0 17.71197 0 16.76264 P78310 CXAR_HUMAN "Coxsackievirus and adenovirus receptor, CAR, hCAR (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR)" CXADR CAR Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633] beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618] GO:0001618; GO:0001669; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0005923; GO:0007005; GO:0007157; GO:0007507; GO:0008013; GO:0008354; GO:0010669; GO:0014704; GO:0016323; GO:0016327; GO:0030054; GO:0030165; GO:0030175; GO:0030426; GO:0030593; GO:0031532; GO:0031594; GO:0032991; GO:0034109; GO:0042802; GO:0043005; GO:0044297; GO:0045121; GO:0045216; GO:0046629; GO:0050839; GO:0051607; GO:0055013; GO:0070633; GO:0071253; GO:0086067; GO:0086072; GO:0086082; GO:0098904 TPQSPTLPPAKVAAPNLSR 6.96999979 1 1 0.09737292 1945.037302 12.34644 0 15.08348 13.83093 8.175155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78314 3BP2_HUMAN "SH3 domain-binding protein 2, 3BP-2" SH3BP2 3BP2 RES4-23 Homo sapiens (Human) signal transduction [GO:0007165] phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; signal transduction [GO:0007165] phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124] GO:0001784; GO:0007165; GO:0017124 TWFFSASSEEER 2.769999981 1 1 0.125303657 1476.110823 0 0 13.1246 0 13.14446 0 0 0 0 0 0 0 0 15.41711 0 0 0 0 0 0 0 16.63717 0 13.97138 0 15.98883 0 16.2956 0 0 0 0 0 0 0 0 0 16.97758 16.6596 0 17.25239 16.17513 17.47327 0 0 0 0 0 P78316 NOP14_HUMAN Nucleolar protein 14 (Nucleolar complex protein 14) NOP14 C4orf9 NOL14 RES4-25 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]" 90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]" enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515] GO:0000447; GO:0000462; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0019899; GO:0030490; GO:0030515; GO:0030686; GO:0030692; GO:0032040; GO:0042274 EIQTLLSHKTPK 9.069999695 1 1 0.556953479 1393.820031 0 0 0 0 0 0 18.47214 0 0 0 0 18.6774 18.87749 0 0 19.27534 0 0 0 0 0 0 0 0 0 0 0 0 0 19.50138 0 0 0 0 0 19.11095 0 0 0 0 0 17.85351 0 0 18.96084 0 0 0 P78318 IGBP1_HUMAN "Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4, Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16)" IGBP1 IBP1 Homo sapiens (Human) B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165] protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888] GO:0000122; GO:0005737; GO:0005829; GO:0007165; GO:0019888; GO:0032873; GO:0034612; GO:0035303; GO:0042113; GO:0043154; GO:0051721; GO:0060632; GO:0070555 KYGALPDQGIAK 5.769999981 1 1 9.18E-13 1261.052149 11.73881 13.27674 10.66244 14.75607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.35206 0 0 0 0 0 0 0 0 0 0 4.238778 0 0 0 0 0 0 13.91702 0 0 10.94239 0 0 0 0 P78329 CP4F2_HUMAN "Cytochrome P450 4F2, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase, EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1, EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2, EC 1.14.14.78)" CYP4F2 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805]" "20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]" GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008391; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0052872; GO:0055078; GO:0070330; GO:0097258; GO:0097259; GO:0097267; GO:0102033; GO:0102207 VLPDHTEPR 7.5 0.002162628 0.002162628 0.127417813 1063.476198 0 18.37406 14.30178 0 16.54371 14.42214 15.26597 15.03939 14.20514 14.86491 15.34476 16.52557 15.0212 17.97562 15.04192 14.46198 13.88138 16.82517 14.55191 14.89562 16.08877 17.53926 15.65714 0 17.29461 0 15.88325 15.32207 13.60636 0 0 15.97421 0 14.75091 16.88958 16.72918 17.24712 13.18476 17.94216 0 0 0 15.33256 0 16.66759 17.10876 15.8623 19.07397 P78332 RBM6_HUMAN RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3) RBM6 DEF3 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]" DNA binding [GO:0003677]; RNA binding [GO:0003723] GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0006396 EHSGMNVNR 3.180000067 1 1 4.63E-13 1056.903242 0 14.15255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.08289 0 10.68692 0 0 0 0 14.51242 13.97567 0 0 0 0 0 0 0 14.14843 13.0251 11.24978 0 0 0 0 0 0 P78333 GPC5_HUMAN Glypican-5 [Cleaved into: Secreted glypican-5 ] GPC5 Homo sapiens (Human) cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475] GO:0005576; GO:0005615; GO:0005796; GO:0005886; GO:0009986; GO:0016021; GO:0016477; GO:0043202; GO:0046658; GO:0062023; GO:0090263; GO:1905475 HGMKTTTR 4.550000191 1 1 0.157082431 946.4182141 0 16.40325 17.36738 0 0 11.80322 0 0 0 16.62717 0 0 0 16.60781 0 0 0 0 0 0 16.05877 17.40988 0 15.19201 0 0 13.91649 10.17163 0 0 16.71804 14.77275 0 0 0 0 17.19734 18.5482 18.97791 15.20605 0 16.44619 0 0 14.58302 17.16394 0 0 P78344 IF4G2_HUMAN "Eukaryotic translation initiation factor 4 gamma 2, eIF-4-gamma 2, eIF-4G 2, eIF4G 2 (Death-associated protein 5, DAP-5) (p97)" EIF4G2 DAP5 OK/SW-cl.75 Homo sapiens (Human) cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of cell cycle [GO:0051726]; regulation of translational initiation [GO:0006446] adherens junction [GO:0005912]; axon [GO:0030424]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020] "adherens junction [GO:0005912]; axon [GO:0030424]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of cell cycle [GO:0051726]; regulation of translational initiation [GO:0006446]" "cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0005912; GO:0006446; GO:0007507; GO:0008135; GO:0008219; GO:0010507; GO:0016020; GO:0016281; GO:0030307; GO:0030424; GO:0034645; GO:0045296; GO:0045727; GO:0045773; GO:0051726; GO:0060999 ESAIAEGGASR 5.050000191 0.571685076 0.571685076 0.211662125 1046.708313 16.43524 15.71106 16.41683 17.69015 15.09348 17.65618 13.17778 15.75444 14.94991 15.52017 16.55206 12.46594 15.11713 15.35684 10.31196 13.88869 14.56098 15.72097 15.37095 15.8855 15.49817 17.74374 16.59781 12.93507 15.87759 15.22439 17.69312 0 12.97649 16.33354 0 17.68203 0 17.17947 0 0 0 18.0924 0 15.0753 16.69592 0 15.08899 16.49226 16.90182 15.64072 0 0 P78346 RPP30_HUMAN "Ribonuclease P protein subunit p30, RNaseP protein p30 (RNase P subunit 2)" RPP30 RNASEP2 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]" multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] "multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]" ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0006364; GO:0008033; GO:0030681; GO:0033204; GO:0090502 GLAFELVYSPAIKDSTMR 9.670000076 1 1 0.354837494 2014.622935 0 0 0 0 0 0 17.03017 0 0 0 18.47764 0 0 0 0 0 0 0 0 0 17.57453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78348 ASIC1_HUMAN "Acid-sensing ion channel 1, ASIC1 (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2, BNaC2)" ASIC1 ACCN2 BNAC2 Homo sapiens (Human) associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280] GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0005887; GO:0006814; GO:0007165; GO:0007613; GO:0008306; GO:0009268; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0035725; GO:0042391; GO:0044736; GO:0045202; GO:0046929; GO:0050915; GO:0070207; GO:0070588; GO:0071467 VVFTRYGK 10.86999989 0.219259754 0.219259754 0.147879153 969.3744886 14.04808 14.41084 16.7074 14.94415 15.89815 13.60204 0 13.25651 0 16.50965 19.87745 13.91145 0 0 0 0 11.45915 14.6341 0 17.21376 15.22869 15.17692 15.27864 10.86104 17.59632 14.92687 0 17.08243 0 16.57258 14.96291 17.87439 15.11796 17.84067 13.20927 0 13.94713 14.94113 16.04766 11.98983 14.77741 17.16876 17.57795 13.25592 13.4826 17.97478 0 16.45289 P78357 CNTP1_HUMAN "Contactin-associated protein 1, Caspr, Caspr1 (Neurexin IV) (Neurexin-4) (p190)" CNTNAP1 CASPR NRXN4 Homo sapiens (Human) "axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; signal transduction [GO:0007165]" integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone membrane [GO:0048787] "integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone membrane [GO:0048787]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; signal transduction [GO:0007165]" SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023] GO:0002175; GO:0005887; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016021; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048787; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0097106; GO:0098529; GO:1990227 YMLLYGDR 1.929999948 1.04E-08 1.04E-08 0.079711579 1044.513085 0 14.96635 12.98489 17.23559 14.32092 14.13439 15.46838 13.22422 0 0 14.98618 0 0 16.1762 12.23644 15.61702 16.22203 10.19302 0 0 0 16.43049 18.46323 14.38394 17.11619 0 0 15.2476 16.04309 15.67189 13.28151 0 16.46865 15.79073 17.48018 13.56975 17.79729 0 17.56615 15.94826 16.942 0 17.20846 14.64761 0 0 16.4712 0 P78362 SRPK2_HUMAN "SRSF protein kinase 2, EC 2.7.11.1 (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2, SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal ]" SRPK2 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723] GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889; GO:0106310 CVKSIIR 9.81000042 0.460923374 0.460923374 0.11513376 874.4541612 16.36854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.01179 0 0 0 18.04086 16.32869 0 0 0 0 17.83213 0 0 0 0 0 0 0 0 0 0 16.48444 0 0 0 17.3165 0 0 0 0 0 16.69123 18.13186 P78363 ABCA4_HUMAN "Retinal-specific phospholipid-transporting ATPase ABCA4, EC 7.6.2.1 (ATP-binding cassette sub-family A member 4) (RIM ABC transporter, RIM proteinv, RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein)" ABCA4 ABCR Homo sapiens (Human) "lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]" cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; rod photoreceptor disc membrane [GO:0120202] "cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; rod photoreceptor disc membrane [GO:0120202]; 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501]; retinol transmembrane transporter activity [GO:0034632]; transporter activity [GO:0005215]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]" 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501]; retinol transmembrane transporter activity [GO:0034632]; transporter activity [GO:0005215] GO:0001523; GO:0001750; GO:0003924; GO:0005215; GO:0005319; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0007603; GO:0016020; GO:0016887; GO:0031410; GO:0034632; GO:0042574; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0055085; GO:0090555; GO:0097381; GO:0120202; GO:0140326; GO:0140327; GO:0140347; GO:0140359 AAKPLLMGK 5.650000095 1 1 0.22909836 928.5766783 0 0 0 0 0 0 16.10185 0 0 0 0 0 0 0 0 0 18.99758 0 0 0 0 17.51108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0942 0 P78367 NKX32_HUMAN Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B) NKX3-2 BAPX1 NKX3B Homo sapiens (Human) animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0060576; GO:1990837 GANTLTSFSIQAILNKK 4.789999962 0.906781793 0.906781793 0.092932496 1807.017562 14.64096 14.59316 16.744 13.83294 10.70653 13.18586 11.95541 14.30892 13.28769 17.93561 11.42506 14.98538 17.17951 0 0 13.1808 16.77586 15.39828 0 16.58246 14.67975 16.22064 14.92513 15.05364 16.1316 18.2595 0 12.58681 0 14.63658 15.05471 0 14.78091 0 0 14.64849 12.7917 18.19166 14.58946 15.99081 16.05066 15.60381 0 0 14.52768 0 14.82905 0 P78368 KC1G2_HUMAN "Casein kinase I isoform gamma-2, CKI-gamma 2, EC 2.7.11.1" CSNK1G2 CK1G2 Homo sapiens (Human) endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006897; GO:0007165; GO:0016020; GO:0016055; GO:0018105; GO:0030148; GO:0090263; GO:0106310 TVLMIAIQLITRMEYVHTK 6.190000057 1 1 0.318726873 2276.230842 15.39621 12.66564 17.80079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.17578 0 0 P78369 CLD10_HUMAN "Claudin-10 (Oligodendrocyte-specific protein-like, OSP-like)" CLDN10 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] GO:0005198; GO:0005737; GO:0005886; GO:0005923; GO:0006811; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0043269; GO:0070830 VGGSDKAK 2.920000076 1 1 0.181802524 760.9137519 0 16.68108 17.41803 10.00897 15.21432 16.22514 0 0 13.89572 16.43321 17.29163 16.79487 0 16.69709 0 12.86219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.00031 0 16.56354 0 0 0 0 0 0 17.23585 0 14.64831 0 16.00671 0 P78371 TCPB_HUMAN "T-complex protein 1 subunit beta, TCP-1-beta (CCT-beta)" CCT2 99D8.1 CCTB Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0035578; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874 STLGPK 5.71999979 1 1 0.092197314 601.3320199 0 0 0 0 14.85576 15.5416 13.79932 0 14.18192 15.69027 16.07737 15.69861 0 0 0 14.75944 15.3309 0 0 14.89722 0 0 15.79983 14.86455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5806 0 P78381 S35A2_HUMAN "UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter, UDP-Gal-Tr, UGT)" SLC35A2 UGALT UGT UGTL Homo sapiens (Human) carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334] UDP-galactose transmembrane transporter activity [GO:0005459] GO:0000139; GO:0005459; GO:0005654; GO:0005783; GO:0005794; GO:0006012; GO:0008643; GO:0030173; GO:0072334 MAAVGAGGSTAAPGPGAVSAGALEPGTASAAHRR 5.809999943 1 1 0.035686031 2974.320691 0 15.80112 13.77737 14.31109 0 12.50001 12.97438 0 0 12.93987 0 14.90673 12.1585 12.7884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78382 S35A1_HUMAN "CMP-sialic acid transporter, CMP-SA-Tr, CMP-Sia-Tr (Solute carrier family 35 member A1)" SLC35A1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate metabolic process [GO:0005975]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782] antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; UDP-galactose transmembrane transporter activity [GO:0005459] GO:0000139; GO:0005456; GO:0005459; GO:0005794; GO:0005887; GO:0005975; GO:0006464; GO:0008643; GO:0015297; GO:0015782; GO:0016021; GO:0030173 LYCLAVMTLMAAVYTIALRYTR 3.710000038 1 1 1.38E-12 2608.299756 15.72068 14.08662 3.630296 14.54883 15.22621 0 16.06914 0 0 14.41233 14.77473 0 11.83354 0 12.65956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78406 RAE1L_HUMAN mRNA export factor RAE1 (Rae1 protein homolog) (mRNA-associated protein mrnp 41) RAE1 MRNP41 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130] GO:0000972; GO:0001650; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0006913; GO:0007049; GO:0008017; GO:0043130; GO:0051301; GO:0060236; GO:0071407; GO:0097431 AQQMHTGPVLDVCWSDDGSK 7.010000229 1 1 0.182682267 2246.307656 13.69067 13.78366 15.41933 0 0 0 0 0 0 0 0 13.19137 13.85695 0 0 0 13.68648 0 0 12.10064 0 0 14.08503 0 0 0 0 0 0 0 14.9397 0 0 11.54164 0 0 15.65352 0 15.95173 0 0 13.21413 0 0 0 13.68533 0 0 P78411 IRX5_HUMAN Iroquois-class homeodomain protein IRX-5 (Homeodomain protein IRX-2A) (Homeodomain protein IRXB2) (Iroquois homeobox protein 5) IRX5 IRX2A IRXB2 Homo sapiens (Human) cell development [GO:0048468]; embryonic cranial skeleton morphogenesis [GO:0048701]; gonad development [GO:0008406]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; vitamin D binding [GO:0005499]; cell development [GO:0048468]; embryonic cranial skeleton morphogenesis [GO:0048701]; gonad development [GO:0008406]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; vitamin D binding [GO:0005499]" GO:0000785; GO:0000978; GO:0000981; GO:0005499; GO:0005634; GO:0006357; GO:0007601; GO:0008406; GO:0030182; GO:0048468; GO:0048701; GO:0050896; GO:1990837 NDEDEPQKPEDKGDPEGPEAGGAEQK 11.35999966 0.136541501 0.136541501 0.200932998 2765.072697 0 0 0 0 19.1602 0 0 0 0 0 0 18.42662 0 19.56995 0 0 0 0 0 0 0 0 0 0 18.37676 16.26259 0 0 17.29655 0 19.522 19.58566 18.9548 19.27189 0 0 0 19.75602 0 0 0 0 0 18.79523 18.49041 18.17261 18.47347 0 P78413 IRX4_HUMAN Iroquois-class homeodomain protein IRX-4 (Homeodomain protein IRXA3) (Iroquois homeobox protein 4) IRX4 IRXA3 Homo sapiens (Human) cell development [GO:0048468]; establishment of animal organ orientation [GO:0048561]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; establishment of animal organ orientation [GO:0048561]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007507; GO:0030182; GO:0048468; GO:0048561 MSLAAGGGAALDEDLERAR 8.06000042 1 1 1.83E-12 1902.599915 14.04364 0 0 14.74642 16.49265 12.57235 14.77365 17.18326 14.7172 16.35272 14.77726 15.62133 0 0 15.4779 15.73171 15.32114 16.43541 0 15.74552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78414 IRX1_HUMAN Iroquois-class homeodomain protein IRX-1 (Homeodomain protein IRXA1) (Iroquois homeobox protein 1) IRX1 IRXA1 Homo sapiens (Human) cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0030182; GO:0043565; GO:0048468; GO:0072086; GO:0072272; GO:1990837 EAPEPGSTR 10.27999973 1 1 0.124053753 944.2949512 16.29367 0 15.92038 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10254 0 0 0 0 0 0 0 0 0 0 0 0 0 18.87146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78417 GSTO1_HUMAN "Glutathione S-transferase omega-1, GSTO-1, EC 2.5.1.18 (Glutathione S-transferase omega 1-1, GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase, EC 1.8.5.1) (Monomethylarsonic acid reductase, MMA(V) reductase, EC 1.20.4.2) (S-(Phenacyl)glutathione reductase, SPG-R)" GSTO1 GSTTLP28 Homo sapiens (Human) cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491] GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0060315; GO:0060316; GO:0070062; GO:0071243 GSAPPGPVPEGSIRIYSMR 5.480000019 1 1 0.113727359 1986.444051 14.9358 14.44153 0 0 15.68414 0 0 0 14.5961 0 0 0 0 0 12.86938 0 0 0 0 0 0 0 0 0 0 0 0 14.86391 14.67447 0 0 0 0 0 0 0 0 0 16.96375 14.74532 12.73142 0 0 0 0 0 0 0 P78423 X3CL1_HUMAN Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine ] CX3CL1 FKN NTT SCYD1 A-152E5.2 Homo sapiens (Human) aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883] cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883] CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102] GO:0001774; GO:0001954; GO:0002052; GO:0002523; GO:0002548; GO:0002931; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0006952; GO:0006954; GO:0006955; GO:0007155; GO:0007186; GO:0007267; GO:0007568; GO:0008009; GO:0008284; GO:0009986; GO:0010812; GO:0010976; GO:0016020; GO:0016021; GO:0016322; GO:0019221; GO:0030336; GO:0030593; GO:0030595; GO:0031664; GO:0031737; GO:0032233; GO:0032690; GO:0032691; GO:0032715; GO:0032720; GO:0032914; GO:0033622; GO:0035425; GO:0042056; GO:0042995; GO:0043005; GO:0043025; GO:0043066; GO:0043123; GO:0043410; GO:0043547; GO:0045237; GO:0045944; GO:0048020; GO:0048167; GO:0048245; GO:0048247; GO:0048471; GO:0048661; GO:0050729; GO:0050767; GO:0050902; GO:0050918; GO:0051041; GO:0051092; GO:0051281; GO:0051897; GO:0060055; GO:0060326; GO:0061518; GO:0070050; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0098609; GO:0098883; GO:0110091; GO:1900450; GO:1903721; GO:1903979; GO:1904141; GO:2001223; GO:2001234; GO:2001240 LGVLITPVPDAQAATRR 3.50999999 1 1 0.359032873 1777.208214 13.65478 14.84992 0 0 0 0 0 0 0 0 15.56385 13.30653 11.52079 0 0 0 0 13.74743 0 14.75012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.69872 0 16.75398 0 0 0 0 0 0 0 0 0 P78424 PO6F2_HUMAN "POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1, RPF-1)" POU6F2 RPF1 Homo sapiens (Human) "central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 AGMQNLTEFIGSEPSK 7.389999866 0.025273658 0.025273658 0.198127147 1710.795818 0 18.94085 14.45746 0 0 0 0 0 0 0 17.15071 14.85876 0 17.6386 0 13.75468 0 0 14.96068 13.24239 0 0 16.67819 15.06551 12.50912 10.23629 16.12743 18.72256 15.03533 0 14.68049 15.27129 17.9815 18.91825 0 14.07115 17.21705 11.21363 17.1319 0 20.45263 13.61591 0 0 17.97806 13.74399 0 0 P78508 KCJ10_HUMAN "ATP-sensitive inward rectifier potassium channel 10 (ATP-dependent inwardly rectifying potassium channel Kir4.1) (Inward rectifier K(+) channel Kir1.2) (Potassium channel, inwardly rectifying subfamily J member 10)" KCNJ10 Homo sapiens (Human) adult walking behavior [GO:0007628]; central nervous system myelination [GO:0022010]; glutamate reuptake [GO:0051935]; non-motile cilium assembly [GO:1905515]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of resting membrane potential [GO:0060075]; visual perception [GO:0007601] astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; ciliary base [GO:0097546]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793] astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; ciliary base [GO:0097546]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; adult walking behavior [GO:0007628]; central nervous system myelination [GO:0022010]; glutamate reuptake [GO:0051935]; non-motile cilium assembly [GO:1905515]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of resting membrane potential [GO:0060075]; visual perception [GO:0007601] ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242] GO:0005242; GO:0005524; GO:0005886; GO:0005887; GO:0006813; GO:0007601; GO:0007628; GO:0015272; GO:0016323; GO:0022010; GO:0034765; GO:0044297; GO:0048169; GO:0051935; GO:0055075; GO:0060075; GO:0097449; GO:0097546; GO:0098793; GO:1905515; GO:1990573 VANMRK 1.809999943 0.566258252 0.566258252 0.239276562 716.024978 0 13.60061 0 0 14.95015 0 0 15.32828 0 0 0 0 0 15.9438 15.5415 0 16.19769 0 0 0 0 0 0 0 0 0 16.78321 0 0 0 0 0 0 0 0 0 0 17.14205 0 0 0 0 15.5256 0 0 0 0 0 P78509 RELN_HUMAN "Reelin, EC 3.4.21.-" RELN Homo sapiens (Human) "associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of NMDA receptor activity [GO:2000310]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of NMDA receptor activity [GO:2000310]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]" lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326] GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0045664; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060025; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:0110157; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969; GO:2001222 ALVFNKDGR 10.43000031 0.317293137 0.317293137 0.019427665 1015.779817 13.15355 16.63336 0 0 0 0 11.45171 13.63727 15.31154 16.01729 0 0 0 12.37396 13.32453 15.94768 0 0 14.3082 0 0 15.32452 0 16.92204 0 0 0 0 14.55884 0 0 14.47804 0 14.52446 0 17.15068 16.67493 12.5958 0 14.61925 17.45077 0 0 0 15.15967 0 0 0 P78524 DEN2B_HUMAN DENN domain-containing protein 2B (HeLa tumor suppression 1) (Suppression of tumorigenicity 5 protein) DENND2B HTS1 ST5 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374] cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005886; GO:0005938; GO:0055037; GO:0070374 EGSGSTKPGTPGNSPSSQR 2.220000029 1 1 0.082509998 1829.757976 13.56242 0 15.81812 0 0 0 0 0 0 0 14.26961 0 15.06392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71978 0 0 0 0 0 0 0 0 0 0 0 P78527 PRKDC_HUMAN "DNA-dependent protein kinase catalytic subunit, DNA-PK catalytic subunit, DNA-PKcs, EC 2.7.11.1 (DNPK1) (p460)" PRKDC HYRC HYRC1 Homo sapiens (Human) activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; U3 snoRNA binding [GO:0034511]; activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]" ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; U3 snoRNA binding [GO:0034511] GO:0000460; GO:0000723; GO:0000781; GO:0001756; GO:0001933; GO:0002218; GO:0002326; GO:0002328; GO:0002360; GO:0003690; GO:0003723; GO:0004672; GO:0004674; GO:0004677; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0006464; GO:0006468; GO:0006974; GO:0007420; GO:0007507; GO:0008630; GO:0010332; GO:0016020; GO:0016233; GO:0018105; GO:0018107; GO:0019899; GO:0019904; GO:0031571; GO:0031648; GO:0032040; GO:0032869; GO:0032991; GO:0032993; GO:0033077; GO:0033152; GO:0033153; GO:0034462; GO:0034511; GO:0035234; GO:0042752; GO:0043065; GO:0043066; GO:0045087; GO:0045621; GO:0045648; GO:0045727; GO:0045944; GO:0048511; GO:0048660; GO:0050678; GO:0061629; GO:0070418; GO:0070419; GO:0097681; GO:0106310; GO:1902036; GO:1905221; GO:2001034 ALKMSPYK 10.68000031 0.591060877 0.591060877 0.211284229 952.7742565 0 18.54961 0 15.25253 14.60767 14.86355 14.76576 14.17582 0 0 15.80803 13.80286 15.64865 0 15.3886 15.71905 0 14.71714 0 16.47168 16.71548 0 15.31949 16.07169 15.69221 14.96621 15.37257 13.46071 16.53569 13.39303 14.40136 15.79914 16.28712 15.88103 0 0 14.98672 14.50515 13.97474 13.5938 0 15.22104 14.32154 15.58288 13.23676 0 12.16277 14.21984 P78536 ADA17_HUMAN "Disintegrin and metalloproteinase domain-containing protein 17, ADAM 17, EC 3.4.24.86 (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)" ADAM17 CSVP TACE Homo sapiens (Human) "amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]" actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]" endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124] GO:0000139; GO:0001666; GO:0001934; GO:0002446; GO:0002467; GO:0002690; GO:0004175; GO:0004222; GO:0005112; GO:0005138; GO:0005178; GO:0005737; GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0006509; GO:0007155; GO:0007173; GO:0007219; GO:0007220; GO:0008233; GO:0008237; GO:0008284; GO:0009410; GO:0009986; GO:0010820; GO:0015629; GO:0016020; GO:0016324; GO:0016485; GO:0017124; GO:0030165; GO:0030183; GO:0030307; GO:0030335; GO:0030511; GO:0030512; GO:0032496; GO:0032722; GO:0033025; GO:0033077; GO:0033627; GO:0035313; GO:0035624; GO:0042987; GO:0043536; GO:0045121; GO:0045737; GO:0045741; GO:0046872; GO:0048536; GO:0048870; GO:0050830; GO:0051272; GO:0071403; GO:0120163; GO:1900087; GO:1902945; GO:1903265; GO:1905564 MDTIQEDPSTDSHMDEDGFEK 2.680000067 0.502673388 0.502673388 0.030040214 2463.99221 0 8.8047 0 10.49651 0 0 0 17.56976 12.21216 0 11.39443 0 11.76199 7.977896 14.35592 12.52374 10.81268 0 12.85856 0 0 0 12.23238 12.50696 15.06873 13.23395 15.1772 0 0 0 0 16.58966 0 0 12.80665 0 0 0 0 12.1406 13.47701 0 0 0 0 0 11.90637 15.17134 P78540 ARGI2_HUMAN "Arginase-2, mitochondrial, EC 3.5.3.1 (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase)" ARG2 Homo sapiens (Human) "adaptive immune response [GO:0002250]; arginine catabolic process to ornithine [GO:0019547]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657]" cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginase activity [GO:0004053]; manganese ion binding [GO:0030145]; adaptive immune response [GO:0002250]; arginine catabolic process to ornithine [GO:0019547]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657]" arginase activity [GO:0004053]; manganese ion binding [GO:0030145] GO:0000050; GO:0001657; GO:0002250; GO:0002829; GO:0004053; GO:0005737; GO:0005739; GO:0005759; GO:0006809; GO:0006941; GO:0019547; GO:0030145; GO:0032651; GO:0032696; GO:0032700; GO:0032720; GO:0045087; GO:0071641; GO:0071644; GO:0071650; GO:1900425; GO:1903426; GO:1905403; GO:2000562; GO:2000774 EAGLMK 4.039999962 0.043280583 0.043280583 0.211863059 663.5177496 14.94866 15.22009 15.48619 15.94601 14.98519 15.59106 15.67781 14.8102 14.88103 14.90841 15.62219 15.61874 12.68381 15.17829 14.55255 0 0 15.20737 0 16.01755 14.98729 17.53962 16.75471 17.09578 0 16.21498 15.55299 0 15.59048 15.62746 15.35968 15.62283 0 0 16.19136 16.91476 16.33604 16.57495 16.09908 15.76114 13.31561 0 0 15.99099 16.74173 0 0 15.38883 P78543 BTG2_HUMAN Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3) BTG2 PC3 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914] transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006479; GO:0006974; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0014070; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0045930; GO:0051602; GO:0060213; GO:0070062; GO:2000178 NYVMAVSS 9.56000042 0.886669934 0.886669934 1.14E-12 869.3957995 15.56309 0 0 18.07521 16.16008 18.11085 15.88246 15.79299 15.43768 15.2391 10.93391 19.1288 14.83038 0 15.38756 13.90372 15.55409 14.49767 11.88076 13.51546 15.73214 16.24994 0 18.18322 16.75214 16.6843 0 14.05073 16.37453 13.81083 15.508 0 15.20022 18.08972 17.74096 14.91252 16.3709 18.48576 15.2461 16.89276 16.60817 14.7598 16.07004 17.29218 14.89199 0 16.06581 17.38839 P78559 MAP1A_HUMAN "Microtubule-associated protein 1A, MAP-1A (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2 ]" MAP1A MAP1L Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202]; actin binding [GO:0003779]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882] actin binding [GO:0003779]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631] GO:0000226; GO:0003779; GO:0005198; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0007409; GO:0007613; GO:0008017; GO:0008093; GO:0008306; GO:0015631; GO:0016358; GO:0030424; GO:0030425; GO:0031114; GO:0032435; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0044307; GO:0045202; GO:0048156; GO:0048167; GO:0050882; GO:0070050; GO:0099641; GO:0099642; GO:0150001; GO:1901588; GO:1902817; GO:1903829; GO:1904115; GO:1990535; GO:2000010 DGHSPMSK 1.019999981 1 1 0.080410034 877.7594301 14.90687 0 0 0 0 0 0 0 0 0 14.64216 0 0 0 0 0 0 15.03714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.40927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.62839 P78562 PHEX_HUMAN "Phosphate-regulating neutral endopeptidase PHEX, EC 3.4.24.- (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein, HYP)" PHEX PEX Homo sapiens (Human) bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular protein modification process [GO:0006464]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular protein modification process [GO:0006464]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0001501; GO:0004222; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006464; GO:0006508; GO:0007267; GO:0008270; GO:0016485; GO:0019637; GO:0030282; GO:0030324; GO:0042476; GO:0048471; GO:0060348; GO:0060416; GO:0071305; GO:0071374; GO:1904383; GO:1990418 AFNCPPNSTMNR 2.470000029 1 1 0.240058838 1425.303341 14.22343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.81688 16.12339 0 0 0 0 14.09513 0 0 14.72145 14.19822 14.10993 0 0 0 0 0 0 17.65359 16.03639 0 0 16.25412 0 15.35983 0 0 0 12.09464 0 P78563 RED1_HUMAN "Double-stranded RNA-specific editase 1, EC 3.5.4.37 (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)" ADARB1 ADAR2 DRADA2 RED1 Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965] double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] GO:0003723; GO:0003725; GO:0003726; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045087; GO:0045202; GO:0046872; GO:0050884; GO:0051607; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049 ARLFTAFIK 9.069999695 0.193426535 0.193426535 0.061661535 1065.549767 0 18.28167 0 12.16347 0 0 0 0 0 0 0 0 15.53261 17.18306 0 14.82353 0 14.15927 10.89888 14.58064 14.14963 0 10.97858 0 13.42807 0 14.47029 0 14.73676 0 13.80669 18.52674 16.66856 0 0 9.984141 0 0 0 16.40659 0 0 15.40839 17.6274 0 13.11564 15.71935 0 P80162 CXCL6_HUMAN "C-X-C motif chemokine 6 (Chemokine alpha 3, CKA-3) (Granulocyte chemotactic protein 2, GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3 ]" CXCL6 GCP2 SCYB6 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165] chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201] GO:0001776; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007267; GO:0008009; GO:0008201; GO:0030593; GO:0032642; GO:0042119; GO:0042742; GO:0045236; GO:0061844; GO:0070098; GO:0070951; GO:0071222 LQVFPAGPQCSK 7.949999809 0.011608184 0.011608184 0.106828162 1331.478075 18.56622 0 15.55088 13.92114 0 0 13.01587 15.10229 0 0 16.78293 0 12.46746 0 0 15.87503 0 14.10078 0 14.63636 15.96848 0 0 0 15.57145 15.87092 13.75312 0 0 14.01912 8.619217 14.73118 0 15.56256 0 0 0 15.6282 14.6359 16.2039 0 16.77355 17.60533 0 0 16.08963 14.81533 13.83168 P80365 DHI2_HUMAN "11-beta-hydroxysteroid dehydrogenase type 2, 11-DH2, 11-beta-HSD2, EC 1.1.1.- (11-beta-hydroxysteroid dehydrogenase type II, 11-HSD type II, 11-beta-HSD type II) (Corticosteroid 11-beta-dehydrogenase isozyme 2) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 3)" HSD11B2 HSD11K SDR9C3 Homo sapiens (Human) cortisol metabolic process [GO:0034650]; female pregnancy [GO:0007565]; regulation of blood volume by renal aldosterone [GO:0002017]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; 11-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0070523]; NAD binding [GO:0051287]; steroid binding [GO:0005496]; cortisol metabolic process [GO:0034650]; female pregnancy [GO:0007565]; regulation of blood volume by renal aldosterone [GO:0002017]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] 11-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0070523]; NAD binding [GO:0051287]; steroid binding [GO:0005496] GO:0001666; GO:0002017; GO:0005496; GO:0005654; GO:0005789; GO:0005811; GO:0007565; GO:0009410; GO:0032094; GO:0032868; GO:0034650; GO:0051287; GO:0051384; GO:0070523 SCMEVNFFGALELTKGLLPLLR 1.120000005 1 1 2.29E-12 2509.052327 15.89465 0 0 0 0 0 14.21882 13.32347 11.72552 0 15.24319 0 11.56476 0 0 0 0 0 15.24436 12.60862 0 0 14.73248 0 14.06652 0 0 0 0 14.04171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.294927 13.98645 P80370 DLK1_HUMAN "Protein delta homolog 1, DLK-1 (pG2) [Cleaved into: Fetal antigen 1, FA1 ]" DLK1 DLK Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746] calcium ion binding [GO:0005509] GO:0005509; GO:0005615; GO:0005737; GO:0016020; GO:0016021; GO:0030154; GO:0045746 VSMKELNK 2.109999895 0.678392291 0.678392291 0.232406676 962.900881 15.35591 12.70529 13.39125 15.0646 15.11522 14.3008 0 0 14.4974 14.48275 15.88327 0 0 14.56567 16.05377 15.28491 11.57096 14.88394 0 15.92529 14.93773 0 15.2942 13.94139 14.44973 0 0 14.78506 14.39696 13.77328 14.16954 12.81785 14.86414 13.98883 14.54941 15.90839 14.02605 12.85408 0 0 0 0 15.57075 0 14.66469 0 16.88873 14.89964 P80404 GABT_HUMAN "4-aminobutyrate aminotransferase, mitochondrial, EC 2.6.1.19 ((S)-3-amino-2-methylpropionate transaminase, EC 2.6.1.22) (GABA aminotransferase, GABA-AT) (Gamma-amino-N-butyrate transaminase, GABA transaminase, GABA-T) (L-AIBAT)" ABAT GABAT Homo sapiens (Human) aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] GO:0001666; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042802; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450 ASMLLAQR 7.480000019 0.675725639 0.675725639 0.172214553 889.3074644 17.84327 16.68305 17.60863 13.86132 15.30974 0 16.57631 16.93931 17.01244 16.19764 15.47534 16.70654 14.99795 0 0 0 13.1364 0 0 0 14.7496 17.65633 0 0 16.96816 0 0 14.42926 0 12.40203 12.73866 13.23725 17.37613 0 0 14.92369 0 0 16.48597 0 15.80482 15.35406 0 0 14.56424 0 12.36744 17.44588 P80723 BASP1_HUMAN Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22) BASP1 NAP22 Homo sapiens (Human) "diaphragm development [GO:0060539]; glomerular visceral epithelial cell differentiation [GO:0072112]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; vesicle [GO:0031982] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; vesicle [GO:0031982]; protein domain specific binding [GO:0019904]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; diaphragm development [GO:0060539]; glomerular visceral epithelial cell differentiation [GO:0072112]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]" protein domain specific binding [GO:0019904]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] GO:0000785; GO:0000976; GO:0003714; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007356; GO:0008406; GO:0016363; GO:0016605; GO:0016607; GO:0019904; GO:0021762; GO:0030054; GO:0030426; GO:0031982; GO:0045892; GO:0060231; GO:0060421; GO:0060539; GO:0070062; GO:0072075; GO:0072112; GO:2001076 TEAPAAPAAQETK 11.60000038 0.462975144 0.462975144 0.485540099 1284.719318 0 0 0 18.2246 18.32791 0 0 17.9437 0 0 16.88243 0 0 17.67093 0 0 18.4243 0 0 0 0 0 0 0 0 0 0 0 0 17.66978 0 0 0 0 18.75898 0 19.04482 0 0 0 18.92914 15.70966 0 0 0 0 16.28868 0 P80748 LV321_HUMAN Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT) IGLV3-21 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] antigen binding [GO:0003823] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562 VEAGDEADYYCQVWDSSSDHPT 6.21999979 1 1 0.18511913 2531.197429 12.56069 0 15.86059 0 0 0 0 0 15.07697 0 15.06046 16.35926 0 0 14.87643 15.50814 0 0 15.18761 0 0 17.24943 15.67692 0 17.37318 0 14.45414 0 0 0 0 16.43806 16.19993 14.40827 0 15.42905 0 0 18.5731 0 0 15.48072 0 0 0 0 0 0 P81274 GPSM2_HUMAN G-protein-signaling modulator 2 (Mosaic protein LGN) GPSM2 LGN Homo sapiens (Human) cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236] dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621] GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832 HLEISR 14.68000031 0.211586028 0.211586028 0.191369826 755.2904788 17.22524 19.86753 0 15.60316 16.54783 0 14.70875 11.68604 13.55177 14.87407 16.54449 15.98744 15.24701 13.25655 10.67486 16.3233 0 0 0 16.53258 15.36499 17.65563 15.48843 15.7043 17.39316 16.95105 0 17.29291 18.58455 13.99456 20.50205 17.17324 18.1366 17.79955 12.39781 15.67212 16.87826 17.3993 17.04942 19.22843 15.46178 0 0 0 18.24131 18.20104 18.24957 0 P81408 F189B_HUMAN Protein FAM189B (Protein COTE1) FAM189B C1orf2 COTE1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; WW domain binding [GO:0050699] WW domain binding [GO:0050699] GO:0016021; GO:0050699 MMPSPSDSSR 6.670000076 0.55117923 0.55117923 0.157803296 1111.179581 0 14.94595 0 12.52859 0 0 0 0 12.28289 14.1458 10.94046 13.59897 16.32021 14.78142 15.90945 12.84807 14.90134 17.08641 16.39256 15.48881 18.25901 17.24979 0 15.45449 15.26099 14.28849 13.5806 14.6873 14.77191 18.89858 17.61954 17.30015 17.48822 0 0 13.83709 17.53588 16.98896 17.36791 16.45591 14.87548 13.27628 16.26727 0 9.934694 16.77416 15.71026 15.10934 P82279 CRUM1_HUMAN Protein crumbs homolog 1 CRB1 Homo sapiens (Human) blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular protein localization [GO:0034613]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular protein localization [GO:0034613]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842] calcium ion binding [GO:0005509] GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0010001; GO:0010467; GO:0010842; GO:0016021; GO:0016324; GO:0032991; GO:0034613; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386 FQTVQPMALLLFR 22.62999916 1 1 0.254672005 1580.030357 10.39801 9.62536 13.05708 15.48158 0 0 14.29234 14.71725 0 0 0 17.3594 16.91651 13.35657 0 0 15.81485 13.90786 0 0 13.93722 0 0 0 0 0 0 0 0 0 0 16.75031 0 0 0 0 0 0 0 17.19278 0 14.08166 0 0 0 0 0 0 P82663 RT25_HUMAN "28S ribosomal protein S25, mitochondrial, MRP-S25, S25mt (Mitochondrial small ribosomal subunit protein mS25)" MRPS25 RPMS25 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543 YCLRECICEVEGQVPCPSLVPLPK 7.190000057 1 1 0.124699017 2904.02062 0 12.36089 0 15.18849 13.3006 0 0 12.77717 0 13.13826 0 12.62132 0 0 13.83512 14.33814 0 15.60267 18.9058 0 13.19956 0 0 0 14.16287 15.21346 16.05082 14.24674 0 0 0 0 0 0 0 0 0 0 0 0 15.1113 0 0 0 0 0 0 11.46725 P82673 RT35_HUMAN "28S ribosomal protein S35, mitochondrial, MRP-S35, S35mt (28S ribosomal protein S28, mitochondrial, MRP-S28, S28mt) (Mitochondrial small ribosomal subunit protein mS35)" MRPS35 MRPS28 HDCMD11P MDS023 PSEC0213 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543 LIKLVGER 8.239999771 0.64988023 0.64988023 0.193477981 926.3876975 0 0 16.04644 12.90564 0 0 15.33187 16.74243 15.93885 0 14.15709 0 0 0 0 0 0 0 0 15.30613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P82675 RT05_HUMAN "28S ribosomal protein S5, mitochondrial, MRP-S5, S5mt (Mitochondrial small ribosomal subunit protein uS5m)" MRPS5 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543 VLVAVGNGKGAAGFSIGK 3.200000048 1 1 0.305423461 1645.460822 13.88942 15.1475 13.99621 16.43687 0 14.37676 12.45492 0 15.39958 16.11153 16.96868 0 15.71996 0 15.0879 0 0 0 0 0 0 0 0 16.79263 0 0 0 0 0 0 0 16.11257 0 0 15.05606 16.50319 0 0 17.02902 0 0 0 15.9824 17.13283 0 0 0 0 P82921 RT21_HUMAN "28S ribosomal protein S21, mitochondrial, MRP-S21, S21mt (Mitochondrial small ribosomal subunit protein bS21m)" MRPS21 RPMS21 MDS016 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543 INFLMR 18.76000023 0.671834707 0.671834707 0.09880202 808.4338117 17.21058 18.77052 15.37557 19.09672 17.28871 0 18.70747 17.01197 16.82806 18.15485 18.23485 17.64516 17.75361 15.97517 16.46646 17.0587 16.66052 16.56445 17.20124 17.56855 17.69651 16.98775 18.05601 18.14016 0 19.81186 0 16.45366 18.88077 16.5539 16.50977 16.48412 15.44322 16.52947 16.91611 18.15552 15.82689 18.10538 18.66339 0 0 17.94158 17.62634 18.01371 16.54878 0 16.25175 16.27261 P82930 RT34_HUMAN "28S ribosomal protein S34, mitochondrial, MRP-S34, S34mt (Mitochondrial small ribosomal subunit protein mS34)" MRPS34 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543 AKGTPV 2.460000038 1 1 0.259282056 569.4091211 0 0 0 0 0 0 0 0 0 0 17.59894 0 0 0 0 18.92919 19.15811 0 0 0 18.89458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.48076 0 0 0 0 0 0 0 P82987 ATL3_HUMAN "ADAMTS-like protein 3, ADAMTSL-3 (Punctin-2)" ADAMTSL3 KIAA1233 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0030198; GO:0031012; GO:0043231 ANGTVQVVSPR 13.57999992 1 1 0.371870962 1128.660295 0 0 0 0 0 0 21.08774 0 0 0 0 0 0 0 0 0 0 17.67794 0 0 0 0 0 0 0 21.29974 0 0 0 0 0 0 0 0 20.96049 0 0 0 0 0 0 0 0 0 0 0 0 0 P83105 HTRA4_HUMAN "Serine protease HTRA4, EC 3.4.21.- (High-temperature requirement factor A4)" HTRA4 Homo sapiens (Human) negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252] GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0012501; GO:0030512; GO:0042802; GO:0043065 AENRAAR 2.460000038 0.132308453 0.132308453 0.234706851 787.0012372 0 17.79713 17.99995 0 0 16.29683 0 0 0 0 0 17.97571 0 16.81205 17.61915 17.22593 0 0 0 0 0 17.32586 0 0 0 0 0 0 0 0 19.64041 17.85976 17.75603 0 18.82034 0 0 17.37691 17.75334 17.70219 18.30595 0 0 0 0 0 0 0 P83111 LACTB_HUMAN "Serine beta-lactamase-like protein LACTB, mitochondrial, EC 3.4.-.-" LACTB MRPL56 UNQ843/PRO1781 Homo sapiens (Human) lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216] identical protein binding [GO:0042802]; peptidase activity [GO:0008233] GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802 IALEFDK 2.180000067 1 1 0.11739997 834.3770594 0 0 13.38432 0 0 14.95873 15.61521 0 9.737894 12.776 0 13.08567 0 0 0 14.11219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.56971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P83369 LSM11_HUMAN U7 snRNA-associated Sm-like protein LSm11 LSM11 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin organization [GO:1902275] histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683] histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683]; U7 snRNA binding [GO:0071209]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin organization [GO:1902275] U7 snRNA binding [GO:0071209] GO:0005634; GO:0005654; GO:0005683; GO:0005697; GO:0006398; GO:0016604; GO:0071204; GO:0071209; GO:1900087; GO:1902275 GPGRSR 8.930000305 0.839136004 0.839136004 0.158910917 632.2884866 0 0 0 0 0 15.96299 0 0 0 0 14.29793 0 15.88354 0 0 0 0 0 0 0 0 0 0 17.3734 15.85223 16.75826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.43631 14.43061 0 0 0 P84074 HPCA_HUMAN Neuron-specific calcium-binding protein hippocalcin (Calcium-binding protein BDR-2) HPCA BDR2 Homo sapiens (Human) activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; retina development in camera-type eye [GO:0060041] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; retina development in camera-type eye [GO:0060041] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900] GO:0003779; GO:0005509; GO:0005737; GO:0005829; GO:0007420; GO:0019722; GO:0019898; GO:0019900; GO:0030424; GO:0031283; GO:0031584; GO:0032590; GO:0032809; GO:0032839; GO:0042802; GO:0043204; GO:0044327; GO:0045762; GO:0048839; GO:0060041; GO:0071257; GO:0071277; GO:0090314; GO:0098978; GO:0099149; GO:1901385; GO:1901986; GO:1902065; GO:1904009; GO:1904010 EEMLEIVQAIYK 14.73999977 0.226357818 0.226357818 0.032474607 1482.116467 14.96981 0 0 16.3493 0 0 15.22648 0 16.88739 0 0 0 17.2414 18.61985 0 16.69648 0 0 0 0 0 0 14.72913 13.7092 0 0 16.86998 0 0 0 15.22835 0 0 18.1539 17.97884 0 15.84721 14.27239 14.98548 18.62449 0 0 0 0 16.73775 15.1098 0 0 P84098 RL19_HUMAN 60S ribosomal protein L19 (Large ribosomal subunit protein eL19) RPL19 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0045202 MPEKVTWMR 8.460000038 1 1 0.33497506 1209.557045 0 15.50477 0 15.24216 0 0 0 0 15.10218 0 0 0 0 15.81357 0 0 0 0 0 16.57952 0 0 15.45178 16.51987 16.72537 0 0 0 15.83766 16.77743 0 0 0 0 0 13.09929 0 0 14.53695 16.50309 0 0 12.74419 11.26368 0 16.8891 0 16.55654 P84550 SKOR1_HUMAN "SKI family transcriptional corepressor 1 (Functional Smad-suppressing element on chromosome 15, Fussel-15) (LBX1 corepressor 1) (Ladybird homeobox corepressor 1)" SKOR1 CORL1 FUSSEL15 LBXCOR1 Homo sapiens (Human) "negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0006355; GO:0030425; GO:0030514; GO:0043025; GO:0046332; GO:1990837 AMFNGGTR 5.269999981 1 1 0.156482857 866.3676804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64384 0 0 0 0 16.5725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P85299 PRR5_HUMAN "Proline-rich protein 5 (Protein observed with Rictor-1, Protor-1)" PRR5 PROTOR1 PP610 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; TORC2 complex [GO:0031932] cytosol [GO:0005829]; TORC2 complex [GO:0031932]; cell cycle [GO:0007049]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; TORC2 signaling [GO:0038203] GO:0001934; GO:0005829; GO:0007010; GO:0007049; GO:0014068; GO:0016310; GO:0030307; GO:0031669; GO:0031932; GO:0038203; GO:0043066 FYEGQK 9.670000076 0.659758091 0.659758091 0.167167164 770.4203166 17.51473 17.04577 16.85724 15.9807 17.36126 14.90365 0 16.09416 0 16.71706 0 14.91996 15.34036 18.18549 16.11027 16.69602 16.66927 0 16.04521 16.80098 14.17209 19.29599 12.09572 0 16.45218 0 17.34789 0 13.92058 0 15.80308 15.3781 16.91273 14.86623 14.53215 16.2398 17.78908 15.90199 0 16.49687 14.56817 14.99214 0 15.52115 17.60751 17.23801 0 15.00214 P86397 HTD2_HUMAN "Hydroxyacyl-thioester dehydratase type 2, mitochondrial, HsHTD2, EC 4.2.1.59 (3-hydroxyacyl-[acyl-carrier-protein] dehydratase)" HTD2 Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949] (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317] GO:0004317; GO:0005730; GO:0005739; GO:0005759; GO:0006631; GO:0008659; GO:0008693; GO:0018812; GO:0046949; GO:0047451 VMVPEASKS 6.309999943 0.384634376 0.384634376 0.216948544 946.4453382 15.97576 15.40101 17.42211 12.78814 15.9156 15.93588 0 16.03278 12.85738 0 13.96859 14.80977 16.04153 15.13226 12.73998 0 0 0 0 0 15.30882 17.59004 16.8425 0 16.69873 15.98171 14.93561 15.0918 12.20297 0 16.08189 16.0294 18.68885 0 14.00489 0 0 16.9942 15.42476 0 0 16.54472 15.95455 15.77495 14.88805 16.29915 15.38711 12.84447 P86452 ZBED6_HUMAN Zinc finger BED domain-containing protein 6 ZBED6 Homo sapiens (Human) "blastocyst hatching [GO:0001835]; negative regulation of cell death [GO:0060548]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]" centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]; blastocyst hatching [GO:0001835]; negative regulation of cell death [GO:0060548]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000981; GO:0001227; GO:0001835; GO:0003309; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0034451; GO:0045787; GO:0045892; GO:0046872; GO:0046983; GO:0051148; GO:0060548; GO:0061178 GRPGSHLGTSTLQR 5.179999828 1 1 0.169038926 1467.835894 0 0 16.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42358 0 0 17.7669 0 0 0 16.0095 0 0 0 0 0 0 0 P87889 GAK10_HUMAN "Endogenous retrovirus group K member 10 Gag polyprotein (HERV-K10 Gag protein) (HERV-K107 Gag protein) (HERV-K_5q33.3 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-10 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 TWWIDGVQEQVRR 6.170000076 1 1 0.087236235 1671.808506 0 14.61484 16.15098 0 0 0 0 0 14.48161 0 0 0 0 0 9.540847 0 0 0 0 0 0 14.67813 0 0 0 0 15.90708 14.63697 0 14.82141 0 0 0 0 0 0 0 0 0 15.35617 0 0 15.30964 0 0 0 0 0 P98088 MUC5A_HUMAN "Mucin-5AC, MUC-5AC (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin, TBM)" MUC5AC MUC5 Homo sapiens (Human) phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; phosphatidylinositol-mediated signaling [GO:0048015] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005615; GO:0005737; GO:0005796; GO:0005886; GO:0031012; GO:0048015; GO:0070062; GO:0070701 SVECRAEDAPGVPLR 9.270000458 1 1 0.315101962 1655.828407 0 0 17.10004 0 0 0 0 0 16.14919 0 15.19091 0 17.22892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.79945 0 0 18.07553 0 0 0 0 0 18.81486 0 17.58505 0 0 0 0 17.50516 0 0 16.17813 0 P98155 VLDLR_HUMAN "Very low-density lipoprotein receptor, VLDL receptor, VLDL-R" VLDLR Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] GO:0005041; GO:0005509; GO:0005765; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007165; GO:0007399; GO:0007613; GO:0008203; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006 CPASEIQCGSGECIHKK 3.160000086 1 1 0.354436877 1960.577753 0 15.1643 10.11792 13.6676 8.990589 13.92411 0 0 0 15.92483 12.49665 0 0 0 0 14.81955 11.26006 0 13.32023 15.37913 0 0 0 15.50637 0 0 0 0 0 0 14.82979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98160 PGBM_HUMAN "Basement membrane-specific heparan sulfate proteoglycan core protein, HSPG (Perlecan, PLC) [Cleaved into: Endorepellin; LG3 peptide ]" HSPG2 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022] GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907 SIGASVEFHCAVPSDR 4.409999847 1 1 0.157181043 1731.169557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98161 PKD1_HUMAN "Polycystin-1, PC1 (Autosomal dominant polycystic kidney disease 1 protein)" PKD1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell-cell signaling by wnt [GO:0198738]; cell-matrix adhesion [GO:0007160]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of cell polarity [GO:0030010]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]; calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; Wnt-activated receptor activity [GO:0042813]; anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell-cell signaling by wnt [GO:0198738]; cell-matrix adhesion [GO:0007160]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of cell polarity [GO:0030010]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510] calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; Wnt-activated receptor activity [GO:0042813] GO:0000139; GO:0001502; GO:0001701; GO:0001822; GO:0001889; GO:0001892; GO:0002133; GO:0005262; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006611; GO:0006816; GO:0007156; GO:0007160; GO:0007161; GO:0007204; GO:0007259; GO:0007507; GO:0009653; GO:0009986; GO:0016020; GO:0016021; GO:0016323; GO:0016328; GO:0018105; GO:0019901; GO:0019904; GO:0021510; GO:0021915; GO:0030010; GO:0030155; GO:0030246; GO:0030660; GO:0031514; GO:0032092; GO:0034405; GO:0034703; GO:0034704; GO:0036303; GO:0042813; GO:0042994; GO:0043588; GO:0044325; GO:0045737; GO:0045944; GO:0048565; GO:0048754; GO:0048806; GO:0050982; GO:0051216; GO:0051290; GO:0051726; GO:0060170; GO:0060236; GO:0060428; GO:0060674; GO:0061136; GO:0070062; GO:0070588; GO:0072164; GO:0072177; GO:0072205; GO:0072218; GO:0072237; GO:0072287; GO:0198738; GO:2000045 AVFLELTR 1.580000043 1 1 0.10556598 949.4080118 0 15.69222 15.19138 15.04783 13.76627 0 0 15.59998 13.05251 17.80483 0 0 0 0 0 0 0 0 0 0 0 0 14.06749 0 0 0 0 12.01901 16.40454 13.11815 0 0 0 0 0 0 0 16.43413 0 15.00932 0 0 0 0 0 0 0 0 P98169 ZXDB_HUMAN Zinc finger X-linked protein ZXDB ZXDB Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0005634; GO:0006357; GO:0046872 EIPKLLPAR 12.26000023 1 1 0.250885626 1038.571777 0 0 0 15.38701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.49706 15.99748 0 0 0 0 0 16.73801 0 0 14.97474 0 0 15.20275 0 0 0 0 0 0 0 0 0 0 0 0 P98170 XIAP_HUMAN "E3 ubiquitin-protein ligase XIAP, EC 2.3.2.27 (Baculoviral IAP repeat-containing protein 4) (IAP-like protein, ILP, hILP) (Inhibitor of apoptosis protein 3, IAP-3, hIAP-3, hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein, X-linked IAP)" XIAP API3 BIRC4 IAP3 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006974; GO:0010804; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046330; GO:0046872; GO:0050727; GO:0051402; GO:0051726; GO:0055070; GO:0060785; GO:0061630; GO:0070424; GO:0090263; GO:0097340; GO:0120283; GO:1902530; GO:1990001 DSMQDESSQTSLQK 11.81000042 1 1 0.446593394 1584.187682 17.50076 18.31447 11.25885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.87019 0 0 0 0 0 17.79813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98171 RHG04_HUMAN Rho GTPase-activating protein 4 (Rho-GAP hematopoietic protein C1) (Rho-type GTPase-activating protein 4) (p115) ARHGAP4 KIAA0131 RGC1 RHOGAP4 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802] GO:0005096; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0007010; GO:0007266; GO:0010764; GO:0030336; GO:0030426; GO:0030517; GO:0042802; GO:0051056 QAKFMEHK 5.949999809 0.929957747 0.929957747 0.220279022 1037.698402 16.74676 0 0 0 17.39382 14.55409 0 14.87217 11.71614 16.72951 0 0 0 0 0 0 0 0 0 0 0 0 16.52583 0 0 16.51042 0 15.73494 13.79132 0 17.62178 0 16.8988 0 17.64956 17.58513 16.58261 16.32693 0 16.86502 17.1627 13.63934 0 15.55241 0 0 16.72286 0 P98172 EFNB1_HUMAN "Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]" EFNB1 EFL3 EPLG2 LERK2 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ephrin receptor binding [GO:0046875]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295] ephrin receptor binding [GO:0046875] GO:0001755; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0007411; GO:0009880; GO:0031295; GO:0042102; GO:0045121; GO:0045202; GO:0046875; GO:0048013; GO:0070062 LATPLAK 8.579999924 1 1 0.178667499 714.786318 0 0 15.54706 0 0 0 13.24029 0 14.78237 0 17.2558 0 16.51756 0 0 0 15.80433 0 0 0 17.07204 14.5336 16.35943 0 0 16.9194 0 16.04116 15.35678 0 0 14.04577 0 0 15.72551 15.76535 0 0 0 0 17.54587 0 0 16.15567 15.82911 0 0 0 P98173 FAM3A_HUMAN Protein FAM3A (Cytokine-like protein 2-19) FAM3A 2-19 2.19 Homo sapiens (Human) antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890] extracellular space [GO:0005615] extracellular space [GO:0005615]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890] GO:0005615; GO:0019732; GO:0045721; GO:0046890; GO:0061844; GO:1905035 YEGWPEALEMEGCIPRR 7.849999905 1 1 0.030680802 2109.801257 10.72247 14.21578 0 0 13.73555 0 14.49188 0 12.79288 0 14.9883 13.72831 14.07262 0 0 14.68967 0 0 0 0 0 0 0 0 14.47607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.79645 0 0 0 P98175 RBM10_HUMAN "RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1, S1-1)" RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 Homo sapiens (Human) "3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] GO:0000122; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0008285; GO:0016607; GO:0032991; GO:0034393; GO:0035198; GO:0042802; GO:0046872; GO:0048025; GO:0070935 DRAAER 7.78000021 0.578762591 0.578762591 0.076524888 716.6247491 13.97782 14.24446 14.02073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.75406 0 0 0 0 0 0 0 0 0 P98177 FOXO4_HUMAN Forkhead box protein O4 (Fork head domain transcription factor AFX1) FOXO4 AFX AFX1 MLLT7 Homo sapiens (Human) "aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]" "beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007095; GO:0007517; GO:0007568; GO:0008013; GO:0008285; GO:0008286; GO:0014911; GO:0016525; GO:0016607; GO:0019899; GO:0031667; GO:0042802; GO:0043565; GO:0045944; GO:0048863; GO:0051151; GO:0070317; GO:0140297; GO:1990785; GO:1990837; GO:1990841 AASMDSSSK 3.349999905 0.002145959 0.002145959 0.279817859 899.8266368 0 0 16.52324 0 0 0 16.68164 0 0 17.85969 0 17.2781 18.67351 16.65868 0 0 0 18.09267 0 0 0 0 0 0 0 19.01526 17.25444 0 0 0 17.19337 16.21908 0 0 0 0 0 0 0 17.27215 0 17.8462 0 16.88539 16.6639 15.60011 16.51469 0 P98182 ZN200_HUMAN Zinc finger protein 200 ZNF200 ZNFMF Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005634; GO:0046872 HEKTHSACK 5.900000095 0.533334434 0.533334434 0.197517049 1096.629413 15.96887 0 13.78021 15.58273 14.98974 0 0 0 11.71654 14.19235 13.75412 0 14.25999 12.47069 0 14.69186 13.93399 15.81897 15.27291 13.01125 16.13785 0 11.88348 0 15.78503 15.2711 0 0 0 0 0 0 0 0 0 0 0 15.02334 0 0 17.19864 0 0 0 0 0 0 0 P98194 AT2C1_HUMAN "Calcium-transporting ATPase type 2C member 1, ATPase 2C1, EC 7.2.2.10 (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1, SPCA1)" ATP2C1 KIAA1347 PMR1L HUSSY-28 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613] GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0015662; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0030173; GO:0031532; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0034220; GO:0042998; GO:0043123; GO:0046872; GO:0070588; GO:0098629; GO:0140613 TPLQKSMDLLGK 3.549999952 1 1 0.365376921 1345.364192 12.07363 13.83246 12.60731 13.13042 0 15.73045 0 0 14.80994 10.9901 12.93333 15.29039 14.62847 0 14.72756 0 0 0 0 0 16.31178 0 0 0 13.21715 0 0 0 0 15.75527 0 0 0 0 0 0 0 0 0 0 0 15.28636 0 0 0 0 0 0 P98196 AT11A_HUMAN "Phospholipid-transporting ATPase IH, EC 7.6.2.1 (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A)" ATP11A ATPIH ATPIS KIAA1021 Homo sapiens (Human) in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] GO:0000287; GO:0001701; GO:0005524; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0010831; GO:0016020; GO:0016887; GO:0035579; GO:0043231; GO:0045332; GO:0055037; GO:0070821; GO:0090555; GO:0090556; GO:0140326; GO:0140346; GO:1990531 DLTLLGATAVEDRLQEK 1.730000019 1 1 0.218965156 1874.695526 11.91422 9.165891 8.837191 13.25782 13.0803 0 0 14.55231 14.37602 16.20026 0 15.96008 0 0 15.02548 13.71261 0 0 15.59419 0 12.55615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05384 0 0 0 0 0 0 0 0 0 0 0 0 Q00056 HXA4_HUMAN Homeobox protein Hox-A4 (Homeobox protein Hox-1.4) (Homeobox protein Hox-1D) HOXA4 HOX1D Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0009952; GO:0016604; GO:0048704; GO:1990837 LPNTKMR 6.769999981 0.471686721 0.471686721 0.199794923 861.6569696 14.7803 14.27041 12.66263 15.87738 13.86568 13.64574 14.81398 0 14.73748 15.40493 15.48575 15.19946 0 15.43627 14.17911 12.6844 16.10146 14.77214 16.02324 15.45551 0 15.01628 0 0 0 0 14.60507 0 0 15.90084 0 14.53729 0 0 0 16.1878 0 0 15.60201 0 0 0 0 0 0 0 0 0 Q00169 PIPNA_HUMAN "Phosphatidylinositol transfer protein alpha isoform, PI-TP-alpha, PtdIns transfer protein alpha, PtdInsTP alpha" PITPNA PITPN Homo sapiens (Human) lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; stearic acid binding [GO:0070540]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601] fatty-acyl-CoA binding [GO:0000062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; stearic acid binding [GO:0070540] GO:0000062; GO:0005634; GO:0005737; GO:0005829; GO:0006629; GO:0007601; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0070062; GO:0070540; GO:0120019; GO:1901611 QLDEMR 11.64000034 0.132624596 0.132624596 0.051249596 807.8901541 17.79198 0 15.60151 15.81491 17.2596 16.42995 0 16.40644 0 17.98764 17.93525 15.54255 0 0 14.33344 16.21651 0 15.67024 0 16.40719 17.01695 0 0 17.8171 0 0 16.79858 15.60067 15.15097 0 15.19418 17.78852 0 17.49001 15.90207 0 0 17.51234 18.16638 17.19495 0 16.21001 16.80344 0 0 0 16.18028 0 Q00325 MPCP_HUMAN "Phosphate carrier protein, mitochondrial (Phosphate transport protein, PTP) (Solute carrier family 25 member 3)" SLC25A3 PHC OK/SW-cl.48 Homo sapiens (Human) mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435] extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877]; mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435] inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877] GO:0005315; GO:0005739; GO:0005743; GO:0005887; GO:0015317; GO:0016020; GO:0031305; GO:0035435; GO:0044877; GO:0070062; GO:1990547 DAAPK 1.659999967 1 1 0.277829794 502.0102 15.89019 15.10861 0 0 16.89513 16.16642 0 0 16.34767 16.10365 17.44177 15.77255 0 0 0 17.09608 0 17.53235 17.64632 18.25799 0 0 0 0 0 17.13822 0 0 17.25206 16.61279 17.6004 0 17.33162 16.75538 0 0 0 16.67965 19.06133 17.75435 17.73147 0 16.54237 16.62024 16.4493 17.13236 16.3946 16.57594 Q00341 VIGLN_HUMAN "Vigilin (High density lipoprotein-binding protein, HDL-binding protein)" HDLBP HBP VGL Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869] cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844] cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869] cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0045296 DLIIEQRFHR 5.789999962 0.481925786 0.481925786 0.102447473 1326.617267 13.66619 14.39933 13.48622 15.40085 13.26199 12.81131 13.61818 14.72647 14.80443 0 11.91178 0 0 0 0 0 0 0 12.47476 0 0 14.86839 0 0 0 15.36728 13.9296 0 14.3924 14.8557 0 0 14.42692 12.23674 11.4572 0 0 14.13075 0 12.58899 0 0 12.66482 15.02994 11.65205 0 0 0 Q00403 TF2B_HUMAN "Transcription initiation factor IIB, EC 2.3.1.48 (General transcription factor TFIIB) (S300-II)" GTF2B TF2B TFIIB Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083]" chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] "chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; acetyltransferase activity [GO:0016407]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083]" acetyltransferase activity [GO:0016407]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; zinc ion binding [GO:0008270] GO:0000979; GO:0000993; GO:0001174; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005694; GO:0006352; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032993; GO:0046966; GO:0051123; GO:0090575; GO:0097550; GO:0140297; GO:1904798; GO:1990114; GO:1990841 AMMNAFK 3.470000029 1 1 0.233715714 811.8488049 0 0 15.92427 16.40691 17.59659 0 0 0 17.47003 14.61123 0 0 0 0 0 0 0 0 0 0 0 15.98106 14.68018 0 15.68017 0 0 0 0 0 15.51838 17.57682 0 15.07424 14.22978 0 16.43336 0 0 0 0 0 0 0 0 0 0 15.60449 Q00535 CDK5_HUMAN "Cyclin-dependent kinase 5, EC 2.7.11.1 (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit, TPKII catalytic subunit)" CDK5 CDKN5 PSSALRE Homo sapiens (Human) "axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]" axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685] "axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]" acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635] GO:0000083; GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006468; GO:0006886; GO:0006913; GO:0007005; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0009611; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016310; GO:0016533; GO:0016572; GO:0018105; GO:0018107; GO:0019233; GO:0019901; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0030866; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0034352; GO:0035249; GO:0035418; GO:0042501; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046777; GO:0046826; GO:0046875; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098685; GO:0098793; GO:0098883; GO:0098978; GO:0099635; GO:0106310; GO:1901215; GO:1901387; GO:1903076; GO:1903421; GO:1904646; GO:2000251 HKNIVR 17.94000053 0.731312335 0.731312335 0.297407743 766.9975491 18.77433 17.7145 18.65128 17.34744 18.29691 0 0 21.24397 0 0 18.43351 18.01321 0 0 0 0 18.3692 17.95963 0 17.55663 16.65524 0 17.87792 0 0 0 0 19.26956 18.12523 0 0 19.93414 0 18.85303 0 20.72654 17.35696 21.25883 0 18.43114 0 0 17.47214 0 17.19384 0 0 17.4746 Q00536 CDK16_HUMAN "Cyclin-dependent kinase 16, EC 2.7.11.22 (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)" CDK16 PCTAIRE1 PCTK1 Homo sapiens (Human) exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000083; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0015630; GO:0030252; GO:0031175; GO:0031234; GO:0043005; GO:0061178; GO:0106310 RQLSMTLR 8.380000114 1 1 0.466385873 1017.728869 0 0 18.4896 0 19.27969 0 0 18.4048 0 0 0 0 19.12867 0 0 20.3159 0 19.12062 0 0 18.92368 0 0 0 0 19.68562 0 18.30233 17.26978 17.74712 20.07993 19.4383 0 0 0 0 0 0 0 0 0 0 0 18.99442 18.61102 0 0 0 Q00537 CDK17_HUMAN "Cyclin-dependent kinase 17, EC 2.7.11.22 (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)" CDK17 PCTAIRE2 PCTK2 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000083; GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310 ASLSEIGFGK 10.89999962 1 1 0.27021881 1011.120716 15.98227 15.43145 13.33971 15.15368 13.50965 13.2844 12.59024 13.66202 15.84428 14.12504 0 14.69423 15.28929 15.69835 15.39284 14.41544 0 0 0 15.6111 0 0 0 0 0 17.12839 15.5078 0 0 15.04947 0 0 16.64517 0 15.2702 17.56924 0 0 16.13196 0 0 0 15.85284 0 15.32161 0 0 15.63193 Q00653 NFKB2_HUMAN "Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10, Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit ]" NFKB2 LYT10 Homo sapiens (Human) "extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; spleen development [GO:0048536]" Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; spleen development [GO:0048536]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002268; GO:0002467; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0030198; GO:0033257; GO:0038061; GO:0045944; GO:0048511; GO:0048536; GO:0071159; GO:1990837 GPETRDK 7.429999828 1 1 0.291872952 803.4488278 0 14.54671 15.10011 0 0 0 0 13.67546 14.58456 16.16841 0 14.51289 0 16.17552 0 0 0 16.51819 0 17.42493 0 0 0 0 0 15.03493 0 15.90117 0 14.18114 14.95027 0 14.60955 0 0 14.6431 13.98394 0 11.33484 0 15.51276 14.27316 10.83948 10.64604 14.57266 14.53273 15.45786 13.9979 Q00722 PLCB2_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-2) (Phospholipase C-beta-2, PLC-beta-2)" PLCB2 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipid metabolic process [GO:0006644] cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543]; activation of phospholipase C activity [GO:0007202]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipid metabolic process [GO:0006644] calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543] GO:0001580; GO:0004435; GO:0004629; GO:0005509; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0006644; GO:0007186; GO:0007200; GO:0007202; GO:0016042; GO:0031680; GO:0031683; GO:0046488; GO:0048015 LKEAMGGLPEKPFPLASPVASQVNGALAPTSNGSPAAR 6.21999979 1 1 0.162541002 3745.894828 0 0 16.50043 0 0 0 13.74763 0 0 0 15.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.16592 0 0 0 0 0 0 0 0 0 0 14.76219 0 16.50941 0 0 0 0 12.83768 0 0 0 0 Q00872 MYPC1_HUMAN "Myosin-binding protein C, slow-type, Slow MyBP-C (C-protein, skeletal muscle slow isoform)" MYBPC1 MYBPCS Homo sapiens (Human) cell adhesion [GO:0007155]; muscle contraction [GO:0006936] cytosol [GO:0005829]; myofibril [GO:0030016]; myosin filament [GO:0032982] cytosol [GO:0005829]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin binding [GO:0003779]; myosin binding [GO:0017022]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cell adhesion [GO:0007155]; muscle contraction [GO:0006936] actin binding [GO:0003779]; myosin binding [GO:0017022]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432] GO:0003779; GO:0005829; GO:0006936; GO:0007155; GO:0008307; GO:0017022; GO:0030016; GO:0031432; GO:0032982 GRIHK 2.880000114 1 1 0.190380887 610.4342973 0 0 15.81486 12.7017 15.04998 14.17451 0 0 14.76845 14.20787 15.55138 16.78807 15.0888 0 15.67774 0 14.06072 0 0 16.51681 0 0 0 14.76184 15.25553 15.02248 0 0 0 0 0 0 0 0 15.22152 0 0 0 0 0 14.37708 0 0 16.73073 0 15.64091 16.29792 16.01763 Q00975 CAC1B_HUMAN "Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III, BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2)" CACNA1B CACH5 CACNL1A5 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; protein C-terminus binding [GO:0008022]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; protein C-terminus binding [GO:0008022]; voltage-gated calcium channel activity [GO:0005245] GO:0001540; GO:0005245; GO:0005509; GO:0005524; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0008022; GO:0008331; GO:0034765; GO:0045202; GO:0050804; GO:0070509; GO:1904645 ARTMALYNPIPVK 11.02999973 1 1 0.487983813 1472.812219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64796 0 0 0 17.78571 0 0 0 0 0 0 0 0 0 17.13847 0 0 18.61656 0 18.35679 0 0 0 0 18.5929 0 0 0 0 17.97306 0 0 0 Q00994 BEX3_HUMAN Protein BEX3 (Brain-expressed X-linked protein 3) (Nerve growth factor receptor-associated protein 1) (Ovarian granulosa cell 13.0 kDa protein HGR74) (p75NTR-associated cell death executor) BEX3 DXS6984E NADE NGFRAP1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165] cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005163; GO:0005634; GO:0005737; GO:0005829; GO:0006919; GO:0007165; GO:0007275; GO:0008625; GO:0008656; GO:0042802; GO:0046872 QINDGMGGDGDDMEIFMEEMR 1.980000019 1 1 1.37E-12 2420.798015 0 12.88762 11.6261 15.89766 0 15.21568 13.14151 0 0 0 13.98128 0 0 11.9989 5.916334 14.39033 0 12.79227 0 13.22343 13.05707 0 0 0 0 14.41197 13.62004 0 11.51381 11.93375 0 0 0 0 0 0 0 0 0 13.48017 0 0 0 13.41166 11.17179 0 12.35913 0 Q01064 PDE1B_HUMAN "Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B, Cam-PDE 1B, EC 3.1.4.17 (63 kDa Cam-PDE)" PDE1B PDES1B Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter levels [GO:0001505]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; signal transduction [GO:0007165]; visual learning [GO:0008542] cytosol [GO:0005829]; neuronal cell body [GO:0043025] "cytosol [GO:0005829]; neuronal cell body [GO:0043025]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter levels [GO:0001505]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; signal transduction [GO:0007165]; visual learning [GO:0008542]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]" GO:0001505; GO:0001975; GO:0004114; GO:0004115; GO:0004117; GO:0005516; GO:0005829; GO:0006915; GO:0007165; GO:0007626; GO:0008542; GO:0030224; GO:0036006; GO:0042053; GO:0042428; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0097011 SDAVPSEVR 21.28000069 0.566990137 0.566990137 0.462287655 960.4104939 17.69439 19.76056 0 0 18.02165 0 0 0 0 0 19.00774 0 0 0 0 0 19.52567 0 16.92981 0 17.70926 0 0 20.05742 0 21.32247 21.50541 0 16.25776 0 0 0 0 0 18.83125 0 0 22.47102 18.22619 0 0 18.76124 0 20.26186 0 0 19.68869 0 Q01081 U2AF1_HUMAN Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit) U2AF1 U2AF35 U2AFBP FP793 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0030628; GO:0046872; GO:0071013; GO:0089701 GRGGGGGGGGGGGGR 3.450000048 0.00930344 0.00930344 0.183554805 1072.019539 0 0 15.19162 14.05837 0 16.87345 0 0 12.27913 0 0 14.48487 14.36909 17.72645 0 17.90604 12.92845 0 16.14039 0 0 0 0 16.25888 16.9455 14.89293 14.48363 0 15.52309 0 0 0 0 0 14.66434 0 16.6002 15.73614 0 12.59925 0 15.93087 0 17.822 16.67206 16.31662 0 0 Q01082 SPTB2_HUMAN "Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)" SPTBN1 SPTB2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390] axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731] axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200] GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007182; GO:0008091; GO:0014069; GO:0014731; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078 ETASELLMRLK 2.180000067 1 1 0.69738817 1305.514237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01118 SCN7A_HUMAN Sodium channel protein type 7 subunit alpha (Putative voltage-gated sodium channel subunit alpha Nax) (Sodium channel protein cardiac and skeletal muscle subunit alpha) (Sodium channel protein type VII subunit alpha) SCN7A SCN6A Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; glial cell projection [GO:0097386]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; glial cell projection [GO:0097386]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0006936; GO:0009617; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0055078; GO:0086010; GO:0097386 LKEFVHR 11.36999989 1 1 0.218788889 928.0382078 14.16079 15.96532 14.48494 0 0 14.42639 0 0 0 14.5672 12.66322 0 0 0 0 0 0 0 0 15.45416 17.32269 0 0 0 0 0 0 0 0 18.07576 0 0 0 0 17.27019 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01151 CD83_HUMAN "CD83 antigen, hCD83 (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83)" CD83 Homo sapiens (Human) "defense response [GO:0006952]; humoral immune response [GO:0006959]; negative regulation of interleukin-4 production [GO:0032713]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]" external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; defense response [GO:0006952]; humoral immune response [GO:0006959]; negative regulation of interleukin-4 production [GO:0032713]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]" GO:0005886; GO:0005887; GO:0006952; GO:0006959; GO:0007165; GO:0009897; GO:0014070; GO:0032713; GO:0032733; GO:0032743; GO:0043372 LLEGGEER 5.599999905 0.2271595 0.2271595 0.268949032 901.6429572 18.3219 0 0 0 18.40643 19.27757 18.11848 0 0 16.54429 17.28163 0 16.60759 0 0 0 0 0 17.46265 16.11578 16.3342 18.43714 0 0 0 0 0 17.91958 0 0 19.96668 19.24266 0 0 0 19.7213 17.93129 0 20.11892 0 0 0 0 0 0 17.30191 17.78817 19.18712 Q01201 RELB_HUMAN Transcription factor RelB (I-Rel) RELB Homo sapiens (Human) "antigen processing and presentation [GO:0019882]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063]" chromatin [GO:0000785]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; antigen processing and presentation [GO:0019882]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006357; GO:0006954; GO:0007249; GO:0010628; GO:0017053; GO:0019882; GO:0019901; GO:0030098; GO:0032688; GO:0032922; GO:0032991; GO:0034097; GO:0038061; GO:0042802; GO:0043011; GO:0045063; GO:0045087; GO:0045892; GO:0045944; GO:0071159; GO:0071470 DHDSYGVDK 2.789999962 1 1 0.08000125 1034.980229 0 0 0 0 0 0 0 0 0 0 0 14.25865 0 0 0 0 15.36042 0 0 0 0 0 0 0 15.85579 0 0 15.45184 15.84562 0 0 0 12.43298 0 0 0 0 0 0 0 0 0 0 0 0 0 14.40555 0 Q01344 IL5RA_HUMAN "Interleukin-5 receptor subunit alpha, IL-5 receptor subunit alpha, IL-5R subunit alpha, IL-5R-alpha, IL-5RA (CDw125) (CD antigen CD125)" IL5RA IL5R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165] cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914] GO:0002437; GO:0004896; GO:0004914; GO:0005615; GO:0005886; GO:0007165; GO:0009897; GO:0016021; GO:0019221; GO:0019955; GO:0032674; GO:0043235; GO:0070665 NVNLEYQVK 5.460000038 0.282229811 0.282229811 0.177997614 1103.537735 12.4168 7.650814 13.72603 13.09255 13.61117 11.29896 0 15.13016 0 12.06332 0 13.2325 14.28022 0 14.01814 14.01548 14.86636 0 0 0 14.72674 0 0 15.59448 0 14.02582 0 0 0 14.98043 15.05348 0 14.79861 14.40155 13.94574 13.72811 0 13.58448 13.52833 15.10902 0 14.43157 0 0 16.44794 0 0 0 Q01415 GALK2_HUMAN "N-acetylgalactosamine kinase, EC 2.7.1.157 (GalNAc kinase) (Galactokinase 2)" GALK2 GK2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012] ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858] GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858 AATSHFNIR 4.309999943 0.922966659 0.922966659 0.139054207 1017.508227 0 0 0 0 15.64374 0 15.59529 16.34508 0 0 0 0 16.52721 16.42826 0 16.46836 0 0 0 16.63783 13.49794 0 0 0 0 0 0 10.46961 0 0 15.64847 14.4292 0 14.51542 0 14.02342 0 15.53834 0 0 0 0 0 14.45809 17.61605 0 0 0 Q01432 AMPD3_HUMAN "AMP deaminase 3, EC 3.5.4.6 (AMP deaminase isoform E) (Erythrocyte AMP deaminase)" AMPD3 Homo sapiens (Human) AMP catabolic process [GO:0006196]; AMP metabolic process [GO:0046033]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP catabolic process [GO:0006196]; AMP metabolic process [GO:0046033]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872] GO:0003876; GO:0005576; GO:0005829; GO:0006188; GO:0006196; GO:0032264; GO:0034774; GO:0046033; GO:0046872; GO:1904813 EFLHK 10.21000004 0.373507261 0.373507261 0.139975763 673.4877573 16.66371 16.28241 17.22622 0 16.73049 15.83932 15.74117 16.64943 16.56141 16.29214 17.73045 16.78338 18.04227 16.07555 16.99462 17.40107 16.9773 16.68502 17.35559 17.72049 17.31581 15.20599 17.45751 16.51198 16.61151 17.90181 17.36148 17.26273 17.87074 17.58972 18.23969 17.23742 0 16.70417 17.02297 15.46986 17.57975 17.12981 17.13473 18.07293 17.62351 16.64482 16.89054 16.58127 16.14596 17.78556 17.63416 17.60039 Q01433 AMPD2_HUMAN "AMP deaminase 2, EC 3.5.4.6 (AMP deaminase isoform L)" AMPD2 Homo sapiens (Human) AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] cytosol [GO:0005829] cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0046033; GO:0046872; GO:0052652; GO:0097009 HFPLDLRTSMDGK 5.440000057 1 1 0.158936404 1531.910652 14.92481 0 13.4915 14.77137 15.70589 13.16584 15.43666 15.32289 0 15.14765 0 0 15.122 11.05253 13.64009 0 12.29934 13.11847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01484 ANK2_HUMAN "Ankyrin-2, ANK-2 (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)" ANK2 ANKB Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259 AGQVEVVR 8.960000038 1 1 0.128015356 858.334164 0 13.31343 13.60927 0 16.57537 0 0 16.71115 0 12.64419 16.12045 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88814 0 0 0 0 0 0 0 0 0 15.22568 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01538 MYT1_HUMAN "Myelin transcription factor 1, MyT1 (Myelin transcription factor I, MyTI) (PLPB1) (Proteolipid protein-binding protein)" MYT1 KIAA0835 KIAA1050 MTF1 MYTI PLPB1 Homo sapiens (Human) "cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007399; GO:0008270; GO:0030154 LSGDEVLSPKFK 13.5 0.47557795 0.47557795 0.156538642 1320.199688 14.08448 14.85333 0 15.50437 0 0 0 0 0 0 18.04161 0 0 0 0 16.43546 0 0 17.39702 0 0 0 0 12.75416 17.32027 17.66609 19.26654 0 0 0 0 0 0 0 0 0 0 15.91732 0 0 0 0 0 0 0 0 0 0 Q01581 HMCS1_HUMAN "Hydroxymethylglutaryl-CoA synthase, cytoplasmic, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)" HMGCS1 HMGCS Homo sapiens (Human) "acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]" hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803] GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0010142; GO:0042803 TGVAPDVFAENMKLR 4.829999924 1 1 0.377713927 1647.506371 0 0 0 0 0 0 0 0 0 0 0 15.7531 16.13859 0 0 0 0 0 0 0 0 0 0 0 0 0 17.67798 0 0 0 0 0 0 0 18.32953 0 17.69785 0 20.18344 0 0 0 0 16.91972 17.83151 0 18.03039 0 Q01629 IFM2_HUMAN "Interferon-induced transmembrane protein 2 (Dispanin subfamily A member 2c, DSPA2c) (Interferon-inducible protein 1-8D)" IFITM2 Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; immune response [GO:0006955]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] cell junction [GO:0030054]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell junction [GO:0030054]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; immune response [GO:0006955]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] GO:0005654; GO:0005765; GO:0005886; GO:0006955; GO:0009615; GO:0016021; GO:0030054; GO:0031902; GO:0032991; GO:0034341; GO:0035455; GO:0035456; GO:0035458; GO:0045071; GO:0046597; GO:0051607; GO:0060337 KMVGDVTGAQAYASTAK 6.949999809 1 1 9.22E-13 1713.084408 16.55168 0 11.83033 12.71823 14.80793 0 0 0 15.0625 0 14.91902 0 0 14.10484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01668 CAC1D_HUMAN "Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)" CACNA1D CACH3 CACN4 CACNL1A2 CCHL1A2 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605] alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059] GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007188; GO:0007605; GO:0030018; GO:0030506; GO:0045762; GO:0046872; GO:0051393; GO:0051928; GO:0060372; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086046; GO:0086059; GO:0086091; GO:1901016; GO:1901379; GO:1990454 TEGNLEQANEELRAVIK 1.320000052 1 1 0.277715197 1913.104316 0 0 0 0 0 0 0 0 0 13.62453 15.18919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.33375 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01726 MSHR_HUMAN "Melanocyte-stimulating hormone receptor, MSH-R (Melanocortin receptor 1, MC1-R)" MC1R MSHR Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625] GO:0004930; GO:0004977; GO:0004980; GO:0005737; GO:0005886; GO:0005887; GO:0007187; GO:0007189; GO:0007275; GO:0008528; GO:0009650; GO:0010739; GO:0019222; GO:0019233; GO:0031625; GO:0032720; GO:0035556; GO:0042438; GO:0042562; GO:0043473; GO:0045944; GO:0051897; GO:0070914; GO:0090037; GO:2000253 AVQGSQR 10.47000027 0.91760689 0.91760689 0.020054239 744.4392453 0 15.75051 0 12.44218 0 0 0 11.79094 14.19207 18.22303 14.55044 0 16.00311 16.16341 15.66612 15.27517 14.21096 14.91183 16.64772 13.75768 15.60462 17.44912 0 0 15.92893 15.42645 12.34268 0 0 0 16.16321 14.69396 0 13.26603 10.45659 0 15.74151 16.28917 0 10.46861 14.15868 0 14.90577 0 12.92795 0 16.32965 16.02453 Q01740 FMO1_HUMAN "Dimethylaniline monooxygenase [N-oxide-forming] 1, EC 1.14.13.8 (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1, FMO 1)" FMO1 Homo sapiens (Human) NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; response to osmotic stress [GO:0006970]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; response to osmotic stress [GO:0006970]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]" "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" GO:0004497; GO:0004499; GO:0005788; GO:0005789; GO:0006082; GO:0006805; GO:0006970; GO:0009404; GO:0016021; GO:0032496; GO:0050660; GO:0050661; GO:0070995 SVVSNSCK 6.78000021 1 1 0.128171111 881.0044543 15.27709 11.97105 13.50879 14.33144 13.99451 13.66379 12.93301 0 15.19402 15.17321 15.84264 15.50437 14.60953 13.11331 14.20643 13.31577 0 14.39965 14.35954 14.92156 0 15.94443 0 14.09691 0 0 0 0 0 0 0 0 0 0 0 0 15.48232 0 0 0 0 14.80126 0 0 0 0 0 0 Q01814 AT2B2_HUMAN "Plasma membrane calcium-transporting ATPase 2, PMCA2, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2)" ATP2B2 PMCA2 Homo sapiens (Human) brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022] GO:0003407; GO:0005388; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0007420; GO:0007605; GO:0008022; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030182; GO:0032591; GO:0032809; GO:0034220; GO:0035254; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0070062; GO:0098688; GO:0098839; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:1903779; GO:1905056; GO:1905059 ASMHKK 5.610000134 0.736428201 0.736428201 0.122133907 716.9873161 14.07804 14.11581 16.88393 16.18818 16.22305 0 11.68613 13.59464 14.64875 15.66982 16.80809 0 16.9861 14.86038 17.63614 13.14303 14.46477 0 16.58975 0 15.23666 13.58331 14.64401 12.60855 16.61619 15.61888 15.03209 16.42819 16.50643 15.17924 12.57143 15.39153 16.38359 16.75123 16.65017 0 11.02547 0 11.62211 13.7916 16.60498 17.24986 14.92782 17.20121 13.9534 14.42056 12.91221 13.5433 Q01826 SATB1_HUMAN DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1) SATB1 Homo sapiens (Human) chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003690; GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006357; GO:0016363; GO:0016604; GO:0016605; GO:0043565 DHLNEATQGK 6.829999924 0.675147891 0.675147891 0.164921555 1112.554794 12.44407 15.31885 14.77392 0 0 0 0 0 0 0 15.12162 0 0 12.86448 14.378 0 0 0 15.3165 0 0 16.93588 0 0 13.53021 12.49653 13.08466 12.18712 12.8357 13.67812 12.51285 12.8581 15.47565 15.16728 13.17911 14.86884 0 15.87218 0 13.74392 14.90968 14.4898 13.7034 14.73369 12.06131 11.70338 13.8979 14.32764 Q01844 EWS_HUMAN RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein) EWSR1 EWS Homo sapiens (Human) Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0003723; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0015030; GO:0042802; GO:0046872 GGMSR 2.930000067 0.329243243 0.329243243 0.05883209 523.7653575 17.21283 12.58255 0 17.99013 13.23871 16.02632 11.26424 0 15.6102 17.93219 0 17.87056 0 16.38022 14.39544 14.94437 0 0 17.37306 15.23583 16.13104 0 0 17.04775 16.88484 17.80438 14.99803 15.85901 17.1538 16.1132 13.44206 0 17.69533 10.42266 17.92287 16.49228 16.11389 17.41164 13.18292 16.36484 16.55035 17.15984 0 13.67953 19.2529 14.50065 16.37803 16.64704 Q01850 CDR2_HUMAN Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen) CDR2 PCD17 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 LVPDSLYVPFK 6.769999981 1 1 0.417674246 1276.774813 0 0 0 0 0 0 0 0 0 15.29723 15.93183 0 0 0 0 0 0 16.55097 17.18279 0 15.43486 0 0 0 0 0 0 0 0 0 15.73482 15.0613 0 15.85374 16.92117 16.42519 16.36173 0 14.80509 0 16.80409 0 0 17.22949 0 15.30215 14.62918 14.62144 Q01851 PO4F1_HUMAN "POU domain, class 4, transcription factor 1 (Brain-specific homeobox/POU domain protein 3A, Brain-3A, Brn-3A) (Homeobox/POU domain protein RDC-1) (Oct-T1)" POU4F1 BRN3A RDC1 Homo sapiens (Human) axonogenesis [GO:0007409]; cell migration in hindbrain [GO:0021535]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; central nervous system neuron differentiation [GO:0021953]; habenula development [GO:0021986]; heart development [GO:0007507]; innervation [GO:0060384]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; neuron projection development [GO:0031175]; peripheral nervous system neuron development [GO:0048935]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; proprioception involved in equilibrioception [GO:0051355]; regulation of cell cycle [GO:0051726]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory system development [GO:0048880]; suckling behavior [GO:0001967]; synapse assembly [GO:0007416]; trigeminal nerve development [GO:0021559]; ventricular compact myocardium morphogenesis [GO:0003223] chromatin [GO:0000785]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; axonogenesis [GO:0007409]; cell migration in hindbrain [GO:0021535]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; central nervous system neuron differentiation [GO:0021953]; habenula development [GO:0021986]; heart development [GO:0007507]; innervation [GO:0060384]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; neuron projection development [GO:0031175]; peripheral nervous system neuron development [GO:0048935]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; proprioception involved in equilibrioception [GO:0051355]; regulation of cell cycle [GO:0051726]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory system development [GO:0048880]; suckling behavior [GO:0001967]; synapse assembly [GO:0007416]; trigeminal nerve development [GO:0021559]; ventricular compact myocardium morphogenesis [GO:0003223]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001967; GO:0003223; GO:0003682; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007409; GO:0007416; GO:0007498; GO:0007507; GO:0010628; GO:0010629; GO:0021535; GO:0021559; GO:0021953; GO:0021986; GO:0031175; GO:0043005; GO:0043065; GO:0043066; GO:0043069; GO:0043524; GO:0043565; GO:0045672; GO:0045944; GO:0048665; GO:0048880; GO:0048935; GO:0050767; GO:0051020; GO:0051090; GO:0051355; GO:0051726; GO:0060384; GO:0061629; GO:0071345; GO:0071392; GO:0072332; GO:0090575; GO:1990837; GO:2000679 MSMNSK 6.5 0.76463449 0.76463449 0.110197547 728.7061253 0 21.02493 15.96624 0 0 0 15.18544 9.510246 17.07266 0 0 0 0 13.88147 13.4149 11.81508 14.34995 15.28625 14.02505 15.8835 14.90215 16.75235 16.12657 0 0 16.89064 0 0 16.57777 16.38141 15.37508 15.79154 18.09389 18.97135 16.83949 16.48672 16.31725 15.80083 16.98992 17.78589 0 16.02777 15.54456 15.52016 15.71131 0 12.76003 16.84366 Q01955 CO4A3_HUMAN Collagen alpha-3(IV) chain (Goodpasture antigen) [Cleaved into: Tumstatin ] COL4A3 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; response to glucose [GO:0009749]; sensory perception of sound [GO:0007605] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; response to glucose [GO:0009749]; sensory perception of sound [GO:0007605] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; structural molecule activity [GO:0005198] GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005783; GO:0005788; GO:0006919; GO:0007155; GO:0007166; GO:0007605; GO:0008015; GO:0008191; GO:0008285; GO:0009749; GO:0016525; GO:0030020; GO:0030198; GO:0031012; GO:0032836; GO:0038063; GO:0043231; GO:0062023; GO:0072577; GO:1905563 GAMGDAGPR 7.110000134 1 1 0.570046992 832.3788057 0 0 0 0 0 0 0 0 13.50736 0 0 0 0 0 9.483438 0 0 14.97743 0 0 0 0 0 0 0 0 0 15.01068 0 0 12.79081 15.14298 0 15.65686 0 0 0 15.52387 16.63281 0 9.808957 0 0 0 0 0 14.90282 0 Q01959 SC6A3_HUMAN "Sodium-dependent dopamine transporter, DA transporter, DAT (Solute carrier family 6 member 3)" SLC6A3 DAT1 Homo sapiens (Human) adenohypophysis development [GO:0021984]; aging [GO:0007568]; dopamine biosynthetic process [GO:0042416]; dopamine catabolic process [GO:0042420]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; dopamine uptake involved in synaptic transmission [GO:0051583]; hyaloid vascular plexus regression [GO:1990384]; lactation [GO:0007595]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; positive regulation of multicellular organism growth [GO:0040018]; prepulse inhibition [GO:0060134]; regulation of dopamine metabolic process [GO:0042053]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; flotillin complex [GO:0016600]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; flotillin complex [GO:0016600]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; amine binding [GO:0043176]; dopamine binding [GO:0035240]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; adenohypophysis development [GO:0021984]; aging [GO:0007568]; dopamine biosynthetic process [GO:0042416]; dopamine catabolic process [GO:0042420]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; dopamine uptake involved in synaptic transmission [GO:0051583]; hyaloid vascular plexus regression [GO:1990384]; lactation [GO:0007595]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; positive regulation of multicellular organism growth [GO:0040018]; prepulse inhibition [GO:0060134]; regulation of dopamine metabolic process [GO:0042053]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] amine binding [GO:0043176]; dopamine binding [GO:0035240]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] GO:0002020; GO:0005102; GO:0005326; GO:0005330; GO:0005334; GO:0005737; GO:0005886; GO:0005887; GO:0006836; GO:0007568; GO:0007595; GO:0007608; GO:0007626; GO:0008504; GO:0009410; GO:0009986; GO:0010039; GO:0015844; GO:0015872; GO:0015874; GO:0016021; GO:0016600; GO:0021984; GO:0030424; GO:0032809; GO:0035094; GO:0035240; GO:0035725; GO:0040018; GO:0042053; GO:0042220; GO:0042416; GO:0042420; GO:0042734; GO:0043005; GO:0043025; GO:0043176; GO:0043679; GO:0044877; GO:0045121; GO:0045471; GO:0046872; GO:0047485; GO:0051583; GO:0051591; GO:0051721; GO:0060134; GO:0090494; GO:0098691; GO:0099055; GO:0099056; GO:1990384 GVTLPGAIDGIR 4.269999981 1 1 2.51E-12 1168.986825 15.69033 0 13.91199 15.90881 14.10991 16.81905 0 15.46351 11.41565 14.27536 11.67899 0 10.869 13.53073 16.91662 16.24415 0 0 0 0 16.69368 11.1972 15.45012 0 14.85473 15.19809 13.68202 11.41297 11.42483 0 0 16.57031 0 12.87243 14.23831 0 0 15.64558 13.24649 0 9.759056 8.672221 0 15.44414 0 13.4304 12.27199 0 Q01970 PLCB3_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3, PLC-beta-3)" PLCB3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629] GO:0003073; GO:0004435; GO:0004629; GO:0005509; GO:0005516; GO:0005634; GO:0005829; GO:0007186; GO:0016020; GO:0016042; GO:0032991; GO:0045296; GO:0046488; GO:0048015; GO:0099524 IAAFEEGGKFVGHR 5.75 1 1 0.386515402 1518.500483 0 0 0 0 20.38991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.37686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01973 ROR1_HUMAN "Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)" ROR1 NTRKR1 Homo sapiens (Human) astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725] "axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" "ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]" GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092; GO:1904929 NILIGEQLHVK 29.70000076 1 1 0.538705089 1262.897501 0 0 17.63337 18.1973 17.44654 0 0 0 0 17.18734 0 17.7811 17.30287 0 0 18.22428 18.84914 0 0 0 0 17.80731 0 0 0 0 0 0 16.62077 17.31097 0 0 0 0 18.43169 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01995 TAGL_HUMAN "Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha, SM22-alpha)" TAGLN SM22 WS3-10 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; muscle organ development [GO:0007517] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; epithelial cell differentiation [GO:0030855]; muscle organ development [GO:0007517] actin filament binding [GO:0051015] GO:0005737; GO:0005856; GO:0007517; GO:0030855; GO:0051015 GPSYGMSR 6.199999809 0.505950868 0.505950868 0.266319785 853.0779765 15.3759 15.33414 16.06796 0 15.05524 15.53721 15.39057 16.86964 12.48685 0 18.11842 16.06922 13.42802 15.69505 15.23949 0 15.69272 0 16.92725 15.58964 0 17.07683 16.12648 16.83998 16.45086 16.80154 17.08943 15.5902 15.49135 17.70698 16.90217 16.32187 14.58702 0 15.46577 17.09739 10.66669 15.82506 15.94721 0 0 16.23837 15.75329 10.58758 16.29006 15.094 0 0 Q02040 AK17A_HUMAN "A-kinase anchor protein 17A, AKAP-17A (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A, PRKA17A) (Splicing factor, arginine/serine-rich 17A)" AKAP17A CXYorf3 DXYS155E SFRS17A XE7 Homo sapiens (Human) "B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]" protein kinase A binding [GO:0051018]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018 STMDFIR 5.380000114 1 1 0.077253118 884.469946 0 17.33116 14.43489 15.01326 15.0369 16.9823 17.51952 0 14.2004 0 8.968304 0 0 15.20127 15.60202 0 16.48784 15.48221 15.32548 0 16.52278 0 0 17.46202 14.17277 16.33568 14.38986 14.50038 0 0 15.99092 17.44527 0 14.43471 16.68979 16.00687 0 0 11.43836 0 14.59482 15.07796 16.23148 0 15.96329 16.97192 14.06919 15.70183 Q02080 MEF2B_HUMAN Myocyte-specific enhancer factor 2B (RSRFR2) (Serum response factor-like protein 2) MEF2B XMEF2 Homo sapiens (Human) cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007517; GO:0030054; GO:0030154; GO:0042826; GO:0045944; GO:0046983; GO:1990837 VLLKYTEYSEPHESR 8.720000267 1 1 0.265473491 1850.181932 13.86262 0 13.06017 0 0 0 0 13.73577 0 0 0 0 0 0 0 16.43179 14.9578 0 0 0 14.86765 0 15.30399 16.12513 0 0 16.33557 0 15.30233 15.12373 14.37077 11.59262 0 15.37711 0 15.28354 0 0 0 0 0 0 0 0 0 0 0 0 Q02156 KPCE_HUMAN "Protein kinase C epsilon type, EC 2.7.11.13 (nPKC-epsilon)" PRKCE PKCE Homo sapiens (Human) "apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]" cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor activator activity [GO:0030546]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]" 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor activator activity [GO:0030546] GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0008047; GO:0010634; GO:0010763; GO:0010811; GO:0018105; GO:0019899; GO:0030546; GO:0030838; GO:0031397; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0043123; GO:0043231; GO:0043278; GO:0043410; GO:0045111; GO:0046872; GO:0048471; GO:0050730; GO:0050996; GO:0051279; GO:0051301; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0106310; GO:1903078; GO:2000650; GO:2001031 VMLAELK 8.829999924 1 1 0.168557886 818.954529 15.26135 0 15.98314 0 0 14.55814 14.49127 0 12.22108 19.04009 16.03854 17.14177 0 0 0 0 0 0 0 0 0 0 0 0 16.94481 0 0 17.44981 0 0 0 16.33108 0 0 0 0 0 17.97741 0 0 0 0 0 0 0 0 0 0 Q02218 ODO1_HUMAN "2-oxoglutarate dehydrogenase complex component E1, E1o, OGDC-E1, OGDH-E1, EC 1.2.4.2 (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase, Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase)" OGDH Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976] GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077 DPAAAPATGNK 13.31999969 1 1 0.478420745 1011.207699 0 18.71668 0 19.40862 17.38501 0 18.13123 0 0 17.50635 0 0 0 0 0 0 18.10114 0 0 17.88435 0 0 0 0 0 18.66995 0 0 18.91631 0 0 0 0 19.34698 21.03711 18.49658 0 0 0 17.58996 17.9177 0 19.53313 18.82158 18.88612 18.69606 0 0 Q02224 CENPE_HUMAN "Centromere-associated protein E (Centromere protein E, CENP-E) (Kinesin-7) (Kinesin-related protein CENPE)" CENPE Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071] "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]" ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0000278; GO:0000775; GO:0000776; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0008017; GO:0008574; GO:0015630; GO:0016020; GO:0030071; GO:0030496; GO:0043231; GO:0043515; GO:0045171; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0072686; GO:0099606; GO:0099607; GO:1990023 EEQHESINK 2.519999981 1 1 2.30E-13 1113.223342 12.59208 0 0 0 0 0 0 0 0 0 0 0 13.12895 0 0 14.37844 0 14.02646 14.47231 0 13.17218 0 0 0 0 0 0 0 0 0 12.83051 0 0 12.9176 14.80378 13.98394 0 0 17.19579 0 0 0 0 0 0 0 0 0 Q02241 KIF23_HUMAN Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149 MIVCVNPK 6.659999847 0.371962547 0.371962547 0.228591432 961.0024696 16.99418 14.40764 14.0249 12.59059 0 0 0 0 0 0 0 0 12.7325 0 0 0 0 15.23986 0 0 0 0 0 0 0 16.75187 0 0 15.5641 0 0 0 0 17.25563 0 0 0 0 0 15.81582 0 0 16.34627 0 16.66606 11.86912 13.88372 0 Q02252 MMSA_HUMAN "Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, MMSDH, Malonate-semialdehyde dehydrogenase [acylating], EC 1.2.1.18, EC 1.2.1.27 (Aldehyde dehydrogenase family 6 member A1)" ALDH6A1 MMSDH Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity [GO:0102662]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]; branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]" "fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity [GO:0102662]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]" GO:0000062; GO:0003723; GO:0004491; GO:0005654; GO:0005739; GO:0005759; GO:0006210; GO:0006573; GO:0006574; GO:0009083; GO:0018478; GO:0019859; GO:0050873; GO:0102662 ILQVSSKVK 1.950000048 1 1 0.032218615 1001.588604 17.44798 0 0 0 15.91619 0 0 0 0 17.26728 0 0 0 14.14085 13.84467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02297 NRG1_HUMAN "Pro-neuregulin-1, membrane-bound isoform, Pro-NRG1 [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity, ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin, HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor) ]" NRG1 GGF HGL HRGA NDF SMDF Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB signaling pathway [GO:0038127]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; protein-containing complex disassembly [GO:0032984]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB signaling pathway [GO:0038127]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; protein-containing complex disassembly [GO:0032984]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] GO:0000165; GO:0000902; GO:0003161; GO:0003222; GO:0003712; GO:0005102; GO:0005125; GO:0005176; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007154; GO:0007169; GO:0007171; GO:0007399; GO:0007416; GO:0007626; GO:0008083; GO:0008283; GO:0008284; GO:0010628; GO:0010667; GO:0014032; GO:0016020; GO:0016324; GO:0021781; GO:0021842; GO:0022011; GO:0030154; GO:0030296; GO:0030297; GO:0030307; GO:0030424; GO:0030879; GO:0030971; GO:0031334; GO:0031594; GO:0032148; GO:0032984; GO:0035556; GO:0038127; GO:0038129; GO:0038130; GO:0038138; GO:0042060; GO:0042177; GO:0043125; GO:0045213; GO:0045499; GO:0045785; GO:0045892; GO:0046579; GO:0048018; GO:0048513; GO:0048663; GO:0048709; GO:0051048; GO:0051155; GO:0051897; GO:0055007; GO:0055012; GO:0060045; GO:0060379; GO:0060956; GO:0070374; GO:0070886; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:0099149; GO:0099527; GO:0099560; GO:1900086; GO:2001223; GO:2001240 ASLADSGEYMCK 10.81999969 1 1 0.451621113 1347.203548 19.08724 20.37949 0 0 20.84619 0 0 19.42525 20.66261 0 0 0 0 21.43326 0 0 0 0 20.22317 18.71846 0 0 0 20.78869 19.57745 19.06438 0 0 0 19.56374 0 20.39973 0 0 22.09475 0 21.20185 0 0 20.8735 21.18248 0 0 21.14359 18.89387 0 0 0 Q02318 CP27A_HUMAN "Sterol 26-hydroxylase, mitochondrial, EC 1.14.15.15 (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)" CYP27A1 CYP27 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125]" "3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]" GO:0005506; GO:0005739; GO:0005743; GO:0005759; GO:0006699; GO:0006707; GO:0008203; GO:0008395; GO:0016125; GO:0020037; GO:0030343; GO:0031073; GO:0036378; GO:0047103; GO:0047748; GO:0047749 SIGLMFQNSLYATFLPK 3.930000067 0.992457092 0.992457092 6.94E-13 1945.84238 15.5162 15.71988 0 0 14.63202 0 0 0 0 0 0 0 16.90265 0 0 0 0 0 0 0 0 0 0 0 0 12.58506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.02878 0 Q02338 BDH_HUMAN "D-beta-hydroxybutyrate dehydrogenase, mitochondrial, EC 1.1.1.30 (3-hydroxybutyrate dehydrogenase, BDH) (Short chain dehydrogenase/reductase family 9C member 1)" BDH1 BDH SDR9C1 Homo sapiens (Human) lipid metabolic process [GO:0006629] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; lipid metabolic process [GO:0006629] 3-hydroxybutyrate dehydrogenase activity [GO:0003858] GO:0003858; GO:0005739; GO:0005759; GO:0006629; GO:0099617 AVLVTGCDSGFGFSLAKHLHSK 2.059999943 1 1 0.237175233 2332.385692 12.07836 0 11.5046 0 0 0 0 13.60747 14.08392 0 0 0 0 0 0 0 0 0 14.4266 0 10.89394 15.95693 13.63155 15.72935 0 0 14.04857 13.62581 0 0 0 0 13.50227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02388 CO7A1_HUMAN "Collagen alpha-1(VII) chain (Long-chain collagen, LC collagen)" COL7A1 Homo sapiens (Human) cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544] basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576; GO:0005590; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008544; GO:0030020; GO:0030134; GO:0033116; GO:0035987; GO:0062023 EGRDGPK 1.450000048 1 1 0.092638966 757.156273 0 13.69992 12.11433 14.73382 0 0 0 0 0 0 13.76145 10.94707 12.79029 0 0 15.68599 0 13.92082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02505 MUC3A_HUMAN "Mucin-3A, MUC-3A (Intestinal mucin-3A)" MUC3A MUC3 Homo sapiens (Human) extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]" "extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]" GO:0005201; GO:0005576; GO:0005796; GO:0005886; GO:0016021; GO:0030197 SGWWGGQR 8.380000114 1 1 1.03E-12 932.6075072 15.52916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.27187 0 0 0 0 0 0 13.81044 14.84775 0 0 12.99434 0 13.09721 0 16.44987 15.37012 0 0 15.69034 16.33071 15.46732 0 0 0 0 0 0 0 Q02509 OC90_HUMAN "Otoconin-90, Oc90 (Phospholipase A2 homolog)" OC90 PLA2L Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; otolith mineralization [GO:0045299]; phospholipid metabolic process [GO:0006644] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; otolith mineralization [GO:0045299]; phospholipid metabolic process [GO:0006644] calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623] GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0031012; GO:0045299; GO:0050482 ATSPPGSAEIVATR 9.529999733 1 1 0.209705387 1351.793875 16.2254 0 0 16.07718 16.20886 0 16.93773 0 0 17.09147 0 0 0 0 15.12964 15.82512 15.57004 15.21098 0 15.67622 0 0 17.66508 14.8244 0 17.40531 0 0 0 0 0 0 17.90215 14.80728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02539 H11_HUMAN Histone H1.1 (Histone H1a) H1-1 H1F1 HIST1H1A Homo sapiens (Human) chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982] cell surface [GO:0009986]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283] chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492] GO:0000785; GO:0000786; GO:0000791; GO:0003690; GO:0005634; GO:0005654; GO:0006334; GO:0007283; GO:0008201; GO:0009986; GO:0016584; GO:0030261; GO:0031490; GO:0031492; GO:0031982; GO:0045910; GO:0048260 MSETVPPAPAASAAPEKPLAGK 4.340000153 1 1 0.267643787 2121.223976 0 13.52593 9.799041 14.97141 14.75389 14.73765 13.99924 14.94625 14.10909 15.79965 14.76437 13.37191 15.47874 0 14.61778 15.01199 15.50689 0 0 0 0 0 0 16.49731 0 0 0 0 0 0 0 0 0 0 14.02841 0 15.77483 0 0 0 0 13.30948 0 0 0 0 0 0 Q02641 CACB1_HUMAN "Voltage-dependent L-type calcium channel subunit beta-1, CAB1 (Calcium channel voltage-dependent subunit beta 1)" CACNB1 CACNLB1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of voltage-gated calcium channel activity [GO:1901385] plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of voltage-gated calcium channel activity [GO:1901385] high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0008331; GO:0042383; GO:0045202; GO:0045933; GO:0070588; GO:1901385; GO:1902514; GO:1904646 MVQKTSMSR 1.600000024 0.456063747 0.456063747 0.176291174 1082.601669 0 15.17512 14.42062 14.64943 0 0 0 13.44269 12.96387 0 0 0 0 0 0 0 15.7395 10.82605 0 15.07981 16.3789 13.44846 0 0 0 15.98456 14.55375 16.02421 12.89883 15.35279 15.813 0 14.84079 13.53282 0 0 0 13.46185 0 0 0 0 15.13824 0 15.1787 15.39588 0 0 Q02643 GHRHR_HUMAN "Growth hormone-releasing hormone receptor, GHRH receptor (Growth hormone-releasing factor receptor, GRF receptor, GRFR)" GHRHR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]" G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046] GO:0004930; GO:0005637; GO:0005640; GO:0005737; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007595; GO:0008284; GO:0008340; GO:0008528; GO:0009986; GO:0016021; GO:0016363; GO:0016520; GO:0017046; GO:0019838; GO:0019933; GO:0030104; GO:0030141; GO:0032868; GO:0032869; GO:0033143; GO:0040018; GO:0042383; GO:0042445; GO:0043568; GO:0043627; GO:0046010; GO:0048469; GO:0048609; GO:0051246; GO:0051384; GO:0060124; GO:0060133; GO:0071333 AKWTTPSR 14.46000004 1 1 0.025962565 945.8971001 0 0 0 0 0 0 17.77651 0 16.744 16.30673 0 16.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.13237 0 0 16.73776 0 0 0 0 0 0 0 21.78753 0 0 0 0 17.09928 0 0 0 0 Q02763 TIE2_HUMAN "Angiopoietin-1 receptor, EC 2.7.10.1 (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2, hTIE2) (p140 TEK) (CD antigen CD202b)" TEK TIE2 VMCM VMCM1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352 GDNVNISFK 5.519999981 1 1 0.195056427 993.385382 15.46298 15.1199 0 0 14.0556 14.50068 15.4095 11.20136 0 0 0 0 0 0 0 12.57204 0 0 0 0 0 16.91346 0 13.23238 0 0 0 0 0 0 0 0 0 15.65114 0 0 16.73522 0 0 15.8056 0 17.97216 0 0 14.81596 0 0 0 Q02779 M3K10_HUMAN "Mitogen-activated protein kinase kinase kinase 10, EC 2.7.11.25 (Mixed lineage kinase 2) (Protein kinase MST)" MAP3K10 MLK2 MST Homo sapiens (Human) "apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein autophosphorylation [GO:0046777]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein autophosphorylation [GO:0046777]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]" ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0005524; GO:0005737; GO:0006915; GO:0007165; GO:0007224; GO:0007254; GO:0018105; GO:0018107; GO:0042803; GO:0043065; GO:0043425; GO:0043433; GO:0043507; GO:0045892; GO:0046330; GO:0046777; GO:0106310 EEEEGAVAK 4.480000019 0.236107633 0.236107633 0.151623871 960.5888904 15.02588 0 12.79301 13.21378 0 13.48706 5.317218 0 14.66066 14.07791 0 16.89116 14.87061 0 0 0 14.50218 16.30989 0 11.75179 16.51366 11.22556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.59433 0 0 0 0 0 0 0 0 0 0 Q02809 PLOD1_HUMAN "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, EC 1.14.11.4 (Lysyl hydroxylase 1, LH1)" PLOD1 LLH PLOD Homo sapiens (Human) epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666] catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867] catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475] GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0008475; GO:0008544; GO:0017185; GO:0030867; GO:0031418; GO:0070062; GO:1902494 HTLGHLLSLDSYR 13.57999992 1 1 0.008693053 1510.954377 16.10531 0 0 0 0 15.0699 0 0 15.51841 0 0 0 0 15.02326 0 0 0 0 0 15.89824 0 0 0 0 13.73593 15.07259 0 0 17.34586 14.45857 15.30407 0 0 0 0 0 16.49508 0 0 0 0 0 12.13656 0 13.37682 0 0 15.10696 Q02817 MUC2_HUMAN "Mucin-2, MUC-2 (Intestinal mucin-2)" MUC2 SMUC Homo sapiens (Human) maintenance of gastrointestinal epithelium [GO:0030277] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; inner mucus layer [GO:0070702]; outer mucus layer [GO:0070703]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; inner mucus layer [GO:0070702]; outer mucus layer [GO:0070703]; plasma membrane [GO:0005886]; maintenance of gastrointestinal epithelium [GO:0030277] GO:0005615; GO:0005796; GO:0005886; GO:0030277; GO:0031012; GO:0062023; GO:0070702; GO:0070703 CVTADKCGCYVEDTHYPPGASVPTEETCK 5.400000095 1 1 3.20E-12 3332.309904 0 0 12.6226 0 0 0 0 15.09884 0 0 0 11.91927 0 0 12.74082 12.08036 0 0 12.88645 0 0 11.50371 0 0 0 0 0 13.46379 12.72317 0 13.59272 14.91611 10.73436 12.45822 0 0 0 0 0 0 12.3398 0 14.59352 0 13.30388 0 0 0 Q02833 RASF7_HUMAN Ras association domain-containing protein 7 (HRAS1-related cluster protein 1) RASSF7 C11orf13 HRC1 Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165] GO:0005737; GO:0006915; GO:0007165; GO:0034451; GO:0070507 ALEAELQLAAEAPGPPSPMASATER 2.25 1 1 0.095288559 2503.000863 9.035954 12.56209 13.63477 13.25506 15.71458 12.41905 0 0 0 0 0 0 0 0 15.37697 14.00798 0 12.07009 0 0 15.40545 11.19294 0 0 0 0 10.74678 0 9.870693 0 0 14.44361 0 0 0 0 0 0 10.55028 11.79578 13.12403 15.11042 10.21133 0 0 0 0 9.87142 Q02846 GUC2D_HUMAN "Retinal guanylyl cyclase 1, RETGC-1, EC 4.6.1.2 (CG-E) (Guanylate cyclase 2D, retinal) (Rod outer segment membrane guanylate cyclase, ROS-GC)" GUCY2D CORD6 GUC1A4 GUC2D RETGC RETGC1 Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] GO:0001653; GO:0001750; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005640; GO:0005789; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0019934; GO:0022400; GO:0038023; GO:0042622; GO:0042803; GO:0044877; GO:0097381 AAAGGR 3.819999933 0.050310113 0.050310113 0.295463473 501.6237666 17.41238 0 16.48067 16.59225 0 17.70796 16.41121 0 15.70979 17.5235 16.61772 17.02296 0 0 0 16.96598 17.92414 17.22528 17.83739 16.64606 17.16808 16.8947 0 17.20248 17.45155 0 0 16.6852 16.61677 15.63671 16.49014 17.64243 0 0 0 16.18333 0 16.86451 17.49775 17.54016 0 0 18.22954 17.25812 16.78583 0 17.70512 17.01839 Q02880 TOP2B_HUMAN "DNA topoisomerase 2-beta, EC 5.6.2.2 (DNA topoisomerase II, beta isozyme)" TOP2B Homo sapiens (Human) axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]" "ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]" GO:0000712; GO:0000819; GO:0001764; GO:0003677; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006265; GO:0007409; GO:0008022; GO:0019899; GO:0030900; GO:0042826; GO:0045870; GO:0046872; GO:0046982; GO:1990904 ADASK 14.05000019 0.603010535 0.603010535 0.172068965 490.3151642 15.07102 15.61122 16.92739 15.70871 14.43002 15.00698 15.85794 15.45997 15.35375 14.82453 15.20726 15.97559 15.68522 14.2808 14.6117 15.63117 0 11.62394 14.04065 15.34279 15.26662 15.76886 13.00937 16.43596 14.95945 15.66235 15.00469 14.14818 15.92284 13.2037 0 15.06159 0 0 16.20871 0 0 0 16.21514 15.11727 0 0 14.78537 0 14.91495 0 0 0 Q02928 CP4AB_HUMAN "Cytochrome P450 4A11, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80)" CYP4A11 CYP4A2 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078] alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497] GO:0001676; GO:0001822; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006631; GO:0006691; GO:0008391; GO:0008392; GO:0016324; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0031408; GO:0032305; GO:0043231; GO:0043651; GO:0046456; GO:0048252; GO:0050051; GO:0055078; GO:0070330; GO:0097267; GO:0102033 SVSVLSPSR 1.799999952 1 1 0.292884289 931.1237649 0 0 16.97428 16.33536 0 0 0 0 0 0 0 0 0 0 0 0 16.79733 0 15.729 0 0 0 0 0 0 0 18.44647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02952 AKA12_HUMAN "A-kinase anchor protein 12, AKAP-12 (A-kinase anchor protein 250 kDa, AKAP 250) (Gravin) (Myasthenia gravis autoantigen)" AKAP12 AKAP250 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018] GO:0005516; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007186; GO:0007193; GO:0008179; GO:0010738; GO:0010739; GO:0032496; GO:0032760; GO:0035733; GO:0043025; GO:0043116; GO:0050804; GO:0051018; GO:0051602; GO:0051770; GO:0061870; GO:0070374; GO:0071347; GO:0071356; GO:0090036; GO:0098685; GO:1900143 EDEVEASEK 6.070000172 0.739284098 0.739284098 0.297530743 1036.033093 11.65697 15.69108 12.51298 0 0 0 16.05739 0 0 0 0 0 14.97767 0 0 0 0 0 0 16.18017 14.88761 16.46214 15.13198 0 0 16.99485 16.24523 15.6249 16.39533 15.63126 0 0 16.17373 0 0 0 0 0 0 15.23385 14.65246 0 0 0 0 0 0 0 Q02978 M2OM_HUMAN "Mitochondrial 2-oxoglutarate/malate carrier protein, OGCP (Solute carrier family 25 member 11)" SLC25A11 SLC20A4 Homo sapiens (Human) malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117] GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005887; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015367; GO:0015709; GO:0015729; GO:0035435; GO:0071422; GO:0071423 NVFNALIR 4.389999866 1 1 0.199236931 947.4865212 15.11559 16.57971 15.99181 15.43891 0 0 13.72816 0 16.96684 15.52105 15.73968 17.22737 0 0 0 15.26393 11.01451 15.95513 0 0 0 0 16.49788 0 15.6378 0 15.74972 0 15.63659 17.00058 16.38024 14.85256 15.47014 16.06363 16.63984 16.80834 0 0 0 16.7695 0 0 14.26828 15.24007 16.07599 14.14412 14.87028 14.92663 Q03001 DYST_HUMAN "Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1, BPA, Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein)" DST BP230 BP240 BPAG1 DMH DT KIAA0728 Homo sapiens (Human) cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] GO:0000226; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008022; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031122; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 AADPSSLQSHIPVLDKGR 4.139999866 0.213439569 0.213439569 0.067568491 1887.900686 0 0 15.6522 9.518503 0 12.91568 15.31872 13.91213 0 0 0 0 15.96839 0 0 0 16.54289 15.91535 15.17609 0 14.64643 0 0 0 16.89762 0 0 0 0 0 0 18.7168 18.07944 15.20086 16.99634 15.82535 15.76001 0 0 18.0365 16.09747 16.09881 15.69718 0 17.43006 0 15.99503 0 Q03052 PO3F1_HUMAN "POU domain, class 3, transcription factor 1 (Octamer-binding protein 6, Oct-6) (Octamer-binding transcription factor 6, OTF-6) (POU domain transcription factor SCIP)" POU3F1 OCT6 OTF6 Homo sapiens (Human) "axon ensheathment [GO:0008366]; forebrain development [GO:0030900]; keratinocyte differentiation [GO:0030216]; myelination in peripheral nervous system [GO:0022011]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; axon ensheathment [GO:0008366]; forebrain development [GO:0030900]; keratinocyte differentiation [GO:0030216]; myelination in peripheral nervous system [GO:0022011]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0008366; GO:0010628; GO:0022011; GO:0030216; GO:0030900; GO:0043565; GO:0045893; GO:1990837 LHAGAAYR 4.710000038 0.287619531 0.287619531 0.143164212 858.8211124 0 13.52237 13.26275 15.16223 13.71855 17.22716 17.23692 14.51704 13.59941 16.00539 0 15.44017 16.10475 18.86727 16.17663 13.74963 15.20662 16.65518 11.85338 17.58854 0 0 15.03145 15.11529 16.69199 16.95533 15.58445 17.22012 17.89715 17.06253 0 16.49351 0 17.65418 15.78151 17.44985 18.02171 0 15.61486 16.01965 18.8508 10.65337 12.4187 11.28888 15.02917 17.56216 0 0 Q03111 ENL_HUMAN Protein ENL (YEATS domain-containing protein 1) MLLT1 ENL LTG19 YEATS1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of protein kinase activity [GO:0006469]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; fibrillar center [GO:0001650]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] cytosol [GO:0005829]; fibrillar center [GO:0001650]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; histone binding [GO:0042393]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of protein kinase activity [GO:0006469]; regulation of transcription by RNA polymerase II [GO:0006357] histone binding [GO:0042393] GO:0001650; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006469; GO:0008023; GO:0016573; GO:0032783; GO:0035267; GO:0042393 APPPK 4.570000172 0.301207364 0.301207364 0.285395781 509.7444274 18.94998 20.71637 20.53437 21.461 0 18.95425 0 0 18.12445 18.91116 0 19.20178 0 0 19.69235 20.5808 0 19.44791 0 18.25209 0 19.42549 18.52135 0 19.47433 0 0 0 17.93137 19.21775 20.20349 19.3515 18.02323 0 21.1527 20.58962 0 0 18.77363 16.70825 19.26954 20.85345 19.21426 19.36435 18.65321 17.508 0 19.83067 Q03164 KMT2A_HUMAN "Histone-lysine N-methyltransferase 2A, Lysine N-methyltransferase 2A, EC 2.1.1.364 (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A, EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa, p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa, p180) ]" KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 Homo sapiens (Human) "apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]" cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]" histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] GO:0003680; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006915; GO:0008270; GO:0032411; GO:0032922; GO:0035097; GO:0035162; GO:0042800; GO:0042802; GO:0042803; GO:0043984; GO:0044648; GO:0045322; GO:0045893; GO:0045944; GO:0051568; GO:0051571; GO:0065003; GO:0070577; GO:0071339; GO:0071440; GO:0080182; GO:0097692; GO:0106363; GO:1905642; GO:2000615 EALSFPHLHLRGQR 3.470000029 1 1 7.00E-13 1662.085603 15.77327 0 0 0 13.19774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84667 0 0 0 0 0 0 0 0 0 0 0 Q03167 TGBR3_HUMAN "Transforming growth factor beta receptor type 3, TGF-beta receptor type 3, TGFR-3 (Betaglycan) (Transforming growth factor beta receptor III, TGF-beta receptor type III)" TGFBR3 Homo sapiens (Human) animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]" "activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]" GO:0001666; GO:0001837; GO:0001889; GO:0003007; GO:0003150; GO:0003151; GO:0003223; GO:0005024; GO:0005114; GO:0005160; GO:0005539; GO:0005615; GO:0005737; GO:0005887; GO:0006955; GO:0007179; GO:0007181; GO:0008201; GO:0009897; GO:0009986; GO:0015026; GO:0016477; GO:0017015; GO:0017134; GO:0030165; GO:0030509; GO:0030511; GO:0030512; GO:0031012; GO:0031100; GO:0032354; GO:0034673; GO:0034695; GO:0034699; GO:0035556; GO:0043235; GO:0043393; GO:0046332; GO:0048185; GO:0050431; GO:0050680; GO:0051271; GO:0055010; GO:0060038; GO:0060045; GO:0060216; GO:0060317; GO:0060318; GO:0060347; GO:0060389; GO:0060412; GO:0060939; GO:0060979; GO:0061384; GO:0062009; GO:0070062; GO:0070123 ESERSMTMTK 9.979999542 1 1 6.87E-13 1232.141026 16.16304 16.32115 0 0 15.24817 14.43098 16.46722 15.96864 16.64334 0 0 15.61638 0 14.21896 0 0 0 0 0 0 15.14028 14.25049 0 15.35883 0 15.33176 0 15.1008 0 15.60707 0 0 12.99462 11.71279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03181 PPARD_HUMAN "Peroxisome proliferator-activated receptor delta, PPAR-delta (NUCI) (Nuclear hormone receptor 1, NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta, PPAR-beta)" PPARD NR1C2 PPARB Homo sapiens (Human) "adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol metabolic process [GO:0008203]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; glucose transmembrane transport [GO:1904659]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid biosynthetic process [GO:0008654]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol metabolic process [GO:0008203]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; glucose transmembrane transport [GO:1904659]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid biosynthetic process [GO:0008654]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006006; GO:0006029; GO:0006091; GO:0006357; GO:0006629; GO:0006631; GO:0006635; GO:0006776; GO:0006915; GO:0007507; GO:0007566; GO:0008203; GO:0008270; GO:0008283; GO:0008289; GO:0008366; GO:0008654; GO:0009062; GO:0009749; GO:0009755; GO:0010628; GO:0010887; GO:0014068; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0019216; GO:0030154; GO:0030308; GO:0031589; GO:0032966; GO:0033189; GO:0033993; GO:0035774; GO:0042060; GO:0042311; GO:0043066; GO:0043415; GO:0043616; GO:0045600; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046697; GO:0048662; GO:0050680; GO:0050728; GO:0051059; GO:0051546; GO:0060612; GO:0070539; GO:0071222; GO:0071456; GO:0097190; GO:0140297; GO:1902894; GO:1904659; GO:1990837; GO:2000288 ELTEFAK 9.569999695 0.642555594 0.642555594 0.280741699 837.4409063 0 0 0 16.60181 0 17.31115 16.69414 16.14992 18.51727 0 11.53109 0 17.50825 16.83841 15.83932 0 0 0 0 18.27529 0 0 17.12701 17.32499 14.70317 0 0 16.02235 0 16.57214 0 15.7043 0 18.7074 16.62862 0 0 15.23276 0 0 0 0 0 0 13.28962 0 0 0 Q03188 CENPC_HUMAN "Centromere protein C, CENP-C (Centromere autoantigen C) (Centromere protein C 1, CENP-C 1) (Interphase centromere complex protein 7)" CENPC CENPC1 ICEN7 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455] "condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]" "condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455]" centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802] GO:0000278; GO:0000776; GO:0000779; GO:0003677; GO:0005654; GO:0005721; GO:0005829; GO:0007059; GO:0016604; GO:0019237; GO:0030496; GO:0042802; GO:0051301; GO:0051315; GO:0051382; GO:0051455 EKHHNILPK 2.480000019 1 1 0.177273142 1116.643419 15.71391 13.73194 0 0 0 0 0 0 13.37164 15.28098 15.06937 0 0 15.71002 15.74432 15.33711 0 0 0 14.78503 15.75663 0 0 14.8532 15.70476 13.35153 12.11466 0 14.74866 13.10181 14.70911 12.82214 0 14.89324 13.50513 14.87862 12.08346 16.23174 0 0 12.67158 13.96251 0 14.05659 0 15.39575 14.60737 10.78293 Q03252 LMNB2_HUMAN Lamin-B2 LMNB2 LMN2 Homo sapiens (Human) intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0005637; GO:0005882; GO:0031965; GO:0042802 AELDEVNK 5.130000114 1 1 0.225850023 920.1713747 0 11.33113 16.31811 15.32366 16.25981 14.41583 0 14.37747 0 0 14.79489 0 0 0 0 0 16.02984 14.96145 0 15.34562 16.63616 17.73723 0 0 15.26321 0 15.83087 15.45456 12.31862 12.99929 15.19135 15.27415 15.71504 15.24298 14.51527 13.84851 15.01247 16.14175 16.3136 14.68625 14.86526 14.86224 12.0053 15.76861 14.58531 15.14921 12.67507 16.89511 Q03468 ERCC6_HUMAN "DNA excision repair protein ERCC-6, EC 3.6.4.- (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)" ERCC6 CSB Homo sapiens (Human) "base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]" B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023] "B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]" GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006366; GO:0006979; GO:0007254; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0034243; GO:0035066; GO:0035264; GO:0042262; GO:0044877; GO:0045494; GO:0045739; GO:0045943; GO:0045944; GO:0045945; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:0110016; GO:0140658; GO:1905168; GO:2001033 KSVGVHSVMK 6.159999847 0.717871368 0.717871368 0.222847738 1084.137889 0 0 0 0 14.69214 0 0 15.57886 12.78462 0 0 16.6162 0 0 0 0 0 0 0 16.33735 18.13993 0 0 0 0 17.28439 0 0 10.6477 13.55616 0 0 0 0 12.63353 0 0 0 0 0 15.90806 0 16.75187 12.90785 15.72201 14.02859 15.10584 11.68128 Q03519 TAP2_HUMAN "Antigen peptide transporter 2, APT2, EC 7.4.2.- (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2, PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein, RING11)" TAP2 ABCB3 PSF2 RING11 Y1 Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]; ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]" ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980] GO:0002250; GO:0002489; GO:0005524; GO:0005783; GO:0005789; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016020; GO:0016021; GO:0016607; GO:0019885; GO:0023029; GO:0030176; GO:0030670; GO:0033116; GO:0042605; GO:0042626; GO:0042824; GO:0042825; GO:0046872; GO:0046967; GO:0046968; GO:0046978; GO:0046980; GO:0055085 ALYLLVR 15.59000015 0.97877419 0.97877419 0.278104805 846.926361 15.69115 17.48926 0 0 14.66181 15.90647 14.68227 15.07469 0 0 14.69918 16.66827 0 0 15.86095 0 15.99782 15.09334 0 17.67828 18.44324 0 16.88659 0 0 0 16.22435 15.9039 0 15.36288 15.04418 0 14.55418 17.18059 16.70155 0 15.89409 0 15.72017 0 14.99425 16.08382 0 0 0 15.8676 0 0 Q03692 COAA1_HUMAN Collagen alpha-1(X) chain COL10A1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005599; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023 GFPGEMGPIGPPGPQGPPGER 8.5 0.805894017 0.805894017 0.212085449 2047.147769 0 0 0 0 0 14.76029 15.30039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.00874 0 0 0 0 0 0 0 0 0 0 0 0 13.81195 0 0 0 Q03701 CEBPZ_HUMAN "CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor, CBF, CCAAT-binding factor)" CEBPZ CBF2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634] CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944] RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944 DDMDFAGNVK 1.799999952 0.159218714 0.159218714 0.104248203 1128.021746 0 16.85178 0 12.2894 0 0 0 17.56799 0 16.21181 0 0 15.12279 0 0 17.07751 15.92299 0 0 14.81927 17.67675 0 14.94013 12.287 0 14.06229 15.04911 0 0 16.61705 0 0 0 15.60795 0 0 14.82243 0 15.47012 0 0 12.46187 0 0 0 0 0 0 Q03924 ZN117_HUMAN "Zinc finger protein 117 (Provirus-linked krueppel, h-PLK) (Zinc finger protein HPF9)" ZNF117 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270 SSTLIGHK 16.30999947 1 1 0.485692413 842.332358 0 17.84724 15.64727 0 0 17.29417 0 0 16.90929 0 0 17.85095 0 16.48472 17.90616 18.55222 0 0 0 0 0 0 0 18.13561 0 0 18.42548 0 0 0 0 0 0 0 18.454 17.78728 0 0 18.32381 17.10925 0 0 18.84333 0 0 18.35389 0 0 Q03933 HSF2_HUMAN "Heat shock factor protein 2, HSF 2 (Heat shock transcription factor 2, HSTF 2)" HSF2 HSTF2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001162; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007283; GO:0042802; GO:0045944; GO:1990837 KQSSNVPAFLSK 7.179999828 1 1 0.19127027 1306.016163 14.81279 0 0 0 0 0 0 0 15.36817 0 0 16.36585 0 0 0 0 15.33769 14.03465 13.98673 0 0 14.00018 0 0 0 14.1764 0 0 0 0 0 0 16.24499 0 11.65396 0 0 0 0 16.67949 0 0 0 0 0 0 0 0 Q03938 ZNF90_HUMAN Zinc finger protein 90 (Zinc finger protein HTF9) ZNF90 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270 IIHSGEKPYK 13.64000034 0.541611254 0.541611254 0.247352036 1172.054749 0 14.4332 0 15.37173 0 0 0 13.95898 13.08919 0 11.54657 0 0 15.10349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92717 15.61091 0 16.19632 14.699 0 0 0 0 0 16.07275 0 0 0 0 0 0 0 15.18665 Q03989 ARI5A_HUMAN "AT-rich interactive domain-containing protein 5A, ARID domain-containing protein 5A (Modulator recognition factor 1, MRF-1)" ARID5A MRF1 Homo sapiens (Human) "cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; retinoid X receptor binding [GO:0046965]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]" androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; retinoid X receptor binding [GO:0046965]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] GO:0000122; GO:0000976; GO:0002062; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0008134; GO:0030331; GO:0032729; GO:0032740; GO:0032755; GO:0032760; GO:0035066; GO:0035613; GO:0042802; GO:0043565; GO:0045087; GO:0045892; GO:0045944; GO:0046965; GO:0046966; GO:0050681; GO:0071222; GO:0071391; GO:2000318; GO:2000556 AVSPFLK 12.81999969 1 1 0.2292807 760.5619576 0 0 18.34053 0 0 0 18.17455 0 17.81138 0 0 0 0 0 0 17.71487 0 0 0 0 0 17.26205 0 0 0 16.50491 0 0 0 0 0 0 0 17.92179 0 0 0 0 18.99911 0 18.6143 0 18.11431 0 0 0 0 0 Q04609 FOLH1_HUMAN "Glutamate carboxypeptidase 2, EC 3.4.17.21 (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase, FGCP) (Glutamate carboxypeptidase II, GCPII) (Membrane glutamate carboxypeptidase, mGCP) (N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I) (Prostate-specific membrane antigen, PSM, PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)" FOLH1 FOLH NAALAD1 PSM PSMA GIG27 Homo sapiens (Human) C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]; C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508] Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493] GO:0004180; GO:0004181; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0035609; GO:0046872; GO:0070062; GO:1904492; GO:1904493 YADKIYSISMK 12.23999977 1 1 0.574806528 1318.317955 19.18199 18.04092 0 19.6985 0 19.10013 0 0 0 0 19.71306 0 19.97913 0 20.04136 17.1316 0 0 19.29363 0 16.3879 0 0 0 18.94794 0 0 18.18468 0 0 19.90743 18.58104 0 0 0 20.0119 0 0 0 0 0 19.35147 0 0 17.1586 0 20.05415 0 Q04637 IF4G1_HUMAN "Eukaryotic translation initiation factor 4 gamma 1, eIF-4-gamma 1, eIF-4G 1, eIF-4G1 (p220)" EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413]" "ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]" GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0010801; GO:0010942; GO:0016020; GO:0016281; GO:0030307; GO:0031369; GO:0031669; GO:0032270; GO:0032502; GO:0033138; GO:0034645; GO:0036493; GO:0042802; GO:0045666; GO:0060090; GO:0060964; GO:0080135; GO:0097009; GO:1900087; GO:1901215; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696 AASLLLEILGLLCKSMGPK 6.800000191 1 1 1.83E-12 2027.412048 0 0 0 0 0 14.94584 0 0 0 0 0 0 0 0 0 15.5596 0 0 0 0 0 0 0 0 0 0 0 14.25115 0 0 0 0 14.89507 10.49996 12.03615 0 0 12.66068 0 13.34718 14.29486 16.2498 0 14.49105 0 0 0 0 Q04656 ATP7A_HUMAN "Copper-transporting ATPase 1, EC 7.2.2.8 (Copper pump 1) (Menkes disease-associated protein)" ATP7A MC1 MNK Homo sapiens (Human) blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568] apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140] apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532] GO:0001568; GO:0001701; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007565; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010468; GO:0010592; GO:0014069; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0016887; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0030424; GO:0030425; GO:0030670; GO:0031069; GO:0031252; GO:0031267; GO:0031526; GO:0031901; GO:0032588; GO:0032767; GO:0032773; GO:0033162; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043204; GO:0043473; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0048023; GO:0048251; GO:0048286; GO:0048471; GO:0048812; GO:0050679; GO:0051087; GO:0051216; GO:0051542; GO:0055070; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:0140581; GO:1903036; GO:1903136; GO:1904754; GO:1904959 SPSYTNDSTATFIIDGMHCK 1.779999971 1 1 1.38E-12 2245.683366 12.90988 12.61414 12.53804 14.1025 13.41551 13.40416 13.3196 8.795127 10.87823 12.40369 8.625686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04671 P_HUMAN P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog) OCA2 D15S12 P Homo sapiens (Human) cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; L-tyrosine transmembrane transporter activity [GO:0005302]; transporter activity [GO:0005215]; cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286] L-tyrosine transmembrane transporter activity [GO:0005302]; transporter activity [GO:0005215] GO:0005215; GO:0005302; GO:0005737; GO:0005765; GO:0005789; GO:0006726; GO:0007286; GO:0008283; GO:0010008; GO:0016021; GO:0030318; GO:0033162; GO:0042438 QISQEDK 19.85000038 1 1 0.167775219 847.5543616 0 14.50044 17.18675 16.44411 19.70057 14.52628 17.61931 17.03557 17.90154 18.5263 18.74257 19.09187 18.15864 18.69015 18.58202 16.62221 17.63364 16.29442 15.44681 18.42594 0 17.6217 18.54571 17.94998 18.70675 0 17.76982 0 18.19909 18.6568 19.30513 19.46638 19.6212 18.36942 14.41682 0 17.77418 15.58443 19.02732 16.32124 15.63223 17.12438 17.38589 17.94196 14.91984 17.03899 19.44298 17.63086 Q04695 K1C17_HUMAN "Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17, CK-17) (Keratin-17, K17)" KRT17 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; positive regulation of cell growth [GO:0030307]; positive regulation of hair follicle development [GO:0051798]; positive regulation of translation [GO:0045727] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; positive regulation of cell growth [GO:0030307]; positive regulation of hair follicle development [GO:0051798]; positive regulation of translation [GO:0045727] structural molecule activity [GO:0005198] GO:0001533; GO:0005198; GO:0005829; GO:0005856; GO:0030307; GO:0030855; GO:0031069; GO:0031424; GO:0045095; GO:0045109; GO:0045111; GO:0045727; GO:0051798 DYSQYYR 10.81000042 0.378516406 0.378516406 0.246704747 994.4718428 18.36171 18.66052 20.02773 18.11696 16.41002 18.80966 20.31351 14.66908 18.51357 0 0 17.44554 0 16.47324 0 0 17.27269 17.06725 17.46999 17.49064 17.36218 0 17.63867 0 19.23986 18.68604 17.85008 15.61945 0 0 19.68283 19.53874 19.34937 17.96828 0 17.7989 0 0 0 17.88036 18.44006 16.5191 17.72623 18.28738 17.83114 17.3103 17.9376 0 Q04721 NOTC2_HUMAN "Neurogenic locus notch homolog protein 2, Notch 2, hN2 [Cleaved into: Notch 2 extracellular truncation, N2ECD; Notch 2 intracellular domain, N2ICD ]" NOTCH2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023] GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204 GEQCVHTASGPR 11.56000042 1 1 0.001751911 1299.626878 10.26213 14.17862 13.58464 12.24557 14.81694 13.19458 12.77438 12.26464 14.22429 13.46894 0 15.4056 0 0 0 13.60545 15.40598 0 15.16947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.61195 0 15.73328 0 0 0 0 0 15.67469 Q04726 TLE3_HUMAN "Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3, ESG3)" TLE3 KIAA1547 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] transcription corepressor activity [GO:0003714] GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0007165; GO:0009887; GO:0016055; GO:0090090; GO:0120163; GO:1990907 GSADYSMEAK 6.710000038 1 1 0.191303502 1074.47062 12.36206 10.6897 0 16.74081 0 13.72808 0 0 0 0 0 0 0 0 0 13.99009 14.75665 12.63162 15.07974 0 0 0 13.85422 0 16.0222 0 0 16.5569 0 13.3248 0 14.80788 13.30308 13.10872 13.32222 0 0 0 14.21763 0 0 16.18384 0 0 16.00648 0 15.99723 0 Q04727 TLE4_HUMAN Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4) TLE4 GRG4 KIAA1261 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907 EIAARYDSDGEK 3.470000029 1 1 0.18143993 1353.683413 0 0 15.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.72426 0 0 0 0 0 0 0 0 0 0 Q04759 KPCT_HUMAN "Protein kinase C theta type, EC 2.7.11.13 (nPKC-theta)" PRKCQ PRKCT Homo sapiens (Human) "axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]" aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886] "aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]" ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001558; GO:0001772; GO:0002376; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006468; GO:0006509; GO:0006954; GO:0007411; GO:0016235; GO:0018105; GO:0032212; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0038095; GO:0042102; GO:0046627; GO:0046872; GO:0050870; GO:0051092; GO:0051973; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:1904355; GO:2000318; GO:2000570 GSFGK 2.380000114 1 1 0.083311329 493.2466279 13.70205 0 0 0 15.42267 14.14237 14.5273 0 0 15.56489 16.3303 13.44683 0 15.27721 15.86901 0 0 15.3509 17.11911 0 0 16.57802 0 0 14.14196 0 15.70071 16.06959 14.25002 0 0 0 0 0 14.71884 0 0 0 0 14.29964 14.8435 16.4818 0 0 16.41409 0 0 0 Q04760 LGUL_HUMAN "Lactoylglutathione lyase, EC 4.4.1.5 (Aldoketomutase) (Glyoxalase I, Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)" GLO1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357] lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270] GO:0004462; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066; GO:0070062 CDFPIMK 13.81999969 1 1 0.147620467 927.18281 15.80873 16.47677 14.77676 15.48279 0 15.79216 16.64714 15.73019 0 14.52877 0 16.68336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04912 RON_HUMAN "Macrophage-stimulating protein receptor, MSP receptor, EC 2.7.10.1 (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain ]" MST1R PTK8 RON Homo sapiens (Human) cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001725; GO:0004712; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0005887; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009925; GO:0009986; GO:0016477; GO:0019899; GO:0033674; GO:0043235; GO:0043406; GO:0045087; GO:0051897 DVLIPHER 3.819999933 1 1 0.280529304 979.7549869 0 0 16.44749 0 0 0 17.52408 0 0 18.72255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.90343 0 0 0 0 0 0 0 0 17.78404 0 0 0 0 17.9067 0 0 0 Q04917 1433F_HUMAN 14-3-3 protein eta (Protein AS1) YWHAH YWHA1 Homo sapiens (Human) "cellular protein localization [GO:0034613]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; cellular protein localization [GO:0034613]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]" actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] GO:0002028; GO:0003779; GO:0005159; GO:0005737; GO:0005829; GO:0005886; GO:0006713; GO:0006886; GO:0007165; GO:0014704; GO:0017080; GO:0019899; GO:0019904; GO:0021762; GO:0034613; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045664; GO:0045893; GO:0046982; GO:0048167; GO:0050774; GO:0070062; GO:0086010; GO:2000649 KNSVVEASEAAYK 1.049999952 1 1 2.43E-13 1395.272111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05048 CSTF1_HUMAN "Cleavage stimulation factor subunit 1 (CF-1 50 kDa subunit) (Cleavage stimulation factor 50 kDa subunit, CSTF 50 kDa subunit, CstF-50)" CSTF1 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124] mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654] mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005848; GO:0031124 MLAKSAMPIEVMMNETAQQNMENHPVIR 4.840000153 0.379318088 0.379318088 0.084113315 3230.105446 12.41745 15.31683 13.17435 0 0 11.80941 10.95914 14.82864 0 0 13.15046 13.91754 0 0 10.46096 12.91773 0 0 0 0 12.61336 0 0 0 15.47025 0 0 0 15.38226 0 0 0 0 0 11.92119 0 0 0 0 14.89558 14.98201 0 10.5888 0 0 0 0 12.69776 Q05086 UBE3A_HUMAN "Ubiquitin-protein ligase E3A, EC 2.3.2.26 (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)" UBE3A E6AP EPVE6AP HPVE6A Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502] cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:1905528; GO:1990416; GO:2000058 VYEILELCR 6.179999828 1 1 0.240927548 1193.96428 15.88875 15.11411 0 14.39827 0 13.61565 0 0 15.15912 0 0 0 0 15.79759 0 0 14.38619 15.74612 0 14.64091 0 0 0 15.78422 0 13.96823 0 15.55773 0 0 13.05478 0 0 16.32067 12.43784 12.99252 0 0 0 0 0 0 0 0 0 0 15.31188 0 Q05193 DYN1_HUMAN "Dynamin-1, EC 3.6.5.5" DNM1 DNM Homo sapiens (Human) endocytosis [GO:0006897]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; toxin transport [GO:1901998] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] GO:0001917; GO:0003723; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0006898; GO:0007032; GO:0008017; GO:0016020; GO:0016185; GO:0019901; GO:0030117; GO:0031623; GO:0042802; GO:0045202; GO:0048488; GO:0050804; GO:0070062; GO:0098684; GO:0098835; GO:0098978; GO:1901998 GWLTINNIGIMKGGSK 4.710000038 1 1 0.056980688 1687.994215 0 0 15.71024 0 0 0 0 0 0 0 0 0 16.48044 0 0 0 0 0 0 0 0 0 0 0 0 16.65958 0 0 0 17.80714 0 0 0 17.85376 18.32991 0 19.86804 0 0 0 0 0 0 17.49983 0 0 0 0 Q05195 MAD1_HUMAN "Max dimerization protein 1, Max dimerizer 1 (Protein MAD)" MXD1 MAD Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; Mad-Max complex [GO:0070443]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; Mad-Max complex [GO:0070443]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0046983; GO:0070443 GLVPLGPESSRHTTLSLLTK 1.799999952 1 1 2.29E-12 2105.600832 0 12.40606 15.62844 14.66982 0 0 18.4418 10.75061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.43398 0 12.75047 14.44192 0 15.09149 0 0 0 0 0 0 0 0 0 16.23856 0 0 15.73469 0 0 14.80528 0 0 0 0 Q05209 PTN12_HUMAN "Tyrosine-protein phosphatase non-receptor type 12, EC 3.1.3.48 (PTP-PEST) (Protein-tyrosine phosphatase G1, PTPG1)" PTPN12 Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0042995; GO:0071364; GO:1901185; GO:2000587 HNIAGTTHSGAEKDVDVSEDSPPPLPER 7.690000057 1 1 9.16E-13 2956.574036 0 10.81372 10.90728 12.66895 0 0 10.33197 13.40667 11.06053 14.92112 14.17314 15.59308 0 0 16.22349 0 0 0 12.476 14.03628 0 12.61724 13.0999 13.50834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05329 DCE2_HUMAN "Glutamate decarboxylase 2, EC 4.1.1.15 (65 kDa glutamic acid decarboxylase, GAD-65) (Glutamate decarboxylase 65 kDa isoform)" GAD2 GAD65 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410] anchored component of membrane [GO:0031225]; axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672] anchored component of membrane [GO:0031225]; axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170]; chemical synaptic transmission [GO:0007268]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410] glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170] GO:0000139; GO:0004351; GO:0005829; GO:0005886; GO:0006540; GO:0007268; GO:0009410; GO:0016595; GO:0030170; GO:0030424; GO:0030672; GO:0031225; GO:0042136; GO:0042734; GO:0044877; GO:0048471; GO:0060077; GO:0061202 IWMHVDAAWGGGLLMSR 3.539999962 1 1 0.410348679 1931.589258 0 0 0 0 16.31427 15.6076 0 15.35702 0 0 15.42169 16.45482 0 0 0 0 0 0 16.00669 0 0 0 0 15.59199 0 0 0 0 0 0 13.9682 0 15.80608 14.81755 0 0 11.75232 0 0 0 0 16.18499 0 12.65622 0 16.04381 0 0 Q05397 FAK1_HUMAN "Focal adhesion kinase 1, FADK 1, EC 2.7.10.2 (Focal adhesion kinase-related nonkinase, FRNK) (Protein phosphatase 1 regulatory subunit 71, PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)" PTK2 FAK FAK1 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102] GO:0001525; GO:0001725; GO:0001890; GO:0001932; GO:0001934; GO:0003007; GO:0003779; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010594; GO:0010632; GO:0010759; GO:0010763; GO:0014068; GO:0016477; GO:0018108; GO:0019901; GO:0019903; GO:0022408; GO:0030010; GO:0030154; GO:0030155; GO:0030335; GO:0031234; GO:0033628; GO:0035995; GO:0036064; GO:0038007; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0043087; GO:0043197; GO:0043231; GO:0043552; GO:0045087; GO:0045667; GO:0045860; GO:0046777; GO:0048010; GO:0048013; GO:0048870; GO:0051493; GO:0051893; GO:0051897; GO:0060396; GO:0090303; GO:0120041; GO:1900024; GO:2000060; GO:2000811 SFLQVR 7.380000114 1 1 0.124288571 748.9612073 0 15.12623 15.53593 0 0 0 13.92612 0 0 0 14.97912 13.33182 0 0 0 0 0 15.77051 0 0 15.52804 0 0 0 0 0 0 13.4084 0 0 0 0 0 0 13.20791 0 0 0 17.6487 0 0 14.87325 14.47553 15.25949 15.57907 15.33097 12.89076 16.27158 Q05586 NMDZ1_HUMAN "Glutamate receptor ionotropic, NMDA 1, GluN1 (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1, NMD-R1)" GRIN1 NMDAR1 Homo sapiens (Human) "brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]" amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] GO:0001540; GO:0004972; GO:0005509; GO:0005516; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0006812; GO:0007268; GO:0007420; GO:0008021; GO:0008542; GO:0009986; GO:0010524; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0018964; GO:0022849; GO:0030425; GO:0035235; GO:0038023; GO:0042165; GO:0042391; GO:0043005; GO:0043083; GO:0043195; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0045471; GO:0045944; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0055074; GO:0060076; GO:0060079; GO:0097060; GO:0097553; GO:0098655; GO:0098976; GO:1903428; GO:1904062; GO:1905429; GO:2000463; GO:2001056 GCVGNTNIWKTGPLFK 4.889999866 0.360014647 0.360014647 0.032567008 1790.917731 12.68994 0 15.42365 18.1229 13.16008 12.18642 15.98278 14.85089 14.37593 0 0 0 11.5729 12.71783 0 13.42283 16.00377 10.69816 15.29398 12.51569 13.17895 13.77329 0 16.4556 13.29077 13.8899 17.44064 14.27738 14.41034 0 18.50213 16.89721 17.78297 0 0 14.22166 0 17.42329 9.700487 0 13.06431 12.70297 14.42798 14.23382 0 16.71707 0 17.06571 Q05639 EF1A2_HUMAN "Elongation factor 1-alpha 2, EF-1-alpha-2 (Eukaryotic elongation factor 1 A-2, eEF1A-2) (Statin-S1)" EEF1A2 EEF1AL STN Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid kinase activity [GO:0090218]; regulation of chaperone-mediated autophagy [GO:1904714]; translation [GO:0006412]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; eukaryotic translation elongation factor 1 complex [GO:0005853]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; eukaryotic translation elongation factor 1 complex [GO:0005853]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid kinase activity [GO:0090218]; regulation of chaperone-mediated autophagy [GO:1904714]; translation [GO:0006412]; translational elongation [GO:0006414]" "GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]" GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005853; GO:0006412; GO:0006414; GO:0008135; GO:0019901; GO:0043065; GO:0045202; GO:0090218; GO:0098574; GO:1904714 EVSAYIKK 4.260000229 1 1 0.126525855 939.4396731 0 14.71753 11.99394 16.06714 12.15245 8.527781 13.00568 0 14.71493 14.86741 12.89129 0 13.27683 10.3602 13.58274 14.48363 8.172278 15.21112 15.56989 13.49417 15.10034 9.938073 13.03195 16.32427 14.99941 14.60996 14.99382 0 15.00979 15.09342 16.58087 14.1556 0 0 0 0 16.08526 0 0 16.08585 0 14.22372 0 15.07827 15.66183 0 0 0 Q05655 KPCD_HUMAN "Protein kinase C delta type, EC 2.7.11.13 (Tyrosine-protein kinase PRKCD, EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1, SDK1) ]" PRKCD PKCD Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021] azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021] ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004712; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0007049; GO:0007165; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035307; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235 AAEEPVSEVTVGVSVLAER 7.690000057 1 1 0.31560312 1941.243241 0 13.9431 0 0 0 0 0 0 0 0 14.36534 0 0 0 16.49481 0 14.3087 15.14507 0 0 0 0 0 15.59041 0 12.21632 0 13.86204 13.60661 15.42747 0 0 15.12915 0 12.23401 16.0379 14.87517 14.02566 16.89806 13.68667 0 14.39203 15.57871 0 0 15.61556 13.28993 0 Q05682 CALD1_HUMAN "Caldesmon, CDM" CALD1 CAD CDM Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523]; actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936] actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523] GO:0001525; GO:0003779; GO:0005516; GO:0005523; GO:0005829; GO:0005856; GO:0005886; GO:0006936; GO:0015629; GO:0017022; GO:0030016; GO:0030478; GO:0045296; GO:0051017 AAAQERER 14.31000042 1 1 0.283490466 930.1439988 13.96179 15.20933 0 14.43218 15.88237 0 11.6737 14.31488 15.47853 15.48544 15.30484 15.81401 15.17783 14.08177 0 16.18767 0 16.74404 0 15.03479 14.39134 17.55719 16.46488 17.06207 0 16.20416 14.99809 14.88482 15.33723 0 15.3194 15.93272 0 0 0 0 0 0 17.02889 0 0 14.98801 0 0 15.49885 17.43368 0 0 Q05707 COEA1_HUMAN Collagen alpha-1(XIV) chain (Undulin) COL14A1 UND Homo sapiens (Human) cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614] collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198] collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] GO:0003723; GO:0005201; GO:0005518; GO:0005576; GO:0005581; GO:0005596; GO:0005614; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0062023; GO:0098609 GPDGPR 4.309999943 0.29339841 0.29339841 0.237980357 600.7298512 15.94463 15.83819 0 16.34246 11.86503 12.05777 0 15.54747 12.9052 0 0 0 13.70601 0 14.36544 15.88239 0 16.41451 15.81122 0 15.25591 15.36771 15.68689 0 15.15218 15.21821 15.54946 15.4461 0 14.48205 16.25109 0 15.7139 15.51542 17.13556 17.12004 15.71454 16.23268 15.53177 14.09153 15.31112 10.03243 0 15.25906 15.03747 17.28331 16.01311 0 Q05823 RN5A_HUMAN "2-5A-dependent ribonuclease, 2-5A-dependent RNase, EC 3.1.26.- (Ribonuclease 4) (Ribonuclease L, RNase L)" RNASEL RNS4 Homo sapiens (Human) defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0003723; GO:0004521; GO:0004540; GO:0004672; GO:0005524; GO:0005759; GO:0005829; GO:0006364; GO:0006396; GO:0006397; GO:0006468; GO:0016363; GO:0019843; GO:0042802; GO:0043021; GO:0043488; GO:0045071; GO:0045444; GO:0045944; GO:0046326; GO:0046872; GO:0051607 NVGNESDIK 7.829999924 1 1 0.230643363 974.8553932 16.20166 0 0 12.73196 15.04183 14.16914 15.56241 12.51922 15.35509 0 14.51973 0 13.24507 0 13.92821 0 0 0 0 0 0 15.80445 0 0 15.52234 0 0 14.43001 14.47445 10.17717 15.8446 16.29808 15.05945 0 14.12833 0 0 0 0 15.51836 0 0 0 0 0 0 0 0 Q05923 DUS2_HUMAN "Dual specificity protein phosphatase 2, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PAC-1)" DUSP2 PAC1 Homo sapiens (Human) endoderm formation [GO:0001706]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; endoderm formation [GO:0001706]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] GO:0001706; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008330; GO:0017017; GO:0031965; GO:0043409; GO:0051019 LVRGELAR 9.289999962 0.644912004 0.644912004 0.238690783 913.6354201 0 0 13.81806 18.97731 0 0 0 15.80897 9.578279 0 0 0 15.79577 0 15.24232 14.29027 16.40927 16.80405 18.24875 15.60238 16.18219 0 0 0 0 16.17127 0 0 17.22955 15.08933 18.07078 15.83362 0 0 15.9365 0 0 16.42116 0 15.88519 0 15.44554 0 16.60233 15.12597 0 16.7401 0 Q05925 HME1_HUMAN "Homeobox protein engrailed-1, Homeobox protein en-1, Hu-En-1" EN1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cerebellum development [GO:0021549]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; drinking behavior [GO:0042756]; embryonic brain development [GO:1990403]; embryonic forelimb morphogenesis [GO:0035115]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; motor learning [GO:0061743]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; skeletal system development [GO:0001501]; social behavior [GO:0035176] chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634] "chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cerebellum development [GO:0021549]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; drinking behavior [GO:0042756]; embryonic brain development [GO:1990403]; embryonic forelimb morphogenesis [GO:0035115]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; motor learning [GO:0061743]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; skeletal system development [GO:0001501]; social behavior [GO:0035176]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0008344; GO:0009653; GO:0009953; GO:0009954; GO:0016020; GO:0021549; GO:0030182; GO:0030901; GO:0030917; GO:0035115; GO:0035176; GO:0035264; GO:0042220; GO:0042756; GO:0043473; GO:0043524; GO:0045944; GO:0048666; GO:0061743; GO:0071542; GO:1990403; GO:1990837 YSDRPSSGPR 5.599999905 1 1 0.122069001 1120.862178 11.90442 13.93509 12.78764 12.90038 14.80566 13.77365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8019 0 0 0 0 0 0 0 0 0 15.49901 0 0 0 0 0 0 0 0 0 0 0 0 Q05996 ZP2_HUMAN "Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2, Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2 ]" ZP2 ZPA Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; acrosin binding [GO:0032190]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804]; binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468] acrosin binding [GO:0032190]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804] GO:0005576; GO:0005771; GO:0005783; GO:0005886; GO:0007339; GO:0015026; GO:0016021; GO:0032190; GO:0035804; GO:0035805; GO:0042802; GO:0060468; GO:0062023 NDMLLNINVESLTPPVASVK 9.760000229 0.018162979 0.018162979 1.83E-12 2170.780238 0 0 0 0 14.43462 13.75095 0 0 14.70043 14.31574 0 0 0 0 0 0 0 0 0 14.58068 0 14.13292 0 16.52555 15.82073 0 0 0 0 0 0 15.17473 0 0 0 0 0 0 9.188151 0 0 0 0 0 0 0 0 0 Q05BQ5 MBTD1_HUMAN MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) "chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; embryonic skeletal system development [GO:0048706]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; nucleus [GO:0005634] "NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; embryonic skeletal system development [GO:0048706]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0000724; GO:0000786; GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0016573; GO:0035064; GO:0035267; GO:0042393; GO:0042981; GO:0043967; GO:0043968; GO:0045892; GO:0045893; GO:0048706; GO:0051726; GO:1905168; GO:2000779 ENQSASSK 6.230000019 0.369322836 0.369322836 0.286036761 850.5941957 19.22931 0 16.92939 17.71533 17.62151 16.54242 18.97611 0 20.95825 16.75961 0 0 17.25208 16.39305 0 17.81326 0 0 0 0 17.06415 19.42414 18.14358 18.61026 19.17275 0 0 0 0 17.16629 19.09188 0 0 0 20.22747 19.80909 19.22563 0 0 17.42264 0 0 18.82803 17.50054 0 0 16.78174 16.8998 Q05BV3 EMAL5_HUMAN "Echinoderm microtubule-associated protein-like 5, EMAP-5" EML5 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; catalytic activity [GO:0003824]; microtubule binding [GO:0008017] catalytic activity [GO:0003824]; microtubule binding [GO:0008017] GO:0003824; GO:0005737; GO:0005874; GO:0008017; GO:0070062 AALAPGSK 12.28999996 0.261318833 0.261318833 0.244849032 714.7238189 16.11194 14.61307 14.76993 0 13.95876 13.99272 15.86632 16.41089 14.80011 14.90261 14.13465 14.15122 0 16.53336 0 0 0 0 0 15.2306 14.33986 18.08057 16.72796 0 0 0 0 0 15.58962 16.43053 0 0 14.96808 0 0 0 16.41408 16.41344 0 0 0 0 16.03723 16.08676 15.08054 0 16.00411 16.62197 Q06124 PTN11_HUMAN "Tyrosine-protein phosphatase non-receptor type 11, EC 3.1.3.48 (Protein-tyrosine phosphatase 1D, PTP-1D) (Protein-tyrosine phosphatase 2C, PTP-2C) (SH-PTP2, SHP-2, Shp2) (SH-PTP3)" PTPN11 PTP2C SHPTP2 Homo sapiens (Human) abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]; abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641] cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159] GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0032331; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033628; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0050839; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071364; GO:1990782 GVDGSFLARPSK 15.13000011 1 1 0.629719003 1233.401422 20.90428 0 19.1169 0 0 0 0 19.20665 0 0 0 0 0 0 0 0 0 0 0 0 0 19.47094 0 0 0 0 0 0 0 17.75074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.75733 0 0 0 Q06187 BTK_HUMAN "Tyrosine-protein kinase BTK, EC 2.7.10.2 (Agammaglobulinemia tyrosine kinase, ATK) (B-cell progenitor kinase, BPK) (Bruton tyrosine kinase)" BTK AGMX1 ATK BPK Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cytokine production [GO:0001818]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cytokine production [GO:0001818]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]" "ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]" GO:0001805; GO:0001812; GO:0001818; GO:0002250; GO:0002344; GO:0002553; GO:0002721; GO:0002755; GO:0002902; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007249; GO:0007498; GO:0016004; GO:0018108; GO:0019722; GO:0030889; GO:0031410; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0046777; GO:0046872; GO:0048469; GO:0048471; GO:0050853; GO:0051092; GO:0071226; GO:0097190; GO:0098761 SDIWAFGVLMWEIYSLGKMPYER 2.069999933 1 1 0.199641155 2822.987356 14.64362 11.36619 10.37134 10.06087 14.67931 14.21328 14.73351 12.65244 14.09753 14.9183 0 0 12.63074 13.4808 0 16.00905 13.20467 13.66714 0 0 0 0 0 0 0 11.44597 13.11598 0 0 0 0 15.37391 0 0 0 0 0 0 0 0 0 0 14.93457 0 10.30806 0 12.30469 0 Q06190 P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) PPP2R3A PPP2R3 Homo sapiens (Human) eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244] protein phosphatase type 2A complex [GO:0000159] protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244] calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263 APMFRAAGGEK 5.789999962 1 1 0.040621424 1134.247166 15.7456 0 14.86096 15.01386 0 16.08904 14.33878 15.01639 16.25669 0 0 0 0 0 0 0 0 12.96424 17.39803 0 0 14.40889 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3331 13.59134 15.79075 0 16.39831 13.91558 0 0 0 0 0 0 15.09076 Q06203 PUR1_HUMAN "Amidophosphoribosyltransferase, ATase, EC 2.4.2.14 (Glutamine phosphoribosylpyrophosphate amidotransferase, GPAT)" PPAT GPAT Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164] cytosol [GO:0005829] "cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]" "4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]" GO:0004044; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009113; GO:0044208; GO:0046872; GO:0051539; GO:0097294 SGHCTACLTGKYPVELEW 9.430000305 0.339682072 0.339682072 0.149677101 2109.079697 0 10.08757 15.82058 0 16.01148 0 18.21721 0 11.01711 16.40681 0 0 0 0 13.99451 11.99734 0 0 12.4945 14.58057 0 0 0 10.91506 0 0 0 0 15.75792 15.66419 18.10484 18.93666 0 19.97561 0 0 10.24807 15.81774 16.20535 0 17.06885 14.51371 0 0 12.10961 15.38605 0 16.3299 Q06210 GFPT1_HUMAN "Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1, EC 2.6.1.16 (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1, GFAT 1, GFAT1) (Hexosephosphate aminotransferase 1)" GFPT1 GFAT GFPT Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360] GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0070062; GO:0097367 EDTETIKNTK 7.710000038 1 1 0.200765567 1178.599981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06278 AOXA_HUMAN "Aldehyde oxidase, EC 1.2.3.1 (Aldehyde oxidase 1) (Azaheterocycle hydroxylase, EC 1.17.3.-)" AOX1 AO Homo sapiens (Human) lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805]" "2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]" GO:0004031; GO:0005506; GO:0005829; GO:0006629; GO:0006805; GO:0016491; GO:0042802; GO:0042803; GO:0043546; GO:0050660; GO:0051287; GO:0051537; GO:0070062; GO:0071949; GO:0102797; GO:0102798 GPDQYK 3.480000019 1 1 0.279467773 707.8858269 14.075 0 14.53282 14.59967 14.85899 0 0 15.6916 15.83165 15.0383 0 14.73888 0 15.79754 0 15.01199 0 0 0 0 0 0 16.85762 17.04742 15.7346 0 16.58383 0 0 0 15.99599 0 16.89446 15.43583 15.8295 0 0 16.7827 16.06545 15.76413 15.77598 14.30006 0 13.45556 0 16.06073 15.48911 0 Q06413 MEF2C_HUMAN Myocyte-specific enhancer factor 2C (Myocyte enhancer factor 2C) MEF2C Homo sapiens (Human) "apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; excitatory postsynaptic potential [GO:0060079]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; myotube differentiation [GO:0014902]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary heart field specification [GO:0003138]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine development [GO:0060998]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of neuron apoptotic process [GO:0043523]; regulation of neurotransmitter secretion [GO:0046928]; regulation of NMDA receptor activity [GO:2000310]; regulation of synapse assembly [GO:0051963]; regulation of synaptic activity [GO:0060025]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal tubule morphogenesis [GO:0061333]; response to ischemia [GO:0002931]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; excitatory postsynaptic potential [GO:0060079]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; myotube differentiation [GO:0014902]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary heart field specification [GO:0003138]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine development [GO:0060998]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of neuron apoptotic process [GO:0043523]; regulation of neurotransmitter secretion [GO:0046928]; regulation of NMDA receptor activity [GO:2000310]; regulation of synapse assembly [GO:0051963]; regulation of synaptic activity [GO:0060025]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal tubule morphogenesis [GO:0061333]; response to ischemia [GO:0002931]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000165; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001764; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0002931; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003680; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006915; GO:0006959; GO:0007399; GO:0007507; GO:0007517; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0010694; GO:0014033; GO:0014902; GO:0016528; GO:0016607; GO:0030154; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035984; GO:0042100; GO:0042826; GO:0043231; GO:0043406; GO:0043523; GO:0043524; GO:0043537; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046928; GO:0046982; GO:0048167; GO:0048643; GO:0048666; GO:0048667; GO:0050853; GO:0051145; GO:0051963; GO:0051966; GO:0055012; GO:0060025; GO:0060045; GO:0060079; GO:0060998; GO:0061333; GO:0061629; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:0098794; GO:0140297; GO:1904706; GO:1904753; GO:1905563; GO:1990837; GO:2000111; GO:2000310; GO:2000311; GO:2000727; GO:2000987; GO:2001013; GO:2001016 SEPVSPPR 12.72999954 1 1 0.426661359 869.7505506 0 0 0 0 0 0 0 0 0 0 0 0 0 18.65778 18.10912 0 0 0 20.88303 0 19.08023 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7926 0 0 0 19.01407 0 17.04328 17.92471 0 0 0 20.59266 0 0 Q06418 TYRO3_HUMAN "Tyrosine-protein kinase receptor TYRO3, EC 2.7.10.1 (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF)" TYRO3 BYK DTK RSE SKY TIF Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron cellular homeostasis [GO:0070050]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron cellular homeostasis [GO:0070050]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068] ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618] GO:0001618; GO:0001779; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005634; GO:0005635; GO:0005789; GO:0005887; GO:0006909; GO:0007155; GO:0007165; GO:0007169; GO:0007218; GO:0007283; GO:0007399; GO:0009986; GO:0014065; GO:0016477; GO:0021885; GO:0030168; GO:0032940; GO:0033674; GO:0034122; GO:0034446; GO:0042698; GO:0043235; GO:0043277; GO:0043491; GO:0043524; GO:0043548; GO:0045824; GO:0046777; GO:0050728; GO:0051250; GO:0060068; GO:0070050; GO:0070527; GO:1903902 IEATLDSLGISDELK 5.039999962 1 1 0.12443595 1603.548919 0 0 15.95957 0 0 0 0 0 0 0 0 0 15.94401 0 15.71989 0 0 0 17.02437 0 0 0 0 0 13.38638 0 0 12.87024 0 0 14.32648 0 12.75022 13.81674 14.71572 11.17059 0 0 0 0 0 0 0 0 0 0 0 0 Q06455 MTG8_HUMAN Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2) RUNX1T1 AML1T1 CBFA2T1 CDR ETO MTG8 ZMYND2 Homo sapiens (Human) "negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]" nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0016363; GO:0045599; GO:0045892; GO:0046872; GO:0140297 DSYRHPSHR 8.06000042 0.237457782 0.237457782 0.182560214 1152.004201 0 0 0 0 0 17.36695 15.91403 18.24039 0 0 0 0 15.43487 16.15928 16.41341 16.70898 18.62111 16.59307 0 0 0 18.77117 0 19.41402 18.7545 15.43762 17.58514 0 19.0183 0 15.12752 17.02433 0 17.35583 0 17.38808 19.11465 18.4499 0 20.4236 17.19277 0 17.35706 0 0 17.50061 19.69793 15.808 Q06546 GABPA_HUMAN "GA-binding protein alpha chain, GABP subunit alpha (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60)" GABPA E4TF1A Homo sapiens (Human) blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001825; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030154; GO:0045653; GO:0045944; GO:1903351; GO:1990837 SSPGNR 5.510000229 1 1 0.054981876 617.5543936 0 0 0 15.80587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.69617 0 0 0 0 0 0 0 0 0 17.62772 0 0 0 0 16.79855 0 0 0 0 0 0 0 0 Q06710 PAX8_HUMAN Paired box protein Pax-8 PAX8 Homo sapiens (Human) "anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to gonadotropin stimulus [GO:0071371]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric nephron tubule formation [GO:0072289]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; otic vesicle development [GO:0071599]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of thyroid-stimulating hormone secretion [GO:2000612]; regulation of transcription by RNA polymerase II [GO:0006357]; sulfur compound metabolic process [GO:0006790]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventricular septum development [GO:0003281]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid-stimulating hormone receptor activity [GO:0004996]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to gonadotropin stimulus [GO:0071371]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric nephron tubule formation [GO:0072289]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; otic vesicle development [GO:0071599]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of thyroid-stimulating hormone secretion [GO:2000612]; regulation of transcription by RNA polymerase II [GO:0006357]; sulfur compound metabolic process [GO:0006790]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventricular septum development [GO:0003281]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid-stimulating hormone receptor activity [GO:0004996]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001655; GO:0001658; GO:0001822; GO:0001823; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0004996; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0006790; GO:0007417; GO:0009653; GO:0010667; GO:0030878; GO:0039003; GO:0042472; GO:0042981; GO:0045893; GO:0045944; GO:0048793; GO:0048856; GO:0071371; GO:0071599; GO:0072108; GO:0072207; GO:0072221; GO:0072278; GO:0072284; GO:0072289; GO:0072305; GO:0072307; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000594; GO:2000611; GO:2000612 LSIDSQSSSSGPRK 7.659999847 1 1 0.354895824 1448.895087 15.39889 0 0 0 0 0 0 0 0 0 15.87059 13.63036 0 0 0 0 0 16.35096 0 0 0 0 18.11608 0 0 0 0 15.7963 0 16.12202 0 12.38251 16.62693 0 15.60873 0 15.8888 16.92482 15.87828 0 16.50583 15.62893 0 16.33812 0 16.76709 0 0 Q06730 ZN33A_HUMAN "Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain, ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)" ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872 HIGENLMNEMDIR 4.269999981 0.878921747 0.878921747 0.386345368 1592.828506 13.56955 13.88332 14.27194 13.89064 12.68208 14.55847 12.70593 14.6465 0 12.85378 0 13.46911 0 0 0 0 0 0 0 0 0 0 0 0 15.8521 0 0 15.29085 0 15.33788 15.10187 14.60718 15.63811 15.65703 0 17.56842 0 16.01898 0 16.13177 15.91577 18.17441 0 0 15.48224 0 0 0 Q06732 ZN33B_HUMAN Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2) ZNF33B KOX2 ZNF11B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 TFSQKSNLIVHQR 2.660000086 0.661153734 0.661153734 2.30E-13 1557.092704 0 0 0 0 0 0 0 0 15.01041 16.09769 18.72049 0 0 14.61912 12.92759 0 0 0 0 0 0 0 0 0 0 9.849862 11.70353 0 0 0 0 0 0 0 0 0 0 15.70506 0 14.04141 15.37443 0 0 0 0 0 0 14.11145 Q06787 FMR1_HUMAN "Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1, FMRP, Protein FMR-1)" FMR1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]" "axon [GO:0030424]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]" "axon [GO:0030424]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; transmembrane transporter binding [GO:0044325]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]" chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; transmembrane transporter binding [GO:0044325] GO:0000381; GO:0000775; GO:0001934; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006397; GO:0006974; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0014069; GO:0015030; GO:0016020; GO:0017148; GO:0019897; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0031047; GO:0031369; GO:0032433; GO:0033129; GO:0033592; GO:0034046; GO:0034644; GO:0035064; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042802; GO:0042803; GO:0042995; GO:0043005; GO:0043022; GO:0043025; GO:0043197; GO:0043204; GO:0043488; GO:0043679; GO:0044325; GO:0044326; GO:0044830; GO:0045182; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060964; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0072711; GO:0097386; GO:0098586; GO:0098793; GO:0098794; GO:0098908; GO:1900453; GO:1901254; GO:1901386; GO:1901800; GO:1902373; GO:1902416; GO:1902737; GO:1990124; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766; GO:2001022 EPCCWWLAKVR 4.230000019 0.001364865 0.001364865 0.19666118 1503.889123 14.02087 16.31732 0 14.3808 14.55019 14.29956 15.47389 11.94858 0 0 16.23836 15.59811 0 0 0 12.59129 0 0 0 0 0 0 13.37168 0 0 0 0 0 0 15.57305 0 0 0 14.62873 16.05621 0 14.67616 0 0 16.25451 15.30202 0 0 0 0 0 15.73082 0 Q07002 CDK18_HUMAN "Cyclin-dependent kinase 18, EC 2.7.11.22 (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3)" CDK18 PCTAIRE3 PCTK3 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000083; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310 AKSVPTK 5.429999828 0.953535616 0.953535616 0.108129521 727.4712088 0 0 0 14.6231 0 0 0 15.59417 0 0 0 0 15.60176 15.56388 15.70532 0 0 0 0 0 0 0 17.09086 17.7645 0 0 16.82322 0 0 15.00628 16.86602 0 0 16.71176 14.18055 14.08587 0 0 15.86154 0 15.54644 16.90222 16.55664 16.43581 16.40583 0 0 0 Q07065 CKAP4_HUMAN "Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein, Climp-63, p63)" CKAP4 Homo sapiens (Human) azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005811; GO:0005856; GO:0005886; GO:0016020; GO:0016021; GO:0035577; GO:0035579; GO:0042599; GO:0048471; GO:0070062 PSAKQR 7.96999979 1 1 0.133785289 686.2449799 0 15.60033 14.19046 15.63619 15.89383 0 12.94474 12.35776 16.05638 0 15.25712 0 0 0 15.17007 15.62067 14.74295 0 14.56608 0 0 0 0 0 15.35621 0 16.06349 0 0 0 0 15.86185 0 0 16.22306 0 0 0 0 0 15.0999 0 0 16.33825 0 0 0 0 Q07075 AMPE_HUMAN "Glutamyl aminopeptidase, EAP, EC 3.4.11.7 (Aminopeptidase A, AP-A) (Differentiation antigen gp160) (CD antigen CD249)" ENPEP Homo sapiens (Human) angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165] aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] GO:0001525; GO:0002003; GO:0003081; GO:0004177; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0005903; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0008283; GO:0009897; GO:0016324; GO:0016477; GO:0031410; GO:0032835; GO:0042277; GO:0043171; GO:0045177; GO:0070006; GO:0070062 MNFAEREGSK 5.389999866 1 1 0.001803573 1185.639987 14.13332 15.95842 14.6366 0 0 13.25477 0 2.465566 0 0 0 0 0 0 13.74306 0 0 0 0 14.42044 14.97025 0 0 0 14.90049 14.80136 16.71693 14.61079 0 0 0 0 0 0 15.66326 0 0 0 0 0 0 0 14.79507 16.99528 15.67168 0 0 0 Q07092 COGA1_HUMAN Collagen alpha-1(XVI) chain COL16A1 FP1572 Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894] collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178] GO:0005178; GO:0005201; GO:0005576; GO:0005588; GO:0005597; GO:0005615; GO:0005788; GO:0007155; GO:0007229; GO:0007565; GO:0030020; GO:0030198; GO:0031012; GO:0033622; GO:0033627; GO:0051894; GO:0062023; GO:0071230 GLPGTKGEK 4.110000134 1 1 0.115398976 885.3640075 0 15.43397 0 0 0 14.82133 0 13.33051 0 10.44698 12.99156 14.63 15.88162 14.51057 0 11.68508 9.783952 0 0 0 0 0 0 16.17066 18.08863 16.02625 0 16.45706 0 16.35367 0 0 0 0 14.00212 0 0 0 0 0 15.20732 0 16.17126 16.20182 13.14861 0 0 0 Q07283 TRHY_HUMAN Trichohyalin TCHH THH THL TRHY Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] GO:0001533; GO:0005509; GO:0005829; GO:0005856; GO:0031424; GO:0045109; GO:0046914 DLKNLLER 3.809999943 1 1 0.249308158 1001.676403 20.13673 20.3735 19.41194 21.30654 0 14.75595 0 0 0 0 17.84848 18.03326 0 17.36487 0 0 0 0 0 0 0 0 0 0 17.97116 19.86382 0 0 17.78163 18.91421 17.92446 18.79403 0 18.42372 0 0 0 0 0 20.44508 0 0 16.76164 0 19.24153 17.18725 17.47372 0 Q07325 CXCL9_HUMAN "C-X-C motif chemokine 9 (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma, HuMIG, MIG) (Small-inducible cytokine B9)" CXCL9 CMK MIG SCYB9 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; cytokine activity [GO:0005125]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165] chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; cytokine activity [GO:0005125] GO:0005125; GO:0005576; GO:0005615; GO:0006935; GO:0006952; GO:0006954; GO:0006968; GO:0007165; GO:0007186; GO:0007189; GO:0007267; GO:0008009; GO:0009897; GO:0030593; GO:0031640; GO:0042127; GO:0045236; GO:0045663; GO:0048248; GO:0051281; GO:0051607; GO:0061844; GO:0070098; GO:0071222; GO:1901741 DLKQFAPSPSCEK 5.190000057 1 1 6.96E-13 1507.435008 0 16.43694 16.31169 15.83302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07617 SPAG1_HUMAN Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) SPAG1 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]; single fertilization [GO:0007338] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]; single fertilization [GO:0007338] GTP binding [GO:0005525]; hydrolase activity [GO:0016787] GO:0005525; GO:0005737; GO:0005829; GO:0007338; GO:0016787; GO:0050821; GO:0070286; GO:0101031; GO:0120293 EEPGRPAGEVSMGCLASEK 6.960000038 1 1 0.39488264 2019.961048 19.13461 21.15317 0 0 18.81078 0 0 0 18.59434 0 0 0 18.81161 0 0 20.59874 18.27675 0 0 0 0 19.61356 19.74146 0 0 0 0 0 0 0 0 0 0 0 0 20.70223 0 0 20.9039 0 0 20.12495 0 0 0 0 0 18.01963 Q07666 KHDR1_HUMAN "KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein, Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)" KHDRBS1 SAM68 Homo sapiens (Human) "G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]" DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] GO:0000082; GO:0000086; GO:0000122; GO:0000381; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007283; GO:0008143; GO:0008266; GO:0016020; GO:0017124; GO:0019904; GO:0032991; GO:0035591; GO:0042169; GO:0042802; GO:0044877; GO:0045892; GO:0045948; GO:0046831; GO:0046833; GO:0048024; GO:0050852; GO:0070618; GO:1990782 GAPAPR 7.050000191 0.530669034 0.530669034 0.297844922 567.8804296 0 17.83321 0 16.68437 17.60258 17.44579 18.43859 18.81584 0 18.24079 18.10195 0 17.97733 16.10803 0 0 18.95144 0 0 16.74049 0 0 17.30913 0 0 0 0 0 0 17.68151 0 19.57834 0 0 0 0 0 0 0 17.54572 0 0 0 0 0 0 0 0 Q07699 SCN1B_HUMAN Sodium channel subunit beta-1 SCN1B Homo sapiens (Human) axon guidance [GO:0007411]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; corticospinal neuron axon guidance [GO:0021966]; locomotion [GO:0040011]; membrane depolarization [GO:0051899]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; node of Ranvier [GO:0033268]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; node of Ranvier [GO:0033268]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; axon guidance [GO:0007411]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; corticospinal neuron axon guidance [GO:0021966]; locomotion [GO:0040011]; membrane depolarization [GO:0051899]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725] sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062] GO:0001518; GO:0005244; GO:0005248; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010765; GO:0010976; GO:0014704; GO:0017080; GO:0019227; GO:0019871; GO:0021966; GO:0030315; GO:0033268; GO:0035725; GO:0040011; GO:0043204; GO:0044325; GO:0051899; GO:0060048; GO:0060307; GO:0060371; GO:0061337; GO:0086002; GO:0086006; GO:0086012; GO:0086047; GO:0086062; GO:0086091; GO:2000649 ENCTGVQVAE 4.809999943 0.409832209 0.409832209 0.160353878 1107.79559 0 0 15.26786 0 0 15.08571 14.889 15.73318 14.39164 15.88331 15.18116 0 0 14.5316 14.88933 0 0 14.89637 14.80883 0 0 0 15.35001 16.41356 16.17846 0 0 0 0 12.79772 15.52772 16.34771 0 0 12.23302 0 14.09842 14.2327 15.61156 0 15.54704 13.78723 10.82489 0 6.330514 0 15.34696 0 Q07820 MCL1_HUMAN "Induced myeloid leukemia cell differentiation protein Mcl-1 (Bcl-2-like protein 3, Bcl2-L-3) (Bcl-2-related protein EAT/mcl1) (mcl1/EAT)" MCL1 BCL2L3 Homo sapiens (Human) cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; regulation of response to DNA damage stimulus [GO:2001020]; response to cytokine [GO:0034097] Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; BH3 domain binding [GO:0051434]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein transmembrane transporter activity [GO:0008320]; cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; regulation of response to DNA damage stimulus [GO:2001020]; response to cytokine [GO:0034097] BH3 domain binding [GO:0051434]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein transmembrane transporter activity [GO:0008320] GO:0001709; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0008320; GO:0008630; GO:0010507; GO:0016020; GO:0016021; GO:0019725; GO:0034097; GO:0042803; GO:0042981; GO:0043065; GO:0043066; GO:0046982; GO:0051434; GO:0097136; GO:0097192; GO:1903378; GO:2000811; GO:2001020; GO:2001240; GO:2001243 AAPLEEMEAPAADAIMSPEEELDGYEPEPLGK 1.850000024 0.387719363 0.387719363 1.83E-12 3416.157502 12.24713 13.66541 12.8028 12.77194 12.60345 0 0 0 0 0 0 0 0 0 12.86383 10.43099 0 14.02042 0 0 0 0 15.2957 0 10.28484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.29063 0 13.23347 0 0 0 0 16.0051 0 Q07864 DPOE1_HUMAN "DNA polymerase epsilon catalytic subunit A, EC 2.7.7.7 (3'-5' exodeoxyribonuclease, EC 3.1.11.-) (DNA polymerase II subunit A)" POLE POLE1 Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]" epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]" "4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]" GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 CILNSFYGYVMR 11.73999977 1 1 0.342778933 1538.639513 14.5413 15.69537 13.43747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.35357 0 0 Q07889 SOS1_HUMAN "Son of sevenless homolog 1, SOS-1" SOS1 Homo sapiens (Human) axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296] DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124] GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0042127; GO:0042129; GO:0043025; GO:0043405; GO:0043547; GO:0045742; GO:0046982; GO:0048011; GO:0048514; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:1905360; GO:2000973 LVGNYVR 11.21000004 1 1 0.015150679 820.5883269 0 15.83381 15.62358 15.69769 0 0 15.72872 0 0 16.56608 12.77931 0 0 15.08366 0 0 0 0 12.94714 0 0 0 15.01971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07890 SOS2_HUMAN "Son of sevenless homolog 2, SOS-2" SOS2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; B cell homeostasis [GO:0001782]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982] GO:0001782; GO:0003677; GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0033081; GO:0042129; GO:0043547; GO:0046982; GO:0051057; GO:2000973 ELNMIIK 8.31000042 1 1 0.144269139 877.2728454 14.38034 15.39753 12.1972 15.45626 14.85261 0 15.63921 0 16.35817 16.24006 16.69049 15.2589 0 14.67656 0 15.16971 0 15.33625 0 15.89169 15.04588 0 16.52981 15.35954 14.55848 0 15.28628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.56326 0 0 0 0 Q07912 ACK1_HUMAN "Activated CDC42 kinase 1, ACK-1, EC 2.7.10.2, EC 2.7.11.1 (Tyrosine kinase non-receptor protein 2)" TNK2 ACK1 Homo sapiens (Human) cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase mediated signal transduction [GO:0007264]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase mediated signal transduction [GO:0007264]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699] GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005095; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007166; GO:0007169; GO:0007264; GO:0016020; GO:0016310; GO:0030136; GO:0030154; GO:0030659; GO:0031234; GO:0031625; GO:0042802; GO:0043231; GO:0045087; GO:0046872; GO:0048471; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:0106310; GO:2000369 GECHK 3.289999962 0.722785592 0.722785592 0.19060886 628.2154458 0 0 0 0 0 0 0 0 17.56225 0 0 0 0 0 18.48959 17.03937 0 16.21655 0 13.84643 16.44963 0 13.37559 14.99094 0 0 0 16.13674 0 0 0 0 0 0 16.97131 0 0 0 0 0 0 0 16.64919 0 0 0 0 14.07737 Q07954 LRP1_HUMAN "Prolow-density lipoprotein receptor-related protein 1, LRP-1 (Alpha-2-macroglobulin receptor, A2MR) (Apolipoprotein E receptor, APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit, LRP-85; Low-density lipoprotein receptor-related protein 1 515 kDa subunit, LRP-515; Low-density lipoprotein receptor-related protein 1 intracellular domain, LRPICD ]" LRP1 A2MR APR Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein receptor complex [GO:0062136]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein receptor complex [GO:0062136]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023] GO:0001523; GO:0001540; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0010629; GO:0010715; GO:0010875; GO:0010942; GO:0014912; GO:0016020; GO:0016323; GO:0016964; GO:0030178; GO:0030226; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032956; GO:0034185; GO:0035909; GO:0038023; GO:0038024; GO:0042953; GO:0043235; GO:0043277; GO:0043395; GO:0044877; GO:0045056; GO:0045807; GO:0060392; GO:0060394; GO:0062136; GO:0070325; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:0150104; GO:1900223; GO:1903078; GO:1904300; GO:1904646; GO:1905049; GO:1905167; GO:2000587 DVIEVAQMK 3.950000048 1 1 0.242987118 1048.320114 17.60935 0 0 12.54894 0 17.31341 0 15.29589 16.32651 16.37692 15.67747 16.3228 0 15.31187 0 14.83546 15.71267 14.96318 0 0 0 0 16.54662 16.17927 0 19.02221 17.25742 17.28434 13.01869 14.91192 0 0 0 18.00999 0 0 17.61442 0 0 18.09862 15.29819 16.04014 18.61311 17.08971 15.45436 0 15.49115 12.71177 Q07955 SRSF1_HUMAN "Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1, ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)" SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; regulation of RNA splicing [GO:0043484]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; regulation of RNA splicing [GO:0043484]" DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000380; GO:0000395; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0016607; GO:0043484; GO:0044547; GO:0051028; GO:0071013 GGGGGGGGGAPR 5.690000057 0.946176291 0.946176291 0.289249487 857.0016062 16.9908 14.69415 16.20741 0 15.18376 0 16.86765 16.67274 14.24934 14.56927 15.10323 14.55243 16.95765 14.58014 0 15.30735 16.57797 0 0 0 0 16.17003 15.08241 16.23394 0 0 15.61744 0 13.68061 14.61543 16.93882 0 16.64256 0 0 0 15.7441 15.52779 0 14.56707 15.6508 14.2457 15.05247 0 0 15.57916 0 0 Q08116 RGS1_HUMAN "Regulator of G-protein signaling 1, RGS1 (B-cell activation protein BL34) (Early response protein 1R20)" RGS1 1R20 BL34 IER1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GO:0001965; GO:0003924; GO:0005096; GO:0005516; GO:0005829; GO:0005886; GO:0006955; GO:0007165; GO:0007186; GO:0007193; GO:0008277; GO:0009617; GO:0009968; GO:0031234; GO:0043547; GO:0061737 DVLSAAEVMQWSQSLEK 8.649999619 1 1 2.07E-12 1937.708705 0 0 0 14.25818 0 0 0 0 0 0 0 14.01285 0 0 13.72715 0 0 0 18.98971 0 13.21655 0 0 0 0 0 0 14.9189 0 0 14.22689 17.0262 0 0 0 0 9.11864 15.49455 0 0 0 0 0 0 0 0 0 0 Q08170 SRSF4_HUMAN "Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)" SRSF4 SFRS4 SRP75 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825 DSKAGSSK 10.68999958 1 1 0 780.6323389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38461 0 0 0 0 0 0 0 0 0 16.64358 0 0 16.6092 0 0 0 0 0 0 0 Q08188 TGM3_HUMAN "Protein-glutamine gamma-glutamyltransferase E, EC 2.3.2.13 (Transglutaminase E, TG(E), TGE, TGase E) (Transglutaminase-3, TGase-3) [Cleaved into: Protein-glutamine gamma-glutamyltransferase E 50 kDa catalytic chain; Protein-glutamine gamma-glutamyltransferase E 27 kDa non-catalytic chain ]" TGM3 Homo sapiens (Human) cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; hair follicle morphogenesis [GO:0031069]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; protein-containing complex [GO:0032991]; acyltransferase activity [GO:0016746]; calcium ion binding [GO:0005509]; catalytic activity [GO:0003824]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural molecule activity [GO:0005198]; cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; hair follicle morphogenesis [GO:0031069]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149] acyltransferase activity [GO:0016746]; calcium ion binding [GO:0005509]; catalytic activity [GO:0003824]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural molecule activity [GO:0005198] GO:0003810; GO:0003824; GO:0005198; GO:0005509; GO:0005737; GO:0006464; GO:0016746; GO:0018149; GO:0030216; GO:0031069; GO:0031234; GO:0031424; GO:0032991; GO:0043163; GO:0070062 FSSQELILR 11.47000027 0.00211179 0.00211179 0.024548257 1095.867589 0 0 17.95312 0 0 0 19.83443 0 16.41924 0 13.89338 0 0 0 19.05622 15.96725 8.562559 18.0036 0 17.0553 0 17.78304 0 0 16.61486 17.92994 17.53047 18.86376 15.87843 0 0 16.49876 0 0 0 0 0 0 0 10.33169 16.45913 17.39974 0 10.57589 17.46922 14.45787 0 0 Q08211 DHX9_HUMAN "ATP-dependent RNA helicase A, EC 3.6.4.13 (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin, LKP) (Nuclear DNA helicase II, NDH II) (RNA helicase A)" DHX9 DDX9 LKP NDH2 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]" actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]" 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142] GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032760; GO:0032991; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061629; GO:0061676; GO:0065003; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1900152; GO:1903608; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767 GMTLVTPLQLLLFASK 4.309999943 1 1 0.550680712 1748.175293 0 18.74759 0 0 0 16.91486 0 0 19.31925 0 0 0 0 0 0 0 0 0 0 16.90215 15.64011 0 0 0 0 0 0 0 0 18.05545 0 0 0 0 0 0 0 0 0 17.88951 0 0 17.16233 0 0 17.45259 17.86936 0 Q08345 DDR1_HUMAN "Epithelial discoidin domain-containing receptor 1, Epithelial discoidin domain receptor 1, EC 2.7.10.1 (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10, MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)" DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE Homo sapiens (Human) "axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]" extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]" ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001558; GO:0001952; GO:0004712; GO:0004714; GO:0005518; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007566; GO:0007595; GO:0008285; GO:0010715; GO:0014909; GO:0033674; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:0070062; GO:1990138 GPAMAWEGEPMR 2.630000114 1 1 2.29E-12 1333.507901 13.67168 12.95035 0 14.34208 14.44962 13.61053 0 0 15.01098 13.82953 14.34096 0 13.92982 0 15.27298 0 0 0 0 0 0 0 15.80435 0 0 14.05952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9941 0 0 0 Q08378 GOGA3_HUMAN "Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa, GCP170) (Golgin-160)" GOLGA3 Homo sapiens (Human) spermatogenesis [GO:0007283] cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; spermatogenesis [GO:0007283] cadherin binding [GO:0045296] GO:0000139; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0007283; GO:0016020; GO:0032580; GO:0045296; GO:0090498 DKFMLQAK 3.910000086 1 1 0.286093925 996.009814 16.96085 15.48891 15.40892 0 0 0 0 0 0 17.98174 0 0 14.46315 0 0 0 0 0 14.4491 0 0 0 15.56646 0 15.43692 16.47824 0 0 0 0 0 0 0 0 15.74448 0 0 16.6032 0 0 0 0 0 0 0 0 0 15.53189 Q08379 GOGA2_HUMAN "Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein, GM130) (GM130 autoantigen) (Golgin-95)" GOLGA2 Homo sapiens (Human) asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905] GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307 LAHLLASAQK 10.09000015 1 1 0.302032924 1052.221227 13.88035 16.37358 15.4451 14.92213 0 15.03625 0 14.5296 15.13132 11.54752 9.931681 14.79926 14.38002 15.61143 14.26645 0 0 0 0 0 0 0 0 14.51048 0 0 16.24307 0 16.18036 0 16.38888 0 0 0 0 0 0 16.21827 0 14.33592 15.9498 13.91041 13.87454 0 0 16.17485 0 0 Q08462 ADCY2_HUMAN "Adenylate cyclase type 2, EC 4.6.1.1 (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)" ADCY2 KIAA1060 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0019933; GO:0030145; GO:0030425; GO:0045121; GO:1904322 ENECMR 2.849999905 1 1 0.194209424 854.615858 14.93736 15.88795 13.51871 15.4756 0 0 15.92294 15.72676 14.42832 0 16.28641 14.91533 0 0 0 17.26357 0 0 0 0 0 0 0 0 14.37907 0 0 15.18333 0 0 0 14.39167 0 0 0 0 0 17.1132 0 0 0 0 0 0 0 0 0 0 Q08477 CP4F3_HUMAN "Cytochrome P450 4F3, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3, EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2, EC 1.14.14.94)" CYP4F3 LTB4H Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692]; arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692] GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0006691; GO:0008391; GO:0010430; GO:0016021; GO:0019369; GO:0020037; GO:0036101; GO:0042361; GO:0042376; GO:0043231; GO:0050051; GO:0070330; GO:0097258; GO:0097259; GO:0097267; GO:0102033; GO:0102207; GO:0120319; GO:0140692; GO:2001302; GO:2001304 VVLGLTLLR 10.44999981 1 1 0.29630232 984.0033637 14.92194 13.79364 14.35564 14.29685 13.56049 14.80451 13.62292 11.22916 0 0 14.81535 0 15.18731 0 15.69435 0 14.4071 0 0 14.97637 0 15.2597 15.5532 15.22455 14.16341 16.47042 0 0 0 0 0 0 0 14.05827 15.84751 0 0 0 0 11.38986 15.74551 0 0 0 0 0 12.75975 0 Q08493 PDE4C_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 4C, EC 3.1.4.53 (DPDE1) (PDE21)" PDE4C DPDE1 Homo sapiens (Human) cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165] cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" GO:0004114; GO:0004115; GO:0005615; GO:0005634; GO:0005829; GO:0005929; GO:0006198; GO:0007165; GO:0046872; GO:0048471 ALDPQSSPGLGR 5.360000134 0.341059238 0.341059238 0.47916037 1196.85828 16.79156 0 0 17.44776 18.58297 0 16.55416 0 0 0 0 0 0 0 17.27161 0 0 0 0 0 0 0 18.90803 0 0 0 0 0 0 16.96235 0 0 0 0 0 0 0 0 0 0 0 0 17.12205 0 0 0 0 0 Q08554 DSC1_HUMAN "Desmocollin-1 (Cadherin family member 1) (Desmosomal glycoprotein 2/3, DG2/DG3)" DSC1 CDHF1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0001533; GO:0005509; GO:0005886; GO:0005911; GO:0005921; GO:0007156; GO:0016020; GO:0016021; GO:0030057; GO:0070062; GO:0098609; GO:0101003 EKCDTYQLIMEVR 3.5 1 1 0.271024163 1685.56087 0 12.97843 0 0 0 0 13.73223 0 0 0 0 0 0 0 0 0 17.7664 0 0 0 0 0 18.3524 0 17.8952 0 19.08347 0 0 0 0 0 19.61881 0 0 0 0 0 0 0 0 0 15.02823 0 15.94386 0 0 0 Q08722 CD47_HUMAN "Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein, IAP) (Protein MER6) (CD antigen CD47)" CD47 MER6 Homo sapiens (Human) ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053]; ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680] cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053] GO:0005886; GO:0005887; GO:0007229; GO:0008284; GO:0009986; GO:0016477; GO:0022409; GO:0032649; GO:0032653; GO:0032655; GO:0032675; GO:0032680; GO:0035579; GO:0045428; GO:0050729; GO:0050766; GO:0050870; GO:0051496; GO:0070053; GO:0070062; GO:0070821; GO:0071346; GO:0071347; GO:0071349; GO:0086080; GO:0098632; GO:1904669; GO:1905450; GO:2000439 TIQPPRK 1.409999967 1 1 0.131762506 839.7027248 0 12.78294 0 13.81484 13.44374 0 15.84086 14.67418 0 0 15.46096 0 0 0 0 13.29997 0 14.67615 0 0 15.22764 0 15.84296 16.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08752 PPID_HUMAN "Peptidyl-prolyl cis-trans isomerase D, PPIase D, EC 5.2.1.8 (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40, CYP-40) (Cyclophilin-related protein) (Rotamase D)" PPID CYP40 CYPD Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076] cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134] GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019076; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0045070; GO:0050714; GO:0051879; GO:0061077; GO:0065003; GO:0071492 AVIETADR 1.409999967 1 1 0.182555542 873.8612044 15.39485 0 12.63855 13.46813 16.025 0 13.81234 0 0 0 0 0 0 0 0 0 14.79785 0 0 0 0 0 15.46932 15.26822 0 15.81707 14.75428 0 0 0 16.02573 15.96278 0 14.97258 15.72548 0 0 0 15.2767 17.50307 0 0 16.53387 0 0 0 0 0 Q08828 ADCY1_HUMAN "Adenylate cyclase type 1, EC 4.6.1.1 (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase)" ADCY1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]; response to xenobiotic stimulus [GO:0009410] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0007409; GO:0007420; GO:0007616; GO:0007623; GO:0008294; GO:0009410; GO:0010226; GO:0019933; GO:0032793; GO:0042752; GO:0045121; GO:0046872; GO:0070062; GO:0071277; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0150076; GO:1900273; GO:1904322; GO:2000300 RPPVCPMPGVSVR 7.320000172 0.054527655 0.054527655 0.520498899 1467.183083 0 0 0 0 0 0 18.35394 18.72077 19.3072 0 0 19.51984 18.75311 0 0 0 18.52083 0 0 0 18.96033 0 0 0 0 0 0 19.66223 17.49246 20.36747 21.47166 0 0 0 0 20.60203 0 0 20.64136 20.56218 0 0 0 20.09792 20.27473 0 18.9292 0 Q08830 FGL1_HUMAN "Fibrinogen-like protein 1 (HP-041) (Hepassocin, HPS) (Hepatocyte-derived fibrinogen-related protein 1, HFREP-1) (Liver fibrinogen-related protein 1, LFIRE-1)" FGL1 HFREP1 Homo sapiens (Human) adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776] signaling receptor binding [GO:0005102] GO:0002250; GO:0005102; GO:0005576; GO:0005577; GO:0005615; GO:0050776; GO:0050868; GO:0062023; GO:0072574 MAKVFSFILVTTALTMGR 2.569999933 0.816740334 0.816740334 2.97E-12 2013.823516 14.75925 7.565807 13.71171 15.02456 11.30651 13.10707 0 15.51062 0 0 10.81509 14.84019 14.75382 15.07917 12.36629 15.61834 11.96649 14.13415 0 0 0 0 15.06463 0 0 13.67834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.85255 0 0 0 0 0 0 0 Q08945 SSRP1_HUMAN "FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit, FACT 80 kDa subunit, FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1, hSSRP1) (T160)" SSRP1 FACT80 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275] FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275] DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0031491; GO:0035101; GO:0042393; GO:1902275 GSSSK 4.769999981 0.645693898 0.645693898 0.263144246 465.5479916 0 15.10642 0 15.40516 17.21402 14.33077 16.52642 0 16.30795 0 0 0 14.78736 0 0 0 16.07155 14.15752 15.70912 18.04123 0 16.29806 14.77638 12.51149 17.58245 0 16.08735 17.4564 16.11981 15.76862 17.87848 16.98027 0 18.02039 15.85493 18.14184 17.51718 17.68918 15.57949 16.82581 0 17.53641 0 16.05049 17.24951 0 0 14.82384 Q08999 RBL2_HUMAN "Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein, p130) (Retinoblastoma-related protein 2, RBR-2) (pRb2)" RBL2 RB2 Homo sapiens (Human) cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0007049; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:0070062; GO:1990841; GO:2000134 SFQNIMRCYR 11.68000031 1 1 3.19E-12 1390.97828 16.81364 0 0 0 0 16.56151 16.11902 0 15.96412 14.76617 0 0 0 19.26333 17.22321 17.14058 16.74269 0 0 0 0 0 0 0 0 16.76226 14.49373 15.36448 15.75213 15.92728 14.54075 16.93757 0 0 14.58946 15.91649 16.31989 18.83637 18.45492 0 0 12.90459 0 12.84724 14.61233 17.02112 0 17.09423 Q08AD1 CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1) CAMSAP2 CAMSAP1L1 KIAA1078 Homo sapiens (Human) axon development [GO:0061564]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of dendrite development [GO:0050773]; regulation of Golgi organization [GO:1903358]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule end [GO:1990752] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule end [GO:1990752]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; axon development [GO:0061564]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of dendrite development [GO:0050773]; regulation of Golgi organization [GO:1903358]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043] calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507] GO:0000226; GO:0005516; GO:0005794; GO:0005829; GO:0007026; GO:0030507; GO:0031113; GO:0031122; GO:0033043; GO:0036064; GO:0050773; GO:0051011; GO:0061564; GO:1903358; GO:1990752 EDSVQRSTPNR 5.639999866 1 1 0.407359327 1288.140641 0 0 0 0 0 0 0 0 17.91174 0 0 17.71022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.73018 0 0 Q08AE8 SPIR1_HUMAN "Protein spire homolog 1, Spir-1" SPIRE1 KIAA1135 SPIR1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] actin binding [GO:0003779] GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030041; GO:0030659; GO:0031307; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781 KLRPVSPEEIR 3.789999962 0.448135108 0.448135108 0.024206553 1323.633215 0 0 11.87399 12.89944 10.39276 0 8.186041 12.23048 12.66369 14.82517 12.56251 0 11.12253 0 11.1461 0 0 0 13.59371 0 0 0 0 0 13.15395 11.74325 14.85239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.14165 0 0 0 0 0 0 Q08AG5 ZN844_HUMAN Zinc finger protein 844 ZNF844 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 HTLERNPIR 3.650000095 0.211252108 0.211252108 0.074773386 1136.821718 0 0 17.43709 0 0 0 13.85775 17.43207 0 15.29575 0 14.12559 0 14.48236 18.07705 15.15787 0 0 0 0 14.44539 17.28385 15.21542 13.76344 17.23504 0 0 0 0 0 12.09704 0 0 0 16.4736 18.22081 17.71075 0 0 0 0 0 0 18.15796 0 0 0 0 Q08AG7 MZT1_HUMAN Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1) MZT1 C13orf37 MOZART1 Homo sapiens (Human) gamma-tubulin complex localization [GO:0033566]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; interphase microtubule organizing center [GO:0031021]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; interphase microtubule organizing center [GO:0031021]; spindle [GO:0005819]; gamma-tubulin complex localization [GO:0033566]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307] GO:0000931; GO:0005813; GO:0005819; GO:0005829; GO:0031021; GO:0033566; GO:0051415; GO:0090307 LCEQGINPEALSSVIKELR 8.590000153 1 1 0.20263494 2157.076485 17.66288 14.82189 15.82738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.93338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08AH1 ACSM1_HUMAN "Acyl-coenzyme A synthetase ACSM1, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 1) (Benzoate--CoA ligase, EC 6.2.1.25) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B)" ACSM1 BUCS1 LAE MACS1 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; benzoate metabolic process [GO:0018874]; butyrate metabolic process [GO:0019605]; cholesterol homeostasis [GO:0042632]; energy derivation by oxidation of organic compounds [GO:0015980]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; long-chain fatty acid-CoA ligase activity [GO:0004467]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; benzoate metabolic process [GO:0018874]; butyrate metabolic process [GO:0019605]; cholesterol homeostasis [GO:0042632]; energy derivation by oxidation of organic compounds [GO:0015980]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; xenobiotic metabolic process [GO:0006805] ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; long-chain fatty acid-CoA ligase activity [GO:0004467]; metal ion binding [GO:0046872] GO:0004321; GO:0004467; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0006805; GO:0015645; GO:0015980; GO:0016405; GO:0018858; GO:0018874; GO:0019395; GO:0019605; GO:0042632; GO:0046872; GO:0047760; GO:0070062; GO:0072562; GO:0102391 EMGDLTR 1.289999962 0.495234698 0.495234698 0.301485224 836.3596217 0 18.17088 18.36909 18.48446 0 0 0 0 17.87434 18.84871 19.01484 0 0 17.21739 0 17.60057 17.30527 0 0 18.07014 0 19.02702 0 0 0 0 18.89266 0 16.42078 0 0 0 0 19.14788 16.5101 0 20.2176 0 17.11975 17.78299 17.36781 0 18.48467 0 18.5442 0 18.1033 16.71293 Q08AI8 MB214_HUMAN Protein mab-21-like 4 MAB21L4 C2orf54 Homo sapiens (Human) MVLLWASVLFLAPEDWAELQGAVYR 3.130000114 1 1 3.20E-12 2894.052532 12.83144 13.47825 14.12189 0 10.25163 0 0 12.77242 13.34821 13.6616 0 12.78012 11.28062 10.76633 15.08963 15.58893 0 14.98456 17.41649 0 0 0 15.20425 0 0 0 0 0 0 0 0 0 0 11.72558 12.4417 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08AM6 VAC14_HUMAN Protein VAC14 homolog (Tax1-binding protein 2) VAC14 TAX1BP2 TRX Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; PAS complex [GO:0070772] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; PAS complex [GO:0070772]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] GO:0000139; GO:0000306; GO:0005783; GO:0005829; GO:0006661; GO:0007165; GO:0010008; GO:0031901; GO:0031902; GO:0033674; GO:0038023; GO:0042802; GO:0043231; GO:0070772 GPFIIR 5.840000153 0.228924736 0.228924736 0.159251342 702.403294 16.49645 15.17189 0 0 0 0 15.54138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.04104 0 0 0 0 0 0 0 0 14.51769 15.95328 17.33658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08AN1 ZN616_HUMAN Zinc finger protein 616 ZNF616 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 DGETNDK 7.579999924 1 1 0.223854262 776.3322031 0 0 0 15.82471 0 0 0 0 0 0 0 0 0 0 0 19.11148 0 0 0 0 0 0 0 0 16.527 0 0 0 0 0 0 0 0 0 0 0 0 15.94888 0 0 0 0 0 0 0 15.66516 0 0 Q09013 DMPK_HUMAN "Myotonin-protein kinase, MT-PK, EC 2.7.11.1 (DM-kinase, DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase)" DMPK DM1PK MDPK Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; muscle cell apoptotic process [GO:0010657]; nuclear envelope organization [GO:0006998]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction [GO:0014853]; regulation of heart contraction [GO:0008016]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of mitochondrial outer membrane [GO:0031307]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of mitochondrial outer membrane [GO:0031307]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin phosphatase regulator activity [GO:0017020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; muscle cell apoptotic process [GO:0010657]; nuclear envelope organization [GO:0006998]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction [GO:0014853]; regulation of heart contraction [GO:0008016]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin phosphatase regulator activity [GO:0017020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0002028; GO:0004674; GO:0004712; GO:0005524; GO:0005640; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006874; GO:0006998; GO:0008016; GO:0010657; GO:0010830; GO:0014722; GO:0014853; GO:0017020; GO:0018105; GO:0031307; GO:0031965; GO:0033017; GO:0035556; GO:0046872; GO:0051823; GO:0106310 EMEAIR 12.39000034 1 1 0.22593847 764.3264606 20.15292 19.89665 21.16914 0 20.41545 18.38149 18.46548 20.16853 0 0 0 0 19.89178 0 20.71208 19.15499 21.3942 18.8348 0 18.69531 0 18.28081 19.38713 0 0 0 0 0 0 0 18.51072 0 21.79505 21.09788 21.24051 19.23859 19.08638 18.30076 19.13932 19.05552 0 0 19.32317 20.05893 17.61672 0 0 18.51151 Q09019 DMWD_HUMAN Dystrophia myotonica WD repeat-containing protein (Dystrophia myotonica-containing WD repeat motif protein) (Protein 59) (Protein DMR-N9) DMWD DM9 Homo sapiens (Human) dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204] dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204] GO:0005634; GO:0030425; GO:0043204 LGEPDSAGAGEPPATPAGLGSGGDR 4.309999943 1 1 0.044382092 2236.80089 14.90535 12.96668 0 12.91819 12.94009 14.38238 13.75846 14.45323 14.55941 14.38656 14.17813 12.65295 0 13.63492 0 14.18626 13.26762 0 14.7566 13.77927 14.15339 0 16.66195 13.3507 10.01906 0 14.64504 0 0 13.76784 15.70474 0 0 0 0 0 16.80775 16.05049 0 12.64632 15.7445 0 8.992576 0 0 0 0 0 Q09328 MGT5A_HUMAN "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, EC 2.4.1.155 (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V, GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V, Secreted GNT-V) ]" MGAT5 GGNT5 Homo sapiens (Human) negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]" "alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]" GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1903614; GO:1904894 LAEPGQSCKQVCQESQLICEPSFFQHLNK 8.199999809 0.798162222 0.798162222 0.19854598 3462.130721 18.00458 18.85111 0 0 19.19776 16.95204 16.82319 18.31708 15.02483 16.09056 17.8475 0 0 15.06411 15.31825 18.66194 13.6775 15.30888 18.27583 0 16.46572 18.45874 0 0 17.5555 15.43762 18.0851 18.53527 14.4543 0 17.09126 15.93829 18.54511 14.85716 0 16.54253 19.33762 0 18.5736 19.18833 17.73779 0 18.06683 16.70701 19.22399 16.76125 16.65576 16.29501 Q09428 ABCC8_HUMAN ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) ABCC8 HRINS SUR SUR1 Homo sapiens (Human) cellular glucose homeostasis [GO:0001678]; cellular response to organic substance [GO:0071310]; female pregnancy [GO:0007565]; inorganic cation transmembrane transport [GO:0098662]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of wound healing [GO:0061045]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325]; cellular glucose homeostasis [GO:0001678]; cellular response to organic substance [GO:0071310]; female pregnancy [GO:0007565]; inorganic cation transmembrane transport [GO:0098662]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of wound healing [GO:0061045]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] GO:0001678; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016020; GO:0016525; GO:0019829; GO:0030672; GO:0031004; GO:0032496; GO:0032760; GO:0032868; GO:0042383; GO:0042626; GO:0044325; GO:0046676; GO:0055085; GO:0060253; GO:0061045; GO:0061855; GO:0071310; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1903818; GO:1905075; GO:1905604; GO:1990573 QRISVAR 7.949999809 1 1 0.324425325 829.4571644 0 0 17.01907 0 17.50898 16.12441 0 16.00328 16.21529 16.25404 16.02907 16.75738 0 15.74642 0 0 0 0 16.19292 16.70444 0 0 0 0 0 0 0 0 16.41286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q09666 AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK (Desmoyokin) AHNAK PM227 Homo sapiens (Human) positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493]; positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1901385; GO:1905686 FSMPGFKGEGPDVDVTLPK 10.59000015 0.481221795 0.481221795 0.227018606 2017.87126 14.72537 12.67943 14.58192 0 0 14.58997 0 0 13.95598 0 0 0 0 0 0 13.56372 16.40714 0 0 0 0 0 0 0 14.65732 0 0 12.70895 15.01428 14.29242 13.02416 14.8015 14.87169 0 15.17349 12.71212 0 0 15.57314 15.14811 0 14.18007 12.11174 0 0 0 0 0 Q09FC8 ZN415_HUMAN Zinc finger protein 415 ZNF415 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872 HWRIHTGEKPYK 3.00999999 1 1 0.246564268 1551.254629 16.30229 0 0 0 15.17172 0 14.53643 0 16.76971 16.3158 14.86644 0 0 0 0 0 0 14.44491 0 0 15.25622 0 16.05951 0 15.98217 0 15.30274 16.60394 0 0 0 17.00531 0 0 15.52008 0 0 0 0 0 0 0 0 0 0 0 17.16851 0 Q09MP3 R51A2_HUMAN RAD51-associated protein 2 RAD51AP2 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297] double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] GO:0000724; GO:0003690; GO:0003697; GO:0032991; GO:0036297 QIGIIGIQNLITR 2.690000057 0.022008244 0.022008244 0.512684098 1438.260524 0 0 0 0 0 0 0 0 0 0 0 0 16.97953 0 17.07885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.67772 0 0 18.21212 0 18.28623 0 0 0 0 0 0 0 0 0 0 Q0D2J5 ZN763_HUMAN Zinc finger protein 763 ZNF763 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 SLIEGNVNEIK 6.739999771 0.264810741 0.264810741 0.04764788 1213.251889 11.92958 0 0 13.47055 9.79976 14.86224 12.09572 0 13.64587 0 0 0 10.85009 13.93284 0 15.83275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.75956 12.44435 0 0 0 0 0 Q0IIM8 TBC8B_HUMAN TBC1 domain family member 8B TBC1D8B Homo sapiens (Human) activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829] cytosol [GO:0005829]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; vesicle-mediated transport [GO:0016192] calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] GO:0003094; GO:0005096; GO:0005509; GO:0005829; GO:0016192; GO:0090630 DDAEAVTALNR 9.06000042 1 1 0.091231362 1173.896388 11.26269 0 12.98564 0 13.76949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.99251 0 0 13.49542 0 17.33408 0 0 0 0 0 0 0 0 14.72753 0 0 0 0 0 0 0 Q0IIN9 ZNFS1_HUMAN Putative uncharacterized protein ZNF252P-AS1 (ZNF252P antisense RNA 1) (ZNF252P antisense gene protein 1) ZNF252P-AS1 C8orf77 Homo sapiens (Human) GALSPSLGR 3.210000038 1 1 0.19764193 857.4092145 0 14.20658 14.92356 14.51554 13.49022 11.01616 14.30709 15.2449 0 0 15.63489 0 14.30302 14.4171 15.12986 14.55 0 12.55949 0 0 0 0 0 0 0 12.64778 0 0 0 0 0 0 0 14.80449 0 0 13.14029 0 0 0 0 0 15.19425 15.89268 0 0 15.66839 0 Q0JRZ9 FCHO2_HUMAN F-BAR domain only protein 2 FCHO2 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835] "clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]" "identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]" GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098835 FAESKGTGK 4.730000019 1 1 0.250852397 923.3208385 0 0 0 18.53074 0 17.11599 0 0 0 18.38458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.08578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97838 0 0 0 0 0 0 0 Q0P6D6 CCD15_HUMAN Coiled-coil domain-containing protein 15 CCDC15 Homo sapiens (Human) centrosome [GO:0005813] centrosome [GO:0005813] GO:0005813 LFMDIER 1.279999971 1 1 0.120981815 922.8556337 14.32397 16.54199 14.71139 0 15.97254 0 0 0 0 12.31927 15.41602 15.65022 0 0 0 14.92806 14.44058 14.99482 13.88457 16.41321 0 14.27039 0 0 0 0 0 0 0 0 0 0 16.44026 0 0 0 0 0 0 0 0 14.8887 0 0 0 0 0 0 Q0VAA2 LR74A_HUMAN Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74) LRRC74A C14orf166B LRRC74 Homo sapiens (Human) SLNPTGTMK 3.359999895 1 1 0.146498186 964.2129078 15.05932 11.13174 13.76277 13.33813 12.91695 16.23054 0 13.53774 15.1823 0 14.92285 15.69585 16.53053 14.37688 0 0 11.27748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.30929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.61058 0 Q0VAK6 LMOD3_HUMAN "Leiomodin-3 (Leiomodin, fetal form)" LMOD3 Homo sapiens (Human) actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of skeletal muscle fiber development [GO:0048743]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of skeletal muscle fiber development [GO:0048743]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523] GO:0003785; GO:0005523; GO:0005737; GO:0005856; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0030016; GO:0030239; GO:0030240; GO:0031430; GO:0045010; GO:0048741; GO:0048743; GO:0051694 EMLLDFVNAMK 1.679999948 1 1 0.193366567 1325.687737 0 0 13.59807 14.92426 13.87748 13.37363 0 12.40461 15.25234 0 0 0 0 0 13.29631 0 0 0 0 0 0 0 0 0 14.36254 15.84392 11.25754 13.73744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.45026 0 0 0 Q0VD83 APOBR_HUMAN "Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor, Apolipoprotein B48 receptor, apoB-48R)" APOBR APOB48R Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; triglyceride metabolic process [GO:0006641] chylomicron [GO:0042627]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] chylomicron [GO:0042627]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; triglyceride metabolic process [GO:0006641] very-low-density lipoprotein particle receptor activity [GO:0030229] GO:0005886; GO:0006641; GO:0006869; GO:0008203; GO:0016020; GO:0030229; GO:0034361; GO:0034362; GO:0042627 QDSGAGETAKAAR 15.68000031 1 1 0.064740118 1260.464829 0 0 0 0 14.48358 0 0 0 13.82293 0 0 0 0 0 0 0 13.06497 15.51265 0 0 0 0 16.70125 0 0 0 0 0 0 0 16.46061 16.59182 0 14.43229 0 15.08186 14.80561 15.92239 0 0 0 0 17.78062 17.48424 15.73037 17.0843 0 0 Q0VDF9 HSP7E_HUMAN Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60) HSPA14 HSP60 HSP70L1 Homo sapiens (Human) 'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016020; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051083; GO:0051085; GO:0051787 YEIDTGEETKFVNPEDVAR 5.21999979 1 1 9.25E-13 2213.171065 0 14.77097 16.0274 14.41843 14.28701 15.03845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VF96 CGNL1_HUMAN Cingulin-like protein 1 (Junction-associated coiled-coil protein) (Paracingulin) CGNL1 JACOP KIAA1749 Homo sapiens (Human) actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105] bicellular tight junction [GO:0005923]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991] bicellular tight junction [GO:0005923]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105] GO:0005923; GO:0007015; GO:0016459; GO:0032991; GO:0051058; GO:0051497; GO:0150105 AGSYGVSIR 7.699999809 0.719096363 0.719096363 0.219089202 909.784052 0 0 16.22267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8754 0 0 0 0 0 0 0 17.94899 0 15.47108 16.00912 0 17.46378 0 17.34924 15.34381 0 0 0 0 0 0 0 0 Q0VFZ6 CF210_HUMAN Protein CFAP210 (Cilia- and flagella- associated protein 210) (Coiled-coil domain-containing protein 173) CFAP210 C2orf77 CCDC173 Homo sapiens (Human) NFHSGLLLSRVMK 16.23999977 1 1 0.399707775 1501.892049 14.96165 17.18717 14.97572 14.95504 16.53875 0 14.08843 12.97025 0 0 18.49967 0 13.43135 15.02299 0 16.18246 15.92726 18.86009 15.22981 14.28232 18.52483 14.38459 18.17645 15.45072 15.65923 0 0 0 0 0 17.93374 0 0 0 0 0 0 0 0 16.08578 0 0 0 15.83378 0 0 19.02308 0 Q0VG06 FP100_HUMAN Fanconi anemia core complex-associated protein 100 (Fanconi anemia-associated protein of 100 kDa) FAAP100 C17orf70 Homo sapiens (Human) interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] DNA binding [GO:0003677] GO:0000785; GO:0003677; GO:0005654; GO:0005829; GO:0006513; GO:0036297; GO:0043240 APSPLGPTR 11.81000042 1 1 0.281431334 892.4570603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.98244 0 0 0 0 17.58659 0 0 0 Q0VGE8 ZN816_HUMAN Zinc finger protein 816 ZNF816 ZNF816A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AVMLENYRNLEFVDSSLK 4.349999905 0.282074928 0.282074928 0.059832161 2142.963691 15.82286 7.584185 14.27823 10.84104 13.48766 0 0 13.36495 0 0 0 14.97279 14.66516 11.10452 12.24583 13.66384 13.46228 13.86915 15.0499 13.94005 14.73888 0 13.71207 12.10808 15.49489 13.75098 0 0 0 0 0 0 11.88336 0 0 0 13.93249 16.37534 13.61216 0 0 0 0 12.69598 14.29276 0 13.65682 0 Q0Z7S8 FABP9_HUMAN "Fatty acid-binding protein 9 (Testis lipid-binding protein, TLBP) (Testis-type fatty acid-binding protein, T-FABP)" FABP9 Homo sapiens (Human) acrosome assembly [GO:0001675]; fatty acid transport [GO:0015908] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; acrosome assembly [GO:0001675]; fatty acid transport [GO:0015908] fatty acid binding [GO:0005504] GO:0001669; GO:0001675; GO:0005504; GO:0005634; GO:0005829; GO:0015908 MMTIRTESSFQDTK 8.869999886 1 1 0.230786822 1707.960619 0 0 13.02615 0 0 0 0 0 0 0 15.38947 16.10301 0 0 0 0 15.26853 0 0 0 0 0 0 0 0 0 0 0 0 0 15.24885 0 14.68446 15.76179 0 0 0 0 0 0 15.36797 15.68967 15.2469 16.09081 0 0 0 0 Q0ZGT2 NEXN_HUMAN Nexilin (F-actin-binding protein) (Nelin) NEXN Homo sapiens (Human) axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493] actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307] GO:0005886; GO:0005912; GO:0005925; GO:0007156; GO:0007411; GO:0008307; GO:0015629; GO:0030018; GO:0030334; GO:0030424; GO:0051015; GO:0051493; GO:0070593; GO:0098632 FEAMQR 10.14999962 0.239273623 0.239273623 0.255915858 796.4102194 17.66896 16.46177 14.69303 0 17.75861 16.63856 15.25037 15.78611 15.62248 17.53489 15.87241 14.75103 16.85486 15.63127 16.64138 16.15269 16.65452 16.91459 16.8121 15.9521 0 18.22032 18.00914 18.70011 16.94915 17.50556 16.76902 15.59807 15.53218 15.95609 17.36738 17.33474 15.66642 16.0561 15.99015 16.63568 17.36968 16.57049 17.15233 16.88256 16.38254 16.79282 16.29837 17.62074 17.15473 17.84788 17.52175 17.28156 Q10567 AP1B1_HUMAN AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit) AP1B1 ADTB1 BAM22 CLAPB2 Homo sapiens (Human) basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] clathrin binding [GO:0030276]; protein kinase binding [GO:0019901] GO:0000139; GO:0001822; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030121; GO:0030276; GO:0030659; GO:0032588; GO:0043231; GO:0060155; GO:0110010; GO:1903232 QVGSISMDLQLTNK 4.559999943 1 1 0.481339393 1551.144538 11.9591 0 0 0 0 13.16705 0 0 13.77797 0 13.57405 10.8834 16.66139 0 14.99625 0 0 0 0 0 0 16.2876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.02279 0 0 19.29578 0 0 0 0 0 0 0 Q10570 CPSF1_HUMAN "Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit, CPSF 160 kDa subunit)" CPSF1 CPSF160 Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925] GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0019899; GO:0035925; GO:0098789 DRNLMVYMYLPEAK 1.870000005 1 1 0.400220109 1775.303048 17.29749 16.68771 0 0 12.23725 0 0 0 12.31323 0 0 15.10504 0 0 0 0 0 14.84279 0 0 0 0 0 0 0 18.08858 0 0 14.33889 0 0 0 0 0 0 0 0 18.5416 0 15.81126 0 0 0 9.824821 0 0 0 0 Q10571 MN1_HUMAN Transcriptional activator MN1 (Probable tumor suppressor protein MN1) MN1 Homo sapiens (Human) "intramembranous ossification [GO:0001957]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; intramembranous ossification [GO:0001957]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001957; GO:0005634; GO:0006355; GO:0033689; GO:0070564; GO:1902806 QVPGGAFPGASAMPRAAGMVGLSK 3.970000029 0.04826124 0.04826124 0.174145878 2274.223994 0 13.26732 13.65168 12.5833 0 0 0 0 0 0 0 16.69919 0 0 14.00174 13.05566 0 0 0 0 0 5.593435 0 0 0 0 14.84518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.08859 0 0 0 0 Q10586 DBP_HUMAN "D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302, TaxREB302)" DBP Homo sapiens (Human) circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007623; GO:0045944; GO:0090575; GO:1990837 AALPAATTPGPGLETAGPADAPAGAVVGGGSPR 3.589999914 1 1 0.235455972 2853.566518 0 15.77548 10.32825 14.81871 14.78175 0 17.83749 12.85416 15.56822 0 0 0 0 0 0 14.13048 0 0 11.56709 0 0 0 0 16.12284 0 14.44765 0 0 0 0 0 0 0 0 0 0 15.00954 0 0 0 15.43535 15.12385 7.086082 0 13.23 0 0 0 Q10588 BST1_HUMAN "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2, EC 3.2.2.6 (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1, BST-1) (Cyclic ADP-ribose hydrolase 2, cADPr hydrolase 2) (CD antigen CD157)" BST1 Homo sapiens (Human) humoral immune response [GO:0006959]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cellular extravasation [GO:0002691]; regulation of inflammatory response [GO:0050727]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of neutrophil chemotaxis [GO:0090022]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of superoxide metabolic process [GO:0090322]; signal transduction [GO:0007165] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; uropod [GO:0001931] "anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; uropod [GO:0001931]; ADP-ribosyl cyclase activity [GO:0061811]; cyclic ADP-ribose hydrolase [GO:0061812]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]; humoral immune response [GO:0006959]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cellular extravasation [GO:0002691]; regulation of inflammatory response [GO:0050727]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of neutrophil chemotaxis [GO:0090022]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of superoxide metabolic process [GO:0090322]; signal transduction [GO:0007165]" "ADP-ribosyl cyclase activity [GO:0061811]; cyclic ADP-ribose hydrolase [GO:0061812]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]" GO:0001931; GO:0001952; GO:0002691; GO:0003953; GO:0005576; GO:0005886; GO:0006959; GO:0007165; GO:0008284; GO:0016740; GO:0016849; GO:0019898; GO:0030890; GO:0031225; GO:0032956; GO:0035579; GO:0050135; GO:0050727; GO:0050730; GO:0050848; GO:0061809; GO:0061811; GO:0061812; GO:0070062; GO:0090022; GO:0090322; GO:2001044 AAQGCAASR 2.220000029 1 1 0.30064953 891.7027498 17.76853 18.00359 12.35729 0 18.14924 16.33835 0 0 17.44713 16.8725 0 0 0 0 15.74201 0 0 17.34059 17.51038 0 0 18.43262 18.18508 0 17.38628 18.39063 0 0 0 17.47091 0 19.99886 18.40836 17.70806 18.10131 0 17.91997 17.09074 17.4537 17.57371 0 0 16.02273 0 18.47423 16.87398 17.71062 18.58931 Q10713 MPPA_HUMAN Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55) PMPCA INPP5E KIAA0123 MPPA Homo sapiens (Human) protein processing involved in protein targeting to mitochondrion [GO:0006627] extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739] extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005615; GO:0005739; GO:0005743; GO:0006627; GO:0017087; GO:0046872 EFILMGGTVDTVELER 8.760000229 1 1 0.066200147 1808.080403 0 0 0 0 0 0 0 0 0 0 0 0 0 16.63014 16.59763 0 0 0 16.44748 16.91184 0 16.62152 15.57758 15.94406 15.15444 14.87762 0 0 14.83986 15.72534 16.48899 13.10997 14.7356 0 16.42533 14.84851 0 0 0 0 0 0 0 0 0 0 0 0 Q11206 SIA4C_HUMAN "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4, Alpha 2,3-ST 4, Beta-galactoside alpha-2,3-sialyltransferase 4, EC 2.4.99.2, EC 2.4.99.4 (Alpha 2,3-sialyltransferase IV) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase, EC 2.4.99.6) (SAT-3) (ST-4) (ST3Gal IV, ST3GalIV) (ST3GalA.2) (STZ) (Sialyltransferase 4C, SIAT4-C)" ST3GAL4 CGS23 NANTA3 SIAT4C STZ Homo sapiens (Human) cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]; cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]" "beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]" GO:0000139; GO:0003836; GO:0004513; GO:0005576; GO:0006486; GO:0008118; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0016021; GO:0016266; GO:0018146; GO:0019082; GO:0030194; GO:0030259; GO:0032580; GO:0047288; GO:0050890; GO:0097503; GO:1903238; GO:1990743 NSSLGDAINK 14.27000046 0.922327399 0.922327399 0.258445891 1018.708698 20.11616 17.20646 16.23134 0 20.02279 19.58641 0 0 19.46795 19.45614 0 0 17.9198 0 16.51909 0 18.69532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.67696 19.79011 0 0 0 20.6636 0 0 0 19.81395 0 0 16.6186 17.54998 18.2052 Q12756 KIF1A_HUMAN "Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein, hUnc-104)" KIF1A ATSV C2orf20 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; dense core granule cytoskeletal transport [GO:0099519]; microtubule-based movement [GO:0007018]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; dense core granule cytoskeletal transport [GO:0099519]; microtubule-based movement [GO:0007018]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003774; GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:0042802; GO:0045202; GO:0048471; GO:0060998; GO:0061001; GO:0098674; GO:0098992; GO:0099519; GO:1904115; GO:1990048; GO:1990049 GILLQAASDK 8.550000191 0.428292245 0.428292245 0.222774245 1015.531074 16.0846 14.13052 16.04079 12.31861 13.77478 0 0 15.94486 15.85265 15.43063 16.66422 16.71443 16.20513 13.6951 16.38459 14.09835 13.74673 0 0 0 16.57109 14.63651 0 15.33973 14.37607 13.9165 0 0 0 14.31466 17.15919 0 16.28315 0 0 16.51446 0 16.20609 17.12751 15.47712 0 0 18.06801 14.75446 13.54078 15.21431 14.80231 0 Q12767 TMM94_HUMAN Transmembrane protein 94 TMEM94 KIAA0195 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EKHLGEPPSALGLSTR 5.429999828 1 1 0.209419892 1692.543027 0 0 15.61562 13.9932 16.68289 0 0 14.87036 16.09964 16.41921 16.82897 0 15.64166 14.95551 15.53602 17.52652 15.78273 0 0 14.09 0 15.3203 0 0 16.20265 14.66225 0 14.56043 14.33513 17.12557 14.85449 17.52917 16.44279 17.60928 14.18097 16.90428 0 14.89768 0 17.71465 14.4426 12.88108 14.49733 14.40312 0 0 15.08108 16.54243 Q12769 NU160_HUMAN Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160) NUP160 KIAA0197 NUP120 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] structural constituent of nuclear pore [GO:0017056] GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006913; GO:0015031; GO:0017056; GO:0031080; GO:0072006 LFSVTRNR 7.130000114 1 1 0.152205077 993.2459018 13.80795 15.9172 15.03899 13.65549 14.71704 15.65038 0 0 12.22117 0 14.42799 0 15.49563 0 0 13.34586 0 0 0 0 0 0 0 0 0 15.55066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12770 SCAP_HUMAN "Sterol regulatory element-binding protein cleavage-activating protein, SCAP, SREBP cleavage-activating protein" SCAP KIAA0199 PSEC0227 Homo sapiens (Human) aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933] protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082] GO:0000139; GO:0001666; GO:0005783; GO:0005789; GO:0005794; GO:0006955; GO:0007568; GO:0008203; GO:0012507; GO:0016021; GO:0032868; GO:0032933; GO:0032934; GO:0032991; GO:0042304; GO:0044255; GO:0044877; GO:0045541; GO:0045542; GO:0051082; GO:0090110 VAALGLATGIVLVLLLLCLYR 16.15999985 1 1 0.17117943 2241.976319 0 0 13.42465 0 14.07387 12.51488 14.78797 12.65928 14.14258 13.40534 14.26261 11.19977 0 11.00313 14.71295 0 0 13.41991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12772 SRBP2_HUMAN "Sterol regulatory element-binding protein 2, SREBP-2 (Class D basic helix-loop-helix protein 2, bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2) ]" SREBF2 BHLHD2 SREBP2 Homo sapiens (Human) cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; SREBP signaling pathway [GO:0032933] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; SREBP signaling pathway [GO:0032933]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000139; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0008022; GO:0008203; GO:0008593; GO:0009267; GO:0010886; GO:0012507; GO:0032933; GO:0032937; GO:0042632; GO:0043231; GO:0045542; GO:0045944; GO:0046983; GO:0070888; GO:0071404; GO:0071499; GO:0090370; GO:1902895; GO:1903146; GO:1903955; GO:1990837 LLHSFVDSVGVMSPPLSRSSVLK 7.730000019 1 1 0.197076687 2471.368046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8938 0 0 0 0 0 0 17.0785 0 0 15.9569 0 0 0 0 0 16.08197 0 16.7879 0 0 0 0 0 0 0 0 15.61668 0 0 0 0 0 0 Q12774 ARHG5_HUMAN Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM) ARHGEF5 TIM Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular signal transduction [GO:0035556]; myeloid dendritic cell chemotaxis [GO:0002408]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein import [GO:1904591]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102] cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular signal transduction [GO:0035556]; myeloid dendritic cell chemotaxis [GO:0002408]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein import [GO:1904591]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] GO:0002102; GO:0002408; GO:0005085; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008289; GO:0030036; GO:0030054; GO:0032956; GO:0035556; GO:0042995; GO:0043087; GO:0043507; GO:0051056; GO:0051091; GO:0051493; GO:0051496; GO:0061484; GO:0071803; GO:0071944; GO:0090630; GO:1904591 DEAGVSEHPEAPAR 5.21999979 0.137883857 0.137883857 0.442895508 1465.15018 0 14.54199 14.60955 0 0 0 0 0 0 0 16.84524 0 0 0 0 15.98726 13.35607 15.67317 16.02935 0 16.03693 15.21339 16.16037 16.9565 15.12253 0 14.14316 15.66244 0 15.78823 0 15.08042 15.72281 0 14.20337 0 0 0 0 0 0 0 0 0 0 0 16.99643 0 Q12789 TF3C1_HUMAN "General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit, TFIIIC 220 kDa subunit, TFIIIC220) (Transcription factor IIIC subunit alpha)" GTF3C1 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797] DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904 CTMVEAFDRWGK 11.31999969 0.124028206 0.124028206 0.123770158 1515.191513 16.49962 0 14.1715 0 0 0 0 0 0 0 0 0 15.36061 18.53643 0 18.83105 0 0 0 14.01466 0 0 17.50195 0 0 0 0 0 0 17.79841 0 0 0 0 0 0 15.22503 0 0 0 14.4777 0 0 0 18.76607 0 0 0 Q12791 KCMA1_HUMAN "Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel, MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog, Slo homolog, hSlo)" KCNMA1 KCNMA SLO Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; cellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083] actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] GO:0001666; GO:0003779; GO:0005249; GO:0005886; GO:0005901; GO:0006813; GO:0006970; GO:0008076; GO:0015269; GO:0016021; GO:0016324; GO:0030007; GO:0034465; GO:0034765; GO:0042391; GO:0042802; GO:0043065; GO:0045211; GO:0045794; GO:0046872; GO:0051592; GO:0060072; GO:0060073; GO:0060083; GO:0060087 EEAVAAEVGWMTSVK 16.31999969 1 1 0.328626706 1623.849079 0 13.7647 0 14.9952 13.69944 13.81045 13.31987 0 11.03575 14.02112 14.14839 14.94264 0 14.06841 14.80835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12796 PNRC1_HUMAN Proline-rich nuclear receptor coactivator 1 (Proline-rich protein 2) (Protein B4-2) PNRC1 PROL2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 TVVSVPQR 3.079999924 1 1 0.24460022 885.1979084 18.73903 0 0 0 0 0 0 0 0 0 0 0 0 0 15.96973 0 0 17.28553 0 0 0 0 0 0 20.15 0 0 0 0 0 0 0 17.43353 20.12304 0 0 0 19.34356 0 0 0 0 0 0 0 0 0 0 Q12802 AKP13_HUMAN "A-kinase anchor protein 13, AKAP-13 (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene, LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13, PRKA13) (p47)" AKAP13 BRX HT31 LBC Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056] cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056] cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267] GO:0004691; GO:0005078; GO:0005085; GO:0005634; GO:0005829; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0031267; GO:0035023; GO:0035025; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051056; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023 APPSGRER 8.020000458 0.871123195 0.871123195 6.87E-13 869.3881974 0 15.56786 0 0 12.91119 13.58581 0 13.63017 0 0 0 0 0 0 0 13.95084 15.53891 0 0 11.73236 0 0 0 0 0 14.9872 12.64389 0 11.99812 0 0 0 10.91298 0 0 0 16.67789 0 0 0 15.78705 0 0 0 0 0 0 0 Q12809 KCNH2_HUMAN "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1, ERG-1, Eag-related protein 1, Ether-a-go-go-related protein 1, H-ERG, hERG-1, hERG1) (Voltage-gated potassium channel subunit Kv11.1)" KCNH2 ERG ERG1 HERG Homo sapiens (Human) "cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]" cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] "cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]" C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] GO:0000976; GO:0003064; GO:0005242; GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0008076; GO:0009986; GO:0031625; GO:0042391; GO:0042802; GO:0042803; GO:0045893; GO:0048471; GO:0055075; GO:0055131; GO:0060048; GO:0060306; GO:0060307; GO:0071466; GO:0071805; GO:0086005; GO:0086008; GO:0086009; GO:0086010; GO:0086011; GO:0086013; GO:0086091; GO:0097110; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573 GDPFLASPTSDREIIAPK 1.840000033 1 1 0 1914.900578 0 0 0 0 0 0 0 0 15.03913 0 14.35095 13.05647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12815 TROAP_HUMAN Tastin (Trophinin-assisting protein) (Trophinin-associated protein) TROAP Homo sapiens (Human) cell adhesion [GO:0007155] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell adhesion [GO:0007155] GO:0005737; GO:0007155 ENREMSHTR 12.03999996 1 1 6.89E-13 1177.607804 0 0 14.65128 0 0 13.74646 0 0 0 0 0 13.14043 0 0 12.42151 0 0 0 15.70052 0 0 0 15.10243 0 0 14.65291 0 0 0 0 0 16.73081 15.34147 0 0 0 0 0 0 16.08454 0 0 0 0 0 0 0 0 Q12829 RB40B_HUMAN "Ras-related protein Rab-40B (SOCS box-containing protein RAR, Protein Rar)" RAB40B SEC4L Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998] endosome [GO:0005768]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] endosome [GO:0005768]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005635; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0048471; GO:0072659; GO:1901998 MSALGSPVR 2.769999981 1 1 0.458582536 917.4750658 0 0 0 0 0 0 17.48656 0 17.6206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12830 BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen) BPTF FAC1 FALZ Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" ATPase complex [GO:1904949]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589] "ATPase complex [GO:1904949]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] GO:0000122; GO:0000785; GO:0000978; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007420; GO:0007492; GO:0009952; GO:0016589; GO:0035064; GO:0042766; GO:0043565; GO:0045944; GO:0046872; GO:0070062; GO:1904949 DVGPYGIR 8.569999695 1 1 0.186740135 875.8995553 16.45269 14.96656 14.0559 0 0 0 0 0 14.85799 15.99482 16.17006 0 15.94698 15.41322 15.6986 0 16.27895 0 14.13048 0 0 16.58043 16.45698 0 0 0 0 0 14.98566 0 12.55419 14.20443 14.14347 0 0 16.0509 15.95925 17.30628 15.86229 16.11461 13.26018 0 0 16.16517 0 0 0 12.80671 Q12837 PO4F2_HUMAN "POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B, Brain-3B, Brn-3B)" POU4F2 BRN3B Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000165; GO:0000785; GO:0000791; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002039; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007283; GO:0007411; GO:0007507; GO:0007605; GO:0010666; GO:0016607; GO:0030182; GO:0030520; GO:0031290; GO:0032869; GO:0043068; GO:0043433; GO:0045596; GO:0045597; GO:0045672; GO:0045773; GO:0045944; GO:0046326; GO:0048675; GO:0050885; GO:0051090; GO:0060041; GO:0071345; GO:0071392; GO:0071453; GO:0072332; GO:0090259; GO:1902870; GO:1904178; GO:1990791; GO:1990841; GO:2000679 ACLPTPPSNIFGGLDESLLAR 7.889999866 0.078829594 0.078829594 4.56E-13 2227.775053 14.34465 0 17.81418 0 0 0 16.57355 12.92313 0 0 0 15.52442 17.24232 0 0 0 0 0 15.79932 0 12.81538 15.48432 0 0 0 12.75602 0 0 0 0 0 9.58836 0 0 0 0 0 0 18.09142 0 14.42439 0 0 0 0 0 0 0 Q12840 KIF5A_HUMAN "Kinesin heavy chain isoform 5A (Kinesin heavy chain neuron-specific 1) (Neuronal kinesin heavy chain, NKHC)" KIF5A NKHC1 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192] axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007268; GO:0007411; GO:0008017; GO:0008574; GO:0016020; GO:0016192; GO:0016887; GO:0019894; GO:0030705; GO:0032839; GO:0035253; GO:0043204; GO:0045202; GO:0048471; GO:0048489; GO:0098971; GO:0099641; GO:1904115; GO:1990049 DVLAGYNGTIFAYGQTSSGK 5.980000019 1 1 0.108644121 2050.187963 12.49773 13.84643 13.61713 15.7399 0 0 0 17.67514 13.24779 0 0 0 0 0 13.44772 0 0 13.49941 13.7603 15.09789 11.28378 0 0 0 16.55867 15.16886 14.14704 14.68631 13.92987 13.3122 0 0 0 0 0 0 0 0 0 0 0 0 12.66254 0 0 0 9.654997 0 Q12841 FSTL1_HUMAN Follistatin-related protein 1 (Follistatin-like protein 1) FSTL1 FRP Homo sapiens (Human) cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510] calcium ion binding [GO:0005509]; heparin binding [GO:0008201] GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0008201; GO:0030154; GO:0030510; GO:0043066; GO:0043542; GO:0045446; GO:0061484; GO:0070062 ECAVTEK 8.399999619 0.451223701 0.451223701 0.085752749 835.9061392 0 14.61855 18.215 13.96661 0 12.5789 0 17.64826 15.64898 16.66714 0 14.68183 0 13.89486 0 10.89161 15.87014 15.14527 15.89914 16.89708 0 16.26395 12.08498 15.27921 0 14.85397 0 14.57141 15.9642 0 18.78975 15.76327 0 18.64425 0 0 15.31287 13.02777 16.31695 15.78286 17.04752 9.632765 14.99448 0 0 16.00459 0 12.53948 Q12851 M4K2_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 2, EC 2.7.11.1 (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase, GC kinase) (MAPK/ERK kinase kinase kinase 2, MEK kinase kinase 2, MEKKK 2) (Rab8-interacting protein)" MAP4K2 GCK RAB8IP Homo sapiens (Human) immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903] basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139] basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000139; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0006903; GO:0006955; GO:0007254; GO:0008349; GO:0016323; GO:0031435; GO:0035556; GO:0043507; GO:0045087; GO:0046330; GO:0106310 FELLQRVGAGTYGDVYK 6.260000229 0.35990718 0.35990718 0.3053461 1916.123388 14.72402 14.74105 14.6798 0 0 0 0 16.59292 13.85857 0 0 0 0 0 13.8883 0 14.10248 16.18908 16.556 0 15.89309 16.01873 0 14.7294 0 16.04346 0 13.55958 15.15827 14.04254 15.59661 15.88139 16.27725 15.85025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12852 M3K12_HUMAN "Mitogen-activated protein kinase kinase kinase 12, EC 2.7.11.25 (Dual leucine zipper bearing kinase, DLK) (Leucine-zipper protein kinase, ZPK) (MAPK-upstream kinase, MUK) (Mixed lineage kinase)" MAP3K12 ZPK Homo sapiens (Human) "histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0043507; GO:0043539; GO:0045860; GO:0045893; GO:0046777; GO:0070374; GO:0106310; GO:2000672 AGSQHLTPAALLYR 1.860000014 1 1 0.488431297 1496.37413 18.4423 0 0 0 0 0 0 17.93949 0 0 18.48824 0 0 0 0 0 16.84538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.51839 0 0 0 0 0 0 0 0 17.29233 0 0 0 0 0 0 0 Q12857 NFIA_HUMAN "Nuclear factor 1 A-type, NF1-A, Nuclear factor 1/A (CCAAT-box-binding transcription factor, CTF) (Nuclear factor I/A, NF-I/A, NFI-A) (TGGCA-binding protein)" NFIA KIAA1439 Homo sapiens (Human) "DNA replication [GO:0006260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]" cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; DNA replication [GO:0006260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006355; GO:0006357; GO:0019079; GO:0030054; GO:0045944; GO:0060074; GO:0072189; GO:0140297 YHPQETLK 23.36000061 1 1 0.370191529 1012.739747 0 17.9824 0 0 0 0 0 0 0 0 0 0 0 0 17.59649 0 0 0 0 0 0 0 0 0 0 0 18.50883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12860 CNTN1_HUMAN Contactin-1 (Glycoprotein gp135) (Neural cell surface protein F3) CNTN1 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system myelin formation [GO:0032289]; cerebellum development [GO:0021549]; locomotory behavior [GO:0007626]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sodium ion transport [GO:0010765] anchored component of postsynaptic membrane [GO:0099025]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] anchored component of postsynaptic membrane [GO:0099025]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system myelin formation [GO:0032289]; cerebellum development [GO:0021549]; locomotory behavior [GO:0007626]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sodium ion transport [GO:0010765] carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632] GO:0005886; GO:0007155; GO:0007219; GO:0007411; GO:0007420; GO:0007626; GO:0010628; GO:0010765; GO:0010976; GO:0016020; GO:0021549; GO:0030246; GO:0030424; GO:0032289; GO:0045121; GO:0050731; GO:0070062; GO:0098609; GO:0098632; GO:0099025; GO:0099026 AVDLIPWMEYEFR 2.099999905 1 1 0.591003626 1682.977504 0 0 0 18.67152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.96015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12864 CAD17_HUMAN "Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin, LI-cadherin)" CDH17 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; germinal center B cell differentiation [GO:0002314]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; marginal zone B cell differentiation [GO:0002315]; oligopeptide transmembrane transport [GO:0035672]; oligopeptide transport [GO:0006857]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; spleen development [GO:0048536] basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; transporter activity [GO:0005215]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; germinal center B cell differentiation [GO:0002314]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; marginal zone B cell differentiation [GO:0002315]; oligopeptide transmembrane transport [GO:0035672]; oligopeptide transport [GO:0006857]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; spleen development [GO:0048536] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; transporter activity [GO:0005215] GO:0002314; GO:0002315; GO:0005178; GO:0005215; GO:0005427; GO:0005509; GO:0005654; GO:0005886; GO:0006857; GO:0007155; GO:0007156; GO:0007229; GO:0009986; GO:0016021; GO:0016323; GO:0016339; GO:0016342; GO:0030054; GO:0033626; GO:0035672; GO:0045296; GO:0048536; GO:0098742 LPMDGLFLIQTYAGMLQLAK 2.970000029 1 1 0.16863069 2239.551784 0 0 16.80939 0 12.94546 12.60555 0 14.77962 16.55042 0 16.27346 0 0 0 0 14.43437 13.91141 12.46291 16.66807 0 0 0 15.80502 13.10296 0 14.88435 0 15.66883 0 0 0 15.66088 15.42414 0 0 14.45234 0 0 0 0 0 0 0 0 0 0 14.81933 0 Q12872 SFSWA_HUMAN "Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)" SFSWAP SFRS8 SWAP Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]" nucleus [GO:0005634] "nucleus [GO:0005634]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]" RNA binding [GO:0003723] GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025 AMLAASK 8.609999657 1 1 0.239670549 708.9700843 15.88118 15.86119 15.5402 0 0 15.79183 16.15991 0 14.10398 15.69776 15.58383 16.00212 0 0 0 0 16.38148 16.0202 15.11972 0 0 0 0 16.3887 0 15.72205 15.74791 0 0 0 0 0 15.24144 16.00688 0 0 0 0 0 0 0 15.87692 0 16.18956 0 0 0 0 Q12873 CHD3_HUMAN "Chromodomain-helicase-DNA-binding protein 3, CHD-3, EC 3.6.4.12 (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase, hZFH)" CHD3 Homo sapiens (Human) "centrosome cycle [GO:0007098]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]" centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605] "centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; centrosome cycle [GO:0007098]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] GO:0000122; GO:0000976; GO:0003677; GO:0003678; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006333; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736 ERPEGETGDLGK 2.210000038 0.406411409 0.406411409 0.157028079 1289.581201 16.1146 0 0 17.50521 0 0 0 13.38792 15.18661 15.08489 16.23643 0 0 0 0 0 13.07471 10.93977 0 0 0 0 0 0 0 11.12556 0 0 15.42079 15.69531 0 16.97641 0 11.79415 0 0 0 12.70042 13.84406 14.39091 16.03127 11.62759 0 0 0 0 13.32044 13.63993 Q12879 NMDE1_HUMAN "Glutamate receptor ionotropic, NMDA 2A, GluN2A (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A, NMDAR2A, NR2A, hNR2A)" GRIN2A NMDAR2A Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; directional locomotion [GO:0033058]; dopamine metabolic process [GO:0042417]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; serotonin metabolic process [GO:0042428]; sleep [GO:0030431]; startle response [GO:0001964]; visual learning [GO:0008542]" cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] "cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity [GO:0097202]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; directional locomotion [GO:0033058]; dopamine metabolic process [GO:0042417]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; serotonin metabolic process [GO:0042428]; sleep [GO:0030431]; startle response [GO:0001964]; visual learning [GO:0008542]" amyloid-beta binding [GO:0001540]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270] GO:0001540; GO:0001964; GO:0001975; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007420; GO:0007611; GO:0007613; GO:0008021; GO:0008270; GO:0008542; GO:0009410; GO:0009611; GO:0009986; GO:0014069; GO:0015276; GO:0017146; GO:0019233; GO:0022008; GO:0022849; GO:0030431; GO:0030659; GO:0033058; GO:0035235; GO:0038023; GO:0042177; GO:0042417; GO:0042428; GO:0042734; GO:0043065; GO:0043197; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0051968; GO:0060079; GO:0060291; GO:0097060; GO:0097202; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1903539; GO:1904062; GO:2000463 GPPALNIAVMLGHSHDVTER 5.760000229 1 1 1.37E-12 2134.494216 14.42828 7.326535 13.99076 14.27406 11.96112 15.3848 0 14.6047 0 13.3508 0 0 0 8.119555 12.05867 11.46318 16.02106 11.46035 15.82599 0 0 0 0 0 0 0 13.18747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.79565 0 0 0 0 11.28574 0 Q12882 DPYD_HUMAN "Dihydropyrimidine dehydrogenase [NADP(+)], DHPDHase, DPD, EC 1.3.1.2 (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)" DPYD Homo sapiens (Human) beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]" "4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]" GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0006248; GO:0006249; GO:0017113; GO:0019483; GO:0042803; GO:0046050; GO:0046079; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539 GKPVPR 1.620000005 1 1 0.11355461 652.5524168 0 0 15.20951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12888 TP53B_HUMAN "TP53-binding protein 1, 53BP1, p53-binding protein 1, p53BP1" TP53BP1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]" damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin modification-dependent histone binding [GO:0061649] GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0042393; GO:0045830; GO:0045893; GO:0045944; GO:0051091; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:1990391; GO:2000042 ASSLHRTSSGTSLSAMHSSGSSGK 4.920000076 0.850175381 0.850175381 1.37E-12 2336.543694 0 15.33086 16.10574 14.59661 0 0 0 14.29517 0 16.09769 18.71879 14.06332 0 0 0 0 0 0 0 0 0 0 14.70451 0 15.26442 0 15.46779 15.17511 0 14.51055 0 15.51192 0 0 0 0 0 16.32097 0 10.59597 15.51089 0 12.9678 14.31655 14.26811 0 15.36581 0 Q12893 TM115_HUMAN Transmembrane protein 115 (Placental protein 6) (Protein PL6) TMEM115 PL6 LUCA11.2 Homo sapiens (Human) "negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" identical protein binding [GO:0042802] GO:0000139; GO:0005634; GO:0005794; GO:0006890; GO:0008285; GO:0015031; GO:0016021; GO:0032580; GO:0042802 QTMGDCVVLRVPQVR 3.900000095 1 1 0.162799092 1773.011804 0 16.32031 13.27799 0 13.70596 0 15.10678 14.88127 0 0 16.19765 15.62352 0 15.08323 0 0 0 0 0 0 0 0 0 0 0 0 0 15.03417 0 0 0 0 0 0 0 0 0 0 0 0 0 13.95801 15.5387 0 0 0 0 0 Q12905 ILF2_HUMAN Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa) ILF2 NF45 PRO3063 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; positive regulation of transcription, DNA-templated [GO:0045893]" DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0045893; GO:1904724; GO:1904813; GO:1990904 VLQSALAAIR 3.390000105 0.314452767 0.314452767 0.227907335 1040.058496 0 13.61474 15.46787 15.66327 15.90161 15.35032 14.56017 14.46681 15.7729 15.39332 13.3082 15.91697 14.50972 13.87506 0 0 15.91604 14.99701 15.60592 0 17.08264 16.52776 0 15.19507 0 0 0 15.21027 15.83132 14.75506 0 15.85379 12.10786 12.92048 15.03381 15.16635 16.00278 10.87296 0 0 13.6216 13.49122 14.73304 15.5892 13.82394 14.23723 15.54699 15.23299 Q12912 IRAG2_HUMAN "Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2 ]" IRAG2 JAW1 LRMP Homo sapiens (Human) immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] microtubule binding [GO:0008017] GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005815; GO:0005886; GO:0005887; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0016021; GO:0035577 DGALDVKR 10.22000027 1 1 0.083463352 869.8598286 15.7308 0 13.66829 0 0 16.20588 0 0 9.571892 0 0 0 0 0 0 14.03319 13.94511 0 0 0 0 0 0 0 14.10357 15.34358 0 15.23638 0 14.27054 16.65591 0 0 15.12166 15.71852 0 0 0 12.2178 12.58172 0 14.8949 0 0 0 0 0 15.88083 Q12913 PTPRJ_HUMAN "Receptor-type tyrosine-protein phosphatase eta, Protein-tyrosine phosphatase eta, R-PTP-eta, EC 3.1.3.48 (Density-enhanced phosphatase 1, DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J, R-PTP-J) (CD antigen CD148)" PTPRJ DEP1 Homo sapiens (Human) B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] GO:0001772; GO:0004725; GO:0005161; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0008013; GO:0008285; GO:0009986; GO:0010642; GO:0016791; GO:0019221; GO:0019901; GO:0030155; GO:0030183; GO:0030308; GO:0030336; GO:0032587; GO:0032760; GO:0035335; GO:0035579; GO:0035584; GO:0042059; GO:0043116; GO:0043407; GO:0043410; GO:0045295; GO:0045296; GO:0045785; GO:0048008; GO:0050731; GO:0050852; GO:0050860; GO:0050918; GO:0051019; GO:0051894; GO:0051897; GO:0051898; GO:0060242; GO:0070062; GO:0070097; GO:1905451 EPALVLK 4.409999847 1 1 0.001131754 768.500755 0 0 0 0 0 14.3745 0 0 0 0 0 14.54485 0 0 0 0 0 14.22997 16.28385 16.81037 0 16.64308 17.14101 0 17.15492 14.30311 15.14649 0 14.24894 16.66751 0 0 0 0 0 0 0 0 0 0 15.49106 0 0 0 0 0 0 0 Q12923 PTN13_HUMAN "Tyrosine-protein phosphatase non-receptor type 13, EC 3.1.3.48 (Fas-associated protein-tyrosine phosphatase 1, FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E, PTP-E1, hPTPE1) (Protein-tyrosine phosphatase PTPL1)" PTPN13 PNP1 PTP1E PTPL1 Homo sapiens (Human) negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725] GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0035335; GO:0036312; GO:0043005; GO:0044297; GO:0070062 AVIPQGAAESDGRIHK 2.450000048 0.419624627 0.419624627 0.450850705 1648.965244 0 13.2281 0 15.90979 17.44425 12.05944 10.85054 14.30634 13.81254 0 17.31091 14.19205 0 0 0 14.06721 0 16.78156 0 15.26011 0 0 0 17.35461 15.67675 0 0 14.84624 15.0473 16.91083 0 0 0 16.99336 0 17.12914 14.86036 0 16.44046 15.45469 17.18573 0 15.26217 17.11347 0 0 0 16.22774 Q12926 ELAV2_HUMAN "ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B, HuB) (Nervous system-specific RNA-binding protein Hel-N1)" ELAVL2 HUB Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] "nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]" mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005654; GO:0006355; GO:1990904 TNKTHK 3.75 1 1 0.024251436 728.5671761 0 0 14.93712 15.22537 0 16.33776 0 14.31667 0 0 0 0 0 0 0 17.63597 0 16.13761 13.89036 16.12739 0 14.88532 14.79842 0 0 15.81497 13.60644 0 0 0 0 16.25673 16.97544 0 0 0 16.39898 13.86212 0 14.44741 14.36755 0 15.13998 0 15.65239 13.66615 0 0 Q12929 EPS8_HUMAN Epidermal growth factor receptor kinase substrate 8 EPS8 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] actin binding [GO:0003779]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267] GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030426; GO:0030832; GO:0031267; GO:0031532; GO:0031982; GO:0032420; GO:0032426; GO:0032587; GO:0035023; GO:0035591; GO:0036336; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830 SAAQKK 6.78000021 0.135072246 0.135072246 0.207785965 630.447196 0 15.691 15.06163 14.0605 11.43516 0 0 16.73308 0 0 0 0 0 14.91777 0 15.41656 15.60407 16.21146 16.19624 0 0 0 0 0 0 16.31221 0 15.2772 0 15.25981 0 0 17.56014 0 0 0 16.02608 17.92973 16.61094 16.69123 0 0 0 0 15.92328 16.63337 15.77977 0 Q12931 TRAP1_HUMAN "Heat shock protein 75 kDa, mitochondrial, HSP 75 (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein, TRAP-1)" TRAP1 HSP75 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386] cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082] GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0071944; GO:1901856; GO:1903427; GO:1903751 RTTAQLGPR 5.050000191 1 1 0.017156312 1000.337187 0 14.86962 14.37811 12.89305 0 13.92087 0 14.49923 12.78212 14.07522 0 15.90005 13.08752 15.00162 14.11429 14.65954 14.76049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.98257 15.64638 0 0 0 0 0 0 0 Q12933 TRAF2_HUMAN "TNF receptor-associated factor 2, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)" TRAF2 TRAP3 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238 SIGLKDLAMADLEQK 6.769999981 1 1 0.447604634 1631.790402 0 0 0 17.97144 0 0 0 0 19.76501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.89159 0 0 0 0 0 Q12934 BFSP1_HUMAN "Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115, CP115) (Lens intermediate filament-like heavy, LIFL-H) [Cleaved into: Filensin C-terminal fragment; Filensin N-terminal fragment ]" BFSP1 Homo sapiens (Human) cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307] structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212] GO:0005200; GO:0005212; GO:0005737; GO:0005882; GO:0005886; GO:0005938; GO:0045109; GO:0048469; GO:0070307 SGEKSS 9.239999771 1 1 5.74E-13 593.2152132 15.39891 0 12.57422 13.76869 14.09944 16.11982 15.52868 0 11.4259 15.30394 13.80202 0 0 0 0 0 0 16.24695 0 0 0 0 0 0 0 15.67545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12946 FOXF1_HUMAN "Forkhead box protein F1 (Forkhead-related activator 1, FREAC-1) (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1)" FOXF1 FKHL5 FREAC1 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001570; GO:0001701; GO:0001756; GO:0001763; GO:0002053; GO:0003197; GO:0003214; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0007224; GO:0007368; GO:0007494; GO:0007507; GO:0009887; GO:0010811; GO:0014822; GO:0030198; GO:0030323; GO:0030324; GO:0030335; GO:0031016; GO:0043305; GO:0043565; GO:0045198; GO:0045893; GO:0045944; GO:0048286; GO:0048371; GO:0048557; GO:0048565; GO:0048613; GO:0048617; GO:0050728; GO:0051145; GO:0060426; GO:0060438; GO:0060441; GO:0060461; GO:0060463; GO:0060841; GO:0061030; GO:0071345; GO:0071407; GO:0072189; GO:0090131; GO:0097070; GO:0098609 MSSAPEKQQPPHGGGGGGGGGGGAAMDPASSGPSK 3.019999981 1 1 5.95E-12 3080.427215 0 0 13.61713 0 14.39799 0 15.16927 15.03736 12.82676 0 0 0 0 13.97735 0 12.72957 0 12.6633 11.92828 0 11.78791 0 13.47781 0 9.774635 0 13.629 0 12.72537 11.65072 16.24666 16.96522 0 0 0 0 0 0 0 0 0 0 0 14.582 0 0 0 0 Q12952 FOXL1_HUMAN "Forkhead box protein L1 (Forkhead-related protein FKHL11) (Forkhead-related transcription factor 7, FREAC-7)" FOXL1 FKHL11 FREAC7 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]" "DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007495; GO:0007507; GO:0008301; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146 SSPKSSDK 6.070000172 0.874079525 0.874079525 0.226275887 833.9997713 14.18839 12.60442 0 0 13.92925 13.84546 5.413892 15.8614 14.77359 0 13.56493 15.47089 0 0 14.51666 15.97023 0 0 15.75815 0 15.30431 0 8.076458 15.33852 0 13.05766 0 15.62446 14.77549 0 0 15.12465 0 0 0 16.11899 15.62826 0 0 15.21461 16.1277 13.8159 11.72699 0 0 0 12.32375 0 Q12955 ANK3_HUMAN "Ankyrin-3, ANK-3 (Ankyrin-G)" ANK3 Homo sapiens (Human) axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165] axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018] axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165] cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259 GLPQTAVCNLNITLPAHK 2.319999933 1 1 0.232810484 1948.087159 11.54089 14.40475 12.74105 13.31739 0 11.34104 0 12.78342 7.084725 0 14.77632 0 15.53297 15.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68926 0 0 Q12959 DLG1_HUMAN "Disks large homolog 1 (Synapse-associated protein 97, SAP-97, SAP97) (hDlg)" DLG1 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110] cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325] GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0004385; GO:0004721; GO:0005604; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007015; GO:0007163; GO:0007268; GO:0008022; GO:0008092; GO:0008284; GO:0008360; GO:0009898; GO:0014704; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0019902; GO:0030054; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031434; GO:0031503; GO:0031579; GO:0031594; GO:0031641; GO:0032147; GO:0033268; GO:0035748; GO:0042110; GO:0042130; GO:0042383; GO:0042391; GO:0042982; GO:0043005; GO:0043113; GO:0043219; GO:0043268; GO:0043622; GO:0044325; GO:0045121; GO:0045197; GO:0045296; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070062; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0097120; GO:0098609; GO:0098839; GO:0098911; GO:0098919; GO:0098978; GO:0099645; GO:1902305; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903760; GO:1903764; GO:2000134 ALFDYDK 3.730000019 1 1 0.09834576 871.6236845 0 0 0 0 14.45034 0 0 15.74833 16.12078 0 0 0 0 0 0 0 0 15.51421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.15024 0 0 0 0 0 0 0 0 0 0 Q12965 MYO1E_HUMAN Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E) MYO1E MYO1C Homo sapiens (Human) actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091] GO:0000146; GO:0001570; GO:0001701; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030136; GO:0031982; GO:0032437; GO:0032836; GO:0035091; GO:0035166; GO:0048008; GO:0051015; GO:0070062; GO:0072015 KYVQMR 8.699999809 1 1 0.176482103 840.4624491 16.06732 0 0 0 0 0 0 0 0 0 0 0 17.21359 18.37119 16.19969 15.97516 17.80864 16.02232 17.99387 17.33689 17.16966 17.01461 16.782 0 16.58504 16.50281 17.20759 15.91177 17.3282 15.90763 17.39679 0 15.89222 18.32557 15.2513 17.01423 15.6722 18.86964 14.51267 17.83845 16.05099 16.68857 18.11159 14.24758 13.84821 18.03197 15.52051 15.59141 Q12967 GNDS_HUMAN "Ral guanine nucleotide dissociation stimulator, RalGDS (Ral guanine nucleotide exchange factor, RalGEF)" RALGDS KIAA1308 RGF Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] brush border [GO:0005903]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] brush border [GO:0005903]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005634; GO:0005829; GO:0005886; GO:0005903; GO:0007265; GO:0030695; GO:0043547 LLQSACNNYSIAPDEQFGAWFRAVER 11.25 1 1 0.03042763 3042.358785 16.84169 0 0 15.09498 0 0 0 0 0 17.65338 18.49036 16.49063 0 0 18.62997 0 0 15.45718 0 0 17.10669 0 14.1236 0 17.24425 0 0 0 0 0 0 0 0 0 0 0 0 14.0797 0 0 0 0 16.29917 0 16.68157 0 13.7687 0 Q12979 ABR_HUMAN Active breakpoint cluster region-related protein ABR Homo sapiens (Human) activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005096; GO:0005829; GO:0007264; GO:0016020; GO:0030424; GO:0043197; GO:0050804; GO:0051056; GO:0090630; GO:0098685; GO:0098978 DTAEPK 3.089999914 0.1470256 0.1470256 0.280060776 659.9881815 0 0 0 0 0 0 20.4064 0 0 0 16.71669 0 0 17.29714 0 20.80958 0 0 0 0 0 0 0 16.74461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.63716 0 0 0 0 0 0 Q12986 NFX1_HUMAN "Transcriptional repressor NF-X1, EC 2.3.2.- (Nuclear transcription factor, X box-binding protein 1)" NFX1 NFX2 Homo sapiens (Human) "inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006366; GO:0006954; GO:0008270; GO:0016567; GO:0045347; GO:0051865; GO:0061630 DVLCGTDVGK 5.380000114 0.475031644 0.475031644 0.122984328 1062.427246 0 0 0 0 0 0 0 0 11.57943 0 0 0 16.70806 16.90191 17.14172 17.37187 16.14575 17.38941 0 0 17.06414 16.9825 0 0 0 12.51874 17.17925 0 14.96602 0 0 16.68583 0 14.42453 16.56704 17.33138 18.6865 18.51862 17.15854 17.49936 18.35364 14.74589 18.04931 15.83245 18.61129 18.37117 16.86945 14.40179 Q12996 CSTF3_HUMAN "Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit, CSTF 77 kDa subunit, CstF-77)" CSTF3 Homo sapiens (Human) mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006378; GO:0006379; GO:0031123 GDMNNAK 8.239999771 0.607895255 0.607895255 0.162702333 764.9473777 17.04314 12.7455 17.92461 14.74275 0 9.178978 0 18.84385 17.87928 0 16.80542 15.18329 14.64896 0 18.66253 14.88964 13.39847 16.08015 15.97601 17.73642 0 0 0 14.67451 14.48593 0 0 14.33878 0 14.33651 17.37297 12.58354 14.89264 13.49733 14.18015 10.96449 16.44395 16.30553 16.50511 18.82934 11.06096 11.45376 16.89286 0 17.05394 0 11.39209 0 Q13003 GRIK3_HUMAN "Glutamate receptor ionotropic, kainate 3, GluK3 (Excitatory amino acid receptor 5, EAA5) (Glutamate receptor 7, GluR-7, GluR7)" GRIK3 GLUR7 Homo sapiens (Human) "G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]" axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195] "axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]" adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015276; GO:0015277; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315 FSLTCQR 8.039999962 1 1 0.205687205 911.3467547 0 15.70067 14.9914 14.97783 13.77112 14.31681 10.62286 14.41055 14.94538 15.4937 16.48319 0 15.68631 0 0 15.31953 0 15.33607 15.06889 0 14.76127 14.60433 13.80072 15.621 0 14.54468 14.42609 0 14.58819 0 14.83745 15.20478 16.29929 14.95601 11.34799 14.74473 16.08563 14.5625 15.19371 16.37585 0 12.72898 10.96572 15.52038 15.51695 10.59041 14.73062 0 Q13009 TIAM1_HUMAN "Rho guanine nucleotide exchange factor TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1, TIAM-1)" TIAM1 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; lipid binding [GO:0008289]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; lipid binding [GO:0008289] GO:0005085; GO:0005829; GO:0005886; GO:0005911; GO:0007160; GO:0007264; GO:0008284; GO:0008289; GO:0010717; GO:0010718; GO:0016020; GO:0016477; GO:0016601; GO:0019900; GO:0030335; GO:0031234; GO:0032092; GO:0044291; GO:0045202; GO:0048013; GO:0050772; GO:0051056; GO:0060071; GO:0065003; GO:0090630; GO:1904338; GO:2000050 IDMDEKMK 11.88000011 0.495987862 0.495987862 0.186745148 1026.337151 15.92348 14.67551 15.69276 13.67466 13.8664 0 13.58297 14.49829 14.4593 15.28362 16.65777 15.09274 15.14743 13.87395 14.13832 12.97363 0 0 0 0 0 0 0 0 14.79529 0 15.8759 13.73751 15.38043 13.75146 17.1673 14.8379 14.61664 0 15.62991 0 0 14.26136 0 14.47263 0 14.88188 0 12.91164 16.32886 12.30834 16.55586 15.28728 Q13011 ECH1_HUMAN "Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial, EC 5.3.3.-" ECH1 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]; fatty acid beta-oxidation [GO:0006635]" "delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]" GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0016020; GO:0051750; GO:0070062 MFTAGIDLMDMASDILQPK 6.239999771 1 1 0.188880138 2129.473775 11.37372 0 0 13.16221 0 0 0 9.349054 0 0 0 16.14412 15.03815 0 0 0 0 0 0 0 13.51716 0 0 0 9.511147 12.66303 0 2.24726 15.14071 0 0 0 12.3904 0 14.42399 13.12236 14.94898 0 0 11.81147 11.72004 0 0 0 16.30856 13.67096 12.2577 15.45257 Q13015 AF1Q_HUMAN Protein AF1q MLLT11 AF1Q Homo sapiens (Human) "extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of transcription, DNA-templated [GO:0045893]" cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005654; GO:0005815; GO:0005829; GO:0043065; GO:0045893; GO:0051901; GO:0090200; GO:0097191; GO:0097193 VKDSSVGK 19.55999947 0.325341105 0.325341105 0.226368301 820.5180696 16.6768 16.63196 16.37879 17.93892 15.35142 0 16.53892 16.41944 16.85904 17.5364 14.77114 16.10388 16.5062 13.59346 14.92315 16.54464 17.44162 0 15.88566 16.46839 0 17.41588 16.9427 17.28053 15.3082 16.76571 17.05941 16.71135 14.8113 16.16508 15.91912 0 16.92381 17.53911 13.79936 17.31977 17.49357 18.85577 14.16508 17.12906 16.64491 16.43789 15.98334 17.10733 17.37817 17.22593 17.37053 16.19044 Q13017 RHG05_HUMAN Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B) ARHGAP5 RHOGAP5 Homo sapiens (Human) cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]; cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169] GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007266; GO:0030879; GO:0042169; GO:0051056 ASMGMLR 6.090000153 0.133473203 0.133473203 0.258794189 796.1140493 15.68383 18.34369 0 0 0 13.4427 0 0 18.53219 0 0 0 0 16.91481 0 0 0 18.35344 16.26236 16.61809 0 18.18924 0 0 0 0 0 14.95208 14.67764 0 0 16.00043 16.51853 17.05081 0 0 19.41842 0 0 0 16.53745 17.37422 0 0 0 17.49491 15.3273 0 Q13018 PLA2R_HUMAN "Secretory phospholipase A2 receptor, PLA2-R, PLA2R (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor, Soluble PLA2-R, Soluble PLA2R ]" PLA2R1 CLEC13C Homo sapiens (Human) "negative regulation of arachidonic acid secretion [GO:1900139]; negative regulation of phospholipase A2 activity [GO:1900138]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of glomerular visceral epithelial cell apoptotic process [GO:1904635]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]" cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023]; negative regulation of arachidonic acid secretion [GO:1900139]; negative regulation of phospholipase A2 activity [GO:1900138]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of glomerular visceral epithelial cell apoptotic process [GO:1904635]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]" carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023] GO:0001819; GO:0005576; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0016021; GO:0030246; GO:0038023; GO:0043235; GO:0043274; GO:0043517; GO:0072593; GO:0090238; GO:0090399; GO:0090403; GO:1900138; GO:1900139; GO:1904635 REWICK 6.230000019 0.924707532 0.924707532 0.209131053 891.6235282 0 15.63593 14.30779 15.15904 15.13327 14.41282 0 15.93034 15.34209 15.68061 13.19374 14.82202 14.40812 14.61065 16.08166 13.29434 14.30417 0 13.91845 11.56617 12.33276 14.97846 14.07011 15.64098 15.75898 15.55611 0 15.87772 14.9534 14.15062 15.58816 13.65916 0 0 0 0 16.41651 0 0 15.6649 15.96636 0 0 15.39032 0 15.74942 15.00793 16.05915 Q13023 AKAP6_HUMAN "A-kinase anchor protein 6, AKAP-6 (A-kinase anchor protein 100 kDa, AKAP 100) (Protein kinase A-anchoring protein 6, PRKA6) (mAKAP)" AKAP6 AKAP100 KIAA0311 Homo sapiens (Human) action potential [GO:0001508]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; protein targeting [GO:0006605]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315] calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; adenylate cyclase binding [GO:0008179]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325]; action potential [GO:0001508]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; protein targeting [GO:0006605]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] adenylate cyclase binding [GO:0008179]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325] GO:0001508; GO:0005635; GO:0005737; GO:0005901; GO:0006605; GO:0008179; GO:0010738; GO:0010880; GO:0014701; GO:0014704; GO:0016529; GO:0019933; GO:0030307; GO:0030315; GO:0031965; GO:0034237; GO:0034704; GO:0043495; GO:0044325; GO:0048471; GO:0051018; GO:0051281; GO:0060090; GO:0060306; GO:0060316; GO:0061051; GO:0070886; GO:0071320; GO:0071345; GO:1901381; GO:1902261 GKPNVTSK 6.619999886 0.51880151 0.51880151 0.329186402 829.3449427 0 0 0 0 0 16.5139 17.02641 0 0 16.55645 0 0 16.63625 15.78345 16.36953 0 13.65758 0 0 14.49722 15.38462 16.52258 0 0 14.84607 15.42109 0 0 16.02955 11.8214 0 0 16.20557 15.64414 16.15473 0 16.85815 14.46829 14.88661 0 17.046 15.41548 0 15.87537 0 16.77437 0 17.01987 Q13029 PRDM2_HUMAN "PR domain zinc finger protein 2, EC 2.1.1.355 (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ)" PRDM2 KMT8 RIZ Homo sapiens (Human) "determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0010468; GO:0042054; GO:0043565; GO:0045944 EEEELNDSSEELYTTIK 5.239999771 1 1 0.267175737 2029.31022 13.80418 16.95425 13.82822 0 0 15.15425 0 0 0 0 0 0 0 0 0 0 16.58719 0 13.96868 13.59084 0 0 15.69388 0 15.94112 0 0 15.3568 0 14.77194 15.23771 0 14.21562 14.23285 0 15.15813 0 9.979179 13.72716 0 14.50635 12.59759 15.88036 0 0 0 0 0 Q13033 STRN3_HUMAN Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen) STRN3 GS2NA SG2NA Homo sapiens (Human) "negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]" armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] GO:0000122; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443 DELAGGGGGGPGMAAPPR 10.68000031 0.714185655 0.714185655 0.476107361 1581.650111 17.27465 0 16.065 16.62467 0 0 0 0 0 20.23133 0 0 17.00816 0 0 0 0 0 17.31592 18.08846 0 0 0 0 0 0 0 0 0 0 0 19.73712 18.2461 0 0 0 0 0 20.35993 0 0 0 0 0 0 0 0 0 Q13042 CDC16_HUMAN "Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6, APC6) (CDC16 homolog, CDC16Hs) (Cyclosome subunit 6)" CDC16 ANAPC6 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686 ATTLEK 6.869999886 1 1 0.088008916 662.1454868 0 13.38567 14.45525 0 15.6639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17753 0 0 0 0 0 0 0 0 0 0 15.27346 0 0 0 0 0 0 0 0 0 15.51316 0 0 0 0 0 0 0 Q13045 FLII_HUMAN Protein flightless-1 homolog FLII FLIL Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; myofibril assembly [GO:0030239] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; myofibril assembly [GO:0030239]" "actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005903; GO:0005925; GO:0008154; GO:0015629; GO:0030239; GO:0034451; GO:0051014; GO:0051015; GO:0051016 KFESLFPGK 3.680000067 1 1 0.229043207 1053.463103 20.34112 0 0 0 15.94056 0 0 0 17.40648 0 0 0 0 0 17.47855 0 16.99623 0 0 0 0 0 0 0 16.0413 0 0 0 0 0 18.77062 0 17.17245 0 0 16.77868 17.78263 0 18.05377 0 0 0 0 0 0 0 0 18.22953 Q13057 COASY_HUMAN "Bifunctional coenzyme A synthase, CoA synthase (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase, EC 2.7.7.3 (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase, PPAT); Dephospho-CoA kinase, DPCK, EC 2.7.1.24 (Dephosphocoenzyme A kinase, DPCOAK) ]" COASY PSEC0106 Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937] ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595] GO:0004140; GO:0004595; GO:0005524; GO:0005741; GO:0005759; GO:0015937; GO:0070062 LLPELLQPYTER 20.62999916 0.503819883 0.503819883 0.458633473 1471.466962 0 18.26169 17.68041 18.81136 17.65485 18.24049 18.00356 0 17.38213 0 18.10536 17.6914 14.33903 0 14.06909 0 0 0 0 17.20611 0 17.86806 18.03647 15.09956 16.12727 15.40206 0 15.75622 0 0 0 15.47655 0 0 15.06431 0 16.97961 17.24958 17.83033 0 17.71824 17.64075 17.1915 17.5034 0 15.75801 16.47704 17.04627 Q13061 TRDN_HUMAN Triadin TRDN Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum membrane organization [GO:0090158]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to bacterium [GO:0009617] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cellular calcium ion homeostasis [GO:0006874]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum membrane organization [GO:0090158]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to bacterium [GO:0009617] protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] GO:0005102; GO:0005783; GO:0005829; GO:0005886; GO:0006874; GO:0006936; GO:0009617; GO:0010649; GO:0010880; GO:0014701; GO:0014808; GO:0016021; GO:0016529; GO:0030314; GO:0030674; GO:0031122; GO:0033017; GO:0033018; GO:0044325; GO:0051279; GO:0060047; GO:0060315; GO:0060316; GO:0086036; GO:0090158; GO:1901846 MSKAGK 3.819999933 0.057074577 0.057074577 0.015184783 637.4811227 15.80251 0 12.47569 0 0 13.71183 14.72037 0 0 0 0 14.74726 16.2972 16.01453 0 0 0 0 0 18.1482 0 0 18.09573 0 0 0 0 13.3738 0 14.11514 0 0 0 15.64111 0 0 0 0 0 0 15.91213 15.4506 0 0 0 0 0 0 Q13064 MKRN3_HUMAN "Probable E3 ubiquitin-protein ligase makorin-3, EC 2.3.2.27 (RING finger protein 63) (RING-type E3 ubiquitin transferase makorin-3) (Zinc finger protein 127)" MKRN3 D15S9 RNF63 ZNF127 Homo sapiens (Human) protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0003723; GO:0016567; GO:0042802; GO:0046872; GO:0061630; GO:1990904 RGGLRPAPASGGGAWPSPLPSR 2.25999999 1 1 0.049071313 2143.744148 15.85248 14.02587 0 14.37761 0 13.40752 15.00658 11.10775 0 14.93587 14.58424 13.78792 13.42209 14.44746 12.24405 0 0 0 13.55828 0 0 0 13.57975 14.27685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13075 BIRC1_HUMAN Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein) NAIP BIRC1 Homo sapiens (Human) defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981] ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283] GO:0002221; GO:0005524; GO:0005737; GO:0006954; GO:0007399; GO:0010804; GO:0016045; GO:0016323; GO:0032731; GO:0042742; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0045087; GO:0046330; GO:0046456; GO:0046872; GO:0050729; GO:0061702; GO:0070269; GO:0072557; GO:0120283 GGKMR 5.679999828 0.314957023 0.314957023 0.26832961 549.7158541 17.03679 15.69483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.61815 0 16.83867 16.67051 0 16.85143 0 0 0 0 17.0892 0 0 18.54959 0 0 0 0 18.49747 0 0 0 0 0 Q13084 RM28_HUMAN "39S ribosomal protein L28, mitochondrial, L28mt, MRP-L28 (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes) (Mitochondrial large ribosomal subunit protein bL28m)" MRPL28 MAAT1 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005829; GO:0006412; GO:0032543 QDPQLHPEDPER 1.470000029 1 1 0.569633499 1461.248029 0 0 0 0 0 17.22938 0 0 0 0 0 0 0 0 0 0 0 16.59928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.61998 0 0 0 0 0 Q13103 SPP24_HUMAN "Secreted phosphoprotein 24, Spp-24 (Secreted phosphoprotein 2)" SPP2 SPP24 Homo sapiens (Human) bone remodeling [GO:0046849]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; bone remodeling [GO:0046849]; skeletal system development [GO:0001501] endopeptidase inhibitor activity [GO:0004866] GO:0001501; GO:0004866; GO:0005576; GO:0005788; GO:0031089; GO:0046849; GO:0062023 ARINTDFE 8.329999924 0.776203752 0.776203752 0.233251685 965.3238187 15.16501 14.93951 15.66988 16.05988 16.33975 0 14.30384 14.70829 14.33983 16.75118 14.27708 14.12189 0 15.88024 0 14.62921 0 0 17.41649 14.78644 0 16.1739 15.45934 0 14.71294 14.8066 0 0 0 14.33141 0 16.54907 0 16.48296 14.72213 0 15.09228 16.88873 11.94472 0 15.62958 0 2.903741 13.75324 0 0 0 0 Q13107 UBP4_HUMAN "Ubiquitin carboxyl-terminal hydrolase 4, EC 3.4.19.12 (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein homolog)" USP4 UNP UNPH Homo sapiens (Human) negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511] adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843] GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872 QTLQSKSSTAPSR 8.890000343 0.581496775 0.581496775 0.149680524 1390.373587 15.30869 14.31405 14.32617 16.40925 15.93638 14.95113 14.21384 16.16177 14.64287 16.13558 17.49709 16.69839 14.57903 16.35772 14.79146 9.617546 14.77124 12.37328 0 0 13.96662 14.5542 17.4161 15.63361 18.90072 14.4476 0 0 0 16.64124 16.37548 16.64103 12.51938 16.21452 15.75282 12.47711 14.16093 0 16.47818 18.3747 16.63225 14.50519 11.3484 15.85337 16.81477 14.09268 0 12.85766 Q13112 CAF1B_HUMAN "Chromatin assembly factor 1 subunit B, CAF-1 subunit B (Chromatin assembly factor I p60 subunit, CAF-I 60 kDa subunit, CAF-I p60) (M-phase phosphoprotein 7)" CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393; GO:0051082 EKPVLNMR 4.380000114 1 1 0.230417321 1002.703664 21.82562 0 14.33476 15.24339 0 0 0 0 17.71386 21.0205 17.91858 17.36512 0 0 0 19.11642 0 0 18.65561 0 0 17.45237 0 0 20.50208 0 21.33656 17.66314 0 0 0 18.71756 0 0 18.16735 0 0 18.81091 0 0 18.9257 20.94732 19.73673 0 0 0 0 0 Q13115 DUS4_HUMAN "Dual specificity protein phosphatase 4, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2, MAP kinase phosphatase 2, MKP-2)" DUSP4 MKP2 VH2 Homo sapiens (Human) dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409] MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0043409; GO:0070373; GO:1990439 SPRAESLR 8.479999542 1 1 0.097297288 915.775741 0 16.73298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.07825 0 0 0 0 0 Q13126 MTAP_HUMAN "S-methyl-5'-thioadenosine phosphorylase, EC 2.4.2.28 (5'-methylthioadenosine phosphorylase, MTA phosphorylase, MTAP, MTAPase)" MTAP MSAP Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]" "1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]" GO:0004645; GO:0005654; GO:0005829; GO:0006139; GO:0006166; GO:0017061; GO:0019509; GO:0033574; GO:0070062 ENANKAK 13.5 1 1 0.17764681 771.6505124 16.15644 16.44898 0 17.73705 18.03669 0 15.18519 0 0 17.12613 0 16.73499 0 16.66385 16.01718 13.13035 0 16.9891 0 0 0 16.53226 15.62356 15.0881 16.69694 0 18.94043 0 15.1726 15.26464 0 16.89033 0 0 17.42915 0 16.26247 0 0 16.19752 0 15.01049 0 0 17.70816 17.29819 15.6313 15.44689 Q13127 REST_HUMAN RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor) REST NRSF XBR Homo sapiens (Human) "auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0061629; GO:0070933; GO:0071257; GO:0071385; GO:0071466; GO:0097150; GO:0099563; GO:1902459; GO:1902894; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798 TADRSNFK 6.96999979 0.62349999 0.62349999 0.274555361 937.9479974 14.22041 16.35242 14.53684 15.76273 16.22339 13.93082 0 11.07697 14.34724 0 0 0 15.20203 14.81572 14.08278 15.39349 16.84816 16.2792 16.07479 0 0 15.90223 15.91844 0 16.77444 15.9814 0 15.33655 0 0 18.08123 16.36577 16.50005 14.35481 0 16.12312 15.30539 0 16.10565 14.96111 0 0 0 14.60441 15.47329 0 0 16.25977 Q13136 LIPA1_HUMAN "Liprin-alpha-1 (LAR-interacting protein 1, LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1, PTPRF-interacting protein alpha-1)" PPFIA1 LIP1 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808] GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077 LDSATVRTYSC 10.21000004 0.481265038 0.481265038 0.382964889 1274.425784 13.04985 13.02996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9072 16.10275 16.96688 0 0 0 16.50702 15.87869 16.03035 0 15.61153 0 0 0 16.67081 0 13.86985 0 0 0 0 0 0 0 17.36803 16.65897 16.16593 0 0 17.22701 11.7976 15.60289 Q13144 EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852 AAPVVAPPGVVVSRANK 6.869999886 0.611792803 0.611792803 1.37E-12 1630.920209 14.62749 11.70309 0 0 0 0 0 11.19352 14.18141 0 0 0 0 0 11.71471 14.46655 0 16.40976 0 14.60577 16.60637 14.05799 13.91241 0 0 0 15.07973 15.02246 16.8616 0 0 12.94214 16.0799 0 15.82911 16.21309 0 0 0 12.3452 0 15.40591 0 0 0 0 0 14.87162 Q13153 PAK1_HUMAN "Serine/threonine-protein kinase PAK 1, EC 2.7.11.1 (Alpha-PAK) (p21-activated kinase 1, PAK-1) (p65-PAK)" PAK1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060] ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001726; GO:0001934; GO:0002223; GO:0004672; GO:0004674; GO:0004712; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0014704; GO:0016310; GO:0016477; GO:0030018; GO:0030027; GO:0030335; GO:0030424; GO:0030425; GO:0031116; GO:0031532; GO:0031965; GO:0032587; GO:0032956; GO:0032991; GO:0033138; GO:0033148; GO:0035556; GO:0038096; GO:0042060; GO:0042802; GO:0043015; GO:0043408; GO:0043507; GO:0046777; GO:0048012; GO:0048013; GO:0048754; GO:0048812; GO:0050770; GO:0051496; GO:0060244; GO:0090063; GO:0106310 SILPGDK 5.510000229 0.322979689 0.322979689 0.094831779 731.1872563 15.95207 0 14.0563 0 14.63823 15.3545 15.02444 15.03926 12.91653 0 0 0 0 0 15.81239 15.10042 0 0 0 0 0 17.10555 0 0 0 0 0 15.89799 0 0 0 0 0 0 0 0 0 16.99532 0 0 0 0 0 0 0 0 0 0 Q13155 AIMP2_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1) AIMP2 JTV1 PRO0992 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510] molecular adaptor activity [GO:0060090] GO:0005634; GO:0005829; GO:0006412; GO:0006915; GO:0008285; GO:0016020; GO:0017101; GO:0031398; GO:0060090; GO:0060510; GO:0065003; GO:1901216; GO:1903632 HNAVNATLIDSWVDIAIFQLK 11.59000015 1 1 0.034597498 2369.227947 13.93561 12.7477 0 0 12.87667 12.47154 14.67269 10.94339 0 10.16141 11.53501 11.70876 11.80807 0 0 0 0 6.616193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.89874 0 0 0 0 0 0 0 0 Q13162 PRDX4_HUMAN "Peroxiredoxin-4, EC 1.11.1.24 (Antioxidant enzyme AOE372, AOE37-2) (Peroxiredoxin IV, Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)" PRDX4 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379] GO:0005576; GO:0005634; GO:0005783; GO:0005829; GO:0006979; GO:0007252; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0034774; GO:0042802; GO:0045454; GO:0070062; GO:0072593; GO:1904813; GO:2000255 LTDYRGK 6.159999847 1 1 0.048769084 851.8222148 0 0 0 0 0 0 16.3075 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71587 0 0 0 0 0 0 0 0 14.60449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13185 CBX3_HUMAN "Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma, HP1 gamma) (Modifier 2 protein)" CBX3 Homo sapiens (Human) "cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]" "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221] GO:0000122; GO:0000775; GO:0000779; GO:0000781; GO:0000785; GO:0000791; GO:0000792; GO:0001221; GO:0003682; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005721; GO:0005819; GO:0006325; GO:0006338; GO:0006974; GO:0019899; GO:0019904; GO:0031507; GO:0035064; GO:0035985; GO:0042802; GO:0045892; GO:0048511; GO:0061793; GO:0071549; GO:0090575; GO:0090734; GO:1990226 SLSDSESDDSK 6.889999866 1 1 6.88E-13 1170.447992 0 15.12655 13.45548 14.31964 0 0 10.78019 0 15.0753 0 0 14.06102 0 12.70289 0 0 0 0 0 0 16.98307 0 0 0 15.76181 17.66529 16.53652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.70843 0 0 18.08392 0 Q13188 STK3_HUMAN "Serine/threonine-protein kinase 3, EC 2.7.11.1 (Mammalian STE20-like protein kinase 2, MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit, MST2/N; Serine/threonine-protein kinase 3 20kDa subunit, MST2/C ]" STK3 KRS1 MST2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006606; GO:0006915; GO:0007165; GO:0007417; GO:0008285; GO:0032092; GO:0032991; GO:0035329; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0050821; GO:0051091; GO:0051262; GO:0051897; GO:0060215; GO:0060706; GO:0060800; GO:0090090; GO:0097284; GO:0106310; GO:1902043 ATATQLLQHPFIKNAKPVSILR 3.359999895 1 1 0.20492037 2447.353664 0 0 0 0 8.235969 13.41767 13.31157 15.21031 14.56466 0 10.06672 15.18314 0 0 0 0 0 0 0 0 9.397076 0 14.87944 0 0 0 9.867883 8.382201 0 12.43562 14.67552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13200 PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2) PSMD2 TRAP2 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]" enzyme regulator activity [GO:0030234] GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016020; GO:0022624; GO:0030234; GO:0034515; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813 LALMLNDMELVEDIFTSCK 1.409999967 1 1 3.20E-12 2257.076995 0 14.06569 12.75837 0 0 0 0 11.60029 14.59235 15.24148 12.42074 0 0 0 0 0 0 0 0 0 10.76776 0 14.5493 0 14.63183 16.79865 13.4705 0 0 0 0 0 12.49877 0 0 0 0 0 0 0 0 0 0 0 13.81504 15.74325 11.37086 0 Q13201 MMRN1_HUMAN "Multimerin-1 (EMILIN-4) (Elastin microfibril interface located protein 4, Elastin microfibril interfacer 4) (Endothelial cell multimerin) [Cleaved into: Platelet glycoprotein Ia*; 155 kDa platelet multimerin, p-155, p155 ]" MMRN1 ECM EMILIN4 GPIA* MMRN Homo sapiens (Human) blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0007155; GO:0007596; GO:0031091; GO:0031093; GO:0033627; GO:0061045; GO:0062023; GO:1901731; GO:1990972 KSNEQATSLNTVGGTGGIGGVGGTGGVGNR 3.569999933 1 1 0.187241751 2697.966029 14.77423 12.98009 14.6586 0 0 0 0 0 0 0 0 0 15.16127 15.88491 15.18221 0 0 15.80866 0 16.03016 0 0 0 0 14.73465 14.01244 0 14.58684 13.9325 15.07434 0 14.34447 0 13.16986 9.667798 14.84434 14.74489 14.12761 0 0 0 13.15853 0 0 13.34613 14.86641 0 0 Q13203 MYBPH_HUMAN "Myosin-binding protein H, MyBP-H (H-protein)" MYBPH Homo sapiens (Human) cell adhesion [GO:0007155]; regulation of striated muscle contraction [GO:0006942] myosin filament [GO:0032982] myosin filament [GO:0032982]; structural constituent of muscle [GO:0008307]; cell adhesion [GO:0007155]; regulation of striated muscle contraction [GO:0006942] structural constituent of muscle [GO:0008307] GO:0006942; GO:0007155; GO:0008307; GO:0032982 MEIQGNPK 10.48999977 1 1 0 930.7574832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.57051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13206 DDX10_HUMAN "Probable ATP-dependent RNA helicase DDX10, EC 3.6.4.13 (DEAD box protein 10)" DDX10 Homo sapiens (Human) anterior head development [GO:0097065]; rRNA processing [GO:0006364] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; anterior head development [GO:0097065]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0016887; GO:0097065 EVQYLYR 4.690000057 0.045438614 0.045438614 0.258172476 971.4781422 0 0 0 0 15.09848 0 17.96738 0 0 15.70224 0 0 17.06799 0 0 0 0 17.75637 0 0 0 18.68012 0 18.59507 0 19.51368 0 0 0 0 0 19.18813 16.45507 18.8132 0 0 0 18.77517 0 0 0 0 17.8262 17.99596 16.21428 17.5167 16.71108 0 Q13214 SEM3B_HUMAN "Semaphorin-3B (Sema A(V)) (Semaphorin-V, Sema V)" SEMA3B SEMA5 SEMAA Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0005615; GO:0005783; GO:0005887; GO:0007267; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0061643; GO:0062023; GO:0071526 MGRAGAAAVIPGLALLWAVGLGSAAPSPPR 2.930000067 1 1 0 2843.534471 0 0 14.84618 0 13.52396 13.45007 0 15.67929 15.44305 0 0 11.60632 0 0 0 0 15.65304 0 0 0 0 16.01747 0 16.70438 0 14.26123 0 0 13.44715 10.64695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13216 ERCC8_HUMAN DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA) ERCC8 CKN1 CSA Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] protein-containing complex binding [GO:0044877] GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0005654; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0044877; GO:0045739; GO:0051865; GO:0080008; GO:0090262; GO:0097680 MLGFLSAR 4.480000019 1 1 0.17866682 911.0541638 0 0 14.62172 0 0 13.49547 0 15.70937 15.60035 13.46155 0 0 0 0 0 0 0 15.177 0 0 15.49507 14.8559 15.80331 0 0 0 0 0 14.40406 0 0 18.31352 16.14165 0 0 0 0 16.77755 16.62366 0 16.20522 0 0 0 0 14.66143 0 14.73545 Q13217 DNJC3_HUMAN "DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6, ER-resident protein ERdj6, ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa, Protein kinase inhibitor p58)" DNAJC3 P58IPK PRKRI Homo sapiens (Human) cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986] chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912 MVAPGSVTSR 10.63000011 0.284210265 0.284210265 0.0611732 1019.987993 12.81179 10.64522 0 0 0 14.59386 0 0 0 0 13.02993 0 17.02991 0 0 0 16.67312 0 17.00235 0 16.33278 14.01152 14.93373 0 16.57369 15.43281 14.22816 0 0 16.13106 17.73295 17.00611 17.20731 0 14.716 14.39356 13.81853 0 0 0 11.52287 16.9057 9.712174 0 16.24509 16.80112 16.62897 11.63463 Q13219 PAPP1_HUMAN "Pappalysin-1, EC 3.4.24.79 (Insulin-like growth factor-dependent IGF-binding protein 4 protease, IGF-dependent IGFBP-4 protease, IGFBP-4ase) (Pregnancy-associated plasma protein A, PAPP-A)" PAPPA Homo sapiens (Human) cellular protein metabolic process [GO:0044267]; female pregnancy [GO:0007565]; response to follicle-stimulating hormone [GO:0032354]; response to glucocorticoid [GO:0051384] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cellular protein metabolic process [GO:0044267]; female pregnancy [GO:0007565]; response to follicle-stimulating hormone [GO:0032354]; response to glucocorticoid [GO:0051384] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0004222; GO:0005576; GO:0005615; GO:0007565; GO:0008237; GO:0008270; GO:0032354; GO:0044267; GO:0051384 HPAFVK 17.31999969 1 1 0.271565441 697.8921831 14.51624 0 0 0 0 0 0 17.50212 0 0 0 0 0 0 0 0 0 18.02444 0 0 0 0 0 0 16.66761 0 0 17.84939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1809 0 16.97564 0 0 Q13224 NMDE2_HUMAN "Glutamate receptor ionotropic, NMDA 2B, GluN2B (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B, NMDAR2B, NR2B) (N-methyl-D-aspartate receptor subunit 3, NR3, hNR3)" GRIN2B NMDAR2B Homo sapiens (Human) "brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; amyloid-beta binding [GO:0001540]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]" amyloid-beta binding [GO:0001540]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270] GO:0001540; GO:0004972; GO:0005737; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007420; GO:0007611; GO:0008270; GO:0009986; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0022849; GO:0035235; GO:0038023; GO:0043005; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0060079; GO:0060291; GO:0097060; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:1901216; GO:1902951; GO:1904062; GO:2000463; GO:2001056 DKSLQMK 10.52000046 0.589194238 0.589194238 0.17182744 849.8785697 0 14.20862 0 0 0 14.05238 16.90441 0 0 14.81323 14.83061 0 0 0 0 0 15.53889 12.47066 0 0 0 0 0 15.05863 15.49609 0 16.08714 0 0 0 14.08315 0 15.88067 15.21618 0 0 0 0 12.74195 0 0 0 0 0 0 11.63446 13.77808 0 Q13227 GPS2_HUMAN "G protein pathway suppressor 2, GPS-2" GPS2 Homo sapiens (Human) B cell differentiation [GO:0030183]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003712; GO:0003713; GO:0003714; GO:0005095; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006357; GO:0007254; GO:0010804; GO:0010875; GO:0017053; GO:0019216; GO:0030183; GO:0030332; GO:0034122; GO:0035360; GO:0045598; GO:0045599; GO:0045944; GO:0046329; GO:0050728; GO:0050859; GO:0098780; GO:1900045 KEMEER 9.579999924 0.41687566 0.41687566 0.136920215 835.2402877 17.83847 0 15.844 0 0 0 18.22606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.18017 17.66723 0 0 0 0 0 0 0 0 0 0 0 0 0 13.85061 0 0 0 0 0 0 15.77055 0 0 0 Q13233 M3K1_HUMAN "Mitogen-activated protein kinase kinase kinase 1, EC 2.7.11.25 (MAPK/ERK kinase kinase 1, MEK kinase 1, MEKK 1)" MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270] GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0071260; GO:0106310 ATSPEAGGGGGALK 12.01000023 1 1 0.135498226 1168.840746 15.61387 15.35287 0 14.16854 0 0 15.40211 15.71975 14.47568 0 15.06117 14.50967 0 0 0 15.73023 0 0 0 0 0 0 0 13.10568 0 0 0 0 0 0 0 0 0 0 0 0 16.8971 0 0 0 0 0 0 0 0 0 0 0 Q13242 SRSF9_HUMAN "Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)" SRSF9 SFRS9 SRP30C Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]" nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]" protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] GO:0000380; GO:0000398; GO:0003723; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0009636; GO:0016607; GO:0019904; GO:0043279; GO:0048025 DLEDLFYK 21.62000084 0.233182058 0.233182058 0.135332529 1041.999523 17.08821 18.3033 17.47962 15.98031 11.52056 17.12803 0 15.87423 14.51183 17.69873 17.76747 18.63335 17.33707 17.99522 0 16.3152 14.83004 16.0813 0 17.10376 17.48799 0 0 14.75745 16.25202 17.34376 0 16.51439 15.87544 0 16.94279 14.78458 0 18.14724 17.17088 18.38545 0 16.95618 18.13318 17.65938 14.43042 15.32992 15.37117 13.45872 15.98143 14.82746 17.18856 15.88048 Q13243 SRSF5_HUMAN "Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)" SRSF5 HRS SFRS5 SRP40 Homo sapiens (Human) "cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of cell cycle [GO:0051726]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of cell cycle [GO:0051726]" mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0016607; GO:0032869; GO:0033120; GO:0043422; GO:0051726; GO:0097421 SKSPASVDR 2.380000114 0.796537697 0.796537697 0.130739988 947.5076324 15.6571 0 11.1612 0 0 0 0 0 0 0 19.41302 17.8646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67061 0 0 14.77195 0 0 0 0 0 0 0 0 0 0 15.74157 0 15.87294 0 17.06094 0 0 Q13263 TIF1B_HUMAN "Transcription intermediary factor 1-beta, TIF1-beta (E3 SUMO-protein ligase TRIM28, EC 2.3.2.27) (KRAB-associated protein 1, KAP-1) (KRAB-interacting protein 1, KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)" TRIM28 KAP1 RNF96 TIF1B Homo sapiens (Human) "chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; suppression of viral release by host [GO:0044790]" chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; suppression of viral release by host [GO:0044790]" chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0007265; GO:0007566; GO:0008270; GO:0016925; GO:0019789; GO:0031625; GO:0032991; GO:0035851; GO:0042307; GO:0043045; GO:0043388; GO:0044790; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0046777; GO:0060028; GO:0060669; GO:0070087; GO:0090309; GO:0090575; GO:1901536; GO:1990841; GO:2000653 FASWALESDNNTALLLSKK 20.37999916 1 1 2.74E-12 2107.533963 0 16.33562 11.85658 0 13.30876 14.67436 15.2698 16.01868 10.9686 0 0 12.0474 15.39888 0 0 14.26274 0 0 0 0 0 15.18865 0 0 14.83784 15.80471 0 13.13294 13.86106 0 14.05128 0 15.99161 14.89851 0 12.34235 0 15.35581 0 16.58202 0 0 0 16.00388 0 0 0 11.42546 Q13268 DHRS2_HUMAN "Dehydrogenase/reductase SDR family member 2, mitochondrial, EC 1.1.1.- (Dicarbonyl reductase HEP27) (Protein D) (Short chain dehydrogenase/reductase family 25C member 1, Protein SDR25C1)" DHRS2 SDR25C1 Homo sapiens (Human) C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; electron transport chain [GO:0022900]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to toxic substance [GO:0009636] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; electron transport chain [GO:0022900]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to toxic substance [GO:0009636]" "carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" GO:0004090; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0008207; GO:0008285; GO:0009636; GO:0016616; GO:0022900; GO:0034599; GO:0043011; GO:0043066 LSAVAR 11.13000011 0.188181326 0.188181326 0.087362007 616.9950272 17.17731 0 17.45066 13.66393 14.08061 17.85992 0 0 0 0 0 16.98137 0 14.54136 0 0 15.78507 17.51338 16.75052 16.69664 0 0 14.42708 14.89149 17.1531 17.26866 0 14.73616 15.38764 17.16789 13.44256 15.75304 0 0 13.69214 15.90891 0 17.26801 15.64404 16.47879 0 0 13.18044 15.85801 0 0 13.56032 16.00573 Q13275 SEM3F_HUMAN "Semaphorin-3F (Sema III/F) (Semaphorin IV, Sema IV)" SEMA3F Homo sapiens (Human) axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0021612; GO:0021637; GO:0021675; GO:0021785; GO:0030215; GO:0030335; GO:0036486; GO:0045499; GO:0048843; GO:0048846; GO:0050919; GO:0061549; GO:0071526; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1902285; GO:1902287 LESGKGK 7.28000021 1 1 0.2052585 718.4813591 15.30935 14.55562 12.67255 13.85905 15.65881 15.1834 0 16.20462 16.1477 0 0 15.26587 15.71039 0 15.13528 0 14.72519 15.4748 15.97847 12.91862 15.29301 0 16.53809 15.96046 15.64046 15.60519 0 0 0 0 16.8964 0 0 16.12918 16.01746 0 0 16.20565 17.33807 0 14.94597 0 0 0 0 16.03053 15.9846 0 Q13286 CLN3_HUMAN Battenin (Batten disease protein) (Protein CLN3) CLN3 BTS Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cell migration [GO:0016477]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]" autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] "autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]; actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cell migration [GO:0016477]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]" calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146] GO:0000139; GO:0001508; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0008306; GO:0009992; GO:0010762; GO:0016021; GO:0016243; GO:0016477; GO:0016485; GO:0030036; GO:0030176; GO:0031901; GO:0031902; GO:0032228; GO:0035235; GO:0035752; GO:0036359; GO:0042133; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0043086; GO:0043524; GO:0044754; GO:0044857; GO:0045121; GO:0045861; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048306; GO:0048549; GO:0050885; GO:0051453; GO:0051480; GO:0051489; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061024; GO:0061909; GO:0070613; GO:0072659; GO:0090160; GO:0090384; GO:0090385; GO:0097352; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288 MGGCAGSR 5.159999847 0.407441616 0.407441616 0.049413457 794.8993251 19.71768 16.30089 18.13819 18.72212 17.90107 17.93939 0 17.46789 17.11365 16.58081 16.40582 17.47927 18.88604 18.25698 17.22054 18.99136 17.13692 17.73851 17.7667 18.66299 17.27368 17.87725 18.28862 18.88276 17.45714 18.24358 17.30708 17.89945 0 17.36264 18.07425 18.207 17.98961 16.33185 17.88247 15.93168 19.12081 18.11785 18.13729 16.97336 18.05065 17.05792 18.37919 17.27839 16.95466 16.49822 13.61875 15.65299 Q13287 NMI_HUMAN "N-myc-interactor, Nmi (N-myc and STAT interactor)" NMI Homo sapiens (Human) interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; transcription by RNA polymerase II [GO:0006366] identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] GO:0002281; GO:0003712; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007259; GO:0008285; GO:0009615; GO:0016020; GO:0032687; GO:0032688; GO:0034142; GO:0042802; GO:0045089; GO:0045824; GO:0050729; GO:0060333; GO:1901223; GO:1901224; GO:1902524 SRNGGGEVDR 2.99000001 1 1 0.134073913 1047.809871 15.14564 15.07474 0 0 15.656 15.26853 15.17024 14.21692 15.38491 14.80276 15.52076 15.16652 0 15.20274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54852 0 0 0 0 0 0 0 15.75416 0 Q13303 KCAB2_HUMAN "Voltage-gated potassium channel subunit beta-2, EC 1.1.1.- (K(+) channel subunit beta-2) (Kv-beta-2, hKvbeta2)" KCNAB2 KCNA2B KCNK2 Homo sapiens (Human) NADPH oxidation [GO:0070995]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; pinceau fiber [GO:1990031]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; voltage-gated potassium channel complex [GO:0008076] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; pinceau fiber [GO:1990031]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; NADPH oxidation [GO:0070995]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008] aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0031234; GO:0035579; GO:0044224; GO:0044325; GO:0045202; GO:0070821; GO:0070995; GO:0098900; GO:1901379; GO:1990031; GO:2000008 MYPESTTGSPARLSLR 9.800000191 1 1 4.58E-13 1781.286695 0 0 15.35496 14.59316 13.15567 0 0 0 11.79222 0 0 16.47555 12.27195 16.22128 15.00204 0 0 0 0 0 0 0 14.83632 0 16.7573 0 0 13.33247 0 0 0 14.62409 0 0 13.6969 13.277 16.27325 13.66171 0 0 16.18656 0 0 0 0 0 0 0 Q13304 GPR17_HUMAN "Uracil nucleotide/cysteinyl leukotriene receptor, UDP/CysLT receptor (G-protein coupled receptor 17) (P2Y-like receptor) (R12)" GPR17 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0007186; GO:0035025; GO:0051482 SLRQGLR 11.02000046 1 1 0.215297549 828.4439189 15.89683 15.6648 14.75949 16.59678 14.90187 17.30162 0 0 14.31325 14.66904 15.41041 14.21627 15.31018 15.93905 15.30685 16.26308 14.90309 14.46357 14.90272 16.24366 0 0 0 0 16.51943 16.79176 15.9462 0 15.7094 0 0 0 16.57682 15.51931 0 0 16.16722 0 0 15.32384 15.53873 0 0 13.72764 0 16.27321 15.20704 0 Q13315 ATM_HUMAN "Serine-protein kinase ATM, EC 2.7.11.1 (Ataxia telangiectasia mutated, A-T mutated)" ATM Homo sapiens (Human) "brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; spindle [GO:0005819] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]" 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877] GO:0000077; GO:0000723; GO:0000724; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0003677; GO:0004674; GO:0004677; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0005829; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0007094; GO:0007095; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0016572; GO:0018105; GO:0030335; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033129; GO:0033151; GO:0035264; GO:0036289; GO:0042159; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0047485; GO:0048538; GO:0048599; GO:0051402; GO:0051726; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090398; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905843; GO:1990391 HLVELSILAR 6.809999943 1 1 0.242408597 1150.842461 18.13395 0 15.67817 0 0 0 0 0 0 0 15.1918 15.29667 0 0 0 0 0 0 0 0 0 0 0 18.67816 0 0 15.36967 0 0 15.88534 0 14.62244 0 0 0 15.42491 0 0 0 15.88929 0 0 0 0 16.08604 0 0 0 Q13316 DMP1_HUMAN "Dentin matrix acidic phosphoprotein 1, DMP-1, Dentin matrix protein 1" DMP1 Homo sapiens (Human) biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178] GO:0001503; GO:0005178; GO:0005509; GO:0005576; GO:0005634; GO:0005788; GO:0010811; GO:0030198; GO:0031012; GO:0031214; GO:0050840; GO:0070173 SERGNSR 16.70000076 1 1 0.128236832 805.7161405 14.65088 14.44049 15.415 0 2.393256 0 15.50295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.74808 0 0 0 0 0 0 Q13322 GRB10_HUMAN Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR) GRB10 GRBIR KIAA0207 Homo sapiens (Human) ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of phosphorylation [GO:0042326]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of phosphorylation [GO:0042327]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; response to insulin [GO:0032868]; vascular associated smooth muscle cell migration [GO:1904738] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]; ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of phosphorylation [GO:0042326]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of phosphorylation [GO:0042327]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; response to insulin [GO:0032868]; vascular associated smooth muscle cell migration [GO:1904738] identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159] GO:0005158; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0010467; GO:0030159; GO:0030178; GO:0030949; GO:0032868; GO:0032991; GO:0042326; GO:0042327; GO:0042802; GO:0045719; GO:0046325; GO:0046627; GO:0048009; GO:0070371; GO:0120162; GO:1904738 ASGPPR 9.890000343 0.556246936 0.556246936 0.072782352 583.4287448 15.31685 16.65962 15.23695 15.96243 17.1761 15.98388 19.66538 16.29917 15.65474 16.89411 18.26668 17.09406 0 14.75751 0 13.39969 14.24886 15.87956 15.35749 17.72037 15.47536 15.47836 0 15.5435 16.45129 16.75628 15.96927 16.22705 14.9187 14.3229 15.23433 15.50527 16.49156 16.23956 14.88531 14.71254 16.92555 0 15.71094 15.71304 16.59076 16.96616 16.51769 15.15445 15.45484 16.48567 14.20889 16.46212 Q13324 CRFR2_HUMAN "Corticotropin-releasing factor receptor 2, CRF-R-2, CRF-R2, CRFR-2 (Corticotropin-releasing hormone receptor 2, CRH-R-2, CRH-R2)" CRHR2 CRF2R CRH2R Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291] axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291] corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046] GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0008528; GO:0015056; GO:0017046; GO:0030425; GO:0043404; GO:0043679; GO:0060291 KYDLHYR 7.78000021 1 1 0.055911383 994.1692588 0 0 0 16.21501 15.60133 0 13.48631 0 15.97959 13.34266 0 0 13.35494 0 16.67941 16.60687 14.77197 16.29385 0 0 0 15.95063 0 0 0 0 16.79467 12.97197 14.05849 15.60721 17.51605 16.94183 15.06947 18.32037 14.74524 16.08563 18.37961 17.83671 14.77843 0 14.94123 0 15.52059 0 16.06308 16.14126 12.71976 0 Q13330 MTA1_HUMAN Metastasis-associated protein MTA1 MTA1 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of gene expression, epigenetic [GO:0040029]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of gene expression, epigenetic [GO:0040029]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]" chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006302; GO:0006338; GO:0007165; GO:0010212; GO:0016575; GO:0016581; GO:0032922; GO:0040029; GO:0042659; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:0045892; GO:0045893; GO:0046872; GO:0061629; GO:1902499; GO:2000736 LDGERPGPNR 10 0.432997495 0.432997495 0.393044974 1109.544322 14.40494 0 14.10038 0 0 13.03595 0 0 0 0 16.26706 0 0 0 0 16.60536 0 0 14.46511 14.86039 0 0 0 0 14.72248 17.3392 16.04663 0 0 0 0 0 0 0 0 0 16.85211 15.14777 0 16.47415 14.32422 0 14.1011 0 12.82397 15.73798 16.0871 16.467 Q13332 PTPRS_HUMAN "Receptor-type tyrosine-protein phosphatase S, R-PTP-S, EC 3.1.3.48 (Receptor-type tyrosine-protein phosphatase sigma, R-PTP-sigma)" PTPRS Homo sapiens (Human) negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560] axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560] chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725] GO:0004721; GO:0004725; GO:0005829; GO:0005886; GO:0005887; GO:0006470; GO:0008201; GO:0010977; GO:0030285; GO:0030424; GO:0030426; GO:0030517; GO:0032687; GO:0032688; GO:0034164; GO:0035335; GO:0035374; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0070062; GO:0099061; GO:0099560 SRGGLGEEAAEVLSIPEDTPR 3.210000038 1 1 0.25037937 2182.824094 15.10059 14.85809 0 0 11.59916 0 0 0 0 0 17.27674 16.07188 0 0 0 14.74189 0 0 12.80529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.84446 0 0 0 0 0 0 0 0 Q13342 SP140_HUMAN "Nuclear body protein SP140 (Lymphoid-restricted homolog of Sp100, LYSp100) (Nuclear autoantigen Sp-140) (Speckled 140 kDa)" SP140 LYSP100 Homo sapiens (Human) defense response [GO:0006952]; regulation of transcription by RNA polymerase II [GO:0006357] fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PML body [GO:0016605] "fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; defense response [GO:0006952]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" GO:0000981; GO:0001650; GO:0003677; GO:0005634; GO:0005739; GO:0006357; GO:0006952; GO:0016605; GO:0046872 AQQGQQGQMASGDSNLNFR 24.68000031 0.369252175 0.369252175 0.049959099 2036.051512 18.79892 19.41188 18.97955 0 19.2985 0 20.78355 19.47733 0 18.68255 0 0 0 0 0 0 19.15012 0 19.04241 18.97195 0 19.01727 19.34811 18.58535 19.89494 19.97638 0 0 19.76078 0 19.95518 0 0 0 0 0 18.79685 19.36968 0 0 0 19.90288 0 0 18.41759 0 0 0 Q13347 EIF3I_HUMAN "Eukaryotic translation initiation factor 3 subunit I, eIF3i (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1, TRIP-1) (eIF-3-beta) (eIF3 p36)" EIF3I EIF3S2 TRIP1 Homo sapiens (Human) cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]" RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0001732; GO:0002183; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0070062; GO:0071541 DPSQIDNNEPYMK 5.960000038 1 1 0.310547557 1565.355338 12.42718 13.47615 15.37443 0 12.95442 0 0 0 0 0 0 0 12.16236 0 0 0 0 10.42078 12.97454 15.49488 0 0 0 15.20718 0 0 0 0 0 0 0 0 0 13.93269 0 0 0 0 14.71114 0 14.95997 15.44859 12.77677 12.16074 16.95708 12.68331 8.728999 15.14585 Q13356 PPIL2_HUMAN "RING-type E3 ubiquitin-protein ligase PPIL2, EC 2.3.2.27 (CYC4) (Cyclophilin-60, Cyclophilin-like protein Cyp-60, Cyp60, hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2, PPIase) (Rotamase PPIL2)" PPIL2 Homo sapiens (Human) protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0072659 GDEILAATMKAPEK 5.489999771 0.164503217 0.164503217 5.24E-12 1474.359346 0 0 0 0 0 0 14.11795 17.53951 0 0 0 0 15.6464 0 0 0 15.99786 0 17.87886 14.57381 0 13.74413 0 14.50471 16.35862 15.88428 0 0 14.0219 15.89723 13.89114 7.264241 15.1565 0 17.97649 0 0 16.1714 17.95827 14.83803 13.45994 15.32634 17.39467 13.58769 15.51439 17.30992 0 16.7783 Q13360 ZN177_HUMAN Zinc finger protein 177 ZNF177 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] blood microparticle [GO:0072562]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:0072562; GO:1990837 TPTGQK 5.260000229 1 1 0.272615966 626.6452053 16.08966 15.68754 15.87127 16.43806 15.22931 0 0 14.49889 14.61513 16.02521 0 15.60406 16.6658 0 15.53771 0 15.92554 0 0 15.47868 0 0 15.96977 0 15.77045 0 0 16.73534 0 15.41332 0 16.7311 0 0 0 16.2588 15.60935 16.49716 16.46106 0 0 17.05581 15.09352 16.53313 0 16.25341 0 0 Q13361 MFAP5_HUMAN "Microfibrillar-associated protein 5, MFAP-5 (MP25) (Microfibril-associated glycoprotein 2, MAGP-2)" MFAP5 MAGP2 Homo sapiens (Human) definitive hemopoiesis [GO:0060216]; embryonic eye morphogenesis [GO:0048048]; supramolecular fiber organization [GO:0097435] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; definitive hemopoiesis [GO:0060216]; embryonic eye morphogenesis [GO:0048048]; supramolecular fiber organization [GO:0097435] extracellular matrix structural constituent [GO:0005201] GO:0001527; GO:0005201; GO:0005576; GO:0048048; GO:0060216; GO:0062023; GO:0097435 MSLLGPK 2.50999999 1 1 0.228899205 745.7187885 16.28671 11.68475 13.45196 0 14.78315 14.89997 0 0 0 13.45812 14.89872 0 0 15.67877 15.61119 0 0 0 15.41766 0 0 16.62194 13.23322 0 16.60134 15.43699 0 0 0 0 0 15.3422 0 15.85323 14.07557 0 0 0 0 0 0 16.16013 15.55309 0 0 0 15.5691 0 Q13362 2A5G_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]" protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] GO:0000159; GO:0000775; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006470; GO:0006977; GO:0007165; GO:0008285; GO:0019888; GO:0042771; GO:0043161; GO:0072542 IMEPLFR 34.27999878 1 1 0.081390861 905.7305221 21.20466 20.51707 21.47322 20.86341 19.60842 21.11116 0 20.133 20.05882 0 20.48373 0 22.97377 0 18.15106 20.41107 19.57396 20.67099 20.10201 21.35054 0 20.05244 0 20.33079 18.87472 16.55421 17.64074 19.20984 0 0 18.74614 0 0 19.05875 19.7184 0 0 20.63961 20.09307 18.42338 0 18.97137 0 17.27919 19.18209 18.00718 19.68001 17.89678 Q13368 MPP3_HUMAN MAGUK p55 subfamily member 3 (Discs large homolog 3) (Protein MPP3) MPP3 DLG3 Homo sapiens (Human) cell-cell junction [GO:0005911]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165] PDZ domain binding [GO:0030165] GO:0005886; GO:0005911; GO:0030165 LVVLIGSLGAR 4.25 1 1 0.013564472 1098.316768 13.52878 0 0 13.31188 0 14.77236 14.54463 0 0 0 12.31431 0 0 0 0 13.05733 0 12.98493 0 0 0 0 0 14.6873 0 0 0 0 0 0 0 0 0 0 14.05922 0 0 0 11.87845 0 13.66907 13.02823 14.86825 0 0 0 0 0 Q13370 PDE3B_HUMAN "cGMP-inhibited 3',5'-cyclic phosphodiesterase B, EC 3.1.4.17 (CGIPDE1, CGIP1) (Cyclic GMP-inhibited phosphodiesterase B, CGI-PDE B)" PDE3B Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to insulin stimulus [GO:0032869]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of lipid catabolic process [GO:0050995]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; protein kinase B binding [GO:0043422]; angiogenesis [GO:0001525]; cellular response to insulin stimulus [GO:0032869]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of lipid catabolic process [GO:0050995]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; protein kinase B binding [GO:0043422]" GO:0001525; GO:0004114; GO:0004115; GO:0004119; GO:0005783; GO:0005794; GO:0005829; GO:0007162; GO:0007165; GO:0007186; GO:0016020; GO:0016021; GO:0016525; GO:0032045; GO:0032869; GO:0033629; GO:0043422; GO:0043951; GO:0046872; GO:0050995 IPTQQFMNYFR 2.710000038 0.324099749 0.324099749 0.275396281 1461.030028 0 0 0 0 16.48924 15.51578 15.8634 10.44893 15.46105 0 19.28346 17.60951 14.02384 14.73628 0 12.28498 18.87627 0 14.5107 14.30723 18.36881 15.94779 0 17.27417 0 17.60511 15.28654 18.49638 14.00656 17.09151 0 0 17.01219 0 15.66316 16.34265 0 16.79431 16.13664 11.77569 17.2654 16.25603 16.60889 0 0 15.7624 15.766 15.20094 Q13371 PHLP_HUMAN "Phosducin-like protein, PHLP" PDCL PHLOP1 PhLP1 Homo sapiens (Human) cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005737; GO:0005829; GO:0005929; GO:0007165; GO:0007601; GO:0008277; GO:0030030; GO:0045880; GO:1902605 GGELIGNFVR 8.18999958 1 1 6.89E-13 1060.814491 0 15.15722 0 0 0 13.58886 0 15.43372 15.32312 0 0 14.55845 0 14.32529 14.52052 16.19261 15.61855 0 15.68447 0 0 0 0 0 0 13.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13395 TARB1_HUMAN "Probable methyltransferase TARBP1, EC 2.1.1.- (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa, TRP-185)" TARBP1 TRM3 TRP185 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488] nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488] RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423] GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488 LQKFLVTYISLLPEEIK 7.440000057 1 1 0.278963858 2034.47713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.00445 0 0 0 21.57458 0 0 0 0 20.14936 21.90141 0 20.80829 0 21.8055 0 19.36227 0 19.69311 0 0 0 0 0 0 0 0 0 Q13398 ZN211_HUMAN Zinc finger protein 211 (Zinc finger protein C2H2-25) ZNF211 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 SNLMQHR 15.27999973 1 1 0.267261695 902.2985464 0 0 15.8861 0 0 0 0 0 16.65466 0 0 0 17.71201 0 0 0 0 0 0 0 0 0 0 0 0 0 18.39424 0 0 18.23806 17.62161 0 17.35281 20.39416 19.74082 0 0 0 0 0 0 0 0 0 0 0 16.77494 0 Q13402 MYO7A_HUMAN Unconventional myosin-VIIa MYO7A USH1B Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cellular protein localization [GO:0034613]; equilibrioception [GO:0050957]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagolysosome assembly [GO:0001845]; pigment granule transport [GO:0051904]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory organ development [GO:0007423]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myosin complex [GO:0016459]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myosin complex [GO:0016459]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cellular protein localization [GO:0034613]; equilibrioception [GO:0050957]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagolysosome assembly [GO:0001845]; pigment granule transport [GO:0051904]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory organ development [GO:0007423]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507] GO:0000146; GO:0001750; GO:0001845; GO:0001917; GO:0005516; GO:0005524; GO:0005737; GO:0005765; GO:0005829; GO:0005902; GO:0005938; GO:0006886; GO:0007015; GO:0007040; GO:0007423; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016459; GO:0019904; GO:0030048; GO:0030050; GO:0030507; GO:0031982; GO:0032391; GO:0032420; GO:0034613; GO:0042462; GO:0042470; GO:0042490; GO:0045202; GO:0048563; GO:0050953; GO:0050957; GO:0051015; GO:0051904; GO:0060088; GO:0120044 HAGKSK 10.77000046 0.687597692 0.687597692 0.225732875 627.2649815 16.02338 14.85619 14.96168 15.28711 15.06856 15.50384 13.14875 14.8416 14.85876 0 0 0 0 16.03441 15.95419 14.95377 0 16.66578 15.38264 14.86372 0 15.66021 16.67435 15.85877 0 17.55538 0 16.93077 0 16.07809 15.3139 0 15.91079 0 0 15.88661 15.85657 16.00181 0 0 17.41345 0 16.25441 16.49505 16.54441 16.74187 14.98089 0 Q13404 UB2V1_HUMAN "Ubiquitin-conjugating enzyme E2 variant 1, UEV-1 (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)" UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19 Homo sapiens (Human) "cell differentiation [GO:0030154]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of transcription, DNA-templated [GO:0045893]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-UEV1A complex [GO:0035370]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-UEV1A complex [GO:0035370]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; cell differentiation [GO:0030154]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of transcription, DNA-templated [GO:0045893]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000151; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006301; GO:0006355; GO:0030154; GO:0031371; GO:0032991; GO:0035370; GO:0043123; GO:0045893; GO:0051092; GO:0070062; GO:0070534; GO:1902523; GO:1902533 MAATTGSGVKVPR 9.649999619 0.988025427 0.988025427 0.441591603 1293.39262 0 0 0 0 0 0 15.99222 14.81397 0 0 15.9124 15.03169 0 0 0 0 0 0 15.12513 0 16.14285 0 17.49349 17.03353 0 0 0 0 0 0 0 17.58448 0 16.34081 19.51215 15.74292 0 0 16.9397 17.42923 15.31466 0 0 0 0 0 0 0 Q13405 RM49_HUMAN "39S ribosomal protein L49, mitochondrial, L49mt, MRP-L49 (Mitochondrial large ribosomal subunit protein mL49) (Neighbor of FAU, NOF) (Protein NOF1)" MRPL49 C11orf4 NOF1 OK/SW-cl.67 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 IPDPPK 4.929999828 1 1 0.252546165 666.9270239 18.50889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.06295 0 0 18.46416 19.93124 0 18.94938 0 0 0 0 17.4642 0 0 0 18.95713 0 0 0 0 Q13418 ILK_HUMAN "Integrin-linked protein kinase, EC 2.7.11.1 (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK)" ILK ILK1 ILK2 Homo sapiens (Human) "branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000902; GO:0001658; GO:0001934; GO:0003151; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0007160; GO:0007229; GO:0008284; GO:0009967; GO:0010761; GO:0016020; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0042327; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0070527; GO:0090263; GO:0106310; GO:1900026; GO:1901224; GO:2000178 MGQNLNR 9.569999695 0.651828289 0.651828289 0.220969058 831.7417544 16.79988 15.8042 17.02829 15.30654 13.58999 16.43261 17.15177 17.91121 16.26835 16.3227 17.62478 15.58205 16.39198 17.47722 14.40113 12.95871 17.01062 15.242 15.43606 17.1542 16.41619 16.82137 16.052 16.85977 13.93533 15.23781 16.72213 16.06367 17.18482 15.64296 16.0734 16.88453 0 17.41619 15.91723 16.84176 15.90947 16.39732 16.69699 0 17.63364 16.89053 0 16.59455 0 14.86412 0 15.59154 Q13421 MSLN_HUMAN "Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor, MPF; Mesothelin, cleaved form ]" MSLN MPF Homo sapiens (Human) cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; pancreas development [GO:0031016] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; pancreas development [GO:0031016] GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0007155; GO:0007160; GO:0009986; GO:0016020; GO:0031016; GO:0031225 QLDVLYPK 4.409999847 0.399064809 0.399064809 0.244416989 976.4918283 15.91268 15.12912 16.39867 14.70494 14.6638 14.78362 14.04679 15.80544 0 0 14.94291 14.54218 14.79138 14.83686 0 13.82292 13.32763 15.68502 15.26485 16.87001 0 0 14.95647 14.3637 15.7913 15.01697 0 0 0 14.74511 16.79724 13.46384 0 0 16.1475 15.18918 0 15.05472 0 15.88754 0 0 0 15.99308 14.75959 0 0 0 Q13423 NNTM_HUMAN "NAD(P) transhydrogenase, mitochondrial, EC 7.1.1.1 (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)" NNT Homo sapiens (Human) NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099] NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661] GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0016020; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600 APVKPGIPYK 10.67000008 1 1 0.162557231 1068.951154 15.74537 0 14.80093 15.32823 14.30645 0 15.52586 12.33258 0 15.11674 0 15.2899 0 0 0 0 0 0 0 0 0 0 17.41932 0 0 0 0 0 0 0 0 0 0 0 0 16.00389 0 0 0 0 14.65538 0 0 0 0 0 0 0 Q13427 PPIG_HUMAN "Peptidyl-prolyl cis-trans isomerase G, PPIase G, Peptidyl-prolyl isomerase G, EC 5.2.1.8 (CASP10) (Clk-associating RS-cyclophilin, CARS-Cyp, CARS-cyclophilin, SR-cyclophilin, SR-cyp, SRcyp) (Cyclophilin G) (Rotamase G)" PPIG Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723] GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231 DFMVQGGDFSEGNGRGGESIYGGFFEDESFAVK 6.320000172 0.415827721 0.415827721 0.185390758 3552.524178 15.50797 15.30515 0 12.92224 11.03824 0 0 0 12.42556 0 0 0 0 10.50377 14.50657 0 0 0 0 0 0 0 12.77335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.524495 13.58534 0 0 0 14.36029 0 0 0 Q13428 TCOF_HUMAN Treacle protein (Treacher Collins syndrome protein) TCOF1 Homo sapiens (Human) neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; transporter activity [GO:0005215]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501] protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; transporter activity [GO:0005215] GO:0001501; GO:0001650; GO:0003723; GO:0005215; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0014029; GO:0014032; GO:0030674; GO:0042790; GO:0046982; GO:0097110 AALAPAK 3.670000076 1 1 0.126202725 639.9800271 15.46075 0 0 0 0 0 0 0 0 0 0 0 0 16.12891 0 16.4115 0 0 0 0 16.26392 0 0 0 0 0 0 0 16.01631 0 16.79413 15.29323 0 14.56514 0 0 15.55482 0 0 0 17.5331 0 15.60882 0 0 0 0 13.70813 Q13434 MKRN4_HUMAN "Putative E3 ubiquitin-protein ligase makorin-4, EC 2.3.2.27 (Makorin RING finger protein pseudogene 4) (Makorin RING finger protein pseudogene 5) (RING finger protein 64) (RING-type E3 ubiquitin transferase makorin-4) (Zinc finger protein 127-Xp, ZNF127-Xp) (Zinc finger protein 127-like 1)" MKRN4P MKRN4 MKRNP5 RNF64 ZNF127L1 Homo sapiens (Human) protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0016567; GO:0046872; GO:0061630 QEEATATELTTK 3.460000038 0.632642329 0.632642329 0.30890583 1317.311295 15.03795 15.87587 18.03634 14.78952 12.45787 0 9.146317 15.48571 13.6896 14.97751 15.10898 15.35503 0 15.81164 0 0 0 0 16.22423 14.43691 0 15.77401 0 0 16.69021 0 15.56099 0 15.20388 0 0 0 0 0 0 0 0 0 0 15.19366 0 0 0 0 0 0 0 16.42974 Q13435 SF3B2_HUMAN "Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit, SF3b145) (Spliceosome-associated protein 145, SAP 145)" SF3B2 SAP145 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0016607; GO:0071005; GO:0071011; GO:0071013 LHDAFFKWQTKPK 4.579999924 1 1 2.75E-12 1645.879542 15.08273 0 13.3993 14.84015 15.36193 15.10337 14.35212 0 0 0 15.90575 12.34958 13.18845 0 11.81471 0 15.274 0 0 0 0 0 12.91834 0 0 12.13831 15.02924 15.81055 0 14.80493 15.55304 0 0 0 0 0 0 0 0 15.12716 0 15.25109 0 0 0 0 0 0 Q13439 GOGA4_HUMAN Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230) GOLGA4 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; small GTPase binding [GO:0031267]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192] GTPase binding [GO:0051020]; small GTPase binding [GO:0031267] GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0016192; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020; GO:0070062 EAAISSLR 7.920000076 1 1 0.18684387 845.4576349 15.35568 0 0 0 0 0 14.0379 13.32646 12.68558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13442 HAP28_HUMAN "28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein, PAP) (PDGFA-associated protein 1, PAP1)" PDAP1 HASPP28 Homo sapiens (Human) signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; signal transduction [GO:0007165] RNA binding [GO:0003723] GO:0003723; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:1904813 MHLAGK 1.120000005 1 1 0.159006488 656.406021 15.32219 0 14.13606 0 0 0 15.25456 0 0 16.06381 13.22566 0 15.20128 0 16.53965 0 0 14.57975 0 0 16.22171 0 0 0 0 0 0 0 0 0 15.15454 0 0 0 0 16.93512 0 16.25101 0 0 0 0 0 0 0 0 0 15.68324 Q13443 ADAM9_HUMAN "Disintegrin and metalloproteinase domain-containing protein 9, ADAM 9, EC 3.4.24.- (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)" ADAM9 KIAA0021 MCMP MDC9 MLTNG Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233]; collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124] GO:0004222; GO:0005080; GO:0005178; GO:0005518; GO:0005615; GO:0005925; GO:0006509; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008237; GO:0009986; GO:0010042; GO:0016021; GO:0016477; GO:0016485; GO:0017124; GO:0030216; GO:0030335; GO:0031233; GO:0031293; GO:0033627; GO:0033630; GO:0033631; GO:0034241; GO:0034612; GO:0042117; GO:0042542; GO:0042987; GO:0043236; GO:0043406; GO:0046872; GO:0050714; GO:0051044; GO:0051384; GO:0051549; GO:0051592; GO:0070062; GO:0071222; GO:1902945 DLLPEDFVVYTYNK 2.549999952 0.079339616 0.079339616 4.56E-13 1717.051675 14.62201 14.06615 15.19156 0 16.06593 0 0 15.16442 0 0 0 14.57497 0 0 0 0 16.2874 13.89353 17.45216 0 12.8139 0 17.59074 14.13727 0 0 0 0 0 13.38639 15.05122 0 15.0475 13.02775 0 0 17.93669 0 16.68221 15.7803 0 0 0 0 15.3807 0 15.15077 16.25117 Q13445 TMED1_HUMAN "Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1, Tp24, p24gamma1)" TMED1 IL1RL1L IL1RL1LG Homo sapiens (Human) cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165] signaling receptor binding [GO:0005102] GO:0005102; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0007165; GO:0007267; GO:0016021; GO:0030134; GO:0033116 NLQEGNLER 6.260000229 1 1 0.081946747 1073.308099 0 10.43294 15.88032 13.99102 16.97544 13.70796 14.11932 14.98376 14.58384 15.50319 0 14.10182 15.39149 0 11.7176 15.01488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.40272 0 0 0 0 0 0 0 0 Q13449 LSAMP_HUMAN "Limbic system-associated membrane protein, LSAMP (IgLON family member 3)" LSAMP IGLON3 LAMP Homo sapiens (Human) cell adhesion [GO:0007155]; nervous system development [GO:0007399] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; nervous system development [GO:0007399] GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0007399; GO:0031225 HLTPTGR 9.699999809 1 1 0.305647824 781.7064589 15.74301 17.62641 0 0 0 18.1695 0 0 17.78034 18.03849 0 17.6468 0 16.58251 0 0 0 0 0 0 16.72799 18.8301 0 17.63251 17.8122 0 0 0 0 0 0 0 18.97072 17.67477 19.88098 0 16.61873 18.08628 19.03423 0 0 0 0 0 17.02594 17.88468 0 18.16502 Q13451 FKBP5_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP5, PPIase FKBP5, EC 5.2.1.8 (51 kDa FK506-binding protein, 51 kDa FKBP, FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5, FKBP-5) (FKBP54, p54) (HSP90-binding immunophilin) (Rotamase)" FKBP5 AIG6 FKBP51 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617] FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0000413; GO:0003755; GO:0005528; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0009617; GO:0016020; GO:0031072; GO:0061077; GO:0070062 LQISMCQK 6.110000134 1 1 0.149957573 1008.45766 13.75526 0 0 0 0 0 0 15.30532 0 0 15.26772 0 0 0 0 0 0 0 0 0 14.95868 0 0 13.4524 0 0 0 0 13.8592 0 0 14.01253 0 0 14.87186 0 0 0 15.07612 0 0 0 0 0 15.06157 0 0 0 Q13454 TUSC3_HUMAN "Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3, Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)" TUSC3 N33 Homo sapiens (Human) cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085] magnesium ion transmembrane transporter activity [GO:0015095] GO:0005739; GO:0005789; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0018279; GO:0050890; GO:0055085 ENLLAEK 21.07999992 1.23E-05 1.23E-05 0.255372311 815.6149896 0 18.17075 19.16272 0 0 18.82667 20.51067 20.25373 0 19.63844 0 18.40676 0 0 19.37134 17.73226 0 19.70794 17.49251 0 18.20327 20.60297 0 19.0176 20.50087 20.38181 19.90574 18.91854 0 0 21.81751 17.79106 21.76125 0 0 19.91964 17.21062 20.82137 21.18775 20.01738 19.38895 18.43753 19.61944 19.97467 16.91296 0 0 19.22841 Q13459 MYO9B_HUMAN Unconventional myosin-IXb (Unconventional myosin-9b) MYO9B MYR5 Homo sapiens (Human) actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267]; actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267] GO:0000146; GO:0003779; GO:0005096; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005884; GO:0005938; GO:0007266; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0031267; GO:0035023; GO:0035385; GO:0043531; GO:0046872; GO:0048471; GO:0048495; GO:0051056 EAGSSGRR 11.22000027 0.288480133 0.288480133 0.299099876 817.8333462 14.32056 0 15.96744 0 0 0 16.84498 16.30559 14.90198 0 0 0 17.17137 16.89029 17.97577 17.58023 16.95209 18.10577 0 17.90709 17.70606 17.80501 0 15.09372 17.54492 16.93866 18.29054 15.76661 15.34529 17.57436 17.0928 15.24131 18.76279 17.56909 16.77721 17.72707 19.00094 16.68064 19.33938 18.3024 16.55601 15.3113 17.28981 15.39224 17.02668 18.3138 16.43632 18.42076 Q13464 ROCK1_HUMAN "Rho-associated protein kinase 1, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I, ROCK-I) (p160 ROCK-1, p160ROCK)" ROCK1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; glomerular visceral epithelial cell migration [GO:0090521]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939] bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774] bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; glomerular visceral epithelial cell migration [GO:0090521]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939] aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0000139; GO:0000281; GO:0001726; GO:0001837; GO:0003180; GO:0003383; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005576; GO:0005737; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0006939; GO:0007159; GO:0007165; GO:0007249; GO:0007266; GO:0010494; GO:0010506; GO:0010508; GO:0010613; GO:0010628; GO:0010922; GO:0016525; GO:0018105; GO:0018107; GO:0019828; GO:0022614; GO:0030027; GO:0030036; GO:0030155; GO:0030334; GO:0030866; GO:0031032; GO:0031175; GO:0031267; GO:0032059; GO:0032060; GO:0032091; GO:0032956; GO:0034774; GO:0035306; GO:0035509; GO:0042326; GO:0043410; GO:0043524; GO:0045616; GO:0045664; GO:0046872; GO:0048156; GO:0048598; GO:0050321; GO:0050900; GO:0050901; GO:0051045; GO:0051451; GO:0051492; GO:0051893; GO:0051894; GO:0061157; GO:0070168; GO:0070507; GO:0071559; GO:0072518; GO:0072659; GO:0090521; GO:0097746; GO:0106310; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1901888; GO:1902003; GO:1902430; GO:1902992; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000114; GO:2000145 EEEISNLKAAFEK 5.010000229 0.87825948 0.87825948 0.117268153 1505.27137 0 0 0 0 0 16.42419 14.5066 0 12.84794 0 0 0 0 0 0 0 0 0 0 0 0 0 14.76907 13.90609 15.79418 15.72939 17.2917 0 0 0 0 0 11.88319 0 0 0 0 16.20992 16.09618 0 0 0 0 0 0 0 0 0 Q13472 TOP3A_HUMAN "DNA topoisomerase 3-alpha, EC 5.6.2.1 (DNA topoisomerase III alpha)" TOP3A TOP3 Homo sapiens (Human) chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; resolution of recombination intermediates [GO:0071139] mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RecQ family helicase-topoisomerase III complex [GO:0031422] "mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RecQ family helicase-topoisomerase III complex [GO:0031422]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; resolution of recombination intermediates [GO:0071139]" "DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]" GO:0000724; GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005759; GO:0006265; GO:0008270; GO:0016605; GO:0031422; GO:0032042; GO:0051304; GO:0051321; GO:0071139 NDAAKGIADLLSNGR 3.609999895 0.014115586 0.014115586 0.219434346 1518.416986 14.167 13.96496 0 0 0 0 0 15.38051 0 0 15.08881 0 0 0 16.62887 14.07973 14.50793 14.19483 15.74353 0 0 11.7244 16.03231 14.1255 0 0 14.51445 15.52665 0 0 13.27667 15.15149 0 0 0 0 0 0 0 0 15.36341 15.8691 16.66967 14.87942 0 0 0 0 Q13474 DRP2_HUMAN "Dystrophin-related protein 2, DRP-2" DRP2 Homo sapiens (Human) central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536] zinc ion binding [GO:0008270] GO:0005886; GO:0007417; GO:0008270; GO:0014069; GO:0030425; GO:0043204; GO:0050808; GO:0098978; GO:0099536 VTIAEQVKHQTK 14.31000042 1 1 0.152700347 1381.13485 13.42433 13.31276 13.04418 0 0 0 0 15.79542 0 0 0 0 0 0 15.96963 0 0 0 0 0 0 0 0 0 0 0 0 15.30979 12.80637 0 0 15.77235 0 15.60019 16.04396 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13480 GAB1_HUMAN GRB2-associated-binding protein 1 (GRB2-associated binder 1) (Growth factor receptor bound protein 2-associated protein 1) GAB1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; endothelial cell chemotaxis to vascular endothelial growth factor [GO:0090668]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; response to hepatocyte growth factor [GO:0035728]; vascular endothelial growth factor signaling pathway [GO:0038084] cell-cell junction [GO:0005911]; cytosol [GO:0005829] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; endothelial cell chemotaxis to vascular endothelial growth factor [GO:0090668]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; response to hepatocyte growth factor [GO:0035728]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001525; GO:0005829; GO:0005911; GO:0007173; GO:0008286; GO:0031532; GO:0035728; GO:0038084; GO:0038089; GO:0045766; GO:0090668 SSGSGSSVADER 19.48999977 1 1 0.29650184 1137.68038 0 0 0 0 0 0 11.23531 15.36234 15.54401 14.63503 14.84566 14.996 0 15.62744 15.12984 14.68334 15.69528 15.19391 0 17.89826 18.89818 0 0 15.76329 17.6679 18.69469 17.14514 15.34535 15.38476 16.78918 0 17.98591 0 18.57576 18.25454 0 20.0561 19.57298 0 19.51539 19.39701 19.32121 19.34402 18.59147 18.89766 19.55849 16.15896 19.41177 Q13488 VPP3_HUMAN "V-type proton ATPase 116 kDa subunit a 3, V-ATPase 116 kDa subunit a 3 (Osteoclastic proton pump 116 kDa subunit, OC-116 kDa, OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein, TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)" TCIRG1 ATP6N1C ATP6V0A3 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035] "apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035]" "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]" GO:0000045; GO:0000220; GO:0001503; GO:0002158; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0007042; GO:0008284; GO:0010008; GO:0010155; GO:0010272; GO:0010467; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030010; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0031529; GO:0033176; GO:0033365; GO:0035709; GO:0035711; GO:0043029; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0051650; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600 GSMFRSEEVALVQLFLPTAAAYTCVSR 7.860000134 1 1 4.57E-12 3018.721016 0 16.66955 0 0 16.01412 0 10.36513 0 13.88381 11.93619 0 13.20584 13.00862 11.97204 0 0 0 0 0 0 14.15518 0 0 0 0 15.17078 15.48734 13.50327 0 0 0 0 0 0 0 0 0 0 0 0 15.0957 0 13.48651 15.40538 12.68707 0 15.2149 0 Q13489 BIRC3_HUMAN "Baculoviral IAP repeat-containing protein 3, EC 2.3.2.27 (Apoptosis inhibitor 2, API2) (Cellular inhibitor of apoptosis 2, C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1, hIAP-1, hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)" BIRC3 API2 MIHC RNF49 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0007283; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0044877; GO:0045088; GO:0045121; GO:0046872; GO:0050727; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070424; GO:2000116 ANQDFSALMR 7.340000153 1 1 0.207916358 1167.866022 0 0 0 0 0 0 0 15.07373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.53485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6534 0 0 Q13490 BIRC2_HUMAN "Baculoviral IAP repeat-containing protein 2, EC 2.3.2.27 (Cellular inhibitor of apoptosis 1, C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2, hIAP-2, hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)" BIRC2 API1 MIHB RNF48 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741] CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209] chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377 NLFVDKNMK 11.88000011 1 1 0.068550489 1108.325537 14.96108 16.30565 16.57979 0 0 13.48264 13.9659 0 0 15.1194 0 15.83463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13495 MAMD1_HUMAN Mastermind-like domain-containing protein 1 (F18) (Protein CG1) MAMLD1 CG1 CXorf6 Homo sapiens (Human) male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005654; GO:0005794; GO:0005813; GO:0006357; GO:0008584; GO:0016604 AWRQVPAPLLPSCDATAR 3.440000057 1 1 0 2008.884224 0 0 0 0 0 0 0 0 15.05202 0 0 0 13.06292 14.06188 0 0 0 0 12.73914 13.45778 0 0 14.34778 15.77381 0 0 0 0 0 0 12.96075 14.99624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13496 MTM1_HUMAN "Myotubularin (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTM1 CG2 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]" "intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]" GO:0001726; GO:0004438; GO:0004721; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008333; GO:0015031; GO:0019215; GO:0030175; GO:0031674; GO:0032007; GO:0032435; GO:0035091; GO:0044088; GO:0045109; GO:0046716; GO:0046856; GO:0048311; GO:0048633; GO:0051898; GO:0052629; GO:0070584; GO:1902902 GRVYITNYR 2.25 0.744905531 0.744905531 0.242329106 1141.928217 13.64638 14.91016 14.09028 15.51452 0 16.18847 0 0 14.8247 12.43201 0 13.28877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.70347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.05333 0 0 0 0 0 0 Q13505 MTX1_HUMAN Metaxin-1 (Mitochondrial outer membrane import complex protein 1) MTX1 MTX MTXN Homo sapiens (Human) inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401]; inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040] GO:0001401; GO:0005737; GO:0005741; GO:0007005; GO:0007007; GO:0007595; GO:0016021; GO:0045040; GO:0140275 LLGGPPR 4.480000019 1 1 0.114281102 710.5212061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.15245 0 0 0 0 0 0 0 0 0 17.54947 0 17.78204 0 16.47715 0 0 17.15034 17.47034 0 0 0 0 0 0 0 0 0 Q13507 TRPC3_HUMAN "Short transient receptor potential channel 3, TrpC3 (Transient receptor protein 3, TRP-3, hTrp-3, hTrp3)" TRPC3 TRP3 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338] cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]" "calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244 LANIEK 3.420000076 1 1 0.075292813 686.6019617 15.73714 12.16498 0 18.40331 0 0 14.59734 14.56112 15.99589 0 0 13.99871 0 11.54006 0 16.20466 16.72024 0 14.01168 0 0 0 16.40966 11.80515 0 0 0 0 0 13.49981 17.31675 0 15.46523 16.77119 15.40231 0 0 15.05074 17.05123 0 0 17.3466 0 0 0 0 14.01269 0 Q13508 NAR3_HUMAN "Ecto-ADP-ribosyltransferase 3, EC 2.4.2.31 (ADP-ribosyltransferase C2 and C3 toxin-like 3, ARTC3) (Mono(ADP-ribosyl)transferase 3) (NAD(P)(+)--arginine ADP-ribosyltransferase 3)" ART3 TMART Homo sapiens (Human) peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NADP+-protein-arginine ADP-ribosyltransferase activity [GO:0106275]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NADP+-protein-arginine ADP-ribosyltransferase activity [GO:0106275] GO:0003950; GO:0005576; GO:0005886; GO:0006471; GO:0018120; GO:0031225; GO:0031226; GO:0070062; GO:0106274; GO:0106275 TQIFLPMNFK 5.739999771 1 1 0.179413372 1238.857543 0 11.77949 14.49056 0 0 0 16.49282 0 14.13241 0 15.33663 14.79022 0 0 0 0 0 0 14.38497 0 0 0 0 0 0 16.31597 16.25655 0 0 16.63161 0 0 0 0 0 0 0 0 0 14.48113 0 15.7336 0 0 0 0 0 17.03293 Q13515 BFSP2_HUMAN "Phakinin (49 kDa cytoskeletal protein) (Beaded filament structural protein 2) (Lens fiber cell beaded filament protein CP 47, CP47) (Lens fiber cell beaded filament protein CP 49, CP49) (Lens intermediate filament-like light, LIFL-L)" BFSP2 Homo sapiens (Human) cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; response to stimulus [GO:0050896]; visual perception [GO:0007601] structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212] GO:0005200; GO:0005212; GO:0005856; GO:0005882; GO:0005886; GO:0005938; GO:0007601; GO:0045109; GO:0048469; GO:0050896; GO:0070307 AHLLAR 22.77000046 0.214761347 0.214761347 0.018164733 679.4629593 0 20.24072 20.04775 20.19418 21.21476 20.42071 20.6992 0 19.07105 21.18272 20.03892 19.14118 0 20.34567 20.57897 0 19.61736 19.46073 0 0 0 0 0 19.60399 19.30084 19.86255 0 19.68776 0 19.55117 19.95271 18.43375 19.78937 19.41177 20.13346 18.61513 0 0 19.63367 18.94691 20.07505 0 20.18968 20.47891 19.42604 19.36489 20.23854 19.06649 Q13520 AQP6_HUMAN "Aquaporin-6, AQP-6 (Aquaporin-2-like) (Kidney-specific aquaporin, hKID)" AQP6 AQP2L Homo sapiens (Human) carbon dioxide transport [GO:0015670]; odontogenesis [GO:0042476]; renal water transport [GO:0003097]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; odontogenesis [GO:0042476]; renal water transport [GO:0003097]; water transport [GO:0006833] nitrate transmembrane transporter activity [GO:0015112]; water channel activity [GO:0015250] GO:0003097; GO:0005886; GO:0006833; GO:0015112; GO:0015250; GO:0015670; GO:0016021; GO:0016324; GO:0030659; GO:0042476 ETLGINVVR 5.269999981 1 1 0.176793919 1000.743123 0 17.15566 0 0 17.77326 14.51403 0 14.00494 0 0 15.24685 13.00192 14.44729 0 0 0 0 0 0 0 0 17.02505 0 0 0 0 0 0 0 0 0 0 0 0 15.66153 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13522 PPR1A_HUMAN "Protein phosphatase 1 regulatory subunit 1A (Protein phosphatase inhibitor 1, I-1, IPP-1)" PPP1R1A IPP1 Homo sapiens (Human) glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556] protein serine/threonine phosphatase inhibitor activity [GO:0004865] GO:0004865; GO:0005737; GO:0005977; GO:0035556 ITPTMK 2.75999999 0.417607158 0.417607158 0.145623344 691.3265959 17.06451 17.08771 0 0 0 0 0 0 0 0 0 0 0 0 17.81719 0 0 0 0 0 18.23993 0 0 16.74379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13523 PRP4B_HUMAN "Serine/threonine-protein kinase PRP4 homolog, EC 2.7.11.1 (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog)" PRPF4B KIAA0536 PRP4 PRP4H PRP4K Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]" catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]" ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005694; GO:0006468; GO:0008380; GO:0016607; GO:0045292; GO:0071013; GO:0106310 SSSTK 6.449999809 0.36381796 0.36381796 0.276412559 510.4376635 0 0 15.2088 17.58433 0 0 0 0 0 15.98001 16.72167 13.98451 16.43645 21.70251 0 0 0 13.07654 0 0 0 0 16.6034 0 0 16.23717 19.79429 0 0 0 17.20133 0 0 0 0 0 21.87134 0 0 0 16.03841 0 15.03679 0 0 16.05751 0 0 Q13535 ATR_HUMAN "Serine/threonine-protein kinase ATR, EC 2.7.11.1 (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)" ATR FRP1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of double-strand break repair [GO:2000779]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to arsenic-containing substance [GO:0046685]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]" ATR-ATRIP complex [GO:0070310]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "ATR-ATRIP complex [GO:0070310]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of double-strand break repair [GO:2000779]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to arsenic-containing substance [GO:0046685]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]" ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000077; GO:0000723; GO:0003677; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006139; GO:0006260; GO:0006281; GO:0006468; GO:0006974; GO:0007275; GO:0008156; GO:0009410; GO:0016605; GO:0018105; GO:0031297; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0036297; GO:0043517; GO:0046685; GO:0046777; GO:0070198; GO:0070310; GO:0071480; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1904884; GO:2000779 CPHSK 7.840000153 1 1 0.094290264 624.6143262 16.61443 16.24302 13.16223 18.76237 0 12.71729 0 16.56268 13.86326 14.20853 0 0 0 15.42407 0 0 13.55852 15.84167 14.50037 0 16.23112 0 16.017 15.31722 14.56807 13.56427 0 12.34089 0 15.37717 13.43414 0 15.22389 15.86719 15.19793 0 0 0 15.54161 16.11088 13.87458 0 17.11715 13.52066 15.70253 0 15.79569 0 Q13541 4EBP1_HUMAN "Eukaryotic translation initiation factor 4E-binding protein 1, 4E-BP1, eIF4E-binding protein 1 (Phosphorylated heat- and acid-stable protein regulated by insulin 1, PHAS-I)" EIF4EBP1 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929] eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371] GO:0000082; GO:0005737; GO:0005829; GO:0008190; GO:0030371; GO:0031929; GO:0045931; GO:0045947 SGGSSCSQTPSR 2.019999981 0.848240256 0.848240256 0.437912891 1207.043441 20.07094 0 0 18.06987 0 0 0 0 19.6149 18.15903 17.48381 0 0 0 0 0 18.5879 18.48686 0 0 0 0 18.22668 0 0 0 18.57112 0 0 0 0 0 19.33314 20.34833 21.10911 0 0 18.56512 0 0 0 0 0 0 0 18.6464 0 0 Q13547 HDAC1_HUMAN "Histone deacetylase 1, HD1, EC 3.5.1.98 (Protein deacetylase HDAC1, EC 3.5.1.-) (Protein decrotonylase HDAC1, EC 3.5.1.-)" HDAC1 RPD3L1 Homo sapiens (Human) "cellular response to platelet-derived growth factor stimulus [GO:0036120]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of amyloid-beta clearance [GO:1900221]; regulation of cell fate specification [GO:0042659]; regulation of endopeptidase activity [GO:0052548]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; Krueppel-associated box domain binding [GO:0035851]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of amyloid-beta clearance [GO:1900221]; regulation of cell fate specification [GO:0042659]; regulation of endopeptidase activity [GO:0052548]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]" core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; Krueppel-associated box domain binding [GO:0035851]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] GO:0000118; GO:0000122; GO:0000785; GO:0000792; GO:0000978; GO:0000979; GO:0001046; GO:0001222; GO:0002039; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006338; GO:0006346; GO:0006357; GO:0006476; GO:0007492; GO:0008284; GO:0009913; GO:0010628; GO:0010629; GO:0016575; GO:0016580; GO:0016581; GO:0017053; GO:0019213; GO:0019899; GO:0021766; GO:0030182; GO:0030336; GO:0030512; GO:0032922; GO:0032991; GO:0033558; GO:0035851; GO:0036120; GO:0042475; GO:0042659; GO:0042733; GO:0042826; GO:0043025; GO:0043066; GO:0043124; GO:0043922; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0048661; GO:0048714; GO:0051059; GO:0052548; GO:0060766; GO:0060789; GO:0061029; GO:0061198; GO:0061629; GO:0070888; GO:0070932; GO:0070933; GO:0090090; GO:0140297; GO:0160009; GO:1900221; GO:1902455; GO:1902459; GO:1990841; GO:2000273; GO:2000736; GO:2001243 VMTVSFHK 12.80000019 0.428011984 0.428011984 0.181418298 966.5673798 0 15.08894 15.09189 0 0 0 16.60533 0 15.42413 0 15.42169 16.88264 16.70699 16.34007 16.05016 16.94802 15.99783 16.30895 0 15.99587 0 0 15.99439 15.80645 16.20832 16.22571 15.86058 16.14408 15.16315 15.55912 16.23397 14.8605 15.59745 0 15.24761 0 0 0 14.0775 15.42786 13.39212 0 12.61704 13.52277 14.74911 13.47138 0 14.73736 Q13555 KCC2G_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit gamma, CaM kinase II subunit gamma, CaMK-II subunit gamma, EC 2.7.11.17" CAMK2G CAMK CAMK-II CAMKG Homo sapiens (Human) cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004683; GO:0004712; GO:0004723; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005954; GO:0007399; GO:0010975; GO:0014733; GO:0016020; GO:0030073; GO:0030154; GO:0030666; GO:0033017; GO:0042802; GO:0042803; GO:0043005; GO:0051924; GO:0106310 GAILTTMLVSRNFSAAK 1.320000052 1 1 1.83E-12 1795.334712 0 14.25372 14.42708 0 0 14.44954 0 14.42131 12.51289 0 0 14.60108 0 15.13216 0 15.5242 0 0 0 0 0 15.76779 15.81033 0 0 14.36377 17.54168 0 0 11.58739 16.45395 15.09212 14.195 0 16.29123 0 14.47747 15.15675 0 12.57881 14.47716 0 0 15.27204 0 16.82598 0 0 Q13557 KCC2D_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit delta, CaM kinase II subunit delta, CaMK-II subunit delta, EC 2.7.11.17" CAMK2D CAMKD Homo sapiens (Human) cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of histone deacetylase activity [GO:1901725]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of histone deacetylase activity [GO:1901725]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325] GO:0001558; GO:0002026; GO:0003254; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005954; GO:0006357; GO:0006468; GO:0008016; GO:0010613; GO:0010649; GO:0010666; GO:0010880; GO:0010881; GO:0016020; GO:0018105; GO:0018107; GO:0019871; GO:0030666; GO:0031432; GO:0032469; GO:0033017; GO:0042383; GO:0042802; GO:0042803; GO:0043005; GO:0044325; GO:0046777; GO:0055119; GO:0060314; GO:0060341; GO:0071277; GO:0086003; GO:0086091; GO:0098901; GO:0098909; GO:0106310; GO:1901725; GO:1901844; GO:1901897; GO:1902306; GO:1902514; GO:2000650 SKGAAVK 2.859999895 1 1 0.130088269 661.3425027 0 12.56515 0 0 17.56273 0 0 0 17.86989 16.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.24597 18.50072 13.68016 0 0 0 0 17.50776 0 0 0 0 0 0 0 0 0 0 0 17.63321 0 0 Q13564 ULA1_HUMAN "NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa, APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)" NAE1 APPBP1 HPP1 Homo sapiens (Human) mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165] NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625] GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0019781; GO:0031625; GO:0032446; GO:0032991; GO:0033314; GO:0042981; GO:0043523; GO:0045116; GO:0046982; GO:0051402 GTIPDMIADSGKYIK 1.889999986 1 1 0.03692039 1624.356208 16.26831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13568 IRF5_HUMAN "Interferon regulatory factor 5, IRF-5" IRF5 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0006954; GO:0019221; GO:0019901; GO:0032481; GO:0032494; GO:0032495; GO:0032727; GO:0032728; GO:0032735; GO:0042802; GO:0043065; GO:0043565; GO:0045087; GO:0045944; GO:0051607; GO:1990837 MNQSIPVAPTPPRR 3.380000114 1 1 0.314071414 1562.969939 0 0 0 13.93313 0 0 0 0 0 0 0 0 0 0 0 16.32326 0 0 0 0 0 0 0 14.20311 0 0 16.21283 0 0 0 0 0 0 0 0 0 0 17.07915 0 0 0 0 16.95827 0 0 0 0 15.38191 Q13572 ITPK1_HUMAN "Inositol-tetrakisphosphate 1-kinase, EC 2.7.1.134 (Inositol 1,3,4-trisphosphate 5/6-kinase, Inositol-triphosphate 5/6-kinase, Ins(1,3,4)P(3) 5/6-kinase, EC 2.7.1.159)" ITPK1 Homo sapiens (Human) blood coagulation [GO:0007596]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; cytosol [GO:0005829] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; blood coagulation [GO:0007596]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165]" "ATP binding [GO:0005524]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]" GO:0000287; GO:0000825; GO:0003824; GO:0005524; GO:0005829; GO:0007165; GO:0007596; GO:0016324; GO:0016787; GO:0016853; GO:0021915; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266 AEADAGGTAK 9.140000343 1 1 0.034235768 887.805867 13.8242 0 0 0 0 14.5919 15.68766 14.62221 0 15.58983 0 0 0 14.16656 16.71863 0 0 0 0 0 0 0 0 0 0 15.53531 0 0 0 0 0 0 0 0 0 0 15.05397 0 0 0 0 14.61837 0 0 0 0 0 0 Q13586 STIM1_HUMAN Stromal interaction molecule 1 STIM1 GOK Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020] GO:0002020; GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006874; GO:0030176; GO:0032237; GO:0032541; GO:0033017; GO:0042802; GO:0044853; GO:0045762; GO:0045766; GO:0051010; GO:0051924; GO:0070166; GO:2001256 QLLVAK 8.350000381 1 1 0.197184177 671.5308981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.84441 0 0 0 0 0 0 0 0 17.93755 0 0 0 0 0 0 0 0 0 18.2394 0 0 16.97256 0 0 0 0 Q13608 PEX6_HUMAN "Peroxisome assembly factor 2, PAF-2 (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)" PEX6 PXAAA1 Homo sapiens (Human) "peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0044877; GO:0050821; GO:0097733 KFAAC 10.93999958 0.258877218 0.258877218 0.190621438 595.4405088 16.10456 15.87054 15.93712 15.61607 16.88646 16.32662 12.95236 14.80205 15.33444 15.48571 0 16.62087 14.60153 16.87198 16.5745 0 16.65698 16.55874 16.96553 17.02992 0 16.63682 16.03366 16.51835 16.52353 15.41645 17.36114 16.236 17.17925 15.85186 0 13.86055 17.09046 17.51874 0 16.94259 17.46328 16.94649 18.45307 16.08368 17.61034 17.54497 17.10563 17.17866 16.19382 0 18.06591 17.30193 Q13614 MTMR2_HUMAN "Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR2 KIAA1073 Homo sapiens (Human) dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]" "identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]" GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645 EDEKYLQAIMDSNAQSHK 5.210000038 1 1 1.38E-12 2101.385075 13.53891 16.15454 0 12.44137 15.34103 14.80651 0 11.95175 0 0 14.09461 0 0 0 0 0 0 13.83392 0 0 0 0 0 14.56885 12.89427 0 0 0 14.35323 14.41303 0 15.8706 13.10167 0 0 0 12.09112 0 0 0 0 14.93666 0 0 0 0 0 0 Q13615 MTMR3_HUMAN "Myotubularin-related protein 3, EC 3.1.3.48 (FYVE domain-containing dual specificity protein phosphatase 1, FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)" MTMR3 KIAA0371 ZFYVE10 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]" "metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]" GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785 QLSAMSCSSAHLHSRNLHHK 2.75999999 1 1 0.154412286 2317.969899 15.00064 16.23569 0 15.55075 0 0 0 11.75658 14.8155 0 0 0 0 0 0 0 0 15.53981 0 0 13.70193 0 0 14.89318 0 14.14004 12.32425 0 14.67546 13.47885 0 11.22691 15.49663 0 8.450513 0 0 0 0 0 14.08763 14.574 0 11.62077 0 0 0 0 Q13616 CUL1_HUMAN "Cullin-1, CUL-1" CUL1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] GO:0000082; GO:0005654; GO:0005829; GO:0005886; GO:0006513; GO:0008283; GO:0009887; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031625; GO:0070936; GO:0097193; GO:1990452 FINNNAVTK 11.96000004 1 1 0.002985093 1019.486822 15.8834 14.11337 16.21312 0 14.74838 17.00471 17.40596 0 0 16.49301 15.40993 0 15.85143 16.72259 0 0 15.49475 0 17.01579 0 0 0 16.58256 16.6773 0 0 0 16.75639 16.25017 0 0 0 0 0 17.92405 17.67572 0 19.24855 16.16919 17.22624 0 17.19017 0 0 17.89642 0 0 17.24234 Q13617 CUL2_HUMAN "Cullin-2, CUL-2" CUL2 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891] Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] GO:0000082; GO:0005654; GO:0005730; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0044877; GO:0097193 DTPQEMEQTR 5.289999962 1 1 0.192341925 1231.057748 12.97794 0 0 13.40751 0 13.98427 0 0 0 0 0 0 15.08422 13.91965 14.73383 0 0 12.97332 0 14.11008 12.00635 14.37696 0 0 13.54414 0 0 14.11365 0 0 0 0 0 0 13.80409 14.23993 14.60265 0 0 0 11.8106 15.02818 14.45829 0 0 14.5373 0 15.30713 Q13618 CUL3_HUMAN "Cullin-3, CUL-3" CUL3 KIAA0617 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] GO:0000082; GO:0000122; GO:0000209; GO:0000922; GO:0001831; GO:0005112; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0008284; GO:0016020; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070062; GO:0070936; GO:0071630; GO:0072576; GO:0072686; GO:0097193; GO:1901992 EPKSK 3.579999924 1 1 0.276118853 589.119212 18.88385 0 0 0 0 0 0 17.36991 17.6392 0 0 0 0 0 0 0 0 0 0 16.97556 0 19.1228 0 0 18.16207 0 0 0 17.19641 15.22179 0 0 0 18.23628 0 18.82095 0 0 0 0 0 0 0 16.06642 0 0 18.07296 0 Q13619 CUL4A_HUMAN "Cullin-4A, CUL-4A" CUL4A Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019] protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008284; GO:0016567; GO:0030097; GO:0030674; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042254; GO:0043161; GO:0048511; GO:0051246; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819 LHEAVR 3.049999952 0.536819994 0.536819994 0.183201988 723.4654552 0 15.37702 0 0 0 16.4944 16.08072 16.35523 0 0 16.46283 15.09857 0 16.5714 15.45201 15.9397 15.49308 0 0 0 0 17.77132 0 0 15.84188 15.68588 16.60097 15.06933 14.32067 15.49506 0 14.34214 16.5125 0 16.84467 16.88695 17.45765 15.07876 15.98282 13.85321 15.34151 16.62641 15.18821 15.67551 15.75362 15.66283 16.495 16.11287 Q13620 CUL4B_HUMAN "Cullin-4B, CUL-4B" CUL4B KIAA0695 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914] protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] GO:0000082; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0010498; GO:0016567; GO:0030674; GO:0031146; GO:0031175; GO:0031461; GO:0031464; GO:0031465; GO:0031625; GO:0034644; GO:0035518; GO:0042254; GO:0045732; GO:0070062; GO:0070914; GO:0080008; GO:1900087 IMIIFR 23.37999916 0.421558499 0.421558499 0.205259554 796.4536751 15.46363 14.69687 0 12.92286 17.25577 14.24679 14.9472 15.6445 0 17.97898 16.5021 15.34917 16.36615 15.73323 15.88986 12.16017 10.25821 13.77442 0 0 13.01953 16.55907 0 17.01686 15.23988 0 15.77304 13.94578 14.97371 14.51731 16.61606 14.89835 16.13925 15.94073 0 15.67271 15.76206 15.62406 0 0 15.18564 0 0 15.29348 0 15.59887 0 0 Q13621 S12A1_HUMAN Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter) SLC12A1 NKCC2 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725] potassium:chloride symporter activity [GO:0015379]; sodium:potassium:chloride symporter activity [GO:0008511] GO:0005886; GO:0006811; GO:0006884; GO:0008511; GO:0015379; GO:0016020; GO:0016021; GO:0016324; GO:0034220; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:1902476; GO:1990573 EMNSGMAK 7.03000021 0.250868082 0.250868082 0.220051693 901.3938637 14.75072 14.53314 15.45836 15.14328 13.91822 15.12589 15.30394 15.947 0 16.4664 14.70689 16.76246 15.80538 16.20508 0 15.64128 16.03371 0 16.97742 17.21031 15.85664 15.62785 16.12606 16.17492 15.81153 15.30777 16.3699 15.59828 18.16295 17.43851 15.95191 15.99819 17.22643 17.51192 16.7663 15.36926 16.65283 17.31149 18.06074 15.72572 16.21359 15.69753 15.65933 16.96992 16.49226 16.09511 0 0 Q13625 ASPP2_HUMAN "Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein, Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2, 53BP2, p53-binding protein 2, p53BP2)" TP53BP2 ASPP2 BBP Homo sapiens (Human) cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124] GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0017124; GO:0030054; GO:0042802; GO:0045786; GO:0048471; GO:0051059; GO:0072332; GO:1900119 ALKGHVEQK 4.010000229 1 1 0.133706707 1010.128109 0 0 0 0 17.07337 0 0 0 0 0 0 0 14.90318 0 0 16.8467 0 13.00675 0 0 0 0 0 14.37996 19.03211 15.6329 0 0 13.47655 14.81945 16.00167 0 14.29065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13627 DYR1A_HUMAN "Dual specificity tyrosine-phosphorylation-regulated kinase 1A, EC 2.7.12.1 (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog, MNBH, hMNB)" DYRK1A DYRK MNB MNBH Homo sapiens (Human) "amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631] GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0015631; GO:0016607; GO:0018105; GO:0018107; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0033120; GO:0034205; GO:0036289; GO:0038083; GO:0042802; GO:0043518; GO:0043621; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0090312; GO:0106310; GO:1990904 RAGESGHTVADYLK 12.77000046 1 1 0.484954135 1502.43575 0 0 17.76602 0 17.0707 0 0 0 0 19.12153 0 0 0 18.61447 0 0 0 17.87079 0 0 0 20.32942 0 0 0 0 20.15262 0 0 0 15.16457 0 18.57014 17.51313 16.71167 0 0 0 0 0 0 0 19.64495 17.64711 16.74697 0 0 0 Q13630 FCL_HUMAN "GDP-L-fucose synthase, EC 1.1.1.271 (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)" GFUS SDR4E1 TSTA3 Homo sapiens (Human) 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]" "electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]" GO:0005829; GO:0007159; GO:0009055; GO:0010595; GO:0019673; GO:0042351; GO:0042356; GO:0042802; GO:0047918; GO:0050577; GO:0070062; GO:1904906 GEPQGSMRILVTGGSGLVGK 4.360000134 0.760000169 0.760000169 1.38E-12 1942.631175 0 0 0 0 0 0 0 14.83766 14.75327 0 15.52472 0 0 0 0 0 0 0 0 16.26198 0 0 16.69666 16.16946 0 0 0 0 0 0 0 0 15.78133 0 15.88315 0 0 0 16.14045 0 15.91131 0 0 0 0 0 0 0 Q13635 PTC1_HUMAN "Protein patched homolog 1, PTC, PTC1" PTCH1 PTCH Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]" apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]" cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119] GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005634; GO:0005886; GO:0005901; GO:0007224; GO:0007346; GO:0007420; GO:0008158; GO:0008201; GO:0008589; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010875; GO:0014069; GO:0015485; GO:0016021; GO:0016485; GO:0021522; GO:0021532; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030666; GO:0030850; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040015; GO:0042593; GO:0043231; GO:0043433; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045606; GO:0045668; GO:0045879; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0050680; GO:0051782; GO:0060037; GO:0060170; GO:0060603; GO:0060644; GO:0060831; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421 DPPREGLWPPPYRPR 10.09000015 0.794503808 0.794503808 2.06E-12 1833.684513 0 0 0 15.47912 13.24971 14.95853 14.97137 12.59966 15.39623 16.09181 15.49544 0 0 0 0 0 14.18572 0 0 0 0 0 0 12.71582 15.21739 16.25391 0 0 15.59868 0 16.5255 0 0 0 0 15.75529 0 14.68556 0 0 0 0 0 0 0 16.43595 15.93287 0 Q13639 5HT4R_HUMAN "5-hydroxytryptamine receptor 4, 5-HT-4, 5-HT4 (Serotonin receptor 4)" HTR4 Homo sapiens (Human) "adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]" G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007198; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202; GO:0051378 TETKAAK 4.28000021 0.882031322 0.882031322 0.068309042 749.2825367 16.52372 0 12.74472 0 13.24052 16.00822 18.64826 0 0 16.71365 15.74932 0 13.50299 12.56915 12.92077 0 0 0 15.71308 12.86784 16.35791 0 17.39136 0 16.08789 16.81697 0 0 0 16.30552 16.13359 14.91628 18.38307 0 16.41169 14.28866 17.19589 13.20755 16.32201 16.22641 14.51702 13.38025 0 0 0 0 17.25469 0 Q13642 FHL1_HUMAN "Four and a half LIM domains protein 1, FHL-1 (Skeletal muscle LIM-protein 1, SLIM, SLIM-1)" FHL1 SLIM1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016] metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] GO:0003254; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007517; GO:0009887; GO:0010972; GO:0030154; GO:0030308; GO:0043268; GO:0044325; GO:0046872; GO:1901016; GO:2000134 DNPGTTTASTAK 4.269999981 1 1 0.082509642 1163.387778 14.62755 13.9647 14.81569 14.41934 0 15.3388 0 0 14.77268 15.94054 14.44629 14.21447 0 0 13.41358 13.18247 4.663669 13.2653 0 0 14.11288 0 15.00033 0 0 12.97014 0 0 0 0 0 0 0 0 0 0 14.1722 0 0 0 0 0 13.97719 0 0 0 0 0 Q13683 ITA7_HUMAN Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form ] ITGA7 UNQ406/PRO768 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519] integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872] GO:0005178; GO:0005886; GO:0007160; GO:0007229; GO:0007517; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0033627; GO:0034113; GO:0035987; GO:0043236; GO:0046872; GO:0050900; GO:0098609 DSASR 2.690000057 0.296095759 0.296095759 0.272840692 534.8121309 15.35541 0 0 15.80443 15.69515 0 0 15.01173 0 0 16.45167 15.91162 15.71364 0 0 14.45453 0 0 0 0 0 0 0 0 16.41342 15.51644 0 14.93376 0 15.54364 0 0 15.81547 15.37776 0 0 0 0 0 0 15.87506 0 0 16.59875 14.94694 13.55474 16.0843 13.58232 Q13698 CAC1S_HUMAN "Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)" CACNA1S CACH1 CACN1 CACNL1A3 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; muscle contraction [GO:0006936]; positive regulation of muscle contraction [GO:0045933]; regulation of ion transmembrane transport [GO:0034765] cytoplasm [GO:0005737]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891] cytoplasm [GO:0005737]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; muscle contraction [GO:0006936]; positive regulation of muscle contraction [GO:0045933]; regulation of ion transmembrane transport [GO:0034765] calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006936; GO:0008331; GO:0030315; GO:0031674; GO:0034765; GO:0045933; GO:0046872; GO:0070509; GO:0070588; GO:0071313; GO:1990454 SEEEKSTMAK 1.039999962 1 1 0.19930192 1155.490088 0 0 11.01523 15.03104 15.5301 0 11.63381 15.36309 14.71132 14.39921 14.90076 15.75655 0 0 0 0 0 14.92792 15.18491 0 13.56104 0 0 0 0 0 0 14.87035 15.22428 0 0 0 0 16.0602 0 16.12173 14.19715 0 15.51075 15.17078 15.67982 14.21654 15.53694 0 0 0 0 0 Q13702 RAPSN_HUMAN "43 kDa receptor-associated protein of the synapse, RAPsyn (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205)" RAPSN RNF205 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]" centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634] "centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein-membrane adaptor activity [GO:0043495]; chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein-membrane adaptor activity [GO:0043495] GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007268; GO:0007271; GO:0031594; GO:0033130; GO:0035255; GO:0043495; GO:0043525; GO:0046872; GO:0099634; GO:1900075; GO:1901626; GO:1903540 YRAMSQYHMAVAYR 3.339999914 1 1 0.143429501 1779.233974 0 0 14.32194 0 0 0 18.1994 0 0 17.59055 17.42337 17.8257 0 14.57544 16.8987 0 0 15.52719 0 0 15.14075 0 12.22743 0 18.28721 18.79317 16.80786 0 0 0 0 16.62975 0 0 0 18.58624 0 0 18.8986 0 0 15.48732 14.74065 16.46976 0 0 17.61923 0 Q13705 AVR2B_HUMAN "Activin receptor type-2B, EC 2.7.11.30 (Activin receptor type IIB, ACTR-IIB)" ACVR2B Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]" activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]" activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000122; GO:0001702; GO:0001822; GO:0001946; GO:0001974; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007368; GO:0007498; GO:0007507; GO:0009749; GO:0009791; GO:0009952; GO:0017002; GO:0019838; GO:0030073; GO:0030324; GO:0030501; GO:0030509; GO:0031016; GO:0032147; GO:0032924; GO:0032927; GO:0032991; GO:0035265; GO:0042475; GO:0043235; GO:0045669; GO:0046872; GO:0048179; GO:0048185; GO:0048617; GO:0048705; GO:0060021; GO:0060836; GO:0060840; GO:0060841; GO:0061298; GO:0071363; GO:0120163 KMRPTIK 4.210000038 0.860309482 0.860309482 0.225109118 874.5676169 13.89775 15.0575 15.90558 16.95085 15.15548 15.24271 14.37945 0 15.86978 15.52515 15.45993 15.84019 0 15.3813 14.67999 16.18038 0 16.24221 15.43438 16.10522 15.80673 16.11621 16.48366 0 16.50074 15.89699 16.29624 15.22665 15.50671 14.4785 17.37 16.31992 18.60707 0 0 0 0 17.91698 14.42327 15.5064 15.60757 15.931 14.98009 0 15.62322 14.68848 16.87003 15.02467 Q13724 MOGS_HUMAN "Mannosyl-oligosaccharide glucosidase, EC 3.2.1.106 (Processing A-glucosidase I)" MOGS GCS1 Homo sapiens (Human) oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573]; glucosidase activity [GO:0015926]; oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573]; glucosidase activity [GO:0015926] GO:0004573; GO:0005783; GO:0005789; GO:0006457; GO:0006487; GO:0009311; GO:0015926; GO:0016020; GO:0016021; GO:0019082; GO:0070062 AVPAEGVR 9.539999962 1 1 0.250334191 798.6822171 16.90468 17.62568 14.06477 17.6203 16.04206 0 13.11838 15.3683 15.83274 17.09605 10.93102 0 16.30934 0 16.12339 15.74072 13.84135 0 15.53513 17.24434 0 16.95735 0 17.08469 15.13071 0 0 0 0 14.49958 17.67803 18.2953 17.3712 0 0 0 0 0 16.51724 15.92666 15.30863 17.10814 15.5162 17.07458 15.7196 16.88636 16.35297 16.52985 Q13733 AT1A4_HUMAN "Sodium/potassium-transporting ATPase subunit alpha-4, Na(+)/K(+) ATPase alpha-4 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-4)" ATP1A4 ATP1AL2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transport [GO:0006811]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104] integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225] integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; cell surface receptor signaling pathway [GO:0007166]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transport [GO:0006811]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391] GO:0005391; GO:0005524; GO:0005886; GO:0005887; GO:0005890; GO:0006811; GO:0006813; GO:0006814; GO:0006883; GO:0007166; GO:0007283; GO:0009566; GO:0016887; GO:0019829; GO:0019900; GO:0030007; GO:0030317; GO:0030641; GO:0035725; GO:0036376; GO:0042391; GO:0045121; GO:0046872; GO:0071805; GO:0097225; GO:0097733; GO:0120200; GO:0150104; GO:1902600; GO:1990573 GHSHQRAK 6.889999866 0.961003542 0.961003542 0.161912208 920.5278641 12.90365 15.22667 14.55072 0 0 14.31739 15.97878 10.56187 15.28818 15.11338 16.73655 16.04274 15.52581 0 0 0 0 0 0 0 0 0 0 0 16.3487 0 0 0 0 0 0 0 15.78766 16.02346 0 0 0 0 0 0 0 15.97807 0 0 0 0 0 0 Q13751 LAMB3_HUMAN Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta) LAMB3 LAMNB1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-5 complex [GO:0005610] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-5 complex [GO:0005610]; extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] GO:0005198; GO:0005201; GO:0005576; GO:0005610; GO:0008544; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0035987; GO:0043256; GO:0044877; GO:0050873; GO:0062023; GO:0070831 QAGGGGGTGSPK 16.22999954 1 1 0.181906319 973.2186609 13.00683 15.89714 13.92559 14.99827 13.6633 14.50709 14.65473 15.1409 0 0 13.86125 15.5201 16.28688 0 0 13.1207 0 15.30633 14.2498 0 0 0 15.87312 13.44145 0 12.10127 15.39602 0 15.35786 0 0 0 15.58448 15.18642 0 16.18566 16.23404 0 17.71768 0 15.52633 16.59017 0 0 0 17.33871 0 0 Q13753 LAMC2_HUMAN "Laminin subunit gamma-2 (Cell-scattering factor 140 kDa subunit, CSF 140 kDa subunit) (Epiligrin subunit gamma) (Kalinin subunit gamma) (Kalinin/nicein/epiligrin 100 kDa subunit) (Ladsin 140 kDa subunit) (Laminin B2t chain) (Laminin-5 subunit gamma) (Large adhesive scatter factor 140 kDa subunit) (Nicein subunit gamma)" LAMC2 LAMB2T LAMNB2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888] basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888] heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:0005604; GO:0005607; GO:0005615; GO:0005938; GO:0007155; GO:0008045; GO:0008201; GO:0008284; GO:0008544; GO:0009887; GO:0009888; GO:0016020; GO:0016358; GO:0030335; GO:0048471; GO:0062023 SGYYNLDGGNPEGCTQCFCYGHSASCR 1.980000019 1 1 4.59E-13 3109.872563 15.06752 0 15.65657 14.3511 14.31032 0 14.98165 15.41915 13.95627 0 0 0 0 0 0 12.31933 0 12.06794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13772 NCOA4_HUMAN "Nuclear receptor coactivator 4, NCoA-4 (Androgen receptor coactivator 70 kDa protein, 70 kDa AR-activator, 70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ret-activating protein ELE1)" NCOA4 ARA70 ELE1 RFG Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to estrogen stimulus [GO:0071391]; cellular response to testosterone stimulus [GO:0071394]; intracellular estrogen receptor signaling pathway [GO:0030520]; male gonad development [GO:0008584]; protein targeting to lysosome [GO:0006622]; response to hormone [GO:0009725] autolysosome [GO:0044754]; nucleus [GO:0005634] autolysosome [GO:0044754]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; cellular iron ion homeostasis [GO:0006879]; cellular response to estrogen stimulus [GO:0071391]; cellular response to testosterone stimulus [GO:0071394]; intracellular estrogen receptor signaling pathway [GO:0030520]; male gonad development [GO:0008584]; protein targeting to lysosome [GO:0006622]; response to hormone [GO:0009725] transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0006622; GO:0006879; GO:0008584; GO:0009725; GO:0030520; GO:0044754; GO:0071391; GO:0071394 LLFQSYNVNDWLVK 6.650000095 1 1 0.49195743 1737.267769 0 16.02724 13.94833 11.76233 13.97969 0 0 0 0 0 13.25214 0 10.15104 0 15.21659 14.16463 14.77317 0 0 0 0 15.73808 0 0 0 0 16.35991 0 0 0 0 0 0 0 0 16.64392 0 0 0 0 15.73391 0 0 0 0 0 0 0 Q13796 SHRM2_HUMAN Protein Shroom2 (Apical-like protein) (Protein APXL) SHROOM2 APXL Homo sapiens (Human) actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438] actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280] GO:0002089; GO:0003779; GO:0005737; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0007015; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062 ATSFK 3.109999895 0.363764018 0.363764018 0.238942938 554.5850016 12.68279 14.65059 15.5092 14.98448 14.68459 14.80549 16.79715 13.31533 0 15.98589 15.6763 16.07589 15.15596 14.98403 0 0 16.13578 15.2439 0 15.37998 13.84884 15.4429 15.07675 0 17.11302 14.6072 15.19823 0 0 15.13091 0 0 16.19266 0 16.78278 15.87705 0 16.37723 17.19042 0 0 17.85424 0 16.16169 16.77729 0 15.89054 16.06768 Q13797 ITA9_HUMAN Integrin alpha-9 (Integrin alpha-RLC) ITGA9 Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593] integrin binding [GO:0005178]; metal ion binding [GO:0046872] GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0046872; GO:0050900; GO:0098609 DEGQVTVYINR 4.78000021 1 1 0.223989764 1293.445243 0 0 0 0 0 0 13.55961 0 0 0 0 0 0 0 17.06066 0 16.42634 0 0 0 0 0 0 0 0 0 0 13.86726 16.64614 0 0 0 17.10722 0 0 0 0 17.20244 0 15.41744 0 0 0 0 0 17.55787 0 0 Q13813 SPTN1_HUMAN "Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)" SPTAN1 NEAS SPTA2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200] GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0005886; GO:0008091; GO:0015630; GO:0016020; GO:0030036; GO:0030054; GO:0030864; GO:0035580; GO:0042995; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0070062; GO:1903561; GO:1904724 EWIEEK 4.829999924 1 1 0.110876522 834.6140219 0 14.05871 13.20141 8.565074 15.37274 13.36698 14.78204 15.2712 14.09562 0 15.33832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13823 NOG2_HUMAN Nucleolar GTP-binding protein 2 (Autoantigen NGP-1) GNL2 NGP1 Homo sapiens (Human) ribosome biogenesis [GO:0042254] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723] GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254 DPMGTR 11.22999954 0.428022295 0.428022295 0.235762796 693.1060209 0 14.52673 0 13.44914 17.39633 0 13.66561 14.64796 0 17.2725 0 17.82918 0 0 0 14.03377 14.61906 13.89257 14.93759 0 0 13.56989 0 15.8797 0 0 0 14.75665 16.27209 14.22953 0 0 0 16.75652 18.25116 0 0 0 16.58999 0 16.05839 14.55786 17.30498 0 18.69766 0 0 0 Q13829 BACD2_HUMAN "BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, hBACURD2 (BTB/POZ domain-containing protein TNFAIP1) (Protein B12) (Tumor necrosis factor, alpha-induced protein 1, endothelial)" TNFAIP1 BACURD2 EDP1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration [GO:0016477]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006915; GO:0006955; GO:0016477; GO:0016567; GO:0030332; GO:0031267; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260 YYLIQGLVNMCQSALQDK 7.159999847 0.314446211 0.314446211 0.025418918 2159.402724 0 0 0 0 0 0 0 0 0 0 0 15.28514 0 0 0 0 0 0 0 16.30261 0 0 0 0 0 16.67985 17.24164 0 0 0 0 16.59507 0 0 0 8.363275 13.37045 18.46362 15.47076 0 0 15.31399 0 0 0 0 17.94915 0 Q13835 PKP1_HUMAN "Plakophilin-1 (Band 6 protein, B6P)" PKP1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; intermediate filament bundle assembly [GO:0045110]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; intermediate filament [GO:0005882]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; intermediate filament [GO:0005882]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; lamin binding [GO:0005521]; structural constituent of skin epidermis [GO:0030280]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; intermediate filament bundle assembly [GO:0045110]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165] cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; lamin binding [GO:0005521]; structural constituent of skin epidermis [GO:0030280] GO:0001533; GO:0005521; GO:0005634; GO:0005654; GO:0005737; GO:0005882; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007165; GO:0010628; GO:0019215; GO:0030057; GO:0030280; GO:0045110; GO:0045296; GO:0098609; GO:0101003; GO:1902373; GO:1990124 QRVQEQVMMTVK 6.21999979 1 1 0.221494267 1477.564046 0 7.565827 13.01238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.52864 16.63935 0 0 0 0 17.04283 0 0 0 0 16.0057 0 0 0 0 0 0 0 0 19.10314 0 0 0 0 Q13838 DX39B_HUMAN "Spliceosome RNA helicase DDX39B, EC 3.6.4.13 (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)" DDX39B BAT1 UAP56 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]" GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002 KDEEVLK 6.289999962 1 1 1.15E-13 860.7328211 0 0 11.00436 0 0 0 0 12.74464 14.60297 0 0 0 0 0 0 15.59669 15.73544 0 0 0 0 0 0 0 0 0 17.30049 0 0 0 12.48485 16.01389 0 0 17.15484 0 0 15.86021 0 0 0 0 0 0 0 0 0 0 Q13867 BLMH_HUMAN "Bleomycin hydrolase, BH, BLM hydrolase, BMH, EC 3.4.22.40" BLMH Homo sapiens (Human) homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802] GO:0000209; GO:0004177; GO:0004180; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008234; GO:0009410; GO:0009636; GO:0042802; GO:0043418; GO:0070062 MVAASIK 2.099999905 1 1 1.03E-12 735.4221463 14.56129 13.77299 15.15157 0 0 0 13.00759 0 15.21283 16.12769 0 14.70767 15.37965 0 0 0 0 0 15.32645 0 0 15.69729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13882 PTK6_HUMAN "Protein-tyrosine kinase 6, EC 2.7.10.2 (Breast tumor kinase) (Tyrosine-protein kinase BRK)" PTK6 BRK Homo sapiens (Human) cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] GO:0001726; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007260; GO:0010976; GO:0016477; GO:0016604; GO:0030154; GO:0031234; GO:0038128; GO:0042531; GO:0042802; GO:0045087; GO:0045742; GO:0045787; GO:0045926; GO:0046777; GO:0060575; GO:0061099; GO:0071300 VGDFGLARLIK 7.440000057 0.281557411 0.281557411 0 1191.47392 14.40207 0 10.7486 13.71365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.83549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13884 SNTB1_HUMAN "Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1, DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43, TIP-43)" SNTB1 SNT2B1 Homo sapiens (Human) muscle contraction [GO:0006936] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; muscle contraction [GO:0006936] actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202 HTVILR 6.010000229 1 1 0.156278676 738.2632307 16.18101 0 16.30087 15.76474 0 13.90923 0 0 17.30006 0 16.42507 15.57385 0 16.04811 0 14.27306 0 0 0 0 15.18342 0 0 0 15.38967 0 0 15.83084 0 0 16.02518 16.42647 0 16.54608 0 0 0 0 0 0 0 0 15.65207 0 0 17.17602 0 0 Q13885 TBB2A_HUMAN Tubulin beta-2A chain (Tubulin beta class IIa) TUBB2A TUBB2 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200] GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0070062; GO:0072686; GO:1903561 NSSYFVEWIPNNVK 2.319999933 1 1 2.29E-12 1697.676581 15.06997 0 0 0 0 0 0 0 14.06294 0 15.63172 14.05447 16.40087 15.85932 0 0 0 0 0 16.37363 0 0 0 14.59959 12.75734 15.13509 16.40279 16.33732 17.27395 16.5056 0 0 16.24492 15.84729 0 0 17.52958 15.62655 0 0 0 15.60401 0 0 0 0 0 0 Q13888 TF2H2_HUMAN "General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit, BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)" GTF2H2 BTF2P44 Homo sapiens (Human) G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]; G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270] GO:0000438; GO:0000439; GO:0002031; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0006367; GO:0008270; GO:0009411; GO:0016251; GO:0016607; GO:0047485; GO:1905776 HITSLKK 15 0.183471575 0.183471575 0.263338389 826.2781782 17.17612 17.74716 16.98068 13.5942 17.97333 0 0 0 18.7409 17.04806 18.11011 17.45672 18.65292 0 16.51786 0 0 0 0 0 0 0 0 0 17.92777 0 0 0 0 0 0 20.11021 0 17.99953 18.20777 0 19.33906 19.42924 17.94839 0 19.95623 17.66187 0 19.50883 0 18.22466 18.16327 0 Q13889 TF2H3_HUMAN "General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit, BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit)" GTF2H3 Homo sapiens (Human) DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366] metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251] GO:0000438; GO:0000439; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006366; GO:0016251; GO:0046872; GO:0047485; GO:0070816; GO:0097550 DNQEMKSR 2.650000095 1 1 0.269342673 1007.509494 0 0 15.98948 0 0 0 0 0 17.44923 0 0 16.41339 0 0 0 0 0 0 0 0 0 0 17.6138 0 16.83984 0 0 16.28499 0 0 0 0 0 0 0 0 0 0 18.25373 17.39894 0 0 0 0 0 0 0 16.08467 Q13901 C1D_HUMAN "Nuclear nucleic acid-binding protein C1D, hC1D" C1D Homo sapiens (Human) apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; regulation of gene expression [GO:0010468] DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] GO:0000176; GO:0000178; GO:0000460; GO:0003677; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006915; GO:0010468; GO:0016922; GO:0017053 SKNASK 1.370000005 0.124442875 0.124442875 0.195481597 632.4978087 0 0 12.46994 14.6354 17.41806 16.45585 16.93781 16.60639 0 0 0 0 0 15.38665 17.15495 18.42168 16.52203 0 0 20.11696 0 0 16.12903 18.13268 18.45476 0 0 16.88656 17.66959 17.90837 18.82585 17.89819 19.03239 0 17.65808 19.0596 0 16.53267 18.37667 17.75557 17.26406 0 0 20.02952 0 17.0829 0 15.60742 Q13905 RPGF1_HUMAN Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G) RAPGEF1 GRF2 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124] GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0007165; GO:0007169; GO:0007265; GO:0007399; GO:0010976; GO:0017124; GO:0032486; GO:0038180; GO:0043231; GO:0043547; GO:0061028; GO:0071320; GO:1901888; GO:1990090 LLMELVFR 12.52000046 1 1 0.028071738 1036.522839 0 15.82878 16.92041 14.97963 0 16.48288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13936 CAC1C_HUMAN "Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2)" CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; embryonic forelimb morphogenesis [GO:0035115]; heart development [GO:0007507]; immune system development [GO:0002520]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; embryonic forelimb morphogenesis [GO:0035115]; heart development [GO:0007507]; immune system development [GO:0002520]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] GO:0002520; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0006816; GO:0007204; GO:0007507; GO:0008331; GO:0010881; GO:0014069; GO:0016021; GO:0030018; GO:0030425; GO:0035115; GO:0035585; GO:0043010; GO:0043204; GO:0045762; GO:0046872; GO:0051393; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086064; GO:0086091; GO:0098839; GO:0098911; GO:0098912; GO:1990454 IFKITR 4.570000172 1 1 0.224393121 777.0301137 0 18.12568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.17488 0 0 0 0 0 0 0 18.15404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32291 Q13939 CALI_HUMAN Calicin CCIN Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; cytoskeletal calyx [GO:0033150]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; cytoskeletal calyx [GO:0033150]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] actin filament binding [GO:0051015] GO:0005634; GO:0007283; GO:0007420; GO:0015629; GO:0030036; GO:0030154; GO:0032839; GO:0033150; GO:0051015 LVGMENTSSHTTLIESVLMDRK 7.739999771 1 1 0.140633836 2471.618903 0 15.25152 0 0 0 0 15.29774 0 0 14.03253 0 0 0 0 0 0 0 0 0 15.35574 0 0 0 0 14.73691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.28279 0 0 0 0 0 0 0 Q13956 CNCG_HUMAN "Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma, GMP-PDE gamma, EC 3.1.4.35" PDE6H Homo sapiens (Human) positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601] photoreceptor outer segment membrane [GO:0042622] "photoreceptor outer segment membrane [GO:0042622]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]" GO:0004857; GO:0007601; GO:0030553; GO:0042622; GO:0043410; GO:0045742; GO:0045745; GO:0047555; GO:0050896 SDNTTLPAPASNQGPTTPRK 8.640000343 1 1 0.447719864 2052.623085 19.41935 16.86166 14.02878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13972 RGRF1_HUMAN "Ras-specific guanine nucleotide-releasing factor 1, Ras-GRF1 (Guanine nucleotide-releasing protein, GNRP) (Ras-specific nucleotide exchange factor CDC25)" RASGRF1 CDC25 GNRP GRF1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0008283; GO:0030426; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043005; GO:0043547; GO:0046578; GO:0046579; GO:0048167; GO:0048168; GO:0090630; GO:2000310 QHYFTVNFSHENQKALELR 1.309999943 1 1 0.393565702 2362.002338 14.30462 0 14.71504 14.03158 0 12.08324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.57618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.107 0 0 0 0 0 0 0 0 0 Q13976 KGP1_HUMAN "cGMP-dependent protein kinase 1, cGK 1, cGK1, EC 2.7.11.12 (cGMP-dependent protein kinase I, cGKI)" PRKG1 PRKG1B PRKGR1A PRKGR1B Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165] ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672] GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0016358; GO:0019934; GO:0030036; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:1904706; GO:1904753 SEESKTFAMK 14.93000031 0.204659775 0.204659775 0.387009538 1158.130176 13.23366 15.06272 0 15.14693 15.68862 0 0 0 14.07844 0 0 0 0 0 0 0 0 17.66396 0 15.39038 0 0 0 16.07051 0 0 13.37961 0 14.76878 0 0 14.4727 0 16.49974 0 0 0 0 0 0 0 0 0 15.81403 0 0 0 0 Q14004 CDK13_HUMAN "Cyclin-dependent kinase 13, EC 2.7.11.22, EC 2.7.11.23 (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13, hCDK13) (Cholinesterase-related cell division controller)" CDK13 CDC2L CDC2L5 CHED KIAA1791 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction [GO:0009966]; transcription elongation from RNA polymerase II promoter [GO:0006368]" cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction [GO:0009966]; transcription elongation from RNA polymerase II promoter [GO:0006368]" ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] GO:0000307; GO:0000380; GO:0002945; GO:0003723; GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006368; GO:0006468; GO:0007088; GO:0007275; GO:0008024; GO:0008284; GO:0008353; GO:0009966; GO:0016607; GO:0019901; GO:0019908; GO:0030097; GO:0030332; GO:0032968; GO:0070816; GO:0106310; GO:1904813; GO:2000737 HSSYER 6.059999943 0.887243807 0.887243807 0.248064427 777.5985693 0 15.57122 15.75117 12.69713 0 0 15.14033 15.71228 0 15.86772 0 9.05366 0 15.80374 0 0 0 0 13.83368 15.07247 17.25644 14.66773 14.22524 15.12389 0 0 0 16.6441 15.63713 15.92633 15.59502 16.22315 0 16.68502 0 14.8543 16.60511 15.92024 0 0 0 15.10308 15.54331 0 16.27613 0 15.48439 0 Q14005 IL16_HUMAN "Pro-interleukin-16 [Cleaved into: Interleukin-16, IL-16 (Lymphocyte chemoattractant factor, LCF) ]" IL16 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924] CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125] GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0005925; GO:0006955; GO:0016607; GO:0019221; GO:0030595; GO:0032730; GO:0032735; GO:0032755; GO:0042609; GO:0050729; GO:0050930; GO:0051924; GO:0090543; GO:1902565 SFEILVR 22.63999939 0.190015107 0.190015107 0.264676181 863.2207797 18.87725 18.19181 19.79305 17.71592 15.48967 17.41168 0 0 19.99866 16.12195 18.81618 18.12746 0 18.16527 0 18.65494 0 18.78356 0 0 17.65482 18.31823 17.9527 18.21785 19.07364 0 19.51331 0 18.88609 17.36217 19.23494 19.41505 0 0 0 17.66636 19.73017 19.76105 17.42532 17.14896 0 0 18.82502 0 0 16.49243 0 17.93335 Q14008 CKAP5_HUMAN "Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein, Ch-TOG)" CKAP5 KIAA0097 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051] cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; ribonucleoprotein complex binding [GO:0043021] GO:0000776; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0061863; GO:0090063 AKAPGLSSK 2.890000105 0.617307782 0.617307782 0.184462552 855.4041361 0 11.77219 14.85558 14.80963 0 0 15.65509 0 0 15.45817 0 15.4993 15.55512 0 0 15.89551 0 0 0 0 0 0 16.37071 0 15.31528 16.00591 15.20811 16.15747 13.24618 15.54519 16.24028 13.17675 16.46433 16.92048 16.7156 14.68079 15.44385 0 0 15.02763 0 0 17.58118 17.25546 0 0 16.11034 16.14931 Q14011 CIRBP_HUMAN Cold-inducible RNA-binding protein (A18 hnRNP) (Glycine-rich RNA-binding protein CIRP) CIRBP A18HNRNP CIRP Homo sapiens (Human) "mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371]; mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]" mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371] GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0009409; GO:0009411; GO:0010494; GO:0030371; GO:0034063; GO:0045727; GO:0048026; GO:0048255; GO:0070181 SGGYGGSR 8.31000042 1 1 0.243738742 741.292271 0 0 13.29667 17.23098 0 0 0 0 0 0 0 16.8262 0 17.85611 0 0 0 14.60109 0 0 0 16.27144 16.57419 0 0 18.78359 18.88158 14.6641 0 17.56953 0 0 0 16.43423 0 15.82736 15.9234 0 0 0 0 15.6416 0 0 0 14.09211 15.00496 0 Q14019 COTL1_HUMAN Coactosin-like protein COTL1 CLP Homo sapiens (Human) defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833] cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899] GO:0003779; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0034774; GO:0050832; GO:0051015; GO:0070062; GO:1904813 EVVQNFAK 8.369999886 1 1 0.210113353 932.1719032 15.51264 0 12.1931 0 0 0 0 0 15.07973 0 0 13.49639 0 0 0 15.59933 0 12.96053 0 0 0 0 0 0 12.83292 16.34539 0 0 17.61577 0 0 0 0 0 0 14.91283 15.00943 16.90195 16.08474 15.21567 12.14664 13.50604 0 0 0 16.50835 0 16.32055 Q14028 CNGB1_HUMAN "Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4, CNG channel 4, CNG-4, CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1, CNG channel beta-1) (Glutamic acid-rich protein, GARP)" CNGB1 CNCG2 CNCG3L CNCG4 RCNC2 Homo sapiens (Human) "cation transport [GO:0006812]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; detection of light stimulus involved in visual perception [GO:0050908]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; membrane depolarization [GO:0051899]; olfactory nerve maturation [GO:0021630]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; protein localization to organelle [GO:0033365]; response to odorant [GO:1990834]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495] "ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; cation transport [GO:0006812]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; detection of light stimulus involved in visual perception [GO:0050908]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; membrane depolarization [GO:0051899]; olfactory nerve maturation [GO:0021630]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; protein localization to organelle [GO:0033365]; response to odorant [GO:1990834]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276] GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007601; GO:0007602; GO:0010628; GO:0015276; GO:0021630; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0045494; GO:0050908; GO:0050911; GO:0051899; GO:0060170; GO:0099105; GO:1902495; GO:1990834 LEMALPQPVLHGK 4.28000021 1 1 0.36037494 1449.443038 15.01204 0 13.50278 14.49823 14.2781 0 14.38614 0 0 0 0 0 14.16424 0 0 0 0 0 15.63921 14.69799 0 0 0 0 13.75482 0 0 14.8876 0 0 0 13.83317 0 0 14.68256 0 0 0 0 15.1154 0 0 0 0 0 0 12.7702 0 Q14031 CO4A6_HUMAN Collagen alpha-6(IV) chain COL4A6 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198] collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005201; GO:0005576; GO:0005587; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030198; GO:0031012; GO:0038063; GO:0062023; GO:0071230 GDPVLAPGSFK 6.730000019 1 1 0.133015721 1084.718385 13.53808 0 14.8779 10.93821 12.31697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.36328 0 0 0 0 0 0 0 0 Q14050 CO9A3_HUMAN Collagen alpha-3(IX) chain COL9A3 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005201; GO:0005576; GO:0005594; GO:0005604; GO:0005615; GO:0005788; GO:0008584; GO:0008585; GO:0030020; GO:0030198; GO:0031012; GO:0062023 AGELGEAGPSGEPGVPGDAGMPGERGEAGHR 1.25 1 1 0.522342244 2918.72239 0 0 0 0 0 0 17.40085 0 0 0 0 0 0 0 0 0 0 0 0 0 14.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14055 CO9A2_HUMAN Collagen alpha-2(IX) chain COL9A2 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0001501; GO:0005201; GO:0005576; GO:0005594; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0062023 GDKGSPGK 14.82999992 1 1 0.269776749 744.0382156 0 0 16.32907 0 12.78645 14.69846 15.55216 15.43529 0 17.0048 11.84193 13.63431 16.00185 11.45642 14.55436 14.87509 15.67125 16.66039 15.7416 16.26813 16.09642 14.36783 14.09468 16.00406 0 0 15.66427 16.04897 0 15.14801 0 0 0 16.86366 13.64923 15.04176 14.30488 16.54622 17.73417 15.68196 16.32104 14.82061 15.94337 11.81059 14.88106 13.26817 17.41613 15.34487 Q14088 RB33A_HUMAN Ras-related protein Rab-33A (Small GTP-binding protein S10) RAB33A RABS10 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005886; GO:0019882; GO:0032482 VQVWDTAGQERFR 1.960000038 1 1 0.309160151 1592.953854 12.98955 15.98344 16.29917 13.58933 0 0 10.45909 0 15.57789 0 0 0 0 0 0 15.79505 0 0 0 0 0 0 0 0 14.5344 0 15.43779 0 0 0 16.64125 16.67402 17.80552 0 0 0 13.25563 0 0 0 0 0 0 0 0 0 13.32282 0 Q14093 CYLC2_HUMAN Cylicin-2 (Cylicin II) (Multiple-band polypeptide II) CYLC2 CYL2 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634] cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005634; GO:0007283; GO:0030154; GO:0033150 GGTEKDSK 9.210000038 1 1 0.125295013 819.4622331 0 0 16.323 0 0 0 0 0 0 0 0 16.66992 16.18198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14094 CCNI_HUMAN Cyclin-I CCNI Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0007283; GO:0016538; GO:0031965; GO:0044772 GSMLALAMVSLEMEK 7.840000153 1 1 0.107425367 1657.660104 15.17854 13.92767 14.54521 0 0 13.666 0 0 0 0 0 0 0 0 0 8.425894 12.97833 13.02234 15.82528 0 16.38285 15.60647 0 0 14.61703 15.0011 0 13.26058 10.0677 13.90465 0 0 13.24428 0 12.90269 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14117 DPYS_HUMAN "Dihydropyrimidinase, DHP, DHPase, EC 3.5.2.2 (Dihydropyrimidine amidohydrolase) (Hydantoinase)" DPYS Homo sapiens (Human) CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212] dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270] GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0042802; GO:0046050; GO:0046079; GO:0051219; GO:0070062 EIGAIAQVHAENGDLIAEGAK 7.739999771 1 1 2.30E-12 2105.092933 0 0 0 0 0 15.29914 0 0 14.71057 15.18776 16.81522 15.28042 0 0 0 0 0 0 0 0 0 0 0 16.21271 0 15.11324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.38287 0 0 0 0 0 0 0 Q14118 DAG1_HUMAN "Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan, Alpha-DG; Beta-dystroglycan, Beta-DG ]" DAG1 Homo sapiens (Human) aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403] adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383] adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403] actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618] GO:0001618; GO:0001954; GO:0002009; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005737; GO:0005788; GO:0005796; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006509; GO:0007411; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016021; GO:0016203; GO:0016323; GO:0016340; GO:0016476; GO:0017166; GO:0021675; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043231; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0062023; GO:0070062; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261 IVPTPTSPAIAPPTETMAPPVR 5.889999866 1 1 4.57E-12 2254.547068 15.87526 16.01691 0 0 15.2681 0 12.60921 0 0 0 0 0 0 0 16.72986 16.15247 0 16.6657 16.42668 16.11402 16.71867 0 18.40558 0 16.78609 0 14.42877 0 0 0 16.22527 0 16.08547 15.43646 15.01229 17.04501 0 16.45594 0 16.80067 16.56391 14.3665 0 17.3916 0 0 0 17.49655 Q14134 TRI29_HUMAN Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein) TRIM29 ATDC Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122] adherens junction [GO:0005912]; lysosome [GO:0005764] adherens junction [GO:0005912]; lysosome [GO:0005764]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122] cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270] GO:0000122; GO:0002039; GO:0005764; GO:0005912; GO:0008270; GO:0042802; GO:0045087; GO:0098641; GO:1900181 AALEQREQDAVDQVK 2.99000001 1 1 0.364561609 1699.305466 15.52317 13.8737 13.42585 14.62661 0 0 12.85686 0 13.61922 15.7438 0 0 16.15535 15.36917 15.21548 12.39686 0 0 0 0 0 0 0 0 16.34756 0 0 0 0 15.5799 0 0 0 0 0 0 0 0 0 0 17.23327 0 0 0 0 0 0 0 Q14135 VGLL4_HUMAN "Transcription cofactor vestigial-like protein 4, Vgl-4" VGLL4 KIAA0121 Homo sapiens (Human) "negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell growth [GO:0030308]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cellular protein catabolic process [GO:1903364]" nucleus [GO:0005634] "nucleus [GO:0005634]; transcription coactivator binding [GO:0001223]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell growth [GO:0030308]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cellular protein catabolic process [GO:1903364]" transcription coactivator binding [GO:0001223] GO:0001223; GO:0005634; GO:0030178; GO:0030308; GO:0035331; GO:0045892; GO:0060044; GO:1903364 MQTLPVASALSSHRTGPPPISPSK 6.159999847 1 1 1.83E-12 2476.057697 0 0 0 0 0 0 0 0 0 0 12.87878 7.441803 0 0 0 0 0 0 17.5254 7.114703 0 0 0 0 12.82599 0 13.15864 13.90664 13.8503 15.05704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14139 UBE4A_HUMAN "Ubiquitin conjugation factor E4 A, EC 2.3.2.27 (RING-type E3 ubiquitin transferase E4 A)" UBE4A KIAA0126 Homo sapiens (Human) protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin-ubiquitin ligase activity [GO:0034450] GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0030433; GO:0034450 INKPGNMIMAFSNLAER 1.149999976 1 1 0.346681634 1921.75135 0 0 0 14.89102 0 0 0 11.92011 13.77752 0 15.91176 0 0 0 12.10882 0 14.8795 0 0 13.66466 0 0 0 0 0 0 0 0 0 0 16.73834 15.4533 0 0 16.52648 0 0 17.0101 17.35378 0 0 0 0 12.63534 0 0 13.67651 15.39609 Q14140 SRTD2_HUMAN "SERTA domain-containing protein 2 (Transcriptional regulator interacting with the PHD-bromodomain 2, TRIP-Br2)" SERTAD2 KIAA0127 TRIPBR2 Homo sapiens (Human) negative regulation of cell growth [GO:0030308] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; negative regulation of cell growth [GO:0030308] transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030308 MLGKGGK 5.170000076 0.572767198 0.572767198 0.252809471 707.0160264 0 0 15.47905 0 0 14.5726 18.10239 19.36983 16.99442 16.4024 0 14.13556 0 0 15.45559 0 15.41121 14.79252 0 0 0 0 16.75646 14.63397 0 0 0 0 0 0 0 17.95116 0 15.46909 0 0 15.90744 0 0 13.52675 0 0 0 0 0 0 16.10159 16.47246 Q14146 URB2_HUMAN Unhealthy ribosome biogenesis protein 2 homolog URB2 KIAA0133 Homo sapiens (Human) regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254] aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730] aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254] GO:0005730; GO:0016235; GO:0030496; GO:0042254; GO:1901796 AFGDVTAHLLQPCLVLR 8.420000076 1 1 2.98E-12 1907.041392 0 13.59046 9.967553 0 14.08024 0 0 0 0 0 0 0 15.85818 16.27518 0 14.77938 16.32666 0 0 0 0 0 0 17.31816 14.25036 0 0 0 0 0 0 15.6612 14.59332 0 0 0 16.41449 14.98479 0 0 15.10573 0 0 0 0 15.61889 0 0 Q14151 SAFB2_HUMAN "Scaffold attachment factor B2, SAF-B2" SAFB2 KIAA0138 Homo sapiens (Human) regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062 LSEGRGLPPPPR 6.210000038 1 1 0.498413547 1276.359907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.55023 18.50323 0 0 18.73234 0 0 0 0 0 0 0 0 0 18.37864 0 0 0 0 0 18.73777 0 0 0 0 0 0 0 0 0 0 0 Q14152 EIF3A_HUMAN "Eukaryotic translation initiation factor 3 subunit A, eIF3a (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185)" EIF3A EIF3S10 KIAA0139 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]" mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743] GO:0001732; GO:0002188; GO:0003723; GO:0003729; GO:0003743; GO:0005198; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005852; GO:0005874; GO:0006413; GO:0014069; GO:0016020; GO:0016282; GO:0030971; GO:0033290; GO:0043614; GO:0070373; GO:0071540; GO:0071541; GO:0075522; GO:0075525 KSHLAK 17.63999939 1 1 0.270543364 682.3012132 18.88682 18.90172 17.59488 0 17.51228 0 0 0 17.69938 17.78926 18.97473 0 0 0 0 17.58676 0 0 0 17.12884 0 19.34553 18.78037 0 0 18.49972 17.45486 19.96106 0 0 18.99191 19.70149 19.82335 0 0 0 20.15564 19.7535 19.39944 0 20.63219 0 0 0 0 0 0 18.04863 Q14153 FA53B_HUMAN Protein FAM53B (Protein simplet) FAM53B KIAA0140 SMP Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein import into nucleus [GO:0006606]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] nucleus [GO:0005634]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein import into nucleus [GO:0006606]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] GO:0005634; GO:0006606; GO:0016055; GO:0060828; GO:0090263 AEPAAAWR 1.399999976 1 1 1.15E-12 874.8196721 14.60172 0 0 0 0 14.6813 0 0 14.70622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.06793 0 0 0 14.23233 0 0 0 0 13.94338 0 0 0 0 0 14.78908 0 15.11956 15.10947 0 15.98935 0 0 0 13.36932 Q14154 DELE1_HUMAN "DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form, DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form, DELE1(S), S-DELE1 ]" DELE1 DELE KIAA0141 Homo sapiens (Human) extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281] protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] GO:0005739; GO:0005743; GO:0005829; GO:0008625; GO:0019901; GO:0043281; GO:0043539; GO:0140467; GO:0140468 GLGVQR 15.28999996 0.010608478 0.010608478 0.152589048 630.2327545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0115 0 0 0 0 0 0 0 0 18.44495 20.02964 0 0 0 0 0 0 18.41561 0 0 0 0 0 0 0 0 0 Q14156 EFR3A_HUMAN Protein EFR3 homolog A (Protein EFR3-like) EFR3A KIAA0143 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0046854; GO:0072659 SEIMMFIMGK 5.929999828 1 1 0.208573044 1218.004761 13.75887 0 14.71919 16.23834 14.0467 0 14.45749 12.85918 0 0 15.25953 16.06246 16.29061 14.92492 15.22394 16.66349 13.95793 0 0 0 16.37432 15.54122 12.97295 0 16.28954 15.1342 15.8379 0 0 0 0 15.41117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14160 SCRIB_HUMAN "Protein scribble homolog, Scribble, hScrib (Protein LAP4)" SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]" adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750] "adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750]; cadherin binding [GO:0045296]; activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]" cadherin binding [GO:0045296] GO:0001768; GO:0001772; GO:0001843; GO:0001921; GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016080; GO:0016323; GO:0016477; GO:0021747; GO:0030027; GO:0030054; GO:0030859; GO:0032729; GO:0034750; GO:0035089; GO:0035748; GO:0036342; GO:0042060; GO:0043065; GO:0043113; GO:0043615; GO:0044291; GO:0045197; GO:0045296; GO:0045930; GO:0046007; GO:0048488; GO:0050918; GO:0060088; GO:0060561; GO:0060603; GO:0070062; GO:0071896; GO:0090630; GO:0097120; GO:0098609; GO:0098793; GO:0098887; GO:0098968; GO:0098978; GO:0099147; GO:0099149 GAGTAVQMR 6.889999866 0.068647385 0.068647385 0.246334829 905.0145949 16.38569 14.86357 0 0 0 0 16.261 15.92695 16.93204 15.57021 0 0 0 0 0 14.3968 14.88916 16.24482 15.21027 0 17.19611 0 14.36557 0 15.13075 0 0 14.28842 0 0 0 15.11809 0 0 0 0 15.76615 16.22177 0 0 0 17.95459 0 0 0 0 0 0 Q14161 GIT2_HUMAN "ARF GTPase-activating protein GIT2, ARF GAP GIT2 (Cool-interacting tyrosine-phosphorylated protein 2, CAT-2, CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)" GIT2 KIAA0148 Homo sapiens (Human) regulation of G protein-coupled receptor signaling pathway [GO:0008277] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872 QLVTITTK 4.550000191 0.289805532 0.289805532 0.242870815 900.4302803 18.93577 16.70528 16.83197 14.69831 13.80194 0 19.77857 20.20448 17.93856 0 0 0 0 0 0 0 18.04359 0 0 0 17.96369 0 0 0 18.67984 20.72304 0 0 0 19.01348 17.84898 18.92167 0 0 0 17.11687 0 19.16211 20.13716 16.29761 0 17.91085 0 18.62989 0 17.7662 18.02572 0 Q14164 IKKE_HUMAN "Inhibitor of nuclear factor kappa-B kinase subunit epsilon, I-kappa-B kinase epsilon, IKK-E, IKK-epsilon, IkBKE, EC 2.7.11.10 (Inducible I kappa-B kinase, IKK-i)" IKBKE IKKE IKKI KIAA0151 Homo sapiens (Human) cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mRNA stabilization [GO:0048255]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex assembly [GO:0043254]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mRNA stabilization [GO:0048255]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex assembly [GO:0043254]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625] GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008384; GO:0008630; GO:0010467; GO:0010884; GO:0016605; GO:0018105; GO:0019903; GO:0031625; GO:0031966; GO:0035456; GO:0036435; GO:0042802; GO:0043123; GO:0043254; GO:0048255; GO:0051091; GO:0051607; GO:0060337; GO:0060340; GO:0097400; GO:0098586; GO:1902554 ELDDDEKFVSVYGTEEYLHPDMYER 5.889999866 1 1 4.59E-12 3094.865681 0 12.01971 0 16.05289 15.1702 12.88122 0 11.63419 15.05912 13.82801 11.67898 0 11.62377 13.63672 12.83828 0 0 12.32018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14181 DPOA2_HUMAN DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit) POLA2 Homo sapiens (Human) "DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]" alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]" DNA binding [GO:0003677] GO:0003677; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006269; GO:0006270 GGAGNISLKVLGCPEALTGSYK 11.94999981 0.176109672 0.176109672 1.83E-12 2192.210961 13.06949 14.44666 0 10.55271 12.47216 12.22601 0 0 12.8479 15.02973 0 12.93659 0 0 0 0 0 17.05605 0 0 0 0 13.12917 0 0 0 0 0 14.61468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14188 TFDP2_HUMAN Transcription factor Dp-2 (E2F dimerization partner 2) TFDP2 DP2 Homo sapiens (Human) "cell cycle [GO:0007049]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007049; GO:0007507; GO:0008134; GO:0019904; GO:0045892; GO:0045944; GO:0051726; GO:0072686; GO:0090575 RVYDALNVLMAMNIISK 2.970000029 1 1 0.220379231 1966.154322 0 0 12.65547 15.15583 14.10352 15.23707 0 0 11.96466 0 0 0 0 0 0 0 0 0 0 15.33775 14.61298 0 12.94656 0 15.75437 0 13.63404 14.16436 0 14.76379 0 0 0 0 0 0 13.47642 13.08781 0 0 0 0 15.73531 0 0 0 10.67045 0 Q14191 WRN_HUMAN "Werner syndrome ATP-dependent helicase, EC 3.6.4.12 (DNA helicase, RecQ-like type 3, RecQ3) (Exonuclease WRN, EC 3.1.-.-) (RecQ protein-like 2)" WRN RECQ3 RECQL2 Homo sapiens (Human) aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820] "centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]" "centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]" 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403] GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773 FGIGLPILFLR 11.75 1 1 0.261754495 1244.783631 15.40785 15.3888 0 14.91603 14.0053 14.01871 0 15.16135 15.01454 0 15.86353 0 16.60305 15.53666 14.92322 15.07193 0 16.32862 18.05246 14.93469 0 0 0 0 0 0 15.84132 0 0 13.60559 0 13.77767 0 0 14.68367 0 0 16.83671 0 0 16.41277 0 0 0 0 0 0 0 Q14192 FHL2_HUMAN "Four and a half LIM domains protein 2, FHL-2 (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3, SLIM-3)" FHL2 DRAL SLIM3 Homo sapiens (Human) atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885 KTIMPGTR 4.630000114 1 1 0.204694017 919.2513804 13.68589 14.00071 17.11532 0 15.82671 13.64731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4948 0 17.53279 15.5063 0 0 13.96585 0 0 0 0 16.76266 17.46506 0 0 0 0 0 15.77433 0 0 0 0 0 0 0 0 Q14194 DPYL1_HUMAN "Dihydropyrimidinase-related protein 1, DRP-1 (Collapsin response mediator protein 1, CRMP-1) (Inactive dihydropyrimidinase) (Unc-33-like phosphoprotein 3, ULIP-3)" CRMP1 DPYSL1 ULIP3 Homo sapiens (Human) axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139] centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; midbody [GO:0030496]; perikaryon [GO:0043204]; spindle [GO:0005819] "centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; midbody [GO:0030496]; perikaryon [GO:0043204]; spindle [GO:0005819]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]" "filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]" GO:0000226; GO:0005813; GO:0005819; GO:0005829; GO:0006139; GO:0007399; GO:0007411; GO:0010977; GO:0016810; GO:0030426; GO:0030496; GO:0031005; GO:0042802; GO:0043204; GO:1904530 GLGAVILVHAENGDLIAQEQKR 4.820000172 1 1 1.38E-12 2331.998535 11.7804 15.15724 0 0 0 15.28586 0 13.39937 12.6598 0 17.36799 0 0 0 0 0 0 11.30289 0 0 17.49751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14203 DCTN1_HUMAN "Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150, DP-150) (p135) (p150-glued)" DCTN1 Homo sapiens (Human) "cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]" axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] "axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]" microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631] GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0007399; GO:0007528; GO:0008017; GO:0010457; GO:0015630; GO:0015631; GO:0016020; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0031122; GO:0034454; GO:0035371; GO:0042147; GO:0043005; GO:0043025; GO:0045171; GO:0048156; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535 TPSGSRMSAEASARPLR 1.350000024 1 1 0.326087601 1774.149504 12.97543 14.73333 14.50786 13.99965 14.6823 12.6291 15.68766 0 0 0 9.227219 0 0 13.51317 16.68533 0 0 0 0 0 0 0 0 15.74306 13.07972 15.53531 0 0 0 0 0 0 0 16.98906 0 0 15.05397 17.3276 0 0 0 14.58281 0 0 0 16.06257 0 0 Q14204 DYHC1_HUMAN "Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)" DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 Homo sapiens (Human) cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723] GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0016020; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832 GRTGNVLK 7.920000076 0.236538708 0.236538708 0.260986287 844.9001826 16.05958 13.85565 15.81302 14.90746 15.26362 14.8493 14.3619 15.10633 16.00796 17.02416 15.60159 14.98668 14.09028 16.61562 15.03472 14.25636 0 14.2563 11.80197 15.04227 16.63736 15.34458 15.2696 0 16.24271 16.28927 15.93394 13.58638 15.60935 15.49419 15.71383 16.99281 16.74752 16.52835 15.51601 15.48726 15.89229 15.77103 0 0 14.66348 16.12847 14.66952 14.89315 15.76752 16.04251 14.041 14.52161 Q14207 NPAT_HUMAN "Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus, Nuclear protein of the ATM locus) (p220)" NPAT CAND3 E14 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0000083; GO:0001701; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008022; GO:0010468; GO:0015030; GO:0045893; GO:0045944; GO:0097504 EKPPLPK 14.44999981 1 1 0.208419772 808.5022703 0 15.25162 12.71355 0 0 0 0 14.33892 0 0 0 0 0 0 14.90845 12.48336 0 15.05644 0 12.36786 14.86453 0 15.94248 0 0 14.62352 15.55375 0 0 0 14.41391 16.27978 14.92799 0 15.14102 15.75602 14.72424 15.35173 13.88498 0 0 0 15.60762 0 0 0 0 0 Q14209 E2F2_HUMAN "Transcription factor E2F2, E2F-2" E2F2 Homo sapiens (Human) cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; lens fiber cell apoptotic process [GO:1990086]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; lens fiber cell apoptotic process [GO:1990086]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005654; GO:0006357; GO:0006367; GO:0007049; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0072332; GO:0090575; GO:1903671; GO:1990086; GO:1990837 TPKSPGEK 7.659999847 1 1 0.078167655 844.1605576 0 0 0 11.50559 0 13.82305 0 0 16.11813 0 15.28138 0 17.49123 0 17.52903 15.2317 0 18.45329 16.53335 18.31802 15.91561 16.44514 0 17.67846 17.7051 15.20026 0 14.18977 15.57217 0 16.80368 0 16.68047 16.98325 15.64044 18.6224 0 17.7674 16.40088 0 0 0 11.65875 16.09367 17.19031 18.15527 0 0 Q14241 ELOA1_HUMAN "Elongin-A, EloA (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3)" ELOA TCEB3 MSTP059 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] elongin complex [GO:0070449]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] elongin complex [GO:0070449]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0005615; GO:0005654; GO:0006357; GO:0006367; GO:0006368; GO:0070449; GO:0090734 CAYLPK 9.909999847 0.378670841 0.378670841 0.257253356 752.1132545 15.12348 16.2653 14.75908 15.17499 15.16768 14.22081 16.08307 15.42749 14.75979 0 14.98361 16.68174 0 14.35612 15.35821 0 15.5201 16.09454 0 0 15.92031 16.23917 16.60699 0 15.72688 0 0 14.999 14.54247 15.19684 15.18451 16.35837 17.69639 12.92228 15.99908 15.49307 17.32203 17.93671 16.3926 15.29892 0 0 0 0 0 16.45137 0 16.57582 Q14244 MAP7_HUMAN "Ensconsin (Epithelial microtubule-associated protein of 115 kDa, E-MAP-115) (Microtubule-associated protein 7, MAP-7)" MAP7 Homo sapiens (Human) establishment or maintenance of cell polarity [GO:0007163]; microtubule cytoskeleton organization [GO:0000226]; protein localization to plasma membrane [GO:0072659]; response to osmotic stress [GO:0006970] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; establishment or maintenance of cell polarity [GO:0007163]; microtubule cytoskeleton organization [GO:0000226]; protein localization to plasma membrane [GO:0072659]; response to osmotic stress [GO:0006970] signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] GO:0000226; GO:0005102; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0006970; GO:0007163; GO:0015630; GO:0016323; GO:0030424; GO:0048471; GO:0072659 AAHSR 5.769999981 1 1 0.273530536 541.6937951 0 0 0 0 0 0 0 0 0 0 17.71295 15.90775 0 0 0 0 0 0 15.47871 0 18.11982 0 0 0 16.75178 0 0 0 0 17.61329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14247 SRC8_HUMAN Src substrate cortactin (Amplaxin) (Oncogene EMS1) CTTN EMS1 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]" cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] "cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]" actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522] GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030041; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045296; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097062; GO:0097581; GO:1903146; GO:1990023; GO:2001237 DYSSGFGGK 7.699999809 0.293169886 0.293169886 0.194395471 916.2684985 17.73756 0 17.60985 12.56441 0 16.36855 13.01008 0 18.35344 15.92298 16.54364 12.60753 0 0 16.11964 12.7782 0 16.69439 13.13697 15.53316 15.6832 17.27831 13.76381 14.99029 16.59737 0 16.27292 16.56167 16.05664 0 0 0 0 18.37301 0 17.42249 18.16249 18.64216 18.34396 0 15.16433 16.27589 15.39792 16.2887 19.24332 0 16.66667 12.71431 Q14315 FLNC_HUMAN "Filamin-C, FLN-C, FLNc (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)" FLNC ABPL FLN2 Homo sapiens (Human) sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; sarcomere organization [GO:0045214] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045214; GO:0051015 FTVETRGAGTGGLGLAIEGPSEAK 11.64000034 1 1 0.117509842 2317.859056 14.0328 14.32901 0 13.1172 0 12.93444 13.54897 10.25075 15.26437 0 0 12.5087 13.98958 12.2031 0 15.49085 0 0 14.68667 0 0 0 16.98387 0 0 0 12.95257 0 0 0 0 0 0 0 0 0 14.48753 0 0 0 14.13694 0 0 0 13.28252 0 0 0 Q14324 MYPC2_HUMAN "Myosin-binding protein C, fast-type, Fast MyBP-C (C-protein, skeletal muscle fast isoform)" MYBPC2 MYBPCF Homo sapiens (Human) cell adhesion [GO:0007155]; muscle contraction [GO:0006936] cytosol [GO:0005829]; myosin filament [GO:0032982] cytosol [GO:0005829]; myosin filament [GO:0032982]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell adhesion [GO:0007155]; muscle contraction [GO:0006936] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] GO:0003779; GO:0005829; GO:0006936; GO:0007155; GO:0008307; GO:0032982 HILIFSDVVQEDR 1.690000057 1 1 0.213595096 1570.977733 13.13054 15.24186 16.48421 0 0 0 15.24054 0 6.6469 0 0 15.10516 0 0 14.98088 15.70638 0 0 0 0 0 0 14.49043 0 0 0 11.95211 13.62223 12.13093 13.93065 14.57608 17.53514 0 0 0 0 0 0 0 0 16.26569 0 0 0 15.94302 0 0 0 Q14344 GNA13_HUMAN "Guanine nucleotide-binding protein subunit alpha-13, G alpha-13, G-protein subunit alpha-13" GNA13 Homo sapiens (Human) activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165] D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872] GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005085; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008217; GO:0008360; GO:0010259; GO:0016020; GO:0030154; GO:0030168; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0042470; GO:0046872; GO:0051056; GO:0070062; GO:1904706; GO:1904753 APMAAQGMVETR 1.179999948 1 1 0.007800176 1294.252361 12.40259 0 0 11.60619 0 0 12.42084 0 10.98017 0 12.98413 12.48869 10.93002 16.41673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7345 10.08664 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14393 GAS6_HUMAN "Growth arrest-specific protein 6, GAS-6 (AXL receptor tyrosine kinase ligand)" GAS6 AXLLG Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]" cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093] "cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activator activity [GO:0030296]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]" calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activator activity [GO:0030296]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] GO:0001764; GO:0001786; GO:0001934; GO:0001961; GO:0003104; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0006468; GO:0006909; GO:0007165; GO:0007167; GO:0007596; GO:0009267; GO:0010628; GO:0010804; GO:0018105; GO:0019064; GO:0019079; GO:0030296; GO:0030674; GO:0030971; GO:0031093; GO:0031100; GO:0031589; GO:0032008; GO:0032148; GO:0032689; GO:0032692; GO:0032715; GO:0032720; GO:0032825; GO:0033138; GO:0035457; GO:0035754; GO:0040008; GO:0043027; GO:0043066; GO:0043154; GO:0043277; GO:0043433; GO:0043491; GO:0045860; GO:0045892; GO:0046718; GO:0046813; GO:0046827; GO:0048018; GO:0048146; GO:0050766; GO:0051897; GO:0061098; GO:0070062; GO:0070168; GO:0070374; GO:0070588; GO:0071307; GO:0071333; GO:0071363; GO:0071466; GO:0072659; GO:0085029; GO:0097028; GO:0097241; GO:1900142; GO:2000270; GO:2000352; GO:2000510; GO:2000533; GO:2000669 ACRDVDECLQGR 5 1 1 0.083941077 1479.321002 0 0 11.70633 15.6496 0 0 0 0 0 0 0 0 0 0 0 0 0 12.42879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14409 GLPK3_HUMAN "Glycerol kinase 3, GK 3, Glycerokinase 3, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 3) (Glycerol kinase 3 pseudogene) (Glycerol kinase, testis specific 1)" GK3P GKP3 GKTB Homo sapiens (Human) glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]" "ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167 EILDAMNR 3.130000114 1 1 0.217687997 961.1153414 14.22277 14.02054 14.00433 0 0 0 0 15.34445 0 14.31795 0 14.6415 0 0 0 0 0 0 13.69432 13.07352 0 0 0 0 0 0 15.49353 0 14.1902 0 0 13.29051 0 15.10136 13.17167 0 0 15.18017 0 0 0 0 0 0 0 0 0 0 Q14410 GLPK2_HUMAN "Glycerol kinase 2, GK 2, Glycerokinase 2, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)" GK2 GKP2 GKTA Homo sapiens (Human) flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226] "extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641]" "ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0007283; GO:0016310; GO:0016773; GO:0019563; GO:0030317; GO:0046167; GO:0070062; GO:0097225; GO:0097226; GO:0120317 IPGNSNFVK 9.539999962 1 1 0.175397268 974.3304617 0 0 14.99362 0 13.96462 0 0 13.88255 0 0 14.88 0 14.05276 0 15.05442 14.58149 0 14.8805 0 0 0 0 17.19332 0 0 0 0 0 0 13.89993 16.61523 0 0 0 0 0 0 0 0 14.19357 0 0 0 0 0 13.07812 0 0 Q14416 GRM2_HUMAN "Metabotropic glutamate receptor 2, mGluR2" GRM2 GPRC1B MGLUR2 Homo sapiens (Human) "behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]" astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] "astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]" adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0035095; GO:0042220; GO:0042734; GO:0051896; GO:0051966; GO:0090461; GO:0097110; GO:0097449; GO:0099055; GO:2001023 LGAHILDSCSK 1.74000001 1 1 0.07441536 1199.632807 13.06722 12.09644 15.53261 0 10.38965 0 8.942883 14.09189 11.46114 15.19337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14435 GALT3_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 3, EC 2.4.1.41 (Polypeptide GalNAc transferase 3, GalNAc-T3, pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)" GALNT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283] calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005509; GO:0005794; GO:0005975; GO:0006493; GO:0007283; GO:0008543; GO:0016020; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0070062 MQIGAPVR 4.550000191 1 1 0.270074404 885.6443932 0 0 0 0 0 0 0 20.65878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.69386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14442 PIGH_HUMAN "Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (Phosphatidylinositol-glycan biosynthesis class H protein, PIG-H)" PIGH Homo sapiens (Human) cellular protein modification process [GO:0006464]; GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; catalytic activity [GO:0003824]; cellular protein modification process [GO:0006464]; GPI anchor biosynthetic process [GO:0006506] catalytic activity [GO:0003824] GO:0000506; GO:0003824; GO:0005783; GO:0005789; GO:0006464; GO:0006506 EFCLSCPR 7.170000076 1 1 0.122568599 1069.474404 14.07602 0 0 0 13.4523 15.29583 0 15.81873 0 15.91772 14.78455 0 0 0 16.42186 0 15.04168 13.51194 0 0 0 13.49658 0 0 13.81323 0 14.8046 0 15.02656 14.55278 14.60909 0 14.13515 0 0 15.23477 0 13.05563 0 16.14434 0 15.45402 15.71515 0 0 0 0 0 Q14444 CAPR1_HUMAN "Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137, GPI-p137, p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105)" CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 Homo sapiens (Human) negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; postsynapse [GO:0098794] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003] RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0050775; GO:0061003; GO:0098794; GO:0098978 LNQDQLDAVSK 6.96999979 1 1 0.011241763 1227.578281 0 0 12.43257 15.24688 12.82157 0 15.55088 0 11.57671 0 10.56363 0 11.61447 12.52975 0 0 0 14.64067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14451 GRB7_HUMAN Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein) GRB7 Homo sapiens (Human) epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of translation [GO:0017148]; positive regulation of cell migration [GO:0030335]; stress granule assembly [GO:0034063] cell projection [GO:0042995]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] cell projection [GO:0042995]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of translation [GO:0017148]; positive regulation of cell migration [GO:0030335]; stress granule assembly [GO:0034063] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] GO:0003723; GO:0005829; GO:0005886; GO:0005925; GO:0007173; GO:0010494; GO:0017148; GO:0019901; GO:0030335; GO:0034063; GO:0035091; GO:0042802; GO:0042995 GTSKDPR 3.980000019 1 1 4.59E-13 759.611798 0 16.20935 0 14.22999 14.25241 14.7549 0 0 15.07007 0 0 0 15.88938 16.17941 0 0 0 0 0 0 0 15.1761 0 16.23245 15.55055 0 0 0 0 0 0 0 0 16.83021 0 0 16.37487 0 0 0 16.40535 0 0 0 0 0 0 0 Q14469 HES1_HUMAN "Transcription factor HES-1 (Class B basic helix-loop-helix protein 39, bHLHb39) (Hairy and enhancer of split 1) (Hairy homolog) (Hairy-like protein, hHL)" HES1 BHLHB39 HL HRY Homo sapiens (Human) "adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hair cell differentiation [GO:0035315]; hindbrain morphogenesis [GO:0021575]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to organic cyclic compound [GO:0014070]; response to thyroid hormone [GO:0097066]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hair cell differentiation [GO:0035315]; hindbrain morphogenesis [GO:0021575]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to organic cyclic compound [GO:0014070]; response to thyroid hormone [GO:0097066]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]" "chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001889; GO:0003143; GO:0003151; GO:0003266; GO:0003281; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007399; GO:0008284; GO:0008432; GO:0009952; GO:0010628; GO:0010629; GO:0010977; GO:0014070; GO:0016363; GO:0016477; GO:0021537; GO:0021555; GO:0021557; GO:0021558; GO:0021575; GO:0021861; GO:0021984; GO:0030324; GO:0030513; GO:0030901; GO:0031016; GO:0032991; GO:0035019; GO:0035315; GO:0035910; GO:0042102; GO:0042531; GO:0042803; GO:0042826; GO:0043254; GO:0043279; GO:0043388; GO:0043398; GO:0043433; GO:0043565; GO:0044877; GO:0045598; GO:0045608; GO:0045665; GO:0045747; GO:0045892; GO:0045944; GO:0045977; GO:0046331; GO:0046425; GO:0046427; GO:0048469; GO:0048538; GO:0048667; GO:0048711; GO:0048715; GO:0048844; GO:0050678; GO:0050767; GO:0051087; GO:0060122; GO:0060164; GO:0060253; GO:0060412; GO:0060675; GO:0060716; GO:0061009; GO:0061106; GO:0061309; GO:0061626; GO:0061629; GO:0065003; GO:0070888; GO:0071347; GO:0071356; GO:0071398; GO:0071820; GO:0072012; GO:0072049; GO:0072050; GO:0072141; GO:0072282; GO:0090102; GO:0090162; GO:0090281; GO:0097066; GO:0097084; GO:0097150; GO:1905934; GO:1990090; GO:1990837; GO:2000227; GO:2000737; GO:2000974; GO:2000978 PADIMEK 9.289999962 0.016748223 0.016748223 0.21678398 820.5731111 15.86814 16.16836 0 15.13655 14.65365 0 15.48666 15.40894 16.05914 15.26419 16.05098 12.97008 15.92142 15.65891 17.02457 15.98226 15.12668 16.17407 15.15131 16.17866 15.51544 16.33462 0 17.38224 15.47692 0 15.9965 15.71154 15.28354 15.5967 16.58706 17.1116 14.89147 15.8264 16.93794 16.39091 16.39635 16.51291 14.97739 0 15.21892 15.81918 15.00213 15.93391 16.1677 15.56292 11.47156 15.56296 Q14493 SLBP_HUMAN Histone RNA hairpin-binding protein (Histone stem-loop-binding protein) SLBP HBP Homo sapiens (Human) cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; histone pre-mRNA DCP binding [GO:0071208]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028] histone pre-mRNA DCP binding [GO:0071208]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006398; GO:0042802; GO:0051028; GO:0062073; GO:0071204; GO:0071207; GO:0071208; GO:1990904 SSSGSSDSK 3.420000076 1 1 0.210587641 842.5407122 11.4291 15.14412 0 15.9184 14.52511 16.29981 15.86408 15.454 18.02724 15.14696 16.77028 0 16.14992 13.15016 15.90781 14.82677 15.24558 14.96206 14.55979 0 15.29423 15.39633 14.79452 15.03002 17.15475 16.649 0 0 0 16.08185 0 0 0 0 16.46075 0 16.8016 0 15.80833 16.81127 16.58827 0 0 0 0 15.72481 14.82912 0 Q14498 RBM39_HUMAN "RNA-binding protein 39 (CAPER alpha, CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1)" RBM39 HCC1 RNPC2 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] "centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" RNA binding [GO:0003723]; RS domain binding [GO:0050733] GO:0003723; GO:0005654; GO:0006396; GO:0006397; GO:0008380; GO:0015630; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733 IESIQLMMDSETGRSK 7.329999924 1 1 4.59E-13 1843.981152 0 14.38815 14.06614 0 14.72458 0 0 0 0 16.59244 0 0 0 0 11.39074 14.8792 12.16879 0 0 14.29148 14.60202 14.30462 0 15.66099 0 15.22021 11.91876 0 0 0 0 0 0 0 0 0 14.95129 0 0 12.3245 0 0 13.23098 0 0 0 0 0 Q14500 KCJ12_HUMAN "ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2, IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12)" KCNJ12 IRK2 KCNJN1 Homo sapiens (Human) muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] inward rectifier potassium channel activity [GO:0005242] GO:0005242; GO:0005886; GO:0006813; GO:0006936; GO:0008016; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573 MTAASR 3.730000019 0.792112648 0.792112648 0.332586063 635.1881665 18.60668 17.46655 18.30959 18.37243 19.41263 18.42294 17.81077 0 0 18.48105 0 0 17.81505 0 0 18.11481 20.81812 21.19035 0 17.3001 0 17.24416 0 16.72306 17.74032 17.5808 20.98018 17.2858 0 19.29598 0 18.66544 19.66141 0 0 21.4461 0 0 19.4662 0 22.4437 0 17.74489 19.79755 21.45941 22.92868 0 0 Q14507 EP3A_HUMAN "Epididymal secretory protein E3-alpha (Human epididymis-specific protein 3-alpha, HE3-alpha)" EDDM3A FAM12A HE3A Homo sapiens (Human) sperm displacement [GO:0007321] extracellular space [GO:0005615] extracellular space [GO:0005615]; sperm displacement [GO:0007321] GO:0005615; GO:0007321 CDVLMR 4.960000038 1 1 0.247295154 807.6103143 14.51701 15.19951 16.68051 12.75078 0 14.98456 0 15.83996 0 0 12.91904 14.62297 15.99005 0 15.02074 14.72842 14.90859 15.46007 14.48993 0 0 15.77759 16.16576 14.95156 16.43936 15.92354 0 15.12802 15.67164 15.3978 0 15.74126 0 0 16.725 15.10906 16.57982 0 16.77931 17.34466 16.17554 16.38809 0 15.91342 0 15.81735 16.08812 15.2774 Q14508 WFDC2_HUMAN WAP four-disulfide core domain protein 2 (Epididymal secretory protein E4) (Major epididymis-specific protein E4) (Putative protease inhibitor WAP5) WFDC2 HE4 WAP5 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004866; GO:0004867; GO:0004869; GO:0005615; GO:0006508; GO:0007283; GO:0019731; GO:0019828; GO:0045087; GO:0070062 VSCVTPNF 6.71999979 1 1 0.274340992 923.9778482 0 15.19928 18.78664 18.47726 17.92214 0 0 17.59903 17.87962 16.96087 0 0 17.78681 0 18.29492 17.60436 0 0 0 17.39166 0 17.19248 17.46227 0 0 0 0 17.8063 17.38645 0 0 0 0 0 17.33751 18.46034 0 17.97293 18.26919 0 0 17.96592 0 18.0386 16.65292 0 16.63222 0 Q14512 FGFP1_HUMAN "Fibroblast growth factor-binding protein 1, FGF-BP, FGF-BP1, FGF-binding protein 1, FGFBP-1 (17 kDa heparin-binding growth factor-binding protein, 17 kDa HBGF-binding protein, HBp17)" FGFBP1 FGFBP HBP17 Homo sapiens (Human) cell-cell signaling [GO:0007267]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; signal transduction [GO:0007165] fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201] GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007267; GO:0008201; GO:0008285; GO:0009986; GO:0017134; GO:0019838; GO:0045743; GO:0090050; GO:1903589 NGLHSK 1.220000029 0.245217741 0.245217741 0.208326748 656.1019251 15.119 0 0 0 0 15.19527 13.50223 12.19512 0 14.38531 13.36351 11.47045 0 0 0 0 0 0 18.91353 0 14.41244 0 0 0 16.08388 17.20824 14.61867 13.07188 17.38202 15.50098 0 0 0 0 18.12264 16.67903 17.07148 16.2417 0 15.54471 16.0349 16.88076 0 0 0 0 0 0 Q14524 SCN5A_HUMAN Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1) SCN5A Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell communication [GO:0086067]; brainstem development [GO:0003360]; bundle of His cell action potential [GO:0086043]; cardiac conduction system development [GO:0003161]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cerebellum development [GO:0021549]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of action potential [GO:0045760]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; SA node cell action potential [GO:0086015]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; ventricular cardiac muscle cell action potential [GO:0086005] caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; nitric-oxide synthase binding [GO:0050998]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in AV node cell action potential [GO:0086060]; voltage-gated sodium channel activity involved in bundle of His cell action potential [GO:0086061]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; voltage-gated sodium channel activity involved in SA node cell action potential [GO:0086063]; atrial cardiac muscle cell action potential [GO:0086014]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell communication [GO:0086067]; brainstem development [GO:0003360]; bundle of His cell action potential [GO:0086043]; cardiac conduction system development [GO:0003161]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cerebellum development [GO:0021549]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of action potential [GO:0045760]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; SA node cell action potential [GO:0086015]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; ventricular cardiac muscle cell action potential [GO:0086005] ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; nitric-oxide synthase binding [GO:0050998]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in AV node cell action potential [GO:0086060]; voltage-gated sodium channel activity involved in bundle of His cell action potential [GO:0086061]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; voltage-gated sodium channel activity involved in SA node cell action potential [GO:0086063] GO:0001518; GO:0002027; GO:0003161; GO:0003231; GO:0003360; GO:0005244; GO:0005248; GO:0005516; GO:0005654; GO:0005730; GO:0005783; GO:0005886; GO:0005901; GO:0006814; GO:0009986; GO:0010765; GO:0014704; GO:0014894; GO:0016021; GO:0016328; GO:0017134; GO:0019228; GO:0019899; GO:0019901; GO:0019904; GO:0021537; GO:0021549; GO:0030018; GO:0030315; GO:0030506; GO:0031625; GO:0035725; GO:0042383; GO:0042475; GO:0044325; GO:0045760; GO:0048471; GO:0050679; GO:0050998; GO:0051899; GO:0060048; GO:0060307; GO:0060371; GO:0060372; GO:0060373; GO:0071277; GO:0086002; GO:0086004; GO:0086005; GO:0086006; GO:0086010; GO:0086012; GO:0086014; GO:0086015; GO:0086016; GO:0086043; GO:0086045; GO:0086046; GO:0086047; GO:0086048; GO:0086060; GO:0086061; GO:0086062; GO:0086063; GO:0086067; GO:0086091; GO:0097110; GO:0098912; GO:1902305 WHMMDFFHAFLIIFR 14.01000023 1 1 2.07E-12 2042.403556 15.13398 0 13.44872 12.61119 12.31849 15.81487 14.38165 15.22758 14.51905 13.87037 11.37984 0 13.0099 10.00606 0 7.309761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14526 HIC1_HUMAN "Hypermethylated in cancer 1 protein, Hic-1 (Zinc finger and BTB domain-containing protein 29)" HIC1 ZBTB29 Homo sapiens (Human) "intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872; GO:1990837 AEAAEVAAGAAGLGPPFGGGGDK 6.760000229 1 1 0.122798734 1970.62493 13.82087 14.01179 16.75245 15.92213 0 0 0 0 0 0 0 0 0 16.24866 0 0 0 0 0 0 0 0 0 14.63308 0 0 0 0 0 0 0 15.29375 0 16.29698 0 15.20652 0 15.29392 0 0 0 0 0 0 0 0 0 0 Q14527 HLTF_HUMAN "Helicase-like transcription factor, EC 2.3.2.27, EC 3.6.4.- (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)" HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1 Homo sapiens (Human) mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]" "ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008270; GO:0016020; GO:0016363; GO:0016567; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0061630; GO:0090575; GO:0140658 DPNNPYDK 7.849999905 1 1 0.057797574 962.7191797 14.18352 0 15.55168 0 0 12.47881 0 0 0 0 0 0 16.13229 15.06148 14.49182 14.67953 13.88946 8.890539 0 0 0 0 0 0 0 0 16.76374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14534 ERG1_HUMAN "Squalene monooxygenase, EC 1.14.14.17 (Squalene epoxidase, SE)" SQLE ERG1 Homo sapiens (Human) cellular aromatic compound metabolic process [GO:0006725]; cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506]; cellular aromatic compound metabolic process [GO:0006725]; cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126] FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506] GO:0004506; GO:0005783; GO:0005789; GO:0006725; GO:0008203; GO:0010033; GO:0016021; GO:0016126; GO:0042127; GO:0043231; GO:0071949; GO:0140042 AAMAEPNAK 5.440000057 1 1 0.287746163 918.1201261 0 0 0 0 0 0 0 0 0 0 0 0 15.82719 0 0 0 0 0 0 0 0 0 0 0 0 17.53009 19.39878 19.01036 0 0 0 0 0 0 0 0 0 0 17.66325 0 0 0 16.11742 0 0 0 0 0 Q14554 PDIA5_HUMAN "Protein disulfide-isomerase A5, EC 5.3.4.1 (Protein disulfide isomerase-related protein)" PDIA5 PDIR Homo sapiens (Human) electron transport chain [GO:0022900]; protein folding [GO:0006457] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; electron transport chain [GO:0022900]; protein folding [GO:0006457] oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] GO:0003756; GO:0005788; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0022900 KHTLVMFYAPWCPHCK 4.420000076 1 1 0 2074.413074 0 0 0 0 0 0 0 0 0 13.00104 14.77899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14562 DHX8_HUMAN "ATP-dependent RNA helicase DHX8, EC 3.6.4.13 (DEAH box protein 8) (RNA helicase HRH1)" DHX8 DDX8 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013 ASYGK 3.380000114 0.077928357 0.077928357 0.285769394 523.0277658 17.41155 16.67956 16.52612 16.42686 15.09486 15.80632 0 14.88562 15.50788 16.15497 16.62302 14.91344 16.23697 0 15.95876 0 16.30928 15.0206 15.61179 16.01773 0 15.95244 13.69806 16.967 0 0 16.66956 15.43692 16.08111 15.97588 14.62286 15.49686 16.74373 16.782 15.31698 15.52349 16.50177 16.48859 16.34093 17.24113 16.80455 16.44255 17.64167 16.75111 16.21338 15.8752 16.77311 17.10862 Q14563 SEM3A_HUMAN "Semaphorin-3A (Semaphorin III, Sema III)" SEMA3A SEMAD Homo sapiens (Human) apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; branchiomotor neuron axon guidance [GO:0021785]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neural crest cell migration involved in sympathetic nervous system development [GO:1903045]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of male gonad development [GO:2000020]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of heart rate [GO:0002027]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; branchiomotor neuron axon guidance [GO:0021785]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neural crest cell migration involved in sympathetic nervous system development [GO:1903045]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of male gonad development [GO:2000020]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of heart rate [GO:0002027]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486] chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0001764; GO:0002027; GO:0005576; GO:0005615; GO:0005887; GO:0006915; GO:0007411; GO:0007413; GO:0008045; GO:0010633; GO:0010977; GO:0021612; GO:0021637; GO:0021675; GO:0021772; GO:0021785; GO:0021828; GO:0030215; GO:0030335; GO:0030424; GO:0030425; GO:0036486; GO:0038191; GO:0045499; GO:0046330; GO:0048485; GO:0048841; GO:0048843; GO:0048846; GO:0048880; GO:0050919; GO:0060385; GO:0060666; GO:0061549; GO:0061551; GO:0071526; GO:0097490; GO:0097491; GO:0150020; GO:1901166; GO:1902285; GO:1902287; GO:1903045; GO:1903375; GO:2000020; GO:2001224 IGQICK 8.300000191 1 1 2.30E-13 717.5293463 0 15.85547 12.45294 0 0 0 15.30186 0 0 0 0 15.03263 0 0 0 13.93331 0 15.05398 0 17.99394 0 0 0 14.01348 0 15.37611 16.31822 0 0 0 0 17.38409 0 16.73954 0 0 16.67953 0 0 0 0 0 0 0 0 0 0 0 Q14566 MCM6_HUMAN "DNA replication licensing factor MCM6, EC 3.6.4.12 (p105MCM)" MCM6 Homo sapiens (Human) DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-dependent DNA replication initiation [GO:0030174] "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-dependent DNA replication initiation [GO:0030174]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697] GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006268; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969 GVLLMLFGGVPK 4.300000191 0.470317006 0.470317006 0.161452288 1247.269426 16.56788 16.70498 15.54803 16.35799 0 0 14.54154 0 15.1162 0 16.89052 17.16138 12.84142 11.62464 13.48851 0 13.88631 0 15.8352 18.23485 0 16.8859 0 16.72091 15.83157 0 12.0852 18.14924 15.08449 15.81894 0 15.85222 0 0 11.69823 15.39145 15.7261 13.77068 16.53346 15.84062 16.34071 12.08976 0 0 15.18912 15.33966 0 0 Q14571 ITPR2_HUMAN "Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2, IP3R 2, InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor, Type 2 InsP3 receptor)" ITPR2 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667] "cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]" "calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]" GO:0001666; GO:0005220; GO:0005509; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005938; GO:0007165; GO:0015085; GO:0016020; GO:0016021; GO:0016529; GO:0030659; GO:0030667; GO:0031095; GO:0033017; GO:0035091; GO:0043235; GO:0044325; GO:0051209; GO:0070679; GO:0071320; GO:0071361; GO:0097110 EETLLNVIK 3.930000067 0.300433338 0.300433338 0.005471434 1057.659447 13.69745 13.3804 13.70785 16.33372 15.25134 13.84476 0 0 13.09047 0 16.53871 12.76077 15.28195 13.78326 0 0 0 14.67893 0 15.10031 0 0 0 13.9142 0 15.84286 0 14.84255 0 16.06305 14.7456 16.85117 0 16.75142 15.79831 0 0 13.49913 6.506029 0 16.13885 0 0 16.33281 13.56859 14.63283 15.34598 15.56279 Q14573 ITPR3_HUMAN "Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3, IP3R 3, InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor, Type 3 InsP3 receptor)" ITPR3 Homo sapiens (Human) calcium ion transport into cytosol [GO:0060402]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917] apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667] "apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]; calcium ion transport into cytosol [GO:0060402]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917]" "calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]" GO:0000822; GO:0005220; GO:0005509; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005903; GO:0007186; GO:0007204; GO:0007613; GO:0015278; GO:0016020; GO:0016529; GO:0030659; GO:0030667; GO:0031095; GO:0035091; GO:0043025; GO:0043209; GO:0043235; GO:0043533; GO:0045177; GO:0050909; GO:0050913; GO:0050916; GO:0050917; GO:0051209; GO:0051592; GO:0060291; GO:0060402; GO:0070679 ASLAHLLDMMK 13.18999958 0.648336768 0.648336768 0.456033625 1230.354813 0 0 0 18.75472 18.25688 0 18.69787 0 0 0 0 0 0 0 0 0 0 0 18.91123 0 0 18.54911 18.98195 0 0 0 0 18.554 0 0 0 18.60123 0 0 0 0 0 20.79716 0 0 0 0 0 19.81719 0 16.48991 0 0 Q14574 DSC3_HUMAN Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP) DSC3 CDHF3 DSC4 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; protein stabilization [GO:0050821] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; protein stabilization [GO:0050821] calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295] GO:0001533; GO:0001701; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0005911; GO:0007155; GO:0007156; GO:0016020; GO:0016021; GO:0030054; GO:0030057; GO:0045295; GO:0050821; GO:0098609 GWITIDEISGSIITSK 3.380000114 1 1 1.16E-12 1719.481362 14.65066 16.56436 0 15.15972 17.29875 18.25127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.11723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14584 ZN266_HUMAN Zinc finger protein 266 (Zinc finger protein HZF1) ZNF266 KIAA2007 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 QCGDVSSEHSCLK 8.31000042 1 1 0.224958643 1506.783174 0 15.18967 13.42732 14.81388 0 0 0 15.41037 0 15.9381 0 0 14.81316 13.68804 14.80385 14.61415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0118 0 0 0 0 0 0 0 Q14585 ZN345_HUMAN Zinc finger protein 345 (Zinc finger protein HZF10) ZNF345 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0046872; GO:1990837 AFYSGSSLTQHQRIHTGEK 3.619999886 1 1 2.75E-12 2146.83531 13.46548 0 12.67646 0 0 12.25556 15.63313 12.34348 13.67373 0 0 0 0 14.09548 0 15.20346 0 0 0 0 0 0 0 0 0 0 0 16.129 0 0 0 0 0 0 0 0 0 0 0 0 15.38586 16.41847 0 15.7644 0 0 0 14.17254 Q14586 ZN267_HUMAN Zinc finger protein 267 (Zinc finger protein HZF2) ZNF267 Homo sapiens (Human) multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0046872 SSCLTQHRK 3.519999981 1 1 0.126271477 1116.54833 14.63114 14.243 0 17.89639 14.42277 13.58833 0 0 13.39071 0 0 0 12.09191 0 0 0 0 0 0 0 12.42701 0 14.82397 16.95187 15.8052 0 14.92558 14.64589 15.55313 14.90284 0 15.50993 14.4295 17.67476 0 0 0 16.04235 0 0 0 0 0 0 0 0 0 0 Q14587 ZN268_HUMAN Zinc finger protein 268 (Zinc finger protein HZF3) ZNF268 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0051726; GO:0071356; GO:0090073; GO:1901224 CGTHGK 5.619999886 1 1 0.171998299 660.3503205 12.2249 15.74134 0 12.56269 12.45127 16.36169 15.28593 15.82724 15.24796 16.39104 13.34527 14.92857 14.27325 0 15.93511 15.06015 12.74255 13.92522 17.30673 0 0 17.45622 0 0 15.56714 0 15.34936 14.84182 15.87089 0 0 0 16.39303 13.24543 0 14.39543 0 0 15.46633 16.76406 15.88427 0 0 16.93316 0 15.88715 0 16.29135 Q14590 ZN235_HUMAN "Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog, Zfp-93) (Zinc finger protein HZF6)" ZNF235 ZFP93 ZNF270 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 ELQTQR 9.470000267 1 1 0.214151633 773.6170306 0 14.98541 15.42966 15.27703 0 0 0 0 0 15.43555 15.53815 12.91165 17.68386 17.77975 17.67395 17.77793 16.65632 16.96401 17.97029 0 17.0526 17.59474 16.86678 16.97901 16.8843 0 15.82565 16.25884 0 0 0 17.78242 17.61589 16.88113 13.5118 15.48993 18.57563 18.48061 18.84384 16.54617 0 19.14142 15.81861 16.7997 17.79949 17.23421 15.95334 0 Q14593 ZN273_HUMAN Zinc finger protein 273 (Zinc finger protein HZF9) ZNF273 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 TPGLPGSLEMGPLTFR 8.800000191 0.054029968 0.054029968 0.102227101 1688.374931 0 0 0 0 16.16559 16.8138 15.71831 14.06708 16.10258 0 0 0 16.88658 0 0 15.15721 15.8289 16.82834 0 0 0 0 0 0 16.50853 17.91489 17.15066 0 0 0 16.18712 0 0 16.69885 16.79728 19.32046 0 17.18661 16.71348 0 0 0 0 17.79675 0 0 0 0 Q14596 NBR1_HUMAN Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B) NBR1 1A13B KIAA0049 M17S2 MIG19 Homo sapiens (Human) macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872] autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235] autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235]; mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872] mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] GO:0000407; GO:0005654; GO:0005758; GO:0005764; GO:0005770; GO:0005776; GO:0005778; GO:0005829; GO:0008270; GO:0016020; GO:0016236; GO:0016604; GO:0030500; GO:0031430; GO:0032872; GO:0043130; GO:0043231; GO:0043235; GO:0045668; GO:0051019 QLNLRLLK 18.23999977 1 1 0.626359786 996.8547216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14624 ITIH4_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H4, ITI heavy chain H4, ITI-HC4, Inter-alpha-inhibitor heavy chain 4 (Inter-alpha-trypsin inhibitor family heavy chain-related protein, IHRP) (Plasma kallikrein sensitive glycoprotein 120, Gp120, PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 ]" ITIH4 IHRP ITIHL1 PK120 PRO1851 Homo sapiens (Human) acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097] endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562 ETLFSVMPGLKMTMDK 3.99000001 1 1 0.234451609 1842.828243 0 0 0 0 0 13.95664 16.31387 0 0 0 14.52346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.43064 0 0 0 0 0 0 0 0 0 0 Q14626 I11RA_HUMAN "Interleukin-11 receptor subunit alpha, IL-11 receptor subunit alpha, IL-11R subunit alpha, IL-11R-alpha, IL-11RA [Cleaved into: Soluble interleukin-11 receptor subunit alpha, sIL-11R, sIL-11RA, sIL11RA ]" IL11RA Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888]; cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284] cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0004896; GO:0004921; GO:0005576; GO:0005886; GO:0005887; GO:0008284; GO:0009897; GO:0019221; GO:0019955; GO:0019970; GO:0032502; GO:0043235; GO:0060322 SSSCSGLSR 7.900000095 0.93107605 0.93107605 0.210443695 938.4119922 0 12.17434 0 0 15.56973 14.59619 16.17627 0 0 0 0 0 0 0 0 0 15.55619 0 0 15.10852 0 0 16.33924 0 0 0 0 15.55699 14.64776 15.86177 15.2058 12.38243 15.05352 0 15.47459 0 17.13052 0 0 0 17.77974 0 0 0 13.64587 0 0 0 Q14642 I5P1_HUMAN "Inositol polyphosphate-5-phosphatase A, EC 3.1.3.56 (43 kDa inositol polyphosphate 5-phosphatase) (Type I inositol 1,4,5-trisphosphate 5-phosphatase, 5PTase)" INPP5A 5PTASE Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] "dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]" "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]" GO:0004445; GO:0005886; GO:0016020; GO:0030425; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215 DNNGTALLEFDK 3.720000029 1 1 0.060766357 1335.972327 13.17236 13.68898 0 12.29586 14.01287 11.41784 8.044075 12.28236 0 0 0 0 12.8934 0 13.96397 0 0 15.64528 0 0 0 0 15.96096 16.29745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14643 ITPR1_HUMAN "Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1, IP3R 1, InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor, Type 1 InsP3 receptor)" ITPR1 INSP3R1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882] calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] "calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]" "calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]" GO:0000902; GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0019904; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:0098685; GO:0098695 CQDMVMAELVNSGEDVLVFYNDR 2.160000086 0.626472712 0.626472712 0.023878495 2736.677381 14.21702 11.94331 0 12.37398 15.54248 13.83522 14.81971 14.49635 14.86753 0 14.36395 15.00676 0 0 0 0 0 0 0 0 0 0 0 15.01684 14.50229 0 15.25691 0 0 0 0 0 0 0 0 0 15.92193 0 0 16.15354 15.24725 0 0 0 0 0 0 0 Q14653 IRF3_HUMAN "Interferon regulatory factor 3, IRF-3" IRF3 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon signaling pathway [GO:0060337] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon signaling pathway [GO:0060337]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006915; GO:0006974; GO:0019904; GO:0031663; GO:0032481; GO:0032727; GO:0032728; GO:0035666; GO:0039530; GO:0042802; GO:0042803; GO:0042981; GO:0043123; GO:0043565; GO:0045944; GO:0050727; GO:0051607; GO:0060337; GO:0060340; GO:0071360; GO:0071888; GO:0097300; GO:0098586; GO:1990837; GO:1990841 GVMSYVR 3.75999999 1 1 0.078802919 828.0325638 0 15.50332 13.96809 0 14.36428 15.98556 14.39189 0 13.68231 0 0 16.0717 0 14.81466 12.48519 0 16.67451 13.22877 15.09213 0 0 0 14.86424 0 0 15.92301 0 0 0 0 0 0 0 15.77082 0 0 0 0 17.18383 0 0 0 0 0 0 0 14.96928 0 Q14656 TM187_HUMAN Transmembrane protein 187 (Protein ITBA1) TMEM187 CXorf12 DXS9878E ITBA1 Homo sapiens (Human) integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] GO:0016021; GO:0030133 FHPSGGK 6.170000076 1 1 0.187756422 730.5505344 0 0 0 0 0 0 16.90054 0 0 0 0 17.46858 18.1406 0 0 0 0 0 0 0 16.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24.10687 0 Q14667 K0100_HUMAN Protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein) KIAA0100 BCOX1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 LLIGLSVGDKNPGK 3.549999952 1 1 2.06E-12 1410.816665 14.8494 13.71649 14.62231 13.10838 0 4.732379 14.70699 0 14.4238 0 14.75671 0 15.37773 0 0 0 0 0 0 14.65371 0 0 0 0 14.39025 0 14.76834 14.8677 14.71251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.76753 0 0 0 0 Q14671 PUM1_HUMAN "Pumilio homolog 1, HsPUM, Pumilio-1" PUM1 KIAA0099 PUMH1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863] miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637 QHGEQLGGGGSGGGGYNNSKHR 1.139999986 1 1 0.250561064 2155.482042 0 0 0 0 0 0 14.32625 0 0 0 13.49704 13.52569 13.67827 0 0 12.79681 0 0 0 0 0 0 0 0 0 0 14.37947 0 0 0 0 0 0 0 0 0 14.43986 0 0 0 0 0 11.80218 0 0 0 0 0 Q14676 MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) MDC1 KIAA0170 NFBD1 Homo sapiens (Human) DNA repair [GO:0006281]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573] chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; protein C-terminus binding [GO:0008022]; DNA repair [GO:0006281]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573] FHA domain binding [GO:0070975]; protein C-terminus binding [GO:0008022] GO:0005634; GO:0005654; GO:0005694; GO:0005925; GO:0006281; GO:0008022; GO:0016604; GO:0031573; GO:0070975 AIPGDQHPESPVHTEPMGIQGRGR 4.079999924 1 1 0.045133401 2581.271189 0 16.56976 15.11526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14677 EPN4_HUMAN "Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region, Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein, EpsinR)" CLINT1 ENTH EPN4 EPNR KIAA0171 Homo sapiens (Human) endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897] cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] GO:0005543; GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0030125; GO:0030276; GO:0043231; GO:0045296; GO:0048471 IGSTIDDTISK 1.25999999 1 1 0.012853074 1154.295203 15.58967 0 0 0 15.40071 0 0 14.29341 0 0 0 14.8024 0 0 0 0 0 0 0 0 15.16097 0 0 0 0 0 11.25254 0 10.53004 0 0 0 12.65352 0 13.92638 12.53186 0 0 0 0 0 0 0 0 0 0 0 0 Q14678 KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) KANK1 ANKRD15 KANK KIAA0172 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] beta-catenin binding [GO:0008013] GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393 DGNKDSNGAK 7.03000021 1 1 0.379030359 1005.521018 16.34314 16.69003 16.16658 15.55179 15.70838 16.33676 0 15.52183 0 15.18803 0 16.93355 16.3078 16.09009 16.05907 16.30911 16.78809 16.94409 16.50683 16.06664 0 16.47021 17.23429 0 16.12614 0 16.15134 0 16.36608 0 0 15.14716 0 16.90358 0 16.4546 17.66838 0 0 0 0 16.11156 0 0 0 0 0 0 Q14679 TTLL4_HUMAN "Tubulin monoglutamylase TTLL4, EC 6.3.2.- (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)" TTLL4 KIAA0173 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222 SLASAISGK 21.21999931 1 1 0.381995733 833.5478292 19.54319 19.19823 0 19.90115 0 18.96174 0 0 0 0 0 0 0 0 0 20.73211 0 0 19.13504 17.03803 0 20.57516 0 0 19.84086 18.13102 19.06878 0 0 19.37195 0 19.81964 0 0 0 0 0 21.40161 0 0 0 0 0 0 0 17.41888 0 0 Q14681 KCTD2_HUMAN BTB/POZ domain-containing protein KCTD2 (Potassium channel tetramerization domain-containing protein 2) KCTD2 KIAA0176 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cullin family protein binding [GO:0097602]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] cullin family protein binding [GO:0097602]; protein-containing complex binding [GO:0044877] GO:0005737; GO:0031463; GO:0043161; GO:0044877; GO:0051260; GO:0097602 HGKLIITK 21.44000053 1 1 0.006140819 905.6993119 0 15.83546 0 14.4465 0 13.6875 0 0 15.92189 0 0 0 15.86033 0 0 15.09826 0 0 0 0 0 0 0 0 0 0 0 0 16.54143 15.98811 0 0 0 0 0 0 0 0 0 16.70489 0 0 0 15.82489 0 0 0 0 Q14683 SMC1A_HUMAN "Structural maintenance of chromosomes protein 1A, SMC protein 1A, SMC-1-alpha, SMC-1A (Sb1.8)" SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 Homo sapiens (Human) cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827] "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] GO:0000070; GO:0000775; GO:0000776; GO:0000794; GO:0003677; GO:0003682; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0009314; GO:0016363; GO:0016887; GO:0019827; GO:0030893; GO:0034089; GO:0034991; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431 EKDSELNQK 5.300000191 1 1 1.83E-12 1091.013109 10.78944 17.59565 17.44936 0 15.40883 13.49815 0 0 0 0 16.11787 15.14736 16.87362 0 16.99994 16.23674 16.16745 0 0 0 17.68802 0 15.21282 0 0 18.49867 17.75787 18.0569 0 16.28587 0 0 17.96656 0 19.28693 17.02243 0 18.56423 19.65148 19.27687 0 14.9402 0 16.99109 0 0 0 0 Q14686 NCOA6_HUMAN "Nuclear receptor coactivator 6 (Activating signal cointegrator 2, ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250, NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein, PPAR-interacting protein, PRIP) (Thyroid hormone receptor-binding protein)" NCOA6 AIB3 KIAA0181 RAP250 TRBP Homo sapiens (Human) "brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; histone H3-K4 methylation [GO:0051568]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]" cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; histone H3-K4 methylation [GO:0051568]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]" chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0035097; GO:0043231; GO:0044666; GO:0045893; GO:0045944; GO:0046965; GO:0046966; GO:0051568 SLQGGPSR 4.079999924 1 1 0.240504236 800.8006689 0 15.58095 0 0 0 0 0 0 0 0 0 0 0 16.31977 0 0 0 0 17.19394 16.5922 0 16.21416 0 15.95972 0 0 0 0 0 16.80031 0 16.65619 0 17.10934 16.53201 16.03137 0 17.84435 16.67365 16.49319 16.91131 16.52702 16.2239 17.84695 15.78647 16.19618 17.71675 16.78353 Q14689 DIP2A_HUMAN "Disco-interacting protein 2 homolog A, DIP2 homolog A, EC 6.2.1.1" DIP2A C21orf106 DIP2 KIAA0184 Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758] cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; acetate-CoA ligase activity [GO:0003987]; acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758] acetate-CoA ligase activity [GO:0003987] GO:0003987; GO:0005739; GO:0005886; GO:0006085; GO:0009986; GO:0010629; GO:0016020; GO:0043197; GO:0060997; GO:2000758 GLGAQTGVLR 3.099999905 0.199586928 0.199586928 0.247499555 971.1252802 15.07492 15.52985 0 13.94112 0 12.6138 15.20455 14.24518 17.4797 14.20141 14.92636 0 15.65653 14.54263 0 14.70333 0 16.19559 0 0 0 15.99215 0 16.09664 14.51336 15.20173 15.48117 14.44463 14.74749 15.99101 12.95698 16.17669 10.93209 15.53273 14.89496 14.6231 10.30316 14.87597 0 0 13.72043 16.1251 13.77098 14.33809 14.94925 0 0 14.51259 Q14690 RRP5_HUMAN "Protein RRP5 homolog (NF-kappa-B-binding protein, NFBP) (Programmed cell death protein 11)" PDCD11 KIAA0185 Homo sapiens (Human) rRNA processing [GO:0006364] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040; GO:0051059 CVVSSLGITDR 3.880000114 1 1 0.108762012 1205.292693 9.562236 0 14.12538 0 0 13.46728 0 0 0 0 0 0 0 11.19983 0 14.09542 0 0 0 0 11.60018 0 0 0 0 11.18551 0 13.27218 10.03938 12.06357 13.26994 12.0353 6.009861 14.31749 12.71252 12.72404 13.55498 0 0 0 0 0 15.68581 14.78825 0 0 0 0 Q14692 BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog) BMS1 BMS1L KIAA0187 Homo sapiens (Human) "endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" 90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0030686; GO:0034511 ILALLDALSTVHSQKMK 3.380000114 1 1 0.044973841 1880.677831 0 14.67542 13.03147 11.44325 14.33333 0 15.82811 0 0 13.045 14.79612 0 0 14.43194 0 0 0 0 11.94268 0 0 15.66009 0 0 0 12.31283 14.60632 0 0 0 0 0 0 0 15.54788 0 0 0 0 0 0 13.1657 14.17759 0 10.30806 0 0 0 Q14693 LPIN1_HUMAN "Phosphatidate phosphatase LPIN1, EC 3.1.3.4 (Lipin-1)" LPIN1 KIAA0188 Homo sapiens (Human) animal organ regeneration [GO:0031100]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of myelination [GO:0031642]; negative regulation of phosphatidate phosphatase activity [GO:1903741]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; animal organ regeneration [GO:0031100]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of myelination [GO:0031642]; negative regulation of phosphatidate phosphatase activity [GO:1903741]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0006642; GO:0006654; GO:0007077; GO:0008195; GO:0009062; GO:0019432; GO:0031100; GO:0031642; GO:0031965; GO:0032869; GO:0044255; GO:0045740; GO:0045944; GO:0046473; GO:0120162; GO:1903741 SSSPHK 4.460000038 1 1 0.183020087 641.1400293 0 0 17.54236 0 0 16.13879 0 0 0 0 0 15.31502 0 14.89911 0 0 0 0 0 0 0 16.34127 17.43598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.84034 16.72959 16.81834 16.68771 16.19316 15.44022 16.90973 16.46952 0 0 0 Q14696 MESD_HUMAN LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61) MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 Homo sapiens (Human) mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055] identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750] GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395 RPSAPVDFSK 1.429999948 1 1 0.199867983 1103.23203 0 0 0 0 0 0 0 0 0 0 0 16.34738 0 13.51 0 16.4212 0 0 0 0 0 0 0 0 0 0 14.96122 0 0 0 0 0 0 0 0 15.11081 0 0 0 0 14.0267 15.42813 16.89404 0 0 0 0 0 Q14703 MBTP1_HUMAN "Membrane-bound transcription factor site-1 protease, EC 3.4.21.112 (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1, SKI-1)" MBTPS1 KIAA0091 S1P SKI1 Homo sapiens (Human) ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976] serine-type endopeptidase activity [GO:0004252] GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0060627 LPIKVK 9.659999847 0.162881121 0.162881121 0.154576993 693.3923742 14.32559 14.97188 13.73491 12.14208 14.36776 14.02524 15.55909 0 0 0 0 0 14.02123 16.84674 8.724483 0 0 0 0 0 0 16.47601 14.94918 0 15.59355 15.47978 0 15.06568 14.72941 0 0 0 0 0 16.84092 0 0 15.09318 0 0 0 0 0 0 16.69666 0 0 14.9362 Q14721 KCNB1_HUMAN "Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1, DRK1, h-DRK1) (Voltage-gated potassium channel subunit Kv2.1)" KCNB1 Homo sapiens (Human) action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904] axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904] delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016021; GO:0016328; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0097623; GO:0098900; GO:1900454; GO:2000671 EQGSPEKAR 3.089999914 1 1 0.317056648 1001.276101 17.85933 0 18.19378 0 0 0 0 0 0 18.27516 0 0 0 16.68087 0 0 0 0 0 17.72647 0 0 0 0 0 17.8708 16.96231 16.30172 0 0 0 0 0 18.8406 0 0 0 0 0 0 0 0 0 15.48708 0 0 0 16.34439 Q14722 KCAB1_HUMAN "Voltage-gated potassium channel subunit beta-1, EC 1.1.1.- (K(+) channel subunit beta-1) (Kv-beta-1)" KCNAB1 KCNA1B Homo sapiens (Human) negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379] aldo-keto reductase (NADP) activity [GO:0004033]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] GO:0004033; GO:0005249; GO:0005829; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0019904; GO:0031234; GO:0034705; GO:0044224; GO:0044325; GO:0070402; GO:1901379; GO:1902259; GO:1902260; GO:1903817 KASENAK 11.97000027 0.246909708 0.246909708 0.130161602 747.0304686 0 15.67267 14.06575 14.77951 10.90378 15.14306 10.80798 14.00279 0 13.33924 15.1065 16.6652 14.68567 14.43438 15.92083 0 17.21465 17.22884 9.588581 14.69865 11.16532 0 14.26784 14.24939 11.53059 0 10.8138 15.28335 14.2214 15.7445 17.66318 15.61177 16.24218 14.71301 15.01966 14.48473 17.22845 16.67844 0 14.687 0 15.49229 16.81559 0 13.72697 16.2247 18.28115 12.15821 Q14738 2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta) PPP2R5D Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0019888; GO:0035307; GO:0072542 VMEPLFR 13.25 1 1 0.090750935 907.0790228 15.61603 14.48673 16.38467 14.45759 13.63327 0 14.92595 0 12.54401 16.17097 15.7327 13.16419 14.48879 14.31422 0 0 0 0 0 0 0 0 15.21566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.30014 0 0 0 0 0 0 0 Q14739 LBR_HUMAN "Delta(14)-sterol reductase LBR, Delta-14-SR, EC 1.3.1.70 (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase, C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase)" LBR Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]" "chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]" GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005639; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0016021; GO:0016126; GO:0016627; GO:0030223; GO:0031965; GO:0050613; GO:0070087; GO:0070402 NDAPHK 2.160000086 0.474781573 0.474781573 0.202350679 682.0323739 0 0 0 14.18 0 0 15.03043 0 0 0 0 0 0 16.87114 0 0 15.72453 0 0 0 15.08358 15.78822 17.77477 16.83683 0 0 16.98688 0 18.34167 0 17.38756 13.59391 0 15.4345 17.17472 16.74919 19.22736 0 16.28894 0 16.25808 0 16.16675 0 15.81649 0 0 0 Q14766 LTBP1_HUMAN "Latent-transforming growth factor beta-binding protein 1, LTBP-1 (Transforming growth factor beta-1-binding protein 1, TGF-beta1-BP-1)" LTBP1 Homo sapiens (Human) regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583] calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024] GO:0001527; GO:0005024; GO:0005509; GO:0005576; GO:0005788; GO:0031012; GO:0032991; GO:0035583; GO:0050431; GO:0050436; GO:0062023; GO:1901388 NTEGSFR 13.28999996 0.710636854 0.710636854 0.278242431 810.3548051 15.98645 15.74847 12.98032 15.64601 0 16.08164 15.27962 15.34482 15.86174 17.15494 0 15.78204 15.31556 15.10095 16.67105 15.97429 15.55247 15.70163 16.78178 16.85804 16.67465 16.4668 0 16.39569 17.20451 16.45391 16.38932 15.67127 15.07403 16.34493 16.2816 16.48708 16.6843 16.27066 16.5535 15.97494 17.21745 17.41966 16.64419 16.68086 0 17.64963 17.75237 16.27197 16.54073 15.91797 16.59138 16.85714 Q14781 CBX2_HUMAN Chromobox protein homolog 2 CBX2 Homo sapiens (Human) cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122] euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064] GO:0000122; GO:0000791; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0030154; GO:0031519; GO:0035064; GO:0035102; GO:0045137 APSGGAVEQK 2.940000057 1 1 0.271978318 944.1137932 0 14.81321 13.6257 14.02611 0 16.58149 0 14.70752 0 14.57137 15.55124 14.24197 10.59936 0 0 0 15.32414 15.19857 0 0 0 0 0 0 0 0 16.15649 0 13.99698 0 14.90602 0 15.22204 0 14.56214 15.872 0 14.96649 0 0 16.01667 0 0 16.56583 0 0 13.72191 0 Q14789 GOGB1_HUMAN "Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein, GCP372) (Giantin) (Macrogolgin)" GOLGB1 Homo sapiens (Human) "chondrocyte proliferation [GO:0035988]; Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of transcription, DNA-templated [GO:0006355]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; chondrocyte proliferation [GO:0035988]; Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of transcription, DNA-templated [GO:0006355]" RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] GO:0000139; GO:0003723; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005829; GO:0006355; GO:0007030; GO:0016020; GO:0016021; GO:0035988; GO:0043565; GO:1905793 DQLIQEAAAENNKLK 3.200000048 1 1 2.46E-13 1684.013964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q147U1 ZN846_HUMAN Zinc finger protein 846 ZNF846 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 AFSNSSHLIGHGR 11.43999958 1 1 0.165184587 1382.094682 15.03008 14.91786 10.01925 0 0 14.08214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.06144 0 0 0 0 15.23977 0 0 0 0 0 0 Q14807 KIF22_HUMAN Kinesin-like protein KIF22 (Kinesin-like DNA-binding protein) (Kinesin-like protein 4) KIF22 KID KNSL4 Homo sapiens (Human) DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634] chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0006281; GO:0007018; GO:0007062; GO:0007080; GO:0008017; GO:0016607; GO:0016887; GO:0051310; GO:0072686 EGKLYLIDLAGSEDNR 11.36999989 1 1 0.05422227 1792.791131 15.63101 0 0 0 15.91068 0 12.53988 0 15.5941 11.36332 15.738 0 14.03949 0 0 0 15.27058 15.91978 0 0 0 0 0 15.73705 14.67525 0 15.55457 14.11833 0 0 0 0 13.9789 0 0 0 0 14.61353 14.91596 0 0 0 0 0 0 0 0 0 Q14831 GRM7_HUMAN "Metabotropic glutamate receptor 7, mGluR7" GRM7 GPRC1G MGLUR7 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axon development [GO:0061564]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]" asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235] "asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axon development [GO:0061564]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]" adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905] GO:0001640; GO:0001642; GO:0005509; GO:0005886; GO:0005887; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0008066; GO:0010855; GO:0014050; GO:0016021; GO:0016595; GO:0030165; GO:0030424; GO:0030425; GO:0032279; GO:0043198; GO:0043235; GO:0045211; GO:0046983; GO:0048786; GO:0051966; GO:0061564; GO:0070085; GO:0070905 AVVTAATMSSR 8.949999809 1 1 0 1093.62543 0 15.29657 15.00567 0 0 0 16.28946 0 0 0 0 0 0 0 0 0 15.61222 0 16.48389 16.16774 0 0 0 0 0 16.79426 0 0 16.50274 16.04353 0 17.41704 0 0 0 0 0 0 18.76499 0 0 0 0 0 0 0 0 0 Q14832 GRM3_HUMAN "Metabotropic glutamate receptor 3, mGluR3" GRM3 GPRC1C MGLUR3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]" astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]" adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0043197; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099055; GO:0099056 INFTAPFNPNK 11.67000008 1 1 0.309225177 1263.841493 14.30679 15.10916 0 0 0 16.06344 0 0 0 0 0 0 0 0 16.08396 0 0 0 0 16.65299 16.51218 0 16.79483 16.44299 17.03827 14.42134 0 14.48936 13.31554 14.62164 12.51629 16.245 16.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14839 CHD4_HUMAN "Chromodomain-helicase-DNA-binding protein 4, CHD-4, EC 3.6.4.12 (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)" CHD4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" "centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]" "centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] GO:0000781; GO:0000785; GO:0001221; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0006338; GO:0008270; GO:0010629; GO:0016020; GO:0016575; GO:0016581; GO:0016887; GO:0032991; GO:0042659; GO:0042826; GO:0045892; GO:0045893; GO:0061629; GO:0090575; GO:0140658; GO:2000736 NDMDEPPSGDFGGDEEKSR 5.96999979 0.683359802 0.683359802 0.255277977 2082.679306 0 15.12619 0 16.03242 16.52992 14.5585 15.49879 0 0 15.08426 0 0 12.69519 0 0 13.49154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.09709 0 0 0 14.96378 0 0 16.44263 12.70438 0 0 0 15.15559 0 0 0 Q14865 ARI5B_HUMAN "AT-rich interactive domain-containing protein 5B, ARID domain-containing protein 5B (MRF1-like protein) (Modulator recognition factor 2, MRF-2)" ARID5B DESRT MRF2 Homo sapiens (Human) "adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]" DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] GO:0000122; GO:0000976; GO:0001822; GO:0001889; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006807; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0045892; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0051091; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830 TINDIFK 4.019999981 1 1 0.171904015 850.2241368 15.34776 0 0 0 0 17.65718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14894 CRYM_HUMAN "Ketimine reductase mu-crystallin, EC 1.5.1.25 (NADP-regulated thyroid-hormone-binding protein)" CRYM THBP Homo sapiens (Human) lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0006554; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070062; GO:0070324; GO:0070327 LVTFYEDR 7.769999981 1 1 0.091233095 1043.34461 14.15949 0 13.70214 13.26294 14.47467 0 14.85323 15.07278 14.99733 15.6212 16.62412 16.0492 0 0 0 15.39721 0 11.15787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14896 MYPC3_HUMAN "Myosin-binding protein C, cardiac-type, Cardiac MyBP-C (C-protein, cardiac muscle isoform)" MYBPC3 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; heart morphogenesis [GO:0003007]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of muscle filament sliding [GO:0032971]; regulation of striated muscle contraction [GO:0006942]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] A band [GO:0031672]; C zone [GO:0014705]; cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863] A band [GO:0031672]; C zone [GO:0014705]; cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin binding [GO:0003779]; ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; heart morphogenesis [GO:0003007]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of muscle filament sliding [GO:0032971]; regulation of striated muscle contraction [GO:0006942]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] actin binding [GO:0003779]; ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432] GO:0001671; GO:0003007; GO:0003779; GO:0005829; GO:0005863; GO:0006942; GO:0007155; GO:0008307; GO:0014705; GO:0017022; GO:0030017; GO:0031432; GO:0031672; GO:0032036; GO:0032781; GO:0032971; GO:0042802; GO:0046872; GO:0055010; GO:0060048; GO:0097512 IPDTIVVVAGNK 5.639999866 1 1 0.157888221 1230.426786 0 8.841285 0 13.50558 10.4974 12.77671 14.92197 0 0 0 0 13.44125 12.9099 0 0 0 0 0 0 0 0 15.2543 0 0 0 14.8203 0 0 0 0 0 0 0 0 0 0 14.41148 0 14.30132 0 0 0 14.11991 0 0 14.58366 0 0 Q14914 PTGR1_HUMAN "Prostaglandin reductase 1, PRG-1 (15-oxoprostaglandin 13-reductase, EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein, D3T-inducible gene 1 protein, DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase, EC 1.3.1.74)" PTGR1 LTB4DH Homo sapiens (Human) leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327] 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] GO:0005737; GO:0006691; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0070062; GO:0097257; GO:0097327; GO:2001302 GTIVLASPGWTTHSISDGKDLEK 3.75999999 1 1 1.83E-12 2412.881703 14.52804 0 11.55705 0 14.42752 0 0 0 0 0 0 13.16718 0 0 0 0 0 0 15.15034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.75833 0 0 0 0 0 12.48128 0 Q14929 ZN169_HUMAN Zinc finger protein 169 ZNF169 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 ASLSIHQRK 8.850000381 0.62375474 0.62375474 0.143593222 1040.095515 16.31304 16.58177 13.24345 0 15.62728 15.26221 17.15672 16.24673 17.31656 0 14.31059 0 15.0335 16.3716 17.25168 15.93053 0 17.15638 16.93301 0 0 17.54851 0 14.17452 16.89677 18.05593 13.63559 0 16.75731 14.72638 16.95266 18.47309 17.47558 10.71028 12.54143 0 15.27602 17.61441 17.67713 18.65491 12.95338 17.18226 18.37235 17.76034 17.13359 15.61584 0 18.7588 Q14934 NFAC4_HUMAN "Nuclear factor of activated T-cells, cytoplasmic 4, NF-ATc4, NFATc4 (T-cell transcription factor NFAT3, NF-AT3)" NFATC4 NFAT3 Homo sapiens (Human) brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular respiration [GO:0045333]; cellular response to lithium ion [GO:0071285]; cellular response to UV [GO:0034644]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; muscle cell development [GO:0055001]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synapse maturation [GO:2000297]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]; smooth muscle cell differentiation [GO:0051145] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular respiration [GO:0045333]; cellular response to lithium ion [GO:0071285]; cellular response to UV [GO:0034644]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; muscle cell development [GO:0055001]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synapse maturation [GO:2000297]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]; smooth muscle cell differentiation [GO:0051145]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001569; GO:0005634; GO:0005667; GO:0005829; GO:0006357; GO:0006954; GO:0007507; GO:0007616; GO:0008630; GO:0016607; GO:0030178; GO:0031547; GO:0032091; GO:0032760; GO:0033173; GO:0034644; GO:0035562; GO:0042975; GO:0043524; GO:0045333; GO:0045944; GO:0050774; GO:0051145; GO:0055001; GO:0060291; GO:0071285; GO:1902894; GO:1990837; GO:2000297; GO:2001235 FGLGSPLPSPR 5.210000038 1 1 0.218929949 1125.930514 0 0 0 14.63515 0 0 0 0 0 13.29846 0 0 0 0 13.86624 0 0 0 0 0 0 17.55266 0 0 15.37726 11.6803 15.84748 0 17.09707 17.40811 0 0 16.47137 0 0 0 0 0 0 15.75158 0 0 0 0 0 15.55237 11.86788 14.20479 Q14940 SL9A5_HUMAN "Sodium/hydrogen exchanger 5 (Na(+)/H(+) exchanger 5, NHE-5) (Solute carrier family 9 member 5)" SLC9A5 NHE5 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719 SSFAFPPSLAK 4.260000229 1 1 0.305830705 1151.677096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.10015 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38988 0 0 0 0 0 Q14943 KI3S1_HUMAN "Killer cell immunoglobulin-like receptor 3DS1 (Natural killer-associated transcript 10, NKAT-10)" KIR3DS1 NKAT10 Homo sapiens (Human) immune response [GO:0006955]; natural killer cell activation [GO:0030101] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class I receptor activity [GO:0032393]; immune response [GO:0006955]; natural killer cell activation [GO:0030101] MHC class I receptor activity [GO:0032393] GO:0005886; GO:0005887; GO:0006955; GO:0030101; GO:0032393 GSHPHSPTGWSAPSNPMVIMVTGNHR 5.079999924 1 1 0.151532198 2768.704206 14.06868 0 0 14.79145 14.2131 13.72653 15.45084 0 15.45194 0 14.25276 0 14.14826 0 0 14.71264 14.20044 14.35327 0 0 0 14.17044 16.43667 14.39825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14952 KI2S3_HUMAN "Killer cell immunoglobulin-like receptor 2DS3 (Natural killer-associated transcript 7, NKAT-7)" KIR2DS3 NKAT7 Homo sapiens (Human) cellular defense response [GO:0006968] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cellular defense response [GO:0006968] GO:0005886; GO:0005887; GO:0006968 KNASVMDQGPAGNR 5.420000076 1 1 4.59E-13 1462.635086 0 16.19872 0 0 15.49495 0 14.73201 0 0 0 0 14.54173 0 12.474 15.27813 0 0 14.33522 0 0 0 0 0 0 0 0 0 12.93589 0 0 0 15.97949 15.83217 16.20397 15.22233 0 16.01123 14.9173 0 16.58694 16.2093 0 0 0 0 0 0 0 Q14953 KI2S5_HUMAN "Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (Natural killer-associated transcript 9, NKAT-9) (CD antigen CD158g)" KIR2DS5 CD158G NKAT9 Homo sapiens (Human) immune response [GO:0006955] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; HLA-C specific inhibitory MHC class I receptor activity [GO:0030110]; immune response [GO:0006955] HLA-C specific inhibitory MHC class I receptor activity [GO:0030110] GO:0005886; GO:0005887; GO:0006955; GO:0016021; GO:0030110 LPAGPK 4.119999886 0.000918195 0.000918195 0.18123889 583.4665652 15.73763 16.62717 16.00279 16.6332 0 0 16.27306 0 16.21581 0 16.28035 0 0 17.39965 17.09943 0 17.5454 16.67412 15.92554 16.90707 0 17.96096 17.98787 17.95573 16.76998 15.98632 18.7638 16.27577 16.79415 17.40907 18.17356 18.01448 17.23783 17.24426 16.28034 17.37097 17.76127 17.13675 17.3829 15.72265 17.26126 17.15247 17.18768 17.44345 16.89866 16.44842 15.88713 16.42808 Q14966 ZN638_HUMAN "Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1, CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein)" ZNF638 NP220 ZFML Homo sapiens (Human) RNA splicing [GO:0008380] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; RNA splicing [GO:0008380] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0043231 AVSLQRK 1.570000052 0.227253616 0.227253616 0.148217983 801.7501186 0 0 0 0 0 16.90235 11.72666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42338 0 0 0 0 0 0 0 0 0 0 0 16.46721 0 0 0 0 0 0 0 0 0 17.14123 0 0 14.06573 Q14974 IMB1_HUMAN "Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit, PTAC97)" KPNB1 NTF97 Homo sapiens (Human) astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404] enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0010494; GO:0016020; GO:0019899; GO:0019904; GO:0030953; GO:0031267; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0042564; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0090307; GO:1904813 YMEAFKPFLGIGLK 4.039999962 1 1 0.777174187 1630.770148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.11484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14980 NUMA1_HUMAN "Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22, NMP-22) (Nuclear mitotic apparatus protein, NuMA protein) (SP-H antigen)" NUMA1 NMP22 NUMA Homo sapiens (Human) anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236] disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631] GO:0000132; GO:0000139; GO:0000922; GO:0001578; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005938; GO:0006997; GO:0007059; GO:0008017; GO:0008022; GO:0015631; GO:0016328; GO:0016363; GO:0019897; GO:0019904; GO:0030425; GO:0030513; GO:0030953; GO:0031116; GO:0031616; GO:0032388; GO:0032991; GO:0035091; GO:0035371; GO:0036449; GO:0043025; GO:0044877; GO:0045618; GO:0051010; GO:0051011; GO:0051301; GO:0051321; GO:0051798; GO:0051984; GO:0055028; GO:0055048; GO:0060236; GO:0061673; GO:0070062; GO:0070840; GO:0072686; GO:0090235; GO:0097427; GO:0097431; GO:0097575; GO:0097718; GO:0099738; GO:1902365; GO:1902846; GO:1904778; GO:1905720; GO:1905820; GO:1905832; GO:1990023 ELEVMTAKYEGAK 4.800000191 1 1 0.105936785 1484.677272 14.16709 15.41251 14.32762 0 0 0 0 14.73972 0 0 0 0 9.907016 0 0 13.65701 12.22664 0 0 0 0 0 0 0 0 10.65304 0 14.84862 10.57791 0 0 0 0 14.05326 15.03605 0 0 0 0 14.06424 0 0 14.87515 11.31882 0 0 0 15.96167 Q14995 NR1D2_HUMAN "Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor, RVR) (Rev-erb-beta) (V-erbA-related protein 1-related, EAR-1R)" NR1D2 Homo sapiens (Human) "cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 IDCSMK 3.140000105 0.264877439 0.264877439 0.203928263 752.1712864 0 16.31732 16.04565 0 14.85114 14.29956 0 0 13.95462 16.6526 0 0 0 0 0 13.35209 0 0 0 0 0 0 0 15.50436 0 0 0 0 0 0 0 0 0 0 0 0 0 15.38282 0 0 0 14.92011 0 0 0 0 0 15.23984 Q14997 PSME4_HUMAN Proteasome activator complex subunit 4 (Proteasome activator PA200) PSME4 KIAA0077 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628] GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035093; GO:0070577; GO:0070628; GO:1990111 MVADMCR 1.24000001 1 1 0.290897516 882.8642407 18.24619 0 0 0 17.26315 16.9277 0 0 17.00837 17.06133 0 0 0 0 17.18524 0 0 0 18.02528 17.36147 15.71492 0 0 0 0 0 0 0 0 0 17.03063 0 0 0 17.9076 0 17.78332 0 18.23427 0 0 0 16.41482 0 0 0 0 0 Q14999 CUL7_HUMAN "Cullin-7, CUL-7" CUL7 KIAA0076 Homo sapiens (Human) epithelial to mesenchymal transition [GO:0001837]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; placenta development [GO:0001890]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]; vasculogenesis [GO:0001570] 3M complex [GO:1990393]; anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] 3M complex [GO:1990393]; anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ubiquitin protein ligase binding [GO:0031625]; epithelial to mesenchymal transition [GO:0001837]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; placenta development [GO:0001890]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]; vasculogenesis [GO:0001570] ubiquitin protein ligase binding [GO:0031625] GO:0000226; GO:0000281; GO:0001570; GO:0001837; GO:0001890; GO:0005680; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0006508; GO:0006511; GO:0007030; GO:0007088; GO:0016567; GO:0031461; GO:0031467; GO:0031625; GO:0048471; GO:0050775; GO:1990393 DTLQPGMR 19.27000046 0.199781731 0.199781731 0.043469474 929.6097653 0 16.59456 17.13485 18.0704 13.68655 15.77858 10.56915 0 15.80867 0 18.32312 0 0 0 16.90776 15.80204 17.51309 17.56793 17.45918 16.10512 17.68625 17.41698 17.09656 15.27414 18.97645 17.01061 0 13.36777 17.12066 15.48401 16.50931 17.55974 16.39444 13.5839 16.40368 0 18.0196 0 17.96211 17.81829 16.89639 16.64029 17.5249 14.45867 16.5283 16.70791 16.09422 0 Q149M9 NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 NWD1 Homo sapiens (Human) negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; nucleolus [GO:0005730] cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628] ATP binding [GO:0005524] GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088 GKPCR 11.97000027 0.639899373 0.639899373 0.208675277 617.4503313 14.21529 15.15513 16.56778 0 15.1257 14.98447 16.30409 14.81361 14.77623 16.30144 16.48738 0 0 15.98647 14.74179 0 15.24684 0 0 0 0 16.26935 0 0 16.70627 15.56354 15.90187 0 15.8887 0 16.4399 15.99278 16.18049 16.48021 15.67514 0 16.12759 0 0 14.66421 0 13.83982 16.08134 15.9539 0 16.43968 15.55452 16.39466 Q149N8 SHPRH_HUMAN "E3 ubiquitin-protein ligase SHPRH, EC 2.3.2.27, EC 3.6.4.- (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)" SHPRH KIAA2023 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] nucleoplasm [GO:0005654]; nucleosome [GO:0000786] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0016787; GO:0031625; GO:0046872; GO:0061630; GO:0140658 EEVAHR 1.840000033 1 1 0.264131739 739.2913875 0 16.22335 15.16066 0 15.79072 0 0 0 16.14713 0 0 0 16.58406 0 0 0 14.99778 0 0 0 0 0 16.77242 16.36031 0 0 0 15.41723 16.25861 15.30261 0 15.38029 16.8608 0 0 16.03849 17.10749 0 0 0 0 0 0 0 0 0 14.3928 0 Q14BN4 SLMAP_HUMAN "Sarcolemmal membrane-associated protein, Sarcolemmal-associated protein" SLMAP KIAA1601 SLAP UNQ1847/PRO3577 Homo sapiens (Human) muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150] integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790] integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150] GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150 FEMTEQEK 6.920000076 1 1 0.079243465 1059.509619 15.08693 15.64094 14.03749 0 15.69886 0 0 0 15.19299 0 17.00781 0 0 15.03551 0 0 0 13.37817 0 0 14.60002 0 0 0 0 15.56875 0 14.21139 0 0 15.00233 11.45916 0 15.11606 12.63467 0 0 0 0 0 13.90612 0 0 0 16.71194 0 0 0 Q14C86 GAPD1_HUMAN GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6) GAPVD1 GAPEX5 KIAA1521 RAP6 Homo sapiens (Human) endocytosis [GO:0006897]; regulation of GTPase activity [GO:0043087]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; regulation of GTPase activity [GO:0043087]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165] cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0030139; GO:0031267; GO:0032794; GO:0043087; GO:0045296; GO:0051223 LPNFGSHVLTPAEMEAFKQR 4.059999943 1 1 0.042527475 2287.922811 12.42719 0 14.37346 0 0 0 0 14.65376 0 0 15.60012 12.54023 15.80833 15.15048 14.42267 15.25431 0 14.31174 16.11785 15.95291 0 0 0 14.75398 0 14.66609 15.2686 0 0 13.42205 0 0 15.65667 0 15.82927 14.41862 15.49316 16.28946 17.01224 0 0 0 0 0 0 12.56137 0 0 Q14C87 T132D_HUMAN "Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein, Mature OL transmembrane protein)" TMEM132D HBE120 KIAA1944 MOLT Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ERTDYTGK 9.649999619 0.672527969 0.672527969 1.14E-13 969.6254875 13.99892 0 14.16686 0 0 15.29936 0 14.33205 15.25326 0 14.50692 15.64787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.55443 0 13.41757 11.95781 13.47846 13.61131 15.27238 12.40115 13.77552 16.54903 13.98656 0 16.09073 16.6116 14.85579 0 0 0 0 0 14.58823 Q14CM0 FRPD4_HUMAN "FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis, Preso)" FRMPD4 KIAA0316 PDZD10 PDZK10 Homo sapiens (Human) positive regulation of synapse structural plasticity [GO:0051835] cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; protein-containing complex [GO:0032991] "cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; protein-containing complex [GO:0032991]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of synapse structural plasticity [GO:0051835]" "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0005546; GO:0005856; GO:0032991; GO:0043197; GO:0051835 LHMGSVAYSCTSK 4.369999886 1 1 0.448674285 1457.5739 17.18623 0 18.32444 0 0 18.73462 0 0 17.99747 0 0 0 0 0 18.7218 0 0 0 0 17.66811 0 0 0 0 0 19.13451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.73732 0 0 0 0 0 Q14CN2 CLCA4_HUMAN "Calcium-activated chloride channel regulator 4, EC 3.4.-.- (Calcium-activated chloride channel family member 4, hCLCA4) (Calcium-activated chloride channel protein 2, CaCC-2, hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form ]" CLCA4 CaCC2 UNQ562/PRO1124 Homo sapiens (Human) chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006821; GO:0016324; GO:0034220; GO:0046872 AHGGANTAR 1.299999952 1 1 0.078388387 855.3939511 0 0 0 0 0 0 0 15.04791 0 0 0 0 12.7692 0 0 0 0 15.69919 0 0 0 0 0 0 0 0 0 0 16.41487 13.43689 0 0 16.31292 0 16.69368 0 0 0 0 0 0 0 0 0 0 15.90067 0 0 Q14CN4 K2C72_HUMAN "Keratin, type II cytoskeletal 72 (Cytokeratin-72, CK-72) (Keratin-72, K72) (Type II inner root sheath-specific keratin-K6irs2) (Type-II keratin Kb35)" KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 Homo sapiens (Human) cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] GO:0005829; GO:0045095; GO:0070062 SLALSAAARR 10.68000031 0.518424809 0.518424809 0.231269084 1013.257829 16.19272 0 10.95972 16.84034 15.88822 0 16.21534 11.5992 13.32967 16.76761 10.70963 14.81176 14.79982 15.52644 14.82603 9.825819 11.76138 13.87014 16.25753 15.15756 0 14.03605 15.34707 11.10279 0 16.82955 16.05318 0 15.36674 14.76112 0 15.43579 0 0 16.62903 0 0 17.18499 0 0 0 16.65884 0 17.4028 0 15.78715 0 16.09995 Q14CW9 AT7L3_HUMAN Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog) ATXN7L3 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone monoubiquitination [GO:0010390]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone monoubiquitination [GO:0010390]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] GO:0000124; GO:0003713; GO:0005634; GO:0006282; GO:0006325; GO:0006357; GO:0008270; GO:0010390; GO:0016578; GO:0030374; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0071819 KMEEMSLSGLDNSK 4.409999847 1 1 0.197975466 1600.868444 0 0 14.48141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.34356 0 14.44003 14.61363 16.39353 15.96798 0 0 13.97003 0 14.48546 0 14.0716 16.07579 0 12.7389 0 15.0596 0 0 0 Q14CX7 NAA25_HUMAN "N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20, NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)" NAA25 C12orf30 MDM20 NAP1 Homo sapiens (Human) N-terminal peptidyl-methionine acetylation [GO:0017196] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196] GO:0005737; GO:0005794; GO:0005829; GO:0017196; GO:0031416 DLNVFFSWDPK 5.150000095 1 1 0.56624277 1367.285828 0 0 0 0 0 0 16.52748 17.19823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.33559 18.21937 0 0 18.80378 0 0 0 0 0 0 0 0 0 0 0 17.53889 0 Q14CZ7 FAKD3_HUMAN "FAST kinase domain-containing protein 3, mitochondrial" FASTKD3 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528] RNA binding [GO:0003723] GO:0000963; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0033617; GO:0035770; GO:0044528; GO:0070131 LFSQNTVHWLQE 3.160000086 0.339035213 0.339035213 0.012569748 1500.941934 15.24825 16.16336 14.83029 17.07038 9.775543 15.55696 0 11.13361 0 16.40034 13.9156 13.59685 0 14.79917 0 13.96418 17.53338 0 0 12.47594 0 11.98009 17.88556 13.56854 12.30716 15.61201 0 0 0 13.6501 18.07808 12.51605 12.7801 15.50339 15.90601 14.89381 0 16.08477 0 16.84957 0 13.50059 0 0 17.20936 16.65116 14.63973 0 Q14D04 MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted) VEPH1 KIAA1692 VEPH Homo sapiens (Human) negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966] phosphatidylinositol-5-phosphate binding [GO:0010314] GO:0005886; GO:0009966; GO:0010314; GO:0030512; GO:0060392 LIVTENEDHEK 3.559999943 0.000522895 0.000522895 0.207013039 1326.920013 15.96313 14.9905 13.97855 0 0 15.91511 14.97347 0 0 0 0 0 12.2073 0 0 0 0 15.66327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1709 0 0 0 0 Q14D33 RTP5_HUMAN Receptor-transporting protein 5 (3CxxC-type zinc finger protein 5) (CXXC-type zinc finger protein 11) RTP5 C2orf85 CXXC11 Z3CXXC5 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] olfactory receptor binding [GO:0031849] GO:0001580; GO:0006612; GO:0016021; GO:0031849; GO:0051205 DRAGADMWASTFTLAMAER 6.840000153 1 1 0.142758497 2128.097133 0 0 0 14.24444 13.75256 0 15.21071 0 0 0 13.89247 0 15.88749 12.79752 17.8211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.21114 0 0 0 0 0 0 Q15003 CND2_HUMAN "Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H, hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)" NCAPH BRRN BRRN1 CAPH KIAA0074 Homo sapiens (Human) cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] chromatin binding [GO:0003682] GO:0000794; GO:0000796; GO:0003682; GO:0005654; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0051301; GO:0051309; GO:0051984; GO:1905820; GO:1905821 EADAEANHR 6.900000095 0.528186917 0.528186917 0.240447061 1012.673624 15.64407 0 15.41156 14.06575 14.73396 16.2521 0 15.19783 0 17.60909 14.36763 16.08989 0 14.44956 12.78306 0 15.38866 0 0 17.07266 14.48603 0 14.41205 12.88927 15.2202 15.51546 0 0 14.97782 15.15344 18.45687 14.9143 0 15.31117 0 16.33416 0 0 15.74572 0 0 16.29422 14.87895 13.70137 0 15.42944 0 13.9504 Q15005 SPCS2_HUMAN "Signal peptidase complex subunit 2 (Microsomal signal peptidase 25 kDa subunit, SPase 25 kDa subunit)" SPCS2 KIAA0102 SPC25 Homo sapiens (Human) protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465] peptidase activity [GO:0008233] GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021; GO:0045047 MAAAAVQGGRSGGSGGCSGAGGASNCGTGSGR 7.559999943 1 1 6.39E-12 2769.644804 0 9.687933 8.689016 0 12.98337 0 7.517529 0 9.438098 11.23512 0 0 0 12.31192 0 14.32968 0 0 15.17907 0 0 17.74889 13.64961 0 0 13.28516 0 11.77499 12.56602 10.5086 0 0 0 0 0 0 0 0 0 0 0 11.62114 0 0 15.36715 0 0 0 Q15006 EMC2_HUMAN "ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35, TPR repeat protein 35)" EMC2 KIAA0103 TTC35 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005737; GO:0005783; GO:0005789; GO:0042406; GO:0045050; GO:0071816; GO:0072546 ALFGLYMSASHIASNPK 3.089999914 1 1 0.213287202 1823.247189 9.348573 16.10849 17.3224 12.95411 0 0 13.10961 17.32612 0 0 0 0 0 0 0 16.11685 0 0 0 0 0 0 0 0 0 16.44086 16.07962 0 0 0 0 0 16.35774 0 0 17.22787 0 0 13.74165 0 0 0 0 0 0 0 19.10897 0 Q15008 PSMD6_HUMAN 26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A) PSMD6 KIAA0107 PFAAP4 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] enzyme regulator activity [GO:0030234] GO:0000502; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0022624; GO:0030234; GO:0034774; GO:0043161; GO:1904813 TVALGHR 7.199999809 0.541916907 0.541916907 0.161094496 754.3163953 17.10027 17.46671 16.65597 14.00241 0 13.92556 0 0 14.08066 17.25011 15.62619 0 17.53037 17.12237 0 15.80391 11.1515 0 12.91559 15.86101 0 0 17.46015 0 14.79304 0 0 13.44001 0 0 0 19.21856 0 16.90081 18.33246 14.14942 16.81937 0 18.60494 17.36207 16.50473 15.64289 16.15029 0 17.05342 16.16748 0 0 Q15018 ABRX2_HUMAN BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B) ABRAXAS2 ABRO1 FAM175B KIAA0157 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931] microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593] GO:0000278; GO:0000922; GO:0002931; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0051301; GO:0070536; GO:0070552; GO:0090307 MPSSGFAAEGR 1.429999948 0.02792218 0.02792218 0.103465828 1105.632404 0 0 0 14.25501 17.0579 0 0 0 13.72461 16.96911 16.48461 12.75106 16.01402 17.10429 16.13329 16.25605 13.835 15.09943 11.56866 12.40127 0 16.6881 0 15.57108 0 0 0 13.344 17.10239 17.59456 15.81578 18.64572 14.76646 0 15.92416 17.06072 0 0 0 14.44011 14.91796 17.24174 12.18916 14.29215 14.17323 16.06254 0 16.14958 Q15019 SEPT2_HUMAN "Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5, NEDD-5)" SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] GO:0000776; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0008021; GO:0015629; GO:0015630; GO:0017157; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0032391; GO:0034613; GO:0042802; GO:0045171; GO:0045296; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730 MQAQMQMQMQGGDGDGGALGHHV 2.710000038 1 1 9.21E-13 2447.64231 13.75428 0 0 0 12.4171 0 13.04018 15.28894 10.03378 12.24708 0 14.17276 0 0 0 0 0 12.52338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15021 CND1_HUMAN "Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2, hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog)" NCAPD2 CAPD2 CNAP1 KIAA0159 Homo sapiens (Human) cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821] "condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]" histone binding [GO:0042393] GO:0000779; GO:0000793; GO:0000796; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0042393; GO:0051301; GO:1905821 CSSVMLLGMMAR 11.88000011 1 1 2.52E-12 1371.486218 14.74979 0 14.96603 0 14.01522 14.00772 0 0 13.32706 0 0 14.90411 13.69379 12.49557 0 11.29086 12.79229 0 14.8922 14.74352 12.44853 9.37339 14.07189 13.43763 0 13.18789 0 15.829 13.71776 12.5717 0 9.936569 13.31138 13.38437 14.37128 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15024 EXOS7_HUMAN Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8) EXOSC7 KIAA0116 RRP42 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723] GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019 GVVTCMRK 2.789999962 0.903079748 0.903079748 0.212887989 951.7401347 15.29195 16.75135 0 16.80164 15.69022 15.71524 15.22157 14.80955 13.90129 16.24888 0 0 14.17829 16.75752 15.3051 15.63872 0 13.98417 0 0 15.13773 16.42763 0 16.23928 17.09472 16.31815 15.17266 14.00273 15.19341 15.2235 15.71634 16.11686 15.52852 0 14.8616 13.19108 0 0 0 15.02456 14.01688 14.93532 16.07992 15.83832 0 0 12.9398 12.28696 Q15025 TNIP1_HUMAN "TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1, ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1, Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein, VAN, hVAN)" TNIP1 KIAA0113 NAF1 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412] identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019] GO:0002755; GO:0005654; GO:0005829; GO:0006357; GO:0006412; GO:0006952; GO:0006954; GO:0007159; GO:0009101; GO:0042802; GO:0043124; GO:0045071; GO:0045944; GO:0050729; GO:0051019; GO:0070373; GO:0071222; GO:1903003 MLGELLEESQMEATR 3.099999905 1 1 0.475125579 1769.692515 15.79644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.62761 0 0 0 0 Q15027 ACAP1_HUMAN "Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1, Cnt-b1)" ACAP1 CENTB1 KIAA0050 Homo sapiens (Human) protein transport [GO:0015031] membrane [GO:0016020]; recycling endosome membrane [GO:0055038] membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0015031; GO:0016020; GO:0046872; GO:0055038 GADLGARDSEGR 3.24000001 1 1 0.213582476 1201.212091 0 0 0 0 14.56894 0 0 14.83743 0 10.16094 0 0 0 14.20166 14.63176 0 0 15.82582 0 0 0 0 14.77549 15.5989 15.03786 0 15.67876 0 16.96322 15.55353 0 0 0 14.9142 0 15.22678 0 0 0 15.95223 16.40151 0 14.09281 0 0 0 15.56573 15.24123 Q15029 U5S1_HUMAN "116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog, hSNU114) (U5 snRNP-specific protein, 116 kDa, U5-116 kDa)" EFTUD2 KIAA0031 SNRP116 Homo sapiens (Human) "cellular response to xenobiotic stimulus [GO:0071466]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to xenobiotic stimulus [GO:0071466]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623] GO:0000398; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016020; GO:0016607; GO:0030623; GO:0042220; GO:0043231; GO:0046540; GO:0071005; GO:0071007; GO:0071013; GO:0071466; GO:1990904 CFAETPNKK 5.03000021 1 1 0.215069016 1093.821169 19.62734 0 19.25459 0 0 0 0 19.9768 19.63722 16.3584 0 19.50293 19.32859 17.84555 0 0 17.71014 16.83368 0 0 0 0 0 18.28475 0 0 0 17.6101 18.08394 0 19.72553 20.97241 18.78731 0 0 0 0 19.55324 18.43356 0 0 19.71866 18.04385 0 0 17.53823 0 17.94871 Q15031 SYLM_HUMAN "Leucine--tRNA ligase, mitochondrial, EC 6.1.1.4 (Leucyl-tRNA synthetase, LeuRS)" LARS2 KIAA0028 Homo sapiens (Human) leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823] GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006429; GO:0032543 ASGKSPQPQLLSNK 9.789999962 1 1 0.162432952 1453.896171 13.13112 0 14.03106 13.78306 14.25531 0 12.47236 0 13.24802 0 15.12865 0 0 0 0 15.36932 0 15.70803 0 0 0 0 0 0 0 13.48704 0 0 11.9638 12.43469 0 14.37617 15.37133 12.47803 14.89556 0 0 0 0 0 0 0 0 0 0 0 16.35888 0 Q15032 R3HD1_HUMAN R3H domain-containing protein 1 R3HDM1 KIAA0029 R3HDM Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 GDSSGSSKSIGR 9.569999695 1 1 0.048672814 1138.074272 0 0 0 0 0 0 0 0 0 0 14.26045 0 15.36128 0 0 15.62809 13.23317 0 12.16823 15.44577 0 0 0 0 14.99806 0 0 0 0 0 15.00461 0 0 0 14.84656 0 13.26064 0 16.38442 0 8.817944 0 0 0 0 0 0 0 Q15034 HERC3_HUMAN "Probable E3 ubiquitin-protein ligase HERC3, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 3) (HECT-type E3 ubiquitin transferase HERC3)" HERC3 KIAA0032 Homo sapiens (Human) cytoplasmic vesicle [GO:0031410] cytoplasmic vesicle [GO:0031410]; ubiquitin-protein transferase activity [GO:0004842] ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0031410 YYITLTIPLAMAILR 5.570000172 0.391465366 0.391465366 0.289815474 1768.135658 0 0 14.63898 0 0 0 0 0 0 0 0 0 16.68126 15.90018 0 15.1136 0 0 17.29496 16.847 0 0 15.34605 0 0 0 0 0 16.25477 0 0 15.69907 0 13.596 0 16.77809 0 0 0 0 17.26129 11.88963 0 0 0 18.54401 0 0 Q15042 RB3GP_HUMAN "Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130, Rab3-GAP)" RAB3GAP1 KIAA0066 RAB3GAP Homo sapiens (Human) brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0005085; GO:0005096; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0007420; GO:0021854; GO:0031267; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0060079; GO:0060325; GO:0061646; GO:0070062; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786 GHAGR 6.519999981 0.610762775 0.610762775 0.248668479 499.6484668 0 0 15.1936 0 0 16.08014 0 14.52093 15.11264 0 0 14.83547 15.66989 15.12701 16.42997 16.20772 0 15.90323 16.23846 15.76032 17.94275 0 0 0 17.60006 0 16.89395 15.4021 17.6285 15.25415 0 16.42677 0 15.62261 0 0 17.31109 13.27021 15.05511 16.7345 16.63208 0 15.54355 0 13.78148 17.8729 17.1201 15.52004 Q15047 SETB1_HUMAN "Histone-lysine N-methyltransferase SETDB1, EC 2.1.1.366 (ERG-associated protein with SET domain, ESET) (Histone H3-K9 methyltransferase 4, H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1)" SETDB1 ESET KIAA0067 KMT1E Homo sapiens (Human) heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265] chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007265; GO:0008270; GO:0010629; GO:0018024; GO:0043231; GO:0045869; GO:0046974; GO:0051567; GO:0070828; GO:0090309; GO:1990841 AGGSRMEAEK 2.74000001 1 1 0.163564392 1039.326455 14.28052 12.96847 15.17864 14.70311 0 0 0 15.39472 13.45301 0 0 0 0 0 0 0 0 0 0 0 15.10817 0 0 0 15.36689 15.10785 0 13.63847 13.88652 12.64149 13.64139 14.70148 12.22001 0 13.19448 0 12.02265 16.02484 15.5469 14.64443 15.1689 14.28106 11.17708 0 0 0 0 0 Q15048 LRC14_HUMAN Leucine-rich repeat-containing protein 14 LRRC14 KIAA0014 Homo sapiens (Human) negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; kinase binding [GO:0019900]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122] kinase binding [GO:0019900] GO:0005737; GO:0019900; GO:0032088; GO:0034122 ELSMGSSLLSGR 3.839999914 1 1 0.194215488 1252.437917 0 15.17369 15.0013 0 0 0 15.64097 0 16.14854 0 0 0 0 0 0 0 0 0 0 16.73707 0 0 0 0 0 17.57361 16.21264 0 0 0 14.90147 0 15.61146 15.96374 0 0 16.2234 0 16.13006 15.7045 14.84967 15.50664 16.00868 0 14.92181 0 0 16.56827 Q15050 RRS1_HUMAN Ribosome biogenesis regulatory protein homolog RRS1 KIAA0112 RRR Homo sapiens (Human) "endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]" "condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]" "condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]" 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723] GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0002244; GO:0003723; GO:0005654; GO:0005730; GO:0005783; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570 KGGLGGK 10.94999981 0.811682403 0.811682403 0.203333967 616.5188588 13.78838 13.95049 0 0 16.92517 15.67105 0 0 14.37867 16.31097 0 0 16.8357 0 16.001 0 0 16.10555 16.58013 0 16.45928 0 0 15.93948 15.13522 0 0 0 17.2436 0 16.40809 0 0 0 14.63663 0 15.79546 16.02068 0 0 0 0 15.15541 0 0 15.66096 18.32788 15.71101 Q15051 IQCB1_HUMAN "IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein, PIQ)" IQCB1 KIAA0036 NPHP5 OK/SW-cl.85 Homo sapiens (Human) cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494] calmodulin binding [GO:0005516]; enzyme binding [GO:0019899] GO:0001750; GO:0005516; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0070062; GO:0072686 KPTGTDPR 8.619999886 1 1 0.121161583 870.9259021 13.84754 15.73291 0 13.14374 14.74755 15.79809 0 17.38656 13.09818 0 16.50336 12.98059 13.42513 0 15.81789 15.45084 0 0 0 0 0 16.75388 16.27582 16.28404 16.43297 0 0 0 0 0 0 13.66706 17.77542 0 0 18.53261 15.17406 0 16.45298 18.14827 12.24668 15.40091 14.91031 16.90306 0 16.43839 17.21592 0 Q15053 K0040_HUMAN Uncharacterized protein KIAA0040 KIAA0040 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RPSLPV 6.440000057 0.246709287 0.246709287 0.169718542 668.1841522 0 0 16.1626 16.86334 16.67532 0 17.4377 16.76834 14.31022 15.95947 16.11219 15.08029 0 0 14.53178 14.5422 16.08984 15.32699 13.97101 9.055669 11.82093 14.85326 16.48693 15.96592 8.877218 0 15.8915 11.21004 16.57357 0 15.84788 16.15376 0 17.12729 17.14552 15.03741 15.81393 17.11415 0 16.20609 0 0 0 0 0 16.29819 15.80082 13.98219 Q15057 ACAP2_HUMAN "Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2, Cnt-b2)" ACAP2 CENTB2 KIAA0041 Homo sapiens (Human) actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456] endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726] endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0001726; GO:0005096; GO:0010008; GO:0016020; GO:0030029; GO:0032456; GO:0046872; GO:1990090 AFCVANKQFMNGIR 1.49000001 1 1 0.191565328 1670.059012 0 0 13.38176 0 0 0 0 0 14.94796 0 0 0 0 0 0 0 15.37393 0 0 0 0 0 0 0 0 16.05639 15.44923 15.05451 0 13.93405 0 0 15.14397 12.96281 0 15.75206 15.26227 16.5353 15.29553 0 15.20445 15.94577 15.18509 0 12.94331 0 0 0 Q15058 KIF14_HUMAN Kinesin-like protein KIF14 KIF14 KIAA0042 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446] cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233] cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631] GO:0001558; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0008284; GO:0008574; GO:0010389; GO:0015631; GO:0016020; GO:0016887; GO:0019901; GO:0021685; GO:0021693; GO:0021695; GO:0021766; GO:0021772; GO:0021846; GO:0021987; GO:0030155; GO:0030165; GO:0030334; GO:0030496; GO:0031146; GO:0031641; GO:0032147; GO:0032467; GO:0032487; GO:0033624; GO:0034446; GO:0043066; GO:0043161; GO:0043523; GO:0043524; GO:0045184; GO:0051233; GO:0051301; GO:0090543; GO:1903429; GO:2000045 ANENVALK 12.27999973 1 1 0.022909502 860.8352713 0 0 0 0 0 0 14.67136 0 14.91227 0 0 13.80249 15.3901 0 0 0 0 0 0 0 0 0 14.16326 0 0 0 0 0 16.55484 13.96054 0 16.12746 0 0 0 0 0 0 0 0 15.71407 0 0 0 0 0 0 0 Q15061 WDR43_HUMAN WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog) WDR43 KIAA0007 UTP5 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; rRNA processing [GO:0006364] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation regulator activity [GO:0003711]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; rRNA processing [GO:0006364] RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation regulator activity [GO:0003711] GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0034243; GO:0045943; GO:2000036; GO:2000234 EKSAVMSFTVTDEPVYIDLTLSENK 11.61999989 0.337015063 0.337015063 0.179545733 2832.846118 0 15.22995 12.64414 0 0 0 0 14.32964 0 0 15.21695 14.7816 0 15.44353 0 0 0 0 0 0 14.47001 0 0 14.02229 0 0 0 12.18295 11.87299 15.22784 0 0 0 0 0 15.29211 0 15.6264 0 17.17562 0 14.18539 0 15.74137 0 0 0 13.9533 Q15063 POSTN_HUMAN "Periostin, PN (Osteoblast-specific factor 2, OSF-2)" POSTN OSF2 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888] cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872] GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009888; GO:0030198; GO:0031012; GO:0046872; GO:0050839; GO:0062023; GO:0071307 VASEALMK 12.71000004 1 1 0.282446863 846.3791803 19.08572 16.66887 18.19933 0 0 0 0 0 0 0 0 18.37125 0 0 16.66895 0 17.48654 18.40566 0 0 0 0 17.14905 0 0 0 0 0 0 0 0 0 19.00997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15070 OXA1L_HUMAN "Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein, OXA1-like protein)" OXA1L Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262] integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262] membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803] GO:0005739; GO:0005759; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0033617; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177 VVHDLDK 10.52999973 1 1 0.170957311 825.9587716 0 15.12569 0 0 15.61051 17.89898 0 17.65057 16.98528 16.57242 0 0 16.27917 0 0 0 0 15.11528 12.9984 0 0 0 15.56914 16.71145 0 14.78781 14.84032 16.32089 17.67804 0 15.32711 18.44329 0 18.06345 16.47929 17.31914 16.72355 0 18.5634 0 16.31526 16.24981 16.70769 0 17.39575 18.37684 0 16.50746 Q15072 OZF_HUMAN Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146) ZNF146 OZF Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270 SNLTEHEK 11.71000004 1 1 0.398413838 956.2380933 0 20.38863 16.53399 0 0 0 19.84156 20.69789 0 0 0 0 0 20.87478 0 20.18973 20.04416 0 0 0 0 19.61917 0 0 0 22.07177 0 0 0 0 21.58579 0 0 0 22.11994 21.41937 0 21.58211 0 0 18.90218 21.00041 20.81047 0 19.61791 20.10996 0 0 Q15075 EEA1_HUMAN Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) EEA1 ZFYVE2 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694] axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; serine-pyruvate aminotransferase complex [GO:0005969] axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694] 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0005516; GO:0005545; GO:0005737; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0008270; GO:0016020; GO:0016189; GO:0019897; GO:0030742; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0045022; GO:0070062 GEATQK 4.730000019 1 1 0.057249039 632.7511555 0 12.07302 0 0 0 0 0 0 0 18.22157 15.65896 0 15.23914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15078 CD5R1_HUMAN "Cyclin-dependent kinase 5 activator 1, CDK5 activator 1 (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35, p35; Cyclin-dependent kinase 5 activator 1, p25, p25 (Tau protein kinase II 23 kDa subunit, p23) ]" CDK5R1 CDK5R NCK5A Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signaling receptor activity [GO:2000273]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]" axon [GO:0030424]; contractile fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533] "axon [GO:0030424]; contractile fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; activation of protein kinase activity [GO:0032147]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signaling receptor activity [GO:2000273]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]" actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] GO:0000079; GO:0000226; GO:0000307; GO:0001764; GO:0002020; GO:0004672; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016241; GO:0016301; GO:0016533; GO:0018105; GO:0018107; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030295; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0031116; GO:0031175; GO:0031594; GO:0032147; GO:0032956; GO:0035235; GO:0035255; GO:0042501; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043231; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045348; GO:0045664; GO:0045737; GO:0045892; GO:0046875; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0070315; GO:0090314; GO:0098693; GO:0098793; GO:2000273 GTVLSLSPSYR 4.380000114 1 1 0.231053062 1179.102545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.43636 0 0 0 15.90262 15.85745 0 15.09177 14.46664 16.83244 16.1548 15.10585 13.67685 14.31494 15.27293 0 16.83205 0 0 16.10535 0 0 15.23594 16.24961 0 0 0 Q15080 NCF4_HUMAN "Neutrophil cytosol factor 4, NCF-4 (Neutrophil NADPH oxidase factor 4) (SH3 and PX domain-containing protein 4) (p40-phox, p40phox)" NCF4 SH3PXD4 Homo sapiens (Human) phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; phosphatidylinositol-3-phosphate binding [GO:0032266]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554] phosphatidylinositol-3-phosphate binding [GO:0032266]; superoxide-generating NADPH oxidase activator activity [GO:0016176] GO:0005737; GO:0005829; GO:0005886; GO:0006909; GO:0010008; GO:0016020; GO:0016176; GO:0032010; GO:0032266; GO:0042554; GO:0043020; GO:0045730 VYVGVKQEIAEMR 4.559999943 0.600545824 0.600545824 0.423751484 1519.581791 0 0 11.99633 15.95126 0 0 0 0 0 14.42404 0 0 0 13.56548 16.45324 0 0 0 0 16.62231 16.25186 0 0 0 0 0 0 0 15.83415 14.83029 15.94189 16.13166 11.1607 0 15.19372 14.16992 0 0 0 16.19355 0 16.97358 15.9588 16.75834 0 17.28474 0 17.33318 Q15111 PLCL1_HUMAN "Inactive phospholipase C-like protein 1, PLC-L1 (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein, PRIP)" PLCL1 Homo sapiens (Human) "gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]" cytoplasm [GO:0005737]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]" "GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]" GO:0004435; GO:0004629; GO:0005737; GO:0005886; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0035556; GO:0048015; GO:0050811; GO:0070679; GO:0120163; GO:1900122 FMWLKTVFEAADVDGNGIMLEDTSVELIK 1.409999967 1 1 1.83E-12 3270.63911 0 10.70178 0 0 12.01745 0 0 0 0 15.02259 0 15.64151 0 0 0 0 0 0 0 0 0 0 13.35752 11.69586 0 0 0 0 0 0 0 0 0 0 0 0 15.22897 0 0 0 0 0 13.56143 0 12.22797 0 0 0 Q15113 PCOC1_HUMAN "Procollagen C-endopeptidase enhancer 1 (Procollagen COOH-terminal proteinase enhancer 1, PCPE-1, Procollagen C-proteinase enhancer 1) (Type 1 procollagen C-proteinase enhancer protein) (Type I procollagen COOH-terminal proteinase enhancer)" PCOLCE PCPE1 Homo sapiens (Human) multicellular organism development [GO:0007275] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; multicellular organism development [GO:0007275] collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504] GO:0005518; GO:0005576; GO:0005615; GO:0007275; GO:0008201; GO:0016504; GO:0070062 EPGEGLAVTVSLIGAYK 1.190000057 1 1 1.38E-12 1704.482453 0 14.8936 13.94352 0 0 0 0 14.02216 0 0 0 0 0 0 15.7792 0 0 0 0 0 0 15.87668 0 13.22918 15.16558 0 0 0 0 0 14.22636 0 0 0 0 0 0 0 13.20309 0 0 15.2674 0 0 0 0 0 0 Q15118 PDK1_HUMAN "[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 1, PDH kinase 1)" PDK1 PDHK1 Homo sapiens (Human) cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] GO:0004672; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006468; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0097411 DGYENAR 8.119999886 1 1 0.497556734 824.6335976 15.34266 0 0 15.63029 0 0 0 0 0 0 0 14.50544 0 0 16.02068 0 0 0 0 0 0 0 0 0 0 0 0 14.94286 14.46893 0 0 14.91637 15.93943 12.65649 0 0 0 0 0 0 17.23896 0 0 0 0 17.43552 14.16123 12.73552 Q15120 PDK3_HUMAN "[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 3)" PDK3 PDHK3 Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006468; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377 KELPVR 4.179999828 1 1 0.223084687 741.1323937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.92903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41251 0 0 0 Q15126 PMVK_HUMAN "Phosphomevalonate kinase, PMKase, hPMK, EC 2.7.4.2" PMVK PMKI Homo sapiens (Human) "cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]" ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631] GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0019287; GO:0070062; GO:0070723 APLGGAPR 14.27999973 0.944415748 0.944415748 0.273750813 737.501087 18.1768 17.67585 17.27153 17.93211 0 15.17672 17.65707 18.2051 15.7415 17.80464 19.13704 17.28502 0 17.76023 16.83166 16.94139 18.37725 18.41084 16.41491 17.59237 17.89561 17.91923 0 16.73454 18.06813 17.07707 0 16.89448 18.28389 18.06409 0 19.05206 18.35007 0 17.83778 0 0 17.9571 0 0 16.83202 0 17.87994 18.83274 0 16.81435 16.86419 17.71337 Q15147 PLCB4_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4, PLC-beta-4)" PLCB4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] cytosol [GO:0005829] cytosol [GO:0005829]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629] GO:0004435; GO:0004629; GO:0005509; GO:0005829; GO:0007186; GO:0016042; GO:0048015 AMQIIEMYEPDEDLKK 5.300000191 1 1 0.198473948 1969.386903 13.51618 14.9402 16.52758 15.97964 11.80037 11.75177 17.79169 0 0 14.02279 0 12.68097 0 0 0 0 0 0 0 0 0 0 0 0 13.6179 0 0 17.12644 13.30472 0 0 14.33904 0 0 0 0 0 0 0 0 0 0 0 16.09736 0 0 0 0 Q15149 PLEC_HUMAN "Plectin, PCN, PLTN (Hemidesmosomal protein 1, HD1) (Plectin-1)" PLEC PLEC1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin contractile ring assembly actin filament organization [GO:2000689]; adherens junction organization [GO:0034332]; cardiac muscle cell development [GO:0055013]; cell morphogenesis [GO:0000902]; cellular protein localization [GO:0034613]; cellular response to extracellular stimulus [GO:0031668]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to mechanical stimulus [GO:0071260]; establishment of skin barrier [GO:0061436]; fibroblast migration [GO:0010761]; gene expression [GO:0010467]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte development [GO:0003334]; leukocyte migration involved in immune response [GO:0002522]; mitochondrion morphogenesis [GO:0070584]; multicellular organism growth [GO:0035264]; myoblast differentiation [GO:0045445]; negative regulation of protein kinase activity [GO:0006469]; nucleus organization [GO:0006997]; peripheral nervous system myelin maintenance [GO:0032287]; protein-containing complex organization [GO:0043933]; regulation of ATP citrate synthase activity [GO:2000983]; regulation of vascular permeability [GO:0043114]; respiratory electron transport chain [GO:0022904]; response to food [GO:0032094]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]; skeletal myofibril assembly [GO:0014866]; T cell chemotaxis [GO:0010818]; tight junction organization [GO:0120193]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060] axon [GO:0030424]; brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] axon [GO:0030424]; brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; actin cytoskeleton reorganization [GO:0031532]; actomyosin contractile ring assembly actin filament organization [GO:2000689]; adherens junction organization [GO:0034332]; cardiac muscle cell development [GO:0055013]; cell morphogenesis [GO:0000902]; cellular protein localization [GO:0034613]; cellular response to extracellular stimulus [GO:0031668]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to mechanical stimulus [GO:0071260]; establishment of skin barrier [GO:0061436]; fibroblast migration [GO:0010761]; gene expression [GO:0010467]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte development [GO:0003334]; leukocyte migration involved in immune response [GO:0002522]; mitochondrion morphogenesis [GO:0070584]; multicellular organism growth [GO:0035264]; myoblast differentiation [GO:0045445]; negative regulation of protein kinase activity [GO:0006469]; nucleus organization [GO:0006997]; peripheral nervous system myelin maintenance [GO:0032287]; protein-containing complex organization [GO:0043933]; regulation of ATP citrate synthase activity [GO:2000983]; regulation of vascular permeability [GO:0043114]; respiratory electron transport chain [GO:0022904]; response to food [GO:0032094]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]; skeletal myofibril assembly [GO:0014866]; T cell chemotaxis [GO:0010818]; tight junction organization [GO:0120193]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060] actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198] GO:0000902; GO:0002162; GO:0002522; GO:0003334; GO:0003723; GO:0003779; GO:0005198; GO:0005200; GO:0005737; GO:0005741; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0006469; GO:0006997; GO:0008307; GO:0010467; GO:0010761; GO:0010818; GO:0014866; GO:0016020; GO:0016528; GO:0019226; GO:0022904; GO:0030018; GO:0030056; GO:0030424; GO:0030425; GO:0030506; GO:0031532; GO:0031581; GO:0031668; GO:0032094; GO:0032287; GO:0034332; GO:0034613; GO:0035264; GO:0042060; GO:0042383; GO:0043034; GO:0043114; GO:0043209; GO:0043621; GO:0043933; GO:0045104; GO:0045109; GO:0045111; GO:0045214; GO:0045296; GO:0045445; GO:0048471; GO:0048741; GO:0055013; GO:0061436; GO:0070062; GO:0070584; GO:0071260; GO:0071464; GO:0071498; GO:0120193; GO:2000689; GO:2000983 ASFEKAAAGK 5.860000134 1 1 0.204560983 979.1845326 13.58891 0 14.19689 0 0 0 0 15.71023 14.08725 0 0 13.41874 0 13.25399 14.20541 12.87551 0 14.51314 14.51818 15.59242 0 0 13.67312 0 15.27232 0 0 15.52708 0 0 13.7821 0 0 14.19977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15154 PCM1_HUMAN "Pericentriolar material 1 protein, PCM-1, hPCM-1" PCM1 Homo sapiens (Human) centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176] apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991] apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176] identical protein binding [GO:0042802] GO:0000242; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007098; GO:0016020; GO:0022027; GO:0031122; GO:0031965; GO:0032991; GO:0034451; GO:0034453; GO:0034454; GO:0035176; GO:0035735; GO:0035869; GO:0036064; GO:0042802; GO:0045177; GO:0050768; GO:0060271; GO:0071539; GO:0090316; GO:0097150; GO:1905515 EDLVEK 6.849999905 1 1 0.230788202 733.2875363 15.08037 0 14.27741 15.00185 14.06846 14.94094 0 15.10579 15.4438 13.65642 0 14.82045 15.1335 16.85286 15.41267 15.49281 15.68419 15.541 0 16.6167 16.53952 0 0 0 0 0 0 16.06118 13.45517 15.32065 16.63059 0 0 15.47626 16.43411 15.94165 16.53879 16.55184 16.5707 0 15.02207 0 0 15.90995 0 0 0 16.96449 Q15166 PON3_HUMAN "Serum paraoxonase/lactonase 3, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1" PON3 Homo sapiens (Human) aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; coumarin catabolic process [GO:0046226]; establishment of localization in cell [GO:0051649]; negative regulation of superoxide anion generation [GO:0032929]; phenylacetate catabolic process [GO:0010124]; renal sodium ion transport [GO:0003096]; response to toxic substance [GO:0009636] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; 3,4-dihydrocoumarin hydrolase activity [GO:0018733]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; coumarin catabolic process [GO:0046226]; establishment of localization in cell [GO:0051649]; negative regulation of superoxide anion generation [GO:0032929]; phenylacetate catabolic process [GO:0010124]; renal sodium ion transport [GO:0003096]; response to toxic substance [GO:0009636]" "3,4-dihydrocoumarin hydrolase activity [GO:0018733]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" GO:0003096; GO:0004063; GO:0004064; GO:0005576; GO:0005615; GO:0009636; GO:0010124; GO:0018733; GO:0019439; GO:0032929; GO:0042803; GO:0043231; GO:0046226; GO:0046395; GO:0046872; GO:0051649; GO:0070062; GO:0102007 NIHIMEK 3.980000019 0.455293715 0.455293715 0.228858706 885.2742443 0 0 14.09456 13.44299 15.17428 0 0 0 14.98918 15.15374 16.2396 14.76425 14.84053 14.91998 16.88838 0 14.07449 15.22726 14.76153 14.04574 15.8019 0 15.41015 16.45528 0 15.1634 0 15.46973 0 15.98665 16.13333 0 0 16.09884 16.85341 14.91912 15.7683 0 14.5688 15.9889 0 14.90782 0 0 0 16.08891 16.23285 0 Q15198 PGFRL_HUMAN "Platelet-derived growth factor receptor-like protein, PDGFR-like protein (PDGF receptor beta-like tumor suppressor)" PDGFRL PRLTS Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019] platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019] GO:0004992; GO:0005019; GO:0005576 DSANSAPKTQSIMMQVLDK 5.159999847 1 1 0.291679343 2094.918629 0 10.47303 14.29091 9.679258 0 7.951466 14.13028 13.87362 13.06485 14.18979 0 13.68585 12.24655 13.72694 12.411 14.41087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.30805 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15208 STK38_HUMAN "Serine/threonine-protein kinase 38, EC 2.7.11.1 (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1)" STK38 NDR1 Homo sapiens (Human) cellular protein modification process [GO:0006464]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular protein modification process [GO:0006464]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006468; GO:0018105; GO:0031435; GO:0035556; GO:0043407; GO:0045296; GO:0106310 MAMTGSTPCSSMSNHTK 12.98999977 0.274705678 0.274705678 0.092503373 1860.031316 16.53708 17.00293 18.7874 0 15.38392 16.79084 17.24761 0 0 14.87335 0 18.59724 17.48072 16.23102 17.44928 0 17.46268 0 0 13.07119 0 0 16.86494 16.40805 0 0 17.98129 13.36777 0 17.69287 16.84216 17.65801 14.30843 15.93226 16.50993 0 15.33037 18.48431 17.01866 0 17.38269 16.69076 0 0 15.53533 16.40331 14.50709 0 Q15223 NECT1_HUMAN "Nectin-1 (Herpes virus entry mediator C, Herpesvirus entry mediator C, HveC) (Herpesvirus Ig-like receptor, HIgR) (Nectin cell adhesion molecule 1) (Poliovirus receptor-related protein 1) (CD antigen CD111)" NECTIN1 HVEC PRR1 PVRL1 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virion binding [GO:0046790]; virus receptor activity [GO:0001618] GO:0001618; GO:0002089; GO:0002934; GO:0005576; GO:0005886; GO:0005912; GO:0006826; GO:0006955; GO:0007155; GO:0007156; GO:0007157; GO:0007411; GO:0015026; GO:0016020; GO:0016021; GO:0019062; GO:0030246; GO:0030425; GO:0032584; GO:0042802; GO:0042803; GO:0043231; GO:0043296; GO:0044291; GO:0044877; GO:0046718; GO:0046790; GO:0050839; GO:0051963; GO:0060041; GO:0070166; GO:0098609; GO:0098686; GO:0099059; GO:1902414 MGLAGAAGR 11.60999966 0.815202773 0.815202773 0.203021547 803.2933688 14.914 14.8461 12.81294 16.00487 0 0 15.51246 15.79858 14.74193 0 15.93568 14.98503 13.34342 12.63546 15.10496 0 0 0 14.03799 0 0 0 0 0 17.02268 0 14.59338 14.5665 0 15.25037 15.7459 14.6547 0 0 15.41852 0 16.59299 0 0 0 15.14609 16.12714 0 0 0 0 0 0 Q15233 NONO_HUMAN "Non-POU domain-containing octamer-binding protein, NonO protein (54 kDa nuclear RNA- and DNA-binding protein, p54(nrb), p54nrb) (55 kDa nuclear protein, NMT55) (DNA-binding p52/p100 complex, 52 kDa subunit)" NONO NRB54 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" chromosome [GO:0005694]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575] "chromosome [GO:0005694]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0001650; GO:0002218; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0006397; GO:0007623; GO:0008380; GO:0016020; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0042802; GO:0045087; GO:0045892; GO:0090575; GO:1903377 ALIEMEK 4.610000134 1 1 0.118505026 849.186881 0 0 0 0 0 15.8496 14.34221 0 15.92658 0 0 12.38398 14.48825 15.83135 0 14.38764 12.76673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.31422 0 15.08098 12.9706 13.07935 0 16.36748 15.72642 13.49522 15.80679 10.31128 0 15.88606 Q15262 PTPRK_HUMAN "Receptor-type tyrosine-protein phosphatase kappa, Protein-tyrosine phosphatase kappa, R-PTP-kappa, EC 3.1.3.48" PTPRK PTPK Homo sapiens (Human) "cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]" adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]" beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041 AAYFDMIR 6.730000019 1 1 0.235481216 1001.768713 13.66362 18.21702 18.63136 14.48057 14.55681 16.78174 16.95326 16.09964 0 0 0 0 16.83062 0 17.22213 17.49499 19.77803 16.94691 0 0 0 17.58028 0 0 0 0 0 0 0 0 0 0 0 18.46989 0 0 0 0 18.58279 16.28424 17.94678 0 0 0 0 0 0 0 Q15269 PWP2_HUMAN Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]" nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] "nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]" RNA binding [GO:0003723] GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388 DSEEEMLA 7.849999905 0.916638613 0.916638613 0.244725594 939.9739122 14.36241 0 14.52683 0 13.29151 14.72806 15.47594 15.48285 14.42118 14.81902 14.68904 0 0 0 0 16.73837 0 0 16.48999 10.26016 16.12273 12.56223 15.21312 16.2789 0 0 15.67661 11.9866 0 14.56232 16.14857 13.8545 0 14.20315 0 15.915 12.24414 14.74408 0 0 16.35135 0 12.03969 0 15.13713 0 16.13277 0 Q15276 RABE1_HUMAN Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17) RABEP1 RAB5EP RABPT5 RABPT5A Homo sapiens (Human) apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:0061025; GO:1903441 QSSEDSSHQISALVLR 2.769999981 1 1 0.284461529 1756.025464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.66748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15283 RASA2_HUMAN "Ras GTPase-activating protein 2 (GTPase-activating protein 1m, GAP1m)" RASA2 GAP1M RASGAP Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0035556; GO:0043087; GO:0046580; GO:0046872; GO:0048471 EGDNVENNKENLR 25.28000069 1 1 6.92E-13 1528.215283 0 0 0 0 0 16.93213 0 0 16.97638 16.76692 16.97521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15287 RNPS1_HUMAN RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2) RNPS1 LDC2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]" ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]" mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723] GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0008380; GO:0016607; GO:0043065; GO:0048025; GO:0061574 SRSSSNSSR 4.949999809 1 1 0 969.813425 10.19687 14.56372 0 0 0 14.82053 14.85589 0 0 0 0 0 15.34236 0 0 0 0 0 18.92211 11.8978 16.70539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6754 0 0 0 0 0 Q15293 RCN1_HUMAN Reticulocalbin-1 RCN1 RCN Homo sapiens (Human) camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701] calcium ion binding [GO:0005509] GO:0001701; GO:0005509; GO:0005783; GO:0005788; GO:0043010 AKPTVR 1.620000005 1 1 0.266574569 672.0671496 0 0 0 0 0 0 14.00646 0 0 16.09495 0 16.70816 0 0 0 15.6304 0 16.28226 0 0 17.35038 0 16.96728 0 17.0921 0 0 15.45959 15.53751 0 0 0 17.64724 0 0 0 0 0 15.75093 15.83566 0 17.05415 0 0 0 16.95779 0 0 Q15303 ERBB4_HUMAN "Receptor tyrosine-protein kinase erbB-4, EC 2.7.10.1 (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain, 4ICD, E4ICD (s80HER4) ]" ERBB4 HER4 Homo sapiens (Human) "cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235] "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; neuregulin receptor activity [GO:0038131]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; neuregulin receptor activity [GO:0038131]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0000976; GO:0001755; GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005154; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007399; GO:0007416; GO:0007507; GO:0007595; GO:0008284; GO:0008285; GO:0009880; GO:0009925; GO:0014068; GO:0016323; GO:0016477; GO:0018108; GO:0021551; GO:0021889; GO:0030334; GO:0033674; GO:0038130; GO:0038131; GO:0038138; GO:0042531; GO:0042803; GO:0043066; GO:0043235; GO:0043552; GO:0043653; GO:0045165; GO:0045211; GO:0045893; GO:0046427; GO:0046777; GO:0060045; GO:0060644; GO:0060749; GO:0061026; GO:0070374; GO:0071364; GO:0072046; GO:0098978; GO:0098982; GO:0099056; GO:0099061; GO:2000010 GMMYLEER 15.43999958 1 1 1.37E-12 1043.595507 0 0 0 14.65892 14.44456 14.3726 15.17961 14.95099 0 15.05746 14.50415 0 14.92214 14.399 16.32561 15.81444 14.12933 0 0 0 16.05139 0 0 0 0 0 0 16.29933 15.43109 16.12523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15306 IRF4_HUMAN "Interferon regulatory factor 4, IRF-4 (Lymphocyte-specific interferon regulatory factor, LSIRF) (Multiple myeloma oncogene 1) (NF-EM5)" IRF4 MUM1 Homo sapiens (Human) "defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]" chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]" GO:0000785; GO:0000786; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016020; GO:0032733; GO:0032736; GO:0032743; GO:0032753; GO:0034122; GO:0042110; GO:0042832; GO:0043011; GO:0043388; GO:0043565; GO:0043966; GO:0043967; GO:0045622; GO:0045893; GO:0045944; GO:0072540; GO:0120162; GO:1990837 GGEFGMSAVSCGNGK 11.64000034 0.456298918 0.456298918 0.133753423 1473.070251 15.75898 15.71624 15.62852 16.33324 12.07032 13.9612 0 16.48713 13.04539 17.39146 16.83359 14.77948 15.93258 14.53548 14.12735 15.31957 17.36169 0 0 15.06649 12.30285 19.33252 15.89526 14.77062 17.1951 15.96418 16.05472 13.83342 0 14.93645 13.73734 14.42044 18.51309 0 15.821 14.19536 17.05344 17.32336 16.92801 18.01892 0 0 0 18.12601 16.33798 0 0 0 Q15311 RBP1_HUMAN "RalA-binding protein 1, RalBP1 (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase, DNP-SG ATPase, EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1)" RALBP1 RLIP RLIP1 RLIP76 Homo sapiens (Human) chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0000922; GO:0001934; GO:0005096; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006897; GO:0006935; GO:0007264; GO:0008559; GO:0015431; GO:0016020; GO:0022857; GO:0031267; GO:0032489; GO:0042626; GO:0042910; GO:0043087; GO:0043547; GO:0051056; GO:0055085; GO:0090141; GO:1900753; GO:1990961 IAQEIASLSK 12.31999969 1 1 0.061819078 1056.558611 0 0 0 0 0 0 0 0 18.81334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15319 PO4F3_HUMAN "POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C, Brain-3C, Brn-3C)" POU4F3 BRN3C Homo sapiens (Human) axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837 MMAMNSK 2.339999914 1 1 0.267629375 844.944032 0 0 14.77218 0 16.60466 0 0 0 0 0 0 0 0 15.94172 15.75058 15.69478 0 15.74978 0 15.97125 0 0 0 15.18852 0 16.79358 16.41258 0 16.78633 0 17.1376 17.88753 16.66472 16.52909 0 0 16.74334 0 0 16.96925 16.09217 16.7377 17.00978 17.28983 17.11951 17.1598 15.55384 17.67187 Q15326 ZMY11_HUMAN Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69) ZMYND11 BRAM1 BS69 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237 LATQHK 4.03000021 0.921088517 0.921088517 0 697.6231659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.33296 13.89059 0 0 0 0 0 16.26836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15334 L2GL1_HUMAN "Lethal(2) giant larvae protein homolog 1, LLGL (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein)" LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] adherens junction [GO:0005912]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] adherens junction [GO:0005912]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198] GO:0000137; GO:0000139; GO:0005096; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0007409; GO:0008593; GO:0019901; GO:0030424; GO:0030864; GO:0030866; GO:0031901; GO:0032588; GO:0032878; GO:0045159; GO:0045197; GO:0050708; GO:0051294; GO:0065003 DPTKILIGYSR 2.910000086 1 1 0.025677312 1262.933562 13.15287 14.8706 0 13.92642 12.66815 13.10128 0 15.6784 0 14.41983 10.60272 12.97035 0 13.51084 0 0 15.43204 0 16.18076 0 0 0 0 14.89769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.30737 0 0 0 0 0 0 0 0 Q15349 KS6A2_HUMAN "Ribosomal protein S6 kinase alpha-2, S6K-alpha-2, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 2, p90-RSK 2, p90RSK2) (MAP kinase-activated protein kinase 1c, MAPK-activated protein kinase 1c, MAPKAP kinase 1c, MAPKAPK-1c) (Ribosomal S6 kinase 3, RSK-3) (pp90RSK3)" RPS6KA2 MAPKAPK1C RSK3 Homo sapiens (Human) brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0000287; GO:0001556; GO:0002035; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007268; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0018105; GO:0035556; GO:0043065; GO:0045202; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310 MDLSMKK 13.03999996 0.52723223 0.52723223 0.194348685 852.4909061 0 0 10.51201 0 0 15.84095 16.60219 0 0 0 15.13173 0 0 0 0 0 0 0 0 0 14.60386 0 9.923775 0 16.01339 0 0 0 15.50733 16.84521 0 0 0 0 16.27458 0 0 0 0 0 0 0 0 0 13.87326 0 0 15.9082 Q15365 PCBP1_HUMAN "Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1, hnRNP E1) (Nucleic acid-binding protein SUB2.3)" PCBP1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]" "cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]" GO:0000981; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010468; GO:0016020; GO:0016607; GO:0036464; GO:0039694; GO:0045296; GO:0045944; GO:0051252; GO:0070062; GO:0098847 GMGCS 2.75 0.142886505 0.142886505 0.241650339 510.035216 23.60294 0 0 0 21.63396 22.42804 17.68967 0 20.92361 23.57718 21.33696 17.01475 23.33804 15.96519 23.99295 22.80141 22.07223 23.04521 17.63911 22.88627 23.42544 23.0835 0 23.43832 0 23.484 22.94203 15.77489 23.35035 23.75535 20.16621 22.98475 0 23.44913 22.87537 22.73927 0 23.11452 23.00313 0 23.38743 23.28196 22.73921 23.41472 0 23.42832 22.73858 24.0261 Q15366 PCBP2_HUMAN "Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2, hnRNP E2)" PCBP2 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; mRNA metabolic process [GO:0016071]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; C-rich single-stranded DNA binding [GO:1990829]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; mRNA metabolic process [GO:0016071]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694] C-rich single-stranded DNA binding [GO:1990829]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0010468; GO:0014069; GO:0016020; GO:0016071; GO:0019899; GO:0031625; GO:0039694; GO:0043161; GO:0045087; GO:0045944; GO:0050687; GO:0051252; GO:0051607; GO:0070062; GO:0075522; GO:1990829 AITIAGIPQSIIECVK 4.929999828 0.866804361 0.866804361 0.139822709 1713.499919 15.01248 13.65551 17.05215 14.54939 13.64053 9.847911 14.52252 14.12039 14.3894 14.50056 12.3312 0 15.53591 0 0 12.40324 0 18.53643 12.76427 0 13.09525 0 15.3377 16.87931 13.12719 0 17.3785 15.06971 12.01329 15.40487 14.99747 14.77547 15.96783 0 0 12.70211 0 17.05424 16.0496 0 16.72087 12.0777 14.59219 16.62446 13.69392 0 0 0 Q15370 ELOB_HUMAN "Elongin-B, EloB (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)" ELOB TCEB2 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449 MDVFLMIR 6.75 1 1 6.93E-13 1041.399748 16.91127 0 0 0 16.21964 15.96989 0 0 0 0 0 0 0 0 0 0 0 0 17.10188 0 15.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.68043 0 0 0 Q15375 EPHA7_HUMAN "Ephrin type-A receptor 7, EC 2.7.10.1 (EPH homology kinase 3, EHK-3) (EPH-like kinase 11, EK11, hEK11)" EPHA7 EHK3 HEK11 Homo sapiens (Human) apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006915; GO:0007169; GO:0007411; GO:0007420; GO:0008046; GO:0016310; GO:0019838; GO:0022407; GO:0030425; GO:0031290; GO:0031594; GO:0031952; GO:0033674; GO:0043005; GO:0043025; GO:0043235; GO:0043281; GO:0043525; GO:0045499; GO:0046875; GO:0048013; GO:0048671; GO:0048755; GO:0050730; GO:0050919; GO:0051964; GO:0070372; GO:0072178; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0099175 GIAAGMRYLADMGYVHR 9.75 1 1 0.191338446 1895.883445 0 0 0 0 14.39492 0 13.71306 13.94212 0 0 0 14.63934 16.3448 0 15.79043 15.21084 14.68311 0 16.35615 16.28281 0 0 16.59892 0 0 0 0 16.56197 0 16.38242 0 0 0 17.31074 15.75247 0 0 16.92091 0 13.90661 0 0 0 0 0 0 0 0 Q15386 UBE3C_HUMAN "Ubiquitin-protein ligase E3C, EC 2.3.2.26 (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2, HectH2) (RTA-associated ubiquitin ligase, RAUL)" UBE3C KIAA0010 KIAA10 Homo sapiens (Human) protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; proteasome complex [GO:0000502] nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin protein ligase activity [GO:0061630]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0000502; GO:0005634; GO:0006511; GO:0035519; GO:0061630; GO:0070936 IGPLQSTLDVGLESPPLSVSEER 2.039999962 1 1 9.20E-13 2422.433004 15.57288 0 0 0 0 14.99924 0 0 16.27801 15.85001 0 15.58666 0 15.06755 0 15.29492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.79684 0 0 0 0 12.9656 0 0 0 0 0 0 Q15388 TOM20_HUMAN Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20) TOMM20 KIAA0016 Homo sapiens (Human) "protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to muscle activity [GO:0014850]; tRNA import into mitochondrion [GO:0016031]" integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225] "integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to muscle activity [GO:0014850]; tRNA import into mitochondrion [GO:0016031]" mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082] GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0014850; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0031307; GO:0044233; GO:0045040; GO:0051082; GO:0097225; GO:1905242 RSDPNFK 6.199999809 1 1 0.111754318 864.0510605 15.3184 13.99699 14.02648 15.21816 15.34097 13.57495 15.02234 13.04338 0 16.2436 14.95108 0 14.6809 11.7154 13.40811 15.98567 0 14.38741 13.8474 12.85316 14.28077 0 15.4475 16.58121 13.65137 0 15.57589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.40606 0 0 0 Q15389 ANGP1_HUMAN "Angiopoietin-1, ANG-1" ANGPT1 KIAA0003 Homo sapiens (Human) activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014] identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] GO:0001525; GO:0001701; GO:0001933; GO:0001934; GO:0002040; GO:0002092; GO:0002719; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0005902; GO:0007162; GO:0007171; GO:0010595; GO:0010628; GO:0014068; GO:0014842; GO:0030097; GO:0030154; GO:0030210; GO:0030971; GO:0031398; GO:0031589; GO:0032680; GO:0033138; GO:0034394; GO:0042308; GO:0042802; GO:0043066; GO:0043116; GO:0043122; GO:0043393; GO:0043524; GO:0043536; GO:0045121; GO:0045785; GO:0048014; GO:0050731; GO:0050918; GO:0051897; GO:0062023; GO:0070062; GO:0070374; GO:0072012; GO:1905605; GO:2000352; GO:2000446 GHTGTAGK 6.960000038 1 1 0.164257753 729.2719082 0 0 0 0 0 0 16.01136 0 0 16.46862 16.26711 0 0 0 0 15.92014 16.58115 0 0 0 0 0 16.82917 0 0 0 17.02034 17.09714 0 0 16.29216 15.93441 0 0 15.64795 0 0 17.38886 0 16.20958 0 0 16.14528 0 0 16.68846 14.21415 0 Q15390 MTFR1_HUMAN Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region) MTFR1 CHPPR FAM54A2 KIAA0009 Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] GO:0000266; GO:0005739; GO:0005829; GO:0005886; GO:0007005; GO:0009060 VLFGPHMLKPTGK 10.31000042 0.458219171 0.458219171 0.067699449 1440.247764 14.25767 14.77194 0 0 15.17551 0 0 0 0 0 15.65069 12.74558 13.2456 13.88673 13.88605 0 0 14.01676 12.54649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.37911 0 Q15391 P2Y14_HUMAN "P2Y purinoceptor 14, P2Y14 (G-protein coupled receptor 105) (UDP-glucose receptor)" P2RY14 GPR105 KIAA0001 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UDP receptor activity [GO:0045029]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UDP receptor activity [GO:0045029] GO:0005886; GO:0007186; GO:0016021; GO:0045028; GO:0045029 SFIIYLK 4.880000114 0.788902283 0.788902283 0.238789586 883.4708494 0 18.25076 16.59179 0 15.38746 0 0 0 0 16.76071 19.29826 13.61893 0 0 0 0 0 0 0 0 0 15.09783 16.93331 0 14.57848 15.12804 16.03352 15.09992 0 0 16.91413 15.43333 14.46022 0 15.15438 0 0 0 15.95247 15.13503 0 0 0 14.85781 0 0 0 0 Q15393 SF3B3_HUMAN "Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit, SF3b130) (STAF130) (Spliceosome-associated protein 130, SAP 130)" SF3B3 KIAA0017 SAP130 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620] GO:0000124; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006282; GO:0008380; GO:0030620; GO:0035521; GO:0035522; GO:0042177; GO:0043484; GO:0043966; GO:0044877; GO:0045893; GO:0071005; GO:0071013 SEHPPLCGRDHLSFR 4.980000019 1 1 0.342929193 1804.238782 11.73533 15.3589 0 9.831487 0 13.02746 14.79028 0 0 15.51257 0 13.30655 15.14274 0 0 0 0 16.07712 0 15.01231 0 16.71077 15.91864 0 0 0 0 0 0 0 0 0 0 0 0 16.36086 0 0 0 0 0 0 0 0 0 0 0 0 Q15397 PUM3_HUMAN "Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8, HLA-HA8)" PUM3 cPERP-C KIAA0020 PUF-A XTP5 Homo sapiens (Human) regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417] chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835 EGGPK 2.450000048 1 1 0.200973859 487.4227964 0 0 16.38727 15.72904 14.96386 15.24891 15.34184 16.03811 0 16.19232 0 0 14.81978 15.16652 0 15.82825 15.53854 0 0 0 0 16.70503 0 0 0 0 0 0 15.89977 0 16.02078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15398 DLGP5_HUMAN "Disks large-associated protein 5, DAP-5 (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein, HURP)" DLGAP5 DLG7 KIAA0008 Homo sapiens (Human) centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; microtubule binding [GO:0008017]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052] microtubule binding [GO:0008017] GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007052; GO:0007059; GO:0007079; GO:0007346; GO:0008017; GO:0023052; GO:0031616; GO:0034451; GO:0045842; GO:0051382; GO:0051642 NVETKPDK 8.479999542 0.219535992 0.219535992 0.16162088 931.486156 0 16.14426 17.3172 18.1318 17.74934 15.93419 18.06581 18.27695 16.96516 16.40203 18.47642 17.58895 16.70465 16.59378 17.43167 14.95142 16.92039 17.65883 18.18448 16.10512 17.69122 17.34088 18.61052 15.51696 16.50794 15.424 14.57117 16.07439 17.29985 0 17.41223 17.75926 0 14.36514 0 15.59572 14.1303 19.55841 17.0465 16.43272 0 16.91544 16.68157 0 16.47082 0 16.45361 16.48455 Q15399 TLR1_HUMAN "Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein, TIL) (CD antigen CD281)" TLR1 KIAA0012 Homo sapiens (Human) cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354] "Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]" "identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]" GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0050135; GO:0061809; GO:0071221; GO:0071723; GO:0071727 ILIISHNR 11.84000015 1 1 0.243118019 966.6717345 17.5034 17.03132 13.58961 17.67095 17.89412 14.1697 14.86125 12.41632 17.68938 10.23153 18.17527 14.92597 17.1696 11.83974 16.91036 13.61101 12.66115 14.91261 18.38997 11.9342 14.86467 17.48967 8.000308 16.70778 14.53007 15.41445 18.3373 0 0 17.77201 14.62482 0 0 18.64263 17.78003 17.25582 0 0 16.47564 0 0 18.00447 16.56945 0 17.33299 13.8096 0 0 Q15404 RSU1_HUMAN "Ras suppressor protein 1, RSP-1, Rsu-1" RSU1 RSP1 Homo sapiens (Human) positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] GO:0005829; GO:0005925; GO:0007165; GO:0010811; GO:0043547; GO:0070062 LTVLPPELGNLDLTGQK 11.48999977 1 1 0.140168838 1807.014684 13.22316 0 0 0 0 0 14.65671 0 0 0 0 0 0 0 15.51493 0 0 0 0 0 15.42573 0 0 0 16.2854 15.24775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.01506 0 14.24346 0 16.70412 15.67776 Q15406 NR6A1_HUMAN "Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor, GCNF, hGCNF) (Retinoid receptor-related testis-specific receptor, RTR, hRTR)" NR6A1 GCNF Homo sapiens (Human) gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005654; GO:0005667; GO:0006357; GO:0007276; GO:0008270; GO:0042803; GO:0043565; GO:1990837 YWYICQDFTEYK 7.579999924 1 1 0.073677699 1711.452145 0 0 0 0 0 0 0 0 0 0 15.08469 14.43588 15.56897 0 0 0 15.99373 0 0 0 0 0 0 15.97539 0 0 0 0 15.09792 12.83946 15.99255 0 0 12.08094 13.84237 16.54884 0 15.72939 0 13.97204 15.03342 0 16.28045 17.32292 0 0 0 0 Q15413 RYR3_HUMAN "Ryanodine receptor 3, RYR-3, RyR3 (Brain ryanodine receptor-calcium release channel) (Brain-type ryanodine receptor) (Type 3 ryanodine receptor)" RYR3 HBRR Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to ATP [GO:0071318]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; cellular response to magnesium ion [GO:0071286]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209] calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018] calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to ATP [GO:0071318]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; cellular response to magnesium ion [GO:0071286]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209] calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219] GO:0005219; GO:0005509; GO:0005516; GO:0005790; GO:0005886; GO:0006816; GO:0015278; GO:0016021; GO:0016529; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0042383; GO:0048763; GO:0051209; GO:0051289; GO:0070588; GO:0071277; GO:0071286; GO:0071313; GO:0071318 AQDAK 5.71999979 0.285290956 0.285290956 0.237458569 534.0189823 13.01365 14.29813 13.24821 9.855077 14.84747 0 0 0 0 15.6265 15.29162 15.51746 14.56917 0 15.73638 0 14.86852 13.11205 15.45018 15.64422 0 0 14.68797 0 14.79642 15.73075 0 15.0862 15.2582 15.14324 14.79061 0 0 15.32981 13.88795 14.91078 0 11.92817 0 15.31524 15.10121 15.97231 16.58428 14.79288 15.21128 0 0 16.13178 Q15418 KS6A1_HUMAN "Ribosomal protein S6 kinase alpha-1, S6K-alpha-1, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 1, p90-RSK 1, p90RSK1, p90S6K) (MAP kinase-activated protein kinase 1a, MAPK-activated protein kinase 1a, MAPKAP kinase 1a, MAPKAPK-1a) (Ribosomal S6 kinase 1, RSK-1)" RPS6KA1 MAPKAPK1A RSK1 Homo sapiens (Human) "cell cycle [GO:0007049]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]" ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007268; GO:0018105; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045202; GO:0045597; GO:0045893; GO:0045944; GO:0072574; GO:0106310; GO:2000491 AKLGMPQFLSTEAQSLLR 4.420000076 0.336288393 0.336288393 0.103843316 2005.465821 13.79205 16.03595 15.89767 0 12.40114 14.86224 15.75383 14.82602 15.89243 0 12.21299 0 0 15.47564 15.27943 0 14.01443 15.62598 15.84016 0 0 0 0 14.13032 15.37047 15.14159 0 0 16.72257 13.70803 15.45011 15.04206 15.52212 16.5078 14.6793 15.09613 16.86231 15.66769 0 15.10644 14.97207 15.23445 0 0 0 16.36841 0 15.51357 Q15424 SAFB1_HUMAN "Scaffold attachment factor B1, SAF-B, SAF-B1 (HSP27 estrogen response element-TATA box-binding protein, HSP27 ERE-TATA-binding protein)" SAFB HAP HET SAFB1 Homo sapiens (Human) chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] GO:0000978; GO:0003682; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0030496; GO:0030520; GO:0043565; GO:0050684 DSESHSR 6.360000134 0.882324994 0.882324994 0.228156106 817.0793664 0 15.15632 12.38712 0 10.25619 13.5558 0 15.3165 13.36601 13.9424 14.99641 0 12.83916 16.45246 15.33264 14.63492 0 15.24411 0 0 13.09551 0 0 0 13.78304 14.51284 15.3134 15.22184 11.95566 14.43856 13.97138 12.35853 16.30741 0 14.94468 0 0 0 0 0 0 0 0 0 0 0 17.45284 14.65572 Q15431 SYCP1_HUMAN "Synaptonemal complex protein 1, SCP-1 (Cancer/testis antigen 8, CT8)" SYCP1 SCP1 Homo sapiens (Human) cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] "central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]" "central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]" DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690] GO:0000711; GO:0000775; GO:0000795; GO:0000801; GO:0000802; GO:0001673; GO:0003677; GO:0003690; GO:0005694; GO:0007129; GO:0007130; GO:0007131; GO:0007283; GO:0032880; GO:0035092; GO:0051026; GO:0051289; GO:0051301; GO:0051878 DEVKCK 5.880000114 1 1 0.025585239 778.1535973 0 0 0 0 15.37327 16.19477 0 0 15.75509 17.38737 0 0 0 13.07902 15.53268 0 17.36049 15.32981 0 0 0 0 0 14.28784 0 15.09181 17.91743 15.10567 13.06324 0 15.64496 16.84466 0 14.84604 0 16.94535 0 0 15.84213 15.95042 0 15.94191 12.65357 0 0 0 0 11.89262 Q15434 RBMS2_HUMAN "RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3)" RBMS2 SCR3 Homo sapiens (Human) RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA processing [GO:0006396] mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006396; GO:0008143; GO:0008266; GO:1990904 CEAIITHFNGK 11.81000042 1 1 0.242827635 1290.230025 0 15.82556 12.23182 0 0 16.24511 16.3685 0 0 0 0 12.1513 15.94956 13.74137 13.74543 14.73415 0 16.66174 0 0 15.04445 14.286 15.65369 0 0 14.54243 0 0 0 0 15.61317 0 0 0 16.57698 0 0 14.5551 0 0 0 0 0 0 0 15.67937 0 0 Q15436 SC23A_HUMAN "Protein transport protein Sec23A, hSec23A (SEC23-related protein A)" SEC23A Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0072659; GO:0090110 LAVSSAA 4.019999981 1 1 0.255367905 618.7730428 16.17269 0 12.52288 0 0 14.95933 16.28214 0 0 0 0 0 0 16.49193 0 15.25921 13.55518 0 0 0 0 0 16.45263 0 0 15.57029 15.74798 0 0 0 0 0 0 0 0 0 0 0 0 16.96142 17.12939 0 0 0 0 0 15.91854 0 Q15437 SC23B_HUMAN "Protein transport protein Sec23B, hSec23B (SEC23-related protein B)" SEC23B Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012505; GO:0030127; GO:0048471; GO:0070971; GO:0090110 LSDSFSLYPQFMFHLRR 2.480000019 1 1 0.112506024 2141.016275 0 0 15.23759 0 0 0 0 15.35833 0 0 0 16.37587 0 12.35411 0 0 0 14.04948 0 14.06345 0 15.03996 0 0 11.45883 0 0 0 14.01721 0 14.61105 15.15933 0 0 12.17935 14.61596 0 0 0 0 15.02608 13.24089 0 0 0 0 0 0 Q15459 SF3A1_HUMAN "Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114, SAP 114)" SF3A1 SAP114 Homo sapiens (Human) "mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" RNA binding [GO:0003723] GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241 MQEHMR 8.600000381 1 1 0.292286666 831.0404863 0 18.57569 0 0 18.38471 0 0 0 18.49764 16.49102 0 0 15.75132 16.47712 17.92108 0 0 0 0 0 17.45505 0 0 18.3556 0 0 0 0 17.65736 17.34649 0 17.8139 20.22981 19.28976 0 18.2002 0 17.33354 0 0 0 0 0 17.5158 0 17.55871 0 0 Q15465 SHH_HUMAN "Sonic hedgehog protein, SHH (HHG-1) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains, ShhNC) [Cleaved into: Sonic hedgehog protein N-product, ShhN (Shh N-terminal processed signaling domains, ShhNp) ]" SHH Homo sapiens (Human) "androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of cell polarity [GO:0030010]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270]; androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of cell polarity [GO:0030010]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]" calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270] GO:0000122; GO:0000139; GO:0001569; GO:0001570; GO:0001656; GO:0001658; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002076; GO:0002320; GO:0003140; GO:0004175; GO:0005113; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0007224; GO:0007228; GO:0007267; GO:0007389; GO:0007398; GO:0007405; GO:0007411; GO:0007417; GO:0007418; GO:0007442; GO:0007507; GO:0007596; GO:0008209; GO:0008270; GO:0008284; GO:0009880; GO:0009949; GO:0009953; GO:0009986; GO:0010468; GO:0010628; GO:0010629; GO:0014003; GO:0014706; GO:0014858; GO:0014902; GO:0016015; GO:0016539; GO:0016540; GO:0021513; GO:0021522; GO:0021794; GO:0021904; GO:0021930; GO:0021938; GO:0021978; GO:0030010; GO:0030162; GO:0030177; GO:0030324; GO:0030326; GO:0030336; GO:0030539; GO:0030850; GO:0030878; GO:0030900; GO:0030901; GO:0030902; GO:0031016; GO:0031069; GO:0032435; GO:0033077; GO:0033089; GO:0033092; GO:0034244; GO:0034504; GO:0035115; GO:0035116; GO:0042127; GO:0042130; GO:0042307; GO:0042475; GO:0042481; GO:0042733; GO:0043010; GO:0043066; GO:0043237; GO:0043369; GO:0045059; GO:0045060; GO:0045109; GO:0045121; GO:0045445; GO:0045596; GO:0045880; GO:0045893; GO:0045944; GO:0046638; GO:0046639; GO:0048468; GO:0048538; GO:0048557; GO:0048617; GO:0048643; GO:0048645; GO:0048663; GO:0048706; GO:0048709; GO:0048714; GO:0048745; GO:0048754; GO:0048839; GO:0048859; GO:0048864; GO:0051155; GO:0051781; GO:0060020; GO:0060021; GO:0060070; GO:0060174; GO:0060428; GO:0060439; GO:0060445; GO:0060447; GO:0060458; GO:0060459; GO:0060463; GO:0060484; GO:0060516; GO:0060523; GO:0060662; GO:0060664; GO:0060685; GO:0060738; GO:0060769; GO:0060782; GO:0060783; GO:0060840; GO:0060916; GO:0061053; GO:0061189; GO:0062023; GO:0071285; GO:0071542; GO:0072136; GO:0072205; GO:0090090; GO:0090370; GO:0097190; GO:1900175; GO:1900180; GO:1904339; GO:1905327; GO:2000062; GO:2000063; GO:2000357; GO:2000358; GO:2000729; GO:2001054 MLLLARCLLLVLVSSLLVCSGLACGPGR 7.039999962 1 1 4.58E-13 3058.379744 15.58539 15.25342 13.86627 0 0 11.8682 0 0 13.21633 0 0 0 0 0 0 0 0 0 13.96716 0 0 0 0 0 12.53105 9.006156 0 0 0 0 0 0 0 0 0 0 14.46122 0 0 14.95511 7.610174 0 0 0 0 0 12.39724 0 Q15468 STIL_HUMAN SCL-interrupting locus protein (TAL-1-interrupting locus protein) STIL SIL Homo sapiens (Human) centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099]; identical protein binding [GO:0042802]; centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] identical protein binding [GO:0042802] GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0033504; GO:0035264; GO:0042802; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905832 TESDNGMMGLSPDAYR 4.489999771 1 1 0.283693785 1759.580182 0 0 0 0 0 0 15.27533 0 15.45915 0 0 0 0 0 0 0 0 0 0 0 0 16.49172 0 0 0 0 0 16.04771 0 12.55689 14.37576 15.46505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15477 SKIV2_HUMAN "Helicase SKI2W, Ski2, EC 3.6.4.- (Helicase-like protein, HLP)" SKIV2L DDX13 SKI2W SKIV2 W Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]" cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087] "cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]" ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0016787; GO:0055087; GO:0070478 VLFATETFAMGVNMPARTVVFDSMR 1.440000057 1 1 3.66E-12 2799.999211 14.15381 0 0 0 0 15.26275 13.91289 0 15.92543 0 0 13.32348 0 14.89677 9.989975 0 0 0 14.94706 0 0 13.57139 12.59199 0 0 15.49647 0 15.13553 14.61804 0 15.72706 0 13.36263 14.87902 15.2318 0 0 14.0729 0 0 0 0 0 0 0 0 0 0 Q15485 FCN2_HUMAN Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) FCN2 FCNL Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370] "blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065 GEAGTNGK 1.840000033 1 1 0.157672114 733.4866622 0 18.11256 16.85279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.52026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15493 RGN_HUMAN "Regucalcin, RC (Gluconolactonase, GNL, EC 3.1.1.17) (Senescence marker protein 30, SMP-30)" RGN SMP30 Homo sapiens (Human) aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283] calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270] GO:0001822; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006874; GO:0007283; GO:0007568; GO:0008270; GO:0010867; GO:0010907; GO:0010922; GO:0019853; GO:0030234; GO:0032515; GO:0032781; GO:0034260; GO:0043066; GO:0043547; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0051344; GO:0097421; GO:1901318; GO:1901671; GO:1901896; GO:1902679; GO:1903011; GO:1903052; GO:1903611; GO:1903625; GO:1903629; GO:1903634; GO:2000279 FNDGKVDPAGR 5.860000134 0.228776529 0.228776529 0.036822641 1174.543939 15.83296 16.87434 14.95435 0 15.68606 14.33862 0 15.35677 14.37867 0 0 0 18.4456 0 0 17.48243 0 11.9351 0 14.94943 16.38657 0 12.29327 0 14.32506 0 16.63074 13.05512 12.05658 11.24432 0 16.5329 15.57212 0 12.58123 0 14.39541 17.36042 16.6898 0 10.95629 0 15.59973 12.69345 12.59004 11.17614 14.46066 15.87091 Q15506 SP17_HUMAN "Sperm surface protein Sp17 (Cancer/testis antigen 22, CT22) (Sp17-1) (Sperm autoantigenic protein 17, Sperm protein 17)" SPA17 SP17 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228] cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] calmodulin binding [GO:0005516] GO:0003351; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0007283; GO:0007338; GO:0007339; GO:0009897; GO:0031514; GO:0035686; GO:0097228 IQAAFR 4.260000229 1 1 0.21783419 704.2314769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.85241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15527 SURF2_HUMAN "Surfeit locus protein 2, Surf-2" SURF2 Homo sapiens (Human) nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005730; GO:0005886; GO:0016607 CPEHVLR 5.480000019 1 1 0.235258609 910.8126736 15.24185 0 13.68841 0 0 15.57738 0 14.64599 15.96961 14.5876 15.16571 15.67898 15.80579 0 15.49254 0 11.89893 0 0 0 0 0 0 0 0 0 0 0 14.54206 15.01886 0 15.56028 0 0 0 0 0 0 0 16.75351 0 0 0 0 0 0 14.45136 0 Q15532 SSXT_HUMAN Protein SSXT (Protein SYT) (Synovial sarcoma translocated to X chromosome protein) SS18 SSXT SYT Homo sapiens (Human) cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell differentiation [GO:0045596]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410] chromatin [GO:0000785]; GBAF complex [GO:0140288]; microtubule cytoskeleton [GO:0015630]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; GBAF complex [GO:0140288]; microtubule cytoskeleton [GO:0015630]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; nuclear receptor coactivator activity [GO:0030374]; cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell differentiation [GO:0045596]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410] nuclear receptor coactivator activity [GO:0030374] GO:0000226; GO:0000785; GO:0000902; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0009410; GO:0015630; GO:0016514; GO:0030374; GO:0035556; GO:0045596; GO:0045944; GO:0048013; GO:0071564; GO:0097150; GO:0140288; GO:1902459 GKGEITPAAIQK 10.48999977 1 1 0.122086713 1212.38833 0 0 14.88029 0 0 16.1406 0 13.10238 14.60069 16.19485 0 0 14.7437 16.56722 0 16.41497 17.33258 16.71069 16.65495 0 14.69573 17.66679 0 0 0 0 16.42715 14.48867 11.89367 16.14767 0 18.08319 17.61259 13.64428 17.50997 16.34795 14.23384 16.63669 0 14.74249 0 14.82118 17.52243 17.17918 16.72976 15.90909 0 15.15228 Q15544 TAF11_HUMAN "Transcription initiation factor TFIID subunit 11 (TFIID subunit p30-beta) (Transcription initiation factor TFIID 28 kDa subunit, TAF(II)28, TAFII-28, TAFII28)" TAF11 TAF2I PRO2134 Homo sapiens (Human) mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; vitamin D receptor binding [GO:0042809]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; vitamin D receptor binding [GO:0042809] GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005794; GO:0006366; GO:0006367; GO:0006468; GO:0016251; GO:0017025; GO:0042789; GO:0042809; GO:0043923; GO:0046966; GO:0046982; GO:0047485; GO:0051123; GO:0060261 SKGQIPNSK 10.15999985 0.746895432 0.746895432 0.216593987 957.4799568 0 0 0 17.61056 18.24173 0 0 0 0 0 0 0 16.96121 17.19569 18.53914 17.09748 17.69081 16.06326 0 16.3943 17.13762 17.25402 18.76011 0 0 17.55049 17.63378 17.51046 0 17.00828 0 18.19991 18.05994 17.81246 16.84833 18.31557 18.51499 18.44258 17.64178 17.67785 16.97963 15.31872 0 17.18137 17.24149 17.38371 18.78109 16.87954 Q15560 TCEA2_HUMAN Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l) TCEA2 Homo sapiens (Human) "DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] "centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006351; GO:0006354; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0045944 LSAQIEECIFR 8.119999886 0.903567612 0.903567612 0.235145196 1364.840502 0 0 0 15.77065 0 12.576 0 0 12.09172 0 12.85743 14.21077 15.93161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.71482 0 14.78713 17.0634 0 15.68638 0 0 0 0 14.99518 17.13651 14.25882 0 0 0 0 14.44355 0 Q15562 TEAD2_HUMAN "Transcriptional enhancer factor TEF-4 (TEA domain family member 2, TEAD-2)" TEAD2 TEF4 Homo sapiens (Human) "cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; negative regulation of cell death [GO:0060548]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; vasculogenesis [GO:0001570]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; negative regulation of cell death [GO:0060548]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; vasculogenesis [GO:0001570]" "disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]" GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001570; GO:0001843; GO:0003143; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006355; GO:0006357; GO:0030903; GO:0035329; GO:0043231; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0048568; GO:0060548; GO:0065003; GO:0071300; GO:0097718; GO:0140552; GO:1990837; GO:2000736 MGEPR 9.279999733 1.28E-10 1.28E-10 0.263218946 587.2424438 0 18.37471 0 0 18.17223 0 0 0 18.85059 0 0 0 17.57753 17.72501 0 0 16.37462 15.79789 0 0 17.55178 0 0 0 0 17.98033 17.35436 0 0 0 0 19.07206 19.08138 18.01139 18.56179 18.55322 0 0 17.70273 18.47965 0 18.72436 0 0 0 0 16.74571 18.55484 Q15572 TAF1C_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit C (RNA polymerase I-specific TBP-associated factor 110 kDa, TAFI110) (TATA box-binding protein-associated factor 1C, TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C)" TAF1C Homo sapiens (Human) transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361] RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] GO:0001164; GO:0001181; GO:0001650; GO:0005654; GO:0005730; GO:0006360; GO:0006361; GO:0006366 SQQHTPVLSSSQPLR 5.179999828 1 1 0.434431172 1665.884343 15.08286 0 0 14.64399 15.20015 11.67422 14.60617 14.65035 0 0 13.91047 0 0 14.72824 15.30187 11.748 0 0 15.7082 0 0 0 0 0 0 0 0 0 0 0 0 14.52672 0 0 0 0 0 0 16.22186 0 0 0 0 15.67548 0 0 0 0 Q15573 TAF1A_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa, TAFI48) (TATA box-binding protein-associated factor 1A, TBP-associated factor 1A) (Transcription factor SL1) (Transcription initiation factor SL1/TIF-IB subunit A)" TAF1A Homo sapiens (Human) transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase I transcription regulator complex [GO:0000120] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase I transcription regulator complex [GO:0000120]; DNA binding [GO:0003677]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366] DNA binding [GO:0003677] GO:0000120; GO:0003677; GO:0005654; GO:0006360; GO:0006366; GO:0015630 HGENTSSR 7.5 1 1 0.239757178 888.1878557 15.09367 15.45719 15.71017 0 0 15.50012 14.89987 15.18898 14.10615 15.89482 0 0 12.8724 16.10593 14.94985 15.08799 13.09577 14.67577 17.45289 15.39629 16.60858 14.75614 14.90548 15.88738 15.0092 13.80519 14.44332 0 0 0 16.30435 0 15.64207 0 15.94359 0 16.48253 0 0 0 15.32771 0 0 16.22482 0 16.99783 15.47909 0 Q15582 BGH3_HUMAN "Transforming growth factor-beta-induced protein ig-h3, Beta ig-h3 (Kerato-epithelin) (RGD-containing collagen-associated protein, RGD-CAP)" TGFBI BIGH3 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178] GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062 LLERMK 4.889999866 0.665235758 0.665235758 0.223947523 788.5073719 13.42495 14.46821 14.26898 18.00662 15.15724 14.45871 15.71493 15.14963 0 18.08778 15.26486 15.87094 15.54113 15.61296 13.7628 13.30332 0 16.24996 12.79791 15.96461 14.9743 14.79338 14.50464 15.88058 0 0 0 0 0 0 14.15109 15.99829 15.6125 13.84534 15.59082 0 14.67642 15.32307 0 16.46927 0 0 0 15.45883 15.33573 0 0 0 Q15596 NCOA2_HUMAN "Nuclear receptor coactivator 2, NCoA-2 (Class E basic helix-loop-helix protein 75, bHLHe75) (Transcriptional intermediary factor 2, hTIF2)" NCOA2 BHLHE75 SRC2 TIF2 Homo sapiens (Human) "cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to progesterone [GO:0032570]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to progesterone [GO:0032570]" aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713] GO:0000122; GO:0000785; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019904; GO:0030374; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035357; GO:0042789; GO:0045475; GO:0045944; GO:0046983; GO:0090575; GO:1900076; GO:1904017; GO:1904179 EQMGMPMGR 3.299999952 0.592853248 0.592853248 0.245796802 1067.871744 13.1418 14.51709 15.29163 0 0 14.07853 0 15.40683 14.31999 0 0 14.67333 0 0 0 14.40332 0 0 15.15834 14.94544 0 0 15.3037 0 0 0 0 15.20536 0 0 0 11.63531 0 10.43104 0 0 0 0 0 0 0 0 0 0 13.06349 0 0 0 Q155Q3 DIXC1_HUMAN "Dixin (Coiled-coil protein DIX1, Coiled-coil-DIX1) (DIX domain-containing protein 1)" DIXDC1 CCD1 KIAA1735 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex development [GO:0021695]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507] axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991] axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex development [GO:0021695]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507] actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904] GO:0003779; GO:0005829; GO:0005856; GO:0005925; GO:0019904; GO:0021695; GO:0021799; GO:0021869; GO:0030177; GO:0031435; GO:0032956; GO:0032991; GO:0043015; GO:0043025; GO:0043679; GO:0045665; GO:0046330; GO:0050772; GO:0060070; GO:0070507 ELLKCK 7.909999847 1 1 0.276929242 791.8338414 16.78382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.19758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15612 OR1Q1_HUMAN "Olfactory receptor 1Q1 (OST226) (Olfactory receptor 1Q2) (Olfactory receptor 1Q3) (Olfactory receptor 9-A, OR9-A) (Olfactory receptor OR9-25) (Olfactory receptor TPCR106)" OR1Q1 OR1Q2 OR1Q3 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 LHIPMYIFLSNLALTDICFTSTTVPK 5.840000153 0.506001294 0.506001294 3.66E-12 2994.932279 17.10466 15.8811 0 15.25506 0 15.67224 0 14.59507 0 0 15.73791 0 0 0 13.8537 0 0 0 0 14.75362 0 0 0 0 14.16344 13.29904 14.45927 0 0 16.90171 0 15.93738 0 0 0 0 0 14.17435 0 12.9512 13.11424 0 0 0 0 0 15.64742 0 Q15628 TRADD_HUMAN "Tumor necrosis factor receptor type 1-associated DEATH domain protein, TNFR1-associated DEATH domain protein (TNFRSF1A-associated via death domain)" TRADD Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of hair follicle development [GO:0051798]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]; death domain binding [GO:0070513]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of hair follicle development [GO:0051798]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] death domain binding [GO:0070513]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; tumor necrosis factor receptor binding [GO:0005164] GO:0002947; GO:0005068; GO:0005164; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006915; GO:0007165; GO:0008625; GO:0019900; GO:0030335; GO:0031264; GO:0033209; GO:0042802; GO:0043065; GO:0043123; GO:0043235; GO:0044877; GO:0045121; GO:0050729; GO:0051092; GO:0051798; GO:0070513; GO:0071356; GO:0097191; GO:1901224 CGSGAR 4.489999771 0.421011508 0.421011508 0.258958963 608.1843441 13.22333 12.07675 16.10137 15.56927 0 0 16.37204 14.10239 0 0 16.46012 15.09338 15.83031 12.11607 0 16.13618 17.14113 16.01152 0 0 0 0 0 16.85768 0 0 16.56651 14.71138 15.14948 0 0 0 0 16.21127 0 0 16.13366 16.40676 15.5576 17.19606 17.04736 0 0 16.70987 15.98973 0 16.48502 0 Q15633 TRBP2_HUMAN RISC-loading complex subunit TARBP2 (TAR RNA-binding protein 2) (Trans-activation-responsive RNA-binding protein) TARBP2 TRBP Homo sapiens (Human) miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; multicellular organism growth [GO:0035264]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of protein kinase activity [GO:0006469]; neural precursor cell proliferation [GO:0061351]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of viral transcription [GO:0046782]; single fertilization [GO:0007338]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; skeletal muscle tissue regeneration [GO:0043403]; spermatid development [GO:0007286]; targeting of mRNA for destruction involved in RNA interference [GO:0030423] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; pre-mRNA binding [GO:0036002]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; multicellular organism growth [GO:0035264]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of protein kinase activity [GO:0006469]; neural precursor cell proliferation [GO:0061351]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of viral transcription [GO:0046782]; single fertilization [GO:0007338]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; skeletal muscle tissue regeneration [GO:0043403]; spermatid development [GO:0007286]; targeting of mRNA for destruction involved in RNA interference [GO:0030423] double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; pre-mRNA binding [GO:0036002]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197] GO:0003725; GO:0005654; GO:0005737; GO:0005829; GO:0006469; GO:0007286; GO:0007338; GO:0016442; GO:0016604; GO:0019899; GO:0030422; GO:0030423; GO:0031054; GO:0035087; GO:0035196; GO:0035197; GO:0035198; GO:0035264; GO:0035280; GO:0036002; GO:0042802; GO:0042803; GO:0043403; GO:0045070; GO:0045727; GO:0046782; GO:0047485; GO:0048471; GO:0050689; GO:0051149; GO:0061351; GO:0070578; GO:0070883; GO:0090065; GO:1903798 GEAAR 8.079999924 0.734649003 0.734649003 0.154588343 503.2721079 16.56074 15.60116 17.0051 16.87451 16.45673 16.41856 15.01053 15.81059 15.8009 16.12704 16.50074 16.7139 16.52388 15.93579 15.98515 16.23593 17.34527 0 16.3147 16.64983 16.01237 17.2204 16.69827 17.05768 16.49115 15.61352 16.91632 17.01999 16.4783 15.62086 16.40824 17.05393 16.11264 17.35442 15.48519 16.30386 16.93973 15.85658 17.25187 17.37033 16.03997 17.23897 16.61199 0 17.00865 16.66883 16.97591 16.95739 Q15643 TRIPB_HUMAN "Thyroid receptor-interacting protein 11, TR-interacting protein 11, TRIP-11 (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210, GMAP-210) (Trip230)" TRIP11 CEV14 Homo sapiens (Human) cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133] cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]; cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713] GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0006366; GO:0006486; GO:0006888; GO:0007030; GO:0016607; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0090161; GO:0099041 ETEYQALQETNMKFSMMLR 2.470000029 0.11333739 0.11333739 0.065045377 2350.71792 14.03413 0 10.80961 0 0 14.8962 0 0 14.37867 14.24636 0 0 0 0 0 0 12.999 0 0 0 0 0 15.63108 0 0 13.0726 16.42777 11.6972 13.90621 0 0 0 15.57212 0 0 18.82295 15.53866 10.26982 0 0 0 0 0 13.92524 0 13.76214 18.15443 0 Q15645 PCH2_HUMAN "Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein, 16E1-BP, HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13, TR-interacting protein 13, TRIP-13)" TRIP13 PCH2 Homo sapiens (Human) double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366] chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] GO:0001556; GO:0001673; GO:0003712; GO:0005524; GO:0005634; GO:0005694; GO:0006302; GO:0006366; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0016887; GO:0042802; GO:0048477; GO:0051598 DEAVGDLK 11.28999996 0.936810076 0.936810076 0.080269413 846.5150142 15.70148 0 0 0 0 12.84541 0 0 12.01666 13.3489 16.1188 15.42009 14.91503 0 0 15.61623 0 17.2303 0 14.66107 13.45885 16.31979 13.97526 15.34697 0 14.72437 15.09689 0 18.73891 9.210407 16.30129 0 0 15.7886 0 14.89735 0 0 14.90274 16.38068 15.19651 11.92416 15.04351 0 14.39818 15.31418 0 0 Q15648 MED1_HUMAN "Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component, ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein, PBP, PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component, Trap220) (Thyroid receptor-interacting protein 2, TR-interacting protein 2, TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)" MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 Homo sapiens (Human) "androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809] GO:0000122; GO:0000902; GO:0001223; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0010628; GO:0010839; GO:0016020; GO:0016592; GO:0016922; GO:0030216; GO:0030224; GO:0030331; GO:0030374; GO:0030518; GO:0031100; GO:0032968; GO:0033148; GO:0035050; GO:0035116; GO:0035162; GO:0035357; GO:0035729; GO:0035855; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0044877; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051123; GO:0060261; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0070318; GO:0070562; GO:0070847; GO:0071364; GO:0071383; GO:0097067; GO:0140297; GO:1990841; GO:2000347; GO:2001141 CMSIPVTMR 8.529999733 1 1 2.28E-13 1110.210711 0 0 15.02393 16.58949 14.01421 0 0 0 0 16.20396 0 0 0 0 0 0 0 0 15.43222 0 14.6053 0 0 13.18932 0 15.50156 0 17.07423 0 11.52625 15.14089 0 17.73404 0 0 0 0 0 15.18763 0 0 0 0 0 0 0 0 15.25703 Q15651 HMGN3_HUMAN "High mobility group nucleosome-binding domain-containing protein 3 (Thyroid receptor-interacting protein 7, TR-interacting protein 7, TRIP-7)" HMGN3 TRIP7 PNAS-24 Homo sapiens (Human) chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; thyroid hormone receptor binding [GO:0046966]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; thyroid hormone receptor binding [GO:0046966] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0031492; GO:0045944; GO:0046966; GO:0061178 EEKQEAGK 3.150000095 1 1 0.14159789 920.4373953 0 0 0 0 0 0 15.86463 0 0 0 0 0 0 0 0 0 0 0 0 16.47046 14.12928 15.00883 0 0 0 12.15737 13.872 0 14.38658 14.95102 15.60632 13.58265 0 0 0 0 0 0 0 0 14.5054 15.06349 0 0 13.83202 0 0 0 Q15652 JHD2C_HUMAN "Probable JmjC domain-containing histone demethylation protein 2C, EC 1.14.11.- (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8, TR-interacting protein 8, TRIP-8)" JMJD1C JHDM2C KIAA1380 TRIP8 Homo sapiens (Human) "blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712] GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006325; GO:0006355; GO:0006357; GO:0007596; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0046966; GO:0051213 AGVIR 9.760000229 1 1 0.246725191 516.2931202 15.56895 0 0 0 0 0 17.4929 0 0 0 0 0 0 0 0 0 0 0 17.89065 0 0 17.04761 0 0 0 0 17.7639 17.39774 0 0 0 0 18.88003 0 0 0 0 18.17096 17.54722 0 18.09039 17.39745 0 0 0 0 0 0 Q15653 IKBB_HUMAN "NF-kappa-B inhibitor beta, NF-kappa-BIB (I-kappa-B-beta, IkB-B, IkB-beta, IkappaBbeta) (Thyroid receptor-interacting protein 9, TR-interacting protein 9, TRIP-9)" NFKBIB IKBB TRIP9 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; inflammatory response [GO:0006954]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; inflammatory response [GO:0006954]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005829; GO:0006351; GO:0006954; GO:0007165; GO:0007253; GO:0043122; GO:0071222 EEEESEEDWK 13.06999969 1 1 0.259431281 1310.230162 16.25556 0 0 16.30327 16.82091 0 16.66367 16.94207 0 0 0 0 17.34436 15.95826 0 0 0 0 0 0 17.6453 16.2583 16.17722 15.39081 0 15.82086 17.15811 0 16.17795 0 15.86931 0 16.17256 16.03386 0 17.01325 13.40227 15.09345 15.78269 15.99225 0 0 0 14.39001 13.18624 15.399 16.34871 16.56434 Q15661 TRYB1_HUMAN "Tryptase alpha/beta-1, Tryptase-1, EC 3.4.21.59 (Tryptase I) (Tryptase alpha-1)" TPSAB1 TPS1 TPS2 TPSB1 Homo sapiens (Human) defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368] extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508] identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006952; GO:0008236; GO:0022617; GO:0042802; GO:1905368 VGIVGGQEAPR 8.699999809 0.03084968 0.03084968 0.145529986 1082.206552 15.63002 12.89042 13.86902 14.13666 12.52373 13.16044 18.92781 13.05416 0 12.87638 12.13625 0 16.11071 0 0 0 0 13.92147 0 0 0 0 0 0 0 0 0 15.18351 0 0 15.3964 17.33005 0 0 13.00595 0 0 0 15.0488 0 0 0 15.9264 0 16.63558 0 0 16.05742 Q15669 RHOH_HUMAN Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein) RHOH ARHH TTF Homo sapiens (Human) "actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]" cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0001772; GO:0003924; GO:0005095; GO:0005525; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0006355; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016601; GO:0019210; GO:0019901; GO:0030031; GO:0030217; GO:0030865; GO:0031267; GO:0031410; GO:0032956; GO:0042995; GO:0043124; GO:0043652; GO:0045576; GO:0045582; GO:1902622 CVLVGDSAVGKTSLLVR 2.700000048 1 1 0.492301727 1774.205679 18.93929 0 10.10868 0 0 0 0 0 0 0 16.57287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.38631 0 0 0 17.98114 0 18.37195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15672 TWST1_HUMAN "Twist-related protein 1 (Class A basic helix-loop-helix protein 38, bHLHa38) (H-twist)" TWIST1 BHLHA38 TWIST Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in heart valve development [GO:2000793]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cranial suture morphogenesis [GO:0060363]; developmental process [GO:0032502]; embryonic camera-type eye formation [GO:0060900]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion morphogenesis [GO:0003203]; eyelid development in camera-type eye [GO:0061029]; in utero embryonic development [GO:0001701]; mitral valve morphogenesis [GO:0003183]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; outer ear morphogenesis [GO:0042473]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell motility [GO:2000147]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [GO:2000802]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of bone mineralization [GO:0030500]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; roof of mouth development [GO:0060021]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator binding [GO:0001221]; aortic valve morphogenesis [GO:0003180]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in heart valve development [GO:2000793]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cranial suture morphogenesis [GO:0060363]; developmental process [GO:0032502]; embryonic camera-type eye formation [GO:0060900]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion morphogenesis [GO:0003203]; eyelid development in camera-type eye [GO:0061029]; in utero embryonic development [GO:0001701]; mitral valve morphogenesis [GO:0003183]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; outer ear morphogenesis [GO:0042473]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell motility [GO:2000147]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [GO:2000802]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of bone mineralization [GO:0030500]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; roof of mouth development [GO:0060021]" "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator binding [GO:0001221]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001221; GO:0001503; GO:0001649; GO:0001701; GO:0001764; GO:0001843; GO:0003180; GO:0003183; GO:0003203; GO:0003253; GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0010628; GO:0010718; GO:0014067; GO:0019904; GO:0030500; GO:0032000; GO:0032502; GO:0032720; GO:0032755; GO:0032760; GO:0033128; GO:0035067; GO:0035115; GO:0035116; GO:0035359; GO:0042473; GO:0042476; GO:0042733; GO:0042803; GO:0043066; GO:0043425; GO:0043433; GO:0043518; GO:0045668; GO:0045766; GO:0045892; GO:0045944; GO:0048511; GO:0048642; GO:0048701; GO:0050679; GO:0060021; GO:0060363; GO:0060900; GO:0061029; GO:0070888; GO:0071363; GO:0071456; GO:0071639; GO:0140297; GO:2000144; GO:2000147; GO:2000276; GO:2000679; GO:2000773; GO:2000780; GO:2000793; GO:2000802 QRTQSLNEAFAALR 4.619999886 0.875827491 0.875827491 0.351943789 1604.553374 0 0 14.33479 14.06758 13.93141 15.64974 0 0 1.877092 0 0 14.31055 15.20802 14.56477 14.67724 0 13.59713 0 11.19132 0 0 0 0 0 14.78485 0 0 14.34553 0 13.03488 0 0 0 0 0 0 15.13098 0 0 0 0 13.88582 0 15.38705 0 0 14.84717 0 Q15678 PTN14_HUMAN "Tyrosine-protein phosphatase non-receptor type 14, EC 3.1.3.48 (Protein-tyrosine phosphatase pez)" PTPN14 PEZ PTPD2 Homo sapiens (Human) lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]; lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825] protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712] GO:0001946; GO:0003712; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006470; GO:0008285; GO:0030971; GO:0046825 HTNSMLEGTK 8.920000076 0.084949799 0.084949799 2.31E-13 1116.3478 0 0 0 0 20.31581 0 0 0 0 0 18.01124 0 0 0 0 17.26016 0 0 0 0 0 0 0 0 16.83232 0 0 0 0 0 16.93892 0 17.78795 0 0 16.44914 0 0 0 0 0 0 0 0 16.91946 0 14.55821 0 Q15697 ZN174_HUMAN Zinc finger protein 174 (AW-1) (Zinc finger and SCAN domain-containing protein 8) ZNF174 ZSCAN8 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001650; GO:0003700; GO:0005634; GO:0006357; GO:0016604; GO:0042803; GO:0043565; GO:0045892; GO:0046872; GO:1990837 ASKKPK 2.819999933 1 1 0.190562824 657.597496 0 0 0 0 15.41869 0 14.20749 0 0 0 0 14.77193 15.49419 16.35151 0 0 0 15.49531 0 15.36312 0 15.96134 16.14086 16.15821 17.79625 0 0 16.59874 17.0866 0 17.31934 0 0 0 15.92544 16.2649 16.39696 0 0 0 15.09434 16.61613 0 16.93932 0 12.60586 15.39991 16.64894 Q15700 DLG2_HUMAN "Disks large homolog 2 (Channel-associated protein of synapse-110, Chapsyn-110) (Postsynaptic density protein PSD-93)" DLG2 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642] adherens junction [GO:0005912]; axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] adherens junction [GO:0005912]; axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900]; anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642] guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900] GO:0004385; GO:0005829; GO:0005886; GO:0005912; GO:0007268; GO:0014069; GO:0016020; GO:0016323; GO:0019900; GO:0030054; GO:0031594; GO:0035865; GO:0043005; GO:0043113; GO:0043204; GO:0044224; GO:0045197; GO:0097120; GO:0098609; GO:0098839; GO:0099641; GO:0099642; GO:1904115 GSFNDKR 8.789999962 0.402984709 0.402984709 0.21324755 822.7427099 18.98382 17.0069 0 16.12507 0 0 15.50237 0 15.85905 18.41437 16.56685 16.78356 16.14328 14.87783 15.65244 13.63881 0 13.12908 17.56001 17.42377 0 18.3349 17.8755 16.95394 0 16.25788 0 0 13.05747 15.31082 0 0 14.35501 10.58369 16.19334 17.24493 18.26913 17.52229 17.86724 17.68488 18.43309 14.08731 16.60681 0 16.83447 16.57811 14.79031 11.10948 Q15714 T22D1_HUMAN TSC22 domain family protein 1 (Cerebral protein 2) (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein) TSC22D1 KIAA1994 TGFB1I4 TSC22 hucep-2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] GO:0005634; GO:0005737; GO:0006357; GO:0006366 NSQLEQENNLLK 2.339999914 1 1 0.0049172 1429.015287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15722 LT4R1_HUMAN "Leukotriene B4 receptor 1, LTB4-R 1, LTB4-R1 (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7, P2Y7)" LTB4R BLT BLT1 BLTR CMKRL1 GPR16 P2RY7 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; muscle contraction [GO:0006936]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; nucleotide binding [GO:0000166]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; muscle contraction [GO:0006936]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; nucleotide binding [GO:0000166] GO:0000166; GO:0001632; GO:0004974; GO:0005886; GO:0005887; GO:0006936; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007218; GO:0008528 RGGSLGQTAR 7.710000038 1 1 0.100572615 1001.85959 16.49066 0 15.9835 14.31165 14.68011 13.94868 12.07982 13.46928 15.9581 15.98793 0 15.89954 15.59225 0 15.00981 0 13.86953 14.99897 0 0 15.55473 15.99972 15.36616 15.82388 0 0 0 0 0 0 0 15.01306 16.48491 0 0 0 0 15.8524 0 0 0 0 0 0 0 0 0 0 Q15735 PI5PA_HUMAN "Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A, EC 3.1.3.56 (Inositol polyphosphate 5-phosphatase J)" INPP5J PIB5PA PIPP Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]" "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]" GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0010977; GO:0017124; GO:0019898; GO:0030426; GO:0031115; GO:0033137; GO:0034485; GO:0043198; GO:0043647; GO:0046855; GO:0046856; GO:0052658; GO:0052659 TGLGGYWGNKGGVSVR 4.28000021 1 1 0.222830093 1607.840548 0 14.59197 0 0 15.1419 14.76449 0 13.93694 0 0 16.16281 14.32693 0 0 15.10286 14.99983 0 0 0 0 0 15.83925 0 13.28713 0 0 0 0 0 0 14.35189 14.15953 0 16.78211 13.54085 0 0 14.48439 0 0 0 0 16.18604 14.47392 0 15.2311 0 0 Q15738 NSDHL_HUMAN "Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, EC 1.1.1.170 (Protein H105e3)" NSDHL H105E3 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224]" "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]" GO:0000252; GO:0001942; GO:0003854; GO:0005783; GO:0005789; GO:0005811; GO:0006695; GO:0007224; GO:0008203; GO:0016021; GO:0016616; GO:0047012; GO:0060716; GO:0102175; GO:0103066; GO:0103067 NVIETCK 9.529999733 1 1 0.504473385 863.3182256 0 0 17.28937 0 0 0 0 0 0 0 0 17.31137 0 0 0 0 0 0 0 19.38737 0 0 0 0 0 0 0 0 0 0 0 0 18.24644 18.95622 0 0 0 0 0 0 0 0 19.48513 0 0 19.25363 0 0 Q15746 MYLK_HUMAN "Myosin light chain kinase, smooth muscle, MLCK, smMLCK, EC 2.7.11.18 (Kinase-related protein, KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form ]" MYLK MLCK MLCK1 MYLK1 Homo sapiens (Human) aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672] GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303 ITGRPQPQVTWLK 3.380000114 1 1 0.37685244 1524.089669 13.41602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15751 HERC1_HUMAN "Probable E3 ubiquitin-protein ligase HERC1, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)" HERC1 Homo sapiens (Human) cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175] guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885 FVSGR 12.65999985 8.05E-05 8.05E-05 0.262366452 565.2504685 0 0 20.48667 16.12131 0 0 21.11973 0 21.47198 0 0 0 0 17.69674 0 20.19321 0 20.2476 19.08296 0 0 0 0 0 21.01398 0 16.59161 0 16.67963 0 22.15944 22.28066 21.77039 0 0 21.42838 0 0 21.01723 20.22534 20.1518 0 20.40635 21.18751 15.97133 19.9517 20.3757 19.91485 Q15762 CD226_HUMAN "CD226 antigen (DNAX accessory molecule 1, DNAM-1) (CD antigen CD226)" CD226 DNAM1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell recognition [GO:0008037]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of mast cell activation [GO:0033005]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of T cell receptor signaling pathway [GO:0050862]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of mast cell activation [GO:0033005]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of T cell receptor signaling pathway [GO:0050862]; signal transduction [GO:0007165] cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901] GO:0002729; GO:0002860; GO:0002891; GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007165; GO:0008037; GO:0009897; GO:0009986; GO:0019901; GO:0032729; GO:0033005; GO:0045121; GO:0045954; GO:0050839; GO:0050862; GO:0060369 APNNYR 5.590000153 1 1 0.289178751 737.0042033 17.86736 16.30591 0 0 0 0 0 0 16.02493 15.8144 0 0 0 0 0 0 15.65383 0 17.04094 0 0 0 17.09704 14.98742 0 16.56728 0 0 0 16.13311 0 0 0 0 0 16.9677 18.40337 18.33602 0 0 0 0 17.39567 0 17.47598 0 0 17.00777 Q15771 RAB30_HUMAN Ras-related protein Rab-30 RAB30 Homo sapiens (Human) Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482] cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802] cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0007030; GO:0031985; GO:0032482; GO:0043231 SANALILTYDITCEESFR 12.52000046 1 1 0.229612408 2101.624591 16.37746 0 15.72171 0 0 14.88457 15.99946 15.68599 16.56826 0 0 0 15.48718 14.21031 15.64785 15.30503 0 15.34564 0 15.27936 14.90404 14.77569 15.98106 0 0 0 16.57678 0 16.8178 14.94491 16.07225 0 16.25597 15.85154 0 0 17.18096 15.68778 0 16.29446 16.75507 16.60642 17.76059 0 0 16.42313 15.60684 0 Q15772 SPEG_HUMAN "Striated muscle preferentially expressed protein kinase, EC 2.7.11.1 (Aortic preferentially expressed protein 1, APEG-1)" SPEG APEG1 KIAA1297 Homo sapiens (Human) muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0007517; GO:0008285; GO:0042692; GO:0106310 AGPEAEKR 8.210000038 0.357725948 0.357725948 0.251722583 856.7934404 17.66035 20.30079 19.65582 0 0 0 0 0 0 0 20.52256 0 0 0 0 0 0 0 0 0 0 0 0 18.03841 18.66824 0 0 0 0 17.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15773 MLF2_HUMAN Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2) MLF2 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0005737; GO:0006355; GO:0016020 AHILQR 12.72000027 1 1 0.119077651 734.3982965 15.17492 16.78677 12.81823 0 0 0 0 0 16.53409 15.14371 0 0 0 16.37633 0 0 0 0 0 0 0 18.05361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15776 ZKSC8_HUMAN Zinc finger protein with KRAB and SCAN domains 8 (LD5-1) (Zinc finger protein 192) ZKSCAN8 ZNF192 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GSSGDQEMTATLLTAGFQTLEKIEDMAVSLIR 1.330000043 0.314845979 0.314845979 1.37E-12 3427.794829 10.21671 12.02386 0 13.31227 13.36745 13.77152 16.84101 11.96838 13.34491 16.16869 13.98341 15.04524 14.50845 14.84237 0 15.31073 0 0 0 0 0 0 0 0 0 0 13.12637 0 0 0 0 0 0 0 13.22154 0 14.29649 0 0 15.41149 15.63204 0 0 0 0 0 0 0 Q15782 CH3L2_HUMAN Chitinase-3-like protein 2 (Chondrocyte protein 39) (YKL-39) CHI3L2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; hydrolase activity [GO:0016787]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032] carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; hydrolase activity [GO:0016787] GO:0005576; GO:0005615; GO:0005975; GO:0006032; GO:0008061; GO:0016787; GO:0030246 GMPSEK 6.489999771 1 1 0.013245722 663.4708367 16.13328 15.38234 0 0 0 16.11223 15.53814 12.27281 0 0 12.0352 14.89822 0 0 15.7152 0 0 0 0 0 0 18.13074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15785 TOM34_HUMAN "Mitochondrial import receptor subunit TOM34, hTom34 (Translocase of outer membrane 34 kDa subunit)" TOMM34 URCC3 Homo sapiens (Human) protein targeting to mitochondrion [GO:0006626] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; heat shock protein binding [GO:0031072]; protein targeting to mitochondrion [GO:0006626] heat shock protein binding [GO:0031072] GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0016020; GO:0016021; GO:0031072; GO:0043231 DCTEALK 5.429999828 0.839038491 0.839038491 0.183388984 837.7844973 16.62606 15.1625 16.65414 15.59608 0 0 0 0 14.34998 0 0 0 0 16.53 14.3797 15.55213 0 14.78602 0 16.10021 0 0 0 16.34499 0 0 0 0 0 0 15.26766 0 0 0 16.22725 0 16.78141 0 0 16.7934 0 0 13.62784 0 0 15.27996 13.80132 16.56391 Q15788 NCOA1_HUMAN "Nuclear receptor coactivator 1, NCoA-1, EC 2.3.1.48 (Class E basic helix-loop-helix protein 74, bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1, SRC-1)" NCOA1 BHLHE74 SRC1 Homo sapiens (Human) "cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; labyrinthine layer morphogenesis [GO:0060713]; mRNA transcription by RNA polymerase II [GO:0042789]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; labyrinthine layer morphogenesis [GO:0060713]; mRNA transcription by RNA polymerase II [GO:0042789]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]" aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713] GO:0000435; GO:0000785; GO:0002155; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005886; GO:0016922; GO:0017162; GO:0019899; GO:0030331; GO:0030374; GO:0032870; GO:0032991; GO:0035357; GO:0042789; GO:0043065; GO:0043967; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0047485; GO:0060713; GO:0090575; GO:1900076; GO:1904017; GO:1904179 LNIQPAKAESK 14.76000023 1 1 1.60E-12 1198.915752 0 12.12543 0 0 13.96241 0 0 12.80631 14.65477 0 0 0 0 0 13.84081 12.93228 0 11.99777 0 0 15.20592 0 17.75822 0 14.30606 0 0 12.77078 0 14.50744 14.20949 13.66415 14.62481 9.530681 9.445889 14.82991 0 0 0 13.95648 15.18418 0 0 0 0 0 0 14.20774 Q15796 SMAD2_HUMAN "Mothers against decapentaplegic homolog 2, MAD homolog 2, Mothers against DPP homolog 2 (JV18-1) (Mad-related protein 2, hMAD-2) (SMAD family member 2, SMAD 2, Smad2, hSMAD2)" SMAD2 MADH2 MADR2 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]" activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] "activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]" "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0007369; GO:0008285; GO:0009653; GO:0009749; GO:0009791; GO:0009952; GO:0010628; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030154; GO:0030324; GO:0030325; GO:0030509; GO:0030513; GO:0031016; GO:0031053; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042060; GO:0042802; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0061629; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0071141; GO:0071142; GO:0071144; GO:0097718; GO:0140297; GO:1900224 MSSILPFTPPVVKR 17.37999916 0.29062286 0.29062286 0.454881068 1587.062279 21.97269 0 18.09935 0 0 0 19.90443 0 0 0 0 22.12028 21.90495 0 0 0 0 22.57702 0 0 0 23.05238 16.94968 17.31201 0 21.8102 0 0 20.85517 23.91348 0 0 0 0 17.32711 0 0 0 17.68007 0 0 0 0 0 18.75842 22.25669 22.67124 21.88808 Q15811 ITSN1_HUMAN Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17) ITSN1 ITSN SH3D1A Homo sapiens (Human) cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064] GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0016197; GO:0030027; GO:0034613; GO:0035556; GO:0043005; GO:0051056; GO:0055037; GO:0060090; GO:0070064; GO:0098793; GO:0150007 CKGMPLSSFILKPMQR 3.210000038 1 1 0.397719736 1908.865996 16.23431 0 0 18.26516 0 14.96792 0 0 0 0 15.74321 13.64671 16.17654 0 0 0 0 0 0 0 0 0 15.81607 0 17.56934 16.80709 16.45406 0 0 0 0 0 0 15.60843 0 0 0 0 0 0 0 0 15.92723 0 0 0 17.27094 0 Q15818 NPTX1_HUMAN "Neuronal pentraxin-1, NP1 (Neuronal pentraxin I, NP-I)" NPTX1 Homo sapiens (Human) axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133] glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] metal ion binding [GO:0046872] GO:0005739; GO:0005886; GO:0006839; GO:0007268; GO:0007417; GO:0030133; GO:0035865; GO:0043005; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0098962; GO:0098978; GO:0099151; GO:0099645 FQLTFPLR 9.010000229 0.482115418 0.482115418 0.31377978 1019.429874 0 14.28462 0 0 0 13.69138 0 21.11012 0 0 12.96778 0 13.68103 0 0 0 0 0 0 0 0 0 16.07668 14.04495 0 0 0 0 0 0 0 11.01523 0 19.42931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15842 KCNJ8_HUMAN "ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)" KCNJ8 Homo sapiens (Human) defense response to virus [GO:0051607]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; transport across blood-brain barrier [GO:0150104] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; defense response to virus [GO:0051607]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; transport across blood-brain barrier [GO:0150104] ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] GO:0001822; GO:0005242; GO:0005524; GO:0005739; GO:0005886; GO:0006813; GO:0007507; GO:0008076; GO:0008282; GO:0015272; GO:0017098; GO:0019829; GO:0030016; GO:0031004; GO:0032496; GO:0034765; GO:0042383; GO:0043330; GO:0051607; GO:0071805; GO:0098662; GO:0098915; GO:0150104; GO:1902282; GO:1990573 NNSMRR 6.869999886 0.371970206 0.371970206 0.211667584 778.5603027 16.24683 15.7079 16.37302 0 15.17861 0 13.91029 12.33312 13.64147 17.44301 16.53609 16.36879 15.09478 16.35241 9.365269 15.11709 0 13.437 16.07435 14.566 15.39076 0 15.20204 16.2313 15.19987 0 0 15.67516 15.3127 16.00734 17.0878 16.68679 17.30091 15.26568 16.08445 0 17.18301 15.70506 15.43621 15.04109 0 0 11.7244 15.79808 15.03885 0 16.18913 16.3716 Q15853 USF2_HUMAN "Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12, bHLHb12) (FOS-interacting protein, FIP) (Major late transcription factor 2) (Upstream transcription factor 2)" USF2 BHLHB12 Homo sapiens (Human) lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]" "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000430; GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0019086; GO:0042803; GO:0043231; GO:0043425; GO:0043565; GO:0045944; GO:0046982; GO:0055088; GO:1990837 GGILSK 8.449999809 1 1 0.255144573 574.0410442 14.31706 17.11441 13.66205 16.02585 14.92738 15.29468 0 0 15.57072 0 0 0 0 0 0 0 14.51848 14.0448 0 16.66225 14.95265 17.62757 17.03378 0 14.57528 0 0 0 0 16.27707 15.15411 0 0 15.98123 0 0 0 0 0 0 0 16.36717 16.09302 0 0 16.4548 0 16.17302 Q15858 SCN9A_HUMAN "Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel, hNE-Na) (Peripheral sodium channel 1, PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)" SCN9A NENA Homo sapiens (Human) behavioral response to formalin induced pain [GO:0061368]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; behavioral response to formalin induced pain [GO:0061368]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006954; GO:0009408; GO:0009409; GO:0009636; GO:0009791; GO:0019228; GO:0019233; GO:0030424; GO:0031402; GO:0034765; GO:0035725; GO:0045759; GO:0061368; GO:0086010 GDAEKLSK 27.87999916 1 1 0.13058594 847.5235429 16.77713 0 0 15.57878 0 16.96724 14.55553 13.83834 0 15.40423 15.87236 0 14.47263 0 0 16.53234 0 0 0 0 0 0 15.61827 16.52385 0 13.15851 14.90339 0 0 0 14.62273 16.65061 16.43329 0 0 0 16.69193 0 0 0 0 0 19.21361 0 11.89198 0 0 0 Q15878 CAC1E_HUMAN "Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II, BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3)" CACNA1E CACH6 CACNL1A6 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; regulation of ion transmembrane transport [GO:0034765] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; regulation of ion transmembrane transport [GO:0034765] calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843] GO:0005245; GO:0005509; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0022843; GO:0034765; GO:0045202; GO:0070509 ASSMPR 5.550000191 1 1 0.136457626 647.2857063 14.81303 0 0 0 14.34418 14.19986 15.43844 14.70038 13.86987 13.03669 0 0 0 14.76835 12.77355 13.79709 0 0 0 0 0 0 0 0 0 0 0 15.96458 0 0 16.49848 0 0 0 15.51833 0 0 0 16.97268 0 16.30202 0 0 0 0 0 0 0 Q15904 VAS1_HUMAN "V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)" ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar acidification [GO:0007035] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; ATP binding [GO:0005524]; small GTPase binding [GO:0031267]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar acidification [GO:0007035] ATP binding [GO:0005524]; small GTPase binding [GO:0031267] GO:0000139; GO:0005524; GO:0005765; GO:0005789; GO:0005886; GO:0006879; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016021; GO:0016469; GO:0030641; GO:0031267; GO:0033116; GO:0033176; GO:0036035; GO:0036295; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:0099638; GO:1902600 MAAMATAR 12.89000034 0.367831081 0.367831081 0.045755377 839.4808326 17.48634 15.47803 0 0 13.24672 0 17.39882 0 14.44259 0 15.69432 17.0686 0 16.78671 16.0923 17.38292 14.77305 17.45578 0 17.24847 0 15.54834 15.20434 18.17637 17.08168 18.1904 17.94703 15.48396 0 15.70865 16.50506 0 18.44621 0 17.35534 0 20.59898 0 19.56947 17.0141 18.30882 0 18.23241 17.28259 0 18.63082 17.41669 18.10386 Q15906 VPS72_HUMAN Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1) VPS72 TCFL1 YL1 Homo sapiens (Human) "histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]" NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]" DNA binding [GO:0003677]; histone binding [GO:0042393] GO:0000122; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0016573; GO:0016607; GO:0032991; GO:0035019; GO:0035267; GO:0042393; GO:0042981; GO:0043486; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779 VQERQGQSR 6.920000076 0.621879756 0.621879756 0.046134777 1086.824409 15.69193 11.59879 0 0 0 0 15.79606 7.807497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.84398 0 Q15910 EZH2_HUMAN "Histone-lysine N-methyltransferase EZH2, EC 2.1.1.356 (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)" EZH2 KMT6 Homo sapiens (Human) "B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; subtelomeric heterochromatin assembly [GO:0031509]; synaptic transmission, GABAergic [GO:0051932]" "chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; pronucleus [GO:0045120]; synapse [GO:0045202]" "chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; pronucleus [GO:0045120]; synapse [GO:0045202]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; subtelomeric heterochromatin assembly [GO:0031509]; synaptic transmission, GABAergic [GO:0051932]" chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] GO:0000122; GO:0000781; GO:0000785; GO:0000978; GO:0000979; GO:0001222; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005737; GO:0006306; GO:0006325; GO:0006338; GO:0006355; GO:0008284; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0030183; GO:0031490; GO:0031509; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0045120; GO:0045202; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048468; GO:0048511; GO:0051154; GO:0051932; GO:0070301; GO:0070314; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1900016; GO:1902808; GO:1904772; GO:1990841; GO:2000134 VHGDR 17.75 3.39E-09 3.39E-09 0.227105462 583.5157355 22.04046 0 0 0 0 21.38398 18.67087 0 16.41492 0 0 20.39174 0 0 21.82368 0 21.03763 0 18.80379 0 20.21462 0 0 22.02426 0 0 19.12612 0 0 0 17.89397 0 21.56611 0 19.27551 0 21.60058 0 0 0 0 0 0 21.80548 20.76873 0 0 0 Q15911 ZFHX3_HUMAN "Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3, ZFH-3)" ZFHX3 ATBF1 C16orf47 Homo sapiens (Human) "brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007420; GO:0007517; GO:0008270; GO:0016604; GO:0019899; GO:0032922; GO:0045662; GO:0045663; GO:0045664; GO:0045785; GO:0045893; GO:0045944; GO:0051726; GO:0071559; GO:1904059 SMKHQR 6.949999809 0.371435642 0.371435642 0.095380956 800.2708041 16.56835 0 0 15.67749 0 0 0 0 0 0 17.04414 0 17.48096 0 0 0 0 0 18.74016 0 0 0 14.96191 14.13509 15.71155 0 0 0 0 16.9883 11.41659 0 16.17458 14.98886 18.622 0 0 0 0 0 16.7725 0 16.57807 14.94003 15.58563 0 0 0 Q15928 ZN141_HUMAN Zinc finger protein 141 ZNF141 D4S90 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; limb morphogenesis [GO:0035108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; limb morphogenesis [GO:0035108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006366; GO:0009653; GO:0035108; GO:0046872 SRVLNEHK 10.59000015 0.572269917 0.572269917 0.197712766 980.3110032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.34843 17.70488 0 0 0 0 0 0 0 0 0 0 18.41291 0 17.09862 0 0 Q15935 ZNF77_HUMAN Zinc finger protein 77 (ZNFpT1) ZNF77 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 SLYRDVMLETCR 9.289999962 1 1 0.09241205 1558.546529 0 15.84784 0 0 0 14.05251 0 0 0 16.30595 15.27727 12.76751 0 16.40199 15.96789 0 0 0 0 14.30343 14.15536 0 14.20263 0 13.84502 15.51498 0 0 0 0 0 0 0 0 0 0 0 16.50738 0 13.6193 16.61053 0 14.79832 0 13.2169 0 0 0 Q15973 ZN124_HUMAN Zinc finger protein 124 (Zinc finger protein HZF-16) ZNF124 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0046872 QCQKTSLSVTR 7.760000229 1 1 4.69E-13 1308.105567 0 0 0 0 0 0 19.2274 0 0 0 18.32745 0 0 0 0 0 0 0 0 0 16.32679 0 0 0 0 0 0 0 0 0 0 0 0 0 19.82019 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16082 HSPB2_HUMAN "Heat shock protein beta-2, HspB2 (DMPK-binding protein, MKBP)" HSPB2 Homo sapiens (Human) response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; structural constituent of eye lens [GO:0005212]; response to unfolded protein [GO:0006986] enzyme activator activity [GO:0008047]; structural constituent of eye lens [GO:0005212] GO:0005212; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0008047 AAPAGEGSR 9.25 1 1 0.2408018 815.0720416 18.84178 0 0 13.9532 0 0 17.42564 13.59956 0 16.36225 0 17.18761 0 0 15.78354 14.12283 12.91196 16.00154 0 0 15.99701 15.52964 0 15.41317 0 0 15.09955 14.59299 15.75644 16.22239 15.37238 14.28413 15.20078 16.53469 0 0 16.35148 17.51447 0 0 14.41259 0 0 0 0 15.20015 0 18.95074 Q16099 GRIK4_HUMAN "Glutamate receptor ionotropic, kainate 4, GluK4 (Excitatory amino acid receptor 1, EAA1) (Glutamate receptor KA-1, KA1)" GRIK4 GRIK Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]" hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] "hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]" glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0008066; GO:0015276; GO:0015277; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0045211; GO:0050804; GO:0098686; GO:0099055; GO:0099056; GO:1904315 ARPSPAR 9.729999542 1 1 0.254925406 754.9680265 15.29823 15.82068 0 15.52592 14.89297 0 15.00927 14.33211 13.02943 17.27096 16.50358 16.6048 16.19696 0 14.80111 15.91567 13.62065 0 16.74035 0 0 0 16.2581 0 16.95017 16.4038 16.83772 0 16.10049 15.24002 0 16.91537 15.47786 17.2113 15.80733 16.53552 16.78501 16.39566 17.42065 0 0 0 15.55231 0 15.89379 0 0 16.37158 Q16181 SEPT7_HUMAN Septin-7 (CDC10 protein homolog) SEPTIN7 CDC10 SEPT7 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725] axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283] cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198] GO:0000776; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0034613; GO:0042802; GO:0045296; GO:0060090; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857 MEMEMEQVFEMK 8.920000076 1 1 0.536877314 1572.92481 0 0 0 0 0 0 0 0 0 0 18.74123 17.31984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.60672 0 17.72434 0 0 0 0 0 0 0 0 0 0 0 Q16204 CCDC6_HUMAN Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) CCDC6 D10S170 TST1 Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 LENDTISK 2.809999943 0.511065423 0.511065423 0.173449585 920.5638414 14.34049 0 14.70265 0 0 15.02175 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12562 0 0 0 0 0 14.63517 0 0 16.98907 0 12.20286 15.33358 13.64549 15.335 0 0 0 13.45341 0 0 0 16.3509 17.56539 15.01323 14.92916 0 0 14.41933 Q16236 NF2L2_HUMAN "Nuclear factor erythroid 2-related factor 2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2 (HEBP1) (Nuclear factor, erythroid derived 2, like 2)" NFE2L2 NRF2 Homo sapiens (Human) aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lithium ion [GO:0010226] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lithium ion [GO:0010226]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006357; GO:0006954; GO:0007568; GO:0010226; GO:0010499; GO:0010628; GO:0010667; GO:0010976; GO:0016567; GO:0019904; GO:0030194; GO:0030968; GO:0032993; GO:0034599; GO:0036003; GO:0036091; GO:0036499; GO:0042149; GO:0043161; GO:0043536; GO:0043565; GO:0045088; GO:0045454; GO:0045766; GO:0045944; GO:0045995; GO:0046223; GO:0046326; GO:0061419; GO:0061629; GO:0070301; GO:0071280; GO:0071356; GO:0071466; GO:0071498; GO:0071499; GO:0090575; GO:0140467; GO:1902037; GO:1902176; GO:1903071; GO:1903206; GO:1903788; GO:1904385; GO:1904753; GO:2000121; GO:2000352; GO:2000379 DGNVFLVPK 7.420000076 0.796585619 0.796585619 0.222487355 989.3970414 0 16.027 14.44061 15.35151 0 15.33501 15.49761 0 0 0 14.93906 14.57843 16.43436 14.39593 15.35729 15.3458 12.95861 15.60048 16.34663 14.26754 15.43866 17.30674 0 0 14.37253 15.82798 16.42137 13.61938 14.05564 14.55156 16.59516 0 0 15.19892 15.96112 15.99417 13.31334 15.45093 0 16.26645 15.4238 15.62217 14.36267 13.30139 14.97433 14.05736 14.23514 15.86852 Q16254 E2F4_HUMAN "Transcription factor E2F4, E2F-4" E2F4 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000083; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0002064; GO:0003677; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0006884; GO:0008015; GO:0009887; GO:0019904; GO:0042127; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251; GO:1990837; GO:1990841 SLGLLTTKFVSLLQEAK 9.430000305 1 1 0.365474502 1848.515612 14.99606 15.86347 0 0 14.81144 0 0 0 0 13.83276 14.3221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3392 0 0 15.67576 0 0 0 0 0 0 0 0 0 0 0 0 0 14.65198 0 0 0 0 Q16288 NTRK3_HUMAN "NT-3 growth factor receptor, EC 2.7.10.1 (GP145-TrkC, Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase)" NTRK3 TRKC Homo sapiens (Human) activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; heart development [GO:0007507]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] axon [GO:0030424]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; heart development [GO:0007507]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001764; GO:0001933; GO:0001934; GO:0002039; GO:0004712; GO:0004714; GO:0005004; GO:0005030; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007507; GO:0008284; GO:0010628; GO:0010976; GO:0014068; GO:0030335; GO:0030424; GO:0032148; GO:0033138; GO:0033674; GO:0043121; GO:0043235; GO:0043406; GO:0045471; GO:0048665; GO:0048678; GO:0048712; GO:0050927; GO:0051412; GO:0051896; GO:0060548; GO:0071300; GO:0090102; GO:0090630; GO:0098978; GO:0099055; GO:0099151; GO:1905606; GO:1990090; GO:2000251 FYGVCGDGDPLIMVFEYMK 2.029999971 1 1 0.15538984 2242.064822 0 0 0 0 11.78362 11.62876 15.67127 8.853601 0 0 13.69494 0 13.36345 12.49492 0 12.84948 0 11.17543 0 15.69893 0 0 0 0 14.79089 0 13.56954 0 0 0 14.95719 14.4382 14.99108 12.85563 0 9.479057 0 13.30175 0 0 0 0 0 0 0 13.85351 0 11.86041 Q16322 KCA10_HUMAN Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8) KCNA10 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] delayed rectifier potassium channel activity [GO:0005251]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249] GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805 MGSTDSLNK 1.909999967 1 1 0.140564116 953.6238519 16.49466 14.65982 15.43026 0 0 0 14.8448 0 10.87349 0 15.05309 0 0 0 0 0 0 0 0 0 0 0 0 0 15.99522 0 15.90871 0 0 0 0 0 0 0 15.9439 0 0 0 0 16.15416 0 0 0 0 0 0 0 15.33675 Q16363 LAMA4_HUMAN Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha) LAMA4 Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0030155; GO:0030334; GO:0045995; GO:0062023; GO:0070062; GO:0120163 ATAARQR 10.75 0.406806678 0.406806678 0.271866606 769.9735878 0 0 15.54428 0 14.64915 15.49772 0 15.15715 15.76112 14.81736 0 0 0 0 16.92643 0 0 0 15.98947 17.87962 14.46035 0 0 0 16.74141 0 16.55707 15.39254 0 0 13.4577 15.12338 16.62729 0 15.93379 15.38451 0 16.37096 16.03506 16.88704 15.77798 0 14.93562 0 16.79597 0 0 16.58888 Q16401 PSMD5_HUMAN 26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B) PSMD5 KIAA0072 Homo sapiens (Human) proteasome regulatory particle assembly [GO:0070682] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle assembly [GO:0070682] GO:0000502; GO:0005654; GO:0005829; GO:0022624; GO:0070682 MAAQALALLR 5.019999981 1 1 0.278285784 1058.555966 0 17.17194 0 0 0 0 0 0 0 0 0 17.16189 0 0 17.11327 0 0 0 0 15.78681 17.41923 0 17.62107 16.87802 18.02492 18.05993 17.72221 0 0 16.89889 0 0 19.01787 17.8983 0 18.04174 0 18.02856 0 17.95769 0 0 0 0 0 16.79338 0 17.57324 Q16478 GRIK5_HUMAN "Glutamate receptor ionotropic, kainate 5, GluK5 (Excitatory amino acid receptor 2, EAA2) (Glutamate receptor KA-2, KA2)" GRIK5 GRIK2 Homo sapiens (Human) "cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]" dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; terminal bouton [GO:0043195] "dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]" glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0005654; GO:0005783; GO:0005886; GO:0006621; GO:0008066; GO:0015276; GO:0015277; GO:0017124; GO:0030165; GO:0030425; GO:0031630; GO:0032983; GO:0035249; GO:0038023; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043525; GO:0045211; GO:0050804; GO:0051649; GO:0060079; GO:0071333; GO:0098686; GO:0098978; GO:0099056; GO:0099061; GO:1904315 ADLAVAAFTITAER 5.389999866 1 1 0.501800548 1449.592108 15.38431 16.28395 18.31925 20.15237 0 19.41608 0 19.21532 0 17.49766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.66259 0 20.8153 19.05762 0 0 0 0 17.81394 18.30869 0 0 0 Q16513 PKN2_HUMAN "Serine/threonine-protein kinase N2, EC 2.7.11.13 (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)" PKN2 PRK2 PRKCL2 Homo sapiens (Human) apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165] apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium-dependent protein kinase C activity [GO:0004698]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium-dependent protein kinase C activity [GO:0004698]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267] GO:0003723; GO:0004672; GO:0004674; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0018105; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0106310; GO:2000145 TKIEVIR 5.670000076 1 1 0.120693972 858.3066305 0 0 0 0 12.85185 14.76763 17.65874 0 0 14.34456 15.58283 12.33599 14.92688 0 0 14.2847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16520 BATF_HUMAN "Basic leucine zipper transcriptional factor ATF-like (B-cell-activating transcription factor, B-ATF) (SF-HT-activated gene 2 protein, SFA-2)" BATF Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hematopoietic stem cell differentiation [GO:0060218]; integrated stress response signaling [GO:0140467]; isotype switching [GO:0045190]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of cytokine production [GO:0001819]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 2 cell differentiation [GO:0045064]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hematopoietic stem cell differentiation [GO:0060218]; integrated stress response signaling [GO:0140467]; isotype switching [GO:0045190]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of cytokine production [GO:0001819]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 2 cell differentiation [GO:0045064]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001819; GO:0002320; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006974; GO:0030330; GO:0042832; GO:0043011; GO:0043565; GO:0045064; GO:0045190; GO:0060218; GO:0072539; GO:0072540; GO:0090575; GO:0140467; GO:1990837; GO:2000319 SPPPGK 6.75 1 1 0.155378503 583.4960785 0 0 0 15.69959 0 0 0 0 0 0 0 0 0 0 0 0 0 16.18258 0 16.94363 0 0 17.92029 17.46245 18.54019 0 17.23595 0 16.66672 16.93298 16.6586 0 16.25501 17.10684 16.4761 17.22683 17.67957 17.73052 17.22453 16.23227 0 0 18.00803 16.76499 17.23225 0 17.76141 16.49666 Q16531 DDB1_HUMAN "DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a, DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1, XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1, UV-DDB 1) (XPE-binding factor, XPE-BF) (Xeroderma pigmentosum group E-complementing protein, XPCe)" DDB1 XAP1 Homo sapiens (Human) biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055] "chromosome, telomeric region [GO:0000781]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]" "chromosome, telomeric region [GO:0000781]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055]" cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987] GO:0000781; GO:0003677; GO:0003684; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006511; GO:0006974; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0030674; GO:0031464; GO:0031465; GO:0032991; GO:0034644; GO:0035518; GO:0035861; GO:0042752; GO:0043066; GO:0043161; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051702; GO:0070062; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:1901990 YLLGDMEGR 5.360000134 1 1 0.224481535 1068.607648 0 0 0 0 0 0 15.74892 0 0 17.43333 0 0 0 0 16.63542 0 0 0 0 0 15.50372 0 0 0 18.67903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.15507 17.24654 0 0 0 0 16.61326 17.07219 Q16533 SNPC1_HUMAN "snRNA-activating protein complex subunit 1, SNAPc subunit 1 (Proximal sequence element-binding transcription factor subunit gamma, PSE-binding factor subunit gamma, PTF subunit gamma) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit, SNAPc 43 kDa subunit)" SNAPC1 SNAP43 Homo sapiens (Human) snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; sequence-specific DNA binding [GO:0043565]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; sequence-specific DNA binding [GO:0043565] GO:0000995; GO:0005654; GO:0005730; GO:0016251; GO:0019185; GO:0042795; GO:0042796; GO:0043565 AEVTEEFK 10.42000008 0.629959762 0.629959762 0.223377831 951.7891056 16.19521 14.34926 16.15513 16.52568 0 0 0 15.62637 15.73858 14.98082 13.8769 16.082 15.39964 0 16.49789 16.0302 14.60384 0 0 0 0 0 17.21801 0 0 15.47964 0 16.07463 15.93353 16.37435 13.89337 14.83619 14.59846 15.84908 0 16.16039 0 15.33746 0 16.14583 15.99152 14.67408 14.87129 15.31383 15.26581 16.66902 15.67064 12.66666 Q16538 GP162_HUMAN Probable G-protein coupled receptor 162 (Gene-rich cluster gene A protein) GPR162 GRCA Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021 MARGGAGAEEASLR 12.98999977 1 1 0.222169164 1376.181037 18.88653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16552 IL17_HUMAN "Interleukin-17A, IL-17, IL-17A (Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8)" IL17A CTLA8 IL17 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cell-cell signaling [GO:0007267]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cell-cell signaling [GO:0007267]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760] cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0002225; GO:0002250; GO:0005125; GO:0005576; GO:0005615; GO:0006915; GO:0006954; GO:0006955; GO:0007219; GO:0007267; GO:0008219; GO:0009897; GO:0032731; GO:0032735; GO:0032739; GO:0032747; GO:0032755; GO:0032760; GO:0042803; GO:0045087; GO:0045672; GO:0045944; GO:0046982; GO:0050829; GO:0050830; GO:0050832; GO:0060729; GO:0071347; GO:0072537; GO:0097400; GO:0097530; GO:1900017; GO:1903348; GO:2000340 AGITIPR 5.150000095 1 1 0.111386135 724.4980549 14.83744 16.11393 14.7634 0 0 0 0 0 14.06768 15.98149 0 0 0 0 0 0 0 0 0 12.42449 15.33219 0 0 0 0 0 0 0 12.06139 0 0 14.69341 0 0 0 0 0 0 0 0 0 15.468 0 0 14.8335 0 14.85479 0 Q16553 LY6E_HUMAN "Lymphocyte antigen 6E, Ly-6E (Retinoic acid-induced gene E protein, RIG-E) (Stem cell antigen 2, SCA-2) (Thymic shared antigen 1, TSA-1)" LY6E 9804 RIGE SCA2 TSA1 Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500]; adrenal gland development [GO:0030325]; cell surface receptor signaling pathway [GO:0007166]; epinephrine secretion [GO:0048242]; in utero embryonic development [GO:0001701]; negative regulation of viral entry into host cell [GO:0046597]; norepinephrine metabolic process [GO:0042415]; organ growth [GO:0035265]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]; acetylcholine receptor signaling pathway [GO:0095500]; adrenal gland development [GO:0030325]; cell surface receptor signaling pathway [GO:0007166]; epinephrine secretion [GO:0048242]; in utero embryonic development [GO:0001701]; negative regulation of viral entry into host cell [GO:0046597]; norepinephrine metabolic process [GO:0042415]; organ growth [GO:0035265]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550] GO:0001701; GO:0005576; GO:0005886; GO:0007166; GO:0030325; GO:0030550; GO:0031225; GO:0033130; GO:0035265; GO:0042415; GO:0045202; GO:0046597; GO:0048242; GO:0055010; GO:0095500 IFLPVLLAALLGVER 10.47000027 1 1 0.204683059 1623.899754 17.22647 0 0 0 0 0 16.67496 16.55489 16.23175 0 0 0 0 0 0 0 0 0 0 17.38378 0 17.16437 0 0 0 16.42346 15.43517 0 16.19953 16.84237 16.27275 0 16.30061 0 0 0 16.26774 0 0 0 0 0 16.8768 0 0 0 0 0 Q16560 U1SBP_HUMAN "U11/U12 small nuclear ribonucleoprotein 35 kDa protein, U11/U12 snRNP 35 kDa protein, U11/U12-35K (Protein HM-1) (U1 snRNP-binding protein homolog)" SNRNP35 HM1 U1SNRNPBP Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" mRNA binding [GO:0003729]; snRNA binding [GO:0017069] GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0008380; GO:0017069 GYAFIEYK 4.559999943 0.870999634 0.870999634 0.102208675 989.190763 13.36375 15.33719 15.00416 0 0 0 13.97904 18.15439 0 0 0 0 0 0 14.78927 0 0 0 0 17.33059 0 0 0 0 0 15.43436 0 0 0 0 0 14.87752 12.42935 15.33844 0 0 12.21276 0 0 0 0 0 0 0 0 15.11442 0 16.11896 Q16566 KCC4_HUMAN "Calcium/calmodulin-dependent protein kinase type IV, CaMK IV, EC 2.7.11.17 (CaM kinase-GR)" CAMK4 CAMK CAMK-GR CAMKIV Homo sapiens (Human) "adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]" ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001650; GO:0002250; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0018105; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0046777; GO:0070062; GO:0098794; GO:0098978; GO:0106310 QKGTQKPYALK 6.210000038 0.230148628 0.230148628 0.190004935 1261.101053 16.63851 0 0 17.39779 12.90196 14.27615 13.06552 0 13.01127 0 0 13.91463 14.68418 18.34177 15.61457 16.55108 17.1292 16.1153 17.98921 15.686 15.08761 15.37091 17.74021 12.71344 13.73863 14.42143 0 15.24772 17.09973 15.36795 16.43699 17.41827 18.36209 14.79215 16.55066 16.66949 16.46286 15.73205 18.88415 0 0 16.12263 15.22466 18.19783 0 16.67559 0 17.1527 Q16572 VACHT_HUMAN "Vesicular acetylcholine transporter, VAChT (Solute carrier family 18 member 3)" SLC18A3 VACHT Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195] AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; acetylcholine transmembrane transporter activity [GO:0005277]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] acetylcholine transmembrane transporter activity [GO:0005277]; transmembrane transporter activity [GO:0022857] GO:0005277; GO:0005886; GO:0006836; GO:0007268; GO:0016021; GO:0022857; GO:0030121; GO:0030122; GO:0030669; GO:0043195; GO:0060201 ESAEPAGQAR 4.230000019 1 1 0.023121147 1014.612894 0 0 0 0 0 0 0 0 15.79792 0 15.25974 12.97785 0 0 0 0 0 0 0 0 0 0 0 0 14.80635 0 0 0 0 15.57206 0 14.19699 0 0 13.51161 0 0 0 0 0 0 0 0 13.54242 0 0 0 0 Q16584 M3K11_HUMAN "Mitogen-activated protein kinase kinase kinase 11, EC 2.7.11.25 (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase)" MAP3K11 MLK3 PTK1 SPRK Homo sapiens (Human) cell cycle G1/S phase transition [GO:0044843]; cell death [GO:0008219]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule-based process [GO:0007017]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; cell cycle G1/S phase transition [GO:0044843]; cell death [GO:0008219]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule-based process [GO:0007017]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267] GO:0000165; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007017; GO:0007254; GO:0008219; GO:0016020; GO:0031267; GO:0031434; GO:0031435; GO:0042802; GO:0042803; GO:0043065; GO:0043507; GO:0043525; GO:0044843; GO:0046330; GO:0046777; GO:0106310 ELTLLLQQVDRERPHVR 10.39000034 0.608926535 0.608926535 4.57E-12 2102.261825 0 18.10396 0 19.11632 18.50659 0 0 0 0 0 19.02521 18.48958 0 0 17.83665 19.41207 18.23659 0 0 0 18.30459 18.80685 18.71118 18.79136 0 18.00873 17.53246 18.30155 0 18.38939 0 0 17.33533 17.18379 17.88639 0 17.65235 0 0 17.69348 0 0 0 15.9345 18.47948 18.25919 0 18.17438 Q16587 ZNF74_HUMAN Zinc finger protein 74 (Zinc finger protein 520) (hZNF7) ZNF74 ZNF520 Homo sapiens (Human) "multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007275; GO:0015629; GO:0046872 ENLEDISGWGLPEARSK 15.32999992 0.359327197 0.359327197 0.482658036 1900.871596 0 19.05022 0 0 0 0 0 17.75686 0 0 18.29385 0 18.18436 0 0 0 17.54137 16.56619 0 0 0 0 16.79842 0 0 18.83504 17.32899 0 0 0 18.89931 19.18965 0 0 0 0 0 0 0 0 18.21554 0 16.44893 0 0 0 0 0 Q16610 ECM1_HUMAN Extracellular matrix protein 1 (Secretory component p85) ECM1 Homo sapiens (Human) angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]; enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165] enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022] GO:0001503; GO:0001525; GO:0001938; GO:0001960; GO:0002020; GO:0002063; GO:0002828; GO:0003416; GO:0005134; GO:0005576; GO:0005615; GO:0006357; GO:0006954; GO:0007165; GO:0008022; GO:0010466; GO:0019899; GO:0030500; GO:0030502; GO:0031012; GO:0031089; GO:0031214; GO:0043123; GO:0043236; GO:0045766; GO:0062023; GO:0070062; GO:2000404 VTPNLMGHLCGNQR 4.210000038 1 1 0.356001372 1612.238823 18.48355 0 14.76396 0 0 0 18.33242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.71638 0 0 17.40222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16620 NTRK2_HUMAN "BDNF/NT-3 growth factors receptor, EC 2.7.10.1 (GP145-TrkB, Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B)" NTRK2 TRKB Homo sapiens (Human) "brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]" axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] "axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor-activated receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]" ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor-activated receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0001570; GO:0001764; GO:0001934; GO:0002020; GO:0004712; GO:0004714; GO:0005030; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007612; GO:0007623; GO:0007631; GO:0008284; GO:0010628; GO:0010976; GO:0014047; GO:0014068; GO:0014069; GO:0019227; GO:0021954; GO:0021987; GO:0022011; GO:0030182; GO:0030424; GO:0030425; GO:0031547; GO:0031901; GO:0033138; GO:0033674; GO:0042490; GO:0042803; GO:0043087; GO:0043121; GO:0043195; GO:0043197; GO:0043235; GO:0043410; GO:0043524; GO:0043679; GO:0046548; GO:0046777; GO:0048403; GO:0048471; GO:0048709; GO:0048935; GO:0050772; GO:0051896; GO:0051965; GO:0060175; GO:0060291; GO:0071230; GO:0099183; GO:0099551; GO:1902430; GO:1990090; GO:1990416; GO:2000811 VGGHTMLPIR 6.420000076 0.137475818 0.137475818 0.079498087 1080.814648 0 15.82905 11.01223 0 15.79255 0 0 14.03617 0 16.44177 14.74258 0 0 0 13.59553 15.60626 14.82874 0 14.4095 0 0 14.60711 0 13.47409 0 13.09707 0 16.94068 0 16.16981 18.06446 0 13.19381 0 0 14.97054 14.83085 0 0 16.37994 0 14.40274 0 16.26504 0 0 15.32565 14.4413 Q16625 OCLN_HUMAN Occludin OCLN Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827] protein domain specific binding [GO:0019904] GO:0001933; GO:0005765; GO:0005886; GO:0005911; GO:0005923; GO:0010592; GO:0010628; GO:0010629; GO:0010827; GO:0016021; GO:0016324; GO:0016327; GO:0019904; GO:0030054; GO:0030139; GO:0031116; GO:0031252; GO:0031410; GO:0032991; GO:0035633; GO:0045216; GO:0046326; GO:0065003; GO:0070160; GO:0070830; GO:0090303; GO:1902463; GO:1905605 KMVGDYDR 6.980000019 0.243256882 0.243256882 0.19332057 998.2764531 16.89428 13.35712 17.07773 16.968 0 11.70386 12.56128 0 0 17.28896 16.16532 18.02548 16.69717 0 16.37584 15.70928 16.86321 17.5494 15.96417 0 15.78402 0 0 17.5771 14.35563 14.83806 14.7525 0 0 0 14.95499 0 13.53078 17.48223 11.63845 16.79193 16.16746 16.78848 17.49896 14.59331 0 0 11.32954 11.47572 14.80133 17.22216 0 16.35173 Q16626 MEA1_HUMAN "Male-enhanced antigen 1, MEA-1" MEA1 MEA Homo sapiens (Human) cell differentiation [GO:0030154]; male gonad development [GO:0008584]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell differentiation [GO:0030154]; male gonad development [GO:0008584]; spermatogenesis [GO:0007283] GO:0005737; GO:0007283; GO:0008584; GO:0030154 EISDAQWEDVVQKALQAR 2.069999933 1 1 0.639786578 2086.152654 0 18.83576 0 0 0 18.13846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.57356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16630 CPSF6_HUMAN "Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit, CPSF 68 kDa subunit) (Cleavage factor Im complex 68 kDa subunit, CFIm68) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7)" CPSF6 CFIM68 Homo sapiens (Human) messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005847; GO:0005849; GO:0006397; GO:0016020; GO:0016607; GO:0031124; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1990120; GO:1990448; GO:1990904 ELHGQNPVVTPCNK 16.76000023 1 1 0.565920338 1592.993342 0 0 0 0 18.94914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41697 0 0 0 18.80201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.56405 0 0 0 0 0 Q16643 DREB_HUMAN Drebrin (Developmentally-regulated brain protein) DBN1 D0S117E Homo sapiens (Human) actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cytoplasmic sequestering of protein [GO:0051220]; in utero embryonic development [GO:0001701]; maintenance of protein location in cell [GO:0032507]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168] actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427] actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cytoplasmic sequestering of protein [GO:0051220]; in utero embryonic development [GO:0001701]; maintenance of protein location in cell [GO:0032507]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522] GO:0001701; GO:0003779; GO:0005522; GO:0005737; GO:0005856; GO:0005886; GO:0005921; GO:0007015; GO:0010643; GO:0010644; GO:0014069; GO:0015629; GO:0030027; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0030863; GO:0030864; GO:0031915; GO:0032507; GO:0042641; GO:0045211; GO:0045296; GO:0045773; GO:0048168; GO:0048812; GO:0050773; GO:0051015; GO:0051220; GO:0061003; GO:0061351; GO:0098974; GO:0098978; GO:0099524; GO:1902685 MAGVSFSGHR 4.150000095 0.768232107 0.768232107 2.29E-13 1048.50767 0 0 0 0 0 0 0 0 0 0 17.48973 0 0 0 0 14.65569 0 14.50208 16.89557 11.14928 0 8.124182 16.83158 0 13.52314 15.27349 17.11379 0 0 0 0 0 17.42272 0 16.9304 0 0 17.27125 0 0 17.15615 0 0 0 16.82745 0 16.87911 14.46465 Q16647 PTGIS_HUMAN "Prostacyclin synthase, EC 5.3.99.4 (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Prostaglandin I2 synthase)" PTGIS CYP8 CYP8A1 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516] caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]; apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516]" "heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]" GO:0001516; GO:0004497; GO:0005506; GO:0005615; GO:0005634; GO:0005783; GO:0005789; GO:0005901; GO:0006690; GO:0008116; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0032088; GO:0034356; GO:0035360; GO:0045019; GO:0045766; GO:0050728; GO:0071347; GO:0071354; GO:0071456; GO:0097190; GO:0106256; GO:1900119 LLPKLAR 10.52000046 1 1 0.068197855 809.5905038 15.57879 15.13744 0 0 0 0 0 16.07917 16.13757 0 0 14.89504 0 0 0 12.36964 0 0 0 16.97196 0 0 0 0 17.08441 0 0 0 15.87746 0 0 16.31205 16.98186 15.91775 0 16.33801 15.69334 0 0 17.33364 14.92087 14.49164 16.2635 0 0 0 15.9881 0 Q16658 FSCN1_HUMAN Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091 NGQLAASVETAGDSELFLMK 4.78000021 1 1 0.200817806 2081.138893 0 13.668 15.27485 15.3319 0 0 0 14.90065 14.83145 0 13.72008 14.52765 14.49215 12.67734 0 0 0 11.88499 0 15.46831 0 0 15.60088 0 15.88547 0 0 0 14.3416 0 0 0 0 13.47338 15.0597 0 13.81754 14.85608 0 0 0 14.18421 0 15.06127 0 0 0 0 Q16659 MK06_HUMAN "Mitogen-activated protein kinase 6, MAP kinase 6, MAPK 6, EC 2.7.11.24 (Extracellular signal-regulated kinase 3, ERK-3) (MAP kinase isoform p97, p97-MAPK)" MAPK6 ERK3 PRKM6 Homo sapiens (Human) cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0007165; GO:0019901; GO:0032156; GO:0032991; GO:0035556; GO:0046982; GO:0060999; GO:0106310 KYLDGDR 10.43999958 1 1 0.195178333 866.023802 16.76678 15.47918 17.03121 15.27602 14.36059 12.8489 16.10837 0 0 15.78614 0 0 14.08396 15.91845 0 15.87497 0 0 0 0 0 15.23514 0 15.1751 0 0 0 0 0 0 0 0 16.46407 0 16.245 0 9.050385 15.43869 0 0 0 0 0 18.00078 15.24477 0 0 0 Q16666 IF16_HUMAN "Gamma-interferon-inducible protein 16, Ifi-16 (Interferon-inducible myeloid differentiation transcriptional activator)" IFI16 IFNGIP1 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to interferon-beta [GO:0035458]; cellular response to ionizing radiation [GO:0071479]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of DNA binding [GO:0043392]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression, epigenetic [GO:0040029]" cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to interferon-beta [GO:0035458]; cellular response to ionizing radiation [GO:0071479]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of DNA binding [GO:0043392]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression, epigenetic [GO:0040029]" double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134] GO:0000122; GO:0001819; GO:0002218; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006914; GO:0006954; GO:0008134; GO:0010506; GO:0016020; GO:0016607; GO:0030099; GO:0030224; GO:0032731; GO:0035458; GO:0040029; GO:0042149; GO:0042771; GO:0042802; GO:0043392; GO:0045071; GO:0045087; GO:0045824; GO:0045892; GO:0045944; GO:0051607; GO:0071479; GO:0072332; GO:0097202; GO:2000117 NNDPKSMK 3.269999981 0.176921293 0.176921293 0.254531672 950.6532609 0 0 0 0 17.56471 0 0 19.07226 0 0 0 0 0 0 0 0 0 0 20.67959 0 0 0 0 0 0 0 0 0 14.6207 0 18.68262 0 17.2047 0 0 17.96656 0 0 0 0 0 19.24942 0 0 0 18.05774 0 0 Q16671 AMHR2_HUMAN "Anti-Muellerian hormone type-2 receptor, EC 2.7.11.30 (Anti-Muellerian hormone type II receptor, AMH type II receptor) (MIS type II receptor, MISRII, MRII)" AMHR2 AMHR MISR2 Homo sapiens (Human) activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179] activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]; activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]" GO:0001880; GO:0004674; GO:0005026; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007548; GO:0008584; GO:0008585; GO:0017002; GO:0032924; GO:0042562; GO:0042803; GO:0043235; GO:0046872; GO:0048179; GO:0048185; GO:0060389; GO:0071363; GO:1990262; GO:1990272 AQVEMQGCR 9.75 1 1 0.043628859 1094.70768 0 16.49128 10.01361 14.45804 15.19992 0 0 13.81838 12.99149 13.34494 16.54108 12.74854 14.64893 14.97659 0 0 0 0 14.91071 12.26229 0 0 14.68437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16706 MA2A1_HUMAN "Alpha-mannosidase 2, EC 3.2.1.114 (Golgi alpha-mannosidase II, AMan II, Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)" MAN2A1 MANA2 Homo sapiens (Human) in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082] cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082]" "alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0019082; GO:0030246; GO:0042803; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062 MTLSKLPLQANVYPMTTMAYIQDAK 1.340000033 0.731106997 0.731106997 6.39E-12 2845.625512 0 0 0 12.61428 10.90699 13.79985 0 0 12.06264 0 10.61234 12.08115 0 15.73705 0 0 0 7.704344 0 12.84223 13.02759 14.05988 0 0 0 0 10.02037 0 0 0 0 0 16.22806 12.81177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16719 KYNU_HUMAN "Kynureninase, EC 3.7.1.3 (L-kynurenine hydrolase)" KYNU Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441] 3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0061981; GO:0097053 DENAIYFLGNSLGLQPKMVK 4.400000095 1 1 0.086870098 2236.222768 12.05582 11.74794 0 14.26189 11.8631 11.52681 4.767719 0 0 0 13.59152 0 0 14.06681 0 10.81407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.48225 0 0 0 0 0 0 0 Q16720 AT2B3_HUMAN "Plasma membrane calcium-transporting ATPase 3, PMCA3, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)" ATP2B3 Homo sapiens (Human) calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480] extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; parallel fiber [GO:1990032]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886] extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; parallel fiber [GO:1990032]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165] GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0006874; GO:0015085; GO:0016887; GO:0019829; GO:0030165; GO:0034220; GO:0043231; GO:0046872; GO:0051480; GO:0098688; GO:0098978; GO:0098982; GO:0099056; GO:1903561; GO:1903779; GO:1905056; GO:1990032; GO:1990034 QQDGAMESSQTK 4.110000134 1 1 0.226230374 1324.818969 0 15.83323 0 0 0 14.38608 0 0 0 0 0 0 0 0 0 0 12.94316 0 0 16.32777 0 0 0 0 0 0 0 0 16.24497 0 14.78289 0 0 0 0 0 0 16.19678 0 0 16.06601 17.52887 0 0 0 0 0 0 Q16740 CLPP_HUMAN "ATP-dependent Clp protease proteolytic subunit, mitochondrial, EC 3.4.21.92 (Endopeptidase Clp)" CLPP Homo sapiens (Human) membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603] endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603] ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006508; GO:0006515; GO:0008233; GO:0009368; GO:0033619; GO:0042802; GO:0051117; GO:0051603 DRYMSPMEAQEFGILDK 9.350000381 1 1 0.084311378 2046.520544 12.07431 14.03635 0 13.81391 12.86457 0 13.37353 14.20284 13.51016 15.4104 0 10.9957 13.87511 11.41331 14.50596 16.03711 0 0 0 10.62711 0 0 13.63932 15.30982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16760 DGKD_HUMAN "Diacylglycerol kinase delta, DAG kinase delta, EC 2.7.1.107 (130 kDa diacylglycerol kinase) (Diglyceride kinase delta, DGK-delta)" DGKD KIAA0145 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0010033; GO:0015031; GO:0019900; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370 DMEQELAHAVNASSKSMDR 4.869999886 1 1 0.303274999 2134.125183 0 14.73298 11.11938 0 0 0 0 0 0 0 0 0 0 0 11.52611 0 10.23092 0 15.25371 0 0 0 14.63669 0 16.48872 13.59157 0 14.08916 0 0 0 0 15.67899 0 0 0 14.52873 0 0 0 15.67885 10.48464 0 0 0 0 0 0 Q16787 LAMA3_HUMAN "Laminin subunit alpha-3 (Epiligrin 170 kDa subunit, E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha)" LAMA3 LAMNA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] GO:0001738; GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005783; GO:0007229; GO:0007411; GO:0008544; GO:0009887; GO:0009888; GO:0016477; GO:0030155; GO:0030334; GO:0035987; GO:0045995; GO:0062023; GO:0070062; GO:0098609 DGLHGIQRGDIDAMISSAK 9.300000191 1 1 0.254084192 2001.452856 0 0 13.47408 0 0 15.42733 15.9054 0 15.80032 0 0 0 12.42146 0 0 0 14.41792 0 13.00185 12.11757 10.14926 16.4971 16.24797 0 13.80514 12.49925 13.36873 0 0 0 16.38156 0 15.51862 0 0 0 0 0 0 15.953 0 13.52788 16.51167 0 15.10901 0 0 0 Q16795 NDUA9_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD, CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)" NDUFA9 NDUFS2L Homo sapiens (Human) "aerobic respiration [GO:0009060]; circadian rhythm [GO:0007623]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]" mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; circadian rhythm [GO:0007623]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]" NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877] GO:0003954; GO:0005634; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006814; GO:0007623; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776; GO:0044877; GO:1901006 AAAAQSRVVR 2.700000048 1 1 0.001217163 1027.411089 14.79495 16.32314 0 0 0 0 15.10308 0 0 16.72315 15.15935 12.31235 12.88786 13.97735 13.81626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.46963 0 0 0 0 0 0 0 0 0 0 0 0 0 15.11543 0 0 0 0 Q16798 MAON_HUMAN "NADP-dependent malic enzyme, mitochondrial, NADP-ME, EC 1.1.1.40 (Malic enzyme 3)" ME3 Homo sapiens (Human) aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; oxaloacetate decarboxylase activity [GO:0008948]; aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090] malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; oxaloacetate decarboxylase activity [GO:0008948] GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0009060; GO:0046872; GO:0051287; GO:0070401; GO:0072592 QQSDLDK 6.380000114 0.46258989 0.46258989 0.204250085 833.4683651 0 15.49641 0 13.94308 0 15.85358 15.11455 14.58029 0 0 0 0 0 14.51607 0 16.60169 16.60876 16.57793 14.51393 0 15.32594 0 14.73195 16.06558 0 0 16.17864 0 13.57482 14.53667 14.38092 0 15.74303 16.30737 15.52498 15.84094 15.85596 13.10916 15.45842 14.4433 15.62661 15.52925 0 0 13.04417 14.74524 16.96966 0 Q16799 RTN1_HUMAN Reticulon-1 (Neuroendocrine-specific protein) RTN1 NSP Homo sapiens (Human) negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182] GO:0000139; GO:0005783; GO:0005789; GO:0030176; GO:0030182; GO:1902430 LFLVQDLVDSLK 11.48999977 1 1 0.597336188 1388.915533 0 0 0 0 0 0 0 0 18.59349 19.15301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16821 PPR3A_HUMAN "Protein phosphatase 1 regulatory subunit 3A (Protein phosphatase 1 glycogen-associated regulatory subunit) (Protein phosphatase type-1 glycogen targeting subunit, RG1)" PPP1R3A PP1G Homo sapiens (Human) glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979] integral component of membrane [GO:0016021]; protein phosphatase type 1 complex [GO:0000164] integral component of membrane [GO:0016021]; protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979] glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157] GO:0000164; GO:0005977; GO:0005979; GO:0008157; GO:0016021; GO:2001069 EKAIIAK 7.579999924 0.358134747 0.358134747 0.299190862 775.1665435 16.8323 14.73876 15.38812 14.84936 0 15.02439 15.05723 0 14.82745 0 14.21102 0 15.86235 15.92748 16.23796 0 0 15.72003 16.09288 15.4681 0 15.32777 0 15.86376 16.46933 16.72852 17.04307 15.78607 13.48665 15.18837 16.07579 16.13426 16.0317 15.5118 17.52524 15.97774 17.01047 17.19047 15.14643 0 15.44172 17.44716 17.28169 17.31155 16.03238 16.88498 15.7731 15.07328 Q16831 UPP1_HUMAN "Uridine phosphorylase 1, UPase 1, UrdPase 1, EC 2.4.2.3" UPP1 UP Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleobase-containing compound metabolic process [GO:0006139]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleobase-containing compound metabolic process [GO:0006139]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218] deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850] GO:0004850; GO:0005654; GO:0005829; GO:0006139; GO:0006218; GO:0006248; GO:0006249; GO:0009032; GO:0042149; GO:0042802; GO:0044206; GO:0046050; GO:0046074; GO:0046079; GO:0047847 YAMYKVGPVLSVSHGMGIPSISIMLHELIK 6.539999962 1 1 0.06471632 3302.1728 17.20425 16.03261 10.56058 0 0 0 0 0 12.04455 12.5883 0 0 0 11.67675 11.12258 0 0 0 0 0 9.005888 0 14.62668 0 13.44431 15.79906 11.58356 0 0 0 0 20.90502 19.17465 0 0 0 0 13.42518 0 0 16.9751 0 14.32896 14.1044 13.46091 0 0 0 Q16836 HCDH_HUMAN "Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial, HCDH, EC 1.1.1.35 (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)" HADH HAD HAD1 HADHSC SCHAD Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740] GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0009410; GO:0014823; GO:0016740; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162 EDIDTAMK 5.449999809 1 1 0.11856701 921.2258594 16.69769 0 14.77683 0 0 15.8092 15.07538 13.75488 0 0 14.2775 0 0 0 13.15882 14.02962 0 0 0 0 0 0 14.77611 0 10.38027 0 11.80033 0 0 0 0 0 0 0 0 0 0 0 17.09337 0 0 0 0 0 0 0 0 15.11242 Q16849 PTPRN_HUMAN "Receptor-type tyrosine-protein phosphatase-like N, R-PTP-N (Islet cell antigen 512, ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment, ICA512-NTF; ICA512-transmembrane fragment, ICA512-TMF; ICA512-cleaved cytosolic fragment, ICA512-CCF ]" PTPRN ICA3 ICA512 Homo sapiens (Human) dense core granule maturation [GO:1990502]; insulin secretion [GO:0030073]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; luteinization [GO:0001553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; response to reactive oxygen species [GO:0000302] axon terminus [GO:0043679]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] axon terminus [GO:0043679]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; spectrin binding [GO:0030507]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; dense core granule maturation [GO:1990502]; insulin secretion [GO:0030073]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; luteinization [GO:0001553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; response to reactive oxygen species [GO:0000302] spectrin binding [GO:0030507]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389] GO:0000302; GO:0001553; GO:0005634; GO:0005768; GO:0005886; GO:0008134; GO:0016021; GO:0030073; GO:0030141; GO:0030507; GO:0030658; GO:0035773; GO:0043025; GO:0043204; GO:0043679; GO:0044389; GO:0045202; GO:0045944; GO:1904692; GO:1990502 TMEGPVEGR 6.019999981 0.696742058 0.696742058 0.110212588 976.7487836 16.79384 16.31394 0 10.55883 17.32532 16.73327 13.70232 0 0 0 0 14.8712 0 0 0 10.02496 0 16.48529 0 14.33446 0 16.57878 0 13.90489 15.00388 17.61795 0 0 16.41706 16.00748 14.61778 0 16.52437 0 18.67855 17.67747 0 17.86091 0 0 12.63549 0 0 16.5136 0 0 15.90945 0 Q16851 UGPA_HUMAN "UTP--glucose-1-phosphate uridylyltransferase, EC 2.7.7.9 (UDP-glucose pyrophosphorylase, UDPGP, UGPase)" UGP2 UGP1 Homo sapiens (Human) brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011] glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983] GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062 KDLDGFR 11.26000023 0.000102049 0.000102049 0.262829418 851.2429237 0 17.5757 0 0 0 0 17.8235 18.24239 19.37015 18.04853 0 0 0 0 0 0 19.62498 0 0 0 16.9323 19.32086 0 0 19.28637 0 0 0 0 0 0 0 17.85904 18.53233 20.54473 19.40279 0 0 0 0 0 0 18.9464 0 17.46683 18.42023 0 17.09157 Q16853 AOC3_HUMAN "Membrane primary amine oxidase, EC 1.4.3.21 (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase, SSAO) (Vascular adhesion protein 1, VAP-1)" AOC3 VAP1 Homo sapiens (Human) amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677] aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593] GO:0005507; GO:0005509; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0006954; GO:0007155; GO:0008131; GO:0009308; GO:0009986; GO:0016021; GO:0042802; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283 GSPPPAREALAIVFFGR 5.75 1 1 4.60E-13 1783.986529 15.86601 13.35403 0 13.72651 12.85892 0 0 0 0 11.44223 15.06343 0 10.93826 14.87441 0 15.47982 0 14.11185 14.68254 13.85666 0 0 13.08176 0 0 0 0 0 0 0 0 0 0 0 0 0 15.28687 0 0 0 0 0 16.07772 0 0 0 0 0 Q16877 F264_HUMAN "6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4, 6PF-2-K/Fru-2,6-P2ase 4, PFK/FBPase 4 (6PF-2-K/Fru-2,6-P2ase testis-type isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]" PFKFB4 Homo sapiens (Human) "fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]" cytosol [GO:0005829] "cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]" "6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]" GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003 DVVKTYK 10.68000031 1 1 0.309247904 851.8314498 0 0 15.60239 0 0 0 0 0 0 0 0 0 0 0 0 17.12689 0 0 0 0 16.85798 16.50909 16.29932 0 0 0 0 0 17.21137 16.2799 16.16072 16.79766 16.97024 15.44878 0 0 16.62796 0 15.35333 0 17.11843 16.8172 16.26506 0 0 16.50294 0 16.46167 Q16880 CGT_HUMAN "2-hydroxyacylsphingosine 1-beta-galactosyltransferase, EC 2.4.1.47 (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase)" UGT8 CGT UGT4 Homo sapiens (Human) central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid metabolic process [GO:0006687]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid metabolic process [GO:0006687]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]" "2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]" GO:0002175; GO:0003851; GO:0005783; GO:0005886; GO:0006682; GO:0006687; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0016021; GO:0030913; GO:0043231; GO:0047263; GO:0048812 NIFSGR 8.350000381 0.461994886 0.461994886 0.011207411 691.3882539 16.03187 17.98369 16.40552 15.94407 16.66408 0 17.01791 0 15.22945 16.77162 18.38042 0 0 15.89404 0 15.19185 0 0 0 0 16.38002 16.34671 17.80727 16.23056 16.58099 12.65892 0 0 16.25004 16.23159 0 18.14198 0 16.63535 17.77677 0 16.56333 0 0 0 0 0 15.91804 0 16.2518 0 16.60192 0 Q16891 MIC60_HUMAN MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89) IMMT HMP MIC60 MINOS2 PIG4 PIG52 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560] membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401] membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; RNA binding [GO:0003723]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560] RNA binding [GO:0003723] GO:0001401; GO:0003723; GO:0005739; GO:0005743; GO:0005758; GO:0007007; GO:0016020; GO:0042407; GO:0044284; GO:0051560; GO:0061617; GO:0140275 AVDEAADALLKAK 8.979999542 1 1 0.245868212 1315.036833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.78764 0 0 14.2981 0 16.13581 0 14.78849 0 0 0 0 15.71921 0 0 0 0 0 15.27881 14.72549 0 0 0 0 0 0 Q17R60 IMPG1_HUMAN "Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa, IPM-150) (Sialoprotein associated with cones and rods)" IMPG1 IPM150 SPACR Homo sapiens (Human) extracellular matrix organization [GO:0030198]; visual perception [GO:0007601] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; chondroitin sulfate binding [GO:0035374]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]; extracellular matrix organization [GO:0030198]; visual perception [GO:0007601] chondroitin sulfate binding [GO:0035374]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540] GO:0001750; GO:0001917; GO:0005201; GO:0005540; GO:0005576; GO:0007601; GO:0008201; GO:0030198; GO:0031012; GO:0033165; GO:0035374 MYKMSTMR 6.03000021 1 1 0.189867985 1080.524949 0 0 0 0 0 16.91241 0 0 13.72465 18.02118 15.66481 0 0 0 0 15.44427 0 16.69289 0 16.48481 16.52075 0 0 0 0 15.352 0 14.31498 0 0 0 16.23905 0 16.33627 14.13243 0 17.63468 15.56134 0 0 16.59389 0 0 0 0 0 0 15.97815 Q17R98 ZN827_HUMAN Zinc finger protein 827 ZNF827 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; establishment of protein localization to telomere [GO:0070200]; negative regulation of shelterin complex assembly [GO:1904791]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; telomere maintenance [GO:0000723]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325]; chromatin remodeling [GO:0006338]; establishment of protein localization to telomere [GO:0070200]; negative regulation of shelterin complex assembly [GO:1904791]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; telomere maintenance [GO:0000723]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325] GO:0000723; GO:0000781; GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0010468; GO:0045892; GO:0045944; GO:0046872; GO:0070200; GO:0120325; GO:1904791; GO:1990904 EHNHTK 4 1 1 0.115765585 765.0204174 14.63909 11.98665 15.89892 0 0 13.95298 15.30227 14.92141 0 0 13.40278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RC7 EX3L4_HUMAN Exocyst complex component 3-like protein 4 EXOC3L4 C14orf73 Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887] exocyst [GO:0000145] exocyst [GO:0000145]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887] SNARE binding [GO:0000149] GO:0000145; GO:0000149; GO:0006887; GO:0051601 ELQPLFR 22.79999924 0.856251538 0.856251538 0.290233038 902.0622626 18.94564 17.86097 18.45502 17.79362 17.26597 17.47273 17.3941 17.8224 17.08589 18.07226 0 16.91172 0 0 15.4721 0 17.18437 17.87216 0 17.88681 16.93937 17.83328 15.49702 17.47027 0 19.80522 0 16.44245 15.12069 15.26879 16.73747 0 0 17.30924 17.18251 0 19.29025 0 16.78617 17.0898 17.50137 20.1692 18.50292 17.86819 15.85588 18.46845 18.04478 17.34851 Q17RD7 SYT16_HUMAN Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein) SYT16 STREP14 SYT14L SYT14R Homo sapiens (Human) exocytosis [GO:0006887] exocytosis [GO:0006887] GO:0006887 EKVTFAK 3.869999886 1 1 2.30E-13 821.6640256 0 17.64342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.79657 0 0 0 0 14.5539 14.75438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RG1 KCD19_HUMAN BTB/POZ domain-containing protein KCTD19 KCTD19 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 AHSTASEK 6.289999962 1 1 0.204890632 828.7586741 16.01001 0 0 0 0 0 0 15.01593 0 0 0 0 0 17.43916 0 0 16.3622 16.50125 16.23674 16.6625 18.88618 0 16.52355 16.54357 0 0 15.21085 0 0 14.74176 17.12201 17.77121 16.18946 15.47144 16.04539 15.43929 17.62935 16.26409 15.9463 17.96783 15.72303 18.1182 14.16886 17.32975 13.41066 18.11857 16.76251 18.27301 Q17RH7 TPRXL_HUMAN Putative protein TPRXL TPRXL Homo sapiens (Human) CSISGSTK 4.940000057 0.706355393 0.706355393 0.325449269 839.9548557 17.25587 0 0 0 0 0 17.22729 0 0 0 17.55606 18.79078 0 0 0 0 19.05627 18.38008 16.83315 16.78305 0 0 0 0 18.66368 0 0 17.82261 16.53597 0 0 0 0 17.51295 17.62659 18.09793 0 0 18.33619 0 18.27298 17.42918 18.31495 16.95872 17.15549 18.39284 18.68923 0 Q17RM4 CC142_HUMAN Coiled-coil domain-containing protein 142 CCDC142 PSEC0243 Homo sapiens (Human) QDFGVVR 3.650000095 1 1 0.115077293 821.2163424 17.58655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.22727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RN3 FA98C_HUMAN Protein FAM98C FAM98C Homo sapiens (Human) tRNA-splicing ligase complex [GO:0072669] tRNA-splicing ligase complex [GO:0072669] GO:0072669 EAGAEVLSAGDGPGAEEDFLRQLGSLLR 3.00999999 1 1 0 2858.109538 0 11.56595 13.49408 14.55323 13.96143 0 12.11378 0 14.74054 15.63464 0 14.83119 12.87711 13.49497 14.72979 12.02732 9.837444 14.00304 9.661214 12.60977 0 0 12.00128 14.26336 0 0 0 0 15.32803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RS7 GEN_HUMAN "Flap endonuclease GEN homolog 1, EC 3.1.-.-" GEN1 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139] centrosome [GO:0005813]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; nucleoplasm [GO:0005654]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139] 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] GO:0000287; GO:0000400; GO:0000724; GO:0005654; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0071139; GO:0071140; GO:0090267 GVPGVGK 3.410000086 0.4798792 0.4798792 0.173876523 612.5410746 0 0 14.3668 16.08088 0 14.64164 0 15.82622 16.20221 0 0 0 0 0 15.10052 0 0 0 0 0 15.85395 14.82376 16.17677 15.9868 15.939 16.37893 0 0 15.26726 14.93208 16.5461 0 0 16.67523 0 16.84194 14.95197 0 16.62046 15.68731 0 0 16.42084 13.33525 0 15.15047 15.78059 0 Q17RW2 COOA1_HUMAN Collagen alpha-1(XXIV) chain COL24A1 Homo sapiens (Human) extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0062023 DNPAR 7.190000057 0.286106884 0.286106884 0.211513189 572.4446545 14.27303 14.70958 15.31397 15.6995 10.25208 15.90626 16.39384 15.80403 15.31387 17.61112 16.05613 14.93611 16.3743 14.49401 15.14875 13.93989 15.59993 14.67246 16.2331 14.41687 14.68152 0 17.51958 14.4651 15.9532 15.49462 15.91135 15.78853 15.49703 0 15.76323 0 0 0 16.30655 16.43271 0 15.48635 17.2584 16.2612 15.46217 15.6231 13.89621 0 17.08154 15.80306 0 0 Q19T08 ECSCR_HUMAN "Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression, ARIA) (Endothelial cell-specific molecule 2)" ECSCR ECSM2 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; negative regulation of angiogenesis [GO:0016525]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of proteasomal protein catabolic process [GO:1901800] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; negative regulation of angiogenesis [GO:0016525]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of proteasomal protein catabolic process [GO:1901800] GO:0001525; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0006935; GO:0016021; GO:0016525; GO:0030154; GO:0043231; GO:1901800; GO:2000353 DSITLISMK 1.879999995 0.459200412 0.459200412 0.246955582 1008.654895 16.44528 13.00307 15.39995 12.1938 15.17394 13.14288 14.7194 13.81655 14.31822 16.08894 10.65466 13.22564 15.96917 0 13.53142 15.7349 10.87702 3.771567 14.17908 14.36807 0 0 16.56161 16.3071 0 17.22287 16.44417 12.88167 0 15.21188 15.79168 17.66602 0 16.34265 0 0 16.79982 0 0 16.19267 0 0 0 17.48277 15.09865 15.32427 16.92741 0 Q1A5X7 WHAL1_HUMAN "Putative WASP homolog-associated protein with actin, membranes and microtubules-like protein 1 (WAS protein homolog associated with actin, Golgi membranes and microtubules pseudogene 3) (WAS protein homology region 2 domain-containing protein 1-like protein 1, WH2 domain-containing protein 1-like protein 1, WHDC1-like protein 1)" WHAMMP3 WHAMML1 WHDC1L1 Homo sapiens (Human) Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Arp2/3 complex binding [GO:0071933]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] Arp2/3 complex binding [GO:0071933] GO:0005737; GO:0006888; GO:0033116; GO:0034314; GO:0071933 NNMEASVPK 11.06000042 1 1 0.220042392 1005.660032 16.29761 14.93012 0 0 16.07436 12.38301 14.81992 16.25937 0 0 16.05451 15.60357 16.30688 15.14544 11.65202 9.802341 17.35929 13.61757 14.4682 13.04196 0 0 0 15.78191 13.39062 12.90443 0 0 15.41709 0 0 17.08197 19.02502 0 0 0 14.93273 17.76393 0 15.65119 16.91966 15.58377 0 15.84459 15.40145 0 17.0337 0 Q1ED39 KNOP1_HUMAN Lysine-rich nucleolar protein 1 (Protein FAM191A) (Testis-specific gene 118 protein) KNOP1 C16orf88 FAM191A TSG118 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005730 DVGDTCSVGK 5.360000134 1 1 1.15E-12 1037.294874 14.25828 13.67297 0 13.87235 15.26193 12.90639 13.67469 15.45539 0 14.91534 0 15.67175 0 0 12.82747 0 0 12.06794 0 0 0 0 15.36375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q1KMD3 HNRL2_HUMAN "Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2, SAF-A2)" HNRNPUL2 HNRPUL2 Homo sapiens (Human) membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0016020 EEAQPIVTKYK 10.02999973 1 1 0.306894008 1305.074823 0 0 15.59501 15.99225 15.5445 14.59909 13.85422 15.66967 0 14.65114 0 14.03338 0 0 0 15.30764 15.03327 16.12669 0 0 15.18405 14.21819 15.49537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q1L5Z9 LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192) LONRF2 RNF192 Homo sapiens (Human) metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0046872; GO:0061630 AELYLTMK 9.199999809 0.349849164 0.349849164 0.198692885 984.1953805 17.01998 16.97067 17.6057 0 19.24825 18.62191 0 17.36063 16.11661 18.55898 18.72416 17.88876 14.99754 17.13482 17.77394 17.482 13.48334 18.62329 0 0 15.82049 0 0 0 18.52532 16.7023 0 0 18.71548 0 16.38639 19.39824 18.57199 13.37274 15.87436 0 15.29882 0 13.41248 17.18602 0 0 0 0 0 0 0 18.0669 Q1L6U9 MSMP_HUMAN Prostate-associated microseminoprotein (PC3-secreted microprotein) MSMP PSMP Homo sapiens (Human) inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; CCR2 chemokine receptor binding [GO:0031727]; cytokine activity [GO:0005125]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548] CCR2 chemokine receptor binding [GO:0031727]; cytokine activity [GO:0005125] GO:0002548; GO:0005125; GO:0005615; GO:0005737; GO:0006954; GO:0031727; GO:0048247 SDPRLPCK 1.480000019 1 1 0.283414525 970.9990964 0 16.07494 17.68854 0 17.09088 0 0 0 0 16.33801 0 0 16.87949 0 16.32619 0 0 17.57845 0 0 0 15.40536 0 0 19.05475 0 0 0 0 17.16861 0 0 0 18.4234 0 0 17.00279 0 0 0 0 0 0 0 16.09806 17.53776 0 0 Q1MSJ5 CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 CSPP1 CSPP Homo sapiens (Human) positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0032467; GO:0034451; GO:0051781 SGLSSALGEMVSPR 8.510000229 1 1 0.310517375 1391.749352 15.79974 15.11527 15.00801 0 0 0 0 0 0 0 0 0 13.14912 13.56623 0 13.41003 14.56113 15.37099 0 0 15.81381 0 0 13.41926 15.24167 13.97591 0 0 13.56411 0 0 0 0 0 0 0 0 16.52692 0 0 0 0 0 0 14.5422 0 0 0 Q1RMZ1 SAMTR_HUMAN "S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog, EC 2.1.1.-)" BMT2 C7orf60 SAMTOR Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262] cytosol [GO:0005829] cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262] methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047] GO:0005829; GO:0008168; GO:0032259; GO:0034198; GO:1904047; GO:1904262 EVGDFDK 9.930000305 0.41472134 0.41472134 0.227155367 809.5970784 15.48754 0 15.61296 17.7461 17.62253 0 17.74177 0 0 0 0 17.37523 0 0 0 0 0 0 15.41492 0 15.99674 0 17.86547 0 15.30945 18.60609 17.80119 0 17.91842 0 0 0 16.8577 16.66684 0 0 0 0 0 0 0 15.29048 0 17.4187 18.1844 18.0778 15.27588 0 Q1W6H9 F110C_HUMAN Protein FAM110C FAM110C Homo sapiens (Human) positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell projection assembly [GO:0060491] cell cortex [GO:0005938]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922] cell cortex [GO:0005938]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell projection assembly [GO:0060491] alpha-tubulin binding [GO:0043014] GO:0000922; GO:0005634; GO:0005815; GO:0005874; GO:0005938; GO:0030335; GO:0043014; GO:0051897; GO:0060491 SAAPSSVPAAPPGPEPRVVR 4.230000019 1 1 0.362791292 1941.692273 0 0 0 0 0 0 15.03986 0 0 0 0 12.15746 0 0 0 0 0 0 0 12.7105 16.04836 0 0 0 0 15.26943 16.6293 0 0 0 14.00231 15.24953 15.08891 15.59287 14.12718 0 0 16.99328 16.0927 16.62819 15.00077 0 17.0179 15.4883 0 0 15.69036 0 Q1X8D7 LRC36_HUMAN Leucine-rich repeat-containing protein 36 (ROR gamma-binding protein 70) LRRC36 RORBP70 Homo sapiens (Human) KIFTK 19.01000023 0.472334832 0.472334832 0.230217441 635.5168624 19.81129 19.42146 20.91532 17.14399 19.90903 20.33257 17.43144 20.70727 18.26969 16.22284 18.29488 20.04231 0 17.33634 14.94012 16.63806 0 22.00642 19.8653 18.09991 0 20.4215 21.56559 20.73293 20.60112 21.10676 0 0 19.81962 21.71539 18.02561 18.38056 0 21.78534 19.54803 22.86525 0 18.7451 17.73532 17.58855 20.66852 18.8536 21.28522 17.62947 22.02892 0 0 0 Q1XH10 SKDA1_HUMAN SKI/DACH domain-containing protein 1 (Protein DLN-1) SKIDA1 C10orf140 DLN1 Homo sapiens (Human) ALATKAPPPER 6.510000229 1 1 0.249613955 1150.320725 0 15.451 14.32063 15.69533 14.10934 16.12402 14.14779 13.71583 0 14.65491 13.89092 0 0 0 15.08021 14.04786 0 13.834 15.34543 0 0 14.26741 0 15.38006 14.88588 0 0 0 0 0 0 14.75825 15.59794 0 0 0 13.82365 16.6405 14.17124 15.05156 15.02354 14.32152 0 0 14.64744 0 0 0 Q24JP5 T132A_HUMAN Transmembrane protein 132A (HSPA5-binding protein 1) TMEM132A HSPA5BP1 KIAA1583 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] GO:0000139; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016021; GO:0070062 QVAGSVGGNTGVRGK 5.880000114 0.681205332 0.681205332 0.206059451 1386.148584 0 14.7385 13.73491 0 0 0 0 0 14.38657 12.43982 0 14.10425 13.34287 14.7718 8.724483 0 0 0 0 0 14.51483 0 0 0 0 14.95072 0 0 16.7714 10.1694 0 15.36438 0 0 0 0 16.38452 0 0 15.60419 0 0 0 0 13.3277 0 13.08712 14.9362 Q29RF7 PDS5A_HUMAN "Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112, SCC-112)" PDS5A KIAA0648 PDS5 PIG54 Homo sapiens (Human) cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156]" GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005886; GO:0006281; GO:0007064; GO:0008156; GO:0051301 IISVTPVK 1.529999971 1 1 0.28429771 856.3767053 0 16.13089 0 0 0 0 0 0 0 0 0 0 0 0 15.36711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.33104 0 0 0 0 17.86022 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2I0M5 RSPO4_HUMAN "R-spondin-4 (Roof plate-specific spondin-4, hRspo4)" RSPO4 C20orf182 Homo sapiens (Human) nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055] extracellular region [GO:0005576] extracellular region [GO:0005576]; heparin binding [GO:0008201]; nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055] heparin binding [GO:0008201] GO:0005576; GO:0008201; GO:0016055; GO:0030177; GO:0035878 GQEVNRCK 1.210000038 0.564201415 0.564201415 0.098939094 987.8111237 16.23026 15.90506 15.79316 14.36486 0 0 13.0527 16.17974 15.70725 0 15.35152 0 0 11.60349 0 17.31031 14.17398 13.85723 17.33146 0 15.148 0 16.39373 0 0 0 12.31194 14.80062 0 0 16.79916 9.923174 16.19168 16.57978 13.11035 0 15.84211 15.45624 13.36414 14.35183 0 0 16.34131 14.7595 0 11.55815 14.2556 0 Q2KHM9 MOONR_HUMAN "Protein moonraker, MNR (OFD1- and FOPNL-interacting protein)" KIAA0753 MNR OFIP Homo sapiens (Human) centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539] GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0034451; GO:0071539 ALQMFVTQFTDRGEHPLPAR 6.539999962 1 1 3.20E-12 2330.610939 12.6858 0 10.32333 14.86825 10.61792 12.98698 14.77524 0 13.79948 11.46316 11.94896 0 15.56939 0 11.91054 13.98755 13.57002 0 13.52531 0 0 0 14.3994 13.39048 0 0 11.00871 14.30049 0 12.44017 12.1174 10.96353 13.8121 9.461546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2KHR2 RFX7_HUMAN DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2) RFX7 RFXDC2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837 DHPTVEMLG 6.320000172 0.797766805 0.797766805 0.186934312 1015.500115 14.92479 0 13.62438 14.54346 15.49069 0 15.16281 12.71425 14.36724 15.01098 0 16.74221 0 0 15.2225 0 0 11.86421 0 0 14.99758 15.71031 14.43741 15.8299 10.99684 15.06261 0 15.26033 0 0 11.82545 0 16.6205 14.09814 15.74556 12.99104 17.11259 0 0 16.01161 12.89273 0 12.97863 15.24723 13.43276 0 0 0 Q2KHR3 QSER1_HUMAN Glutamine and serine-rich protein 1 QSER1 Homo sapiens (Human) chromosome [GO:0005694] chromosome [GO:0005694] GO:0005694 SVSTPLTTLDATSDK 2.309999943 0.322107404 0.322107404 0.14967021 1534.633955 11.89132 12.03062 10.62206 0 0 16.74912 0 13.96284 11.79325 15.23555 15.79885 18.19191 15.08754 0 15.50292 15.91231 0 14.97862 0 11.57827 15.3581 0 15.56376 13.58873 15.07977 16.33134 0 13.17804 0 0 0 14.75543 0 14.76121 17.76142 0 15.15556 17.93642 16.07945 0 17.28475 0 13.38108 0 16.6044 12.97266 14.59082 15.03255 Q2KJY2 KI26B_HUMAN Kinesin-like protein KIF26B KIF26B Homo sapiens (Human) establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0022409; GO:0030010; GO:0072092 DGTMPRAGR 4.96999979 1 1 0.072691578 977.8723029 0 0 0 0 0 14.77843 13.59148 15.25991 14.97983 15.80384 15.63926 0 0 0 12.33719 12.0521 0 14.72416 14.40486 17.40948 14.70987 17.29881 17.70776 17.2358 14.0537 16.52563 0 16.73328 0 0 15.79552 18.37466 0 0 13.1903 15.456 18.46191 0 14.50242 15.56741 12.44813 0 15.77906 0 13.871 0 15.29212 19.26455 Q2LD37 K1109_HUMAN Transmembrane protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488] GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793 EISMSVGLGR 2.269999981 1 1 0.256304 1048.896753 0 0 0 0 0 0 0 0 0 17.52262 0 0 0 0 0 0 0 0 0 0 0 16.8202 16.66186 17.63072 0 16.7147 18.93933 16.10462 0 0 0 0 0 0 18.12364 0 0 16.3953 0 0 0 15.92357 0 17.17469 0 0 0 19.62048 Q2M1K9 ZN423_HUMAN "Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein, hOAZ) (Smad- and Olf-interacting zinc finger protein)" ZNF423 KIAA0760 NPHP14 OAZ Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0061512; GO:0120163 GFSSTSSLQSHMQAHK 4.929999828 1 1 0.448204861 1747.051942 0 15.64514 15.29875 15.0196 0 0 0 14.77363 0 14.98261 13.39006 14.56386 15.56505 0 0 0 0 15.07871 0 0 0 0 0 0 0 16.85054 0 0 0 0 0 0 0 0 0 0 15.80134 0 0 0 0 0 0 0 0 0 0 0 Q2M1P5 KIF7_HUMAN Kinesin-like protein KIF7 KIF7 UNQ340/PRO539 Homo sapiens (Human) microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0036064; GO:0045879; GO:0045880; GO:0097542 DIQLREDER 1.870000005 0.434641689 0.434641689 0.219684561 1175.428781 0 16.97725 11.61951 14.04613 0 13.11896 14.11666 13.22559 0 0 0 12.76818 15.9179 0 14.02589 16.37742 14.13782 14.69241 0 0 16.93526 0 0 0 0 0 0 0 14.86154 16.64391 16.31427 0 0 0 0 0 16.56368 0 0 0 0 0 17.84224 16.81884 15.48733 15.68926 0 0 Q2M1Z3 RHG31_HUMAN Rho GTPase-activating protein 31 (Cdc42 GTPase-activating protein) ARHGAP31 CDGAP KIAA1204 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] GO:0005096; GO:0005829; GO:0005925; GO:0007264; GO:0017124; GO:0030027; GO:0051056 NGSVFVRGQR 11.71000004 0.965562999 0.965562999 0.196792439 1120.107021 16.22702 13.22495 17.10399 0 0 0 0 0 0 0 0 0 15.98903 14.55375 15.35691 14.97586 0 10.75313 12.47974 13.88518 13.78553 11.64368 15.18292 0 14.61728 0 0 15.93245 14.7808 14.44265 15.89022 0 0 0 15.69149 14.67992 13.82299 0 14.57632 0 0 0 0 14.40825 0 15.19533 12.45222 0 Q2M2E5 CE064_HUMAN Uncharacterized protein C5orf64 C5orf64 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 KVLPTTMMFSMLADCVLK 5.559999943 1 1 0.038399796 2116.416888 14.80276 0 0 12.96197 0 14.64928 0 0 15.21317 0 0 0 0 0 0 14.32946 16.16258 14.26849 12.10209 11.68296 0 13.40736 15.22735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2H8 MGAL_HUMAN "Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase, EC 3.2.1.3 (Glucan 1,4-alpha-glucosidase) ]" MGAM2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]" "alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" GO:0004339; GO:0004553; GO:0004558; GO:0005975; GO:0016021; GO:0030246 EVVSRNR 13.68000031 1 1 0.289777705 858.1021931 0 0 0 13.01102 14.056 0 15.39972 0 0 0 0 0 0 0 0 0 12.33218 0 0 0 0 16.62745 0 0 0 0 0 0 0 0 0 0 0 15.95901 12.03767 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2I3 FA83E_HUMAN Protein FAM83E FAM83E Homo sapiens (Human) signal transduction [GO:0007165] protein kinase binding [GO:0019901]; signal transduction [GO:0007165] protein kinase binding [GO:0019901] GO:0007165; GO:0019901 DTPAKALMR 8.170000076 0.236290216 0.236290216 0.22771587 1018.889794 15.91787 15.45349 11.57094 13.2303 14.88126 14.94407 14.16969 0 15.64716 15.35361 14.87087 15.09902 0 0 0 0 15.97342 0 0 14.61431 0 0 15.23971 0 14.7759 13.50788 15.11605 14.78086 14.57479 10.82628 15.21908 12.3672 15.44587 12.56944 0 11.50202 10.84997 0 15.26346 15.3735 13.85254 0 13.28078 0 0 15.2433 11.43682 12.2186 Q2M2I5 K1C24_HUMAN "Keratin, type I cytoskeletal 24 (Cytokeratin-24, CK-24) (Keratin-24, K24) (Type I keratin-24)" KRT24 KA24 Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062 ASSSRAGGSSSAR 6.78000021 0.073738776 0.073738776 0.589602849 1181.033526 0 0 0 0 18.54186 0 0 0 0 0 0 0 0 0 0 0 19.6611 17.74348 0 0 17.89585 0 0 0 0 18.33609 0 0 0 0 0 0 0 18.16721 17.95122 0 0 0 0 18.64393 0 0 18.25635 0 0 0 17.2307 0 Q2M2I8 AAK1_HUMAN "AP2-associated protein kinase 1, EC 2.7.11.1 (Adaptor-associated kinase 1)" AAK1 KIAA1048 Homo sapiens (Human) endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880] cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; terminal bouton [GO:0043195] cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880] AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005112; GO:0005524; GO:0005737; GO:0005829; GO:0005905; GO:0006468; GO:0006897; GO:0019897; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0046777; GO:0050821; GO:0061024; GO:0106310; GO:2000369 EQGGSGLGSGSSGGGGSTSGLGSGYIGR 7.159999847 1 1 0.291853409 2387.343288 18.23099 14.87105 17.99296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2W7 CQ058_HUMAN UPF0450 protein C17orf58 C17orf58 Homo sapiens (Human) collagen-containing extracellular matrix [GO:0062023] collagen-containing extracellular matrix [GO:0062023] GO:0062023 KPDSRGCPSAEETPGPR 6.78000021 1 1 0.139268484 1840.096982 0 15.63195 0 0 10.212 14.34146 14.30894 14.1509 13.59212 0 0 0 13.69449 0 14.60402 0 0 0 0 13.94432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.33865 0 0 0 0 0 0 0 0 0 0 0 Q2M329 CCD96_HUMAN Coiled-coil domain-containing protein 96 CCDC96 Homo sapiens (Human) cilium assembly [GO:0060271] axoneme [GO:0005930]; ciliary basal body [GO:0036064] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium assembly [GO:0060271] GO:0005930; GO:0036064; GO:0060271 EMSAVR 9.619999886 0.971573591 0.971573591 0.223032496 707.4980003 14.62358 14.1107 15.73408 14.88451 15.93728 14.90507 15.83439 15.93658 15.12735 16.13257 14.93776 16.27989 15.77625 13.90679 15.21897 15.55209 15.77904 16.55556 13.23559 15.19164 14.71588 16.57164 17.18231 17.84945 15.1616 14.93027 0 15.9026 14.73596 0 0 16.17873 16.61489 0 16.27706 15.90654 15.36228 16.74031 15.9707 15.19302 15.8895 16.09713 0 0 0 15.67529 15.41915 15.29164 Q2M3C7 SPKAP_HUMAN A-kinase anchor protein SPHKAP (SPHK1-interactor and AKAP domain-containing protein) (Sphingosine kinase type 1-interacting protein) SPHKAP KIAA1678 SKIP Homo sapiens (Human) cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein kinase A binding [GO:0051018] protein kinase A binding [GO:0051018] GO:0005737; GO:0005739; GO:0051018 ASSVSK 1.389999986 0.013491042 0.013491042 0.210796453 579.4627958 0 0 14.46888 13.84435 14.80285 0 16.20314 0 14.88124 0 15.19183 0 14.73685 0 15.39188 16.92624 0 0 0 0 0 16.33793 0 15.73809 0 16.22464 0 16.54814 0 0 15.70736 16.60353 0 0 16.86201 16.67301 16.3493 16.74751 0 15.7086 16.55207 15.09581 14.94616 16.31454 0 0 0 0 Q2M3D2 EX3L2_HUMAN Exocyst complex component 3-like protein 2 (HBV X-transactivated gene 7 protein) (HBV XAg-transactivated protein 7) EXOC3L2 XTP7 Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887] exocyst [GO:0000145] exocyst [GO:0000145]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887] SNARE binding [GO:0000149] GO:0000145; GO:0000149; GO:0006887; GO:0051601 FHENPAVR 7.639999866 0.744922817 0.744922817 0.196551921 968.5624575 0 0 11.53818 0 15.26429 0 15.63526 0 0 0 16.88065 0 15.90928 5.791163 15.46661 0 16.36845 0 16.11533 0 17.24858 0 0 0 0 16.47114 16.94147 16.22508 16.92317 15.82216 16.47107 15.41192 0 15.19633 14.86897 0 0 13.46289 13.35856 14.29233 16.97922 13.03965 14.73304 0 12.98877 14.88555 13.90767 15.02646 Q2M3G0 ABCB5_HUMAN "ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5, EC 7.6.2.2)" ABCB5 Homo sapiens (Human) cell differentiation [GO:0030154]; eye development [GO:0001654]; regulation of membrane potential [GO:0042391]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; cell differentiation [GO:0030154]; eye development [GO:0001654]; regulation of membrane potential [GO:0042391]; transmembrane transport [GO:0055085] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562] GO:0001654; GO:0005524; GO:0005886; GO:0005887; GO:0008559; GO:0015562; GO:0016021; GO:0030154; GO:0042391; GO:0042626; GO:0055085 ENSERAEEMQENYQR 1.940000057 1 1 0.198326653 1927.853784 11.96763 0 0 15.57893 0 12.78096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.23216 0 0 0 0 0 0 15.54734 0 0 0 0 0 0 0 0 0 0 0 0 Q2M3G4 SHRM1_HUMAN Protein Shroom1 (Apical protein 2) SHROOM1 APXL2 KIAA1960 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; microtubule [GO:0005874] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902] actin filament binding [GO:0051015]; myosin II binding [GO:0045159] GO:0000902; GO:0005874; GO:0005912; GO:0007015; GO:0016324; GO:0030864; GO:0043296; GO:0045159; GO:0051015; GO:0051017 EHVARR 3.099999905 1 1 0.120101955 766.7103788 0 0 0 0 0 0 0 0 14.50091 0 0 0 0 15.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8966 13.63998 0 0 0 16.16415 0 0 13.23367 0 0 0 0 15.00105 Q2M3R5 S35G1_HUMAN Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20) SLC35G1 C10orf60 POST TMEM20 Homo sapiens (Human) calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034 TGFIGPK 3.25999999 1.09E-05 1.09E-05 0.162926365 719.6587147 10.74152 14.38119 17.36234 17.15968 0 14.72169 15.90175 0 14.63634 16.49935 17.13316 15.40357 16.16011 0 14.06866 0 0 17.80318 14.80855 16.1848 15.86282 15.9316 0 0 17.31832 14.62235 16.03923 15.08898 0 17.35721 11.66502 17.16345 17.56271 0 13.80046 15.81267 11.73267 17.09094 16.07023 16.10881 16.80749 14.14476 14.38889 16.41779 18.00826 15.22765 11.32781 13.43714 Q2M3T9 HYAL4_HUMAN "Hyaluronidase-4, Hyal-4, EC 3.2.1.35 (Chondroitin sulfate endo-beta-N-acetylgalactosaminidase) (Chondroitin sulfate hydrolase, CSHY) (Hyaluronoglucosaminidase-4)" HYAL4 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214] hyalurononglucosaminidase activity [GO:0004415] GO:0004415; GO:0005975; GO:0006027; GO:0009986; GO:0016021; GO:0030207; GO:0030214; GO:0031410 SLGDSENILR 1.860000014 1 1 4.60E-13 1102.805759 0 13.78374 0 14.10133 0 0 12.94353 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.33529 0 0 17.13818 0 0 0 0 0 13.20972 0 Q2M3V2 SWAHA_HUMAN Ankyrin repeat domain-containing protein SOWAHA (Ankyrin repeat domain-containing protein 43) (Protein sosondowah homolog A) SOWAHA ANKRD43 Homo sapiens (Human) AYQYLRPGSSYALRR 3.109999895 1 1 0 1800.191733 15.09385 15.56345 13.96146 0 12.11274 12.30546 14.83942 0 0 15.25723 13.0026 0 0 0 0 0 13.74161 0 0 0 0 0 15.9803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M5E4 RGS21_HUMAN "Regulator of G-protein signaling 21, RGS21" RGS21 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] GTPase activity [GO:0003924] GO:0003924; GO:0005886; GO:0007186; GO:0009968 IASKAK 16.79000092 0.002793448 0.002793448 0.242956242 615.4764648 19.58893 0 21.03395 0 17.29678 0 17.26077 0 19.11306 0 18.58927 17.42345 17.72538 0 18.95248 17.56408 18.30314 0 17.59927 0 18.69974 16.84921 18.44641 19.02174 18.82758 18.4038 19.38334 19.19244 19.50479 0 0 0 18.14819 0 0 0 0 0 18.06384 0 0 18.20603 0 17.98291 18.79171 0 18.42961 17.29967 Q2NKJ3 CTC1_HUMAN CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B) CTC1 C17orf68 Homo sapiens (Human) bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538] "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538]" G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162] GO:0000723; GO:0000781; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0010389; GO:0010833; GO:0016233; GO:0032211; GO:0035264; GO:0042162; GO:0045740; GO:0048146; GO:0048536; GO:0048538; GO:0048539; GO:0071425; GO:0090399; GO:0098505; GO:1990879 DQSGSLPCLLLAK 13.15999985 1 1 0.467553755 1403.598199 0 16.40237 0 15.27192 0 0 0 0 0 0 0 0 0 0 14.14371 0 0 0 0 0 0 15.81496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.27193 0 0 15.99922 0 0 Q2NKQ1 SGSM1_HUMAN Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) SGSM1 KIAA1941 RUTBC2 Homo sapiens (Human) activation of GTPase activity [GO:0090630] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267; GO:0090630 ASAPAEAETR 7.670000076 0.738238573 0.738238573 0.227103466 1003.111262 16.38788 14.90362 16.23513 16.71689 0 16.9278 16.95515 0 0 16.9957 15.20161 16.63964 0 16.01758 16.57858 17.47914 0 0 0 0 0 0 0 0 15.5172 16.83807 0 0 0 0 0 16.80969 0 0 16.41808 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2NKX8 ERC6L_HUMAN "DNA excision repair protein ERCC-6-like, EC 3.6.4.12 (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15)" ERCC6L PICH Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; cell cycle [GO:0007049]; cell division [GO:0051301] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616] GO:0000776; GO:0003677; GO:0003678; GO:0005524; GO:0005829; GO:0007049; GO:0015616; GO:0016020; GO:0016887; GO:0051301; GO:0140658 MEASR 5.130000114 1 1 3.44E-13 609.7282492 0 0 12.71186 14.2145 11.64799 0 15.84362 12.48256 0 15.14324 0 14.90614 13.81885 14.17406 0 0 0 0 0 0 0 0 0 0 0 0 16.40248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2NL67 PARP6_HUMAN "Protein mono-ADP-ribosyltransferase PARP6, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 17, ARTD17) (Poly [ADP-ribose] polymerase 6, PARP-6)" PARP6 Homo sapiens (Human) positive regulation of dendrite morphogenesis [GO:0050775]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404] GO:0003950; GO:0006471; GO:0050775; GO:0070213; GO:0140289; GO:1990404 NIPTLEYGFLVQIMKYAEQR 3.049999952 1 1 0 2428.917767 0 14.95863 14.23169 0 0 13.89932 14.86341 15.91034 12.93614 13.82542 0 15.228 0 15.65005 11.67342 14.96776 14.76174 15.00819 0 0 0 0 0 0 0 0 0 0 0 0 0 16.36432 0 0 0 0 16.55147 0 0 0 15.21821 0 0 0 0 0 0 0 Q2NL82 TSR1_HUMAN Pre-rRNA-processing protein TSR1 homolog TSR1 KIAA1401 Homo sapiens (Human) "endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511 LLLLDTQQEAGMLLR 4.489999771 1 1 0.629572587 1714.023538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.65369 0 0 0 0 0 0 0 0 0 0 0 0 Q2NL98 VMAC_HUMAN Vimentin-type intermediate filament-associated coiled-coil protein VMAC Homo sapiens (Human) cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098] cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098] GO:0005737; GO:0045098 AAELEAR 3.119999886 1 1 0.014198956 761.5806523 0 0 0 0 0 0 0 16.11917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14983 16.39718 0 0 0 0 0 0 0 0 0 0 0 Q2PPJ7 RGPA2_HUMAN "Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt, AS250) (p220)" RALGAPA2 C20orf74 KIAA1272 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0046982; GO:0051056; GO:0090630 AVLIIFR 14.02999973 0.364871532 0.364871532 0.50758288 829.97444 16.78314 17.95302 17.05273 0 17.01872 14.11664 16.13995 16.55533 17.81536 0 17.17777 17.65516 0 18.2717 0 0 0 0 16.78515 17.78627 0 0 0 0 17.18563 0 16.37278 16.72598 0 16.11987 0 0 0 0 0 16.89541 15.15103 17.22665 0 17.02768 0 0 0 17.76837 0 16.30348 16.82656 0 Q2Q1W2 LIN41_HUMAN "E3 ubiquitin-protein ligase TRIM71, EC 2.3.2.27 (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)" TRIM71 LIN41 Homo sapiens (Human) 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637 IQIFTFEGQFLLK 4.150000095 1 1 0.469866862 1583.930251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.11009 0 0 0 0 18.99085 0 0 0 19.69424 0 17.95122 0 0 0 17.66137 0 0 0 18.11758 0 0 0 0 0 0 17.67814 Q2QGD7 ZXDC_HUMAN Zinc finger protein ZXDC (ZXD-like zinc finger protein) ZXDC ZXDL Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0030275; GO:0045893; GO:0046872; GO:0070742 APAPLGASPAR 3.099999905 0.698470891 0.698470891 0.173882587 1005.641961 13.44392 0 15.08579 0 13.73455 15.26729 16.09104 13.6625 14.2674 0 0 0 13.67578 15.58786 16.01504 0 14.65737 14.37174 12.60636 15.26129 0 15.16711 14.86794 16.04327 0 13.67159 14.50752 14.07248 15.22677 13.4193 0 12.46694 15.01177 16.10907 15.78024 14.22768 15.66511 14.63697 15.51138 14.73957 14.24155 14.84398 11.4905 12.64963 15.56081 0 0 0 Q2T9K0 TMM44_HUMAN Transmembrane protein 44 TMEM44 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MRQALGFAK 4.610000134 0.836968958 0.836968958 0.2162461 1034.623364 0 0 0 0 0 0 14.28744 0 0 0 0 0 0 0 14.1408 0 0 0 0 0 0 0 0 0 0 0 0 0 12.94905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.77895 18.03801 0 0 Q2TAC2 CCD57_HUMAN Coiled-coil domain-containing protein 57 CCDC57 Homo sapiens (Human) centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931] GO:0000086; GO:0005737; GO:0005813; GO:0005814; GO:0005876; GO:0007020; GO:0007099; GO:0034451; GO:0045931; GO:0060271 RPVKMQAGIATPGMK 1.409999967 1 1 0.402369531 1579.138749 0 15.46902 19.00968 17.73295 0 0 0 17.58122 0 0 0 18.56751 0 0 18.05564 0 19.26118 0 0 0 17.07766 0 0 0 19.53474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.02998 0 0 0 17.89549 0 0 Q2TAC6 KIF19_HUMAN Kinesin-like protein KIF19 KIF19 Homo sapiens (Human) axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462] axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874] axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0060404; GO:0070462 LFMIDLAGSER 7.670000076 0.026113836 0.026113836 0.201610044 1268.57109 0 10.41102 0 0 0 0 0 16.48975 0 0 0 0 14.08788 0 0 0 0 15.00787 0 0 0 0 20.22841 0 0 0 0 0 0 0 0 13.29776 0 15.54286 16.88137 16.44385 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAK8 PWP3A_HUMAN "PWWP domain-containing DNA repair factor 3A, PWWP3A (Mutated melanoma-associated antigen 1, MUM-1) (PWWP domain-containing protein MUM1) (Protein expandere)" PWWP3A EXPAND1 MUM1 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA repair [GO:0006281] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; chromatin organization [GO:0006325]; DNA repair [GO:0006281] nucleosome binding [GO:0031491] GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0031491 DMGSK 3.190000057 1 1 0.178766781 536.4868127 15.48468 15.16192 15.02521 0 0 0 0 14.56436 0 13.55905 15.78577 13.46554 13.44783 14.73836 15.84388 13.7895 14.27323 0 0 15.30575 12.98687 14.41842 0 0 0 15.24599 0 12.6068 15.13663 14.97574 15.5653 15.81432 15.50821 16.76271 15.64112 13.94941 14.99681 16.32024 13.91088 14.51161 13.98727 15.69002 15.60401 13.28951 14.82621 13.8893 16.98368 15.38069 Q2TAL5 SMTL2_HUMAN Smoothelin-like protein 2 SMTNL2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; positive regulation of vasoconstriction [GO:0045907] filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815] filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; positive regulation of vasoconstriction [GO:0045907] protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523] GO:0005523; GO:0005815; GO:0008157; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0045907 QVEALGLASGMSPVPGTPGTPSPPPAPGVPDR 6.210000038 1 1 4.59E-13 3052.465055 0 13.22851 14.52525 15.24083 13.46552 0 15.31391 14.142 15.45708 15.02226 11.72368 15.83611 0 0 14.3986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TB10 ZN800_HUMAN Zinc finger protein 800 ZNF800 PP902 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 KPKLSAGFDFK 7.309999943 1 1 1.14E-12 1237.886512 0 10.0308 0 14.44501 12.02355 10.66885 13.39988 15.28362 0 15.20096 12.12706 13.29785 0 0 12.9693 14.58706 0 14.3716 14.26513 10.62493 0 13.03711 12.86339 13.80534 0 0 0 0 0 0 0 0 0 0 14.5601 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TB18 ASTE1_HUMAN Protein asteroid homolog 1 ASTE1 HT001 Homo sapiens (Human) nuclease activity [GO:0004518] nuclease activity [GO:0004518] GO:0004518 EELQEDGAKMLYAEFQR 4.269999981 1 1 0.229747957 2071.591436 0 0 0 0 13.97929 0 0 0 0 0 0 12.90032 0 16.63387 0 11.59673 15.72771 0 0 0 0 16.38293 16.30538 0 15.15508 13.7555 15.33123 14.41705 16.03646 0 0 0 12.34374 0 12.95796 15.16225 14.643 14.63527 0 12.63555 12.68051 14.23816 15.47204 0 0 0 0 14.27205 Q2TB90 HKDC1_HUMAN "Hexokinase HKDC1, EC 2.7.1.1 (Hexokinase domain-containing protein 1)" HKDC1 Homo sapiens (Human) cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318] cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318] ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158] GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006096; GO:0008865; GO:0019158; GO:0019318; GO:0031966; GO:0051156 GTLIGWTKGFK 6.860000134 0.43261686 0.43261686 0.231748985 1208.206205 15.06789 15.67995 13.88159 14.96802 11.53934 0 0 0 10.92832 0 13.84299 14.22909 0 14.37509 14.63799 9.941988 14.53765 0 13.78604 0 0 0 15.28132 0 15.27729 0 0 0 0 0 15.11575 0 0 0 0 13.49257 0 0 0 0 0 0 0 0 0 0 0 0 Q2TBA0 KLH40_HUMAN Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5) (Sarcosynapsin) KLHL40 KBTBD5 SRYP Homo sapiens (Human) negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528] A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674] A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528] GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032435; GO:0032436; GO:0048741; GO:0098528 EIAYAAGATFLPVR 11.38000011 0.551831722 0.551831722 0.342369966 1477.950465 0 0 0 0 0 15.11669 0 0 14.5453 0 14.28747 14.67071 0 0 0 0 0 0 0 16.19816 0 16.80001 0 0 16.74937 0 0 0 0 17.80236 0 0 17.43095 0 0 0 18.4732 0 0 0 0 14.89873 0 19.68954 0 11.98323 0 15.53727 Q2TBE0 C19L2_HUMAN CWF19-like protein 2 CWF19L2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" post-mRNA release spliceosomal complex [GO:0071014] "post-mRNA release spliceosomal complex [GO:0071014]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0071014 FMGKTDGDYYTLDDMFVSK 3.25 1 1 0.267504216 2232.765157 11.81268 14.63426 11.63867 0 0 0 0 0 0 0 0 0 8.706917 14.58871 0 0 12.46585 13.48406 0 11.94048 12.50277 15.77685 16.3334 14.65015 10.75142 0 0 14.10098 8.817921 0 15.39343 16.01869 0 14.09277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TBF2 WSCD2_HUMAN WSC domain-containing protein 2 WSCD2 KIAA0789 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GKDGNER 6.880000114 1 1 0.1964885 775.4569058 14.22053 0 15.02637 16.09361 14.22283 15.35259 0 16.00532 15.68118 16.36659 16.08869 0 0 15.15206 15.69928 15.99695 14.57023 14.75745 0 15.27618 14.48419 0 0 15.10705 0 0 15.14461 14.0273 15.14626 0 0 0 14.00088 0 15.08047 0 0 0 0 0 15.62172 15.76127 15.72878 0 16.23775 0 0 0 Q2TV78 MST1L_HUMAN "Putative macrophage stimulating 1-like protein (Brain rescue factor 1, BRF-1) (Hepatocyte growth factor-like protein homolog)" MST1L D1F15S1A MST1P9 MSTP9 Homo sapiens (Human) regulation of receptor signaling pathway via JAK-STAT [GO:0046425] extracellular space [GO:0005615] extracellular space [GO:0005615]; peptidase activity [GO:0008233]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] peptidase activity [GO:0008233]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005615; GO:0008233; GO:0030971; GO:0046425 LQALTLGRHALMSGTR 4.46999979 1 1 0.20473495 1742.094551 0 14.6517 0 14.56305 0 14.36171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.45252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2UY09 COSA1_HUMAN Collagen alpha-1(XXVIII) chain COL28A1 COL28 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0030198; GO:0031012; GO:0062023 GLPGEGFPGPK 7.929999828 1 1 0.172972298 1056.996625 16.13904 17.57003 14.66734 15.60801 0 14.52465 0 0 13.15034 0 0 0 0 0 0 0 0 0 14.66826 0 0 0 15.40934 0 15.60791 0 14.6229 0 0 0 0 15.79217 0 0 0 0 0 16.13353 0 0 0 0 0 0 0 0 0 15.00682 Q2V2M9 FHOD3_HUMAN "FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2, hFHOS2)" FHOD3 FHOS2 KIAA1695 Homo sapiens (Human) actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214] actin filament binding [GO:0051015] GO:0005737; GO:0005856; GO:0030018; GO:0030837; GO:0030866; GO:0045214; GO:0051015; GO:0051639; GO:0055003 DNCSASSVSSSSSTLER 4.53000021 0.842168808 0.842168808 0.386746002 1773.163316 0 15.13674 11.08363 0 14.86198 0 0 0 0 0 0 0 0 0 0 0 0 15.19366 0 0 0 0 0 14.73117 0 0 0 0 0 0 0 0 17.20583 0 0 15.13822 13.93084 0 0 0 0 13.58899 14.31302 15.65434 16.92892 0 0 0 Q2VIQ3 KIF4B_HUMAN Chromosome-associated kinesin KIF4B (Chromokinesin-B) KIF4B Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052] cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052] ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0016363; GO:0046872; GO:0051256; GO:0051536 LNQEIWMMK 13.56999969 1 1 0.922608759 1208.637856 0 0 0 0 0 0 0 0 0 0 0 0 19.22649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2VIR3 IF2GL_HUMAN "Eukaryotic translation initiation factor 2 subunit 3B, EC 3.6.5.3 (Eukaryotic translation initiation factor 2 subunit gamma A, eIF-2-gamma A, eIF-2gA)" EIF2S3B Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903] eukaryotic translation initiation factor 2 complex [GO:0005850] eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] GO:0000049; GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005850; GO:0045903 DFTSEPR 5.989999771 0.041176915 0.041176915 0.25073281 852.6618812 0 0 0 16.30301 0 0 17.4776 0 16.67175 0 0 15.90461 15.24277 15.36731 0 16.37853 16.1509 0 15.2057 0 0 17.04141 0 0 0 0 0 14.02572 15.57063 16.9144 0 0 0 0 15.16876 14.6469 0 0 0 0 0 0 0 13.76102 0 0 0 0 Q2VPA4 CR1L_HUMAN Complement component receptor 1-like protein (Complement C4b-binding protein CR-1-like protein) CR1L Homo sapiens (Human) "negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]" cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235] "cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]" GO:0005615; GO:0005737; GO:0016020; GO:0030449; GO:0043235; GO:0045959; GO:1903659 NPPDPVNGMAHVIK 9.979999542 1 1 6.87E-13 1504.115181 14.86081 14.1042 0 9.340553 15.49782 14.44421 0 11.37234 0 15.4395 9.68795 11.20657 0 16.51122 0 0 0 0 0 0 17.8366 15.51428 0 0 14.45097 0 0 14.60076 0 13.27924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2VPJ9 LR75B_HUMAN Leucine-rich repeat-containing protein 75B (Leucine-rich repeat-containing protein FAM211B) LRRC75B C22orf36 FAM211B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 TLLPDILYR 10 1 1 0.130412129 1103.13813 15.20289 16.07313 0 0 11.37272 17.36724 0 0 0 11.85612 0 15.8706 0 0 0 0 0 0 0 0 0 0 0 0 16.43449 16.13928 0 0 0 0 0 0 16.22495 0 0 0 0 0 0 0 0 16.58909 0 0 0 0 0 0 Q2VWP7 PRTG_HUMAN Protogenin (Protein Shen-Dan) PRTG Homo sapiens (Human) negative regulation of neurogenesis [GO:0050768] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; negative regulation of neurogenesis [GO:0050768] identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] GO:0005615; GO:0005886; GO:0016021; GO:0038023; GO:0042802; GO:0050768 EPQDVTVTR 5.610000134 0.713170469 0.713170469 0.279236093 1044.464619 0 0 0 0 0 0 0 0 16.63606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.27389 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10915 Q2WGJ6 KLH38_HUMAN Kelch-like protein 38 KLHL38 C8orfK36 Homo sapiens (Human) HDLQARK 2.319999933 1 1 0.118534004 867.0311836 0 0 12.37228 14.90204 11.48233 14.30971 0 15.04687 15.82462 0 14.256 0 13.08867 15.52788 14.90292 0 0 0 0 15.24266 0 0 0 0 0 0 0 0 0 16.32931 15.44701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.05326 Q2WGJ9 FR1L6_HUMAN Fer-1-like protein 6 FER1L6 C8orfK23 Homo sapiens (Human) plasma membrane organization [GO:0007009]; response to bacterium [GO:0009617] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; plasma membrane organization [GO:0007009]; response to bacterium [GO:0009617] metal ion binding [GO:0046872] GO:0007009; GO:0009617; GO:0016021; GO:0046872 GLILANKAAK 20.95999908 0.485645801 0.485645801 0.276241043 1001.689088 17.50029 16.09807 0 15.8271 0 17.16815 14.35257 14.97788 16.05735 0 16.81294 0 20.74464 21.69994 21.53172 21.15547 18.15991 21.46077 18.48641 21.67611 19.54666 20.14189 21.48141 18.98586 21.0983 20.33719 16.50367 20.42988 20.65233 20.93066 21.27589 20.11492 20.39294 21.29329 0 20.57174 21.50533 0 19.41543 21.66788 21.67514 21.8503 22.30656 21.63424 22.19328 21.37303 21.90396 22.3266 Q2WGN9 GAB4_HUMAN "GRB2-associated-binding protein 4 (GRB2-associated binder 2-like, GAB2-like) (GRB2-associated binder 4) (GRB2-associated-binding protein 2-like) (Growth factor receptor bound protein 2-associated protein 4)" GAB4 Homo sapiens (Human) EIQKGYMFDIK 3.75999999 1 1 0.341677924 1368.345897 15.9113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.04741 0 0 0 0 0 0 0 0 15.545 0 15.32779 0 0 0 15.23524 13.44602 16.24025 15.36877 15.59254 17.98357 16.48395 17.56178 16.48985 0 16.41073 0 0 16.75469 0 0 0 Q32M45 ANO4_HUMAN Anoctamin-4 (Transmembrane protein 16D) ANO4 TMEM16D Homo sapiens (Human) calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] GO:0005229; GO:0005254; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0046983; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476 EASSSGITNGK 4 0.774528205 0.774528205 0.158534273 1046.652062 15.73923 15.73146 14.16482 0 15.43548 0 0 14.65882 0 14.94315 0 0 13.99454 0 15.30418 0 15.24762 15.64306 14.74668 0 0 0 14.90976 0 15.00477 13.86621 15.5528 13.46402 13.66861 0 15.33337 0 13.82856 0 14.41488 0 10.69265 0 17.28866 0 0 16.45007 14.88729 11.08231 15.13212 0 16.67978 0 Q32M78 ZN699_HUMAN Zinc finger protein 699 (Hangover homolog) ZNF699 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 IQYECK 8.81000042 0.105309017 0.105309017 0.245825243 840.5831598 17.1449 18.78148 16.98095 0 0 0 18.23489 0 19.85111 18.75364 17.57843 0 0 0 0 0 0 0 17.17063 0 0 0 0 17.07756 18.7792 0 0 0 16.93458 16.68273 18.89201 0 0 18.26497 0 0 0 0 0 18.81127 18.28724 0 0 0 0 0 0 0 Q32M84 BTBDG_HUMAN BTB/POZ domain-containing protein 16 BTBD16 C10orf87 Homo sapiens (Human) MIMSNTHK 10.02000046 1 1 0.390719701 960.9585351 14.67615 13.69873 13.61114 0 15.18175 14.91207 0 15.49761 15.50487 0 15.41488 16.46602 0 15.77282 16.03315 13.7717 15.76621 0 16.76442 15.16354 15.66111 0 0 0 16.24649 0 0 0 0 0 0 16.19687 0 0 16.37025 15.95521 16.70079 0 0 17.82149 0 16.083 0 0 0 0 16.40651 17.00485 Q32MZ4 LRRF1_HUMAN "Leucine-rich repeat flightless-interacting protein 1, LRR FLII-interacting protein 1 (GC-binding factor 2) (TAR RNA-interacting protein)" LRRFIP1 GCF2 TRIP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003725; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006357; GO:0042803; GO:0045296 GGNEKGK 12.27999973 1 1 0.2625736 689.8680516 17.20561 14.3407 17.94404 0 0 0 0 0 0 0 0 0 0 0 0 0 17.44623 0 0 0 0 0 0 0 0 0 18.79923 0 0 16.88103 0 17.57721 0 0 0 0 0 15.35762 0 0 0 17.28617 0 0 0 0 0 0 Q32P41 TRM5_HUMAN "tRNA (guanine(37)-N1)-methyltransferase, EC 2.1.1.228 (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog)" TRMT5 KIAA1393 TRM5 Homo sapiens (Human) mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175] GO:0002939; GO:0005634; GO:0005737; GO:0005759; GO:0008175; GO:0009019; GO:0030488; GO:0052906; GO:0070901 DANPAEDVR 10.63000011 1 1 0.286711882 986.3295965 18.23691 0 0 0 20.38431 0 17.02359 0 0 0 17.03246 0 17.48906 18.30701 0 0 0 17.83896 0 0 17.01929 16.25486 16.72905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.45463 0 17.35113 17.07308 17.21792 0 0 0 17.23061 Q32P51 RA1L2_HUMAN "Heterogeneous nuclear ribonucleoprotein A1-like 2, hnRNP A1-like 2 (hnRNP core protein A1-like 2)" HNRNPA1L2 HNRNPA1L Homo sapiens (Human) mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681] cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028 RGSGNFGGGR 8.43999958 1 1 0.242415948 964.5401115 17.16873 19.62201 17.75149 16.99489 20.35543 20.18715 0 20.75126 0 0 0 0 0 18.81639 0 20.4869 0 21.28007 0 0 0 21.09945 18.10986 19.95376 0 21.25922 0 16.06244 19.48408 21.31036 0 0 0 0 18.44604 21.0434 20.24323 18.07627 18.64651 0 17.8418 17.76777 0 0 19.81869 0 16.99952 0 Q330K2 NDUF6_HUMAN "NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)" NDUFAF6 C8orf38 Homo sapiens (Human) biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981 KVFLPMDICMLHGVSQEDFLR 5.400000095 1 1 9.37E-13 2551.138668 0 0 0 0 19.25561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.57729 0 0 0 0 17.55373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q38SD2 LRRK1_HUMAN "Leucine-rich repeat serine/threonine-protein kinase 1, EC 2.7.11.1" LRRK1 KIAA1790 Homo sapiens (Human) bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0004722; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0036035; GO:0042802; GO:0043231; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533 APNAVVLVVGTHLDLIEAK 3.599999905 1 1 0.110564625 1958.566644 16.46589 15.65264 0 16.10467 14.38452 0 0 0 15.3112 15.75193 0 14.43666 14.89791 0 0 14.10364 0 15.48082 0 0 15.19671 0 0 0 14.71613 15.89192 16.40424 0 0 14.66917 0 16.13377 0 0 0 0 15.72504 16.77619 0 16.11635 16.4763 0 16.28734 14.32405 0 0 15.21918 0 Q3B726 RPA43_HUMAN DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein) POLR1F TWISTNB Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription, initiation [GO:0006352]" nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] "nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription, initiation [GO:0006352]" DNA-directed 5'-3' RNA polymerase activity [GO:0003899] GO:0003899; GO:0005654; GO:0005736; GO:0006352; GO:1990830 RSEVSEEVTENGTEEAAK 2.269999981 1 1 4.60E-13 1963.807598 0 14.11486 14.02004 14.01958 13.72243 0 13.83038 0 0 0 0 14.54455 14.23034 0 9.432412 13.28748 14.87829 14.00004 0 14.03528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3B7J2 GFOD2_HUMAN "Glucose-fructose oxidoreductase domain-containing protein 2, EC 1.-.-.-" GFOD2 UNQ9430/PRO34691 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]; extracellular matrix organization [GO:0030198] nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491] GO:0000166; GO:0005576; GO:0016491; GO:0030198; GO:0031012 MKMLPGVGVFGTGSSAR 3.230000019 1 1 0.212658248 1726.441517 0 0 15.05136 0 14.31094 14.18799 0 0 0 0 0 0 14.67227 15.7425 0 0 0 0 0 0 0 0 15.85494 0 0 0 14.39257 0 0 0 0 17.32554 17.58673 0 0 0 0 0 0 0 0 0 15.30138 0 0 0 0 0 Q3B7T1 EDRF1_HUMAN Erythroid differentiation-related factor 1 EDRF1 C10orf137 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634] "nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005634; GO:0045893 GNYSSQSGMIPGSWQHKMK 1.74000001 1 1 0.037852266 2138.591281 13.01859 12.83922 0 10.91222 0 14.39631 0 13.30147 14.1297 14.5254 11.47123 14.06547 0 0 0 0 14.56966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9874 0 0 0 0 0 0 0 0 0 0 Q3B8N5 PROX2_HUMAN "Prospero homeobox protein 2 (Homeobox prospero-like protein PROX2, PROX-2)" PROX2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 ARVETIVR 5.639999866 1 1 0.075408145 941.2588205 14.74186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81658 12.84304 0 0 0 0 0 14.95726 11.73623 0 12.57696 14.01405 13.83744 0 0 12.32827 0 0 15.49668 0 0 0 0 13.38114 12.0337 0 0 Q3C1V9 YK041_HUMAN Putative uncharacterized protein ENSP00000334305 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin ligase complex [GO:0000151] ubiquitin ligase complex [GO:0000151]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0006511 EEMNVPSLR 7.889999866 1 1 0.105989163 1072.385403 15.47944 0 15.50564 15.70798 0 0 0 0 12.80108 0 0 0 15.33603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.18568 14.11548 0 0 0 15.01462 16.33111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KP31 ZN791_HUMAN Zinc finger protein 791 ZNF791 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 SFSARPAFR 5.829999924 0.078589521 0.078589521 0.218614733 1039.63037 20.97795 16.82834 13.6286 0 17.55882 15.99831 0 17.53258 0 0 16.38235 0 0 0 0 18.10223 0 15.7486 0 0 0 0 0 0 0 0 0 17.42431 0 0 16.0334 0 0 0 0 0 17.45281 0 17.03703 0 0 0 0 15.60098 0 16.14491 0 0 Q3KQU3 MA7D1_HUMAN MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1) MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; microtubule cytoskeleton organization [GO:0000226] GO:0000226; GO:0005737; GO:0005819; GO:0015630 LMTPTLSFLAR 1.360000014 0.365308911 0.365308911 0.49916243 1264.679452 17.76697 0 0 0 17.11723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.49249 0 0 0 0 17.42362 0 0 0 0 0 0 0 Q3KQV9 UAP1L_HUMAN "UDP-N-acetylhexosamine pyrophosphorylase-like protein 1, EC 2.7.7.-" UAP1L1 Homo sapiens (Human) UDP-N-acetylglucosamine biosynthetic process [GO:0006048] UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977] GO:0003977; GO:0006048 LGVTYPKGMYR 4.699999809 1 1 9.24E-13 1285.821737 0 0 15.72142 14.97367 12.20868 0 0 0 0 0 0 16.35515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KQZ1 S2535_HUMAN Solute carrier family 25 member 35 SLC25A35 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] GO:0005743; GO:0016021 MDFLMSGLAACGACVFTNPLEVVK 6.869999886 1 1 4.59E-13 2645.057204 11.92427 0 0 13.04748 0 0 0 0 13.58928 0 0 0 0 0 0 0 15.25237 0 0 0 0 0 15.12519 0 16.36265 0 0 0 0 0 0 15.70918 0 0 0 15.00098 0 0 0 0 0 0 0 0 0 0 0 0 Q3L8U1 CHD9_HUMAN "Chromodomain-helicase-DNA-binding protein 9, CHD-9, EC 3.6.4.12 (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator, CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein)" CHD9 KIAA0308 KISH2 PRIC320 AD-013 x0008 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0140658 NYSQSK 11.40999985 0.639806747 0.639806747 0.21207021 727.1105629 0 0 0 14.39548 0 14.90247 14.72249 18.71477 16.4719 16.0997 15.53718 11.40871 13.36845 0 0 15.25727 0 9.983633 0 0 0 0 0 0 17.59264 0 0 0 0 0 16.82071 15.14437 16.9667 0 16.95621 14.5498 0 0 0 0 0 0 0 0 15.07435 0 0 0 Q3LI58 KR211_HUMAN Keratin-associated protein 21-1 KRTAP21-1 KAP21.1 Homo sapiens (Human) hair follicle development [GO:0001942] cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882]; hair follicle development [GO:0001942] GO:0001942; GO:0005829; GO:0005882 RCYSSC 1.580000043 1 1 0 831.4574115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LIE5 ADPRM_HUMAN "Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase, EC 3.6.1.13, EC 3.6.1.16, EC 3.6.1.53 (ADPRibase-Mn) (CDP-choline phosphohydrolase)" ADPRM C17orf48 MDS006 Nbla03831 Homo sapiens (Human) cytosol [GO:0005829] "cytosol [GO:0005829]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]" "2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]" GO:0005829; GO:0008663; GO:0030145; GO:0047631; GO:0047734 SLELVMDMFK 4.71999979 0.219502255 0.219502255 3.42E-12 1243.652249 0 14.37723 14.42006 13.29768 0 0 15.28705 14.51654 0 15.21808 0 13.85073 15.75051 0 11.39879 13.14696 12.7353 12.56952 0 13.4307 14.97319 0 16.14919 0 0 10.90556 0 12.78031 15.94863 0 0 13.80281 0 14.10895 17.25891 16.43878 16.17024 17.29934 15.29036 13.60882 15.2492 15.43411 15.90576 7.979604 15.21734 0 15.15199 0 Q3MHD2 LSM12_HUMAN Protein LSM12 homolog LSM12 Homo sapiens (Human) EAALSS 7.519999981 1 1 0.144560171 579.8569185 14.07384 0 15.08547 0 14.8363 15.30712 0 13.96529 15.08888 13.51581 13.90647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.28565 0 0 0 0 0 14.97485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MII6 TBC25_HUMAN TBC1 domain family member 25 TBC1D25 OATL1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] GTPase activator activity [GO:0005096] GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:0090630; GO:1901096 RSSLTTAALPFTQSILTQVGR 12.57999992 1 1 0.396457246 2247.999593 0 20.13299 0 18.46679 0 0 20.30453 0 19.16336 18.07323 19.29082 0 0 0 0 20.77072 0 0 0 18.86195 19.52192 19.4252 0 20.32179 20.14009 0 0 0 19.6474 18.45226 0 0 0 0 0 19.29239 19.64609 18.77757 19.65376 20.44386 18.62484 16.99196 0 0 0 19.28904 20.83733 0 Q3MIN7 RGL3_HUMAN "Ral guanine nucleotide dissociation stimulator-like 3, RalGDS-like 3" RGL3 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0043547 LSAKLAR 15.48999977 1 1 0.280576875 758.4403636 0 0 0 0 0 0 0 0 0 0 0 0 0 17.03749 18.3596 0 0 0 17.79318 17.03183 0 0 0 0 19.42356 0 0 0 0 0 0 0 0 0 0 0 20.07654 0 18.23819 18.82582 0 0 0 17.53557 0 0 18.4177 0 Q3MIS6 ZN528_HUMAN Zinc finger protein 528 ZNF528 KIAA1827 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 IFTQKSSLTNHHR 2.410000086 1 1 0.187039871 1569.549087 15.21975 0 0 15.39396 10.56331 15.0116 0 16.24252 7.558211 14.87743 15.58153 15.83117 14.60596 13.60492 0 0 0 0 0 0 14.10657 0 0 0 0 0 9.917341 0 0 15.42447 0 17.65086 0 0 0 0 14.95295 0 0 0 0 0 0 14.5426 16.23039 0 14.18941 0 Q3MIW9 MUCL3_HUMAN Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1) MUCL3 C6orf37 DPCR1 PBLT Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005737; GO:0005886; GO:0016021 STEIHEQKR 3.940000057 0.585564017 0.585564017 0.185853584 1127.450389 0 0 12.56349 0 0 0 15.74027 16.26407 0 0 15.65315 0 0 0 15.02163 0 0 0 15.33755 0 0 14.43822 0 15.44468 0 15.59499 0 16.62797 12.29734 13.84871 16.42799 13.98363 15.46017 16.61301 12.28038 16.00825 16.70129 14.87615 16.08626 15.16314 13.48567 10.0428 14.9651 10.94656 13.25062 14.28164 13.49887 12.17833 Q3MIX3 ADCK5_HUMAN "Uncharacterized aarF domain-containing protein kinase 5, EC 2.7.11.-" ADCK5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein serine/threonine kinase activity [GO:0004674] protein serine/threonine kinase activity [GO:0004674] GO:0004674; GO:0016021 FEVALR 5.53000021 1 1 0.061796137 734.7449906 0 0 0 0 0 0 12.61802 0 15.56046 0 0 0 0 0 0 0 0 0 0 17.81808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MJ13 WDR72_HUMAN WD repeat-containing protein 72 WDR72 Homo sapiens (Human) enamel mineralization [GO:0070166]; extracellular matrix disassembly [GO:0022617]; protein localization to plasma membrane [GO:0072659] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; enamel mineralization [GO:0070166]; extracellular matrix disassembly [GO:0022617]; protein localization to plasma membrane [GO:0072659] GO:0005634; GO:0005737; GO:0005768; GO:0022617; GO:0070166; GO:0072659 ARLLEGGSLVK 5.340000153 1 1 0.41255398 1142.238436 0 15.76945 0 13.53953 14.42702 0 16.06897 0 14.07349 16.97816 14.43979 11.37578 14.77683 15.90188 0 13.84231 0 15.777 0 14.857 0 0 0 15.22728 15.07688 0 15.50912 0 0 0 0 0 15.85918 0 0 0 16.25173 0 0 0 15.99968 0 0 0 0 16.21726 0 0 Q3SXM0 DC4L1_HUMAN DDB1- and CUL4-associated factor 4-like protein 1 (WD repeat-containing protein 21B) DCAF4L1 WDR21B Homo sapiens (Human) LGGIRGAAPGLLMAVR 8.539999962 1 1 6.90E-13 1566.642544 0 0 14.87211 0 0 15.14936 0 0 14.98775 0 0 0 0 0 0 0 0 10.76529 0 0 0 14.34438 0 0 0 0 12.73882 0 13.61991 14.95781 14.97631 0 14.06204 0 15.22149 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SXY8 AR13B_HUMAN "ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1, ARL2-like protein 1)" ARL13B ARL2L1 Homo sapiens (Human) cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730] axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0001947; GO:0003924; GO:0005525; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515 EAMSEMLR 5.28000021 1 1 0.267225784 999.0283541 15.87446 0 15.73696 16.7397 17.34529 17.56332 0 0 0 17.7586 18.32747 0 15.85734 0 0 0 0 0 0 0 0 0 17.82945 0 18.54296 19.78375 17.25649 18.25666 0 17.90011 18.46299 16.52808 0 18.92276 0 17.11622 0 19.11206 0 0 15.72398 17.67357 0 0 16.70178 17.37401 0 0 Q3SXZ3 ZN718_HUMAN Zinc finger protein 718 ZNF718 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 THTGGKF 6.619999886 1 1 0.286789537 747.5453527 17.87526 17.97264 16.13096 0 16.898 18.94591 0 17.81637 17.9444 17.60048 16.12351 17.65083 0 17.35596 0 0 0 0 0 0 0 0 0 17.45392 0 0 0 0 0 0 0 18.65151 0 0 0 18.58748 0 0 0 0 17.34396 0 16.97529 19.25829 0 0 0 16.91212 Q3SY00 T10IP_HUMAN Testis-specific protein 10-interacting protein (Tsga10-interacting protein) TSGA10IP Homo sapiens (Human) cilium organization [GO:0044782] photoreceptor connecting cilium [GO:0032391] photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782] GO:0032391; GO:0044782 QGCLGSGDGVPNQDLQQR 5.78000021 0.347872049 0.347872049 0.312970573 1929.381787 15.97833 0 0 0 0 0 0 15.58355 0 0 0 0 14.37266 0 0 0 0 0 0 0 0 0 15.11366 0 0 0 0 0 0 16.09979 12.94977 15.95851 12.92241 15.19394 8.993846 14.71662 0 15.69572 0 0 14.29261 14.08871 0 0 0 15.96073 8.776133 15.24816 Q3SY52 ZIK1_HUMAN Zinc finger protein interacting with ribonucleoprotein K (Zinc finger protein 762) ZIK1 ZNF762 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 LLRSLVFPGGK 4.849999905 0.260606229 0.260606229 0.362574122 1186.603106 13.04937 13.33304 14.92732 15.93273 0 13.38984 0 15.39162 0 13.79 0 0 12.57816 15.28929 0 0 15.82611 14.05445 0 0 0 16.10482 0 0 0 0 0 15.82839 0 0 0 0 0 0 0 16.79734 15.80619 17.03905 17.02698 0 0 15.85051 0 0 16.21667 0 0 0 Q3SY69 AL1L2_HUMAN "Mitochondrial 10-formyltetrahydrofolate dehydrogenase, Mitochondrial 10-FTHFDH, mtFDH, EC 1.5.1.6 (Aldehyde dehydrogenase family 1 member L2)" ALDH1L2 Homo sapiens (Human) 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730]" "aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]" GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155; GO:0016742; GO:0046655; GO:0070062 KEPLGVCAIIIPWNYPLMMLAWK 6.230000019 0.278535426 0.278535426 0.164494377 2758.851434 7.583083 12.33205 14.03116 12.04897 0 0 0 13.68343 10.04701 12.18202 14.62161 15.43892 0 12.27534 13.66149 0 0 0 9.105042 0 0 0 0 15.12902 16.61635 0 16.74842 0 0 0 0 16.98722 0 0 0 0 17.5055 0 0 0 0 12.54568 0 0 13.54794 0 16.00218 0 Q3SY84 K2C71_HUMAN "Keratin, type II cytoskeletal 71 (Cytokeratin-71, CK-71) (Keratin-71, K71) (Type II inner root sheath-specific keratin-K6irs1, Keratin 6 irs, hK6irs, hK6irs1) (Type-II keratin Kb34)" KRT71 K6IRS1 KB34 KRT6IRS1 Homo sapiens (Human) hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] GO:0005829; GO:0031069; GO:0045095; GO:0045109; GO:0070062 AGSKGLSGGFGSR 6.090000153 1 1 0.302403116 1181.449428 0 0 14.91754 14.2392 0 0 15.06637 14.08578 14.82875 14.76234 14.61037 0 0 0 0 15.4772 0 0 0 0 0 0 0 0 15.3155 14.38236 15.9437 0 12.35623 0 0 0 0 0 0 0 0 0 0 0 16.03481 0 0 16.44892 0 0 0 0 Q3SYA9 P12L1_HUMAN Putative POM121-like protein 1 POM121L1P POM121L1 Homo sapiens (Human) KFPLLPR 5.820000172 1 1 0.006567016 872.5570842 0 12.90955 14.93733 0 16.17445 0 15.56505 17.78699 13.59593 14.27378 7.170825 0 0 14.72081 14.22366 0 0 0 14.83766 12.33335 0 0 15.27559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SYG4 PTHB1_HUMAN Protein PTHB1 (Bardet-Biedl syndrome 9 protein) (Parathyroid hormone-responsive B1 gene protein) BBS9 PTHB1 Homo sapiens (Human) cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; pericentriolar material [GO:0000242] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; pericentriolar material [GO:0000242]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0000242; GO:0005829; GO:0005929; GO:0007601; GO:0015031; GO:0016020; GO:0034451; GO:0034464; GO:0035869; GO:0045444; GO:0050896; GO:0060170; GO:0060271; GO:0061512 DPVLQVEVGK 4.139999866 0.000638054 0.000638054 0.50208872 1083.450185 0 0 0 0 0 0 18.58972 0 18.33862 0 18.17563 0 17.51847 0 0 17.64949 0 0 0 0 0 0 18.47736 0 0 18.9143 0 0 0 16.51774 18.43361 0 0 0 18.33348 0 0 0 17.91938 0 17.67204 0 0 0 0 0 0 0 Q3T906 GNPTA_HUMAN "N-acetylglucosamine-1-phosphotransferase subunits alpha/beta, EC 2.7.8.17 (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta ]" GNPTAB GNPTA KIAA1208 Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835 FEIMGEEEIAFK 6.860000134 1 1 0.174378728 1457.866952 0 14.85192 15.65383 13.78246 13.36962 14.58135 0 15.94472 0 15.02856 16.47536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3V5L5 MGT5B_HUMAN "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, EC 2.4.1.-, EC 2.4.1.155 (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B) (GlcNAc-T Vb, GNT-Vb, hGnTVb) (Mannoside acetylglucosaminyltransferase 5B) (N-acetylglucosaminyl-transferase Vb) (N-acetylglucosaminyltransferase IX, GNT-IX)" MGAT5B KIAA2008 Homo sapiens (Human) protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation via serine [GO:0018242] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation via serine [GO:0018242]" "alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]" GO:0000139; GO:0005794; GO:0006487; GO:0016021; GO:0018242; GO:0030144; GO:0030145 DQCEAPSDPKFPDCSGK 3.319999933 1 1 9.18E-13 1933.054451 14.18703 0 0 0 0 0 15.67946 15.1674 0 0 0 13.17881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.78346 0 0 0 0 0 0 0 0 0 0 15.03009 0 0 0 10.96597 11.8345 0 0 0 Q3YBR2 TBRG1_HUMAN Transforming growth factor beta regulator 1 (Nuclear interactor of ARF and Mdm2) TBRG1 NIAM Homo sapiens (Human) cell cycle [GO:0007049]; DNA replication [GO:0006260]; negative regulation of cell population proliferation [GO:0008285]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; DNA replication [GO:0006260]; negative regulation of cell population proliferation [GO:0008285]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005654; GO:0006260; GO:0007049; GO:0008285; GO:0050821; GO:0051726; GO:1990173 IYASMK 2.680000067 1 1 0.162524278 711.4849031 0 0 0 0 0 0 0 0 0 16.57274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6027 0 0 0 16.32095 0 0 17.60856 18.88531 16.18594 0 0 0 0 0 0 19.66002 0 0 0 0 0 0 0 Q3ZCN5 OTOGL_HUMAN Otogelin-like protein OTOGL C12orf64 Homo sapiens (Human) L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; alpha-L-arabinofuranosidase activity [GO:0046556]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] alpha-L-arabinofuranosidase activity [GO:0046556] GO:0005615; GO:0007605; GO:0031012; GO:0046373; GO:0046556 LSEDHK 7.130000114 0.768933356 0.768933356 0.231419771 728.6080629 0 17.98009 16.00084 14.62003 15.98696 12.43279 17.10454 16.31771 14.81055 16.37017 14.21792 16.83422 13.95912 15.14422 14.75369 16.21424 12.74096 0 0 16.27342 12.87705 0 15.39661 17.61633 16.28072 16.34062 0 0 14.848 16.23018 16.85102 0 16.10512 0 0 0 0 16.59318 0 15.63696 0 0 13.68493 15.79826 0 0 0 15.82277 Q3ZCQ8 TIM50_HUMAN Mitochondrial import inner membrane translocase subunit TIM50 TIMM50 TIM50 PRO1512 Homo sapiens (Human) intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836] interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] GO:0001836; GO:0003723; GO:0004721; GO:0004722; GO:0004725; GO:0005134; GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0006470; GO:0006886; GO:0007006; GO:0016021; GO:0016607; GO:0030150; GO:0043021 MAASAAVFSR 4.269999981 1 1 0.094211618 1008.021659 0 14.22808 12.54743 0 14.73318 14.36993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3ZCT8 KBTBC_HUMAN Kelch repeat and BTB domain-containing protein 12 (Kelch domain-containing protein 6) KBTBD12 KLHDC6 Homo sapiens (Human) LYVCGGFHGADR 4.659999847 0.4114317 0.4114317 1.60E-12 1352.499483 0 0 0 14.60316 0 0 0 0 0 0 14.98849 0 0 0 0 0 0 0 0 0 0 0 0 9.901195 14.99331 0 0 0 0 0 0 11.00747 0 0 0 12.04353 0 0 13.83923 0 0 0 0 0 15.0707 14.63082 0 0 Q3ZCU0 GVQW3_HUMAN Protein GVQW3 (GVQW motif-containing protein 3) GVQW3 Homo sapiens (Human) ENLNMR 21.29999924 1 1 0.160944787 795.0564972 17.21391 0 16.01467 0 16.36685 0 0 14.69401 0 15.31155 0 14.31234 15.12861 0 0 16.72562 0 15.30762 14.05477 13.05255 16.29377 0 15.74757 0 0 14.93359 0 0 0 0 0 0 17.51403 0 0 0 0 16.03628 0 0 0 0 0 0 0 0 0 0 Q3ZCV2 LEXM_HUMAN Lymphocyte expansion molecule LEXM LEM C1orf177 Homo sapiens (Human) GSGAK 7.519999981 0.740128815 0.740128815 0.08387783 419.335806 19.04789 18.41166 17.39922 15.46519 17.35724 0 15.9949 15.02035 17.22567 15.7582 16.67544 14.98287 15.72505 15.17038 16.06389 0 0 0 0 0 0 17.70457 0 16.97564 14.84912 0 0 17.11861 16.02618 14.67552 16.19111 15.77808 16.06291 15.99773 15.72232 15.87192 18.37133 17.54448 16.74808 17.75277 18.54263 17.33909 15.39252 15.77008 15.98912 17.75188 17.74787 17.4222 Q460N3 PAR15_HUMAN "Protein mono-ADP-ribosyltransferase PARP15, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 7, ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15, PARP-15)" PARP15 BAL3 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0070212; GO:0070403; GO:0140289; GO:1990404 EAGSVLPAGNR 18.69000053 1 1 0.240237083 1070.383355 15.30767 15.58599 0 15.88282 15.40508 0 15.60014 0 15.88054 0 15.22738 15.22379 0 0 15.09579 0 0 15.0518 0 0 16.03603 0 0 0 0 16.39642 0 14.99275 0 0 0 0 0 15.84727 0 0 11.74858 14.37387 14.55232 15.77991 15.13553 0 14.51535 16.12277 11.65257 16.15026 12.80476 13.90439 Q460N5 PAR14_HUMAN "Protein mono-ADP-ribosyltransferase PARP14, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 8, ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14, PARP-14)" PARP14 BAL2 KIAA1268 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404 EKPLIK 6.039999962 1 1 0.131328204 727.4498522 0 0 15.58591 0 0 11.97842 0 13.08811 0 0 0 13.3271 0 11.97107 0 13.42356 0 0 14.70814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.63255 0 Q494R0 FBAS1_HUMAN Putative uncharacterized protein FBXL19-AS1 (FBXL19 antisense RNA 1) (FBXL19 antisense gene protein 1) FBXL19-AS1 NCRNA00095 Homo sapiens (Human) DGRLPSLSR 3.980000019 1 1 0.097848023 1000.740239 0 14.49226 14.65759 13.39886 0 0 0 14.91229 0 0 0 0 11.94054 0 0 0 13.04247 0 0 0 0 0 0 0 0 0 0 0 0 15.47483 14.05485 0 14.95193 14.70868 0 15.57004 14.61265 11.83967 13.23502 14.80096 14.5404 15.77797 0 15.59007 15.41343 0 0 0 Q495W5 FUT11_HUMAN "Alpha-(1,3)-fucosyltransferase 11, EC 2.4.1.- (Fucosyltransferase XI, Fuc-TXI, FucT-XI) (Galactoside 3-L-fucosyltransferase 11, Fucosyltransferase 11)" FUT11 Homo sapiens (Human) fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0036071; GO:0046920 NDEEYMK 16.81999969 1 1 3.58E-13 929.0518705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495X7 TRI60_HUMAN Tripartite motif-containing protein 60 (RING finger protein 129) (RING finger protein 33) TRIM60 RNF129 RNF33 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 FSSGR 3.630000114 1 1 0.071450963 554.4702083 0 0 0 0 0 10.47351 0 0 0 0 0 0 0 0 0 0 0 13.45254 0 15.3812 14.42691 0 16.27742 0 0 0 14.44259 0 12.40332 13.38966 0 14.843 0 0 0 13.96445 0 0 0 0 0 0 0 15.81678 16.58174 0 0 0 Q496A3 SPAS1_HUMAN Spermatogenesis-associated serine-rich protein 1 SPATS1 Homo sapiens (Human) NGIPKLTPGDNPYMYPEQSK 10.65999985 1 1 0.185011533 2248.966919 0 17.3084 16.56826 15.28122 0 0 12.30889 17.00321 13.35833 0 18.13277 0 0 0 12.305 0 0 13.02839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q496F6 CLM2_HUMAN "CMRF35-like molecule 2, CLM-2 (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2, IREM-2) (Polymeric immunoglobulin receptor 2, PIgR-2, PIgR2, Poly-Ig receptor 2) (CD antigen CD300e)" CD300E CD300LE CLM2 CMRF35A5 IREM2 Homo sapiens (Human) immune system process [GO:0002376] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376] transmembrane signaling receptor activity [GO:0004888] GO:0002376; GO:0004888; GO:0005886; GO:0016021 NLSTGEVLTQNSGFR 7.869999886 0.004950723 0.004950723 0.167680106 1622.265821 0 13.87356 0 15.93678 0 0 14.70522 15.34216 13.67702 16.23624 0 0 14.66288 15.906 13.88521 0 0 0 15.27015 0 0 14.99777 15.72665 0 14.78229 0 17.23426 15.78386 0 13.58901 0 15.07759 0 0 0 0 14.90367 0 0 0 0 0 14.67163 0 0 0 0 0 Q496Y0 LONF3_HUMAN LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127) LONRF3 RNF127 Homo sapiens (Human) metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0046872; GO:0061630 AGQQPPPPLR 6.829999924 0.304046512 0.304046512 0.200554824 1061.80874 15.03674 15.99251 0 0 16.18866 15.27532 0 15.36687 0 0 0 14.72929 13.53895 15.11235 0 6.157752 0 14.21785 13.83821 12.50026 14.78732 13.3515 15.26152 15.93435 14.40122 15.24081 0 11.93415 14.42024 0 13.82035 13.58244 10.58542 13.94597 14.51274 13.38166 13.6023 12.03081 14.49589 0 12.27135 12.80661 14.52838 10.82718 14.80243 15.09126 15.783 13.10576 Q499Z4 ZN672_HUMAN Zinc finger protein 672 ZNF672 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0046872 IHVSRSPTRPR 9.130000114 1 1 0.273152835 1304.066936 14.65701 16.92789 0 0 0 0 0 16.11579 0 15.74624 16.11242 0 0 0 0 0 0 14.38169 14.05162 0 16.4515 0 0 0 0 0 0 16.99529 0 0 0 0 17.03315 0 15.47435 18.22275 0 0 0 0 17.54154 0 15.53506 15.98148 16.07477 0 18.23385 17.88475 Q49AA0 ZFP69_HUMAN Zinc finger protein 69 homolog (Zinc finger protein 642) ZFP69 ZNF642 Homo sapiens (Human) lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872 NTYKLDLINHPTSYIR 1.220000029 1 1 0.125254473 1947.416446 0 0 12.16862 0 0 0 14.33695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12465 0 0 11.25121 0 0 0 0 0 17.61639 14.07437 0 0 0 0 0 14.55172 0 0 0 0 0 0 0 0 Q49AH0 CDNF_HUMAN Cerebral dopamine neurotrophic factor (ARMET-like protein 1) (Conserved dopamine neurotrophic factor) CDNF ARMETL1 Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175] growth factor activity [GO:0008083] GO:0005615; GO:0005783; GO:0008083; GO:0031175; GO:0071542 ILSEVTRPMSVHMPAMK 6.980000019 1 1 0.394471735 1959.546986 0 0 0 0 0 0 18.61805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49MI3 CERKL_HUMAN Ceramide kinase-like protein CERKL Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665] lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625] GO:0001727; GO:0001750; GO:0001917; GO:0003951; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006665; GO:0016310; GO:0030148; GO:0043066; GO:0046625; GO:0048471 AQGSPK 3 1 1 0.318977042 587.8548044 0 16.99572 16.51845 0 15.96777 15.22603 16.10344 13.81926 16.18088 0 14.4924 0 0 0 0 15.95304 0 0 0 17.02178 0 0 0 16.68238 0 0 0 14.61922 16.00397 0 0 0 0 15.80677 0 17.08263 0 0 15.05926 0 0 0 16.53097 17.1902 16.31848 16.71527 14.15255 16.84081 Q4AC94 C2CD3_HUMAN C2 domain-containing protein 3 C2CD3 Homo sapiens (Human) brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589] GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515 GPPIDSSDIR 5.840000153 1 1 0.030935004 1057.45471 15.25251 0 14.28376 15.75763 11.76072 14.31997 0 10.63078 0 0 0 0 14.88124 0 0 0 0 0 0 0 0 0 0 0 0 13.07045 0 0 0 0 0 0 0 0 0 0 16.02261 0 0 0 0 0 0 11.23236 0 0 0 0 Q4ADV7 RIC1_HUMAN Guanine nucleotide exchange factor subunit RIC1 (Connexin-43-interacting protein of 150 kDa) (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1) RIC1 CIP150 KIAA1432 Homo sapiens (Human) "cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147]" guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0000139; GO:0003330; GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0043547; GO:1903363; GO:1904888 FSLQKTLSMPSGPSGK 3.029999971 1 1 0.112623017 1657.810967 13.45809 0 14.13773 14.56935 14.72977 15.34361 15.08678 12.56752 0 15.5279 0 15.02346 14.31895 0 0 13.97078 15.66862 11.63019 13.4187 16.26259 15.57306 0 13.52078 0 0 0 0 14.80718 0 14.95279 0 0 0 0 0 0 16.76748 0 0 15.53674 13.58473 15.87337 0 0 0 17.5049 15.37026 0 Q4FZB7 KMT5B_HUMAN "Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1, Su(var)4-20 homolog 1, Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B, EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B, EC 2.1.1.361)" KMT5B SUV420H1 CGI-85 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] "condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]" chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] GO:0000779; GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0007517; GO:0018024; GO:0034772; GO:0034773; GO:0042799; GO:0045830; GO:0046872; GO:1904047; GO:2001034 HDSSSK 7.110000134 1 1 0.285955447 658.9039539 16.12882 15.36903 15.74457 15.25099 15.9592 14.44479 14.7676 9.875813 14.9854 15.76103 15.02184 15.1791 15.37022 15.28811 14.95589 14.33329 14.56423 15.38137 16.95325 15.5288 0 15.13423 0 16.0969 17.25936 0 16.41341 16.22176 16.35795 14.23446 16.18583 16.25592 14.68569 17.32384 16.38441 15.48636 18.35592 0 17.13176 15.6868 16.50484 0 16.54344 15.73114 15.94569 16.02668 18.08735 16.27064 Q4G0A6 MINY4_HUMAN "Probable ubiquitin carboxyl-terminal hydrolase MINDY-4, EC 3.4.19.12 (Probable deubiquitinating enzyme MINDY-4)" MINDY4 C7orf67 FAM188B Homo sapiens (Human) Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843] Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:1990380 GIAARSDIGFLSLFEHYNMCQVGCFLK 1.960000038 1 1 0.597222796 3134.001264 0 0 0 0 0 0 0 0 0 0 0 0 16.50105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.52351 0 0 0 0 0 0 19.79537 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0J3 LARP7_HUMAN "La-related protein 7 (La ribonucleoprotein domain family member 7, hLARP7) (P-TEFb-interaction protein for 7SK stability, PIP7S)" LARP7 HDCMA18P Homo sapiens (Human) "box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]" 7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532] "7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]" 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] GO:0000122; GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0030532; GO:0032897; GO:0034244; GO:0048024; GO:0097322; GO:0120259; GO:1904871; GO:1905382; GO:1990438; GO:1990904 QVLADIAK 8.369999886 0.919344604 0.919344604 0.209832728 856.4726731 15.49419 15.15226 15.44823 15.01132 0 15.39376 0 16.32167 12.94062 14.74011 15.72286 12.43674 0 14.81564 15.79267 0 0 15.55206 0 15.77598 0 15.61192 0 16.18839 15.44931 16.27073 0 0 0 15.56852 16.05638 16.54106 0 0 0 17.24783 15.40689 16.6243 16.34916 15.02325 13.58504 15.84659 0 15.31129 15.38536 15.74617 15.43532 15.4421 Q4G0M1 ERFE_HUMAN Erythroferrone (Complement C1q tumor necrosis factor-related protein 15) (Myonectin) ERFE C1QTNF15 CTRP15 FAM132B Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of fatty acid transport [GO:2000193]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of fatty acid metabolic process [GO:0019217] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; cellular iron ion homeostasis [GO:0006879]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of fatty acid transport [GO:2000193]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of fatty acid metabolic process [GO:0019217] hormone activity [GO:0005179]; identical protein binding [GO:0042802] GO:0005179; GO:0005576; GO:0005615; GO:0006879; GO:0019217; GO:0042802; GO:0045721; GO:0046326; GO:0046628; GO:2000193 GPGESR 3.109999895 0.262454182 0.262454182 0.038753383 602.7225384 0 14.28796 15.24599 0 15.43916 15.40345 0 0 0 0 12.18956 16.96067 13.3576 17.60746 14.52623 14.15386 0 13.27887 13.6359 14.2893 13.9334 16.92682 12.0694 15.15824 14.24132 0 9.632298 8.608623 15.30166 0 12.78006 14.44324 0 0 14.7638 15.17528 17.49068 14.65121 16.49767 14.60094 17.11442 14.66267 16.6364 0 0 15.98673 13.09033 16.9889 Q4G0N4 NAKD2_HUMAN "NAD kinase 2, mitochondrial, EC 2.7.1.23 (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)" NADK2 C5orf33 MNADK NADKD1 Homo sapiens (Human) NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741] ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803] GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803 VVVVAK 5.150000095 0.549252987 0.549252987 0.139427023 615.5192003 0 14.88171 15.82277 0 0 0 0 0 0 0 0 0 15.38355 0 0 14.21046 13.85159 15.53164 0 16.06469 15.40713 14.39308 15.40466 15.50593 14.7172 0 16.16551 15.51813 16.15504 16.08257 0 15.87435 17.47988 16.33327 0 15.18141 13.94197 15.24201 16.54006 14.78138 16.07182 15.08521 16.49158 16.17218 16.50041 0 0 16.56916 Q4G0N8 SL9C1_HUMAN "Sodium/hydrogen exchanger 10 (Na(+)/H(+) exchanger 10, NHE-10) (Solute carrier family 9 member 10) (Solute carrier family 9 member C1) (Sperm-specific Na(+)/H(+) exchanger, sNHE)" SLC9C1 SLC9A10 Homo sapiens (Human) cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; spermatogenesis [GO:0007283] ion channel activity [GO:0005216]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] GO:0005216; GO:0005886; GO:0007283; GO:0015385; GO:0015386; GO:0016021; GO:0030154; GO:0030317; GO:0031514; GO:0051453; GO:0071805; GO:0098719 EIDEIFNTEAMELANR 6.650000095 1 1 0.533590346 1911.320305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.40416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.48132 Q4G0P3 HYDIN_HUMAN Hydrocephalus-inducing protein homolog HYDIN HYDIN1 KIAA1864 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718 EGTYAAK 11.21000004 1 1 0.115867402 738.9957815 14.77694 15.44373 0 0 15.29517 0 13.54652 13.79765 15.37243 0 14.82989 0 16.64779 0 16.49182 0 0 0 16.04556 0 0 14.85972 0 0 16.35093 15.23522 0 16.03254 0 14.02837 0 0 0 0 0 0 0 0 0 0 0 0 17.54074 0 0 0 0 0 Q4G0T1 SRCRM_HUMAN Scavenger receptor cysteine-rich domain-containing protein SCART1 (Scavenger receptor family member expressed on T cells 1) SCART1 Homo sapiens (Human) T cell mediated immunity [GO:0002456] brush border [GO:0005903]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] brush border [GO:0005903]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; T cell mediated immunity [GO:0002456] scavenger receptor activity [GO:0005044] GO:0002456; GO:0005044; GO:0005737; GO:0005903; GO:0009897; GO:0016021 FGRGSGPVWTEAFR 12.27000046 1 1 0.286103678 1566.689668 0 13.43385 14.89857 0 13.05915 16.25147 0 0 14.66945 0 15.05268 0 13.98677 16.01561 0 15.11851 0 14.78468 0 0 15.42445 0 14.95067 15.41576 0 0 0 0 0 0 0 0 16.00042 0 0 16.46246 0 15.94041 0 0 0 0 0 0 0 0 0 0 Q4G0W2 DUS28_HUMAN "Dual specificity phosphatase 28, EC 3.1.3.16, EC 3.1.3.48" DUSP28 Homo sapiens (Human) dephosphorylation [GO:0016311] phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311] phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0004722; GO:0004725; GO:0008138; GO:0016311; GO:0016791 AFQMVK 6.010000229 0.367746502 0.367746502 0.301936329 723.928709 0 12.86751 0 15.3483 13.7631 0 15.54366 14.99997 14.94971 16.03214 15.01795 17.46494 17.41594 16.25029 0 0 16.33204 13.36327 0 0 0 17.93303 0 16.47505 0 0 17.48994 0 0 0 0 15.81596 16.08874 0 0 15.58439 16.45122 16.08863 0 16.77575 16.25672 0 16.13915 16.22236 15.46754 14.37444 15.54166 15.20342 Q4G0X9 CCD40_HUMAN Coiled-coil domain-containing protein 40 CCDC40 KIAA1640 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356] GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0070286; GO:0071907; GO:0071910 AEPGGAAGRSHPEDGSASEGEK 8.710000038 0.405265391 0.405265391 0.06375795 2096.331427 13.00413 0 12.82485 0 0 15.8474 0 16.03425 14.3754 0 15.31048 15.50411 0 0 0 15.19683 12.1753 0 14.75202 0 16.02172 15.17545 14.23743 10.29927 12.50831 8.606413 0 14.4203 15.51725 15.0469 15.87571 0 15.7459 15.30141 14.49069 14.83883 0 14.03851 0 0 0 11.08547 0 0 0 0 0 15.55242 Q4G112 HSF5_HUMAN "Heat shock factor protein 5, HSF 5 (Heat shock transcription factor 5, HSTF 5)" HSF5 HSTF5 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:1990837 TTSFTSFIR 5.800000191 1 1 0.596974679 1059.882043 0 0 0 0 18.12115 0 0 0 0 0 0 0 19.17793 0 0 0 18.72334 17.14723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.85629 20.51385 0 0 0 0 0 0 0 0 0 0 0 0 Q4G163 FBX43_HUMAN F-box only protein 43 (Endogenous meiotic inhibitor 2) FBXO43 EMI2 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; negative regulation of meiotic nuclear division [GO:0045835]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; meiotic cell cycle [GO:0051321]; negative regulation of meiotic nuclear division [GO:0045835]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088] metal ion binding [GO:0046872] GO:0005634; GO:0007088; GO:0016567; GO:0045835; GO:0046872; GO:0051321 HKGTPK 1.100000024 1 1 0.211741382 670.9341624 15.73519 13.32337 0 0 0 0 0 0 0 0 0 0 0 0 16.74393 14.03271 0 15.18455 0 0 16.6504 0 0 0 0 0 0 0 0 0 0 0 0 0 15.64437 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4JDL3 PTN20_HUMAN "Tyrosine-protein phosphatase non-receptor type 20, hPTPN20, EC 3.1.3.48" PTPN20 PTPN20A PTPN20B Homo sapiens (Human) centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725] protein tyrosine phosphatase activity [GO:0004725] GO:0004725; GO:0005654; GO:0005737; GO:0005874; GO:0034451 SKVFENK 6.940000057 1 1 0.29862597 850.6713999 15.05975 15.50989 12.91108 12.12103 14.41578 0 0 15.48591 0 0 0 14.65964 0 13.47618 0 0 0 11.41707 0 0 0 0 0 0 0 0 14.70875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4KMG0 CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes CDON CDO Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; embryonic morphogenesis [GO:0048598]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; embryonic morphogenesis [GO:0048598]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224] GO:0005886; GO:0005887; GO:0007155; GO:0007224; GO:0007399; GO:0045663; GO:0045664; GO:0048598; GO:0098609 YVTYMVNVLEHASISK 3.380000114 1 1 1.60E-12 1870.451106 13.13941 13.70549 13.95827 0 0 0 0 0 14.44812 0 0 0 0 11.99439 0 0 15.40983 16.12276 0 15.45735 0 14.83209 0 0 0 14.51144 0 0 14.60588 14.36129 14.21334 0 12.57787 14.55794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4KMG9 TM52B_HUMAN Transmembrane protein 52B TMEM52B C12orf59 UNQ5927/PRO19821 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] GO:0016021; GO:0070062 QLPPTEKESTR 5.579999924 1 1 2.41E-13 1285.245628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4KMQ1 TPRN_HUMAN Taperin TPRN C9orf75 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] stereocilium [GO:0032420]; stereocilium base [GO:0120044] stereocilium [GO:0032420]; stereocilium base [GO:0120044]; phosphatase binding [GO:0019902]; auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] phosphatase binding [GO:0019902] GO:0007605; GO:0019902; GO:0032420; GO:0060088; GO:0120044; GO:0120045 AAVPAWK 8.619999886 1 1 0.288039062 741.8950377 0 0 0 0 0 0 0 0 0 18.47228 0 0 0 0 17.99277 17.1454 0 0 17.07886 17.91051 0 17.12551 19.74755 0 0 17.77534 0 0 17.31387 0 18.71943 0 0 18.33507 18.85662 18.24809 17.71143 0 0 19.10921 18.17065 0 18.79385 18.42849 17.34346 0 17.91455 0 Q4KMQ2 ANO6_HUMAN "Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel, SCAN channel) (Transmembrane protein 16F)" ANO6 TMEM16F Homo sapiens (Human) "activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]" cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] "cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]" calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244] GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005254; GO:0005829; GO:0005886; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035725; GO:0043065; GO:0045794; GO:0046872; GO:0046931; GO:0046983; GO:0055085; GO:0060100; GO:0061589; GO:0061590; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353 EVCHPDIGGK 10.05000019 0.853705585 0.853705585 0.174234049 1111.868115 15.09885 14.69134 16.07165 15.54909 12.2683 0 13.60621 11.90293 12.63101 0 13.31668 12.27838 0 0 14.25898 0 0 0 0 0 13.82879 14.20196 0 0 0 0 0 12.15515 0 0 0 0 0 15.19924 0 0 0 16.17663 0 0 0 0 0 0 12.81149 0 15.45572 15.46311 Q4KMZ1 IQCC_HUMAN IQ domain-containing protein C IQCC Homo sapiens (Human) MEPELLVRK 4.210000038 0.31564033 0.31564033 2.28E-12 1115.235413 18.16112 14.7542 0 0 0 13.76068 0 0 13.65881 0 0 0 0 0 0 15.56405 0 0 11.36776 11.666 0 0 14.75482 0 14.63758 0 15.63336 0 0 0 0 0 0 0 16.95479 0 15.34549 13.46222 0 13.71096 16.15211 0 16.6921 0 16.13206 15.85651 9.774176 15.18851 Q4KWH8 PLCH1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-eta-1) (Phospholipase C-eta-1, PLC-eta-1) (Phospholipase C-like protein 3, PLC-L3)" PLCH1 KIAA1069 PLCL3 Homo sapiens (Human) lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; phosphatidylinositol phospholipase C activity [GO:0004435] GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0043231; GO:0048015; GO:0050429 DTSQGDTIVSTAHMSVTGEQLGMSSPRGGR 2.49000001 1 1 0 3095.283818 7.631774 13.00137 13.21103 0 0 0 15.45562 0 0 0 0 0 0 0 0 11.69245 14.96865 0 0 0 0 11.58305 0 12.77905 11.29089 15.93051 10.65914 12.49556 12.88542 0 13.86767 13.11996 0 0 13.79969 0 14.29192 12.38735 0 0 9.782114 0 0 0 0 14.01744 0 0 Q4L180 FIL1L_HUMAN "Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1, DOC-1)" FILIP1L COL4A3BPIP DOC1 GIP90 Homo sapiens (Human) cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] GO:0005634; GO:0005737; GO:0016020 HTKGHSFQGPK 7.769999981 0.635849774 0.635849774 0.195372073 1223.326244 15.26774 10.21004 0 0 0 0 0 0 15.09213 0 16.69365 0 0 14.01875 15.35212 0 17.09672 11.22013 0 0 17.03223 14.34622 0 13.30051 15.84721 15.82485 14.89451 0 0 13.28129 0 0 0 14.5233 15.84932 15.17646 15.26746 14.30488 0 15.88765 11.04093 10.93818 14.10785 15.68659 15.90666 16.13984 8.392829 14.6208 Q4L235 ACSF4_HUMAN "Beta-alanine-activating enzyme, EC 6.2.1.- (Acyl-CoA synthetase family member 4) (Protein NRPS998)" AASDH ACSF4 U26 HSPC318 Homo sapiens (Human) amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524] GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041 DPSCVAK 4.650000095 0.500534177 0.500534177 0.222194382 776.0459255 0 15.39315 0 0 15.0281 15.9409 0 13.93797 0 15.0339 0 0 0 0 0 15.40256 16.0567 15.40568 16.62613 17.74339 16.20487 0 16.41656 15.79961 0 16.36415 16.29542 14.87127 9.528615 16.07438 0 0 15.22233 14.18437 17.3138 15.7394 0 0 0 16.13038 0 0 15.13362 0 0 0 0 16.74292 Q4LDE5 SVEP1_HUMAN "Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein, SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)" SVEP1 C9orf13 CCP22 SELOB Homo sapiens (Human) cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682] GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193 KSNPK 4.579999924 0.949057698 0.949057698 0.19551809 575.0972078 14.24029 15.40452 0 14.81989 14.9194 15.75952 16.69224 15.65263 0 15.67783 16.40998 0 14.5461 15.64356 15.74663 16.01673 15.39818 16.0995 0 0 0 17.6342 17.47711 15.68224 0 0 16.95851 16.37613 0 0 0 0 0 17.14634 0 0 0 0 0 0 0 15.7985 0 0 0 0 0 0 Q4LE39 ARI4B_HUMAN "AT-rich interactive domain-containing protein 4B, ARID domain-containing protein 4B (180 kDa Sin3-associated polypeptide, Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)" ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180 Homo sapiens (Human) establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription cis-regulatory region binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] transcription cis-regulatory region binding [GO:0000976] GO:0000122; GO:0000976; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006349; GO:0006357; GO:0007283; GO:0016580; GO:0030336; GO:0030512; GO:0034773; GO:0036124; GO:0045944; GO:0097368; GO:1902455; GO:1902459 NDLISK 5.829999924 1 1 0.249061981 689.0979339 0 0 0 16.50157 0 0 0 15.63316 0 0 0 15.38926 0 0 0 0 0 0 0 0 0 0 17.17324 0 0 0 16.92776 14.77374 0 0 16.64962 16.45045 15.94792 16.14637 0 16.41637 17.49483 17.07234 0 17.41428 16.67122 0 16.61765 14.36011 15.10782 15.33722 16.25964 16.64478 Q4LEZ3 AARD_HUMAN Alanine and arginine-rich domain-containing protein AARD C8orf85 Homo sapiens (Human) GPGDFR 5.400000095 1 1 0.184633789 649.5392062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.57407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4U2R8 S22A6_HUMAN "Solute carrier family 22 member 6 (Organic anion transporter 1, hOAT1) (PAH transporter, hPAHT) (Renal organic anion transporter 1, hROAT1)" SLC22A6 OAT1 PAHT Homo sapiens (Human) alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to organic cyclic compound [GO:0014070]; sodium-independent organic anion transport [GO:0043252] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to organic cyclic compound [GO:0014070]; sodium-independent organic anion transport [GO:0043252] anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0014070; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0032991; GO:0042802; GO:0043252; GO:0070062; GO:0097254 ELTMGK 11.47000027 0.008612338 0.008612338 0.229887315 676.2400681 0 0 0 0 0 0 0 0 0 0 16.15976 0 18.29813 17.73716 16.3221 16.07869 0 0 0 0 16.53234 0 0 16.52292 0 0 15.20415 16.37424 13.51308 0 0 19.04248 19.55064 0 0 0 0 0 0 0 0 13.95406 15.46169 16.14372 14.74132 0 0 16.33314 Q4V328 GRAP1_HUMAN "GRIP1-associated protein 1, GRASP-1 [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form) ]" GRIPAP1 KIAA1167 Homo sapiens (Human) "neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]" axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038] "axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]" identical protein binding [GO:0042802] GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0072562; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244 DLVKPGDENLR 15.26000023 0.373620182 0.373620182 0.126776946 1255.225217 0 0 14.08105 14.16706 14.66309 0 14.7011 13.09858 15.88188 14.07344 14.99387 0 13.879 0 0 13.94705 0 0 0 14.54565 15.58616 0 15.46865 0 0 13.85387 13.07199 14.73842 0 0 0 0 0 0 0 0 0 0 0 0 13.87666 0 0 0 0 13.16537 9.783981 14.56482 Q4VC44 FWCH1_HUMAN FLYWCH-type zinc finger-containing protein 1 FLYWCH1 KIAA1552 Homo sapiens (Human) cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005654; GO:0005829; GO:0016604; GO:0046872 RVMVMR 14.27999973 1 1 0.232054196 808.587519 0 0 0 18.95191 0 0 20.64497 0 20.34454 0 19.70568 0 0 19.54976 0 21.88819 20.55899 20.75596 0 18.77923 20.41905 0 0 20.01118 0 18.45103 0 0 0 19.47208 18.41136 20.47887 19.71589 19.02255 20.78525 18.88666 21.73646 0 19.80522 21.02046 0 19.36948 0 0 21.44621 20.47278 19.26918 0 Q4VCS5 AMOT_HUMAN Angiomotin AMOT KIAA1071 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570] actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725] actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570] angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023] GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0007043; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0045793; GO:0051056; GO:0051496 DQALSNAQAK 15.64999962 1 1 0.412153987 1045.366907 0 0 0 15.66754 14.66872 15.72712 0 15.86702 14.80609 16.57583 16.4155 15.39978 0 0 14.93478 0 0 15.67964 0 13.28287 16.94613 0 16.20439 0 0 0 0 15.76985 0 16.17893 0 0 15.59922 0 15.72192 0 0 0 0 0 16.13763 16.05363 0 16.17468 16.03315 0 16.41455 0 Q4VNC1 AT134_HUMAN "Probable cation-transporting ATPase 13A4, EC 7.2.2.- (P5-ATPase isoform 4)" ATP13A4 UNQ3052/PRO9871 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872] GO:0005524; GO:0005886; GO:0006874; GO:0016021; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0034220; GO:0046872; GO:0055038 EVLNPFYIFQLFSVCLWFSEDYK 4.150000095 1 1 0.829133813 2943.936417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.31958 0 0 0 0 0 0 0 0 0 Q4VXF1 F74A3_HUMAN Putative protein FAM74A3 FAM74A3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ESSEAVPEK 8.069999695 1 1 0.33809863 972.6928854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.20001 0 0 0 0 0 0 0 0 0 0 18.03031 0 0 0 0 0 0 0 0 Q4VXU2 PAP1L_HUMAN Polyadenylate-binding protein 1-like PABPC1L C20orf119 Homo sapiens (Human) cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:0070062; GO:1990904 AVVHMNGKEVSGR 5.789999962 0.464063495 0.464063495 1.14E-12 1383.082116 0 0 16.40552 0 16.82906 15.43636 17.37855 17.85486 15.22945 16.95729 0 0 16.29366 14.01408 15.9025 14.88448 15.04201 0 0 0 0 0 17.66449 17.23056 16.58099 0 0 17.43942 16.03212 0 18.53484 0 16.24322 15.93016 0 18.08547 16.49449 0 14.35675 0 12.41509 16.9043 16.70157 0 16.40159 0 14.09873 14.46969 Q4ZG55 GREB1_HUMAN Protein GREB1 (Gene regulated in breast cancer 1 protein) GREB1 KIAA0575 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021; GO:0070062 LDTEAQTK 6.050000191 1 1 0.279189089 904.7660977 18.02736 0 17.18328 17.74827 0 16.88391 0 0 0 0 0 0 16.30728 0 17.7847 16.49229 0 0 0 15.8265 17.18775 0 18.62151 0 0 17.17622 17.29915 0 18.05584 0 0 18.80805 0 0 17.84517 0 17.56841 0 18.57868 17.30238 16.82758 16.85069 0 0 16.91207 16.47626 0 17.62833 Q4ZHG4 FNDC1_HUMAN Fibronectin type III domain-containing protein 1 (Activation-associated cDNA protein) (Expressed in synovial lining protein) FNDC1 FNDC2 KIAA1866 MEL4B3 Homo sapiens (Human) extracellular region [GO:0005576]; nuclear speck [GO:0016607] extracellular region [GO:0005576]; nuclear speck [GO:0016607] GO:0005576; GO:0016607 EDGGRQAEATAQTLR 7.670000076 0.350863636 0.350863636 0.051886787 1603.48884 15.80164 0 14.5592 0 15.89152 14.55904 13.78844 14.05852 14.44758 0 11.8382 13.77321 0 14.49699 14.6559 13.00861 0 0 14.65406 0 0 15.93212 14.84184 0 14.14253 0 14.65906 0 0 0 0 0 0 0 0 0 14.89823 0 0 0 12.08872 15.37262 0 0 0 0 13.86856 0 Q4ZIN3 MBRL_HUMAN Membralin (Transmembrane protein 259) TMEM259 C19orf6 Homo sapiens (Human) negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976] GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294 VEVRHNSSR 5.940000057 1 1 9.26E-13 1083.251247 14.54157 0 0 0 14.67008 0 0 0 14.0266 0 0 14.62465 11.25846 0 14.02518 12.05218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q502W6 VWA3B_HUMAN "von Willebrand factor A domain-containing protein 3B, VWA domain-containing protein 3B" VWA3B Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 QRMDWLTSK 7.440000057 0.36180976 0.36180976 0.014089483 1164.780671 0 13.01354 13.53959 14.71059 15.79016 14.72709 0 0 15.17601 14.60938 0 15.05775 0 0 14.36849 15.853 15.39013 13.77389 0 0 14.76541 0 13.62215 16.15875 0 12.85543 15.05804 12.33718 15.16824 14.89342 14.69129 10.75325 14.48418 0 10.58947 14.7648 16.23128 13.07323 0 0 17.32874 14.81153 15.03004 14.52966 15.3553 14.42365 15.28637 10.04952 Q504Q3 PAN2_HUMAN "PAN2-PAN3 deadenylation complex catalytic subunit PAN2, EC 3.1.13.4 (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2, PAN deadenylation complex subunit 2)" PAN2 KIAA0710 USP52 Homo sapiens (Human) mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535] GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0005829; GO:0006397; GO:0010606; GO:0031251; GO:0046872 SDGTKSTIKPSQMSVAR 1.950000048 1 1 1.16E-12 1809.999531 15.60519 14.72796 0 0 0 15.33712 0 0 15.38164 0 0 0 0 14.55014 0 0 0 13.79879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17788 0 0 0 0 0 0 0 0 0 0 0 0 16.73956 Q504Y2 PKDCC_HUMAN "Extracellular tyrosine-protein kinase PKDCC, EC 2.7.10.2 (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)" PKDCC SGK493 VLK Homo sapiens (Human) bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001501; GO:0004672; GO:0004712; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 YSRGGPGPGAGRPER 5.889999866 1 1 0.258544337 1514.169606 13.82361 0 15.64774 0 0 0 0 14.85145 0 0 0 14.53762 0 0 16.65201 0 15.00279 15.80807 17.20155 18.17146 16.84458 16.84588 0 16.25851 0 0 15.18331 0 17.31956 16.34083 0 0 0 0 16.70902 16.7283 16.32434 0 0 16.3503 17.82169 16.49248 14.92093 15.21144 0 0 16.89114 16.3567 Q52LC2 VAS1L_HUMAN V-type proton ATPase subunit S1-like protein (Vacuolar proton pump subunit S1-like protein) ATP6AP1L Homo sapiens (Human) regulation of cellular pH [GO:0030641] integral component of membrane [GO:0016021]; proton-transporting V-type ATPase complex [GO:0033176] integral component of membrane [GO:0016021]; proton-transporting V-type ATPase complex [GO:0033176]; regulation of cellular pH [GO:0030641] GO:0016021; GO:0030641; GO:0033176 DTAEEKELLR 5.179999828 1 1 0.074780244 1204.608541 8.524769 15.22043 0 12.91009 16.25641 0 12.93333 0 11.18617 12.44265 14.67613 12.78045 11.49681 0 0 0 12.61454 10.58794 0 0 0 14.15528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q52LW3 RHG29_HUMAN Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29) ARHGAP29 PARG1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165] GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0030165; GO:0032991; GO:0046872; GO:0051056; GO:0090630 AALTHK 2.230000019 0.306777984 0.306777984 0.054966577 638.7916312 12.25791 15.60235 16.68237 0 0 7.035766 17.12166 17.04599 14.09766 16.45622 16.21684 16.71295 12.11687 18.15324 16.4001 12.86325 11.73402 11.34139 15.67946 13.74709 14.46408 15.19468 16.61587 17.70522 16.52143 10.72294 0 18.17546 14.9932 16.02987 0 17.49023 17.384 0 17.5806 0 14.29444 16.4229 15.74766 0 14.37743 16.00971 0 14.93697 15.35731 9.82727 0 10.76698 Q52M93 Z585B_HUMAN Zinc finger protein 585B (zinc finger protein 41-like protein) ZNF585B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 CGICGKGFVQK 1.970000029 1 1 0 1251.329952 0 0 0 0 0 0 0 0 15.8004 0 0 0 0 0 0 10.9718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.05291 0 0 0 11.62352 0 11.82094 11.37715 Q537H7 SPT45_HUMAN Spermatogenesis-associated protein 45 SPATA45 C1orf227 HSD-44 HSD44 Homo sapiens (Human) ASINRTIEIMK 19.20999908 1 1 0.245405837 1291.686434 0 0 13.83427 18.99651 18.56701 0 0 0 0 0 16.77624 0 17.76111 0 0 17.96523 0 17.84145 0 0 0 18.72878 18.67652 17.9608 17.45143 17.90771 19.27098 19.46814 18.57366 17.40102 18.99684 14.81614 17.42563 17.33003 0 0 0 16.06606 18.60445 18.6085 0 18.98632 19.34844 0 0 18.37558 0 18.97267 Q53EL6 PDCD4_HUMAN Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a) PDCD4 H731 Homo sapiens (Human) "apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]" RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007569; GO:0030509; GO:0043066; GO:0043508; GO:0045786; GO:0045892; GO:0050729; GO:0060940; GO:0071222; GO:1900016; GO:1901224; GO:1904706; GO:1904761; GO:1905064; GO:1905461; GO:2000353 ATVLLSMSK 2.890000105 1 1 0.092219867 949.2787329 0 0 0 0 0 0 0 12.2217 0 15.06404 0 0 0 0 0 0 0 14.55195 12.74178 0 16.01656 0 16.88025 16.30862 0 15.53925 15.27493 0 15.14947 12.78095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53EL9 SEZ6_HUMAN "Seizure protein 6 homolog, SEZ-6, hSEZ-6" SEZ6 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer development [GO:0021680]; excitatory postsynaptic potential [GO:0060079]; regulation of dendrite development [GO:0050773]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] apical dendrite [GO:0097440]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical dendrite [GO:0097440]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer development [GO:0021680]; excitatory postsynaptic potential [GO:0060079]; regulation of dendrite development [GO:0050773]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] GO:0005783; GO:0005886; GO:0008344; GO:0016021; GO:0021680; GO:0043025; GO:0043197; GO:0043198; GO:0048471; GO:0050773; GO:0060074; GO:0060079; GO:0090036; GO:0097440 NATTGR 1.75 1 1 0.09174922 619.9556811 11.8906 16.15388 0 12.35622 0 12.58227 13.60609 0 10.34391 16.17205 0 11.19998 0 15.94333 0 16.39394 0 0 0 17.40357 14.70171 0 16.82738 18.30707 14.21544 17.41172 0 14.0982 0 0 0 16.5164 16.34422 16.17257 17.2465 15.7343 0 13.02779 15.20693 16.44014 16.16366 18.10696 15.25858 7.899835 15.21746 0 16.42743 0 Q53EP0 FND3B_HUMAN Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37) FNDC3B FAD104 NS5ABP37 UNQ2421/PRO4979/PRO34274 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0016021 FRLTASNTEGK 4.570000172 0.325886577 0.325886577 0.147619273 1224.520207 14.59779 0 17.51005 16.59199 0 16.64071 0 0 17.39126 0 16.79231 16.14053 0 13.62271 0 0 0 9.391575 0 17.04992 0 16.52808 16.71378 17.39119 0 0 0 11.72853 16.45499 13.53896 16.55914 16.7045 0 14.66681 14.28605 15.66443 14.57398 17.78369 17.18421 0 17.30328 12.17209 0 0 0 0 5.833508 0 Q53ET0 CRTC2_HUMAN "CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2, TORC-2, Transducer of CREB protein 2)" CRTC2 TORC2 Homo sapiens (Human) gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; histone H3-K9 acetylation [GO:0043970]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; histone H3-K9 acetylation [GO:0043970]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; toxin transport [GO:1901998] cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006094; GO:0008140; GO:0032793; GO:0042593; GO:0043970; GO:0045944; GO:0051289; GO:0070062; GO:1901998 ATSGANGPGSATASASNPR 5.079999924 1 1 0.517740186 1671.49103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53EU6 GPAT3_HUMAN "Glycerol-3-phosphate acyltransferase 3, GPAT-3, EC 2.3.1.15 (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10, AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9, 1-AGP acyltransferase 9, 1-AGPAT 9, EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3, hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta, LPAAT-theta) (MAG-1)" GPAT3 AGPAT9 MAG1 HMFN0839 UNQ2753/PRO6492 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420] GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006072; GO:0006654; GO:0016021; GO:0016024; GO:0019432; GO:0032006; GO:0102420 EGAELAGK 9.090000153 1 1 0.151973071 775.2944859 0 15.10998 15.75467 14.29952 14.6423 15.2324 0 0 0 0 0 0 0 0 15.77633 15.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17072 0 16.04992 0 13.57084 15.12852 0 0 0 16.64171 15.71747 0 15.17314 0 18.98562 18.73328 16.84407 0 Q53EZ4 CEP55_HUMAN "Centrosomal protein of 55 kDa, Cep55 (Up-regulated in colon cancer 6)" CEP55 C10orf3 URCC6 Homo sapiens (Human) cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496]; identical protein binding [GO:0042802]; cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] identical protein binding [GO:0042802] GO:0000281; GO:0005737; GO:0005813; GO:0005814; GO:0014066; GO:0016020; GO:0030496; GO:0032154; GO:0042802; GO:0045171; GO:0045184; GO:0061952; GO:0090543; GO:1904888 SSRSTK 2.730000019 1 1 0.160181374 666.5521868 16.41329 14.71603 16.79593 13.96836 14.76068 14.14919 15.40066 0 14.60727 0 14.89884 0 0 0 15.66157 16.8977 0 0 0 0 16.64989 0 0 0 0 0 0 15.56396 14.17172 0 16.85644 0 16.1709 0 0 0 0 0 0 0 18.4861 0 0 0 0 15.79199 15.47572 0 Q53F19 NCBP3_HUMAN Nuclear cap-binding protein subunit 3 (Protein ELG) NCBP3 C17orf85 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; RNA interference [GO:0016246]; snRNA export from nucleus [GO:0006408] cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518] cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; RNA interference [GO:0016246]; snRNA export from nucleus [GO:0006408] mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339] GO:0000339; GO:0000340; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005845; GO:0005846; GO:0006370; GO:0006406; GO:0006408; GO:0016246; GO:0016607; GO:0034518; GO:0042789; GO:0051607 AWGALIK 16.40999985 1 1 0.232301873 757.7787229 14.17637 0 0 0 0 0 0 0 15.36799 0 0 0 15.12596 0 0 16.05735 0 0 0 14.72273 0 0 0 0 17.46101 0 0 0 0 0 16.41952 0 0 0 17.77574 0 0 0 0 0 0 15.73766 0 0 0 14.82956 0 0 Q53F39 MPPE1_HUMAN "Metallophosphoesterase 1, EC 3.1.-.- (Post-GPI attachment to proteins factor 5)" MPPE1 PGAP5 PP579 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506] cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506] GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145] GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971 QNFHPLK 2.079999924 1 1 0.24422907 884.2820161 0 0 0 0 0 0 0 0 0 19.58678 0 0 18.43098 0 0 18.42813 0 18.33668 0 0 0 0 17.60918 0 0 0 0 0 0 0 0 19.02617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53FP2 NACHO_HUMAN Novel acetylcholine receptor chaperone TMEM35A NACHO TMEM35 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of protein localization to cell surface [GO:2000010] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; acetylcholine receptor regulator activity [GO:0030548]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of protein localization to cell surface [GO:2000010] acetylcholine receptor regulator activity [GO:0030548] GO:0005778; GO:0005783; GO:0005789; GO:0016021; GO:0030548; GO:0031410; GO:0051131; GO:2000010 LLIARKPEDR 6.739999771 1 1 0.538560928 1209.306726 16.95356 0 15.03162 0 0 15.2408 17.08094 0 0 0 0 0 17.64885 15.74844 0 0 0 0 0 0 0 16.97571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.28992 0 0 0 0 0 0 0 0 Q53FZ2 ACSM3_HUMAN "Acyl-coenzyme A synthetase ACSM3, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase, EC 6.2.1.17) (Protein SA homolog)" ACSM3 SAH Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; methylbutanoate-CoA ligase activity [GO:0043759]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217] ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; methylbutanoate-CoA ligase activity [GO:0043759]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218] GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0008217; GO:0015645; GO:0018729; GO:0042632; GO:0043759; GO:0046872; GO:0047760; GO:0050218 CENLHSKLIVSENSR 6.320000172 1 1 0.38988474 1786.268921 0 15.90094 17.63949 0 0 0 0 0 17.6764 0 0 0 0 0 0 0 0 0 0 16.22937 0 0 0 0 0 0 0 17.2871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53GA4 PHLA2_HUMAN "Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C, p17-BWR1C)" PHLDA2 BWR1C HLDA2 IPL TSSC3 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of gene expression [GO:0010468]; regulation of glycogen metabolic process [GO:0070873]; regulation of growth hormone activity [GO:1903547]; regulation of spongiotrophoblast cell proliferation [GO:0060721] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of gene expression [GO:0010468]; regulation of glycogen metabolic process [GO:0070873]; regulation of growth hormone activity [GO:1903547]; regulation of spongiotrophoblast cell proliferation [GO:0060721] phosphatidylinositol phosphate binding [GO:1901981] GO:0001890; GO:0005737; GO:0006915; GO:0009887; GO:0010468; GO:0016020; GO:0030334; GO:0043065; GO:0045995; GO:0060721; GO:0070873; GO:1901981; GO:1903547 RALQDFR 25.07999992 1 1 0.485335839 905.4810948 0 0 0 0 18.70611 17.3898 0 0 0 0 19.17684 0 0 0 0 17.65449 0 0 0 0 18.11114 16.93352 0 0 17.77356 18.40312 18.07248 17.43372 16.95983 0 0 0 16.77806 17.86356 17.93036 0 0 0 0 0 17.9587 17.83593 17.57523 17.41378 17.24334 0 0 17.27522 Q53GD3 CTL4_HUMAN "Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1, hTPPT1)" SLC44A4 C6orf29 CTL4 NG22 TPPT1 UNQ441/PRO874 Homo sapiens (Human) acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085] choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857] GO:0005886; GO:0006656; GO:0008292; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0055085; GO:0061526; GO:0070062; GO:0090422 MGGKQR 4.590000153 1 1 0.159721969 693.4646405 11.97463 0 15.05611 0 14.7634 12.61665 15.97779 0 14.93299 15.11989 14.30861 12.84477 0 13.56392 0 14.9859 16.9569 0 0 0 0 15.20649 0 0 0 14.41698 0 16.02838 0 16.05658 0 15.89851 0 0 14.92291 0 16.00062 15.53981 0 0 0 16.12811 16.02069 14.24241 16.77456 16.23916 0 0 Q53GG5 PDLI3_HUMAN PDZ and LIM domain protein 3 (Actinin-associated LIM protein) (Alpha-actinin-2-associated LIM protein) PDLIM3 ALP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371] GO:0001725; GO:0003779; GO:0005829; GO:0005912; GO:0007507; GO:0030018; GO:0030036; GO:0031941; GO:0046872; GO:0051371; GO:0061061 LAPNIPLEMELPGVK 3.299999952 0.677848816 0.677848816 0.001330342 1637.200502 14.99714 17.06996 0 0 14.90272 15.60445 12.03434 16.06731 0 0 16.00812 14.24343 12.94456 0 12.64428 15.91413 15.87686 17.46092 14.88741 11.83 14.47612 0 16.28066 0 15.74071 15.56972 17.33983 0 0 0 0 16.07032 17.41224 16.91414 0 14.51248 18.33452 14.51826 0 0 17.36016 16.42434 16.49805 17.43013 0 16.78977 0 13.93703 Q53GL0 PKHO1_HUMAN "Pleckstrin homology domain-containing family O member 1, PH domain-containing family O member 1 (C-Jun-binding protein, JBP) (Casein kinase 2-interacting protein 1, CK2-interacting protein 1, CKIP-1) (Osteoclast maturation-associated gene 120 protein)" PLEKHO1 CKIP1 OC120 HQ0024c Homo sapiens (Human) lamellipodium morphogenesis [GO:0072673]; myoblast fusion [GO:0007520]; myoblast migration [GO:0051451]; regulation of cell shape [GO:0008360]; regulation of myoblast fusion [GO:1901739] cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; lamellipodium morphogenesis [GO:0072673]; myoblast fusion [GO:0007520]; myoblast migration [GO:0051451]; regulation of cell shape [GO:0008360]; regulation of myoblast fusion [GO:1901739] GO:0005634; GO:0005737; GO:0007520; GO:0008360; GO:0032587; GO:0036195; GO:0051451; GO:0072673; GO:1901739 TLQLRAEEPPTPALPNPGQLSR 7.309999943 1 1 4.60E-13 2384.138587 16.01641 0 15.18543 14.46214 0 0 0 0 0 0 14.25627 0 0 0 0 0 0 0 0 15.97287 0 15.94009 0 0 0 0 0 15.23367 0 11.73462 0 0 0 0 15.17303 0 15.36891 0 0 0 0 0 0 0 0 0 0 0 Q53GL7 PAR10_HUMAN "Protein mono-ADP-ribosyltransferase PARP10, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 10, ARTD10) (Poly [ADP-ribose] polymerase 10, PARP-10)" PARP10 Homo sapiens (Human) NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]; translesion synthesis [GO:0019985]; viral protein processing [GO:0019082] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]; translesion synthesis [GO:0019985]; viral protein processing [GO:0019082] DNA-binding transcription factor binding [GO:0140297]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0003950; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0010629; GO:0010847; GO:0019082; GO:0019985; GO:0032088; GO:0034356; GO:0045071; GO:0048147; GO:0070212; GO:0070213; GO:0070530; GO:0140289; GO:0140297; GO:1900045; GO:1990404 MVAMAEAEAGVAVEVR 5.940000057 1 1 4.57E-13 1664.225372 14.53369 0 15.11882 12.58852 11.76208 0 14.44932 0 14.87658 0 14.30633 12.49867 0 8.809167 0 0 14.36593 13.14425 15.07227 13.12976 14.19769 11.86252 12.58456 13.51562 14.5136 14.77514 0 15.53806 15.19354 0 14.89197 0 0 0 0 0 0 0 0 0 14.21531 0 0 0 0 0 0 0 Q53GS7 GLE1_HUMAN "mRNA export factor GLE1, hGLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1)" GLE1 GLE1L Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449] identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369] GO:0000822; GO:0005543; GO:0005615; GO:0005635; GO:0005643; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006406; GO:0006446; GO:0006449; GO:0006913; GO:0015031; GO:0016020; GO:0016973; GO:0031369; GO:0031965; GO:0036064; GO:0042802; GO:0044614 EIFDK 2.960000038 0.064786434 0.064786434 0.17212967 651.1645971 16.99216 15.2192 0 14.28131 18.27162 15.89082 0 0 0 15.67791 0 0 16.96594 0 15.54953 0 0 0 0 14.90927 0 13.55427 0 0 0 0 0 17.17902 14.84368 0 0 17.72011 0 16.83482 19.13878 15.69353 0 0 18.39608 0 0 0 14.02135 0 0 0 18.04695 0 Q53GT1 KLH22_HUMAN Kelch-like protein 22 KLHL22 Homo sapiens (Human) cell division [GO:0051301]; cellular response to leucine [GO:0071233]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; 14-3-3 protein binding [GO:0071889]; cell division [GO:0051301]; cellular response to leucine [GO:0071233]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513] 14-3-3 protein binding [GO:0071889] GO:0000070; GO:0005634; GO:0005737; GO:0005764; GO:0005813; GO:0005827; GO:0005829; GO:0006513; GO:0007094; GO:0010507; GO:0015630; GO:0030307; GO:0031463; GO:0043161; GO:0043231; GO:0045171; GO:0051301; GO:0071233; GO:0071889; GO:0072686; GO:1904263 DTVASALMYHR 7.840000153 1 1 0.324722489 1261.695028 14.10998 0 15.72653 0 12.98476 14.95508 14.26221 14.64253 15.71667 14.55124 14.49895 0 14.49282 12.19596 0 14.65129 0 15.86385 14.1985 15.44016 0 15.05156 15.84385 0 14.12992 0 0 0 0 0 0 15.7651 0 0 16.02982 0 15.98287 16.76353 0 0 0 0 16.82726 0 0 0 0 0 Q53H54 TYW2_HUMAN "tRNA wybutosine-synthesizing protein 2 homolog, tRNA-yW-synthesizing protein 2, EC 2.5.1.114 (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase)" TRMT12 TRM12 TYW2 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488] tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175] GO:0005737; GO:0008175; GO:0030488; GO:0102522 NNLEINGVADR 29.61000061 1 1 0.285979972 1215.671202 0 17.73816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53H96 P5CR3_HUMAN "Pyrroline-5-carboxylate reductase 3, P5C reductase 3, P5CR 3, EC 1.5.1.2 (Pyrroline-5-carboxylate reductase-like protein)" PYCR3 PYCRL Homo sapiens (Human) L-proline biosynthetic process [GO:0055129] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129] pyrroline-5-carboxylate reductase activity [GO:0004735] GO:0004735; GO:0005829; GO:0045171; GO:0055129; GO:0072686 AAAEPSPR 5.670000076 0.319127321 0.319127321 0.245768954 797.5868087 13.01567 16.56262 12.97847 0 14.25755 15.69756 15.36352 14.52402 14.98516 15.21127 14.41731 15.61509 0 15.42323 15.0699 16.62812 15.22523 17.12376 15.3096 11.3429 14.87396 15.93046 14.71875 15.80875 15.12447 15.42083 0 17.0577 0 15.81867 0 0 16.15552 15.55322 0 0 15.23344 0 0 0 0 0 0 0 0 0 0 0 Q53HC0 CCD92_HUMAN Coiled-coil domain-containing protein 92 (Limkain beta-2) CCDC92 Homo sapiens (Human) innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688] identical protein binding [GO:0042802] GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0042802; GO:0043231; GO:0045087; GO:0050688 AHVGVAHRIHHATPPQAQPEVK 1.519999981 1 1 0.117425958 2379.596682 14.37338 0 0 0 0 14.25244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.69957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.92453 0 0 0 0 0 0 17.25166 0 Q53LP3 SWAHC_HUMAN Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C) SOWAHC ANKRD57 C2orf26 Homo sapiens (Human) HGRQELLAMLVNFANK 4.550000191 1 1 0.462048203 1841.231801 0 0 0 0 15.52927 14.62146 0 13.10373 17.51165 17.20241 17.79734 0 0 0 0 0 0 0 0 0 15.76785 0 0 0 0 0 0 0 0 0 0 17.91884 19.40881 0 0 0 0 0 17.46978 0 0 0 17.70562 0 16.57667 16.5719 16.98293 0 Q53QZ3 RHG15_HUMAN Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15) ARHGAP15 BM-024 BM-030 BM-046 Homo sapiens (Human) regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0008360; GO:0016020; GO:0043087; GO:0051056 QQALSNMK 10.13000011 1 1 0.22824682 915.4300404 16.89303 16.11707 0 15.13889 16.77954 0 0 17.91438 16.6701 17.11761 16.61072 0 0 0 0 0 0 0 0 0 17.56504 0 16.41169 0 0 17.25463 17.16686 0 0 14.88053 16.71688 17.0431 0 0 0 0 0 17.21363 0 16.0264 0 0 0 0 0 0 0 0 Q53R41 FAKD1_HUMAN "FAST kinase domain-containing protein 1, mitochondrial" FASTKD1 KIAA1800 Homo sapiens (Human) mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528] RNA binding [GO:0003723] GO:0000959; GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0035770; GO:0044528 LDHYGR 10.14000034 0.078689076 0.078689076 0.265555889 759.4330779 18.27008 0 19.54748 0 19.44683 0 0 0 19.48565 17.59099 0 0 17.85188 0 0 16.67555 19.15512 17.45172 18.66841 0 0 0 18.04545 17.67684 18.4622 0 18.45388 16.5892 0 0 0 0 19.85699 0 0 19.73992 0 0 0 0 0 20.148 0 18.5492 0 0 19.03087 0 Q53RT3 APRV1_HUMAN "Retroviral-like aspartic protease 1, EC 3.4.23.- (Skin-specific retroviral-like aspartic protease, SASPase, Skin aspartic protease) (TPA-inducible aspartic proteinase-like protein, TAPS)" ASPRV1 SASP Homo sapiens (Human) protein processing [GO:0016485]; skin development [GO:0043588] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; aspartic-type endopeptidase activity [GO:0004190]; protein processing [GO:0016485]; skin development [GO:0043588] aspartic-type endopeptidase activity [GO:0004190] GO:0004190; GO:0016021; GO:0016485; GO:0043588 VANGAEMK 4.400000095 1 1 3.47E-13 818.6133202 0 15.95342 0 0 15.22495 0 0 0 15.42522 0 0 0 15.10987 0 0 0 0 0 0 0 0 0 0 0 0 0 16.34805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.58605 0 Q53RY4 KCP3_HUMAN "Keratinocyte-associated protein 3, KCP-3" KRTCAP3 KCP3 UNQ3066/PRO9898 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CSLCAFDAAR 12.60999966 1 1 0.530275368 1171.298749 0 0 0 0 17.55136 0 0 0 0 0 17.68542 17.30595 17.94835 0 0 0 0 0 0 17.31614 0 18.62303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.09052 0 18.8147 0 0 0 17.532 Q53T59 H1BP3_HUMAN "HCLS1-binding protein 3 (HS1-binding protein 3, HSP1BP-3)" HS1BP3 Homo sapiens (Human) regulation of apoptotic process [GO:0042981] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; regulation of apoptotic process [GO:0042981] phosphatidylinositol binding [GO:0035091] GO:0005739; GO:0005783; GO:0035091; GO:0042981 LAAFKSAK 2.519999981 1 1 0.187751918 837.0926075 14.46244 13.66583 14.32538 0 0 0 0 0 0 17.09264 0 15.27047 0 13.79785 0 15.70935 0 0 0 0 0 0 0 14.10594 0 0 16.27205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.08814 0 0 13.51506 0 0 0 Q53T94 TAF1B_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa, TAFI63) (TATA box-binding protein-associated factor 1B, TBP-associated factor 1B) (Transcription initiation factor SL1/TIF-IB subunit B)" TAF1B Homo sapiens (Human) "nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]; metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025] GO:0001164; GO:0001188; GO:0005634; GO:0005654; GO:0005668; GO:0005730; GO:0006351; GO:0017025; GO:0042790; GO:0046872; GO:0070860 SKQAYCK 4.630000114 1 1 0.269844196 882.0218436 14.16021 0 14.02268 13.37889 0 14.16588 0 14.18447 14.7023 0 15.07736 0 0 15.51746 17.1633 0 0 16.09325 0 17.64765 14.53745 15.84711 15.84795 14.86694 16.36676 0 14.92032 15.71971 15.47255 15.96198 0 0 0 13.9498 14.89002 14.34055 15.5348 0 16.18653 15.27143 15.8196 14.34309 14.10596 10.53706 15.52613 13.41302 15.37064 14.34242 Q53TN4 CYBR1_HUMAN "Plasma membrane ascorbate-dependent reductase CYBRD1, EC 7.2.1.3 (Cytochrome b reductase 1) (Duodenal cytochrome b) (Ferric-chelate reductase 3)" CYBRD1 DCYTB FRRS3 Homo sapiens (Human) ascorbate homeostasis [GO:0140576]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; reductive iron assimilation [GO:0033215]; response to iron ion [GO:0010039] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions [GO:0016722]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]; ascorbate homeostasis [GO:0140576]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; reductive iron assimilation [GO:0033215]; response to iron ion [GO:0010039]" "identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions [GO:0016722]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]" GO:0005765; GO:0005886; GO:0006879; GO:0010039; GO:0016021; GO:0016324; GO:0016491; GO:0016722; GO:0031526; GO:0033215; GO:0042802; GO:0046872; GO:0055072; GO:0070062; GO:0140571; GO:0140575; GO:0140576 MAMEGYWR 7.03000021 0.983703196 0.983703196 0.221827592 1060.267964 15.82997 15.67634 13.51604 17.56808 11.15038 13.41493 13.31964 15.41788 14.47157 11.82191 16.00339 16.43105 14.86495 0 15.31355 0 0 14.65754 15.84486 16.37171 0 15.15583 0 0 15.47465 16.25171 16.45308 0 0 0 14.84604 0 0 15.61594 0 15.33125 17.5735 16.75502 16.72923 0 0 0 0 19.00414 16.74346 0 0 0 Q53TQ3 IN80D_HUMAN INO80 complex subunit D INO80D Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000723; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 KTKPPALTK 7.039999962 1 1 0.166706673 984.8418704 0 14.99211 14.54901 12.81766 15.44685 14.00351 0 15.72839 14.91441 17.30343 0 14.62583 14.94262 14.27308 0 16.0361 0 16.30293 0 0 0 15.79116 17.33354 16.04684 13.94328 15.02987 0 0 0 14.42277 18.02822 0 15.19368 0 13.70771 0 0 0 0 0 15.321 0 0 0 0 0 0 14.97836 Q562E7 WDR81_HUMAN WD repeat-containing protein 81 WDR81 Homo sapiens (Human) aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014] GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530 LQSFPGHSGAVK 5.090000153 1 1 0.248691943 1227.920736 15.62104 0 0 14.88274 13.86524 14.53604 15.63489 13.68765 14.61195 0 14.43583 14.67854 14.47811 0 0 0 15.97454 0 17.42852 0 0 15.30215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.47252 0 0 0 0 0 0 0 0 0 0 Q562F6 SGO2_HUMAN Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2) (Tripin) SGO2 SGOL2 Homo sapiens (Human) "cell division [GO:0051301]; homologous chromosome segregation [GO:0045143]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic sister chromatid segregation [GO:0000070]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; homologous chromosome segregation [GO:0045143]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic sister chromatid segregation [GO:0000070]" GO:0000070; GO:0000775; GO:0000776; GO:0005654; GO:0005829; GO:0016604; GO:0030892; GO:0045143; GO:0051177; GO:0051301; GO:0051754 VKDSSSEK 5.190000057 1 1 0.020419432 882.6006489 0 0 0 0 0 0 0 14.23453 0 0 0 0 0 0 0 0 0 0 13.99781 0 0 0 15.79959 0 0 0 14.93469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q562R1 ACTBL_HUMAN Beta-actin-like protein 2 (Kappa-actin) ACTBL2 Homo sapiens (Human) axonogenesis [GO:0007409]; cell motility [GO:0048870] actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202] actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870] ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973] GO:0005524; GO:0005615; GO:0005737; GO:0005884; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0070062; GO:0098973; GO:0098978 GVLTLK 6.659999847 0.432683378 0.432683378 0.163270326 625.4737216 16.37523 15.02814 15.99743 14.67057 15.4246 14.90427 15.68927 16.43833 15.20905 15.51692 16.83109 15.99274 16.13966 10.23686 16.31933 15.32164 0 15.89053 16.88626 17.5354 17.03948 16.78637 0 15.6648 17.21122 0 15.94739 16.65244 16.86038 15.43205 16.39474 17.23295 15.66784 16.69077 17.34336 15.79912 16.12054 16.44432 16.00146 16.47624 17.20641 14.67309 16.98176 16.15369 17.52862 16.74231 15.9291 16.73882 Q567U6 CCD93_HUMAN Coiled-coil domain-containing protein 93 CCDC93 Homo sapiens (Human) endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231] early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] GO:0005769; GO:0006893; GO:0015031; GO:0032456; GO:0043231 YNMEK 7.71999979 0.882183671 0.882183671 0.274885985 684.5532695 18.60838 0 0 17.26803 17.79871 17.56583 0 0 0 17.45375 0 0 16.50123 0 18.6922 18.74742 0 0 0 0 0 0 17.42261 0 0 19.53305 0 16.68194 0 18.14714 0 17.96872 20.11773 0 0 0 18.62194 0 0 0 17.38793 18.41969 17.34575 19.30921 0 0 18.20018 0 Q56UN5 M3K19_HUMAN "Mitogen-activated protein kinase kinase kinase 19, EC 2.7.11.1 (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)" MAP3K19 RCK YSK4 Homo sapiens (Human) ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0106310 LSVSVR 7.130000114 1 1 0.159906408 662.2684924 14.0166 13.37078 0 0 14.86788 0 13.94885 0 16.14029 14.14359 15.44032 0 15.09338 0 0 0 16.29045 15.10828 0 16.33313 16.30806 0 16.72114 0 0 0 0 15.52076 14.75827 0 15.18242 0 0 17.20703 15.78201 15.7908 17.63142 16.59672 0 16.15667 0 16.59037 16.73726 0 14.15337 0 0 0 Q587J7 TDR12_HUMAN "Putative ATP-dependent RNA helicase TDRD12, EC 3.6.4.13 (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12)" TDRD12 ECAT8 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] PET complex [GO:1990923] PET complex [GO:1990923]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:1990923 AGRPLCPYLK 6.21999979 0.487641513 0.487641513 0.209667557 1173.66137 0 0 0 14.05339 12.38167 0 0 0 0 0 0 15.46147 14.44714 0 14.89829 14.0547 0 0 0 0 0 15.23126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93471 0 0 0 0 0 0 0 0 0 15.27293 0 Q587J8 KHDC3_HUMAN KH domain-containing protein 3 (ES cell-associated transcript 1 protein) (KHDC3-like protein) KHDC3L C6orf221 ECAT1 Homo sapiens (Human) actin filament organization [GO:0007015]; establishment of organelle localization [GO:0051656]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite development [GO:1900006]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297] apical cortex [GO:0045179]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333] apical cortex [GO:0045179]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; establishment of organelle localization [GO:0051656]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite development [GO:1900006]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005813; GO:0005938; GO:0007015; GO:0031297; GO:0032880; GO:0032991; GO:0040019; GO:0043066; GO:0045179; GO:0050769; GO:0051656; GO:0106333; GO:1900006; GO:1905168; GO:2000781 IFGRGGER 3.359999895 1 1 0.09011112 889.3519187 0 14.82539 0 0 0 0 0 0 14.89055 10.81243 14.99062 0 0 13.44192 0 15.74407 0 9.320238 0 0 0 0 0 0 0 0 0 0 0 15.27118 0 0 0 0 0 0 0 0 0 0 0 15.23016 0 0 0 0 0 0 Q58A45 PAN3_HUMAN "PAN2-PAN3 deadenylation complex subunit PAN3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3, PAN deadenylation complex subunit 3)" PAN3 Homo sapiens (Human) "mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251] "cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672] GO:0000289; GO:0000932; GO:0004672; GO:0005524; GO:0005829; GO:0006397; GO:0008143; GO:0010606; GO:0031251; GO:0046872; GO:0090503 LVPMGSK 1.919999957 0.178090781 0.178090781 0.255752451 731.2106161 16.49765 17.26956 16.2119 14.82765 16.86705 15.42177 16.52517 15.13451 0 16.45256 14.7723 16.50571 16.04263 16.67369 15.89633 16.27005 15.43461 16.67671 15.47995 16.17102 16.59571 15.99066 0 15.9501 16.99785 0 0 16.3152 16.51401 15.72139 16.81201 16.3843 16.44411 16.81438 0 16.19742 0 17.71611 16.0765 16.15881 16.51347 16.0199 16.53417 17.25726 16.86899 16.67444 15.38987 15.90552 Q58DX5 NADL2_HUMAN "Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2, NAALADase L2" NAALADL2 Homo sapiens (Human) response to bacterium [GO:0009617] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; response to bacterium [GO:0009617] GO:0005654; GO:0009617; GO:0016021 ERAPIR 6.659999847 1 1 0.08970939 740.228726 0 0 0 12.30481 0 0 0 0 0 13.43781 0 13.43207 0 15.57782 0 11.9694 12.18932 0 0 0 0 0 0 15.94109 0 0 14.94422 0 15.41673 0 0 0 0 0 15.84265 0 17.38074 15.2737 0 0 16.34132 16.13481 0 0 0 0 0 14.37032 Q58EX2 SDK2_HUMAN Protein sidekick-2 SDK2 KIAA1514 Homo sapiens (Human) camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0045202; GO:0060219 GINNPGATWAELTSMYSMR 3.430000067 0.091261499 0.091261499 0.111918481 2129.879757 16.93812 0 0 0 0 15.265 0 0 17.73623 0 0 17.04274 0 0 14.53164 0 0 0 17.86506 0 0 0 0 0 0 14.7646 0 0 15.30316 15.05566 0 13.92996 14.62185 16.58883 14.83683 13.59056 0 15.39721 13.56078 15.00877 15.80389 14.9516 0 11.8148 0 12.02561 9.437829 13.16604 Q58EX7 PKHG4_HUMAN "Puratrophin-1 (Pleckstrin homology domain-containing family G member 4, PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1)" PLEKHG4 PRTPHN1 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0051056 FEIWFRR 13.77000046 1 1 0.177539152 1054.916936 0 10.54012 15.21878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.97773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q58F21 BRDT_HUMAN "Bromodomain testis-specific protein (Cancer/testis antigen 9, CT9) (RING3-like protein)" BRDT Homo sapiens (Human) "chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; histone binding [GO:0042393]; histone reader [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" histone binding [GO:0042393]; histone reader [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; transcription coactivator activity [GO:0003713] GO:0000785; GO:0003713; GO:0005634; GO:0006338; GO:0006355; GO:0006397; GO:0007140; GO:0007141; GO:0008380; GO:0035093; GO:0042393; GO:0043484; GO:0051039; GO:0070577; GO:0140566 EELHSQK 7.519999981 1 1 0.167710891 869.8510886 0 0 0 0 0 0 0 0 15.09918 15.90859 12.89753 13.48593 0 0 0 0 0 0 0 0 0 15.84048 15.39658 0 0 0 16.97647 0 0 0 0 0 0 0 0 0 17.1708 0 0 15.85435 14.33975 0 15.35894 0 0 16.42822 0 0 Q58FF8 H90B2_HUMAN "Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b, Heat shock protein 90Bb)" HSP90AB2P HSP90BB Homo sapiens (Human) cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; unfolded protein binding [GO:0051082] GO:0005524; GO:0005829; GO:0005886; GO:0006457; GO:0016887; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0070062; GO:0097718 DHLAVR 7.360000134 0.183698982 0.183698982 0.294975638 708.0588545 13.26879 0 15.45084 14.55377 14.73064 14.96316 14.54178 0 12.79612 16.28164 15.88645 0 0 15.91487 16.00643 15.77386 14.95226 16.06475 0 14.10405 14.8362 16.85637 17.48473 0 0 0 0 0 0 0 0 16.36439 16.9973 0 0 0 15.61934 17.25998 17.51837 15.6479 15.16777 0 0 15.69983 0 0 15.07555 0 Q58HT5 AWAT1_HUMAN "Acyl-CoA wax alcohol acyltransferase 1, EC 2.3.1.75 (Diacylglycerol O-acyltransferase 2-like protein 3) (Diacylglycerol acyltransferase 2) (Long-chain-alcohol O-fatty-acyltransferase 1)" AWAT1 DGA2 DGAT2L3 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025] arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196] GO:0005789; GO:0006629; GO:0010025; GO:0016021; GO:0019369; GO:0047196; GO:0102966 FQSCFRR 6.75 0.203663155 0.203663155 0.263437503 1001.278992 16.38249 15.73145 15.78001 12.06299 0 0 15.83996 16.45357 15.85059 16.90784 0 15.97403 0 15.88511 0 0 0 13.46564 0 8.448284 15.85259 16.40429 15.68979 17.63011 0 15.51157 17.53705 15.4258 17.18779 16.36887 16.67762 16.494 17.69004 0 18.21748 14.81845 17.20467 18.18169 0 16.15154 16.12319 0 16.37573 0 14.96052 15.70965 17.10339 15.95277 Q58WW2 DCAF6_HUMAN "DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein, ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein, NRIP)" DCAF6 IQWD1 MSTP055 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] nuclear receptor coactivator activity [GO:0030374] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0016567; GO:0030374; GO:0045944; GO:0080008 ANIFSAK 6.179999828 0.088140532 0.088140532 0.27073109 749.7542043 15.23364 15.83392 15.22813 14.83929 0 0 14.8107 0 0 15.26571 0 0 14.53662 15.08031 15.98247 0 15.84039 0 0 16.09236 16.68539 16.56093 17.53495 17.4923 0 16.01765 0 0 16.06136 14.90666 0 15.76219 16.82621 16.29515 15.85118 16.15979 16.51026 16.45523 16.90611 16.02115 15.18951 17.41165 16.72282 17.2533 14.54232 14.6952 0 16.17418 Q59EK9 RUN3A_HUMAN "RUN domain-containing protein 3A (Rap2-interacting protein 8, RPIP-8)" RUNDC3A RAP2IP RPIP8 Homo sapiens (Human) positive regulation of cGMP-mediated signaling [GO:0010753]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; positive regulation of cGMP-mediated signaling [GO:0010753]; small GTPase mediated signal transduction [GO:0007264] GTPase regulator activity [GO:0030695] GO:0005829; GO:0005886; GO:0007264; GO:0010753; GO:0030695; GO:0043231 MEASFVQTTMALGLSSKK 3.730000019 1 1 0.083722226 1960.782934 15.38051 13.41327 14.97578 0 0 0 0 16.64757 0 0 0 15.29851 0 0 0 0 0 0 0 16.67122 0 0 0 0 0 0 0 0 0 16.3055 0 0 0 17.14512 13.74189 0 0 16.13421 0 14.8338 15.04053 15.26065 0 0 0 15.46036 0 0 Q5BIV9 SPRN_HUMAN "Shadow of prion protein, Protein shadoo" SPRN SHO Homo sapiens (Human) protein import into nucleus [GO:0006606] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; protein import into nucleus [GO:0006606] nucleic acid binding [GO:0003676] GO:0003676; GO:0005576; GO:0005634; GO:0005886; GO:0006606; GO:0031225 VRVRPAQR 4.139999866 1 1 0.19272437 982.3551031 0 0 0 0 0 0 13.50248 18.40837 0 0 0 14.81526 0 16.13437 16.5678 0 0 14.70662 0 0 0 15.41108 0 0 16.50535 16.69059 0 14.22566 0 0 15.68069 15.18396 0 12.13766 0 15.23167 0 0 15.70132 0 0 0 0 0 0 0 0 0 Q5BJE1 CC178_HUMAN Coiled-coil domain-containing protein 178 CCDC178 C18orf34 Homo sapiens (Human) ciliary basal body [GO:0036064] ciliary basal body [GO:0036064] GO:0036064 NKFITMR 6.079999924 1 1 2.34E-13 925.8577531 0 0 0 0 0 0 0 0 0 0 15.01918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.42313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BJF2 SGMR2_HUMAN "Sigma intracellular receptor 2, Sigma-2 receptor, Sigma2 receptor (Meningioma-associated protein 30) (Transmembrane protein 97)" TMEM97 MAC30 S2R Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; regulation of cell growth [GO:0001558] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; cholesterol homeostasis [GO:0042632]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005764; GO:0005783; GO:0005791; GO:0005886; GO:0016021; GO:0030867; GO:0031965; GO:0042632 MGAPATR 1.649999976 1 1 0.177161967 718.3837916 15.0897 0 15.92513 0 0 0 0 0 0 0 0 0 0 15.91028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BJF6 ODFP2_HUMAN Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2) ODF2 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286] small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198] GO:0000922; GO:0001520; GO:0005198; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0007286; GO:0008104; GO:0010457; GO:0031267; GO:0036064; GO:0036126; GO:0043231; GO:0044782; GO:0097539; GO:0120103; GO:1902017 EHALSKER 4.03000021 1 1 0.061115096 968.3714489 0 0 0 0 0 15.33387 0 14.16339 13.76497 0 0 0 0 0 0 14.70234 0 13.88909 13.87964 0 11.94344 0 0 0 0 0 0 0 0 15.06421 0 15.71501 0 13.58229 0 0 0 13.01713 16.01826 0 0 13.40068 0 0 0 0 0 0 Q5BKX6 S45A4_HUMAN Solute carrier family 45 member 4 SLC45A4 KIAA1126 Homo sapiens (Human) sucrose transport [GO:0015770] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; sucrose:proton symporter activity [GO:0008506]; sucrose transport [GO:0015770] sucrose:proton symporter activity [GO:0008506] GO:0008506; GO:0015770; GO:0016020; GO:0016021 DALGGYTR 7.349999905 4.89E-05 4.89E-05 0.289131643 854.0021072 0 0 0 0 0 16.14075 0 0 0 0 16.87683 0 0 0 18.09648 0 18.31822 0 0 0 15.74842 0 0 16.45003 18.67759 0 0 0 0 0 0 0 0 0 0 0 17.79519 0 18.10459 0 0 0 0 0 0 0 17.221 0 Q5BKX8 CAVN4_HUMAN Caveolae-associated protein 4 (Muscle-related coiled-coil protein) (Muscle-restricted coiled-coil protein) CAVIN4 MURC Homo sapiens (Human) cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of Rho protein signal transduction [GO:0035023] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of Rho protein signal transduction [GO:0035023] GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007517; GO:0010468; GO:0030018; GO:0030154; GO:0035023; GO:0042383; GO:0045944 EMGVDIIAR 13.76000023 1 1 0 1020.097723 14.39001 0 0 13.65904 0 0 0 13.28726 15.15517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.22036 0 0 13.07232 0 0 0 0 0 0 0 0 0 0 0 0 0 14.32129 0 0 0 0 0 Q5BKZ1 ZN326_HUMAN DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1) ZNF326 ZIRD Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993] GO:0000993; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016363; GO:0032784; GO:0043231; GO:0043484; GO:0044609; GO:0046872 NTYQGFNGMDRDYGPGSYGGMDR 1.110000014 0.582038045 0.582038045 3.20E-12 2568.464503 0 13.77094 0 0 0 11.54956 0 12.83848 14.67767 0 14.70199 15.12772 14.24199 0 0 12.79277 0 13.24462 15.76309 0 0 0 0 0 0 0 0 14.47704 0 14.14325 0 0 0 0 0 0 0 16.04743 0 12.89678 14.78781 0 0 16.18125 14.03909 0 12.99841 0 Q5BLP8 CD048_HUMAN Neuropeptide-like protein C4orf48 C4orf48 Chr4_55 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MAPPPACR 13.43000031 0.672300935 0.672300935 0.200839677 899.5819068 20.36531 20.55723 20.16782 19.06108 0 17.78386 0 0 18.66693 17.81743 19.71454 0 18.66341 0 17.83458 0 0 19.63638 0 18.06693 17.0456 19.73042 0 0 19.32879 18.14824 19.97346 17.53094 0 17.97997 19.96993 0 0 18.76821 18.43786 18.11343 19.31574 19.84785 17.97044 0 17.92713 0 19.3833 0 0 0 16.71627 19.4241 Q5BVD1 TTMP_HUMAN TPA-induced transmembrane protein TTMP C3orf52 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 IPEECVAEEELPHLLTER 1.00999999 0.634119451 0.634119451 0.011564621 2163.524177 13.67807 14.61916 0 13.87137 15.88165 13.74348 12.98522 0 0 0 0 0 0 0 0 0 14.50333 8.792977 0 0 0 0 15.65833 13.79735 15.7093 0 0 14.10819 16.23847 0 0 0 0 0 0 17.82338 0 13.33335 0 0 0 0 0 0 0 8.429543 18.74326 0 Q5C9Z4 NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730] nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274] RNA binding [GO:0003723] GO:0003723; GO:0005730; GO:0042274; GO:0048820 TAGPEQGPGLGGRSGAEEASGHR 4.980000019 1 1 0.07412388 2177.231658 14.98417 15.60165 14.06468 13.34743 0 0 0 15.6879 14.21516 0 0 0 0 15.01202 13.31015 0 0 0 12.28822 0 15.04848 17.07908 0 15.81166 14.88219 14.45189 0 12.67673 0 0 15.90553 0 14.38886 0 13.72634 14.08658 15.9086 0 16.08345 0 12.63482 0 0 0 0 0 0 0 Q5CZ79 AN20B_HUMAN Ankyrin repeat domain-containing protein 20B (Ankyrin repeat domain-containing protein 20A pseudogene) ANKRD20A8P ANKRD20B Homo sapiens (Human) LAAAIGK 4.519999981 1 1 0.104026781 642.0587585 0 0 0 15.62532 0 0 0 0 0 0 0 15.68435 0 0 0 0 15.87405 0 0 0 0 0 0 16.35059 15.49028 0 0 0 0 14.91308 16.37296 13.65417 0 0 0 16.90203 0 0 0 0 0 0 17.48388 0 0 0 0 0 Q5CZC0 FSIP2_HUMAN Fibrous sheath-interacting protein 2 FSIP2 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288] sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288] GO:0007288; GO:0030317; GO:0061512; GO:0097224; GO:0097225; GO:0097228; GO:0097229 ALPSDQIIAAGK 9.159999847 1 1 6.87E-13 1183.411553 14.45915 0 0 13.85729 0 13.99466 7.999961 0 6.540313 12.86794 0 9.919008 14.58053 12.58708 12.517 0 14.54222 0 0 0 0 0 14.42099 0 0 0 0 0 0 0 0 0 0 0 0 14.30728 0 0 0 0 0 0 0 0 0 0 0 0 Q5D862 FILA2_HUMAN "Filaggrin-2, FLG-2 (Intermediate filament-associated and psoriasis-susceptibility protein, Ifapsoriasin)" FLG2 IFPS Homo sapiens (Human) cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914]; cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436] calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914] GO:0001533; GO:0005198; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0007155; GO:0036457; GO:0046914; GO:0048730; GO:0061436; GO:1904724 GYGAR 6.619999886 0.240608588 0.240608588 0.246705903 520.1261909 0 15.60981 17.06063 15.70316 14.07833 0 16.12455 0 15.57807 16.55569 15.62686 15.60835 16.49614 0 0 15.6983 0 15.70879 0 16.43895 16.3841 0 16.86634 0 16.43048 15.49712 16.11497 0 0 0 16.88115 14.74657 16.27569 15.16082 15.15904 15.24287 16.22203 0 0 15.7738 0 15.67122 14.81692 0 17.13051 15.98713 15.25859 15.96564 Q5DID0 UROL1_HUMAN Uromodulin-like 1 (Olfactorin) UMODL1 Homo sapiens (Human) adipose tissue development [GO:0060612]; cellular response to gonadotropin-releasing hormone [GO:0097211]; multicellular organismal reproductive process [GO:0048609]; neutrophil migration [GO:1990266]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; single fertilization [GO:0007338] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414]; adipose tissue development [GO:0060612]; cellular response to gonadotropin-releasing hormone [GO:0097211]; multicellular organismal reproductive process [GO:0048609]; neutrophil migration [GO:1990266]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; single fertilization [GO:0007338] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414] GO:0005201; GO:0005509; GO:0005615; GO:0005737; GO:0007338; GO:0009897; GO:0009986; GO:0010468; GO:0016021; GO:0016324; GO:0030414; GO:0042981; GO:0048609; GO:0060612; GO:0097211; GO:1990266; GO:2000354 MQIVSLQAGSVVVR 4.170000076 1 1 0.062436947 1502.255907 16.16916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.26299 0 0 0 0 0 0 12.45935 0 0 0 12.88369 0 0 0 0 0 0 0 0 0 0 12.27613 0 0 0 Q5EBM4 ZN542_HUMAN Putative zinc finger protein 542 (Zinc finger protein 542 pseudogene) ZNF542P ZNF542 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 LENYQNLVWLGLSISK 4.130000114 1 1 0.236362714 1878.077391 0 0 14.56721 0 16.7993 0 16.13612 0 0 0 16.18761 16.59288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.33414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EG05 CAR16_HUMAN "Caspase recruitment domain-containing protein 16 (Caspase recruitment domain-only protein 1, CARD-only protein 1) (Caspase-1 inhibitor COP) (Pseudo interleukin-1 beta converting enzyme, Pseudo-ICE, Pseudo-IL1B-converting enzyme)" CARD16 COP COP1 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-C [GO:0071494]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of protein binding [GO:0032091]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991] protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-C [GO:0071494]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of protein binding [GO:0032091]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900] GO:0004869; GO:0010804; GO:0019900; GO:0031665; GO:0032091; GO:0032691; GO:0032991; GO:0042802; GO:0043123; GO:0043154; GO:0050700; GO:0051092; GO:0071222; GO:0071456; GO:0071494; GO:0089720; GO:0097179; GO:0097340 IPGLGKELQTGTHK 1.539999962 0.186682388 0.186682388 0.402313438 1477.903342 16.83624 0 0 0 0 0 0 0 0 14.76783 0 14.78118 0 0 0 14.67363 15.5779 0 0 0 0 0 0 0 0 0 16.93029 14.93438 15.30907 17.32483 0 14.8567 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2058 0 0 Q5F1R6 DJC21_HUMAN DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3) DNAJC21 DNAJA5 Homo sapiens (Human) protein folding [GO:0006457] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ribosome [GO:0005840]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; protein folding [GO:0006457] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006457; GO:0008270 ATGHAR 4.070000172 1 1 0.157892574 612.4267646 15.41359 0 0 0 0 0 0 15.18828 15.72115 0 0 0 0 0 0 0 0 0 0 13.7084 0 16.0793 16.81116 0 0 15.7353 0 15.9839 0 14.9977 11.85012 14.74256 0 16.73598 15.78223 13.64949 0 0 0 0 0 15.74698 15.56057 16.24737 0 14.5547 0 0 Q5FVE4 ACBG2_HUMAN "Long-chain-fatty-acid--CoA ligase ACSBG2, EC 6.2.1.3 (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2, EC 6.2.1.15) (Bubblegum-related protein) (PRTD-NY3)" ACSBG2 BGR UNQ2443/PRO5005 Homo sapiens (Human) cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; spermatogenesis [GO:0007283] acyl-CoA hydrolase activity [GO:0047617]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957] GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006631; GO:0007283; GO:0016020; GO:0016405; GO:0030154; GO:0031957; GO:0035338; GO:0042759; GO:0047617; GO:0047676 CEMNQMSGEPLDK 5.929999828 1 1 0.048222256 1554.508189 0 0 18.66799 0 0 0 18.90646 0 19.35556 0 17.93411 0 0 0 0 0 0 0 0 0 16.53033 0 0 0 0 18.0267 0 0 0 0 17.61778 0 0 0 20.45546 0 18.73951 0 0 0 0 0 0 0 0 0 0 0 Q5FWF5 ESCO1_HUMAN "N-acetyltransferase ESCO1, EC 2.3.1.- (CTF7 homolog 1) (Establishment factor-like protein 1, EFO1, EFO1p, hEFO1) (Establishment of cohesion 1 homolog 1, ECO1 homolog 1, ESO1 homolog 1)" ESCO1 EFO1 KIAA1911 Homo sapiens (Human) peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062] acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270] GO:0000785; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733 ENSSKVTK 7.070000172 1 1 0.215624919 893.2110555 18.67892 0 0 0 17.02623 18.44758 0 0 0 0 16.97913 15.25054 0 0 0 0 17.41726 0 0 0 0 17.16696 0 17.90099 0 0 0 0 0 0 0 0 0 18.13341 0 0 18.46172 0 0 0 0 18.72308 0 16.76636 16.53427 0 0 0 Q5FYB0 ARSJ_HUMAN "Arylsulfatase J, ASJ, EC 3.1.6.-" ARSJ UNQ372/PRO708 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872 YFEHYRSIININR 12.10999966 0.426299185 0.426299185 0.574266083 1724.509716 0 19.83705 19.86154 19.07064 16.47234 15.11091 15.29776 15.78878 17.71118 17.84931 18.26426 17.48815 17.6837 0 17.05262 0 0 0 17.09303 0 0 17.09572 0 18.11472 21.07832 0 0 0 17.13223 18.59083 0 18.53559 20.28968 19.7989 19.08036 20.36186 0 19.14477 18.69102 18.44128 17.47604 0 18.73136 18.65502 0 0 18.85653 17.71377 Q5GFL6 VWA2_HUMAN "von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen, AMACO) (Colon cancer secreted protein 2, CCSP-2)" VWA2 AMACO Homo sapiens (Human) calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] GO:0005509; GO:0005604; GO:0005615; GO:0007161; GO:0042802; GO:0046626; GO:0062023; GO:0070062 MMWCSAAVDIMFLLDGSNSVGK 2.25 1 1 4.59E-13 2444.467349 14.62252 14.82084 13.0154 13.81125 12.22638 0 0 0 0 11.94827 0 0 12.34681 0 0 0 0 15.69561 13.39486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5GH72 XKR7_HUMAN XK-related protein 7 XKR7 C20orf159 XRG7 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742 MAAKSDGAAASASPDPEGAAGGAR 5.949999809 1 1 0.028562292 2132.158028 0 0 14.45837 11.94938 13.98402 0 14.45719 0 14.617 0 0 0 16.00621 15.87287 14.9516 0 0 0 16.58302 0 0 15.23341 15.87885 0 14.27837 0 15.67242 0 14.98703 13.67591 0 0 15.24182 16.10793 16.39083 0 0 0 0 15.76075 0 0 0 17.15464 0 0 0 0 Q5GH76 XKR4_HUMAN "XK-related protein 4, hXKR4 [Cleaved into: XK-related protein 4, processed form ]" XKR4 KIAA1889 XRG4 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] phospholipid scramblase activity [GO:0017128] GO:0005886; GO:0016020; GO:0016021; GO:0017128; GO:0043652; GO:0070782; GO:1902742 AILAFECSPSPPR 4.130000114 1 1 0.078160804 1442.041686 13.78681 14.45919 14.0036 13.80359 10.46199 12.98751 12.14483 14.37488 15.24051 12.94538 12.88148 15.3184 0 14.43963 13.8313 16.1609 0 14.24672 0 0 15.40411 0 0 0 15.45439 14.70038 14.72389 0 0 13.35992 0 0 0 0 0 0 13.49597 0 0 0 0 0 15.47484 0 16.31867 0 0 0 Q5GH77 XKR3_HUMAN XK-related protein 3 (X Kell blood group-related 3) (XTES) XKR3 XRG3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 CLHTIR 3.849999905 0.318578005 0.318578005 0.244317091 799.7308971 15.82868 13.70272 17.06756 13.12738 12.31261 15.03218 16.68855 15.61843 0 0 0 0 0 16.44674 0 0 16.12097 0 0 0 15.35597 16.78105 16.19538 16.46367 0 16.79539 0 14.51337 15.81081 15.79351 16.51785 15.75009 16.1642 0 0 0 0 16.23729 16.79924 15.55673 14.97576 0 0 15.04914 0 0 14.53203 15.48105 Q5GLZ8 HERC4_HUMAN "Probable E3 ubiquitin-protein ligase HERC4, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)" HERC4 KIAA1593 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; fibrillar center [GO:0001650] cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283] ubiquitin-protein transferase activity [GO:0004842] GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154; GO:0045879 FSGVDMNAAR 4.889999866 1 1 0.403330697 1083.635225 0 0 0 0 0 0 18.43487 0 0 0 0 0 0 0 0 0 0 17.53276 0 0 0 19.58829 20.01917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2195 0 0 0 0 0 0 0 0 Q5H8A4 PIGG_HUMAN "GPI ethanolamine phosphate transferase 2, EC 2.-.-.- (GPI7 homolog, hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein, PIG-G)" PIGG GPI7 UNQ1930/PRO4405 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]" "CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]" GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267 LSEMDSVLMK 2.930000067 0.599211693 0.599211693 0.175610139 1168.608187 0 0 0 0 0 16.14366 0 0 0 17.26557 19.53212 0 17.95175 0 0 0 18.63218 0 0 0 0 19.68982 18.51458 0 0 0 18.68697 0 0 0 0 0 0 18.63768 0 18.91027 0 0 0 19.62809 17.40143 19.41843 0 17.92011 0 17.67774 17.63548 0 Q5H8C1 FREM1_HUMAN FRAS1-related extracellular matrix protein 1 (Protein QBRICK) FREM1 C9orf143 C9orf145 C9orf154 Homo sapiens (Human) cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] GO:0005576; GO:0005604; GO:0007154; GO:0007160; GO:0016021; GO:0030246; GO:0046872; GO:0097094 KAEIAMNMGETR 1.360000014 1 1 0.134867263 1381.993748 14.9984 0 0 0 13.67866 0 0 15.86865 15.20628 0 11.5623 13.37843 13.73273 0 15.75122 14.41621 14.84078 13.54133 0 0 0 0 0 0 0 0 0 0 0 0 0 17.10504 0 0 0 0 0 0 0 0 0 15.14093 15.45012 0 15.81279 0 0 0 Q5H943 KKLC1_HUMAN "Kita-kyushu lung cancer antigen 1, KK-LC-1 (Cancer/testis antigen 83)" CT83 CXorf61 KKLC1 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005634; GO:0005886; GO:0016021 GASPHR 11.05000019 0.001077825 0.001077825 0.09227497 623.1087937 15.22527 14.93754 18.1487 0 0 0 0 16.36985 0 18.70637 16.88105 0 0 16.26862 13.20811 12.2374 11.24131 14.17188 10.36503 0 15.31679 16.23728 0 17.68833 17.24129 0 0 16.30281 0 0 11.45771 0 0 16.60056 13.17431 14.95998 16.77167 0 15.34229 15.98066 10.78024 0 0 13.95955 17.72805 13.7985 14.08865 15.61211 Q5H9B9 BM2KL_HUMAN Putative BMP-2-inducible kinase-like protein BMP2KL Homo sapiens (Human) IAPSPK 9.409999847 0.709456563 0.709456563 0.173267496 612.3232738 15.32155 16.14061 0 15.6009 13.90086 14.83421 14.77301 16.11077 15.38983 0 14.49765 15.12198 0 0 14.79354 0 0 15.47574 15.38132 12.78127 14.78894 12.98826 15.4592 0 13.69892 14.03598 14.08661 0 0 0 15.41797 0 0 16.51287 15.16621 15.048 15.55882 0 17.3202 0 0 15.14888 0 14.68887 0 0 0 0 Q5H9F3 BCORL_HUMAN "BCL-6 corepressor-like protein 1, BCoR-L1, BCoR-like protein 1" BCORL1 Homo sapiens (Human) chromatin organization [GO:0006325] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325] GO:0005654; GO:0005886; GO:0006325 NLLLPNK 29.35000038 0.023055254 0.023055254 0.224636748 810.5526643 18.10441 18.75359 19.10748 20.02481 0 19.81225 19.19981 19.49874 19.00409 18.27023 19.1528 19.53933 18.91846 19.78637 19.49664 0 19.45956 18.70322 19.4724 18.93974 18.34528 18.78769 19.0905 19.94272 20.29041 20.23861 19.92443 18.9543 0 19.99239 19.60381 20.09396 0 19.30783 19.35342 19.93378 19.70457 19.33519 18.5613 0 18.72852 18.90471 20.64096 19.62639 18.57016 18.84735 19.28559 19.71125 Q5H9J9 T11X2_HUMAN T-complex protein 11 X-linked protein 2 TCP11X2 Homo sapiens (Human) protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165] GO:0001669; GO:0007165; GO:0010737; GO:0036126; GO:1902490 SFSGEVLFR 14.06999969 1 1 0.13436412 1038.414654 0 0 13.29979 0 0 0 7.941629 0 0 15.79668 0 0 12.41518 0 0 0 0 14.8055 0 0 16.71538 0 0 0 14.38695 0 0 0 0 0 0 14.67745 0 0 0 0 14.95051 10.44867 0 0 0 15.83547 15.89391 0 0 0 0 0 Q5H9K5 ZMAT1_HUMAN Zinc finger matrin-type protein 1 ZMAT1 KIAA1789 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0008270 HLSSENNTADHQAGHK 8.050000191 0.00027706 0.00027706 0.146374797 1744.631878 17.60372 0 0 17.73693 9.00833 0 18.52559 17.64594 15.29016 18.77392 0 14.65449 12.15117 0 14.95243 14.5987 12.75835 15.70451 15.70338 15.53458 17.48203 13.84777 10.12452 18.49166 0 0 0 0 15.97199 15.14275 14.87383 0 0 0 0 0 15.91962 17.46892 16.90053 18.30771 14.28699 0 0 0 0 15.09267 0 17.13797 Q5H9R4 ARMX4_HUMAN Armadillo repeat-containing X-linked protein 4 ARMCX4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ASAQPQIFAK 8.470000267 1 1 0.391632906 1060.947292 0 15.29973 15.59908 0 14.94954 14.64052 0 16.23714 13.61677 14.63037 14.67706 0 15.36621 13.64847 13.90771 16.02565 0 15.33625 15.39328 0 0 0 16.30853 16.25028 0 0 0 13.44946 16.01764 15.67444 0 0 0 0 0 0 16.51287 0 0 0 15.49718 0 0 0 0 15.74044 13.12641 0 Q5H9R7 PP6R3_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) regulation of phosphoprotein phosphatase activity [GO:0043666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666] protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666 DLPDEVR 6 1 1 1.15E-13 842.8086679 0 0 15.09536 0 0 0 0 0 0 0 15.07309 0 15.8523 0 15.11516 15.31449 0 0 0 0 0 0 16.53008 0 0 0 15.45027 0 16.54992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5H9U9 DDX6L_HUMAN "Probable ATP-dependent RNA helicase DDX60-like, EC 3.6.4.13 (DEAD box protein 60-like)" DDX60L Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0016887 FYAYTMESTDR 8.710000038 1 1 0.228740313 1399.167893 12.8569 15.04681 11.53437 0 0 15.68321 0 0 0 12.65242 16.11484 0 0 0 0 0 0 16.46153 0 0 16.6756 17.25012 0 0 16.44517 16.3316 16.01381 0 0 0 0 0 0 15.49589 0 0 18.13633 0 0 0 0 0 0 0 0 0 0 0 Q5HY64 FA47C_HUMAN Putative protein FAM47C FAM47C Homo sapiens (Human) VSSLCPEPTK 9.220000267 1 1 0.132986383 1117.242859 15.2172 13.22495 17.13699 0 0 0 0 0 0 14.96537 0 12.82931 14.22418 0 14.35313 0 0 0 0 13.8793 13.71036 0 0 0 0 0 13.69384 13.70307 0 0 15.88393 14.22009 15.22791 14.07099 14.28129 14.63159 0 0 0 0 12.70082 0 0 14.52777 15.19899 0 0 13.22581 Q5HY92 FIGN_HUMAN Fidgetin FIGN Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022] GO:0005524; GO:0005737; GO:0005815; GO:0005874; GO:0007049; GO:0008022; GO:0008568; GO:0016363; GO:0016887; GO:0051301 STQSPMYR 12.84000015 1 1 0.401836906 983.933917 17.74358 19.35141 20.53923 0 0 20.35266 0 0 20.22394 17.3538 14.85208 19.38096 18.67052 19.9178 20.42469 18.48548 19.43522 0 19.02336 0 19.93002 20.50945 21.63449 18.72688 0 0 19.46163 0 20.49606 0 20.09005 19.56918 21.23017 20.60247 20.88663 0 0 0 0 18.1239 18.49664 20.28206 19.85893 18.79897 0 0 0 18.70054 Q5HYA8 MKS3_HUMAN Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67) TMEM67 MKS3 Homo sapiens (Human) cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433] centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433] filamin binding [GO:0031005]; unfolded protein binding [GO:0051082] GO:0005789; GO:0005813; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035869; GO:0036038; GO:0051082; GO:0060170; GO:0060271 EAENLCSQR 3.779999971 1 1 0.028301438 1106.472813 14.11608 12.5767 15.32618 16.0855 12.65787 14.26474 13.27003 12.80828 12.53854 0 12.79612 14.67866 0 0 14.43989 14.28144 0 0 13.7901 0 0 0 16.10016 0 0 0 0 0 13.44554 14.49345 14.80621 0 0 0 0 0 0 0 0 0 0 14.47628 9.364709 0 0 14.31073 12.91912 0 Q5HYC2 K2026_HUMAN Uncharacterized protein KIAA2026 KIAA2026 Homo sapiens (Human) VPVPPPVPTVSLTSVIK 3.279999971 1 1 9.19E-13 1724.999255 0 0 15.27835 0 0 0 0 0 0 0 0 0 0 0 14.57838 15.72668 0 14.64089 15.84825 14.27361 0 0 0 0 13.65137 14.56451 0 0 0 0 0 0 0 0 0 0 13.21404 0 0 0 0 0 0 0 0 0 0 0 Q5HYJ1 TECRL_HUMAN "Trans-2,3-enoyl-CoA reductase-like, EC 1.3.1.- (Steroid 5-alpha-reductase 2-like 2 protein)" TECRL SRD5A2L2 Homo sapiens (Human) very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; very long-chain fatty acid biosynthetic process [GO:0042761]" "oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]" GO:0005783; GO:0016021; GO:0016491; GO:0016627; GO:0042761 KSAMIPFIL 11.21000004 1 1 0.146750325 1022.040439 0 14.23131 13.14004 14.76008 16.09352 0 0 15.16602 0 0 15.73107 14.20231 0 0 16.80189 0 0 15.47742 0 0 15.40841 16.29355 0 0 0 0 11.12846 0 17.48596 13.15864 15.98535 0 0 0 0 0 0 0 0 14.97218 14.00941 0 0 0 0 0 0 0 Q5HYK3 COQ5_HUMAN "2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, EC 2.1.1.201 (Ubiquinone biosynthesis methyltransferase COQ5)" COQ5 Homo sapiens (Human) methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142] "extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142]; 2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0043430]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]" "2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0043430]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]" GO:0005743; GO:0005759; GO:0006744; GO:0008168; GO:0031314; GO:0032259; GO:0032991; GO:0043333; GO:0043430; GO:0110142 FLCLEFSQVNNPLISR 4.659999847 1 1 0.430471231 1936.036795 0 0 0 0 0 0 0 0 0 18.84968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.85803 0 0 0 18.48034 0 0 0 0 0 0 0 Q5HYK9 ZN667_HUMAN Zinc finger protein 667 ZNF667 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 SGQSICQK 5.5 0.721264124 0.721264124 0.096668399 908.4534757 0 13.6997 0 0 0 0 14.58054 0 16.32063 0 12.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 16.27418 0 0 16.53074 0 0 18.37306 16.16929 16.97864 0 0 16.01019 0 0 0 0 0 0 0 0 0 15.10985 0 0 Q5HYW2 NHSL2_HUMAN NHS-like protein 2 NHSL2 Homo sapiens (Human) cell differentiation [GO:0030154] cell differentiation [GO:0030154] GO:0030154 KKPSPPTR 8.56000042 1 1 0.081083408 911.1391043 14.52411 0 12.35066 13.62611 14.84301 0 0 0 0 17.02361 12.88738 15.6486 13.12817 13.52985 0 0 12.72241 13.31882 0 0 0 0 0 0 16.41521 0 0 0 0 0 0 0 0 0 0 15.7687 0 0 0 16.28061 0 0 0 0 0 0 0 0 Q5HYW3 RTL5_HUMAN Retrotransposon Gag-like protein 5 (Retrotransposon gag domain-containing protein 4) RTL5 KIAA2001 RGAG4 Homo sapiens (Human) ALAEVNSLR 6.380000114 0.194737539 0.194737539 0.233565884 972.0587671 0 0 16.50352 15.89627 0 0 14.39063 0 9.765297 0 0 0 12.12887 0 16.94625 0 14.88115 0 0 0 0 0 0 0 15.27793 0 16.56174 11.39043 13.0154 14.94187 15.54529 15.29104 16.79148 11.59643 12.68868 0 0 15.40592 0 10.07718 11.79824 16.41264 0 16.31071 0 0 0 14.48027 Q5IJ48 CRUM2_HUMAN Protein crumbs homolog 2 (Crumbs-like protein 2) CRB2 Homo sapiens (Human) circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]; visual perception [GO:0007601] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]; visual perception [GO:0007601] aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877] GO:0001707; GO:0001756; GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0007157; GO:0007601; GO:0010470; GO:0010718; GO:0010951; GO:0014028; GO:0016021; GO:0016324; GO:0016327; GO:0019828; GO:0030010; GO:0030513; GO:0032991; GO:0035003; GO:0043296; GO:0044877; GO:0045197; GO:0045199; GO:0045494; GO:0046549; GO:0050896; GO:0055111; GO:0070062; GO:0072359 NGSLAGGVR 5.739999771 1 1 0.146580394 829.8879019 15.95049 0 0 0 0 0 15.84029 0 0 0 14.39018 16.33348 0 0 0 14.29345 0 0 0 0 0 0 16.0551 0 0 0 16.12363 0 0 0 0 0 18.59614 0 0 0 0 16.37083 0 0 0 0 0 0 0 0 0 0 Q5JNZ3 ZN311_HUMAN Zinc finger protein 311 (Zinc finger protein zfp-31) ZNF311 ZFP31 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 NLNPNSKHSQCNK 3.579999924 1 1 0.271784021 1541.075775 0 0 13.01491 14.14127 0 0 15.98184 0 14.99268 0 14.4672 0 0 0 0 0 0 0 16.48527 0 0 0 0 0 0 0 0 0 0 14.06235 14.65448 0 0 0 0 0 16.23661 0 0 0 0 0 0 0 0 16.81033 13.20066 0 Q5JPB2 ZN831_HUMAN Zinc finger protein 831 ZNF831 C20orf174 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 ATPLHPAAPAPAEHPSLATPPQAPR 10.96000004 0.883595943 0.883595943 3.66E-12 2495.605407 0 0 0 0 18.22453 0 16.6676 0 0 17.68869 0 0 0 0 0 16.04449 14.04867 0 0 0 0 17.19053 16.42322 0 15.13904 0 14.35416 0 0 0 0 17.56693 0 0 0 0 16.83333 11.54503 13.92317 16.154 0 15.87226 0 15.17528 0 0 16.11911 0 Q5JPF3 AN36C_HUMAN Ankyrin repeat domain-containing protein 36C (Protein immuno-reactive with anti-PTH polyclonal antibodies) ANKRD36C Homo sapiens (Human) ion channel inhibitor activity [GO:0008200] ion channel inhibitor activity [GO:0008200] GO:0008200 DGEISRTVTSEKPAGLK 9.989999771 1 1 2.35E-13 1787.271801 16.7393 9.859726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JQC9 AKAP4_HUMAN "A-kinase anchor protein 4, AKAP-4 (A-kinase anchor protein 82 kDa, AKAP 82, hAKAP82) (Major sperm fibrous sheath protein, HI) (Protein kinase A-anchoring protein 4, PRKA4)" AKAP4 AKAP82 Homo sapiens (Human) establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; Z disc [GO:0030018] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; Z disc [GO:0030018]; protein kinase A binding [GO:0051018]; establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] protein kinase A binding [GO:0051018] GO:0005634; GO:0005737; GO:0005856; GO:0005952; GO:0007165; GO:0007178; GO:0007338; GO:0008104; GO:0030018; GO:0030317; GO:0031514; GO:0035686; GO:0044458; GO:0045184; GO:0048471; GO:0051018; GO:0097224; GO:0097225; GO:0097228; GO:0097229 AAEKGYSVGGLLQEVMK 5.519999981 0.2339544 0.2339544 0.009133103 1795.917671 16.0814 0 0 0 0 14.88938 12.90465 0 0 11.73989 11.54409 0 0 0 13.40232 14.26217 0 0 16.08677 0 13.79668 12.25853 15.45293 0 16.04718 0 0 0 13.72862 0 0 15.12577 0 0 15.30967 0 0 17.31108 0 0 15.86413 0 13.90762 15.46636 15.33032 0 0 15.82092 Q5JQF8 PAP1M_HUMAN Polyadenylate-binding protein 1-like 2 (RNA-binding motif protein 32) (RNA-binding protein 32) PABPC1L2A PABPC1L2 RBM32A; PABPC1L2B PABPC1L2 RBM32B Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0070062 ALETLNFDVIKGRPVR 9.850000381 1 1 0.272392204 1828.271845 13.46462 0 13.45287 0 15.84674 12.89053 14.6074 16.44789 0 13.74915 0 0 14.03759 0 15.37562 0 0 0 0 0 0 0 0 0 0 0 0 16.46011 0 0 0 0 0 0 15.61688 0 0 0 0 0 0 0 15.74682 0 15.29326 15.86406 0 0 Q5JR59 MTUS2_HUMAN "Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150, Tracking protein of 150 kDa)" MTUS2 CAZIP KIAA0774 TIP150 Homo sapiens (Human) cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] GO:0005634; GO:0005737; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 AAGGDLKPSANLYEK 3.099999905 1 1 0.327135601 1534.209753 0 0 18.08704 0 17.43103 0 18.83707 0 19.45184 0 0 17.99357 14.2007 0 0 0 18.57003 0 0 0 17.05698 0 0 0 0 18.71223 0 0 0 0 19.69838 0 0 0 18.99626 0 18.71555 0 18.12633 0 0 0 0 0 0 0 16.78728 0 Q5JR98 DYLT4_HUMAN Dynein light chain Tctex-type 4 (Protein N22.1) (Tctex-2-beta) (Tctex1 domain-containing protein 4) DYNLT4 TCTEX1D4 Homo sapiens (Human) microtubule-based movement [GO:0007018] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; dynein intermediate chain binding [GO:0045505]; protein phosphatase 1 binding [GO:0008157]; microtubule-based movement [GO:0007018] dynein intermediate chain binding [GO:0045505]; protein phosphatase 1 binding [GO:0008157] GO:0001669; GO:0005634; GO:0005737; GO:0005815; GO:0005868; GO:0005930; GO:0007018; GO:0008157; GO:0036126; GO:0045505 GSMLGLAASFSRR 3.150000095 0.058475059 0.058475059 0.037793825 1367.814898 13.83119 0 0 0 0 0 0 14.95438 0 0 0 0 0 0 0 0 15.43815 0 0 15.73779 0 16.56923 0 16.10446 0 13.48398 0 16.43828 15.64807 15.77713 16.09383 15.93791 0 0 0 0 0 0 0 0 0 17.05822 0 0 0 0 0 0 Q5JRA6 TGO1_HUMAN "Transport and Golgi organization protein 1 homolog, TANGO1 (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3)" MIA3 KIAA0268 TANGO UNQ6077/PRO20088 Homo sapiens (Human) cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060] cargo receptor activity [GO:0038024] GO:0002042; GO:0002687; GO:0005788; GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0007162; GO:0009306; GO:0015031; GO:0016020; GO:0016021; GO:0030336; GO:0035459; GO:0038024; GO:0042060; GO:0042953; GO:0043231; GO:0070971; GO:0070973; GO:0090110; GO:0140052; GO:1903038; GO:2000402 EAANLR 7.300000191 1 1 0.083025968 673.3921675 14.90854 14.07247 15.65767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.19843 0 0 15.87822 0 0 0 16.25194 0 0 0 16.27033 15.57949 0 15.5647 14.00127 16.29886 0 0 0 0 0 0 0 0 0 0 0 0 Q5JRK9 GGEE3_HUMAN "Putative G antigen family E member 3 (Prostate-associated gene 2B protein, PAGE-2B)" PAGE2B GAGEE3 Homo sapiens (Human) VLEAGDAQP 4.889999866 1 1 0.237274733 899.2687976 15.26287 14.72305 0 12.82096 15.30634 0 0 13.88821 12.90956 9.370031 17.09719 0 14.95541 0 17.2241 15.1131 15.20032 16.3702 14.63898 16.00386 15.83633 16.98502 16.06371 16.15765 0 0 14.93418 15.03576 13.84539 15.38003 15.85464 17.88218 14.4914 16.25049 14.38923 12.84253 0 0 16.45547 0 0 0 0 0 15.09667 8.824966 15.03834 16.29464 Q5JRX3 PREP_HUMAN "Presequence protease, mitochondrial, hPreP, EC 3.4.24.- (Pitrilysin metalloproteinase 1, Metalloprotease 1, hMP1)" PITRM1 KIAA1104 MP1 PREP Homo sapiens (Human) protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508] enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485 LTLSMRPDDK 5.489999771 1 1 0.266947723 1191.09798 13.13021 13.36145 12.6768 13.15642 12.27826 0 16.77687 13.23769 0 16.43623 13.62821 12.68709 0 0 14.73625 15.40164 13.21237 0 15.31246 0 15.81283 0 0 0 0 17.24827 0 14.16103 0 0 0 0 0 0 0 0 16.38564 0 0 0 17.56554 15.5003 14.03406 0 15.99932 17.00673 0 15.09194 Q5JS13 RGPS1_HUMAN "Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2, RalGEF 2) (RalA exchange factor RalGPS1)" RALGPS1 KIAA0351 RALGEF2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737; GO:0005886; GO:0007265; GO:0032485; GO:0035556; GO:0043547 ARHLLDDSVLESR 10.43000031 1 1 0.265072455 1509.612649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.65658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JS37 NHLC3_HUMAN NHL repeat-containing protein 3 NHLRC3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576] azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0005576; GO:0035578; GO:0043161; GO:0061630 GDNIPK 13.65999985 0.760124981 0.760124981 0.038870859 643.5678801 0 0 16.95095 0 16.04494 17.35154 0 11.59948 0 0 0 0 14.83866 13.63763 14.79263 0 12.07471 0 16.43811 0 14.61477 15.77437 17.38993 16.78189 0 18.84275 0 10.38368 0 0 13.16987 0 0 14.65961 0 12.72053 0 0 15.70543 13.39091 0 11.62759 0 0 9.684146 17.18761 0 0 Q5JSH3 WDR44_HUMAN WD repeat-containing protein 44 (Rabphilin-11) WDR44 RPH11 Homo sapiens (Human) cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] GO:0005794; GO:0005829; GO:0010008; GO:0048471 VVQDLSGEHMGAVWTMK 6.989999771 1 1 0.168550743 1903.950496 0 0 0 15.12696 13.63929 14.40739 16.49903 13.93364 14.79706 13.47206 0 14.55924 14.54314 0 15.98264 0 0 15.65576 0 0 0 15.49663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.21952 0 0 Q5JSJ4 INT6L_HUMAN Integrator complex subunit 6-like (Protein DDX26B) INTS6L DDX26B Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039] integrator complex [GO:0032039]; snRNA 3'-end processing [GO:0034472] GO:0032039; GO:0034472 GMMIDEADEFVAGPQNKVK 1.460000038 1 1 0.142820706 2093.858596 17.72932 16.14836 14.88478 14.73275 13.76948 14.89549 7.801178 0 0 11.67604 15.42298 0 13.70368 0 14.58404 0 0 0 14.65421 0 15.8614 14.97313 17.57178 16.38205 0 0 0 0 15.81269 0 16.01788 18.25353 13.41493 0 0 0 13.59708 13.64991 15.60271 15.66578 0 0 0 12.90452 0 14.95458 16.97238 17.14676 Q5JSL3 DOC11_HUMAN "Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor, ACG) (Zizimin-2)" DOCK11 ZIZ2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0001782; GO:0002315; GO:0005085; GO:0005829; GO:0007264; GO:0031267; GO:0043547; GO:0051491 ETEQLNK 7.550000191 1 1 0.251580111 858.4977619 0 0 15.85042 15.79887 14.37805 14.81095 0 0 0 0 0 12.4852 15.6799 0 0 0 0 0 0 0 0 0 15.76284 0 0 14.72694 12.87923 0 14.1156 14.09928 14.75983 16.30688 15.05499 0 0 0 0 0 0 0 0 0 0 16.5211 12.59 15.58356 10.64845 0 Q5JSP0 FGD3_HUMAN "FYVE, RhoGEF and PH domain-containing protein 3 (Zinc finger FYVE domain-containing protein 5)" FGD3 ZFYVE5 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872; GO:0051056 MESGRGSSTPPGPIAALGMPDTGPGSSSLGK 4.599999905 1 1 4.13E-12 2915.054198 14.91265 0 0 0 0 16.05155 13.8091 0 0 15.12654 0 0 0 0 0 12.93156 0 0 13.39938 0 13.80661 0 11.94697 0 11.71288 0 0 0 0 11.82957 0 0 0 0 0 0 0 14.62166 0 13.14084 0 0 13.80557 0 10.98093 0 0 0 Q5JST6 EFHC2_HUMAN EF-hand domain-containing family member C2 EFHC2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975] alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509] GO:0000281; GO:0005509; GO:0005930; GO:0007052; GO:0010975; GO:0036064; GO:0043014; GO:0060285; GO:0072686; GO:1990830 DSYGSK 10.15999985 0.042415351 0.042415351 0.184516341 657.5166423 16.59557 13.87803 16.66072 15.48309 17.13968 16.64716 0 15.96045 14.75222 16.24277 16.0831 14.94784 16.3309 16.01786 16.9723 14.96253 15.77631 16.10765 15.94639 16.37101 16.44232 17.05227 18.30602 16.79675 0 16.31403 16.175 15.41929 16.30572 14.46396 15.87948 15.52836 15.80294 17.02349 16.06833 16.58036 16.49967 17.80131 17.3081 16.44705 15.42977 16.81278 16.40481 0 16.36525 16.50543 16.20626 0 Q5JTD0 TJAP1_HUMAN Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4) TJAP1 PILT TJP4 Homo sapiens (Human) Golgi organization [GO:0007030] bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030] GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0007030 MTSAAPAKKPYR 2.74000001 1 1 0.159301638 1320.166308 15.27496 0 15.53246 0 0 0 0 0 0 0 0 0 0 0 0 14.96165 0 0 0 13.04839 16.01285 12.41398 14.82005 0 0 0 0 0 0 0 0 15.09306 0 0 0 0 17.18901 0 0 15.54294 15.74755 16.06514 0 0 0 16.10361 0 0 Q5JTD7 LRC73_HUMAN Leucine-rich repeat-containing protein 73 LRRC73 C6orf154 Homo sapiens (Human) LPSSIQISGEPLSGAEVR 5.659999847 0.154029697 0.154029697 0.390056006 1843.725012 0 15.58188 0 15.65628 16.00562 16.33675 0 15.10943 0 0 0 0 0 16.38933 15.46533 0 0 0 0 13.81834 0 0 0 0 0 17.57976 0 0 0 0 0 0 0 0 0 0 0 17.03438 0 0 18.1115 15.28316 16.42872 0 0 0 0 0 Q5JTH9 RRP12_HUMAN RRP12-like protein RRP12 KIAA0690 Homo sapiens (Human) rRNA processing [GO:0006364] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0003723; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0016021; GO:0031965; GO:0043231 LYSTIRPYLESKAHGVQK 14.84000015 0.267957985 0.267957985 0.285644533 2089.173212 15.07878 0 0 0 18.42634 17.78488 17.01044 20.10204 18.82707 15.58206 17.33255 18.70227 12.82854 18.1291 16.67527 18.11105 0 17.42185 16.15425 0 17.1237 0 13.38828 0 15.93793 0 19.02056 0 17.97784 14.50062 18.64826 18.07579 18.30223 0 0 0 19.19225 19.88107 17.62098 16.50014 12.85666 18.04952 0 15.49698 17.99335 17.12041 17.65335 17.99656 Q5JTN6 WDR38_HUMAN WD repeat-containing protein 38 WDR38 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244 MNSGVPATLAVR 2.470000029 1 1 0.312844056 1231.256747 16.51703 0 0 13.95548 13.95115 14.69197 0 15.65268 15.21564 0 0 13.03182 15.03723 0 0 0 16.0066 0 0 15.66542 0 15.30269 0 0 14.56386 0 0 0 0 0 0 0 15.3377 0 15.56705 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JTV8 TOIP1_HUMAN "Torsin-1A-interacting protein 1 (Lamin-associated protein 1B, LAP1B)" TOR1AIP1 LAP1 Homo sapiens (Human) membrane organization [GO:0061024]; nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521]; membrane organization [GO:0061024]; nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504] ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521] GO:0001671; GO:0005521; GO:0005634; GO:0005637; GO:0008092; GO:0016020; GO:0016021; GO:0031965; GO:0032781; GO:0034504; GO:0051117; GO:0061024; GO:0071763; GO:0090435 SDSAKEEVR 3.450000048 1 1 0.095990246 1019.48378 18.1228 0 0 0 0 0 0 0 0 16.77981 14.22392 0 14.98852 15.53907 0 0 0 0 0 14.33081 0 15.43541 0 0 0 0 0 0 0 0 0 0 12.85072 0 0 14.48702 0 14.80395 0 0 0 0 13.69594 0 0 0 0 0 Q5JTW2 CEP78_HUMAN "Centrosomal protein of 78 kDa, Cep78" CEP78 C9orf81 Homo sapiens (Human) cilium organization [GO:0044782] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; cilium organization [GO:0044782] GO:0005813; GO:0005814; GO:0005829; GO:0036064; GO:0044782 MCSPSPDATSGTGSQRK 1.600000024 1 1 0.4419634 1781.971938 16.81617 12.74844 15.01932 0 0 0 0 0 0 0 0 18.44368 0 17.11468 0 0 0 17.18068 0 0 0 0 0 0 18.80358 0 19.66808 0 0 0 20.48009 19.99535 19.92168 0 19.49179 0 20.07228 0 0 0 0 0 0 0 0 17.42229 0 0 Q5JU85 IQEC2_HUMAN IQ motif and SEC7 domain-containing protein 2 IQSEC2 KIAA0522 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685] cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737; GO:0030036; GO:0032012; GO:0050804; GO:0098685; GO:0098696 GPPGR 3.599999905 0.143695548 0.143695548 0.290775369 481.0312145 16.26682 15.67366 16.23034 15.56405 12.97992 0 14.68883 16.49963 15.62048 16.01374 15.7709 15.96461 0 0 15.25087 15.8424 14.58704 16.05201 15.86643 0 0 15.36827 16.62061 0 16.13569 15.41248 15.64055 15.92658 15.30504 0 15.28004 0 0 0 16.94337 0 0 16.45115 15.12825 15.1646 0 15.03504 16.09367 16.67092 15.23544 17.46214 0 0 Q5JUK3 KCNT1_HUMAN Potassium channel subfamily T member 1 (KCa4.1) KCNT1 KIAA1422 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271] intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271] GO:0005228; GO:0005886; GO:0015271; GO:0016021 APKQAGR 6.210000038 1 1 0.163457298 728.7697219 0 15.93621 14.32655 0 0 0 0 0 0 0 0 0 0 15.6336 0 0 0 15.11034 0 0 0 0 0 17.21834 0 0 14.2141 15.74234 0 14.01671 0 0 0 0 0 0 16.94291 17.06272 0 0 17.18324 0 15.75308 0 0 0 0 0 Q5JUR7 TEX30_HUMAN Testis-expressed protein 30 TEX30 C13orf27 Homo sapiens (Human) hydrolase activity [GO:0016787] hydrolase activity [GO:0016787] GO:0016787 MQAPHKIHWIEK 27.03000069 0.000689835 0.000689835 0.220488773 1532.82913 21.15711 16.32931 0 19.86873 15.14042 0 17.6597 21.31096 18.94238 0 21.35679 20.81112 22.34649 20.67843 21.43239 0 0 17.17115 22.05924 20.36659 20.42982 17.78941 22.18701 21.14532 20.63305 21.38129 20.53271 19.7366 20.39002 20.97482 19.91807 21.3768 0 22.00254 20.30237 21.17376 0 20.69159 18.29226 18.54381 0 17.52155 22.00191 21.17759 21.37775 21.34727 21.53622 19.94348 Q5JUX0 SPIN3_HUMAN "Spindlin-3 (Spindlin-like protein 3, SPIN-3)" SPIN3 Homo sapiens (Human) "gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; methylated histone binding [GO:0035064]; gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]" methylated histone binding [GO:0035064] GO:0005654; GO:0005829; GO:0006355; GO:0007276; GO:0035064 AAAGQRSR 12.60000038 1 1 5.73E-13 815.6547854 0 0 12.16453 14.25578 14.59232 12.8092 0 0 14.77422 0 15.69636 15.51733 0 13.80601 15.51985 12.94936 12.38947 13.96835 0 13.47023 0 0 0 0 0 0 15.9421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.67763 Q5JV73 FRPD3_HUMAN FERM and PDZ domain-containing protein 3 FRMPD3 KIAA1817 Homo sapiens (Human) cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] GO:0005856; GO:0005886; GO:0030667; GO:0070821 KGGKPGSSR 3.519999981 0.628057182 0.628057182 0.022093267 873.4662439 14.00918 16.96991 16.42058 17.59546 0 13.20748 15.26779 13.8799 0 16.01178 16.54412 14.14875 16.13033 12.76755 13.90695 16.0334 16.40936 15.98274 0 15.22981 14.66979 15.73906 15.17785 14.81755 16.36044 17.05656 14.67694 15.99148 10.39747 17.25882 15.39419 17.00827 18.07518 15.3243 19.00167 15.34758 13.11499 15.6973 17.2366 17.74522 14.25727 14.80877 0 13.89585 15.72726 17.20918 16.62107 15.06674 Q5JVF3 PCID2_HUMAN PCI domain-containing protein 2 (CSN12-like protein) PCID2 HT004 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear mRNA surveillance [GO:0071028]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]" cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] "cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear mRNA surveillance [GO:0071028]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]" double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0071028; GO:0090267; GO:2000117 SKVGDMLEK 7.039999962 1 1 0.155607971 1022.360965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.37238 0 0 0 0 0 18.8854 0 0 0 0 0 0 0 0 0 0 Q5JVS0 HABP4_HUMAN "Intracellular hyaluronan-binding protein 4, IHABP-4, IHABP4 (Hyaluronan-binding protein 4) (Ki-1/57 intracellular antigen)" HABP4 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; mRNA processing [GO:0006397]; negative regulation of DNA binding [GO:0043392]; PML body organization [GO:0030578]; positive regulation of RNA splicing [GO:0033120]; positive regulation of translational initiation [GO:0045948]; RNA splicing [GO:0008380] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Gemini of coiled bodies [GO:0097504]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sarcomere [GO:0030017]; sarcoplasm [GO:0016528] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Gemini of coiled bodies [GO:0097504]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sarcomere [GO:0030017]; sarcoplasm [GO:0016528]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; cellular response to mechanical stimulus [GO:0071260]; mRNA processing [GO:0006397]; negative regulation of DNA binding [GO:0043392]; PML body organization [GO:0030578]; positive regulation of RNA splicing [GO:0033120]; positive regulation of translational initiation [GO:0045948]; RNA splicing [GO:0008380] RNA binding [GO:0003723]; SUMO binding [GO:0032183] GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0010494; GO:0015030; GO:0016528; GO:0016607; GO:0030017; GO:0030578; GO:0031965; GO:0032183; GO:0033120; GO:0043392; GO:0045948; GO:0071260; GO:0097504 DEAAAAAGAGPR 8.43999958 0.857553422 0.857553422 0.198626345 1055.407203 13.22871 15.33075 15.04682 10.78734 0 0 0 16.12965 0 15.99402 15.40036 0 0 14.82665 15.8135 0 0 0 16.72029 14.81404 13.7531 14.81787 13.92086 14.30289 0 0 0 0 14.49212 14.90519 15.0988 15.58187 14.89091 15.18655 14.3464 14.48168 0 0 16.43357 0 0 0 0 13.01621 0 8.09767 0 16.05609 Q5JVX7 CA141_HUMAN Uncharacterized protein C1orf141 C1orf141 Homo sapiens (Human) INRLQSEGR 3.809999943 0.547834814 0.547834814 0.197893727 1073.326464 14.58744 16.77176 0 15.57455 16.00134 13.94284 17.24385 16.04793 15.43066 16.14678 15.65166 14.35203 0 15.10444 14.99219 0 15.52205 15.12001 0 15.68742 0 0 16.35614 16.62466 15.49541 0 15.90148 14.63308 14.77076 16.26121 11.00222 15.67961 13.73573 15.15181 14.89908 14.97325 16.25457 15.48249 13.20736 16.13825 15.36226 0 13.70842 14.94083 15.95711 16.11824 13.61907 14.10261 Q5JW98 CAHM4_HUMAN Calcium homeostasis modulator protein 4 (Protein FAM26D) CALHM4 C6orf78 FAM26D UNQ6481/PRO21277 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261] cation channel activity [GO:0005261] GO:0005261; GO:0005887 ISPLECK 6.849999905 1 1 0.09124467 848.370582 14.26321 13.08471 15.30814 0 0 14.285 0 0 0 0 0 0 0 0 0 0 0 16.19909 0 0 0 0 0 0 0 0 15.30788 0 0 0 15.08334 14.64012 0 0 0 0 0 13.14505 0 16.25584 0 14.13945 0 0 0 0 0 0 Q5JX71 F209A_HUMAN Protein FAM209A FAM209A C20orf106 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634] GO:0005634; GO:0005637; GO:0016021; GO:0070062 AMATGSGSNLR 2.859999895 1 1 0.073472623 1064.177985 17.536 10.97559 15.97162 14.00453 14.0611 0 0 12.99382 0 0 14.79351 15.92326 0 14.05483 0 0 0 14.68542 13.79189 0 0 0 16.23944 14.51474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JY77 GASP1_HUMAN "G-protein coupled receptor-associated sorting protein 1, GASP-1" GPRASP1 GASP KIAA0443 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172] cytosol [GO:0005829] cytosol [GO:0005829]; endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172] GO:0005829; GO:0008333; GO:1990172 KETVFSDDDFNIEPLISAFHK 3.430000067 1 1 2.75E-12 2451.725444 0 13.90431 14.1353 0 14.89981 13.41869 13.97959 0 13.51973 0 0 14.30256 0 0 13.82413 0 0 14.72552 14.21439 0 12.33853 0 15.24927 0 13.46085 12.9481 13.79598 13.86563 14.77485 14.06536 14.39384 16.23897 0 0 0 0 0 17.29439 0 0 0 0 0 0 0 0 16.15011 0 Q5JYT7 K1755_HUMAN Uncharacterized protein KIAA1755 KIAA1755 Homo sapiens (Human) IACLPGGRDR 8.090000153 1 1 0.176813568 1115.294567 13.97589 14.65144 0 0 15.5159 12.89768 0 0 15.60365 0 14.97367 0 13.78111 12.95242 14.69951 0 12.40799 14.70737 0 0 0 0 0 0 0 0 14.45743 13.72849 14.03037 8.158913 14.54458 13.47296 14.17314 0 0 15.05363 0 0 0 14.79824 0 0 0 0 0 14.6117 0 14.05174 Q5JZY3 EPHAA_HUMAN "Ephrin type-A receptor 10, EC 2.7.10.1" EPHA10 Homo sapiens (Human) axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0016021; GO:0033674; GO:0043005; GO:0043235 ELDAKSVTLER 6.400000095 1 1 0.339492789 1260.118195 0 0 0 0 15.35654 0 0 12.85071 0 0 0 16.19664 16.92958 0 16.80286 16.51765 16.07785 14.76742 16.18638 0 0 0 0 0 0 14.60685 0 16.16382 0 16.21507 0 17.14627 0 0 0 0 0 0 0 0 15.44292 0 16.34431 0 0 16.60099 0 0 Q5K651 SAMD9_HUMAN "Sterile alpha motif domain-containing protein 9, SAM domain-containing protein 9" SAMD9 C7orf5 DRIF1 KIAA2004 OEF1 Homo sapiens (Human) endosomal vesicle fusion [GO:0034058] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058] GO:0005737; GO:0005829; GO:0034058; GO:0043231 IDQCFK 16.45999908 0.359456271 0.359456271 0.202918681 811.3735955 15.8943 0 15.54891 0 0 0 0 15.59404 0 15.95296 0 0 15.94344 0 0 15.51027 15.4746 15.55442 17.4341 0 0 15.97408 0 16.70689 14.2909 0 16.56477 17.22922 0 0 16.77841 16.51776 16.08317 13.83801 16.46594 14.37276 0 16.19586 15.52169 14.87957 0 16.15411 16.14734 15.75277 0 13.11352 15.66585 0 Q5KSL6 DGKK_HUMAN "Diacylglycerol kinase kappa, DAG kinase kappa, DGK-kappa, EC 2.7.1.107 (142 kDa diacylglycerol kinase) (Diglyceride kinase kappa)" DGKK Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979] ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] GO:0003951; GO:0004143; GO:0005524; GO:0005886; GO:0006979; GO:0007205; GO:0030168; GO:0035556; GO:0046339; GO:0046834; GO:0046872 TIQQGEIYK 5.460000038 1 1 0.193664905 1079.46718 0 14.45577 15.91026 0 14.86444 0 0 15.70238 0 0 14.71681 13.42874 0 14.09417 0 12.71361 0 18.04309 15.56867 16.27341 0 14.02521 0 0 0 16.90171 16.8518 0 15.17594 0 0 17.43838 0 16.29968 15.92294 0 0 16.01969 0 15.02261 0 0 0 17.58333 0 15.37558 0 0 Q5KU26 COL12_HUMAN "Collectin-12 (Collectin placenta protein 1, CL-P1, hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)" COLEC12 CLP1 NSR2 SCARA4 SRCL Homo sapiens (Human) "carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]" collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]" galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006910; GO:0006952; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0038187; GO:0042742; GO:0044857; GO:0045087; GO:0046872; GO:0071360 CYYFSVEK 5 1 1 0.125914575 1096.73582 13.71965 14.80389 13.84868 0 14.38979 13.58186 15.26561 12.62927 0 0 0 0 13.93638 14.93042 14.19279 12.71715 0 13.62405 0 0 12.8241 0 0 0 0 15.6495 0 0 0 13.91382 0 0 16.25541 0 15.07037 0 0 0 0 0 0 14.4756 12.13232 0 0 0 15.99346 0 Q5M775 CYTSB_HUMAN "Cytospin-B (Nuclear structure protein 5, NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1)" SPECC1 CYTSB NSP5 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824] apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654] apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824] GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177 SVSSPTSSNTPTPTKHLR 5.539999962 1 1 0 1892.926883 0 0 0 0 0 13.71824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.01484 0 16.22008 16.67496 0 0 0 0 0 16.28008 0 0 0 0 0 0 Q5M7Z0 RNFT1_HUMAN "E3 ubiquitin-protein ligase RNFT1, EC 2.3.2.27 (Protein PTD016) (RING finger and transmembrane domain-containing protein 1)" RNFT1 PTD016 Homo sapiens (Human) positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865] metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630] GO:0005783; GO:0005789; GO:0016021; GO:0043130; GO:0046872; GO:0051865; GO:0061630; GO:1904294 ECAENASSRNIR 8.239999771 1 1 0.411461532 1406.580752 15.80665 0 18.74233 0 0 0 17.76847 0 0 0 0 0 0 0 0 18.17401 18.56263 0 0 0 0 0 17.9918 0 0 18.18176 0 0 0 0 0 0 18.08692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5M8T2 S35D3_HUMAN Solute carrier family 35 member D3 (Fringe connection-like protein 1) SLC35D3 FRCL1 Homo sapiens (Human) carbohydrate transport [GO:0008643]; energy homeostasis [GO:0097009]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; energy homeostasis [GO:0097009]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863] antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] GO:0005461; GO:0005462; GO:0005463; GO:0005769; GO:0005783; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0070863; GO:0097009 FMETR 2.269999981 0.414923251 0.414923251 0.272795197 682.9949045 16.20916 15.2856 14.11642 0 0 0 15.79806 16.27 0 0 0 0 14.53904 16.46131 0 0 0 16.34085 0 0 16.24577 16.68771 16.76935 0 0 15.82524 14.6467 0 16.18871 14.91052 15.98881 0 0 15.62642 15.73048 16.77291 0 15.97564 15.70395 16.13424 11.47008 0 14.65948 15.97827 14.32436 16.97096 17.73511 17.0235 Q5M9N0 CD158_HUMAN Coiled-coil domain-containing protein 158 CCDC158 Homo sapiens (Human) LLADLHKR 3.569999933 0.382597446 0.382597446 0.218916477 963.4177846 13.32961 16.4465 11.72318 15.55872 0 0 16.12162 0 0 16.41592 15.90096 0 0 0 15.24126 14.36509 0 0 0 0 0 16.85681 15.53224 15.42968 14.56957 15.9977 16.06035 0 15.38083 15.40472 14.96487 15.89813 9.501472 13.72328 16.51 14.61316 16.15234 14.81495 15.70381 14.64103 16.35061 14.14693 16.08471 14.87851 13.39173 16.66648 16.05074 15.5074 Q5M9Q1 NKAPL_HUMAN NKAP-like protein NKAPL C6orf194 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154 EMVHKK 10.10000038 0.697117031 0.697117031 0.214870044 772.3351574 16.12512 15.80205 15.28684 14.60085 0 15.63899 14.94232 12.93301 0 17.37723 14.21627 0 14.80249 14.93821 15.97381 15.86635 14.80103 16.09136 15.51291 14.3419 15.5094 16.34917 9.752864 15.97805 0 0 16.27816 16.62634 0 15.45564 15.7341 16.41364 15.46219 0 15.91567 0 16.5069 16.48036 12.7637 14.3539 0 14.96782 14.0752 15.54635 13.92747 16.38019 0 16.24171 Q5MIZ7 P4R3B_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2) PPP4R3B KIAA1387 PP4R3B SMEK2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; histone dephosphorylation [GO:0016576]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; histone dephosphorylation [GO:0016576]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779] protein phosphatase activator activity [GO:0072542] GO:0000785; GO:0005654; GO:0005737; GO:0005813; GO:0006470; GO:0006974; GO:0016576; GO:0016607; GO:0030289; GO:0033128; GO:0045722; GO:0072542; GO:2000779 LGILPALEIVMGMDDLQVR 2.789999962 1 1 0.151025724 2099.371375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5MJ07 SPXN5_HUMAN "Sperm protein associated with the nucleus on the X chromosome N5 (Nuclear-associated protein SPAN-Xn5, SPANX-N5) (SPANX family member N5)" SPANXN5 Homo sapiens (Human) MKTSEYSTVLVLCYR 5.96999979 1 1 4.60E-13 1866.230505 0 15.79427 16.02037 15.90814 15.08603 0 0 0 15.72694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.76324 0 0 0 0 0 0 0 0 0 0 0 15.4003 16.22012 13.89062 0 0 0 0 0 16.40766 0 0 Q5MJ08 SPXN4_HUMAN "Sperm protein associated with the nucleus on the X chromosome N4 (Nuclear-associated protein SPAN-Xn4, SPANX-N4) (SPANX family member N4)" SPANXN4 Homo sapiens (Human) EKGDLDISAGSPQDGGQN 6.730000019 1 1 0.246974653 1786.707564 13.86928 14.63995 0 14.75774 0 0 0 14.12415 14.56909 16.42405 0 0 13.30154 0 0 11.83052 0 0 0 0 0 0 16.0027 0 0 16.5536 0 0 0 0 0 0 0 14.70782 0 15.77831 0 0 17.0146 11.37553 0 0 0 0 16.12075 0 0 0 Q5MJ70 SPDYA_HUMAN "Speedy protein A (Rapid inducer of G2/M progression in oocytes A, RINGO A, hSpy/Ringo A) (Speedy-1, Spy1)" SPDYA SPDY1 SPY1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein kinase activity [GO:0045860] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein kinase activity [GO:0045860] protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] GO:0000082; GO:0005634; GO:0005654; GO:0006974; GO:0007140; GO:0008284; GO:0019901; GO:0030295; GO:0045737; GO:0045860 AKFTISEHTR 6.599999905 1 1 0.163863263 1189.729415 12.19053 14.59038 12.78638 0 13.4207 0 14.21924 0 0 14.39351 12.38496 15.84478 0 0 0 0 0 0 0 0 16.10814 0 13.93069 0 13.83822 0 0 0 0 0 0 0 15.70728 0 0 0 14.97002 0 17.33261 11.30105 0 0 0 0 0 0 0 0 Q5MNV8 FBX47_HUMAN F-box only protein 47 FBXO47 Homo sapiens (Human) LLLQDFHNLELPDR 9.359999657 1 1 0.583892031 1721.045089 0 0 19.28968 17.87244 0 18.80801 0 0 18.67376 0 0 0 0 0 0 0 0 0 0 16.54537 0 0 0 0 0 0 0 0 0 0 0 19.08533 0 0 0 18.86304 0 0 0 0 0 0 0 0 0 17.20289 0 0 Q5PRF9 SMAG2_HUMAN "Protein Smaug homolog 2, Smaug 2, hSmaug2 (Sterile alpha motif domain-containing protein 4B, SAM domain-containing protein 4B)" SAMD4B SMAUG2 Homo sapiens (Human) nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371] GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371 MGLLSPSGIGGVSPR 6.480000019 1 1 0.346503062 1444.529231 13.89989 14.04933 0 0 12.67159 10.52411 15.29937 14.22316 14.63248 14.35865 0 0 15.70266 0 0 0 0 0 0 0 0 0 0 15.32765 16.12493 0 0 0 0 0 0 0 0 0 0 0 12.56075 0 0 16.67206 15.70735 14.88632 15.30098 14.96249 0 0 0 15.68095 Q5PSV4 BRM1L_HUMAN Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40) BRMS1L Homo sapiens (Human) histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of growth [GO:0040008] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of growth [GO:0040008] histone deacetylase binding [GO:0042826] GO:0000122; GO:0005634; GO:0016575; GO:0016580; GO:0030336; GO:0030512; GO:0040008; GO:0042826; GO:0070822; GO:1902455; GO:1902459 AMATLGPHR 12.90999985 1 1 8.01E-13 970.4464935 13.72007 12.47567 14.29302 13.8503 0 13.99768 14.531 11.41263 15.23027 15.56349 13.17486 14.12597 0 13.60404 13.43163 12.97575 14.58315 13.65342 13.46068 12.59666 0 0 11.23203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5QFB9 PAPAS_HUMAN Protein PAPPAS (DIPLA1 antisense RNA 1) (DIPLA1 antisense gene protein 1) (DIPLA1-antisense expressed) (PAPPAS antisense RNA 1) (PAPPAS antisense gene protein 1) (PAPPAS-antisense expressed) PAPPA-AS1 DIPAS PAPPAS Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 HLDMFLSVIGQR 1.75999999 0.251813799 0.251813799 0.283985802 1431.903935 16.19319 14.26467 15.48836 0 0 0 15.2836 0 13.71115 0 12.19388 14.91433 15.83714 15.98198 0 14.62034 15.99753 0 14.80047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.76188 0 0 0 0 0 0 0 0 0 0 0 Q5QJ38 TCHL1_HUMAN Trichohyalin-like protein 1 (Basalin) (Protein S100-A17) (S100 calcium-binding protein A17) TCHHL1 S100A17 THHL1 Homo sapiens (Human) transition metal ion binding [GO:0046914] transition metal ion binding [GO:0046914] GO:0046914 EASTTKQ 4.369999886 0.068895482 0.068895482 0.306103192 761.7766248 15.95669 14.75872 15.49534 14.57157 13.00586 0 16.45039 15.43962 0 15.96605 14.93956 16.51252 15.55214 15.07174 14.83829 15.90721 14.80316 0 15.19465 14.95582 0 0 0 16.48745 16.81665 17.12625 16.28875 0 14.69261 14.01029 16.41799 15.15193 16.63751 15.90984 15.36358 14.921 0 15.21972 0 16.06487 16.21957 15.23165 14.90491 0 0 15.59418 13.85234 15.71558 Q5QP82 DCA10_HUMAN DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) DCAF10 WDR32 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567] GO:0005654; GO:0016567; GO:0080008 FSPTHCQIASGCLSGRVSLYQPK 1.950000048 1 1 0.356452395 2593.795096 0 0 15.36186 14.34111 13.74646 13.1342 0 0 0 0 13.91307 0 0 0 14.49618 12.05164 0 0 0 0 0 16.00297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5R372 RBG1L_HUMAN Rab GTPase-activating protein 1-like RABGAP1L HHL KIAA0471 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0006897; GO:0015031; GO:0031267; GO:0032880; GO:0090630 LTYLGCMKVSSPR 6.920000076 0.82420969 0.82420969 0.057742507 1528.3886 0 13.34919 13.48506 14.39667 0 15.60614 0 0 18.09369 14.61512 0 16.15467 14.72618 15.84092 15.55914 10.41048 14.77443 15.24614 0 0 11.48907 0 15.47462 0 0 10.58321 16.1809 12.8044 0 14.48509 0 17.67317 15.99217 0 15.68282 0 16.13739 15.59893 0 11.49303 14.93851 14.13874 0 0 0 18.61603 0 0 Q5R3I4 TTC38_HUMAN "Tetratricopeptide repeat protein 38, TPR repeat protein 38" TTC38 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 MAAASPLR 9.31000042 1 1 0.210644375 832.4251742 15.97214 14.25687 0 16.4272 0 0 0 18.00962 0 0 0 0 0 0 0 14.58208 16.00385 16.40984 0 0 0 14.50261 0 17.13724 0 14.77416 15.90073 15.74567 0 0 14.89134 15.32984 0 15.25393 0 0 16.25578 0 14.39926 0 0 14.25291 0 0 0 16.27606 0 15.21477 Q5RHP9 ERIC3_HUMAN Glutamate-rich protein 3 ERICH3 C1orf173 Homo sapiens (Human) ANALK 1.75 1 1 0.121459745 515.4553112 0 0 15.39123 0 15.34857 0 13.88907 10.70766 15.3053 16.05535 15.85892 16.2929 14.71957 0 0 0 0 14.67778 16.80176 0 0 0 0 15.13863 0 0 15.65134 0 0 0 16.12024 0 0 0 15.83387 0 0 0 0 0 0 0 0 0 16.80205 0 0 0 Q5RKV6 EXOS6_HUMAN "Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog, hMtr3) (p11)" EXOSC6 MTR3 Homo sapiens (Human) "DNA deamination [GO:0045006]; isotype switching [GO:0045190]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; DNA deamination [GO:0045006]; isotype switching [GO:0045190]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" RNA binding [GO:0003723] GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0045006; GO:0045190; GO:0045830; GO:0071028; GO:0071051; GO:0101019 AGLLSQAKGSAYLEAGGTK 2.589999914 1 1 6.89E-13 1816.812418 0 13.24606 14.61131 0 14.47632 0 11.73264 15.9058 0 15.06921 14.57921 0 11.94916 0 15.21366 0 0 0 0 0 13.2665 0 0 0 0 0 13.33678 0 0 0 0 0 15.83598 0 0 0 0 0 0 0 0 0 0 0 13.54531 0 0 0 Q5RL73 RBM48_HUMAN RNA-binding protein 48 RBM48 C7orf64 HSPC304 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005654 TTQLQERK 9.109999657 0.139721498 0.139721498 0.072273152 1002.089767 0 9.033824 0 9.656753 0 0 14.51379 0 11.12693 13.09885 0 17.08019 16.8821 16.95479 13.65669 18.01945 16.37227 16.16326 14.28907 9.617247 0 0 0 16.73854 12.84509 0 14.98242 0 15.38216 14.64153 16.95262 14.64854 0 15.1912 15.60324 16.86453 15.49775 19.0459 14.93613 0 13.46407 0 17.02703 0 17.24593 0 0 16.0455 Q5S007 LRRK2_HUMAN "Leucine-rich repeat serine/threonine-protein kinase 2, EC 2.7.11.1, EC 3.6.5.- (Dardarin)" LRRK2 PARK8 Homo sapiens (Human) "autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]" "amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]" "amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]; actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]" actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0004722; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007165; GO:0007254; GO:0007283; GO:0007528; GO:0008017; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016234; GO:0016242; GO:0016301; GO:0016310; GO:0017075; GO:0018105; GO:0018107; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031398; GO:0031410; GO:0031647; GO:0031966; GO:0032091; GO:0032092; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034613; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043406; GO:0044325; GO:0044753; GO:0044754; GO:0045121; GO:0045860; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051770; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0070997; GO:0071287; GO:0071407; GO:0072593; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900244; GO:1901214; GO:1901215; GO:1901727; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903125; GO:1903206; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300 CYNIVVEAMKAFPMSER 13.64999962 0.676503956 0.676503956 0.102471047 2076.336558 0 14.80967 0 16.76141 0 0 0 0 0 0 0.4614795 0 0 15.9767 0 0 13.51547 15.18386 0 10.59204 0 17.65881 0 16.71193 13.29368 16.89545 0 16.47162 16.01621 17.86945 0 0 17.87271 14.00565 18.92503 13.2274 13.81772 16.71931 0 0 0 0 17.99761 0 0 15.01582 13.24917 0 Q5SQN1 SNP47_HUMAN "Synaptosomal-associated protein 47, SNAP-47 (Epididymis luminal protein 170) (Synaptosomal-associated 47 kDa protein)" SNAP47 C1orf142 HEL170 SVAP1 Homo sapiens (Human) exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201] endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906] SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905] GO:0005484; GO:0005886; GO:0006887; GO:0006906; GO:0012505; GO:0016082; GO:0019905; GO:0031201; GO:0031629; GO:0048471; GO:0098793 EASHFIFSSITILEK 1.269999981 1 1 0.282553789 1721.033201 0 14.75741 0 0 0 0 0 12.74464 14.60297 0 0 0 0 0 0 0 0 16.12202 0 0 0 0 15.59704 9.713362 0 0 0 0 0 0 0 0 17.09171 0 0 0 0 0 14.20286 0 0 0 0 0 18.19863 0 17.34412 0 Q5SQQ9 VAX1_HUMAN Ventral anterior homeobox 1 VAX1 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; negative regulation of neuroblast proliferation [GO:0007406]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; negative regulation of neuroblast proliferation [GO:0007406]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle cell differentiation [GO:0035914]" "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0001764; GO:0005634; GO:0006357; GO:0007406; GO:0007411; GO:0007417; GO:0007420; GO:0030182; GO:0031490; GO:0035914; GO:0043010; GO:0060021; GO:1990837 MFGKPDK 13.56000042 0.043752044 0.043752044 0.269691136 838.2234526 17.80264 18.25256 0 18.34863 17.57449 17.52482 20.44973 0 20.68309 0 17.64452 16.99977 17.49881 16.9471 0 0 18.50524 0 0 16.25193 17.19448 0 0 0 17.95906 0 0 17.58007 0 0 19.46682 0 19.92704 0 17.75665 18.91003 0 0 19.46223 0 17.25173 0 0 17.98635 18.43382 17.91677 0 17.54539 Q5SQS7 SH24B_HUMAN SH2 domain-containing protein 4B SH2D4B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AAKVLEER 2.079999924 0.04704446 0.04704446 0.282650622 915.1307538 0 16.33909 18.21795 0 0 0 16.0856 0 18.15732 0 17.49552 0 0 0 17.35398 0 0 17.27241 16.8589 0 17.50876 0 0 16.29257 0 18.76083 0 0 0 0 0 0 17.11897 17.75579 16.97755 17.4527 17.65069 17.85256 0 0 0 0 17.87913 0 0 16.86444 0 0 Q5SRN2 TSBP1_HUMAN Testis-expressed basic protein 1 (Uncharacterized protein C6orf10) TSBP1 C6orf10 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 GQEAQVEKSEMGVPR 5.769999981 1 1 0.446627309 1644.98471 0 16.0264 0 0 0 0 0 15.1626 0 0 0 0 0 0 0 0 0 0 17.14161 0 0 0 0 16.81656 0 16.46559 0 0 0 0 14.77435 0 0 0 0 0 0 0 16.91675 0 0 0 0 0 0 0 0 0 Q5ST30 SYVM_HUMAN "Valine--tRNA ligase, mitochondrial, EC 6.1.1.9 (Valyl-tRNA synthetase, ValRS) (Valyl-tRNA synthetase-like)" VARS2 KIAA1885 VARS2L VARSL Homo sapiens (Human) valyl-tRNA aminoacylation [GO:0006438] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832] GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006438 SLGNVLDPRDIISGVEMQVLQEK 4.389999866 1 1 0.06909733 2555.156888 0 0 0 0 0 11.0937 0 15.17165 0 0 0 14.33358 14.41682 0 11.37109 10.78229 14.26199 0 13.41684 0 0 14.68811 14.33146 15.53092 0 0 0 0 13.13187 0 11.11676 13.48745 13.32182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SVQ8 ZBT41_HUMAN Zinc finger and BTB domain-containing protein 41 ZBTB41 FRBZ1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 SLLLGKK 11.30000019 1 1 0.296540974 759.0638749 0 0 0 0 0 0 17.51717 0 0 0 0 18.20117 0 0 0 0 15.7607 0 18.02556 0 0 18.36482 0 0 19.61025 20.19626 0 0 0 0 0 0 0 20.17815 0 0 0 0 17.3193 18.82803 0 18.2445 17.95701 0 0 0 0 0 Q5SVZ6 ZMYM1_HUMAN Zinc finger MYM-type protein 1 ZMYM1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270] protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270] GO:0005634; GO:0008270; GO:0046983 SMKISDELCHPK 7.650000095 0.61274749 0.61274749 0.246224925 1461.099451 16.84852 14.473 13.84777 14.94119 16.42609 0 0 0 14.35523 0 15.72733 0 15.25107 0 0 0 0 0 0 0 16.25815 0 0 0 15.36814 0 0 15.10613 0 0 0 0 17.60366 0 0 16.6231 0 0 0 0 0 0 0 0 16.44618 16.5731 0 0 Q5SW79 CE170_HUMAN "Centrosomal protein of 170 kDa, Cep170 (KARP-1-binding protein, KARP1-binding protein)" CEP170 FAM68A KAB KIAA0470 Homo sapiens (Human) centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; spindle [GO:0005819] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; spindle [GO:0005819] GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0120103 AKVVTQR 4.75 1 1 0.080145523 800.8176973 0 14.87565 15.94807 15.24582 0 13.2117 0 0 15.12067 0 13.99118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.41882 17.24743 0 0 17.80203 0 0 0 0 0 18.66304 0 18.50809 Q5SW96 ARH_HUMAN Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein) LDLRAP1 ARH Homo sapiens (Human) amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076] axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] "axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]" "amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]" GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030669; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602 SLVATGNLLDLEETAK 6.869999886 1 1 6.92E-13 1672.807463 0 0 0 0 0 0 0 16.90906 19.70546 0 15.44203 0 16.29497 0 0 0 19.47347 0 0 0 0 0 0 0 16.85545 0 16.36447 0 0 0 15.71922 0 17.47132 0 0 0 0 17.49962 0 0 0 0 0 0 0 16.35342 0 0 Q5SWA1 PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B PPP1R15B Homo sapiens (Human) ER overload response [GO:0006983]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542] endoplasmic reticulum [GO:0005783]; protein phosphatase type 1 complex [GO:0000164] endoplasmic reticulum [GO:0005783]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase regulator activity [GO:0019888]; ER overload response [GO:0006983]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542] protein phosphatase regulator activity [GO:0019888] GO:0000164; GO:0001933; GO:0005783; GO:0006983; GO:0019888; GO:0032516; GO:0034976; GO:0042542; GO:0070262; GO:1903898; GO:1903912 SQAGSSK 2.690000057 0.258664578 0.258664578 0.263899395 664.8712305 17.6349 16.2798 16.35283 16.90662 13.59832 17.41674 15.18336 15.1495 15.28456 15.13124 17.52933 15.72795 15.68364 14.39266 15.0053 15.33535 15.21595 15.84674 15.63575 16.63772 14.55478 15.6034 16.53388 14.82914 17.41255 14.79355 16.47598 16.00577 0 16.61431 16.87585 16.41055 18.6879 15.74809 0 17.55115 16.8705 15.52504 16.91668 17.17752 16.26249 0 15.65147 15.29037 16.09547 15.76222 16.8644 16.2219 Q5SWX8 ODR4_HUMAN "Protein odr-4 homolog, hODR-4 (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1)" ODR4 C1orf27 TTG1 TTG1A Homo sapiens (Human) protein localization [GO:0008104] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein localization [GO:0008104] GO:0008104; GO:0016021 TYDIHDPK 3.25 3.71E-11 3.71E-11 0.322470568 988.1776286 0 0 0 17.51299 17.15676 0 0 0 18.78791 0 0 17.94942 0 0 0 17.87783 19.13151 0 16.41205 0 0 0 0 0 18.09278 0 17.98986 18.6352 15.77958 17.28427 0 18.50684 0 18.67137 18.26895 18.53656 18.87573 0 0 0 0 0 17.03232 0 0 0 16.77795 17.0625 Q5SXM1 ZN678_HUMAN Zinc finger protein 678 ZNF678 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 FSSLTQHRR 14.39000034 0.496763587 0.496763587 0.748939288 1131.298338 0 16.80654 0 0 0 0 0 0 0 0 0 17.51641 0 0 17.40442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.65224 0 0 0 Q5SXM2 SNPC4_HUMAN "snRNA-activating protein complex subunit 4, SNAPc subunit 4 (Proximal sequence element-binding transcription factor subunit alpha, PSE-binding factor subunit alpha, PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit, SNAPc 190 kDa subunit)" SNAPC4 SNAP190 Homo sapiens (Human) snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995] GO:0000995; GO:0003677; GO:0005634; GO:0005654; GO:0016251; GO:0019185; GO:0042795; GO:0042796 MLTQLVQEMR 8.68999958 1 1 0.335957604 1265.615634 0 0 14.99025 0 0 0 14.64788 0 16.29879 0 0 15.9623 0 14.90361 17.04295 0 0 17.31682 0 18.71487 0 0 17.03596 16.32889 16.1389 0 0 0 0 16.25541 17.44362 16.25423 16.49419 17.12831 17.10605 16.15698 18.39485 16.43546 0 15.5284 0 16.20486 0 0 0 16.87444 18.12262 17.60695 Q5SXM8 DNLZ_HUMAN "DNL-type zinc finger protein (Hsp70-escort protein 1, HEP1) (mtHsp70-escort protein)" DNLZ C9orf151 Homo sapiens (Human) protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821] chaperone binding [GO:0051087]; zinc ion binding [GO:0008270] GO:0005654; GO:0005739; GO:0006457; GO:0008270; GO:0030150; GO:0050821; GO:0051087 VCGTR 1.340000033 1 1 0.285012971 591.1453576 16.13166 16.5755 16.08646 0 16.38357 15.13163 15.73242 15.40983 15.88243 0 15.80199 16.671 0 13.80523 16.18365 0 0 16.24784 0 0 0 0 0 0 16.05007 0 0 0 0 15.74841 0 0 0 16.45111 0 0 16.04152 0 0 16.40555 0 15.85648 16.10118 0 17.03365 16.46122 0 16.96956 Q5SY16 NOL9_HUMAN "Polynucleotide 5'-hydroxyl-kinase NOL9, EC 2.7.1.- (Nucleolar protein 9)" NOL9 Homo sapiens (Human) "cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]" intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]" ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723] GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0016020; GO:0045111; GO:0051731 ARPQLILSR 20.38999939 0.639324069 0.639324069 0.371163845 1056.904724 17.07399 15.88627 14.56575 14.30525 0 15.6678 0 15.9082 0 16.77361 16.13762 0 16.5137 16.85714 0 0 0 16.25013 18.61948 0 0 0 18.7337 18.17042 15.91335 0 0 15.31119 0 0 0 0 0 15.31566 16.69821 15.85502 0 0 0 13.79948 0 0 15.43077 0 0 0 17.03434 0 Q5SYB0 FRPD1_HUMAN FERM and PDZ domain-containing protein 1 (FERM domain-containing protein 2) FRMPD1 FRMD2 KIAA0967 Homo sapiens (Human) establishment of protein localization to membrane [GO:0090150]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; establishment of protein localization to membrane [GO:0090150]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0005829; GO:0005856; GO:0005886; GO:0008277; GO:0032991; GO:0090150 EVTNKNGTNVFQEESR 3.710000038 1 1 0.500339391 1852.235242 18.55407 0 0 0 18.36507 0 0 0 0 0 0 18.53937 0 0 0 0 0 0 0 0 0 0 0 0 19.18564 0 0 0 0 19.96996 19.14893 0 18.98555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SZD1 CF141_HUMAN Uncharacterized protein C6orf141 C6orf141 Homo sapiens (Human) METRGPQGAANPMDSSR 2.180000067 1 1 0.008750818 1819.608941 14.61635 12.74549 0 0 0 10.68822 0 11.97333 14.8081 0 0 11.6424 16.2033 0 14.11921 15.64447 0 11.25893 15.95684 0 0 14.13538 15.96558 0 0 13.2452 14.17367 14.52711 16.61966 14.50648 0 0 16.31389 15.63078 15.65803 15.60606 14.7592 0 14.54095 14.04896 0 16.59587 0 0 0 0 0 14.90389 Q5SZD4 GLYL3_HUMAN "Glycine N-acyltransferase-like protein 3, EC 2.3.1.13 (Acyl-CoA:glycine-N-acyltransferase-like protein 3)" GLYATL3 C6orf140 Homo sapiens (Human) lipid metabolic process [GO:0006629] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; lipid metabolic process [GO:0006629] glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410] GO:0005739; GO:0006629; GO:0016410; GO:0047961 FHRLILTPATFSGLPHL 10.06999969 1 1 0.3129262 1920.282448 15.15281 0 13.91058 13.40547 13.54988 11.86441 0 13.47924 0 0 14.66629 16.9875 14.87061 0.5218458 0 13.33375 14.85349 14.22019 12.38537 0 0 11.95782 15.53797 14.25178 0 0 15.67913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SZJ8 BEND6_HUMAN BEN domain-containing protein 6 BEND6 C6orf65 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714] GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0007399; GO:0045666; GO:0045746 EKLTNTR 4.039999962 1 1 0.239252821 860.7682564 0 0 0 0 0 14.9615 14.79229 0 0 0 0 0 0 17.39598 16.88319 0 0 0 0 0 0 0 0 18.703 0 0 0 19.65926 0 16.42812 0 0 0 0 0 0 0 0 0 0 0 17.09382 0 0 0 0 17.15524 0 Q5SZK8 FREM2_HUMAN FRAS1-related extracellular matrix protein 2 (ECM3 homolog) FREM2 Homo sapiens (Human) cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] metal ion binding [GO:0046872] GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0016021; GO:0042733; GO:0046872; GO:0048839; GO:0070062 HSAGTPGLSSRR 17.80999947 1 1 0.253026984 1225.859586 0 14.82245 0 14.92339 0 0 0 0 0 13.17819 0 0 0 0 0 0 0 15.94647 18.12456 0 18.33595 0 0 0 0 17.34011 18.08047 0 17.16843 0 16.15978 0 0 0 18.02987 0 19.88357 19.49401 20.14282 0 0 18.49088 19.20117 0 18.00641 19.72207 19.45969 19.4306 Q5SZL2 CE85L_HUMAN Centrosomal protein of 85 kDa-like (Serologically defined breast cancer antigen NY-BR-15) CEP85L C6orf204 Homo sapiens (Human) neuron migration [GO:0001764] centrosome [GO:0005813]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242] centrosome [GO:0005813]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242]; neuron migration [GO:0001764] GO:0000242; GO:0001764; GO:0005737; GO:0005813 EGLLRQK 4.659999847 1 1 0.247693219 842.3081739 15.01539 0 14.33815 0 0 0 12.08051 16.30451 16.88182 0 14.30562 0 16.10252 14.71416 0 15.20149 0 0 0 0 0 0 0 0 16.23344 0 13.21649 15.39576 0 0 16.2408 15.32655 16.56433 0 14.4244 0 0 16.17442 0 0 0 0 0 0 0 16.45091 14.46609 0 Q5T011 SZT2_HUMAN KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog) SZT2 C1orf84 KIAA0467 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668] GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262 HKTESVR 5.559999943 1 1 0.229999224 856.6070913 0 0 16.79222 16.79501 0 0 0 14.52473 0 0 0 0 13.74521 14.42399 15.41288 16.14442 15.06125 0 0 16.50649 0 0 16.44184 16.85472 12.09103 0 16.84468 0 0 0 16.84767 14.87777 8.886654 0 15.72289 0 0 0 0 17.08261 0 0 12.76938 14.84685 15.79246 0 0 14.81755 Q5T013 HYI_HUMAN "Putative hydroxypyruvate isomerase, EC 5.3.1.22 (Endothelial cell apoptosis protein E-CE1)" HYI HT036 SB156 Homo sapiens (Human) glyoxylate metabolic process [GO:0046487] hydroxypyruvate isomerase activity [GO:0008903]; glyoxylate metabolic process [GO:0046487] hydroxypyruvate isomerase activity [GO:0008903] GO:0008903; GO:0046487 IHLMAGR 6.539999962 0.572448492 0.572448492 0.170014941 812.8333432 16.4268 17.85976 0 0 0 15.44808 15.40709 13.70628 0 0 0 0 0 0 13.95497 0 0 16.32311 0 0 0 0 0 15.6411 0 17.29861 15.1584 0 16.04825 0 18.29497 0 15.28883 0 0 0 0 0 0 0 0 0 0 0 0 13.72777 0 0 Q5T0F9 C2D1B_HUMAN "Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2, FRE under dual repression-binding protein 2, Freud-2)" CC2D1B KIAA1836 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005635; GO:0005654; GO:0006357; GO:0043231 CLLFSK 2.940000057 1 1 0.203405903 768.8467559 15.79365 13.98571 13.9161 14.92351 15.63714 11.83741 0 15.38404 0 16.01633 16.25667 14.95995 16.19411 0 15.94602 0 0 14.72526 0 0 0 0 0 0 16.78416 17.01894 16.63403 0 0 15.64505 17.01757 0 16.84601 0 16.70354 16.07796 16.14867 15.82879 15.5289 0 0 0 15.42324 0 16.46631 0 0 15.72488 Q5T0N1 CFA70_HUMAN "Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18, TPR repeat protein 18)" CFAP70 TTC18 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular exosome [GO:0070062]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular exosome [GO:0070062]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement [GO:0003341] GO:0003341; GO:0005930; GO:0036064; GO:0036126; GO:0036157; GO:0060271; GO:0070062 DIDGRPRPGDVQAPSIK 5.679999828 1 1 0.151197841 1820.790106 0 14.56952 13.67483 13.72303 16.69341 14.55498 0 0 14.36523 0 0 0 0 13.50907 15.06137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0N5 FBP1L_HUMAN "Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1, Toca-1)" FNBP1L C1orf39 TOCA1 Homo sapiens (Human) autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289]; autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0031410; GO:0045296; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320 AIYPFDGHNEGTLAMK 5.730000019 0.118506551 0.118506551 0.129988401 1763.601744 14.43754 0 0 0 0 0 14.06565 0 16.88859 16.48625 18.01918 0 0 20.5622 0 19.43328 0 0 16.68428 0 0 19.10695 14.71351 14.83101 0 15.76672 0 19.39327 0 0 0 0 18.19773 0 9.539261 15.12977 17.10325 19.42727 0 0 0 15.98222 17.67205 0 0 14.99087 17.0984 0 Q5T0W9 FA83B_HUMAN Protein FAM83B FAM83B C6orf143 Homo sapiens (Human) cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165] epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901] GO:0005154; GO:0005737; GO:0007165; GO:0007173; GO:0008283; GO:0016020; GO:0019901; GO:0036312; GO:0036313 EDLLKSSK 31.18000031 1 1 0.238790646 918.5913938 14.51629 18.30243 10.96141 0 17.5059 0 16.04609 0 0 0 18.08132 0 17.03398 17.09602 0 0 16.11004 16.83984 0 0 0 0 17.36944 0 15.56159 0 16.36733 16.9227 13.969 17.22962 0 17.60469 16.42382 0 15.60137 0 0 0 0 0 0 0 0 18.00171 17.16644 17.20861 17.36793 0 Q5T0Z8 CF132_HUMAN Uncharacterized protein C6orf132 C6orf132 Homo sapiens (Human) DPSQMEK 4.900000095 0.29154712 0.29154712 0.172568147 850.2883051 15.90319 0 13.60298 0 0 17.02363 0 0 0 0 0 0 0 0 0 0 0 0 15.31916 15.88842 14.54083 0 13.6753 0 17.50112 19.88775 17.4087 18.31479 0 17.16628 0 17.72351 0 0 0 17.12188 16.95047 12.17805 0 14.67773 15.8795 16.72061 16.67098 0 12.58992 14.0772 16.6015 0 Q5T160 SYRM_HUMAN "Probable arginine--tRNA ligase, mitochondrial, EC 6.1.1.19 (Arginyl-tRNA synthetase, ArgRS)" RARS2 RARSL Homo sapiens (Human) arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723] GO:0003723; GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006420; GO:0032543 YNFDTMIYVTDK 2.170000076 1 1 0.297375762 1509.687864 0 0 0 0 0 15.54073 0 0 0 0 0 0 0 0 19.19517 0 0 0 0 0 0 0 0 0 0 0 0 16.84441 14.87152 0 0 0 0 0 0 16.32807 0 0 0 0 0 15.82958 0 0 0 11.00142 0 0 Q5T1A1 DCST2_HUMAN DC-STAMP domain-containing protein 2 DCST2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AADQGHR 5.380000114 1 1 0.234602978 752.284745 16.23936 13.92825 15.80662 14.40224 13.66683 0 15.1844 15.18021 14.94009 15.85242 16.09596 0 13.70636 14.67332 14.47066 16.26424 14.03226 14.60959 12.44708 14.10819 15.52336 16.13112 15.96157 17.06617 16.06167 15.25906 13.64103 16.14162 14.93085 15.67653 0 16.53856 0 0 15.94104 0 14.97033 15.96023 0 0 0 13.69059 0 15.55716 16.49504 15.52644 0 15.86579 Q5T1B0 AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 AXDND1 C1orf125 Homo sapiens (Human) AHDVK 6.699999809 0 0 0.259494396 570.2263783 18.42959 19.5038 0 19.53509 0 0 17.3367 18.89088 18.92394 0 17.1291 0 18.66177 18.3345 18.73882 18.92497 18.37416 0 18.58797 18.28765 0 17.27109 18.32559 0 18.47983 0 19.85026 19.98099 18.15776 17.14886 19.73051 0 18.8144 0 18.88358 0 0 0 0 0 18.08615 0 19.27537 0 0 19.15365 18.79398 19.6092 Q5T1C6 THEM4_HUMAN "Acyl-coenzyme A thioesterase THEM4, Acyl-CoA thioesterase THEM4, EC 3.1.2.2 (Carboxyl-terminal modulator protein) (Thioesterase superfamily member 4)" THEM4 CTMP Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid metabolic process [GO:0006631]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0005886; GO:0006631; GO:0016290; GO:0032587; GO:0043491; GO:0102991; GO:1902108 LLFDQFMK 9.270000458 1 1 0.262082424 1057.769773 0 0 0 0 15.33384 0 13.01126 0 0 0 0 0 0 0 0 0 16.31013 0 16.1232 0 0 0 0 0 16.44959 15.67187 0 0 0 0 17.46181 0 0 0 18.44325 0 0 0 0 0 17.06645 0 0 0 0 0 17.19292 0 Q5T1H1 EYS_HUMAN "Protein eyes shut homolog (Epidermal growth factor-like protein 10, EGF-like protein 10) (Epidermal growth factor-like protein 11, EGF-like protein 11) (Protein spacemaker homolog)" EYS C6orf178 C6orf179 C6orf180 EGFL10 EGFL11 SPAM UNQ9424/PRO34591 Homo sapiens (Human) detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403] calcium ion binding [GO:0005509] GO:0001750; GO:0005509; GO:0005737; GO:0005815; GO:0033165; GO:0043403; GO:0050908; GO:0070062 LKGMHTVNSK 6.860000134 0.925359726 0.925359726 0.232203853 1109.998254 15.07514 15.2763 15.14359 13.27707 14.80567 13.92739 0 13.69607 0 14.14205 14.01195 15.97682 0 0 9.934797 14.49382 13.53947 15.89488 0 0 0 0 0 0 0 9.138339 0 15.2537 0 0 16.07633 0 13.02332 0 0 0 0 15.18254 0 0 0 0 0 0 0 14.87241 15.50679 15.55713 Q5T1M5 FKB15_HUMAN "FK506-binding protein 15, FKBP-15 (133 kDa FK506-binding protein, 133 kDa FKBP, FKBP-133) (WASP- and FKBP-like protein, WAFL)" FKBP15 KIAA0674 Homo sapiens (Human) endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; endocytosis [GO:0006897] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 FGAGDEDDTDFLSPSGGAR 2.170000076 0.000194994 0.000194994 0.607680733 1913.51839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.39569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.35262 0 0 Q5T1R4 ZEP3_HUMAN "Transcription factor HIVEP3 (Human immunodeficiency virus type I enhancer-binding protein 3) (Kappa-B and V(D)J recombination signal sequences-binding protein) (Kappa-binding protein 1, KBP-1) (Zinc finger protein ZAS3)" HIVEP3 KBP1 KIAA1555 KRC ZAS3 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0035914; GO:0045893; GO:0046872 SAPPGK 2.859999895 0.071430929 0.071430929 0.086302458 555.9717503 16.07331 13.59132 12.04061 0 0 0 14.88646 13.10974 16.65371 14.71955 0 0 16.77994 16.25863 13.88305 14.2977 0 0 15.20804 13.69782 12.74674 0 14.34007 16.77746 17.82327 15.4568 0 0 0 14.33304 15.305 15.03392 14.7633 14.67073 13.06156 0 13.28288 14.18893 18.32822 0 15.18181 14.62137 0 17.53111 0 13.9532 0 15.90756 Q5T1V6 DDX59_HUMAN "Probable ATP-dependent RNA helicase DDX59, EC 3.6.4.13 (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5)" DDX59 ZNHIT5 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0046872 LGADLLSEAVQK 11.5 1 1 0.187395412 1244.104516 0 16.61286 0 0 15.0545 13.412 14.14563 0 13.94682 0 0 0 0 0 0 0 0 14.78207 0 0 0 0 0 0 0 16.49687 16.52001 0 14.88943 0 0 0 0 0 0 0 15.13233 0 0 0 0 0 0 0 0 0 15.8671 0 Q5T200 ZC3HD_HUMAN Zinc finger CCCH domain-containing protein 13 ZC3H13 KIAA0853 Homo sapiens (Human) mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0036396; GO:0046872; GO:0080009; GO:2000036 SGDDQSGRK 2.480000019 0.544772863 0.544772863 0.101728097 950.6304485 17.43193 14.36421 11.49959 0 0 12.31312 14.29029 15.09715 16.11111 15.71312 12.03738 0 0 0 0 0 14.44634 15.27958 14.65869 15.50222 0 15.12457 16.82183 0 16.16623 12.51621 0 0 16.7539 12.94706 14.96783 0 18.31588 17.55277 0 0 18.58989 0 14.3091 0 0 0 15.26201 0 16.75251 0 16.5527 0 Q5T230 UTF1_HUMAN Undifferentiated embryonic cell transcription factor 1 UTF1 Homo sapiens (Human) male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0006357; GO:0008584; GO:0045944 GPGSPPPPPAR 1.110000014 1 1 0.121033085 1029.911906 17.12337 0 0 12.00217 15.65661 0 14.43906 17.80592 15.39186 0 0 0 16.89882 15.45971 0 0 0 14.17989 0 0 0 0 0 13.78091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.21767 0 0 0 0 19.56815 0 0 15.21435 0 Q5T2D2 TRML2_HUMAN "Trem-like transcript 2 protein, TLT-2 (Triggering receptor expressed on myeloid cells-like protein 2)" TREML2 C6orf76 TLT2 UNQ6268/PRO20473 Homo sapiens (Human) T cell activation [GO:0042110] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; T cell activation [GO:0042110] signaling receptor activity [GO:0038023] GO:0005886; GO:0009986; GO:0016021; GO:0038023; GO:0042110 SGDLSTRSPTTGLCLTSR 8.75 1 1 7.04E-13 1909.833828 12.14591 0 11.89011 0 0 15.74146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T2S8 ODAD2_HUMAN Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4) ODAD2 ARMC4 Homo sapiens (Human) cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary base [GO:0097546] axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546 CCMWGR 7.809999943 1 1 0.245032469 868.4670817 0 0 0 0 0 0 12.87742 15.65335 15.0049 0 0 14.41245 0 0 15.27978 0 0 0 0 0 15.41381 0 0 13.75839 0 0 0 13.89504 0 0 13.97912 0 0 14.15525 15.98715 0 0 0 0 0 11.67831 17.32595 0 15.2225 0 0 0 0 Q5T2T1 MPP7_HUMAN MAGUK p55 subfamily member 7 MPP7 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591]; bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896] cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591] GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0016328; GO:0019904; GO:0030010; GO:0030054; GO:0031334; GO:0035591; GO:0045296; GO:0060090; GO:0070830; GO:0071896; GO:0097025 DEQTGAIIVARIMR 13.85000038 1 1 0.510846798 1589.087214 0 0 0 0 16.0624 0 15.2312 0 16.01649 0 0 0 0 0 0 16.02648 0 0 9.279874 0 0 0 15.86819 14.48806 0 0 0 0 0 16.15914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.50788 0 0 Q5T3F8 CSCL2_HUMAN CSC1-like protein 2 (Transmembrane protein 63B) TMEM63B C6orf110 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760] calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760] GO:0005227; GO:0005886; GO:0008381; GO:0015629; GO:0016021; GO:1990760 LALVTDADR 4.539999962 1 1 0.153911002 972.5382496 0 16.7067 14.13245 0 15.87633 16.0872 13.8091 12.97621 0 0 17.84883 13.20789 0 0 13.8425 16.91477 0 0 0 16.36333 0 0 0 0 13.88185 0 16.83326 0 0 0 16.50558 0 16.91387 17.86523 12.15565 0 0 15.88356 0 0 0 0 14.31185 0 10.98093 0 16.8531 15.37631 Q5T3J3 LRIF1_HUMAN "Ligand-dependent nuclear receptor-interacting factor 1 (HP1-binding protein enriched in inactive X chromosome protein 1, HBiX1) (Receptor-interacting factor 1)" LRIF1 C1orf103 RIF1 Homo sapiens (Human) "dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of transcription, DNA-templated [GO:0006355]" Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] "Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; retinoic acid receptor binding [GO:0042974]; dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of transcription, DNA-templated [GO:0006355]" retinoic acid receptor binding [GO:0042974] GO:0001740; GO:0005654; GO:0006355; GO:0009048; GO:0016363; GO:0034451; GO:0042974 NLLQLLPIPK 27.45000076 0.280804098 0.280804098 0.356906237 1149.92075 18.52009 18.55627 0 0 18.44576 19.03811 17.80246 18.74449 18.0723 18.63309 0 17.60476 16.61523 18.66683 19.02698 0 16.87167 0 18.25172 15.73176 0 17.85702 17.17397 15.80028 18.53225 18.0015 19.33125 19.34163 12.75833 10.83088 18.54176 15.79602 17.07169 18.55457 0 17.0864 17.52436 18.74297 19.52128 16.77618 18.20291 16.58562 17.89134 17.974 18.11471 17.93946 18.60833 15.20077 Q5T3U5 MRP7_HUMAN "ATP-binding cassette sub-family C member 10, EC 7.6.2.2, EC 7.6.2.3 (Multidrug resistance-associated protein 7)" ABCC10 MRP7 SIMRP7 Homo sapiens (Human) leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626] GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0015431; GO:0016020; GO:0016021; GO:0016323; GO:0042626; GO:0043225; GO:0055085; GO:0071716; GO:0140359 CYLALGLLK 3.680000067 1 1 0.075690564 1051.514062 12.78025 0 0 13.81365 0 13.97452 0 0 0 0 0 0 13.95515 14.28722 15.01635 0 15.40941 0 0 0 0 14.59235 0 0 12.82453 0 0 14.05878 11.02505 0 0 12.43676 12.52755 0 0 15.7556 0 0 0 0 0 0 0 0 0 0 0 0 Q5T447 HECD3_HUMAN "E3 ubiquitin-protein ligase HECTD3, EC 2.3.2.26 (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3)" HECTD3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0019905; GO:0043161; GO:0048471 EQVAAMQAGLLKVVPQAVLDLLTWQELEK 2.5 1 1 0.046223988 3236.705827 11.40325 14.34015 13.84776 12.29848 14.9752 14.19077 14.5969 0 10.37886 13.73029 12.43023 0 0 0 0 0 0 0 12.15709 0 0 0 14.19182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.94284 14.27806 0 0 0 0 0 0 Q5T4B2 GT253_HUMAN Inactive glycosyltransferase 25 family member 3 (Cerebral endothelial cell adhesion molecule) CERCAM CEECAM1 GLT25D3 KIAA1502 Homo sapiens (Human) cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159] endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886] endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159] identical protein binding [GO:0042802] GO:0005788; GO:0005886; GO:0007155; GO:0007159; GO:0042802 TAEYFPTK 2.930000067 1 1 0.196180978 957.0648021 14.72995 13.85904 12.56055 16.80995 16.49625 0 0 14.65589 0 16.87846 14.48845 0 14.09115 15.16489 0 14.91708 0 0 0 0 0 15.23252 0 0 0 16.00302 0 0 0 13.08404 0 16.35261 17.23032 0 15.77384 16.30467 15.69044 15.59959 14.65148 0 13.57494 13.36218 0 13.88669 13.9763 14.5159 13.36657 0 Q5T4F4 ZFY27_HUMAN Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27) ZFYVE27 SPG33 Homo sapiens (Human) endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621] GO:0005654; GO:0005783; GO:0005829; GO:0016192; GO:0030176; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0042802; GO:0043231; GO:0043621; GO:0045773; GO:0046872; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659 ARLPDSELMR 7.039999962 1 1 0.178396321 1202.484685 0 13.48115 0 0 13.16869 0 0 0 14.92501 0 0 0 16.00092 15.40184 16.09779 0 0 0 15.82169 16.60596 0 0 0 0 0 0 0 14.40813 0 15.64061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84333 0 Q5T4S7 UBR4_HUMAN "E3 ubiquitin-protein ligase UBR4, EC 2.3.2.27 (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa, RBAF600, p600) (Zinc finger UBR1-type protein 1)" UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ubiquitin-dependent protein catabolic process [GO:0006511] calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0035579; GO:0061630; GO:0070821; GO:0101003 EGVGSPK 5.730000019 0.000511107 0.000511107 0.200418468 669.7337564 0 14.97293 0 0 0 0 0 0 16.12749 0 0 16.1776 0 14.63274 15.90235 15.52143 0 15.71421 16.65845 0 0 16.04495 0 16.25413 0 0 15.95615 0 0 0 0 0 0 0 16.18464 0 0 0 16.53415 16.94326 15.47267 14.94009 17.24663 15.35225 14.91946 16.32324 17.16412 0 Q5T4T6 SYC2L_HUMAN "Synaptonemal complex protein 2-like, SCP-2-like (145 kDa nucleolar protein homolog, hsNO145)" SYCP2L C6orf177 NO145 Homo sapiens (Human) meiotic nuclear division [GO:0140013]; negative regulation of cell death [GO:0060548] "condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]" "condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; meiotic nuclear division [GO:0140013]; negative regulation of cell death [GO:0060548]" GO:0000779; GO:0000800; GO:0005654; GO:0060548; GO:0140013 EDEPLLIRQGLIPK 9.390000343 1 1 0.367915902 1620.772567 0 0 16.32525 17.05383 0 0 0 0 0 0 0 0 19.14178 0 0 0 0 0 0 0 0 0 0 0 0 17.67994 0 0 0 0 0 0 0 0 19.35342 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T4W7 ARTN_HUMAN Artemin (Enovin) (Neublastin) ARTN EVN Homo sapiens (Human) axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165] glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007405; GO:0007411; GO:0007422; GO:0008083; GO:0030116; GO:0030971; GO:0050930; GO:0061146; GO:0097021 GGRAAR 5.260000229 0.77080673 0.77080673 1.15E-13 586.363128 0 0 0 16.26766 0 15.75085 13.14356 0 0 0 15.58649 0 15.12245 0 0 0 0 15.99938 16.40829 15.13462 0 12.90829 16.14717 0 0 0 16.66851 0 0 0 0 0 0 0 16.27153 0 16.27145 0 0 0 0 0 0 0 15.62451 16.31493 0 15.72344 Q5T5C0 STXB5_HUMAN Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) STXBP5 LLGL3 Homo sapiens (Human) exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0050708; GO:0098674; GO:0098686; GO:2000300 MLCIAGVSAHVIIYRFSK 2.609999895 1 1 0.328861094 2082.762014 0 13.85191 14.05936 15.50162 15.92026 15.39689 0 12.42939 10.32671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.60818 0 0 0 16.25427 12.98911 11.58135 0 14.2679 0 0 0 0 0 0 0 16.35239 0 0 0 0 0 0 0 0 Q5T5F5 A4AS1_HUMAN Uncharacterized protein ADAMTSL4-AS1 (ADAMTSL4 antisense RNA 1) (ADAMTSL4 antisense gene protein 1) ADAMTSL4-AS1 C1orf138 Homo sapiens (Human) AGLEK 14.39000034 0.077620283 0.077620283 0.256949936 516.8553149 0 0 0 0 0 0 14.42843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.32854 0 0 17.01466 0 0 18.03145 0 0 0 17.3446 22.10998 17.58446 0 21.3911 0 0 0 0 0 0 0 0 20.97008 0 0 0 Q5T5J6 SWT1_HUMAN Transcriptional protein SWT1 SWT1 C1orf26 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ESCGK 1.059999943 1 1 0.190910969 579.6805194 15.51439 14.46382 13.23897 0 15.21673 14.78646 11.99956 13.26358 0 15.59359 0 10.67239 14.85323 0 11.85766 0 0 12.48022 0 0 0 0 0 15.55742 0 17.02624 0 15.29152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32786 0 0 Q5T5M9 CCNJ_HUMAN Cyclin-J CCNJ Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0016538; GO:0044772 HLAVYLLDLFMDR 6.329999924 1 1 0.114637258 1621.895082 14.88005 15.43251 13.38602 0 0 0 0 0 0 0 0 13.19592 0 13.18508 0 0 16.35938 0 15.24671 0 0 0 0 0 0 0 16.51221 0 15.80503 0 0 0 0 14.82277 0 0 0 16.81455 0 15.8795 14.82316 16.25147 0 0 0 0 0 0 Q5T5N4 CF118_HUMAN Uncharacterized protein C6orf118 C6orf118 Homo sapiens (Human) QDLLKNDFTGSK 3.369999886 3.00E-05 3.00E-05 0.452037594 1365.173149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.31764 0 18.82403 0 0 0 0 0 0 0 17.9582 0 0 0 0 0 0 0 0 0 0 0 0 17.60849 0 0 Q5T5P2 SKT_HUMAN Sickle tail protein homolog KIAA1217 SKT Homo sapiens (Human) embryonic skeletal system development [GO:0048706] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; embryonic skeletal system development [GO:0048706] GO:0005737; GO:0048706 AQNGSSSK 7.739999771 0.058135662 0.058135662 0.299803105 779.2979701 0 18.34143 16.48369 0 17.28367 0 0 14.32678 0 18.99311 15.03538 18.43933 0 15.47965 17.03368 16.56652 0 16.05593 17.32196 0 0 19.23062 15.59017 18.23704 16.31594 18.04648 17.74771 0 17.08493 15.89967 18.02363 16.81722 15.20679 17.1241 18.25056 17.86457 18.4939 0 17.05334 17.76918 18.1742 18.43637 16.46732 17.869 15.85487 18.54689 18.20993 17.57213 Q5T5U3 RHG21_HUMAN Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21) ARHGAP21 ARHGAP10 KIAA1424 Homo sapiens (Human) establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051645; GO:0051683; GO:0051684; GO:0072384 IADSQK 7.159999847 0.370355517 0.370355517 0.301414739 657.8850043 0 0 0 17.10826 0 17.3631 0 17.3577 18.33687 0 0 19.12444 0 0 18.46626 0 0 0 20.13054 0 17.59215 0 17.45433 0 0 0 0 0 0 0 0 0 0 0 18.49316 0 0 0 0 19.02788 0 0 0 0 19.01976 0 0 0 Q5T5Y3 CAMP1_HUMAN Calmodulin-regulated spectrin-associated protein 1 CAMSAP1 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113] cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113] calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507] GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011 APIKMSAHMAMVDALMMAYTVEMISIEK 6.909999847 1 1 3.66E-12 3143.384658 13.07171 15.39031 0 11.82069 15.737 0 12.82914 0 11.61634 17.66104 14.51678 12.57156 0 0 0 0 10.86697 0 0 0 13.79766 0 0 0 0 0 15.49326 16.22846 0 0 0 0 14.60487 0 9.212381 0 0 0 15.41991 14.9198 14.05977 0 15.20199 0 12.9799 0 0 13.65984 Q5T601 AGRF1_HUMAN Adhesion G-protein coupled receptor F1 (G protein-coupled receptor 110) (G protein-coupled receptor KPG_012) (G protein-coupled receptor PGR19) ADGRF1 GPR110 PGR19 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; neuron projection development [GO:0031175]; positive regulation of CREB transcription factor activity [GO:0032793]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; neuron projection development [GO:0031175]; positive regulation of CREB transcription factor activity [GO:0032793]; synapse assembly [GO:0007416] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005576; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007613; GO:0016021; GO:0031175; GO:0032793 GIPVNK 6.909999847 1 1 0.157023278 627.5635212 15.44368 15.24774 0 14.36357 0 0 0 0 0 0 15.2143 0 0 15.2739 0 16.99882 0 15.83158 0 0 0 0 0 16.82574 0 16.47224 0 15.98434 16.96593 15.86256 15.7736 15.75937 0 0 17.22379 16.75983 17.144 17.92104 17.94748 16.24039 15.11415 16.81141 18.53492 17.32557 18.01036 17.78208 0 17.10707 Q5T653 RM02_HUMAN "39S ribosomal protein L2, mitochondrial, L2mt, MRP-L2 (Mitochondrial large ribosomal subunit protein uL2m)" MRPL2 CGI-22 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0032543 SGGRDHTGR 5.820000172 0 0 0.284626057 943.5631921 16.67854 15.30481 0 12.19596 16.79771 0 16.02196 15.04106 15.49493 16.28643 0 15.58677 16.17845 15.46976 14.61561 13.41457 0 0 0 0 15.29133 15.70779 15.58395 0 9.342497 14.2936 15.44608 12.46828 14.91101 13.31954 16.78702 14.50083 0 0 0 0 0 0 0 15.11724 0 0 0 16.78481 0 0 14.93203 15.14804 Q5T655 CFA58_HUMAN Cilia- and flagella-associated protein 58 (Coiled-coil domain-containing protein 147) CFAP58 C10orf80 CCDC147 Homo sapiens (Human) cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317] centrosome [GO:0005813]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] centrosome [GO:0005813]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317] GO:0005615; GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317 HVLARQPGPEAAEQLK 6.739999771 1 1 0.42610016 1743.626319 18.83387 0 0 0 0 0 0 17.81318 0 0 0 18.50637 0 0 0 0 0 0 0 0 17.4257 0 0 0 18.93377 0 19.46106 0 0 0 0 0 0 0 0 18.09106 17.60762 0 0 0 0 0 0 0 0 0 0 0 Q5T681 CJ062_HUMAN Uncharacterized protein C10orf62 C10orf62 Homo sapiens (Human) MLWVQR 8.640000343 1 1 0.154600155 834.4465563 14.58722 15.26525 10.74567 14.64948 14.48714 14.16751 15.29096 0 0 16.54147 13.67034 14.88037 0 11.35108 14.61963 16.30345 0 16.15036 16.15395 12.77585 0 14.10805 14.63307 15.75786 14.30083 0 16.81727 16.07953 15.24348 0 16.233 14.82207 15.3457 16.62019 11.06691 0 0 0 0 0 15.63216 15.25329 0 0 0 0 13.04434 0 Q5T6C5 AT7L2_HUMAN Ataxin-7-like protein 2 ATXN7L2 Homo sapiens (Human) EPSGTR 2.059999943 1 1 0.267010911 646.6313054 0 0 17.26174 0 18.04275 0 0 0 0 0 0 0 17.22313 0 16.76872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.17119 0 0 0 0 0 0 0 Q5T6F0 DCA12_HUMAN DDB1- and CUL4-associated factor 12 (Centrosome-related protein TCC52) (Testis cancer centrosome-related protein) (WD repeat-containing protein 40A) DCAF12 KIAA1892 TCC52 WDR40A Homo sapiens (Human) regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0005737; GO:0005813; GO:0010506; GO:0080008; GO:0140627; GO:1990756 ALAFNNKNK 10.28999996 0.306640238 0.306640238 0.15191484 1019.717814 0 18.65409 16.24964 0 13.88793 14.4744 0 15.19794 0 13.59602 0 17.89384 19.24922 0 0 0 16.12727 13.7355 15.53863 16.44871 8.704863 15.68357 15.0392 14.40207 0 16.51631 14.47781 16.19917 14.72893 0 15.40121 19.37144 15.31499 13.93507 16.14523 0 13.15733 16.66172 16.37173 18.85824 16.00818 13.70291 0 18.57976 14.51662 0 14.35357 0 Q5T6F2 UBAP2_HUMAN "Ubiquitin-associated protein 2, UBAP-2" UBAP2 KIAA1491 Homo sapiens (Human) regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of gene expression [GO:0010468] cadherin binding [GO:0045296]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0010468; GO:0045296 SQPEPSPVLSQLSQR 5.659999847 1 1 0.027248086 1653.810364 14.68818 14.44455 0 13.37397 15.55607 15.566 0 0 14.26883 15.2405 14.6234 11.60657 0 0 0 0 0 0 0 13.66627 0 0 0 0 0 0 0 0 14.94859 0 0 0 0 0 0 0 0 0 0 15.38219 0 0 14.46684 0 13.68481 0 0 0 Q5T6J7 GNTK_HUMAN "Probable gluconokinase, EC 2.7.1.12 (Gluconate kinase)" IDNK C9orf103 Homo sapiens (Human) D-gluconate catabolic process [GO:0046177] ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]; D-gluconate catabolic process [GO:0046177] ATP binding [GO:0005524]; gluconokinase activity [GO:0046316] GO:0005524; GO:0046177; GO:0046316 DGVALKCEESGK 13.53999996 1 1 0.234616915 1290.937329 0 0 0 0 0 0 0 0 0 0 0 0 15.80112 0 0 17.8578 0 0 0 0 0 0 0 0 0 0 15.47876 19.42177 0 0 0 0 0 0 0 15.46127 0 0 0 0 0 0 0 0 15.2337 0 0 0 Q5T6L9 EMARD_HUMAN "Endoplasmic reticulum membrane-associated RNA degradation protein, ER membrane-associated RNA degradation protein" ERMARD C6orf70 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 IMLPYWEVALVKFK 10.07999992 1 1 0.279212641 1737.285897 0 15.50597 0 14.68731 0 0 0 0 0 15.01187 10.89475 14.6317 14.56975 0 0 0 15.62776 13.99197 0 15.41165 0 15.99832 0 0 0 16.30818 0 0 0 0 0 0 0 16.49441 16.66246 18.14678 14.88507 17.21866 16.12363 0 15.3164 15.59863 14.37376 15.92132 0 11.78372 0 0 Q5T6S3 PHF19_HUMAN "PHD finger protein 19 (Polycomb-like protein 3, hPCL3)" PHF19 PCL3 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0019827; GO:0035064; GO:0035098; GO:0046872; GO:0048863; GO:0061087 KGAIAR 10.02000046 0.435852855 0.435852855 0.150009358 616.4787152 16.40009 16.26182 15.38645 0 0 15.66154 0 0 15.51726 15.08897 0 15.7228 16.44142 15.6264 0 16.51633 14.90581 15.5259 16.0313 15.90674 16.74854 0 15.18227 0 17.26293 15.54156 16.49987 16.50058 16.15114 14.04033 16.13341 15.91989 16.06196 15.48546 16.08676 16.4607 0 16.78479 15.98722 16.99467 16.15417 16.18419 15.98866 16.26114 0 17.02619 16.8034 15.61576 Q5T6V5 QSPP_HUMAN Queuosine salvage protein C9orf64 Homo sapiens (Human) tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] GO:0006400; GO:0101030 ALHELNPR 2.789999962 0.395761967 0.395761967 0.245750928 948.3006403 16.67653 15.5008 16.45609 0 15.29753 12.31942 14.68463 16.35526 15.2767 0 16.02544 15.20152 15.87433 15.28697 17.26664 16.15795 9.611901 13.71442 0 15.26943 16.40914 14.33082 15.15794 16.59318 15.76499 0 14.99716 0 14.73159 0 0 0 0 15.61744 15.58042 0 0 0 18.13202 15.8738 15.53554 0 0 15.97114 14.96055 0 15.44469 0 Q5T6X5 GPC6A_HUMAN "G-protein coupled receptor family C group 6 member A, hGPRC6A (G-protein coupled receptor GPCR33, hGPCR33)" GPRC6A Homo sapiens (Human) response to amino acid [GO:0043200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; response to amino acid [GO:0043200] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0005887; GO:0043200 SATWQKSK 8.920000076 0.380686462 0.380686462 0.260760154 937.9739978 15.1511 15.18299 13.3034 15.15323 14.92275 13.17486 14.11654 0 14.34743 0 0 16.0547 14.91356 15.53354 0 15.49969 0 0 16.02279 0 0 0 0 0 0 13.74992 14.93779 0 0 0 0 0 15.05378 0 0 0 0 0 15.83624 14.92144 0 0 0 0 0 0 15.1549 0 Q5T749 KPRP_HUMAN "Keratinocyte proline-rich protein, hKPRP" KPRP C1orf45 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] GO:0005737; GO:0070062 IEISSPCCPRQVPPQR 1.159999967 1 1 0.336355742 1928.270434 12.5612 0 0 13.78908 0 13.6035 0 0 0 0 0 15.54237 0 13.48495 0 0 0 0 0 0 0 0 0 15.65269 0 0 0 0 0 16.31779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7B8 KIF24_HUMAN Kinesin-like protein KIF24 KIF24 C9orf48 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018 AALDHSCSPSK 7.46999979 1 1 0.171069056 1173.005853 14.88321 14.47133 13.29573 0 14.92376 0 0 13.63412 0 15.70187 0 11.54237 14.02036 0 0 14.85725 0 0 0 16.1167 0 0 14.77466 0 0 0 0 0 0 0 0 0 0 0 0 17.12315 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7M9 DIK1A_HUMAN Divergent protein kinase domain 1A (Protein FAM69A) DIPK1A FAM69A Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 FSYVRMK 5.75 1 1 0.161502668 947.1665156 0 0 0 0 0 0 0 0 14.9889 0 0 15.74471 0 0 0 13.39798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.54287 0 0 0 0 0 0 0 0 0 0 15.40698 0 0 0 0 0 0 Q5T7N2 LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 (ES cell-associated protein 11) L1TD1 ECAT11 Homo sapiens (Human) "transposition, RNA-mediated [GO:0032197]" intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904] "intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904]; single-stranded RNA binding [GO:0003727]; transposition, RNA-mediated [GO:0032197]" single-stranded RNA binding [GO:0003727] GO:0003727; GO:0032197; GO:0043231; GO:1990904 MSDVSTSVQSK 8.899999619 1 1 0.071020923 1183.406081 0 0 0 0 13.54761 13.56862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7N3 KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 (Ankyrin repeat domain-containing protein 38) KANK4 ANKRD38 Homo sapiens (Human) negative regulation of actin filament polymerization [GO:0030837] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; negative regulation of actin filament polymerization [GO:0030837] GO:0005737; GO:0005829; GO:0005856; GO:0015630; GO:0030837 AERYKPSEEFLNACR 9.640000343 1 1 0.244162454 1870.5755 14.39982 14.83222 12.0256 0 0 14.00596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.02814 0 0 12.49085 0 13.33927 14.82855 14.08064 0 0 14.6137 14.63532 14.87058 13.36358 0 14.46329 15.67901 0 13.53652 Q5T7P8 SYT6_HUMAN "Synaptotagmin-6 (Synaptotagmin VI, SytVI)" SYT6 Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] GO:0000149; GO:0001786; GO:0005509; GO:0005829; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0060478; GO:0070382; GO:0071277; GO:0097038 GNMADKLK 2.859999895 1 1 0.037613951 891.8489525 0 16.60094 0 6.697042 12.31943 15.62616 0 0 13.72214 15.92624 13.63732 14.80089 0 0 12.53402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7W0 ZN618_HUMAN Zinc finger protein 618 ZNF618 KIAA1952 Homo sapiens (Human) positive regulation of chromatin binding [GO:0035563] chromatin [GO:0000785]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] chromatin [GO:0000785]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator binding [GO:0001221]; positive regulation of chromatin binding [GO:0035563] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator binding [GO:0001221] GO:0000785; GO:0001221; GO:0003677; GO:0003700; GO:0005634; GO:0005721; GO:0035563; GO:0042802; GO:0046872 LMFLKSNML 9.93999958 0.744631886 0.744631886 0.159933996 1096.640135 0 0 13.82662 14.44859 13.85723 12.32637 14.25313 0 0 0 0 14.63227 13.95165 7.764138 13.23379 0 0 0 13.70501 13.91735 14.46877 0 0 0 11.68163 0 15.19449 0 10.99015 0 10.81506 16.06358 14.84865 15.43576 16.59956 14.54472 12.09153 14.7259 13.45182 11.43973 14.49554 11.54665 0 0 15.03362 14.62407 14.76466 11.88395 Q5T848 GP158_HUMAN Probable G-protein coupled receptor 158 GPR158 KIAA1136 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021; GO:0072659 GLGRSIMR 21.29999924 0.124484904 0.124484904 0.174190761 905.5973244 14.58152 15.46899 15.7111 0 16.1297 14.54313 15.04869 16.7085 0 15.50925 15.15045 16.23677 16.53675 0 17.67462 0 0 15.39769 16.82655 0 17.51571 16.99322 15.53918 16.0851 15.60888 15.4632 0 15.58598 15.80676 16.11436 16.52707 16.06709 14.86578 15.29211 14.70682 15.06536 16.16975 16.78757 16.52065 13.01277 15.62945 15.73079 15.0922 16.59243 14.68585 18.21727 17.71188 14.64015 Q5T890 ER6L2_HUMAN "DNA excision repair protein ERCC-6-like 2, EC 3.6.4.- (DNA repair and recombination protein RAD26-like)" ERCC6L2 C9orf102 RAD26L Homo sapiens (Human) cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901]; cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297] ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901] GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0140658 ELWCVMDWAVPGLLGSGTYFK 10.02999973 1 1 0.125474115 2445.348832 14.55711 0 15.21718 15.39159 0 15.92816 0 0 0 0 16.69733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.01149 0 0 0 0 0 0 0 0 0 0 0 17.21849 0 0 Q5T8A7 PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 PPP1R26 KIAA0649 Homo sapiens (Human) negative regulation of phosphatase activity [GO:0010923] nucleolus [GO:0005730] nucleolus [GO:0005730]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923] protein phosphatase inhibitor activity [GO:0004864] GO:0004864; GO:0005730; GO:0010923 GDPVPPR 3.950000048 0.211265802 0.211265802 0.220510029 738.273685 0 0 17.23803 0 0 16.77951 0 17.09013 0 0 0 18.56001 18.14085 0 17.14452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.38753 0 0 0 18.1241 0 0 0 0 0 0 0 0 15.4944 16.76769 0 16.5947 16.40658 Q5T8I3 F102B_HUMAN Protein FAM102B FAM102B Homo sapiens (Human) EDTASEK 4.78000021 1 1 0.289145264 781.1563555 14.99586 0 15.20239 15.41948 15.32496 14.35946 12.64013 0 14.31144 15.27579 14.57327 15.66217 13.1387 13.75078 14.74096 15.59915 0 15.50279 15.03256 15.35847 0 13.99976 15.94532 0 14.96574 0 16.45333 0 0 0 0 0 0 0 15.80637 0 15.81629 0 16.18913 0 0 15.15222 0 14.83652 0 15.36077 16.1505 0 Q5T8P6 RBM26_HUMAN RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26) RBM26 C13orf10 PRO1777 Homo sapiens (Human) mRNA processing [GO:0006397] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397] metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0006397; GO:0046872 GAVHGR 8.319999695 1 1 0.232807639 596.3473554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.68112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.35396 0 0 0 0 0 0 0 0 0 18.87844 0 0 0 0 0 0 0 0 Q5T8R8 DOAS1_HUMAN Uncharacterized protein DOCK8-AS1 (DOCK8 antisense RNA 1) DOCK8-AS1 C9orf66 Homo sapiens (Human) AGSGGR 1.529999971 0.000191442 0.000191442 0.14149035 503.321221 18.42366 17.52191 17.99291 18.03959 17.95881 17.8388 17.99337 17.80389 17.76775 17.22877 17.92227 18.14055 17.6329 18.48133 16.71551 18.27015 17.94565 17.34595 17.61685 18.0123 18.3536 18.26725 18.38695 17.6206 17.81301 17.5923 16.7608 18.48531 18.05369 17.18165 13.23161 18.76088 18.67551 19.37707 18.10049 17.17686 17.23219 17.85894 17.89736 17.89728 19.07886 18.75412 18.32906 18.90002 17.546 18.10116 17.08606 17.85203 Q5T9A4 ATD3B_HUMAN ATPase family AAA domain-containing protein 3B (AAA-TOB3) ATAD3B KIAA1273 TOB3 Homo sapiens (Human) mitochondrion organization [GO:0007005] ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrion organization [GO:0007005] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005739; GO:0005743; GO:0005886; GO:0007005; GO:0016887; GO:0030667; GO:0101003 ICSWMGTGLCPGPLSPR 1.980000019 1 1 0.092589085 1904.995916 0 16.08963 14.65949 0 0 0 13.67297 16.03629 0 15.10654 0 0 13.62768 13.49497 15.37008 0 0 0 0 0 0 0 0 0 15.0754 0 0 16.74989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T9C2 F102A_HUMAN Protein FAM102A (Early estrogen-induced gene 1 protein) FAM102A C9orf132 EEIG1 Homo sapiens (Human) MAFLMKK 7.78000021 0.768185377 0.768185377 0.234292392 887.6177309 0 0 17.06049 15.91477 0 14.73579 16.13753 0 15.12116 14.95979 0 0 0 16.05887 0 0 0 0 0 0 0 0 0 0 0 15.15421 0 0 0 14.39429 14.58631 0 0 0 0 0 0 17.2451 0 15.05481 16.13083 15.60757 0 0 15.15573 0 13.84704 0 Q5T9S5 CCD18_HUMAN Coiled-coil domain-containing protein 18 (Sarcoma antigen NY-SAR-24) CCDC18 Homo sapiens (Human) SSMQTGAGLNQGENV 7.78000021 1 1 0.188998809 1508.776154 14.46466 0 15.42305 10.90624 0 0 13.05424 15.58837 0 15.39685 13.22674 15.241 0 0 15.15827 14.80106 15.86389 0 9.712244 13.0085 0 15.13522 14.6967 0 15.68068 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3378 0 0 0 0 0 0 0 0 0 Q5TA45 INT11_HUMAN "Integrator complex subunit 11, Int11, EC 3.1.27.- (Cleavage and polyadenylation-specific factor 3-like protein, CPSF3-like protein) (Protein related to CPSF subunits of 68 kDa, RC-68)" INTS11 CPSF3L RC68 Homo sapiens (Human) snRNA processing [GO:0016180] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; snRNA processing [GO:0016180] endoribonuclease activity [GO:0004521] GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0032039; GO:0072562 LVSSEQALK 11.22999954 1 1 0.482702934 974.4026732 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0336 18.1945 0 0 17.48329 18.20457 0 18.19391 0 17.26734 0 0 0 0 0 0 0 0 17.35462 0 17.39799 0 17.6323 0 0 0 0 17.69577 0 0 0 0 0 0 0 Q5TA89 HES5_HUMAN "Transcription factor HES-5 (Class B basic helix-loop-helix protein 38, bHLHb38) (Hairy and enhancer of split 5)" HES5 BHLHB38 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; central nervous system myelination [GO:0022010]; comma-shaped body morphogenesis [GO:0072049]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glial cell fate commitment [GO:0021781]; inner ear receptor cell stereocilium organization [GO:0060122]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of epithelial cell proliferation [GO:0050678]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; specification of loop of Henle identity [GO:0072086]; telencephalon development [GO:0021537]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; central nervous system myelination [GO:0022010]; comma-shaped body morphogenesis [GO:0072049]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glial cell fate commitment [GO:0021781]; inner ear receptor cell stereocilium organization [GO:0060122]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of epithelial cell proliferation [GO:0050678]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; specification of loop of Henle identity [GO:0072086]; telencephalon development [GO:0021537]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007420; GO:0008284; GO:0009952; GO:0014003; GO:0021537; GO:0021781; GO:0021861; GO:0021915; GO:0022010; GO:0030513; GO:0031641; GO:0042531; GO:0043010; GO:0045595; GO:0045608; GO:0045665; GO:0045747; GO:0045893; GO:0045944; GO:0046427; GO:0046983; GO:0048469; GO:0048661; GO:0048708; GO:0048712; GO:0048715; GO:0050678; GO:0050767; GO:0051216; GO:0060122; GO:0065003; GO:0072049; GO:0072050; GO:0072086; GO:0072282; GO:0090162; GO:0097150; GO:1990837; GO:2000737; GO:2000974; GO:2000978 HQPNSK 9.890000343 1 1 0.185259967 710.3786085 15.87037 10.9434 13.13724 14.65599 15.22285 13.45801 14.6221 13.50207 16.49502 14.21316 15.09213 13.44219 0 0 13.99797 17.14637 15.03118 0 0 16.39808 0 16.90903 0 0 0 15.85015 15.39721 17.38565 0 15.70497 14.74888 15.4756 16.22668 16.8205 15.42172 0 17.37279 16.06296 0 16.40098 0 0 15.83858 0 16.81133 17.28811 15.56279 16.82325 Q5TAA0 TTC22_HUMAN "Tetratricopeptide repeat protein 22, TPR repeat protein 22" TTC22 Homo sapiens (Human) AKMGLGGMPDR 2.859999895 1 1 0.216381739 1148.222198 0 14.30453 0 0 0 0 0 0 0 15.22986 0 16.52716 0 12.89753 0 0 0 0 0 0 0 0 0 0 13.54636 0 0 0 0 14.87462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68863 0 0 Q5TAB7 RIPP2_HUMAN Protein ripply2 RIPPLY2 C6orf159 Homo sapiens (Human) bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; embryonic pattern specification [GO:0009880]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756] nucleus [GO:0005634] nucleus [GO:0005634]; bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; embryonic pattern specification [GO:0009880]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756] GO:0000122; GO:0001503; GO:0001756; GO:0005634; GO:0007219; GO:0007368; GO:0009880; GO:0032525; GO:0036342; GO:0060349 KEEETPNHAAEAMPDGPGMTAASGK 9.270000458 1 1 2.30E-12 2542.234338 15.34198 0 0 14.19057 0 0 11.07841 0 11.20955 0 0 0 13.30665 0 0 14.22147 12.73615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.62847 0 0 0 0 0 0 0 Q5TAH2 SL9C2_HUMAN "Sodium/hydrogen exchanger 11 (Na(+)/H(+) exchanger 11, NHE-11) (Solute carrier family 9 member 11) (Solute carrier family 9 member C2)" SLC9C2 SLC9A11 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] GO:0005886; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719 DVVIALKTK 3.470000029 1 1 0.104451223 984.2686151 12.35159 12.85059 14.8849 14.13822 13.62603 15.38946 14.32594 15.66977 6.895161 13.65913 12.48796 16.24809 0 0 0 0 13.0045 0 0 0 0 17.54546 0 0 0 0 0 0 0 0 16.28816 15.6173 0 0 0 0 0 0 16.80523 0 0 0 0 0 0 0 0 0 Q5TAP6 UT14C_HUMAN U3 small nucleolar RNA-associated protein 14 homolog C UTP14C KIAA0266 Homo sapiens (Human) cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040] cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283] GO:0005730; GO:0005829; GO:0006364; GO:0007283; GO:0030154; GO:0032040; GO:0051321 QAMQEQLAKNK 5.579999924 0.64642489 0.64642489 0.395606067 1287.556555 14.85046 13.72163 12.7261 13.89699 13.90883 14.48996 14.1496 10.50176 12.02306 15.37341 0 0 0 0 0 15.26597 15.93413 14.2283 0 0 0 0 16.54585 15.54784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.73493 16.11106 0 0 0 0 16.80349 0 16.06402 16.18945 Q5TAQ9 DCAF8_HUMAN DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A) DCAF8 H326 WDR42A Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016567; GO:0080008 FLPNSGDSTLAMCAR 6.78000021 1 1 6.89E-13 1639.997905 15.40582 15.89155 15.92003 14.7443 0 15.04495 15.7029 15.81757 15.10426 15.99108 15.25933 0 14.32099 0 0 15.11894 0 14.60974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.28147 0 0 0 0 0 Q5TAT6 CODA1_HUMAN Collagen alpha-1(XIII) chain (COLXIIIA1) COL13A1 Homo sapiens (Human) cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; morphogenesis of a branching structure [GO:0001763]; notochord development [GO:0030903]; skeletal system development [GO:0001501] cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen type XIII trimer [GO:0005600]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen type XIII trimer [GO:0005600]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; morphogenesis of a branching structure [GO:0001763]; notochord development [GO:0030903]; skeletal system development [GO:0001501] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201] GO:0001501; GO:0001763; GO:0001958; GO:0005201; GO:0005576; GO:0005581; GO:0005600; GO:0005615; GO:0005788; GO:0005886; GO:0005911; GO:0007160; GO:0008201; GO:0030154; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0045211; GO:0062023; GO:0098609 GFPGFPGPIGLDGKPGHPGPK 5.210000038 1 1 0.111010021 2028.231191 14.53088 13.34712 15.2674 0 0 14.92994 15.63093 12.53309 11.33173 0 12.8434 0 14.49024 13.9075 0 10.12945 0 0 0 0 0 0 0 0 13.12952 15.30689 16.53963 14.30462 0 11.23602 0 15.09934 0 0 0 0 0 15.63891 0 15.27849 0 0 15.37882 0 0 0 0 0 Q5TAX3 TUT4_HUMAN "Terminal uridylyltransferase 4, TUTase 4, EC 2.7.7.52 (Zinc finger CCHC domain-containing protein 11)" TUT4 KIAA0191 ZCCHC11 Homo sapiens (Human) "miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]" miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270] GO:0000289; GO:0001556; GO:0003723; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0071076; GO:1990074 TETDNQSNAMKEK 6.949999809 1 1 0.251535911 1511.955404 15.67501 0 14.12867 0 0 11.36215 0 15.35994 0 0 0 0 0 19.26869 17.62308 16.60926 0 0 0 0 0 0 16.04565 17.47859 0 0 0 0 13.88334 0 19.37048 17.78332 15.01351 17.02127 0 19.16969 16.43545 16.11564 14.37446 18.08202 20.85248 0 15.4759 16.53839 0 14.51428 0 0 Q5TB30 DEP1A_HUMAN DEP domain-containing protein 1A DEPDC1 DEPDC1A Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]" GTPase activator activity [GO:0005096] GO:0005096; GO:0005634; GO:0017053; GO:0035556; GO:0045892 MESQGVPPGPYRATK 3.940000057 1 1 0 1618.061854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TB80 CE162_HUMAN "Centrosomal protein of 162 kDa, Cep162 (Protein QN1 homolog)" CEP162 C6orf84 KIAA1009 QN1 Homo sapiens (Human) cilium assembly [GO:0060271] axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819] axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cilium assembly [GO:0060271] GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0060271 IKQMEMR 6.070000172 1 1 0.165401912 951.3476384 15.51417 15.29364 13.58309 0 14.02628 13.56185 15.32469 13.08501 0 15.39776 16.14578 0 0 0 15.04114 0 0 0 0 0 14.85662 0 0 0 11.4894 14.37054 15.90695 14.32967 0 14.91871 0 0 0 16.74065 15.30024 0 13.53269 0 16.52353 0 16.45564 0 0 0 14.5032 0 13.00479 0 Q5TBA9 FRY_HUMAN Protein furry homolog FRY C13orf14 Homo sapiens (Human) cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922]; enzyme inhibitor activity [GO:0004857]; cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] enzyme inhibitor activity [GO:0004857] GO:0000902; GO:0000922; GO:0004857; GO:0005815; GO:0005938; GO:0030427; GO:0031175; GO:1904428 DPKMAR 6.179999828 1 1 0.235170686 716.6414371 16.42619 15.02352 16.25651 15.47928 16.13382 0 12.8681 14.07637 16.59912 14.87254 14.47889 16.4503 14.94163 0 14.9402 16.56866 15.6495 15.51736 16.74945 15.38694 15.66767 15.59958 0 0 16.56997 16.01978 0 16.63494 0 14.88199 14.69967 0 0 0 16.12777 15.66642 13.98898 15.71352 16.02917 16.14975 16.64758 0 15.56183 17.38502 0 16.99552 15.04737 0 Q5TC79 ZBT37_HUMAN Zinc finger and BTB domain-containing protein 37 ZBTB37 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990837 VTPNLNRSLSPR 8.779999733 1 1 3.43E-12 1352.711988 0 13.18955 0 9.493533 0 9.853085 0 12.05631 12.41497 8.068188 0 17.19782 0 13.06651 0 0 11.27251 0 9.37573 0 0 0 0 0 11.67134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TCQ9 MAGI3_HUMAN "Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3, MAGI-3)" MAGI3 KIAA1634 Homo sapiens (Human) apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165] ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; molecular adaptor activity [GO:0060090] GO:0004385; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006915; GO:0007165; GO:0016020; GO:0030054; GO:0035556; GO:0046328; GO:0060090 SASPKK 7.170000076 0.620313466 0.620313466 0.281039105 614.8400662 16.16865 0 15.78049 0 0 13.84714 0 0 0 0 15.75033 0 0 0 0 0 0 15.48075 0 16.35539 0 0 16.53953 16.40771 16.62875 14.31171 16.07299 16.56929 15.92677 15.28055 15.55554 0 16.34392 16.62087 15.26054 15.99774 16.72455 15.91883 15.41452 16.15583 16.59163 15.84841 16.77719 15.92806 16.36279 15.66712 16.67029 16.15717 Q5TCS8 KAD9_HUMAN "Adenylate kinase 9, AK 9, EC 2.7.4.4, EC 2.7.4.6 (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)" AK9 AKD1 AKD2 C6orf199 C6orf224 Homo sapiens (Human) AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569] adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145] GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571 AMNAAGCLKPK 7.21999979 1 1 0.25636843 1177.102074 0 0 0 0 15.37041 12.8567 0 0 15.14398 0 0 0 0 0 0 11.17007 0 0 0 0 0 0 0 0 0 0 0 0 0 14.25539 0 17.16745 0 12.33886 0 0 0 0 0 0 16.71187 0 16.89778 0 0 0 16.56465 0 Q5TCX8 M3K21_HUMAN "Mitogen-activated protein kinase kinase kinase 21, EC 2.7.11.25 (Mitogen-activated protein kinase kinase kinase MLK4) (Mixed lineage kinase 4)" MAP3K21 KIAA1804 MLK4 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004706; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0042803; GO:0046777; GO:0106310 EARLFAMLR 2.390000105 1 1 0.228783316 1122.878062 0 13.76618 13.67471 0 0 0 0 0 15.9222 0 0 10.82431 0 0 0 0 0 0 0 16.65714 0 0 0 0 0 14.9523 15.73017 13.23679 0 0 14.51906 0 0 0 0 0 0 0 0 14.55575 0 16.01252 0 16.50839 0 14.26147 14.69374 0 Q5TCY1 TTBK1_HUMAN "Tau-tubulin kinase 1, EC 2.7.11.1 (Brain-derived tau kinase)" TTBK1 BDTK KIAA1855 Homo sapiens (Human) learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0006468; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032091; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980; GO:1904031; GO:2001056 AQPDGTPSPGGSK 6.989999771 1 1 0.263842691 1197.630895 15.43756 15.14964 11.68917 0 0 13.83176 15.67829 0 15.076 0 15.23804 0 0 0 0 12.37323 0 12.16909 0 15.12239 14.87571 15.8907 0 0 0 0 16.59959 15.92079 0 13.63702 14.44026 0 0 0 12.11475 13.47723 14.83363 0 15.78507 0 0 0 0 14.55355 13.85253 0 11.77591 0 Q5TCZ1 SPD2A_HUMAN SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains) SH3PXD2A FISH KIAA0418 SH3MD1 TKS5 Homo sapiens (Human) in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102] "cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]" "phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]" GO:0001701; GO:0002020; GO:0002102; GO:0005546; GO:0005737; GO:0005829; GO:0006801; GO:0010314; GO:0016176; GO:0030054; GO:0032266; GO:0042554; GO:0042995; GO:0043325; GO:0070273; GO:0072675 GTPKVR 3.880000114 1 1 0.241130005 658.4944348 0 0 0 0 0 0 0 0 0 0 0 16.45092 0 0 0 0 0 0 0 15.5615 0 0 0 0 0 0 0 0 0 0 0 0 16.99387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TD94 RSH4A_HUMAN Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3) RSPH4A RSHL3 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] axoneme [GO:0005930]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535] axoneme [GO:0005930]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] GO:0001534; GO:0001535; GO:0003341; GO:0005654; GO:0005730; GO:0005930; GO:0031514; GO:0035082; GO:0060294; GO:0062177; GO:0120221 MAHFSKK 6.849999905 1 1 0.147681733 848.8114496 17.92382 0 0 0 0 0 0 0 0 0 0 0 15.97081 12.62062 15.34129 12.62576 0 15.90788 0 0 16.17089 0 0 0 0 0 0 15.36441 15.89431 16.45671 0 0 0 0 0 0 0 15.64567 16.06074 0 0 0 0 0 0 0 0 12.84641 Q5TDH0 DDI2_HUMAN "Protein DDI1 homolog 2, EC 3.4.23.-" DDI2 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130] GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752 SLASYGLKDGDVVILR 2.099999905 1 1 0.533070188 1707.187359 0 0 0 19.58573 0 0 0 0 0 0 0 0 0 16.42529 0 0 0 0 0 0 0 0 0 17.84255 18.06969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.57101 0 0 16.75413 0 0 17.44236 0 Q5TDP6 LGSN_HUMAN Lengsin (Glutamate-ammonia ligase domain-containing protein 1) (Lens glutamine synthase-like) LGSN GLULD1 LGS Homo sapiens (Human) nitrogen compound metabolic process [GO:0006807] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; nitrogen compound metabolic process [GO:0006807] catalytic activity [GO:0003824] GO:0003824; GO:0005737; GO:0005886; GO:0006807; GO:0016020 ATCFNSDIVLMPELSTFR 4.929999828 1 1 0.113961481 2101.48212 0 0 13.37628 10.59748 15.76578 0 0 0 0 18.43439 13.92286 0 0 16.1342 0 12.84192 0 0 0 0 0 0 0 0 12.91379 0 0 0 13.73061 0 0 0 0 0 0 0 0 0 0 14.78067 0 0 0 14.59162 0 0 0 0 Q5TEA3 DAAF9_HUMAN "Dynein axonemal assembly factor 9, DNAAF9" DNAAF9 C20orf194 Homo sapiens (Human) RLHSSAQK 3.130000114 0.024489934 0.024489934 0.271120465 927.6374246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8127 0 17.78927 0 0 0 0 0 0 0 0 0 18.13543 0 0 0 0 0 0 Q5TEA6 SE1L2_HUMAN "Protein sel-1 homolog 2 (Suppressor of lin-12-like protein 2, Sel-1L2)" SEL1L2 C20orf50 Homo sapiens (Human) ERAD pathway [GO:0036503] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503] GO:0005789; GO:0016021; GO:0036503 AADMGNLK 8.170000076 0.38476941 0.38476941 0.054971269 838.6169082 17.16334 0 14.89258 14.32023 14.63478 16.02754 14.79904 14.91587 17.31492 14.37882 14.44349 0 16.11726 15.25422 0 15.98042 17.66917 11.54349 16.83456 15.31943 17.00146 15.9065 17.79032 15.87219 13.43685 15.81067 13.23042 16.83652 16.11589 0 18.31495 14.60341 17.68945 17.65809 16.87287 0 15.79425 14.95946 17.02501 12.55215 14.27562 14.63268 12.67434 17.96884 12.31894 0 14.49399 15.77514 Q5TEC6 H37_HUMAN Histone H3-7 H3-7 H3-2 HIST2H3PS2 Homo sapiens (Human) nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] GO:0000786; GO:0003677; GO:0005634; GO:0046982 DIQLVSRIR 1.460000038 0.318796754 0.318796754 0.31744068 1101.006082 0 0 0 0 0 0 0 0 0 0 0 0 0 17.11571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TEU4 NDUF5_HUMAN "Arginine-hydroxylase NDUFAF5, mitochondrial, EC 1.-.-.- (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5, EC 2.1.1.-)" NDUFAF5 C20orf7 Homo sapiens (Human) methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961] methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491] GO:0005739; GO:0005743; GO:0008168; GO:0016491; GO:0030961; GO:0031314; GO:0032259; GO:0032981 REVTSGVSPR 1.340000033 0.244490623 0.244490623 0.199198721 1089.154771 13.81223 13.85154 0 14.50526 14.11782 0 0 14.85847 0 0 0 0 0 0 0 14.4156 13.75161 15.34002 0 12.55727 15.36501 0 0 0 0 0 0 0 0 17.01863 0 16.97173 0 0 9.794019 0 16.73706 0 0 14.64443 0 0 0 0 0 0 16.27039 14.12564 Q5TF58 IFFO2_HUMAN Intermediate filament family orphan 2 IFFO2 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 GLMSDPMTDLDTKIQEK 5.150000095 0.420786858 0.420786858 0.1093404 1938.378073 14.02792 16.64416 0 15.69469 0 0 16.0503 0 11.49697 0 0 0 0 17.23782 0 0 11.98023 17.72917 0 0 11.44151 0 0 18.67805 12.90635 0 12.58015 15.35146 14.80027 13.08224 15.28315 16.84426 15.66668 0 0 16.45452 0 0 14.60342 16.29483 14.42319 0 0 14.31734 0 16.90192 0 0 Q5TFG8 ZC21B_HUMAN Zinc finger C2HC domain-containing protein 1B ZC2HC1B C6orf94 FAM164B Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 DQSSRR 5.78000021 0.58754921 0.58754921 0.119783977 750.459333 0 16.16336 16.41058 0 0 15.55696 16.87423 17.43858 0 0 0 0 0 0 0 0 0 0 0 12.47594 16.82133 11.98009 18.23984 15.75282 12.30716 16.26526 13.09326 0 0 14.08714 18.46116 0 0 16.18761 16.11991 17.24588 16.53366 0 16.43763 16.09344 0 13.50059 0 0 17.98483 0 0 15.4693 Q5TG53 SEAS1_HUMAN Putative uncharacterized protein SERTAD4-AS1 (SERTAD4 antisense RNA 1) (SERTAD4 antisense gene protein 1) SERTAD4-AS1 C1orf133 Homo sapiens (Human) VSATASIPFSCK 6.960000038 1 1 0.340997734 1267.28649 0 0 0 0 0 0 15.03167 16.72058 13.73429 13.40363 11.95864 13.70711 0 14.69854 0 15.66866 0 0 16.41885 0 0 0 14.42686 15.5346 0 0 0 0 0 0 0 0 0 0 0 0 0 16.03656 0 0 0 0 0 0 16.91686 0 0 0 Q5TGI4 SAMD5_HUMAN "Sterile alpha motif domain-containing protein 5, SAM domain-containing protein 5" SAMD5 SAMDC1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 CTNIVYEWLK 9 0.142464548 0.142464548 0.451720598 1325.811925 15.60749 0 0 0 0 14.52328 15.61576 0 16.3969 14.94104 14.95887 15.64569 0 15.61827 15.7152 12.98641 0 15.38031 16.75038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.17704 17.07301 0 0 15.04269 0 0 0 16.78429 0 0 15.96604 Q5TGJ6 HDGL1_HUMAN Hepatoma-derived growth factor-like protein 1 (PWWP domain-containing protein 1) HDGFL1 PWWP1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712] GO:0003690; GO:0003712; GO:0005634; GO:0006357 SGDLVFAK 5.159999847 0.860842168 0.860842168 0.259065299 834.7288738 15.3821 0 17.11728 13.77355 15.70149 16.29337 15.16531 13.89466 0 15.9953 14.42244 16.85297 15.54362 16.1048 15.01016 0 0 16.02674 15.48133 0 0 16.02196 15.81487 18.12115 0 15.57673 0 0 0 15.61331 15.63221 16.02336 0 16.04107 14.11749 15.08175 15.98966 17.1869 0 16.15364 15.71881 16.0236 0 15.72307 13.93372 0 0 0 Q5TGP6 MROH9_HUMAN Maestro heat-like repeat-containing protein family member 9 MROH9 C1orf129 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DSSYLQERIMVIINK 3.970000029 1 1 0.258845387 1814.478668 0 15.33364 0 0 15.21033 14.21735 15.19125 14.90638 0 0 0 14.78861 0 0 12.22829 15.09414 0 0 14.92335 0 0 0 0 0 14.10185 0 0 0 0 0 0 16.08772 0 0 15.49352 0 12.95933 0 16.02776 0 14.3466 0 0 0 0 16.10557 0 0 Q5TGY3 AHDC1_HUMAN AT-hook DNA-binding motif-containing protein 1 AHDC1 Homo sapiens (Human) DNA binding [GO:0003677] DNA binding [GO:0003677] GO:0003677 AAETFPK 9.380000114 0.782700002 0.782700002 0.304664487 763.7917861 0 19.23786 18.66798 19.3162 0 0 0 18.95703 0 0 19.9864 0 16.56975 0 0 0 18.51092 0 0 0 17.87945 0 0 0 18.03547 17.64516 19.22546 19.30318 0 19.85841 20.52652 19.27379 18.94767 0 0 19.79759 19.0349 0 0 0 0 0 0 18.24669 0 19.02925 18.88405 0 Q5TH69 BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) ARFGEF3 BIG3 C6orf92 KIAA1244 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658] integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0016021; GO:0030036; GO:0030658; GO:0032012 EHMGESLSLKAGGGDLLLPPSPK 7.760000229 1 1 2.29E-12 2357.727344 13.62603 13.38863 0 0 12.94593 14.24859 14.32403 13.47906 0 15.96965 15.4192 8.937363 0 14.27429 13.39478 14.27809 0 15.09699 13.15828 11.14545 12.06071 0 0 14.84452 0 0 0 0 0 0 0 0 0 14.02924 0 0 0 0 0 15.51845 0 14.52097 0 0 0 0 0 0 Q5THJ4 VP13D_HUMAN Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) VPS13D KIAA0453 Homo sapiens (Human) mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526 GGLLSTDDK 17.53000069 1 1 0.326743045 908.2047746 0 0 0 16.94085 0 0 0 0 0 0 16.37132 0 0 0 0 16.57173 0 0 0 18.4613 0 18.16528 0 15.89639 0 0 0 0 0 0 0 0 0 0 16.44703 0 16.8569 0 0 0 17.47425 0 0 0 0 0 0 0 Q5THK1 PR14L_HUMAN Protein PRR14L (Proline rich 14-like protein) PRR14L C22orf30 Homo sapiens (Human) EEKYIR 8.850000381 0.277132481 0.277132481 0.230618164 837.0499807 0 0 13.01876 0 0 15.94547 0 0 15.67715 0 13.9702 0 13.79782 15.85173 0 12.90229 0 15.33007 14.499 17.16068 0 0 15.50547 0 15.84041 0 0 15.56545 14.96201 0 14.89734 0 0 0 16.59913 0 16.34012 15.30133 0 14.69816 15.01103 16.27344 15.05453 16.35663 0 0 0 16.57379 Q5THR3 EFCB6_HUMAN "EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein, DJBP)" EFCAB6 DJBP KIAA1672 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509; GO:0005654 FSSETAATPMATGDSAVAQR 9.359999657 1 1 0.068197986 1998.455291 0 16.39025 0 0 0 0 11.83153 0 0 0 8.857583 0 9.328116 0 0 16.98736 15.67225 0 0 0 0 0 0 0 14.02692 15.64992 0 0 0 0 14.92409 0 0 14.39033 12.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TIA1 MEI1_HUMAN Meiosis inhibitor protein 1 (Meiosis defective protein 1) MEI1 Homo sapiens (Human) meiosis I [GO:0007127] meiosis I [GO:0007127] GO:0007127 DHQSTPPVQYGELQALLEAMLNR 1.830000043 1 1 0.497097658 2610.750761 0 0 0 0 0 0 19.18279 0 18.00491 0 15.34189 0 0 0 0 0 0 0 0 0 15.10987 0 0 20.119 0 0 0 0 0 0 15.02855 0 0 0 17.59419 0 18.81648 0 0 0 0 0 0 0 0 0 0 0 Q5TID7 CC181_HUMAN Coiled-coil domain-containing protein 181 CCDC181 C1orf114 Homo sapiens (Human) cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017] microtubule binding [GO:0008017] GO:0002177; GO:0005737; GO:0005874; GO:0008017; GO:0036126 TILVERDGK 13.88000011 1 1 0.26054647 1029.526068 0 0 0 14.51012 14.93349 15.76891 0 0 14.32113 0 0 0 0 0 0 14.22173 0 0 0 0 0 0 0 14.68673 0 0 16.82961 0 0 0 0 0 0 0 0 0 0 0 16.42451 0 0 0 0 0 0 0 0 0 Q5TKA1 LIN9_HUMAN "Protein lin-9 homolog, HuLin-9, hLin-9 (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein)" LIN9 BARA TGS Homo sapiens (Human) "cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]" nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053] "nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677] GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0007049; GO:0017053; GO:0051726; GO:0071897 EMNTEAEKLK 2.359999895 0.234929413 0.234929413 0.07554179 1193.149371 13.93036 0 15.69822 0 15.15341 13.18353 12.69396 16.89369 0 14.96362 0 0 0 14.53954 0 0 12.93554 0 14.39487 0 13.80053 16.26685 16.31989 13.89646 0 0 0 15.42124 13.73915 16.03313 16.40831 14.5745 15.38313 13.88681 15.17489 17.63016 0 0 0 0 12.75753 0 0 15.82504 13.12173 0 10.66209 16.44762 Q5TYW1 ZN658_HUMAN Zinc finger protein 658 ZNF658 Homo sapiens (Human) "cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042254; GO:0045892; GO:0046872; GO:0071294 CGKTFSQK 8.550000191 1 1 0.417999419 954.5783338 0 0 0 0 0 0 0 13.58183 14.8905 12.71653 0 13.63002 7.779477 14.22341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.36433 0 0 0 0 0 Q5TYW2 A20A1_HUMAN Ankyrin repeat domain-containing protein 20A1 ANKRD20A1 ANKRD20A Homo sapiens (Human) plasma membrane [GO:0005886] plasma membrane [GO:0005886] GO:0005886 HSESVK 21.65999985 0.879861772 0.879861772 0.257706371 685.6922584 18.23535 18.76257 17.15574 0 0 0 0 18.28341 19.28328 17.53461 17.35962 18.46827 18.23203 0 17.63128 18.78704 0 18.78812 0 0 17.42327 0 0 17.68877 0 0 17.87271 0 17.69325 17.11644 0 19.22432 0 0 19.09856 0 0 0 0 18.03231 0 0 16.77605 18.84082 18.0126 0 0 18.62426 Q5TZA2 CROCC_HUMAN Rootletin (Ciliary rootlet coiled-coil protein) CROCC KIAA0445 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365] 9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219] 9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365] actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051656; GO:0070062; GO:0097729; GO:0120219; GO:1903566 AEAALEK 6.449999809 0.087849662 0.087849662 0.238801283 730.90886 0 14.79949 14.83658 0 0 0 15.15442 18.18345 0 16.96422 0 15.8689 0 16.65157 0 14.27718 13.51048 0 18.28854 17.03178 15.82403 17.37817 15.09973 16.14679 0 0 0 0 0 0 17.4631 0 0 16.91735 0 16.75849 0 0 0 18.72159 0 0 0 0 0 16.5731 15.0896 16.59716 Q5U5R9 HECD2_HUMAN "Probable E3 ubiquitin-protein ligase HECTD2, EC 2.3.2.26 (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2)" HECTD2 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842] ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005829 GIINSLLR 10.31999969 1 1 0.277580853 885.1116955 15.00805 0 15.08123 13.81788 14.71793 15.55513 15.32195 0 0 15.25249 0 17.13446 14.82351 15.26418 16.98054 0 16.2631 0 15.09577 0 0 0 15.16032 0 0 14.54786 0 14.15007 15.51162 0 0 15.4372 16.62196 0 14.15914 16.37319 0 15.8168 16.62636 0 0 0 14.78397 0 0 16.68642 15.98224 14.89322 Q5U5X0 LYRM7_HUMAN Complex III assembly factor LYRM7 (LYR motif-containing protein 7) LYRM7 C5orf31 MZM1L Homo sapiens (Human) cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551] GO:0005759; GO:0031966; GO:0034551; GO:0045333 SETSSK 10.02999973 1 1 0.202114172 638.7073375 0 15.30877 15.99605 14.08834 14.26359 0 0 15.39133 0 14.77904 0 13.64797 16.28588 0 15.73317 0 0 15.86451 17.08606 15.66385 0 16.913 0 0 17.27327 16.36954 0 15.36652 15.64 0 16.66009 0 14.09957 0 15.98162 14.02331 0 16.23182 0 0 0 14.96508 0 0 16.377 0 12.56215 0 Q5U5X8 F222A_HUMAN Protein FAM222A FAM222A C12orf34 Homo sapiens (Human) VPQHKHLSR 8.739999771 0.358312875 0.358312875 0.108322287 1100.644479 0 0 0 0 11.88644 0 0 12.50858 0 16.74991 0 0 17.99549 0 15.59962 17.14349 16.62278 0 0 0 15.01071 0 0 0 17.12528 0 0 0 14.32702 0 0 0 0 0 0 0 0 0 0 0 13.97666 17.22178 0 0 9.701971 0 0 0 Q5U623 MCAF2_HUMAN "Activating transcription factor 7-interacting protein 2, ATF7-interacting protein 2 (MBD1-containing chromatin-associated factor 2)" ATF7IP2 MCAF2 Homo sapiens (Human) "positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription coregulator activity [GO:0003712]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription, DNA-templated [GO:0006355]" transcription coregulator activity [GO:0003712] GO:0003712; GO:0005634; GO:0005667; GO:0006355; GO:0090309 TRDTLPPQKPELK 1.00999999 1 1 0 1523.835284 18.00911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5UCC4 EMC10_HUMAN ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1) EMC10 C19orf63 INM02 UNQ764/PRO1556 Homo sapiens (Human) angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0001525; GO:0001938; GO:0005576; GO:0005789; GO:0010595; GO:0016021; GO:0030176; GO:0045050; GO:0045766; GO:0071816; GO:0072546; GO:1900745 LLLLLLMAVAAPSRAR 4.789999962 1 1 0.407738683 1724.469953 14.50104 13.38031 0 13.62629 0 0 0 13.73253 15.99292 0 0 15.69638 16.15677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.79851 0 0 0 0 14.07406 0 0 16.3872 0 16.16599 0 0 15.99114 0 0 0 0 0 0 0 Q5UE93 PI3R6_HUMAN "Phosphoinositide 3-kinase regulatory subunit 6 (Phosphoinositide 3-kinase gamma adapter protein of 87 kDa) (p84 PI3K adapter protein, p84 PIKAP) (p87 PI3K adapter protein, p87PIKAP)" PIK3R6 C17orf38 Homo sapiens (Human) angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of T cell differentiation [GO:0045582]; regulation of natural killer cell mediated cytotoxicity [GO:0042269] "cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of T cell differentiation [GO:0045582]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]" "1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" GO:0001525; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006955; GO:0007186; GO:0016020; GO:0042269; GO:0043406; GO:0045582; GO:0045766; GO:0046934; GO:0046935 TLEHYFHAVVAALEQMASEASPSR 3.349999905 1 1 0.004287192 2659.243203 15.98002 0 0 13.54303 0 12.35291 13.13154 14.31166 13.23014 13.52519 16.20725 14.16681 7.235061 0 14.3681 16.02155 15.18247 11.28747 11.95539 0 0 0 16.87781 16.29256 12.69478 15.42511 0 15.59647 0 0 0 14.85482 0 0 0 10.15122 0 15.47406 0 15.00478 16.94428 14.01623 15.56608 0 0 17.07201 0 0 Q5UIP0 RIF1_HUMAN Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; subtelomeric heterochromatin assembly [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]" "chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]" "chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; subtelomeric heterochromatin assembly [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]" GO:0000122; GO:0000723; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006974; GO:0007049; GO:0016604; GO:0019827; GO:0031509; GO:0031965; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0051574; GO:0140445; GO:1990830; GO:2000042; GO:2001034 HNTTSAKGFLSPGSR 12.98999977 1 1 0.157522176 1562.681627 0 0 0 0 0 0 0 0 0 0 0 0 11.90286 13.84651 16.33229 0 15.60447 0 0 13.24347 0 15.67291 14.54252 15.85223 0 0 0 15.42109 0 12.41384 0 0 14.37007 15.25828 0 15.311 0 15.08099 0 15.27748 14.50733 0 0 0 15.40601 0 0 0 Q5VIY5 ZN468_HUMAN Zinc finger protein 468 ZNF468 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 CEECCK 1.49000001 1 1 0.232730764 885.8143967 0 0 15.35498 0 15.32081 15.59213 15.67074 0 14.91403 0 14.97643 0 15.24998 15.61555 14.68438 0 15.8818 16.03367 0 14.115 0 17.0179 0 0 15.8837 16.48568 0 0 14.2341 15.29339 14.87224 17.29898 16.03308 15.81506 15.75923 15.78746 16.61126 16.89164 16.4596 16.12338 16.34637 15.47241 0 0 13.8089 16.40665 13.65951 0 Q5VSG8 MANEL_HUMAN "Glycoprotein endo-alpha-1,2-mannosidase-like protein, EC 3.2.1.-" MANEAL Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559] alpha-mannosidase activity [GO:0004559] GO:0000139; GO:0004559; GO:0005794; GO:0016021 ISASYPR 15.35999966 0.511272907 0.511272907 0.227247277 793.9401668 16.91185 19.96799 16.12896 18.30274 17.09788 16.18547 0 15.69435 15.32695 16.21243 14.68721 0 0 0 16.38635 17.3693 13.50718 0 16.92581 0 18.70619 17.06744 18.61162 17.60418 22.08652 17.4244 15.89431 17.48141 16.45212 17.55867 19.31471 22.14936 20.74445 19.81432 17.05985 16.18849 19.12667 19.35246 19.30707 17.37049 17.69289 18.60329 16.74942 16.28979 17.1939 15.81935 18.50718 15.63115 Q5VSL9 STRP1_HUMAN Striatin-interacting protein 1 (Protein FAM40A) STRIP1 FAM40A KIAA1761 Homo sapiens (Human) cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0005634; GO:0005829; GO:0007010; GO:0019901; GO:0022604; GO:0030866; GO:0031267; GO:0070062 DEVMPPPLQHPQTDRLTCPK 13.68999958 1 1 0.522039716 2375.107007 0 0 16.24279 0 16.72041 0 0 0 0 0 16.84039 17.3482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.59715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VSP4 LC1L1_HUMAN Putative lipocalin 1-like protein 1 (Lipocalin 1-like pseudogene 1) LCN1P1 LCN1L1 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; small molecule binding [GO:0036094] small molecule binding [GO:0036094] GO:0005615; GO:0036094 AAGARGLSTESILIPR 7.53000021 1 1 2.29E-13 1611.440433 0 15.58534 0 0 0 0 0 0 18.5019 0 0 0 0 0 0 16.43408 17.07747 0 0 0 0 0 0 0 14.81875 16.38585 0 0 0 0 0 0 0 0 0 0 0 15.40085 0 0 0 0 0 0 0 0 0 0 Q5VST9 OBSCN_HUMAN "Obscurin, EC 2.7.11.1 (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase, Obscurin-MLCK)" OBSCN KIAA1556 KIAA1639 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018] "cell-cell junction [GO:0005911]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cell-cell adhesion [GO:0098609]; protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214]" "ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]" GO:0004674; GO:0004712; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0008307; GO:0010314; GO:0016604; GO:0030016; GO:0030018; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0036309; GO:0042383; GO:0043325; GO:0045214; GO:0046872; GO:0050839; GO:0051056; GO:0070273; GO:0098609; GO:0106310 APTRSSPEPTPWEDIGQVSLVQIR 4.389999866 1 1 4.12E-12 2662.470631 13.73085 15.16875 0 0 13.0946 0 0 0 15.15485 0 0 14.414 0 7.933332 0 0 0 0 0 0 14.65299 0 14.82996 0 0 0 0 0 0 14.9395 0 16.21524 0 0 0 0 11.91264 0 0 0 0 0 15.26339 0 0 0 0 0 Q5VT06 CE350_HUMAN "Centrosome-associated protein 350, Cep350 (Centrosome-associated protein of 350 kDa)" CEP350 CAP350 KIAA0480 GM133 Homo sapiens (Human) microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539] cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819] cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539] microtubule binding [GO:0008017] GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0016020; GO:0034453; GO:0042995; GO:0071539; GO:1905515 DIHEQK 5.25 1 1 0.16905505 768.5739941 16.98533 14.38044 16.59826 0 0 14.70739 14.49412 0 14.68302 16.45868 0 0 14.55113 15.43754 15.05865 0 0 0 15.48639 0 12.7186 0 0 0 0 0 0 15.49255 0 15.54419 0 0 0 0 15.88501 0 0 0 0 0 0 0 0 15.98376 15.14449 0 15.47621 0 Q5VT25 MRCKA_HUMAN "Serine/threonine-protein kinase MRCK alpha, EC 2.7.11.1 (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha, MRCK alpha, Myotonic dystrophy protein kinase-like alpha)" CDC42BPA KIAA0451 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0042641; GO:0042802; GO:0070062; GO:0106310 DVLVNGDNK 8.989999771 0.712771833 0.712771833 0.196746296 972.7846704 10.65823 15.80762 15.36401 0 12.21322 12.42273 17.27429 0 0 16.39051 15.33902 16.59296 15.69232 14.10559 14.21103 0 0 0 0 0 15.31439 0 0 17.19746 14.21383 15.02844 0 0 12.78086 0 16.16728 16.23587 17.0987 15.50245 14.8711 16.95707 0 0 0 0 14.52472 0 0 0 0 0 16.33401 0 Q5VT28 FAM27_HUMAN Protein FAM27A/B/C FAM27B FAM27A FAM27A1 FAM27A2; FAM27C FAM27A3 Homo sapiens (Human) EDACIFSR 4.210000038 1 1 0.316914205 996.8879866 0 17.343 0 0 0 0 0 0 0 0 0 0 0 0 0 17.60805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.16423 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3467 0 0 0 Q5VT52 RPRD2_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 2 RPRD2 KIAA0460 HSPC099 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124] "nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]" "nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]" RNA polymerase II complex binding [GO:0000993] GO:0000993; GO:0005654; GO:0016591; GO:0031124 DPSVSK 2.480000019 0.277001679 0.277001679 0.308537338 631.4977366 0 0 0 0 0 0 0 0 0 0 0 17.79483 0 0 0 0 0 0 0 0 0 0 0 17.6275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VT66 MARC1_HUMAN "Mitochondrial amidoxime-reducing component 1, mARC1, EC 1.7.-.- (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1, MOSC domain-containing protein 1, Moco sulfurase C-terminal domain-containing protein 1)" MTARC1 MARC1 MOSC1 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958] "integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]; cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]" "molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]" GO:0005739; GO:0005741; GO:0006809; GO:0008940; GO:0016021; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809; GO:1903958 DLLLPIK 27.45000076 0.028124491 0.028124491 0.219403301 811.8148532 20.08244 19.86635 19.00977 17.56266 15.13689 18.99162 17.35976 19.43639 17.95198 16.31389 17.09111 19.07445 0 0 19.18021 0 17.71633 17.93519 18.70953 17.87787 0 19.10674 0 19.90526 20.43973 16.73001 21.96197 16.88286 0 18.21433 21.95201 22.05439 0 14.2649 0 19.82451 21.1017 20.94867 0 0 18.87481 18.55483 0 0 0 0 20.04529 20.4097 Q5VT97 SYDE2_HUMAN "Rho GTPase-activating protein SYDE2 (Synapse defective protein 1 homolog 2, Protein syd-1 homolog 2)" SYDE2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0007165; GO:0016477; GO:0051056; GO:0090630 GAAYR 5.079999924 1 1 0.241267538 537.3795378 19.14417 0 17.6857 0 0 18.14813 0 0 17.70769 0 0 0 0 0 17.02626 0 0 0 0 18.92616 0 0 0 0 17.8354 0 19.34042 0 0 0 16.89028 17.93538 19.976 0 0 0 19.12174 0 0 0 0 0 0 0 16.93616 19.0144 0 0 Q5VTH2 FLTOP_HUMAN Protein Flattop (Cilia- and flagella-associated protein 126) CFAP126 C1orf192 FLTP Homo sapiens (Human) cilium organization [GO:0044782] apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737] apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782] GO:0005737; GO:0005929; GO:0016324; GO:0036064; GO:0044782 MATNYSANQYEK 6.659999847 1 1 0.41904268 1436.992346 12.8915 17.44657 0 0 0 0 0 0 0 0 0 0 0 16.5479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.50941 0 0 0 0 0 0 0 0 18.29662 0 0 0 0 0 0 Q5VTH9 DNAI4_HUMAN Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78) DNAI4 WDR78 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] GO:0002244; GO:0003341; GO:0005858; GO:0005930; GO:0007018; GO:0031514; GO:0045503; GO:0045504; GO:0070286; GO:0120293 FTTILFAK 2.319999933 1 1 0.164664966 939.6467675 18.3858 13.02574 0 16.6438 0 18.77534 0 0 15.75431 0 18.58334 16.00923 0 15.7252 16.29313 0 0 0 0 0 0 0 16.36197 0 0 16.41718 0 17.60596 17.83734 0 19.43168 16.94658 17.91882 16.99826 15.75624 15.04692 17.28599 14.0728 14.65256 19.91211 16.81297 0 0 16.79578 0 0 0 0 Q5VTJ3 KLD7A_HUMAN Kelch domain-containing protein 7A KLHDC7A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LGSEPK 20.35000038 0.330959886 0.330959886 0.235051678 630.2345713 0 15.57532 0 15.13846 14.76381 5.903064 15.56075 0 15.085 0 15.53642 0 14.24496 15.02758 16.12865 0 16.85107 15.89042 0 15.57851 0 15.5625 16.23104 16.45055 15.92578 0 0 0 0 0 0 0 15.46085 0 15.68585 0 0 0 16.87998 0 16.87453 0 0 16.43336 0 16.33624 0 0 Q5VTL8 PR38B_HUMAN Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27) PRPF38B Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] precatalytic spliceosome [GO:0071011] precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0006397; GO:0008380; GO:0071011 AGGGCVMTIGEMLR 4.300000191 1 1 0.351984622 1466.964474 16.39409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.04921 0 0 0 0 0 0 0 0 Q5VTM2 AGAP9_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9, AGAP-9 (Centaurin-gamma-like family member 6)" AGAP9 CTGLF6 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005634; GO:0046872 SSKSK 10.47999954 0.792694747 0.792694747 0.298030447 536.7345151 0 14.21614 15.73828 16.25813 15.8799 15.56535 14.03213 15.54661 15.57273 0 15.3112 0 15.22243 16.00102 15.34585 0 15.77165 15.65671 0 13.19478 14.17335 16.05881 0 16.36707 0 0 16.41839 15.26163 16.1955 14.03072 15.6236 16.06571 0 0 15.72941 0 0 16.12935 0 15.03665 16.83614 16.07506 0 0 14.76951 15.76011 16.49287 16.44734 Q5VTR2 BRE1A_HUMAN "E3 ubiquitin-protein ligase BRE1A, BRE1-A, hBRE1, EC 2.3.2.27 (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A)" RNF20 BRE1A Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0000209; GO:0002039; GO:0003682; GO:0003713; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006511; GO:0010390; GO:0030336; GO:0031062; GO:0031625; GO:0033503; GO:0033523; GO:0042393; GO:0042802; GO:0045893; GO:0046872; GO:0061630; GO:0071894; GO:1900364; GO:2001168 DMFNFK 10.67000008 0.856389523 0.856389523 0.320984212 800.737437 13.40211 15.60146 15.08468 0 14.78494 14.82087 14.50171 15.61647 15.94365 15.51002 0 0 19.17927 14.72015 15.29635 14.57496 14.63127 17.12143 16.50534 19.96277 18.60971 18.73611 17.9085 18.92355 18.68038 14.1998 15.01344 18.58092 15.88797 14.5842 17.92667 18.0814 19.43676 0 20.00881 19.29714 15.48146 20.5271 21.02655 19.40408 16.68738 19.67143 15.42635 19.72765 19.49338 17.476 19.92069 19.72279 Q5VTT5 MYOM3_HUMAN Myomesin-3 (Myomesin family member 3) MYOM3 Homo sapiens (Human) muscle contraction [GO:0006936] M band [GO:0031430] M band [GO:0031430]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; muscle contraction [GO:0006936] actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803] GO:0006936; GO:0031430; GO:0042803; GO:0051015 VSDLQPGK 2.650000095 1 1 0.032266024 842.6584839 0 0 0 0 0 14.56353 10.79607 13.31364 15.45498 14.69003 14.96108 15.56829 14.94447 0 0 0 14.91936 0 0 0 0 0 0 13.02241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.90867 Q5VTY9 HHAT_HUMAN "Protein-cysteine N-palmitoyltransferase HHAT, EC 2.3.1.- (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2, MART-2) (Skinny hedgehog protein 1)" HHAT MART2 SKI1 Homo sapiens (Human) N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acyltransferase activity [GO:0016746]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224] acyltransferase activity [GO:0016746]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409] GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0008374; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345 YLVLFGVPALLMRLDGLTPPALPR 5.510000229 1 1 4.58E-12 2623.425467 0 0 11.53933 0 13.90797 13.24402 13.17207 0 0 15.9674 0 0 0 0 14.67937 0 0 0 11.77144 14.79026 11.14117 0 0 0 0 12.70098 0 13.18229 9.724465 12.91898 0 0 0 0 0 0 15.21981 0 0 0 0 0 0 0 0 0 0 0 Q5VU43 MYOME_HUMAN Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein) PDE4DIP CMYA2 KIAA0454 KIAA0477 MMGL Homo sapiens (Human) astral microtubule organization [GO:0030953]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; astral microtubule organization [GO:0030953]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358] enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090] GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0019899; GO:0030016; GO:0030953; GO:0060090; GO:0065003; GO:0090063; GO:1903358 LVQALMER 10.31000042 1 1 0 972.7332587 0 0 14.1523 0 15.03249 0 12.91783 14.71466 0 0 0 0 13.6057 11.19493 0 14.83259 0 0 0 0 0 19.19296 0 0 0 0 0 0 0 0 0 0 0 0 14.78022 0 0 0 15.27559 0 0 17.10488 0 0 0 0 0 15.1385 Q5VU57 CBPC6_HUMAN "Cytosolic carboxypeptidase 6, EC 3.4.17.24 (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6)" AGBL4 CCP6 Homo sapiens (Human) anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0008285; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060 AGTGRR 1.169999957 1 1 0.273964328 618.7379253 15.06578 15.37382 12.78575 13.8963 14.5378 15.36271 13.94883 14.12517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.764 0 0 0 0 0 0 0 17.65085 0 15.82891 16.42506 0 0 0 0 0 15.10791 16.29004 14.99327 0 15.6237 0 17.05664 0 15.2847 Q5VU65 P210L_HUMAN Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like) NUP210L Homo sapiens (Human) integral component of membrane [GO:0016021]; nuclear pore [GO:0005643] integral component of membrane [GO:0016021]; nuclear pore [GO:0005643] GO:0005643; GO:0016021 AVRILAAATR 10.38000011 0.569455266 0.569455266 0.228510204 1038.539188 0 0 0 0 0 0 0 0 0 0 0 14.95007 0 0 15.57862 0 0 0 0 13.95392 0 16.23124 16.37998 0 16.64065 15.23042 0 0 13.12292 0 0 16.0624 17.0634 0 15.33736 17.62549 0 0 0 0 18.514 0 0 0 0 15.82063 15.4635 0 Q5VU92 DC121_HUMAN DDB1- and CUL4-associated factor 12-like protein 1 (WD repeat-containing protein 40B) DCAF12L1 WDR40B Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] GO:0080008 AGSALSR 10.31000042 0.90943104 0.90943104 0.265623636 660.0706905 0 17.64853 0 18.28395 0 17.22184 0 18.12252 0 18.96063 17.05788 0 0 17.50789 16.60753 16.77254 0 15.96678 16.59039 0 17.07056 0 16.72911 17.7334 18.43777 17.85332 0 17.10301 0 0 0 18.60874 0 19.03456 17.6478 0 18.55071 18.17285 17.80381 0 0 0 0 0 0 0 0 0 Q5VU97 CAHD1_HUMAN "VWFA and cache domain-containing protein 1, Cache domain-containing protein 1" CACHD1 KIAA1573 VWCD1 Homo sapiens (Human) voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245] voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005891 DSSEEDK 8.93999958 1 1 0.275761554 808.4869899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.21792 0 0 0 0 0 0 0 0 0 0 0 0 0 17.96973 0 0 0 0 0 Q5VUA4 ZN318_HUMAN Zinc finger protein 318 (Endocrine regulatory protein) ZNF318 HRIHFB2436 Homo sapiens (Human) "meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]" nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0003676; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0051321 DDGGGGPR 7.110000134 0.654793203 0.654793203 0.260469259 731.2820331 16.70827 16.10206 15.42471 14.80823 15.61316 15.17216 15.59022 15.50996 13.76238 15.97433 15.59872 15.918 16.06287 13.99362 16.09131 0 16.14904 16.01933 15.46903 15.91597 16.63844 16.71885 0 17.06439 16.97876 0 16.46449 15.03662 0 0 16.19133 16.34165 17.84272 17.2163 16.69311 16.62078 0 18.71052 17.98681 16.63305 16.64833 17.1759 17.52668 16.42451 17.17122 17.65309 16.86623 15.89757 Q5VUD6 DIK1B_HUMAN Divergent protein kinase domain 1B (Protein FAM69B) DIPK1B C9orf136 FAM69B PP6977 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 DNRVSLAEAK 10.93000031 0.839510202 0.839510202 0.271240729 1101.168403 0 17.32604 14.06889 0 0 0 0 0 0 16.76172 0 12.90051 0 0 16.37285 16.97033 0 0 0 15.90212 0 15.0941 0 15.66102 17.38639 17.40149 16.55327 15.08683 0 0 10.65613 16.92708 0 0 0 17.3467 16.2703 17.20153 18.21778 0 0 0 16.15151 15.81007 15.53169 17.1375 16.00702 15.97988 Q5VUJ6 LRCH2_HUMAN Leucine-rich repeat and calponin homology domain-containing protein 2 LRCH2 KIAA1495 Homo sapiens (Human) IAAQLLQQEQK 13.13000011 1 1 0.45385775 1268.526297 20.85432 19.51933 17.60905 0 18.29157 0 0 0 21.08597 0 15.48922 19.63176 21.34248 0 0 22.32721 0 0 0 0 18.20491 21.26782 21.43849 21.88809 0 17.45029 0 18.42421 0 0 0 0 20.73981 0 18.33267 0 18.69942 17.22582 0 0 0 20.68539 21.02118 17.25467 0 18.76678 17.09119 17.74279 Q5VV41 ARHGG_HUMAN Rho guanine nucleotide exchange factor 16 (Ephexin-4) ARHGEF16 EPHEXIN4 NBR Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078] cytosol [GO:0005829] cytosol [GO:0005829]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267] GO:0005085; GO:0005829; GO:0030165; GO:0030971; GO:0031267; GO:0045296; GO:0060326; GO:0090630; GO:1903078 AKTPAR 3.680000067 1 1 0.152570234 642.3242969 14.15699 15.60341 0 15.37464 0 14.51805 0 15.7501 0 14.90893 16.02322 15.2176 15.10053 16.02127 0 14.84127 0 0 0 0 0 0 0 0 0 17.08711 0 0 0 0 0 0 16.83192 0 0 0 0 0 15.52025 0 0 0 17.58726 0 0 0 0 0 Q5VV42 CDKAL_HUMAN "Threonylcarbamoyladenosine tRNA methylthiotransferase, EC 2.8.4.5 (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)" CDKAL1 Homo sapiens (Human) maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]" "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]" GO:0005783; GO:0005789; GO:0005791; GO:0016020; GO:0016021; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712; GO:1990145 KAQEENK 32.54999924 0.002631636 0.002631636 0.224547484 847.4821178 19.52641 18.80006 19.04523 18.28552 0 19.7895 19.74642 0 19.55707 0 20.15391 0 18.73356 0 16.96095 19.1093 0 0 19.92968 0 20.07459 0 0 0 0 19.55328 19.1722 0 18.96715 19.9271 20.38153 19.35649 20.90938 15.22709 0 18.63491 0 19.23407 19.28727 0 19.11868 0 18.02724 19.29931 0 0 20.26118 19.01508 Q5VV43 K0319_HUMAN Dyslexia-associated protein KIAA0319 KIAA0319 Homo sapiens (Human) multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996] GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030669; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:2000171 HVLVLPNNSITLDGSR 4.460000038 1 1 0.084156323 1738.322181 13.17624 13.56178 0 0 0 0 0 0 0 0 0 0 0 0 0 12.78565 11.95005 0 12.29671 0 0 12.52815 0 0 11.85601 15.88616 15.92192 0 15.46609 14.63199 14.79597 13.70686 14.57245 15.78923 13.05189 0 13.66987 13.67958 0 0 0 0 13.88888 0 15.2854 0 0 13.21566 Q5VV63 ATRN1_HUMAN Attractin-like protein 1 ATRNL1 KIAA0534 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] carbohydrate binding [GO:0030246] GO:0005604; GO:0007186; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0030246; GO:0034446 AVLHGK 7.050000191 1 1 0.267331519 623.914692 0 14.97682 15.28578 0 0 0 0 13.39013 0 15.81713 0 0 0 0 0 16.64693 0 0 0 0 0 0 0 16.13916 15.77725 0 0 0 15.94675 0 0 0 0 0 0 0 0 0 0 0 16.23014 0 0 14.65469 16.35039 0 0 16.50577 Q5VVW2 GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 GARNL3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0051056; GO:0090630 QMHVLETLDLLVLRADK 5.389999866 0.942818165 0.942818165 0.132965788 1994.485107 0 14.99749 16.28909 16.53054 15.22626 0 15.08181 0 15.69114 16.81705 0 16.53149 0 16.33158 12.55485 14.28541 16.27522 0 15.69159 13.68344 13.29745 13.84885 15.58945 0 16.91218 0 15.84793 0 15.37204 13.39827 15.62813 15.61102 15.58844 14.67826 0 15.69327 0 0 15.89495 14.52762 0 15.19772 16.80773 13.37753 15.71165 14.97945 15.9492 16.80457 Q5VVX9 UBE2U_HUMAN "Ubiquitin-conjugating enzyme E2 U, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme U) (Ubiquitin carrier protein U) (Ubiquitin-protein ligase U)" UBE2U Homo sapiens (Human) DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] HULC complex [GO:0033503] HULC complex [GO:0033503]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] GO:0000209; GO:0005524; GO:0006281; GO:0016574; GO:0033503; GO:0043161; GO:0061631 TTSFSDYYQTWSR 3.480000019 1 1 0.248830642 1639.702727 0 0 14.98711 15.5625 0 0 0 0 0 0 0 15.01165 0 16.51267 0 0 0 0 0 0 0 0 0 0 0 0 0 15.25142 15.41292 0 16.29965 0 14.87787 17.08475 0 16.31924 0 17.86992 0 0 0 0 0 0 0 0 0 0 Q5VW38 GP107_HUMAN Protein GPR107 (Lung seven transmembrane receptor 1) GPR107 KIAA1624 LUSTR1 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583] clathrin heavy chain binding [GO:0032050] GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030136; GO:0032050; GO:0072583 MAALAPVGSPASRGPR 11.93999958 1 1 0.502664969 1554.972376 0 0 0 0 0 0 0 0 0 0 17.93008 20.17197 0 21.01993 0 0 0 21.40844 21.30387 0 0 0 0 0 0 0 0 19.84221 0 0 0 0 21.9315 0 0 0 0 0 0 0 0 0 0 0 0 22.2768 0 0 Q5VWG9 TAF3_HUMAN "Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit, TAF(II)140, TAF140, TAFII-140, TAFII140)" TAF3 Homo sapiens (Human) maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulator inhibitor activity [GO:0140416]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123] metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulator inhibitor activity [GO:0140416] GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006468; GO:0016251; GO:0031965; GO:0042789; GO:0043433; GO:0046872; GO:0046982; GO:0051123; GO:0051457; GO:0060261; GO:0140416 LLSTKGDTLDVVLLEAR 2.980000019 1 1 0.231090913 1836.287926 13.53326 12.87063 0 0 14.23985 0 13.09257 12.22996 0 15.00002 0 14.07513 14.17762 0 14.26381 0 0 13.85735 0 0 0 0 0 0 0 0 16.75228 0 0 0 0 0 0 0 0 0 0 0 0 17.79603 0 0 0 0 0 0 0 0 Q5VWI1 TCRGL_HUMAN Transcription elongation regulator 1-like protein TCERG1L Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; RNA polymerase binding [GO:0070063]; transcription coregulator activity [GO:0003712] RNA polymerase binding [GO:0070063]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0005634; GO:0070063 LLEESKVSPR 6.320000172 1 1 0.342191171 1156.701914 0 12.76362 0 0 0 0 14.0782 0 12.70441 14.71553 14.98771 0 14.89102 0 0 15.06961 0 0 16.05509 14.47675 14.07935 15.95436 0 15.25449 0 0 0 0 0 16.0428 0 0 0 0 0 0 0 16.94754 0 0 0 0 15.27576 0 0 0 0 0 Q5VWJ9 SNX30_HUMAN Sorting nexin-30 SNX30 Homo sapiens (Human) positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031] early endosome [GO:0005769]; early endosome membrane [GO:0031901] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phosphatidylinositol binding [GO:0035091]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031] phosphatidylinositol binding [GO:0035091] GO:0005769; GO:0015031; GO:0031901; GO:0035091; GO:2000786 ALPSTGPHSLR 6.289999962 1 1 4.71E-13 1135.298728 0 0 0 0 0 0 0 0 0 0 15.45203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWK5 IL23R_HUMAN "Interleukin-23 receptor, IL-23 receptor, IL-23R" IL23R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496] external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496] cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896] GO:0001916; GO:0002230; GO:0002827; GO:0004896; GO:0005886; GO:0006954; GO:0006955; GO:0009897; GO:0010536; GO:0019221; GO:0019955; GO:0032496; GO:0032693; GO:0032725; GO:0032729; GO:0032735; GO:0032740; GO:0032819; GO:0034341; GO:0038155; GO:0042102; GO:0042104; GO:0042509; GO:0042531; GO:0043235; GO:0043382; GO:0045672; GO:0046427; GO:0050829; GO:0051135; GO:0051142; GO:0072536; GO:2000318; GO:2000330 ILLLIPK 34.68000031 1 1 0.314040272 810.6053763 19.08963 20.45534 16.32932 16.0902 15.8445 21.39779 20.09955 20.43065 20.41722 18.16706 0 21.29852 20.62179 20.87066 20.40854 20.46861 20.63404 0 20.40341 19.69969 0 18.22191 20.2105 18.00417 0 0 20.66004 0 19.28505 18.05676 20.15426 20.84419 0 0 18.68554 0 0 0 19.39395 0 0 0 21.71539 20.32608 0 0 20.34338 0 Q5VWM3 PRA18_HUMAN PRAME family member 18 PRAMEF18 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 GRVILELLTPLQAELMR 1.220000029 1 1 0.123891809 1967.2731 17.51693 0 14.80964 0 14.07568 0 0 13.92092 0 0 0 12.6661 14.66202 0 0 13.89714 0 0 0 12.28765 10.73667 16.38619 13.97482 0 11.66725 16.28447 0 0 0 0 18.27514 17.14724 0 14.91672 0 16.28008 17.54921 11.69871 0 16.97381 0 15.82815 12.8842 12.31181 15.86858 17.16175 14.9716 14.44499 Q5VWM4 PRAM8_HUMAN PRAME family member 8 PRAMEF8 PRAMEF24 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 ASACIPPDNK 5.28000021 1 1 0.248030899 1072.992757 13.86623 0 0 0 0 12.56137 0 0 0 0 0 0 0 0 0 14.55152 0 15.13971 0 0 0 0 0 0 0 0 0 14.90695 0 13.85805 0 15.3254 15.19815 14.73163 0 15.76424 0 14.58081 0 16.07866 0 0 0 0 0 15.15402 0 10.85944 Q5VWM6 PRA13_HUMAN Putative PRAME family member 13 PRAMEF13 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 NCMSMGALK 5.869999886 1 1 0.166002005 1010.409065 14.43573 12.12184 14.65084 13.29781 14.20141 0 0 14.61738 0 0 16.61549 17.35691 0 0 0 0 14.03373 0 0 0 0 0 0 0 0 15.6123 14.68099 0 0 0 0 0 16.39022 0 0 0 0 0 0 0 0 0 0 14.82245 0 0 0 0 Q5VWN6 TASO2_HUMAN Protein TASOR 2 TASOR2 C10orf18 FAM208B KIAA2006 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 DGEVGVNSDMHYELSGDSDLDLLGDCRNPR 3.170000076 1 1 3.21E-12 3350.98006 10.46612 12.03624 5.601154 13.47002 14.65165 12.65511 0 0 0 0 0 14.55572 13.25781 13.07917 0 0 11.13793 0 12.63164 15.55261 0 0 0 15.39258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.51587 14.99929 0 0 0 0 0 0 0 Q5VWP2 TET5C_HUMAN "Terminal nucleotidyltransferase 5C, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46C)" TENT5C FAM46C Homo sapiens (Human) in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596] polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723] GO:0001701; GO:0003723; GO:0004652; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0045596; GO:0048255; GO:1990817 DNGLGCK 16.37000084 0.228005409 0.228005409 0.219444052 761.3389357 15.67649 15.36401 16.30027 0 0 0 0 0 0 0 0 16.06635 16.69024 16.78556 0 16.7333 15.05792 0 0 17.1808 17.77309 0 15.85142 16.91661 17.71998 0 16.24122 0 16.9954 16.06967 16.02099 0 16.456 16.30178 16.85889 0 16.84677 17.2716 17.04157 16.64992 17.13719 15.82504 15.76794 17.36307 16.91631 17.17983 15.79225 17.13281 Q5VWP3 MLIP_HUMAN "Muscular LMNA-interacting protein (Cardiac Isl1-interacting protein, CIP) (Muscular-enriched A-type laminin-interacting protein)" MLIP C6orf142 Cip Homo sapiens (Human) negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcolemma [GO:0042383] nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcolemma [GO:0042383]; lamin binding [GO:0005521]; transcription corepressor activity [GO:0003714]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] lamin binding [GO:0005521]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0005521; GO:0005634; GO:0005635; GO:0010614; GO:0016605; GO:0031981; GO:0042383; GO:0045944; GO:1903243 SNDYLTLNAGSQQERDQAK 5.610000134 1 1 0.127639101 2138.49429 0 13.50196 0 0 14.09549 13.59552 14.02569 0 14.39224 0 0 12.18324 13.67302 14.50294 0 13.55802 0 0 16.38677 15.81188 15.69497 0 14.58937 0 16.33706 16.41062 0 15.66617 0 15.37384 16.16214 15.27938 16.18316 0 15.14298 15.53757 15.09548 14.73439 14.90139 16.40995 15.02502 0 0 0 0 0 0 0 Q5VWQ0 RSBN1_HUMAN "Lysine-specific demethylase 9, KDM9, EC 1.14.11.- (Round spermatid basic protein 1)" RSBN1 Homo sapiens (Human) chromatin organization [GO:0006325] nucleus [GO:0005634] nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325] dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] GO:0005634; GO:0006325; GO:0046872; GO:0051213 AGPMR 13.56000042 0.90100342 0.90100342 0.177552687 547.300654 0 16.99402 16.38782 16.9895 17.51817 16.96028 16.85191 17.03525 16.29026 17.00143 16.68938 0 16.32708 16.89457 16.25322 16.85501 15.8818 16.85955 17.35267 16.75479 17.03264 16.36513 17.01256 17.13478 16.94686 0 0 17.84723 16.4553 17.50233 17.09893 16.80073 18.26361 0 17.7443 17.76448 17.40681 17.6388 0 17.41999 16.77757 17.04728 18.83968 17.87971 17.57344 0 18.66833 17.09331 Q5VWQ8 DAB2P_HUMAN "Disabled homolog 2-interacting protein, DAB2 interaction protein, DAB2-interacting protein (ASK-interacting protein 1, AIP-1) (DOC-2/DAB-2 interactive protein)" DAB2IP AF9Q34 AIP1 KIAA1743 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell cycle [GO:0051726]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]" AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886] "AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell cycle [GO:0051726]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]" 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184] GO:0000122; GO:0001525; GO:0001933; GO:0005096; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007049; GO:0007252; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0014067; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032088; GO:0032266; GO:0032809; GO:0034144; GO:0034260; GO:0034620; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0038026; GO:0040008; GO:0042059; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043124; GO:0043184; GO:0043254; GO:0043407; GO:0043410; GO:0043507; GO:0043539; GO:0043548; GO:0043553; GO:0044257; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045296; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050680; GO:0051721; GO:0051726; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0071901; GO:0071902; GO:0072577; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1903363; GO:1903896; GO:1990032; GO:1990597; GO:2001224; GO:2001235 ARYQTITILPMEMYK 3.880000114 0.589540601 0.589540601 0.343149598 1890.586091 15.55756 0 14.82188 0 12.99419 0 0 0 0 0 0 0 0 0 15.44251 0 15.60782 0 15.78972 0 0 0 0 0 0 0 0 13.1566 0 0 15.66323 15.83175 15.15053 0 0 14.94589 15.70793 15.82039 0 0 15.74686 0 0 15.68086 0 0 0 0 Q5VWW1 C1QL3_HUMAN "Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13, C1q/TNF-related protein 13)" C1QL3 CTRP13 Homo sapiens (Human) regulation of synapse organization [GO:0050807] collagen trimer [GO:0005581]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807] identical protein binding [GO:0042802] GO:0005581; GO:0005615; GO:0042802; GO:0050807 LDGGKAHGGNNNK 19.95999908 0.934963465 0.934963465 0.376840095 1282.939536 16.30172 0 17.1233 0 16.93791 0 0 0 0 16.2042 16.45483 17.58757 15.81598 0 12.46072 13.49903 16.84596 0 0 17.12172 0 0 0 0 0 0 0 0 0 0 0 0 14.5193 0 0 0 0 0 0 16.37996 0 15.62958 0 0 17.47077 0 11.49241 0 Q5VWX1 KHDR2_HUMAN "KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1, SLM-1, hSLM-1)" KHDRBS2 SLM1 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] GO:0000381; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024 GVLTPRGSTVTR 1.960000038 1 1 0.154548443 1244.42678 13.70142 0 12.10484 13.50784 12.64814 0 12.1058 0 0 12.96116 0 0 16.00086 0 13.655 0 12.32751 13.89463 0 0 0 0 0 0 15.74421 16.77135 0 0 0 0 0 0 13.43134 0 0 0 0 0 0 0 0 0 0 0 15.17592 0 12.81956 0 Q5VWZ2 LYPL1_HUMAN "Lysophospholipase-like protein 1, EC 3.1.2.22" LYPLAL1 Homo sapiens (Human) protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084] carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474] GO:0002084; GO:0004622; GO:0005737; GO:0005829; GO:0008474; GO:0052689 SLGVTTKFHSFPNVYHELSK 6.989999771 1 1 0.168830944 2290.401067 0 0 16.11652 0 0 0 0 0 18.03085 0 0 16.00702 0 0 0 0 0 0 0 0 16.34816 0 0 0 0 17.22121 0 0 0 0 19.14232 0 0 0 16.94522 0 0 0 18.54005 0 0 0 0 15.87804 0 0 0 0 Q5VX52 SPAT1_HUMAN Spermatogenesis-associated protein 1 (Sperm-specific protein SP-2) SPATA1 Homo sapiens (Human) acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669] GO:0001669 MKLIVEVK 10.71000004 1 1 0.20683329 974.5294764 0 0 0 0 17.94626 16.0139 17.8901 0 0 0 16.49651 0 0 18.75021 18.91793 17.17839 18.03811 18.38092 18.44985 16.42043 17.63695 16.94206 17.2965 16.06183 0 0 17.39986 17.36121 16.14973 16.40546 18.10366 18.67313 0 18.14323 16.14659 0 18.45687 19.23331 17.77362 17.95879 18.26707 0 18.58773 17.95635 18.59254 17.7303 18.96377 17.29999 Q5VX71 SUSD4_HUMAN Sushi domain-containing protein 4 SUSD4 UNQ196/PRO222 Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]" extracellular region [GO:0005576]; integral component of membrane [GO:0016021] "extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]" GO:0005576; GO:0006958; GO:0016021; GO:0030449; GO:0045087; GO:0045957; GO:0045959 MFQTKFK 2.329999924 0.468210965 0.468210965 0.099636494 944.2702928 0 0 14.38122 13.36178 0 14.96303 0 0 0 0 0 0 0 14.89228 0 0 0 14.69792 0 0 0 0 13.98456 0 0 0 0 16.32339 0 0 0 0 15.72878 0 0 0 0 0 0 13.93842 15.18189 0 0 0 0 0 0 0 Q5VXT5 SYPL2_HUMAN Synaptophysin-like protein 2 SYPL2 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; substantia nigra development [GO:0021762]; T-tubule organization [GO:0033292] integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672] integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; substantia nigra development [GO:0021762]; T-tubule organization [GO:0033292] GO:0006874; GO:0007507; GO:0016021; GO:0021762; GO:0030672; GO:0033292 VLQWLFAIFAFGSCGSYSGETGAMVR 3.900000095 0.581546366 0.581546366 0.04948583 2854.083516 15.16796 0 0 0 0 15.99731 0 14.48074 0 0 13.89697 0 16.30922 16.68717 0 13.88382 0 0 16.66619 15.50712 0 13.14725 0 15.62011 0 0 14.30948 12.07134 0 14.64889 15.08572 15.96205 0 16.03665 14.68267 0 14.21933 15.05352 13.79484 13.47177 14.8771 0 15.88265 14.41692 17.06452 0 0 13.76579 Q5VYJ5 MALR1_HUMAN MAM and LDL-receptor class A domain-containing protein 1 MALRD1 C10orf112 DIET1 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858] GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858 LGSPVLTK 13.46000004 1 1 0.067494904 814.5546843 0 11.67152 16.08923 0 16.20046 15.75685 14.26145 12.71785 17.19996 12.68686 13.44359 0 0 17.70961 0 16.33673 17.38795 15.84862 20.1092 0 0 14.52161 14.71076 0 0 14.22328 16.15536 14.32872 0 0 0 15.85415 0 14.50557 0 0 17.60225 18.16068 0 0 16.20922 0 0 14.97999 0 15.57622 0 14.986 Q5VYK3 ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) ECPAS ECM29 KIAA0368 Homo sapiens (Human) proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433] molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0030433; GO:0031410; GO:0043248; GO:0060090; GO:0070628 AAMDSARLSAAK 2.940000057 1 1 0.174906194 1206.774289 0 0 15.76401 0 13.20897 12.4489 13.74291 0 13.44624 0 13.9055 0 0 0 14.74828 14.57743 0 0 0 0 0 0 13.52653 15.84445 0 11.92481 0 0 0 0 0 0 0 0 14.80633 0 0 0 0 0 12.49352 11.46761 0 13.96277 0 0 14.53557 15.02403 Q5VYM1 CI131_HUMAN Uncharacterized protein C9orf131 C9orf131 Homo sapiens (Human) SMGVLSDSEARCGDIQK 2.180000067 1 1 0.277150707 1868.625498 14.57362 16.07343 0 0 13.68337 0 0 13.58415 0 0 14.13746 12.08586 0 14.15328 11.87227 7.961958 15.12926 0 16.87181 6.668258 0 16.63089 0 0 0 0 12.11102 14.92488 0 14.68852 0 15.50674 0 0 12.67118 0 0 0 0 0 0 0 14.61988 13.82277 15.52351 0 16.55096 0 Q5VYP0 S31A3_HUMAN Spermatogenesis-associated protein 31A3 (Protein FAM75A3) SPATA31A3 FAM75A3 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 KPNCQGSCK 4.960000038 0.209843755 0.209843755 0.227196068 1074.674887 0 14.83128 0 0 0 0 0 0 0 0 15.98578 0 15.74973 13.00913 14.38091 0 0 15.60091 0 16.07463 0 0 0 14.68357 0 0 0 15.30123 15.46329 0 14.46329 14.97794 15.50141 14.02116 15.45626 15.05348 0 15.46865 15.81134 15.10985 13.52788 15.13187 14.17488 15.81078 8.333624 11.95278 14.55446 11.08348 Q5VYS8 TUT7_HUMAN "Terminal uridylyltransferase 7, TUTase 7, EC 2.7.7.52 (Zinc finger CCHC domain-containing protein 6)" TUT7 HS2 KIAA1711 ZCCHC6 Homo sapiens (Human) "miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]" miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] GO:0000289; GO:0001556; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0016779; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0071076; GO:1990074 GHGSK 3.839999914 0.210399553 0.210399553 0.234419928 485.1529203 13.87724 15.92391 15.38367 16.21622 16.23964 15.09474 0 15.29443 0 0 15.80426 14.4016 16.53025 15.75403 15.41284 14.36207 0 16.38073 0 0 0 14.79099 0 0 15.79216 0 0 14.74673 15.71379 16.09698 14.47066 13.34343 14.49552 15.63995 16.45675 15.27032 14.97592 17.54874 0 13.62489 17.47426 17.0558 16.09658 15.98222 12.3451 15.82039 16.30858 16.74192 Q5VYV7 SLX4I_HUMAN Protein SLX4IP (SLX4-interacting protein) SLX4IP C20orf94 Homo sapiens (Human) EIIVEK 7.429999828 1 1 0.28544911 731.2885345 18.93632 16.43324 0 16.02925 0 0 0 16.97088 18.35566 17.3262 0 0 17.38645 0 0 17.27956 0 0 0 0 15.49622 17.08161 0 16.38025 16.98477 0 0 17.58095 0 0 17.27247 19.76835 0 0 0 0 17.4753 0 0 18.55457 0 0 0 0 0 0 0 0 Q5VZ18 SHE_HUMAN SH2 domain-containing adapter protein E SHE Homo sapiens (Human) phosphotyrosine residue binding [GO:0001784] phosphotyrosine residue binding [GO:0001784] GO:0001784 AKPGGGGGK 12.07999992 1 1 0.168151467 728.629308 0 15.28349 16.48616 0 16.38296 14.94012 13.70055 15.97687 14.48472 0 0 16.6201 0 0 0 0 0 0 0 0 0 0 0 0 0 16.43187 0 0 16.03894 0 0 15.8171 0 0 16.33452 0 0 0 0 13.63646 14.21611 0 0 0 0 0 0 0 Q5VZ19 TDR10_HUMAN Tudor domain-containing protein 10 TDRD10 UNQ9380/PRO34205 Homo sapiens (Human) P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] P granule [GO:0043186] P granule [GO:0043186]; RNA binding [GO:0003723]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] RNA binding [GO:0003723] GO:0003723; GO:0030719; GO:0034587; GO:0043186 AAFFAVPLEMRGSFLVLLLR 9.090000153 1 1 0.28258147 2265.682424 0 15.8261 13.18366 14.67128 13.87416 12.14724 14.44539 0 12.96626 13.35504 0 13.45682 9.910794 12.7787 14.7832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.72589 0 0 0 0 Q5VZ46 K1614_HUMAN Uncharacterized protein KIAA1614 KIAA1614 Homo sapiens (Human) centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein kinase C binding [GO:0005080]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341] protein kinase C binding [GO:0005080] GO:0005080; GO:0005634; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0060341 APPVPRTLQELQAACGMER 5.639999866 1 1 0.160873185 2140.684921 15.94539 11.41855 17.80346 14.90283 13.17719 0 14.55455 0 14.76551 0 0 0 15.17045 0 0 0 0 0 9.220171 0 0 16.27474 17.26203 0 9.189033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.59843 0 14.95124 0 Q5VZ66 JKIP3_HUMAN Janus kinase and microtubule-interacting protein 3 (Neuroendocrine long coiled-coil protein 2) JAKMIP3 C10orf14 C10orf39 JAMIP3 NECC2 Homo sapiens (Human) Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017] kinase binding [GO:0019900]; microtubule binding [GO:0008017] GO:0005794; GO:0008017; GO:0019900 IAELSAIIR 6.769999981 1 1 0.297973616 985.8792201 17.66757 0 16.19171 17.35336 0 0 0 16.60836 0 0 0 16.79917 0 0 0 0 0 0 0 0 0 0 0 0 0 17.70681 0 0 0 0 0 19.08694 18.62972 0 0 18.31468 0 0 0 0 0 16.90775 16.83123 0 0 0 0 0 Q5VZ72 IZUM3_HUMAN Izumo sperm-egg fusion protein 3 IZUMO3 C9orf134 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803] protein homodimerization activity [GO:0042803] GO:0005886; GO:0016021; GO:0042803 VSHSDK 1.879999995 1 1 1.19E-13 674.0281805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.45954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.57858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZ89 DEN4C_HUMAN DENN domain-containing protein 4C DENND4C C9orf55 C9orf55B Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005794; GO:0005829; GO:0005886; GO:0015031; GO:0030659; GO:0030904; GO:0031410; GO:0032483; GO:0032593; GO:0032869; GO:0043231; GO:0072659 AGLIFR 20.98999977 1 1 0.197372217 677.1485999 15.55361 15.94791 0 0 16.24016 0 0 0 0 0 0 0 15.56919 15.69584 15.69037 0 0 16.47916 0 0 0 0 17.51159 0 0 0 0 16.66474 0 0 17.25842 0 16.58438 17.07639 0 0 17.16279 17.09461 16.14882 17.30905 0 15.77787 17.10383 0 17.2335 16.65206 0 17.8118 Q5VZK9 CARL1_HUMAN "F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)" CARMIL1 CARMIL LRRC16 LRRC16A Homo sapiens (Human) actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] protein-containing complex binding [GO:0044877] GO:0005654; GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813 RYGVQVMGSGLLAEMK 1.75999999 1 1 0.360972512 1755.644203 16.22297 15.78853 0 15.18355 14.2506 12.40432 14.35576 0 0 16.50611 15.51244 0 14.25272 14.72636 0 0 15.09643 15.85897 0 0 0 0 0 0 0 17.11339 0 15.11771 0 16.36226 0 18.41051 15.86907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.23775 Q5VZL5 ZMYM4_HUMAN Zinc finger MYM-type protein 4 (Zinc finger protein 262) ZMYM4 KIAA0425 ZNF262 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604] DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0007010; GO:0007275; GO:0008270; GO:0022604 SDPLGSTQDHALSQESSEPGCRVR 3.809999943 1 1 1.83E-12 2612.872797 15.27942 0 0 14.87541 14.16427 15.61255 0 12.92303 0 17.01347 0 0 0 0 0 0 0 15.44072 0 0 0 0 0 0 0 0 0 14.92069 0 0 0 0 0 0 16.09754 0 0 0 0 0 0 0 0 0 17.8041 0 0 0 Q5VZQ5 TEX36_HUMAN Testis-expressed protein 36 TEX36 C10orf122 Homo sapiens (Human) EAMVVSSFRR 7.860000134 0.655876756 0.655876756 0.05701275 1181.161869 13.02378 0 13.27234 0 15.96567 14.72759 14.76 13.13749 15.40777 14.22789 14.34049 11.55332 17.20847 11.69877 0 17.06529 13.8619 14.93564 15.30721 0 13.5748 16.77072 15.47642 0 15.90492 16.43427 15.05583 14.76195 14.60135 15.9844 0 15.57499 14.19176 0 13.0744 14.46859 17.06078 14.91751 15.36317 14.19051 12.6722 13.15107 0 16.06367 10.68416 16.50002 16.06568 14.59172 Q5W041 ARMC3_HUMAN "Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81, CT81) (KU-CT-1)" ARMC3 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 KEVEPPPK 5.400000095 0.81779176 0.81779176 0.213823007 922.8711719 0 12.38547 0 17.23442 19.02973 15.08633 16.08416 16.85808 18.50584 0 0 0 0 0 0 13.62213 0 15.82321 16.09091 0 0 0 17.52119 0 0 0 0 0 0 0 0 0 13.84815 15.81202 0 0 0 0 17.8801 0 0 0 17.4938 14.00489 14.38926 0 0 16.13057 Q5W0A0 ERI6B_HUMAN Glutamate-rich protein 6B (Protein FAM194B) ERICH6B FAM194B Homo sapiens (Human) KMLSK 7.840000153 0.802198172 0.802198172 0.262384413 607.6024377 16.60259 18.90455 18.15739 0 18.90004 0 19.19646 16.84586 20.30989 18.60837 19.26254 0 0 0 0 0 17.41648 18.49349 0 17.14685 0 18.79364 0 19.4744 18.57734 19.07586 19.32244 0 18.99636 0 0 20.8939 18.3757 0 20.36215 19.38874 0 19.69377 0 18.16726 17.98426 18.26006 18.10489 0 0 17.18171 18.54433 0 Q5W0N0 CI057_HUMAN Uncharacterized protein C9orf57 C9orf57 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IVFAGVILFR 33.84000015 0.934809864 0.934809864 0.294564353 1133.722785 0 0 0 17.4704 14.86192 0 0 16.74542 0 0 16.49043 0 0 19.42741 20.91481 19.53902 0 0 21.88821 0 0 0 0 19.25277 0 18.82888 0 0 20.16601 0 19.9492 0 0 0 20.73057 18.65561 0 0 0 20.86996 0 0 0 20.95292 0 20.53535 20.84351 0 Q5W0Q7 USPL1_HUMAN "SUMO-specific isopeptidase USPL1, EC 3.4.22.- (Ubiquitin-specific peptidase-like protein 1, USP-like 1)" USPL1 C13orf22 D13S106 Homo sapiens (Human) Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301] Cajal body [GO:0015030]; extracellular space [GO:0005615] Cajal body [GO:0015030]; extracellular space [GO:0005615]; SUMO binding [GO:0032183]; SUMO-specific isopeptidase activity [GO:0070140]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301] SUMO binding [GO:0032183]; SUMO-specific isopeptidase activity [GO:0070140] GO:0005615; GO:0008283; GO:0009301; GO:0015030; GO:0016926; GO:0030576; GO:0032183; GO:0070140 LAALMSSPQSRTVR 5.579999924 1 1 0.329408435 1533.212658 14.23141 0 13.08449 0 0 0 0 0 13.48896 0 13.86457 0 0 15.21722 0 0 15.52107 0 0 16.66749 0 0 0 0 16.08405 14.5015 0 0 15.16803 0 0 0 0 14.14974 15.36211 0 0 14.00929 0 16.06039 0 0 13.98773 0 13.5928 13.94677 14.67589 14.69455 Q5XG92 EST4A_HUMAN "Carboxylesterase 4A, EC 3.1.1.-" CES4A CES8 UNQ440/PRO873 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689] carboxylic ester hydrolase activity [GO:0052689] GO:0005576; GO:0052689 KMAFWMSLYQSQRPEK 4.610000134 1 1 0.129672608 2046.991168 0 12.85971 13.7308 0 14.01693 11.60216 12.75972 13.00709 13.18868 14.3287 11.53729 15.28718 11.3222 12.06159 15.00152 14.99747 0 14.68583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5XKE5 K2C79_HUMAN "Keratin, type II cytoskeletal 79 (Cytokeratin-79, CK-79) (Keratin-6-like, Keratin-6L) (Keratin-79, K79) (Type-II keratin Kb38)" KRT79 K6L KB38 KRT6L Homo sapiens (Human) cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; enzyme binding [GO:0019899] enzyme binding [GO:0019899] GO:0005829; GO:0019899; GO:0045095; GO:0070062 AFMGQGAGR 8.430000305 0.654155016 0.654155016 0.061075976 911.125651 0 0 14.88655 0 0 15.44778 14.74569 0 0 14.13444 15.17839 13.01327 16.13931 0 0 0 14.26527 0 0 16.89037 0 0 14.30826 16.37757 15.95211 0 0 0 0 12.89865 12.38872 0 18.42123 17.47218 0 13.17981 17.29233 16.98213 0 0 12.26816 16.1423 0 0 11.18535 0 14.79471 0 Q5XKK7 F219B_HUMAN Protein FAM219B FAM219B C15orf17 Homo sapiens (Human) APGAAGPPSGQIGNRALR 5.170000076 1 1 0.246731321 1689.17505 15.62379 15.01783 0 0 0 15.03038 0 15.58532 0 0 0 0 18.49288 0 0 0 13.86632 0 0 0 0 0 0 0 0 0 0 0 0 0 16.65142 0 0 0 0 0 0 0 16.38284 0 0 0 0 0 0 0 17.22549 0 Q5XKP0 MIC13_HUMAN MICOS complex subunit MIC13 (Protein P117) MICOS13 C19orf70 MIC13 QIL1 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401] MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] GO:0001401; GO:0005654; GO:0005739; GO:0005743; GO:0007007; GO:0042407; GO:0044284; GO:0061617; GO:0140275 VWSLMR 10.80000019 1 1 0.150115682 804.8969794 0 0 14.98148 15.25693 14.11081 16.72917 0 17.24603 0 0 15.99629 16.89424 0 0 0 15.45062 0 14.86757 0 0 16.45009 0 0 17.1485 15.71858 16.83288 0 15.71305 0 0 0 16.96119 19.21264 17.12444 0 15.90061 16.86794 0 17.92814 16.18383 14.66191 0 0 17.65722 0 15.70988 11.40701 15.62509 Q5XKR4 OTP_HUMAN Homeobox protein orthopedia OTP Homo sapiens (Human) forebrain neuron differentiation [GO:0021879]; hypothalamus cell differentiation [GO:0021979]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurohypophysis development [GO:0021985]; neuron differentiation [GO:0030182]; positive regulation of neuroblast proliferation [GO:0002052] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; forebrain neuron differentiation [GO:0021879]; hypothalamus cell differentiation [GO:0021979]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurohypophysis development [GO:0021985]; neuron differentiation [GO:0030182]; positive regulation of neuroblast proliferation [GO:0002052]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0002052; GO:0003677; GO:0005654; GO:0016604; GO:0021879; GO:0021979; GO:0021985; GO:0030182 DAAELLGHR 7.860000134 0.945163131 0.945163131 0.196176947 981.2696715 15.47874 0 12.91438 0 0 0 0 16.60702 0 0 0 0 0 0 0 13.55062 14.64697 0 0 15.10621 0 14.12999 0 15.12241 16.98505 20.34049 0 0 0 0 0 14.34557 16.02411 0 0 17.97917 12.3753 0 0 16.28588 0 16.22406 0 0 0 0 15.29942 0 Q5XPI4 RN123_HUMAN "E3 ubiquitin-protein ligase RNF123, EC 2.3.2.27 (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)" RNF123 KPC1 FP1477 Homo sapiens (Human) proteolysis involved in cellular protein catabolic process [GO:0051603] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603 LLLDNKDDNGGEASR 7.550000191 1 1 0.266576766 1621.370041 15.53908 0 13.68734 12.42012 15.55209 14.39892 0 0 0 0 16.01135 14.90975 0 15.93177 15.07328 0 14.14585 0 0 0 0 0 0 0 17.19016 0 13.65583 0 0 0 0 16.48917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5XX13 FBW10_HUMAN F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor) FBXW10 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 INLSKK 15.64000034 1 1 0.150975813 698.627909 15.30733 0 0 0 0 0 0 11.89037 0 14.95507 0 14.58772 0 13.89887 15.76493 0 0 0 17.85298 14.62258 0 13.93272 17.04298 0 0 0 0 0 0 0 0 15.33616 16.23701 0 0 0 0 0 17.7741 0 0 0 0 16.74798 0 0 0 0 Q5YKI7 GGNB1_HUMAN Putative gametogenetin-binding protein 1 GGNBP1 Homo sapiens (Human) cell differentiation [GO:0030154]; mitochondrial fission [GO:0000266]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; cell differentiation [GO:0030154]; mitochondrial fission [GO:0000266]; spermatogenesis [GO:0007283] GO:0000266; GO:0005737; GO:0005794; GO:0007283; GO:0016020; GO:0030154 LLGMQQESR 11.52999973 1 1 4.58E-13 1061.284253 13.114 13.68264 12.7379 0 0 11.08942 0 11.82514 0 15.22331 0 0 0 0 0 0 0 0 0 12.81352 0 0 15.21653 0 0 0 15.72617 0 14.00125 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47488 0 0 0 0 0 Q5ZPR3 CD276_HUMAN "CD276 antigen (4Ig-B7-H3) (B7 homolog 3, B7-H3) (Costimulatory molecule) (CD antigen CD276)" CD276 B7H3 PSEC0249 UNQ309/PRO352 Homo sapiens (Human) positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] signaling receptor binding [GO:0005102] GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0032729; GO:0042102; GO:0042110; GO:0050776; GO:0050852 NPVLQQDAHSSVTITPQR 3.940000057 1 1 0.023658591 1986.906201 0 0 0 7.680967 12.61416 0 11.95259 0 0 15.52345 0 0 14.8727 0 0 10.87767 14.51262 0 0 0 13.37795 0 16.64032 0 0 0 0 14.70801 0 0 0 0 0 0 17.98343 14.96579 0 0 0 0 0 0 0 0 15.62488 14.15196 16.014 0 Q60I27 AL2CL_HUMAN ALS2 C-terminal-like protein ALS2CL Homo sapiens (Human) endosome organization [GO:0007032] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; endosome organization [GO:0007032] GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802] GO:0005096; GO:0005829; GO:0007032; GO:0042802 YTGHWER 7.289999962 0.684146523 0.684146523 0.085083148 947.6013187 0 14.09991 14.17024 15.27371 0 0 12.08167 15.6799 0 11.77091 0 0 0 0 11.90688 9.661605 16.02856 0 0 0 14.52956 14.73777 13.95501 0 14.77004 0 15.44201 0 14.28043 15.03629 0 0 15.48911 0 0 0 0 16.11394 0 0 0 0 0 0 11.55303 0 12.5211 11.09577 Q63HK3 ZKSC2_HUMAN Zinc finger protein with KRAB and SCAN domains 2 (Zinc finger protein 694) ZKSCAN2 ZNF694 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KEPWTLGLHSSNK 5.880000114 0.527576327 0.527576327 0.11333575 1497.037599 14.42141 17.78155 0 15.75753 0 0 0 17.98785 15.34381 17.3838 16.06783 13.77096 11.89625 12.08274 15.51575 15.77843 0 13.003 0 12.92584 14.03341 16.58737 0 16.01932 15.39647 0 15.17787 15.23121 9.732815 16.70348 15.95819 14.45265 16.23627 15.83701 16.54255 0 14.41708 0 16.80128 15.86133 0 0 0 0 0 14.13262 0 0 Q63HK5 TSH3_HUMAN Teashirt homolog 3 (Zinc finger protein 537) TSHZ3 KIAA1474 TSH3 ZNF537 Homo sapiens (Human) "long-term synaptic potentiation [GO:0060291]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; long-term synaptic potentiation [GO:0060291]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" GO:0000785; GO:0000981; GO:0002087; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0030426; GO:0045892; GO:0046872; GO:0051968; GO:0060291 ATPSPCSSEVGEPIK 3.660000086 0.235588297 0.235588297 0.391933476 1558.983901 13.23669 15.47277 15.14045 14.91136 16.18638 13.88719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.90718 0 0 0 0 0 0 17.5454 0 0 0 0 16.79731 0 0 15.68933 0 0 0 0 0 0 0 0 Q63HN8 RN213_HUMAN "E3 ubiquitin-protein ligase RNF213, EC 2.3.2.27, EC 3.6.4.- (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213, EC 2.3.2.-) (Mysterin) (RING finger protein 213)" RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Homo sapiens (Human) angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 CLRENSDVK 6.050000191 0.173961937 0.173961937 0.282450062 1121.364477 14.07312 12.66844 0 0 0 13.2945 0 15.45093 15.15583 14.1092 13.66018 13.75256 0 0 0 0 15.68516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12642 15.35042 0 0 0 0 0 0 Q63HQ0 AP1AR_HUMAN "AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein, GBAR, Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor, Gadkin)" AP1AR C4orf16 PRO0971 Homo sapiens (Human) "cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]" cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133] "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]" AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894] GO:0001920; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0015031; GO:0019894; GO:0030133; GO:0034315; GO:0034613; GO:0035650; GO:0048203; GO:1900025; GO:2000146 VGGGGGSKYFR 5.03000021 1 1 0.285407516 1084.253293 10.30375 0 14.37786 8.639108 13.93401 9.994537 0 0 13.02641 0 0 0 0 15.90386 15.32484 16.04933 15.23214 0 13.04686 17.52306 16.90903 0 13.92407 0 0 0 16.27971 14.38097 14.68043 14.5671 14.19138 14.08247 0 0 0 16.34937 17.03267 17.16552 15.84725 0 0 0 14.6352 0 14.97688 0 0 15.44117 Q63HQ2 EGFLA_HUMAN "Pikachurin (Agrin-like protein) (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)" EGFLAM AGRINL AGRNL PIKA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888] basement membrane [GO:0005604]; cell projection [GO:0042995]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083] basement membrane [GO:0005604]; cell projection [GO:0042995]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888] calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539] GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009887; GO:0009888; GO:0010811; GO:0019800; GO:0030198; GO:0042995; GO:0043083; GO:0048786 TGKSPGMMR 3.519999981 1 1 0.300115583 964.6925706 0 17.7237 0 0 0 0 0 19.14874 16.64494 0 0 17.41557 0 0 16.45103 0 0 0 0 16.55219 0 0 0 0 0 0 0 0 0 17.82811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63HR2 TNS2_HUMAN "Tensin-2, EC 3.1.3.48 (C1 domain-containing phosphatase and tensin homolog, C1-TEN) (Tensin-like C1 domain-containing phosphatase)" TNS2 KIAA1075 TENC1 Homo sapiens (Human) cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850] dendrite [GO:0030425]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] dendrite [GO:0030425]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850] identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] GO:0001822; GO:0004725; GO:0005886; GO:0005925; GO:0008285; GO:0014850; GO:0019725; GO:0019900; GO:0030425; GO:0032963; GO:0035264; GO:0035335; GO:0042802; GO:0043025; GO:0046627; GO:0046872; GO:0048871; GO:0098794 AASRPRK 6.760000229 1 1 0.218093575 785.2977445 14.97263 16.57297 14.49142 15.01301 16.68451 13.76585 0 14.70647 0 16.07442 15.59814 14.25328 14.95248 14.18385 15.55539 0 15.56572 15.151 15.39263 15.51129 0 0 17.28374 16.06657 0 0 0 0 0 15.54366 16.55834 0 0 16.72151 0 16.23875 0 0 0 0 0 15.87853 15.48193 0 16.02828 0 0 0 Q63ZY3 KANK2_HUMAN "KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein, SIP, SRC-interacting protein, SRC1-interacting protein)" KANK2 ANKRD25 KIAA1518 MXRA3 SIP Homo sapiens (Human) apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023] GO:0000122; GO:0005737; GO:0005739; GO:0006915; GO:0008285; GO:0033147; GO:0035023; GO:0043069; GO:0070563; GO:0072073; GO:0090521; GO:2000134 LSSLPR 17.17000008 1 1 0.178401812 672.4566567 19.89695 19.10624 18.82956 0 19.56014 18.16038 19.22329 19.01825 19.43449 18.50932 18.47764 17.70446 19.29564 18.22975 19.53402 0 0 18.28147 18.89141 19.60438 18.66148 18.86986 0 0 0 0 19.73877 19.89805 19.23481 17.59036 0 18.13711 19.09272 0 19.32512 19.88904 18.03028 19.64742 21.32901 18.66902 17.99525 19.91841 19.04842 0 20.01741 19.32694 18.9047 20.02425 Q63ZY6 NSN5C_HUMAN "Putative methyltransferase NSUN5C, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 5C) (Williams-Beuren syndrome chromosomal region 20C protein)" NSUN5P2 NSUN5C WBSCR20B WBSCR20C Homo sapiens (Human) RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] nucleolus [GO:0005730] nucleolus [GO:0005730]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] methyltransferase activity [GO:0008168]; RNA binding [GO:0003723] GO:0001510; GO:0003723; GO:0005730; GO:0008168; GO:0070475 VEMPTSASQAK 7.550000191 1 1 0.527687671 1152.563679 0 0 15.72705 0 14.67619 0 14.76987 13.53257 0 16.44301 0 0 0 15.48071 15.1086 0 0 14.76676 0 0 0 0 0 0 0 0 0 15.90001 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17853 0 0 16.8495 15.36033 0 0 Q658L1 SAXO2_HUMAN Stabilizer of axonemal microtubules 2 SAXO2 FAM154B Homo sapiens (Human) microtubule anchoring [GO:0034453] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453] microtubule binding [GO:0008017] GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0034453; GO:0036064; GO:0036126 RSTAPFNGITSHR 1.639999986 1 1 0.087837172 1444.869611 14.91204 16.35013 16.02512 13.722 0 12.18239 14.76592 0 0 14.91616 14.26126 10.20494 0 0 0 12.99672 0 0 0 0 0 0 14.68907 0 0 14.34194 0 0 0 0 0 0 0 0 0 0 0 0 0 15.04145 0 15.7069 0 0 13.57688 0 0 0 Q659A1 ICE2_HUMAN Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2) ICE2 BRCC1 NARG2 UNQ3101/PRO10100 Homo sapiens (Human) positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] GO:0000791; GO:0005654; GO:0005829; GO:0008023; GO:0015030; GO:0016604; GO:0035363; GO:0042795; GO:0042796; GO:0045945 ASDGK 5.590000153 0.772803545 0.772803545 0.290600888 476.1039029 0 15.13353 15.31531 15.30799 16.40722 14.44611 15.24168 15.7021 13.65388 15.85385 15.68077 16.31985 15.69687 16.30119 15.38575 14.96562 15.1891 15.03359 15.06978 14.82858 16.2915 0 16.14888 0 17.13525 16.3977 0 0 0 16.6905 16.17535 16.2217 15.55627 16.44602 16.32479 16.14037 0 15.5654 0 16.12928 15.23152 16.40767 15.25647 0 0 0 15.2445 14.71106 Q659C4 LAR1B_HUMAN La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2) LARP1B LARP2 Homo sapiens (Human) positive regulation of translation [GO:0045727] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005829; GO:0010494; GO:0045727 KLNLISK 6.730000019 1 1 0.263218293 814.9090609 0 17.70156 0 15.30876 0 16.64095 0 18.47851 21.35466 17.84613 0 18.30256 17.82101 0 0 17.86503 0 0 18.14322 0 0 0 0 16.86695 0 0 19.65489 0 0 0 0 0 18.28946 0 18.6034 0 19.04431 19.55481 19.39822 0 17.01911 0 18.72193 0 0 0 0 16.97795 Q66GS9 CP135_HUMAN "Centrosomal protein of 135 kDa, Cep135 (Centrosomal protein 4)" CEP135 CEP4 KIAA0635 Homo sapiens (Human) centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857] protein C-terminus binding [GO:0008022] GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008022; GO:0010457; GO:1902857; GO:1904951 MRLEHGIK 2.75 1 1 0.225858436 998.7529174 0 0 0 0 20.31903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66K14 TBC9B_HUMAN TBC1 domain family member 9B TBC1D9B KIAA0676 Homo sapiens (Human) activation of GTPase activity [GO:0090630] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] GO:0005096; GO:0005509; GO:0016021; GO:0090630 QPGSIGSR 5.400000095 1 1 0.367624498 800.8975108 18.65587 0 0 0 17.52671 0 0 0 19.16137 20.7762 0 0 19.90485 0 0 0 0 18.97478 17.66192 0 0 19.18697 19.06618 0 0 0 0 0 18.84701 16.99753 0 0 0 0 19.62496 0 0 0 0 18.05052 0 0 0 0 0 0 0 0 Q66K41 Z385C_HUMAN Zinc finger protein 385C ZNF385C Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0005634; GO:0008270 GHKHAR 9.069999695 0.01706502 0.01706502 0.148307787 705.0820907 14.04684 15.66395 0 9.771791 0 0 0 11.29576 15.5251 17.06691 0 15.81439 0 15.23655 14.12627 14.3494 0 16.95925 16.17758 16.53602 14.59756 0 16.33055 14.81424 0 0 17.67132 15.13573 17.91333 0 15.15039 0 18.49872 15.7106 15.40807 18.55685 10.85851 14.02622 18.86034 16.10095 15.85128 16.9362 14.60611 14.58005 0 0 0 0 Q66K74 MAP1S_HUMAN "Microtubule-associated protein 1S, MAP-1S (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1, VCY2-interacting protein 1, VCY2IP-1) [Cleaved into: MAP1S heavy chain; MAP1S light chain ]" MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite development [GO:0016358]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; regulation of chromatin disassembly [GO:0010848]; regulation of microtubule depolymerization [GO:0031114] cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; synapse [GO:0045202] cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite development [GO:0016358]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; regulation of chromatin disassembly [GO:0010848]; regulation of microtubule depolymerization [GO:0031114] actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] GO:0000226; GO:0001578; GO:0003677; GO:0003779; GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0006914; GO:0006915; GO:0007399; GO:0007409; GO:0007420; GO:0008017; GO:0010848; GO:0015631; GO:0016358; GO:0030054; GO:0030425; GO:0031114; GO:0042802; GO:0042995; GO:0043025; GO:0045202; GO:0047497; GO:0048471; GO:0048487; GO:0048812; GO:0051015 AAAPKATPVAAAK 8.279999733 1 1 0.086166325 1167.260366 0 15.27363 16.49378 0 0 16.85091 14.02017 13.39937 0 0 17.38679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.13448 14.4837 10.71215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66K79 CBPZ_HUMAN "Carboxypeptidase Z, CPZ, EC 3.4.17.-" CPZ Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016055; GO:0016485 GVVTDK 1.5 1 1 0 618.7323626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66K80 RUAS1_HUMAN Putative uncharacterized protein RUSC1-AS1 (RUSC1 antisense RNA 1) (RUSC1 antisense gene protein 1) RUSC1-AS1 C1orf104 Homo sapiens (Human) GGALAQPTLR 8.550000191 1 1 0.194263735 981.8139108 13.30154 15.75204 14.82248 0 15.09769 16.68921 0 16.57233 15.27198 16.45601 0 14.7567 0 0 0 0 0 0 0 0 0 0 0 15.03654 15.36105 14.9485 0 0 0 0 14.99784 0 15.54736 0 16.20429 16.53205 15.5994 15.77962 17.04814 15.25936 0 0 16.58963 15.00588 15.1849 13.71498 12.83682 0 Q66K89 E4F1_HUMAN "Transcription factor E4F1, EC 2.3.2.27 (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F)" E4F1 E4F Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]" "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transferase activity [GO:0016740]" GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0006357; GO:0007049; GO:0009794; GO:0010564; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0045944; GO:0046872; GO:0051301; GO:0051726; GO:0061629 LCGASFR 19.70000076 1 1 0.277783777 811.0711972 0 16.44172 0 0 0 15.23886 0 0 16.43135 17.29986 0 14.85246 0 0 0 0 16.28788 16.0531 16.11312 0 0 0 0 0 16.80521 0 17.56658 0 17.14802 15.39206 15.65709 0 0 0 0 0 0 0 0 0 0 0 17.45119 0 0 0 0 0 Q66LE6 2ABD_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta) PPP2R2D KIAA1541 Homo sapiens (Human) cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262] protein phosphatase regulator activity [GO:0019888] GO:0000159; GO:0000278; GO:0005829; GO:0010458; GO:0019888; GO:0051301; GO:0070262 VPILKPMDLMVEASPRR 8.140000343 0.514770746 0.514770746 4.57E-12 1968.346732 15.29339 14.07045 10.78754 14.36586 0 14.76328 0 13.36683 0 14.08043 0 0 14.79712 0 0 0 0 0 0 13.65796 0 0 15.1616 0 0 0 0 0 12.76797 0 0 15.90977 0 0 0 0 0 15.89654 0 13.39348 15.20224 0 12.67854 0 8.610801 0 14.44672 0 Q674X7 KAZRN_HUMAN Kazrin KAZN C1orf196 KAZ KIAA1026 HRIHFB2003 Homo sapiens (Human) keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; keratinization [GO:0031424] GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424 AAELDHHWVAK 4.820000172 1 1 4.61E-13 1275.704589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6559 0 0 0 16.09661 0 0 0 0 0 0 0 14.75846 0 0 0 16.48415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q676U5 A16L1_HUMAN Autophagy-related protein 16-1 (APG16-like 1) ATG16L1 APG16L UNQ9393/PRO34307 Homo sapiens (Human) autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792] GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787] GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0051020; GO:0051607; GO:0061739; GO:0097225; GO:0098792; GO:0120095 LLATGGMDRR 2.180000067 1 1 2.35E-13 1089.837468 17.85423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q685J3 MUC17_HUMAN "Mucin-17, MUC-17 (Small intestinal mucin-3, MUC-3)" MUC17 MUC3 Homo sapiens (Human) cellular homeostasis [GO:0019725] apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]" "extracellular matrix constituent, lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]" GO:0005576; GO:0005796; GO:0005886; GO:0009897; GO:0016021; GO:0016324; GO:0019725; GO:0030165; GO:0030197; GO:0062023 MSTPSEGSSSLTTMLLSSTYVTSSEASTPSTPSVDR 1.49000001 1 1 1.38E-12 3680.604484 13.90074 14.09596 0 0 0 0 10.24421 0 0 8.770654 9.177488 12.83278 0 0 0 0 0 0 0 0 0 12.69893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68CK6 ACS2B_HUMAN "Acyl-coenzyme A synthetase ACSM2B, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 2B) (Benzoate--CoA ligase, EC 6.2.1.25) (Butyrate--CoA ligase 2B) (Butyryl-coenzyme A synthetase 2B) (Middle-chain acyl-CoA synthetase 2B) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A)" ACSM2B ACSM2 HYST1046 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; xenobiotic metabolic process [GO:0006805] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; xenobiotic metabolic process [GO:0006805] ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872] GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0006805; GO:0015645; GO:0016405; GO:0018858; GO:0046872; GO:0047760; GO:0102391 VAVMLPR 9.289999962 1 1 2.34E-13 800.7140169 0 0 0 0 0 0 0 13.09647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.62663 19.47503 0 0 0 17.2539 0 0 0 0 0 0 0 Q68CP4 HGNAT_HUMAN "Heparan-alpha-glucosaminide N-acetyltransferase, EC 2.3.1.78 (Transmembrane protein 76)" HGSNAT TMEM76 Homo sapiens (Human) lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259] acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019] GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0051259; GO:0070821 SGQARAAER 10.76000023 5.94E-11 5.94E-11 0.239921462 946.0384095 0 0 18.37799 0 0 17.90559 15.45705 0 15.97615 0 17.56751 0 0 16.94477 0 14.64554 0 17.06329 17.58571 11.72539 13.7806 0 0 0 18.02979 0 16.61407 0 0 0 0 18.44853 0 0 0 15.53738 15.81475 0 19.0814 0 16.25942 15.13206 0 14.65756 0 15.84935 16.21457 12.87581 Q68CP9 ARID2_HUMAN "AT-rich interactive domain-containing protein 2, ARID domain-containing protein 2 (BRG1-associated factor 200, BAF200) (Zinc finger protein with activation potential) (Zipzap/p200)" ARID2 BAF200 KIAA1557 Homo sapiens (Human) cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0046872; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:1905168; GO:2000045; GO:2000781; GO:2000819 EGPITKHIR 5.289999962 0.432848692 0.432848692 0.265391952 1050.233601 0 0 0 0 0 0 15.77351 0 0 0 0 12.33427 0 14.59951 0 0 14.99117 15.26456 0 14.92757 0 16.78462 14.98948 0 15.02858 16.91148 15.61882 14.47264 11.62346 14.73394 14.44926 16.14463 15.8765 15.6594 13.05311 15.91654 16.15462 14.77572 15.95848 15.8972 16.94431 15.02821 15.71662 14.94829 13.78315 15.52883 14.24351 14.63232 Q68CQ1 MROH7_HUMAN Maestro heat-like repeat-containing protein family member 7 (HEAT repeat-containing protein 8) MROH7 C1orf175 HEATR8 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0005737; GO:0016021 DLLDLLLGSLK 6.190000057 1 1 0.543511035 1200.127464 0 15.32545 14.50171 0 0 0 0 0 17.56681 0 0 0 0 0 0 0 0 0 0 0 0 19.06149 0 0 0 0 0 19.63733 0 0 0 0 18.85232 0 0 0 0 18.46231 0 0 0 20.08461 0 0 0 0 0 16.49215 Q68CQ4 UTP25_HUMAN U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component) UTP25 C1orf107 DEF DIEXF Homo sapiens (Human) "embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]; embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]" RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511] GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019; GO:0048568; GO:1902570 ELFLIMNSYR 8.659999847 1 1 0.440859249 1300.989415 0 0 14.14405 0 0 0 0 0 0 7.809146 15.27031 0 0 0 0 0 0 0 16.52566 0 0 0 0 14.04601 0 12.40351 0 17.23166 0 0 17.26208 16.94345 0 16.62159 0 0 0 16.29254 0 0 0 0 12.20953 15.90335 0 17.11695 15.32179 16.3443 Q68CR1 SE1L3_HUMAN "Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3, Sel-1L3)" SEL1L3 KIAA0746 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 YGRPSMCR 9.079999924 1 1 0.242559719 1026.125786 0 16.5592 0 0 0 0 16.40863 0 0 0 0 0 0 14.83257 0 0 0 15.80181 0 0 16.30994 17.15371 0 0 0 0 17.01622 0 0 0 0 0 0 0 0 0 14.09255 0 0 0 0 0 0 16.55835 0 0 0 14.87916 Q68CZ1 FTM_HUMAN "Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein, RPGRIP1-like protein)" RPGRIP1L FTM KIAA1005 NPHP8 Homo sapiens (Human) cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] thromboxane A2 receptor binding [GO:0031870] GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515 DIAYGTK 2.970000029 0.825017095 0.825017095 0.228055505 764.7919961 0 0 15.9017 13.77508 0 12.33847 0 0 15.77408 15.80907 15.12765 15.67569 0 0 14.72714 0 0 0 15.99279 0 0 15.25918 0 0 0 0 15.87643 0 16.0846 0 0 0 0 0 14.45032 0 0 16.6015 0 0 0 0 0 0 0 0 0 0 Q68CZ6 HAUS3_HUMAN HAUS augmin-like complex subunit 3 HAUS3 C4orf15 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:1990498 ASNSSMK 9.279999733 0.663388431 0.663388431 0.149490563 737.6559256 16.73264 17.96909 0 0 0 16.32306 14.16681 0 16.46053 0 16.49541 10.81549 17.70119 0 12.86088 17.76896 15.6041 15.92599 0 13.03525 13.85764 19.33252 15.52408 17.74377 16.50255 17.65232 0 11.37002 17.06466 16.86672 0 18.1251 0 16.30071 13.75946 0 17.8804 18.35157 18.75556 15.09883 16.92833 12.93704 0 0 0 16.35662 15.3104 0 Q68D10 SPT2_HUMAN Protein SPT2 homolog (Protein KU002155) (SPT2 domain-containing protein 1) SPTY2D1 Homo sapiens (Human) "histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase I core binding [GO:0001042]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase I core binding [GO:0001042] GO:0001042; GO:0003677; GO:0005654; GO:0005730; GO:0006334; GO:0006355; GO:0010847; GO:0042393; GO:0043486 EQQKEEAK 10.22000027 0.791187942 0.791187942 0.256105292 988.9945493 0 13.51544 15.2986 15.1915 15.39122 0 0 0 0 0 0 13.83467 14.10195 15.04433 0 13.72747 0 0 15.36598 17.15682 0 16.55124 0 16.12952 0 14.73552 13.90731 0 12.46308 0 16.5493 0 15.24986 0 0 0 16.11132 15.68969 0 14.93544 15.96911 0 18.10015 0 15.95905 15.60151 14.61813 16.46269 Q68D51 DEN2C_HUMAN DENN domain-containing protein 2C DENND2C Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005654 LHSYTGKELPPTK 1.629999995 1 1 0.120774928 1471.515833 12.03641 14.56832 13.1923 0 0 14.42458 16.25329 15.13064 0 0 13.61018 16.59159 0 0 0 0 0 0 0 0 0 0 0 0 0 15.73994 0 0 0 0 0 0 0 15.19813 17.16426 0 0 0 0 13.41079 16.57693 14.24846 0 0 15.58824 0 14.89391 0 Q68DA7 FMN1_HUMAN Formin-1 (Limb deformity protein homolog) FMN1 FMN LD Homo sapiens (Human) actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092] actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124]; actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092] actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124] GO:0003779; GO:0005634; GO:0005737; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0010467; GO:0017124; GO:0030838; GO:0035136; GO:0035137; GO:0045010; GO:0048705; GO:0051127; GO:0051894; GO:0072092 AGQPR 5.010000229 0.448863924 0.448863924 0.082218477 527.1161414 17.80946 17.07802 13.05361 15.11588 15.35553 17.23098 0 16.80739 17.05993 12.05089 0 0 0 16.02454 15.38072 15.95853 0 17.72722 14.45082 0 0 9.485068 16.94537 16.5053 15.65882 15.16132 13.63811 14.76178 14.84698 0 14.9984 0 15.673 0 16.17698 13.23598 0 16.41156 16.7819 0 17.17942 0 15.84803 0 14.8367 0 11.76271 16.03957 Q68DC2 ANKS6_HUMAN "Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6, SAM domain-containing protein 6)" ANKS6 ANKRD14 PKDR1 SAMD6 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822] ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737] ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822] GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0097543 DNGPGSTR 8.390000343 1 1 0.06615466 802.7747625 16.12766 17.793 0 17.26157 17.74951 16.81528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68DI1 ZN776_HUMAN Zinc finger protein 776 ZNF776 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GTSFVK 5.400000095 0.288175374 0.288175374 0.321748001 636.9615604 16.00871 0 0 14.14647 0 15.93254 0 0 15.425 15.39643 0 16.27562 15.45157 15.85357 0 15.26919 14.56309 15.65634 0 15.89826 17.48886 17.57215 18.69042 17.55911 0 13.1417 0 0 16.87957 0 16.64171 16.23372 0 0 0 16.31121 0 16.00051 16.7328 0 15.68097 0 15.22393 16.09769 16.391 16.10664 16.15439 15.87553 Q68DK2 ZFY26_HUMAN "Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein, FYVE-CENT) (Spastizin)" ZFYVE26 KIAA0321 Homo sapiens (Human) autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901] GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:0046872; GO:1905037 ADEVEWILDLK 2.710000038 1 1 0.243343532 1330.656028 16.00303 0 0 15.04245 0 0 15.30778 14.25255 13.74073 0 17.04142 14.43902 0 0 0 14.33712 0 0 0 15.98571 0 14.41733 0 0 0 0 0 0 16.29599 0 0 0 16.79562 0 0 0 0 17.23251 0 0 0 0 0 0 0 0 0 0 Q68DN1 CB016_HUMAN Uncharacterized protein C2orf16 C2orf16 Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleus [GO:0005634] GO:0005634; GO:0070062 ILPGSPVK 12.55000019 0.097189315 0.097189315 0.183624841 809.5558858 16.53548 16.93541 17.66014 17.25839 16.09769 16.77414 16.94757 16.19675 16.43701 18.64729 16.22933 15.3063 15.84649 17.45888 16.21392 15.77136 16.57911 16.4579 15.69934 16.3645 16.12924 16.64168 17.14956 16.28041 16.54455 17.1514 0 13.71614 15.8166 16.31659 0 16.66195 14.31026 0 16.34741 15.9235 15.59204 17.45766 0 15.38879 16.3508 17.23893 14.97369 16.22888 14.63695 0 16.32673 15.50191 Q68DQ2 CRBG3_HUMAN "Very large A-kinase anchor protein, vlAKAP (Beta/gamma crystallin domain-containing protein 3)" CRYBG3 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212] GO:0002088; GO:0005212; GO:0007601; GO:0030246; GO:0032991; GO:0051018 DGGKTEVMPLALEVVNTYQK 6.440000057 1 1 0 2207.832522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68DU8 KCD16_HUMAN BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16) KCTD16 KIAA1317 Homo sapiens (Human) protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235] cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260 DTANDLAK 4.980000019 0.595747352 0.595747352 0.247484354 847.7508805 17.46345 18.6585 17.85468 0 17.88025 0 17.60055 0 18.18549 0 0 0 0 0 0 0 17.74724 18.25092 18.58144 0 0 0 0 0 0 0 0 0 0 0 0 0 20.32128 0 0 0 0 0 18.43078 0 0 0 0 0 0 0 16.89657 0 Q68DX3 FRPD2_HUMAN FERM and PDZ domain-containing protein 2 (PDZ domain-containing protein 4) (PDZ domain-containing protein 5C) FRMPD2 PDZD5C PDZK4 PDZK5C Homo sapiens (Human) bicellular tight junction assembly [GO:0070830] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; 1-phosphatidylinositol binding [GO:0005545]; bicellular tight junction assembly [GO:0070830] 1-phosphatidylinositol binding [GO:0005545] GO:0005545; GO:0005737; GO:0005856; GO:0005923; GO:0016323; GO:0070830 HTFVTDSAK 5.630000114 1 1 2.30E-13 1006.829423 13.89024 14.82744 0 13.23632 0 0 13.79239 10.40975 0 15.53624 0 14.54183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.83262 0 0 0 Q68DY1 ZN626_HUMAN Zinc finger protein 626 ZNF626 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 GCISVDECKVHK 9.039999962 1 1 0.05547526 1430.923632 15.22114 0 0 0 0 0 0 0 0 0 0 0 16.40932 0 0 0 0 0 0 0 16.70115 0 15.23212 0 0 0 0 0 0 0 0 0 16.76081 0 0 0 0 0 16.07265 0 0 0 0 0 0 0 0 0 Q68E01 INT3_HUMAN "Integrator complex subunit 3, Int3 (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A, SOSS-A, Sensor of ssDNA subunit A)" INTS3 C1orf193 C1orf60 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180] GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0010212; GO:0016180; GO:0032039; GO:0035861; GO:0044818; GO:0070876 SSSSK 3.289999962 1 1 0.116163021 494.1702749 14.99391 10.61788 9.872809 0 14.72827 13.83696 14.32735 0 15.27875 0 15.14988 0 0 13.38232 15.37104 10.17117 16.15505 0 16.12482 14.87645 0 17.20319 17.82026 15.68493 14.59552 14.92838 0 13.612 0 15.39304 17.06513 0 0 0 0 0 0 0 0 0 0 0 0 15.22092 0 15.46962 15.07743 0 Q68EA5 ZNF57_HUMAN Zinc finger protein 57 (Zinc finger protein 424) ZNF57 ZNF424 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 MHTGQKSHECQSYSK 3.890000105 1 1 0.211764076 1822.954904 14.95329 13.64717 0 0 0 0 0 14.97507 0 0 0 0 0 0 0 0 15.11187 14.83272 0 0 0 0 0 0 0 0 0 15.45814 15.12061 14.45007 13.81448 0 0 0 0 0 14.3969 14.69371 0 0 0 0 0 0 0 0 11.81325 0 Q68EM7 RHG17_HUMAN "Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1, RICH-1)" ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] GO:0005096; GO:0005829; GO:0005886; GO:0005923; GO:0007015; GO:0007165; GO:0017124; GO:0017156; GO:0032956; GO:0035020 RPASMAVMEGDLVK 1.809999943 1 1 0.10524596 1519.424149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76649 15.79537 0 0 0 0 0 0 13.14031 0 13.92507 0 15.17458 12.94601 11.36009 12.67246 0 0 15.8372 0 0 0 0 0 0 0 0 0 0 Q68EN5 K895L_HUMAN Uncharacterized protein KIAA0895-like KIAA0895L Homo sapiens (Human) YRQQLEHIMATNR 3.730000019 1 1 0.176877561 1675.659938 0 12.07529 13.77859 0 0 0 0 13.29143 0 13.1605 0 0 0 0 0 0 0 12.9091 0 0 0 0 0 0 0 0 0 0 16.49354 0 0 0 0 0 15.12634 0 0 0 0 0 0 0 0 0 0 0 0 0 Q693B1 KCD11_HUMAN BTB/POZ domain-containing protein KCTD11 (KCASH1 protein) (Potassium channel tetramerization domain-containing protein 11) (RING-type E3 ubiquitin transferase subunit KCTD11) KCTD11 C17orf36 REN Homo sapiens (Human) cell cycle [GO:0007049]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] identical protein binding [GO:0042802]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] identical protein binding [GO:0042802]; transferase activity [GO:0016740] GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0042802; GO:0045666; GO:0051260 GYGETALLR 3.75999999 1 1 0.01065912 979.187679 15.11596 13.8117 12.55464 14.75714 10.74814 13.78337 9.836652 0 15.45202 15.71195 14.99293 15.52826 0 0 0 0 0 13.06031 13.01569 0 0 0 17.0347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YH5 CDCA2_HUMAN "Cell division cycle-associated protein 2 (Recruits PP1 onto mitotic chromatin at anaphase protein, Repo-Man)" CDCA2 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0007059; GO:0007088; GO:0035307; GO:0051301; GO:0051983 DANSK 9.279999733 1 1 0.278168613 535.6335824 14.96402 0 15.85694 14.16151 12.21996 0 0 0 0 16.31286 16.02349 15.40227 0 14.24136 0 15.36885 0 0 0 0 0 15.64673 15.97154 16.45164 0 0 0 15.86658 15.89254 0 0 0 15.93878 16.4107 16.48663 16.01223 15.23258 0 16.25806 0 15.44769 0 16.94328 0 0 0 0 15.73039 Q69YN2 C19L1_HUMAN "CWF19-like protein 1, C19L1" CWF19L1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" post-mRNA release spliceosomal complex [GO:0071014] "post-mRNA release spliceosomal complex [GO:0071014]; RNA lariat debranching enzyme activator activity [GO:0061632]; mRNA splicing, via spliceosome [GO:0000398]" RNA lariat debranching enzyme activator activity [GO:0061632] GO:0000398; GO:0061632; GO:0071014 SSTGRDSK 4.880000114 1 1 0.196659934 839.6058453 0 0 14.92634 0 13.55721 0 14.52513 13.28638 15.14845 14.81927 15.59719 0 0 16.36938 0 0 0 0 0 13.9952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.69132 0 0 0 0 0 0 16.03556 0 0 0 0 0 0 Q69YN4 VIR_HUMAN Protein virilizer homolog VIRMA KIAA1429 MSTP054 Homo sapiens (Human) mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396; GO:0080009; GO:0110104 GGFSGNRGGR 3.440000057 0.437619388 0.437619388 0.138400154 963.0602248 0 15.58375 0 0 16.91679 0 10.97896 17.10583 0 0 0 0 0 0 0 0 0 15.65916 0 13.00493 12.13929 0 0 0 18.33303 13.7752 15.41886 0 14.7983 0 17.69222 17.57172 11.98651 12.76546 0 14.39696 0 15.26153 0 0 15.00806 16.04997 15.74615 0 0 16.60533 17.10818 8.456114 Q69YQ0 CYTSA_HUMAN "Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like, SPECC1-like protein)" SPECC1L CYTSA KIAA0376 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0007155; GO:0015629; GO:0030036; GO:0031941; GO:0051301 ISTGTASSTK 5.179999828 0.43517077 0.43517077 0.127518929 951.5585602 16.57243 13.99968 0 0 15.32001 0 14.35971 0 0 0 16.03931 17.45038 0 16.76324 16.40989 13.89484 0 0 0 0 0 0 0 0 0 0 16.62108 14.33502 16.3115 14.41264 14.61425 14.23947 0 0 15.29627 15.8235 16.24975 15.54928 14.46589 14.42626 0 0 16.00136 16.67727 0 15.25455 15.45134 16.07037 Q6A162 K1C40_HUMAN "Keratin, type I cytoskeletal 40 (Cytokeratin-40, CK-40) (Keratin-40, K40) (Type I hair keratin Ka36)" KRT40 KA36 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109 EDLLCLKK 28.67000008 1 1 0.395708697 1018.409575 0 17.64908 0 17.54828 16.97825 0 0 0 17.47125 0 0 0 0 17.82542 0 0 18.37277 0 0 0 0 0 0 0 0 17.48835 16.00408 0 0 0 0 16.73854 0 0 17.06046 0 0 0 0 0 0 18.29955 17.41688 18.44966 0 17.73554 16.80716 0 Q6A163 K1C39_HUMAN "Keratin, type I cytoskeletal 39 (Cytokeratin-39, CK-39) (Keratin-39, K39) (Type I hair keratin Ka35)" KRT39 KA35 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109 ATKCEPSPWTSCK 2.789999962 1 1 0.06714556 1551.515542 0 13.81214 0 16.6504 16.08223 16.27222 16.31781 17.17967 15.23943 15.85537 0 0 0 0 0 14.7423 16.98096 0 0 0 0 0 0 16.24103 16.48519 0 0 0 0 0 0 17.10933 17.54276 0 0 0 0 18.10338 17.09439 0 14.5158 0 0 0 0 0 0 0 Q6AHZ1 Z518A_HUMAN Zinc finger protein 518A ZNF518A KIAA0335 ZNF518 Homo sapiens (Human) chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006325; GO:0006357; GO:0046872 AEEEGVKMSAK 5.159999847 1 1 0.377147386 1190.362774 0 15.64351 13.57195 15.99621 15.44693 0 15.12119 0 0 0 0 15.6372 0 15.00091 0 15.05219 14.46637 15.56336 0 0 16.90173 0 0 0 0 0 16.45447 0 0 14.45287 17.23755 0 0 0 0 14.44987 15.12495 0 16.08966 0 16.09623 0 16.09599 16.47136 16.45938 17.01471 15.45053 16.62153 Q6AI14 SL9A4_HUMAN "Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4, NHE-4) (Solute carrier family 9 member 4)" SLC9A4 NHE4 Homo sapiens (Human) epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] GO:0001696; GO:0002064; GO:0005774; GO:0005886; GO:0006811; GO:0009651; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0031410; GO:0051453; GO:0055075; GO:0071805; GO:0098719 QEAQEIIPMKSLHR 6.869999886 0.283288658 0.283288658 0.388319972 1696.876945 16.12084 0 0 0 17.19308 0 18.01103 16.40667 0 16.61931 0 16.30913 0 0 0 15.77665 0 0 17.17127 0 0 0 0 0 0 0 18.44863 0 0 0 0 0 17.32705 0 0 0 0 0 0 0 0 0 0 16.5341 0 0 15.36189 16.63614 Q6AZY7 SCAR3_HUMAN Scavenger receptor class A member 3 (Cellular stress response gene protein) SCARA3 CSR Homo sapiens (Human) response to oxidative stress [GO:0006979]; UV protection [GO:0009650] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; response to oxidative stress [GO:0006979]; UV protection [GO:0009650] scavenger receptor activity [GO:0005044] GO:0000139; GO:0005044; GO:0005581; GO:0005615; GO:0005783; GO:0005789; GO:0006979; GO:0009650; GO:0016021; GO:0062023 GAMGPK 15.94999981 0.117282085 0.117282085 0.224743281 575.0720209 15.20685 16.77394 0 0 0 0 0 0 16.99537 0 0 0 15.83663 0 0 0 0 16.6828 0 0 0 19.85054 17.15951 19.54807 0 0 0 0 0 16.54385 0 0 16.34309 0 14.89611 16.94366 16.70715 0 16.79292 0 15.99551 0 0 0 0 0 0 0 Q6B0I6 KDM4D_HUMAN "Lysine-specific demethylase 4D, EC 1.14.11.66 (JmjC domain-containing histone demethylation protein 3D) (Jumonji domain-containing protein 2D) ([histone H3]-trimethyl-L-lysine(9) demethylase 4D)" KDM4D JHDM3D JMJD2D Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932] blood microparticle [GO:0072562]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861] blood microparticle [GO:0072562]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932] chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872] GO:0000724; GO:0001932; GO:0003684; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0031490; GO:0032452; GO:0032454; GO:0033169; GO:0035563; GO:0035861; GO:0046872; GO:0071479; GO:0072562; GO:0140684; GO:1900113; GO:2001034 ASGCSWAPVP 6.630000114 0.064332515 0.064332515 0.101654165 1031.3805 13.44915 10.83329 15.06541 13.84062 13.41216 15.86932 13.488 0 13.48112 16.06463 15.87924 15.90137 13.35347 13.46747 13.70365 13.99266 14.07987 0 0 15.4992 13.27458 0 14.99311 0 0 0 0 0 0 0 0 0 0 12.06052 0 17.5496 0 0 0 15.18957 0 14.06619 0 0 0 0 0 0 Q6BCY4 NB5R2_HUMAN "NADH-cytochrome b5 reductase 2, b5R.2, EC 1.6.2.2" CYB5R2 Homo sapiens (Human) bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] "endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]" "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]" GO:0004128; GO:0005634; GO:0005789; GO:0015701; GO:0016020; GO:0016126; GO:0071949 KTLADHLGMIAGGTGITPMLQLIR 1.600000024 1 1 0.650300978 2525.181119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6BEB4 SP5_HUMAN Transcription factor Sp5 SP5 Homo sapiens (Human) bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0036342; GO:0046872; GO:0060349; GO:0071407 TPSASPDLGK 8.920000076 0.300967753 0.300967753 0.140676115 973.5933366 0 16.07717 15.30133 17.19214 0 0 14.17537 14.28337 14.84897 14.86358 12.07567 15.68808 16.24993 16.31512 15.50619 16.30773 17.4073 14.74725 0 14.76576 15.7684 18.07051 18.7606 0 14.918 16.20992 17.05956 13.54834 16.94076 17.01574 0 17.81488 16.06048 0 16.74935 14.47964 17.70737 17.22715 16.83266 0 11.56801 14.58489 16.14917 18.35185 9.097556 15.55047 17.12475 0 Q6DHV5 C2D2B_HUMAN Protein CC2D2B CC2D2B C10orf130 C10orf131 Homo sapiens (Human) non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491] ciliary transition zone [GO:0035869] ciliary transition zone [GO:0035869]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491] GO:0035869; GO:1904491; GO:1905515 DMMPR 12.18000031 0.197220445 0.197220445 0.09837642 664.5805599 16.24249 14.51281 17.02871 16.43006 12.49537 0 0 12.22379 15.69814 0 14.01079 15.86577 16.04955 16.98386 0 13.75224 17.31429 12.46069 16.42437 0 0 17.0721 16.43699 0 18.41252 0 16.3703 0 16.78117 16.88266 17.08883 16.67519 0 13.67713 16.25043 18.60586 0 17.53374 16.65031 16.96204 17.88832 16.26248 13.15712 18.48044 14.62968 15.74602 15.1373 16.67472 Q6DHV7 ADAL_HUMAN "Adenosine deaminase-like protein, EC 3.5.4.- (Adenosine deaminase-like protein isoform 1) (N6-mAMP deaminase, HsMAPDA) (N6-methyl-AMP aminohydrolase)" ADAL ADAL1 Homo sapiens (Human) adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] cytosol [GO:0005829]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-mAMP deaminase activity [GO:0062154]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117] adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-mAMP deaminase activity [GO:0062154] GO:0004000; GO:0005829; GO:0006154; GO:0009117; GO:0046103; GO:0046872; GO:0062154 KLIAQKPDLK 1.49000001 0.004274439 0.004274439 0.20703109 1150.36254 13.01312 14.56696 14.63705 0 14.33872 12.9589 0 15.05609 0 0 0 0 0 0 15.82819 13.93858 0 14.65407 0 0 14.62225 0 0 0 0 0 12.53514 11.71323 0 12.51808 0 0 0 0 0 0 0 14.57679 0 0 0 0 0 12.10724 16.38848 0 0 0 Q6DKI2 LEG9C_HUMAN "Galectin-9C, Gal-9C (Galectin-9-like protein B)" LGALS9C Homo sapiens (Human) "negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]" carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936] GO:0005634; GO:0005829; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:2000562 NLPTINKLEVGGDIQLTHVQT 1.169999957 1 1 0.162581639 2290.040776 15.2269 14.33165 12.40053 0 0 0 14.16949 15.93464 0 0 11.06105 0 13.71686 0 0 12.69161 0 0 0 0 0 0 14.25909 15.86516 9.669819 15.31348 13.95518 0 0 0 0 0 0 0 14.62988 0 15.72359 0 0 0 0 14.71806 0 0 0 0 15.00788 0 Q6DKK2 TTC19_HUMAN "Tetratricopeptide repeat protein 19, mitochondrial, TPR repeat protein 19" TTC19 Homo sapiens (Human) mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281] centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469] centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281] GO:0000281; GO:0005739; GO:0005743; GO:0005813; GO:0030496; GO:0034551; GO:0070469 ASDLAR 15.06000042 0.202782109 0.202782109 1.60E-12 634.3364315 16.01473 0 17.94377 16.35841 17.30051 0 17.72043 0 16.22901 18.0749 0 0 0 16.41612 0 0 0 0 0 17.99745 0 0 17.89135 17.31028 17.0732 0 0 0 0 0 0 14.86635 0 17.47928 0 0 0 18.75758 0 0 0 0 0 15.67414 0 0 0 18.49458 Q6DN03 H2B2C_HUMAN "Putative histone H2B type 2-C (H2B-clustered histone 20 pseudogene) (Histone H2B.t, H2B/t)" H2BC20P HIST2H2BC Homo sapiens (Human) nucleosome assembly [GO:0006334] nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982 AHNTKHR 12.22999954 0.136646941 0.136646941 0.269359923 859.9035324 16.34246 15.00128 15.28168 16.20679 14.91409 14.61695 14.66391 0 0 0 15.93129 15.9521 0 0 15.3811 0 0 0 16.00669 16.58329 16.67104 16.69076 0 16.84546 15.63378 16.09793 0 15.95096 15.40593 14.8559 12.02337 15.35143 14.83278 14.56966 16.02279 14.97974 0 16.53777 14.44663 16.49939 16.33289 15.18437 15.11048 15.84537 15.08868 14.67502 15.48799 15.93213 Q6DN12 MCTP2_HUMAN Multiple C2 and transmembrane domain-containing protein 2 MCTP2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; regulation of neurotransmitter secretion [GO:0046928] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; regulation of neurotransmitter secretion [GO:0046928] calcium ion binding [GO:0005509] GO:0005509; GO:0005654; GO:0005829; GO:0016020; GO:0016021; GO:0019722; GO:0030672; GO:0046928 GVIYLEMDLIYNPVKASIR 4.369999886 1 1 2.29E-12 2207.532633 14.46491 0 14.60632 0 0 13.747 0 14.45717 14.18927 14.68106 13.04531 0 0 13.84772 0 15.53915 0 16.38597 0 0 0 0 0 0 13.95986 0 15.8901 15.12005 0 16.02669 13.34273 14.16662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DN14 MCTP1_HUMAN Multiple C2 and transmembrane domain-containing protein 1 MCTP1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928] calcium ion binding [GO:0005509] GO:0005509; GO:0005789; GO:0016021; GO:0019722; GO:0030336; GO:0030672; GO:0045806; GO:0046928; GO:0048168; GO:0055037; GO:1902883 DVTMLMR 10.76000023 0.273836136 0.273836136 1.71E-12 898.0213221 0 0 0 18.27935 0 0 0 0 0 0 10.8321 17.01277 15.89716 0 0 0 18.32619 15.67947 0 17.17027 0 0 0 0 0 17.81764 16.56459 0 0 14.50526 0 0 0 0 0 0 0 17.59266 0 17.61142 0 0 16.64715 15.79556 0 19.07815 0 0 Q6DN72 FCRL6_HUMAN "Fc receptor-like protein 6, FcR-like protein 6, FcRL6 (Fc receptor homolog 6, FcRH6) (IFGP6)" FCRL6 FCRH6 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class II protein binding [GO:0042289]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166] MHC class II protein binding [GO:0042289]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009897; GO:0019902; GO:0019903; GO:0042289 ENQTLSMGAATVQSR 4.360000134 1 1 1.15E-12 1593.339406 13.52618 0 13.53428 0 0 14.31199 0 0 0 0 0 15.83926 0 0 0 12.36783 0 0 10.6607 14.60937 0 0 0 0 0 13.42774 0 0 0 0 15.53184 0 0 13.39851 0 10.55046 0 0 0 0 0 0 0 0 15.2639 0 0 0 Q6DT37 MRCKG_HUMAN "Serine/threonine-protein kinase MRCK gamma, EC 2.7.11.1 (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma, MRCK gamma, MRCKG, Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha)" CDC42BPG DMPK2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0018107; GO:0031032; GO:0031252; GO:0031532; GO:0034451; GO:0106310 KHQEALHAPTDHR 19.87999916 1 1 0.454516571 1539.745682 0 0 0 0 0 0 17.59581 0 0 0 0 0 0 0 0 19.30613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6E0U4 DMKN_HUMAN Dermokine (Epidermis-specific secreted protein SK30/SK89) DMKN UNQ729/PRO1411 Homo sapiens (Human) cornified envelope assembly [GO:1903575] extracellular space [GO:0005615] extracellular space [GO:0005615]; cornified envelope assembly [GO:1903575] GO:0005615; GO:1903575 AIGKEAGGAAGSK 8.340000153 1 1 0.398651611 1115.704618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.59478 0 0 0 0 0 0 0 0 0 0 18.36724 0 0 0 0 0 Q6E213 AWAT2_HUMAN "Acyl-CoA wax alcohol acyltransferase 2, EC 2.3.1.75 (11-cis-specific retinyl-ester synthase, 11-cis-RE-synthase) (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diacylglycerol O-acyltransferase 2-like protein 4) (Diacylglycerol O-acyltransferase candidate 4, hDC4) (Long-chain-alcohol O-fatty-acyltransferase 2) (Multifunctional O-acyltransferase) (Wax synthase, hWS)" AWAT2 DC4 DGAT2L4 MFAT WS Homo sapiens (Human) acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252]; acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025] 2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252] GO:0001523; GO:0003846; GO:0005789; GO:0006629; GO:0006640; GO:0010025; GO:0016021; GO:0036155; GO:0047196; GO:0050252; GO:0102966 LLPSKK 12.88000011 1 1 0.248053289 685.5486213 0 0 0 0 15.69601 0 0 0 0 17.64765 0 0 0 0 0 0 0 0 16.75829 0 0 0 0 0 19.73228 0 0 0 17.14418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6EMB2 TTLL5_HUMAN "Tubulin polyglutamylase TTLL5, EC 6.3.2.- (SRC1 and TIF2-associated modulatory protein, STAMP protein) (Tubulin--tyrosine ligase-like protein 5)" TTLL5 KIAA0998 STAMP Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GO:0000226; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0060041; GO:0070740 LSRPSSAKAGSCYLNK 5.150000095 0.928852797 0.928852797 0.351949064 1739.179193 13.31028 12.66334 10.64134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7166 14.19889 0 0 0 0 15.50467 0 9.983346 0 0 19.29135 0 14.31699 0 0 0 0 0 0 0 0 0 0 0 Q6EMK4 VASN_HUMAN Vasorin (Protein slit-like 2) VASN SLITL2 UNQ314/PRO357/PRO1282 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; transforming growth factor beta binding [GO:0050431]; cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] cadherin binding [GO:0045296]; transforming growth factor beta binding [GO:0050431] GO:0005615; GO:0005739; GO:0005765; GO:0005886; GO:0009986; GO:0010719; GO:0016021; GO:0030512; GO:0031012; GO:0045296; GO:0050431; GO:0070062; GO:0071456; GO:0071461 LERLYLGK 10.57999992 1 1 0.15279034 993.0694092 16.01543 15.03452 14.89873 0 0 0 0 0 0 0 0 0 15.31376 0 0 0 0 0 14.6897 0 0 0 0 0 0 0 14.39472 0 13.44853 0 0 0 15.63356 15.32687 12.02171 14.76254 13.13038 0 0 13.44139 0 15.27446 13.68083 0 15.0023 0 0 0 Q6F5E7 TR3N_HUMAN "Putative uncharacterized protein TXNRD3NB (Thioredoxin reductase 2 intronic transcript 1) (Thioredoxin reductase 3 intronic transcript 1) (Thioredoxin reductase 3 neighbor gene protein, TXNRD3 neighbor gene protein) (Thioredoxin reductase 3 new transcript 1)" TXNRD3NB TR2IT1 TXNRD3IT1 TXNRD3NT1 Homo sapiens (Human) VFGQGFPSPLEEIK 8.779999733 1 1 0.054236185 1548.941557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6F5E8 CARL2_HUMAN "Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)" CARMIL2 LRRC16C RLTPR Homo sapiens (Human) "actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]" actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]" phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] GO:0001726; GO:0005543; GO:0005737; GO:0005886; GO:0007163; GO:0010592; GO:0015629; GO:0016020; GO:0030011; GO:0030027; GO:0030335; GO:0031234; GO:0031252; GO:0044319; GO:0044354; GO:0044877; GO:0045111; GO:0051639; GO:0061339; GO:0090091; GO:1900029; GO:1902745; GO:2000813 GGGPNP 3.769999981 0.284782678 0.284782678 0.134387431 497.3533039 17.06143 19.74316 16.72191 16.82312 16.43101 18.488 16.83303 17.9656 16.05551 16.53855 19.11399 18.75991 15.93064 18.23887 16.66786 17.78551 17.76175 18.06266 16.39683 19.96182 19.13431 0 17.70674 16.97375 20.25429 18.13402 16.60684 18.29175 0 19.40796 20.02437 0 19.47085 18.52452 17.37117 0 0 0 17.43435 19.86382 0 17.14726 18.17115 18.11383 17.69233 0 0 17.69965 Q6GMR7 FAAH2_HUMAN "Fatty-acid amide hydrolase 2, EC 3.5.1.99 (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)" FAAH2 AMDD Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042] anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077] GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073 EAFQLQGMPNSSGLMNRR 10.43999958 1 1 0.12212775 2036.247213 0 0 0 0 0 0 0 14.21634 13.90895 0 0 0 0 14.84853 14.66253 13.78409 0 13.6452 12.75896 12.70672 11.11769 14.90105 0 0 15.45869 11.94185 0 12.7632 15.50936 13.74007 0 0 9.725576 0 13.53775 14.60558 0 0 12.5613 12.93859 0 13.32166 0 0 12.54973 0 0 12.03436 Q6GQQ9 OTU7B_HUMAN "OTU domain-containing protein 7B, EC 3.4.19.12 (Cellular zinc finger anti-NF-kappa-B protein, Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)" OTUD7B ZA20D1 Homo sapiens (Human) adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380 IMNGGIGGGPPPAK 4.710000038 1 1 6.88E-13 1265.833586 11.56612 15.73054 0 0 14.78614 11.87966 0 15.07615 0 13.35748 0 15.71606 14.06528 14.33696 0 0 16.11546 15.6611 0 14.50379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.75621 0 Q6GTX8 LAIR1_HUMAN "Leukocyte-associated immunoglobulin-like receptor 1, LAIR-1, hLAIR1 (CD antigen CD305)" LAIR1 CD305 Homo sapiens (Human) adaptive immune response [GO:0002250] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; adaptive immune response [GO:0002250] GO:0002250; GO:0005886; GO:0016021; GO:0035579; GO:0070821 EGNAGLYR 6.590000153 0.862052262 0.862052262 0.174679216 879.1469119 0 0 0 18.28131 17.39338 12.70125 0 15.78858 0 15.04291 0 15.73829 18.58228 16.47399 12.25309 16.30534 16.83136 13.37966 0 0 15.67353 18.9289 14.64044 16.42506 12.92419 17.49598 11.08781 11.97055 15.79689 18.59087 16.96947 0 19.05242 16.33401 16.66691 18.06155 0 0 17.27792 12.90222 17.78656 16.40717 17.66341 0 17.03976 17.56519 13.52133 16.45958 Q6GYQ0 RGPA1_HUMAN "Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12, GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240)" RALGAPA1 GARNL1 KIAA0884 TULIP1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630 EPFIKAR 7.429999828 1 1 0.226387593 860.6621603 15.53589 0 0 0 0 0 14.8999 0 0 0 15.18563 0 0 0 17.05012 15.30751 12.69323 15.8903 0 16.68265 0 0 0 0 18.48582 0 14.96787 0 0 0 0 16.07922 0 0 17.47039 0 16.04035 0 0 16.42729 0 14.32132 16.37091 0 17.59085 17.12325 17.34412 0 Q6H3X3 ULBP5_HUMAN UL-16 binding protein 5 (Retinoic acid early transcript 1G protein) RAET1G ULBP5 Homo sapiens (Human) natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell cytokine production [GO:0002729] anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell cytokine production [GO:0002729] natural killer cell lectin-like receptor binding [GO:0046703] GO:0002729; GO:0005576; GO:0005615; GO:0005783; GO:0005886; GO:0009897; GO:0016021; GO:0031225; GO:0042267; GO:0043231; GO:0046703 VLWSDSYQIAKRPLSGGHVTR 6.340000153 1 1 3.65E-12 2369.598404 13.95193 16.62369 16.06646 15.77721 14.54682 0 18.59506 16.98191 17.40237 16.3295 16.41119 16.834 13.35643 15.04588 18.04211 0 15.41276 13.59476 16.94285 12.84689 13.60153 0 0 11.70499 16.8646 0 0 15.03493 0 14.04772 0 0 14.79583 9.776876 0 15.85939 16.05402 16.15145 0 16.74656 11.7162 15.24263 0 0 15.13546 0 15.21381 0 Q6H8Q1 ABLM2_HUMAN "Actin-binding LIM protein 2, abLIM-2 (Actin-binding LIM protein family member 2)" ABLIM2 KIAA1808 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]" actin filament binding [GO:0051015]; metal ion binding [GO:0046872] GO:0005737; GO:0006351; GO:0015629; GO:0030032; GO:0030036; GO:0046872; GO:0051015 HFHVPDTGVK 2.670000076 1 1 0.105196559 1136.938843 0 9.026956 0 0 0 0 0 15.21137 0 14.43277 0 0 0 0 15.26474 0 14.18768 0 0 0 0 0 0 0 0 0 17.02075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IA86 ELP2_HUMAN "Elongator complex protein 2, ELP2 (SHINC-2) (STAT3-interacting protein 1, StIP1)" ELP2 STATIP1 Homo sapiens (Human) regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] protein kinase binding [GO:0019901] GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0006417; GO:0008023; GO:0019901; GO:0033588; GO:0046425 LLSASMDK 4.349999905 0.43176353 0.43176353 0.215333169 882.8312074 17.68966 15.05351 16.26138 13.83154 17.10429 0 13.73455 0 0 17.0498 18.10334 16.20663 15.97503 0 16.9716 0 0 15.07351 17.9778 16.19667 13.79116 13.6403 0 0 18.37698 0 14.50813 16.67053 17.41105 0 17.24509 17.72607 18.39298 17.44131 16.23042 11.26392 18.8422 18.04633 18.32044 15.37573 16.33652 17.83194 16.36994 0 14.08509 0 15.23841 14.27153 Q6IAN0 DRS7B_HUMAN "Dehydrogenase/reductase SDR family member 7B, EC 1.1.-.- (Short-chain dehydrogenase/reductase family 32C member 1, Protein SDR32C1)" DHRS7B SDR32C1 CGI-93 UNQ212/PRO238 Homo sapiens (Human) adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; ether lipid biosynthetic process [GO:0008611]; inflammatory response [GO:0006954]; negative regulation of protein binding [GO:0032091]; neutrophil differentiation [GO:0030223]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of cold-induced thermogenesis [GO:0120161] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; transcription regulator complex [GO:0005667] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; transcription regulator complex [GO:0005667]; acylglycerone-phosphate reductase activity [GO:0000140]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; ether lipid biosynthetic process [GO:0008611]; inflammatory response [GO:0006954]; negative regulation of protein binding [GO:0032091]; neutrophil differentiation [GO:0030223]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of cold-induced thermogenesis [GO:0120161] acylglycerone-phosphate reductase activity [GO:0000140]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714] GO:0000140; GO:0003714; GO:0005634; GO:0005667; GO:0005778; GO:0005789; GO:0006656; GO:0006954; GO:0008611; GO:0016020; GO:0016021; GO:0030223; GO:0032091; GO:0050873; GO:0060612; GO:0120161; GO:0140297 MVSPATRK 4.28000021 0.75069195 0.75069195 0.257594312 890.1473095 14.71547 15.09326 0 13.08659 0 0 15.97117 15.04107 11.47899 15.11 0 15.88978 0 15.71432 16.1405 15.20864 0 0 0 15.9815 15.32466 0 15.76423 0 0 0 15.33347 16.55844 0 0 15.58715 15.17502 16.35735 0 0 15.78429 0 16.32891 16.82153 0 0 0 0 0 15.16339 0 0 15.56329 Q6IB77 GLYAT_HUMAN "Glycine N-acyltransferase, EC 2.3.1.13 (Acyl-CoA:glycine N-acyltransferase, AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase, EC 2.3.1.71) (HRP-1(CLP))" GLYAT ACGNAT CAT GAT Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyltransferase activity [GO:0016746]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] acyltransferase activity [GO:0016746]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; N-acyltransferase activity [GO:0016410] GO:0005739; GO:0005759; GO:0006544; GO:0006637; GO:0006805; GO:0009636; GO:0016410; GO:0016746; GO:0032787; GO:0047961; GO:0047962; GO:1901787 ELTPFLLKSK 12.01000023 1 1 0.099497458 1176.887897 15.07526 10.42387 0 13.86208 14.22925 0 0 0 0 0 15.93458 15.16943 16.28163 0 15.26638 0 14.78798 15.78923 0 0 14.99065 0 0 14.82892 0 0 0 0 0 0 0 0 0 0 0 0 0 17.18217 0 0 0 16.33241 0 0 0 0 0 0 Q6IBS0 TWF2_HUMAN "Twinfilin-2 (A6-related protein, hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein)" TWF2 PTK9L MSTP011 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989] actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420] "actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989]" "actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]" GO:0003723; GO:0003785; GO:0005080; GO:0005524; GO:0005546; GO:0005737; GO:0005884; GO:0010591; GO:0010592; GO:0010976; GO:0030016; GO:0030027; GO:0030030; GO:0030042; GO:0030175; GO:0030426; GO:0030837; GO:0032420; GO:0032532; GO:0032956; GO:0042989; GO:0045296; GO:0045773; GO:0048471; GO:0051015; GO:0051016; GO:0070062; GO:0071300; GO:0071363 HQTLQGLAFPLQPEAQR 5.570000172 1 1 0.146683919 1934.078901 0 0 0 0 15.7379 0 0 0 0 0 0 0 0 15.25 0 0 0 0 0 0 0 0 0 0 0 0 0 14.59399 15.61292 16.17819 0 0 15.55202 0 13.26527 16.75959 16.0341 0 0 0 14.31798 0 0 0 0 0 0 0 Q6IBW4 CNDH2_HUMAN "Condensin-2 complex subunit H2 (Chromosome-associated protein H2, hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2)" NCAPH2 CAPH2 Homo sapiens (Human) female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077] cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077] chromatin binding [GO:0003682] GO:0000794; GO:0000796; GO:0003682; GO:0005634; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0030054; GO:0033077; GO:0045171; GO:0051306; GO:0051309; GO:0051984; GO:1905820 FQTYAAPSMAQP 3.029999971 1 1 0.422211479 1326.452758 0 16.49964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4691 15.80781 0 0 0 0 16.85198 17.47805 0 0 15.89304 0 15.25908 0 0 0 0 17.30239 0 15.55328 0 0 12.69373 0 15.66921 0 16.48667 0 0 0 0 0 Q6ICC9 RTL6_HUMAN Retrotransposon Gag-like protein 6 (Leucine zipper protein down-regulated in cancer cells-like) (Mammalian retrotransposon-derived protein 6) (Protein LDOC1L) RTL6 LDOC1L MAR6 MART6 Homo sapiens (Human) NNYQGFLAELRR 9.550000191 1 1 0.439545809 1480.551452 0 13.43148 13.21787 14.78807 0 0 16.22794 14.86168 0 0 0 0 0 0 16.1132 18.11279 14.73227 0 0 0 0 15.66681 16.17716 14.93978 0 0 0 17.87416 0 0 16.45114 0 0 18.73583 16.00229 0 20.13876 14.39041 16.96163 18.35744 0 0 15.45961 0 16.84695 19.19452 15.57934 0 Q6ICG8 WBP2L_HUMAN Postacrosomal sheath WW domain-binding protein (WW domain-binding protein 2-like) WBP2NL PAWP Homo sapiens (Human) "egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827] "nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699]; egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]" chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699] GO:0003713; GO:0005634; GO:0007343; GO:0031490; GO:0033011; GO:0035038; GO:0035039; GO:0036126; GO:0045893; GO:0050699; GO:0051321; GO:0061827 AASAAAR 9.510000229 0.401728749 0.401728749 0.304791469 615.7634657 16.48917 16.11967 16.0088 15.21714 15.94204 14.84788 15.44063 14.78245 15.21913 0 16.25876 0 0 0 0 13.96111 0 15.92313 0 0 0 15.71586 15.64868 0 15.93776 15.43338 15.0083 16.96322 15.33653 14.99172 0 15.24263 15.58944 0 16.24503 0 0 0 0 0 0 16.29449 0 16.62019 0 0 0 16.71269 Q6ICL7 S35E4_HUMAN Solute carrier family 35 member E4 SLC35E4 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297] antiporter activity [GO:0015297] GO:0005794; GO:0015297; GO:0016021 CPPEHHDGR 5.429999828 1 1 0.169428166 1104.498801 0 0 12.36709 14.14918 16.24891 0 14.39928 14.22126 0 0 0 15.55517 0 0 0 16.36263 12.34925 0 15.68434 15.47928 14.44509 12.51531 15.55002 14.60196 0 14.69006 15.17019 14.71095 0 0 0 0 0 0 14.12468 0 14.35116 0 0 0 0 0 0 0 16.29801 0 0 0 Q6IE81 JADE1_HUMAN Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17) JADE1 KIAA1807 PHF17 Homo sapiens (Human) "apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713] GO:0000123; GO:0001558; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0006275; GO:0006355; GO:0006357; GO:0006915; GO:0016570; GO:0016607; GO:0030308; GO:0036064; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:0090090; GO:2000134; GO:2000278 KGGAMKPTR 11.51000023 0.299252272 0.299252272 0.06158778 958.215206 0 12.96196 0 12.41478 0 13.57403 15.90974 0 0 15.81736 0 0 0 13.73329 0 16.90331 17.42189 13.27117 15.86917 15.80611 11.78966 14.35981 13.52086 15.88406 16.56567 0 0 14.83536 0 16.30863 11.55573 13.57718 0 0 0 9.021918 18.21734 15.65064 0 9.555106 0 13.31643 14.19872 16.5215 15.57845 16.20846 13.17985 13.4917 Q6IEE7 T132E_HUMAN Transmembrane protein 132E TMEM132E Homo sapiens (Human) posterior lateral line neuromast hair cell development [GO:0035677] cell body [GO:0044297]; integral component of membrane [GO:0016021] cell body [GO:0044297]; integral component of membrane [GO:0016021]; posterior lateral line neuromast hair cell development [GO:0035677] GO:0016021; GO:0035677; GO:0044297 APGMSGR 8.199999809 0.635077953 0.635077953 0.030513364 674.8727271 0 16.81867 0 0 0 0 12.67287 0 11.23521 17.47688 0 13.73757 15.28397 15.09379 0 0 0 0 0 0 14.507 0 0 0 17.23723 0 0 14.82022 0 0 0 16.28994 0 0 0 0 0 14.47085 0 0 17.93902 15.2421 16.12841 0 0 0 0 0 Q6IEE8 SN12L_HUMAN Schlafen family member 12-like SLFN12L SLFN5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 VTLGENNRK 4.860000134 0.279488593 0.279488593 0.183515445 1032.403683 0 0 0 0 0 15.40583 0 0 0 0 10.9756 0 16.15252 14.4559 0 0 0 15.85838 0 11.65664 0 0 0 0 0 13.69568 9.835728 0 13.92913 14.73255 16.28239 14.81536 0 16.55927 15.75406 0 16.10747 0 0 0 0 14.50832 11.86436 14.8114 12.83932 0 15.87531 15.66116 Q6IEZ7 OR2T5_HUMAN Olfactory receptor 2T5 (Olfactory receptor OR1-62) OR2T5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 ANITRMANHTGK 18.98999977 1 1 0.419974658 1313.166745 0 0 11.46878 0 14.86112 13.37146 12.73016 0 12.47571 0 14.61701 14.58726 14.68336 16.23563 0 0 15.4725 15.4751 15.66259 0 0 0 0 14.57817 0 0 0 0 0 0 0 0 0 0 0 16.90333 0 0 17.6287 0 0 0 0 0 0 0 0 0 Q6IF82 O4A47_HUMAN Olfactory receptor 4A47 (Olfactory receptor OR11-113) OR4A47 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 TFPIDK 4.46999979 1 1 0.031060724 718.3598064 0 0 0 0 0 0 0 18.53103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IMI4 ST6B1_HUMAN "Sulfotransferase 6B1, ST6B1 (Thyroxine sulfotransferase, EC 2.8.2.n2)" SULT6B1 Homo sapiens (Human) sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923] sulfotransferase activity [GO:0008146] GO:0005737; GO:0005829; GO:0008146; GO:0051923 HLDGDNVK 8.960000038 1 1 0.267961212 897.8300713 13.1639 8.267688 15.46573 13.59661 0 0 0 0 0 17.17948 0 0 0 15.40929 0 0 14.34261 0 12.78394 0 0 0 11.01556 10.79853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IMN6 CAPR2_HUMAN Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (Gastric cancer multidrug resistance-associated protein) (Protein EEG-1) (RNA granule protein 140) CAPRIN2 C1QDC1 EEG1 KIAA1873 RNG140 Homo sapiens (Human) negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102] GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030308; GO:0032092; GO:0033138; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263 DFKGGLNGAVYLPSK 2.619999886 1 1 0.241137213 1566.782339 0 15.72456 0 0 0 0 15.53348 0 0 0 0 0 0 14.53541 0 14.09529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.69039 0 15.61442 0 0 16.32997 0 14.81218 15.17542 0 0 0 0 0 Q6IN84 MRM1_HUMAN "rRNA methyltransferase 1, mitochondrial, EC 2.1.1.- (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)" MRM1 Homo sapiens (Human) rRNA 2'-O-methylation [GO:0000451] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451] RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0070039 DIPVLRPR 9.199999809 1 1 0.03602259 966.6656094 14.61311 0 13.91093 0 0 15.93779 0 14.72429 0 0 0 0 14.57801 0 0 0 0 0 0 0 0 0 0 0 0 14.96023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9196 13.71073 Q6IN85 P4R3A_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1) PPP4R3A KIAA2010 PP4R3A SMEK1 MSTP033 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] protein phosphatase activator activity [GO:0072542] GO:0005654; GO:0005815; GO:0005829; GO:0006470; GO:0006974; GO:0016607; GO:0030289; GO:0072542 GMSLLVR 11.51000023 1 1 0.185733166 774.3540291 0 0 0 13.47558 16.15542 15.11799 0 0 0 0 0 0 0 17.19192 16.20614 16.9083 16.12721 16.06655 0 0 17.28006 0 15.62124 0 17.01065 16.48104 14.66307 15.01039 18.2298 14.73645 0 15.78482 16.16265 16.2189 15.75903 15.2268 0 16.55799 17.22283 14.6533 16.13756 17.15434 14.41912 16.06973 15.9493 16.11765 0 0 Q6IN97 FRP2L_HUMAN Putative protein FRMPD2-like (FERM and PDZ domain-containing protein 2 pseudogene 1) (FERM and PDZ domain-containing protein 2B pseudogene) (PDZ domain-containing protein 5A) FRMPD2B FRMPD2L1 FRMPD2L2 FRMPD2P1 FRMPD2P2 PDZD5A PDZD5B PDZK5A PDZK5B Homo sapiens (Human) bicellular tight junction assembly [GO:0070830] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; 1-phosphatidylinositol binding [GO:0005545]; bicellular tight junction assembly [GO:0070830] 1-phosphatidylinositol binding [GO:0005545] GO:0005545; GO:0005923; GO:0016323; GO:0070830 LGRYSFSSPLTR 5.130000114 1 1 0.037467604 1384.15896 0 0 15.63975 0 15.89561 0 12.52019 0 0 0 13.27692 0 15.29887 0 14.48487 13.61717 0 0 0 0 14.71178 0 17.10273 0 0 0 11.59869 10.81996 15.11329 16.56491 0 0 0 0 0 0 0 15.38874 0 0 15.6818 0 13.46645 0 0 16.60574 0 0 Q6IPM2 IQCE_HUMAN IQ domain-containing protein E IQCE KIAA1023 Homo sapiens (Human) limb morphogenesis [GO:0035108] ciliary membrane [GO:0060170]; cilium [GO:0005929] ciliary membrane [GO:0060170]; cilium [GO:0005929]; limb morphogenesis [GO:0035108] GO:0005929; GO:0035108; GO:0060170 MGSALLSLSRSVQELTEENQSLK 2.109999895 1 1 0.158095263 2519.925707 12.18143 0 0 11.08676 7.960487 10.47317 9.632308 10.01641 0 0 11.48942 0 0 10.44884 0 0 0 0 0 0 14.47072 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92829 0 15.49194 0 0 0 0 0 0 0 0 0 0 0 Q6IPX3 TCAL6_HUMAN "Transcription elongation factor A protein-like 6, TCEA-like protein 6 (Transcription elongation factor S-II protein-like 6)" TCEAL6 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] WW domain binding [GO:0050699] GO:0005634; GO:0050699 DVQDPFAPR 12.81999969 1 1 0.160840783 1040.929883 0 0 14.85857 15.73315 15.60505 0 0 14.19182 0 0 0 0 0 15.16543 13.82057 13.48153 14.6648 0 0 0 14.01074 0 15.85644 0 0 0 0 0 0 0 0 0 0 0 0 0 16.09998 0 0 16.05269 16.46912 15.71205 15.42105 16.02653 0 0 0 0 Q6IQ23 PKHA7_HUMAN "Pleckstrin homology domain-containing family A member 7, PH domain-containing family A member 7" PLEKHA7 Homo sapiens (Human) cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; zonula adherens maintenance [GO:0045218] cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915] cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; zonula adherens maintenance [GO:0045218] delta-catenin binding [GO:0070097] GO:0005654; GO:0005813; GO:0005829; GO:0005915; GO:0030054; GO:0044331; GO:0045218; GO:0046930; GO:0046931; GO:0070062; GO:0070097; GO:0090136 LSIFCEQDR 19.76000023 1 1 0.709120494 1166.72248 21.1292 0 0 0 21.12919 0 0 0 0 0 0 0 0 0 18.68142 0 0 0 0 0 0 22.44216 0 0 0 21.55191 0 0 0 0 0 0 0 0 20.97509 0 0 22.81601 0 0 20.6398 0 0 0 21.108 18.85257 0 0 Q6IQ26 DEN5A_HUMAN "DENN domain-containing protein 5A (Rab6-interacting protein 1, Rab6IP1)" DENND5A KIAA1091 RAB6IP1 Homo sapiens (Human) "negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]" guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147 DQSSMEDGEDTPVTKLQR 9.170000076 1 1 0.134729385 2051.611809 12.95024 15.05669 16.02296 12.67905 12.25028 0 15.18727 15.6138 12.66513 12.7959 13.76304 14.29183 0 13.69172 0 0 0 0 0 0 0 15.3557 0 13.29148 0 0 14.56954 0 13.52991 12.87865 16.27495 0 0 0 0 0 0 0 0 14.4688 0 0 0 0 0 0 0 0 Q6IQ55 TTBK2_HUMAN "Tau-tubulin kinase 2, EC 2.7.11.1" TTBK2 KIAA0847 Homo sapiens (Human) cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224] ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0000226; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0007026; GO:0007165; GO:0007224; GO:0018105; GO:0019894; GO:0021549; GO:0021681; GO:0021935; GO:0030334; GO:0035869; GO:0036064; GO:0048156; GO:0050321; GO:0051010; GO:0060271; GO:0106310; GO:1902817; GO:1904527 DVWEEMDANK 3.210000038 1 1 1.60E-12 1237.25159 13.53373 12.53813 11.96296 14.90073 0 0 12.04939 0 0 13.48883 12.63945 0 0 14.48875 12.27359 14.65052 11.41461 15.54279 12.88855 0 0 0 16.22324 0 12.95627 14.35608 0 0 0 0 0 0 0 0 0 0 13.96614 0 0 0 12.78382 14.47397 0 0 0 0 0 0 Q6IS24 GLT17_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 17, EC 2.4.1.41 (Polypeptide GalNAc transferase-like protein 3, GalNAc-T-like protein 3, pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein)" GALNT17 WBSCR17 Homo sapiens (Human) protein glycosylation [GO:0006486] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872 VKSSLYK 9.020000458 0.366568983 0.366568983 0.257531581 825.0847229 17.47761 17.31817 17.55732 15.02066 17.46319 14.04814 17.1659 14.93367 15.18138 16.60976 16.9809 0 13.42953 0 15.56773 13.07226 15.75235 16.95288 18.90747 16.49703 14.65304 16.60536 16.81745 16.86115 16.58265 16.67369 17.35242 16.855 18.19324 16.95701 17.3356 0 16.59521 15.68637 16.69381 16.17635 14.38143 16.81805 11.86998 16.08977 0 16.40466 17.14695 17.11347 17.54589 16.611 16.27431 14.7459 Q6ISB3 GRHL2_HUMAN Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3) GRHL2 BOM TFCP2L3 Homo sapiens (Human) anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357] cell-cell junction [GO:0005911]; chromatin [GO:0000785]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell-cell junction [GO:0005911]; chromatin [GO:0000785]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000978; GO:0000981; GO:0001161; GO:0001228; GO:0001843; GO:0003208; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006357; GO:0007155; GO:0007420; GO:0008283; GO:0008544; GO:0016020; GO:0021915; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0043010; GO:0043565; GO:0044030; GO:0045617; GO:0045944; GO:0048701; GO:0051973; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132 SVVMVVFSEDK 8.25 1 1 0.251571322 1255.39467 0 0 0 16.60181 0 0 0 16.14992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.78625 14.70317 0 0 0 0 0 0 14.80776 16.04548 0 0 0 0 0 0 0 0 0 0 0 13.86908 0 0 0 Q6IV72 ZN425_HUMAN Zinc finger protein 425 ZNF425 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0045892; GO:0046872 EKPSSL 6.059999943 1 1 0.231487902 659.9933199 0 0 17.05978 0 0 0 0 0 0 0 18.57 18.87379 0 0 0 0 0 0 0 0 0 19.96108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.93174 0 18.7768 0 19.00995 0 18.32242 0 0 0 0 0 Q6IWH7 ANO7_HUMAN "Anoctamin-7 (Dresden transmembrane protein of the prostate, D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G)" ANO7 NGEP PCANAP5 TMEM16G Homo sapiens (Human) calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0006821; GO:0016021; GO:0030054; GO:0034220; GO:0046983; GO:0055085; GO:0061588; GO:1902476 WAMTSETSSGSHCAR 5.909999847 1 1 9.26E-13 1683.630724 14.43641 0 0 13.90244 0 0 0 0 0 0 14.50066 0 0 0 0 0 0 0 0 15.23492 0 16.99747 16.91844 0 0 0 0 0 0 16.46933 0 13.95196 0 16.83021 14.82087 16.04101 0 0 0 0 0 0 0 0 0 0 0 0 Q6JBY9 CPZIP_HUMAN CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1) RCSD1 CAPZIP Homo sapiens (Human) cellular hyperosmotic response [GO:0071474]; skeletal muscle contraction [GO:0003009] actin filament [GO:0005884] actin filament [GO:0005884]; actin filament binding [GO:0051015]; cellular hyperosmotic response [GO:0071474]; skeletal muscle contraction [GO:0003009] actin filament binding [GO:0051015] GO:0003009; GO:0005884; GO:0051015; GO:0071474 LQANLTFDPAALLPGASPK 2.220000029 1 1 0.104468801 1924.789524 14.51633 0 15.40628 11.94876 0 13.27001 12.90022 16.57665 14.74883 13.417 12.72176 13.07525 14.78084 0 0 0 10.22367 0 0 0 0 13.66704 14.9619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6JEL2 KLH10_HUMAN Kelch-like protein 10 KLHL10 Homo sapiens (Human) cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286] GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873 AYMFILHNFEEMVK 8.340000153 1 1 0.502477807 1787.864344 17.56701 0 0 18.83107 0 16.70258 18.59185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.40295 0 0 Q6JQN1 ACD10_HUMAN "Acyl-CoA dehydrogenase family member 10, ACAD-10, EC 1.3.99.-" ACAD10 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660] GO:0003995; GO:0005739; GO:0005759; GO:0006635; GO:0050660 ENMVLGPGR 2.640000105 1 1 0.141220998 989.7171881 0 0 16.70448 12.87957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.45807 0 0 0 0 16.29082 0 0 0 15.4423 0 0 0 0 0 0 0 0 15.90002 12.24327 0 0 0 Q6JVE6 LCN10_HUMAN Epididymal-specific lipocalin-10 LCN10 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; small molecule binding [GO:0036094] small molecule binding [GO:0036094] GO:0005576; GO:0036094 KLGASVVK 7.179999828 1 1 0.235947358 801.3249204 0 0 0 0 0 0 18.14934 0 0 0 17.81054 0 17.65589 0 0 0 0 0 0 0 15.6136 0 0 0 0 0 0 0 16.12477 0 0 0 0 0 0 17.35911 18.32562 0 0 0 0 0 0 0 18.52059 0 0 16.35815 Q6KC79 NIPBL_HUMAN Nipped-B-like protein (Delangin) (SCC2 homolog) NIPBL IDN3 SCC2 Homo sapiens (Human) "brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038]" chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] "chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038]" chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485] GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008022; GO:0019827; GO:0031065; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0034613; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045892; GO:0045944; GO:0045995; GO:0047485; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061780; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0071921; GO:0090694; GO:1990414; GO:1990841; GO:2001224 AAMYDIISSPSK 5.239999771 1 1 0.41147977 1299.34919 0 15.99167 0 0 0 0 0 13.12474 0 0 0 0 0 0 16.4533 0 0 0 0 0 0 0 0 0 0 0 14.5654 0 0 16.29479 15.31836 0 0 0 0 0 0 15.94789 17.18402 0 14.74029 0 0 0 0 15.70581 0 0 Q6KCM7 SCMC2_HUMAN Calcium-binding mitochondrial carrier protein SCaMC-2 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25) SLC25A25 APC3 KIAA1896 MCSC3 SCAMC2 UNQ549/PRO1106 Homo sapiens (Human) adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094] ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] GO:0002021; GO:0005347; GO:0005509; GO:0005743; GO:0014823; GO:0016021; GO:0032094; GO:0035264; GO:0043010; GO:0045333; GO:0046034; GO:0060612; GO:0070588 MQAQASIEGAPEVTMSSLFK 5.110000134 1 1 0.254127726 2140.296991 13.56446 5.862149 14.38931 0 12.6616 0 15.24694 0 15.20493 0 0 0 15.6853 10.55819 0 14.83831 0 15.43017 0 0 0 0 15.61578 14.90598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.11424 0 0 0 0 0 0 Q6KF10 GDF6_HUMAN "Growth/differentiation factor 6, GDF-6 (Bone morphogenetic protein 13, BMP-13) (Growth/differentiation factor 16)" GDF6 BMP13 GDF16 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]" extracellular space [GO:0005615] "extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]" cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802] GO:0001656; GO:0005125; GO:0005615; GO:0006915; GO:0008083; GO:0010862; GO:0030509; GO:0032332; GO:0032924; GO:0035788; GO:0042802; GO:0045444; GO:0045666; GO:0045893; GO:0060389; GO:0060395; GO:1900745; GO:1990009 LTPISILYIDAGNNVVYK 5.480000019 1 1 0.479571609 1993.420413 0 0 0 0 16.80633 0 0 0 0 0 0 0 0 19.01725 0 17.92337 0 0 0 0 0 0 18.30079 0 0 0 0 0 0 0 0 21.18885 0 0 17.28053 0 0 20.83076 0 0 0 0 0 0 0 0 0 0 Q6L8Q7 PDE12_HUMAN "2',5'-phosphodiesterase 12, 2'-PDE, 2-PDE, EC 3.1.4.- (Mitochondrial deadenylase, EC 3.1.13.4)" PDE12 Homo sapiens (Human) "cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535] GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0005829; GO:0006397; GO:0034611; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0051607; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503 AALRVIR 13.01000023 1 1 0.146949193 799.2297436 0 0 13.77792 0 0 0 14.1429 12.48627 0 17.03194 0 0 14.95889 15.57187 0 16.72681 13.6814 15.97526 0 11.6708 14.87241 0 0 0 0 0 0 0 0 0 0 0 0 11.81753 0 15.35984 0 15.6183 0 0 0 0 0 15.25168 17.39211 0 0 0 Q6L9T8 FA72D_HUMAN Protein FAM72D (Gastric cancer up-regulated protein 2) FAM72D GCUD2 Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] GO:0005829; GO:0043231 LKDIACLK 7.53000021 1 1 0 960.2140831 15.41843 13.28494 15.39221 13.51879 0 14.21783 0 0 0 14.48196 0 12.83587 14.63777 0 0 0 0 0 14.6891 0 0 0 0 0 0 0 0 0 15.23808 0 0 0 0 0 0 0 0 0 0 13.76655 15.27926 0 0 0 0 0 0 0 Q6MZM0 HPHL1_HUMAN "Ferroxidase HEPHL1, EC 1.16.3.1 (Hephaestin-like protein 1)" HEPHL1 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491] GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0016021; GO:0016491; GO:0055072 DAVFQR 12.27999973 3.59E-06 3.59E-06 0.277894245 735.5075982 17.70469 17.63661 13.98259 17.4132 0 17.35682 17.37838 0 0 0 17.85796 0 0 16.55288 16.47315 0 17.55909 0 0 17.27901 16.73534 0 0 0 0 0 0 18.87434 0 15.59545 17.68385 0 0 0 0 18.62376 19.76644 0 0 16.30861 18.34599 16.1397 0 0 0 0 16.63248 0 Q6MZP7 LIN54_HUMAN Protein lin-54 homolog (CXC domain-containing protein 1) LIN54 CXCDC1 KIAA2037 Homo sapiens (Human) "cell cycle [GO:0007049]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067]; cell cycle [GO:0007049]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]" metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067] GO:0001067; GO:0003680; GO:0005634; GO:0005654; GO:0006355; GO:0007049; GO:0016584; GO:0046872 IGKGK 2.430000067 0.895844162 0.895844162 0.116976599 503.2839663 16.96917 17.33594 17.57676 16.19227 17.05814 16.94612 16.71264 16.423 16.7622 16.13437 17.20624 17.29727 18.50425 16.51161 17.20647 17.57894 17.01962 18.98146 17.69918 18.62185 16.86489 16.23232 17.91996 14.9175 16.87905 18.788 16.39041 0 14.84788 16.54661 17.6267 16.88062 18.10743 0 17.48413 16.51533 0 16.4055 16.38985 15.57466 16.95413 17.59779 15.82127 16.26121 16.95513 16.7228 0 16.37367 Q6MZQ0 PRR5L_HUMAN "Proline-rich protein 5-like (Protein observed with Rictor-2, Protor-2)" PRR5L PROTOR2 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203] TORC2 complex [GO:0031932] TORC2 complex [GO:0031932]; ubiquitin protein ligase binding [GO:0031625]; cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203] ubiquitin protein ligase binding [GO:0031625] GO:0001933; GO:0001934; GO:0009968; GO:0010762; GO:0014068; GO:0031625; GO:0031932; GO:0034599; GO:0038203; GO:0061014; GO:0090316 CLLLPPSFPPPHR 14.81000042 0.012079632 0.012079632 0.539260309 1531.518071 0 0 0 0 0 0 0 0 17.06806 0 0 0 0 0 0 18.6974 0 0 0 0 0 0 0 0 0 0 17.26172 0 0 0 0 0 20.35211 0 0 0 0 0 0 18.44212 18.32572 18.73615 0 0 0 18.22297 18.0437 0 Q6MZT1 R7BP_HUMAN Regulator of G-protein signaling 7-binding protein (R7 family-binding protein) RGS7BP R7BP Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078] anchored component of postsynaptic density membrane [GO:0099031]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794] anchored component of postsynaptic density membrane [GO:0099031]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078] GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0030424; GO:0043005; GO:0043198; GO:0043204; GO:0044327; GO:0060078; GO:0098794; GO:0098978; GO:0099026; GO:0099031 MSSAPNGRK 3.940000057 1 1 0.132937789 946.3089005 13.13955 13.25656 13.7153 14.30231 14.12762 13.67084 0 0 0 0 0 0 14.18556 0 0 14.30237 0 0 0 0 0 0 0 16.9182 0 13.89122 0 0 13.37703 14.18751 14.92966 14.39459 0 0 16.27175 13.31507 0 0 0 0 0 0 0 0 0 0 0 0 Q6MZW2 FSTL4_HUMAN Follistatin-related protein 4 (Follistatin-like protein 4) FSTL4 KIAA1061 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000] extracellular region [GO:0005576]; secretory granule [GO:0030141] extracellular region [GO:0005576]; secretory granule [GO:0030141]; brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000] brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0030141; GO:0030154; GO:0031549; GO:0048403; GO:0048671; GO:0061000 QLSLLANGSELHISSVR 1.00999999 1 1 0.432001616 1824.65204 0 0 0 0 17.70703 0 0 0 0 0 18.34258 0 0 0 0 0 0 0 0 0 0 17.91216 0 0 0 0 0 0 0 0 0 0 19.71649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6MZZ7 CAN13_HUMAN "Calpain-13, EC 3.4.22.- (Calcium-activated neutral proteinase 13, CANP 13)" CAPN13 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; negative regulation of apoptotic process [GO:0043066]; proteolysis [GO:0006508] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0043066 IFLKMPDSDR 10.51000023 1 1 0 1237.032284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6N021 TET2_HUMAN "Methylcytosine dioxygenase TET2, EC 1.14.11.n2" TET2 KIAA1546 Nbla00191 Homo sapiens (Human) 5-methylcytosine catabolic process [GO:0006211]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; histone H3-K4 trimethylation [GO:0080182]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; response to organic cyclic compound [GO:0014070] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; histone H3-K4 trimethylation [GO:0080182]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; response to organic cyclic compound [GO:0014070] DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270] GO:0002521; GO:0003677; GO:0005634; GO:0006211; GO:0006325; GO:0006493; GO:0007049; GO:0008198; GO:0008270; GO:0014070; GO:0030099; GO:0035511; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182 TMSVTTDSTVTTSPYAFTR 13.65999985 1 1 0.06713109 2080.801954 15.66148 14.8192 0 14.25321 0 13.35669 0 0 12.76172 13.57224 11.92153 0 13.6555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.08993 0 0 12.8292 0 0 0 0 0 0 0 0 16.4484 0 15.47129 0 0 Q6N043 Z280D_HUMAN Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 SKVNTALR 7.880000114 1 1 0.239359277 888.9243627 0 0 15.39544 0 0 0 0 0 0 10.1827 17.0503 14.10633 0 0 0 15.68763 0 13.24211 0 0 0 0 0 0 0 0 0 14.82736 12.88939 14.89588 0 0 0 0 0 0 0 0 0 0 0 0 12.94251 0 0 0 15.20446 0 Q6NS38 ALKB2_HUMAN "DNA oxidative demethylase ALKBH2, EC 1.14.11.33 (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1)" ALKBH2 ABH2 Homo sapiens (Human) DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511] cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516] GO:0005654; GO:0006307; GO:0008198; GO:0035511; GO:0035516; GO:0043734; GO:0051747; GO:0070989; GO:0080111 DRFLVK 4.239999771 1 1 0.109203239 778.090638 13.5187 15.64011 0 0 14.29749 12.75667 14.99961 0 15.25354 0 0 15.09325 0 0 0 0 0 0 14.24317 0 0 0 0 0 15.68434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSI3 FA53A_HUMAN Protein FAM53A (Dorsal neural-tube nuclear protein) FAM53A Homo sapiens (Human) protein import into nucleus [GO:0006606] nucleus [GO:0005634] nucleus [GO:0005634]; protein import into nucleus [GO:0006606] GO:0005634; GO:0006606 MVTLITEK 9.930000305 0.964940071 0.964940071 0.282195263 951.1888347 17.02522 16.13771 17.16081 18.11317 16.3731 0 16.73918 18.00137 0 18.70007 17.31473 18.19193 17.00075 0 16.71021 0 0 0 17.69619 0 17.12948 0 16.88624 0 17.67247 0 0 17.47775 0 16.96056 0 17.96928 0 0 18.12586 0 0 0 18.75824 16.48268 0 0 0 16.92521 16.49088 0 16.08024 0 Q6NSI4 RADX_HUMAN "RPA-related protein RADX (RPA-related and RAD51-antagonist, X-chromosome)" RADX CXorf57 Homo sapiens (Human) negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282] nuclear speck [GO:0016607]; replication fork [GO:0005657] nuclear speck [GO:0016607]; replication fork [GO:0005657]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282] RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0003697; GO:0003723; GO:0005657; GO:0006282; GO:0016607; GO:2000042 RAGSQGPR 11.47999954 1 1 0.043187901 825.5514086 0 13.47308 13.43731 12.70475 14.69505 12.79343 12.93127 15.10552 15.05499 15.4948 15.62875 15.05287 0 0 13.15569 0 14.73857 0 15.39497 0 14.48646 0 15.19298 14.53168 13.74601 12.8612 15.5481 15.2239 13.81772 14.98805 0 0 0 0 0 0 0 15.75438 0 0 15.05236 0 0 0 0 0 13.35763 0 Q6NSJ0 MYORG_HUMAN "Myogenesis-regulating glycosidase, EC 3.2.1.- (Uncharacterized family 31 glucosidase KIAA1161)" MYORG KIAA1161 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]" "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897 AAAPELSYR 8.539999962 1 1 0.174529705 977.3828751 15.27143 15.13913 14.8625 0 17.40555 14.05175 10.44374 0 13.89384 14.88959 0 0 0 0 15.35828 0 13.9646 15.94484 15.55178 0 0 0 0 0 15.27462 0 0 0 0 0 0 0 14.72622 0 0 15.51964 0 0 0 0 0 0 0 14.43136 0 0 0 0 Q6NSJ5 LRC8E_HUMAN Volume-regulated anion channel subunit LRRC8E (Leucine-rich repeat-containing protein 8E) LRRC8E Homo sapiens (Human) anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361] cytoplasm [GO:0005737]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361] volume-sensitive anion channel activity [GO:0005225] GO:0005225; GO:0005737; GO:0005886; GO:0005887; GO:0006884; GO:0015810; GO:0030176; GO:0034702; GO:0071470; GO:0098656; GO:0140361; GO:1905103 AATLESLR 13.26000023 0.54183048 0.54183048 0.248723778 858.2325325 14.92441 16.86854 15.9427 16.11834 16.21099 0 14.88661 0 0 0 14.9709 14.10054 14.72518 12.75568 13.39204 14.05565 14.91448 15.17831 17.37673 16.09931 16.06584 15.73621 15.48752 0 15.99838 14.61873 17.19801 18.03503 16.24772 14.87993 12.13565 16.78436 14.5495 14.37533 14.42643 15.68952 13.92115 16.32668 0 0 0 0 15.70108 0 0 15.10824 15.96461 15.95244 Q6NSW5 DE10B_HUMAN Putative DENN domain-containing protein 10 B (DENND10 pseudogene 1) (Putative protein FAM45B) DENND10P1 FAM45 FAM45BP HT011 Homo sapiens (Human) protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641] late endosome [GO:0005770] late endosome [GO:0005770]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0005085; GO:0005770; GO:0015031; GO:0031267; GO:2000641 AAAELADTQLMLGVGLIEK 15.02000046 1 1 0.376978672 1958.826185 14.3877 0 11.62118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSW7 NANP8_HUMAN Homeobox protein NANOGP8 NANOGP8 Homo sapiens (Human) positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357] intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0043231; GO:1902808 QPTSAENSVAK 2.779999971 1 1 0.184504712 1129.871703 0 16.58748 15.14763 0 0 0 15.19127 14.91145 14.38996 0 0 0 0 14.86098 0 0 13.72155 0 0 0 0 0 0 15.76202 0 0 0 0 13.21245 14.88235 15.80119 0 0 0 0 15.56312 0 15.18394 15.88696 0 11.12362 0 14.73688 0 0 12.06115 0 0 Q6NSZ9 ZSC25_HUMAN Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498) ZSCAN25 ZNF498 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 LKEHPEMAEAPQQQLGIPVVK 9.010000229 0.939745903 0.939745903 0.233553194 2341.49301 0 0 0 0 0 13.74198 0 0 14.17185 0 17.62578 0 0 0 0 0 13.75655 0 15.90923 0 0 0 15.12187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.75866 0 0 0 0 0 0 0 0 19.56022 0 Q6NT04 TIGD7_HUMAN Tigger transposable element-derived protein 7 TIGD7 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] DNA binding [GO:0003677] GO:0003677; GO:0005634 DICLPGK 15.73999977 1 1 0.142390437 802.9364439 0 0 0 16.25271 0 15.75461 0 0 0 14.26962 0 0 0 0 0 14.80013 15.00405 0 0 0 0 0 17.55302 0 0 0 0 16.44409 0 0 0 0 16.70114 0 16.25813 0 0 17.06128 15.46001 0 0 0 15.95483 18.68639 18.14326 0 0 0 Q6NT55 CP4FN_HUMAN "Ultra-long-chain fatty acid omega-hydroxylase, EC 1.14.14.177 (Cytochrome P450 4F22)" CYP4F22 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690]" "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016021; GO:0016705; GO:0020037; GO:0046513 CVFSYNSNCQEK 4.909999847 1 1 0.373836051 1535.234455 0 0 13.06747 0 0 16.27856 15.55341 0 0 0 0 13.91397 15.78512 12.35159 15.35566 0 0 15.36892 14.54531 0 16.94625 17.25945 17.41418 16.99784 0 0 0 0 0 0 0 13.37553 15.35636 0 15.93163 15.93729 16.08143 0 16.27205 15.46485 15.65194 14.12193 15.09342 15.71104 0 0 0 14.49259 Q6NTE8 MRNIP_HUMAN MRN complex-interacting protein (MRN-interacting protein) MRNIP C5orf45 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032 KSSHVDSEQPR 9.390000343 0.174714312 0.174714312 0.184681196 1266.0731 14.32131 15.28862 15.05749 15.13815 0 14.55599 0 16.04017 17.65603 13.41455 15.81935 15.73889 0 0 0 0 15.48848 0 0 0 0 0 0 0 16.8242 0 17.45811 16.33497 0 0 0 0 0 0 0 0 0 18.38881 0 0 0 0 17.23311 0 17.07364 17.92846 18.60773 18.06542 Q6NUI2 GPAT2_HUMAN "Glycerol-3-phosphate acyltransferase 2, mitochondrial, GPAT-2, EC 2.3.1.15 (1-acylglycerol-3-phosphate O-acyltransferase GPAT2, EC 2.3.1.51) (xGPAT1)" GPAT2 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; piRNA biosynthetic process [GO:1990511]; triglyceride biosynthetic process [GO:0019432] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; piRNA biosynthetic process [GO:1990511]; triglyceride biosynthetic process [GO:0019432] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420] GO:0003841; GO:0004366; GO:0005739; GO:0005741; GO:0006072; GO:0006631; GO:0006654; GO:0008654; GO:0016021; GO:0016024; GO:0019432; GO:0031966; GO:0102420; GO:1990511 LAISAVWTFR 8.550000191 1 1 0.452846432 1163.86673 0 13.21164 0 0 0 0 0 0 18.55483 0 0 0 16.63918 0 0 0 18.40037 0 0 0 16.20931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.596 0 0 0 0 16.7695 17.39846 16.90146 0 17.88724 0 0 Q6NUI6 CHADL_HUMAN Chondroadherin-like protein CHADL SLRR4B Homo sapiens (Human) negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021] GO:0005518; GO:0005615; GO:0030021; GO:0031012; GO:0032331; GO:0062023; GO:0098633; GO:1904027 LDLQGNLLK 17.04999924 0.311291307 0.311291307 0.14140759 1012.461036 17.18458 15.0663 16.3662 16.16453 0 0 0 0 0 0 12.40299 0 0 0 11.09169 0 0 0 12.23745 0 0 0 0 15.57859 0 0 17.10555 0 0 0 14.20447 18.15797 17.54192 14.42878 0 17.10947 0 15.53871 0 0 0 16.15809 0 0 12.7701 0 0 0 Q6NUK1 SCMC1_HUMAN Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) SLC25A24 APC1 MCSC1 SCAMC1 Homo sapiens (Human) ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941] ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0010941; GO:0015867; GO:0016021; GO:0034599; GO:0071277 TGQYSGIYDCAKK 2.950000048 1 1 0.358980081 1492.661475 15.30165 13.39377 0 0 15.06415 7.770059 0 0 0 0 0 15.62975 0 0 0 0 0 0 14.94516 0 15.29583 0 16.27657 0 0 0 0 0 13.27368 0 15.33849 0 0 12.84288 0 0 0 0 0 16.12141 0 0 0 0 0 0 0 16.21897 Q6NUK4 REEP3_HUMAN Receptor expression-enhancing protein 3 REEP3 C10orf74 Homo sapiens (Human) cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule binding [GO:0008017]; cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998] microtubule binding [GO:0008017] GO:0005789; GO:0005881; GO:0006998; GO:0007084; GO:0008017; GO:0016020; GO:0016021; GO:0051301; GO:0071782; GO:0071786 MVSWMISRAVVLVFGMLYPAYYSYK 4.75 1 1 0.817608201 2990.942041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUN0 ACSM5_HUMAN "Acyl-coenzyme A synthetase ACSM5, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 5)" ACSM5 MACS3 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872] GO:0004321; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0031956; GO:0046872; GO:0047760 HLVLQALRNSR 20.98999977 1 1 0.29112758 1302.536164 0 0 0 0 0 0 0 0 0 0 20.25207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.47415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUQ1 RINT1_HUMAN "RAD50-interacting protein 1 (RAD50 interactor 1, HsRINT-1, RINT-1)" RINT1 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] "cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939 IFWQMLVEK 5.369999886 1 1 0 1192.699776 0 11.38133 9.662509 14.52969 0 0 0 13.7467 0 13.65044 8.118926 14.8882 14.19495 0 9.9596 0 0 0 0 0 0 0 0 0 0 0 16.70033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.32892 0 0 0 Q6NV74 CRCDL_HUMAN CRACD-like protein CRACDL C2orf55 KIAA1211L Homo sapiens (Human) AASPAGPR 6.71999979 0.240788519 0.240788519 0.301373547 726.9367431 14.53765 13.35359 15.45341 16.01474 16.11207 15.50838 14.36365 0 0 15.55581 15.40521 15.83615 15.3593 15.37549 15.36205 13.6639 14.52873 15.55078 0 15.04452 14.75359 15.55445 15.34794 12.98921 15.82686 13.86798 0 16.08762 14.86381 0 0 15.68899 0 15.70545 0 0 15.53758 0 0 0 16.59231 15.8488 17.18626 0 16.32989 17.04379 16.46153 15.03923 Q6NVU6 UFSP1_HUMAN "Inactive Ufm1-specific protease 1, UfSP1" UFSP1 Homo sapiens (Human) MGDKPPGFR 14.65999985 1 1 0.178710872 1004.237064 13.03438 16.3611 15.08659 13.55547 12.65564 14.19839 16.92614 12.16015 0 0 16.04837 17.58771 14.73434 15.74691 15.41908 14.96101 0 12.06005 17.60576 0 15.68827 15.98179 16.68833 16.62053 19.4167 0 15.72878 0 0 0 18.0593 12.81955 0 17.12776 14.98695 0 16.2807 15.56873 17.05258 0 0 14.56658 13.20029 13.69598 16.00452 0 18.52205 8.133441 Q6NVY1 HIBCH_HUMAN "3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, EC 3.1.2.4 (3-hydroxyisobutyryl-coenzyme A hydrolase, HIB-CoA hydrolase, HIBYL-CoA-H)" HIBCH Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574] 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860] GO:0003860; GO:0005739; GO:0005759; GO:0006574; GO:0009083 QLMEGSSKTLQEVLTMEYR 2.299999952 1 1 2.75E-12 2264.060729 12.67769 12.31408 0 0 0 9.028734 0 0 0 12.80045 15.89683 0 0 0 0 13.86214 0 0 0 0 0 0 0 13.17573 0 11.14414 0 0 0 0 0 0 0 0 0 0 10.8616 0 0 0 9.373373 12.05435 0 0 0 0 0 0 Q6NW34 NEPRO_HUMAN Nucleolus and neural progenitor protein NEPRO C3orf17 Homo sapiens (Human) negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747] nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747] GO:0005634; GO:0005730; GO:0045665; GO:0045747 SATDTSAK 5.409999847 1 1 0.096820897 778.5302192 0 0 0 0 0 0 0 0 0 0 0 0 17.77209 0 0 0 0 0 0 0 0 18.49545 0 16.22717 0 0 12.31241 0 17.35779 16.80163 0 16.32689 0 16.861 0 0 0 17.42529 17.62488 0 0 0 0 0 0 16.57073 0 0 Q6NWY9 PR40B_HUMAN Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C) PRPF40B HYPC Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005685; GO:0016607; GO:0045292; GO:0071004 AAALDAGNIK 4.079999924 1 1 3.46E-13 938.3479287 15.86613 0 0 0 15.20793 0 0 0 0 0 0 0 0 0 0 14.00374 0 0 0 0 0 0 14.60703 0 0 0 11.75462 0 0 0 0 0 0 0 0 12.29759 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXE6 ARMC6_HUMAN Armadillo repeat-containing protein 6 ARMC6 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] cytosol [GO:0005829] cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244; GO:0005829 AGVLPLLTGAITHHGHHTDVVR 12.64000034 0.405379534 0.405379534 0.050392472 2297.527731 0 0 0 0 0 0 0 0 0 0 0 0 0 14.19358 10.11527 11.90915 0 13.60531 10.26345 0 0 0 0 0 15.66743 13.67618 12.23563 13.10507 15.52539 0 12.28493 13.9821 0 0 0 14.91636 12.42031 0 0 0 14.26807 0 0 0 0 0 0 0 Q6NXG1 ESRP1_HUMAN Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A) ESRP1 RBM35A Homo sapiens (Human) mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016604; GO:0042669; GO:0043484; GO:1990904 NGEALVR 3.589999914 1 1 0.33627627 757.2647363 0 17.16591 13.9744 15.46792 0 0 16.56918 0 0 15.87705 17.39516 0 16.43188 16.37906 16.20143 16.78686 16.55127 16.67324 16.72252 17.93727 17.6415 17.21863 17.22798 15.22198 16.51579 16.85548 16.95184 16.54867 17.28171 16.80861 15.16996 16.50672 17.07208 17.26165 16.17767 15.49609 17.36241 17.19347 17.43064 16.49109 17.44729 16.83901 17.43944 16.15374 17.41414 17.23875 18.07078 17.60279 Q6NXP0 EFC12_HUMAN EF-hand calcium-binding domain-containing protein 12 EFCAB12 C3orf25 Homo sapiens (Human) calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509 IIMVPR 5.400000095 1 1 0.299049973 744.1020184 0 0 0 0 0 0 17.62666 0 0 0 0 0 0 0 0 17.97645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.90785 0 0 18.51917 0 0 0 20.6315 0 19.23901 0 19.62309 17.26878 17.58227 18.75226 0 0 0 Q6NXP6 NXRD1_HUMAN "NADP-dependent oxidoreductase domain-containing protein 1, EC 1.-.-.- (Pyrroline-5-carboxylate reductase-like protein C14orf148)" NOXRED1 C14orf148 Homo sapiens (Human) L-proline biosynthetic process [GO:0055129] pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129] pyrroline-5-carboxylate reductase activity [GO:0004735] GO:0004735; GO:0055129 AYGKNLSQERPFPWFDLTAVQLK 5.809999943 1 1 4.57E-12 2708.733232 13.81406 0 15.18261 16.65239 14.48257 12.67904 11.34123 0 15.98982 15.40819 15.33317 0 0 9.809332 0 14.72719 0 15.56845 0 16.44144 13.93113 0 13.25091 0 14.10491 13.83836 0 0 0 14.11438 0 13.5033 0 0 0 0 0 0 0 13.18455 16.31248 0 14.83514 15.88165 14.10684 0 0 15.03283 Q6NXR4 TTI2_HUMAN TELO2-interacting protein 2 TTI2 C8orf41 Homo sapiens (Human) positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821] ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TTT complex [GO:0110078] ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TTT complex [GO:0110078]; positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821] GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0050821; GO:0070209; GO:0110078; GO:2000003 VKGLLAK 1.129999995 1 1 0.032512795 727.6363886 0 0 0 0 0 0 0 0 0 18.49818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.40177 0 0 0 0 Q6NXT1 ANR54_HUMAN Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein) ANKRD54 LIAR Homo sapiens (Human) nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859] protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531 ASGGAQSPLR 7.809999943 1 1 0.177291945 944.5036118 13.69717 0 13.28151 0 14.81832 12.29329 14.86117 14.30262 0 0 0 14.54748 15.09451 0 16.35418 15.45696 14.28456 15.04063 0 16.01893 14.74439 16.54314 16.22153 14.1804 0 0 15.13049 13.99303 13.70923 14.34949 16.29012 17.07398 15.11365 15.65893 15.40396 14.71058 14.34327 15.5432 0 16.26971 14.82348 0 15.59464 14.33813 0 16.16953 15.93159 15.28481 Q6NYC8 PPR18_HUMAN Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18) PPP1R18 HKMT1098 KIAA1949 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; phosphatase binding [GO:0019902] actin binding [GO:0003779]; phosphatase binding [GO:0019902] GO:0003779; GO:0005737; GO:0005856; GO:0019902 ATIPDWKLQLLAR 10.35999966 1 1 0.20930222 1524.721054 15.79148 17.09308 0 13.82893 16.6155 13.49303 0 14.79102 0 0 15.92191 0 0 13.26926 0 14.16137 15.77149 0 0 0 16.83536 0 0 0 14.4168 0 15.4895 0 0 0 13.97055 0 0 0 14.56258 16.47388 15.95647 0 17.76868 0 0 0 0 0 0 0 0 0 Q6NZ67 MZT2B_HUMAN Mitotic-spindle organizing protein 2B (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2B) MZT2B FAM128B MOZART2B Homo sapiens (Human) centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819] GO:0000931; GO:0005654; GO:0005813; GO:0005819; GO:0005829 SSREGSSQR 5.420000076 0.603614986 0.603614986 0.252911082 992.9695922 15.12062 14.11254 0 14.42779 0 0 16.82159 0 0 14.99754 0 0 17.39615 0 0 14.89611 16.11301 0 0 16.25649 17.92226 0 0 0 15.99431 14.57907 16.07697 15.84489 15.31512 15.04615 16.15604 14.00523 14.71394 16.30681 15.49926 13.03743 14.11432 16.19969 14.97153 15.72086 15.28393 14.14019 15.88059 13.68997 17.65189 15.28664 16.31644 16.33587 Q6NZI2 CAVN1_HUMAN Caveolae-associated protein 1 (Cavin-1) (Polymerase I and transcript release factor) CAVIN1 PTRF FKSG13 Homo sapiens (Human) positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005901; GO:0006361; GO:0006363; GO:0009303; GO:0009306; GO:0032991; GO:0042134; GO:0042802; GO:0043231; GO:0045121; GO:2000147 VSVNVK 1.960000038 1 1 0.153648828 641.5303798 15.36792 16.11559 0 0 0 16.24932 16.53407 16.45682 0 0 0 0 0 0 0 0 0 0 17.69531 16.88408 0 16.68903 0 0 0 0 0 16.00704 0 16.4469 16.44451 0 16.49297 0 17.25447 0 0 0 0 16.13017 0 15.95576 15.85543 0 16.90085 17.28759 0 0 Q6NZY7 BORG3_HUMAN Cdc42 effector protein 5 (Binder of Rho GTPases 3) CDC42EP5 BORG3 CEP5 Homo sapiens (Human) JNK cascade [GO:0007254]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; small GTPase binding [GO:0031267]; JNK cascade [GO:0007254]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] small GTPase binding [GO:0031267] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007254; GO:0007266; GO:0008360; GO:0012505; GO:0016020; GO:0030838; GO:0031267; GO:0031274 RPDRGALSISAPLGDFR 9.470000267 1 1 6.90E-13 1828.823572 0 13.02702 13.69562 0 0 0 0 0 0 0 0 0 11.69364 0 0 0 14.43679 0 0 0 0 0 0 15.33301 0 0 15.73265 0 0 0 0 13.93651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P087 RUSD3_HUMAN "Mitochondrial mRNA pseudouridine synthase RPUSD3, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 3)" RPUSD3 Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GO:0000455; GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0009982; GO:0035770; GO:0070131 IQAALK 7 1 1 0.265493993 644.6431003 19.39307 17.86772 17.04242 0 0 17.0484 0 17.41405 19.74829 0 0 0 18.95799 0 0 0 18.8272 17.92151 0 0 17.66746 18.52784 0 0 19.82463 17.78163 0 0 18.32067 16.73155 0 18.52016 19.64355 0 0 0 17.90144 0 18.16357 19.09169 0 0 0 0 19.07573 0 18.20727 0 Q6P093 ADCL2_HUMAN "Arylacetamide deacetylase-like 2, EC 3.1.1.-" AADACL2 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of membrane [GO:0016021] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787] carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787] GO:0005576; GO:0016021; GO:0016787; GO:0052689 YGVDPTR 13.75 0.003120581 0.003120581 0.290810614 805.7248115 18.53893 0 0 0 0 0 0 0 17.25941 0 0 15.87272 17.46617 0 17.89965 0 0 0 0 16.16418 0 0 0 0 0 0 0 0 18.10606 15.88747 19.29062 17.84414 0 0 0 0 21.49607 0 20.64265 0 17.96289 18.2008 0 0 0 0 0 16.92444 Q6P0N0 M18BP_HUMAN "Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog, HsKNL-2) (P243)" MIS18BP1 C14orf106 KIAA1903 KNL2 M18BP1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] "chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]" DNA binding [GO:0003677] GO:0000775; GO:0003677; GO:0005654; GO:0007049; GO:0051301 GKGSQK 10.23999977 1 1 0.244411844 605.2015809 15.66226 13.89662 14.91701 0 0 0 16.57512 0 0 15.0138 14.86053 0 16.12982 0 15.04105 0 0 16.14592 16.36452 17.10524 18.32544 12.89966 16.02746 17.38482 16.12369 16.51731 17.33504 16.15365 0 15.68074 16.61043 0 13.79812 15.19454 16.28327 16.35941 16.24384 16.30084 0 15.6886 16.40807 14.64363 16.64312 17.52464 16.07296 15.15029 14.87531 16.69823 Q6P0Q8 MAST2_HUMAN "Microtubule-associated serine/threonine-protein kinase 2, EC 2.7.11.1" MAST2 KIAA0807 MAST205 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 GKDGQESR 5.429999828 0.854440391 0.854440391 0.07371308 876.7814788 0 11.85334 0 0 0 14.52691 14.40673 13.42608 15.75769 17.71375 0 0 0 0 13.23081 0 13.32947 16.70426 14.25976 17.33435 11.09171 0 14.84153 16.21903 15.53143 16.17827 15.78044 0 0 16.93121 0 15.50363 11.3429 15.44917 12.50717 18.62007 16.21234 15.48479 16.13866 17.31319 12.1408 16.66184 13.62849 0 15.78464 14.48166 17.91773 0 Q6P158 DHX57_HUMAN "Putative ATP-dependent RNA helicase DHX57, EC 3.6.4.13 (DEAH box protein 57)" DHX57 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0046872 GGRSHASK 10.32999992 1 1 0.268653884 798.3368025 18.08296 16.32261 18.00706 17.56958 13.43591 18.5948 0 18.61309 18.73955 0 0 21.13614 15.73111 0 0 0 0 0 17.52464 0 16.35172 18.17257 0 0 17.61765 0 18.9124 19.21701 17.27378 0 0 18.0915 18.21 18.39862 0 18.69701 0 19.56718 0 18.50236 0 18.03054 0 0 0 18.42756 0 18.98572 Q6P161 RM54_HUMAN "39S ribosomal protein L54, mitochondrial, L54mt, MRP-L54 (Mitochondrial large ribosomal subunit protein mL54)" MRPL54 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 KPVMKGAK 24.38999939 0.616825402 0.616825402 5.74E-13 857.5612737 14.31131 15.68402 15.03038 16.40695 0 0 0 14.82394 0 0 0 7.044021 0 0 0 0 0 0 15.34243 15.69201 0 0 15.09363 15.9739 0 0 0 0 0 0 0 0 0 15.03606 14.82392 15.88381 0 0 0 17.00543 0 0 0 0 0 0 0 0 Q6P179 ERAP2_HUMAN "Endoplasmic reticulum aminopeptidase 2, EC 3.4.11.- (Leukocyte-derived arginine aminopeptidase, L-RAP)" ERAP2 LRAP Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] GO:0002250; GO:0002474; GO:0004175; GO:0004177; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0070006 LLDFYEK 13.25 0.701947391 0.701947391 0.242436998 925.0958782 15.51777 15.90729 14.9648 13.92518 15.85505 16.56729 14.84775 14.20742 0 15.94691 18.45436 16.17902 0 16.11036 15.65629 14.75887 15.0748 15.00379 0 0 16.32793 0 15.54771 16.79949 16.49374 16.45798 0 14.35534 0 0 0 17.09378 0 0 15.55413 0 16.91708 16.91208 0 0 15.59917 16.11365 15.87784 16.01125 15.908 15.685 13.1119 15.58556 Q6P1J6 PLB1_HUMAN "Phospholipase B1, membrane-associated, Phospholipase B, hPLB (Lysophospholipase, EC 3.1.1.5) (Phospholipase A2, EC 3.1.1.4) (Phospholipase B/lipase, PLB/LIP) (Triacylglycerol lipase, EC 3.1.1.3)" PLB1 PLB Homo sapiens (Human) diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806] GO:0001523; GO:0004620; GO:0004622; GO:0004623; GO:0004806; GO:0005886; GO:0006644; GO:0016021; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0036151; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:0102545; GO:2000344 HKFENK 6.179999828 0.071385041 0.071385041 0.298100581 800.8982977 0 16.41982 0 17.31685 18.07819 0 0 16.57794 0 0 16.83722 0 17.86428 0 0 0 18.01011 0 0 0 0 0 18.04433 0 19.56863 0 18.79661 0 0 19.69644 19.09291 0 17.50256 19.66542 16.60457 19.30072 17.65773 19.37347 0 0 0 0 16.58516 0 17.35882 0 0 0 Q6P1J9 CDC73_HUMAN Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein) CDC73 C1orf28 HRPT2 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] "Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]" RNA polymerase II complex binding [GO:0000993] GO:0000122; GO:0000781; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134 KTQTPAAQPVPRPVSQARPPPNQK 2.809999943 1 1 3.20E-12 2594.327743 0 0 10.45669 0 0 11.54907 0 0 0 0 0 0 12.99585 0 0 12.78719 0 0 13.21291 0 0 11.745 13.05427 10.03175 0 0 13.1814 10.26729 11.23758 0 0 13.31626 0 8.760623 13.9366 13.28067 13.18525 0 0 0 9.820259 0 0 0 13.79989 0 0 0 Q6P1K8 T2H2L_HUMAN General transcription factor IIH subunit 2-like protein (General transcription factor IIH polypeptide 2-like protein) GTF2H2C; GTF2H2C_2 GTF2H2D Homo sapiens (Human) "nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] "nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" zinc ion binding [GO:0008270] GO:0000439; GO:0005675; GO:0006289; GO:0006351; GO:0006357; GO:0008270; GO:0016607 YCELPVECK 3.920000076 1 1 0.149391792 1197.890906 0 14.21492 14.42708 15.83423 0 0 13.6869 0 11.60786 0 0 0 0 15.13216 13.80298 0 0 0 0 15.36846 0 15.79489 0 0 15.26333 0 0 0 0 0 15.70699 15.54246 14.48605 14.51419 0 14.49483 16.33775 15.71394 0 0 0 16.18745 14.40604 0 0 16.68668 14.83077 14.80701 Q6P1L5 F117B_HUMAN Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) FAM117B ALS2CR13 Homo sapiens (Human) NKVNFIPK 2.680000067 0.609150231 0.609150231 0.193043012 958.6360871 0 16.98396 0 17.02506 0 14.39889 0 16.13132 0 12.94678 14.19747 0 13.26632 12.62458 17.52779 0 0 16.08161 0 0 0 14.94414 0 17.0121 0 0 0 14.3391 15.07069 0 13.39861 15.61961 18.51409 0 14.15614 14.8268 0 0 0 15.30391 16.79897 0 0 0 0 0 0 0 Q6P1M0 S27A4_HUMAN "Long-chain fatty acid transport protein 4, FATP-4, Fatty acid transport protein 4 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4, ACSVL4, EC 6.2.1.-)" SLC27A4 ACSVL4 FATP4 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760]" brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] "brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; activation of GTPase activity [GO:0090630]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760]" arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957] GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0005902; GO:0006631; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043065; GO:0043588; GO:0044381; GO:0044539; GO:0046627; GO:0047676; GO:0062003; GO:0090433; GO:0090434; GO:0090630; GO:0150104; GO:1901480; GO:1990379 AGMAAVASPTGNCDLER 9.770000458 1 1 2.06E-12 1735.053163 15.01466 0 13.39808 0 0 0 0 11.96982 13.95908 0 0 0 11.76621 13.24695 11.76074 13.08778 15.14754 14.00804 0 14.52259 15.40928 13.85719 0 0 7.834656 14.17964 0 0 0 15.57526 11.33706 14.13503 0 14.9279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1M3 L2GL2_HUMAN LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2) LLGL2 Homo sapiens (Human) cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165] GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0008593; GO:0015820; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0043231; GO:0045159; GO:0045197; GO:0050708; GO:0051294; GO:0051301 LKLTALEGSR 6.400000095 1 1 0.18501495 1088.475016 14.06407 0 14.38164 0 0 13.28665 0 0 0 0 0 0 0 0 0 0 0 16.91287 0 17.20753 0 0 0 0 13.37877 0 13.56729 14.71609 0 0 15.28544 0 0 14.64222 0 0 0 0 0 0 15.24683 0 0 0 0 0 0 0 Q6P1M9 ARMX5_HUMAN Armadillo repeat-containing X-linked protein 5 ARMCX5 Homo sapiens (Human) AMPMSR 2.75 1 1 0.227734617 707.0666221 15.34475 15.54433 0 0 0 0 0 15.91865 10.95241 0 0 0 0 0 0 0 0 0 0 0 0 17.1917 0 16.45507 0 0 0 0 0 0 0 16.22651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1N0 C2D1A_HUMAN "Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1, FRE under dual repression-binding protein 1, Freud-1) (Putative NF-kappa-B-activating protein 023N)" CC2D1A AKI1 Homo sapiens (Human) negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]" "cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0006357; GO:0016020; GO:0043123; GO:0045296; GO:0070062; GO:1905381 FEVVHK 1.360000014 1 1 0.249711293 759.7653925 0 0 15.2485 14.95189 15.16839 15.57771 0 0 0 14.73092 13.43133 0 0 14.94155 0 0 0 0 0 0 15.56807 0 0 0 0 0 15.94349 15.76049 0 0 0 14.74129 0 15.49489 0 15.63187 0 0 15.69596 15.32286 0 15.58954 0 0 0 16.21692 16.33505 0 Q6P1N9 TATD1_HUMAN "Deoxyribonuclease TATDN1, EC 3.1.21.- (Hepatocarcinoma high expression protein)" TATDN1 CDA11 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; metal ion binding [GO:0046872] 3'-5'-exodeoxyribonuclease activity [GO:0008296]; metal ion binding [GO:0046872] GO:0005654; GO:0008296; GO:0046872 TEANLEVLK 11.51000023 1 1 0.299239068 1016.924127 0 0 0 15.68417 0 18.0696 0 14.79102 17.18286 14.66697 0 0 15.27442 17.95372 14.27684 15.16137 15.77149 17.38407 0 0 16.25525 0 0 15.63773 17.91701 17.19849 14.39742 14.59255 15.87336 16.68789 13.97055 0 17.87836 0 0 18.47065 0 0 0 16.99565 14.75677 0 0 0 16.57195 0 18.2447 0 Q6P1Q9 MET2B_HUMAN "tRNA N(3)-methylcytidine methyltransferase METTL2B, EC 2.1.1.- (Methyltransferase-like protein 2B)" METTL2B Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488] tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735] GO:0005737; GO:0016427; GO:0030488; GO:0052735 CSSKSLEHK 3.390000105 0.795054972 0.795054972 0.303092417 1076.643899 0 0 0 0 0 0 15.98571 13.22897 14.90743 15.78888 0 0 0 0 0 14.62722 0 0 0 0 16.4163 0 0 0 11.2307 0 0 15.65904 0 0 0 15.71843 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27271 18.98283 0 Q6P1R4 DUS1L_HUMAN "tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like, EC 1.3.1.88 (tRNA-dihydrouridine synthase 1-like)" DUS1L Homo sapiens (Human) flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150] flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150] GO:0017150; GO:0050660 YAKCDQCGNPK 13.64000034 1 1 0.253828918 1340.905214 0 0 14.22403 0 0 0 0 0 0 0 0 0 0 17.26841 0 0 17.36732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.07216 0 0 0 0 0 0 0 0 0 18.14128 0 0 0 0 0 Q6P1W5 CA094_HUMAN Uncharacterized protein C1orf94 C1orf94 Homo sapiens (Human) ADPAVERHHLMEWSPGTK 7.5 1 1 0.160732142 2077.62747 15.19874 0 0 0 0 0 0 0 0 0 0 0 13.37382 0 15.34947 11.2022 0 0 12.39031 14.34535 14.95573 14.47902 12.7764 14.28084 15.34875 0 0 14.1921 13.53719 0 12.12936 12.0599 0 0 11.82444 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1X5 TAF2_HUMAN "Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit, TAF(II)150, TAFII-150, TAFII150)" TAF2 CIF150 TAF2B Homo sapiens (Human) "G2/M transition of mitotic cell cycle [GO:0000086]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976] GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0006468; GO:0014070; GO:0016251; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0051123; GO:0060261 ESTASK 6.5 1 1 0.174855123 622.4225515 0 13.37412 0 15.35801 15.52759 0 16.21599 0 15.67397 13.63521 14.21669 14.0981 0 0 0 17.04239 0 16.22866 0 0 0 15.63189 16.53195 0 17.09948 15.26965 16.67938 0 0 0 15.36385 14.0806 14.64411 0 0 15.67542 16.18037 15.50597 0 0 15.37327 16.64856 0 0 0 0 15.46523 0 Q6P280 ZN529_HUMAN Zinc finger protein 529 ZNF529 KIAA1615 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 VHAQLTR 8.399999619 1 1 0.305124686 823.1513954 16.51592 21.06928 0 0 0 0 0 0 16.0729 18.52922 0 0 0 0 0 0 16.77684 0 16.8935 0 0 18.47875 17.70835 0 0 0 0 0 16.54869 16.97434 19.14706 0 0 0 0 0 0 0 0 0 17.97495 0 0 18.10416 0 0 0 0 Q6P2C8 MED27_HUMAN "Mediator of RNA polymerase II transcription subunit 27 (Cofactor required for Sp1 transcriptional activation subunit 8, CRSP complex subunit 8) (Mediator complex subunit 27) (P37 TRAP/SMCC/PC2 subunit) (Transcriptional coactivator CRSP34)" MED27 CRSP34 CRSP8 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367] core mediator complex [GO:0070847]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151] core mediator complex [GO:0070847]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367] transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630] GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0006357; GO:0006367; GO:0016592; GO:0019827; GO:0032968; GO:0051123; GO:0060261; GO:0061630; GO:0070847 DGMRNK 10.35000038 1 1 0.168549028 720.5570188 14.45335 14.8772 16.41758 15.92192 0 0 0 0 14.54338 0 0 0 0 0 13.88605 16.65244 13.00239 14.01676 0 0 16.65429 0 0 0 0 0 0 15.81995 0 17.7135 15.42232 0 0 15.20651 0 0 0 0 16.86255 15.95826 0 0 0 0 0 0 0 0 Q6P2D0 ZFP1_HUMAN "Zinc finger protein 1 homolog, Zfp-1 (Zinc finger protein 475)" ZFP1 ZNF475 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 ADDQMER 14.96000004 1 1 0.168004068 864.674005 0 13.61394 15.80556 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6333 0 0 0 0 0 0 15.71239 0 0 16.4938 0 16.12882 14.99665 16.88462 0 0 15.66484 0 14.08342 0 15.65949 13.55381 14.92607 15.78641 0 0 0 0 0 0 0 Q6P2H3 CEP85_HUMAN "Centrosomal protein of 85 kDa, Cep85 (Coiled-coil domain-containing protein 21)" CEP85 CCDC21 Homo sapiens (Human) chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602] GO:0000242; GO:0000922; GO:0005730; GO:0005794; GO:0005813; GO:0005829; GO:0006469; GO:0007059; GO:0046602 QSVEETSGEGPEVEMESWQKR 4.03000021 1 1 0.479876586 2438.554654 12.56683 13.25266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2H8 TMM53_HUMAN Transmembrane protein 53 TMEM53 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 RGCIVIR 5.769999981 0.164215788 0.164215788 0.25846167 871.9908243 16.36 14.56489 15.62003 15.83626 14.98379 11.94598 13.51728 0 0 16.20338 15.14004 0 16.0651 13.89497 15.12491 14.44615 15.59239 0 0 15.81812 12.95192 16.31854 0 0 15.7614 0 0 14.73403 0 0 0 14.53798 0 0 0 0 0 17.6142 0 16.52423 15.26107 0 15.21443 0 15.02783 0 0 0 Q6P2Q9 PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220) PRPF8 PRPC8 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070] GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157 ALHVNNDR 3.470000029 0.208428234 0.208428234 0.087063297 939.0230198 19.8176 13.02574 17.48122 0 16.16026 0 14.39664 0 0 6.461735 9.055608 0 14.33708 15.7252 13.94558 0 0 15.60075 9.72191 0 13.04429 0 15.63296 0 0 0 0 0 17.4236 0 15.98185 17.80664 17.63494 0 16.17952 16.11577 0 15.40359 15.28289 16.66204 13.52701 0 0 0 0 0 17.25414 16.67258 Q6P3S1 DEN1B_HUMAN DENN domain-containing protein 1B (Connecdenn 2) (Protein FAM31B) DENND1B C1orf218 FAM31B Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267] GO:0005085; GO:0005829; GO:0006897; GO:0015031; GO:0016607; GO:0030136; GO:0031267; GO:0032456; GO:0043231; GO:0043547; GO:0050776; GO:0050852; GO:1901981; GO:2000553 KGGALFNTAMTK 15.39000034 0.999265134 0.999265134 0.388868897 1254.866314 18.44925 15.51566 0 0 0 22.08054 17.47045 0 0 17.38152 0 0 19.30884 18.83101 20.82459 0 19.40603 0 19.80889 20.63904 0 20.7459 19.3684 18.19027 20.41587 20.30836 0 17.63655 0 20.93267 0 0 22.31053 0 20.31872 22.17795 21.39582 21.82349 22.26907 0 0 0 0 20.38372 21.42039 0 21.66185 0 Q6P3S6 FBX42_HUMAN F-box only protein 42 (Just one F-box and Kelch domain-containing protein) FBXO42 FBX42 JFK KIAA1332 Homo sapiens (Human) AMSSK 13.31999969 0.007549284 0.007549284 0.271267568 522.890166 16.25674 17.99255 16.21461 0 0 16.05542 16.14415 16.1898 15.64529 0 0 0 15.1367 15.72089 16.54324 0 0 16.17384 14.97789 16.11402 16.06726 16.13982 14.9887 16.81468 16.58999 0 15.3693 15.39418 14.801 16.1656 16.18601 16.40793 16.06931 16.84089 16.09493 0 16.21357 15.90755 16.09893 16.03103 15.30547 0 16.49702 15.41423 16.34809 16.35537 16.18307 16.81773 Q6P3W7 SCYL2_HUMAN SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa) SCYL2 CVAK104 KIAA1360 Homo sapiens (Human) brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102] GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0090090; GO:2000286; GO:2000370 LKSQQPLKPQVHTPVATVK 2.519999981 1 1 4.59E-13 2100.208866 12.9311 13.51503 9.54168 0 0 0 13.95093 0 0 0 15.46684 0 0 0 0 13.54861 0 13.88407 0 0 0 0 0 0 0 13.81995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.84756 0 0 0 Q6P3X3 TTC27_HUMAN "Tetratricopeptide repeat protein 27, TPR repeat protein 27" TTC27 Homo sapiens (Human) MWTPELAILR 6.179999828 0.714890897 0.714890897 0.246965343 1246.762076 17.04455 16.42047 0 16.40164 15.13954 0 13.85839 15.1793 0 14.45041 0 0 15.56466 16.03804 0 0 0 15.17559 0 0 0 0 13.42023 0 16.03263 0 0 0 14.80499 0 0 14.89474 0 0 0 0 16.03844 15.80833 0 15.38877 0 0 0 0 0 0 0 0 Q6P3X8 PGBD2_HUMAN PiggyBac transposable element-derived protein 2 PGBD2 Homo sapiens (Human) sequence-specific DNA binding [GO:0043565] sequence-specific DNA binding [GO:0043565] GO:0043565 VFTSVKLMSILR 4.730000019 1 1 0.145881934 1394.38047 15.43136 0 0 0 15.59992 0 0 0 0 0 0 12.75685 0 16.59694 0 14.16627 0 0 14.56851 15.58792 0 0 0 14.88447 0 0 15.17225 0 12.80507 0 14.47759 0 14.49318 0 0 16.07975 0 0 0 14.91773 0 0 15.0322 0 0 0 16.15107 0 Q6P444 MTFR2_HUMAN Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1) MTFR2 DUFD1 FAM54A Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] GO:0000266; GO:0005739; GO:0007005; GO:0009060 EEMVNTK 7.5 1 1 0.112343748 864.7319967 0 0 0 0 0 15.4162 0 0 0 0 16.11494 0 0 0 0 0 0 15.47124 0 0 0 0 16.92764 14.61972 0 0 15.42222 0 0 0 16.1965 0 18.03753 0 0 0 0 0 17.06904 0 0 0 0 0 0 0 0 0 Q6P4A7 SFXN4_HUMAN Sideroflexin-4 (Breast cancer resistance marker 1) SFXN4 BCRM1 Homo sapiens (Human) amino acid transport [GO:0006865]; mitochondrial transmembrane transport [GO:1990542] integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; mitochondrial transmembrane transport [GO:1990542] ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857] GO:0005654; GO:0005739; GO:0006865; GO:0015075; GO:0022857; GO:0031305; GO:0043231; GO:1990542 AVRETLASR 14.39999962 0.677349508 0.677349508 0.257565448 1002.481184 0 16.91375 14.95092 15.33064 15.83458 16.05773 16.83464 16.08006 0 16.70286 16.38268 16.54732 13.68171 15.58064 15.51468 14.40747 0 15.97488 16.25968 0 0 0 15.00886 0 0 16.01112 0 0 0 0 16.33345 16.02202 15.56141 0 0 0 15.4381 16.38797 0 14.93042 15.85259 0 0 15.235 0 14.49541 15.70409 0 Q6P4A8 PLBL1_HUMAN "Phospholipase B-like 1, EC 3.1.1.- (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C ]" PLBD1 Homo sapiens (Human) phospholipid catabolic process [GO:0009395] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; phospholipase activity [GO:0004620]; phospholipid catabolic process [GO:0009395] phospholipase activity [GO:0004620] GO:0004620; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0009395 GDPCNTICCREDLNSPNPSPGGCYDTK 8.68999958 1 1 0.079756107 3083.728343 0 12.33721 0 15.54117 11.49431 12.50553 0 12.42422 0 14.10303 13.8857 0 15.71316 13.87492 14.06709 15.00214 15.17431 0 13.21816 0 12.40508 0 0 0 0 0 0 0 0 0 0 17.01513 0 0 14.73777 0 0 0 0 0 0 14.34119 0 0 0 0 0 0 Q6P4E1 GOLM2_HUMAN "Protein GOLM2 (Cancer susceptibility candidate gene 4 protein, CASC4) (Golgi membrane protein 2)" GOLM2 CASC4 UNQ2573/PRO6308 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] GO:0005794; GO:0016021 QIDQKEADYGR 3.480000019 1 1 4.67E-13 1322.221916 0 0 0 0 0 14.59153 0 0 0 0 0 0 0 0 0 0 0 0 15.56544 16.6241 0 0 0 0 0 0 0 0 0 0 0 14.46235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P4F2 FDX2_HUMAN "Ferredoxin-2, mitochondrial (Adrenodoxin-like protein) (Ferredoxin-1-like protein)" FDX2 FDX1L Homo sapiens (Human) electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353] iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]" "2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]" GO:0005739; GO:0005759; GO:0009055; GO:0016226; GO:0022900; GO:0046872; GO:0051353; GO:0051537; GO:0140647; GO:1990229 MHVMAASMAR 5.710000038 1 1 0.272354554 1121.916214 14.15375 14.54776 0 14.69911 12.7221 0 12.752 0 15.67697 15.60447 0 16.71317 0 14.54567 0 0 14.63798 14.49555 14.58811 0 0 0 0 0 0 0 0 15.30424 15.64418 15.84877 14.32419 0 0 0 0 0 0 15.24933 0 0 14.59782 0 0 0 14.19177 0 0 0 Q6P4F7 RHGBA_HUMAN Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A) ARHGAP11A KIAA0013 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056 SFLKMR 14.68999958 1 1 3.48E-13 796.359397 14.40692 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01761 0 0 0 0 0 15.99238 17.27534 0 0 0 0 0 0 0 15.75965 16.10215 13.83473 0 15.94472 15.45798 0 0 0 0 0 0 0 0 0 0 0 16.92465 0 Q6P4Q7 CNNM4_HUMAN Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4) CNNM4 ACDP4 KIAA1592 Homo sapiens (Human) enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601] magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857] GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0032991; GO:0043231; GO:0050896; GO:0055065; GO:0070166 LMEMLKVTEPYNDLVK 1.570000052 1 1 0.089153202 1922.88537 14.09469 11.77199 12.81483 14.95449 0 0 0 0 12.64894 0 0 0 0 0 0 0 0 0 0 0 14.33772 0 16.57961 0 0 0 0 0 0 0 13.31523 15.33794 0 14.23949 0 0 0 0 0 0 11.87487 0 0 15.34307 0 0 0 0 Q6P4R8 NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G) NFRKB INO80G Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" DNA binding [GO:0003677]; protease binding [GO:0002020] GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0051726; GO:0060382 EWRTQQR 5.989999771 1 1 0.219238376 1003.514368 15.87618 15.06873 17.90745 16.18782 14.81871 15.65324 14.62518 15.17349 13.49354 16.30042 15.96666 15.16127 13.59175 16.28288 13.17648 0 14.82861 0 0 0 16.37984 16.02468 15.45176 0 14.94479 0 0 0 0 0 16.77275 0 0 0 15.02826 14.2797 0 0 0 15.84591 0 0 0 0 15.12255 0 0 14.90406 Q6P575 BGP11_HUMAN Putative inactive beta-glucuronidase protein GUSBP11 (Beta-glucuronidase pseudogene 11) GUSBP11 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]" "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" GO:0004553; GO:0005975 DAVSPR 4.96999979 0.695370913 0.695370913 0.257962973 643.6815489 0 15.80607 16.23515 14.79204 15.26717 0 0 0 0 14.85068 16.84868 14.29342 16.76098 14.86557 15.34047 10.95589 16.56723 14.89872 0 15.74951 0 0 13.97371 0 0 0 16.03617 16.09821 16.55226 15.73324 0 0 16.75786 16.78693 16.09366 15.92111 14.35936 17.09036 0 0 0 15.08644 16.33679 17.06316 15.40169 0 0 0 Q6P582 MZT2A_HUMAN Mitotic-spindle organizing protein 2A (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2A) MZT2A FAM128A MOZART2A Homo sapiens (Human) centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819] GO:0000931; GO:0005654; GO:0005813; GO:0005819; GO:0005829 LPKGGGPGK 17.95000076 0.317417681 0.317417681 0.118016055 807.3587139 17.64289 0 15.79565 15.87453 0 15.82203 17.07387 16.94637 17.06944 0 17.65343 17.22709 15.9389 14.95126 17.40232 14.89406 0 16.83362 16.66141 14.28048 0 15.84107 0 16.75263 16.2425 16.93816 16.95291 0 15.89013 15.86334 0 15.68486 16.24484 0 16.0975 18.01443 16.57544 18.1016 0 16.80447 14.4045 16.87002 16.397 17.27789 17.08366 0 15.98689 17.83003 Q6P587 FAHD1_HUMAN "Acylpyruvase FAHD1, mitochondrial, EC 3.7.1.5 (Fumarylacetoacetate hydrolase domain-containing protein 1, FAH domain-containing protein 1) (Oxaloacetate decarboxylase, OAA decarboxylase, EC 4.1.1.112) (YisK-like protein)" FAHD1 C16orf36 YISKL Homo sapiens (Human) cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948] acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948] GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621 DVQDECKK 5.789999962 0.039389513 0.039389513 0.211061354 1021.229213 15.6744 15.81966 13.92194 12.65668 14.3702 0 0 0 13.30597 0 15.58042 15.17175 14.53292 0 14.84935 15.48195 15.23943 16.02605 15.74277 0 0 0 13.61438 0 0 0 0 17.29308 0 9.694593 0 15.2664 0 0 0 0 13.72607 0 0 15.81177 0 0 0 0 0 0 14.93009 0 Q6P597 KLC3_HUMAN Kinesin light chain 3 (KLC2-like) (kinesin light chain 2) KLC3 KLC2 KLC2L Homo sapiens (Human) axo-dendritic transport [GO:0008088]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] ciliary rootlet [GO:0035253]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005] ciliary rootlet [GO:0035253]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; axo-dendritic transport [GO:0008088]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] kinesin binding [GO:0019894]; microtubule binding [GO:0008017] GO:0005739; GO:0005871; GO:0005874; GO:0007283; GO:0007286; GO:0008017; GO:0008088; GO:0019894; GO:0031514; GO:0035253; GO:0043005; GO:0120317 GEAAAGAAGMK 7.239999771 1 1 0.003788089 929.6941224 14.4395 15.72373 0 0 0 0 0 0 14.14324 0 14.55609 0 0 0 0 0 0 0 0 0 15.57153 0 0 0 14.5576 15.8288 0 0 16.50127 0 0 0 0 0 0 0 0 0 0 15.44027 0 0 14.6054 0 0 0 0 15.88748 Q6P5Q4 LMOD2_HUMAN "Leiomodin-2 (Cardiac leiomodin, C-LMOD) (Leiomodin)" LMOD2 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838]; sarcomere organization [GO:0045214] actin filament [GO:0005884]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865] actin filament [GO:0005884]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838]; sarcomere organization [GO:0045214] actin binding [GO:0003779]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523] GO:0003779; GO:0003785; GO:0005523; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0030016; GO:0030017; GO:0030041; GO:0030239; GO:0030838; GO:0031430; GO:0045010; GO:0045214; GO:0051694 GTPSSSPYVSPR 8.020000458 0.580409288 0.580409288 0.18164943 1236.145836 0 0 14.09577 0 12.45214 0 14.09278 12.65137 12.88671 17.6431 0 11.08877 0 14.40395 0 15.62459 14.29349 0 0 0 0 0 0 0 0 15.72135 0 0 0 0 0 0 0 0 15.24031 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P5S2 LEG1H_HUMAN Protein LEG1 homolog LEG1 C6orf58 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] GO:0005615; GO:0070062 SSFPETMNK 7.320000172 0.423205435 0.423205435 0.120496241 1057.201807 14.3389 0 0 17.8845 11.99424 12.77104 0 0 15.5421 16.59718 0 11.70402 0 0 0 0 0 0 15.67118 14.16585 0 0 14.42134 17.54429 0 7.481563 0 12.06103 0 14.71361 19.05261 18.39206 0 0 17.38736 11.46747 17.63614 14.26339 0 0 16.84514 15.4314 14.97686 0 0 14.06873 17.26704 19.0717 Q6P5Z2 PKN3_HUMAN "Serine/threonine-protein kinase N3, EC 2.7.11.13 (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3)" PKN3 PKNBETA Homo sapiens (Human) epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267] GO:0004672; GO:0004674; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0010631; GO:0018105; GO:0031267; GO:0035556; GO:0048471; GO:0106310 TPLGEEMTPPPKPPR 4.25 1 1 0.19858711 1643.798194 0 11.29179 13.31194 0 15.25006 0 0 16.14466 16.4782 15.84521 14.222 16.72346 9.181613 15.97412 17.57879 0 15.91166 17.21427 11.62016 16.83442 13.6893 0 0 16.39393 12.79108 0 14.04783 0 15.87979 15.03492 0 16.62894 0 0 0 0 0 16.44541 0 0 0 11.35815 0 17.38342 0 12.80181 0 17.02148 Q6P6B1 ERIC5_HUMAN Glutamate-rich protein 5 ERICH5 C8orf47 Homo sapiens (Human) VSEGAETK 15.75 0.380966663 0.380966663 0.227893435 820.4097973 0 0 15.03171 16.09449 16.17031 13.95022 16.09332 16.63471 14.04294 17.09199 0 15.54771 0 15.73212 15.00845 14.41386 15.64938 0 15.59055 14.26736 15.22456 16.0498 15.84828 0 0 0 0 0 0 0 0 0 15.01241 15.59535 16.50237 0 16.60203 17.23109 0 16.48388 15.41086 0 0 16.14655 16.24734 0 0 16.07054 Q6P995 F171B_HUMAN Protein FAM171B FAM171B KIAA1946 NPD019 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 SATLPR 7.21999979 1 1 0.123023738 644.2210472 0 14.80889 0 15.95021 0 0 14.10235 14.64544 12.71568 0 0 15.55686 0 14.21251 0 15.95661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.11833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P996 PDXD1_HUMAN "Pyridoxal-dependent decarboxylase domain-containing protein 1, EC 4.1.1.-" PDXDC1 KIAA0251 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; cadherin binding [GO:0045296]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; carboxylic acid metabolic process [GO:0019752] cadherin binding [GO:0045296]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170] GO:0005794; GO:0016831; GO:0019752; GO:0030170; GO:0043231; GO:0045296 QLVPASGLTVMDLEAEGTCLR 9.619999886 0.355924845 0.355924845 0.185175735 2253.508143 0 14.04737 15.59097 15.04003 15.47309 0 13.86546 0 12.40375 16.30002 16.03227 12.64507 11.20289 0 14.47517 9.872174 0 0 0 0 15.15047 13.90285 15.08623 0 13.34506 0 0 0 14.56748 0 0 0 0 0 0 0 0 15.21577 0 0 14.27346 0 13.06454 12.02293 12.51867 0 0 0 Q6P9A2 GLT18_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 18, EC 2.4.1.41 (Polypeptide GalNAc transferase 18, GalNAc-T18) (Polypeptide GalNAc transferase-like protein 4, GalNAc-T-like protein 4, pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4)" GALNT18 GALNTL4 Homo sapiens (Human) protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0030246; GO:0046872 QEGLIR 3.49000001 1 1 0.048982947 717.6507782 0 0 14.8924 0 0 0 0 0 14.26467 0 0 0 0 0 0 14.51654 0 12.35353 0 0 15.95565 0 0 0 0 15.82483 15.65364 0 13.65745 0 13.70687 14.08557 14.481 15.407 0 14.83626 0 14.02384 0 15.86113 0 15.17276 0 0 15.42805 0 0 0 Q6P9A3 ZN549_HUMAN Zinc finger protein 549 ZNF549 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 VHITEEP 18.06999969 0.567886174 0.567886174 0.101198322 823.6404986 16.88754 16.43574 16.84373 15.54505 17.71031 15.16517 15.31541 16.32411 17.31212 19.61145 16.77595 16.98591 16.82496 16.20269 0 15.70348 18.45031 17.81937 16.11653 18.845 17.53468 17.85904 17.67683 0 14.83778 16.50915 18.43143 16.48658 12.83216 14.9036 19.18459 15.7411 15.25734 18.13926 20.04023 17.46164 17.17012 0 16.97584 14.41081 14.36209 13.04478 0 13.59228 0 17.24353 14.57946 0 Q6P9B9 INT5_HUMAN "Integrator complex subunit 5, Int5" INTS5 KIAA1698 Homo sapiens (Human) snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472 VLSCGLK 14.77999973 0.327866137 0.327866137 0.233998413 776.5969715 16.3117 0 0 16.18409 15.31352 0 12.78172 16.78585 16.92399 16.36207 0 15.20728 0 0 16.06999 14.92439 0 0 0 15.83729 15.76133 0 0 15.25792 0 18.09537 0 15.63179 13.30092 15.54463 0 0 0 0 14.94092 0 0 16.42897 0 0 16.57495 0 16.12569 16.15186 0 0 0 15.27345 Q6P9F0 CCD62_HUMAN Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa) CCDC62 Homo sapiens (Human) blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944] estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374] GO:0001835; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0030331; GO:0030374; GO:0045944; GO:0071392 MNPPAAFLAGR 12.53999996 1 1 0.512560818 1144.230429 18.65942 18.44252 18.47938 0 0 17.06423 18.68826 0 0 0 18.79253 0 0 0 0 0 0 0 18.54982 0 18.74824 18.50955 0 0 0 18.0682 0 19.59583 0 0 0 0 0 0 20.47515 0 0 18.85363 0 19.60686 16.77062 0 0 17.26666 0 0 0 18.97723 Q6P9G9 ZN449_HUMAN Zinc finger protein 449 (Zinc finger and SCAN domain-containing protein 19) ZNF449 ZSCAN19 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; spermatogonial cell division [GO:0007284] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogonial cell division [GO:0007284]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007284; GO:0046872; GO:1990837 KSPGEKPHR 11.43999958 1 1 0.186294364 1035.8272 13.45483 13.59764 14.73481 0 0 14.68534 13.49928 0 0 13.85796 16.40115 15.10348 13.61903 0 0 0 15.72771 0 15.79914 0 16.78382 0 0 0 14.85215 15.19061 0 0 14.33723 16.23993 15.91099 0 0 17.23019 0 15.28337 0 0 15.15699 15.81093 0 15.74879 15.62857 15.25381 15.28395 0 15.70386 15.35143 Q6PB30 CSAG1_HUMAN "Putative chondrosarcoma-associated gene 1 protein (Cancer/testis antigen 24.1, CT24.1) (Cancer/testis antigen CSAGE)" CSAG1 CSAGE Homo sapiens (Human) EVPGTK 7.599999905 0.920771658 0.920771658 0.198383641 631.5269265 15.29179 0 17.48828 15.52028 0 0 0 9.013974 0 0 0 15.86712 16.28063 16.74372 0 16.19671 0 16.18108 0 0 17.10216 0 17.17318 0 17.03155 17.22217 16.01464 17.05724 16.90419 0 15.31618 0 0 17.52832 16.54555 17.90378 0 18.84859 18.64092 0 17.95276 0 17.7153 17.66275 17.97791 0 0 17.72596 Q6PCB0 VWA1_HUMAN von Willebrand factor A domain-containing protein 1 VWA1 Homo sapiens (Human) behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; identical protein binding [GO:0042802]; behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198] identical protein binding [GO:0042802] GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0030198; GO:0042802; GO:0048266; GO:0062023; GO:0070062 GSILDAMRPQQLHATEITSSGFR 10.82999992 0.335223109 0.335223109 0.478396404 2532.642159 18.92678 0 0 0 0 0 0 0 0 0 17.09218 0 0 18.11129 0 0 0 0 0 0 0 0 0 0 0 0 0 18.78438 15.56789 18.17287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.07667 0 0 0 Q6PCB8 EMB_HUMAN Embigin EMB Homo sapiens (Human) axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; plasma membrane lactate transport [GO:0035879] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; plasma membrane lactate transport [GO:0035879] cell-cell adhesion mediator activity [GO:0098632] GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0035879; GO:0045202; GO:0070593; GO:0098632 FTIINSKQMGSYSCFFR 9.069999695 1 1 0.093891442 2102.160297 0 0 0 15.99365 15.70294 0 0 0 0 16.00179 0 0 15.81154 0 0 16.19218 16.88913 0 17.47086 0 16.88564 0 0 0 0 0 0 15.32783 0 16.31803 0 0 0 0 0 0 15.94144 0 0 0 0 0 18.08455 0 16.75389 0 0 0 Q6PCD5 RFWD3_HUMAN "E3 ubiquitin-protein ligase RFWD3, EC 2.3.2.27 (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)" RFWD3 RNF201 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212] MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630] GO:0000724; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031052; GO:0031297; GO:0031571; GO:0036297; GO:0046872; GO:0061630; GO:0090734; GO:0097371; GO:2000001 EQMLRK 10.53999996 0.533596277 0.533596277 0.286460103 819.2936529 23.90294 0 18.91689 18.08719 0 0 18.48287 18.23017 18.69993 14.60921 18.10563 0 0 0 17.63368 0 0 0 0 0 0 0 0 0 19.49573 0 0 0 0 0 0 0 19.16706 0 19.24308 18.3825 0 19.55145 19.64716 20.80047 0 19.38449 0 0 17.90512 0 0 0 Q6PCE3 PGM2L_HUMAN "Glucose 1,6-bisphosphate synthase, EC 2.7.1.106 (PMMLP) (Phosphoglucomutase-2-like 1)" PGM2L1 BM32A Homo sapiens (Human) glucose metabolic process [GO:0006006] cytosol [GO:0005829] "cytosol [GO:0005829]; glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]; glucose metabolic process [GO:0006006]" "glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]" GO:0005829; GO:0006006; GO:0016868; GO:0046872; GO:0047933 DVTTGYDSSQPNKK 3.75 1 1 0.529756166 1539.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.66622 0 0 0 0 14.41359 0 0 0 0 0 17.63296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.90467 0 0 Q6PCT2 FXL19_HUMAN F-box/LRR-repeat protein 19 (F-box and leucine-rich repeat protein 19) FBXL19 FBL19 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; histone demethylase activity [GO:0032452]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] histone demethylase activity [GO:0032452]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] GO:0003712; GO:0005829; GO:0006357; GO:0006482; GO:0008270; GO:0019005; GO:0032452; GO:0043161; GO:0045322 EAGNEPPTPRK 5.840000153 0.37096864 0.37096864 0.097131123 1196.135193 12.09365 0 0 0 0 0 0 0 0 16.5827 15.69342 0 14.6438 0 0 12.38143 0 0 0 0 0 0 0 0 15.14701 0 0 0 0 0 9.79639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.92438 0 Q6PEY0 CXB7_HUMAN "Gap junction beta-7 protein (Connexin-25, Cx25)" GJB7 CX25 Homo sapiens (Human) cell-cell signaling [GO:0007267]; transmembrane transport [GO:0055085] connexin complex [GO:0005922]; integral component of membrane [GO:0016021] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; transmembrane transport [GO:0055085] gap junction channel activity [GO:0005243] GO:0005243; GO:0005922; GO:0007267; GO:0016021; GO:0055085 KPQVLSV 3.859999895 0.94654876 0.94654876 0.125533099 769.4740806 0 14.72773 15.37652 0 15.33585 0 15.31925 0 0 0 0 14.82353 0 0 0 0 0 0 16.63897 0 0 0 0 0 0 0 12.37533 0 16.26601 15.36563 16.09115 16.63001 15.84352 0 15.41577 0 16.36528 14.70073 0 0 0 15.44649 0 0 15.80097 14.67956 16.40679 15.237 Q6PF15 KLH35_HUMAN Kelch-like protein 35 KLHL35 Homo sapiens (Human) LLEHVR 3.170000076 1 1 0.172988497 767.3663171 15.21939 0 0 0 0 0 14.2675 0 0 13.95589 0 0 0 14.85553 0 0 15.92819 0 0 15.12836 0 0 0 15.83144 15.14249 0 15.71567 0 0 14.82933 0 0 0 0 0 0 0 16.16349 0 14.25565 13.57495 15.62315 0 14.94725 0 0 0 0 Q6PG37 ZN790_HUMAN Zinc finger protein 790 ZNF790 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 MAHLMMFR 22.73999977 1 1 0.167854109 1036.669649 18.82532 18.88725 18.43911 19.18722 19.1727 19.21227 18.06862 17.8157 18.23406 18.23123 16.98812 20.13183 18.95589 18.78086 18.3388 14.97103 15.47253 17.06332 16.91773 17.77884 16.49544 17.30619 17.47107 17.51807 0 17.43413 15.87036 17.3198 15.24278 18.15973 18.16374 16.54722 16.95093 12.76997 18.34444 16.0411 17.75365 17.32664 17.13474 13.2693 17.09819 15.71696 19.00359 14.15638 17.73519 17.06188 17.27196 17.1767 Q6PGN9 PSRC1_HUMAN Proline/serine-rich coiled-coil protein 1 PSRC1 DDA3 FP3214 Homo sapiens (Human) "cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell growth [GO:0030308]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic spindle organization [GO:0060236]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell growth [GO:0030308]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic spindle organization [GO:0060236]" microtubule binding [GO:0008017] GO:0000922; GO:0001578; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007080; GO:0008017; GO:0015630; GO:0030308; GO:0030496; GO:0031116; GO:0045737; GO:0045893; GO:0051301; GO:0060236 RPSNMKR 6.659999847 0.039006185 0.039006185 0.183623886 901.6813998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.75928 16.18338 0 15.86252 0 0 0 0 16.93434 0 0 15.76765 0 16.33559 0 15.56665 14.602 16.74439 15.2509 0 16.55952 0 0 17.58061 0 14.12185 13.93615 16.68591 0 0 15.16452 12.04549 0 0 Q6PGP7 TTC37_HUMAN "Tetratricopeptide repeat protein 37, TPR repeat protein 37 (SKI3 homolog, Ski3) (Tricho-hepatic-enteric syndrome protein, Thespin)" TTC37 KIAA0372 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]" GO:0000791; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0034427; GO:0055087 AEALIK 1.190000057 1 1 0.031284628 644.4903975 0 0 0 11.68947 16.24188 0 0 0 0 0 0 14.59366 0 0 0 0 0 0 0 0 0 0 0 0 15.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88474 0 0 0 13.40392 0 Q6PHW0 IYD1_HUMAN "Iodotyrosine deiodinase 1, IYD-1, EC 1.21.1.1 (Iodotyrosine dehalogenase 1)" IYD C6orf71 DEHAL1 Homo sapiens (Human) thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570] cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570] FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491] GO:0005654; GO:0005886; GO:0005887; GO:0006570; GO:0010181; GO:0016491; GO:0030659; GO:0042403; GO:0140616 DPDVKHK 6.519999981 1 1 0.144878623 837.7690579 14.46315 0 12.38623 0 15.60988 16.78912 14.27588 0 15.43426 16.11058 14.43423 0 12.80479 14.1431 0 15.40532 0 0 0 0 0 0 0 0 14.72812 0 17.06363 14.07292 15.56638 14.24043 0 0 0 0 0 0 0 0 0 0 0 0 0 13.95677 0 0 13.16403 0 Q6PI47 KCD18_HUMAN BTB/POZ domain-containing protein KCTD18 KCTD18 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 EAGNNVQYIWSYYSVAELK 5.460000038 0.130742982 0.130742982 0.140935255 2236.181888 17.45407 16.35296 0 13.69518 0 16.05844 15.02038 13.80236 0 0 0 0 16.90619 16.07759 11.45117 0 0 0 0 0 0 18.34645 15.54022 15.45873 14.07958 0 0 13.46103 15.40477 11.69769 0 18.01562 15.75778 0 8.468326 0 17.66325 0 0 0 14.23333 0 0 0 0 14.57402 0 16.17422 Q6PI48 SYDM_HUMAN "Aspartate--tRNA ligase, mitochondrial, EC 6.1.1.12 (Aspartyl-tRNA synthetase, AspRS)" DARS2 Homo sapiens (Human) aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039] aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] GO:0000049; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006422; GO:0042803; GO:0043039; GO:0050560; GO:0070145 LRSQMVMK 7.389999866 1 1 9.22E-13 1009.719278 0 0 14.49228 13.12497 11.56961 18.35164 14.93902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PI77 BHLH9_HUMAN "Protein BHLHb9, bHLHb9 (Transcription regulator of 60 kDa, p60TRP)" BHLHB9 KIAA1701 Homo sapiens (Human) learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965] protein homodimerization activity [GO:0042803] GO:0005634; GO:0005737; GO:0007611; GO:0042803; GO:0043524; GO:0050769; GO:0051965; GO:0061003; GO:0070062 AGAER 4.650000095 0.315870196 0.315870196 0.242861284 503.4656959 17.44161 16.1847 0 0 16.8049 16.11167 14.77215 0 16.45865 16.36924 16.15166 15.78334 15.54211 0 0 16.1387 16.1118 16.2281 0 0 0 0 0 16.53245 0 17.18776 0 17.53899 0 16.78585 0 0 0 16.68919 0 17.20903 0 16.95314 0 16.94563 0 16.18961 0 0 15.46448 0 16.68038 0 Q6PI78 TMM65_HUMAN Transmembrane protein 65 TMEM65 Homo sapiens (Human) cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779] integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779] GO:0003231; GO:0005739; GO:0005743; GO:0005886; GO:0014704; GO:0016021; GO:1903779 GLLALAPPGGLPGGPR 1.919999957 1 1 0.486507757 1442.194097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.63572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.66529 0 0 0 0 0 18.03783 0 0 0 0 0 0 0 0 0 0 Q6PI98 IN80C_HUMAN "INO80 complex subunit C (IES6 homolog, hIes6)" INO80C C18orf37 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654] "Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0051726; GO:0060382; GO:0071339 ATSIVP 10.34000015 1 1 0.136870312 584.6499311 17.36497 0 0 0 16.49865 16.55994 0 14.86211 16.27554 0 0 0 0 0 0 0 0 0 0 0 16.37899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIF6 MYO7B_HUMAN Unconventional myosin-VIIb MYO7B Homo sapiens (Human) actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007423; GO:0007605; GO:0015629; GO:0016459; GO:0030050; GO:0030154; GO:0031982; GO:0051015; GO:0090651; GO:1904970 AGNHLFK 3.24000001 1 1 0.276498304 785.7657141 16.77899 18.00566 13.05649 0 17.34338 16.97186 0 17.82016 0 17.91169 0 0 0 17.31824 0 0 18.16058 16.59949 0 0 0 0 17.76906 0 19.26399 17.5144 18.14741 0 0 16.53763 0 0 18.81757 18.51593 0 17.12828 18.74031 19.66612 0 0 18.79366 0 18.34477 16.69201 17.62358 0 17.45109 18.32072 Q6PII3 CC174_HUMAN Coiled-coil domain-containing protein 174 CCDC174 C3orf19 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654 KEMEASGAHR 8.630000114 0.217960984 0.217960984 0.070189563 1114.969479 0 0 15.13138 0 0 0 17.72447 16.71527 12.75495 16.37626 0 10.68019 9.476319 13.67763 13.46715 15.90295 0 0 14.36712 0 13.72859 15.21519 15.65342 0 17.65468 0 17.03137 0 15.83064 17.13752 0 19.04433 15.60602 16.41198 17.73299 0 19.51026 15.29315 15.813 18.19915 16.89874 0 16.66475 0 16.692 15.5581 0 14.72233 Q6PIJ6 FBX38_HUMAN F-box only protein 38 FBXO38 SP329 Homo sapiens (Human) adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0019005; GO:0031146; GO:0070936 AARDIPEK 32.45000076 0.011235616 0.011235616 0.125352485 898.4895042 18.09955 17.04915 20.52061 17.9824 18.70264 18.07162 17.55125 19.54553 18.28521 19.59923 19.56573 14.16041 0 17.55793 19.45147 13.3296 16.04407 17.89807 19.67428 18.40168 17.524 0 15.66848 0 17.83288 16.2431 18.0115 0 16.87898 18.73155 0 15.55435 18.4646 18.67862 18.08057 18.43711 19.12685 17.20353 15.00395 0 18.36672 19.41323 20.13505 19.37761 17.86144 18.78371 19.19921 0 Q6PIL6 KCIP4_HUMAN "Kv channel-interacting protein 4, KChIP4 (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4)" KCNIP4 CALP KCHIP4 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379] calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244] GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0043025; GO:0072659; GO:1901379 QHVETFFQK 14.82999992 1 1 0.551734526 1164.313689 18.65769 0 0 0 0 0 0 0 18.30523 0 0 0 0 20.61697 0 0 0 0 0 0 20.92309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIV2 FOXR1_HUMAN Forkhead box protein R1 (Forkhead box protein N5) FOXR1 FOXN5 DLNB13 Homo sapiens (Human) chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0005634; GO:1990837 LTEEGHR 3.029999971 1 1 0.278990348 841.9530059 12.56236 0 12.31084 17.52958 15.91714 0 16.03274 16.15215 0 14.98078 16.14886 16.64466 15.92947 15.02298 15.06291 15.00749 0 0 0 0 0 0 0 0 0 16.0689 16.83273 16.23371 0 0 16.33741 13.04477 17.29746 0 0 0 0 0 17.17262 15.60137 18.41825 16.37118 16.01385 0 13.62506 0 0 16.53141 Q6PIW4 FIGL1_HUMAN "Fidgetin-like protein 1, EC 3.6.4.-" FIGNL1 Homo sapiens (Human) ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568] GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243 EQLWVDQQK 5.179999828 1 1 0.064901801 1173.78861 12.45952 14.8191 0 0 14.17794 0 0 0 0 0 0 13.9909 0 16.9744 0 0 14.82594 0 0 15.90929 0 0 0 15.10678 0 0 0 0 16.68503 16.02904 17.57464 0 16.85422 0 0 17.83767 17.77756 0 0 0 15.90595 16.73938 0 0 0 17.54741 0 17.71447 Q6PIY5 ARMD1_HUMAN Armadillo-like helical domain containing protein 1 (p40) ARMH1 C1orf228 NCRNA00082 Homo sapiens (Human) GLMAAMGNTDHSNSQR 3.029999971 1 1 4.61E-13 1721.19169 14.84157 12.78883 13.41039 0 0 0 0 15.03708 13.00632 0 0 14.40584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.44187 0 0 0 0 15.55394 0 0 0 0 0 0 16.51567 Q6PJ61 FBX46_HUMAN F-box only protein 46 (F-box only protein 34-like) FBXO46 FBX46 FBXO34L Homo sapiens (Human) ASSMK 2.190000057 0.800792634 0.800792634 0.158607751 523.2187161 16.98425 16.46223 16.07808 17.2168 15.54644 15.66276 16.03934 16.45969 15.73204 16.03123 16.70956 16.95375 15.12517 16.18216 15.78251 15.78802 16.37757 16.11736 16.18729 15.65448 17.4195 0 15.01126 16.69845 15.66224 16.43081 16.44748 16.7792 0 16.69407 0 16.27861 16.37887 17.04463 0 16.0996 15.65586 16.11631 16.20521 16.96226 17.12933 16.53922 15.4605 15.31599 17.50777 16.73816 15.75742 16.00643 Q6PJF5 RHDF2_HUMAN "Inactive rhomboid protein 2, iRhom2 (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6)" RHBDF2 IRHOM2 RHBDL5 RHBDL6 Homo sapiens (Human) negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708] endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; protein transporter activity [GO:0140318]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708] growth factor binding [GO:0019838]; protein transporter activity [GO:0140318] GO:0002862; GO:0005789; GO:0005796; GO:0005886; GO:0015031; GO:0016021; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0140318 SVSLQEPRSR 5.21999979 1 1 0.018110957 1157.643159 16.51575 0 0 0 0 0 0 0 0 17.81683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PJG2 MDEAS_HUMAN Mitotic deacetylase-associated SANT domain protein (ELM2 and SANT domain-containing protein 1) MIDEAS C14orf117 C14orf43 ELMSAN1 Homo sapiens (Human) "histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0003677; GO:0003714; GO:0005654; GO:0005667; GO:0006357; GO:0016575; GO:0045892 LAPNGRER 11.36999989 0.352380633 0.352380633 0.28580623 913.1725872 15.44372 16.11529 0 14.36685 15.77792 13.2745 14.90841 15.34337 13.86734 17.75504 15.66438 15.86611 17.76046 14.93074 16.04636 15.55359 15.38479 17.01236 14.22401 15.47443 15.98705 0 17.05517 0 14.91681 0 13.57354 0 15.07283 15.15633 15.55066 0 16.9238 0 14.31131 0 15.51147 16.03429 0 15.77896 16.86027 16.74172 0 15.4154 16.45422 0 14.9026 15.09242 Q6PJG9 LRFN4_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 4 LRFN4 SALM3 Homo sapiens (Human) regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] GO:0005886; GO:0009986; GO:0098978; GO:0098982; GO:0099061; GO:0099151; GO:0099560; GO:1905606 SHSVHGGLLGAGCR 4.659999847 0.658822536 0.658822536 0.006405524 1408.282368 13.94508 15.1115 11.67058 11.07319 12.98696 14.82718 13.94536 13.89663 13.15124 14.81241 13.25359 15.45047 0 12.79347 16.17117 15.43332 0 0 16.02466 15.13518 15.76379 15.69932 15.44423 0 13.94119 0 13.27759 10.65701 12.91519 14.47989 0 0 0 0 0 0 15.01799 0 0 0 16.53676 15.13552 0 0 16.41298 17.00544 14.87631 14.89186 Q6PJI9 WDR59_HUMAN GATOR complex protein WDR59 (WD repeat-containing protein 59) WDR59 KIAA1923 FP977 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263] GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765] GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263] GO:0005765; GO:0032008; GO:0034198; GO:0061700; GO:1904262; GO:1904263 KPSTAVEYLAAHLSK 6.869999886 1 1 0.452360317 1615.847073 17.10491 0 15.28267 0 0 18.81984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.48164 0 0 0 0 0 0 0 0 20.33094 0 20.94303 0 0 0 20.30991 0 0 0 0 0 0 0 19.14947 18.69966 0 0 Q6PJP8 DCR1A_HUMAN "DNA cross-link repair 1A protein (Beta-lactamase DCLRE1A, EC 3.5.2.6) (SNM1 homolog A, hSNM1, hSNM1A)" DCLRE1A KIAA0086 SNM1 SNM1A Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848] 5'-3' exodeoxyribonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872] GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0008800; GO:0031848; GO:0035312; GO:0036297; GO:0046872; GO:0051301 IADVIPQTK 6.670000076 1 1 0.226747962 983.800423 16.80407 0 17.0913 0 0 14.98386 0 0 0 14.98759 16.21231 0 0 14.54632 0 0 14.68167 0 0 0 15.25625 0 0 14.87174 17.01912 14.71606 15.71015 15.40001 14.99834 0 0 14.61017 0 16.49854 0 0 14.74314 15.3159 15.2579 0 16.19425 15.52013 13.06198 12.69819 0 16.06829 14.50752 0 Q6PJT7 ZC3HE_HUMAN "Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2, MSUT-2) (Renal carcinoma antigen NY-REN-37)" ZC3H14 Homo sapiens (Human) negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488] metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0008143; GO:0016607; GO:0032839; GO:0043488; GO:0046872; GO:1900364; GO:1904115; GO:1990904 RPSLPPSK 10.56000042 0.603862941 0.603862941 0.242250706 882.6234741 18.00555 19.73678 15.95649 20.08429 21.61817 18.42215 18.48806 17.91386 16.7747 0 18.38763 0 16.77231 17.46345 0 18.0442 18.04988 17.26859 0 17.75121 15.49084 18.18966 0 0 0 17.81777 0 0 0 18.48263 18.53748 17.09171 19.81221 0 18.72677 0 20.58224 18.4185 19.76163 18.82887 17.63519 17.53409 20.39337 17.48133 19.26714 0 0 0 Q6PJW8 CNST_HUMAN Consortin CNST C1orf71 Homo sapiens (Human) positive regulation of Golgi to plasma membrane protein transport [GO:0042998] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; connexin binding [GO:0071253]; phosphatase binding [GO:0019902]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] connexin binding [GO:0071253]; phosphatase binding [GO:0019902] GO:0005802; GO:0005886; GO:0016020; GO:0016021; GO:0019902; GO:0030133; GO:0032991; GO:0042998; GO:0043231; GO:0071253 GFNGEDFER 5.25 1 1 0.22696161 1069.250642 14.63341 14.81151 15.54089 16.01972 15.6636 12.63074 0 14.48441 0 0 15.25913 0 15.55631 14.08477 13.51873 0 0 0 16.20398 0 0 17.5656 0 0 16.55671 0 15.32549 0 15.83894 0 15.02376 0 0 0 15.14808 0 15.03483 0 0 17.73476 15.80308 0 0 0 16.17882 0 0 0 Q6PK04 CC137_HUMAN Coiled-coil domain-containing protein 137 CCDC137 cPERP-B Homo sapiens (Human) chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0001650; GO:0003723; GO:0005634; GO:0005694; GO:0005730 KKPEPQL 11.98999977 1 1 1.23E-13 836.2445948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PK81 ZN773_HUMAN Zinc finger protein 773 (Zinc finger protein 419B) ZNF773 ZNF419B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 CNECGRFFSENSSLVK 6.510000229 0.96572417 0.96572417 0.233147504 1934.407354 14.332 0 14.74905 11.98554 13.27036 15.84844 0 0 0 0 0 0 0 0 10.27792 0 16.38576 13.52865 0 0 11.94344 0 0 0 14.08102 15.19138 0 11.59342 15.59876 14.17136 13.54557 15.9095 12.78369 0 13.53925 0 0 0 0 0 0 0 0 10.4079 14.67515 14.83235 0 14.89458 Q6PKC3 TXD11_HUMAN Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1) TXNDC11 EFP1 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 GPMSAVYIEKFVR 4.880000114 1 1 0.286359144 1512.826636 14.6275 14.66459 0 0 0 0 14.17968 0 0 0 0 13.26825 16.82482 0 16.4596 14.18712 0 0 0 15.13152 0 0 15.61888 0 0 0 14.82537 0 0 16.34602 0 0 0 0 0 0 0 0 0 16.25488 0 0 0 0 0 0 0 0 Q6PKG0 LARP1_HUMAN La-related protein 1 (La ribonucleoprotein domain family member 1) LARP1 KIAA0731 LARP Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; posttranscriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; posttranscriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413] cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369] GO:0000339; GO:0000340; GO:0003723; GO:0003730; GO:0005737; GO:0005829; GO:0006413; GO:0008190; GO:0008283; GO:0008494; GO:0010494; GO:0010608; GO:0016020; GO:0016239; GO:0017148; GO:0031369; GO:0031929; GO:0038202; GO:0043024; GO:0045070; GO:0045296; GO:0045727; GO:0045947; GO:0045948; GO:0048027; GO:0048255; GO:0072752; GO:1990928 GEPGPNDVR 4.110000134 1 1 0.203767341 939.9843812 14.03205 15.76805 14.40138 16.10911 15.10096 16.24475 14.93702 16.54195 15.15499 14.36504 14.51851 15.44448 13.65824 15.70326 8.545734 15.51086 14.90542 14.78744 15.7759 14.18288 0 14.72445 0 13.35596 15.21434 0 0 0 0 15.02573 0 0 0 0 0 16.12236 14.53883 0 0 0 0 15.15842 0 0 0 15.26998 0 0 Q6PL18 ATAD2_HUMAN "ATPase family AAA domain-containing protein 2, EC 3.6.1.- (AAA nuclear coregulator cancer-associated protein, ANCCA)" ATAD2 L16 PRO2000 Homo sapiens (Human) "chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393] GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0016887; GO:0042393; GO:0045893; GO:0045944; GO:0070062 SSHKAK 4.099999905 0.449039638 0.449039638 0.196738591 657.2081532 13.67869 13.2136 0 16.76691 15.82677 0 0 13.42228 0 0 15.73015 15.63169 15.73338 0 0 0 0 15.53496 0 0 0 0 16.40352 14.5276 0 0 15.97684 16.76217 15.01244 0 0 0 16.14936 0 15.4889 0 0 15.64647 16.44953 0 0 0 0 14.49775 0 0 0 0 Q6PML9 ZNT9_HUMAN "Zinc transporter 9, ZnT-9 (Human embryonic lung protein, HuEL) (Solute carrier family 30 member 9)" SLC30A9 C4orf1 HUEL Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829] cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374] GO:0003682; GO:0005634; GO:0005783; GO:0005856; GO:0006289; GO:0006829; GO:0006882; GO:0008324; GO:0016021; GO:0016922; GO:0030374; GO:0031410; GO:0045944 AAACNPSDR 2.460000038 1 1 0.203799289 960.8683452 0 14.72114 15.02333 15.07233 15.00917 0 0 15.68822 0 0 0 9.395177 0 14.25661 16.06102 14.15871 16.066 0 0 0 0 0 0 0 0 0 16.99944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47488 0 0 0 Q6PRD1 GP179_HUMAN "Probable G-protein coupled receptor 179 (Probable G-protein coupled receptor 158-like 1, GPR158-like)" GPR179 GPR158L GPR158L1 Homo sapiens (Human) visual perception [GO:0007601] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; visual perception [GO:0007601] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0007601; GO:0016021 AKAAMASLVR 5.909999847 1 1 0.106924264 1034.572833 15.41439 0 0 0 0 13.9463 0 0 0 14.05055 0 0 0 0 0 14.85372 14.9058 0 0 15.46667 17.12968 0 0 0 0 14.23172 16.15512 11.57444 0 0 13.26637 14.27641 9.3755 13.96162 0 14.86615 0 15.07425 0 0 15.09427 0 14.52501 14.8902 14.11029 15.76957 11.58227 15.92076 Q6Q759 SPG17_HUMAN Sperm-associated antigen 17 (Projection protein PF6 homolog) SPAG17 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 VKHYEFYK 6.320000172 0.306501716 0.306501716 0.16138975 1111.712482 13.64581 0 0 15.78431 12.34119 13.28534 16.20596 14.61469 15.17972 13.28509 15.56322 16.67239 0 15.00299 13.63803 11.34801 15.4812 0 0 0 0 0 14.20211 17.57353 14.46624 14.75766 16.33238 0 0 0 0 0 15.02831 0 15.95559 14.5059 0 0 0 0 13.696 0 0 0 0 14.6678 0 0 Q6R2W3 SCND3_HUMAN SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9) ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452 Homo sapiens (Human) DNA integration [GO:0015074]; positive regulation of cell cycle [GO:0045787]; positive regulation of epithelial cell proliferation [GO:0050679] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; positive regulation of cell cycle [GO:0045787]; positive regulation of epithelial cell proliferation [GO:0050679] nucleic acid binding [GO:0003676] GO:0003676; GO:0005634; GO:0005737; GO:0015074; GO:0045787; GO:0050679 KSSELK 3.960000038 1 1 0.215400288 691.0624651 0 16.36621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05085 0 16.88099 0 0 0 0 0 0 0 15.79274 18.46572 0 17.68784 0 0 0 Q6R327 RICTR_HUMAN "Rapamycin-insensitive companion of mTOR (AVO3 homolog, hAVO3)" RICTOR KIAA1999 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of protein kinase B signaling [GO:0051896]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; TORC2 complex [GO:0031932] cytosol [GO:0005829]; TORC2 complex [GO:0031932]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; actin cytoskeleton reorganization [GO:0031532]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of protein kinase B signaling [GO:0051896]; TORC2 signaling [GO:0038203] protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022] GO:0005829; GO:0007010; GO:0009792; GO:0010468; GO:0016310; GO:0018105; GO:0019901; GO:0030307; GO:0030838; GO:0031532; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0033135; GO:0038203; GO:0043022; GO:0043066; GO:0043087; GO:0043539; GO:0050727; GO:0050731; GO:0051896; GO:0051897; GO:2000114 ADVELER 10.07999992 0.000128558 0.000128558 0.320283789 833.0658117 18.52969 17.70075 17.6392 0 0 17.61724 17.47441 0 0 16.58109 0 0 0 16.87232 0 0 0 0 0 0 15.6636 0 0 0 0 0 0 0 17.88622 0 0 0 18.77769 18.77735 0 0 0 0 0 0 0 0 0 0 0 17.4511 0 0 Q6SA08 TSSK4_HUMAN "Testis-specific serine/threonine-protein kinase 4, TSK-4, TSSK-4, Testis-specific kinase 4, EC 2.7.11.1 (Serine/threonine-protein kinase 22E)" TSSK4 C14orf20 STK22E TSSK5 Homo sapiens (Human) fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877] GO:0000287; GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0032793; GO:0035556; GO:0036126; GO:0042803; GO:0044877; GO:0106310; GO:1990443 RATILDIIK 7.590000153 1 1 0.027848458 1041.560261 0 0 15.65549 0 14.96116 15.20503 14.0664 0 14.35847 13.84226 16.63761 16.02676 0 16.74976 0 0 0 0 0 0 13.34047 0 0 15.05154 13.48532 14.93848 0 0 0 0 17.57441 14.21424 16.55251 0 0 0 13.16822 12.5119 0 0 15.16131 0 9.786716 0 15.21587 0 0 13.3646 Q6SJ93 F111B_HUMAN "Serine protease FAM111B, EC 3.4.21.- (Cancer-associated nucleoprotein)" FAM111B CANP Homo sapiens (Human) DNA replication [GO:0006260] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; peptidase activity [GO:0008233]; DNA replication [GO:0006260] peptidase activity [GO:0008233] GO:0000785; GO:0005634; GO:0006260; GO:0008233 DTVMKQTHADTPVDHCLSGIR 3.019999981 0.047762264 0.047762264 0.120325638 2381.817479 14.39164 13.2378 9.662509 0 13.63951 15.9201 0 17.46379 0 15.11577 8.118926 14.55659 13.6961 0 11.14702 0 0 0 12.24814 0 0 0 0 0 0 0 0 13.43902 0 7.780546 14.07915 0 0 0 0 0 12.30994 15.48697 0 12.01926 0 0 0 12.96969 0 0 0 0 Q6SPF0 SAMD1_HUMAN "Sterile alpha motif domain-containing protein 1, SAM domain-containing protein 1 (Atherin)" SAMD1 Homo sapiens (Human) "chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634] "chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle binding [GO:0030169]; chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle binding [GO:0030169] GO:0000122; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0042393; GO:0045892; GO:0051260; GO:0090077; GO:0090308 GPQSAK 7.360000134 1 1 0.124831252 587.3093125 16.17981 14.60601 15.26258 15.42726 14.69845 0 13.722 0 0 0 0 0 15.27333 14.61352 0 15.64447 15.13496 16.90217 0 0 17.07903 0 0 0 0 0 0 0 0 0 0 16.0999 0 16.05155 0 0 0 0 0 0 0 17.17743 0 0 0 0 0 16.92613 Q6STE5 SMRD3_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 (60 kDa BRG-1/Brm-associated factor subunit C) (BRG1-associated factor 60C, BAF60C)" SMARCD3 BAF60C Homo sapiens (Human) "cardiac right ventricle formation [GO:0003219]; chromatin remodeling [GO:0006338]; muscle cell differentiation [GO:0042692]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein binding [GO:0043393]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]" brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]; cardiac right ventricle formation [GO:0003219]; chromatin remodeling [GO:0006338]; muscle cell differentiation [GO:0042692]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein binding [GO:0043393]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]" DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221] GO:0000785; GO:0001221; GO:0002052; GO:0003139; GO:0003219; GO:0003407; GO:0003712; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0016514; GO:0016922; GO:0030071; GO:0030374; GO:0035060; GO:0042692; GO:0043393; GO:0045582; GO:0045597; GO:0045663; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140297; GO:2000045; GO:2000781; GO:2000819 EYINGDK 2.039999962 1 1 0.040306355 838.5757681 16.75098 0 16.11043 14.89139 0 14.18993 14.38838 0 0 0 0 15.8862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84134 0 0 0 0 0 0 14.59944 13.90423 14.73966 0 0 0 0 Q6SZW1 SARM1_HUMAN "NAD(+) hydrolase SARM1, NADase SARM1, hSARM1, EC 3.2.2.6 (NADP(+) hydrolase SARM1, EC 3.2.2.-) (Sterile alpha and Armadillo repeat protein) (Sterile alpha and TIR motif-containing protein 1) (Sterile alpha motif domain-containing protein 2, MyD88-5, SAM domain-containing protein 2) (Tir-1 homolog, HsTIR)" SARM1 KIAA0524 SAMD2 SARM Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165]" "identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]" GO:0003953; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0007165; GO:0007399; GO:0009749; GO:0019677; GO:0030154; GO:0030424; GO:0030425; GO:0031315; GO:0034128; GO:0035591; GO:0042802; GO:0042981; GO:0045087; GO:0045202; GO:0048678; GO:0048814; GO:0050135; GO:0061809; GO:1901214; GO:1901216 EQQVDGDLLLR 1.139999986 1 1 0.055006355 1282.734667 13.31992 0 0 13.39734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.442521 0 0 0 9.789652 0 0 0 0 14.53026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6T4P5 PLPR3_HUMAN "Phospholipid phosphatase-related protein type 3 (Inactive phospholipid phosphatase PLPPR3) (Lipid phosphate phosphatase-related protein type 3) (PAP-2-like protein 2) (Plasticity-related gene 2 protein, PRG-2)" PLPPR3 LPPR3 PHP2 PRG2 Homo sapiens (Human) phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195] GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0042577; GO:0046839 LLQVIAMSK 7.289999962 0.78703618 0.78703618 0.26644696 1017.249539 0 0 14.16791 0 13.82288 14.88469 14.96341 0 15.61074 0 0 16.2712 0 0 14.0531 15.36937 15.20333 14.75271 15.10551 15.02571 14.79708 15.35126 15.60367 15.74625 15.3728 0 0 0 13.70803 0 15.41062 0 15.84033 0 0 14.66353 0 14.15703 0 0 0 15.55664 16.38634 14.14849 0 14.32299 16.68611 15.30923 Q6TFL3 CC171_HUMAN Coiled-coil domain-containing protein 171 CCDC171 C9orf93 Homo sapiens (Human) ADPNSR 13.51000023 0.348925442 0.348925442 0.188052324 658.4736429 0 16.05063 13.75046 15.34412 15.94424 15.6387 15.73528 15.12611 14.93827 15.70742 13.3517 12.89439 15.76871 15.39286 15.80927 13.6036 15.69234 14.0175 0 15.74848 15.10198 16.98292 0 16.34069 17.06963 0 15.89684 16.15975 0 15.6965 15.01184 0 0 16.48273 15.64318 0 15.25791 15.78293 16.01941 0 0 0 15.96101 0 0 16.74394 0 16.53906 Q6TFL4 KLH24_HUMAN "Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6, KRIP6) (Protein DRE1)" KLHL24 DRE1 Homo sapiens (Human) intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312] GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312 AVLSACSSYFR 5.849999905 1 1 0.065444221 1259.536991 0 0 0 0 0 0 13.90827 0 14.51703 0 0 0 0 0 0 0 0 0 0 0 0 0 15.75087 0 13.26993 0 0 0 0 14.1914 15.46624 15.97865 16.10181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6TGC4 PADI6_HUMAN "Protein-arginine deiminase type-6, EC 3.5.3.15 (Peptidyl arginine deiminase-like protein) (Peptidylarginine deiminase VI, hPADVI) (Protein-arginine deiminase type VI)" PADI6 PAD6 Homo sapiens (Human) cytoplasm organization [GO:0007028]; cytoskeleton organization [GO:0007010]; embryonic cleavage [GO:0040016]; histone citrullination [GO:0036414]; regulation of translation by machinery localization [GO:0043143] cortical granule [GO:0060473]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634] cortical granule [GO:0060473]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668]; cytoplasm organization [GO:0007028]; cytoskeleton organization [GO:0007010]; embryonic cleavage [GO:0040016]; histone citrullination [GO:0036414]; regulation of translation by machinery localization [GO:0043143] calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668] GO:0004668; GO:0005509; GO:0005634; GO:0005737; GO:0007010; GO:0007028; GO:0036414; GO:0040016; GO:0043143; GO:0045111; GO:0060473 AMSKTLR 4.679999828 0.230643332 0.230643332 0.236537499 806.7222292 16.6663 0 0 13.42376 16.14215 0 17.4233 0 18.55639 14.52851 18.03776 15.25845 0 16.9331 16.81789 15.09195 16.80938 15.06133 0 0 17.07004 19.14771 18.52409 17.43624 0 0 17.43613 16.65274 16.31135 0 0 0 16.75853 16.05065 17.44545 16.82909 17.02735 0 16.79856 0 0 0 15.06651 0 0 0 16.57891 17.3359 Q6UB35 C1TM_HUMAN "Monofunctional C1-tetrahydrofolate synthase, mitochondrial, EC 6.3.4.3 (Formyltetrahydrofolate synthetase)" MTHFD1L FTHFSDC1 Homo sapiens (Human) 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999] ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803] GO:0001843; GO:0004329; GO:0004488; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006760; GO:0009257; GO:0015942; GO:0016020; GO:0035999; GO:0042803; GO:0048702; GO:0048703 TPAAR 6.239999771 1 1 0.14358802 514.0235824 0 0 0 0 0 0 0 14.70428 12.51123 14.84457 15.67743 0 0 0 0 15.37214 14.54417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.67057 0 0 13.38323 0 0 0 0 0 15.87507 13.35247 14.82849 12.94778 15.37698 Q6UB98 ANR12_HUMAN Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein) ANKRD12 ANCO2 KIAA0874 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 DDKSTK 4.96999979 0.039619911 0.039619911 0.047381796 692.6675478 0 0 15.4997 0 17.39872 10.27106 15.65574 0 17.39233 0 0 12.03685 15.11751 17.68824 15.42719 0 16.75475 17.13656 13.19251 12.85898 0 15.46519 0 17.0643 0 16.05801 16.45601 15.59662 12.85259 0 16.76065 14.11733 18.91358 16.03967 13.14271 15.86134 15.64755 16.28869 17.23609 0 15.32539 13.39279 16.50828 0 10.35956 0 16.73279 16.31697 Q6UB99 ANR11_HUMAN Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) ANKRD11 ANCO1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anatomical structure morphogenesis [GO:0009653]; face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] GO:0005634; GO:0005654; GO:0005829; GO:0009653; GO:0042475; GO:0048705; GO:0060325 ETKSNSFISIPK 2.319999933 1 1 0.508619896 1350.916876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UE05 TM270_HUMAN Transmembrane protein 270 (Williams-Beuren syndrome chromosomal region 28 protein) TMEM270 WBSCR28 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MEALPPVR 9.640000343 0.348894179 0.348894179 0.035990724 931.3821536 13.29412 12.14953 14.65194 15.7772 12.4632 12.10128 14.98806 16.54233 13.98887 0 15.79603 15.30472 16.49433 16.09963 15.60833 15.73819 0 13.6417 16.73788 16.70285 13.16658 15.2474 12.191 16.42744 16.39796 14.39222 0 14.81975 15.04163 10.69293 14.0804 15.26636 17.24488 13.84673 17.90407 14.96693 15.9925 16.79678 18.47128 16.8859 17.76674 15.22701 16.09661 12.98684 17.26837 17.51769 15.76125 16.76237 Q6UN15 FIP1_HUMAN "Pre-mRNA 3'-end-processing factor FIP1, hFip1 (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia)" FIP1L1 FIP1 RHE Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005829; GO:0005847; GO:0006378; GO:0098789 ANSSVGK 9.800000191 1 1 6.90E-13 661.415749 14.48945 15.75347 15.05742 16.28757 0 13.35261 15.95256 0 0 0 0 0 0 0 0 14.65106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.82971 15.45653 14.44841 0 15.72762 0 0 0 Q6UVK1 CSPG4_HUMAN Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan) CSPG4 MCSP Homo sapiens (Human) angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771] coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901] GO:0001525; GO:0001726; GO:0005576; GO:0005654; GO:0005796; GO:0005886; GO:0005887; GO:0005925; GO:0006929; GO:0008283; GO:0008347; GO:0009986; GO:0015026; GO:0016324; GO:0019901; GO:0031258; GO:0035556; GO:0043202; GO:0043410; GO:0048008; GO:0048771; GO:0050731; GO:0062023; GO:0070062; GO:0097178 MQSGPRPPLPAPGLALALTLTMLAR 1.889999986 1 1 0.217145183 2604.606108 0 15.0157 14.71128 0 0 0 0 0 14.51456 0 12.01201 15.3882 15.30388 0 0 0 0 0 0 14.78057 0 15.99832 0 0 0 0 0 0 0 0 0 16.05696 16.11064 0 0 14.02349 16.45144 0 15.73361 13.79141 14.05488 0 0 15.75086 0 11.78372 0 14.32189 Q6UVY6 MOXD1_HUMAN "DBH-like monooxygenase protein 1, EC 1.14.17.- (Monooxygenase X)" MOXD1 MOX UNQ2493/PRO5780 Homo sapiens (Human) dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500] GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0016021; GO:0030667; GO:0042420; GO:0042421 AEPLVCGTSSSSSLHR 7.170000076 0.686009288 0.686009288 0.53306871 1686.353822 14.17347 18.08923 18.83547 19.03954 18.44077 15.59075 19.86034 0 0 0 0 0 0 0 0 0 16.45604 0 19.57111 17.90893 17.63999 18.51531 19.95581 0 0 20.37344 20.46441 18.79248 0 0 20.7683 0 20.12368 18.08858 0 20.21374 0 21.31727 20.42492 0 19.94992 0 17.86604 0 17.0735 0 20.25491 18.67821 Q6UW49 SPESP_HUMAN "Sperm equatorial segment protein 1, SP-ESP (Equatorial segment protein, ESP) (Glycosylated 38 kDa sperm protein C-7/8)" SPESP1 UNQ732/PRO1418 Homo sapiens (Human) acrosome reaction [GO:0007340]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; acrosome reaction [GO:0007340]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] GO:0001669; GO:0005654; GO:0005829; GO:0007340; GO:0007342; GO:0009566; GO:0035036; GO:0043231 AATVFNTLKNMCR 6.78000021 1 1 6.89E-13 1541.636636 0 0 13.19212 0 12.58622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5036 15.50339 0 0 0 14.78768 14.4163 16.17953 16.72897 0 15.99159 14.79566 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWE0 LRSM1_HUMAN "E3 ubiquitin-protein ligase LRSAM1, EC 2.3.2.27 (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase, hTAL)" LRSAM1 TAL UNQ6496/PRO21356 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786 EHTQLLQQSSSQKDEILQTVK 10.86999989 1 1 0.634158683 2440.775088 0 0 0 0 0 0 0 0 0 0 0 16.92127 17.53014 0 0 0 0 0 17.35664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.11275 0 0 0 0 0 0 0 0 0 Q6UWF7 NXPE4_HUMAN NXPE family member 4 (Protein FAM55D) NXPE4 C11orf33 FAM55D UNQ3018/PRO9799 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 ARMSSPALMAGASGK 5.900000095 1 1 1.61E-12 1450.401668 0 0 14.6743 0 0 13.76831 0 0 15.47075 0 13.55017 0 15.77159 0 13.31742 15.11027 14.22482 0 15.50157 14.15654 0 14.34013 13.65113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWH4 GAK1B_HUMAN Golgi-associated kinase 1B (Expressed in nerve and epithelium during development) (Protein FAM198B) GASK1B C4orf18 ENED FAM198B AD021 UNQ2512/PRO6001 Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] GO:0000139; GO:0005794; GO:0016021 TLPSVSR 9.210000038 0.001261604 0.001261604 0.049315034 758.9710661 16.59358 17.16833 16.34805 0 18.50069 16.32287 13.96509 17.2187 13.79406 14.72008 18.63695 16.55283 15.72326 17.27503 15.72467 0 14.48408 15.86668 0 15.9685 0 17.74562 15.32694 14.96053 17.73872 11.20809 18.01875 15.179 13.26027 10.21271 16.15241 0 15.91676 17.15614 14.0821 0 16.13257 16.01215 0 0 17.84374 16.26308 0 12.95311 16.9513 13.95909 15.7076 13.17897 Q6UWI2 PARM1_HUMAN "Prostate androgen-regulated mucin-like protein 1, PARM-1" PARM1 UNQ1879/PRO4322 Homo sapiens (Human) positive regulation of telomerase activity [GO:0051973] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; positive regulation of telomerase activity [GO:0051973] GO:0000139; GO:0005654; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0016021; GO:0043231; GO:0051973 TPPTTVSGK 5.760000229 0.639854074 0.639854074 8.02E-13 887.7533948 15.79758 14.13053 0 0 14.41874 13.90974 11.43636 0 13.45279 14.93556 0 13.11806 12.62386 12.44104 15.39686 13.96047 14.54752 0 13.10264 14.65872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.66151 0 0 0 0 0 0 0 0 Q6UWI4 SHSA2_HUMAN Protein shisa-2 homolog (Transmembrane protein 46) SHISA2 C13orf13 TMEM46 UNQ9166/PRO28631 Homo sapiens (Human) negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178] GO:0005783; GO:0005789; GO:0016021; GO:0030178; GO:0040037 APGGNR 3.799999952 1 1 0.14037914 571.2843303 0 0 16.57288 13.64205 0 15.85408 0 15.71465 16.01923 0 0 0 0 0 0 0 0 0 0 0 0 15.67472 0 0 0 14.43972 0 16.75334 0 16.42157 16.34421 0 14.30352 15.6886 13.66232 15.86264 13.76381 15.21406 3.114474 0 15.68369 14.587 15.3984 15.05886 15.86141 15.24953 16.14474 15.5002 Q6UWJ1 TMCO3_HUMAN Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein) TMCO3 C13orf11 UNQ2419/PRO4976 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386] potassium:proton antiporter activity [GO:0015386] GO:0015386; GO:0016021 SVKGVNFEAVLR 4.940000057 1 1 0.151714618 1319.493106 0 0 0 0 0 11.86229 0 14.00038 10.02768 0 0 0 0 9.019891 14.54812 0 0 0 14.60996 0 0 0 13.73756 0 0 0 0 0 0 0 0 12.98758 0 0 0 0 0 0 0 0 0 0 14.02637 0 0 14.56924 0 15.1266 Q6UWL6 KIRR2_HUMAN Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3) KIRREL2 NEPH3 UNQ5827/PRO19646 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933] cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933] cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802] GO:0001933; GO:0005886; GO:0005887; GO:0005911; GO:0007155; GO:0016021; GO:0036057; GO:0042802; GO:0050839; GO:0098609 DPTNGYYK 17.46999931 0.843445539 0.843445539 0.072296279 958.2849045 0 12.55343 15.88863 14.84877 15.24144 14.06604 16.50039 16.16005 0 15.88853 13.69639 15.61666 0 15.68435 15.49696 14.33641 15.00501 0 16.32421 15.90359 0 0 0 14.29226 0 17.06549 0 15.05173 15.95225 15.94625 0 15.48888 17.77515 16.10381 0 0 15.43588 17.74286 18.80096 15.28412 14.88478 14.42977 15.23293 14.50551 16.76706 0 15.93382 16.13025 Q6UWM7 LCTL_HUMAN Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein) LCTL KLPH UNQ3022/PRO9820 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; lens morphogenesis in camera-type eye [GO:0002089]; response to stimulus [GO:0050896]; visual perception [GO:0007601] brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; lens morphogenesis in camera-type eye [GO:0002089]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" GO:0002089; GO:0004553; GO:0005789; GO:0005903; GO:0005975; GO:0007601; GO:0016021; GO:0050896 LLPTGIR 3.799999952 0.509981215 0.509981215 0.232793894 767.6274684 13.80003 15.2861 15.91572 14.74495 0 16.33103 15.77383 15.16718 15.48385 0 15.08208 16.3288 0 15.97059 15.74201 16.04213 15.19358 15.28427 16.12245 15.19593 14.52191 16.96897 17.54101 16.2446 15.68779 15.80676 16.91624 15.71397 16.37525 15.40535 0 17.14626 15.86542 17.37353 0 16.82311 17.14091 16.40619 16.85328 15.17757 16.52986 16.36865 15.35004 16.06082 15.28783 17.28091 16.52634 15.64039 Q6UWP8 SBSN_HUMAN Suprabasin SBSN UNQ698/PRO1343 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 ETEKFGQGVHHAASQFGK 13.39000034 1.30E-08 1.30E-08 0.161854921 1958.259479 15.96294 0 0 0 0 16.58893 15.96812 0 18.33809 16.54064 15.03358 0 0 0 0 16.43302 0 0 0 0 0 16.88355 0 0 18.36299 15.04941 0 17.67412 0 0 0 17.98528 19.04607 18.01592 16.07826 18.4054 17.49035 0 0 0 0 0 16.8553 0 14.14025 0 16.93347 0 Q6UWS5 PT117_HUMAN "Protein PET117 homolog, mitochondrial" PET117 UNQ607/PRO1194 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617] GO:0005739; GO:0033617 LRDGVIR 11.80000019 0.528396606 0.528396606 0.161974737 828.1605349 18.70465 14.22753 16.30816 17.70536 14.57407 14.47783 0 14.10135 17.32232 18.04958 0 16.71474 12.43109 0 13.62101 15.35296 15.90435 16.32981 17.41746 17.05916 13.73829 18.44993 16.22407 17.41452 0 15.55758 16.59392 17.36122 0 12.7824 16.67509 17.58545 19.11972 0 16.1154 0 17.42108 0 15.9089 0 0 14.57759 13.8132 0 0 18.14396 16.42819 14.42538 Q6UWU2 GLB1L_HUMAN "Beta-galactosidase-1-like protein, EC 3.2.1.-" GLB1L UNQ229/PRO262 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] extracellular region [GO:0005576]; vacuole [GO:0005773] extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975] beta-galactosidase activity [GO:0004565] GO:0004565; GO:0005576; GO:0005773; GO:0005975 LGSKLDILVENMGR 6.039999962 1 1 0.176535927 1559.792417 0 0 16.2416 0 0 0 0 0 17.73672 0 17.67025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1474 0 18.42236 0 0 0 0 0 0 0 0 0 Q6UWV6 ENPP7_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 7, E-NPP 7, NPP-7, EC 3.1.4.12 (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase, Alk-SMase)" ENPP7 UNQ3077/PRO9912 Homo sapiens (Human) fatty acid homeostasis [GO:0055089]; glycosphingolipid metabolic process [GO:0006687]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; fatty acid homeostasis [GO:0055089]; glycosphingolipid metabolic process [GO:0006687]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] GO:0004767; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0006684; GO:0006685; GO:0006687; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0016020; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 RAGDLVEFHK 13.10999966 1 1 0.491605383 1171.379574 0 0 0 0 0 0 0 0 0 0 18.5073 0 0 17.25369 18.25811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.22082 0 0 0 0 0 0 0 17.83817 Q6UWW8 EST3_HUMAN "Carboxylesterase 3, EC 3.1.1.1 (Liver carboxylesterase 31 homolog)" CES3 UNQ869/PRO1887 Homo sapiens (Human) low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030] GO:0005788; GO:0005829; GO:0006805; GO:0034383; GO:0052689; GO:0070062; GO:0080030 EGEELVLSK 5.320000172 0.163011149 0.163011149 0.239770788 1002.243084 14.94651 15.47558 14.1519 0 0 0 18.18212 0 15.24741 16.63722 11.90608 15.93732 0 0 0 0 0 14.89857 0 0 0 0 0 16.42678 0 0 0 0 0 0 0 16.56538 0 0 0 0 0 0 0 0 16.77376 0 0 0 0 0 16.23761 0 Q6UWX4 HIPL2_HUMAN HHIP-like protein 2 HHIPL2 HHIP3 KIAA1822L UNQ841/PRO1779 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; catalytic activity [GO:0003824] catalytic activity [GO:0003824] GO:0003824; GO:0005576 AGSHGKR 4.929999828 1 1 0.208464908 713.8625513 0 0 0 0 13.31311 14.16926 15.05151 0 15.38918 0 0 15.67792 0 14.98213 0 0 0 13.85628 0 0 0 14.75984 14.78826 0 0 0 15.60299 0 15.07891 13.53477 0 14.97979 0 17.29719 0 0 0 15.71644 16.80725 15.15698 0 0 0 16.95559 15.88744 16.83597 15.66148 0 Q6UWY5 OLFL1_HUMAN Olfactomedin-like protein 1 OLFML1 UNQ564/PRO1126 Homo sapiens (Human) signal transduction [GO:0007165] extracellular space [GO:0005615] extracellular space [GO:0005615]; signal transduction [GO:0007165] GO:0005615; GO:0007165 VLEQGLEK 4.320000172 0.222374469 0.222374469 0.20675592 915.756034 0 0 16.55803 0 0 0 0 0 15.21733 0 0 17.00009 14.65232 15.49258 13.79684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7706 0 14.97177 16.1734 0 0 0 16.00749 16.57956 0 0 0 0 15.56626 0 0 0 Q6UX01 LMBRL_HUMAN "Protein LMBR1L (Limb region 1 protein homolog-like) (Lipocalin-1-interacting membrane receptor, LIMR)" LMBR1L KIAA1174 LIMR UNQ458/PRO783 Homo sapiens (Human) hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055] transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005789; GO:0005886; GO:0005887; GO:0006898; GO:0007165; GO:0016055; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090 LPLPVSGFPQASR 8.409999847 1 1 0.451965627 1369.340914 0 0 17.40772 0 0 0 0 0 0 0 14.61742 0 0 0 18.72656 0 0 0 17.96338 0 17.29489 0 0 0 0 17.32862 0 0 0 0 15.76122 0 0 0 19.32836 19.28983 0 0 16.61428 0 0 0 16.39978 0 0 18.83219 17.47886 0 Q6UX06 OLFM4_HUMAN "Olfactomedin-4, OLM4 (Antiapoptotic protein GW112) (G-CSF-stimulated clone 1 protein, hGC-1) (hOLfD)" OLFM4 GW112 UNQ362/PRO698 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cadherin binding [GO:0045296]; catalytic activity [GO:0003824]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165] cadherin binding [GO:0045296]; catalytic activity [GO:0003824]; structural molecule activity [GO:0005198] GO:0003824; GO:0005198; GO:0005576; GO:0005615; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0007155; GO:0007165; GO:0032991; GO:0035580; GO:0042581; GO:0045171; GO:0045296; GO:0048471; GO:0070062; GO:1900026; GO:1904724 LETLDKNNVLAIR 1.320000052 1 1 2.32E-13 1498.030949 0 0 17.34545 0 0 0 0 0 0 0 0 16.61124 0 0 0 17.33804 0 0 0 0 15.12116 0 0 0 0 0 0 0 0 0 0 0 0 0 20.193 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX46 ALKL2_HUMAN "ALK and LTK ligand 2 (Augmentor alpha, AUG-alpha)" ALKAL2 FAM150B UNQ542/PRO1097 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976] extracellular region [GO:0005576] extracellular region [GO:0005576]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976] receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971] GO:0005576; GO:0010976; GO:0030298; GO:0030971; GO:0070374; GO:0070378 GGAEPR 5.809999943 0.270650804 0.270650804 0.208358791 587.8639092 0 14.96529 0 15.44288 14.93251 14.54676 0 16.22361 0 0 0 16.29336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.45448 0 0 0 16.56986 0 0 0 0 Q6UX52 IL40_HUMAN "Protein IL-40 (Interleukin-40, IL-40)" C17orf99 IL40 UNQ464/PRO809 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776] cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888] GO:0002250; GO:0002313; GO:0004888; GO:0005125; GO:0005615; GO:0005887; GO:0007166; GO:0050776; GO:2000558 VLEVFPKGR 5.75 0.13822417 0.13822417 0.228487595 1044.3965 15.87572 16.30144 16.90049 17.56484 16.03488 15.84408 16.36321 18.29455 0 18.10237 17.12084 15.44495 17.19101 16.15795 16.22674 14.57713 15.07604 0 0 17.01497 16.12366 15.82955 16.62904 0 16.06868 16.88191 17.05202 15.2345 16.75112 16.47879 16.31964 0 0 17.23831 17.66546 17.75315 16.23608 16.21961 0 15.9463 0 16.28389 16.43451 16.07377 15.86636 15.81958 16.66114 15.27988 Q6UX53 MET7B_HUMAN "Thiol S-methyltransferase METTL7B (Methyltransferase-like protein 7B, EC 2.1.1.9)" METTL7B UNQ594/PRO1180 Homo sapiens (Human) methylation [GO:0032259] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; thiol S-methyltransferase activity [GO:0018708]; methylation [GO:0032259] methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; thiol S-methyltransferase activity [GO:0018708] GO:0005789; GO:0005811; GO:0008168; GO:0008757; GO:0018708; GO:0032259 DLENAQFSEIQMER 7.190000057 0.544333398 0.544333398 0.509142406 1725.314421 0 16.39577 15.82391 0 0 0 0 18.62643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.08124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX65 DRAM2_HUMAN DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77) DRAM2 TMEM77 PSEC0031 UNQ154/PRO180 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601] GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0043231; GO:0045494 QVHALSPEENVIIK 8.979999542 1 1 0.392920147 1577.261838 0 0 0 0 0 0 19.99823 0 0 0 17.72134 0 20.19864 0 0 19.99743 0 18.3146 0 0 19.58213 0 0 0 0 0 0 0 0 17.96352 18.70092 0 0 0 0 0 20.93593 0 20.24464 0 0 0 0 18.05769 0 0 0 0 Q6UX72 B3GN9_HUMAN "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, BGnT-9, Beta-1,3-Gn-T9, Beta-1,3-N-acetylglucosaminyltransferase 9, Beta3Gn-T9, EC 2.4.1.-" B3GNT9 UNQ1922/PRO4397 Homo sapiens (Human) poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486] glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194] GO:0000139; GO:0006486; GO:0008194; GO:0016021; GO:0016757; GO:0016758; GO:0030311 SVAEDFER 9.329999924 1 1 0.159083254 951.3548499 14.16227 15.21472 14.79443 16.71444 15.25828 0 0 14.35852 14.15712 0 12.24731 13.36743 0 0 0 0 15.4951 0 0 12.70294 0 0 15.0736 16.74946 0 0 14.87468 14.97189 15.06212 0 14.74087 11.70554 15.49125 16.43602 0 13.56363 15.37296 0 0 0 0 0 0 0 0 0 0 0 Q6UX82 LYPD8_HUMAN Ly6/PLAUR domain-containing protein 8 LYPD8 UNQ511/PRO1026 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; defense response to Gram-negative bacterium [GO:0050829] GO:0005576; GO:0005615; GO:0005886; GO:0031225; GO:0050829 NDIESKSLVLK 3.789999962 1 1 0.032018897 1246.496613 15.10036 0 0 14.28523 0 14.94217 0 0 16.70699 0 16.91635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.46521 0 0 0 0 0 0 0 0 0 0 0 0 15.97404 0 0 14.61236 0 0 0 0 0 Q6UXA7 CF015_HUMAN Uncharacterized protein C6orf15 (Protein STG) C6orf15 STG UNQ1840/PRO3566 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0030198; GO:0031012 SNDLARVPLK 1.00999999 1 1 0.063129742 1111.840341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.14627 0 0 0 0 17.62407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXB4 CLC4G_HUMAN "C-type lectin domain family 4 member G (Liver and lymph node sinusoidal endothelial cell C-type lectin, LSECtin)" CLEC4G UNQ431/PRO792 Homo sapiens (Human) negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of viral life cycle [GO:1903902]; viral entry into host cell [GO:0046718] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; glycosylated region protein binding [GO:0140081]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of viral life cycle [GO:1903902]; viral entry into host cell [GO:0046718] carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; glycosylated region protein binding [GO:0140081]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618] GO:0001618; GO:0002710; GO:0005537; GO:0005886; GO:0005887; GO:0009897; GO:0030246; GO:0030247; GO:0042130; GO:0046718; GO:0070061; GO:0097367; GO:0120274; GO:0140081; GO:1903902 DGWICEK 9.520000458 1 1 0.217536645 907.8792183 15.9591 13.63089 16.02654 15.7229 14.20318 0 0 0 0 0 0 0 15.33363 14.47261 0 0 14.62304 15.6941 14.96549 0 0 15.42483 15.60501 0 0 0 14.7599 0 0 15.44359 16.41655 15.49809 0 0 0 16.33006 16.79255 0 0 0 0 0 0 14.91316 0 14.40361 0 16.51675 Q6UXG2 ELAP1_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein) ELAPOR1 EIG121 KIAA1324 UNQ2426/PRO4985 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090] RNA binding [GO:0003723] GO:0000045; GO:0003723; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0009267; GO:0016021; GO:0031902; GO:0044090; GO:0070062; GO:2000786 IPEGESGFSK 1.730000019 0.3272641 0.3272641 0.06582226 1050.179803 0 0 15.53268 0 0 0 13.41587 16.11157 12.07367 15.99368 15.97872 16.00671 13.82749 0 0 13.79108 0 15.89713 16.52637 8.562593 15.2272 17.95484 0 18.12738 0 17.3046 0 16.88264 0 0 14.25672 14.45597 15.08871 17.75337 18.06039 0 0 17.27238 18.12736 14.13744 16.14081 0 16.37925 0 11.53864 16.54271 14.91386 14.13634 Q6UXH8 CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog) CCBE1 KIAA1983 UNQ1921/PRO4395 Homo sapiens (Human) lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020] GO:0001946; GO:0002020; GO:0002040; GO:0003016; GO:0005509; GO:0005518; GO:0005581; GO:0005615; GO:0010575; GO:0010595; GO:0010954; GO:0030324; GO:0031012; GO:0045766; GO:0048845; GO:1900748; GO:1901492 GSMGPMGPSPDLSHIK 4.96999979 1 1 0.262291167 1626.060299 13.22794 12.00204 0 0 10.64624 0 14.55571 15.38904 12.41357 12.27504 15.7435 9.380159 0 0 0 14.24597 0 0 0 0 0 0 13.51769 0 15.77919 15.43851 0 0 0 0 0 0 0 0 0 0 17.1067 0 15.74014 0 15.93964 0 0 0 0 0 0 0 Q6UXI7 VITRN_HUMAN Vitrin VIT UNQ647/PRO1277 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; glycosaminoglycan binding [GO:0005539]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510] glycosaminoglycan binding [GO:0005539] GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198; GO:0062023 TVLQFVTNLTK 1.350000024 1 1 0.212159887 1263.422676 0 0 15.98508 14.41382 0 13.18783 0 0 0 0 0 0 0 0 0 13.48902 0 0 15.43593 0 0 16.13658 0 0 0 0 15.89665 0 13.32087 14.0717 0 0 16.50104 15.02435 0 13.30628 0 0 0 0 16.13478 0 0 0 0 0 0 0 Q6UXI9 NPNT_HUMAN Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like) NPNT EGFL6L POEM UNQ295/PRO334 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; ureteric bud development [GO:0001657] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; ureteric bud development [GO:0001657] calcium ion binding [GO:0005509]; integrin binding [GO:0005178] GO:0001657; GO:0001658; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0007160; GO:0010694; GO:0010811; GO:0016020; GO:0030198; GO:0030485; GO:0030511; GO:0033631; GO:0045184; GO:0045669; GO:0045987; GO:0062023; GO:0070062; GO:0070374; GO:0071356; GO:0097195; GO:2000721 QTQITLR 12.09000015 1 1 1.16E-13 859.8465158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.73318 0 0 0 0 17.0218 0 0 0 0 0 0 0 0 17.99565 0 0 0 17.11909 0 0 0 0 16.16434 0 0 0 0 Q6UXK2 ISLR2_HUMAN Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein) ISLR2 KIAA1465 LINX UNQ1885/PRO4329 Homo sapiens (Human) positive regulation of axon extension [GO:0045773] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; positive regulation of axon extension [GO:0045773] GO:0005886; GO:0009986; GO:0016021; GO:0045773 HAPGAGGEPDGQAPTSERK 2.940000057 1 1 0.21759267 1858.416573 15.91628 11.59664 15.13503 0 0 0 0 0 0 15.90016 0 0 0 0 0 14.31215 8.723572 0 15.86883 0 0 15.86269 0 0 0 15.57082 15.81801 0 14.60505 12.79835 0 17.17542 0 0 0 16.74127 0 0 0 12.4435 0 0 15.72133 0 0 15.85508 13.45238 0 Q6UXM1 LRIG3_HUMAN "Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3" LRIG3 LIG3 UNQ287/PRO326/PRO335 Homo sapiens (Human) otolith morphogenesis [GO:0032474] cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474] GO:0005615; GO:0005886; GO:0016021; GO:0030659; GO:0031012; GO:0032474 DNELLHDAEMENYAHLR 3.819999933 1 1 1.38E-12 2069.637453 14.59246 0 0 0 0 0 0 11.12028 0 0 0 0 0 0 0 11.42122 0 0 14.52832 0 16.04659 0 0 0 0 13.0373 0 0 0 0 0 0 0 0 0 0 14.66814 0 0 0 13.5237 0 0 0 0 0 0 0 Q6UXN2 TRML4_HUMAN "Trem-like transcript 4 protein, TLT-4 (Triggering receptor expressed on myeloid cells-like protein 4)" TREML4 TLT4 UNQ9425/PRO34675 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157] signaling receptor activity [GO:0038023] GO:0005576; GO:0005886; GO:0009986; GO:0034157; GO:0038023; GO:0045087 APACLGSGGPR 5.210000038 1 1 0 1040.506001 0 0 14.47176 0 14.13525 14.88395 0 0 13.38194 13.67788 14.15469 12.5581 0 13.64983 0 14.50287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74182 16.22625 0 0 0 0 0 0 0 Q6UXP9 YO001_HUMAN Putative uncharacterized protein UNQ9370/PRO34162 UNQ9370/PRO34162 Homo sapiens (Human) AGSNR 2.339999914 1 1 0.223352562 504.6031493 0 17.01043 14.95847 15.38553 15.73464 0 15.77043 16.85379 0 0 0 0 0 0 0 0 15.66859 0 0 0 0 0 0 0 15.82163 0 0 0 16.51459 0 0 0 0 16.929 0 17.25961 16.54092 19.5383 0 0 0 0 0 15.70084 0 0 0 0 Q6UXR4 SPA13_HUMAN Putative serpin A13 SERPINA13P SERPINA13 UNQ6121/PRO20043 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005615; GO:0010951 EKASHR 5.579999924 1 1 0.036907552 727.1874589 0 0 0 0 0 15.2821 0 0 0 0 0 0 0 0 0 14.21127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.72662 15.46324 0 0 0 0 0 0 0 0 0 15.03048 0 0 0 Q6UXV0 GFRAL_HUMAN GDNF family receptor alpha-like GFRAL C6orf144 UNQ9356/PRO34128 Homo sapiens (Human) glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; stress-activated protein kinase signaling cascade [GO:0031098] actin cytoskeleton [GO:0015629]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; stress-activated protein kinase signaling cascade [GO:0031098] glial cell-derived neurotrophic factor receptor activity [GO:0016167]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023] GO:0002023; GO:0005654; GO:0005886; GO:0005925; GO:0007399; GO:0009897; GO:0015629; GO:0016021; GO:0016167; GO:0030971; GO:0031098; GO:0035860; GO:0038023; GO:0043235; GO:0043410; GO:0043524; GO:0051897; GO:2001240 DPSSIQIPGEL 10.47000027 0.344974816 0.344974816 0.115473179 1158.325095 17.28708 15.02211 0 11.56284 14.84174 14.2877 0 17.41162 13.8271 12.31008 15.3992 0 15.92433 0 14.55821 16.21655 0 14.69722 14.62675 14.75682 12.92593 0 17.17676 16.60139 19.05237 15.32489 14.57135 15.34853 17.27974 14.16215 16.36568 16.60965 12.08653 13.18341 17.19616 0 17.14488 16.46857 15.05994 14.98451 13.71411 15.99649 15.75705 12.80115 0 16.86244 13.83495 0 Q6UXV1 IZUM2_HUMAN Izumo sperm-egg fusion protein 2 IZUMO2 C19orf41 SCRL UNQ6978/PRO21961 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AGAVLMGMEGPFFR 6.380000114 1 1 0.416480544 1513.923853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.26886 0 0 0 0 0 0 0 0 0 0 18.43375 0 0 0 0 0 0 0 18.82049 0 0 0 0 0 Q6UXX5 ITIH6_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H6 (Inter-alpha-trypsin inhibitor heavy chain H5-like protein, Inter-alpha inhibitor H5-like protein)" ITIH6 ITIH5L UNQ6369/PRO21074 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576; GO:0030212 HQGQYQLVVSLRPGQLVK 4.269999981 1 1 1.83E-12 2051.277103 0 14.90664 12.18171 0 0 0 0 14.95438 0 0 0 0 0 0 0 0 0 0 0 0 0 16.44507 0 16.10446 0 0 13.95591 15.91937 15.64807 14.7337 0 0 14.75212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXY1 BI2L2_HUMAN "Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2, BAI1-associated protein 2-like protein 2 (Planar intestinal- and kidney-specific BAR domain protein, Pinkbar)" BAIAP2L2 UNQ9336/PRO34007 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838] cell-cell contact zone [GO:0044291]; clathrin complex [GO:0071439]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] cell-cell contact zone [GO:0044291]; clathrin complex [GO:0071439]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; phospholipid binding [GO:0005543]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838] phospholipid binding [GO:0005543] GO:0005543; GO:0005654; GO:0005829; GO:0005886; GO:0007009; GO:0012506; GO:0030659; GO:0030838; GO:0044291; GO:0051017; GO:0051764; GO:0061024; GO:0071439; GO:2000251 LHAQMQAFVSESQR 2.130000114 1 1 0.124038748 1647.64033 15.50357 0 0 0 13.73621 0 0 13.48193 0 0 0 0 0 0 0 0 0 14.27334 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21372 15.57427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXY8 TMC5_HUMAN Transmembrane channel-like protein 5 TMC5 UNQ8238/PRO33604 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381; GO:0070062 ANLNHPGSR 3.930000067 1 1 3.47E-13 967.2095042 16.46292 14.60819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.55202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXZ4 UNC5D_HUMAN Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D) UNC5D KIAA1777 UNC5H4 UNQ6012/PRO34692 Homo sapiens (Human) apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222] netrin receptor activity [GO:0005042] GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0016021; GO:0021859; GO:0098742; GO:2001222 LSDSGNYTCMAANIVAK 3.640000105 1 1 0.159522808 1830.768813 0 15.02233 0 0 0 15.31939 0 14.2191 0 0 0 0 13.07308 0 0 13.7661 14.59892 13.26552 14.66612 12.95097 0 0 0 12.75296 13.20631 0 0 15.3369 13.90151 0 0 0 14.85156 13.7085 0 13.00255 0 0 0 0 0 0 0 0 0 0 0 0 Q6UY01 LRC31_HUMAN Leucine-rich repeat-containing protein 31 LRRC31 UNQ9367/PRO34156 Homo sapiens (Human) VGGNLPLILQKFQK 8.029999733 0.441472054 0.441472054 0.167557314 1555.526993 14.49148 15.98099 14.42824 0 14.52463 12.73474 0 0 14.98892 0 0 0 11.342 0 0 13.86418 14.81069 14.78468 15.73926 14.61683 0 0 0 0 16.11815 14.81258 13.76407 0 16.64421 0 16.39961 14.9369 15.05258 0 0 0 16.07936 16.14441 0 15.62728 14.04 0 0 0 0 0 0 0 Q6UY18 LIGO4_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D) LINGO4 LRRN6D UNQ9248/PRO34002 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0016021; GO:0031012 MDAATAPK 7.309999943 1 1 1.14E-13 803.3255192 15.43186 0 15.02045 0 15.58415 0 14.98785 0 15.36255 15.14172 0 0 0 14.42053 0 0 15.85488 0 0 14.51147 16.10784 0 0 0 0 12.93135 0 0 0 0 12.6901 0 0 0 0 0 0 0 0 0 0 0 13.93894 0 0 0 0 0 Q6UYE1 LEU7_HUMAN Leukemia-associated protein 7 (Deleted in lymphocytic leukemia 7) DLEU7 LEU7 Homo sapiens (Human) DPDHVSTAPAR 3.960000038 1 1 0.596911895 1164.874436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.70004 0 0 0 0 0 0 0 0 0 0 0 0 16.37992 0 0 0 0 0 0 0 Q6V0I7 FAT4_HUMAN "Protocadherin Fat 4, hFat4 (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)" FAT4 CDHF14 FATJ Nbla00548 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] calcium ion binding [GO:0005509] GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609 HTGIIQTAAILDR 9.590000153 1 1 0.094579144 1407.616956 16.55875 14.48831 14.29705 0 13.65273 14.60173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.87312 16.89718 15.69389 0 0 0 0 0 0 0 0 0 14.49553 0 16.78787 0 0 0 0 0 0 15.38319 0 17.44599 0 Q6V1X1 DPP8_HUMAN "Dipeptidyl peptidase 8, DP8, EC 3.4.14.5 (Dipeptidyl peptidase IV-related protein 1, DPRP-1) (Dipeptidyl peptidase VIII, DPP VIII) (Prolyl dipeptidase DPP8)" DPP8 DPRP1 MSTP097 MSTP135 MSTP141 Homo sapiens (Human) apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006955; GO:0008236; GO:0008239 FEGAFKYK 8.06000042 0.791704237 0.791704237 0.213510133 988.4498157 0 0 12.69952 16.59276 18.84229 15.30196 17.11765 12.51983 0 0 0 0 14.98983 13.4579 0 14.40788 13.33821 0 0 0 16.09031 0 0 15.73011 14.46538 0 0 0 0 17.03609 14.32922 0 0 16.06605 16.55513 0 0 15.38596 0 14.65441 0 0 0 16.35468 0 0 14.37807 0 Q6VEQ5 WASH2_HUMAN WAS protein family homolog 2 (CXYorf1-like protein on chromosome 2) (Protein FAM39B) WASH2P FAM39B Homo sapiens (Human) "Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]" autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203] "autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]" actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015] GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0006887; GO:0015031; GO:0016197; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0042147; GO:0043014; GO:0043015; GO:0055037; GO:0055038; GO:0071203 LQEYGSIFTGAQDPGLQR 2.25999999 0.276869595 0.276869595 0.181260511 1979.555144 0 0 11.04852 15.33091 0 0 0 0 0 0 0 0 17.96926 0 0 14.75757 15.76549 0 0 0 17.41991 0 0 14.68451 0 0 18.23936 0 0 0 0 16.31679 0 17.27872 0 15.80052 0 0 0 0 0 0 0 0 0 0 0 0 Q6VUC0 AP2E_HUMAN "Transcription factor AP-2-epsilon, AP2-epsilon (Activating enhancer-binding protein 2-epsilon)" TFAP2E Homo sapiens (Human) anatomical structure development [GO:0048856]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0042127; GO:0042802; GO:0048856; GO:1990837 ALGLDPR 5.420000076 0.771043003 0.771043003 0.250456209 742.5971702 15.49367 16.13576 15.57315 0 18.49169 0 17.50511 0 0 0 0 0 18.14687 16.54368 0 0 0 0 0 17.4035 0 0 0 0 0 0 0 0 0 0 0 0 18.59527 0 0 0 0 0 18.15725 0 0 0 0 0 0 0 0 0 Q6VY07 PACS1_HUMAN "Phosphofurin acidic cluster sorting protein 1, PACS-1" PACS1 KIAA1175 Homo sapiens (Human) protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; transmembrane transporter binding [GO:0044325]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] transmembrane transporter binding [GO:0044325] GO:0005794; GO:0005829; GO:0030137; GO:0034067; GO:0044325; GO:0072659 MAERGGAGGGPGGAGGGSGQR 7.550000191 1 1 0.110088968 1742.918798 13.89795 0 0 0 16.01516 15.23173 0 0 0 0 0 0 14.75176 11.20905 15.16807 0 0 0 15.2619 0 0 13.39062 0 15.98876 0 14.90061 0 0 0 15.91555 15.76119 0 14.35631 0 0 0 15.25952 13.21536 13.10089 0 15.11453 0 0 0 0 0 0 0 Q6W2J9 BCOR_HUMAN "BCL-6 corepressor, BCoR" BCOR KIAA1575 Homo sapiens (Human) "blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]" BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]" DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000415; GO:0000976; GO:0000977; GO:0001835; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007507; GO:0030502; GO:0031072; GO:0035518; GO:0042476; GO:0042826; GO:0045892; GO:0051572; GO:0060021; GO:0065001; GO:0070171; GO:0140261; GO:0140297 DGSSPPLLEK 5.920000076 1 1 0.302925254 1041.459872 0 0 0 0 18.75028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.44971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6W3E5 GDPD4_HUMAN "Glycerophosphodiester phosphodiesterase domain-containing protein 4, EC 3.1.-.- (Glycerophosphodiester phosphodiesterase 6) (UgpQ)" GDPD4 GDE6 UGPQ Homo sapiens (Human) lipid metabolic process [GO:0006629] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629] glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872] GO:0006629; GO:0008889; GO:0016020; GO:0016021; GO:0046872 NAVTPLKPGK 4.119999886 0.546487808 0.546487808 0.228658725 1022.277991 14.45132 13.96698 0 0 14.79698 14.84342 0 13.85988 15.34997 13.75074 0 11.68529 0 14.43869 0 0 15.60049 14.255 0 0 0 12.6632 14.85905 0 0 14.2078 0 15.10999 15.05959 13.73691 13.68987 0 0 12.25804 15.28517 13.80485 0 0 16.04646 0 0 0 0 12.96089 0 16.21065 12.74347 14.31713 Q6WCQ1 MPRIP_HUMAN "Myosin phosphatase Rho-interacting protein, M-RIP (Rho-interacting protein 3, RIP3) (p116Rip)" MPRIP KIAA0864 MRIP RHOIP3 Homo sapiens (Human) actin filament organization [GO:0007015] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin filament organization [GO:0007015] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] GO:0005829; GO:0005925; GO:0007015; GO:0015629; GO:0045296; GO:0051015 AETKEIVSGWLEMLMVYPR 6.579999924 1 1 0.098141806 2263.758386 0 0 0 0 0 12.64372 0 0 0 0 0 0 15.28016 0 16.4846 0 15.36825 13.73495 0 14.988 16.62605 15.27312 13.63401 0 15.41032 15.34872 0 0 0 13.75702 0 15.17296 0 0 14.44021 0 0 0 0 0 17.62498 16.27159 0 0 0 18.48013 0 16.189 Q6WKZ4 RFIP1_HUMAN "Rab11 family-interacting protein 1, Rab11-FIP1 (Rab-coupling protein)" RAB11FIP1 RCP Homo sapiens (Human) negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; small GTPase binding [GO:0031267]; negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055] small GTPase binding [GO:0031267] GO:0005829; GO:0015031; GO:0030670; GO:0031267; GO:0043231; GO:0045055; GO:0055037; GO:0070164 HLFSSTENLAAGSWKEPAEGGGLSSDR 4.5 1 1 0.146875742 2803.855125 11.53757 15.70844 12.73258 0 14.95162 14.29889 0 14.51153 12.97294 11.90201 14.11833 10.69358 11.43251 0 0 15.60289 0 11.81742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9461 0 0 0 0 0 0 Q6WRI0 IGS10_HUMAN "Immunoglobulin superfamily member 10, IgSF10 (Calvaria mechanical force protein 608, CMF608)" IGSF10 CMF608 Homo sapiens (Human) cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222] extracellular region [GO:0005576] extracellular region [GO:0005576]; cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222] GO:0001503; GO:0005576; GO:0030154; GO:2001222 GSSEK 4.449999809 1.70E-05 1.70E-05 0.275812567 506.0839762 0 0 16.38748 0 17.52319 18.20059 0 18.51494 0 0 16.86442 16.70251 18.18683 18.40617 17.46915 0 18.71647 19.02491 18.69774 0 17.77015 19.32516 0 0 0 0 0 18.90374 0 18.7832 0 0 20.43825 19.34698 0 19.49708 0 19.27006 0 18.14378 17.32632 0 0 18.9945 17.80961 18.89889 19.57865 15.813 Q6XPR3 RPTN_HUMAN Repetin RPTN Homo sapiens (Human) cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] GO:0001533; GO:0005509; GO:0005576; GO:0005829; GO:0046914 AQLLNSILSVIDVFHKYAK 6.170000076 1 1 0.671277068 2159.71998 0 0 0 0 0 0 18.75612 0 0 0 0 0 0 0 0 0 0 0 16.65285 0 18.75894 0 0 0 0 0 17.53175 0 0 0 0 0 0 0 0 0 0 22.59741 0 0 0 0 0 0 0 0 0 0 Q6XPS3 TPTE2_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2, EC 3.1.3.67 (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)" TPTE2 TPIP Homo sapiens (Human) cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; protein tyrosine phosphatase activity [GO:0004725]; cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]" "phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; protein tyrosine phosphatase activity [GO:0004725]" GO:0000139; GO:0004725; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008285; GO:0014065; GO:0016021; GO:0016311; GO:0016314; GO:0042995; GO:0046856; GO:0048870; GO:0051800; GO:0051896 VQVVMEK 9.590000153 1 1 0.164963967 844.6695348 0 0 0 0 0 0 0 0 0 0 18.2625 0 0 0 0 0 0 0 0 0 0 18.29497 0 0 0 18.61324 0 0 0 0 20.56726 0 0 0 0 18.31793 20.56922 0 0 0 0 0 0 0 0 0 0 0 Q6XUX3 DUSTY_HUMAN "Dual serine/threonine and tyrosine protein kinase, EC 2.7.12.1 (Dusty protein kinase, Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496, SgK496)" DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P Homo sapiens (Human) cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0030054; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070374; GO:0106310 CSHNHTCLSSLTGGGGAER 2.519999981 0.979844928 0.979844928 0.238580321 2001.364792 15.62529 11.92363 14.11884 0 13.7078 14.38886 11.57501 13.81629 0 15.20715 14.89463 0 0 0 0 0 0 0 14.53176 0 0 0 15.64216 0 10.36578 13.12017 16.4549 0 0 0 0 0 0 0 0 0 15.54572 0 0 15.04076 0 0 0 0 0 0 0 0 Q6XYB7 LBX2_HUMAN Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2) LBX2 LP3727 Homo sapiens (Human) muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:1904105; GO:1990837; GO:2000052 DGLATR 10.57999992 1 1 0.232744281 632.6772229 16.43287 17.81182 0 14.74766 15.27058 0 0 16.11497 15.95339 15.40515 16.21359 16.92778 14.87104 16.31395 15.03147 16.7324 17.08116 16.68543 16.15167 15.17891 17.27275 18.23389 16.26904 15.40177 18.99784 15.39341 14.88395 11.64417 15.59412 15.73112 16.20026 16.20394 17.88219 16.59785 17.95115 16.71704 16.37959 17.50385 16.86443 16.2013 17.47345 17.72055 16.75053 16.89709 16.44775 17.37976 15.39257 0 Q6XZB0 LIPI_HUMAN "Lipase member I, LIPI, EC 3.1.1.- (Cancer/testis antigen 17, CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta, mPA-PLA1 beta)" LIPI LPDL PRED5 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620]; fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433] heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620] GO:0004465; GO:0004620; GO:0005615; GO:0005886; GO:0006633; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0019433 LYEKNKPFYK 9.649999619 0.837644398 0.837644398 0.366161318 1329.725496 11.56434 14.92938 15.80241 0 0 15.03545 0 0 14.06702 0 0 0 0 0 0 0 0 14.38657 0 16.23441 15.83991 0 0 0 0 0 15.96276 15.65062 14.92272 0 14.35821 15.25375 11.41867 14.98037 15.941 15.1947 0 0 15.54045 0 0 16.35937 16.45747 0 16.19731 0 15.41404 15.44533 Q6XZF7 DNMBP_HUMAN Dynamin-binding protein (Scaffold protein Tuba) DNMBP ARHGEF36 KIAA1010 TUBA Homo sapiens (Human) aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005794; GO:0005795; GO:0005829; GO:0005856; GO:0005911; GO:0007568; GO:0008360; GO:0035556; GO:0045202; GO:0051056; GO:0098793 EMTLLSSQSSSLVAPSGSVSAENPEQR 2.609999895 0.999980748 0.999980748 0.02013646 2791.620063 15.85518 0 0 0 13.99978 16.73124 15.36292 0 14.21468 14.25227 14.53817 14.15942 0 15.37962 0 0 0 0 0 0 14.54696 0 14.57564 0 11.04031 15.1067 0 13.39855 0 14.60747 0 0 0 0 13.79071 0 0 15.44457 0 0 14.04686 0 0 14.9244 12.17417 0 15.38848 15.39377 Q6Y2X3 DJC14_HUMAN "DnaJ homolog subfamily C member 14 (DnaJ protein homolog 3) (Dopamine receptor-interacting protein of 78 kDa, DRIP78) (Human DnaJ protein 3, hDj-3)" DNAJC14 DRIP78 HDJ3 Homo sapiens (Human) protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein transport [GO:0015031] GO:0005789; GO:0015031; GO:0016020; GO:0016021 VSSGK 6.25 0.75527513 0.75527513 0.114570722 476.3494365 19.88541 15.39395 18.23203 19.47218 18.59406 19.54048 18.19934 19.07242 19.17399 17.83376 0 17.87159 18.86889 0 18.11916 0 19.95098 0 19.49607 19.61438 18.88979 19.96566 19.47626 19.82408 19.51436 19.72345 17.33669 19.38234 17.0302 19.3711 17.73658 19.09253 18.42495 19.30035 19.65263 20.01072 19.19575 0 19.06137 19.43703 18.54702 19.42544 18.94615 18.06308 20.47588 19.24813 19.92913 19.78106 Q6YN16 HSDL2_HUMAN "Hydroxysteroid dehydrogenase-like protein 2, EC 1.-.-.- (Short chain dehydrogenase/reductase family 13C member 1)" HSDL2 C9orf99 SDR13C1 Homo sapiens (Human) membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491] oxidoreductase activity [GO:0016491] GO:0005739; GO:0005777; GO:0016020; GO:0016491 LMNQMNAR 4.650000095 1 1 0.190029415 1009.465513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.99229 19.1514 0 0 0 0 0 0 0 0 0 0 Q6YP21 KAT3_HUMAN "Kynurenine--oxoglutarate transaminase 3, EC 2.6.1.7 (Cysteine-S-conjugate beta-lyase 2, EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III, KATIII) (Kynurenine--glyoxylate transaminase, EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)" KYAT3 CCBL2 KAT3 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053] cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053 DSTLDAAEEIIK 8.109999657 1 1 0.259657368 1304.6522 16.4563 15.13202 15.05812 0 0 14.68768 16.0029 15.86721 15.48975 15.84695 0 14.69665 0 0 0 14.87259 0 0 14.4478 0 0 0 13.19046 0 0 14.67194 0 17.31127 14.17721 13.45207 0 15.95776 0 0 0 0 0 0 0 15.31239 15.43074 0 17.18439 0 0 0 0 16.42661 Q6ZMH5 S39A5_HUMAN "Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5, ZIP-5)" SLC39A5 ZIP5 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; eye development [GO:0001654]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neural precursor cell proliferation [GO:0061351]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; zinc ion import across plasma membrane [GO:0071578]" basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] "basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; BMP signaling pathway [GO:0030509]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; eye development [GO:0001654]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neural precursor cell proliferation [GO:0061351]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; zinc ion import across plasma membrane [GO:0071578]" zinc ion transmembrane transporter activity [GO:0005385] GO:0001654; GO:0005385; GO:0005887; GO:0006882; GO:0016323; GO:0030509; GO:0034224; GO:0048026; GO:0061351; GO:0070062; GO:0070315; GO:0071578 LGQHGPLTGR 5.610000134 1 1 0.202727813 1036.514287 0 18.6214 0 18.04491 0 0 18.18083 17.50788 17.63156 0 0 20.19158 0 17.93926 0 0 16.45391 0 16.0226 0 0 0 0 18.27463 17.98511 0 19.58295 0 0 0 18.5331 18.29679 18.9081 17.81596 0 0 0 0 19.19103 17.99221 0 17.62256 16.86606 17.5131 0 17.8938 0 16.74514 Q6ZMI0 PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1) PPP1R21 CCDC128 KLRAQ1 Homo sapiens (Human) early endosome [GO:0005769]; membrane [GO:0016020] early endosome [GO:0005769]; membrane [GO:0016020] GO:0005769; GO:0016020 EALTEEMK 1.070000052 1 1 0.179231956 967.4810407 0 0 14.30791 11.58116 14.84433 0 14.41224 0 0 0 0 0 0 0 0 0 11.71068 15.98741 16.04863 0 13.73386 15.64382 0 0 0 0 13.74931 13.88608 14.94879 0 15.55265 0 15.10612 0 0 0 0 0 0 0 15.43898 0 0 0 0 0 0 0 Q6ZMI3 GLDN_HUMAN Gliomedin [Cleaved into: Gliomedin shedded ectodomain ] GLDN COLM UNQ9339/PRO34011 Homo sapiens (Human) clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]; signal transduction [GO:0007165] axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]; signal transduction [GO:0007165] protein binding involved in heterotypic cell-cell adhesion [GO:0086080] GO:0005581; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0016021; GO:0030424; GO:0032528; GO:0045162; GO:0086080 GGSNTLVR 5.539999962 0.969047904 0.969047904 0.230310853 804.0435335 0 18.23165 16.81208 0 0 0 0 0 0 0 19.90372 0 0 17.71589 0 0 0 0 18.35584 0 0 0 0 17.53105 0 0 0 17.26346 0 0 0 0 0 0 19.61825 0 0 0 0 0 18.35658 0 17.79231 0 0 0 0 0 Q6ZMJ2 SCAR5_HUMAN Scavenger receptor class A member 5 (Scavenger receptor hlg) SCARA5 UNQ2938/PRO28700 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to heat [GO:0034605]; endocytosis [GO:0006897]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; ferritin receptor activity [GO:0070287]; scavenger receptor activity [GO:0005044]; cellular iron ion homeostasis [GO:0006879]; cellular response to heat [GO:0034605]; endocytosis [GO:0006897]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207] ferritin receptor activity [GO:0070287]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005887; GO:0006879; GO:0006897; GO:0009897; GO:0034605; GO:0034755; GO:0070207; GO:0070287 FGQGTGR 11.43999958 0.988149881 0.988149881 0.16306197 724.3357967 15.53252 14.12286 0 14.24412 0 0 0 13.58724 14.76769 15.97935 0 0 13.29537 0 16.87322 0 0 16.25792 0 0 0 16.18153 16.55386 17.05498 17.42308 15.95772 16.59417 14.08924 0 14.35392 14.19779 16.35894 16.96027 0 15.58999 17.71916 15.58698 15.73068 15.63873 15.68828 15.84945 15.41197 16.37968 0 16.29956 0 16.04126 15.45748 Q6ZMJ4 IL34_HUMAN "Interleukin-34, IL-34" IL34 C16orf77 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157] GO:0001934; GO:0005125; GO:0005157; GO:0005576; GO:0005615; GO:0006954; GO:0008083; GO:0008284; GO:0010628; GO:0010759; GO:0042802; GO:0043406; GO:0045087; GO:0045651; GO:0045657; GO:0048714; GO:0061098; GO:0061514; GO:0061518; GO:0120041 AQGEGLLP 1.75999999 1 1 0.1997302 784.6670286 12.25625 15.0568 16.14116 15.44788 14.29137 12.0634 15.88301 15.55599 15.09626 14.32722 15.03689 0 0 0 16.37828 15.30198 0 0 0 0 0 0 0 0 0 0 0 0 0 15.79369 0 16.87126 0 0 16.07307 16.08935 0 0 16.61503 0 0 0 0 14.57042 0 0 0 14.83204 Q6ZMP0 THSD4_HUMAN "Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6, ADAMTS-like protein 6, ADAMTSL-6)" THSD4 UNQ9334/PRO34005 Homo sapiens (Human) elastic fiber assembly [GO:0048251] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; hydrolase activity [GO:0016787]; elastic fiber assembly [GO:0048251] hydrolase activity [GO:0016787] GO:0001527; GO:0016787; GO:0048251; GO:0062023; GO:0070062 GGQRPGAPAR 3.140000105 1 1 0.225362205 966.0910417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41303 0 0 0 0 0 0 0 19.56046 Q6ZMS4 ZN852_HUMAN Zinc finger protein 852 ZNF852 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 NMMESSELTPK 7.460000038 0.851217747 0.851217747 0.475945268 1283.619266 0 0 0 0 15.03548 15.58706 0 14.55075 0 0 0 0 0 0 0 15.78171 13.80298 0 15.15326 0 16.96557 0 0 0 14.14773 0 16.01922 0 0 0 15.179 16.25313 14.57775 16.9112 17.39978 16.4164 18.53027 0 0 0 0 0 17.35078 16.88588 17.02922 16.71126 17.81105 17.08427 Q6ZMS7 ZN783_HUMAN Zinc finger protein 783 ZNF783 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0042802 NRPGGPSR 11.31999969 1 1 0.26034785 837.2964795 19.37145 14.92237 0 0 0 0 18.9014 17.68141 19.57246 19.81334 18.40099 17.78484 18.71585 0 0 0 0 0 17.17703 0 17.99417 0 0 0 17.51092 0 0 0 0 0 0 0 19.47417 18.37764 0 0 18.7757 0 18.71913 0 18.96354 0 0 18.16187 19.5661 0 0 0 Q6ZMT1 STAC2_HUMAN SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2) STAC2 Homo sapiens (Human) positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]; metal ion binding [GO:0046872]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009] metal ion binding [GO:0046872] GO:0003009; GO:0005829; GO:0031234; GO:0042383; GO:0046872; GO:1901387; GO:1903078 ENEPDDAATHSPPGTVSALQETK 1.320000052 1 1 2.74E-12 2393.046594 13.33499 13.24389 0 12.20123 11.53032 0 0 0 15.46464 15.1699 0 0 12.11878 0 0 0 12.42504 15.48958 0 12.65614 0 0 12.20378 0 0 0 11.39095 0 0 0 0 14.18455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMT4 KDM7A_HUMAN "Lysine-specific demethylase 7A (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7) ([histone H3]-dimethyl-L-lysine9 demethylase 7A, EC 1.14.11.65)" KDM7A JHDM1D KDM7 KIAA1718 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558; GO:0140683 NLLETLKELR 4.539999962 1 1 0.449147815 1229.621787 19.15606 17.82323 17.96379 0 0 0 18.00679 17.2826 19.11306 0 17.53553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.34624 0 0 0 0 18.16497 0 19.05362 15.70194 17.3261 0 0 0 0 0 0 17.49058 16.93753 0 0 0 18.42563 0 Q6ZMT9 DTHD1_HUMAN Death domain-containing protein 1 DTHD1 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 GTCASVKVYK 8.130000114 1 1 0.370295066 1112.170986 0 0 0 0 0 0 0 0 0 0 0 17.4569 0 0 0 0 0 0 0 15.67446 16.79182 0 0 0 0 15.65838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.87063 0 18.60455 0 0 0 0 Q6ZMV5 P4R3C_HUMAN Protein PPP4R3C (SMEK homolog 3) (Serine/threonine-protein phosphatase 4 regulatory subunit 3C) PPP4R3C PPP4R3CP SMEK3P Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289] nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] protein phosphatase activator activity [GO:0072542] GO:0005654; GO:0006470; GO:0006974; GO:0030289; GO:0072542 EDETSPK 13.81999969 1 1 0.224999546 805.5689811 13.7312 15.38124 15.26924 11.92994 12.56594 14.66236 15.66826 15.04517 0 15.54588 12.79998 15.97293 0 0 0 0 0 0 0 15.93852 0 15.83053 0 0 0 0 0 0 0 0 0 16.50715 0 14.62718 0 0 0 16.03622 15.23924 0 0 0 0 0 16.11145 18.47098 15.22183 0 Q6ZMV7 LEKR1_HUMAN Protein LEKR1 LEKR1 Homo sapiens (Human) AMEKEMK 5.46999979 1 1 2.30E-13 897.4407193 14.91072 0 0 12.89285 0 15.79099 0 0 0 0 0 0 0 15.33448 16.01661 13.60588 14.17546 0 0 14.99733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMV8 ZN730_HUMAN Putative zinc finger protein 730 ZNF730 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 GALTFR 4.170000076 1 1 0.216947166 663.8245054 0 0 16.75937 0 0 0 0 0 0 0 0 12.51753 0 0 0 0 0 15.68414 0 0 0 19.19586 19.46737 19.69497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6807 16.86986 16.47275 17.56417 0 0 0 0 0 0 Q6ZMV9 KIF6_HUMAN Kinesin-like protein KIF6 KIF6 C6orf102 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887 LEVGADMR 22.95999908 1 1 0.266353557 905.6269997 0 17.95393 0 0 0 0 18.26311 0 0 18.00732 18.63911 18.85257 0 17.52856 0 0 0 0 0 17.57106 0 0 17.09691 0 17.60749 17.67107 18.12384 0 18.24765 17.59577 0 17.85389 0 0 18.09223 0 19.23143 17.97295 0 0 18.38266 0 0 0 0 17.47842 0 17.5672 Q6ZMW2 ZN782_HUMAN Zinc finger protein 782 ZNF782 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 AHPGD 1.179999948 0.271086961 0.271086961 0.187922573 497.2735227 15.98213 16.7364 0 15.59683 15.74116 16.19472 14.47655 0 15.54762 16.5865 16.56359 15.85213 15.03318 14.04282 16.00668 16.51904 14.9955 15.82873 12.86346 15.64413 15.22059 15.67534 15.93473 13.14081 15.23112 10.55119 15.83676 13.54257 0 15.79852 14.83209 15.18852 14.84438 15.40745 15.52937 14.47514 0 0 0 16.92082 16.21165 0 15.45689 16.61504 16.20319 15.84148 15.52307 16.60115 Q6ZMY3 SPOC1_HUMAN SPOC domain-containing protein 1 SPOCD1 Homo sapiens (Human) "cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" chromosome [GO:0005694]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0005694; GO:0006306; GO:0006351; GO:0007283; GO:0010529; GO:0030154; GO:0031047 LVQALPTVIR 1.879999995 0.457767218 0.457767218 0.249042143 1110.925618 15.47276 0 0 12.89322 0 0 0 15.73653 13.27297 13.81524 15.9949 0 15.40205 13.53535 12.46087 0 0 15.67516 14.26071 16.10136 13.8124 13.09673 0 0 0 0 0 15.13545 15.52681 0 15.31881 0 0 0 0 14.9434 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMZ3 SYNE3_HUMAN "Nesprin-3 (KASH domain-containing protein 3, KASH3) (Nuclear envelope spectrin repeat protein 3)" SYNE3 C14orf139 C14orf49 LINC00341 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360] actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444] GO:0005635; GO:0005640; GO:0005737; GO:0005791; GO:0007010; GO:0007097; GO:0008360; GO:0016020; GO:0016021; GO:0031965; GO:0034993; GO:0051015; GO:0090150; GO:0140444 MEVDSGK 1.269999981 1 1 0.187523824 779.0529084 14.03006 14.55278 0 0 0 14.33679 0 0 0 0 15.93755 15.15933 16.54176 0 0 15.06856 0 0 0 0 0 0 15.38752 15.15436 0 0 12.63075 15.5693 14.31814 0 16.19948 0 0 15.62217 14.80713 14.8499 15.43268 14.20698 15.60359 14.91496 0 0 0 0 0 14.15478 0 0 Q6ZN04 MEX3B_HUMAN RNA-binding protein MEX3B (RING finger and KH domain-containing protein 3) (RING finger protein 195) MEX3B KIAA2009 RKHD3 RNF195 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] calcium ion binding [GO:0005509]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005509; GO:0005654; GO:0005829; GO:0006468; GO:0046777 KEDVAMAR 1.409999967 1 1 1.16E-13 936.1005313 0 0 16.37633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.29703 0 0 0 0 0 0 13.33729 0 0 0 0 0 0 12.40666 0 15.13945 14.19002 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN17 LN28B_HUMAN "Protein lin-28 homolog B, Lin-28B" LIN28B CSDD2 Homo sapiens (Human) miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779] RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0008270; GO:0010587; GO:0031054; GO:0031123; GO:0050779; GO:1990837; GO:2000627; GO:2000632; GO:2000635 SPQEASSTK 5.269999981 1 1 0.252551318 934.4727222 17.78372 17.30377 17.38899 17.72744 0 0 17.02946 0 17.22 0 18.44346 17.88331 0 0 0 0 18.44079 18.60336 0 16.24532 0 18.05649 15.95818 0 17.35153 0 18.50425 0 17.16495 16.86428 18.25651 18.9515 18.48635 0 0 0 17.8253 0 0 17.56307 0 0 0 0 0 0 0 16.71247 Q6ZN19 ZN841_HUMAN Zinc finger protein 841 ZNF841 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 VFSYYSCLAR 8.779999733 0.287344337 0.287344337 0.570676736 1265.543441 0 0 0 0 18.33156 0 0 0 0 0 0 0 0 17.13891 0 0 0 0 0 0 0 0 0 0 0 0 0 18.39185 0 17.85265 19.69151 18.73642 0 0 0 0 0 19.13866 0 0 17.42623 0 18.03236 0 0 0 0 0 Q6ZN28 MACC1_HUMAN Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944] growth factor activity [GO:0008083] GO:0005634; GO:0005737; GO:0005739; GO:0008083; GO:0045944; GO:0051781 IAQSMSEANLIDMEAGK 6.03000021 1 1 0.18734869 1822.93191 0 0 0 0 0 14.62397 0 13.96572 0 16.3367 0 0 0 0 0 0 0 0 0 0 13.78738 0 0 0 13.08323 17.47635 0 0 16.38726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.53605 Q6ZN30 BNC2_HUMAN Zinc finger protein basonuclin-2 BNC2 Homo sapiens (Human) "endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]" metal ion binding [GO:0046872]; rDNA binding [GO:0000182] GO:0000182; GO:0000785; GO:0003416; GO:0005634; GO:0005654; GO:0006355; GO:0043586; GO:0046872; GO:0060021; GO:0060485 SSMPVK 3.74000001 1 1 0.158823882 662.0285147 0 0 0 0 0 0 0 0 0 0 16.70401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.41265 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN54 DEFI8_HUMAN "Differentially expressed in FDCP 8 homolog, DEF-8" DEF8 Homo sapiens (Human) lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029] metal ion binding [GO:0046872]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029] metal ion binding [GO:0046872] GO:0032418; GO:0045780; GO:0046872; GO:1900029 EAMEARLLLQLQDR 1.929999948 1 1 0.588171077 1702.117442 0 0 0 0 0 0 0 17.87071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN55 ZN574_HUMAN Zinc finger protein 574 ZNF574 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 LQAHEAAHAAAGPGEVLAK 11.89999962 1 1 1.61E-12 1841.749596 17.29191 15.41738 0 11.93419 0 12.92878 13.56121 0 12.50117 0 0 14.6837 14.6678 13.91865 13.3923 13.84575 0 0 13.87975 12.73864 15.41817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN66 GBP6_HUMAN "Guanylate-binding protein 6, EC 3.6.5.- (GTP-binding protein 6, GBP-6) (Guanine nucleotide-binding protein 6)" GBP6 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0006955; GO:0031410; GO:0042742; GO:0042832; GO:0050830; GO:0070062; GO:0071346 IEQDYWQVPR 4.789999962 1 1 0.400071536 1333.493634 12.34773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.54026 0 0 15.69221 0 0 0 16.17866 0 15.12734 0 0 14.44791 14.88549 15.13994 0 0 0 16.06053 0 16.803 0 16.44305 0 17.14915 15.66847 0 0 16.53778 0 0 0 0 Q6ZN84 CCD81_HUMAN Coiled-coil domain-containing protein 81 CCDC81 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 EHLADRTAELER 2.130000114 1 1 0.33808538 1440.309549 14.3848 16.34142 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01819 0 0 16.22533 0 17.56364 0 0 0 0 0 0 0 17.32249 0 0 14.2421 15.03777 15.91738 0 0 17.22061 0 16.26769 14.9726 16.99956 0 15.38977 16.07169 16.39536 14.05786 16.53552 17.17672 Q6ZN92 DUTL_HUMAN "Putative inactive deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323, dUTPase-like protein" Homo sapiens (Human) dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081] dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081] dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287] GO:0000287; GO:0004170; GO:0006226; GO:0046081 MPVIPALGEAK 5.710000038 0.987504363 0.987504363 0.238724375 1140.910696 0 0 0 0 0 15.15489 13.73746 0 0 0 0 0 0 0 0 16.02236 16.13251 16.13864 0 0 0 0 0 0 15.65603 0 0 0 0 0 17.04853 15.53795 0 0 0 0 14.12291 0 0 0 0 0 0 0 11.82625 0 0 0 Q6ZNA4 RN111_HUMAN "E3 ubiquitin-protein ligase Arkadia, EC 2.3.2.27 (RING finger protein 111, hRNF111) (RING-type E3 ubiquitin transferase Arkadia)" RNF111 Homo sapiens (Human) "global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630]; global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]" metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0007389; GO:0016567; GO:0016605; GO:0030511; GO:0030579; GO:0031398; GO:0032184; GO:0032991; GO:0045893; GO:0046332; GO:0046872; GO:0061630; GO:0070911 EVLARR 4.53000021 1 1 0.216326958 742.6326297 15.38414 15.66181 11.47904 15.73384 16.50628 14.60631 15.33285 17.11176 0 0 0 0 0 15.05389 0 0 0 0 0 0 0 15.23876 0 0 15.58572 14.88526 13.34185 0 14.97731 0 0 14.1928 0 0 0 14.87529 12.43778 0 0 0 15.29399 14.46276 16.81742 14.95922 0 0 0 0 Q6ZNA5 FRRS1_HUMAN "Ferric-chelate reductase 1, EC 1.-.-.- (Stromal cell-derived receptor 2, SDR-2)" FRRS1 SDFR2 SDR2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]; cellular iron ion homeostasis [GO:0006879]" "metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]" GO:0006879; GO:0016021; GO:0016722; GO:0046872 GFLLEAR 6.440000057 1 1 0.156893908 803.4904085 0 11.03274 0 12.10163 0 0 12.3059 0 12.67185 15.24376 12.70609 16.31647 0 0 15.21957 0 0 14.94321 16.0502 0 0 0 0 13.64825 0 14.73997 14.79501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.07051 0 0 Q6ZNB6 NFXL1_HUMAN "NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein, hOZFP)" NFXL1 OZFP Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634] "chromatin [GO:0000785]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006355; GO:0008270; GO:0016020; GO:0016021 KITTADVNEK 10.14999962 0.937030971 0.937030971 0.166745901 1118.855991 0 15.73119 13.4548 0 13.28611 0 15.24537 14.38774 15.89131 0 15.61868 0 10.51893 16.11676 13.59138 13.59448 14.42321 14.95776 14.15452 14.58116 0 0 14.99854 14.77673 0 0 14.98255 14.86102 0 0 0 0 13.60324 0 0 0 12.23449 14.83661 15.83929 0 0 0 0 0 0 0 0 0 Q6ZNE9 RUFY4_HUMAN RUN and FYVE domain-containing protein 4 RUFY4 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cellular response to interleukin-4 [GO:0071353]; positive regulation of macroautophagy [GO:0016239] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; cellular response to interleukin-4 [GO:0071353]; positive regulation of macroautophagy [GO:0016239] metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266] GO:0000045; GO:0005776; GO:0016239; GO:0031410; GO:0032266; GO:0046872; GO:0071353 EQEGELQALREQLSR 5.949999809 1 1 0.547402159 1785.170517 0 0 0 0 0 0 0 18.76529 0 17.19944 19.01527 0 0 0 0 18.66643 0 0 0 0 0 0 0 0 0 19.33578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNG1 ZN600_HUMAN Zinc finger protein 600 ZNF600 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 STLESHKR 1.879999995 0.046104979 0.046104979 0.213126054 957.4649389 14.3922 14.67816 0 16.31802 16.39114 14.26418 0 0 15.52929 0 0 0 0 0 0 15.57854 15.34696 16.35687 15.65102 16.36901 15.26543 14.94419 0 16.13031 16.98499 0 16.67529 14.72159 16.16991 13.26001 15.57617 16.22253 16.5397 16.71991 14.75634 15.16774 14.96581 16.14425 14.74488 11.99363 0 0 14.76684 15.04108 15.53138 15.82453 16.30046 14.97716 Q6ZNG9 KRBA2_HUMAN KRAB-A domain-containing protein 2 KRBA2 Homo sapiens (Human) "DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]" "nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]" nucleic acid binding [GO:0003676] GO:0003676; GO:0006355; GO:0015074 YHPGQSQGSLEGASR 7.099999905 1 1 0.500064173 1571.885067 0 0 0 0 0 0 0 0 0 0 0 17.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.07748 0 0 0 Q6ZNI0 GCNT7_HUMAN "Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7, EC 2.4.1.-" GCNT7 C20orf105 Homo sapiens (Human) protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; protein glycosylation [GO:0006486] acetylglucosaminyltransferase activity [GO:0008375] GO:0000139; GO:0006486; GO:0008375; GO:0016021 SGLVVR 3.220000029 0.714221954 0.714221954 0.146811862 630.0413954 15.36921 0 16.03163 14.68951 0 12.09084 13.42761 0 13.30351 19.21861 17.71853 16.89226 16.42257 0 0 0 16.38452 15.88396 14.41585 14.64788 14.83216 0 12.19012 15.94664 15.59192 16.61783 15.45549 15.91249 8.854975 14.83602 16.51988 16.42504 16.26769 0 15.27001 16.35806 0 14.35812 15.98771 16.59914 16.69357 0 0 14.82258 14.03326 0 0 0 Q6ZNJ1 NBEL2_HUMAN Neurobeachin-like protein 2 NBEAL2 KIAA0540 UNQ253/PRO290 Homo sapiens (Human) platelet formation [GO:0030220]; protein localization [GO:0008104] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; protein kinase binding [GO:0019901]; platelet formation [GO:0030220]; protein localization [GO:0008104] protein kinase binding [GO:0019901] GO:0005783; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019901; GO:0030220; GO:0070821; GO:0101003 DVVNCVGGMGALLPLLER 6.699999809 1 1 0.391302468 1929.358425 0 14.87446 0 13.88015 0 13.01012 0 14.19505 0 0 13.95365 0 0 14.18105 14.46962 0 0 0 0 0 0 0 15.47151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.60923 Q6ZNL6 FGD5_HUMAN "FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23)" FGD5 ZFYVE23 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] GO:0001726; GO:0005085; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0032587; GO:0043087; GO:0046847; GO:0046872; GO:0051056 AVPGLMR 2.170000076 1 1 0.168159717 761.0574967 0 12.93935 0 14.47044 0 12.78782 15.4345 15.14927 15.7721 13.85138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNM6 TEX43_HUMAN Testis-expressed protein 43 TEX43 C5orf48 Homo sapiens (Human) flagellated sperm motility [GO:0030317] flagellated sperm motility [GO:0030317] GO:0030317 ENMIFR 12.36999989 1 1 0.186786959 808.5740448 0 15.23769 16.326 16.58782 0 0 17.44071 0 0 15.54048 14.40764 16.48022 16.02804 16.06938 0 16.07013 0 0 16.44324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.31796 18.06227 0 0 0 0 0 0 0 17.02512 0 Q6ZNQ3 LRC69_HUMAN Leucine-rich repeat-containing protein 69 LRRC69 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 MPSALGK 13.40999985 1 1 0.251854177 704.1266466 16.53142 0 15.3281 0 0 15.88932 0 15.05034 15.2485 0 16.20963 0 0 15.01586 0 0 16.73772 0 0 13.66178 0 0 16.45446 0 14.89583 15.738 16.45079 14.26431 15.17425 0 0 15.48659 0 0 0 0 0 0 0 16.28007 0 0 0 0 16.50941 0 16.61475 0 Q6ZP01 RBM44_HUMAN RNA-binding protein 44 (RNA-binding motif protein 44) RBM44 Homo sapiens (Human) cytoplasm [GO:0005737]; intercellular bridge [GO:0045171] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0042803; GO:0045171 ENLLLSSNGCDEVK 3.460000038 1 1 0.394884801 1576.183017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.05607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZP82 CC141_HUMAN Coiled-coil domain-containing protein 141 (Coiled-coil protein associated with myosin II and DISC1) CCDC141 CAMDI Homo sapiens (Human) centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799] centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuron projection [GO:0043005] centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799] GO:0005737; GO:0005813; GO:0021799; GO:0043005; GO:0051642 NLQEQSLGSSLSDNEDR 5.179999828 1 1 0.183492127 1890.522817 0 0 0 0 0 0 14.6757 12.85071 14.61105 0 0 0 16.1228 0 0 0 15.08638 14.81607 16.18638 15.48838 0 16.87744 0 0 0 0 0 0 0 0 0 0 0 16.4117 15.99488 0 0 0 0 15.29507 0 16.3686 0 0 0 16.9928 0 16.30993 Q6ZPD9 D19L3_HUMAN "Probable C-mannosyltransferase DPY19L3, EC 2.4.1.- (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)" DPY19L3 Homo sapiens (Human) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] mannosyltransferase activity [GO:0000030] GO:0000030; GO:0005637; GO:0016021; GO:0018406 FGLGATR 1.090000033 1 1 0.198499041 722.0585683 12.90528 0 15.81135 0 0 0 14.74241 0 0 18.72041 0 0 0 0 15.32775 14.94706 0 0 0 17.10483 0 0 0 0 0 0 0 0 15.28695 0 0 15.55452 0 0 0 0 16.26067 14.61485 15.8329 0 0 14.56842 0 15.86564 16.28413 0 15.71353 0 Q6ZQQ2 S31D1_HUMAN Spermatogenesis-associated protein 31D1 (Protein FAM75D1) SPATA31D1 FAM75D1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 IHESLSLLRPQSK 9.539999962 1 1 0.443838658 1507.701457 17.11801 0 0 0 0 0 0 17.11862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.88385 0 0 0 0 0 0 0 0 0 0 0 0 18.81694 0 0 0 0 0 0 18.08196 0 0 17.38021 0 0 Q6ZQQ6 WDR87_HUMAN WD repeat-containing protein 87 (Testis development protein NYD-SP11) WDR87 Homo sapiens (Human) DLASKGNLEWLHLAK 8.590000153 1 1 0.462342582 1695.816133 0 19.07167 18.2895 19.49729 16.55384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.92593 17.79589 0 17.76499 0 21.25944 20.66252 0 0 0 0 0 20.05061 17.56072 0 0 0 0 0 0 17.93069 0 17.16499 0 19.15076 0 0 0 0 Q6ZQW0 I23O2_HUMAN "Indoleamine 2,3-dioxygenase 2, IDO-2, EC 1.13.11.- (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1)" IDO2 INDOL1 Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process to kynurenine [GO:0019441]" "heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]" GO:0002376; GO:0004833; GO:0005737; GO:0005829; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872 TLGQMHDYVDPDIFYAGIR 3.309999943 1 1 2.29E-12 2228.234921 11.57133 14.07743 14.19972 12.06888 12.37487 14.19105 14.95985 14.07666 0 13.83628 0 0 0 11.60963 14.05363 14.37977 14.90501 0 0 11.84183 0 0 0 0 0 14.77956 16.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 14.53232 0 0 0 13.81695 0 0 0 Q6ZQX7 LIAT1_HUMAN Protein LIAT1 (Ligand of ATE1 protein) LIAT1 C17orf97 Homo sapiens (Human) protein arginylation [GO:0016598] protein arginylation [GO:0016598] GO:0016598 HQSQSLK 9.090000153 1 1 0.202147417 826.8173045 15.92867 15.67363 0 0 15.02283 0 15.67924 0 16.01167 16.38154 16.66221 15.71844 15.75007 0 15.92125 0 16.529 0 15.39505 16.2915 0 16.18652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6079 0 0 0 Q6ZQY2 LR74B_HUMAN Leucine-rich repeat-containing protein 74B LRRC74B Homo sapiens (Human) ISAMGALSLGLGLR 5.420000076 0.81687516 0.81687516 0.083624417 1369.524379 14.47793 14.99819 11.60061 0 14.54095 0 0 0 0 13.45996 14.94085 9.316155 13.7991 12.08907 11.87899 12.95603 0 0 0 0 15.13678 0 0 0 0 0 13.48448 0 14.1727 13.63854 0 0 0 0 12.59304 0 0 0 0 0 16.00937 0 0 0 11.83557 16.86595 13.61713 0 Q6ZR08 DYH12_HUMAN Dynein axonemal heavy chain 12 (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein axonemal heavy chain 7-like) (Dynein heavy chain domain-containing protein 2) DNAH12 DHC3 DLP12 DNAH12L DNAH7L DNAHC3 DNHD2 HDHC3 HL19 Homo sapiens (Human) microtubule-based movement [GO:0007018] cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874] cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; minus-end-directed microtubule motor activity [GO:0008569] GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286 EIYDSKEPHNAK 4.059999943 1 1 6.89E-13 1430.851216 13.60365 15.91366 14.65573 14.34304 0 15.39054 0 0 0 0 14.87341 11.32011 11.46222 13.78264 15.15165 0 0 0 14.21144 12.66419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.64509 0 0 0 0 0 0 0 Q6ZRF8 RN207_HUMAN RING finger protein 207 RNF207 C1orf188 Homo sapiens (Human) cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207] chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901018; GO:1901207; GO:1902261; GO:1903762; GO:1903954 NNAASAR 6.019999981 1 1 0.245510173 703.9150358 15.67337 15.31946 15.97153 14.84503 15.40576 14.54138 0 15.34091 14.0801 15.06277 13.40683 0 14.43247 13.66616 15.0191 15.50653 14.56077 0 16.8862 0 16.28952 0 0 16.5298 15.33868 14.81421 14.67272 0 0 0 0 0 0 16.08638 0 0 0 0 0 16.28608 14.98925 17.80222 0 0 0 17.0612 0 0 Q6ZRI0 OTOG_HUMAN Otogelin OTOG OTGN Homo sapiens (Human) adult locomotory behavior [GO:0008344]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; alpha-L-arabinofuranosidase activity [GO:0046556]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] alpha-L-arabinofuranosidase activity [GO:0046556]; structural molecule activity [GO:0005198] GO:0005198; GO:0005615; GO:0007605; GO:0008344; GO:0016324; GO:0031012; GO:0046373; GO:0046556 VLGKGPYQLSSLAAGGALVGMK 8.229999542 1 1 1.37E-12 2133.139393 15.72857 14.26614 0 0 0 15.04062 14.93032 0 13.228 15.99417 14.01045 14.42035 16.43643 14.50166 13.28195 14.98019 0 0 0 0 0 0 14.66635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.45324 0 0 0 0 0 15.85855 0 Q6ZRI6 CO039_HUMAN Uncharacterized protein C15orf39 C15orf39 FP6578 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 QLGDFDTEAGAVSSSEPTVAR 5.949999809 1 1 0.163927966 2137.562045 0 0 14.97934 0 0 0 0 16.20918 0 0 13.71102 15.83357 0 0 14.01317 12.59428 0 14.88674 0 0 0 16.22662 0 0 14.99956 0 0 0 0 11.94382 0 0 0 15.37911 0 0 0 0 0 0 0 14.18224 0 0 0 0 0 0 Q6ZRI8 RHG36_HUMAN Rho GTPase-activating protein 36 ARHGAP36 Homo sapiens (Human) signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0007165 ISFPIGQRLLGSK 1.879999995 0.799538791 0.799538791 0.124766707 1415.320243 0 0 14.41303 11.1648 0 11.97877 0 0 0 0 0 0 0 0 0 12.33008 0 0 0 14.64504 0 0 0 0 0 0 0 0 13.73907 0 13.7493 12.93078 0 0 0 0 13.76864 0 0 0 0 13.87063 0 0 0 0 0 0 Q6ZRK6 CCD73_HUMAN Coiled-coil domain-containing protein 73 (Sarcoma antigen NY-SAR-79) CCDC73 Homo sapiens (Human) DVKTAVHMK 10.18000031 1 1 0.204988788 1044.360918 14.72969 15.08146 0 0 0 0 16.28897 0 15.68115 15.09363 0 0 14.91053 16.04436 15.70846 15.26095 0 0 0 15.20046 15.8984 0 15.13705 14.33215 15.79343 16.81698 15.9563 0 15.08479 15.04513 16.62061 0 0 16.0883 0 0 0 0 0 15.74008 14.94246 14.99097 0 16.64967 0 0 0 0 Q6ZRQ5 MMS22_HUMAN Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like) MMS22L C6orf167 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] GO:0000724; GO:0005654; GO:0005829; GO:0031297; GO:0043596 LLFNLSEVKSIFSK 9.119999886 1 1 0.484675441 1623.568231 19.26542 0 17.52936 0 18.4668 0 0 19.16281 0 0 0 18.5892 18.80451 18.18488 18.91621 0 19.01184 19.8435 17.59909 0 0 18.47396 19.31864 0 0 18.26397 0 0 0 0 20.33347 0 0 19.88074 0 20.97002 0 0 0 18.34888 0 0 20.24595 0 16.62329 0 0 0 Q6ZRR7 LRRC9_HUMAN Leucine-rich repeat-containing protein 9 LRRC9 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 MEGLESCINLEELTLDGNCISK 1.889999986 1 1 4.57E-12 2525.013892 0 0 0 16.11699 17.13676 0 0 0 14.56587 13.98207 0 0 19.11106 0 0 0 0 13.12517 0 0 0 0 16.3509 0 0 0 14.77195 14.86243 0 0 16.89776 16.44039 17.77619 0 16.366 0 0 0 0 0 0 0 0 0 16.23685 0 0 0 Q6ZRS2 SRCAP_HUMAN "Helicase SRCAP, EC 3.6.4.- (Domino homolog 2) (Snf2-related CBP activator)" SRCAP KIAA0309 Homo sapiens (Human) "histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812] "Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713] GO:0000786; GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043486; GO:0048471; GO:0140658 SPADAGR 4.539999962 1 1 0.270693051 670.9825551 14.92453 0 0 0 0 17.15028 0 14.83025 15.37295 0 16.17673 16.5896 0 0 15.2082 0 0 0 0 0 0 0 0 0 0 15.4916 0 15.17224 15.94536 0 16.07818 0 14.18029 14.54539 16.27881 16.0591 16.37721 16.41011 0 14.18353 13.79009 15.47002 15.88373 15.39917 16.72136 0 0 16.67621 Q6ZS17 RIPR1_HUMAN Rho family-interacting cell polarization regulator 1 RIPOR1 FAM65A KIAA1930 Homo sapiens (Human) cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506]; 14-3-3 protein binding [GO:0071889]; cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] 14-3-3 protein binding [GO:0071889] GO:0005737; GO:0005794; GO:0007266; GO:0009267; GO:0009611; GO:0012506; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0070062; GO:0071889; GO:0090316; GO:1990869; GO:2001107 ASTVTK 17.17000008 1 1 0.266825491 607.2605138 16.57853 0 0 0 0 16.94742 0 17.63538 18.36505 0 0 19.01068 0 17.4906 0 0 0 0 0 0 18.57503 0 16.82645 0 0 0 0 0 18.08046 17.51166 0 0 0 0 0 19.55922 0 0 0 18.16818 17.76488 0 0 17.64777 18.30966 0 0 0 Q6ZS30 NBEL1_HUMAN Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein) NBEAL1 ALS2CR16 ALS2CR17 Homo sapiens (Human) protein localization [GO:0008104] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; protein kinase binding [GO:0019901]; protein localization [GO:0008104] protein kinase binding [GO:0019901] GO:0005829; GO:0008104; GO:0016020; GO:0019901 DREGGESK 1.850000024 0.447268397 0.447268397 0.163314236 878.2881817 0 0 0 0 0 0 15.13271 15.85631 0 0 0 0 0 0 0 0 16.34282 14.09173 0 16.7251 0 0 0 0 0 0 0 0 0 14.96677 0 0 0 0 0 0 0 0 19.06042 0 0 0 0 0 0 0 16.19872 0 Q6ZS46 YF009_HUMAN Putative uncharacterized protein FLJ45840 Homo sapiens (Human) AGLPEGKGPGGR 6.429999828 0.502664387 0.502664387 0.203663525 1098.820485 0 0 16.13989 14.64968 13.44408 13.56956 0 11.50507 14.30847 0 0 0 0 0 0 0 0 0 0 0 0 12.1957 0 0 0 14.0506 0 13.83502 9.030363 14.88587 0 0 0 0 0 14.97198 0 14.12544 0 0 0 14.55003 14.91798 0 0 16.39381 0 0 Q6ZS81 WDFY4_HUMAN WD repeat- and FYVE domain-containing protein 4 WDFY4 C10orf64 KIAA1607 Homo sapiens (Human) "antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]" early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783] "early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]" GO:0005769; GO:0005783; GO:0006914; GO:0019882; GO:0036037; GO:0098586 ILVTPK 4.389999866 1 1 0.042559992 670.5409878 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1168 0 15.1572 0 0 0 0 0 14.9452 0 16.03288 0 0 0 0 16.84643 0 0 0 0 0 0 16.79763 0 17.09657 0 0 0 0 0 0 0 0 0 0 Q6ZS82 R9BP_HUMAN Regulator of G-protein signaling 9-binding protein (RGS9-anchoring protein) RGS9BP R9AP Homo sapiens (Human) detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] GO:0001750; GO:0007186; GO:0009968; GO:0016021; GO:0043005; GO:0050908 DRGLAADER 20.96999931 1 1 0.427900772 1002.272915 0 0 19.08243 0 19.80266 0 16.46565 0 20.26145 19.12283 19.15325 19.57714 0 0 0 0 0 0 0 18.92135 0 0 0 0 19.05546 0 0 19.13809 0 0 0 19.96567 0 0 0 19.19428 19.84891 0 19.70995 0 0 0 0 18.83263 17.90948 18.71238 19.14541 0 Q6ZS86 GLPK5_HUMAN "Putative glycerol kinase 5, GK 5, Glycerokinase 5, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 5)" GK5 Homo sapiens (Human) glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641] mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]" "ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167 AAGIQMNQIVGLGISTQR 4.309999943 1 1 0.309783014 1856.369268 14.64969 14.72286 0 0 0 0 0 0 0 0 0 15.18801 15.46449 15.31541 16.31688 0 0 0 0 16.74529 16.00215 16.14178 17.03504 0 0 0 16.19985 0 15.99505 16.69434 0 0 15.22113 16.58323 15.62219 0 0 16.37067 14.4207 15.07193 0 15.97686 15.23595 0 0 16.46063 0 16.19981 Q6ZS92 YD022_HUMAN Putative uncharacterized protein FLJ45721 Homo sapiens (Human) VRLSIGLADFGLPGIAR 10.14000034 1 1 0.251337867 1754.693721 15.7468 0 13.44449 18.23376 15.01731 0 2.407135 0 17.80356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.39239 0 0 16.47338 0 0 0 0 0 18.06248 16.74146 0 0 15.55502 0 0 0 0 0 0 0 0 0 0 Q6ZSC3 RBM43_HUMAN RNA-binding protein 43 (RNA-binding motif protein 43) RBM43 C2orf38 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 APERTVVVAGLPVDLFSDQLLAVLVK 5.570000172 1 1 3.21E-12 2749.640429 14.59717 0 8.62534 11.69773 0 0 0 11.59902 0 0 0 0 0 0 0 12.35711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.51415 0 0 0 Q6ZSG2 INSY2_HUMAN "Inhibitory synaptic factor 2A, InSyn2" INSYN2A C10orf141 FAM196A INSYN2 Homo sapiens (Human) inhibitory postsynaptic potential [GO:0060080] postsynaptic density [GO:0014069] postsynaptic density [GO:0014069]; inhibitory postsynaptic potential [GO:0060080] GO:0014069; GO:0060080 YMTVPAR 5.789999962 1 1 0.178537549 853.1153199 0 0 13.28305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.56045 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSK4 NTAS1_HUMAN Putative uncharacterized protein NTM-AS1 (NTM antisense RNA 1) (NTM antisense gene protein 1) NTM-AS1 C11orf39 Homo sapiens (Human) GEGCTDPEIK 7.710000038 0.885463953 0.885463953 0.183637956 1106.254628 14.64123 12.69474 0 10.06859 16.15438 0 0 0 13.01526 0 17.94948 0 0 0 14.49682 0 0 0 0 0 0 0 0 0 0 0 15.22591 0 0 0 0 16.08982 0 14.31792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSN1 YI023_HUMAN Putative uncharacterized protein FLJ45355 Homo sapiens (Human) GGRGAGSQSLPR 17.48999977 0.127023533 0.127023533 0.062753535 1141.523326 0 0 16.42623 13.68972 0 0 12.3242 13.27086 0 16.94868 0 13.66331 14.97583 0 13.75908 0 8.281269 0 11.87022 15.95285 12.55318 13.66723 12.41319 14.37772 15.40558 0 0 0 0 14.23922 17.42662 17.6692 11.08839 15.41175 15.6077 15.26148 12.33652 16.4263 0 0 0 0 0 0 14.51708 0 0 0 Q6ZSZ5 ARHGI_HUMAN "Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor, p114-Rho-GEF, p114RhoGEF) (Septin-associated RhoGEF, SA-RhoGEF)" ARHGEF18 KIAA0521 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872] GO:0005085; GO:0005829; GO:0005856; GO:0005886; GO:0007264; GO:0008360; GO:0016324; GO:0030036; GO:0030054; GO:0035023; GO:0045177; GO:0046872; GO:0051497; GO:0070062; GO:0150105 MGDDQEDDFPRR 12.03999996 1 1 0.178151254 1479.676618 0 0 0 0 0 15.09223 0 13.5075 0 0 0 13.93791 0 13.72513 0 0 0 0 0 15.59949 16.5167 0 0 0 0 15.56191 14.89402 0 16.90973 17.61514 0 0 0 0 0 0 17.70733 15.92266 14.78777 0 0 0 15.45961 0 16.62905 15.43505 0 15.05058 Q6ZSZ6 TSH1_HUMAN Teashirt homolog 1 (Antigen NY-CO-33) (Serologically defined colon cancer antigen 33) TSHZ1 SDCCAG33 TSH1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; middle ear morphogenesis [GO:0042474]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; anterior/posterior pattern specification [GO:0009952]; middle ear morphogenesis [GO:0042474]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0009952; GO:0042474; GO:0046872; GO:0060023 SNVSAMEELVEKVTGK 1.980000019 1 1 0.025850825 1736.743669 14.6196 0 15.01561 0 15.47177 14.04147 13.16917 13.36036 0 15.15164 15.47662 16.07176 15.13454 15.63184 14.48059 0 0 0 0 0 15.25142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.06622 0 Q6ZT07 TBCD9_HUMAN TBC1 domain family member 9 (TBC1 domain family member 9A) TBC1D9 KIAA0882 TBC1D9A Homo sapiens (Human) activation of GTPase activity [GO:0090630] calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] GO:0005096; GO:0005509; GO:0090630 ADLIEQMRFK 14.97000027 1 1 0.107616558 1249.534829 10.23698 17.03383 16.74157 17.43629 0 0 16.5572 16.95363 18.74621 16.64306 16.01186 0 18.21175 0 18.76781 0 0 17.62837 0 16.39122 17.44315 18.96471 0 18.68389 17.88995 17.52231 17.90289 17.2462 17.41199 0 16.26155 0 17.82115 18.43197 18.66026 0 18.82049 19.75104 20.25979 18.29682 18.14811 19.1514 18.40311 17.61248 16.09509 0 16.93706 16.99449 Q6ZT12 UBR3_HUMAN "E3 ubiquitin-protein ligase UBR3, EC 2.3.2.27 (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)" UBR3 KIAA2024 ZNF650 Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016021; GO:0016567; GO:0061630; GO:0071596 APVFEPGGSMQQGMYTPK 2.99000001 1 1 0.440953261 1939.041451 0 13.37307 14.97023 0 14.26654 0 0 14.93647 10.71993 15.37802 14.89547 0 0 11.53692 0 14.18612 0 15.83798 15.58923 0 0 0 0 0 0 0 0 0 0 0 16.66981 0 15.79432 0 0 16.09658 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZT52 FA43B_HUMAN Protein FAM43B FAM43B Homo sapiens (Human) FVLVEDEAK 2.289999962 1 1 0.080729037 1050.628898 16.4636 0 15.28905 0 16.06334 0 13.95093 0 12.68248 0 0 0 14.16006 0 0 15.78391 15.24726 13.35949 0 0 12.79211 16.62968 0 0 0 14.49337 13.96705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.87677 0 0 0 Q6ZT62 BGIN_HUMAN Bargin (Chimeric SH3BP1-PDXP protein) BARGIN Homo sapiens (Human) negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897] cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; GTPase activator activity [GO:0005096]; linear polyubiquitin binding [GO:1990450]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; linear polyubiquitin binding [GO:1990450] GO:0005096; GO:0005829; GO:0007165; GO:0019897; GO:0032956; GO:0035020; GO:0043547; GO:0051058; GO:1990450 NSGSSQGLGGSPGSHSHTTMANKVETLK 4.989999771 1 1 0 2785.702372 14.9278 15.38184 15.43609 13.63883 0 0 0 15.06309 14.18325 0 15.4447 0 12.7437 0 15.25105 14.41257 4.854673 0 0 16.04261 14.91606 0 0 0 0 0 14.29612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZT89 S2548_HUMAN Solute carrier family 25 member 48 SLC25A48 Homo sapiens (Human) acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; acyl carnitine transmembrane transporter activity [GO:0015227]; acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865] acyl carnitine transmembrane transporter activity [GO:0015227] GO:0005743; GO:0006844; GO:0006865; GO:0015227; GO:0016021 CGEPEASPPR 17.30999947 1 1 0.250678488 1099.600528 0 0 0 0 0 0 16.80916 0 17.7522 0 17.81127 0 0 0 0 16.78181 0 17.18298 0 0 0 0 17.18567 16.52233 0 0 0 0 16.58593 0 19.11614 19.27787 0 0 16.64335 0 0 0 17.80469 0 17.28564 16.75884 0 17.86063 0 0 17.67035 0 Q6ZTA4 TRI67_HUMAN Tripartite motif-containing protein 67 (TRIM9-like protein) TRIM67 TNL Homo sapiens (Human) negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of protein localization [GO:0032880] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; zinc ion binding [GO:0008270]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of protein localization [GO:0032880] zinc ion binding [GO:0008270] GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0032880; GO:0046580; GO:2000060 DMMLGK 4.53000021 0.035720307 0.035720307 0.138090305 709.8827728 17.71333 0 0 6.131516 16.74289 13.45485 0 0 0 14.86641 13.82303 0 0 16.84002 12.57641 16.4242 16.54847 0 0 0 0 15.83774 16.20512 15.85202 16.5295 11.67822 13.49796 0 15.76949 12.03296 15.26247 18.58058 17.2294 16.66606 15.61117 12.64308 13.81985 0 15.36498 0 17.25154 16.79212 17.46376 16.24484 0 16.10708 12.99115 17.07151 Q6ZTK2 YP015_HUMAN Putative uncharacterized protein LOC400499 Homo sapiens (Human) GPQQELNLTAAYR 1.909999967 1 1 0.222468549 1460.43653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTQ3 RASF6_HUMAN Ras association domain-containing protein 6 RASSF6 Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] GO:0006915; GO:0007165; GO:0042981 DEPDSPVLYRTMSEAALVR 4.010000229 0.526928902 0.526928902 0.132120513 2165.203127 0 13.5006 11.87158 0 15.82312 0 0 0 0 0 18.34391 0 0 0 15.52834 0 0 0 15.45818 16.5121 14.8563 16.90638 17.12586 0 0 0 13.44595 0 13.89829 15.39756 14.66779 17.91672 15.02667 0 14.60386 0 12.70259 16.1084 14.36803 15.26881 15.389 16.127 0 14.71174 15.14856 15.62151 15.77832 11.60833 Q6ZTQ4 CDHR3_HUMAN Cadherin-related family member 3 (Cadherin-like protein 28) CDHR3 CDH28 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; virus receptor activity [GO:0001618]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; virus receptor activity [GO:0001618] GO:0000902; GO:0001618; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 DPLTQMPK 3.599999905 1 1 0.231687113 932.8506109 16.14562 17.04727 14.3072 0 0 17.325 0 15.57812 13.55672 14.82473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.70586 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTR5 CFA47_HUMAN Cilia- and flagella-associated protein 47 CFAP47 CHDC2 CXorf22 CXorf30 CXorf59 Homo sapiens (Human) sperm axoneme assembly [GO:0007288] sperm connecting piece [GO:0097224] sperm connecting piece [GO:0097224]; sperm axoneme assembly [GO:0007288] GO:0007288; GO:0097224 AATIRSK 6.130000114 1 1 0.147667335 743.3083783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.41508 0 15.4403 0 0 15.70448 0 18.86607 0 0 0 0 0 0 0 17.03285 0 0 0 0 0 0 0 Q6ZTR7 CBAR2_HUMAN CBY1-interacting BAR domain-containing protein 2 (Protein FAM92B) CIBAR2 FAM92B Homo sapiens (Human) cilium assembly [GO:0060271] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271] GO:0005737; GO:0005814; GO:0035869; GO:0036064; GO:0060271 TTLQLEETVDGFQR 3.119999886 1 1 0.351685738 1632.321471 12.58185 0 0 0 0 0 0 0 0 18.27727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTW0 TPGS1_HUMAN "Tubulin polyglutamylase complex subunit 1, PGs1" TPGS1 C19orf20 Homo sapiens (Human) adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202]; microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648] microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740] GO:0005737; GO:0005813; GO:0005874; GO:0007268; GO:0007288; GO:0008017; GO:0018095; GO:0030424; GO:0030425; GO:0030534; GO:0031514; GO:0045202; GO:0051648; GO:0070740 AVGGR 4.71999979 0.074935265 0.074935265 0.137536851 459.286538 16.30457 16.66527 16.96683 16.34553 16.67539 16.55744 16.26052 16.92389 16.43576 16.41677 0 17.17624 16.93756 16.94053 16.37537 17.1463 17.14258 16.51504 17.02778 16.67157 15.70344 16.24898 16.64541 16.99088 17.5435 17.19239 16.9296 15.89563 17.26243 16.46993 17.3497 16.56559 16.30093 16.53043 16.45664 17.34058 16.82299 17.07184 15.8299 16.27344 16.73277 0 16.73513 16.36543 15.39498 16.49528 16.90985 17.0647 Q6ZTY9 CG065_HUMAN Putative uncharacterized protein LINC02902 (Long intergenic non-protein coding RNA 2902) LINC02902 C7orf65 Homo sapiens (Human) ADAESFR 10.47999954 1 1 0.03143856 795.0837883 14.13276 0 0 16.74038 0 0 10.57512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.51349 0 0 0 0 0 0 0 0 13.65004 0 0 0 13.99213 0 13.61932 0 0 0 16.12917 0 0 0 0 0 0 Q6ZU35 CRACD_HUMAN Capping protein-inhibiting regulator of actin dynamics (Cancer-related regulator of actin dynamics) CRACD CRAD KIAA1211 Homo sapiens (Human) epithelial structure maintenance [GO:0010669]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838] cytosol [GO:0005829] cytosol [GO:0005829]; epithelial structure maintenance [GO:0010669]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838] GO:0005829; GO:0010669; GO:0030277; GO:0030838; GO:2000813 TLQQQLGK 8.710000038 1 1 0.187273194 914.5269121 17.82125 14.78856 0 0 16.09562 14.17055 12.38867 0 15.22083 0 0 0 0 0 0 15.39617 0 0 0 0 0 0 0 0 0 0 0 0 14.13734 16.06498 0 0 0 0 0 0 12.84831 13.78161 0 0 0 0 0 0 15.20769 15.74203 0 15.56778 Q6ZU45 CL20A_HUMAN Putative C-type lectin domain family 20 member A CLEC20A Homo sapiens (Human) carbohydrate binding [GO:0030246] carbohydrate binding [GO:0030246] GO:0030246 DLVLVKEALSWYDAQQHCR 2.619999886 1 1 0.189398261 2330.343463 0 16.59768 12.43365 12.4951 12.45574 0 0 15.54961 11.24922 13.78668 13.19464 0 13.24353 0 0 0 14.50353 8.572876 0 14.37768 0 7.29533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZU65 UBN2_HUMAN Ubinuclein-2 UBN2 KIAA2030 Homo sapiens (Human) DNA replication-independent chromatin assembly [GO:0006336] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA replication-independent chromatin assembly [GO:0006336] GO:0005615; GO:0005634; GO:0005654; GO:0006336 GWMQAR 9.890000343 0.152033672 0.152033672 0.328206855 763.8555775 0 0 13.23003 19.45932 0 16.09226 20.16281 0 0 0 20.02765 0 0 16.59673 0 17.33409 0 17.10117 17.13148 17.23437 16.33104 17.08505 19.51339 19.29848 18.01084 0 18.40878 0 16.22442 0 19.48282 0 17.57823 18.39183 18.63085 0 17.1503 19.53702 0 0 0 17.31101 16.78645 16.59109 17.35044 17.48446 16.74777 17.46474 Q6ZU69 F205A_HUMAN Protein FAM205A FAM205A C9orf144B Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 LLEVHVK 2.829999924 1 1 0.042973867 837.3456067 0 0 0 15.69159 0 0 0 13.32347 15.22747 0 0 14.67798 12.11188 13.93947 0 0 0 0 0 0 0 0 0 0 0 11.83839 15.57684 0 0 14.52994 10.4673 0 0 0 12.69316 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZU80 CE128_HUMAN "Centrosomal protein of 128 kDa, Cep128" CEP128 C14orf145 C14orf61 Homo sapiens (Human) protein localization [GO:0008104] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; protein localization [GO:0008104] GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0008104; GO:0120103 SDAETK 2.960000038 1 1 0.102194475 650.0272917 0 0 14.46783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.84996 14.13218 0 16.35403 0 0 0 0 0 0 0 16.03148 14.63817 20.20364 0 0 0 0 0 0 0 0 0 0 0 0 0 16.25558 0 Q6ZUA9 MROH5_HUMAN Maestro heat-like repeat family member 5 MROH5 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 IGQLVGILGMLCQDPDRATQR 12.35999966 1 1 0.261289603 2341.016975 14.28608 16.74374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.73384 0 0 0 0 0 0 0 0 0 0 Q6ZUB1 S31E1_HUMAN Spermatogenesis-associated protein 31E1 (Protein FAM75E1) SPATA31E1 C9orf79 FAM75E1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 SSREPQR 11.43000031 1 1 0.09159735 859.6324452 16.65439 14.96011 0 15.22362 0 0 0 15.9 0 0 0 0 0 0 0 0 0 14.94534 0 12.67252 15.01149 0 0 0 0 0 12.60542 0 15.36533 0 0 0 13.65045 0 0 0 15.5365 0 15.33977 0 0 0 0 0 0 0 0 0 Q6ZUG5 YC006_HUMAN Uncharacterized protein FLJ43738 Homo sapiens (Human) DLLPSSAMIK 4.699999809 1 1 0.682682424 1090.316075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.68363 0 0 0 0 0 18.46575 0 0 0 20.07911 0 0 0 0 0 19.58618 0 0 19.21659 0 0 0 0 0 18.92083 0 0 0 20.46021 Q6ZUI0 TPRG1_HUMAN Tumor protein p63-regulated gene 1 protein (Protein FAM79B) TPRG1 FAM79B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 IPLSAVYRICLGK 2.430000067 1 1 0.237425403 1489.293055 0 15.57981 14.23413 0 8.825101 13.79769 0 0 13.37817 14.7785 13.23327 0 0 0 0 0 13.29112 14.29129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.58837 Q6ZUJ8 BCAP_HUMAN Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1) PIK3AP1 BCAP Homo sapiens (Human) positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102] GO:0003953; GO:0005102; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727 LLCGVR 2.99000001 1 1 0.073224504 716.3179824 16.35178 14.53118 0 14.8659 16.1602 0 14.76891 0 14.66901 16.39295 0 15.40631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUL3 CH086_HUMAN Uncharacterized protein C8orf86 C8orf86 Homo sapiens (Human) TGSSK 2.200000048 1 1 0.270359363 479.5463827 0 0 17.95674 18.26741 18.10785 0 0 0 0 0 0 0 18.8627 0 0 0 0 0 0 0 0 0 0 0 0 17.91138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUT1 NKAP1_HUMAN Uncharacterized protein NKAPD1 (NKAP domain containing protein 1) NKAPD1 C11orf57 Homo sapiens (Human) identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0042802 KMLPSSSSR 6.880000114 0.395253122 0.395253122 0.285033804 1007.955398 0 13.8253 15.05814 15.83361 0 0 0 0 0 0 0 0 15.46637 0 0 0 0 0 0 13.75006 0 16.82284 17.47781 15.05987 14.55299 0 12.38048 0 15.65389 0 17.07262 14.81848 0 0 0 13.70631 16.21284 17.23983 16.64428 15.73086 0 0 0 16.70141 0 0 0 0 Q6ZUT3 FRMD7_HUMAN FERM domain-containing protein 7 FRMD7 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005615; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007399; GO:0010592; GO:0010975; GO:0030426; GO:0032091; GO:0043005; GO:0043025; GO:0051057; GO:0051497 NPKEIVFK 17.90999985 0.376471668 0.376471668 0.427884156 974.4188968 22.3336 0 0 0 0 0 0 21.25266 21.32881 18.5955 21.85181 0 0 0 0 21.3841 20.19238 18.88089 0 0 0 0 21.32854 0 17.94667 0 18.17265 19.02022 21.9392 0 0 22.84021 20.89825 0 17.60467 0 21.65978 0 0 18.49442 21.89057 16.97899 21.75065 0 0 17.69584 0 21.90387 Q6ZUT6 CCD9B_HUMAN Coiled-coil domain-containing protein 9B CCDC9B C15orf52 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 SGAQQGLAPR 3.579999924 0.922941029 0.922941029 0.306482886 984.8717526 0 0 0 0 0 0 0 0 0 0 0 16.89562 0 16.07688 14.90162 17.52901 0 16.81808 0 0 0 0 16.84633 0 0 0 0 16.58147 0 0 0 0 19.04016 0 0 17.66159 16.93863 17.56065 18.79334 0 0 0 0 18.4953 0 0 0 0 Q6ZUT9 DEN5B_HUMAN DENN domain-containing protein 5B (Rab6IP1-like protein) DENND5B Homo sapiens (Human) positive regulation of triglyceride transport [GO:1905885] cytosol [GO:0005829]; integral component of membrane [GO:0016021] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of triglyceride transport [GO:1905885] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0016021; GO:1905885 GIDDGSLERILIGELMTSASDEDLVK 4.889999866 0.820491374 0.820491374 3.65E-12 2775.71167 0 18.12572 0 0 18.23672 16.09851 18.11197 0 0 19.87391 0 14.91613 15.49309 0 16.76287 0 15.52327 0 0 16.53874 14.96701 17.1415 0 0 0 0 0 18.11157 15.84119 19.50868 18.41109 19.62405 19.31964 15.04897 18.69855 17.63298 0 17.19058 0 18.32005 16.6207 16.47598 17.74457 18.27644 17.55182 15.925 0 15.95909 Q6ZUV0 BACHL_HUMAN "Putative cytosolic acyl coenzyme A thioester hydrolase-like, EC 3.1.2.2 (Acyl-CoA thioesterase 7-like)" ACOT7L BACHL Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; palmitic acid biosynthetic process [GO:1900535] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; palmitic acid biosynthetic process [GO:1900535] acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] GO:0005654; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0036042; GO:0047617; GO:0052689; GO:0102991; GO:1900535 AASVFT 5.889999866 1 1 0.263007112 593.6866399 0 16.73267 15.4886 14.35016 14.57037 0 11.99897 16.38728 0 0 15.49316 0 0 15.99224 16.94184 0 15.46564 14.93243 15.89614 14.45962 0 16.65059 0 16.86031 0 15.17543 0 14.87952 15.68502 0 15.1887 0 0 0 0 16.86818 0 0 0 0 0 16.74353 0 0 0 0 16.207 0 Q6ZUX3 TGRM2_HUMAN TOG array regulator of axonemal microtubules protein 2 (Crescerin-2) TOGARAM2 FAM179A Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307] cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307] microtubule binding [GO:0008017] GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0008017; GO:0072686; GO:0090307 QQGIEDNDELPSAK 7.659999847 1 1 0.207945554 1538.819516 15.57591 15.08508 14.7857 0 0 0 13.56656 0 0 0 14.53178 0 0 0 0 0 0 0 0 0 0 0 18.09162 17.16617 0 15.20114 0 0 15.01786 0 0 0 11.79424 0 14.96552 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZV29 PLPL7_HUMAN "Patatin-like phospholipase domain-containing protein 7, EC 3.1.1.-, EC 3.1.1.5" PNPLA7 C9orf111 Homo sapiens (Human) phosphatidylcholine catabolic process [GO:0034638] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylcholine catabolic process [GO:0034638] lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545] GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0016021; GO:0034638; GO:0102545 EPPPSLLEADLTEFDVK 4.159999847 1 1 0.437915302 1901.989439 14.36602 0 15.93386 0 0 0 0 0 0 0 0 0 0 0 0 0 16.44291 0 0 0 0 0 0 0 0 0 0 0 14.50646 0 15.99895 15.96717 15.99527 10.27897 0 0 0 0 15.70629 0 14.92614 0 0 0 16.43499 0 0 0 Q6ZV65 FA47E_HUMAN Protein FAM47E FAM47E Homo sapiens (Human) epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; positive regulation of histone methylation [GO:0031062]; protein localization to chromatin [GO:0071168] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; positive regulation of histone methylation [GO:0031062]; protein localization to chromatin [GO:0071168] enzyme activator activity [GO:0008047] GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0031062; GO:0045815; GO:0071168 EGVNCR 6.949999809 1 1 4.62E-13 734.4036566 15.68047 15.15368 15.02542 17.04957 0 0 0 0 0 0 0 0 0 0 0 16.63575 0 0 0 0 0 0 0 16.50074 0 0 0 0 0 0 0 0 0 0 16.48916 0 18.3066 0 0 0 0 0 0 0 0 0 0 0 Q6ZV73 FGD6_HUMAN "FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)" FGD6 KIAA1362 ZFYVE24 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872 DEWLEAISRAIEEYAK 6.179999828 0.637321532 0.637321532 0.316592746 1923.064417 0 0 0 0 13.29369 0 0 15.45689 14.45308 0 15.07755 11.93909 0 0 0 0 0 0 0 0 16.2948 0 0 0 0 0 14.60846 0 0 0 0 0 0 17.8326 0 0 0 0 0 0 0 0 0 0 0 0 0 17.03984 Q6ZVC0 NYAP1_HUMAN Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1 NYAP1 C7orf51 Homo sapiens (Human) neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] GO:0014065; GO:0048812 SSSKEVAPAGSAGPAAGQGPGVR 3.190000057 1 1 0.004965332 2038.834252 0 0 0 0 0 0 12.65344 14.29481 18.41111 14.64851 0 14.11855 0 15.55865 0 12.86319 15.48954 13.81287 0 12.67995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.95511 0 0 13.72221 0 0 0 0 0 Q6ZVF9 GRIN3_HUMAN "G protein-regulated inducer of neurite outgrowth 3, GRIN3" GPRIN3 KIAA2027 Homo sapiens (Human) neuron projection development [GO:0031175] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; neuron projection development [GO:0031175] GO:0005886; GO:0031175 LSDSCGSISKADHSGSLDPTNK 5.699999809 0.429237872 0.429237872 0.136874264 2275.447331 15.54188 0 12.22313 14.04134 11.95829 14.61349 13.97619 0 0 13.84348 13.69305 0 14.62666 0 0 14.70645 15.70661 14.69756 0 0 13.32621 0 18.47619 15.05736 15.70837 17.44087 15.54208 0 0 0 0 0 15.52441 17.60631 15.33575 0 0 16.05776 0 0 0 0 0 0 0 0 0 0 Q6ZVH7 ESPNL_HUMAN Espin-like protein ESPNL Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; stereocilium tip [GO:0032426] cytoplasm [GO:0005737]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605] actin filament binding [GO:0051015] GO:0005737; GO:0007605; GO:0032426; GO:0051015; GO:0051017 AIMAHVPAR 4.760000229 1 1 0 979.9640113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVK8 NUD18_HUMAN "8-oxo-dGDP phosphatase NUDT18, EC 3.6.1.58 (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (MutT homolog 3) (Nucleoside diphosphate-linked moiety X motif 18, Nudix motif 18)" NUDT18 MTH3 Homo sapiens (Human) dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086] cytosol [GO:0005829] cytosol [GO:0005829]; 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]; dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086] 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005829; GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712; GO:0055086 GLLGLQHLGR 11.61999989 0.457744539 0.457744539 0.071459468 1063.219817 0 0 14.88936 15.46951 0 16.52292 14.81014 13.04002 0 0 0 0 17.46747 0 0 0 0 18.30168 17.69894 18.57106 0 0 17.44713 0 17.67333 0 0 0 16.29133 17.27598 0 16.52565 0 0 18.0852 0 0 0 0 0 0 0 0 12.27255 17.23741 0 0 0 Q6ZVL6 K154L_HUMAN UPF0606 protein KIAA1549L KIAA1549L C11orf41 C11orf69 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GYYDFPAVETSKGLTER 1.960000038 0.004611395 0.004611395 2.51E-12 1932.996884 14.37803 0 0 12.37434 0 12.8259 0 0 11.32578 0 15.06049 0 13.32508 0 0 0 14.58117 0 14.64822 16.37766 12.70856 16.00384 16.11058 0 0 13.34951 14.48973 0 16.66338 0 0 15.43117 16.38329 0 0 15.92921 16.23086 0 0 0 14.41994 0 13.31867 0 13.91539 0 16.38839 11.92846 Q6ZVL8 YP033_HUMAN Putative uncharacterized protein FLJ42384 Homo sapiens (Human) GMHTGGIIR 4.889999866 1 1 0.216199397 940.7398914 14.59854 14.37323 12.90972 14.48163 14.14485 15.85126 15.89454 0 14.65621 13.13361 0 15.52674 0 0 15.73369 12.12729 15.09715 0 0 0 0 0 0 0 0 12.31283 0 0 0 0 17.02855 0 12.80879 14.67987 0 15.48987 16.67349 0 0 0 16.20529 0 0 0 0 0 0 0 Q6ZVS7 F183B_HUMAN Protein FAM183BP (Testis highly expressed protein 6) FAM183BP FAM183B THEG6 Homo sapiens (Human) ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005856; GO:0097546 KPMSWHDNLEEPADAR 1.600000024 1 1 2.78E-13 1896.276472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVT6 CF20D_HUMAN Protein CFAP20DC (Uncharacterized protein C3orf67) CFAP20DC C3orf67 Homo sapiens (Human) EMNPPSPSNPR 3.910000086 1 1 0.305203478 1241.182886 16.09911 12.64433 13.07555 0 0 0 0 16.27569 0 0 0 0 0 14.8364 15.21068 0 0 0 0 15.4478 15.96703 0 0 4.615199 0 0 0 0 16.42633 15.37683 0 12.56342 14.6459 0 14.12106 16.60032 0 15.08204 0 15.12733 16.81376 0 0 0 16.33598 16.18262 0 15.04987 Q6ZVU0 YK022_HUMAN Putative uncharacterized protein FLJ42102 Homo sapiens (Human) CTWMLGASGFPPR 1.059999943 1 1 0.233949528 1494.563026 15.60994 15.53775 14.6094 0 0 0 0 0 0 0 0 0 0 11.39128 0 14.46371 0 15.66823 0 0 0 0 0 0 0 0 13.04418 15.32109 0 14.0425 0 13.62622 13.20161 0 0 0 0 0 0 16.52009 0 0 0 0 0 0 0 0 Q6ZVW7 I17EL_HUMAN "Putative interleukin-17 receptor E-like, IL-17 receptor E-like, IL-17RE-like" IL17REL Homo sapiens (Human) interleukin-17 receptor activity [GO:0030368] interleukin-17 receptor activity [GO:0030368] GO:0030368 SVLEALTSSTAMQCVPSDGCAMLLR 2.769999981 1 1 0.222441579 2714.242956 0 0 0 0 15.16369 14.88616 14.30186 15.17913 13.73945 0 0 15.09432 14.08836 13.74728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVX9 PAQR9_HUMAN "Membrane progestin receptor epsilon, mPR epsilon (Membrane progesterone P4 receptor epsilon) (Membrane progesterone receptor epsilon) (Progesterone and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member IX)" PAQR9 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] GO:0005496; GO:0005886; GO:0016021; GO:0038023 DPPASAKPLLR 4.019999981 1 1 6.94E-13 1165.607076 0 0 0 0 0 0 0 0 0 0 0 0 0 13.59274 0 13.80653 14.07513 0 0 0 0 0 0 0 0 0 0 15.88345 14.10787 0 16.22147 0 14.99205 0 12.62456 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVZ8 ASB18_HUMAN "Ankyrin repeat and SOCS box protein 18, ASB-18" ASB18 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 DEMEWQVK 14.53999996 0.006158316 0.006158316 1.37E-12 1061.708075 0 16.22561 9.820671 17.00011 0 0 15.97275 0 16.98054 15.88266 0 12.55808 0 0 14.63697 0 0 0 0 10.60577 11.52354 17.63244 17.97571 14.45851 0 16.06999 16.35486 14.45756 11.91454 17.51524 14.52072 13.6515 16.15812 16.88576 16.11794 16.81713 0 16.25925 15.26116 0 12.85745 0 15.83175 17.46182 17.68004 14.97717 0 19.2916 Q6ZW05 PTHD4_HUMAN Patched domain-containing protein 4 (p53-regulated patched protein) PTCHD4 C6orf138 PTCH53 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 ENLPFKDR 23.37999916 1 1 1.15E-13 1021.434488 0 13.07627 16.3945 16.53489 14.42901 15.39766 16.31315 0 0 15.62292 0 0 0 0 16.00045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZW31 SYDE1_HUMAN "Rho GTPase-activating protein SYDE1 (Synapse defective protein 1 homolog 1, Protein syd-1 homolog 1)" SYDE1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of cytoskeleton organization [GO:0051493]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of cytoskeleton organization [GO:0051493]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] GO:0005096; GO:0007165; GO:0016477; GO:0030695; GO:0031532; GO:0051493; GO:0090630; GO:1901165 YHLDSSVGGPGPAAGPGGTRSPR 3.539999962 1 1 0.242221955 2193.635068 13.91905 14.70187 14.60387 15.09564 12.93948 14.78861 13.3592 0 0 13.19924 15.85511 0 0 0 0 0 0 0 15.13617 0 0 0 0 11.04886 0 0 0 0 14.56026 0 0 0 0 16.02558 0 0 9.915959 0 0 0 12.18781 9.870347 10.32971 0 13.6741 0 0 0 Q6ZW49 PAXI1_HUMAN PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) PAXIP1 PAXIP1L PTIP CAGF28 Homo sapiens (Human) "adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]" chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]" GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022 KLYILGGEVAESAQK 11.22000027 1 1 0.392307189 1606.469385 19.97192 15.78636 13.16648 0 0 0 0 0 0 0 0 0 0 0 0 18.43786 0 0 0 0 0 0 0 0 19.25356 0 0 0 17.39784 0 0 0 0 0 0 0 0 0 0 0 0 0 17.36726 0 0 0 0 16.87469 Q6ZW61 BBS12_HUMAN Bardet-Biedl syndrome 12 protein BBS12 C4orf24 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; photoreceptor cell maintenance [GO:0045494] cilium [GO:0005929] cilium [GO:0005929]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; photoreceptor cell maintenance [GO:0045494] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005929; GO:0016887; GO:0042073; GO:0042755; GO:0045494; GO:0045599; GO:0051131 VEADNNTSRTLK 2.849999905 1 1 0.064431528 1347.821418 13.07138 10.84022 14.96774 12.19019 0 13.92601 0 0 0 0 0 0 11.85337 13.9254 0 0 0 12.04826 0 0 0 0 0 0 0 0 0 0 0 13.69743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWE6 PKHM3_HUMAN "Pleckstrin homology domain-containing family M member 3, PH domain-containing family M member 3 (Differentiation associated protein)" PLEKHM3 DAPR PLEKHM1L Homo sapiens (Human) myoblast differentiation [GO:0045445] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445] metal ion binding [GO:0046872] GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872 MVDTVLYDNTQLQLK 1.00999999 1 1 0.234213327 1796.399882 17.86165 0 0 14.71625 0 0 0 14.72519 0 0 0 0 0 0 15.10558 0 0 0 0 0 16.02149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21328 0 0 0 0 0 14.8938 0 11.495 0 0 0 Q6ZWH5 NEK10_HUMAN "Serine/threonine-protein kinase Nek10, EC 2.7.11.1 (Never in mitosis A-related kinase 10, NimA-related protein kinase 10)" NEK10 Homo sapiens (Human) mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] extracellular region [GO:0005576]; protein kinase complex [GO:1902911]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 LILPNK 12.32999992 0.905802965 0.905802965 0.279136919 697.8754535 15.32251 15.1516 15.97679 15.75181 0 15.44871 0 14.26729 0 16.79328 0 14.74201 0 0 16.12435 13.87298 15.02831 0 17.01896 0 0 15.60694 16.25499 14.92727 15.91718 14.81652 0 16.20757 0 15.18696 14.21646 14.32513 16.69717 0 16.46204 14.93087 15.89825 14.86867 15.89176 16.31733 0 17.06636 14.82291 17.13502 0 15.99951 15.98825 0 Q6ZWI9 RFPLB_HUMAN Ret finger protein-like 4B (RING finger protein 211) RFPL4B RNF211 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 AMCPLCRDVVK 8.06000042 0.680192769 0.680192769 0.456946941 1365.709529 17.34228 20.14988 16.20037 17.62051 18.91634 0 0 19.01077 0 18.15157 18.2449 0 0 0 0 0 17.96222 0 0 0 18.5796 0 0 0 18.70853 0 0 18.95419 0 0 0 0 19.96143 0 0 0 0 0 0 0 0 0 0 19.14575 0 0 0 0 Q6ZWK6 TM11F_HUMAN "Transmembrane protease serine 11F, EC 3.4.21.- (Airway trypsin-like protease 4)" TMPRSS11F HATL4 Homo sapiens (Human) regulation of water loss via skin [GO:0033561] cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; regulation of water loss via skin [GO:0033561] serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005576; GO:0005887; GO:0009986; GO:0033561 IFRHSSVGGR 9.920000076 1 1 0.38378871 1115.643928 17.24786 17.64102 0 14.07662 0 16.81569 0 15.8556 0 0 0 16.90354 17.73781 0 16.06527 14.36318 17.33867 0 15.86957 17.48245 16.42552 15.95764 0 0 0 0 0 14.84258 0 15.3555 15.73941 16.39146 0 16.3934 0 0 0 17.46435 17.00592 0 16.59428 0 15.63293 0 0 17.54598 0 0 Q6ZWT7 MBOA2_HUMAN "Lysophospholipid acyltransferase 2, LPLAT 2, EC 2.3.1.- (1-acylglycerophosphate O-acyltransferase MBOAT2, EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2, EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase, EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase, LPAAT, Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase, LPCAT, Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4, Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase, LPEAT, Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2, O-acyltransferase domain-containing protein 2)" MBOAT2 LPCAT4 OACT2 Homo sapiens (Human) lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746] GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047184; GO:0106262; GO:0106263 HSSLKQ 1.440000057 1 1 0.140907332 699.0434792 15.8024 0 0 15.99948 15.60038 14.06595 0 0 0 16.14875 0 0 0 15.84585 0 16.73536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZXV5 TMTC3_HUMAN "Protein O-mannosyl-transferase TMTC3, EC 2.4.1.109 (Protein SMILE) (Transmembrane and TPR repeat-containing protein 3)" TMTC3 Homo sapiens (Human) positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0034976; GO:0035269; GO:1901800 VCKLFLDNK 2.960000038 0.820084035 0.820084035 0.250891982 1137.210596 0 13.01861 13.87501 0 0 14.38063 0 14.54678 15.24047 0 17.43528 12.79686 0 0 12.58911 13.64752 12.05505 12.82325 16.03311 15.50911 0 14.19503 0 0 0 0 0 0 0 0 0 0 15.34319 0 0 0 15.83925 15.52422 0 14.91092 14.88664 14.99967 0 0 14.39007 0 15.77684 0 Q709C8 VP13C_HUMAN Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C) VPS13C KIAA1421 Homo sapiens (Human) Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868] GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090 DPMEMR 8.470000267 0.199030161 0.199030161 0.119776761 778.4763651 18.47135 0 13.29171 13.32874 13.49082 0 17.3477 12.7592 0 13.30072 0 0 9.973505 16.01664 12.44112 16.67957 0 0 0 15.56998 14.14846 12.64481 15.96156 16.75593 0 0 16.334 16.63703 14.01439 0 0 17.91471 19.21229 17.99778 17.08432 0 17.17801 16.62738 16.1102 13.29589 15.36853 15.19795 0 0 15.66785 6.729833 0 0 Q709F0 ACD11_HUMAN "Acyl-CoA dehydrogenase family member 11, ACAD-11, EC 1.3.8.-" ACAD11 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099] GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0005777; GO:0006635; GO:0017099; GO:0031966; GO:0033539; GO:0050660; GO:0070991 SNPTFYLQK 1.559999943 1 1 0.29294701 1093.919407 17.71836 0 16.09328 0 0 0 0 0 0 0 0 0 0 18.55931 0 0 0 0 16.13964 0 0 0 17.34013 0 18.51008 16.91467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.87016 0 0 0 Q70CQ1 UBP49_HUMAN "Ubiquitin carboxyl-terminal hydrolase 49, EC 3.4.19.12 (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49)" USP49 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]" cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0000398; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0006325; GO:0006511; GO:0008270; GO:0016579; GO:0035616; GO:0042393 FTETEALEGR 14.01000023 1 1 0.183838749 1152.672495 0 15.19127 0 12.68224 14.9444 13.04502 0 0 0 0 0 0 0 10.96853 13.66747 0 0 0 13.65805 13.23559 0 14.93531 13.97639 0 12.04482 16.2506 0 0 0 14.76742 14.48667 14.55222 0 0 0 0 0 0 0 0 0 0 13.79923 0 0 16.20491 0 0 Q70CQ2 UBP34_HUMAN "Ubiquitin carboxyl-terminal hydrolase 34, EC 3.4.19.12 (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34)" USP34 KIAA0570 KIAA0729 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016055; GO:0016579; GO:0071108; GO:0090263 DDEGATPIK 6.289999962 1 1 0.251090279 945.3662264 15.74988 13.56056 16.33802 14.78584 15.95872 0 15.57072 15.93117 14.75671 16.21476 0 16.9942 0 0 13.10034 0 0 0 15.65363 0 0 17.37731 14.45041 0 0 16.66095 18.1743 0 14.97278 14.89696 18.39866 0 17.82689 0 17.06259 0 15.79541 0 0 16.62956 15.65645 17.05007 0 15.67037 0 16.66309 14.93501 16.54884 Q70CQ4 UBP31_HUMAN "Ubiquitin carboxyl-terminal hydrolase 31, EC 3.4.19.12 (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31)" USP31 KIAA1203 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634] nucleus [GO:0005634]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:0005634; GO:0006511; GO:0016579 AGGSSVK 4.289999962 1 1 0.12420909 607.427388 0 14.51867 0 16.30708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70EK8 UBP53_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) USP53 KIAA1350 Homo sapiens (Human) protein deubiquitination [GO:0016579]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; protein deubiquitination [GO:0016579]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605] GO:0005911; GO:0005923; GO:0007605; GO:0010996; GO:0016579 CPSNCGQK 9.319999695 1 1 0.124984355 949.6734073 16.66742 0 0 0 0 0 0 15.67045 0 0 0 14.96983 15.10276 0 16.53971 14.33437 16.11224 0 0 0 14.73656 14.56432 16.33809 0 0 14.39111 12.29744 15.54216 13.69148 0 11.54567 15.64662 15.0511 15.60606 13.88493 17.45784 0 0 0 0 13.97147 0 14.03469 0 11.89205 0 0 0 Q70EK9 UBP51_HUMAN "Ubiquitin carboxyl-terminal hydrolase 51, EC 3.4.19.12 (Deubiquitinating enzyme 51) (Ubiquitin thioesterase 51) (Ubiquitin-specific-processing protease 51)" USP51 Homo sapiens (Human) DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694] chromosome [GO:0005694]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin binding [GO:0003682]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0003682; GO:0004843; GO:0005694; GO:0006281; GO:0006511; GO:0008270; GO:0010564; GO:0010569; GO:0016578; GO:0016579; GO:0042393; GO:2001020; GO:2001032 AKSCICHVCSTHMNR 6.900000095 0.69062376 0.69062376 0.008649508 1875.990869 0 14.41662 14.9308 11.27988 13.38149 11.26838 9.445975 13.98279 13.4319 0 0 0 14.90389 0 14.51069 14.98448 0 0 15.28847 15.43206 0 11.86424 0 0 0 13.83642 13.72721 0 14.98359 0 0 0 0 0 0 0 0 16.79671 0 16.23978 16.29905 0 0 15.66783 14.11939 0 0 14.89499 Q70EL2 UBP45_HUMAN "Ubiquitin carboxyl-terminal hydrolase 45, EC 3.4.19.12 (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45)" USP45 Homo sapiens (Human) cell migration [GO:0016477]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; neural retina development [GO:0003407]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; neural retina development [GO:0003407]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0001917; GO:0003407; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006511; GO:0008270; GO:0016477; GO:0016579; GO:0045494; GO:0070911 GPLSPK 1.24000001 1 1 0.26448427 599.548463 15.37454 0 13.70223 15.23401 16.17962 14.92933 12.95183 15.76363 15.21297 0 12.32949 15.29689 0 15.60602 14.64807 0 0 0 0 16.09295 16.01244 0 15.01221 15.55216 0 0 16.1129 16.61505 15.62679 0 0 0 15.4425 15.52144 15.47425 0 16.6709 15.64078 15.5993 0 0 0 15.57205 15.80314 0 0 0 0 Q70EL4 UBP43_HUMAN "Ubiquitin carboxyl-terminal hydrolase 43, EC 3.4.19.12 (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)" USP43 Homo sapiens (Human) protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; ISG15-specific protease activity [GO:0019785]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] ISG15-specific protease activity [GO:0019785]; thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0019785; GO:0019985 AEVTEQLAALVR 10.07999992 1 1 0.403886441 1295.764128 14.3131 14.03307 14.56071 0 0 0 0 0 0 0 15.25844 0 0 0 0 0 0 0 0 17.74664 0 15.09713 0 0 0 0 16.5638 0 0 15.7362 0 0 14.99187 15.89066 0 0 0 11.6701 0 0 0 0 16.25757 0 0 0 16.04673 0 Q70IA8 MOB3C_HUMAN MOB kinase activator 3C (Mob1 homolog 2C) (Mps one binder kinase activator-like 2C) MOB3C MOBKL2C Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0046872 RPAKLSAPR 7.400000095 0.852916837 0.852916837 0.230142742 994.7018043 0 0 16.10583 0 15.0914 0 14.59863 0 0 0 0 0 0 0 16.37222 13.3368 14.40616 12.01832 15.9183 0 0 16.68385 15.92468 0 15.74123 14.28283 14.28559 0 15.75607 15.36661 12.98756 0 15.2099 15.52189 14.26316 16.05716 15.94823 15.16118 14.09262 0 15.15732 15.55396 0 14.25205 15.97634 14.1255 15.19797 13.5668 Q70SY1 CR3L2_HUMAN "Cyclic AMP-responsive element-binding protein 3-like protein 2, cAMP-responsive element-binding protein 3-like protein 2 (BBF2 human homolog on chromosome 7) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2 ]" CREB3L2 BBF2H7 Homo sapiens (Human) "cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]" chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038] "chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]; cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]" "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000981; GO:0001228; GO:0002062; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0006357; GO:0006888; GO:0009611; GO:0010628; GO:0010976; GO:0016021; GO:0030968; GO:0034976; GO:0035497; GO:0045893; GO:0051216; GO:0097038 AAPRAPSALSSSPLLTAPHK 3.089999914 1 1 0.092968432 1972.355058 0 13.13233 0 0 0 16.14715 0 0 10.53417 0 15.8414 0 0 0 0 0 0 12.17717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70YC5 ZN365_HUMAN Protein ZNF365 (DISC1-binding zinc-finger protein) (Protein su48) ZNF365 DBZ KIAA0844 Homo sapiens (Human) cerebellar molecular layer morphogenesis [GO:0021687]; dendrite arborization [GO:0140059]; dendritic spine morphogenesis [GO:0060997]; negative regulation of neuron projection development [GO:0010977]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA strand resection involved in replication fork processing [GO:0110026]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neuron projection development [GO:0010975]; telomere maintenance [GO:0000723] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cerebellar molecular layer morphogenesis [GO:0021687]; dendrite arborization [GO:0140059]; dendritic spine morphogenesis [GO:0060997]; negative regulation of neuron projection development [GO:0010977]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA strand resection involved in replication fork processing [GO:0110026]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neuron projection development [GO:0010975]; telomere maintenance [GO:0000723] identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0000723; GO:0005737; GO:0005813; GO:0010569; GO:0010975; GO:0010977; GO:0021687; GO:0034451; GO:0042802; GO:0046872; GO:0048714; GO:0060997; GO:0110026; GO:0140059 KPKCLSR 7.53000021 0.539095163 0.539095163 0.181205149 888.4441477 0 15.79598 0 16.87542 16.32711 15.9664 12.71914 0 17.90336 18.01021 11.02642 17.08856 0 16.99145 14.15681 0 0 0 11.95539 17.73845 0 0 16.59238 14.4184 17.63057 16.48835 15.79484 14.15736 0 14.90837 16.32116 16.84118 18.01334 16.59684 16.95082 15.95871 16.6418 16.87386 17.30511 0 15.94245 0 16.46266 12.63486 0 20.09158 17.17188 16.06478 Q70Z44 5HT3D_HUMAN "5-hydroxytryptamine receptor 3D, 5-HT3-D, 5-HT3D (Serotonin receptor 3D)" HTR3D Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098662; GO:1904602 ATSNTISQCGWSASANWTPSISPSMDR 5.840000153 1 1 4.59E-13 2928.517026 13.25812 13.84486 14.97763 0 0 11.79483 12.33522 0 0 13.67562 14.13891 13.20742 12.15687 14.8686 0 15.19024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70Z53 F10C1_HUMAN Protein FRA10AC1 FRA10AC1 C10orf4 PRO2972 Homo sapiens (Human) dephosphorylation [GO:0016311] nucleus [GO:0005634] nucleus [GO:0005634]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311] phosphatase activity [GO:0016791] GO:0005634; GO:0016311; GO:0016791 GHSSSK 6.96999979 1 1 0.10693427 602.4528548 0 16.84685 14.32562 17.17904 14.52116 0 0 15.31254 14.71072 15.00929 0 11.42849 0 0 14.85304 0 0 0 0 0 0 0 0 0 0 16.28769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.92979 0 0 0 15.4218 0 Q711Q0 CEFIP_HUMAN Cardiac-enriched FHL2-interacting protein CEFIP C10orf71 Homo sapiens (Human) positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] Z disc [GO:0030018] Z disc [GO:0030018]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] GO:0030018; GO:0070886 QEPVSNGVILPNGLEESPPNELSK 2.480000019 1 1 0.327920061 2546.579038 17.22966 16.55221 0 17.35796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q719I0 AHSA2_HUMAN Putative activator of 90 kDa heat shock protein ATPase homolog 2 (Activator of HSP90 ATPase homolog 2 pseudogene) AHSA2P AHSA2 Homo sapiens (Human) positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457] cytosol [GO:0005829] cytosol [GO:0005829]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457] ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879] GO:0001671; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879 VREALGDYLK 7.320000172 0.396435946 0.396435946 0.08311241 1163.58602 22.14839 21.75786 21.44054 21.03477 22.10328 18.80104 21.6919 21.74143 21.24086 20.67356 22.3799 19.21469 21.489 21.64971 20.56483 21.15978 22.70564 22.75673 20.51762 20.54139 20.35574 21.07916 21.4619 20.4756 22.61626 22.0837 22.36385 22.23279 20.61868 20.46471 22.65867 21.59605 21.96822 22.82849 22.76707 23.35804 22.57523 22.17839 22.12879 20.58021 21.7978 21.86054 22.51384 22.3238 21.5309 21.27598 20.34525 20.70212 Q71F56 MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like) MED13L KIAA1025 PROSIT240 THRAP2 TRAP240L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] mediator complex [GO:0016592] mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] transcription coregulator activity [GO:0003712] GO:0003712; GO:0006357; GO:0016592 NAMSIFSSATKTDVR 1.629999995 1 1 0.020604438 1644.321497 15.77209 0 0 0 16.61367 0 16.41875 0 15.85985 0 0 0 0 0 16.01638 0 0 0 0 0 0 17.19994 0 0 0 0 0 0 0 0 0 0 0 16.4857 15.39968 0 0 0 17.06329 0 0 0 17.67761 0 0 0 0 0 Q71H61 ILDR2_HUMAN Immunoglobulin-like domain-containing receptor 2 (Angulin-3) ILDR2 C1orf32 Homo sapiens (Human) cell differentiation [GO:0030154]; homeostasis of number of cells within a tissue [GO:0048873]; insulin secretion [GO:0030073]; negative regulation of T cell activation [GO:0050868]; pancreas development [GO:0031016]; regulation of RNA splicing [GO:0043484]; response to glucose [GO:0009749] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; tight junction [GO:0070160] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; tight junction [GO:0070160]; cell differentiation [GO:0030154]; homeostasis of number of cells within a tissue [GO:0048873]; insulin secretion [GO:0030073]; negative regulation of T cell activation [GO:0050868]; pancreas development [GO:0031016]; regulation of RNA splicing [GO:0043484]; response to glucose [GO:0009749] GO:0005789; GO:0009749; GO:0016020; GO:0016021; GO:0030073; GO:0030154; GO:0031016; GO:0043484; GO:0048873; GO:0050868; GO:0070160 GPSYRGR 3.650000095 1 1 0.236366875 793.2656245 17.11888 0 0 18.58844 0 0 17.27697 18.29802 0 0 0 0 0 0 16.6214 0 0 0 0 0 0 0 0 0 0 0 0 18.05249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q75N90 FBN3_HUMAN Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide ] FBN3 KIAA1776 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; anatomical structure morphogenesis [GO:0009653] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012; GO:0062023 CELCPLPGTSAYR 7.909999847 1 1 0.428109507 1522.898327 15.72189 0 19.72808 16.32852 0 0 21.50361 0 0 0 0 0 0 0 0 0 0 0 0 0 18.30539 0 0 0 0 0 0 18.66555 18.1079 0 0 0 0 20.72789 20.67109 0 0 21.68622 20.80803 0 0 0 0 0 0 0 18.44874 0 Q75QN2 INT8_HUMAN "Integrator complex subunit 8, Int8 (Protein kaonashi-1)" INTS8 C8orf52 Homo sapiens (Human) snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleoplasm [GO:0005654] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005654; GO:0016180; GO:0032039; GO:0034472 ESTLGIMYR 7.96999979 0.345079184 0.345079184 0.179675644 1090.156927 0 14.77341 12.36764 0 0 0 0 0 13.85815 0 14.894 0 6.294082 0 15.02169 14.78835 12.29913 0 0 0 0 0 15.30933 15.10861 15.84642 15.11515 13.59719 0 11.91378 12.3018 15.20701 0 12.13084 15.30612 13.91979 0 0 11.80704 0 0 0 15.04555 0 13.02981 0 15.70115 13.24604 14.86788 Q75T13 PGAP1_HUMAN "GPI inositol-deacylase, EC 3.1.-.- (Post-GPI attachment to proteins factor 1, hPGAP1)" PGAP1 UNQ3024/PRO9822 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]" "hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]" GO:0005783; GO:0005789; GO:0006505; GO:0006888; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0050185; GO:1902953 EEITSIYR 4.650000095 0.707232833 0.707232833 0.230431528 1009.840884 9.3578 0 13.96915 15.67422 16.01597 0 0 0 0 14.23585 13.39974 0 15.07189 0 15.25574 0 14.22303 15.18347 16.63057 13.72962 0 0 15.6155 16.27929 13.35698 15.10578 14.74975 0 17.15752 13.64378 16.2191 0 15.79625 14.55234 13.09904 13.45745 16.21327 0 16.1153 0 0 0 0 0 0 0 0 15.37614 Q75V66 ANO5_HUMAN Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) ANO5 GDD1 TMEM16E Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983; GO:0055085; GO:1902476 HVMIEENKAQLAK 6.210000038 1 1 0.335766133 1511.933385 16.14461 15.25881 0 0 0 0 0 0 0 0 15.35241 15.68875 0 0 17.61771 16.63025 15.44382 15.80906 16.42636 16.07726 0 15.94311 12.26647 0 0 13.99953 0 16.18358 17.44414 15.5812 16.99119 15.71199 0 0 15.54712 0 16.57296 16.17684 17.81819 16.54694 17.09763 0 0 19.071 0 0 0 17.81672 Q75VX8 GARE2_HUMAN GRB2-associated and regulator of MAPK protein 2 (GRB2-associated and regulator of MAPK1-like) GAREM2 FAM59B GAREML KIAA2038 HRIHFB2063 Homo sapiens (Human) LCLPAPRAPGLAR 13.65999985 1 1 2.32E-13 1391.18379 14.44552 16.62008 16.65266 0 0 22.68799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76FK4 NOL8_HUMAN Nucleolar protein 8 (Nucleolar protein Nop132) NOL8 C9orf34 NOP132 Homo sapiens (Human) protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:1902570 GSKSPK 8.06000042 0.02069889 0.02069889 0.222247712 603.3939569 16.9589 19.81638 19.59083 15.85349 18.08511 17.5288 16.23813 15.62836 16.6309 19.78811 18.96115 19.53055 15.81951 15.9979 17.86736 16.56021 18.62062 17.92335 17.105 17.01737 15.48691 19.47501 18.88804 19.07565 18.15206 18.51929 18.42521 17.90394 16.31745 18.66764 17.90647 15.26022 19.29607 15.07264 19.49563 18.74227 20.237 17.7569 19.27807 16.38685 16.52057 15.63553 19.4806 16.27719 0 17.89697 19.46078 18.68698 Q76G19 PDZD4_HUMAN PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein) PDZD4 KIAA1444 PDZK4 PDZRN4L Homo sapiens (Human) cell cortex [GO:0005938] cell cortex [GO:0005938] GO:0005938 AREQR 8.170000076 0.117379315 0.117379315 0.192349229 659.7187175 14.27116 0 0 0 0 0 0 0 15.68832 15.58627 15.1572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.09131 0 0 0 0 0 15.6557 16.62275 0 14.85009 0 0 0 0 0 16.19196 18.39731 16.47868 0 0 0 0 0 Q76I76 SSH2_HUMAN "Protein phosphatase Slingshot homolog 2, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 2, SSH-2L, hSSH-2L)" SSH2 KIAA1725 SSH2L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470] actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0006470; GO:0008138; GO:0030036; GO:0030837 GDILPNPCHTPK 5.590000153 1 1 0.105544881 1348.492032 0 0 14.75816 0 0 0 0 0 0 0 0 0 16.24596 0 0 0 0 0 0 0 0 0 0 0 0 16.03174 0 16.97923 0 0 0 0 16.64482 17.11467 0 0 0 0 0 14.81001 16.98789 0 0 17.0213 0 0 0 0 Q76KD6 SPERI_HUMAN Speriolin (Spermatogenesis and centriole-associated protein 1) (Spermatogenesis-associated protein 15) (Spermatogenic cell-specific Cdc20-binding protein) SPATC1 SPATA15 SPRN Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 ENHELKSAIK 5.309999943 0.578192234 0.578192234 0.201868005 1168.373037 12.59505 9.54282 17.00309 15.82929 14.18734 13.2444 15.28522 0 0 0 13.38448 14.60069 10.35795 13.37574 16.09353 0 0 0 16.10725 0 0 0 0 14.07246 0 0 14.89002 0 0 0 16.44871 0 0 15.17788 0 14.76589 0 0 0 14.42117 0 0 14.67875 0 0 0 0 0 Q76KX8 ZN534_HUMAN Zinc finger protein 534 (KRAB domain only protein 3) ZNF534 KRBO3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 RDPWTLQSEVK 7.239999771 1 1 0.441043126 1358.332858 0 0 0 0 0 0 0 0 18.65967 0 17.6462 0 0 16.39446 0 18.19692 0 0 0 0 0 0 0 0 0 0 0 0 17.32359 17.91006 18.36883 0 17.83077 0 18.20832 0 0 0 0 17.73689 0 0 0 0 16.22887 0 0 17.03036 Q76L83 ASXL2_HUMAN Putative Polycomb group protein ASXL2 (Additional sex combs-like protein 2) ASXL2 ASXH2 KIAA1685 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517] nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; animal organ morphogenesis [GO:0009887]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975] GO:0003677; GO:0003682; GO:0005654; GO:0009887; GO:0035360; GO:0035517; GO:0042975; GO:0045600; GO:0045944; GO:0046872 AGPSK 1.99000001 0.942426801 0.942426801 0.100690038 459.3108585 15.52051 16.63708 16.03483 16.38389 16.54305 16.5214 17.24749 16.39134 16.65743 16.8187 16.87171 17.86024 0 16.53282 17.47936 15.69712 16.62427 16.46859 0 15.79975 17.27793 17.23209 16.91054 17.39378 0 16.96124 16.96577 16.36198 0 17.21748 0 16.81067 0 0 16.40824 0 16.81521 17.11679 0 0 16.65129 0 0 16.93086 0 15.82179 0 17.09026 Q76LX8 ATS13_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 13, ADAM-TS 13, ADAM-TS13, ADAMTS-13, EC 3.4.24.87 (von Willebrand factor-cleaving protease, vWF-CP, vWF-cleaving protease)" ADAMTS13 C9orf8 UNQ6102/PRO20085 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; extracellular matrix organization [GO:0030198]; glycoprotein metabolic process [GO:0009100]; integrin-mediated signaling pathway [GO:0007229]; peptide catabolic process [GO:0043171]; platelet activation [GO:0030168]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; extracellular matrix organization [GO:0030198]; glycoprotein metabolic process [GO:0009100]; integrin-mediated signaling pathway [GO:0007229]; peptide catabolic process [GO:0043171]; platelet activation [GO:0030168]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0004222; GO:0005178; GO:0005509; GO:0005615; GO:0005788; GO:0006508; GO:0007160; GO:0007229; GO:0008237; GO:0008270; GO:0009100; GO:0009636; GO:0009986; GO:0014075; GO:0016485; GO:0030168; GO:0030198; GO:0031012; GO:0035864; GO:0043171; GO:0071222; GO:0071346; GO:0071353; GO:0071356 AGLAWSPCSRR 6.900000095 0.801054239 0.801054239 0.255495038 1256.376314 13.65882 14.38506 13.79897 14.07459 14.19297 14.3929 0 14.34762 14.94701 0 16.54998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.70249 0 0 0 0 0 0 0 0 0 0 18.92673 0 15.80549 14.25559 0 14.88276 0 0 0 0 14.12646 0 Q76MJ5 ERN2_HUMAN "Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2, hIRE2p) (Ire1-beta, IRE1b) [Includes: Serine/threonine-protein kinase, EC 2.7.11.1; Endoribonuclease, EC 3.1.26.- ]" ERN2 IRE2 Homo sapiens (Human) "apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; unfolded protein binding [GO:0051082]; apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]" ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; unfolded protein binding [GO:0051082] GO:0000287; GO:0004519; GO:0004521; GO:0004674; GO:0004712; GO:0005524; GO:0005783; GO:0005829; GO:0006397; GO:0006468; GO:0016021; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604 MASAVR 3.799999952 0.084246837 0.084246837 0.336249493 634.8895557 15.8106 0 16.40613 14.97916 16.41057 0 0 16.59903 16.58436 0 0 13.68882 16.46548 0 0 0 14.96935 0 0 0 0 0 0 0 0 0 0 0 16.34887 0 16.38601 0 0 16.72514 0 0 0 0 0 16.26266 17.2393 0 0 17.62372 17.05839 0 0 16.53414 Q76N32 CEP68_HUMAN "Centrosomal protein of 68 kDa, Cep68" CEP68 KIAA0582 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; protein localization to organelle [GO:0033365] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; protein localization to organelle [GO:0033365] protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] GO:0005654; GO:0005813; GO:0005829; GO:0007098; GO:0010457; GO:0019901; GO:0019904; GO:0030054; GO:0033365; GO:0034451 HLDMGSPQLR 1.480000019 1 1 0.148602801 1153.84349 13.04763 17.36078 0 15.43013 14.43448 14.35359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.51477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76N89 HECW1_HUMAN "E3 ubiquitin-protein ligase HECW1, EC 2.3.2.26 (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1, hNEDL1)" HECW1 KIAA0322 NEDL1 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814] ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0005737; GO:0005829; GO:0016567; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:0090090; GO:2000650 EGSLSPVNSQKITLLLQSPAVK 4.610000134 1 1 0.102819966 2308.932199 0 0 16.20339 16.09704 0 17.1468 12.75268 14.83539 15.44326 15.52504 0 0 15.38974 0 0 0 15.78958 15.36915 15.76997 0 15.87507 0 15.91929 14.90373 0 15.21548 0 15.50005 14.7047 13.76262 0 0 0 15.48018 15.05347 12.79716 16.97165 0 16.17991 0 0 14.99214 14.01587 15.52115 0 0 0 15.23901 Q76NI1 KNDC1_HUMAN "Kinase non-catalytic C-lobe domain-containing protein 1, KIND domain-containing protein 1 (Cerebral protein 9) (Protein very KIND, v-KIND) (Ras-GEF domain-containing family member 2)" KNDC1 C10orf23 KIAA1768 RASGEF2 VKIND hucep-9 Homo sapiens (Human) cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; guanyl-nucleotide exchange factor activity [GO:0005085]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 GPRASPTK 6.840000153 0.592758417 0.592758417 0.107476669 814.0647617 11.3542 14.28141 14.15944 0 11.35416 0 14.23001 0 15.30878 0 0 0 14.25156 11.01938 0 13.70013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.49358 0 0 0 0 14.43972 0 0 0 Q7KZ85 SPT6H_HUMAN "Transcription elongation factor SPT6, hSPT6 (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein, Tat-CT2 protein)" SUPT6H KIAA0162 SPT6H Homo sapiens (Human) blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723] GO:0000791; GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0031491; GO:0032968; GO:0034728; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0061086 QRTMAIER 21.10000038 1 1 0.434336216 1022.472384 0 0 0 20.66632 21.23092 0 17.41531 22.21412 21.87521 20.85174 0 21.68407 16.94446 0 0 21.80252 15.91057 0 22.00946 0 20.43753 0 20.46163 0 21.05898 22.08837 21.19319 21.09175 0 20.19082 0 19.27542 19.1086 19.59084 19.23552 21.27039 22.12183 20.8905 0 22.02777 16.65891 0 0 17.15402 18.14521 0 0 0 Q7KZF4 SND1_HUMAN "Staphylococcal nuclease domain-containing protein 1, EC 3.1.31.1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)" SND1 TDRD11 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564] cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442] cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]; cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564] cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GO:0001649; GO:0003712; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016020; GO:0016442; GO:0031047; GO:0042470; GO:0045296; GO:0070062; GO:0097433; GO:1905172 LMENMR 14.93999958 0.823036253 0.823036253 0.2735576 805.6349032 18.30179 17.99337 17.34898 18.03698 0 18.48126 0 0 17.08132 0 14.58187 17.96755 0 17.93112 0 0 17.08294 0 17.16442 0 17.80724 18.98872 18.3254 0 18.20473 0 0 0 0 0 0 0 0 0 19.42852 18.2081 20.07772 21.07743 20.48856 0 0 17.68151 17.70211 16.91879 0 17.88634 18.53716 18.41736 Q7KZI7 MARK2_HUMAN "Serine/threonine-protein kinase MARK2, EC 2.7.11.1, EC 2.7.11.26 (ELKL motif kinase 1, EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b, Par-1b, Par1b)" MARK2 EMK1 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055] actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0000226; GO:0000287; GO:0000422; GO:0001764; GO:0003723; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005884; GO:0005886; GO:0006468; GO:0008289; GO:0010976; GO:0016020; GO:0016055; GO:0016328; GO:0018105; GO:0018107; GO:0030010; GO:0030295; GO:0030425; GO:0032147; GO:0035556; GO:0045197; GO:0045296; GO:0046777; GO:0048156; GO:0050321; GO:0050770; GO:0051493; GO:0051646; GO:0061564; GO:0070507; GO:0071963; GO:0097427; GO:0106310; GO:1904526 FTWSMKTTSSMEPNEMMR 2.880000114 1 1 2.75E-12 2209.219849 15.71775 0 0 14.24732 13.95858 15.38964 0 13.29449 15.10835 0 14.87439 15.5696 12.61907 0 0 14.23946 0 0 15.32222 0 0 0 15.85584 13.51596 16.29622 0 0 0 0 0 0 15.10853 0 0 15.70519 0 15.60605 0 0 0 15.48474 0 0 0 16.45247 0 0 0 Q7L014 DDX46_HUMAN "Probable ATP-dependent RNA helicase DDX46, EC 3.6.4.13 (DEAD box protein 46) (PRP5 homolog)" DDX46 KIAA0801 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0015030; GO:0016020; GO:0016607; GO:0016887 ILNSLKK 17.98999977 1 1 0.254869734 818.0457889 0 14.60902 0 15.91542 16.30417 0 0 16.2803 12.82876 15.43398 0 16.45792 15.98034 16.05252 0 16.52728 16.05529 0 0 16.36729 13.4093 0 0 16.95231 17.0589 0 0 15.44327 16.41385 0 14.82996 15.33988 0 0 17.62491 16.95796 17.42401 18.2382 15.23148 0 15.82608 0 0 0 16.12047 16.03751 0 16.49695 Q7L0R7 RNF44_HUMAN RING finger protein 44 RNF44 KIAA1100 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 ASAPAGGSPR 5.980000019 0.168337956 0.168337956 0.216670462 866.5721024 12.351 10.25263 13.6462 0 12.93184 14.44262 10.49767 0 0 12.77374 0 0 0 12.46511 0 14.34985 0 10.28371 0 0 0 0 0 0 0 0 0 0 0 0 15.90165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L0X0 TRIL_HUMAN TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644) TRIL KIAA0644 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; lipopolysaccharide binding [GO:0001530]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142] lipopolysaccharide binding [GO:0001530] GO:0001530; GO:0002718; GO:0005615; GO:0006954; GO:0031012; GO:0034142; GO:0045087; GO:0046696 LLLVVCGCLALPPLAEPVCPER 7.380000114 1 1 4.58E-13 2475.43472 0 14.09999 14.61192 11.88546 0 14.50915 15.4193 14.77661 0 0 0 15.57142 12.56366 0 11.87933 0 0 0 14.57917 14.51398 0 0 0 0 13.9922 0 0 0 0 0 0 0 0 0 17.54314 0 0 0 0 0 0 14.6867 0 0 0 0 0 0 Q7L190 DPPA4_HUMAN Developmental pluripotency-associated protein 4 DPPA4 Homo sapiens (Human) lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0048731; GO:0060484 MLRGSASSTSMEK 2.25999999 1 1 0.020250742 1416.768974 16.37524 0 0 0 0 0 0 0 14.09762 0 0 0 0 0 0 14.63413 0 15.31526 0 0 0 0 15.83899 0 0 0 0 15.56087 0 0 0 0 0 16.31104 0 15.39298 0 0 0 0 0 0 0 0 14.09138 0 0 14.20867 Q7L1I2 SV2B_HUMAN Synaptic vesicle glycoprotein 2B SV2B KIAA0735 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] transmembrane transporter activity [GO:0022857] GO:0001669; GO:0005886; GO:0006836; GO:0007268; GO:0008021; GO:0016020; GO:0016021; GO:0022857; GO:0030672; GO:0043005 GQTDLMAER 4.449999809 1 1 0.260561589 1036.644104 17.30624 18.12989 0 0 0 0 0 16.93941 0 0 17.33876 0 0 17.06204 14.83458 0 16.39468 0 16.83009 0 15.98343 0 0 0 0 0 0 17.72353 0 0 0 0 0 0 18.1675 0 16.75005 0 0 18.82907 0 0 16.59214 0 16.1695 0 0 0 Q7L1Q6 5MP2_HUMAN eIF5-mimic protein 2 (Basic leucine zipper and W2 domain-containing protein 1) (Protein Orf) BZW1 5MP2 BZAP45 KIAA0005 Homo sapiens (Human) regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of translational initiation [GO:0006446] cadherin binding [GO:0045296]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0006446; GO:0016020; GO:0045296 KEELVAEQAIK 6.400000095 1 1 0 1257.394189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L1S5 CHST9_HUMAN "Carbohydrate sulfotransferase 9, EC 2.8.2.- (GalNAc-4-O-sulfotransferase 2, GalNAc-4-ST2, GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)" CHST9 UNQ2549/PRO6175 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446; GO:0047756 IMSTEK 1.029999971 1 1 0.269308246 723.7940318 0 13.91743 15.29786 15.94017 13.00323 0 14.08596 13.40646 15.01852 0 14.11437 0 0 15.28942 0 0 0 0 15.40416 0 0 15.59966 16.83121 0 0 0 0 0 16.18835 0 0 16.27026 0 0 0 0 17.59387 0 0 15.81598 17.34831 16.85679 0 17.08681 0 15.83605 0 0 Q7L1T6 NB5R4_HUMAN "Cytochrome b5 reductase 4, EC 1.6.2.2 (Flavohemoprotein b5/b5R, b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R)" CYB5R4 NCB5OR Homo sapiens (Human) bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]" "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]" GO:0003032; GO:0004128; GO:0005783; GO:0005789; GO:0006091; GO:0006801; GO:0015701; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0072593 VLNGMLPKSQVTDTLAK 10.44999981 0.359869689 0.359869689 0.2553776 1832.603973 10.46975 0 0 0 0 0 0 0 0 15.37059 15.21598 0 19.68565 0 0 0 0 19.35424 0 0 0 19.29671 18.33298 19.75491 0 18.23157 0 18.58504 0 0 0 19.69489 0 0 20.41202 0 0 0 0 0 0 0 0 0 0 0 20.69832 0 Q7L1V2 MON1B_HUMAN Vacuolar fusion protein MON1 homolog B (HSV-1 stimulation-related gene 1 protein) (HSV-I stimulating-related protein) MON1B HSRG1 KIAA0872 SAND2 Homo sapiens (Human) early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; Mon1-Ccz1 complex [GO:0035658] cytoplasm [GO:0005737]; Mon1-Ccz1 complex [GO:0035658]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] GO:0005737; GO:0006623; GO:0016192; GO:0019085; GO:0019086; GO:0035658 GELLAVHAQIVSTLTR 4.840000153 0.792838931 0.792838931 0.196585059 1707.455304 0 0 0 16.84548 14.89314 14.91352 18.13238 0 12.86163 17.24547 13.14889 0 19.19097 16.27255 15.96871 17.07162 0 0 17.77534 0 0 0 0 16.27619 0 17.44042 0 16.95903 12.99564 0 0 0 15.98259 14.56809 0 0 18.03027 14.40839 0 14.43201 0 15.17757 14.93135 11.6671 16.057 0 0 0 Q7L1W4 LRC8D_HUMAN "Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D, HsLRRC8D)" LRRC8D LRRC5 UNQ213/PRO239 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular glucose homeostasis [GO:0001678]; cellular response to osmotic stress [GO:0071470]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular glucose homeostasis [GO:0001678]; cellular response to osmotic stress [GO:0071470]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] volume-sensitive anion channel activity [GO:0005225] GO:0001678; GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0016021; GO:0034214; GO:0034702; GO:0071470; GO:0098656 LVIHNDGTK 13.35000038 0.889745414 0.889745414 0.33972418 997.3894491 14.53315 0 0 15.13001 0 0 0 0 0 0 0 0 15.83493 15.96827 16.49687 16.05121 15.99655 16.65974 16.76073 15.19878 17.0582 0 0 0 16.50792 15.48647 16.21344 13.31579 12.79437 14.10626 14.3027 13.58959 13.10638 15.55641 14.81117 13.52816 16.11608 14.28508 16.64075 16.36314 0 0 0 16.66264 0 14.49983 0 13.80114 Q7L2J0 MEPCE_HUMAN "7SK snRNA methylphosphate capping enzyme, MePCE, EC 2.1.1.- (Bicoid-interacting protein 3 homolog, Bin3 homolog)" MEPCE BCDIN3 Homo sapiens (Human) negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031] 7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031] 7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069] GO:0000122; GO:0001510; GO:0003723; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0035562; GO:0040031; GO:0097322; GO:0120259; GO:1900087; GO:1904871; GO:1905382; GO:1990276; GO:1990904 GGTER 3.230000019 1 1 0.102261421 518.6967174 16.87954 0 14.12108 0 11.91149 15.07143 0 0 0 16.96295 0 14.9731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.50401 0 0 0 0 Q7L3T8 SYPM_HUMAN "Probable proline--tRNA ligase, mitochondrial, EC 6.1.1.15 (Prolyl-tRNA synthetase, ProRS)" PARS2 Homo sapiens (Human) prolyl-tRNA aminoacylation [GO:0006433] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433] ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827] GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433 AMEKLVR 22.32999992 0.515793622 0.515793622 0.26062175 863.1090178 17.81955 17.6691 19.3712 16.76957 16.75442 18.87612 17.96438 15.61933 20.16656 16.16806 16.94743 18.22171 15.88713 18.6841 13.38056 16.5503 17.21864 18.86233 16.09723 0 18.08504 19.57262 18.40848 18.29975 18.22508 17.54087 19.36866 17.59746 17.21463 15.7838 16.37566 0 16.82389 19.7989 20.03634 19.2037 18.54416 19.33297 18.77434 18.41569 17.59027 18.26865 14.21758 16.95696 0 17.50496 17.17006 15.82511 Q7L523 RRAGA_HUMAN "Ras-related GTP-binding protein A, Rag A, RagA, EC 3.6.5.- (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1)" RRAGA Homo sapiens (Human) apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; negative regulation of cytolysis [GO:0045918]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; negative regulation of cytolysis [GO:0045918]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625] GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006915; GO:0008219; GO:0009267; GO:0010506; GO:0010507; GO:0031625; GO:0032008; GO:0033209; GO:0034198; GO:0034613; GO:0042803; GO:0045918; GO:0046982; GO:0051219; GO:0071230; GO:1904263; GO:1990131 MPNTAMK 9.890000343 1 1 0.127565681 808.1870884 0 15.49934 17.82728 0 0 0 0 0 0 0 0 0 0 0 0 0 15.22944 14.99102 0 0 16.39108 0 16.53222 16.25473 15.19669 18.57864 0 0 0 0 17.01153 16.60793 16.32834 0 0 15.60724 0 0 0 0 0 0 0 0 0 0 0 0 Q7L576 CYFP1_HUMAN "Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1, Sra-1) (p140sra-1)" CYFIP1 KIAA0068 Homo sapiens (Human) "axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]" axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724] "axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation regulator activity [GO:0045182]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]" actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation regulator activity [GO:0045182] GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0010592; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030833; GO:0031209; GO:0031267; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0044294; GO:0044295; GO:0045182; GO:0045202; GO:0045773; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:0099578; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601 FALVEVIAMIK 10.01000023 1 1 0.310250226 1250.024633 12.17779 14.82515 0 0 0 13.65198 0 0 0 0 0 14.2632 0 0 16.42532 15.93091 14.89495 0 15.4848 0 0 0 0 0 0 15.68591 0 13.81237 14.21631 14.93703 15.80813 15.37717 15.94261 13.28603 0 0 0 0 0 0 15.12345 15.31021 0 0 0 16.07088 0 14.31795 Q7L590 MCM10_HUMAN "Protein MCM10 homolog, HsMCM10" MCM10 PRO2249 Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270] DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697] GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005730; GO:0006270; GO:0006974; GO:0008283; GO:0019899; GO:0031298; GO:0042802; GO:0046872 VLPAPAPRR 2.579999924 1 1 0.28911481 977.1804085 0 0 0 0 0 0 0 0 0 0 0 17.10323 17.98859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L591 DOK3_HUMAN Docking protein 3 (Downstream of tyrosine kinase 3) DOK3 Homo sapiens (Human) Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005886; GO:0007169; GO:0007265; GO:0030667; GO:0101003 KVWALLYAGGPSGVAR 18.59000015 1 1 0.318607866 1645.826294 0 0 0 0 0 0 0 0 0 0 16.00407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.97432 0 0 0 0 0 0 0 19.47822 0 19.8641 0 Q7L5L3 GDPD3_HUMAN "Lysophospholipase D GDPD3, EC 3.1.4.- (Glycerophosphodiester phosphodiesterase 7) (Glycerophosphodiester phosphodiesterase domain-containing protein 3)" GDPD3 GDE7 Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phosphatidylcholine catabolic process [GO:0034638] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phosphatidylcholine catabolic process [GO:0034638] lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081] GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016021; GO:0034638; GO:0046475; GO:0046872; GO:0048471; GO:0070062; GO:0070291 RPHLLHTPR 3.220000029 0.54271841 0.54271841 0.179955587 1126.253605 14.93779 13.76108 0 13.47835 14.85776 15.61831 0 0 13.02042 18.23165 13.11253 14.72333 13.00922 0 12.3275 8.02264 0 0 0 0 0 0 15.59283 0 15.74398 0 0 0 0 0 15.22313 0 0 0 15.03601 0 0 13.94319 0 0 0 0 0 0 0 16.508 0 13.79878 Q7L5Y1 ENOF1_HUMAN "Mitochondrial enolase superfamily member 1, EC 4.2.1.68 (Antisense RNA to thymidylate synthase, rTS) (L-fuconate dehydratase)" ENOSF1 RTS TYMSAS Homo sapiens (Human) carbohydrate catabolic process [GO:0016052]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; hydro-lyase activity [GO:0016836]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; carbohydrate catabolic process [GO:0016052]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275] hydro-lyase activity [GO:0016836]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005739; GO:0009063; GO:0016052; GO:0016836; GO:0016853; GO:0044275; GO:0050023 ASYMPPK 4.46999979 1 1 0.195856142 808.3523463 0 0 17.21217 15.10306 0 0 17.3656 0 15.9416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.23449 15.79082 0 0 0 0 0 0 0 0 0 17.27219 0 0 0 0 0 16.95416 0 0 0 0 Q7L622 G2E3_HUMAN "G2/M phase-specific E3 ubiquitin-protein ligase, EC 2.3.2.26 (G2/M phase-specific HECT-type E3 ubiquitin transferase)" G2E3 KIAA1333 Homo sapiens (Human) apoptotic process [GO:0006915] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0043231; GO:0046872 CCVCKK 5.039999962 0.65266788 0.65266788 0.175464871 854.3702569 14.44962 0 0 13.57576 15.05714 13.27255 0 0 15.32049 0 15.13591 0 0 0 0 0 15.37884 15.93519 0 0 0 16.45947 0 16.20273 16.96726 0 0 16.65392 16.40272 0 0 0 0 13.00229 0 13.3113 0 15.25746 15.14933 0 0 14.74353 14.85899 15.70672 0 0 0 0 Q7L775 EPMIP_HUMAN EPM2A-interacting protein 1 (Laforin-interacting protein) EPM2AIP1 KIAA0766 My007 Homo sapiens (Human) positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868] identical protein binding [GO:0042802] GO:0005634; GO:0032868; GO:0042802; GO:0045725; GO:0098554; GO:2000467 AARAGLGLCR 9.430000305 0.214339375 0.214339375 0.305699907 1045.595667 16.46296 15.39045 15.57261 15.96107 14.41743 0 0 16.8921 13.25267 16.53203 14.73659 16.31418 16.6911 15.97654 16.00692 16.60982 17.01796 16.33859 0 0 16.82327 14.35331 17.22832 0 15.94813 0 0 15.94901 16.34253 16.36816 15.8005 16.19166 0 17.25627 17.07183 16.4515 18.14634 17.19913 16.87795 17.11796 0 0 0 16.80596 15.88265 16.5906 16.52502 16.9515 Q7L7V1 DHX32_HUMAN "Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32, EC 3.6.4.13 (DEAD/H box 32) (DEAD/H helicase-like protein 1, DHLP1) (DEAH box protein 32) (HuDDX32)" DHX32 DDX32 Homo sapiens (Human) mitochondrion [GO:0005739]; spliceosomal complex [GO:0005681] mitochondrion [GO:0005739]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005739; GO:0016887 QILGSSSSGK 5.409999847 1 1 0.124839469 964.0785765 13.17213 0 13.53998 0 0 12.30034 0 0 0 0 0 0 0 14.91145 14.82144 0 14.6597 10.25881 0 9.504245 13.66785 0 0 0 0 0 15.75601 0 14.8197 14.53523 13.3866 13.30853 9.985357 15.28812 11.22709 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L7X3 TAOK1_HUMAN "Serine/threonine-protein kinase TAO1, EC 2.7.11.1 (Kinase from chicken homolog B, hKFC-B) (MARK Kinase, MARKK) (Prostate-derived sterile 20-like kinase 2, PSK-2, PSK2, Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1, TAOK1, hTAOK1)" TAOK1 KIAA1361 MAP3K16 MARKK Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; regulation of microtubule cytoskeleton organization [GO:0070507] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; regulation of microtubule cytoskeleton organization [GO:0070507] alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740] GO:0000165; GO:0000226; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0006974; GO:0007026; GO:0007095; GO:0015630; GO:0016301; GO:0016310; GO:0016740; GO:0032874; GO:0032956; GO:0035556; GO:0043014; GO:0043408; GO:0043539; GO:0046330; GO:0046777; GO:0048156; GO:0048471; GO:0048487; GO:0048812; GO:0050321; GO:0051493; GO:0070050; GO:0070062; GO:0070507; GO:0097194; GO:0106310; GO:1901985 QHQKQLMTLENK 2.039999962 0.149781153 0.149781153 0.181094585 1513.09881 0 0 0 0 0 0 16.005 0 13.44588 0 0 16.64903 0 18.53643 17.44929 18.83105 0 14.55184 16.43967 0 12.56182 16.83515 18.75552 0 15.40603 14.99402 0 15.904 0 16.77177 0 0 17.69953 18.21948 0 17.79204 0 0 0 0 0 15.42395 0 0 17.74022 0 0 15.24961 Q7L804 RFIP2_HUMAN "Rab11 family-interacting protein 2, Rab11-FIP2 (NRip11)" RAB11FIP2 KIAA0941 Homo sapiens (Human) establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669] cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038] cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0001891; GO:0005654; GO:0005768; GO:0006909; GO:0019901; GO:0030010; GO:0030659; GO:0031267; GO:0035669; GO:0035773; GO:0042802; GO:0042803; GO:0042995; GO:0043231; GO:0043547; GO:0045055; GO:0055038 AGKFSNS 1.669999957 1 1 0.013482149 711.3650527 0 0 0 0 0 0 0 14.09854 15.34741 15.51038 0 0 14.2736 0 0 17.63179 0 15.17195 0 14.15964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L8A9 VASH1_HUMAN "Tubulinyl-Tyr carboxypeptidase 1, EC 3.4.17.17 (Tubulin carboxypeptidase 1) (Tyrosine carboxypeptidase 1, TTCP 1) (Vasohibin-1)" VASH1 KIAA1036 VASH Homo sapiens (Human) angiogenesis [GO:0001525]; cell cycle [GO:0007049]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611] actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181] GO:0001525; GO:0001937; GO:0003779; GO:0004181; GO:0005615; GO:0005737; GO:0005783; GO:0006508; GO:0007049; GO:0009611; GO:0010596; GO:0016525; GO:0043537; GO:0045177; GO:0045765; GO:0060716; GO:1901491; GO:2000772 DGGVPFFVNR 5.809999943 1 1 0.129032941 1106.755323 16.97305 16.62768 15.73648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L8J4 3BP5L_HUMAN "SH3 domain-binding protein 5-like, SH3BP-5-like" SH3BP5L KIAA1720 UNQ2766/PRO7133 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099] guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860] GO:0004860; GO:0005085; GO:0005737; GO:0035556; GO:0061099 CDSVEHLR 3.470000029 1 1 0.188618955 1015.083107 15.26825 0 0 0 14.76056 0 0 0 14.5376 0 13.73058 0 0 0 0 0 0 0 0 0 15.66047 0 0 0 13.48951 9.50865 0 14.45317 0 11.733 15.09881 12.64053 13.0345 0 0 0 0 0 0 14.49922 14.27046 0 0 15.76016 0 15.89496 13.38279 15.42745 Q7L8W6 DPH6_HUMAN "Diphthine--ammonia ligase, EC 6.3.1.14 (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)" DPH6 ATPBD4 Homo sapiens (Human) peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178] GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0017178; GO:0017183 FLELHLEDK 7.800000191 1 1 0.316198851 1144.18525 16.85581 0 0 0 0 0 0 0 0 16.67981 0 16.14904 0 0 17.80585 17.85792 0 0 17.36713 0 0 0 0 16.55579 0 0 0 0 0 0 17.49671 18.06894 0 0 0 18.31843 0 0 0 0 0 0 16.57562 0 0 0 16.89952 17.20087 Q7L945 ZN627_HUMAN Zinc finger protein 627 ZNF627 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GGVPYKCK 4.730000019 0.823989213 0.823989213 0.181169736 908.6604774 18.73137 0 16.86284 0 14.01455 0 15.44159 0 15.51137 0 0 0 0 0 0 13.99058 0 0 0 0 17.92951 0 16.06094 16.3748 16.21988 0 14.38275 15.16349 0 15.05693 0 0 0 17.60187 13.14807 0 0 0 0 0 14.96889 16.17971 16.30256 0 4.919318 0 0 0 Q7L985 LIGO2_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C) LINGO2 LERN3 LRRN6C UNQ9234/PRO31993 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965] GO:0005615; GO:0016021; GO:0031012; GO:0051965 SNGRATVLGDGTLEIR 3.019999981 0.38166526 0.38166526 0.304000372 1660.303606 15.97901 0 0 0 0 14.3153 0 0 11.07383 0 0 0 0 0 0 17.57565 0 0 0 0 13.17672 0 0 0 15.13943 15.54444 16.79932 0 13.78744 0 0 16.46161 0 17.03752 14.81101 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7LFX5 CHSTF_HUMAN "Carbohydrate sulfotransferase 15, EC 2.8.2.33 (B-cell RAG-associated gene protein, hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase, GalNAc4S-6ST)" CHST15 BRAG GALNAC4S6ST KIAA0598 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659 LEDHASNVKYTMHK 5.920000076 1 1 0.269487092 1687.570523 0 15.62957 15.91934 0 0 0 0 0 14.26152 0 0 0 0 0 15.28326 0 14.6713 14.49539 0 0 0 0 15.40722 0 0 12.81936 0 0 0 0 0 0 0 0 16.1603 0 0 0 0 0 0 0 0 0 0 0 16.04525 0 Q7LGA3 HS2ST_HUMAN "Heparan sulfate 2-O-sulfotransferase 1, 2-O-sulfotransferase, 2OST, EC 2.8.2.-" HS2ST1 HS2ST KIAA0448 Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]" heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0004394; GO:0006024; GO:0008146; GO:0015014; GO:0015015; GO:0016020; GO:0016021 FGDDYRPGLRR 9.229999542 1 1 2.06E-12 1351.074104 0 0 13.01723 14.68416 15.69499 0 13.63718 0 0 0 11.28783 14.6916 15.10683 0 14.63289 0 0 14.25564 15.94738 0 0 0 14.2852 0 13.28611 0 0 13.97079 0 12.7558 13.90433 9.920076 0 0 0 0 0 14.64177 0 13.97612 0 0 0 15.11779 13.3372 0 15.97098 14.30041 Q7LGC8 CHST3_HUMAN "Carbohydrate sulfotransferase 3, EC 2.8.2.17, EC 2.8.2.21 (Chondroitin 6-O-sulfotransferase 1, C6ST-1) (Chondroitin 6-sulfotransferase, C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0, GST-0)" CHST3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206 DPRAVLASR 4.929999828 1 1 0.285883444 981.6065118 9.631454 13.28698 11.29166 11.5199 0 0 0 13.70994 0 13.38207 15.3326 12.34975 0 11.48971 0 11.19189 13.81921 8.245331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7M4L6 SHF_HUMAN SH2 domain-containing adapter protein F SHF Homo sapiens (Human) apoptotic process [GO:0006915] phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915] phosphotyrosine residue binding [GO:0001784] GO:0001784; GO:0006915 SCLSPGREEK 3.700000048 1 1 0.118463186 1162.811888 13.08705 11.18699 0 15.51685 14.50917 14.01231 0 0 0 0 0 13.0906 0 0 0 13.0079 13.86162 0 0 16.23847 13.51949 15.08918 15.1697 12.32598 17.02458 16.85903 0 0 0 0 0 0 0 0 0 0 15.0635 0 15.62101 0 0 0 14.91006 0 17.04212 0 0 12.22369 Q7RTP0 NIPA1_HUMAN Magnesium transporter NIPA1 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 1) (Spastic paraplegia 6 protein) NIPA1 SPG6 Homo sapiens (Human) magnesium ion transport [GO:0015693]; transmembrane transport [GO:0055085] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; transmembrane transport [GO:0055085] magnesium ion transmembrane transporter activity [GO:0015095] GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021; GO:0055085 MGTAAAAAAAAAAAAAGEGAR 6.730000019 1 1 0.095537471 1702.197708 0 0 0 0 13.33664 0 0 0 13.94758 0 15.97133 0 0 0 14.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.49984 0 0 0 0 0 0 17.35018 0 0 0 0 0 0 0 0 Q7RTP6 MICA3_HUMAN "[F-actin]-monooxygenase MICAL3, EC 1.14.13.225 (Molecule interacting with CasL protein 3, MICAL-3)" MICAL3 KIAA0819 KIAA1364 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; small GTPase binding [GO:0031267]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]" "actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; small GTPase binding [GO:0031267]" GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0030042; GO:0031267; GO:0042995; GO:0045171; GO:0046872; GO:0051015; GO:0051301; GO:0071949; GO:0090543 GPSQATSPIR 8.140000343 1 1 0.540227048 1013.082027 0 0 0 0 0 0 0 0 0 0 0 0 16.37212 0 0 0 0 0 0 0 0 0 17.6545 0 0 0 0 0 0 0 0 0 0 0 0 17.85198 0 0 0 0 0 0 0 0 0 17.66195 0 0 Q7RTR0 NLRP9_HUMAN "NACHT, LRR and PYD domains-containing protein 9 (Nucleotide-binding oligomerization domain protein 6) (PYRIN and NACHT-containing protein 12)" NLRP9 NALP9 NOD6 PAN12 Homo sapiens (Human) defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-18 production [GO:0032741]; pyroptosis [GO:0070269] inflammasome complex [GO:0061702] inflammasome complex [GO:0061702]; ATP binding [GO:0005524]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-18 production [GO:0032741]; pyroptosis [GO:0070269] ATP binding [GO:0005524] GO:0005524; GO:0006954; GO:0032741; GO:0045087; GO:0051607; GO:0061702; GO:0070269 AGSQSFPPK 8.789999962 1 1 0.194077162 917.550155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59247 0 0 0 0 0 0 0 0 0 0 0 0 18.32078 17.58218 0 0 0 0 0 0 0 0 Q7RTR2 NLRC3_HUMAN "NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2, CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)" NLRC3 NOD3 Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110] ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312] GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223 ALADALKINR 5.679999828 1 1 0.378626629 1083.674753 0 17.0273 0 0 0 0 0 0 15.59499 0 0 0 0 0 0 0 0 0 0 18.20442 0 0 0 0 0 0 15.24604 0 16.62305 0 15.74339 0 0 0 0 0 0 0 0 0 16.56373 0 0 0 16.39122 0 0 16.11992 Q7RTS5 OTOP3_HUMAN Proton channel OTOP3 (Otopetrin-3) OTOP3 Homo sapiens (Human) proton transmembrane transport [GO:1902600] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600] proton channel activity [GO:0015252] GO:0005886; GO:0015252; GO:0016021; GO:1902600 AAATRPR 15.92000008 0.521158755 0.521158755 0.318521011 741.015574 14.71008 15.37873 0 15.59242 0 0 0 15.19981 0 14.8008 16.97 0 0 0 15.50566 14.31774 0 0 0 14.87294 0 0 0 0 0 0 14.73743 0 13.84004 15.80489 0 0 0 14.73359 16.1231 16.12818 16.9402 0 17.04649 16.60321 0 15.49943 0 0 0 0 16.71519 0 Q7RTS7 K2C74_HUMAN "Keratin, type II cytoskeletal 74 (Cytokeratin-74, CK-74) (Keratin-5c, K5C) (Keratin-74, K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)" KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 Homo sapiens (Human) intermediate filament cytoskeleton organization [GO:0045104] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; keratin filament binding [GO:1990254]; intermediate filament cytoskeleton organization [GO:0045104] keratin filament binding [GO:1990254] GO:0005737; GO:0005829; GO:0045095; GO:0045104; GO:0070062; GO:1990254 STPASIPAR 3.809999943 0.269407839 0.269407839 0.137078238 900.58227 18.39003 17.17452 15.68477 0 0 16.79432 10.86889 16.56138 16.05654 11.85941 11.37306 15.21954 16.91738 17.39836 0 0 15.62935 13.5071 16.09162 17.38293 0 17.96667 0 18.46375 15.82012 0 17.22321 17.69597 0 14.77624 13.8675 16.99975 15.8248 13.56223 16.75002 11.5025 16.48759 17.49582 13.04088 0 15.30074 15.09674 14.26409 16.91875 15.26639 15.12591 15.69686 0 Q7RTT9 S29A4_HUMAN "Equilibrative nucleoside transporter 4, hENT4 (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)" SLC29A4 ENT4 PMAT PSEC0113 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0001692; GO:0005326; GO:0005337; GO:0005342; GO:0005886; GO:0006836; GO:0008324; GO:0008504; GO:0015101; GO:0015562; GO:0015695; GO:0015844; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098655; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1903825 GRPGLGR 7.179999828 1 1 0.168997851 712.460231 0 14.80138 14.92679 15.73566 14.90139 0 0 0 0 0 0 0 0 15.22723 0 0 16.30463 15.45811 17.10608 16.79063 15.92567 16.93768 16.46657 0 16.30464 16.82681 0 16.91361 15.07213 0 16.06292 16.69412 16.54378 17.60009 16.56867 17.11371 17.59156 17.3656 0 16.79445 17.0225 16.72769 16.65845 17.04309 0 16.78555 17.32509 17.59128 Q7RTU0 TCF24_HUMAN "Transcription factor 24, TCF-24" TCF24 Homo sapiens (Human) developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0032502; GO:0046983 DSRPGRTGPGPAGPGGGSR 2.819999933 1 1 0.022346433 1734.89564 0 13.21426 0 10.28451 0 0 15.102 13.22486 15.06424 15.27129 0 11.55172 11.58835 0 0 9.524519 14.60904 14.46606 0 14.53082 14.47076 11.96808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTU9 STRC_HUMAN Stereocilin STRC Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910] cell surface [GO:0009986]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426] cell surface [GO:0009986]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426]; auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910] GO:0007160; GO:0009986; GO:0032426; GO:0050910; GO:0060088; GO:0060091 ASQPSAHISPR 8.43999958 1 1 0.195091991 1146.86652 0 0 0 14.57748 0 0 13.45569 15.32954 15.33705 0 15.5165 14.36292 0 0 0 0 0 13.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTX0 TS1R3_HUMAN Taste receptor type 1 member 3 (Sweet taste receptor T1R3) TAS1R3 T1R3 TR3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sweet taste receptor complex [GO:1903767] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sweet taste receptor complex [GO:1903767]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] GO:0001582; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0016021; GO:0050916; GO:0050917; GO:1903767 FSSNGLLWALAMKMAVEEINNK 1.929999948 1 1 0.442232904 2483.842589 15.24009 18.44106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTX7 CTSR4_HUMAN "Cation channel sperm-associated protein 4, CatSper4" CATSPER4 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] GO:0001669; GO:0005227; GO:0005245; GO:0005886; GO:0006814; GO:0030317; GO:0034765; GO:0036128; GO:0048240; GO:0097228 MGFGGAVAALR 4.309999943 1 1 0.094373208 1050.095754 0 0 0 0 13.05199 0 15.47023 18.57141 13.53526 18.98104 0 0 17.11824 0 0 0 0 0 0 0 0 0 0 0 0 16.00208 11.95447 15.09149 0 0 0 13.69364 0 0 0 0 0 0 0 0 0 0 0 15.99311 14.42208 0 0 14.53643 Q7RTY5 PRS48_HUMAN "Serine protease 48, EC 3.4.21.- (Epidermis-specific serine protease-like protein)" PRSS48 ESSPL Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005615; GO:0006508 WINATISR 8.550000191 0.065615766 0.065615766 0.220420473 959.3642273 15.93267 16.23007 0 15.71384 15.56375 15.62669 14.43295 11.92011 15.75965 0 16.1508 0 12.84052 14.81205 13.78008 16.99261 0 0 0 0 0 0 0 15.34682 15.57331 14.15887 15.17082 15.15975 0 16.69774 14.91707 16.23508 16.83 17.38036 0 14.60106 17.39783 16.38875 13.75042 0 16.00836 0 13.68921 0 15.28391 14.97127 16.49183 0 Q7RTY7 OVCH1_HUMAN "Ovochymase-1, EC 3.4.21.-" OVCH1 Homo sapiens (Human) extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005576; GO:0005886; GO:0046872 VMIFLDWIQSKINGPASLQTNNK 6.679999828 1 1 0.21818046 2632.242154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.93501 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTY8 TMPS7_HUMAN "Transmembrane protease serine 7, EC 3.4.21.- (Matriptase-3)" TMPRSS7 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0016021 MDKENSDVSAAPADLK 3.599999905 1 1 0.297194256 1706.487408 16.35701 0 0 0 0 15.25616 0 0 0 14.40436 15.58174 14.22799 0 0 0 0 16.29163 16.0434 15.72517 0 0 0 0 0 0 14.46824 16.30478 15.03805 0 14.96671 0 0 0 12.77783 0 0 0 0 0 16.54238 15.96276 16.1741 15.01179 0 17.16714 16.15568 0 0 Q7Z2D5 PLPR4_HUMAN "Phospholipid phosphatase-related protein type 4 (Brain-specific phosphatidic acid phosphatase-like protein 1) (Inactive 2-lysophosphatidate phosphatase PLPPR4) (Lipid phosphate phosphatase-related protein type 4) (Plasticity-related gene 1 protein, PRG-1)" PLPPR4 KIAA0455 LPPR4 PHP1 PRG1 Homo sapiens (Human) "axonogenesis [GO:0007409]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; lipid import into cell [GO:0140354]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]" glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] "glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; axonogenesis [GO:0007409]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; lipid import into cell [GO:0140354]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]" lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195] GO:0005886; GO:0005887; GO:0006644; GO:0007165; GO:0007186; GO:0007409; GO:0008195; GO:0042577; GO:0046839; GO:0048839; GO:0051966; GO:0098839; GO:0098978; GO:0099061; GO:0140354 IMQVIAMSK 4.409999847 1 1 0.030300785 1037.294428 15.28022 0 0 0 0 0 15.9177 0 0 15.88346 0 14.9731 14.6393 0 16.36285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.08672 15.60129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32911 16.18039 Q7Z2K6 ERMP1_HUMAN "Endoplasmic reticulum metallopeptidase 1, EC 3.4.-.- (Felix-ina)" ERMP1 FXNA KIAA1815 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508] metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235] GO:0005783; GO:0005789; GO:0006508; GO:0008235; GO:0016020; GO:0016021; GO:0030968; GO:0034599; GO:0046872 YDTADR 6.829999924 1 1 0.149466239 740.853859 0 0 0 0 0 15.19174 15.99435 0 17.1132 0 17.42046 0 0 0 0 0 0 17.06427 15.36619 0 0 0 0 0 0 18.62164 0 0 0 0 16.91202 0 0 0 14.40139 0 0 0 19.30563 16.74185 0 0 0 0 0 0 0 0 Q7Z2K8 GRIN1_HUMAN "G protein-regulated inducer of neurite outgrowth 1, GRIN1" GPRIN1 KIAA1893 Homo sapiens (Human) neuron projection development [GO:0031175] growth cone [GO:0030426]; plasma membrane [GO:0005886] growth cone [GO:0030426]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; neuron projection development [GO:0031175] phosphoprotein binding [GO:0051219] GO:0005886; GO:0030426; GO:0031175; GO:0051219 MDPMCSGKPELLSPGQAERVSVGK 6.380000114 1 1 0.245655387 2588.529336 15.05169 13.9395 16.0277 0 0 0 0 11.51309 0 0 0 12.77438 15.505 13.06638 14.79543 14.4514 0 0 12.67665 0 0 0 0 0 13.65137 14.79818 15.53094 0 0 0 0 0 17.63924 0 0 0 12.65331 0 0 0 15.66523 13.99709 0 0 0 0 0 0 Q7Z2W4 ZCCHV_HUMAN "Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13, ARTD13) (Inactive Poly [ADP-ribose] polymerase 13, PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein, ZAP)" ZC3HAV1 ZC3HDC2 PRO1677 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615] cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0009615; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0046872; GO:0051607; GO:0061014; GO:1900246 IADDADPR 4.190000057 0.730724752 0.730724752 0.191811507 872.5450628 14.4844 0 0 0 15.23736 15.27249 14.24642 0 0 0 15.20494 0 13.85794 0 0 0 15.39237 14.91031 0 0 0 0 15.75338 0 14.47164 8.412798 14.91434 10.64304 15.18157 14.79827 16.39144 16.09519 16.57824 13.63353 14.07944 14.41924 15.39457 16.22461 13.01128 13.75239 15.63681 15.88821 14.09682 13.62816 15.01366 13.52882 15.01348 14.77324 Q7Z2W7 TRPM8_HUMAN "Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6, LTrpC-6, LTrpC6) (Transient receptor potential p8, Trp-p8)" TRPM8 LTRPC6 TRPP8 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955] endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955] calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604] GO:0005261; GO:0005262; GO:0005789; GO:0005886; GO:0005887; GO:0006874; GO:0009409; GO:0009897; GO:0016048; GO:0042802; GO:0045121; GO:0050955; GO:0070588; GO:0098655; GO:0099604; GO:0120162 NFALKPRMR 6.900000095 1 1 0.192249005 1149.071289 0 14.41083 0 0 14.04118 0 15.01486 14.10392 14.99481 15.21896 12.35966 15.09878 14.34147 14.9812 0 17.76555 14.65798 14.39005 0 15.98747 0 0 0 16.86433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.48044 0 0 0 0 0 0 15.03203 0 Q7Z2Y5 NRK_HUMAN "Nik-related protein kinase, EC 2.7.11.1" NRK Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0031532; GO:0035556; GO:0043408; GO:0048812; GO:0106310 GIPLIFER 3.160000086 0.650114357 0.650114357 0.17320794 942.4112413 16.01144 0 0 12.94706 0 0 0 0 0 0 0 0 16.26448 13.02496 13.38678 16.00453 0 0 16.59793 0 0 0 14.60591 0 0 0 0 0 13.79093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.81568 0 0 0 14.78687 Q7Z2Y8 GVIN1_HUMAN Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1) GVINP1 GVIN1 VLIG1 Homo sapiens (Human) cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525] GTP binding [GO:0005525] GO:0005525; GO:0005634; GO:0005829 EFTSPQAEFMFTQMVEK 3.440000057 0.980145335 0.980145335 1.83E-12 2066.874718 14.28537 15.63161 14.04499 16.25514 15.25151 0 0 12.338 13.21351 12.28989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.01281 0 12.64134 15.73839 13.70112 0 0 0 15.83121 0 0 0 0 0 0 0 0 0 Q7Z2Z1 TICRR_HUMAN "Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)" TICRR C15orf42 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0007095; GO:0010212; GO:0030174; GO:0033314; GO:0043231 RGVPR 10.07999992 1 1 0.005757297 584.8557968 0 0 0 0 0 0 13.90973 0 0 0 0 16.3901 0 0 0 16.34481 0 15.52398 15.76211 0 0 12.08631 0 0 0 0 0 0 0 0 0 17.4845 15.57283 0 0 0 0 15.16901 0 15.86816 0 0 16.22252 0 15.51861 0 0 0 Q7Z2Z2 EFL1_HUMAN Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A) EFL1 EFTUD1 FAM42A Homo sapiens (Human) GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746] GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904 VLQEEMK 1.789999962 0.002647907 0.002647907 0.309040588 874.0617811 18.66705 16.8921 16.02437 0 0 17.22157 18.61434 0 17.0761 0 0 0 16.25 15.3496 0 16.99967 18.93468 0 16.45393 16.78648 0 0 0 17.40867 0 0 0 17.72179 0 0 0 0 0 18.95945 0 0 16.759 17.35857 18.65442 17.01924 0 0 17.5376 0 16.28857 18.07086 16.73946 16.79083 Q7Z333 SETX_HUMAN "Probable helicase senataxin, EC 3.6.4.- (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)" SETX ALS4 KIAA0625 SCAR1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]" ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147] GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806 CLHLLWVSSQQWVEAVVK 2.839999914 1 1 3.66E-12 2180.447936 0 15.50229 12.49126 0 11.45803 0 14.80495 0 0 0 0 0 0 13.71005 13.99571 0 13.74037 0 0 12.64048 14.72103 0 16.14968 0 0 14.40982 0 0 0 13.46188 0 14.81212 0 0 14.85614 13.80757 15.66362 0 17.50636 15.75577 16.36163 0 0 16.71434 0 17.5011 0 0 Q7Z340 ZN551_HUMAN Zinc finger protein 551 (Zinc finger protein KOX23) ZNF551 KOX23 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 VHTEERP 9.079999924 1 1 0.340470112 868.5725086 14.78547 0 15.70222 14.86607 15.89643 0 0 0 0 14.90416 12.15397 0 0 14.34295 11.96215 0 15.01179 15.64879 0 0 0 16.21262 0 0 0 0 0 0 0 0 0 0 0 15.48483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z353 HDX_HUMAN Highly divergent homeobox HDX CXorf43 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 EEDHHAVTTDNVK 6.800000191 1 1 0.527456571 1494.595735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.21674 0 0 19.30973 0 0 0 19.24675 0 0 0 0 17.46315 0 0 0 0 0 20.04005 0 17.83285 19.35899 0 0 0 0 0 Q7Z388 D19L4_HUMAN "Probable C-mannosyltransferase DPY19L4, EC 2.4.1.- (Dpy-19-like protein 4) (Protein dpy-19 homolog 4)" DPY19L4 Homo sapiens (Human) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] mannosyltransferase activity [GO:0000030] GO:0000030; GO:0005637; GO:0016021; GO:0018406 GSFVAK 4.670000076 0.273962587 0.273962587 0.016536454 608.7224546 11.85044 0 14.08867 15.58527 16.27881 10.64795 15.16935 17.37144 0 15.29365 0 15.1393 15.25998 13.68986 15.51507 12.8763 16.44745 16.34914 16.56932 14.66584 14.18808 13.94124 16.05442 15.87952 16.95469 12.74206 15.20601 14.85006 15.11799 13.27726 15.3407 13.86283 13.78907 16.08843 16.43932 0 14.14115 11.12757 14.99747 16.83703 14.97176 13.56579 15.55594 16.60247 14.52556 15.14363 13.39958 8.498507 Q7Z392 TPC11_HUMAN Trafficking protein particle complex subunit 11 TRAPPC11 C4orf41 Homo sapiens (Human) constitutive secretory pathway [GO:0045054]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; regulation of protein complex stability [GO:0061635]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; constitutive secretory pathway [GO:0045054]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; regulation of protein complex stability [GO:0061635]; vesicle tethering [GO:0099022] GO:0005737; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0045054; GO:0048208; GO:0061635; GO:0099022; GO:1990072 CHKDETVTIETVFPFDVAVK 1.940000057 1 1 0.036958955 2334.17241 13.31365 0 13.99973 12.69167 13.2771 0 0 13.55181 13.8212 16.36237 0 0 15.65953 0 0 0 0 0 13.27978 0 0 0 0 0 0 0 0 0 15.39863 0 0 0 0 0 0 0 0 16.09339 0 0 0 0 0 0 0 0 12.83107 0 Q7Z3B3 KANL1_HUMAN "KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1, hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog)" KANSL1 CENP-36 KIAA1267 MSL1V1 NSL1 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]" histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]" histone acetyltransferase binding [GO:0035035] GO:0000123; GO:0000776; GO:0005634; GO:0005654; GO:0006325; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0051571; GO:0071339 TSGSK 7.820000172 1 1 0.132375454 478.2916593 0 0 0 0 0 0 16.01954 0 20.72891 0 18.04763 0 0 0 0 0 0 0 0 0 17.87988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.95215 0 0 0 0 0 0 0 0 0 0 0 Q7Z3D4 LYSM3_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 3 LYSMD3 Homo sapiens (Human) Golgi organization [GO:0007030] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Golgi organization [GO:0007030] GO:0005794; GO:0005886; GO:0007030; GO:0016021 RENLNEVVSALTAQQMR 5.690000057 0.550551474 0.550551474 0.233946346 1973.145268 0 0 0 0 0 14.22817 0 13.72285 0 0 14.48177 0 0 0 0 0 0 0 0 0 0 0 0 13.96218 0 0 0 0 0 0 0 0 12.42935 0 0 16.7381 0 0 15.45182 0 0 0 0 0 0 0 11.8204 0 Q7Z3D6 GLUCM_HUMAN "D-glutamate cyclase, mitochondrial, EC 4.2.1.48" DGLUCY C14orf159 UNQ2439/PRO5000 Homo sapiens (Human) glutamate metabolic process [GO:0006536] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; D-glutamate cyclase activity [GO:0047820]; glutamate metabolic process [GO:0006536] D-glutamate cyclase activity [GO:0047820] GO:0005759; GO:0006536; GO:0047820 APGDQAWTQALPSVIK 2.839999914 1 1 0.07336935 1681.145845 16.91613 0 0 17.33587 15.38779 0 0 0 0 16.95479 14.54001 0 14.77457 13.10478 0 0 0 14.72594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3E2 CC186_HUMAN Coiled-coil domain-containing protein 186 (CTCL tumor antigen HD-CL-01/L14-2) CCDC186 C10orf118 Homo sapiens (Human) insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; small GTPase binding [GO:0031267]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518] small GTPase binding [GO:0031267] GO:0005802; GO:0009617; GO:0031267; GO:0035773; GO:0099518 EAMVMK 8.470000267 1 1 0.124858449 709.4209819 0 0 14.38145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01133 0 0 0 0 0 0 0 0 17.08518 16.59523 0 17.95201 0 0 0 15.63663 Q7Z3E5 ARMC9_HUMAN LisH domain-containing protein ARMC9 (Armadillo repeat-containing protein 9) (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21) ARMC9 KIAA1868 Homo sapiens (Human) cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005737; GO:0005814; GO:0036064; GO:0045880; GO:0060271; GO:0070062; GO:0097542 KGLANVQWSGDEPLQRPVTPGGHR 2.130000114 1 1 2.74E-12 2600.34787 15.50489 13.25755 0 13.23215 14.14063 13.79956 0 0 13.37855 14.97249 14.47587 14.69565 0 13.95104 11.95024 15.39926 11.81875 0 0 15.38865 14.66834 0 0 0 0 14.73582 14.53614 0 0 0 0 0 0 0 0 0 14.45502 0 0 0 0 15.10479 11.55672 0 0 0 0 0 Q7Z3F1 GP155_HUMAN Integral membrane protein GPR155 (G-protein coupled receptor PGR22) GPR155 PGR22 Homo sapiens (Human) cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085] GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062 DTQNASQNK 3.74000001 1 1 0.419224097 1009.262186 16.11531 15.54634 14.21053 15.60726 0 0 15.69242 14.23082 14.50693 15.96953 14.20014 14.2288 0 0 0 0 15.4042 16.96301 0 15.96136 0 0 15.31056 0 0 0 0 0 16.32544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3G6 PRIC2_HUMAN Prickle-like protein 2 PRICKLE2 Homo sapiens (Human) "Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytoplasm [GO:0005737]; nuclear membrane [GO:0031965] "cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; zinc ion binding [GO:0008270]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" zinc ion binding [GO:0008270] GO:0005737; GO:0008270; GO:0031965; GO:0060071 GSIQVPK 2.160000086 1 1 0.272095777 727.504264 0 18.6265 18.51076 0 17.61967 0 18.62847 17.05516 0 0 0 0 18.20308 16.81873 0 0 17.47444 0 0 15.44539 0 0 0 0 19.28304 17.95201 18.4873 17.07492 17.35152 0 19.48388 0 0 0 18.89432 0 0 0 18.13394 0 16.00934 18.58832 17.7343 0 0 0 0 17.23084 Q7Z3I7 ZN572_HUMAN Zinc finger protein 572 ZNF572 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042802; GO:0046872 SFGLSSHLIR 5.579999924 1 1 0.148853857 1116.227236 0 15.32014 0 0 16.14758 15.23032 12.02528 12.49921 0 17.78717 14.54371 14.10744 0 13.42872 0 0 14.89757 14.24998 14.40945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.63245 0 0 16.3682 0 0 0 0 0 0 0 0 Q7Z3J2 VP35L_HUMAN VPS35 endosomal protein-sorting factor-like (Esophageal cancer-associated protein) VPS35L C16orf62 101F10.2 Homo sapiens (Human) endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] GO:0005768; GO:0005886; GO:0006893; GO:0015031; GO:0016021; GO:0032456; GO:0101003 DDNSVVGSDFEPWTNK 16.98999977 1 1 0.304947479 1810.241417 0 0 0 0 0 0 16.01805 0 0 0 0 0 0 0 16.14931 0 15.07759 0 0 0 0 0 16.33334 0 17.7226 0 16.8024 0 0 15.27175 14.79322 16.26538 0 0 15.25667 17.47045 0 13.09514 13.13311 16.7215 13.10699 15.30776 13.13711 17.28236 15.01584 13.53963 15.4703 13.74964 Q7Z3K3 POGZ_HUMAN Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635) POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 Homo sapiens (Human) cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007064; GO:0010468; GO:0045944; GO:0046872; GO:0051301; GO:0051382; GO:1905168 MIHEDTR 3.579999924 0.911760092 0.911760092 0.135891091 917.4079275 11.71482 0 14.3692 0 13.45429 14.17275 14.25333 14.69174 13.30608 15.19913 0 0 0 14.73993 15.34308 13.07765 0 0 15.47213 13.97248 0 16.18078 16.15801 0 0 0 0 0 0 0 14.2031 0 15.9406 0 0 0 0 0 0 14.75231 0 0 0 14.89884 0 16.56512 0 0 Q7Z3T8 ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein) ZFYVE16 KIAA0305 Homo sapiens (Human) endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]; vesicle organization [GO:0016050] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]; vesicle organization [GO:0016050]" "1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" GO:0005545; GO:0005547; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0016050; GO:0016197; GO:0030100; GO:0031901; GO:0043231; GO:0046872 MMSPTGSNLK 3 1 1 0.078437832 1065.35129 0 0 12.00731 15.00827 0 0 15.79547 14.3854 0 0 0 0 0 0 0 0 0 12.71646 0 15.41978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.75428 0 0 0 0 0 0 Q7Z3U7 MON2_HUMAN Protein MON2 homolog (Protein SF21) MON2 KIAA1040 SF21 Homo sapiens (Human) Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] GO:0005829; GO:0006895; GO:0015031; GO:0031901; GO:0070062 LLETGLVNMHR 8.510000229 1 1 0.048485103 1296.590667 0 13.39787 0 0 0 0 0 0 14.76721 0 0 0 13.02928 0 0 0 0 0 14.96035 0 0 10.23922 0 0 0 0 0 13.41429 0 0 0 11.60635 0 0 14.44546 0 0 0 13.00162 12.19864 0 9.719749 14.37441 0 0 0 0 0 Q7Z3V5 ZN571_HUMAN Zinc finger protein 571 ZNF571 HSPC059 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 RINHHLQYNGLGDNMECK 6.829999924 1 1 0.765222154 2198.520651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.01595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3Y7 K1C28_HUMAN "Keratin, type I cytoskeletal 28 (Cytokeratin-28, CK-28) (Keratin-25D, K25D) (Keratin-28, K28) (Type I inner root sheath-specific keratin-K25irs4)" KRT28 KRT25D Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062 DAEAWFNEK 47.47999954 1 1 0.477230832 1109.181504 17.01352 0 18.09337 0 0 18.31317 0 18.8695 0 0 0 0 0 0 0 0 0 0 0 18.94892 0 0 0 16.8221 0 0 0 0 0 0 0 18.24003 0 18.96683 0 0 0 0 0 0 0 0 0 0 0 0 0 18.43433 Q7Z3Y8 K1C27_HUMAN "Keratin, type I cytoskeletal 27 (Cytokeratin-27, CK-27) (Keratin-25C, K25C) (Keratin-27, K27) (Type I inner root sheath-specific keratin-K25irs3)" KRT27 KRT25C Homo sapiens (Human) hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0031069; GO:0045109; GO:0070062 FSSTSRR 5.929999828 1 1 0.108151356 841.4724484 0 16.01776 17.89967 17.44514 0 12.82239 14.71086 14.25617 0 0 0 16.99214 10.32795 0 0 0 13.65197 13.92676 15.69435 15.63444 16.52386 0 0 0 0 15.48254 18.30172 16.9637 9.801312 0 0 0 0 15.81749 0 0 0 18.14631 16.25413 18.12015 0 18.20204 17.78744 0 16.45115 18.05205 16.766 14.45107 Q7Z3Z0 K1C25_HUMAN "Keratin, type I cytoskeletal 25 (Cytokeratin-25, CK-25) (Keratin-25, K25) (Keratin-25A, K25A) (Type I inner root sheath-specific keratin-K25irs1)" KRT25 KRT25A Homo sapiens (Human) aging [GO:0007568]; cytoskeleton organization [GO:0007010]; hair cycle [GO:0042633]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; protein heterodimerization activity [GO:0046982]; structural molecule activity [GO:0005198]; aging [GO:0007568]; cytoskeleton organization [GO:0007010]; hair cycle [GO:0042633]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] protein heterodimerization activity [GO:0046982]; structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0007010; GO:0007568; GO:0031069; GO:0042633; GO:0045095; GO:0045109; GO:0046982; GO:0070062 DPAKAIVVK 6.670000076 1 1 0.023576165 941.6315464 0 0 14.16824 0 0 0 0 0 0 0 0 0 0 0 0 0 15.33448 12.80777 0 0 0 0 0 15.1007 15.95433 11.75076 0 0 0 0 0 18.2242 0 14.72676 0 0 0 0 0 0 0 0 0 0 16.30361 0 0 0 Q7Z3Z3 PIWL3_HUMAN Piwi-like protein 3 PIWIL3 Homo sapiens (Human) cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] piRNA binding [GO:0034584]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0043186; GO:0051321 MGGALWK 7.599999905 0.897135675 0.897135675 0.193612592 763.4885281 15.83858 15.70902 16.27003 13.89652 15.83478 14.95828 16.35273 0 15.07667 0 15.68931 15.15379 15.99544 0 0 0 16.09045 15.46768 0 17.25453 16.45197 15.40597 0 0 16.40264 17.3268 0 16.80286 15.85325 15.24902 17.02417 14.7305 0 16.9245 17.92751 16.72029 15.75632 16.76765 16.9846 16.19937 16.07838 16.25885 12.22822 15.16367 15.98744 17.12355 16.45715 16.84443 Q7Z3Z4 PIWL4_HUMAN Piwi-like protein 4 PIWIL4 HIWI2 PIWI Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; epithelial structure maintenance [GO:0010669]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; epithelial structure maintenance [GO:0010669]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] piRNA binding [GO:0034584]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006417; GO:0007283; GO:0010529; GO:0010669; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0043046; GO:0043186; GO:0051321; GO:0071547 LSMYQIGRNFYNPSEPMEIPQHK 3.230000019 1 1 0.044306634 2811.426019 0 15.57482 0 0 0 14.78669 0 0 0 0 14.21193 15.12936 0 15.35118 0 0 0 0 0 14.56017 0 16.10839 15.26877 14.31115 0 13.72902 15.04045 11.85681 17.05722 15.37702 16.33454 0 14.66908 0 0 0 0 14.59778 13.52778 13.07367 0 0 0 0 0 0 0 0 Q7Z401 MYCPP_HUMAN C-myc promoter-binding protein (DENN domain-containing protein 4A) DENND4A IRLB MYCPBP Homo sapiens (Human) "regulation of Rab protein signal transduction [GO:0032483]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Rab protein signal transduction [GO:0032483]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 SAHKIAK 3.630000114 1 1 0.247024644 754.842966 0 18.73511 17.02201 0 0 18.6 20.47419 17.79655 18.72829 0 17.79357 0 0 19.07642 18.07131 0 19.49018 19.85083 17.45247 18.09448 17.96474 19.17739 17.30285 18.57686 0 17.56785 0 0 0 0 0 0 18.88222 19.17477 19.79107 19.36769 20.60894 18.66521 19.65805 20.60879 19.30529 17.73981 17.64548 20.29675 17.27807 19.39991 0 0 Q7Z402 TMC7_HUMAN Transmembrane channel-like protein 7 TMC7 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381 SVEGFK 5.449999809 0.656583071 0.656583071 0.058142453 665.296161 19.31923 0 15.85282 0 0 15.82478 0 0 0 16.22884 14.69857 0 12.46746 12.545 0 16.38227 0 0 13.85636 0 0 0 0 16.19174 15.392 0 0 16.56284 16.56516 14.01912 11.52928 0 0 15.66905 0 13.34196 17.18116 0 0 15.33022 16.41569 17.1461 18.08848 0 0 0 15.72485 14.68251 Q7Z403 TMC6_HUMAN Transmembrane channel-like protein 6 (Epidermodysplasia verruciformis protein 1) (Protein LAK-4) TMC6 EVER1 EVIN1 Homo sapiens (Human) cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; mechanosensitive ion channel activity [GO:0008381] mechanosensitive ion channel activity [GO:0008381] GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0008381; GO:0031965; GO:0035579; GO:0070062; GO:0070821 FLVMDFVLMLLDTLFGELVWR 11.18000031 1 1 5.03E-12 2572.69227 0 15.11625 14.57221 0 13.89666 0 14.33595 0 14.30249 0 0 0 12.92725 0 0 14.23442 0 13.59343 0 0 0 0 0 15.49227 12.72294 16.28283 13.7841 13.54984 15.08745 10.1522 0 0 15.44087 0 14.71242 15.88381 0 0 0 0 16.15008 0 0 17.47705 0 0 0 15.67478 Q7Z404 TMC4_HUMAN Transmembrane channel-like protein 4 TMC4 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381; GO:0070062 LCGPFR 15.32999992 1 1 0.234382958 750.3398688 21.63213 20.69674 0 17.79132 20.48217 17.94249 0 21.26868 20.06476 21.72096 21.74741 16.92853 20.65842 20.91765 20.28852 22.70156 20.84529 20.53139 21.19975 19.24191 18.7745 19.8833 19.04214 20.42764 20.17844 20.2001 21.0523 20.7596 20.45959 20.46053 18.83929 20.64618 21.28294 20.377 22.15408 21.22981 20.50368 19.42005 18.19624 22.64665 0 22.71243 19.81089 19.93475 0 21.94159 18.97932 19.82255 Q7Z406 MYH14_HUMAN "Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc, NMHC II-C)" MYH14 KIAA2034 FP17425 Homo sapiens (Human) actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625] actomyosin [GO:0042641]; brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725] actomyosin [GO:0042641]; brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0001725; GO:0003009; GO:0005516; GO:0005524; GO:0005829; GO:0005903; GO:0007519; GO:0007605; GO:0008360; GO:0016020; GO:0016460; GO:0019228; GO:0030048; GO:0030426; GO:0031032; GO:0042641; GO:0051015; GO:0070062; GO:0070584; GO:0071625; GO:0097513 LVLDQLR 7.369999886 1 1 4.58E-13 854.5096715 15.6617 14.82651 0 14.23925 0 0 14.80098 0 0 0 0 14.7694 0 0 0 0 0 0 0 13.13218 0 0 0 0 0 0 0 0 0 13.98193 15.09341 0 0 15.0681 0 16.52869 15.94384 0 0 14.64757 15.01347 0 0 16.86435 0 0 0 0 Q7Z407 CSMD3_HUMAN CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) CSMD3 KIAA1894 Homo sapiens (Human) regulation of dendrite development [GO:0050773] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773] GO:0005886; GO:0016021; GO:0050773 AIDFKSR 7.769999981 0.867275834 0.867275834 0.139842681 837.0538544 0 0 13.6569 0 0 0 0 0 0 0 15.70917 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9771 0 16.5355 0 0 0 0 0 0 0 0 0 17.52505 0 0 0 0 0 0 0 0 0 0 0 Q7Z408 CSMD2_HUMAN CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2) CSMD2 KIAA1884 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ITCLGGRR 4.71999979 1 1 0.006678421 933.3571382 13.20465 12.39562 12.65256 14.05825 13.46547 0 15.32793 0 0 0 15.10134 14.36345 0 0 14.87093 13.48821 12.88283 15.9544 0 0 0 0 15.00413 15.60486 15.00472 0 0 13.61013 14.88012 0 16.71832 15.80325 0 0 0 0 0 13.57481 0 0 0 14.37587 0 0 0 0 0 0 Q7Z410 TMPS9_HUMAN "Transmembrane protease serine 9, EC 3.4.21.- (Polyserase-I) (Polyserine protease 1, Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3 ]" TMPRSS9 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252] serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005887 IVGGSAAGR 4.429999828 1 1 0.339570075 787.1603392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.63205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z417 NUFP2_HUMAN "Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein, 82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2)" NUFIP2 KIAA1321 PIG1 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0016604; GO:0042788 YETGPGGTSRGKPAVGDMLR 2.559999943 1 1 0.104157325 2065.009452 12.47242 14.30516 0 0 0 0 0 14.0666 13.97807 15.01268 13.78821 16.68116 0 0 0 10.46259 11.13698 17.38622 14.30733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z418 KCNKI_HUMAN Potassium channel subfamily K member 18 (TWIK-related individual potassium channel) (TWIK-related spinal cord potassium channel) KCNK18 TRESK TRIK Homo sapiens (Human) cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322] calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841] GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623 CCPEALGK 9.329999924 1 1 0.019282786 933.8603412 0 0 0 0 13.87935 14.67572 15.94715 0 15.7104 0 0 0 14.12195 0 0 14.3873 0 0 0 0 0 16.26064 0 0 0 15.38889 0 0 0 15.90787 0 15.58096 0 0 0 13.85707 16.48918 0 15.52509 15.4306 0 0 0 0 0 0 0 0 Q7Z442 PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2) PKD1L2 KIAA1879 PC1L2 Homo sapiens (Human) detection of mechanical stimulus [GO:0050982] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982 DPAEQK 3.650000095 1 1 0.307756177 686.4252663 0 0 17.96114 0 0 0 0 0 0 19.25929 0 0 0 0 0 18.57167 0 0 0 0 17.69909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z444 RASE_HUMAN "GTPase ERas, E-Ras, EC 3.6.5.2 (Embryonic stem cell-expressed Ras)" ERAS HRAS2 HRASP Homo sapiens (Human) Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003 ELTLDSGDCILNVLDTAGQAIHRALR 5.309999943 1 1 0.397464213 2852.316413 0 0 19.00007 0 0 0 17.25892 0 0 0 20.55801 0 0 0 0 0 0 0 0 0 0 0 0 19.92363 0 0 0 0 0 0 20.49091 0 0 19.25929 0 0 0 0 18.4354 20.83854 0 0 0 0 0 0 0 0 Q7Z460 CLAP1_HUMAN "CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1, hOrbit1)" CLASP1 KIAA0622 MAST1 Homo sapiens (Human) "astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]" basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] "basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]" dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010] GO:0000226; GO:0000776; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005815; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0072686; GO:0090091; GO:0090162; GO:0090307; GO:1903690; GO:1904261 DHSIR 10.18999958 1 1 0.223437001 627.6019641 17.07342 0 15.78234 15.44522 0 0 0 0 16.50906 0 16.01214 0 16.12667 17.14868 17.17793 15.71602 0 16.7318 0 16.57154 0 18.38163 16.60043 17.1307 16.5515 16.72926 17.39567 16.36762 17.22646 16.46007 16.60014 17.69507 16.49763 17.31194 16.21232 17.21939 16.90015 0 17.42096 16.3272 16.00417 17.19935 16.62104 17.15796 17.56363 16.26248 0 17.09231 Q7Z478 DHX29_HUMAN "ATP-dependent RNA helicase DHX29, EC 3.6.4.13 (DEAH box protein 29) (Nucleic acid helicase DDXx)" DHX29 DDX29 Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255] cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282] cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743] GO:0001731; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0008494; GO:0016282; GO:0016887; GO:0017111; GO:0022627; GO:0042255; GO:0043024; GO:0045296; GO:0045948 FEGFMDYSVPEILR 10.07999992 0.083743282 0.083743282 0.127087468 1718.618945 0 0 0 0 12.50044 0 15.88191 15.30357 10.23371 0 15.06417 10.9977 16.99131 17.83834 15.01482 16.80576 14.55188 0 0 17.26103 0 15.45885 0 0 12.19891 13.93196 15.45196 18.95079 16.22281 18.32656 16.81478 15.86579 0 14.91998 15.69131 13.41554 10.14713 13.69411 12.92007 13.94293 16.99351 14.67404 13.29008 0 14.90615 17.2004 15.06461 17.46883 Q7Z4H3 HDDC2_HUMAN "5'-deoxynucleotidase HDDC2, EC 3.1.3.89 (HD domain-containing protein 2) (Hepatitis C virus NS5A-transactivated protein 2, HCV NS5A-transactivated protein 2)" HDDC2 C6orf74 NS5ATP2 CGI-130 Homo sapiens (Human) 5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872] 5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872] GO:0002953; GO:0046872 EEEAMK 8.18999958 1 1 0.221305764 753.3192108 0 0 14.59773 15.4784 14.76961 15.13527 16.23155 16.0659 15.70352 14.55971 15.95084 0 14.17956 0 14.84894 15.71074 14.99688 0 0 0 0 0 0 0 0 15.67083 0 0 0 16.02031 0 0 0 0 0 0 16.01841 0 16.26948 14.92621 0 0 16.09581 0 0 0 0 14.62769 Q7Z4H7 HAUS6_HUMAN HAUS augmin-like complex subunit 6 HAUS6 DGT6 FAM29A KIAA1574 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225] microtubule binding [GO:0008017] GO:0000226; GO:0005813; GO:0005829; GO:0007098; GO:0008017; GO:0051225; GO:0051301; GO:0070652; GO:1990498 MGTPK 4.829999924 1 1 0.255376821 550.0852616 16.94831 16.16497 17.88436 16.40051 0 0 0 18.07461 0 0 0 0 0 0 0 0 0 17.84358 0 0 0 0 0 0 0 0 0 0 16.89965 17.41152 18.60154 0 0 0 18.89034 0 0 0 0 0 17.4667 0 0 0 0 0 0 0 Q7Z4I7 LIMS2_HUMAN "LIM and senescent cell antigen-like-containing domain protein 2 (LIM-like protein 2) (Particularly interesting new Cys-His protein 2, PINCH-2)" LIMS2 PINCH2 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] metal ion binding [GO:0046872] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0043066; GO:0045216; GO:0046872; GO:0098609; GO:1900026; GO:2000178; GO:2000346; GO:2001046 FPLELKK 7.659999847 1 1 0.231052247 875.6502684 0 16.01691 17.71964 17.11601 0 16.25445 0 16.59023 0 0 16.45675 16.17808 16.46926 15.51443 15.55546 0 15.47985 0 0 15.39799 0 15.40341 0 0 15.44917 0 17.83619 13.79638 0 0 16.6787 15.9882 16.09475 12.91782 15.18852 16.46177 0 0 0 0 15.63025 0 16.49562 0 17.2298 0 0 0 Q7Z4K8 TRI46_HUMAN "Tripartite motif-containing protein 46 (Gene Y protein, GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein)" TRIM46 TRIFIC Homo sapiens (Human) anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of protein localization [GO:0032880] axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769] axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769]; zinc ion binding [GO:0008270]; anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of protein localization [GO:0032880] zinc ion binding [GO:0008270] GO:0001578; GO:0001764; GO:0005856; GO:0007409; GO:0008270; GO:0030517; GO:0032880; GO:0043194; GO:0044304; GO:0048490; GO:0099612; GO:1901953; GO:1904115; GO:1990769 TLPKPDR 4.269999981 1 1 0.116321332 825.9757456 0 0 13.85321 0 0 0 0 0 0 0 0 0 0 0 0 0 15.02947 13.01277 0 0 0 0 0 0 0 16.99322 0 0 0 0 0 15.40881 14.89346 14.19579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4L5 TT21B_HUMAN "Tetratricopeptide repeat protein 21B, TPR repeat protein 21B (Intraflagellar transport 139 homolog)" TTC21B IFT139 KIAA1992 Nbla10696 Homo sapiens (Human) Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; chromatin binding [GO:0003682]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] chromatin binding [GO:0003682] GO:0003682; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799 EFEAIKNK 1.279999971 1 1 0.184842311 977.4994609 15.41121 15.37537 0 14.20599 14.57736 0 14.68746 14.85262 0 14.82587 14.27651 15.01236 12.94598 13.74211 14.2722 13.12875 0 0 15.51122 13.16227 6.75904 14.30916 15.36434 14.68845 0 15.37065 16.54981 13.27043 14.70835 13.23151 0 16.03475 14.09812 14.97816 14.31675 13.02594 16.29008 14.43642 0 0 0 15.1936 15.59658 17.94252 15.1016 0 11.95926 14.55813 Q7Z4P5 GDF7_HUMAN "Growth/differentiation factor 7, GDF-7" GDF7 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]" extracellular space [GO:0005615] "extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]" cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802] GO:0005125; GO:0005615; GO:0007411; GO:0008083; GO:0010628; GO:0010862; GO:0021509; GO:0021527; GO:0022612; GO:0030509; GO:0030855; GO:0030901; GO:0032924; GO:0042802; GO:0045165; GO:0045666; GO:0045893; GO:0048608; GO:0048754; GO:0048853; GO:0060389; GO:0060395; GO:0060571; GO:2001051 RLGFGWPGGGGSAAEER 3.359999895 1 1 6.89E-13 1703.289465 12.29656 13.76098 14.57491 0 13.99588 0 0 14.74658 16.36316 0 0 0 13.09374 0 0 0 0 0 0 0 0 0 0 0 16.09679 0 0 0 14.39382 15.06745 0 0 0 0 0 0 0 15.9143 0 0 0 0 13.15622 0 15.00874 0 0 0 Q7Z4Q2 HEAT3_HUMAN HEAT repeat-containing protein 3 HEATR3 Homo sapiens (Human) protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273] unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273] unfolded protein binding [GO:0051082] GO:0006606; GO:0042273; GO:0051082 EDGTLETLK 4.53000021 0.348137587 0.348137587 0.103016405 1002.779037 0 12.96428 13.45948 0 17.29222 17.08094 16.29008 15.60734 0 14.97389 16.2984 15.47021 15.295 17.05543 15.54487 16.43489 15.57659 17.03156 0 14.80658 14.67421 15.07758 17.3422 16.46488 18.17477 0 0 10.54445 13.64159 15.29503 14.91378 0 0 14.3414 15.39728 14.14777 0 15.00831 14.83846 16.65998 17.10507 14.65536 15.78239 11.54594 13.14531 14.93974 0 15.38848 Q7Z4S6 KI21A_HUMAN Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62) KIF21A KIAA1708 KIF2 Homo sapiens (Human) microtubule-based movement [GO:0007018] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887; GO:0030424; GO:0030425; GO:0071532 LCGEVKPK 6.5 1 1 0.240155763 930.871632 15.7535 15.45296 16.18876 0 16.72108 0 0 16.18905 15.14067 15.84143 15.77987 16.10863 0 15.77168 15.56475 14.81544 16.46197 0 0 16.29514 16.75413 0 0 0 0 14.16486 0 15.22726 14.81619 14.28597 17.07182 0 14.64454 15.23162 14.68044 15.39052 14.45437 15.74701 16.45507 15.80594 0 0 0 15.40257 15.93769 13.39289 13.63678 14.64942 Q7Z4T9 CFA91_HUMAN "Cilia- and flagella-associated protein 91, CFAP91 (AMY-1-associating protein expressed in testis 1, AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1)" CFAP91 AAT1 C3orf15 MAATS1 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514] axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283] GO:0003341; GO:0005739; GO:0005930; GO:0007283; GO:0031514; GO:1904158 VVQNMMFEGK 3.869999886 1 1 0.184289907 1181.50444 0 0 12.84007 15.36458 13.4201 11.88797 0 10.51608 14.48972 0 0 13.95551 16.15164 0 12.77583 0 14.00082 0 0 14.65565 0 0 0 0 14.87947 0 0 14.60679 0 0 15.07731 0 16.11166 0 0 0 0 0 0 0 0 0 0 0 0 0 14.41797 0 Q7Z4V0 ZN438_HUMAN Zinc finger protein 438 ZNF438 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045892; GO:0046872 TMTNLSPTILGNAVQLISSVPK 3.630000114 1 1 0.164027847 2284.458649 12.87558 14.08271 13.69081 0 0 0 16.34986 0 13.37065 0 0 12.17619 0 14.53409 0 0 0 0 0 12.90341 0 13.26868 0 15.46585 0 12.15289 15.67274 0 13.53156 10.60953 16.54142 0 15.47909 0 13.07157 13.47792 12.00244 10.71976 16.50546 15.19286 13.85064 15.63691 0 15.38015 0 0 0 0 Q7Z4V5 HDGR2_HUMAN "Hepatoma-derived growth factor-related protein 2, HDGF-related protein 2, HRP-2 (Hepatoma-derived growth factor 2, HDGF-2)" HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 Homo sapiens (Human) muscle cell differentiation [GO:0042692]; positive regulation of cell growth [GO:0030307]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; H3K27me3 modified histone binding [GO:0061628]; H3K9me3 modified histone binding [GO:0062072]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; muscle cell differentiation [GO:0042692]; positive regulation of cell growth [GO:0030307]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403] double-stranded DNA binding [GO:0003690]; H3K27me3 modified histone binding [GO:0061628]; H3K9me3 modified histone binding [GO:0062072]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712] GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0030307; GO:0035064; GO:0042692; GO:0043403; GO:0061628; GO:0062072; GO:1905168 AAEVYTRLK 6.210000038 1 1 0.096219105 1051.020503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.46957 0 0 0 0 0 0 0 0 0 0 13.9338 14.03691 0 0 0 13.62746 0 0 0 0 0 15.19827 14.40197 0 0 0 0 0 0 0 0 Q7Z553 MDGA2_HUMAN MAM domain-containing glycosylphosphatidylinositol anchor protein 2 (MAM domain-containing protein 1) MDGA2 MAMDC1 UNQ8188/PRO23197 Homo sapiens (Human) nervous system development [GO:0007399]; spinal cord motor neuron differentiation [GO:0021522] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; nervous system development [GO:0007399]; spinal cord motor neuron differentiation [GO:0021522] GO:0005576; GO:0005886; GO:0007399; GO:0021522; GO:0031225 EGDTIELQCQVTGKPKPIILWSRADK 4.920000076 1 1 2.29E-12 2982.96764 16.7496 15.01785 14.75592 0 0 14.69468 15.21146 12.18643 13.39729 0 11.19816 14.66636 0 0 0 13.18136 0 0 0 0 0 0 0 13.77477 15.09114 0 15.0636 0 0 0 0 16.36109 0 0 0 0 15.56194 0 0 16.19142 0 0 12.79583 0 0 0 0 0 Q7Z569 BRAP_HUMAN "BRCA1-associated protein, EC 2.3.2.27 (BRAP2) (Impedes mitogenic signal propagation, IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)" BRAP RNF52 Homo sapiens (Human) MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265] identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630 RSAMLCILTVPAAMTSHDLMK 1.690000057 0.136027113 0.136027113 0.040808059 2361.703072 17.02494 0 15.96449 0 0 0 15.93552 0 0 0 17.04066 15.75711 0 0 0 0 16.40508 0 0 0 14.07706 0 16.86122 0 9.907558 0 0 0 0 0 0 0 16.01674 0 15.7957 0 14.87696 0 0 0 14.71413 13.99232 0 0 14.28368 0 0 0 Q7Z570 Z804A_HUMAN Zinc finger protein 804A ZNF804A C2orf10 Homo sapiens (Human) positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; regulation of neuron projection development [GO:0010975] cytoplasm [GO:0005737]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] cytoplasm [GO:0005737]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; metal ion binding [GO:0046872]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; regulation of neuron projection development [GO:0010975] metal ion binding [GO:0046872] GO:0005634; GO:0005737; GO:0005886; GO:0010628; GO:0010975; GO:0010976; GO:0030426; GO:0043025; GO:0043197; GO:0043198; GO:0046872; GO:0098793; GO:0098794; GO:1901588; GO:1902952 EVSSEK 6.53000021 1 1 0.279142627 678.652206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.69257 0 0 0 0 0 0 0 0 0 0 0 0 19.86104 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z572 SPT21_HUMAN Spermatogenesis-associated protein 21 SPATA21 Homo sapiens (Human) calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509 DFLAVMTDTR 5.150000095 1 1 0.459153932 1185.171964 0 17.94358 0 0 0 0 19.03964 18.41613 18.25734 0 18.27768 0 0 0 0 0 0 0 0 0 17.01133 17.96428 0 0 0 0 0 0 17.48385 0 0 0 0 0 19.05095 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z589 EMSY_HUMAN BRCA2-interacting transcriptional repressor EMSY EMSY C11orf30 GL002 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]" identical protein binding [GO:0042802] GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802 MASTRLPSPK 5.460000038 0.669987798 0.669987798 0.175446639 1103.753559 15.42841 0 14.69602 13.84711 16.07088 12.11882 14.33472 14.17019 15.72997 16.34089 13.89135 13.20596 14.6688 13.3437 13.78753 13.57082 13.03136 10.58705 0 0 0 0 0 15.03608 0 0 0 10.97961 0 15.17473 0 0 15.64721 0 12.336 0 0 0 16.47598 13.91537 14.67851 13.4677 15.07885 0 16.07941 14.9099 14.6245 0 Q7Z591 AKNA_HUMAN Microtubule organization protein AKNA (AT-hook-containing transcription factor) AKNA KIAA1968 Homo sapiens (Human) delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727] DNA binding [GO:0003677] GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234 TLAAEMAVPGSEFEGHK 2.839999914 1 1 0 1790.308487 13.60765 16.50337 0 16.00546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5A7 TAFA5_HUMAN Chemokine-like protein TAFA-5 TAFA5 FAM19A5 UNQ5208/PRO34524 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044] cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018] GO:0001664; GO:0005125; GO:0005615; GO:0005737; GO:0007186; GO:0048018; GO:0061044; GO:1904706; GO:1904753 MAPSPR 6.389999866 1 1 0.132660645 657.1492671 0 14.18343 0 0 0 12.30288 13.17019 0 0 16.52242 0 14.5302 14.79423 16.28023 0 0 0 0 0 0 0 0 0 0 0 16.47827 15.83012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5B4 RIC3_HUMAN Protein RIC-3 (Resistant to inhibitor of cholinesterase 3) RIC3 UNQ720/PRO1385 Homo sapiens (Human) "positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]" endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202] "endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; protein folding chaperone [GO:0044183]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine receptor binding [GO:0033130]; protein folding chaperone [GO:0044183] GO:0000139; GO:0005789; GO:0007204; GO:0007271; GO:0016021; GO:0033130; GO:0034394; GO:0043005; GO:0043025; GO:0043231; GO:0044183; GO:0045202; GO:2000010 MAYSTVQRVALASGLVLALSLLLPK 6.300000191 0.297984123 0.297984123 0.038213391 2613.486107 16.15983 0 0 16.0466 18.13993 0 17.26002 0 13.14751 14.90687 0 17.49491 18.5306 14.75493 9.743142 0 14.07203 16.99574 0 0 0 0 0 15.78746 17.21135 0 0 13.21843 18.24458 0 17.81162 19.03243 18.07632 0 16.35575 18.03657 16.95644 15.1296 15.56856 18.18755 0 16.35355 16.70935 0 0 11.37156 0 14.72696 Q7Z5H3 RHG22_HUMAN Rho GTPase-activating protein 22 (Rho-type GTPase-activating protein 22) ARHGAP22 RHOGAP2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0001525; GO:0005096; GO:0005634; GO:0005829; GO:0005925; GO:0007165; GO:0030154; GO:0051056; GO:0090630; GO:0098978; GO:0099175 ASSGDR 9.420000076 6.56E-11 6.56E-11 0.269519118 593.5578251 16.62502 16.64426 17.89576 0 18.27651 16.42868 0 17.54014 19.87751 0 0 0 0 0 0 0 19.46369 15.99964 0 0 17.41731 0 16.70644 0 0 0 18.01354 17.21534 18.99178 18.21314 18.02748 16.95931 0 17.62218 19.81977 0 18.77386 0 16.92139 16.91597 0 0 17.61591 0 18.81423 0 0 0 Q7Z5J1 DHI1L_HUMAN "Hydroxysteroid 11-beta-dehydrogenase 1-like protein, EC 1.1.1.- (11-beta-hydroxysteroid dehydrogenase type 3, 11-DH3, 11-beta-HSD3) (Short chain dehydrogenase/reductase family 26C member 2) (Short-chain dehydrogenase/reductase 10)" HSD11B1L HSD3 SCDR10 SDR26C2 Homo sapiens (Human) extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; oxidoreductase activity [GO:0016491] oxidoreductase activity [GO:0016491] GO:0005576; GO:0005654; GO:0016491; GO:0043231 TEKNDGHLEPVTAWEVQVPR 1.389999986 1 1 0.191862127 2305.010062 15.2896 14.51325 15.28896 0 13.45009 12.25691 12.03808 13.45231 8.709785 0 13.84187 14.33934 0 0 0 0 0 0 0 0 0 0 13.37777 0 0 0 0 0 0 0 0 0 0 0 0 0 14.09134 0 0 11.2381 0 0 13.94678 0 14.11464 0 0 0 Q7Z5J4 RAI1_HUMAN Retinoic acid-induced protein 1 RAI1 KIAA1820 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" metal ion binding [GO:0046872] GO:0001501; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0032922; GO:0040015; GO:0045893; GO:0046872 YISSCK 5.119999886 1 1 0.284276445 757.0975435 0 20.00138 17.90802 0 19.5157 0 0 0 0 16.82154 0 0 0 0 0 0 0 0 0 0 0 0 0 19.79237 0 19.19418 0 0 0 0 0 0 0 0 0 19.43135 0 0 19.77705 0 0 0 0 0 0 0 0 18.31459 Q7Z5K2 WAPL_HUMAN Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor) WAPL FOE KIAA0261 WAPAL Homo sapiens (Human) cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]" GO:0000278; GO:0000775; GO:0000785; GO:0000795; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0009636; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0048146; GO:0051301; GO:0051983; GO:0060623; GO:0071168; GO:0071922; GO:0072686 APAPPSK 4.710000038 1 1 0.241494742 667.0271672 0 14.18913 16.12671 15.54686 15.0912 0 0 0 0 0 14.37177 0 0 15.89001 0 15.93385 15.00811 16.33343 14.91613 16.60847 13.38896 15.11382 15.0699 14.6774 0 0 0 0 0 15.09797 0 0 0 16.38999 0 0 16.35122 0 0 0 0 0 15.43378 15.5038 0 0 0 0 Q7Z5M8 AB12B_HUMAN "Protein ABHD12B, EC 3.-.-.- (Abhydrolase domain-containing protein 12B) (Alpha/beta hydrolase domain-containing protein 12B)" ABHD12B C14orf29 Homo sapiens (Human) monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474] GO:0004622; GO:0005789; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651 LYEIAR 14.85999966 1 1 0.313523947 764.1122742 0 0 17.10463 0 0 17.30376 0 0 0 0 0 0 0 18.47323 0 0 0 17.45484 0 0 0 0 19.52754 0 0 0 0 0 0 0 21.40524 0 20.57392 16.93357 0 0 0 18.7985 0 0 0 0 0 18.28606 0 0 0 18.9673 Q7Z5N4 SDK1_HUMAN Protein sidekick-1 SDK1 Homo sapiens (Human) behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] identical protein binding [GO:0042802] GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0042802; GO:0045202; GO:0048148; GO:0060998 AGPGRPR 3.369999886 1.33E-05 1.33E-05 0.292836811 710.8776716 16.38211 0 0 0 16.4638 0 17.73583 0 0 0 17.68885 16.67187 0 0 0 16.97201 16.58586 0 16.48421 0 16.45104 0 17.91094 17.63177 0 0 0 0 0 16.74862 0 0 16.85438 18.87487 0 17.72556 17.82341 17.31291 0 0 0 0 0 0 16.15449 0 0 17.61026 Q7Z5P9 MUC19_HUMAN "Mucin-19, MUC-19" MUC19 Homo sapiens (Human) extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] GO:0005576; GO:0005796; GO:0005886 YGAGFSSSGASLDVGFGWGISDEK 1.710000038 0.029665867 0.029665867 0.070547539 2393.737694 0 0 12.88365 14.54686 0 12.92742 0 0 9.926513 15.30504 0 9.502404 0 0 0 0 0 0 0 0 0 0 0 0 13.98755 0 18.70836 0 0 10.05353 16.06298 18.82426 15.66951 0 0 14.59442 0 0 0 0 0 0 0 15.90449 0 0 16.71815 0 Q7Z5Q5 DPOLN_HUMAN "DNA polymerase nu, EC 2.7.7.7" POLN Homo sapiens (Human) DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985] cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887] GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006302; GO:0019985; GO:0030332; GO:0036297 DLHPLPK 8.529999733 0.133853212 0.133853212 0.136618153 819.3596573 16.5938 0 13.53522 0 0 0 10.75603 14.76042 14.67769 15.01343 0 16.02302 11.52004 13.00522 16.42904 0 14.54362 14.81453 16.87144 0 17.03402 0 0 0 0 15.67653 16.04994 14.68267 14.83929 0 0 0 0 16.86641 9.904092 14.59332 0 0 0 0 0 0 12.23958 0 14.18526 0 0 0 Q7Z5R6 AB1IP_HUMAN "Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1) (Proline-rich EVH1 ligand 1, PREL-1) (Proline-rich protein 73) (Rap1-GTP-interacting adapter molecule, RIAM) (Retinoic acid-responsive proline-rich protein 1, RARP-1)" APBB1IP PREL1 RARP1 RIAM Homo sapiens (Human) positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] GO:0002291; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0030027; GO:0042101; GO:0045785 RQENPGHPGGAGGGEQDFMSDLMK 10.19999981 0.520694435 0.520694435 0.014067359 2530.129871 14.95833 17.04821 14.81936 0 0 14.79716 11.5957 14.46267 13.43682 0 0 0 0 0 15.11365 0 0 0 0 0 0 0 15.74893 0 16.71267 16.25505 0 0 0 16.37068 0 19.61181 0 0 0 0 0 15.83596 0 14.52174 17.70097 0 15.64501 11.92062 12.64575 0 0 0 Q7Z5V6 PPR32_HUMAN Protein phosphatase 1 regulatory subunit 32 PPP1R32 C11orf66 Homo sapiens (Human) ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; phosphatase binding [GO:0019902] phosphatase binding [GO:0019902] GO:0005737; GO:0019902; GO:0036064 SIGAK 10.72000027 1 1 0.283883369 475.8369371 0 0 0 0 0 0 19.85439 18.22932 18.28337 18.47775 0 0 17.67975 0 0 0 0 0 0 0 0 0 19.40921 0 0 18.29931 0 0 0 0 18.34253 0 17.62797 19.83553 0 0 17.21164 0 19.81868 0 0 0 0 17.69851 0 0 16.9093 0 Q7Z5W3 BN3D2_HUMAN "RNA 5'-monophosphate methyltransferase, EC 2.1.1.- (BCDIN3 domain-containing protein)" BCDIN3D Homo sapiens (Human) miRNA 2'-O-methylation [GO:0061715]; miRNA metabolic process [GO:0010586]; negative regulation of pre-miRNA processing [GO:2000632]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; tRNA methyltransferase activity [GO:0008175]; miRNA 2'-O-methylation [GO:0061715]; miRNA metabolic process [GO:0010586]; negative regulation of pre-miRNA processing [GO:2000632]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488] O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; tRNA methyltransferase activity [GO:0008175] GO:0001510; GO:0005654; GO:0005737; GO:0005829; GO:0008171; GO:0008173; GO:0008175; GO:0010586; GO:0030488; GO:0061715; GO:2000632 MAVPTELDGGSVK 2.470000029 0.124114424 0.124114424 0.070772922 1318.821773 15.48512 16.32254 8.801674 14.9335 0 0 0 0 12.24708 0 10.04285 0 12.47568 0 15.32416 0 0 0 0 13.30949 0 0 14.46725 0 16.3252 16.36736 0 13.57731 0 16.41861 13.45132 0 18.12612 0 17.21218 0 13.69156 16.1291 14.23853 0 0 13.59737 15.85719 0 15.78544 14.47457 14.41356 11.10067 Q7Z601 GP142_HUMAN Probable G-protein coupled receptor 142 (G-protein coupled receptor PGR2) GPR142 PGR2 Homo sapiens (Human) cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005829; GO:0005886; GO:0016021; GO:0030054 VFVMLYHMYVAPVHR 2.859999895 1 1 0.546177882 1878.893741 15.23631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.13387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z628 ARHG8_HUMAN Neuroepithelial cell-transforming gene 1 protein (Proto-oncogene p65 Net1) (Rho guanine nucleotide exchange factor 8) NET1 ARHGEF8 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001558; GO:0005085; GO:0005634; GO:0005829; GO:0007165; GO:0035025; GO:0035556; GO:0043065; GO:0043547; GO:0051056; GO:0051451; GO:0070301; GO:0071479 QEAIYEMSRGEQDLIEDLK 11.07999992 0.775666475 0.775666475 0.380651124 2283.207735 18.14637 15.08256 18.18045 0 0 0 20.04127 19.23872 0 0 0 0 0 0 0 18.39153 0 0 0 0 0 0 0 18.75496 20.574 18.84642 0 16.34277 0 0 0 18.53787 0 0 19.89418 0 0 19.83831 19.38435 0 0 0 0 0 0 0 0 0 Q7Z695 ADCK2_HUMAN "Uncharacterized aarF domain-containing protein kinase 2, EC 2.7.11.-" ADCK2 AARF Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] GO:0004674; GO:0005524; GO:0016021 LESNFASIVFAIMVLEGLGR 2.900000095 1 1 0.267795511 2163.003392 12.82157 14.55169 10.21056 0 14.20579 0 16.03613 14.38124 12.89512 0 0 0 0 0 0 0 0 13.17596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68141 0 Q7Z6E9 RBBP6_HUMAN "E3 ubiquitin-protein ligase RBBP6, EC 2.3.2.27 (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1, RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)" RBBP6 P2PR PACT RBQ1 My038 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511] protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0001701; GO:0003723; GO:0004842; GO:0005634; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630 SNSSPSR 6.46999979 0.679065108 0.679065108 0.215850263 734.2128076 16.47383 0 14.4996 15.14078 16.67289 14.6498 15.31864 15.96145 16.7287 14.449 16.57512 16.17873 0 0 14.98865 14.1513 15.33788 0 16.01971 0 0 0 15.16296 16.02858 0 0 16.38245 16.30596 16.60951 0 16.11235 15.35603 0 0 16.15662 16.72277 0 14.90279 15.39112 16.5007 15.37173 0 0 17.11061 0 16.21768 0 16.81745 Q7Z6G8 ANS1B_HUMAN "Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1, AIDA-1) (E2A-PBX1-associated protein, EB-1)" ANKS1B Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383] ephrin receptor binding [GO:0046875] GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013; GO:1900383 ILASLGDRLHDDPPQKPPR 16.42000008 0.182077408 0.182077408 1.82E-12 2124.72823 14.29512 14.30241 13.02403 0 0 0 14.80642 0 0 14.11161 14.40437 0 0 0 0 15.84128 0 15.61373 0 9.976824 0 14.34073 16.35636 15.82861 12.45352 15.78178 11.71186 15.16132 0 0 0 15.93535 15.48437 13.28894 13.82639 0 0 0 0 13.41967 0 0 15.78732 14.33487 15.59994 17.02264 14.37013 0 Q7Z6I6 RHG30_HUMAN Rho GTPase-activating protein 30 (Rho-type GTPase-activating protein 30) ARHGAP30 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0007264; GO:0031410; GO:0043231; GO:0051056 SNKGTLRPAK 2.25 1 1 0.152993452 1070.684893 0 14.2881 0 0 13.23854 0 0 0 11.7524 15.66487 0 15.03648 15.91553 0 12.96061 14.95547 11.40144 0 0 0 0 0 17.31166 0 0 0 0 0 15.38316 15.7511 16.75755 0 0 0 15.37489 15.55767 0 17.02802 14.87071 0 0 14.885 0 15.7454 0 0 0 0 Q7Z6J0 SH3R1_HUMAN "E3 ubiquitin-protein ligase SH3RF1, EC 2.3.2.27 (Plenty of SH3s, Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)" SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]" MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043154; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564; GO:2001237 MDESALLDLLECPVCLER 8.420000076 1 1 0.197553432 2162.183451 0 0 0 0 0 0 0 0 0 0 0 14.18497 15.92157 0 16.13091 15.78396 15.50111 15.57252 0 0 0 16.64628 15.94798 13.64515 17.03214 16.74253 15.10802 16.39462 17.08333 0 15.22004 14.6789 15.36673 0 14.76437 0 16.0254 0 15.77924 14.04166 15.08675 16.04799 0 18.47422 0 0 0 15.38846 Q7Z6J4 FGD2_HUMAN "FYVE, RhoGEF and PH domain-containing protein 2 (Zinc finger FYVE domain-containing protein 4)" FGD2 ZFYVE4 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267] GO:0001726; GO:0005085; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0031901; GO:0032587; GO:0043087; GO:0043507; GO:0046847; GO:0046872; GO:0051056; GO:1901981 TRIDVAGMK 8.81000042 0.493010223 0.493010223 0.402077021 1005.418564 15.66433 15.7111 16.3679 16.69434 16.84982 0 16.02423 17.07469 16.61107 0 15.34805 16.64272 16.23315 0 0 16.33252 16.61268 16.75096 0 0 17.21469 0 16.43095 15.95649 16.30489 18.07167 16.81884 17.30912 16.48892 0 0 0 0 0 0 16.9904 16.73004 18.06606 0 17.41454 16.91099 16.95627 18.10688 0 0 0 16.99473 18.8799 Q7Z6J9 SEN54_HUMAN "tRNA-splicing endonuclease subunit Sen54 (SEN54 homolog, HsSEN54) (tRNA-intron endonuclease Sen54)" TSEN54 SEN54 Homo sapiens (Human) "mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" GO:0000214; GO:0000379; GO:0005654; GO:0005730; GO:0006388; GO:0006397 AENGVTGAGK 1.669999957 1 1 0.163813218 903.731816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.24125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.32124 0 0 0 0 0 Q7Z6K5 ARPIN_HUMAN Arpin (Arp2/3 inhibition protein) ARPIN C15orf38 Homo sapiens (Human) directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393] lamellipodium [GO:0030027] lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393] GO:0030027; GO:0030336; GO:0033058; GO:0051126; GO:2000393 TGASWTDNIMAQK 6.21999979 1 1 0.163909377 1432.975307 14.62953 0 0 0 0 0 14.81255 0 14.19784 0 0 0 0 0 0 0 0 14.99518 0 14.84821 0 0 0 0 0 14.60311 0 0 17.17473 0 0 0 15.83849 16.26602 16.25505 0 0 0 0 13.11651 14.84675 0 0 15.22172 0 0 0 0 Q7Z6M1 RABEK_HUMAN Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40) RABEPK RAB9P40 Homo sapiens (Human) receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904] cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904] GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588 YEHASFIPSCTPDR 7.309999943 1 1 0.320364193 1679.843596 0 14.00931 14.20496 0 0 0 15.22935 0 0 0 0 0 15.19007 0 15.92422 0 15.00576 15.71113 0 0 0 16.35445 0 0 0 0 15.12193 16.92812 14.79663 0 14.90264 14.28742 15.61888 0 17.75641 13.87525 16.49387 0 17.79979 14.58231 16.55279 0 0 0 0 0 14.53638 0 Q7Z6M2 FBX33_HUMAN F-box only protein 33 FBXO33 FBX33 Homo sapiens (Human) positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0016567; GO:0019005; GO:0031146; GO:0031398 MLLFLSVPQPRPPGAR 5.610000134 1 1 0.249657333 1779.141121 14.71547 13.91052 15.37033 15.81029 14.63216 14.95501 0 0 0 0 0 0 13.7682 0 0 13.8688 0 0 14.45385 0 0 16.38117 14.66681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6M3 MILR1_HUMAN "Allergin-1 (Allergy inhibitory receptor 1) (Mast cell antigen 32, MCA-32) (Mast cell immunoglobulin-like receptor 1)" MILR1 C17orf60 MCA32 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; mast cell degranulation [GO:0043303]; negative regulation of mast cell activation [GO:0033004] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; mast cell degranulation [GO:0043303]; negative regulation of mast cell activation [GO:0033004] transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005887; GO:0007166; GO:0033004; GO:0043303; GO:0098742 AMRNNVPR 14.09000015 1 1 0.09962788 956.0332074 14.14535 14.586 15.66444 12.80018 14.58907 14.62494 13.84838 13.78336 13.71653 0 13.98403 0 0 0 13.85965 14.3983 0 0 0 0 15.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6P3 RAB44_HUMAN Ras-related protein Rab-44 RAB44 Homo sapiens (Human) azurophil granule membrane [GO:0035577]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005509; GO:0005525; GO:0005886; GO:0035577; GO:0035579 EAFLAFMEQLGTGHLLPK 9.899999619 0.341908485 0.341908485 0.394781045 2002.123062 15.10366 20.09239 19.41194 10.56781 21.42293 20.36637 0 0 0 0 0 0 0 0 0 19.79064 19.29001 17.99085 17.84131 16.87321 0 16.79256 0 19.40523 0 19.86382 0 19.26267 0 18.83615 0 0 0 0 0 0 0 0 0 20.40279 17.86726 19.2423 0 17.88747 19.19082 0 0 0 Q7Z6Z7 HUWE1_HUMAN "E3 ubiquitin-protein ligase HUWE1, EC 2.3.2.26 (ARF-binding protein 1, ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9, HectH9) (Large structure of UREB1, LASU1) (Mcl-1 ubiquitin ligase E3, Mule) (Upstream regulatory element-binding protein 1, URE-B1, URE-binding protein 1)" HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 Homo sapiens (Human) base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813 DLHMMK 4.550000191 0.002040365 0.002040365 0.270576175 789.1633679 17.82602 0 19.62053 14.93092 17.2936 20.53169 0 0 18.20017 0 0 0 17.59065 21.026 19.86191 0 21.03372 16.89048 20.86552 0 0 0 0 0 0 20.45478 0 16.79033 0 0 17.69124 22.28149 0 0 0 0 0 0 21.89129 22.0541 18.17561 0 0 0 21.41603 18.06512 19.09207 19.73013 Q7Z736 PKHH3_HUMAN "Pleckstrin homology domain-containing family H member 3, PH domain-containing family H member 3" PLEKHH3 Homo sapiens (Human) signal transduction [GO:0007165] cytoskeleton [GO:0005856]; extracellular space [GO:0005615] cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; signal transduction [GO:0007165] GO:0005615; GO:0005856; GO:0007165 QTSGPAGPPGLPATQDPAALR 3.349999905 0.309961349 0.309961349 0.431936398 2001.114608 0 0 0 14.66241 0 0 0 0 0 0 0 0 0 0 19.65502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z745 MRO2B_HUMAN "Maestro heat-like repeat-containing protein family member 2B (HEAT repeat-containing protein 7B2) (Sperm PKA-interacting factor, SPIF)" MROH2B HEATR7B2 Homo sapiens (Human) cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283] GO:0001669; GO:0005737; GO:0007283; GO:0010737; GO:0030154; GO:0036126; GO:0097225 IVMGDLSTKVR 7.269999981 1 1 0.412521164 1235.003693 0 0 0 0 17.77637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.11251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6741 0 Q7Z7A1 CNTRL_HUMAN "Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa, Cep110)" CNTRL CEP1 CEP110 Homo sapiens (Human) aorta development [GO:0035904]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281] cytoskeletal protein binding [GO:0008092] GO:0001822; GO:0003281; GO:0005813; GO:0005815; GO:0005829; GO:0007049; GO:0008092; GO:0016020; GO:0034451; GO:0035904; GO:0048471; GO:0051301; GO:0051493; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103 DAEANQLK 16.15999985 1 1 0.331925228 889.4575832 0 13.31143 12.67448 16.16827 0 0 13.74739 13.82484 0 14.33771 12.3428 0 13.13206 14.80087 17.15729 0 0 10.44036 0 0 0 0 0 0 0 0 0 0 0 0 16.29181 0 0 16.80054 0 0 0 16.62908 0 0 0 0 0 0 0 15.62411 0 0 Q7Z7A4 PXK_HUMAN "PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase, MONaKA)" PXK Homo sapiens (Human) inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271] actin binding [GO:0003779]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022] GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0043271; GO:0050804 GALLSSIQNFQKGTLR 3.869999886 0.785314023 0.785314023 0.274273955 1737.616641 0 12.2378 0 16.80634 0 15.71082 0 13.54926 11.3094 0 17.34712 17.66214 15.67748 15.97137 0 16.53249 15.55789 14.11138 0 16.78409 15.4485 15.79712 0 17.67335 0 16.37343 17.59596 17.2049 14.98098 18.06837 16.31331 0 16.90851 0 17.75545 0 16.75753 15.01325 0 15.92778 16.23396 14.9125 0 17.02538 14.81207 15.40952 16.45022 17.04428 Q7Z7B0 FLIP1_HUMAN "Filamin-A-interacting protein 1, FILIP" FILIP1 KIAA1275 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] GO:0005730; GO:0005829; GO:0005886; GO:0015629 DELIGK 15.90999985 0.213374898 0.213374898 0.290114217 674.1813053 16.37055 0 16.31546 0 0 0 0 0 16.93566 0 15.40888 15.38447 17.06488 0 17.12103 17.02103 0 0 15.1517 0 0 18.28259 0 0 18.40214 18.21528 18.33925 18.34068 17.47886 0 0 19.28442 0 17.71258 17.28217 0 18.2143 19.02894 0 0 0 17.13662 16.88876 18.41568 0 16.63878 0 0 Q7Z7C8 TAF8_HUMAN "Transcription initiation factor TFIID subunit 8 (Protein taube nuss) (TBP-associated factor 43 kDa) (TBP-associated factor 8) (Transcription initiation factor TFIID 43 kDa subunit, TAFII-43, TAFII43, hTAFII43)" TAF8 TAFII43 TBN Homo sapiens (Human) cell differentiation [GO:0030154]; DNA-templated transcription open complex formation [GO:0001112]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of fat cell differentiation [GO:0045598]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; cell differentiation [GO:0030154]; DNA-templated transcription open complex formation [GO:0001112]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of fat cell differentiation [GO:0045598]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367] protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251] GO:0001112; GO:0001833; GO:0005634; GO:0005654; GO:0005669; GO:0006367; GO:0006468; GO:0016251; GO:0030154; GO:0042789; GO:0045598; GO:0046982; GO:0048471; GO:0051123; GO:0051457; GO:0060261 EPVSDYQVLREK 2.279999971 0.076859027 0.076859027 0.381963048 1462.769332 0 0 15.00525 12.9738 0 0 0 0 0 0 0 0 0 14.48783 0 0 0 0 16.82673 16.50274 16.70755 0 15.88327 0 0 0 0 14.95042 15.00023 14.70884 0 0 16.25466 16.21164 0 0 14.92669 0 0 16.23477 0 0 16.56478 16.75048 0 14.43479 14.60821 0 Q7Z7G0 TARSH_HUMAN "Target of Nesh-SH3, Tarsh (ABI gene family member 3-binding protein) (Nesh-binding protein, NeshBP)" ABI3BP NESHBP TARSH Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005576; GO:0005615; GO:0010811; GO:0030198; GO:0062023 KSCSGK 5.860000134 0.014526759 0.014526759 0.2310238 667.2317623 15.35866 14.53348 0 0 14.99969 0 0 0 0 0 15.63136 15.00204 16.41805 15.1465 16.19429 15.79033 16.96848 16.44699 16.08475 18.23143 0 0 17.06872 0 17.40504 16.88467 14.66724 0 18.11287 0 16.96841 16.24615 16.2346 16.12347 15.64281 15.78359 15.22722 18.10886 17.2489 17.04493 17.86327 17.94193 15.17875 15.62349 16.41756 19.69172 15.74699 0 Q7Z7G8 VP13B_HUMAN Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) VPS13B CHS1 COH1 KIAA0532 Homo sapiens (Human) protein transport [GO:0015031] protein transport [GO:0015031] GO:0015031 LVSSDLWR 12.25 1 1 0.446003327 976.0807001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.34844 0 0 0 0 0 0 0 19.29511 0 0 0 0 0 0 0 0 0 17.92803 0 0 Q7Z7H8 RM10_HUMAN "39S ribosomal protein L10, mitochondrial, L10mt, MRP-L10 (39S ribosomal protein L8, mitochondrial, L8mt, MRP-L8) (Mitochondrial large ribosomal subunit protein uL10m)" MRPL10 MRPL8 RPML8 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:1990904 AAAVAGMLR 5.909999847 0.968715072 0.968715072 0.202302522 861.677679 0 0 0 0 0 14.70292 15.24355 0 0 0 14.98398 0 0 0 16.95251 17.48577 15.97472 17.34222 17.49238 16.77632 18.3937 17.46027 16.53704 16.30806 0 17.79921 16.91419 0 17.56268 17.86684 17.72801 15.89187 17.05648 18.03609 16.37477 17.17857 18.30663 17.87221 17.91209 17.58614 15.88866 16.28527 0 18.08555 15.46757 16.56918 17.5008 14.36009 Q7Z7J5 DPPA2_HUMAN Developmental pluripotency-associated protein 2 (Pluripotent embryonic stem cell-related gene 1 protein) DPPA2 PESCRG1 Homo sapiens (Human) system development [GO:0048731] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; system development [GO:0048731] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0048731 DTLRDWCQQLGLSTNGK 8.979999542 1 1 1.83E-12 1990.987237 0 14.44084 11.76475 14.08877 9.408435 0 0 14.3838 0 0 14.42862 0 0 13.91204 12.28586 15.8655 0 16.36715 9.577834 13.66778 15.3426 0 14.07341 0 0 0 0 0 0 0 0 16.42202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7K6 CENPV_HUMAN "Centromere protein V, CENP-V (Nuclear protein p30) (Proline-rich protein 6)" CENPV PRR6 Homo sapiens (Human) ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044] cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233] cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044] carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872] GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301 RSASQAGSK 6.849999905 1 1 0.058105944 891.5320116 14.44394 13.44741 17.19307 11.77145 16.96012 16.1553 13.56221 0 15.3995 0 18.20789 0 17.54588 16.26171 0 0 15.38058 0 14.86703 17.58214 11.36506 0 0 0 13.31829 14.67161 0 0 15.8943 0 17.15674 17.87435 18.03231 16.31146 0 16.11481 0 0 0 0 13.21942 10.76976 14.9779 0 0 0 15.2391 0 Q7Z7L1 SLN11_HUMAN "Schlafen family member 11, EC 3.6.-.-" SLFN11 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; tRNA binding [GO:0000049]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; tRNA binding [GO:0000049] GO:0000049; GO:0002376; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0008156; GO:0010942; GO:0016887; GO:0043111; GO:0051607; GO:0090734; GO:2000134 EVLGCAKENVDPDSLR 14.85999966 1 1 0 1802.189716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7L9 ZSCA2_HUMAN "Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog, Zfp-29) (Zinc finger protein 854)" ZSCAN2 ZFP29 ZNF854 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0046872 SHLITHER 13.5 8.11E-07 8.11E-07 0.244940508 996.1032728 13.75014 16.97454 14.51666 0 14.57108 14.68577 0 16.09222 13.48753 0 15.13321 15.49122 14.49027 0 0 0 0 0 0 0 0 0 15.54268 0 15.8081 0 13.60225 14.27212 0 14.82758 14.0105 12.42355 15.25761 15.52479 14.27997 13.70201 13.4028 14.32007 17.01236 15.05616 0 15.75012 0 13.72134 15.57475 14.25639 17.20319 12.22546 Q7Z7M0 MEGF8_HUMAN "Multiple epidermal growth factor-like domains protein 8, Multiple EGF-like domains protein 8 (Epidermal growth factor-like protein 4, EGF-like protein 4)" MEGF8 C19orf49 EGFL4 KIAA0817 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888] calcium ion binding [GO:0005509] GO:0003143; GO:0005509; GO:0005634; GO:0009887; GO:0009888; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0070062; GO:0071907; GO:0097094; GO:0097155 AGGSCFR 5.460000038 1 1 0.235693642 754.1823742 0 0 13.34833 0 16.93778 0 15.34727 0 0 0 0 0 0 0 0 0 0 16.20272 19.24985 0 16.70172 16.79759 15.07335 15.39742 16.52506 0 0 0 15.84352 0 16.11384 16.4568 16.21126 0 0 0 0 17.06468 16.31092 16.0349 13.05929 13.19542 0 0 15.90111 0 16.84881 17.25074 Q7Z7M1 AGRD2_HUMAN Adhesion G-protein coupled receptor D2 (G-protein coupled receptor 144) (G-protein coupled receptor PGR24) ADGRD2 GPR144 PGR24 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 TAGGVCK 14.31000042 0.375900805 0.375900805 0.285340579 691.8134874 15.74744 0 14.98454 0 15.38696 13.33407 0 15.01767 15.26827 0 0 0 16.3743 17.03907 17.22241 17.17853 15.73779 17.24857 17.10931 16.22024 0 0 15.74315 17.2502 16.35755 17.6165 15.90101 17.72988 17.33234 16.57958 16.8103 17.19308 17.79941 17.2863 16.74454 16.71394 17.70215 18.04662 17.27438 0 18.60152 18.19506 18.96741 16.63293 16.56739 16.51046 15.07624 0 Q7Z7M9 GALT5_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 5, EC 2.4.1.41 (Polypeptide GalNAc transferase 5, GalNAc-T5, pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)" GALNT5 Homo sapiens (Human) glycosaminoglycan biosynthetic process [GO:0006024]; O-glycan processing [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; glycosaminoglycan biosynthetic process [GO:0006024]; O-glycan processing [GO:0016266] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0006024; GO:0016021; GO:0016266; GO:0030246; GO:0046872 TDGRGTKPEASSHQGTPK 9.630000114 0.834431231 0.834431231 0.453051279 1856.043673 17.24603 0 0 0 0 0 0 14.92395 15.33406 15.39735 15.68724 0 15.69333 0 0 0 0 0 0 0 0 0 0 15.33313 15.02059 0 15.64766 0 0 0 15.52309 0 15.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SE9 PCGF5_HUMAN Polycomb group RING finger protein 5 (RING finger protein 159) PCGF5 RNF159 Homo sapiens (Human) histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872] GO:0000805; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0045944; GO:0046872; GO:0060819 MATQRK 3.529999971 0.964306116 0.964306116 0.183685747 749.9995839 14.60936 15.56091 16.79165 0 15.12868 14.97215 0 0 0 16.5858 0 15.37012 0 0 0 0 0 0 0 0 0 0 0 0 15.16837 0 0 15.05445 15.68696 0 16.45604 15.90637 0 16.54227 0 0 0 0 16.54843 15.27262 15.54448 16.98553 16.20817 0 16.14319 0 0 0 Q86SF2 GALT7_HUMAN "N-acetylgalactosaminyltransferase 7, EC 2.4.1.41 (Polypeptide GalNAc transferase 7, GalNAc-T7, pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7)" GALNT7 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0005975; GO:0006493; GO:0016020; GO:0016021; GO:0016266; GO:0030246; GO:0046872; GO:0070062 FTHIPSGK 6.960000038 0.106758446 0.106758446 0.144934026 886.3237839 14.20332 0 14.12098 0 0 11.47296 0 0 0 0 16.33505 0 16.33673 15.68487 16.71976 14.53509 0 17.35505 0 17.43695 16.84458 0 16.61524 13.37404 15.95685 13.68114 15.10218 0 14.32092 13.51152 15.499 16.68643 14.34581 15.36392 15.94594 15.03019 15.56928 13.7205 15.55238 14.50611 0 0 14.56534 14.34991 15.01658 14.02915 16.0465 0 Q86SK9 SCD5_HUMAN "Stearoyl-CoA desaturase 5, EC 1.14.19.1 (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2)" SCD5 ACOD4 SCD2 SCD4 Homo sapiens (Human) monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636] iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768] GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0016491; GO:1903966 RATKPMIEAR 4.369999886 1 1 0.316409877 1187.815426 0 0 17.40014 0 0 17.52645 0 0 0 0 0 0 13.66108 0 0 0 0 0 0 0 0 0 0 0 0 0 18.63655 0 0 0 17.44063 0 0 0 0 0 18.63561 0 0 0 0 0 0 0 0 0 15.71568 0 Q86SP6 GP149_HUMAN Probable G-protein coupled receptor 149 (G-protein coupled receptor PGR10) GPR149 PGR10 Homo sapiens (Human) antral ovarian follicle growth [GO:0001547]; negative regulation of ovulation [GO:0060280]; neuropeptide signaling pathway [GO:0007218]; preantral ovarian follicle growth [GO:0001546] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; antral ovarian follicle growth [GO:0001547]; negative regulation of ovulation [GO:0060280]; neuropeptide signaling pathway [GO:0007218]; preantral ovarian follicle growth [GO:0001546] G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277] GO:0001546; GO:0001547; GO:0004930; GO:0005887; GO:0007218; GO:0042277; GO:0042923; GO:0043005; GO:0060280 DAFSDKTGGDINYEETTFSEGPER 3.410000086 0.721816421 0.721816421 4.58E-13 2665.393754 14.25951 13.40422 0 0 0 0 0 16.15968 0 15.79528 9.725824 0 13.18383 0 0 15.879 0 17.11736 0 0 0 0 0 8.847219 0 0 0 0 0 0 0 15.09282 0 0 16.344 0 0 15.72344 14.16769 0 0 0 0 0 13.75015 15.13458 15.40223 0 Q86SQ0 PHLB2_HUMAN Pleckstrin homology-like domain family B member 2 (Protein LL5-beta) PHLDB2 LL5B Homo sapiens (Human) "establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]" basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886] "basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]" cadherin binding [GO:0045296] GO:0000226; GO:0005829; GO:0005886; GO:0010470; GO:0010717; GO:0031252; GO:0045111; GO:0045180; GO:0045184; GO:0045296; GO:0051497; GO:0051895; GO:0070507; GO:1903690; GO:1904261 TPEGISEEQR 8.399999619 1 1 0.527359169 1145.218626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.47353 0 0 18.05924 0 18.01403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SQ3 AGRE4_HUMAN Putative adhesion G protein-coupled receptor E4P (EGF-like module receptor 4) (EGF-like module-containing mucin-like hormone receptor-like 4) (G-protein coupled receptor 127) (G-protein coupled receptor PGR16) ADGRE4P EMR4 EMR4P GPR127 PGR16 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005509; GO:0005576; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 MGSRFLLVLLSGASCPPCPK 4.079999924 0.695588827 0.695588827 0.498741823 2207.170896 16.41267 16.43772 0 0 16.61036 0 17.4599 17.32971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2226 0 0 0 0 0 0 0 0 0 0 0 17.77706 0 0 0 0 0 0 0 0 0 0 0 Q86SR1 GLT10_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 10, EC 2.4.1.41 (Polypeptide GalNAc transferase 10, GalNAc-T10, pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)" GALNT10 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 IAWDLPK 16.02000046 1 1 0.203318199 841.7657346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SS6 SYT9_HUMAN "Synaptotagmin-9 (Synaptotagmin IX, SytIX)" SYT9 Homo sapiens (Human) calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192] clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192]" "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030667; GO:0030669; GO:0031045; GO:0042802; GO:0045956; GO:0050796; GO:0070382; GO:0071277; GO:0098686; GO:0099502 VSLMCDGR 5.630000114 1 1 0.177662839 937.4880604 15.33222 0 15.17029 14.96648 0 0 0 0 0 0 0 0 0 0 0 0 17.01099 0 0 0 0 0 0 16.07418 0 0 0 0 0 0 16.36764 0 14.44776 14.83354 0 15.11669 14.48674 0 13.52778 0 11.35415 16.50694 0 0 0 0 15.99861 0 Q86T13 CLC14_HUMAN "C-type lectin domain family 14 member A (Epidermal growth factor receptor 5, EGFR-5)" CLEC14A C14orf27 EGFR5 UNQ236/PRO269 Homo sapiens (Human) cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; lymphangiogenesis [GO:0001946]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor-3 signaling pathway [GO:0036325] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; lymphangiogenesis [GO:0001946]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor-3 signaling pathway [GO:0036325] carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430] GO:0001946; GO:0002042; GO:0009897; GO:0016021; GO:0016477; GO:0030246; GO:0036324; GO:0036325; GO:0050840; GO:0062023; GO:1990430 CAVLQATGGVEPAGWK 1.159999967 0.2366243 0.2366243 0.494302261 1644.343621 17.34557 17.78758 18.43851 0 0 0 0 0 0 0 0 0 16.94647 0 0 0 0 0 0 0 17.19444 18.27783 0 17.78506 0 0 0 0 0 17.31005 0 0 19.42507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86T24 KAISO_HUMAN Transcriptional regulator Kaiso (Zinc finger and BTB domain-containing protein 33) ZBTB33 KAISO ZNF348 Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008327; GO:0016055; GO:0035556; GO:0043565; GO:0045892; GO:0046872; GO:1990837 DDGIGYK 5.730000019 0.482929528 0.482929528 0.005563619 767.3793539 0 13.78494 18.10309 15.59094 0 0 16.36255 0 0 15.75744 15.10035 0 0 0 15.08063 17.57637 15.28952 15.20246 15.86174 18.12153 13.09191 15.2667 17.23869 14.67271 17.65166 19.89828 0 15.92663 0 0 17.49155 14.54077 18.58354 0 0 0 15.61288 15.39227 15.33376 0 20.1627 13.07894 15.74977 14.55476 11.91322 16.4323 17.23346 16.3288 Q86T82 UBP37_HUMAN "Ubiquitin carboxyl-terminal hydrolase 37, EC 3.4.19.12 (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37)" USP37 KIAA1594 Homo sapiens (Human) cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843] GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006275; GO:0006511; GO:0016579; GO:0019901; GO:0035871; GO:0051301; GO:0071108 AMTDPSR 4.920000076 0.046446294 0.046446294 0.185414708 775.7878281 11.50207 14.54233 14.40648 0 15.06221 15.24386 13.45564 16.50446 0 15.04035 0 0 14.3571 14.48717 13.19519 0 0 15.73355 0 15.05049 14.96917 0 0 17.04373 0 0 16.79446 0 0 14.79356 0 0 0 0 16.15343 0 17.83456 0 0 0 11.94866 0 0 0 0 15.00422 0 0 Q86TB3 ALPK2_HUMAN "Alpha-protein kinase 2, EC 2.7.11.1 (Heart alpha-protein kinase)" ALPK2 HAK Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468] basolateral plasma membrane [GO:0016323] basolateral plasma membrane [GO:0016323]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0003007; GO:0003308; GO:0004674; GO:0004712; GO:0005524; GO:0010468; GO:0016323; GO:0030010; GO:0042981; GO:0055013; GO:0106310; GO:1905223 ESHKGEEPTISVHWR 2.849999905 1 1 0.416433072 1791.844801 0 17.8786 13.16731 0 0 0 0 0 0 0 0 18.68411 18.74405 0 0 0 0 0 0 16.32813 0 0 0 0 17.73966 19.20672 0 0 18.9383 0 0 0 0 19.98275 0 0 0 0 0 0 0 0 0 0 0 16.71984 0 17.92457 Q86TE4 LUZP2_HUMAN Leucine zipper protein 2 LUZP2 UNQ2566/PRO6246 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 NKLLSGNK 4.820000172 0.058554936 0.058554936 0.251076498 874.228533 16.24505 0 0 15.2624 15.7556 14.14588 16.72947 16.77656 15.71937 0 0 12.75484 14.48525 14.46002 15.38108 15.2484 15.50369 14.63934 15.23738 15.24796 14.49054 0 16.45417 0 15.62065 0 16.15956 15.18026 15.83705 14.82344 0 16.83263 0 15.05189 14.9118 16.48326 16.379 0 17.09493 15.65294 15.74005 16.13538 16.70989 15.71506 14.77953 15.25225 14.78729 15.47481 Q86TH1 ATL2_HUMAN "ADAMTS-like protein 2, ADAMTSL-2" ADAMTSL2 KIAA0605 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril binding [GO:0050436]; extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] microfibril binding [GO:0050436] GO:0005576; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481 DGTSCK 5.550000191 0.209781393 0.209781393 0.294817478 667.116783 15.67688 0 16.71641 15.31684 15.4171 14.38521 0 0 0 15.3722 16.46402 15.46225 16.70589 15.86476 16.43171 16.48126 0 0 17.00317 15.70518 15.67858 16.8654 0 0 0 16.86328 17.38868 17.15969 16.44144 16.06797 14.54503 16.42245 15.42237 16.78619 17.09694 16.45335 15.39081 16.43328 17.6461 16.35115 0 17.1858 16.873 17.60529 14.69244 17.4483 16.00125 16.89222 Q86TI0 TBCD1_HUMAN TBC1 domain family member 1 TBC1D1 KIAA1108 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of protein localization [GO:0032880] nucleus [GO:0005634] nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of protein localization [GO:0032880] GTPase activator activity [GO:0005096] GO:0005096; GO:0005634; GO:0032880; GO:0090630 IEGMNSSK 13 1 1 0.135252717 881.6656101 14.78168 15.11541 15.74495 14.44093 15.25166 0 14.45667 13.68178 0 15.20174 15.02216 15.34025 0 15.57169 0 15.41516 0 0 15.88966 14.61878 0 0 0 0 0 15.90967 15.54068 14.85202 14.81014 14.72369 0 0 0 15.95406 0 0 15.65817 15.40738 16.85366 0 13.88505 0 15.98407 15.92841 0 0 0 0 Q86TI2 DPP9_HUMAN "Dipeptidyl peptidase 9, DP9, EC 3.4.14.5 (Dipeptidyl peptidase IV-related protein 2, DPRP-2) (Dipeptidyl peptidase IX, DPP IX) (Dipeptidyl peptidase-like protein 9, DPLP9)" DPP9 DPRP2 Homo sapiens (Human) pyroptosis [GO:0070269] cell leading edge [GO:0031252]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634] cell leading edge [GO:0031252]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]; pyroptosis [GO:0070269] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236] GO:0004177; GO:0005634; GO:0005829; GO:0005874; GO:0008236; GO:0008239; GO:0031252; GO:0042802; GO:0070269 TQCSGPR 5.420000076 1 1 0.115455932 803.9210302 14.0433 15.77215 16.17553 13.74414 0 0 0 0 0 0 0 14.79825 0 14.15984 13.36294 15.69386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TI4 WDR86_HUMAN WD repeat-containing protein 86 WDR86 Homo sapiens (Human) GAPRPPPPMRSLSR 9.119999886 0.219525233 0.219525233 0.501241803 1518.350129 14.91956 19.1395 9.932972 0 20.79274 0 14.51807 0 0 0 0 0 16.99208 0 0 0 19.21416 0 0 0 0 0 0 17.55284 0 0 0 0 0 0 0 0 0 17.88345 20.43052 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TJ2 TAD2B_HUMAN "Transcriptional adapter 2-beta (ADA2-like protein beta, ADA2-beta)" TADA2B ADA2B Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] GO:0000124; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006338; GO:0006357; GO:0008270; GO:0035066; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0070461 YHGYQLVDGGRFTLWGPEAEGGWTSR 2.25 1 1 0.104534341 2939.733344 15.54916 0 0 13.82767 8.990589 13.81932 0 14.80867 12.38532 0 0 0 0 15.64494 12.94185 0 0 12.68784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TJ5 ZN554_HUMAN Zinc finger protein 554 ZNF554 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872 MAAGYLPR 6.630000114 1 1 0.229938856 879.5734433 0 0 0 18.38222 15.78124 0 16.07296 13.11742 13.3739 18.82269 16.48866 13.53472 16.35155 13.29949 14.61688 10.82964 13.42103 16.08622 0 15.86641 15.06153 15.97341 0 0 15.28142 0 16.14036 0 16.10914 14.58563 16.40488 0 0 15.57774 0 0 16.27751 0 16.44062 0 0 16.86036 0 0 16.03881 15.88133 16.18328 11.48647 Q86TL2 STIMA_HUMAN Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110) STIMATE TMEM110 Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] calcium channel regulator activity [GO:0005246] GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268 RLTPLKPVK 4.630000114 1 1 0.283679432 1052.732939 0 0 0 0 0 0 0 0 0 19.95966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.46051 0 0 0 0 0 0 0 Q86TP1 PRUN1_HUMAN "Exopolyphosphatase PRUNE1, EC 3.6.1.1 (Drosophila-related expressed sequence 17, DRES-17, DRES17) (HTcD37) (Protein prune homolog 1, hPrune)" PRUNE1 PRUNE Homo sapiens (Human) regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767] exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631] GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767 GDIVFFLQK 9.489999771 1 1 0.19705457 1066.416724 14.27213 15.40512 15.0639 0 14.85631 14.69218 0 16.91405 14.05188 0 14.24949 0 15.9528 14.04578 0 9.538822 15.73551 14.24984 15.41924 14.71267 17.59575 13.45351 17.3994 10.95144 0 14.2756 15.38382 0 16.79546 0 0 0 0 17.76521 0 0 15.91332 0 0 0 0 15.59926 15.48382 0 0 15.51297 16.70269 0 Q86TU6 CN070_HUMAN Putative uncharacterized protein encoded by LINC00523 LINC00523 C14orf70 Homo sapiens (Human) GIGTGHTSMNK 3.390000105 1 1 0.12857459 1100.566525 13.41301 0 0 0 14.56088 12.56096 0 0 0 0 0 0 0 0 0 0 0 9.142589 0 0 0 0 12.69434 0 0 0 0 0 0 0 0 0 0 13.84754 0 0 0 0 0 15.74601 0 0 0 0 15.45466 0 0 0 Q86TU7 SETD3_HUMAN "Actin-histidine N-methyltransferase, EC 2.1.1.85 (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3, hSETD3)" SETD3 C14orf154 Homo sapiens (Human) "actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]" actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] GO:0000785; GO:0003713; GO:0003779; GO:0005654; GO:0005737; GO:0010452; GO:0018021; GO:0018023; GO:0018026; GO:0018027; GO:0018064; GO:0030047; GO:0042800; GO:0045893; GO:0045944; GO:0046975; GO:0051149; GO:0061629; GO:0070472 CSSPAPGPGK 4.019999981 0.001795161 0.001795161 0.282385317 957.6261104 0 0 0 0 17.47208 0 17.74945 0 0 0 0 17.00619 18.35973 0 0 0 17.87596 0 0 0 18.51595 16.44518 18.1158 0 0 0 0 17.1929 0 16.55768 0 19.14613 0 0 0 18.24551 18.42207 0 18.08888 0 17.90491 17.98632 0 17.6516 18.02589 18.63694 0 0 Q86TV6 TTC7B_HUMAN "Tetratricopeptide repeat protein 7B, TPR repeat protein 7B (Tetratricopeptide repeat protein 7-like-1, TPR repeat protein 7-like-1)" TTC7B TTC7L1 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0046854; GO:0072659 LIANDDMAELLLGESKLEQYLK 1.659999967 1 1 0.387268005 2521.397736 16.81797 19.40401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TZ1 TTC6_HUMAN "Tetratricopeptide repeat protein 6, TPR repeat protein 6" TTC6 C14orf25 NCRNA00291 Homo sapiens (Human) ALCYTK 6.849999905 7.38E-06 7.38E-06 0.321847198 756.8371479 0 0 0 0 0 17.91004 18.29761 19.09469 0 18.82498 18.4975 0 0 0 18.963 0 0 17.65228 0 18.76649 0 0 0 0 0 0 0 0 0 0 17.41796 19.19261 0 0 0 0 0 0 0 0 17.88416 17.37853 0 16.79453 17.31084 0 0 0 Q86U06 RBM23_HUMAN "Probable RNA-binding protein 23 (CAPER beta, CAPERbeta) (RNA-binding motif protein 23) (RNA-binding region-containing protein 4) (Splicing factor SF2)" RBM23 RNPC4 PP239 Homo sapiens (Human) "mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]" membrane [GO:0016020]; nucleus [GO:0005634] "membrane [GO:0016020]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]" RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016020; GO:0045893; GO:0048024 SPHFREK 7.820000172 1 1 0.173471199 900.7494809 0 0 14.15519 14.91502 14.3883 13.38495 15.61283 0 13.0951 15.03594 15.85601 15.41609 0 14.43118 0 0 0 15.81788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22035 0 0 0 0 0 Q86U42 PABP2_HUMAN "Polyadenylate-binding protein 2, PABP-2, Poly(A)-binding protein 2 (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II, PABII) (Polyadenylate-binding nuclear protein 1)" PABPN1 PAB2 PABP2 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; muscle contraction [GO:0006936]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; muscle contraction [GO:0006936]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; RNA processing [GO:0006396] RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063] GO:0000165; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006936; GO:0016607; GO:0016973; GO:0042405; GO:0070063; GO:0071222; GO:1904247; GO:1990904 GSGPGR 1.570000052 0.013975806 0.013975806 0.155181219 530.6513101 18.247 17.89511 0 13.53049 18.01346 14.93957 17.23436 0 0 15.36203 0 14.42649 14.09049 13.76573 15.50975 14.74775 18.23073 16.87605 16.85672 15.39278 18.67249 14.38177 17.06309 18.04084 14.78257 18.6649 0 14.78497 14.14157 14.81847 0 0 0 0 19.42548 17.02382 16.67536 19.39273 17.96362 17.90986 17.28508 16.84301 13.30472 16.00438 19.31258 16.47843 8.78833 16.51626 Q86U86 PB1_HUMAN "Protein polybromo-1, hPB1 (BRG1-associated factor 180, BAF180) (Polybromo-1D)" PBRM1 BAF180 PB1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; DNA binding [GO:0003677] GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005654; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 DVPLPVVR 2.349999905 1 1 0.012666071 894.925613 0 0 0 0 0 13.82507 0 0 0 15.03689 0 14.24543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.41049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UB9 TM135_HUMAN "Transmembrane protein 135 (Peroxisomal membrane protein 52, PMP52)" TMEM135 Homo sapiens (Human) peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094] GO:0005777; GO:0005778; GO:0005811; GO:0007031; GO:0009409; GO:0016021; GO:0031966; GO:0032094; GO:0090140 VLDVFGTGASK 4.119999886 1 1 0.016361526 1092.744932 14.97091 14.85669 0 17.9167 0 0 12.36449 15.02566 14.54962 0 16.22039 0 15.71518 0 0 15.38318 0 13.62711 16.04358 16.35652 0 16.03277 0 0 0 14.24903 14.79789 0 14.05485 0 0 0 15.50929 0 15.21123 14.33428 0 0 0 14.9749 15.74069 0 0 0 13.89992 17.52925 16.91992 14.13855 Q86UC2 RSPH3_HUMAN Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2) RSPH3 RSHL2 RSP3 Homo sapiens (Human) cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005856; GO:0005929 ELLGQDEETAMR 7.659999847 1 1 0.139631063 1390.810892 0 0 0 0 0 0 0 0 15.38715 0 17.09659 0 0 0 0 0 0 0 0 0 12.98028 0 0 0 18.98203 14.3058 0 17.37409 0 0 17.62949 0 16.49574 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64256 18.28843 Q86UD0 SAPC2_HUMAN "Suppressor APC domain-containing protein 2 (Tumor specificity and mitosis phase-dependent expression protein, TS/MDEP) (p42.3)" SAPCD2 C9orf140 Homo sapiens (Human) establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] GO:0000132; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777 LLPKVQEVAR 6.289999962 0.668801188 0.668801188 0.233678328 1152.140165 14.03002 10.64594 0 14.44578 0 0 0 0 0 12.62894 0 18.55796 0 13.93923 0 0 0 0 0 0 0 0 0 0 14.61398 0 0 15.37542 0 0 0 0 14.99846 0 14.29265 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UD4 ZN329_HUMAN Zinc finger protein 329 ZNF329 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 LFRNIAGLIR 17.10000038 1 1 0.127047423 1170.804175 13.94232 0 0 0 0 0 0 0 15.04277 0 0 0 15.69157 15.13022 0 0 0 15.65497 0 0 0 0 16.16982 15.8383 0 14.98436 0 0 14.91214 0 0 0 0 16.55955 0 0 0 0 0 0 0 0 16.70633 14.00754 15.37152 0 0 16.42204 Q86UE3 ZN546_HUMAN Zinc finger protein 546 (Zinc finger protein 49) ZNF546 ZNF49 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 HQMGCVSQMLIQK 3.059999943 1 1 0.350588255 1593.16597 14.07632 14.44099 13.85912 12.92458 0 14.71328 13.30494 14.59473 14.78824 14.80509 15.02723 14.17661 9.448749 14.58602 15.10929 0 12.2777 0 14.68804 10.81085 0 13.19248 14.2007 14.5561 0 14.68301 15.93572 0 0 0 0 0 0 15.04732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UE4 LYRIC_HUMAN "Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein, AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein)" MTDH AEG1 LYRIC Homo sapiens (Human) lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357] double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0000122; GO:0001650; GO:0003712; GO:0003713; GO:0003723; GO:0003725; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005923; GO:0006357; GO:0010508; GO:0016021; GO:0016324; GO:0016604; GO:0031663; GO:0031965; GO:0043066; GO:0043123; GO:0045766; GO:0046581; GO:0048471; GO:0051059; GO:0051092; GO:0051897; GO:0061629 QPPEIDK 12.35000038 1 1 0.119346278 825.919707 16.17979 13.87749 15.40183 0 0 12.8069 15.80017 13.69095 13.70594 11.96683 0 13.93636 13.10211 0 0 0 0 0 14.78664 12.74788 0 14.59658 0 0 0 14.24149 0 0 12.65688 13.7948 12.3518 0 0 0 0 0 0 0 0 13.06511 11.94324 0 15.1708 0 13.78282 0 14.08624 14.21917 Q86UF2 CTGE6_HUMAN "cTAGE family member 6, Protein cTAGE-6" CTAGE6 CTAGE6P Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971 IMTEFYQEDEMK 5.75 0.694542587 0.694542587 0.162655548 1578.523799 13.62586 14.85439 10.67012 15.22027 13.83619 0 11.34233 11.7108 13.02138 15.5588 14.67752 14.48093 0 0 0 0 0 0 0 0 12.61449 0 0 0 11.70063 0 16.96639 0 0 0 0 0 16.46195 0 0 0 0 16.49433 0 0 0 0 0 13.692 0 0 0 13.40676 Q86UF4 CC190_HUMAN Coiled-coil domain-containing protein 190 CCDC190 C1orf110 Homo sapiens (Human) MAQDTCKSK 1.450000048 1 1 0.024801455 1071.309156 16.02621 0 17.97229 0 13.52555 0 0 0 14.78463 15.5318 0 13.78792 0 0 0 0 0 0 13.55828 0 0 0 0 0 0 0 0 0 0 0 0 16.41277 0 0 0 0 0 0 16.41223 0 16.57106 0 0 0 13.4027 0 0 0 Q86UG4 SO6A1_HUMAN "Solute carrier organic anion transporter family member 6A1 (Cancer/testis antigen 48, CT48) (Gonad-specific transporter, GST) (Organic anion-transporting polypeptide 6A1) (Organic anion-transporting polypeptide I, OATP-I) (Solute carrier family 21 member 19)" SLCO6A1 OATP6A1 SLC21A19 Homo sapiens (Human) sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252] sodium-independent organic anion transmembrane transporter activity [GO:0015347] GO:0005887; GO:0015347; GO:0043252 KEETDL 6.820000172 1 1 0.296430053 734.9530964 12.76061 14.88581 15.24402 15.36727 14.84592 14.57901 0 0 0 15.29745 0 16.27983 0 14.52251 0 8.401042 0 0 15.58832 14.53441 16.08774 16.01567 15.41101 15.49765 0 15.03897 0 0 16.02413 0 16.8969 0 16.58762 0 0 0 16.65606 0 16.19048 16.31724 0 17.15523 0 0 17.78354 0 0 0 Q86UK0 ABCAC_HUMAN "Glucosylceramide transporter ABCA12, EC 7.6.2.1 (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12, ATP-binding cassette 12)" ABCA12 ABC12 Homo sapiens (Human) cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016021; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010 ILGLEKLLK 2.359999895 1 1 0.273820739 1025.974943 0 16.5311 17.5069 0 0 0 20.29499 17.26037 17.60985 0 0 0 17.18918 0 18.06172 16.08078 0 0 0 0 0 0 0 0 0 18.72437 17.48778 17.22879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.36436 0 0 17.74353 Q86UK5 LBN_HUMAN "Limbin (Ellis-van Creveld syndrome protein 2, EVC2)" EVC2 LBN Homo sapiens (Human) smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane protein complex [GO:0098797] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane protein complex [GO:0098797]; smoothened signaling pathway [GO:0007224] GO:0005634; GO:0005737; GO:0005856; GO:0005929; GO:0007224; GO:0016021; GO:0060170; GO:0098797 ALGMD 5.820000172 0.357789725 0.357789725 0.250088916 509.5731745 16.24414 16.9344 16.5824 0 17.11209 0 0 0 17.10175 0 16.4409 17.40698 16.04039 16.62663 17.34444 0 0 0 16.41 16.78238 0 0 0 15.9505 17.56207 16.96909 0 17.39178 15.92513 17.30273 17.60588 17.32335 16.43531 18.19222 16.85902 16.16711 16.40268 16.96523 15.92465 17.37892 17.67604 16.74952 16.98653 15.7463 16.69309 16.991 17.14115 15.54758 Q86UK7 ZN598_HUMAN "E3 ubiquitin-protein ligase ZNF598, EC 2.3.2.27 (Zinc finger protein 598)" ZNF598 Homo sapiens (Human) protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829] cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] GO:0003723; GO:0005829; GO:0006417; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344; GO:1990116 DFLQSDEAR 5.449999809 1 1 0.121186822 1081.968847 13.51242 15.13003 0 0 0 15.23624 0 0 0 0 0 0 15.88792 0 0 13.9228 0 0 0 15.63222 0 0 0 0 0 0 0 0 0 0 0 0 13.0757 0 0 0 0 0 12.02068 0 0 0 0 0 0 0 0 0 Q86UL3 GPAT4_HUMAN "Glycerol-3-phosphate acyltransferase 4, EC 2.3.1.15 (1-acylglycerol-3-phosphate O-acyltransferase 6, 1-AGP acyltransferase 6, 1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta, LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7, TSARG7)" GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420] GO:0002071; GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006654; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339; GO:0102420 ALTAIITYHDRENRPR 1.809999943 0.620627642 0.620627642 0.474285137 1926.471058 16.59006 0 0 16.99041 17.62093 16.46851 0 18.68858 0 0 0 0 0 0 17.39543 0 15.84506 0 17.79288 0 0 0 0 0 0 18.16338 0 16.0444 0 16.25618 19.40443 0 0 18.72167 0 0 0 0 0 16.76052 0 0 16.85437 0 0 16.99028 0 0 Q86UP0 CAD24_HUMAN Cadherin-24 CDH24 CDH11L UNQ2834/PRO34009 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097] GO:0000902; GO:0005509; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045294; GO:0045296; GO:0070097; GO:0098609; GO:0098742 VEATNTLIDPAYLR 8.409999847 1 1 0.26428041 1575.653277 14.64426 0 0 15.44041 0 14.26627 0 16.27534 15.65669 0 0 0 0 0 0 0 10.02448 0 0 0 0 0 0 0 0 14.86698 0 15.54248 0 0 0 13.73597 15.16851 15.52406 11.71359 0 15.65711 16.61023 0 0 15.88859 15.70048 0 14.50229 0 15.61851 0 14.10437 Q86UP2 KTN1_HUMAN Kinectin (CG-1 antigen) (Kinesin receptor) KTN1 CG1 KIAA0004 Homo sapiens (Human) microtubule-based movement [GO:0007018]; protein transport [GO:0015031] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031] cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723] GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005887; GO:0007018; GO:0015031; GO:0016020; GO:0016021; GO:0019894; GO:0030176; GO:0045296 EDAAATK 6.289999962 1 1 0.106485188 704.2347938 12.84764 14.32348 14.12301 15.23948 15.09792 15.20784 14.63342 14.75398 13.21424 13.64968 14.58621 14.52139 14.88633 14.24061 13.96668 0 0 0 0 0 0 14.21912 16.11394 11.71255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UP3 ZFHX4_HUMAN "Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4, ZFH-4)" ZFHX4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 HMQKYQLVAHIK 19.59000015 1 1 0.534466513 1495.745613 0 18.64878 0 0 0 0 16.36351 0 0 0 0 0 0 0 0 0 18.90956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.07722 0 0 19.80132 0 0 0 0 0 0 Q86UQ0 ZN589_HUMAN Zinc finger protein 589 (Stem cell zinc finger protein 1) ZNF589 SZF1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0046872 QKAVTAEK 4.610000134 1 1 0.208256595 872.9448591 14.00619 13.83134 14.73663 17.42183 15.79213 14.30344 13.57094 0 0 0 15.57852 14.77806 0 0 0 14.19671 11.29993 16.1546 14.87159 0 13.00355 0 0 0 16.75243 0 16.19608 16.36694 0 0 0 15.81383 0 0 0 0 0 0 15.96926 16.41891 0 0 0 0 0 16.16673 0 0 Q86UQ4 ABCAD_HUMAN "ATP-binding cassette sub-family A member 13, EC 7.6.2.-" ABCA13 Homo sapiens (Human) ceramide transport [GO:0035627]; lipid transport [GO:0006869]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of synaptic vesicle endocytosis [GO:1900244] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; ceramide transport [GO:0035627]; lipid transport [GO:0006869]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of synaptic vesicle endocytosis [GO:1900244] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0030667; GO:0032376; GO:0035577; GO:0035627; GO:0042626; GO:0043231; GO:0097708; GO:0140359; GO:1900244 MNLEDMR 19.20999908 1 1 0.402480095 923.4435747 14.35308 0 0 0 0 0 0 0 0 0 0 0 0 0 17.68363 0 0 20.16604 0 0 0 17.6766 0 0 0 0 0 0 19.00573 0 0 0 0 17.14929 0 0 0 0 0 0 18.35825 0 0 19.89567 0 0 16.11802 0 Q86UR1 NOXA1_HUMAN "NADPH oxidase activator 1, NOX activator 1 (Antigen NY-CO-31) (NCF2-like protein) (P67phox-like factor) (p51-nox)" NOXA1 P51NOX Homo sapiens (Human) regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020] cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; superoxide-generating NADPH oxidase activator activity [GO:0016176] GO:0005829; GO:0006801; GO:0010310; GO:0016176; GO:0017124; GO:0019899; GO:0031267; GO:0042554; GO:0042802; GO:0043020; GO:0060263 RGADLSSLR 6.829999924 0.377216637 0.377216637 0.250491947 973.4706368 0 0 0 0 0 0 0 17.13381 16.66191 0 0 0 0 16.24581 16.56684 17.49578 0 0 0 17.09907 16.86658 0 0 0 17.06562 0 0 0 17.08063 0 18.20173 19.03812 17.3775 17.61886 0 0 0 0 19.07547 0 0 0 0 0 0 16.68122 0 0 Q86UR5 RIMS1_HUMAN "Regulating synaptic membrane exocytosis protein 1 (Rab-3-interacting molecule 1, RIM 1) (Rab-3-interacting protein 2)" RIMS1 KIAA0340 RAB3IP2 RIM1 Nbla00761 Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic plasticity [GO:0048167]; response to stimulus [GO:0050896]; secretion [GO:0046903]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601] cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; GTPase regulator activity [GO:0030695]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic plasticity [GO:0048167]; response to stimulus [GO:0050896]; secretion [GO:0046903]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601] GTPase regulator activity [GO:0030695]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] GO:0003723; GO:0005829; GO:0005886; GO:0006886; GO:0007601; GO:0010628; GO:0016079; GO:0017156; GO:0030154; GO:0030695; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0045055; GO:0046872; GO:0046903; GO:0046928; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0050896; GO:0060478; GO:0061025; GO:0065003; GO:0097151; GO:1903861; GO:2000463 HSDVALPRTEAGAALPEGK 1.779999971 1 1 0.288871651 1919.674832 13.97453 0 0 13.57043 14.05581 0 15.92609 9.859631 13.5145 15.72116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.66085 15.14683 14.77248 11.04628 0 0 15.7333 0 0 0 0 0 0 0 0 0 0 15.21368 0 0 15.75074 0 0 0 Q86US8 EST1A_HUMAN "Telomerase-binding protein EST1A, EC 3.1.-.- (Ever shorter telomeres 1A, hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a)" SMG6 C17orf31 EST1A KIAA0732 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomerase activity [GO:0051972]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomerase activity [GO:0051972]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0043021; GO:0046872; GO:0051972; GO:0070034; GO:0070182; GO:1904354 DEIVNDR 4.860000134 1 1 0.167040903 860.3076878 9.26422 15.59723 12.75432 14.49308 15.30949 14.21194 13.89523 0 12.2693 0 14.7722 14.4249 0 0 0 0 16.07526 0 0 15.81599 17.85512 15.52193 16.66343 0 15.89931 0 0 0 15.8585 0 17.66039 0 0 0 13.43761 0 0 17.05144 0 0 16.28257 0 0 0 15.77833 0 0 0 Q86UT5 NHRF4_HUMAN "Na(+)/H(+) exchange regulatory cofactor NHE-RF4, NHERF-4 (Intestinal and kidney-enriched PDZ protein) (Natrium-phosphate cotransporter IIa C-terminal-associated protein 2, Na/Pi cotransporter C-terminal-associated protein 2, NaPi-Cap2) (PDZ domain-containing protein 2) (PDZ domain-containing protein 3) (Sodium-hydrogen exchanger regulatory factor 4)" PDZD3 IKEPP NHERF4 PDZK2 DLNB27 Homo sapiens (Human) ion transport [GO:0006811]; negative regulation of cGMP-mediated signaling [GO:0010754]; protein localization to plasma membrane [GO:0072659]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to toxic substance [GO:0009636]; water transport [GO:0006833] apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829] apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829]; guanylate cyclase inhibitor activity [GO:0030251]; ion channel inhibitor activity [GO:0008200]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-specific protease binding [GO:1990381]; ion transport [GO:0006811]; negative regulation of cGMP-mediated signaling [GO:0010754]; protein localization to plasma membrane [GO:0072659]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to toxic substance [GO:0009636]; water transport [GO:0006833] guanylate cyclase inhibitor activity [GO:0030251]; ion channel inhibitor activity [GO:0008200]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-specific protease binding [GO:1990381] GO:0005829; GO:0005903; GO:0006811; GO:0006833; GO:0007168; GO:0008022; GO:0008200; GO:0009636; GO:0010754; GO:0016324; GO:0030251; GO:0043296; GO:0043495; GO:0045177; GO:0072659; GO:1990381 FFSMVR 3.440000057 0.395589113 0.395589113 0.147935084 801.8078068 0 13.51271 14.69581 15.00851 12.4415 12.71537 0 0 0 0 14.98444 0 13.44242 13.78569 0 0 15.49034 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98135 14.90425 0 0 14.41894 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UT6 NLRX1_HUMAN "NLR family member X1 (Caterpiller protein 11.3, CLR11.3) (Nucleotide-binding oligomerization domain protein 26) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9)" NLRX1 NOD26 NOD5 NOD9 Homo sapiens (Human) innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of RIG-I signaling pathway [GO:0039536] cell junction [GO:0030054]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell junction [GO:0030054]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of RIG-I signaling pathway [GO:0039536] ATP binding [GO:0005524] GO:0005524; GO:0005739; GO:0005741; GO:0005886; GO:0030054; GO:0032688; GO:0032715; GO:0035556; GO:0039536; GO:0043124; GO:0045087; GO:0045824; GO:0050728 GATLNPWR 3.549999952 1 1 0.086247128 914.3959531 11.05704 0 0 0 0 0 0 17.06462 6.929166 0 0 0 11.69364 0 0 14.78578 14.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9411 0 Q86UU0 BCL9L_HUMAN "B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein (Protein BCL9-2)" BCL9L DLNB11 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604] beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0008013; GO:0010718; GO:0022604; GO:0030512; GO:0045944; GO:0060070; GO:1990907 SMGMQRPLGMAGSGMGQSMEMER 13.64999962 1 1 2.75E-12 2507.789812 15.90895 11.27243 16.87725 15.11324 14.935 0 13.61587 15.84625 14.34325 0 14.83847 0 14.58044 10.66204 14.57716 14.40401 0 12.9091 10.63137 14.74156 0 14.78363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UV5 UBP48_HUMAN "Ubiquitin carboxyl-terminal hydrolase 48, EC 3.4.19.12 (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific peptidase 48) (Ubiquitin-specific protease 48) (Ubiquitin-specific-processing protease 48)" USP48 USP31 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006511; GO:0016579 LQQYFPK 3.450000048 1 1 0.332455679 924.2485383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.59799 0 0 0 0 0 0 0 0 0 0 Q86UW2 OSTB_HUMAN "Organic solute transporter subunit beta, OST-beta (Solute carrier family 51 subunit beta)" SLC51B OSTB Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of protein stability [GO:0031647] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of protein stability [GO:0031647] bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982] GO:0005886; GO:0015125; GO:0015721; GO:0016021; GO:0016323; GO:0031647; GO:0032782; GO:0032991; GO:0046982; GO:0060050; GO:0070863; GO:0090314 MQPPEKETPEVLHLDEAK 1.429999948 1 1 0.055553418 2107.926762 8.935024 0 12.2966 0 0 0 13.20398 0 0 13.66723 13.08594 16.73185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.23487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UW6 N4BP2_HUMAN "NEDD4-binding protein 2, N4BP2, EC 3.-.-.- (BCL-3-binding protein)" N4BP2 B3BP KIAA1413 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ubiquitin binding [GO:0043130] ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ubiquitin binding [GO:0043130] GO:0004519; GO:0005524; GO:0005829; GO:0043130; GO:0046404 KTANPK 7.139999866 3.47E-11 3.47E-11 0.307133097 656.6965417 19.63434 17.75402 0 18.6795 0 0 0 17.49667 20.43552 18.34665 0 16.77197 0 17.59852 0 18.86467 0 0 0 0 0 19.88413 0 20.54555 0 0 18.55215 20.27379 16.73241 19.31657 0 0 0 20.064 0 0 0 0 0 0 17.70209 18.79817 19.70593 0 0 0 0 0 Q86UW7 CAPS2_HUMAN "Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2, CAPS-2)" CADPS2 CAPS2 KIAA1591 Homo sapiens (Human) dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; presynapse [GO:0098793] cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] lipid binding [GO:0008289]; metal ion binding [GO:0046872] GO:0005654; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0030659; GO:0043231; GO:0045921; GO:0046872; GO:0098793; GO:0098978; GO:1990504 NIANSLPNVALPK 13.53999996 0.595837533 0.595837533 0.443865574 1349.634227 0 17.94865 19.09063 14.99098 0 0 18.48061 0 19.34063 19.74292 16.16097 0 0 17.14661 18.27255 17.90302 0 0 0 0 0 0 0 0 0 0 19.13242 0 17.39118 0 0 20.32188 0 0 0 19.16363 0 0 0 16.8954 0 0 0 18.00838 0 0 18.54663 18.673 Q86UX2 ITIH5_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H5, ITI heavy chain H5, ITI-HC5, Inter-alpha-inhibitor heavy chain 5" ITIH5 KIAA1953 PP14776 UNQ311/PRO354 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576; GO:0030212; GO:0062023 DALFTILHDLRPQDR 10.52999973 1 1 0.411810604 1810.75626 0 0 0 0 14.39747 0 0 15.42658 0 0 15.91344 0 0 0 14.12712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UX6 ST32C_HUMAN "Serine/threonine-protein kinase 32C, EC 2.7.11.1 (PKE) (Yet another novel kinase 3)" STK32C YANK3 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0018105; GO:0035556; GO:0046872; GO:0106310 MGSSMSAATAR 5.909999847 1 1 0.113754347 1100.963858 0 16.03261 0 0 0 0 0 14.13642 12.04455 14.1489 0 0 0 0 0 0 0 0 0 0 14.23917 0 0 0 0 17.10012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.73894 Q86UY8 NT5D3_HUMAN "5'-nucleotidase domain-containing protein 3, EC 3.1.3.- (GRP94-neighboring nucleotidase)" NT5DC3 GNN TU12B1-TY Homo sapiens (Human) receptor complex [GO:0043235] receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] GO:0008253; GO:0043235; GO:0046872 GIMYRAIEADIEK 9.300000191 1 1 0.321314886 1525.815 17.1493 15.14605 14.55542 0 10.91042 0 0 14.71472 14.16178 0 15.46952 0 0 14.99607 15.44328 16.29839 0 17.78105 0 0 0 0 15.55217 0 13.66889 0 15.3847 15.14363 10.98888 8.723024 0 0 17.31971 0 17.02967 0 0 0 0 15.20767 0 0 13.19636 0 0 15.47782 0 0 Q86V15 CASZ1_HUMAN Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) CASZ1 CST SRG ZNF693 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0043231; GO:0045664; GO:0045893; GO:0045944; GO:0046872 DLGTAEGTR 9.479999542 0.251146674 0.251146674 0.251400948 920.0275103 16.89636 0 16.85331 0 0 0 14.68904 0 12.71925 0 0 17.06981 0 0 0 0 12.5708 14.6361 16.43782 0 16.30545 17.44055 0 0 15.04015 0 17.25 13.95023 17.1719 0 16.36296 18.02738 15.32486 17.15072 16.10477 15.20667 0 16.88109 0 16.46155 0 17.20634 0 16.20174 13.85196 0 11.54941 0 Q86V21 AACS_HUMAN "Acetoacetyl-CoA synthetase, EC 6.2.1.16 (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog)" AACS ACSF1 Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024] cytosol [GO:0005829] cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024] acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524] GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024; GO:0046951 MGLSAR 2.119999886 1 1 0.274267036 651.4543413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.76673 17.2012 0 0 0 0 0 0 0 0 Q86V25 VASH2_HUMAN "Tubulinyl-Tyr carboxypeptidase 2, EC 3.4.17.17 (Vasohibin-2) (Vasohibin-like protein)" VASH2 VASHL Homo sapiens (Human) axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; microtubule binding [GO:0008017]; axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768] actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; microtubule binding [GO:0008017] GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0005856; GO:0006508; GO:0008017; GO:0045765; GO:0045766; GO:0060716; GO:0061564; GO:0140253 YGSLGMSR 7.46999979 0.991523385 0.991523385 0.277042038 870.8576554 16.08146 18.17101 0 19.75238 16.47158 15.71589 0 0 0 0 18.3515 17.16631 0 16.37949 17.36562 18.01862 0 18.54336 17.00052 0 18.11595 0 0 20.10446 0 17.66287 18.60007 0 16.68611 0 0 0 17.00643 0 0 0 19.03795 19.16961 0 0 0 18.82718 0 0 0 0 0 0 Q86V48 LUZP1_HUMAN Leucine zipper protein 1 LUZP1 Homo sapiens (Human) artery development [GO:0060840]; neural fold bending [GO:0021503]; ventricular septum development [GO:0003281] extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; artery development [GO:0060840]; neural fold bending [GO:0021503]; ventricular septum development [GO:0003281] GO:0003281; GO:0005634; GO:0016020; GO:0021503; GO:0060840; GO:0070062 MAELEKLEEAFSR 12.28999996 1 1 0.001025621 1565.620502 0 0 21.45498 19.52531 0 0 20.62684 0 21.38259 20.07569 21.61653 21.1353 0 20.11634 18.65487 0 0 0 0 19.41315 0 0 0 19.28862 19.61084 20.44916 0 0 0 0 0 0 0 21.46863 0 0 0 0 19.23594 0 0 0 0 0 0 0 18.19424 0 Q86V59 PNM8A_HUMAN Paraneoplastic antigen-like protein 8A (PNMA-like protein 1) PNMA8A PNMAL1 Homo sapiens (Human) GPGSRR 7.460000038 0.022944313 0.022944313 0.015614826 627.4071598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4853 0 0 0 15.44345 0 0 0 17.90238 17.91752 18.25251 17.20314 0 0 15.50101 0 15.9105 15.85454 16.3574 0 0 0 0 0 0 Q86V71 ZN429_HUMAN Zinc finger protein 429 ZNF429 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AFSRYSTLTTHK 3.630000114 1 1 0 1410.550766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V81 THOC4_HUMAN "THO complex subunit 4, Tho4 (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF)" ALYREF ALY BEF THOC4 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]" C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000018; GO:0000346; GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0031297; GO:0032786; GO:0046784; GO:0062153; GO:0070062; GO:0071013 GAGRNSK 4.659999847 1 1 0.124864317 687.1634103 11.15018 10.84075 0 0 0 0 15.52631 0 0 0 16.14469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.51706 0 17.60016 16.26276 15.30494 14.93492 0 0 0 15.11514 0 0 Q86V85 GP180_HUMAN Integral membrane protein GPR180 (Intimal thickness-related receptor) GPR180 ITR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236] GO:0007186; GO:0016021; GO:0019236 ICLALSLGCGLYQIITVERSTLK 5.099999905 1 1 0.434546337 2610.334983 0 22.34264 20.48881 0 0 0 0 0 18.37894 0 0 0 0 0 0 0 0 0 0 0 0 20.95002 0 0 0 0 0 0 20.34644 0 0 0 0 0 16.92929 22.07083 17.12452 0 0 0 0 0 0 0 0 0 0 0 Q86V97 KBTB6_HUMAN Kelch repeat and BTB domain-containing protein 6 KBTBD6 Homo sapiens (Human) negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020]; response to unfolded protein [GO:0006986] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020]; response to unfolded protein [GO:0006986] GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0009968; GO:0031463; GO:0035020; GO:0043161; GO:0070936 LLLITSR 32.77000046 0.01453375 0.01453375 0.123980205 814.5465898 19.5871 19.09072 19.77551 20.42334 19.64107 19.8422 20.94309 19.5554 20.20392 19.50278 18.19854 19.2459 19.43987 18.07378 20.32199 20.09239 18.46221 20.28653 19.53281 18.58245 19.45719 19.3869 19.71839 19.67782 17.55202 20.50107 20.5781 18.81751 20.57493 19.58163 20.37407 19.6212 19.62672 19.71169 18.58654 18.67335 20.06515 19.22756 18.87544 19.39186 16.64973 19.06248 18.82372 19.87605 20.47217 20.15578 17.99725 18.84708 Q86VB7 C163A_HUMAN "Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163, sCD163 ]" CD163 M130 Homo sapiens (Human) acute-phase response [GO:0006953] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0006953; GO:0009897; GO:0030666; GO:0097110 RWGHSECGHK 1.659999967 1 1 0.092023243 1254.516643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.46414 0 0 Q86VD1 MORC1_HUMAN "MORC family CW-type zinc finger protein 1 (Cancer/testis antigen 33, CT33)" MORC1 MORC Homo sapiens (Human) "behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; DNA hypermethylation [GO:0044026]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of transposition [GO:0010529]; regulation of gene expression, epigenetic [GO:0040029]; spermatogenesis [GO:0007283]" male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] "male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; DNA hypermethylation [GO:0044026]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of transposition [GO:0010529]; regulation of gene expression, epigenetic [GO:0040029]; spermatogenesis [GO:0007283]" zinc ion binding [GO:0008270] GO:0001662; GO:0001673; GO:0005634; GO:0007283; GO:0008270; GO:0010529; GO:0030154; GO:0031047; GO:0040029; GO:0043046; GO:0044026; GO:2000143 TSLSSAK 4.300000191 1 1 0.331177385 691.0890337 0 0 16.36336 0 0 0 0 16.81474 0 16.53332 0 17.38679 0 0 0 0 0 0 17.27677 0 0 0 0 0 16.59123 0 17.60304 17.70173 0 17.29432 0 0 0 0 0 0 17.74226 17.39161 0 0 0 0 0 17.85443 0 0 0 0 Q86VD7 S2542_HUMAN Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42) SLC25A42 Homo sapiens (Human) ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349] adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228] GO:0005347; GO:0005634; GO:0005739; GO:0005743; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122 TAVAPLDR 19.55999947 1 1 0.609890458 843.6118624 0 0 0 0 0 0 0 0 15.79557 0 18.1211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.42684 0 0 0 15.94874 0 0 0 18.61447 0 0 0 17.63718 0 0 0 0 0 0 0 0 0 Q86VD9 PIGZ_HUMAN "GPI mannosyltransferase 4, EC 2.4.1.- (GPI mannosyltransferase IV, GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein, PIG-Z) (SMP3 homolog, hSMP3)" PIGZ SMP3 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]" "alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]" GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021; GO:0016254 EPAPGPR 6.960000038 0.679856002 0.679856002 0.171183063 723.4545482 14.83883 14.12558 15.68107 15.76105 15.02565 15.22548 0 0 15.99448 0 0 15.18805 15.53608 16.62541 14.73483 0 14.83508 15.2155 15.94245 14.3565 16.14594 15.92255 0 16.45219 17.11477 0 15.55042 15.85663 15.88073 14.88732 16.55504 15.12685 16.13308 15.05731 0 16.84579 14.76342 17.04625 17.67757 16.37517 14.31302 16.62974 0 15.68968 16.73722 0 16.43571 17.05527 Q86VE3 SATL1_HUMAN "Spermidine/spermine N(1)-acetyltransferase-like protein 1, EC 2.3.1.-" SATL1 Homo sapiens (Human) N-acetyltransferase activity [GO:0008080] N-acetyltransferase activity [GO:0008080] GO:0008080 QTSMDYFQIRHAEAGDCPEILR 3.349999905 1 1 0.235792872 2653.910133 12.3071 12.51434 15.41113 0 15.03284 0 14.31471 15.35318 14.71568 15.22651 12.85376 0 0 0 15.02462 0 9.000342 0 0 0 0 0 15.18565 0 0 15.4259 17.50836 0 0 0 0 0 0 0 0 0 0 0 0 14.28674 15.07546 0 0 0 0 0 14.3642 0 Q86VE9 SERC5_HUMAN Serine incorporator 5 SERINC5 C5orf12 Homo sapiens (Human) defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; L-serine transmembrane transporter activity [GO:0015194]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665] L-serine transmembrane transporter activity [GO:0015194] GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0008654; GO:0009597; GO:0015194; GO:0016020; GO:0016021; GO:0042552; GO:0043209; GO:0043231; GO:0045087; GO:0048471; GO:0051607; GO:0070062; GO:1904219; GO:1904222 AGDTCEK 5.070000172 0.606594801 0.606594801 0.051786512 779.5964342 0 0 14.36211 0 0 0 15.81308 0 15.22113 17.56745 9.91701 0 17.56092 14.16355 15.61433 0 14.88755 15.3083 12.46669 12.95488 15.72864 14.38775 11.67954 17.55465 16.62864 8.935303 0 0 14.01824 0 0 17.88492 15.37751 17.66058 14.17442 0 16.60802 0 15.59949 0 15.22652 12.84327 17.22969 0 15.04594 16.34067 10.71596 16.64852 Q86VF7 NRAP_HUMAN "Nebulin-related-anchoring protein, N-RAP" NRAP Homo sapiens (Human) cardiac muscle thin filament assembly [GO:0071691] fascia adherens [GO:0005916]; muscle tendon junction [GO:0005927]; Z disc [GO:0030018] fascia adherens [GO:0005916]; muscle tendon junction [GO:0005927]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; vinculin binding [GO:0017166]; cardiac muscle thin filament assembly [GO:0071691] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; vinculin binding [GO:0017166] GO:0003779; GO:0005916; GO:0005927; GO:0017166; GO:0030018; GO:0046872; GO:0051015; GO:0051371; GO:0071691 FHLPMDMVNIRHAK 4.360000134 1 1 0.419304219 1725.203489 0 14.66403 13.3037 0 13.60516 14.16461 0 13.1228 15.62317 0 13.90629 0 0 14.58639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.99325 0 14.9203 16.5717 0 0 0 0 0 0 14.4421 0 0 0 15.37367 Q86VH2 KIF27_HUMAN Kinesin-like protein KIF27 KIF27 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271 ELRQISALELSLR 15.52999973 0.388335645 0.388335645 0.200095178 1527.556112 15.82739 15.35796 0 0 0 15.39208 0 0 0 0 0 15.13229 16.33448 14.01282 0 0 0 15.34982 16.66802 0 0 16.44819 13.81516 0 0 0 0 0 0 15.59922 0 16.24985 16.09333 16.4316 0 0 0 0 0 15.31928 16.52942 0 0 16.79361 0 0 0 0 Q86VH4 LRRT4_HUMAN Leucine-rich repeat transmembrane neuronal protein 4 LRRTM4 UNQ3075/PRO9907 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211] GO:0005615; GO:0016021; GO:0031012; GO:0045211 VFQDCR 7.590000153 1 1 0.19081818 821.4034286 14.54391 0 0 13.76702 15.94857 15.70992 0 0 0 0 0 0 0 13.97198 15.65708 0 0 0 0 0 0 0 0 0 14.81771 0 0 14.8404 0 15.39431 16.04586 0 0 0 0 0 0 0 0 0 0 15.66956 0 0 0 0 0 0 Q86VI3 IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 IQGAP3 Homo sapiens (Human) cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; small GTPase binding [GO:0031267]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087] actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; small GTPase binding [GO:0031267] GO:0000082; GO:0001934; GO:0005096; GO:0005516; GO:0005737; GO:0005829; GO:0005911; GO:0007265; GO:0008361; GO:0010628; GO:0010629; GO:0016328; GO:0031267; GO:0032956; GO:0033601; GO:0043087; GO:0043410; GO:0051015; GO:0070371; GO:0070856; GO:0071310 FQLHYQDLLQLQYEGVAVMKLFNK 5.880000114 0.245503888 0.245503888 0.146122984 2943.731681 0 0 14.85362 11.59485 0 0 12.74575 0 13.15013 0 17.84801 17.86219 17.99588 16.35288 0 0 12.20528 17.27757 0 0 0 15.99193 15.04563 0 0 6.204323 18.28988 0 0 0 0 14.36273 15.41584 0 0 0 0 0 0 0 16.28029 0 0 12.96317 0 11.74323 14.29918 0 Q86VI4 LAP4B_HUMAN Lysosomal-associated transmembrane protein 4B (Lysosome-associated transmembrane protein 4-beta) LAPTM4B PSEC0001 Homo sapiens (Human) endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of transforming growth factor beta1 production [GO:0032911]; regulation of lysosomal membrane permeability [GO:0097213]; regulation of lysosome organization [GO:1905671] "cell projection [GO:0042995]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]" "cell projection [GO:0042995]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; ceramide binding [GO:0097001]; kinase binding [GO:0019900]; phosphatidylinositol bisphosphate binding [GO:1902936]; ubiquitin protein ligase binding [GO:0031625]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of transforming growth factor beta1 production [GO:0032911]; regulation of lysosomal membrane permeability [GO:0097213]; regulation of lysosome organization [GO:1905671]" ceramide binding [GO:0097001]; kinase binding [GO:0019900]; phosphatidylinositol bisphosphate binding [GO:1902936]; ubiquitin protein ligase binding [GO:0031625] GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007032; GO:0016021; GO:0019900; GO:0031625; GO:0031902; GO:0032509; GO:0032585; GO:0032911; GO:0042995; GO:0097001; GO:0097213; GO:0097487; GO:1902936; GO:1905166; GO:1905671 GTDPAEAR 16.55999947 1 1 2.31E-13 815.0376027 0 0 0 0 0 0 0 0 0 0 0 16.97991 0 0 0 0 0 16.90946 0 0 0 0 0 0 16.35912 17.22972 17.37786 17.62465 0 0 0 0 0 18.91991 0 0 0 18.02761 0 0 18.79531 0 0 0 0 0 0 0 Q86VM9 ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) ZC3H18 NHN1 Homo sapiens (Human) RNA destabilization [GO:0050779] nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; RNA destabilization [GO:0050779] metal ion binding [GO:0046872]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] GO:0003723; GO:0016607; GO:0030674; GO:0032991; GO:0046872; GO:0050779; GO:0140262; GO:1990904 IPRDVR 4.230000019 1 1 0.152982368 756.720383 0 0 0 14.77214 15.08993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.448 0 0 0 17.56192 0 0 16.41386 0 0 0 0 15.79053 0 0 0 0 0 0 0 0 Q86VP3 PACS2_HUMAN "Phosphofurin acidic cluster sorting protein 2, PACS-2 (PACS1-like protein)" PACS2 KIAA0602 PACS1L Homo sapiens (Human) apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; transmembrane transporter binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659] transmembrane transporter binding [GO:0044325] GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456 VVALLR 2.130000114 0.000593443 0.000593443 0.006911559 672.476935 0 0 16.41425 0 12.6314 16.05783 0 0 0 0 15.65513 15.28072 16.52117 16.21941 14.09558 0 0 12.7756 15.00463 14.26544 0 0 18.8604 0 16.50477 17.54912 0 0 0 0 0 0 17.5866 15.35827 15.77784 0 0 0 0 17.66972 0 16.36518 13.15882 15.89428 14.2907 14.72573 15.20415 14.49363 Q86VQ0 LCA5_HUMAN Lebercilin (Leber congenital amaurosis 5 protein) LCA5 C6orf152 Homo sapiens (Human) intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031] protein-containing complex binding [GO:0044877] GO:0005929; GO:0005930; GO:0015031; GO:0032391; GO:0036064; GO:0042073; GO:0044877; GO:0045494 KDTDLVTK 17.03000069 0.327021867 0.327021867 0.166337029 919.5509055 18.25322 17.3033 0 18.29043 19.88006 18.78308 0 19.10381 19.10521 0 19.59212 17.58303 18.4805 17.85716 19.55084 18.70917 17.68803 0 0 19.49722 17.98518 18.1955 20.41511 0 19.83436 18.71554 19.79643 20.13412 17.55346 17.96275 19.5932 19.19271 19.993 20.00914 21.07989 19.45567 0 20.62624 19.77221 19.42515 19.43639 19.5465 16.409 18.63895 18.39033 17.76412 18.83091 19.26723 Q86VQ1 GLCI1_HUMAN Glucocorticoid-induced transcript 1 protein GLCCI1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 MSTASSSSSSSSSQTPHPPSQRMR 2.230000019 1 1 0.146053943 2523.616653 12.0858 0 14.68058 13.27588 13.47561 11.5396 0 0 0 11.77775 0 10.42463 12.69294 0 0 7.93563 0 13.09165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VQ6 TRXR3_HUMAN "Thioredoxin reductase 3, EC 1.8.1.9 (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2)" TXNRD3 TGR TRXR3 Homo sapiens (Human) cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; glutathione oxidoreductase activity [GO:0097573]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283] flavin adenine dinucleotide binding [GO:0050660]; glutathione oxidoreductase activity [GO:0097573]; thioredoxin-disulfide reductase activity [GO:0004791] GO:0004791; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0007283; GO:0030154; GO:0045454; GO:0050660; GO:0097573 SPPQSPGPGKAGDAPNR 5.010000229 0.787204802 0.787204802 0.289249005 1632.528865 16.08733 0 0 17.79159 0 0 0 14.67614 15.37028 0 0 0 11.99404 0 0 0 0 14.97341 0 0 0 0 0 0 0 0 0 16.43039 16.52523 14.60007 0 0 0 0 15.67445 0 0 0 0 0 14.38198 14.9716 0 0 15.32667 0 0 0 Q86VR8 FJX1_HUMAN Four-jointed box protein 1 (Four-jointed protein homolog) FJX1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842] extracellular space [GO:0005615] extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842] GO:0005615; GO:0007267; GO:0010842 MRGAAATAGLWLLALGSLLALWGGLLPPR 6.670000076 1 1 6.41E-12 2962.238527 13.68358 14.21648 0 0 0 12.03866 9.585228 14.60763 15.42273 11.96074 16.23654 15.59308 10.95505 13.04036 11.99467 0 13.18889 11.05955 11.03284 0 0 14.01978 0 13.10115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VS8 HOOK3_HUMAN "Protein Hook homolog 3, h-hook3, hHK3" HOOK3 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005829; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719 AKSVIR 8.409999847 0.544336319 0.544336319 0.250280087 670.9233709 0 14.67868 16.55521 15.71797 16.55957 14.05464 14.72215 14.94277 16.14607 14.77983 15.98203 14.60503 15.6957 0 16.71814 16.32966 15.8618 16.53823 16.58601 16.67083 0 17.12609 15.48288 17.22534 15.8828 15.41826 15.31897 16.34494 16.16133 0 0 15.9149 16.03674 15.83253 16.20361 0 0 0 0 0 0 0 16.59478 17.10846 16.86281 0 15.32895 0 Q86VV4 RNB3L_HUMAN Ran-binding protein 3-like RANBP3L Homo sapiens (Human) mesenchymal cell differentiation involved in bone development [GO:1901706]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of myoblast differentiation [GO:0045663]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; SMAD binding [GO:0046332]; mesenchymal cell differentiation involved in bone development [GO:1901706]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of myoblast differentiation [GO:0045663]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] SMAD binding [GO:0046332] GO:0005643; GO:0005737; GO:0006611; GO:0045663; GO:0045668; GO:0046332; GO:0050790; GO:1901706 EKTNNK 8.270000458 0.385006338 0.385006338 0.172916368 734.1613153 12.20506 17.8403 0 17.31651 15.42122 15.44119 0 0 15.51228 0 0 13.80443 15.08709 15.62199 17.69517 17.28715 12.20153 12.6417 15.74157 0 10.33875 0 15.77882 16.11716 17.90903 0 16.54892 0 11.59745 0 16.97931 12.82613 16.71356 16.89985 16.33278 0 0 16.96819 0 14.70783 13.97493 13.59327 14.60116 0 0 17.611 15.9654 14.32204 Q86VV8 RTTN_HUMAN Rotatin RTTN Homo sapiens (Human) centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368] GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064 LAFGDGK 3.559999943 1 1 0.25679355 704.9974109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.11909 0 0 0 19.00687 0 0 0 19.90709 0 0 0 19.45426 0 0 0 0 0 0 0 0 0 Q86VX9 MON1A_HUMAN Vacuolar fusion protein MON1 homolog A MON1A SAND1 Homo sapiens (Human) protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Mon1-Ccz1 complex [GO:0035658] cytosol [GO:0005829]; Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0006623; GO:0009306; GO:0016192; GO:0035658 AHNASRPLK 7.980000019 1 1 0.350495132 993.3844191 0 14.99778 0 14.7594 0 16.67528 16.54795 0 17.08771 16.18385 0 15.85353 0 14.59457 0 14.80231 17.10972 14.75111 15.29542 17.92069 0 0 0 15.26299 17.22273 0 0 0 15.24057 14.56929 0 15.22318 14.43374 13.38997 13.67449 11.99934 15.82516 0 0 13.14889 15.21556 16.13156 14.52343 14.12294 13.41279 14.3366 14.77398 0 Q86VY4 TSYL5_HUMAN "Testis-specific Y-encoded-like protein 5, TSPY-like protein 5" TSPYL5 KIAA1750 Homo sapiens (Human) cellular response to gamma radiation [GO:0071480]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; cellular response to gamma radiation [GO:0071480]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008] chromatin binding [GO:0003682]; histone binding [GO:0042393] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0008284; GO:0031398; GO:0040008; GO:0042393; GO:0051897; GO:0071480 KGAAGENTSVSAGEEK 13.31999969 1 1 2.74E-12 1535.732116 0 0 15.1405 10.69378 13.30966 12.14441 0 14.19229 13.97609 0 0 14.03899 15.85934 0 0 14.23955 12.26849 0 0 0 0 17.06311 0 15.40924 0 10.50611 0 14.04668 15.95679 0 15.61411 15.67472 0 0 14.60659 12.68736 0 12.58222 0 0 13.99624 14.54457 0 0 0 0 0 0 Q86VY9 T200A_HUMAN Transmembrane protein 200A TMEM200A KIAA1913 HBE61 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 NNSKGYMK 2.880000114 1 1 0 957.6126157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VZ2 WDR5B_HUMAN WD repeat-containing protein 5B WDR5B Homo sapiens (Human) histone H3-K4 methylation [GO:0051568] Set1C/COMPASS complex [GO:0048188] Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568] histone binding [GO:0042393] GO:0042393; GO:0048188; GO:0051568 FSPNGK 4.25 1 1 0.266660745 648.3290425 0 14.87019 0 17.87021 0 0 0 16.52973 0 0 17.96921 0 0 0 0 0 17.58723 0 0 17.11063 0 0 0 0 0 0 18.27953 0 0 0 0 0 0 0 0 0 0 18.78995 18.44877 16.47719 18.57342 0 16.24371 0 0 0 0 0 Q86VZ4 LRP11_HUMAN "Low-density lipoprotein receptor-related protein 11, LRP-11" LRP11 Homo sapiens (Human) multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414] phosphoprotein binding [GO:0051219] GO:0005886; GO:0009408; GO:0009409; GO:0009414; GO:0009612; GO:0016021; GO:0033555; GO:0035902; GO:0042594; GO:0051219 APAAVRGWR 7.820000172 0.810056806 0.810056806 0.160675015 983.5341828 0 0 13.1346 14.01441 0 15.59578 15.1192 12.71551 15.00939 15.11646 0 0 15.13514 0 0 14.71102 15.79289 0 0 0 0 0 14.82945 16.13437 0 15.11875 0 0 12.90454 13.27692 0 16.78089 0 0 0 0 14.19462 15.95987 0 15.52057 0 0 0 0 0 0 0 0 Q86VZ5 SMS1_HUMAN "Phosphatidylcholine:ceramide cholinephosphotransferase 1, EC 2.7.8.27 (Medulla oblongata-derived protein, Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23)" SGMS1 MOB SMS1 TMEM23 Homo sapiens (Human) apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188] GO:0000138; GO:0000139; GO:0002950; GO:0005634; GO:0005783; GO:0005886; GO:0005887; GO:0006686; GO:0006915; GO:0016020; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:2001242 CITMYVTTLPVPGMHFNCSPK 5.269999981 1 1 4.58E-13 2484.134525 14.2661 0 0 12.39946 0 12.5267 15.50773 14.39757 0 14.2031 0 0 9.766802 0 0 0 13.21503 0 0 0 13.46667 0 0 0 0 0 16.71106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.76765 0 0 0 0 0 Q86W10 CP4Z1_HUMAN "Cytochrome P450 4Z1, EC 1.14.14.1 (CYPIVZ1) (Laurate 7-monooxygenase, EC 1.14.14.130)" CYP4Z1 UNQ3060/PRO9882 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252]" "arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]" GO:0005506; GO:0005789; GO:0008404; GO:0016021; GO:0019369; GO:0020037; GO:0048252; GO:0052722; GO:0070330 NCIGQHFAIIECK 8.340000153 1 1 0.409257134 1590.190723 0 0 0 12.47706 0 13.77529 16.05942 0 0 15.97639 0 0 0 0 0 0 16.80049 16.09676 0 17.6949 0 16.30611 0 17.5435 0 15.87667 0 0 0 0 16.19594 0 0 0 15.51343 0 16.99636 0 0 0 0 16.39981 0 0 0 16.53466 16.78775 16.34655 Q86W24 NAL14_HUMAN "NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)" NLRP14 NALP14 NOD5 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] ATP binding [GO:0005524] GO:0005524; GO:0005737; GO:0007283; GO:0030154 SLLQSTSYK 2.630000114 1 1 0.21246744 1025.317723 0 0 12.21839 0 15.43628 17.11341 0 0 0 0 0 0 0 0 0 0 0 15.44181 0 0 0 0 16.04573 0 0 0 0 16.49065 14.60737 0 0 0 0 0 0 0 17.65252 0 0 0 0 15.88151 0 0 17.53074 16.82341 0 0 Q86W28 NALP8_HUMAN "NACHT, LRR and PYD domains-containing protein 8 (Nucleotide-binding oligomerization domain protein 16) (PYRIN and NACHT-containing protein 4)" NLRP8 NALP8 NOD16 PAN4 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524] ATP binding [GO:0005524] GO:0005524; GO:0005737 SLDLSFNSLK 4.380000114 1 1 0.131445605 1121.650973 14.2965 12.85566 13.07039 0 16.11427 0 10.93372 0 12.28156 14.44689 13.42707 14.89231 13.3034 0 13.21381 0 0 0 0 0 0 0 0 0 0 14.88048 0 0 0 0 0 14.56448 0 0 0 0 0 0 0 0 0 0 14.3741 0 0 0 0 0 Q86W33 TPRA1_HUMAN Transmembrane protein adipocyte-associated 1 (Integral membrane protein GPR175) (Transmembrane protein 227) TPRA1 GPR175 TMEM227 PP6566 Homo sapiens (Human) aging [GO:0007568]; embryonic cleavage [GO:0040016]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of mitotic cell cycle phase transition [GO:1901991] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; aging [GO:0007568]; embryonic cleavage [GO:0040016]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of mitotic cell cycle phase transition [GO:1901991] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0006629; GO:0007186; GO:0007568; GO:0016021; GO:0040016; GO:1901991 CQVDETEEPDVHLPQPYAVAR 1.279999971 1 1 3.67E-12 2452.587589 0 12.71216 14.4808 0 11.779 9.657674 14.26877 13.27113 0 12.15808 14.03015 9.570735 11.59693 11.86935 10.89595 0 0 9.313341 0 9.475618 13.69693 13.67036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W34 AMZ2_HUMAN "Archaemetzincin-2, EC 3.4.-.- (Archeobacterial metalloproteinase-like protein 2)" AMZ2 BM-014 Homo sapiens (Human) metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] GO:0008237; GO:0046872 CLAVLQK 11.68000031 0.006296034 0.006296034 0.291851519 828.9121329 19.12793 0 17.54093 0 18.51088 0 18.78335 18.67567 19.61042 0 19.66876 0 16.52307 0 17.0864 0 17.4993 0 17.91724 16.11033 0 0 0 19.87721 18.70455 19.5963 0 16.49123 18.00703 18.30494 18.96959 0 0 0 0 18.53656 19.68434 19.40848 19.75668 0 0 16.60184 17.44353 20.63305 17.52413 16.77504 0 19.41809 Q86W50 MET16_HUMAN "RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16, EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase, EC 2.1.1.346)" METTL16 METT10D Homo sapiens (Human) "mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]" 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629] GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049; GO:1905869 DLMNQLCTYIR 10.11999989 0.428631902 0.428631902 0.821760204 1427.510829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.24283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.24341 0 0 0 0 0 0 0 0 0 0 0 0 Q86W54 SPA24_HUMAN Spermatogenesis-associated protein 24 (Testis protein T6441 homolog) SPATA24 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154 NVMVLQDENFVSKEEFQAVEK 1.789999962 1 1 0.28186944 2498.692869 17.32944 18.9386 15.36809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.53622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.65498 0 Q86W56 PARG_HUMAN "Poly(ADP-ribose) glycohydrolase, EC 3.2.1.143" PARG Homo sapiens (Human) "ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair, gap-filling [GO:0006287]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair, gap-filling [GO:0006287]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]" poly(ADP-ribose) glycohydrolase activity [GO:0004649] GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005975; GO:0006282; GO:0006287; GO:0009225; GO:0031056; GO:0043231; GO:1990966 DVVYFTFGDSELMR 1.50999999 1 1 0.108084239 1694.518834 13.89226 9.074371 13.84828 12.72754 15.40058 14.95843 14.80477 15.35415 15.23352 0 17.63412 16.93015 14.40366 0 15.70687 0 16.79115 15.25331 0 10.13904 12.53248 12.72018 15.84744 0 0 15.15101 11.19805 17.26769 9.593304 14.87759 14.58857 16.76303 17.20308 17.43314 16.95082 13.39436 16.43046 0 15.10864 0 14.005 13.03535 16.06273 0 14.12744 14.43964 0 14.82859 Q86W92 LIPB1_HUMAN "Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1, PTPRF-interacting protein-binding protein 1) (hSGT2)" PPFIBP1 KIAA1230 Homo sapiens (Human) cell adhesion [GO:0007155]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] cadherin binding [GO:0045296] GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007528; GO:0045296; GO:0048786; GO:0050808 ALEYSNGIFDCQSPTSPFMGSLR 3.940000057 1 1 0.323404793 2578.038766 0 0 15.20408 0 0 14.44632 0 0 0 0 0 0 16.77151 16.69294 15.80442 0 11.87591 15.09625 0 17.43616 0 0 16.26132 15.61039 15.3687 0 0 0 0 14.10698 15.71373 14.79314 15.00764 13.4865 13.31487 0 0 0 0 0 0 17.92204 0 0 0 0 0 0 Q86WA8 LONP2_HUMAN "Lon protease homolog 2, peroxisomal, EC 3.4.21.53 (Lon protease-like protein 2, Lon protease 2) (Peroxisomal Lon protease, pLon)" LONP2 LONP Homo sapiens (Human) peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0016558; GO:0016887; GO:0019899; GO:0031998 TSSMPEQAHKVCVK 2.25 0.981836438 0.981836438 0.135397852 1602.186646 14.41878 0 14.80882 14.33901 15.74938 14.58078 15.4783 0 10.68551 0 12.89198 18.1348 15.92388 12.26541 14.51535 15.1104 13.71637 14.85821 0 0 8.013034 15.26269 14.17513 13.90189 17.03204 0 16.87015 12.26115 13.94424 0 0 17.58464 15.88498 11.48491 16.25418 0 15.98982 15.61175 15.86755 11.32638 15.79277 14.29186 16.06092 0 16.39565 15.71035 0 0 Q86WB0 ZC3C1_HUMAN "Zinc finger C3HC-type protein 1 (Nuclear-interacting partner of ALK, hNIPA) (Nuclear-interacting partner of anaplastic lymphoma kinase)" ZC3HC1 NIPA HSPC216 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567] protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016567; GO:0019901; GO:0031965; GO:0051301; GO:2001240 TRPVTRSMGTGDTPGLEVPSSPLR 12.56999969 1 1 2.29E-12 2527.529649 13.8426 13.8384 0 13.97902 14.4347 12.30972 13.46612 14.23864 15.85508 14.062 0 0 13.52185 13.88789 9.227702 0 14.78859 14.87451 13.44788 14.6296 0 0 13.76518 10.13795 0 0 0 0 0 0 16.38614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WG5 MTMRD_HUMAN Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2) SBF2 CMT4B2 KIAA1766 MTMR13 Homo sapiens (Human) autophagy [GO:0006914]; myelination [GO:0042552]; regulation of GTPase activity [GO:0043087] axon [GO:0030424]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774] axon [GO:0030424]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091]; autophagy [GO:0006914]; myelination [GO:0042552]; regulation of GTPase activity [GO:0043087] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091] GO:0005085; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0043087; GO:0048471 DWDDTPFPQGIELFCQPGGWQLSRER 5.909999847 1 1 0.156518178 3133.268397 15.07878 0 0 0 18.42634 17.78488 17.01044 20.10204 18.82707 15.62774 15.92425 0 12.82854 18.1291 16.67527 18.11105 0 17.42185 16.15425 0 17.1237 0 14.24492 0 17.15918 0 0 0 17.07409 0 0 0 18.30223 18.94387 0 17.37517 0 0 17.59625 16.48546 17.08586 0 0 0 18.52024 17.12041 0 0 Q86WI3 NLRC5_HUMAN "Protein NLRC5 (Caterpiller protein 16.1, CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4)" NLRC5 NOD27 NOD4 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549] ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0032088; GO:0035556; GO:0043549; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340 GISHLVK 8.699999809 1 1 0.026345976 750.4060766 0 15.80841 14.86182 0 0 0 0 0 0 0 0 0 0 0 0 0 16.87336 0 0 16.129 0 0 0 0 0 0 15.67011 15.61055 0 14.60286 0 0 0 0 0 0 0 16.82229 0 0 0 0 0 0 0 0 0 0 Q86WJ1 CHD1L_HUMAN "Chromodomain-helicase-DNA-binding protein 1-like, EC 3.6.4.12 (Amplified in liver cancer protein 1)" CHD1L ALC1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166] GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006338; GO:0006974; GO:0016887; GO:0140658 ACLQQDLK 9.579999924 0.565570533 0.565570533 0.233119547 976.6175084 16.85428 14.43666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.22617 0 0 18.00985 18.68813 17.70408 0 0 16.04866 0 18.59425 0 0 18.99823 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WQ0 NR2CA_HUMAN Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein) NR2C2AP TRA16 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 VLGEKV 9.270000458 0.709814072 0.709814072 0.058596301 644.8768695 14.09303 14.80621 14.97785 16.62912 13.01285 0 14.17602 16.16921 14.56877 14.72909 11.83792 16.24209 0 15.7619 17.17484 5.46996 13.79926 15.05873 0 14.72161 16.32003 0 16.79287 17.31371 17.26305 14.30058 14.81231 0 14.18257 15.56991 13.09766 15.42291 18.89362 0 17.58342 15.00759 17.04003 17.64437 16.41451 17.8322 19.67109 16.74098 16.17735 0 13.82029 18.02088 17.55077 0 Q86WR0 CCD25_HUMAN Coiled-coil domain-containing protein 25 CCDC25 Homo sapiens (Human) positive regulation of cell motility [GO:2000147] endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887] endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; DNA binding [GO:0003677]; positive regulation of cell motility [GO:2000147] DNA binding [GO:0003677] GO:0003677; GO:0005887; GO:0012505; GO:2000147 FPDLAAEK 5.380000114 0.675664902 0.675664902 0.236855661 890.0932685 13.47762 0 14.75087 0 11.20422 14.69878 15.95959 14.14566 0 0 0 15.01313 13.95046 0 12.98414 13.8688 14.19017 0 0 15.03 0 14.46138 14.66681 16.19588 0 0 0 16.6795 0 0 0 15.80308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WR7 PRSR2_HUMAN Proline and serine-rich protein 2 PROSER2 C10orf47 Homo sapiens (Human) SDASDMNSDTSPSCR 4.519999981 0.996935666 0.996935666 4.58E-13 1646.5218 14.54745 13.53718 14.125 13.58603 13.5234 15.99361 0 0 11.73432 0 15.21726 0 16.01908 0 0 0 15.07159 0 0 0 0 0 0 15.44855 0 0 0 0 0 0 15.46276 15.38262 14.41158 0 0 0 0 0 15.04329 0 17.13993 0 13.52112 0 0 0 0 0 Q86WS4 CL040_HUMAN Uncharacterized protein C12orf40 C12orf40 Homo sapiens (Human) MTIKTK 21.84000015 1.01E-05 1.01E-05 0.290560387 737.5025155 18.17354 0 0 0 16.14198 17.99203 0 0 0 0 0 0 0 17.50998 0 0 0 0 0 19.36367 0 0 16.05653 0 0 0 17.33464 0 16.32007 0 19.76948 0 0 0 0 0 0 0 19.65088 0 0 19.9516 17.42973 0 0 17.99245 17.83216 17.68995 Q86WU2 LDHD_HUMAN "Probable D-lactate dehydrogenase, mitochondrial, DLD, Lactate dehydrogenase D, EC 1.1.2.4" LDHD Homo sapiens (Human) lactate catabolic process [GO:1903457] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457] D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660] GO:0004458; GO:0005739; GO:0005743; GO:0008720; GO:0050660; GO:0071949; GO:1903457 AVLDPQGLMNPGKVL 13.10000038 1 1 0.469583436 1551.152956 16.77986 0 0 0 0 0 0 17.45392 0 0 0 0 0 0 0 0 0 0 0 0 0 17.72222 17.45581 0 0 0 0 0 17.64443 0 0 0 19.93955 0 0 0 0 0 18.55449 0 0 0 0 0 0 0 0 17.22718 Q86WV6 STING_HUMAN "Stimulator of interferon genes protein, hSTING (Endoplasmic reticulum interferon stimulator, ERIS) (Mediator of IRF3 activation, hMITA) (Transmembrane protein 173)" STING1 ERIS MITA STING TMEM173 Homo sapiens (Human) activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine/threonine protein kinase complex [GO:1902554]; STING complex [GO:1990231] "autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine/threonine protein kinase complex [GO:1902554]; STING complex [GO:1990231]; 2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709]" "2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]" GO:0000045; GO:0000421; GO:0002218; GO:0002230; GO:0005654; GO:0005741; GO:0005768; GO:0005776; GO:0005777; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0016239; GO:0019901; GO:0030176; GO:0030659; GO:0030667; GO:0031625; GO:0032092; GO:0032481; GO:0032728; GO:0035438; GO:0035458; GO:0042802; GO:0042803; GO:0045087; GO:0045944; GO:0048471; GO:0050727; GO:0051091; GO:0051259; GO:0051607; GO:0060340; GO:0061507; GO:0061629; GO:0061709; GO:0071360; GO:0071407; GO:1902554; GO:1990231; GO:1990701 GAVSQR 2.029999971 1 1 0.033900762 617.3313446 15.54978 15.92615 0 0 0 0 0 0 0 0 0 0 0 0 16.03077 15.96621 15.13149 0 0 0 0 0 0 0 0 15.769 0 0 0 0 0 0 0 0 14.04317 0 0 15.78342 0 16.24063 0 0 0 0 0 0 0 0 Q86WZ0 HEAT4_HUMAN HEAT repeat-containing protein 4 HEATR4 Homo sapiens (Human) oxidoreductase activity [GO:0016491] oxidoreductase activity [GO:0016491] GO:0016491 EAWLLPPEKEAR 9.180000305 0.492427081 0.492427081 0.231349612 1438.49072 0 0 0 0 0 0 0 0 0 0 0 15.69582 0 0 0 0 15.48354 0 0 0 0 0 0 0 17.97118 0 16.21079 0 0 18.19857 17.00717 18.15306 15.84849 16.10188 16.69499 16.55007 0 16.30714 16.28466 17.23582 0 15.89483 14.50389 16.13728 17.53189 0 16.43096 15.80778 Q86X10 RLGPB_HUMAN Ral GTPase-activating protein subunit beta (p170) RALGAPB KIAA1219 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] GO:0005096; GO:0046982; GO:0051056; GO:0090630 EMVANWR 6.239999771 0.726544142 0.726544142 0.180623487 922.5780375 0 12.22153 16.59706 14.73853 0 12.4511 0 14.89987 14.81293 0 14.93923 0 0 14.02464 0 0 13.47235 15.55743 16.48881 14.32886 0 0 14.69533 0 15.87989 15.94978 15.27529 13.92168 16.90605 0 17.03582 0 15.60378 14.8375 15.83318 11.6024 13.27188 15.86507 16.73828 15.91823 15.39858 14.70667 14.9999 14.56371 0 16.21023 14.4294 15.42627 Q86X24 HORM1_HUMAN "HORMA domain-containing protein 1 (Cancer/testis antigen 46, CT46) (Newborn ovary HORMA protein)" HORMAD1 NOHMA Homo sapiens (Human) blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629 MATAQLQRTPMSALVFPNK 4.849999905 0.424136847 0.424136847 1.39E-12 2135.063199 15.57786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.91443 0 0 0 0 0 0 0 14.8817 0 0 0 0 0 0 0 0 0 0 0 Q86X29 LSR_HUMAN Lipolysis-stimulated lipoprotein receptor (Angulin-1) LSR ILDR3 LISCH Homo sapiens (Human) epithelial structure maintenance [GO:0010669]; establishment of blood-brain barrier [GO:0060856]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; maintenance of blood-brain barrier [GO:0035633]; protein localization to tricellular tight junction [GO:0061833]; tricellular tight junction assembly [GO:1904274] chylomicron [GO:0042627]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; very-low-density lipoprotein particle [GO:0034361] chylomicron [GO:0042627]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; very-low-density lipoprotein particle [GO:0034361]; epithelial structure maintenance [GO:0010669]; establishment of blood-brain barrier [GO:0060856]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; maintenance of blood-brain barrier [GO:0035633]; protein localization to tricellular tight junction [GO:0061833]; tricellular tight junction assembly [GO:1904274] GO:0001889; GO:0005886; GO:0010669; GO:0016020; GO:0016021; GO:0034361; GO:0034362; GO:0035633; GO:0042627; GO:0060856; GO:0061436; GO:0061689; GO:0061833; GO:0070062; GO:0070160; GO:1904274 DNGSRSGDLPYDGR 6.889999866 1 1 0.445323258 1509.577844 14.04189 0 0 0 0 0 0 15.37801 0 0 0 0 0 16.08886 0 13.65456 0 0 0 0 0 0 16.96018 0 0 0 0 0 0 14.34846 14.97694 14.35719 16.66214 0 15.26152 14.58946 0 15.77112 16.89087 0 17.59152 0 14.57923 0 16.0899 0 0 0 Q86X51 EZHIP_HUMAN EZH inhibitory protein EZHIP CXorf67 Homo sapiens (Human) negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K27 trimethylation [GO:1902465] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K27 trimethylation [GO:1902465] GO:0005634; GO:0005654; GO:0005829; GO:0061086; GO:1902465 RGCDSAPGPAR 3.819999933 1 1 0.222155672 1144.300518 16.44087 0 15.68425 13.98235 14.16137 0 13.96315 16.84959 0 0 0 0 0 14.01196 13.40852 15.28612 0 12.39418 0 0 0 0 15.47858 0 13.85055 16.00147 0 0 11.89527 15.70294 16.16492 18.32006 0 0 0 0 0 15.67786 0 14.81121 0 0 0 0 13.74112 0 15.40522 14.82534 Q86X52 CHSS1_HUMAN "Chondroitin sulfate synthase 1, EC 2.4.1.175, EC 2.4.1.226 (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1, ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1)" CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923] acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] GO:0000139; GO:0002063; GO:0005576; GO:0008376; GO:0009954; GO:0016020; GO:0016021; GO:0030206; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0051923; GO:0060349 DLHNSK 9.079999924 1 1 0.18225222 712.6653493 15.26246 0 15.75812 14.42072 0 12.96398 0 0 0 0 0 13.16728 0 0 0 0 19.42927 16.5585 0 0 16.36523 0 0 0 0 0 0 0 0 0 15.79977 14.04296 0 16.26077 15.94468 14.12982 16.23736 0 0 14.46046 0 0 16.97094 0 16.41428 15.92335 15.57084 0 Q86X53 ERIC1_HUMAN Glutamate-rich protein 1 ERICH1 HSPC319 Homo sapiens (Human) QHTDGTTISKNK 16.70000076 1 1 2.29E-13 1330.5459 13.82734 14.96327 12.29151 9.663583 0 0 13.59124 0 13.5526 11.93428 17.0503 0 13.34016 14.3776 0 14.37236 0 0 0 9.6728 13.39002 0 0 0 13.31159 0 14.65871 0 12.80708 0 0 0 0 0 0 0 0 16.2481 0 0 0 0 0 14.98165 13.35022 0 0 0 Q86X55 CARM1_HUMAN "Histone-arginine methyltransferase CARM1, EC 2.1.1.319 (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4)" CARM1 PRMT4 Homo sapiens (Human) "aging [GO:0007568]; chromatin organization [GO:0006325]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of dendrite development [GO:2000171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor coactivator activity [GO:0030374]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; aging [GO:0007568]; chromatin organization [GO:0006325]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of dendrite development [GO:2000171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]" beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor coactivator activity [GO:0030374]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] GO:0000976; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0007568; GO:0008013; GO:0008276; GO:0008284; GO:0008469; GO:0016274; GO:0016571; GO:0030374; GO:0033146; GO:0034970; GO:0034971; GO:0035242; GO:0035642; GO:0042054; GO:0045600; GO:0051591; GO:0070577; GO:1902415; GO:2000171 AGDTLSGTCLLIANK 11.10000038 0.446781725 0.446781725 0.095123662 1532.916768 15.02156 14.99727 14.07498 10.1268 15.14812 13.84334 16.76504 11.68383 0 16.17874 0 0 16.10983 15.96337 16.28658 13.60086 15.97008 0 15.45022 14.84135 15.92342 15.17017 0 15.36366 0 15.00655 0 0 10.78912 9.965697 14.70273 11.40843 15.26578 0 0 0 16.89975 17.93784 15.85628 18.22058 15.44178 15.19785 11.27292 11.04341 15.03406 14.25463 15.7042 17.12661 Q86X83 COMD2_HUMAN COMM domain-containing protein 2 COMMD2 HSPC042 My004 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 IAVEFLR 9.5 1 1 0.217808675 847.699269 15.18027 0 14.50868 0 14.86465 15.11601 0 14.43215 0 0 14.43123 0 0 14.4465 15.56571 12.20883 0 0 0 16.07295 0 0 0 0 14.98391 0 17.41596 0 16.52676 15.57476 17.23597 17.04859 0 0 0 0 14.14108 15.7502 17.32304 0 15.68586 15.43161 14.83316 0 13.30001 14.82011 16.73506 0 Q86X95 CIR1_HUMAN Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin) CIR1 CIR Homo sapiens (Human) "in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]" histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0001701; GO:0003714; GO:0005634; GO:0005737; GO:0005815; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0042826; GO:0044877; GO:0045892 HSPEKR 10.68000031 1 1 0.196870792 753.5958222 15.48306 15.56701 0 0 15.74529 16.86712 15.04124 15.83504 0 14.24463 15.20416 15.62012 16.90899 0 18.49436 15.62025 15.90859 15.87541 16.84793 18.03529 17.71224 0 0 0 16.47656 16.67238 15.25047 15.41801 16.99594 16.13854 16.25038 16.38137 0 16.30798 16.41796 16.34383 18.11689 16.4476 17.04431 17.11664 17.79131 16.70013 16.60398 0 14.69332 18.10433 16.05853 17.40704 Q86XA9 HTR5A_HUMAN HEAT repeat-containing protein 5A HEATR5A C14orf125 KIAA1316 Homo sapiens (Human) "endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endocytic vesicle [GO:0030139] "cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147 ARLEAAIK 1.74000001 1 1 0.373808417 871.9384194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XD8 ZFAN4_HUMAN AN1-type zinc finger protein 4 (AN1-type zinc finger and ubiquitin domain-containing protein-like 1) ZFAND4 ANUBL1 Homo sapiens (Human) zinc ion binding [GO:0008270] zinc ion binding [GO:0008270] GO:0008270 CFEFGK 2.279999971 0.462404281 0.462404281 0.144853079 787.261569 0 11.20423 0 16.50227 0 15.10078 0 14.79681 0 13.26351 0 0 11.37855 18.9216 0 16.9324 0 17.35587 14.74822 14.34563 13.71373 15.88191 15.17464 16.72688 18.32788 13.06832 15.86111 0 18.07799 0 0 17.11082 0 13.83099 0 15.85765 16.61276 0 16.97909 0 0 16.47389 13.50537 0 16.30448 16.11882 17.91963 0 Q86XE0 SNX32_HUMAN Sorting nexin-32 (Sorting nexin-6B) SNX32 SNX6B Homo sapiens (Human) "protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endosome [GO:0005768] "cytosol [GO:0005829]; endosome [GO:0005768]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" phosphatidylinositol binding [GO:0035091] GO:0005768; GO:0005829; GO:0015031; GO:0016241; GO:0035091; GO:0042147 NLIELAELELKHAK 12.85000038 0.494017065 0.494017065 0.08099431 1621.27961 0 0 16.59867 15.43755 15.36025 0 0 15.7901 0 16.35296 17.0427 18.09818 0 0 16.29744 16.13845 15.5005 0 16.42857 17.99828 16.5263 0 17.20711 0 15.99141 15.17286 0 0 16.80128 0 14.17465 16.43911 12.58446 14.73735 14.89323 15.53581 16.99164 16.49838 15.6919 0 0 0 0 0 9.584064 16.53769 16.73118 16.53318 Q86XH1 DRC11_HUMAN Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1) IQCA1 DRC11 IQCA Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005737; GO:0005856; GO:0016887; GO:0031514 IQVDELMR 27.44000053 1 1 0.161383688 1015.382645 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68567 0 0 13.57653 0 0 0 0 0 15.93639 15.30404 0 0 0 14.55362 0 0 0 0 0 0 0 0 15.52002 14.60105 14.88001 0 0 11.14081 0 13.42578 0 11.92439 0 16.50575 Q86XJ0 CAHM3_HUMAN Calcium homeostasis modulator protein 3 (Protein A) CALHM3 FAM26A Homo sapiens (Human) ATP transport [GO:0015867]; protein heterooligomerization [GO:0051291]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; voltage-gated ion channel activity [GO:0005244]; ATP transport [GO:0015867]; protein heterooligomerization [GO:0051291]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909] cation channel activity [GO:0005261]; voltage-gated ion channel activity [GO:0005244] GO:0005244; GO:0005261; GO:0005887; GO:0015867; GO:0016323; GO:0050896; GO:0050909; GO:0051291 FLDFANMTPSQVQLFLAKVPCK 7.559999943 1 1 0.173010442 2571.146664 0 14.31928 0 0 0 0 16.46214 0 12.72192 0 0 13.62845 0 14.07123 0 11.79375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1931 0 0 0 14.29331 15.28806 0 0 0 9.610691 0 0 0 16.78582 0 12.3758 0 12.46278 Q86XJ1 GA2L3_HUMAN GAS2-like protein 3 (Growth arrest-specific protein 2-like 3) GAS2L3 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017] GO:0000226; GO:0003779; GO:0005737; GO:0005874; GO:0005884; GO:0008017; GO:0008093; GO:0015629; GO:0015630; GO:0030036; GO:0051015; GO:0051764 TQTAPK 5.059999943 6.35E-10 6.35E-10 0.302128996 646.111302 0 0 0 0 0 0 0 0 0 18.75362 0 0 0 0 0 0 0 16.89061 0 0 0 0 0 17.94988 0 18.18537 0 0 0 0 0 0 19.58849 0 19.14345 0 18.09135 17.49979 0 0 0 0 18.33426 0 0 0 0 17.35418 Q86XK2 FBX11_HUMAN "F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1, VIT-1)" FBXO11 FBX11 PRMT9 VIT1 UG063H01 Homo sapiens (Human) cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0042981 FYQINPEEYEHPNPWK 4.5 1 1 0.158862823 2091.17286 0 0 14.21089 0 0 0 0 0 13.8851 0 0 14.88201 15.97095 0 14.21486 13.96321 14.98426 0 15.20044 0 15.02637 0 0 0 16.58643 15.43406 0 0 0 16.40257 0 0 15.17942 0 0 0 15.30668 16.4552 17.16005 16.27029 16.07816 0 0 15.13926 0 14.69973 14.62252 0 Q86XL3 ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) ANKLE2 KIAA0692 LEM4 Homo sapiens (Human) cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790] protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888] GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0030176; GO:0035307; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721 YGGSPR 1.409999967 1 1 0.175765612 633.0289528 0 15.02223 0 0 0 0 0 16.68017 0 0 0 0 13.6521 16.6657 0 0 0 14.91078 0 0 16.58017 0 0 0 16.07972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.51469 0 0 15.5461 0 0 0 16.25001 0 Q86XN6 ZN761_HUMAN Zinc finger protein 761 ZNF761 KIAA2033 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 LTGITER 10.13000011 1 1 0.255167886 788.8794971 18.08376 18.0856 0 0 0 0 0 0 0 18.90765 18.08092 0 17.367 0 0 0 17.44068 0 0 0 0 16.87285 17.91487 0 0 19.01454 0 0 0 0 0 18.98186 0 0 0 0 0 0 0 0 0 0 0 17.55945 0 0 0 0 Q86XN8 MEX3D_HUMAN RNA-binding protein MEX3D (RING finger and KH domain-containing protein 1) (RING finger protein 193) (TINO) MEX3D KIAA2031 RKHD1 RNF193 Homo sapiens (Human) mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609] metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0010609; GO:0035925; GO:0046872; GO:0048471; GO:0061157 KEDVEMAK 5.289999962 1 1 0.282368375 964.7101065 0 0 0 0 15.99676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.47058 0 0 18.71551 19.35666 0 0 0 0 0 0 0 17.7215 0 Q86XP1 DGKH_HUMAN "Diacylglycerol kinase eta, DAG kinase eta, EC 2.7.1.107 (Diglyceride kinase eta, DGK-eta)" DGKH Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of catalytic activity [GO:0043086]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; SAM domain binding [GO:0032093]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of catalytic activity [GO:0043086]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; SAM domain binding [GO:0032093] GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0005768; GO:0005886; GO:0006654; GO:0007205; GO:0015629; GO:0019900; GO:0030168; GO:0032093; GO:0032991; GO:0035556; GO:0042802; GO:0043086; GO:0043231; GO:0046339; GO:0046473; GO:0046834; GO:0046872 ENLPVLNTR 4.809999943 1 1 0.166590637 1056.16039 13.66946 0 0 14.51756 12.92468 13.7797 0 13.61879 0 0 16.86613 0 0 14.08812 0 0 15.29076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.31811 0 0 0 0 0 0 0 0 0 0 0 0 Q86XP3 DDX42_HUMAN "ATP-dependent RNA helicase DDX42, EC 3.6.4.13 (DEAD box protein 42) (RNA helicase-like protein, RHELP) (RNA helicase-related protein, RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein, SF3b125)" DDX42 Homo sapiens (Human) protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0016887; GO:0042981 DMIGIAKTGSGK 6.449999809 0.20294717 0.20294717 0.156542111 1194.739254 0 15.55365 0 13.11031 0 10.08306 12.95088 13.75235 12.18459 13.59094 15.56637 15.6621 0 7.126432 11.78128 12.19358 13.09022 18.0659 0 12.93933 0 0 0 0 0 0 0 0 0 13.51921 14.92171 0 0 0 0 0 0 11.71698 0 0 15.79702 0 0 0 0 14.20568 0 0 Q86XR2 NIBA3_HUMAN Protein Niban 3 (B-cell novel protein 1) (Niban-like protein 2) (Protein FAM129C) NIBAN3 BCNP1 FAM129C Homo sapiens (Human) SGFHR 10.19999981 1 1 3.45E-13 602.3589682 0 0 17.28153 0 0 0 0 0 0 0 0 0 0 0 0 16.30872 0 0 0 16.24858 0 0 0 15.87567 0 0 0 15.60367 16.5288 0 16.97754 16.42073 0 17.46023 0 18.19878 0 16.65173 0 0 0 0 0 0 0 0 0 0 Q86XR5 PRIMA_HUMAN "Proline-rich membrane anchor 1, PRiMA" PRIMA1 Homo sapiens (Human) neurotransmitter catabolic process [GO:0042135] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neurotransmitter catabolic process [GO:0042135] GO:0005886; GO:0016021; GO:0042135; GO:0045202 LLRDLVLR 3.380000114 0.716371953 0.716371953 0.289664994 996.8838472 12.47084 14.57985 10.14314 0 14.6501 14.50166 17.06392 14.12657 0 0 16.37787 0 14.80666 0 13.39723 0 0 0 0 0 0 0 15.2773 0 0 0 0 14.64695 0 15.01526 0 0 0 0 0 0 0 16.17609 16.36728 0 0 0 0 0 0 0 0 0 Q86XT2 VP37D_HUMAN Vacuolar protein sorting-associated protein 37D (ESCRT-I complex subunit VPS37D) (Williams-Beuren syndrome chromosomal region 24 protein) VPS37D WBSCR24 Homo sapiens (Human) macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902] endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] GO:0000813; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0070062 SFPAAAVLPTGAARGPPAVPR 1.5 1 1 0.139569186 2003.326276 0 14.49133 15.31889 0 0 15.40988 0 0 15.80049 0 0 0 0 12.02446 15.85342 0 0 0 0 0 14.58249 0 0 12.32728 0 13.7606 14.38587 0 14.24569 0 14.89502 12.04138 8.171821 0 0 12.39262 0 13.70415 0 12.9633 0 0 13.00159 9.702353 16.33918 0 0 13.2375 Q86XX4 FRAS1_HUMAN Extracellular matrix organizing protein FRAS1 (Fraser syndrome 1 protein) FRAS1 KIAA1500 Homo sapiens (Human) cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588] extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872] GO:0002009; GO:0003338; GO:0005201; GO:0005604; GO:0005886; GO:0007154; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021 GMSAASR 4.760000229 1 1 0.228366282 694.3388453 0 15.36877 12.13238 15.03426 0 0 14.48661 0 0 0 15.31162 15.22482 16.459 0 0 0 15.87761 0 17.57873 18.05809 17.5293 0 0 0 16.6805 0 0 17.87748 0 17.15333 16.78994 17.09114 17.24714 0 16.92397 16.39896 0 17.81305 17.70438 18.10809 18.42678 17.70231 18.68838 17.64391 18.46441 17.65468 17.34176 0 Q86XZ4 SPAS2_HUMAN Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr) SPATS2 SCR59 SPATA10 Nbla00526 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005829 AIVPNK 4.510000229 1 1 6.89E-13 641.417512 15.0076 0 0 0 15.79681 0 0 0 0 0 0 0 0 0 0 14.83827 16.22504 0 15.08636 15.79883 0 15.04461 17.54657 0 0 15.69547 16.25899 16.58433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y22 CONA1_HUMAN Collagen alpha-1(XXIII) chain COL23A1 Homo sapiens (Human) extracellular matrix organization [GO:0030198] cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] GO:0005201; GO:0005581; GO:0005615; GO:0005788; GO:0005886; GO:0008201; GO:0009986; GO:0016021; GO:0030198; GO:0031012; GO:0042802; GO:0062023 GNAAGGGGGGR 12.81999969 1 1 0.002173535 831.5341443 15.54571 15.65686 15.43455 13.69562 14.4877 14.72118 15.41071 15.47773 14.33043 14.16407 12.77964 0 0 10.59576 0 14.84192 13.97576 12.72319 15.23139 15.6291 12.71073 0 14.20051 13.49742 12.62654 15.27279 13.42775 0 15.29294 0 0 0 0 0 0 0 0 0 0 0 0 16.32041 18.09118 0 0 18.00324 0 0 Q86Y26 NUTM1_HUMAN NUT family member 1 (Nuclear protein in testis) NUTM1 C15orf55 NUT Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 THRSADR 9.119999886 0.274120301 0.274120301 0.094128661 842.2881905 0 16.10092 15.00327 13.85116 16.47422 16.40424 14.98174 18.41749 14.30181 18.25357 16.58783 13.87389 15.15034 0 16.0361 16.73936 14.57645 16.88846 14.82433 0 13.73627 15.91592 18.189 0 12.02394 0 16.17258 17.00155 15.03328 16.76424 16.69215 17.16545 16.70524 0 15.58797 17.97868 17.36376 17.31758 0 14.92135 16.75418 15.35019 17.23242 12.79165 16.18492 0 16.97859 17.40512 Q86Y37 CACL1_HUMAN CDK2-associated and cullin domain-containing protein 1 (Cdk-associated cullin 1) CACUL1 C10orf46 CAC1 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511] protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511] protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] GO:0000082; GO:0006511; GO:0008284; GO:0019901; GO:0031625; GO:0045860 ELIQNGFTRGDQSR 6.320000172 1 1 0.379268786 1621.053164 0 11.86613 0 15.75733 15.46827 0 15.14719 0 14.91222 0 17.15226 0 0 0 0 0 0 14.79688 0 16.45738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y38 XYLT1_HUMAN "Xylosyltransferase 1, EC 2.4.2.26 (Peptide O-xylosyltransferase 1) (Xylosyltransferase I, XT-I, XylT-I)" XYLT1 XT1 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] GO:0000137; GO:0000139; GO:0005615; GO:0006024; GO:0015012; GO:0016021; GO:0030158; GO:0030166; GO:0030203; GO:0030206; GO:0043931; GO:0046872; GO:0048706; GO:0050650 NFGGLLGPMDEPVGMQKWGK 5.090000153 1 1 0.045818797 2161.369433 14.84891 0 15.88119 0 16.29508 0 15.76299 0 0 13.53499 0 0 15.56094 0 0 14.00123 15.60846 0 0 0 0 0 0 0 16.26152 0 0 0 0 0 0 15.54575 17.33363 17.77807 16.69765 0 0 0 14.97392 0 0 0 0 0 12.44412 0 0 0 Q86Y46 K2C73_HUMAN "Keratin, type II cytoskeletal 73 (Cytokeratin-73, CK-73) (Keratin-73, K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)" KRT73 K6IRS3 KB36 KRT6IRS3 Homo sapiens (Human) cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; nucleus [GO:0005634] GO:0005634; GO:0005829; GO:0045095; GO:0070062 GDCALK 12.69999981 0.363138348 0.363138348 0.258557772 663.1991452 19.11005 17.59958 18.45091 19.52602 17.60752 17.06342 17.27338 19.39987 17.43558 17.56927 17.85942 17.03381 0 17.21272 0 0 18.12119 0 16.74305 16.93838 0 0 0 18.75773 0 0 0 17.47919 0 17.10979 19.95621 21.78458 0 17.19184 0 0 18.6429 18.69975 18.35515 18.02376 17.70578 0 16.25306 16.62909 0 0 0 17.97975 Q86Y79 PTH_HUMAN "Probable peptidyl-tRNA hydrolase, PTH, EC 3.1.1.29" PTRH1 C9orf115 Homo sapiens (Human) aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723] aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723] GO:0003723; GO:0004045 GHNGVR 5.110000134 1 1 0.29223372 638.9124415 14.70525 0 0 0 16.45915 15.82776 0 16.10534 0 0 0 16.26034 0 0 0 0 14.18939 0 16.91512 16.9142 17.09136 16.4948 0 0 17.2083 0 0 14.35168 0 0 0 0 0 17.29809 16.4866 0 0 0 16.49685 16.63046 16.76832 0 0 0 0 19.48628 0 0 Q86Y91 KI18B_HUMAN Kinesin-like protein KIF18B KIF18B Homo sapiens (Human) cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302] astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0000070; GO:0000235; GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0008574; GO:0016604; GO:0016887; GO:0019894; GO:0035371; GO:0051301; GO:0051302; GO:0061673; GO:1990023; GO:1990752 TSGLAR 3.940000057 1 1 0.310933908 605.7202787 17.3412 0 0 0 0 0 0 0 0 17.8133 0 0 0 0 16.94835 0 18.3983 0 0 0 16.77458 0 0 0 17.96295 17.28665 0 0 0 17.63296 0 0 0 0 17.72688 0 0 0 17.99245 0 17.46918 17.97454 16.0605 0 0 0 0 18.15182 Q86YA3 ZGRF1_HUMAN Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1) ZGRF1 C4orf21 Homo sapiens (Human) replication fork reversal [GO:0071932] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; 5'-flap endonuclease activity [GO:0017108]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; replication fork reversal [GO:0071932] 5'-flap endonuclease activity [GO:0017108]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0004386; GO:0005737; GO:0008270; GO:0016021; GO:0017108; GO:0071932 AILYDDKGACLESLFLK 14.31000042 1 1 0.318287295 1955.980289 18.65487 21.01493 20.06779 0 20.20901 15.34513 0 0 17.35358 20.73949 0 20.43964 0 0 19.80384 17.50702 16.29572 17.67447 18.88301 20.04976 0 20.47632 18.99099 0 20.02572 21.15234 0 20.18394 17.86386 20.95913 20.41599 20.49008 18.70266 21.47472 21.29285 18.08274 18.987 20.20673 0 0 20.09047 0 19.70997 0 19.49054 0 18.04612 0 Q86YC2 PALB2_HUMAN Partner and localizer of BRCA2 PALB2 FANCN Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; inner cell mass cell proliferation [GO:0001833]; mesoderm development [GO:0007498]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756] DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; animal organ morphogenesis [GO:0009887]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; inner cell mass cell proliferation [GO:0001833]; mesoderm development [GO:0007498]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756] DNA binding [GO:0003677] GO:0000724; GO:0001756; GO:0001833; GO:0003677; GO:0005634; GO:0005654; GO:0007498; GO:0009887; GO:0032991; GO:0035264; GO:0036342; GO:0043066; GO:0048568; GO:1990391 IKHSIK 6.25 0.2580975 0.2580975 0.118151239 725.0364602 0 12.96745 16.20285 15.79831 0 0 13.72244 16.53725 15.50833 17.51853 14.3148 16.95675 14.90183 12.93618 16.37407 17.92172 0 16.24557 15.8909 0 13.8661 15.04033 0 16.68231 0 17.39183 0 14.38619 13.85919 16.50686 17.06969 0 15.35548 15.73261 16.17097 0 14.32316 0 15.68534 17.24378 13.09927 16.87484 14.99554 0 15.65472 16.59049 14.3703 16.51216 Q86YD1 PTOV1_HUMAN "Prostate tumor-overexpressed gene 1 protein, PTOV-1 (Activator interaction domain-containing protein 2)" PTOV1 ACID2 PP642 UNQ6127/PRO20092 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005654; GO:0005667; GO:0005886; GO:0045944; GO:0048471 GPQPPRIR 9.93999958 1 1 0.35826155 920.8769497 0 0 15.02115 0 0 0 0 0 15.77025 15.94446 0 16.21605 0 15.68681 0 0 14.89799 0 0 0 0 0 0 0 0 0 0 0 0 13.27155 12.13611 14.88618 16.47135 16.14143 13.44188 15.33222 14.86167 13.83654 14.91788 0 14.87326 14.26375 0 15.32409 0 0 0 0 Q86YD3 TMM25_HUMAN Transmembrane protein 25 TMEM25 UNQ2531/PRO6030 Homo sapiens (Human) negative regulation of excitatory postsynaptic potential [GO:0090394]; regulation of protein stability [GO:0031647] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; negative regulation of excitatory postsynaptic potential [GO:0090394]; regulation of protein stability [GO:0031647] GO:0005576; GO:0005764; GO:0005770; GO:0005886; GO:0016021; GO:0031647; GO:0090394 QMAQNNSRPELLDPEPGGLLTSQGFIR 2.609999895 0.153177559 0.153177559 0 2967.360496 0 11.98469 0 0 0 0 0 13.89322 0 0 0 13.95773 0 0 14.01746 13.50249 0 0 0 0 0 0 15.05736 0 0 13.18409 12.09901 15.03638 13.29561 14.8518 13.37242 0 14.00486 0 0 11.89766 0 0 0 14.52504 12.46756 0 0 0 14.74232 0 0 15.34209 Q86YE8 ZN573_HUMAN Zinc finger protein 573 ZNF573 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AYSTGSNLIQHR 6.360000134 0.441058338 0.441058338 0.076446918 1346.09401 0 0 14.21301 0 0 13.83825 13.55006 14.67973 0 16.26431 13.57707 0 15.75165 17.27654 0 14.65722 16.07727 0 15.98132 19.57332 12.45743 16.52804 14.01258 17.55562 0 15.75483 12.84879 16.98456 0 13.79764 0 0 16.13214 15.34486 0 15.2039 10.97151 16.34144 15.97881 0 0 10.24855 14.37263 18.78088 10.81641 0 14.3318 0 Q86YJ6 THNS2_HUMAN "Threonine synthase-like 2, TSH2, EC 4.2.3.- (Secreted osteoclastogenic factor of activated T-cells, SOFAT)" THNSL2 Homo sapiens (Human) 2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; 2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071] cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905] GO:0005125; GO:0005615; GO:0009071; GO:0016311; GO:0016829; GO:0030170; GO:0046360; GO:0070905 TVFADVAFVKK 6.340000153 1 1 0.18708529 1223.554731 13.83652 7.499741 13.22875 14.6185 15.74312 12.89158 16.47494 13.99696 11.89721 11.60451 0 0 0 0 0 11.73411 0 10.95626 0 0 0 13.74899 0 0 0 0 0 16.14838 0 16.07038 0 0 15.53613 0 0 0 0 0 0 16.60254 0 0 0 0 0 0 0 0 Q86YJ7 AN13B_HUMAN Ankyrin repeat domain-containing protein 13B ANKRD13B Homo sapiens (Human) negative regulation of receptor internalization [GO:0002091] cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091] ubiquitin-dependent protein binding [GO:0140036] GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0043231; GO:0048471; GO:0140036 KGPEGK 5.650000095 1 1 0.199516932 615.7802019 17.515 18.46916 15.86759 13.99969 15.0456 14.90531 15.51962 0 13.54576 0 14.19415 14.34967 0 0 0 0 0 0 0 0 0 14.33284 0 0 14.68556 16.83146 0 16.81556 15.69105 14.04701 0 16.72556 0 0 17.07673 0 16.86107 18.60175 16.18552 0 15.7214 0 0 0 0 15.67735 16.5145 0 Q86YL5 TDRP_HUMAN Testis development-related protein (Protein INM01) TDRP C8orf42 Homo sapiens (Human) spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0043231 SGFWDNLVLK 2.690000057 1 1 1.15E-12 1181.517014 14.0407 0 0 0 0 8.077859 13.97535 0 0 0 16.41252 0 0 0 0 0 0 0 14.71774 0 14.87342 0 0 0 0 0 0 0 14.15399 0 0 0 16.64143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YP4 P66A_HUMAN "Transcriptional repressor p66-alpha, Hp66alpha (GATA zinc finger domain-containing protein 2A)" GATAD2A Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565] GO:0000122; GO:0005634; GO:0005654; GO:0006306; GO:0006338; GO:0016575; GO:0016581; GO:0016607; GO:0030674; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000736 GTQNIPAGKPSLQTSSAR 7.960000038 1 1 0.356439025 1813.031647 16.22284 15.92149 10.37686 13.5119 14.03634 14.66098 13.17137 13.75839 0 15.40851 15.11177 13.23411 0 0 13.06126 0 0 0 0 0 0 0 0 0 0 16.44904 0 0 0 0 0 0 15.73949 0 16.45454 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YR5 GPSM1_HUMAN G-protein-signaling modulator 1 (Activator of G-protein signaling 3) GPSM1 AGS3 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239] GDP-dissociation inhibitor activity [GO:0005092] GO:0000139; GO:0005092; GO:0005789; GO:0005829; GO:0005886; GO:0007399; GO:0016239; GO:0030154; GO:0032991; GO:0034260; GO:1905098 MGEAKASGNLGNTLK 9.56000042 1 1 0.160515448 1507.28631 0 0 16.16658 0 0 16.07639 0 0 0 15.18803 0 15.98849 0 0 0 15.6098 16.72655 0 0 0 0 16.30778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YR7 MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2) MCF2L2 DRG KIAA0861 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737 CAENPELLAHCFLKR 15.5 1 1 0.456854365 1856.771996 0 15.35701 16.48737 0 0 16.0951 16.54066 0 0 0 0 15.10278 0 15.04102 0 0 0 15.7808 0 0 16.16839 0 0 0 16.40576 0 0 0 0 0 0 0 0 15.75254 0 17.36481 0 0 0 0 0 0 15.11321 15.72386 0 0 0 0 Q86YS3 RFIP4_HUMAN "Rab11 family-interacting protein 4, FIP4-Rab11, Rab11-FIP4 (Arfophilin-2)" RAB11FIP4 ARFO2 KIAA1821 Homo sapiens (Human) endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] GO:0005509; GO:0005615; GO:0005768; GO:0005815; GO:0005819; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0055038 VERVAALGLR 8.050000191 0.717615783 0.717615783 0.126208023 1082.659164 0 0 0 0 15.62866 15.79345 0 12.60537 0 0 0 0 14.96419 14.18467 0 15.30268 0 0 0 0 12.33787 16.69631 16.25485 14.10042 0 0 0 0 0 0 0 0 16.02234 0 0 0 0 0 0 0 0 0 0 0 14.99503 0 0 0 Q86YS7 C2CD5_HUMAN C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) C2CD5 CDP138 KIAA0528 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0065002; GO:0072659; GO:0090314 ASDLTDAFVEVK 9.300000191 1 1 0.202218528 1295.453896 0 15.75428 13.91136 14.24579 12.03748 0 14.90166 0 0 12.82533 0 13.65301 10.15792 0 0 0 0 0 0 0 0 14.78465 0 0 0 16.83996 0 0 0 0 0 0 0 0 0 0 17.18591 0 0 0 0 0 0 0 0 0 0 0 Q86YT6 MIB1_HUMAN "E3 ubiquitin-protein ligase MIB1, EC 2.3.2.27 (DAPK-interacting protein 1, DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)" MIB1 DIP1 KIAA1323 ZZANK2 Homo sapiens (Human) blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807 EQVQSRTK 6.579999924 1 1 0.095603114 974.0517933 0 0 0 14.84295 0 0 0 0 13.66607 13.72338 0 0 0 18.46811 18.92131 0 0 0 0 0 0 0 0 0 0 18.41728 0 0 0 0 0 17.41938 0 0 0 0 0 0 18.51763 0 0 18.63536 0 0 0 0 18.0154 0 Q86YV0 RASL3_HUMAN RAS protein activator like-3 RASAL3 Homo sapiens (Human) negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802] GO:0005096; GO:0005737; GO:0005829; GO:0005938; GO:0007165; GO:0016020; GO:0042802; GO:0043087; GO:0046580; GO:0051142; GO:0070062; GO:0098562 TEPETAGPNQVHNVRGLLK 2.039999962 1 1 1.38E-12 2060.446245 0 12.6281 0 0 11.42301 13.97646 12.24565 13.68803 0 16.84542 14.75157 14.1612 12.08537 14.50791 12.61614 13.99266 14.08173 0 0 0 13.16639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YV5 PRAG1_HUMAN "Inactive tyrosine-protein kinase PRAG1 (PEAK1-related kinase-activating pseudokinase 1) (Pragmin) (Sugen kinase 223, SgK223)" PRAG1 SGK223 Homo sapiens (Human) cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] identical protein binding [GO:0042802]; protein kinase activity [GO:0004672] GO:0004672; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006468; GO:0008360; GO:0008593; GO:0010977; GO:0016477; GO:0035025; GO:0042802; GO:2000145 QEDAPVVYLGSFRGVQKPAGPSTSPDGNSR 2.700000048 1 1 3.66E-12 3115.417218 0 14.85845 15.11465 0 0 0 0 14.41581 0 0 15.42541 13.58535 0 0 15.92457 12.40579 14.15574 13.889 0 0 0 0 0 14.14932 15.87467 0 13.19778 0 15.59087 0 0 13.77028 12.71405 10.5138 0 0 13.34456 0 0 0 11.47384 0 0 0 0 0 0 0 Q86YV9 HPS6_HUMAN "Hermansky-Pudlak syndrome 6 protein (Ruby-eye protein homolog, Ru)" HPS6 Homo sapiens (Human) blood coagulation [GO:0007596]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]; protein localization to membrane [GO:0072657] BLOC-2 complex [GO:0031084]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] BLOC-2 complex [GO:0031084]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267]; blood coagulation [GO:0007596]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]; protein localization to membrane [GO:0072657] GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267] GO:0005765; GO:0005769; GO:0005783; GO:0006996; GO:0007596; GO:0016020; GO:0030318; GO:0030742; GO:0031084; GO:0031267; GO:0031901; GO:0032418; GO:0046907; GO:0060155; GO:0072657; GO:1903232 HSSTFR 2.940000057 1 1 0.169555272 735.4343416 0 17.24743 0 0 0 0 0 0 0 0 17.97598 0 18.13889 0 0 0 0 0 0 0 0 0 0 16.0286 14.19543 18.2218 14.91095 15.96525 0 0 0 0 0 0 0 12.73447 0 0 16.76547 0 0 0 0 0 0 0 0 0 Q86YW9 MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like) MED12L KIAA1635 TNRC11L TRALP TRALPUSH PRO0314 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] mediator complex [GO:0016592] mediator complex [GO:0016592]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0006357; GO:0008013; GO:0016592 EGLLTSLQNQVNQILSNWR 1.379999995 1 1 0.153292285 2210.323309 16.07147 14.69453 12.76219 10.66615 11.07494 0 17.35913 14.96705 11.87303 14.68781 0 13.5029 13.21709 0 13.46181 0 0 0 11.80023 0 12.33534 15.4145 11.45958 0 0 15.65314 0 15.27698 0 9.132486 0 0 0 0 0 0 0 16.33321 0 13.35021 14.52211 0 0 0 12.70908 0 0 15.18186 Q86YZ3 HORN_HUMAN Hornerin HRNR S100A18 Homo sapiens (Human) cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424] calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] GO:0001533; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0031424; GO:0035578; GO:0036457; GO:0043163; GO:0046914; GO:0048471; GO:0061436; GO:0062023; GO:0070062 QGSGSGHSPSR 7.349999905 1 1 0.220567664 1057.225493 16.12914 0 15.01458 14.22026 14.70635 0 0 15.40334 13.32331 15.3813 15.82905 12.94659 0 0 12.21191 14.07624 15.51118 0 15.63213 0 0 15.04981 16.14025 0 0 14.0014 16.36404 0 0 14.42497 0 0 0 0 0 0 16.12309 0 13.84471 15.54542 16.46105 0 0 0 0 0 0 0 Q86Z02 HIPK1_HUMAN "Homeodomain-interacting protein kinase 1, EC 2.7.11.1 (Nuclear body-associated kinase 2)" HIPK1 KIAA0630 MYAK NBAK2 Homo sapiens (Human) adherens junction assembly [GO:0034333]; anterior/posterior pattern specification [GO:0009952]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; retina layer formation [GO:0010842]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adherens junction assembly [GO:0034333]; anterior/posterior pattern specification [GO:0009952]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; retina layer formation [GO:0010842]; smoothened signaling pathway [GO:0007224] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0001654; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007224; GO:0008284; GO:0009952; GO:0010803; GO:0010842; GO:0016605; GO:0016607; GO:0018105; GO:0018107; GO:0030182; GO:0034333; GO:0042771; GO:0045766; GO:0048596; GO:0060059; GO:0060216; GO:0060235; GO:0061072; GO:0072577; GO:0097191; GO:0106310 RVHMYDTVSQIK 5.199999809 1 1 0.304399803 1493.414738 0 12.95286 0 0 12.52627 0 12.33273 13.77663 11.83312 9.442307 16.56704 13.47082 13.73362 0 0 15.04219 0 0 0 0 0 15.6432 17.50673 0 0 0 0 0 0 0 0 0 0 0 13.38811 0 16.50507 0 0 0 16.3595 0 16.43362 14.498 17.81286 0 0 0 Q86Z14 KLOTB_HUMAN "Beta-klotho, BKL, BetaKlotho (Klotho beta-like protein)" KLB Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]" "fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" GO:0004553; GO:0005104; GO:0005886; GO:0005975; GO:0008284; GO:0008543; GO:0016021; GO:0017134; GO:0090080 LSDIYNR 4.699999809 1 1 0.116061646 879.2581658 0 15.86135 16.37478 14.95383 0 0 0 15.59387 16.55862 0 0 15.92302 0 0 0 16.38334 0 0 12.22308 0 0 0 0 16.76066 15.56404 15.95081 0 15.9725 0 9.267852 15.83868 0 17.17396 0 17.7641 0 0 0 0 0 0 0 0 12.84923 14.28219 17.43165 0 0 Q8HWS3 RFX6_HUMAN DNA-binding protein RFX6 (Regulatory factor X 6) (Regulatory factor X domain-containing protein 1) RFX6 RFXDC1 Homo sapiens (Human) "endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104 VDTLIMMYK 3.839999914 0.602782965 0.602782965 0.185222047 1128.590763 15.09059 14.17261 0 13.77001 15.4289 14.40015 14.99859 15.42847 12.5894 14.79507 15.35185 13.31723 15.37066 0 13.83456 0 12.1212 0 16.33888 14.40508 0 0 15.61977 0 16.17645 0 0 0 0 16.07061 0 0 0 15.16835 15.16441 0 15.99774 16.41816 16.76285 16.34836 16.64484 13.87858 16.39199 15.92208 14.84597 16.32591 9.294958 15.94873 Q8IU53 CASC2_HUMAN "Protein CASC2, isoforms 1/2 (Cancer susceptibility candidate gene 2 protein isoforms 1/2)" CASC2 C10orf5 Homo sapiens (Human) MAGTRGLMLLGPGPVAGPR 11.59000015 1 1 0.296214664 1867.12844 0 0 14.77342 13.76082 12.03612 0 0 0 0 13.53595 0 14.66148 0 13.41371 0 0 0 11.57702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IU68 TMC8_HUMAN Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2) TMC8 EVER2 EVIN2 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069] mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120] GO:0001558; GO:0005615; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0008381; GO:0031333; GO:0031965; GO:0032091; GO:0043120; GO:0055069; GO:0070062; GO:0140311; GO:1902041 GSGTPVRGLPYAMMDK 1.960000038 1 1 0.107332786 1695.340114 14.11618 13.85485 15.30814 15.02444 15.32967 0 0 0 15.00905 0 0 0 0 0 0 13.89241 0 16.19909 0 0 0 0 0 0 0 0 0 0 0 0 15.06987 0 0 0 0 0 14.8974 14.99976 0 0 15.71759 0 0 0 0 0 0 12.68412 Q8IU80 TMPS6_HUMAN "Transmembrane protease serine 6, EC 3.4.21.- (Matriptase-2)" TMPRSS6 UNQ354/PRO618 Homo sapiens (Human) "cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]" extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]" metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252] GO:0000122; GO:0004222; GO:0004252; GO:0005615; GO:0005886; GO:0006879; GO:0016021; GO:0022617; GO:0030514; GO:0030574; GO:0033619; GO:0045892; GO:0045944; GO:0055072; GO:0097264 ATFQCK 2.160000086 1 1 0.295235883 753.1203964 0 18.67281 20.33567 0 0 17.19247 18.83683 17.29955 0 0 0 0 20.3547 17.12481 0 0 0 0 16.53256 17.28259 16.74371 18.03851 17.83758 16.8917 17.30057 0 17.76989 0 0 16.98511 0 19.56568 0 0 0 18.90101 0 0 0 17.67652 0 18.39749 17.16474 18.10289 17.89643 0 0 0 Q8IU81 I2BP1_HUMAN "Interferon regulatory factor 2-binding protein 1, IRF-2-binding protein 1, IRF-2BP1 (Probable E3 ubiquitin-protein ligase IRF2BP1, EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1)" IRF2BP1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] GO:0000122; GO:0000209; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0046872; GO:0061630 ATSSGR 5.869999886 1 1 1.15E-13 578.2181545 14.26464 14.73083 13.56742 14.43164 0 11.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 15.77503 15.86771 0 0 0 12.09848 14.17964 0 0 15.24893 16.19275 14.85343 0 0 15.48553 11.77433 0 0 0 0 0 0 0 16.03769 0 0 0 0 0 Q8IUC8 GLT13_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 13, EC 2.4.1.41 (Polypeptide GalNAc transferase 13, GalNAc-T13, pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13)" GALNT13 KIAA1918 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030246; GO:0046872 AVLIPK 17.45999908 1 1 0.297866761 639.6243652 0 0 0 0 0 0 0 0 0 17.31922 0 0 0 18.6388 16.1825 0 17.52081 0 0 0 0 0 0 19.03428 21.55595 21.80117 19.00088 0 0 0 0 20.41023 0 18.05215 0 20.57495 0 19.45261 0 0 0 0 0 0 19.72641 0 0 0 Q8IUD2 RB6I2_HUMAN "ELKS/Rab6-interacting/CAST family member 1, ERC-1 (Rab6-interacting protein 2)" ERC1 ELKS KIAA1081 RAB6IP2 Homo sapiens (Human) "I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]" centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] "centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]" cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882] GO:0000139; GO:0005737; GO:0005813; GO:0006355; GO:0007252; GO:0007274; GO:0008385; GO:0015031; GO:0030165; GO:0031267; GO:0036064; GO:0042147; GO:0042734; GO:0045202; GO:0045296; GO:0048167; GO:0048788; GO:0048790; GO:0051092; GO:0098882 EMVLAQEESARTNAEK 1.200000048 0.795149922 0.795149922 0.305815124 1803.886414 0 0 0 17.56155 0 0 0 0 0 0 0 0 0 0 16.38341 15.8601 15.91056 12.92868 0 0 0 0 12.99503 0 0 17.31723 0 16.16677 0 0 0 15.61669 0 0 0 0 0 15.4975 0 0 0 0 0 0 15.37426 0 0 0 Q8IUE1 TF2LX_HUMAN "Homeobox protein TGIF2LX (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, X-linked) (TGIF-like on the X)" TGIF2LX TGIFLX Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837 EKQPDPESAPSQK 12.59000015 1 1 0.405447237 1441.483548 16.87099 0 0 0 0 0 0 16.91613 0 13.53499 0 0 0 14.98954 0 13.86221 13.84155 0 0 0 0 0 17.43106 16.13271 0 0 0 0 16.31798 0 0 0 0 17.54925 16.07034 0 0 0 14.97392 0 0 0 0 0 12.44412 0 15.27184 0 Q8IUF8 RIOX2_HUMAN "Ribosomal oxygenase 2 (60S ribosomal protein L27a histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA, EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) (Mineral dust-induced gene protein) (Nucleolar protein 52) (Ribosomal oxygenase MINA, ROX)" RIOX2 MDIG MINA MINA53 NO52 Homo sapiens (Human) histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0016706; GO:0032452; GO:0032453; GO:0034720; GO:0042254; GO:0042802; GO:0046872; GO:0051864; GO:0070544 ELLSSDMK 14.02999973 0.201442569 0.201442569 0.196503286 919.7506535 14.78136 15.17725 15.14122 15.20292 15.48493 16.21941 0 0 0 15.73366 0 14.18018 0 13.14005 0 14.35989 12.9039 14.17483 14.93286 0 0 0 0 15.78369 0 15.75595 0 0 0 0 0 0 0 0 0 0 0 0 0 15.19885 12.46811 14.91365 0 0 14.89824 0 0 0 Q8IUH3 RBM45_HUMAN "RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1, RB-1) (RNA-binding motif protein 45)" RBM45 DRB1 DRBP1 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0007399; GO:0030154; GO:0042802; GO:1990904 IFLVISK 15.07999992 0.19946374 0.19946374 0.249932194 820.3825678 0 15.65025 0 16.78145 14.95064 15.54722 0 15.69207 15.36445 16.93278 15.17893 0 0 0 15.18822 15.02217 14.69181 0 0 15.35331 0 15.47598 16.5004 16.68974 15.1281 15.91693 17.8293 0 16.34561 0 0 16.83736 0 0 0 0 16.89489 18.99202 0 16.73705 16.72306 15.57479 15.97237 15.99721 16.37452 16.35947 15.34305 16.19318 Q8IUH8 SPP2C_HUMAN "Signal peptide peptidase-like 2C, SPP-like 2C, SPPL2c, EC 3.4.23.- (Intramembrane protease 5, IMP-5)" SPPL2C IMP5 Homo sapiens (Human) membrane protein proteolysis [GO:0033619] endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765] "endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]" "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]" GO:0005765; GO:0005789; GO:0030660; GO:0033619; GO:0042500; GO:0042803; GO:0071458; GO:0071556 KSMSTQAPL 4.829999924 1 1 0.195541993 977.4870828 14.4818 14.52014 14.90002 0 15.7093 0 13.62299 16.35666 16.2504 14.99748 15.4266 16.36312 13.8976 14.79594 14.79474 12.87216 0 13.37422 0 11.61738 14.86621 0 0 16.65145 0 0 0 16.70919 0 16.37526 15.3796 0 0 0 0 0 0 0 15.15328 0 0 0 0 0 0 15.84343 0 16.04956 Q8IUL8 CILP2_HUMAN "Cartilage intermediate layer protein 2, CILP-2 [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2 ]" CILP2 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] GO:0005615; GO:0070062 ADGKPYSGPVEARVTFVDPR 3.789999962 0.532295525 0.532295525 0.173339942 2160.672613 10.82316 14.95428 0 0 14.10962 8.959558 0 0 12.84433 0 12.6834 11.51908 8.591025 11.21587 13.18202 0 0 0 0 0 0 0 12.36674 0 14.72024 11.70859 16.1639 0 14.4571 0 0 0 0 0 14.70291 0 16.90981 0 0 15.78239 14.21828 0 0 12.59148 0 0 14.6829 13.79768 Q8IUM7 NPAS4_HUMAN "Neuronal PAS domain-containing protein 4, Neuronal PAS4 (Class E basic helix-loop-helix protein 79, bHLHe79) (HLH-PAS transcription factor NXF) (PAS domain-containing protein 10)" NPAS4 BHLHE79 NXF PASD10 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]" chromatin [GO:0000785]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0035176; GO:0044877; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862 GASKAR 8.369999886 0.933829784 0.933829784 0.244827229 588.6021222 15.09531 14.9881 15.27444 15.98143 15.77846 13.72536 15.54639 15.38933 15.74428 0 13.99784 0 14.78197 0 0 0 15.30891 0 17.14677 15.9809 17.00467 12.09915 0 0 16.22138 16.39629 0 15.73255 15.8097 15.21048 15.613 0 0 14.33874 13.28387 16.5748 0 16.73284 16.24294 14.90809 16.27512 0 0 15.19359 16.75891 0 16.79951 0 Q8IUR0 TPPC5_HUMAN Trafficking protein particle complex subunit 5 TRAPPC5 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0006901; GO:0030008; GO:0048208; GO:0099022; GO:1990070; GO:1990071; GO:1990072 GTTLMIK 19.42000008 1 1 0.164783807 762.2986819 0 0 0 0 0 18.00883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22.60726 0 0 0 0 0 0 0 0 0 0 21.19327 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUW3 SPA2L_HUMAN "Spermatogenesis-associated protein 2-like protein, SPATA2-like protein" SPATA2L C16orf76 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AQMDTLLYNSPGARP 20.71999931 0.135294735 0.135294735 0.425945546 1648.945309 18.10694 14.23644 21.81012 16.05322 17.61917 19.34448 0 21.42664 20.32375 22.11121 18.47913 17.66929 0 0 21.68099 22.12629 21.97642 22.1517 0 0 21.45802 21.09884 18.73045 0 0 21.50354 18.74991 19.37635 18.3658 18.02654 23.45083 22.15372 18.32727 23.79829 19.77817 24.24259 16.27339 21.36255 0 20.29842 22.20187 18.99468 18.36348 0 0 22.33081 18.47435 21.13243 Q8IUX1 T126B_HUMAN "Complex I assembly factor TMEM126B, mitochondrial (Transmembrane protein 126B)" TMEM126B HT007 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005739; GO:0005743; GO:0016021; GO:0032981 LFVIDALYSDNISK 7.820000172 1 1 0.324074335 1596.668379 14.46239 13.48534 0 0 0 0 0 15.58538 0 15.01589 0 0 0 0 17.99802 0 17.90826 18.60692 18.48053 15.21558 18.58292 0 0 15.32008 16.2935 15.19393 18.01332 0 13.34249 0 16.46449 15.62891 12.96095 15.04465 15.40815 14.8301 0 16.28016 0 12.92456 10.99993 0 0 0 11.17205 13.59285 16.71364 15.85975 Q8IUX8 EGFL6_HUMAN "Epidermal growth factor-like protein 6, EGF-like protein 6 (MAM and EGF domains-containing gene protein)" EGFL6 MAEG PP648 UNQ281/PRO320 Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020] basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] calcium ion binding [GO:0005509]; integrin binding [GO:0005178] GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0007155; GO:0010811; GO:0016020; GO:0030154; GO:0030198 GGNSHGGKK 15.35999966 1 1 0.022421452 842.535722 16.36844 16.00115 0 0 0 14.45759 14.51941 0 16.8204 0 14.47131 15.51048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.35651 0 0 0 0 0 0 0 0 0 0 0 13.11979 15.88218 0 0 0 0 0 0 0 Q8IV03 LUR1L_HUMAN Leucine rich adaptor protein 1-like LURAP1L C9orf150 HYST0841 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0043123 MEDSPLPDLR 4.190000057 0.050966844 0.050966844 0.376014594 1185.274652 12.83228 0 0 0 0 11.99739 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14558 0 0 0 17.37337 0 0 0 0 11.60081 0 13.71256 0 0 13.86338 0 0 0 0 0 0 16.89681 0 0 0 0 0 0 0 Q8IV32 CCD71_HUMAN Coiled-coil domain-containing protein 71 CCDC71 Homo sapiens (Human) VARTLAK 7.559999943 0.380064666 0.380064666 0.140966892 757.4387346 17.10141 16.57789 0 16.21269 16.08165 16.00696 0 14.6753 15.35197 16.58299 15.8552 0 11.30952 18.16323 17.55721 15.80375 17.8315 0 16.30962 17.40962 16.03915 0 0 0 17.30039 0 15.80376 17.1956 17.68546 0 0 16.83983 17.19141 16.20163 17.16551 17.79204 0 13.91735 17.32701 15.66811 0 15.84997 15.57871 16.44335 17.74022 16.41628 17.22598 16.18822 Q8IV38 ANKY2_HUMAN Ankyrin repeat and MYND domain-containing protein 2 ANKMY2 Homo sapiens (Human) cilium [GO:0005929] cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] enzyme binding [GO:0019899]; metal ion binding [GO:0046872] GO:0005929; GO:0019899; GO:0046872 DMNEVLAMK 9.979999542 1 1 0.030894742 1066.315018 15.93901 14.01571 0 0 15.03669 0 13.57017 13.89574 13.82223 0 15.41391 14.46863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42361 0 Q8IV45 UN5CL_HUMAN UNC5C-like protein (Protein unc-5 homolog C-like) (ZU5 and death domain-containing protein) UNC5CL ZUD Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330] netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233] GO:0005042; GO:0005737; GO:0008233; GO:0016020; GO:0016021; GO:0043123; GO:0046330 DNQGLELDEK 7.019999981 1 1 0.168865112 1160.900445 14.49441 0 0 0 10.61735 13.69016 14.49062 0 0 13.82176 0 13.91814 0 15.54124 0 14.79753 0 0 0 0 14.16012 0 0 0 0 16.0384 15.93749 0 13.68121 0 0 13.94496 0 0 0 0 0 0 0 0 15.17148 0 14.14561 0 0 0 0 0 Q8IV53 DEN1C_HUMAN DENN domain-containing protein 1C (Connecdenn 3) (Protein FAM31C) DENND1C FAM31C Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897] centrosome [GO:0005813]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981] GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0006897; GO:0030136; GO:0032456; GO:0043231; GO:1901981 GVQSLLMYK 3.25 0.235389039 0.235389039 0.047739894 1038.434731 17.65093 16.99385 14.69457 16.99037 13.71024 0 13.02963 0 14.11905 14.88605 15.07268 0 10.72847 0 13.55501 14.54953 0 14.06764 15.157 15.8769 14.93438 15.76301 0 16.9189 15.50448 15.39432 16.1877 0 16.07874 0 15.95626 17.22866 17.60687 14.88696 14.64446 9.53383 17.43889 0 17.338 16.12226 0 15.69574 14.74194 0 13.08496 15.48025 9.900425 12.71562 Q8IV61 GRP3_HUMAN Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1) RASGRP3 GRP3 KIAA0846 Homo sapiens (Human) MAPK cascade [GO:0000165]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267]; MAPK cascade [GO:0000165]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267] GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0005887; GO:0007264; GO:0007265; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0043547; GO:0048471 IVLLMHR 7.349999905 0.568655074 0.568655074 0.23563476 896.4949138 17.01848 0 0 0 17.73194 0 0 0 15.16272 0 18.25534 19.85053 0 0 17.09968 0 0 0 0 0 0 0 0 0 0 19.04762 0 0 18.06278 0 0 0 0 0 0 0 0 0 0 0 0 0 18.31855 0 0 0 0 0 Q8IVB5 LIX1L_HUMAN LIX1-like protein LIX1L Homo sapiens (Human) autophagosome maturation [GO:0097352] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352] GO:0005737; GO:0097352 EAVEAVVR 7.46999979 0.74929744 0.74929744 0.09269869 872.3183567 0 18.53753 16.65164 16.32913 0 0 19.95509 16.07391 15.78292 16.97628 19.17265 15.4683 13.17398 16.81769 0 0 0 0 18.17116 0 0 18.2561 0 18.53595 18.519 17.53881 14.38062 12.67662 17.31985 0 0 0 16.76001 18.43306 0 14.86686 18.60637 0 16.42126 18.84493 18.04664 17.32023 18.32861 15.97864 15.68683 18.83883 10.40463 16.97424 Q8IVC4 ZN584_HUMAN Zinc finger protein 584 ZNF584 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 VHTPERR 7.349999905 1 1 0.220179283 895.0367605 0 0 15.4863 0 0 14.44269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.64101 0 0 0 0 0 0 0 0 0 0 0 17.11321 0 0 0 0 0 0 0 0 0 0 0 Q8IVD9 NUDC3_HUMAN NudC domain-containing protein 3 NUDCD3 KIAA1068 Homo sapiens (Human) cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793] unfolded protein binding [GO:0051082] GO:0005737; GO:0005868; GO:0006457; GO:0051082; GO:0060271; GO:1905793 VLMEGKLTHK 3.569999933 1 1 0.164743696 1170.7071 0 0 14.92801 14.19369 0 0 0 0 0 0 13.48574 14.24825 11.32965 15.23363 13.15924 14.39255 0 0 0 0 0 0 0 0 0 14.64258 0 0 0 0 0 16.81563 0 17.03168 0 0 0 15.84531 0 0 0 0 14.93715 12.5454 0 0 0 0 Q8IVE3 PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 PLEKHH2 KIAA2028 Homo sapiens (Human) negative regulation of actin filament depolymerization [GO:0030835] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; negative regulation of actin filament depolymerization [GO:0030835] actin binding [GO:0003779] GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016604; GO:0030027; GO:0030835; GO:0030864 ALNSPLGK 10.81000042 0.141342625 0.141342625 0.17324138 800.481182 14.77254 0 0 0 0 14.26442 0 13.89967 0 15.50404 14.64157 0 16.04697 15.09436 18.984 19.00421 16.15409 18.85196 17.41912 17.92977 17.96548 0 19.43061 18.70732 16.36596 15.6086 17.67407 16.63536 19.87818 19.10268 18.98632 18.07844 14.99358 14.76544 17.70514 17.77365 17.79577 17.00017 16.40266 17.09948 18.67475 13.48555 20.63865 16.8926 17.96962 17.64137 17.3914 18.51189 Q8IVF2 AHNK2_HUMAN Protein AHNAK2 AHNAK2 C14orf78 KIAA2019 Homo sapiens (Human) regulation of RNA splicing [GO:0043484] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; regulation of RNA splicing [GO:0043484] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030315; GO:0042383; GO:0043484 AGPGSQRR 6.309999943 1 1 0.220561172 828.6559357 16.68268 0 15.81554 15.63038 0 15.16555 0 16.51085 0 0 13.43816 0 17.38399 16.91557 0 18.38278 17.80014 15.41036 17.18971 17.7728 17.04633 16.46916 16.95418 16.32959 17.05029 16.72956 17.4004 17.47536 17.91676 15.80057 16.85028 17.6566 16.64009 16.74041 17.34101 18.48435 18.32285 17.53059 18.7849 17.29887 17.99684 16.33991 17.62842 18.01126 18.03157 17.11574 17.92362 17.53315 Q8IVF4 DYH10_HUMAN Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10) DNAH10 KIAA2017 Homo sapiens (Human) microtubule-based movement [GO:0007018] axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874] axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959 ATEVSEKLK 6.769999981 1 1 0.222131138 1005.413717 0 15.11355 13.74625 14.2624 0 15.31318 15.40192 15.15407 0 12.74519 13.3628 14.35412 15.75568 0 16.0381 14.99174 15.81428 14.5434 14.19669 15.53353 0 14.52096 0 0 0 0 15.96982 15.24433 12.48688 16.51873 13.3365 0 0 0 15.48903 15.78436 0 15.58606 13.89767 0 15.13587 14.27904 0 14.6359 15.51494 14.18975 14.18159 15.3196 Q8IVF5 TIAM2_HUMAN "Rho guanine nucleotide exchange factor TIAM2 (SIF and TIAM1-like exchange factor) (T-lymphoma invasion and metastasis-inducing protein 2, TIAM-2)" TIAM2 KIAA2016 STEF Homo sapiens (Human) activation of GTPase activity [GO:0090630]; positive regulation of axonogenesis [GO:0050772]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; synapse [GO:0045202] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; positive regulation of axonogenesis [GO:0050772]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0007264; GO:0016020; GO:0030027; GO:0030175; GO:0030426; GO:0043204; GO:0045202; GO:0050772; GO:0051056; GO:0070062; GO:0090630 AMEKVASHINEMQK 1.769999981 1 1 6.96E-13 1647.231763 0 0 0 0 0 0 0 0 16.69086 0 0 0 0 0 0 0 0 0 0 14.8813 0 0 0 14.38509 0 0 0 0 0 0 0 0 16.50015 0 0 0 0 0 16.83932 0 16.93467 0 0 0 0 0 0 0 Q8IVF6 AN18A_HUMAN Ankyrin repeat domain-containing protein 18A ANKRD18A KIAA2015 Homo sapiens (Human) MITKTVAR 11.85000038 1 1 0.276353202 917.2301446 17.75291 17.21385 15.78974 0 17.79114 0 17.77509 0 0 0 19.31224 17.5653 0 0 17.58873 18.28426 0 0 16.13276 0 0 0 0 0 18.18462 0 0 0 0 16.77301 19.42018 18.77169 0 0 0 0 0 20.32819 18.60856 19.87132 0 16.33122 0 15.55896 0 16.36603 18.75611 0 Q8IVG5 SAM9L_HUMAN "Sterile alpha motif domain-containing protein 9-like, SAM domain-containing protein 9-like" SAMD9L C7orf6 DRIF2 KIAA2005 UEF Homo sapiens (Human) cytoplasm [GO:0005737]; early endosome [GO:0005769] cytoplasm [GO:0005737]; early endosome [GO:0005769] GO:0005737; GO:0005769 HFYIKEK 5.679999828 0.278196096 0.278196096 0.126118253 964.3604334 0 15.50818 13.62148 12.8944 15.96909 14.39384 11.58035 14.70023 13.42933 16.18445 14.65975 15.54237 0 0 14.87046 0 12.39364 0 0 0 0 0 15.37043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.36139 0 0 0 0 0 0 0 0 Q8IVH2 FOXP4_HUMAN Forkhead box protein P4 (Fork head-related protein-like A) FOXP4 FKHLA Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 VQMQVVQQLEIQLAK 9.970000267 0.336612612 0.336612612 0.06567743 1769.913573 0 17.99823 13.37679 0 14.1094 15.53512 0 0 0 0 13.52789 0 17.99442 14.29196 18.23474 12.43575 0 14.60425 0 15.81355 0 13.78636 13.8056 0 0 0 15.98765 19.38055 0 16.75633 0 0 0 0 0 0 18.19813 13.33528 0 20.53962 0 15.64051 16.59177 0 0 12.78586 17.10261 0 Q8IVH4 MMAA_HUMAN "Methylmalonic aciduria type A protein, mitochondrial, EC 3.6.-.-" MMAA Homo sapiens (Human) cobalamin metabolic process [GO:0009235] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metallochaperone activity [GO:0016530]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metallochaperone activity [GO:0016530]; protein homodimerization activity [GO:0042803] GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009235; GO:0016530; GO:0042802; GO:0042803 MKDFQDLMLASGELTAK 4.039999962 1 1 0.619193356 1912.758589 17.91545 0 0 0 0 0 18.74029 18.60336 0 0 0 0 0 0 0 18.37653 0 0 0 0 0 0 0 0 0 19.38443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.34395 0 0 Q8IVH8 M4K3_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 3, EC 2.7.11.1 (Germinal center kinase-related protein kinase, GLK) (MAPK/ERK kinase kinase kinase 3, MEK kinase kinase 3, MEKKK 3)" MAP4K3 RAB8IPL1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556; GO:0106310 GTNLSRK 5.71999979 0.949284256 0.949284256 0.126746863 770.4734279 0 0 0 0 0 0 0 0 0 16.23019 0 15.61847 0 16.46534 0 16.94044 0 15.58903 0 0 0 0 0 0 14.94228 17.54913 0 14.0561 16.93311 14.57377 16.99168 17.29992 0 16.78862 14.96471 15.71499 0 15.37068 15.40588 0 17.01105 0 18.47654 18.03996 15.63101 17.05802 0 15.5897 Q8IVJ1 S41A1_HUMAN Solute carrier family 41 member 1 SLC41A1 Homo sapiens (Human) cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001] inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857] GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0022890; GO:0030001; GO:0032991; GO:0061768; GO:0071286; GO:1903830 GPAPPSPLK 1.350000024 1 1 0.038409919 864.9831307 15.90743 14.04363 13.33524 15.22458 12.93085 15.67308 0 14.39701 14.23751 15.27101 0 16.75352 14.46059 13.96043 13.6367 16.57435 0 14.6265 0 0 0 15.81711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.56633 0 15.43572 0 Q8IVJ8 APRG1_HUMAN APRG1 tumor suppressor candidate (AP20 region protein 1) APRG1 C3orf35 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MKTMATR 5.429999828 0.245229974 0.245229974 0.145436217 838.4010604 17.05647 0 0 15.36624 0 0 0 17.25961 16.72134 13.43867 0 0 13.79003 0 12.65281 13.9568 0 0 18.5046 0 0 0 0 0 0 17.46573 0 18.18437 17.03233 13.90788 0 19.71805 11.8053 16.3252 14.6933 0 0 0 17.34262 17.87928 0 1.17742 0 16.19902 0 0 0 14.36446 Q8IVL0 NAV3_HUMAN "Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3, unc53H3)" NAV3 KIAA0938 POMFIL1 STEERIN3 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116] nuclear outer membrane [GO:0005640] nuclear outer membrane [GO:0005640]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017] GO:0005524; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703 AISHSGSFR 4.769999981 0.453248352 0.453248352 0.250551188 961.7639749 15.94425 17.37635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.78279 0 0 0 0 0 17.46429 0 0 0 0 0 17.26927 0 0 0 0 18.88847 0 0 18.57962 0 0 0 0 0 0 0 16.83939 18.16127 0 Q8IVL1 NAV2_HUMAN "Neuron navigator 2, EC 3.6.4.12 (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2, unc53H2)" NAV2 HELAD1 KIAA1419 POMFIL2 RAINB1 STEERIN2 Homo sapiens (Human) glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564] interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654] interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heparin binding [GO:0008201] GO:0003025; GO:0005524; GO:0005614; GO:0005654; GO:0007399; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0016887; GO:0021554; GO:0021563; GO:0021564; GO:0022008; GO:0043138 SLPRPSKSNSR 3.099999905 1 1 0.213380967 1229.772853 0 16.18501 7.598227 0 0 0 0 0 0 0 0 19.00956 0 0 0 0 16.91685 0 0 0 0 0 0 0 0 0 0 0 0 0 17.02225 19.2659 0 0 20.12163 0 0 0 0 0 0 19.44869 0 0 0 16.79793 19.76552 0 Q8IVM0 CCD50_HUMAN Coiled-coil domain-containing protein 50 (Protein Ymer) CCDC50 C3orf6 Homo sapiens (Human) sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase binding [GO:0031625]; sensory perception of sound [GO:0007605] ubiquitin protein ligase binding [GO:0031625] GO:0005737; GO:0005829; GO:0007605; GO:0031625 ELQEEKK 13.84000015 0.122403063 0.122403063 0.213890952 902.2331803 0 14.03156 14.9935 0 0 0 15.19492 0 0 14.85742 0 0 0 0 0 0 0 0 16.2451 0 15.18977 0 16.71952 16.85101 0 15.71643 0 0 16.10088 13.22471 0 0 15.79491 0 15.19024 0 0 17.59185 0 0 0 0 0 0 0 0 0 0 Q8IVM8 S22A9_HUMAN Solute carrier family 22 member 9 (Organic anion transporter 7) SLC22A9 hOAT4 OAT7 UST3 Homo sapiens (Human) hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252] anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] GO:0009914; GO:0015301; GO:0015347; GO:0015636; GO:0015711; GO:0015913; GO:0016021; GO:0016323; GO:0043252 AAHRSGMK 10.68999958 0.744733274 0.744733274 0.237530675 860.1071716 0 15.27487 16.05213 16.45152 0 15.14856 16.85544 14.29433 13.65702 12.60885 15.5496 17.05785 17.88814 0 0 0 14.75363 0 0 0 12.94174 0 0 16.38001 14.95442 14.92902 15.85448 16.0472 14.79429 14.66306 0 0 17.08416 16.63617 0 14.86703 0 0 0 0 0 0 14.70631 0 0 0 0 0 Q8IVN3 MSTN1_HUMAN Musculoskeletal embryonic nuclear protein 1 MUSTN1 Homo sapiens (Human) chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; tissue regeneration [GO:0042246] nucleus [GO:0005634] nucleus [GO:0005634]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; tissue regeneration [GO:0042246] GO:0002062; GO:0005634; GO:0035988; GO:0042246 MSQAGAQEAPIK 3.160000086 0.772103071 0.772103071 0.108725296 1231.346005 17.47216 17.44083 16.61995 17.54318 0 15.43257 17.45012 16.5871 13.22725 16.92971 0 16.92137 15.53043 13.98988 0 17.04191 15.2744 0 15.40247 0 0 0 18.43831 14.03438 14.89787 0 0 0 14.92794 16.25996 0 15.89887 0 17.62724 17.36073 0 0 15.42505 9.498008 0 13.69559 15.93142 15.55074 0 12.50751 15.94865 0 17.35119 Q8IVQ6 ZDH21_HUMAN "Palmitoyltransferase ZDHHC21, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 21, DHHC-21) (Zinc finger DHHC domain-containing protein 21)" ZDHHC21 Homo sapiens (Human) adrenergic receptor signaling pathway [GO:0071875]; hair follicle development [GO:0001942]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of leukocyte adhesion to arterial endothelial cell [GO:1904997]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of vascular associated smooth muscle contraction [GO:0003056]; sebaceous gland development [GO:0048733] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; adrenergic receptor signaling pathway [GO:0071875]; hair follicle development [GO:0001942]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of leukocyte adhesion to arterial endothelial cell [GO:1904997]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of vascular associated smooth muscle contraction [GO:0003056]; sebaceous gland development [GO:0048733] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] GO:0000139; GO:0001942; GO:0003056; GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0048733; GO:0050999; GO:0071875; GO:1903140; GO:1904997 CNLMRPKR 11.5 1 1 0.218197001 1073.831124 15.03668 0 16.18379 14.96454 0 0 0 14.1868 15.88486 0 15.50355 0 0 14.98839 15.57562 12.75011 12.06567 0 16.01072 14.90687 16.39526 0 16.9108 16.56403 0 0 12.21434 0 14.47965 0 15.2553 14.7743 0 14.68251 15.63982 0 0 14.79678 0 13.33338 0 14.15709 0 0 0 0 0 0 Q8IVT2 MISP_HUMAN Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein) MISP C19orf21 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776] actin filament [GO:0005884]; cell cortex [GO:0005938]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616] actin filament [GO:0005884]; cell cortex [GO:0005938]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; actin filament binding [GO:0051015]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776] actin filament binding [GO:0051015] GO:0000132; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0016477; GO:0031616; GO:0043231; GO:0051015; GO:0051301; GO:0051640; GO:0051660; GO:0090307; GO:1904776 EGLHVGRASTPDWVSEGPQPGLR 5.880000114 1 1 0.243285575 2441.8198 14.68936 16.20768 15.11609 0 13.99019 13.06631 0 15.18456 15.3577 0 15.46106 0 16.90972 14.90155 0 14.96368 15.95706 15.80688 0 0 17.06204 17.08217 16.58349 15.00086 0 15.89702 0 0 15.88547 0 17.05001 16.51648 16.53284 0 0 0 0 0 0 0 0 0 0 0 0 0 17.01512 0 Q8IVT5 KSR1_HUMAN "Kinase suppressor of Ras 1, EC 2.7.11.1" KSR1 KSR Homo sapiens (Human) cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; signal transduction [GO:0007165] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005078; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0007165; GO:0007265; GO:0008022; GO:0016020; GO:0019933; GO:0032587; GO:0032991; GO:0042127; GO:0043231; GO:0043405; GO:0043410; GO:0046872; GO:0071889; GO:0106310 CGASGDECGRLQYALTCLR 3.769999981 1 1 0.159602225 2182.008971 14.21677 13.66067 15.28071 0 16.02468 0 0 12.61316 0 0 13.51627 0 0 0 15.06071 0 15.1244 14.14578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVU1 IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule) IGDCC3 PUNC Homo sapiens (Human) cell-cell adhesion [GO:0098609]; neuromuscular process controlling balance [GO:0050885] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cell-cell adhesion [GO:0098609]; neuromuscular process controlling balance [GO:0050885] GO:0005887; GO:0050885; GO:0098609 NGQVLGPGGHVRLK 15.03999996 1 1 0.109639458 1426.47027 0 13.53295 15.48962 0 0 14.88497 0 0 14.25989 0 0 15.74853 0 0 0 13.74788 0 14.96047 15.78549 17.33 0 15.67229 0 16.09555 14.42344 15.23484 13.01549 0 13.22371 0 16.16634 13.79104 16.28594 15.98379 15.18544 12.73317 15.46414 0 0 0 0 0 0 0 17.06594 0 0 0 Q8IVU3 HERC6_HUMAN "Probable E3 ubiquitin-protein ligase HERC6, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 6) (HECT-type E3 ubiquitin transferase HERC6)" HERC6 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; response to bacterium [GO:0009617] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; hematopoietic progenitor cell differentiation [GO:0002244]; response to bacterium [GO:0009617] ubiquitin-protein transferase activity [GO:0004842] GO:0002244; GO:0004842; GO:0005654; GO:0005829; GO:0009617 AVCEMSK 3.559999943 1 1 0.118581608 840.9876909 0 15.47252 0 0 0 15.21378 0 0 0 15.51806 16.03852 13.18742 0 0 0 0 0 0 0 0 0 0 0 0 16.42104 0 0 14.77802 0 0 0 18.98129 0 0 0 0 0 0 0 0 15.61757 0 0 0 0 0 0 0 Q8IVV2 LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 LOXHD1 Homo sapiens (Human) sensory perception of sound [GO:0007605] stereocilium [GO:0032420] stereocilium [GO:0032420]; sensory perception of sound [GO:0007605] GO:0007605; GO:0032420 EQNDTFIMEILDIAPFTKMR 2.470000029 0.603762448 0.603762448 0.266827911 2428.544722 12.72657 0 15.35317 0 13.17754 15.08602 15.49002 0 0 0 0 0 14.5727 0 0 16.0877 15.08408 0 0 0 0 14.34669 0 16.30238 14.80302 11.78849 13.34096 0 13.29911 11.41603 16.27384 13.78723 14.5578 0 0 16.26469 0 0 16.57727 15.16802 0 0 0 0 0 0 0 0 Q8IW19 APLF_HUMAN "Aprataxin and PNK-like factor, EC 3.1.-.- (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1)" APLF C2orf13 PALF XIP1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA ligation [GO:0051106]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA ligation [GO:0051106]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012] 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006974; GO:0008408; GO:0035861; GO:0045191; GO:0046872; GO:0051106 DGGPRVALAPGETVIGR 8.420000076 0.884688497 0.884688497 0.188485146 1663.320838 13.30448 0 17.96829 13.37873 15.52492 14.98051 0 0 0 0 0 14.43716 14.98681 15.21085 13.84017 13.39222 10.89544 0 14.46511 14.86039 10.5302 0 14.40914 0 16.40298 15.34576 16.04663 0 15.88036 13.84868 0 16.67718 0 14.05013 17.22626 13.97836 0 16.31269 8.541345 15.15143 0 15.73524 0 14.56998 0 0 0 0 Q8IW35 CEP97_HUMAN "Centrosomal protein of 97 kDa, Cep97 (Leucine-rich repeat and IQ domain-containing protein 2)" CEP97 LRRIQ2 Homo sapiens (Human) cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; calmodulin binding [GO:0005516]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673] calmodulin binding [GO:0005516] GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018 MAPAYLPR 11.34000015 0.507045925 0.507045925 0.203728671 919.3179901 15.73703 14.98298 12.6241 0 14.70061 15.02459 0 0 16.15276 0 0 15.93756 14.49442 12.29517 16.54069 13.88831 15.39858 12.69071 0 0 14.16697 15.78015 15.24211 0 16.0382 12.46777 12.93782 15.17518 13.04523 13.6624 15.73806 14.68119 0 14.85021 15.23475 11.74864 12.71648 16.77643 14.98527 12.4823 12.99817 15.17087 14.203 14.71294 12.61183 15.42421 14.44814 0 Q8IW40 CC103_HUMAN Coiled-coil domain-containing protein 103 CCDC103 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; protein homodimerization activity [GO:0042803]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] protein homodimerization activity [GO:0042803] GO:0001947; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036158; GO:0036159; GO:0042803; GO:0060287; GO:0070286; GO:0071907 LQAMGNPRSVK 17.18000031 1 1 0.077711207 1216.915151 21.47741 0 0 0 0 0 0 0 0 0 0 0 0 0 19.24067 0 0 0 0 0 0 18.62115 18.29243 0 0 0 0 16.81721 0 0 19.22125 20.10713 18.85697 0 0 19.5776 20.08517 0 0 0 0 0 19.179 20.47506 0 0 0 0 Q8IW93 ARHGJ_HUMAN Rho guanine nucleotide exchange factor 19 (Ephexin-2) ARHGEF19 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" cytosol [GO:0005829] "cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005096; GO:0005829; GO:0032956; GO:0042060; GO:0051056; GO:0060071; GO:0090630 LGEAPV 7.239999771 1 1 0.099794186 585.4821604 18.9101 17.92037 15.4109 16.22185 18.22447 18.71526 15.4394 0 16.34802 17.81496 0 16.43106 16.59317 16.25891 18.81176 16.22074 17.67701 19.35972 14.90863 0 16.98583 16.08147 15.22217 0 0 0 0 17.4412 15.33691 0 17.26747 18.43864 0 17.18616 18.09617 16.86107 0 18.87599 17.91873 16.62238 19.53184 0 15.91198 18.35868 16.72311 17.4739 15.59881 0 Q8IWA0 WDR75_HUMAN WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog) WDR75 UTP17 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0045943; GO:2000234 DVPESFTSEAYQWLNR 1.129999995 1 1 0.048012872 1941.137795 14.05938 14.46649 12.93297 0 13.10125 0 13.63332 15.00153 14.34594 12.74335 0 14.83731 15.00059 0 14.71437 0 14.08064 13.51884 15.41418 0 0 0 0 13.63113 13.25681 12.42065 0 0 0 13.77168 0 0 0 14.85405 11.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWA4 MFN1_HUMAN "Mitofusin-1, EC 3.6.5.- (Fzo homolog) (Transmembrane GTPase MFN1)" MFN1 Homo sapiens (Human) GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918] integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799] integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0008053; GO:0010918; GO:0016021; GO:0031306; GO:0031307; GO:0042802; GO:0046039; GO:0051646; GO:0098799; GO:1990613 HIEDGMGR 3.410000086 1 1 0.17151087 928.7524015 0 0 0 0 15.67988 0 0 0 15.67394 0 0 0 0 15.49622 15.73888 0 16.32416 0 0 17.41454 0 17.21885 0 0 0 15.50635 0 14.43886 0 0 16.56784 0 0 15.21218 16.7245 0 15.80228 16.61483 16.70189 0 11.51557 14.01533 14.62465 9.397943 16.37024 14.88144 16.86987 16.34378 Q8IWA5 CTL2_HUMAN Choline transporter-like protein 2 (Solute carrier family 44 member 2) SLC44A2 CTL2 PSEC0210 Homo sapiens (Human) choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085] choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857] GO:0005739; GO:0005765; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0035579; GO:0043123; GO:0055085; GO:0070062 LLNKTNK 8.909999847 0.379900038 0.379900038 0.285947159 828.8089889 16.7211 15.99703 16.65182 0 0 0 0 15.99014 15.26388 16.23663 16.11371 16.72031 16.44976 14.17684 0 0 0 12.62245 15.79181 12.60513 14.52533 16.34811 16.2204 13.26031 14.89888 15.25546 14.70331 16.40107 17.38462 14.65065 15.09825 17.12089 15.50591 17.18923 15.66668 0 18.2741 16.80075 16.77335 0 16.28034 16.37898 0 16.99682 0 0 16.55525 0 Q8IWA6 CCD60_HUMAN Coiled-coil domain-containing protein 60 CCDC60 Homo sapiens (Human) MEILMK 12.10000038 0.00556007 0.00556007 0.299359355 796.961293 18.41567 0 17.99296 0 0 17.46308 0 0 0 0 0 0 0 0 0 0 16.26974 0 0 0 0 17.70769 0 0 0 21.64119 0 0 0 0 22.10584 0 0 0 0 0 0 0 0 0 18.30863 18.20799 0 17.43393 0 20.46197 17.84857 17.15745 Q8IWB1 IPRI_HUMAN "Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER)" ITPRIP DANGER KIAA1754 Homo sapiens (Human) negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042] protein kinase inhibitor activity [GO:0004860] GO:0004860; GO:0005640; GO:0005886; GO:0016020; GO:0016021; GO:1902042 MAMGLFR 5.989999771 1 1 0.164847963 840.842196 0 14.83676 13.35652 13.38197 14.25279 12.73895 0 14.35032 13.63194 14.66526 15.55316 15.84834 0 0 0 0 16.2305 0 14.30755 0 0 0 14.29787 0 0 0 0 0 0 0 0 16.4489 0 0 0 0 0 0 0 0 0 16.71298 14.91345 0 0 0 0 0 Q8IWB9 TEX2_HUMAN Testis-expressed protein 2 (Transmembrane protein 96) TEX2 KIAA1738 TMEM96 Homo sapiens (Human) lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665] lipid binding [GO:0008289] GO:0005783; GO:0005789; GO:0006665; GO:0006869; GO:0007165; GO:0008289; GO:0016021; GO:0031965 ARPKLGER 9.090000153 0.451999784 0.451999784 0.147986626 926.7918263 14.75737 15.69103 15.53697 15.69506 12.83298 16.42113 15.07578 13.70194 12.98875 15.54869 0 13.77157 14.53823 15.99736 15.49699 15.11041 0 15.9655 13.01754 15.96252 16.80741 16.42824 13.96982 0 16.97092 14.07613 0 16.51597 16.64491 16.94003 15.90546 14.84889 15.79497 15.85233 15.1427 16.06611 15.33673 16.1678 0 16.58456 15.66749 15.55834 17.36288 14.61266 17.28754 16.45951 16.30797 0 Q8IWC1 MA7D3_HUMAN MAP7 domain-containing protein 3 MAP7D3 MDP3 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785] cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819] cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785] microtubule binding [GO:0008017]; tubulin binding [GO:0015631] GO:0000226; GO:0005737; GO:0005819; GO:0008017; GO:0015630; GO:0015631; GO:0016020; GO:0046785 HMIYEESGNK 1.720000029 0.196203887 0.196203887 0.185026988 1211.227023 11.72544 11.73984 0 0 10.29301 12.71147 0 0 0 11.32157 14.39102 0 0 0 0 0 0 0 0 0 0 0 15.29846 16.09597 14.21856 13.50294 0 0 15.11517 13.37128 0 0 0 0 0 0 0 0 0 0 0 0 13.89468 0 0 0 0 0 Q8IWE2 NXP20_HUMAN Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1) FAM114A1 NOXP20 Homo sapiens (Human) cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] GO:0005654; GO:0005794; GO:0005829 MLTELLFELHVAATPDKLNK 10.89999962 1 1 0.146515139 2300.000356 14.97803 17.86225 16.18891 0 17.78773 0 17.18882 0 17.00426 0 14.6479 0 0 0 0 15.87982 0 19.11349 0 17.73998 0 0 15.16152 0 0 0 0 17.6535 17.96155 0 0 0 0 0 0 16.42408 17.79664 0 0 0 0 0 0 0 0 18.73037 0 19.69622 Q8IWE5 PKHM2_HUMAN "Pleckstrin homology domain-containing family M member 2, PH domain-containing family M member 2 (Salmonella-induced filaments A and kinesin-interacting protein, SifA and kinesin-interacting protein)" PLEKHM2 KIAA0842 SKIP Homo sapiens (Human) Golgi organization [GO:0007030]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880] endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765] endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; kinesin binding [GO:0019894]; Golgi organization [GO:0007030]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880] kinesin binding [GO:0019894] GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:1903527 EEAQALDPPDACTELEVIR 2.74000001 1 1 2.75E-12 2155.506184 0 15.26215 10.70192 0 14.87642 0 13.35387 0 11.86952 11.10282 11.09803 12.76144 11.94513 0 0 11.56732 0 0 0 0 0 0 0 0 15.47025 0 14.17074 0 0 0 0 0 0 0 0 0 14.11044 15.31598 0 15.26375 0 0 0 13.83188 13.47992 0 0 12.59693 Q8IWF9 CCD83_HUMAN Coiled-coil domain-containing protein 83 CCDC83 HSD9 Homo sapiens (Human) EENSGTEFGDTDMK 5.5 1 1 0.433592997 1560.733716 0 15.95797 0 14.33604 0 0 0 0 0 0 0 16.37451 15.16778 15.39713 16.00436 0 0 0 0 15.95044 0 0 0 0 0 16.91522 16.98165 0 0 15.07652 17.21869 16.5103 16.33463 0 0 17.55115 0 0 17.81601 16.75246 0 17.04103 17.47783 0 18.29283 16.92426 0 17.06338 Q8IWG1 DNAI3_HUMAN Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) DNAI3 WDR63 Homo sapiens (Human) cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] GO:0005737; GO:0005858; GO:0007018; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 FFVGTEEGEVIYTDWKMEK 7.039999962 1 1 4.12E-12 2323.390856 15.41168 12.9311 0 10.59813 13.38659 12.83969 0 12.93477 0 12.63377 0 14.54699 16.76455 13.72447 12.04425 15.06409 14.2231 14.70482 12.43511 13.97045 0 0 9.391733 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10855 0 0 0 0 11.67004 0 0 0 0 0 0 Q8IWI9 MGAP_HUMAN MAX gene-associated protein (MAX dimerization protein 5) MGA KIAA0518 MAD5 Homo sapiens (Human) cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0005654; GO:0006357; GO:0046983; GO:0071339 AFSEIQGLTDQADK 4.510000229 0.618424535 0.618424535 0.12476369 1518.780686 12.90709 15.65947 16.21163 0 17.61941 16.43249 0 0 15.64813 12.49319 14.57185 14.88318 14.24184 0 15.64493 12.55138 19.15369 14.34152 12.46382 16.07979 0 16.52691 10.86561 14.98966 15.41731 14.95477 14.58091 17.12892 15.85872 12.91869 14.21326 0 14.2084 13.25536 15.91138 15.06793 17.34577 0 14.94065 0 15.96259 0 13.52653 0 15.95416 15.47206 0 13.69637 Q8IWJ2 GCC2_HUMAN "GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein, GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4, RanBP2L4) (Renal carcinoma antigen NY-REN-53)" GCC2 KIAA0336 RANBP2L4 Homo sapiens (Human) "Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]" identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0031267; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161 DQLSASMR 21.94000053 0.413854986 0.413854986 0.163220123 922.6440328 18.6907 20.54091 19.28699 19.47714 0 18.75418 19.00074 20.18049 20.21017 19.37689 20.2829 19.50648 19.29325 18.10639 19.39669 20.2499 16.42558 18.06045 16.69028 20.53484 18.46813 17.59347 19.55547 20.20307 18.83865 15.83289 19.12701 19.61588 17.44764 17.81702 10.64862 15.81276 0 19.91334 20.24982 19.12989 19.63742 15.61022 19.05559 18.7662 16.63849 16.95416 19.32585 15.45129 18.89076 19.44088 19.74767 17.88284 Q8IWN7 RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein RP1L1 Homo sapiens (Human) axoneme assembly [GO:0035082]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] axoneme [GO:0005930]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; axoneme assembly [GO:0035082]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] GO:0001750; GO:0005874; GO:0005930; GO:0007601; GO:0032391; GO:0035082; GO:0035556; GO:0042461; GO:0045494; GO:0060041 EAPGTSSSR 7.909999847 0.325853348 0.325853348 0.183340695 891.8456339 0 16.20154 10.16829 13.3435 19.42758 13.52253 15.29258 12.93015 15.47852 15.29182 17.5729 17.33485 0 0 16.08454 15.26572 14.24447 14.095 0 17.51664 11.51799 15.55787 15.85612 17.84342 13.29528 14.36679 0 16.09103 0 14.52281 15.24691 17.43106 17.7665 15.76624 15.53936 0 16.11537 16.56701 17.50976 0 0 13.77027 0 0 17.54806 15.91279 0 15.85311 Q8IWQ3 BRSK2_HUMAN "Serine/threonine-protein kinase BRSK2, EC 2.7.11.1 (Brain-selective kinase 2, EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2, BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A)" BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]" ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0000086; GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030182; GO:0031532; GO:0035556; GO:0036503; GO:0042149; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807 DKPLSSIK 8.569999695 1 1 0.081084596 886.1077585 0 0 0 0 0 0 0 0 14.71074 0 0 0 0 14.10394 0 0 0 0 13.47481 0 14.43513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.87529 0 0 0 0 0 0 0 0 0 0 Q8IWR0 Z3H7A_HUMAN Zinc finger CCCH domain-containing protein 7A ZC3H7A ZC3H7 ZC3HDC7 HSPC055 Homo sapiens (Human) posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196] metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0010608; GO:0035196; GO:0035198; GO:0046872 DLSTSTSR 4.079999924 1 1 0.115397278 866.9594984 0 0 0 0 14.72671 0 15.42092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67765 0 17.22134 15.51606 0 0 16.5714 0 0 0 0 0 16.86946 16.6807 0 0 0 0 0 0 0 0 Q8IWS0 PHF6_HUMAN PHD finger protein 6 (PHD-like zinc finger protein) PHF6 CENP-31 KIAA1823 Homo sapiens (Human) blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tubulin binding [GO:0015631] GO:0000122; GO:0000776; GO:0001835; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0015631; GO:0019899; GO:0042393; GO:0042826; GO:0043021; GO:0046872; GO:0051219; GO:0097110 TYHYHCGVQDK 7.179999828 1 1 0.431705697 1405.267707 16.82807 15.66851 14.14075 0 0 0 0 0 0 0 0 0 16.62551 14.66335 0 0 12.58195 0 0 16.02386 0 0 0 15.21597 16.13513 15.60232 0 16.204 15.93101 0 12.93034 13.18146 0 0 15.60865 13.54475 0 0 0 0 12.88761 0 0 0 0 0 15.92945 0 Q8IWT3 CUL9_HUMAN "Cullin-9, CUL-9 (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein)" CUL9 H7AP1 KIAA0708 PARC Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625] GO:0000226; GO:0005524; GO:0005829; GO:0006511; GO:0007088; GO:0016567; GO:0016740; GO:0031461; GO:0031625; GO:0046872 CNHGFCWR 1.75 1 1 2.31E-13 1137.400183 14.80681 17.05095 18.3315 16.61422 15.65743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWT6 LRC8A_HUMAN "Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A, HsLRRC8A) (Swelling protein 1)" LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; anion transport [GO:0006820]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular glucose homeostasis [GO:0001678]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transport [GO:0015734] cell surface [GO:0009986]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; anion transport [GO:0006820]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular glucose homeostasis [GO:0001678]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transport [GO:0015734] cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225] GO:0001678; GO:0002329; GO:0005225; GO:0005886; GO:0005887; GO:0006820; GO:0006884; GO:0006970; GO:0007283; GO:0009986; GO:0015734; GO:0015810; GO:0016020; GO:0016021; GO:0032024; GO:0034214; GO:0034702; GO:0042802; GO:0045663; GO:0098656; GO:0140360; GO:0140361; GO:1902476; GO:1905103 ALHLGNNVLQSLPSR 6.210000038 0.003921647 0.003921647 0.419184443 1617.954059 0 19.43821 16.86327 17.25839 16.1252 0 16.76196 15.43109 16.65359 0 13.78251 15.618 0 16.25145 0 15.05901 0 0 0 0 15.19479 15.36426 14.82646 0 0 0 18.12019 0 0 16.83935 0 0 0 17.11856 18.15696 0 15.59204 17.08024 15.42145 16.80795 18.16003 0 17.39358 0 16.50351 0 16.32673 16.50191 Q8IWU2 LMTK2_HUMAN "Serine/threonine-protein kinase LMTK2, EC 2.7.11.1 (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase, hBREK) (CDK5/p35-regulated kinase, CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2)" LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2 Homo sapiens (Human) axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037] cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001881; GO:0004674; GO:0004712; GO:0004864; GO:0005524; GO:0005769; GO:0005794; GO:0005829; GO:0005887; GO:0006468; GO:0007169; GO:0007409; GO:0016021; GO:0018105; GO:0018107; GO:0030426; GO:0032456; GO:0033572; GO:0033674; GO:0043025; GO:0043235; GO:0045022; GO:0046777; GO:0048471; GO:0055037; GO:0070853; GO:0106310 MPGPPALR 9.090000153 0.366959244 0.366959244 0.186892587 855.8099008 17.12122 15.97006 0 0 15.38312 0 0 15.80314 15.7888 0 16.733 16.41463 15.58212 16.83453 16.74247 0 17.61625 14.22071 0 0 0 0 17.16566 15.90579 17.60258 11.71756 9.349394 16.71121 16.57315 0 15.80816 0 0 16.51501 17.97737 16.65019 0 15.55265 11.39832 15.32427 16.67497 17.02449 15.63811 15.8622 0 16.4316 17.38922 0 Q8IWU5 SULF2_HUMAN "Extracellular sulfatase Sulf-2, hSulf-2, EC 3.1.6.-" SULF2 KIAA1247 UNQ559/PRO1120 Homo sapiens (Human) bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384 LSLAGRR 13.23999977 0.066551328 0.066551328 0.143605857 772.4226265 16.00722 15.37938 15.55687 14.4362 0 15.17175 14.15084 0 0 14.21033 15.31168 16.36583 21.21947 16.16093 17.32104 0 17.39765 16.86801 17.3039 17.29291 16.48296 15.89475 0 0 0 0 16.864 16.28997 22.64449 15.43729 14.34685 21.19089 0 17.70458 0 0 15.34351 0 0 0 17.20763 0 23.01636 0 0 16.23072 0 0 Q8IWU6 SULF1_HUMAN "Extracellular sulfatase Sulf-1, hSulf-1, EC 3.1.6.-" SULF1 KIAA1077 Homo sapiens (Human) apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] GO:0001822; GO:0001937; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0005886; GO:0006915; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0032836; GO:0035860; GO:0040036; GO:0040037; GO:0045121; GO:0048010; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686 EKHGFDYAK 3.440000057 1 1 0.215674221 1095.067649 14.49807 0 14.95472 14.84818 14.03339 14.4572 0 14.92835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.55077 0 0 0 15.19247 0 13.55934 0 0 0 0 0 15.9299 0 13.94099 0 15.56786 14.83168 0 0 0 Q8IWU9 TPH2_HUMAN "Tryptophan 5-hydroxylase 2, EC 1.14.16.4 (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2)" TPH2 NTPH Homo sapiens (Human) aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427] cytosol [GO:0005829]; neuron projection [GO:0043005] cytosol [GO:0005829]; neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427] iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510] GO:0004510; GO:0005506; GO:0005829; GO:0007623; GO:0009072; GO:0014823; GO:0031667; GO:0042427; GO:0043005; GO:0043627; GO:0051384; GO:0051592; GO:0071285 HALSDK 4.78000021 1 1 0.205145443 671.4642963 15.95913 14.89611 14.0245 15.2841 15.76956 0 0 14.99812 0 0 13.72026 14.26091 15.50535 15.56235 0 16.33397 15.63558 16.56925 0 15.53241 0 17.41713 0 16.02958 16.57528 16.68729 0 0 16.36164 16.19192 14.50112 14.55217 16.57403 0 15.39314 0 16.01093 16.16471 17.44212 0 0 16.13463 16.90415 0 16.93216 16.65335 15.40977 0 Q8IWV1 LAX1_HUMAN Lymphocyte transmembrane adapter 1 (Linker for activation of X cells) (Membrane-associated adapter protein LAX) LAX1 LAX Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell activation [GO:0042113]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; lymphocyte activation [GO:0046649]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of T cell activation [GO:0050868] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell activation [GO:0042113]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; lymphocyte activation [GO:0046649]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of T cell activation [GO:0050868] protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169] GO:0002250; GO:0005794; GO:0005829; GO:0005886; GO:0006955; GO:0016020; GO:0016021; GO:0019901; GO:0035556; GO:0042113; GO:0042169; GO:0043407; GO:0046649; GO:0050851; GO:0050868 QEDLGR 4.289999962 1 1 1.03E-12 715.4289075 0 0 13.97128 0 15.4363 0 16.02685 0 0 0 0 0 0 14.57026 0 14.12615 0 0 0 0 0 0 0 13.82897 0 0 15.97182 0 17.31175 0 0 0 16.22003 0 0 16.23024 15.79081 0 0 0 15.87111 16.5621 0 0 0 0 0 0 Q8IWV7 UBR1_HUMAN "E3 ubiquitin-protein ligase UBR1, EC 2.3.2.27 (N-recognin-1) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I)" UBR1 Homo sapiens (Human) cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0000151; GO:0000502; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0032007; GO:0061630; GO:0070728; GO:0071233; GO:0071596 CLVLVAQVVAEMWRR 13.17000008 1 1 0.111610688 1846.174014 0 0 0 0 0 15.07189 15.08689 13.6828 16.33415 16.8204 0 15.99729 16.51625 0 17.13309 16.96772 15.86355 15.96362 0 0 16.20711 17.42214 17.59669 17.39816 19.03789 16.15924 0 12.83953 16.27217 17.09673 13.82364 15.53987 15.19856 18.35597 0 0 17.53763 14.09194 0 0 16.05018 17.87372 0 0 0 0 16.65406 19.13649 Q8IWV8 UBR2_HUMAN "E3 ubiquitin-protein ligase UBR2, EC 2.3.2.27 (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)" UBR2 C6orf133 KIAA0349 Homo sapiens (Human) cellular response to leucine [GO:0071233]; heterochromatin assembly [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; heterochromatin assembly [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596 GPNPFPQK 1.909999967 0.780125737 0.780125737 0.20780334 883.5367831 0 15.00134 14.49158 13.96996 14.28511 14.52412 15.49286 0 12.32566 0 15.09956 0 16.41111 14.68419 14.87461 16.17425 0 14.11174 0 17.45646 15.42943 14.93004 0 0 0 14.71837 19.34715 0 0 0 18.29015 16.99145 16.26019 15.63797 0 0 0 15.88579 0 16.12113 0 15.76488 15.13309 0 16.23466 0 0 15.17604 Q8IWW6 RHG12_HUMAN Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12) ARHGAP12 Homo sapiens (Human) "actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; phagocytic cup [GO:0001891] "cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]" GTPase activator activity [GO:0005096] GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0006911; GO:0007015; GO:0007165; GO:0043087; GO:0051058 ALMPPVKQVAGLPNNSTK 4.010000229 0.000616866 0.000616866 0.173204419 1881.224737 15.44026 14.78184 17.24544 0 14.24045 12.86541 14.94401 16.11463 15.44022 16.35586 0 14.51314 0 13.6054 14.69826 12.60257 9.813562 15.71608 17.01157 0 14.95976 14.65648 15.58994 15.32095 0 18.43744 0 0 16.21538 17.55587 16.64806 18.39242 16.39049 0 12.67717 17.6816 0 15.91688 15.57063 11.32515 14.76756 10.43545 16.89319 14.76158 14.03361 15.80184 0 12.73632 Q8IWW8 HOT_HUMAN "Hydroxyacid-oxoacid transhydrogenase, mitochondrial, HOT, EC 1.1.99.24 (Alcohol dehydrogenase iron-containing protein 1, ADHFe1) (Fe-containing alcohol dehydrogenase)" ADHFE1 HMFT2263 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]; lipid metabolic process [GO:0006629] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]; lipid metabolic process [GO:0006629] alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872] GO:0004022; GO:0005739; GO:0005759; GO:0006103; GO:0006539; GO:0006629; GO:0046872; GO:0047988 NVCLMTDK 2.210000038 0.183746785 0.183746785 0.252301409 996.2543506 16.64228 11.77066 14.82553 13.02775 14.7423 0 0 0 14.99586 18.03303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97106 15.22389 15.53057 0 0 0 0 15.15806 0 0 0 0 16.55084 0 0 16.43667 0 16.94772 0 0 15.81769 0 15.7795 Q8IWX7 UN45B_HUMAN "Protein unc-45 homolog B, Unc-45B (SMUNC45)" UNC45B CMYA4 UNC45 Homo sapiens (Human) cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517] cytosol [GO:0005829] cytosol [GO:0005829]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517] Hsp90 protein binding [GO:0051879] GO:0002088; GO:0005829; GO:0007517; GO:0030154; GO:0051879; GO:0061077 KWLCNMSIDTR 2.349999905 1 1 0.166534095 1440.38509 0 0 16.05995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97901 0 0 0 0 0 0 0 0 0 15.1813 17.14793 0 0 13.6789 0 16.01017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWY9 CDAN1_HUMAN Codanin-1 CDAN1 UNQ664/PRO1295 Homo sapiens (Human) chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497 SLSKPK 2.190000057 1 1 0.013304745 659.5559445 0 0 0 0 0 0 0 0 0 0 0 13.3425 0 14.58696 0 16.28293 0 0 0 0 0 14.80637 0 0 15 0 0 0 0 0 0 0 15.95626 0 0 13.84458 0 0 0 0 16.07622 15.95923 14.6801 0 0 0 0 0 Q8IWZ3 ANKH1_HUMAN "Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain, hMASK)" ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) innate immune response [GO:0045087] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087] RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0045087 DQQAAEANKNASILLK 2.049999952 1 1 0.252433226 1713.797293 15.1837 0 0 0 14.14245 0 0 0 14.35078 12.04098 0 14.18345 12.71679 0 0 0 0 0 0 0 0 0 0 0 0 16.27037 0 0 0 14.70279 14.30744 0 0 0 0 0 12.00025 0 0 0 0 0 0 0 0 0 0 0 Q8IWZ8 SUGP1_HUMAN SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4) SUGP1 SF4 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380 MEMDKTR 5.800000191 1 1 0.091897685 927.1254071 16.92826 0 14.66237 15.08129 14.59015 0 15.78674 16.27293 15.59406 14.85547 15.34438 0 14.75998 0 0 0 0 0 0 0 0 0 0 0 0 13.3731 0 15.76841 17.04335 0 0 0 0 0 15.4109 0 0 0 0 0 0 0 16.19967 17.22838 0 0 0 0 Q8IX01 SUGP2_HUMAN "SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)" SUGP2 KIAA0365 SFRS14 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0016604 AMLYSR 17.95000076 1 1 2.29E-13 755.3407485 0 0 0 16.20692 0 0 0 0 14.06877 0 0 13.289 14.55404 15.85109 14.69818 0 0 0 0 14.43563 0 0 0 16.2643 12.646 15.66902 0 0 0 0 0 17.42797 0 14.8292 0 0 0 0 16.13288 0 0 15.64169 0 0 0 0 14.56581 0 Q8IX03 KIBRA_HUMAN "Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein, KIBRA) (WW domain-containing protein 1)" WWC1 KIAA0869 Homo sapiens (Human) "cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]" kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713] GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0032991; GO:0035330; GO:0035331; GO:0043410; GO:0046621; GO:0048471; GO:0060090 EELLKEMR 3.579999924 1 1 0.205867526 1067.437034 14.67167 15.18246 0 0 15.69005 0 15.55664 14.5125 13.72817 0 14.30301 13.79825 16.20743 15.01446 0 15.37931 16.09569 15.76019 15.05857 15.56216 0 11.58274 14.67833 13.51245 0 14.89264 0 15.29533 14.86783 0 0 16.11968 0 0 16.14008 0 15.20136 0 18.2424 16.00185 0 0 15.88868 16.11333 0 0 0 0 Q8IX06 GOR_HUMAN "Putative exonuclease GOR, EC 3.1.-.- (Antigen GOR homolog) (RNA exonuclease 1 homolog-like 1)" REXO1L1P GOR REXO1L1 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004527; GO:0005634; GO:0005737 GSKVGR 12.82999992 1 1 0.093932771 602.4682516 17.17768 15.69936 17.80781 16.20473 17.4666 16.83053 17.16739 15.65947 17.47085 16.43879 16.99246 16.64928 16.52993 15.24851 16.90436 16.7456 17.34244 17.80282 17.3868 17.36307 17.19746 16.87284 16.47988 16.41432 17.60886 15.26532 16.96141 16.77265 16.90421 16.51648 17.47952 17.63677 17.40188 0 16.98374 18.246 17.43227 14.79296 16.33056 17.62461 18.13021 16.27514 17.28188 15.77026 16.24715 18.17533 17.73018 18.59078 Q8IX15 HOMEZ_HUMAN Homeobox and leucine zipper protein Homez (Homeodomain leucine zipper-containing factor) HOMEZ KIAA1443 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357 HNSVPGRVGPTEYLSPDMQR 4.699999809 1 1 4.61E-13 2255.57001 0 0 0 0 0 0 0 0 0 11.21022 15.92723 0 0 11.53032 13.45659 0 0 0 0 0 0 0 0 0 0 0 0 11.15446 0 13.28976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IX21 SLF2_HUMAN SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1) SLF2 C10orf6 FAM178A Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] GO:0000724; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006974; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0043231; GO:0044877; GO:1990166; GO:2000781 RPDGPHQK 9.159999847 1 1 0.20183905 933.8977226 0 0 0 0 0 0 14.65975 16.22973 15.95379 0 0 0 15.92016 15.74346 0 12.68219 12.12574 15.90778 0 16.17911 13.84382 0 0 0 14.27824 16.12227 0 0 14.85644 0 0 0 0 0 0 0 0 0 14.65152 15.48863 0 0 0 15.65347 0 0 0 13.568 Q8IX29 FBX16_HUMAN F-box only protein 16 FBXO16 FBX16 Homo sapiens (Human) MAFAPPKNTDGPK 10.48999977 0.299701869 0.299701869 0.183205836 1388.834441 15.94628 0 12.13238 0 0 0 0 0 14.78611 0 0 14.83891 14.68256 0 14.54739 0 0 0 0 0 17.40814 0 0 0 0 0 0 0 0 0 0 0 0 17.11833 0 0 0 0 0 0 0 0 0 0 0 0 0 16.36141 Q8IX30 SCUB3_HUMAN "Signal peptide, CUB and EGF-like domain-containing protein 3" SCUBE3 CEGF3 Homo sapiens (Human) positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165] BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700 AEPMESCRPGQHR 1.350000024 1 1 0.261346469 1555.465488 14.21148 14.69479 0 0 0 13.60046 0 0 15.49878 0 14.79824 0 0 0 0 15.01988 0 15.88761 0 0 0 0 16.67737 0 0 14.72776 0 15.56585 0 13.65016 14.31868 13.08912 0 0 0 14.58904 0 0 12.6792 0 0 0 14.52944 16.69422 14.99743 14.15478 13.23416 14.54316 Q8IX94 CTGE4_HUMAN "cTAGE family member 4, Protein cTAGE-4" CTAGE4 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971 MTSLDK 15.18999958 0.539557099 0.539557099 0.260656353 693.7920532 0 18.10361 16.65041 15.82683 16.46612 16.91569 0 18.46214 17.04218 0 0 16.77824 17.21018 16.67676 0 15.78747 0 16.84789 18.81589 0 16.63954 17.85742 0 0 0 16.06006 17.51988 0 15.8907 16.31746 12.79957 0 0 16.54958 16.21846 0 0 16.91477 0 0 0 0 18.335 0 0 16.34962 17.98737 0 Q8IXB1 DJC10_HUMAN "DnaJ homolog subfamily C member 10, EC 1.8.4.- (Endoplasmic reticulum DNA J domain-containing protein 5, ER-resident protein ERdj5, ERdj5) (Macrothioredoxin, MTHr)" DNAJC10 ERDJ5 UNQ495/PRO1012 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]" "ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]" GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0051087; GO:0051117; GO:0051787; GO:0070059 DDYIRDLK 16.19000053 1 1 0.553757254 1036.993126 22.47825 0 0 0 0 18.77416 0 0 18.24224 0 0 0 0 20.67164 0 0 0 0 20.19276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.70252 0 0 0 0 0 0 0 19.506 0 0 0 0 Q8IXF0 NPAS3_HUMAN "Neuronal PAS domain-containing protein 3, Neuronal PAS3 (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12, bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6)" NPAS3 BHLHE12 MOP6 PASD6 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982 DSDSAGEAGAQASSK 5.480000019 1 1 0.281403797 1379.301146 12.74281 11.43402 15.68914 14.9815 12.41616 0 10.78084 0 0 0 15.05573 14.86182 0 0 0 13.57036 13.98228 0 13.33597 14.3734 14.6221 13.64668 15.25501 13.80936 0 15.48964 0 0 0 0 0 16.1545 0 0 0 0 0 0 0 15.95648 0 0 0 0 0 15.96282 15.85063 0 Q8IXH7 NELFD_HUMAN "Negative elongation factor C/D, NELF-C/D (TH1-like protein)" NELFCD NELFD TH1 TH1L HSPC130 Homo sapiens (Human) negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244] membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654] membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0016020; GO:0032021; GO:0034244 YIHILAYAASVVETWK 4.21999979 0.823179305 0.823179305 0.28433949 1865.991384 0 0 0 15.75148 14.25793 0 14.46962 14.63375 13.93819 0 14.71737 13.70215 0 14.90379 14.10655 13.78474 13.98966 14.87602 12.8455 0 0 0 0 14.43443 9.502902 0 0 0 0 0 0 16.1843 0 0 0 0 0 0 0 0 14.33327 0 0 0 0 0 12.29372 0 Q8IXH8 CAD26_HUMAN Cadherin-like protein 26 (Cadherin-like protein VR20) CDH26 Homo sapiens (Human) "CD4-positive, alpha-beta T cell activation [GO:0035710]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]" catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] "catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]" alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178] GO:0005178; GO:0005509; GO:0005886; GO:0007156; GO:0008013; GO:0015630; GO:0016021; GO:0016342; GO:0035710; GO:0045294; GO:0045296; GO:0070097; GO:0098742 MAMRSGR 6.650000095 1 1 0.032812652 841.2446757 0 0 8.708381 0 0 0 0 0 0 15.17805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.89086 0 0 0 0 0 14.48674 16.56864 11.37627 11.59389 13.24671 0 0 0 15.20169 0 0 0 0 14.43483 0 0 0 Q8IXI1 MIRO2_HUMAN "Mitochondrial Rho GTPase 2, MIRO-2, hMiro-2, EC 3.6.5.- (Ras homolog gene family member T2)" RHOT2 ARHT2 C16orf39 Homo sapiens (Human) cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0097345 GLLGVVGAAVAAVLSFSLYR 1.779999971 1 1 0.178489003 1961.68683 16.07063 13.2525 11.97564 0 0 0 14.98537 0 0 0 15.59012 0 0 0 0 0 0 0 0 0 13.12248 0 0 0 0 0 0 0 0 0 0 0 0 0 15.00844 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXI2 MIRO1_HUMAN "Mitochondrial Rho GTPase 1, MIRO-1, hMiro-1, EC 3.6.5.- (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1)" RHOT1 ARHT1 Homo sapiens (Human) cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0097345 ILLVGEPR 2.839999914 1 1 0.236040861 897.0734317 0 14.58606 0 0 0 0 0 0 0 15.30577 0 0 0 14.88164 0 0 0 0 16.14824 15.46753 0 15.88051 0 0 0 0 0 0 15.06492 0 13.70368 13.98033 13.97316 14.06358 0 16.54045 14.07979 0 0 16.00456 14.88325 16.56331 0 0 0 16.42106 0 14.84447 Q8IXK0 PHC2_HUMAN "Polyhomeotic-like protein 2, hPH2 (Early development regulatory protein 2)" PHC2 EDR2 PH2 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0008270; GO:0031519; GO:0035102; GO:0042393; GO:0042802; GO:0045892 EEGAPLKLK 4.639999866 1 1 0.122531409 985.5691682 13.87877 15.08297 14.62183 0 13.30041 15.85872 0 0 0 0 0 0 13.33274 0 0 0 0 14.40042 0 0 0 16.16768 0 0 15.20276 0 0 0 16.93529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.56255 0 0 0 0 Q8IXK2 GLT12_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 12, EC 2.4.1.41 (Polypeptide GalNAc transferase 12, GalNAc-T12, pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12)" GALNT12 Homo sapiens (Human) O-glycan processing [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0030246; GO:0046872 EALLVLLALLALAGLGSVLRAQR 4.25 1 1 0.125630632 2360.29162 0 0 14.81653 0 0 0 0 11.7515 12.86451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.71768 0 0 14.9839 0 0 0 0 0 0 12.35985 14.46668 0 11.52974 0 0 0 13.91335 0 16.35768 13.9492 0 0 15.89415 Q8IXM2 BAP18_HUMAN Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa) BAP18 C17orf49 Homo sapiens (Human) chromatin organization [GO:0006325] cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589] cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325] DNA binding [GO:0003677]; identical protein binding [GO:0042802] GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0016589; GO:0042802; GO:0071339 MTSASTKVGEIFSAAGAAFTK 6.679999828 1 1 0.253338833 2091.720111 0 13.88657 14.83355 13.57793 16.25468 14.85571 14.23896 14.49853 0 14.92695 13.23815 15.50575 0 14.68632 0 0 0 0 0 0 0 0 15.65945 12.97533 0 11.79479 0 0 0 0 0 0 0 15.59946 0 0 10.11269 0 0 0 0 10.99591 13.10021 0 0 0 0 0 Q8IXM3 RM41_HUMAN "39S ribosomal protein L41, mitochondrial, L41mt, MRP-L41 (39S ribosomal protein L27 homolog) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog) (Mitochondrial large ribosomal subunit protein mL41)" MRPL41 BMRP MRPL27 RPML27 PIG3 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0006915; GO:0007049; GO:0032543; GO:1990904 GIGFLTSGWR 8.529999733 0.151917517 0.151917517 0.441272442 1093.603555 17.67553 16.82862 17.61135 0 0 0 17.62276 15.87046 15.87433 17.64161 16.85358 0 16.29965 16.52178 0 16.69259 16.55036 17.02467 17.64527 0 0 17.02539 0 18.08013 0 17.2898 16.66125 0 16.78482 0 0 18.14634 0 0 0 0 0 17.16622 0 17.01417 17.11038 16.4847 16.46406 17.05049 0 0 16.70694 0 Q8IXM7 OD3L1_HUMAN Outer dense fiber protein 3-like protein 1 ODF3L1 Homo sapiens (Human) cytoskeleton [GO:0005856] cytoskeleton [GO:0005856] GO:0005856 GPGPAK 3.349999905 0.621449947 0.621449947 0.290209484 526.8138034 0 13.10724 16.58728 0 0 0 0 0 16.10199 15.9587 0 0 16.45412 15.52308 0 0 15.55207 0 0 14.4331 16.47249 0 0 16.46811 0 17.51852 0 15.81895 16.66984 0 0 14.989 0 17.02758 18.00386 15.53991 16.40745 13.66012 0 14.08786 16.58862 15.76145 0 13.98857 17.07267 15.20394 16.4172 16.26152 Q8IXN7 RIMKA_HUMAN "N-acetylaspartylglutamate synthase A, NAAG synthetase A, NAAGS, EC 6.3.2.41 (N-acetylaspartylglutamylglutamate synthase A, EC 6.3.2.42) (Ribosomal protein S6 modification-like protein A)" RIMKLA FAM80A Homo sapiens (Human) cellular protein modification process [GO:0006464]; glutamine family amino acid metabolic process [GO:0009064] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]; cellular protein modification process [GO:0006464]; glutamine family amino acid metabolic process [GO:0009064]" "ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]" GO:0005524; GO:0005737; GO:0005829; GO:0006464; GO:0009064; GO:0016879; GO:0046872; GO:0072590 IASELK 12.25 1 1 0.277813904 658.7919732 14.63027 0 15.39657 15.71438 15.5999 16.03074 0 16.42299 14.86433 16.00656 15.21982 14.01114 0 16.80469 0 0 0 14.90199 0 14.71017 17.96614 0 15.78317 15.55175 0 16.474 0 15.78991 0 15.11428 16.13143 15.29632 15.83076 0 15.45034 15.86269 0 16.73362 0 15.85088 15.58179 14.46119 15.75461 0 0 0 15.35218 0 Q8IXQ5 KLHL7_HUMAN Kelch-like protein 7 KLHL7 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0016567; GO:0031463; GO:0042802; GO:0042803; GO:0048471 EEAKLLAGFMGVMNNMR 9.470000267 1 1 0.117818525 1921.956565 0 17.47632 13.18183 0 15.39671 17.52423 0 17.94979 0 16.82269 12.92934 12.36704 15.04525 0 16.68525 0 0 0 0 15.63283 17.42763 0 0 18.35208 17.14404 15.10182 14.98746 16.12992 0 16.88853 15.39596 0 16.11242 0 0 0 0 16.94323 0 14.58822 0 14.60662 13.60307 0 15.40512 14.00103 16.9485 17.3697 Q8IXQ8 PDZD9_HUMAN PDZ domain-containing protein 9 PDZD9 C16orf65 Homo sapiens (Human) LQPGDVLISVGHANVLGYTLR 7.300000191 1 1 1.83E-12 2223.109339 0 12.77836 0 0 0 13.5919 0 0 0 13.98633 16.30296 0 15.28491 0 0 0 0 0 0 0 15.26799 0 16.0032 13.66846 13.18389 0 15.69804 0 0 0 0 0 18.92821 13.73477 0 0 0 16.307 0 0 0 0 0 0 15.03995 0 14.42033 0 Q8IXS2 DRC2_HUMAN Dynein regulatory complex subunit 2 (Coiled-coil domain-containing protein 65) (Testis development protein NYD-SP28) CCDC65 DRC2 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352] GO:0003352; GO:0005858; GO:0005930; GO:0031514; GO:0036064; GO:0060271; GO:0060285; GO:0070286 DEKSSK 7.059999943 1 1 0.163347459 693.5654293 16.81948 16.88134 0 0 0 14.9584 14.77735 13.38872 15.50774 15.0121 16.7136 15.80173 0 14.98331 16.58309 16.98756 14.57918 16.00134 15.8539 16.27999 17.9178 0 13.8449 16.26481 16.56321 16.8761 16.37181 16.92719 16.97038 0 16.38949 16.75571 16.21238 18.20683 14.88066 14.88401 18.21173 18.70713 18.38032 17.63921 17.09701 15.38945 16.72365 16.85509 17.3554 16.89315 17.93453 17.51129 Q8IXS8 F126B_HUMAN Protein FAM126B FAM126B Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0046854; GO:0072659 ELLSPGAPLTK 9.090000153 0.238190427 0.238190427 0.212165182 1125.460984 14.39739 0 0 0 0 14.73049 14.95408 0 0 0 0 15.54975 13.97499 14.55822 0 0 0 0 14.85888 0 15.58789 0 0 0 14.84498 14.69059 10.7676 0 15.39284 0 0 14.88929 12.21188 14.73917 0 15.37633 14.14436 11.83286 11.63343 13.14395 14.62311 13.67785 13.60959 0 0 15.42999 0 15.10939 Q8IXT2 DMRTD_HUMAN Doublesex- and mab-3-related transcription factor C2 DMRTC2 Homo sapiens (Human) germ cell development [GO:0007281]; male meiosis I [GO:0007141]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; spermatid nucleus elongation [GO:0007290] chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741] "chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; spermatid nucleus elongation [GO:0007290]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001741; GO:0005634; GO:0006357; GO:0007141; GO:0007281; GO:0007290; GO:0007548; GO:0042802; GO:0046872; GO:1900111; GO:1900114; GO:1990837 APNHFR 1.370000005 0.455157638 0.455157638 0.09828528 741.9445672 13.95231 15.87855 16.77444 15.67734 14.50104 0 0 17.85354 14.28822 15.68328 0 16.77879 0 14.90831 0 14.31353 0 15.43012 0 14.3513 13.96091 17.22161 14.32157 0 0 13.37396 15.60546 16.50674 16.98691 15.51504 0 15.81559 12.33082 13.73321 14.51851 16.27622 17.16509 0 15.96911 0 17.50013 0 0 14.55871 0 14.37462 11.61253 14.29528 Q8IXT5 RB12B_HUMAN RNA-binding protein 12B (RNA-binding motif protein 12B) RBM12B Homo sapiens (Human) regulation of RNA splicing [GO:0043484] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0043484; GO:1990904 EAPEEDPR 4.380000114 1 1 0.180522169 943.4459232 15.03582 0 15.32024 11.43554 15.1771 14.14921 16.41401 16.27425 14.069 17.69688 0 15.71041 14.07984 0 14.39505 0 0 0 13.91062 0 0 0 0 0 14.77222 15.83264 0 16.27431 0 0 0 16.51511 0 0 15.94234 0 0 0 0 16.30616 17.5908 13.48696 0 0 0 0 0 0 Q8IXV7 KLD8B_HUMAN Kelch domain-containing protein 8B KLHDC8B FP17659 Homo sapiens (Human) mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813] cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496] cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813] GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410 DGMVYALGGMGPDTAPQAQVR 4.099999905 1 1 2.75E-12 2133.626211 0 0 8.974174 0 16.51683 0 0 0 15.30968 0 0 0 0 0 0 0 13.16266 0 0 0 0 0 0 14.1979 0 14.42566 0 0 0 0 0 0 0 0 0 0 0 0 14.86826 0 0 0 0 0 13.06305 0 0 0 Q8IXW0 LMTD2_HUMAN Lamin tail domain-containing protein 2 LMNTD2 C11orf35 Homo sapiens (Human) regulation of chromatin assembly [GO:0010847] lamin filament [GO:0005638] lamin filament [GO:0005638]; structural constituent of chromatin [GO:0030527]; regulation of chromatin assembly [GO:0010847] structural constituent of chromatin [GO:0030527] GO:0005638; GO:0010847; GO:0030527 FPPGTLLAPR 4.920000076 0.72964406 0.72964406 0.141853398 1069.019015 0 14.39921 0 12.02343 15.70288 0 0 12.92237 0 0 0 0 0 0 0 0 13.95039 0 0 0 0 0 0 0 14.43118 14.19503 0 0 0 0 13.42614 0 0 0 0 0 16.11506 0 0 0 0 0 16.29628 0 0 0 15.5415 0 Q8IXW5 RPAP2_HUMAN "Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2, EC 3.1.3.16 (RNA polymerase II-associated protein 2)" RPAP2 C1orf82 Homo sapiens (Human) dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]" metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008420; GO:0009301; GO:0016591; GO:0043175; GO:0046872; GO:0070940 HPDFQLLK 12.06999969 0.157687306 0.157687306 0.221112467 999.0222857 0 14.45893 11.90507 14.57218 14.61826 15.68314 0 16.26884 14.40794 16.11435 15.73791 16.68042 0 16.41393 0 0 14.59723 0 0 15.74417 14.75703 16.77445 14.96288 17.57579 0 0 0 16.49768 14.72276 0 0 16.9542 0 0 13.65422 0 13.50591 0 0 0 0 0 0 15.69846 0 17.91797 0 0 Q8IXZ2 ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor) ZC3H3 KIAA0150 SMICL ZC3HDC3 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363] DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412] GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046872; GO:0051028; GO:0070412; GO:1900363 EGEGEPPR 9.920000076 0.430024505 0.430024505 0.214147886 868.7579759 0 0 0 15.4115 0 0 14.59092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.05463 0 0 0 0 0 0 0 17.03389 0 17.08235 0 0 0 0 0 0 0 0 0 0 Q8IY17 PLPL6_HUMAN "Patatin-like phospholipase domain-containing protein 6, EC 3.1.1.5 (Neuropathy target esterase)" PNPLA6 NTE Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470] lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545] GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0016021; GO:0046470; GO:0046475; GO:0102545 LFPSPGLPTRTSPVR 6.489999771 0.651815474 0.651815474 2.28E-13 1625.22498 15.18252 15.35752 13.44247 11.35616 15.09224 14.85646 13.88258 0 0 14.11215 15.94795 10.91399 16.02154 15.77269 0 0 0 13.77535 0 15.13174 16.16392 0 13.47806 0 15.88655 15.2428 12.42487 0 14.56937 14.77094 0 0 0 0 0 0 0 0 0 16.04134 15.81833 0 14.64118 16.51099 14.97688 0 13.45477 15.29058 Q8IY18 SMC5_HUMAN "Structural maintenance of chromosomes protein 5, SMC protein 5, SMC-5, hSMC5" SMC5 KIAA0594 SMC5L1 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]" "cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0016887; GO:0016925; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0032204; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398 DPSSEVPSK 7.289999962 0.619521797 0.619521797 0.061177267 947.4500483 15.74403 0 15.52056 14.05657 16.0664 0 0 0 0 0 17.22846 15.65478 9.832493 0 0 13.85074 14.48948 16.88095 18.3017 18.10794 17.96969 11.28518 0 16.91072 15.88347 13.05134 0 15.63014 0 16.98412 0 11.95506 13.52166 17.49476 19.63058 15.17319 0 0 15.28196 16.46511 0 0 15.76663 15.64945 0 17.03588 15.36962 13.36464 Q8IY21 DDX60_HUMAN "Probable ATP-dependent RNA helicase DDX60, EC 3.6.4.13 (DEAD box protein 60)" DDX60 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727] GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246 QLVEILFR 12.89000034 1 1 0.141287523 1018.622381 0 15.25758 13.8921 12.53855 17.23306 15.36415 15.53808 0 0 14.39619 0 0 0 0 0 0 0 0 0 0 0 0 0 14.83226 0 14.81532 0 0 0 0 0 0 14.87799 0 0 0 0 0 17.07389 0 0 15.86335 0 0 14.73092 0 0 0 Q8IY33 MILK2_HUMAN "MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2, MICAL-L2)" MICALL2 JRAB Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] GO:0001725; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:1903955 ATGEPGTFVCTSHLPAAASASPK 4.96999979 1 1 0.279922768 2259.65522 14.41155 0 15.20576 10.20134 0 14.47048 0 15.53189 0 0 12.68186 8.414618 12.89188 13.68804 0 14.86753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY34 S15A3_HUMAN Solute carrier family 15 member 3 (Osteoclast transporter) (Peptide transporter 3) (Peptide/histidine transporter 2) SLC15A3 OCTP PHT2 PTR3 Homo sapiens (Human) dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein transport [GO:0015031] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein transport [GO:0015031] dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] GO:0005765; GO:0006811; GO:0010008; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016021; GO:0043231; GO:0045087; GO:0070434; GO:0071916; GO:0140206 YERASQGPASHSR 8.609999657 1 1 1.37E-12 1445.401757 0 0 0 0 14.85611 0 0 0 15.40372 0 0 0 0 0 0 0 13.4356 14.93678 0 0 0 0 0 16.27305 0 0 0 0 14.07122 11.151 14.90674 0 0 13.08643 13.67412 0 0 0 13.36689 15.54272 0 12.82218 0 13.8638 0 14.99905 0 0 Q8IY37 DHX37_HUMAN "Probable ATP-dependent RNA helicase DHX37, EC 3.6.4.13 (DEAH box protein 37)" DHX37 DDX37 KIAA1517 Homo sapiens (Human) "brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]" cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]; brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511] GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0007420; GO:0016887; GO:0031965; GO:0034511; GO:0042254; GO:0042255; GO:2000020 ISSLSGAHR 1.279999971 1 1 0.281245402 926.7499547 0 0 0 0 0 0 0 0 0 0 0 0 0 15.64617 17.46867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42507 Q8IY47 KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 (BTB and kelch domain-containing protein 1) KBTBD2 BKLHD1 KIAA1489 CGI-73 Homo sapiens (Human) gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; response to insulin [GO:0032868] gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; response to insulin [GO:0032868] GO:0006006; GO:0006629; GO:0010467; GO:0014065; GO:0032868 AMFMSGLSESKQTHVHLR 5.110000134 1 1 0.297195312 2074.014537 0 15.80943 15.56022 0 0 0 14.50394 0 12.10637 0 0 14.34075 13.94911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97529 0 0 17.79241 0 0 0 0 0 0 0 0 14.40678 0 15.73116 0 0 0 0 Q8IY49 PAQRA_HUMAN Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X) MMD2 PAQR10 Homo sapiens (Human) positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880] integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471] integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880] protein kinase activity [GO:0004672] GO:0004672; GO:0030173; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471 VPAHKR 3.220000029 1 1 0.311146749 706.6279437 17.02417 0 0 0 15.90342 16.6724 0 0 17.42491 16.13181 0 17.54452 0 0 0 0 16.65015 18.40859 0 0 16.53757 18.16752 0 0 0 0 18.0585 17.50163 0 0 19.94492 17.34056 17.61009 18.94978 0 0 0 19.18726 16.06783 0 17.41591 0 0 15.29673 0 0 0 0 Q8IY50 S35F3_HUMAN Putative thiamine transporter SLC35F3 (Solute carrier family 35 member F3) SLC35F3 Homo sapiens (Human) thiamine transport [GO:0015888] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; thiamine transport [GO:0015888] GO:0015888; GO:0016021 LLLGSAK 36.33000183 0.267932445 0.267932445 0.129476106 701.5109694 16.26839 16.99774 16.56437 16.28792 16.05625 16.87129 16.4661 17.286 16.35731 16.5659 16.33013 16.27061 15.67997 16.57895 16.83744 17.21928 15.60869 16.38868 16.80918 16.87643 16.43545 17.14534 16.48021 16.49055 17.26557 16.70345 16.77094 17.4353 16.87669 16.39897 15.52472 16.74058 17.06464 16.7319 16.78409 16.75987 17.1391 16.41587 17.2003 16.86161 16.98139 16.89306 17.27934 16.75636 17.24088 16.86293 17.02747 16.34242 Q8IY51 TIGD4_HUMAN Tigger transposable element-derived protein 4 TIGD4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] DNA binding [GO:0003677] GO:0003677; GO:0005634 CSNGWLDRFK 7.309999943 1 1 0.000272173 1282.01965 14.85243 15.24896 12.65435 0 0 0 0 0 15.61808 0 0 0 0 0 0 0 0 14.26089 0 0 0 0 0 12.76864 17.21045 14.50517 15.89106 14.39186 15.86417 0 0 14.45383 0 16.60545 0 0 16.65783 15.95254 16.5551 16.46211 0 0 0 16.25962 0 0 0 14.23206 Q8IY57 YAF2_HUMAN YY1-associated factor 2 YAF2 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0045892; GO:0045893; GO:0046872 CMMCDVR 6.079999924 1 1 0.325239824 1003.30803 16.67501 16.95222 15.01668 15.55164 16.25472 15.76237 15.98885 15.7929 15.90021 15.24851 0 0 0 16.25246 15.91051 16.54752 0 15.08228 0 0 0 0 0 0 0 16.31316 0 0 0 0 0 16.73131 0 0 0 0 0 0 0 15.87172 0 0 0 0 0 0 0 0 Q8IY67 RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 (Protein raver-1) RAVER1 KIAA1978 Homo sapiens (Human) "regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737 VSFCAPGPPGR 3.789999962 1 1 6.90E-13 1145.670841 15.38865 0 16.62898 10.27316 0 14.82577 0 0 13.01416 14.82816 13.98012 13.98574 0 0 0 0 0 0 0 0 0 0 0 13.57932 0 0 15.75044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.04854 0 0 0 0 15.99085 0 Q8IY82 DRC7_HUMAN Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog) DRC7 C16orf50 CCDC135 Homo sapiens (Human) cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] GO:0005737; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031514; GO:0048870 LMEAEKAKPDALHGLR 1.730000019 0.222337648 0.222337648 0.523529421 1793.915761 0 0 15.7869 0 0 0 0 17.83551 0 0 0 18.37788 0 0 0 0 0 0 18.48224 0 0 0 0 0 0 19.9516 17.7754 0 0 0 0 0 0 0 0 19.13645 19.11914 18.74563 20.34546 18.58257 0 18.11236 17.65235 0 0 0 0 0 Q8IY84 NIM1_HUMAN "Serine/threonine-protein kinase NIM1, EC 2.7.11.1 (NIM1 serine/threonine-protein kinase)" NIM1K NIM1 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0035556; GO:0042149; GO:0106310 TAVYMNGGGLVNPHYARWDR 1.25 1 1 1.37E-12 2293.250889 0 15.51104 0 0 0 0 0 0 0 0 0 0 12.36957 14.89123 7.705428 13.97682 0 0 13.85715 14.07683 0 0 0 0 0 9.931844 0 0 0 0 0 0 0 0 0 0 13.0015 0 0 12.91201 0 0 0 0 0 0 0 0 Q8IY85 EFC13_HUMAN EF-hand calcium-binding domain-containing protein 13 EFCAB13 C17orf57 Homo sapiens (Human) KHSSLQK 16.28000069 1 1 0.011977137 826.7297353 16.21986 0 14.5925 0 0 0 15.89204 15.07916 0 0 0 0 12.06354 0 0 0 0 11.76879 0 13.43478 14.64423 0 0 0 0 0 0 0 0 0 12.33698 0 15.19198 14.47086 15.85379 10.9917 0 0 0 0 16.51384 15.32255 0 0 0 0 0 0 Q8IY92 SLX4_HUMAN Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12) SLX4 BTBD12 KIAA1784 KIAA1987 Homo sapiens (Human) DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820] "cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]" "cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]" DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0003677; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0010792; GO:0019899; GO:0030054; GO:0032206; GO:0033557; GO:0036297; GO:0046872; GO:0061820; GO:0072429; GO:0090656; GO:1904357; GO:1904431 TGQMMDESDEDFKELCASFFQR 5.769999981 1 1 0.008777833 2702.731014 0 0 0 0 0 0 0 0 0 0 0 12.5171 0 16.77634 16.53811 0 0 15.57687 15.61806 0 0 0 0 15.45951 14.95583 14.5366 14.34578 14.39616 13.36541 0 15.41608 15.3593 0 12.55875 11.15244 14.67695 0 0 16.1918 0 0 0 0 0 0 10.10843 0 0 Q8IY95 TM192_HUMAN Transmembrane protein 192 TMEM192 Homo sapiens (Human) endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803] protein homodimerization activity [GO:0042803] GO:0005654; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0016021; GO:0042803; GO:0048471 HNALLSK 5.400000095 1 1 0.169056876 782.6616496 15.38869 15.53337 0 0 0 0 15.24831 0 15.77506 0 15.15175 0 0 0 0 0 0 0 0 18.43776 0 0 0 0 16.81046 0 15.75139 16.90586 0 0 17.98839 0 0 0 17.92138 18.85506 17.35185 0 16.16354 0 16.35353 0 15.56478 16.6366 0 17.50821 17.42305 16.90576 Q8IYA6 CKP2L_HUMAN "Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein, Radmis)" CKAP2L Homo sapiens (Human) centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] GO:0000922; GO:0005813; GO:0005829; GO:0015630; GO:0072686 CFIFR 11.19999981 0.697775304 0.697775304 0.165052053 744.7715308 14.84175 14.045 0 0 0 17.30403 14.47905 11.56697 0 0 0 17.73787 15.0359 13.2764 0 15.32733 17.91696 0 0 15.77984 0 0 14.38756 17.86615 17.08135 0 0 0 18.44441 19.21395 0 0 0 0 0 16.72123 17.75504 0 0 14.34379 17.10398 16.67681 17.21011 0 15.69393 16.49261 17.09069 0 Q8IYA7 MKX_HUMAN Homeobox protein Mohawk MKX C10orf48 IRXL1 Homo sapiens (Human) cell development [GO:0048468]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007517; GO:0048468 YLNDSLR 1.860000014 0.954927325 0.954927325 0.164449158 880.9787699 16.62661 16.932 14.43624 14.49256 13.88841 0 14.06955 0 0 0 0 0 14.44472 15.20347 0 0 0 14.58732 0 0 0 0 0 0 0 0 16.67054 0 15.40076 0 0 17.4944 17.32635 0 14.78331 16.65556 15.07962 0 0 0 0 15.19324 0 13.89065 13.05309 0 13.28424 10.01099 Q8IYB1 M21D2_HUMAN "Nucleotidyltransferase MB21D2, EC 2.7.7.- (Mab-21 domain-containing protein 2, hMB21D2)" MB21D2 C3orf59 Homo sapiens (Human) cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877] cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877] GO:0044877; GO:0045296 MKMAAPTANK 6.960000038 0.749589801 0.749589801 0.276490771 1079.015902 18.1594 15.69476 17.56477 0 0 0 0 0 15.47637 13.92654 13.46234 17.06814 0 0 0 17.09543 17.30742 0 15.61424 0 0 17.49391 17.62106 0 0 0 0 0 0 0 18.23613 0 0 0 18.03139 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYB3 SRRM1_HUMAN "Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa, SRm160) (Ser/Arg-related nuclear matrix protein)" SRRM1 SRM160 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" DNA binding [GO:0003677]; RNA binding [GO:0003723] GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0008380; GO:0016363; GO:0016607; GO:0048024; GO:0071013 AVAAAAAAAVTPAAIAAATTTLAQEEPVAAPEPKK 1.279999971 1 1 3.20E-12 3241.732204 14.81762 16.10613 11.97868 14.54408 8.193334 17.16228 0 12.39857 13.73004 15.57748 0 13.73786 0 0 14.02518 0 0 0 0 0 14.74602 0 12.49499 0 9.835664 16.46603 15.79247 0 15.47556 0 0 0 0 0 13.36701 0 0 0 0 0 0 0 0 0 0 0 0 14.58968 Q8IYB8 SUV3_HUMAN "ATP-dependent RNA helicase SUPV3L1, mitochondrial, EC 3.6.4.13 (Suppressor of var1 3-like protein 1, SUV3-like protein 1)" SUPV3L1 SUV3 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401] mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0016887; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:2000827 GTKALGSK 7.739999771 1 1 0.149561455 758.7965678 12.52337 14.29281 14.34602 0 0 14.01456 14.77947 0 0 0 0 15.64681 0 0 0 0 15.5546 0 0 0 0 0 0 0 0 16.20072 0 0 0 0 0 17.7891 15.40359 0 0 16.25514 16.25862 15.35822 15.37623 0 0 0 0 0 0 15.12088 0 17.04936 Q8IYD1 ERF3B_HUMAN "Eukaryotic peptide chain release factor GTP-binding subunit ERF3B, Eukaryotic peptide chain release factor subunit 3b, eRF3b (G1 to S phase transition protein 2 homolog)" GSPT2 ERF3B Homo sapiens (Human) "cell cycle [GO:0007049]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]" cytosol [GO:0005829]; translation release factor complex [GO:0018444] "cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cell cycle [GO:0007049]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747] GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007049; GO:0018444 GGQTR 8.489999771 1 1 0.213896697 519.2130628 14.07186 16.36498 15.19135 0 14.64584 15.93431 15.65587 0 16.21817 15.52787 16.06731 15.9761 16.5537 16.36583 16.33268 0 15.78386 15.57138 0 0 16.47056 0 0 0 16.1204 16.24715 16.24692 15.45358 16.86926 16.3489 18.07666 16.89429 14.36779 16.54782 16.74238 17.03234 15.50632 16.28292 15.93748 14.88895 17.08429 16.02318 16.01493 17.13777 16.7992 17.24966 14.5935 15.52966 Q8IYD8 FANCM_HUMAN "Fanconi anemia group M protein, Protein FACM, EC 3.6.4.13 (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa, FAAP250) (Protein Hef ortholog)" FANCM KIAA1596 Homo sapiens (Human) double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724] GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:0071932; GO:1902527 YKMIHK 7.710000038 1 1 0.217082097 835.8197884 0 0 0 14.90259 0 14.60966 0 0 0 0 0 0 0 0 0 0 15.39841 0 0 15.02382 0 15.37008 0 0 17.60436 15.52704 0 15.91611 15.57915 13.4207 0 15.27003 0 15.03592 15.80058 0 15.79799 13.51064 0 14.76662 0 16.47505 0 0 0 0 0 0 Q8IYD9 LAS2_HUMAN Lung adenoma susceptibility protein 2 LAS2 C18orf54 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285] extracellular region [GO:0005576] extracellular region [GO:0005576]; negative regulation of cell population proliferation [GO:0008285] GO:0005576; GO:0008285 HHGPVEALK 4.989999771 1 1 0.269074575 987.3697864 17.09965 19.39764 18.61867 0 0 18.00855 0 17.92905 17.38786 15.25962 15.96091 0 0 0 16.25726 17.23952 17.05481 0 0 0 17.38071 0 0 17.92521 18.32539 0 0 15.60012 18.65276 17.94385 0 0 0 16.80493 17.76595 0 0 0 17.8877 17.95009 0 17.45461 0 0 16.16764 18.15755 17.09867 15.97475 Q8IYE0 CC146_HUMAN Coiled-coil domain-containing protein 146 CCDC146 KIAA1505 Homo sapiens (Human) centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005814; GO:0005856 KMNGYQR 4.130000114 0.517726481 0.517726481 0.221674038 913.8119846 14.56074 0 13.77881 0 13.46803 14.52326 13.96838 15.08002 15.46297 15.17921 0 0 13.44844 0 0 15.28345 0 0 14.63151 0 0 16.59243 0 14.91829 15.06773 0 0 0 14.11896 14.60799 16.41048 0 15.02138 14.78677 16.52287 12.48246 0 0 0 14.75429 0 0 0 14.7336 0 15.26608 15.02626 14.72973 Q8IYE1 CCD13_HUMAN Coiled-coil domain-containing protein 13 CCDC13 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515] cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515] GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515 GATDAGAKPPRAQMGDR 5.139999866 1 1 0.353318816 1714.43833 13.75278 13.67974 14.00223 0 0 0 0 0 14.78949 0 15.98335 0 0 14.12662 0 15.72333 0 0 0 15.79303 0 14.77016 0 15.57299 0 0 0 15.98114 0 0 0 0 0 13.96765 0 16.36007 0 0 0 0 17.05174 0 0 0 0 0 10.39456 0 Q8IYF1 ELOA2_HUMAN "Elongin-A2, EloA2 (RNA polymerase II transcription factor SIII subunit A2) (Transcription elongation factor B polypeptide 3B)" ELOA2 TCEB3B TCEB3L Homo sapiens (Human) "regulation of DNA-templated transcription, elongation [GO:0032784]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" elongin complex [GO:0070449]; nucleoplasm [GO:0005654] "elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0005654; GO:0006366; GO:0006368; GO:0032784; GO:0070449 LSALPMTADILAETGIR 8.359999657 1 1 0.375389747 1772.007871 0 0 15.19282 14.10687 0 0 0 0 0 0 0 0 0 13.27431 15.87307 0 12.85935 12.27131 15.94124 0 0 15.57737 0 10.03815 0 0 0 0 0 0 0 14.25551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYF3 TEX11_HUMAN "Testis-expressed protein 11 (Protein ZIP4 homolog, ZIP4H)" TEX11 ZIP4 Homo sapiens (Human) chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694] central element [GO:0000801]; chromosome [GO:0005694]; chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0043066; GO:0051026 LIMMNMR 16.32999992 1 1 0.274469463 923.4851048 16.93802 16.55089 17.91126 19.01082 19.08541 19.33922 17.7518 19.84729 18.50415 19.58538 19.63299 15.24797 19.55209 16.56142 18.62521 0 16.45427 19.96918 0 19.15051 0 18.61632 16.71002 0 16.58267 16.68497 18.89369 19.07453 17.11251 19.62861 0 19.7377 19.01367 17.36308 17.63331 20.11666 19.82494 19.0545 17.66173 19.18742 17.49658 18.14212 18.92729 19.49375 19.39614 19.13579 18.78408 17.18986 Q8IYH5 ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 ZZZ3 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0006357; GO:0008270; GO:0031063; GO:0035064; GO:0043966; GO:0043967; GO:0044154; GO:0045995; GO:0051302; GO:0051726; GO:0070577; GO:0072686; GO:0090043; GO:0140672 GLSSSEK 10.06000042 1 1 0.065445507 705.4564746 15.59861 14.74674 16.17634 16.37894 0 12.79736 16.13112 14.51141 9.70986 15.6558 16.60322 16.54779 12.92453 0 16.08039 0 0 16.04212 15.32506 14.76326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYI6 EXOC8_HUMAN Exocyst complex component 8 (Exocyst complex 84 kDa subunit) EXOC8 Homo sapiens (Human) cellular protein localization [GO:0034613]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; cellular protein localization [GO:0034613]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267] GO:0000145; GO:0000281; GO:0005770; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0007032; GO:0008104; GO:0015031; GO:0016020; GO:0016241; GO:0022617; GO:0030426; GO:0031252; GO:0031267; GO:0034613; GO:0035091; GO:0048471; GO:0090148; GO:0090522 GGPKATR 2.420000076 1 1 0.105667237 686.3750953 15.16856 0 0 0 0 0 0 15.61405 0 0 0 0 0 0 0 15.74298 0 0 0 0 0 0 15.95617 0 0 15.80764 15.94734 0 15.74286 15.19334 0 15.7801 0 14.29601 15.42631 16.20929 0 0 0 0 0 0 17.31149 13.27494 17.10903 0 15.3861 0 Q8IYJ2 CJ067_HUMAN "Uncharacterized protein C10orf67, mitochondrial" C10orf67 LINC01552 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 HYQQNEDKMR 13.81000042 0.394869924 0.394869924 0.091334362 1348.995891 20.34969 0 0 0 18.77741 17.78386 0 0 0 0 0 0 0 0 17.98005 0 0 0 19.18964 0 18.05052 0 0 0 0 0 0 18.65257 18.17483 0 0 0 0 0 0 0 19.31574 0 18.67064 0 0 0 0 0 0 19.94312 17.71627 18.47954 Q8IYJ3 SYTL1_HUMAN Synaptotagmin-like protein 1 (Exophilin-7) (Protein JFC1) SYTL1 SLP1 SB146 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267] GO:0005886; GO:0006886; GO:0006887; GO:0019897; GO:0031267; GO:0031528; GO:0042043; GO:0042470; GO:0070062; GO:0070382 NLNPVFNETLRYSVPQAELQGR 1.840000033 1 1 0.110449957 2544.542991 13.38765 0 0 12.46781 0 0 0 0 14.15594 9.463132 0 14.64006 13.14424 0 12.21615 0 13.94228 0 0 12.82782 0 0 0 0 13.51454 14.59151 11.77441 8.2451 14.78286 14.69208 11.58421 0 0 0 10.58027 0 0 12.83845 0 0 0 0 14.49277 0 14.9127 0 0 0 Q8IYK2 CC105_HUMAN Coiled-coil domain-containing protein 105 CCDC105 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 EAAQAMAR 5.320000172 0.836568475 0.836568475 0.100215534 862.941795 12.98061 0 16.54743 15.3759 15.49459 14.02847 17.56654 0 12.13009 14.34496 0 13.47284 18.0856 0 15.17698 0 0 17.21695 0 16.87863 13.60154 16.35611 0 13.13336 15.5276 0 18.10398 0 11.52387 0 12.97833 15.54073 15.72345 0 16.95004 0 12.42926 18.81599 15.77964 13.35893 15.2867 15.88766 13.18762 0 15.73814 18.67947 14.53846 0 Q8IYK4 GT252_HUMAN "Procollagen galactosyltransferase 2, EC 2.4.1.50 (Collagen beta(1-O)galactosyltransferase 2, ColGalT 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)" COLGALT2 C1orf17 GLT25D2 KIAA0584 Homo sapiens (Human) collagen fibril organization [GO:0030199] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; collagen fibril organization [GO:0030199] procollagen galactosyltransferase activity [GO:0050211] GO:0005788; GO:0030199; GO:0050211 ALNTSQLK 2.49000001 0.14666824 0.14666824 0.21308412 874.3838313 0 15.90398 14.893 14.59933 0 13.97401 0 15.44475 0 14.986 15.3697 15.78825 14.88166 13.8367 15.53205 15.43525 0 15.5712 0 14.71136 0 15.06594 16.6925 12.18558 15.52098 0 14.18081 15.20794 16.58304 12.79993 16.27907 15.52065 16.63245 0 15.51386 14.84794 0 15.81777 0 14.75686 0 16.40068 0 16.33003 14.92175 0 0 14.5282 Q8IYK8 REM2_HUMAN GTP-binding protein REM 2 (Rad and Gem-like GTP-binding protein 2) REM2 Homo sapiens (Human) plasma membrane [GO:0005886] plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005246; GO:0005525; GO:0005886 DGIFKVMLVGESGVGK 3.579999924 1 1 1.38E-12 1651.668952 15.68245 17.83895 8.857656 0 7.741599 16.1347 14.82475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.64535 0 0 0 14.75828 0 14.89346 0 0 16.77825 19.49865 0 0 0 0 0 0 0 0 0 0 0 Q8IYL3 CA174_HUMAN UPF0688 protein C1orf174 C1orf174 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 TACLTSSSHK 1.470000029 1 1 0.277868392 1092.417786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYM0 F186B_HUMAN Protein FAM186B FAM186B C12orf25 Homo sapiens (Human) protein-containing complex [GO:0032991] protein-containing complex [GO:0032991] GO:0032991 ACVPLQMAR 9.520000458 0.38786149 0.38786149 0.181592446 1045.777082 15.00848 0 15.10982 0 14.93469 16.41417 0 0 0 16.65635 15.92828 0 0 20.73166 21.78869 0 0 21.7451 21.49634 0 0 0 0 0 20.84075 20.61169 20.94863 21.23848 21.24993 0 0 20.91238 0 21.89695 0 0 21.35624 18.62008 0 0 0 21.88945 0 20.65444 0 21.79197 0 21.83565 Q8IYM2 SLN12_HUMAN "Ribonuclease SLFN12, EC 3.1.-.- (Schlafen family member 12)" SLFN12 Homo sapiens (Human) MPVHHFCMEKK 6.630000114 0.36606282 0.36606282 0.431091542 1474.472794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.84852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYP9 ZDH23_HUMAN "Palmitoyltransferase ZDHHC23, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 23, DHHC-23, zDHHC23)" ZDHHC23 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] protein-cysteine S-palmitoyltransferase activity [GO:0019706] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659 MTQKGSMKPVK 9.06000042 1 1 0.05177682 1250.726952 11.15342 0 14.72995 12.31417 15.08322 0 14.40478 15.7491 15.34315 0 0 13.95511 0 0 14.71824 15.2998 0 0 0 0 15.36608 0 0 0 14.72132 0 0 0 14.98359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.94624 0 0 0 0 Q8IYQ7 THNS1_HUMAN "Threonine synthase-like 1, TSH1" THNSL1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 IAVVAFFPENGVSDFQK 5.570000172 1 1 1.84E-12 1868.272464 13.80665 0 0 0 11.77233 15.43472 12.70553 10.63443 13.22208 0 14.21549 0 0 14.64493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYR2 SMYD4_HUMAN "SET and MYND domain-containing protein 4, EC 2.1.1.-" SMYD4 KIAA1936 Homo sapiens (Human) heart development [GO:0007507]; methylation [GO:0032259] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; heart development [GO:0007507]; methylation [GO:0032259] metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168] GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0032259; GO:0046872 DYTGAAVLYSK 7.5 1 1 0.194522813 1187.076543 12.92342 0 9.516332 14.70714 14.25067 10.45767 15.31426 12.66282 8.172881 11.02335 0 13.91615 13.91326 12.31077 12.58161 0 15.88363 0 0 0 0 0 0 0 14.54137 0 0 0 0 0 0 0 13.69039 0 0 16.70162 15.84588 0 0 17.71687 0 0 0 0 0 0 0 0 Q8IYR6 TEFF1_HUMAN "Tomoregulin-1, TR-1 (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain)" TMEFF1 C9orf2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888] signaling receptor binding [GO:0005102] GO:0005102; GO:0005604; GO:0005886; GO:0008045; GO:0009887; GO:0009888; GO:0016021; GO:0016358 ASNQPPGGGGGSGGDCPGGKGK 11.02000046 0.070521109 0.070521109 0.144946163 1899.800407 18.45027 12.07302 0 18.84328 18.31859 17.22532 16.62479 18.88244 17.50191 0 14.0574 0 14.54744 0 0 17.8634 17.10784 17.33019 0 0 0 0 0 16.89796 16.55247 15.79627 16.24304 0 0 0 18.87461 0 0 0 17.95494 0 0 15.60393 18.43573 13.52606 0 0 0 0 0 0 17.78062 0 Q8IYS1 P20D2_HUMAN "Xaa-Arg dipeptidase, EC 3.4.13.4 (Beta-Ala-Lys dipeptidase)" PM20D2 ACY1L2 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0032268; GO:0042802 QQMKPTWRVHGIIK 4.71999979 0.461029828 0.461029828 0.274420666 1722.122403 14.77971 9.51987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.86253 0 16.18317 0 0 15.30988 0 0 15.26105 0 15.6065 15.16551 14.66697 0 14.33866 14.78956 14.68536 16.1837 14.38062 0 0 0 0 18.28717 0 0 16.07403 0 15.15517 0 0 Q8IYT1 GAR4_HUMAN "Golgi associated RAB2 interactor protein 4 (Golgi-associated Rab2B interactor-like 4, GARI-L4)" GARIN4 FAM71A Homo sapiens (Human) Golgi organization [GO:0007030] Golgi apparatus [GO:0005794]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; Golgi organization [GO:0007030] GO:0005634; GO:0005794; GO:0007030 VRMVTMGIAR 10.75 0.619184434 0.619184434 0.337466987 1149.690232 0 15.5 16.03678 0 0 15.49918 0 0 0 0 0 0 0 10.54105 0 16.53396 16.11386 0 0 17.0385 15.19988 18.97415 17.69485 16.36654 16.23312 14.99681 15.69601 0 13.74521 0 16.49328 15.73134 14.33408 16.35605 15.81636 15.00362 16.32979 14.36016 17.00833 0 16.07826 15.80742 13.32519 12.42058 0 14.50429 13.40602 16.85289 Q8IYT2 CMTR2_HUMAN "Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2, EC 2.1.1.296 (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2, HMTr2, MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog)" CMTR2 AFT FTSJD1 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310] mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483] GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097309; GO:0097310 MTLNFGTEMKR 10.13000011 1 1 0 1358.7515 0 17.61405 16.17949 16.5581 17.0936 16.44705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYT3 CC170_HUMAN Coiled-coil domain-containing protein 170 CCDC170 C6orf97 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794] ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226] microtubule binding [GO:0008017] GO:0000226; GO:0005794; GO:0008017; GO:0036064 AASCTEEKEK 10.19999981 1 1 0.116557868 1151.116253 0 13.14384 0 0 0 16.51408 14.84278 11.87235 0 14.53945 0 16.60047 0 14.80908 0 0 16.25755 14.22841 16.55509 0 15.84903 15.31634 16.34822 13.97981 15.94047 15.1762 15.13833 15.01253 14.98126 15.22475 14.01714 15.0437 11.88114 0 0 16.92581 15.94514 16.09022 14.95482 14.83812 14.163 0 16.13884 15.38492 15.91592 13.74732 16.76431 15.53755 Q8IYT4 KATL2_HUMAN "Katanin p60 ATPase-containing subunit A-like 2, Katanin p60 subunit A-like 2, EC 5.6.1.1 (p60 katanin-like 2)" KATNAL2 Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568] GO:0000922; GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0016853; GO:0016887 MKTELLVQMDGLAR 3.650000095 1 1 0.137074548 1613.717038 11.89007 15.43002 0 0 14.72698 0 0 0 14.54246 0 0 0 0 0 15.45994 0 0 0 0 15.66244 0 16.04371 0 15.45572 0 0 0 15.74233 0 0 0 0 0 0 16.8436 0 17.28439 16.24032 0 0 0 0 0 14.60323 15.51004 0 0 15.31562 Q8IYT8 ULK2_HUMAN "Serine/threonine-protein kinase ULK2, EC 2.7.11.1 (Unc-51-like kinase 2)" ULK2 KIAA0623 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; phagophore assembly site membrane [GO:0034045] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000045; GO:0000422; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006914; GO:0007165; GO:0010508; GO:0018105; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0044805; GO:0046777; GO:0048671; GO:0048675; GO:0061709; GO:0106310 SGKLSPSTAVK 10.97000027 1 1 0.151260695 1073.756252 14.33386 15.29292 15.97509 0 13.79485 13.12001 14.64099 0 13.88345 0 0 0 0 0 16.40021 0 0 0 0 0 15.60026 0 0 0 13.86297 16.22049 0 15.89268 0 0 14.25119 15.62167 0 0 0 0 0 16.74951 0 14.98169 0 0 0 15.5673 0 15.00451 0 16.60847 Q8IYU2 HACE1_HUMAN "E3 ubiquitin-protein ligase HACE1, EC 2.3.2.26 (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1)" HACE1 KIAA1320 Homo sapiens (Human) cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511] small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000139; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0006511; GO:0007030; GO:0007049; GO:0016567; GO:0016601; GO:0016604; GO:0030334; GO:0031267; GO:0032580; GO:0043161; GO:0045732; GO:0061025; GO:0061630; GO:0070936 ILTSLAEVATTNGHKLLSLSSNYDAQMK 3.170000076 1 1 0.308032507 3020.826594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYV9 IZUM1_HUMAN "Izumo sperm-egg fusion protein 1 (Oocyte binding/fusion factor, OBF) (Sperm-specific protein izumo)" IZUMO1 Homo sapiens (Human) cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heterotypic cell-cell adhesion [GO:0034113]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heterotypic cell-cell adhesion [GO:0034113]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] identical protein binding [GO:0042802]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] GO:0002080; GO:0005102; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0016021; GO:0034113; GO:0035036; GO:0042802; GO:0042803; GO:0086080 CGVMLQTLIWCK 11.57999992 0.264094263 0.264094263 0.544237443 1524.176093 0 19.17615 0 0 0 0 0 18.97248 0 0 0 0 18.18741 19.67805 0 0 0 0 0 17.00509 0 0 0 0 19.65691 0 0 0 0 0 0 20.20724 19.48103 18.83237 20.05641 0 0 19.0771 18.92244 0 0 0 0 0 0 0 0 0 Q8IYW2 CFA46_HUMAN Cilia- and flagella-associated protein 46 (Tetratricopeptide repeat protein 40) CFAP46 C10orf123 C10orf124 C10orf92 C10orf93 TTC40 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294] axoneme [GO:0005930] axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294] GO:0005930; GO:0035082; GO:0060294 ALEMGIK 4.039999962 1 1 0.243145041 776.0135055 0 17.08127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.57712 0 0 0 0 0 0 Q8IYW4 ENTD1_HUMAN ENTH domain-containing protein 1 (Epsin-2B) ENTHD1 Homo sapiens (Human) endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897] clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0030125; GO:0030276 EREVACR 8 1 1 0.083484452 919.9158107 14.92825 0 0 16.6091 13.39004 15.09534 13.51022 14.12724 16.49911 16.57951 15.69409 0 14.93185 11.92207 14.40039 9.161159 13.9564 0 0 0 0 0 0 0 16.61635 0 17.32219 0 0 0 0 0 0 15.01624 17.33595 0 0 0 0 0 0 12.54568 0 0 0 0 0 14.79445 Q8IYW5 RN168_HUMAN "E3 ubiquitin-protein ligase RNF168, hRNF168, EC 2.3.2.27 (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168)" RNF168 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0010212; GO:0016567; GO:0031491; GO:0032991; GO:0034244; GO:0035518; GO:0035861; GO:0036297; GO:0036351; GO:0036352; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0046872; GO:0070530; GO:0070534; GO:0070535 QEEQDRLLALQLQK 12.14999962 1 1 0.476884272 1711.527297 0 0 0 0 0 0 19.63036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYX1 TBC21_HUMAN TBC1 domain family member 21 (Male germ cell Rab GTPase-activating protein) TBC1D21 MGCRABGAP Homo sapiens (Human) activation of GTPase activity [GO:0090630]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283] actin binding [GO:0003779]; GTPase activator activity [GO:0005096] GO:0001669; GO:0003779; GO:0005096; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0070062; GO:0090630; GO:0097225; GO:0120317 ALCQMYEK 6.289999962 1 1 0.149480481 1058.603371 0 0 0 0 14.60309 10.3156 13.88371 0 14.55241 14.648 14.07573 15.00152 13.65264 0 11.42743 11.13292 0 13.18188 13.89847 14.23127 14.79563 13.97927 14.50709 14.19981 0 0 0 0 0 0 16.21472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYX3 CC116_HUMAN Coiled-coil domain-containing protein 116 CCDC116 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 IHLSSETHR 5.829999924 1 1 0.210638884 1080.248657 0 0 0 0 0 0 0 0 0 0 0 0 0 14.68648 0 0 15.6002 0 0 0 0 0 0 0 16.44299 0 15.47156 0 0 0 16.24199 15.10161 15.12558 0 0 0 16.55273 0 0 0 0 0 0 0 16.40012 0 0 0 Q8IYX4 DND1_HUMAN "Dead end protein homolog 1 (RNA-binding motif, single-stranded-interacting protein 4)" DND1 RBMS4 Homo sapiens (Human) 3'-UTR-mediated mRNA destabilization [GO:0061158]; germ cell development [GO:0007281]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; germ cell development [GO:0007281]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; spermatogenesis [GO:0007283] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0007281; GO:0007283; GO:0048255; GO:0060965; GO:0061158 GAQAAIATLHNHPLRPSCPLLVCR 5.730000019 0.507140458 0.507140458 2.28E-12 2652.475134 16.86653 0 15.75567 0 16.88697 14.15742 13.38514 0 13.90077 17.60226 0 0 8.807484 14.00615 17.13961 0 14.74243 14.96096 0 15.86726 14.93807 14.75089 17.4593 15.85665 16.58397 14.53426 13.00252 15.72511 16.51793 0 0 0 0 13.77688 0 0 0 16.70504 0 14.06406 0 16.45979 0 15.6609 0 14.22267 12.73558 16.20966 Q8IYX7 SAXO1_HUMAN Stabilizer of axonemal microtubules 1 SAXO1 C9orf138 FAM154A Homo sapiens (Human) cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821] microtubule binding [GO:0008017] GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0034453; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417 EMGRCLASYPEPPGYTFEEVDALGHR 3.589999914 0.97533983 0.97533983 1.38E-12 2980.793225 0 0 0 0 12.61416 15.63212 11.95259 0 0 0 0 0 0 0 0 0 0 0 0 0 13.37795 0 0 13.79353 0 0 0 14.48129 0 0 0 0 0 0 0 14.96579 0 12.82989 0 0 0 0 0 0 0 14.15196 15.59076 0 Q8IYY4 DZI1L_HUMAN Cilium assembly protein DZIP1L (DAZ-interacting zinc finger protein 1-like) DZIP1L Homo sapiens (Human) ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] metal ion binding [GO:0046872] GO:0005737; GO:0005814; GO:0005930; GO:0007224; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0046872; GO:0060271; GO:0061512; GO:1905349 KVEGIHK 17.60000038 1 1 0 810.5941905 0 16.79169 0 0 0 0 0 20.84605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZ02 LRC34_HUMAN Leucine-rich repeat-containing protein 34 LRRC34 Homo sapiens (Human) cell differentiation [GO:0030154] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; cell differentiation [GO:0030154] GO:0005730; GO:0005737; GO:0030154 SMGSSREAAR 5.829999924 0.055541225 0.055541225 0.210571551 1067.791109 16.07092 15.83173 12.88386 0 13.34115 16.2772 14.79171 14.47279 0 0 0 14.88447 17.97277 0 9.467688 12.19091 12.63421 9.438167 0 16.10357 0 0 0 0 0 0 0 0 0 14.33899 0 15.17737 0 14.86957 16.6392 0 15.77908 0 0 0 0 0 13.47721 0 15.07742 0 0 0 Q8IZ13 ZBED8_HUMAN Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8) ZBED8 Buster3 C5orf54 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 EKLSAFVR 1.200000048 1 1 0.24214682 949.0046191 14.83375 15.20679 14.83872 14.10719 12.16752 13.40517 16.18585 14.50085 15.43231 16.71238 14.4064 16.46309 13.38556 14.34603 0 14.23105 15.95439 0 0 0 0 0 12.0782 0 15.55319 14.7834 0 0 0 0 0 0 0 0 0 0 14.56265 0 0 16.03988 0 0 14.6415 0 15.44003 0 0 0 Q8IZ41 RASEF_HUMAN Ras and EF-hand domain-containing protein (Ras-related protein Rab-45) RASEF RAB45 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005829; GO:0019003; GO:0042802; GO:0048471 ALCTELR 8.210000038 1 1 0.247426192 862.9821823 0 0 17.65401 0 0 17.28576 0 0 0 16.9194 0 0 16.54633 17.86631 15.74933 0 0 0 0 0 0 0 0 0 17.77968 18.28546 0 0 0 0 0 0 0 0 0 15.21046 16.80091 0 0 0 0 0 0 16.75125 16.54289 16.97945 0 0 Q8IZ52 CHSS2_HUMAN "Chondroitin sulfate synthase 2, EC 2.4.1.175, EC 2.4.1.226 (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor, ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2)" CHPF CSS2 UNQ651/PRO1281 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206] cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759] cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206] acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] GO:0000139; GO:0005759; GO:0005829; GO:0008376; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510 GMEYTLDLQLEALTPQGGR 5.539999962 1 1 0.205230734 2108.245967 0 14.37674 0 13.22304 13.48404 13.54366 13.82531 13.74973 0 0 14.41359 13.00825 0 12.94209 0 11.21127 0 0 0 0 0 0 0 0 0 0 0 0 0 15.43162 0 13.91602 0 0 13.03996 0 14.59114 0 0 0 0 0 0 0 0 15.49666 0 0 Q8IZ57 NRSN1_HUMAN "Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa, Vesicular membrane protein p24)" NRSN1 VMP Homo sapiens (Human) nervous system development [GO:0007399] cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133] cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; nervous system development [GO:0007399] GO:0007399; GO:0016021; GO:0030133; GO:0030426; GO:0031410; GO:0043005; GO:0043025 SSCSNVCGSRQAQAAAEGGYQR 1.389999986 1 1 0.230883102 2343.972692 13.41899 12.14048 0 13.28331 0 14.26541 0 13.08756 12.65991 0 15.1551 15.91903 0 12.5952 14.98209 12.81326 0 0 0 0 13.25329 0 0 0 0 0 0 0 0 0 0 15.58164 0 12.28707 12.90633 0 12.68101 0 0 0 0 0 15.90241 0 0 0 0 0 Q8IZ73 RUSD2_HUMAN "Pseudouridylate synthase RPUSD2, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 2)" RPUSD2 C15orf19 Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GO:0000455; GO:0003723; GO:0009982; GO:1990481 EPILVVSYKVGVCR 13.77000046 0.453158438 0.453158438 0.195424782 1617.803113 0 0 19.96881 0 0 16.45789 17.43793 19.02074 0 0 17.45562 0 0 17.59604 14.34042 17.29176 0 0 0 0 0 17.47034 0 0 18.27859 0 0 18.48827 0 15.9063 15.52641 15.76807 13.91761 0 17.9027 0 0 16.67873 19.76082 0 18.05405 0 0 0 16.61617 0 0 0 Q8IZA3 H18_HUMAN "Histone H1.8 (Histone H1oo) (Oocyte-specific histone H1) (Oocyte-specific linker histone H1, osH1)" H1-8 H1FOO H1OO OSH1 Homo sapiens (Human) chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; negative regulation of stem cell differentiation [GO:2000737]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of DNA methylation [GO:0044030] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; negative regulation of stem cell differentiation [GO:2000737]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of DNA methylation [GO:0044030] double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492] GO:0000786; GO:0003690; GO:0005634; GO:0005737; GO:0006334; GO:0016584; GO:0030261; GO:0031492; GO:0044030; GO:0045910; GO:0051321; GO:0070062; GO:2000737 NGAASPTK 2.410000086 1 1 0.177774577 745.5218854 0 0 14.55189 14.57477 15.90339 15.36147 0 14.28511 15.71631 0 14.37516 15.88898 0 14.67752 0 15.28391 15.42153 15.6289 15.13563 15.03431 0 16.85274 0 16.40695 15.60287 0 0 15.55032 14.23969 15.50291 0 16.71395 14.94746 13.38593 15.38486 15.02239 16.54428 16.72448 0 0 16.57062 16.75356 16.29946 15.73067 15.56977 16.82267 0 15.60686 Q8IZC4 RTKN2_HUMAN "Rhotekin-2 (Pleckstrin homology domain-containing family K member 1, PH domain-containing family K member 1)" RTKN2 PLEKHK1 Homo sapiens (Human) hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165] GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243 MEGPSLR 5.03000021 1 1 0.195056834 789.0445738 13.22105 15.23752 0 17.58315 14.8872 0 14.73792 13.08531 9.256167 13.16244 13.00121 17.28813 0 15.17814 14.86293 12.98867 12.07554 0 0 14.45695 15.74925 0 16.15661 0 0 15.50554 0 12.28163 0 15.33936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZC6 CORA1_HUMAN Collagen alpha-1(XXVII) chain COL27A1 KIAA1870 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] GO:0003431; GO:0005201; GO:0005576; GO:0005583; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023 AWNGQIFEAGGQFRPEVSMDGCKVQDGR 4.190000057 1 1 0.042831634 3155.437417 0 11.41701 17.96441 15.66316 6.443247 0 12.37731 0 0 13.35297 12.37023 12.01278 0 12.91967 11.68229 9.220152 0 0 0 0 14.71829 0 15.59425 0 0 10.66012 0 0 0 0 0 0 0 0 14.6765 0 15.09082 0 0 15.89806 0 0 9.158997 0 12.91676 0 0 0 Q8IZD0 SAM14_HUMAN "Sterile alpha motif domain-containing protein 14, SAM domain-containing protein 14" SAMD14 Homo sapiens (Human) actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175] actin filament binding [GO:0051015] GO:0005737; GO:0007015; GO:0014069; GO:0015629; GO:0019722; GO:0030425; GO:0031175; GO:0051015 GSNRLSMGSR 4.699999809 1 1 0.357773922 1081.104611 0 0 0 0 0 0 16.15159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.62603 0 15.59483 15.08934 15.46279 0 0 0 0 0 0 0 0 Q8IZD9 DOCK3_HUMAN "Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein, PBP)" DOCK3 KIAA0299 MOCA Homo sapiens (Human) positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124] GO:0005085; GO:0005829; GO:0007264; GO:0017124; GO:0051056; GO:1903997 HFAGALAYK 1.639999986 1 1 0.223731274 976.6976361 0 17.00281 0 0 0 0 15.67155 0 17.287 0 0 0 0 0 0 0 16.41216 0 0 0 13.52067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZF0 NALCN_HUMAN Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) NALCN VGCNL1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0005244; GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805 GRLEVDLDK 12.56999969 0.129867584 0.129867584 0.043719073 1046.573449 17.2768 16.08558 0 13.08487 0 0 0 0 0 0 0 14.93695 17.21885 16.59996 15.24582 14.44368 16.35864 14.77262 14.60966 17.47463 15.43697 16.09399 0 14.09328 12.58859 16.01691 0 15.76505 18.42612 14.21278 12.81247 16.24895 10.51361 16.78906 14.62615 14.37876 17.76034 0 16.24364 0 16.21498 16.87482 14.25402 7.31095 14.29397 0 15.597 15.1098 Q8IZF2 AGRF5_HUMAN Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116) ADGRF5 GPR116 KIAA0758 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of phospholipid biosynthetic process [GO:0071073]; surfactant homeostasis [GO:0043129] apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of phospholipid biosynthetic process [GO:0071073]; surfactant homeostasis [GO:0043129] G protein-coupled receptor activity [GO:0004930] GO:0003094; GO:0004930; GO:0005886; GO:0006112; GO:0007166; GO:0007186; GO:0009986; GO:0016021; GO:0031410; GO:0042593; GO:0043031; GO:0043129; GO:0045177; GO:0045444; GO:0048821; GO:0061626; GO:0071073 TDLETAFRK 4.460000038 0.853598654 0.853598654 0.243220855 1081.499603 14.09284 0 16.69482 0 0 14.37345 15.07786 15.32968 0 0 16.54647 0 0 0 14.80468 0 0 0 12.42374 0 15.65534 16.0872 0 15.39789 14.74681 14.01518 17.10596 17.02204 16.84011 16.15442 15.39954 0 0 16.4233 0 0 17.23064 0 0 0 16.17835 0 16.8266 16.42334 16.17884 15.48414 16.01876 14.58968 Q8IZF6 AGRG4_HUMAN Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) ADGRG4 GPR112 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 KMILHDLK 11.68000031 0.284540147 0.284540147 0.145648979 1015.133447 16.87521 0 0 0 0 0 0 0 0 0 15.56962 15.33068 0 12.23556 16.45203 15.92686 16.17492 14.99135 14.77755 16.16453 0 0 16.82566 18.39539 0 15.05584 16.37722 13.86447 0 0 13.91817 14.47804 0 16.05242 15.19757 0 15.79423 0 15.87295 14.47531 0 0 14.40188 17.07445 0 15.84097 0 16.93962 Q8IZH2 XRN1_HUMAN "5'-3' exoribonuclease 1, EC 3.1.13.- (Strand-exchange protein 1 homolog)" XRN1 SEP1 Homo sapiens (Human) "cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795 VQEIITWLK 21.04000092 0.2499502 0.2499502 0.165312675 1129.051917 19.29514 20.44705 18.93113 19.81992 19.43012 0 18.83857 20.00221 0 19.36876 19.77277 0 17.90063 19.4565 18.95982 18.76954 18.67673 0 18.37224 18.85287 19.20129 18.96172 19.1935 19.67562 18.33774 19.06189 18.81273 0 0 18.95837 19.38184 19.2291 19.96045 0 18.14216 19.18102 18.96082 19.60488 18.27062 19.9707 19.40984 18.11655 19.4818 19.6344 19.22276 0 15.37762 18.25151 Q8IZJ4 RGDSR_HUMAN "Ral-GDS-related protein, hRGR (Ral guanine nucleotide dissociation stimulator-like 4, RalGDS-like 4)" RGL4 RGR Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005886; GO:0007265; GO:0031410; GO:0043547 MEQLSDK 8.159999847 0.567822516 0.567822516 0.224273477 865.4148891 17.42472 0 16.12107 0 0 0 15.88921 0 15.17741 16.10624 16.03541 15.76693 12.03466 0 14.35955 14.3087 16.36742 14.81581 0 0 0 15.87162 0 0 0 14.98726 0 15.47987 15.98745 14.16101 17.00824 15.70338 15.23802 13.24549 12.72728 15.57755 13.7528 17.32822 0 16.70878 0 0 15.12454 15.4467 16.61217 0 0 13.95053 Q8IZK6 MCLN2_HUMAN "Mucolipin-2 (Transient receptor potential channel mucolipin 2, TRPML2)" MCOLN2 Homo sapiens (Human) adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031] calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345] GO:0002250; GO:0005262; GO:0005764; GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0031902; GO:0042802; GO:0045087; GO:0055038; GO:0070588; GO:0071639; GO:0071642; GO:0071651; GO:0072345; GO:1905517; GO:1990266; GO:2000343 RQIPWK 11.97000027 1 1 0.318524107 828.9524618 0 18.40409 19.01018 17.13241 16.69874 18.39082 16.01539 0 18.51381 16.93164 18.31639 17.68542 0 17.85783 16.05934 16.42545 17.19123 17.17543 18.69105 0 16.60106 0 17.65838 16.67312 16.34544 17.56993 16.71351 0 14.60841 14.43401 17.33733 0 0 0 17.54317 16.67983 0 16.31763 17.1325 17.78958 17.18371 18.40466 18.0148 15.06355 17.64105 15.64189 0 16.31406 Q8IZN3 ZDH14_HUMAN "Palmitoyltransferase ZDHHC14, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 14, DHHC-14) (NEW1 domain-containing protein, NEW1CP) (Zinc finger DHHC domain-containing protein 14)" ZDHHC14 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580 MPPGGGGPMK 10.85999966 0.401574582 0.401574582 0.249011346 959.5531021 0 19.16788 17.23934 0 16.69999 0 0 0 14.4366 15.62237 0 0 17.31495 16.13892 0 0 17.4387 0 16.39808 0 0 17.91331 0 17.38371 0 0 20.01326 17.50402 0 16.68647 0 18.50091 17.06714 0 18.06396 19.11956 19.31067 19.35082 19.9591 0 17.18104 0 0 16.54531 0 15.69102 17.62776 0 Q8IZP0 ABI1_HUMAN "Abl interactor 1 (Abelson interactor 1, Abi-1) (Abl-binding protein 4, AblBP4) (Eps8 SH3 domain-binding protein, Eps8-binding protein) (Nap1-binding protein, Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1)" ABI1 SSH3BP1 Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-tyrosine phosphorylation [GO:0018108]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-tyrosine phosphorylation [GO:0018108]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] GO:0001756; GO:0005634; GO:0005783; GO:0005829; GO:0005856; GO:0007169; GO:0008092; GO:0008154; GO:0008285; GO:0014069; GO:0017124; GO:0018108; GO:0030027; GO:0030296; GO:0030426; GO:0031209; GO:0032433; GO:0035591; GO:0035855; GO:0045296; GO:0048813; GO:0070062; GO:0072673 HNSTTSSTSSGGYR 6.139999866 0.554276109 0.554276109 5.25E-12 1442.093381 14.82598 8.028003 0 15.65931 12.15193 0 15.85404 12.47569 12.09802 14.42828 14.53929 12.66658 13.01085 0 0 14.48626 7.853102 13.54593 0 0 16.6639 0 10.60192 0 14.55186 11.4891 13.72936 14.1932 0 14.42245 14.77135 14.60168 14.55329 11.1577 0 16.78289 15.94686 14.78034 13.55523 12.14166 0 0 11.98303 0 12.85236 0 0 15.92809 Q8IZP6 R113B_HUMAN RING finger protein 113B (Zinc finger protein 183-like 1) RNF113B RNF161 ZNF183L1 Homo sapiens (Human) snoRNA splicing [GO:0034247] U2-type spliceosomal complex [GO:0005684] U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; snoRNA splicing [GO:0034247] metal ion binding [GO:0046872] GO:0005684; GO:0034247; GO:0046872 AAPPSPGR 4.139999866 0.625798345 0.625798345 0.25722063 752.9539519 18.16502 0 0 16.672 14.79106 0 16.42568 16.04355 15.74496 0 15.0205 0 0 17.59535 0 15.42263 15.48949 16.92236 0 18.04987 0 0 16.13794 0 0 0 0 14.95642 16.14893 15.43864 14.59215 16.47046 0 14.84025 0 15.49487 15.97483 0 0 0 16.71412 17.22427 0 14.46866 0 15.31114 15.12863 0 Q8IZP7 H6ST3_HUMAN "Heparan-sulfate 6-O-sulfotransferase 3, HS6ST-3, EC 2.8.2.-" HS6ST3 Homo sapiens (Human) "heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]" integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]" heparan sulfate 6-O-sulfotransferase activity [GO:0017095] GO:0015015; GO:0016021; GO:0017095 DHQWPK 9.090000153 0.190801665 0.190801665 0.233802822 809.3633692 0 16.58959 14.83021 15.05827 16.14284 16.38059 0 15.54533 15.3096 0 14.34684 15.36681 17.69098 14.53394 0 0 0 0 0 17.00097 17.11794 0 15.82499 0 16.22754 14.34435 16.26355 15.22922 15.68913 15.18932 16.06077 15.82553 16.21104 17.56966 15.92758 16.12896 17.12817 15.51336 12.85134 15.57659 14.24771 0 16.00121 14.63092 16.47948 13.98078 16.72337 16.33397 Q8IZQ1 WDFY3_HUMAN "WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein, Alfy)" WDFY3 KIAA0993 Homo sapiens (Human) aggrephagy [GO:0035973] autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973] 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872] GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635 GEALAPTTQSKLSR 6 0.700247943 0.700247943 0.373049503 1459.196052 0 0 0 0 0 16.67225 0 0 0 0 0 0 0 0 0 17.22128 0 17.0077 0 0 0 0 0 14.71313 0 0 16.93465 0 0 0 0 0 0 0 15.628 0 18.1111 0 0 0 0 0 0 0 0 0 0 0 Q8IZQ8 MYCD_HUMAN Myocardin MYOCD MYCD Homo sapiens (Human) "cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; cardiocyte differentiation [GO:0035051]; cellular component maintenance [GO:0043954]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; lung alveolus development [GO:0048286]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of skeletal muscle cell differentiation [GO:2001015]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003257]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of histone acetylation [GO:0035065]; regulation of myoblast differentiation [GO:0045661]; regulation of phenotypic switching [GO:1900239]; regulation of smooth muscle cell differentiation [GO:0051150]; response to hypoxia [GO:0001666]; smooth muscle cell differentiation [GO:0051145]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell differentiation [GO:0055012]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; cardiocyte differentiation [GO:0035051]; cellular component maintenance [GO:0043954]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; lung alveolus development [GO:0048286]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of skeletal muscle cell differentiation [GO:2001015]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003257]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of histone acetylation [GO:0035065]; regulation of myoblast differentiation [GO:0045661]; regulation of phenotypic switching [GO:1900239]; regulation of smooth muscle cell differentiation [GO:0051150]; response to hypoxia [GO:0001666]; smooth muscle cell differentiation [GO:0051145]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell differentiation [GO:0055012]" DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] GO:0000122; GO:0000785; GO:0001560; GO:0001570; GO:0001666; GO:0003231; GO:0003257; GO:0003713; GO:0005634; GO:0008284; GO:0008285; GO:0010628; GO:0010667; GO:0010832; GO:0030511; GO:0035035; GO:0035051; GO:0035065; GO:0035886; GO:0042826; GO:0043388; GO:0043954; GO:0045661; GO:0045736; GO:0045893; GO:0045944; GO:0045987; GO:0048286; GO:0048565; GO:0051091; GO:0051145; GO:0051150; GO:0051152; GO:0055007; GO:0055012; GO:0060065; GO:0060157; GO:0060354; GO:0061629; GO:0070412; GO:0097070; GO:0140297; GO:1900222; GO:1900239; GO:1902895; GO:1904706; GO:1904753; GO:2000587; GO:2000721; GO:2000724; GO:2000727; GO:2001015 DPKPK 6.559999943 0.848833382 0.848833382 0.136162403 583.2211221 0 0 0 16.71318 18.0348 0 16.56482 0 0 15.97513 0 16.75529 16.88004 0 17.12157 0 17.36531 15.9363 19.78975 15.18019 14.97127 17.46902 16.02854 16.42416 0 12.68842 14.6226 0 15.01476 0 17.3889 15.57477 0 18.39658 0 14.5203 15.78209 16.91769 0 0 14.37253 13.8157 16.64359 11.90451 0 16.76359 0 16.46091 Q8IZR5 CKLF4_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4) CMTM4 CKLFSF4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LDTFSYSTNVTVRK 5 1 1 0.045331404 1632.174293 15.83694 16.04615 13.1883 0 0 11.84553 0 13.62348 15.32995 0 0 0 13.94483 0 0 16.20397 0 11.21749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZT6 ASPM_HUMAN "Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog, Asp homolog)" ASPM MCPH5 Homo sapiens (Human) cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051] calmodulin binding [GO:0005516] GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0007283; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431 FRSLLVR 8.619999886 0.025295736 0.025295736 0.186240499 890.8967434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.79913 0 0 0 0 0 0 0 0 0 0 0 17.2035 0 0 0 0 0 Q8IZT8 HS3S5_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 5, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5, 3-OST-5, Heparan sulfate 3-O-sulfotransferase 5, h3-OST-5)" HS3ST5 3OST5 HS3OST5 Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]" 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467] GO:0000139; GO:0006024; GO:0006477; GO:0008467; GO:0015015; GO:0016021; GO:0046596; GO:0050656; GO:0050819 AIIIGVRK 7.570000172 1 1 0.183977209 870.524176 0 15.8778 0 15.86671 15.09386 13.53507 0 15.45881 14.71257 0 0 14.98872 0 0 0 15.52705 15.08775 13.86687 14.65915 15.4027 0 15.37274 0 0 15.5436 16.01465 16.48586 0 16.0617 0 0 0 0 16.09411 14.53048 0 0 0 0 15.10987 0 0 14.94268 0 0 16.47829 0 0 Q8IZT9 FAM9C_HUMAN Protein FAM9C FAM9C Homo sapiens (Human) meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] synaptonemal complex [GO:0000795] synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000795; GO:0007286; GO:0051321 DEEGDGEK 2.690000057 1 1 0.143301982 876.9710171 15.79403 0 15.30019 13.45108 0 16.4809 0 14.40156 0 0 0 0 0 0 0 14.15941 0 0 0 0 0 0 0 0 0 0 16.95887 15.59916 14.76085 15.33799 0 0 13.67212 15.23326 15.4625 16.54898 15.39868 0 0 15.26479 0 13.68006 14.94105 14.79856 0 14.39138 0 0 Q8IZU0 FAM9B_HUMAN Protein FAM9B FAM9B Homo sapiens (Human) meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795] nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000795; GO:0005654; GO:0007286; GO:0051321 MDKTCSK 4.659999847 1 1 0.202623801 869.9520368 11.28937 15.72038 12.44685 14.58449 15.22621 16.10437 16.75306 16.52069 0 0 15.90877 0 0 0 0 13.88526 14.81525 0 0 12.55613 0 0 0 15.65057 0 0 0 0 0 0 15.98513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZU1 FAM9A_HUMAN Protein FAM9A FAM9A Homo sapiens (Human) meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] nucleolus [GO:0005730]; synaptonemal complex [GO:0000795] nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000795; GO:0005730; GO:0007286; GO:0051321 AAPAKK 1.539999962 0.283433348 0.283433348 0.128182922 584.3712969 14.93128 14.95236 14.6335 15.278 14.29858 0 0 0 14.01994 15.69025 0 0 0 0 16.37097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZU2 WDR17_HUMAN WD repeat-containing protein 17 WDR17 Homo sapiens (Human) IWDYTQDACINILNGHTAPVR 4.039999962 1 1 0.325644664 2457.482305 0 15.0578 0 0 0 0 0 0 14.82216 0 0 0 15.96818 16.0068 0 13.56389 14.74044 0 0 17.23529 13.15075 0 0 16.64522 0 0 0 0 15.88105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZU3 SYCP3_HUMAN "Synaptonemal complex protein 3, SCP-3" SYCP3 SCP3 Homo sapiens (Human) "cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" "chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]" "chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" DNA binding [GO:0003677] GO:0000775; GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007141; GO:0007286; GO:0035093; GO:0051301; GO:0051321 ILNMFR 15.46000004 1 1 0.221599705 808.4730611 17.31795 11.653 15.82257 0 0 0 17.32657 0 18.54622 19.01499 0 0 0 0 0 17.9208 18.42958 16.97256 17.65115 0 18.29871 0 0 19.19116 20.4865 0 19.26486 0 0 0 0 0 0 0 0 0 0 0 18.82019 18.1557 19.20532 0 0 0 0 0 0 0 Q8IZW8 TENS4_HUMAN Tensin-4 (C-terminal tensin-like protein) TNS4 CTEN PP14434 Homo sapiens (Human) apoptotic process [GO:0006915]; protein localization [GO:0008104] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; apoptotic process [GO:0006915]; protein localization [GO:0008104] actin binding [GO:0003779] GO:0003779; GO:0005829; GO:0005856; GO:0005925; GO:0006915; GO:0008104 FCGMDPEQRK 1.460000038 0.122449026 0.122449026 3.19E-12 1282.851922 13.75678 11.57608 12.77396 13.52884 0 0 0 0 0 0 0 0 13.29601 0 15.18114 0 12.5225 0 12.55313 0 14.03595 14.90266 0 15.66369 0 0 0 13.79878 13.27603 11.15504 0 14.81433 14.89535 13.97815 13.28121 15.15837 12.08525 15.14344 14.95187 0 14.56008 16.19662 0 14.51821 13.35778 11.95483 12.78169 0 Q8IZX4 TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like (TAF(II)210) (TBP-associated factor 1-like) (TBP-associated factor 210 kDa) (Transcription initiation factor TFIID 210 kDa subunit) TAF1L Homo sapiens (Human) "male meiotic nuclear division [GO:0007140]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]" nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669] "nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; male meiotic nuclear division [GO:0007140]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]" DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025] GO:0003677; GO:0004402; GO:0004674; GO:0005654; GO:0005669; GO:0006357; GO:0007140; GO:0016251; GO:0017025; GO:0045893; GO:0051123; GO:0070577 AFIAAMK 4.480000019 0.500626087 0.500626087 0.216791326 751.3618831 0 15.99248 15.63618 0 0 0 0 0 0 0 0 0 15.69965 17.05174 16.62303 16.43587 16.52779 0 0 0 0 17.91923 19.18538 18.18232 0 0 0 0 0 0 0 0 0 17.12905 0 17.02005 16.51489 0 0 0 15.78787 16.53219 15.91642 16.02627 0 0 17.50383 16.45247 Q8IZY2 ABCA7_HUMAN "Phospholipid-transporting ATPase ABCA7, EC 7.6.2.1 (ABCA-SSN) (ATP-binding cassette sub-family A member 7) (Autoantigen SS-N) (Macrophage ABC transporter)" ABCA7 Homo sapiens (Human) amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta formation [GO:0034205]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; memory [GO:0007613]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of endocytosis [GO:0045806]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; plasma membrane raft organization [GO:0044857]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to nucleus [GO:0034504]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of lipid metabolic process [GO:0019216]; visual learning [GO:0008542] cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor activity [GO:0034188]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta formation [GO:0034205]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; memory [GO:0007613]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of endocytosis [GO:0045806]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; plasma membrane raft organization [GO:0044857]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to nucleus [GO:0034504]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of lipid metabolic process [GO:0019216]; visual learning [GO:0008542] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor activity [GO:0034188]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548] GO:0000139; GO:0001891; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005794; GO:0005886; GO:0006869; GO:0006909; GO:0007613; GO:0008542; GO:0009986; GO:0010875; GO:0016021; GO:0018149; GO:0019216; GO:0030054; GO:0031901; GO:0032587; GO:0033344; GO:0033700; GO:0034188; GO:0034205; GO:0034380; GO:0034504; GO:0038027; GO:0042626; GO:0042985; GO:0043231; GO:0043409; GO:0044857; GO:0045332; GO:0045806; GO:0050766; GO:0070374; GO:0090554; GO:0090556; GO:0097386; GO:0140328; GO:0140359; GO:0150094; GO:1900223; GO:1901076; GO:1902430; GO:1902991; GO:1902995; GO:1903898; GO:2000010 DRLPAGGR 12.51000023 1 1 0.195882171 842.6099394 22.86216 22.22369 0 0 21.11715 0 19.06855 21.85618 0 15.61104 21.11623 21.72476 20.06869 22.38105 0 22.28155 20.43009 18.6064 20.56639 0 18.97435 17.64074 18.80636 0 22.31722 19.66999 0 21.0331 22.8849 0 0 0 22.75377 0 22.22496 0 22.62389 0 22.37291 19.30613 17.12875 18.6203 0 0 0 22.15048 22.7999 20.1095 Q8MH63 LAT1N_HUMAN "Putative L-type amino acid transporter 1-like protein MLAS (hLAT1 3-transmembrane protein MLAS, hLAT1 3TM MLAS)" SLC7A5P1 MLAS Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179] L-amino acid transmembrane transporter activity [GO:0015179] GO:0015179; GO:0016021 ALAAPVAEEK 16.03000069 1 1 0.27703988 998.5048305 0 0 17.98428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.42119 0 0 18.25554 0 0 0 0 0 0 0 0 0 0 0 0 0 17.55532 0 0 0 0 0 0 18.34999 0 16.31284 0 17.17101 0 Q8N0S2 SYCE1_HUMAN "Synaptonemal complex central element protein 1 (Cancer/testis antigen 76, CT76)" SYCE1 C10orf94 Homo sapiens (Human) cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694]; synaptonemal complex [GO:0000795] central element [GO:0000801]; chromosome [GO:0005694]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0000801; GO:0005694; GO:0007130; GO:0051301 ESEAHR 11.90999985 1 1 0.145648201 728.8427701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.77798 0 17.58235 16.5176 0 16.72664 0 0 0 16.29182 15.82876 0 0 15.86254 16.83745 0 0 0 0 0 17.51876 17.4109 0 0 0 17.61751 Q8N0S6 CENPL_HUMAN "Centromere protein L, CENP-L (Interphase centromere complex protein 33)" CENPL C1orf155 ICEN33 Homo sapiens (Human) "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]" GO:0000775; GO:0005654; GO:0005829 VAFLLHK 1.370000005 9.99E-07 9.99E-07 0.29217752 827.01708 17.37483 0 0 0 0 0 0 0 0 0 0 18.34487 0 0 0 17.30597 17.44102 0 0 0 0 0 0 0 0 0 0 0 17.8857 16.9084 0 0 0 18.00961 0 0 19.48198 0 0 0 17.19714 18.27483 0 0 0 0 0 0 Q8N0T1 RBIS_HUMAN Ribosomal biogenesis factor RBIS C8orf59 Homo sapiens (Human) ribosome biogenesis [GO:0042254] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254] GO:0005654; GO:0005730; GO:0005829; GO:0042254 AFVNVQK 5.340000153 1 1 0.288244238 806.5948324 12.90669 0 0 0 0 0 0 18.82258 18.35198 0 0 18.36418 17.5624 0 0 0 0 0 0 0 16.74668 18.3133 0 17.81955 20.22055 0 0 0 0 18.03707 21.61802 0 0 0 17.86395 0 0 18.76489 0 17.24914 0 0 0 0 0 0 17.18445 0 Q8N0U7 CA087_HUMAN Uncharacterized protein C1orf87 C1orf87 Homo sapiens (Human) APAPPMEPEVPEMSQSKTEHMK 7.550000191 1 1 4.58E-13 2466.744155 15.20293 0 10.16301 0 12.39567 13.49631 0 0 13.23164 0 0 0 0 0 13.42123 0 0 14.68812 15.71558 13.68406 0 0 13.03252 0 0 0 17.21969 0 0 14.55139 11.5723 12.64859 0 0 0 0 13.57702 0 0 0 12.8737 0 0 14.8938 0 0 14.38133 15.07257 Q8N0V5 GNT2A_HUMAN "N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, N-acetylglucosaminyltransferase, EC 2.4.1.150 (I-branching enzyme) (IGNT)" GCNT2 GCNT5 II NACGT1 Homo sapiens (Human) glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]" GO:0000139; GO:0005794; GO:0006024; GO:0006486; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0016021; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374 IPGVPGSMPNASWTGNLRAIK 1.059999943 1 1 4.11E-12 2184.695721 0 0 0 14.76037 15.26747 15.15286 0 11.76453 14.81201 0 0 16.68143 0 0 14.36864 14.53033 0 0 0 0 0 0 0 16.025 18.43553 0 16.73077 0 0 18.638 0 0 0 8.585806 19.54846 0 15.44994 0 12.89989 0 0 16.07431 0 17.37191 17.04037 15.34237 16.95041 17.79765 Q8N0W3 FCSK_HUMAN "L-fucose kinase, Fucokinase, EC 2.7.1.52" FCSK FUK Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350] ATP binding [GO:0005524]; fucokinase activity [GO:0050201] GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350 ARHVLEAR 4.869999886 1 1 0.071774287 952.412896 0 0 14.72445 14.43797 0 12.37562 0 6.129736 0 0 0 0 15.99446 0 0 0 0 0 14.98736 16.76536 0 14.56279 15.15811 0 12.81783 0 0 0 0 0 0 0 0 0 0 0 16.49294 0 0 0 14.64842 0 0 0 16.63808 0 0 14.19514 Q8N0X2 SPG16_HUMAN Sperm-associated antigen 16 protein (Pf20 protein homolog) SPAG16 PF20 Homo sapiens (Human) axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288] axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288] GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716 DILVSCGEDR 4.840000153 1 1 0.495549206 1162.352749 0 0 0 0 0 0 0 0 17.89091 0 0 0 17.57853 0 17.91673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Z2 ABRA_HUMAN "Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling, STARS)" ABRA Homo sapiens (Human) positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606] actin binding [GO:0003779] GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045944; GO:0051091 EMMDMCFIICTMAR 10.11999989 1 1 0.16757913 1856.879038 0 15.00693 14.65385 15.69023 0 0 15.419 16.85522 0 0 0 0 0 0 0 0 0 0 13.03364 0 0 0 15.32681 15.45991 14.55739 0 0 0 0 0 0 0 0 0 0 0 14.49221 0 0 0 15.11841 13.54867 0 0 0 0 14.46822 16.2354 Q8N0Z3 SPICE_HUMAN Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein) SPICE1 CCDC52 SPICE Homo sapiens (Human) cell division [GO:0051301]; metaphase plate congression [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599] GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0046599; GO:0051301; GO:0051310; GO:0090307 KPNLHALSKPKK 14.39000034 1 1 0.763665191 1356.073463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.84629 0 16.74856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Z6 TTC5_HUMAN "Tetratricopeptide repeat protein 5, TPR repeat protein 5 (Stress-responsive activator of p300, Protein Strap)" TTC5 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022] GO:0003677; GO:0003682; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410; GO:0043022; GO:0045944; GO:0061014 LAVQMDVHDGR 4.980000019 0.254412115 0.254412115 0.131964092 1256.04913 15.4038 15.32962 0 14.50201 0 0 12.76039 15.33414 0 0 0 15.95385 0 0 0 13.40603 9.432482 0 0 0 11.5428 15.72043 0 0 0 0 14.38973 0 0 16.66004 0 0 14.65486 0 15.10509 0 0 0 0 0 14.10723 0 14.44341 0 0 0 0 0 Q8N103 TAGAP_HUMAN T-cell activation Rho GTPase-activating protein (T-cell activation GTPase-activating protein) TAGAP TAGAP1 FKSG15 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005096; GO:0005829; GO:0007165; GO:0051056 MLEAHCLLPPLPPAHHVEDSR 11.14999962 1 1 4.12E-12 2435.289332 0 0 0 14.5368 0 14.95222 0 13.33438 0 13.02728 15.30158 0 16.71728 0 0 0 13.6315 0 0 0 0 0 0 0 15.24987 17.00488 0 15.4916 0 0 14.20781 9.878799 15.08508 0 0 0 0 13.98595 0 0 0 0 0 0 14.85582 17.54616 0 0 Q8N104 D106A_HUMAN "Beta-defensin 106 (Beta-defensin 6, BD-6, DEFB-6) (Defensin, beta 106)" DEFB106A BD6 DEFB106 DEFB6; DEFB106B Homo sapiens (Human) antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634] extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634]; CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530] GO:0001530; GO:0005634; GO:0008201; GO:0019898; GO:0031727; GO:0045087; GO:0050829; GO:0050830; GO:0061760; GO:1990742 RTFLFLFAVLFFLTPAK 2.519999981 1 1 0.053923729 2031.507902 14.98011 15.01235 12.99994 14.03505 13.66391 0 16.79333 0 12.84442 0 12.96394 13.87376 11.28748 13.70469 13.96049 11.02292 12.98981 0 13.19205 0 0 0 15.51918 14.40587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N122 RPTOR_HUMAN "Regulatory-associated protein of mTOR, Raptor (p150 target of rapamycin (TOR)-scaffold protein)" RPTOR KIAA1303 RAPTOR Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156] GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0010800; GO:0016310; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045821; GO:0045945; GO:0046889; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0071889; GO:0071902; GO:1900087; GO:1905857 EQELEVAAINPNHPLAQMPLPPSMK 9.600000381 1 1 0.068679406 2754.485752 0 12.77757 12.6241 0 0 0 0 14.65891 12.35215 0 0 0 0 0 14.79285 0 14.55071 0 13.62962 0 0 0 14.89338 0 0 12.75333 14.5399 14.66521 11.41178 0 13.51557 0 15.53683 9.756865 16.36452 0 15.47816 12.05688 0 0 15.0838 0 14.05135 0 0 0 0 17.14539 Q8N129 CNPY4_HUMAN Protein canopy homolog 4 CNPY4 PSEC0237 UNQ1909/PRO4354 Homo sapiens (Human) positive regulation of protein localization to plasma membrane [GO:1903078] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; positive regulation of protein localization to plasma membrane [GO:1903078] signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:1903078 TGSHPK 5.21999979 1 1 0.239135627 625.6418331 0 0 0 18.20941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.31506 0 0 0 0 0 0 20.40438 0 0 0 0 18.99604 18.80956 0 0 0 0 0 0 0 0 0 0 Q8N130 NPT2C_HUMAN "Sodium-dependent phosphate transport protein 2C, Sodium-phosphate transport protein 2C (Na(+)-dependent phosphate cotransporter 2C) (Sodium/inorganic phosphate cotransporter IIC) (Sodium/phosphate cotransporter 2C, Na(+)/Pi cotransporter 2C, NaPi-2c) (Solute carrier family 34 member 3)" SLC34A3 NPT2C NPTIIC Homo sapiens (Human) cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]; sodium-dependent phosphate transport [GO:0044341] sodium:phosphate symporter activity [GO:0005436] GO:0005436; GO:0005886; GO:0005903; GO:0006814; GO:0006817; GO:0016021; GO:0016324; GO:0030643; GO:0031526; GO:0031982; GO:0044341 LLNSVLR 20.98999977 0.244070947 0.244070947 0.225549421 814.4572499 15.55594 15.58735 16.66314 15.69159 16.21535 16.20954 16.19515 16.81288 0 15.76259 17.75571 15.75237 16.2202 16.05502 16.70707 17.78677 16.92481 15.953 16.25469 16.61115 16.34045 16.37416 17.75296 16.10321 16.9534 16.54544 17.10131 15.83054 16.22789 16.51098 16.28195 16.68994 17.32134 16.15159 16.09112 16.75356 17.26244 16.0696 16.39327 16.87703 16.21728 16.18717 16.30043 16.21107 17.22477 16.88108 18.48926 17.2118 Q8N135 LGI4_HUMAN Leucine-rich repeat LGI family member 4 (LGI1-like protein 3) (Leucine-rich glioma-inactivated protein 4) LGI4 LGIL3 UNQ6515/PRO21485 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641] GO:0005576; GO:0005615; GO:0008344; GO:0014009; GO:0022011; GO:0031641; GO:0042551 YIGDSMVMR 6.690000057 1 1 0.415003945 1104.440186 15.48496 0 11.9616 15.49663 0 15.29741 0 15.14694 0 15.59952 0 11.69698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07725 0 0 0 0 0 15.68273 0 0 0 0 0 0 0 17.72171 0 0 0 0 15.00141 0 0 Q8N145 LGI3_HUMAN Leucine-rich repeat LGI family member 3 (LGI1-like protein 4) (Leucine-rich glioma-inactivated protein 3) LGI3 LGIL4 UNQ8190/PRO23199 Homo sapiens (Human) exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157] extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021] extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; catalytic activity [GO:0003824]; exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157] catalytic activity [GO:0003824] GO:0003824; GO:0005576; GO:0006887; GO:0008021; GO:0017157; GO:0043005 AFCYMPAGDAQLLLAPSFK 3.220000029 0.756844044 0.756844044 4.60E-13 2100.401268 0 0 12.56212 13.0953 0 0 12.23511 0 13.3682 0 0 0 0 0 0 0 0 0 0 0 13.92645 0 14.83446 0 0 0 0 0 0 0 0 0 0 0 15.28703 0 0 0 0 0 0 0 12.49282 0 0 0 0 0 Q8N158 GPC2_HUMAN Glypican-2 [Cleaved into: Secreted glypican-2 ] GPC2 Homo sapiens (Human) cell migration [GO:0016477]; neuron differentiation [GO:0030182]; positive regulation of neuron projection development [GO:0010976]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; smoothened signaling pathway [GO:0007224] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell migration [GO:0016477]; neuron differentiation [GO:0030182]; positive regulation of neuron projection development [GO:0010976]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; smoothened signaling pathway [GO:0007224] GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007224; GO:0009966; GO:0009986; GO:0010976; GO:0016477; GO:0030182; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:1905475 MAADASLEAAPCWTGAGR 4.5 0.001381578 0.001381578 0.064401051 1834.205578 0 0 0 14.15629 0 15.59389 16.96111 0 15.95359 17.73002 0 15.65108 0 12.90655 13.14254 0 14.85727 14.41447 0 14.56004 16.56554 0 0 0 0 15.33913 0 0 19.96435 0 0 16.21552 0 13.3778 16.05701 0 14.57864 16.79635 0 0 17.44141 0 0 0 15.12499 0 13.15291 14.79798 Q8N159 NAGS_HUMAN "N-acetylglutamate synthase, mitochondrial, EC 2.3.1.1 (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form ]" NAGS Homo sapiens (Human) arginine biosynthetic process [GO:0006526]; glutamate metabolic process [GO:0006536]; urea cycle [GO:0000050] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; arginine binding [GO:0034618]; methione N-acyltransferase activity [GO:0103045]; arginine biosynthetic process [GO:0006526]; glutamate metabolic process [GO:0006536]; urea cycle [GO:0000050] acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; arginine binding [GO:0034618]; methione N-acyltransferase activity [GO:0103045] GO:0000050; GO:0004042; GO:0005739; GO:0005759; GO:0006526; GO:0006536; GO:0034618; GO:0103045 ERQQMR 10.44999981 0.259719908 0.259719908 0.18080533 865.1044298 15.03226 14.58456 14.54551 0 15.46241 17.68692 18.2728 15.16642 12.12038 0 13.91434 16.65145 18.43125 18.0302 0 0 17.58546 0 13.96015 0 14.65647 15.31621 17.57475 15.13883 18.45311 16.95559 0 16.95468 0 18.65716 18.0429 17.57384 19.37138 0 0 0 16.78196 18.26634 0 17.717 0 17.13909 0 16.92426 15.85171 16.98476 17.17894 13.77742 Q8N163 CCAR2_HUMAN "Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein, DBC-1, DBC.1) (NET35) (p30 DBC)" CCAR2 DBC1 KIAA1967 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]" enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993] GO:0000785; GO:0000993; GO:0003723; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005819; GO:0006355; GO:0006397; GO:0006974; GO:0007049; GO:0008380; GO:0009411; GO:0016055; GO:0019899; GO:0030308; GO:0030374; GO:0031647; GO:0032435; GO:0032784; GO:0042752; GO:0043065; GO:0043086; GO:0043653; GO:0044609; GO:0045892; GO:0048511; GO:0090263; GO:0090311; GO:1902230; GO:2000003 ILLTLGIR 12.86999989 1 1 8.07E-13 899.0338649 0 14.93602 0 0 0 13.1317 0 0 0 0 0 0 0 15.10635 0 0 0 15.09422 0 0 15.35145 0 0 0 0 0 12.35964 11.42839 0 14.95557 0 0 0 0 0 16.44758 0 16.13524 0 0 0 0 0 0 0 0 0 0 Q8N183 NDUF2_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 (B17.2-like, B17.2L) (Mimitin) (Myc-induced mitochondrial protein, MMTN) (NDUFA12-like protein)" NDUFAF2 NDUFA12L Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex binding [GO:0044877]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179] protein-containing complex binding [GO:0044877] GO:0005739; GO:0005743; GO:0032981; GO:0044877; GO:0061179 SQDFYEK 8.100000381 0.267772943 0.267772943 0.06009764 916.2031342 0 16.36396 0 13.84352 14.10598 13.79499 0 15.50704 14.34047 0 0 0 14.65047 14.92007 17.44113 0 14.46236 17.4892 0 13.4192 15.93574 0 0 14.62534 0 15.98502 17.03728 0 0 0 18.17141 0 17.21994 12.52089 16.45781 14.43472 13.35768 15.17135 16.66512 0 16.57229 0 0 16.27931 0 0 16.72937 10.43655 Q8N184 ZN567_HUMAN Zinc finger protein 567 ZNF567 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 AFRMK 6.400000095 1 1 0.07014117 668.5488106 13.13873 0 0 0 0 15.79306 0 0 15.20171 13.12864 0 15.83892 0 0 16.83442 0 0 0 0 0 16.61158 15.87059 0 15.38078 15.7486 0 0 0 0 0 0 15.50424 14.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N187 CARTF_HUMAN "Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor, CaRF) (Testis development protein NYD-SP24)" CARF ALS2CR8 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357] granular component [GO:0001652]; nucleus [GO:0005634] "granular component [GO:0001652]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001228; GO:0001652; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0035865; GO:0051090; GO:0061400; GO:0071277 NLVDAGGVLR 11.39999962 1 1 0.137296256 1013.919353 0 13.66193 14.67918 0 0 0 0 0 0 0 0 12.21659 13.18279 14.218 0 14.69726 0 0 15.96815 15.35476 13.80438 0 0 0 0 13.00297 0 13.27978 14.89859 15.78447 15.80212 15.49815 14.09426 15.10472 13.67142 13.67126 16.22811 15.61689 15.85445 16.10938 15.15454 0 0 15.908 0 15.95911 0 0 Q8N1B4 VPS52_HUMAN Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein) VPS52 SACM2L Homo sapiens (Human) "ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" syntaxin binding [GO:0019905] GO:0000938; GO:0005794; GO:0005829; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:1990745 SRNTIFTLGTR 2.230000019 1 1 0.388822526 1266.009564 14.42791 0 16.27409 12.93776 15.07902 0 0 16.73804 0 15.10536 15.92111 0 0 0 0 16.23938 0 0 0 0 16.81851 0 15.52115 0 0 0 16.1374 0 15.85084 0 0 0 16.15697 0 0 0 0 0 0 16.39309 18.25693 16.67764 0 0 0 0 18.0714 0 Q8N1C3 GBRG1_HUMAN Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) GABRG1 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:1902476; GO:1902711; GO:1904315 DAVPAR 6.619999886 0.151061341 0.151061341 0.193346567 628.5380241 14.33189 15.52698 0 15.87381 13.00383 12.54427 15.30337 0 15.30108 15.82621 0 15.94344 12.66094 15.47095 14.86304 14.78183 13.4054 15.79734 15.87574 17.35278 16.82644 15.47984 0 14.04289 16.34706 15.6305 16.60237 16.23934 15.41353 15.69867 14.96474 15.71327 0 0 0 16.7179 14.96072 0 19.0621 0 16.19617 0 0 16.68371 0 0 16.19718 0 Q8N1D5 CF107_HUMAN Protein CFAP107 (Cilia- and flagella-associated protein 107) CFAP107 C1orf158 Homo sapiens (Human) HGYNPGLPPLR 6.199999809 1 1 0.083602008 1219.75494 12.57801 0 13.33669 12.92183 12.72536 0 0 0 14.24198 0 14.24934 0 15.36622 13.5257 0 0 0 11.10951 12.19215 0 0 0 0 0 0 0 0 0 13.39338 0 0 0 0 13.38511 14.29301 0 0 0 0 0 0 0 0 0 0 14.18709 0 0 Q8N1F7 NUP93_HUMAN Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93) NUP93 KIAA0095 Homo sapiens (Human) nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; SMAD protein signal transduction [GO:0060395] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; SMAD protein signal transduction [GO:0060395] structural constituent of nuclear pore [GO:0017056] GO:0005635; GO:0005643; GO:0005813; GO:0005829; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0016973; GO:0017056; GO:0031965; GO:0034399; GO:0051292; GO:0060391; GO:0060395 NMALSIAER 20.46999931 1 1 0.421800406 1020.607016 16.80181 0 0 17.69942 0 16.10609 0 0 0 0 18.79128 0 0 0 0 0 18.95164 17.91553 0 0 16.05305 18.84879 21.2075 0 0 18.87463 0 17.67227 0 18.30086 15.67374 0 0 0 18.02599 0 0 0 17.87192 20.05856 18.83577 17.42203 0 0 17.78061 0 0 0 Q8N1G0 ZN687_HUMAN Zinc finger protein 687 ZNF687 KIAA1441 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005654; GO:0005829; GO:0046872 AVVLPGGTATSPKMIAK 3.339999914 1 1 0.284937234 1656.973228 0 17.8989 0 0 0 0 0 0 0 0 0 0 0 15.82166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.71849 0 0 0 0 0 0 Q8N1G1 REXO1_HUMAN "RNA exonuclease 1 homolog, EC 3.1.-.- (Elongin-A-binding protein 1, EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1)" REXO1 ELOABP1 KIAA1138 TCEB3BP1 Homo sapiens (Human) nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604 GLAPSAVPGLSKTSGR 7.010000229 1 1 0.318185027 1498.073938 0 0 14.1096 0 0 14.65233 0 14.66248 14.35286 14.89278 0 14.38802 15.20616 12.35252 14.81755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12562 0 0 15.74617 0 0 0 Q8N1G2 CMTR1_HUMAN "Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1, EC 2.1.1.57 (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1, MTr1, hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein, ISG95)" CMTR1 FTSJD2 KIAA0082 MTR1 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009] mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004483; GO:0005634; GO:0005654; GO:0005737; GO:0006370; GO:0043231; GO:0080009; GO:0097309 NFVLDNTDR 6.53000021 1 1 0.438435751 1093.058906 18.89803 16.97416 16.23957 0 0 0 0 19.51992 18.70577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0741 0 0 0 0 0 0 0 Q8N1G4 LRC47_HUMAN Leucine-rich repeat-containing protein 47 LRRC47 KIAA1185 Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432] phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432] phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723] GO:0003723; GO:0004826; GO:0006432 LKEINFR 22.5 1 1 0.271794508 919.7462992 15.24151 0 15.9492 0 13.13579 18.57391 0 18.16107 0 0 16.82561 16.93178 15.06442 15.01864 17.33399 13.69746 17.40637 18.50588 14.96526 0 15.37265 16.53076 12.11384 0 16.52317 17.40196 15.44303 0 17.41896 17.23927 15.27724 15.6233 0 16.45309 15.89418 0 17.59209 0 17.72498 15.37379 18.03419 15.75353 16.76618 15.75527 18.77182 16.87918 16.39596 17.24179 Q8N1H7 S6OS1_HUMAN Protein SIX6OS1 (Six6 opposite strand transcript 1) SIX6OS1 C14orf39 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283] central element [GO:0000801]; chromosome [GO:0005694] central element [GO:0000801]; chromosome [GO:0005694]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283] GO:0000801; GO:0005694; GO:0007129; GO:0007283; GO:0010705; GO:0048477; GO:0051090 ESPGLSFLMSYTSR 5.090000153 1 1 0.514536233 1592.571855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1I0 DOCK4_HUMAN Dedicator of cytokinesis protein 4 DOCK4 KIAA0716 Homo sapiens (Human) cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] GO:0005085; GO:0005096; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017124; GO:0030165; GO:0030971; GO:0031267; GO:0032420; GO:0032421; GO:0060326; GO:1904694; GO:1904754 ITGCLSK 11.15999985 0.106829152 0.106829152 0.243895479 778.2576437 15.73084 16.01294 0 17.39506 15.16256 15.17862 15.55359 0 15.52236 15.24605 15.45456 15.89814 15.70044 16.69615 16.22163 15.5578 15.54639 0 16.74921 17.77216 16.20029 0 15.26805 18.54448 16.37467 0 0 16.23482 15.91794 15.55257 17.02547 17.19077 15.49403 16.53548 0 17.07457 17.29107 0 17.71053 15.03761 15.3389 0 16.76575 17.61908 17.26324 16.59089 16.32714 17.10469 Q8N1K5 THMS1_HUMAN Protein THEMIS (Thymocyte-expressed molecule involved in selection) THEMIS C6orf190 C6orf207 Homo sapiens (Human) adaptive immune response [GO:0002250]; negative T cell selection [GO:0043383]; positive T cell selection [GO:0043368]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; adaptive immune response [GO:0002250]; negative T cell selection [GO:0043383]; positive T cell selection [GO:0043368]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0005634; GO:0005737; GO:0005911; GO:0008180; GO:0043368; GO:0043383; GO:0050852 TIVIHKK 6.25 1 1 0.224536302 839.2961333 14.17924 0 15.39407 0 16.30921 0 11.92764 0 15.55395 0 0 0 0 0 15.5575 0 14.2067 0 0 14.90584 0 16.65081 0 0 16.18313 0 0 16.10364 14.97656 14.41346 0 0 0 0 14.1908 0 14.49589 0 16.17886 16.03545 0 0 14.61623 15.62735 0 0 0 0 Q8N1L4 CP4Z2_HUMAN Putative inactive cytochrome P450 family member 4Z2 CYP4Z2P Homo sapiens (Human) integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037 SAVSHK 3.829999924 0.915351927 0.915351927 0.128556946 629.3711251 16.65345 0 0 0 0 14.76093 0 0 16.07969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.35519 15.95104 0 15.48938 0 16.05552 0 18.33037 0 17.46419 17.83289 18.34329 0 0 0 0 15.21789 0 0 0 0 0 0 0 Q8N1N2 DYNAP_HUMAN "Dynactin-associated protein, Full" DYNAP C18orf26 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; cellular response to ergosterol [GO:1901625]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; activation of protein kinase B activity [GO:0032148]; cellular response to ergosterol [GO:1901625]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981] GO:0000139; GO:0005794; GO:0005886; GO:0008284; GO:0016021; GO:0032148; GO:0042981; GO:1901625 MVADIK 16.45000076 1 1 0.210082313 693.411885 15.52557 0 0 17.0856 0 16.72246 0 17.92164 0 0 16.0603 17.07458 17.48241 17.34071 18.79007 16.03773 16.70864 17.53143 17.46598 17.629 17.31231 0 18.7054 17.27022 15.91565 0 0 19.21596 17.15047 17.03961 18.96444 0 17.89493 18.96992 0 0 18.39362 17.81811 18.12304 0 17.5116 0 17.66588 15.4256 0 0 16.82894 17.68435 Q8N1N4 K2C78_HUMAN "Keratin, type II cytoskeletal 78 (Cytokeratin-78, CK-78) (Keratin-5b) (Keratin-78, K78) (Type-II keratin Kb40)" KRT78 K5B KB40 Homo sapiens (Human) cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095] GO:0005615; GO:0005829; GO:0045095; GO:0070062 YEEEAHRR 13.13000011 0.406527847 0.406527847 0.239525122 1089.738879 0 17.1321 15.34592 0 0 0 0 15.36605 0 0 16.52511 0 0 0 20.71329 20.60037 20.15539 20.03974 19.35692 21.50039 21.5315 19.12506 0 20.07107 0 19.26628 0 0 20.05091 0 19.10743 0 0 20.69809 0 19.82595 0 19.29789 20.49682 20.39685 0 19.5224 20.6628 21.71882 21.80173 20.60803 0 0 Q8N1P7 CRBG2_HUMAN Beta/gamma crystallin domain-containing protein 2 (Absent in melanoma 1-like protein) CRYBG2 AIM1L Homo sapiens (Human) carbohydrate binding [GO:0030246] carbohydrate binding [GO:0030246] GO:0030246 GPGAPAASSPTQKEVVK 10.27000046 0.201691419 0.201691419 0.434687558 1622.357476 20.05361 9.928284 17.05505 0 17.65482 0 0 19.43639 15.87882 19.40016 15.76285 0 0 18.59633 0 0 0 0 0 0 0 19.68216 19.66778 0 0 20.25284 0 0 0 19.68766 19.75616 0 0 0 0 0 0 21.73887 20.83613 18.48938 18.87481 18.55483 18.0866 18.51923 17.98171 0 19.84424 18.89369 Q8N1T3 MYO1H_HUMAN Unconventional myosin-Ih (Myosin-1H) MYO1H Homo sapiens (Human) actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0051015 INSSLVNK 8.670000076 0.992633462 0.992633462 0.27401751 874.0011701 14.66865 0 15.72382 0 13.81557 0 16.62788 16.10719 0 0 0 0 15.3399 0 13.55658 15.72204 0 15.14408 0 0 15.83244 15.94926 0 13.18557 15.17878 14.30944 15.89326 0 15.02356 0 0 0 0 0 0 15.46967 17.55729 0 16.26687 0 0 15.77034 0 0 0 15.19881 14.29008 0 Q8N1V2 CFA52_HUMAN Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC) CFAP52 WDR16 WDRPUH Homo sapiens (Human) cilium assembly [GO:0060271]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium assembly [GO:0060271]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] GO:0005930; GO:0030317; GO:0060271; GO:0061966; GO:0097729 LLTDVGPAK 2.299999952 1 1 0.12640455 913.6091825 0 0 0 13.30462 15.53898 0 14.29221 0 14.01783 12.86132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.07286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1W1 ARG28_HUMAN "Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor, p190-RhoGEF, p190RhoGEF) (Rho guanine nucleotide exchange factor)" ARHGEF28 KIAA1998 RGNEF Homo sapiens (Human) cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; ephrin receptor signaling pathway [GO:0048013]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; ephrin receptor signaling pathway [GO:0048013]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0000902; GO:0003723; GO:0005085; GO:0005829; GO:0005886; GO:0030154; GO:0035023; GO:0046872; GO:0048013; GO:0051056 QRSLPAVLLPGGPEVMELNR 6.809999943 1 1 0 2191.358193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1W2 ZN710_HUMAN Zinc finger protein 710 ZNF710 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 FNLKGNLSR 3.029999971 1 1 0.181145492 1049.213078 12.02602 0 13.48101 17.95693 0 14.47653 0 0 0 0 0 13.45427 17.22942 15.5657 0 0 0 0 0 0 0 0 0 0 0 0 16.28084 0 14.13786 0 18.2708 17.63213 16.44034 0 16.9763 0 12.27947 14.04815 0 0 0 0 0 0 0 0 0 0 Q8N1X5 YF001_HUMAN Uncharacterized protein FLJ37310 Homo sapiens (Human) AAAGVTAKAGGGTSAAAASLIR 5.909999847 1 1 0.334651671 1871.874152 17.34169 16.3863 13.47596 14.18578 0 0 0 14.41379 0 0 12.82167 0 12.57682 0 0 7.961958 0 0 0 6.668258 13.74246 14.63112 15.18207 0 0 0 0 0 0 17.88692 0 0 16.66577 0 0 0 0 16.7315 0 0 13.86724 0 0 0 0 0 0 0 Q8N201 INT1_HUMAN "Integrator complex subunit 1, Int1" INTS1 KIAA1440 UNQ1821/PRO3434 Homo sapiens (Human) snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] GO:0005654; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034474 LLAVQK 8.93999958 0.657904387 0.657904387 0.245938998 670.1163697 17.27638 0 0 0 15.85844 15.27936 0 16.06374 0 15.74322 14.45278 0 0 15.8082 17.1715 12.457 0 0 0 17.43946 0 0 16.89978 14.7496 15.73815 16.32483 14.96758 0 0 0 17.62959 17.58724 0 0 0 0 0 0 0 16.5512 0 16.36651 15.68888 16.68505 0 15.38219 0 0 Q8N205 SYNE4_HUMAN "Nesprin-4 (KASH domain-containing protein 4, KASH4) (Nuclear envelope spectrin repeat protein 4)" SYNE4 C19orf46 Homo sapiens (Human) establishment of epithelial cell apical/basal polarity [GO:0045198] integral component of nuclear outer membrane [GO:0031309]; meiotic nuclear membrane microtubule tethering complex [GO:0034993] integral component of nuclear outer membrane [GO:0031309]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; establishment of epithelial cell apical/basal polarity [GO:0045198] GO:0031309; GO:0034993; GO:0045198 LARHQR 2.339999914 1 1 0.005576183 781.3443668 0 12.56112 13.38539 0 0 0 0 14.7298 14.64382 0 13.9027 10.86914 0 0 0 0 0 0 16.22293 0 0 0 15.77303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.80474 0 0 0 0 0 0 Q8N228 SCML4_HUMAN Sex comb on midleg-like protein 4 SCML4 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin binding [GO:0003682]; histone binding [GO:0042393] GO:0003682; GO:0005634; GO:0042393; GO:0045892 GRPSLHSTPMK 1.980000019 0.448222756 0.448222756 0.170252396 1226.787999 0 0 16.47368 0 0 0 18.73167 0 0 0 15.51508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3942 0 0 0 0 0 15.28786 0 15.68507 0 0 0 0 0 0 0 0 0 Q8N239 KLH34_HUMAN Kelch-like protein 34 KLHL34 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 VPEAR 11.72999954 1 1 0.303521881 571.6630303 17.05521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.14544 0 0 0 0 0 0 0 0 0 0 Q8N264 RHG24_HUMAN "Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP, FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa, RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)" ARHGAP24 FILGAP Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]" adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] "adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]" GTPase activator activity [GO:0005096] GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028 DRMTANHESYLLMASTQNDMEDWVK 2.00999999 1 1 3.66E-12 3018.09234 0 13.11536 0 0 12.53662 14.59669 0 0 0 13.64676 0 0 0 0 0 0 0 0 0 0 0 0 15.74272 0 0 0 15.50611 18.60488 0 0 0 16.43816 0 13.04377 0 0 0 0 14.20734 0 0 0 0 0 17.20246 11.56682 0 0 Q8N271 PROM2_HUMAN "Prominin-2, PROM-2 (Prominin-like protein 2, hPROML2)" PROM2 PROML2 UNQ2521/PRO6014 Homo sapiens (Human) negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087] cholesterol binding [GO:0015485] GO:0001934; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016323; GO:0016324; GO:0031346; GO:0031410; GO:0031528; GO:0042995; GO:0043087; GO:0044393; GO:0048550; GO:0060170; GO:0070062; GO:0071914; GO:2001287 AVAQQPEGVR 12.64999962 0.100369535 0.100369535 0.162946964 1056.540477 0 14.19895 0 0 15.09661 13.78161 0 0 14.70557 0 0 0 14.96737 14.63434 0 13.83548 0 12.23727 0 0 14.34578 0 14.17331 0 16.46828 14.45467 0 13.66474 14.55653 0 14.35999 0 0 0 15.42771 15.08555 0 0 0 0 0 15.14501 16.16499 13.0714 13.71574 0 13.34991 0 Q8N283 ANR35_HUMAN Ankyrin repeat domain-containing protein 35 ANKRD35 Homo sapiens (Human) EAVAEER 28.70000076 0.471229553 0.471229553 0.297728314 803.8903782 0 18.88345 18.19049 0 0 0 16.63418 16.08384 0 0 18.22803 0 0 0 0 17.74199 0 18.17934 0 17.19188 17.84348 0 0 0 0 0 0 17.33251 0 16.4727 0 20.04125 18.59233 0 19.75361 0 0 18.74352 0 0 19.11523 0 0 0 16.39158 16.44694 18.63777 17.58184 Q8N2C7 UNC80_HUMAN Protein unc-80 homolog UNC80 C2orf21 KIAA1843 Homo sapiens (Human) cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886] axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080] cation channel activity [GO:0005261] GO:0005261; GO:0005886; GO:0030424; GO:0034703; GO:0055080 DSGMLK 7.110000134 1 1 0.102116232 649.1344679 0 15.93564 0 0 13.7329 13.90875 0 15.94314 15.11032 12.09253 14.69502 0 0 15.66403 0 0 0 0 15.25134 13.71188 15.10074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2E2 VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein VWDE Homo sapiens (Human) anatomical structure development [GO:0048856] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856] signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:0009986; GO:0048856 EGYTGRR 9.010000229 1 1 6.89E-13 838.709882 0 12.47657 12.52751 13.43037 0 11.36339 15.02799 16.66388 13.97424 12.89228 12.98456 14.40602 0 0 0 0 0 0 13.05337 15.70256 0 16.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2H3 PYRD2_HUMAN "Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2, EC 1.-.-.-" PYROXD2 C10orf33 Homo sapiens (Human) mitochondrion organization [GO:0007005] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005] oxidoreductase activity [GO:0016491] GO:0005759; GO:0007005; GO:0016491 CLLLGTDMAENQKQIAQFSQK 6.25 0.29807201 0.29807201 0.090701664 2438.60394 14.69463 0 0 12.62662 0 0 0 0 0 14.60435 0 0 0 0 0 0 15.01148 0 0 0 0 0 0 0 13.98433 12.75421 15.91276 13.54068 0 0 13.56916 0 0 0 0 15.0787 0 0 0 13.92077 0 8.998926 13.34926 14.4182 0 0 0 15.99183 Q8N2I2 ZN619_HUMAN Zinc finger protein 619 ZNF619 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 SDIPAGARR 4.329999924 0.145331755 0.145331755 0.2244301 941.7982804 0 14.65277 11.88866 11.31207 14.56659 13.86283 15.18013 13.55487 13.74435 0 15.06952 15.3636 14.23801 15.99238 0 11.73984 0 0 14.85429 15.23809 17.25232 0 0 0 16.48778 0 0 0 0 0 0 16.02014 0 0 0 0 16.69022 0 17.83247 15.6929 0 0 0 0 15.29022 0 0 15.67505 Q8N2I9 STK40_HUMAN "Serine/threonine-protein kinase 40, EC 2.7.11.1 (SINK-homologous serine/threonine-protein kinase) (Sugen kinase 495, SgK495)" STK40 SGK495 SHIK Homo sapiens (Human) glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0003016; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0010468; GO:0035264; GO:0043066; GO:0043408; GO:0048286; GO:0060425; GO:0106310 LGHDAQPMTSLDTAILAQR 10.23999977 0.738556027 0.738556027 9.18E-13 2034.271419 0 0 0 0 13.83454 0 15.16713 0 0 0 0 14.56167 0 0 16.16119 13.49185 0 0 0 0 0 0 16.0218 0 14.35346 13.40315 0 15.16382 14.66817 0 0 0 0 0 0 0 0 13.74084 0 0 0 0 0 14.53649 12.91087 0 13.73379 14.04979 Q8N2K0 ABD12_HUMAN "Lysophosphatidylserine lipase ABHD12, EC 3.1.-.- (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12, hABHD12) (Monoacylglycerol lipase ABHD12, EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12, EC 3.1.-.-)" ABHD12 C20orf22 Homo sapiens (Human) acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996] AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996] acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016020; GO:0016021; GO:0019369; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0050727; GO:0052651 CAADAGMK 2.380000114 0.172512159 0.172512159 0.103408945 840.4014643 14.44663 0 14.60821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68456 0 0 0 0 0 0 16.16204 16.21892 0 0 0 0 0 0 0 0 0 0 16.5007 16.70729 16.95838 15.75579 15.83095 0 16.67878 0 0 0 0 0 Q8N2M8 CLASR_HUMAN "CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)" CLASRP SFRS16 SWAP2 UNQ2428/PRO4988 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0005654; GO:0006397; GO:0008380 GGYGPRR 3.339999914 0.601350844 0.601350844 8.06E-13 763.3614031 10.0564 16.11996 10.1534 0 0 0 12.50853 0 16.60669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.32315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2N9 AN36B_HUMAN Ankyrin repeat domain-containing protein 36B (CLL-associated antigen KW-1) ANKRD36B Homo sapiens (Human) identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0042802 EGQQSGTVSPQKQSAQK 3.950000048 1 1 9.17E-13 1788.809852 14.98924 15.51521 13.93414 0 14.84602 15.35013 14.90709 15.10941 8.629694 17.1676 0 14.20539 12.10446 15.3153 16.01523 0 0 12.10735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.06358 0 0 0 0 0 0 0 0 0 15.1606 0 0 0 0 0 Q8N2R0 OSR2_HUMAN Protein odd-skipped-related 2 OSR2 Homo sapiens (Human) "bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0001655; GO:0001656; GO:0001823; GO:0002062; GO:0005634; GO:0006357; GO:0008284; GO:0009792; GO:0010628; GO:0030154; GO:0030501; GO:0033687; GO:0035115; GO:0035116; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048704; GO:0050679; GO:0060021; GO:0060272; GO:0060322; GO:0060349; GO:0061029; GO:0072498; GO:1990837 HSLTHTPR 9.68999958 1 1 0.219635609 949.5049479 0 15.65638 14.50472 0 0 0 0 0 15.43024 0 0 16.34943 0 15.0628 15.86852 0 12.69521 0 11.62431 14.00507 15.28753 0 13.87851 13.29064 13.44889 0 12.93291 14.75529 14.81497 15.74024 13.51279 0 16.90403 0 15.71409 15.9591 0 0 16.74587 16.65396 15.28507 16.84405 15.66687 16.21061 0 0 0 0 Q8N2W9 PIAS4_HUMAN "E3 SUMO-protein ligase PIAS4, EC 2.3.2.27 (PIASy) (Protein inhibitor of activated STAT protein 4) (Protein inhibitor of activated STAT protein gamma, PIAS-gamma)" PIAS4 PIASG Homo sapiens (Human) "central nervous system development [GO:0007417]; double-strand break repair [GO:0006302]; hair follicle development [GO:0001942]; limb epidermis development [GO:0060887]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vitamin D metabolic process [GO:0042359]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234] "cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; double-strand break repair [GO:0006302]; hair follicle development [GO:0001942]; limb epidermis development [GO:0060887]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vitamin D metabolic process [GO:0042359]; Wnt signaling pathway [GO:0016055]" DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0000122; GO:0001942; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006357; GO:0007417; GO:0008022; GO:0008270; GO:0010804; GO:0016055; GO:0016363; GO:0016605; GO:0016925; GO:0019789; GO:0031625; GO:0032088; GO:0033235; GO:0042359; GO:0045892; GO:0060887; GO:0061665; GO:1902174; GO:1902231; GO:1905168; GO:1990234 SGLKHELVTR 4.159999847 1 1 0.102304288 1140.495418 0 0 0 16.04395 0 0 0 17.39466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.22797 17.64247 0 0 0 0 0 0 0 Q8N2Y8 RUSC2_HUMAN "AP-4 complex accessory subunit RUSC2 (Interacting protein of Rab1, Iporin) (RUN and SH3 domain-containing protein 2)" RUSC2 KIAA0375 Homo sapiens (Human) cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; small GTPase binding [GO:0031267] small GTPase binding [GO:0031267] GO:0005829; GO:0031267; GO:0031410; GO:0070062 GLVKAVNIAVDLIVAHFGTSR 7.28000021 1 1 0.028058237 2180.20172 0 0 0 0 16.08091 0 13.30112 13.21707 13.26287 0 0 14.96101 0 0 0 13.56412 14.32932 0 0 0 0 0 0 0 0 0 0 0 14.0172 0 0 0 14.81629 0 9.365597 0 14.02146 0 0 0 0 0 0 12.52073 0 0 0 0 Q8N300 SVBP_HUMAN Small vasohibin-binding protein (Coiled coil domain-containing protein 23) SVBP CCDC23 Homo sapiens (Human) axon development [GO:0061564]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein ubiquitination [GO:0031397]; protein secretion [GO:0009306]; proteolysis [GO:0006508]; regulation of metallopeptidase activity [GO:1905048] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; microtubule binding [GO:0008017]; axon development [GO:0061564]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein ubiquitination [GO:0031397]; protein secretion [GO:0009306]; proteolysis [GO:0006508]; regulation of metallopeptidase activity [GO:1905048] microtubule binding [GO:0008017] GO:0005576; GO:0005737; GO:0005856; GO:0006508; GO:0008017; GO:0009306; GO:0010596; GO:0031397; GO:0045177; GO:0061564; GO:1905048 QRAEIYALNR 6.440000057 1 1 0.319371703 1232.828306 0 14.37581 0 13.82914 13.5217 14.79668 14.08212 0 12.19508 15.15904 15.32132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42469 0 0 0 15.31384 0 0 0 0 0 0 0 0 0 0 0 16.22698 0 0 0 Q8N302 AGGF1_HUMAN "Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q, hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein)" AGGF1 GPATC7 GPATCH7 VG5Q Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; nucleic acid binding [GO:0003676]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] nucleic acid binding [GO:0003676] GO:0001525; GO:0001570; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0045766; GO:0048471 DLNSEDQK 5.699999809 0.774256825 0.774256825 0.184148096 949.3597252 16.23045 18.51422 11.1612 15.13495 15.76408 13.56019 0 0 0 0 18.56796 17.8646 14.24873 0 0 15.71619 0 12.79801 0 0 0 0 0 14.70284 0 0 0 0 0 0 15.95223 15.67201 13.50457 0 0 0 16.62628 0 0 0 0 0 0 0 14.28006 15.10752 0 15.73106 Q8N307 MUC20_HUMAN "Mucin-20, MUC-20" MUC20 KIAA1359 UNQ2782/PRO7170 Homo sapiens (Human) hepatocyte growth factor receptor signaling pathway [GO:0048012] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; hepatocyte growth factor receptor signaling pathway [GO:0048012] identical protein binding [GO:0042802] GO:0005576; GO:0005796; GO:0005886; GO:0009925; GO:0016323; GO:0016324; GO:0031528; GO:0042802; GO:0048012 VAERLMQQLHR 6.360000134 1 1 0.297225102 1396.096761 14.87589 14.27289 0 14.72236 0 14.74814 0 0 0 0 0 0 0 13.92194 12.744 0 0 11.70796 0 0 0 0 0 0 0 0 16.57943 0 0 0 0 0 0 0 16.53699 0 17.51532 0 0 0 0 0 0 0 0 0 16.17473 0 Q8N319 CF223_HUMAN Uncharacterized protein C6orf223 C6orf223 Homo sapiens (Human) IAGARLMR 14.84000015 0.567214251 0.567214251 0.229753658 902.7009413 15.84153 14.07961 15.23505 0 0 13.98448 15.30309 15.83945 0 14.79609 0 0 15.02668 15.14073 16.87109 0 15.88194 0 16.29941 0 15.13341 15.27075 16.85314 16.02475 16.96908 14.99393 16.09522 13.68687 16.64382 0 15.89708 14.28654 0 16.25484 15.71065 16.33239 15.86784 13.05758 17.1522 16.68892 17.07289 14.67268 0 0 0 0 17.24595 16.54234 Q8N323 NXPE1_HUMAN NXPE family member 1 (Protein FAM55A) NXPE1 FAM55A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MSSNTMLQK 2.890000105 1 1 0.357679279 1054.689846 0 0 0 0 0 0 0 0 15.0477 0 0 0 0 15.14353 0 0 0 0 0 0 0 15.06232 0 16.19624 14.44118 0 15.62448 0 0 0 15.31497 15.57558 16.08361 0 13.94062 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N336 ELMD1_HUMAN ELMO domain-containing protein 1 ELMOD1 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096] GO:0005096; GO:0043547 ICYNTKPGASRTMK 2.980000019 1 1 0.242324912 1627.645974 0 0 16.9305 0 0 0 0 0 0 0 13.20777 0 0 0 0 0 0 0 14.73051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53047 0 14.68176 0 0 0 0 0 0 0 0 0 16.33064 0 0 Q8N349 OR2LD_HUMAN Olfactory receptor 2L13 (Olfactory receptor 2L14) OR2L13 OR2L14 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 NKEVLGAMR 7.340000153 1 1 0.036584803 1034.292629 0 14.74383 0 0 0 0 0 0 0 14.6114 12.97405 0 15.07611 0 0 0 0 0 15.02854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.90897 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N365 CIART_HUMAN "Circadian-associated transcriptional repressor (ChIP-derived repressor of network oscillator, Chrono) (Computationally highlighted repressor of the network oscillator)" CIART C1orf51 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634]; PML body [GO:0016605] "nucleus [GO:0005634]; PML body [GO:0016605]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; negative regulation of transcription, DNA-templated [GO:0045892]" E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0005634; GO:0016605; GO:0032922; GO:0045475; GO:0045892; GO:0070888 KMTIGHR 11.72999954 1 1 0.183536464 858.713486 14.24196 13.50222 0 16.70564 15.35836 11.88936 13.33297 0 14.75969 15.84868 15.5629 14.26348 14.54061 12.74763 0 0 0 0 0 0 0 15.25626 15.62542 0 13.8258 0 15.3476 0 0 0 0 0 0 0 0 0 0 15.4829 14.1911 0 15.99223 0 0 0 14.56631 0 15.049 0 Q8N371 KDM8_HUMAN "Bifunctional peptidase and arginyl-hydroxylase JMJD5, EC 1.14.11.73, EC 3.4.-.- (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)" KDM8 JMJD5 Homo sapiens (Human) "chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]" chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; peptidyl-arginine 3-dioxygenase activity [GO:0106157]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]" 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; peptidyl-arginine 3-dioxygenase activity [GO:0106157] GO:0000086; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0016706; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0051864; GO:0070544; GO:0106157 LEKTVPR 13.10000038 1 1 0.256385398 842.9329606 17.57477 0 0 0 0 0 18.49207 0 0 0 0 0 0 18.23646 0 17.72478 0 0 21.91941 0 17.05809 0 0 16.99331 0 20.32665 0 0 0 0 19.39095 0 0 0 0 0 0 0 0 0 18.85262 0 0 0 0 0 0 0 Q8N392 RHG18_HUMAN Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18) ARHGAP18 Homo sapiens (Human) regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096] GO:0001726; GO:0005096; GO:0005737; GO:0005829; GO:0005881; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0045296; GO:0051056; GO:2000145 IGDLAPQDMK 1.850000024 1 1 0.153560088 1104.398192 0 14.26373 13.66213 0 0 0 0 0 0 0 0 0 0 16.21139 13.92908 0 0 0 16.05893 0 16.55814 0 14.65744 0 0 0 0 13.07119 0 14.89959 0 0 0 0 0 0 0 0 0 0 0 16.80538 0 0 0 0 0 0 Q8N394 TMTC2_HUMAN "Protein O-mannosyl-transferase TMTC2, EC 2.4.1.109 (Transmembrane and TPR repeat-containing protein 2)" TMTC2 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0016021; GO:0035269; GO:0055074 LIEAAEMAK 10.82999992 1 1 0.230861988 978.5075791 15.08665 14.67729 14.63222 15.61843 14.96187 14.98185 0 0 0 14.77836 13.11584 15.62516 0 0 0 0 0 0 0 14.64839 15.02593 0 0 0 0 0 15.64133 0 0 0 0 15.48324 0 16.09194 15.32098 0 0 0 0 0 0 15.47229 0 18.02912 0 15.71995 0 0 Q8N398 VW5B2_HUMAN von Willebrand factor A domain-containing protein 5B2 VWA5B2 Homo sapiens (Human) AALAGR 8.850000381 0.68293339 0.68293339 0.112797901 558.4422287 17.12834 18.21461 17.58725 17.41101 15.97976 17.84256 17.59091 17.38354 17.45908 17.82002 18.55255 18.2555 17.6342 16.48046 17.95102 17.51979 17.52467 17.90031 17.15506 0 18.21548 17.55234 17.58192 18.22763 17.23393 18.3071 17.02819 17.09485 17.43585 16.92643 15.87774 17.4946 18.03132 17.76616 18.03008 17.92411 18.29554 17.96487 17.54109 17.58188 17.79374 17.89681 17.76058 16.5147 18.09912 17.97909 18.50379 17.8714 Q8N3A8 PARP8_HUMAN "Protein mono-ADP-ribosyltransferase PARP8, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 16, ARTD16) (Poly [ADP-ribose] polymerase 8, PARP-8)" PARP8 Homo sapiens (Human) protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404] GO:0003950; GO:0006471; GO:0070213; GO:0140289; GO:1990404 CIPVRDR 9.850000381 0.140408218 0.140408218 0.479014728 914.9523351 18.53577 0 16.14328 0 0 0 0 0 14.53744 0 0 0 0 0 0 0 0 0 0 0 15.57712 0 0 0 0 0 0 0 0 17.62002 0 0 18.29436 19.73738 17.39022 0 0 0 0 18.8653 0 0 0 0 0 0 0 0 Q8N3C0 ASCC3_HUMAN "Activating signal cointegrator 1 complex subunit 3, EC 3.6.4.12 (ASC-1 complex subunit p200, ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)" ASCC3 HELIC1 RQT2 Homo sapiens (Human) cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0016887; GO:0032508; GO:0043138; GO:0072344; GO:0099053; GO:1990116 TASHYYIK 6.800000191 0.397880197 0.397880197 0.243036131 983.1183302 0 0 16.99479 0 0 16.13996 13.05705 0 16.02158 0 16.66375 14.80337 0 0 15.78231 13.25775 0 12.3515 0 14.96964 0 0 14.20881 0 0 0 0 13.32692 0 15.64398 0 17.03301 16.81002 16.10646 15.44788 15.41371 0 15.52091 16.48218 0 0 0 17.2834 0 0 0 16.3213 14.58708 Q8N3D4 EH1L1_HUMAN EH domain-binding protein 1-like protein 1 EHBP1L1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036] endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815] endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; actin cytoskeleton organization [GO:0030036] GO:0005768; GO:0005815; GO:0016020; GO:0030036; GO:0031941 AAEVEMQLR 6.099999905 0.466410995 0.466410995 0.192807604 1046.722146 15.18264 13.95041 0 15.66885 9.411106 14.90321 15.79136 0 0 0 8.196527 15.08138 14.42611 15.93877 14.44854 0 0 15.40258 16.10114 15.18587 11.93343 0 0 0 0 0 0 0 13.85493 0 0 17.39845 0 0 0 0 15.79655 17.65862 15.44811 14.10323 0 12.30744 16.5172 15.3651 0 0 0 13.93768 Q8N3F8 MILK1_HUMAN "MICAL-like protein 1 (Molecule interacting with Rab13, MIRab13)" MICALL1 KIAA1668 MIRAB13 Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458] extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267] GO:0005770; GO:0006612; GO:0006897; GO:0006898; GO:0019898; GO:0031175; GO:0031267; GO:0031902; GO:0032456; GO:0032458; GO:0036010; GO:0042802; GO:0045296; GO:0046872; GO:0055038; GO:0070300; GO:0097320 GGLNEGR 23.07999992 0.405714601 0.405714601 0.250965068 698.8574702 15.5116 0 13.38524 13.53099 17.1565 14.512 16.38987 15.15808 0 0 0 16.87883 15.64442 15.7291 17.00766 15.13769 16.8764 16.39746 14.86447 15.85506 16.53231 16.04115 15.1552 15.83651 0 15.15589 0 0 0 15.97878 0 16.89531 16.14276 0 0 16.17412 16.38797 17.93021 0 15.50836 16.23359 15.19017 0 0 0 0 15.59208 0 Q8N3H0 TAFA2_HUMAN Chemokine-like protein TAFA-2 TAFA2 FAM19A2 Homo sapiens (Human) memory [GO:0007613]; visual learning [GO:0008542] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; receptor ligand activity [GO:0048018]; memory [GO:0007613]; visual learning [GO:0008542] receptor ligand activity [GO:0048018] GO:0005615; GO:0005634; GO:0005737; GO:0007613; GO:0008542; GO:0048018 CCNKNK 7.309999943 1 1 0.159194132 823.4408025 0 0 13.94449 0 14.99707 12.59686 13.95963 0 15.16195 15.68675 0 15.28841 0 0 0 14.20401 13.80813 0 16.63092 15.94493 12.52115 0 0 0 0 0 0 0 0 0 15.03992 15.11187 14.89005 13.86188 13.26575 0 0 16.44627 0 0 0 15.51324 0 0 0 0 0 0 Q8N3I7 BBS5_HUMAN Bardet-Biedl syndrome 5 protein BBS5 Homo sapiens (Human) cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0001947; GO:0005829; GO:0005930; GO:0007601; GO:0015031; GO:0032266; GO:0032402; GO:0034451; GO:0034464; GO:0036064; GO:0044458; GO:0046907; GO:0050896; GO:0060170; GO:0060271; GO:0061629 EINSLHK 4.53000021 1 1 0.229253208 838.7496451 13.91339 14.95038 15.48876 15.34463 16.34894 13.36681 16.00999 0 15.56835 0 0 0 0 14.53583 15.54945 15.34319 0 0 0 0 0 0 0 0 0 16.29645 0 15.60195 0 15.39249 15.77578 16.67078 15.44566 15.76341 0 15.51776 0 15.50142 0 16.36387 16.44906 14.90321 15.53093 17.23123 13.19287 15.31624 16.68874 15.84429 Q8N3J2 METL4_HUMAN "N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4, EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4, EC 2.1.1.-)" METTL4 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049] methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347] GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0006325; GO:0008168; GO:0008173; GO:0009007; GO:0032775; GO:0043484; GO:0090296; GO:0106347; GO:0120049; GO:1902275; GO:1903108 EDLMNGVK 8.640000343 1 1 0.221097697 921.8045788 16.29038 0 0 0 15.00226 0 13.54095 13.61726 13.908 15.55812 0 0 14.87214 14.81212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.04616 0 16.4847 0 0 0 16.65642 0 0 0 0 0 0 0 0 0 0 0 15.22751 0 Q8N3J5 PPM1K_HUMAN "Protein phosphatase 1K, mitochondrial, EC 3.1.3.16 (PP2C domain-containing protein phosphatase 1K) (PP2C-like mitochondrial protein) (PP2C-type mitochondrial phosphoprotein phosphatase, PTMP) (Protein phosphatase 2C isoform kappa, PP2C-kappa)" PPM1K PP2CM Homo sapiens (Human) mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005739; GO:0005759; GO:0046872 GKPMK 15.86999989 0.07181827 0.07181827 0.203879225 575.2324618 0 0 0 0 0 16.89894 15.51884 15.19928 15.91783 0 0 15.70114 16.64319 0 0 16.15842 0 16.75167 0 0 0 20.00675 17.89969 18.76777 15.86833 16.06026 0 15.61608 16.78927 0 15.43569 15.27354 16.70972 18.33115 16.63522 15.64448 16.97007 16.60743 16.01055 0 15.39201 15.17458 17.06757 14.59306 14.72656 0 16.15171 17.73804 Q8N3K9 CMYA5_HUMAN Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) CMYA5 C5orf10 DTNBP2 SPRYD2 TRIM76 Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] GO:0005634; GO:0005829; GO:0005886; GO:0016529; GO:0016607; GO:0031430; GO:0043231; GO:0048471 EIEPSSSTTTASVTK 1.779999971 1 1 0.378075551 1537.456004 10.77763 12.99725 0 0 14.23016 15.1568 0 0 15.60989 14.87755 0 14.80075 15.73141 14.88877 14.10148 14.49401 0 0 0 0 0 0 0 16.41339 0 0 0 0 0 14.89547 15.66025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3S3 PHTF2_HUMAN Protein PHTF2 PHTF2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] GO:0005783; GO:0016021 ADMSVLEISGMIMNR 5.090000153 1 1 6.89E-13 1682.21793 0 0 14.86118 0 15.27774 0 0 11.53553 12.92563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.91894 0 0 0 0 0 0 0 0 0 14.40976 0 0 17.25006 0 0 0 14.77208 0 Q8N3T1 GLT15_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 15, EC 2.4.1.41 (Polypeptide GalNAc transferase-like protein 2, GalNAc-T-like protein 2, pp-GaNTase-like protein 2) (Polypeptide N-acetylgalactosaminyltransferase-like protein 2) (Protein-UDP acetylgalactosaminyltransferase-like protein 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2)" GALNT15 GALNTL2 UNQ770/PRO1564 Homo sapiens (Human) O-glycan processing [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0030133; GO:0030246; GO:0046872 RLGAIR 8.180000305 1 1 0.09987587 686.6390541 0 0 15.88382 0 0 0 0 0 0 0 0 0 0 15.36673 15.51494 0 0 0 0 15.3057 0 0 0 0 17.08651 0 17.14914 14.48262 0 16.05644 0 15.52586 15.93403 17.29927 15.4433 15.68334 17.1549 15.99137 16.90046 0 15.12559 15.7904 0 15.22659 0 15.42891 0 0 Q8N3U4 STAG2_HUMAN Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2) STAG2 SA2 Homo sapiens (Human) cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]" chromatin binding [GO:0003682] GO:0000775; GO:0000785; GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0034089; GO:0034991; GO:0051301; GO:0090307; GO:0097431 NSLLAGGDDDTMSVISGISSR 4.369999886 1 1 4.67E-13 2096.181463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3V7 SYNPO_HUMAN Synaptopodin SYNPO KIAA1029 Homo sapiens (Human) modification of dendritic spine [GO:0098886]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of stress fiber assembly [GO:0051492]; spine apparatus assembly [GO:1905355] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spine apparatus [GO:0097444]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spine apparatus [GO:0097444]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; modification of dendritic spine [GO:0098886]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of stress fiber assembly [GO:0051492]; spine apparatus assembly [GO:1905355] actin binding [GO:0003779] GO:0001725; GO:0003779; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0014069; GO:0015629; GO:0030018; GO:0032233; GO:0043197; GO:0043204; GO:0051492; GO:0097444; GO:0098886; GO:1905355 SPRPQRHIMSR 3.529999971 1 1 0.321799502 1380.162956 16.35724 14.77156 0 12.42069 0 12.80662 0 15.39489 0 15.40786 14.13154 0 0 0 14.67597 0 0 0 0 0 0 0 0 0 0 15.80113 0 14.88704 0 14.66195 15.04481 0 0 16.4088 0 0 0 0 0 0 0 0 0 0 15.44595 0 0 0 Q8N3Y3 LARG2_HUMAN "Xylosyl- and glucuronyltransferase LARGE2, EC 2.4.-.- (Glycosyltransferase-like 1B) (LARGE xylosyl- and glucuronyltransferase 2) [Includes: Alpha-1,3-xylosyltransferase LARGE2, EC 2.4.2.-; Beta-1,3-glucuronyltransferase LARGE2, EC 2.4.1.- ]" LARGE2 GYLTL1B PP5656 Homo sapiens (Human) muscle cell cellular homeostasis [GO:0046716]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; muscle cell cellular homeostasis [GO:0046716]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285] GO:0000139; GO:0005794; GO:0006493; GO:0015020; GO:0016021; GO:0030145; GO:0035252; GO:0035269; GO:0042285; GO:0046716 EPGGR 5.360000134 0.823099256 0.823099256 0.088468002 518.8263281 15.06978 14.04486 16.67555 16.42905 16.6083 15.94476 16.95902 0 15.91766 15.50439 16.77445 17.03203 16.25223 15.44412 18.27296 16.70697 15.89664 16.81199 17.88981 16.65174 16.71539 14.84114 0 15.72993 16.67331 17.62725 13.98365 15.19438 15.2263 15.58799 15.60222 15.12947 12.14652 17.10737 16.10777 17.40784 16.6314 15.74739 16.30915 0 16.21968 16.7147 14.53164 0 10.68148 17.28688 15.58405 14.63755 Q8N3Y7 RDHE2_HUMAN "Epidermal retinol dehydrogenase 2, EPHD-2, RDH-E2, EC 1.1.1.105 (Retinal short-chain dehydrogenase reductase 2, retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5)" SDR16C5 RDHE2 Homo sapiens (Human) keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor binding [GO:0140297]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]" "DNA-binding transcription factor binding [GO:0140297]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]" GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0016021; GO:0016616; GO:0017053; GO:0031065; GO:0035067; GO:0042572; GO:0042574; GO:0043616; GO:0061629; GO:0140297 IVEAILQEK 3.549999952 1 1 0.118908381 1043.529791 15.65149 15.14503 14.85179 0 0 0 0 0 15.08338 0 16.19674 0 15.64986 15.04307 14.3519 0 0 0 0 16.44167 0 0 0 0 0 0 0 0 0 14.93248 0 15.22002 0 16.50219 0 0 13.0356 13.94405 16.32809 16.54548 14.1005 15.21396 15.05197 0 15.79243 15.56759 14.97827 0 Q8N3Z3 GTPB8_HUMAN GTP-binding protein 8 GTPBP8 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] GTP binding [GO:0005525]; metal ion binding [GO:0046872] GO:0005525; GO:0005739; GO:0046872 KPGHTK 4.179999828 0.73464644 0.73464644 3.43E-13 667.696506 0 17.07251 0 12.73083 0 0 14.90245 0 9.552724 0 8.501308 0 0 0 0 16.3167 0 16.63148 14.3271 9.336699 0 12.14405 14.95468 0 15.15452 13.66577 15.93276 0 0 0 0 0 15.5587 0 16.41814 0 15.39996 15.16765 0 15.49869 0 0 15.93264 0 0 14.84684 14.99918 9.720037 Q8N414 PGBD5_HUMAN "PiggyBac transposable element-derived protein 5, EC 3.1.-.- (PiggyBac domain-related protein 5) (PiggyBac transposase 5)" PGBD5 Homo sapiens (Human) "non-replicative transposition, DNA-mediated [GO:0098038]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; transposase activity [GO:0004803]; non-replicative transposition, DNA-mediated [GO:0098038]" endonuclease activity [GO:0004519]; transposase activity [GO:0004803] GO:0004519; GO:0004803; GO:0005634; GO:0005654; GO:0098038 SLALVMSQAR 8.979999542 1 1 0.21949943 1076.023126 12.15991 12.12645 0 0 14.68455 15.6186 14.47614 0 14.41405 15.23307 10.55202 13.76421 0 0 0 16.04258 12.59144 0 0 0 0 0 0 0 15.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98707 Q8N423 LIRB2_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 2, LIR-2, Leukocyte immunoglobulin-like receptor 2 (CD85 antigen-like family member D) (Immunoglobulin-like transcript 4, ILT-4) (Monocyte/macrophage immunoglobulin-like receptor 10, MIR-10) (CD antigen CD85d)" LILRB2 ILT4 LIR2 MIR10 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; interleukin-10-mediated signaling pathway [GO:0140105]; learning or memory [GO:0007611]; negative regulation of antigen processing and presentation [GO:0002578]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of postsynaptic density organization [GO:1905875]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; regulation of dendritic cell differentiation [GO:2001198]; regulation of long-term synaptic potentiation [GO:1900271]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; interleukin-10-mediated signaling pathway [GO:0140105]; learning or memory [GO:0007611]; negative regulation of antigen processing and presentation [GO:0002578]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of postsynaptic density organization [GO:1905875]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; regulation of dendritic cell differentiation [GO:2001198]; regulation of long-term synaptic potentiation [GO:1900271]; signal transduction [GO:0007165] amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877] GO:0001540; GO:0002250; GO:0002578; GO:0002645; GO:0002666; GO:0002767; GO:0002774; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007267; GO:0007611; GO:0008157; GO:0009986; GO:0016020; GO:0019221; GO:0023025; GO:0023029; GO:0032396; GO:0032755; GO:0034113; GO:0035307; GO:0042102; GO:0042130; GO:0042288; GO:0042803; GO:0044877; GO:0045591; GO:0050839; GO:0051248; GO:0051926; GO:0070821; GO:0071222; GO:0101003; GO:0140105; GO:1900271; GO:1900454; GO:1905875; GO:2000524; GO:2001198 AGAADAPLR 9.739999771 0.581162035 0.581162035 0.22457309 839.3004736 15.33278 0 13.9047 0 14.76025 16.31593 0 0 15.67277 0 0 0 16.71028 16.07458 15.45251 16.18339 16.00192 15.49757 16.98829 15.79114 0 14.05568 16.77922 17.26669 18.07399 15.69105 15.44567 0 17.59831 16.58271 0 16.7558 0 17.42495 15.67168 16.44044 14.50923 16.37154 16.9402 16.44942 0 0 13.59066 17.66685 14.28788 16.72761 15.72726 14.86347 Q8N427 TXND3_HUMAN "Thioredoxin domain-containing protein 3 (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2, Sptrx-2)" NME8 SPTRX2 TXNDC3 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] microtubule binding [GO:0008017] GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007283; GO:0008017; GO:0016607; GO:0030154; GO:0030317; GO:0034614; GO:0036157; GO:0060271; GO:0097225; GO:0097228; GO:0097598 KDDVLR 8.319999695 1 1 0.16521632 742.6118743 0 13.0837 13.11263 0 14.39006 0 0 15.74182 14.5431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84624 15.57616 11.88902 13.4129 14.10864 15.08046 15.12809 14.22142 13.59946 15.97519 15.05886 0 15.27524 13.11407 16.71132 16.54154 0 0 15.74339 15.74262 0 14.70233 0 0 0 Q8N428 GLT16_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 16, EC 2.4.1.41 (Polypeptide GalNAc transferase 16, GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1, GalNAc-T-like protein 1, pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1)" GALNT16 GALNTL1 KIAA1130 Homo sapiens (Human) protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018242; GO:0018243; GO:0030246; GO:0046872 AHAASSGGR 10.69999981 0.052050501 0.052050501 0.248089413 810.7510401 17.70818 0 17.98445 0 14.19164 15.14648 17.37493 13.8869 0 0 0 16.70769 0 0 0 17.02618 0 15.49423 0 0 16.78449 13.35506 0 0 0 17.77011 15.60102 0 0 0 18.64187 0 13.77994 15.25393 0 16.76399 16.9417 0 0 0 14.3059 0 14.34221 15.01168 0 0 16.2026 0 Q8N436 CPXM2_HUMAN Inactive carboxypeptidase-like protein X2 CPXM2 CPX2 UNQ676/PRO1310 Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485 TANDGDYWR 6.369999886 1 1 0.295438974 1096.5739 0 9.130994 0 0 0 0 0 0 14.81507 0 0 0 15.92837 0 0 14.49725 0 0 0 0 0 0 0 0 0 0 15.33562 0 0 0 0 0 0 14.15228 0 14.06053 0 0 0 0 0 0 0 0 15.59406 0 0 0 Q8N443 RIBC1_HUMAN RIB43A-like with coiled-coils protein 1 RIBC1 Homo sapiens (Human) MYNIKQSTDTK 7.670000076 1 1 0.575638936 1345.179473 0 17.62523 0 0 0 0 0 0 0 0 0 0 0 0 18.06667 0 0 0 0 0 0 0 0 0 0 0 0 18.5391 17.51472 0 18.86063 19.92841 0 0 18.69958 0 18.6402 0 0 0 0 0 0 0 18.04755 0 0 0 Q8N448 LNX2_HUMAN Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1) LNX2 PDZRN1 Homo sapiens (Human) identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0030165; GO:0042802; GO:0046872 DGVIAR 15.43999958 0.646909356 0.646909356 5.70E-13 630.6318436 0 16.20357 16.50258 15.55969 0 13.34445 14.8235 14.96037 15.91874 0 0 15.70835 14.90829 14.8729 15.62452 17.13149 15.73603 16.92275 14.78898 15.28949 16.40039 16.97976 16.66925 14.78906 14.60126 0 17.41596 14.72192 0 17.59102 18.55237 0 17.10536 16.818 0 0 13.92155 15.0181 16.23047 0 14.92432 13.67915 16.51564 13.58666 15.66419 15.85215 14.96281 14.38044 Q8N474 SFRP1_HUMAN "Secreted frizzled-related protein 1, FRP-1, sFRP-1 (Secreted apoptosis-related protein 2, SARP-2)" SFRP1 FRP FRP1 SARP2 Homo sapiens (Human) "bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; osteoblast differentiation [GO:0001649]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; osteoblast differentiation [GO:0001649]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147] GO:0001649; GO:0001657; GO:0001954; GO:0002244; GO:0004197; GO:0005109; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0008201; GO:0008284; GO:0008285; GO:0008584; GO:0008585; GO:0009267; GO:0009410; GO:0009950; GO:0009986; GO:0010564; GO:0010629; GO:0010719; GO:0010975; GO:0014034; GO:0014070; GO:0017147; GO:0030177; GO:0030178; GO:0030279; GO:0030307; GO:0030308; GO:0030336; GO:0030514; GO:0033689; GO:0035019; GO:0042802; GO:0043065; GO:0043066; GO:0043508; GO:0043547; GO:0044344; GO:0044345; GO:0045578; GO:0045600; GO:0045668; GO:0045671; GO:0045765; GO:0045880; GO:0045892; GO:0045893; GO:0046676; GO:0046851; GO:0048147; GO:0048546; GO:0050679; GO:0050680; GO:0050732; GO:0051496; GO:0051894; GO:0060070; GO:0060218; GO:0060346; GO:0060527; GO:0060687; GO:0060766; GO:0062023; GO:0070062; GO:0071305; GO:0071347; GO:0071356; GO:0071363; GO:0071380; GO:0071391; GO:0071392; GO:0071456; GO:0071481; GO:0071504; GO:0071542; GO:0071560; GO:0071773; GO:0090090; GO:0090179; GO:0090244; GO:0090246; GO:0090263; GO:1902043; GO:1904956; GO:2000041; GO:2000052; GO:2000054; GO:2000080; GO:2000270; GO:2000271 MGIGRSEGGR 6.46999979 0.873770475 0.873770475 0.252097998 1020.158829 11.55849 14.74969 12.63097 15.01599 0 0 12.25713 14.77985 13.66971 16.4326 16.06412 15.92692 0 0 14.36517 0 0 13.34378 0 0 0 15.1577 0 15.74986 0 0 14.80591 0 15.55071 0 0 17.36746 0 0 15.49373 16.62162 0 0 0 0 15.18896 0 14.51187 0 0 0 0 0 Q8N475 FSTL5_HUMAN Follistatin-related protein 5 (Follistatin-like protein 5) FSTL5 KIAA1263 Homo sapiens (Human) cell differentiation [GO:0030154] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0030154 EGGYGLKSYQPLMR 8.229999542 0.783851445 0.783851445 0.166856113 1613.847179 19.85783 18.50859 18.48547 19.23091 18.95293 0 0 18.36223 0 18.21289 18.05972 18.80766 18.74528 19.5578 19.12991 18.82008 19.5418 17.31164 0 18.784 19.6444 18.2904 19.9239 19.78041 0 17.86959 0 0 17.73758 18.51956 17.87142 18.54353 18.882 17.68589 18.6182 18.63426 19.09564 18.39851 17.88832 18.76183 0 19.34268 0 18.50775 18.67097 18.00611 17.01111 17.98705 Q8N488 RYBP_HUMAN "RING1 and YY1-binding protein (Apoptin-associating protein 1, APAP-1) (Death effector domain-associated factor, DED-associated factor) (YY1 and E4TF1-associated factor 1)" RYBP DEDAF YEAF1 Homo sapiens (Human) "apoptotic process [GO:0006915]; histone H2A monoubiquitination [GO:0035518]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; histone H2A monoubiquitination [GO:0035518]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006915; GO:0007275; GO:0032435; GO:0035518; GO:0043065; GO:0045893; GO:0046872 INSQLVAQQVAQQYATPPPPK 2.299999952 1 1 3.20E-12 2278.595734 9.276822 13.66541 12.8028 12.77194 11.96674 0 13.04208 0 0 0 6.078761 12.74166 0 0 0 10.43099 0 14.02042 0 0 0 0 0 0 0 12.69439 0 0 0 0 0 14.75995 0 0 13.89602 0 0 0 0 10.29063 12.57131 13.91779 0 0 11.91965 0 0 0 Q8N4A0 GALT4_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 4, EC 2.4.1.41 (Polypeptide GalNAc transferase 4, GalNAc-T4, pp-GaNTase 4) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4)" GALNT4 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0048471; GO:0070062 ELGSRR 6.440000057 0.253284752 0.253284752 0.266853512 717.0045119 0 14.70293 15.9768 15.46463 15.53743 16.14213 16.22794 15.48008 16.03134 16.50648 14.38598 16.37875 14.94498 15.29231 15.70878 15.34776 0 16.02678 15.69839 16.58451 17.40425 14.91743 16.31189 0 16.00762 16.09114 0 0 14.6099 16.06376 0 0 16.3029 15.90548 15.79937 0 0 0 0 0 16.88327 0 0 0 0 14.79527 15.98788 0 Q8N4B4 FBX39_HUMAN F-box only protein 39 FBXO39 FBX39 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0019005; GO:0031146 LTVEQGCQILDSLSYMR 12.93000031 1 1 0.039100663 2027.977151 0 15.22338 15.90433 0 0 17.02027 0 0 13.71571 0 18.49036 17.23859 0 0 0 17.23015 0 0 0 0 17.36786 20.11544 0 0 14.95833 0 17.22706 13.61477 16.68553 0 0 0 14.91779 0 0 17.55438 0 0 14.25825 17.45378 17.30109 0 0 0 0 16.12468 0 17.65495 Q8N4C6 NIN_HUMAN "Ninein, hNinein (Glycogen synthase kinase 3 beta-interacting protein, GSK3B-interacting protein)" NIN KIAA1565 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasmic microtubule [GO:0005881]; dendrite [GO:0030425]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasmic microtubule [GO:0005881]; dendrite [GO:0030425]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; microtubule minus-end binding [GO:0051011]; centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104] calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; microtubule minus-end binding [GO:0051011] GO:0000242; GO:0000922; GO:0005509; GO:0005525; GO:0005654; GO:0005730; GO:0005813; GO:0005814; GO:0005881; GO:0005886; GO:0008104; GO:0010457; GO:0019900; GO:0021540; GO:0021957; GO:0030425; GO:0031116; GO:0034454; GO:0044295; GO:0045177; GO:0048668; GO:0050772; GO:0051011; GO:0051642; GO:0072686; GO:0090222; GO:0097431; GO:0097539; GO:0120103 ATCETADR 4.809999943 0.336298257 0.336298257 0.276045639 924.197065 14.68402 0 15.97882 0 0 0 0 0 0 0 16.18279 0 0 15.89385 15.46004 0 0 0 14.65624 0 16.40519 0 15.48255 0 13.51482 15.78678 0 14.31267 0 16.80533 15.46489 17.18264 16.01951 14.47855 10.28437 16.13332 0 14.96914 15.39243 16.19619 15.78184 0 16.08808 16.23721 14.32561 14.15812 13.19803 16.39928 Q8N4C8 MINK1_HUMAN "Misshapen-like kinase 1, EC 2.7.11.1 (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6, MEK kinase kinase 6, MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6)" MINK1 B55 MAP4K6 MINK YSK2 ZC3 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of MAPK cascade [GO:0043408] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of MAPK cascade [GO:0043408] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0001952; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007254; GO:0007268; GO:0007420; GO:0014069; GO:0022407; GO:0030334; GO:0030424; GO:0030425; GO:0031532; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048812; GO:0048813; GO:0070062; GO:0106310; GO:1900745; GO:2000311 KGSVVNVNPTNTR 3.470000029 1 1 1.15E-12 1387.021482 0 15.73827 0 12.79704 0 12.6456 0 14.38415 14.32146 14.79222 0 11.80456 0 0 0 16.5725 0 0 0 0 0 0 0 0 16.83665 0 0 0 0 13.62454 0 15.47244 0 0 0 0 0 0 0 14.30917 14.80828 0 0 0 0 0 0 0 Q8N4F4 S22AO_HUMAN Steroid transmembrane transporter SLC22A24 (Solute carrier family 22 member 24) SLC22A24 Homo sapiens (Human) organic anion transport [GO:0015711]; steroid metabolic process [GO:0008202]; sterol transmembrane transport [GO:0035382] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; organic anion transport [GO:0015711]; steroid metabolic process [GO:0008202]; sterol transmembrane transport [GO:0035382] transmembrane transporter activity [GO:0022857] GO:0008202; GO:0015711; GO:0016021; GO:0022857; GO:0035382 SMVQSLFMAGSLLGGLIYGHLSDR 4.960000038 1 1 0.147187631 2552.899915 0 8.159921 13.43628 0 12.56841 13.18783 13.22884 13.7143 0 13.4806 0 14.87241 10.63401 12.70739 14.98416 13.91901 0 9.066246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54358 0 15.77572 0 0 0 0 0 0 0 Q8N4F7 RN175_HUMAN RING finger protein 175 RNF175 Homo sapiens (Human) ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent ERAD pathway [GO:0030433] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0000139; GO:0005789; GO:0016021; GO:0030433; GO:0046872; GO:0061630 MAAGTAAR 8.029999733 0.008020496 0.008020496 0.275621444 748.8604423 0 15.63777 16.15498 14.76394 15.357 14.14633 0 16.58388 14.68803 15.70732 0 0 0 15.6253 17.07586 16.08129 16.46576 0 15.0333 0 0 16.81024 0 17.06584 17.02892 15.81883 0 16.12082 15.49676 14.61431 15.89184 17.31128 0 14.28337 16.20972 16.46147 16.22446 15.35449 15.80453 15.96812 0 0 13.94925 15.85296 16.54991 16.49305 14.40266 0 Q8N4G2 ARL14_HUMAN ADP-ribosylation factor-like protein 14 (ADP-ribosylation factor 7) ARL14 ARF7 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0016192; GO:0031410 QAQVLLLGLDSAGKSTLLYK 3.960000038 1 1 4.58E-13 2118.185519 15.55535 0 14.65033 14.92373 14.18904 0 0 0 0 14.92839 15.78741 14.12676 15.89995 0 0 13.99862 0 12.23182 0 11.82176 0 0 0 0 0 0 15.73367 0 0 14.12177 0 0 0 0 0 0 0 0 0 0 0 0 13.76989 0 14.07081 0 0 0 Q8N4L1 T151A_HUMAN Transmembrane protein 151A TMEM151A TMEM151 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LATVPR 5.079999924 0.448733002 0.448733002 0.068994462 657.394317 14.7891 0 13.24143 16.87675 14.05763 15.06139 0 0 0 14.33465 15.85996 13.52204 15.92981 13.56917 16.54427 0 15.18466 12.87005 13.57213 16.06697 17.82724 13.3333 13.7068 16.92924 0 14.96517 12.403 12.65174 15.4403 0 9.907684 15.28942 15.40167 15.57224 0 12.17086 17.5426 15.39815 14.05616 16.03274 15.18059 7.027355 0 13.62597 0 15.30616 0 17.5305 Q8N4N3 KLH36_HUMAN Kelch-like protein 36 KLHL36 C16orf44 Homo sapiens (Human) protein ubiquitination [GO:0016567] cullin family protein binding [GO:0097602]; protein ubiquitination [GO:0016567] cullin family protein binding [GO:0097602] GO:0016567; GO:0097602 AIAGGSACVCALEPRPEDK 2.960000038 1 1 0.318988535 2000.682006 13.46311 13.05542 15.91374 0 10.54582 0 0 14.52406 0 0 0 0 0 0 0 13.37417 0 0 0 0 0 0 0 0 0 0 0 0 16.48603 0 17.72829 0 0 0 0 0 0 16.90219 15.61074 14.30589 15.80677 0 0 0 0 0 0 0 Q8N4N8 KIF2B_HUMAN Kinesin-like protein KIF2B KIF2B Homo sapiens (Human) cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000776; GO:0003777; GO:0005524; GO:0005730; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0015630; GO:0016887; GO:0045171; GO:0051301; GO:0051310; GO:0051983; GO:0072686 VPSKPCLMK 1.320000052 1 1 0.146473985 1059.05139 0 17.73394 16.71233 14.71683 14.28578 15.26021 0 0 16.82708 0 13.58532 0 0 0 0 13.01788 14.34571 15.86827 16.25037 15.8386 14.03115 17.61972 0 13.80878 11.15778 0 15.88096 0 0 16.88897 17.29887 0 0 13.32284 0 0 0 13.65341 16.73149 18.32103 15.88607 16.88141 18.09391 13.60552 0 0 14.90958 17.84976 Q8N4P6 LRC71_HUMAN Leucine-rich repeat-containing protein 71 LRRC71 C1orf92 Homo sapiens (Human) CLPPLTQLQAINLWK 3.849999905 1 1 0.102629318 1794.115111 0 19.78252 0 0 0 18.75373 0 17.01103 14.53334 18.30493 0 0 0 17.85732 15.88597 0 17.88678 0 0 0 0 0 0 17.44155 13.74307 0 14.09984 16.58558 15.70372 0 0 16.29491 0 16.58174 0 14.67187 0 15.02243 0 0 16.27111 0 0 0 9.393864 0 18.56819 16.09175 Q8N4Q0 PTGR3_HUMAN "Prostaglandin reductase 3, PRG-3, EC 1.3.1.48 (Zinc-binding alcohol dehydrogenase domain-containing protein 2)" PTGR3 ZADH2 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599] peroxisome [GO:0005777] peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599] 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270] GO:0005777; GO:0008270; GO:0036132; GO:0045599; GO:0047522 ELGGLSEGKK 32.04000092 0.83245188 0.83245188 0.407703125 1018.465573 0 20.28625 0 18.77163 0 0 0 0 0 18.63689 21.67447 0 0 0 0 0 21.83966 0 17.92331 0 0 0 0 0 20.12248 20.3965 0 21.94986 23.60411 23.88306 0 0 23.85394 0 0 0 0 0 19.92829 0 0 0 0 0 0 20.23562 22.70664 17.67826 Q8N4T0 CBPA6_HUMAN "Carboxypeptidase A6, EC 3.4.17.-" CPA6 CPAH Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005615; GO:0006508; GO:0008270 SDPAMRK 20.94000053 0.892264724 0.892264724 0.280844604 821.0585342 18.986 0 0 20.70131 0 0 0 0 17.90038 0 0 0 18.62037 0 0 0 0 17.54763 0 0 0 0 17.80028 0 0 0 16.34392 0 0 0 18.01755 20.40455 18.21659 0 19.53728 0 18.07281 19.00332 0 17.77354 0 0 21.32233 0 20.98505 0 0 0 Q8N4U5 T11L2_HUMAN T-complex protein 11-like protein 2 TCP11L2 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 QCVGEDQPSDSDSSR 3.00999999 0.29813078 0.29813078 0.069628255 1665.672785 0 0 0 17.30342 16.72856 15.68256 0 14.88424 16.72035 17.85953 0 15.51521 15.50388 0 0 18.86021 15.03358 13.39171 15.63322 0 15.30708 0 17.06987 0 16.1339 17.44367 17.48072 0 0 0 17.30844 16.7684 16.21056 0 16.80053 15.93475 0 0 0 14.72433 0 0 0 0 0 15.36972 0 18.68362 Q8N4V2 SVOP_HUMAN "Synaptic vesicle 2-related protein, SV2-related protein" SVOP Homo sapiens (Human) integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857] transmembrane transporter activity [GO:0022857] GO:0008021; GO:0016021; GO:0022857; GO:0030672 EWGQEMVGRGMHGAGVTR 1.570000052 1 1 0.248822989 1974.979856 14.7582 14.21725 0 0 0 0 0 0 0 0 0 0 0 0 0 14.30944 0 12.38103 0 0 16.27303 0 0 0 15.53979 13.465 14.67448 0 0 0 0 0 12.78585 0 0 12.58338 0 0 0 0 0 14.79641 0 0 0 0 0 0 Q8N4X5 AF1L2_HUMAN "Actin filament-associated protein 1-like 2, AFAP1-like protein 2" AFAP1L2 KIAA1914 XB130 Homo sapiens (Human) "inflammatory response [GO:0006954]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of interleukin-6 production [GO:0032675]; regulation of mitotic cell cycle [GO:0007346]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine kinase activator activity [GO:0030296]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; inflammatory response [GO:0006954]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of interleukin-6 production [GO:0032675]; regulation of mitotic cell cycle [GO:0007346]" protein tyrosine kinase activator activity [GO:0030296]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007346; GO:0017124; GO:0030296; GO:0032675; GO:0032757; GO:0035591; GO:0042169; GO:0045742; GO:0045893 ETLLKCTDK 6.940000057 1 1 0.17391282 1108.614528 14.00723 15.20856 10.32008 0 12.32229 14.5434 0 15.76553 0 0 14.88815 15.23533 0 14.00119 15.70347 0 15.39799 0 11.93038 0 0 0 0 17.27762 0 0 16.05995 0 0 0 0 17.10568 15.53967 0 16.93082 0 15.5351 0 0 17.15832 14.38202 12.2027 0 0 0 0 0 0 Q8N4Y2 EFC4A_HUMAN "EF-hand calcium-binding domain-containing protein 4A (Calcium release-activated calcium channel regulator 2B, CRAC channel regulator 2B) (Calcium release-activated channel regulator 2B)" CRACR2B EFCAB4A Homo sapiens (Human) cellular protein localization [GO:0034613]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; cellular protein localization [GO:0034613]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] calcium ion binding [GO:0005509] GO:0002115; GO:0005509; GO:0005737; GO:0034613; GO:2001256 AHEALR 4.21999979 0.425103247 0.425103247 0.265587367 696.3595123 15.632 13.45064 16.50528 14.84461 14.38682 16.34611 16.71963 16.68717 0 0 0 0 0 14.59604 0 0 0 14.90897 0 0 14.32614 0 0 0 0 0 16.8979 0 0 14.57694 0 0 16.76793 14.08233 0 0 17.2283 0 0 0 15.12947 17.48866 0 0 16.1932 14.75768 0 0 Q8N531 FBXL6_HUMAN F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A) FBXL6 FBL6 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] ubiquitin-protein transferase activity [GO:0004842] GO:0000086; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0019005; GO:0031146; GO:0043153; GO:0051726 LTLAKEGSPFLTQK 4.239999771 1 1 2.34E-13 1533.613966 14.29998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.31417 0 0 0 0 0 0 0 0 0 0 14.84218 13.8144 15.40109 14.0878 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N543 OGFD1_HUMAN "Prolyl 3-hydroxylase OGFOD1, EC 1.14.11.- (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase)" OGFOD1 KIAA1612 TPA1 Homo sapiens (Human) cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543] GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0019511; GO:0031418; GO:0031543; GO:0031544; GO:0034063 ELMNLDFHEK 20.39999962 1 1 0.217790222 1291.567422 0 0 0 19.01557 0 0 17.02772 0 0 0 18.0199 0 0 17.6058 0 0 0 16.63266 0 0 0 0 0 0 17.34284 0 0 19.33541 0 0 0 16.87839 17.85583 18.17845 0 16.80926 0 16.94897 0 0 0 0 0 0 16.75735 0 0 0 Q8N556 AFAP1_HUMAN "Actin filament-associated protein 1 (110 kDa actin filament-associated protein, AFAP-110)" AFAP1 AFAP Homo sapiens (Human) regulation of cytoskeleton organization [GO:0051493]; regulation of signal transduction [GO:0009966] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; regulation of cytoskeleton organization [GO:0051493]; regulation of signal transduction [GO:0009966] actin binding [GO:0003779]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] GO:0003779; GO:0005829; GO:0005925; GO:0009966; GO:0015629; GO:0017124; GO:0042169; GO:0051493 ADPAAVVKR 13.63000011 1 1 0.272274853 925.1665297 0 0 0 0 0 16.81421 0 0 0 18.48104 0 0 0 16.26165 0 0 0 0 0 0 0 18.08136 0 0 0 17.85053 0 17.35516 0 0 0 0 0 0 17.73263 0 0 0 0 0 17.43578 16.80253 0 0 0 18.07841 0 0 Q8N568 DCLK2_HUMAN "Serine/threonine-protein kinase DCLK2, EC 2.7.11.1 (CaMK-like CREB regulatory kinase 2, CL2, CLICK-II, CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2)" DCLK2 DCAMKL2 DCDC3B DCK2 Homo sapiens (Human) hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000226; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005856; GO:0008017; GO:0018105; GO:0021766; GO:0021860; GO:0035556; GO:0106310; GO:1900181 GGTSR 9.460000038 1 1 0.108902613 475.7583968 15.15736 0 16.26635 0 11.51143 15.24562 0 17.1355 16.2901 15.94515 0 0 0 16.305 0 0 16.19437 15.97173 0 14.09364 0 16.15978 14.71292 15.79883 0 0 0 14.63532 0 14.36731 0 0 0 0 0 0 0 0 0 0 13.97147 0 0 0 13.88842 0 0 0 Q8N584 TT39C_HUMAN "Tetratricopeptide repeat protein 39C, TPR repeat protein 39C" TTC39C C18orf17 Homo sapiens (Human) cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474] cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474] GO:0032474; GO:0060271 IINLLGFPGDR 16.13999939 1 1 0.241067383 1214.594702 0 0 13.18516 15.83517 15.74804 0 14.47324 0 14.10564 15.44551 14.6822 13.94184 0 13.88056 15.605 14.09801 0 0 0 0 14.58879 0 15.56432 0 0 0 0 0 0 14.75069 0 0 0 0 0 0 0 0 0 0 13.17786 16.38171 0 0 0 0 0 0 Q8N5A5 ZGPAT_HUMAN Zinc finger CCCH-type with G patch domain-containing protein (G patch domain-containing protein 6) (Zinc finger CCCH domain-containing protein 9) (Zinc finger and G patch domain-containing protein) ZGPAT GPATC6 GPATCH6 KIAA1847 ZC3H9 ZC3HDC9 ZIP Homo sapiens (Human) "negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0007175; GO:0043565; GO:0045892; GO:0046872 DMYHASK 10.97999954 1 1 0.204428917 868.2002607 0 0 0 0 0 0 0 16.69913 0 0 0 0 0 0 0 0 0 0 0 15.58819 0 0 0 0 0 0 0 0 0 0 15.44605 0 0 0 0 0 16.964 17.45405 0 0 0 0 0 16.25634 0 0 0 0 Q8N5C6 SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 SRBD1 Homo sapiens (Human) nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412] mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412] mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735] GO:0003729; GO:0003735; GO:0006139; GO:0006412 AMLNCK 9.840000153 1 1 0.010115704 752.6486426 0 0 0 0 0 14.30307 0 0 0 0 0 0 0 0 17.0133 16.29771 16.90362 0 0 14.62787 0 0 0 0 17.08393 0 0 0 0 0 0 0 0 0 0 16.87211 0 16.98364 0 0 0 0 17.4739 0 0 0 0 0 Q8N5D0 WDTC1_HUMAN WD and tetratricopeptide repeats protein 1 WDTC1 KIAA1037 Homo sapiens (Human) cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361] enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826] GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008 SYDYQFR 10.5 0.330490172 0.330490172 0.147104618 978.2519677 0 15.43989 18.6248 15.74861 0 0 16.69005 13.31217 15.58063 14.41022 15.37296 15.85798 15.3549 15.40012 13.74205 0 0 0 14.49611 13.08092 0 16.95268 0 0 15.08808 16.98116 17.30622 15.39712 14.28133 13.53517 13.2932 13.97885 13.89813 15.10594 17.00775 0 14.45147 0 15.76991 0 0 0 15.15407 11.53119 11.60078 14.21629 17.19569 12.90161 Q8N5H7 SH2D3_HUMAN "SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer, Chat-H) (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1, SHEP1)" SH2D3C NSP3 UNQ272/PRO309/PRO34088 Homo sapiens (Human) JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264] axon [GO:0030424]; cytosol [GO:0005829]; ruffle membrane [GO:0032587] axon [GO:0030424]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784] GO:0001784; GO:0005085; GO:0005829; GO:0007254; GO:0007264; GO:0030424; GO:0032587; GO:0033138 AALLHK 10.18999958 0.54372263 0.54372263 0.007459612 651.5859713 14.76624 17.17743 14.83508 0 15.80205 14.62146 16.8352 17.30552 0 14.32579 0 0 14.60013 15.46911 15.08022 15.00157 15.18821 0 17.20512 17.73026 12.8664 16.73243 17.28431 17.2618 0 17.27687 12.86487 16.7298 15.855 15.96612 12.38124 0 14.75216 18.41664 17.12432 16.22678 18.46661 15.34542 14.7899 17.48275 14.36348 16.93244 18.91242 12.11302 17.14797 16.41112 17.0634 0 Q8N5I2 ARRD1_HUMAN Arrestin domain-containing protein 1 (Alpha-arrestin 1) ARRDC1 Homo sapiens (Human) extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]; arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] GO:0005737; GO:0005886; GO:0006511; GO:0006858; GO:0015031; GO:0016567; GO:0031410; GO:0031625; GO:0042802; GO:0045746; GO:0070062; GO:0140112; GO:1903561; GO:1990756; GO:1990763 RWIHDVR 12.39999962 0.510746479 0.510746479 0.199422984 982.302628 19.91998 17.57869 18.73722 16.63136 16.89567 18.96782 17.10315 12.8888 15.07044 0 0 0 10.08666 16.92329 0 16.05044 16.71864 15.40302 17.20213 16.76677 18.6871 18.51689 16.33249 13.94963 0 16.15531 0 0 16.53899 16.4395 4.211888 0 0 15.42757 14.16879 16.53259 19.84901 15.64676 19.7932 0 16.0201 14.94095 0 0 15.5612 0 19.56428 0 Q8N5M4 TTC9C_HUMAN "Tetratricopeptide repeat protein 9C, TPR repeat protein 9C" TTC9C Homo sapiens (Human) DAVSR 16.12000084 1 1 0.164946604 546.754447 0 0 0 18.74961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5M9 JAGN1_HUMAN Protein jagunal homolog 1 JAGN1 Homo sapiens (Human) cellular response to tunicamycin [GO:1904577]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cellular response to tunicamycin [GO:1904577]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0002446; GO:0005783; GO:0005789; GO:0006887; GO:0007029; GO:0015031; GO:0016021; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:0061179; GO:1904577; GO:1990266 VAMHYQMSVTLKYEIK 9.289999962 1 1 0.287836398 1956.877433 0 12.87324 11.9393 12.66965 0 0 0 14.69704 0 0 0 0 0 0 0 11.33896 0 0 0 0 0 0 0 0 0 12.96929 0 0 15.8547 16.15707 0 15.55547 13.48271 0 14.70868 14.69482 13.94586 0 0 9.44357 14.27987 0 13.6469 13.83602 0 0 0 15.87621 Q8N5N4 CC022_HUMAN Uncharacterized protein C3orf22 C3orf22 Homo sapiens (Human) IQAQENFAKK 6.800000191 0.050392438 0.050392438 0.122107461 1176.570556 16.66269 15.27162 0 0 8.50181 0 16.48819 15.94488 0 0 0 0 17.2626 0 15.79475 0 14.99914 0 18.11834 0 11.57259 17.68171 17.24749 16.94263 16.67712 0 14.23462 0 13.90621 12.891 18.19779 19.71504 14.60828 17.37053 0 18.88161 15.46848 17.90533 16.30363 0 0 0 0 13.92524 0 16.06812 18.0027 15.86169 Q8N5N7 RM50_HUMAN "39S ribosomal protein L50, mitochondrial, L50mt, MRP-L50 (Mitochondrial large ribosomal subunit protein mL50)" MRPL50 Homo sapiens (Human) mitochondrial translation [GO:0032543] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005762; GO:0005829; GO:0032543 AYTPPEDLQSRLESYVK 8.359999657 0.163725168 0.163725168 0.191498253 1996.555492 0 0 15.02909 14.54621 0 12.83712 16.91134 0 7.33361 0 0 16.09736 15.82467 12.68531 0 0 0 0 0 0 10.23152 0 15.50249 15.93373 15.21952 11.21461 0 0 0 0 14.17888 0 17.80372 0 13.84364 12.44776 17.03777 12.03922 15.2883 0 0 0 15.89593 0 0 17.08187 12.24817 0 Q8N5P1 ZC3H8_HUMAN Zinc finger CCCH domain-containing protein 8 ZC3H8 ZC3HDC8 Homo sapiens (Human) "apoptotic process [GO:0006915]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029]" Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] "Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; apoptotic process [GO:0006915]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]" GO:0000785; GO:0000791; GO:0001162; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0006915; GO:0008023; GO:0015030; GO:0016604; GO:0033085; GO:0035363; GO:0042795; GO:0042796; GO:0043029; GO:0045892; GO:0045945; GO:0046677; GO:0046872; GO:0070245 DTPQAAKQK 7.190000057 0.438833058 0.438833058 2.17E-12 988.7994838 0 15.78042 15.7961 13.5942 14.91627 10.49266 15.76151 17.23325 0 15.59568 13.91697 0 13.18773 0 0 14.93841 14.98888 12.35257 16.22624 16.33192 15.30457 14.8633 17.81224 16.89557 15.24873 14.34281 0 15.8854 14.19315 8.314504 0 16.84986 13.66237 15.9172 13.13407 0 15.32955 14.10333 15.19055 10.53474 15.60952 0 0 0 12.19722 14.91132 16.56182 15.56705 Q8N5Q1 GAR5B_HUMAN Golgi associated RAB2 interactor protein 5B GARIN5B C19orf16 FAM71E2 Homo sapiens (Human) RVSQEPMR 7.150000095 1 1 0.201817978 1018.596422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.82608 0 17.18965 0 0 0 17.58591 0 0 19.06847 0 0 0 0 0 0 0 0 0 17.652 0 0 0 0 0 19.94409 18.01583 0 0 17.94786 19.39604 19.90163 18.94147 0 Q8N5R6 CCD33_HUMAN "Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61, CT61)" CCDC33 Homo sapiens (Human) peroxisome [GO:0005777] peroxisome [GO:0005777] GO:0005777 QELLSYKIPIK 6.820000172 1 1 9.16E-13 1335.667571 0 0 0 0 0 0 0 0 0 14.28576 13.06066 14.33998 0 0 0 0 12.28176 11.01788 13.26501 0 0 12.76665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5S1 S2541_HUMAN "Mitochondrial carrier protein SCaMC-3L (Mitochondrial ATP-Mg/Pi carrier protein SLC25A41) (Small calcium-binding mitochondrial carrier protein 3-like, SCaMC-3-like, SCaMC-3L) (Solute carrier family 25 member 41)" SLC25A41 Homo sapiens (Human) ADP transport [GO:0015866]; ATP transport [GO:0015867]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544] ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347] GO:0005347; GO:0005739; GO:0005743; GO:0015217; GO:0015866; GO:0015867; GO:0016021; GO:0140021; GO:1990544 FLLSGAMAGAVSRTGTAPLDR 5.679999828 1 1 9.14E-13 2090.451353 13.90299 15.01737 14.31405 14.07404 14.57351 12.49222 13.4147 13.27699 0 0 10.94263 14.70948 14.3232 10.79781 14.82492 0 0 0 12.40263 11.90882 7.070092 0 12.90759 13.91454 0 0 0 0 14.0263 14.79074 0 0 0 0 0 0 0 0 0 0 15.69592 0 0 0 0 0 0 0 Q8N5S9 KKCC1_HUMAN "Calcium/calmodulin-dependent protein kinase kinase 1, CaM-KK 1, CaM-kinase kinase 1, CaMKK 1, EC 2.7.11.17 (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha, CaM-KK alpha, CaM-kinase kinase alpha, CaMKK alpha)" CAMKK1 CAMKKA Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0035556; GO:0045860; GO:0106310 SMSAPGNLLVK 24.70999908 1 1 0.549006644 1132.391934 18.81718 18.68677 19.31841 0 0 18.87266 0 0 0 18.22721 0 19.14821 0 0 0 17.7807 0 0 0 18.031 0 0 0 0 0 0 0 0 17.02924 17.1286 0 0 17.90761 0 0 0 0 0 0 18.19785 0 18.26609 0 17.87709 0 0 0 17.17203 Q8N5U0 CK042_HUMAN Uncharacterized protein C11orf42 C11orf42 Homo sapiens (Human) SLPVAFSCLK 5.489999771 1 1 0.183000821 1122.894569 0 13.51985 14.73825 12.38126 15.74839 15.25546 15.59751 12.94466 12.84387 13.43555 14.87968 0 14.87634 0 12.59632 16.0273 0 0 0 0 15.34615 0 0 16.61752 0 0 0 15.72712 15.00596 0 15.88114 0 0 16.02817 15.15901 0 14.95804 15.79418 14.46991 0 17.08027 15.29671 14.89804 0 14.46208 16.22998 0 0 Q8N5U6 RNF10_HUMAN RING finger protein 10 RNF10 KIAA0262 RIE2 Homo sapiens (Human) "negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autoubiquitination [GO:0051865]" cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autoubiquitination [GO:0051865]" metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630] GO:0000976; GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0045893; GO:0045944; GO:0046872; GO:0051865; GO:0061630; GO:0098978; GO:0099147; GO:0099527 EKGVLVALPK 1.980000019 0.505338669 0.505338669 0.056583047 1053.890715 13.37233 14.89081 0 0 14.85559 0 0 0 0 0 13.97009 15.4392 13.99815 0 14.00004 13.3863 0 13.16901 0 0 0 0 0 16.31702 0 0 16.07135 0 0 0 0 0 0 0 0 0 0 0 0 16.44969 14.51377 14.22433 0 0 0 0 0 0 Q8N5V2 NGEF_HUMAN Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor) NGEF Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020] cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0043087; GO:0048013; GO:0051056; GO:0061002; GO:0090630 FVSFTSR 14.25 1 1 0.07132961 842.6353315 0 0 14.58987 15.3078 15.51662 0 14.59059 15.02458 0 0 15.27795 13.7961 15.35878 0 0 15.66712 14.10472 0 14.90614 13.75614 13.55525 14.60361 15.39059 15.17594 0 0 15.13877 14.96075 14.91689 13.94397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5Z5 KCD17_HUMAN BTB/POZ domain-containing protein KCTD17 KCTD17 Homo sapiens (Human) cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] GO:0005737; GO:0005783; GO:0030030; GO:0031463; GO:0032469; GO:0042802; GO:0043161; GO:0045724; GO:0051260; GO:0097602 DMAEEGVLEEAEFYNIGPLIRIIK 1.220000029 0.386464596 0.386464596 1.37E-12 2749.665439 0 15.27569 0 17.22329 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3191 16.46729 0 0 10.85742 17.03271 0 16.41333 14.70247 0 0 0 0 0 0 17.93635 0 14.77608 0 17.33969 16.57475 0 0 18.46323 0 16.39928 0 0 17.31712 16.65644 13.39294 Q8N609 TR1L1_HUMAN Translocating chain-associated membrane protein 1-like 1 TRAM1L1 Homo sapiens (Human) "protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" integral component of endoplasmic reticulum membrane [GO:0030176] "integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0006616; GO:0030176; GO:0045048 RMQFTK 3.930000067 0.01816834 0.01816834 0.275962945 810.7002401 0 0 0 16.13705 17.11039 0 17.2983 0 0 17.27808 0 16.48385 0 0 0 0 16.65167 0 0 0 16.46967 0 0 17.33764 0 17.5348 18.06605 0 0 0 17.36146 0 0 0 0 16.42391 0 0 0 0 0 0 0 0 0 17.95108 15.95779 0 Q8N612 FHI1B_HUMAN "FHF complex subunit HOOK interacting protein 1B, FHIP1B (FTS and Hook-interacting protein, FHIP)" FHIP1B C11orf56 FAM160A2 KIAA1759 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] cytosol [GO:0005829]; FHF complex [GO:0070695] cytosol [GO:0005829]; FHF complex [GO:0070695]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] GO:0005829; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0070695; GO:1905719 SLLQVLGSVK 9.970000267 1 1 0.254840378 1044.094219 9.953814 15.70865 15.15474 0 14.34403 14.79257 15.92978 0 14.43451 16.25069 15.18278 0 0 0 0 0 0 0 0 16.49456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.26856 0 0 0 0 0 0 0 0 0 Q8N614 TM156_HUMAN Transmembrane protein 156 TMEM156 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ETQIIMR 15.67000008 1 1 3.44E-13 907.5041232 14.51026 14.15927 14.17959 13.22869 0 13.64725 0 0 0 0 0 0 0 0 12.22829 14.82613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.84679 15.18154 0 0 0 0 0 15.47352 0 15.0196 0 14.53309 0 0 0 0 0 0 Q8N668 COMD1_HUMAN COMM domain-containing protein 1 (Protein Murr1) COMMD1 C2orf5 MURR1 Homo sapiens (Human) copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037] "Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]" "copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]" GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0032088; GO:0032434; GO:0042802; GO:0042803; GO:0043325; GO:0048227; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:1902306; GO:2000009 SIASADMDFNQLEAFLTAQTK 13.69999981 1 1 0.235708908 2316.941921 14.68812 14.74265 10.00151 0 0 0 0 0 0 0 0 0 17.07282 0 17.09859 0 17.36332 0 17.07829 17.91193 17.4544 15.08229 17.01957 16.11172 15.63135 13.2646 0 0 0 15.83041 0 17.45813 17.20274 0 16.35112 19.15409 21.44876 21.59987 0 15.14291 13.10675 0 18.95079 22.13668 20.02573 16.7616 17.55241 18.14772 Q8N693 ESX1_HUMAN "Homeobox protein ESX1 (Extraembryonic, spermatogenesis, homeobox 1) [Cleaved into: Homeobox protein ESX1-N; Homeobox protein ESX1-C ]" ESX1 ESX1L ESX1R Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0006357; GO:0016607; GO:0043565; GO:0045892; GO:0051726; GO:1990837 LTVTSLMAR 6.650000095 1 1 0.504710151 1008.928099 19.51631 18.10751 17.83894 0 0 0 0 0 0 17.24963 0 0 0 19.10912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.24767 0 0 0 0 0 0 0 0 0 0 Q8N697 S15A4_HUMAN "Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1, hPHT1)" SLC15A4 PHT1 PTR4 FP12591 Homo sapiens (Human) dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] GO:0005290; GO:0005765; GO:0005886; GO:0006811; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0031303; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0035579; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206; GO:1905103 APLLGARR 10.26000023 0.773017585 0.773017585 2.28E-13 851.5288555 15.00336 0 13.07699 16.50648 0 16.70219 14.88017 16.89886 16.80022 0 16.83117 0 16.08574 0 0 15.22744 0 15.15984 0 14.39497 0 16.28697 14.67581 0 15.71276 15.0759 16.80371 0 14.0441 0 15.14076 15.13878 15.97486 0 13.99199 0 17.08246 13.47318 0 13.33272 16.65586 0 0 0 14.48247 12.98345 11.64269 15.45512 Q8N6C7 PGSF1_HUMAN Putative uncharacterized protein encoded by MIR7-3HG (Pituitary gland-specific factor 1) MIR7-3HG C19orf30 LINC00306 NCRNA00306 PGSF1 Homo sapiens (Human) SVLTFS 7.71999979 1 1 0.126779934 654.0449243 0 16.08578 0 0 15.27306 0 0 0 0 0 0 16.21694 16.2289 0 0 15.42032 0 0 0 0 0 0 0 0 0 14.43561 0 0 15.69944 16.11154 16.20832 16.43877 0 12.91599 11.44303 15.12662 0 0 0 0 0 0 0 15.49988 0 14.84049 15.08126 15.8073 Q8N6G5 CGAT2_HUMAN "Chondroitin sulfate N-acetylgalactosaminyltransferase 2, EC 2.4.1.174 (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2)" CSGALNACT2 CHGN2 GALNACT2 PRO0082 Homo sapiens (Human) "chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]" Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] "Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]" acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872] GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030173; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050652; GO:0050653 DVCIHQDKK 9.779999733 1 1 0.142256155 1141.523295 12.94848 14.64076 16.51552 13.19339 14.22199 17.35033 0 14.51031 11.39887 14.61884 14.03908 13.4627 13.45489 0 0 0 0 0 0 0 0 16.23757 0 0 12.35821 17.56975 0 13.17739 0 0 0 13.48645 0 0 0 0 0 0 0 0 15.78441 12.94757 0 0 14.8173 0 0 0 Q8N6K0 TEX29_HUMAN Testis-expressed protein 29 TEX29 C13orf16 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LGLKPASPGPPSAGPSMK 4.269999981 1 1 0.17934306 1708.095039 16.51447 14.48084 0 13.07725 0 0 0 0 0 0 12.42269 0 14.71333 0 15.01894 0 12.22016 13.39198 0 0 0 0 14.66107 0 14.36829 0 13.70431 14.10362 0 0 11.04467 12.66031 14.53682 15.49217 13.95839 0 11.73408 16.39129 0 14.2939 8.833574 15.4503 0 0 0 0 0 0 Q8N6L0 KASH5_HUMAN Protein KASH5 (Coiled-coil domain-containing protein 155) (KASH domain-containing protein 5) KASH5 CCDC155 Homo sapiens (Human) actin filament organization [GO:0007015]; chromosome localization to nuclear envelope involved in homologous chromosome segregation [GO:0090220]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome pairing at meiosis [GO:0007129]; microtubule cytoskeleton organization involved in homologous chromosome segregation [GO:0090172]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]; spindle localization [GO:0051653]; telomere localization [GO:0034397] "chromosome, telomeric region [GO:0000781]; integral component of membrane [GO:0016021]; lateral element [GO:0000800]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; meiotic spindle pole [GO:0090619]; nuclear outer membrane [GO:0005640]" "chromosome, telomeric region [GO:0000781]; integral component of membrane [GO:0016021]; lateral element [GO:0000800]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; meiotic spindle pole [GO:0090619]; nuclear outer membrane [GO:0005640]; dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; actin filament organization [GO:0007015]; chromosome localization to nuclear envelope involved in homologous chromosome segregation [GO:0090220]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome pairing at meiosis [GO:0007129]; microtubule cytoskeleton organization involved in homologous chromosome segregation [GO:0090172]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]; spindle localization [GO:0051653]; telomere localization [GO:0034397]" dynein complex binding [GO:0070840]; identical protein binding [GO:0042802] GO:0000724; GO:0000781; GO:0000800; GO:0005640; GO:0007015; GO:0007129; GO:0007283; GO:0016021; GO:0034397; GO:0034993; GO:0042802; GO:0048477; GO:0051225; GO:0051653; GO:0070840; GO:0090172; GO:0090220; GO:0090619 ELQQALVPVMKK 12.86999989 0.95057869 0.95057869 6.86E-13 1399.796133 0 0 0 0 17.68289 0 0 17.77771 18.33348 17.66421 0 0 0 0 0 0 0 0 0 0 18.63003 0 0 0 0 16.42781 0 0 0 19.22631 0 0 0 15.80837 0 17.97833 15.51087 17.00369 0 0 0 15.61977 0 0 0 0 16.72502 17.15044 Q8N6M3 FITM2_HUMAN "Acyl-coenzyme A diphosphatase FITM2, EC 3.6.1.- (Fat storage-inducing transmembrane protein 2) (Fat-inducing protein 2)" FITM2 C20orf142 FIT2 Homo sapiens (Human) cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]; cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730] acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129] GO:0005789; GO:0007010; GO:0008654; GO:0010866; GO:0010890; GO:0010945; GO:0017129; GO:0019915; GO:0019992; GO:0022604; GO:0030176; GO:0030730; GO:0034389; GO:0035356; GO:0036115; GO:0055088; GO:0106399; GO:0140042 RYLPWALVASMLAGSLLK 3.099999905 1 1 0.276728691 2005.701123 6.898997 0 0 0 14.98681 16.6077 14.65798 0 9.654253 14.81438 13.17158 15.35065 0 13.52461 0 0 0 12.85085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.38587 0 Q8N6M8 IQCF1_HUMAN IQ domain-containing protein F1 IQCF1 Homo sapiens (Human) positive regulation of acrosome reaction [GO:2000344]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474] acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669]; calmodulin binding [GO:0005516]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474] calmodulin binding [GO:0005516] GO:0001669; GO:0005516; GO:0060474; GO:2000344 LILSKILK 17.32999992 1 1 0.119789425 927.6657059 16.49504 16.26269 15.28366 15.46597 16.51459 15.1805 14.58748 16.71841 15.79995 15.88749 0 0 13.6812 14.46968 16.69993 0 15.74273 15.74119 15.30954 15.27784 15.17428 16.60669 16.95383 0 15.40562 0 16.07717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6N6 NATD1_HUMAN Protein NATD1 (N-acetyltransferase domain-containing protein 1) NATD1 C17orf103 GTLF3B Homo sapiens (Human) GIAKHLAK 5.849999905 1 1 0.24246301 837.9802672 16.33814 14.70676 16.46097 0 0 12.84467 0 0 0 0 15.69433 16.63288 0 0 0 0 0 0 0 0 0 0 0 0 15.86188 0 0 0 0 16.10424 0 0 0 0 0 0 0 14.96614 0 0 0 0 14.92576 0 0 0 0 0 Q8N6P7 I22R1_HUMAN "Interleukin-22 receptor subunit alpha-1, IL-22 receptor subunit alpha-1, IL-22R-alpha-1, IL-22RA1 (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9, CRF2-9) (ZcytoR11)" IL22RA1 IL22R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829] cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015] GO:0004896; GO:0004904; GO:0005886; GO:0005887; GO:0019221; GO:0042015; GO:0050829 SATKMTDR 4.039999962 0.401144475 0.401144475 0.129493758 926.0843475 0 13.93696 15.87288 0 15.69052 0 0 0 0 0 0 0 0 0 0 0 14.85081 0 0 0 0 0 0 0 14.51594 0 0 0 16.17781 0 0 0 12.77963 15.69196 0 11.86008 19.90975 0 0 0 0 0 0 0 0 0 0 0 Q8N6Q8 MET25_HUMAN "Probable methyltransferase-like protein 25, EC 2.1.1.-" METTL25 C12orf26 Homo sapiens (Human) methylation [GO:0032259] methyltransferase activity [GO:0008168]; methylation [GO:0032259] methyltransferase activity [GO:0008168] GO:0008168; GO:0032259 AVEFMNMKK 5.119999886 1 1 0.078305423 1097.677878 15.50562 0 0 0 0 12.4186 14.63745 0 13.18455 0 0 14.97084 0 0 0 0 0 0 0 0 0 0 0 0 0 14.51073 0 0 0 0 0 13.59121 0 0 0 0 0 0 0 0 0 0 0 13.86837 0 0 0 0 Q8N6R0 EFNMT_HUMAN "eEF1A lysine and N-terminal methyltransferase, eEF1A-KNMT (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase, EC 2.1.1.-; eEF1A N-terminal methyltransferase, EC 2.1.1.- ]" METTL13 EEF1AKNMT FEAT KIAA0859 CGI-01 Homo sapiens (Human) methylation [GO:0032259]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122] methyltransferase activity [GO:0008168] GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0008168; GO:0032259; GO:1902807 DVSHK 4.329999924 0.3779293 0.3779293 0.131365642 585.0039964 0 0 0 0 0 16.81905 16.79966 0 13.00588 0 0 16.4143 14.70102 16.71026 15.8977 16.14422 16.44939 14.69395 18.42908 17.48561 14.67232 16.85127 17.07678 16.62189 16.45603 18.05282 13.70484 0 16.61176 0 14.79479 0 15.69111 17.94674 17.20238 15.12338 16.57743 14.63281 17.49683 17.19329 17.03886 12.42724 14.5688 17.6659 19.70485 15.8954 0 0 Q8N6S4 AN13C_HUMAN Ankyrin repeat domain-containing protein 13C ANKRD13C Homo sapiens (Human) protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469] signaling receptor binding [GO:0005102] GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010469; GO:0048471; GO:2000209 AIMESLSK 1.340000033 1 1 0.244413809 894.8334505 17.43517 0 0 0 0 0 16.89126 0 0 0 15.91679 18.41573 0 0 0 0 18.31373 0 0 0 15.53703 0 0 0 15.9717 0 0 0 0 0 0 0 16.49191 0 0 0 0 0 0 0 0 0 0 0 17.25739 0 0 0 Q8N6T0 TO6BL_HUMAN "Type 2 DNA topoisomerase 6 subunit B-like (Type 2 DNA topoisomerase VI subunit B-like, TOPOVIBL)" TOP6BL C11orf80 Homo sapiens (Human) meiotic DNA double-strand break formation [GO:0042138]; reciprocal meiotic recombination [GO:0007131] chromosome [GO:0005694] chromosome [GO:0005694]; meiotic DNA double-strand break formation [GO:0042138]; reciprocal meiotic recombination [GO:0007131] GO:0005694; GO:0007131; GO:0042138 GALLEGQLVISIEGLNSK 15.09000015 1 1 0.196995729 1839.911571 0 0 11.85645 14.35321 0 14.81761 0 0 0 0 0 0 0 0 0 15.08955 13.16522 0 0 0 0 0 0 0 13.77108 11.93175 0 0 0 0 0 0 13.75046 0 0 14.45461 0 13.59805 0 0 0 0 0 0 10.81926 0 0 0 Q8N6Y0 USBP1_HUMAN "Usher syndrome type-1C protein-binding protein 1, USH1C-binding protein 1 (AIE-75-binding protein) (MCC-2) (Mutated in colon cancer protein 2)" USHBP1 AIEBP MCC2 Homo sapiens (Human) PDZ domain binding [GO:0030165] PDZ domain binding [GO:0030165] GO:0030165 EPWETQDSFSLAHPLLRR 1.639999986 1 1 0.216043972 2181.5746 0 0 15.55688 0 0 0 15.36219 0 0 0 16.49168 15.09314 0 0 0 0 0 0 0 0 16.37279 0 0 0 17.69253 15.92132 0 0 0 0 0 0 0 0 0 0 14.11318 0 0 0 0 0 0 11.95046 0 0 0 0 Q8N715 CC185_HUMAN Coiled-coil domain-containing protein 185 CCDC185 C1orf65 Homo sapiens (Human) AGFSHFSQPPYR 1.070000052 1 1 0.290547344 1394.178386 16.6658 0 0 15.46818 0 16.60631 10.62934 0 0 0 0 0 0 0 0 0 0 0 0 0 12.14475 0 16.76167 12.13958 0 0 15.36842 0 0 0 0 0 0 0 0 17.42909 0 0 0 0 0 0 0 0 0 0 15.70477 0 Q8N720 ZN655_HUMAN Zinc finger protein 655 (Vav-interacting Krueppel-like protein) ZNF655 VIK Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0046872; GO:2000134 VLRIQNTDDNDK 2.150000095 1 1 0.355511194 1429.981081 0 0 13.91485 0 15.85741 0 0 0 0 0 0 0 0 0 15.16799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.86166 0 0 0 0 0 0 15.85272 0 0 0 0 0 0 0 0 Q8N729 NPW_HUMAN "Neuropeptide W (Preproprotein L8, hPPL8) [Cleaved into: Neuropeptide W-23, NPW23, hL8; Neuropeptide W-30, NPW30, hL8C ]" NPW PPL8 PPNPW Homo sapiens (Human) feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] G protein-coupled receptor binding [GO:0001664] GO:0001664; GO:0005576; GO:0007186; GO:0007218; GO:0007631 YHTVGRAAGLLMGLR 2.74000001 1 1 0.165035614 1614.645669 0 0 15.5513 14.2783 0 0 15.37233 0 14.40314 0 13.53992 12.21372 0 0 0 15.49009 0 0 0 0 0 0 0 0 0 0 0 0 0 15.27019 0 0 13.79867 0 0 14.20365 15.56495 15.64746 0 0 0 0 15.49818 0 16.39555 0 0 0 Q8N766 EMC1_HUMAN ER membrane protein complex subunit 1 EMC1 KIAA0090 PSEC0263 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005789; GO:0016021; GO:0030176; GO:0032991; GO:0045050; GO:0071816; GO:0072546 DEFNLQKMMVMVTASGK 17.15999985 1 1 0.354459591 1927.872728 20.89802 0 19.45049 0 0 0 0 20.75126 20.73716 0 19.32063 0 18.00563 0 20.56624 0 0 0 19.48294 0 21.11379 21.09945 0 19.94386 0 21.25922 21.04999 0 19.50341 0 20.58906 20.02289 0 21.88432 20.47241 20.99307 17.66665 21.00307 0 17.59417 0 0 0 21.58656 19.81869 19.57541 0 0 Q8N7C3 TRIMM_HUMAN "Probable E3 ubiquitin-protein ligase TRIML2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TRIML2) (SPRY domain-containing protein 6) (Tripartite motif family-like protein 2)" TRIML2 SPRYD6 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051092; GO:0061630 ASEQVR 1.710000038 0.000907174 0.000907174 0.121356995 688.5905511 15.46575 0 0 16.61345 0 16.04455 0 0 17.37956 15.88311 0 14.9714 16.78704 0 0 16.42082 0 0 0 0 0 0 0 13.59606 0 0 16.20634 0 0 0 0 0 18.03501 0 0 0 0 0 0 16.9316 0 0 0 0 0 0 0 0 Q8N7F7 UBL4B_HUMAN Ubiquitin-like protein 4B UBL4B Homo sapiens (Human) positive regulation of protein targeting to mitochondrion [GO:1903955] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; positive regulation of protein targeting to mitochondrion [GO:1903955] GO:0005737; GO:1903955 MFLTVKLLLGQR 2.220000029 1 1 0.23406827 1435.446707 15.00158 0 0 0 0 0 0 0 0 0 16.64859 0 0 13.24494 13.51427 0 0 0 0 0 14.92344 0 0 0 0 0 0 0 0 0 12.02061 0 15.39623 0 0 0 0 0 0 0 15.96596 0 0 0 0 0 0 0 Q8N7H1 CL061_HUMAN Putative uncharacterized protein encoded by LINC01465 LINC01465 C12orf61 Homo sapiens (Human) MGGKSAVR 2.599999905 0.357782185 0.357782185 0.236712133 820.7534621 17.11768 16.95447 0 15.72701 15.14038 15.07223 0 0 0 15.16889 16.84036 17.83593 16.8683 13.78005 0 14.68878 15.543 0 0 0 0 0 0 0 15.72244 0 0 15.09265 15.6054 13.86128 0 16.94365 0 14.20442 11.9102 0 0 0 0 0 16.95143 16.01834 0 15.52867 17.48518 0 14.68932 0 Q8N7J2 AMER2_HUMAN "APC membrane recruitment protein 2, Amer2 (Protein FAM123A)" AMER2 FAM123A Homo sapiens (Human) ectoderm development [GO:0007398]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] "plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ectoderm development [GO:0007398]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]" "beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0005546; GO:0005886; GO:0007398; GO:0008013; GO:0016055; GO:0060828; GO:0090090 IPVSK 10.18999958 0.519546628 0.519546628 0.304159294 541.8144935 0 17.55054 0 17.34657 17.39017 18.72062 0 0 18.24923 0 0 0 18.99796 0 16.78269 19.10685 19.54716 18.27144 17.48505 0 18.73078 0 17.90819 0 0 18.46676 0 0 0 0 0 20.43003 0 0 20.8062 0 17.61826 0 19.1863 0 19.26432 17.75334 0 17.10544 18.12075 0 0 0 Q8N7L0 F216B_HUMAN Protein FAM216B FAM216B C13orf30 Homo sapiens (Human) TSAMTRR 6.989999771 0.618450701 0.618450701 0.254545324 838.0693274 0 14.30857 12.16018 15.55884 0 15.297 0 0 0 0 0 15.18049 16.3435 16.5206 0 0 16.84108 14.94279 0 0 0 0 15.20195 0 14.49077 15.1561 16.49614 15.28996 16.69328 16.12658 17.40768 15.1355 14.26652 17.24049 0 15.15401 0 0 14.59229 15.51535 15.82185 15.51181 15.71584 14.09316 14.2205 0 15.05534 15.49666 Q8N7M2 ZN283_HUMAN Zinc finger protein 283 (Zinc finger protein HZF19) ZNF283 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AFFWGSSLAK 2.029999971 1 1 0.079478541 1112.890783 15.52757 0 7.148802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.34728 0 0 0 0 0 0 0 0 0 14.35765 13.73043 0 14.75492 14.65649 16.30972 0 16.97117 0 0 0 0 0 0 0 0 0 15.9803 0 0 0 Q8N7P1 PLD5_HUMAN "Inactive phospholipase D5, Inactive PLD 5 (Inactive choline phosphatase 5) (Inactive phosphatidylcholine-hydrolyzing phospholipase D5) (PLDc)" PLD5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; catalytic activity [GO:0003824] catalytic activity [GO:0003824] GO:0003824; GO:0016021 NHTFPR 4.170000076 0.408070862 0.408070862 0.24198017 769.6536346 18.19982 14.88858 14.07395 13.06595 0 0 15.59912 0 14.8514 0 14.89476 15.76456 15.43433 15.09608 13.49944 0 0 16.11002 14.15585 14.69105 11.97752 0 16.76322 15.23008 16.23088 15.99105 15.25717 15.13778 0 0 0 17.4173 0 14.72585 0 0 0 0 0 15.71129 16.18417 0 15.50478 15.15085 16.86351 0 0 0 Q8N7R1 P1L12_HUMAN POM121-like protein 12 POM121L12 Homo sapiens (Human) protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] nuclear pore [GO:0005643] nuclear pore [GO:0005643]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] GO:0005643; GO:0006405; GO:0006606; GO:0008139; GO:0017056 RPALPGETALGR 7.199999809 1 1 0.246548645 1238.352008 15.51327 0 15.02212 16.53862 15.7062 0 13.8255 14.75859 0 15.1836 16.75079 0 0 16.09604 15.62735 15.67224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7U6 EFHB_HUMAN EF-hand domain-containing family member B EFHB Homo sapiens (Human) calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion sensor activity [GO:0061891]; calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256] calcium ion sensor activity [GO:0061891] GO:0005737; GO:0006816; GO:0032091; GO:0061891; GO:0070884; GO:2001256 GLEMGLERQNISR 2.789999962 0.177569062 0.177569062 0.376354715 1503.394496 0 0 15.58021 0 0 0 0 0 0 14.6399 0 0 0 16.82172 17.50777 0 15.89375 14.84888 0 16.50313 0 17.24837 0 0 16.96015 0 0 17.06017 16.55526 0 0 13.95077 16.07577 15.22276 12.63413 0 0 0 15.40852 15.62191 17.26707 16.12391 13.3154 0 15.45499 0 0 13.69145 Q8N7U7 TPRX1_HUMAN Tetra-peptide repeat homeobox protein 1 TPRX1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 LLLDL 10.5 0.022635339 0.022635339 0.248480718 582.5648826 15.37582 16.37504 15.77333 14.94758 15.54045 0 15.91386 16.03831 0 16.34328 16.59447 16.39651 14.07774 16.0132 16.46146 15.34073 15.4845 16.17491 16.9181 16.67555 16.73505 16.29594 15.3332 15.5406 14.74126 15.67306 15.44331 14.83181 16.03287 15.85676 0 16.26923 15.86676 16.21346 16.15681 16.00636 16.61036 17.10098 15.91641 17.08476 0 16.14234 17.59575 0 0 16.88023 15.89203 0 Q8N7W2 BEND7_HUMAN BEN domain-containing protein 7 BEND7 C10orf30 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; DNA binding [GO:0003677] DNA binding [GO:0003677] GO:0003677; GO:0070062 ETQPIFLGDESMEIKK 2.079999924 1 1 4.61E-13 1880.782068 14.53496 0 0 0 0 0 0 0 13.96501 0 0 0 0 0 0 13.88302 0 13.0427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.87937 0 0 0 0 0 0 13.5254 0 14.35798 0 15.77068 0 0 0 Q8N7X0 ADGB_HUMAN Androglobin (Calpain-7-like protein) ADGB C6orf103 CAPN7L Homo sapiens (Human) calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825] GO:0004198; GO:0019825; GO:0020037 EKSSEK 7.510000229 1 1 0.327183006 706.9838131 15.76204 15.64942 0 17.37051 0 15.36693 0 0 13.76871 14.6672 17.11727 0 0 15.91296 0 0 0 16.29743 17.10531 0 0 18.01476 17.77551 16.25496 0 16.82956 0 15.15064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.98316 0 0 15.5343 0 Q8N7X8 SIGL1_HUMAN SIGLEC family-like protein 1 SIGLECL1 C19orf75 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] sialic acid binding [GO:0033691] GO:0005886; GO:0007155; GO:0016021; GO:0033691 MLPLLQLVPAK 7.889999866 1 1 2.28E-13 1221.697435 15.14055 15.95124 0 0 14.30013 16.62659 0 13.71785 17.90026 8.51382 0 14.45176 0 17.4804 16.30598 14.71495 0 16.40265 14.86633 0 0 0 14.71076 17.0965 15.39586 0 15.51595 0 14.37209 15.47277 15.79621 16.64971 0 14.50557 17.24762 0 16.09627 18.34933 18.39499 14.89313 17.36627 17.4642 16.53068 15.25471 15.83065 16.19576 14.79899 15.98601 Q8N7Z5 ANR31_HUMAN Ankyrin repeat domain-containing protein 31 ANKRD31 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343] GO:0000785; GO:0005634; GO:0007129; GO:0010780; GO:1903343 ESMQSSPR 7.480000019 0.679632783 0.679632783 0.135985982 938.5598158 0 0 0 12.27485 16.90626 13.98494 0 0 10.95529 12.77809 12.6882 0 13.70224 14.32233 16.08947 0 0 15.45791 16.00905 0 0 0 0 0 0 0 0 12.88221 15.0896 0 0 0 0 0 0 18.23712 0 0 0 0 15.92988 0 13.64399 17.48608 9.530744 15.60005 0 0 Q8N807 PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis PDILT Homo sapiens (Human) cell migration [GO:0016477]; protein folding [GO:0006457]; spermatid development [GO:0007286] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; protein disulfide isomerase activity [GO:0003756]; cell migration [GO:0016477]; protein folding [GO:0006457]; spermatid development [GO:0007286] protein disulfide isomerase activity [GO:0003756] GO:0003756; GO:0005783; GO:0006457; GO:0007286; GO:0016477 GPPVQKK 3.890000105 0.842654407 0.842654407 0.176550038 752.3841076 15.3115 0 14.75751 14.67781 14.5236 15.36717 0 0 0 16.54427 17.20656 0 15.55639 14.95581 15.12889 0 0 0 16.68252 0 0 14.5131 0 0 0 14.73254 0 13.65949 16.03001 0 18.04236 0 0 0 0 17.07166 16.39293 16.47198 15.18315 15.21594 0 0 0 0 0 0 0 0 Q8N815 CNTD1_HUMAN Cyclin N-terminal domain-containing protein 1 CNTD1 CNTD Homo sapiens (Human) reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; site of double-strand break [GO:0035861] chromosome [GO:0005694]; site of double-strand break [GO:0035861]; reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283] GO:0005694; GO:0007131; GO:0007283; GO:0035861; GO:0051445 ALKTVASSNT 3.680000067 1 1 3.46E-13 990.8135088 0 13.17101 11.67969 14.17885 14.89995 0 15.46048 14.1164 14.49073 13.35868 13.52922 14.68391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.44983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N819 PPM1N_HUMAN "Probable protein phosphatase 1N, EC 3.1.3.16" PPM1N Homo sapiens (Human) negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of canonical Wnt signaling pathway [GO:0090263] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of canonical Wnt signaling pathway [GO:0090263] magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0030145; GO:0043124; GO:0090263 LRSLWPR 13.60999966 1 1 0.164739644 929.7068162 0 0 15.09802 0 0 0 0 0 14.73177 0 13.92034 14.95401 0 0 0 0 0 0 0 0 0 15.37935 14.97301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.01816 14.76285 0 0 0 15.68982 0 Q8N823 ZN611_HUMAN Zinc finger protein 611 ZNF611 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 IHTAKK 13.15999985 0.622527659 0.622527659 0.121470264 696.4860395 0 14.08759 18.23922 17.98418 17.73582 0 15.01739 0 0 15.01667 17.39637 17.80597 17.78455 16.49251 15.51642 11.9796 13.77124 16.93278 16.00624 16.94306 15.07299 15.36368 0 18.21311 17.78552 15.00552 0 17.17712 15.36763 17.82395 15.9427 0 17.58268 17.05301 15.61344 16.06108 0 17.4683 18.82718 0 17.45318 0 15.74775 14.60321 16.90038 17.32721 17.40318 15.67718 Q8N831 TSYL6_HUMAN "Testis-specific Y-encoded-like protein 6, TSPY-like protein 6" TSPYL6 Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] chromatin binding [GO:0003682]; histone binding [GO:0042393] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393 SHGAIK 4.940000057 0.478047609 0.478047609 0.207325642 611.5458355 0 14.28151 0 0 14.59232 15.89336 14.41783 14.41071 15.24915 11.64827 14.15537 16.00149 0 16.21972 17.07609 16.16086 16.75658 14.27361 14.46461 15.66908 15.69497 14.97969 15.22647 12.5674 14.18962 12.97192 13.90792 15.98469 15.38804 14.97273 0 0 16.13246 16.40268 16.79662 17.49723 0 17.25216 18.13266 0 16.19039 0 14.99298 16.22582 17.86812 14.44474 16.20058 16.0499 Q8N841 TTLL6_HUMAN "Tubulin polyglutamylase TTLL6, EC 6.3.2.- (Protein polyglutamylase TTLL6) (Tubulin--tyrosine ligase-like protein 6)" TTLL6 TTL.6 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GO:0000226; GO:0001578; GO:0003353; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0036064; GO:0046872; GO:0051013; GO:0060296; GO:0070739; GO:0070740; GO:0097731 SHASAMR 13.44999981 0.167534158 0.167534158 0.041946208 762.5350576 17.09195 0 15.87674 14.66169 0 0 17.25779 0 18.11928 17.44318 17.47792 14.62563 0 0 16.57087 16.1149 17.12653 18.06144 16.62572 17.70698 17.96544 0 17.00912 16.13899 0 18.42175 17.79292 0 16.34832 0 15.35031 0 15.78813 18.77285 0 15.98278 0 16.86253 0 0 0 0 17.4148 17.25208 16.69028 16.27676 16.9726 15.01558 Q8N878 FRMD1_HUMAN FERM domain-containing protein 1 FRMD1 Homo sapiens (Human) positive regulation of hippo signaling [GO:0035332] cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856] cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; positive regulation of hippo signaling [GO:0035332] GO:0005856; GO:0035332; GO:0098592 VRPTLQQLR 8.149999619 1 1 0.098035009 1111.263001 14.29782 0 16.16966 0 13.28268 0 0 0 12.43044 0 0 16.58962 0 0 0 0 0 0 0 0 0 0 0 0 13.35489 0 15.39271 0 14.56467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.34288 Q8N8A6 DDX51_HUMAN "ATP-dependent RNA helicase DDX51, EC 3.6.4.13 (DEAD box protein 51)" DDX51 Homo sapiens (Human) rRNA processing [GO:0006364] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020; GO:0016887 AGKTGQAFTLLLK 4.320000172 1 1 0.180894389 1346.42736 16.65376 0 15.01769 0 0 0 0 0 0 0 0 14.93034 16.44851 0 0 16.17292 0 14.80653 14.56815 0 15.47758 0 0 0 0 0 0 15.31038 0 0 0 17.10591 0 0 0 0 0 0 16.62132 0 16.26455 0 0 0 0 0 0 0 Q8N8B7 TEANC_HUMAN Transcription elongation factor A N-terminal and central domain-containing protein (TFIIS central domain-containing protein 1) TCEANC Homo sapiens (Human) "transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0006351 MSDKNQIAAR 6.239999771 0.581684232 0.581684232 0.12751932 1132.752323 0 0 15.88686 13.15516 0 11.6317 12.5721 13.52368 0 0 0 15.35867 0 15.69088 0 0 0 15.56128 0 13.81953 0 0 0 0 0 0 0 0 13.17381 14.65524 14.23511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05964 0 Q8N8C0 ZN781_HUMAN Zinc finger protein 781 ZNF781 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 EHILMK 16.03000069 1 1 0.150521125 785.9905504 0 0 0 0 0 0 16.498 11.22613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.25542 0 0 0 0 0 0 0 16.73261 0 0 14.28385 0 0 0 0 0 0 0 0 0 Q8N8E2 ZN513_HUMAN Zinc finger protein 513 ZNF513 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976] GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041 QSHPQPVK 5.130000114 0.51661694 0.51661694 0.268896894 920.5613406 16.92791 17.5289 12.80195 15.42021 17.44432 17.71525 18.12405 0 0 16.74181 0 17.48806 17.4243 0 0 0 0 0 16.54802 0 0 0 16.38182 0 0 18.20375 15.45909 0 0 16.45954 18.59297 0 0 17.48007 0 19.0038 0 0 0 0 16.67953 0 15.90407 0 0 0 0 0 Q8N8E3 CE112_HUMAN "Centrosomal protein of 112 kDa, Cep112 (Coiled-coil domain-containing protein 46)" CEP112 CCDC46 Homo sapiens (Human) receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120] GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120 ANSKLK 9.180000305 0.766512573 0.766512573 0.203170605 663.0381966 0 0 0 0 0 0 0 0 0 0 0 0 0 16.69461 0 0 0 0 16.63074 0 0 18.66876 19.09391 18.49784 14.91666 0 0 15.35977 15.06322 14.65786 0 0 0 17.53152 16.40411 15.71586 15.82245 0 0 15.6736 0 14.84309 16.11936 14.06017 0 17.49317 15.25458 17.55521 Q8N8H1 ZN321_HUMAN Putative protein ZNF321 (Zinc finger protein 321 pseudogene) ZNF321P ZNF321 Homo sapiens (Human) HESHHIR 8.800000191 1 1 0.2378926 914.9638405 0 0 0 0 0 0 0 16.2454 0 0 0 0 0 0 0 0 0 16.6539 0 0 0 0 0 0 0 0 0 0 0 15.83664 0 0 0 0 0 0 0 16.04697 13.19742 0 0 0 16.73186 0 0 16.44395 15.44744 0 Q8N8J0 PI4P1_HUMAN Putative inactive phosphatidylinositol 4-kinase alpha-like protein P1 PI4KAP1 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; phosphatidylinositol kinase activity [GO:0052742] GO:0004430; GO:0005737; GO:0005886; GO:0016020; GO:0046854; GO:0048015; GO:0052742 EQLVEENTGSLSGPAK 2.49000001 1 1 0.24341655 1658.047867 17.55539 13.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.22284 0 0 0 0 0 0 17.23074 17.73574 13.76509 18.47159 15.89484 0 16.07238 0 0 16.80368 0 15.94837 0 13.44095 0 0 0 0 0 0 0 0 0 0 Q8N8J6 ZN615_HUMAN Zinc finger protein 615 ZNF615 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 KNDLITHQR 3.819999933 1 1 0.147252316 1121.431505 13.06973 0 14.85135 0 15.00889 12.75274 0 0 0 0 0 0 0 0 0 15.59075 0 0 0 0 0 0 12.69102 14.42064 0 13.47819 0 0 14.95923 15.47592 14.58701 0 0 12.00361 16.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8K9 K1958_HUMAN Uncharacterized protein KIAA1958 KIAA1958 Homo sapiens (Human) YMYIHRPPTQMEAK 11.14000034 1 1 0.256539329 1766.150406 16.32113 0 0 0 0 0 0 0 13.00381 0 0 14.50703 0 0 0 0 0 15.19897 0 16.10292 16.90183 0 0 0 0 15.10382 0 0 0 0 0 0 0 0 14.79937 0 0 0 16.18478 16.99699 16.51145 16.50098 0 0 0 0 0 0 Q8N8L6 ARL10_HUMAN ADP-ribosylation factor-like protein 10 ARL10 ARL10A Homo sapiens (Human) GTP binding [GO:0005525]; GTPase activity [GO:0003924] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525 DPDLPVVVVANKQDLSEAMSMGELQR 5.090000153 1 1 0.18936985 2858.055442 0 0 16.40379 13.58833 0 13.42679 15.20509 14.70012 14.62202 15.75109 14.66195 15.09471 0 0 0 12.35031 0 0 0 0 0 0 0 0 0 16.34099 14.96486 0 13.21154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.44731 15.6767 0 16.97774 15.09993 Q8N8N0 RN152_HUMAN "E3 ubiquitin-protein ligase RNF152, EC 2.3.2.27 (RING finger protein 152) (RING-type E3 ubiquitin transferase RNF152)" RNF152 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567] integral component of organelle membrane [GO:0031301]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] integral component of organelle membrane [GO:0031301]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005764; GO:0005765; GO:0006915; GO:0010508; GO:0016567; GO:0031267; GO:0031301; GO:0034198; GO:0046872; GO:0061630; GO:0070534; GO:0070936; GO:1904262 LLPGSQQK 15.22999954 1 1 0.261082492 870.9972718 0 0 17.79234 0 0 0 0 0 0 0 0 16.72801 0 0 15.74893 0 0 0 18.84634 17.52502 0 0 0 0 0 17.39486 18.72407 0 17.20373 0 0 0 19.16525 19.76769 17.59419 0 18.94857 0 18.03501 18.24011 0 18.97963 0 18.45217 17.04643 19.9352 0 0 Q8N8P6 YX004_HUMAN Putative uncharacterized protein FLJ39060 Homo sapiens (Human) HSASVPMATGANGLETK 4.010000229 1 1 0.364124318 1687.694494 0 15.6392 0 0 0 0 15.36973 0 15.88413 0 0 0 0 0 16.73018 0 0 0 0 0 17.09798 17.24943 15.67692 0 17.58928 16.40161 0 15.9762 17.66408 0 16.62508 0 0 0 0 17.17813 17.33716 15.85273 15.297 16.64542 0 0 0 15.464 16.68142 0 0 0 Q8N8S7 ENAH_HUMAN Protein enabled homolog ENAH MENA Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411] cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411] actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699] GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358 QDILDEMR 6.539999962 0.274243206 0.274243206 0.259638867 1037.788355 16.84592 15.68206 15.7529 15.32092 14.95909 16.28994 0 0 0 17.16839 18.45204 16.57783 15.80112 0 0 15.85725 0 16.34309 0 14.37259 16.13617 16.00806 16.52879 15.44118 16.43213 0 0 15.7066 15.7531 16.17745 16.52207 16.13692 0 0 17.69555 17.60853 16.74692 16.62411 0 16.93566 16.50083 14.33901 0 0 0 0 16.755 0 Q8N8V4 ANS4B_HUMAN "Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein, Harp)" ANKS4B HARP Homo sapiens (Human) brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976] brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886] brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976] GO:0005789; GO:0005886; GO:0005902; GO:0005903; GO:0030154; GO:0034976; GO:0065003; GO:1904106; GO:1904970 GGDPDR 3.380000114 0.361933082 0.361933082 0.229044405 616.0951189 15.45292 15.70004 0 14.81024 15.37495 0 0 14.94673 14.9158 0 0 0 14.40507 16.06139 14.30449 0 0 0 0 0 0 15.74795 0 0 0 0 0 0 0 16.03363 0 0 0 0 0 0 0 0 0 15.15106 0 0 0 0 0 0 15.62605 0 Q8N8W4 PLPL1_HUMAN "Omega-hydroxyceramide transacylase, EC 2.3.1.296 (Patatin-like phospholipase domain-containing protein 1)" PNPLA1 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; omega-hydroxyceramide biosynthetic process [GO:0106342]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020] "cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; omega-hydroxyceramide transacylase activity [GO:0106341]; structural constituent of skin epidermis [GO:0030280]; triglyceride lipase activity [GO:0004806]; ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; omega-hydroxyceramide biosynthetic process [GO:0106342]; triglyceride catabolic process [GO:0019433]" "acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; omega-hydroxyceramide transacylase activity [GO:0106341]; structural constituent of skin epidermis [GO:0030280]; triglyceride lipase activity [GO:0004806]" GO:0004806; GO:0005737; GO:0005811; GO:0016020; GO:0016747; GO:0019433; GO:0030280; GO:0046513; GO:0055088; GO:0106341; GO:0106342 EWVPKGDGR 6.579999924 0.242534548 0.242534548 0.295043581 1043.624869 0 14.56387 15.92176 15.42098 15.55824 14.76877 0 15.59223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.96702 0 0 0 0 16.34806 15.64312 0 15.85684 0 0 0 16.89437 0 0 0 0 0 15.58168 0 0 0 0 0 0 0 Q8N8Y5 ZFP41_HUMAN "Zinc finger protein 41 homolog, Zfp-41" ZFP41 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0046872; GO:1990837 MEKPAGR 6.639999866 1.67E-07 1.67E-07 0.285302 787.5507143 18.09867 0 17.26708 17.46839 18.09389 0 0 0 0 0 17.84329 17.38244 17.47265 17.89414 18.03095 0 0 0 0 0 0 0 0 17.31655 18.01679 0 0 0 0 0 18.69037 0 0 18.63088 0 0 0 19.01643 18.48428 18.31625 0 0 0 0 0 0 0 0 Q8N8Z6 DCBD1_HUMAN "Discoidin, CUB and LCCL domain-containing protein 1" DCBLD1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GGGALARAAGR 1.669999957 1 1 0.103268653 956.2026904 16.16887 0 0 15.04757 15.81569 0 15.8306 0 16.14167 0 15.4414 0 15.7139 17.09914 14.56345 9.818698 15.33017 14.4483 16.42643 0 17.20442 17.25795 12.71364 15.85608 0 15.92105 15.53597 15.4174 13.54684 15.15381 13.76087 0 0 17.50278 15.0521 15.41383 17.8087 17.27729 0 13.57063 15.5143 0 15.28154 0 0 16.69281 15.91278 15.93706 Q8N907 DAND5_HUMAN "DAN domain family member 5 (Cerberus-like protein 2, Cerl-2) (Cysteine knot superfamily 1, BMP antagonist 3) (Gremlin-3)" DAND5 CER2 CKTSF1B3 GREM3 SP1 Homo sapiens (Human) atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; morphogen activity [GO:0016015]; atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281] morphogen activity [GO:0016015] GO:0003140; GO:0003281; GO:0003283; GO:0005576; GO:0005615; GO:0016015; GO:0023019; GO:0030512; GO:0030514; GO:0035582; GO:0038101; GO:0061371; GO:1900108; GO:1900176 ISTMLIEGCHCSPK 7.690000057 0.723415017 0.723415017 0.428342222 1648.372017 14.78301 15.31598 0 0 0 0 15.95724 0 15.44367 0 0 15.13599 0 0 0 15.79789 16.93157 0 0 0 0 0 0 0 16.59723 0 15.53212 17.0388 16.5262 15.80509 17.96345 16.59022 16.26197 16.40804 0 15.58922 16.30198 17.86193 17.04903 17.23908 0 17.58017 0 17.19492 16.93571 0 0 17.10514 Q8N944 AMER3_HUMAN "APC membrane recruitment protein 3, Amer3 (Protein FAM123C)" AMER3 FAM123C Homo sapiens (Human) regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] "plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]" "beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0005546; GO:0005886; GO:0008013; GO:0016055; GO:0060828 EPGPPGVLGCFR 1.909999967 1 1 0.195450978 1286.831365 0 0 14.5842 16.82375 15.8631 14.29665 13.87825 0 10.73962 13.90544 0 14.59366 13.66066 12.55565 0 0 0 0 0 0 14.06911 0 0 0 0 0 0 15.42282 14.91294 0 15.85071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.40392 0 Q8N954 GPT11_HUMAN G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75) GPATCH11 CCDC75 CENP-Y Homo sapiens (Human) kinetochore [GO:0000776] kinetochore [GO:0000776]; nucleic acid binding [GO:0003676] nucleic acid binding [GO:0003676] GO:0000776; GO:0003676 EEKQQEANLK 4.650000095 1 1 0.190512477 1215.689025 16.45748 10.80651 13.18409 11.74022 0 14.8104 14.4439 0 14.48461 14.76065 14.68444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N960 CE120_HUMAN "Centrosomal protein of 120 kDa, Cep120 (Coiled-coil domain-containing protein 100)" CEP120 CCDC100 Homo sapiens (Human) astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951] protein C-terminus binding [GO:0008022] GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951 DGKVPAILAGLDPR 20.57999992 0.104295909 0.104295909 0.26898378 1421.980091 18.77778 20.44656 18.87621 20.94823 19.60847 20.24682 18.98517 19.63457 19.86159 18.88795 18.60112 20.24727 0 20.38773 16.33706 20.09073 18.15942 18.67071 17.83606 0 0 0 18.37461 0 0 0 18.90889 0 0 17.77722 0 0 0 18.60762 0 20.16319 0 0 20.34228 0 19.98225 19.67495 19.55635 0 20.17068 0 0 0 Q8N961 ABTB2_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein 2 ABTB2 Homo sapiens (Human) cellular response to toxic substance [GO:0097237] protein heterodimerization activity [GO:0046982]; cellular response to toxic substance [GO:0097237] protein heterodimerization activity [GO:0046982] GO:0046982; GO:0097237 ALGVPWK 4.139999866 0.017711479 0.017711479 0.196462383 771.1996592 14.23342 15.46614 12.86566 15.69617 0 15.85169 0 15.51231 15.53497 0 0 0 16.35789 0 0 0 0 0 0 0 0 16.94942 0 0 0 0 0 15.63526 0 0 14.32458 15.22139 15.38675 0 0 17.29347 15.98155 16.45125 0 0 15.22316 0 0 18.03064 15.53478 0 0 0 Q8N966 ZDH22_HUMAN "Palmitoyltransferase ZDHHC22, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 22, DHHC-22, zDHHC22)" ZDHHC22 C14orf59 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] protein-cysteine S-palmitoyltransferase activity [GO:0019706] GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659 EDPAAAR 2.75 0.00901772 0.00901772 0.121238242 730.4214621 0 16.29153 0 13.88197 0 0 14.49041 16.38867 0 0 0 0 14.84921 0 13.76616 0 0 15.73862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N967 LRTM2_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 2 LRTM2 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965] heparin binding [GO:0008201]; Roundabout binding [GO:0048495] GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919; GO:0051965 HRPASVRR 6.570000172 1 1 5.78E-13 982.1392909 15.02755 0 14.02004 0 0 0 0 16.04074 11.11729 13.74435 0 0 14.23034 0 9.432412 0 0 0 0 0 0 13.99689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N998 CCD89_HUMAN Coiled-coil domain-containing protein 89 (Bc8 orange-interacting protein) CCDC89 BOIP Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 VLQLTVR 4.579999924 1 1 0.273721786 828.0908057 0 0 0 0 0 16.50406 0 0 0 0 0 0 0 0 17.85903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.70148 0 0 0 0 0 0 18.0376 0 0 0 0 0 0 Q8N999 CL029_HUMAN Uncharacterized protein C12orf29 C12orf29 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244 DIIFDV 11.27999973 0.591372252 0.591372252 0.24942126 721.7717096 17.3867 14.37946 16.08438 0 17.19331 15.18811 17.77852 17.63572 16.24837 18.37406 0 0 18.91131 17.53305 15.32365 15.91307 16.84809 17.77056 18.93358 20.06613 0 16.7019 0 0 18.38478 18.02645 0 18.23945 17.61672 15.42772 16.94201 16.87858 17.72594 17.19887 17.76847 18.69663 17.43501 18.34874 16.14814 0 19.29264 16.09815 16.08738 16.11449 18.62836 19.1908 18.80095 16.11626 Q8N9C0 IGS22_HUMAN "Immunoglobulin superfamily member 22, IgSF22" IGSF22 Homo sapiens (Human) AMPPPGLTTT 1.350000024 1 1 0.139399513 1000.491777 12.76388 13.65935 10.32025 0 10.94887 0 0 14.39584 0 0 0 0 0 0 12.93918 15.4359 0 0 0 15.983 16.18888 0 0 0 0 0 0 15.1286 15.15659 15.23117 16.44 0 15.30485 0 12.95277 0 0 15.21416 0 0 0 0 0 0 0 0 0 16.11746 Q8N9F7 GDPD1_HUMAN "Lysophospholipase D GDPD1, EC 3.1.4.- (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)" GDPD1 GDE4 Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081] GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291 LKEPHTMSR 2.440000057 1 1 0.067314134 1098.608876 13.37613 0 16.416 0 0 0 0 0 0 14.74324 0 0 14.57277 0 0 0 0 0 0 0 0 0 0 0 0 15.80766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38357 0 0 0 Q8N9F8 ZN454_HUMAN Zinc finger protein 454 ZNF454 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 VNSSLTEHQR 14.39999962 0.682106674 0.682106674 0.32651085 1168.774001 14.46173 15.12433 15.24751 0 14.59696 15.18802 0 16.1769 14.33006 14.80649 14.78848 0 0 0 13.63606 16.84313 16.16313 0 0 0 15.88373 15.66044 0 0 0 17.07262 0 14.65824 10.31189 16.35272 15.1084 0 0 0 0 0 17.60266 0 0 0 0 0 0 0 17.37413 0 0 17.65989 Q8N9H8 MUT7_HUMAN "Exonuclease mut-7 homolog, EC 3.1.-.- (Exonuclease 3'-5' domain-containing protein 3)" EXD3 HBE269 Homo sapiens (Human) 3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676] 3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676] GO:0003676; GO:0008408; GO:0046872 DMMKQLMWLSSHQEGPR 1.190000057 1 1 0.311203224 2090.816965 16.39706 0 13.12157 0 0 0 15.84905 0 14.60078 13.66986 0 16.59958 15.08394 15.27927 13.91895 14.63637 14.82759 0 0 0 0 0 0 0 0 0 0 0 0 14.78091 0 15.7716 0 0 0 0 8.953203 13.98779 0 0 13.16328 0 0 0 13.37041 0 0 0 Q8N9I0 SYT2_HUMAN "Synaptotagmin-2 (Synaptotagmin II, SytII)" SYT2 Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] "axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]" "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0042584; GO:0043533; GO:0048488; GO:0048791; GO:0070382; GO:0071277; GO:1903861 NEAIGKIFVGSNATGTELR 3.789999962 1 1 0.395628751 1976.945183 0 13.28478 0 14.66424 0 0 0 0 0 0 12.35499 14.76167 0 0 0 0 0 0 0 14.1003 0 0 0 0 0 0 15.82982 0 0 0 0 15.30035 0 0 0 0 0 0 0 0 0 0 14.63366 0 0 0 0 0 Q8N9L9 ACOT4_HUMAN "Peroxisomal succinyl-coenzyme A thioesterase, EC 3.1.2.3 (Acyl-coenzyme A thioesterase 4, Acyl-CoA thioesterase 4, EC 3.1.2.2) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib, PTE-Ib)" ACOT4 PTE2B PTEIB Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038] acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778] GO:0000038; GO:0001676; GO:0004778; GO:0005777; GO:0005782; GO:0005829; GO:0006104; GO:0006631; GO:0006633; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0044466; GO:0046459; GO:0047617; GO:0052689; GO:0102991 QSVRAGR 7.510000229 1 1 0.224524398 773.2520113 14.06519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3592 17.94965 0 0 0 16.14308 15.84687 0 0 16.6124 0 0 17.26361 17.22073 0 0 0 18.89433 17.55616 16.48475 16.34607 0 17.20442 16.2017 16.55694 17.56997 17.89931 15.17974 18.30956 Q8N9M5 TM102_HUMAN "Transmembrane protein 102 (Common beta-chain associated protein, CBAP)" TMEM102 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165] GO:0005739; GO:0005886; GO:0006915; GO:0007165; GO:0009986; GO:0010820; GO:0016021; GO:0032991; GO:0034097; GO:0042981; GO:0045785; GO:0050730; GO:1901028; GO:2000406 DFVFSLLGLVHR 5.829999924 1 1 0.334803931 1401.76966 16.66157 16.48205 15.50267 0 0 15.32996 0 0 14.92267 0 0 0 0 0 0 15.34741 0 15.62604 0 11.95551 16.61348 13.95606 0 17.1771 15.68172 0 15.8018 15.99184 0 16.24322 0 16.31955 15.19286 15.36493 15.68723 15.65741 12.67978 15.49309 13.78482 0 16.12873 0 0 15.90931 16.23992 16.21111 15.83534 16.01998 Q8N9N2 ASCC1_HUMAN Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) ASCC1 CGI-18 Homo sapiens (Human) "DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]" neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]" RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0006281; GO:0006355; GO:0016607; GO:0031594 VHMKDGSNR 2.74000001 1 1 0.180260426 1056.532553 16.18841 16.4435 16.50823 14.61322 11.19798 0 15.33502 15.99586 11.08527 16.64141 0 0 14.33344 0 0 0 13.31508 15.54157 0 14.61451 15.76692 0 14.49154 0 0 17.08615 15.56722 0 15.12755 16.72183 0 16.82661 0 0 0 15.4815 0 0 0 0 0 0 0 17.08439 0 15.99769 15.85023 0 Q8N9N5 BANP_HUMAN Protein BANP (BEN domain-containing protein 1) (Btg3-associated nuclear protein) (Scaffold/matrix-associated region-1-binding protein) BANP BEND1 SMAR1 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504] DNA binding [GO:0003677]; identical protein binding [GO:0042802] GO:0003677; GO:0005654; GO:0006325; GO:0007049; GO:0016604; GO:0034504; GO:0042177; GO:0042802 EVQAVSNLSGQGK 3.74000001 1 1 0.099149954 1315.6206 10.0843 0 0 0 12.60131 10.51083 0 0 11.61483 12.88702 0 0 0 12.21694 13.17851 12.34451 9.817026 0 14.76897 0 0 0 13.8667 0 15.15749 11.83956 12.26499 0 0 0 0 14.2281 0 15.08637 0 0 13.48298 0 0 0 0 0 12.80673 0 0 14.13947 0 0 Q8N9N7 LRC57_HUMAN Leucine-rich repeat-containing protein 57 LRRC57 Homo sapiens (Human) extracellular exosome [GO:0070062]; membrane [GO:0016020] extracellular exosome [GO:0070062]; membrane [GO:0016020] GO:0016020; GO:0070062 AHVETAQK 4.949999809 0.019140432 0.019140432 0.23364529 883.9783156 14.76923 0 14.76177 14.71072 0 13.16353 15.12532 13.90435 15.84103 14.85116 13.24848 14.04379 0 14.65785 11.29519 14.93016 15.13583 15.00961 15.36831 15.11209 15.51056 16.16312 16.44777 15.34176 16.30724 15.7827 13.31658 14.79336 14.26696 15.92191 15.76606 0 0 0 0 0 0 0 0 16.3123 0 0 15.45596 16.12396 0 13.16358 14.41446 0 Q8N9R6 CDRT4_HUMAN CMT1A duplicated region transcript 4 protein CDRT4 Homo sapiens (Human) KPMMRMLPTVR 6.929999828 1 1 0.477199957 1392.193586 17.74091 0 0 0 19.15492 0 0 0 0 0 0 18.59587 0 0 0 0 0 0 0 19.74281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9T8 KRI1_HUMAN Protein KRI1 homolog KRI1 Homo sapiens (Human) "endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]" 90S preribosome [GO:0030686]; nucleolus [GO:0005730] "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]" RNA binding [GO:0003723] GO:0000447; GO:0003723; GO:0005730; GO:0030686 QQGPKNSS 11.94999981 1 1 0.086095803 845.5163561 0 16.38761 0 0 0 0 0 0 0 0 0 0 0 0 15.90554 0 13.7746 0 0 15.75363 0 0 16.3134 0 0 0 17.12866 15.997 0 15.91354 0 0 16.33608 15.87211 0 15.86979 0 17.30842 15.98554 15.51259 15.18153 0 17.61185 0 0 0 0 0 Q8N9V3 WSDU1_HUMAN "WD repeat, SAM and U-box domain-containing protein 1" WDSUB1 WDSAM1 Homo sapiens (Human) ubiquitin-protein transferase activity [GO:0004842] ubiquitin-protein transferase activity [GO:0004842] GO:0004842 CLHSEK 2.980000019 1 1 1.18E-13 773.1124487 16.64347 17.40013 17.85337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9V7 TOPZ1_HUMAN Protein TOPAZ1 (Testis- and ovary-specific PAZ domain-containing protein 1) TOPAZ1 C3orf77 Homo sapiens (Human) apoptotic process [GO:0006915]; ncRNA transcription [GO:0098781]; positive regulation of meiotic cell cycle phase transition [GO:1901995]; spermatid development [GO:0007286]; spermatocyte division [GO:0048137] cytosol [GO:0005829] cytosol [GO:0005829]; apoptotic process [GO:0006915]; ncRNA transcription [GO:0098781]; positive regulation of meiotic cell cycle phase transition [GO:1901995]; spermatid development [GO:0007286]; spermatocyte division [GO:0048137] GO:0005829; GO:0006915; GO:0007286; GO:0048137; GO:0098781; GO:1901995 VDKGVLGR 5.119999886 1 1 0.259731487 844.3050677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.73471 0 0 0 0 0 0 Q8N9W4 GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 GOLGA6L2 Homo sapiens (Human) MWPQPHLPPHPMMSEKTR 2.650000095 0.071393877 0.071393877 0.490403314 2232.195395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.49565 0 0 0 0 0 0 0 0 0 20.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9W5 DAAF3_HUMAN Dynein axonemal assembly factor 3 DNAAF3 C19orf51 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458] dynein axonemal particle [GO:0120293] dynein axonemal particle [GO:0120293]; axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458] GO:0044458; GO:0070286; GO:0120293 HMLIFSLALEEPEK 4.730000019 1 1 0.372541242 1656.89092 0 15.64896 17.62985 0 15.21824 16.27705 18.73955 0 19.05157 17.42714 0 0 0 0 0 18.90648 17.53803 17.93559 0 17.09778 16.80336 17.68865 0 18.35422 0 0 0 0 0 15.68018 17.39151 18.63237 0 0 16.60783 0 0 0 0 17.14522 0 0 0 0 0 16.99303 17.04582 17.20742 Q8N9W7 YO010_HUMAN Putative transmembrane protein FLJ36131 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LSSLLTTTSYSVS 2.130000114 1 1 6.88E-13 1357.716132 0 0 0 10.18091 13.48369 0 0 12.32392 12.2933 0 0 0 0 0 0 10.6741 0 9.288009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0692 0 12.29533 0 13.19447 0 0 0 Q8N9W8 GAR2_HUMAN Golgi associated RAB2 interactor protein 2 GARIN2 C14orf54 FAM71D Homo sapiens (Human) flagellated sperm motility [GO:0030317] sperm midpiece [GO:0097225] sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317] GO:0030317; GO:0097225 GESIYLHNR 2.75999999 1 1 0.210580257 1088.536292 13.29778 12.09289 0 14.81723 13.38455 14.43448 12.9927 13.13043 14.10462 14.22571 14.0174 16.69895 14.33838 15.0191 0 14.70599 13.9199 13.82987 15.50288 0 11.3228 17.6943 15.90983 15.45507 0 0 14.7823 0 0 0 15.69777 15.45676 0 14.03235 0 0 15.50548 0 0 0 0 0 0 0 0 0 0 0 Q8N9Z2 CC71L_HUMAN Coiled-coil domain-containing protein 71L CCDC71L C7orf74 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; positive regulation of fat cell differentiation [GO:0045600] cellular lipid metabolic process [GO:0044255]; positive regulation of fat cell differentiation [GO:0045600] GO:0044255; GO:0045600 GGDFR 8.130000114 1 1 0.11653641 550.2055078 0 16.39676 15.21253 0 0 0 14.21827 0 0 13.92307 0 0 0 16.64421 0 0 13.60087 15.88901 16.24306 0 0 15.32313 0 0 15.87341 0 15.51863 0 0 0 0 16.168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NA03 FSIP1_HUMAN Fibrous sheath-interacting protein 1 FSIP1 HSD10 Homo sapiens (Human) ALTGHNMSEALVTEAENMK 1.470000029 1 1 0.11615255 2061.035178 12.24773 14.98641 0 0 0 0 0 0 13.45652 0 0 14.21285 0 14.66494 0 11.03454 0 0 0 0 0 0 0 0 0 0 0 0 14.28413 0 0 0 0 0 14.43818 0 0 14.06017 0 0 15.02042 13.66219 0 10.23367 15.60006 0 0 0 Q8NA31 TERB1_HUMAN Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79) TERB1 CCDC79 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] "chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]" "chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]" GO:0000781; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197 EIGGLMFVK 6.980000019 0.597271204 0.597271204 0.173212185 990.0153987 13.36375 14.16806 0 0 14.64177 19.20677 13.11785 0 0 0 0 0 0 0 0 0 14.9944 0 0 16.9256 15.67607 15.29912 0 17.44123 0 14.35982 0 0 0 0 15.26171 16.21957 13.76552 0 0 0 0 0 0 0 0 0 0 0 13.42683 0 0 0 Q8NA47 CCD63_HUMAN Coiled-coil domain-containing protein 63 CCDC63 Homo sapiens (Human) cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286] axoneme [GO:0005930] axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286] GO:0003341; GO:0005930; GO:0007286; GO:0036158 NYMELR 10.39000034 1 1 0.498863748 841.8710113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NA54 IQUB_HUMAN IQ and ubiquitin-like domain-containing protein IQUB Homo sapiens (Human) cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224] GO:0001669; GO:0007224; GO:0031514; GO:0060271 WKYHSDTTPK 4.25 1 1 0.270208887 1261.142974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.32602 14.89522 14.81607 0 15.48838 0 0 0 0 0 15.84757 0 0 0 0 0 0 16.26365 0 0 0 17.20929 0 0 15.32134 16.38491 16.39228 0 0 0 15.41647 0 16.31544 Q8NA57 CL050_HUMAN Uncharacterized protein C12orf50 C12orf50 Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973] mRNA binding [GO:0003729] GO:0003729; GO:0016973 EPKPNLSPDK 12.72999954 1 1 0.301567473 1123.98795 0 15.17297 15.0285 15.68951 15.546 15.16688 0 16.14531 14.50659 15.20206 0 13.435 0 0 0 15.60245 0 0 0 15.96606 0 0 0 15.72889 0 0 16.65886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95699 0 0 0 16.68027 0 0 Q8NA61 CBY2_HUMAN Protein chibby homolog 2 (Spermatid-associated protein) CBY2 SPERT Homo sapiens (Human) cytoplasmic vesicle [GO:0031410] cytoplasmic vesicle [GO:0031410]; identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0031410; GO:0042802 TLQVLRAEHR 3.650000095 1 1 0.22226131 1223.199601 15.80083 14.6815 11.72738 0 0 14.70811 0 0 0 0 0 0 0 0 0 15.81028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.10913 0 0 0 0 0 0 0 0 15.6014 0 0 0 0 0 0 0 15.78369 Q8NA69 TEX45_HUMAN Testis-expressed protein 45 TEX45 C19orf45 Homo sapiens (Human) LHEGTMR 1.539999962 0.252387404 0.252387404 0.223418893 844.3108937 0 0 0 17.29879 0 0 17.93107 0 0 0 0 0 0 16.9125 0 0 0 0 18.61971 0 0 18.36174 18.99623 0 0 0 0 17.31121 17.02307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.43843 17.64886 18.74377 0 Q8NA70 FA47B_HUMAN Protein FAM47B FAM47B Homo sapiens (Human) RAAPHSYSAQR 5.309999943 1 1 0.420278677 1244.414771 14.11737 13.70183 14.06952 12.71473 16.02678 13.19287 14.35934 12.33121 0 16.02431 12.24177 0 0 0 15.13461 17.0469 11.49808 16.41373 0 0 0 0 0 0 0 16.68603 0 0 0 0 0 0 0 0 0 0 0 16.94467 0 0 0 16.12463 0 0 0 0 16.99396 0 Q8NA72 POC5_HUMAN "Centrosomal protein POC5 (Protein of centriole 5, hPOC5)" POC5 C5orf37 Homo sapiens (Human) cell cycle [GO:0007049] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049] GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007049 AGRTITAR 3.859999895 0.835357547 0.835357547 0.263147946 846.7611633 0 16.75422 14.63421 0 14.46674 0 6.9701 14.47549 16.04112 0 0 0 0 15.63325 0 0 0 0 16.75727 0 0 0 0 0 15.86863 0 0 0 0 0 0 0 15.8392 0 0 0 0 0 0 0 0 16.13383 0 0 16.58696 0 0 0 Q8NA75 DC4L2_HUMAN DDB1- and CUL4-associated factor 4-like protein 2 (WD repeat-containing protein 21C) DCAF4L2 WDR21C Homo sapiens (Human) VGLNAPSMLR 9.069999695 1 1 0.306175158 1073.901132 14.78654 0 15.54516 13.26503 0 0 15.62351 14.63832 0 13.42653 15.28239 0 0 0 11.55577 14.39468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.07642 0 0 0 0 0 0 0 0 0 0 Q8NA82 MARHA_HUMAN "Probable E3 ubiquitin-protein ligase MARCHF10, EC 2.3.2.27 (Membrane-associated RING finger protein 10) (Membrane-associated RING-CH protein X, MARCH-X) (RING finger protein 190) (RING-type E3 ubiquitin transferase MARCHF10)" MARCHF10 MARCH10 RNF190 Homo sapiens (Human) protein ubiquitination [GO:0016567] transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] transferase activity [GO:0016740]; zinc ion binding [GO:0008270] GO:0008270; GO:0016567; GO:0016740 RPNQER 4.760000229 1 1 0.277036544 799.9328838 13.99271 0 0 0 0 0 0 0 14.97709 0 0 15.41058 17.94929 16.97105 15.26958 16.24714 0 15.23105 15.87223 0 16.69337 0 0 18.01551 14.67007 0 0 0 0 0 0 18.84679 0 0 16.24934 15.1089 13.79415 15.04394 0 0 19.94016 19.43026 0 14.97072 15.73813 16.0291 15.57708 0 Q8NAA5 LR75A_HUMAN Leucine-rich repeat-containing protein 75A (Leucine-rich repeat-containing protein FAM211A) LRRC75A C17orf76 FAM211A Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 GSLAERASPGAAPGPR 1.120000005 1 1 4.66E-13 1493.810807 0 0 0 0 0 0 16.72398 0 0 0 0 0 0 0 0 0 0 0 0 0 14.97284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAF0 ZN579_HUMAN Zinc finger protein 579 ZNF579 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]" GO:0000976; GO:0000981; GO:0003723; GO:0005634; GO:0006357; GO:0046872 ASGARNSAK 2.630000114 0.5444538 0.5444538 0.188548318 860.4952183 14.87033 13.32479 12.41462 13.35493 0 13.39665 15.46507 14.88203 14.9879 0 0 16.18354 14.94668 16.06724 17.31596 16.09241 16.21593 0 16.98503 16.76503 16.03967 17.26564 16.78432 16.9731 17.95951 16.75422 0 0 16.66725 16.23074 16.60534 17.89901 0 17.46968 17.25634 16.9833 16.98582 17.60569 16.08954 16.98803 16.95091 16.22053 18.02002 16.74724 14.93394 17.49201 15.75464 16.62302 Q8NAJ2 CI106_HUMAN Putative uncharacterized protein encoded by LINC02913 LINC02913 C9orf106 Homo sapiens (Human) ALMPGGHCPLCVPCKR 1.580000043 1 1 6.93E-13 1852.006072 15.33215 0 15.8111 0 0 0 0 15.69786 15.36313 0 0 0 0 0 0 0 0 0 0 0 0 0 15.45883 15.42637 0 15.98462 0 0 0 0 14.35117 0 0 0 0 11.86008 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAM6 ZSCA4_HUMAN Zinc finger and SCAN domain-containing protein 4 (Zinc finger protein 494) ZSCAN4 ZNF494 Homo sapiens (Human) negative regulation of mitotic recombination [GO:0045950]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833] "chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of mitotic recombination [GO:0045950]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000781; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010833; GO:0045950; GO:0046872; GO:1990837 VHQIIHTGK 6.429999828 1 1 0.104893456 1032.489923 0 0 0 0 0 14.72518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5901 0 16.28358 14.2361 0 12.28326 0 16.03441 0 0 0 13.4846 8.256381 14.79286 0 0 0 0 0 0 0 0 0 0 Q8NAN2 MIGA1_HUMAN Mitoguardin 1 (Protein FAM73A) MIGA1 FAM73A Homo sapiens (Human) mitochondrial fusion [GO:0008053] integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; mitochondrial fusion [GO:0008053] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0005739; GO:0005741; GO:0005887; GO:0008053; GO:0042803; GO:0046982 ILSALIVK 7.519999981 0.812632561 0.812632561 0.467319058 856.6155127 17.85473 0 0 18.30014 0 17.83738 0 0 0 19.45803 0 0 0 0 0 0 0 0 0 0 0 0 17.86113 0 0 17.76327 0 18.73843 18.31192 0 0 0 0 0 0 0 0 0 0 0 0 17.29427 0 0 0 0 18.5224 0 Q8NAP3 ZBT38_HUMAN Zinc finger and BTB domain-containing protein 38 ZBTB38 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of transcription, DNA-templated [GO:0006355]" blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0006355; GO:0006974; GO:0008327; GO:0042803; GO:0045892; GO:0045944; GO:0046872; GO:0072562 SYVTLSSLRR 4.860000134 1 1 0.130028311 1181.210458 15.27681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95435 15.01674 0 0 0 13.09511 0 0 0 16.81847 0 15.21332 16.3415 0 0 0 15.68716 0 0 0 17.75182 0 0 0 0 Q8NAT1 PMGT2_HUMAN "Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2, POMGnT2, EC 2.4.1.312 (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)" POMGNT2 AGO61 C3orf39 EOGTL GTDC2 Homo sapiens (Human) neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; protein O-GlcNAc transferase activity [GO:0097363]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; protein O-GlcNAc transferase activity [GO:0097363] GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0016021; GO:0016757; GO:0035269; GO:0097363 GRPGPR 1.159999967 0.261570424 0.261570424 0.097643716 638.521843 13.13924 0 12.34503 15.56174 0 0 14.73022 0 16.31117 0 15.89433 16.29353 12.99319 0 15.52745 15.31858 16.65215 10.73761 17.0394 0 15.11435 0 15.59478 15.97244 11.56912 14.30687 17.12564 11.91174 14.14787 0 11.85961 15.71983 16.9492 15.64273 17.91545 16.00686 15.36606 0 0 16.00695 16.14286 15.21046 10.04891 0 14.59891 13.7011 0 0 Q8NAT2 TDRD5_HUMAN Tudor domain-containing protein 5 TDRD5 TUDOR3 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; P granule [GO:0043186]; pi-body [GO:0071546] chromatoid body [GO:0033391]; P granule [GO:0043186]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0007283; GO:0007286; GO:0030719; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0071546 AGSLLMLKK 5.820000172 1 1 0.240662309 975.7433406 16.24417 0 0 0 13.68266 14.89711 15.79927 15.3238 0 0 0 0 0 0 0 0 15.59764 0 0 16.45878 15.06304 0 14.61792 16.17057 0 0 0 14.94119 0 0 0 15.39409 0 0 0 0 0 15.75173 15.12683 0 0 0 0 15.20598 0 15.07435 0 0 Q8NAV1 PR38A_HUMAN Pre-mRNA-splicing factor 38A PRPF38A Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0071005; GO:0071011 DLDKPRR 18.93000031 1 1 0.337335428 901.0020988 16.03812 15.63773 15.36709 17.29518 13.93114 14.01565 15.33992 14.08889 0 0 0 0 0 13.64298 16.05719 0 15.96399 15.47403 14.24752 15.16723 0 16.11549 15.8582 18.36436 0 16.14405 0 0 0 0 17.74262 0 0 0 0 0 0 0 0 15.17011 0 0 0 0 16.09289 0 0 0 Q8NAV2 CH058_HUMAN Uncharacterized protein C8orf58 C8orf58 Homo sapiens (Human) LPTAPTSLSGQHR 1.269999981 0.01669029 0.01669029 0.086429756 1365.633856 0 13.53261 13.23394 0 0 8.242704 0 10.59642 0 0 14.0119 13.9925 0 0 0 14.13652 0 13.46499 8.907818 14.70321 13.67983 15.44928 15.74722 0 15.82182 14.74625 15.15791 0 10.83864 0 0 15.9886 15.18902 16.23489 14.65512 16.25726 15.14805 0 0 15.00656 13.96828 8.637056 14.26293 9.893558 0 13.52726 14.07803 15.29724 Q8NB14 UBP38_HUMAN "Ubiquitin carboxyl-terminal hydrolase 38, EC 3.4.19.12 (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38)" USP38 KIAA1891 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579 RQVLSLNLNGCNSLMK 3.980000019 1 1 0.393620037 1846.02968 0 16.89694 16.32253 14.94793 16.11339 0 13.01864 15.69996 13.89067 17.70887 0 0 15.96054 11.66231 14.16738 0 15.22021 16.37479 0 15.97566 0 14.29648 0 0 0 0 16.47312 16.37292 14.925 17.46813 0 0 0 16.20782 16.32158 0 19.21119 0 0 0 0 0 0 16.0676 0 17.87839 13.58005 14.84863 Q8NB16 MLKL_HUMAN "Mixed lineage kinase domain-like protein, hMLKL" MLKL Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] GO:0004672; GO:0004706; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0019901; GO:0030054; GO:0042802; GO:0044877; GO:0051607; GO:0070207; GO:0070266; GO:0097527; GO:0097528 HIITLGQVIHKR 16.27000046 6.47E-05 6.47E-05 0.397734709 1414.014616 21.25636 22.72854 19.87634 0 0 0 20.22952 0 0 0 20.71379 19.69677 0 0 19.40286 21.27619 20.57525 20.80894 0 0 19.55734 0 20.93444 19.94204 0 0 21.60603 0 19.50533 20.65223 22.26306 22.38037 21.69942 22.34213 21.15059 0 20.07103 18.58255 21.74085 19.80852 0 0 21.23573 0 0 0 18.39968 0 Q8NB25 F184A_HUMAN Protein FAM184A FAM184A C6orf60 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 FELEDEGKAMLASLR 4.059999943 1 1 0.33614041 1725.243593 13.37678 0 0 0 0 15.10346 0 0 14.28954 0 14.76721 16.83293 0 13.24141 0 15.92682 0 14.64847 16.64179 0 0 0 0 16.27176 14.34737 11.29423 0 14.10751 14.42017 0 0 16.52386 15.29152 0 0 16.24031 0 0 16.43575 0 0 13.98854 0 15.08533 0 16.31772 16.34275 0 Q8NB46 ANR52_HUMAN "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C, PP6-ARS-C, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C (Ankyrin repeat domain-containing protein 52)" ANKRD52 Homo sapiens (Human) DVEEVRSLLSQK 17.04000092 1 1 0.594561963 1401.793286 0 19.61415 0 0 0 19.61329 20.11841 0 17.73759 17.96274 0 0 0 0 0 0 0 0 0 0 16.70225 0 0 0 0 0 0 0 17.28415 0 17.62146 0 0 0 0 19.74034 0 17.87537 0 0 0 0 20.14322 0 0 0 18.94154 0 Q8NB66 UN13C_HUMAN Protein unc-13 homolog C (Munc13-3) UNC13C Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] "calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075] GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007268; GO:0007528; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0048786; GO:0061789; GO:0098688; GO:0098831; GO:0099525 STQSLSGYEDSGSSLMGRFR 4.340000153 1 1 0 2180.768554 0 14.88008 16.73835 11.02352 12.62179 15.27371 0 0 0 14.70468 0 13.52529 14.63229 0 14.05604 0 10.86786 0 0 14.55843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB78 KDM1B_HUMAN "Lysine-specific histone demethylase 1B, EC 1.14.99.66 (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2)" KDM1B AOF1 C6orf193 LSD2 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genomic imprinting [GO:0006349] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genomic imprinting [GO:0006349] chromatin binding [GO:0003682]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] GO:0000122; GO:0000786; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0008270; GO:0016491; GO:0032452; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949; GO:0140682 AALSVHVPGMNR 3.779999971 0.843665242 0.843665242 0.316360291 1267.540638 16.47939 0 0 15.27087 0 0 0 0 0 16.32403 0 14.7531 0 0 0 16.80427 0 0 0 0 0 17.2704 0 0 0 0 0 0 0 0 0 0 0 17.08138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB90 AFG2H_HUMAN "ATPase family protein 2 homolog, EC 3.6.4.10 (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)" SPATA5 AFG2 SPAF Homo sapiens (Human) brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0007283; GO:0007420; GO:0016887; GO:0030154 IIYVPLPDAATR 5.809999943 1 1 4.57E-13 1329.876985 0 14.13896 14.26303 12.6347 0 0 14.26209 7.900814 14.04371 5.838625 16.26046 12.96381 0 0 0 13.80743 14.78291 14.47956 15.84763 15.79322 16.37941 16.96475 0 0 16.0651 0 15.97218 0 0 0 0 0 0 0 0 0 0 0 0 15.12568 0 16.31551 0 0 0 0 0 0 Q8NBB2 STAS1_HUMAN Putative uncharacterized protein ST20-AS1 (ST20 antisense RNA 1) (ST20 antisense gene protein 1) ST20-AS1 C15orf37 Homo sapiens (Human) PRPASESWSPIQSRIPAYK 1.529999971 1 1 0.203709226 2169.506573 16.262 15.50501 12.55872 11.98099 0 13.30359 0 14.90194 0 14.24092 0 0 0 0 0 11.92853 9.607883 0 0 0 0 0 0 0 0 15.12047 15.37184 10.48058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.51857 0 0 0 Q8NBI3 DRAXI_HUMAN Draxin (Dorsal inhibitory axon guidance protein) (Dorsal repulsive axon guidance protein) (Neucrin) DRAXIN C1orf187 PSEC0258 UNQ3119/PRO10268 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of neuron apoptotic process [GO:0043524]; Wnt signaling pathway [GO:0016055] extracellular region [GO:0005576] extracellular region [GO:0005576]; anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of neuron apoptotic process [GO:0043524]; Wnt signaling pathway [GO:0016055] GO:0005576; GO:0007411; GO:0016055; GO:0021516; GO:0021528; GO:0021960; GO:0030517; GO:0030900; GO:0043524; GO:0090090 ALVRGPSSLMK 2.00999999 1 1 0.292599963 1174.160254 0 0 0 0 0 0 0 0 0 0 15.37877 0 0 0 0 0 0 0 0 15.71831 15.9296 16.74082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.02695 0 0 0 0 15.44505 0 0 0 0 0 0 Q8NBI5 S43A3_HUMAN Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3) SLC43A3 ENBT1 PSEC0252 Homo sapiens (Human) hypoxanthine transport [GO:0035344] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910]; hypoxanthine transport [GO:0035344] adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0015207; GO:0015208; GO:0015245; GO:0016021; GO:0016323; GO:0035344; GO:0042910 LFGLVMALSAVVSLLQFPIFTLIK 6.039999962 1 1 0.335534611 2637.737304 0 0 14.08432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.34962 0 0 0 0 0 15.34825 0 12.52353 14.20416 16.33061 15.23349 0 15.0787 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBI6 XXLT1_HUMAN "Xyloside xylosyltransferase 1, EC 2.4.2.62 (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)" XXYLT1 C3orf21 PSEC0251 Homo sapiens (Human) O-glycan processing [GO:0016266] integral component of endoplasmic reticulum membrane [GO:0030176] "integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]; O-glycan processing [GO:0016266]" "magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]" GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252; GO:0140560 AMARLGAVR 4.639999866 1 1 0.255182344 958.7154601 14.08135 0 14.97775 13.41711 14.89487 15.22923 12.28786 14.05727 15.0603 12.07184 15.91905 0 14.82179 14.40003 14.35854 0 14.82063 0 0 12.32918 16.374 0 13.85935 0 15.42461 14.34429 15.66135 14.78609 16.6346 0 15.52784 15.98065 0 15.27693 14.84829 0 15.08188 16.31927 0 15.00126 0 16.33485 0 0 0 0 0 0 Q8NBJ4 GOLM1_HUMAN Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2) GOLM1 C9orf155 GOLPH2 PSEC0242 UNQ686/PRO1326 Homo sapiens (Human) nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216] GO:0005615; GO:0005788; GO:0005794; GO:0005887; GO:0006997; GO:0019216 AAAERGAVELK 5.909999847 1 1 0.101886347 1113.45334 13.83009 15.32337 0 0 0 13.4469 16.10779 16.15119 14.24913 13.49199 0 14.36711 0 0 9.775922 15.08213 0 0 14.08087 0 0 13.75045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBJ5 GT251_HUMAN "Procollagen galactosyltransferase 1, EC 2.4.1.50 (Collagen beta(1-O)galactosyltransferase 1, ColGalT 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1)" COLGALT1 GLT25D1 PSEC0241 Homo sapiens (Human) collagen fibril organization [GO:0030199]; positive regulation of collagen fibril organization [GO:1904028] endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020] endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; procollagen galactosyltransferase activity [GO:0050211]; collagen fibril organization [GO:0030199]; positive regulation of collagen fibril organization [GO:1904028] procollagen galactosyltransferase activity [GO:0050211] GO:0005788; GO:0016020; GO:0030199; GO:0050211; GO:1904028 LMNLMR 19.78000069 1 1 0.158576729 796.4936762 15.6695 14.5773 14.22289 0 14.8802 9.83789 14.00721 15.22244 14.58051 15.87475 8.534503 15.55185 0 0 16.25716 0 12.2777 15.68075 15.1256 15.444 0 0 0 15.76489 0 16.89592 14.34779 0 15.62233 0 0 0 16.2281 16.67161 0 15.68129 0 17.10403 0 0 0 0 0 0 0 0 15.56824 0 Q8NBL3 T178A_HUMAN Transmembrane protein 178A TMEM178A TMEM178 PSEC0131 UNQ5926/PRO19820 Homo sapiens (Human) negative regulation of osteoclast differentiation [GO:0045671]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; negative regulation of osteoclast differentiation [GO:0045671]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005789; GO:0016020; GO:0016021; GO:0045671; GO:0051480 DIDTLILK 3.920000076 1 1 0.041491696 930.6476824 17.67805 15.47618 0 0 0 0 0 0 0 0 0 0 0 0 17.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.69022 0 0 0 0 0 0 0 Q8NBM4 UBAC2_HUMAN "Ubiquitin-associated domain-containing protein 2, UBA domain-containing protein 2 (Phosphoglycerate dehydrogenase-like protein 1)" UBAC2 PHGDHL1 PSEC0110 Homo sapiens (Human) "negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]" GO:0005783; GO:0005789; GO:0016021; GO:0016055; GO:0070972; GO:0090090; GO:1904153 FTSTGSSGLYKAPLSK 4.099999905 0.068924062 0.068924062 0.134062825 1644.598512 0 14.34429 18.67327 16.5359 17.42454 13.64347 15.25307 17.71627 0 0 0 16.5378 0 17.9743 16.30917 16.77988 0 17.50589 16.72537 16.80523 16.28321 0 0 14.92642 0 16.97686 17.27968 9.620028 17.14562 0 13.01175 18.84443 17.96514 14.52392 15.84336 16.24505 0 17.30561 18.01022 16.94575 0 15.8511 16.65125 14.38779 17.81974 14.27656 0 14.03552 Q8NBM8 PCYXL_HUMAN "Prenylcysteine oxidase-like, EC 1.8.3.-" PCYOX1L PSEC0105 Homo sapiens (Human) prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] prenylcysteine oxidase activity [GO:0001735] GO:0001735; GO:0005576; GO:0016020; GO:0030327; GO:0030328; GO:0031093 LQMWVEEVMEKFMR 8.670000076 1 1 0.217839826 1871.466629 14.05733 0 0 0 14.93793 0 0 14.3618 0 0 0 9.970335 12.65893 0 0 15.23857 0 0 0 0 0 0 0 0 0 16.81297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53972 0 0 0 0 Q8NBN7 RDH13_HUMAN "Retinol dehydrogenase 13, EC 1.1.1.300 (Short chain dehydrogenase/reductase family 7C member 3)" RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430 Homo sapiens (Human) eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743] mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] NADP-retinol dehydrogenase activity [GO:0052650] GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 SRYLLPLSALGTVAGAAVLLK 8.699999809 1 1 0.191618992 2113.099838 15.47194 11.58941 13.37034 14.21459 12.53896 11.84888 0 12.40669 0 14.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.66357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBP0 TTC13_HUMAN "Tetratricopeptide repeat protein 13, TPR repeat protein 13" TTC13 PSEC0076 Homo sapiens (Human) AMGLAALEVMQAVQRTWTNSK 7.869999886 1 1 0.070896894 2338.304212 12.73272 0 0 12.86629 0 0 0 11.52214 12.63954 13.24878 13.82598 9.426271 11.89346 0 0 9.490721 15.15974 0 0 0 0 15.31971 0 14.60607 12.00378 0 0 14.3275 0 0 0 11.90215 11.02676 13.96667 0 0 0 0 15.50641 0 0 0 0 0 0 0 0 0 Q8NBP5 MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 MELGGHWDMNSAPR 10.68999958 1 1 9.22E-13 1633.818641 0 0 0 0 8.512427 0 0 0 0 0 13.79948 13.3985 0 0 0 14.81383 0 0 0 0 0 0 0 0 13.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 15.29875 0 0 0 0 0 0 0 0 0 Q8NBP7 PCSK9_HUMAN "Proprotein convertase subtilisin/kexin type 9, EC 3.4.21.- (Neural apoptosis-regulated convertase 1, NARC-1) (Proprotein convertase 9, PC9) (Subtilisin/kexin-like protease PC9)" PCSK9 NARC1 PSEC0052 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor recycling [GO:0001920]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641] cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor recycling [GO:0001920]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641] apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326] GO:0001822; GO:0001889; GO:0001920; GO:0002091; GO:0002092; GO:0003723; GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005791; GO:0005794; GO:0005886; GO:0006641; GO:0006644; GO:0006915; GO:0007041; GO:0008203; GO:0009267; GO:0009986; GO:0010469; GO:0010989; GO:0016540; GO:0019871; GO:0022008; GO:0030134; GO:0030169; GO:0030182; GO:0030547; GO:0031232; GO:0032802; GO:0032805; GO:0032869; GO:0034185; GO:0034189; GO:0034190; GO:0036020; GO:0042157; GO:0042632; GO:0043523; GO:0043525; GO:0043621; GO:0048471; GO:0050750; GO:0070326; GO:1905596; GO:1905598; GO:1905601; GO:1990666; GO:1990667; GO:2000650 MEAQGGKLVCR 8.140000343 1 1 0.539793045 1263.255356 0 0 0 0 18.80409 18.32131 0 19.25282 0 0 0 0 0 0 18.97446 0 0 0 0 0 0 0 0 18.62116 0 0 0 0 0 0 0 0 0 0 0 17.77853 0 0 0 0 18.15482 17.3075 0 18.9959 0 0 0 0 Q8NBR0 P5I13_HUMAN Tumor protein p53-inducible protein 13 (Damage-stimulated cytoplasmic protein 1) TP53I13 DSCP1 Homo sapiens (Human) negative regulation of cell cycle [GO:0045786]; response to organic cyclic compound [GO:0014070]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell cycle [GO:0045786]; response to organic cyclic compound [GO:0014070]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410] GO:0005737; GO:0005886; GO:0009410; GO:0009411; GO:0014070; GO:0016021; GO:0045786 QPSSSGAK 10.07999992 0.829382658 0.829382658 0.278700732 761.7520883 14.63832 15.98825 0 15.03956 15.43908 15.4346 0 15.85285 16.29516 0 0 15.27683 16.42468 15.71701 0 16.4716 0 0 16.17839 17.75068 16.54172 14.40893 16.05953 0 17.49521 16.05703 16.06124 15.64986 16.15333 16.55886 16.79189 16.80276 17.12529 16.93789 16.80349 16.12735 16.63474 17.24249 16.38902 17.03518 16.07505 15.81827 16.39731 17.55134 15.15748 17.333 17.19513 16.64664 Q8NBS3 S4A11_HUMAN "Solute carrier family 4 member 11 (Sodium borate cotransporter 1, NaBC1)" SLC4A11 BTR1 Homo sapiens (Human) bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; proton transmembrane transporter activity [GO:0015078]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; water transmembrane transporter activity [GO:0005372]; bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085] active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; proton transmembrane transporter activity [GO:0015078]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; water transmembrane transporter activity [GO:0005372] GO:0005272; GO:0005372; GO:0005452; GO:0005886; GO:0006814; GO:0012506; GO:0015078; GO:0015106; GO:0015252; GO:0015293; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0030003; GO:0034599; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0050801; GO:0051881; GO:0055085; GO:0071476; GO:1902600; GO:2000739 MAAATR 3.839999914 0.959017634 0.959017634 0.256169537 636.7684362 0 0 0 0 0 0 18.937 0 17.65919 17.05723 18.38239 19.35918 0 18.34732 0 0 0 0 15.76084 0 0 16.22628 17.65117 0 0 0 0 0 0 0 0 19.28638 0 0 0 0 17.74806 0 0 0 0 0 0 0 0 19.42176 0 0 Q8NBS9 TXND5_HUMAN "Thioredoxin domain-containing protein 5, EC 1.8.4.-, EC 5.3.4.1 (Endoplasmic reticulum resident protein 46, ER protein 46, ERp46) (Thioredoxin-like protein p46)" TXNDC5 TLP46 UNQ364/PRO700 Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0015035; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0070062 FVLSQAKDEL 6.980000019 1 1 0.093506112 1149.238963 0 0 14.53681 16.32895 12.86337 0 9.721788 14.4909 12.22493 16.10906 0 0 0 0 0 0 0 0 0 14.17137 0 0 0 0 13.94171 12.55267 0 0 11.96304 13.89318 0 0 0 0 0 0 0 0 0 0 17.34521 14.35234 0 0 0 0 0 0 Q8NBU5 ATAD1_HUMAN "Outer mitochondrial transmembrane helix translocase, EC 7.4.2.- (ATPase family AAA domain-containing protein 1, hATAD1) (Thorase)" ATAD1 FNP001 Homo sapiens (Human) "extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]" cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211] "cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; transmembrane protein dislocase activity [GO:0140567]; extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; transmembrane protein dislocase activity [GO:0140567] GO:0002092; GO:0005524; GO:0005741; GO:0005778; GO:0005829; GO:0007612; GO:0007613; GO:0016020; GO:0016021; GO:0016887; GO:0045211; GO:0051967; GO:0140567; GO:0140570 QAEKLMK 22.37000084 1 1 0.275494471 847.247809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.81076 0 0 0 0 0 0 Q8NBV4 PLPP7_HUMAN Inactive phospholipid phosphatase 7 (Phosphatidic acid phosphatase type 2 domain-containing protein 3) PLPP7 C9orf67 PPAPDC3 Homo sapiens (Human) negative regulation of myotube differentiation [GO:0010832] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; negative regulation of myotube differentiation [GO:0010832] sphingosine-1-phosphate phosphatase activity [GO:0042392] GO:0005635; GO:0005789; GO:0010832; GO:0016020; GO:0016021; GO:0042392 GGPEPR 3.150000095 1 1 0.074159011 611.3600504 13.83513 11.77972 14.43882 12.47732 14.99477 13.90087 12.65873 15.59084 15.20365 15.66682 16.29104 14.17135 15.26156 0 0 15.40173 0 15.48405 0 15.14859 0 16.11488 0 0 0 0 0 15.98136 0 15.3686 0 0 0 0 0 0 15.90159 13.08243 0 14.19909 15.83526 16.41382 0 0 0 0 0 0 Q8NBZ0 IN80E_HUMAN INO80 complex subunit E (Coiled-coil domain-containing protein 95) INO80E CCDC95 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 NGPADGEVDYK 7.199999809 1 1 0.072509313 1163.04429 14.17182 16.12729 9.780681 13.42592 13.14022 0 0 0 0 0 15.70893 11.32236 0 0 12.10273 0 0 0 0 0 0 0 15.78854 0 0 14.634 0 15.03513 0 14.89046 0 0 0 0 0 0 12.27989 0 0 0 0 0 0 0 0 0 0 0 Q8NBZ9 NEAS1_HUMAN Putative uncharacterized protein NEXN-AS1 (NEXN antisense RNA 1) NEXN-AS1 C1orf118 Homo sapiens (Human) QGSPGPGPAR 5.559999943 1 1 0.189247019 922.8689521 14.79727 16.29256 15.01698 15.79171 15.08589 15.06056 0 0 0 0 18.58444 0 0 0 0 15.59359 15.28636 0 0 0 15.61053 0 15.47064 0 16.58877 0 0 0 0 0 0 0 0 16.01336 17.68802 0 0 17.52935 0 0 15.18334 0 0 0 0 0 0 0 Q8NC01 CLC1A_HUMAN "C-type lectin domain family 1 member A (C-type lectin-like receptor 1, CLEC-1)" CLEC1A CLEC1 UNQ569/PRO1131 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952] integral component of plasma membrane [GO:0005887]; intracellular anatomical structure [GO:0005622] integral component of plasma membrane [GO:0005887]; intracellular anatomical structure [GO:0005622]; carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952] carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005622; GO:0005887; GO:0006952; GO:0007166; GO:0030246 RAGMVKPESLHVPPETLGEGD 8.039999962 1 1 0.168702783 2218.952363 0 14.76126 12.50623 0 5.327851 15.09223 0 13.5075 15.69827 0 0 11.73211 16.02572 13.72513 0 14.05106 14.38686 14.35665 0 15.59949 16.50155 0 0 0 0 0 0 0 18.78771 16.41059 18.10768 18.38273 17.53077 18.80124 0 0 0 15.72333 0 0 15.95388 0 0 0 16.23361 15.43505 0 16.02764 Q8NC26 ZN114_HUMAN Zinc finger protein 114 ZNF114 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" extracellular exosome [GO:0070062]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0042802; GO:0046872; GO:0070062 TFPEANR 5.610000134 0.016497718 0.016497718 0.226482001 834.6724967 0 16.07333 12.05143 0 0 12.34142 14.87105 14.89549 14.27791 14.79778 0 15.78189 11.1538 0 15.23069 0 15.54656 16.2221 0 16.27827 0 0 0 0 0 0 0 15.18407 0 0 0 0 0 0 0 0 16.91904 0 15.68757 0 0 0 14.98635 0 0 0 0 0 Q8NC51 PAIRB_HUMAN "Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1, PAI-RBP1) (SERPINE1 mRNA-binding protein 1)" SERBP1 PAIRBP1 CGI-55 Homo sapiens (Human) PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488] cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183] GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0070062 EEGPK 4.320000172 1 1 0.233740949 559.8320901 0 0 0 0 0 0 0 0 0 0 0 0 16.63923 15.48681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.77958 14.83443 0 16.70374 0 0 0 0 0 Q8NC56 LEMD2_HUMAN "LEM domain-containing protein 2, hLEM2" LEMD2 Homo sapiens (Human) heart formation [GO:0060914]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914] integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; chromatin DNA binding [GO:0031490]; heart formation [GO:0060914]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914] chromatin DNA binding [GO:0031490] GO:0005635; GO:0005637; GO:0005639; GO:0006998; GO:0016020; GO:0016021; GO:0022008; GO:0030514; GO:0031490; GO:0031965; GO:0035914; GO:0043409; GO:0051898; GO:0060914; GO:0071168 ARPAAASPR 1.409999967 1 1 0.130229392 896.7605426 16.90845 0 0 0 14.5825 0 0 0 17.81216 15.72495 19.19844 0 0 0 0 0 0 15.33008 0 0 17.16319 0 0 15.58838 0 0 0 0 0 0 0 0 0 19.41256 0 18.39983 0 16.43467 17.64539 0 0 0 0 0 15.0667 0 0 0 Q8NC67 NETO2_HUMAN Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) NETO2 BTCL2 UNQ1926/PRO4401 Homo sapiens (Human) regulation of kainate selective glutamate receptor activity [GO:2000312] integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069] integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; ionotropic glutamate receptor binding [GO:0035255]; regulation of kainate selective glutamate receptor activity [GO:2000312] ionotropic glutamate receptor binding [GO:0035255] GO:0014069; GO:0016021; GO:0035255; GO:2000312 AKFCSTVANDVMLK 7.679999828 1 1 0.201144646 1599.763813 0 0 0 15.91277 0 6.512053 0 0 13.36625 12.96662 0 13.78736 0 0 0 0 0 0 0 0 15.41398 0 0 0 9.260201 14.43004 16.87201 0 15.7019 0 0 0 0 0 0 0 15.02267 0 0 0 15.14014 0 0 0 0 0 13.46569 0 Q8NC74 RB8NL_HUMAN RBBP8 N-terminal-like protein RBBP8NL C20orf151 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ASRPSAMTHEAPK 5.739999771 1 1 0.477116631 1381.123245 15.69918 15.27976 14.59294 0 0 11.63343 0 14.97093 0 0 0 15.41621 0 15.51916 13.71263 0 0 0 0 0 0 0 15.70317 0 0 0 0 0 0 0 15.59569 0 0 0 0 0 15.93741 0 0 0 0 0 15.07764 0 0 0 0 0 Q8NCD3 HJURP_HUMAN Holliday junction recognition protein (14-3-3-associated AKT substrate) (Fetal liver-expressing gene 1 protein) (Up-regulated in lung cancer 9) HJURP FAKTS FLEG1 URLC9 Homo sapiens (Human) cell cycle [GO:0007049]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254] "chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254]" DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802] GO:0000775; GO:0000776; GO:0003677; GO:0005654; GO:0005730; GO:0005739; GO:0007049; GO:0007059; GO:0034080; GO:0042393; GO:0042802; GO:0043254; GO:0051101 RLSLPSSK 4.050000191 1 1 0.165342216 887.7015965 0 0 15.71901 0 0 0 0 0 0 0 15.96914 14.46059 0 0 0 0 16.84395 15.84171 0 0 0 15.76873 0 14.97352 0 0 14.22807 0 0 16.33453 16.56549 15.29098 17.19196 16.08927 14.57304 15.88104 16.66679 15.98488 16.2877 16.7865 17.16953 15.1523 15.38439 16.96929 14.145 15.65361 0 0 Q8NCE0 SEN2_HUMAN "tRNA-splicing endonuclease subunit Sen2, EC 4.6.1.16 (tRNA-intron endonuclease Sen2, HsSen2)" TSEN2 SEN2 Homo sapiens (Human) "mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" centrosome [GO:0005813]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] "centrosome [GO:0005813]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213] GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006388; GO:0006397; GO:0016829 ELMLCYLIKPSTMTDKEMESPECMK 5.059999943 0.468453676 0.468453676 0.149153146 3096.164368 14.48787 15.57204 14.148 16.4319 15.61338 16.28002 13.6446 0 14.57256 14.20956 0 14.75267 16.68514 0 0 14.18793 0 0 8.616723 0 0 0 15.84044 0 12.33528 0 15.55368 0 0 0 0 0 0 0 0 0 13.2703 0 0 0 15.07989 0 0 0 0 0 0 0 Q8NCF5 NF2IP_HUMAN "NFATC2-interacting protein (45 kDa NF-AT-interacting protein, 45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein)" NFATC2IP NIP45 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005634; GO:0005737; GO:0045944 GRWSGGSGAGR 8.210000038 1 1 0.076745636 1046.591499 14.6133 14.89587 0 0 0 0 0 0 0 0 13.31084 0 0 0 0 0 0 0 14.77987 0 0 0 14.65139 0 0 0 15.13644 0 0 0 15.91717 0 0 0 14.68307 0 12.67026 0 0 0 13.53881 0 0 0 0 0 0 0 Q8NCH0 CHSTE_HUMAN "Carbohydrate sulfotransferase 14, EC 2.8.2.35 (Dermatan 4-sulfotransferase 1, D4ST-1, hD4ST1)" CHST14 D4ST1 UNQ1925/PRO4400 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655] N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062 DPWDLPVGQR 4.539999962 0.252966404 0.252966404 0.041813463 1182.746061 14.9158 0 17.74426 0 4.520619 15.78047 13.36515 0 0 0 0 0 0 0 0 0 0 0 14.23013 0 13.78765 0 9.683378 16.75773 0 0 14.66479 18.48545 16.357 0 13.96893 15.22858 0 12.37493 16.21254 0 16.23035 0 0 0 17.1701 15.6847 0 0 0 0 17.22438 15.50855 Q8NCI6 GLBL3_HUMAN "Beta-galactosidase-1-like protein 3, EC 3.2.1.-" GLB1L3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] vacuole [GO:0005773] vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975] beta-galactosidase activity [GO:0004565] GO:0004565; GO:0005773; GO:0005975 MMSGSDIK 2.690000057 1 1 0.226214488 868.0240211 0 0 0 0 7.797433 0 15.46832 0 14.31986 0 15.90699 14.6699 0 0 0 15.55761 0 0 0 0 0 0 0 0 0 16.2814 0 17.30631 0 14.37293 0 0 0 0 0 0 0 0 0 0 0 14.98065 15.41826 0 0 0 17.79751 0 Q8NCJ5 SPRY3_HUMAN SPRY domain-containing protein 3 SPRYD3 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010] GO:0005737; GO:0007010; GO:0007166 EDDSVMMVDSYEDEWGR 6.730000019 1 1 0.285423998 2079.069759 13.45186 17.17576 0 0 0 0 0 14.53838 15.55541 0 0 14.32346 0 0 0 0 14.80673 0 0 0 15.2035 12.26429 0 0 0 7.544382 0 13.77569 0 0 0 0 0 11.3244 0 0 0 12.04058 13.22606 13.41605 0 15.05086 0 0 0 0 0 0 Q8NCM8 DYHC2_HUMAN "Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11, hDHC11) (Dynein heavy chain isotype 1B)" DYNC2H1 DHC1B DHC2 DNCH2 DYH1B KIAA1997 Homo sapiens (Human) cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; kidney development [GO:0001822]; microtubule-based movement [GO:0007018]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522] apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; kidney development [GO:0001822]; microtubule-based movement [GO:0007018]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522] ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0001822; GO:0003774; GO:0005524; GO:0005794; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007018; GO:0007030; GO:0007368; GO:0008569; GO:0009953; GO:0016485; GO:0021522; GO:0030286; GO:0030326; GO:0030900; GO:0031514; GO:0035721; GO:0045177; GO:0045505; GO:0045880; GO:0051959; GO:0060271; GO:0060976; GO:0061512; GO:0070062; GO:0097542; GO:1905515 ADSQQK 2.529999971 0.395219415 0.395219415 0.140203899 677.5508567 19.18733 18.59005 0 17.36237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.39044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCN2 ZBT34_HUMAN Zinc finger and BTB domain-containing protein 34 ZBTB34 KIAA1993 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0006357; GO:0046872 LCDIIVHIQGQPFRAHK 4.760000229 1 1 0.132791905 2031.018154 14.93995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.98184 18.02279 0 0 0 0 0 0 0 16.33967 0 0 0 0 14.20284 0 16.50234 0 0 0 0 0 0 0 0 0 Q8NCN5 PDPR_HUMAN "Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial, PDPr" PDPR KIAA1990 Homo sapiens (Human) positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253]; oxidoreductase activity [GO:0016491]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] oxidoreductase activity [GO:0016491] GO:0005737; GO:0005739; GO:0005759; GO:0006470; GO:0016491; GO:0045253; GO:1904184 GQVTGVETDK 1.720000029 1 1 0.118560528 1034.478869 15.72571 13.87054 15.11148 14.24616 0 0 13.84733 0 0 0 0 0 15.22629 0 0 0 15.96731 0 14.57053 14.53196 0 15.26401 0 13.68699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCP5 ZBT44_HUMAN Zinc finger and BTB domain-containing protein 44 (BTB/POZ domain-containing protein 15) (Zinc finger protein 851) ZBTB44 BTBD15 ZNF851 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 VQDKIFR 26 1 1 0.537421559 905.3895803 0 0 0 0 18.09468 0 0 0 0 0 18.32818 0 0 0 0 18.38516 0 0 0 0 0 0 0 0 18.63576 0 0 17.8587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.74921 0 0 0 0 0 Q8NCQ3 NC301_HUMAN Putative uncharacterized protein encoded by LINC00301 LINC00301 C11orf64 NCRNA00301 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ELQLLVR 8.520000458 0.714058995 0.714058995 0.275702308 869.8429456 0 18.34459 16.63148 0 17.24977 0 16.60092 19.18727 18.92255 0 0 0 0 0 18.17782 0 0 0 16.12918 0 0 0 0 0 19.13181 16.68657 0 0 0 0 19.2217 0 0 0 19.19495 19.92804 19.40797 18.79422 0 0 0 0 0 0 0 0 18.32154 0 Q8NCQ5 FBX15_HUMAN F-box only protein 15 FBXO15 FBX15 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 GGGAAR 1.629999995 0.0259117 0.0259117 0.272458713 486.8718696 15.49008 16.33393 15.88882 15.16634 16.34266 16.09096 15.42902 16.21174 0 15.88975 15.42431 0 0 0 0 15.97435 15.67464 0 0 15.9275 0 18.52556 18.32357 16.43356 0 0 0 0 0 16.06966 16.15005 16.43849 16.59601 0 16.50854 14.27154 15.94393 13.79624 15.6662 16.4423 16.8039 15.43817 0 15.66025 0 14.99583 0 0 Q8NCQ7 PRCA1_HUMAN Protein PROCA1 (Protein interacting with cyclin A1) PROCA1 Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; phospholipid metabolic process [GO:0006644] cyclin binding [GO:0030332]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; phospholipid metabolic process [GO:0006644] cyclin binding [GO:0030332]; phospholipase A2 activity [GO:0004623] GO:0004623; GO:0006644; GO:0030332; GO:0050482 GHLLAGVASSTDVSTFSEGGDCK 5.559999943 1 1 0.513447765 2295.074077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.98793 15.94448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCR6 SMRP1_HUMAN Spermatid-specific manchette-related protein 1 (Ciliated bronchial epithelial protein 1) (Testis development protein NYD-SP22) SMRP1 C9orf24 CBE1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; manchette [GO:0002177]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; manchette [GO:0002177]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] alpha-tubulin binding [GO:0043014] GO:0002177; GO:0005634; GO:0005654; GO:0005829; GO:0007283; GO:0030154; GO:0043014; GO:0048471 METAVRGMPLECPPRPER 2.559999943 1 1 3.65E-12 2140.958462 14.76821 0 0 0 12.91543 11.42295 14.92488 14.22894 0 9.191272 0 11.54147 13.58279 16.58951 13.76858 0 0 13.60585 14.30809 0 15.00682 0 0 0 15.30712 13.9713 11.36834 13.5327 13.72345 0 0 0 0 0 0 0 13.69345 14.4576 0 0 14.25618 0 0 12.61125 13.16867 0 14.88626 14.43702 Q8NCU1 CC197_HUMAN Uncharacterized protein CCDC197 (Coiled-coil domain-containing protein 197) CCDC197 C14orf48 LINC00521 Homo sapiens (Human) AAMDTGQRADPSNPGDK 9.640000343 0.733387411 0.733387411 0.571253007 1730.289692 0 0 0 17.98589 19.57555 19.65829 0 0 20.03675 0 19.42155 0 0 18.54688 0 0 18.69706 17.90925 0 19.4887 0 0 0 19.54136 20.13625 0 0 0 0 0 0 0 0 17.71363 0 0 19.90048 20.53144 0 0 0 20.43722 19.50298 0 19.88704 19.80473 0 0 Q8NCU4 CC191_HUMAN Coiled-coil domain-containing protein 191 CCDC191 KIAA1407 Homo sapiens (Human) ILAEKK 17.87000084 1 1 0.138849891 703.3328152 17.03198 0 0 0 15.45343 0 0 0 0 0 0 13.97481 0 14.36525 0 0 0 0 14.2852 0 15.52023 14.61712 0 0 14.80278 0 15.4205 15.29564 0 15.36673 15.36851 13.23302 14.63569 14.54209 11.87401 14.50775 0 0 0 17.72402 0 14.85311 0 0 0 0 0 0 Q8NCX0 CC150_HUMAN Coiled-coil domain-containing protein 150 CCDC150 Homo sapiens (Human) ALDEANFR 4.739999771 0.800928056 0.800928056 0.225619047 935.817036 0 0 15.7662 0 14.79958 0 0 14.75755 14.01769 0 0 15.58083 0 13.89499 0 14.70277 0 14.35444 15.896 0 14.29858 15.76605 0 16.75823 15.87747 11.28845 14.11758 10.00666 14.97355 0 15.04822 0 14.01291 14.67568 0 0 0 14.9732 16.39521 14.6137 14.63532 16.14076 0 15.26932 14.46329 14.72086 14.86018 13.0437 Q8ND04 SMG8_HUMAN Nonsense-mediated mRNA decay factor SMG8 (Amplified in breast cancer gene 2 protein) (Protein smg-8 homolog) SMG8 ABC2 C17orf71 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]" cytosol [GO:0005829] "cytosol [GO:0005829]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]" GO:0000184; GO:0005829; GO:0045859 FMCSGPDKVMK 4.690000057 1 1 0.084982663 1315.519237 14.35747 15.4143 13.1046 10.57537 0 14.91478 0 0 0 0 0 10.39951 0 0 0 0 0 0 0 13.6253 0 0 0 0 0 0 16.03646 13.21946 0 15.56156 14.69445 0 0 0 0 0 0 0 0 0 15.30449 0 0 0 0 0 13.41572 14.36034 Q8ND23 CARL3_HUMAN "Capping protein, Arp2/3 and myosin-I linker protein 3 (Capping protein regulator and myosin 1 linker protein 3) (Leucine-rich repeat-containing protein 16B)" CARMIL3 C14orf121 LRRC16B Homo sapiens (Human) cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] GO:0005737; GO:0005886 LCPLEPVQDELLYAR 6.789999962 1 1 0.043361516 1816.412435 14.99181 12.13362 0 13.21644 0 14.13494 0 15.6227 0 14.56677 12.80278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41535 0 0 0 0 0 0 16.14483 14.44176 0 0 0 0 0 0 0 Q8ND24 RN214_HUMAN RING finger protein 214 RNF214 Homo sapiens (Human) metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0046872 AQMTNILQQIK 10.27000046 1 1 0.247452815 1286.612164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53818 0 17.55572 0 0 0 0 0 0 0 0 0 0 0 0 0 16.55142 Q8ND30 LIPB2_HUMAN "Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2, PTPRF-interacting protein-binding protein 2)" PPFIBP2 Homo sapiens (Human) neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786] cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786]; identical protein binding [GO:0042802]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] identical protein binding [GO:0042802] GO:0005615; GO:0005829; GO:0007528; GO:0042802; GO:0048786; GO:0050808 SPPTICQPDATGSSLLRLR 2.430000067 1 1 0.210343137 2068.052066 9.730255 13.06931 0 10.79053 0 0 0 14.49599 11.66544 13.2289 0 0 0 0 12.78521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.20854 0 0 0 16.35465 15.68801 0 0 0 0 Q8ND56 LS14A_HUMAN "Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein, AlphaSNBP) (RNA-associated protein 55A, hRAP55, hRAP55A)" LSM14A C19orf13 FAM61A RAP55 RAP55A Homo sapiens (Human) mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; RIG-I signaling pathway [GO:0039529]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitotic spindle [GO:0072686]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitotic spindle [GO:0072686]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; RIG-I signaling pathway [GO:0039529]; stress granule assembly [GO:0034063] double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] GO:0000932; GO:0003690; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0005737; GO:0005829; GO:0010494; GO:0017148; GO:0033962; GO:0034063; GO:0036464; GO:0039529; GO:0060340; GO:0072686; GO:0090307; GO:1990124 GGGRGGTFTAPR 1.75999999 0.124045856 0.124045856 0.066354144 1134.907029 0 12.31252 14.9678 0 0 14.41619 0 0 0 0 0 0 12.99516 0 0 15.98329 0 10.86556 0 0 0 15.43265 13.19371 15.69255 18.06765 15.86168 13.40703 0 12.10132 14.24922 0 0 0 13.05078 14.7383 0 18.71628 0 14.34429 0 19.34821 13.9078 0 0 10.97675 15.99737 14.04502 0 Q8ND61 CC020_HUMAN Uncharacterized protein C3orf20 C3orf20 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] GO:0005737; GO:0016021 THQETLNR 4.369999886 0.187427625 0.187427625 0.237369262 996.6917049 0 15.96027 14.89449 15.38387 13.05432 16.57695 17.07891 14.18716 15.37147 13.73707 14.84664 16.81495 0 0 12.88014 0 15.75748 15.44282 14.06292 15.25899 0 17.02271 17.02672 13.84615 0 16.51338 15.54215 14.28041 0 16.27285 0 15.50962 0 0 15.85683 0 15.63257 16.17088 17.61343 17.01338 15.3581 0 15.01395 15.31639 16.48309 16.15671 16.91585 0 Q8ND76 CCNY_HUMAN "Cyclin-Y, Cyc-Y (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X)" CCNY C10orf9 CBCP1 CFP1 Homo sapiens (Human) cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; Wnt signaling pathway [GO:0016055] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; Wnt signaling pathway [GO:0016055] cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] GO:0000086; GO:0000307; GO:0000308; GO:0005634; GO:0005886; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0045859; GO:0051301; GO:0060828; GO:0061575 WSPAIIS 7.150000095 1 1 0.24701849 773.8928708 11.46617 0 0 16.17008 11.91305 14.53078 12.80656 15.16146 13.11866 15.64115 12.9188 13.6734 0 14.72776 0 15.90505 0 0 0 16.59665 0 0 16.44734 0 16.14655 0 13.69268 14.27335 15.81544 14.06717 16.04893 0 0 0 16.46899 16.86243 0 0 16.31012 18.73742 0 0 14.21129 14.8391 13.90456 13.11339 0 15.01682 Q8NDA2 HMCN2_HUMAN Hemicentin-2 HMCN2 Homo sapiens (Human) response to stimulus [GO:0050896] cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896] calcium ion binding [GO:0005509] GO:0005509; GO:0005615; GO:0031012; GO:0032154; GO:0050896; GO:0062023 AGLYR 9.569999695 0.483003646 0.483003646 0.264958717 578.1973198 16.50213 0 16.84598 18.03376 16.26863 0 0 0 0 17.38283 0 0 16.97545 17.09641 16.14877 0 17.26636 16.94472 0 15.66495 16.11945 0 0 0 0 17.17785 0 17.312 0 16.52618 18.62322 0 0 0 0 0 0 0 18.56604 16.13829 0 0 17.5403 0 16.39997 0 0 16.68075 Q8NDA8 MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A) MROH1 HEATR7A KIAA1833 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DPKADSVR 4.369999886 1 1 0.149385906 887.167341 15.44607 14.85325 6.700792 14.42431 16.25773 11.70541 15.23858 15.66058 16.52117 15.7622 13.99535 13.3726 0 13.27431 15.20694 14.1548 0 0 14.00907 0 0 15.72619 14.9402 0 0 0 0 0 15.42882 0 0 0 0 16.99153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDB2 BANK1_HUMAN B-cell scaffold protein with ankyrin repeats BANK1 Homo sapiens (Human) B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; negative regulation of B cell activation [GO:0050869]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to bacterium [GO:0009617] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; NAD+ nucleosidase activity [GO:0003953]; phospholipase binding [GO:0043274]; protease binding [GO:0002020]; protein tyrosine kinase binding [GO:1990782]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; negative regulation of B cell activation [GO:0050869]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to bacterium [GO:0009617] NAD+ nucleosidase activity [GO:0003953]; phospholipase binding [GO:0043274]; protease binding [GO:0002020]; protein tyrosine kinase binding [GO:1990782]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102] GO:0002020; GO:0003953; GO:0005102; GO:0009617; GO:0032715; GO:0035591; GO:0042113; GO:0043274; GO:0043410; GO:0045947; GO:0048471; GO:0050731; GO:0050853; GO:0050869; GO:0051898; GO:1990782 FCGLPK 9.93999958 0.920250475 0.920250475 0.313693763 720.9226736 14.72281 0 14.67315 15.91473 16.43233 14.97162 15.7475 0 0 14.60926 14.8844 13.97547 15.66573 15.16368 0 16.33381 0 15.24712 0 0 0 16.49114 0 0 0 0 0 14.80032 16.18044 15.85344 16.82415 0 15.55141 15.17296 15.69404 16.28214 15.23068 16.17402 16.41848 15.90727 0 0 0 16.21144 0 16.44829 14.61064 16.35217 Q8NDB6 FA156_HUMAN Protein FAM156A/FAM156B (Transmembrane protein 29/29B) FAM156A TMEM29 PP12994 PRO0659; FAM156B TMEM29B Homo sapiens (Human) integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; methylated histone binding [GO:0035064] methylated histone binding [GO:0035064] GO:0005635; GO:0016021; GO:0035064 MDPLQK 2.349999905 1 1 0.165634301 732.3360929 0 0 0 0 0 15.24365 0 0 0 0 0 0 15.74383 0 16.32186 0 0 0 0 0 0 0 0 0 0 0 16.13516 0 0 15.15432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDF8 PAPD5_HUMAN "Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5, EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase, EC 2.7.7.-) (Terminal uridylyltransferase 3, TUTase 3) (Topoisomerase-related function protein 4-2, TRF4-2)" TENT4B GLD4 PAPD5 TRF4-2 TUT3 Homo sapiens (Human) carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050] DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006364; GO:0006378; GO:0007049; GO:0010587; GO:0031123; GO:0031499; GO:0032211; GO:0033500; GO:0043629; GO:0043630; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870 ASGGR 1.940000057 0.520370007 0.520370007 0.271231991 448.9618625 16.69889 0 0 0 0 0 0 0 16.10671 0 0 17.23285 17.75133 15.0802 0 0 0 0 0 0 0 0 0 17.70391 17.9632 17.94516 0 0 16.15083 14.50701 15.59279 0 17.42935 13.79038 13.32515 18.1207 11.28162 11.19963 14.29036 0 0 17.27352 17.76367 0 13.12528 17.78387 17.51494 13.78029 Q8NDH2 CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 (Coiled-coil domain-containing protein 168) CCDC168 C13orf40 Homo sapiens (Human) ADTLR 7.679999828 1 1 0.162272311 576.3090067 15.23773 13.58498 0 15.55409 0 0 15.92705 16.31428 0 0 15.28148 0 15.16883 0 16.34096 0 0 16.30827 17.01187 0 14.80823 0 16.15478 0 0 0 15.63838 0 0 13.95791 16.14492 17.46618 0 16.57774 16.48147 0 0 17.27297 0 0 0 0 16.3727 15.35009 14.5081 0 0 17.32758 Q8NDH6 ICA1L_HUMAN Islet cell autoantigen 1-like protein (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein) ICA1L ALS2CR14 ALS2CR15 Homo sapiens (Human) regulation of transport [GO:0051049] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; protein domain specific binding [GO:0019904]; regulation of transport [GO:0051049] protein domain specific binding [GO:0019904] GO:0005794; GO:0019904; GO:0051049 MMDATGK 6.610000134 1 1 0.229964423 753.3381965 16.0241 14.87431 0 14.31873 16.38711 15.17958 14.61458 15.34172 0 15.57483 15.46193 11.91957 14.38113 15.11222 15.1894 12.543 15.79251 15.48728 0 13.81329 0 15.25227 15.99485 0 0 15.21725 0 15.53301 15.90708 0 0 16.24883 15.74279 0 0 0 0 17.20131 16.70063 0 0 0 16.234 15.13804 0 16.09922 0 0 Q8NDI1 EHBP1_HUMAN EH domain-binding protein 1 EHBP1 KIAA0903 NACSIN Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031] GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941 ALATSSINMK 2.640000105 1 1 0.351561489 1050.816926 0 0 0 0 15.75933 0 0 0 17.73686 0 18.16534 0 0 0 17.13467 0 0 15.47658 0 0 0 0 17.35937 0 0 0 0 0 0 0 0 18.04777 0 0 0 0 0 17.20298 0 0 16.60771 0 0 0 0 0 0 0 Q8NDL9 CBPC5_HUMAN "Cytosolic carboxypeptidase-like protein 5, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5)" AGBL5 CCP5 Homo sapiens (Human) C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0045171; GO:0051607; GO:0072686 GGMPGK 3.119999886 1 1 0.08744495 559.4792676 13.89415 13.65758 13.81928 15.49702 0 15.48584 15.55844 0 0 15.00968 13.80845 16.97681 0 0 15.95598 0 14.19428 0 16.78497 0 14.81254 16.08339 16.80891 14.96411 0 10.86757 0 16.24257 15.06259 16.10931 12.9297 0 0 0 16.27312 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDM7 CFA43_HUMAN Cilia- and flagella-associated protein 43 (WD repeat-containing protein 96) CFAP43 C10orf79 WDR96 Homo sapiens (Human) brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288] GO:0003356; GO:0005576; GO:0005930; GO:0007288; GO:0007420; GO:0060271; GO:0090660; GO:0097729; GO:0120197 LRALMDMMGGVLEVK 3.660000086 0.360584706 0.360584706 0.315955532 1662.326577 19.55972 0 18.35034 0 15.97141 15.28163 19.02718 17.04858 0 18.61965 0 0 0 13.24469 15.45651 0 16.97647 17.47331 18.85095 17.79294 0 0 16.91213 0 0 0 15.53751 15.52942 14.23654 17.53471 0 0 0 15.90001 16.83204 0 15.92809 16.30407 18.57829 15.53659 14.84526 17.99885 0 15.03372 18.45802 0 17.74141 13.38573 Q8NDT2 RB15B_HUMAN "Putative RNA-binding protein 15B (One-twenty two protein 3, HsOTT3, HuOTT3) (RNA-binding motif protein 15B)" RBM15B OTT3 Homo sapiens (Human) "dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]" nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0001510; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0009048; GO:0016607; GO:0036396 AKVAMSGR 1.419999957 1 1 0.111590221 836.2571645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.57008 0 0 0 0 0 0 0 0 0 0 0 0 14.76346 0 Q8NDV2 GPR26_HUMAN G-protein coupled receptor 26 GPR26 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0016021 IDVITMQTLVLLVDLHPSVR 2.609999895 0.423344135 0.423344135 4.58E-13 2278.145964 0 16.31188 0 0 0 0 0 0 13.60304 0 15.77445 0 0 0 0 0 0 0 13.93865 0 0 13.92152 14.70257 0 0 0 0 0 0 0 0 0 16.87204 0 15.34358 0 0 0 0 12.62694 16.80699 0 15.73109 0 16.48298 0 16.14504 0 Q8NDV3 SMC1B_HUMAN "Structural maintenance of chromosomes protein 1B, SMC protein 1B, SMC-1-beta, SMC-1B" SMC1B SMC1L2 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062] "chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] GO:0000775; GO:0000800; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007062; GO:0008278; GO:0016887; GO:0030893; GO:0034991; GO:0051321 EHGMLTR 6.21999979 6.75E-05 6.75E-05 0.311122343 859.8346905 0 17.66076 0 16.59475 20.48347 0 0 19.21067 0 0 0 0 17.79294 0 0 0 0 0 0 16.42696 18.17855 17.9987 0 0 19.66222 0 0 0 0 0 17.28776 20.18348 0 19.96624 0 0 0 0 0 17.67004 17.19595 0 0 17.2449 18.11837 0 0 0 Q8NDW8 TT21A_HUMAN "Tetratricopeptide repeat protein 21A, TPR repeat protein 21A (Stress-inducible protein 2)" TTC21A STI2 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; intraciliary retrograde transport [GO:0035721]; protein localization to cilium [GO:0061512]; spermatid development [GO:0007286] cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; flagellated sperm motility [GO:0030317]; intraciliary retrograde transport [GO:0035721]; protein localization to cilium [GO:0061512]; spermatid development [GO:0007286] GO:0005929; GO:0007286; GO:0030317; GO:0030991; GO:0035721; GO:0061512 EGNMTTVSSLKTQK 6.380000114 1 1 0.42843835 1524.885776 12.06309 15.70699 16.31562 0 0 0 0 15.34131 0 0 0 0 0 0 0 15.80039 16.30028 13.96887 16.68049 0 0 13.67188 0 0 16.01724 0 0 0 16.28871 0 0 15.60338 0 0 15.6704 0 0 0 16.00073 15.99583 14.67179 0 14.40411 15.76318 0 0 0 0 Q8NDX1 PSD4_HUMAN "PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B, Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein)" PSD4 EFA6B TIC Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012] membrane [GO:0016020]; ruffle membrane [GO:0032587] membrane [GO:0016020]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; regulation of ARF protein signal transduction [GO:0032012] guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] GO:0005085; GO:0005543; GO:0016020; GO:0032012; GO:0032587 KPHVFQLRTADWR 5.369999886 0.821484864 0.821484864 0.385872389 1652.737359 14.41731 0 12.62691 0 0 15.48907 14.16555 15.21726 0 0 0 0 0 0 16.37701 0 15.04822 14.93912 0 17.83444 16.47958 0 14.89219 0 0 0 0 0 0 0 0 0 16.43557 0 0 0 14.45354 16.56405 16.93272 0 0 16.26787 0 0 15.66874 16.15863 0 0 Q8NDX2 VGLU3_HUMAN "Vesicular glutamate transporter 3, VGluT3 (Solute carrier family 17 member 8)" SLC17A8 VGLUT3 Homo sapiens (Human) "anion transport [GO:0006820]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]" apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672] "apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]" L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] GO:0003407; GO:0005313; GO:0005326; GO:0005771; GO:0006811; GO:0006814; GO:0006820; GO:0007420; GO:0007605; GO:0015293; GO:0016021; GO:0022857; GO:0030285; GO:0030672; GO:0035249; GO:0043204; GO:0043679; GO:0050803; GO:0060076; GO:0090102; GO:0097440; GO:0097441; GO:0097451; GO:0098700; GO:1990030 ILKPGK 6.039999962 1 1 0.245743327 656.0003252 14.77278 0 0 15.62175 0 16.7778 0 15.8139 16.53914 0 16.23153 16.39893 0 16.35522 0 16.53932 15.82586 0 16.95066 16.76418 18.50132 0 0 0 17.27492 0 15.79185 15.51071 0 15.54335 0 0 0 0 16.33076 0 0 16.0322 16.02113 0 16.40868 16.05538 16.2432 17.16295 16.64365 0 0 0 Q8NDX9 LY65B_HUMAN Lymphocyte antigen 6 complex locus protein G5b LY6G5B C6orf19 G5B Homo sapiens (Human) external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0005576; GO:0009897; GO:0032991; GO:0042802 VPVPDIR 1.600000024 1 1 0.129737624 797.3457853 14.08058 0 0 13.70608 0 0 0 0 0 0 0 14.83385 0 0 0 13.21704 15.5414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDZ2 SIMC1_HUMAN SUMO-interacting motif-containing protein 1 (Platform element for inhibition of autolytic degradation) SIMC1 C5orf25 PLEIAD Homo sapiens (Human) negative regulation of peptidase activity [GO:0010466] cytoplasm [GO:0005737]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; sarcomere [GO:0030017]; peptidase inhibitor activity [GO:0030414]; SUMO polymer binding [GO:0032184]; negative regulation of peptidase activity [GO:0010466] peptidase inhibitor activity [GO:0030414]; SUMO polymer binding [GO:0032184] GO:0005737; GO:0010466; GO:0030017; GO:0030414; GO:0032184 LEPIPHRR 28 1 1 0.108476486 1019.417914 0 0 0 19.03304 0 0 0 0 0 0 0 0 0 23.46776 0 0 0 0 0 0 0 0 0 0 23.87607 0 0 0 0 0 17.85794 0 23.42533 0 0 0 0 0 21.01682 0 0 0 0 0 0 0 0 0 Q8NDZ6 T161B_HUMAN Transmembrane protein 161B TMEM161B UNQ679/PRO1313 Homo sapiens (Human) regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027] GO:0002027; GO:0005886; GO:0016021; GO:0098901 ESIPLMTEATFDTLR 3.269999981 0.96923846 0.96923846 0.226553841 1735.700727 15.80108 12.83333 0 16.5314 0 15.80196 0 14.27438 0 0 0 17.27658 16.23966 15.7226 15.55638 12.01648 0 9.572886 0 15.78316 17.1932 18.65577 16.96889 17.00174 18.1547 14.89787 6.579021 16.98658 0 16.25727 0 18.50595 0 14.12612 0 14.00674 16.38105 0 17.08576 16.396 16.02771 16.37267 15.74817 0 0 15.42644 16.49297 14.85509 Q8NE01 CNNM3_HUMAN Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3) CNNM3 ACDP3 Homo sapiens (Human) ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960] transmembrane transporter activity [GO:0022857] GO:0005886; GO:0006811; GO:0010960; GO:0016020; GO:0016021; GO:0022857; GO:0043231 ESGSEAER 3.019999981 0.315634966 0.315634966 0.105424937 865.1867945 0 12.46519 12.3944 17.09895 14.93989 16.45161 17.15209 14.15893 0 0 17.33822 15.5062 17.99907 12.47693 13.36843 15.89893 16.61239 16.10465 11.32125 0 14.39421 0 14.92977 0 14.62391 16.75932 0 17.16649 13.7797 16.16952 0 17.80699 0 15.12681 13.0825 15.20424 18.06446 15.13442 18.09218 14.50354 15.20879 0 0 0 14.17247 15.74891 0 16.81662 Q8NE09 RGS22_HUMAN "Regulator of G-protein signaling 22, RGS22" RGS22 Homo sapiens (Human) negative regulation of signal transduction [GO:0009968] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; G-protein alpha-subunit binding [GO:0001965]; negative regulation of signal transduction [GO:0009968] G-protein alpha-subunit binding [GO:0001965] GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629 ASSSTMSLKK 2.75999999 1 1 0.147502172 1040.148986 15.26318 0 15.52125 8.644258 14.49382 0 0 17.74726 0 17.29719 0 0 13.38537 14.76193 13.89328 14.51067 0 0 0 0 14.93712 0 0 0 0 16.41425 0 0 0 14.22775 0 0 0 0 0 0 0 0 0 16.10214 0 0 0 0 0 0 0 0 Q8NE18 NSUN7_HUMAN "Putative methyltransferase NSUN7, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 7)" NSUN7 Homo sapiens (Human) methylation [GO:0032259] methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; methylation [GO:0032259] methyltransferase activity [GO:0008168]; RNA binding [GO:0003723] GO:0003723; GO:0008168; GO:0032259 DPDLKTLFTK 3.099999905 1 1 0.173490683 1178.199184 0 0 0 0 13.2032 0 17.98737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.74679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE22 SETD9_HUMAN "SET domain-containing protein 9, EC 2.1.1.-" SETD9 C5orf35 Homo sapiens (Human) methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796] lysine N-methyltransferase activity [GO:0016278] GO:0005654; GO:0016278; GO:0032259; GO:1901796 SCNGRDR 2.950000048 0.275471389 0.275471389 0.288006722 863.845527 0 18.08094 0 16.57185 0 0 14.47514 0 18.26553 17.70074 0 0 0 0 0 0 0 0 0 18.49618 16.11267 0 0 0 0 18.81313 0 0 16.7437 0 0 17.70045 0 16.60061 20.16531 17.97688 16.1479 16.78964 15.64682 0 0 17.77056 0 16.5503 17.86182 0 0 0 Q8NE28 STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 (Serine/threonine kinase-like domain-containing protein 1) (Sugen kinase 071) STKLD1 C9orf96 SGK071 Homo sapiens (Human) ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] GO:0004674; GO:0005524 LGPGSNRR 12.84000015 1 1 0.063685322 857.1808701 15.75167 14.53023 11.83033 14.2529 15.31639 15.08389 12.65412 13.52479 0 13.23324 14.19879 13.69517 0 16.64497 17.07996 0 13.75944 0 16.31906 15.65663 0 0 0 0 15.2036 15.97459 12.53888 14.16965 0 15.01421 0 0 0 0 0 0 0 12.62585 0 0 0 0 14.53572 0 0 0 0 0 Q8NE62 CHDH_HUMAN "Choline dehydrogenase, mitochondrial, CDH, CHD, EC 1.1.99.1" CHDH Homo sapiens (Human) choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285] mitochondrial inner membrane [GO:0005743] mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285] choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660 EIDAFVRAK 9.159999847 1 1 0.029679645 1048.278334 16.12027 0 12.26799 0 0 17.77871 0 15.90899 12.84695 14.74764 17.63899 16.61228 0 12.60129 16.74648 0 15.93214 13.17765 0 17.4087 14.27761 15.05617 0 0 15.21727 15.11785 16.53937 0 0 14.95992 15.71853 16.54016 14.56497 0 0 0 16.60733 16.21118 15.32874 0 0 0 15.84854 0 0 18.19857 16.54664 0 Q8NE63 HIPK4_HUMAN "Homeodomain-interacting protein kinase 4, EC 2.7.11.1" HIPK4 Homo sapiens (Human) histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of signal transduction by p53 class mediator [GO:1901796] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of signal transduction by p53 class mediator [GO:1901796] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0016572; GO:0018105; GO:0018107; GO:0046777; GO:0106310; GO:1901796 KPPAGSK 9.350000381 0.962692499 0.962692499 0.23137053 684.72582 15.48991 15.17494 12.90463 15.03312 0 15.65095 14.86352 14.45995 0 16.04308 15.91942 0 14.81013 15.48889 15.62203 0 0 17.07591 17.42025 0 16.2975 0 0 0 15.5787 15.96843 16.04835 16.1814 15.74178 15.95095 15.18437 16.53199 17.03671 16.6975 16.42879 17.38176 16.62217 17.78322 17.11856 0 17.43397 16.84601 16.22675 17.07353 17.17723 16.84907 0 16.5676 Q8NE65 ZN738_HUMAN Zinc finger protein 738 ZNF738 Homo sapiens (Human) "protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0006355 VMLENFR 18.82999992 0.579600334 0.579600334 0.064941535 908.6171546 13.68798 14.89283 0 13.51549 11.84469 0 0 0 0 0 16.39403 0 14.9637 0 12.46477 0 12.45646 17.34521 15.33374 0 14.42729 0 12.17163 16.45825 11.96636 13.51938 0 0 14.16338 15.08645 0 14.53087 9.635116 13.9437 0 0 15.81862 14.27389 0 13.54316 14.9355 0 15.7993 12.80051 18.0022 0 0 0 Q8NE71 ABCF1_HUMAN ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein) ABCF1 ABC50 Homo sapiens (Human) inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]" "ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]" GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0042788; GO:0043022; GO:0045727 GKTTLLK 8.430000305 1 1 0.036391166 761.5140913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE79 POPD1_HUMAN "Blood vessel epicardial substance, hBVES (Popeye domain-containing protein 1, Popeye protein 1)" BVES POP1 POPDC1 Homo sapiens (Human) cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]; cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192] cAMP binding [GO:0030552]; structural molecule activity [GO:0005198] GO:0001921; GO:0002027; GO:0002244; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007517; GO:0007519; GO:0008360; GO:0016021; GO:0016192; GO:0016328; GO:0030054; GO:0030552; GO:0031253; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048278; GO:0051146; GO:0060931; GO:0060973; GO:0090136; GO:2001135 IEKELSGMYR 3.880000114 0.815625966 0.815625966 0.110770676 1241.57327 17.17579 0 16.68487 0 15.34111 0 13.19229 0 0 0 15.71578 15.1246 11.68098 15.43221 16.01211 17.6146 17.59768 16.03705 0 13.87903 0 12.68939 15.33523 17.21999 14.21629 15.7684 14.53327 15.86896 16.70939 11.32278 13.92886 15.81104 14.80733 16.58286 15.43147 14.92202 16.62338 16.1765 14.83037 16.24378 15.05074 15.20529 15.23801 15.08126 0 12.20097 0 17.0989 Q8NEA6 GLIS3_HUMAN Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515) GLIS3 ZNF515 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0045944; GO:0046872 AMNAANLNIPPSDTRSLISR 4.840000153 0.194128692 0.194128692 0.173347531 2157.65089 0 0 0 0 0 0 0 17.34221 13.31693 0 0 12.75953 0 14.90452 0 11.73637 16.08014 14.02466 0 13.75862 0 0 0 0 11.36491 0 0 13.80925 0 14.66894 0 0 0 13.08747 17.23222 0 0 0 15.76748 0 14.84675 0 0 0 0 0 0 0 Q8NEA9 GMCL2_HUMAN Germ cell-less protein-like 2 (Germ cell-less protein-like 1-like) GMCL2 GCL GMCL1L GMCL1P1 Homo sapiens (Human) germ cell development [GO:0007281]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] nuclear matrix [GO:0016363]; nucleus [GO:0005634] nuclear matrix [GO:0016363]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; germ cell development [GO:0007281]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] cullin family protein binding [GO:0097602] GO:0005634; GO:0007281; GO:0007283; GO:0016363; GO:0016567; GO:0097602 VLGQPRR 9.020000458 0.558201849 0.558201849 0.055455635 823.4484488 0 0 0 16.80439 0 15.80708 15.25796 0 0 14.53003 0 0 14.63454 16.1867 16.62483 12.5023 14.25972 14.92124 17.89902 14.95393 0 15.26833 0 15.42355 0 15.83156 15.12361 16.49294 16.60078 0 16.81064 0 0 0 0 0 14.42435 16.42575 0 11.29606 0 15.72182 0 17.24747 16.90098 0 0 7.942005 Q8NEB9 PK3C3_HUMAN "Phosphatidylinositol 3-kinase catalytic subunit type 3, PI3-kinase type 3, PI3K type 3, PtdIns-3-kinase type 3, EC 2.7.1.137 (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)" PIK3C3 VPS34 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201] "autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]" "autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]" 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672] GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006468; GO:0006497; GO:0006622; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0010506; GO:0016020; GO:0016236; GO:0016241; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0030670; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742; GO:0097352 TPGRTSSTLSEDQMSR 2.319999933 1 1 6.91E-13 1768.434989 16.69258 12.22541 0 0 0 0 14.05874 13.91956 0 0 0 12.38049 0 12.91189 14.20061 0 0 0 0 0 0 0 0 0 0 0 17.47232 0 0 0 0 0 0 0 0 0 0 0 0 16.93728 0 0 0 0 0 0 0 0 Q8NEC5 CTSR1_HUMAN "Cation channel sperm-associated protein 1, CatSper1, hCatSper" CATSPER1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of ion transmembrane transport [GO:0034765]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of ion transmembrane transport [GO:0034765]; spermatogenesis [GO:0007283] calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0030154; GO:0030317; GO:0034765; GO:0036128; GO:0060296; GO:0097228 TGVFPYHVAHPRGSAHSMTR 2.849999905 1 1 0.085023939 2224.874537 11.68474 12.38917 0 17.06453 14.33409 0 16.10779 13.29882 0 0 0 0 0 11.96664 0 13.46023 0 0 13.27098 10.56302 0 13.42428 15.238 14.51122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEC7 GSTCD_HUMAN Glutathione S-transferase C-terminal domain-containing protein GSTCD Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] GO:0005737; GO:0070062 NNMIVGVPI 11.61999989 0.371739566 0.371739566 0.254444668 970.1116586 12.13828 16.4327 15.18531 15.12546 15.84045 0 15.40584 14.52125 0 16.61447 16.1466 0 0 15.71129 0 0 0 15.57242 0 0 14.2892 17.1334 0 0 0 0 0 14.89142 0 14.2388 0 0 0 0 0 0 0 0 15.84267 0 0 15.96787 0 15.38062 0 15.73725 0 0 Q8NEE8 TTC16_HUMAN "Tetratricopeptide repeat protein 16, TPR repeat protein 16" TTC16 Homo sapiens (Human) AEGAQGKSQGMSSTSSK 5.110000134 1 1 0.015428153 1656.68202 0 18.52686 0 0 17.21688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.57191 0 0 0 0 0 0 19.47612 0 15.53786 0 0 0 0 0 0 0 0 0 0 0 15.58026 13.74309 0 Q8NEF3 CC112_HUMAN Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1) CCDC112 MBC1 Homo sapiens (Human) SIEMSMK 3.380000114 0.067416996 0.067416996 0.184196824 857.4963037 13.75278 15.16507 14.82497 16.22091 0 0 14.83127 14.78944 15.12534 0 15.33171 0 15.29875 17.33313 17.12817 16.46768 16.66263 16.21925 17.50915 0 16.84383 16.6465 15.95672 17.1109 16.80935 16.17845 17.57493 15.9439 16.89233 16.7321 15.9799 15.24404 16.12983 16.65264 16.67943 16.84525 17.14729 17.54947 17.81313 15.11466 17.3772 16.01789 14.73805 15.94906 15.72704 17.36755 16.93426 17.63542 Q8NEF9 SRFB1_HUMAN Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP) SRFBP1 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490] 90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0030490; GO:0030686; GO:0048471 TPADPK 2.059999943 0.792409956 0.792409956 0.133121667 627.3166566 14.58069 16.48837 15.31932 0 0 14.23148 0 16.00524 0 14.64695 15.10287 13.70842 0 0 0 0 0 0 0 0 0 0 16.69785 0 0 0 15.73202 0 0 14.62016 0 0 0 0 0 0 17.55292 15.26793 0 0 16.65838 14.23495 8.215543 15.31295 0 14.38197 0 0 Q8NEG0 GAR6_HUMAN Golgi associated RAB2 interactor protein 6 GARIN6 FAM71C Homo sapiens (Human) ARMVTMGIVR 2.519999981 1 1 0.242627059 1154.182518 13.90489 0 15.62042 14.43184 0 0 13.49084 16.01341 0 13.53739 15.38514 14.57869 14.572 15.6635 0 13.21255 14.82378 13.19209 15.40966 15.17733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.82038 0 0 0 16.60159 0 0 0 0 0 0 0 0 Q8NEG7 DEN6B_HUMAN Protein DENND6B (DENN domain-containing protein 6B) DENND6B FAM116B Homo sapiens (Human) cytosol [GO:0005829]; recycling endosome [GO:0055037] cytosol [GO:0005829]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0055037 DALLGTGPR 5.409999847 1 1 0.442977488 900.2500069 14.04375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49791 15.81485 0 0 17.08052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEH6 MNS1_HUMAN Meiosis-specific nuclear structural protein 1 MNS1 Homo sapiens (Human) cilium organization [GO:0044782]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; intermediate filament [GO:0005882]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; intermediate filament [GO:0005882]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; sperm flagellum [GO:0036126]; identical protein binding [GO:0042802]; cilium organization [GO:0044782]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288] identical protein binding [GO:0042802] GO:0005635; GO:0005882; GO:0005930; GO:0007288; GO:0031514; GO:0036126; GO:0042802; GO:0044782; GO:0045724; GO:0051321; GO:0070986 NVNSQIR 9.090000153 0.441634655 0.441634655 0.188864079 831.4321229 17.41646 0 17.04546 0 0 0 0 0 0 0 0 0 15.59667 15.40244 13.76688 13.24318 0 0 0 0 14.23039 0 0 15.30019 0 0 13.70716 16.44637 14.63268 0 0 0 0 14.28205 11.38293 0 0 0 0 16.84732 0 0 14.25938 0 15.39912 16.41278 0 0 Q8NEK8 TET5D_HUMAN "Terminal nucleotidyltransferase 5D, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46D)" TENT5D FAM46D Homo sapiens (Human) mRNA stabilization [GO:0048255] polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; mRNA stabilization [GO:0048255] polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817] GO:0004652; GO:0048255; GO:1990817 GSNGMS 7.820000172 1 1 0.198799966 568.3145053 0 0 16.486 17.34215 17.87832 0 0 15.44971 0 0 0 0 0 15.10096 0 0 14.07846 15.23223 0 0 0 0 0 0 0 0 0 13.48452 16.09915 0 17.08894 0 16.35111 15.21313 0 0 0 18.40761 0 0 0 15.94648 0 0 0 0 0 0 Q8NEL9 DDHD1_HUMAN "Phospholipase DDHD1, EC 3.1.1.- (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog, PA-PLA1)" DDHD1 KIAA1705 Homo sapiens (Human) lipid catabolic process [GO:0016042]; positive regulation of mitochondrial fission [GO:0090141] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]; positive regulation of mitochondrial fission [GO:0090141] metal ion binding [GO:0046872]; phospholipase activity [GO:0004620] GO:0004620; GO:0005737; GO:0005829; GO:0016042; GO:0046872; GO:0090141 NTAMMR 9.680000305 1 1 0.297416368 740.147996 0 0 15.04717 0 0 0 0 0 0 0 0 0 17.81066 0 0 0 16.88453 0 0 15.94827 0 0 17.21468 0 0 0 0 0 0 0 0 0 17.83278 0 18.21638 0 20.17542 0 19.82649 18.54577 18.67738 15.99037 18.63023 17.41784 19.37386 19.25798 19.01054 19.34033 Q8NEM2 SHCBP_HUMAN SHC SH2 domain-binding protein 1 SHCBP1 Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177] cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819] cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; SH2 domain binding [GO:0042169]; fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177] SH2 domain binding [GO:0042169] GO:0005737; GO:0005819; GO:0008543; GO:0030496; GO:0042169; GO:2000177 MADGSLTGGGLEAAAMAPER 1.980000019 1 1 0.185094315 1920.140838 15.65547 0 0 15.72168 15.24184 0 0 11.92011 0 0 0 0 12.66616 0 0 0 0 0 15.1453 0 0 0 0 0 0 0 0 0 0 0 0 0 15.99199 0 0 0 0 0 0 0 17.52846 14.68808 13.98569 0 16.0802 0 0 0 Q8NEM7 SP20H_HUMAN "Transcription factor SPT20 homolog (p38-interacting protein, p38IP)" SUPT20H C13orf19 FAM48A FP757 Homo sapiens (Human) "autophagy [GO:0006914]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] "SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; transcription coregulator activity [GO:0003712]; autophagy [GO:0006914]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" transcription coregulator activity [GO:0003712] GO:0000124; GO:0003712; GO:0006282; GO:0006357; GO:0006914; GO:0007369; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0070461 HRPPPIK 1.299999952 1 1 0.22160242 843.5920047 0 0 0 0 0 0 17.29598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEM8 CBPC3_HUMAN "Cytosolic carboxypeptidase 3, EC 3.4.17.- (ATP/GTP-binding protein-like 3) (Protein deglutamylase CCP3)" AGBL3 CCP3 Homo sapiens (Human) protein side chain deglutamylation [GO:0035610] cytosol [GO:0005829] cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005829; GO:0008270; GO:0035610 ELEEMERHITLEK 4.429999828 0.445106298 0.445106298 0.267436619 1672.094458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.66105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEP3 DAAF1_HUMAN Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50) DNAAF1 LRRC50 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356] dynein complex binding [GO:0070840] GO:0000922; GO:0001947; GO:0003341; GO:0003356; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0005930; GO:0016607; GO:0030324; GO:0035469; GO:0036158; GO:0036159; GO:0044458; GO:0060271; GO:0060287; GO:0060972; GO:0070286; GO:0070840; GO:0071907; GO:0071910 MTKSSLQK 4.170000076 1 1 0.084215693 922.28491 0 0 0 0 0 0 0 0 14.50312 0 0 13.8544 0 0 0 0 0 0 0 0 0 0 0 0 15.18233 14.98226 16.98479 0 0 14.77894 14.21959 16.1332 14.99594 14.15825 14.37329 15.09683 0 0 16.11316 0 14.54833 13.04331 15.44312 10.18089 0 0 0 0 Q8NEP7 KLDC9_HUMAN Kelch domain-containing protein 9 (Kelch/ankyrin repeat-containing cyclin A1-interacting protein) KLHDC9 KARCA1 Homo sapiens (Human) cyclin binding [GO:0030332] cyclin binding [GO:0030332] GO:0030332 MAVAVPPGR 4.199999809 1 1 0.213823044 912.6497782 0 15.39067 17.02141 16.38571 0 0 14.35446 14.91565 14.04488 16.84389 0 16.44771 0 14.6075 15.00245 0 16.3883 0 0 0 0 0 0 0 14.94851 17.94011 16.90215 15.28392 0 16.8954 0 0 0 0 0 0 18.67256 0 0 16.63674 18.04802 15.32562 0 15.89231 15.4298 0 0 0 Q8NEP9 ZN555_HUMAN Zinc finger protein 555 ZNF555 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 EHVRMHPEDK 5.070000172 1 1 1.38E-12 1276.262988 0 14.61155 12.82645 12.80772 0 12.76545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.04794 0 14.43269 15.91576 12.98954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NER1 TRPV1_HUMAN "Transient receptor potential cation channel subfamily V member 1, TrpV1 (Capsaicin receptor) (Osm-9-like TRP channel 1, OTRPC1) (Vanilloid receptor 1)" TRPV1 VR1 Homo sapiens (Human) behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955] cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; voltage-gated calcium channel activity [GO:0005245]; behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955] ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; voltage-gated calcium channel activity [GO:0005245] GO:0000122; GO:0001660; GO:0001774; GO:0002024; GO:0002790; GO:0003085; GO:0004888; GO:0005216; GO:0005230; GO:0005231; GO:0005245; GO:0005262; GO:0005516; GO:0005524; GO:0005739; GO:0005829; GO:0005886; GO:0005887; GO:0006629; GO:0007166; GO:0007635; GO:0009897; GO:0010459; GO:0010917; GO:0014047; GO:0015278; GO:0016021; GO:0017081; GO:0031226; GO:0032591; GO:0034605; GO:0035091; GO:0042802; GO:0043025; GO:0043065; GO:0043434; GO:0045211; GO:0045429; GO:0046872; GO:0048266; GO:0050954; GO:0050955; GO:0050960; GO:0050965; GO:0050968; GO:0051219; GO:0051289; GO:0060083; GO:0060454; GO:0070588; GO:0071312; GO:0071318; GO:0071356; GO:0071468; GO:0071502; GO:0090212; GO:0097603; GO:0098703; GO:1901594; GO:1990090 KGMTPLALAAGTGK 11.27999973 0.158562258 0.158562258 0.035652493 1332.932016 0 0 14.31754 0 0 0 0 11.6694 10.20918 11.67764 13.14045 9.606188 13.10164 0 0 12.64872 0 0 12.62376 0 0 0 0 0 0 14.83058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.51879 0 Q8NET4 RTL9_HUMAN Retrotransposon Gag-like protein 9 (Retrotransposon gag domain-containing protein 1) (Tumor antigen BJ-HCC-23) RTL9 KIAA1318 RGAG1 Homo sapiens (Human) GMSTPLMRASGPGTMSTPQTAFGVMSTPEIK 6.340000153 1 1 0.017125822 3200.539291 0 11.90969 15.78876 0 0 14.79406 0 0 0 13.40843 0 0 12.35103 13.76978 0 13.43736 0 11.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07898 Q8NET6 CHSTD_HUMAN "Carbohydrate sulfotransferase 13, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3, C4ST-3, C4ST3)" CHST13 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166] chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756 AYLAFLFVR 8.399999619 1 1 9.21E-13 1101.414506 15.36575 5.492909 15.40907 0 16.75423 0 0 0 13.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.41224 0 0 0 0 0 0 15.91895 0 15.14166 0 0 0 0 0 14.86737 0 0 0 0 0 0 0 0 0 Q8NET8 TRPV3_HUMAN "Transient receptor potential cation channel subfamily V member 3, TrpV3 (Vanilloid receptor-like 3, VRL-3)" TRPV3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; negative regulation of hair cycle [GO:0042636]; positive regulation of calcium ion import [GO:0090280]; response to heat [GO:0009408] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; negative regulation of hair cycle [GO:0042636]; positive regulation of calcium ion import [GO:0090280]; response to heat [GO:0009408] calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216] GO:0005216; GO:0005262; GO:0005886; GO:0005887; GO:0009408; GO:0042636; GO:0042802; GO:0043235; GO:0070588; GO:0090280; GO:0098703 TDFNK 4.78000021 1 1 0.015636466 625.4186986 0 15.72658 14.87422 16.44158 14.04038 15.06451 0 0 0 0 0 0 16.15203 0 0 0 0 16.03606 0 0 0 0 0 0 16.16135 0 0 0 0 15.07503 15.86223 15.13529 14.84298 16.14301 14.99413 15.20822 17.07965 0 0 16.42124 0 0 0 15.51622 0 0 0 14.92534 Q8NEU8 DP13B_HUMAN "DCC-interacting protein 13-beta, Dip13-beta (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)" APPL2 DIP13B Homo sapiens (Human) "adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]" cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982] "cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]" identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] GO:0001726; GO:0001786; GO:0002024; GO:0005634; GO:0005768; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0009631; GO:0010008; GO:0010762; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0031982; GO:0032009; GO:0032587; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0036186; GO:0042593; GO:0042802; GO:0042803; GO:0044354; GO:0044877; GO:0045088; GO:0046322; GO:0046325; GO:0050768; GO:0051289; GO:0060100; GO:0070062; GO:0120162; GO:1900016; GO:1900077; GO:1905303; GO:1905451; GO:2000045; GO:2000178 NSEMENENDKIVPK 5.179999828 1 1 0.387284172 1661.303767 13.19147 15.49439 16.43158 0 15.39372 15.26918 0 0 0 14.75555 0 14.7354 13.53652 0 0 0 0 0 0 0 0 0 0 16.73092 0 0 0 15.15441 0 0 13.94519 14.42503 0 0 0 0 0 0 0 13.83938 15.75949 0 0 16.1885 0 0 0 0 Q8NEV4 MYO3A_HUMAN "Myosin-IIIa, EC 2.7.11.1" MYO3A Homo sapiens (Human) cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000146; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0030175; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0050896; GO:0060002; GO:0090103; GO:0106310 HQRIVTTPTEVAR 5.670000076 1 1 6.91E-13 1507.8403 13.93275 14.32079 11.50212 0 0 13.99732 13.99254 0 15.70164 15.44184 0 0 14.90064 15.01159 0 0 0 15.21776 0 15.15746 16.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.40779 0 0 0 0 0 0 0 0 0 0 0 Q8NEV8 EXPH5_HUMAN "Exophilin-5 (Synaptotagmin-like protein homolog lacking C2 domains b, SlaC2-b, Slp homolog lacking C2 domains b)" EXPH5 KIAA0624 SLAC2B Homo sapiens (Human) intracellular protein transport [GO:0006886]; keratinocyte development [GO:0003334]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714] endosome [GO:0005768] endosome [GO:0005768]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; keratinocyte development [GO:0003334]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714] small GTPase binding [GO:0031267] GO:0003334; GO:0005768; GO:0006886; GO:0031267; GO:0045921; GO:0050714; GO:0071985 KGPLPFLINR 7.329999924 1 1 0.263171207 1154.27854 14.19921 0 14.69212 0 0 16.02612 0 14.10534 14.16208 13.75776 15.45801 0 0 0 0 13.18834 0 0 15.91179 0 0 15.66417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93643 0 0 15.1389 0 15.60572 0 0 0 Q8NEX5 WFDC9_HUMAN Protein WFDC9 WFDC9 WAP9 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005615; GO:0019731; GO:0045087 DPFLDMIR 6.150000095 1 1 0.099906957 1023.083789 0 12.08151 16.88982 16.26308 15.21951 0 0 0 13.50287 14.28966 16.62698 0 0 15.19003 13.59065 17.09389 15.81645 15.169 0 0 0 16.25665 15.49303 15.80898 17.49951 0 0 14.69031 15.92667 14.44563 14.29123 17.42895 13.3183 15.00131 15.16463 16.57999 16.42481 0 14.02149 16.5933 15.89666 13.16254 14.63058 16.37166 9.923353 16.60618 17.49308 0 Q8NEY1 NAV1_HUMAN "Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1, unc53H1)" NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; nervous system development [GO:0007399]; neuron migration [GO:0001764] axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule bundle formation [GO:0001578]; nervous system development [GO:0007399]; neuron migration [GO:0001764] GO:0001578; GO:0001764; GO:0005737; GO:0005874; GO:0007399; GO:0015630; GO:0043194 APGGGGGMAK 3.599999905 1 1 5.76E-13 802.6318919 0 0 0 0 0 0 0 0 0 10.99452 15.6815 0 13.13608 14.32478 15.25889 0 0 0 0 15.60787 14.06418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.47449 0 0 0 14.18081 0 0 0 Q8NEY8 PPHLN_HUMAN "Periphilin-1 (CDC7 expression repressor, CR) (Gastric cancer antigen Ga50)" PPHLN1 HSPC206 HSPC232 Homo sapiens (Human) "keratinization [GO:0031424]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; keratinization [GO:0031424]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0031424; GO:0045814; GO:0045892; GO:0090309; GO:0097355 SFSHDR 5.949999809 1 1 0.203299758 748.5522722 0 15.54238 14.8978 8.947333 0 0 0 14.41513 0 14.64917 14.50319 0 0 0 15.00928 14.68614 0 0 15.34783 15.56234 0 0 15.41196 0 15.34428 0 0 15.50184 0 0 0 0 0 0 0 0 0 0 15.00683 0 0 0 0 0 0 0 0 0 Q8NEZ2 VP37A_HUMAN "Vacuolar protein sorting-associated protein 37A, hVps37A (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1)" VPS37A HCRP1 Homo sapiens (Human) macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] GO:0000813; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043231 MSWLFPLTK 4.980000019 1 1 0.530551583 1122.25535 0 0 0 0 0 0 19.11779 0 0 0 0 0 0 0 0 19.19706 0 0 0 17.65599 0 17.87271 0 0 0 0 0 0 0 0 0 0 0 0 0 17.99211 17.35271 0 0 19.82345 0 0 18.84933 0 0 0 0 0 Q8NEZ3 WDR19_HUMAN WD repeat-containing protein 19 (Intraflagellar transport 144 homolog) WDR19 IFT144 KIAA1638 Homo sapiens (Human) cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] GO:0000902; GO:0001701; GO:0001750; GO:0005737; GO:0005856; GO:0005929; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060830; GO:0060831; GO:0061055; GO:0065003; GO:0097542; GO:0097730; GO:1903441 RIGNVGIVMSLEQIK 3.180000067 0.501076579 0.501076579 0.02356078 1657.845046 14.88896 0 16.18907 0 0 0 0 0 0 19.61828 0 16.28818 0 0 14.9707 16.62466 0 15.39224 0 17.17333 0 16.86601 16.36447 15.65658 0 0 17.85735 13.97132 0 0 0 18.70383 0 0 0 0 17.21986 0 14.59078 0 15.71649 0 0 0 0 0 17.56328 0 Q8NEZ4 KMT2C_HUMAN "Histone-lysine N-methyltransferase 2C, Lysine N-methyltransferase 2C, EC 2.1.1.364 (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)" KMT2C HALR KIAA1506 MLL3 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045944; GO:0046872; GO:0051568; GO:0097692 ADVFQR 4.5 1 1 0.131866863 732.3771183 0 0 0 0 0 15.50803 0 0 0 0 0 0 16.18375 0 0 0 0 0 0 0 0 0 0 0 16.24019 14.70973 15.18888 0 14.84499 0 0 15.34075 16.04069 17.68525 16.73535 0 0 0 0 0 0 0 0 0 0 16.07768 0 0 Q8NF37 PCAT1_HUMAN "Lysophosphatidylcholine acyltransferase 1, LPC acyltransferase 1, LPCAT-1, LysoPC acyltransferase 1, EC 2.3.1.23 (1-acylglycerol-3-phosphate O-acyltransferase, EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase, EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase, EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase, Acetyl-CoA:lyso-PAF acetyltransferase, Lyso-PAF acetyltransferase, LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3)" LPCAT1 AYTL2 PFAAP3 Homo sapiens (Human) negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200]; negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200] GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006654; GO:0008654; GO:0016020; GO:0016021; GO:0035577; GO:0036148; GO:0036151; GO:0043129; GO:0045732; GO:0047144; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0050200; GO:0060041; GO:2001246 GLGLKPEK 14.52000046 1 1 0.575489005 842.6974802 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5589 19.88791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.45571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NF50 DOCK8_HUMAN Dedicator of cytokinesis protein 8 DOCK8 Homo sapiens (Human) cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001771; GO:0005085; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0031252; GO:0031256; GO:0031258; GO:0036336; GO:0043547; GO:0051056; GO:0061485; GO:0070233; GO:1903905; GO:1990869; GO:2000406 ENEQAEK 23.67000008 1 1 0.249302092 844.8450653 0 17.90007 0 0 0 16.83732 15.5556 16.86524 0 0 15.05281 0 12.50084 14.75109 0 14.87184 0 0 0 18.45702 0 15.85641 15.43582 16.40111 0 0 14.90339 0 0 15.48558 14.48267 17.19968 17.0539 0 16.70047 0 18.42102 0 0 0 0 0 15.81669 0 13.87631 15.78706 0 16.75505 Q8NF64 ZMIZ2_HUMAN Zinc finger MIZ domain-containing protein 2 (PIAS-like protein Zimp7) ZMIZ2 KIAA1886 ZIMP7 HRIHFB2007 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear receptor coactivator activity [GO:0030374]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008270; GO:0030374; GO:0043596; GO:0045944 EEPDGPALK 3.079999924 1 1 0.085378641 955.1406314 13.74116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.06172 15.50732 0 13.99799 0 15.57289 0 0 0 0 0 0 0 15.75631 0 0 14.44702 0 0 11.29079 Q8NF86 PRS33_HUMAN "Serine protease 33, EC 3.4.21.- (Serine protease EOS)" PRSS33 Homo sapiens (Human) protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508] serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0070528 GDLALLQLRRPVPLSAR 2.900000095 1 1 4.72E-13 1874.08094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38649 0 0 0 18.78081 0 0 0 0 0 0 0 0 0 0 0 Q8NF91 SYNE1_HUMAN "Nesprin-1 (Enaptin) (KASH domain-containing protein 1, KASH1) (Myocyte nuclear envelope protein 1, Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1, Syne-1)" SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1 Homo sapiens (Human) Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090292; GO:0140444 AATNK 3.519999981 0.001509666 0.001509666 0.131357449 503.2945446 16.83229 16.78294 16.14368 16.5942 0 16.22338 17.86131 17.52398 16.9987 16.86116 17.02152 16.37874 16.59636 16.23844 15.79686 16.05587 16.807 17.30902 16.75058 17.71894 16.60917 16.66774 16.72951 17.38396 16.06288 15.87855 16.63404 16.06478 16.60367 16.16417 16.746 17.04929 16.89365 16.98079 17.33525 16.96665 17.98638 16.93803 16.2381 17.03914 17.51138 17.21984 16.63986 17.87624 16.65922 16.76388 17.14224 15.41209 Q8NF99 ZN397_HUMAN Zinc finger protein 397 (Zinc finger and SCAN domain-containing protein 15) (Zinc finger protein 47) ZNF397 ZNF47 ZSCAN15 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0015630; GO:0042803; GO:0045892; GO:0046872; GO:0046982 AFRQSSELITHQR 9.829999924 1 1 0.133906164 1573.385442 14.83858 14.53283 14.46523 13.48164 7.4904 0 13.11041 0 14.92253 13.54814 14.9072 0 15.67008 14.84018 10.64579 14.58387 0 0 0 14.50165 0 0 14.89546 0 14.34208 11.0407 0 15.23449 12.11979 0 15.16201 0 0 0 14.24981 0 0 16.14039 0 12.94833 14.54572 0 0 0 9.518812 0 0 13.9061 Q8NFD5 ARI1B_HUMAN "AT-rich interactive domain-containing protein 1B, ARID domain-containing protein 1B (BRG1-associated factor 250b, BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2, hOsa2) (p250R)" ARID1B BAF250B DAN15 KIAA1235 OSA2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 GSPVSSLPAVGK 6.269999981 0.470381796 0.470381796 0.20130312 1097.855774 0 14.65783 0 0 14.4249 0 0 0 0 0 0 0 0 0 16.5443 13.7941 0 0 14.04479 0 12.91846 16.22812 12.42375 14.79718 15.32537 14.12585 14.26219 15.63279 15.77524 0 15.91773 14.98485 14.08384 16.12495 15.21688 0 12.82899 14.8306 14.46456 0 0 15.94613 0 11.37861 0 15.19205 15.66485 11.95225 Q8NFF2 NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) SLC24A4 NCKX4 Homo sapiens (Human) amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; ion transport [GO:0006811]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signaling receptor activity [GO:0010469]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] "apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]; amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; ion transport [GO:0006811]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signaling receptor activity [GO:0010469]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]" "calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]" GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010469; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834 TASASK 1.929999948 1 1 0.241888951 563.9608179 0 21.02821 0 0 0 0 0 0 0 0 17.14021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.88233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFF5 FAD1_HUMAN "FAD synthase, EC 2.7.7.2 (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region ]" FLAD1 PP591 Homo sapiens (Human) FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802]; FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771] ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802] GO:0003919; GO:0005524; GO:0005759; GO:0005829; GO:0005886; GO:0006747; GO:0006771; GO:0042802 GWDLGTRLFQR 15.19999981 1 1 0.518311199 1350.083004 15.9979 16.10444 0 0 0 0 0 0 0 17.22528 0 0 0 18.78345 0 0 0 0 17.53756 0 0 17.8359 0 16.37481 18.85331 0 0 0 0 18.73724 0 18.84978 0 17.84152 0 0 18.63506 0 0 0 16.71599 0 0 16.1385 0 0 0 0 Q8NFG4 FLCN_HUMAN Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) FLCN BHD Homo sapiens (Human) cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877] GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044877; GO:0045785; GO:0045944; GO:0046578; GO:0051898; GO:0070373; GO:0072686; GO:0097009; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1903444; GO:1904263; GO:2000973; GO:2001170; GO:2001244 KLPVFK 1.019999981 0.391373783 0.391373783 0.05423108 730.7076445 14.4823 15.43186 0 16.99547 17.46952 0 14.08097 16.43572 16.41241 8.712402 15.59443 14.2198 14.17043 15.35854 16.12217 0 15.89996 15.35355 16.98906 0 17.18595 16.72658 14.96471 16.5554 17.07405 0 16.73952 16.02037 0 16.4654 14.55462 14.21562 15.47435 0 15.82368 16.38899 17.62482 16.69023 16.95373 15.70837 16.05696 0 15.53003 15.65936 16.64143 0 13.41538 16.10228 Q8NFH5 NUP35_HUMAN "Nucleoporin NUP35 (35 kDa nucleoporin) (Mitotic phosphoprotein 44, MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53)" NUP35 MP44 NUP53 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; regulation of transcription, DNA-templated [GO:0006355]" identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056] GO:0003697; GO:0005543; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0042802; GO:0044613; GO:0044615; GO:0051028; GO:1990830 YQSKLQAR 2.420000076 1 1 0.17013241 993.9117038 15.40211 15.42807 14.58221 15.84097 0 0 0 12.5654 0 0 0 13.8744 0 0 16.24894 0 14.98881 0 12.66291 16.00114 0 16.37539 14.50047 0 0 0 15.06321 0 0 14.64022 0 15.68276 0 15.7064 8.467731 12.69609 0 15.94253 0 0 12.46004 0 0 13.47251 10.84836 12.66245 11.30933 0 Q8NFI3 ENASE_HUMAN "Cytosolic endo-beta-N-acetylglucosaminidase, ENGase, EC 3.2.1.96" ENGASE Homo sapiens (Human) protein deglycosylation [GO:0006517]; protein folding [GO:0006457] cytosol [GO:0005829] "cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]" "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]" GO:0004553; GO:0005829; GO:0006457; GO:0006517; GO:0033925 MEAAAVTVTR 4.309999943 1 1 0.100413298 1065.89916 0 14.54214 0 12.1247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.44391 0 0 0 0 15.45586 0 0 0 0 0 14.99616 16.20036 15.7591 0 0 0 0 0 15.55028 0 0 0 0 0 0 0 0 0 Q8NFJ8 BHE22_HUMAN "Class E basic helix-loop-helix protein 22, bHLHe22 (Class B basic helix-loop-helix protein 5, bHLHb5) (Trinucleotide repeat-containing gene 20 protein)" BHLHE22 BHLHB5 TNRC20 Homo sapiens (Human) neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0046983; GO:1990837 AGVADPR 5.03000021 1 1 0.113127171 683.9595941 16.20355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27331 0 0 0 16.09223 0 0 0 15.51136 0 0 0 0 0 0 0 0 0 0 14.56098 0 0 0 0 0 0 Q8NFJ9 BBS1_HUMAN Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) cilium assembly [GO:0060271]; Golgi to plasma membrane protein transport [GO:0043001]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization to cilium [GO:0061512]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601] axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; cytosol [GO:0005829] axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; patched binding [GO:0005113]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; smoothened binding [GO:0005119]; cilium assembly [GO:0060271]; Golgi to plasma membrane protein transport [GO:0043001]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization to cilium [GO:0061512]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601] patched binding [GO:0005113]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; smoothened binding [GO:0005119] GO:0005113; GO:0005119; GO:0005813; GO:0005829; GO:0005930; GO:0007601; GO:0007608; GO:0034464; GO:0043001; GO:0045494; GO:0050896; GO:0060170; GO:0060271; GO:0061512; GO:0061629; GO:1905515 EMLESIRETAEEPLSIQSLR 3.309999943 1 1 0.216550771 2346.273528 10.65773 15.23608 0 12.32378 0 0 0 0 0 0 11.88912 0 0 0 0 14.21081 0 0 0 0 15.02446 0 0 0 0 12.31498 0 0 0 0 0 0 0 0 0 0 12.44621 17.08439 0 13.37011 13.06472 0 0 0 8.558591 0 13.87519 0 Q8NFK1 CXG3_HUMAN "Gap junction gamma-3 protein (Connexin-30.2, Cx30.2) (Connexin-31.3, Cx31.3) (Gap junction epsilon-1 protein)" GJC3 GJE1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; myelination [GO:0042552]; sensory perception of sound [GO:0007605] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; myelination [GO:0042552]; sensory perception of sound [GO:0007605] gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802] GO:0005243; GO:0005922; GO:0007267; GO:0007605; GO:0016021; GO:0042552; GO:0042802; GO:0043209 LLLPVLLGFR 4.090000153 1 1 0.002349562 1141.843946 14.09025 14.20674 0 0 0 10.69138 13.63056 0 13.56683 13.16936 15.00009 15.65909 14.42037 14.13124 16.93699 0 14.25676 0 15.24864 0 0 14.10416 15.97147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFL0 B3GN7_HUMAN "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, BGnT-7, Beta-1,3-Gn-T7, Beta-1,3-N-acetylglucosaminyltransferase 7, Beta3Gn-T7, EC 2.4.1.-" B3GNT7 Homo sapiens (Human) keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" "acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" GO:0000139; GO:0008194; GO:0008375; GO:0008499; GO:0008532; GO:0016021; GO:0016266; GO:0016757; GO:0018146; GO:0030311 LLPPELLAMWGLVHSNLTCSR 16.56999969 0.472982943 0.472982943 4.57E-12 2422.482771 0 0 0 18.43822 0 0 19.50761 18.87553 17.43143 0 18.30763 19.04647 0 0 0 0 0 0 0 0 0 18.1855 19.97136 20.47799 0 0 17.90029 18.57334 0 0 0 18.30241 0 17.95319 0 18.53872 0 0 0 0 0 18.51382 0 18.23251 18.37653 19.26471 0 0 Q8NFN8 GP156_HUMAN Probable G-protein coupled receptor 156 (G-protein coupled receptor PGR28) (GABAB-related G-protein coupled receptor) GPR156 GABABL PGR28 Homo sapiens (Human) gamma-aminobutyric acid signaling pathway [GO:0007214] G protein-coupled receptor heterodimeric complex [GO:0038039]; plasma membrane [GO:0005886] G protein-coupled receptor heterodimeric complex [GO:0038039]; plasma membrane [GO:0005886]; G protein-coupled GABA receptor activity [GO:0004965]; transmembrane signaling receptor activity [GO:0004888]; gamma-aminobutyric acid signaling pathway [GO:0007214] G protein-coupled GABA receptor activity [GO:0004965]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0004965; GO:0005886; GO:0007214; GO:0038039 MEPEINCSELCDSFPGQELDR 5.449999809 1 1 0.012467689 2541.218602 0 0 0 0 0 13.47117 0 0 0 14.78231 0 14.60303 0 0 0 15.01023 0 13.92433 15.97302 0 0 0 0 0 0 15.3349 0 14.03279 14.11259 0 0 0 16.20079 0 0 0 0 0 0 0 15.92541 0 0 0 0 0 0 0 Q8NFP4 MDGA1_HUMAN "MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein, GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3)" MDGA1 MAMDC3 Homo sapiens (Human) brain development [GO:0007420]; cerebral cortex radially oriented cell migration [GO:0021799]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527] anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; brain development [GO:0007420]; cerebral cortex radially oriented cell migration [GO:0021799]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527] GO:0001764; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0007399; GO:0007420; GO:0021527; GO:0021799; GO:0046658; GO:0098982; GO:0099179; GO:1905606 LTPYTTFGAGDMASR 7.21999979 1 1 0.247850461 1603.59025 14.6973 11.66523 15.17999 0 0 14.29731 0 12.92264 10.99225 14.24833 0 14.44268 9.25215 0 14.8856 15.68102 0 0 0 0 0 0 0 0 0 14.61962 0 0 0 0 0 0 0 0 16.76035 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFP9 NBEA_HUMAN Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) NBEA BCL8B KIAA1544 LYST2 Homo sapiens (Human) protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; protein kinase binding [GO:0019901]; protein localization [GO:0008104] protein kinase binding [GO:0019901] GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 DTSDVK 1.799999952 0.990711451 0.990711451 0.280090805 662.5337292 0 0 18.15756 0 17.39282 0 16.90643 0 0 0 0 0 0 0 17.4579 0 0 0 0 15.93171 0 0 0 0 18.71161 0 0 0 0 16.49627 0 0 0 18.25069 17.144 17.48827 0 0 0 18.00024 0 0 0 0 16.49833 16.50208 0 0 Q8NFQ5 BPIB6_HUMAN BPI fold-containing family B member 6 (Bactericidal/permeability-increasing protein-like 3) BPIFB6 BPIL3 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; lipid binding [GO:0008289] lipid binding [GO:0008289] GO:0005576; GO:0008289 MAAEAGK 10.27000046 3.20E-05 3.20E-05 0.283148571 693.8333322 0 0 0 16.73659 17.96264 18.30388 0 17.29953 19.02755 18.93645 18.39841 17.04449 16.08658 18.44455 0 18.27237 18.34634 17.26943 18.7191 0 19.16801 18.71237 0 19.30984 18.44398 18.72579 17.441 19.50513 0 0 0 19.33245 0 19.19326 0 0 19.26633 18.343 20.18926 0 0 18.15337 18.58952 16.16792 0 0 0 0 Q8NFQ6 BPIFC_HUMAN "BPI fold-containing family C protein (Bactericidal/permeability-increasing protein-like 2, BPI-like 2)" BPIFC BPIL2 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; lipopolysaccharide binding [GO:0001530]; phospholipid binding [GO:0005543] lipopolysaccharide binding [GO:0001530]; phospholipid binding [GO:0005543] GO:0001530; GO:0005543; GO:0005615 LALPESNRSNIEVLR 1.090000033 1 1 0.462187871 1711.318315 0 0 0 0 0 0 0 0 18.624 0 0 0 0 0 0 18.13528 0 0 0 0 0 0 0 19.69074 0 20.91103 19.22031 0 19.31653 0 20.67903 0 0 0 18.89949 0 0 0 0 0 19.12045 19.54129 18.26544 0 0 0 21.04473 21.37416 Q8NFQ8 TOIP2_HUMAN Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1) TOR1AIP2 IFRG15 LULL1 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435] ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117] GO:0001671; GO:0005783; GO:0005789; GO:0007029; GO:0016020; GO:0016021; GO:0031965; GO:0032781; GO:0051117; GO:0061024; GO:0090435 CLSHHVADAYTSSQK 2.390000105 0.054532997 0.054532997 0.353679412 1704.464782 14.06252 14.80276 0 16.30301 15.05524 0 0 13.86471 16.70971 14.28182 15.97595 15.90461 14.05404 0 0 0 0 0 0 0 0 0 0 0 0 17.04446 0 0 0 16.86955 16.90217 0 0 0 15.5504 0 0 0 0 0 0 0 0 0 0 0 12.5824 0 Q8NFR7 CC148_HUMAN Coiled-coil domain-containing protein 148 CCDC148 Homo sapiens (Human) ALTEAKK 8.779999733 1 1 0.261195744 760.7982797 0 0 19.27638 0 18.19016 0 0 0 18.7306 0 0 17.28347 16.7277 0 0 18.42081 0 17.10934 0 0 16.97689 0 0 0 0 17.15975 0 0 0 0 18.19583 0 0 19.1187 19.15662 0 20.31706 18.99152 18.09739 19.02224 0 18.27023 0 18.59643 17.20934 0 18.59297 0 Q8NFT2 STEA2_HUMAN "Metalloreductase STEAP2, EC 1.16.1.- (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer, PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1)" STEAP2 PCANAP1 STAMP1 UNQ6507/PRO23203 Homo sapiens (Human) copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; iron ion import across plasma membrane [GO:0098711]; regulated exocytosis [GO:0045055]; response to hormone [GO:0009725] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; iron ion import across plasma membrane [GO:0098711]; regulated exocytosis [GO:0045055]; response to hormone [GO:0009725] cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; metal ion binding [GO:0046872] GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006893; GO:0006897; GO:0008823; GO:0009725; GO:0010008; GO:0015677; GO:0030140; GO:0030173; GO:0045055; GO:0046872; GO:0052851; GO:0098705; GO:0098711 ILIDVSNNMR 10.47999954 1 1 0.327487958 1189.725916 0 14.03991 15.62142 0 0 0 0 0 13.53302 0 0 15.54883 13.90599 15.84502 16.6741 0 15.31431 16.17974 16.27357 14.23085 15.93249 16.30998 0 0 16.83915 0 0 0 0 15.50519 16.60269 15.51264 14.72825 18.10252 17.31736 14.07175 18.00042 18.10086 0 0 0 16.26598 0 0 0 18.45825 18.33948 15.25269 Q8NFT6 DBF4B_HUMAN "Protein DBF4 homolog B (Activator of S phase kinase-like protein 1, ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1)" DBF4B ASKL1 DRF1 Homo sapiens (Human) cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270] GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987 DGEPSPRSAAHTMPR 4.019999981 1 1 0.57070329 1625.634543 0 0 0 0 0 17.50962 0 0 0 0 0 0 0 0 18.51472 0 0 0 0 0 0 0 0 18.62142 0 0 17.33698 0 0 0 0 18.49844 0 0 0 0 17.82875 0 0 0 0 16.8931 16.74779 17.17129 0 0 0 0 Q8NFT8 DNER_HUMAN Delta and Notch-like epidermal growth factor-related receptor DNER BET UNQ262/PRO299 Homo sapiens (Human) central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888] GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741 SIVALR 4.519999981 1 1 0.123053194 660.435788 14.17271 15.91707 0 15.86292 14.72667 0 0 0 11.91175 0 0 0 0 0 15.2533 0 0 0 0 0 0 0 16.96803 0 14.55289 0 0 14.57414 15.25955 0 14.47229 0 0 0 0 0 0 0 0 0 15.67718 14.48147 15.43088 0 15.93297 16.14933 15.8324 12.38243 Q8NFU3 TSTD1_HUMAN "Thiosulfate:glutathione sulfurtransferase, TST, EC 2.8.1.-" TSTD1 KAT Homo sapiens (Human) "glucose metabolic process [GO:0006006]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; thiosulfate-thiol sulfurtransferase activity [GO:0050337]; glucose metabolic process [GO:0006006]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; thiosulfate-thiol sulfurtransferase activity [GO:0050337]" GO:0000981; GO:0003690; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0036464; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048471; GO:0050337; GO:0070221 SLGYTGAR 12.26000023 1 1 0.356277169 823.2932257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.41974 0 0 0 0 0 0 0 0 0 Q8NFU5 IPMK_HUMAN "Inositol polyphosphate multikinase, EC 2.7.1.140, EC 2.7.1.151, EC 2.7.1.153 (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)" IPMK IMPK Homo sapiens (Human) inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]" "ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" GO:0000823; GO:0000824; GO:0000825; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008440; GO:0016301; GO:0032957; GO:0032958; GO:0043647; GO:0046872; GO:0046934; GO:0047326; GO:0051765; GO:0052812; GO:0070266; GO:0097243; GO:0102732 MATEPPSPLRVEAPGPPEMR 5.519999981 1 1 0.211321632 2175.445407 15.68855 0 0 15.40332 0 14.95903 14.16647 15.41318 15.12376 15.36468 14.04283 0 0 0 0 0 15.70278 16.42665 0 0 0 16.30385 17.03812 16.20588 16.98438 0 15.36778 0 0 0 0 16.86296 17.60758 17.44016 15.34731 0 0 0 0 0 0 0 0 0 14.34899 14.77904 0 0 Q8NFU7 TET1_HUMAN "Methylcytosine dioxygenase TET1, EC 1.14.11.n2 (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein)" TET1 CXXC6 KIAA1676 LCX Homo sapiens (Human) 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oxidative demethylation [GO:0070989]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634]; Sin3 complex [GO:0016580] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oxidative demethylation [GO:0070989]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; stem cell population maintenance [GO:0019827] DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270] GO:0000122; GO:0001826; GO:0003677; GO:0005506; GO:0005634; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008284; GO:0008327; GO:0016580; GO:0019827; GO:0030336; GO:0030512; GO:0031062; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0090310; GO:1902455; GO:1902459 CGHGEEQK 1.039999962 1 1 0.321210742 945.3097356 14.32539 15.14054 15.54735 0 0 14.65171 0 14.86818 14.38973 0 0 15.37537 0 13.97256 14.91383 14.41559 0 14.98697 14.93949 0 0 13.62308 16.8454 15.54786 12.36149 0 0 14.70048 14.86125 10.32903 11.07561 15.39019 13.83595 15.87212 14.76313 13.9034 16.41491 13.14939 12.18577 16.25244 12.85061 0 0 0 0 12.4451 13.77504 16.6372 Q8NFV4 ABHDB_HUMAN "Protein ABHD11, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 11, Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein)" ABHD11 WBSCR21 PP1226 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739]; hydrolase activity [GO:0016787] hydrolase activity [GO:0016787] GO:0005739; GO:0016787 LADEQLSSVIQDMAVR 1.850000024 1 1 0.328795488 1791.612998 15.7836 0 12.43209 0 0 0 0 0 0 0 0 0 15.34381 0 14.46401 15.09686 11.19257 14.9936 0 16.6382 16.35332 0 0 0 0 0 0 13.22939 13.62303 14.75948 15.22681 14.61692 14.96237 0 11.96352 0 0 16.54107 0 13.34938 0 0 0 0 13.69905 0 0 0 Q8NFW1 COMA1_HUMAN Collagen alpha-1(XXII) chain COL22A1 Homo sapiens (Human) angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198] extracellular matrix structural constituent [GO:0005201] GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012 DGPNGPPGPPGTK 4.239999771 1 1 0.149668323 1189.602777 12.61265 13.10002 12.73503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.72435 0 11.02862 14.69984 0 0 13.07322 14.68239 0 13.72146 11.80851 14.28206 11.9969 10.00202 14.24112 0 14.37844 14.56867 13.8058 13.76041 12.05807 0 14.20025 0 13.89238 0 0 0 0 0 Q8NFW5 DMBX1_HUMAN Diencephalon/mesencephalon homeobox protein 1 (Orthodenticle homolog 3) (Paired-like homeobox protein DMBX1) DMBX1 MBX OTX3 PAXB Homo sapiens (Human) "adult feeding behavior [GO:0008343]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; central nervous system development [GO:0007417]; developmental growth [GO:0048589]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adult feeding behavior [GO:0008343]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; central nervous system development [GO:0007417]; developmental growth [GO:0048589]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007417; GO:0007420; GO:0008343; GO:0008344; GO:0042802; GO:0043565; GO:0045892; GO:0048589; GO:1990837 SRTAFTAQQLEALEK 4.820000172 1 1 9.20E-13 1693.893065 0 0 0 14.86062 0 0 0 0 14.31152 16.89529 0 0 0 0 0 0 0 0 0 15.30941 0 0 0 0 17.20343 16.72917 0 0 0 0 0 17.67082 0 0 0 0 0 0 16.87373 0 0 16.02549 0 0 0 0 0 0 Q8NFW8 NEUA_HUMAN "N-acylneuraminate cytidylyltransferase, EC 2.7.7.43 (CMP-N-acetylneuraminic acid synthase, CMP-NeuNAc synthase)" CMAS Homo sapiens (Human) N-acetylneuraminate metabolic process [GO:0006054] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054] N-acylneuraminate cytidylyltransferase activity [GO:0008781] GO:0005634; GO:0005654; GO:0006054; GO:0008781; GO:0016020 MAYYEMR 6.239999771 1 1 3.45E-13 978.8071891 0 0 0 0 0 0 0 0 0 0 0 13.97961 16.849 0 0 0 16.06928 0 0 0 16.83921 17.44436 0 0 0 0 0 0 0 0 0 0 0 17.18506 0 19.18645 0 12.71785 0 0 0 0 0 0 0 0 0 17.9708 Q8NFW9 MYRIP_HUMAN "Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C, SlaC2-c, Slp homolog lacking C2 domains c)" MYRIP SLAC2C Homo sapiens (Human) intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024] cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133] cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024] actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] GO:0000145; GO:0001750; GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0030133; GO:0030864; GO:0031045; GO:0031267; GO:0032024; GO:0042470; GO:0045202; GO:0048471; GO:0051018 GMFPRGTDQVR 3.099999905 0.492906123 0.492906123 1.60E-12 1263.74219 16.37142 0 0 0 0 0 0 13.74736 14.27641 15.81882 0 0 0 0 0 11.62845 0 0 0 0 0 0 0 0 0 0 0 15.2958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.29618 0 0 0 Q8NFY4 SEM6D_HUMAN Semaphorin-6D SEMA6D KIAA1479 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of smooth muscle cell migration [GO:0014911]; semaphorin-plexin signaling pathway [GO:0071526]; ventricular system development [GO:0021591] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of smooth muscle cell migration [GO:0014911]; semaphorin-plexin signaling pathway [GO:0071526]; ventricular system development [GO:0021591] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0005615; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0007411; GO:0009986; GO:0014911; GO:0014912; GO:0021591; GO:0030215; GO:0030335; GO:0030517; GO:0045499; GO:0048843; GO:0050919; GO:0071526 CSAENEEDKK 5.389999866 1 1 0.127178159 1209.245691 0 8.868517 13.53663 0 12.73383 12.38475 0 0 0 13.55896 0 0 15.7528 13.67217 12.0992 0 0 0 0 0 14.59213 0 13.84014 0 0 14.79234 0 15.0707 0 0 13.23471 0 17.77242 0 14.77832 0 0 0 0 0 0 0 0 0 0 15.43531 12.58132 15.21347 Q8NFY9 KBTB8_HUMAN "Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein, TA-KRP)" KBTBD8 KIAA1842 TAKRP Homo sapiens (Human) neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; spindle [GO:0005819] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417] GO:0005794; GO:0005819; GO:0005829; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463 LWDLGRHFECAVAK 4.559999943 1 1 0.212656195 1701.346141 17.81047 16.20069 14.24333 13.8747 13.57212 0 0 14.93298 0 14.63653 14.31041 0 13.2136 11.99834 0 15.61366 0 0 0 0 0 0 17.27962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFZ0 FBH1_HUMAN "F-box DNA helicase 1, hFBH1, EC 3.6.4.12 (F-box only protein 18)" FBH1 FBX18 FBXO18 Homo sapiens (Human) "cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]" chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] "chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]" 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042 QNLVIKDK 9.569999695 0.180544466 0.180544466 0.055398486 957.1214453 0 13.41236 0 15.67031 0 0 0 15.15823 11.71395 0 13.01319 14.48523 17.12663 16.14384 0 14.69755 17.55872 0 13.2687 14.30411 0 16.22692 16.70378 16.98477 0 0 11.21774 14.14145 13.61457 15.29074 17.2841 0 16.86562 15.52346 14.65314 13.20894 17.22706 15.59456 17.12142 12.6527 0 16.05796 14.71725 6.678573 16.04135 16.24435 15.83091 15.47727 Q8NFZ3 NLGNY_HUMAN "Neuroligin-4, Y-linked, Neuroligin Y" NLGN4Y KIAA0951 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625] "asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099060 VGCNMLDTTDMVECLKNK 2.99000001 1 1 0.23604663 2143.300676 0 0 0 0 0 14.11641 0 0 13.60501 0 0 0 0 0 15.88236 0 0 0 15.705 13.18897 14.57611 0 0 0 0 14.94206 16.41014 14.88227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.36883 17.88559 11.28819 0 0 14.08984 Q8NFZ4 NLGN2_HUMAN Neuroligin-2 NLGN2 KIAA1366 Homo sapiens (Human) "brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to cell surface [GO:0034394]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic transmission, GABAergic [GO:0051932]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]" "cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to cell surface [GO:0034394]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic transmission, GABAergic [GO:0051932]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]" cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023] GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007416; GO:0007420; GO:0007630; GO:0008284; GO:0009986; GO:0016020; GO:0019233; GO:0032024; GO:0032230; GO:0034394; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0045217; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051932; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0072553; GO:0072578; GO:0089717; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098609; GO:0098690; GO:0098691; GO:0098983; GO:0099054; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809 DEATLNPPDTDIRDPGK 2.920000076 1 1 0.243177331 1853.972505 0 16.63039 18.08514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG08 HELB_HUMAN "DNA helicase B, hDHB, EC 3.6.4.12" HELB Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]" 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116] GO:0000462; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006260; GO:0006269; GO:0006281; GO:0006974; GO:0016887; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042 GGCGK 3.380000114 1 1 0.284707234 477.8352091 18.09105 0 17.19794 17.86814 19.22245 0 19.74823 0 0 0 18.38394 0 0 0 19.31128 18.5539 19.44123 16.70304 0 0 0 0 0 18.00004 0 20.48185 0 0 0 0 19.75352 17.25979 19.60422 18.17653 18.69807 0 19.01214 0 18.11659 18.84989 17.89977 0 0 0 0 19.0961 0 0 Q8NG27 PJA1_HUMAN "E3 ubiquitin-protein ligase Praja-1, Praja1, EC 2.3.2.27 (RING finger protein 70) (RING-type E3 ubiquitin transferase Praja-1)" PJA1 RNF70 Homo sapiens (Human) protein catabolic process [GO:0030163] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein catabolic process [GO:0030163] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0005737; GO:0030163; GO:0046872; GO:0061630 SLAGPPPHFSSFSR 6.260000229 0.004529997 0.004529997 0.148997712 1486.797081 17.50968 14.97254 16.96315 14.99164 15.08373 17.38585 11.68874 0 13.22956 15.06043 16.7263 15.32612 15.06034 13.45791 0 14.72903 15.10908 14.4026 10.85843 0 14.62359 15.65603 13.42908 15.35468 15.69998 0 12.79276 0 15.34239 13.30611 0 17.0361 12.35565 14.85127 0 15.16165 16.3298 14.36271 15.84142 10.61386 0 11.51586 0 0 15.26771 14.37462 16.78095 0 Q8NG48 LINES_HUMAN Protein Lines homolog 1 (Wnt-signaling molecule Lines homolog 1) LINS1 LINS WINS1 Homo sapiens (Human) cognition [GO:0050890] cognition [GO:0050890] GO:0050890 AVMSK 3.470000029 1 1 0.183595044 552.3813725 14.82948 0 0 15.31588 15.97046 14.71075 15.88161 0 0 0 8.881319 0 14.6869 14.6602 16.22388 15.73207 15.955 15.387 0 14.43723 0 0 15.41516 0 0 0 0 15.18657 0 15.46939 0 0 0 0 0 16.04501 0 16.8064 0 0 15.96735 0 0 0 0 0 0 0 Q8NG66 NEK11_HUMAN "Serine/threonine-protein kinase Nek11, EC 2.7.11.1 (Never in mitosis A-related kinase 11, NimA-related protein kinase 11)" NEK11 Homo sapiens (Human) chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006468; GO:0007059; GO:0016572; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990 EPTLQNHL 9.890000343 1 1 0.111888246 953.6622754 12.92837 0 15.95826 0 0 0 0 0 0 0 15.35704 14.62938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41178 0 0 0 0 17.92368 0 0 0 0 0 0 16.26665 0 0 0 0 0 0 0 0 0 Q8NG75 OR5T1_HUMAN Olfactory receptor 5T1 (Olfactory receptor OR11-179) OR5T1 OR5T1P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 MQSAEGRR 5.420000076 0.685964525 0.685964525 0.074041043 934.6873291 17.6311 0 12.67325 0 16.26812 14.76192 13.18509 14.11683 13.71927 16.21432 16.26668 0 0 0 0 0 0 12.77489 17.12341 14.30555 14.17386 16.55249 13.7274 15.83719 16.37735 15.60963 13.98276 13.92009 0 0 0 17.42712 12.90001 17.26114 16.6895 13.22931 0 12.75928 0 12.82762 14.82635 13.90704 15.75925 0 16.78682 14.76453 12.0386 15.31806 Q8NG76 O2T33_HUMAN Olfactory receptor 2T33 (Olfactory receptor OR1-56) OR2T33 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 WLGTCVNIK 1.899999976 1 1 0.151684824 1088.881725 0 0 0 14.56538 0 0 0 0 14.89826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.83287 0 0 0 0 13.35954 13.02647 15.91378 0 13.74636 13.79372 0 0 0 0 0 14.25971 0 0 0 0 0 14.26467 Q8NGA1 OR1M1_HUMAN "Olfactory receptor 1M1 (Olfactory receptor 19-6, OR19-6) (Olfactory receptor OR19-5)" OR1M1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 EKASAVMYTAVTPMLNPFIYSLR 2.970000029 1 1 5.03E-12 2617.283378 0 13.02523 12.24265 13.21406 0 13.55658 10.67101 14.30081 0 0 0 0 0 0 13.40513 14.0816 14.34037 14.96981 13.52529 0 0 0 0 0 0 0 15.41825 0 0 0 0 0 0 0 0 0 16.65932 0 0 0 15.49544 12.35192 13.07932 0 0 0 0 0 Q8NGB8 O4F15_HUMAN Olfactory receptor 4F15 (Olfactory receptor OR15-14) OR4F15 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 LAHFTKIL 8.779999733 1 1 0.227417826 942.2625169 0 15.23804 0 0 0 0 0 0 16.22638 16.49289 0 0 16.5484 0 0 0 0 14.56014 0 0 0 0 16.21954 15.05383 16.71303 0 0 15.62017 0 0 0 17.13464 0 0 0 0 0 0 16.12136 0 17.5756 0 0 0 15.01967 0 0 0 Q8NGC5 OR6J1_HUMAN Olfactory receptor 6J1 (Olfactory receptor 6J2) OR6J1 OR6J2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 GVFEKR 7.170000076 0.194044396 0.194044396 0.153213938 735.3342086 16.79948 18.19866 0 0 0 0 0 0 15.82906 0 0 7.987227 18.14645 10.1449 15.46085 0 15.6041 0 17.08008 17.60282 0 0 16.23836 16.70794 13.43703 0 0 18.61351 16.82789 16.62255 16.26405 17.12563 16.95288 17.67579 15.88561 16.45444 0 0 0 0 0 0 18.17162 0 17.32549 16.52249 15.75324 17.30602 Q8NGE0 O10AD_HUMAN Olfactory receptor 10AD1 (Olfactory receptor OR12-1) OR10AD1 OR10AD1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 ALLFALFLALYSLTMAMNGLIIFITSWTDPK 3.420000076 0.921778977 0.921778977 0.178119335 3490.666333 14.85419 0 10.97891 0 0 0 0 0 0 0 13.30289 0 13.52953 0 0 13.98189 15.02766 11.26667 0 0 14.90282 0 0 8.408895 0 0 0 11.00037 15.69656 0 14.28996 14.41899 0 14.8048 13.6957 0 13.04743 14.14305 0 14.97531 0 0 0 0 0 0 0 0 Q8NGF1 O52R1_HUMAN Olfactory receptor 52R1 (Olfactory receptor OR11-22) OR52R1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 LVCADTSISR 6.420000076 0.390847802 0.390847802 0.330593202 1121.797941 0 0 0 0 0 0 15.96725 0 0 0 17.11238 0 0 0 20.33398 20.24526 19.20216 17.05758 15.90748 0 0 0 18.39412 19.56125 16.13074 0 16.72982 0 0 0 0 0 0 0 0 0 0 18.66831 0 0 0 0 0 0 17.50074 0 0 0 Q8NGF3 O51D1_HUMAN Olfactory receptor 51D1 (Olfactory receptor OR11-14) OR51D1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 IGLSALTR 8.31000042 1 1 1.19E-13 829.2351557 0 0 0 0 0 17.10092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.36628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGI1 O56B2_HUMAN Putative olfactory receptor 56B2 OR56B2P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 LGVKGT 2.210000038 1 1 0.176708596 575.7382149 16.36747 16.12454 0 14.60522 0 0 0 0 0 0 15.09584 0 0 0 0 0 0 0 0 0 14.24031 0 0 0 0 17.00413 0 17.00078 16.36713 0 0 0 0 0 16.56419 0 0 0 0 16.28773 15.3515 0 0 0 0 0 0 0 Q8NGI3 O56B1_HUMAN Olfactory receptor 56B1 (Olfactory receptor OR11-65) OR56B1 OR56B1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 MNHMSASLKISNSSK 6.309999943 1 1 0.320722516 1650.345331 0 0 15.79328 0 14.96462 0 0 0 0 0 14.99745 0 0 15.11047 0 16.38164 0 0 16.34894 15.23111 16.46326 15.76836 0 0 16.41576 0 16.43023 17.25054 14.9321 0 16.21777 0 15.45526 0 0 0 0 0 0 17.6064 16.48664 0 17.15066 15.62852 0 16.4226 0 15.53041 Q8NGI4 OR4DB_HUMAN Olfactory receptor 4D11 OR4D11 OR4D11P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 ELGNVTRVK 1.870000005 1 1 0.29219027 1015.838973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.15523 0 0 0 0 0 0 0 0 0 0 0 0 17.93426 0 0 0 0 0 15.27236 0 0 0 19.32884 0 0 Q8NGI9 OR5A2_HUMAN Olfactory receptor 5A2 (Olfactory receptor OR11-248) OR5A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 EIKNAMR 6.159999847 0.4893336 0.4893336 0.199844897 862.687715 15.38357 13.95793 0 13.69495 15.08685 13.42162 0 13.10072 13.9891 15.03671 14.91651 0 17.07758 0 0 15.23267 15.41478 15.38731 14.50145 15.76304 15.33496 16.67469 15.12733 15.68598 0 0 0 0 16.07201 0 0 0 0 15.52128 0 0 0 15.82487 16.21099 16.46877 14.63034 0 0 15.24174 0 0 15.17472 16.52808 Q8NGJ0 OR5A1_HUMAN Olfactory receptor 5A1 (OST181) (Olfactory receptor OR11-249) OR5A1 OR5A1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 YAAISSPLLYPTIMTQGLCTR 4.380000114 1 1 0.142341954 2371.763813 14.04268 15.94633 0 0 12.16449 11.68422 13.8958 10.94339 12.50282 12.94506 10.24326 4.075396 12.6254 9.157925 12.47514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGJ9 O51T1_HUMAN Olfactory receptor 51T1 (Olfactory receptor OR11-26) OR51T1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 TVLGIVARK 6.550000191 1 1 0.018601735 954.5096027 15.81598 14.89733 15.41636 0 0 15.53142 0 0 14.27465 0 0 0 14.62601 0 0 0 0 12.28496 14.28687 0 0 0 0 0 0 16.17681 0 17.63188 13.99879 15.08876 0 0 0 0 14.71841 0 0 0 0 0 0 0 0 0 0 15.99813 0 13.92397 Q8NGL3 OR5DE_HUMAN Olfactory receptor 5D14 (Olfactory receptor OR11-141) (Olfactory receptor OR11-150) OR5D14 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 FVAICNPLLYTVAMSQR 1.399999976 0.679116666 0.679116666 0.183512567 1999.903534 17.9063 0 0 0 0 15.16244 0 14.68141 0 0 15.97901 0 0 0 13.66547 0 0 0 0 0 0 0 15.47313 0 0 0 17.05471 15.61083 15.10397 0 0 16.38766 0 0 0 0 14.78153 0 0 0 0 0 0 15.27576 0 0 0 0 Q8NGL6 O4A15_HUMAN Olfactory receptor 4A15 (Olfactory receptor OR11-118) OR4A15 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 HLSPTPSEEHMK 4.539999962 1 1 0.248798288 1409.362742 11.48303 0 14.0654 0 13.12794 15.71382 14.85007 0 0 13.75287 0 0 0 0 10.49732 0 0 0 16.09409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.99904 0 0 0 0 0 0 0 0 0 0 0 Q8NGL9 OR4CG_HUMAN Olfactory receptor 4C16 (Olfactory receptor OR11-135) OR4C16 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 KLITDDK 9.960000038 0.42115435 0.42115435 0.303766235 831.8973833 16.10101 18.42504 0 0 0 18.22804 0 16.86324 19.03564 0 0 0 0 16.7148 16.42396 17.56874 0 0 0 0 0 0 0 0 19.15072 20.07875 0 0 0 0 0 0 0 19.25742 0 0 0 20.02872 0 0 0 0 0 0 0 18.2915 0 0 Q8NGN0 OR4D5_HUMAN Olfactory receptor 4D5 (Olfactory receptor OR11-276) OR4D5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 AVSVLYTIVTPMLNPAIYTLR 3.24000001 1 1 0 2350.41003 15.64475 17.35285 17.84499 10.36672 15.03263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.42341 Q8NGP3 OR5M9_HUMAN Olfactory receptor 5M9 (Olfactory receptor OR11-190) OR5M9 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 DVKEAVNK 6.96999979 1 1 0.161025036 901.7387072 14.48008 16.14688 13.48163 0 14.46128 14.98246 15.34868 11.73149 0 13.87828 13.45455 15.76625 0 0 0 0 0 0 0 0 0 16.04989 15.24225 0 15.13607 0 0 0 0 0 0 0 15.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGQ6 OR9I1_HUMAN Olfactory receptor 9I1 (Olfactory receptor OR11-228) OR9I1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 SSGGR 3.5 1 1 0.226683944 462.4835237 15.80965 15.58921 15.04691 15.8992 17.13382 14.67466 15.26137 11.92104 15.29654 16.04277 14.58027 14.95393 16.38957 15.79896 15.92122 15.61323 16.52737 15.00277 16.58448 15.70328 0 15.06139 15.24099 17.10817 16.49502 0 14.08243 0 0 14.71132 16.14432 15.95331 14.84136 16.33405 0 16.65946 16.22355 15.47511 15.9703 16.16887 0 16.24995 15.29898 0 15.25527 0 15.67769 0 Q8NGS0 OR1N1_HUMAN "Olfactory receptor 1N1 (Olfactory receptor 1-26, OR1-26) (Olfactory receptor 1N3) (Olfactory receptor OR9-22)" OR1N1 OR1N3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 SIVSS 9.93999958 1 1 0.262327196 492.6787842 0 20.12928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0576 0 0 19.9101 20.53351 0 0 0 0 0 0 0 0 0 17.84041 0 0 19.93264 19.31016 0 0 0 0 18.89099 0 0 0 0 0 0 17.18236 Q8NGS2 OR1J2_HUMAN Olfactory receptor 1J2 (HSA5) (HTPCRX15) (OST044) (Olfactory receptor 1J3) (Olfactory receptor 1J5) (Olfactory receptor OR9-19) OR1J2 OR1J3 OR1J5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 DMKEALGK 8.800000191 0.410874605 0.410874605 0.277704373 906.6813572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.73105 0 17.0506 0 0 0 0 0 17.27028 0 0 18.45187 0 0 0 0 0 18.27713 0 0 18.38548 18.3647 0 0 17.82278 0 0 Q8NGU2 OR9A4_HUMAN Olfactory receptor 9A4 (Olfactory receptor OR7-1) OR9A4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 SNVVNNFFCDR 8.989999771 1 1 0.118135722 1372.1065 11.5973 0 14.13998 0 0 0 11.5347 13.71132 13.37003 0 12.30695 13.62567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.51727 9.896397 0 15.53028 0 0 0 0 13.45808 0 0 0 0 0 0 Q8NGY3 OR6K3_HUMAN Olfactory receptor 6K3 (Olfactory receptor OR1-18) OR6K3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 NKDMNNAIK 8.420000076 0.369807243 0.369807243 0.113368866 1064.559941 15.19441 16.98384 18.07832 14.595 0 13.54086 0 14.8761 0 0 14.22406 17.19141 13.47941 0 0 0 15.52642 16.01439 14.10501 0 14.70924 0 14.86985 0 0 0 16.50197 13.20319 0 18.3559 14.16151 18.72232 0 14.75091 16.88958 14.37835 17.10119 12.67274 0 0 0 0 15.4281 17.34791 0 0 15.5853 0 Q8NH00 OR2T4_HUMAN Olfactory receptor 2T4 (Olfactory receptor OR1-60) OR2T4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 DVMGALKK 6.119999886 0.018367356 0.018367356 0.139590457 861.0016457 16.83533 14.81522 13.84252 0 12.28104 10.37085 0 16.18136 16.53256 15.07771 14.16817 0 15.11476 0 0 16.32256 0 0 19.71271 13.44803 17.39168 17.4691 17.86035 0 0 17.34216 17.29659 17.64904 0 17.60797 15.05122 17.77976 0 12.16101 15.76532 15.73424 13.91222 14.53791 17.91632 0 0 0 11.03226 0 15.02745 17.4472 18.53832 14.6464 Q8NH48 OR5B3_HUMAN Olfactory receptor 5B3 (Olfactory receptor 5B13) (Olfactory receptor OR11-239) OR5B3 OR5B13 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 MAPVFYTMVIPMLNPLVYSLR 4.480000019 1 1 0.286955988 2471.589459 14.47745 14.56388 15.25115 0 0 0 0 14.7378 0 0 0 14.06719 0 0 0 14.29554 0 0 0 0 0 0 17.20183 15.31129 15.93868 0 16.24872 0 0 0 0 0 0 0 0 0 0 0 0 15.41682 0 14.86673 16.43797 0 0 0 0 0 Q8NH59 O51Q1_HUMAN Olfactory receptor 51Q1 OR51Q1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 NILGTATWAER 4.409999847 1 1 0.301893023 1231.505252 16.11076 0 10.41548 0 0 0 14.9158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.63599 14.95779 15.43168 16.52322 14.34009 15.22659 14.38455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH61 O51F2_HUMAN Olfactory receptor 51F2 (Olfactory receptor OR11-23) OR51F2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 VLIQKHSK 3.650000095 1 1 0.122871389 952.3822553 0 0 13.9251 13.58138 0 10.92689 0 10.33571 14.42296 12.73005 0 0 0 0 0 0 0 0 0 0 15.0956 0 0 0 0 15.60266 0 0 15.62089 0 15.62986 0 0 0 0 0 0 16.67534 0 0 15.95455 0 0 0 0 0 0 15.06067 Q8NH72 OR4C6_HUMAN Olfactory receptor 4C6 (Olfactory receptor OR11-138) OR4C6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 AMAVSDSIITPMLNPLIYTLRNAEVK 4.869999886 1 1 3.66E-12 2875.503634 12.76775 14.64179 0 0 0 14.5729 0 13.48813 14.04089 0 0 0 0 12.40161 0 0 13.83423 0 0 0 12.08591 0 0 11.68659 16.71675 0 0 0 0 13.29452 14.69795 0 0 10.68146 0 0 0 16.00505 0 0 14.71529 12.67964 0 11.68368 0 0 0 0 Q8NH76 O56B4_HUMAN Olfactory receptor 56B4 (Olfactory receptor OR11-67) OR56B4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 LNSAEAMSK 1.450000048 1 1 0.259011743 966.4609001 0 0 16.40199 0 0 0 0 0 0 16.87176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.41533 0 0 0 15.59225 17.57338 0 18.17322 0 17.74036 0 0 0 18.21219 19.24012 0 16.92784 0 0 0 0 0 0 0 Q8NH87 OR9G1_HUMAN Olfactory receptor 9G1 (Olfactory receptor 9G5) (Olfactory receptor OR11-114) OR9G1 OR9G5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 ISSSK 12.14999962 0.849684656 0.849684656 0.206335138 521.5274224 0 15.13375 16.61545 0 0 0 16.16324 0 16.51393 0 0 0 15.88151 0 16.71904 15.99749 0 15.76914 16.42682 0 16.62631 0 16.22574 0 16.06667 16.22973 16.98014 0 16.1653 16.15593 16.25411 0 17.07405 16.70139 16.14857 16.78255 16.0884 15.43074 16.3885 16.38796 15.95237 15.72684 15.88292 0 16.25285 0 0 0 Q8NHC5 O14AG_HUMAN Olfactory receptor 14A16 (Olfactory receptor 5AT1) (Olfactory receptor OR1-45) OR14A16 OR5AT1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 VALGMLIK 3.940000057 1 1 0.318178683 844.7451298 15.23938 12.19818 14.31482 0 0 0 16.24934 14.30338 16.48208 15.81575 14.49755 0 16.70966 0 0 0 0 15.81872 0 14.42761 0 0 15.66878 15.31489 0 0 16.16066 0 12.27732 0 0 0 0 0 15.08965 0 0 0 0 0 0 0 13.37962 14.81461 0 10.86714 0 15.58673 Q8NHC8 OR2T6_HUMAN Olfactory receptor 2T6 (OST703) (Olfactory receptor 2T9) OR2T6 OR2T6P OR2T9 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 ILITVHQMTSAEGRK 4.099999905 1 1 0.475324466 1699.306923 15.60757 15.374 13.43421 0 0 13.52354 15.96646 11.2973 0 15.10924 15.08853 16.47974 0 0 0 0 0 0 0 0 0 0 0 0 0 16.33156 0 0 0 0 0 0 0 0 0 0 0 16.12434 0 15.07873 15.71322 0 0 0 0 0 0 16.42317 Q8NHH9 ATLA2_HUMAN "Atlastin-2, EC 3.6.5.- (ADP-ribosylation factor-like protein 6-interacting protein 2, ARL-6-interacting protein 2, Aip-2)" ATL2 ARL6IP2 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] GO:0003924; GO:0005525; GO:0005783; GO:0007029; GO:0007030; GO:0016020; GO:0016021; GO:0042802; GO:0051260; GO:0098826; GO:1990809 IYQGEELPHPKSMLQATAEANNLAAVAGAR 5.150000095 1 1 1.83E-12 3165.911607 14.2198 12.47084 12.5677 15.04633 0 0 0 13.44536 15.36809 0 0 0 0 0 0 11.30717 0 10.79281 0 12.6688 15.33252 13.20987 13.69219 0 0 8.95488 0 0 0 0 14.75237 13.97567 0 0 0 0 12.98702 0 0 10.3239 11.95483 0 0 0 0 0 0 0 Q8NHM5 KDM2B_HUMAN "Lysine-specific demethylase 2B, EC 1.14.11.27 (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein, Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B)" KDM2B CXXC2 FBL10 FBXL10 JHDM1B NDY1 PCCX2 Homo sapiens (Human) chromatin organization [GO:0006325]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] GO:0000122; GO:0000978; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0007283; GO:0008270; GO:0019843; GO:0021555; GO:0021592; GO:0021670; GO:0021678; GO:0021993; GO:0030307; GO:0030900; GO:0030901; GO:0030902; GO:0032452; GO:0035518; GO:0043524; GO:0045322; GO:0048596; GO:0051864; GO:0070544; GO:0140680; GO:1902459; GO:2000178 KPKAPALR 8.840000153 1 1 0.616698894 878.746372 0 0 0 0 18.98269 18.58655 0 0 0 0 18.13585 0 0 0 0 0 16.51742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.88981 0 0 0 18.67394 0 0 18.33709 0 0 0 0 Q8NHP1 ARK74_HUMAN "Aflatoxin B1 aldehyde reductase member 4, EC 1.-.-.- (AFB1 aldehyde reductase 3, AFB1-AR 3) (Aldoketoreductase 7-like)" AKR7L AFAR3 AKR7A4 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldo-keto reductase (NADP) activity [GO:0004033] aldo-keto reductase (NADP) activity [GO:0004033] GO:0004033; GO:0005737; GO:0005829; GO:0070062 ARPATVLGAMEMGR 3.890000105 0.479316264 0.479316264 0.490209594 1475.605784 10.71179 13.20141 16.14068 15.15782 15.38175 14.11727 0 0 15.73198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.12955 16.07228 15.88439 0 17.06097 0 17.18105 0 0 17.49113 0 0 17.93539 0 16.60938 17.46573 16.34888 0 0 16.8377 16.12091 15.82469 Q8NHP6 MSPD2_HUMAN Motile sperm domain-containing protein 2 MOSPD2 Homo sapiens (Human) chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023] GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0035579; GO:0044232; GO:0090023; GO:0090026; GO:0140284 YHVKDQK 1.210000038 1 1 0.212903167 917.9400077 13.84597 14.40931 15.07742 15.38029 14.80561 14.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHQ1 CEP70_HUMAN "Centrosomal protein of 70 kDa, Cep70 (p10-binding protein)" CEP70 BITE Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507] centrosome [GO:0005813]; cytosol [GO:0005829] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507] gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802] GO:0005813; GO:0005829; GO:0042802; GO:0043015; GO:0060271; GO:0070507 RVPHTVLDR 4.949999809 1 1 0.623661774 1092.373904 17.23188 0 0 0 0 0 0 0 0 0 0 0 0 0 17.87436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.48878 0 0 0 0 Q8NHQ9 DDX55_HUMAN "ATP-dependent RNA helicase DDX55, EC 3.6.4.13 (DEAD box protein 55)" DDX55 KIAA1595 Homo sapiens (Human) cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887 LEDMFR 20.45000076 0.332799613 0.332799613 0.206634137 810.7718936 0 20.77423 21.17211 19.37641 17.56013 17.65058 17.50826 16.17527 17.1593 17.18993 18.71129 17.79763 0 17.75574 0 16.54154 0 0 17.96041 0 18.09383 0 0 0 18.57244 16.76759 0 17.10678 0 0 17.8002 0 0 0 0 0 0 17.95463 18.6671 18.67322 17.79892 18.06501 18.11425 17.73173 16.60547 18.58229 18.3726 0 Q8NHS4 CLHC1_HUMAN Clathrin heavy chain linker domain-containing protein 1 CLHC1 C2orf63 Homo sapiens (Human) KAILCLCK 4.059999943 0.529860497 0.529860497 0.242901741 1005.391359 13.7559 14.78775 15.05686 0 15.10602 0 13.68038 0 12.70295 15.70647 15.72393 13.57048 14.092 15.05521 12.97391 0 0 15.51255 0 0 0 0 15.1536 16.37011 16.40869 15.7225 14.36494 14.85869 0 15.49031 0 0 16.92891 15.00933 0 14.38529 0 17.05588 15.9032 0 15.15063 16.05738 0 0 0 15.93875 15.22866 15.28056 Q8NHU6 TDRD7_HUMAN "Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2, Trap)" TDRD7 PCTAIRE2BP Homo sapiens (Human) lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283] mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485] GO:0002089; GO:0003729; GO:0005737; GO:0005759; GO:0007283; GO:0010608; GO:0030719; GO:0033391; GO:0034587; GO:0035770; GO:0043186; GO:0047485; GO:0070306 GNSVGVKPDAEMSPYMLHTTLGNEAFK 3.529999971 1 1 5.03E-12 2909.958347 0 0 0 17.92217 0 0 13.94271 0 0 0 13.95831 10.99418 0 14.41362 0 0 0 15.22083 0 0 0 0 15.70174 0 0 17.95292 0 8.473534 14.89456 0 0 0 0 0 0 17.15109 0 18.18614 0 16.49824 0 0 15.69855 15.16484 15.7881 0 14.63142 16.54904 Q8NHX4 SPTA3_HUMAN Spermatogenesis-associated protein 3 (Testis and spermatogenesis cell-related protein 1) (Testis spermatocyte apoptosis-related protein 1) SPATA3 TSARG1 Homo sapiens (Human) NCGCGSGGSR 7.400000095 1 1 0.000189343 1010.634509 0 15.94841 0 16.55575 16.08092 13.4781 0 0 16.45144 0 0 0 13.45479 0 0 0 0 0 0 0 15.89838 0 0 0 0 0 0 12.39572 0 0 17.55278 15.15423 18.52455 0 0 15.31429 0 0 0 0 0 0 0 0 14.85714 0 0 0 Q8NHX9 TPC2_HUMAN Two pore channel protein 2 (Two pore calcium channel protein 2) TPCN2 TPC2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cellular calcium ion homeostasis [GO:0006874]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; ion transmembrane transport [GO:0034220]; lysosome organization [GO:0007040]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of ion transmembrane transport [GO:0034765]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725] cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] "cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; cellular calcium ion homeostasis [GO:0006874]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; ion transmembrane transport [GO:0034220]; lysosome organization [GO:0007040]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of ion transmembrane transport [GO:0034765]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]" "identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]" GO:0005245; GO:0005764; GO:0005765; GO:0005829; GO:0006874; GO:0006939; GO:0007040; GO:0010008; GO:0010506; GO:0015280; GO:0016021; GO:0017157; GO:0019065; GO:0019722; GO:0019901; GO:0031902; GO:0034220; GO:0034765; GO:0035725; GO:0036020; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0090117; GO:0097682 VQLDSSHK 6.829999924 1 1 1.03E-12 912.3330881 14.57777 0 0 13.54338 0 14.44071 14.66255 13.08461 14.99671 14.23536 0 14.75193 13.75991 13.24443 0 14.32464 13.20238 14.71319 0 0 0 0 15.38128 15.20375 14.44093 13.9182 15.43674 14.4328 14.75359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHY2 COP1_HUMAN "E3 ubiquitin-protein ligase COP1, EC 2.3.2.27 (Constitutive photomorphogenesis protein 1 homolog, hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2)" COP1 RFWD2 RNF200 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005654; GO:0005829; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630 MSGSR 9.550000191 0.403381765 0.403381765 0.213470018 537.7311808 15.58307 18.99248 15.63805 15.57303 14.44469 15.74539 15.79765 0 14.89287 16.65062 18.01513 13.95032 0 16.39257 15.37109 13.28395 15.92298 15.2389 14.68375 15.627 0 0 0 0 0 0 0 13.02861 13.85933 0 15.51199 0 0 0 0 0 17.99129 0 17.13295 14.18794 15.68202 0 17.90009 0 0 0 16.08782 16.35764 Q8NHY5 HUS1B_HUMAN "Checkpoint protein HUS1B, hHUS1B" HUS1B Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723] checkpoint clamp complex [GO:0030896]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861] checkpoint clamp complex [GO:0030896]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861]; double-strand break repair via homologous recombination [GO:0000724]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723] GO:0000723; GO:0000724; GO:0005730; GO:0006289; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778 AARSAAGASSLK 16.29000092 0.529487967 0.529487967 0.235295086 1090.149863 0 15.1292 15.19864 14.29068 15.47994 0 15.58898 12.05241 12.20151 15.79359 13.79746 13.21457 17.52066 0 0 0 0 15.20166 0 0 0 16.65655 0 0 0 0 0 14.67597 13.49984 0 15.49237 14.83804 16.27555 16.7292 14.60859 0 15.00127 0 0 15.99707 16.3334 0 0 0 0 13.80082 13.19356 14.91053 Q8NHY6 ZFP28_HUMAN "Zinc finger protein 28 homolog, Zfp-28 (Krueppel-like zinc finger factor X6)" ZFP28 KIAA1431 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 EPTPLPGRGAPR 22.43000031 0.64673543 0.64673543 0.397149428 1248.03885 0 0 0 18.42428 0 0 0 0 0 16.79492 14.26286 0 0 0 0 0 0 0 0 0 16.836 0 18.0828 0 0 0 0 0 0 0 0 0 0 18.43954 0 18.68909 0 0 0 0 18.6549 18.47647 0 18.21035 0 0 0 18.39868 Q8NI08 NCOA7_HUMAN Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1) NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 Homo sapiens (Human) negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979] nucleus [GO:0005634] nucleus [GO:0005634]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979] nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374] GO:0005634; GO:0006357; GO:0006979; GO:0016922; GO:0030374; GO:0045944; GO:1900408; GO:1902083; GO:1903204 ETSHGSPTVTK 4.260000229 1 1 0.404349267 1143.254313 0 0 15.36957 0 0 14.96756 0 15.56975 0 14.72944 15.2373 0 0 13.40468 0 0 0 17.04504 0 0 0 0 0 0 0 16.91998 0 0 17.09864 15.47164 0 0 0 0 0 0 16.93496 0 0 0 0 15.51523 0 0 0 0 0 0 Q8NI27 THOC2_HUMAN "THO complex subunit 2, Tho2 (hTREX120)" THOC2 CXorf3 Homo sapiens (Human) generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] mRNA binding [GO:0003729] GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0016973; GO:0046784; GO:0048666; GO:0048699 NETYNSHPLLVKVK 14.02999973 1 1 0 1642.426594 0 0 15.16949 0 0 0 14.53677 13.70632 0 0 16.08287 15.48786 0 0 0 0 13.54845 0 0 0 0 15.97419 0 0 0 0 14.89761 0 14.70364 0 0 15.20848 0 0 0 0 0 0 0 0 14.11361 0 0 0 12.33657 0 0 0 Q8NI32 LPD6B_HUMAN Ly6/PLAUR domain-containing protein 6B LYPD6B Homo sapiens (Human) anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetylcholine receptor regulator activity [GO:0030548] acetylcholine receptor regulator activity [GO:0030548] GO:0005576; GO:0005886; GO:0030548; GO:0031225 STSITKK 5.769999981 1 1 0.094816129 764.3053715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.80334 0 0 0 14.9463 0 0 0 14.95501 15.77342 0 0 0 14.70902 15.08178 15.07806 16.31335 14.57244 0 0 14.71135 0 0 0 0 16.54611 0 0 0 0 0 Q8NI35 INADL_HUMAN "InaD-like protein, Inadl protein, hINADL (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions)" PATJ CIPP INADL Homo sapiens (Human) establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192] apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192] GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0016324; GO:0030054; GO:0031023; GO:0034451; GO:0035089; GO:0035556; GO:0043296; GO:0045177; GO:0045197; GO:0048471; GO:0070062; GO:0070507; GO:0120192 GGAADLDGR 11.22000027 1 1 0.159000095 833.5327277 15.50249 0 0 0 0 0 0 0 15.43678 0 0 0 0 0 0 15.25048 0 0 16.11684 0 0 0 0 0 16.16653 0 0 14.59359 14.57317 13.04711 0 0 0 14.81718 14.52123 14.65084 16.08287 0 0 0 14.88069 15.94179 14.49789 0 0 0 15.46016 14.85488 Q8NI36 WDR36_HUMAN "WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein, TA-WDRP)" WDR36 Homo sapiens (Human) response to stimulus [GO:0050896]; rRNA processing [GO:0006364]; visual perception [GO:0007601] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; response to stimulus [GO:0050896]; rRNA processing [GO:0006364]; visual perception [GO:0007601] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0050896 KLINQMR 13.5 0.983242869 0.983242869 0.189003735 917.3647942 17.97239 17.49106 17.26583 0 18.21901 16.89772 16.87239 16.10705 15.139 17.42126 0 14.67516 15.27208 14.98073 15.80897 0 16.05233 0 18.64904 0 0 18.04987 0 16.03576 0 14.45539 16.08033 0 0 17.08501 15.06964 16.41506 15.05043 14.92817 0 0 0 16.73358 0 15.8434 17.27298 18.55781 17.64362 0 0 17.27856 17.37079 0 Q8NI60 COQ8A_HUMAN "Atypical kinase COQ8A, mitochondrial, EC 2.7.-.- (Chaperone activity of bc1 complex-like, Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)" COQ8A ADCK3 CABC1 PP265 Homo sapiens (Human) phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301] GO:0005524; GO:0005739; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531 IGRLANFGGLAVGLGFGALAEVAK 5.869999886 1 1 0.236403052 2299.445699 0 0 0 0 0 13.0021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.91638 0 12.66416 0 0 0 0 0 12.13398 0 0 8.49739 0 0 11.49863 0 15.3624 0 0 0 0 0 0 Q8NI77 KI18A_HUMAN "Kinesin-like protein KIF18A (Marrow stromal KIF18A, MS-KIF18A)" KIF18A OK/SW-cl.108 Homo sapiens (Human) cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520] actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463] GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023 HSMPVPSMVPSYMAMTTAAK 2.380000114 1 1 0.225016908 2147.04313 17.04313 0 0 0 17.56128 0 16.10745 0 12.56298 15.01201 0 0 0 0 0 0 0 0 11.82652 0 15.60026 0 0 0 13.86297 0 15.60367 0 14.44631 11.0175 13.99504 15.62167 15.69655 0 0 0 0 0 0 0 0 0 11.24052 15.5673 0 0 10.79859 14.18564 Q8TA86 RP9_HUMAN "Retinitis pigmentosa 9 protein (Pim-1-associated protein, PAP-1)" RP9 Homo sapiens (Human) cognition [GO:0050890]; RNA splicing [GO:0008380] nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785] nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cognition [GO:0050890]; RNA splicing [GO:0008380] metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005785; GO:0008380; GO:0046872; GO:0050890 EDVGAAGAR 8.670000076 1 1 0.15284888 846.5268097 12.91017 0 0 0 15.68289 0 14.69535 0 15.48174 18.18818 0 18.36215 0 15.20568 16.45511 0 15.2597 15.03151 0 0 14.92202 15.23842 0 17.85408 16.20265 0 17.62711 0 0 0 14.8018 18.09722 17.71051 16.5959 0 15.45854 0 0 14.22211 15.90266 14.4426 15.55262 14.3337 14.40312 13.69946 17.17776 0 0 Q8TA94 ZN563_HUMAN Zinc finger protein 563 ZNF563 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AFFWPSLLRMHER 4.300000191 1 1 0.041682264 1706.470566 11.70058 0 11.97317 0 15.38984 0 0 14.34365 13.15133 0 0 0 14.12049 15.19084 0 0 13.1719 13.20691 0 0 13.03343 14.45461 0 15.01029 14.49461 11.39088 0 14.44728 0 14.42422 13.11337 0 12.90245 15.51003 0 15.72927 0 0 0 13.75415 0 0 12.29729 0 0 0 0 0 Q8TAE7 KCNG3_HUMAN Potassium voltage-gated channel subfamily G member 3 (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3) KCNG3 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805 ERNEYFFDR 2.640000105 1 1 0.135578166 1278.532 14.34616 16.07056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.69493 0 0 0 0 0 0 13.13928 0 0 0 0 14.77902 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAF3 WDR48_HUMAN WD repeat-containing protein 48 (USP1-associated factor 1) (WD repeat endosomal protein) (p80) WDR48 KIAA1449 UAF1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283] DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005654; GO:0005764; GO:0005770; GO:0005829; GO:0006974; GO:0007283; GO:0007338; GO:0016579; GO:0035264; GO:0043130; GO:0043231; GO:0043588; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1903003; GO:1905168 DAGFSSPDGSDPK 5.519999981 1 1 0.225463647 1280.142376 16.26552 14.96824 0 0 0 0 12.87854 13.80185 0 0 0 14.51928 14.81147 14.55559 0 12.87543 13.88307 0 14.49313 0 16.23118 0 0 0 14.10362 0 16.03476 0 16.10647 12.68017 0 0 0 15.89477 0 0 0 17.63071 18.25272 0 16.48476 14.88556 15.6694 0 0 17.60317 17.40467 18.42287 Q8TAF5 LQK1_HUMAN Putative uncharacterized protein LQK1 (FLVCR1 antisense RNA 1) (FLVCR1 divergent transcript) FLVCR1-DT FLVCR1-AS1 LQK1 Homo sapiens (Human) FIGIYSVR 15.10999966 1 1 0.356175601 954.4228993 0 0 0 0 0 0 15.57136 0 0 0 14.87665 0 15.31922 0 0 15.85047 9.039984 16.02124 14.94721 11.50332 15.99109 0 17.01192 0 0 0 0 0 0 0 17.26243 13.52748 0 0 0 0 0 0 0 14.56879 0 15.24146 0 0 0 12.03552 14.5831 0 Q8TAG6 VEXIN_HUMAN Vexin VXN C8orf46 Homo sapiens (Human) neurogenesis [GO:0022008]; neuron differentiation [GO:0030182] nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleus [GO:0005634]; plasma membrane [GO:0005886]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182] GO:0005634; GO:0005886; GO:0022008; GO:0030182 GAVLMRGSR 12.44999981 1 1 0.150327568 946.0925401 15.13187 14.35992 11.23982 10.38137 15.25039 16.0461 11.07284 14.12371 15.3985 14.94829 15.66984 0 14.39163 13.28853 14.89319 15.6406 12.36329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAG9 EXOC6_HUMAN Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1) EXOC6 SEC15A SEC15L SEC15L1 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0030426; GO:0048471; GO:0090148; GO:0090522; GO:0090543 DARHAAEGEIYTK 2.289999962 1 1 0.054445999 1460.4397 14.70742 16.71503 15.75755 0 0 0 15.4873 0 0 15.31792 16.02514 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84268 0 0 0 0 0 0 0 0 16.01122 0 0 15.36584 0 0 0 0 0 0 0 0 0 15.21045 0 Q8TAI1 TYMOS_HUMAN TYMS opposite strand protein TYMSOS C18orf56 Homo sapiens (Human) ASHVPNGTLR 5.829999924 1 1 0.213337892 1051.388837 0 17.68228 15.73403 0 0 0 13.6273 0 0 14.55842 17.75939 15.56067 14.09285 0 13.25896 13.06477 14.93036 0 17.64344 0 0 16.72034 16.51349 14.95738 17.06849 15.43964 0 0 0 0 0 0 16.70987 0 0 17.31168 0 0 15.64984 0 15.99457 0 0 0 0 0 0 0 Q8TAK5 GABP2_HUMAN "GA-binding protein subunit beta-2, GABP subunit beta-2, GABPB-2" GABPB2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944] identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976] GO:0000976; GO:0005634; GO:0042802; GO:0045944 RLLEAAR 11 0.655627549 0.655627549 0.091270294 827.4857592 17.37493 16.16544 16.72934 17.20539 14.83822 15.78085 15.21908 16.48438 16.6865 16.93592 16.57144 16.9708 18.01571 17.42733 18.23469 14.6922 16.0145 0 0 15.80953 14.23319 17.79035 14.69594 0 18.27505 17.25101 0 16.09277 17.69635 16.70089 0 0 17.14087 15.94805 0 0 0 17.97737 17.34159 17.78364 0 17.89793 16.56139 17.0584 17.35433 0 17.9857 17.42284 Q8TAL6 FIBIN_HUMAN Fin bud initiation factor homolog FIBIN PSEC0235 Homo sapiens (Human) protein kinase C signaling [GO:0070528]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; protein homodimerization activity [GO:0042803]; protein kinase C signaling [GO:0070528]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042] protein homodimerization activity [GO:0042803] GO:0005576; GO:0005783; GO:0005794; GO:0010042; GO:0042803; GO:0070528; GO:0071548 SHGTRLGR 16.44000053 1 1 0.308661305 883.8347238 19.75295 17.78186 19.0912 0 0 19.37636 16.16838 18.91673 0 0 19.46648 0 0 0 0 0 0 0 0 0 0 17.4455 0 0 17.63265 17.89202 0 0 19.1456 0 18.403 0 0 20.42745 19.0465 0 16.38853 19.50125 0 18.60605 0 0 0 0 0 0 0 0 Q8TAM1 BBS10_HUMAN Bardet-Biedl syndrome 10 protein BBS10 C12orf58 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cilium [GO:0005929] cilium [GO:0005929]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; chaperone-mediated protein complex assembly [GO:0051131]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to stimulus [GO:0050896]; visual perception [GO:0007601] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0005524; GO:0005929; GO:0007601; GO:0016887; GO:0043254; GO:0045494; GO:0050896; GO:0051131; GO:0061629; GO:1905515 CHQSEETMVSMIIANALLGIPK 5.420000076 1 1 0.566956396 2458.07807 0 19.39477 0 13.24426 0 0 0 0 0 0 0 0 0 18.65652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAP6 CEP76_HUMAN "Centrosomal protein of 76 kDa, Cep76" CEP76 C18orf9 Homo sapiens (Human) regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; regulation of centriole replication [GO:0046599] GO:0005813; GO:0005814; GO:0005829; GO:0032991; GO:0046599 LLDTPR 3.410000086 0.194086403 0.194086403 0.102615467 713.5743772 15.31262 13.22381 0 13.77377 0 0 0 15.70576 0 0 14.00934 0 0 19.63386 12.56283 0 16.48159 0 14.01329 17.21692 10.69314 0 17.80613 16.55492 0 18.23302 17.4397 0 12.75049 0 0 14.45042 0 0 12.96733 13.32943 0 0 17.33196 16.95376 0 15.81318 16.6783 0 0 0 0 0 Q8TAQ5 ZN420_HUMAN Zinc finger protein 420 ZNF420 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 ECGIDFSHGSQVYM 10.88000011 1 1 0.383964326 1645.315126 14.07388 15.69937 0 16.64614 0 13.38634 0 14.52254 0 0 17.47818 0 16.08318 0 0 0 0 0 15.61969 0 0 0 15.93271 0 0 16.5305 0 13.32084 14.38837 15.75562 0 18.3194 0 0 17.4417 0 0 18.65889 0 0 0 0 0 13.20502 0 0 0 0 Q8TAQ9 SUN3_HUMAN SUN domain-containing protein 3 (Sad1/unc-84 domain-containing protein 1) SUN3 SUNC1 Homo sapiens (Human) nuclear envelope organization [GO:0006998] integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635] integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; protein-membrane adaptor activity [GO:0043495]; nuclear envelope organization [GO:0006998] protein-membrane adaptor activity [GO:0043495] GO:0005635; GO:0005639; GO:0006998; GO:0034993; GO:0043495 VHGTPGKHI 3.569999933 1 1 0.237122647 945.9597019 13.82147 14.15541 13.08154 13.32567 12.84988 14.01453 0 15.07165 14.11051 13.54539 15.11345 14.30844 13.07203 0 0 0 0 0 0 14.69016 0 0 0 0 0 0 0 0 0 0 0 0 0 16.28181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAV0 FA76A_HUMAN Protein FAM76A FAM76A Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 EEVATLK 4.239999771 1 1 0.262123155 789.0129727 0 15.74549 15.73123 16.66732 0 14.83306 0 16.02888 14.60035 15.60603 16.10244 0 0 0 14.45464 0 0 0 0 0 0 17.81861 15.72859 16.68314 16.46865 16.81095 0 15.63511 0 15.45806 16.34579 17.5778 0 0 0 0 16.3851 15.70525 0 0 16.71907 15.16657 0 16.25474 16.64878 0 0 0 Q8TAV3 CP2W1_HUMAN "Cytochrome P450 2W1, EC 1.14.14.- (CYPIIW1)" CYP2W1 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; steroid hydroxylase activity [GO:0008395]; aflatoxin metabolic process [GO:0046222]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805]" "all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; steroid hydroxylase activity [GO:0008395]" GO:0001972; GO:0004497; GO:0005503; GO:0005506; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006082; GO:0006644; GO:0006805; GO:0008395; GO:0008401; GO:0009986; GO:0016712; GO:0020037; GO:0034653; GO:0043231; GO:0046222; GO:1904768 SLMELSER 8.079999924 1 1 0.562728524 979.6125778 0 0 0 0 0 0 18.60159 0 0 0 0 0 16.4166 0 0 0 0 0 0 0 0 0 16.66746 0 18.20544 0 0 17.77826 0 0 0 0 0 0 0 0 0 0 0 16.47724 0 0 0 0 0 18.00081 0 0 Q8TAV4 STML3_HUMAN "Stomatin-like protein 3, SLP-3" STOML3 Homo sapiens (Human) signal transduction [GO:0007165] cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; signal transduction [GO:0007165] GO:0005886; GO:0005929; GO:0007165; GO:0016021; GO:0045121 DSRVSSPEK 7.440000057 1 1 0.273301713 1006.327436 16.10325 0 17.01509 16.33927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.43537 0 0 0 0 0 0 0 0 Q8TAW3 ZN671_HUMAN Zinc finger protein 671 ZNF671 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 HTLVLHQR 9.989999771 0.719304502 0.719304502 0.620556498 1005.363799 0 0 0 17.37102 18.03941 0 16.89104 0 0 0 0 18.05671 0 0 17.46065 0 0 0 0 18.99778 17.11748 0 0 0 0 0 0 18.28878 0 0 19.28038 0 0 0 0 0 0 0 0 0 0 19.08985 0 0 0 0 0 0 Q8TAX9 GSDMB_HUMAN "Gasdermin-B (Gasdermin-like protein) [Cleaved into: Gasdermin-B, N-terminal, GSDMB-NT, p30; Gasdermin-B, C-terminal, GSDMB-CT, p16 ]" GSDMB GSDML PP4052 PRO2521 Homo sapiens (Human) cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; defense response to bacterium [GO:0042742]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; pyroptosis [GO:0070269] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; defense response to bacterium [GO:0042742]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; pyroptosis [GO:0070269]" "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]" GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0016021; GO:0019835; GO:0022829; GO:0042742; GO:0070269; GO:0070273; GO:0140507; GO:1902483 DGASSCLGK 2.900000095 1 1 0.281349681 891.3794526 0 19.06055 0 0 0 0 0 0 18.1044 18.26342 0 0 0 16.88712 16.69344 0 0 0 0 0 0 0 17.70253 0 18.20173 0 0 0 0 0 0 19.34623 18.58458 0 0 0 0 0 0 17.08727 16.65127 0 17.59018 0 0 0 17.30066 17.05124 Q8TAZ6 CKLF2_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 2 (Chemokine-like factor superfamily member 2) CMTM2 CKLFSF2 Homo sapiens (Human) chemotaxis [GO:0006935] extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; cytokine activity [GO:0005125]; chemotaxis [GO:0006935] cytokine activity [GO:0005125] GO:0005125; GO:0005615; GO:0006935; GO:0016021 AVQDHK 9.470000267 0.405497104 0.405497104 0.250497101 695.3259092 17.16839 0 16.68953 16.05479 15.42034 15.73161 15.80905 16.41935 14.67277 14.0944 15.87234 16.10349 0 0 17.3056 0 0 16.63387 0 0 17.48769 0 17.15491 17.01836 0 0 0 16.54552 16.22196 0 17.51975 16.84684 16.15909 0 17.97098 17.87667 0 17.11191 18.20503 16.97693 17.34119 17.42287 16.46041 17.35063 16.84131 17.0464 17.39651 17.11144 Q8TB24 RIN3_HUMAN Ras and Rab interactor 3 (Ras interaction/interference protein 3) RIN3 Homo sapiens (Human) endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0002091; GO:0005085; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006897; GO:0007165; GO:0030139; GO:0030424; GO:0030425; GO:0031267; GO:0031410; GO:0031982; GO:0043025; GO:0060755; GO:0097494 VVAGMFLVR 14.05000019 0.362090141 0.362090141 0.183731307 1009.010415 0 16.07716 0 17.36697 0 0 0 17.28959 15.89843 17.15039 0 17.19423 16.61692 17.73586 0 17.03905 15.37459 13.88758 0 0 14.89032 12.26824 0 0 16.38527 0 16.47612 0 16.14258 0 0 0 0 13.26906 0 15.4687 16.52211 15.73588 17.13467 15.79937 0 15.83163 17.42728 17.58116 0 0 17.63964 0 Q8TB37 NUBPL_HUMAN Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1) NUBPL C14orf127 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]" "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]" GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0016887; GO:0032981; GO:0046872; GO:0051539; GO:0070584 GLMVMSAIEK 3.390000105 1 1 0.134559892 1093.775872 9.710573 15.06657 13.17191 0 0 12.79751 14.02157 0 11.30793 0 0 14.07967 13.95415 14.34082 11.46899 14.68158 13.90619 14.38244 0 0 14.17803 0 0 0 15.81428 14.25186 0 0 0 0 0 0 0 0 0 0 0 0 16.94173 0 0 0 0 0 0 0 0 0 Q8TB52 FBX30_HUMAN F-box only protein 30 FBXO30 FBX30 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005829; GO:0008270; GO:0061630 VPCLNSDFGCPFTMARNK 1.169999957 1 1 0.243476856 2114.242237 0 0 0 0 13.43165 0 0 0 0 0 13.06757 0 19.72366 0 0 0 0 12.92909 0 0 0 0 0 0 0 0 16.09099 15.85949 14.69287 0 0 0 0 0 0 0 0 0 0 0 14.04295 0 0 0 0 0 0 16.48941 Q8TB72 PUM2_HUMAN "Pumilio homolog 2, Pumilio-2" PUM2 KIAA0235 PUMH2 Homo sapiens (Human) adipose tissue development [GO:0060612]; chromosome organization [GO:0051276]; hair follicle development [GO:0001942]; mitochondrion organization [GO:0007005]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; respiratory electron transport chain [GO:0022904]; skeletal system development [GO:0001501]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pumilio-response element binding [GO:0062104]; RNA binding [GO:0003723]; adipose tissue development [GO:0060612]; chromosome organization [GO:0051276]; hair follicle development [GO:0001942]; mitochondrion organization [GO:0007005]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; respiratory electron transport chain [GO:0022904]; skeletal system development [GO:0001501]; stress granule assembly [GO:0034063] lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pumilio-response element binding [GO:0062104]; RNA binding [GO:0003723] GO:0001501; GO:0001942; GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007005; GO:0010494; GO:0010608; GO:0022904; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051276; GO:0051983; GO:0060612; GO:0060964; GO:0062104; GO:0106222; GO:1900246; GO:2000637 IVSEIRGK 3.160000086 1 1 0.138128039 900.6203596 13.91935 15.3283 15.2886 13.90716 13.63031 15.06251 0 0 12.50656 0 0 0 0 0 14.08491 0 0 0 0 0 0 0 0 16.21351 0 15.92416 0 14.58601 0 12.99098 15.60794 14.60629 0 0 15.21601 0 0 0 0 0 12.77264 0 0 0 12.12737 0 0 0 Q8TB92 HMGC2_HUMAN "3-hydroxy-3-methylglutaryl-CoA lyase, cytoplasmic, EC 4.1.3.4 (3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1, HMGCL-like 1) (Endoplasmic reticulum 3-hydroxy-3-methylglutaryl-CoA lyase, er-cHL)" HMGCLL1 Homo sapiens (Human) ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629] hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872] GO:0004419; GO:0005783; GO:0005789; GO:0005829; GO:0006552; GO:0006629; GO:0016020; GO:0046872; GO:0046951; GO:0048471 SARHMNIPAR 4.340000153 1 1 0.124427395 1149.464082 0 0 14.17623 13.18806 14.42926 15.30405 0 0 0 19.25436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.73863 0 0 0 0 0 0 0 14.84243 0 14.27412 0 0 0 Q8TBA6 GOGA5_HUMAN Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein) GOLGA5 RETII RFG5 PIG31 Homo sapiens (Human) "Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0030133; GO:0031267; GO:0031985; GO:0042803; GO:0048193 TKNTLQSR 5.130000114 1 1 0.058446685 947.1663108 0 13.44383 15.11874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBB5 KLDC4_HUMAN Kelch domain-containing protein 4 KLHDC4 Homo sapiens (Human) TAAKMEK 1.379999995 1 1 0.297838912 794.9550934 0 14.03522 14.02504 18.51094 17.87656 0 18.10499 0 17.8019 0 0 0 0 0 0 0 19.49185 17.718 0 17.68467 16.71932 0 17.43803 0 0 18.97768 0 0 0 0 0 0 0 17.73852 0 0 0 18.87863 0 17.73527 0 0 0 0 0 17.19086 18.02681 0 Q8TBB6 S7A14_HUMAN Probable cationic amino acid transporter (Solute carrier family 7 member 14) SLC7A14 KIAA1613 Homo sapiens (Human) amino acid transport [GO:0006865] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transport [GO:0006865] amino acid transmembrane transporter activity [GO:0015171] GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0015171; GO:0016021; GO:0043231 MSGFFTSLDPR 2.5 1 1 0.082182283 1269.422082 15.30259 10.31174 0 0 0 14.55427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.02955 0 0 0 0 0 0 0 0 0 0 0 14.72295 15.02438 0 0 0 16.0915 0 0 0 0 16.46165 0 0 0 0 0 Q8TBC5 ZSC18_HUMAN Zinc finger and SCAN domain-containing protein 18 (Zinc finger protein 447) ZSCAN18 ZNF447 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 SKEQMLELLVLEQFLGILPDK 1.330000043 0.862228811 0.862228811 3.66E-12 2443.596307 12.6187 0 0 0 0 0 0 10.9744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.42719 14.13892 0 0 0 0 0 15.73101 0 10.77617 13.75868 0 0 15.15942 0 0 0 0 0 0 0 0 13.10433 0 Q8TBE0 BAHD1_HUMAN "Bromo adjacent homology domain-containing 1 protein, BAH domain-containing protein 1" BAHD1 KIAA0945 Homo sapiens (Human) "heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] "chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin binding [GO:0003682] GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892 RPLVPEKPKACK 1.419999957 1 1 0.306217905 1422.116894 14.92344 14.72041 14.41754 12.35897 14.46137 11.96507 14.53674 14.2906 0 14.11205 13.79736 14.27693 0 12.16271 0 0 0 0 0 0 0 0 0 0 0 16.13244 0 0 0 0 0 0 0 16.06045 0 0 0 0 17.10703 0 15.45601 0 0 0 0 0 0 0 Q8TBE3 FNDC9_HUMAN Fibronectin type III domain-containing protein 9 FNDC9 C5orf40 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EEDLQGLPLVEMPRK 9.029999733 0.105896346 0.105896346 0.147745025 1767.630852 0 16.66701 0 0 18.36206 0 0 0 12.77889 0 16.94762 14.36376 17.99442 18.3933 14.47499 0 0 17.19504 17.08977 0 15.73943 0 0 15.27271 14.68512 0 17.86399 19.61029 13.09184 14.46486 0 0 19.14957 0 0 0 18.3122 18.57761 16.02197 16.55326 0 0 17.7121 0 14.44517 14.57081 15.12393 16.68327 Q8TBF5 PIGX_HUMAN "Phosphatidylinositol-glycan biosynthesis class X protein, PIG-X" PIGX Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506] GO:0005789; GO:0006506; GO:0016021 SDAGIRAMCSEIILR 7.079999924 1 1 6.89E-13 1705.433758 15.06892 12.5294 13.29642 0 0 0 0 0 0 15.2359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.70659 0 0 0 0 14.28532 0 0 0 0 0 0 0 0 15.13145 0 0 0 0 0 0 0 0 0 Q8TBF8 FA81A_HUMAN Protein FAM81A FAM81A Homo sapiens (Human) DDIVNSLQKMQNK 7.869999886 1 1 0.265638143 1549.434428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.74404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBG4 AT2L1_HUMAN "Ethanolamine-phosphate phospho-lyase, EC 4.2.3.2 (Alanine--glyoxylate aminotransferase 2-like 1)" ETNPPL AGXT2L1 Homo sapiens (Human) mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] GO:0005759; GO:0008483; GO:0030170; GO:0050459 CELYSK 7.329999924 1 1 0.118513007 798.2964803 0 0 0 0 15.23474 15.95206 0 0 14.40177 0 14.52464 14.92289 0 12.20752 0 11.07672 15.39657 0 0 15.24137 0 0 0 0 15.88006 0 0 0 0 0 0 0 0 0 0 14.79226 0 0 0 0 0 0 16.2479 0 0 0 0 0 Q8TBJ5 FEZF2_HUMAN Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like) FEZF2 FEZL ZNF312 FKSG36 Homo sapiens (Human) axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0007413; GO:0007626; GO:0008285; GO:0010468; GO:0016358; GO:0021542; GO:0021797; GO:0021853; GO:0021902; GO:0043697; GO:0045665; GO:0045666; GO:0046872; GO:0048664; GO:0050767; GO:1902667 KLHDSVGPAAPSAK 10.05000019 1 1 0.254677444 1372.904934 0 0 0 0 0 14.55559 0 0 0 0 0 0 0 0 16.61087 15.34953 15.62773 16.9053 0 0 13.99824 16.37033 0 0 17.29677 17.94785 15.85658 0 0 0 0 0 17.23495 16.90879 0 14.95152 0 0 0 0 0 0 0 0 14.75625 15.5771 0 0 Q8TBM8 DJB14_HUMAN DnaJ homolog subfamily B member 14 DNAJB14 UNQ9427/PRO34683 Homo sapiens (Human) cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] Hsp70 protein binding [GO:0030544] GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030433; GO:0030544; GO:0031965; GO:0051085; GO:0065003; GO:0071218 DQVDGVLSINKCK 3.079999924 1 1 0.287458168 1472.531117 0 0 0 0 0 0 0 15.14841 15.61535 0 0 0 16.19775 12.86347 0 15.52382 0 0 0 0 0 0 0 0 0 0 0 0 16.45719 0 0 0 17.26506 0 0 0 16.42831 17.59876 0 14.22581 16.22842 16.90014 17.24568 18.01349 17.12364 17.78014 17.89973 0 Q8TBN0 R3GEF_HUMAN "Guanine nucleotide exchange factor for Rab-3A (Rab-3A-interacting-like protein 1, Rab3A-interacting-like protein 1) (Rabin3-like 1)" RAB3IL1 Homo sapiens (Human) exocytosis [GO:0006887]; protein transport [GO:0015031] cytosol [GO:0005829]; Golgi to plasma membrane transport vesicle [GO:0070319] cytosol [GO:0005829]; Golgi to plasma membrane transport vesicle [GO:0070319]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; exocytosis [GO:0006887]; protein transport [GO:0015031] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802] GO:0005085; GO:0005829; GO:0006887; GO:0015031; GO:0042802; GO:0070319 KGHSR 4.789999962 1 1 0.245845267 580.9992645 0 0 13.98101 17.31399 0 0 17.10054 0 0 0 0 0 0 0 18.19327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.62005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBP0 TBC16_HUMAN TBC1 domain family member 16 TBC1D16 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of receptor recycling [GO:0001919] cytosol [GO:0005829]; early endosome [GO:0005769] cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of receptor recycling [GO:0001919] GTPase activator activity [GO:0005096] GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0090630 YCTEMQLKDQQVAPDK 1.220000029 1 1 0.453150033 1969.181377 0 4.348106 0 17.45901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBX8 PI42C_HUMAN "Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, EC 2.7.1.149 (Phosphatidylinositol 5-phosphate 4-kinase type II gamma, PI(5)P 4-kinase type II gamma, PIP4KII-gamma)" PIP4K2C PIP5K2C Homo sapiens (Human) "1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]" autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular organelle [GO:0043229]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular organelle [GO:0043229]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]" 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; identical protein binding [GO:0042802] GO:0005524; GO:0005654; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0010506; GO:0016308; GO:0016309; GO:0042802; GO:0043229; GO:0046627; GO:0046854; GO:0070062; GO:0090217; GO:1902635; GO:2000786 ASSKIK 3.069999933 1 1 0.238066848 632.9469896 0 15.01138 16.75399 15.99328 13.41905 16.00648 16.07788 16.24775 0 15.84793 14.93266 0 0 0 0 15.51365 0 15.33997 15.33346 0 0 0 15.61932 0 0 18.12412 16.5489 0 16.19642 16.5081 0 0 17.01471 0 0 16.31566 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBY9 CF251_HUMAN Cilia- and flagella-associated protein 251 (WD repeat-containing protein 66) CFAP251 WDR66 Homo sapiens (Human) cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126 AGISR 6.400000095 0.335156232 0.335156232 0.128062141 503.3010025 16.35207 16.84654 16.44268 16.53467 16.46835 15.76608 16.0919 16.84079 16.50061 16.10692 16.48801 16.86619 16.68068 15.87824 17.65995 16.85344 16.99933 16.90847 17.32349 16.8262 17.27573 17.87873 17.09871 16.45637 16.37835 16.87367 17.3528 16.61314 17.37782 16.66068 16.30291 16.89494 16.27318 16.81673 16.90899 16.97071 16.94217 17.48369 18.35822 17.17672 17.93389 17.41462 16.58365 17.25933 17.18876 17.45375 16.97715 17.03066 Q8TBZ2 MYBPP_HUMAN "MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1, AMAP-1)" MYCBPAP AMAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202] cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283] GO:0005737; GO:0007268; GO:0007283; GO:0016020; GO:0030154; GO:0045202 LEYLGDEMTGLVMTK 1.789999962 1 1 0.340127652 1715.558202 18.54248 14.70509 15.40463 0 0 0 0 0 0 17.8404 0 0 0 0 17.13801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC05 MDM1_HUMAN Nuclear protein MDM1 MDM1 Homo sapiens (Human) negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041] microtubule binding [GO:0008017] GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0008017; GO:0034451; GO:0046600; GO:0060041 GNMPNQVK 8.699999809 1 1 0.176523286 887.9290678 0 0 15.5995 0 0 12.3705 11.89934 0 0 0 0 12.8998 0 0 0 13.6659 16.14333 0 0 0 14.73422 0 0 0 11.77349 0 13.60647 0 0 0 0 0 15.08249 0 0 0 0 16.4319 17.67755 0 16.8457 15.81967 0 0 0 0 0 0 Q8TC12 RDH11_HUMAN "Retinol dehydrogenase 11, EC 1.1.1.300 (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1, RalR1) (Short chain dehydrogenase/reductase family 7C member 1)" RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82 Homo sapiens (Human) cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]" "11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0102354; GO:0110095 VVVVTGANTGIGK 8.140000343 0.258479983 0.258479983 0.00690937 1214.962863 0 12.4191 0 0 0 15.04306 0 13.1768 14.81985 14.0656 0 0 0 14.58968 0 0 0 0 0 12.42393 14.56137 0 0 14.36442 0 14.96592 13.31672 0 15.58098 0 0 11.50792 15.3726 0 0 11.777 15.40942 14.4911 0 0 0 0 0 14.05205 14.09325 15.07994 13.43705 0 Q8TC21 ZN596_HUMAN Zinc finger protein 596 ZNF596 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 KAMNM 5.03000021 1 1 0.075319712 593.1923466 14.40336 15.29923 15.12306 10.62025 10.76812 13.66863 14.95856 0 0 15.20155 0 15.4654 15.31511 0 14.78282 16.84486 15.46245 0 14.9486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.73547 0 0 0 0 Q8TC27 ADA32_HUMAN "Disintegrin and metalloproteinase domain-containing protein 32, ADAM 32" ADAM32 UNQ5982/PRO21340 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0007155; GO:0007339; GO:0016021 NLICGR 3.859999895 1 1 4.60E-13 732.7499133 0 13.4219 0 0 14.57606 14.75037 14.80952 0 0 0 0 0 15.16625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.54941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.98824 0 Q8TC44 POC1B_HUMAN POC1 centriolar protein homolog B (Pix1) (Proteome of centriole protein 1B) (WD repeat-containing protein 51B) POC1B WDR51B Homo sapiens (Human) cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895] GO:0000922; GO:0001895; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008283; GO:0036064; GO:0060271 LHFDSPPHLLDIYPR 7.039999962 0.830417037 0.830417037 0.148364027 1818.979876 15.27773 0 0 0 15.26502 0 0 0 15.03375 14.28998 0 0 0 0 13.31165 0 0 0 0 0 0 0 0 0 16.80274 0 15.1668 0 0 0 16.69936 0 0 0 0 0 0 17.61796 0 0 15.28592 0 14.71619 16.31237 0 0 0 15.05766 Q8TC57 M1AP_HUMAN Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37) M1AP C2orf65 SPATA37 Homo sapiens (Human) cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283] identical protein binding [GO:0042802] GO:0005737; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016021; GO:0030154; GO:0031497; GO:0042802; GO:0051308 MPAASK 10.81000042 0.112931758 0.112931758 0.225130509 605.4760299 14.61262 15.3076 16.17458 0 0 14.46095 14.09565 15.42969 14.8251 15.94396 15.838 12.44139 0 14.97613 14.01844 15.01236 14.49926 15.88307 14.86659 15.01304 15.98504 0 0 14.9808 0 15.47991 0 15.02148 16.53842 16.44195 0 0 14.705 16.80407 16.25068 17.02871 0 0 16.20081 0 0 0 0 0 0 16.30574 15.57332 0 Q8TC59 PIWL2_HUMAN "Piwi-like protein 2, EC 3.1.26.- (Cancer/testis antigen 80, CT80)" PIWIL2 HILI Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of meiosis I [GO:0060903]; positive regulation of translation [GO:0045727]; rhythmic process [GO:0048511]; RNA 5'-end processing [GO:0000966]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of meiosis I [GO:0060903]; positive regulation of translation [GO:0045727]; rhythmic process [GO:0048511]; RNA 5'-end processing [GO:0000966]; spermatogenesis [GO:0007283] endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; RNA binding [GO:0003723] GO:0000966; GO:0003723; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0007283; GO:0010370; GO:0010529; GO:0030718; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0042754; GO:0043046; GO:0043186; GO:0045727; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060903; GO:0071442; GO:0071546; GO:0097433; GO:1905538; GO:1990511; GO:1990923; GO:2000617 AAGGISR 9.220000267 1 1 0.1189465 630.4796792 13.13777 15.0307 0 15.26281 0 15.61786 0 14.90328 13.67746 14.8213 15.09955 0 0 0 0 15.51673 0 15.40236 0 0 16.54476 0 0 0 0 0 0 0 0 0 16.05606 0 0 0 0 0 0 0 19.10727 0 0 0 0 16.75133 16.91796 18.73892 0 0 Q8TC84 FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 FANK1 HSD13 UNQ6504/PRO21382 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]" ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]" GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0042981; GO:0043065; GO:0043066; GO:0045893; GO:0051091; GO:0097546 MEPQKIMPPSKPHPPVVGK 2.910000086 1 1 1.37E-12 2130.159493 13.10647 11.26327 0 11.50944 14.791 0 15.20616 14.38833 12.0619 14.92952 0 0 0 13.69481 0 0 0 0 0 0 0 0 0 0 15.28987 16.23543 0 0 0 14.2719 0 12.1682 0 0 0 0 0 16.22841 0 0 15.13491 0 13.19146 15.89952 13.03484 0 0 0 Q8TC99 FNDC8_HUMAN Fibronectin type III domain-containing protein 8 FNDC8 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 GLPLASK 4.010000229 1 1 0.252612094 685.6147736 12.16092 15.72284 14.46422 14.40861 15.55046 0 0 15.81584 0 15.00734 0 15.56014 15.19037 15.942 0 14.27755 0 0 13.61423 15.663 0 0 0 16.04181 16.02886 0 0 14.21149 0 0 0 0 0 0 16.22561 0 0 0 0 0 15.04307 0 0 0 0 0 0 15.89274 Q8TCC7 S22A8_HUMAN "Solute carrier family 22 member 8 (Organic anion transporter 3, hOAT3)" SLC22A8 OAT3 Homo sapiens (Human) response to toxic substance [GO:0009636]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; response to toxic substance [GO:0009636]; transport across blood-brain barrier [GO:0150104] anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452] GO:0005452; GO:0005886; GO:0009636; GO:0015301; GO:0016021; GO:0016323; GO:0016324; GO:0070062; GO:0150104 SSKALK 10.64000034 1 1 0.051969542 636.6305366 15.19012 15.47856 14.45317 0 14.50128 9.668531 13.57489 14.48513 15.00507 0 15.17748 16.2331 14.44115 0 0 0 13.98141 15.62301 17.05043 17.36993 16.63566 15.53495 15.62405 0 0 0 16.06153 0 0 0 15.66542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCF1 ZFAN1_HUMAN AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1) ZFAND1 Homo sapiens (Human) cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617] proteasome binding [GO:0070628]; zinc ion binding [GO:0008270] GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843 MAATQK 5.829999924 1 1 0.067613895 664.8168562 0 15.12811 13.83053 0 14.85565 14.80216 15.84757 0 0 0 15.43354 0 0 0 0 0 16.03123 0 0 15.5209 0 0 16.44872 16.38561 0 0 0 0 16.34649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCG1 CIP2A_HUMAN Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen) CIP2A KIAA1524 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803] cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803] GO:0005737; GO:0005829; GO:0005886; GO:0016021; GO:0042803; GO:0045296 DPDSSSK 11.32999992 0.701355517 0.701355517 0.319776363 735.9442314 0 14.92314 0 14.95197 0 0 0 0 0 15.3773 13.04531 0 17.12453 0 0 16.41602 0 16.65405 15.72827 17.65853 0 15.18617 0 16.87683 16.616 0 16.24127 16.89169 16.91039 0 0 17.45144 0 16.79061 0 16.22759 18.25087 14.60982 18.96352 0 0 17.43034 0 0 17.23873 12.7551 16.32306 0 Q8TCG2 P4K2B_HUMAN "Phosphatidylinositol 4-kinase type 2-beta, EC 2.7.1.67 (Phosphatidylinositol 4-kinase type II-beta, PI4KII-BETA)" PI4K2B Homo sapiens (Human) endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] GO:0000139; GO:0004430; GO:0005524; GO:0005768; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0031901; GO:0046854 IVHLSNSFTQTVNCR 5.349999905 0.817293346 0.817293346 0.29945092 1776.159618 0 0 0 0 15.42528 13.94072 0 0 11.40873 0 0 0 0 0 0 0 15.25873 0 0 0 0 0 0 0 16.72283 0 12.94481 13.82883 0 13.48174 12.15224 0 0 14.6198 13.01873 18.0456 13.82236 0 19.2911 15.20562 0 0 6.793787 13.20364 0 15.0579 0 16.28421 Q8TCI5 PIFO_HUMAN Protein pitchfork PIFO C1orf88 Homo sapiens (Human) cilium organization [GO:0044782]; embryonic heart tube left/right pattern formation [GO:0060971]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; gamma-tubulin binding [GO:0043015]; kinesin binding [GO:0019894]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cilium organization [GO:0044782]; embryonic heart tube left/right pattern formation [GO:0060971]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344] beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; gamma-tubulin binding [GO:0043015]; kinesin binding [GO:0019894]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0005634; GO:0005802; GO:0008092; GO:0019894; GO:0019901; GO:0031267; GO:0031344; GO:0031410; GO:0033674; GO:0036064; GO:0043015; GO:0044782; GO:0048487; GO:0060971 GYTLGAR 6.550000191 0.021808356 0.021808356 0.254926136 738.10289 16.34102 15.65921 17.43496 15.88232 14.27868 14.8792 16.43623 0 17.0162 16.01588 15.76867 15.6483 15.07322 0 14.17316 16.19494 16.90329 16.06439 15.65293 15.30486 0 16.51535 16.21544 0 15.87245 16.7763 16.61494 16.47174 15.08474 0 16.81849 0 17.39788 16.52913 16.52363 15.56295 16.40722 17.63088 17.28185 15.84463 16.63709 14.25961 0 0 16.00076 15.25296 16.24287 0 Q8TCJ0 FBX25_HUMAN F-box only protein 25 FBXO25 FBX25 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567] actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0016567; GO:0019005 QVNNGLTLSDLPLHMLNNILYR 5.170000076 1 1 0.416412996 2537.937302 14.10965 0 0 0 0 17.03706 0 0 0 19.54744 0 19.27054 0 0 0 0 0 0 0 0 0 19.72465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1098 0 0 0 0 0 0 Q8TCJ2 STT3B_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, Oligosaccharyl transferase subunit STT3B, STT3-B, EC 2.4.99.18 (Source of immunodominant MHC-associated peptides homolog)" STT3B SIMP Homo sapiens (Human) co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872] GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872 IAEGEHPK 3.650000095 1 1 1.15E-12 880.0150717 15.84884 0 13.60134 11.12806 12.53586 13.27667 15.12658 0 0 0 0 16.50212 0 0 0 0 0 0 0 0 14.73446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95382 15.65087 0 0 0 0 0 15.13818 0 Q8TCN5 ZN507_HUMAN Zinc finger protein 507 ZNF507 KIAA1084 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872 SQKCLLIGK 6.639999866 1 1 4.58E-13 1046.359661 13.73115 12.97482 14.57596 13.72889 13.84526 13.38315 13.32081 15.16822 13.59157 0 15.25517 0 11.8271 14.59583 14.3381 15.10871 0 11.66999 14.59366 0 0 0 0 13.50858 0 14.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCP9 F200A_HUMAN Protein FAM200A FAM200A C7orf38 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TPESR 2.589999914 0.77814424 0.77814424 0.205763467 588.7709544 12.88859 15.31742 0 15.89995 13.64431 0 16.09799 0 0 16.08248 15.70099 0 0 0 0 0 16.05835 0 0 15.37608 0 0 0 0 16.43047 0 0 14.68843 14.62626 0 15.29874 0 0 0 0 0 0 0 17.32011 15.88781 0 0 0 0 0 0 0 0 Q8TCS8 PNPT1_HUMAN "Polyribonucleotide nucleotidyltransferase 1, mitochondrial, EC 2.7.7.8 (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1, PNPase 1) (Polynucleotide phosphorylase-like protein)" PNPT1 PNPASE Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cell cycle [GO:0051726]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cell cycle [GO:0051726]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928] 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723] GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0051726; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772 ALWSSAGSR 13.19999981 1 1 0.280979088 933.2701461 16.07443 15.24414 18.27845 0 0 0 0 15.86635 0 0 13.21226 15.21403 17.33488 14.35171 0 16.15065 14.37046 15.40017 13.14812 17.19142 0 0 0 18.30627 18.41099 0 14.79645 17.65886 15.72814 0 16.766 15.5072 16.5449 16.57867 0 15.26025 16.507 0 14.20133 0 15.37504 14.47443 0 0 17.15316 16.10555 0 0 Q8TCT0 CERK1_HUMAN "Ceramide kinase, hCERK, EC 2.7.1.138 (Acylsphingosine kinase) (Lipid kinase 4, LK4)" CERK KIAA1646 Homo sapiens (Human) ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665] ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951] GO:0000287; GO:0001727; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016021; GO:0016310; GO:0102773 SAGVDQNHPR 4.53000021 1 1 0.288523876 1082.309079 14.54288 0 14.73298 13.81701 15.97608 0 13.75345 15.02216 0 15.365 0 0 0 0 0 0 14.8125 15.41753 16.05939 0 0 0 14.33083 0 0 0 0 0 0 0 0 0 0 0 16.02638 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCT1 PHOP1_HUMAN "Phosphoethanolamine/phosphocholine phosphatase, EC 3.1.3.75" PHOSPHO1 Homo sapiens (Human) bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; regulation of bone mineralization [GO:0030500] cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010] cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; regulation of bone mineralization [GO:0030500] metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462] GO:0001958; GO:0005829; GO:0016462; GO:0016791; GO:0030282; GO:0030500; GO:0031012; GO:0035630; GO:0046872; GO:0052731; GO:0052732; GO:0065010 CPANMCK 4.539999962 1 1 0.302403251 897.0399517 0 0 17.66017 0 0 15.60572 19.52979 0 0 20.57155 0 0 0 0 0 0 0 0 18.42408 16.55342 0 0 0 17.98188 20.08363 18.59729 0 0 17.22932 0 0 17.71325 0 0 0 0 0 0 0 17.77034 16.43046 18.2951 0 16.8521 0 0 0 0 Q8TCT7 SPP2B_HUMAN "Signal peptide peptidase-like 2B, SPP-like 2B, SPPL2b, EC 3.4.23.- (Intramembrane protease 4, IMP-4) (Presenilin homologous protein 4, PSH4) (Presenilin-like protein 1)" SPPL2B IMP4 KIAA1532 PSL1 Homo sapiens (Human) membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]" "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]" GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0010803; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556 VRLAQGSGAR 1.389999986 1 1 0.178640632 1015.276885 0 0 0 0 15.43332 0 15.48472 11.3992 14.50672 17.76293 15.82216 13.84629 0 0 0 15.47433 0 0 13.37614 13.11517 0 14.51424 0 0 15.69511 0 15.07627 0 16.92862 0 16.22215 0 16.19332 0 0 16.57061 0 0 0 0 0 0 18.05144 11.06105 0 0 14.50906 16.55053 Q8TCU4 ALMS1_HUMAN Alstrom syndrome protein 1 ALMS1 KIAA0328 Homo sapiens (Human) endosomal transport [GO:0016197]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of stress fiber assembly [GO:0051492] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; endosomal transport [GO:0016197]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of stress fiber assembly [GO:0051492] microtubule binding [GO:0008017] GO:0000922; GO:0005813; GO:0005829; GO:0005929; GO:0008017; GO:0016197; GO:0046599; GO:0051492; GO:0120162 AKHVNLSASLDQNNSHFK 6.519999981 0.687035501 0.687035501 0.093787065 2009.961941 15.14036 0 0 0 0 14.41151 0 0 13.09694 0 0 0 12.34081 13.45802 15.04582 14.21266 0 0 0 16.68387 0 0 15.39091 0 15.29977 0 0 0 11.66188 15.2064 0 15.68479 0 0 13.94083 0 13.98617 0 0 15.2488 14.77399 0 0 0 0 0 0 15.12339 Q8TCU6 PREX1_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein, P-Rex1, PtdIns(3,4,5)-dependent Rac exchanger 1" PREX1 KIAA1415 Homo sapiens (Human) actin filament polymerization [GO:0030041]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of small GTPase mediated signal transduction [GO:0051056]; superoxide metabolic process [GO:0006801]; T cell differentiation [GO:0030217] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; actin filament polymerization [GO:0030041]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of small GTPase mediated signal transduction [GO:0051056]; superoxide metabolic process [GO:0006801]; T cell differentiation [GO:0030217] enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] GO:0005085; GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0006801; GO:0007186; GO:0019899; GO:0030041; GO:0030217; GO:0030593; GO:0035556; GO:0042119; GO:0043547; GO:0051056; GO:1900026 TPGKHPDHPAVQSALQAMK 10.27999973 1 1 0.460041314 2013.065307 17.86068 0 15.57006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.68207 17.4043 0 0 0 0 0 0 0 19.45517 18.45407 0 0 0 0 0 0 0 18.48836 0 0 0 0 17.6916 17.97167 0 0 Q8TCX1 DC2L1_HUMAN "Cytoplasmic dynein 2 light intermediate chain 1, Dynein 2 light intermediate chain" DYNC2LI1 D2LIC LIC3 CGI-60 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017] apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514] apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017] dynein heavy chain binding [GO:0045504] GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005929; GO:0005930; GO:0007368; GO:0031514; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045177; GO:0045504; GO:0097542; GO:1902017 SHVDKVIMK 13.59000015 0.335257381 0.335257381 0.281690436 1073.927128 17.52438 18.1919 17.76598 0 16.66889 0 0 17.46065 0 0 16.44457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68093 0 0 17.50896 17.97905 19.00114 0 17.77517 0 0 17.76596 0 17.63853 0 0 0 0 Q8TCX5 RHPN1_HUMAN Rhophilin-1 (GTP-Rho-binding protein 1) RHPN1 KIAA1929 Homo sapiens (Human) negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] GO:0005829; GO:0007165; GO:0051497 EELEELSGGVDPGRHGSEAVTVPMIPLGLK 3.910000086 0.351955891 0.351955891 0.284894929 3133.42029 0 14.86875 0 0 14.38184 0 14.41987 16.05383 0 15.568 0 0 13.76786 11.42242 13.53166 14.92031 15.29342 11.15787 0 0 0 14.17538 0 11.20104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67738 0 0 0 0 0 0 0 0 Q8TCY9 URGCP_HUMAN Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein) URGCP KIAA1507 URG4 Homo sapiens (Human) cell cycle [GO:0007049] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; cell cycle [GO:0007049] GTP binding [GO:0005525] GO:0005525; GO:0005634; GO:0005829; GO:0007049 RVSVEDMAHAAR 7.21999979 1 1 0.120024168 1340.016972 0 0 0 0 15.68687 0 0 0 0 0 0 0 0 0 0 0 0 16.16977 0 0 0 12.8859 0 0 0 0 17.03106 0 14.77904 0 0 0 0 15.19112 14.4931 14.84934 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD07 RAE1E_HUMAN "Retinoic acid early transcript 1E (Lymphocyte effector toxicity activation ligand) (NKG2D ligand 4, N2DL-4, NKG2DL4) (RAE-1-like transcript 4) (UL16-binding protein 4)" RAET1E LETAL N2DL4 ULBP4 UNQ1867/PRO4303 Homo sapiens (Human) natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954] natural killer cell lectin-like receptor binding [GO:0046703] GO:0005615; GO:0005886; GO:0009897; GO:0016021; GO:0042267; GO:0045954; GO:0046703 LSKGDCDHWLR 5.570000172 1 1 0.166195481 1384.733877 16.1109 14.2065 0 12.43657 0 12.66953 0 15.92134 15.71118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.67459 15.56586 17.40425 14.90388 0 15.23624 0 0 16.12901 0 15.97222 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD08 MK15_HUMAN "Mitogen-activated protein kinase 15, MAP kinase 15, MAPK 15, EC 2.7.11.24 (Extracellular signal-regulated kinase 7, ERK-7) (Extracellular signal-regulated kinase 8, ERK-8)" MAPK15 ERK7 ERK8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; dopamine uptake [GO:0090494]; endoplasmic reticulum organization [GO:0007029]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of spindle assembly [GO:1905832]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to ciliary transition zone [GO:1904491]; regulation of autophagy [GO:0010506]; regulation of cilium assembly [GO:1902017]; regulation of COPII vesicle coating [GO:0003400] autophagosome [GO:0005776]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; nucleus [GO:0005634] autophagosome [GO:0005776]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; SH3 domain binding [GO:0017124]; cellular response to DNA damage stimulus [GO:0006974]; dopamine uptake [GO:0090494]; endoplasmic reticulum organization [GO:0007029]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of spindle assembly [GO:1905832]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to ciliary transition zone [GO:1904491]; regulation of autophagy [GO:0010506]; regulation of cilium assembly [GO:1902017]; regulation of COPII vesicle coating [GO:0003400] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; SH3 domain binding [GO:0017124] GO:0003400; GO:0003682; GO:0004672; GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005776; GO:0005794; GO:0005814; GO:0005911; GO:0005923; GO:0006974; GO:0007029; GO:0008284; GO:0010506; GO:0016301; GO:0017124; GO:0030336; GO:0031410; GO:0032212; GO:0035556; GO:0036064; GO:0046777; GO:0051973; GO:0072687; GO:0090494; GO:0106310; GO:1902017; GO:1904355; GO:1904491; GO:1905188; GO:1905832 RMFSTSALQGAQGGAR 2.420000076 1 1 9.23E-13 1649.395151 16.80287 0 0 0 0 0 16.46107 0 9.909394 0 0 0 0 14.34838 0 14.16784 0 0 0 0 0 0 0 0 15.71605 0 0 14.96881 15.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.08361 0 0 0 0 Q8TD16 BICD2_HUMAN "Protein bicaudal D homolog 2, Bic-D 2" BICD2 KIAA0699 Homo sapiens (Human) "centrosome localization [GO:0051642]; microtubule anchoring at microtubule organizing center [GO:0072393]; microtubule-based movement [GO:0007018]; minus-end-directed organelle transport along microtubule [GO:0072385]; mRNA transport [GO:0051028]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] "annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein light intermediate chain binding [GO:0051959]; small GTPase binding [GO:0031267]; centrosome localization [GO:0051642]; microtubule anchoring at microtubule organizing center [GO:0072393]; microtubule-based movement [GO:0007018]; minus-end-directed organelle transport along microtubule [GO:0072385]; mRNA transport [GO:0051028]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein light intermediate chain binding [GO:0051959]; small GTPase binding [GO:0031267] GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006890; GO:0007018; GO:0008093; GO:0015031; GO:0031267; GO:0031410; GO:0033365; GO:0034067; GO:0034452; GO:0051028; GO:0051642; GO:0051959; GO:0070507; GO:0070840; GO:0072385; GO:0072393 SEMEQLK 9.109999657 0.605595708 0.605595708 0.183295849 879.3412088 16.43767 17.12313 15.24043 16.65477 17.17879 15.84906 15.59508 15.07036 15.92773 15.84636 17.13406 16.49585 16.39933 0 16.19513 15.11018 17.23181 15.46912 16.55922 16.24661 16.68383 16.00318 0 15.86724 16.69668 16.72475 15.82052 15.89054 16.4075 14.60166 15.57034 14.89334 17.624 14.16453 14.9823 15.68038 12.86386 13.90638 17.89897 0 16.91393 15.55022 16.59487 17.05752 15.20684 15.61557 16.21581 14.70637 Q8TD19 NEK9_HUMAN "Serine/threonine-protein kinase Nek9, EC 2.7.11.1 (Nercc1 kinase) (Never in mitosis A-related kinase 9, NimA-related protein kinase 9) (NimA-related kinase 8, Nek8)" NEK9 KIAA1995 NEK8 NERCC Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cell division [GO:0051301] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0007049; GO:0019901; GO:0046872; GO:0051301; GO:0106310 AGILHRDIK 6.159999847 1 1 0.146945461 1022.226655 15.18355 14.58583 0 0 12.31437 14.47405 13.83228 15.58258 15.35046 15.28033 15.49156 0 0 14.45542 0 16.72498 5.800009 13.13231 0 0 0 11.64495 14.02703 13.70685 15.02718 14.48296 0 14.25243 0 0 0 0 0 0 0 0 0 0 0 0 0 16.00804 0 0 0 0 0 14.48804 Q8TD20 GTR12_HUMAN "Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12, GLUT-12)" SLC2A12 GLUT12 Homo sapiens (Human) hexose transmembrane transport [GO:0008645] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; hexose transmembrane transport [GO:0008645] D-glucose transmembrane transporter activity [GO:0055056] GO:0005886; GO:0008645; GO:0012505; GO:0016021; GO:0048471; GO:0055056 GCSLEQISMELAK 5.639999866 0.415431887 0.415431887 0.324447443 1482.402395 12.665 0 13.27989 0 0 0 15.65377 0 0 0 15.2922 0 0 0 0 0 0 16.7342 0 15.63645 0 16.63647 16.34128 16.17381 0 0 14.61605 17.50946 0 0 17.67051 0 15.62694 16.25699 0 0 0 0 0 0 10.42837 0 0 0 0 16.32295 18.37879 0 Q8TD30 ALAT2_HUMAN "Alanine aminotransferase 2, ALT2, EC 2.6.1.2 (Glutamate pyruvate transaminase 2, GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)" GPT2 AAT2 ALT2 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851] L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170] GO:0004021; GO:0005759; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853 EKESVLGNLAK 11.68999958 1 1 1.83E-12 1185.81842 14.64062 14.24808 15.52276 0 14.39675 13.21802 0 0 0 0 0 0 0 13.75876 0 0 0 0 0 15.54355 0 0 0 0 0 14.69783 0 0 0 0 14.17005 0 0 17.15592 17.36579 0 0 0 0 0 15.70025 0 0 0 0 0 0 0 Q8TD43 TRPM4_HUMAN "Transient receptor potential cation channel subfamily M member 4, hTRPM4 (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4, LTrpC-4, LTrpC4) (Melastatin-4)" TRPM4 LTRPC4 Homo sapiens (Human) adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transmembrane transport [GO:0098655]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272]; adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transmembrane transport [GO:0098655]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310] ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272] GO:0002250; GO:0002407; GO:0002724; GO:0005227; GO:0005261; GO:0005272; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0007204; GO:0008284; GO:0010460; GO:0016925; GO:0019722; GO:0030502; GO:0034706; GO:0035774; GO:0042310; GO:0042802; GO:0043025; GO:0044214; GO:0045600; GO:0045668; GO:0045907; GO:0051289; GO:0070588; GO:0071318; GO:0086045; GO:0086047; GO:0086048; GO:0086091; GO:0089717; GO:0090263; GO:0098655; GO:0098662; GO:0098719; GO:0098911; GO:0099604; GO:1903949; GO:1904179; GO:1904199 LLISHGLSLGHFLTPMR 3.410000086 1 1 0.319050606 1908.064156 16.31234 15.48776 0 0 0 0 18.54104 0 0 15.82985 14.24853 14.84352 0 0 0 0 0 0 0 0 0 16.02689 0 0 0 15.71634 0 14.09261 0 0 0 17.322 0 0 0 0 0 0 0 15.54433 16.38716 0 16.80718 16.88084 15.51602 0 16.18625 0 Q8TD55 PKHO2_HUMAN "Pleckstrin homology domain-containing family O member 2, PH domain-containing family O member 2 (Pleckstrin homology domain-containing family Q member 1, PH domain-containing family Q member 1)" PLEKHO2 PLEKHQ1 PP9099 Homo sapiens (Human) macrophage apoptotic process [GO:0071888] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; macrophage apoptotic process [GO:0071888] GO:0005576; GO:0071888; GO:1904813 SSGGLLGFWK 1.460000038 1 1 0.208493384 1051.632719 0 0 15.39883 0 13.7861 0 0 0 0 15.82952 18.25525 0 0 0 0 0 0 14.43269 0 0 0 0 0 0 13.40846 0 14.00084 0 14.98098 0 0 0 0 14.63841 0 17.1544 0 0 0 0 0 0 13.94038 11.61578 9.235785 0 0 0 Q8TD57 DYH3_HUMAN "Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3, HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)" DNAH3 DNAHC3B Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285 ADIVEK 7.03000021 1 1 0 671.4981047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD84 DSCL1_HUMAN Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2) DSCAML1 DSCAM2 KIAA1132 Homo sapiens (Human) axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803] GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0016021; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632 DVFISSSERSFK 11 0.247435316 0.247435316 0.427160309 1401.883615 16.32287 17.10176 0 16.5701 15.70294 0 0 0 0 0 0 0 16.51046 16.93587 16.49928 0 17.06455 0 0 0 0 0 0 16.46707 17.27596 17.52847 16.93537 0 0 15.89714 0 0 0 0 17.03212 16.93188 18.65726 17.91803 0 18.32088 16.71653 16.80357 17.61308 17.02879 16.75389 17.68921 0 0 Q8TDB6 DTX3L_HUMAN "E3 ubiquitin-protein ligase DTX3L, EC 2.3.2.27 (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2, Rhysin2)" DTX3L BBAP Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]" enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842] GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034 KPLSQQERDSCISPSEPETK 3.160000086 0.050530575 0.050530575 0.34350938 2315.600906 19.16304 0 0 18.63871 0 18.69721 0 0 0 0 0 0 18.70347 0 18.51 18.93075 17.86902 18.80663 0 17.80412 0 18.88157 18.63997 0 19.76582 20.17484 17.65652 19.2803 17.61223 0 19.08593 0 19.72489 19.42716 0 18.87216 16.48692 0 0 0 0 0 18.51071 19.00558 17.2036 17.32978 0 19.72456 Q8TDB8 GTR14_HUMAN "Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14, GLUT-14)" SLC2A14 GLUT14 Homo sapiens (Human) cell differentiation [GO:0030154]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; monosaccharide transmembrane transport [GO:0015749]; spermatogenesis [GO:0007283] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; cell differentiation [GO:0030154]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; monosaccharide transmembrane transport [GO:0015749]; spermatogenesis [GO:0007283] D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149] GO:0005355; GO:0005634; GO:0005886; GO:0005887; GO:0007283; GO:0015149; GO:0015749; GO:0016020; GO:0030154; GO:0033300; GO:0046323; GO:0055056; GO:0070837; GO:1904659 KEENATR 10.36999989 1 1 0.125795282 846.8381557 15.9595 0 0 0 0 0 0 0 14.22855 0 0 0 0 0 0 15.13125 0 0 16.5819 0 14.92321 0 0 0 16.4101 0 16.57187 15.51615 0 0 16.53274 0 0 0 15.08708 17.50836 15.6646 13.9937 15.13732 15.49432 15.15337 15.76736 16.52943 15.62059 15.2863 0 0 12.67853 Q8TDD1 DDX54_HUMAN "ATP-dependent RNA helicase DDX54, EC 3.6.4.13 (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)" DDX54 Homo sapiens (Human) intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016020; GO:0016070; GO:0016887; GO:0030331; GO:0030520 GPAAGPR 4.260000229 1 1 0.308281605 624.6402463 18.91857 0 0 0 18.31209 16.86449 0 0 17.91423 0 0 0 0 16.78446 0 0 0 0 18.58508 17.83259 0 0 0 0 0 18.41788 0 17.61168 0 17.98194 0 0 18.85188 0 0 0 0 0 18.8719 0 18.25465 17.36314 18.0849 0 0 0 0 18.37728 Q8TDD5 MCLN3_HUMAN "Mucolipin-3 (Transient receptor potential channel mucolipin 3, TRPML3)" MCOLN3 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626] autophagosome membrane [GO:0000421]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] autophagosome membrane [GO:0000421]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; calcium ion transmembrane transport [GO:0070588]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626] calcium channel activity [GO:0005262]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345] GO:0000421; GO:0005262; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0016020; GO:0016021; GO:0031901; GO:0031902; GO:0042491; GO:0070588; GO:0072345 DLPNSGK 6.619999886 1 1 0.265316229 731.0741885 0 0 18.18301 0 0 0 0 0 18.63192 0 0 0 0 0 23.29911 0 17.6091 0 0 0 0 0 20.29884 0 18.87464 0 0 0 0 0 0 0 0 0 0 19.40411 0 0 0 0 0 0 0 0 0 22.77874 0 0 Q8TDG4 HELQ_HUMAN "Helicase POLQ-like, EC 3.6.4.12 (Mus308-like helicase) (POLQ-like helicase)" HELQ HEL308 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518] GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006364; GO:0016887; GO:1990518 NAMTGNAKAQTPIFSR 8.979999542 1 1 0.275732828 1723.652867 10.87353 15.83435 14.44276 15.65078 15.11525 14.3857 13.19976 14.69852 0 14.47778 10.5267 0 0 0 0 14.79646 0 0 13.67135 16.79175 0 0 0 12.74123 0 15.80237 15.55547 0 0 0 0 0 0 0 0 0 0 0 0 14.83191 0 0 13.28959 14.48642 14.95306 0 0 0 Q8TDI0 CHD5_HUMAN "Chromodomain-helicase-DNA-binding protein 5, CHD-5, EC 3.6.4.12 (ATP-dependent helicase CHD5)" CHD5 KIAA0444 Homo sapiens (Human) "cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] "cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; metal ion binding [GO:0046872] GO:0000792; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008285; GO:0016020; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035093; GO:0043967; GO:0046872; GO:0061628; GO:0098532; GO:0140658; GO:1901798 APPSPEQLPR 1.129999995 1 1 0.19553437 1091.156155 13.95941 12.27062 12.89274 13.96531 0 0 0 0 0 0 14.18663 14.55047 15.04747 0 14.52425 0 0 16.66263 15.01608 0 12.26036 0 0 14.35025 15.67654 0 12.20805 12.65875 0 12.63391 0 13.98532 13.70195 12.86382 15.19426 13.83162 0 16.2202 0 11.41152 15.36804 14.76477 0 11.92533 0 16.44921 12.98186 15.49604 Q8TDI8 TMC1_HUMAN Transmembrane channel-like protein 1 (Transmembrane cochlear-expressed protein 1) TMC1 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]; mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]; auditory receptor cell development [GO:0060117]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005] mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005887; GO:0008381; GO:0009897; GO:0032426; GO:0050910; GO:0060005; GO:0060117; GO:1903169 AAAAAGRQ 3.269999981 1 1 0.279931699 715.7685687 0 0 14.81861 15.97304 0 15.29367 14.3401 15.84215 0 15.98454 14.77867 0 0 15.57785 14.74167 15.41678 16.40452 15.30994 15.66574 16.53908 14.53561 0 16.00243 16.35716 0 17.36122 0 0 0 0 0 0 16.46755 15.44988 16.52538 0 17.01969 0 0 0 17.08521 15.60599 15.89241 15.09558 0 0 14.87131 0 Q8TDJ6 DMXL2_HUMAN DmX-like protein 2 (Rabconnectin-3) DMXL2 KIAA0856 Homo sapiens (Human) vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; small GTPase binding [GO:0031267]; vacuolar acidification [GO:0007035] small GTPase binding [GO:0031267] GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 DRYLIPNIK 22.60000038 1 1 0.447940277 1131.48055 14.68608 0 16.29254 0 0 16.28823 0 0 0 17.33159 17.23052 0 0 0 0 16.30646 0 14.35219 0 0 16.62721 0 0 0 17.46776 0 16.25823 0 0 0 0 0 0 0 15.82915 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDM5 SACA4_HUMAN Sperm acrosome membrane-associated protein 4 (Sperm acrosomal membrane-associated protein 14) SPACA4 SAMP14 UNQ3046/PRO9862 Homo sapiens (Human) cell adhesion [GO:0007155] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0001669; GO:0005576; GO:0005886; GO:0007155; GO:0031225 GCLRATSCGLEEPVSYR 8.819999695 1 1 0.144123938 1955.362406 10.61158 0 0 13.389 0 12.69088 12.91256 0 0 13.44531 0 0 13.11225 0 0 0 0 0 0 15.73355 0 0 13.62768 0 12.31644 10.88567 0 0 14.06237 0 6.886953 17.13215 14.76317 14.14705 15.27563 0 0 0 0 13.93666 0 0 15.66814 0 0 0 0 14.0932 Q8TDM6 DLG5_HUMAN Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186] adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186] beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159] GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609 IDYLLPGPGPAHSPQPSK 2.75 1 1 0.105460323 1873.87267 0 0 13.45215 0 14.67292 0 0 0 14.97821 15.95899 0 15.70401 13.71255 17.98226 12.948 12.88863 15.61197 14.92767 12.32803 16.1803 14.78202 15.85524 18.6683 15.57619 0 13.52975 0 14.62345 14.84335 12.31483 0 15.81522 16.34957 0 13.87949 15.23276 15.48888 14.92111 15.44909 0 0 8.747839 0 14.77553 0 15.57425 16.87635 16.479 Q8TDN1 KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 (Voltage-gated potassium channel subunit Kv6.4) KCNG4 KCNG3 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005654; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0044325; GO:0051260; GO:0071805 ILYVMR 19.94000053 1 1 0.153403711 809.5115764 0 20.13599 0 20.74759 21.03032 20.75462 0 19.58412 17.54395 20.17444 18.93725 0 17.00015 20.22911 19.77697 21.23927 19.81938 17.44132 0 17.6695 19.76809 20.05876 20.51023 20.37867 0 19.08692 17.5072 0 0 20.25195 19.02717 18.77915 19.29958 17.50742 19.87067 19.68164 0 19.65912 20.23559 20.06116 19.52041 18.018 0 0 0 20.04546 0 17.454 Q8TDN4 CABL1_HUMAN "CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1, Ik3-1)" CABLES1 CABLES Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005829; GO:0007049; GO:0007399; GO:0051301; GO:0051726 LVQSS 10.46000004 0.58992821 0.58992821 0.244811307 532.5493496 15.90934 17.8764 17.49142 0 15.31659 16.5303 15.9829 0 15.899 17.36788 17.54342 17.06741 0 15.47209 16.80923 15.80783 14.84117 14.36759 0 17.01032 16.6498 0 17.20847 17.04842 13.57532 16.73534 0 0 15.95705 15.95479 0 16.1057 15.05271 17.40909 16.26926 15.89704 15.45611 18.00137 16.29979 16.31428 17.71532 16.26768 15.09373 17.90796 16.92286 15.14803 16.49427 12.93996 Q8TDR0 MIPT3_HUMAN "TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3, MIP-T3)" TRAF3IP1 IFT54 MIPT3 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507] microtubule binding [GO:0008017] GO:0001738; GO:0001822; GO:0001933; GO:0005813; GO:0005929; GO:0005930; GO:0008017; GO:0030992; GO:0031333; GO:0032480; GO:0035720; GO:0035869; GO:0036064; GO:0042073; GO:0050687; GO:0060271; GO:0070507; GO:0097542; GO:0097546 LQQSPKPGEK 6.079999924 0.000341502 0.000341502 0.086491343 1112.623504 11.7907 17.30545 14.80459 14.17133 0 12.66168 13.23084 0 14.5846 16.92553 14.77744 0 14.95606 15.81464 15.87354 13.05693 15.53864 0 0 13.16844 14.59233 16.64536 14.48149 12.87518 17.50613 16.42326 15.23752 14.07249 13.02833 16.18395 19.27069 15.73502 16.32412 0 0 16.10221 17.28006 0 20.17052 13.72554 15.43886 15.27537 13.15953 14.93071 0 12.49508 15.57241 0 Q8TDR2 STK35_HUMAN "Serine/threonine-protein kinase 35, EC 2.7.11.1 (CLP-36-interacting kinase 1, CLIK-1) (PDLIM1-interacting kinase 1) (Serine/threonine-protein kinase 35 L1)" STK35 CLIK1 PDIK1 STK35L1 Homo sapiens (Human) meiotic cell cycle [GO:0051321] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; meiotic cell cycle [GO:0051321] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016604; GO:0051321; GO:0106310 AATSRAAR 9.140000343 0.232363254 0.232363254 0.301338987 803.945781 16.04567 14.75369 0 0 0 0 13.66988 15.78452 10.92346 15.65005 16.00931 0 0 14.83038 0 15.47501 0 0 0 0 0 15.01175 16.01236 0 0 14.40727 0 15.51445 0 16.02918 15.49148 16.84851 0 15.42925 0 0 16.56279 16.73078 0 0 0 16.81606 14.81723 15.97206 0 0 16.04178 0 Q8TDS7 MRGRD_HUMAN Mas-related G-protein coupled receptor member D (Beta-alanine receptor) (G-protein coupled receptor TGR7) MRGPRD MRGD Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005615; GO:0005886; GO:0007186; GO:0016021 VHELMKR 6.980000019 1 1 0.17043171 913.5840186 13.33833 0 13.69035 14.94099 0 0 0 0 11.53045 0 0 12.06772 16.10824 15.08544 0 0 0 14.04543 12.91499 0 0 0 11.77254 14.25328 13.18639 0 14.52116 0 0 14.55114 13.20295 0 14.45639 14.88481 0 15.26322 15.97032 0 17.63487 15.51696 0 0 0 0 0 15.86271 0 0 Q8TDW0 LRC8C_HUMAN Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C) LRRC8C AD158 FAD158 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] volume-sensitive anion channel activity [GO:0005225] GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0034214; GO:0034702; GO:0045444; GO:0071470; GO:0098656; GO:0140361 ELPPWMYGLR 18.95000076 0.579352736 0.579352736 0.190152322 1262.479583 15.21237 15.1441 15.57856 0 0 15.03403 0 0 16.00945 0 14.12562 15.57917 0 0 0 14.31909 0 0 0 15.23043 14.91069 0 15.33568 0 0 15.65774 0 0 0 0 0 0 0 0 15.47637 0 14.56435 0 0 14.73203 15.70367 0 0 13.50111 15.77485 0 16.04107 0 Q8TDW7 FAT3_HUMAN "Protocadherin Fat 3, hFat3 (Cadherin family member 15) (FAT tumor suppressor homolog 3)" FAT3 CDHF15 KIAA1989 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005886; GO:0007156; GO:0016021; GO:0098609 DKGSPQK 8.899999619 1 1 0.219874389 758.1963402 0 16.92364 0 16.60888 14.54763 15.38398 12.79552 13.03091 14.33571 16.86621 15.46266 15.24894 16.50242 0 0 0 0 16.2219 0 0 0 17.07147 0 0 0 0 18.07904 0 0 9.988763 0 15.98729 0 0 0 0 0 16.52693 0 0 0 0 0 0 0 0 0 0 Q8TDX6 CGAT1_HUMAN "Chondroitin sulfate N-acetylgalactosaminyltransferase 1, CsGalNAcT-1, EC 2.4.1.174 (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1, Beta4GalNAcT-1)" CSGALNACT1 CHGN GALNACT1 UNQ656/PRO1287 Homo sapiens (Human) "cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]" Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] "Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]" acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955] GO:0000139; GO:0001958; GO:0008376; GO:0008955; GO:0015014; GO:0015020; GO:0019276; GO:0030166; GO:0030173; GO:0030198; GO:0030206; GO:0030210; GO:0032580; GO:0046398; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050653; GO:0051216 LILFRPFGPIMK 3.670000076 1 1 0.237452223 1431.243301 0 14.15488 0 0 0 14.18811 0 0 0 0 0 0 0 12.03644 0 0 0 13.33 0 0 0 0 0 0 16.53439 14.59749 15.53332 0 0 0 0 0 0 15.60044 14.91321 0 14.95437 18.07516 0 15.67576 15.12354 15.93044 0 0 0 12.67806 0 0 Q8TDX7 NEK7_HUMAN "Serine/threonine-protein kinase Nek7, EC 2.7.11.1 (Never in mitosis A-related kinase 7, NimA-related protein kinase 7)" NEK7 Homo sapiens (Human) cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000922; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0035865; GO:0046872; GO:0051225; GO:0051973; GO:0106310; GO:1900227; GO:1904355 QLVNMCINPDPEK 10.77000046 1 1 0.242353409 1573.403311 0 0 18.46668 0 0 0 18.59229 0 19.01768 19.28768 17.01111 0 19.09958 0 0 0 0 0 0 0 19.11231 0 0 0 0 19.32209 0 0 0 0 17.60864 0 0 0 16.5188 0 0 0 19.05249 0 0 0 0 17.50686 0 0 17.48807 0 Q8TDX9 PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 (PC1-like 1 protein) (Polycystin-1L1) PKD1L1 UNQ5785/PRO19563 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] calcium channel activity [GO:0005262] GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609 APARLTSK 12.52999973 1 1 0.029134956 842.3313627 14.19963 14.7767 15.6013 0 14.86143 0 0 0 0 0 0 0 0 0 15.6963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDY2 RBCC1_HUMAN "RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa, FIP200)" RB1CC1 KIAA0203 RBICC Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0001889; GO:0001934; GO:0005764; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007049; GO:0007507; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0045793; GO:0046330; GO:0046777; GO:0060090; GO:0061709; GO:0061723; GO:1903059; GO:1990316; GO:2001237 CFDSMSR 7.010000229 1 1 0.291944089 918.0643916 0 0 0 16.39437 0 0 0 0 15.27579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.00496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDY4 ASAP3_HUMAN "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (Development and differentiation-enhancing factor-like 1) (Protein up-regulated in liver cancer 1)" ASAP3 DDEFL1 UPLC1 Homo sapiens (Human) cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; regulation of stress fiber assembly [GO:0051492] cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ruffle [GO:0001726] cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; regulation of stress fiber assembly [GO:0051492] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0001726; GO:0005096; GO:0005654; GO:0005829; GO:0005925; GO:0016477; GO:0043231; GO:0043547; GO:0046872; GO:0051492 CFDLVTHNR 6.050000191 1 1 0.140314493 1162.235896 11.17728 15.0922 14.97553 13.55942 13.67183 14.25416 13.18302 0 10.90459 0 0 0 0 11.0505 0 0 0 0 0 0 0 0 0 14.09227 0 0 0 0 0 0 0 0 9.056863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDY8 IGDC4_HUMAN "Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36, hDDM36)" IGDCC4 DDM36 KIAA1628 NOPE Homo sapiens (Human) cell-cell adhesion [GO:0098609] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion [GO:0098609] GO:0005886; GO:0016021; GO:0098609 MARGDAGR 12.18999958 0.001351809 0.001351809 0.082454562 849.4250625 0 16.58228 16.11173 13.93285 0 15.91951 16.40915 13.81233 8.133709 12.8503 14.25709 16.05602 16.5856 0 15.09345 15.75173 16.34545 15.34151 16.52417 17.38664 17.10845 0 15.82578 0 17.11922 14.78808 15.61301 14.37889 15.87973 14.59309 15.67543 15.33964 0 13.07388 16.23683 15.76749 15.39309 0 15.29304 16.27057 0 17.08583 15.57667 16.0782 17.2165 0 18.13985 15.47138 Q8TDZ2 MICA1_HUMAN "[F-actin]-monooxygenase MICAL1, EC 1.14.13.225, EC 1.6.3.1 (Molecule interacting with CasL protein 1, MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains)" MICAL1 MICAL NICAL Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]" "actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]" GO:0001933; GO:0003779; GO:0005737; GO:0005829; GO:0005882; GO:0005886; GO:0007010; GO:0007165; GO:0015629; GO:0016174; GO:0016709; GO:0017124; GO:0019417; GO:0019901; GO:0030042; GO:0030496; GO:0031267; GO:0043154; GO:0045171; GO:0046872; GO:0051015; GO:0051017; GO:0071949; GO:1903305; GO:1990026 LLLGLVGDCLVEPFWPLGTGVAR 9.989999771 1 1 0.165560342 2483.018451 15.10071 0 13.8914 0 0 0 13.25285 0 16.05996 0 0 0 14.68258 0 0 0 0 12.87556 0 0 0 15.8265 0 0 0 0 16.09099 0 16.98783 0 16.79307 0 15.17884 14.16339 15.886 0 0 0 13.98377 0 15.13101 15.2253 0 0 0 15.00719 0 0 Q8TE04 PANK1_HUMAN "Pantothenate kinase 1, hPanK, hPanK1, EC 2.7.1.33 (Pantothenic acid kinase 1)" PANK1 PANK Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937] cell periphery [GO:0071944]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037] cell periphery [GO:0071944]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]; coenzyme A biosynthetic process [GO:0015937] acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803] GO:0004594; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0015937; GO:0030136; GO:0042803; GO:0055037; GO:0071944; GO:1905502 FIQMGSEK 6.769999981 0.516967356 0.516967356 0.244192104 956.4874686 16.16474 14.20439 15.08012 16.13005 0 16.65525 14.44478 0 0 16.8529 16.19786 16.11118 16.14778 16.32191 0 0 0 15.34992 15.2942 0 16.28665 16.49405 0 17.45062 17.31873 0 16.51346 15.67794 16.91068 14.97647 17.0073 16.06874 13.28098 15.80163 0 14.01193 14.33738 16.56282 13.81921 0 16.32978 16.45491 15.44288 15.84772 15.19622 15.3171 15.5075 16.7918 Q8TE23 TS1R2_HUMAN Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2) TAS1R2 GPR71 T1R2 TR2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytokinesis [GO:0032467]; sensory perception of sweet taste [GO:0050916] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sweet taste receptor complex [GO:1903767] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sweet taste receptor complex [GO:1903767]; G protein-coupled receptor activity [GO:0004930]; sweet taste receptor activity [GO:0033041]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytokinesis [GO:0032467]; sensory perception of sweet taste [GO:0050916] G protein-coupled receptor activity [GO:0004930]; sweet taste receptor activity [GO:0033041]; taste receptor activity [GO:0008527] GO:0001582; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0016021; GO:0032467; GO:0033041; GO:0043235; GO:0050916; GO:1903767 STCTKR 3.319999933 1 1 0.200344758 754.4989976 0 0 0 0 13.81578 0 0 0 0 0 13.19112 16.64236 0 14.25589 0 0 0 16.50818 14.95438 0 0 0 15.6403 17.04819 0 15.39191 0 0 15.63986 17.64411 15.85571 17.22101 0 0 0 0 0 0 0 0 0 0 0 16.14584 13.36235 13.57628 14.92873 16.60017 Q8TE49 OTU7A_HUMAN "OTU domain-containing protein 7A, EC 3.4.19.12 (Zinc finger protein Cezanne 2)" OTUD7A C15orf16 CEZANNE2 OTUD7 Homo sapiens (Human) negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016579; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947 LAHLILSLEAK 12.18999958 0.214168325 0.214168325 0.406729302 1208.503324 12.55387 0 0 11.08895 15.06038 14.35829 15.05594 15.16307 14.20216 13.64739 0 15.64723 16.22289 14.63476 15.37539 15.88073 0 0 0 0 0 15.92919 0 0 15.21316 0 0 0 0 0 0 13.24914 15.65174 0 14.52311 0 15.99454 0 16.11612 0 0 0 17.15427 15.57552 0 0 0 0 Q8TE56 ATS17_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 17, ADAM-TS 17, ADAM-TS17, ADAMTS-17, EC 3.4.24.-" ADAMTS17 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005576; GO:0030198; GO:0031012; GO:0046872 DFYANKMR 8.470000267 1 1 0.141846866 1041.660139 16.49144 0 14.9462 14.59325 15.93838 0 16.1431 15.58598 15.52094 15.33441 15.54493 15.96228 16.0624 15.30424 15.2801 14.92524 0 15.91259 14.73446 15.53007 13.14162 0 0 0 0 15.23269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7683 0 15.19982 16.83657 0 0 0 0 Q8TE57 ATS16_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 16, ADAM-TS 16, ADAM-TS16, ADAMTS-16, EC 3.4.24.-" ADAMTS16 KIAA2029 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017 MMQNHGHENITTYVLTILNMVSALFK 9.539999962 1 1 0.13634033 3056.972592 14.39001 0 0 0 0 15.04827 0 0 14.58524 13.26791 13.11746 0 0 14.74919 0 0 0 0 0 0 13.88544 0 0 0 0 13.27711 0 0 13.07232 10.01367 0 12.83105 0 0 0 0 0 11.76329 0 14.1776 0 0 0 0 13.26834 0 0 0 Q8TE58 ATS15_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 15, ADAM-TS 15, ADAM-TS15, ADAMTS-15, EC 3.4.24.-" ADAMTS15 Homo sapiens (Human) extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520] endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0004175; GO:0004222; GO:0005615; GO:0007520; GO:0008201; GO:0008270; GO:0009986; GO:0022617; GO:0030198; GO:0031012; GO:0050840; GO:0062023 DSGPK 17.46999931 0.221255839 0.221255839 0.133997337 503.300997 16.56945 16.64106 16.87164 16.46061 16.72318 16.37738 15.71325 16.18946 16.44351 16.53051 16.08587 16.68821 16.51105 0 16.32083 16.76011 17.32802 15.95105 16.66728 17.02571 17.02974 17.09129 18.39037 16.79289 18.23936 16.24955 16.25414 16.94776 15.79244 16.52396 17.13725 16.00481 17.30342 15.63207 15.98984 16.07772 16.90418 16.89466 14.70961 16.51072 15.59386 17.1069 17.26913 17.00226 18.12878 17.19694 17.09869 18.39899 Q8TE67 ES8L3_HUMAN "Epidermal growth factor receptor kinase substrate 8-like protein 3, EPS8-like protein 3 (Epidermal growth factor receptor pathway substrate 8-related protein 3, EPS8-related protein 3)" EPS8L3 EPS8R3 Homo sapiens (Human) positive regulation of ruffle assembly [GO:1900029]; regulation of hair cycle [GO:0042634]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; positive regulation of ruffle assembly [GO:1900029]; regulation of hair cycle [GO:0042634]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0005886; GO:0007266; GO:0032587; GO:0035023; GO:0042634; GO:1900029 MLGISP 4.639999866 1 1 0.032382503 616.7676866 0 0 0 0 15.1558 14.55559 0 0 0 0 0 14.36029 15.45438 0 0 0 0 0 15.32663 0 16.68366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.97606 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE68 ES8L1_HUMAN "Epidermal growth factor receptor kinase substrate 8-like protein 1, EPS8-like protein 1 (Epidermal growth factor receptor pathway substrate 8-related protein 1, EPS8-related protein 1)" EPS8L1 DRC3 EPS8R1 PP10566 Homo sapiens (Human) positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608]; positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608] GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0032587; GO:0032991; GO:0035023; GO:0042608; GO:0045296; GO:0050790; GO:0070062; GO:1900029 AVPGPR 3.140000105 1 1 0.10139276 596.4259217 0 16.89377 17.19362 0 0 0 0 14.83942 0 0 0 0 0 17.37925 0 15.77369 12.76365 16.18572 16.54184 0 0 0 0 15.8716 17.0913 15.62008 0 0 0 16.32821 0 0 17.26969 17.84556 0 0 0 0 0 15.21115 0 0 0 0 16.1174 17.05973 0 0 Q8TE73 DYH5_HUMAN Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) DNAH5 DNAHC5 HL1 KIAA1603 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0097729 AVLAVLAAAK 11.93999958 0.104840428 0.104840428 0.277290624 927.2239006 17.80235 0 18.51057 17.69089 0 17.55509 19.31564 19.83901 0 20.24221 17.41334 0 17.59331 17.70084 0 17.76688 0 16.51608 17.45742 0 0 17.53378 17.08668 0 18.40882 18.56997 19.41413 18.24942 18.60291 16.77703 19.07138 19.92961 17.46701 0 0 20.67403 18.53264 18.30394 0 0 17.61625 17.12069 18.58105 0 16.78748 0 17.04395 19.32232 Q8TE76 MORC4_HUMAN MORC family CW-type zinc finger protein 4 (Zinc finger CW-type coiled-coil domain protein 2) (Zinc finger CW-type domain protein 4) MORC4 ZCW4 ZCWCC2 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0008270; GO:0016887; GO:0035064 GPFVAVVGVAKGVR 10.97000027 1 1 0.299661062 1356.249284 0 0 0 0 0 0 20.02043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE77 SSH3_HUMAN "Protein phosphatase Slingshot homolog 3, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 3, SSH-3L, hSSH-3L)" SSH3 SSH3L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837] actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0008138; GO:0030036; GO:0030837 SPPGSGASTPVGPWDQAVQRR 2.359999895 1 1 2.30E-12 2145.638137 14.88529 15.02227 0 0 12.4876 0 0 9.559211 0 0 0 0 0 0 0 14.67459 13.75355 0 0 0 0 0 0 0 0 0 0 13.13845 0 0 16.08685 15.83161 0 0 13.1886 14.20297 14.60721 13.37778 0 15.04665 0 0 0 0 0 0 0 0 Q8TE82 S3TC1_HUMAN SH3 domain and tetratricopeptide repeat-containing protein 1 SH3TC1 Homo sapiens (Human) SSLISMQGPVSELESAIFLNEEEK 2.900000095 1 1 0.222890633 2637.730268 15.70691 14.1219 14.21744 14.8911 14.27733 0 0 11.97334 0 0 0 13.2992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE85 GRHL3_HUMAN Grainyhead-like protein 3 homolog (Sister of mammalian grainyhead) (Transcription factor CP2-like 4) GRHL3 SOM TFCP2L4 Homo sapiens (Human) central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; eyelid development in camera-type eye [GO:0061029]; gene expression [GO:0010467]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; eyelid development in camera-type eye [GO:0061029]; gene expression [GO:0010467]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]" "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001736; GO:0001843; GO:0005634; GO:0005654; GO:0006357; GO:0007389; GO:0007398; GO:0007417; GO:0008544; GO:0010467; GO:0010628; GO:0031490; GO:0032956; GO:0042060; GO:0043547; GO:0043565; GO:0045944; GO:0061029; GO:0061436; GO:0090103; GO:0090179 GLALSSNKVK 7.96999979 1 1 0.513697616 1017.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.31338 0 0 0 0 18.92066 0 0 0 0 0 0 0 0 0 0 0 0 19.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE96 DQX1_HUMAN "ATP-dependent RNA helicase DQX1, EC 3.6.4.12 (DEAQ box polypeptide 1)" DQX1 Homo sapiens (Human) spliceosomal complex [GO:0005681] spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723] GO:0003678; GO:0003723; GO:0005524; GO:0005681; GO:0016887 SVYNPR 11.02999973 0.752141774 0.752141774 0.185024702 738.3188334 13.89997 15.37183 16.76664 16.47644 15.74157 0 0 0 14.41747 15.28968 16.31939 14.93841 0 0 0 15.79163 0 0 0 16.75343 17.50976 16.0811 0 15.65609 0 16.39473 16.12955 0 0 15.46397 17.16299 15.92384 0 0 0 0 15.98299 15.79186 15.71075 16.78268 0 0 0 14.94135 16.71176 16.6564 13.12476 0 Q8TE99 PXYP1_HUMAN "2-phosphoxylose phosphatase 1, EC 3.1.3.- (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124)" PXYLP1 ACPL2 HEL124 XYLP UNQ370/PRO706 Homo sapiens (Human) chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909] phosphatase activity [GO:0016791] GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650 NGMSSK 8.06000042 0.392581314 0.392581314 0.222121475 639.6196281 15.49713 14.62225 15.76488 0 0 0 0 0 14.66878 16.46972 0 14.78605 16.43305 16.63189 16.5031 15.08926 16.19436 16.67245 17.3604 16.17033 16.79427 16.22281 17.78685 0 16.84155 0 0 14.92598 16.32606 16.1818 16.13745 16.85212 15.42033 17.11849 16.07221 17.28319 17.84859 16.7387 18.41598 17.25022 0 17.26208 18.72656 17.30162 16.47283 0 17.60077 18.29008 Q8TEA7 TBCK_HUMAN TBC domain-containing protein kinase-like protein TBCK TBCKL HSPC302 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; regulation of TOR signaling [GO:0032006] cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; regulation of TOR signaling [GO:0032006] ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672] GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0008283; GO:0030036; GO:0030496; GO:0032006; GO:0072686; GO:0090630 VDIPPLMR 14.75 1 1 0.23180386 941.65918 0 0 14.79589 0 0 16.06113 15.69044 16.29679 0 0 14.71311 16.10786 15.45835 0 0 15.36082 0 0 0 0 0 0 0 0 15.54536 0 16.22896 0 0 0 0 0 0 0 14.67247 0 0 0 16.44816 17.2517 16.90639 16.12325 15.66068 14.43826 15.77399 0 0 0 Q8TEB9 RHBL4_HUMAN "Rhomboid-related protein 4, RRP4, EC 3.4.21.105 (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)" RHBDD1 RHBDL4 HSD-50 HSD50 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]" endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0030176; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211 ALQASLWDR 1.75999999 1 1 0.125491124 1060.01064 0 14.1253 0 14.48575 12.38816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.95979 0 0 0 15.45587 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEC5 SH3R2_HUMAN "E3 ubiquitin-protein ligase SH3RF2, EC 2.3.2.27 (Heart protein phosphatase 1-binding protein, HEPP1) (POSH-eliminating RING protein) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2)" SH3RF2 POSH3 POSHER PPP1R39 RNF158 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; ubiquitin protein ligase activity [GO:0061630] GO:0004864; GO:0005634; GO:0005654; GO:0008157; GO:0016567; GO:0019902; GO:0030335; GO:0031397; GO:0032436; GO:0043066; GO:0046329; GO:0046330; GO:0046872; GO:0051865; GO:0061630 GRSSMR 8.68999958 1 1 3.44E-13 708.5153085 0 15.0624 0 17.0663 17.81117 0 16.38017 0 0 0 0 14.89173 0 0 0 15.75856 16.47604 0 0 0 0 0 0 0 0 0 0 15.01039 0 0 15.39327 0 16.44941 0 16.35826 0 0 15.94842 0 0 0 0 0 0 0 0 0 0 Q8TED0 UTP15_HUMAN U3 small nucleolar RNA-associated protein 15 homolog UTP15 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0006364; GO:0045943; GO:2000234 EISHVLNFLIRNLSQPR 5.659999847 1 1 0.408592461 2035.686739 0 0 0 0 0 0 0 0 0 0 0 0 0 19.73301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TED9 AF1L1_HUMAN "Actin filament-associated protein 1-like 1, AFAP1-like protein 1" AFAP1L1 Homo sapiens (Human) cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102] cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102]; SH3 domain binding [GO:0017124] SH3 domain binding [GO:0017124] GO:0002102; GO:0005829; GO:0017124; GO:0030054; GO:0042995 HQWPSEEASMHLVR 11.32999992 0.014918661 0.014918661 0.551537532 1723.36964 18.63997 14.03703 0 0 17.41491 0 0 0 0 0 0 18.65936 0 18.28901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.33466 18.95541 0 0 0 0 0 0 0 0 0 0 18.32132 0 0 17.56869 0 0 18.15465 Q8TEK3 DOT1L_HUMAN "Histone-lysine N-methyltransferase, H3 lysine-79 specific, EC 2.1.1.360 (DOT1-like protein) (Histone H3-K79 methyltransferase, H3-K79-HMTase) (Lysine N-methyltransferase 4)" DOT1L KIAA1814 KMT4 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin assembly [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin assembly [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200] DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] GO:0000077; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008284; GO:0010467; GO:0018024; GO:0031151; GO:0031507; GO:0032200; GO:0032991; GO:0034729; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:2000677 ALTYNDLIQAQK 5.829999924 1 1 0.327856048 1379.701063 0 0 0 0 15.18888 0 0 16.15025 0 0 0 0 0 0 0 0 14.13286 16.09439 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18484 0 14.84879 0 16.56213 0 0 0 0 8.791348 0 16.7087 0 14.28946 0 16.47789 0 Q8TEL6 TP4AP_HUMAN "Short transient receptor potential channel 4-associated protein, Trp4-associated protein, Trpc4-associated protein (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein, Protein TRUSS)" TRPC4AP C20orf188 TRRP4AP Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0005262; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756 ILAVTISEMDTGNDDK 5.260000229 1 1 0.273136641 1737.919826 14.20364 13.90382 15.39972 0 0 0 0 14.45096 15.53821 0 0 15.92622 0 13.06591 15.27644 14.67101 0 14.32341 0 14.8415 0 15.58951 0 0 15.26662 12.82298 15.43725 0 11.8613 0 0 0 0 16.95353 16.41256 12.80984 15.12099 15.55473 16.39544 14.67541 0 0 0 0 16.12436 16.2067 0 0 Q8TEM1 PO210_HUMAN "Nuclear pore membrane glycoprotein 210, Nuclear pore protein gp210 (Nuclear envelope pore membrane protein POM 210, POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)" NUP210 KIAA0906 PSEC0245 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0016021; GO:0031965; GO:0051028 QVVPVSSHR 10.59000015 0.326304048 0.326304048 0.445867451 1008.575027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97681 0 0 0 0 0 0 0 0 0 16.70813 11.67314 15.05638 15.23223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.48071 0 Q8TEP8 CE192_HUMAN "Centrosomal protein of 192 kDa, Cep192, Cep192/SPD-2" CEP192 KIAA1569 PP8407 Homo sapiens (Human) centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901] GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0009617; GO:0019901; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099 ATSISTPSDSYSSVRNPR 7.019999981 1 1 5.25E-12 1921.347508 13.71037 14.86115 13.35138 11.6598 13.52153 14.37617 0 12.84079 0 12.21614 16.1369 12.53916 0 14.82531 14.70818 14.59259 14.19187 14.75235 0 15.55748 15.10823 13.94681 14.27351 16.12405 14.02837 15.72334 14.49738 15.31029 15.8431 14.91412 0 0 0 0 11.12461 0 13.59388 14.19388 0 14.83289 16.25475 0 14.42259 0 15.62839 0 0 0 Q8TEQ0 SNX29_HUMAN Sorting nexin-29 (RUN domain-containing protein 2A) SNX29 RUNDC2A Homo sapiens (Human) phosphatidylinositol binding [GO:0035091] phosphatidylinositol binding [GO:0035091] GO:0035091 GLALTAAAIK 2.940000057 0.446825057 0.446825057 0.178571466 928.9742289 0 0 0 12.117 14.7479 15.32773 13.75718 0 0 0 0 0 0 0 0 0 0 0 0 15.48923 0 0 0 0 14.78586 0 14.26393 0 0 0 0 0 0 0 0 16.33303 0 0 0 15.37651 0 0 0 0 0 0 0 0 Q8TEQ6 GEMI5_HUMAN "Gem-associated protein 5, Gemin5" GEMIN5 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]" mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504 YGNTKTYR 2.980000019 0.518285334 0.518285334 0.283567397 1002.966232 14.11532 0 0 21.25613 0 16.80761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.175 0 0 18.50963 0 0 0 16.26668 20.60842 16.70977 17.71792 0 0 17.37402 0 0 0 0 0 0 0 0 0 17.95763 0 0 Q8TEQ8 PIGO_HUMAN "GPI ethanolamine phosphate transferase 3, EC 2.-.-.- (Phosphatidylinositol-glycan biosynthesis class O protein, PIG-O)" PIGO UNQ632/PRO1249 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506] mannose-ethanolamine phosphotransferase activity [GO:0051377] GO:0005789; GO:0006506; GO:0016020; GO:0016021; GO:0051377 GAEATLPTVIAELQQFLRGAR 1.25999999 1 1 0.176732573 2242.400578 0 13.33617 11.84314 14.78666 0 11.15152 10.92742 12.45012 0 15.23952 12.61775 13.09317 13.82605 8.948967 0 16.94199 0 0 0 11.68055 0 0 9.370547 0 8.97318 0 14.02681 0 10.99315 0 0 0 0 0 0 0 16.67431 0 15.76407 13.25676 0 0 0 0 12.53512 0 11.89709 0 Q8TER0 SNED1_HUMAN "Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1, IRE-BP1)" SNED1 Homo sapiens (Human) cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012 EATDPAMLRR 4.630000114 1 1 0.082648888 1176.753664 14.59551 15.9258 0 0 0 0 15.41407 0 13.02441 0 12.19311 9.525046 15.74467 0 0 0 0 0 0 13.88467 0 0 0 0 0 0 15.93376 15.16683 0 0 0 0 12.23094 0 0 0 12.9281 0 14.59564 11.49137 12.56503 14.02729 0 0 0 0 0 0 Q8TER5 ARH40_HUMAN Rho guanine nucleotide exchange factor 40 (Protein SOLO) ARHGEF40 SOLO Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0005886; GO:0051056 CLAPGGGR 2.650000095 0.999322534 0.999322534 0.237611349 786.349484 15.65167 15.80911 14.18294 14.33985 0 0 0 13.77845 15.23705 15.4972 0 15.27263 0 14.88815 15.42273 16.17827 0 0 0 0 15.28285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.52367 0 0 0 0 15.26618 0 0 0 0 0 16.14542 0 Q8TES7 FBF1_HUMAN "Fas-binding factor 1, FBF-1 (Protein albatross)" FBF1 ALB KIAA1863 Homo sapiens (Human) apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162] cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; spindle pole [GO:0000922] cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; spindle pole [GO:0000922]; apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162] GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0030054; GO:0036064; GO:0043297; GO:0060271; GO:0090162; GO:0097539 AESMQRALEEQR 6.769999981 1 1 0.537984305 1464.323094 0 0 0 19.93709 0 0 0 0 0 0 0 0 0 0 0 18.65257 0 18.60157 0 0 0 0 0 0 19.16693 19.37957 18.29626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.28528 0 0 0 0 Q8TET4 GANC_HUMAN "Neutral alpha-glucosidase C, EC 3.2.1.20" GANC Homo sapiens (Human) N-glycan processing [GO:0006491] "alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; N-glycan processing [GO:0006491]" "alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]" GO:0004553; GO:0004558; GO:0006491; GO:0030246; GO:0032450; GO:0090599 QYSHLTGTQAMPPLFSLGYHQCR 4.050000191 1 1 0.067222311 2692.609169 0 0 9.238907 0 0 0 0 0 0 0 0 0 0 0 0 19.82388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.49998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEU7 RPGF6_HUMAN "Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2, PDZ-GEF2) (RA-GEF-2)" RAPGEF6 PDZGEF2 Homo sapiens (Human) microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087] GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267] GO:0005085; GO:0005813; GO:0005829; GO:0005886; GO:0007265; GO:0016324; GO:0030033; GO:0030139; GO:0030742; GO:0031267; GO:0043087; GO:0043547; GO:0070300; GO:0072659 ANTVSGGR 4.139999866 1 1 0.174247064 762.5047497 11.74875 14.81814 0 0 0 13.3884 0 16.4794 17.25594 0 0 16.22809 15.65602 0 0 0 15.99014 15.42762 15.57086 0 16.05106 0 14.5086 0 14.84519 0 0 0 0 16.34877 15.76246 0 0 0 16.66505 0 17.81771 17.49529 16.99806 17.04287 15.44553 0 16.38727 16.4709 0 16.66547 16.20063 0 Q8TEU8 WFKN2_HUMAN "WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (Growth and differentiation factor-associated serum protein 1, GASP-1, hGASP-1) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing-related protein) (WFIKKN-related protein)" WFIKKN2 GASP1 WFIKKNRP UNQ9235/PRO31996 Homo sapiens (Human) muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular space [GO:0005615] extracellular space [GO:0005615]; metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179] metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431] GO:0001501; GO:0004867; GO:0005615; GO:0007179; GO:0008191; GO:0030512; GO:0032091; GO:0043392; GO:0048019; GO:0050431; GO:0055001; GO:0060021 LREVMHK 8.380000114 1 1 0.498420288 929.0238539 0 0 0 0 0 0 17.00144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.74788 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEV9 SMCR8_HUMAN Guanine nucleotide exchange protein SMCR8 (Smith-Magenis syndrome chromosomal region candidate gene 8 protein) SMCR8 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432] Atg1/ULK1 kinase complex [GO:1990316]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793] Atg1/ULK1 kinase complex [GO:1990316]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432] guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] GO:0000785; GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0006469; GO:0006914; GO:0010506; GO:0010629; GO:0016242; GO:0019901; GO:0032008; GO:0032045; GO:0043547; GO:0045920; GO:0050777; GO:0098793; GO:0098794; GO:1901098; GO:1902902; GO:1903432; GO:1990316 IPSAYPAGLSSDRHK 5.400000095 1 1 0.233892461 1599.184211 0 0 13.77792 0 17.95931 0 0 11.51496 15.62582 0 0 0 0 0 16.56394 16.36204 17.68144 10.34422 0 0 14.81524 0 0 0 16.21354 15.81617 0 15.71314 0 0 0 13.63947 14.12454 0 0 0 0 0 15.77447 0 0 0 0 0 0 16.99869 0 0 Q8TEW0 PARD3_HUMAN "Partitioning defective 3 homolog, PAR-3, PARD-3 (Atypical PKC isotype-specific-interacting protein, ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)" PARD3 PAR3 PAR3A Homo sapiens (Human) asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; tight junction [GO:0070160] "adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]" "phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0000226; GO:0005546; GO:0005547; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0007205; GO:0007409; GO:0008104; GO:0008356; GO:0010801; GO:0012505; GO:0016324; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0033269; GO:0035091; GO:0043296; GO:0045197; GO:0051660; GO:0065003; GO:0070160; GO:0070830; GO:0090162; GO:0120157 GAAIQDGRLK 2.119999886 0.523690879 0.523690879 0 1025.99713 0 14.69765 0 0 0 0 14.12495 0 0 17.52412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.22804 15.98691 0 15.78015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEW8 PAR3L_HUMAN "Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein, PAR3-L protein)" PARD3B ALS2CR19 PAR3B PAR3L Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; protein localization [GO:0008104] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; endomembrane system [GO:0012505]; protein-containing complex [GO:0032991] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; endomembrane system [GO:0012505]; protein-containing complex [GO:0032991]; phosphatidylinositol binding [GO:0035091]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; protein localization [GO:0008104] phosphatidylinositol binding [GO:0035091] GO:0000226; GO:0005912; GO:0005923; GO:0005938; GO:0007049; GO:0007155; GO:0008104; GO:0012505; GO:0016324; GO:0030010; GO:0030054; GO:0032991; GO:0035091; GO:0043296; GO:0045197; GO:0051301; GO:0051660 GFGAMLR 1.570000052 1 1 0.212847591 750.1233038 14.66766 15.53673 12.41709 0 15.26414 0 16.17571 14.03493 13.8673 16.58254 0 15.96217 0 0 0 0 0 15.56929 0 0 0 17.08916 0 0 15.48211 16.49153 16.82567 14.03051 0 17.09102 16.72412 0 0 14.8904 16.45088 0 16.08615 0 15.44731 15.76803 16.01759 0 0 0 0 15.63182 0 0 Q8TEY7 UBP33_HUMAN "Ubiquitin carboxyl-terminal hydrolase 33, EC 3.4.19.12 (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1, hVDU1)" USP33 KIAA1097 VDU1 Homo sapiens (Human) axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511] cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891] cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0001664; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0009267; GO:0010506; GO:0016477; GO:0016579; GO:0030891; GO:0031267; GO:0032091; GO:0032092; GO:0044297; GO:0048471; GO:0050821; GO:0051298; GO:0070536; GO:0071108 EKMCNK 10.10000038 1 1 1.21E-13 826.4491774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF01 PNISR_HUMAN "Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130, SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)" PNISR C6orf111 SFRS18 SRRP130 HSPC261 HSPC306 Homo sapiens (Human) cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016607; GO:0048786 QEPPQIDAVK 2.019999981 1.22E-05 1.22E-05 0.283660187 1124.735467 0 20.18651 17.46281 18.50309 0 17.35165 20.3693 0 19.24895 0 0 17.52437 18.11378 18.29048 21.03248 0 18.74127 0 18.63799 18.87059 18.59578 19.46684 0 20.20609 0 17.67901 0 0 0 0 19.09214 18.39883 20.03595 0 19.91899 0 0 18.80013 0 0 0 21.08394 0 0 20.56229 19.41624 20.89969 17.53142 Q8TF05 PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 PPP4R1 MEG1 PP4R1 Homo sapiens (Human) protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] protein phosphatase 4 complex [GO:0030289] protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] protein phosphatase regulator activity [GO:0019888] GO:0006468; GO:0006470; GO:0007165; GO:0019888; GO:0030289 MAPMVGK 6.300000191 0.717386782 0.717386782 0.242040325 750.0966825 0 15.86352 0 0 15.91328 0 0 0 15.38605 0 0 13.09426 13.84919 0 16.08796 16.21313 15.11016 0 0 0 0 0 0 0 0 14.6777 0 15.72521 15.74441 16.62186 16.86094 0 16.30299 15.71812 14.67633 0 16.36376 0 15.86507 14.44935 16.77736 16.48769 14.88441 15.22976 15.43171 0 15.44747 0 Q8TF09 DLRB2_HUMAN "Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)" DYNLRB2 DNCL2B DNLC2B ROBLD2 Homo sapiens (Human) microtubule-based movement [GO:0007018] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0045505; GO:0097542 KHEIMVAPDK 2.609999895 1 1 0.27567704 1183.461439 0 0 0 15.1584 0 0 0 0 0 0 0 0 0 15.27525 0 0 0 0 0 0 0 0 0 17.1153 0 10.67537 0 15.14048 0 0 16.66038 0 0 0 0 0 0 15.93715 0 0 0 0 0 0 0 0 0 0 Q8TF17 S3TC2_HUMAN SH3 domain and tetratricopeptide repeat-containing protein 2 SH3TC2 KIAA1985 PP12494 Homo sapiens (Human) peripheral nervous system myelin maintenance [GO:0032287]; regulation of ERBB signaling pathway [GO:1901184]; regulation of intracellular protein transport [GO:0033157] plasma membrane [GO:0005886]; recycling endosome [GO:0055037] plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of ERBB signaling pathway [GO:1901184]; regulation of intracellular protein transport [GO:0033157] GO:0005886; GO:0032287; GO:0033157; GO:0055037; GO:1901184 CFLPQNINPDLTLSFCVK 1.519999981 1 1 0.201690884 2166.53747 11.72418 14.50118 13.327 0 0 11.84793 0 0 0 14.9322 0 0 0 13.9762 0 15.87842 0 0 0 14.91058 11.9608 0 0 0 15.01016 0 13.13631 0 0 0 0 0 0 0 0 0 0 16.27621 0 0 0 0 0 0 0 0 0 0 Q8TF20 ZN721_HUMAN Zinc finger protein 721 ZNF721 KIAA1982 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 AFRQSAILYVHR 6.429999828 1 1 0.050563398 1458.930361 17.051 17.90167 15.57557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF21 ANR24_HUMAN Ankyrin repeat domain-containing protein 24 ANKRD24 KIAA1981 Homo sapiens (Human) QSVVPASEHR 3.710000038 1 1 0.185233823 1111.903359 0 0 13.26582 6.691679 14.44095 0 0 0 0 0 15.68603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.26745 10.45381 15.97773 14.26221 0 13.58111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF27 AGA11_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11, AGAP-11 (Centaurin-gamma-like protein KIAA1975)" AGAP11 KIAA1975 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005634; GO:0046872 WPSLATSACAPISSSK 1.289999962 1 1 6.92E-13 1662.234518 16.96 15.23095 0 0 0 0 0 0 0 0 0 15.56068 12.59678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.35475 0 16.67137 15.7237 0 0 0 0 0 15.07631 0 0 0 13.00656 0 0 0 0 Q8TF39 ZN483_HUMAN Zinc finger protein 483 (Zinc finger protein with KRAB and SCAN domains 16) ZNF483 KIAA1962 ZKSCAN16 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AFRQNSCLTR 6.21999979 1 1 0.405025969 1252.05232 0 13.52827 0 15.45906 13.82574 0 0 0 13.90574 0 11.46046 0 0 0 0 15.82318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.71692 0 0 0 0 0 17.6797 0 0 0 0 0 0 17.32411 0 0 Q8TF40 FNIP1_HUMAN Folliculin-interacting protein 1 FNIP1 KIAA1961 Homo sapiens (Human) cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929] ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0000122; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0005765; GO:0005829; GO:0008285; GO:0009267; GO:0019899; GO:0031334; GO:0031929; GO:0032007; GO:0032008; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:2000973 CSSDANMLGEMMFGSVAMSYKGSTLK 3.180000067 0.620553792 0.620553792 1.83E-12 2835.000887 15.15857 0 14.11681 12.20256 11.85872 14.59538 11.80924 14.51297 10.71229 0 0 0 0 0 0 0 0 0 14.61601 0 0 0 16.38462 13.93407 15.25685 0 0 0 0 0 0 0 0 0 15.01797 0 15.91522 0 0 14.13863 0 12.11839 0 0 0 0 15.11202 0 Q8TF44 C2C4C_HUMAN C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C) C2CD4C FAM148C KIAA1957 NLF3 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 LRGSGENGAAR 8.880000114 1 1 0.230968499 1087.344179 0 12.18599 14.86105 14.7585 9.745162 15.05015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF46 DI3L1_HUMAN "DIS3-like exonuclease 1, EC 3.1.13.-" DIS3L DIS3L1 KIAA1955 Homo sapiens (Human) RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886]; 3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] 3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723] GO:0000175; GO:0000177; GO:0000178; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0016075; GO:0019899 ASYEIKK 8.020000458 1 1 0.1632404 838.6746607 13.91872 0 0 0 16.26965 0 0 0 0 15.86428 12.98134 0 0 0 0 0 17.49028 0 16.84267 17.29238 0 14.678 0 0 0 0 15.03628 0 0 13.86599 15.92095 0 15.70083 15.66412 14.9643 0 15.37338 14.88555 0 16.6319 14.27929 16.34021 0 0 15.58778 0 0 0 Q8TF61 FBX41_HUMAN F-box only protein 41 FBXO41 FBX41 KIAA1940 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 SQPPRSSGLR 8.069999695 1 1 0.176749685 1084.45556 10.70522 0 0 0 0 0 0 14.85565 0 17.30588 0 0 0 17.16118 14.86113 15.53003 16.14236 16.03819 18.19436 17.60502 0 16.00906 15.67859 15.49377 0 16.25404 17.5858 0 16.38659 0 15.24861 14.47893 0 16.79835 0 0 0 17.27327 16.7487 16.88456 16.91425 0 17.71693 0 17.19516 15.51149 18.11634 16.51365 Q8TF62 AT8B4_HUMAN "Probable phospholipid-transporting ATPase IM, EC 7.6.2.1 (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4)" ATP8B4 KIAA1939 Homo sapiens (Human) Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005524; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0016887; GO:0035579; GO:0045332; GO:0070821; GO:0140326; GO:1990531 FQYADNR 5.389999866 0.466278821 0.466278821 0.219977535 911.8542122 19.23459 20.17556 17.48154 17.49083 18.34047 19.49113 19.39013 17.6592 20.0731 18.04986 16.52233 0 0 17.89277 17.62963 18.0049 17.11371 18.56087 18.29356 16.50742 16.64792 18.33845 0 17.44213 16.22035 16.39655 17.4765 16.85129 15.64993 16.19389 18.42308 18.51113 16.86398 19.31487 17.68313 17.59494 19.50945 19.17057 16.16736 0 17.20166 19.52893 18.83045 17.94995 16.53936 0 18.44033 14.71756 Q8TF64 GIPC3_HUMAN PDZ domain-containing protein GIPC3 GIPC3 C19orf64 Homo sapiens (Human) MEGAAAR 3.99000001 0.906974554 0.906974554 0.259055445 721.0761161 14.40794 14.64338 0 0 0 0 0 14.8337 0 15.83349 0 15.70579 0 0 0 0 0 0 15.00253 0 0 15.81922 14.61728 14.36136 16.87479 14.88962 0 0 15.75324 9.469991 16.76161 14.34413 15.89106 0 14.31638 15.85751 0 0 0 0 16.48056 14.31432 0 0 0 0 0 15.04059 Q8TF65 GIPC2_HUMAN PDZ domain-containing protein GIPC2 GIPC2 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0005737; GO:0042802; GO:0070062 IKDGGVIDSVK 4.139999866 0.482271671 0.482271671 0.243307659 1131.039564 16.25142 12.80506 0 0 15.777 0 0 0 0 0 0 14.42892 0 0 0 15.02089 0 0 15.82552 15.92262 0 0 13.93441 14.83618 0 15.28901 0 15.70066 0 0 0 0 0 15.80839 15.35194 0 13.49928 0 15.30132 15.09815 0 9.548111 14.39829 12.55774 12.8737 14.54415 13.7008 15.6902 Q8TF68 ZN384_HUMAN "Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4, Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein)" ZNF384 CAGH1 CIZ NMP4 TNRC1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872; GO:1990837 KVASTLTEEGGGGGGGGGSVAPKPPR 1.139999986 1 1 4.75E-13 2322.415185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.72828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF72 SHRM3_HUMAN "Protein Shroom3 (Shroom-related protein, hShrmL)" SHROOM3 KIAA1481 SHRML MSTP013 Homo sapiens (Human) actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360] actin filament binding [GO:0051015] GO:0000902; GO:0001843; GO:0002064; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0051015 ADTLSSK 14.39999962 1 1 0.222103411 722.3476355 0 0 14.56186 14.52337 15.92391 16.90268 17.23861 15.9839 16.33677 16.41523 16.24384 0 14.56604 0 0 17.08383 16.58845 18.61184 0 0 0 16.76233 18.83716 0 17.27712 17.29791 0 0 0 0 16.83886 0 17.40278 15.46552 9.170922 0 0 0 0 0 0 16.99493 0 16.37634 15.60988 16.79642 0 0 Q8TF74 WIPF2_HUMAN WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein) WIPF2 WICH WIRE PP10631 Homo sapiens (Human) actin filament-based movement [GO:0030048] actin filament [GO:0005884]; cytosol [GO:0005829] actin filament [GO:0005884]; cytosol [GO:0005829]; actin binding [GO:0003779]; actin filament-based movement [GO:0030048] actin binding [GO:0003779] GO:0003779; GO:0005829; GO:0005884; GO:0030048 APAYNR 6.46999979 0.506570458 0.506570458 0.174052691 690.9861254 0 17.18192 18.32459 0 16.93614 17.79268 17.73892 14.14747 14.67989 16.5255 16.99343 0 13.97086 0 16.43065 13.84924 0 17.11136 17.24848 0 0 17.20751 0 0 17.38833 0 0 15.16751 0 0 17.35721 0 0 18.1786 0 16.81105 16.51669 10.60988 17.7763 0 15.96778 16.81748 13.81458 0 0 16.5496 15.96015 0 Q8TF76 HASP_HUMAN "Serine/threonine-protein kinase haspin, EC 2.7.11.1 (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)" HASPIN GSG2 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]" centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chromatin organization [GO:0006325]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]" ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000278; GO:0004672; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006325; GO:0006468; GO:0007064; GO:0035556; GO:0071459; GO:0072354; GO:0106310; GO:2000751 CNTPAMK 4.230000019 0.985543132 0.985543132 0.183206367 837.7265994 14.72234 15.68693 0 14.30918 0 0 0 0 0 0 15.58578 14.13949 15.68565 15.49229 15.03022 15.84451 14.03079 13.58507 15.97047 0 0 0 0 17.3416 16.7388 14.87017 0 15.8721 0 14.80207 13.18462 14.86775 16.30205 15.87858 15.90671 15.56257 17.47711 15.49652 15.55554 15.83858 15.4834 13.44672 15.63218 13.03006 0 16.1653 15.25887 17.13889 Q8WTP8 AEN_HUMAN "Apoptosis-enhancing nuclease, EC 3.1.-.- (Interferon-stimulated 20 kDa exonuclease-like 1)" AEN ISG20L1 SBBI58 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212] exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0010212; GO:0031965; GO:0042771 CVAIDCEMVGTGPR 10.27999973 0.818094432 0.818094432 0.108675001 1564.796745 15.57595 17.54299 15.97025 13.64525 15.30384 14.79837 15.29842 14.06371 0 14.12568 15.28275 18.02493 14.33414 11.91045 0 11.70342 0 16.27394 0 0 0 13.39092 16.3361 16.69094 16.24643 0 16.67013 11.44082 0 12.18932 12.46042 0 16.85346 12.6222 0 16.15808 15.85049 16.47842 11.95853 11.49494 15.87372 17.40136 13.60968 0 15.83344 14.32982 10.79269 13.88051 Q8WTQ4 CP078_HUMAN Uncharacterized protein C16orf78 C16orf78 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 SEQQMDLK 7.380000114 0.44999972 0.44999972 0.163106957 977.2196663 16.83918 0 0 18.73964 16.18335 15.87039 16.16222 0 0 15.74413 0 0 18.20649 18.27702 15.43541 13.45172 0 12.54286 16.5767 0 0 17.28111 0 0 0 17.36338 15.39004 0 15.11873 0 0 19.80445 16.0997 0 0 18.3366 0 18.25759 18.61393 10.47756 16.71793 16.40446 11.56421 0 0 15.38235 16.27468 16.09149 Q8WTQ7 GRK7_HUMAN "Rhodopsin kinase GRK7, EC 2.7.11.14 (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7)" GRK7 GPRK7 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381] cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; visual perception [GO:0007601] ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254] GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0007601; GO:0009966; GO:0022400; GO:0046777; GO:0050254; GO:0097381 GGEKMALLEK 9.449999809 0.310029179 0.310029179 0.263371431 1092.25701 13.62028 12.01378 15.69486 13.2967 13.63802 14.06533 15.51397 0 0 0 13.52762 16.17562 0 0 13.93234 0 15.59983 14.54809 15.34703 0 0 0 0 0 0 0 15.90093 0 0 14.31706 0 0 14.36793 0 15.85433 0 0 16.12713 15.31989 0 0 0 0 0 16.40341 14.79502 0 14.52723 Q8WTS6 SETD7_HUMAN "Histone-lysine N-methyltransferase SETD7, EC 2.1.1.364 (Histone H3-K4 methyltransferase SETD7, H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9)" SETD7 KIAA1717 KMT7 SET7 SET9 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription, DNA-templated [GO:0006355]" histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279] GO:0002039; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0051570; GO:0070828 FIDGEMIEGK 5.75 0.815376937 0.815376937 0.14645 1158.413076 0 10.79946 14.33033 12.73627 16.73457 13.09583 13.97927 16.37049 15.67277 16.18836 14.0776 16.09428 14.42337 14.47663 14.03354 13.75177 15.02213 0 0 0 0 0 0 0 15.58432 0 0 14.61893 0 15.01997 16.31983 0 14.19066 14.36246 0 0 0 0 14.78627 14.14125 0 0 0 16.28465 0 0 0 0 Q8WTT2 NOC3L_HUMAN "Nucleolar complex protein 3 homolog, NOC3 protein homolog (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)" NOC3L AD24 C10orf117 FAD24 Homo sapiens (Human) DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444] mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444] chromatin binding [GO:0003682]; RNA binding [GO:0003723] GO:0003682; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006270; GO:0016607; GO:0045444 KPIPLENPK 25.95000076 0.597402036 0.597402036 0.268558354 1036.866239 19.8218 19.0121 16.89846 20.2161 20.71198 20.17376 20.09872 19.23336 19.62961 19.29621 19.6266 20.13905 17.40374 19.47473 17.94315 18.35254 19.53417 18.18746 18.24645 16.89761 18.15755 0 18.1173 18.33877 19.32202 18.44417 18.77619 14.76479 17.40246 19.291 15.99777 17.16077 17.73906 15.51648 16.78304 17.33458 17.11914 17.41 17.73962 16.64339 11.5864 0 18.44341 17.16291 16.32534 17.94224 0 19.8049 Q8WTU0 DDI1_HUMAN "Protein DDI1 homolog 1, EC 3.4.23.-" DDI1 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] aspartic-type endopeptidase activity [GO:0004190]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] aspartic-type endopeptidase activity [GO:0004190] GO:0004190; GO:0010498; GO:0031647; GO:0072711; GO:0097752 CNIMRLVDR 10.89999962 1 1 0.308040141 1191.790335 14.1445 15.98001 0 14.82151 12.62724 11.9935 15.0369 0 12.56925 15.55012 14.24021 0 15.33858 14.62371 0 14.69682 15.87346 0 13.85876 0 0 0 0 0 0 12.28572 0 0 0 15.44338 0 13.82761 0 0 0 0 16.85892 0 0 0 16.51201 0 0 11.89727 0 0 14.64284 0 Q8WTU2 SRB4D_HUMAN Scavenger receptor cysteine-rich domain-containing group B protein (Four scavenger receptor cysteine-rich domains-containing protein) (S4D-SRCRB) SSC4D SRCRB4D Homo sapiens (Human) extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044] scavenger receptor activity [GO:0005044] GO:0005044; GO:0005576; GO:0016020 SEGSVR 6.960000038 1 1 0.175889279 635.4550072 14.00113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.17108 17.19258 0 0 0 0 0 0 0 0 0 18.10476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTV0 SCRB1_HUMAN "Scavenger receptor class B member 1, SRB1 (CD36 and LIMPII analogous 1, CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)" SCARB1 CD36L1 CLA1 Homo sapiens (Human) adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]; wound healing [GO:0042060] caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; scavenger receptor activity [GO:0005044]; transporter activity [GO:0005215]; virus receptor activity [GO:0001618]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]; wound healing [GO:0042060] 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; scavenger receptor activity [GO:0005044]; transporter activity [GO:0005215]; virus receptor activity [GO:0001618] GO:0001530; GO:0001540; GO:0001618; GO:0001786; GO:0001875; GO:0001935; GO:0005044; GO:0005215; GO:0005545; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0008289; GO:0009986; GO:0010595; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0030666; GO:0032497; GO:0033344; GO:0034185; GO:0034186; GO:0034375; GO:0034381; GO:0034383; GO:0034384; GO:0035461; GO:0042060; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050764; GO:0050892; GO:0051000; GO:0070062; GO:0070328; GO:0070506; GO:0070508 IDPSSLSFNMWK 4.260000229 0.548928797 0.548928797 0.048882552 1425.107528 0 0 0 0 0 0 0 0 0 0 13.66507 0 0 11.04957 0 0 0 0 14.0672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.83304 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTV1 THAP3_HUMAN THAP domain-containing protein 3 THAP3 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0045944; GO:0046872 EKVLPEAGAGEDSPGR 3.00999999 0.567455292 0.567455292 0.042819814 1611.74579 18.20928 15.50106 0 11.69082 10.12704 13.18136 13.80369 14.70369 0 14.80322 14.10561 0 0 0 13.83578 15.85079 0 0 14.73272 0 14.44464 15.67831 14.40664 15.50194 14.40448 0 16.24499 12.01375 0 0 0 15.16736 0 11.88645 0 17.48491 17.18015 14.97173 15.82953 0 15.06767 16.07852 16.52575 9.771217 13.08591 12.38627 14.59776 0 Q8WTX7 CAST1_HUMAN Cytosolic arginine sensor for mTORC1 subunit 1 (Cellular arginine sensor for mTORC1 protein 1) (GATS-like protein 3) CASTOR1 GATSL3 Homo sapiens (Human) cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] cytosol [GO:0005829] cytosol [GO:0005829]; arginine binding [GO:0034618]; identical protein binding [GO:0042802]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] arginine binding [GO:0034618]; identical protein binding [GO:0042802] GO:0005829; GO:0034618; GO:0042802; GO:1902531; GO:1903577; GO:1904262 EVGGEPVPVTR 10.77999973 0.476069897 0.476069897 0.345684023 1137.620382 15.26994 0 0 15.37819 13.50004 16.05665 0 0 14.81688 15.40114 12.55409 15.0946 15.55444 0 15.27078 15.17984 9.731052 12.99952 14.88954 15.10311 0 14.81499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64138 15.7813 0 0 0 0 0 15.49366 0 0 0 Q8WU10 PYRD1_HUMAN "Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1, EC 1.8.1.-" PYROXD1 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599] nucleus [GO:0005634]; sarcomere [GO:0030017] nucleus [GO:0005634]; sarcomere [GO:0030017]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599] flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] GO:0005634; GO:0016491; GO:0030017; GO:0034599; GO:0050660 IAHKR 3.980000019 1 1 0.168690219 625.0879294 0 0 0 0 0 14.77249 13.2881 0 15.72227 0 0 0 15.7756 0 0 15.63871 0 0 0 0 18.08931 0 0 0 0 0 0 0 0 0 0 15.64839 0 0 0 16.37202 0 0 0 0 0 0 16.21021 0 15.37907 0 0 0 Q8WU20 FRS2_HUMAN "Fibroblast growth factor receptor substrate 2, FGFR substrate 2 (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1, SNT-1)" FRS2 Homo sapiens (Human) "anterior/posterior axis specification, embryo [GO:0008595]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]" adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; anterior/posterior axis specification, embryo [GO:0008595]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]" fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] GO:0001702; GO:0001759; GO:0003281; GO:0005068; GO:0005104; GO:0005168; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0007169; GO:0007185; GO:0007186; GO:0007405; GO:0008543; GO:0008595; GO:0012505; GO:0016020; GO:0019211; GO:0030900; GO:0042981; GO:0043410; GO:0046619; GO:0050678; GO:0060527; GO:0070307; GO:0070372; GO:1904707; GO:2000726 HNSTDLPM 15.71000004 0.256775886 0.256775886 0.200126153 929.9210988 0 0 0 0 14.97187 14.39646 14.94214 15.36582 12.95702 14.99572 16.07656 14.08324 0 0 0 15.03043 0 17.03903 0 0 0 14.05441 14.68898 11.26441 0 16.64642 0 16.3827 16.95842 13.76173 15.03908 17.97954 0 17.06371 13.95492 0 14.39097 0 0 0 0 0 0 0 0 16.26122 0 15.34627 Q8WU39 MZB1_HUMAN "Marginal zone B- and B1-cell-specific protein (Mesenteric estrogen-dependent adipose 7, MEDA-7) (Plasma cell-induced resident endoplasmic reticulum protein, Plasma cell-induced resident ER protein, pERp1) (Proapoptotic caspase adapter protein)" MZB1 MEDA7 PACAP HSPC190 Homo sapiens (Human) apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626] GO:0002639; GO:0005576; GO:0005737; GO:0005788; GO:0006915; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626 LHTSNSGGRR 8.760000229 1 1 9.16E-13 1085.688721 14.70528 0 0 14.1475 14.73128 0 15.79284 0 0 13.81852 0 0 0 0 0 0 16.19551 0 16.81618 0 0 12.5271 0 0 0 0 0 0 0 15.04828 0 15.02673 15.63781 15.719 0 0 0 16.31097 0 16.14947 17.0047 16.1457 0 0 0 0 0 0 Q8WU66 TSEAR_HUMAN "Thrombospondin-type laminin G domain and EAR repeat-containing protein, TSP-EAR" TSPEAR C21orf29 Homo sapiens (Human) hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]; hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505] GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170 IFSQCDLFPEEFSIVVTLR 4.119999886 1 1 4.57E-13 2299.031588 0 16.03821 0 13.65759 14.13151 0 15.40047 15.56012 13.42708 0 15.20462 13.66428 15.39518 15.17231 16.00204 13.41305 0 13.62827 0 14.45696 16.30642 16.28647 16.80564 15.48691 0 0 0 14.28381 13.618 0 15.46299 14.03766 0 13.10902 0 14.40683 14.05804 14.60765 0 16.0505 14.10911 14.9405 11.86235 0 14.795 0 0 0 Q8WU90 ZC3HF_HUMAN Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4) ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547] cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0002181; GO:0003723; GO:0005634; GO:0005829; GO:0019221; GO:0043547; GO:0045296; GO:0046872 ERSALGPNVTK 7.579999924 0.487134397 0.487134397 0.148136777 1171.528725 13.41899 12.14048 0 0 0 14.16897 14.87907 15.69018 0 16.26497 15.1551 15.91903 15.19378 9.443712 13.4989 12.59515 0 0 16.40676 0 0 0 15.76994 0 0 0 0 0 0 0 0 0 14.98543 0 0 0 12.56859 0 0 0 0 0 0 0 0 0 0 0 Q8WUA7 TB22A_HUMAN TBC1 domain family member 22A TBC1D22A C22orf4 Homo sapiens (Human) activation of GTPase activity [GO:0090630] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; activation of GTPase activity [GO:0090630] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803] GO:0005096; GO:0042803; GO:0071889; GO:0090630 YLQFAFRWMNNLLMR 16.59000015 1 1 0.237358612 2038.47945 0 0 16.15609 0 15.46867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88334 16.63647 0 0 0 0 0 0 0 0 16.46509 0 0 16.45755 0 0 0 0 0 0 Q8WUA8 TSK_HUMAN Tsukushi (E2-induced gene 4 protein) (Leucine-rich repeat-containing protein 54) TSKU E2IG4 LRRC54 TSK UNQ850/PRO1788 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; bone growth [GO:0098868]; camera-type eye development [GO:0043010]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; ciliary body morphogenesis [GO:0061073]; corpus callosum morphogenesis [GO:0021540]; energy homeostasis [GO:0097009]; growth plate cartilage chondrocyte development [GO:0003431]; hippocampus development [GO:0021766]; inner ear receptor cell stereocilium organization [GO:0060122]; lateral ventricle development [GO:0021670]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of hair cycle [GO:0042635]; regulation of gene expression [GO:0010468]; wound healing [GO:0042060] extracellular space [GO:0005615] extracellular space [GO:0005615]; transforming growth factor beta binding [GO:0050431]; anterior commissure morphogenesis [GO:0021960]; bone growth [GO:0098868]; camera-type eye development [GO:0043010]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; ciliary body morphogenesis [GO:0061073]; corpus callosum morphogenesis [GO:0021540]; energy homeostasis [GO:0097009]; growth plate cartilage chondrocyte development [GO:0003431]; hippocampus development [GO:0021766]; inner ear receptor cell stereocilium organization [GO:0060122]; lateral ventricle development [GO:0021670]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of hair cycle [GO:0042635]; regulation of gene expression [GO:0010468]; wound healing [GO:0042060] transforming growth factor beta binding [GO:0050431] GO:0003431; GO:0005615; GO:0008203; GO:0010468; GO:0010977; GO:0021540; GO:0021670; GO:0021766; GO:0021960; GO:0030178; GO:0032911; GO:0033344; GO:0042060; GO:0042632; GO:0042635; GO:0043010; GO:0050431; GO:0060122; GO:0061073; GO:0097009; GO:0098868; GO:1904761 RPGSSPK 13.5 1 1 0.226777788 728.6581653 0 17.21187 0 15.36407 16.89386 12.36458 15.74531 0 0 16.19461 0 16.52412 0 0 0 0 0 0 0 16.03614 0 0 15.01775 0 15.81821 0 0 0 14.60269 0 0 15.83208 0 0 0 16.68166 0 0 0 15.93109 0 0 0 0 0 0 0 0 Q8WUB8 PHF10_HUMAN "PHD finger protein 10 (BRG1-associated factor 45a, BAF45a) (XAP135)" PHF10 BAF45A Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] "chromatin [GO:0000785]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] GO:0000776; GO:0000785; GO:0003712; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045944; GO:0046872; GO:0070316; GO:0071564; GO:1902459; GO:2000045; GO:2000781; GO:2000819 VLPTERTK 6.730000019 1 1 0.085719529 944.7484824 14.72662 14.84242 11.73716 0 0 0 0 0 0 14.28869 12.89097 0 0 0 0 14.46834 0 0 0 0 15.95359 0 16.18908 16.18196 0 14.44572 9.861358 15.7377 0 14.27296 15.10072 14.74894 0 13.44882 0 0 12.40479 0 0 15.53102 14.42784 0 10.05668 0 14.49062 0 0 14.99412 Q8WUF5 IASPP_HUMAN "RelA-associated inhibitor (Inhibitor of ASPP protein, Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein)" PPP1R13L IASPP NKIP1 PPP1R13BL RAI Homo sapiens (Human) "apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; ventricular cardiac muscle tissue development [GO:0003229]" cell junction [GO:0030054]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; ventricular cardiac muscle tissue development [GO:0003229]" cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] GO:0000122; GO:0003215; GO:0003229; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006357; GO:0006915; GO:0008134; GO:0009791; GO:0030054; GO:0031076; GO:0035264; GO:0042633; GO:0042802; GO:0045171; GO:0045296; GO:0045597; GO:0048871; GO:0060048 AGSPR 3.160000086 5.62E-14 5.61E-14 0.206401928 486.1877511 15.58675 14.76451 0 0 0 0 0 15.48697 0 15.9795 0 0 15.16168 17.2035 15.18138 0 16.53809 14.73958 17.50389 17.17124 15.07348 0 0 0 15.10504 16.32215 15.90279 15.28192 0 14.69064 14.90476 15.16812 15.63607 15.3118 14.90516 17.2797 17.31368 14.52107 0 0 16.24577 18.07529 0 0 0 15.89572 16.31594 16.34473 Q8WUG5 S22AH_HUMAN "Solute carrier family 22 member 17 (24p3 receptor, 24p3R) (Brain-type organic cation transporter) (Lipocalin-2 receptor) (Neutrophil gelatinase-associated lipocalin receptor, NgalR)" SLC22A17 BOCT BOIT Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; siderophore transport [GO:0015891] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; transmembrane signaling receptor activity [GO:0004888]; transmembrane transporter activity [GO:0022857]; cellular iron ion homeostasis [GO:0006879]; siderophore transport [GO:0015891] transmembrane signaling receptor activity [GO:0004888]; transmembrane transporter activity [GO:0022857] GO:0004888; GO:0005774; GO:0005886; GO:0005887; GO:0006879; GO:0015891; GO:0022857; GO:0031301 KLLPEVLR 10 0.360266179 0.360266179 9.12E-13 968.1935581 16.33028 12.04459 0 16.14658 0 11.56823 14.40993 13.57023 0 0 0 0 0 0 0 13.28137 11.04544 0 14.23171 0 14.34847 13.97468 0 0 0 0 11.51048 15.91364 0 0 12.98673 16.17232 12.8483 14.96699 15.88286 0 0 0 15.35477 14.83047 0 15.46927 13.76405 13.0177 15.06257 13.16713 0 14.21418 Q8WUJ1 NEUFC_HUMAN Neuferricin (Cytochrome b5 domain-containing protein 2) CYB5D2 Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020] endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]; heme binding [GO:0020037]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] heme binding [GO:0020037] GO:0005576; GO:0007399; GO:0012505; GO:0016020; GO:0020037; GO:0045666 DWIGVPR 7.090000153 1 1 0.273897317 841.5333239 0 0 0 0 0 0 0 0 0 19.62055 0 0 0 18.11343 0 0 0 0 0 0 0 0 0 0 18.16627 0 0 0 0 0 18.46864 0 0 18.27769 0 0 19.05164 0 0 19.27644 0 0 0 0 0 0 0 0 Q8WUJ3 CEMIP_HUMAN "Cell migration-inducing and hyaluronan-binding protein, EC 3.2.1.35" CEMIP KIAA1199 Homo sapiens (Human) hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605] clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415] GO:0004415; GO:0005540; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005886; GO:0005905; GO:0007605; GO:0010800; GO:0030213; GO:0030214; GO:0030335; GO:0030665; GO:0032050; GO:0045334; GO:0046923; GO:0051281; GO:0090314; GO:1900020 FAFCSMK 7.789999962 1 1 3.46E-13 910.4997351 16.5153 0 0 0 0 0 13.98416 13.80117 0 16.73108 0 0 0 0 0 0 0 0 16.28723 0 0 0 17.71412 0 0 0 0 17.27649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.13964 0 0 0 0 0 Q8WUM4 PDC6I_HUMAN "Programmed cell death 6-interacting protein, PDCD6-interacting protein (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95)" PDCD6IP AIP1 ALIX KIAA1375 Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702] actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815] actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702] calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871] GO:0000281; GO:0000915; GO:0001772; GO:0005768; GO:0005815; GO:0005829; GO:0005923; GO:0005925; GO:0006915; GO:0010824; GO:0015031; GO:0016020; GO:0031871; GO:0036258; GO:0039702; GO:0042470; GO:0042641; GO:0042803; GO:0045199; GO:0046755; GO:0048306; GO:0051260; GO:0061952; GO:0070062; GO:0070830; GO:0070971; GO:0071985; GO:0090543; GO:0090559; GO:0090611; GO:1903543; GO:1903551; GO:1903553; GO:1903561 ATRDK 6.139999866 1 1 0.287512261 590.7554534 17.48787 18.33466 0 0 18.58647 16.91282 0 0 19.01013 0 0 15.9082 0 17.28343 17.6388 18.67418 0 0 0 0 0 0 0 16.04009 0 0 0 18.27242 18.44224 17.96252 0 0 18.97744 18.98594 0 18.79538 19.88218 18.0798 18.9105 17.68375 0 0 18.80167 17.79164 18.53416 0 19.12056 18.10191 Q8WUQ7 CATIN_HUMAN Cactin (Renal carcinoma antigen NY-REN-24) CACTIN C19orf29 Homo sapiens (Human) "cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]" RNA binding [GO:0003723] GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356 SDSEEER 3.579999924 1 1 0.025610511 851.559723 12.74378 15.13796 12.31067 14.62653 14.97915 0 14.48616 14.60286 15.84377 14.26131 11.63213 15.97271 0 15.11996 0 0 0 0 0 0 0 0 0 0 14.56277 17.35814 0 0 0 0 0 0 0 0 15.33482 0 15.62464 0 0 0 0 0 0 0 0 0 0 0 Q8WUR7 CO040_HUMAN UPF0235 protein C15orf40 C15orf40 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 SDVVLDKGGK 10.18999958 1 1 0.072446972 1017.172597 15.67031 15.0843 13.86632 13.50552 14.27771 14.54543 11.98274 14.94004 10.34111 15.36539 12.50153 16.29938 14.68112 0 0 13.43878 14.66124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUT9 S2543_HUMAN Solute carrier family 25 member 43 SLC25A43 Homo sapiens (Human) transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transport [GO:0055085] GO:0005743; GO:0016021; GO:0055085 GPWATGHRVWR 7.71999979 0.281042844 0.281042844 0.050015727 1322.106324 12.8227 0 12.16988 0 0 12.72443 0 0 13.98106 12.56097 12.01585 11.68734 13.11397 0 0 11.86807 0 9.320042 0 11.59799 0 0 0 0 11.52595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.36657 0 0 13.71281 0 0 0 13.03106 15.96692 Q8WUU4 ZN296_HUMAN "Zinc finger protein 296, ZFP296 (Zinc finger protein 342)" ZNF296 ZNF342 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007283; GO:0045944; GO:0046872; GO:1990837 EELKALSCLR 7.849999905 1 1 1.14E-12 1219.824728 0 0 0 0 0 14.62792 0 0 0 0 0 0 14.75318 0 0 0 15.05676 0 13.95177 0 12.33053 0 16.69604 15.58533 13.80183 0 14.56929 10.62141 0 12.2066 15.15775 11.58172 13.89267 14.22006 13.00678 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUU5 GATD1_HUMAN GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein) GATAD1 ODAG Homo sapiens (Human) "chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription, DNA-templated [GO:0006355]" sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006355; GO:0008270; GO:0043565 SAPAAEK 11.85000038 1 1 0.28785135 674.287116 0 20.45217 18.11038 0 19.90973 0 0 18.33957 0 19.72423 20.55769 0 0 0 0 0 18.88356 0 0 0 0 0 21.31235 0 0 0 0 20.99685 0 18.09677 0 0 0 21.57409 0 20.99271 17.99736 21.2803 0 0 0 21.12351 0 0 0 20.53527 19.12209 0 Q8WUX1 S38A5_HUMAN Sodium-coupled neutral amino acid transporter 5 (Solute carrier family 38 member 5) (System N transporter 2) SLC38A5 JM24 SN2 SNAT5 PP7194 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104] alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889] GO:0003333; GO:0005290; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0015171; GO:0015182; GO:0015186; GO:0015187; GO:0015194; GO:0015816; GO:0015825; GO:0022858; GO:0022889; GO:0032329; GO:0089709; GO:0150104; GO:1903713; GO:1904557 MNGALPSDAVGYR 7.53000021 1 1 0.102593823 1353.097907 0 0 10.98634 0 9.517805 0 8.167038 0 0 0 0 12.93555 0 0 15.87855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUY3 PRUN2_HUMAN Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1) PRUNE2 BMCC1 BNIPXL C9orf65 KIAA0367 Homo sapiens (Human) apoptotic process [GO:0006915] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; apoptotic process [GO:0006915] metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462] GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0016462; GO:0046872 DVQTGMSADNLQPK 4.599999905 1 1 4.72E-13 1520.49506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV28 BLNK_HUMAN "B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa, SLP-65)" BLNK BASH SLP65 Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of gene expression [GO:0010628]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of gene expression [GO:0010628]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] enzyme binding [GO:0019899]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] GO:0005068; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006959; GO:0007169; GO:0010628; GO:0016020; GO:0019899; GO:0019901; GO:0030183; GO:0035556; GO:0035591; GO:0042169; GO:0043231; GO:0043274; GO:0050853; GO:1990782 GEYIDNRSSQR 3.569999933 1 1 0.206767028 1324.395068 0 14.04586 14.66317 14.18519 0 14.48055 14.75034 13.52803 15.50436 0 15.08512 0 15.93952 0 0 14.87494 0 0 0 16.23501 0 0 16.32777 0 16.92097 15.9 15.9728 0 0 0 16.50219 14.36264 0 0 0 0 13.62418 0 0 0 0 0 13.99242 0 14.83017 0 0 0 Q8WV35 LRC29_HUMAN Leucine-rich repeat-containing protein 29 (F-box and leucine-rich repeat protein 9) (F-box protein FBL9) (F-box/LRR-repeat protein 9) LRRC29 FBL9 FBXL9 Homo sapiens (Human) GCPSLEHLALSHCSRLSDK 10.10999966 0.960474491 0.960474491 0.204053329 2167.675109 15.08602 15.51656 0 0 0 15.25628 0 0 0 0 0 14.67029 16.71499 0 15.56551 0 15.18381 14.39746 0 0 15.18807 0 18.02238 16.94601 0 16.35483 15.60633 0 0 14.67895 15.72785 0 0 13.93822 15.42276 13.5506 0 0 0 16.33257 14.88804 15.51749 0 15.0028 0 14.94652 0 0 Q8WV44 TRI41_HUMAN "E3 ubiquitin-protein ligase TRIM41, EC 2.3.2.27 (RING finger-interacting protein with C kinase, RINCK) (Tripartite motif-containing protein 41)" TRIM41 RINCK Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005730; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0016604; GO:0042802; GO:0051091; GO:0051607; GO:0060340; GO:0061630; GO:0071222; GO:0071225 MFCQAAR 3.099999905 1 1 0.207102753 882.5139532 0 0 0 0 0 15.03137 0 0 0 0 0 18.93148 0 0 0 15.85975 0 0 14.72751 0 0 0 0 17.82992 0 0 0 16.19607 0 0 14.90855 15.68084 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18811 15.58333 0 Q8WV93 AFG1L_HUMAN "AFG1-like ATPase (Lactation elevated protein 1, EC 3.6.-.-) (Protein AFG1 homolog)" AFG1L AFG1 LACE1 Homo sapiens (Human) "mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]" cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694 GLYVYGDVGTGK 3.279999971 1 1 0.187784148 1229.054677 0 0 12.84483 0 0 0 0 0 0 0 0 14.19117 0 0 0 0 0 15.09752 14.62488 0 0 0 0 13.40771 0 13.79164 15.4895 0 13.77658 9.877111 12.97914 11.08293 11.23558 14.87918 10.07879 13.32862 12.05206 15.75956 15.43658 14.65231 0 0 13.70391 0 14.38925 0 0 0 Q8WVC0 LEO1_HUMAN RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein) LEO1 RDL Homo sapiens (Human) endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269] GO:0001650; GO:0001711; GO:0005634; GO:0005654; GO:0005813; GO:0006368; GO:0006378; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0031442; GO:0032968; GO:0033523; GO:0045638; GO:1990269 CSKTQK 10.76000023 1 1 0.222370689 750.3700543 0 16.12556 15.49144 0 0 15.54078 14.747 14.71154 0 0 0 0 14.68399 0 0 17.65671 16.42961 16.48788 15.46189 0 0 15.06489 0 0 0 0 0 0 16.9128 0 15.71006 0 15.00393 0 0 0 0 17.00302 16.25235 0 14.53726 15.81239 0 15.70896 0 16.84897 0 0 Q8WVE0 EFMT1_HUMAN "EEF1A lysine methyltransferase 1, EC 2.1.1.- (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase N6AMT2) (eEF1A-KMT)" EEF1AKMT1 N6AMT2 Homo sapiens (Human) peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479] cytosol [GO:0005829] cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479] methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279] GO:0003676; GO:0005829; GO:0006479; GO:0008168; GO:0016279; GO:0018022 ENFSIYIFEYDK 13.48999977 0.15347825 0.15347825 0.422069807 1567.810805 21.15903 0 21.78462 18.37662 17.48005 0 17.17558 19.59192 17.4467 19.71365 21.74035 21.51366 20.67287 20.27238 0 18.06525 18.56209 18.60113 19.27747 19.80836 20.21569 20.25318 20.30772 0 18.84659 0 19.32137 18.88202 19.59962 19.06008 21.32681 21.20005 23.18063 20.05097 22.17712 20.71697 19.87787 19.57749 20.46098 19.61868 20.07487 18.04765 21.06591 21.27672 19.15353 18.80553 0 20.73573 Q8WVE6 TM171_HUMAN Transmembrane protein 171 TMEM171 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TPTSEGAASER 6.21999979 1 1 0.061007358 1104.723447 14.17276 14.37255 0 0 15.48691 0 0 0 0 0 0 0 0 0 15.72236 16.15497 0 14.53129 15.58594 0 16.07039 16.06104 0 0 15.77073 0 0 0 0 0 0 14.9325 0 0 0 0 16.71327 0 0 0 16.04045 15.7088 0 0 0 0 0 0 Q8WVF2 UCMA_HUMAN "Unique cartilage matrix-associated protein [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment, Ucma-C (Gla-rich protein, GRP) ]" UCMA C10orf49 Homo sapiens (Human) embryonic skeletal system development [GO:0048706]; negative regulation of biomineralization [GO:0110150]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; embryonic skeletal system development [GO:0048706]; negative regulation of biomineralization [GO:0110150]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392] BMP binding [GO:0036122] GO:0005615; GO:0005737; GO:0031012; GO:0036122; GO:0045668; GO:0048706; GO:0060392; GO:0110150 IFMQESDASNFLKR 4.679999828 1 1 0.323206129 1701.506182 0 13.42377 15.17956 0 15.61776 0 15.14514 11.20656 0 0 15.25416 13.08436 0 16.1394 0 0 14.87689 0 0 0 15.36876 14.53765 14.75592 15.53092 16.07441 0 0 0 13.20092 0 0 0 0 14.38009 0 0 0 0 0 0 0 0 0 0 0 0 14.15039 0 Q8WVF5 KCTD4_HUMAN BTB/POZ domain-containing protein KCTD4 KCTD4 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 HNSLEDTDQGK 10.02999973 1 1 0.217841615 1243.784319 0 14.99218 0 0 0 0 0 0 16.34589 0 0 0 0 0 16.19872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVL7 ANR49_HUMAN Ankyrin repeat domain-containing protein 49 (Fetal globin-inducing factor) ANKRD49 FGIF Homo sapiens (Human) "cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" GO:0005634; GO:0005829; GO:0007283; GO:0030154; GO:0045893 DSKDTLELLLMNR 4.059999943 0.576443017 0.576443017 0.049879306 1547.070694 17.91617 16.24334 13.68432 0 0 13.17817 0 0 0 0 14.83826 13.28241 0 13.74394 0 14.41714 0 0 12.65869 14.10558 13.44721 14.94863 13.07301 0 12.61752 12.78778 15.32542 13.82261 13.72104 14.07543 0 13.03297 0 0 14.18432 0 0 15.11 0 14.01144 15.1209 0 0 13.1633 12.41901 0 15.0141 0 Q8WVM0 TFB1M_HUMAN "Dimethyladenosine transferase 1, mitochondrial, EC 2.1.1.- (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1, h-mtTFB, h-mtTFB1, hTFB1M, mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)" TFB1M CGI-75 Homo sapiens (Human) rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation from mitochondrial promoter [GO:0006391] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation from mitochondrial promoter [GO:0006391]" "DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" GO:0000154; GO:0000179; GO:0003677; GO:0003723; GO:0005759; GO:0006391; GO:0031167; GO:0034246; GO:0042645 FIPGLQMLSDAAPGKLR 1.850000024 1 1 0.207553909 1830.130224 0 0 0 0 0 0 0 0 0 14.12125 0 0 0 0 0 0 0 0 0 0 0 0 15.65962 0 16.18455 15.937 13.76183 17.70497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVM8 SCFD1_HUMAN "Sec1 family domain-containing protein 1 (SLY1 homolog, Sly1p) (Syntaxin-binding protein 1-like 2)" SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23 Homo sapiens (Human) "cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle-mediated transport [GO:0016192]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle-mediated transport [GO:0016192]" protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905] GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0051223; GO:0060628; GO:1901998; GO:1902902 MCQDLR 2.670000076 1 1 0.176578205 838.2455662 0 0 0 14.42779 15.70063 0 0 0 17.09259 0 0 0 0 0 0 0 0 14.58972 0 0 0 0 0 0 13.6643 0 0 0 0 0 0 17.31094 0 0 0 15.72391 0 15.91506 0 0 0 14.4147 0 14.42205 13.34177 15.74463 0 15.32743 Q8WVQ1 CANT1_HUMAN "Soluble calcium-activated nucleotidase 1, SCAN-1, EC 3.6.1.6 (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)" CANT1 SHAPY Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166] adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134] GO:0004382; GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030166; GO:0032580; GO:0035580; GO:0042803; GO:0043123; GO:0043262; GO:0045134; GO:0070062; GO:1904724; GO:1904813 GRGMELSDLIVFNGK 7.230000019 0.902347445 0.902347445 0.184707677 1635.725171 14.58877 0 16.26715 13.37242 14.18188 15.40285 18.92625 18.30475 14.7551 16.8849 18.58939 15.25739 14.16969 19.72664 0 13.52032 16.51725 13.87558 18.59444 15.68389 0 13.75032 19.85823 0 0 0 18.57378 19.69432 18.43872 19.10602 0 0 13.26861 0 18.56485 17.07901 17.41389 17.41918 14.73936 0 0 0 0 15.91898 0 18.13625 0 12.83245 Q8WVR3 TPC14_HUMAN Trafficking protein particle complex subunit 14 (Microtubule-associated protein 11) TRAPPC14 C7orf43 MAP11 Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127] centriolar satellite [GO:0034451]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; TRAPPII protein complex [GO:1990071] centriolar satellite [GO:0034451]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; TRAPPII protein complex [GO:1990071]; alpha-tubulin binding [GO:0043014]; cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127] alpha-tubulin binding [GO:0043014] GO:0005886; GO:0030496; GO:0034451; GO:0042127; GO:0043014; GO:0043231; GO:0060271; GO:0072686; GO:1990071 EGLEVPLIAVVQWSTPK 7.900000095 1 1 0.110202582 1866.778898 13.78413 15.80735 15.92556 0 13.85867 0 0 0 14.57781 0 0 14.1474 0 0 0 0 0 0 14.39578 13.88406 0 0 15.97897 0 0 0 14.92957 0 11.60355 14.63428 0 0 0 0 0 0 0 16.56217 0 0 14.27568 0 0 8.196934 0 0 14.0004 15.11123 Q8WVS4 DC2I1_HUMAN Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60) DYNC2I1 WDR60 Homo sapiens (Human) cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] GO:0000242; GO:0005615; GO:0005813; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0042073; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097014; GO:0097542; GO:0097546 NRGASSK 6.269999981 0.378266424 0.378266424 0.185287287 719.4468789 0 15.8407 0 14.82338 0 0 0 14.29863 0 15.65872 14.4336 0 15.36708 15.9406 15.44781 13.28897 15.89303 16.04809 15.81545 16.08127 15.99282 0 0 0 16.13549 15.8288 16.48891 13.56116 16.42609 14.48995 16.24376 15.85598 15.28084 16.11597 13.62973 16.3921 16.59633 16.33772 17.24401 14.28197 15.25945 15.74697 16.24302 16.92315 16.68933 16.57492 16.57311 15.84997 Q8WVT3 TPC12_HUMAN "Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15, TPR repeat protein 15, TTC-15) (Trafficking of membranes and mitosis)" TRAPPC12 TRAMM TTC15 CGI-87 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022] GO:0000776; GO:0005634; GO:0005654; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0048208; GO:0051310; GO:0090234; GO:0099022; GO:1905342; GO:1990072 ENLTMPGLR 4.380000114 1 1 0.262199573 1046.588476 18.26424 0 0 0 16.47842 0 0 18.36108 0 0 0 0 0 0 0 0 17.13984 0 0 17.79429 0 0 0 0 0 18.17183 0 0 17.16261 0 0 17.18703 0 0 0 0 16.77989 0 0 0 0 0 0 0 0 17.10631 16.42401 0 Q8WVV4 POF1B_HUMAN Protein POF1B (Premature ovarian failure protein 1B) POF1B Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382] actin filament [GO:0005884]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; desmosome [GO:0030057] actin filament [GO:0005884]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; desmosome [GO:0030057]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382] actin filament binding [GO:0051015] GO:0003382; GO:0005884; GO:0005912; GO:0005923; GO:0007015; GO:0030036; GO:0030057; GO:0051015; GO:0070830 TYSGPMNK 6.679999828 1 1 4.59E-13 913.519427 13.54828 0 13.32439 0 13.79268 13.32805 0 0 14.32106 14.76124 13.67744 11.68659 14.12042 14.09707 14.40521 14.91907 14.01602 14.27943 15.10975 12.66637 0 15.85985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.14785 0 Q8WVV5 BT2A2_HUMAN Butyrophilin subfamily 2 member A2 BTN2A2 BT2.2 BTF2 Homo sapiens (Human) negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] signaling receptor binding [GO:0005102] GO:0001817; GO:0001818; GO:0005102; GO:0005886; GO:0009897; GO:0014067; GO:0016021; GO:0045591; GO:0046007; GO:0050852; GO:0050860; GO:0051898; GO:0070373; GO:2000134 SYDEAILR 5.829999924 0.348208308 0.348208308 0.200945805 966.8615271 0 11.0453 15.65942 0 15.43907 14.97339 12.5006 13.25517 0 17.21319 0 0 0 16.73079 0 15.79224 0 15.09342 0 0 0 0 17.58903 15.88896 14.75457 16.49104 0 13.89514 0 0 13.5279 0 0 15.72873 0 16.54657 0 0 0 0 0 0 12.84993 16.37543 0 0 15.32539 0 Q8WVV9 HNRLL_HUMAN "Heterogeneous nuclear ribonucleoprotein L-like, hnRNPLL (Stromal RNA-regulating factor)" HNRNPLL HNRPLL SRRF BLOCK24 Homo sapiens (Human) mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484] membrane [GO:0016020]; nucleus [GO:0005634] membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0016020; GO:0033120; GO:0043484 NNRFTSAGQASK 14.30000019 1 1 0.193932973 1282.031051 0 16.12548 0 17.90075 0 0 0 0 0 0 0 0 0 18.32879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVX9 FACR1_HUMAN "Fatty acyl-CoA reductase 1, EC 1.2.1.84 (Male sterility domain-containing protein 2)" FAR1 MLSTD2 UNQ2423/PRO4981 Homo sapiens (Human) ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491] GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0016491; GO:0035336; GO:0043231; GO:0046474; GO:0080019; GO:0102965 VEEVLSGKLFDR 2.119999886 1 1 0.38483214 1391.82424 16.31752 0 15.35177 0 17.14773 15.66388 0 0 17.06455 0 0 15.87039 15.74569 15.74772 0 0 0 0 17.20238 14.10917 0 0 15.1967 0 0 0 0 16.54979 12.88972 15.15124 13.80116 15.11238 0 17.12818 16.84297 0 0 15.59302 0 0 0 0 0 0 0 15.93115 14.44966 0 Q8WW24 TEKT4_HUMAN Tektin-4 TEKT4 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] GO:0005634; GO:0015630; GO:0036126; GO:0060271; GO:0060294 NLEDIHMSLEKDIAAMTNSLFIDR 4.690000057 1 1 2.75E-12 2807.234972 0 0 13.12764 10.29137 0 13.37082 0 15.29608 12.61542 15.57857 12.72678 0 12.60412 15.33074 0 0 13.13888 0 14.42184 0 0 0 0 0 0 11.8134 0 0 0 0 0 0 0 0 14.38588 0 0 0 0 0 0 14.47194 0 0 0 0 0 0 Q8WW33 GTSF1_HUMAN Gametocyte-specific factor 1 (Protein FAM112B) GTSF1 FAM112B Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] metal ion binding [GO:0046872] GO:0005737; GO:0007283; GO:0030154; GO:0046872 NNLASGMR 2.480000019 0.531582355 0.531582355 0.054632875 861.3933383 17.52258 14.91904 15.00581 17.27226 16.11393 16.3739 14.41621 18.34515 0 0 15.71274 16.75581 0 14.68254 0 0 17.8494 12.90624 13.61074 13.21963 0 13.74662 14.96011 17.30587 16.65268 12.55532 16.25076 13.40248 15.57918 0 11.52658 0 16.40132 0 13.51567 11.74787 16.64209 17.98093 17.05951 0 15.57759 15.78854 15.89748 0 11.39327 14.28715 13.86719 13.69845 Q8WW36 ZCH13_HUMAN Zinc finger CCHC domain-containing protein 13 ZCCHC13 Homo sapiens (Human) positive regulation of cytoplasmic translation [GO:2000767] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767] mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270] GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767 GGGHGR 2.75999999 0.303523004 0.303523004 0.124097958 541.4047869 15.73418 17.61238 15.86667 16.25254 17.71126 16.72999 0 16.89101 15.63078 16.22329 16.84429 16.8842 17.23513 15.47681 17.02685 16.4395 16.75575 0 18.42922 0 17.55272 16.0328 16.52011 16.42323 0 16.62566 17.7473 15.71186 16.13164 16.94748 16.26423 0 16.62494 17.39148 17.52734 16.39732 16.80037 16.34565 0 0 18.14256 16.65454 16.01374 16.68602 17.02246 16.96084 0 0 Q8WW38 FOG2_HUMAN "Zinc finger protein ZFPM2 (Friend of GATA protein 2, FOG-2, Friend of GATA 2, hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2)" ZFPM2 FOG2 ZNF89B Homo sapiens (Human) "cell differentiation [GO:0030154]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]" DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0000122; GO:0000785; GO:0001570; GO:0001701; GO:0003148; GO:0003221; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007506; GO:0007507; GO:0008270; GO:0030154; GO:0030324; GO:0045599; GO:0045892; GO:0045944; GO:0048568; GO:0060045; GO:0060412; GO:0060548; GO:0061629; GO:2000020; GO:2000195 AMQTKDASSDTELDK 9.75 1 1 0.214284253 1640.314116 0 0 14.05443 15.61342 0 14.35991 0 0 14.38454 0 13.5789 0 0 0 0 0 0 14.31965 0 0 0 0 14.77341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW52 F151A_HUMAN Protein FAM151A FAM151A C1orf179 UNQ3034/PRO9836 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0005615; GO:0016020; GO:0016021; GO:0070062 MHELVGGVPQR 3.970000029 1 1 0.120901654 1239.654911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.25852 0 0 0 0 0 0 0 0 Q8WWC4 MAIP1_HUMAN "m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)" MAIP1 C2orf47 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ribosome binding [GO:0043022]; calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204] ribosome binding [GO:0043022] GO:0005743; GO:0005759; GO:0007007; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560 EVLHALK 5.21999979 0.00020578 0.00020578 0.284374262 809.5765193 16.43505 0 18.03819 0 0 16.55724 16.03791 0 17.7765 17.63085 17.22279 17.19782 0 0 0 18.71051 0 0 0 0 16.08313 0 0 17.57518 17.01563 18.59878 17.34859 0 16.70166 18.08585 0 16.99766 0 17.27098 0 0 0 19.19392 18.31467 0 0 18.6294 0 0 17.98975 18.3204 16.7915 0 Q8WWH5 TRUB1_HUMAN "Pseudouridylate synthase TRUB1, EC 5.4.99.- (TruB pseudouridine synthase homolog 1) (tRNA pseudouridine 55 synthase TRUB1, Psi55 synthase TRUB1, EC 5.4.99.25)" TRUB1 PUS4 Homo sapiens (Human) mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005739; GO:0005829; GO:0006400; GO:0009982; GO:1990481 LSTLMK 8.220000267 1 1 0.096858678 691.7955155 0 14.24513 12.84412 0 0 0 0 0 0 0 16.49543 15.55035 17.95782 17.78577 0 0 0 0 0 14.37025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.73579 16.72129 0 0 0 17.59903 0 18.41644 0 18.63895 0 0 Q8WWI1 LMO7_HUMAN "LIM domain only protein 7, LMO-7 (F-box only protein 20) (LOMP)" LMO7 FBX20 FBXO20 KIAA0858 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 AFEDFRK 5.369999886 0.76615864 0.76615864 0.229134932 912.2595123 0 17.29595 15.85135 15.03545 0 0 0 15.86882 17.92174 16.3669 17.10731 16.52239 17.48109 16.00245 16.70675 14.96836 0 0 0 0 14.99805 16.30607 16.6866 17.83603 16.74204 17.84395 0 16.32397 16.00136 0 0 15.22686 0 0 15.05499 16.46009 18.35124 15.31553 16.22266 16.9916 0 15.52936 16.5301 16.41417 16.0772 17.38493 0 15.33191 Q8WWI5 CTL1_HUMAN Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92) SLC44A1 CD92 CDW92 CTL1 Homo sapiens (Human) choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857] GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0042426; GO:0055085; GO:0070062; GO:0150104 MGCCSSASSAAQSSK 10.11999989 0.879242241 0.879242241 0.293793212 1536.156917 15.45367 13.97048 15.15206 0 0 14.3745 0 0 0 0 0 0 16.34073 15.74638 18.11711 15.26661 13.02262 0 0 0 0 0 18.04888 0 0 0 0 16.31968 14.05606 0 0 0 0 0 0 0 0 0 0 0 0 15.96427 0 0 16.68738 0 0 0 Q8WWK9 CKAP2_HUMAN Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein) CKAP2 LB1 TMAP Homo sapiens (Human) apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000281; GO:0000922; GO:0005737; GO:0005813; GO:0005874; GO:0006915; GO:0007026; GO:0015630; GO:0045944; GO:0072686 DESSAATK 7.03000021 1 1 0.070053995 807.3034283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.60355 0 0 15.47947 0 15.65709 0 13.53586 0 15.73734 0 0 14.51889 12.27043 0 0 13.92579 0 14.95227 0 0 0 0 0 15.10594 0 0 15.71418 0 16.39555 13.42221 0 0 Q8WWL2 SPIR2_HUMAN "Protein spire homolog 2, Spir-2" SPIRE2 KIAA1832 SPIR2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] actin binding [GO:0003779] GO:0003779; GO:0005829; GO:0005856; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030041; GO:0030659; GO:0032154; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048193; GO:0051295; GO:0051639; GO:0070649; GO:2000781 ELFSSLKK 21.03000069 2.62E-05 2.62E-05 0.277980971 951.3520809 0 0 0 0 18.24807 0 19.42447 0 18.94842 0 0 0 0 20.68094 16.96647 0 0 0 0 0 0 18.9917 0 0 0 0 0 0 0 18.04679 19.36376 0 0 0 0 20.09491 19.09344 0 0 0 17.68981 0 0 0 0 18.03519 17.19275 17.63255 Q8WWL7 CCNB3_HUMAN G2/mitotic-specific cyclin-B3 CCNB3 CYCB3 Homo sapiens (Human) cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0016607; GO:0019901; GO:0044772; GO:0051301; GO:0051321 KPKTEESIPTHK 8.93999958 0.021952821 0.021952821 0.187784879 1395.578562 14.57667 14.4176 13.07192 15.12181 0 0 0 0 13.69495 0 17.46324 13.12284 13.00561 14.52585 13.5812 0 0 13.67185 0 0 12.98787 11.57613 0 0 0 0 15.21691 15.90206 0 0 0 0 0 0 0 0 15.62652 0 0 0 0 0 0 0 0 0 0 0 Q8WWM7 ATX2L_HUMAN Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein) ATXN2L A2D A2LG A2LP A2RP Homo sapiens (Human) mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063] cadherin binding [GO:0045296]; RNA binding [GO:0003723] GO:0003723; GO:0005829; GO:0010494; GO:0016020; GO:0016071; GO:0016607; GO:0034063; GO:0045296 CSSSRGGRPGLSSLPPR 8.670000076 0.166345596 0.166345596 0.123928503 1771.730202 0 15.75238 16.08103 15.30138 0 14.70121 0 13.64524 15.63814 15.69701 15.39198 15.07403 14.52517 16.94747 0 16.02953 0 0 0 16.57512 15.97392 0 0 0 15.65946 0 16.63535 0 15.34561 0 0 16.32775 0 0 15.17446 0 17.39754 0 0 16.84208 17.17147 0 0 16.79965 16.36804 0 16.99271 17.29171 Q8WWM9 CYGB_HUMAN "Cytoglobin (Histoglobin, HGb) (Stellate cell activation-associated protein)" CYGB STAP Homo sapiens (Human) fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601]; fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601] GO:0001666; GO:0004096; GO:0004601; GO:0005344; GO:0005506; GO:0005829; GO:0006979; GO:0010764; GO:0015671; GO:0019395; GO:0019825; GO:0020037; GO:0032966; GO:0043005; GO:0043025; GO:0047888; GO:2000490 KAVQAMWAR 8.399999619 0.867286384 0.867286384 0.19590787 1075.536098 14.38238 14.86746 14.4921 14.56973 15.40256 14.06843 0 16.04698 14.49335 14.97548 13.90389 0 0 15.69423 0 15.82765 14.34996 13.6074 15.11159 16.3591 13.80801 14.4288 0 0 0 15.67885 16.34122 12.52701 15.05133 15.47109 15.43744 11.21655 15.58543 15.1334 15.84297 15.70818 15.64585 12.90875 12.55354 13.88212 15.60617 14.79778 12.99542 12.71063 12.94472 0 14.73476 12.94112 Q8WWN8 ARAP3_HUMAN "Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (Centaurin-delta-3, Cnt-d3)" ARAP3 CENTD3 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; cytoskeleton organization [GO:0007010]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]" "GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]" GO:0001726; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005886; GO:0007010; GO:0007165; GO:0016192; GO:0030027; GO:0043325; GO:0043547; GO:0046872 SSPQAR 6.840000153 0.486129671 0.486129671 0.068249868 647.138194 13.34528 0 0 16.838 15.44937 15.65073 0 0 14.26821 0 16.52032 0 0 14.889 0 14.42664 0 9.866041 12.63871 16.21707 12.80995 14.73431 13.87626 14.49408 0 13.25347 14.0497 0 17.36236 0 0 15.15774 0 13.60312 15.63976 0 0 17.37976 0 16.57926 0 15.89367 0 0 0 0 14.32155 0 Q8WWQ0 PHIP_HUMAN "PH-interacting protein, PHIP (DDB1- and CUL4-associated factor 14) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11)" PHIP DCAF14 WDR11 Homo sapiens (Human) "cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577]; cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]" insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577] GO:0001932; GO:0005158; GO:0005634; GO:0006357; GO:0007010; GO:0008284; GO:0008286; GO:0008360; GO:0022604; GO:0043066; GO:0043568; GO:0045840; GO:0045893; GO:0045944; GO:0070577; GO:2001237 DQTCYNIIPLYNSMKK 5.380000114 1 1 0.425291291 2004.323307 0 0 0 0 0 0 0 0 0 0 22.58535 0 0 0 0 18.05327 0 0 0 19.49454 0 0 0 0 0 0 0 0 0 15.86917 21.99156 21.42952 0 0 0 0 0 0 0 0 0 20.94732 0 21.46167 0 0 0 0 Q8WWQ2 HPSE2_HUMAN "Inactive heparanase-2, Hpa2" HPSE2 HPA2 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cell population proliferation [GO:0008284] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; heparanase activity [GO:0030305]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cell population proliferation [GO:0008284] heparan sulfate proteoglycan binding [GO:0043395]; heparanase activity [GO:0030305] GO:0005576; GO:0005886; GO:0006027; GO:0008284; GO:0030198; GO:0030305; GO:0031012; GO:0043395 NPAKSR 18.45999908 0.27088058 0.27088058 0.304395863 673.1065739 15.52655 16.07796 16.37469 15.57237 15.95676 0 14.98265 14.74724 15.18456 0 12.23871 14.9306 14.47163 15.92157 16.6285 0 0 0 16.90125 14.54856 0 15.59276 16.21636 17.29294 15.98526 0 16.21874 16.93853 15.17941 14.09642 16.71553 0 0 14.76491 0 16.24852 0 0 16.05281 0 0 0 16.28283 0 16.40611 0 16.06865 0 Q8WWQ8 STAB2_HUMAN "Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2, FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis) ]" STAB2 FEEL2 FELL FEX2 HARE Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; receptor-mediated endocytosis [GO:0006898] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030666; GO:0042742; GO:0050830 CGAGR 4.659999847 0.482469499 0.482469499 0.054764894 521.9448667 0 13.51775 16.51694 17.0697 19.19829 16.40514 15.3662 13.22672 0 17.48537 16.62228 0 0 0 0 0 0 0 0 0 0 16.73596 15.5107 0 0 12.42122 0 11.43771 0 0 0 16.36683 16.90192 0 18.33481 17.17536 16.51376 19.83204 17.50942 17.90171 18.10177 17.98313 15.31542 0 16.36329 0 0 17.2946 Q8WWR8 NEUR4_HUMAN "Sialidase-4, EC 3.2.1.18 (N-acetyl-alpha-neuraminidase 4)" NEU4 LP5125 Homo sapiens (Human) ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; negative regulation of neuron projection development [GO:0010977]; oligosaccharide catabolic process [GO:0009313] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; organelle inner membrane [GO:0019866]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; organelle inner membrane [GO:0019866]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; negative regulation of neuron projection development [GO:0010977]; oligosaccharide catabolic process [GO:0009313] exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308] GO:0004308; GO:0005737; GO:0005741; GO:0005743; GO:0005764; GO:0005789; GO:0005886; GO:0006516; GO:0006689; GO:0009313; GO:0010977; GO:0016020; GO:0019866; GO:0043005; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796 TGLTYR 1.830000043 1 1 0.154411343 710.5807431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWT9 S13A3_HUMAN "Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3, NaDC-3, hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)" SLC13A3 NADC3 SDCT2 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104] alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141] GO:0005310; GO:0005886; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015362; GO:0015746; GO:0016021; GO:0016323; GO:0017153; GO:0034634; GO:0034775; GO:0070062; GO:0071422; GO:0098656; GO:0150104 MAALAAAAK 1.149999976 0.104497865 0.104497865 0.317096942 832.6145852 0 19.50847 0 16.47867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWU5 TCP11_HUMAN T-complex protein 11 homolog TCP11 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] GO:0001669; GO:0007165; GO:0007189; GO:0007281; GO:0007283; GO:0010737; GO:0016021; GO:0036126; GO:0097225; GO:1902490 NMGLVALSSDNTASLMGQLQNIAK 5.519999981 1 1 0 2493.044974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWU7 ITLN2_HUMAN Intelectin-2 (Endothelial lectin HL-2) ITLN2 UNQ2789/PRO7179 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492] metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492] GO:0005615; GO:0046872; GO:0070492 NGVVYQTFCDMTSGGGGWTLVASVHENDMR 9.220000267 1 1 3.65E-12 3303.28852 0 0 0 16.03044 16.76285 0 17.29507 17.47554 16.2014 17.59808 12.36298 15.38327 0 0 0 13.30702 0 17.40401 18.01793 0 16.61032 14.72781 0 14.73713 15.9146 15.23612 15.11517 13.76905 16.48642 16.82998 14.33958 16.47264 15.13238 18.19535 0 0 12.73425 16.43442 0 0 0 0 10.30849 0 0 0 17.0641 16.18717 Q8WWV6 FCAMR_HUMAN High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor (Fc alpha/mu receptor) (CD antigen CD351) FCAMR FKSG87 Homo sapiens (Human) adaptive immune response [GO:0002250] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250] transmembrane signaling receptor activity [GO:0004888] GO:0002250; GO:0004888; GO:0005886; GO:0016021 REMTTTK 2.579999924 1 1 0.215116884 879.9449706 0 0 14.15539 0 0 16.1252 0 15.52192 15.87292 15.44985 0 0 0 0 0 0 0 0 0 0 14.92179 0 0 0 16.21098 0 0 0 15.37038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWX8 SC5AB_HUMAN "Sodium/myo-inositol cotransporter 2, Na(+)/myo-inositol cotransporter 2 (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2, SMIT2) (Solute carrier family 5 member 11)" SLC5A11 KST1 SLGTX SMIT2 Homo sapiens (Human) apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]; apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409] glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166] GO:0005412; GO:0005886; GO:0006915; GO:0015166; GO:0015798; GO:0016021; GO:0032409 GGALMAAYLK 2.480000019 0.396217644 0.396217644 0.208800758 1008.972288 0 12.21276 0 0 15.04749 0 13.43369 0 12.13213 12.86365 0 0 14.71422 0 0 15.53939 0 0 0 0 0 0 0 0 0 17.18294 16.2556 0 0 0 0 17.57725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWY3 PRP31_HUMAN "U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein, Protein 61K, hPrp31)" PRPF31 PRP31 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]" Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] "Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]" identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526 ARISK 5.889999866 1 1 0.217691625 575.7656527 0 16.60186 0 0 0 0 0 0 0 0 0 0 0 18.91838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.23708 0 0 0 0 0 0 0 0 0 Q8WWZ1 IL1FA_HUMAN "Interleukin-1 family member 10, IL-1F10 (Family of interleukin 1-theta, FIL1 theta) (Interleukin-1 HY2, IL-1HY2) (Interleukin-1 theta, IL-1 theta) (Interleukin-38, IL-38)" IL1F10 FIL1T IL1HY2 IL38 FKSG75 UNQ6119/PRO20041 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of gene expression [GO:0010628] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of gene expression [GO:0010628] cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0010628; GO:0019221; GO:0071222 MCSLPMAR 4.820000172 1 1 0.023193131 963.6496917 0 0 0 0 0 0 0 0 15.49553 0 16.22384 0 14.98511 0 0 0 0 13.13057 0 0 0 0 0 0 0 17.22618 16.89663 15.48015 0 0 0 15.91493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.39703 Q8WWZ4 ABCAA_HUMAN "ATP-binding cassette sub-family A member 10, EC 7.6.2.-" ABCA10 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0140359 CSDQGIR 7.679999828 1 1 0.126423002 834.270939 15.0307 14.35223 14.40133 0 14.32113 12.65249 0 0 0 0 0 12.75184 0 0 0 10.46366 0 0 14.90098 12.92261 0 0 0 0 0 0 12.74285 0 14.24496 12.92162 0 14.75681 0 0 12.89386 0 0 0 13.02983 0 0 0 0 0 0 0 0 0 Q8WWZ7 ABCA5_HUMAN "Cholesterol transporter ABCA5, EC 7.6.2.- (ATP-binding cassette sub-family A member 5)" ABCA5 KIAA1888 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016021; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0140359; GO:1903064 GEILGLLGPNGAGK 8.039999962 1 1 0.07603941 1295.845809 0 0 0 14.81031 13.72218 0 0 15.56564 0 0 0 0 15.40882 0 0 10.36509 15.62009 0 0 0 0 0 0 0 0 0 0 0 17.31689 0 17.68412 0 18.44578 0 15.61991 15.18296 0 16.72664 0 0 0 18.39524 0 0 0 16.60707 15.25925 0 Q8WWZ8 OIT3_HUMAN Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein) OIT3 LZP UNQ826/PRO1753 Homo sapiens (Human) urate homeostasis [GO:1903118] cell surface [GO:0009986]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635] cell surface [GO:0009986]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; urate homeostasis [GO:1903118] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005509; GO:0005615; GO:0005635; GO:0009986; GO:1903118 EALPTLK 2.470000029 1 1 0.268524459 770.6493596 19.1948 0 0 0 0 0 0 0 18.13919 0 0 0 0 0 0 0 16.53949 0 16.73369 0 0 17.92409 0 0 0 0 0 0 0 0 0 0 18.24294 0 0 0 0 0 0 18.27332 0 0 0 0 0 0 0 0 Q8WX93 PALLD_HUMAN Palladin (SIH002) (Sarcoma antigen NY-SAR-77) PALLD KIAA0992 CGI-151 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334] actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371] GO:0001725; GO:0001726; GO:0002102; GO:0003334; GO:0003382; GO:0003779; GO:0005634; GO:0005739; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007010; GO:0007156; GO:0007411; GO:0015629; GO:0016477; GO:0030018; GO:0030027; GO:0030036; GO:0030424; GO:0030426; GO:0051371; GO:0060076; GO:0070593; GO:0098632 VYLECRVTGNPTPR 2.24000001 1 1 0.364895493 1660.863551 0 15.54904 0 0 0 12.61786 0 0 0 0 0 0 0 14.63521 0 0 0 11.68163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21181 0 0 0 16.0644 0 0 0 0 0 0 Q8WXA3 RUFY2_HUMAN RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related) RUFY2 KIAA1537 RABIP4R Homo sapiens (Human) regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100] metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124] GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872 HSRQGLDEMYNEAR 1.110000014 0.737509608 0.737509608 0.287991495 1723.278945 0 0 0 15.76982 16.48579 17.28297 0 0 0 0 0 0 0 0 0 0 15.49237 15.9058 0 0 0 0 0 0 14.27608 13.06571 0 0 0 0 0 17.81953 0 0 0 0 0 14.41317 0 0 0 0 10.60352 0 0 0 15.52644 0 Q8WXB1 MT21A_HUMAN "Protein N-lysine methyltransferase METTL21A, EC 2.1.1.- (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A)" METTL21A FAM119A HCA557B Homo sapiens (Human) peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479] ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0008276; GO:0016279; GO:0018022; GO:0030544; GO:0031072; GO:0032991; GO:0051117 VALEFLK 4 0.182122365 0.182122365 0.192013671 820.3758168 0 15.13047 15.90482 0 16.50011 15.29402 0 16.29174 0 15.65151 16.40907 0 0 0 0 0 0 0 0 15.97686 0 0 0 0 0 14.83344 0 0 0 15.47046 16.29965 0 0 17.06258 0 16.31924 15.61213 15.95958 16.35564 17.00953 16.10262 0 0 17.03813 0 0 0 0 Q8WXB4 ZN606_HUMAN Zinc finger protein 606 (Zinc finger protein 328) ZNF606 KIAA1852 ZNF328 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872 DQLEMYHMNQSTAMR 4.639999866 0.253666967 0.253666967 0.181793467 1885.853801 15.43002 0 18.43013 14.54585 15.96784 0 0 0 0 0 0 0 0 17.30894 0 0 16.87539 0 0 0 0 0 14.61888 13.63263 0 0 17.97164 0 19.1753 15.49478 12.75001 19.73335 17.87007 0 14.81526 15.75111 17.36746 0 14.09995 0 15.42233 18.03166 13.07512 15.07268 0 0 15.10792 15.45979 Q8WXD9 CSKI1_HUMAN Caskin-1 (CASK-interacting protein 1) CASKIN1 KIAA1306 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; identical protein binding [GO:0042802]; signal transduction [GO:0007165] identical protein binding [GO:0042802] GO:0005737; GO:0007165; GO:0016020; GO:0042802 TLSGPVTGLLATARR 5.820000172 0.127831399 0.127831399 0.328506147 1514.788456 13.49834 0 12.83786 14.48019 16.13793 12.98193 17.345 14.11555 15.11603 12.29261 0 11.81943 0 0 0 13.99463 0 15.45943 0 0 0 0 0 0 0 0 0 12.49569 0 14.77668 16.24788 0 0 0 0 0 14.33006 0 0 0 0 14.78876 0 0 0 0 16.10711 0 Q8WXE1 ATRIP_HUMAN ATR-interacting protein (ATM and Rad3-related-interacting protein) ATRIP AGS1 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779] ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530] GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779 LLDGMSK 2.230000019 1 1 1.15E-13 780.4895217 14.87865 14.40863 16.51995 0 13.69747 14.26012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXF7 ATLA1_HUMAN "Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)" ATL1 GBP3 SPG3A Homo sapiens (Human) axonogenesis [GO:0007409]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; axonogenesis [GO:0007409]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] GO:0000137; GO:0000139; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007029; GO:0007409; GO:0016021; GO:0030424; GO:0042802; GO:0051260; GO:0071782; GO:0098826; GO:1990809 EINGNK 5.03000021 0.842133403 0.842133403 0.24788126 675.3225208 0 0 0 0 0 0 0 17.35033 16.49872 0 0 0 18.82083 18.78345 19.15184 0 18.63463 18.03291 19.00422 15.0771 15.88107 18.23973 16.62224 17.33791 0 18.64428 0 17.06334 17.454 18.97825 18.91072 18.97711 0 18.20607 17.27276 18.36675 0 18.6509 19.72139 17.82098 0 18.55486 17.85542 19.06645 19.48483 18.65571 19.72791 20.10325 Q8WXF8 DEDD2_HUMAN DNA-binding death effector domain-containing protein 2 (DED-containing protein FLAME-3) (FADD-like anti-apoptotic molecule 3) DEDD2 FLAME3 PSEC0004 Homo sapiens (Human) "apoptotic nuclear changes [GO:0030262]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; signaling receptor complex adaptor activity [GO:0030159]; apoptotic nuclear changes [GO:0030262]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]" DNA binding [GO:0003677]; signaling receptor complex adaptor activity [GO:0030159] GO:0003677; GO:0005654; GO:0005730; GO:0006396; GO:0008625; GO:0016075; GO:0019725; GO:0030159; GO:0030262; GO:0035556; GO:0045892; GO:2001238 RPQALARQLDVFGQATAVLR 1.029999971 1 1 0.080130306 2209.727946 0 0 13.73789 0 0 0 0 0 0 0 0 0 12.98072 0 0 0 13.05149 0 12.7663 0 12.81455 7.163099 0 13.37923 0 0 10.96859 13.55111 0 13.85382 0 0 15.92675 13.60293 7.953599 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXG1 RSAD2_HUMAN "Radical S-adenosyl methionine domain-containing protein 2, EC 4.2.-.- (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)" RSAD2 CIG5 Homo sapiens (Human) "CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]" "4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]" GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0043621; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553 QPLSSLWR 3.769999981 1 1 0.164875309 986.0559641 0 0 13.36323 14.89934 0 12.81266 13.5487 0 13.34381 0 0 14.75521 13.13054 0 14.94105 0 0 0 0 0 8.919705 13.97002 15.99806 0 0 0 14.19796 0 0 0 0 0 0 0 0 0 0 0 0 10.34211 0 0 0 0 0 0 14.66236 0 Q8WXG6 MADD_HUMAN "MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor, RabGEF) (Rab3 GDP/GTP exchange protein, Rab3GEP)" MADD DENN IG20 KIAA0358 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activator activity [GO:0030295]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] death receptor binding [GO:0005123]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activator activity [GO:0030295] GO:0005085; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0016021; GO:0030295; GO:0030424; GO:0032483; GO:0042981; GO:0043410; GO:0051726; GO:0097194; GO:1902041; GO:2001236 ELYYCVKDSMER 4.940000057 1 1 0.080061599 1590.653409 13.08187 11.58747 16.4058 13.82089 13.73423 13.70844 12.30992 0 13.95961 0 14.29322 13.63078 0 14.2383 13.33409 14.78736 0 15.16195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXG9 AGRV1_HUMAN "Adhesion G-protein coupled receptor V1, ADGRV1, EC 3.4.-.- (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta ]" ADGRV1 GPR98 KIAA0686 KIAA1943 MASS1 VLGR1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0030501; GO:0031647; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696 CAQMEPNALPFR 4.900000095 1 1 0.147146797 1450.928713 13.44088 15.49193 13.77348 12.3937 10.79333 14.2797 15.0303 13.37449 0 14.45132 14.58823 13.96792 0 0 0 0 0 15.4779 0 0 13.68604 0 15.37974 0 0 0 0 0 15.8364 14.81384 0 0 0 0 0 0 0 0 0 0 15.09191 0 0 0 0 0 0 0 Q8WXH0 SYNE2_HUMAN "Nesprin-2 (KASH domain-containing protein 2, KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein, Protein NUANCE) (Synaptic nuclear envelope protein 2, Syne-2)" SYNE2 KIAA1011 NUA Homo sapiens (Human) centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444] GO:0003779; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005925; GO:0007097; GO:0016021; GO:0016529; GO:0021817; GO:0030018; GO:0030335; GO:0031022; GO:0031258; GO:0031527; GO:0031965; GO:0031981; GO:0033017; GO:0034993; GO:0045111; GO:0051015; GO:0051642; GO:0070062; GO:0140444; GO:1902017 DSAVEMAMSK 1.590000033 1 1 0.119037553 1084.807008 14.31163 11.83629 0 0 0 0 14.99139 0 0 0 0 14.74056 14.33893 14.78369 8.850767 0 0 0 0 0 0 15.46749 0 0 0 0 15.78002 15.39345 0 0 0 16.27812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXH2 JPH3_HUMAN "Junctophilin-3, JP-3 (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein)" JPH3 JP3 TNRC22 Homo sapiens (Human) calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167] GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0014701; GO:0016021; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060314; GO:0060402 QSVPYGMAAVIR 10.59000015 1 1 0.614240419 1308.250377 0 0 0 19.00357 0 0 0 0 18.12627 0 0 0 0 0 0 0 0 0 0 0 19.5521 0 0 0 0 0 0 17.61845 0 0 0 19.10092 0 0 0 0 0 0 0 17.53709 0 0 0 0 0 0 18.57924 0 Q8WXI2 CNKR2_HUMAN "Connector enhancer of kinase suppressor of ras 2, Connector enhancer of KSR 2 (CNK homolog protein 2, CNK2)" CNKSR2 CNK2 KIAA0902 KSR2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] GO:0005737; GO:0005886; GO:0009966; GO:0019901; GO:0035556; GO:0042802; GO:0043005; GO:0043025; GO:0070062; GO:0098978; GO:0099147; GO:0099173 ISGDQLLRITHQELEDLGVSR 8.25 1 1 0.117668169 2379.940036 0 14.41908 13.87058 0 0 14.52864 0 0 0 0 8.459628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.60496 15.5006 15.77566 0 0 15.17158 15.3498 16.35462 14.76536 0 0 0 0 0 0 0 0 0 0 16.93336 15.12253 0 Q8WXI7 MUC16_HUMAN "Mucin-16, MUC-16 (Ovarian cancer-related tumor marker CA125, CA-125) (Ovarian carcinoma antigen CA125)" MUC16 CA125 Homo sapiens (Human) cell adhesion [GO:0007155] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cell adhesion [GO:0007155] GO:0005796; GO:0005886; GO:0007155; GO:0016021; GO:0019898; GO:0031982; GO:0070062 DGAATK 7.949999809 0.51345706 0.51345706 0.112944905 562.4388582 14.7138 15.15249 16.8247 11.57712 15.4204 15.15771 12.04037 15.36526 0 14.70128 16.03143 0 17.88041 16.26047 15.02471 19.15364 18.45814 18.19002 0 15.80916 16.75216 15.78781 15.56236 15.9118 0 13.05643 15.72733 14.97917 0 0 15.06201 13.46426 16.70792 17.19646 15.24028 17.10933 17.79132 16.42373 17.01842 19.16624 0 0 15.78989 13.05037 16.92892 17.96086 0 17.81237 Q8WXI9 P66B_HUMAN Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68) GATAD2B KIAA1150 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] GO:0000122; GO:0000781; GO:0000785; GO:0005654; GO:0006338; GO:0008270; GO:0016575; GO:0016581; GO:0016607; GO:0032991; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736 GIEERQQLIK 8.18999958 1 1 0.110962008 1214.422593 0 18.90455 17.06432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.10272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXJ9 ASB17_HUMAN "Ankyrin repeat and SOCS box protein 17, ASB-17" ASB17 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 ELADIHEDAK 13.60000038 1 1 0.231542328 1140.034285 0 13.24009 14.94075 0 0 15.1088 0 0 0 14.15183 14.3363 0 0 15.46507 13.74926 0 0 0 0 16.22764 15.23662 14.75902 0 0 15.52795 12.67152 0 15.67491 0 0 16.16601 14.83177 0 0 0 0 0 16.60132 0 0 15.34719 0 0 0 0 0 0 0 Q8WXQ8 CBPA5_HUMAN "Carboxypeptidase A5, EC 3.4.17.-" CPA5 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005615; GO:0006508; GO:0008270 FSTGGSR 7.579999924 0.579537928 0.579537928 0.262313831 708.5650605 16.40671 16.3853 17.82808 0 0 0 19.31493 0 0 16.41847 16.70553 16.17712 17.45989 0 0 0 0 0 17.25559 17.52889 17.65837 0 0 0 0 18.06207 17.7484 0 0 16.83719 21.11614 19.54718 19.08179 0 0 17.96562 17.73334 0 18.31338 0 0 0 0 0 0 17.1349 0 17.23222 Q8WXR4 MYO3B_HUMAN "Myosin-IIIb, EC 2.7.11.1" MYO3B Homo sapiens (Human) cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0003774; GO:0003779; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103; GO:0106310 RQTVASYFR 1.059999943 0.607401252 0.607401252 0.192848323 1126.95816 14.29405 15.49333 14.08317 0 0 0 15.20267 13.88845 0 0 14.10209 11.80057 16.42082 0 15.97147 0 13.97832 0 16.62148 0 0 15.69647 15.48929 0 14.76356 11.16645 0 0 13.01016 9.947998 13.77961 0 15.65035 0 15.70819 14.84894 0 0 16.4816 12.64617 0 0 14.61943 11.45265 0 13.26722 13.81683 0 Q8WXS5 CCG8_HUMAN "Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8, TARP gamma-8)" CACNG8 CACNG6 Homo sapiens (Human) "calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891] "AMPA glutamate receptor complex [GO:0032281]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]" calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:0014069; GO:0016247; GO:0019226; GO:0030666; GO:0032281; GO:0051968; GO:0098839; GO:0098943; GO:0098970; GO:0099590; GO:1990454; GO:2000311 MESLKR 6.28000021 0.322948039 0.322948039 0.199198869 780.622572 0 14.40053 16.03556 0 14.57434 16.40738 15.76356 15.52295 15.9443 0 0 0 16.8581 15.33369 15.86826 16.97282 17.17467 16.29083 16.18654 0 16.34995 17.30782 15.69154 16.98325 16.03026 17.29869 17.45775 17.03118 17.23775 16.78291 16.43339 17.45587 16.99581 17.34565 17.6287 0 18.44156 17.75864 16.82802 16.97634 17.32236 17.76695 18.58678 17.90368 18.33973 0 17.92842 17.32579 Q8WXS8 ATS14_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 14, ADAM-TS 14, ADAM-TS14, ADAMTS-14, EC 3.4.24.-" ADAMTS14 Homo sapiens (Human) collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0005576; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0046872 CELICQSADTGDVVFMNQVVHDGTR 7.260000229 1 1 0.798383737 2865.797921 0 0 0 0 0 19.3372 0 21.58989 0 0 0 0 0 0 0 0 21.12457 0 21.50592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXU2 DAAF4_HUMAN Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein) DNAAF4 DYX1C1 EKN1 Homo sapiens (Human) cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136] estrogen receptor binding [GO:0030331] GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0043005; GO:0061136; GO:0097730; GO:0120293 LKEDSIPAPR 3.450000048 1 1 0.506318653 1125.509234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.49431 0 0 0 0 17.04634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88307 0 0 Q8WXW3 PIBF1_HUMAN "Progesterone-induced-blocking factor 1, PIBF (Centrosomal protein of 90 kDa, CEP90)" PIBF1 C13orf24 PIBF Homo sapiens (Human) activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539] interleukin-4 receptor binding [GO:0005136] GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515 EAPEWSKK 4.739999771 1 1 0.272253184 974.9858842 0 13.61846 12.85912 13.97085 0 0 0 0 0 0 0 15.38224 12.972 14.91832 15.14748 0 0 14.80376 14.66773 14.52464 0 15.52649 15.16399 16.34498 0 0 16.63486 0 0 13.6353 13.422 0 0 0 15.9193 15.42658 0 15.18322 16.63174 0 0 0 0 0 0 0 0 0 Q8WXX0 DYH7_HUMAN Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) DNAH7 KIAA0944 Homo sapiens (Human) cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 DVLSSLVK 7.760000229 1 1 0.439030978 860.9711916 0 15.63535 15.05588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.49604 0 0 0 15.09939 16.5181 0 0 0 0 0 0 0 0 0 0 0 16.80935 0 13.80031 0 0 14.90052 0 15.93492 0 0 15.97324 Q8WXX5 DNJC9_HUMAN "DnaJ homolog subfamily C member 9, HDJC9 (DnaJ protein SB73)" DNAJC9 Homo sapiens (Human) nucleosome assembly [GO:0006334]; positive regulation of ATP-dependent activity [GO:0032781] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334]; positive regulation of ATP-dependent activity [GO:0032781] chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393] GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006334; GO:0031072; GO:0032781; GO:0042393; GO:0051087; GO:0101031 EMDNFLAQMEAKYCK 1.149999976 1 1 0.317155119 1893.267348 0 12.40962 13.31116 0 12.49933 14.59888 0 0 14.7785 0 14.29506 10.17755 0 14.59898 12.93161 0 0 0 0 0 16.21198 0 15.85256 0 0 15.92543 0 0 0 0 0 0 0 0 14.48498 0 0 0 17.10032 0 16.82082 0 0 0 0 0 0 0 Q8WXX7 AUTS2_HUMAN Autism susceptibility gene 2 protein AUTS2 KIAA0442 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin binding [GO:0003682] GO:0001764; GO:0003682; GO:0005634; GO:0005737; GO:0005856; GO:0010592; GO:0030426; GO:0031532; GO:0035022; GO:0045944; GO:0048675; GO:0051571; GO:0097484; GO:2000620 AAGEEAKQLAR 5.800000191 1 1 0.165866822 1142.392834 14.04101 15.153 13.77785 0 16.15608 16.53896 0 0 14.38748 12.47465 14.72644 16.15768 14.16041 13.87319 14.86245 0 11.37104 14.61261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.05321 0 Q8WY21 SORC1_HUMAN "VPS10 domain-containing receptor SorCS1, hSorCS" SORCS1 SORCS Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuropeptide receptor activity [GO:0008188]; neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892] neuropeptide receptor activity [GO:0008188] GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020; GO:0016021 RGSAGAQYAI 2.380000114 0.52594018 0.52594018 0.17117068 994.8684441 12.19222 14.61281 16.92172 0 15.34148 0 14.96417 14.3656 0 0 0 0 14.89951 0 10.50814 0 0 15.56978 13.41528 0 0 0 16.31904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.40621 0 0 0 0 0 0 0 0 0 0 Q8WY36 BBX_HUMAN HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2) BBX HBP2 Homo sapiens (Human) bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0060348; GO:1990837 DLPSPKK 2.00999999 1 1 0.251326176 783.4937994 18.53224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.82702 18.36204 0 0 0 0 0 0 0 0 0 0 0 0 0 17.87351 Q8WY54 PPM1E_HUMAN "Protein phosphatase 1E, EC 3.1.3.16 (Ca(2+)/calmodulin-dependent protein kinase phosphatase N, CaMKP-N) (CaMKP-nucleus, CaMKN) (Partner of PIX 1) (Partner of PIX-alpha, Partner of PIXA)" PPM1E CAMKN KIAA1072 POPX1 Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006469; GO:0006470; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071466 GNMLHVAWVGDSQVMLVR 3.369999886 1 1 0.571681978 2044.230743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WY64 MYLIP_HUMAN "E3 ubiquitin-protein ligase MYLIP, EC 2.3.2.27 (Inducible degrader of the LDL-receptor, Idol) (Myosin regulatory light chain interacting protein, MIR) (RING-type E3 ubiquitin transferase MYLIP)" MYLIP BZF1 IDOL BM-023 PP5242 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005829; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0046872; GO:0061630 NNQSPSHSPLK 2.319999933 1 1 0.060028884 1205.933914 6.715851 13.62964 0 0 0 9.437288 0 0 0 0 0 12.96986 0 0 0 0 0 0 11.74844 0 0 14.63907 0 0 0 0 0 0 0 0 0 15.0645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYA0 IFT81_HUMAN "Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1, CDV-1)" IFT81 CDV1 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] tubulin binding [GO:0015631] GO:0005737; GO:0005813; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542; GO:0120316 NEPIEGKLSLYR 6.880000114 1 1 0.164136144 1417.800143 0 0 0 0 15.09749 0 0 0 13.57292 0 14.69401 0 13.69787 0 14.60489 0 0 14.94283 0 0 0 16.20165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.31092 0 0 0 0 0 0 0 0 0 0 0 Q8WYA1 BMAL2_HUMAN "Aryl hydrocarbon receptor nuclear translocator-like protein 2 (Basic-helix-loop-helix-PAS protein MOP9) (Brain and muscle ARNT-like 2) (CYCLE-like factor, CLIF) (Class E basic helix-loop-helix protein 6, bHLHe6) (Member of PAS protein 9) (PAS domain-containing protein 9)" ARNTL2 BHLHE6 BMAL2 CLIF MOP9 PASD9 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009649; GO:0032922; GO:0034751; GO:0042753; GO:0045893; GO:0045944; GO:0046983; GO:0070888; GO:1990513 EKLIDAK 16.45000076 7.85E-05 7.85E-05 0.224064392 816.5397926 17.80877 17.52484 19.21719 0 0 17.3886 0 0 0 19.13024 0 17.74981 0 16.19703 16.65453 0 16.77104 0 15.83427 0 0 18.28183 0 0 0 17.38296 18.0113 17.59169 0 16.57409 19.09161 17.63833 0 0 17.86236 17.87115 0 18.15944 17.06914 17.62234 0 0 0 0 15.52491 0 17.59555 0 Q8WYA6 CTBL1_HUMAN "Beta-catenin-like protein 1 (Nuclear-associated protein, NAP) (Testis development protein NYD-SP19)" CTNNBL1 C20orf33 PP8304 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]" centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681] "centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]" enzyme binding [GO:0019899] GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016020; GO:0016445; GO:0019899; GO:0043065 IEGEKHDMVR 5.400000095 1 1 2.31E-13 1228.795197 0 0 0 0 0 14.26197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.54858 0 0 0 6.676742 0 0 0 0 0 0 0 0 0 0 0 0 11.78617 0 0 0 0 0 0 0 13.7318 Q8WYB5 KAT6B_HUMAN "Histone acetyltransferase KAT6B, EC 2.3.1.48 (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4, MYST-4) (Monocytic leukemia zinc finger protein-related factor)" KAT6B KIAA0383 MORF MOZ2 MYST4 Homo sapiens (Human) "histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] "MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712] GO:0000786; GO:0003677; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050793; GO:0061629; GO:0070776; GO:1903706 HISIKAISR 7.869999886 1 1 0.121009769 1023.628681 0 14.06411 14.32448 11.3055 0 0 0 15.2087 13.83254 16.08874 14.84803 14.31691 0 0 14.82712 17.53389 0 13.87554 0 14.27525 0 11.32998 0 15.35242 0 0 0 0 0 0 0 0 0 0 0 0 0 16.30713 0 0 0 0 0 0 0 0 0 0 Q8WYH8 ING5_HUMAN Inhibitor of growth protein 5 (p28ING5) ING5 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] GO:0000123; GO:0001558; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006275; GO:0006325; GO:0006355; GO:0006473; GO:0008285; GO:0016570; GO:0035064; GO:0043065; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045893; GO:0045926; GO:0046872; GO:0050793; GO:0051726; GO:0070776; GO:1903706; GO:2000278; GO:2001235 VQLAMQTYEMVDKHIR 3.089999914 1 1 0.225499668 1993.637167 15.93272 14.183 12.79511 0 0 0 0 0 14.69844 0 0 0 0 12.30627 14.5423 0 13.32531 0 0 0 0 0 14.83549 0 0 0 0 14.92484 0 0 14.99172 13.96531 13.87552 15.04624 12.9945 0 15.11515 0 0 0 0 0 0 0 0 16.51791 0 0 Q8WYJ6 SEPT1_HUMAN Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24) SEPTIN1 DIFF6 PNUTL3 SEPT1 Homo sapiens (Human) cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] GO:0003924; GO:0005525; GO:0005815; GO:0005940; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0034613; GO:0042802; GO:0060090; GO:0061640 QVPEASAR 1.190000057 0.777749002 0.777749002 0.06029636 857.7726607 17.99942 0 16.99453 12.3718 14.53669 11.63729 15.04171 13.022 14.65597 0 15.86281 12.87615 15.60885 0 16.76157 11.16883 14.3463 13.62876 16.91354 14.61064 0 14.73629 0 16.12903 17.08627 16.33894 0 0 16.04872 16.45132 15.91727 14.31985 0 13.71658 16.88659 0 15.67685 17.05052 15.70811 16.06314 0 0 0 14.14688 0 15.25075 15.58077 15.50279 Q8WYK1 CNTP5_HUMAN Contactin-associated protein-like 5 (Cell recognition molecule Caspr5) CNTNAP5 CASPR5 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell adhesion [GO:0007155] GO:0007155; GO:0016021 HTQHFR 7.949999809 1 1 0.181670034 825.6791171 14.12691 11.93294 13.98667 0 0 13.46674 0 0 15.14015 0 0 12.54204 15.33166 12.96188 0 15.23753 15.24794 0 14.92768 0 0 15.28809 15.24762 16.65929 0 15.79224 15.94885 14.38377 15.67709 14.25078 13.59575 0 13.38739 16.17926 15.38022 15.22422 0 15.32703 16.29044 0 0 15.38071 0 16.80041 0 17.44951 0 16.44063 Q8WYL5 SSH1_HUMAN "Protein phosphatase Slingshot homolog 1, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 1, SSH-1L, hSSH-1L)" SSH1 KIAA1298 SSH1L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; regulation of cellular protein metabolic process [GO:0032268] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; regulation of cellular protein metabolic process [GO:0032268] actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0000902; GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005737; GO:0005856; GO:0005886; GO:0006470; GO:0008138; GO:0030027; GO:0030036; GO:0030496; GO:0030837; GO:0032154; GO:0032268; GO:0071318 QRTQEIETR 7.820000172 1 1 0.256798668 1159.725851 0 0 0 0 0 0 0 18.72843 0 0 0 18.01064 0 0 0 0 0 0 0 17.54629 16.7994 0 0 0 0 0 0 0 0 16.93907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38274 0 0 0 Q8WYP3 RIN2_HUMAN Ras and Rab interactor 2 (Ras association domain family 4) (Ras inhibitor JC265) (Ras interaction/interference protein 2) RIN2 RASSF4 Homo sapiens (Human) endocytosis [GO:0006897]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endocytic vesicle [GO:0030139] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0005085; GO:0005096; GO:0005829; GO:0006897; GO:0007264; GO:0010595; GO:0030139; GO:0030695; GO:0031267; GO:1904906; GO:2001214 STKMQK 13.96000004 0.224074885 0.224074885 0.142765 722.039778 17.03507 17.16279 13.83602 11.33803 13.34351 17.47029 16.33422 14.23722 17.58947 14.85276 12.60822 16.27901 13.17381 16.26168 14.8131 14.14104 13.12107 13.72988 15.54025 15.2578 17.21764 16.17231 15.42996 16.04162 13.11986 16.93398 0 13.12141 15.96662 18.01436 10.82406 17.253 19.32731 15.40167 15.31435 16.84284 14.32202 15.60239 0 15.58939 16.3122 0 14.6732 14.60604 15.84793 16.63379 14.18252 14.37176 Q8WYP5 ELYS_HUMAN Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1) AHCTF1 ELYS TMBS62 MSTP108 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] DNA binding [GO:0003677] GO:0000776; GO:0003677; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007049; GO:0015031; GO:0016363; GO:0031965; GO:0032465; GO:0051028; GO:0051292; GO:0051301; GO:0070062 HMYEVCQEMGLMEDLLK 4.860000134 1 1 0.174380972 2125.998438 0 0 0 0 14.96274 12.90698 0 0 0 0 0 0 0 0 0 0 14.71159 16.41685 0 0 0 0 0 0 0 14.68443 0 0 0 0 0 15.97316 14.28956 15.63809 0 0 0 0 0 0 0 0 0 0 0 15.62199 0 0 Q8WYQ4 CV015_HUMAN Uncharacterized protein C22orf15 (Protein N27C7-3) C22orf15 Homo sapiens (Human) IIKGEDMASTR 12.72999954 1 1 2.36E-13 1229.919166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYQ5 DGCR8_HUMAN Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8) DGCR8 C22orf12 DGCRK6 LP4941 Homo sapiens (Human) primary miRNA processing [GO:0031053] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517]; primary miRNA processing [GO:0031053] double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517] GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016604; GO:0020037; GO:0031053; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0140517 GSFSKGR 2.720000029 1 1 0.234549878 738.9901544 0 0 0 6.39463 14.61422 15.54881 0 0 15.99627 15.46039 12.87579 15.93516 16.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.85557 16.14485 0 0 0 0 0 16.4554 15.41136 0 14.89047 0 16.32885 0 0 Q8WYQ9 ZCH14_HUMAN Zinc finger CCHC domain-containing protein 14 (BDG-29) ZCCHC14 KIAA0579 Homo sapiens (Human) nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270] nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270] GO:0003676; GO:0008270; GO:0035091 GSADMK 9.529999733 0.001094674 0.001094674 0.159511307 622.2208477 17.72236 0 15.99044 0 15.36656 14.09927 13.62146 0 0 18.58613 0 0 18.18282 0 0 0 0 16.37434 0 16.66196 0 0 14.29154 17.70412 17.46215 13.8423 0 0 14.02877 16.27209 0 16.86969 0 17.03724 0 0 0 14.78099 17.75843 0 13.43403 0 14.27366 0 14.40409 16.71215 0 16.97717 Q8WZ42 TITIN_HUMAN "Titin, EC 2.7.11.1 (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)" TTN Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] GO:0000794; GO:0002020; GO:0003300; GO:0004674; GO:0004712; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733 AEGGK 9.210000038 0.97248888 0.97248888 0.317457129 462.879855 16.48178 0 15.60743 16.13548 15.23758 0 16.09977 16.73797 16.22259 16.60384 16.31387 14.61548 15.80146 16.2731 16.66769 15.63956 15.6334 15.9097 16.5074 16.01224 14.74375 14.63676 0 0 16.44362 15.44707 16.37677 16.60459 16.70648 17.46128 0 15.32026 15.62217 0 0 0 15.87402 16.38001 14.90153 15.91189 0 14.61609 16.38798 15.55732 0 16.58674 0 0 Q8WZ59 TM190_HUMAN Transmembrane protein 190 TMEM190 MDAC1 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; protein self-association [GO:0043621]; hematopoietic progenitor cell differentiation [GO:0002244] protein self-association [GO:0043621] GO:0002079; GO:0002244; GO:0005634; GO:0016021; GO:0043621 RDVLHMPGFLAGPCDMSK 3.829999924 1 1 2.75E-12 2046.483317 15.89292 0 11.2831 0 0 14.50802 15.95857 0 11.87154 0 12.35585 0 0 0 0 0 0 0 0 0 0 0 14.25018 0 13.54081 13.16403 0 0 0 0 0 17.70987 0 0 0 0 0 0 0 0 14.74852 0 13.26558 0 0 0 14.28512 0 Q8WZ60 KLHL6_HUMAN Kelch-like protein 6 KLHL6 Homo sapiens (Human) B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617] B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617] GO:0002467; GO:0009617; GO:0050853 MLMAGQRGAWTMGDVVEK 4.139999866 1 1 0.348823206 2028.057294 0 7.738597 13.31211 0 14.50706 16.61062 17.16034 0 0 15.68457 0 0 16.95699 0 0 11.35248 0 0 0 0 0 0 0 17.07046 0 0 0 0 0 0 14.8077 0 0 0 0 0 0 0 17.88151 0 0 0 0 0 0 0 16.16327 0 Q8WZ64 ARAP2_HUMAN "Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 (Centaurin-delta-1, Cnt-d1) (Protein PARX)" ARAP2 CENTD1 KIAA0580 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]" "GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" GO:0005096; GO:0005547; GO:0005737; GO:0007165; GO:0043547; GO:0046872 IGISPTGHRR 11.22999954 1 1 0.370498245 1093.705333 16.54746 16.77908 0 0 16.35665 16.42852 0 0 16.94175 16.30645 17.8577 16.03091 0 17.26242 0 0 0 0 0 0 18.06498 0 0 16.74 16.51019 0 16.88187 0 0 0 17.65717 16.94416 17.11241 17.52365 16.38495 18.34849 19.05302 17.43512 19.26603 0 19.45396 18.8536 18.40493 0 0 0 17.01167 0 Q8WZ73 RFFL_HUMAN "E3 ubiquitin-protein ligase rififylin, EC 2.3.2.27 (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2, CARP-2) (FYVE-RING finger protein Sakura, Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like) (RING-type E3 ubiquitin transferase rififylin)" RFFL RNF189 RNF34L Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] GO:0002020; GO:0002039; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0010008; GO:0010762; GO:0010804; GO:0016020; GO:0019901; GO:0031625; GO:0032006; GO:0043161; GO:0046872; GO:0055038; GO:0061630; GO:0070936; GO:1901796; GO:1901797; GO:1902042; GO:2001271 MQAYSNPGYSSFPSPTGLEPSCK 10.14999962 1 1 4.57E-12 2522.274069 0 15.04106 14.13084 0 14.32509 14.90573 0 0 0 16.70994 16.03246 14.56881 0 0 0 15.12074 14.29397 14.48584 13.82649 0 16.39149 14.99801 16.45243 0 15.4197 16.09851 0 14.72986 17.37293 0 18.36417 0 16.54077 13.06788 17.44596 0 0 16.75732 12.92583 15.98552 14.93889 0 16.3718 0 0 0 0 15.35763 Q8WZ74 CTTB2_HUMAN "Cortactin-binding protein 2, CortBP2" CTTNBP2 C7orf8 CORTBP2 KIAA1758 Homo sapiens (Human) brain development [GO:0007420]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274] cell cortex [GO:0005938]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic actin cytoskeleton [GO:0098871]; synaptic vesicle [GO:0008021] cell cortex [GO:0005938]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic actin cytoskeleton [GO:0098871]; synaptic vesicle [GO:0008021]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274] SH3 domain binding [GO:0017124] GO:0005938; GO:0007420; GO:0008021; GO:0017124; GO:0043197; GO:0098871; GO:0098978; GO:1905274 QMAAGFSCEIVR 4.260000229 1 1 0.283821092 1386.350997 13.7297 16.0686 15.29422 15.15851 0 15.95052 0 0 15.10179 0 0 15.19487 0 0 0 15.93063 0 14.24372 0 16.88458 0 0 0 0 0 0 0 0 16.72802 16.34415 16.99383 0 0 17.27956 0 0 0 0 18.55361 0 16.75266 0 0 0 17.04268 0 0 17.49952 Q8WZ75 ROBO4_HUMAN Roundabout homolog 4 (Magic roundabout) ROBO4 UNQ421/PRO3674 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334] axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334] cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023] GO:0001525; GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0030334; GO:0030424; GO:0038023; GO:0061028; GO:0070062; GO:0070593; GO:0098632 STSGSRDLSSSSSLSSR 3.710000038 1 1 0.306799117 1704.522621 16.0972 15.087 14.55542 15.26581 13.01132 0 10.8517 0 12.11526 15.59264 0 0 0 14.8024 15.10636 0 14.96664 0 13.09445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ92 OR5P2_HUMAN Olfactory receptor 5P2 (Olfactory receptor-like protein JCG3) OR5P2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 TSNNDIT 1.639999986 1 1 0.208225275 764.9217156 0 0 17.9647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZA0 LZIC_HUMAN Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein) LZIC Homo sapiens (Human) beta-catenin binding [GO:0008013] beta-catenin binding [GO:0008013] GO:0008013 QPGQLRTR 8.5 0.047125209 0.047125209 0.086839847 955.6622408 0 0 0 17.41454 0 12.56791 16.02086 11.2561 17.17977 13.75003 13.69458 16.08143 13.91667 0 16.16681 14.42936 17.8011 15.91854 14.5377 0 16.95356 14.35635 0 13.68512 0 0 10.26961 15.24748 13.42415 0 0 0 0 13.19243 16.6502 15.90384 14.22227 16.62599 0 16.15872 0 0 15.33672 0 0 0 8.79074 16.8944 Q8WZA1 PMGT1_HUMAN "Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1, POMGnT1, EC 2.4.1.- (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2, GnT I.2)" POMGNT1 MGAT1.2 UNQ746/PRO1475 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]" "acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]" GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223 LLSEAEVLDHSK 3.700000048 0.689407289 0.689407289 0.467972689 1340.379833 0 18.21741 0 16.66738 0 0 0 0 0 0 18.28543 0 0 0 0 0 0 0 0 0 0 0 0 0 19.19649 0 19.97056 18.16102 0 0 0 0 18.87937 0 0 0 0 18.97894 0 0 0 18.01298 0 0 0 0 0 0 Q8WZB0 CI130_HUMAN Putative uncharacterized protein ERCC6L2-AS1 (ERCC6L2 antisense RNA 1) (Nasopharyngeal carcinoma-associated gene 12 protein) ERCC6L2-AS1 C9orf130 LINC00476 NAG12 Homo sapiens (Human) GIPAKVATK 2.00999999 0.000619961 0.000619961 0.278087535 883.6488942 0 0 0 0 0 0 0 0 0 20.38905 0 0 0 17.79109 17.57072 0 0 17.47842 0 0 16.54377 0 0 19.56706 0 0 20.7271 19.14252 0 0 0 18.10797 0 0 20.50316 0 0 0 0 0 0 0 16.26767 0 17.07752 0 0 0 Q92185 SIA8A_HUMAN "Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase, EC 2.4.99.8 (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A, SIAT8-A) (Sialyltransferase St8Sia I, ST8SiaI)" ST8SIA1 SIAT8 SIAT8A Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular response to heat [GO:0034605]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell population proliferation [GO:0008284]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; carbohydrate metabolic process [GO:0005975]; cellular response to heat [GO:0034605]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell population proliferation [GO:0008284]; protein glycosylation [GO:0006486]" "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]" GO:0000139; GO:0003828; GO:0005975; GO:0006486; GO:0006491; GO:0006688; GO:0008284; GO:0008373; GO:0009311; GO:0016021; GO:0034605 KSGCGR 8.170000076 1 1 0.293349324 664.9631683 0 0 17.54246 0 0 0 0 0 20.86227 0 0 0 0 0 0 19.91826 0 0 0 16.80654 0 20.8801 18.18279 0 18.83417 21.82355 0 18.54815 0 0 19.54991 0 19.1168 0 0 17.82056 0 0 0 0 0 0 0 0 0 0 0 0 Q92499 DDX1_HUMAN "ATP-dependent RNA helicase DDX1, EC 3.6.4.13 (DEAD box protein 1) (DEAD box protein retinoblastoma, DBP-RB)" DDX1 Homo sapiens (Human) "defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669] "cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712] GO:0000245; GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006446; GO:0008143; GO:0010494; GO:0016020; GO:0016887; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904 LGKSHIR 12.68000031 1 1 0.119571085 809.0746724 0 16.89331 0 0 16.09954 0 17.28424 0 15.70555 0 0 0 0 0 16.09405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92503 S14L1_HUMAN SEC14-like protein 1 SEC14L1 SEC14L Homo sapiens (Human) choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536] RIG-I binding [GO:0039552] GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087 RSPQPPK 8.180000305 1 1 0.247758345 809.5593192 0 18.65308 17.1371 0 17.21484 0 0 0 0 19.98959 0 0 0 0 18.70925 0 0 0 17.89729 16.78501 0 18.03469 0 0 0 0 18.93923 0 0 0 0 20.5251 0 0 0 0 0 21.75088 0 0 0 0 17.37375 0 0 0 17.12209 18.37161 Q92504 S39A7_HUMAN "Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7, ZIP7)" SLC39A7 HKE4 RING5 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577] zinc ion transmembrane transporter activity [GO:0005385] GO:0005385; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006882; GO:0016020; GO:0016021; GO:0071577 EASPLQSLLEVLGLLGGVIMMVLIAHLE 3.900000095 1 1 4.57E-13 2977.230044 14.79686 0 0 0 13.60652 14.21678 0 13.09695 0 13.6031 13.96597 12.66834 13.57366 0 0 0 0 14.00842 11.60835 15.94016 14.11826 0 14.30286 13.67755 0 8.964761 0 14.51054 13.44011 14.72532 0 0 0 0 0 0 0 15.77772 0 0 14.84943 14.38586 12.02861 0 0 0 0 0 Q92508 PIEZ1_HUMAN "Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment, Mib) (Protein FAM38A)" PIEZO1 FAM38A KIAA0233 Homo sapiens (Human) cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381] GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0016020; GO:0016021; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260 MAGVNTDR 7.880000114 1 1 1.15E-13 878.3233144 0 0 0 0 0 0 11.7845 0 0 0 0 0 16.52965 0 0 0 16.26808 0 0 0 0 0 0 0 0 0 15.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92519 TRIB2_HUMAN "Tribbles homolog 2, TRB-2" TRIB2 TRB2 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405] mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106] GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629 CLIRSILR 9.819999695 0.481147856 0.481147856 0.160790946 1030.422201 14.87401 8.863749 0 0 0 0 0 0 0 0 0 0 14.43414 14.58733 16.87955 0 10.61946 0 0 0 0 12.3022 0 15.37055 0 15.24226 12.44362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01094 16.51881 0 0 0 Q92520 FAM3C_HUMAN Protein FAM3C (Interleukin-like EMT inducer) FAM3C ILEI GS3786 Homo sapiens (Human) negative regulation of gluconeogenesis [GO:0045721] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]; cytokine activity [GO:0005125]; negative regulation of gluconeogenesis [GO:0045721] cytokine activity [GO:0005125] GO:0005125; GO:0005576; GO:0005615; GO:0005794; GO:0031089; GO:0045721; GO:0070062 LIADLGSTSITNLGFR 5.050000191 0.418883264 0.418883264 0.02050179 1677.929843 0 16.09701 17.77161 17.58355 13.24672 15.8003 0 16.16068 14.44259 0 15.79677 0 14.74687 16.78671 15.83724 0 14.77305 14.15269 19.91124 15.43588 16.52386 0 16.09466 17.64274 0 0 0 15.71604 0 15.70865 0 18.66306 0 0 15.64476 17.04626 0 18.72279 19.47734 0 13.23397 0 18.01609 17.21582 14.56786 14.44651 16.77786 0 Q92527 ANKR7_HUMAN Ankyrin repeat domain-containing protein 7 (Testis-specific protein TSA806) ANKRD7 Homo sapiens (Human) centrosome [GO:0005813]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; nucleoplasm [GO:0005654] GO:0005654; GO:0005813 DSENKSPLIK 1.389999986 1 1 0.229467899 1129.771444 16.33839 0 0 16.03625 11.86379 11.48816 0 0 0 15.28527 14.50734 16.82826 0 11.99127 14.9549 15.16985 0 0 0 0 15.11513 0 0 0 15.83763 0 15.56935 14.41019 15.90239 0 15.80937 0 0 0 0 0 0 0 0 0 0 0 0 16.48296 0 0 0 0 Q92529 SHC3_HUMAN "SHC-transforming protein 3 (Neuronal Shc, N-Shc) (Protein Rai) (SHC-transforming protein C) (Src homology 2 domain-containing-transforming protein C3, SH2 domain protein C3)" SHC3 NSHC SHCC Homo sapiens (Human) central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] GO:0001784; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007417; GO:0019901; GO:0030971; GO:0035556 APAMSAAR 2.329999924 0.558652997 0.558652997 0.30384326 775.0511713 15.13773 16.57634 0 14.31415 0 13.59528 12.16524 0 0 16.29097 15.34833 14.66763 15.71618 15.03923 0 15.87071 16.18103 0 15.24224 16.00643 14.33458 15.68061 16.63584 17.40408 16.35568 16.86597 16.66529 0 15.47156 15.34203 15.23958 15.04885 17.53783 0 15.76639 16.33637 17.25513 16.21977 13.2802 0 16.07263 14.77957 15.51037 16.10807 16.73538 15.21091 15.29323 16.09497 Q92538 GBF1_HUMAN "Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1, BFA-resistant GEF 1" GBF1 KIAA0248 Homo sapiens (Human) "cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; cilium assembly [GO:0060271]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] "cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; cilium assembly [GO:0060271]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" "guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]" GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005793; GO:0005794; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006888; GO:0006890; GO:0006892; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0016020; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0060271; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 FVGTDPASDEVVLMKILQVLR 1.00999999 1 1 0.020135944 2347.132829 0 14.294 0 10.00188 11.65655 13.15966 0 0 12.8356 12.64634 0 0 0 13.2466 0 0 0 14.19898 0 0 0 0 0 0 0 14.05489 12.61084 0 0 0 0 0 0 0 0 0 12.87462 0 0 11.87948 0 0 0 0 0 0 0 0 Q92540 SMG7_HUMAN "Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog, hSMG-7)" SMG7 C1orf16 EST1C KIAA0250 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]" protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0045111; GO:0051721; GO:0070034 QNVAVQVK 12.56000042 0.866149724 0.866149724 0.253100938 886.3127801 15.69776 15.06133 15.72361 14.35103 15.62804 15.79989 15.8539 15.84113 0 15.31009 16.47122 16.22906 14.1942 16.01023 15.05853 0 0 14.3656 15.76662 16.50178 15.70452 14.52343 15.37249 15.87475 16.67526 16.40275 14.93065 0 0 15.03503 14.91362 15.6356 17.10805 0 0 0 0 0 0 14.60477 0 0 14.54421 15.023 15.22185 15.07448 0 16.03726 Q92541 RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog RTF1 KIAA0252 Homo sapiens (Human) blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697] GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0051571; GO:0080182; GO:1990269 AMAEDLGDQDK 10.52999973 0.551635206 0.551635206 0.295381283 1207.985608 15.15685 0 0 15.44678 0 0 0 0 11.89367 0 16.15261 0 0 0 0 0 0 14.57376 0 16.55615 0 0 0 16.69977 0 0 0 0 15.20759 15.6146 0 0 0 0 0 0 16.1986 15.36267 17.48644 18.92861 0 16.60346 0 0 0 0 0 0 Q92543 SNX19_HUMAN Sorting nexin-19 SNX19 KIAA0254 Homo sapiens (Human) chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073] phosphatidylinositol binding [GO:0035091] GO:0002062; GO:0005737; GO:0006887; GO:0030073; GO:0031901; GO:0035091; GO:0043231; GO:1990502 TETVPPFQETPAGSSCHLNNLLSSRK 2.660000086 1 1 0.195024039 2871.045738 0 0 0 0 0 12.44796 0 14.54371 0 0 0 0 10.00373 0 0 13.89702 12.44817 13.57408 12.07747 0 0 12.68277 15.05975 0 0 0 0 0 0 0 15.52336 14.77083 0 14.80703 0 13.6646 0 13.81098 15.88311 14.01569 0 0 10.81004 0 17.34438 0 0 0 Q92545 TM131_HUMAN Transmembrane protein 131 (Protein RW1) TMEM131 KIAA0257 RW1 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 LTKAASLPGK 8.859999657 1 1 0.243693847 984.7559424 12.68069 16.26805 13.41486 0 15.33476 13.54461 15.91301 14.22519 14.70499 17.32816 16.22661 16.08346 15.18116 14.88835 15.73444 0 0 15.04776 16.64359 16.98228 14.19557 16.90403 15.02736 16.32646 0 15.5114 0 0 15.02413 0 15.31069 13.78939 0 14.21393 14.23904 0 16.98914 0 17.09891 15.54807 14.89255 0 15.29979 15.85186 0 13.94054 14.05702 0 Q92547 TOPB1_HUMAN "DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1, TopBP1) (DNA topoisomerase II-binding protein 1)" TOPBP1 KIAA0259 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022] GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0042802; GO:0043231; GO:0070532 ESAPSNGSGK 4.550000191 0.001367114 0.001367114 0.285401558 933.1878594 16.90391 16.33356 18.07201 0 0 16.689 18.94517 0 14.93346 17.61236 0 0 0 0 0 0 15.89181 0 0 16.50692 17.75397 17.15289 0 19.02401 18.42695 0 17.24045 0 0 17.44251 18.57345 18.79001 16.72696 16.27053 0 0 0 0 0 16.49012 17.31075 0 0 18.18223 16.76018 0 0 0 Q92552 RT27_HUMAN "28S ribosomal protein S27, mitochondrial, MRP-S27, S27mt (Mitochondrial ribosomal protein S27) (Mitochondrial small ribosomal subunit protein mS27)" MRPS27 KIAA0264 Homo sapiens (Human) cell population proliferation [GO:0008283]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell population proliferation [GO:0008283]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049] GO:0000049; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005763; GO:0008283; GO:0019843; GO:0032543; GO:0070131; GO:0097177 AAKASA 4.139999866 1 1 0.281620008 519.7184585 16.25224 15.48991 16.25913 16.03843 13.87748 0 16.44602 0 16.4912 0 0 0 0 0 0 0 0 0 15.11924 0 0 0 0 0 0 0 0 16.29208 0 0 0 0 0 0 15.90339 0 0 0 0 0 0 16.75451 0 0 0 0 16.23755 16.00423 Q92556 ELMO1_HUMAN Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of catalytic activity [GO:0050790]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of catalytic activity [GO:0050790]" SH3 domain binding [GO:0017124] GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0050790 EKGALK 12.43999958 0.405509353 0.405509353 0.307362967 642.6980509 15.38751 16.08564 16.08367 14.90389 15.60226 17.18653 16.2686 0 13.9202 0 16.13592 0 16.0491 15.91778 14.87233 15.49092 0 15.95303 15.52466 16.39857 16.28662 16.33931 0 15.63887 15.57003 0 15.70862 0 0 17.29413 16.14023 0 16.02027 0 16.29536 0 0 0 0 16.19675 16.16844 0 16.36403 0 17.01619 0 0 16.68511 Q92560 BAP1_HUMAN "Ubiquitin carboxyl-terminal hydrolase BAP1, EC 3.4.19.12 (BRCA1-associated protein 1) (Cerebral protein 6)" BAP1 KIAA0272 hucep-6 Homo sapiens (Human) "cellular protein modification process [GO:0006464]; chromatin organization [GO:0006325]; macrophage homeostasis [GO:0061519]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843]; cellular protein modification process [GO:0006464]; chromatin organization [GO:0006325]; macrophage homeostasis [GO:0061519]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; ubiquitin-dependent protein catabolic process [GO:0006511]" chromatin binding [GO:0003682]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843] GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006464; GO:0006511; GO:0008233; GO:0008285; GO:0010035; GO:0016579; GO:0035517; GO:0035520; GO:0035522; GO:0045892; GO:0050727; GO:0051726; GO:0061519; GO:0071108; GO:1900015; GO:1903955 EVVEATDSR 17.51000023 1 1 0.232375176 1004.974819 12.74335 17.22516 0 0 12.22568 16.1607 17.25777 13.60601 10.17261 15.49332 14.84063 16.72843 15.37881 14.06457 0 0 17.07745 0 0 17.45246 0 0 17.08832 0 15.79134 18.788 0 17.37114 0 15.36744 14.61776 15.48421 0 0 17.04121 14.017 13.08321 0 13.98015 14.60183 13.11836 17.37712 14.89185 18.84724 16.39604 16.06966 0 17.16679 Q92562 FIG4_HUMAN "Polyphosphoinositide phosphatase, EC 3.1.3.-, EC 3.1.3.36, EC 3.1.3.86 (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4, EC 3.1.3.16)" FIG4 KIAA0274 SAC3 Homo sapiens (Human) locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; protein dephosphorylation [GO:0006470]; vacuole organization [GO:0007033] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037] "early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; protein dephosphorylation [GO:0006470]; vacuole organization [GO:0007033]" "phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]" GO:0000139; GO:0004438; GO:0004439; GO:0005783; GO:0005811; GO:0006470; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037 DIMQTLSR 3.559999943 1 1 0.253722645 963.2003361 16.50519 16.37955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92565 RPGF5_HUMAN "Rap guanine nucleotide exchange factor 5 (Guanine nucleotide exchange factor for Rap1) (M-Ras-regulated Rap GEF, MR-GEF) (Related to Epac, Repac)" RAPGEF5 GFR KIAA0277 MRGEF Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005634; GO:0005654; GO:0005886; GO:0007264; GO:0007265; GO:0007399; GO:0016604; GO:0030742; GO:0043547 HTVDEYSPQKK 5.920000076 1 1 0.43395725 1332.887917 13.33498 0 15.84051 0 15.59689 15.14406 14.97221 0 0 11.62807 15.47106 13.47307 0 0 0 0 0 0 0 0 0 0 0 15.18047 0 15.42701 15.81758 0 0 16.11994 0 16.2398 0 0 15.49575 16.08401 0 0 0 15.207 15.40743 15.71667 0 0 0 0 15.62918 15.36108 Q92569 P55G_HUMAN "Phosphatidylinositol 3-kinase regulatory subunit gamma, PI3-kinase regulatory subunit gamma, PI3K regulatory subunit gamma, PtdIns-3-kinase regulatory subunit gamma (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma, PI3-kinase subunit p55-gamma, PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK)" PIK3R3 Homo sapiens (Human) B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; T cell differentiation [GO:0030217] "cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]" "cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; T cell differentiation [GO:0030217]" 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784] GO:0001784; GO:0001934; GO:0002042; GO:0005829; GO:0005942; GO:0005943; GO:0006955; GO:0008286; GO:0010628; GO:0016303; GO:0030183; GO:0030217; GO:0030335; GO:0043491; GO:0043551; GO:0046854; GO:0046935; GO:2000811 DASTKMQGDYTLTLR 1.889999986 1 1 0.053978861 1715.663028 0 15.61249 0 0 0 0 0 0 0 0 0 0 0 17.5615 0 15.21168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.83552 0 0 13.82555 10.87614 0 17.22783 12.10253 14.07952 0 13.67388 13.32718 0 0 0 0 Q92576 PHF3_HUMAN PHD finger protein 3 PHF3 KIAA0244 Homo sapiens (Human) "transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription, DNA-templated [GO:0006351]" metal ion binding [GO:0046872] GO:0005634; GO:0006351; GO:0046872 HREGEK 9.130000114 0.757260561 0.757260561 0.203388587 755.5651458 0 16.37456 14.64774 10.86839 16.16614 14.25487 0 15.51785 0 0 15.08424 0 0 14.10052 15.19161 15.46191 15.02654 15.11939 0 15.21317 0 0 14.90556 0 16.48189 15.44749 13.39342 0 15.11805 0 16.57531 16.48753 15.82392 0 0 16.92258 0 15.52203 0 0 0 0 0 0 16.6769 16.67316 16.46288 0 Q92598 HS105_HUMAN Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) HSPH1 HSP105 HSP110 KIAA0201 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; response to unfolded protein [GO:0006986] adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006986; GO:0016887; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682 NGGVGIK 9.760000229 1 1 0.169366928 644.7509906 0 14.21986 0 14.37965 0 15.33172 0 15.36673 0 0 0 12.93079 14.87695 15.56496 0 0 16.19989 0 0 0 0 0 0 0 0 0 14.8314 0 0 0 14.95528 15.60829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.51301 0 Q92608 DOCK2_HUMAN Dedicator of cytokinesis protein 2 DOCK2 KIAA0209 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; T cell receptor binding [GO:0042608] GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005085; GO:0005096; GO:0005576; GO:0005829; GO:0005856; GO:0006935; GO:0007264; GO:0016020; GO:0030036; GO:0035580; GO:0042608; GO:0044351; GO:0045059; GO:0045060; GO:0046633; GO:0050766; GO:0051056; GO:0070062 MDLKDTGAK 10.05000019 1 1 0.112746927 995.9917754 0 17.31569 0 0 0 0 15.52653 0 0 0 0 0 15.16091 0 0 0 0 0 0 0 0 0 0 0 13.94686 0 16.22371 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68843 0 0 0 15.03544 0 0 0 Q92609 TBCD5_HUMAN TBC1 domain family member 5 TBC1D5 KIAA0210 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]" autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904] "autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]" AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394] GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:0090630; GO:1905394 GADLMNKSR 3.25999999 1 1 0.047736588 1005.508219 16.59126 0 0 0 0 12.10239 14.16757 0 13.72392 0 15.5549 12.8331 0 0 0 0 0 0 0 11.05792 0 0 14.51484 0 16.37288 15.71634 0 0 14.42194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92610 ZN592_HUMAN Zinc finger protein 592 ZNF592 KIAA0211 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 VPTEPPATSVAARSSSLPSGR 5.820000172 1 1 0.057169408 2070.327016 13.45483 0 14.48889 10.99589 0 15.23896 0 12.82042 0 0 0 0 0 0 0 0 15.28596 0 0 0 0 0 0 0 0 0 0 14.30062 0 0 0 0 0 15.13379 0 12.85654 14.32836 15.38087 0 0 14.23729 0 0 14.78383 0 0 0 0 Q92613 JADE3_HUMAN Protein Jade-3 (Jade family PHD finger protein 3) (PHD finger protein 16) JADE3 KIAA0215 PHF16 Homo sapiens (Human) histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654] histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872] GO:0000123; GO:0005654; GO:0006275; GO:0006357; GO:0016570; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:2000278 KDLISAMK 26.69000053 0.327433974 0.327433974 0.219900277 921.8300055 16.48532 17.17877 18.28394 0 15.15207 17.76944 17.39176 17.31439 0 16.77118 0 17.09865 19.5141 17.4849 15.89567 16.02733 17.23403 0 18.33472 16.81931 16.9069 0 16.80524 18.25707 17.80903 16.82632 0 16.99996 17.6384 16.21573 16.14623 0 16.77914 15.06136 0 17.43606 15.02529 17.34208 17.43656 17.44819 17.47126 14.83728 18.33405 15.69882 0 16.85333 12.83011 0 Q92614 MY18A_HUMAN "Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus, MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210, SP-R210)" MYO18A CD245 KIAA0216 MYSPDZ TIAF1 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030] actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802] "actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]" "actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]" GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0008094; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028 AAVAQASR 2.710000038 0.718945146 0.718945146 0.002898312 774.0747368 14.85918 15.45249 15.00851 13.96578 14.58381 0 17.0562 0 0 14.69671 14.76292 0 15.65389 0 0 0 18.48737 13.98372 16.62709 14.90965 0 15.50991 15.26195 0 0 0 16.3789 14.83859 11.37983 17.66287 18.06074 0 0 0 0 0 0 8.398017 0 0 15.22939 14.40753 14.54456 13.09498 0 0 17.09134 17.55012 Q92616 GCN1_HUMAN "eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1, HsGCN1)" GCN1 GCN1L1 KIAA0219 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]" "cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]" GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253 ALGAMVK 4 0.737196982 0.737196982 0.253728476 684.7752634 13.44243 14.04136 16.52035 16.50547 0 16.99167 0 15.62242 15.36865 0 13.63343 0 14.93198 0 0 14.93774 15.31233 15.733 15.43941 0 17.08115 0 0 16.04164 0 0 15.01863 15.14812 12.80977 0 0 16.9907 16.36095 0 0 0 0 0 0 0 15.63857 0 15.55106 0 15.72375 0 0 15.79075 Q92617 NPIB3_HUMAN Nuclear pore complex-interacting protein family member B3 (Nuclear pore complex-interacting protein-like 3) (Protein pps22-1) NPIPB3 KIAA0220 NPIPL3 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 MIISR 4.650000095 0.615680993 0.615680993 0.30453089 636.7161222 16.08992 14.40082 15.40997 14.87649 0 14.17028 16.60436 0 15.68284 0 0 0 15.38489 15.09046 0 0 15.71776 16.84326 16.21951 0 0 16.44159 15.6144 0 0 0 16.3378 15.18768 0 0 0 0 0 18.03404 0 15.09433 0 0 0 0 0 0 0 17.54925 16.64577 0 17.00384 0 Q92618 ZN516_HUMAN Zinc finger protein 516 ZNF516 KIAA0222 Homo sapiens (Human) "adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]" nucleus [GO:0005634] "nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162; GO:0140297 AASMPK 8.159999847 1 1 0.281227449 619.8260081 16.34196 15.01713 16.01623 16.35204 16.66876 14.80961 0 17.06317 0 0 16.15403 15.91984 15.86603 15.43488 16.87453 17.27519 15.36877 16.58509 0 0 17.55099 18.07427 18.91678 17.7244 0 16.82586 0 16.42668 0 15.59191 16.48418 0 13.43441 16.37306 16.70067 0 17.69428 15.92128 15.66753 15.33421 17.0115 15.06798 17.22461 16.11832 15.78141 0 0 18.3205 Q92619 HMHA1_HUMAN "Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1, mHag HA-1 ]" ARHGAP45 HMHA1 KIAA0223 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:0016020; GO:0032587; GO:0034774; GO:0035578; GO:0046872; GO:0051056; GO:0090630 TTLEMEFAK 1.230000019 1 1 0.252323066 1086.452757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.04711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92620 PRP16_HUMAN "Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16, EC 3.6.4.13 (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)" DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0071013 KEQGEPMTPR 4.150000095 1 1 0.121153841 1188.65071 0 0 0 0 0 0 0 0 15.21842 0 0 12.54589 14.89708 0 0 0 14.89108 0 0 0 0 0 0 0 0 14.48109 13.30821 13.27836 13.74517 12.62907 15.26199 15.92414 10.71773 0 13.28473 0 14.51971 13.73705 15.88363 14.72471 12.33445 0 10.82028 15.44772 11.9529 0 0 0 Q92621 NU205_HUMAN Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] structural constituent of nuclear pore [GO:0017056] GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292 DLPSADSVQYRHLPSR 4.010000229 0.611885071 0.611885071 0.437053685 1840.700139 0 0 15.60899 15.02159 15.88083 14.56591 0 0 0 17.25552 16.35347 15.07555 0 0 0 0 0 0 0 0 0 0 0 15.77568 0 14.88532 0 0 0 0 0 0 0 0 0 0 0 0 17.45374 0 0 0 16.87979 0 0 17.01172 0 0 Q92622 RUBIC_HUMAN "Run domain Beclin-1-interacting and cysteine-rich domain-containing protein, Rubicon (Beclin-1 associated RUN domain containing protein, Baron)" RUBCN KIAA0226 Homo sapiens (Human) autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909] cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; phosphatidylinositol phosphate binding [GO:1901981]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909] phosphatidylinositol phosphate binding [GO:1901981] GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:0071985; GO:1901097; GO:1901981 MRPEGAGMELGGGEER 7.690000057 1 1 0.29012561 1691.645894 17.29365 17.13425 14.12077 16.18299 14.85191 0 0 0 15.66602 0 16.18391 14.84587 0 0 0 0 14.98308 0 0 13.23138 0 0 14.30073 0 15.36846 0 0 16.14327 17.05828 0 0 0 0 0 0 0 0 15.59898 0 0 14.4672 15.84381 0 0 0 0 0 0 Q92624 APBP2_HUMAN "Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2, APP-BP2) (Protein interacting with APP tail 1)" APPBP2 KIAA0228 PAT1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] microtubule motor activity [GO:0003777]; ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0003777; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005875; GO:0006886; GO:0030659; GO:0031462; GO:0043161; GO:0046907; GO:1990756 DHFGSK 3.579999924 0.540738344 0.540738344 0.225071409 687.70341 15.863 16.1811 0 0 13.94642 14.24705 15.45047 0 15.88828 0 16.32262 0 16.33218 14.85377 15.72303 0 15.30316 16.11413 0 16.01806 0 16.02514 16.16393 0 16.46977 0 14.42183 16.58227 16.07643 14.79678 16.62935 0 14.95173 16.92865 16.50401 0 0 16.13704 16.04809 0 15.40954 14.48385 0 16.99832 13.65967 14.981 15.79051 15.99104 Q92625 ANS1A_HUMAN Ankyrin repeat and SAM domain-containing protein 1A (Odin) ANKS1A ANKS1 KIAA0229 ODIN Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929] cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929] ephrin receptor binding [GO:0046875] GO:0005654; GO:0005829; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187 LEKSPSFASEWDEIEK 7.650000095 1 1 6.88E-13 1894.255969 13.98429 12.72388 0 13.7722 14.27754 12.00012 0 13.46386 14.87826 13.85201 0 0 0 0 0 13.48902 0 0 0 0 0 15.61997 0 0 0 0 15.89665 0 0 0 0 0 0 0 16.63097 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92628 K0232_HUMAN Uncharacterized protein KIAA0232 KIAA0232 Homo sapiens (Human) ATP binding [GO:0005524] ATP binding [GO:0005524] GO:0005524 DLYMENRK 9.289999962 0.601846099 0.601846099 0.138393167 1081.623496 0 0 0 13.90756 0 0 0 0 15.344 16.34331 0 0 0 0 15.78783 14.37127 13.01481 8.792977 0 0 0 0 17.31905 0 16.0208 0 0 0 0 0 13.60258 0 0 0 14.21511 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92633 LPAR1_HUMAN "Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1 (Lysophosphatidic acid receptor Edg-2)" LPAR1 EDG2 LPA1 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222] G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915] GO:0004930; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007193; GO:0007202; GO:0007204; GO:0008360; GO:0009986; GO:0010977; GO:0019222; GO:0022008; GO:0035025; GO:0035727; GO:0043123; GO:0043410; GO:0051482; GO:0051496; GO:0060326; GO:0070915 DTMMSLLK 3.349999905 1 1 5.79E-13 971.5768842 0 0 0 0 0 0 14.56668 0 15.83465 0 13.9374 0 0 0 0 0 0 0 0 0 13.32937 0 0 0 0 18.53009 0 0 0 0 15.07961 0 0 0 0 0 18.00055 0 0 0 0 0 0 0 0 0 0 0 Q92636 FAN_HUMAN "Protein FAN (Factor associated with neutral sphingomyelinase activation, Factor associated with N-SMase activation)" NSMAF FAN Homo sapiens (Human) ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165] sphingomyelin phosphodiesterase activator activity [GO:0016230] GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0043065 MAFIRK 13.81000042 1 1 0.253891313 766.1074411 0 0 18.50399 0 0 0 0 0 0 0 0 18.77558 0 0 0 0 16.11873 0 18.72795 0 17.83846 0 18.02468 18.05736 0 0 0 0 0 18.26789 0 0 0 0 0 0 0 0 18.72863 17.70733 0 0 0 0 0 0 17.20115 0 Q92665 RT31_HUMAN "28S ribosomal protein S31, mitochondrial, MRP-S31, S31mt (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)" MRPS31 IMOGN38 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543 ISFSNIISDMKVAR 22.12999916 1 1 0.089237808 1581.693285 16.91859 16.59265 0 17.01469 17.15144 0 16.91686 0 16.99022 18.08496 0 15.92993 17.1345 0 16.85267 16.73272 0 16.38634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29819 16.32967 Q92667 AKAP1_HUMAN "A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa, AKAP 149) (Dual specificity A-kinase-anchoring protein 1, D-AKAP-1) (Protein kinase A-anchoring protein 1, PRKA1) (Spermatid A-kinase anchor protein 84, S-AKAP84)" AKAP1 AKAP149 PRKA1 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915] protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723] GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0034237; GO:0140374 LELALTGGEAK 8.279999733 0.805916548 0.805916548 0.209573084 1101.979451 16.67626 17.9623 14.88122 13.14914 0 0 0 15.10966 13.55824 0 17.38532 0 18.32543 12.19048 15.23556 16.74974 0 13.34114 0 15.97266 14.97051 0 0 16.61213 14.37151 12.35041 0 0 8.263093 12.53321 20.76685 0 0 17.58029 14.55343 0 0 17.87462 0 0 15.35845 0 0 0 14.68288 14.58493 0 13.16511 Q92670 ZN75C_HUMAN Putative zinc finger protein 75C (Zinc finger protein 75C pseudogene) ZNF75CP ZNF75C Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GTTVAPGFK 5.360000134 1 1 0.092710947 877.67721 14.69975 0 15.41459 13.08738 0 14.10373 13.65305 13.26412 12.93291 11.71642 14.05064 15.39587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92673 SORL_HUMAN "Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats, LDLR relative with 11 ligand-binding repeats, LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats, SorLA)" SORL1 C11orf32 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910] cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910] amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005041; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0008283; GO:0009986; GO:0010008; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0016477; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032091; GO:0032585; GO:0034067; GO:0038020; GO:0042923; GO:0043025; GO:0043407; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0051604; GO:0055037; GO:0055038; GO:0070062; GO:0070863; GO:0097356; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137 AAQFVTR 9.130000114 0.103398941 0.103398941 0.266363551 792.0134836 19.68638 18.31146 18.60253 18.20602 18.10332 17.69473 17.66722 18.99152 19.19018 0 16.36448 16.39927 0 0 0 17.81496 0 0 16.67878 18.54111 17.84585 17.1997 17.90317 18.19494 17.79928 18.85821 16.81465 15.38395 15.16018 17.47396 19.27366 19.99809 19.63591 19.60453 18.45456 18.88009 17.3981 17.58348 17.88705 0 18.81495 18.78991 18.94481 0 0 15.95972 19.37935 19.39507 Q92729 PTPRU_HUMAN "Receptor-type tyrosine-protein phosphatase U, R-PTP-U, EC 3.1.3.48 (Pancreatic carcinoma phosphatase 2, PCP-2) (Protein-tyrosine phosphatase J, PTP-J, hPTP-J) (Protein-tyrosine phosphatase pi, PTP pi) (Protein-tyrosine phosphatase receptor omicron, PTP-RO) (Receptor-type protein-tyrosine phosphatase psi, R-PTP-psi)" PTPRU FMI PCP2 PTPRO Homo sapiens (Human) animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0007155; GO:0007185; GO:0008013; GO:0008285; GO:0030154; GO:0030336; GO:0031100; GO:0034109; GO:0034394; GO:0051384; GO:0090090; GO:2000049 RFLATFPLAAVSR 4.5 1 1 0.557527789 1446.422993 15.87338 17.61331 0 0 0 17.22845 0 0 16.81862 0 0 0 0 0 18.45861 0 0 0 0 0 16.3016 0 0 0 0 0 18.73429 0 0 0 18.82565 0 0 0 0 0 0 18.69888 0 0 0 0 0 0 18.12359 0 0 0 Q92736 RYR2_HUMAN "Ryanodine receptor 2, RYR-2, RyR2, hRYR-2 (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor)" RYR2 Homo sapiens (Human) calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005] calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018] calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; transmembrane transporter binding [GO:0044325]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; transmembrane transporter binding [GO:0044325] GO:0001666; GO:0002027; GO:0003143; GO:0003220; GO:0003300; GO:0005219; GO:0005262; GO:0005509; GO:0005513; GO:0005516; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0010460; GO:0010881; GO:0010882; GO:0014701; GO:0014808; GO:0014850; GO:0015278; GO:0016020; GO:0016529; GO:0019722; GO:0019899; GO:0030018; GO:0030659; GO:0031000; GO:0032991; GO:0033017; GO:0034236; GO:0034237; GO:0034704; GO:0035584; GO:0035994; GO:0042383; GO:0042802; GO:0043621; GO:0043924; GO:0044325; GO:0048763; GO:0051209; GO:0051284; GO:0051480; GO:0051775; GO:0055117; GO:0060048; GO:0060402; GO:0070296; GO:0071313; GO:0071872; GO:0072599; GO:0086005; GO:0086029; GO:0086064; GO:0097050; GO:0098735; GO:0098904; GO:0098907; GO:0098910; GO:0098911; GO:1901896 AAMVLFLDR 10.80000019 0.356092066 0.356092066 0.185489512 1051.389843 16.1272 15.81045 16.08691 16.54439 15.58122 16.92079 14.79489 14.67476 17.17809 14.29475 17.13747 15.60072 16.24803 15.46969 17.29147 15.85078 15.94224 16.24617 0 17.01233 14.58203 16.24424 15.37116 15.30366 16.67695 14.11676 0 0 0 15.65229 17.34024 16.60393 13.86106 16.7873 15.63509 14.22519 15.04456 14.83237 15.09987 14.03746 16.14375 15.24819 16.09816 15.28322 17.10042 16.82469 14.97716 16.25181 Q92737 RSLAA_HUMAN "Ras-like protein family member 10A, EC 3.6.5.2 (Ras-like protein RRP22) (Ras-related protein on chromosome 22)" RASL10A RRP22 Homo sapiens (Human) small GTPase mediated signal transduction [GO:0007264] nucleolus [GO:0005730]; plasma membrane [GO:0005886] nucleolus [GO:0005730]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005730; GO:0005886; GO:0007264 QRIAETRPAGAPEAPILVVGNK 4.630000114 1 1 0.415105126 2285.784438 0 0 0 0 0 18.2559 0 0 18.50603 0 16.47506 0 0 0 0 0 0 0 0 0 15.46922 0 17.69498 0 0 18.13718 0 0 0 0 17.27516 0 0 0 0 0 0 0 18.95734 0 0 0 0 0 0 0 18.1142 0 Q92738 US6NL_HUMAN "USP6 N-terminal-like protein (Related to the N-terminus of tre, RN-tre)" USP6NL KIAA0019 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]" GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0005829; GO:0005886; GO:0007030; GO:0019068; GO:0031267; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358 ARGCSPDIR 4.639999866 1 1 0 1030.917341 0 0 0 0 0 0 0 0 17.63594 15.87174 0 0 0 0 0 15.38292 0 0 0 0 12.39378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.19223 0 0 0 0 0 0 0 0 Q92743 HTRA1_HUMAN "Serine protease HTRA1, EC 3.4.21.- (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11)" HTRA1 HTRA PRSS11 Homo sapiens (Human) chorionic trophoblast cell differentiation [GO:0060718]; dentinogenesis [GO:0097187]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of defense response to virus [GO:0050687]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation [GO:0050679]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; chorionic trophoblast cell differentiation [GO:0060718]; dentinogenesis [GO:0097187]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of defense response to virus [GO:0050687]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation [GO:0050679]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0001890; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006508; GO:0008236; GO:0012501; GO:0019838; GO:0030512; GO:0030514; GO:0042802; GO:0043065; GO:0050679; GO:0050687; GO:0060718; GO:0062023; GO:0070062; GO:0097187 IDHQGK 7.010000229 1 1 0.08797757 697.993966 0 0 15.15333 0 0 0 0 0 0 0 0 0 0 0 16.15337 0 0 13.98477 0 0 0 0 0 0 0 13.5503 15.62064 15.19476 0 16.22483 15.72857 0 0 16.32065 0 0 0 0 0 0 0 0 0 0 0 15.37148 16.49157 0 Q92750 TAF4B_HUMAN "Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit, TAF(II)105, TAFII-105, TAFII105)" TAF4B TAF2C2 TAFII105 Homo sapiens (Human) mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367] DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251] GO:0001650; GO:0003677; GO:0005654; GO:0005669; GO:0005737; GO:0006367; GO:0006468; GO:0007283; GO:0016251; GO:0042789; GO:0046982; GO:0048477; GO:0051059; GO:0060261 VSSGPRLPAPQIVAVK 13.36999989 1 1 0.35319679 1619.306907 14.23778 15.03858 0 0 16.14178 0 0 16.3614 15.2109 17.41371 15.60717 15.74979 0 0 0 0 0 0 0 13.43952 0 0 0 15.81452 0 0 13.33625 0 0 0 0 0 0 0 0 17.05188 15.70206 14.10194 0 0 16.60237 16.6448 0 0 0 0 0 0 Q92752 TENR_HUMAN "Tenascin-R, TN-R (Janusin) (Restrictin)" TNR Homo sapiens (Human) "associative learning [GO:0008306]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733]; signaling receptor binding [GO:0005102]; associative learning [GO:0008306]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]" signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:0005615; GO:0007155; GO:0007158; GO:0007411; GO:0008306; GO:0009986; GO:0022029; GO:0022408; GO:0030198; GO:0030334; GO:0035641; GO:0045121; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0098685; GO:0098978 MGADGETVVLKNMLIGINLILLGSMIKPSECQLEVTTER 5.860000134 0.440896302 0.440896302 1.10E-11 4305.756168 0 12.14531 12.74463 0 0 0 0 0 0 0 11.75665 14.00995 0 0 0 0 0 0 0 0 0 0 0 0 15.03755 0 0 0 0 0 0 0 0 0 0 0 14.89964 0 0 9.393974 13.69159 0 0 0 0 0 0 0 Q92753 RORB_HUMAN Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) RORB NR1F2 RZRB Homo sapiens (Human) "amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007601; GO:0008270; GO:0008502; GO:0035881; GO:0042462; GO:0042752; GO:0045668; GO:0045892; GO:0045893; GO:0045944; GO:0046548; GO:0046549; GO:0048511; GO:0060041; GO:0071300; GO:1990837 AYQSKSR 14.5 0.145675421 0.145675421 0.148204298 841.2537768 15.04426 15.69825 14.79613 16.91378 14.7313 0 0 0 18.23295 12.06368 0 9.690296 16.53672 15.23282 19.37621 16.77249 19.38812 15.03457 0 15.43915 0 18.68921 14.14704 0 0 0 15.97474 15.97733 0 0 19.82884 9.008538 16.02208 14.92822 0 0 15.59234 17.131 13.43901 15.50756 0 17.74279 13.0192 0 0 0 0 0 Q92754 AP2C_HUMAN "Transcription factor AP-2 gamma, AP2-gamma (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1)" TFAP2C Homo sapiens (Human) "anatomical structure development [GO:0048856]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0007267; GO:0008584; GO:0040029; GO:0042127; GO:0045944; GO:0048856; GO:1990837 HDGSSNGNPR 8.729999542 1 1 0.413165175 1039.834263 13.75937 0 0 0 0 0 0 0 0 0 0 19.15176 0 19.33337 0 0 0 0 0 0 0 0 0 0 0 17.26862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95823 Q92765 SFRP3_HUMAN "Secreted frizzled-related protein 3, sFRP-3 (Frezzled) (Fritz) (Frizzled-related protein 1) (FrzB-1)" FRZB FIZ FRE FRP FRZB1 SFRP3 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053] Wnt-protein binding [GO:0017147] GO:0001501; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0016020; GO:0017147; GO:0030178; GO:0030308; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070367; GO:0090090; GO:0090103 SGRNSNPR 4.550000191 1 1 0.268967091 887.9367285 16.24688 14.53612 0 14.84629 0 15.46671 0 0 0 0 0 0 0 16.13618 0 0 0 0 0 0 18.09968 0 0 0 0 0 0 17.92044 0 0 0 0 16.19254 0 0 0 0 0 0 0 0 0 0 18.31859 0 0 0 18.12094 Q92766 RREB1_HUMAN "Ras-responsive element-binding protein 1, RREB-1 (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1, Zep-1)" RREB1 FINB Homo sapiens (Human) "multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0001650; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0007265; GO:0007275; GO:0010634; GO:0016604; GO:0016607; GO:0033601; GO:0045893; GO:0045944; GO:0046872; GO:0070062; GO:0090336; GO:1900026; GO:1903691; GO:2000394 ALRIHMR 4.800000191 0.266185403 0.266185403 0.32708282 912.5274376 12.90576 14.72865 13.17028 0 13.74107 0 0 0 0 0 0 0 0 16.18184 0 16.34766 0 0 15.52669 0 0 0 13.58939 0 0 11.43841 0 0 12.51503 0 0 0 15.11227 0 0 15.77449 0 0 0 0 0 0 0 0 15.93038 0 0 0 Q92769 HDAC2_HUMAN "Histone deacetylase 2, HD2, EC 3.5.1.98 (Protein deacylase HDAC2, EC 3.5.1.-)" HDAC2 Homo sapiens (Human) "behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin organization [GO:0070828]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin organization [GO:0070828]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]" chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565] GO:0000118; GO:0000122; GO:0000781; GO:0000785; GO:0001975; GO:0003300; GO:0003682; GO:0003723; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0008284; GO:0009410; GO:0009913; GO:0010718; GO:0010977; GO:0016358; GO:0016575; GO:0016580; GO:0016581; GO:0019213; GO:0019899; GO:0030336; GO:0030512; GO:0031000; GO:0031072; GO:0032496; GO:0032732; GO:0032760; GO:0032922; GO:0032967; GO:0032991; GO:0033558; GO:0034605; GO:0035094; GO:0035098; GO:0042220; GO:0042475; GO:0042531; GO:0042659; GO:0042733; GO:0042826; GO:0043066; GO:0043392; GO:0043433; GO:0043565; GO:0045347; GO:0045862; GO:0045892; GO:0045893; GO:0045944; GO:0048149; GO:0048714; GO:0051059; GO:0055093; GO:0060789; GO:0061000; GO:0061029; GO:0061198; GO:0061629; GO:0070301; GO:0070828; GO:0070932; GO:0070933; GO:0071300; GO:0071560; GO:0160009; GO:0160010; GO:1902437; GO:1902455; GO:1902459; GO:1903351; GO:1990841; GO:2000273; GO:2000736; GO:2000757 ISIRASDK 6.260000229 0.229105905 0.229105905 0.097759927 888.0985306 16.72137 17.30225 17.32524 15.2028 0 15.10076 16.32745 16.85694 15.01273 0 17.54846 15.57797 14.52988 16.78554 18.23726 14.781 13.83853 17.03007 13.38678 0 0 18.23895 11.29254 18.2083 16.28922 13.99054 17.60193 14.64012 14.98877 14.83802 18.42974 16.37587 14.6827 16.29358 17.00119 15.54885 13.72804 17.53741 15.98601 17.58996 16.93914 0 15.82333 17.81394 14.24894 16.51003 16.26003 17.6642 Q92772 CDKL2_HUMAN "Cyclin-dependent kinase-like 2, EC 2.7.11.22 (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE)" CDKL2 Homo sapiens (Human) protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; signal transduction [GO:0007165] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; signal transduction [GO:0007165] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0007165; GO:0007548; GO:0106310 DIKPENILVSQSGVVK 15.59000015 1 1 0.57666687 1724.741096 13.92326 16.60186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.16809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.95043 17.81023 0 0 0 0 0 0 Q92777 SYN2_HUMAN Synapsin-2 (Synapsin II) SYN2 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091] ATP binding [GO:0005524]; identical protein binding [GO:0042802] GO:0005524; GO:0005886; GO:0007268; GO:0007269; GO:0014069; GO:0017156; GO:0030672; GO:0031201; GO:0042802; GO:0045202; GO:0097091; GO:0098685; GO:0098978 IGHAHSGMGKVK 13.82999992 1 1 0.256144143 1219.531682 11.98595 14.10849 0 14.22529 0 12.76391 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18729 0 0 0 0 0 16.45916 10.12882 15.82853 16.53378 16.00772 0 16.94696 16.27763 0 0 0 0 16.7415 0 17.16803 15.06198 16.44547 15.33535 15.03338 17.69222 0 16.04714 15.51799 Q92783 STAM1_HUMAN "Signal transducing adapter molecule 1, STAM-1" STAM STAM1 Homo sapiens (Human) macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165] phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389] GO:0005829; GO:0007165; GO:0016236; GO:0031901; GO:0033565; GO:0035091; GO:0036258; GO:0043130; GO:0043231; GO:0043328; GO:0044389; GO:1903543; GO:1903551 DPGTVANKK 8.829999924 1 1 0.255686397 930.2802137 15.91058 16.13818 16.57472 0 15.47116 15.63419 16.63554 15.67879 0 0 14.34935 16.51125 15.74649 0 0 16.78753 16.37145 0 0 16.12582 0 16.61098 15.15589 0 15.48505 0 0 0 15.17074 15.08141 16.78187 17.71859 0 0 0 0 0 16.21041 16.93888 0 14.49314 15.69523 0 0 15.06785 0 17.23625 16.04744 Q92784 DPF3_HUMAN "Zinc finger protein DPF3 (BRG1-associated factor 45C, BAF45C) (Zinc finger protein cer-d4)" DPF3 BAF45C CERD4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514] "brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] GO:0000785; GO:0003712; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0008270; GO:0016514; GO:0030071; GO:0035060; GO:0042393; GO:0045597; GO:0045663; GO:0045892; GO:0045944; GO:0070316; GO:0071565; GO:2000045; GO:2000781; GO:2000819 GSAGGRR 8.449999809 1 1 0.26107156 659.9013735 14.99542 15.17103 15.44941 15.0244 13.4273 15.91033 14.13463 13.58418 14.10435 16.17992 14.17223 15.43578 14.25621 15.29579 0 16.27094 0 0 16.3793 15.40188 15.76548 16.11169 0 15.52273 0 16.3457 16.61775 0 0 15.09093 0 15.26828 15.70869 15.77869 16.08595 0 14.71338 18.33241 15.88147 17.42932 0 16.55372 0 15.33739 14.61431 16.79534 12.94989 14.81869 Q92785 REQU_HUMAN "Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D, BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)" DPF2 BAF45D REQ UBID4 Homo sapiens (Human) "apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000785; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006338; GO:0006357; GO:0006915; GO:0007399; GO:0016514; GO:0030071; GO:0042393; GO:0043231; GO:0045892; GO:0045944; GO:0046872; GO:0062072; GO:0070316; GO:0070577; GO:0071565; GO:0097190; GO:1902459; GO:1905454; GO:2000045; GO:2000781; GO:2000819 LSFPSIKPDTDQTLKK 2.440000057 1 1 0.333365465 1818.966793 15.28523 15.04455 13.68841 0 0 13.47616 0 14.75845 0 15.53903 0 0 0 0 15.18589 0 0 0 15.07986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81794 0 0 0 0 0 0 0 0 0 Q92786 PROX1_HUMAN "Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1, PROX-1)" PROX1 Homo sapiens (Human) "acinar cell differentiation [GO:0090425]; aorta smooth muscle tissue morphogenesis [GO:0060414]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; brain development [GO:0007420]; branching involved in pancreas morphogenesis [GO:0061114]; cell fate determination [GO:0001709]; cerebellar granule cell differentiation [GO:0021707]; circadian rhythm [GO:0007623]; dentate gyrus development [GO:0021542]; dorsal spinal cord development [GO:0021516]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endocardium formation [GO:0060214]; hepatocyte cell migration [GO:0002194]; hepatocyte differentiation [GO:0070365]; hepatocyte proliferation [GO:0072574]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lens placode formation involved in camera-type eye formation [GO:0046619]; liver development [GO:0001889]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; olfactory placode formation [GO:0030910]; otic placode formation [GO:0043049]; pancreas development [GO:0031016]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle checkpoint [GO:1901978]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of forebrain neuron differentiation [GO:2000979]; positive regulation of heart growth [GO:0060421]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle thin filament assembly [GO:0030240]; venous blood vessel morphogenesis [GO:0048845]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; acinar cell differentiation [GO:0090425]; aorta smooth muscle tissue morphogenesis [GO:0060414]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; brain development [GO:0007420]; branching involved in pancreas morphogenesis [GO:0061114]; cell fate determination [GO:0001709]; cerebellar granule cell differentiation [GO:0021707]; circadian rhythm [GO:0007623]; dentate gyrus development [GO:0021542]; dorsal spinal cord development [GO:0021516]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endocardium formation [GO:0060214]; hepatocyte cell migration [GO:0002194]; hepatocyte differentiation [GO:0070365]; hepatocyte proliferation [GO:0072574]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lens placode formation involved in camera-type eye formation [GO:0046619]; liver development [GO:0001889]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; olfactory placode formation [GO:0030910]; otic placode formation [GO:0043049]; pancreas development [GO:0031016]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle checkpoint [GO:1901978]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of forebrain neuron differentiation [GO:2000979]; positive regulation of heart growth [GO:0060421]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle thin filament assembly [GO:0030240]; venous blood vessel morphogenesis [GO:0048845]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]" "DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0001822; GO:0001889; GO:0001938; GO:0001946; GO:0002088; GO:0002194; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007420; GO:0007623; GO:0008284; GO:0008285; GO:0010468; GO:0010595; GO:0016922; GO:0021516; GO:0021542; GO:0021707; GO:0021915; GO:0030240; GO:0030324; GO:0030910; GO:0031016; GO:0031667; GO:0042752; GO:0043049; GO:0043433; GO:0045071; GO:0045737; GO:0045787; GO:0045892; GO:0045944; GO:0046619; GO:0048845; GO:0050692; GO:0050693; GO:0055005; GO:0055009; GO:0055010; GO:0060042; GO:0060059; GO:0060214; GO:0060298; GO:0060412; GO:0060414; GO:0060421; GO:0060836; GO:0060838; GO:0061114; GO:0070309; GO:0070365; GO:0070858; GO:0072574; GO:0090425; GO:0097150; GO:1901978; GO:1990837; GO:2000179; GO:2000979 MPDHDSTALLSRQTK 3.529999971 0.583663762 0.583663762 0.296919061 1713.274007 0 16.7034 14.14948 15.84674 0 0 14.39333 13.42487 0 0 16.7457 17.59115 0 0 0 13.57793 15.66755 0 0 0 17.72489 0 0 13.3222 13.66625 0 14.9027 15.05763 0 0 15.8043 15.15829 0 0 0 15.09231 0 13.31379 0 0 0 0 0 0 0 0 0 0 Q92791 SC65_HUMAN Endoplasmic reticulum protein SC65 (Leprecan-like protein 4) (Nucleolar autoantigen No55) (Prolyl 3-hydroxylase family member 4) (Synaptonemal complex protein SC65) P3H4 LEPREL4 NOL55 SC65 Homo sapiens (Human) bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]; synaptonemal complex assembly [GO:0007130] catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; synaptonemal complex [GO:0000795] catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]; bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]; synaptonemal complex assembly [GO:0007130] GO:0000794; GO:0000795; GO:0005730; GO:0005783; GO:0007130; GO:0017185; GO:0030199; GO:0032964; GO:0043231; GO:0046849; GO:1902494 VAWGLLWLLLGSAGAQYEK 4.489999771 1 1 0.194431251 2076.175981 14.38311 0 0 14.60847 14.10474 12.69849 14.48866 14.42787 17.26489 0 15.76517 0 17.18801 15.61221 0 12.89798 8.815741 0 0 0 0 16.26803 0 0 0 0 0 0 0 0 0 16.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92793 CBP_HUMAN "CREB-binding protein (Histone lysine acetyltransferase CREBBP, EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP, EC 2.3.1.-)" CREBBP CBP Homo sapiens (Human) "cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]" acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006473; GO:0007165; GO:0008270; GO:0008589; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0034212; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0045893; GO:0045944; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0140297; GO:1900034; GO:1990258 VVASSDKTVEVKPGMK 14.77000046 1 1 0.245282149 1674.399976 0 0 17.20025 0 0 0 19.06531 0 13.80292 0 13.94828 0 0 0 0 0 0 0 0 0 15.03151 0 0 0 0 0 0 0 0 0 0 0 0 0 18.42925 0 0 0 16.30323 0 0 0 0 0 0 0 0 0 Q92794 KAT6A_HUMAN "Histone acetyltransferase KAT6A, EC 2.3.1.48 (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3, MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)" KAT6A MOZ MYST3 RUNXBP2 ZNF220 Homo sapiens (Human) "cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605] "cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]" acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] GO:0000786; GO:0003677; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006323; GO:0006334; GO:0006355; GO:0006473; GO:0008270; GO:0010484; GO:0010485; GO:0010628; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0050793; GO:0061629; GO:0070776; GO:0090398; GO:0140297; GO:1901796; GO:1903706 DMELFR 8.819999695 1 1 0.252512898 810.575409 0 0 0 0 0 0 0 0 0 0 0 0 17.8992 16.42322 0 0 0 0 0 0 0 0 0 0 0 0 0 17.15411 0 0 0 0 0 17.58257 18.61062 0 0 0 20.46226 0 17.84771 0 0 0 0 0 18.0508 0 Q92796 DLG3_HUMAN "Disks large homolog 3 (Neuroendocrine-DLG) (Synapse-associated protein 102, SAP-102, SAP102) (XLMR)" DLG3 KIAA1232 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; ubiquitin protein ligase binding [GO:0031625]; cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; ubiquitin protein ligase binding [GO:0031625] GO:0001736; GO:0005615; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008285; GO:0016323; GO:0019900; GO:0019902; GO:0030054; GO:0031625; GO:0032281; GO:0043113; GO:0045197; GO:0061098; GO:0097120; GO:0098609; GO:0098978; GO:0099072 EAGPVVR 6.039999962 1 1 0.042468225 728.3919134 12.24965 13.35543 0 15.83987 0 14.19782 0 0 15.67325 0 0 14.32142 0 0 13.95054 0 0 0 0 0 0 0 0 0 13.99876 0 0 0 0 14.79369 0 0 0 0 0 0 0 0 0 13.79907 0 0 0 0 0 0 0 0 Q92797 SYMPK_HUMAN Symplekin SYMPK SPK Homo sapiens (Human) cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307] GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006378; GO:0007155; GO:0016604; GO:0032091; GO:0035307; GO:0097165 QCKEEPK 7.809999943 0.00050136 0.00050136 0.222953046 918.2262466 0 0 0 0 0 14.39783 0 0 0 0 0 0 0 16.17988 0 0 0 0 0 0 0 0 15.02423 0 15.78213 0 16.61879 0 0 0 0 17.78566 18.38622 15.21421 16.20244 16.34352 18.35533 0 0 0 0 0 0 0 0 0 0 0 Q92800 EZH1_HUMAN "Histone-lysine N-methyltransferase EZH1, EC 2.1.1.356 (ENX-2) (Enhancer of zeste homolog 1)" EZH1 KIAA0388 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; subtelomeric heterochromatin assembly [GO:0031509] "chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]" "chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription corepressor activity [GO:0003714]; anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; subtelomeric heterochromatin assembly [GO:0031509]" chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000781; GO:0000792; GO:0003682; GO:0003714; GO:0005654; GO:0006338; GO:0009653; GO:0018024; GO:0021766; GO:0031507; GO:0031509; GO:0035098; GO:0045944; GO:0070734 TQILNEEWKK 8.949999809 1 1 0.016514756 1287.834538 13.72396 0 13.93259 0 0 13.732 13.55151 16.1719 15.48079 16.19445 0 13.27368 15.81148 16.55387 14.84245 0 0 14.56955 15.37374 16.24759 0 13.37473 0 0 13.82369 19.4073 0 14.30769 0 0 13.34701 0 0 16.61086 12.97412 13.22577 16.27819 17.56179 13.2309 17.69201 0 14.43763 13.05632 0 14.59834 17.25559 0 0 Q92804 RBP56_HUMAN "TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor, TAF(II)68, TAFII68) (RNA-binding protein 56)" TAF15 RBP56 TAF2N Homo sapiens (Human) "mRNA stabilization [GO:0048255]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; mRNA stabilization [GO:0048255]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA splicing [GO:0008380]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008380; GO:0045893; GO:0046872; GO:0048255 GRGGYR 2.279999971 0.569984853 0.569984853 0.285904411 664.8380909 0 18.72915 0 18.30598 18.24564 0 18.61346 0 0 0 0 0 16.40056 15.95206 0 17.28244 0 0 0 0 0 0 0 18.58679 0 0 0 0 0 17.24722 0 18.2231 0 0 0 0 0 0 0 0 0 16.63998 0 16.36373 0 0 0 0 Q92805 GOGA1_HUMAN Golgin subfamily A member 1 (Golgin-97) GOLGA1 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471 TQEELMNSNQMSSDLSQK 9.350000381 1 1 0.221773221 2102.436169 0 0 0 14.52472 16.7769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.26497 0 18.09315 0 0 0 0 0 Q92817 EVPL_HUMAN Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210) EVPL Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060] cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198] GO:0001533; GO:0005198; GO:0005737; GO:0005829; GO:0008544; GO:0016020; GO:0018149; GO:0019215; GO:0030057; GO:0030216; GO:0031424; GO:0042060; GO:0045104; GO:0045111; GO:0045296; GO:0070062 EVTQEVVR 11.10999966 1 1 0.220948953 962.6544981 0 14.23295 14.52957 12.19863 14.1794 13.59459 13.05597 0 15.62839 0 0 0 10.84419 14.93531 0 15.79326 0 16.17205 13.70666 0 0 14.98928 0 12.57647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92819 HYAS2_HUMAN "Hyaluronan synthase 2, EC 2.4.1.212 (Hyaluronate synthase 2) (Hyaluronic acid synthase 2, HA synthase 2)" HAS2 Homo sapiens (Human) atrioventricular canal development [GO:0036302]; bone morphogenesis [GO:0060349]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion to mesenchymal transition [GO:0090500]; estrous cycle [GO:0044849]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; kidney development [GO:0001822]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of urine volume [GO:0035810]; regulation of extracellular matrix assembly [GO:1901201]; renal water absorption [GO:0070295]; vasculogenesis [GO:0001570] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802]; atrioventricular canal development [GO:0036302]; bone morphogenesis [GO:0060349]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion to mesenchymal transition [GO:0090500]; estrous cycle [GO:0044849]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; kidney development [GO:0001822]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of urine volume [GO:0035810]; regulation of extracellular matrix assembly [GO:1901201]; renal water absorption [GO:0070295]; vasculogenesis [GO:0001570] hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802] GO:0001570; GO:0001822; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0008284; GO:0010838; GO:0014911; GO:0030213; GO:0030335; GO:0031410; GO:0035810; GO:0036120; GO:0036302; GO:0042802; GO:0044849; GO:0044853; GO:0045226; GO:0050501; GO:0051549; GO:0060349; GO:0070295; GO:0071347; GO:0071356; GO:0071498; GO:0085029; GO:0090500; GO:1900026; GO:1900127; GO:1900625; GO:1901201 YTARSK 5.900000095 1 1 0.268066787 724.3353888 15.18919 16.32612 13.68851 0 20.19498 16.55641 0 0 16.9734 0 0 17.78072 0 0 0 0 16.55891 0 0 0 0 16.88888 16.5959 0 0 17.71342 16.39718 0 0 0 20.01539 0 0 0 0 0 0 18.38867 0 0 18.42698 0 16.34033 16.58742 0 17.77283 0 0 Q92820 GGH_HUMAN "Gamma-glutamyl hydrolase, EC 3.4.19.9 (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)" GGH Homo sapiens (Human) tetrahydrofolylpolyglutamate metabolic process [GO:0046900] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]; exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900] exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242] GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724 SDYAKVAK 6.039999962 0.54041934 0.54041934 0.338300716 881.0004433 14.60396 0 12.75759 0 15.26605 0 15.21455 0 0 0 0 14.11983 0 0 14.00861 0 14.49719 0 15.78291 0 16.6907 15.92043 12.55292 15.32995 0 14.51705 13.56612 11.86067 0 0 13.19783 14.71495 0 0 10.45657 0 0 0 15.85389 16.34057 0 15.95503 0 15.28732 0 14.90654 0 0 Q92823 NRCAM_HUMAN "Neuronal cell adhesion molecule, Nr-CAM (Neuronal surface protein Bravo, hBravo) (NgCAM-related cell adhesion molecule, Ng-CAM-related)" NRCAM KIAA0343 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416] axon [GO:0030424]; axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] axon [GO:0030424]; axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416] ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080] GO:0001525; GO:0001764; GO:0005576; GO:0005886; GO:0005887; GO:0007409; GO:0007411; GO:0007413; GO:0007416; GO:0007417; GO:0007420; GO:0008104; GO:0009897; GO:0010975; GO:0019227; GO:0030424; GO:0030506; GO:0030516; GO:0031290; GO:0043005; GO:0043194; GO:0045162; GO:0045666; GO:0086080; GO:0098609; GO:0098632; GO:0098978; GO:0099061; GO:0099175 GHLQGYR 3.599999905 1 1 0.302642124 829.8049616 0 0 17.29414 0 19.4399 0 0 0 0 18.66186 17.54228 0 17.6947 0 0 0 0 0 0 0 17.02698 0 0 0 0 0 0 0 0 17.4154 0 0 0 0 0 17.97925 0 18.70062 0 0 0 0 17.56624 0 0 0 0 0 Q92824 PCSK5_HUMAN "Proprotein convertase subtilisin/kexin type 5, EC 3.4.21.- (Proprotein convertase 5, PC5) (Proprotein convertase 6, PC6, hPC6) (Subtilisin/kexin-like protease PC5)" PCSK5 PC5 PC6 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cytokine precursor processing [GO:0140447]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cytokine precursor processing [GO:0140447]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252] GO:0001822; GO:0002001; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005794; GO:0005796; GO:0005802; GO:0006465; GO:0007267; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030173; GO:0030323; GO:0035108; GO:0042277; GO:0043043; GO:0048566; GO:0048706; GO:0051004; GO:0140447 SYSSYK 13.35000038 1 1 0.12839257 735.5367075 0 0 0 16.23897 0 0 0 0 0 18.84881 16.39124 15.2983 0 0 16.94223 18.87405 17.01361 17.48118 0 0 18.08053 17.5856 0 0 0 17.36909 18.13323 14.61281 14.083 15.4593 0 0 17.67056 16.45835 18.26294 16.70124 17.99666 19.69959 17.72445 0 18.07321 16.82837 17.38215 17.0182 17.73799 17.7016 0 17.357 Q92830 KAT2A_HUMAN "Histone acetyltransferase KAT2A, EC 2.3.1.48 (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5, hGCN5) (Histone glutaryltransferase KAT2A, EC 2.3.1.-) (Histone succinyltransferase KAT2A, EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)" KAT2A GCN5 GCN5L2 Homo sapiens (Human) "alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]" ATAC complex [GO:0140672]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "ATAC complex [GO:0140672]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]" chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713] GO:0000123; GO:0000124; GO:0000785; GO:0001701; GO:0001756; GO:0001819; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006282; GO:0006338; GO:0006355; GO:0006357; GO:0007507; GO:0007616; GO:0008283; GO:0010484; GO:0014070; GO:0016573; GO:0016578; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0031063; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0035521; GO:0035522; GO:0042826; GO:0043484; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045722; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0051302; GO:0051726; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0090043; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:0140297; GO:0140672; GO:1903010; GO:1990090; GO:2000036; GO:2000727 DETARLEER 6.53000021 1 1 0.364083432 1119.648844 16.39593 15.6407 14.18347 11.34738 0 16.04762 0 13.80865 14.15316 14.44075 15.85684 0 0 0 0 15.4649 0 0 0 0 0 0 0 0 0 16.43574 0 0 0 0 0 0 0 0 0 15.80365 0 0 0 0 0 0 0 0 15.92432 0 0 0 Q92831 KAT2B_HUMAN "Histone acetyltransferase KAT2B, EC 2.3.1.48 (Histone acetyltransferase PCAF, Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor, P/CAF) (Spermidine acetyltransferase KAT2B, EC 2.3.1.57)" KAT2B PCAF Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]" A band [GO:0031672]; actomyosin [GO:0042641]; ATAC complex [GO:0140672]; centrosome [GO:0005813]; cytosol [GO:0005829]; I band [GO:0031674]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124] "A band [GO:0031672]; actomyosin [GO:0042641]; ATAC complex [GO:0140672]; centrosome [GO:0005813]; cytosol [GO:0005829]; I band [GO:0031674]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell cycle [GO:0007049]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]" "acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]" GO:0000124; GO:0000776; GO:0000977; GO:0003682; GO:0003712; GO:0003713; GO:0004145; GO:0004402; GO:0004468; GO:0004861; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006282; GO:0006338; GO:0006355; GO:0006473; GO:0007049; GO:0007507; GO:0008285; GO:0010835; GO:0016407; GO:0016573; GO:0018076; GO:0018393; GO:0018394; GO:0019901; GO:0031672; GO:0031674; GO:0032869; GO:0032991; GO:0042641; GO:0042826; GO:0043484; GO:0043966; GO:0043970; GO:0045722; GO:0045815; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048511; GO:0051726; GO:0060173; GO:0061733; GO:0072686; GO:0140297; GO:0140672; GO:1902425; GO:2000233 EAGLIDK 3.369999886 1 1 0.159147242 747.5808798 16.25837 12.14617 15.41604 13.45262 14.73939 13.76247 13.66344 12.99333 15.40449 14.02193 14.80865 13.96782 0 0 0 15.53142 0 0 0 16.49235 0 0 0 14.81892 0 0 0 0 15.68666 0 0 0 14.64778 15.16737 0 0 0 0 16.7568 0 0 0 0 16.13678 0 0 0 0 Q92833 JARD2_HUMAN Protein Jumonji (Jumonji/ARID domain-containing protein 2) JARID2 JMJ Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; dosage compensation by inactivation of X chromosome [GO:0009048]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein localization to pericentric heterochromatin [GO:1902682]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]" ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; ubiquitin binding [GO:0043130]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; dosage compensation by inactivation of X chromosome [GO:0009048]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein localization to pericentric heterochromatin [GO:1902682]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; ubiquitin binding [GO:0043130]; ubiquitin modification-dependent histone binding [GO:0061649] GO:0000122; GO:0001889; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005739; GO:0006338; GO:0007417; GO:0009048; GO:0010614; GO:0031061; GO:0032452; GO:0035097; GO:0035098; GO:0043130; GO:0045892; GO:0048536; GO:0048538; GO:0048863; GO:0051574; GO:0060044; GO:0061649; GO:1902682; GO:1990830 LADMLR 3.180000067 0.642022789 0.642022789 0.064868742 718.6092401 15.46676 0 15.49638 15.40256 14.71394 15.45103 16.165 0 0 13.75195 14.12426 14.87615 13.32262 13.36095 14.91075 0 15.75977 0 15.35446 17.39327 14.18062 0 16.21638 14.65203 16.54412 15.85339 0 17.18319 0 14.24357 17.46014 0 16.31558 14.56445 14.02034 14.71361 17.44398 16.94252 17.7709 0 16.71299 16.00934 0 15.54211 0 0 13.95923 15.50812 Q92834 RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator RPGR RP3 XLRP3 Homo sapiens (Human) cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601] guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] GO:0001750; GO:0003723; GO:0005085; GO:0005794; GO:0005813; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271 SLKLSPVQK 9.670000076 0.387821317 0.387821317 0.163183472 1002.503652 0 0 0 15.85341 0 0 15.8842 15.39913 16.70068 16.01599 17.88916 0 0 0 0 16.60941 0 0 0 0 19.0602 0 0 0 18.38533 0 15.85945 15.42013 14.96703 15.46566 0 0 0 0 0 0 0 0 0 14.91692 0 0 0 0 0 0 0 0 Q92835 SHIP1_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1, EC 3.1.3.86 (Inositol polyphosphate-5-phosphatase D, EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa, SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1, SH2 domain-containing inositol phosphatase 1, SHIP-1) (p150Ship, hp51CN)" INPP5D SHIP SHIP1 Homo sapiens (Human) apoptotic process [GO:0006915]; determination of adult lifespan [GO:0008340]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of bone resorption [GO:0045779]; negative regulation of immune response [GO:0050777]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of signal transduction [GO:0009968]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; determination of adult lifespan [GO:0008340]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of bone resorption [GO:0045779]; negative regulation of immune response [GO:0050777]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of signal transduction [GO:0009968]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]" "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]" GO:0004439; GO:0004445; GO:0005829; GO:0005856; GO:0005886; GO:0006661; GO:0006796; GO:0006915; GO:0007165; GO:0008340; GO:0009968; GO:0016064; GO:0016314; GO:0017124; GO:0030889; GO:0032715; GO:0034485; GO:0035556; GO:0043065; GO:0045121; GO:0045579; GO:0045648; GO:0045656; GO:0045659; GO:0045671; GO:0045779; GO:0046856; GO:0050777; GO:0050852; GO:0052658; GO:0052659 TGKDGSFLVR 6.5 1 1 1.37E-12 1080.360078 12.03673 13.85405 15.7667 0 0 14.10276 0 13.26441 13.92396 12.88991 13.16303 12.02445 11.07162 12.38742 13.54969 13.03255 6.986639 13.82037 0 14.24954 10.8784 15.29103 0 0 13.59996 0 0 13.61539 15.25634 13.32688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92844 TANK_HUMAN "TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein, I-TRAF)" TANK ITRAF TRAF2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; proteolysis [GO:0006508]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]; deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; proteolysis [GO:0006508]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337] deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625] GO:0005829; GO:0006508; GO:0006974; GO:0007165; GO:0007249; GO:0031625; GO:0032991; GO:0035800; GO:0043124; GO:0046872; GO:0051607; GO:0060337; GO:0071347; GO:0071356; GO:0071479; GO:1902554; GO:1903003; GO:2000158 DKNIGEQLNK 8.529999733 0.773422837 0.773422837 0.062024183 1157.991897 0 19.04686 0 0 0 0 18.41027 0 19.02962 0 19.35223 0 18.04968 15.55146 0 16.47001 0 0 0 16.26499 0 0 16.87254 15.47682 0 0 17.75403 0 19.39958 17.9532 0 17.84549 18.84041 0 16.93565 17.75973 16.89722 15.90193 15.36651 15.71538 0 0 0 17.90126 17.0551 0 19.62545 18.98714 Q92845 KIFA3_HUMAN "Kinesin-associated protein 3, KAP-3, KAP3 (Smg GDS-associated protein)" KIFAP3 KIF3AP SMAP Homo sapiens (Human) cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903] GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0007165; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019894; GO:0019903; GO:0032391; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:0120170; GO:1990075 NKNIVHMLVK 9.159999847 1 1 1.120003611 1212.051992 0 0 0 0 0 0 0 0 0 0 0 18.22383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.29102 0 0 0 0 0 0 0 0 0 0 Q92847 GHSR_HUMAN "Growth hormone secretagogue receptor type 1, GHS-R (GH-releasing peptide receptor, GHRP) (Ghrelin receptor)" GHSR Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283] G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046] GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0036321; GO:0040018; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1905333; GO:1905564; GO:1990314; GO:2000110 RGDAVVGASLR 10.02000046 1 1 0.172783493 1100.478331 16.15584 16.48177 0 0 13.67656 13.99884 0 13.15041 8.833724 0 14.78893 16.33678 0 13.21879 0 0 0 0 12.64869 0 0 0 16.9671 0 0 0 0 0 0 0 14.21094 17.2866 16.36134 0 15.55793 16.44725 0 0 14.87359 0 17.25567 11.72331 0 0 0 0 0 0 Q92851 CASPA_HUMAN "Caspase-10, CASP-10, EC 3.4.22.63 (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2, FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12 ]" CASP10 MCH4 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981] CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342] CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625] GO:0004197; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0031265; GO:0031625; GO:0035877; GO:0042981; GO:0043123; GO:0097153; GO:0097199; GO:0097200; GO:0097342 TEMTSLSFLAFLEK 5.070000172 0.755443394 0.755443394 0.133858501 1632.737527 17.16123 13.56841 0 14.40263 15.57943 10.77368 17.36182 16.50807 14.44656 19.4342 15.96647 14.59613 16.66891 12.46034 16.93742 16.21227 0 15.08622 15.84572 0 0 18.79776 16.18781 0 16.57632 16.20968 0 11.20415 0 0 15.52663 18.61932 0 0 15.9717 0 0 17.80317 18.22888 0 16.64848 0 17.01206 0 10.86221 16.03927 16.44048 12.74334 Q92859 NEO1_HUMAN Neogenin (Immunoglobulin superfamily DCC subclass member 2) NEO1 IGDCC2 NGN Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; iron ion homeostasis [GO:0055072]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513] axonal growth cone [GO:0044295]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] axonal growth cone [GO:0044295]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; iron ion homeostasis [GO:0055072]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513] co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0009986; GO:0030513; GO:0038023; GO:0039706; GO:0044295; GO:0055072; GO:0098609; GO:0098797 ADSSDK 7.739999771 1 1 1.37E-12 622.6210947 13.73124 0 14.0407 16.55061 14.55872 14.41809 14.75723 0 15.17361 16.39685 13.4519 14.26529 16.56598 16.82322 16.54088 16.37509 0 15.61762 17.40444 16.59051 0 16.50899 0 13.86353 14.28123 0 15.60837 0 16.21795 15.11152 0 0 0 0 0 0 16.56841 0 0 16.26173 0 16.52274 0 0 0 0 0 0 Q92878 RAD50_HUMAN "DNA repair protein RAD50, hRAD50, EC 3.6.-.-" RAD50 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860] "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047] GO:0000019; GO:0000722; GO:0000723; GO:0000729; GO:0000781; GO:0000794; GO:0003677; GO:0003691; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007131; GO:0016020; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042802; GO:0043047; GO:0044818; GO:0046872; GO:0051880; GO:0070192; GO:0070533; GO:0090305; GO:0098687; GO:0110025; GO:1904354 EMMIVMR 3.24000001 1 1 0.127271294 940.5834007 0 0 0 0 0 13.61888 0 14.13297 14.53813 0 0 14.9197 0 0 0 12.94516 15.70146 14.81594 0 0 0 0 0 0 16.55124 12.21576 15.57549 0 0 0 0 0 16.65758 0 0 15.59618 15.10002 0 15.60114 0 0 15.6988 0 0 0 0 0 0 Q92888 ARHG1_HUMAN "Rho guanine nucleotide exchange factor 1 (115 kDa guanine nucleotide exchange factor, p115-RhoGEF, p115RhoGEF) (Sub1.5)" ARHGEF1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] GO:0001664; GO:0003723; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007266; GO:0051056 AVEVHVLLLDDLLLLLQR 13.22000027 1 1 0.0742946 2072.264107 12.92782 13.66751 13.47153 0 0 13.98246 0 0 14.51406 0 0 0 0 0 0 0 14.19441 0 0 0 17.75773 15.98706 0 16.87916 0 0 14.61142 15.3764 15.33347 13.88161 0 15.62902 13.35329 16.03086 15.04745 14.19109 0 0 0 0 0 0 0 0 0 0 0 0 Q92889 XPF_HUMAN "DNA repair endonuclease XPF, EC 3.1.-.- (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)" ERCC4 ERCC11 XPF Homo sapiens (Human) "cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]" "chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]" damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094] GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841 MESGQPAR 5.130000114 0.197534427 0.197534427 0.238449675 891.9868917 13.85376 14.28406 15.71058 14.58546 16.13309 0 0 14.70954 14.80603 0 0 0 0 15.28595 0 16.01211 0 15.49793 0 16.44352 0 0 14.89674 15.00635 15.88191 16.56734 14.32143 14.79131 16.29201 14.84801 14.7929 13.87947 15.74883 15.86454 16.96474 16.74141 16.4104 16.16016 15.67165 16.37829 15.56361 0 15.48211 13.96217 16.0446 15.41683 15.36772 14.39273 Q92896 GSLG1_HUMAN "Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1, ESL-1) (Golgi sialoglycoprotein MG-160)" GLG1 CFR1 ESL1 MG160 Homo sapiens (Human) bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330] fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102] GO:0000139; GO:0005102; GO:0005794; GO:0005856; GO:0005886; GO:0010955; GO:0016020; GO:0016021; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0060349; GO:0070062 LNLTTDPK 7.570000172 1 1 0.55984815 902.2160207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.89938 0 0 0 0 Q92901 RL3L_HUMAN 60S ribosomal protein L3-like (Large ribosomal subunit protein uL3-like) RPL3L Homo sapiens (Human) ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840] cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0000027; GO:0003723; GO:0003735; GO:0005840; GO:0006412; GO:0016020; GO:0022625 EVHRPGLK 2.710000038 1 1 0.072888693 935.567742 13.63207 0 13.95078 0 0 0 11.86915 0 0 0 0 0 0 0 0 15.53089 0 15.43665 0 0 13.84382 0 0 0 0 0 0 0 0 0 18.55274 0 0 0 14.1052 0 0 0 0 0 0 0 17.83397 0 0 0 0 0 Q92905 CSN5_HUMAN "COP9 signalosome complex subunit 5, SGN5, Signalosome subunit 5, EC 3.4.-.- (Jun activation domain-binding protein 1)" COPS5 CSN5 JAB1 Homo sapiens (Human) exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]; exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412] enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743] GO:0000338; GO:0003713; GO:0003743; GO:0004222; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006412; GO:0008021; GO:0008180; GO:0008237; GO:0016579; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045116; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0070122; GO:0140492; GO:1903894; GO:1990182; GO:2000434 ISALALLKMVMHAR 4.539999962 1 1 0.149300159 1570.300192 0 0 14.02099 0 0 0 0 0 0 0 0 0 0 0 0 10.11773 0 0 13.33048 14.77981 0 15.29528 0 0 0 0 12.80317 0 0 13.85804 15.19804 15.90006 15.90863 0 13.69287 0 0 14.96001 14.9608 14.67806 15.5016 0 0 0 0 0 13.37977 0 Q92913 FGF13_HUMAN "Fibroblast growth factor 13, FGF-13 (Fibroblast growth factor homologous factor 2, FHF-2)" FGF13 FHF2 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814] beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] GO:0000165; GO:0001764; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006814; GO:0007026; GO:0007165; GO:0007267; GO:0007399; GO:0007612; GO:0007613; GO:0008017; GO:0008083; GO:0014704; GO:0016328; GO:0017080; GO:0021766; GO:0021795; GO:0030175; GO:0030295; GO:0030424; GO:0030425; GO:0030426; GO:0043005; GO:0044325; GO:0045200; GO:0046785; GO:0048487; GO:0048671; GO:0072659; GO:0098909; GO:1904862; GO:1905150 NKPAAHFLPKPLK 9.380000114 1 1 0.239012997 1457.93669 0 0 0 0 0 0 17.45812 0 18.19274 0 15.8914 0 0 0 0 0 0 0 0 0 14.46505 0 0 0 0 23.2248 0 0 0 0 23.91766 0 0 0 18.99002 0 18.01603 0 0 0 17.37215 0 0 0 0 0 0 0 Q92918 M4K1_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 1, EC 2.7.11.1 (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1, MEK kinase kinase 1, MEKKK 1)" MAP4K1 HPK1 Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007254; GO:0008283; GO:0008349; GO:0016020; GO:0018105; GO:0043410; GO:0046777; GO:0106310; GO:1904628 GLILDLLDK 7.119999886 0.002862959 0.002862959 0.296860963 999.3372414 16.17974 14.47952 0 0 16.19008 0 0 0 0 0 17.59508 0 0 16.26787 16.79788 0 17.86776 17.68688 0 16.15116 0 0 0 0 0 0 17.90898 0 15.22641 0 18.38741 0 17.51836 0 0 17.93241 0 0 17.08535 0 15.65484 0 0 0 16.95774 0 0 0 Q92922 SMRC1_HUMAN "SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155, BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)" SMARCC1 BAF155 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741] "brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713] GO:0000776; GO:0000785; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008286; GO:0009887; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032435; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045893; GO:0045944; GO:0047485; GO:0070316; GO:0071564; GO:0071565; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 ASANAR 1.99000001 0.788591623 0.788591623 0.200950079 587.8795547 17.16597 0 0 13.43384 15.90368 0 0 0 0 0 0 18.2801 18.20651 20.11948 20.95321 0 21.26957 20.24766 16.45297 16.58162 15.59858 0 20.32017 0 0 19.36662 19.04367 16.88364 19.29754 0 0 0 0 0 18.19677 0 18.86598 0 0 17.60279 0 0 0 18.915 0 19.63671 0 20.24311 Q92935 EXTL1_HUMAN "Exostosin-like 1, EC 2.4.1.224 (Exostosin-L) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein)" EXTL1 EXTL Homo sapiens (Human) protein glycosylation [GO:0006486]; skeletal system development [GO:0001501] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; protein glycosylation [GO:0006486]; skeletal system development [GO:0001501] acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757] GO:0001501; GO:0005789; GO:0005794; GO:0006486; GO:0008375; GO:0015020; GO:0016021; GO:0016757; GO:0050508 SLWLALSASWLLLVLLGGFSLLR 4.610000134 1 1 4.86E-13 2528.986672 0 0 0 0 0 0 0 0 0 0 18.34076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92945 FUBP2_HUMAN "Far upstream element-binding protein 2, FUSE-binding protein 2 (KH type-splicing regulatory protein, KSRP) (p75)" KHSRP FUBP2 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000375; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0010468; GO:0010586; GO:0010989; GO:0016020; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345 AINQQTGAFVEISR 13.17000008 0.071707539 0.071707539 0.332445527 1533.923806 14.37913 14.95051 14.58594 12.49084 0 0 16.08247 15.21341 13.11845 9.764253 15.02687 0 14.55904 0 0 0 17.29485 0 13.75715 14.43311 0 0 0 15.94431 0 0 0 18.64132 0 0 0 0 15.76627 0 0 17.07384 0 0 0 0 0 0 0 0 0 0 0 0 Q92947 GCDH_HUMAN "Glutaryl-CoA dehydrogenase, mitochondrial, GCD, EC 1.3.8.6" GCDH Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568] fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361] GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660 LMPRILLANR 29.77000046 0.137987137 0.137987137 2.28E-12 1212.631241 0 16.65482 18.80388 0 0 19.62114 0 0 18.97035 0 18.60969 16.19843 17.89705 17.63131 19.35187 0 0 0 0 18.61109 18.98303 17.25475 19.12989 17.98138 0 18.69403 18.39622 0 18.35764 0 0 19.15022 18.71829 19.0745 19.44089 10.90061 0 0 18.99496 0 18.96774 18.59259 0 19.40185 0 0 0 16.49859 Q92953 KCNB2_HUMAN Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2) KCNB2 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940] delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006940; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659 KDSSQEGCK 3.170000076 1 1 0.13040947 1038.675216 0 12.16466 0 0 13.7224 0 0 0 0 14.31472 0 14.58207 14.80976 0 0 0 15.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 16.91578 0 0 14.8973 0 0 15.8343 0 0 0 0 15.92553 0 0 0 17.50114 0 0 Q92954 PRG4_HUMAN Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part ] PRG4 MSF SZP Homo sapiens (Human) immune response [GO:0006955] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955] polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005615; GO:0006955; GO:0030247; GO:0062023 ALENSPK 16.43000031 1.72E-06 1.72E-06 0.291078036 759.8247987 17.52956 17.54889 0 0 0 0 0 0 18.30655 0 0 0 17.07817 0 0 18.77479 0 0 0 0 0 19.19245 18.08776 18.74247 0 0 19.90419 17.47558 0 18.00594 0 19.08619 18.37949 0 0 0 20.84249 0 20.92208 19.26096 19.45543 0 20.20066 18.17549 0 20.41961 19.81656 17.95396 Q92966 SNPC3_HUMAN "snRNA-activating protein complex subunit 3, SNAPc subunit 3 (Proximal sequence element-binding transcription factor subunit beta, PSE-binding factor subunit beta, PTF subunit beta) (Small nuclear RNA-activating complex polypeptide 3) (snRNA-activating protein complex 50 kDa subunit, SNAPc 50 kDa subunit)" SNAPC3 SNAP50 Homo sapiens (Human) snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006] GO:0000995; GO:0001006; GO:0003677; GO:0003681; GO:0005634; GO:0005654; GO:0005730; GO:0006366; GO:0006383; GO:0009301; GO:0016604; GO:0019185; GO:0042795; GO:0042796 LRGAGDLSLR 3.420000076 1 1 0.166594867 1057.297109 16.24261 11.58941 14.93475 14.04873 12.53896 11.84888 0 0 0 0 13.1361 13.07023 0 15.71156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.54184 0 0 0 0 0 0 0 0 0 0 Q92973 TNPO1_HUMAN "Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein, MIP)" TNPO1 KPNB2 MIP1 TRN Homo sapiens (Human) protein import into nucleus [GO:0006606] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0031267; GO:0061608; GO:0070062 MDRLLPHMHNIVEYMLQR 6.869999886 0.960776329 0.960776329 0.079572731 2328.563097 0 14.68334 15.15625 15.1457 15.25434 0 11.53588 0 14.68979 14.01561 13.92587 13.30707 14.67579 11.33427 0 0 0 13.4447 12.08304 15.03695 15.44812 0 11.56043 0 13.33908 11.77973 15.06781 12.28839 0 0 0 0 0 0 0 0 0 12.08014 0 16.22417 11.94866 0 14.88117 13.33814 0 0 13.52052 15.12337 Q92974 ARHG2_HUMAN "Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1, GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40)" ARHGEF2 KIAA0651 LFP40 Homo sapiens (Human) actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] GO:0000902; GO:0005085; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005856; GO:0005874; GO:0005923; GO:0005925; GO:0006886; GO:0007015; GO:0007026; GO:0007049; GO:0008017; GO:0008270; GO:0031267; GO:0031410; GO:0031982; GO:0032587; GO:0032755; GO:0032760; GO:0032991; GO:0035023; GO:0042127; GO:0045087; GO:0045666; GO:0045944; GO:0050731; GO:0051056; GO:0051092; GO:0055059; GO:0060546; GO:0071225; GO:0071356; GO:0071474; GO:1902042; GO:1902219; GO:2001224 ARIDR 4.860000134 1 1 0.270727666 630.5781632 18.46749 17.09835 0 0 0 0 17.19062 0 17.82137 0 0 0 0 17.90952 17.46798 18.17671 0 17.92412 0 0 0 16.14319 18.62663 0 0 0 17.28164 16.86283 0 0 0 18.13625 19.25588 18.76312 15.92992 16.92277 18.61053 0 0 0 17.16365 16.81559 0 0 0 18.00839 0 16.72255 Q92997 DVL3_HUMAN "Segment polarity protein dishevelled homolog DVL-3, Dishevelled-3 (DSH homolog 3)" DVL3 KIAA0208 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein localization [GO:0032880]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" chromatin [GO:0000785]; cytosol [GO:0005829] "chromatin [GO:0000785]; cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein localization [GO:0032880]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] GO:0000785; GO:0001934; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0031267; GO:0032880; GO:0035556; GO:0035567; GO:0038031; GO:0043507; GO:0043547; GO:0045893; GO:0045944; GO:0050821; GO:0060070; GO:0060071; GO:0090179; GO:0150012 QSFRMAMGNPSEFFVDVM 3.559999943 1 1 0.165488193 2125.226809 14.16112 14.43857 11.49131 14.03221 13.96172 0 14.89466 0 14.31659 15.44288 0 13.68819 15.35027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93008 USP9X_HUMAN "Probable ubiquitin carboxyl-terminal hydrolase FAF-X, EC 3.4.19.12 (Deubiquitinating enzyme FAF-X) (Fat facets in mammals, hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)" USP9X DFFRX FAM USP9 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]; amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179] co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843] GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0032092; GO:0032435; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0061578; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:1901537; GO:1904515; GO:1990000; GO:1990380 ASYDTLCVLDGDK 4.320000172 1 1 0.376978101 1455.122425 15.44039 12.32205 0 0 0 0 0 0 12.26572 15.5446 0 15.37969 0 0 0 16.65981 0 0 0 0 16.53618 0 16.4389 0 16.67113 0 16.94785 16.42719 15.09582 14.91509 16.62373 0 15.9904 0 15.99875 14.99246 16.90117 17.27621 0 17.00327 0 15.81749 16.10294 16.97364 15.99967 16.79323 17.25522 17.73969 Q93009 UBP7_HUMAN "Ubiquitin carboxyl-terminal hydrolase 7, EC 3.4.19.12 (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)" USP7 HAUSP Homo sapiens (Human) "histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]" chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] "chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]" cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625] GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006111; GO:0006283; GO:0006511; GO:0008022; GO:0010216; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031625; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0035616; GO:0042752; GO:0048511; GO:0050821; GO:0051090; GO:0070536; GO:0101005; GO:1901537; GO:1901796; GO:1904353; GO:1905279; GO:1990380 FYPDRPHQK 4.820000172 1 1 0 1188.237813 14.55029 0 13.43089 0 14.1605 16.38371 12.54418 14.04935 9.345576 0 12.27568 16.08752 0 15.26242 14.23354 15.32705 0 0 0 14.63705 0 0 0 0 0 0 0 0 0 0 0 12.68365 0 0 0 0 0 13.78478 0 0 0 17.04176 0 0 15.71444 0 0 0 Q93015 NAA80_HUMAN "N-alpha-acetyltransferase 80, HsNAAA80, EC 2.3.1.- (N-acetyltransferase 6) (Protein fusion-2, Protein fus-2)" NAA80 FUS2 NAT6 Homo sapiens (Human) actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064] acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596] GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502 APNLTAQAAPRGPK 10.82999992 1 1 0.237904384 1391.306677 15.90844 13.88638 15.74524 0 15.61005 15.80559 0 13.18751 0 12.81925 16.40792 16.33648 14.59531 13.76185 15.53876 0 12.94767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.91063 0 0 16.2526 0 0 0 0 0 16.14851 16.21603 0 0 0 0 0 0 Q93033 IGSF2_HUMAN "Immunoglobulin superfamily member 2, IgSF2 (Cell surface glycoprotein V7) (Glu-Trp-Ile EWI motif-containing protein 101, EWI-101) (CD antigen CD101)" CD101 EWI101 IGSF2 V7 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; cell surface receptor signaling pathway [GO:0007166]" "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]" GO:0005886; GO:0007166; GO:0016021; GO:0016812; GO:0070062 QQVVWEGETLAFLCK 24.84000015 1 1 1.15E-12 1808.301247 16.37502 0 15.47311 0 0 0 0 15.8124 0 0 0 0 0 0 0 0 0 15.83395 0 0 0 0 0 15.15054 0 0 0 0 0 0 16.18484 0 0 0 15.21121 16.45362 16.80833 0 0 0 0 0 0 0 0 0 0 14.84528 Q93034 CUL5_HUMAN "Cullin-5, CUL-5 (Vasopressin-activated calcium-mobilizing receptor 1, VACM-1)" CUL5 VACM1 Homo sapiens (Human) ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734] Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]; calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] GO:0000082; GO:0004842; GO:0005262; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0038023; GO:0038128; GO:0090734; GO:0097193 RNETEK 3.049999952 1 1 0.137351001 775.7927865 0 13.84666 15.89455 0 13.93705 15.34554 14.46982 0 15.69377 0 14.16283 0 13.36102 14.30252 0 13.90616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22413 0 15.8643 0 0 0 0 Q93052 LPP_HUMAN Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) LPP Homo sapiens (Human) cell-cell adhesion [GO:0098609] cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609] metal ion binding [GO:0046872] GO:0001725; GO:0005634; GO:0005829; GO:0005886; GO:0005925; GO:0046872; GO:0098609 RMVIPNQPPLTATK 7.940000057 1 1 0.158650718 1581.734905 16.14665 0 0 14.96042 15.34319 0 0 16.44113 0 0 0 14.50075 16.95008 0 13.69368 16.85483 17.73143 16.82168 14.14925 13.67662 0 0 18.17165 12.76305 12.62465 17.59661 15.81449 0 0 17.02485 15.55294 16.59625 15.43449 0 0 0 0 0 0 0 15.76956 17.33673 15.82524 12.43884 15.13546 15.98309 0 11.64762 Q93063 EXT2_HUMAN "Exostosin-2, EC 2.4.1.224, EC 2.4.1.225 (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2)" EXT2 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]" glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982] GO:0000139; GO:0001503; GO:0001707; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006487; GO:0007165; GO:0008217; GO:0010467; GO:0015012; GO:0015014; GO:0015020; GO:0016020; GO:0016021; GO:0016757; GO:0030154; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0051923; GO:0055078; GO:0060047; GO:0060350; GO:0070062 MCASVKYNIR 8.779999733 0.880464256 0.880464256 2.28E-12 1256.567157 16.82959 0 12.8481 0 9.411029 15.90951 0 0 0 14.75005 0 13.24315 0 0 15.80794 11.78236 0 16.86661 15.63397 16.00409 0 15.91348 0 16.04589 0 0 0 0 16.44098 15.6478 0 14.62411 14.79475 0 13.1262 0 0 13.6104 11.96572 0 16.23073 15.98766 18.01974 0 0 10.42628 14.43002 15.54126 Q93073 SBP2L_HUMAN "Selenocysteine insertion sequence-binding protein 2-like, SECIS-binding protein 2-like" SECISBP2L KIAA0256 Homo sapiens (Human) selenocysteine incorporation [GO:0001514] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514] mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368] GO:0001514; GO:0003723; GO:0003730; GO:0035368; GO:0043021; GO:1990904 LVMGLR 6.230000019 0.810303509 0.810303509 0.206438074 689.4015173 0 14.38117 13.31207 0 13.26299 14.47125 15.18811 15.38274 14.57262 14.61849 16.78986 0 16.15325 16.32816 15.3386 15.19365 16.56287 14.85581 16.1979 16.38603 16.53041 0 15.84464 16.28498 16.18464 0 0 0 14.54038 0 0 0 16.69499 14.32181 0 0 15.77121 15.84529 0 15.35178 16.06145 15.23929 15.00325 15.02915 0 0 15.35895 0 Q93074 MED12_HUMAN "Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component, ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component, Trap230) (Trinucleotide repeat-containing gene 11 protein)" MED12 ARC240 CAGH45 HOPA KIAA0192 TNRC11 TRAP230 Homo sapiens (Human) "axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809] GO:0000151; GO:0000978; GO:0001843; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0007492; GO:0007507; GO:0008013; GO:0008022; GO:0014003; GO:0014044; GO:0016020; GO:0016592; GO:0019827; GO:0019904; GO:0021510; GO:0030374; GO:0036342; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0048702; GO:0060070; GO:0060071; GO:0060261; GO:0061630; GO:0090245; GO:1990403 DILKVLNR 3.359999895 0.705258787 0.705258787 0.06672156 968.1666238 0 15.3954 0 0 14.39542 0 0 0 15.24894 16.18763 0 0 0 0 0 0 0 0 0 0 0 0 0 14.20112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93075 TATD2_HUMAN "Putative deoxyribonuclease TATDN2, EC 3.1.21.-" TATDN2 KIAA0218 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] metal ion binding [GO:0046872]; nuclease activity [GO:0004518] GO:0004518; GO:0005654; GO:0046872 DQPLSLTLAALR 11.51000023 0.23804535 0.23804535 0.455557327 1298.586903 0 0 13.89928 0 0 0 0 0 0 0 0 0 0 16.3883 0 0 0 0 18.4584 0 16.12307 16.02674 14.42623 16.69045 17.24074 15.27114 15.86793 17.29282 16.81607 16.48334 17.39184 16.57386 17.79537 17.88761 16.34705 17.25494 17.04206 18.63052 17.51543 16.62059 17.48285 0 17.99163 16.75234 18.22972 15.62454 18.34991 18.26566 Q93097 WNT2B_HUMAN Protein Wnt-2b (Protein Wnt-13) WNT2B WNT13 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190] cytokine activity [GO:0005125]; frizzled binding [GO:0005109] GO:0002062; GO:0002088; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0008584; GO:0009267; GO:0021871; GO:0030182; GO:0043231; GO:0045165; GO:0060070; GO:0060492; GO:0060638; GO:0061072; GO:0061303; GO:0062023; GO:0071425; GO:0090190 AEWLDQT 8.260000229 1 1 0.131669164 860.2591647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29712 0 0 0 0 0 0 0 0 Q93099 HGD_HUMAN "Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)" HGD HGO Homo sapiens (Human) L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]" "homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" GO:0004411; GO:0005829; GO:0006559; GO:0006572; GO:0042802; GO:0046872; GO:0070062 NPAEPN 8.159999847 1 1 0.277596379 641.9409951 0 0 0 0 18.47102 17.7318 19.06816 0 0 0 0 0 0 18.16243 0 0 0 0 0 0 18.33675 19.61547 17.67752 0 0 0 18.45472 0 17.96712 0 0 0 19.38125 0 0 0 0 0 0 0 19.39794 0 0 17.20416 0 18.38865 0 17.35202 Q969D9 TSLP_HUMAN Thymic stromal lymphopoietin TSLP Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139] GO:0001961; GO:0005125; GO:0005139; GO:0005576; GO:0005615; GO:0008284; GO:0032722; GO:0032733; GO:0032736; GO:0032754; GO:0032755; GO:0033005; GO:0042531; GO:0043066; GO:0050729; GO:0050829; GO:0050832; GO:0061844; GO:0071654; GO:0071657; GO:1904894 EMFAMKTK 7.130000114 0.554800928 0.554800928 0.159584699 1002.61152 14.23583 14.48283 16.30966 0 0 15.25142 0 14.13808 0 16.11101 0 13.1622 0 0 0 0 14.98348 11.33662 11.34853 0 0 0 0 0 11.86884 0 16.35855 13.39788 14.75804 14.83549 15.61653 14.95494 16.05464 0 15.63563 14.47852 0 16.90287 15.59011 15.46367 15.17407 14.81849 15.2226 13.8567 14.67416 12.17971 13.19308 14.4509 Q969E1 LEAP2_HUMAN "Liver-expressed antimicrobial peptide 2, LEAP-2" LEAP2 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832] extracellular region [GO:0005576] extracellular region [GO:0005576]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832] GO:0005576; GO:0042742; GO:0050832; GO:0061844 MTPFWRGVSLRPIGASCR 3.529999971 1 1 9.16E-13 2107.0384 13.37233 0 0 11.5582 14.3037 0 14.32893 15.05684 13.41887 0 15.6213 0 12.60066 0 12.84024 10.83144 13.14449 13.16901 16.13827 10.90838 0 0 0 0 0 0 15.72411 0 0 0 0 0 0 0 0 0 0 0 0 15.58541 0 0 0 0 0 0 15.04366 0 Q969F2 NKD2_HUMAN "Protein naked cuticle homolog 2, Naked-2, hNkd2" NKD2 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi vesicle fusion to target membrane [GO:0048210]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein processing [GO:0010954]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055] basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625]; exocytosis [GO:0006887]; Golgi vesicle fusion to target membrane [GO:0048210]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein processing [GO:0010954]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055] ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625] GO:0005509; GO:0005737; GO:0005886; GO:0006887; GO:0010954; GO:0016055; GO:0016323; GO:0016328; GO:0019838; GO:0030178; GO:0031410; GO:0031625; GO:0032036; GO:0032436; GO:0048210; GO:0051117; GO:0070382; GO:0071944; GO:0072659; GO:0090090; GO:1903078 LTVSPEPSSK 16.28000069 1 1 0.137557627 1045.471704 15.49942 15.05814 16.36864 15.62453 14.51343 0 14.37945 12.80057 13.18271 16.06708 14.52153 14.47209 16.00893 15.87346 0 15.91776 0 0 0 0 0 0 0 0 0 0 16.72172 0 0 0 0 0 15.16308 0 0 14.31858 17.61944 13.98779 15.49131 0 15.44321 15.42936 16.2202 16.42534 16.68222 0 0 0 Q969F9 HPS3_HUMAN Hermansky-Pudlak syndrome 3 protein HPS3 Homo sapiens (Human) intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; early endosome [GO:0005769] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155] GO:0005737; GO:0005769; GO:0006996; GO:0031084; GO:0046907; GO:0060155; GO:1903232 AAVALK 2.940000057 1 1 0.274096751 572.9491787 0 0 0 0 0 0 0 0 0 0 0 0 16.87618 0 0 0 0 0 0 0 0 0 17.06077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969G9 NKD1_HUMAN "Protein naked cuticle homolog 1, Naked-1, hNkd, hNkd1" NKD1 NKD PP7246 Homo sapiens (Human) "eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of convergent extension involved in axis elongation [GO:1901233]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of non-canonical Wnt signaling pathway via JNK cascade [GO:1901231]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159] "cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of convergent extension involved in axis elongation [GO:1901233]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of non-canonical Wnt signaling pathway via JNK cascade [GO:1901231]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; Wnt signaling pathway [GO:0016055]" calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165] GO:0000159; GO:0001754; GO:0005509; GO:0005737; GO:0005886; GO:0007525; GO:0016055; GO:0030165; GO:0030178; GO:0045732; GO:0090090; GO:0090249; GO:1901231; GO:1901233; GO:2000096 TDGLGSGDEK 6.940000057 1 1 0.087633819 979.5343869 9.641736 0 0 0 0 0 0 0 15.41709 0 0 0 0 0 0 14.30253 14.75247 0 14.24832 0 0 0 15.46487 15.80492 0 0 0 0 13.98623 0 0 0 15.61108 13.18998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969K7 TMM54_HUMAN Transmembrane protein 54 (Beta-casein-like protein) (Protein CAC-1) TMEM54 BCLP CAC1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LGGLSVGDFR 17.57999992 1 1 0.147011395 1015.234322 0 10.69738 13.64149 14.7349 0 14.71429 14.71353 0 13.91286 0 13.79368 0 11.41986 0 15.58699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969L4 LSM10_HUMAN U7 snRNA-associated Sm-like protein LSm10 LSM10 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380] Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683] Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380] histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209] GO:0005654; GO:0005683; GO:0006398; GO:0008380; GO:0015030; GO:0016604; GO:0071208; GO:0071209; GO:0071254; GO:1900087 NFGGKGQGR 5.159999847 1 1 0.058858441 919.454185 14.48189 0 15.3666 0 13.85671 0 14.53354 13.62613 16.07614 15.85095 0 13.87645 0 15.0786 13.78887 12.31722 13.30106 0 0 14.12751 0 14.91447 15.14431 0 0 0 0 0 0 0 0 15.85955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969M1 TM40L_HUMAN Mitochondrial import receptor subunit TOM40B (Protein TOMM40-like) TOMM40L TOMM40B Homo sapiens (Human) ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150] mitochondrial outer membrane translocase complex [GO:0005742]; pore complex [GO:0046930]; protein-containing complex [GO:0032991] mitochondrial outer membrane translocase complex [GO:0005742]; pore complex [GO:0046930]; protein-containing complex [GO:0032991]; mitochondrion targeting sequence binding [GO:0030943]; porin activity [GO:0015288]; preprotein binding [GO:0070678]; protein transmembrane transporter activity [GO:0008320]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150] mitochondrion targeting sequence binding [GO:0030943]; porin activity [GO:0015288]; preprotein binding [GO:0070678]; protein transmembrane transporter activity [GO:0008320] GO:0005742; GO:0006811; GO:0008320; GO:0015288; GO:0030150; GO:0030943; GO:0032991; GO:0046930; GO:0070678 GNTLGLAPMGTLPR 5.110000134 1 1 0.287275094 1413.192653 14.57416 12.80338 13.32261 15.24578 14.52179 14.73765 0 0 0 15.61877 0 0 0 14.34051 13.02439 13.53177 15.55901 0 14.81883 0 0 0 0 14.92761 0 13.44247 0 0 0 0 0 0 0 0 0 0 0 0 16.96591 15.69456 15.3334 13.77741 0 0 15.83672 0 0 0 Q969M2 CXA10_HUMAN "Gap junction alpha-10 protein (Connexin-62, Cx62)" GJA10 CX62 Homo sapiens (Human) cell-cell signaling [GO:0007267]; detection of light stimulus involved in visual perception [GO:0050908]; gamete generation [GO:0007276]; synapse assembly [GO:0007416] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; detection of light stimulus involved in visual perception [GO:0050908]; gamete generation [GO:0007276]; synapse assembly [GO:0007416] gap junction channel activity [GO:0005243] GO:0005243; GO:0005886; GO:0005922; GO:0007267; GO:0007276; GO:0007416; GO:0016021; GO:0050908 SKTMWQIPQPR 13.78999996 1 1 0 1388.432551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969N2 PIGT_HUMAN GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein) PIGT CGI-06 PSEC0163 UNQ716/PRO1379 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182] GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402 AGLSVLLKADR 8.420000076 0.2479617 0.2479617 0.519551231 1139.251914 0 0 18.22997 0 0 0 0 0 17.42146 0 18.17111 18.78292 14.37199 0 0 0 0 0 0 0 0 0 0 19.45516 0 0 0 18.01183 0 0 20.58559 0 0 0 0 0 0 0 19.80231 17.24622 0 0 0 16.24536 18.99016 0 19.21294 0 Q969P0 IGSF8_HUMAN "Immunoglobulin superfamily member 8, IgSF8 (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2, EWI-2) (Keratinocytes-associated transmembrane protein 4, KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein, PGRL) (CD antigen CD316)" IGSF8 CD81P3 EWI2 KCT4 Homo sapiens (Human) cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519] GO:0005886; GO:0007338; GO:0007399; GO:0007519; GO:0016020; GO:0016021; GO:0043231; GO:0048870; GO:0070062 GRQAPTSPPR 3.400000095 1 1 0.025389155 1067.542909 14.86112 14.8109 0 13.0332 12.61164 16.90412 13.14403 10.99159 0 0 13.97145 0 16.0365 13.44742 12.53306 0 0 0 13.99048 14.56063 12.62377 11.94971 0 0 13.77818 0 0 13.68018 17.07149 15.05764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969P5 FBX32_HUMAN "F-box only protein 32 (Atrogin-1) (Muscle atrophy F-box protein, MAFbx)" FBXO32 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018]; cellular response to dexamethasone stimulus [GO:0071549]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0014894; GO:0016567; GO:0019005; GO:0030018; GO:0071549 DMLNSKTK 7.960000038 0.528506577 0.528506577 0.274500383 952.7410629 14.28934 15.02483 10.20539 14.05484 15.77398 0 16.61847 16.09826 16.27953 0 16.12787 16.05868 16.00567 11.72507 0 0 16.95495 15.34611 16.23061 12.84366 14.50528 13.28535 16.34157 16.71576 15.34272 15.35986 15.17257 0 15.36814 13.42526 0 0 14.8942 0 0 0 16.01037 16.04294 0 0 14.44803 16.03675 0 14.04655 14.75885 0 14.20014 0 Q969P6 TOP1M_HUMAN "DNA topoisomerase I, mitochondrial, TOP1mt, EC 5.6.2.1" TOP1MT Homo sapiens (Human) DNA replication [GO:0006260]; DNA topological change [GO:0006265] chromosome [GO:0005694]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]" "DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]" GO:0003677; GO:0003917; GO:0005654; GO:0005694; GO:0005739; GO:0006260; GO:0006265; GO:0042645 EQVAEARAELR 9.109999657 1 1 0.399366284 1271.61237 18.54137 20.10151 0 17.2115 0 19.45351 0 0 19.61919 21.15152 18.78039 0 0 0 0 0 0 19.50782 0 0 0 0 0 0 0 0 0 0 0 17.03929 0 0 20.30001 0 0 19.81306 0 21.23689 0 0 0 0 0 0 19.64143 17.96291 0 19.92907 Q969Q6 P2R3C_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C) PPP2R3C C14orf10 G5PR Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029] metal ion binding [GO:0046872] GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900 NTNEFYK 10.18000031 1 1 0.48902247 917.0701898 12.07152 14.41262 11.90234 0 0 0 0 0 17.15605 0 0 0 0 20.81236 0 0 0 0 0 0 19.43362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969R5 LMBL2_HUMAN "Lethal(3)malignant brain tumor-like protein 2, H-l(3)mbt-like protein 2, L(3)mbt-like protein 2" L3MBTL2 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0008270; GO:0035064; GO:0042393; GO:0045892 AKEATK 1.029999971 0.329477757 0.329477757 0.286985795 647.7136351 15.27797 16.18765 15.91201 17.21143 12.18674 0 18.786 0 19.05697 0 0 0 0 16.72617 18.44452 0 0 17.51586 0 0 16.54622 18.15252 18.1399 0 0 0 18.34194 19.29426 0 18.52847 19.36172 19.76764 0 18.36926 0 18.9761 0 0 20.16343 0 16.97468 18.44439 0 0 0 16.88342 17.07103 18.47767 Q969S3 ZN622_HUMAN Zinc finger protein 622 (Zinc finger-like protein 9) ZNF622 ZPR9 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]" "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]" RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0008270; GO:0008631; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330 ALGWTGSTGAALMR 7.050000191 1 1 2.52E-12 1391.835188 0 0 14.87471 15.10752 0 0 15.14163 14.44775 15.04992 15.37786 14.49445 0 0 0 0 13.43193 14.63399 0 0 0 15.32625 0 0 0 0 0 0 15.59617 0 0 14.88259 13.53303 0 0 0 0 0 0 0 14.37341 0 0 12.5369 0 0 0 0 0 Q969S8 HDA10_HUMAN "Polyamine deacetylase HDAC10, EC 3.5.1.48, EC 3.5.1.62 (Histone deacetylase 10, HD10)" HDAC10 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]" cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]" acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270] GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006355; GO:0006476; GO:0008270; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048 QRGLEQR 4.849999905 0.890584588 0.890584588 0.178548543 884.2599443 13.67157 15.17416 11.13127 13.28307 0 0 0 0 12.77411 0 0 0 16.68126 15.90018 16.31915 0 15.78955 15.70932 0 16.66097 0 15.00266 0 0 16.22016 15.07164 0 15.77538 0 13.07534 15.08966 14.7381 15.63152 14.21114 14.19891 14.44051 0 13.76263 15.18427 11.79764 14.5967 0 15.69216 12.80233 15.64854 17.17498 13.41109 14.80624 Q969V4 TEKT1_HUMAN Tektin-1 TEKT1 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0031514; GO:0060271; GO:0060294 VMEEIASQEK 5.320000172 0.063481443 0.063481443 0.010475892 1178.880834 11.70101 0 0 17.14472 13.68981 13.42362 0 0 0 0 12.3946 0 14.89009 0 14.39884 0 11.85099 13.16401 0 0 0 17.71401 15.29676 0 15.87907 13.6672 16.44722 0 13.26359 0 0 17.69137 15.50334 15.33673 0 0 0 0 0 0 15.06559 0 0 0 15.19628 13.55869 15.35557 10.35659 Q969V6 MRTFA_HUMAN "Myocardin-related transcription factor A, MRTF-A (MKL/myocardin-like protein 1) (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein)" MRTFA KIAA1438 MAL MKL1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription via serum response element binding [GO:0010735]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription via serum response element binding [GO:0010735]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]" actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0003779; GO:0003785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010735; GO:0030036; GO:0043522; GO:0044319; GO:0045944; GO:0051145; GO:1902895 SAGEALGSSGTPPVR 8.960000038 1 1 0.098576633 1386.230968 0 0 14.95657 0 0 13.93078 0 0 4.261875 0 0 0 12.44202 0 0 12.52695 10.97653 0 0 0 0 0 0 14.42966 0 0 0 0 0 13.24275 13.04829 0 0 0 0 0 0 0 0 0 9.299935 11.62114 15.04278 0 15.36715 0 0 0 Q969W3 F104A_HUMAN Protein FAM104A FAM104A Homo sapiens (Human) ARGGGR 8.619999886 0.424759597 0.424759597 0.276825742 573.5977758 0 16.47015 15.95188 16.8274 0 13.13451 15.41889 15.47455 0 14.1755 16.38424 16.32968 0 0 15.66103 16.08106 0 0 0 0 0 16.48474 0 0 15.5088 0 0 14.7817 0 0 0 16.955 14.8731 0 15.54935 16.13615 15.82951 0 16.64058 0 0 0 0 16.62888 0 0 0 0 Q969X0 RIPL2_HUMAN RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein) RILPL2 RLP2 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445] identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983] GO:0003382; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0016020; GO:0036064; GO:0042802; GO:0046983; GO:0060271; GO:1903445 MERDHLR 6.059999943 1 1 0.190513999 956.1167505 0 15.36037 14.48325 16.43715 13.94319 15.59675 0 0 15.38606 0 15.99378 0 0 0 0 0 0 13.55408 14.03366 15.34735 0 0 16.25755 13.73963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.27372 0 0 0 14.79367 0 0 0 0 Q969X2 SIA7F_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, EC 2.4.99.- (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI, ST6GalNAcVI, hST6GalNAc VI) (Sialyltransferase 7F, SIAT7-F)" ST6GALNAC6 SIAT7F UNQ708/PRO1359 Homo sapiens (Human) cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]" "alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]" GO:0000139; GO:0001574; GO:0001665; GO:0005737; GO:0005886; GO:0006486; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0009312; GO:0009988; GO:0016021 HLPLSR 2.809999943 1 1 0.091788003 722.5895426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.09752 0 0 0 0 0 16.92488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969Z0 FAKD4_HUMAN "FAST kinase domain-containing protein 4 (Cell cycle progression restoration protein 2, Cell cycle progression protein 2) (Protein TBRG4) (Transforming growth factor beta regulator 4)" TBRG4 CPR2 FASTKD4 KIAA0948 Homo sapiens (Human) mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528] RNA binding [GO:0003723] GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0008284; GO:0016071; GO:0035770; GO:0044528; GO:0051726; GO:0090615 LLGSLYALGIPK 3.390000105 1 1 0.177476715 1243.709505 13.94144 0 7.691537 13.27129 13.96747 0 0 0 0 18.23077 14.57209 13.78867 0 6.43672 0 0 15.15005 0 12.31772 14.26388 0 14.07183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969Z3 MARC2_HUMAN "Mitochondrial amidoxime reducing component 2, mARC2, EC 1.7.-.- (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2, MOSC domain-containing protein 2, Moco sulfurase C-terminal domain-containing protein 2)" MTARC2 MARC2 MOSC2 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] "mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]; cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]" "molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]" GO:0005739; GO:0005741; GO:0005777; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809 VGDPVYRMV 6.78000021 1 1 0.240281993 1051.175318 0 16.79167 0 0 15.41158 13.57157 0 0 15.52606 0 11.56882 13.82117 0 0 0 0 0 0 0 0 0 0 0 16.40951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.17649 0 0 0 0 0 0 0 0 0 Q96A05 VATE2_HUMAN "V-type proton ATPase subunit E 2, V-ATPase subunit E 2 (Vacuolar proton pump subunit E 2)" ATP6V1E2 ATP6E1 ATP6EL2 ATP6V1EL2 Homo sapiens (Human) regulation of macroautophagy [GO:0016241] "acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]" "acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]" "proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0001669; GO:0005829; GO:0016241; GO:0033178; GO:0046961 LLEPVMIVR 2.480000019 1 1 0.203796487 1086.07454 12.37603 14.5506 15.57322 0 15.26498 0 0 12.5612 16.01445 0 14.82085 0 0 12.44894 0 14.25894 0 0 13.88695 16.47009 16.12867 0 0 0 0 15.91884 16.38839 0 0 0 0 0 0 15.65476 0 0 0 0 14.71867 0 0 0 15.09568 0 0 0 0 14.83696 Q96A08 H2B1A_HUMAN "Histone H2B type 1-A (Histone H2B, testis, TSH2B.1, hTSH2B) (Testis-specific histone H2B)" H2BC1 HIST1H2BA TSH2B Homo sapiens (Human) "nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] GO:0000781; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0035093; GO:0046982 MPEVSSKGATISK 5.619999886 1 1 0.033551424 1350.392682 0 0 0 0 0 0 0 15.02603 0 0 15.51599 0 14.95279 0 0 0 0 0 0 0 0 0 0 14.24934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.22469 15.13327 0 0 Q96A09 TET5B_HUMAN "Terminal nucleotidyltransferase 5B, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46B)" TENT5B FAM46B Homo sapiens (Human) mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of translation [GO:0045727] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of translation [GO:0045727] polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817] GO:0004652; GO:0005634; GO:0005737; GO:0008285; GO:0043066; GO:0045727; GO:0045786; GO:0048255; GO:1990817 FVDSVRR 4.170000076 1 1 0.084718471 876.1630033 12.14523 13.93307 15.54062 13.30927 15.11929 12.78711 0 0 14.16914 0 0 0 0 0 0 0 15.44419 0 0 0 0 0 0 0 0 0 0 0 15.44647 15.53763 0 0 14.23561 0 0 15.13622 14.58486 0 0 0 0 0 0 0 0 0 0 0 Q96A11 G3ST3_HUMAN "Galactose-3-O-sulfotransferase 3, Gal3ST-3, EC 2.8.2.- (Beta-galactose-3-O-sulfotransferase 3, Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)" GAL3ST3 Homo sapiens (Human) glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146] GO:0001733; GO:0005996; GO:0006790; GO:0008146; GO:0009247; GO:0009311; GO:0016021; GO:0030166; GO:0030246; GO:0030309; GO:0032580; GO:0050656; GO:0050694; GO:0050698 LAAIPAALARAAR 9 1 1 0.341346355 1261.559886 13.98625 12.91556 15.7613 13.20586 0 0 0 0 0 15.16813 0 0 0 0 0 0 0 15.78646 16.38371 0 0 0 0 16.82129 15.33647 16.20896 15.89664 0 15.64158 0 17.59546 14.95619 16.25532 16.03947 0 0 17.52194 15.90667 0 0 0 17.16225 0 0 0 0 17.5472 0 Q96A19 C102A_HUMAN Coiled-coil domain-containing protein 102A CCDC102A Homo sapiens (Human) myosin complex [GO:0016459] myosin complex [GO:0016459] GO:0016459 MAELRGEMER 7.960000038 1 1 0.253072045 1237.519335 15.77609 0 14.0877 0 0 0 0 12.15815 14.17974 0 0 14.40114 0 16.16848 0 0 0 0 0 0 0 0 0 17.8805 0 16.86163 0 0 0 15.90657 16.69871 15.19961 0 0 0 16.49036 0 16.91367 0 0 0 0 17.00217 0 0 16.993 17.62994 0 Q96A22 CK052_HUMAN Uncharacterized protein C11orf52 C11orf52 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 YDSKNGTLV 6 1 1 0.04442681 997.553355 0 0 0 15.76539 14.48196 14.92373 0 0 12.37027 0 12.34279 0 13.25792 13.17684 0 0 0 0 0 0 16.02403 0 15.59048 0 14.73481 0 0 14.88741 14.11917 15.33066 0 15.26358 0 0 0 0 0 0 0 0 0 0 0 0 15.42149 0 0 0 Q96A25 T106A_HUMAN Transmembrane protein 106A TMEM106A Homo sapiens (Human) CD80 biosynthetic process [GO:0035780]; CD86 biosynthetic process [GO:0035781]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of nitric oxide metabolic process [GO:1904407]; positive regulation of tumor necrosis factor production [GO:0032760] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CD80 biosynthetic process [GO:0035780]; CD86 biosynthetic process [GO:0035781]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of nitric oxide metabolic process [GO:1904407]; positive regulation of tumor necrosis factor production [GO:0032760] GO:0005886; GO:0016021; GO:0032731; GO:0032755; GO:0032760; GO:0035780; GO:0035781; GO:0042116; GO:0043123; GO:0043410; GO:0045087; GO:0045348; GO:1904407 IPQELEKQLVALIPYGDQR 4.71999979 1 1 0.12472716 2209.169348 0 0 14.71515 15.21455 0 17.28242 15.18663 0 15.25391 16.38299 14.8657 15.66198 17.16199 15.23094 17.50965 0 0 0 0 0 0 0 17.71319 16.40029 16.01056 0 0 0 0 0 0 0 0 18.65369 0 16.96231 18.07997 0 18.21328 0 14.56333 0 0 16.96086 15.13054 0 17.90984 0 Q96A28 SLAF9_HUMAN "SLAM family member 9 (CD2 family member 10, CD2F-10) (CD84 homolog 1, CD84-H1)" SLAMF9 CD2F10 UNQ1938/PRO4421 Homo sapiens (Human) T cell activation [GO:0042110] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; T cell activation [GO:0042110] GO:0009897; GO:0009986; GO:0016021; GO:0042110 SLATVVPGK 12.17000008 1 1 0.306721326 870.9052658 0 0 16.74056 17.46116 0 0 11.44733 0 0 0 16.33963 17.11569 0 0 0 12.88577 16.64994 16.67364 17.4445 18.74328 0 0 0 16.91485 17.08821 17.45042 0 0 18.05273 0 0 0 0 18.32208 0 15.02251 19.04412 16.34762 0 0 0 0 0 17.56806 16.48711 0 0 0 Q96A29 FUCT1_HUMAN GDP-fucose transporter 1 (Solute carrier family 35 member C1) SLC35C1 FUCT1 Homo sapiens (Human) carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066] antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457] GO:0000139; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0030259; GO:0036066; GO:0036085; GO:0045746 NRAPLK 4.679999828 0.134676769 0.134676769 0.257495125 698.1888963 16.33213 0 0 0 0 0 15.73562 12.25165 0 0 0 13.68669 0 0 0 0 0 14.52763 0 0 0 0 16.40145 0 0 14.46901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A46 MFRN2_HUMAN "Mitoferrin-2 (Mitochondrial RNA-splicing protein 3/4 homolog, MRS3/4, hMRS3/4) (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28)" SLC25A28 MFRN2 NPD016 Homo sapiens (Human) iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072] iron ion transmembrane transporter activity [GO:0005381] GO:0005381; GO:0005743; GO:0016021; GO:0048250; GO:0055072 ELEGRGAGGVAGGPAAGPGR 2.75999999 1 1 0.286013463 1735.783594 0 15.59402 14.10838 14.53929 15.29439 15.01052 0 0 11.78866 15.6085 15.77578 0 0 0 11.45944 0 0 0 0 0 17.18421 0 16.75867 17.57627 0 0 15.90613 0 16.75341 0 0 13.02279 0 0 0 0 0 14.95177 15.16985 14.09999 0 0 0 0 0 0 0 0 Q96A47 ISL2_HUMAN "Insulin gene enhancer protein ISL-2, Islet-2" ISL2 Homo sapiens (Human) axonogenesis [GO:0007409]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; peripheral nervous system neuron development [GO:0048935]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord motor neuron cell fate specification [GO:0021520]; visceral motor neuron differentiation [GO:0021524] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; peripheral nervous system neuron development [GO:0048935]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord motor neuron cell fate specification [GO:0021520]; visceral motor neuron differentiation [GO:0021524]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0000987; GO:0003677; GO:0005634; GO:0006357; GO:0007409; GO:0021520; GO:0021524; GO:0031290; GO:0045665; GO:0046872; GO:0048665; GO:0048666; GO:0048935; GO:1990837 CAKCQVGFSSSDLVMR 8.960000038 1 1 0.004991723 1844.333685 11.71926 15.07689 14.82205 0 0 15.36182 0 8.710751 0 0 0 0 0 13.81454 0 0 12.38107 14.16417 13.155 13.53509 0 13.66278 13.32217 14.36601 14.16774 16.56715 16.89829 14.85548 14.41087 0 12.88304 16.36971 13.89729 0 10.55528 14.49913 0 13.80215 0 0 14.69304 0 0 0 0 0 0 0 Q96A65 EXOC4_HUMAN Exocyst complex component 4 (Exocyst complex component Sec8) EXOC4 KIAA1699 SEC8 SEC8L1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; paraxial mesoderm formation [GO:0048341]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; paraxial mesoderm formation [GO:0048341]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267] GO:0000145; GO:0000281; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006887; GO:0006893; GO:0006904; GO:0007268; GO:0015031; GO:0016020; GO:0016241; GO:0030165; GO:0031267; GO:0032584; GO:0035748; GO:0045202; GO:0047485; GO:0048341; GO:0090148; GO:0090522; GO:0090543 LLLELLELLFDK 4.489999771 1 1 0.436866488 1457.810704 14.68487 15.21355 0 0 0 15.26719 0 0 11.40742 0 0 0 0 15.60115 16.78558 0 16.87931 16.008 0 0 16.67233 0 16.58777 16.74306 0 0 0 0 0 0 16.38098 0 0 16.90405 15.63418 0 17.89004 16.66054 0 0 0 0 0 0 0 0 16.89454 0 Q96A83 COQA1_HUMAN "Collagen alpha-1(XXVI) chain (Alpha-1 type XXVI collagen) (EMI domain-containing protein 2) (Emilin and multimerin domain-containing protein 2, Emu2)" COL26A1 EMID2 EMU2 Homo sapiens (Human) positive regulation of cell-substrate adhesion [GO:0010811] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005576; GO:0005581; GO:0005788; GO:0005794; GO:0005886; GO:0010811; GO:0062023 GTVGPSGEPGVK 5.170000076 1 1 0.142323735 1084.361483 14.33684 15.44285 0 0 13.15033 15.11805 14.55781 12.65292 0 0 10.82838 15.2094 0 14.54213 14.73005 0 13.19472 0 0 0 0 0 0 16.14274 0 0 0 0 0 0 0 0 0 0 0 0 0 17.22713 14.83763 15.18545 15.44476 15.94282 15.8052 14.80915 0 0 17.54577 0 Q96A99 PTX4_HUMAN Pentraxin-4 PTX4 C16orf38 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005576; GO:0046872 ALDLTLGER 7.510000229 0.517896295 0.517896295 0.209459474 987.5938053 15.43669 15.62361 16.20823 15.87577 16.07044 15.1411 17.0275 15.96085 16.32245 0 17.20973 16.67724 0 16.41408 15.04159 16.48944 15.74441 0 15.23917 15.11499 0 0 0 15.39695 17.35988 15.89205 15.96952 16.5815 0 15.27315 15.44483 12.65962 13.2843 14.75905 15.8438 15.64822 0 14.60353 16.02117 0 15.0417 15.93683 16.51241 14.85554 14.86272 13.31705 0 13.65144 Q96AA8 JKIP2_HUMAN Janus kinase and microtubule-interacting protein 2 (CTCL tumor antigen HD-CL-04) (Neuroendocrine long coiled-coil protein 1) JAKMIP2 JAMIP2 KIAA0555 NECC1 Homo sapiens (Human) Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017] kinase binding [GO:0019900]; microtubule binding [GO:0008017] GO:0005794; GO:0008017; GO:0019900 EKITSHPPLK 4.559999943 1 1 0.275458629 1147.113115 12.8105 15.29574 14.03839 0 0 0 0 0 16.06375 0 13.71412 0 0 0 0 12.81097 0 15.07257 13.56353 0 17.37651 0 0 0 0 16.25241 15.37037 0 0 14.69958 0 15.19709 0 16.56248 0 0 15.07372 17.26836 15.37062 14.97314 17.19619 17.32432 0 0 16.85368 16.44321 0 0 Q96AB6 NTAN1_HUMAN "Protein N-terminal asparagine amidohydrolase, EC 3.5.1.121 (Protein NH2-terminal asparagine amidohydrolase, PNAA) (Protein NH2-terminal asparagine deamidase, PNAD, Protein N-terminal Asn amidase, Protein N-terminal asparagine amidase, Protein NTN-amidase)" NTAN1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511] protein-N-terminal asparagine amidohydrolase activity [GO:0008418] GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418 EENENHFPVIYGIAVNIK 2.309999943 1 1 0.180073784 2085.428633 0 11.91253 16.23673 0 0 12.23254 11.83374 13.93317 14.53692 13.07886 15.30583 0 0 11.39786 0 0 13.32695 0 11.82102 14.01345 0 15.62326 0 0 0 14.80147 0 0 14.51096 0 0 13.00393 0 15.27313 13.4722 10.79983 0 0 0 13.21681 13.63457 0 0 0 0 0 0 0 Q96AC6 KIFC2_HUMAN Kinesin-like protein KIFC2 KIFC2 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0072686; GO:0090307 ATAATAMNQR 4.449999809 1 1 0.21951174 1049.771887 0 0 9.54168 0 0 13.29379 0 0 0 13.19433 0 17.52421 0 0 0 0 0 0 16.70074 0 0 16.2864 0 0 0 0 0 0 0 0 14.57604 0 0 0 0 0 14.3054 0 0 0 16.81039 0 0 0 0 15.03864 0 0 Q96AG4 LRC59_HUMAN "Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34, p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed ]" LRRC59 PRO1855 Homo sapiens (Human) positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] cadherin binding [GO:0045296]; RNA binding [GO:0003723] GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0007165; GO:0016020; GO:0016021; GO:0042645; GO:0045296; GO:0046579 LDGNELDLSLSDLNEVPVK 3.99000001 1 1 0.225073643 2071.187284 0 14.62044 0 12.93696 0 10.63005 0 0 13.98739 0 0 0 0 0 0 0 0 0 15.46501 0 0 0 0 15.47828 14.31457 12.73042 14.912 0 0 0 0 0 0 0 15.28839 0 13.15204 0 0 13.83661 12.24485 14.19698 0 0 0 0 13.68031 0 Q96AH0 SOSB2_HUMAN "SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2, SOSS-B2) (Single-stranded DNA-binding protein 2, hSSB2)" NABP1 OBFC2A SSB2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]" DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010212; GO:0035861; GO:0044818; GO:0070876 NRVNDPLIFIR 25.28000069 1 1 0.218458675 1356.489096 20.66305 19.78203 0 0 0 0 0 0 20.14062 0 20.01096 19.36683 19.79935 0 0 0 0 0 20.12233 0 19.23111 20.10517 0 19.85901 20.02607 0 0 19.41439 20.15789 21.62799 21.18921 0 20.63888 0 0 20.1687 0 0 0 19.47803 0 0 0 20.55499 21.26851 0 19.97858 18.43129 Q96AJ1 CLUA1_HUMAN Clusterin-associated protein 1 (Qilin) CLUAP1 KIAA0643 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720] GO:0005654; GO:0005813; GO:0005929; GO:0030992; GO:0035720; GO:0043231; GO:0060271; GO:0097542 GMEGSEIVEEDVNK 5.159999847 1 1 0.145035533 1538.395186 0 15.33106 0 0 16.15998 0 0 16.31663 0 15.10057 16.53486 15.9552 16.29109 0 0 0 0 18.05631 0 0 15.7201 0 0 0 0 0 18.09717 0 14.65905 0 0 0 16.9497 15.48018 17.59125 16.61545 16.47052 0 0 0 16.61331 15.74304 0 16.52115 0 17.17918 0 16.05903 Q96AN5 TM143_HUMAN Transmembrane protein 143 TMEM143 UNQ5922/PRO19813 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] GO:0005739; GO:0016021 ALLNLMLVVSGVAIFVNVGMVVLTDLK 4.349999905 1 1 0.238281613 2860.491058 0 0 12.76887 0 0 0 14.9961 15.2705 0 0 13.12453 0 14.09685 13.38575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AP4 ZUP1_HUMAN "Zinc finger-containing ubiquitin peptidase 1, EC 3.4.19.12 (Lys-63-specific deubiquitinase ZUFSP, DUB) (Zinc finger with UFM1-specific peptidase domain protein)" ZUP1 C6orf113 ZUFSP Homo sapiens (Human) regulation of gene expression [GO:0010468] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; regulation of gene expression [GO:0010468] metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0010468; GO:0046872 NSAQNLTKDSTLK 7.71999979 1 1 0.266568374 1418.772524 16.00114 16.17611 0 0 0 15.25524 0 15.79926 0 0 0 0 0 0 0 15.95894 0 0 0 0 17.01067 0 0 0 0 0 0 0 0 0 15.32446 0 0 15.7547 0 0 0 16.06385 0 16.56889 16.09661 0 0 0 0 0 0 0 Q96AQ1 CC74A_HUMAN Coiled-coil domain-containing protein 74A CCDC74A Homo sapiens (Human) KCLSPPVAER 11.61999989 0.012595458 0.012595458 0.329876352 1157.512012 15.78724 14.77668 11.72916 0 0 13.10579 15.60596 13.60863 13.79836 0 15.50595 14.37606 0 0 0 16.54496 0 0 16.33669 15.52539 0 0 15.86141 0 0 0 15.67485 15.26909 0 0 15.63809 0 0 16.50526 15.90021 15.71523 0 0 16.61972 14.42077 15.73448 0 15.61328 16.31454 15.85036 0 15.95106 0 Q96AQ8 MCUR1_HUMAN "Mitochondrial calcium uniporter regulator 1, MCU regulator 1 (Coiled-coil domain-containing protein 90A, mitochondrial)" MCUR1 C6orf79 CCDC90A Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] GO:0005739; GO:0006851; GO:0031305; GO:0036444; GO:0051561; GO:0070509 DMIILEK 18.90999985 1 1 0.288150753 861.6684941 0 0 0 19.01791 0 17.10544 15.6992 18.01128 0 18.98214 17.94501 0 17.8175 18.03083 18.30545 0 0 16.81989 19.05835 0 16.33453 0 0 0 16.17941 0 0 0 18.51705 0 0 17.77452 0 0 18.21517 0 0 18.04324 17.10586 14.4556 16.65941 18.8215 0 0 0 0 0 0 Q96AV8 E2F7_HUMAN "Transcription factor E2F7, E2F-7" E2F7 Homo sapiens (Human) "chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]" chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0006357; GO:0008285; GO:0016607; GO:0030330; GO:0032466; GO:0032877; GO:0042802; GO:0045944; GO:0060707; GO:0060718; GO:0070365; GO:0071930; GO:0090575; GO:1990837; GO:2000134 LEIPSGGAD 11.27999973 1 1 0.257144777 858.9359481 16.34977 0 17.50994 0 0 0 18.8148 17.56032 20.57144 0 0 17.51937 0 0 0 0 0 17.59654 19.61957 18.63761 17.70668 0 20.58068 20.69668 0 19.78983 19.90367 0 15.8555 0 0 0 0 19.12218 0 0 0 0 19.61514 18.17053 0 17.07972 18.41717 17.22377 0 17.46392 0 18.28479 Q96AX1 VP33A_HUMAN "Vacuolar protein sorting-associated protein 33A, hVPS33A" VPS33A Homo sapiens (Human) autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0034058; GO:0035542; GO:0035751; GO:0048070; GO:0048471; GO:0097352 MAAHLSYGRVNLNVLR 10.56000042 1 1 0.046825088 1813.787089 0 0 13.22151 0 15.27569 0 0 14.88375 13.83792 0 14.0424 13.22006 0 0 0 0 14.63244 14.96552 0 14.54371 0 0 0 0 14.42931 0 0 15.50639 0 14.66526 0 0 0 0 0 0 15.89481 0 0 0 15.07769 13.52399 0 0 0 0 0 0 Q96AX9 MIB2_HUMAN "E3 ubiquitin-protein ligase MIB2, EC 2.3.2.27 (Mind bomb homolog 2) (Novel zinc finger protein, Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)" MIB2 SKD ZZANK1 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein ubiquitination [GO:0016567] actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0043123; GO:0061630 ALDLLRR 9.390000343 1 1 8.03E-13 856.8258089 12.98233 13.49856 0 14.84102 12.55101 13.36837 13.78264 14.83688 15.6951 15.25495 15.21688 14.26397 0 12.94806 0 14.49907 15.71627 0 15.05417 14.94918 0 15.15705 0 13.34515 0 0 0 0 0 0 0 0 0 0 15.28725 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AY2 EME1_HUMAN "Crossover junction endonuclease EME1, EC 3.1.22.- (MMS4 homolog, hMMS4)" EME1 MMS4 Homo sapiens (Human) double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429] endodeoxyribonuclease complex [GO:1905347]; heterochromatin [GO:0000792]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] endodeoxyribonuclease complex [GO:1905347]; heterochromatin [GO:0000792]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429] DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872] GO:0000712; GO:0000792; GO:0003677; GO:0004519; GO:0005654; GO:0005730; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0046872; GO:0048476; GO:0072429; GO:1905347 QNLLADIQVR 7.170000076 1 1 0.461160839 1170.783606 0 0 16.33711 0 0 0 16.78587 0 0 0 0 0 0 0 0 16.99719 0 0 0 0 16.91648 0 0 0 0 0 0 0 0 0 0 19.4969 0 19.04725 17.44471 0 0 0 0 0 0 0 0 0 0 0 16.6009 17.67896 Q96AY3 FKB10_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP10, PPIase FKBP10, EC 5.2.1.8 (65 kDa FK506-binding protein, 65 kDa FKBP, FKBP-65) (FK506-binding protein 10, FKBP-10) (Immunophilin FKBP65) (Rotamase)" FKBP10 FKBP65 PSEC0056 Homo sapiens (Human) aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; wound healing [GO:0042060] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; wound healing [GO:0042060] calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0001701; GO:0003755; GO:0005509; GO:0005528; GO:0005758; GO:0005783; GO:0005788; GO:0016020; GO:0017185; GO:0018208; GO:0030199; GO:0035909; GO:0042060; GO:0085029 NTLVAIVVGVGR 2.079999924 1 1 0.169902516 1196.803732 0 0 12.01332 15.31569 0 0 12.88964 0 14.14497 12.45317 13.60341 13.59012 13.63214 13.2266 7.463736 0 14.99524 13.12646 15.16383 13.7414 0 12.21891 0 0 14.81881 13.94763 14.21668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.50146 0 0 Q96AY4 TTC28_HUMAN "Tetratricopeptide repeat protein 28, TPR repeat protein 28 (TPR repeat-containing big gene cloned at Keio)" TTC28 KIAA1043 TPRBK Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] kinase binding [GO:0019900] GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301 ASAALGEAMK 7.869999886 1 1 0.196589068 965.562762 17.23235 15.21966 14.94577 0 15.78222 15.96679 0 15.74327 15.02107 15.48527 15.39341 11.43808 14.43765 0 16.06729 10.39913 0 0 15.17016 0 15.86683 15.88735 15.72984 15.4688 14.24697 13.89785 14.80961 17.41732 14.23649 14.07999 16.64357 15.414 14.99069 14.93501 12.63148 14.42398 13.43259 14.87595 13.30026 12.3538 0 15.15469 15.53241 16.05263 14.47806 14.15969 16.47727 0 Q96B01 R51A1_HUMAN "RAD51-associated protein 1, HsRAD51AP1 (RAD51-interacting protein)" RAD51AP1 PIR51 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of double-strand break repair via homologous recombination [GO:0010569] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; D-loop DNA binding [GO:0062037]; DNA binding [GO:0003677]; DNA secondary structure binding [GO:0000217]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of double-strand break repair via homologous recombination [GO:0010569]" D-loop DNA binding [GO:0062037]; DNA binding [GO:0003677]; DNA secondary structure binding [GO:0000217]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0000217; GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006974; GO:0010569; GO:0010845; GO:0032991; GO:0036297; GO:0051321; GO:0062037; GO:0071479; GO:1905168 SPNQSLR 6.429999828 1 1 0.238418401 800.1739156 0 13.61365 0 15.02338 14.03782 10.47083 15.78691 13.69106 17.04499 0 0 14.85403 0 0 15.25985 14.86282 0 15.29324 0 0 0 0 0 0 0 0 0 16.34177 0 15.24006 15.75311 0 0 0 0 14.71302 0 0 0 15.47502 14.89 0 0 0 0 0 0 0 Q96B18 DACT3_HUMAN Dapper homolog 3 (Antagonist of beta-catenin Dapper homolog 3) (Arginine-rich region 1 protein) (Dapper antagonist of catenin 3) DACT3 RRR1 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; delta-catenin binding [GO:0070097]; identical protein binding [GO:0042802]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] delta-catenin binding [GO:0070097]; identical protein binding [GO:0042802]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080] GO:0005080; GO:0005737; GO:0010719; GO:0016055; GO:0030178; GO:0030308; GO:0042802; GO:0051018; GO:0070097; GO:0090090 GAGQPRTSPGGADGGPR 1.470000029 1 1 4.11E-12 1537.956177 16.5669 13.27347 0 0 0 0 0 0 12.0655 15.61649 16.75722 0 15.21146 8.849787 14.47329 15.71861 0 14.60231 0 0 13.68801 12.85781 14.70045 13.89077 14.56647 15.82746 14.698 0 12.44922 0 13.78347 13.51806 0 17.78131 16.84013 0 14.44417 16.93516 15.96089 8.09943 0 0 15.11259 0 14.513 13.46116 12.55133 16.27982 Q96B26 EXOS8_HUMAN "Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2, OIP-2) (Ribosomal RNA-processing protein 43) (p9)" EXOSC8 OIP2 RRP43 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925] GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019 EDLCISPGK 24.59000015 0.157936171 0.157936171 0.444436681 1018.554973 16.37432 16.98091 15.85953 16.56307 17.39847 17.19885 16.72612 16.82294 15.35297 16.76894 16.1972 16.83263 16.33661 16.36258 15.9974 0 16.70679 17.23448 16.55802 15.12096 16.30953 16.05385 15.58471 17.1039 17.33759 16.63069 16.28189 16.11975 17.19021 15.39974 16.35737 15.49575 17.06042 17.28213 16.76437 16.32121 0 16.1657 17.14323 16.84474 15.85571 16.1739 16.39296 17.11362 16.31594 15.83636 17.16043 15.34512 Q96B36 AKTS1_HUMAN Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate) AKT1S1 PRAS40 Homo sapiens (Human) negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523] GO:0005654; GO:0005737; GO:0005829; GO:0006469; GO:0032007; GO:0042981; GO:0043523; GO:0045792; GO:0048011 IAASMR 16.30999947 0.897420943 0.897420943 0.270431473 663.1057459 15.54895 0 14.03741 0 15.10469 0 13.06483 14.95813 14.35789 15.25503 16.02257 11.29471 0 15.71349 16.36697 0 16.18638 14.9244 15.48481 0 0 19.0771 17.02145 18.40764 16.5608 0 16.0205 16.02491 15.42866 15.67886 16.76783 15.56303 15.57812 17.85738 15.96173 15.73993 17.20109 16.32846 15.88427 16.42806 16.00838 16.80127 0 16.07408 16.65431 15.37408 16.94219 16.02674 Q96B70 LENG9_HUMAN Leukocyte receptor cluster member 9 LENG9 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 ASRTDLVFGSGSAAGR 1.679999948 1 1 0.261274096 1552.362173 16.73013 16.0083 16.61885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B77 TM186_HUMAN Transmembrane protein 186 TMEM186 C16orf51 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005739; GO:0005743; GO:0016021; GO:0032981 MAALLRAVR 15.93000031 1 1 0.446142702 1000.431554 0 0 0 0 0 0 0 19.61436 0 0 18.83589 0 17.22595 0 18.42716 0 0 19.30233 0 0 0 0 0 0 0 0 0 19.66895 0 0 0 19.77212 0 19.85416 0 0 0 18.81872 0 0 0 18.32876 18.19005 0 0 0 0 0 Q96B97 SH3K1_HUMAN "SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3, CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1, HSB-1)" SH3KBP1 CIN85 Homo sapiens (Human) actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202; GO:0050871 TEEKERPER 7.289999962 1 1 0.605740163 1174.884327 0 0 0 0 0 0 0 0 0 0 16.42888 0 0 0 0 0 0 0 0 17.83028 0 0 0 0 0 0 20.01787 0 0 17.21552 0 0 0 0 0 0 0 0 20.24637 0 0 16.73291 0 0 0 0 0 0 Q96BD0 SO4A1_HUMAN "Solute carrier organic anion transporter family member 4A1, OATP4A1 (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1, OATP-RP1, OATPRP1, POAT) (Organic anion-transporting polypeptide E, OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)" SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12 Homo sapiens (Human) sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252] sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252 QLPGSQR 5.989999771 0.087998062 0.087998062 0.225549665 784.5907658 16.33136 16.15788 14.175 14.43594 15.01046 14.53296 15.63817 15.36816 14.48832 17.65502 15.7461 15.22825 14.60413 14.97565 14.90657 15.31672 13.06465 0 15.95594 0 14.02905 16.07895 0 14.85756 16.13784 14.70579 15.1747 15.71214 15.11805 15.11069 15.65726 0 0 0 14.82383 14.79505 16.57742 0 15.78795 15.64365 15.63064 16.26927 15.82696 15.57269 17.02739 17.23747 17.50262 14.90372 Q96BD5 PF21A_HUMAN PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80) PHF21A BHC80 KIAA1696 BM-006 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0000118; GO:0000122; GO:0003677; GO:0003682; GO:0005654; GO:0006325; GO:0046872; GO:1990391 EMHSSLEK 6.550000191 0.475027978 0.475027978 0.262163346 962.0439932 15.6741 16.28229 15.98257 14.546 16.04732 15.26139 18.4855 16.56862 15.52913 0 16.50951 15.29452 0 13.91769 0 12.89608 15.23327 0 16.45802 0 15.88488 0 16.47299 0 0 0 17.16221 0 0 0 0 0 17.48311 0 16.2448 15.85041 0 15.62767 0 15.31272 0 15.13527 0 0 0 16.42979 0 16.63502 Q96BF6 NACC2_HUMAN "Nucleus accumbens-associated protein 2, NAC-2 (BTB/POZ domain-containing protein 14A) (Repressor with BTB domain and BEN domain)" NACC2 BTBD14A NAC2 RBB Homo sapiens (Human) "negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [GO:1900477]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein homooligomerization [GO:0051260]; protein-containing complex localization [GO:0031503]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [GO:1900477]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein homooligomerization [GO:0051260]; protein-containing complex localization [GO:0031503]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0005739; GO:0006357; GO:0008285; GO:0031503; GO:0042803; GO:0042826; GO:0044877; GO:0045892; GO:0051260; GO:1900477; GO:1902231 SSTSDPSR 11.85000038 0.012325908 0.012325908 0.132876843 836.4664821 0 17.77806 0 17.8453 16.6381 0 0 0 0 16.5206 16.734 17.96015 16.23594 15.80742 0 12.97711 0 0 16.15409 17.63827 17.98112 12.62611 0 15.09834 0 15.39446 0 0 0 18.94037 16.84455 0 0 0 0 15.58077 17.0025 16.25858 16.30055 0 0 0 0 0 0 16.58817 18.5885 16.07739 Q96BH1 RNF25_HUMAN "E3 ubiquitin-protein ligase RNF25, EC 2.3.2.27 (RING finger protein 25) (RING-type E3 ubiquitin transferase RNF25)" RNF25 Homo sapiens (Human) positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630 ESLGLESK 8.020000458 1 1 0.269518208 862.2973519 14.95856 18.54901 19.98418 16.27651 15.46722 14.4498 18.09668 0 16.38759 0 15.5154 0 0 18.55754 0 0 18.56676 0 18.95968 17.65008 17.65485 0 0 18.03801 0 18.48039 19.07207 18.01293 0 0 0 0 17.79219 0 0 19.09708 17.48841 0 0 0 19.3356 0 18.01719 0 0 17.70498 0 0 Q96BJ3 AIDA_HUMAN "Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)" AIDA C1orf80 Homo sapiens (Human) determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333] phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904] GO:0005737; GO:0009953; GO:0016020; GO:0019904; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264 HLQKEAQAQHNNSEFTEEQK 7.21999979 1 1 0.035214635 2396.167404 15.13095 0 0 14.36874 0 15.07475 0 14.07102 14.82156 18.11682 15.49405 15.86075 0 0 16.25338 0 0 16.15063 15.19593 10.4864 0 0 0 12.18704 14.09233 16.66952 0 0 16.86694 11.53289 0 0 16.07863 13.57227 17.93084 15.46018 0 0 18.30273 9.886115 16.00158 0 12.68851 0 0 0 15.41398 0 Q96BJ8 ELMO3_HUMAN Engulfment and cell motility protein 3 ELMO3 Homo sapiens (Human) actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis [GO:0006909] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis [GO:0006909] SH3 domain binding [GO:0017124] GO:0005737; GO:0006909; GO:0006915; GO:0007015; GO:0017124; GO:0048870 LVPLASDMIFAREVISR 1.190000057 1 1 0.106737567 1916.472386 0 0 14.46706 14.37655 13.38992 10.48545 0 14.81948 14.55072 0 0 0 14.54307 0 0 0 0 14.26941 13.23497 0 0 17.2591 16.78058 0 15.09568 16.09607 0 14.75451 0 0 0 16.77932 0 0 10.81244 0 0 0 0 15.37418 12.84397 0 14.12857 0 0 0 0 0 Q96BM1 ANKR9_HUMAN Ankyrin repeat domain-containing protein 9 ANKRD9 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; cellular copper ion homeostasis [GO:0006878]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0005829; GO:0006878; GO:0016567; GO:0031410; GO:0031466; GO:0043161; GO:1990756 RPGGGADGGPEASGAAR 10.25 6.51E-12 6.51E-12 0.273049132 1483.25085 16.91781 14.44318 13.16346 13.89825 12.90913 0 12.71245 15.07513 0 14.10652 4.898625 10.7132 0 0 0 0 0 0 0 0 0 0 0 0 11.75338 14.14428 16.2288 15.44667 14.98589 15.20758 0 0 0 0 0 0 0 0 0 0 14.19793 0 14.90474 10.70571 0 0 0 15.21309 Q96BN2 TADA1_HUMAN "Transcriptional adapter 1 (SPT3-associated factor 42, STAF42) (Transcriptional adapter 1-like protein)" TADA1 TADA1L Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" transcription coactivator activity [GO:0003713] GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006282; GO:0006357; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893 QRLAAK 4.590000153 0.769454598 0.769454598 0.16339087 685.4532527 16.37596 14.51565 15.43368 14.13285 0 15.25075 0 15.66049 0 16.27955 15.60474 16.31588 15.18329 15.03617 14.57594 15.09014 14.65766 14.07811 13.72577 14.1319 16.09072 14.63083 15.68913 15.38386 16.06071 14.87805 15.18221 15.25864 15.61511 16.2529 14.95167 0 15.23958 15.68723 14.35108 16.64259 0 15.5079 13.16962 16.5639 0 0 15.95563 0 0 0 0 15.94996 Q96BN6 F149B_HUMAN Primary cilium assembly protein FAM149B1 FAM149B1 KIAA0974 Homo sapiens (Human) cilium assembly [GO:0060271]; protein localization to cilium [GO:0061512] cilium [GO:0005929] cilium [GO:0005929]; cilium assembly [GO:0060271]; protein localization to cilium [GO:0061512] GO:0005929; GO:0060271; GO:0061512 SQSGGRPVSR 5.670000076 1 1 0.216705522 1030.701424 0 0 0 15.6443 0 15.11973 15.8616 14.17127 15.44342 14.20123 0 12.27265 17.5256 16.042 13.8901 14.88262 14.8888 9.816337 15.94539 14.02257 0 16.20489 0 15.15618 0 15.285 0 0 14.39921 15.76119 0 0 16.15 0 15.32667 0 0 0 0 16.68871 17.01326 15.62987 0 15.28043 0 0 0 15.08496 Q96BN8 OTUL_HUMAN "Ubiquitin thioesterase otulin, EC 3.4.19.12 (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)" OTULIN FAM105B Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797] cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843] GO:0002040; GO:0004843; GO:0005737; GO:0005829; GO:0008234; GO:0010803; GO:0016055; GO:0016567; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:0071797; GO:1990108 GASEPR 5.380000114 1 1 0.221445562 615.3584634 17.75851 18.31265 18.63378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.05104 0 0 16.18027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.97638 0 Q96BP3 PPWD1_HUMAN "Peptidylprolyl isomerase domain and WD repeat-containing protein 1, EC 5.2.1.8 (Spliceosome-associated cyclophilin)" PPWD1 KIAA0073 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]" catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]" cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0016018; GO:0016604; GO:0071013 IFIYDGR 8.5 0.856645048 0.856645048 0.261846923 882.7099461 16.67124 0 18.26475 17.41035 14.56311 0 19.82656 18.68235 0 0 16.68834 17.44043 17.26186 0 0 0 0 17.29894 16.77785 0 17.22886 16.45719 19.06492 0 0 19.21502 0 0 17.82213 18.57455 20.41769 20.69205 0 0 18.79724 16.90027 18.41668 0 18.78271 0 17.81604 17.81267 18.56132 16.66814 17.10979 0 17.77889 18.02374 Q96BQ1 FAM3D_HUMAN Protein FAM3D FAM3D UNQ567/PRO1130 Homo sapiens (Human) negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676] cytokine activity [GO:0005125] GO:0005125; GO:0005576; GO:0005615; GO:0046676; GO:0070093 CGLIKPCPANYFAFK 2.24000001 1 1 0.105262979 1784.464423 0 0 0 0 0 0 0 0 0 0 0 15.16588 0 0 0 0 0 0 0 0 0 0 0 14.28673 14.22018 0 14.80405 15.56707 0 0 0 13.73262 0 13.5106 11.05652 0 0 17.05868 0 0 0 0 0 0 0 0 0 0 Q96BR1 SGK3_HUMAN "Serine/threonine-protein kinase Sgk3, EC 2.7.11.1 (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)" SGK3 CISK SGKL Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090] cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037] cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090] ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080] GO:0001558; GO:0004672; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310 QFPAMALKIPAK 1.909999967 1 1 0.295118839 1326.851245 0 14.67686 0 13.40857 0 0 14.08727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.94149 12.61429 16.86597 17.38199 0 15.79126 0 0 16.26322 0 17.90981 0 0 16.55484 15.75002 0 0 0 0 15.76148 16.54911 0 0 0 0 0 Q96BS2 CHP3_HUMAN "Calcineurin B homologous protein 3 (Tescalcin, TSC)" TESC CHP3 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of cell adhesion mediated by integrin [GO:0033628]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase inhibitor activity [GO:0019212]; protein homodimerization activity [GO:0042803]; protein kinase inhibitor activity [GO:0004860]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of cell adhesion mediated by integrin [GO:0033628]" calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase inhibitor activity [GO:0019212]; protein homodimerization activity [GO:0042803]; protein kinase inhibitor activity [GO:0004860] GO:0000287; GO:0001726; GO:0004860; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0010628; GO:0015031; GO:0019212; GO:0030027; GO:0030154; GO:0030854; GO:0032417; GO:0032587; GO:0033628; GO:0042803; GO:0045654; GO:0045893; GO:0050821; GO:0051604; GO:0071300; GO:0072659 ITLEEYR 4.75 1 1 0.053968723 924.4798412 0 0 0 15.28308 0 0 0 0 0 0 0 13.11261 0 15.62845 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4773 0 0 0 0 15.79624 0 13.98105 14.43684 13.35381 16.02507 0 0 0 0 0 0 0 0 0 0 Q96BT1 CC049_HUMAN Putative uncharacterized protein C3orf49 C3orf49 Homo sapiens (Human) KSDLTVGK 1.99000001 1 1 0.37586916 847.6014647 0 0 17.73361 0 0 0 19.08554 0 18.02697 0 16.61068 0 0 0 0 0 0 18.10351 0 0 0 0 0 0 18.94566 18.11778 0 0 0 0 0 0 19.41142 0 0 0 18.70491 0 0 0 0 0 0 0 0 0 0 0 Q96BT7 ALKB8_HUMAN "Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8, EC 2.1.1.229)" ALKBH8 ABH8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0008270; GO:0016300; GO:0016604; GO:0016706; GO:0030488; GO:0106335 LLRPGGK 19.78000069 1 1 0.154564349 741.6465643 0 0 0 13.60766 14.04134 0 15.24381 0 12.60535 14.3984 0 0 0 0 0 12.00988 0 15.99736 0 0 0 0 0 0 0 0 15.59362 0 0 15.31063 0 14.25803 0 0 15.09251 0 0 16.14948 0 0 0 0 16.08149 0 0 0 15.98701 0 Q96BU1 S1PBP_HUMAN S100P-binding protein (S100P-binding protein Riken) S100PBP S100PBPR Homo sapiens (Human) cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; calcium-dependent protein binding [GO:0048306] calcium-dependent protein binding [GO:0048306] GO:0005634; GO:0005829; GO:0016607; GO:0048306 NGGSHK 5.190000057 1 1 0.2417389 598.6704349 15.86275 14.35947 13.74976 0 16.49344 0 0 14.44653 0 16.89811 16.05649 16.85214 0 15.76759 0 15.20166 15.78635 16.03732 16.10562 15.64332 16.0737 0 0 0 0 0 0 0 0 16.30755 0 0 0 16.67253 0 0 0 0 0 0 0 15.78956 16.23574 0 0 15.6489 0 16.29044 Q96BW1 UPP_HUMAN Uracil phosphoribosyltransferase homolog UPRT Homo sapiens (Human) female pregnancy [GO:0007565]; lactation [GO:0007595]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; female pregnancy [GO:0007565]; lactation [GO:0007595]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222] GTP binding [GO:0005525] GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0006222; GO:0007565; GO:0007595; GO:0032868; GO:0043231 GDFMFSADR 1.75 0.542421758 0.542421758 0.204379795 1062.548207 0 15.11345 0 0 0 15.12836 0 0 15.48089 0 0 0 0 0 0 14.24423 0 0 0 0 0 0 0 14.18478 0 0 13.55872 14.38941 0 0 0 0 0 0 12.55929 0 14.52988 0 15.89646 0 8.983258 0 0 0 0 12.93804 0 0 Q96BX8 MOB3A_HUMAN MOB kinase activator 3A (MOB-LAK) (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A) MOB3A MOBKL2A Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0046872 ILSRLFR 20.86000061 0.458074808 0.458074808 0.194600834 907.8215767 15.40252 15.41949 15.37702 14.83391 15.28359 14.49692 0 0 14.61649 15.25801 0 0 0 0 15.98404 15.9911 15.08144 15.44643 0 14.29088 16.89767 0 15.65261 0 16.68213 14.62927 14.24116 15.66936 14.67004 14.88108 15.76615 0 0 0 14.90846 15.51671 0 16.38765 16.28001 13.98879 16.31997 14.9246 0 15.92407 14.15211 0 0 15.30021 Q96BY6 DOC10_HUMAN Dedicator of cytokinesis protein 10 (Zizimin-3) DOCK10 KIAA0694 ZIZ3 Homo sapiens (Human) B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001782; GO:0002315; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0030334; GO:0043197; GO:0043547; GO:0060997; GO:0070062 VNAGPMAYARAFLEETNAK 2.25 1 1 0.077775711 2069.57567 0 0 0 11.62176 0 14.54556 0 12.73405 0 0 0 0 0 14.21388 15.47433 0 13.29024 0 0 14.19536 0 0 0 0 0 14.57082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BY7 ATG2B_HUMAN Autophagy-related protein 2 homolog B ATG2B C14orf103 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709] endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709] lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266] GO:0000045; GO:0000407; GO:0000422; GO:0005789; GO:0005811; GO:0019898; GO:0032266; GO:0034045; GO:0034727; GO:0044805; GO:0061709; GO:0120013 AAMQEK 5.179999828 0.303779423 0.303779423 0.287278284 693.4186603 18.03223 0 16.01035 0 16.76494 0 0 0 0 0 18.44408 0 0 0 0 0 0 0 18.07116 0 16.02936 18.47079 0 18.52325 0 18.37707 0 0 0 0 0 18.30264 0 0 22.29671 0 0 0 0 0 0 18.98365 0 0 0 0 0 0 Q96BZ4 PLD4_HUMAN "5'-3' exonuclease PLD4, EC 3.1.16.1 (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4) (Phospholipase D family member 4) (Phospholipase D4, PLD 4)" PLD4 C14orf175 UNQ2488/PRO5775 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015] single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145] GO:0002244; GO:0005634; GO:0005769; GO:0005783; GO:0005789; GO:0006909; GO:0006954; GO:0016021; GO:0032588; GO:0045087; GO:0045145; GO:0045335; GO:1900015 AAVAPTWPCSMPPR 9.420000076 1 1 0.20250714 1555.959178 0 0 16.7762 0 0 0 18.23589 0 13.73157 0 0 0 15.31989 0 0 0 0 15.45525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.57621 0 14.52459 0 0 12.19828 0 14.65736 15.08511 16.48525 0 0 0 0 0 0 Q96C11 FGGY_HUMAN "FGGY carbohydrate kinase domain-containing protein (D-ribulokinase FGGY, EC 2.7.1.47)" FGGY Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321] D-ribulokinase activity [GO:0019150]; carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321] D-ribulokinase activity [GO:0019150] GO:0019150; GO:0019321; GO:0046835; GO:0070050 YYVGVDVGTGSVR 3.519999981 1 1 0.34104988 1371.44368 11.92731 0 13.81608 0 14.19684 13.0375 0 14.96996 0 0 0 0 0 0 14.99094 16.407 13.96913 15.0276 0 0 15.48802 0 0 0 0 0 0 0 17.39312 0 0 0 0 0 0 0 0 15.38434 0 0 0 0 0 0 0 0 0 0 Q96C28 ZN707_HUMAN Zinc finger protein 707 ZNF707 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 LDTDDGQLPR 11.81000042 1 1 0.41921244 1129.3037 20.04399 0 0 0 0 19.36336 18.06747 21.76447 0 0 19.94097 0 0 0 0 20.21942 18.69264 0 0 17.78967 0 18.35845 18.16283 19.54823 20.86103 0 0 0 17.29128 0 0 0 19.73253 20.30238 0 0 21.90199 0 20.86134 0 0 19.60369 20.35514 0 18.75895 0 20.58008 19.02336 Q96C74 ROP1L_HUMAN "Ropporin-1-like protein, ROPN1-like protein (AKAP-associated sperm protein)" ROPN1L ASP RSPH11 Homo sapiens (Human) epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240] identical protein binding [GO:0042802] GO:0001932; GO:0003351; GO:0005576; GO:0005737; GO:0005929; GO:0030317; GO:0031514; GO:0042802; GO:0048240 MPLPDTMFCAQQIHIPPELPDILKQFTK 1.620000005 0.767131984 0.767131984 9.15E-13 3325.198982 14.41043 0 11.56558 15.05855 0 0 0 12.32295 0 14.71552 0 0 0 0 0 0 0 0 0 0 12.96218 0 0 0 13.98177 13.63425 0 0 0 12.04903 0 0 0 0 0 0 0 13.224 0 0 0 0 0 0 10.17272 0 11.77979 0 Q96C86 DCPS_HUMAN "m7GpppX diphosphatase, EC 3.6.1.59 (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5, HINT-5) (Scavenger mRNA-decapping enzyme DcpS)" DCPS DCS1 HINT5 HSPC015 Homo sapiens (Human) "cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; methylguanosine-cap decapping [GO:0110156]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; identical protein binding [GO:0042802]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; methylguanosine-cap decapping [GO:0110156]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]" exoribonuclease activity [GO:0004532]; identical protein binding [GO:0042802]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340] GO:0000288; GO:0000290; GO:0000340; GO:0000932; GO:0004532; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0036245; GO:0042802; GO:0043069; GO:0043928; GO:0045292; GO:0050072; GO:0110156 TLTFALR 11.10000038 1 1 0 820.8596378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CA5 BIRC7_HUMAN "Baculoviral IAP repeat-containing protein 7, EC 2.3.2.27 (Kidney inhibitor of apoptosis protein, KIAP) (Livin) (Melanoma inhibitor of apoptosis protein, ML-IAP) (RING finger protein 50) (RING-type E3 ubiquitin transferase BIRC7) [Cleaved into: Baculoviral IAP repeat-containing protein 7 30kDa subunit, Truncated livin, p30-Livin, tLivin ]" BIRC7 KIAP LIVIN MLIAP RNF50 UNQ5800/PRO19607/PRO21344 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247] cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0002088; GO:0004842; GO:0004869; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0010804; GO:0016567; GO:0019899; GO:0031398; GO:0042127; GO:0042981; GO:0043027; GO:0043066; GO:0046330; GO:0046872; GO:0051726; GO:0061630; GO:0070247 GPAFPGMGSEELR 7.71999979 1 1 0.41998523 1364.070046 19.95767 18.40411 0 0 0 0 18.24525 0 0 19.21607 0 0 0 0 0 0 16.66455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CB5 CH044_HUMAN Putative uncharacterized protein C8orf44 C8orf44 Homo sapiens (Human) GSLAIFCWSFQGGCVSK 5.809999943 1 1 0.343329121 1904.556336 13.30374 17.93372 0 0 0 0 0 13.78053 16.89605 0 15.28266 11.10915 0 0 12.30064 0 0 0 0 0 0 13.15108 13.61662 0 0 0 0 0 0 0 0 0 0 0 0 0 15.58373 15.88345 17.04859 15.50382 0 0 0 15.0793 0 0 0 0 Q96CB9 NSUN4_HUMAN "5-methylcytosine rRNA methyltransferase NSUN4, EC 2.1.1.- (5-methylcytosine tRNA methyltransferase NSUN4, EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)" NSUN4 Homo sapiens (Human) RNA methylation [GO:0001510]; rRNA methylation [GO:0031167] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167] methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843] GO:0001510; GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0019843; GO:0031167 CFTFDR 5.670000076 1 1 0.153859192 845.140042 15.05647 0 20.4272 0 0 0 0 0 18.46273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.98681 0 0 18.15875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CD0 FBXL8_HUMAN F-box/LRR-repeat protein 8 (F-box and leucine-rich repeat protein 8) (F-box protein FBL8) FBXL8 FBL8 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0005634; GO:0005829; GO:0019005; GO:0031146; GO:0043153; GO:0051726 VLQPAVPVAALR 6.070000172 0.619063854 0.619063854 0.339100763 1233.640122 0 15.87611 0 0 12.18753 0 0 15.12419 15.06067 0 14.275 14.03618 13.96543 15.73255 0 13.73854 0 0 12.87495 15.03979 0 15.07651 0 16.60297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.62442 0 0 0 15.46568 0 0 Q96CF2 CHM4C_HUMAN "Charged multivesicular body protein 4c (Chromatin-modifying protein 4c, CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3, hSnf7-3) (Vacuolar protein sorting-associated protein 32-3, Vps32-3, hVps32-3)" CHMP4C SHAX3 Homo sapiens (Human) abscission [GO:0009838]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; abscission [GO:0009838]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] protein homodimerization activity [GO:0042803] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0009838; GO:0009898; GO:0010824; GO:0015031; GO:0016236; GO:0030496; GO:0031468; GO:0032466; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044878; GO:0046761; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1902774; GO:1904930 SRAASSQR 5.659999847 1 1 0.200772213 862.6021431 12.45475 14.70572 0 12.85394 15.11582 15.79587 11.44949 15.57205 11.57984 14.73865 0 0 0 0 0 0 15.07409 0 0 16.56047 0 0 0 0 15.06009 0 0 15.16513 0 0 15.36646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CJ1 EAF2_HUMAN ELL-associated factor 2 (Testosterone-regulated apoptosis inducer and tumor suppressor protein) EAF2 TRAITS BM-040 Homo sapiens (Human) "apoptotic process [GO:0006915]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; transcription elongation regulator activity [GO:0003711]; apoptotic process [GO:0006915]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" transcription elongation regulator activity [GO:0003711] GO:0003711; GO:0005654; GO:0006915; GO:0008023; GO:0016607; GO:0030308; GO:0032783; GO:0034243; GO:0045893; GO:0045944; GO:0060770 HSPSEDKMSPASPIDDIER 2.75 1 1 0.286502457 2127.062991 12.5929 0 0 15.49355 0 0 14.04539 14.14691 15.43791 14.23014 13.38191 12.57124 14.83543 12.85869 14.49059 15.7567 13.28658 0 14.43197 0 15.69922 0 16.23944 0 15.95369 0 13.99692 0 0 15.36695 0 0 0 0 15.49986 0 0 0 0 0 0 0 0 15.12521 0 0 0 16.37089 Q96CK0 ZN653_HUMAN Zinc finger protein 653 (67 kDa zinc finger protein) (Zinc finger protein Zip67) ZNF653 ZIP67 Homo sapiens (Human) extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular region [GO:0005576]; nucleus [GO:0005634] extracellular region [GO:0005576]; nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of transcription by RNA polymerase II [GO:0006357] AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0003677; GO:0003712; GO:0003714; GO:0005576; GO:0005634; GO:0006357; GO:0046872; GO:0050682; GO:0140297; GO:1900116; GO:1903507 EDLCLLKK 21.61000061 1 1 0.311011435 1018.26458 16.31038 0 17.20859 0 0 0 0 16.68109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.72098 0 0 0 0 0 0 0 0 Q96CM3 RUSD4_HUMAN "Pseudouridylate synthase RPUSD4, mitochondrial, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 4)" RPUSD4 Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA binding [GO:0000049] GO:0000049; GO:0000455; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0009982; GO:0035770; GO:0070131; GO:0070902; GO:1990400 MDDGKMVK 10.72000027 0.485410303 0.485410303 0.167736441 923.5917966 15.51276 15.27864 0 14.35781 14.88106 14.22429 0 15.95481 15.10584 0 16.17204 14.3555 14.83571 14.69763 16.02505 15.46239 13.28598 14.28185 0 16.0964 15.28148 13.21898 14.58857 0 15.57111 14.46101 16.3075 13.92627 14.93361 0 0 13.55491 15.76455 16.23407 15.76346 13.9364 15.53971 11.85603 14.50184 14.15823 12.44595 13.33504 13.83814 14.82576 14.8939 12.40183 15.93444 0 Q96CN4 EVI5L_HUMAN EVI5-like protein (Ecotropic viral integration site 5-like protein) EVI5L Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0031267; GO:0043547; GO:0090630; GO:1902018 EGQAVASTR 4.239999771 1 1 0.23926652 916.6187042 0 14.30429 14.67672 14.60892 0 15.2858 16.07529 0 14.55308 16.1948 15.45182 0 15.41144 16.4186 14.74139 14.79885 0 13.98486 0 15.79337 14.42532 16.42472 16.27857 14.77313 0 15.53992 0 0 0 0 16.26358 0 16.39259 0 0 0 16.39427 0 0 16.38885 0 15.38987 0 0 0 14.94707 0 0 Q96CN5 LRC45_HUMAN Leucine-rich repeat-containing protein 45 LRRC45 Homo sapiens (Human) centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005813; GO:0005829; GO:0005886 NLLLQNQVDELER 17.01000023 1 1 9.24E-13 1581.360664 17.58759 17.47118 16.53829 0 0 0 0 0 17.7344 0 0 0 17.04173 0 0 0 0 0 0 0 0 0 0 17.23694 0 0 18.32735 0 0 0 0 0 0 0 0 0 0 0 0 0 17.31389 0 0 0 0 0 0 0 Q96CN9 GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1) GCC1 Homo sapiens (Human) cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; small GTPase binding [GO:0031267] small GTPase binding [GO:0031267] GO:0000138; GO:0000139; GO:0005794; GO:0005829; GO:0031267 EALAGR 11.22999954 1 1 0.116044318 615.2266033 14.89695 15.19139 15.72288 15.12928 15.61604 15.972 0 0 15.55029 13.77032 15.33861 14.10091 14.6556 0 0 0 13.10346 0 15.37663 0 0 12.62835 0 15.71979 0 16.9783 0 0 14.38157 13.94306 0 0 14.95421 0 16.03431 0 0 0 0 0 15.19077 0 14.73788 0 0 0 15.15516 0 Q96CP2 FWCH2_HUMAN FLYWCH family member 2 FLYWCH2 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 KGVHCVMSLGVPGPATLAK 4.849999905 1 1 0.045434163 1936.98136 18.80808 0 13.83427 0 18.73361 17.79157 0 0 17.93566 0 16.99182 0 15.80112 0 0 0 18.11906 17.77022 0 18.69911 0 0 0 0 17.35292 0 0 0 0 0 0 0 0 17.15562 17.98039 15.46127 0 16.06606 0 0 0 0 0 0 15.2337 15.36832 16.59146 0 Q96CP6 ASTRA_HUMAN Protein Aster-A (GRAM domain-containing protein 1A) GRAMD1A KIAA1533 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015] GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006914; GO:0015485; GO:0016021; GO:0031227; GO:0031234; GO:0031410; GO:0032366; GO:0032934; GO:0044232; GO:0071397; GO:0120015; GO:0120020; GO:0140268 STPSSSPSLRK 8.279999733 0.587246001 0.587246001 0.21392392 1146.549588 14.02135 14.51165 14.22358 15.94339 14.87503 13.83181 14.0765 14.06359 0 0 0 15.16117 16.93435 14.8576 0 15.82606 11.30989 0 8.825397 0 15.38778 11.37788 14.72578 13.30924 0 0 15.01841 13.51918 0 0 0 0 0 0 0 15.1972 0 0 0 15.33922 13.97977 0 0 0 0 0 0 0 Q96CP7 TLCD1_HUMAN TLC domain-containing protein 1 (Calfacilitin) TLCD1 Homo sapiens (Human) lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035] GO:0005886; GO:0007009; GO:0016021; GO:0055088; GO:0055091; GO:0071709; GO:0097035 MMMKISNAQDHLLYR 9.270000458 1 1 2.36E-13 1850.210255 0 0 0 0 0 0 18.33378 0 0 0 17.09324 16.48423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CQ1 S2536_HUMAN Solute carrier family 25 member 36 SLC25A36 Homo sapiens (Human) mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881] pyrimidine nucleotide transmembrane transporter activity [GO:0015218] GO:0000002; GO:0005739; GO:0005743; GO:0006864; GO:0007005; GO:0015218; GO:0016021; GO:0051881; GO:1990519 TASTMENDEESVKEASDFVGMMLAAATSK 3.700000048 0.454063833 0.454063833 3.66E-12 3093.764591 0 14.63213 14.29312 12.14627 14.39085 0 14.72857 15.09856 17.38904 11.28536 8.937592 0 13.1111 0 11.08618 14.47476 0 0 0 0 0 14.50879 16.19505 0 14.50941 13.14086 15.44383 14.84763 0 14.83516 0 12.72107 0 0 13.30036 0 0 0 0 14.05485 12.64277 0 13.09969 0 0 0 13.63887 11.25296 Q96CS4 ZN689_HUMAN Zinc finger protein 689 ZNF689 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035914; GO:0046872 RSGSLAIHR 6.619999886 0.276673913 0.276673913 0.210379494 994.0351898 0 16.32014 15.58684 19.35073 0 15.63212 15.97783 15.28845 17.02302 0 0 0 0 0 0 10.87767 14.51262 0 0 0 17.20709 0 15.7499 16.58623 0 0 0 15.17043 0 0 0 0 0 0 0 17.90791 0 0 0 16.21059 0 0 16.78932 0 0 17.22361 0 0 Q96CT2 KLH29_HUMAN Kelch-like protein 29 (Kelch repeat and BTB domain-containing protein 9) KLHL29 KBTBD9 KIAA1921 Homo sapiens (Human) FERDYR 8.489999771 1 1 0.304447217 885.2186972 13.98831 15.73139 15.88723 14.93972 15.59998 15.94266 12.28024 15.69444 0 0 0 0 14.23545 15.12542 0 15.00764 14.63975 0 0 0 0 0 0 0 0 0 14.78574 0 0 0 0 0 0 0 15.01522 0 0 0 16.92884 0 15.46584 0 0 0 0 15.54663 12.93427 0 Q96CT7 CC124_HUMAN Coiled-coil domain-containing protein 124 CCDC124 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366] RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0003723; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0006366; GO:0007049; GO:0030496; GO:0051301 GGKAPR 11.47000027 0.004848767 0.004848767 0.146790815 586.2614674 13.89369 15.36863 0 16.77785 0 0 14.18909 17.82682 0 0 14.82134 0 13.6872 16.402 12.14462 13.83166 17.042 0 20.25343 17.24664 15.53688 17.61586 13.41197 16.88955 0 18.97372 14.99899 16.41303 0 17.45745 17.24734 12.45238 16.43594 15.71594 17.01785 12.39565 16.72195 18.94944 16.89499 18.7995 17.5211 14.41238 17.07866 0 0 16.36334 15.72764 17.22009 Q96CV9 OPTN_HUMAN "Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7, HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein, TFIIIA-IntP)" OPTN FIP2 GLC1E HIP7 HYPL NRP Homo sapiens (Human) autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to unfolded protein [GO:0034620]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of receptor recycling [GO:0001920]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy [GO:0010508]; positive regulation of xenophagy [GO:1904417]; protein localization to Golgi apparatus [GO:0034067]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein C-terminus binding [GO:0008022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to unfolded protein [GO:0034620]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of receptor recycling [GO:0001920]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy [GO:0010508]; positive regulation of xenophagy [GO:1904417]; protein localization to Golgi apparatus [GO:0034067]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein C-terminus binding [GO:0008022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] GO:0000139; GO:0001920; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005794; GO:0005802; GO:0005829; GO:0006914; GO:0007030; GO:0007165; GO:0008022; GO:0008219; GO:0010508; GO:0030674; GO:0031267; GO:0031593; GO:0034067; GO:0034620; GO:0042802; GO:0043001; GO:0043122; GO:0043124; GO:0045087; GO:0046872; GO:0048471; GO:0050829; GO:0055038; GO:0061734; GO:0070530; GO:0090161; GO:1904417 AEAEQEK 3.74000001 1 1 0.009860794 805.2666849 0 0 0 15.56996 0 16.99239 15.12938 0 0 16.61196 15.18917 13.98543 0 0 13.66441 0 0 0 0 0 0 0 0 0 0 0 0 0 14.37148 15.42209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.60842 Q96CW5 GCP3_HUMAN "Gamma-tubulin complex component 3, GCP-3, hGCP3 (Gamma-ring complex protein 104 kDa, h104p, hGrip104) (Spindle pole body protein Spc98 homolog, hSpc98)" TUBGCP3 GCP3 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; single fertilization [GO:0007338]; spindle assembly [GO:0051225] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; polar microtubule [GO:0005827]; spindle [GO:0005819] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; polar microtubule [GO:0005827]; spindle [GO:0005819]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; single fertilization [GO:0007338]; spindle assembly [GO:0051225] gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] GO:0000278; GO:0000923; GO:0000930; GO:0005198; GO:0005200; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0007020; GO:0007338; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321 EGDTGGTMEITEAALVR 3.049999952 1 1 0.368639216 1766.953093 15.54725 16.91111 0 0 0 14.55733 0 14.86466 0 13.29414 14.53387 11.38049 0 0 0 0 0 0 0 0 0 0 0 0 15.97966 0 17.04305 16.12062 0 0 0 0 0 0 0 0 18.59149 0 0 0 0 0 0 14.95008 0 0 0 16.46068 Q96CW9 NTNG2_HUMAN Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888] anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888] GO:0005576; GO:0005886; GO:0007409; GO:0009887; GO:0009888; GO:0010975; GO:0016477; GO:0030424; GO:0034446; GO:0043256; GO:0046658; GO:0050804; GO:0070831; GO:0098685; GO:0098698; GO:0098978; GO:0099029; GO:0099560; GO:0150011; GO:1905606; GO:2001222 CNLHANLCSMR 9.069999695 0.969753921 0.969753921 0.076939305 1392.297726 0 14.08759 18.23922 0 17.24883 0 0 0 0 15.01667 15.57632 16.67648 17.78455 0 0 11.9796 0 16.44862 16.00624 16.61766 15.07299 15.36368 0 18.7226 14.14941 15.00552 0 0 15.46143 0 16.00802 8.468799 0 16.90838 0 17.7951 0 0 18.82718 16.83177 16.49351 0 0 14.09687 9.760975 0 0 16.15578 Q96D31 CRCM1_HUMAN Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) ORAI1 CRACM1 TMEM142A Homo sapiens (Human) adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279]; adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279] GO:0002115; GO:0002250; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0015279; GO:0016020; GO:0016323; GO:0034704; GO:0042802; GO:0044853; GO:0045121; GO:0045762; GO:0051924; GO:0051928; GO:0061180; GO:0070509; GO:0070588 SSPELPPSGGSTTSGSRR 2.460000038 1 1 0.181801487 1762.272208 16.69291 0 14.36696 14.21289 14.04549 14.21305 13.53755 16.35697 13.65788 15.81465 16.17558 0 0 0 0 0 0 0 0 0 0 0 17.06823 0 0 0 0 0 0 0 0 0 0 0 0 0 14.69309 0 0 0 0 0 0 0 0 0 0 0 Q96D46 NMD3_HUMAN "60S ribosomal export protein NMD3, hNMD3" NMD3 CGI-07 Homo sapiens (Human) positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055] protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723] GO:0000055; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0015031; GO:0016020; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751 RAAGAGMISK 3.880000114 1 1 0.122833254 978.6275804 15.47874 0 0 0 0 0 13.25708 13.26609 0 0 0 0 0 0 0 0 0 0 0 0 15.0965 0 0 0 0 0 0 0 0 0 17.16713 12.79498 14.75956 0 11.23566 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DA6 TIM14_HUMAN Mitochondrial import inner membrane translocase subunit TIM14 (DnaJ homolog subfamily C member 19) DNAJC19 TIM14 TIMM14 Homo sapiens (Human) genitalia development [GO:0048806]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of cardiolipin metabolic process [GO:1900208]; visual perception [GO:0007601] "inner mitochondrial membrane protein complex [GO:0098800]; integral component of membrane [GO:0016021]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; protein-containing complex [GO:0032991]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]" "inner mitochondrial membrane protein complex [GO:0098800]; integral component of membrane [GO:0016021]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; protein-containing complex [GO:0032991]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATPase activator activity [GO:0001671]; genitalia development [GO:0048806]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of cardiolipin metabolic process [GO:1900208]; visual perception [GO:0007601]" ATPase activator activity [GO:0001671] GO:0001405; GO:0001671; GO:0005739; GO:0005743; GO:0005744; GO:0006457; GO:0006626; GO:0006886; GO:0007601; GO:0016021; GO:0030150; GO:0032991; GO:0048806; GO:0098800; GO:0099617; GO:1900208 INEAKDLLEGQAK 4.28000021 1 1 0.153940329 1430.290616 16.76312 0 15.15883 0 0 0 16.29663 0 0 0 0 0 0 0 0 0 0 0 0 0 17.30655 0 0 0 0 0 15.4577 0 0 0 0 17.44635 15.96099 15.08419 15.61087 0 0 0 15.38308 0 15.87111 16.5621 0 0 0 0 0 14.17254 Q96DB5 RMD1_HUMAN "Regulator of microtubule dynamics protein 1, RMD-1, hRMD-1 (Protein FAM82B)" RMDN1 FAM82B CGI-90 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052] microtubule binding [GO:0008017] GO:0005737; GO:0005876; GO:0007052; GO:0008017; GO:0051315; GO:0097431 LLPFRR 11.22999954 0.775526285 0.775526285 0.201287339 801.1507314 15.71442 16.85034 14.69602 0 0 0 12.29287 0 14.03083 17.84754 0 15.01732 0 0 0 0 0 0 0 0 0 15.82668 0 0 0 0 0 16.98613 0 15.19236 17.04952 0 14.24753 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76924 0 Q96DF8 ESS2_HUMAN "Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H, DGS-H) (Protein ES2)" ESS2 DGCR13 DGCR14 DGSH DGSI ES2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]" catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]" GO:0000398; GO:0005634; GO:0007399; GO:0071013 NSLMYYPEGVPDEEQLFK 1.620000005 1 1 1.39E-12 2177.19373 0 0 0 0 0 10.99409 0 0 16.07892 16.03123 0 10.50738 0 0 0 0 0 11.63737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.81793 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DG6 CMBL_HUMAN "Carboxymethylenebutenolidase homolog, EC 3.1.-.-" CMBL Homo sapiens (Human) xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; xenobiotic metabolic process [GO:0006805] hydrolase activity [GO:0016787] GO:0005829; GO:0006805; GO:0016787; GO:0070062 DSEDIYNLK 8.550000191 0.60588032 0.60588032 0.218947697 1096.845789 14.65669 12.66468 17.17407 14.96318 14.29491 15.97206 0 0 13.23264 13.7628 16.2919 15.89118 14.70993 17.29286 12.79235 16.71583 15.19045 0 0 0 0 14.90476 0 0 13.62737 0 15.5733 0 0 0 14.29798 0 0 0 14.74621 0 9.915959 17.85221 15.99992 0 0 0 14.59458 14.1541 13.90073 0 0 0 Q96DH6 MSI2H_HUMAN "RNA-binding protein Musashi homolog 2, Musashi-2" MSI2 Homo sapiens (Human) stem cell development [GO:0048864] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; polysome [GO:0005844] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; polysome [GO:0005844]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; stem cell development [GO:0048864] identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005829; GO:0005844; GO:0008266; GO:0042802; GO:0043231; GO:0048864 AQPKMVTR 8.100000381 0.426941454 0.426941454 0.259419568 944.1447152 0 0 17.56402 17.51383 0 16.47816 13.50691 17.00334 16.75543 13.80229 15.92399 13.23288 15.60568 13.49038 11.83785 16.8892 15.19542 0 0 16.91622 15.83594 0 0 0 0 16.58775 0 15.06507 16.8265 0 17.36186 17.697 18.16629 15.8959 16.40065 14.85255 0 17.01129 0 15.37569 16.09061 17.05616 0 0 14.72327 0 0 0 Q96DM1 PGBD4_HUMAN PiggyBac transposable element-derived protein 4 PGBD4 Homo sapiens (Human) AMIPRQR 2.359999895 1 1 0.154392623 871.2351121 14.88819 11.64945 13.91753 13.62587 14.70438 12.08945 15.35781 0 14.84596 15.2742 15.6597 15.56172 0 0 0 0 0 0 0 0 0 0 0 16.98517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.59601 0 0 0 15.03754 0 0 0 Q96DM3 RMC1_HUMAN "Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1, Mic-1) (WD repeat-containing protein 98)" RMC1 C18orf8 MIC1 WDR98 Homo sapiens (Human) autophagy [GO:0006914]; regulation of autophagy [GO:0010506] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506] GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658 AGTMSK 2.910000086 1 1 0.119202937 594.3468211 15.22049 13.74553 14.1871 14.15782 15.05404 14.11591 0 14.41991 13.09022 14.17094 0 14.31491 16.02415 0 0 0 0 0 0 17.50119 0 16.04402 14.95617 0 0 0 0 0 0 0 0 0 0 0 0 17.50348 0 17.22237 0 0 0 15.71411 0 0 0 0 16.07467 0 Q96DN0 ERP27_HUMAN "Endoplasmic reticulum resident protein 27, ER protein 27, ERp27 (Inactive protein disulfide-isomerase 27)" ERP27 C12orf46 UNQ781/PRO1575 Homo sapiens (Human) protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] GO:0005783; GO:0005788; GO:0006457; GO:0006986; GO:0034976 MEAAPSR 3.839999914 1 1 0 780.7357063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.91691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DN2 VWCE_HUMAN von Willebrand factor C and EGF domain-containing protein (HBV X protein up-regulated gene 11 protein) (HBxAg up-regulated gene 11 protein) VWCE URG11 Homo sapiens (Human) cellular response to virus [GO:0098586] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005737; GO:0098586 GEESTM 8.159999847 1 1 0.002816315 653.3363245 16.11475 15.02143 15.81486 17.47254 0 0 16.80678 0 0 0 0 15.73959 0 16.15538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.04277 0 0 0 0 0 0 16.32087 0 0 0 0 16.36349 0 17.34097 0 16.47011 0 0 Q96DP5 FMT_HUMAN "Methionyl-tRNA formyltransferase, mitochondrial, MtFMT, EC 2.1.2.9" MTFMT FMT FMT1 Homo sapiens (Human) conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951] methionyl-tRNA formyltransferase activity [GO:0004479] GO:0004479; GO:0005739; GO:0071951 DGWIGVRSVMLK 3.75 1 1 6.89E-13 1376.691326 16.16463 16.57452 15.25526 0 0 0 14.04518 0 13.73748 0 0 14.03551 0 0 14.31051 11.94281 0 0 0 0 0 0 15.41805 0 0 15.97164 15.26414 16.13879 0 0 0 0 0 0 0 0 0 0 0 0 15.99149 0 0 14.41966 0 0 0 13.09859 Q96DR4 STAR4_HUMAN "StAR-related lipid transfer protein 4 (START domain-containing protein 4, StARD4)" STARD4 Homo sapiens (Human) cholesterol import [GO:0070508]; cholesterol transport involved in cholesterol storage [GO:0010879]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol esterification [GO:0010873] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol import [GO:0070508]; cholesterol transport involved in cholesterol storage [GO:0010879]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol esterification [GO:0010873] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] GO:0005737; GO:0005783; GO:0005829; GO:0010873; GO:0010879; GO:0015485; GO:0031410; GO:0032367; GO:0070508; GO:0070859; GO:0120020 EGLSDVASFATK 3.660000086 1 1 6.89E-13 1226.193676 11.7812 0 0 14.14133 0 0 0 0 0 11.91897 15.44852 0 11.86368 0 0 12.42301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DR7 ARHGQ_HUMAN Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; endothelial cell morphogenesis [GO:0001886]; ruffle assembly [GO:0097178] cytosol [GO:0005829]; ruffle [GO:0001726] cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; endothelial cell morphogenesis [GO:0001886]; ruffle assembly [GO:0097178] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001726; GO:0001886; GO:0005085; GO:0005829; GO:0090630; GO:0097178 AVPGGSPK 4.389999866 0.122821838 0.122821838 0.290469802 708.9855475 0 15.36438 0 13.74972 14.34143 12.90325 15.96317 14.802 15.87275 15.55002 0 0 0 14.34824 14.47147 0 0 0 14.69898 0 0 0 16.48567 0 0 0 0 0 0 15.52272 0 16.2519 15.51738 0 15.08049 0 0 0 0 15.88551 15.44864 0 0 15.9837 0 0 0 0 Q96DT5 DYH11_HUMAN Dynein axonemal heavy chain 11 (Axonemal beta dynein heavy chain 11) (Ciliary dynein heavy chain 11) DNAH11 Homo sapiens (Human) cardiac septum morphogenesis [GO:0060411]; cilium movement [GO:0003341]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; microtubule-based movement [GO:0007018]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; proximal portion of axoneme [GO:0120134] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; proximal portion of axoneme [GO:0120134]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cardiac septum morphogenesis [GO:0060411]; cilium movement [GO:0003341]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; microtubule-based movement [GO:0007018]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0003356; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007611; GO:0008569; GO:0030286; GO:0030317; GO:0031514; GO:0035545; GO:0045505; GO:0051959; GO:0060287; GO:0060411; GO:0097728; GO:0097729; GO:0120134; GO:0120229 VIQQTMR 21.39999962 0.339390397 0.339390397 1.03E-12 891.4565194 0 16.82888 0 17.66907 15.97095 16.96347 16.70596 0 16.15324 18.2077 0 15.427 0 14.0429 0 16.21626 16.68782 14.50055 0 0 13.59039 0 0 19.29081 17.56378 11.59124 15.36332 14.04552 14.66299 14.70757 13.64309 18.18132 0 15.55909 17.40676 17.05638 15.91984 0 14.26826 0 14.34391 11.49734 14.5989 16.73582 18.0782 16.49311 0 12.57 Q96DT6 ATG4C_HUMAN "Cysteine protease ATG4C, EC 3.4.22.- (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3, Autophagin-3) (Autophagy-related protein 4 homolog C, HsAPG4C)" ATG4C APG4C AUTL1 AUTL3 Homo sapiens (Human) autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0051697 MEATGTDEVDK 9.100000381 1 1 0.079025322 1193.116723 14.57517 13.5896 0 16.84187 13.32648 12.48089 0 0 0 13.94707 0 0 0 9.754203 0 0 0 0 0 0 0 14.8246 0 0 14.80196 10.62357 0 0 15.73744 0 0 0 0 0 0 0 0 0 0 0 0 0 12.30493 0 0 16.12218 0 0 Q96DT7 ZBT10_HUMAN Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF) ZBTB10 RINZF RINZFC Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; telomeric DNA binding [GO:0042162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; telomeric DNA binding [GO:0042162]" GO:0000122; GO:0000781; GO:0000977; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042162; GO:0046872 SFSEMNRR 5.300000191 1 1 0.138764503 1042.17595 12.93273 15.93118 15.6908 14.85298 0 0 0 0 0 0 0 0 0 14.0897 0 0 0 0 14.96584 0 15.29049 0 0 0 14.95597 12.82703 0 15.24049 0 0 0 15.17561 15.90824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DU3 SLAF6_HUMAN "SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen, NTB-A) (CD antigen CD352)" SLAMF6 KALI UNQ6123/PRO20080 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540] GO:0005886; GO:0009897; GO:0016021; GO:0032729; GO:0032740; GO:0042110; GO:0045087; GO:0045954; GO:0070062; GO:0072540 LSSYTLR 7.480000019 1 1 1.22E-13 837.3731345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.69978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DU9 PABP5_HUMAN "Polyadenylate-binding protein 5, PABP-5, Poly(A)-binding protein 5" PABPC5 PABP5 Homo sapiens (Human) cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005634; GO:0005759; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:1990904 YETHEAAQK 8.050000191 1 1 6.93E-13 1074.988497 0 0 0 0 0 0 0 17.38932 0 0 0 19.57368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.93294 0 0 0 18.45504 0 0 0 0 0 0 0 0 0 0 0 0 17.59422 0 Q96DV4 RM38_HUMAN "39S ribosomal protein L38, mitochondrial, L38mt, MRP-L38 (Mitochondrial large ribosomal subunit protein mL38)" MRPL38 HSPC262 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005762; GO:0032543 TFDFYKK 1.179999948 1 1 0.186515036 948.0585318 16.71735 14.60891 12.60359 0 13.53065 0 11.82025 0 14.18467 0 0 0 0 0 15.07891 0 0 0 0 0 8.893752 14.18136 0 0 0 0 17.29277 15.43718 14.02993 0 0 0 0 0 0 15.45802 0 0 0 14.46048 0 0 11.80944 16.75503 0 0 12.60822 0 Q96DY2 DRC10_HUMAN Dynein regulatory complex protein 10 (IQ domain-containing protein D) IQCD DRC10 Homo sapiens (Human) ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] GO:0005737; GO:0031514; GO:0036064 EDMEGMLGEDVMR 7.480000019 0.759675145 0.759675145 0.167198683 1543.201646 15.61754 0 16.22944 0 15.33227 0 16.03561 13.45649 14.37696 15.7993 16.33455 16.27808 15.21318 12.32551 0 10.875 15.00114 0 14.66324 15.05101 15.14034 16.37912 0 15.17899 13.97033 14.22831 10.24512 16.48535 15.85828 18.93288 0 15.85869 0 0 16.45745 15.49374 14.55941 15.02679 15.8114 15.29123 14.57798 0 15.22839 12.46851 14.97522 15.63812 0 0 Q96DY7 MTBP_HUMAN "Mdm2-binding protein, hMTBP" MTBP Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089] chromatin [GO:0000785]; kinetochore [GO:0000776] chromatin [GO:0000785]; kinetochore [GO:0000776]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089] GO:0000776; GO:0000785; GO:0007049; GO:0007089; GO:0008285; GO:0031396; GO:0034501; GO:0045839 LKDYLPTVGALK 6.670000076 1 1 0.123852894 1318.000297 12.04962 0 17.19493 0 0 0 14.40353 12.39292 0 0 0 12.55358 0 0 0 13.62 0 13.27528 0 13.13588 0 15.49603 0 0 0 0 0 0 13.55134 9.919089 14.00879 14.67926 12.45414 13.32481 12.72791 14.0269 13.88839 13.54449 13.54539 12.81236 12.98031 11.34718 0 0 0 14.47095 0 0 Q96DZ1 ERLEC_HUMAN "Endoplasmic reticulum lectin 1 (ER lectin, Erlectin) (XTP3-transactivated gene B protein)" ERLEC1 C2orf30 XTP3TPB UNQ1878/PRO4321 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]" endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322] "endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]" unfolded protein binding [GO:0051082] GO:0005788; GO:0030433; GO:0030968; GO:0036503; GO:0044322; GO:0051082; GO:1904153 NIEGQMTPYYPVGMGNGTPCSLKQNRPR 2.650000095 1 1 0.072554028 3182.457639 0 13.59998 11.82911 0 15.1812 14.30111 0 14.91759 14.63839 14.2218 14.33762 12.65368 15.9286 10.8399 0 0 0 13.89976 0 0 0 14.06771 0 0 0 0 0 0 0 0 0 15.55728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DZ5 CLIP3_HUMAN "CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein, CLIP-170-related 59 kDa protein, CLIPR-59)" CLIP3 CLIPR59 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840] ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010] GO:0001934; GO:0005634; GO:0005737; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0008017; GO:0010828; GO:0018230; GO:0031115; GO:0031122; GO:0031901; GO:0032588; GO:0035371; GO:0035594; GO:0043065; GO:0044091; GO:0045121; GO:0045444; GO:0045807; GO:0051010; GO:0055038; GO:0098840; GO:1903078 TDFAPGYWYGIELDQPTGK 7.610000134 1 1 0.225361099 2158.306721 14.01918 0 15.12841 0 0 0 0 0 16.96845 0 16.19035 16.46737 0 0 0 0 0 15.97901 0 0 0 16.68691 0 14.02059 0 0 15.5646 14.12921 16.82826 14.63836 0 0 0 15.43923 0 15.90792 0 0 16.59818 0 15.44563 0 0 0 0 0 0 0 Q96DZ7 T4S19_HUMAN Transmembrane 4 L6 family member 19 (Osteoclast maturation-associated gene 4 protein) (Tetraspan membrane protein OCTM4) TM4SF19 OCTM4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 NYLYDR 14.30000019 0.440084755 0.440084755 0.39998465 841.9770936 16.32374 16.0596 0 0 0 16.15045 15.42427 16.07396 15.67432 16.1979 0 0 16.18136 17.08325 0 15.96006 0 0 0 15.78063 16.72993 0 17.02032 0 15.08527 16.41273 15.1172 15.36242 16.3329 0 15.34612 14.64525 16.27247 0 13.66513 0 13.84899 13.47205 17.70284 13.18682 16.32829 15.97034 15.24174 0 15.32425 14.53878 14.6314 14.41417 Q96E11 RRFM_HUMAN "Ribosome-recycling factor, mitochondrial, RRF (Ribosome-releasing factor, mitochondrial)" MRRF Homo sapiens (Human) ribosome disassembly [GO:0032790]; translation [GO:0006412] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; ribosome disassembly [GO:0032790]; translation [GO:0006412] ribosomal large subunit binding [GO:0043023] GO:0005739; GO:0005759; GO:0006412; GO:0032790; GO:0043023 MVHPTFR 5.96999979 1 1 0.081773443 888.8006221 0 0 0 0 0 0 0 14.78431 0 0 0 0 15.60352 0 17.57183 0 0 14.82366 0 0 0 0 0 0 15.25237 0 0 15.35454 0 0 0 15.98349 0 0 0 0 17.33931 15.22024 15.68559 15.74076 15.74155 12.36987 0 0 0 0 0 0 Q96E14 RMI2_HUMAN "RecQ-mediated genome instability protein 2, hRMI2 (BLM-associated protein of 18 kDa, BLAP18)" RMI2 C16orf75 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]; resolution of recombination intermediates [GO:0071139] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]; resolution of recombination intermediates [GO:0071139] DNA binding [GO:0003677] GO:0000724; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0016607; GO:0031422; GO:0033045; GO:0043007; GO:0071139; GO:2000042 VVMADR 16.59000015 1 1 0.204223877 704.8941661 17.56442 0 0 16.96595 15.77704 0 15.54011 17.13331 16.25538 14.61727 0 0 14.71535 15.2549 0 0 0 0 0 17.28509 16.0328 15.00385 14.48463 0 0 0 17.52845 0 0 0 17.90462 0 0 14.83983 0 0 18.74999 0 0 0 16.79796 16.15836 0 0 15.47338 0 14.91459 0 Q96E52 OMA1_HUMAN "Metalloendopeptidase OMA1, mitochondrial, EC 3.4.24.- (Metalloprotease-related protein 1, MPRP-1) (Overlapping with the m-AAA protease 1 homolog)" OMA1 MPRP1 Homo sapiens (Human) cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638] lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0008289; GO:0010637; GO:0016020; GO:0016021; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0042407; GO:0042981; GO:0043065; GO:0046872; GO:0051603; GO:0097009; GO:0120162; GO:0140467; GO:0140468; GO:1903850 EVTAVPSLSVLHPLSPASIR 5.210000038 0.372760385 0.372760385 0.425042933 2072.200689 0 0 0 0 0 0 10.39061 14.51811 12.78816 17.26218 17.1544 14.84643 0 0 11.92493 0 0 12.34458 18.23214 0 14.95013 0 17.29077 0 0 0 16.59431 17.07914 0 15.72124 0 18.99254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.99976 Q96EA4 SPDLY_HUMAN "Protein Spindly, hSpindly (Arsenite-related gene 1 protein) (Coiled-coil domain-containing protein 99) (Rhabdomyosarcoma antigen MU-RMS-40.4A) (Spindle apparatus coiled-coil domain-containing protein 1)" SPDL1 CCDC99 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]; enzyme binding [GO:0019899]; kinetochore binding [GO:0043515]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] enzyme binding [GO:0019899]; kinetochore binding [GO:0043515] GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0005815; GO:0005829; GO:0007080; GO:0007094; GO:0016477; GO:0019899; GO:0034501; GO:0043515; GO:0051301 EGKETSSK 13.98999977 1 1 0.0337895 866.5633844 0 15.76233 13.58432 16.28248 16.46733 0 0 17.30934 0 0 0 0 0 0 0 0 0 15.67928 0 0 0 0 0 0 0 0 0 0 0 0 15.17387 16.56565 0 0 0 15.06636 17.59866 0 15.4593 0 0 15.52733 0 0 0 0 0 0 Q96EB1 ELP4_HUMAN "Elongator complex protein 4, hELP4 (PAX6 neighbor gene protein)" ELP4 C11orf19 PAXNEB Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] phosphorylase kinase regulator activity [GO:0008607] GO:0002098; GO:0005654; GO:0005737; GO:0006357; GO:0006368; GO:0006417; GO:0008023; GO:0008607; GO:0033588 YQLLPKMEIGPVSSSR 3.829999924 1 1 0.253304511 1820.825573 15.86502 0 0 0 12.73281 13.96199 0 13.96572 0 0 0 0 16.97367 0 0 10.72701 0 0 0 12.57272 13.03068 14.86895 0 0 0 0 16.74895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EB6 SIR1_HUMAN "NAD-dependent protein deacetylase sirtuin-1, hSIRT1, EC 2.3.1.286 (NAD-dependent protein deacylase sirtuin-1, EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1, hSIR2) [Cleaved into: SirtT1 75 kDa fragment, 75SirT1 ]" SIRT1 SIR2L1 Homo sapiens (Human) "angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone methylation [GO:0031062]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]" chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553] "chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone methylation [GO:0031062]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]" bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006346; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007569; GO:0008022; GO:0008284; GO:0009267; GO:0010629; GO:0010824; GO:0010875; GO:0010883; GO:0010906; GO:0014068; GO:0016239; GO:0016567; GO:0016575; GO:0016605; GO:0016922; GO:0017136; GO:0018394; GO:0019213; GO:0019899; GO:0030225; GO:0030308; GO:0030512; GO:0031062; GO:0031065; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032071; GO:0032088; GO:0032868; GO:0032922; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0034983; GO:0035356; GO:0035358; GO:0042127; GO:0042149; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043280; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0050872; GO:0051019; GO:0051097; GO:0051152; GO:0051574; GO:0051898; GO:0055089; GO:0060766; GO:0060907; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0070932; GO:0071356; GO:0071441; GO:0071456; GO:0071479; GO:0071900; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0160012; GO:1900034; GO:1900113; GO:1901215; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000480; GO:2000481; GO:2000619; GO:2000655; GO:2000757; GO:2000773; GO:2000774 KCWPNR 5.409999847 1 1 0.094450323 861.4100671 14.77971 9.51987 0 0 0 0 0 0 0 0 0 0 0 16.84798 0 0 0 0 16.6235 18.49624 0 0 0 17.00596 15.24375 16.17831 0 15.51352 14.91649 14.93449 15.92415 15.81732 15.94273 0 0 0 0 0 0 0 0 0 0 0 0 18.61333 16.85796 0 Q96ED9 HOOK2_HUMAN "Protein Hook homolog 2, h-hook2, hHK2" HOOK2 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; trans-Golgi network [GO:0005802] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; trans-Golgi network [GO:0005802]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GO:0005737; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0006897; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0042802; GO:0043231; GO:0045022; GO:0051959; GO:0070695; GO:1905719 QEEAMK 7.239999771 1 1 0.206341053 735.1466747 0 0 15.47159 0 0 0 0 0 0 0 0 0 0 0 17.47566 0 0 17.08309 0 0 0 0 0 0 0 0 0 0 0 0 16.34434 0 0 0 0 16.81762 17.30931 0 17.56268 0 16.98659 0 0 0 0 0 0 0 Q96EE3 SEH1_HUMAN Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein) SEH1L SEC13L SEH1 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503] structural molecule activity [GO:0005198] GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005765; GO:0005829; GO:0006913; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031503; GO:0032008; GO:0034198; GO:0035859; GO:0050830; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904262; GO:1904263 FAPKHMGLMLATCSADGIVR 4.25 1 1 0.235173552 2191.648592 14.04607 0 10.8073 0 0 0 0 13.29687 15.31227 0 11.10312 8.337968 0 15.16024 15.4063 0 14.32748 0 0 15.00206 13.54918 0 16.13629 14.75251 0 0 15.06326 12.8308 15.06221 0 14.87555 3.395534 11.65924 10.15689 0 15.36137 15.12105 0 15.4676 15.02382 0 0 9.94556 13.02896 14.83168 0 0 0 Q96EG3 ZN837_HUMAN Zinc finger protein 837 ZNF837 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872 GAAGGR 10.47000027 1 1 0.190283364 487.2579229 17.61952 17.84656 17.67155 22.01005 17.40205 18.87593 0 17.9041 0 17.60967 0 19.0196 18.43511 17.61537 17.79892 18.58638 16.96482 0 17.16362 0 18.58418 18.64291 18.44212 18.58068 18.87773 0 19.49118 0 18.12511 18.47096 19.71178 18.51175 0 0 0 19.05132 0 0 0 0 18.41899 17.71021 0 16.90556 18.72785 18.68929 0 19.20479 Q96EI5 TCAL4_HUMAN "Transcription elongation factor A protein-like 4, TCEA-like protein 4 (Transcription elongation factor S-II protein-like 4)" TCEAL4 NPD017 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] WW domain binding [GO:0050699] GO:0005634; GO:0050699 EFDNMAKVQDEK 1.840000033 1 1 0.408000019 1452.291162 0 0 0 0 0 0 0 0 17.59195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84027 0 0 0 0 0 0 0 0 0 0 18.54862 0 0 0 0 0 0 0 0 0 Q96EK5 KBP_HUMAN KIF-binding protein (KIF1-binding protein) (Kinesin family binding protein) KIFBP KBP KIAA1279 KIF1BP Homo sapiens (Human) cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399] cytoskeleton [GO:0005856]; mitochondrion [GO:0005739] cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; kinesin binding [GO:0019894]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399] kinesin binding [GO:0019894] GO:0001701; GO:0005739; GO:0005856; GO:0006839; GO:0007399; GO:0019894; GO:0030154 NPEKEPYK 1.529999971 1 1 0.082508846 1002.728727 14.26569 0 14.13181 0 0 0 15.26979 0 15.60234 16.54912 13.17064 11.85363 13.55757 13.59433 13.81792 13.35527 12.61826 16.03442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.67411 0 0 0 Q96EK7 F120B_HUMAN "Constitutive coactivator of peroxisome proliferator-activated receptor gamma, Constitutive coactivator of PPAR-gamma, Constitutive coactivator of PPARG (PPARG constitutive coactivator 1, PGCC1) (Protein FAM120B)" FAM120B CCPG KIAA1838 Homo sapiens (Human) fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357] nucleus [GO:0005634] nucleus [GO:0005634]; fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357] GO:0005634; GO:0035357; GO:0045444 GVRGLQGFVGSTCPHICTVVNFK 2.460000038 1 1 2.74E-12 2533.821802 11.60649 13.88015 0 0 11.84597 7.998786 0 0 0 13.30669 13.11667 0 0 10.71694 0 0 0 13.04129 11.70364 9.524589 0 12.3961 13.43273 0 0 0 0 0 0 0 0 0 0 15.93489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EK9 KTI12_HUMAN Protein KTI12 homolog KTI12 SBBI81 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098] ATP binding [GO:0005524]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098] ATP binding [GO:0005524] GO:0002098; GO:0005524; GO:0006357 EESGAAESPALVTPDSEK 9.210000038 0.66855067 0.66855067 0.211822432 1816.231255 15.70246 11.5385 15.83244 12.57753 14.12146 0 0 0 0 0 12.81475 0 16.71399 0 0 0 0 0 0 0 12.35426 0 15.47335 0 15.85436 17.96969 0 0 0 13.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EM0 T3HPD_HUMAN "Trans-3-hydroxy-L-proline dehydratase, EC 4.2.1.77 (Trans-L-3-hydroxyproline dehydratase)" L3HYPDH C14orf149 Homo sapiens (Human) hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346] hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346] GO:0016836; GO:0050346 MESALAVPR 2.349999905 0.623421907 0.623421907 0.279538737 990.0417998 17.66587 18.53963 0 0 0 0 0 0 18.25704 16.34116 0 0 17.19813 0 0 17.70348 16.58525 0 0 0 16.8211 0 17.39436 0 0 0 0 0 16.94237 0 0 0 0 0 0 0 0 0 0 0 0 18.34556 0 16.99194 16.55196 0 0 18.12046 Q96EN8 MOCOS_HUMAN "Molybdenum cofactor sulfurase, MCS, MOS, MoCo sulfurase, hMCS, EC 2.8.1.9 (Molybdenum cofactor sulfurtransferase)" MOCOS Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545] cytosol [GO:0005829] cytosol [GO:0005829]; lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545] lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170] GO:0005829; GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0032324; GO:0043545; GO:0102867 DPSAPR 3.869999886 0.06630493 0.06630493 0.245609268 642.902395 0 14.80933 0 15.82007 0 14.2739 15.0564 0 14.40637 13.30138 15.41111 0 0 0 0 0 16.1887 14.56328 0 17.31251 16.0894 0 16.00525 0 0 16.40914 0 0 15.58272 15.82843 0 17.17448 0 0 15.16295 0 16.11536 16.85626 16.31947 0 16.29114 15.85276 16.17614 0 14.52747 0 0 0 Q96EN9 REX1B_HUMAN Required for excision 1-B domain-containing protein REX1BD C19orf60 Homo sapiens (Human) LGTVALLQLMETPELAGQEDAVR 7.130000114 0.436993808 0.436993808 5.02E-12 2470.782411 15.4613 16.14546 0 0 15.19557 15.94138 15.25796 0 0 0 15.0491 15.62336 15.36777 13.24421 0 0 14.25972 14.84866 17.38863 13.6199 12.19528 15.26833 14.82493 14.69919 13.66183 16.83156 15.2694 14.57746 14.73958 12.02657 17.81575 16.7627 15.88368 0 17.92997 16.91615 0 16.62555 15.26681 0 0 14.09761 0 17.0075 0 16.7491 0 14.12502 Q96EP1 CHFR_HUMAN "E3 ubiquitin-protein ligase CHFR, EC 2.3.2.27 (Checkpoint with forkhead and RING finger domains protein) (RING finger protein 196) (RING-type E3 ubiquitin transferase CHFR)" CHFR RNF196 Homo sapiens (Human) cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic G2/M transition checkpoint [GO:0044818]; modification-dependent protein catabolic process [GO:0019941]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; PML body [GO:0016605] nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic G2/M transition checkpoint [GO:0044818]; modification-dependent protein catabolic process [GO:0019941]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000166; GO:0000209; GO:0004842; GO:0005634; GO:0006511; GO:0016567; GO:0016605; GO:0019941; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0046872; GO:0051301; GO:0061630 AEREQDPR 9.279999733 0.294627815 0.294627815 0.140513271 1001.481676 18.12476 0 16.48975 13.94004 0 15.72834 16.21728 15.94571 15.30187 9.339234 17.75797 15.53025 0 0 0 0 0 14.6809 0 17.31607 14.05648 13.45581 17.63529 17.30203 16.16464 0 16.09444 18.99745 0 0 18.49949 0 18.66315 16.18258 15.61769 16.77008 15.85281 0 0 15.80788 0 0 17.0372 0 15.70358 17.88956 17.88459 12.66348 Q96ER9 MITOK_HUMAN "Mitochondrial potassium channel, MITOK (Coiled-coil domain-containing protein 51)" CCDC51 MITOK Homo sapiens (Human) cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial ATP-gated potassium channel activity [GO:0062156]; cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805] mitochondrial ATP-gated potassium channel activity [GO:0062156] GO:0005743; GO:0006884; GO:0031305; GO:0062156; GO:0062157; GO:0071805; GO:0140141 LPALGRALGHSIQQR 4.179999828 1 1 0.175461574 1617.298246 0 16.60639 0 16.47013 0 0 0 0 14.92047 0 0 0 0 0 0 0 0 0 0 0 15.90884 0 0 0 0 0 12.03162 0 0 14.99902 0 0 0 0 0 0 0 17.08076 0 14.99254 0 0 0 0 0 0 0 0 Q96ES6 MFSD3_HUMAN Major facilitator superfamily domain-containing protein 3 MFSD3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; solute:proton symporter activity [GO:0015295] solute:proton symporter activity [GO:0015295] GO:0015295; GO:0016021 VLYAPWLLKLAWAPLVDAQGSAR 2.079999924 1 1 0.256178096 2538.614077 0 0 0 0 0 0 0 0 19.57774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EV2 RBM33_HUMAN RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33) RBM33 PRR8 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 EGTIIR 9.020000458 0.979525506 0.979525506 0.279826705 688.0543009 15.75397 0 0 13.48272 14.99299 0 13.47401 16.21072 16.61281 12.58751 14.93967 15.003 14.46713 14.71446 0 16.53933 0 15.91605 16.74242 0 15.85199 14.93726 14.8553 15.65197 0 0 16.3023 15.39736 16.81337 15.47828 0 16.47124 0 0 16.15191 0 16.59288 0 17.01314 16.52066 16.21749 0 15.99901 16.82516 0 16.09335 16.78768 15.35054 Q96EX2 RNFT2_HUMAN RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118) RNFT2 TMEM118 Homo sapiens (Human) positive regulation of ERAD pathway [GO:1904294] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0016021; GO:0046872; GO:0061630; GO:1904294 SFDICGR 5.760000229 0.311293423 0.311293423 0.163514072 854.3155612 0 0 17.39488 19.03567 16.9919 16.49171 18.53633 15.79242 0 0 15.97028 0 0 0 0 16.48459 0 15.28325 0 0 0 0 0 0 0 0 0 13.92171 0 0 17.44682 13.66383 17.50077 14.29557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EY1 DNJA3_HUMAN "DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1, hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)" DNAJA3 HCA57 TID1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082] GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0106137; GO:0140297 MGGKGIPR 9.630000114 0.291900754 0.291900754 0.255479031 831.5880164 19.61098 0 0 17.83191 17.85978 20.10213 19.06733 17.8308 17.37343 19.04143 17.74682 18.14244 16.73892 0 14.54841 17.29938 0 18.02843 18.99825 18.64815 19.0561 0 19.77496 17.61838 18.63885 19.22218 18.92113 18.41811 15.96745 0 0 18.59613 18.39313 0 18.30774 0 18.62796 20.41512 18.54667 18.33686 17.28028 17.59566 18.07228 18.24177 17.70149 0 0 18.72341 Q96EY4 TMA16_HUMAN Translation machinery-associated protein 16 TMA16 C4orf43 Homo sapiens (Human) nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730 KAAQITR 5.769999981 1 1 0.049163439 787.6715488 0 13.26556 0 0 14.80323 0 0 15.82777 15.20946 0 0 15.81699 0 0 0 15.33014 0 14.55408 0 0 15.46193 0 0 0 11.83924 0 0 0 15.06548 0 0 0 0 16.89646 0 14.35013 0 0 0 0 15.80034 15.80107 0 0 0 0 0 0 Q96EY5 MB12A_HUMAN Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A) MVB12A CFBP FAM125A Homo sapiens (Human) endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; virus maturation [GO:0019075] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; vesicle [GO:0031982] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; vesicle [GO:0031982]; lipid binding [GO:0008289]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; virus maturation [GO:0019075] lipid binding [GO:0008289]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130] GO:0000813; GO:0005634; GO:0005813; GO:0005829; GO:0008289; GO:0010008; GO:0015031; GO:0016236; GO:0017124; GO:0019075; GO:0031902; GO:0031982; GO:0032510; GO:0032801; GO:0036258; GO:0039702; GO:0042058; GO:0043130; GO:0043162; GO:0043231; GO:0046755; GO:0070062 DMQGLSLDAASQPSKGGLLER 1.75 1 1 0.195690909 2172.993747 16.92561 14.13634 15.80714 15.90587 13.26512 13.30359 0 12.98713 12.78462 0 0 0 14.12976 0 0 0 0 0 0 0 13.31801 0 0 0 0 13.30163 13.16259 14.13031 0 13.51502 13.17479 17.35327 0 0 0 0 0 15.75165 0 15.91234 0 0 0 15.45637 0 0 0 15.00056 Q96EY7 PTCD3_HUMAN "Pentatricopeptide repeat domain-containing protein 3, mitochondrial (28S ribosomal protein S39, mitochondrial, MRP-S39) (Mitochondrial small ribosomal subunit protein mS39) (Transformation-related gene 15 protein, TRG-15)" PTCD3 MRPS39 TRG15 Homo sapiens (Human) mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417] ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0005829; GO:0005886; GO:0006417; GO:0019843; GO:0032543; GO:0043024 MLGLFRK 4.989999771 1 1 0.075044219 881.6233291 15.191 0 14.92834 13.25677 12.63397 0 14.87119 0 14.43174 13.43577 0 0 0 0 12.42449 0 0 0 0 0 0 0 0 0 16.70214 0 0 0 0 0 0 0 0 17.44867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EY8 MMAB_HUMAN "Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)" MMAB Homo sapiens (Human) cobalamin metabolic process [GO:0009235] mitochondrial matrix [GO:0005759] "mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]; cobalamin metabolic process [GO:0009235]" "ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]" GO:0005524; GO:0005759; GO:0008817; GO:0009235; GO:0031419 FLNRLSDYLFTLAR 2.50999999 1 1 0.315939644 1726.561232 15.8249 0 16.35443 0 11.50786 14.13314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.58121 0 0 0 0 0 0 15.48965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EY9 ADAT3_HUMAN Probable inactive tRNA-specific adenosine deaminase-like protein 3 (tRNA-specific adenosine-34 deaminase subunit ADAT3) ADAT3 TAD3 Homo sapiens (Human) tRNA processing [GO:0008033] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]; tRNA processing [GO:0008033] catalytic activity [GO:0003824]; metal ion binding [GO:0046872] GO:0003824; GO:0005654; GO:0008033; GO:0046872 MEPAPGLVEQPK 3.769999981 1 1 0.049215942 1294.532532 14.43292 14.21765 14.53874 12.74669 12.23756 12.26809 19.02709 0 0 9.444305 0 13.54452 0 0 14.13575 0 0 0 0 0 0 14.53934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EZ8 MCRS1_HUMAN Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2) MCRS1 INO80Q MSP58 Homo sapiens (Human) "cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521] GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006464; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0042766; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751 QPLQVTK 6.460000038 1 1 0.08307379 813.2680738 0 0 0 0 0 0 18.29485 0 0 18.47347 0 0 0 0 0 0 0 0 0 0 17.71093 0 0 0 0 0 0 0 0 0 0 18.39337 0 0 0 0 0 0 0 0 0 0 17.00374 0 0 0 0 0 Q96F07 CYFP2_HUMAN Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121) CYFIP2 KIAA1168 PIR121 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202]; small GTPase binding [GO:0031267]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833] small GTPase binding [GO:0031267] GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609 GLQVLMGRMESVFNQAIR 7.650000095 1 1 0.200444034 2066.144009 12.645 12.30715 0 0 0 14.14154 0 0 12.66838 0 0 0 13.44895 12.71772 15.32557 14.65911 15.03327 0 0 14.26106 14.32438 13.35578 15.49705 15.35673 0 14.14031 0 15.16017 14.97122 14.2705 15.27462 13.4011 12.7236 12.60218 0 0 0 17.42334 0 15.00446 0 0 14.83633 10.50489 14.94558 12.10049 0 0 Q96F10 SAT2_HUMAN "Thialysine N-epsilon-acetyltransferase, EC 2.3.1.- (Diamine acetyltransferase 2, EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2, SSAT-2)" SAT2 SSAT2 Homo sapiens (Human) nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919] diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809] GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204; GO:0070062 GQGIGSKIIK 5.989999771 1 1 0.03447605 1001.536065 13.69673 0 0 0 14.02515 15.53651 15.73197 15.91726 12.94427 0 14.90493 16.66673 16.89744 16.285 0 0 17.80528 17.35817 17.64536 19.0343 0 0 17.37516 18.18558 0 17.62169 17.21873 16.7797 17.00757 0 16.96414 18.86204 16.33334 16.657 0 16.71015 18.14226 0 17.6952 18.86383 17.04067 0 16.92029 0 17.89312 0 0 0 Q96F45 ZN503_HUMAN Zinc finger protein 503 ZNF503 NOLZ1 Homo sapiens (Human) "G1 to G0 transition involved in cell differentiation [GO:0070315]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neural precursor cell proliferation [GO:0061351]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; G1 to G0 transition involved in cell differentiation [GO:0070315]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neural precursor cell proliferation [GO:0061351]" metal ion binding [GO:0046872] GO:0005634; GO:0008285; GO:0010629; GO:0045892; GO:0046872; GO:0061351; GO:0070315 KEPGGGGGGGGGGGGGGGGVSSEK 8.989999771 1 1 0.188747016 1815.046569 14.00447 0 15.01703 15.72755 15.1773 0 13.94451 14.37669 14.65782 14.36265 15.28061 12.87418 16.10872 14.51188 15.49489 12.79602 0 0 16.48783 0 0 0 0 0 15.98389 0 0 16.87501 0 15.75548 0 0 0 0 0 0 17.58472 0 0 0 0 0 0 0 0 0 0 0 Q96F81 DISP1_HUMAN Protein dispatched homolog 1 DISP1 DISPA Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; peptide transmembrane transporter activity [GO:1904680]; determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708] peptide transmembrane transporter activity [GO:1904680] GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016021; GO:0016323; GO:0050708; GO:0060539; GO:0070207; GO:1904680 GPKSELEHEFYELEPLASHSCTAPEK 4.949999809 1 1 0.111311763 2985.601643 14.47954 0 12.57913 0 13.75288 12.17773 9.979993 11.4099 14.98096 15.33569 14.74246 13.56833 13.98832 15.06976 0 9.870968 0 0 0 13.55626 0 0 14.9247 12.45474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96F85 CNRP1_HUMAN "CB1 cannabinoid receptor-interacting protein 1, CRIP-1" CNRIP1 C2orf32 Homo sapiens (Human) negative regulation of signaling receptor activity [GO:2000272]; regulation of signaling receptor activity [GO:0010469] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; type 1 cannabinoid receptor binding [GO:0031718]; negative regulation of signaling receptor activity [GO:2000272]; regulation of signaling receptor activity [GO:0010469] protein C-terminus binding [GO:0008022]; type 1 cannabinoid receptor binding [GO:0031718] GO:0005737; GO:0005886; GO:0008022; GO:0010469; GO:0031718; GO:2000272 SLMWVNKESFL 2.569999933 1 1 0.262171358 1370.379993 0 0 0 0 0 0 0 14.60495 0 0 0 0 0 14.75392 0 14.752 0 0 0 0 0 0 0 0 16.34467 0 16.82317 0 0 0 0 14.40575 0 17.16602 14.75033 0 16.20021 0 0 16.04936 0 0 0 0 0 0 0 0 Q96FB5 MT25B_HUMAN Methyltransferase-like protein 25B (Protein RRNAD1) (Ribosomal RNA adenine dimethylase domain-containing protein 1) METTL25B C1orf66 RRNAD1 CGI-41 Homo sapiens (Human) integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" "rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" GO:0000179; GO:0016021 PGISAR 1.700000048 0.127493098 0.127493098 0.254785378 600.5774933 0 15.70618 17.03413 15.42136 18.02021 0 0 16.1056 18.28632 0 0 0 0 0 0 0 16.92185 0 0 0 0 0 16.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.89084 0 0 0 0 15.85511 0 Q96FC7 PHIPL_HUMAN Phytanoyl-CoA hydroxylase-interacting protein-like PHYHIPL KIAA1796 UNQ6309/PRO20934 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ENKNSNK 10.71000004 1 1 0.155178811 832.831062 0 14.369 0 16.74356 0 13.09397 0 16.43089 12.46099 0 13.27288 13.90937 0 0 14.93319 0 17.12083 0 13.98166 0 12.38869 17.07455 0 12.7062 0 0 0 8.43131 14.70672 0 10.98799 11.71565 11.65154 14.97336 9.06757 14.41105 15.43229 0 0 14.87667 15.6652 17.18931 0 16.27045 0 0 0 15.60228 Q96FC9 DDX11_HUMAN "ATP-dependent DNA helicase DDX11, EC 3.6.4.12 (CHL1-related protein 1, hCHLR1) (DEAD/H-box protein 11) (Keratinocyte growth factor-regulated gene 2 protein, KRG-2)" DDX11 CHL1 CHLR1 KRG2 Homo sapiens (Human) cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062]" "4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]" GO:0000785; GO:0000922; GO:0003677; GO:0003678; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003727; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0007062; GO:0008094; GO:0008186; GO:0016887; GO:0030496; GO:0031297; GO:0032079; GO:0032091; GO:0032508; GO:0034085; GO:0035563; GO:0043139; GO:0044806; GO:0045142; GO:0045876; GO:0046872; GO:0051539; GO:0051880; GO:0070062; GO:0072711; GO:0072719; GO:1901838; GO:1904976; GO:1990700; GO:2000781 EMLETGPEAER 7.710000038 1 1 0.456518015 1280.869936 13.03905 14.40767 0 0 0 0 0 14.73135 11.67502 0 0 0 0 0 0 0 0 15.67851 16.59019 15.55748 16.50573 0 0 16.23178 0 16.36388 16.11883 15.07266 0 0 0 11.5102 14.43218 0 15.54758 17.29734 0 15.66325 0 17.14165 16.36389 0 16.40279 15.13755 0 12.10547 17.282 0 Q96FE5 LIGO1_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A) LINGO1 LERN1 LRRN6A UNQ201/PRO227 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154] epidermal growth factor receptor binding [GO:0005154] GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012 HLNINAIRDYSFK 3.890000105 1 1 0.401406092 1592.445486 14.88103 16.0474 14.2841 14.92536 0 13.83533 14.39031 0 16.21436 0 16.5021 0 16.24489 0 0 15.90509 0 0 14.62861 0 0 0 0 15.00177 15.62603 0 0 0 0 0 16.61606 0 17.93159 0 0 0 0 0 0 0 15.36066 15.3743 11.99555 0 0 0 0 15.99713 Q96FJ0 STALP_HUMAN "AMSH-like protease, AMSH-LP, EC 3.4.19.- (STAM-binding protein-like 1)" STAMBPL1 AMSHLP KIAA1373 Homo sapiens (Human) protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536] cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020] cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536] isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:0005768; GO:0005829; GO:0016020; GO:0016579; GO:0046872; GO:0061578; GO:0070122; GO:0070536; GO:0140492 KLAAMPDHTDVSLSPEER 4.440000057 1 1 0.466827814 2009.955702 16.88764 14.00999 17.24275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FJ2 DYL2_HUMAN "Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b, DLC8b) (Dynein light chain LC8-type 2)" DYNLL2 DLC2 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; microtubule-based process [GO:0007017] dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959] GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0007017; GO:0016020; GO:0030286; GO:0031475; GO:0045505; GO:0051959; GO:0060271; GO:0097542; GO:0097731; GO:0098794; GO:0098978 NADMSEDMQQDAVDCATQAMEK 13.44999981 1 1 0.130042515 2519.62495 0 13.37088 16.79506 0 0 16.07099 0 16.82682 0 17.56014 11.19493 15.25166 14.30524 16.37536 15.88364 15.73341 0 0 0 14.20557 14.76135 16.56123 11.43241 16.29423 15.82951 0 0 0 15.0434 15.93431 0 19.22248 0 16.49585 0 17.79177 0 19.50831 0 0 18.7919 0 0 17.21582 0 0 0 17.90007 Q96FL8 S47A1_HUMAN "Multidrug and toxin extrusion protein 1, MATE-1, hMATE-1 (Solute carrier family 47 member 1)" SLC47A1 MATE1 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; amide transmembrane transporter activity [GO:0042887]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] amide transmembrane transporter activity [GO:0042887]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005886; GO:0015179; GO:0015299; GO:0015695; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031982; GO:0042887; GO:0042908; GO:0042910; GO:0055085; GO:0061459; GO:0089718; GO:0097638; GO:1902475; GO:1990961 ALLVLAGPAFLVQLMVFLISFISSVFCGHLGK 3.579999924 1 1 0.192260074 3448.294155 11.36827 0 13.58993 15.00672 0 12.87456 0 13.33115 0 0 0 0 0 0 14.46399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FM1 PGAP3_HUMAN "Post-GPI attachment to proteins factor 3 (COS16 homolog, hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1)" PGAP3 CAB2 PERLD1 UNQ546/PRO1100 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; hydrolase activity, acting on ester bonds [GO:0016788]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]" "hydrolase activity, acting on ester bonds [GO:0016788]" GO:0000139; GO:0006505; GO:0006506; GO:0016021; GO:0016788; GO:0031227 DTDLTEK 9.930000305 1 1 0.270725522 822.5823991 0 17.82744 19.15094 15.07575 18.17711 0 0 17.14523 0 0 0 0 17.83936 17.61615 17.98396 0 0 0 0 0 16.43432 0 0 0 0 17.73353 17.60039 16.96354 17.14915 0 0 0 0 0 0 17.3072 0 0 18.71678 16.84367 16.54647 18.66814 0 0 0 0 0 0 Q96FN5 KIF12_HUMAN Kinesin-like protein KIF12 KIF12 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0070062 ASGLSGAR 10.90999985 0.054469205 0.054469205 0.240287841 717.6114371 0 14.92394 13.84995 12.53892 13.85178 16.56534 15.73384 15.89919 15.84629 16.08731 15.84567 15.92239 15.98885 15.56221 0 13.85312 16.22084 16.78447 16.64787 16.83643 15.06012 17.42612 14.91799 16.11235 16.22414 16.18912 0 0 0 14.61243 17.43883 0 15.48946 17.23318 0 16.67537 16.82393 15.46179 15.74102 15.58029 15.93648 18.06451 14.37714 0 0 15.14504 16.64489 0 Q96FV2 SCRN2_HUMAN Secernin-2 SCRN2 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805] cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805] GO:0016805; GO:0070004; GO:0070062 IQEGAR 6.690000057 0.000277902 0.000277902 0.271948107 674.4777368 18.12501 20.61987 16.76476 0 0 19.11824 0 0 0 19.72164 20.77119 0 17.4116 0 17.98295 0 19.5731 0 0 0 0 0 18.13336 20.79307 0 17.46533 19.33006 20.74395 0 0 17.70333 0 19.88685 0 19.73272 0 17.80769 21.34578 21.38844 0 20.86139 21.16157 0 0 0 0 19.13321 0 Q96FV9 THOC1_HUMAN "THO complex subunit 1, Tho1 (Nuclear matrix protein p84, p84N5) (hTREX84)" THOC1 HPR1 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]" cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] "cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]" DNA binding [GO:0003677]; RNA binding [GO:0003723] GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002 LMDLQLSDSNFR 11.35999966 0.084962703 0.084962703 0.149831642 1453.619352 13.2655 0 15.79795 0 0 0 0 13.6634 15.71649 0 11.44971 14.20523 0 13.5993 0 14.26551 0 0 0 10.73503 0 0 14.35201 14.46653 13.82491 14.68013 17.71889 0 18.09375 0 15.91761 10.62143 16.00318 19.00689 14.61079 0 13.71584 14.59646 15.51098 0 0 18.69205 0 0 14.27124 0 0 0 Q96FZ7 CHMP6_HUMAN "Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20, Vps20, hVps20)" CHMP6 VPS20 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0007175; GO:0010008; GO:0015031; GO:0016020; GO:0016236; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0047485; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904902; GO:1904930 MHQVMSIEEVER 4.28000021 1 1 0 1503.423148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96G01 BICD1_HUMAN "Protein bicaudal D homolog 1, Bic-D 1" BICD1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; RNA processing [GO:0006396]; stress granule assembly [GO:0034063]; viral process [GO:0016032] centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802] centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267]; structural constituent of cytoskeleton [GO:0005200]; anatomical structure morphogenesis [GO:0009653]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; RNA processing [GO:0006396]; stress granule assembly [GO:0034063]; viral process [GO:0016032] cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005856; GO:0006396; GO:0008093; GO:0008298; GO:0009653; GO:0016020; GO:0016032; GO:0019901; GO:0031267; GO:0031410; GO:0031871; GO:0033365; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0099503; GO:1900275; GO:1900276; GO:1900737; GO:1904781 AMVTETMTK 10.65999985 1 1 0.162832551 1026.528728 0 13.8364 13.38642 12.00217 0 15.13973 0 0 0 0 0 0 11.67324 0 0 14.77615 15.81245 0 0 0 0 0 0 0 0 0 16.92837 14.72605 14.57374 13.5077 15.54297 0 16.89273 14.84156 0 15.19441 0 0 16.33644 0 0 0 0 17.41241 0 17.59139 16.28471 0 Q96G03 PGM2_HUMAN "Phosphopentomutase, EC 5.4.2.7 (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2, EC 5.4.2.2)" PGM2 MSTP006 Homo sapiens (Human) deoxyribose phosphate catabolic process [GO:0046386]; glucose metabolic process [GO:0006006] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; glucose metabolic process [GO:0006006] magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973] GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0006006; GO:0008973; GO:0034774; GO:0046386; GO:0070062; GO:1904813 GVLTLSFALADK 4.550000191 1 1 0.206537378 1234.061217 15.32558 0 0 12.19369 14.80606 15.16784 0 13.64873 12.95331 0 0 0 15.53829 0 0 0 0 0 0 0 0 18.82102 19.00424 0 0 0 0 15.40093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.72994 0 0 Q96G21 IMP4_HUMAN "U3 small nucleolar ribonucleoprotein protein IMP4, U3 snoRNP protein IMP4 (Brix domain-containing protein 4)" IMP4 BXDC4 Homo sapiens (Human) rRNA processing [GO:0006364] fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040] fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364] rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515] GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134 DPSSR 2.640000105 1 1 0.111452974 561.2438853 0 0 15.59324 0 13.27359 16.0331 15.33009 0 0 14.43231 0 0 14.62651 0 14.58278 0 15.62956 0 15.80464 0 0 0 0 0 16.11242 0 16.51121 0 0 0 0 0 0 0 0 0 0 0 16.30292 0 0 0 0 0 0 0 0 0 Q96G28 CFA36_HUMAN Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104) CFAP36 CCDC104 UNQ163/PRO189 Homo sapiens (Human) axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; motile cilium [GO:0031514]; nucleus [GO:0005634] axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein N-terminus binding [GO:0047485] protein N-terminus binding [GO:0047485] GO:0005634; GO:0005930; GO:0031514; GO:0035869; GO:0047485; GO:0097546 LMSMRK 2.690000057 1 1 0.240009836 782.1534517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.12918 0 0 16.9423 0 17.26964 0 18.59216 0 0 0 0 0 0 0 0 18.84089 0 0 0 0 0 0 0 0 17.52321 16.68375 0 0 0 Q96G42 KLD7B_HUMAN Kelch domain-containing protein 7B KLHDC7B Homo sapiens (Human) YNTVTGSWSR 2.599999905 1 1 0.208089551 1170.090187 0 0 0 14.06078 15.33452 14.16249 13.7701 13.88266 15.35328 15.30189 14.47179 12.10015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.44373 0 0 0 0 16.97219 0 0 0 0 0 0 0 0 0 Q96G91 P2Y11_HUMAN "P2Y purinoceptor 11, P2Y11" P2RY11 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; neuronal signal transduction [GO:0023041]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled ATP receptor activity [GO:0045031]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; neuronal signal transduction [GO:0023041]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] G protein-coupled ATP receptor activity [GO:0045031]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023] GO:0005886; GO:0005887; GO:0006952; GO:0007186; GO:0007190; GO:0007200; GO:0019722; GO:0023041; GO:0030594; GO:0038023; GO:0045031; GO:0071318 SPGMTVAEK 1.730000019 1 1 0.225156766 919.5654953 15.99572 12.28808 0 0 0 0 0 0 0 0 0 14.71813 17.29554 0 0 0 0 0 0 0 0 0 16.76681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.48539 0 15.97836 0 16.01985 0 0 0 0 0 0 Q96GA3 LTV1_HUMAN Protein LTV1 homolog LTV1 C6orf93 Homo sapiens (Human) ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]" GO:0000056; GO:0005634; GO:0005654; GO:0005829; GO:0030688; GO:0042274 DPLAADESAPQRVLLPTQK 2.519999981 1 1 9.25E-13 2050.241872 11.35301 0 0 14.83692 0 14.64407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GC5 RM48_HUMAN "39S ribosomal protein L48, mitochondrial, L48mt, MRP-L48 (Mitochondrial large ribosomal subunit protein mL48)" MRPL48 CGI-118 HSPC290 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 LSVKEHTEEDFK 4.96999979 0.415730715 0.415730715 0.344948785 1460.651497 17.73284 15.20645 15.90885 0 0 0 16.62873 0 18.44847 15.83635 14.71019 16.85169 14.57428 14.04954 15.36856 14.30343 15.02562 15.60243 16.08028 13.34035 16.63918 17.06694 16.52411 16.81351 15.96921 15.94724 16.1953 13.59009 15.47318 0 13.60515 17.14385 16.8767 0 0 0 13.07437 0 0 0 16.84661 16.65451 16.53947 15.77216 17.04917 0 15.96198 15.05744 Q96GC6 ZN274_HUMAN "Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2, Zf2)" ZNF274 ZKSCAN19 SP2114 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1900112; GO:1990837 TFSRSTK 2.809999943 9.84E-05 9.84E-05 0.243151958 827.442948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.556 0 16.69986 18.07683 0 17.93999 0 0 0 0 18.17616 0 0 18.29094 0 0 18.92637 0 18.66173 0 16.30616 0 0 0 0 0 0 0 Q96GD0 PLPP_HUMAN "Chronophin, EC 3.1.3.16, EC 3.1.3.74 (Pyridoxal phosphate phosphatase, PLP phosphatase)" PDXP CIN PLP PLPP Homo sapiens (Human) actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]; glycerol-3-phosphatase activity [GO:0043136]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein serine/threonine phosphatase activity [GO:0004722]; pyridoxal phosphatase activity [GO:0033883]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088] glycerol-3-phosphatase activity [GO:0043136]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein serine/threonine phosphatase activity [GO:0004722]; pyridoxal phosphatase activity [GO:0033883] GO:0000287; GO:0004721; GO:0004722; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006470; GO:0007088; GO:0016311; GO:0016791; GO:0030836; GO:0031072; GO:0031247; GO:0031258; GO:0032361; GO:0032465; GO:0032587; GO:0033883; GO:0042803; GO:0043136; GO:0071318 LGFGGLR 13.57999992 1 1 0.2103356 721.308033 0 0 14.0561 0 0 0 0 0 14.24434 15.79062 0 0 15.66954 0 0 0 0 15.07171 15.93173 0 0 0 0 0 0 0 0 0 14.77848 0 0 0 0 0 0 0 0 0 0 16.29303 0 0 0 0 0 0 0 15.78927 Q96GD3 SCMH1_HUMAN Polycomb protein SCMH1 (Sex comb on midleg homolog 1) SCMH1 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" chromatin binding [GO:0003682]; histone binding [GO:0042393] GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0031507; GO:0042393; GO:0045892 DMESFWK 7.179999828 1 1 0.11397135 943.0121252 14.48133 0 0 0 0 0 0 0 14.33862 0 0 0 0 14.37722 15.69207 0 14.85995 0 0 0 0 0 0 0 12.27899 0 14.03411 0 0 0 0 15.0664 15.61036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GE4 CEP95_HUMAN "Centrosomal protein of 95 kDa, Cep95 (Coiled-coil domain-containing protein 45)" CEP95 CCDC45 CEP45 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] GO:0000922; GO:0005737; GO:0005813 ALASPSSK 10.13000011 0.270523071 0.270523071 0.296906877 761.7365942 0 0 17.90497 0 0 0 0 0 18.25345 19.42377 0 0 0 0 0 19.1053 0 0 0 17.99991 0 0 0 0 19.77677 0 0 0 0 0 0 0 19.43603 0 0 0 0 0 0 0 0 0 0 0 18.8378 0 16.95076 0 Q96GE5 ZN799_HUMAN Zinc finger protein 799 (Zinc finger protein 842) ZNF799 ZNF842 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 HMVMHTR 2.450000048 1 1 0.236816178 943.3427387 17.8352 14.71921 15.8266 19.21576 17.53349 0 14.2812 13.0187 0 0 0 16.283 0 16.84534 0 0 0 16.89925 0 14.11973 0 16.65082 0 16.08267 0 0 0 0 0 0 0 17.2242 0 14.61563 0 0 14.69933 15.77274 14.77389 14.44175 0 16.3654 0 0 0 0 0 0 Q96GE6 CALL4_HUMAN Calmodulin-like protein 4 (Serologically defined breast cancer antigen NY-BR-20) CALML4 Homo sapiens (Human) calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234] calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234] GO:0005509; GO:0030234 IKATDLMVAMR 8.899999619 1 1 4.60E-13 1263.69839 16.17159 14.93246 15.14233 0 0 0 14.51941 0 0 0 14.47131 15.36418 0 0 0 0 0 0 0 0 0 0 0 0 15.93393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.07679 0 0 0 0 14.90132 0 Q96GJ1 TRM2B_HUMAN "tRNA (uracil-5-)-methyltransferase homolog B, EC 2.1.1.35 (TRM2 homolog B) (rRNA (uracil-5-)-methyltransferase TRMT2B, EC 2.1.1.-)" TRMT2B CXorf34 Homo sapiens (Human) S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697] S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697] GO:0030697 STFSVNR 10.59000015 0.073178686 0.073178686 0.301217666 808.0501014 13.83926 16.30978 16.79796 16.57206 0 0 16.39669 16.66919 0 0 0 0 16.08763 0 0 16.33377 16.22481 15.49669 15.37582 17.19595 0 0 15.71343 15.61814 15.41313 0 15.70134 15.9339 14.01022 15.24917 0 0 16.87603 16.95908 15.9956 14.4655 16.9614 16.52715 16.24314 0 16.22547 16.24689 17.22552 16.22783 17.25731 14.94005 15.32149 16.60966 Q96GM1 PLPR2_HUMAN "Phospholipid phosphatase-related protein type 2 (Inactive phospholipid phosphatase PLPPR2) (Lipid phosphate phosphatase-related protein type 2) (Plasticity-related gene 4 protein, PRG-4)" PLPPR2 LPPR2 PRG4 Homo sapiens (Human) phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195] GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0042577; GO:0046839 NPRSAGR 8.869999886 1 1 0.022540749 756.3226401 0 15.24867 0 0 14.75976 15.22613 14.89753 14.18467 15.45156 0 0 13.27052 0 20.02162 0 15.59911 0 14.5564 0 0 0 18.78004 19.30831 18.9628 16.888 0 14.62457 13.89993 15.88368 14.94217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GM8 TOE1_HUMAN Target of EGR1 protein 1 TOE1 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]" 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069] GO:0000175; GO:0003723; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503 KQVCGDSIKPEETEQEVAADETR 1.779999971 1 1 2.29E-12 2618.952905 13.94164 15.15004 0 13.70784 13.70119 14.86642 0 14.09962 14.36935 0 0 0 0 0 13.95749 14.03237 14.27908 14.79769 15.41722 14.87339 0 0 14.87885 0 11.97159 14.58101 0 0 15.0365 13.38317 16.23353 0 13.65287 0 11.56982 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GN5 CDA7L_HUMAN Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2) CDCA7L HR1 JPO2 R1 Homo sapiens (Human) "positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284 AFSEGQITR 4.349999905 0.411497593 0.411497593 0.238678031 1008.132975 14.19668 13.28301 12.59932 14.97712 0 0 14.29608 11.77129 14.76218 15.49373 14.35389 16.51213 0 14.42157 14.95889 0 13.96246 15.73785 14.76214 14.97927 14.5373 0 0 0 0 0 14.12215 13.47013 14.31139 11.18494 0 16.41519 12.77454 13.93366 14.28568 0 0 14.86886 0 15.06013 15.8175 14.53108 12.06131 8.279663 12.07738 15.23016 13.66915 0 Q96GP6 SREC2_HUMAN "Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein, SREC-II)" SCARF2 SREC2 SREPCR Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] scavenger receptor activity [GO:0005044] GO:0005044; GO:0005925; GO:0007157; GO:0016021 MEGAGPRGAGPAR 6.699999809 1 1 0.157909387 1243.483231 14.34449 0 12.47736 14.58591 14.7256 12.86185 0 15.42937 13.4679 14.10102 10.05108 10.97814 0 0 0 17.04239 0 0 0 12.10134 0 0 15.97952 0 0 0 15.28386 0 15.28314 14.78812 0 0 0 0 0 0 0 14.79046 0 15.51382 0 16.18062 0 0 0 0 0 0 Q96GQ7 DDX27_HUMAN "Probable ATP-dependent RNA helicase DDX27, EC 3.6.4.13 (DEAD box protein 27)" DDX27 cPERP-F RHLP HSPC259 PP3241 Homo sapiens (Human) rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364; GO:0016887 GEMTAEER 5.119999886 1 1 0.050041569 937.5851352 0 0 0 16.2959 0 0 0 0 0 0 0 0 0 0 16.63622 0 0 15.60875 0 15.06401 0 0 0 0 14.50531 0 0 0 17.2258 0 16.99286 0 14.66908 0 0 0 0 0 0 16.07112 12.44764 15.92521 0 0 0 0 0 14.96921 Q96GR2 ACBG1_HUMAN "Long-chain-fatty-acid--CoA ligase ACSBG1, EC 6.2.1.3 (Acyl-CoA synthetase bubblegum family member 1, hBG1, hsBG, hsBGM) (Lipidosin)" ACSBG1 BGM KIAA0631 LPD Homo sapiens (Human) long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; ovarian follicle atresia [GO:0001552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; ovarian follicle atresia [GO:0001552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038] ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957] GO:0000038; GO:0001552; GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0016405; GO:0031410; GO:0031957; GO:0035338; GO:0042552; GO:0042759; GO:0051384 WEHISYSQYYLLAR 10.68999958 1 1 0.178115758 1827.550916 0 16.02164 16.96832 0 0 0 19.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GX1 TECT2_HUMAN Tectonic-2 TCTN2 C12orf38 TECT2 Homo sapiens (Human) cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] GO:0005737; GO:0005856; GO:0007224; GO:0016021; GO:0036038; GO:0060170; GO:0060271; GO:1904491 DFADFGYKQGDPIMTVK 6.230000019 1 1 0.360802007 1948.702344 0 0 17.53803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GX5 GWL_HUMAN "Serine/threonine-protein kinase greatwall, GW, GWL, hGWL, EC 2.7.11.1 (Microtubule-associated serine/threonine-protein kinase-like, MAST-L)" MASTL GW GWL THC2 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726] ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000086; GO:0000278; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0016301; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721; GO:0051726; GO:0106310; GO:1904668 DALALSK 7.5 0.409932941 0.409932941 0.238707259 716.8179583 13.32964 0 0 0 0 14.24421 0 15.42079 0 0 0 0 15.93911 15.72784 0 0 14.99842 0 0 13.88217 0 16.0356 15.29031 15.93947 15.89493 0 16.56911 0 0 0 14.59095 14.20173 15.4265 0 0 13.89831 16.8773 16.02763 17.28634 15.15444 0 16.44559 0 0 16.01663 0 0 16.0719 Q96GX9 MTNB_HUMAN "Methylthioribulose-1-phosphate dehydratase, MTRu-1-P dehydratase, EC 4.2.1.109 (APAF1-interacting protein, hAPIP)" APIP CGI-29 Homo sapiens (Human) apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372] identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270] GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372 MSGCDAR 1.25999999 0.944618642 0.944618642 4.60E-13 796.3019734 12.77164 0 0 0 0 0 0 0 0 0 0 0 15.0628 0 0 0 0 0 0 0 0 0 0 0 14.85922 0 16.72091 15.72319 0 0 0 0 0 18.91552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GY3 LIN37_HUMAN Protein lin-37 homolog (Antolefinin) LIN37 MSTP064 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053] Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005654; GO:0017053; GO:0031523 LPPPTPPGPPGDACRSR 7.380000114 1 1 1.84E-12 1771.215077 0 15.72584 15.35781 12.45039 16.00597 15.13163 15.15335 15.12416 0 16.24285 0 15.20897 10.88632 13.63704 0 15.56299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H12 MSD3_HUMAN Myb/SANT-like DNA-binding domain-containing protein 3 MSANTD3 C9orf30 L8 Homo sapiens (Human) IMAHER 10.44999981 1 1 0.011447876 771.4663408 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76146 0 14.39207 0 0 0 0 0 17.6529 15.65479 0 15.91517 0 0 0 0 0 15.39168 0 0 15.85305 0 15.22467 0 17.11789 0 16.53457 15.96967 0 0 0 0 0 0 0 Q96H20 SNF8_HUMAN "Vacuolar-sorting protein SNF8 (ELL-associated protein of 30 kDa) (ESCRT-II complex subunit VPS22, hVps22)" SNF8 EAP30 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral budding via host ESCRT complex [GO:1903772] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667]; channel regulator activity [GO:0016247]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral budding via host ESCRT complex [GO:1903772] channel regulator activity [GO:0016247]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485] GO:0000814; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0008022; GO:0010008; GO:0010628; GO:0016020; GO:0016236; GO:0016247; GO:0031902; GO:0032456; GO:0036258; GO:0042176; GO:0042803; GO:0043328; GO:0045022; GO:0045732; GO:0047485; GO:0048471; GO:0055037; GO:0061635; GO:0070062; GO:0071985; GO:0090148; GO:1903543; GO:1903772 GVGAGAIAK 3.180000067 1 1 0.116375781 742.9220436 0 0 0 0 0 0 15.35064 0 14.86841 0 16.30296 0 16.38877 0 0 0 15.54641 0 0 0 0 0 0 0 15.0485 16.13659 15.26123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.11818 0 16.78459 0 0 Q96H35 RBM18_HUMAN Probable RNA-binding protein 18 (RNA-binding motif protein 18) RBM18 Homo sapiens (Human) cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005829; GO:0045171 SGALEGQPR 8.93999958 1 1 0.043626975 914.7392571 15.25567 15.32326 0 16.3097 0 0 12.52097 16.30135 14.85351 0 0 15.06392 0 0 0 0 13.56735 0 16.36667 14.50806 0 13.45038 14.86462 14.49172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H78 S2544_HUMAN Solute carrier family 25 member 44 SLC25A44 KIAA0446 Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; branched-chain amino acid transmembrane transporter activity [GO:0015658]; branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161] branched-chain amino acid transmembrane transporter activity [GO:0015658] GO:0005739; GO:0009083; GO:0015658; GO:0015803; GO:0016021; GO:0031966; GO:0120161 ADGITGLYR 7.409999847 0.409967333 0.409967333 0.168199028 965.0901998 16.82496 0 15.96504 12.12081 11.28561 17.49134 0 16.185 15.49248 16.22111 0 0 9.459302 18.95432 19.79841 12.02991 0 0 14.63864 16.47681 0 19.67877 15.8437 17.46838 16.8954 15.94714 15.76928 18.52976 16.48774 0 16.54843 18.93801 0 0 16.539 16.66421 14.81613 0 0 0 18.76817 18.06736 13.54337 18.1359 19.24377 0 14.68516 17.71539 Q96H79 ZCCHL_HUMAN Zinc finger CCCH-type antiviral protein 1-like ZC3HAV1L C7orf39 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 VVAVSSVRLCAR 2.180000067 1 1 0.120552666 1317.570714 14.1174 14.22768 0 0 0 0 0 14.2117 12.99169 14.22578 0 10.86613 0 0 0 13.70037 0 13.98046 0 12.87808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.93051 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H86 ZN764_HUMAN Zinc finger protein 764 ZNF764 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 QSSEMAAHRR 6.150000095 0.41761747 0.41761747 0.314945122 1187.271151 14.77083 13.08563 15.68855 0 0 7.173616 0 0 0 0 0 0 0 0 0 0 16.01438 0 0 0 0 0 13.57956 15.7892 16.91265 0 16.55501 0 14.20253 0 0 15.24722 13.61803 0 15.86427 14.08229 0 0 0 0 0 0 0 0 0 0 0 17.61038 Q96H96 COQ2_HUMAN "4-hydroxybenzoate polyprenyltransferase, mitochondrial, 4-HB polyprenyltransferase, EC 2.5.1.39 (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog, hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase, PHB:PPT, PHB:polyprenyltransferase)" COQ2 CL640 Homo sapiens (Human) glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743] "integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; 4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]" "4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]" GO:0002083; GO:0004659; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0016765; GO:0031305; GO:0047293 MLGSRAAGFAR 2.220000029 1 1 0.089232084 1152.027774 0 0 0 0 0 0 14.10421 0 0 0 16.66824 0 0 0 0 0 0 18.2028 0 0 0 0 0 0 0 16.07835 0 0 0 0 19.37876 0 0 0 19.26503 0 15.54519 0 17.78839 0 0 0 17.47706 0 17.4669 0 0 0 Q96HA7 TONSL_HUMAN "Tonsoku-like protein (Inhibitor of kappa B-related protein, I-kappa-B-related protein, IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2)" TONSL IKBR NFKBIL2 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] histone binding [GO:0042393] GO:0000724; GO:0005654; GO:0005737; GO:0016604; GO:0031297; GO:0042393; GO:0043596 GVGSAQSRLGPGPPR 9.159999847 0.586380482 0.586380482 0.496741695 1435.934114 0 0 0 0 0 0 0 0 0 0 0 0 19.19699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.91231 0 0 0 21.2932 0 0 0 0 0 0 0 Q96HA9 PX11C_HUMAN "Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma, PEX11-gamma)" PEX11G PEX11C Homo sapiens (Human) peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375] integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375] GO:0005777; GO:0005778; GO:0005779; GO:0016559; GO:0031231; GO:0032991; GO:0044375 LRSPTAPFTSPLPR 5.869999886 1 1 0.323327837 1537.803222 0 14.64328 15.45933 14.40941 0 0 15.12094 14.79731 0 13.55187 0 0 0 15.16143 16.72798 15.15737 0 13.99198 16.34202 16.16213 0 0 0 0 15.7715 16.19345 0 14.99136 15.39363 13.86868 16.79737 16.08052 17.37704 15.85874 14.75176 13.8743 15.22425 15.53369 14.28742 0 16.19234 15.81493 14.30382 0 15.92407 13.16856 15.09744 16.14375 Q96HC4 PDLI5_HUMAN PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein) PDLIM5 ENH L9 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963] actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080] GO:0001725; GO:0003779; GO:0005080; GO:0005829; GO:0005912; GO:0007507; GO:0014069; GO:0015629; GO:0016020; GO:0030018; GO:0030036; GO:0031941; GO:0042805; GO:0042995; GO:0046872; GO:0051371; GO:0051963; GO:0061001; GO:0061049; GO:0061061; GO:0098641; GO:0098793 HIVER 7.050000191 1 1 0.193616628 651.4006568 0 16.14937 14.91317 0 0 0 0 0 0 0 0 0 0 0 16.81285 0 15.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.85511 17.60746 15.49416 17.58604 0 0 0 0 15.76276 0 0 0 0 0 0 0 Q96HD9 ACY3_HUMAN "N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming), EC 3.5.1.114 (Acylase III) (Aminoacylase-3, ACY-3) (Aspartoacylase-2) (Hepatitis C virus core-binding protein 1, HCBP1, HCV core-binding protein 1)" ACY3 ASPA2 Homo sapiens (Human) apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" "aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" GO:0004046; GO:0005829; GO:0016324; GO:0016788; GO:0016811; GO:0042802; GO:0046872; GO:0070062 SSHEVFAMHLCR 6.340000153 1 1 0.035752556 1490.594985 0 0 15.72512 0 0 0 0 0 0 0 0 0 0 0 0 14.4905 0 0 0 17.44437 0 0 0 0 15.20007 0 10.49354 0 0 0 15.64365 14.91931 0 0 0 0 0 19.08335 0 0 0 0 0 0 16.3954 0 0 0 Q96HE9 PRR11_HUMAN Proline-rich protein 11 PRR11 Homo sapiens (Human) regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005737; GO:0016020; GO:0051726 KLIPSPK 5.989999771 1 1 0.220835741 781.4578765 16.31995 14.96631 0 0 0 11.88846 14.27214 15.6876 0 16.42687 0 15.18064 0 0 15.09247 14.90925 16.04246 15.43148 13.52177 15.2373 15.89943 0 14.80334 16.15408 0 0 0 16.23698 16.77473 15.67057 15.76628 16.86502 0 16.68337 16.41209 15.30732 0 0 17.57371 0 17.26451 16.20041 14.98538 0 15.17879 16.16835 15.96118 15.37461 Q96HH4 TM169_HUMAN Transmembrane protein 169 TMEM169 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EEPTAVEGQVQLPSPHQGSLR 1.110000014 1 1 0.101485993 2260.079582 14.94712 0 14.5477 0 0 13.80892 0 0 0 0 0 0 0 0 11.9408 0 0 0 0 0 0 9.500045 13.93441 0 0 11.21881 0 0 11.72174 12.95625 0 0 0 0 10.54299 13.12665 0 0 0 0 0 0 0 0 0 0 0 0 Q96HH9 GRM2B_HUMAN GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2) GRAMD2B GRAMD3 NS3TP2 Homo sapiens (Human) cytoplasmic microtubule [GO:0005881] cytoplasmic microtubule [GO:0005881]; identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0005881; GO:0042802 SQVQFNVEVLCQELTANIVKLEK 2.849999905 1 1 0.08801773 2689.256578 0 14.60042 16.29452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.82674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HN2 SAHH3_HUMAN "Adenosylhomocysteinase 3, AdoHcyase 3, EC 3.3.1.1 (IP(3)Rs binding protein released with IP(3) 2, IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2)" AHCYL2 KIAA0828 Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] hydrolase activity [GO:0016787] GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005 MSVQVVSAAAAAKVPEVELK 4.75 0.807428837 0.807428837 0.294958309 2042.555054 0 0 0 0 0 0 0 17.24587 0 0 0 0 0 0 0 0 0 12.67445 0 0 0 17.82592 14.98663 13.15874 15.74166 0 0 15.90496 0 0 0 0 0 0 0 0 0 14.77346 0 0 0 0 0 0 0 0 17.63098 0 Q96HP0 DOCK6_HUMAN Dedicator of cytokinesis protein 6 DOCK6 KIAA1395 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0007264; GO:0043547; GO:0048471 EETVLTPVEVAIEDMQK 4.579999924 1 1 0.256615519 1946.207145 15.24891 14.58224 12.83641 0 15.3965 14.48033 0 0 0 0 0 0 14.72581 0 16.33156 14.54373 15.25614 0 11.00419 12.87285 0 15.19252 0 0 0 0 13.99869 0 9.716815 14.56017 13.85125 15.85034 14.58801 0 14.09008 12.85604 0 0 0 10.07718 0 14.95685 0 0 0 0 0 0 Q96HQ0 ZN419_HUMAN Zinc finger protein 419 ZNF419 ZNF419A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 ENSTLVR 17.02000046 0.267310172 0.267310172 0.202430729 818.6736944 15.76775 0 15.34627 0 16.17043 15.72166 16.83644 13.76439 15.91055 0 0 15.3906 0 0 16.62316 16.20331 15.87438 16.79729 17.70565 15.96769 0 15.98167 0 0 15.83127 0 16.96235 16.1163 14.98701 17.02612 16.63202 14.15305 0 15.97086 15.3027 15.85645 15.63516 16.59195 17.6233 16.27484 0 16.31123 15.82063 16.2977 0 15.89879 15.76552 14.97368 Q96HR8 NAF1_HUMAN "H/ACA ribonucleoprotein complex non-core subunit NAF1, hNAF1" NAF1 Homo sapiens (Human) box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] GO:0000454; GO:0000493; GO:0003723; GO:0005654; GO:0005732; GO:0005737; GO:0032212; GO:0042254; GO:0042802; GO:0043489; GO:0051973; GO:0070034; GO:0090669; GO:1904358; GO:1904874; GO:1905323 GSDASWK 1.039999962 0.721570075 0.721570075 1.48E-12 749.2075786 15.33938 0 0 17.4717 0 10.60932 16.65899 12.24025 16.38985 0 17.21273 14.82845 15.50827 14.33631 0 15.93874 0 15.11144 15.68537 13.53618 0 17.07682 12.83023 15.26411 0 15.012 16.16281 15.03895 16.0524 17.96435 0 0 16.4327 15.47672 0 17.00982 15.38802 18.25867 0 16.28984 17.19297 0 14.33768 0 17.97189 14.71586 16.18714 15.4488 Q96HY7 DHTK1_HUMAN "2-oxoadipate dehydrogenase complex component E1, E1a, OADC-E1, OADH-E1, EC 1.2.4.- (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase, Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)" DHTKD1 KIAA1630 Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099] oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976] GO:0002244; GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976 RYGGEGAESMMGFFHELLK 2.839999914 1 1 1.37E-12 2173.814644 0 13.21424 0 0 10.61216 7.725059 14.65975 0 15.45698 0 0 13.54486 0 0 0 11.42896 0 11.63737 0 0 0 0 11.00575 0 0 10.48392 0 15.17935 13.16233 0 0 15.51874 13.0213 0 11.81793 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I34 PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3) PPP1R16A MYPT3 Homo sapiens (Human) regulation of protein dephosphorylation [GO:0035304] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; regulation of protein dephosphorylation [GO:0035304] myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888] GO:0005886; GO:0008157; GO:0017020; GO:0019888; GO:0035304 RPCCLLM 12.86999989 1 1 0.166611951 949.2934394 0 0 0 0 0 0 0 0 0 20.99633 0 0 0 0 0 0 0 0 17.47826 0 0 0 0 0 0 0 0 0 0 0 0 0 18.54483 0 0 0 0 0 0 19.03365 0 0 0 0 0 0 0 0 Q96I51 RCC1L_HUMAN "RCC1-like G exchanging factor-like protein, RCC1-like (Williams-Beuren syndrome chromosomal region 16 protein)" RCC1L WBSCR16 Homo sapiens (Human) mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131] GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0003723; GO:0005085; GO:0005525; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613 ALVALVAGARLGR 8.529999733 0.408701777 0.408701777 0.18802652 1262.378546 0 0 8.288651 0 0 0 18.17418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01149 13.05459 0 16.07889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I59 SYNM_HUMAN "Probable asparagine--tRNA ligase, mitochondrial, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS)" NARS2 Homo sapiens (Human) asparaginyl-tRNA aminoacylation [GO:0006421] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421] asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004816; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006421 HKPSAK 3.130000114 1 1 0.074456594 667.6119853 16.02701 0 16.37337 0 14.46485 15.52606 16.02344 13.98632 0 0 0 16.54109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3237 0 15.37855 15.24237 14.95729 0 0 16.89264 0 16.37821 17.49655 0 15.93239 17.67877 15.93403 15.08646 0 0 0 0 Q96I76 GPTC3_HUMAN G patch domain-containing protein 3 GPATCH3 GPATC3 Homo sapiens (Human) "negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]" nucleic acid binding [GO:0003676] GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032480; GO:0039536; GO:0045893 RGLGYHGEK 3.650000095 1 1 0.052118682 1015.601166 0 0 0 0 0 0 0 0 13.07026 0 0 14.19254 0 0 13.89503 15.50314 13.98395 0 0 0 0 0 0 15.50692 0 0 13.14468 0 12.60256 13.15249 15.88375 0 0 0 8.231363 0 0 0 14.26172 0 14.452 0 15.75639 0 0 0 0 14.99179 Q96I82 KAZD1_HUMAN Kazal-type serine protease inhibitor domain-containing protein 1 KAZALD1 FKSG28 FKSG40 UNQ2945/PRO21184 Homo sapiens (Human) cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966] extracellular region [GO:0005576]; interstitial matrix [GO:0005614] extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; insulin-like growth factor binding [GO:0005520]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966] insulin-like growth factor binding [GO:0005520] GO:0001503; GO:0001558; GO:0005520; GO:0005576; GO:0005614; GO:0009966; GO:0030154; GO:0030198 GCLAGRVR 5.989999771 0.83120662 0.83120662 0.218636393 891.7524407 16.63694 0 0 11.69074 13.75816 15.57574 16.99642 16.39345 18.02446 17.02304 16.36514 14.6178 15.44622 14.79963 12.35558 15.43534 11.94885 15.38423 0 15.2093 15.5992 15.90591 15.12862 15.80734 14.37552 15.54226 0 15.88811 0 14.94553 13.76477 16.46419 15.75885 0 0 0 16.90838 0 0 16.46955 0 0 0 14.62003 0 14.86526 15.46797 16.35002 Q96I99 SUCB2_HUMAN "Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial, EC 6.2.1.4 (GTP-specific succinyl-CoA synthetase subunit beta, G-SCS, GTPSCS) (Succinyl-CoA synthetase beta-G chain, SCS-betaG)" SUCLG2 Homo sapiens (Human) succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776] GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006104; GO:0042709; GO:0045244; GO:1901289 DPNVVGQLAKQMIGYNLATK 2.049999952 1 1 0.218576879 2160.435054 11.57835 0 0 14.31352 13.24368 14.01643 0 0 14.65979 13.47999 0 0 0 13.46618 0 0 0 0 0 0 0 0 0 0 0 13.86546 15.87076 0 0 0 0 0 0 0 0 0 14.90628 0 0 12.33548 0 0 0 0 15.4543 0 0 0 Q96IC2 REXO5_HUMAN "RNA exonuclease 5, EC 3.1.-.- (Exonuclease NEF-sp)" REXO5 44M2.3 Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723] exonuclease activity [GO:0004527]; RNA binding [GO:0003723] GO:0003723; GO:0004527; GO:0005634; GO:0005730; GO:0070062 AGDLPK 5.710000038 0.000718088 0.000718088 0.31728852 600.6160872 19.31972 0 0 17.84486 16.85232 15.83789 0 0 0 0 0 0 0 0 0 0 0 18.44326 0 0 0 0 0 0 19.21029 0 0 0 19.85044 0 0 0 0 0 0 18.67239 0 20.66021 19.60345 0 0 0 0 0 18.30127 15.92973 16.72191 0 Q96II8 LRCH3_HUMAN DISP complex protein LRCH3 (Leucine-rich repeat and calponin homology domain-containing protein 3) LRCH3 Homo sapiens (Human) septin cytoskeleton organization [GO:0032185] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; septin cytoskeleton organization [GO:0032185] GO:0005737; GO:0005829; GO:0032185 EQLVER 22.01000023 0.171360523 0.171360523 0.207719164 773.3157428 0 0 15.39237 0 0 17.45848 0 0 0 0 16.14004 13.96572 17.53651 0 0 0 0 16.58163 0 0 0 0 0 15.32243 0 0 0 0 15.52043 0 0 0 16.11998 16.5766 0 0 0 0 0 0 16.00917 16.83504 0 0 15.33256 0 16.48571 0 Q96IJ6 GMPPA_HUMAN "Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A, GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)" GMPPA Homo sapiens (Human) biosynthetic process [GO:0009058] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058] nucleotidyltransferase activity [GO:0016779] GO:0005737; GO:0009058; GO:0016779; GO:0070062 GVTVGEGVR 4.289999962 1 1 0.176478521 873.5186004 0 0 0 0 13.2715 14.08497 0 14.16133 0 15.82233 0 0 14.67366 0 0 12.64255 0 13.57957 0 15.56728 0 0 0 0 0 14.86213 0 0 0 0 0 0 16.46677 0 0 0 0 0 15.80028 0 0 0 0 0 0 0 0 14.76273 Q96IK5 GMCL1_HUMAN Germ cell-less protein-like 1 (Spermatogenesis-associated protein 29) GMCL1 BTBD13 GCL SPATA29 Homo sapiens (Human) germ cell development [GO:0007281]; spermatogenesis [GO:0007283] nuclear matrix [GO:0016363]; nucleus [GO:0005634] nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; germ cell development [GO:0007281]; spermatogenesis [GO:0007283] identical protein binding [GO:0042802] GO:0005634; GO:0007281; GO:0007283; GO:0016363; GO:0042802 EELEGNSMR 8.130000114 0.302191645 0.302191645 0.111166623 1079.484242 12.44587 15.90059 16.59267 12.22848 0 0 17.51805 11.86073 12.20457 16.34971 0 0 15.87392 14.14608 16.31455 10.42612 15.83258 18.37747 14.89183 15.89736 16.28084 13.12624 0 14.72558 16.29364 14.85484 15.31874 17.57655 15.03675 17.68756 10.76444 0 0 13.76568 17.87124 14.54297 16.08281 17.40589 15.41669 16.64557 16.87247 0 0 15.65439 17.59936 16.32884 17.15939 13.92992 Q96IM9 DYDC2_HUMAN DPY30 domain-containing protein 2 DYDC2 Homo sapiens (Human) histone H3-K4 methylation [GO:0051568] MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188] MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568] GO:0044666; GO:0048188; GO:0051568 EAFQHEVAHEMPPGSKSPF 1.090000033 1 1 0 2125.015204 15.47955 14.20068 12.25075 15.97803 0 13.84884 14.89973 15.8064 16.26931 0 0 0 0 0 0 15.39995 0 0 0 0 0 0 0 0 0 0 16.16909 0 15.67851 13.78109 0 13.42293 0 15.78114 16.25908 0 17.24551 14.78006 0 0 15.62416 0 0 17.7997 0 0 0 15.0979 Q96IR2 ZN845_HUMAN Zinc finger protein 845 ZNF845 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 NSHEAPMTEIKQLTGSTNR 8.640000343 1 1 0.073541186 2129.520533 0 0 0 15.26539 0 0 0 0 0 0 0 12.49214 16.11291 15.24946 16.75977 0 12.82225 15.18994 0 0 0 17.01612 0 14.85391 0 0 14.9861 0 15.70073 15.21961 15.01997 0 11.47225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IR7 HPDL_HUMAN "4-hydroxyphenylpyruvate dioxygenase-like protein, HPD-like protein, EC 1.13.-.- (Glyoxalase domain-containing protein 1)" HPDL GLOXD1 Homo sapiens (Human) aromatic amino acid family metabolic process [GO:0009072] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072] 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872] GO:0003868; GO:0005739; GO:0009072; GO:0046872 AAPALR 2.769999981 0.000944733 0.000944733 0.039553929 599.4035457 0 15.89309 15.75238 14.24346 16.23426 18.56141 9.634744 14.01096 15.12389 0 15.94407 10.11293 14.95326 0 14.8733 11.86568 15.78306 14.24887 13.55556 12.23084 13.31292 16.34545 15.94918 16.53776 13.56847 14.0031 13.9686 14.75461 14.03132 16.03916 14.56286 17.3625 14.34521 15.53848 14.78496 12.58811 12.69104 15.84528 17.44973 16.2315 12.9166 14.83233 15.07499 0 10.3289 0 0 14.09092 Q96IT1 ZN496_HUMAN Zinc finger protein 496 (Zinc finger protein with KRAB and SCAN domains 17) ZNF496 ZKSCAN17 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0045893; GO:0046872 SLPASHR 2.900000095 1 1 0.173108862 766.7562541 16.35727 16.21329 13.03933 14.28605 15.14974 15.35357 15.22647 15.44026 15.05634 14.67427 13.80961 16.10734 12.15887 15.76995 0 15.44381 14.11007 15.57992 0 13.96237 14.33856 15.39648 0 0 0 0 0 0 0 0 0 0 0 12.19837 15.5097 0 0 0 18.53322 0 0 0 0 0 0 0 0 0 Q96IX5 ATPMK_HUMAN "ATP synthase membrane subunit K, mitochondrial (ATP synthase membrane subunit DAPIT, mitochondrial) (Diabetes-associated protein in insulin-sensitive tissues) (HCV F-transactivated protein 2) (Up-regulated during skeletal muscle growth protein 5)" ATP5MK ATP5MD DAPIT HCVFTP2 USMG5 PD04912 Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; ATP synthesis coupled proton transport [GO:0015986] GO:0005739; GO:0005743; GO:0005753; GO:0015986; GO:0016021 KTPAVK 9.68999958 0.800463438 0.800463438 0.301426108 644.2055794 0 15.85375 15.50101 14.3901 14.28457 14.11246 15.57492 0 0 14.68451 15.15273 0 14.9436 14.61007 15.7188 0 0 0 0 16.84596 0 0 16.58287 15.90297 15.70636 0 15.86249 0 0 0 14.36502 15.92518 0 16.84946 0 15.81945 15.78889 16.58721 17.58035 16.77326 15.41183 0 15.27919 0 16.46035 16.44564 16.19912 16.14673 Q96IX9 A26L1_HUMAN Putative ankyrin repeat domain-containing protein 26-like 1 (Ankyrin repeat domain-containing protein 36B pseudogene 1) ANKRD36BP1 ANKRD26L1 Homo sapiens (Human) QNGEKSTK 10.63000011 0.97162658 0.97162658 1.15E-12 893.8535825 0 14.39361 0 0 12.95494 15.70603 15.21745 14.1216 0 0 15.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4429 12.06871 14.06244 0 0 0 0 0 0 0 0 10.39127 0 0 0 0 0 0 0 0 14.15157 13.51119 Q96IY1 NSL1_HUMAN Kinetochore-associated protein NSL1 homolog NSL1 C1orf48 DC31 DC8 MIS14 Homo sapiens (Human) cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear speck [GO:0016607] cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear speck [GO:0016607]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] GO:0000070; GO:0000444; GO:0000776; GO:0005829; GO:0016607; GO:0031617; GO:0051301 INLDT 6.21999979 1 1 0.314888128 573.9494716 0 18.94774 0 0 17.76649 18.16301 0 17.75954 0 0 18.30534 17.89312 0 18.843 0 0 0 0 0 0 0 0 19.16113 0 0 0 0 0 0 0 0 0 0 18.70111 18.21983 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IZ5 RBM41_HUMAN RNA-binding protein 41 (RNA-binding motif protein 41) RBM41 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" U12-type spliceosomal complex [GO:0005689] "U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; mRNA splicing, via spliceosome [GO:0000398]" pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626] GO:0000398; GO:0005689; GO:0030626; GO:0097157 REMEIEK 1.200000048 1 1 0.139342588 950.5735315 0 0 0 0 15.82949 0 0 12.60367 0 0 0 16.10163 13.8539 15.2146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.09226 0 0 0 0 0 0 0 0 0 0 0 14.35911 0 0 0 Q96IZ6 MET2A_HUMAN "tRNA N(3)-methylcytidine methyltransferase METTL2A, EC 2.1.1.- (Methyltransferase-like protein 2A)" METTL2A METTL2 HSPC266 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488] tRNA (cytosine-3-)-methyltransferase activity [GO:0052735] GO:0005737; GO:0030488; GO:0052735 MAGSYPEGAPAVLADKR 6.110000134 1 1 0.381485396 1747.94383 15.70607 0 15.51877 0 14.30299 0 14.73195 0 11.02468 15.18262 0 0 12.94645 0 0 14.78078 0 0 0 0 0 15.25452 0 16.59484 0 0 0 0 0 16.32354 0 0 0 0 15.23389 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J02 ITCH_HUMAN "E3 ubiquitin-protein ligase Itchy homolog, Itch, EC 2.3.2.26 (Atrophin-1-interacting protein 4, AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1, NAPP1)" ITCH Homo sapiens (Human) apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; arrestin family protein binding [GO:1990763]; CXCR chemokine receptor binding [GO:0045236]; ligase activity [GO:0016874]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718] arrestin family protein binding [GO:1990763]; CXCR chemokine receptor binding [GO:0045236]; ligase activity [GO:0016874]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0001558; GO:0002669; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006915; GO:0006954; GO:0016020; GO:0016567; GO:0016874; GO:0019787; GO:0031410; GO:0031901; GO:0032088; GO:0032480; GO:0032991; GO:0035519; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046642; GO:0046718; GO:0050687; GO:0051607; GO:0051865; GO:0061630; GO:0070062; GO:0070423; GO:0070534; GO:0070936; GO:0090085; GO:1902036; GO:1990763; GO:2000646 DETRVSTNGSDDPEDAGAGENR 1.929999948 1 1 0.151851379 2292.008421 0 14.02915 11.07246 11.93722 11.98811 14.72175 14.16837 0 0 14.36167 13.569 13.55984 14.47768 0 0 14.90499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J65 MRP9_HUMAN ATP-binding cassette sub-family C member 12 (Multidrug resistance-associated protein 9) ABCC12 MRP9 Homo sapiens (Human) transmembrane transport [GO:0055085] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626] GO:0005524; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0042626; GO:0055085; GO:0140359 AMAEANVSLR 5.840000153 1 1 0.186290593 1057.371426 0 0 0 17.48491 0 0 18.53662 0 16.68089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.51066 0 Q96J84 KIRR1_HUMAN Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1) KIRREL1 KIRREL NEPH1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; glomerular filtration [GO:0003094]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; renal protein absorption [GO:0097017] cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; glomerular filtration [GO:0003094]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; renal protein absorption [GO:0097017] cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022] GO:0001933; GO:0003094; GO:0005886; GO:0005887; GO:0005911; GO:0017022; GO:0030838; GO:0043198; GO:0045217; GO:0048471; GO:0050839; GO:0097017; GO:0098609 DGTQQEGAVASTELLKDGK 10.46000004 0.060107436 0.060107436 7.52E-12 1947.947587 0 15.8418 0 0 0 10.73546 13.65057 13.97472 0 0 0 0 16.9894 18.25171 0 13.62285 15.69304 17.52164 13.83577 16.81303 0 0 12.91603 0 0 15.74333 12.79395 0 15.4047 12.30905 0 15.81047 0 13.50998 14.97946 0 14.9394 17.76111 16.46085 17.24055 16.50291 16.49958 0 0 14.79239 0 13.61484 15.50674 Q96J87 CELF6_HUMAN "CUGBP Elav-like family member 6, CELF-6 (Bruno-like protein 6) (CUG-BP- and ETR-3-like factor 6) (RNA-binding protein BRUNOL-6)" CELF6 BRUNOL6 Homo sapiens (Human) "mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904 LTGLHK 3.460000038 1 1 0.090639577 666.0128498 0 0 15.36099 13.3006 0 0 15.64282 0 0 14.42043 0 0 0 15.27722 0 0 0 0 0 0 0 0 0 0 0 0 16.97954 0 0 0 0 0 0 0 0 0 0 0 0 0 15.10688 0 0 0 0 0 0 0 Q96J92 WNK4_HUMAN "Serine/threonine-protein kinase WNK4, EC 2.7.11.1 (Protein kinase lysine-deficient 4) (Protein kinase with no lysine 4)" WNK4 PRKWNK4 Homo sapiens (Human) cellular cation homeostasis [GO:0030003]; chloride transport [GO:0006821]; distal tubule morphogenesis [GO:0072156]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular cation homeostasis [GO:0030003]; chloride transport [GO:0006821]; distal tubule morphogenesis [GO:0072156]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294] ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005923; GO:0006468; GO:0006811; GO:0006821; GO:0008104; GO:0010766; GO:0016020; GO:0019869; GO:0019870; GO:0030003; GO:0035556; GO:0050801; GO:0070294; GO:0072156; GO:0090188; GO:0106310; GO:1903288; GO:2000651 GSFPTSRR 3.25999999 1 1 0.293329014 904.3251587 0 0 0 0 16.13308 17.94354 0 0 0 17.71816 16.16045 0 0 0 18.30746 0 15.59039 0 0 0 0 0 0 0 0 0 0 15.70115 0 0 0 0 0 0 0 19.75215 0 0 0 0 0 0 0 0 0 0 0 0 Q96J94 PIWL1_HUMAN "Piwi-like protein 1, EC 3.1.26.-" PIWIL1 HIWI Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186] "chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] GO:0003723; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0007286; GO:0010529; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035093; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:1905538 TYRVDDIDWDQNPK 9.710000038 1 1 0.049709981 1766.001606 15.72461 12.02608 0 0 0 14.64821 14.60868 12.89603 0 14.68174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JA3 PKHA8_HUMAN "Pleckstrin homology domain-containing family A member 8, PH domain-containing family A member 8 (Phosphatidylinositol-four-phosphate adapter protein 2, FAPP-2, Phosphoinositol 4-phosphate adapter protein 2, hFAPP2) (Serologically defined breast cancer antigen NY-BR-86)" PLEKHA8 FAPP2 Homo sapiens (Human) ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031] ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; phosphatidylinositol-4-phosphate binding [GO:0070273] GO:0000139; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006869; GO:0015031; GO:0017089; GO:0035621; GO:0035627; GO:0051861; GO:0070273; GO:0097001; GO:0120009; GO:1902387; GO:1902388 TLEECMQIANAAFTSELLYR 3.430000067 0.673340201 0.673340201 0.130327748 2375.489511 11.67452 0 0 15.5458 0 14.96557 0 13.47116 0 0 0 0 0 0 0 13.20969 0 0 0 0 0 0 10.88382 11.61727 14.49366 0 0 0 0 0 0 0 0 0 0 0 15.96704 0 0 0 0 0 0 0 0 0 0 0 Q96JA4 M4A14_HUMAN Membrane-spanning 4-domains subfamily A member 14 (Testis development protein NYD-SP21) MS4A14 MS4A13 MS4A16 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166] GO:0005886; GO:0007166; GO:0016021 NPLTG 3.180000067 0.525250256 0.525250256 0.125809874 500.4937905 0 18.82604 12.13038 0 16.13691 15.70592 11.7161 16.1594 17.01273 18.51636 17.80875 17.46279 17.35536 18.83225 15.75272 20.20746 16.0375 16.72757 15.89605 15.40751 17.27452 14.94736 16.50285 13.72366 14.02346 14.34376 15.85836 16.11989 17.51594 15.25021 14.81054 15.76665 17.79547 10.48965 0 14.57518 16.91057 16.95034 17.02347 17.18757 16.46238 16.80346 17.48751 18.8414 13.53658 18.45735 15.27963 18.00397 Q96JB1 DYH8_HUMAN Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285 AVIRQYNK 22.95000076 0.937243938 0.937243938 0.246382335 991.3390289 0 15.28102 15.22783 0 14.5497 16.13774 14.19805 0 15.14017 15.23173 15.60921 14.93329 7.08172 14.4468 0 15.33889 14.39647 15.50932 0 0 15.42993 0 0 0 15.60001 0 0 14.41252 14.95465 15.60974 16.58326 0 0 0 0 14.95565 0 14.98165 16.43836 15.68016 0 0 0 15.95493 16.00277 0 14.92684 0 Q96JB3 HIC2_HUMAN "Hypermethylated in cancer 2 protein, Hic-2 (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30)" HIC2 HRG22 KIAA1020 ZBTB30 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0008022; GO:0045892; GO:0046872 EAGPKGPCPGEEGEGVGDR 2.519999981 1 1 0.214382089 1898.074866 12.60008 0 15.32621 0 14.93885 13.59507 17.02993 15.83136 0 16.19878 15.72759 0 0 13.42221 0 15.50805 0 0 14.51769 0 0 0 0 0 0 0 17.20599 0 15.53351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JB8 MPP4_HUMAN MAGUK p55 subfamily member 4 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 5 protein) (Discs large homolog 6) MPP4 ALS2CR5 DLG6 Homo sapiens (Human) protein localization to synapse [GO:0035418] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein localization to synapse [GO:0035418] GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0015629; GO:0032991; GO:0035418 GTIMFK 10.01000023 1 1 0.246143432 711.0626793 16.61037 13.87567 17.97519 0 0 0 13.36109 15.78106 0 0 15.64357 0 15.37603 14.78918 14.74877 14.56567 0 0 0 14.82302 16.79316 0 0 0 17.66718 0 17.30644 0 14.35788 0 16.35936 17.42441 0 16.42017 0 16.58068 17.74656 17.45708 0 0 16.54018 14.97011 0 0 16.01517 16.56874 17.20287 0 Q96JD6 AKCL2_HUMAN "1,5-anhydro-D-fructose reductase, AF reductase, EC 1.1.1.263 (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2) (LoopADR) (Testis aldo-keto reductase, htAKR) (Testis-specific protein, hTSP)" AKR1E2 AKR1CL2 AKRDC1 Homo sapiens (Human) cytosol [GO:0005829] "cytosol [GO:0005829]; 1,5-anhydro-D-fructose reductase activity [GO:0050571]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]" "1,5-anhydro-D-fructose reductase activity [GO:0050571]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]" GO:0004032; GO:0005829; GO:0016491; GO:0050571 SPAQILIR 7.570000172 1 1 0.141696147 896.3099347 16.13596 0 14.41366 15.39557 15.28219 0 0 14.64729 0 0 13.50201 16.69737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.74946 0 0 17.91952 0 16.13984 0 0 0 17.08163 0 0 0 0 0 0 0 0 0 Q96JE7 SC16B_HUMAN "Protein transport protein Sec16B (Leucine zipper transcription regulator 2) (Regucalcin gene promoter region-related protein p117, RGPR-p117) (SEC16 homolog B)" SEC16B KIAA1928 LZTR2 RGPR SEC16S Homo sapiens (Human) autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031] GO:0000139; GO:0005789; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0007031; GO:0010628; GO:0012507; GO:0015031; GO:0016559; GO:0043231; GO:0048208; GO:0070863; GO:0070971; GO:0070973 ESSDEADK 5.210000038 1 1 0.20640864 879.9545973 0 0 0 0 0 0 16.14264 0 14.35812 0 16.05158 0 0 0 15.60555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92299 0 0 0 0 0 0 0 0 0 0 15.47485 0 13.72987 15.45934 0 0 0 0 Q96JF6 ZN594_HUMAN Zinc finger protein 594 (Zinc finger protein HZF18) ZNF594 KIAA1871 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872 SGLTEHQK 6.650000095 0.607458711 0.607458711 0.276385735 899.7718315 0 16.00671 14.33548 15.97128 0 14.3562 0 0 15.3119 16.53023 0 15.00436 15.81582 14.35242 14.36203 0 15.35934 15.65115 0 0 16.45599 16.36376 0 14.45574 14.98174 0 15.94753 0 15.6532 0 16.82298 0 0 0 0 0 15.96338 14.41466 0 15.53699 15.75796 0 0 0 0 0 0 0 Q96JG6 VPS50_HUMAN Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50) VPS50 CCDC132 KIAA1861 Homo sapiens (Human) endocytic recycling [GO:0032456]; protein transport [GO:0015031] EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031] SNARE binding [GO:0000149] GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:0070062; GO:1990745 VQQAYRLLGK 1.230000019 0.466427177 0.466427177 0.132046224 1174.659315 13.09964 12.20269 16.63693 13.65206 15.91304 14.74289 11.38092 0 0 0 15.96465 15.07681 0 0 0 0 9.324491 15.08606 0 0 0 0 0 0 0 0 15.36767 12.48326 0 13.9445 14.42465 0 16.26991 0 0 0 0 17.70514 0 0 0 0 0 15.10171 0 0 0 0 Q96JH7 VCIP1_HUMAN "Deubiquitinating protein VCPIP1, EC 3.4.19.12 (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135, VCP/p47 complex-interacting 135-kDa protein)" VCPIP1 KIAA1850 VCIP135 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; thiol-dependent deubiquitinase [GO:0004843]; cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634] thiol-dependent deubiquitinase [GO:0004843] GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634 DRSGSLLYLHDTLEDIK 9.489999771 1 1 0.169456891 1976.018963 0 14.73155 14.54557 10.38215 13.31174 12.60981 14.87081 0 0 14.10211 14.67549 0 0 0 0 0 0 0 0 0 0 0 13.51594 0 13.88898 15.84045 0 0 0 0 0 0 0 14.2278 15.01329 0 0 0 0 0 0 14.11939 0 0 15.92396 0 0 0 Q96JI7 SPTCS_HUMAN Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein) SPG11 KIAA1840 Homo sapiens (Human) autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; walking behavior [GO:0090659] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein kinase binding [GO:0019901]; autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; walking behavior [GO:0090659] protein kinase binding [GO:0019901] GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0048489; GO:0048675; GO:0048741; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256 HYFEVLMR 1.75999999 1 1 0.282963246 1109.480371 15.36286 0 0 0 0 0 0 0 0 0 0 15.50883 14.76058 14.4606 0 16.653 0 0 0 14.42993 0 0 16.18997 0 0 15.53791 15.60707 0 0 0 0 0 0 0 15.83465 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JJ3 ELMO2_HUMAN "Engulfment and cell motility protein 2 (Protein ced-12 homolog A, hCed-12A)" ELMO2 CED12A KIAA1834 Homo sapiens (Human) actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124] GO:0005829; GO:0006909; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0030971; GO:0048870; GO:0060326; GO:0098609 QLMERTQSSNMETR 2.529999971 0.874669611 0.874669611 0.396765782 1725.690723 0 16.16407 14.67484 0 15.45613 14.74494 15.61277 0 0 0 0 15.84912 0 0 0 0 0 12.72434 0 0 0 16.80774 0 0 0 0 16.25008 13.02521 0 17.77654 0 0 18.44634 0 0 17.63489 13.64559 18.09529 0 0 15.73568 0 0 0 11.92113 0 0 0 Q96JJ7 TMX3_HUMAN "Protein disulfide-isomerase TMX3, EC 5.3.4.1 (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3)" TMX3 KIAA1830 TXNDC10 Homo sapiens (Human) peptidyl-cysteine oxidation [GO:0018171] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; peptidyl-cysteine oxidation [GO:0018171] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] GO:0003756; GO:0005783; GO:0005789; GO:0005886; GO:0009986; GO:0015035; GO:0016021; GO:0018171; GO:0031092 LVALAVIDEK 6.900000095 1 1 0.433507716 1067.857535 15.08347 0 0 0 0 0 0 16.90687 0 0 0 0 0 0 0 15.87342 0 0 0 16.14584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JK9 MAML3_HUMAN "Mastermind-like protein 3, Mam-3" MAML3 KIAA1816 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221] transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005654; GO:0007219; GO:0007221; GO:0016607; GO:0045944 SLQGMPGR 5.360000134 1 1 0.040495899 841.7547416 0 14.97279 0 0 0 0 0 16.77673 15.49156 0 0 0 16.99439 14.66193 15.90054 0 0 0 14.89563 0 0 0 0 0 0 0 16.09731 0 16.61843 0 0 0 0 0 0 16.70797 0 0 18.01979 16.69242 16.60803 0 0 0 0 0 0 0 Q96JL9 ZN333_HUMAN Zinc finger protein 333 ZNF333 KIAA1806 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 NGSLPLSMSHPYCGPLAN 11.42000008 1 1 4.57E-13 1930.56119 13.86331 14.47119 13.75643 13.12228 15.70191 0 13.17984 0 0 16.64549 12.91387 0 13.67879 0 0 0 0 15.78945 0 0 0 0 16.90639 14.61456 0 17.42224 0 0 0 0 16.16648 15.43801 17.8991 14.02788 0 0 0 8.79956 0 0 0 0 0 0 0 15.39876 0 0 Q96JM2 ZN462_HUMAN "Zinc finger protein 462 (Zinc finger PBX1-interacting protein, ZFPIP)" ZNF462 KIAA1803 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0006325; GO:0010468; GO:0043392; GO:0045944; GO:0046872 AEDRELMR 12.35000038 0.678183496 0.678183496 0.011712723 1032.618592 16.12914 0 17.43584 0 11.35813 16.4703 15.79673 13.06811 0 0 17.21076 15.44649 15.82099 10.53979 8.605556 0 0 15.57108 16.63921 15.7326 0 0 12.93369 0 12.7466 16.9493 15.74897 15.44475 17.5678 0 15.82549 16.06218 16.71936 13.49888 13.58525 16.54537 0 14.44964 0 12.6726 14.43605 17.28827 0 0 0 16.11827 0 0 Q96JM3 CHAP1_HUMAN Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828) CHAMP1 C13orf8 CAMP CHAMP KIAA1802 ZNF828 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134] metal ion binding [GO:0046872] GO:0000776; GO:0000793; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0016604; GO:0031134; GO:0034501; GO:0035372; GO:0046872; GO:0051315; GO:0090543 HALFPELPK 20.54000092 1 1 0.101764233 1052.623598 14.86525 0 0 0 0 15.61599 15.62204 0 15.10964 0 0 0 0 0 0 0 0 0 0 0 0 0 17.04675 0 16.17022 0 15.72963 0 14.15831 0 0 15.08917 0 0 0 0 0 0 0 0 0 0 0 0 13.83242 0 0 14.63054 Q96JM4 LRIQ1_HUMAN Leucine-rich repeat and IQ domain-containing protein 1 LRRIQ1 KIAA1801 Homo sapiens (Human) DTTANEK 10.59000015 0.000994453 0.000994453 0.29746309 778.1462596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JM7 LMBL3_HUMAN "Lethal(3)malignant brain tumor-like protein 3, H-l(3)mbt-like protein 3, L(3)mbt-like protein 3, L3mbt-like 3 (MBT-1)" L3MBTL3 KIAA1798 MBT1 Homo sapiens (Human) "chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008270; GO:0030225; GO:0030851; GO:0042393; GO:0042802; GO:0043249; GO:0045892; GO:0090308 RNPMFIR 1.5 0.810964525 0.810964525 0.112388994 949.4428308 0 18.46753 0 0 0 0 14.05393 0 15.15258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JN2 CC136_HUMAN Coiled-coil domain-containing protein 136 (Nasopharyngeal carcinoma-associated gene 6 protein) CCDC136 KIAA1793 NAG6 Homo sapiens (Human) acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0001675; GO:0002080; GO:0007283; GO:0007338; GO:0016021 LLMEQMQALQVMYDAGQAK 9.470000267 0.678143919 0.678143919 0.077924272 2187.565753 0 18.62399 0 0 0 0 0 0 0 0 0 0 0 0 0 13.60983 13.60799 0 0 0 0 11.8533 0 9.866829 15.17993 12.3582 0 0 9.922878 0 15.05805 0 0 0 0 0 0 15.07583 0 14.00182 0 0 0 0 0 0 0 14.30966 Q96JN8 NEUL4_HUMAN Neuralized-like protein 4 NEURL4 KIAA1787 Homo sapiens (Human) centriole [GO:0005814]; cytoplasm [GO:0005737] centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630] ubiquitin protein ligase activity [GO:0061630] GO:0005737; GO:0005814; GO:0061630 GDEAHR 11.57999992 0.143872499 0.143872499 0.129274967 684.9574035 19.54757 0 0 17.31023 0 0 0 16.24977 0 17.35176 15.76617 0 16.46592 13.93058 16.35824 0 0 0 14.07502 0 15.96364 0 15.93813 0 16.90476 0 11.27787 0 11.28226 17.62564 0 0 16.53185 15.759 0 12.45472 0 0 17.79025 0 15.31164 0 0 0 0 0 14.1096 0 Q96JP2 MY15B_HUMAN Unconventional myosin-XVB (Myosin XVBP) (Unconventional myosin-15B) MYO15B KIAA1783 MYO15BP Homo sapiens (Human) cytoplasm [GO:0005737]; myosin complex [GO:0016459] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] GO:0003774; GO:0005524; GO:0005737; GO:0016459 IDPKDEALAK 8.479999542 0.484379768 0.484379768 0.359203078 1101.449818 13.85154 12.82012 13.92438 0 15.10724 15.53298 0 13.62455 14.55212 14.23624 0 12.82564 15.5683 0 0 0 0 14.43389 0 16.63579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.69754 0 0 0 0 Q96JP5 ZFP91_HUMAN "E3 ubiquitin-protein ligase ZFP91, EC 2.3.2.27 (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 757) (Zinc finger protein 91 homolog, Zfp-91)" ZFP91 ZNF757 FKSG11 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0007250; GO:0046872; GO:0070534 ETPKPRR 5.71999979 1 1 0.056226264 883.8750017 0 16.0581 15.94106 0 15.83157 14.45293 0 17.24472 14.92938 0 0 0 14.87029 0 16.29402 18.16863 14.69281 0 0 13.21513 13.67776 0 0 16.03071 16.35078 0 0 16.72247 0 15.99836 0 0 0 0 0 16.64438 18.60313 16.07811 0 13.96889 0 16.94851 14.6653 0 16.14587 14.22267 0 14.27153 Q96JP9 CDHR1_HUMAN "Cadherin-related family member 1 (Photoreceptor cadherin, prCAD) (Protocadherin-21)" CDHR1 KIAA1775 PCDH21 PRCAD Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845] integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622] integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0008594; GO:0035845; GO:0042622; GO:0045494 KSVHNK 2.960000038 1 1 0.202882692 709.879215 13.01906 14.82369 12.12703 0 14.62004 0 12.93051 0 0 0 16.12673 0 0 0 0 13.48299 0 0 14.41625 0 0 15.63347 15.89597 0 0 0 0 0 0 0 0 0 0 15.86888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JQ0 PCD16_HUMAN Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1) DCHS1 CDH19 CDH25 FIB1 KIAA1773 PCDH16 Homo sapiens (Human) adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0000902; GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007157; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0021915; GO:0022008; GO:0034332; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072137; GO:0072659; GO:0090102; GO:0098742 AGLLLPGAGATLYR 12.65999985 1 1 0 1372.859725 17.79578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JT2 S45A3_HUMAN Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein) SLC45A3 PCANAP6 PRST Homo sapiens (Human) hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770] sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119] GO:0005886; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713; GO:0051119 EKQVFLPK 2.819999933 0.553469419 0.553469419 0.138447682 986.543719 17.04893 14.79872 0 17.36968 0 0 0 13.7867 0 0 0 0 16.20098 15.26719 17.11481 12.13881 13.46536 0 18.61959 0 18.2278 18.28836 15.98955 16.08028 0 0 17.1862 18.23528 15.8868 0 0 17.82449 15.70172 0 18.38658 15.6025 14.40813 18.0136 0 0 0 0 0 0 17.18101 7.62311 0 17.95359 Q96JX3 SRAC1_HUMAN Protein SERAC1 (Serine active site-containing protein 1) SERAC1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654] GO:0005739; GO:0005783; GO:0008654; GO:0016021; GO:0030198; GO:0031012; GO:0032367; GO:0036148; GO:0044233 ADVLFIHGLMGAAFK 1.929999948 1 1 0 1604.013057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JZ2 HSH2D_HUMAN "Hematopoietic SH2 domain-containing protein, Hematopoietic SH2 protein (Adaptor in lymphocytes of unknown function X)" HSH2D ALX Homo sapiens (Human) negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of mitochondrial depolarization [GO:0051902]; signal transduction [GO:0007165]; T cell activation [GO:0042110] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of mitochondrial depolarization [GO:0051902]; signal transduction [GO:0007165]; T cell activation [GO:0042110] protein-macromolecule adaptor activity [GO:0030674] GO:0002903; GO:0005634; GO:0005739; GO:0005829; GO:0007165; GO:0030674; GO:0042110; GO:0051902 ELLTQPCR 17.77000046 1 1 0.193323477 1016.835784 0 0 17.25757 16.90894 0 0 14.9021 14.55587 12.74219 15.84203 15.79392 15.96794 16.29012 12.80043 16.16119 0 0 0 0 0 15.6713 12.38543 0 0 14.10945 16.08222 0 13.04263 0 15.00553 0 0 16.56729 16.07032 16.84229 0 0 0 16.92698 14.26414 0 0 15.88142 0 0 0 0 0 Q96K30 RITA1_HUMAN RBPJ-interacting and tubulin-associated protein 1 (RBPJ-interacting and tubulin-associated protein) RITA1 C12orf52 RITA PSEC0043 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tubulin binding [GO:0015631]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168] tubulin binding [GO:0015631] GO:0000122; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0007219; GO:0015631; GO:0022008; GO:0045746; GO:0051168 GVGKEASK 2.380000114 1 1 0.168774396 774.6864273 15.39434 16.11843 13.37653 16.59356 0 0 0 14.32985 0 0 15.03158 0 13.80454 0 0 0 0 0 0 0 0 0 0 0 0 15.12441 0 16.04073 0 15.21206 0 0 14.54018 0 0 0 0 0 0 16.75019 12.00943 0 0 14.1117 0 0 0 0 Q96K49 TM87B_HUMAN Transmembrane protein 87B TMEM87B Homo sapiens (Human) "retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0042147 LLVIIVSLGYGIVKPR 6.489999771 1 1 0.400276374 1739.119704 15.19322 15.46047 13.30579 15.56044 0 0 0 0 15.10104 0 0 0 0 0 15.66474 0 0 0 0 17.78325 0 0 0 0 15.02518 0 15.03273 14.42789 0 15.00072 0 0 0 16.59646 0 16.79529 16.83576 12.70452 16.19087 0 15.05671 12.1069 0 12.3003 16.33592 0 16.9578 0 Q96K58 ZN668_HUMAN Zinc finger protein 668 ZNF668 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872 QPADLAMHRR 1.399999976 1 1 1.37E-12 1209.710126 0 12.23851 0 14.20242 13.50493 15.55318 0 14.75598 0 13.3219 15.72378 14.91005 0 14.46912 0 0 0 0 16.26344 0 0 0 0 14.40077 0 0 0 0 0 13.91791 0 0 0 0 0 0 0 0 0 0 0 0 13.46937 0 0 0 15.35301 0 Q96K75 ZN514_HUMAN Zinc finger protein 514 ZNF514 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 FHTGEKPYKCNK 3.799999952 0.351550937 0.351550937 0.438160031 1508.947177 15.60444 15.84161 10.55472 13.199 14.07056 0 0 15.30026 14.16254 0 17.77196 15.3732 0 0 0 0 15.97177 0 0 0 0 16.89925 0 16.23402 0 0 0 9.536364 15.38137 0 16.38139 0 0 0 0 0 0 0 0 0 16.38365 0 4.657876 0 0 16.17538 0 0 Q96K76 UBP47_HUMAN "Ubiquitin carboxyl-terminal hydrolase 47, EC 3.4.19.12 (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47)" USP47 Homo sapiens (Human) "base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to xenobiotic stimulus [GO:0009410]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; thiol-dependent deubiquitinase [GO:0004843]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to xenobiotic stimulus [GO:0009410]; ubiquitin-dependent protein catabolic process [GO:0006511]" cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; thiol-dependent deubiquitinase [GO:0004843]; WD40-repeat domain binding [GO:0071987] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006974; GO:0009410; GO:0010972; GO:0016579; GO:0019005; GO:0030307; GO:0031647; GO:0034644; GO:0035520; GO:0043066; GO:0043154; GO:0045892; GO:0071987; GO:0090263; GO:0101005; GO:1902230 AEGFFR 7.849999905 0.920211196 0.920211196 0.279781588 727.0315548 15.63481 14.46864 15.94636 0 0 14.8415 15.14676 0 0 0 15.45816 16.3789 13.81113 14.28302 15.90896 0 0 0 16.65575 0 0 17.02248 16.20619 0 15.28608 15.61049 14.63732 15.62918 14.68952 15.17339 16.33844 16.43547 15.67968 15.70671 14.83835 14.67376 16.1169 15.75585 15.78196 16.45099 15.36043 16.83218 0 16.10393 16.42854 16.40085 15.914 0 Q96K78 AGRG7_HUMAN Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128) ADGRG7 GPR128 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 GTDGFLR 10.39000034 0.726861119 0.726861119 1.60E-12 765.2979323 16.52541 15.88943 0 16.20015 17.5542 15.63158 0 14.55474 13.65589 0 14.78095 15.81444 15.78953 0 0 15.52439 16.29669 15.12809 15.36427 15.54857 16.63188 14.96997 0 0 16.23424 14.75859 17.36428 0 14.09291 0 12.35688 0 18.18805 0 15.97268 15.74958 15.15556 15.54079 0 17.14405 0 19.10365 16.99916 16.87659 14.39406 15.85847 16.54128 14.83053 Q96K83 ZN521_HUMAN Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3) ZNF521 EHZF LIP3 Homo sapiens (Human) neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0019904; GO:0046872; GO:0048663 ISPSQSDEK 10 0.601685762 0.601685762 0.06652196 989.0746062 15.97433 0 14.69359 0 0 13.27357 0 12.38595 11.93642 0 0 0 13.6313 15.04433 0 13.87265 14.22454 14.90057 0 16.82431 14.28733 17.38956 16.94084 16.70645 12.82125 13.75606 14.77116 0 14.20527 12.70449 16.74278 11.52562 0 15.19495 13.48017 15.8284 15.44897 14.20239 0 0 0 15.70938 14.89373 15.99819 15.46995 16.38311 0 15.37466 Q96KA5 CLP1L_HUMAN "Cleft lip and palate transmembrane protein 1-like protein, CLPTM1-like protein (Cisplatin resistance-related protein 9, CRR9p)" CLPTM1L CRR9 Homo sapiens (Human) apoptotic process [GO:0006915] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915] GO:0006915; GO:0016020; GO:0016021 TVNVSVPKK 11.10000038 0.138891801 0.138891801 0.180800869 970.9346101 0 18.33842 17.34194 16.69201 0 15.93766 0 0 0 10.86832 0 13.51238 15.06064 14.7793 16.01918 0 15.35705 15.40245 0 12.32028 0 17.17954 0 16.91503 15.45187 0 18.86122 16.11493 13.25359 0 0 20.86685 18.59538 15.44799 17.13156 15.16542 18.84905 15.49443 15.46642 0 19.6216 12.98634 14.66927 14.82943 15.78852 0 13.62867 16.63247 Q96KD3 GAR1B_HUMAN Golgi associated RAB2 interactor protein 1B (Testis development protein NYD-SP18) GARIN1B FAM137A FAM71F1 Homo sapiens (Human) acrosome assembly [GO:0001675]; acrosome reaction [GO:0007340] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; acrosome assembly [GO:0001675]; acrosome reaction [GO:0007340] GO:0001675; GO:0005794; GO:0007340 LSSFPHR 3.779999971 1 1 0.243597662 843.8688422 13.80617 14.81526 14.54531 14.67816 15.34658 15.86897 15.41763 15.18112 15.5453 0 15.76565 14.9994 16.81399 0 16.34465 10.71929 15.4487 15.08998 14.40281 15.44124 12.97316 15.39104 0 16.39833 14.34281 0 15.50042 0 0 0 15.5561 16.66351 16.92592 15.86005 16.23662 0 0 0 16.51168 15.86758 0 0 15.38763 14.46933 14.06252 16.30639 0 16.32208 Q96KG7 MEG10_HUMAN "Multiple epidermal growth factor-like domains protein 10, Multiple EGF-like domains protein 10" MEGF10 KIAA1780 Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044] GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288 CEQGTYGNDCHQR 8.470000267 1 1 0.000636411 1623.828685 0 17.71361 17.19379 16.37023 16.80123 18.11694 0 0 17.45711 16.49739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.84775 0 0 0 17.44595 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KG9 SCYL1_HUMAN N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase) SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019 Homo sapiens (Human) "cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]" cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] "cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]" ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713] GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0016020; GO:0021522; GO:0030126; GO:0034613; GO:0045296; GO:0048666 APGGFMSNR 2.329999924 1 1 0.319938836 953.0891753 0 12.93974 0 0 0 0 0 0 0 0 0 0 16.75751 0 0 0 0 0 0 0 16.41308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KM6 Z512B_HUMAN Zinc finger protein 512B ZNF512B KIAA1196 Homo sapiens (Human) negative regulation of miRNA transcription [GO:1902894] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of miRNA transcription [GO:1902894]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0001227; GO:0005654; GO:0046872; GO:1902894 LPMLHDPPKMGMPVVR 3.170000076 1 1 0.242847056 1848.960916 13.40214 14.90435 14.21977 0 0 13.72291 0 16.13553 14.56969 0 15.50934 11.57794 13.96543 12.83628 15.13381 13.73854 0 14.58188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05631 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KN3 PKNX2_HUMAN Homeobox protein PKNOX2 (Homeobox protein PREP-2) (PBX/knotted homeobox 2) PKNOX2 PREP2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0003785; GO:0005654; GO:0005737; GO:0006357; GO:0015629; GO:0015630; GO:0045171; GO:0051015; GO:1990837 TKMHSDNLLR 2.640000105 1 1 0.400183962 1229.924946 0 15.05754 14.66705 13.95907 14.26725 13.68998 0 0 0 11.19927 15.17653 14.5326 15.56009 14.59822 16.26906 0 15.60133 14.86043 0 17.22181 14.70021 17.2312 0 0 15.63004 0 0 15.81306 15.97753 0 0 0 0 15.97892 15.6928 15.67665 0 0 0 0 16.17688 0 0 0 16.51959 0 16.71297 0 Q96KN4 LRAT1_HUMAN "Protein LRATD1 (LRAT domain-containing 1) (Neurologic sensory protein 1, NSE1) (Protein FAM84A)" LRATD1 FAM84A NSE1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; cell motility [GO:0048870] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870] GO:0000902; GO:0005737; GO:0048870 GQECIFSK 7.440000057 0.004971648 0.004971648 0.057701303 968.2368709 0 16.59231 0 0 0 0 14.4012 14.16649 13.72198 0 15.42507 0 0 0 15.42595 0 15.92866 9.554057 14.95337 0 0 15.89966 0 0 0 0 0 0 0 12.3898 13.1938 0 0 0 15.92659 0 16.72026 14.88487 0 0 15.35363 15.95778 14.36698 0 16.65789 0 12.67681 0 Q96KN7 RPGR1_HUMAN "X-linked retinitis pigmentosa GTPase regulator-interacting protein 1, RPGR-interacting protein 1" RPGRIP1 Homo sapiens (Human) neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601] axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206] axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601] GO:0005930; GO:0007601; GO:0032391; GO:0035869; GO:0046548; GO:0050896; GO:0061351; GO:0120206; GO:1905515 DMLILQRK 1.289999962 0.579428136 0.579428136 0.317698807 1032.969111 0 0 0 0 0 16.55829 0 17.44825 0 0 0 0 0 0 0 0 0 0 0 16.70457 0 0 0 0 0 0 0 0 0 16.95798 0 0 18.96323 0 0 0 0 0 0 0 0 0 17.63609 0 17.6868 0 0 0 Q96KN8 PLAT5_HUMAN "Phospholipase A and acyltransferase 5 (Ca(2+)-independent N-acyltransferase, iNAT, EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4) (H-rev107-like protein 5) (HRAS-like suppressor 5, HRSL5)" PLAAT5 HRASLS5 HRLP5 Homo sapiens (Human) N-acylphosphatidylethanolamine metabolic process [GO:0070292] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; N-acylphosphatidylethanolamine metabolic process [GO:0070292] 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] GO:0004623; GO:0005737; GO:0005829; GO:0008970; GO:0016410; GO:0052739; GO:0052740; GO:0070292 VNNKLDGTYLPLPVDK 1.179999948 1 1 0.151708094 1785.16902 0 14.06073 14.02947 13.93366 0 0 13.09302 14.83455 12.92388 13.61362 0 14.28802 0 0 0 0 0 18.10439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.24931 0 0 Q96KN9 CXD4_HUMAN "Gap junction delta-4 protein (Connexin-40.1, Cx40.1)" GJD4 CX40.1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014717] connexin complex [GO:0005922]; integral component of membrane [GO:0016021] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014717] gap junction channel activity [GO:0005243] GO:0005243; GO:0005922; GO:0007267; GO:0014717; GO:0016021 QSGASGHAEGR 12.15999985 1 1 0.333291236 1054.901783 0 14.86896 0 14.02796 0 14.75538 0 14.41114 13.05464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.45962 13.32204 15.31572 0 15.41718 0 14.5138 13.22202 16.08306 15.39144 0 0 15.28844 0 0 0 0 0 0 0 0 13.48988 0 0 Q96KP1 EXOC2_HUMAN Exocyst complex component 2 (Exocyst complex component Sec5) EXOC2 SEC5 SEC5L1 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267] GO:0000145; GO:0000281; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0019901; GO:0031267; GO:0047485; GO:0090148; GO:0090522; GO:0090543; GO:2000535 GDYDVVINDYEK 10.42000008 0.74138087 0.74138087 0.273250733 1429.441546 13.43748 0 12.50439 15.48735 15.29425 14.1339 13.80509 13.67591 0 15.6565 13.58238 0 15.54467 11.66402 14.30145 15.16032 0 0 15.27973 16.40708 0 16.09402 0 11.87889 13.84709 0 0 0 0 0 0 0 0 0 15.60916 0 0 0 0 0 0 0 0 14.69285 14.58096 0 12.8086 0 Q96KP6 TNIP3_HUMAN "TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3, ABIN-3) (Listeria-induced gene protein)" TNIP3 ABIN3 LIND Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 4 signaling pathway [GO:0034142] cytosol [GO:0005829] cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 4 signaling pathway [GO:0034142] polyubiquitin modification-dependent protein binding [GO:0031593] GO:0002756; GO:0005829; GO:0006357; GO:0006954; GO:0031593; GO:0034142; GO:0043124; GO:0071222 NTLANKEK 3.660000086 1 1 0.211477979 916.7879523 14.84379 0 0 0 13.35336 0 14.53057 0 12.87143 15.66236 14.08702 14.53456 0 0 14.86977 15.16464 13.78105 0 16.14681 14.38988 0 13.8001 0 15.45933 0 14.90733 0 0 0 0 0 0 0 15.21445 0 0 0 0 0 0 0 14.20952 0 0 0 16.35814 0 0 Q96KQ4 ASPP1_HUMAN Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B) PPP1R13B ASPP1 KIAA0771 Homo sapiens (Human) intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; p53 binding [GO:0002039]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786] p53 binding [GO:0002039] GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0045786; GO:0072332 AMRGQVDYSK 12.27000046 0.132703856 0.132703856 0.108245946 1170.341051 14.64262 0 0 0 15.59891 0 11.02011 0 0 0 11.876 0 0 14.21624 15.45002 0 0 0 0 0 13.64599 0 0 0 0 11.80609 11.08836 0 0 13.64977 0 15.09091 0 0 0 14.1608 17.32454 0 16.85294 14.71001 15.44783 13.87857 13.63566 0 15.22544 0 0 0 Q96KQ7 EHMT2_HUMAN "Histone-lysine N-methyltransferase EHMT2, EC 2.1.1.-, EC 2.1.1.367 (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3, H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)" EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130] C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0006325; GO:0007130; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010424; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0035265; GO:0036166; GO:0044030; GO:0045471; GO:0046974; GO:0046976; GO:0048148; GO:0048665; GO:0051569; GO:0051570; GO:0060992; GO:0070742; GO:0071314; GO:0071466; GO:1902902; GO:1990841 ALVIQESER 6.230000019 1 1 6.89E-13 1045.51652 16.94814 0 0 0 0 0 0 0 0 0 9.009329 0 0 0 0 0 15.39526 13.14755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.38731 15.25762 0 0 0 0 0 0 0 0 0 0 0 0 Q96KR7 PHAR3_HUMAN "Phosphatase and actin regulator 3 (Scaffold-associated PP1-inhibiting protein, Scapinin)" PHACTR3 C20orf101 SCAPIN1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036] actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864] GO:0003779; GO:0004864; GO:0005654; GO:0008157; GO:0016363; GO:0030036 TPPVRR 5.789999962 1 1 0.110223477 723.2631806 16.07147 0 0 0 0 14.19267 0 0 0 0 0 0 0 0 0 0 0 15.67256 0 0 15.37322 0 0 0 16.16357 0 16.6706 13.16758 16.0106 15.41144 12.85876 15.42097 15.74227 13.77559 15.81657 15.93062 0 0 0 0 0 0 15.88148 0 14.95112 0 0 0 Q96KV6 BT2A3_HUMAN Putative butyrophilin subfamily 2 member A3 BTN2A3P BTN2A3 Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] signaling receptor binding [GO:0005102] GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0050852 NVSCSINDTLLGQK 19.51000023 1 1 0.198368245 1548.729637 14.05512 0 12.4529 0 12.14257 12.53325 10.81501 14.42192 13.32213 12.34295 0 12.03296 0 0 0 0 0 0 0 16.63364 0 0 0 16.22201 16.01188 0 0 0 0 0 16.729 18.29597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KV7 WDR90_HUMAN WD repeat-containing protein 90 WDR90 C16orf15 C16orf16 C16orf17 C16orf18 C16orf19 KIAA1924 Homo sapiens (Human) cilium assembly [GO:0060271] centriole [GO:0005814]; cytoplasm [GO:0005737] centriole [GO:0005814]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271] GO:0005737; GO:0005814; GO:0060271 GAVTGLTATPDGR 10.59000015 1 1 0.299836514 1215.104478 12.5008 13.14199 14.35557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.56678 13.56277 15.43107 0 0 0 13.30119 0 15.19875 0 0 0 0 0 0 0 0 15.33268 0 0 0 Q96KX1 CD036_HUMAN Uncharacterized protein C4orf36 C4orf36 Homo sapiens (Human) ERPAGLR 5.409999847 1 1 0.233523705 799.4217651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.19903 0 16.27338 16.76435 16.26974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.95453 0 0 Q96L34 MARK4_HUMAN "MAP/microtubule affinity-regulating kinase 4, EC 2.7.11.1 (MAP/microtubule affinity-regulating kinase-like 1)" MARK4 KIAA1860 MARKL1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cell cycle [GO:0045787]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cell cycle [GO:0045787]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605] ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130] GO:0000226; GO:0000930; GO:0001578; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0007049; GO:0007399; GO:0008017; GO:0015630; GO:0030425; GO:0030496; GO:0035556; GO:0036064; GO:0043005; GO:0043015; GO:0043068; GO:0043130; GO:0044782; GO:0045724; GO:0045787; GO:0046605; GO:0048156; GO:0050321; GO:0051301; GO:0106310; GO:1904781 ESLTSQK 3.799999952 0.111685395 0.111685395 0.311144427 792.3180359 0 0 0 17.63132 0 19.39362 0 0 0 0 0 18.43726 0 0 0 18.89458 0 0 0 0 17.5732 18.66308 0 0 0 0 0 0 17.27262 0 0 18.79388 0 17.71088 18.01614 0 0 17.8791 19.82281 0 0 0 0 0 0 17.4104 18.31057 18.91685 Q96L42 KCNH8_HUMAN "Potassium voltage-gated channel subfamily H member 8 (ELK1, hElk1) (Ether-a-go-go-like potassium channel 3, ELK channel 3, ELK3) (Voltage-gated potassium channel subunit Kv12.1)" KCNH8 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805 LLQKLDR 12.10000038 1 1 0.082135221 885.8023548 0 14.46914 13.05356 14.15609 15.34927 0 0 0 0 0 0 14.54131 0 0 12.48154 0 0 0 0 0 0 0 0 0 0 0 0 15.72116 0 15.97669 0 16.80836 0 0 0 0 16.66035 0 0 0 0 0 0 0 0 0 0 0 Q96L50 LLR1_HUMAN "Leucine-rich repeat protein 1 (4-1BB-mediated-signaling molecule) (4-1BBlrr) (LRR-repeat protein 1, LRR-1) (Peptidylprolyl isomerase-like 5)" LRR1 PPIL5 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567 NLKLDDNELIQFPCK 7.829999924 0.554613531 0.554613531 0.502140518 1846.489913 15.29544 0 15.20064 0 0 0 18.85787 18.88449 0 19.58538 0 0 0 0 0 0 0 0 0 19.25317 0 0 19.13079 19.23498 0 18.24827 0 0 0 0 0 0 19.60672 0 0 0 0 19.47506 0 0 17.82155 0 0 0 0 0 0 0 Q96L58 B3GT6_HUMAN "Beta-1,3-galactosyltransferase 6, Beta-1,3-GalTase 6, Beta3Gal-T6, Beta3GalT6, EC 2.4.1.134 (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)" B3GALT6 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; UDP-glycosyltransferase activity [GO:0008194]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]" "galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; UDP-glycosyltransferase activity [GO:0008194]" GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006486; GO:0008194; GO:0008499; GO:0015012; GO:0016020; GO:0016021; GO:0016757; GO:0030166; GO:0030203; GO:0030206; GO:0032580; GO:0035250; GO:0047220 ADDDSFAR 5.869999886 1 1 0.305297112 896.6959123 0 0 0 0 11.83966 0 13.25119 0 0 0 0 0 0 14.49537 0 12.553 0 0 0 15.36817 0 11.58539 0 13.14459 16.24648 0 14.71576 14.98776 14.29187 15.9988 0 15.52973 0 0 0 16.8081 0 0 0 17.57697 0 0 0 0 0 0 0 0 Q96L73 NSD1_HUMAN "Histone-lysine N-methyltransferase, H3 lysine-36 specific, EC 2.1.1.357 (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1, NR-binding SET domain-containing protein)" NSD1 ARA267 KMT3B Homo sapiens (Human) "chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]" androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0000122; GO:0000414; GO:0000785; GO:0000978; GO:0003682; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0008270; GO:0016571; GO:0018024; GO:0030331; GO:0033135; GO:0042799; GO:0042974; GO:0045893; GO:0046965; GO:0046966; GO:0046975; GO:0050681; GO:1903025 FSTLLMMLKDMHDSK 2.140000105 1 1 0.562428489 1814.920729 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L91 EP400_HUMAN "E1A-binding protein p400, EC 3.6.4.- (CAG repeat protein 32) (Domino homolog, hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein)" EP400 CAGH32 KIAA1498 KIAA1818 TNRC12 Homo sapiens (Human) "histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812] "NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein antigen binding [GO:1990405]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein antigen binding [GO:1990405] GO:0000786; GO:0000812; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005654; GO:0016573; GO:0016607; GO:0016787; GO:0035267; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:0140658; GO:1905168; GO:1990405; GO:2000779 IYRSSK 10.05000019 0.904504955 0.904504955 0.238085031 751.6950391 0 0 0 0 14.90456 0 0 16.09067 0 15.18883 16.11045 15.9338 15.65129 0 16.33937 0 0 0 0 16.4513 16.5515 18.61381 19.72167 17.92809 16.71878 16.354 16.5904 0 15.40918 15.74157 16.78792 15.94925 16.89041 16.56571 0 15.32898 17.61855 17.14803 17.74979 17.14729 16.57154 16.96125 15.76142 17.63315 16.22338 17.74643 15.83649 16.20773 Q96L93 KI16B_HUMAN Kinesin-like protein KIF16B (Sorting nexin-23) KIF16B C20orf23 KIAA1590 SNX23 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]" GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025 ASVKVAVR 4.900000095 1 1 0.252145371 829.0827637 0 16.91686 15.04309 14.34097 14.72634 0 0 16.68647 16.91857 0 0 0 0 16.26745 0 0 17.86815 0 0 0 0 0 0 0 0 17.58448 0 16.89964 0 15.73069 17.27102 0 16.77894 0 0 0 16.75043 15.94825 0 0 0 0 0 0 0 0 0 15.2802 Q96L96 ALPK3_HUMAN "Alpha-protein kinase 3, EC 2.7.11.1 (Muscle alpha-protein kinase)" ALPK3 KIAA1330 MAK Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; heart development [GO:0007507] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cardiac muscle cell development [GO:0055013]; heart development [GO:0007507] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0007507; GO:0055013; GO:0106310 GPQSSGPVEAK 4.460000038 1 1 0.330921748 1057.202757 13.88241 0 14.86197 15.71385 14.82733 13.39584 15.89567 0 0 0 0 13.93764 15.62887 14.24453 13.3174 14.68009 0 0 0 15.68352 0 0 16.76101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.99435 15.71991 0 Q96LA9 MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 (Sensory neuron-specific G-protein coupled receptor 5/6) MRGPRX4 MRGX4 SNSR5 SNSR6 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0007186; GO:0016021 DPTVPVFGTK 5.5 1 1 0.095992761 1062.608375 0 0 14.18648 12.28813 14.68338 14.08745 0 0 0 0 0 0 16.14502 0 0 15.63741 0 0 0 0 0 0 0 0 16.34668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17352 0 0 0 0 0 Q96LB0 MRGX3_HUMAN Mas-related G-protein coupled receptor member X3 (Sensory neuron-specific G-protein coupled receptor 1/2) MRGPRX3 MRGX3 SNSR1 SNSR2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0007186; GO:0016021 MDSTIPVLGTELTPINGR 6.21999979 1 1 3.66E-12 1929.504969 13.63747 14.24932 16.02336 13.55774 13.04544 15.27106 0 0 0 0 0 15.09268 0 12.9389 14.83596 0 15.19713 0 0 0 0 16.286 16.09139 14.75973 0 14.72013 15.41243 14.0098 0 0 0 0 16.81834 15.02788 0 14.45984 14.50527 0 0 14.50125 0 15.92762 0 0 0 0 0 0 Q96LB3 IFT74_HUMAN "Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein, CMG-1) (Coiled-coil domain-containing protein 2)" IFT74 CCDC2 CMG1 Homo sapiens (Human) cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944] beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682] GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0030992; GO:0031410; GO:0031514; GO:0033630; GO:0035720; GO:0035735; GO:0045944; GO:0048487; GO:0050680; GO:0060271; GO:0097542; GO:1905515 RAETLAVEIK 11.35000038 1 1 0.216014514 1130.746944 0 16.57306 15.45278 0 0 15.93441 0 0 14.14659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.91446 0 17.34198 0 0 15.4145 0 16.84631 0 16.65293 16.5509 17.27449 15.62034 0 0 0 0 0 0 16.0101 Q96LC7 SIG10_HUMAN "Sialic acid-binding Ig-like lectin 10, Siglec-10 (Siglec-like protein 2)" SIGLEC10 SLG2 UNQ477/PRO940 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015] carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691] GO:0002250; GO:0005576; GO:0005886; GO:0007155; GO:0016021; GO:0019902; GO:0030246; GO:0033691; GO:0042169; GO:0045087; GO:0106015 LLPLLLSSLLGGSQAMDGR 9.319999695 1 1 0.15476286 1953.094928 15.75826 14.58353 15.07795 13.54893 13.29492 14.38941 14.4277 14.85679 14.44254 11.21464 12.36713 15.21031 13.28378 15.33711 13.7262 15.71075 15.98872 15.03485 11.67371 13.76517 15.87225 14.51011 14.69372 15.37449 14.98886 14.75852 14.61801 14.72349 15.42518 15.09925 0 0 0 0 0 0 0 0 0 13.90876 15.22007 14.90101 15.71042 0 14.50252 0 0 0 Q96LD8 SENP8_HUMAN "Sentrin-specific protease 8, EC 3.4.22.- (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)" SENP8 DEN1 NEDP1 PRSC2 FKSG8 Homo sapiens (Human) post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579] cytosol [GO:0005829] cytosol [GO:0005829]; NEDD8-specific protease activity [GO:0019784]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579] NEDD8-specific protease activity [GO:0019784] GO:0005829; GO:0016579; GO:0019784; GO:0043687 LEAFLGR 1.779999971 1 1 0.124839455 803.5275224 0 0 14.71828 14.60842 16.18938 14.83702 0 15.16351 0 16.38054 15.4238 0 0 15.83125 0 15.63156 15.69247 15.99179 15.3592 0 15.35053 16.66812 0 0 13.89178 0 15.62676 16.39256 16.38046 15.59046 14.15588 16.41208 0 15.6081 0 0 0 16.12274 16.17688 16.04042 16.45869 0 15.26401 16.03954 16.9898 15.66241 0 0 Q96LI5 CNO6L_HUMAN "CCR4-NOT transcription complex subunit 6-like, EC 3.1.13.4 (Carbon catabolite repressor protein 4 homolog B)" CNOT6L CCR4B Homo sapiens (Human) gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535] GO:0000175; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872 HTVEFNQVAMANSDGSEAMLNR 8.130000114 1 1 0.196868928 2421.198306 0 14.42407 13.37368 11.51949 0 0 0 15.08043 0 0 0 14.74133 0 14.60737 0 0 0 0 0 0 15.65709 0 13.53586 13.07018 0 9.826068 0 0 12.24604 15.78985 16.01649 0 15.24812 0 0 0 0 0 15.98226 0 0 0 0 0 0 0 0 0 Q96LI9 CX058_HUMAN Uncharacterized protein CXorf58 CXorf58 Homo sapiens (Human) MNRSSNVPR 9.340000153 0.953131795 0.953131795 0.159432798 1075.751444 14.18334 13.49248 0 15.98175 12.6634 0 0 16.22296 14.89109 0 0 0 17.59044 0 0 0 14.86739 15.20151 0 13.48732 17.0333 14.67408 16.35942 14.50363 16.97889 16.21246 16.8475 13.30186 17.85864 0 0 0 14.3164 0 17.04556 8.78279 17.60283 0 0 0 18.00826 18.20164 0 18.195 17.67849 17.24334 17.92681 0 Q96LK0 CEP19_HUMAN "Centrosomal protein of 19 kDa, Cep19" CEP19 C3orf34 HSD5 Homo sapiens (Human) "cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]" centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] "centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]" GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712 KSIMDELFEK 4.170000076 0.180954844 0.180954844 0.08346022 1254.484586 0 9.382357 0 13.79287 14.21675 10.24666 10.94638 12.84856 14.18652 15.71461 0 7.775369 13.80758 0 10.19506 14.88513 14.00411 9.23816 0 0 0 0 13.97573 0 0 0 0 0 0 0 0 0 0 0 0 0 12.22883 0 0 0 0 0 0 0 0 0 0 0 Q96LM1 CL037_HUMAN Putative uncharacterized protein encoded by LINC00615 LINC00615 C12orf37 Homo sapiens (Human) AGRELPGR 3.640000105 1 1 0.183042743 855.6512785 14.16341 14.4203 13.68774 12.76603 14.15769 0 0 0 0 15.27414 0 0 0 0 0 15.76759 0 0 0 0 14.59542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LM5 CD045_HUMAN Uncharacterized protein C4orf45 C4orf45 Homo sapiens (Human) DYLPK 4.619999886 1 1 0.286146609 635.3134217 0 0 0 0 0 0 18.66415 0 0 0 0 0 0 18.58487 0 22.43553 18.59815 0 19.87972 0 0 0 0 0 19.01252 0 0 0 0 0 0 0 0 0 0 19.39776 0 0 0 0 17.52382 0 0 18.75389 0 0 0 0 Q96LQ0 PPR36_HUMAN Protein phosphatase 1 regulatory subunit 36 PPP1R36 C14orf50 Homo sapiens (Human) negative regulation of phosphatase activity [GO:0010923] phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923] phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864] GO:0004864; GO:0010923; GO:0019902 MMAKRPAIK 2.339999914 1 1 0.253349096 1079.092097 16.89582 17.83842 16.98604 16.43983 18.09782 16.91468 16.4723 18.96417 18.09831 18.5543 0 0 0 0 17.3868 0 17.66191 16.85851 0 0 0 0 16.74204 19.05366 0 17.13631 0 18.19336 16.71016 18.11077 18.33324 0 17.76193 17.69888 18.31035 0 0 17.40156 16.7341 17.91043 0 16.35534 0 18.68682 0 16.72399 18.19588 0 Q96LR5 UB2E2_HUMAN "Ubiquitin-conjugating enzyme E2 E2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)" UBE2E2 UBCH8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209] ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087 EQVQPK 6.53000021 0.591926634 0.591926634 0.142753351 728.9650403 18.06817 0 16.45742 0 0 0 11.50132 0 14.25899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59249 17.28607 0 0 17.24551 18.85013 0 14.97405 0 0 0 0 18.2815 0 0 16.80232 0 Q96LW1 Z354B_HUMAN Zinc finger protein 354B ZNF354B Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0046872 DSSGVSSLGCK 10.19999981 0.172295898 0.172295898 0.261527014 1096.890487 17.28955 0 12.40735 0 0 0 0 13.13295 17.97536 0 18.32912 11.37948 0 12.47896 14.96696 16.73302 0 15.20139 0 16.84105 0 14.72856 17.02341 0 13.60581 14.77163 15.36846 0 17.14559 13.18599 19.40914 15.10169 0 19.23266 15.81047 0 16.17577 0 17.69462 16.14064 0 0 0 15.92026 0 0 15.69802 0 Q96LW2 KS6R_HUMAN "Ribosomal protein S6 kinase-related protein, EC 2.7.11.1 (Sugen kinase 494)" RSKR SGK494 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0106310 ILGLVAKGSFGTVLK 8.109999657 1 1 0.330678253 1500.664333 0 15.5143 8.860643 0 0 15.29675 0 15.82329 0 0 0 0 0 0 0 16.35442 0 0 0 0 0 0 0 0 16.89069 16.78238 17.08429 14.83741 16.33233 13.57904 15.02144 15.10406 0 15.80976 14.48984 12.3984 13.42042 0 0 15.13891 14.97676 0 0 0 0 0 0 0 Q96LW4 PRIPO_HUMAN "DNA-directed primase/polymerase protein, hPrimpol1, EC 2.7.7.- (Coiled-coil domain-containing protein 111)" PRIMPOL CCDC111 Homo sapiens (Human) error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop disassembly [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657] mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]; error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop disassembly [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270] GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005657; GO:0005759; GO:0006264; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176 LYKSSK 4.730000019 0.682883739 0.682883739 0.202699615 723.886582 15.45317 0 12.25991 0 0 14.91652 0 15.52946 16.40879 15.5226 0 15.0613 0 0 0 0 14.94713 0 0 0 0 17.26076 17.32842 18.0197 13.58598 0 15.46009 0 0 0 15.70546 0 14.99768 0 15.97204 16.31919 14.93866 16.75344 15.84983 0 14.72623 18.39857 14.99975 0 0 0 0 0 Q96LX7 CCD17_HUMAN Coiled-coil domain-containing protein 17 CCDC17 Homo sapiens (Human) TGLARDGR 10.46000004 0.235735223 0.235735223 0.235837024 845.343255 14.52405 15.75978 16.47966 14.79672 0 16.49277 15.79285 0 15.92175 16.00466 16.16067 0 0 15.36727 13.60427 15.64434 0 0 0 14.88036 0 16.19268 14.8127 16.41896 0 15.12366 0 0 14.80069 0 0 15.2673 0 0 16.80139 0 16.52201 15.9716 13.29341 0 15.03393 14.43682 15.83911 0 0 0 16.88496 0 Q96M20 CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 CNBD2 C20orf152 Homo sapiens (Human) spermatogenesis [GO:0007283] cytosol [GO:0005829] cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283] cAMP binding [GO:0030552] GO:0005829; GO:0007283; GO:0030552 KELGLYQLAMDIIIMIR 26.62999916 1 1 0.477071479 2037.299559 17.40733 16.57208 17.0299 0 0 0 0 0 0 0 0 0 16.94741 17.47795 17.11256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M27 PRRC1_HUMAN Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1) PRRC1 Homo sapiens (Human) activation of protein kinase A activity [GO:0034199] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; protein kinase A regulatory subunit binding [GO:0034237]; activation of protein kinase A activity [GO:0034199] protein kinase A regulatory subunit binding [GO:0034237] GO:0005737; GO:0005794; GO:0034199; GO:0034237 RQMIYSAAR 14.35999966 0.359621167 0.359621167 0.256020824 1112.894134 0 15.70256 16.98563 14.16245 14.61491 13.55186 15.5804 13.13166 11.66718 0 15.93579 14.59568 15.48501 15.59672 10.15784 0 0 12.9937 0 0 0 0 15.58458 0 0 0 16.11257 0 0 13.51349 0 0 0 0 0 0 16.16764 16.37791 0 0 0 0 0 0 0 0 14.078 15.55801 Q96M29 TEKT5_HUMAN Tektin-5 TEKT5 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] GO:0005634; GO:0015630; GO:0036126; GO:0060271; GO:0060294 KTFPCTPR 4.929999828 1 1 0.218126106 1005.980016 14.4609 17.32217 17.00667 16.59394 17.71229 0 0 0 17.24352 0 0 0 0 16.5486 0 0 0 0 0 0 0 16.94865 0 0 18.34565 17.35108 0 0 0 0 0 0 0 17.40797 0 0 0 0 0 0 0 0 0 0 0 0 0 16.78817 Q96M32 KAD7_HUMAN "Adenylate kinase 7, AK 7, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 7)" AK7 Homo sapiens (Human) cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550] GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0009142; GO:0030030; GO:0031514 DLTQDCLDHLLVNLR 6.25 1 1 0.339751528 1824.034605 15.16489 0 17.31573 15.03545 13.79229 16.31064 0 15.32664 15.10646 16.3669 0 13.40124 0 0 0 0 14.95653 0 0 0 0 0 0 17.83603 15.27172 0 15.57095 0 0 17.12325 0 0 16.13856 0 17.00275 16.78651 16.1952 0 0 0 0 15.52936 15.0559 0 0 0 16.22049 0 Q96M34 TEX55_HUMAN "Testis-specific expressed protein 55 (Testis-specific conserved, cAMP-dependent type II PK-anchoring protein)" TEX55 C3orf30 TSCPA Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 RSSEK 7.449999809 0.516742408 0.516742408 0.279718439 605.7543211 15.27665 14.94312 15.23776 15.74059 14.28916 14.06102 16.73602 15.44171 14.84994 0 0 14.60739 15.88996 12.9158 15.09819 13.86919 16.45325 17.49912 17.05058 16.51284 16.77905 0 15.55075 15.7735 16.26142 15.57061 16.87707 16.55564 14.8246 17.16501 16.31276 15.60185 16.04862 17.24322 0 0 18.11856 16.32958 17.96184 0 16.96916 18.10288 16.74235 16.83447 16.47292 16.99604 17.70915 16.72307 Q96M42 CU129_HUMAN Putative uncharacterized protein encoded by LINC00479 LINC00479 C21orf129 PRED76 Homo sapiens (Human) KSGSTGNICSVMLNVATGCVR 9.319999695 1 1 0.38963033 2212.428633 14.84492 15.07709 16.20256 18.34293 0 0 0 0 0 0 0 0 0 0 20.49862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M53 TBATA_HUMAN "Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus, brain and testes-associated protein)" TBATA C10orf27 SPATIAL Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] ciliary basal body [GO:0036064]; cytosol [GO:0005829] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005829; GO:0007283; GO:0030154; GO:0036064 ATDVQLADYPLMSPKAELK 10.73999977 1 1 0.04243748 2105.789084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.65382 0 15.24793 0 0 0 14.57329 0 0 0 0 0 0 12.73555 14.54184 0 13.74072 0 0 14.83593 0 0 0 13.28023 0 12.18138 0 0 0 0 0 15.01547 Q96M60 F227B_HUMAN Protein FAM227B FAM227B C15orf33 Homo sapiens (Human) AGPGK 2.119999886 5.94E-05 5.94E-05 0.264537566 428.7490405 0 21.3618 20.27014 0 0 18.05683 16.46176 0 0 18.33824 20.51941 17.62313 17.98331 0 17.02871 21.5129 0 0 0 0 0 19.38122 0 22.03967 0 21.63684 0 0 0 19.34237 0 18.73886 16.09705 18.31839 0 21.05051 19.92652 0 0 22.17628 0 0 20.80024 0 0 0 20.70973 17.64501 Q96M63 ODAD1_HUMAN Outer dynein arm-docking complex subunit 1 (Coiled-coil domain-containing protein 114) ODAD1 CCDC114 Homo sapiens (Human) cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cilium [GO:0005929]; outer dynein arm [GO:0036157] axoneme [GO:0005930]; cilium [GO:0005929]; outer dynein arm [GO:0036157]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0005929; GO:0005930; GO:0036157; GO:0036158 AKMGLLR 13.78999996 1 1 1.03E-12 803.8229032 0 14.69178 13.0968 15.82991 0 13.50683 0 14.16183 15.08326 0 0 0 15.03947 0 14.04645 0 0 11.8429 0 10.82847 16.33077 13.43612 16.12156 17.12136 0 13.70968 14.46541 0 0 0 15.76548 0 0 0 0 0 16.28654 0 0 0 0 0 0 11.20461 0 0 0 0 Q96M69 LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein LRGUK Homo sapiens (Human) axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177] acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385] GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995 YILVVPMNKEK 9.710000038 0.408554167 0.408554167 0.328554716 1332.914364 13.00873 14.55277 12.13382 15.44825 0 13.94606 0 0 0 14.68261 13.72157 15.91484 15.45197 13.72649 0 0 0 0 15.5824 0 0 0 0 0 0 17.37987 18.06184 15.0901 15.20401 0 15.98974 0 10.75176 0 0 0 0 0 15.39518 0 0 16.82635 0 0 16.20189 0 16.68193 15.293 Q96M83 CCDC7_HUMAN Coiled-coil domain-containing protein 7 (Protein BIOT2) CCDC7 BIOT2 C10orf68 Homo sapiens (Human) DIIKGPISAQLK 7.619999886 0.624375463 0.624375463 0.427916027 1283.995892 14.77192 0 14.80134 14.15295 13.11167 17.09624 0 15.36317 15.70475 0 0 0 14.91864 0 16.11356 0 0 0 0 0 16.71721 0 14.76596 0 16.9027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M86 DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35) DNHD1 C11orf47 CCDC35 DHCD1 DNHD1L UNQ5781/PRO12970 Homo sapiens (Human) cilium movement [GO:0003341]; microtubule-based movement [GO:0007018] dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156] dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0005524; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0070062 ALARGLVR 7.099999905 1 1 0.144685359 854.3817727 0 12.93914 15.40037 0 12.39455 14.42395 13.99179 15.77359 14.17127 15.22935 12.5129 12.45872 0 0 15.35792 0 0 14.92241 10.27036 0 0 0 0 14.0082 0 0 0 0 0 0 0 0 14.73682 0 0 0 16.21801 0 0 0 0 16.22868 0 0 0 16.57747 0 0 Q96M89 CC138_HUMAN Coiled-coil domain-containing protein 138 CCDC138 Homo sapiens (Human) FLSTLIVLK 3.460000038 0.30627802 0.30627802 0.062484143 1033.335746 14.26096 15.61067 16.29324 0 14.11428 14.4555 13.3714 0 14.97675 16.20331 0 0 0 14.75426 0 12.44355 15.00901 0 0 0 0 0 13.77214 15.07127 14.89492 16.2687 15.18846 15.4511 14.11029 0 13.80558 0 0 0 0 0 13.45873 0 0 0 0 0 0 0 0 0 0 0 Q96M91 CFA53_HUMAN Cilia- and flagella-associated protein 53 (Coiled-coil domain-containing protein 11) CFAP53 CCDC11 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] cilium [GO:0005929]; extracellular region [GO:0005576] cilium [GO:0005929]; extracellular region [GO:0005576]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] GO:0003341; GO:0005576; GO:0005929; GO:0007368; GO:0060271; GO:0060287 HNAILASIK 4.110000134 0.236725301 0.236725301 0.139325636 966.9403302 0 0 15.29735 0 17.4931 13.077 0 0 0 0 0 16.28139 0 0 12.50727 0 10.79827 0 0 12.00067 0 0 0 16.80621 0 0 15.32508 0 14.61831 7.219273 18.2858 0 0 17.1788 0 13.49214 0 18.76105 0 16.22642 0 16.97892 17.38953 16.52481 0 17.38006 0 0 Q96M93 ADAD1_HUMAN Adenosine deaminase domain-containing protein 1 (Testis nuclear RNA-binding protein) ADAD1 TENR Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286] double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251] GO:0003725; GO:0003726; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0007286; GO:0008251 DGVNRISSMSSSDK 1.850000024 1 1 0.551822531 1499.945026 17.44725 0 0 0 0 0 0 0 0 0 0 0 0 0 17.53034 15.94228 0 0 16.35553 0 15.26489 17.43754 0 0 17.84911 0 0 0 0 0 0 0 0 18.58582 0 0 0 0 0 0 0 17.50191 0 0 0 0 0 0 Q96M95 CCD42_HUMAN Coiled-coil domain-containing protein 42 CCDC42 CCDC42A Homo sapiens (Human) spermatid development [GO:0007286] spermatid development [GO:0007286] GO:0007286 TLLLGTIK 6.159999847 1 1 0.151130512 857.3297246 11.80649 0 14.46269 0 0 0 0 0 0 0 0 0 0 0 0 0 15.42812 0 0 0 0 0 0 0 0 0 0 0 0 0 14.77326 0 0 0 0 0 14.96195 16.48502 16.54133 16.6365 0 16.56537 0 0 0 0 0 0 Q96MC4 C295L_HUMAN CEP295 N-terminal-like protein (KIAA1731 N-terminal like protein) CEP295NL KIAA1731NL Homo sapiens (Human) regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule binding [GO:0008017]; regulation of centriole replication [GO:0046599] microtubule binding [GO:0008017] GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0008017; GO:0046599 MADPEMLPAGEPR 14.61999989 1 1 0.447801214 1445.212977 0 0 9.535025 0 0 0 0 0 0 15.37691 0 0 13.42406 0 15.26308 13.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67867 0 0 16.64168 0 0 0 16.31113 0 0 15.35607 0 0 17.06212 0 0 Q96MD7 CI085_HUMAN Uncharacterized protein C9orf85 C9orf85 Homo sapiens (Human) FDKSVQTK 3.369999886 1 1 2.30E-13 952.5513848 16.07612 15.62749 13.58902 0 0 0 13.31461 0 14.97156 0 0 14.83119 0 13.69727 0 0 9.837444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ME7 ZN512_HUMAN Zinc finger protein 512 ZNF512 KIAA1805 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 KHMENCK 5.309999943 1 1 0.316913435 946.2989553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MF0 YO028_HUMAN Putative uncharacterized protein LOC100506887 Homo sapiens (Human) MPFKTK 21.36000061 0.363423705 0.363423705 0.184147688 751.4748956 19.0862 15.69012 15.35528 17.3869 15.3552 14.27156 15.17885 16.11678 14.83643 16.24649 17.63544 0 14.31544 16.09641 15.11305 13.94382 17.5918 14.50751 0 15.86254 0 15.71145 16.54752 17.51145 15.45208 0 17.70963 19.92294 0 17.65857 0 14.58754 0 14.59737 0 0 0 0 0 17.97861 0 0 0 0 15.87233 18.95223 0 17.90121 Q96MF6 CQ10A_HUMAN "Coenzyme Q-binding protein COQ10 homolog A, mitochondrial" COQ10A UNQ6192/PRO20219 Homo sapiens (Human) cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744] ubiquinone binding [GO:0048039] GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039 SFMGFAAPFTNK 11.02000046 1 1 0.092116444 1313.603955 14.29942 0 12.99714 14.35231 12.22677 0 13.6995 13.3061 11.3745 0 12.54347 14.13404 0 15.13296 14.56055 9.308627 14.99741 0 0 13.64952 14.37599 9.655631 0 14.79402 14.92458 12.86664 0 13.62925 14.53667 14.35637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.69878 0 0 Q96MF7 NSE2_HUMAN "E3 SUMO-protein ligase NSE2, EC 2.3.2.- (E3 SUMO-protein transferase NSE2) (MMS21 homolog, hMMS21) (Non-structural maintenance of chromosomes element 2 homolog, Non-SMC element 2 homolog)" NSMCE2 C8orf36 MMS21 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]" SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016604; GO:0016605; GO:0016925; GO:0019789; GO:0030915; GO:0032204; GO:0034184; GO:0045842; GO:0051301; GO:0061665; GO:0090398 KSDLIQDEALR 24.40999985 1 1 0.264579042 1287.891749 17.8918 21.65588 20.89721 20.67719 21.46579 21.27564 17.57216 19.40845 21.09014 20.66092 21.37836 0 20.21671 19.87253 20.21438 19.18151 21.12086 20.70384 19.41602 0 19.05863 0 0 17.538 20.95082 21.03233 19.75466 18.80599 0 19.17148 20.9283 20.66885 20.1857 0 0 21.42854 0 20.24581 0 19.99237 20.49204 21.48476 19.89378 0 19.85573 0 0 20.85984 Q96MG7 NSE3_HUMAN "Non-structural maintenance of chromosomes element 3 homolog, Non-SMC element 3 homolog (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2)" NSMCE3 HCA4 MAGEG1 NDNL2 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of growth [GO:0040008]; regulation of telomere maintenance [GO:0032204] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; protein dimerization activity [GO:0046983]; cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of growth [GO:0040008]; regulation of telomere maintenance [GO:0032204]" protein dimerization activity [GO:0046983] GO:0000122; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0016925; GO:0030915; GO:0031398; GO:0032204; GO:0034644; GO:0040008; GO:0046983; GO:0071478; GO:0072711 RLGVYPTK 2.880000114 1 1 0.141757631 932.0808388 0 0 0 14.50559 14.73375 0 14.85262 0 0 0 14.17047 0 15.61598 0 0 12.84291 0 0 0 0 0 16.47548 0 0 0 0 14.39219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54201 0 0 0 0 0 Q96MH2 HEXI2_HUMAN Protein HEXIM2 (Hexamethylene bis-acetamide-inducible protein 2) HEXIM2 L3 Homo sapiens (Human) "negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]" 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069] GO:0000122; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0017069; GO:0042802; GO:0045736; GO:0045892; GO:0097322 MESHSEDEDLAGAVGGLGWNSR 11.64000034 1 1 0.408056134 2331.873778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22.83713 0 21.32719 0 0 0 0 0 0 0 21.69984 0 0 0 22.64508 0 0 0 22.45814 0 0 Q96MI6 PPM1M_HUMAN "Protein phosphatase 1M, EC 3.1.3.16 (Protein phosphatase 2C isoform eta, PP2C-eta, PP2CE)" PPM1M PPM1E Homo sapiens (Human) protein dephosphorylation [GO:0006470] nucleus [GO:0005634] nucleus [GO:0005634]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470] manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005634; GO:0006470; GO:0030145 SPARGR 6.550000191 0.570306182 0.570306182 0.261725235 643.6996447 14.38591 0 15.77094 16.26879 15.20205 15.3108 16.83072 15.18501 15.73814 13.7806 15.39211 15.45403 15.64489 14.80354 0 15.86465 15.72686 15.81678 16.66978 15.99403 15.43433 14.76811 16.12598 16.68863 16.24285 15.35302 14.595 16.30449 16.43354 16.07728 16.37846 0 17.08568 0 15.90846 14.97959 15.61575 16.44467 0 15.88966 15.88096 0 15.28797 0 17.00903 15.99438 14.87994 16.06119 Q96MK2 RIPR3_HUMAN RIPOR family member 3 RIPOR3 C20orf175 C20orf176 FAM65C Homo sapiens (Human) SASFAGFSSAQSR 7.480000019 0.254267275 0.254267275 0.364898866 1302.169447 11.80313 14.10605 0 15.97878 15.23419 15.64136 16.35643 15.50209 14.41255 14.14779 14.59169 13.63445 0 0 0 0 0 0 0 15.97394 0 0 0 0 0 15.8819 0 0 0 0 0 0 0 0 0 16.63044 0 16.711 0 0 0 0 0 0 0 0 0 0 Q96MM3 ZFP42_HUMAN "Zinc finger protein 42 homolog, Zfp-42 (Reduced expression protein 1, REX-1, hREX-1) (Zinc finger protein 754)" ZFP42 REX1 ZNF754 Homo sapiens (Human) female gonad development [GO:0008585]; male gonad development [GO:0008584]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0003700; GO:0005667; GO:0005737; GO:0006357; GO:0008584; GO:0008585; GO:0031519; GO:0046872; GO:0051321; GO:1990837 KPPINK 13.81000042 0.265909225 0.265909225 0.300203799 695.9420784 19.7343 0 18.32492 0 0 0 18.67646 16.91716 17.31181 15.67115 0 0 0 0 0 0 0 0 0 18.65884 18.60261 0 19.37976 0 18.90226 19.67797 0 0 17.77996 19.75504 0 20.10801 0 0 0 0 0 0 0 0 0 0 19.08549 0 17.90214 0 19.76243 19.88579 Q96MM6 HS12B_HUMAN Heat shock 70 kDa protein 12B HSPA12B C20orf60 Homo sapiens (Human) ATP binding [GO:0005524] ATP binding [GO:0005524] GO:0005524 WEGGDPGVAHQK 3.950000048 0.895786643 0.895786643 0.226952968 1280.365041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76779 0 0 14.78449 15.1463 0 15.69894 14.9524 14.98478 0 13.67645 14.84224 14.22452 0 14.91226 0 12.70035 0 0 0 14.55184 0 0 0 0 0 0 0 16.09016 0 0 0 0 0 Q96MN2 NALP4_HUMAN "NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58, CT58) (PAAD and NACHT-containing protein 2, PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4, PYPAF4) (Ribonuclease inhibitor 2)" NLRP4 NALP4 PAN2 PYPAF4 RNH2 Homo sapiens (Human) inflammatory response [GO:0006954] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; inflammatory response [GO:0006954] ATP binding [GO:0005524] GO:0005524; GO:0005829; GO:0006954 DQVTISEIYQPR 8.100000381 1 1 0 1449.421404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.245988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.91242 0 0 0 0 0 0 12.74121 0 Q96MN9 ZN488_HUMAN Zinc finger protein 488 ZNF488 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0006355; GO:0014003; GO:0031643; GO:0045892; GO:0046872; GO:0048714 QSAFTELPRMK 8.520000458 1 1 4.58E-13 1307.328855 14.33727 13.98183 12.1881 0 12.50841 15.12646 0 0 14.35796 11.06763 16.01338 0 0 0 15.34789 0 0 0 0 0 0 0 0 13.05232 0 16.51154 0 0 15.12828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.06167 0 0 13.86987 Q96MR6 CFA57_HUMAN Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65) CFAP57 WDR65 Homo sapiens (Human) AQVMLELKTR 4.46999979 0.583907187 0.583907187 0.185332644 1203.624558 15.07876 0 18.25908 14.02294 14.94708 13.9596 0 13.59445 0 14.91021 15.77621 13.00269 0 0 0 0 0 0 0 15.20723 0 14.15367 13.73762 0 15.1538 14.52047 0 0 15.00816 12.09485 16.28362 17.26868 16.02321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.27772 Q96MS0 ROBO3_HUMAN Roundabout homolog 3 (Roundabout-like protein 3) ROBO3 Homo sapiens (Human) axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell adhesion mediator activity [GO:0098632] GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016199; GO:0030424; GO:0070593; GO:0098632 GDPPPRLR 4.150000095 0.109690495 0.109690495 0.234588331 906.6513452 18.78382 0 0 15.80429 16.24405 14.68784 0 0 0 0 0 0 0 16.78913 0 16.01426 0 15.60789 0 16.93089 16.38348 17.65294 19.10637 18.60865 0 0 16.81487 16.99573 0 0 0 0 0 0 0 0 0 0 16.9062 0 15.50737 17.99919 15.92531 15.95365 16.45856 0 16.15903 15.94665 Q96MS3 GL1D1_HUMAN "Glycosyltransferase 1 domain-containing protein 1, EC 2.4.-.-" GLT1D1 Homo sapiens (Human) cytosol [GO:0005829]; extracellular region [GO:0005576] cytosol [GO:0005829]; extracellular region [GO:0005576]; glycosyltransferase activity [GO:0016757] glycosyltransferase activity [GO:0016757] GO:0005576; GO:0005829; GO:0016757 FAVAFTESMK 6.25 0.393981189 0.393981189 0.214677188 1131.212627 10.50871 0 16.55478 16.07738 0 17.68946 9.540174 14.37884 11.08865 0 12.74292 12.37299 14.87139 13.97687 14.08461 15.90031 9.926808 14.94664 0 0 0 14.36174 0 15.59133 0 0 13.37467 0 0 0 0 14.97242 0 0 0 0 10.8616 0 0 0 0 15.5507 0 13.89018 0 0 0 0 Q96MT3 PRIC1_HUMAN Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1) PRICKLE1 RILP Homo sapiens (Human) "aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] "cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" zinc ion binding [GO:0008270] GO:0001843; GO:0005634; GO:0005829; GO:0006606; GO:0008270; GO:0031398; GO:0031965; GO:0032436; GO:0035904; GO:0045892; GO:0060071; GO:0060976; GO:0090090; GO:2000691 PLEMEPK 3.49000001 0.199386984 0.199386984 0.244014496 858.9934692 16.21183 0 0 16.36863 14.50075 15.1322 15.5754 0 17.60842 16.5935 0 16.1681 0 13.67817 0 16.78478 0 0 0 0 14.19031 0 17.31105 14.21408 16.2043 14.59103 17.04093 15.63196 15.52208 15.04523 0 16.22048 0 0 0 16.3338 16.35838 18.84142 16.13572 0 17.24404 17.47237 17.22668 0 0 0 15.08282 15.55901 Q96MT7 CFA44_HUMAN Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) CFAP44 WDR52 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; peptidase activity [GO:0008233]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288] peptidase activity [GO:0008233] GO:0000226; GO:0005737; GO:0005856; GO:0007288; GO:0008233; GO:0031514; GO:0060271; GO:0060285 AFSQEVFK 8.279999733 1 1 0.569080564 955.6071891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38788 0 0 0 0 16.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MT8 CEP63_HUMAN "Centrosomal protein of 63 kDa, Cep63" CEP63 Homo sapiens (Human) cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; spindle pole [GO:0000922]; cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225] GO:0000077; GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0042770; GO:0051225; GO:0051301; GO:0098535 MEAHNNEYK 3.25 1 1 0.115718311 1136.559402 15.57339 0 0 14.61357 13.67823 13.57509 0 0 0 13.5684 9.352005 0 0 0 14.22485 0 0 0 0 0 0 0 12.80575 0 15.34901 13.68716 12.58686 0 14.66097 0 0 0 0 0 14.32651 0 14.17824 15.37862 0 0 15.74553 0 0 0 0 0 0 16.07968 Q96MU6 ZN778_HUMAN Zinc finger protein 778 ZNF778 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 SFTVSSSLTEHAR 12.64999962 1 1 0.124124011 1422.086904 16.11586 14.98803 13.21135 13.94357 0 0 0 14.94287 0 0 0 0 15.89943 0 0 15.61902 0 0 16.58302 16.29692 0 0 15.88121 0 16.99223 0 16.08562 15.17566 14.78862 14.98215 10.78797 14.73617 0 14.97412 17.05251 0 0 15.72943 15.77616 15.4628 16.74524 16.35498 16.08518 14.97084 16.64384 15.60901 0 17.1319 Q96MU7 YTDC1_HUMAN "YTH domain-containing protein 1 (Splicing factor YT521, YT521-B)" YTHDC1 KIAA1966 YT521 Homo sapiens (Human) "dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; posttranscriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; posttranscriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]" mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723] GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247 MLGGVFK 13.90999985 1 1 0.025875307 767.4560281 16.14824 0 13.11857 0 0 0 16.13992 15.65236 0 0 15.33496 15.05501 14.61447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MU8 KREM1_HUMAN Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose) KREMEN1 KREMEN KRM1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] GO:0005886; GO:0006915; GO:0007154; GO:0016020; GO:0016021; GO:0016055; GO:0030279; GO:0043025; GO:0048681; GO:0060173; GO:0060828; GO:0090090 NPLVSD 2.289999962 1 1 0.130850218 642.7182698 16.42447 18.71486 0 0 0 15.90085 14.99204 11.89684 16.88012 14.81055 0 14.07407 0 0 0 13.11387 16.86379 16.59516 17.34129 14.91324 0 15.13157 17.52422 15.67269 15.67394 0 15.34814 14.48762 13.21573 0 0 0 0 17.95175 16.81943 0 0 0 17.85474 0 17.76383 16.36201 0 0 15.77285 16.6316 0 15.04293 Q96MV8 ZDH15_HUMAN "Palmitoyltransferase ZDHHC15, EC 2.3.1.225 (Acyltransferase ZDHHC15, EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15, DHHC-15)" ZDHHC15 UNQ1969/PRO4501 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008270; GO:0014069; GO:0016188; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030173; GO:0061001; GO:0062237; GO:0072657; GO:0098794; GO:0140439; GO:0140450; GO:1900006 GELPSVR 1.379999995 0.029039923 0.029039923 0.304739435 756.9378439 0 16.30906 0 0 13.49195 15.33303 0 14.92551 0 15.56895 0 13.2282 0 14.19905 15.18965 0 0 0 0 16.88288 14.59474 0 15.51577 0 0 15.71618 0 0 0 0 15.36713 16.20959 0 0 0 0 0 16.86918 0 0 0 15.37879 0 15.59275 0 0 0 0 Q96MX3 ZNF48_HUMAN Zinc finger protein 48 (Zinc finger protein 553) ZNF48 ZNF553 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042802; GO:0046872 ARPPAQGPPK 22.81999969 1 1 0.038583156 1021.041154 0 0 15.80911 0 14.37932 14.73996 0 14.90255 14.56322 15.20602 14.23815 0 0 0 16.30211 0 15.86099 0 0 0 0 0 15.5158 0 0 0 0 0 0 0 0 0 0 15.41236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MX6 DAA10_HUMAN Dynein axonemal assembly factor 10 (WD repeat-containing protein 92) (WD repeat-containing protein Monad) DNAAF10 WDR92 Homo sapiens (Human) apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821] dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821] ubiquitin binding [GO:0043130] GO:0006915; GO:0043130; GO:0050821; GO:0070286; GO:0120293; GO:1990062 VLIVTKLNK 3.720000029 1 1 0.127030006 1027.308142 14.85371 15.31106 13.68243 13.1191 0 0 0 0 0 13.85074 0 0 11.23077 14.4425 13.64334 12.83969 14.9436 13.94839 16.82441 0 13.05476 13.96887 16.42262 15.46969 11.51927 13.59502 13.55678 14.04194 14.0713 15.50981 0 0 0 0 0 15.7664 0 0 0 15.22455 0 15.03458 0 0 0 0 0 0 Q96MY1 NOL4L_HUMAN Nucleolar protein 4-like NOL4L C20orf112 C20orf113 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 LPPATALGTASYPSDGCGADGLR 12.77999973 1 1 0.176480655 2246.052904 17.16512 15.96383 15.34541 13.48867 0 15.18026 0 15.76856 0 14.27299 13.92912 0 0 0 0 15.15665 14.25486 14.12705 0 0 0 0 15.16941 15.04735 0 14.7116 14.68658 0 0 0 0 0 0 13.78459 0 0 0 0 12.02116 0 0 0 0 0 0 12.58103 15.27635 0 Q96MY7 F161B_HUMAN Protein FAM161B FAM161B C14orf44 Homo sapiens (Human) cilium organization [GO:0044782] cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630] cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]; cilium organization [GO:0044782] GO:0005881; GO:0015630; GO:0044782 DRGMVQVQCPQALR 1.570000052 0.732243001 0.732243001 0.294748291 1657.801842 0 0 0 0 17.50346 9.185408 0 0 0 0 0 0 0 0 0 14.05886 0 0 0 0 0 0 0 0 0 0 17.09204 16.31913 16.16487 15.88612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MZ4 F218A_HUMAN Protein FAM218A FAM218A C4orf39 Homo sapiens (Human) HGSVSLLR 23.03000069 1 1 0.285731619 869.6952623 0 0 0 0 16.84177 16.85592 0 0 18.9632 18.17405 0 0 0 0 0 0 16.95985 0 0 0 16.49126 18.07749 0 0 20.69605 0 0 0 0 0 19.46738 0 0 0 0 0 0 0 0 18.62187 16.61959 0 0 0 0 0 18.70428 0 Q96N16 JKIP1_HUMAN "Janus kinase and microtubule-interacting protein 1 (GABA-B receptor-binding protein) (Multiple alpha-helices and RNA-linker protein 1, Marlin-1)" JAKMIP1 GABABRBP JAMIP1 MARLIN1 Homo sapiens (Human) cognition [GO:0050890]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; microtubule [GO:0005874]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; microtubule [GO:0005874]; ribonucleoprotein complex [GO:1990904]; GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; cognition [GO:0050890]; protein transport [GO:0015031] GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005874; GO:0008017; GO:0015031; GO:0019898; GO:0019900; GO:0050811; GO:0050890; GO:1990904 LQVLEQQHVIDDLSLER 12.30000019 1 1 2.34E-13 2035.443352 0 0 20.74082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.83582 0 0 0 0 0 0 0 0 20.04074 0 0 0 0 0 0 0 0 0 0 0 18.04381 0 Q96N22 ZN681_HUMAN Zinc finger protein 681 ZNF681 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 NIHTEEKPYK 3.390000105 1 1 0.090271811 1259.764841 14.56069 14.11712 0 14.10882 14.92865 13.63378 13.82529 14.83482 12.14112 13.54432 0 15.26612 0 0 14.62539 0 14.79238 0 15.2244 14.89135 0 0 0 13.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.17492 0 0 Q96N23 CFA54_HUMAN Cilia- and flagella-associated protein 54 CFAP54 C12orf55 C12orf63 Homo sapiens (Human) cell differentiation [GO:0030154]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; mucociliary clearance [GO:0120197]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] axoneme [GO:0005930]; extracellular region [GO:0005576]; cell differentiation [GO:0030154]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; mucociliary clearance [GO:0120197]; spermatogenesis [GO:0007283] GO:0005576; GO:0005930; GO:0007283; GO:0030154; GO:0060271; GO:0060294; GO:0090660; GO:0120197 ATGKMK 5.309999943 1 1 0.06242876 650.5503226 17.21886 13.44566 14.67522 16.39196 13.55424 14.97357 16.85834 0 15.01051 16.39011 14.50055 14.15882 17.0173 18.12155 15.97101 12.57138 15.698 0 0 13.40522 0 16.78712 0 0 13.90797 15.42403 15.28017 17.52779 9.956991 0 17.74165 16.27856 15.94747 15.35768 15.11737 0 15.22394 17.66363 15.80171 16.20956 0 16.60377 16.59068 15.52992 13.48338 15.26148 0 17.96116 Q96N38 ZN714_HUMAN Zinc finger protein 714 ZNF714 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 AFNVSSHLTTHK 10.43000031 0.428289771 0.428289771 0.362336564 1342.925028 15.23365 16.2815 0 0 0 0 15.31606 0 0 0 0 0 0 15.95044 0 0 15.00374 12.08005 17.48193 0 18.08797 0 16.65868 0 15.28273 16.41427 17.01346 15.51949 17.10493 17.45655 17.86994 16.80376 17.51921 0 17.70446 0 16.71884 17.0616 15.47747 17.79283 16.95245 18.2257 0 0 17.4371 15.35335 18.89643 17.30921 Q96N64 PWP2A_HUMAN PWWP domain-containing protein 2A PWWP2A KIAA1935 MST101 Homo sapiens (Human) "negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription, initiation [GO:2000142]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription, initiation [GO:2000142]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325] GO:0003682; GO:0005634; GO:0032968; GO:0035064; GO:0035067; GO:0042393; GO:0120325; GO:1901675; GO:2000142; GO:2000616 EVLKIAK 16.62999916 0.031974386 0.031974386 0.290060946 801.3333981 0 0 0 9.963675 15.50163 14.07105 0 0 0 0 0 16.60207 15.95502 16.06871 16.27481 15.7303 0 17.48297 16.52612 19.27014 17.44145 16.64483 0 0 17.12988 0 15.88942 15.1475 17.46413 16.57711 16.60084 15.03441 16.83203 0 16.97215 17.57082 17.47535 19.08789 17.51112 17.74229 17.38736 17.7126 17.25492 17.85502 17.93173 17.6417 18.27935 17.34514 Q96N66 MBOA7_HUMAN "Lysophospholipid acyltransferase 7, LPLAT 7, EC 2.3.1.- (1-acylglycerophosphatidylinositol O-acyltransferase) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase, LPIAT, Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7, O-acyltransferase domain-containing protein 7, h-mboa-7)" MBOAT7 BB1 LENG4 OACT7 Homo sapiens (Human) layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374]; layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374] GO:0003841; GO:0005783; GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0016021; GO:0016746; GO:0021591; GO:0021819; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0047144; GO:0071617; GO:0090207 KEMASGFSK 6.920000076 1 1 5.72E-13 984.0223774 14.8806 0 9.979915 13.36217 14.99046 15.23707 15.89442 13.77852 15.41308 0 13.14361 16.22386 0 13.84267 13.6353 0 14.84968 12.741 0 0 0 0 0 14.06725 14.79309 0 0 0 0 14.5483 0 0 0 0 0 0 0 0 0 0 0 0 16.1166 0 0 0 0 0 Q96N67 DOCK7_HUMAN Dedicator of cytokinesis protein 7 DOCK7 KIAA1771 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264] axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005] axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0031267; GO:0033138; GO:0043005; GO:0043547; GO:0045178; GO:0045200; GO:0050767; GO:0090630; GO:0120163; GO:1904754 SMSIDDTPR 5.480000019 1 1 0.165141734 1036.793473 15.99779 15.87837 15.41392 14.99423 0 15.40171 0 0 14.48284 14.80016 12.94271 0 13.47858 15.41035 0 11.9132 10.56135 15.78468 0 0 0 0 15.1015 15.73567 15.92527 0 0 0 0 14.18619 13.92832 0 14.14696 9.489473 11.77434 13.93569 15.92057 0 0 9.021073 0 13.36459 0 0 0 0 0 0 Q96N76 HUTU_HUMAN "Urocanate hydratase, Urocanase, EC 4.2.1.49 (Imidazolonepropionate hydrolase)" UROC1 Homo sapiens (Human) histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] cytosol [GO:0005829] cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] urocanate hydratase activity [GO:0016153] GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557 LQYMDNIR 5.389999866 1 1 0.204614927 1069.644606 15.66819 12.91526 15.87359 14.78503 14.83179 11.99905 11.61776 14.94523 0 0 16.12791 0 16.16512 14.40887 0 0 17.354 15.24613 13.51108 0 15.0706 0 14.17938 0 0 15.46081 0 0 0 0 0 0 17.02707 17.22341 0 0 0 15.87284 0 0 13.6638 0 0 15.47338 0 0 15.23858 15.73002 Q96N87 S6A18_HUMAN Inactive sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3) SLC6A18 XTRP2 Homo sapiens (Human) amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725] amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293] GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015293; GO:0016324; GO:0031526; GO:0035725 LYPGWAR 9.529999733 1 1 0.021733812 863.5829876 0 0 0 0 0 0 0 0 11.00003 0 0 0 0 0 0 0 0 16.38564 18.74657 0 0 16.11697 16.13795 0 16.75686 0 0 0 0 0 0 0 16.31401 17.65241 16.29854 15.63269 16.30479 17.41886 0 17.36731 0 0 0 13.60792 0 11.12966 16.20675 16.33716 Q96N95 ZN396_HUMAN Zinc finger protein 396 (Zinc finger and SCAN domain-containing protein 14) ZNF396 ZSCAN14 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0042803; GO:0045892; GO:0046872; GO:0046982; GO:1990837 ELDGPK 5.130000114 1 1 0.146446162 657.5704652 15.15471 14.2964 16.55882 0 15.73966 0 0 13.49006 13.42509 0 0 0 0 16.68771 0 15.7619 0 0 17.02549 0 0 15.59676 0 16.38957 0 0 0 0 15.17613 15.73863 0 0 0 0 14.68609 0 0 0 0 0 0 16.70268 0 15.92478 14.59266 0 0 0 Q96N96 SPT13_HUMAN "Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2, Asef2)" SPATA13 Homo sapiens (Human) cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802] GO:0005085; GO:0005654; GO:0005737; GO:0005829; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0030334; GO:0032587; GO:0042802; GO:0046847; GO:0051056 DCNLSVKNAFK 6.090000153 0.003523319 0.003523319 0.406997001 1295.487944 17.074 16.85986 0 0 16.51261 0 0 0 0 0 0 0 0 16.61971 0 17.73009 16.24041 0 0 16.08237 0 0 0 0 0 0 0 0 0 0 18.39173 17.14493 18.25139 0 18.22298 0 0 16.62348 0 0 17.8727 0 0 0 0 0 0 0 Q96NA8 TSNA1_HUMAN t-SNARE domain-containing protein 1 TSNARE1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0048278 ALLPMAQRGSK 5.309999943 0.135168165 0.135168165 0.055749564 1188.166617 11.4787 16.71837 0 0 14.50441 12.44952 0 0 10.14005 13.73997 0 12.99162 14.72643 0 0 0 14.22527 0 0 0 0 0 10.71721 15.54472 0 12.39393 0 0 0 0 0 0 0 0 0 13.16597 0 0 14.51335 15.00612 0 15.4889 13.73123 0 16.55368 17.54552 14.98795 17.77832 Q96NB1 CEP20_HUMAN Centrosomal protein 20 (FGFR1OP N-terminal-like protein) (FOP-related protein of 20 kDa) (LisH domain-containing protein FOPNL) CEP20 C16orf63 FOPNL FOR20 PHSECRG2 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453] identical protein binding [GO:0042802] GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0031514; GO:0034451; GO:0034453; GO:0036064; GO:0042802; GO:0060271 GPSLQPSDPSLGR 8.960000038 1 1 0.207050603 1307.899844 15.38842 14.67622 0 0 0 0 0 16.84361 0 0 0 0 0 0 0 0 0 0 17.81134 0 17.55766 0 0 0 14.67811 0 0 0 16.77405 0 0 0 0 17.29611 0 0 0 0 0 0 0 15.22485 0 0 0 0 0 17.0703 Q96NB2 SFXN2_HUMAN Sideroflexin-2 SFXN2 Homo sapiens (Human) mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300] serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857] GO:0005739; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542 MNVIGR 19.45000076 1 1 0.201774274 689.4484564 0 0 0 18.30636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.97296 0 0 0 18.79525 0 0 0 0 0 0 0 0 0 18.75161 0 Q96NB3 ZN830_HUMAN Zinc finger protein 830 (Coiled-coil domain-containing protein 16) ZNF830 CCDC16 Homo sapiens (Human) blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; replication fork protection [GO:0048478]; RNA splicing [GO:0008380] chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; replication fork protection [GO:0048478]; RNA splicing [GO:0008380] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0001541; GO:0001546; GO:0001832; GO:0003676; GO:0005634; GO:0005654; GO:0005681; GO:0005694; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0033260; GO:0033314; GO:0043066; GO:0044773; GO:0048478; GO:0051276; GO:0051301; GO:0060729 TPAGK 2.369999886 0.332477748 0.332477748 0.196090062 471.8981588 0 15.98972 0 15.83243 14.42552 0 17.12504 0 0 0 14.18129 15.54743 0 0 0 14.91916 0 15.35365 15.70197 0 0 16.74786 14.73121 16.68335 16.23173 0 0 0 0 0 0 0 0 15.76391 0 0 0 0 0 0 0 0 0 16.5736 0 0 0 0 Q96NC0 ZMAT2_HUMAN Zinc finger matrin-type protein 2 ZMAT2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]" DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0000398; GO:0003677; GO:0005634; GO:0008270; GO:0046540; GO:0071005 RAEEDLTFEEDDEMAAVMGFSGFGSTK 3.329999924 0.256569713 0.256569713 4.11E-12 2985.058377 0 0 0 0 0 0 10.70727 0 14.51993 10.23933 0 0 14.41896 14.95319 15.78993 14.59916 15.39552 0 12.18702 0 0 15.97585 0 0 15.28471 13.66952 0 0 0 15.29021 0 0 14.02565 17.96762 15.14084 16.08563 0 18.06229 16.28957 0 11.38285 16.36651 0 0 15.2722 17.62453 13.42936 15.15491 Q96NE9 FRMD6_HUMAN FERM domain-containing protein 6 (Willin) FRMD6 C14orf31 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; cellular protein localization [GO:0034613]; regulation of actin filament-based process [GO:0032970] apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; cellular protein localization [GO:0034613]; regulation of actin filament-based process [GO:0032970] GO:0003383; GO:0005737; GO:0005856; GO:0005886; GO:0031032; GO:0032970; GO:0034613; GO:0043296 ASGSSAGSMK 5.510000229 1 1 0.176397894 894.4047931 14.46515 15.08873 0 14.43685 14.84806 0 0 17.34652 0 15.50206 0 15.35011 0 13.68128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3881 14.75482 0 0 14.35273 0 0 0 13.86211 0 0 0 0 13.87274 0 0 15.12983 Q96NG3 ODAD4_HUMAN "Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25, TPR repeat protein 25)" ODAD4 TTC25 Homo sapiens (Human) brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229] GO:0003341; GO:0005576; GO:0005737; GO:0005930; GO:0007420; GO:0007507; GO:0030324; GO:0036158; GO:0060287; GO:0090660; GO:0097728; GO:0097729; GO:0120197; GO:0120228; GO:0120229 KTNYVENLK 7.010000229 1 1 0.133115757 1107.302922 0 0 0 0 0 0 11.69485 13.28752 14.73306 0 16.53615 11.05574 0 0 17.74494 13.07921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NG8 ZN582_HUMAN Zinc finger protein 582 ZNF582 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 TLSHDSTTVQPQR 4.300000191 1 1 0.401183993 1470.095535 0 17.89238 0 17.05505 17.26905 0 0 15.77511 0 0 0 0 18.00396 0 0 0 16.90414 0 0 0 0 0 16.06479 0 17.56278 0 0 14.89486 0 0 0 0 14.54029 0 0 0 0 15.21266 0 0 0 0 0 0 0 0 16.17447 0 Q96NH3 BROMI_HUMAN Protein broad-minded (TBC1 domain family member 32) TBC1D32 BROMI C6orf170 C6orf171 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] cilium [GO:0005929]; cytoplasm [GO:0005737] cilium [GO:0005929]; cytoplasm [GO:0005737]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007368; GO:0007507; GO:0042733; GO:0060021; GO:0060831; GO:0061512; GO:1905515 NIMIAVVESMINK 1.179999948 1 1 0.235278115 1478.301375 0 12.73043 14.33324 0 0 15.27423 0 0 0 0 0 14.79731 15.86501 0 0 15.07244 0 0 0 0 0 0 0 0 13.04489 0 15.43237 0 14.8537 0 0 16.10767 0 0 0 0 0 0 15.37807 0 15.30167 0 0 0 15.205 0 0 0 Q96NJ5 KLH32_HUMAN Kelch-like protein 32 (BTB and kelch domain-containing protein 5) KLHL32 BKLHD5 KIAA1900 Homo sapiens (Human) AVIDFLVKHLSELLK 6.619999886 1 1 9.17E-13 1723.967481 0 13.22181 14.45736 14.30725 15.89153 0 10.87763 12.65528 15.16588 0 0 0 13.02892 13.28399 14.87789 13.56481 0 14.62249 0 14.26846 0 15.50442 0 15.71295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NJ6 ZFP3_HUMAN "Zinc finger protein 3 homolog, Zfp-3 (Zinc finger protein 752)" ZFP3 ZNF752 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GTENKEVIPK 4.960000038 1 1 0.171210336 1113.583821 13.03805 12.7316 13.98756 0 15.08335 15.17946 0 16.17382 0 14.82499 0 0 0 0 14.30738 13.13502 0 0 15.43192 0 0 0 0 0 0 0 0 0 0 0 16.29022 0 15.88787 15.28994 0 14.67492 15.34056 12.46341 13.44532 12.08432 10.30455 10.56465 14.63488 0 0 11.70338 14.58097 14.32764 Q96NL0 RUN3B_HUMAN "RUN domain-containing protein 3B (Rap2-binding protein 9) (Rap2-interacting protein 9, RPIP-9)" RUNDC3B RPIB9 RPIP9 Homo sapiens (Human) SNDYLASPTTEMTSPGLTPS 7.519999981 0.315660506 0.315660506 0.136757839 2084.407469 15.37949 0 0 0 13.68509 0 0 0 12.99917 0 0 15.14407 14.68256 12.88254 14.22318 15.58456 0 14.44064 15.56727 16.22019 0 0 14.95928 14.97446 0 0 0 0 0 0 16.88859 0 0 0 0 0 15.78936 15.94874 14.88 15.17202 0 0 0 13.87033 0 0 0 0 Q96NL6 SCLT1_HUMAN Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1) SCLT1 SAP1 Homo sapiens (Human) cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; clathrin binding [GO:0030276]; protein C-terminus binding [GO:0008022]; sodium channel regulator activity [GO:0017080]; cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162] clathrin binding [GO:0030276]; protein C-terminus binding [GO:0008022]; sodium channel regulator activity [GO:0017080] GO:0005813; GO:0005814; GO:0005829; GO:0008022; GO:0017080; GO:0030276; GO:0045162; GO:0060271; GO:0071439; GO:0097539 LEEMHQR 12.14000034 1 1 0.125432327 943.501308 15.59748 16.22267 17.61813 15.4421 16.71367 15.01045 0 0 0 13.79641 15.35778 16.45245 0 0 16.95789 0 0 0 16.22458 19.96385 0 18.111 0 16.6524 19.16121 19.45143 18.11499 17.60919 18.67546 18.57422 17.53532 0 0 18.22117 17.46655 0 0 0 15.52323 17.75158 0 0 0 0 0 0 0 16.98892 Q96NR7 WWAS2_HUMAN Putative uncharacterized protein WWC2-AS2 (WWC2 antisense RNA 2) (WWC2 antisense gene protein 2) WWC2-AS2 C4orf38 Homo sapiens (Human) TSAETASR 6.090000153 0.306082189 0.306082189 0.215173181 822.4259193 0 16.49234 0 0 0 0 0 13.78664 15.49613 0 0 15.39237 0 0 17.36082 15.66263 0 16.36832 16.87259 16.71255 16.54242 14.93831 0 0 17.40392 15.85388 15.76089 14.36655 16.75923 15.0964 16.26859 17.33456 14.78593 17.23405 17.02897 16.01423 17.30351 16.74965 14.50303 16.09172 14.75328 17.1263 15.12973 10.5299 16.71401 16.93709 11.99669 16.29487 Q96NR8 RDH12_HUMAN "Retinol dehydrogenase 12, EC 1.1.1.300 (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2)" RDH12 SDR7C2 Homo sapiens (Human) cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342] endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650] GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095 MLVTLGLLTSFFSFLYMVAPSIR 3.779999971 1 1 5.47E-12 2622.898076 16.89122 0 0 12.09941 17.88364 0 19.53238 14.79131 12.68041 18.43681 15.99622 14.03078 0 0 0 17.03096 14.73647 0 0 11.1036 15.54523 13.45729 0 0 16.89274 19.00568 16.4703 16.51722 14.90523 15.5971 15.51537 17.41405 15.58429 15.19713 16.50219 17.2885 14.66252 16.58246 10.54406 16.1163 0 13.45922 0 15.01569 13.7112 16.28587 0 0 Q96NS8 CLUP3_HUMAN Putative protein CLUHP3 (Clustered mitochondria (cluA/CLU1) homolog pseudogene 3) (KIAA0664-like protein 3) CLUHP3 C16orf67 KIAA0664L3 Homo sapiens (Human) EPEGGRR 16.68000031 1 1 1.15E-13 801.1159298 0 14.77882 12.14441 0 16.25554 0 0 15.27487 14.29131 15.48996 12.04138 15.37842 9.451344 13.65046 0 0 0 0 14.48252 14.00799 0 0 0 14.24112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NT0 CC115_HUMAN Coiled-coil domain-containing protein 115 CCDC115 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; lysosome [GO:0005764]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase complex [GO:0016471] COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; lysosome [GO:0005764]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; unfolded protein binding [GO:0051082]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] unfolded protein binding [GO:0051082] GO:0005764; GO:0005768; GO:0005783; GO:0005793; GO:0006879; GO:0007042; GO:0016020; GO:0016471; GO:0030137; GO:0036295; GO:0042406; GO:0051082; GO:0070072; GO:1905146 QLEPGAA 3.059999943 0.905618906 0.905618906 0.237832332 686.254415 0 0 16.22342 15.40944 0 0 15.28499 0 0 0 16.37921 15.03958 0 0 16.3132 15.621 15.66191 14.92385 0 16.85577 16.55206 0 0 0 17.73079 15.35585 16.582 0 15.56066 15.25953 16.23475 16.45131 16.45655 0 0 0 0 16.10418 18.08945 15.58944 16.22412 0 16.85489 0 16.6683 17.62329 16.07929 18.24705 Q96NT3 GUCD1_HUMAN Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4) GUCD1 C22orf13 LLN4 Homo sapiens (Human) ACKVLVEK 8.039999962 0.573828936 0.573828936 0.29381743 947.1354319 0 18.46774 0 17.06507 0 0 0 21.44325 0 17.93489 18.84247 0 0 0 0 17.4287 0 18.1591 0 0 0 0 16.85111 17.76505 19.71168 0 0 0 0 16.52472 0 18.71216 19.13437 18.04295 0 20.07839 18.43199 22.71785 0 20.67165 16.54088 0 0 17.44409 0 0 0 0 Q96NW4 ANR27_HUMAN Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) ANKRD27 PP12899 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149] GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0016020; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0043231; GO:0045022; GO:0048812; GO:0050775; GO:0097422 MLAKQEAQMNLMK 4.949999809 1 1 0.120666664 1567.182647 15.76793 14.11986 0 0 15.7076 15.38576 15.61178 0 0 16.39924 16.92794 0 0 15.556 16.50441 15.61325 0 0 0 0 0 0 15.93189 0 0 0 0 0 0 0 0 16.59833 0 0 0 0 0 0 0 0 15.59556 0 0 0 0 0 0 0 Q96NW7 LRRC7_HUMAN "Leucine-rich repeat-containing protein 7 (Densin-180, Densin) (Protein LAP1)" LRRC7 KIAA1365 LAP1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120] axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; postsynaptic density [GO:0014069]; specific granule lumen [GO:0035580] axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; postsynaptic density [GO:0014069]; specific granule lumen [GO:0035580]; cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120] GO:0005576; GO:0005829; GO:0010976; GO:0014069; GO:0016323; GO:0030054; GO:0035580; GO:0043113; GO:0043194; GO:0045197; GO:0097120; GO:0098609 AGSHIQTLMGSQSLQHRSR 3.099999905 1 1 9.25E-13 2109.178845 16.26022 17.66921 16.59403 0 15.37259 16.08857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NX5 KCC1G_HUMAN "Calcium/calmodulin-dependent protein kinase type 1G, EC 2.7.11.17 (CaM kinase I gamma, CaM kinase IG, CaM-KI gamma, CaMKI gamma, CaMKIG) (CaMK-like CREB kinase III, CLICK III)" CAMK1G CLICK3 VWS1 Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000139; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005886; GO:0005954; GO:0018105; GO:0043005; GO:0106310 AGQTGVCLIM 3.410000086 0.384673566 0.384673566 0.175710724 1065.485429 16.01097 14.42203 17.77826 15.13279 17.5016 15.04194 0 15.4915 15.20042 15.80931 0 0 0 0 0 13.9517 13.76901 0 0 0 0 0 0 0 16.31268 0 13.53614 0 0 0 0 0 0 0 0 0 0 0 0 0 14.26404 0 0 0 14.0074 0 15.7293 14.90551 Q96NY7 CLIC6_HUMAN Chloride intracellular channel protein 6 (Parchorin) CLIC6 CLIC1L Homo sapiens (Human) chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; D2 dopamine receptor binding [GO:0031749]; D3 dopamine receptor binding [GO:0031750]; D4 dopamine receptor binding [GO:0031751]; voltage-gated ion channel activity [GO:0005244]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765] chloride channel activity [GO:0005254]; D2 dopamine receptor binding [GO:0031749]; D3 dopamine receptor binding [GO:0031750]; D4 dopamine receptor binding [GO:0031751]; voltage-gated ion channel activity [GO:0005244] GO:0005244; GO:0005254; GO:0005737; GO:0005886; GO:0006821; GO:0031749; GO:0031750; GO:0031751; GO:0034707; GO:0034765; GO:0070062 IEEFLEEK 6.670000076 1 1 0.12498726 1037.430674 15.83454 0 0 0 0 0 0 0 0 0 0 14.48878 0 0 15.99042 0 0 14.26235 0 0 0 0 0 0 0 14.07623 0 0 0 15.38572 0 0 0 0 10.26534 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P09 BIRC8_HUMAN "Baculoviral IAP repeat-containing protein 8 (Inhibitor of apoptosis-like protein 2, IAP-like protein 2, ILP-2) (Testis-specific inhibitor of apoptosis)" BIRC8 ILP2 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; regulation of cell cycle [GO:0051726] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0005634; GO:0005737; GO:0005876; GO:0031398; GO:0043027; GO:0043066; GO:0046872; GO:0051726; GO:0061630; GO:0090263 EISPEEPLRR 7.800000191 1 1 0.37849792 1226.652195 13.52337 0 0 0 12.55354 14.14402 0 0 15.2952 0 13.44475 13.5109 0 0 0 0 0 0 15.8872 0 0 0 0 0 0 0 0 0 15.91253 0 0 0 0 0 0 0 16.56006 0 0 0 16.04794 19.75795 0 0 0 0 16.03274 0 Q96P16 RPR1A_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein) RPRD1A P15RS Homo sapiens (Human) dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124] "nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]" "nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]" identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993] GO:0000993; GO:0005654; GO:0016591; GO:0031124; GO:0042802; GO:0070940 AKPNRK 1.539999962 1 1 0.240466522 714.0992464 0 0 15.462 0 0 14.48839 0 13.96099 15.20186 0 0 0 0 0 0 0 17.07731 0 17.00944 0 15.4818 16.89112 17.23105 15.85224 0 0 0 15.8274 0 0 0 0 14.24984 17.14588 0 15.34049 0 16.15292 0 0 0 0 0 0 0 0 0 0 Q96P20 NLRP3_HUMAN "NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1, CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)" NLRP3 C1orf7 CIAS1 NALP3 PYPAF1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; pyroptosis [GO:0070269]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; pyroptosis [GO:0070269]; signal transduction [GO:0007165] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; sequence-specific DNA binding [GO:0043565] GO:0000139; GO:0002221; GO:0002674; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0006952; GO:0006954; GO:0007165; GO:0007231; GO:0009595; GO:0032088; GO:0032691; GO:0032731; GO:0032753; GO:0042802; GO:0042834; GO:0043280; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050728; GO:0050729; GO:0051092; GO:0070269; GO:0071222; GO:0072559; GO:0098586; GO:0140297; GO:1901223; GO:2000553 EGRTNVPGSR 2.599999905 1 1 6.90E-13 1073.416024 8.450943 0 17.87431 14.94861 0 13.47638 14.97259 0 15.45348 0 0 0 0 15.0097 0 0 13.36897 0 0 0 0 0 13.06871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P26 5NT1B_HUMAN "Cytosolic 5'-nucleotidase 1B, cN1B, EC 3.1.3.5 (Autoimmune infertility-related protein) (Cytosolic 5'-nucleotidase IB, cN-IB)" NT5C1B AIRP FKSG85 Homo sapiens (Human) adenosine metabolic process [GO:0046085]; purine nucleotide catabolic process [GO:0006195] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; purine nucleotide catabolic process [GO:0006195] 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166] GO:0000166; GO:0000287; GO:0005634; GO:0005829; GO:0006195; GO:0008253; GO:0046085 LPSSSTSSR 5.75 1 1 0.121050325 921.479938 0 0 0 0 0 0 0 0 0 0 0 18.01985 15.81894 0 16.03431 0 0 17.61362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.52338 0 0 0 18.18726 17.32217 0 0 0 0 9.860026 0 0 13.03659 0 Q96P44 COLA1_HUMAN Collagen alpha-1(XXI) chain COL21A1 COL1AL FP633 Homo sapiens (Human) collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0005829; GO:0062023 GAIGSKGESGVDGLMGPAGPK 1.860000014 1 1 4.60E-13 1901.251101 14.00131 14.57073 15.86778 13.86809 12.04054 0 0 0 0 15.56112 0 15.94558 0 13.89626 16.05868 0 13.86879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P48 ARAP1_HUMAN "Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2, Cnt-d2)" ARAP1 CENTD2 KIAA0782 Homo sapiens (Human) actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; regulation of cellular component movement [GO:0051270]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; regulation of cellular component movement [GO:0051270]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]" "GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" GO:0005096; GO:0005547; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008360; GO:0030037; GO:0031410; GO:0032580; GO:0043231; GO:0043547; GO:0046872; GO:0051056; GO:0051270; GO:0051491; GO:0051497 AVTPNGEIR 7.920000076 0.986490011 0.986490011 0.242955938 960.429873 18.46446 15.3135 15.87025 18.41711 16.6517 14.90827 0 16.52092 0 16.00338 16.22032 15.03731 0 0 15.39423 14.30076 14.93498 15.17052 14.3065 15.83013 0 16.31094 14.26825 0 0 16.23204 0 16.58765 0 0 0 0 0 18.36492 17.0183 0 15.60086 17.26294 16.07153 14.90695 0 0 15.85779 0 16.64804 17.4848 0 0 Q96P50 ACAP3_HUMAN "Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 (Centaurin-beta-5, Cnt-b5)" ACAP3 CENTB5 KIAA1716 Homo sapiens (Human) neuron migration [GO:0001764]; regulation of neuron projection development [GO:0010975] growth cone [GO:0030426] growth cone [GO:0030426]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; neuron migration [GO:0001764]; regulation of neuron projection development [GO:0010975] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0001764; GO:0005096; GO:0010975; GO:0030426; GO:0046872 AYVSTSR 3.400000095 0.954659641 0.954659641 0.231605571 783.0276624 0 0 0 15.29856 13.59557 0 13.17984 15.0244 15.03198 0 15.84816 0 0 0 0 0 13.40359 15.02653 0 16.78936 0 0 0 0 0 16.49573 16.35213 0 0 0 0 0 0 0 16.78168 15.7056 15.78227 0 0 0 16.33073 14.99328 0 0 0 0 15.71016 0 Q96P65 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155) QRFPR GPR103 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186; GO:0016021 ENPVEETK 11.43999958 0.688990057 0.688990057 0.100149916 944.8549754 0 15.38509 17.93564 15.20573 0 0 13.99729 0 13.26081 0 13.4882 8.435581 0 10.36005 0 0 0 0 0 14.32973 14.45844 0 0 0 0 16.19916 16.87202 14.62945 13.61034 0 0 0 0 0 0 0 0 0 0 17.26762 0 0 14.07698 0 8.461637 0 0 15.54476 Q96P88 GNRR2_HUMAN "Putative gonadotropin-releasing hormone II receptor, GnRH II receptor, GnRH-II-R (Type II GnRH receptor)" GNRHR2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277] GO:0004930; GO:0004968; GO:0005886; GO:0005887; GO:0007186; GO:0042277 GHQELSIDSSK 14.43000031 1 1 0.27090224 1200.003123 14.0465 0 0 14.55881 0 12.05793 0 0 0 0 0 0 14.98003 0 9.822898 9.597157 0 0 0 0 0 0 11.22406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.01126 0 Q96PC5 MIA2_HUMAN "Melanoma inhibitory activity protein 2, MIA protein 2 (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11)" MIA2 CTAGE5 MEA11 MEA6 MGEA11 MGEA6 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; enzyme activator activity [GO:0008047]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] cargo receptor activity [GO:0038024]; enzyme activator activity [GO:0008047] GO:0005783; GO:0005789; GO:0006888; GO:0008047; GO:0009306; GO:0016020; GO:0016021; GO:0032527; GO:0035459; GO:0038024; GO:0042953; GO:0070971; GO:0070973 VMTELYQENEMKLHR 4.480000019 1 1 0.167788941 1954.079735 15.69492 14.56293 15.37063 14.91831 14.50848 16.2084 13.81148 0 0 15.31071 15.9895 14.90072 0 0 0 14.56835 0 0 14.00548 0 0 0 16.10994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.95678 16.89136 0 15.49719 0 15.57255 0 0 0 Q96PD7 DGAT2_HUMAN "Diacylglycerol O-acyltransferase 2, EC 2.3.1.20 (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diglyceride acyltransferase 2)" DGAT2 HMFN1045 UNQ738/PRO1433 Homo sapiens (Human) bile acid signaling pathway [GO:0038183]; cellular response to oleic acid [GO:0071400]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; diacylglycerol biosynthetic process [GO:0006651]; diacylglycerol metabolic process [GO:0046339]; fat pad development [GO:0060613]; fatty acid homeostasis [GO:0055089]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; low-density lipoprotein particle clearance [GO:0034383]; monoacylglycerol biosynthetic process [GO:0006640]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cholesterol metabolic process [GO:0090181]; regulation of lipoprotein metabolic process [GO:0050746]; regulation of plasma lipoprotein particle levels [GO:0097006]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; protein homodimerization activity [GO:0042803]; retinol O-fatty-acyltransferase activity [GO:0050252]; bile acid signaling pathway [GO:0038183]; cellular response to oleic acid [GO:0071400]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; diacylglycerol biosynthetic process [GO:0006651]; diacylglycerol metabolic process [GO:0046339]; fat pad development [GO:0060613]; fatty acid homeostasis [GO:0055089]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; low-density lipoprotein particle clearance [GO:0034383]; monoacylglycerol biosynthetic process [GO:0006640]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cholesterol metabolic process [GO:0090181]; regulation of lipoprotein metabolic process [GO:0050746]; regulation of plasma lipoprotein particle levels [GO:0097006]; triglyceride biosynthetic process [GO:0019432] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; protein homodimerization activity [GO:0042803]; retinol O-fatty-acyltransferase activity [GO:0050252] GO:0003846; GO:0004144; GO:0005739; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0010867; GO:0016021; GO:0019432; GO:0019915; GO:0030176; GO:0034383; GO:0035336; GO:0035356; GO:0038183; GO:0042632; GO:0042803; GO:0043231; GO:0045722; GO:0046322; GO:0046339; GO:0048471; GO:0050252; GO:0050746; GO:0055089; GO:0060613; GO:0071400; GO:0090181; GO:0097006; GO:1990578 NWAVWRYFR 10.93000031 0.041099444 0.041099444 0.048131352 1298.301389 14.03369 0 0 0 0 12.197 0 0 0 0 15.37852 0 0 0 0 0 0 0 0 0 0 13.14502 15.24858 13.79869 14.08562 14.91934 12.34784 9.934078 0 14.33108 14.23427 0 0 0 0 0 0 0 0 0 16.51285 17.39745 0 0 17.5646 0 0 0 Q96PE1 AGRA2_HUMAN Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5) ADGRA2 GPR124 KIAA1531 TEM5 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] G protein-coupled receptor activity [GO:0004930] GO:0002040; GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007417; GO:0009986; GO:0010595; GO:0016021; GO:0016055; GO:0030175; GO:0043542; GO:0045765; GO:0050920; GO:0090210; GO:0090263; GO:1900747; GO:1990909 AGNSR 6.360000134 0.060192674 0.060192674 0.171764241 503.2575807 15.03505 17.83058 17.03955 15.98069 16.87576 17.08662 15.77275 16.30149 16.43428 16.13601 16.6966 16.85338 16.28165 16.74792 16.46047 16.70742 15.9823 16.28524 16.6985 16.69421 17.26352 17.17666 17.51847 16.75458 16.70978 17.18551 15.55519 16.8021 17.36896 16.92482 15.72759 17.1829 16.33401 17.74879 16.67576 16.24463 16.94352 16.51157 16.34536 17.65278 16.75137 16.74426 17.65667 16.76085 16.35271 16.48357 17.12393 17.29129 Q96PE2 ARHGH_HUMAN "Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor, p164-RhoGEF, p164RhoGEF) (Tumor endothelial marker 4)" ARHGEF17 KIAA0337 TEM4 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0030036; GO:0051056 DGGVLPAAAEEAAEGPAR 3.24000001 1 1 0.303217803 1682.593385 10.9547 0 15.40946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.40981 0 19.32605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PE3 INP4A_HUMAN "Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)" INPP4A Homo sapiens (Human) inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]" "inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]" GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0034597; GO:0043647; GO:0052828; GO:0055038 VDKLLQK 21.52000046 1 1 0.258079543 844.0900351 0 17.9481 18.94762 19.64652 17.95181 17.33087 19.99719 0 18.7397 18.39228 18.34705 19.94404 0 17.56316 0 0 0 19.26145 19.60533 0 17.63999 18.29074 19.22667 0 21.3326 0 18.48632 18.69222 17.35215 15.14934 21.42808 20.70774 0 20.47758 19.60599 0 16.50845 0 20.42492 0 16.52435 20.21988 0 0 18.0332 19.57005 20.25491 17.93733 Q96PE7 MCEE_HUMAN "Methylmalonyl-CoA epimerase, mitochondrial, EC 5.1.99.1 (DL-methylmalonyl-CoA racemase)" MCEE Homo sapiens (Human) L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626] metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493] GO:0004493; GO:0005759; GO:0019626; GO:0046491; GO:0046872 ARVLK 3.410000086 1 1 0.240325203 585.9833157 0 17.11188 14.89706 16.46553 14.37643 0 16.84654 0 0 15.98138 14.77872 0 0 0 0 0 14.37863 0 0 18.4501 15.39755 0 17.63652 0 17.83531 16.98804 16.18217 16.0428 14.55438 0 14.65679 16.04536 18.59675 0 18.23129 16.35907 0 17.01971 0 16.38506 16.32557 0 17.19747 0 16.82491 0 17.27295 0 Q96PF2 TSSK2_HUMAN "Testis-specific serine/threonine-protein kinase 2, TSK-2, TSK2, TSSK-2, Testis-specific kinase 2, EC 2.7.11.1 (DiGeorge syndrome protein G, DGS-G) (Serine/threonine-protein kinase 22B)" TSSK2 DGSG SPOGA2 STK22B Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877] GO:0000287; GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777; GO:0106310 ATSSASFKR 2.630000114 1 1 0.025583227 955.4635856 13.5331 14.14748 11.32228 0 0 0 0 11.87363 0 0 0 0 0 0 0 15.62117 0 0 0 0 0 0 0 0 0 0 0 14.47805 0 0 0 12.79478 0 14.30584 0 8.443032 0 0 0 0 0 0 0 0 0 0 0 0 Q96PI1 SPRR4_HUMAN Small proline-rich protein 4 SPRR4 Homo sapiens (Human) keratinization [GO:0031424] cell cortex [GO:0005938] cell cortex [GO:0005938]; keratinization [GO:0031424] GO:0005938; GO:0031424 CQETCAPK 7.489999771 1 1 0.269312123 993.8451985 0 16.25745 15.76355 0 0 15.38208 16.48193 14.13616 15.30475 16.94982 16.8703 0 13.96757 0 15.44461 13.73373 15.81057 14.01596 17.19276 15.97245 14.28841 14.2033 17.02417 14.5523 16.04299 15.12889 16.29644 0 14.926 16.26016 17.47089 17.52679 16.87119 15.74564 0 0 0 16.11447 18.05418 0 15.67981 14.66778 15.33878 0 14.81184 16.49589 16.95191 14.34762 Q96PK6 RBM14_HUMAN "RNA-binding protein 14 (Paraspeckle protein 2, PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein, SYT-interacting protein)" RBM14 SIP Homo sapiens (Human) "activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667]; mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]" mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723] GO:0000398; GO:0002218; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0009725; GO:0016575; GO:0016607; GO:0030374; GO:0045087; GO:0045944; GO:0046600; GO:0060395; GO:0098534; GO:1990904 TRLSPPR 14.07999992 1 1 0.314615513 825.9546913 0 0 0 0 0 0 0 17.73462 0 0 0 0 22.41349 0 0 17.78212 0 0 17.34968 0 0 0 16.46508 0 0 0 0 0 17.77741 0 0 0 0 0 0 0 0 21.39632 0 0 0 17.74963 22.03078 0 0 0 0 0 Q96PL1 SG3A2_HUMAN "Secretoglobin family 3A member 2 (Pneumo secretory protein 1, PnSP-1) (Uteroglobin-related protein 1)" SCGB3A2 PNSP1 UGRP1 UNQ566/PRO1128 Homo sapiens (Human) endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615] GO:0005576; GO:0005615; GO:0071682 CVNELGPEASEAVK 3.50999999 1 1 0.416321687 1503.383871 15.87526 0 0 0 0 0 12.60921 17.09692 16.40371 0 0 14.75425 16.70322 16.49494 0 15.96569 0 16.52276 0 0 16.71867 18.31997 0 0 0 0 0 0 16.69719 16.34215 16.04994 17.83224 0 16.58109 14.9533 16.08135 17.03113 0 0 15.33101 0 17.66186 15.48404 0 16.78733 17.04237 0 0 Q96PL5 ERMAP_HUMAN "Erythroid membrane-associated protein, hERMAP (Radin blood group antigen) (Scianna blood group antigen)" ERMAP RD SC Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] signaling receptor binding [GO:0005102] GO:0001817; GO:0005102; GO:0005794; GO:0005829; GO:0005886; GO:0009897; GO:0016021; GO:0050852 VNSSLLPPK 4.53000021 1 1 0.285203012 953.7963497 15.5627 0 14.88631 0 15.687 14.98186 16.48482 16.55322 14.74324 0 0 0 0 15.41914 0 0 13.90242 15.08479 14.83108 0 0 15.94744 0 0 0 0 0 0 14.5295 0 0 0 0 16.66925 15.04581 0 0 16.10424 15.94493 0 0 0 15.25452 0 0 0 13.59508 13.77763 Q96PN6 ADCYA_HUMAN "Adenylate cyclase type 10, EC 4.6.1.1 (AH-related protein) (Adenylate cyclase homolog) (Germ cell soluble adenylyl cyclase, hsAC, sAC) (Testicular soluble adenylyl cyclase)" ADCY10 SAC Homo sapiens (Human) cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005929; GO:0006171; GO:0007283; GO:0016324; GO:0030145; GO:0030425; GO:0030426; GO:0035556; GO:0043025; GO:0043065; GO:0045178; GO:0048471; GO:0051117; GO:0071241; GO:0071890 ELQKALK 13.68999958 0.896615267 0.896615267 0.35155412 829.4834953 16.09822 17.63326 17.70076 0 15.97444 16.78062 15.60171 15.40589 0 15.69044 16.35976 0 0 17.29871 16.95215 0 17.08821 17.15459 0 0 16.54344 17.01309 0 16.79832 15.77738 0 0 0 0 15.80485 0 0 0 0 16.54334 0 16.70173 0 16.58439 15.94924 17.13367 17.01456 0 16.69411 15.67246 0 16.60742 17.00604 Q96PN7 TREF1_HUMAN Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132) TRERF1 BCAR2 RAPA TREP132 Homo sapiens (Human) "cellular response to progesterone stimulus [GO:0071393]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; cellular response to progesterone stimulus [GO:0071393]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0016575; GO:0030374; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050847; GO:0071393 ALATYSK 4.570000172 1 1 0.109744249 752.5830805 15.95397 0 0 0 0 0 0 14.74539 0 0 16.74418 0 0 0 0 0 0 16.72258 0 0 0 0 0 0 15.92745 0 0 0 0 0 0 15.76061 0 15.26655 15.23105 15.92283 17.30671 18.14124 16.48352 0 0 15.61423 17.54906 15.23666 16.55961 16.59138 17.2436 17.11774 Q96PN8 TSSK3_HUMAN "Testis-specific serine/threonine-protein kinase 3, TSK-3, TSSK-3, Testis-specific kinase 3, EC 2.7.11.1 (Serine/threonine-protein kinase 22C)" TSSK3 SPOGA3 STK22C Homo sapiens (Human) cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007283; GO:0030154; GO:0035556; GO:0106310 CENALLQGFNLK 16.85000038 1 1 0.378342226 1407.500726 13.13821 0 0 14.07502 14.02739 13.50184 0 14.17396 14.95596 0 0 0 14.98083 15.07362 0 0 0 0 0 0 0 0 0 0 15.85118 0 0 0 0 0 0 0 0 0 0 0 16.52132 0 0 15.86401 0 0 0 0 16.5171 0 0 15.78233 Q96PP4 TSG13_HUMAN Testis-specific gene 13 protein TSGA13 Homo sapiens (Human) MYPQLTFAPVHERDMR 1.549999952 1 1 1.15E-12 2007.759867 12.64281 0 0 0 0 13.07543 13.86124 15.37179 13.42139 15.34585 16.32151 9.242854 0 13.26941 0 0 0 0 0 13.19477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.60465 0 0 0 0 0 0 0 Q96PQ0 SORC2_HUMAN VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain ] SORCS2 KIAA1329 Homo sapiens (Human) intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218] cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038] cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; neuropeptide receptor activity [GO:0008188]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218] neuropeptide receptor activity [GO:0008188] GO:0005829; GO:0005887; GO:0006886; GO:0007218; GO:0008188; GO:0016020; GO:0016021; GO:0031901; GO:0043197; GO:0043204; GO:0043231; GO:0055038; GO:0060292; GO:0098839 SPPAGR 4.230000019 0.421875477 0.421875477 0.087778687 584.4969091 16.07589 0 0 0 0 0 0 15.60806 0 16.80048 0 16.39433 15.78177 13.61229 16.47116 0 0 0 16.25274 15.20252 0 0 17.18718 0 0 0 0 16.82546 16.81854 0 0 17.86336 16.94071 19.6033 0 17.1478 0 17.13629 0 0 17.65432 17.68416 0 17.75544 18.56611 17.03666 0 16.7199 Q96PQ1 SIG12_HUMAN "Sialic acid-binding Ig-like lectin 12, Siglec-12 (Sialic acid-binding Ig-like lectin-like 1, Siglec-L1)" SIGLEC12 SIGLECL1 SLG UNQ9215/PRO34042 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0033691 SARPAVGVGDTGMEDANAVR 3.819999933 0.14735128 0.14735128 0.295229733 1989.362822 14.77689 17.41592 0 0 0 0 0 16.15665 0 0 0 14.94533 0 12.20377 14.41124 0 0 0 13.47626 0 0 13.57638 0 0 15.20177 0 0 0 0 0 0 15.29883 0 15.45895 0 8.774716 0 0 0 0 0 0 0 0 15.79438 0 0 0 Q96PQ6 ZN317_HUMAN Zinc finger protein 317 ZNF317 KIAA1588 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 SHVKTHR 14.02000046 1 1 0.083980953 865.4679805 12.02661 0 0 0 13.46299 0 14.10204 0 0 0 0 12.50369 0 0 11.08845 11.34294 0 0 14.82968 12.07076 16.05251 0 0 9.75059 0 0 0 9.934078 13.54945 0 14.23427 15.55132 14.89786 0 14.7546 0 0 0 0 0 16.50366 17.19179 0 15.96764 0 0 0 15.9197 Q96PQ7 KLHL5_HUMAN Kelch-like protein 5 KLHL5 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779] actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0005829; GO:0005856 MEGVEPNSLWSLIQYAYTGRLELK 5.360000134 0.083184212 0.083184212 0.075605037 2812.557535 0 17.56397 0 13.89376 16.15122 14.99045 15.41242 17.65707 10.79994 12.94314 16.60785 14.94087 0 0 15.37364 13.42897 14.7113 12.33387 17.19052 0 0 17.85365 0 0 17.44325 16.30979 16.20974 16.44442 15.9343 15.36201 16.60678 17.86017 15.12951 14.26981 0 0 0 16.94098 0 13.88345 0 0 0 15.43557 13.31193 0 17.27469 15.98547 Q96PS1 FACOS_HUMAN FANCD2 opposite strand protein (Fanconi anemia group D2 protein opposite strand transcript protein) FANCD2OS C3orf24 HSD19 Homo sapiens (Human) CTFALQHSK 7.039999962 0.515179753 0.515179753 0.293635194 1090.774552 0 0 15.41088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.30333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.24702 17.33609 0 0 0 0 0 0 0 Q96PU5 NED4L_HUMAN "E3 ubiquitin-protein ligase NEDD4-like, EC 2.3.2.26, EC 2.3.2.36 (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2)" NEDD4L KIAA0439 NEDL3 Homo sapiens (Human) cell differentiation [GO:0030154]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005] potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0003254; GO:0004842; GO:0005654; GO:0005737; GO:0005771; GO:0005794; GO:0005829; GO:0006511; GO:0015459; GO:0016567; GO:0017080; GO:0019870; GO:0019871; GO:0030154; GO:0031647; GO:0034220; GO:0034765; GO:0042391; GO:0043161; GO:0044325; GO:0045732; GO:0048814; GO:0060306; GO:0061630; GO:0070062; GO:0070936; GO:0086005; GO:1901016; GO:1901017; GO:1901380; GO:1902305; GO:1902306; GO:1903861; GO:2000009; GO:2000650; GO:2001288 EPSSR 2.829999924 0.11134731 0.11134731 0.303409093 574.7190977 0 0 0 0 0 0 0 0 17.4952 17.9825 0 0 0 0 0 0 18.09677 0 0 0 16.23146 0 0 0 0 17.9309 0 0 0 0 19.00059 16.68146 0 17.92148 0 20.24474 0 17.60698 0 0 0 0 0 0 18.29755 16.88419 0 17.52985 Q96PV0 SYGP1_HUMAN "Ras/Rap GTPase-activating protein SynGAP (Neuronal RasGAP) (Synaptic Ras GTPase-activating protein 1, Synaptic Ras-GAP 1)" SYNGAP1 KIAA1938 Homo sapiens (Human) dendrite development [GO:0016358]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of axonogenesis [GO:0050771]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; pattern specification process [GO:0007389]; Ras protein signal transduction [GO:0007265]; receptor clustering [GO:0043113]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; dendrite development [GO:0016358]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of axonogenesis [GO:0050771]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; pattern specification process [GO:0007389]; Ras protein signal transduction [GO:0007265]; receptor clustering [GO:0043113]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] GO:0005096; GO:0005829; GO:0005886; GO:0007265; GO:0007389; GO:0008542; GO:0014069; GO:0016358; GO:0017124; GO:0043087; GO:0043113; GO:0043198; GO:0043408; GO:0043524; GO:0046580; GO:0048167; GO:0048169; GO:0050771; GO:0050803; GO:0098880; GO:0098978 EALLKLGPLPR 2.140000105 0.157556698 0.157556698 1.15E-12 1207.624571 0 14.22654 13.1327 11.53353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.23241 0 12.68476 0 12.0243 15.40848 14.9672 0 0 0 0 13.62874 0 7.242949 0 0 0 0 Q96PV4 PNMA5_HUMAN Paraneoplastic antigen-like protein 5 (Tumor antigen BJ-HCC-25) PNMA5 KIAA1934 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] identical protein binding [GO:0042802]; positive regulation of apoptotic process [GO:0043065] identical protein binding [GO:0042802] GO:0042802; GO:0043065 GMDMDPRK 5.900000095 1 1 0.262520929 980.6927657 16.80033 0 17.00759 0 16.48492 18.27445 16.70403 0 0 0 0 0 0 15.93901 0 17.69764 0 17.60799 16.6963 15.81522 0 0 0 0 0 18.17647 0 0 0 0 0 0 19.4911 0 18.47344 0 0 0 0 16.63446 15.98921 16.52061 0 0 0 0 0 18.196 Q96PV6 LENG8_HUMAN Leukocyte receptor cluster member 8 LENG8 KIAA1932 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 DNSSSSSTDSR 12.25 1 1 0.32955029 1142.034898 0 14.28611 15.02967 0 10.89827 0 0 0 0 0 0 15.15021 0 0 0 0 15.97441 14.61161 0 0 15.14541 15.48061 15.5022 0 0 16.93045 0 0 0 0 0 0 0 0 15.14503 0 0 16.37055 16.25217 16.45291 0 11.76709 16.60941 0 17.12446 15.85108 0 0 Q96PV7 F193B_HUMAN Protein FAM193B FAM193B IRIZIO KIAA1931 Homo sapiens (Human) cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016607 GPHPPWTEVRGPPPGIVPENGLVR 1.450000048 1 1 0.179217864 2558.173967 0 15.22641 12.5134 14.854 13.17947 16.33812 0 0 0 0 14.77729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PX6 CC85A_HUMAN Coiled-coil domain-containing protein 85A CCDC85A KIAA1912 Homo sapiens (Human) adherens junction [GO:0005912] adherens junction [GO:0005912] GO:0005912 VSAMLDHSNLIR 3.059999943 1 1 0.099369874 1354.583417 11.95301 0 12.99015 0 9.323339 11.39026 0 0 13.79216 0 0 0 0 0 0 17.59583 11.96925 14.40691 0 0 0 11.2117 0 11.80008 0 0 14.63828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.65279 0 0 0 0 0 Q96PX9 PKH4B_HUMAN "Pleckstrin homology domain-containing family G member 4B, PH domain-containing family G member 4B" PLEKHG4B KIAA1909 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0051056 HQKPPSFPSTDSGGGAWEPAQPLSGLPGR 5.179999828 1 1 0.222841898 2957.260711 13.77218 13.20107 10.23913 0 0 11.83035 0 12.96298 0 0 11.3091 14.68067 15.47091 12.77314 0 0 0 0 0 0 0 0 14.44686 0 0 15.43113 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74849 15.60681 16.23097 0 0 0 0 14.88603 0 Q96PY0 K1908_HUMAN Putative uncharacterized protein PSMG3-AS1 (PSMG3 antisense RNA 1) PSMG3-AS1 KIAA1908 Homo sapiens (Human) SSPGAPEAAERVESAETR 10.22999954 1 1 0.069429293 1844.738019 0 0 17.96379 0 0 0 17.11604 0 17.05155 0 13.94185 0 0 0 0 0 0 0 0 0 15.95152 0 0 0 0 15.72396 0 0 0 0 0 0 0 0 17.3261 0 17.21313 0 17.20885 0 0 0 0 0 0 0 0 0 Q96PY5 FMNL2_HUMAN Formin-like protein 2 (Formin homology 2 domain-containing protein 2) FMNL2 FHOD2 KIAA1902 Homo sapiens (Human) cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360] cytosol [GO:0005829] cytosol [GO:0005829]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267] GO:0005829; GO:0007010; GO:0008360; GO:0016477; GO:0022604; GO:0030866; GO:0031267; GO:0045296; GO:0051015 FAIVLNAMNLPPDKAR 10.64000034 0.867957532 0.867957532 0.638377249 1769.476482 18.73903 20.63809 0 18.78835 19.04931 0 0 0 0 19.42322 0 0 0 18.49313 0 20.13799 0 0 0 18.91159 0 18.42972 17.82868 18.57927 0 0 20.68493 18.71423 0 0 19.40987 20.94355 19.42506 20.11463 21.82839 0 20.58704 21.53213 0 18.75665 17.84745 19.12061 18.76435 0 19.33102 18.20993 0 18.90501 Q96PY6 NEK1_HUMAN "Serine/threonine-protein kinase Nek1, EC 2.7.11.1 (Never in mitosis A-related kinase 1, NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)" NEK1 KIAA1901 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0000242; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310 AWGKSPTDSVLK 13.39999962 0.543632865 0.543632865 0.147836373 1287.616879 19.3304 19.4307 14.92559 18.52638 17.41114 17.47056 17.63256 18.59722 18.36349 14.51701 19.01532 16.68555 17.04231 18.71674 17.5547 17.80961 18.98005 19.27185 15.88496 16.90752 15.78037 16.79911 0 0 0 17.67639 0 17.76945 0 0 18.70913 17.6671 0 18.89138 0 17.8908 0 18.28366 18.67248 16.60272 18.10599 0 0 18.57736 18.14008 0 17.12033 18.25674 Q96PZ0 PUS7_HUMAN "Pseudouridylate synthase 7 homolog, EC 5.4.99.-" PUS7 KIAA1897 Homo sapiens (Human) mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119] nucleus [GO:0005634] nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119] enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380 GYLVK 1.590000033 0.730456531 0.730456531 0.229747792 578.4846278 0 0 14.6109 15.90043 15.0495 16.41591 16.69441 15.8616 15.60162 16.24965 16.16142 15.83893 14.25298 15.58087 14.9079 14.72988 16.4217 0 16.57957 0 0 14.88107 15.68114 0 0 17.24712 0 0 0 16.15832 0 16.30069 16.18746 0 0 16.74793 17.22291 0 0 0 16.43739 16.9764 0 0 0 16.61406 0 16.95846 Q96PZ7 CSMD1_HUMAN CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1) CSMD1 KIAA1890 UNQ5952/PRO19863 Homo sapiens (Human) conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964] GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016021; GO:0035846; GO:0042593; GO:0060745; GO:1990708 EVNETVTK 5.449999809 0.486185819 0.486185819 0.047741113 918.6130481 13.83284 0 16.11692 16.60272 16.54411 10.43184 10.87751 12.30625 14.46797 16.35782 15.69183 14.92047 14.57646 16.40608 16.4927 14.39125 5.017852 13.39276 14.96501 0 0 0 15.19717 16.38688 15.43106 15.2187 14.07603 0 17.23473 14.23412 0 0 14.26777 0 0 16.96086 16.78699 17.28904 16.30321 14.14421 12.1067 16.65963 0 15.91785 15.04628 0 18.10673 17.30075 Q96Q04 LMTK3_HUMAN "Serine/threonine-protein kinase LMTK3, EC 2.7.11.1 (Lemur tyrosine kinase 3)" LMTK3 KIAA1883 TYKLM3 Homo sapiens (Human) protein phosphorylation [GO:0006468] axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000139; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0016021; GO:0030424; GO:0030425; GO:0046872; GO:0106310 RAPETGGAPR 8.609999657 1 1 0.249348169 1011.546777 0 0 15.19206 0 0 0 0 16.90423 0 0 0 17.87859 0 17.56862 0 18.93886 0 0 0 0 0 0 0 16.79681 0 19.7751 0 0 0 15.86651 19.05933 0 19.83419 0 0 0 0 18.98014 0 0 0 17.48915 0 0 0 0 0 0 Q96Q05 TPPC9_HUMAN Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein) (Tularik gene 1 protein) TRAPPC9 KIAA1882 NIBP T1 Homo sapiens (Human) cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0006888; GO:0006901; GO:0021987; GO:0030008; GO:0030182; GO:0051092; GO:0099022; GO:1990071 AVRVLAIQK 7.650000095 0.945565701 0.945565701 0.213027116 999.49454 16.51224 15.99016 15.95611 0 16.27464 0 15.59303 0 15.10367 10.4193 0 0 0 0 0 14.73895 0 15.1201 14.3187 16.69142 0 15.8349 11.90159 15.56076 0 15.47878 14.44288 16.08805 14.46736 14.24806 15.00996 15.63392 0 16.85108 15.116 0 15.58917 15.33281 0 16.10543 14.2383 0 15.58347 13.05512 0 15.18424 17.0839 13.513 Q96Q06 PLIN4_HUMAN Perilipin-4 (Adipocyte protein S3-12) PLIN4 KIAA1881 Homo sapiens (Human) cytosol [GO:0005829]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] cytosol [GO:0005829]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] GO:0005811; GO:0005829; GO:0005886 AVLMGTK 6.599999905 1 1 0.222663261 734.2971623 0 17.63068 16.57856 0 0 0 0 15.68603 15.4453 0 0 0 0 0 0 0 17.44379 0 0 17.36653 0 0 0 0 18.70733 0 0 15.66647 16.03926 16.33998 0 0 16.23964 16.89087 0 15.76818 17.13215 16.21389 0 0 16.65174 0 14.65599 14.44217 0 17.00872 0 0 Q96Q07 BTBD9_HUMAN BTB/POZ domain-containing protein 9 BTBD9 KIAA1880 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]" "adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]" GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050804; GO:0050951; GO:0060586; GO:1900242 DMDLNYRGMLIPEENIATMK 18.27000046 1 1 0.236224626 2369.550356 0 15.78869 0 0 12.50103 15.75853 0 16.06518 16.7087 14.3984 15.01112 16.64881 0 16.973 11.45494 16.57529 14.26296 0 16.55524 0 16.25657 0 15.63946 0 0 0 0 0 0 0 0 0 0 0 0 0 15.32507 0 0 0 0 0 0 0 16.77809 0 0 0 Q96Q15 SMG1_HUMAN "Serine/threonine-protein kinase SMG1, SMG-1, hSMG-1, EC 2.7.11.1 (Lambda/iota protein kinase C-interacting protein, Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)" SMG1 ATX KIAA0421 LIP Homo sapiens (Human) "DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]" chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] "chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]" ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020 LMYNAYEGCANALTSPPK 3.900000095 1 1 0.515156007 2015.032996 0 0 0 0 19.05868 0 0 0 0 0 17.32783 0 0 17.11884 0 0 0 17.70102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.52364 0 0 0 17.60952 0 Q96Q42 ALS2_HUMAN Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein) ALS2 ALS2CR6 KIAA1563 Homo sapiens (Human) "axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]" centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] "centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]" GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0030027; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035022; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260 EEETEGGSR 5.449999809 1 1 0.026956728 993.9784369 0 0 15.03042 0 0 0 0 0 13.56984 0 0 14.53143 0 0 0 0 0 13.339 0 0 0 0 0 0 15.04917 16.52694 15.95233 0 0 13.45584 16.57089 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67054 0 0 0 Q96Q45 TM237_HUMAN Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein) TMEM237 ALS2CR4 Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111] ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200] ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200]; cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111] GO:0016020; GO:0016021; GO:0030111; GO:0032391; GO:0035869; GO:0060271; GO:0120199; GO:0120200 EIKASS 10.90999985 0.047029808 0.047029808 0.270292857 635.2265686 16.23999 15.58606 17.0647 14.50638 14.89654 15.56309 17.73397 16.89926 15.88696 0 15.97574 16.7798 16.48405 15.45062 15.47869 15.78197 15.94908 16.08265 15.75765 16.99256 16.48123 16.48066 17.22632 13.2338 17.09733 16.91392 17.60273 15.83564 17.68727 16.46904 16.84742 16.09751 17.00306 17.92881 17.07644 17.13299 16.99067 17.62747 18.70203 16.49316 17.11751 18.03236 16.46392 18.29462 16.88085 16.47797 18.37806 18.81201 Q96Q89 KI20B_HUMAN "Kinesin-like protein KIF20B (Cancer/testis antigen 90, CT90) (Kinesin family member 20B) (Kinesin-related motor interacting with PIN1) (M-phase phosphoprotein 1, MPP1)" KIF20B KRMP1 MPHOSPH1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088] centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233] centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699] GO:0001843; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007049; GO:0007088; GO:0008017; GO:0008284; GO:0008574; GO:0016887; GO:0030426; GO:0030496; GO:0032467; GO:0035372; GO:0042803; GO:0045171; GO:0048471; GO:0048812; GO:0050699; GO:0051233; GO:0051301; GO:0051726; GO:0070938; GO:0090316; GO:0097431; GO:1903438; GO:1990023; GO:2000114; GO:2001224 DQLVAALEIQLK 2.140000105 1 1 0.312516286 1337.969701 14.13672 14.58397 12.22268 14.7576 0 13.95082 0 12.18394 12.45508 13.27571 0 0 11.28516 14.87573 11.09453 16.40505 15.1228 15.03979 0 15.41816 0 0 0 15.02811 0 0 0 0 0 0 0 0 15.26621 0 0 0 0 0 0 0 14.70004 0 0 0 15.26497 0 0 0 Q96QA5 GSDMA_HUMAN "Gasdermin-A (Gasdermin-1) [Cleaved into: Gasdermin-A, N-terminal, GSDMA-NT; Gasdermin-A, C-terminal, GSDMA-CT ]" GSDMA GSDM GSDM1 FKSG9 Homo sapiens (Human) apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]" "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]" GO:0001786; GO:0005546; GO:0005829; GO:0005886; GO:0006915; GO:0016021; GO:0042742; GO:0048471; GO:0070269; GO:0070273 ILPVQLK 14.39000034 1 1 0.261473407 809.073767 15.17047 14.82151 15.42255 0 0 0 14.82938 16.8684 16.10645 17.41371 15.50445 0 15.2841 0 14.887 0 15.88653 15.84397 0 0 17.02397 0 0 0 0 16.11577 15.36704 16.34404 16.06059 14.54767 15.64726 16.45028 0 16.42324 16.76957 16.108 16.3609 14.38957 16.07912 16.39379 15.96806 17.08376 15.21392 14.26992 16.36437 16.09246 15.53593 15.70308 Q96QA6 YPEL2_HUMAN Protein yippee-like 2 YPEL2 FKSG4 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005730; GO:0046872 MVKMTR 7.150000095 0.08313293 0.08313293 0.196908387 767.5685931 14.32317 15.97274 16.40852 11.66987 15.26457 0 15.14097 0 17.28928 0 16.87769 14.69213 16.13582 14.56161 14.48396 14.49044 16.45898 15.30522 14.83771 15.16352 0 0 0 0 0 16.01813 17.02914 0 0 0 0 0 0 16.05599 0 16.17824 0 0 0 16.31844 16.50099 0 15.85054 0 13.00708 0 0 0 Q96QB1 RHG07_HUMAN "Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein, DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12, StARD12) (StAR-related lipid transfer protein 12)" DLC1 ARHGAP7 KIAA1723 STARD12 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169]; actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169] GO:0001843; GO:0003007; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005901; GO:0005925; GO:0006915; GO:0006919; GO:0007165; GO:0008285; GO:0008289; GO:0008360; GO:0021575; GO:0030036; GO:0030336; GO:0030864; GO:0030900; GO:0032587; GO:0032956; GO:0035023; GO:0035024; GO:0035307; GO:0042169; GO:0045121; GO:0048041; GO:0051056; GO:0051497; GO:0051895; GO:1900119 AAIMLLPDENR 19.85000038 1 1 4.60E-13 1258.626192 0 0 16.61085 0 0 0 17.04376 0 15.21558 0 17.26593 16.84706 14.9153 0 0 0 0 0 0 0 11.40563 0 0 0 0 16.04561 0 0 0 0 15.80042 0 0 0 16.37955 0 0 0 18.93546 0 0 0 0 0 0 0 14.41468 0 Q96QC0 PP1RA_HUMAN Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99) PPP1R10 CAT53 FB19 PNUTS Homo sapiens (Human) negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]; protein import into nucleus [GO:0006606] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]; protein import into nucleus [GO:0006606] DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723] GO:0000785; GO:0003677; GO:0003723; GO:0004864; GO:0005634; GO:0005654; GO:0006606; GO:0008157; GO:0010667; GO:0016604; GO:0032206; GO:0046872; GO:0072357; GO:1904290 QNNTAK 5.320000172 0.844044089 0.844044089 0.269981263 674.8529554 0 15.57357 16.04737 13.74294 14.76681 15.06324 0 0 15.50691 0 15.4062 0 0 0 0 16.58972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.27598 0 0 16.14048 17.56663 17.1784 0 0 15.74081 15.51523 16.19266 16.59327 0 0 0 16.00377 Q96QD5 DEPD7_HUMAN DEP domain-containing protein 7 (Protein TR2/D15) DEPDC7 Homo sapiens (Human) intracellular signal transduction [GO:0035556] intracellular signal transduction [GO:0035556] GO:0035556 IPGTLHK 2.049999952 1 1 0.208259085 769.0700886 0 0 15.47424 0 0 17.09802 18.36761 17.57894 0 15.92786 0 0 0 0 15.90234 0 0 0 0 17.1475 14.63574 17.42758 0 0 17.67481 14.11453 16.57774 14.61055 15.97589 17.45743 16.2429 17.96744 14.3224 0 0 18.17268 17.24682 14.96025 15.77249 0 0 0 0 0 15.37436 15.61692 15.94463 0 Q96QD9 UIF_HUMAN "UAP56-interacting factor (Forty-two-three domain-containing protein 1, Protein 40-2-3)" FYTTD1 UIF Homo sapiens (Human) mRNA export from nucleus [GO:0006406] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005654; GO:0006406; GO:0016607 KPVAVLK 13.40999985 0.037499353 0.037499353 0.280994037 755.0851453 0 20.31639 16.927 19.86914 19.25495 19.2655 17.21632 18.67763 18.6448 16.65535 17.8625 0 0 0 18.73158 18.27101 18.34772 19.71863 16.77194 18.15162 0 17.3574 17.21962 18.54938 0 18.04258 0 19.19054 0 16.38181 18.48337 0 19.47049 18.95554 0 19.11049 19.93559 18.88806 19.49958 0 17.04444 0 20.78625 0 0 0 0 0 Q96QE3 ATAD5_HUMAN ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) ATAD5 C17orf41 FRAG1 Homo sapiens (Human) cell population proliferation [GO:0008283]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770] Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634] Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; cell population proliferation [GO:0008283]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860] GO:0003677; GO:0005524; GO:0005634; GO:0008283; GO:0016887; GO:0030890; GO:0031391; GO:0033260; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:0090305; GO:0090618; GO:1901990; GO:1902166; GO:1902751 DVGAEEPSR 9.430000305 0.948831499 0.948831499 0.136675461 959.4513545 12.13262 16.74454 0 0 0 0 14.1172 13.79566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.63451 15.55705 16.36979 14.43863 0 0 16.36476 15.85038 16.15985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QF7 GCNA_HUMAN Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear acidic peptidase) (Germ cell nuclear antigen) GCNA ACRC Homo sapiens (Human) protein-DNA covalent cross-linking repair [GO:0106300] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; SUMO polymer binding [GO:0032184]; protein-DNA covalent cross-linking repair [GO:0106300] SUMO polymer binding [GO:0032184] GO:0005634; GO:0005654; GO:0016605; GO:0032184; GO:0106300 NIVEPPR 8.210000038 1 1 0.577516412 825.1011914 16.41937 16.06354 11.64303 0 0 0 0 0 0 0 0 0 17.86439 18.06541 0 0 0 0 0 0 0 0 17.57198 18.75411 0 0 0 0 0 0 0 0 0 0 18.77893 0 0 0 20.45382 0 17.48229 0 0 0 0 16.8159 17.54427 0 Q96QG7 MTMR9_HUMAN Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9) MTMR9 C8orf9 MTMR8 Homo sapiens (Human) endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903] GO:0004438; GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304 FVGSLGTIIIK 3.160000086 1 1 0.179796552 1148.513915 15.60763 17.59542 16.64774 0 0 15.99961 0 0 12.50002 19.23779 0 0 8.012565 13.20444 0 0 0 0 0 0 0 12.13754 15.47597 0 0 0 0 12.23894 0 0 0 13.13483 0 0 15.57218 0 0 0 0 0 16.05877 16.64377 15.11244 0 14.77589 0 0 15.04326 Q96QH2 PRAM_HUMAN "PML-RARA-regulated adapter molecule 1, PRAM, PRAM-1" PRAM1 Homo sapiens (Human) integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; regulation of neutrophil degranulation [GO:0043313]; T cell receptor signaling pathway [GO:0050852] plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; regulation of neutrophil degranulation [GO:0043313]; T cell receptor signaling pathway [GO:0050852] lipid binding [GO:0008289]; protein kinase binding [GO:0019901] GO:0005886; GO:0007229; GO:0008289; GO:0019901; GO:0032991; GO:0043313; GO:0050852; GO:0072659 KPLQPEVGEAPLK 1.480000019 1 1 0.261996248 1405.710197 0 0 14.66115 0 0 0 0 12.49068 15.46224 0 0 0 14.98908 0 0 12.18364 14.08859 16.13646 0 0 0 0 0 0 16.16634 15.19791 0 0 0 0 0 16.12564 0 12.88498 9.845115 0 0 0 0 0 0 0 0 0 0 15.90936 0 15.60155 Q96QK1 VPS35_HUMAN "Vacuolar protein sorting-associated protein 35, hVPS35 (Maternal-embryonic 3) (Vesicle protein sorting 35)" VPS35 MEM3 TCCCTA00141 Homo sapiens (Human) "endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]" D1 dopamine receptor binding [GO:0031748] GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0007416; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032456; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1905606; GO:2000331 AELAELPLR 7.349999905 1 1 0.187229781 1011.769652 12.18815 15.53622 15.94501 12.63443 0 0 14.48815 14.46837 15.07862 12.80299 15.4097 16.54626 0 0 0 0 0 0 15.62127 0 0 0 0 0 0 14.89083 0 0 0 0 0 0 0 0 0 0 14.94674 0 0 0 0 0 0 0 15.25379 0 0 14.81779 Q96QT4 TRPM7_HUMAN "Transient receptor potential cation channel subfamily M member 7, EC 2.7.11.1 (Channel-kinase 1) (Long transient receptor potential channel 7, LTrpC-7, LTrpC7)" TRPM7 CHAK1 LTRPC7 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; cation transmembrane transport [GO:0098655]; cellular magnesium ion homeostasis [GO:0010961]; divalent inorganic cation homeostasis [GO:0072507]; necroptotic process [GO:0070266]; protein autophosphorylation [GO:0046777]; protein tetramerization [GO:0051262] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle [GO:0001726] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; cation transmembrane transport [GO:0098655]; cellular magnesium ion homeostasis [GO:0010961]; divalent inorganic cation homeostasis [GO:0072507]; necroptotic process [GO:0070266]; protein autophosphorylation [GO:0046777]; protein tetramerization [GO:0051262] actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001726; GO:0003779; GO:0004674; GO:0004712; GO:0005261; GO:0005262; GO:0005524; GO:0005886; GO:0005887; GO:0006816; GO:0010961; GO:0016340; GO:0017022; GO:0031032; GO:0046777; GO:0046872; GO:0051262; GO:0070266; GO:0070588; GO:0072507; GO:0098655; GO:0106310 DQETVCSK 1.350000024 1 1 0.296373578 966.9185887 0 0 0 0 0 17.86707 0 0 0 17.99039 0 0 0 0 0 0 0 0 0 0 16.67174 0 0 0 0 0 0 0 0 15.9694 0 0 0 0 0 0 0 0 0 0 0 0 17.12903 0 0 0 0 0 Q96QU1 PCD15_HUMAN Protocadherin-15 PCDH15 USH1F Homo sapiens (Human) cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; synapse [GO:0045202] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] calcium ion binding [GO:0005509] GO:0001750; GO:0005509; GO:0005576; GO:0005615; GO:0005887; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0045202; GO:0045494; GO:0048839; GO:0050953; GO:0050957 SAHVDGSLK 6.639999866 0.07869149 0.07869149 0.208690683 913.4163444 0 12.97594 12.40551 16.19627 0 13.54062 0 0 15.40604 15.59498 14.20981 0 0 15.14729 0 0 14.51784 0 0 0 0 0 0 0 0 0 15.53236 0 16.2377 15.46897 16.25596 0 0 15.01752 16.03453 0 0 16.09384 0 0 0 0 0 15.98061 0 0 0 0 Q96QU6 1A1L1_HUMAN "1-aminocyclopropane-1-carboxylate synthase-like protein 1, ACC synthase-like protein 1" ACCS PHACS Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520] identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520] identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] GO:0006520; GO:0008483; GO:0009058; GO:0030170; GO:0042802 SVLSLER 9.609999657 0.510819435 0.510819435 0.231748504 805.36389 13.58397 15.31091 16.00128 15.49771 14.42431 15.20693 15.01503 12.89026 14.74314 15.09963 0 14.60554 13.34744 16.12436 13.75307 0 16.15026 0 15.17577 16.00851 0 16.75197 14.7994 15.71471 0 15.05358 15.40603 0 16.73272 0 0 15.72703 0 16.23322 0 0 0 15.82407 0 0 0 15.86656 0 0 15.7553 15.76265 0 0 Q96QV1 HHIP_HUMAN "Hedgehog-interacting protein, HHIP, HIP" HHIP HIP UNQ5825/PRO19644 Homo sapiens (Human) dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; catalytic activity [GO:0003824]; hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270]; dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705] catalytic activity [GO:0003824]; hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270] GO:0003824; GO:0005576; GO:0005634; GO:0005737; GO:0005887; GO:0007165; GO:0007405; GO:0008270; GO:0009953; GO:0009968; GO:0009986; GO:0040036; GO:0043066; GO:0045879; GO:0048705; GO:0060170; GO:0060441; GO:0097108 CAVDRHPTDININLTILCSDSNGK 5.380000114 0.080236688 0.080236688 0.281837566 2714.16361 0 17.40583 16.09467 0 16.03017 0 0 0 16.16342 0 0 16.60884 15.86033 15.98932 15.68014 0 0 0 0 0 0 0 15.48837 0 0 16.24295 16.96802 15.57755 0 15.95668 0 0 0 0 16.23026 0 0 0 0 0 0 17.04696 0 15.60138 0 18.70544 15.5892 0 Q96QZ7 MAGI1_HUMAN "Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (Atrophin-1-interacting protein 3, AIP-3) (BAI1-associated protein 1, BAP-1) (Membrane-associated guanylate kinase inverted 1, MAGI-1) (Trinucleotide repeat-containing gene 19 protein) (WW domain-containing protein 3, WWP3)" MAGI1 AIP3 BAIAP1 BAP1 TNRC19 Homo sapiens (Human) cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell-cell adhesion [GO:0022409]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell-cell adhesion [GO:0022409]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022] GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007155; GO:0007165; GO:0007166; GO:0008022; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0060090; GO:0065003; GO:0071944 GGLPVPK 3.450000048 0.067223087 0.067223087 0.226060754 666.4287392 17.2583 10.91641 13.89048 16.78679 0 12.99866 0 0 15.82559 0 17.16351 0 0 0 0 15.79115 0 10.38391 15.94221 15.85699 0 14.38509 0 15.43384 16.37197 0 16.25661 0 0 0 0 0 0 16.94894 0 0 0 0 0 0 17.5541 0 0 0 0 15.9712 0 0 Q96R06 SPAG5_HUMAN "Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126, MAP126)" SPAG5 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of metaphase plate congression [GO:0090235]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of metaphase plate congression [GO:0090235]; spindle organization [GO:0007051] microtubule binding [GO:0008017] GO:0000070; GO:0000776; GO:0005737; GO:0005829; GO:0007051; GO:0007059; GO:0008017; GO:0016604; GO:0030496; GO:0032388; GO:0034451; GO:0035371; GO:0051301; GO:0051988; GO:0071539; GO:0072686; GO:0090235; GO:0097431; GO:1905832 EEVAPCMGDR 3.819999933 1 1 0.103720552 1180.418688 13.40816 0 0 0 14.497 15.93245 0 0 12.17503 0 0 0 0 0 0 14.05974 0 0 0 11.29303 0 0 14.3622 0 0 0 0 11.71188 0 10.99039 0 0 0 0 15.3593 0 0 0 0 0 12.54766 0 0 0 0 0 12.32621 0 Q96R08 OR5BC_HUMAN Olfactory receptor 5B12 (Olfactory receptor 5B16) (Olfactory receptor OR11-241) OR5B12 OR5B12P OR5B16 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 SPEGR 9.550000191 1 1 0.341033829 546.915001 16.73036 15.85777 0 0 0 0 0 16.73835 17.12585 0 16.38834 0 0 0 17.31344 0 16.30392 17.44203 0 0 0 17.11591 17.6125 17.13396 0 17.28076 0 16.48783 0 0 0 17.25404 17.76729 0 15.95784 0 0 0 0 17.92294 17.7703 0 0 18.07381 16.75058 0 17.50575 0 Q96RG2 PASK_HUMAN "PAS domain-containing serine/threonine-protein kinase, PAS-kinase, PASKIN, hPASK, EC 2.7.11.1" PASK KIAA0135 Homo sapiens (Human) energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0045727; GO:0046777; GO:0070092; GO:0097009; GO:0106310 DQQITALGREEPVAIESPGQDLLGESR 8.31000042 0.664814115 0.664814115 6.86E-12 2908.39857 13.24535 14.8387 0 0 15.50169 0 0 0 0 0 15.41539 0 0 0 0 0 0 0 0 0 0 0 0 13.90691 8.919384 0 0 0 0 0 15.07672 14.83089 16.51787 15.2293 0 19.14079 0 0 10.97441 0 0 0 0 0 0 0 0 0 Q96RJ6 FER3L_HUMAN "Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31, bHLHa31) (Nephew of atonal 3) (Neuronal twist)" FERD3L BHLHA31 NATO3 NTWIST Homo sapiens (Human) "cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032502; GO:0033504; GO:0045892; GO:0046983; GO:0048468; GO:0050767; GO:1990837 GVSLLGRPK 13.06999969 0.787758887 0.787758887 0.192298867 926.4113676 0 0 16.18424 0 15.04028 16.29918 15.58239 0 16.6819 15.09485 0 16.52567 14.68413 0 16.65582 0 15.14446 15.50371 0 0 15.58534 0 0 16.7161 15.8273 15.83658 15.64937 0 15.67007 14.76837 16.97304 15.71592 16.94936 15.82946 14.69007 0 0 0 15.02391 0 17.09263 16.01009 0 16.25268 0 0 0 0 Q96RK0 CIC_HUMAN Protein capicua homolog CIC KIAA0306 Homo sapiens (Human) "brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0007420; GO:0007612; GO:0007613; GO:0035176; GO:0043231; GO:0045892 AHPDWK 2.539999962 0.000907103 0.000907103 0.278959772 754.3144531 16.5576 0 0 15.77753 0 16.8754 15.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 17.88278 17.49589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RK4 BBS4_HUMAN Bardet-Biedl syndrome 4 protein BBS4 Homo sapiens (Human) adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010629; GO:0015031; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034260; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:1902855; GO:1903546; GO:1905515 VSLLKDNSSLEFDSEMVEMAQK 4.110000134 1 1 0.214928613 2532.409324 0 0 0 10.12517 9.894779 12.11235 0 0 13.12007 11.01571 0 0 15.8751 0 12.57012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RL7 VP13A_HUMAN Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein) (Chorein) (Vacuolar protein sorting-associated protein 13A) VPS13A CHAC KIAA0986 Homo sapiens (Human) autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]; autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0006623; GO:0006895; GO:0006914; GO:0007399; GO:0007626; GO:0008104; GO:0010008; GO:0019898; GO:0030317; GO:0030382; GO:0031966; GO:0035176; GO:0045053; GO:0097225; GO:0099013; GO:1905146 ADGIHR 8.890000343 1 1 0.305683016 667.7498827 18.49546 18.59407 16.85027 0 17.91345 0 0 0 16.57388 0 15.62307 0 0 16.84011 0 0 0 0 17.71932 0 0 17.79827 17.9369 0 18.53526 0 0 0 0 0 0 16.77077 0 18.98648 0 18.50257 0 0 16.31712 0 17.16631 0 0 16.59169 0 18.65963 0 0 Q96RN1 S26A8_HUMAN Testis anion transporter 1 (Anion exchange transporter) (Solute carrier family 26 member 8) SLC26A8 TAT1 Homo sapiens (Human) anion transport [GO:0006820]; chloride transport [GO:0006821]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oxalate transport [GO:0019532]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; chloride transport [GO:0006821]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oxalate transport [GO:0019532]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272] anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] GO:0005254; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0019531; GO:0019532; GO:0030317; GO:0048240; GO:0051321 AQLERSAISGFSSK 2.980000019 1 1 0.086437835 1481.609317 14.22247 15.93213 0 0 14.82129 12.2498 0 0 0 0 0 0 0 0 13.89064 11.00988 0 0 0 0 15.88099 10.95688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RN5 MED15_HUMAN "Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component, ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein, PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein, TIG-1) (Trinucleotide repeat-containing gene 7 protein)" MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827] core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827] transcription coregulator activity [GO:0003712] GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016592; GO:0019827; GO:0032968; GO:0051123; GO:0060261; GO:0070847 DIHNKK 9.819999695 1 1 0.043596544 754.4759413 11.14231 15.20116 12.50403 14.0428 16.92606 0 11.27378 0 15.08904 14.7549 0 11.00718 0 0 0 0 16.46969 0 0 0 0 0 0 0 0 0 0 0 17.1048 0 0 0 0 0 0 0 0 0 0 0 0 16.79213 0 0 0 0 16.42841 0 Q96RP9 EFGM_HUMAN "Elongation factor G, mitochondrial, EF-Gmt (Elongation factor G 1, mitochondrial, mEF-G 1) (Elongation factor G1, hEFG1)" GFM1 EFG EFG1 GFM Homo sapiens (Human) mitochondrial translational elongation [GO:0070125] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125 FVLQDGAHHMVDSNEISFIR 5.78000021 0.692224503 0.692224503 0.043368459 2329.930365 16.39815 13.65814 0 0 15.1069 0 0 13.49265 14.76931 14.67626 16.03262 0 13.27497 0 0 14.04444 16.67069 13.29428 0 0 11.11206 0 17.00082 14.28784 16.85775 0 0 0 10.45704 15.12459 15.60628 16.61116 14.26531 0 16.75977 0 13.38046 15.84953 15.39929 15.0996 15.46471 11.71917 15.33525 0 14.16784 11.93472 15.29408 0 Q96RQ3 MCCA_HUMAN "Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial, MCCase subunit alpha, EC 6.4.1.4 (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)" MCCC1 MCCA Homo sapiens (Human) biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552] "3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]" "3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]" ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485] GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202 EGAQANR 3.25999999 1 1 0.096345899 745.1622289 0 14.55389 0 0 0 14.10566 0 0 0 0 0 15.53908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.98219 0 15.01819 0 15.35862 0 0 0 0 14.70534 0 14.12871 0 0 0 0 0 0 0 14.56664 0 0 Q96RQ9 OXLA_HUMAN "L-amino-acid oxidase, LAAO, LAO, EC 1.4.3.2, EC 1.4.3.25 (Interleukin-4-induced protein 1, IL4-induced protein 1, hIL4I1) (Protein Fig-1, hFIG1)" IL4I1 FIG1 UNQ636/PRO1265 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225]; L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; adaptive immune response [GO:0002250]; cellular amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572] L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592] GO:0001669; GO:0001716; GO:0001772; GO:0002250; GO:0002819; GO:0002841; GO:0005576; GO:0005764; GO:0006559; GO:0006569; GO:0006572; GO:0009063; GO:0016491; GO:0019440; GO:0042130; GO:0045577; GO:0045591; GO:0045944; GO:0046592; GO:0050868; GO:0097225; GO:0106329 DQNTGWIGELGAMR 3.50999999 0.745299101 0.745299101 1.83E-12 1560.945427 0 0 0 16.02733 0 10.13715 13.45659 14.2183 0 0 0 15.07978 14.72212 0 13.90612 0 12.4409 0 0 13.22606 16.81295 15.14803 14.62738 0 0 14.38526 0 11.95991 0 16.28201 9.281772 14.24986 0 0 0 13.32256 14.31382 16.84454 14.65702 0 14.34494 0 0 15.88293 0 13.22132 14.44812 17.92929 Q96RR1 PEO1_HUMAN "Twinkle mtDNA helicase, EC 3.6.4.12 (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)" TWNK C10orf2 PEO1 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697] GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0006390; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333 LVTGPGK 9.210000038 0.591022015 0.591022015 0.061752726 671.6111954 15.70056 16.31119 0 15.91393 0 0 15.09916 11.97528 13.77825 0 16.59989 14.29872 12.83001 15.18396 0 0 12.6501 12.68561 0 14.27297 0 13.08539 15.07582 0 15.98958 15.81273 15.95341 0 13.5602 0 15.52721 17.2032 0 0 14.93792 0 16.79572 15.43298 0 14.76706 16.26691 16.46478 15.40903 14.35938 16.57383 0 15.45235 15.52317 Q96RR4 KKCC2_HUMAN "Calcium/calmodulin-dependent protein kinase kinase 2, CaM-KK 2, CaM-kinase kinase 2, CaMKK 2, EC 2.7.11.17 (Calcium/calmodulin-dependent protein kinase kinase beta, CaM-KK beta, CaM-kinase kinase beta, CaMKK beta)" CAMKK2 CAMKKB KIAA0787 Homo sapiens (Human) "calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]" cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]" ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0000165; GO:0001934; GO:0004683; GO:0004712; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0019722; GO:0034614; GO:0043005; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:0106310; GO:1903599 RQPPGHRPAPR 3.440000057 1 1 1.37E-12 1269.028359 10.98062 13.95328 15.28281 9.27204 6.496202 15.85831 13.79899 11.34265 11.98254 13.61245 11.80385 0 0 10.0169 0 0 0 0 0 0 0 0 0 0 14.03988 0 14.50357 0 0 0 0 0 0 0 13.50944 0 13.84489 0 0 12.66824 0 0 0 0 0 0 0 0 Q96RS6 NUDC1_HUMAN NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66) NUDCD1 CML66 Homo sapiens (Human) immune system process [GO:0002376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; immune system process [GO:0002376] GO:0002376; GO:0005654; GO:0005829 ESNSLEISLIK 3.74000001 1 1 6.86E-13 1233.784818 0 0 13.06576 14.93418 0 0 0 0 13.63858 14.41376 16.07081 14.62479 16.88667 0 12.51128 0 0 0 0 15.23038 0 0 16.51826 0 0 15.21508 0 0 0 0 0 15.34036 0 14.65071 0 0 0 0 13.82399 0 14.69724 0 0 0 0 0 13.57676 0 Q96RT1 ERBIN_HUMAN Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2) ERBIN ERBB2IP KIAA1225 LAP2 Homo sapiens (Human) basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165] ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200] GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0045104; GO:0045175; GO:0045197; GO:0046579; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072 HIEAKK 4.630000114 0.358743131 0.358743131 0.305874074 724.6920008 16.13137 15.77234 15.19372 12.82301 15.33523 14.19137 15.27038 0 9.881262 14.50461 0 16.86325 14.72575 15.39606 17.00359 14.84798 14.97276 0 14.8843 15.3043 0 16.18277 16.01595 16.98275 15.27336 16.31222 0 0 0 15.85604 16.99117 14.75816 0 17.11351 0 0 14.66174 14.28981 15.34387 16.57476 0 0 0 16.20553 0 15.88365 15.71196 16.38605 Q96RT6 CTGE2_HUMAN "cTAGE family member 2, Protein cTAGE-2 (Cancer/testis antigen 21.2, CT21.2)" CTAGE1 CTAGE2 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971 SFNMPSLDK 5.829999924 1 1 0.111392974 1040.784977 15.26548 15.79167 15.05122 16.28523 16.7243 16.27213 15.93737 17.95631 15.79134 16.61292 18.65613 12.48734 16.25355 10.75951 15.07442 16.03095 15.98283 0 0 13.38738 0 16.97792 15.27508 15.43223 16.59374 16.59237 0 0 15.87217 12.58646 13.79294 15.91653 16.71986 17.29678 15.84086 13.74419 16.65074 16.11854 16.55622 18.50599 16.03995 15.01472 16.43048 0 0 15.52485 0 15.06931 Q96RT7 GCP6_HUMAN "Gamma-tubulin complex component 6, GCP-6" TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321 VAYNALFTNLFQDETQQLQPDMSK 3.710000038 1 1 4.58E-12 2817.864039 14.79089 13.54546 12.40839 7.565321 0 0 11.91343 14.50856 0 10.95154 13.96026 0 13.50575 10.972 0 11.46082 0 0 0 0 0 0 16.95701 12.49467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RT8 GCP5_HUMAN "Gamma-tubulin complex component 5, GCP-5" TUBGCP5 GCP5 KIAA1899 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0031122; GO:0043015; GO:0051225; GO:0051321 EDSGIQVDR 4.360000134 0.73765415 0.73765415 0.214626967 1020.099057 15.18769 14.32119 15.76901 0 14.10661 15.96028 0 0 14.90496 15.31868 14.11565 0 14.73929 14.13966 14.48416 0 0 13.40203 10.26766 0 0 0 16.20248 0 14.57754 14.95861 0 13.61829 14.29985 13.47078 13.93451 13.29389 15.95114 15.54482 14.12583 0 0 12.77248 0 16.7018 15.19198 15.09867 13.86844 0 15.82347 14.75663 0 11.81223 Q96RU8 TRIB1_HUMAN "Tribbles homolog 1, TRB-1 (G-protein-coupled receptor-induced gene 2 protein, GIG-2) (SKIP1)" TRIB1 C8FW GIG2 TRB1 Homo sapiens (Human) JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496] mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106] GO:0004860; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0007254; GO:0014912; GO:0031434; GO:0031625; GO:0031665; GO:0032436; GO:0032496; GO:0043405; GO:0043433; GO:0045645; GO:0045651; GO:0045659; GO:0048662; GO:0055106; GO:0061629 IADYLLLPLAER 8.050000191 1 1 0.017824164 1385.873234 16.78188 16.58784 16.72416 18.27604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RV3 PCX1_HUMAN Pecanex-like protein 1 (Pecanex homolog protein 1) PCNX1 KIAA0805 KIAA0995 PCNX PCNXL1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LKAGR 2.880000114 1 1 0.278004211 543.2485563 0 20.5731 17.36781 16.51984 0 17.26852 18.95025 18.76805 0 17.05386 0 0 0 0 0 0 17.52077 0 0 0 0 0 18.31536 0 0 0 0 0 18.28863 0 0 0 0 0 0 0 0 0 0 0 0 0 17.98711 0 0 16.56304 0 16.55676 Q96RW7 HMCN1_HUMAN "Hemicentin-1 (Fibulin-6, FIBL-6)" HMCN1 FIBL6 Homo sapiens (Human) actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527 AIVESIR 2.630000114 1 1 0.260429502 788.8506133 0 0 0 0 0 0 18.75312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.4004 20.82538 0 0 0 0 0 0 0 0 18.55664 0 0 21.84766 0 18.02425 0 0 0 0 0 0 0 Q96RY5 CRML_HUMAN Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein) CRAMP1 C16orf34 CRAMP1L HN1L KIAA1426 Homo sapiens (Human) pattern specification process [GO:0007389] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; pattern specification process [GO:0007389] chromatin binding [GO:0003682]; DNA binding [GO:0003677] GO:0003677; GO:0003682; GO:0005634; GO:0007389 CPRSGAEGK 7.46999979 0.490418285 0.490418285 0.070337271 960.8222059 0 0 0 0 0 0 0 16.03264 16.52279 0 0 0 12.612 0 16.93018 16.84417 16.36393 17.33912 17.84674 0 0 17.33586 18.18736 17.51948 17.14404 0 0 0 0 0 0 0 16.11242 0 17.11288 17.57797 0 0 14.28873 0 0 0 0 0 15.40512 16.46831 0 0 Q96RY7 IF140_HUMAN Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) IFT140 KIAA0590 WDTC2 Homo sapiens (Human) cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097542; GO:1902017; GO:1905515; GO:1990403 GRVAMWR 12.39000034 1 1 0.155691551 890.5283628 0 0 0 16.29333 18.77903 0 0 0 14.09124 14.4964 0 0 14.70416 15.08313 0 0 13.0245 16.99046 0 0 0 0 0 13.93243 0 16.66434 0 0 0 0 0 0 15.95499 0 18.58183 16.80708 0 0 0 13.94795 0 0 0 15.68536 0 0 0 0 Q96S07 PRR25_HUMAN Proline-rich protein 25 PRR25 gs64 Homo sapiens (Human) APSHK 4.239999771 0.303009421 0.303009421 0.18895109 539.3587027 0 17.40725 16.85532 0 19.07813 0 0 17.12169 0 16.02677 16.48391 0 19.31361 17.90567 0 0 17.54667 0 16.38752 17.40187 16.6707 17.49533 17.98218 17.00245 17.92808 16.27794 17.94334 16.12704 16.70947 16.59599 18.2582 18.23448 16.19765 16.0168 16.14469 16.94123 15.85575 17.5268 16.33521 0 18.86763 0 0 16.80551 17.13024 18.04294 17.50832 16.20423 Q96S19 MTL26_HUMAN Methyltransferase-like 26 METTL26 JFP2 C16orf13 Homo sapiens (Human) LVAAAAERNK 13.21000004 1 1 0.23028507 1041.821052 0 16.61744 0 0 15.58078 15.47421 18.31667 0 0 16.76577 15.4719 0 17.18115 0 15.02533 0 16.47676 0 0 0 15.2772 0 0 0 0 17.50571 18.40803 0 16.67106 0 0 17.5364 0 0 0 17.66357 17.47519 16.75557 0 0 0 0 0 0 0 16.28529 15.05744 0 Q96S21 RB40C_HUMAN Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3) RAB40C RARL RASL8C Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0072659 SFSMANGMNAVMMHGR 5.730000019 0.911000013 0.911000013 0.175734238 1740.977748 0 0 0 0 0 16.06022 0 0 0 0 0 0 0 0 0 6.11677 0 15.44072 0 0 0 0 16.57515 0 0 17.75695 0 0 0 0 0 0 0 16.51082 0 0 0 0 0 0 0 0 0 0 0 16.28316 15.92706 0 Q96S38 KS6C1_HUMAN "Ribosomal protein S6 kinase delta-1, S6K-delta-1, EC 2.7.11.1 (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein)" RPS6KC1 RPK118 Homo sapiens (Human) signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signal transduction [GO:0007165] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 TEGNGVDTK 10.28999996 0.971950829 0.971950829 0.250906693 920.3631013 0 0 0 13.99242 15.55183 12.20423 0 17.58697 0 0 0 0 0 0 0 16.64551 0 0 0 13.65823 13.07855 0 13.70263 0 0 0 16.08714 15.27891 0 0 0 16.57946 16.01626 14.461 0 0 0 0 16.20814 0 0 15.44356 0 14.95887 0 0 0 0 Q96S55 WRIP1_HUMAN "ATPase WRNIP1, EC 3.6.1.- (Werner helicase-interacting protein 1)" WRNIP1 WHIP Homo sapiens (Human) DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174] membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116] GO:0000731; GO:0003677; GO:0005524; GO:0005634; GO:0006261; GO:0006282; GO:0008047; GO:0016020; GO:0016887; GO:0017116; GO:0030174; GO:0042802; GO:0045087; GO:0046872; GO:0048471 SSSPGR 4.960000038 0.270875603 0.270875603 0.198796935 589.4431411 0 0 0 0 16.52182 0 18.04091 17.15721 12.29719 17.77265 17.82215 16.49366 21.08745 20.33983 20.53712 0 16.36317 18.92221 21.11167 21.07621 20.5849 20.36367 21.01041 0 20.36866 17.53742 20.22149 19.61874 17.38667 19.17567 18.71462 0 20.03448 20.19569 20.82879 18.9829 21.40565 20.28275 20.83413 17.15159 20.37288 19.70316 20.16759 0 17.61368 19.09914 17.40028 20.93467 Q96S59 RANB9_HUMAN "Ran-binding protein 9, RanBP9 (BPM-L) (BPM90) (Ran-binding protein M, RanBPM) (RanBP7)" RANBP9 RANBPM Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; protein-containing complex assembly [GO:0065003] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; small GTPase binding [GO:0031267]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; protein-containing complex assembly [GO:0065003] enzyme binding [GO:0019899]; small GTPase binding [GO:0031267] GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007010; GO:0007020; GO:0007166; GO:0016604; GO:0019899; GO:0031267; GO:0065003; GO:0070373; GO:1902993 STDQTVLEELASIK 6.909999847 0.936648905 0.936648905 0.149359547 1537.101937 15.27952 14.32776 10.41399 14.45811 14.03985 13.87245 14.09305 12.78119 13.07953 11.81522 0 12.11851 10.99522 0 15.62578 15.29865 0 12.09602 14.21923 13.62428 15.24174 0 0 0 0 15.09571 0 15.33407 15.81475 12.51458 0 13.48117 0 0 0 0 0 15.3798 0 15.26056 15.02163 0 11.60947 0 0 0 13.56068 0 Q96S66 CLCC1_HUMAN Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1) CLCC1 KIAA0761 MCLC Homo sapiens (Human) chloride transport [GO:0006821] chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nuclear membrane [GO:0031965] chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nuclear membrane [GO:0031965]; chloride channel activity [GO:0005254]; chloride transport [GO:0006821] chloride channel activity [GO:0005254] GO:0000139; GO:0005254; GO:0005783; GO:0005789; GO:0006821; GO:0016020; GO:0031965; GO:0034707; GO:0043231; GO:0044233 LAFAQHQAEVAKMEPLNNVCAK 8.479999542 1 1 0.231356321 2484.502101 0 17.62841 0 0 16.97786 0 0 0 0 17.1471 14.65931 17.77365 0 0 0 18.061 0 0 18.15069 0 0 0 0 0 17.57191 19.41339 13.30984 0 0 0 0 0 18.11098 15.53786 16.56873 0 0 0 17.49703 0 0 0 0 0 0 0 13.74309 0 Q96S79 RSLAB_HUMAN "Ras-like protein family member 10B, EC 3.6.5.2 (Ras-like protein VTS58635) (Ras-related protein 17, RRP17)" RASL10B Homo sapiens (Human) positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] G protein activity [GO:0003925]; GTP binding [GO:0005525] GO:0003050; GO:0003925; GO:0005525; GO:0005886; GO:0090277 GVGKSAIVR 11.52999973 0.530512333 0.530512333 0.303017589 887.9032171 0 0 17.38903 0 0 0 0 0 0 18.04989 17.4973 17.04066 16.11793 18.17517 18.29242 0 0 17.33017 0 0 18.55495 0 0 18.29915 18.30184 0 18.63243 0 0 0 19.14858 18.86005 18.63622 0 16.36559 0 0 0 17.61594 0 15.47041 0 0 0 18.48289 0 0 19.34677 Q96S90 LYSM1_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 1 LYSMD1 SB145 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 SYGSLVQSACSPVR 2.150000095 1 1 0.269300597 1510.350618 0 15.72773 13.42897 0 0 0 0 14.87053 0 0 15.39044 13.2282 0 0 15.32595 0 0 0 0 0 0 0 16.82746 15.50476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S94 CCNL2_HUMAN Cyclin-L2 (Paneth cell-enhanced expression protein) CCNL2 SB138 Homo sapiens (Human) regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GO:0000307; GO:0005634; GO:0005654; GO:0006357; GO:0016538; GO:0016607; GO:0042981; GO:0043231; GO:0043484; GO:0046605; GO:0051726 ADNPGK 18.65999985 1 1 4.60E-13 601.3613386 0 0 0 0 0 12.86339 0 0 14.98291 0 0 0 16.15667 0 0 0 0 15.44882 16.30536 0 0 0 0 0 0 0 0 0 14.87085 0 0 14.34394 0 13.00723 16.71574 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S96 PEBP4_HUMAN "Phosphatidylethanolamine-binding protein 4, PEBP-4, hPEBP4 (Protein cousin-of-RKIP 1)" PEBP4 CORK1 UNQ1933/PRO4408 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 GADLKK 8.93999958 1 1 0.111527217 631.1762051 0 15.77912 15.5648 0 0 0 0 0 0 0 0 0 15.83311 0 0 0 0 15.12917 0 16.39205 0 0 0 0 16.11968 0 0 0 0 0 0 0 0 0 11.34912 15.47275 0 0 17.14627 0 0 0 17.77306 15.76693 17.34082 0 0 0 Q96S97 MYADM_HUMAN Myeloid-associated differentiation marker (Protein SB135) MYADM UNQ553/PRO1110 Homo sapiens (Human) establishment of endothelial barrier [GO:0061028]; membrane raft organization [GO:0031579]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of protein kinase C signaling [GO:0090038]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659] cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; establishment of endothelial barrier [GO:0061028]; membrane raft organization [GO:0031579]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of protein kinase C signaling [GO:0090038]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659] GO:0001726; GO:0001933; GO:0005886; GO:0005911; GO:0010629; GO:0016021; GO:0030335; GO:0030837; GO:0030864; GO:0031579; GO:0034115; GO:0045121; GO:0061028; GO:0072659; GO:0090038; GO:1900026 DVSCSR 2.069999933 1 1 0.130294593 721.8006974 15.26962 14.79517 0 0 14.24597 0 0 13.93464 0 0 15.63505 11.09944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.20454 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S99 PKHF1_HUMAN "Pleckstrin homology domain-containing family F member 1, PH domain-containing family F member 1 (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains, Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15)" PLEKHF1 APPD LAPF ZFYVE15 Homo sapiens (Human) apoptotic process [GO:0006915]; endosome organization [GO:0007032]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050] endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; apoptotic process [GO:0006915]; endosome organization [GO:0007032]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050] metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] GO:0005634; GO:0005764; GO:0005765; GO:0006915; GO:0007032; GO:0010008; GO:0010314; GO:0010508; GO:0016050; GO:0032266; GO:0035091; GO:0046872; GO:0048471; GO:0070273; GO:0072659; GO:2001244 ATDICMR 2.74000001 1 1 0.190116451 867.068803 15.5297 0 0 16.03974 0 0 0 15.18839 13.55598 0 12.33811 15.11909 0 0 17.37009 0 0 0 0 0 0 0 0 17.57055 0 0 17.26797 0 16.1292 0 16.21218 16.35348 16.88141 0 14.97111 0 15.62398 16.76866 0 16.28853 15.46963 0 0 16.39125 17.43627 0 0 0 Q96SB8 SMC6_HUMAN "Structural maintenance of chromosomes protein 6, SMC protein 6, SMC-6, hSMC6" SMC6 SMC6L1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] "chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]" ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016607; GO:0016925; GO:0030915; GO:0031625; GO:0032204; GO:0035061; GO:0035861; GO:0051984; GO:0090398; GO:0097431 ATQLEQMK 9.18999958 1 1 2.29E-13 947.9222914 15.31949 12.47379 11.00044 0 14.2323 0 13.78626 0 0 0 0 0 0 0 0 0 14.63021 0 0 0 0 0 0 14.96844 0 0 0 0 0 0 0 0 0 14.05538 0 0 0 0 0 13.91659 0 0 0 0 0 15.28677 15.4224 0 Q96SE0 ABHD1_HUMAN "Protein ABHD1, EC 3.1.1.- (Alpha/beta hydrolase domain-containing protein 1, Abhydrolase domain-containing protein 1) (Lung alpha/beta hydrolase 1)" ABHD1 LABH1 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793] acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338] GO:0008126; GO:0016021; GO:0034338; GO:0044255; GO:0047372; GO:0051792; GO:0051793 SLETPLNSLLFNQPLTAGLCQLVERNR 2.059999943 0.599841416 0.599841416 0.131556537 3083.428633 16.75657 17.07102 15.9504 0 14.31354 0 13.47725 13.85929 15.15331 16.70962 10.50878 10.13145 10.02977 0 13.94253 0 0 0 0 0 10.7707 0 0 0 11.7487 0 14.50843 0 14.65458 12.98879 0 16.35893 0 0 14.53845 0 0 16.12487 0 0 0 0 0 0 0 0 14.12709 14.82086 Q96SE7 ZN347_HUMAN Zinc finger protein 347 (Zinc finger protein 1111) ZNF347 ZNF1111 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 CNECGKAFSQTSK 8.199999809 1 1 0.298758484 1517.245952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SI1 KCD15_HUMAN BTB/POZ domain-containing protein KCTD15 (Potassium channel tetramerization domain-containing protein 15) KCTD15 Homo sapiens (Human) protein homooligomerization [GO:0051260] identical protein binding [GO:0042802]; protein homooligomerization [GO:0051260] identical protein binding [GO:0042802] GO:0042802; GO:0051260 QHYFIDRDGEIFR 16.87999916 1 1 0.202848357 1693.658509 14.3044 15.58041 15.44211 0 0 0 0 16.49517 16.70099 0 0 0 15.69006 15.50015 0 14.77938 0 16.24109 0 0 0 0 0 0 16.87111 0 15.45028 15.47368 15.63458 0 0 15.87916 0 0 15.86123 15.15381 0 0 0 0 0 0 0 0 0 0 0 0 Q96SI9 STRBP_HUMAN Spermatid perinuclear RNA-binding protein STRBP SPNR Homo sapiens (Human) mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634] cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286] DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] GO:0002177; GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005737; GO:0007286; GO:0007638; GO:0008017 DGENVSMK 7.099999905 1 1 0.261751803 896.1442586 17.72326 14.5416 17.29631 18.45393 10.22477 17.37814 16.58452 15.43011 16.84069 15.87522 16.59006 17.63683 14.47468 11.77258 14.99778 16.18056 16.17727 16.48198 15.18269 0 14.53541 0 14.99592 15.33337 15.86331 14.58824 14.58508 13.05041 13.07309 15.30068 15.63536 17.67016 15.41707 17.2534 0 16.56513 17.03634 0 15.36529 15.73541 16.30481 0 14.93664 14.0878 13.97335 0 16.48612 0 Q96SL4 GPX7_HUMAN "Glutathione peroxidase 7, GPx-7, GSHPx-7, EC 1.11.1.9 (CL683)" GPX7 GPX6 UNQ469/PRO828 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599] catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601] GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0005788; GO:0034599 EIESFARR 9.859999657 1 1 0.367024306 1008.145246 0 17.97035 17.59513 19.16829 0 0 0 0 19.65768 18.78472 19.52823 0 0 18.69123 18.75334 17.05803 0 18.04609 16.87219 0 0 0 0 0 0 0 0 17.2795 18.24667 0 18.02516 0 0 0 0 19.21132 0 19.16334 0 19.21898 0 0 19.25046 16.79088 0 0 17.73784 0 Q96SL8 FIZ1_HUMAN Flt3-interacting zinc finger protein 1 (Zinc finger protein 798) FIZ1 ZNF798 Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944] metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] GO:0000785; GO:0001934; GO:0003713; GO:0005634; GO:0005737; GO:0030971; GO:0045944; GO:0046872; GO:0061629 EPASGEPPSGSGR 5.039999962 1 1 0.109948659 1226.912283 15.67289 15.15608 12.67229 13.42191 0 12.75235 12.38848 14.424 14.86943 13.43784 15.11152 12.78512 0 12.52028 0 0 0 0 14.33319 0 0 0 0 0 0 0 15.35902 0 15.19522 13.63452 0 15.55783 0 0 0 0 0 0 0 11.8382 0 0 0 0 0 0 0 0 Q96SM3 CPXM1_HUMAN "Probable carboxypeptidase X1, EC 3.4.17.- (Metallocarboxypeptidase CPX-1)" CPXM1 CPX1 CPXM UNQ3015/PRO9782 Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485 AVIKWMK 5.179999828 0.497409791 0.497409791 0.159511272 891.4334585 13.54905 14.03239 12.98184 15.87752 0 0 15.39211 0 0 15.10494 0 0 0 0 15.84776 11.40079 0 0 0 14.9667 0 16.50886 15.60512 15.71248 0 0 0 0 0 0 15.85237 11.69096 12.92892 15.85312 0 11.66874 15.19145 15.13971 16.53371 13.92436 0 15.15163 0 0 0 0 11.83354 14.69322 Q96SN7 ORAI2_HUMAN Protein orai-2 (CAP-binding protein complex-interacting protein 2) (Transmembrane protein 142B) ORAI2 C7orf19 CBCIP2 TMEM142B PP1729 Homo sapiens (Human) store-operated calcium entry [GO:0002115] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; store-operated calcium channel activity [GO:0015279]; store-operated calcium entry [GO:0002115] store-operated calcium channel activity [GO:0015279] GO:0002115; GO:0015279; GO:0016020; GO:0016021 EIEELHK 5.559999943 1 1 0.291485642 898.9332896 15.6368 14.60042 0 0 17.85645 0 0 17.08809 19.07053 0 0 0 0 0 0 0 18.65363 17.60496 15.66645 16.67428 0 0 0 16.07788 18.72415 0 0 17.94973 16.78736 0 0 19.11083 16.7224 18.54508 17.43733 0 0 0 0 0 0 0 0 0 0 0 17.89318 0 Q96SN8 CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215) CDK5RAP2 CEP215 KIAA1633 Homo sapiens (Human) "brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]" cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922] "cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]" calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631] GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044877; GO:0045664; GO:0045665; GO:0045736; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431 EMDSDQQR 11.84000015 1 1 0.213825838 1007.804298 15.52174 0 0 15.17843 14.88437 0 11.86898 0 0 0 0 0 0 0 0 0 0 0 14.79735 0 15.59648 15.84309 0 0 16.38095 16.83051 18.07153 15.40231 0 14.28755 0 16.7475 0 0 0 0 0 0 0 14.2852 0 0 0 0 16.89055 14.18045 0 15.80095 Q96SQ7 ATOH8_HUMAN "Transcription factor ATOH8 (Class A basic helix-loop-helix protein 21, bHLHa21) (Helix-loop-helix protein hATH-6, hATH6) (Protein atonal homolog 8)" ATOH8 ATH6 BHLHA21 Homo sapiens (Human) "formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010595; GO:0010629; GO:0016607; GO:0030182; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060395; GO:0070888; GO:0140297; GO:1902895 KRPGEATAASSEIK 5.769999981 0.26878503 0.26878503 0.186783953 1445.660263 16.66556 13.59684 0 15.49148 16.22759 0 0 18.85066 15.79321 12.62696 15.63031 14.88519 14.82375 13.25026 13.66591 16.0058 15.52424 15.73658 0 16.8588 15.53324 0 14.07691 0 16.46077 15.25827 10.7288 16.93447 11.35421 16.84392 17.64842 15.39421 12.72631 14.89924 15.62415 15.01542 18.93878 13.18177 0 0 15.5371 15.95812 15.61308 0 14.00331 0 15.41927 13.98227 Q96SQ9 CP2S1_HUMAN "Cytochrome P450 2S1, EC 1.14.14.- (CYPIIS1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Thromboxane-A synthase, EC 5.3.99.5)" CYP2S1 UNQ891/PRO1906 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; organic acid metabolic process [GO:0006082]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; thromboxane-A synthase activity [GO:0004796]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; organic acid metabolic process [GO:0006082]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805]" "12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; thromboxane-A synthase activity [GO:0004796]" GO:0004497; GO:0004796; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006693; GO:0006805; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0016836; GO:0019373; GO:0020037; GO:0036134; GO:0042573; GO:0043231; GO:0106256 ELGAGQAPSLGDR 7.690000057 1 1 0.221498581 1271.42605 0 0 13.62265 13.38288 13.73647 15.41212 0 0 12.14648 0 0 0 0 16.74075 0 0 0 0 0 15.91962 0 0 0 0 0 0 0 15.86833 0 0 0 15.65176 0 0 0 0 0 0 0 0 16.12254 0 0 16.21391 15.81791 0 0 0 Q96SR6 ZN382_HUMAN "Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1, KS1) (Multiple zinc finger and krueppel-associated box protein KS1)" ZNF382 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 NISPIK 9.800000191 1 1 0.265918646 671.3170224 0 0 0 16.66912 0 0 0 18.76792 0 0 17.69208 17.92773 18.34469 0 0 0 17.61824 0 0 0 15.71303 18.41014 0 18.18984 0 18.5273 0 0 0 17.07749 19.18982 0 0 0 0 19.70863 16.54165 0 0 0 19.05301 17.2536 0 0 0 16.41957 16.23256 0 Q96ST2 IWS1_HUMAN Protein IWS1 homolog (IWS1-like protein) IWS1 IWS1L Homo sapiens (Human) mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380] GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010793; GO:0016973; GO:0050684; GO:0090239; GO:2001253 EQRDLEQMPQR 6.650000095 1 1 0.528592974 1446.560338 0 17.07082 0 0 0 0 0 0 0 0 0 19.50903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8513 0 0 0 0 0 0 0 17.40829 0 0 0 0 0 0 Q96ST3 SIN3A_HUMAN Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) SIN3A Homo sapiens (Human) "activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]" chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031453; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0061629; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1902455; GO:1902459; GO:1903351; GO:2000678 AEQLMSDENCFK 6.619999886 1 1 0.425375314 1486.919999 0 0 0 0 0 0 0 0 20.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.66527 Q96ST8 CEP89_HUMAN "Centrosomal protein of 89 kDa, Cep89 (Centrosomal protein 123, Cep123) (Coiled-coil domain-containing protein 123)" CEP89 CCDC123 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515] GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007005; GO:0007268; GO:0031514; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515 EESLNIEGLPSKGPIPPWLLDIK 3.200000048 1 1 0 2546.119868 14.43563 13.07532 12.53251 12.13734 14.55888 0 14.58655 0 15.82404 15.67295 0 15.24282 15.97853 0 0 15.19269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.25316 0 0 0 0 0 0 14.73586 0 Q96SW2 CRBN_HUMAN Protein cereblon CRBN AD-006 Homo sapiens (Human) locomotory exploration behavior [GO:0035641]; negative regulation of large conductance calcium-activated potassium channel activity [GO:1902607]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; locomotory exploration behavior [GO:0035641]; negative regulation of large conductance calcium-activated potassium channel activity [GO:1902607]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016567; GO:0031333; GO:0031334; GO:0031464; GO:0035641; GO:0043161; GO:0044325; GO:0046872; GO:0048471; GO:1902607 FTATKK 4.480000019 1 1 0.301726427 692.1001404 12.60059 12.38813 0 15.7069 14.98878 13.5714 0 14.45198 0 15.80679 15.78736 0 13.87046 15.70273 0 0 16.04939 14.8371 15.08657 16.22285 16.07194 12.82401 14.62371 15.94733 0 0 0 15.79876 0 0 16.44646 0 0 15.56726 0 16.65672 15.92037 16.00451 0 0 0 0 0 14.88862 16.80204 0 15.76425 0 Q96SZ6 CK5P1_HUMAN "Mitochondrial tRNA methylthiotransferase CDK5RAP1, EC 2.8.4.3 (CDK5 activator-binding protein C42) (CDK5 regulatory subunit-associated protein 1) (mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase) (mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase)" CDK5RAP1 C20orf34 CGI-05 HSPC167 Homo sapiens (Human) brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664] cytosol [GO:0005829]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664]" "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]" GO:0005739; GO:0005829; GO:0007420; GO:0019901; GO:0035597; GO:0045664; GO:0045736; GO:0045903; GO:0046872; GO:0051539; GO:0070131; GO:0070900 IGILGCMAER 6.710000038 1 1 0.118224667 1135.76628 16.36651 15.23431 14.85616 0 0 0 0 0 0 12.53231 0 0 0 0 0 0 0 13.81719 0 0 0 0 0 0 0 13.29267 0 0 0 12.79492 0 0 0 0 0 0 0 0 0 0 0 0 0 15.33061 0 0 0 0 Q96T23 RSF1_HUMAN "Remodeling and spacing factor 1, Rsf-1 (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex)" RSF1 HBXAP XAP8 Homo sapiens (Human) "chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of transcription, DNA-templated [GO:0006355]" histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0016584; GO:0031213; GO:0031497; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434 DISTITGHR 3.410000086 1 1 0.181941443 1001.847774 0 14.49133 15.13993 0 0 0 0 15.42573 0 0 0 0 0 0 0 13.78088 13.74926 0 0 11.32166 0 0 0 0 0 12.98721 16.11982 12.65382 0 12.99958 15.13828 14.85141 15.99914 16.11287 0 13.93956 15.43191 0 15.87872 0 15.79628 0 0 0 15.10901 0 11.66641 0 Q96T37 RBM15_HUMAN RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) RBM15 OTT OTT1 Homo sapiens (Human) "branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]" nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674 GDDLR 6.539999962 0.496027619 0.496027619 0.181562555 575.365418 16.10862 0 12.75184 15.81387 15.19718 14.70358 16.19475 15.75039 0 15.59441 15.40921 15.20984 16.05683 15.90582 15.39076 16.34107 15.62669 14.90904 16.7959 14.11327 16.23496 19.48204 15.79876 17.82492 0 15.55127 15.81007 14.09708 0 13.87694 15.04842 15.73134 15.20498 16.19562 15.41819 0 16.55387 14.86275 16.15246 0 0 17.04159 0 16.55139 0 16.29192 14.97682 16.06903 Q96T49 PP16B_HUMAN "Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein, hTIMAP)" PPP1R16B ANKRD4 KIAA0823 Homo sapiens (Human) establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670] cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670] myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888] GO:0001938; GO:0005634; GO:0005886; GO:0008157; GO:0014066; GO:0016607; GO:0017020; GO:0019888; GO:0035304; GO:0035307; GO:0035308; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589; GO:1903670 FKAPIEEMEEK 4.119999886 1 1 0.327672672 1350.327825 14.61365 14.5841 0 11.77175 0 0 13.21395 0 0 15.16936 13.90962 9.41734 13.90473 0 15.53368 0 0 0 0 0 16.52857 0 0 0 0 0 16.02178 0 0 0 0 0 0 0 0 0 0 16.66595 0 0 0 14.89741 0 0 0 0 0 0 Q96T58 MINT_HUMAN Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) SPEN KIAA0929 MINT SHARP Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]" extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0045892; GO:0050769; GO:0061629; GO:0070062 EVSGFRGGGGGPAYGPPPSLHAR 6.579999924 1 1 0.005715284 2222.311972 0 15.11695 13.17962 0 0 14.19291 0 0 15.73882 0 14.9683 0 16.23098 0 0 0 13.33037 15.20945 0 13.03905 12.75838 0 0 12.34701 15.25301 14.60282 14.39942 0 15.49703 15.53049 0 15.92843 14.74467 15.57299 17.34275 14.9592 0 14.82701 0 15.17581 10.42837 0 0 14.84374 0 15.25805 0 0 Q96T60 PNKP_HUMAN "Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]" PNKP Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]" membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; base-excision repair, gap-filling [GO:0006287]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]" ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076] GO:0000718; GO:0003684; GO:0003690; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006261; GO:0006281; GO:0006287; GO:0006303; GO:0006979; GO:0009314; GO:0010836; GO:0016020; GO:0017076; GO:0032212; GO:0035861; GO:0046403; GO:0046404; GO:0046939; GO:0051103; GO:0051973; GO:1904355; GO:2001034 EMTDSSHIPVSDMVMYGYRK 6.179999828 0.514945686 0.514945686 1.37E-12 2347.223539 0 0 11.25953 8.171785 14.92719 0 0 15.04627 0 0 10.20333 0 0 0 0 0 11.87121 14.35869 0 0 0 0 0 0 0 11.89386 14.33433 0 0 0 0 10.30581 0 11.17291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T66 NMNA3_HUMAN "Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3, NMN/NaMN adenylyltransferase 3 (Nicotinamide-nucleotide adenylyltransferase 3, NMN adenylyltransferase 3) (Nicotinate-nucleotide adenylyltransferase 3, NaMN adenylyltransferase 3, EC 2.7.7.18) (Pyridine nucleotide adenylyltransferase 3, PNAT-3, EC 2.7.7.1)" NMNAT3 FKSG76 Homo sapiens (Human) NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165] ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515] GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0009165; GO:0009435 MFEVAR 3.099999905 0.45243305 0.45243305 0.185062888 753.1419922 0 15.88004 0 0 0 14.97457 15.07377 15.81154 0 0 13.2945 15.53693 0 0 0 0 0 0 0 0 0 16.51317 0 0 0 0 0 0 0 0 0 0 0 16.79811 0 0 16.65221 0 0 0 0 0 0 0 0 0 0 0 Q96T68 SETB2_HUMAN "Histone-lysine N-methyltransferase SETDB2, EC 2.1.1.366 (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2)" SETDB2 C13orf4 CLLD8 KMT1F Homo sapiens (Human) "cell division [GO:0051301]; chromosome segregation [GO:0007059]; heart looping [GO:0001947]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; left/right axis specification [GO:0070986]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]" chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; heart looping [GO:0001947]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; left/right axis specification [GO:0070986]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]" DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270] GO:0000278; GO:0001947; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0008270; GO:0010629; GO:0018024; GO:0045892; GO:0046974; GO:0051301; GO:0051567; GO:0070828; GO:0070986; GO:0090309 EHLNSK 3.170000076 1 1 0.23110508 726.2478564 0 14.84746 0 0 14.95415 0 13.00793 0 13.96753 16.03053 0 14.47085 0 0 0 0 0 0 0 17.26587 0 0 0 17.32068 0 0 15.28501 15.66145 0 0 0 14.68196 15.42152 0 13.07135 17.30405 14.22715 16.31206 16.41601 15.69855 18.8393 15.6053 0 0 16.26752 14.69668 12.6578 0 Q96T76 MMS19_HUMAN "MMS19 nucleotide excision repair protein homolog, hMMS19 (MET18 homolog) (MMS19-like protein)" MMS19 MMS19L Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; nucleotide-excision repair [GO:0006289]; phosphorelay signal transduction system [GO:0000160]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to hormone [GO:0009725]; transcription, DNA-templated [GO:0006351]" CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675] "CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; nucleotide-excision repair [GO:0006289]; phosphorelay signal transduction system [GO:0000160]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to hormone [GO:0009725]; transcription, DNA-templated [GO:0006351]" enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713] GO:0000160; GO:0003713; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0006259; GO:0006281; GO:0006289; GO:0006351; GO:0006974; GO:0007059; GO:0009725; GO:0016020; GO:0016226; GO:0019899; GO:0030159; GO:0030331; GO:0030674; GO:0045893; GO:0071817; GO:0097361; GO:0097428; GO:1905168 AGHAEVR 2.029999971 1 1 0.199851047 739.7790991 0 18.81296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T92 INSM2_HUMAN Insulinoma-associated protein 2 (Zinc finger protein IA-6) INSM2 IA6 Nbla106 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of cell cycle process [GO:0010564] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of cell cycle process [GO:0010564]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0001227; GO:0005634; GO:0005737; GO:0010564; GO:0017053; GO:0030182; GO:0046872 APTDCASGPAAAGIK 4.639999866 1 1 0.29860001 1388.091746 14.16959 9.892215 11.24663 0 0 0 0 0 14.39146 0 0 15.43289 0 17.33592 0 0 0 14.95545 15.79589 16.39163 15.18178 0 13.04356 14.95298 16.08754 0 0 16.16347 15.72042 0 15.83796 0 15.4786 17.39938 0 0 0 17.08297 18.09404 0 0 13.96257 0 0 15.88286 12.84362 10.85791 0 Q96TA0 PCDBI_HUMAN "Putative protocadherin beta-18, PCDH-beta-18 (PCDH-psi2)" PCDHB18P PCDHB18 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156 DSEMEKAPPF 7.510000229 1 1 0.15797786 1151.152956 0 0 13.64977 16.35867 17.02487 0 0 0 15.30784 0 17.12866 0 0 14.73598 0 0 18.21362 19.04873 15.22183 0 16.57934 16.27866 18.32946 19.30219 17.62154 0 0 17.82822 18.25268 15.91468 0 0 16.49941 0 16.89879 0 0 0 0 17.51923 0 0 0 17.238 0 0 0 0 Q96TA2 YMEL1_HUMAN "ATP-dependent zinc metalloprotease YME1L1, EC 3.4.24.- (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease, PAMP) (YME1-like protein 1)" YME1L1 FTSH1 YME1L UNQ1868/PRO4304 Homo sapiens (Human) cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0007005; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0016887; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872 AQALTQK 2.599999905 0.424447805 0.424447805 0.239080084 759.2813942 0 0 15.44431 14.6431 15.51435 13.9886 14.86959 0 0 0 15.11673 0 16.04613 15.69711 0 16.08986 14.18406 16.50471 14.72933 16.39733 15.44743 15.85407 16.13712 15.9109 15.45753 12.15497 0 15.89315 0 0 0 16.07516 15.45364 0 16.32187 0 16.94535 0 0 17.02253 0 0 17.1867 0 0 16.08475 0 15.07495 Q96TC7 RMD3_HUMAN "Regulator of microtubule dynamics protein 3, RMD-3, hRMD-3 (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51)" RMDN3 FAM82A2 FAM82C PTPIP51 hucep-10 UNQ3122/PRO10274 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874] microtubule binding [GO:0008017] GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005876; GO:0006874; GO:0006915; GO:0008017; GO:0016021; GO:0030154; GO:0044232; GO:0045171; GO:0097431 AEELQPGFSK 6.71999979 1 1 0.226141945 1106.730134 14.85175 0 0 0 0 0 0 10.8392 0 0 0 0 0 0 0 0 0 0 0 16.72335 0 14.67104 0 0 0 0 0 11.43155 0 0 15.42751 0 13.24428 0 15.45373 0 0 16.71289 0 0 0 0 0 0 0 0 0 0 Q99062 CSF3R_HUMAN "Granulocyte colony-stimulating factor receptor, G-CSF receptor, G-CSF-R (CD antigen CD114)" CSF3R GCSFR Homo sapiens (Human) cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165] endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165] cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023] GO:0004896; GO:0005576; GO:0005765; GO:0005886; GO:0005887; GO:0006952; GO:0007155; GO:0007165; GO:0009897; GO:0019221; GO:0019955; GO:0030593; GO:0030666; GO:0038023; GO:0043235; GO:0045637; GO:0051916 LGAELQPGGR 6.519999981 1 1 0.055745571 997.6324718 0 11.56724 10.38225 0 0 0 0 14.37028 13.84537 0 0 0 15.05363 0 0 15.58352 0 16.64899 0 0 15.12561 0 14.81675 15.04362 0 0 14.50421 0 15.72975 14.00825 16.5709 15.76704 0 0 16.11844 16.23436 16.58177 15.53652 0 0 16.61169 14.54531 0 0 0 17.32607 0 15.84271 Q99250 SCN2A_HUMAN Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) SCN2A NAC2 SCN2A1 SCN2A2 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; membrane depolarization during action potential [GO:0086010]; memory [GO:0007613]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cellular response to hypoxia [GO:0071456]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; membrane depolarization during action potential [GO:0086010]; memory [GO:0007613]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0007399; GO:0007613; GO:0008627; GO:0014704; GO:0016020; GO:0019228; GO:0030315; GO:0030424; GO:0031226; GO:0033268; GO:0033270; GO:0034706; GO:0034765; GO:0035725; GO:0042552; GO:0051402; GO:0071456; GO:0086010; GO:0098978; GO:0099056 GKAISR 2.400000095 1 1 0.059460775 630.4319503 0 14.23196 0 17.00305 0 0 15.90102 0 17.34574 0 0 0 0 0 0 0 0 15.77993 0 0 0 0 0 14.87364 0 0 0 0 0 0 0 0 17.04792 0 16.92716 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99259 DCE1_HUMAN "Glutamate decarboxylase 1, EC 4.1.1.15 (67 kDa glutamic acid decarboxylase, GAD-67) (Glutamate decarboxylase 67 kDa isoform)" GAD1 GAD GAD67 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; glutamate catabolic process [GO:0006538]; glutamate decarboxylation to succinate [GO:0006540]; locomotory exploration behavior [GO:0035641]; neurotransmitter biosynthetic process [GO:0042136]; protein-pyridoxal-5-phosphate linkage [GO:0018352]; social behavior [GO:0035176] axon terminus [GO:0043679]; cell cortex [GO:0005938]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; vesicle membrane [GO:0012506] axon terminus [GO:0043679]; cell cortex [GO:0005938]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; vesicle membrane [GO:0012506]; glutamate decarboxylase activity [GO:0004351]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; chemical synaptic transmission [GO:0007268]; glutamate catabolic process [GO:0006538]; glutamate decarboxylation to succinate [GO:0006540]; locomotory exploration behavior [GO:0035641]; neurotransmitter biosynthetic process [GO:0042136]; protein-pyridoxal-5-phosphate linkage [GO:0018352]; social behavior [GO:0035176] glutamate decarboxylase activity [GO:0004351]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170] GO:0004351; GO:0005886; GO:0005938; GO:0006538; GO:0006540; GO:0007268; GO:0012506; GO:0018352; GO:0030170; GO:0035176; GO:0035641; GO:0042136; GO:0042802; GO:0043679; GO:0048786; GO:0060077; GO:0061202 GVPDSPQR 4.449999809 0.339106143 0.339106143 0.225893559 854.719655 15.5365 15.60865 0 0 13.11221 16.55284 0 0 0 15.81161 15.60134 14.38773 0 0 0 15.65294 0 0 0 15.24115 0 15.09781 0 14.804 0 15.62419 15.73444 0 0 0 16.98518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99418 CYH2_HUMAN "Cytohesin-2 (ARF exchange factor) (ARF nucleotide-binding site opener, Protein ARNO) (PH, SEC7 and coiled-coil domain-containing protein 2)" CYTH2 ARNO PSCD2 PSCD2L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; regulation of ARF protein signal transduction [GO:0032012] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; regulation of ARF protein signal transduction [GO:0032012]" "guanyl-nucleotide exchange factor activity [GO:0005085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]" GO:0000139; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0006897; GO:0008289; GO:0016020; GO:0030036; GO:0030426; GO:0032012; GO:0070679 EVDDPR 2.099999905 1 1 0.110054925 731.703487 14.9433 0 0 0 0 15.79822 0 0 0 0 0 0 0 0 0 16.56117 0 0 16.64965 0 0 0 0 17.45789 17.58957 0 16.68913 15.27598 15.49581 0 16.83485 15.88559 0 16.25574 17.15572 15.0973 0 0 0 0 0 0 0 0 0 0 0 15.08083 Q99426 TBCB_HUMAN Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B) TBCB CG22 CKAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0015630; GO:0030154 QDTVRSFLK 2.309999943 0.000389812 0.000389812 0.350279574 1095.109555 0 0 0 15.63289 0 0 0 0 16.48969 0 0 0 0 0 0 0 0 0 0 0 16.78938 0 0 0 0 17.19356 0 17.30042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99442 SEC62_HUMAN "Translocation protein SEC62 (Translocation protein 1, TP-1, hTP-1)" SEC62 TLOC1 Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]" endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791] "endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]" signaling receptor activity [GO:0038023] GO:0005783; GO:0005791; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023 GPKADLK 4.989999771 1 1 0.272586812 726.8799299 0 0 0 17.06337 0 0 16.79407 0 17.2271 17.17302 0 0 16.3794 0 16.79053 16.14866 0 0 0 14.53417 0 16.57111 0 16.01122 0 0 0 0 0 0 0 18.88105 0 0 0 0 18.00143 0 0 0 0 0 0 0 0 16.41781 0 16.62786 Q99447 PCY2_HUMAN "Ethanolamine-phosphate cytidylyltransferase, EC 2.7.7.14 (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)" PCYT2 Homo sapiens (Human) phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654] ethanolamine-phosphate cytidylyltransferase activity [GO:0004306] GO:0004306; GO:0005789; GO:0006646; GO:0008654 QAGRYR 3.779999971 1 1 0.158052415 749.0238528 14.44598 15.11425 16.03572 0 0 0 0 16.1591 0 14.97732 0 0 0 16.10628 0 0 0 0 0 0 0 0 0 17.32222 0 0 0 16.01217 0 0 0 0 0 13.76589 15.60659 16.42676 0 0 0 13.95107 15.67092 0 0 0 0 0 0 0 Q99463 NPY6R_HUMAN "Putative neuropeptide Y receptor type 6, NPY6-R (NPY Y1-like receptor) (Putative pancreatic polypeptide receptor 2, PP2)" NPY6R NPY1RL Y2B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; pancreatic polypeptide receptor activity [GO:0001602] pancreatic polypeptide receptor activity [GO:0001602] GO:0001602; GO:0016021 ISSMSSLTGIMR 13.82999992 1 1 0.055768181 1282.250497 0 0 13.07208 0 12.31004 14.1344 0 11.52377 0 13.37843 0 13.19618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5121 0 0 0 0 0 0 0 0 0 0 0 0 Q99469 STAC_HUMAN SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein) STAC STAC1 Homo sapiens (Human) cellular response to heat [GO:0034605]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; cellular response to heat [GO:0034605]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009] metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] GO:0003009; GO:0005829; GO:0007165; GO:0030315; GO:0031234; GO:0034605; GO:0044325; GO:0046872; GO:1901387; GO:1903078; GO:2001259 CMGKLPK 1.960000038 0.00067882 0.00067882 0.296011346 850.2685648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.30853 0 0 0 0 0 18.20616 0 0 0 18.54761 0 18.00315 0 17.48296 0 0 0 0 0 Q99487 PAFA2_HUMAN "Platelet-activating factor acetylhydrolase 2, cytoplasmic, EC 3.1.1.47 (PAF:lysophospholipid transacetylase) (PAF:sphingosine transacetylase) (Platelet-activating factor acetyltransferase PAFAH2, EC 2.3.1.149) (Serine-dependent phospholipase A2, SD-PLA2, hSD-PLA2)" PAFAH2 Homo sapiens (Human) blood coagulation [GO:0007596]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; phospholipid binding [GO:0005543]; platelet-activating factor acetyltransferase activity [GO:0047179]; blood coagulation [GO:0007596]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; phospholipid binding [GO:0005543]; platelet-activating factor acetyltransferase activity [GO:0047179] GO:0003847; GO:0005543; GO:0005737; GO:0005789; GO:0006629; GO:0007596; GO:0016042; GO:0047179 RVEEGEK 5.480000019 0.039549917 0.039549917 0.248874404 847.1361552 14.96477 0 0 0 14.59943 15.826 0 14.39307 15.27345 0 13.60296 13.58682 0 15.53655 15.58777 13.82506 15.73811 14.19783 15.27577 0 0 16.47417 15.17219 15.89504 16.5086 0 15.14253 15.63979 0 15.10509 15.23756 12.79453 15.77136 17.10289 14.52625 16.59603 15.83035 15.02666 0 14.48053 0 0 12.76186 13.66751 14.22534 15.28902 15.41813 14.98699 Q99489 OXDD_HUMAN "D-aspartate oxidase, DASOX, DDO, EC 1.4.3.1" DDO Homo sapiens (Human) aspartate catabolic process [GO:0006533]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320] D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949] GO:0003884; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949 TPIPKSNL 6.989999771 1 1 0.458694095 869.9863487 15.03331 0 15.64797 13.84799 0 15.23333 15.49231 0 14.80091 16.19643 0 0 0 0 0 0 14.28696 16.10464 15.41069 16.16118 0 16.01905 0 0 15.14019 17.01012 0 0 16.0749 16.34154 0 0 15.94452 0 0 16.55605 0 16.63892 0 0 0 0 0 0 16.20482 0 0 0 Q99490 AGAP2_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2, AGAP-2 (Centaurin-gamma-1, Cnt-g1) (GTP-binding and GTPase-activating protein 2, GGAP2) (Phosphatidylinositol 3-kinase enhancer, PIKE)" AGAP2 CENTG1 KIAA0167 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; endosomal transport [GO:0016197]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of protein kinase activity [GO:0045860]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; endosomal transport [GO:0016197]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of protein kinase activity [GO:0045860]; protein transport [GO:0015031] ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] GO:0003924; GO:0005096; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0015031; GO:0016020; GO:0016197; GO:0019901; GO:0030036; GO:0030295; GO:0035014; GO:0042177; GO:0043524; GO:0045860; GO:0046872; GO:0061903; GO:0070062; GO:0090543 ALCADMKR 5.840000153 1 1 0.26419946 984.1667855 0 17.40865 17.95711 17.73765 14.82196 0 16.90535 15.85218 14.41056 16.55701 17.24355 14.35006 17.18886 14.32158 13.16109 0 18.89861 0 0 0 17.88183 16.26713 0 0 14.91726 0 0 14.9604 15.86687 0 0 0 0 0 0 16.59896 16.2612 0 0 15.76535 0 0 0 0 16.24704 0 0 0 Q99497 PARK7_HUMAN "Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)" PARK7 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]" adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793] "adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]" "androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]" GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0007005; GO:0007265; GO:0007338; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016570; GO:0016605; GO:0016684; GO:0019249; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033182; GO:0033234; GO:0033864; GO:0034599; GO:0035065; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061727; GO:0070062; GO:0070301; GO:0070994; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268 APLVLK 2.769999981 1 1 0.262336258 640.0244082 0 17.15436 17.31517 0 0 0 18.19912 18.0933 0 0 18.42806 15.94003 0 0 0 0 16.30639 0 15.75586 16.02877 0 17.43422 0 18.19842 0 0 18.18834 18.0911 0 18.74436 19.11944 0 20.07329 0 18.34597 0 19.04756 17.2856 18.96141 0 0 0 0 0 0 18.76913 19.3167 18.86085 Q99500 S1PR3_HUMAN "Sphingosine 1-phosphate receptor 3, S1P receptor 3, S1P3 (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3, S1P receptor Edg-3)" S1PR3 C9orf108 C9orf47 EDG3 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of establishment of endothelial barrier [GO:1903141]; Notch signaling pathway [GO:0007219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of interleukin-1 beta production [GO:0032651]; regulation of metabolic process [GO:0019222] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of establishment of endothelial barrier [GO:1903141]; Notch signaling pathway [GO:0007219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of interleukin-1 beta production [GO:0032651]; regulation of metabolic process [GO:0019222] G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036] GO:0004930; GO:0005178; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007193; GO:0007204; GO:0007219; GO:0008284; GO:0008289; GO:0009653; GO:0019222; GO:0032651; GO:0038036; GO:1903141 LAGRLK 12.81000042 1 1 0.237127261 658.0622805 15.50883 15.21017 14.42753 13.84792 0 15.3785 15.57774 0 0 0 0 0 14.27234 0 15.0568 0 15.91023 16.63318 17.10951 14.4028 16.03766 16.16901 17.73439 17.83935 16.16299 0 0 0 16.5837 0 0 15.40529 15.79981 0 16.35203 0 0 18.26272 16.91385 16.01517 15.91206 19.50437 15.6731 17.95812 0 0 0 16.64032 Q99501 GA2L1_HUMAN GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1) GAS2L1 GAR22 Homo sapiens (Human) actin crosslink formation [GO:0051764]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; protein localization to microtubule plus-end [GO:1904825]; regulation of cell cycle [GO:0051726]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]; actin crosslink formation [GO:0051764]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; protein localization to microtubule plus-end [GO:1904825]; regulation of cell cycle [GO:0051726]; regulation of microtubule polymerization or depolymerization [GO:0031110] actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966] GO:0001578; GO:0005737; GO:0005856; GO:0007026; GO:0008017; GO:0008093; GO:0009267; GO:0010629; GO:0030308; GO:0031110; GO:0045647; GO:0046966; GO:0051015; GO:0051726; GO:0051764; GO:0097067; GO:1904825 DGQHSWVPR 9.43999958 1 1 0 1077.736922 0 0 0 0 16.35946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.20007 0 0 0 0 14.09928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99518 FMO2_HUMAN "Flavin-containing monooxygenase 2, EC 1.14.13.- (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2, FMO 2)" FMO2 Homo sapiens (Human) NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]" "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" GO:0004497; GO:0004499; GO:0005789; GO:0006082; GO:0006739; GO:0006805; GO:0009404; GO:0016020; GO:0016021; GO:0050660; GO:0050661; GO:0070995; GO:0072592 LLCGAIK 13.28999996 1 1 0.184922729 773.3732746 16.37632 17.22218 17.84869 16.19581 0 17.31921 20.00756 15.10123 17.24944 15.84177 15.57987 15.58158 14.13125 15.17932 0 15.7864 16.58859 16.66384 22.66763 17.86189 0 0 0 17.6378 15.84688 0 16.10298 17.71408 16.44581 16.22989 0 0 0 16.18952 15.9133 0 0 22.01288 0 0 19.1563 19.0225 0 0 14.74366 14.54809 15.3932 0 Q99519 NEUR1_HUMAN "Sialidase-1, EC 3.2.1.18 (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1)" NEU1 NANH Homo sapiens (Human) ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580] cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308] GO:0004308; GO:0005576; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0016997; GO:0030054; GO:0035580; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796; GO:0070062 TGERPSTALPDR 7.619999886 1 1 0.070854083 1297.14694 0 0 0 0 0 0 12.97056 0 0 16.056 0 14.69105 0 0 0 16.31539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93239 15.64842 0 0 0 0 15.4209 0 0 0 0 0 0 0 0 Q99536 VAT1_HUMAN "Synaptic vesicle membrane protein VAT-1 homolog, EC 1.-.-.-" VAT1 Homo sapiens (Human) negative regulation of mitochondrial fusion [GO:0010637] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; negative regulation of mitochondrial fusion [GO:0010637] oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] GO:0005576; GO:0005741; GO:0008270; GO:0010637; GO:0016021; GO:0016491; GO:0035578; GO:0070062 VVTYGMANLLTGPK 14.02999973 0.288584381 0.288584381 0.490505336 1477.35124 18.08107 0 17.88606 0 0 0 0 19.33868 18.68879 0 0 0 0 0 0 0 17.36578 0 16.03168 0 0 0 0 0 20.78897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99538 LGMN_HUMAN "Legumain, EC 3.4.22.34 (Asparaginyl endopeptidase) (Protease, cysteine 1)" LGMN PRSC1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156]; activation of cysteine-type endopeptidase activity [GO:0097202]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359] cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156] GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028 TISTMK 14.90999985 0.488323301 0.488323301 0.081585966 693.6708117 17.2633 18.27721 14.52725 16.90097 15.48426 17.1559 0 15.87164 0 0 16.34316 0 0 17.21665 14.80925 0 18.6086 16.1131 16.62598 15.77321 17.78979 16.82313 14.80763 0 15.76349 14.58992 0 0 15.29683 16.48477 0 0 0 15.99254 0 0 12.86843 17.93559 0 15.97799 0 0 0 0 16.51029 15.34962 0 0 Q99541 PLIN2_HUMAN "Perilipin-2 (Adipophilin) (Adipose differentiation-related protein, ADRP)" PLIN2 ADFP Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; long-chain fatty acid transport [GO:0015909]; positive regulation of sequestering of triglyceride [GO:0010890]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; long-chain fatty acid transport [GO:0015909]; positive regulation of sequestering of triglyceride [GO:0010890]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] GO:0005576; GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0005886; GO:0009410; GO:0010890; GO:0014070; GO:0015909; GO:0019915; GO:0042149; GO:1905691 GAVTGSVEKTK 4.300000191 1 1 0.148637257 1076.482638 0 15.39531 16.42288 13.34754 17.22496 0 13.97047 15.24595 17.15166 0 16.48424 0 13.90391 0 12.40051 15.21317 15.21714 0 14.53774 14.84055 12.88161 15.23517 0 0 0 0 0 0 0 0 0 16.53739 0 14.56574 0 0 16.16786 0 0 0 0 11.64413 0 0 0 0 0 0 Q99549 MPP8_HUMAN "M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM, Twa3)" MPHOSPH8 MPP8 Homo sapiens (Human) "negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of DNA methylation [GO:0044030]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of DNA methylation [GO:0044030]" chromatin binding [GO:0003682]; methylated histone binding [GO:0035064] GO:0000786; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0035064; GO:0044030; GO:0045814; GO:0045869; GO:0045892; GO:0090309 EQVAEGAR 9.18999958 0.207073703 0.207073703 0.250898799 859.0371112 0 0 16.69864 0 0 0 0 0 17.45775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.39053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99550 MPP9_HUMAN M-phase phosphoprotein 9 MPHOSPH9 MPP9 Homo sapiens (Human) negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; negative regulation of cilium assembly [GO:1902018] GO:0000139; GO:0005794; GO:0005813; GO:0005814; GO:0016020; GO:1902018 KSSTPTK 1.970000029 0.621762037 0.621762037 0.056137749 748.3128821 0 16.49648 14.55244 13.95147 0 14.972 14.09484 16.1517 13.74582 12.72591 16.82715 13.99336 15.70118 14.50468 14.09186 16.78964 14.58253 15.53193 0 14.7297 15.88523 13.4791 0 17.4583 16.51746 14.80463 13.31518 14.15285 15.32085 15.65928 15.42025 0 0 0 13.84452 15.43572 15.82855 16.73652 19.70504 12.77582 14.4835 0 14.98275 12.62973 14.80946 16.17373 14.03368 15.49183 Q99551 MTEF1_HUMAN "Transcription termination factor 1, mitochondrial (Mitochondrial transcription termination factor 1, mTERF, mTERF1)" MTERF1 MTERF Homo sapiens (Human) "DNA geometric change [GO:0032392]; DNA-templated transcription, termination [GO:0006353]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]" mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA-templated transcription, termination [GO:0006353]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]" double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723] GO:0003676; GO:0003690; GO:0003723; GO:0005739; GO:0005759; GO:0006353; GO:0006355; GO:0006393; GO:0032392; GO:0042645 GLNYLTIMAPGNLWHMR 5.210000038 0.103814729 0.103814729 0.23596252 2019.437721 17.1706 16.98886 13.49093 15.53922 0 16.41166 15.5503 0 0 15.5864 0 0 0 0 0 17.03663 0 0 0 17.88554 0 0 18.97056 0 17.9866 0 17.87069 17.69579 0 0 0 17.64873 0 0 17.46054 0 0 17.34433 0 0 0 0 0 0 14.57743 17.60545 15.92996 0 Q99569 PKP4_HUMAN Plakophilin-4 (p0071) PKP4 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155] cadherin binding [GO:0045296] GO:0000922; GO:0001533; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007267; GO:0009898; GO:0014069; GO:0030054; GO:0030057; GO:0030155; GO:0030496; GO:0032467; GO:0043547; GO:0045296; GO:0048471; GO:0051233; GO:0072686; GO:0098609 RSGMTAVPQHLGPSLQR 1.440000057 1 1 0.356541902 1851.183239 0 16.10419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6552 0 0 0 0 0 15.35521 15.79357 0 0 17.73626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99572 P2RX7_HUMAN "P2X purinoceptor 7, P2X7 (ATP receptor) (P2Z receptor) (Purinergic receptor)" P2RX7 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cellular response to ATP [GO:0071318]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid transfer to membrane [GO:0006649]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of another organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; vesicle budding from membrane [GO:0006900] bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cellular response to ATP [GO:0071318]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid transfer to membrane [GO:0006649]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of another organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; vesicle budding from membrane [GO:0006900] ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102] GO:0000902; GO:0001530; GO:0001614; GO:0001845; GO:0001916; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005524; GO:0005639; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006468; GO:0006509; GO:0006649; GO:0006900; GO:0006954; GO:0007005; GO:0007166; GO:0009410; GO:0009612; GO:0009897; GO:0010043; GO:0010524; GO:0010628; GO:0014049; GO:0014054; GO:0016020; GO:0016079; GO:0016485; GO:0017121; GO:0019233; GO:0030163; GO:0030501; GO:0031594; GO:0031668; GO:0032059; GO:0032060; GO:0032308; GO:0032496; GO:0032730; GO:0032731; GO:0032755; GO:0032963; GO:0033198; GO:0034405; GO:0034767; GO:0035585; GO:0035590; GO:0042098; GO:0042802; GO:0043025; GO:0043029; GO:0043132; GO:0043406; GO:0043409; GO:0045779; GO:0045794; GO:0045821; GO:0046513; GO:0046931; GO:0048705; GO:0048873; GO:0050714; GO:0050830; GO:0051209; GO:0051495; GO:0051592; GO:0051602; GO:0051709; GO:0051899; GO:0051901; GO:0070230; GO:0070588; GO:0071318; GO:0071359; GO:0072593; GO:0097190; GO:0097191; GO:0098793; GO:0098794; GO:1904172; GO:1905114 EPVISSVHTK 2.119999886 1 1 0 1096.053699 0 0 13.28727 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92147 0 0 0 13.33818 8.787059 0 0 0 0 0 14.666 0 0 0 17.30954 0 0 14.33126 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99576 T22D3_HUMAN "TSC22 domain family protein 3 (DSIP-immunoreactive peptide, Protein DIP, hDIP) (Delta sleep-inducing peptide immunoreactor) (Glucocorticoid-induced leucine zipper protein, GILZ) (TSC-22-like protein) (TSC-22-related protein, TSC-22R)" TSC22D3 DSIPI GILZ Homo sapiens (Human) negative regulation of activation-induced cell death of T cells [GO:0070236]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of activation-induced cell death of T cells [GO:0070236]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970] GO:0005634; GO:0005829; GO:0006357; GO:0006970; GO:0070236 LDNSASGASVVAIDNKIEQAMDLVK 4.260000229 1 1 0 2604.776773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.66829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99578 RIT2_HUMAN "GTP-binding protein Rit2, EC 3.6.5.2 (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2)" RIT2 RIN ROC2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic tree [GO:0097447]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic tree [GO:0097447]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264] calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215] GO:0001932; GO:0003682; GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045202; GO:0045944; GO:0050848; GO:0097447 VVMLGAGGVGK 4.159999847 0.458579034 0.458579034 0.195692751 1003.837454 0 15.07052 15.32743 0 0 0 0 0 0 15.35077 12.67008 14.33173 0 0 0 13.09683 0 10.86837 14.54949 0 0 15.50592 15.44735 0 0 9.234185 14.41487 15.37726 14.17651 0 14.27763 11.79835 10.33805 15.48963 13.05048 14.1054 15.60813 15.44332 15.70507 13.7298 12.55162 14.43395 0 13.56757 13.54138 14.72651 15.32549 15.44991 Q99590 SCAFB_HUMAN "Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129, SRrp129)" SCAF11 CASP11 SFRS2IP SIP1 SRSF2IP Homo sapiens (Human) "mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]" nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]" metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0000245; GO:0000375; GO:0003723; GO:0005654; GO:0005730; GO:0006397; GO:0008380; GO:0016604; GO:0046872 DTIDKTK 4.070000172 0.859884024 0.859884024 0.202842867 819.4801245 15.528 15.32496 0 0 0 0 13.21186 16.06754 16.01184 16.11901 0 15.43921 0 0 13.76339 0 0 0 0 0 0 14.12971 0 0 0 0 0 0 0 0 16.57763 15.38368 0 16.17471 0 16.7307 0 17.22785 0 0 0 0 15.96562 0 0 0 0 0 Q99594 TEAD3_HUMAN "Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3, TEAD-3)" TEAD3 TEAD5 TEF5 Homo sapiens (Human) asymmetric neuroblast division [GO:0055059]; embryonic organ development [GO:0048568]; female pregnancy [GO:0007565]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; asymmetric neuroblast division [GO:0055059]; embryonic organ development [GO:0048568]; female pregnancy [GO:0007565]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0005667; GO:0006357; GO:0007565; GO:0035329; GO:0045944; GO:0048568; GO:0055059; GO:0061629 AMNLDQVSK 7.710000038 1 1 0.091486776 1004.363009 0 13.25789 9.002148 0 0 0 0 16.76864 0 15.44645 15.29143 0 0 0 0 0 0 0 0 0 13.18827 0 0 0 0 0 14.67894 0 0 0 14.74633 0 17.61572 0 12.3562 15.49078 0 0 0 0 0 0 0 0 0 0 0 0 Q99608 NECD_HUMAN Necdin NDN Homo sapiens (Human) axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of protein deacetylation [GO:0090312]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233] cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991] "cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of protein deacetylation [GO:0090312]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0001228; GO:0001764; GO:0003016; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007413; GO:0007417; GO:0008285; GO:0008347; GO:0009791; GO:0019233; GO:0032991; GO:0040008; GO:0042995; GO:0043015; GO:0043204; GO:0043433; GO:0048011; GO:0048675; GO:0048871; GO:0071514; GO:0090312; GO:1990841 ASREITK 6.659999847 1 1 0.099950308 805.1763934 15.10352 15.16709 11.07058 12.51997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.03175 0 0 0 0 0 0 15.77406 0 0 17.53036 0 0 0 0 0 0 0 0 0 0 0 Q99611 SPS2_HUMAN "Selenide, water dikinase 2, EC 2.7.9.3 (Selenium donor protein 2) (Selenophosphate synthase 2)" SEPHS2 SPS2 Homo sapiens (Human) selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259]" "ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]" GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0005829; GO:0016259; GO:0016260; GO:0046872 EEVELAYQEAMFNMATLNR 8.229999542 0.183590993 0.183590993 0.070599432 2259.380982 0 0 17.25431 0 0 0 0 16.06777 0 16.57876 0 0 0 14.14858 0 11.80723 0 14.32912 0 11.92807 11.5223 0 0 0 10.26107 13.75078 12.92505 11.49706 0 20.47301 16.72891 0 12.60931 0 12.05321 0 13.65288 12.36671 15.50639 0 14.67612 0 0 0 0 0 0 0 Q99613 EIF3C_HUMAN "Eukaryotic translation initiation factor 3 subunit C, eIF3c (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)" EIF3C EIF3S8 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0043022; GO:0045727; GO:1902416 SEAPSGESR 8.949999809 0.840363145 0.840363145 0.251670311 917.760156 14.52315 14.36885 15.2058 15.46571 12.48423 14.27138 0 9.072755 15.24103 15.80744 14.94068 15.4537 0 13.39471 14.94012 15.18925 0 14.67022 0 16.0524 15.83404 16.41612 0 15.52489 16.91188 0 15.8296 15.83374 14.3683 0 0 16.05266 14.81377 14.89845 0 15.94671 16.18253 17.24368 0 17.44276 0 15.89164 0 0 14.5315 13.98787 14.84109 0 Q99618 CDCA3_HUMAN "Cell division cycle-associated protein 3 (Gene-rich cluster protein C8) (Trigger of mitotic entry protein 1, TOME-1)" CDCA3 C8 GRCC8 TOME1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; cytosol [GO:0005829] adherens junction [GO:0005912]; cytosol [GO:0005829]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567] GO:0005829; GO:0005912; GO:0007049; GO:0016567; GO:0051301 SSGSMR 5.260000229 1 1 0.222337096 639.6462684 0 0 14.81886 15.86132 0 16.1582 16.42959 0 16.23126 14.30124 0 15.83311 15.50285 15.8343 15.55443 0 15.67123 0 16.71378 0 16.86103 17.72651 17.65691 16.91131 16.6742 14.52286 0 0 16.63257 16.10141 16.67659 16.13944 14.08755 17.37148 16.61285 15.83678 15.50897 15.33138 17.94196 17.39248 15.66555 0 16.22616 16.94489 16.20688 16.4123 17.51502 16.72414 Q99643 C560_HUMAN "Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1, QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit, CYBL)" SDHC CYB560 SDH3 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]" electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104] GO:0000104; GO:0005739; GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0009055; GO:0009060; GO:0016021; GO:0020037; GO:0042776; GO:0046872 AALLLR 1.110000014 0.198980808 0.198980808 0.120049226 656.2573964 14.3535 17.48726 14.92874 13.55193 0 16.4453 0 16.3485 12.21511 9.501802 12.53487 13.33297 19.85471 14.97842 12.79725 11.69682 0 0 17.23424 0 0 0 0 18.02144 15.06491 0 17.58501 0 0 0 0 16.02301 17.92673 0 17.90075 0 15.2414 15.26751 0 12.37242 16.04395 15.31719 15.85958 17.17098 14.00496 10.31091 0 0 Q99653 CHP1_HUMAN Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22) CHP1 CHP Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860] GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0005925; GO:0006469; GO:0006611; GO:0006813; GO:0007264; GO:0008017; GO:0010923; GO:0015459; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070062; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1901214 MGSRASTLLR 7.539999962 1 1 0 1090.872497 16.31943 0 0 0 0 16.25904 0 16.82335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99666 RGPD5_HUMAN "RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2, RanBP2-like 1/2, RanBP2L1, RanBP2L2) (Sperm membrane protein BS-63)" RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0050790 LPHETSR 14.93000031 1 1 0.577565365 837.8538513 16.94533 0 0 0 0 17.15353 16.43909 0 0 0 0 0 17.09921 16.62 0 0 0 0 0 0 0 0 0 0 0 17.17947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.62017 Q99683 M3K5_HUMAN "Mitogen-activated protein kinase kinase kinase 5, EC 2.7.11.25 (Apoptosis signal-regulating kinase 1, ASK-1) (MAPK/ERK kinase kinase 5, MEK kinase 5, MEKK 5)" MAP3K5 ASK1 MAPKKK5 MEKK5 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; wound healing [GO:0042060]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; wound healing [GO:0042060]" ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007254; GO:0008631; GO:0009897; GO:0010666; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042802; GO:0042803; GO:0043065; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045860; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0090398; GO:0097190; GO:0097300; GO:0106310; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604 EIICQK 33.40000153 0.020905772 0.020905772 0.132072729 789.3197692 15.77493 15.7938 15.09456 15.88375 0 15.51864 14.02187 0 15.50238 16.77638 0 0 0 13.25384 0 18.35281 0 0 0 15.74855 0 0 0 0 0 0 0 16.34295 0 0 0 0 0 0 0 16.08059 0 0 0 0 0 17.6227 0 0 0 0 0 0 Q99684 GFI1_HUMAN Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163) GFI1 ZNF163 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]" nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000083; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0010956; GO:0010957; GO:0010977; GO:0016032; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0045892; GO:0046872; GO:0051569; GO:0070105; GO:0071222; GO:1990837 ICGKSFK 8.199999809 1 1 0.285967261 840.0337176 0 16.42481 16.3741 0 0 0 0 0 0 0 0 0 0 16.32598 0 0 0 0 0 0 0 14.19585 16.37046 0 0 16.63047 0 0 0 0 15.48453 13.2076 0 16.14553 0 16.32924 16.64664 17.49558 0 0 0 16.29776 0 17.0835 0 0 0 0 Q99689 FEZ1_HUMAN Fasciculation and elongation protein zeta-1 (Zygin I) (Zygin-1) FEZ1 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; establishment of cell polarity [GO:0030010]; establishment of mitochondrion localization [GO:0051654]; hippocampus development [GO:0021766]; mitochondrion morphogenesis [GO:0070584]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; positive regulation of anterograde axonal transport of mitochondrion [GO:0061881]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; establishment of cell polarity [GO:0030010]; establishment of mitochondrion localization [GO:0051654]; hippocampus development [GO:0021766]; mitochondrion morphogenesis [GO:0070584]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; positive regulation of anterograde axonal transport of mitochondrion [GO:0061881]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976] gamma-tubulin binding [GO:0043015]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485] GO:0005080; GO:0005737; GO:0005739; GO:0005794; GO:0005813; GO:0005874; GO:0005886; GO:0007155; GO:0007399; GO:0007411; GO:0010976; GO:0021766; GO:0030010; GO:0030424; GO:0030425; GO:0030426; GO:0043015; GO:0043025; GO:0045666; GO:0047485; GO:0051654; GO:0061881; GO:0070584; GO:0071363; GO:1902902 KASPPSVEDLQMLTNILFAMK 5.53000021 1 1 1.83E-12 2354.801803 0 12.99359 15.09773 14.26882 0 13.18981 0 0 14.47285 0 0 0 13.60008 0 13.24387 0 0 0 0 0 15.87759 0 0 0 12.84889 15.24871 0 16.02634 0 16.36351 0 0 0 15.85544 0 13.57497 0 11.53815 0 0 0 0 0 12.67364 0 0 0 0 Q99698 LYST_HUMAN Lysosomal-trafficking regulator (Beige homolog) LYST CHS CHS1 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630] cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; protein kinase binding [GO:0019901]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031] protein kinase binding [GO:0019901] GO:0005829; GO:0006909; GO:0007040; GO:0008104; GO:0015031; GO:0015630; GO:0016020; GO:0019901; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 ADLIKMIK 7.860000134 0.887892485 0.887892485 0.149485409 948.5425526 15.64313 15.68359 14.9797 16.3145 0 13.37635 16.92254 14.90559 16.01219 16.18091 0 16.55764 15.13065 12.57904 0 0 14.60103 0 16.30125 16.09441 16.8194 15.51352 14.08911 14.87376 0 0 0 0 0 0 0 0 0 0 0 0 0 16.07761 14.08395 16.60081 0 0 0 14.94197 14.87783 0 0 0 Q99700 ATX2_HUMAN Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) ATXN2 ATX2 SCA2 TNRC13 Homo sapiens (Human) negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063] epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723] GO:0002091; GO:0003723; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005844; GO:0006417; GO:0008022; GO:0010494; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904 MSSEGPPR 6.429999828 0.821037471 0.821037471 0.215061914 863.2567908 16.35249 0 14.42416 14.40744 15.42922 0 0 13.77577 16.47651 18.73385 14.07606 14.91216 14.47699 15.97981 16.95937 15.29633 13.65945 17.43797 17.30338 0 13.21074 0 14.10064 15.26675 13.37746 17.07154 15.49077 17.0856 16.56236 0 16.54735 0 12.70537 16.59661 16.05208 17.63489 13.64559 16.81382 16.93164 17.63143 15.73568 0 0 0 11.92113 16.41039 16.80589 14.93626 Q99704 DOK1_HUMAN Docking protein 1 (Downstream of tyrosine kinase 1) (p62(dok)) (pp62) DOK1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell surface receptor signaling pathway [GO:0007166]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0007169; GO:0007265; GO:0038145; GO:0048471 SHLLAADAPSSAAWVQTLCR 5.599999905 0.241539165 0.241539165 0.452645013 2153.096058 9.025551 0 17.08461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.94655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.70169 0 0 0 0 0 0 0 0 0 Q99705 MCHR1_HUMAN "Melanin-concentrating hormone receptor 1, MCH receptor 1, MCH-R1, MCHR-1 (G-protein coupled receptor 24) (MCH-1R, MCH1R, MCHR) (SLC-1) (Somatostatin receptor-like protein)" MCHR1 GPR24 SLC1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204] ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204] G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102] GO:0004930; GO:0005102; GO:0005886; GO:0005887; GO:0005929; GO:0006091; GO:0007166; GO:0007186; GO:0007193; GO:0007204; GO:0007218; GO:0007631; GO:0008022; GO:0008188; GO:0030273; GO:0042277; GO:0042562; GO:0042923; GO:0043005; GO:0051928; GO:0060170; GO:0097730 ILQRMTSSVAPASQR 1.519999981 1 1 0.241634325 1646.859066 0 17.5278 17.63218 17.51039 17.80157 17.26893 0 16.4812 16.39954 15.40059 15.34496 16.90905 15.68034 0 17.10468 17.97322 0 16.01808 16.50033 0 17.3625 0 0 17.66839 17.33447 16.94045 16.33125 0 0 15.13766 14.741 17.99896 14.60975 16.66353 0 17.70267 0 18.73915 16.21067 16.35178 18.47523 16.82917 0 14.90246 16.57032 16.9393 17.24652 17.94555 Q99707 METH_HUMAN "Methionine synthase, MS, EC 2.1.1.13 (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)" MTR Homo sapiens (Human) axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678] cytosol [GO:0005829] cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678] cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270] GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732 VIDLGVMTPCDKILK 3.119999886 1 1 0.108598261 1718.381761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1129 0 0 0 0 0 15.63122 0 14.94007 0 0 0 0 0 0 0 0 15.87637 14.36857 0 0 0 0 0 0 0 0 0 0 0 0 15.53987 0 Q99708 CTIP_HUMAN "DNA endonuclease RBBP8, EC 3.1.-.- (CtBP-interacting protein, CtIP) (Retinoblastoma-binding protein 8, RBBP-8) (Retinoblastoma-interacting protein and myosin-like, RIM) (Sporulation in the absence of SPO11 protein 2 homolog, SAE2)" RBBP8 CTIP Homo sapiens (Human) blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357] BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053] BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053]; damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403]; blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357] damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403] GO:0000014; GO:0000082; GO:0000403; GO:0000406; GO:0000724; GO:0001835; GO:0003684; GO:0003690; GO:0003697; GO:0003714; GO:0005634; GO:0005654; GO:0006281; GO:0006357; GO:0010792; GO:0017053; GO:0035825; GO:0035861; GO:0042802; GO:0043231; GO:0044818; GO:0051301; GO:0051321; GO:0061629; GO:0070336; GO:0070533; GO:0110025; GO:1905168 MDVTVIDTK 5.039999962 0.463662922 0.463662922 0.195395065 1020.403746 14.47524 0 15.36988 14.68664 0 0 0 0 14.15128 0 14.69331 0 15.01657 0 0 0 0 14.04415 0 0 0 0 16.06642 0 0 0 0 15.4278 16.15287 16.6719 0 0 15.37465 0 15.9476 0 0 14.66558 0 16.66892 13.84771 11.35094 13.42777 0 15.79787 15.26069 12.48464 10.31788 Q99714 HCD2_HUMAN "3-hydroxyacyl-CoA dehydrogenase type-2, EC 1.1.1.35 (17-beta-estradiol 17-dehydrogenase, EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase, MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+)), EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase, EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase, EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase, EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2, Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)" HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 Homo sapiens (Human) androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; tRNA methyltransferase complex [GO:0043527] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; tRNA methyltransferase complex [GO:0043527]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; RNA binding [GO:0003723]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]" "17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; RNA binding [GO:0003723]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]" GO:0000049; GO:0003723; GO:0003857; GO:0004303; GO:0005737; GO:0005739; GO:0005759; GO:0005886; GO:0006550; GO:0006629; GO:0006631; GO:0006635; GO:0006699; GO:0007005; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0043527; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180 LDGAIR 6.150000095 1 1 0.097695235 643.9603894 0 0 0 0 0 15.88673 0 0 0 0 0 0 0 0 0 0 15.63407 0 0 0 0 0 16.86846 0 0 0 0 0 0 0 0 0 0 17.25424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99715 COCA1_HUMAN Collagen alpha-1(XII) chain COL12A1 COL12A1L Homo sapiens (Human) cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0035987; GO:0062023; GO:0070062; GO:1903561 DELLAAIK 20.72999954 0.473447621 0.473447621 0.267543882 871.3360669 0 17.65811 17.1463 0 0 0 18.64458 18.35094 0 0 0 0 0 0 16.35095 0 0 0 16.96341 0 0 16.83279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.11355 0 0 17.96266 0 0 0 0 0 0 0 Q99719 SEPT5_HUMAN "Septin-5 (Cell division control-related protein 1, CDCrel-1) (Peanut-like protein 1)" SEPTIN5 PNUTL1 SEPT5 Homo sapiens (Human) adult behavior [GO:0030534]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; social behavior [GO:0035176]; synaptic vesicle targeting [GO:0016080] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; adult behavior [GO:0030534]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; social behavior [GO:0035176]; synaptic vesicle targeting [GO:0016080] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198] GO:0003924; GO:0005198; GO:0005525; GO:0005886; GO:0005940; GO:0008021; GO:0015630; GO:0016080; GO:0017157; GO:0030534; GO:0031105; GO:0032153; GO:0034613; GO:0035176; GO:0042802; GO:0060090; GO:0061640; GO:2000300 NMLIRTHMHDLK 1.879999995 1 1 0.563893494 1525.23161 0 17.54034 19.27233 0 0 0 0 0 0 0 0 0 18.55212 0 0 0 0 0 0 17.23421 0 0 0 0 0 0 0 0 18.2307 0 0 0 0 0 18.15515 0 0 0 0 0 18.4207 0 0 0 0 0 0 0 Q99728 BARD1_HUMAN "BRCA1-associated RING domain protein 1, BARD-1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase BARD1)" BARD1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894] BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894] kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0000152; GO:0000209; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006282; GO:0006974; GO:0016567; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0035518; GO:0035825; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0044818; GO:0045732; GO:0045786; GO:0046826; GO:0046872; GO:0046982; GO:0051726; GO:0051865; GO:0070531; GO:0070532; GO:0070533; GO:0070537; GO:0071479; GO:0085020; GO:0110025; GO:2000001 SAPAMEPDGR 4.789999962 1 1 0.234539516 1030.373726 18.88144 0 0 0 0 0 17.47631 15.13026 17.66413 16.39019 14.26929 14.07657 14.78182 15.89955 0 0 0 15.73296 0 0 0 17.51502 0 16.65255 0 0 0 15.34524 15.22593 0 0 0 0 0 17.09718 16.55068 0 15.82434 0 16.09855 16.91075 13.75974 15.00086 0 16.29813 15.63823 0 19.57297 Q99729 ROAA_HUMAN "Heterogeneous nuclear ribonucleoprotein A/B, hnRNP A/B (APOBEC1-binding protein 1, ABBP-1)" HNRNPAB ABBP1 HNRPAB Homo sapiens (Human) "cellular response to amino acid stimulus [GO:0071230]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to amino acid stimulus [GO:0071230]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]" mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837] GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0016556; GO:0030425; GO:0044877; GO:0045293; GO:0045893; GO:0071230; GO:0071598; GO:0090575; GO:1901537; GO:1904580; GO:1990124; GO:1990837; GO:1990904; GO:2000623 FHTVSGSK 14.85999966 0.290684432 0.290684432 0.229803454 861.4242361 15.21117 12.62123 15.09089 14.74577 15.70227 14.81097 15.60251 16.00845 14.32115 15.87943 15.68062 15.50935 17.38212 16.05792 0 16.71735 0 14.8683 15.75889 17.71874 16.34018 16.07515 15.94483 16.12567 18.26269 16.56278 16.11135 15.39919 15.06525 0 15.11457 0 16.5445 16.77564 17.96402 16.20839 18.57886 16.57118 18.35754 17.64194 0 16.50973 18.95345 16.02616 16.03518 16.98137 16.34649 17.52656 Q99733 NP1L4_HUMAN "Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2, NAP-2)" NAP1L4 NAP2 Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; nucleosome assembly [GO:0006334] chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005737; GO:0006334; GO:0031491; GO:0042393; GO:0051082 NASNTEK 10.60000038 1 1 0.123018829 762.4514567 0 0 0 14.61873 0 0 0 13.00465 0 15.55782 0 0 0 0 0 0 0 14.63047 0 0 0 16.91441 0 0 0 0 0 14.45238 0 0 0 0 16.22117 0 0 0 0 0 0 15.08665 0 0 15.48212 0 0 0 15.18035 0 Q99735 MGST2_HUMAN "Microsomal glutathione S-transferase 2, Microsomal GST-2, EC 2.5.1.18 (Glutathione peroxidase MGST2, EC 1.11.1.-) (Leukotriene C4 synthase MGST2, EC 4.4.1.20) (Microsomal glutathione S-transferase II, Microsomal GST-II)" MGST2 GST2 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729] enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464] GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006629; GO:0006750; GO:0008047; GO:0016020; GO:0016021; GO:0019370; GO:0042802; GO:0043231; GO:0043295; GO:0046466; GO:0050729 MAGNSILLAAVSILSACQQSYFALQVGK 10.63000011 1 1 0.028084466 2956.032672 12.76385 0 10.72632 13.73602 0 13.12907 0 0 0 0 0 0 10.71445 15.58566 12.28418 11.8374 14.42622 11.7106 0 0 0 13.22231 0 15.51757 0 0 15.20268 5.785031 0 13.61478 7.347967 12.50659 13.73351 0 0 0 0 14.06494 0 0 0 14.54827 0 0 0 0 0 0 Q99742 NPAS1_HUMAN "Neuronal PAS domain-containing protein 1, Neuronal PAS1 (Basic-helix-loop-helix-PAS protein MOP5) (Class E basic helix-loop-helix protein 11, bHLHe11) (Member of PAS protein 5) (PAS domain-containing protein 5)" NPAS1 BHLHE11 MOP5 PASD5 Homo sapiens (Human) "central nervous system development [GO:0007417]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; central nervous system development [GO:0007417]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001964; GO:0003700; GO:0005634; GO:0006357; GO:0007417; GO:0042711; GO:0045892; GO:0046982 SRNAAR 5.659999847 0.285797775 0.285797775 0.047593204 674.0025167 0 0 0 0 0 0 0 14.17075 0 13.12068 0 12.29259 0 0 0 0 0 15.1165 13.99205 16.8743 14.05325 17.60124 15.81357 0 17.12201 0 14.34266 0 14.29571 0 16.05303 17.17757 0 17.50367 0 15.16646 0 16.52969 0 16.68079 0 0 14.14373 13.80182 17.15682 0 12.60946 13.94426 Q99755 PI51A_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha, PIP5K1-alpha, PtdIns(4)P-5-kinase 1 alpha, EC 2.7.1.68 (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha, PIP5KIalpha)" PIP5K1A Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165]" "1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]" GO:0000285; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006650; GO:0006661; GO:0006909; GO:0007165; GO:0008654; GO:0010761; GO:0014066; GO:0016308; GO:0016477; GO:0016607; GO:0019900; GO:0030027; GO:0030216; GO:0031532; GO:0032587; GO:0046854; GO:0048041; GO:0052810; GO:0052812; GO:0060326; GO:0072659; GO:0090630; GO:0097178 FQRFMCNTVFK 6.139999866 0.021857779 0.021857779 0.185615989 1477.019518 0 0 16.67617 0 0 0 0 0 0 0 0 0 0 0 0 16.35601 0 0 0 15.53469 0 0 0 0 0 0 0 0 0 0 0 15.60418 0 0 0 15.98722 0 0 0 0 0 0 0 0 0 0 0 0 Q99758 ABCA3_HUMAN "Phospholipid-transporting ATPase ABCA3, EC 7.6.2.1 (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3, ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3, EC 7.6.2.2) [Cleaved into: 150 Kda mature form ]" ABCA3 ABC3 Homo sapiens (Human) cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016021; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0044267; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 LTIFNILSGIATFLMVTIMRIPAVK 5.460000038 1 1 1.38E-12 2778.968207 0 0 0 0 15.80482 0 0 0 0 0 0 14.74472 16.11918 0 0 0 0 0 0 0 0 0 0 0 16.46075 16.44227 15.50481 16.42107 0 0 0 15.47596 0 0 0 0 0 15.71189 0 0 0 0 0 0 0 0 0 15.50255 Q99759 M3K3_HUMAN "Mitogen-activated protein kinase kinase kinase 3, EC 2.7.11.25 (MAPK/ERK kinase kinase 3, MEK kinase 3, MEKK 3)" MAP3K3 MAPKKK3 MEKK3 Homo sapiens (Human) blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0071864; GO:0090050; GO:0106310; GO:1900745; GO:2000773 HQGNLFTLVPSSR 5.760000229 1 1 0.178379279 1456.057767 14.06275 13.18919 0 13.47911 13.08352 0 0 0 0 0 0 0 0 0 0 0 15.45173 16.71746 0 0 0 0 0 0 0 16.08932 0 0 16.01884 15.34406 0 0 0 16.62133 14.91039 0 16.61679 0 17.09795 0 0 16.79947 0 14.90266 0 6.1723 17.02579 0 Q99784 NOE1_HUMAN Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) OLFM1 NOE1 NOEL1 Homo sapiens (Human) atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0007399; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0045202; GO:0060317 FGSWMTDPLAPEGDNRVWYMDGYHNNR 3.890000105 1 1 4.57E-13 3261.471942 13.54229 15.33938 0 0 13.89544 0 14.2338 0 0 15.47495 0 13.26957 0 15.0731 14.9819 16.63143 0 0 0 0 0 0 0 9.165971 13.47793 14.15619 15.26787 0 0 0 0 0 0 0 0 0 12.56709 0 0 0 0 15.05129 14.46715 0 0 0 0 0 Q99788 CML1_HUMAN Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ) CMKLR1 CHEMR23 DEZ Homo sapiens (Human) chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; chemokine receptor activity [GO:0004950]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501] adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; chemokine receptor activity [GO:0004950]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023] GO:0001501; GO:0002430; GO:0004875; GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007204; GO:0010759; GO:0016021; GO:0032088; GO:0032695; GO:0038023; GO:0045600; GO:0050848; GO:0097003; GO:0097004; GO:0120162 MSSMNER 7.960000038 1 1 0.335266144 870.056302 16.06142 0 14.40649 0 0 15.057 14.96979 15.01964 0 14.58527 16.18601 12.75054 0 14.17592 0 0 14.5314 16.05201 15.37469 0 0 15.81213 15.97364 15.17388 0 14.10241 0 0 0 15.94759 0 0 0 0 0 16.61755 0 0 0 0 0 0 0 0 16.16848 0 0 0 Q99801 NKX31_HUMAN Homeobox protein Nkx-3.1 (Homeobox protein NK-3 homolog A) NKX3-1 NKX3.1 NKX3A Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; androgen receptor signaling pathway [GO:0030521]; branching involved in prostate gland morphogenesis [GO:0060442]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal aorta development [GO:0035907]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; heart development [GO:0007507]; male gonad development [GO:0008584]; metanephros development [GO:0001656]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription, DNA-templated [GO:0045892]; pharyngeal system development [GO:0060037]; positive regulation of androgen secretion [GO:2000836]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; salivary gland development [GO:0007431]; somitogenesis [GO:0001756]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; MADS box domain binding [GO:0097162]; nuclear receptor activity [GO:0004879]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; androgen receptor signaling pathway [GO:0030521]; branching involved in prostate gland morphogenesis [GO:0060442]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal aorta development [GO:0035907]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; heart development [GO:0007507]; male gonad development [GO:0008584]; metanephros development [GO:0001656]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription, DNA-templated [GO:0045892]; pharyngeal system development [GO:0060037]; positive regulation of androgen secretion [GO:2000836]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; salivary gland development [GO:0007431]; somitogenesis [GO:0001756]" "cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; MADS box domain binding [GO:0097162]; nuclear receptor activity [GO:0004879]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001656; GO:0001756; GO:0001934; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0006919; GO:0007431; GO:0007507; GO:0008284; GO:0008285; GO:0008584; GO:0008656; GO:0010628; GO:0010629; GO:0010942; GO:0014068; GO:0030154; GO:0030331; GO:0030521; GO:0032880; GO:0033574; GO:0035907; GO:0042826; GO:0043280; GO:0043491; GO:0043565; GO:0043569; GO:0043621; GO:0045892; GO:0045893; GO:0045931; GO:0045944; GO:0048754; GO:0050680; GO:0051091; GO:0051781; GO:0060037; GO:0060442; GO:0060664; GO:0060770; GO:0071347; GO:0071356; GO:0071383; GO:0071456; GO:0071466; GO:0090734; GO:0097162; GO:0140297; GO:0140416; GO:1902807; GO:1990837; GO:2000836; GO:2001022; GO:2001235; GO:2001244 AGAQNDQLSTGPRAAPEEAETLAETEPER 7.559999943 0.729641438 0.729641438 4.12E-12 3038.620103 9.899951 0 0 0 13.4268 0 0 13.7398 0 0 16.04195 13.72593 0 0 14.59289 0 13.86228 14.30718 0 0 0 0 0 10.62911 14.10439 0 0 0 0 0 15.57687 0 0 13.06211 0 0 0 0 0 0 0 0 0 0 0 0 13.52057 0 Q99807 COQ7_HUMAN "5-demethoxyubiquinone hydroxylase, mitochondrial, DMQ hydroxylase, EC 1.14.99.60 (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)" COQ7 Homo sapiens (Human) determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142] "extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142]; 3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]" "3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]" GO:0000122; GO:0003682; GO:0005634; GO:0005739; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0045944; GO:0046872; GO:0110142; GO:2000377 MSCAGAAAAPR 3.890000105 1 1 0.183444752 1078.213704 18.09816 11.11349 0 0 0 0 0 0 19.16415 13.84204 0 0 0 0 0 13.80137 0 0 0 0 0 0 0 0 14.45217 0 16.8295 0 0 0 0 0 0 0 14.21511 15.42622 18.24426 0 0 16.11905 0 0 13.36402 0 15.78438 0 0 14.29243 Q99814 EPAS1_HUMAN "Endothelial PAS domain-containing protein 1, EPAS-1 (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73, bHLHe73) (HIF-1-alpha-like factor, HLF) (Hypoxia-inducible factor 2-alpha, HIF-2-alpha, HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2)" EPAS1 BHLHE73 HIF2A MOP2 PASD2 Homo sapiens (Human) angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001525; GO:0001666; GO:0001892; GO:0001974; GO:0002027; GO:0003677; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007005; GO:0007165; GO:0007601; GO:0016607; GO:0030218; GO:0030324; GO:0042415; GO:0042789; GO:0043129; GO:0043619; GO:0045944; GO:0046982; GO:0048469; GO:0048625; GO:0055072; GO:0061629; GO:0071456; GO:0120162; GO:2000434 ASLPPCCGQASTPLSSMGGR 4.559999943 1 1 0.149425984 2049.387563 12.67525 0 13.02739 0 14.06776 12.22095 8.974989 13.24967 10.35921 14.4021 0 0 9.242476 0 0 0 0 0 0 0 0 12.93738 0 11.88184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99816 TS101_HUMAN Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) TSG101 Homo sapiens (Human) autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790] GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007049; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016236; GO:0019076; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397 KTAGLSDLY 5.460000038 0.556079507 0.556079507 0.019934182 966.843462 10.82227 15.16877 16.02209 16.85012 13.42287 0 18.18344 14.8701 17.62455 18.2307 17.33856 16.46993 15.18486 14.64103 14.69287 13.80116 12.56077 15.62275 14.98227 17.67236 16.78376 16.25967 14.25908 17.21682 17.57372 16.27421 17.44054 9.222054 0 0 0 15.02247 16.10803 0 11.71799 0 17.49127 16.05927 13.19909 16.20137 12.25782 0 16.53041 15.12861 14.80718 0 14.62365 12.59706 Q99848 EBP2_HUMAN Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40) EBNA1BP2 EBP2 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] "chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]" RNA binding [GO:0003723] GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273 KGPSAK 3.089999914 0.27955395 0.27955395 0.117460931 585.4465167 17.25609 15.8977 16.79807 17.79923 17.07274 16.6041 16.77289 16.84908 17.12623 18.58368 15.40586 16.5678 19.07529 17.47807 17.40916 18.89329 17.38999 16.77315 17.28733 17.99192 18.34137 18.48311 17.23227 17.69144 19.32461 15.8072 18.94095 16.52991 18.68549 18.19609 17.62451 16.63056 18.32323 19.53698 18.32609 19.61903 18.08017 17.09546 17.49663 18.09908 19.38037 18.94012 16.19455 17.79836 17.26202 18.75685 18.47131 17.19741 Q99856 ARI3A_HUMAN "AT-rich interactive domain-containing protein 3A, ARID domain-containing protein 3A (B-cell regulator of IgH transcription, Bright) (Dead ringer-like protein 1) (E2F-binding protein 1)" ARID3A DRIL1 DRIL3 DRX E2FBP1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] GO:0003677; GO:0003682; GO:0003712; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0042802; GO:0045121; GO:0045944 KLQAVMETLLQR 11.72999954 0.639745533 0.639745533 0.501808317 1430.335323 0 0 0 0 0 0 0 0 17.99738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2775 0 0 16.56105 18.00574 0 18.83116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99909 SSX3_HUMAN "Protein SSX3 (Cancer/testis antigen 5.3, CT5.3)" SSX3 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 AILPSFMR 10.61999989 0.545287251 0.545287251 0.204782769 933.6443238 0 15.46482 0 16.42201 13.60787 17.56673 14.06061 16.65972 0 0 15.48268 15.78162 14.10629 16.12667 0 0 0 14.65142 0 0 0 11.92854 15.78993 16.54332 0 12.7084 12.71796 12.65712 0 13.74191 16.17073 16.70761 0 17.5467 0 16.07007 17.44373 15.57571 15.30691 16.19059 0 16.31678 0 0 9.259784 15.9991 14.72044 0 Q99928 GBRG3_HUMAN Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) GABRG3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0009410; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099699; GO:1902476; GO:1902711; GO:1904315 FNSTMKILTLNSNMVGLIWIPDTIFR 11.67000008 1 1 3.66E-12 3057.76349 0 0 0 0 0 0 0 20.3201 0 0 0 19.20319 19.71059 18.03391 19.61465 0 0 18.36651 0 0 19.73451 0 0 0 20.56536 18.03177 0 0 0 19.79266 18.21318 18.71545 19.69528 19.36914 0 19.67203 0 19.75019 18.63871 0 0 20.36535 0 0 0 0 18.29548 16.78796 Q99929 ASCL2_HUMAN "Achaete-scute homolog 2, ASH-2, hASH2 (Class A basic helix-loop-helix protein 45, bHLHa45) (Mash2)" ASCL2 BHLHA45 HASH2 Homo sapiens (Human) negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; spongiotrophoblast layer development [GO:0060712] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; spongiotrophoblast layer development [GO:0060712]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001666; GO:0001890; GO:0005634; GO:0005737; GO:0006357; GO:0007423; GO:0010626; GO:0030182; GO:0035019; GO:0045944; GO:0046983; GO:0050767; GO:0060708; GO:0060712; GO:0070888; GO:0090575; GO:1990837 DGGTLPR 9.659999847 1 1 0.213216883 714.4380091 16.72747 0 16.51958 0 0 0 0 0 0 0 0 0 0 0 0 0 17.74709 0 0 0 0 0 16.65651 0 0 18.88522 0 0 0 17.93729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99941 ATF6B_HUMAN "Cyclic AMP-dependent transcription factor ATF-6 beta, cAMP-dependent transcription factor ATF-6 beta (Activating transcription factor 6 beta, ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein, Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta ]" ATF6B CREBL1 G13 Homo sapiens (Human) ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" "cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0005789; GO:0005794; GO:0006357; GO:0007165; GO:0030176; GO:0030968; GO:0032993; GO:0035497; GO:0036500; GO:0045944; GO:0090575; GO:1903892; GO:1990440; GO:1990837 SIVPAPMPGNSCPPEVDAK 2.410000086 1 1 0.306016675 1964.003214 12.17952 15.46195 14.00673 0 0 13.87575 0 0 0 0 0 0 0 0 0 11.37385 0 15.39166 0 15.32936 0 0 0 0 0 0 0 0 0 0 0 0 0 14.95565 0 16.34067 0 0 0 0 0 0 0 0 0 0 0 0 Q99943 PLCA_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 1, 1-AGP acyltransferase 1, 1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha, LPAAT-alpha) (Protein G15)" AGPAT1 G15 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0016024 GGGDYLKKPGGGG 7.329999924 1 1 2.30E-13 1162.734073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.72451 0 0 14.94989 0 0 0 0 0 14.84106 14.93292 0 15.09486 15.35964 0 15.20611 15.59671 0 0 0 0 0 0 0 0 0 17.16586 0 0 0 Q99952 PTN18_HUMAN "Tyrosine-protein phosphatase non-receptor type 18, EC 3.1.3.48 (Brain-derived phosphatase)" PTPN18 BDP1 Homo sapiens (Human) blastocyst formation [GO:0001825]; negative regulation of ERBB signaling pathway [GO:1901185]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; blastocyst formation [GO:0001825]; negative regulation of ERBB signaling pathway [GO:1901185]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] GO:0001825; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0035335; GO:1901185 DVLPYDQTR 7.820000172 1 1 0.236399338 1107.070288 18.26674 17.59528 0 18.39993 0 0 0 0 19.49449 0 0 0 0 0 17.00142 0 0 0 0 0 0 0 20.50918 0 0 0 0 0 0 0 0 0 0 0 0 17.12591 0 0 19.49497 0 0 18.92476 20.45344 0 0 17.4597 0 0 Q99959 PKP2_HUMAN Plakophilin-2 PKP2 Homo sapiens (Human) bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] GO:0001533; GO:0002159; GO:0002934; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005882; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007507; GO:0010765; GO:0014704; GO:0016021; GO:0017080; GO:0019215; GO:0030054; GO:0030057; GO:0044325; GO:0045110; GO:0045294; GO:0045296; GO:0048496; GO:0055010; GO:0060090; GO:0072659; GO:0086002; GO:0086005; GO:0086019; GO:0086064; GO:0086073; GO:0086083; GO:0086091; GO:0098609; GO:0098911 AGTTSR 5.190000057 0.059020668 0.059020668 0.299396414 594.0722154 15.11763 0 15.15864 0 15.0867 15.44779 16.55372 15.77905 0 0 0 14.62865 15.20439 14.97108 15.78386 0 0 15.62539 16.57727 16.09712 0 16.13859 16.29451 15.67907 15.92303 0 15.28397 15.51799 15.58293 15.95227 16.20215 14.76811 14.72641 15.06285 0 16.14175 0 15.20498 17.89598 0 0 16.64512 0 0 0 0 16.67415 0 Q99961 SH3G1_HUMAN "Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein, EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1)" SH3GL1 CNSA1 SH3D2B Homo sapiens (Human) central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289] GO:0002102; GO:0005737; GO:0005829; GO:0007165; GO:0007417; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0098793; GO:0098978 VGGAEGTK 4.920000076 0.281477094 0.281477094 0.232812281 720.0444563 16.38273 14.82561 16.01767 16.52049 16.30952 0 0 17.34053 0 0 0 0 17.79363 17.00086 14.48918 0 16.00626 0 0 0 0 0 0 0 15.96651 16.62498 0 15.38488 0 0 13.90785 18.98062 0 0 0 16.70855 17.42158 0 0 0 0 17.38888 17.26169 0 0 15.23901 14.89274 0 Q99963 SH3G3_HUMAN Endophilin-A3 (EEN-B2) (Endophilin-3) (SH3 domain protein 2C) (SH3 domain-containing GRB2-like protein 3) SH3GL3 CNSA3 SH3D2C Homo sapiens (Human) central nervous system development [GO:0007417]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; positive regulation of neuron differentiation [GO:0045666]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191] "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endosome [GO:0098845]; presynapse [GO:0098793]" "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endosome [GO:0098845]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022]; central nervous system development [GO:0007417]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; positive regulation of neuron differentiation [GO:0045666]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]" identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022] GO:0001669; GO:0005737; GO:0007165; GO:0007417; GO:0008022; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0045666; GO:0098793; GO:0098845; GO:0098978; GO:0099092; GO:1900186 ASQLFSEK 4.619999886 1 1 0.142783362 910.4138961 0 0 14.93618 15.94457 14.98893 0 13.74055 14.05652 14.06098 13.62081 16.30751 17.22725 14.24107 13.89818 14.2219 15.28651 0 13.3051 14.79288 13.64659 13.49625 18.00311 17.38916 0 0 0 0 0 0 0 0 0 0 16.45659 0 0 0 0 15.27049 0 0 0 14.67175 0 0 0 0 0 Q99965 ADAM2_HUMAN "Disintegrin and metalloproteinase domain-containing protein 2, ADAM 2 (Cancer/testis antigen 15, CT15) (Fertilin subunit beta) (PH-30, PH30) (PH30-beta)" ADAM2 FTNB Homo sapiens (Human) adult behavior [GO:0030534]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; positive regulation of gene expression [GO:0010628]; visual learning [GO:0008542] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; adult behavior [GO:0030534]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; positive regulation of gene expression [GO:0010628]; visual learning [GO:0008542] integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004222; GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007339; GO:0007342; GO:0008237; GO:0008542; GO:0009986; GO:0010628; GO:0030534; GO:0032991 LDPFFKQQAVCGNAK 8.510000229 0.211133182 0.211133182 0.193450373 1723.363557 0 0 0 17.5228 16.93191 0 0 0 0 0 0 0 0 0 0 0 16.16542 17.79023 0 0 0 0 0 0 0 16.09831 0 0 0 17.54976 0 16.66134 18.30433 17.8378 0 0 0 16.40028 16.11942 0 0 0 16.47308 0 0 12.28981 0 0 Q99967 CITE2_HUMAN "Cbp/p300-interacting transactivator 2 (MSG-related protein 1, MRG-1) (P35srj)" CITED2 MRG1 Homo sapiens (Human) "adrenal cortex formation [GO:0035802]; bone morphogenesis [GO:0060349]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; cranial nerve morphogenesis [GO:0021602]; decidualization [GO:0046697]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endocardial cushion development [GO:0003197]; erythrocyte development [GO:0048821]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; left/right axis specification [GO:0070986]; left/right pattern formation [GO:0060972]; lens morphogenesis in camera-type eye [GO:0002089]; liver development [GO:0001889]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; peripheral nervous system development [GO:0007422]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pulmonary artery morphogenesis [GO:0061156]; regulation of animal organ formation [GO:0003156]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sex determination [GO:0007530]; skeletal muscle cell differentiation [GO:0035914]; spleen development [GO:0048536]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; LBD domain binding [GO:0050693]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; adrenal cortex formation [GO:0035802]; bone morphogenesis [GO:0060349]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; cranial nerve morphogenesis [GO:0021602]; decidualization [GO:0046697]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endocardial cushion development [GO:0003197]; erythrocyte development [GO:0048821]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; left/right axis specification [GO:0070986]; left/right pattern formation [GO:0060972]; lens morphogenesis in camera-type eye [GO:0002089]; liver development [GO:0001889]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; peripheral nervous system development [GO:0007422]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pulmonary artery morphogenesis [GO:0061156]; regulation of animal organ formation [GO:0003156]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sex determination [GO:0007530]; skeletal muscle cell differentiation [GO:0035914]; spleen development [GO:0048536]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]" chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; LBD domain binding [GO:0050693]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000785; GO:0001570; GO:0001666; GO:0001829; GO:0001843; GO:0001889; GO:0001892; GO:0001947; GO:0002089; GO:0002244; GO:0003151; GO:0003156; GO:0003197; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007179; GO:0007368; GO:0007417; GO:0007422; GO:0007507; GO:0007530; GO:0007569; GO:0008283; GO:0008584; GO:0009612; GO:0010628; GO:0010629; GO:0019904; GO:0021602; GO:0022409; GO:0030336; GO:0030511; GO:0030851; GO:0032991; GO:0034405; GO:0035035; GO:0035360; GO:0035802; GO:0035914; GO:0043066; GO:0043627; GO:0045787; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046697; GO:0048536; GO:0048538; GO:0048596; GO:0048821; GO:0050693; GO:0060044; GO:0060136; GO:0060349; GO:0060412; GO:0060971; GO:0060972; GO:0061156; GO:0061308; GO:0061428; GO:0061629; GO:0070986; GO:1900164; GO:2000020 MADHMMAMNHGR 4.389999866 1 1 0.202128494 1419.200867 19.63597 0 0 18.77969 0 0 17.93781 14.81969 0 12.37714 15.54626 16.50064 15.63002 16.14724 17.74701 15.854 15.0286 14.42101 0 0 14.89851 0 0 0 14.52249 18.14045 15.2285 0 16.71605 0 0 0 17.63294 0 15.10872 13.61295 16.35136 0 17.38037 13.3692 0 7.714822 0 17.06114 0 0 0 15.03699 Q99972 MYOC_HUMAN "Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]" MYOC GLC1A TIGR Homo sapiens (Human) bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]; fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]; bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734] fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971] GO:0001649; GO:0001953; GO:0001968; GO:0005109; GO:0005615; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005791; GO:0005794; GO:0005929; GO:0007165; GO:0014068; GO:0014734; GO:0022011; GO:0030335; GO:0030971; GO:0031175; GO:0031410; GO:0032027; GO:0033268; GO:0035024; GO:0038031; GO:0038133; GO:0043408; GO:0045162; GO:0046872; GO:0051496; GO:0051497; GO:0051894; GO:0051897; GO:0051901; GO:0060348; GO:0062023; GO:0070062; GO:1900026 SELTEVPASR 9.550000191 0.728838027 0.728838027 0.284952125 1089.476742 12.72346 15.16481 15.39279 13.35832 12.62421 13.36088 0 14.26557 0 14.51762 11.85381 0 14.80649 0 16.53799 15.1765 16.09825 15.87253 14.82096 0 0 14.44002 0 0 0 14.68381 0 0 0 0 0 0 0 0 0 0 17.45564 0 0 14.92661 0 0 0 0 0 15.60517 0 0 Q99973 TEP1_HUMAN "Telomerase protein component 1 (Telomerase-associated protein 1, Telomerase protein 1) (p240) (p80 telomerase homolog)" TEP1 TLP1 TP1 Homo sapiens (Human) telomere maintenance via recombination [GO:0000722] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]" ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 DLGAPGASIR 5.28000021 1 1 0.102344507 953.858353 14.90277 14.16509 15.69359 0 0 0 0 0 0 0 16.32467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.61368 0 0 0 0 0 0 0 0 0 Q99990 VGLL1_HUMAN "Transcription cofactor vestigial-like protein 1, Vgl-1 (Protein TONDU)" VGLL1 TDU Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357 ENGNPGQIAGSTGLLFNLPPGSVHYKK 3.420000076 1 1 0.216766401 2796.49239 14.79036 15.44893 0 0 0 15.14368 0 0 15.20337 0 0 0 13.81746 0 0 0 14.57438 12.31982 15.513 0 0 0 13.84941 14.30408 0 14.37317 0 0 0 0 0 16.04984 0 0 0 0 0 0 0 0 0 0 0 0 0 16.70687 0 15.81361 Q99996 AKAP9_HUMAN "A-kinase anchor protein 9, AKAP-9 (A-kinase anchor protein 350 kDa, AKAP 350, hgAKAP 350) (A-kinase anchor protein 450 kDa, AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein, CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9, PRKA9) (Protein yotiao)" AKAP9 AKAP350 AKAP450 KIAA0803 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165] DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0033138; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098962; GO:0098978; GO:0099147; GO:1901018; GO:1903358 ETNFKMNQLTQELFSLK 3.059999943 0.410833925 0.410833925 0.096544771 2086.62615 15.92847 12.36023 0 0 15.8199 0 0 15.76141 16.0849 0 13.19928 0 0 0 0 0 0 0 0 0 0 17.10402 0 11.85761 15.45797 0 15.82252 0 0 0 0 15.95288 17.44073 16.12984 0 0 0 16.34274 0 0 0 0 0 0 13.78122 0 14.75264 0 Q9BPX7 CG025_HUMAN UPF0415 protein C7orf25 C7orf25 Homo sapiens (Human) IAIAKELIK 20.44000053 1 1 0.216702006 997.4756309 0 0 0 20.1177 0 0 0 22.67866 0 0 0 16.93844 0 0 16.76109 0 0 0 0 0 0 0 0 18.01437 0 17.63417 0 0 18.50162 18.77164 20.05702 21.16154 0 17.22603 0 0 19.83122 0 0 19.20434 18.11245 21.00252 0 15.03431 19.96417 0 16.52127 0 Q9BPY3 F118B_HUMAN Protein FAM118B FAM118B Homo sapiens (Human) Cajal body organization [GO:0030576] Cajal body [GO:0015030] Cajal body [GO:0015030]; identical protein binding [GO:0042802]; Cajal body organization [GO:0030576] identical protein binding [GO:0042802] GO:0015030; GO:0030576; GO:0042802 LTCEISTRGTSAGMVR 5.889999866 1 1 0.10898597 1739.504598 13.4156 0 0 0 16.64356 0 0 0 0 0 10.62215 0 0 0 0 0 14.93938 0 0 0 0 0 0 15.85233 0 0 0 0 0 16.4444 0 0 0 0 0 7.361927 0 12.8832 0 0 0 15.31557 0 13.98599 0 0 0 15.28917 Q9BPZ7 SIN1_HUMAN "Target of rapamycin complex 2 subunit MAPKAP1, TORC2 subunit MAPKAP1 (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1, SAPK-interacting protein 1, mSIN1)" MAPKAP1 MIP1 SIN1 Homo sapiens (Human) cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203]" "phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]" GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0016310; GO:0019901; GO:0021762; GO:0030307; GO:0031267; GO:0031410; GO:0031669; GO:0031932; GO:0033138; GO:0038203; GO:0043066; GO:0043325; GO:0046580; GO:0070300; GO:0080025; GO:1900407 EKPPISGKQSILSVR 5.599999905 1 1 0.714927217 1639.343515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.63213 17.59921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.42064 0 0 0 0 18.14623 0 0 0 0 0 0 Q9BQ13 KCD14_HUMAN BTB/POZ domain-containing protein KCTD14 KCTD14 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 AVLDNSDLMHCLEMDIK 1.629999995 1 1 0.306139344 2020.855304 0 13.96765 0 0 16.17111 0 0 14.66417 14.14421 0 0 14.72343 14.63469 0 7.543853 0 12.24416 12.52824 0 0 0 0 15.54724 0 0 14.35613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ24 ZFY21_HUMAN "Zinc finger FYVE domain-containing protein 21, ZF21" ZFYVE21 Homo sapiens (Human) endosome [GO:0005768]; focal adhesion [GO:0005925] endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005768; GO:0005925; GO:0046872 LVRSPSGLR 9.130000114 0.535209656 0.535209656 0.159557991 984.5638704 0 15.92293 0 11.17598 15.13219 14.44515 0 12.84391 14.16954 13.28949 15.04184 14.49179 13.58441 15.83974 15.5441 15.25624 12.76333 15.247 10.90746 15.02334 15.28669 17.45204 16.92546 0 0 14.50724 13.90521 13.97033 0 0 16.23555 15.52091 0 15.35081 11.25255 16.47363 16.09034 14.63687 16.68554 13.35841 12.83583 12.51983 0 0 0 14.0042 13.68929 0 Q9BQ39 DDX50_HUMAN "ATP-dependent RNA helicase DDX50, EC 3.6.4.13 (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)" DDX50 Homo sapiens (Human) membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005886; GO:0016020; GO:0016887 KNVTEMAMNPHIK 1.679999948 1 1 0.229375391 1512.811832 0 0 11.85447 13.07148 0 13.3478 0 15.40837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.13221 0 14.14808 14.2622 0 10.08254 0 0 0 0 15.8943 0 0 0 0 17.00412 0 0 0 0 0 0 0 Q9BQ61 TRIR_HUMAN "Telomerase RNA component interacting RNase, EC 3.1.13.- (Exoribonuclease TRIR)" TRIR C19orf43 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" "3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; RNA binding [GO:0003723] GO:0003723; GO:0008408; GO:0008409; GO:0016075; GO:0090503 EAPGPAGGGGGGSR 6.96999979 0.067634672 0.067634672 0.200727069 1127.829389 15.16254 13.54386 0 14.8358 13.52039 13.17556 13.06029 13.82305 0 0 0 0 13.32089 13.02328 0 0 14.43108 12.34658 0 16.14039 11.19578 16.06877 0 17.05264 0 0 16.32084 0 0 15.72503 0 16.21981 0 0 0 0 15.00264 15.29466 0 0 0 0 0 0 0 0 0 0 Q9BQ89 F110A_HUMAN Protein FAM110A FAM110A C20orf55 F10 Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922] GO:0000922; GO:0005737; GO:0005815 SSVTVEERAR 10.69999981 1 1 0.097976393 1132.710706 12.61818 0 8.333874 13.50259 12.91068 5.172613 14.7091 0 15.07603 0 0 13.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.28853 0 0 0 0 0 0 0 15.25274 13.65839 0 0 14.21749 0 0 0 0 0 0 0 0 Q9BQ95 ECSIT_HUMAN "Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)" ECSIT Homo sapiens (Human) innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635] GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005829; GO:0032981; GO:0045087; GO:0051341; GO:0061635 DLAVYNQLLNIFPKEVFRPR 2.359999895 1 1 0.392731867 2433.108036 0 0 0 17.00268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.87902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQA1 MEP50_HUMAN "Methylosome protein 50, MEP-50 (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50)" WDR77 MEP50 WD45 HKMT1069 Nbla10071 Homo sapiens (Human) "histone H4-R3 methylation [GO:0043985]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374]; histone H4-R3 methylation [GO:0043985]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]" methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374] GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0007309; GO:0008284; GO:0008327; GO:0030374; GO:0034709; GO:0043985; GO:0048026; GO:0060528; GO:0060770 DICIK 3.859999895 0.070328228 0.070328228 0.093405765 648.1041461 19.03044 0 13.52418 17.14813 0 14.88488 12.9975 15.88545 14.55201 12.15144 0 16.142 15.13684 14.02908 9.285678 15.91841 15.68613 0 0 0 10.78546 18.17724 16.91499 12.37945 12.29433 15.36297 0 16.49805 0 0 16.35044 0 0 13.33383 16.91676 13.72032 15.29438 15.95281 16.24492 18.03437 12.22902 14.66291 16.98797 0 14.94581 14.21688 0 0 Q9BQA9 CYBC1_HUMAN "Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein, Eros)" CYBC1 C17orf62 EROS Homo sapiens (Human) innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728] GO:0005783; GO:0005789; GO:0016021; GO:0045087; GO:0045728 GYMVVLR 5.179999828 0.687174618 0.687174618 0.068454413 852.9692368 0 0 0 0 15.9715 0 0 0 0 0 0 0 0 0 13.444 10.39464 15.77243 10.79127 12.156 14.75824 13.7947 0 14.28471 16.42479 17.02257 0 10.28696 15.96964 13.2081 14.76526 15.58971 15.43659 0 15.50121 14.04658 0 0 17.00928 0 15.64093 0 0 16.13047 0 15.76139 0 16.21232 0 Q9BQC6 RT63_HUMAN "Ribosomal protein 63, mitochondrial, hMRP63 (Mitochondrial large ribosomal subunit protein mL63) (Mitochondrial ribosomal protein 63) (Mitochondrial ribosomal protein L57)" MRPL57 MRP63 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 GHAAVRR 2.819999933 0.113558896 0.113558896 0.267243846 766.1214589 15.94298 15.45392 15.11137 16.28538 12.97371 15.81667 0 0 15.61347 14.78096 13.41909 0 0 15.49989 14.11893 13.84362 0 15.785 0 0 0 15.71933 16.47875 15.98139 0 0 0 15.55208 0 16.68579 0 16.97769 16.33945 0 15.63834 0 0 0 0 16.89283 0 0 0 15.6802 16.11456 0 0 0 Q9BQD3 KXDL1_HUMAN KxDL motif-containing protein 1 KXD1 C19orf50 Homo sapiens (Human) lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; vesicle-mediated transport [GO:0016192] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; vesicle-mediated transport [GO:0016192] GO:0016192; GO:0032418; GO:0051036; GO:0062196; GO:0072384; GO:0098574; GO:0099078 ILSMVNTDDVNAIILAQK 7.329999924 0.200255573 0.200255573 0.213954134 1956.878586 0 0 0 15.44443 14.14727 17.09755 0 0 0 16.80384 0 17.9168 0 13.99958 15.70814 14.27996 0 0 14.40486 0 0 0 17.60066 17.52407 14.0537 17.85828 14.50829 14.84233 0 13.20868 15.6605 0 14.84308 0 0 16.23614 0 0 0 13.13143 0 0 15.77906 0 13.871 11.60004 16.844 0 Q9BQE4 SELS_HUMAN "Selenoprotein S, SelS (VCP-interacting membrane protein)" SELENOS SELS VIMP AD-015 SBBI8 Homo sapiens (Human) "cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] "cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381]; cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381] GO:0002865; GO:0005783; GO:0005789; GO:0005881; GO:0005886; GO:0006111; GO:0006983; GO:0009749; GO:0016209; GO:0019899; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0032715; GO:0032720; GO:0032869; GO:0034361; GO:0034362; GO:0034599; GO:0036502; GO:0036513; GO:0038023; GO:0045184; GO:0045454; GO:0045719; GO:0046325; GO:0050728; GO:0051117; GO:0051771; GO:0051775; GO:0071222; GO:0080164; GO:1902236; GO:1990381; GO:2000110 QEALAAAR 4.590000153 1 1 0.207658975 828.5961664 15.65729 16.48683 15.82786 0 0 0 15.56694 14.39757 14.33293 14.2031 0 17.41381 15.35174 0 15.16314 0 0 0 0 16.66779 14.92721 0 15.84107 15.17749 0 0 0 0 0 0 0 0 16.01636 0 0 15.75754 0 15.78584 0 15.64167 0 0 14.71593 0 0 16.38077 16.14916 0 Q9BQG0 MBB1A_HUMAN Myb-binding protein 1A MYBBP1A P160 Homo sapiens (Human) "cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]" B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]" E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] GO:0001649; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0006355; GO:0008134; GO:0016020; GO:0022904; GO:0032922; GO:0035066; GO:0042149; GO:0042254; GO:0042564; GO:0043231; GO:0043565; GO:0045892; GO:0045943; GO:0045944; GO:0045945; GO:0070888; GO:0072332; GO:0110016; GO:1903450; GO:2000210 SPLSALAR 7.71999979 1 1 0.083364371 814.4424919 15.63782 13.25603 0 0 0 0 0 0 0 0 0 0 16.80381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7096 13.12417 0 15.53047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQG2 NUD12_HUMAN "NAD-capped RNA hydrolase NUDT12, DeNADding enzyme NUDT12, EC 3.6.1.- (NADH pyrophosphatase NUDT12, EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12, Nudix motif 12)" NUDT12 Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; methylguanosine-cap decapping [GO:0110156]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742] cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; methylguanosine-cap decapping [GO:0110156]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742] magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270] GO:0000210; GO:0000287; GO:0005634; GO:0005737; GO:0005777; GO:0005782; GO:0006402; GO:0006734; GO:0006742; GO:0008270; GO:0019677; GO:0032922; GO:0034356; GO:0035529; GO:0110153; GO:0110155; GO:0110156; GO:1990174 EAGVVAQAR 2.069999933 0.248183057 0.248183057 0.065763034 900.3672023 0 0 17.1484 15.40184 0 0 16.03422 16.38433 15.17421 17.33764 0 13.4931 16.96854 15.68985 16.56245 0 12.6534 18.17895 0 0 0 0 16.38006 0 16.53312 15.63251 0 0 14.54053 16.78921 0 0 16.41959 14.45995 0 0 14.92471 0 12.89511 0 0 14.3738 16.33681 13.41486 13.60162 12.40221 0 15.00811 Q9BQI0 AIF1L_HUMAN Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2) AIF1L C9orf58 IBA2 UNQ672/PRO1306 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; ruffle assembly [GO:0097178] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; ruffle assembly [GO:0097178] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] GO:0005509; GO:0005737; GO:0005925; GO:0015629; GO:0032587; GO:0051015; GO:0051017; GO:0070062; GO:0097178 ANESSPKPVGPPPER 6.090000153 1 1 0.021877681 1555.913566 0 0 17.47232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.41239 0 0 0 15.80059 0 0 0 0 0 0 0 0 0 Q9BQI3 E2AK1_HUMAN "Eukaryotic translation initiation factor 2-alpha kinase 1, EC 2.7.11.1 (Heme-controlled repressor, HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor, hHRI) (Hemin-sensitive initiation factor 2-alpha kinase)" EIF2AK1 HRI KIAA1369 PRO1362 Homo sapiens (Human) acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0002526; GO:0004672; GO:0004694; GO:0004712; GO:0005524; GO:0005737; GO:0006909; GO:0008285; GO:0010999; GO:0020037; GO:0030225; GO:0042803; GO:0045993; GO:0046501; GO:0046777; GO:0046986; GO:0055072; GO:0106310; GO:0140467; GO:0140468; GO:1990641 GVRDDGK 8.729999542 2.22E-07 2.22E-07 0.26566671 746.0171015 0 0 0 17.3826 0 0 17.51831 0 0 0 18.13218 0 0 17.81042 0 0 0 0 0 0 16.55695 0 0 0 17.82486 17.56604 0 0 17.17812 17.06566 18.05028 0 0 0 0 19.49069 0 0 17.35662 0 0 19.0418 16.83645 0 0 16.80016 0 0 Q9BQI5 SGIP1_HUMAN SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein) SGIP1 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021] AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021] microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124] GO:0002021; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0008017; GO:0017124; GO:0030122; GO:0030136; GO:0048260; GO:0048268; GO:0072583; GO:0097009; GO:2000253 IPDISQKSENGGVGSLLAR 2.609999895 0.321368247 0.321368247 1.82E-12 1942.572565 0 0 0 0 12.35704 12.18432 0 0 0 0 14.14631 11.41614 0 0 0 0 14.1847 16.08638 0 15.81214 0 17.829 0 15.33343 14.60969 0 17.90924 14.2677 14.37926 0 0 0 17.34177 14.74887 0 13.75476 13.932 0 0 9.891138 0 0 0 14.82943 11.7199 0 10.57247 17.27706 Q9BQI6 SLF1_HUMAN SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) (Smc5/6 localization factor 1) SLF1 ANKRD32 BRCTD1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] GO:0000724; GO:0000781; GO:0000786; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0042405; GO:0044877; GO:1990166; GO:2000781 GELPLDYVVSPQIKEELFAITK 1.389999986 1 1 0.150260878 2489.11376 0 12.46135 14.11964 0 0 0 0 12.60602 9.861869 0 16.2147 0 13.40214 0 0 0 0 14.01245 13.5256 0 0 9.517795 0 0 15.36232 14.31705 0 0 12.63421 13.09123 15.28071 0 14.7312 0 10.7408 0 0 0 0 15.21087 0 15.74568 0 0 0 0 0 0 Q9BQN1 FA83C_HUMAN Protein FAM83C FAM83C C20orf128 Homo sapiens (Human) signal transduction [GO:0007165] protein kinase binding [GO:0019901]; signal transduction [GO:0007165] protein kinase binding [GO:0019901] GO:0007165; GO:0019901 GRIVEDFDR 10.48999977 1 1 0.082251181 1107.035904 0 0 13.40134 0 0 13.29885 0 0 0 0 0 0 14.12907 0 0 0 18.24642 17.51439 0 17.15404 18.49958 0 16.64017 16.26982 15.102 0 0 16.2756 0 0 16.20843 0 18.46012 18.15193 16.2631 15.94299 16.25207 16.99906 17.88248 17.72132 18.01227 17.3824 0 0 0 15.97147 15.9913 16.27411 Q9BQR3 PRS27_HUMAN "Serine protease 27, EC 3.4.21.- (Marapsin) (Pancreasin)" PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252] serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005576; GO:0005886 ILQKLAVPIIDTPK 1.720000029 0.063319862 0.063319862 0.113566123 1549.347188 0 10.83256 16.31825 13.65595 0 13.85775 17.05121 0 0 0 13.81258 17.2012 0 14.49499 10.64 0 10.45808 0 18.14917 13.38973 12.21528 0 0 0 0 0 0 0 0 14.94498 12.15776 17.43619 14.28607 15.90339 16.09454 11.0729 17.33811 0 14.17896 7.084331 0 0 14.131 0 15.40215 0 15.90803 0 Q9BQS2 SYT15_HUMAN "Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV, SytXV)" SYT15 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277 WHALCRTTEP 13.34000015 1 1 0.281861735 1270.157719 0 0 0 0 0 0 0 0 0 18.83118 0 0 17.39095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQS7 HEPH_HUMAN "Hephaestin, EC 1.-.-.-" HEPH KIAA0698 UNQ2562/PRO6242 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491] GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0008198; GO:0016021; GO:0016323; GO:0016491; GO:0048471; GO:0055072 DGLLGSR 6.96999979 0.275770187 0.275770187 0.172702144 717.3318992 15.23438 15.08152 11.28772 13.90449 14.65589 15.07486 15.5815 0 14.00957 14.58186 0 15.6654 0 0 0 0 0 15.70436 0 0 0 17.90726 0 0 15.91456 0 0 15.73316 15.0852 0 0 17.05607 0 0 0 15.88355 0 0 0 15.66307 15.26355 16.17867 0 16.11514 14.61627 0 15.1007 13.53591 Q9BQS8 FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7) FYCO1 ZFYVE7 Homo sapiens (Human) plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098] autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020] autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098] metal ion binding [GO:0046872] GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0016020; GO:0043231; GO:0046872; GO:0072383; GO:1901098 EDLERTQK 7.769999981 1 1 0.20385174 1018.987586 14.95894 0 11.40007 0 0 14.67757 0 0 0 0 14.52515 14.78031 14.73929 14.84853 14.66253 0 14.52059 14.26443 0 0 0 0 15.41473 0 16.62436 13.54948 0 0 12.64231 0 13.63773 14.72684 14.59799 0 16.06846 14.96584 0 0 12.69085 0 14.55208 13.28763 0 0 11.88411 15.96975 0 0 Q9BQT8 ODC_HUMAN Mitochondrial 2-oxodicarboxylate carrier (Solute carrier family 25 member 21) SLC25A21 ODC Homo sapiens (Human) lysine catabolic process [GO:0006554]; mitochondrial alpha-ketoglutarate transmembrane transport [GO:1990550] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; lysine catabolic process [GO:0006554]; mitochondrial alpha-ketoglutarate transmembrane transport [GO:1990550] alpha-ketoglutarate transmembrane transporter activity [GO:0015139] GO:0005743; GO:0006554; GO:0015139; GO:0016021; GO:1990550 NMIPVNK 26.05999947 0.605986536 0.605986536 0.208839931 814.5098454 18.89432 18.69645 18.91441 18.44375 19.84648 18.60047 19.11598 19.65436 17.29776 18.8302 18.88264 19.70072 20.04104 19.66741 19.98263 18.47716 19.02178 17.60675 18.65509 19.36619 19.47496 18.6279 18.523 19.29461 19.35214 18.55652 18.40143 17.90326 19.48423 19.43938 19.34128 0 0 18.99314 18.21761 0 19.02546 18.15839 19.65829 18.01 18.99715 0 18.24685 19.09878 18.20369 17.68924 17.29867 0 Q9BR39 JPH2_HUMAN "Junctophilin-2, JP-2 (Junctophilin type 2) [Cleaved into: Junctophilin-2 N-terminal fragment, JP2NT ]" JPH2 JP2 Homo sapiens (Human) "calcium ion homeostasis [GO:0055074]; calcium ion transport into cytosol [GO:0060402]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle tissue development [GO:0055024]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; calcium ion homeostasis [GO:0055074]; calcium ion transport into cytosol [GO:0060402]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle tissue development [GO:0055024]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]" "core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]" GO:0000122; GO:0001046; GO:0001227; GO:0001786; GO:0003677; GO:0005546; GO:0005547; GO:0005634; GO:0005789; GO:0005886; GO:0010314; GO:0014701; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0032266; GO:0045892; GO:0055024; GO:0055074; GO:0060314; GO:0060316; GO:0060402; GO:0070273; GO:0070300; GO:0080025 APKGGGLFQR 5.769999981 1 1 0.273836052 1031.484729 12.35846 13.75842 16.23166 16.21777 0 0 15.60644 15.23954 13.02306 0 0 0 14.42793 0 14.79206 16.23491 0 14.89232 15.47586 0 0 0 14.16128 0 0 15.54839 0 0 0 0 0 0 0 0 0 0 0 16.27695 0 0 0 0 0 0 0 0 0 0 Q9BR76 COR1B_HUMAN Coronin-1B (Coronin-2) CORO1B Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060] actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802] GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007015; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034315; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000394 GDSSIR 3.180000067 1 1 0.027073261 633.6971814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.55883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.87799 0 Q9BR77 CCD77_HUMAN Coiled-coil domain-containing protein 77 CCDC77 Homo sapiens (Human) centrosome [GO:0005813]; membrane [GO:0016020] centrosome [GO:0005813]; membrane [GO:0016020] GO:0005813; GO:0016020 EEEGMRR 13.13000011 1 1 0.234256485 921.6091241 0 14.98049 0 14.12367 14.52514 14.08576 15.16287 14.09147 17.03741 14.73799 0 15.29833 15.46265 0 0 0 0 15.13438 0 12.54363 0 15.96299 0 11.66668 0 0 0 0 0 0 14.08658 0 0 14.41978 16.30008 0 0 0 17.30865 0 15.15024 0 14.5624 0 15.2836 14.55508 15.53434 16.59588 Q9BR84 ZN559_HUMAN Zinc finger protein 559 ZNF559 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 SSFLIRHLR 8.460000038 1 1 0.29619816 1128.167916 15.91229 15.91622 0 0 0 15.21919 0 0 0 0 14.90906 0 0 0 14.71563 14.17449 0 0 17.1599 0 0 15.69088 15.2013 14.4976 0 0 0 16.42814 17.09371 0 17.13675 0 0 15.52601 15.4764 0 15.60945 16.38304 0 0 0 0 0 0 0 16.57116 0 0 Q9BRA2 TXD17_HUMAN "Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein, TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5)" TXNDC17 TXNL5 Homo sapiens (Human) tumor necrosis factor-mediated signaling pathway [GO:0033209] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxidase activity [GO:0004601]; protein-disulfide reductase (NAD(P)) activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209] peroxidase activity [GO:0004601]; protein-disulfide reductase (NAD(P)) activity [GO:0047134] GO:0004601; GO:0005829; GO:0033209; GO:0047134; GO:0070062 AVEQHNGK 6.619999886 0.756079257 0.756079257 0.255431453 880.7017346 19.28523 17.47406 19.68227 0 21.71657 17.6572 17.55758 19.30346 0 0 18.67809 0 0 16.80175 17.76786 0 0 17.69896 0 0 0 0 17.27076 0 18.70997 18.90048 0 16.78061 0 16.53297 0 18.8608 19.45979 0 18.6527 18.551 16.92883 0 0 0 18.29181 0 0 0 0 16.64771 0 17.36294 Q9BRB3 PIGQ_HUMAN "Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein, PIG-Q)" PIGQ GPI1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; carbohydrate metabolic process [GO:0005975]; GPI anchor biosynthetic process [GO:0006506] phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176] GO:0000506; GO:0005783; GO:0005789; GO:0005975; GO:0006506; GO:0016021; GO:0017176 FDEGPVR 8.920000076 0.167715967 0.167715967 0.209626449 818.719096 0 0 0 0 15.42977 15.38184 0 0 0 0 0 0 15.39202 0 0 0 14.75146 0 0 0 13.07283 15.35096 0 0 0 15.58986 14.1595 0 14.85627 17.24023 0 0 0 14.86247 16.16545 0 0 0 0 17.98483 0 0 0 0 0 0 0 0 Q9BRD0 BUD13_HUMAN BUD13 homolog BUD13 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0070274; GO:0071005 HDSSDTSPPRR 4.659999847 1 1 0.319791807 1254.077388 14.36518 14.99309 14.9283 0 0 17.44457 0 0 15.55379 0 0 15.00918 16.19545 15.69639 15.10632 0 15.50444 15.83158 16.40444 17.27057 17.59871 0 17.68379 16.12546 0 0 17.05741 16.25259 16.54568 14.17389 0 17.22369 0 16.89755 16.99483 16.47734 16.675 18.11909 0 14.89281 17.19803 0 16.98101 0 17.0622 16.69768 18.11934 16.67023 Q9BRF8 CPPED_HUMAN "Serine/threonine-protein phosphatase CPPED1, EC 3.1.3.16 (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1)" CPPED1 CSTP1 Homo sapiens (Human) azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005576; GO:0005829; GO:0005886; GO:0035578; GO:0046872 LNPKPK 10.07999992 0.104187526 0.104187526 0.290250681 698.0453113 16.09571 14.65312 0 15.74192 0 0 0 0 14.40776 0 16.32135 0 0 15.03884 0 14.65707 0 0 0 0 15.43381 0 15.74914 0 15.8026 0 0 0 0 0 0 0 15.77349 0 0 0 0 0 0 15.36402 0 0 16.15662 0 16.05104 16.58735 0 0 Q9BRH9 ZN251_HUMAN Zinc finger protein 251 ZNF251 Homo sapiens (Human) hematopoietic stem cell homeostasis [GO:0061484]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic stem cell homeostasis [GO:0061484]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0061484 RSSTLVQHR 1.379999995 1 1 0.125524213 1084.360345 0 0 0 14.79514 0 14.91311 0 0 14.37971 15.61414 0 0 0 14.64868 14.95527 0 15.57979 14.14368 0 14.13207 0 11.97331 0 0 0 0 14.02313 0 16.0358 0 0 0 0 0 0 0 0 0 0 0 15.56519 0 0 0 0 0 0 0 Q9BRI3 ZNT2_HUMAN "Zinc transporter 2, ZnT-2 (Solute carrier family 30 member 2)" SLC30A2 ZNT2 Homo sapiens (Human) positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577] identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385] GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0010043; GO:0016021; GO:0042802; GO:0043231; GO:0061088; GO:0061090; GO:0071577 TASSRLQGK 5.139999866 0.712170601 0.712170601 0.222082256 946.7841387 0 0 0 0 0 14.90872 0 11.69085 0 16.17951 13.57748 0 0 16.45943 0 0 14.70526 15.09351 0 0 15.5006 0 0 15.87284 15.14915 13.74372 0 0 0 0 0 0 0 0 0 0 0 0 0 17.78142 0 0 0 0 0 0 17.46555 0 Q9BRJ7 TIRR_HUMAN Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos) NUDT16L1 SDOS TIRR Homo sapiens (Human) negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] GO:0003723; GO:0005634; GO:0030515; GO:2001033 STAAVPELK 1.820000052 1 1 0.284359641 915.9791464 16.86981 17.29006 0 17.22935 16.89729 0 18.22568 0 0 18.08412 12.67972 0 17.23145 0 0 0 0 16.92536 0 0 0 0 0 0 0 18.54694 18.31649 17.84683 15.93007 0 18.93637 18.34967 17.82478 0 19.00527 0 0 0 21.1261 0 16.89521 0 16.89416 0 0 0 0 16.31476 Q9BRK0 REEP2_HUMAN Receptor expression-enhancing protein 2 REEP2 C5orf19 SGC32445 Homo sapiens (Human) endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule binding [GO:0008017]; taste receptor binding [GO:0031883]; endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916] microtubule binding [GO:0008017]; taste receptor binding [GO:0031883] GO:0005783; GO:0005789; GO:0005881; GO:0005887; GO:0008017; GO:0016020; GO:0031883; GO:0032386; GO:0032596; GO:0050913; GO:0050916; GO:0071782; GO:0071786 RAKPIK 3.779999971 0.697186768 0.697186768 0.302139015 712.7464074 0 0 18.42693 0 0 0 0 0 17.79689 17.37942 18.9185 0 19.17712 0 0 0 0 17.64417 0 0 0 17.86697 16.27088 0 19.39063 0 0 0 0 0 0 0 0 19.35544 0 0 0 0 17.78221 17.73701 0 0 0 18.3034 16.93767 17.5983 0 0 Q9BRP4 PAAF1_HUMAN Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71) PAAF1 WDR71 Homo sapiens (Human) proteasome complex [GO:0000502] proteasome complex [GO:0000502] GO:0000502 APVQVIHRSGAPVLSLLSVR 1.370000005 1 1 0.231186598 2102.87616 11.66003 15.91182 0 0 13.8101 0 13.82073 0 13.78654 0 0 11.22195 16.40027 14.33386 12.87904 0 0 0 15.88339 12.63534 0 13.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 15.74235 0 0 15.46014 0 0 0 0 0 0 0 0 0 Q9BRQ0 PYGO2_HUMAN Pygopus homolog 2 PYGO2 PP7910 Homo sapiens (Human) brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; developmental growth [GO:0048589]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; mammary gland development [GO:0030879]; positive regulation of chromatin binding [GO:0035563]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; roof of mouth development [GO:0060021]; spermatid nucleus differentiation [GO:0007289] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone acetyltransferase regulator activity [GO:0035034]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; developmental growth [GO:0048589]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; mammary gland development [GO:0030879]; positive regulation of chromatin binding [GO:0035563]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; roof of mouth development [GO:0060021]; spermatid nucleus differentiation [GO:0007289] chromatin binding [GO:0003682]; histone acetyltransferase regulator activity [GO:0035034]; histone binding [GO:0042393]; metal ion binding [GO:0046872] GO:0001822; GO:0002088; GO:0003682; GO:0005654; GO:0007289; GO:0007420; GO:0030879; GO:0033599; GO:0035034; GO:0035563; GO:0042393; GO:0046872; GO:0048589; GO:0051569; GO:0060021; GO:0060070; GO:1990907 AELGPPSLSQR 4.820000172 1 1 2.33E-13 1155.080575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98406 0 0 0 0 0 0 0 0 0 0 0 14.4963 0 0 0 0 0 0 0 Q9BRQ5 ORAI3_HUMAN Protein orai-3 (Transmembrane protein 142C) ORAI3 TMEM142C Homo sapiens (Human) store-operated calcium entry [GO:0002115] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; store-operated calcium channel activity [GO:0015279]; store-operated calcium entry [GO:0002115] store-operated calcium channel activity [GO:0015279] GO:0002115; GO:0005886; GO:0015279; GO:0016020; GO:0016021 SLVAHK 6.269999981 1 1 0.163195854 652.986538 0 0 0 0 14.15689 0 13.79117 15.4873 0 0 0 0 0 0 0 0 0 0 0 14.89907 15.88349 0 0 0 0 0 0 0 0 0 0 0 16.01062 0 0 0 0 0 0 14.05221 0 15.10201 0 0 0 0 0 0 Q9BRQ6 MIC25_HUMAN MICOS complex subunit MIC25 (Coiled-coil-helix cristae morphology protein 1) (Coiled-coil-helix-coiled-coil-helix domain-containing protein 6) CHCHD6 CHCM1 MIC25 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401] cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] GO:0001401; GO:0005739; GO:0005743; GO:0005829; GO:0006974; GO:0007007; GO:0042407; GO:0044284; GO:0061617; GO:0140275 ESTLPRSGSSGGQQPSGMK 6.199999809 1 1 0.23317251 1891.897114 14.09194 0 0 0 12.99958 0 0 0 0 0 0 0 0 13.58843 0 0 0 0 0 0 0 15.99848 0 14.37439 16.42396 13.73546 0 14.78073 13.84184 14.18751 0 0 0 0 0 0 0 0 0 0 0 14.36757 0 0 0 0 0 0 Q9BRR9 RHG09_HUMAN Rho GTPase-activating protein 9 (Rho-type GTPase-activating protein 9) ARHGAP9 Homo sapiens (Human) regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]" "GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" GO:0005096; GO:0005547; GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0034774; GO:0043087; GO:0051056 LRFLVDR 7.769999981 1 1 3.47E-13 919.1006835 0 0 0 0 14.11901 0 0 0 0 0 0 0 14.32765 0 0 0 0 0 0 0 0 0 0 15.09987 0 0 14.06117 0 0 0 0 0 16.21925 0 0 0 0 12.70881 15.91233 0 0 0 0 0 0 0 0 0 Q9BRS2 RIOK1_HUMAN "Serine/threonine-protein kinase RIO1, EC 2.7.11.1, EC 3.6.3.- (RIO kinase 1)" RIOK1 RIO1 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274] "cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]" ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234 VVPGQFDDADSSDSENR 5.929999828 0.932536721 0.932536721 0.212773129 1837.426306 11.74669 15.94945 0 0 0 0 0 16.66212 0 0 0 0 0 15.13414 12.35217 0 0 11.773 13.65751 0 15.63997 0 11.13795 15.77169 16.12564 16.13602 15.83901 0 14.2626 15.18218 14.68612 0 14.61875 0 14.17878 15.34749 14.06864 15.69475 0 13.90584 15.42001 0 0 0 0 13.41649 0 14.49025 Q9BRS8 LARP6_HUMAN "La-related protein 6 (Acheron, Achn) (La ribonucleoprotein domain family member 6)" LARP6 Homo sapiens (Human) positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396] mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825] GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904 HAATNK 3.910000086 0.180687249 0.180687249 0.174438625 642.2227925 0 0 15.8829 0 15.90831 16.15159 0 14.55075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.70248 0 0 0 0 0 15.816 14.58673 15.78617 0 0 16.38321 15.42829 16.71549 15.7764 0 14.7178 0 0 16.20126 17.32926 0 18.29748 Q9BRV3 SWET1_HUMAN "Sugar transporter SWEET1, HsSWEET1 (RAG1-activating protein 1) (Solute carrier family 50 member 1) (Stromal cell protein)" SLC50A1 RAG1AP1 SCP Homo sapiens (Human) carbohydrate transport [GO:0008643]; hexose transmembrane transport [GO:0008645] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119]; carbohydrate transport [GO:0008643]; hexose transmembrane transport [GO:0008645] glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119] GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0008645; GO:0012505; GO:0016021; GO:0042947; GO:0051119 DPYIMVSNFPGIVTSFIR 3.779999971 0.00972545 0.00972545 0.237142543 2071.406896 13.22779 0 9.64876 11.48907 12.78473 0 0 15.01057 0 15.52444 0 0 0 0 0 0 0 0 0 0 13.4199 0 0 0 14.45524 14.23172 0 13.78963 10.09973 13.13808 12.65131 13.77137 11.46494 0 0 14.20409 0 13.23852 0 11.18785 0 14.07446 15.12521 13.94435 0 0 0 15.3487 Q9BRX8 PXL2A_HUMAN "Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes, Protein PAMM) (Redox-regulatory protein FAM213A)" PRXL2A C10orf58 FAM213A PAMM PRO2290 PSEC0139 UNQ611/PRO1198 Homo sapiens (Human) regulation of osteoclast differentiation [GO:0045670] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; antioxidant activity [GO:0016209]; regulation of osteoclast differentiation [GO:0045670] antioxidant activity [GO:0016209] GO:0005576; GO:0005737; GO:0016209; GO:0045670 VNLLSVLEAAK 10.82999992 0.434509337 0.434509337 2.29E-13 1155.496066 0 14.87515 0 13.5422 0 0 0 0 10.58764 0 12.15299 0 0 0 0 0 0 0 17.29611 0 0 0 9.787851 0 15.15944 0 0 0 0 0 0 0 0 0 13.53709 0 0 0 0 13.89266 0 0 14.6316 0 13.70241 0 0 0 Q9BRY0 S39A3_HUMAN "Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3, ZIP-3)" SLC39A3 ZIP3 Homo sapiens (Human) cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577] zinc ion transmembrane transporter activity [GO:0005385] GO:0000902; GO:0001701; GO:0005385; GO:0005886; GO:0016020; GO:0016021; GO:0043029; GO:0048701; GO:0060173; GO:0071577 ASPVR 10.93000031 0.795818925 0.795818925 0.248988828 528.5732884 15.31307 17.19752 15.89738 15.01872 15.84814 15.12438 15.56481 15.90793 16.61793 16.1106 17.0625 15.0071 14.79926 0 15.40305 15.6106 0 0 15.34334 0 16.23939 0 16.24936 0 17.24864 17.32029 15.02797 17.13714 14.34326 16.63924 15.13893 14.31997 15.3163 15.63644 14.9599 16.04003 14.17829 15.92013 16.78528 15.0601 13.87037 16.16144 15.11327 15.94392 15.27793 0 15.80028 15.62471 Q9BRZ2 TRI56_HUMAN "E3 ubiquitin-protein ligase TRIM56, EC 2.3.2.27 (RING finger protein 109) (Tripartite motif-containing protein 56)" TRIM56 RNF109 Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]" RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000785; GO:0003723; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0008270; GO:0032479; GO:0032728; GO:0034340; GO:0045087; GO:0045893; GO:0051607; GO:0060340; GO:0061630; GO:0070534 AAAAFARR 11.76000023 1 1 0.158260672 834.549859 18.22674 9.805451 13.21211 0 0 0 0 15.87299 0 0 15.92782 16.19102 0 14.84279 0 14.96073 13.31345 14.55156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.13814 0 0 0 0 0 0 15.72066 15.35067 0 0 0 Q9BS31 ZN649_HUMAN Zinc finger protein 649 ZNF649 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872 AFLTKTMLIVHHR 17.37000084 1 1 0.412609679 1583.747664 17.12949 0 0 16.87736 0 16.4105 0 0 0 0 0 18.06796 16.71445 16.78454 0 16.16908 0 0 0 0 0 0 0 0 0 16.36223 0 16.25953 0 16.18687 16.77916 17.14136 0 0 0 16.59218 15.89307 0 0 0 0 0 0 0 0 16.75088 0 16.35627 Q9BS34 ZN670_HUMAN Zinc finger protein 670 ZNF670 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006629; GO:0044255; GO:0046872 DSVSFEDVAVAFTQEEWALLDPSQK 4.539999962 1 1 2.29E-12 2811.4768 15.41282 0 0 0 16.59456 13.65418 0 15.25132 0 0 15.95497 0 0 0 0 13.27402 0 0 0 0 0 0 0 0 0 14.7561 0 0 0 0 0 13.36147 0 0 14.33966 0 0 0 0 0 0 0 0 0 13.64587 0 0 0 Q9BS40 LXN_HUMAN "Latexin (Endogenous carboxypeptidase inhibitor, ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor, TCI)" LXN Homo sapiens (Human) detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; metalloendopeptidase inhibitor activity [GO:0008191]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954] heparin binding [GO:0008201]; metalloendopeptidase inhibitor activity [GO:0008191] GO:0005615; GO:0005737; GO:0006954; GO:0008191; GO:0008201; GO:0050965 VKQASMEDIPGR 7.21999979 0.353792906 0.353792906 0.161590705 1330.074608 0 0 15.63331 16.11506 0 14.78676 12.55284 11.11618 0 0 14.61082 17.02908 13.73782 11.72692 0 12.97967 15.71739 0 15.93352 15.66899 0 18.27982 15.76212 0 15.80193 0 0 15.82263 0 15.6979 15.38092 0 13.94784 0 18.3117 0 0 0 14.96152 15.58763 10.32186 13.38083 14.97312 0 0 0 14.16957 15.17908 Q9BSB4 ATGA1_HUMAN Autophagy-related protein 101 ATG101 C12orf44 PP894 Homo sapiens (Human) autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059] Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407] Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059] identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] GO:0000045; GO:0000407; GO:0005789; GO:0005829; GO:0006468; GO:0008285; GO:0010508; GO:0042802; GO:0044877; GO:0046777; GO:1903059; GO:1990316 EGTYSIGTVGTQDVDCDFIDFTYVR 4.070000172 1 1 0.199662518 2859.053068 14.96536 0 14.81334 0 14.76229 0 0 15.28455 15.51895 0 13.02663 13.93362 0 0 0 0 15.14718 0 0 0 0 0 0 0 0 15.14066 0 0 0 15.10627 15.5068 15.46584 0 0 13.81707 0 0 0 0 13.57287 0 0 0 0 0 0 0 0 Q9BSC4 NOL10_HUMAN Nucleolar protein 10 NOL10 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" nucleolus [GO:0005730]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" RNA binding [GO:0003723] GO:0000462; GO:0003723; GO:0005730; GO:0032040 LLNPLVSK 4.340000153 0.776547015 0.776547015 0.03847673 886.2907166 14.9435 14.88546 9.851804 0 15.81349 16.71016 0 0 0 0 16.06603 0 0 15.06705 15.9747 15.46849 0 14.32204 15.67445 14.69659 15.96189 15.066 0 17.77613 17.39845 0 14.22298 0 0 13.14919 14.09235 0 16.61996 16.67078 16.67105 13.83854 0 14.40643 16.1794 13.20396 14.78644 0 14.3476 16.41773 0 0 0 16.86773 Q9BSE2 TMM79_HUMAN Transmembrane protein 79 (Mattrin) TMEM79 MATT Homo sapiens (Human) cornification [GO:0070268]; cuticle development [GO:0042335]; epithelial cell maturation [GO:0002070]; establishment of skin barrier [GO:0061436]; hair follicle morphogenesis [GO:0031069]; positive regulation of epidermis development [GO:0045684]; regulated exocytosis [GO:0045055] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; cornification [GO:0070268]; cuticle development [GO:0042335]; epithelial cell maturation [GO:0002070]; establishment of skin barrier [GO:0061436]; hair follicle morphogenesis [GO:0031069]; positive regulation of epidermis development [GO:0045684]; regulated exocytosis [GO:0045055] identical protein binding [GO:0042802] GO:0002070; GO:0005765; GO:0016021; GO:0031069; GO:0032588; GO:0042335; GO:0042802; GO:0045055; GO:0045684; GO:0061436; GO:0070268 EVEIHR 11.5 1 1 3.50E-13 783.1202003 0 0 0 14.47575 0 0 0 0 15.14373 0 0 0 14.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSE4 HERP2_HUMAN Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein HERPUD2 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030968 DQSGMEIPVTLIIKAPNQK 5.920000076 1 1 0.173340664 2096.764736 13.28898 0 0 0 0 0 0 13.9163 0 0 0 0 11.89485 9.708404 0 0 0 13.65976 0 0 14.26918 0 15.53815 0 0 0 0 15.11196 12.51287 13.80169 0 13.09573 14.60487 12.92794 11.11737 0 14.58058 16.40744 0 14.12048 14.09113 13.73043 0 0 0 0 0 0 Q9BSH3 NICN1_HUMAN "Nicolin-1 (NPCEDRG) (Tubulin polyglutamylase complex subunit 5, PGs5)" NICN1 Homo sapiens (Human) microtubule [GO:0005874]; nucleoplasm [GO:0005654] microtubule [GO:0005874]; nucleoplasm [GO:0005654] GO:0005654; GO:0005874 GSVALQVGDVR 7.349999905 1 1 0.021127951 1096.467602 14.85415 0 13.58008 12.19099 0 0 15.95584 0 0 0 18.01477 15.7914 0 17.57914 16.17592 0 18.06587 17.32729 0 22.08512 0 16.07884 15.76383 0 16.87032 15.94785 13.75475 17.40129 0 0 16.19614 18.10273 17.38576 16.56435 0 0 0 17.83125 15.0388 14.55363 15.5365 0 0 18.18194 0 12.75684 0 0 Q9BSI4 TINF2_HUMAN TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2) TINF2 TIN2 Homo sapiens (Human) "negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]; telomeric DNA binding [GO:0042162]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]" telomeric DNA binding [GO:0042162] GO:0000781; GO:0000783; GO:0005654; GO:0010370; GO:0010836; GO:0016233; GO:0016363; GO:0016604; GO:0032202; GO:0032206; GO:0032211; GO:0042162; GO:0050680; GO:0070187; GO:0070198; GO:1904356 ERPTVMLFPFR 5.190000057 1 1 0.017416101 1388.338252 13.43741 0 0 0 0 14.48454 0 0 0 0 14.04318 0 13.96507 15.21153 0 13.3632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49293 0 0 0 0 Q9BSJ2 GCP2_HUMAN "Gamma-tubulin complex component 2, GCP-2, hGCP2 (Gamma-ring complex protein 103 kDa, h103p, hGrip103) (Spindle pole body protein Spc97 homolog, hSpc97)" TUBGCP2 GCP2 Homo sapiens (Human) brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] gamma-tubulin binding [GO:0043015] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0005881; GO:0007020; GO:0007420; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0065003 DCMLTNPELLK 4.070000172 1 1 0.593911938 1348.93396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSJ6 PIMRE_HUMAN Protein PIMREG (CALM-interactor expressed in thymus and spleen) (PICALM-interacting mitotic regulator) (Regulator of chromosome segregation protein 1) PIMREG CATS FAM64A RCS1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005654; GO:0005730; GO:0007049; GO:0051301 AGPSWK 7.429999828 0.259282172 0.259282172 0.244598609 644.5286913 15.42811 0 0 14.74904 0 0 0 0 16.93649 19.06794 0 16.99998 0 0 0 0 17.05807 0 0 15.83264 0 0 0 0 15.91698 17.0099 18.77136 0 0 18.18847 15.60263 18.62428 0 0 18.14546 0 16.73949 0 0 0 18.77079 0 0 0 0 0 0 0 Q9BSQ5 CCM2_HUMAN Cerebral cavernous malformations 2 protein (Malcavernin) CCM2 C7orf22 PP10187 Homo sapiens (Human) blood vessel endothelial cell differentiation [GO:0060837]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial tube morphogenesis [GO:0061154]; endothelium development [GO:0003158]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; multicellular organism growth [GO:0035264]; pericardium development [GO:0060039]; regulation of angiogenesis [GO:0045765]; stress-activated MAPK cascade [GO:0051403]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; blood vessel endothelial cell differentiation [GO:0060837]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial tube morphogenesis [GO:0061154]; endothelium development [GO:0003158]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; multicellular organism growth [GO:0035264]; pericardium development [GO:0060039]; regulation of angiogenesis [GO:0045765]; stress-activated MAPK cascade [GO:0051403]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845] GO:0001570; GO:0001701; GO:0001885; GO:0003158; GO:0005737; GO:0005739; GO:0007229; GO:0007507; GO:0032991; GO:0035264; GO:0045216; GO:0045765; GO:0048839; GO:0048845; GO:0051403; GO:0060039; GO:0060837; GO:0061154 LLSDYIEK 4.599999905 1 1 0.129314076 981.0865761 0 0 15.30001 0 0 0 0 0 0 0 0 0 0 0 12.54056 0 0 0 0 0 0 0 16.50782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.50834 0 0 0 0 Q9BSW7 SYT17_HUMAN "Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII, SytXVII)" SYT17 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0070382; GO:0071277; GO:1903861 AKQLLQTDVSQGSDPFVK 3.170000076 0.430446804 0.430446804 0.313765183 1961.497006 17.33958 0 0 0 0 0 0 0 0 0 0 0 16.66965 0 0 13.17326 0 0 0 0 0 0 0 0 0 16.0825 0 0 14.39454 0 13.25518 0 13.3634 12.28534 10.8253 15.40997 15.53434 0 0 15.05221 0 0 15.25635 0 0 0 0 0 Q9BT09 CNPY3_HUMAN Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein) CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409 Homo sapiens (Human) innate immune response [GO:0045087] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; signaling receptor binding [GO:0005102]; innate immune response [GO:0045087] signaling receptor binding [GO:0005102] GO:0005102; GO:0005788; GO:0045087 KGDTAALGGK 7.349999905 1 1 0.020495821 915.9676612 0 0 0 11.67255 0 0 0 0 13.56646 0 0 0 0 0 0 0 0 0 15.24352 0 11.25338 0 0 13.51327 0 11.09606 0 14.24772 13.28802 15.06557 13.60635 0 14.85156 0 0 0 14.34674 0 0 0 14.40696 0 0 0 0 0 0 0 Q9BT17 MTG1_HUMAN Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1) MTG1 GTPBP7 Homo sapiens (Human) regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129 MQSSLK 2.869999886 1 1 1.15E-13 692.5169487 0 0 12.73233 0 0 15.48591 0 0 0 0 0 0 15.50108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.38779 0 0 14.95653 0 0 0 0 0 0 0 0 15.5084 0 0 0 Q9BT25 HAUS8_HUMAN HAUS augmin-like complex subunit 8 (HEC1/NDC80-interacting centrosome-associated protein 1) (Sarcoma antigen NY-SAR-48) HAUS8 HICE1 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] microtubule binding [GO:0008017] GO:0000922; GO:0005737; GO:0005813; GO:0005829; GO:0005880; GO:0007098; GO:0008017; GO:0051225; GO:0051301; GO:0070652; GO:1990498 KPESTSFSAPRK 10.35000038 0.458201647 0.458201647 0.594582238 1334.928882 0 0 0 17.61222 0 0 17.5357 0 0 0 0 0 0 18.68968 0 0 0 19.56864 0 0 17.26285 0 17.52617 0 0 0 0 19.96974 0 0 19.29279 0 0 0 0 19.15021 0 0 19.13324 0 0 0 20.58467 18.92571 0 0 0 0 Q9BT40 INP5K_HUMAN "Inositol polyphosphate 5-phosphatase K, EC 3.1.3.56 (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase, EC 3.1.3.86) (Phosphatidylinositol-4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (Skeletal muscle and kidney-enriched inositol phosphatase)" INPP5K PPS SKIP Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]" "inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]" GO:0001701; GO:0001726; GO:0001933; GO:0004439; GO:0004445; GO:0005000; GO:0005634; GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0005886; GO:0005979; GO:0006469; GO:0006661; GO:0007186; GO:0010801; GO:0010829; GO:0016020; GO:0016311; GO:0016312; GO:0030036; GO:0032587; GO:0032869; GO:0032870; GO:0033137; GO:0034485; GO:0034594; GO:0034595; GO:0035305; GO:0035810; GO:0042577; GO:0042593; GO:0043005; GO:0043407; GO:0043922; GO:0045719; GO:0045869; GO:0045892; GO:0045893; GO:0046030; GO:0046627; GO:0046855; GO:0046856; GO:0048471; GO:0051497; GO:0051898; GO:0051926; GO:0052658; GO:0052659; GO:0071320; GO:0071356; GO:0071364; GO:0072659; GO:0090315; GO:0097178; GO:2000466; GO:2001153 GGVNICLK 18.51000023 1 1 0.025694179 859.3536441 14.93203 0 0 18.65019 0 0 0 0 14.01467 0 0 0 15.37117 0 16.12938 17.74558 0 17.03684 0 16.11045 0 0 0 13.8252 0 13.66611 0 9.919522 14.16562 13.17119 14.48148 17.00264 13.49828 0 0 16.22323 13.25096 14.88524 12.34113 0 13.67228 10.85326 14.31338 14.37441 10.93953 15.92643 0 13.84882 Q9BTA9 WAC_HUMAN WW domain-containing adapter protein with coiled-coil WAC KIAA1844 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]" chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993] GO:0000993; GO:0003682; GO:0005634; GO:0005654; GO:0005681; GO:0006325; GO:0006974; GO:0010390; GO:0010506; GO:0016239; GO:0016607; GO:0031571; GO:0032435; GO:0045893; GO:0071894; GO:1904263 REVMQATATSGFASGMEDK 3.849999905 1 1 1.61E-12 2028.442031 0 15.83589 0 12.881 0 13.47334 0 0 12.07182 13.75286 14.73068 13.98488 14.50143 13.66265 12.31661 0 0 0 0 10.49895 0 0 0 0 0 15.70892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.74362 0 0 0 Q9BTC0 DIDO1_HUMAN "Death-inducer obliterator 1, DIO-1, hDido1 (Death-associated transcription factor 1, DATF-1)" DIDO1 C20orf158 DATF1 KIAA0333 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]" metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190 GPSPSYLGGPRGVAPSQFEER 1.799999952 1 1 0.226565598 2189.042689 12.58817 0 14.81476 0 13.5219 15.40661 0 12.3915 13.11382 13.30332 14.52928 14.78421 0 0 0 10.46316 0 0 0 0 0 14.9917 0 0 0 0 16.26755 0 0 0 0 0 0 13.55901 13.79959 0 14.59937 0 0 13.09282 14.79756 0 0 0 13.73619 0 0 0 Q9BTC8 MTA3_HUMAN Metastasis-associated protein MTA3 MTA3 KIAA1266 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003682; GO:0003713; GO:0003714; GO:0005654; GO:0005737; GO:0006338; GO:0008284; GO:0010971; GO:0016575; GO:0016581; GO:0042659; GO:0042826; GO:0043231; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0046872; GO:2000736 KPNVIR 2.789999962 1 1 0.020741727 727.4887889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.58113 0 0 16.91704 0 0 0 0 0 15.99142 0 0 16.62396 14.67536 15.37133 0 15.41824 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTD3 TM121_HUMAN Transmembrane protein 121 TMEM121 HHOLE Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AANMALFRDSR 6.360000134 1 1 0.33404825 1266.306204 0 12.07302 16.75148 0 0 0 0 0 0 0 0 0 0 0 0 12.83421 0 0 0 0 0 0 0 0 16.32102 0 0 17.48669 16.57197 0 0 18.43589 15.70107 16.15742 0 17.67038 0 0 0 16.24837 0 0 0 0 0 0 0 0 Q9BTE1 DCTN5_HUMAN Dynactin subunit 5 (Dynactin subunit p25) DCTN5 Homo sapiens (Human) aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281] centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281] GO:0000776; GO:0003281; GO:0005654; GO:0005813; GO:0005829; GO:0031965; GO:0035904; GO:0060976 MELGELLYNK 11.32999992 1 1 0.328268954 1225.053345 0 18.36084 18.22387 0 16.73898 16.25925 17.12227 0 0 0 0 16.86218 14.89392 0 0 0 17.07623 0 0 0 0 0 0 0 0 18.69691 0 0 17.52934 18.2395 16.92044 0 0 0 18.94806 0 0 19.66512 0 0 0 0 0 0 0 0 17.2091 17.62659 Q9BTE3 MCMBP_HUMAN "Mini-chromosome maintenance complex-binding protein, MCM-BP, MCM-binding protein" MCMBP C10orf119 Homo sapiens (Human) cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062] cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006261; GO:0007062; GO:0030054; GO:0051301 FTVNLSGCPR 6.880000114 1 1 0 1151.412933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTL4 IER2_HUMAN Immediate early response gene 2 protein (Protein ETR101) IER2 ETR101 PIP92 Homo sapiens (Human) cell motility [GO:0048870]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fibroblast growth factor [GO:0071774] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell motility [GO:0048870]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fibroblast growth factor [GO:0071774] DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0030182; GO:0045944; GO:0048870; GO:0071774 SLQLSLVMRSAR 19.78000069 1 1 0.235741863 1375.880838 0 0 17.06797 0 0 0 0 0 16.19414 0 0 0 0 0 16.92801 0 16.72767 0 0 18.15743 0 17.64295 0 0 15.70251 15.58443 0 0 0 16.16343 16.61137 0 0 0 14.68331 0 18.13365 0 0 0 0 0 0 0 0 0 0 0 Q9BTP6 ZBED2_HUMAN Zinc finger BED domain-containing protein 2 ZBED2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0045618; GO:0046872 GDLEMK 1.74000001 1 1 0.011630971 707.3849579 0 0 0 15.66864 14.54278 13.696 0 0 0 14.7155 13.66543 16.23513 13.5835 0 14.67316 0 0 0 0 0 0 17.71005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTT6 LRRC1_HUMAN Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein) LRRC1 LANO Homo sapiens (Human) cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020] GO:0005829; GO:0016020 LLHLPLSLTALKLK 3.640000105 1 1 0.530617156 1561.219194 17.23126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.10012 0 0 18.05563 0 0 0 0 18.27681 0 0 0 0 0 0 17.04721 0 18.00299 0 17.07461 17.83455 Q9BTU6 P4K2A_HUMAN "Phosphatidylinositol 4-kinase type 2-alpha, EC 2.7.1.67 (Phosphatidylinositol 4-kinase type II-alpha)" PI4K2A Homo sapiens (Human) endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287] GO:0000139; GO:0000287; GO:0004430; GO:0005524; GO:0005739; GO:0005765; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0030425; GO:0031224; GO:0031410; GO:0031901; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0046854 LELNIVPRTK 4.150000095 0.363611996 0.363611996 0.197982592 1183.294837 0 0 0 14.6665 12.83167 0 13.21523 0 0 10.96656 13.68137 13.28852 14.6957 0 0 0 0 0 0 0 0 0 14.18173 0 0 0 0 0 0 0 13.79847 0 0 0 0 0 0 0 15.02132 0 0 0 0 0 0 0 0 0 Q9BTV5 FSD1_HUMAN Fibronectin type III and SPRY domain-containing protein 1 (MID1-related protein 1) (Microtubule-associated protein GLFND) FSD1 GLFND MIR1 VLP27 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of mitotic spindle organization [GO:0060236] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of mitotic spindle organization [GO:0060236] identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0007049; GO:0008017; GO:0031122; GO:0032154; GO:0032465; GO:0042802; GO:0051301; GO:0051302; GO:0060236 MPSGRGGR 4.710000038 1 1 0.131617981 833.0848795 17.0925 0 17.22772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTV6 DPH7_HUMAN "Diphthine methyltransferase, EC 3.1.1.97 (Diphthamide biosynthesis protein 7) (WD repeat-containing protein 85)" DPH7 C9orf112 WDR85 Homo sapiens (Human) peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] diphthine methylesterase activity [GO:0061685]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] diphthine methylesterase activity [GO:0061685] GO:0017183; GO:0061685 EHILATGSYDEHILLWDTRNMK 5.039999962 1 1 1.39E-12 2658.525712 16.81362 16.16452 18.01802 16.76972 14.84472 15.04349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTW9 TBCD_HUMAN "Tubulin-specific chaperone D (Beta-tubulin cofactor D, tfcD) (SSD-1) (Tubulin-folding cofactor D)" TBCD KIAA0988 SSD1 TFCD PP1096 Homo sapiens (Human) adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096] GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0051087; GO:0070830 FITRPDVKQSK 11.31000042 1 1 0.578870381 1315.786833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.18622 0 0 0 0 Q9BTX1 NDC1_HUMAN "Nucleoporin NDC1, hNDC1 (Transmembrane protein 48)" NDC1 TMEM48 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056]; homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056] GO:0005635; GO:0005643; GO:0005737; GO:0005886; GO:0006913; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0015629; GO:0016020; GO:0016021; GO:0017056; GO:0030674; GO:0031965; GO:0051028; GO:0051292; GO:0051664; GO:0070762 TSLFSSK 7.130000114 1 1 0.120057541 770.3788937 13.28734 0 0 0 15.44779 0 0 0 13.3717 0 0 15.30454 0 0 0 0 0 0 17.42123 0 15.72461 16.36875 0 0 0 0 0 0 16.615 15.79479 0 0 0 0 0 0 0 0 17.46828 0 0 16.02362 0 18.40385 0 0 0 0 Q9BTY7 HGH1_HUMAN Protein HGH1 homolog HGH1 C8orf30A C8orf30B FAM203A FAM203B Homo sapiens (Human) KMLVEAIMLLTATAPGR 4.829999924 1 1 0.138274783 1831.409171 13.07374 0 0 11.23814 15.85993 0 0 0 15.24718 0 0 15.5485 15.71528 0 11.55222 3.768908 11.90878 15.31291 15.14706 0 0 14.58415 0 14.81333 0 17.07516 14.9962 0 0 15.90222 0 0 0 17.65402 18.04867 0 15.73173 17.26723 16.32214 15.58211 0 15.18923 14.28669 13.3756 0 0 0 0 Q9BTZ2 DHRS4_HUMAN "Dehydrogenase/reductase SDR family member 4, EC 1.1.1.184 (NADPH-dependent carbonyl reductase, CR) (NADPH-dependent retinol dehydrogenase/reductase, NRDR, humNRDR) (Peroxisomal short-chain alcohol dehydrogenase, PSCD) (SCAD-SRL) (Short chain dehydrogenase/reductase family 25C member 2, Protein SDR25C2) (Short-chain dehydrogenase/reductase family member 4)" DHRS4 SDR25C2 UNQ851/PRO1800 Homo sapiens (Human) alcohol metabolic process [GO:0006066]; cellular ketone metabolic process [GO:0042180]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; retinal metabolic process [GO:0042574]; steroid metabolic process [GO:0008202] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 3-keto sterol reductase activity [GO:0000253]; alcohol dehydrogenase [NAD(P)+] activity [GO:0018455]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; alcohol metabolic process [GO:0006066]; cellular ketone metabolic process [GO:0042180]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; retinal metabolic process [GO:0042574]; steroid metabolic process [GO:0008202]" "3-keto sterol reductase activity [GO:0000253]; alcohol dehydrogenase [NAD(P)+] activity [GO:0018455]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]" GO:0000253; GO:0004090; GO:0005634; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005789; GO:0005829; GO:0006066; GO:0008202; GO:0016655; GO:0018455; GO:0042180; GO:0042574; GO:0042802; GO:0052650; GO:2000379 MASSGMTRR 10.61999989 0.925852835 0.925852835 0.200774405 1013.934592 15.73709 0 15.09396 0 0 13.78817 0 15.74665 0 0 0 0 16.93181 15.80131 0 16.0344 0 0 15.38563 0 0 0 0 0 0 0 0 0 16.56126 13.94113 0 17.70535 0 0 0 0 0 0 0 0 14.70552 0 0 18.35607 15.27664 0 16.45505 13.96186 Q9BU23 LMF2_HUMAN Lipase maturation factor 2 (Transmembrane protein 112B) (Transmembrane protein 153) LMF2 TMEM112B TMEM153 Homo sapiens (Human) protein maturation [GO:0051604] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein maturation [GO:0051604] GO:0005789; GO:0016020; GO:0016021; GO:0051604 AGSRLPR 2.329999924 1 1 0.136502871 755.2290561 13.65898 16.00002 0 14.20099 13.57301 14.83449 17.98147 13.50988 15.34906 16.629 15.38964 16.20771 0 13.74984 0 0 0 0 0 0 0 0 15.70519 0 0 0 17.14547 0 0 0 0 0 0 0 0 0 17.31041 0 0 0 0 0 0 0 0 0 0 0 Q9BU76 MMTA2_HUMAN "Multiple myeloma tumor-associated protein 2, hMMTAG2" MMTAG2 C1orf35 Homo sapiens (Human) extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005576; GO:0034774; GO:1904813 EALLAALGYKNVK 9.529999733 1 1 0.155519713 1390.587291 15.06851 0 0 0 15.53841 0 0 15.17008 14.30809 12.21403 0 15.51766 0 13.80962 14.23216 13.62363 0 0 0 15.96602 0 13.45773 0 0 14.87435 0 16.86969 0 0 0 0 0 0 0 0 0 0 0 0 13.14721 13.93894 15.38168 0 16.93913 16.42341 0 15.44895 16.54975 Q9BUA6 MYL10_HUMAN "Myosin regulatory light chain 10 (Myosin light chain 2, lymphocyte-specific) (Precursor lymphocyte-specific regulatory light chain)" MYL10 MYLC2PL PLRLC Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509; GO:0005737; GO:0005739; GO:0005829 LMTQADRFSEEEVK 10.02999973 1 1 0.12552589 1681.949878 0 16.01569 15.45778 12.41714 14.76629 10.50476 0 0 13.86633 0 0 10.82431 0 13.76521 0 14.13039 10.83975 0 0 0 13.81304 0 15.73505 0 15.28765 12.42645 0 12.32269 13.5184 12.8542 13.31322 13.11704 0 16.39461 13.0838 0 0 0 0 0 0 16.72403 0 0 0 0 0 0 Q9BUB5 MKNK1_HUMAN "MAP kinase-interacting serine/threonine-protein kinase 1, EC 2.7.11.1 (MAP kinase signal-integrating kinase 1, MAPK signal-integrating kinase 1, Mnk1)" MKNK1 MNK1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872; GO:0106310 DWAHISSEAK 3.289999962 1 1 0.562862724 1142.765247 18.34437 0 0 18.62745 0 0 18.28209 0 18.60342 0 0 0 0 0 19.01534 0 19.28076 0 0 0 0 0 0 0 0 0 0 0 0 0 18.81926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUE6 ISCA1_HUMAN "Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA, hIscA)" ISCA1 HBLD2 GK004 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]" "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]" GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0046872; GO:0051537; GO:0097428 SASLVR 6.050000191 0.523242772 0.523242772 0.164939433 634.280629 17.44539 19.08487 0 15.42378 16.82224 16.10571 14.09293 14.0161 16.75745 0 17.19193 0 19.29363 16.53622 16.30095 16.32191 16.43823 19.73213 19.8127 17.63591 0 16.60821 18.61335 0 0 17.46216 16.34085 15.47794 17.71674 17.92731 16.05139 17.46144 18.18059 17.67241 0 17.23634 17.68622 16.71264 15.85725 19.12674 0 16.24689 16.66269 16.69045 0 0 15.81624 16.23469 Q9BUF5 TBB6_HUMAN Tubulin beta-6 chain (Tubulin beta class V) TUBB6 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200] GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0070062; GO:0072686 GPMSMK 3.220000029 1 1 0.093164836 683.6410763 11.20641 0 0 15.0188 0 0 13.84894 14.92226 12.87107 0 11.53729 11.68027 14.31343 14.39835 14.83579 0 0 0 0 0 0 0 0 0 0 16.63616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUG6 ZSA5A_HUMAN Zinc finger and SCAN domain-containing protein 5A (Zinc finger protein 495) ZSCAN5A ZNF495 ZSCAN5 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 THPEATSQ 4.110000134 0.065337665 0.065337665 0.141644247 870.9704318 15.88325 15.66047 17.35836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUM1 G6PC3_HUMAN "Glucose-6-phosphatase 3, G-6-Pase 3, G6Pase 3, EC 3.1.3.9 (Glucose-6-phosphatase beta, G6Pase-beta) (Ubiquitous glucose-6-phosphatase catalytic subunit-related protein)" G6PC3 UGRP Homo sapiens (Human) gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760] glucose-6-phosphatase activity [GO:0004346] GO:0004346; GO:0005783; GO:0005789; GO:0006094; GO:0015760; GO:0016020; GO:0016021; GO:0051156 RAQLGNGQK 3.279999971 1 1 0.243494255 972.2859208 15.57472 0 14.83241 13.29325 13.52071 12.79364 15.56832 14.97449 13.58544 0 15.36549 14.3642 14.7698 0 14.69338 0 13.64195 0 15.11647 0 0 0 15.53248 0 0 15.50392 15.78311 0 0 15.87129 0 0 15.98568 15.021 0 15.91901 16.43954 0 0 0 0 0 16.83202 0 0 15.30597 0 14.79711 Q9BUN1 MENT_HUMAN Protein MENT (Methylated in normal thymocytes protein) MENT C1orf56 UNQ547/PRO1104 Homo sapiens (Human) regulation of cell population proliferation [GO:0042127] extracellular region [GO:0005576] extracellular region [GO:0005576]; regulation of cell population proliferation [GO:0042127] GO:0005576; GO:0042127 LTSSLPR 4.050000191 0.39532876 0.39532876 0.067411253 772.3369884 15.10742 0 15.58899 15.17995 14.64917 0 13.1147 13.23729 15.87782 0 15.51606 14.2351 0 0 0 0 0 0 0 12.5403 14.11742 15.90078 0 0 0 0 0 0 0 0 0 16.41561 15.27102 0 0 0 0 16.78335 0 0 0 15.2144 0 0 0 0 0 0 Q9BUP0 EFHD1_HUMAN EF-hand domain-containing protein D1 (EF-hand domain-containing protein 1) (Swiprosin-2) EFHD1 SWS2 PP3051 Homo sapiens (Human) neuron projection development [GO:0031175]; regulation of cellular hyperosmotic salinity response [GO:1900069] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; neuron projection development [GO:0031175]; regulation of cellular hyperosmotic salinity response [GO:1900069] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891] GO:0005509; GO:0005739; GO:0005743; GO:0031175; GO:0061891; GO:1900069 LSEIDVALEGVK 4.349999905 1 1 0.122476425 1278.022461 0 14.33021 14.83418 0 0 13.16625 15.16676 12.96389 0 0 0 13.95501 12.63564 0 14.37037 14.13149 0 0 0 15.45022 0 0 0 15.26202 0 0 0 0 0 0 0 0 0 0 15.90127 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUP3 HTAI2_HUMAN "Oxidoreductase HTATIP2, EC 1.1.1.- (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)" HTATIP2 CC3 TIP30 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357] oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713] GO:0001525; GO:0003713; GO:0004674; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006357; GO:0006915; GO:0016020; GO:0016491; GO:0030154; GO:0043066; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170 GEVEAK 11.53999996 0.535352111 0.535352111 1.37E-12 631.7145869 16.18656 12.64406 14.51332 0 0 0 0 15.69066 14.2353 0 15.99597 16.31594 19.5566 18.92479 17.92103 0 17.78405 16.90295 0 0 18.40769 0 17.8492 17.43015 0 16.89706 17.54243 16.48954 16.33902 17.23119 0 0 17.51559 0 19.10093 17.28132 0 0 0 17.90901 0 17.42681 19.43938 12.75009 0 18.254 17.41855 0 Q9BUU2 MET22_HUMAN "Methyltransferase-like protein 22, EC 2.1.1.-" METTL22 C16orf68 LP8272 Homo sapiens (Human) protein methylation [GO:0006479] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; protein methylation [GO:0006479] heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] GO:0005634; GO:0005654; GO:0005730; GO:0006479; GO:0008276; GO:0016279; GO:0031072; GO:0032991 VQLAPAAAMDEVTFR 15.03999996 0.709371328 0.709371328 0.474956143 1617.983052 15.81629 15.57703 0 16.30956 14.58768 0 16.62061 15.72473 16.78442 0 0 0 15.73859 0 16.36175 16.29909 0 0 0 0 0 0 0 0 16.7986 0 0 16.35735 0 16.00515 0 17.18002 17.16577 0 0 0 15.73455 0 16.98764 0 16.34156 0 16.64069 0 0 0 0 0 Q9BUY5 ZN426_HUMAN Zinc finger protein 426 ZNF426 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 AFAVSSNLSGHLRTHTEEK 3.75 1 1 0.070085408 2083.979581 0 0 0 0 0 0 18.74705 0 18.31027 0 0 19.57162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.32097 0 18.78987 0 17.43244 0 0 0 0 17.26341 0 0 0 0 Q9BV10 ALG12_HUMAN "Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, EC 2.4.1.260 (Asparagine-linked glycosylation protein 12 homolog, hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87)" ALG12 PP14673 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase [GO:0052917]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]" "alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase [GO:0052917]; mannosyltransferase activity [GO:0000030]" GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006487; GO:0006488; GO:0016020; GO:0016021; GO:0052917 FYSQLIVR 19.23999977 0.251205146 0.251205146 0.388436081 1025.902657 17.60797 18.76365 17.55775 0 0 0 0 0 0 19.24364 0 19.37771 17.3279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.34995 0 0 18.37973 0 0 0 20.36245 19.04472 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV19 CA050_HUMAN Uncharacterized protein C1orf50 C1orf50 Homo sapiens (Human) identical protein binding [GO:0042802] identical protein binding [GO:0042802] GO:0042802 KVLEDAHR 7.829999924 0.722158194 0.722158194 0.208233868 967.3841031 16.89153 0 15.07475 0 0 0 12.592 0 13.82006 0 16.46619 15.04415 15.02475 18.50131 15.42627 0 16.53351 15.29456 0 14.35451 14.58787 0 0 0 13.81515 9.660505 13.62371 0 0 0 15.36997 14.85122 16.73801 13.69832 0 17.42207 16.93164 0 14.89993 0 11.07756 16.27202 0 0 14.48948 0 0 0 Q9BV20 MTNA_HUMAN "Methylthioribose-1-phosphate isomerase, M1Pi, MTR-1-P isomerase, EC 5.3.1.23 (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)" MRI1 MRDI UNQ6390/PRO21135 Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284] cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284] identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523] GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0042995; GO:0046523 DLADVAAR 7.300000191 1 1 0.102609501 830.7777174 16.35663 16.01382 0 0 0 12.09934 0 18.14682 0 16.3638 16.66043 18.32016 0 0 14.48859 16.80152 0 16.32981 0 16.24745 13.2832 17.715 17.76717 17.69004 14.06527 0 15.6871 0 0 14.61818 18.00218 15.96556 18.09229 16.69991 0 19.65359 12.80748 16.92798 0 0 0 16.50375 16.50541 0 0 17.60396 14.54025 14.85796 Q9BV35 SCMC3_HUMAN Calcium-binding mitochondrial carrier protein SCaMC-3 (Mitochondrial ATP-Mg/Pi carrier protein 2) (Mitochondrial Ca(2+)-dependent solute carrier protein 2) (Small calcium-binding mitochondrial carrier protein 3) (Solute carrier family 25 member 23) SLC25A23 APC2 MCSC2 SCAMC3 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274] ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] GO:0002082; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0016021; GO:0036444; GO:0051282; GO:0051561; GO:0071277; GO:0097274; GO:1900069 LNILGGLR 10.89000034 0.499964952 0.499964952 0.276468453 856.0592557 18.40501 16.57351 17.24938 16.74614 17.78635 0 0 15.83706 0 18.65113 17.57612 17.81589 16.81892 0 17.28692 17.37387 0 16.50646 18.47042 15.51758 0 0 19.06463 16.67204 0 17.25011 17.16211 18.11123 16.3868 16.78877 17.32382 19.32669 19.12282 18.32352 19.50122 18.58364 16.82688 17.61165 0 0 0 0 18.45868 0 0 17.2438 19.36977 17.74611 Q9BV73 CP250_HUMAN "Centrosome-associated protein CEP250 (250 kDa centrosomal protein, Cep250) (Centrosomal Nek2-associated protein 1, C-Nap1) (Centrosomal protein 2)" CEP250 CEP2 CNAP1 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; mitotic cell cycle [GO:0000278]; non-motile cilium assembly [GO:1905515]; positive regulation of protein localization to centrosome [GO:1904781]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of centriole-centriole cohesion [GO:0030997] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein-containing complex [GO:0032991]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; mitotic cell cycle [GO:0000278]; non-motile cilium assembly [GO:1905515]; positive regulation of protein localization to centrosome [GO:1904781]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of centriole-centriole cohesion [GO:0030997] protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] GO:0000278; GO:0001750; GO:0001917; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0008022; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030997; GO:0032991; GO:0033365; GO:0036064; GO:0048471; GO:0050908; GO:0060271; GO:0070062; GO:1904781; GO:1905515 AAHEKEVNQLR 2.099999905 1 1 0.109524631 1291.84096 14.46041 10.80285 12.20857 0 0 0 0 0 0 0 0 0 0 13.00269 0 8.254153 13.47696 0 10.75612 12.45031 0 14.54359 0 0 0 6.235654 14.99127 0 11.34837 0 13.85589 0 14.05194 10.08095 11.66026 13.85421 0 0 0 12.63277 0 14.1219 0 0 0 0 15.83626 0 Q9BV94 EDEM2_HUMAN ER degradation-enhancing alpha-mannosidase-like protein 2 EDEM2 C20orf31 C20orf49 UNQ573/PRO1135 Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]; viral protein processing [GO:0019082]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]; viral protein processing [GO:0019082]" "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0019082; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:0097466; GO:1904154; GO:1904382 WVAQDAGIGAGVDSYFEYLVKGAILLQDK 4.760000229 1 1 0.092782531 3125.528712 13.56718 0 0 0 13.78177 13.74303 0 0 9.602267 0 0 12.8068 15.13841 0 14.17623 0 0 13.45064 10.8559 0 0 15.30595 0 0 14.28965 11.17691 0 0 0 0 14.10116 12.1881 13.67988 0 13.42855 14.57414 13.58685 12.82651 13.70316 0 0 0 0 0 0 0 0 0 Q9BV97 ZN747_HUMAN Zinc finger protein 747 ZNF747 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" "regulation of transcription, DNA-templated [GO:0006355]" GO:0006355 DPNGAGSEWR 4.900000095 0.337019533 0.337019533 0.109726366 1087.964469 10.27942 14.47868 15.61097 15.31216 11.94768 14.07055 14.96724 0 15.47349 0 0 15.93827 16.15017 17.65603 13.42038 14.09787 15.96492 0 15.26774 17.44623 15.9677 15.00901 15.49934 14.41059 14.30472 14.75109 12.70245 14.72728 0 0 15.42177 15.47213 17.49533 15.10844 15.5147 15.70842 18.17508 16.91852 16.54048 13.43585 17.9768 16.03661 15.79208 16.1402 12.90063 16.61527 0 16.1788 Q9BVA0 KTNB1_HUMAN "Katanin p80 WD40 repeat-containing subunit B1, Katanin p80 subunit B1 (p80 katanin)" KATNB1 Homo sapiens (Human) cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of cell death [GO:0010942]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; protein targeting [GO:0006605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; katanin complex [GO:0008352]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; katanin complex [GO:0008352]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of cell death [GO:0010942]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; protein targeting [GO:0006605] ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982] GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006605; GO:0007019; GO:0007026; GO:0007079; GO:0008017; GO:0008352; GO:0010942; GO:0010976; GO:0015630; GO:0016020; GO:0030426; GO:0030496; GO:0031117; GO:0043025; GO:0046982; GO:0051013; GO:0051301; GO:0060590; GO:0070840 ASGRLLATGGDDCR 10.40999985 1 1 0.083993642 1449.40929 15.31586 0 12.00557 0 0 0 15.51245 0 14.89429 0 0 0 14.49167 14.38814 7.355372 0 15.69621 12.05026 0 7.84413 12.80744 10.85635 15.31527 0 0 0 0 14.84522 13.51429 12.619 14.35885 0 9.985357 12.68563 12.48996 0 0 0 0 0 15.7073 0 0 0 0 0 0 0 Q9BVC3 DCC1_HUMAN Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) DSCC1 DCC1 UNQ9337/PRO34008 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275] "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]" DNA binding [GO:0003677] GO:0000775; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006275; GO:0031390; GO:0032508; GO:0034088; GO:0034421; GO:1900264 IADTSNMLLFIPGCK 4.28000021 1 1 0.53358204 1695.073255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVC4 LST8_HUMAN "Target of rapamycin complex subunit LST8, TORC subunit LST8 (G protein beta subunit-like, Gable, Protein GbetaL) (Mammalian lethal with SEC13 protein 8, mLST8)" MLST8 GBL LST8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] protein serine/threonine kinase activator activity [GO:0043539] GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0007010; GO:0010507; GO:0016310; GO:0030307; GO:0030838; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0032008; GO:0032956; GO:0038202; GO:0043066; GO:0043087; GO:0043539; GO:0045821; GO:0046889; GO:0050731; GO:0071456; GO:0071470; GO:1905857 NIASVGFHEDGR 7.980000019 0.618199646 0.618199646 0.149920942 1300.05144 15.97205 12.92818 0 0 0 10.90547 0 0 0 16.39011 0 0 0 13.52139 15.91981 0 0 18.10717 0 0 0 14.96222 0 0 13.74888 15.42403 11.02239 16.0612 14.74194 0 17.29066 0 15.94747 13.62008 15.8648 17.19669 17.54304 16.45163 17.48211 0 13.18373 15.39906 18.31541 0 13.31928 18.49424 17.21897 0 Q9BVC5 ASHWN_HUMAN Ashwin C2orf49 Homo sapiens (Human) embryonic morphogenesis [GO:0048598] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; embryonic morphogenesis [GO:0048598] GO:0005634; GO:0005654; GO:0048598; GO:0072669 KSPSGPVK 4.760000229 0.295726985 0.295726985 0.16650892 798.2622188 14.11764 13.4738 15.21589 14.63663 17.68377 13.89919 14.49193 0 13.58051 16.61058 15.14258 16.04113 13.03664 12.97195 0 8.015192 0 15.27527 0 15.63042 15.93358 15.81522 16.21311 17.4882 19.00033 12.14792 16.89435 13.60346 0 18.21394 0 19.50239 14.28602 16.03067 14.58877 15.56679 16.54825 17.54905 17.22754 0 15.73131 17.03805 0 0 17.33195 15.85714 16.40077 15.52767 Q9BVG4 PBDC1_HUMAN Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1) PBDC1 CXorf26 Homo sapiens (Human) SGEKAM 6.449999809 0.806668818 0.806668818 0.23732912 637.8409274 0 0 0 21.62963 20.02836 0 0 0 19.43167 0 15.5828 17.40898 19.38211 0 18.28906 0 18.23539 0 18.27353 19.29787 18.27077 19.1178 20.38349 18.24495 0 17.76191 19.95778 16.35326 0 0 18.78403 18.71667 20.50284 14.20606 0 0 20.50162 21.2273 0 20.30792 20.73437 18.62444 17.55513 18.13911 18.6252 19.87321 17.42993 17.39959 Q9BVG8 KIFC3_HUMAN Kinesin-like protein KIFC3 KIFC3 Homo sapiens (Human) epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218] centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915] centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003777; GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007018; GO:0007030; GO:0007601; GO:0008017; GO:0008569; GO:0030659; GO:0042802; GO:0045218; GO:0070062; GO:0090136 LTYLLQDSLSGDSK 2.650000095 0.692679107 0.692679107 0.301074967 1539.452883 11.50115 0 15.1308 13.82954 0 14.20416 11.14068 13.12288 14.59527 15.86148 17.04775 14.2027 15.40962 0 0 0 0 0 0 0 0 17.05883 0 0 0 0 0 0 0 0 0 0 0 0 16.04526 0 0 0 0 0 0 0 15.5986 0 0 0 0 0 Q9BVI0 PHF20_HUMAN PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0000123; GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0006357; GO:0016573; GO:0031965; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0046872; GO:0051571; GO:0071339; GO:1900095 GSALDDAVNPLHENGDDSLSPR 4.28000021 1 1 2.29E-12 2278.826847 0 13.90257 0 12.75597 13.44503 11.54795 0 13.67563 13.67312 13.61177 0 0 12.95159 0 0 0 0 0 0 0 0 0 13.40409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVJ6 UT14A_HUMAN U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16) UTP14A SDCCAG16 Homo sapiens (Human) rRNA processing [GO:0006364] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040 ASSEGTIPQVQR 4.559999943 1 1 0.156725316 1273.50701 15.08901 14.7836 0 10.53771 15.08935 0 0 14.34213 0 0 0 14.35163 0 0 0 11.56545 0 0 0 15.49434 0 0 0 0 0 14.13327 17.13262 0 0 0 0 0 16.15675 16.34412 0 0 0 0 0 16.02427 0 15.72581 0 0 0 0 0 0 Q9BVL4 SELO_HUMAN "Protein adenylyltransferase SelO, mitochondrial, EC 2.7.7.-, EC 2.7.7.n1 (Selenoprotein O, SelO)" SELENOO SELO Homo sapiens (Human) protein adenylylation [GO:0018117] chromosome [GO:0005694]; mitochondrion [GO:0005739] chromosome [GO:0005694]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733] GO:0005524; GO:0005694; GO:0005739; GO:0018117; GO:0046872; GO:0070733 SSIREFLCSEAMFHLGVPTTR 4.909999847 1 1 0.502838686 2454.994531 0 20.03485 20.00949 20.00817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVS4 RIOK2_HUMAN "Serine/threonine-protein kinase RIO2, EC 2.7.11.1 (RIO kinase 2)" RIOK2 RIO2 Homo sapiens (Human) cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]" ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234 MGKVNVAK 4.409999847 1 1 0.351456708 863.577439 14.05159 0 16.08109 15.04339 14.64255 0 14.55559 0 0 15.34398 15.23935 0 14.22589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.05049 15.99258 0 0 0 15.00915 0 0 0 0 0 0 0 0 0 0 0 Q9BVV2 FND11_HUMAN Fibronectin type III domain-containing protein 11 FNDC11 C20orf195 Homo sapiens (Human) KASAAHQDWAR 2.289999962 1 1 1.15E-12 1240.111529 0 12.92724 0 15.0867 0 0 0 14.0896 0 6.227137 10.0209 12.55682 0 0 0 0 0 0 12.66642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.79409 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVW5 TIPIN_HUMAN TIMELESS-interacting protein TIPIN Homo sapiens (Human) cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411] DNA binding [GO:0003677] GO:0000076; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0009411; GO:0031298; GO:0031573; GO:0033262; GO:0043111; GO:0044770; GO:0048478; GO:0051301 GHEAEDLKMLIR 3.019999981 1 1 2.30E-13 1411.616099 0 14.86133 0 14.1005 0 0 0 0 0 0 0 0 0 0 0 13.75591 0 0 15.02212 0 0 0 0 0 0 0 16.57288 14.97159 0 14.63615 12.4804 0 16.67715 0 0 16.29198 0 17.0575 15.17225 0 0 0 0 0 0 0 0 0 Q9BW19 KIFC1_HUMAN Kinesin-like protein KIFC1 (Kinesin-like protein 2) (Kinesin-related protein HSET) KIFC1 HSET KNSL2 Homo sapiens (Human) cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307] early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000070; GO:0003777; GO:0005524; GO:0005634; GO:0005769; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0016020; GO:0016887; GO:0051301; GO:0072686; GO:0090307 LDPGLALGPGER 7.679999828 0.30624938 0.30624938 0.201260551 1194.543414 0 13.63182 12.44434 0 15.51278 13.83465 13.46793 14.55217 0 0 15.15151 0 0 16.52192 13.38958 15.06542 17.41408 15.57975 16.94712 17.79719 12.53817 15.52851 0 16.75305 0 14.10101 0 16.49771 0 12.301 17.26013 0 15.34612 17.34964 15.87641 16.40884 15.93818 15.02373 16.74495 16.74364 15.36641 14.75397 15.68197 19.38012 15.04612 17.11454 16.96691 0 Q9BW27 NUP85_HUMAN Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1) NUP85 NUP75 PCNT1 Homo sapiens (Human) "lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]" cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819] "cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]" structural constituent of nuclear pore [GO:0017056] GO:0000776; GO:0005635; GO:0005643; GO:0005654; GO:0005819; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0030032; GO:0031080; GO:0031965; GO:0045893; GO:0048246; GO:0072006 IMLGDEAALLEQK 4.840000153 1 1 0.423352729 1430.765622 18.50371 0 15.28815 0 0 0 0 18.44091 0 0 0 18.61571 18.03645 0 0 18.30259 19.29537 0 0 0 16.80288 18.51988 0 0 19.35583 0 0 0 0 0 20.28671 0 19.96123 0 0 0 0 0 0 0 19.75831 20.1561 0 0 0 0 19.0927 0 Q9BW30 TPPP3_HUMAN Tubulin polymerization-promoting protein family member 3 (TPPP/p20) TPPP3 CGI-38 Homo sapiens (Human) decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273] cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; tubulin binding [GO:0015631]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273] tubulin binding [GO:0015631] GO:0001578; GO:0005737; GO:0005874; GO:0007566; GO:0015631; GO:0032273; GO:0046697; GO:0046785 AKTGGAVDR 2.049999952 1 1 0.236502206 873.6217189 0 0 0 0 0 15.12944 0 0 0 18.08317 0 0 0 0 0 0 0 0 0 0 0 0 0 15.87398 0 0 0 0 0 22.2303 19.30532 0 0 18.43824 0 0 0 21.51879 0 0 0 0 0 0 18.41903 0 0 0 Q9BW62 KATL1_HUMAN "Katanin p60 ATPase-containing subunit A-like 1, Katanin p60 subunit A-like 1, EC 5.6.1.1 (p60 katanin-like 1)" KATNAL1 Homo sapiens (Human) microtubule severing [GO:0051013]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568] GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0042802; GO:0051013 EMAGVGARGPVGR 7.550000191 1 1 0.322638183 1257.825496 0 0 15.25446 14.36339 0 0 0 0 0 0 0 0 14.55824 0 15.59918 0 15.37877 15.21954 0 0 0 15.06447 0 16.0645 18.30276 14.67705 15.51923 15.06894 12.14571 0 17.66127 13.40823 18.16728 16.45166 0 0 0 17.15876 16.33926 16.17985 15.57087 0 0 16.70888 0 17.23003 0 0 Q9BW66 CINP_HUMAN "Cyclin-dependent kinase 2-interacting protein, CDK2-interacting protein" CINP Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260] nucleus [GO:0005634] nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260] GO:0005634; GO:0006260; GO:0006281; GO:0007049; GO:0051301 MEAKTLGTVTPR 12.02999973 1 1 1.094575748 1304.665288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.50809 0 0 0 0 Q9BW71 HIRP3_HUMAN HIRA-interacting protein 3 HIRIP3 Homo sapiens (Human) chromatin assembly or disassembly [GO:0006333] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333] GO:0005634; GO:0005654; GO:0005730; GO:0006333 GEDHPAVMR 4.559999943 1 1 0.222053307 1011.068494 0 0 15.45938 15.46709 16.26173 13.53328 0 16.20328 13.69992 0 15.03252 15.56191 14.6564 12.31259 10.97038 16.19586 15.49837 15.86691 16.73254 14.18678 15.92907 13.34453 14.95318 16.46857 0 18.12514 14.20875 13.26278 14.99026 0 19.24732 17.31943 17.03999 15.48011 17.05226 11.22034 0 13.90791 14.66042 0 0 0 0 0 0 15.7471 0 17.41079 Q9BW72 HIG2A_HUMAN "HIG1 domain family member 2A, mitochondrial (RCF1 homolog B, RCF1b)" HIGD2A Homo sapiens (Human) mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066] GO:0005739; GO:0005743; GO:0016021; GO:0043066; GO:0070469; GO:0097250 SQLMMR 13.06999969 3.49E-06 3.49E-06 0.237387442 781.0732459 20.80226 18.47031 15.88466 18.7448 0 20.12341 17.46461 0 20.85673 20.66644 19.33421 0 0 0 0 18.75797 19.10536 21.14708 0 0 16.67331 0 0 0 20.464 21.18296 0 18.42211 0 0 20.49946 21.16803 0 0 20.82169 0 20.63708 0 0 18.31515 0 0 0 15.8063 0 16.37736 20.14479 0 Q9BW92 SYTM_HUMAN "Threonine--tRNA ligase, mitochondrial, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase-like 1)" TARS2 TARSL1 Homo sapiens (Human) mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829] GO:0002161; GO:0004829; GO:0005524; GO:0005759; GO:0006435; GO:0042803; GO:0070159 EPRTIK 6.880000114 1 1 0.156734784 742.2558848 14.59697 0 0 0 0 0 0 0 0 0 0 0 0 15.28995 0 0 0 0 0 0 0 0 0 0 0 0 0 14.70167 0 0 16.82206 0 0 0 15.9638 15.31897 16.61231 15.44286 14.98778 0 0 0 0 0 16.22423 15.75821 13.89713 13.13108 Q9BWC9 CC106_HUMAN Coiled-coil domain-containing protein 106 CCDC106 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 LAEVGEFDPSKER 2.930000067 0.117826335 0.117826335 0.314084604 1476.346542 15.43911 14.76679 13.47722 0 15.38819 0 0 14.23498 15.43065 0 15.22847 15.09047 11.99572 0 12.75828 0 12.91738 0 0 15.30881 0 15.23298 14.70306 14.21396 0 0 16.14369 0 0 0 17.09582 0 0 0 0 0 0 0 0 0 0 0 17.07606 0 0 0 0 0 Q9BWE0 REPI1_HUMAN Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464) REPIN1 RIP60 ZNF464 Homo sapiens (Human) DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005654; GO:0005664; GO:0005694; GO:0006260; GO:0006357; GO:0043035; GO:0046872 HKPYLAAHRR 5.260000229 0.254324466 0.254324466 0.146433578 1246.158726 14.67405 10.32518 12.34384 0 0 0 0 0 0 0 0 0 11.73304 0 0 0 12.23004 0 0 0 0 14.81834 0 0 0 14.57581 0 11.25483 0 0 0 0 0 0 0 0 0 0 0 14.43486 0 0 0 0 0 13.95331 0 0 Q9BWF2 TRAIP_HUMAN "E3 ubiquitin-protein ligase TRAIP, EC 2.3.2.27 (RING finger protein 206) (TRAF-interacting protein)" TRAIP RNF206 TRIP Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005654; GO:0005730; GO:0006915; GO:0006974; GO:0007165; GO:0010804; GO:0016567; GO:0031297; GO:0032088; GO:0032688; GO:0042802; GO:0046872; GO:0048471; GO:0061630; GO:0090734; GO:0106300 ASGEVADKLR 6.309999943 3.83E-06 3.83E-06 0.058137498 1045.514976 0 15.00945 0 0 0 0 0 15.66326 0 0 0 0 0 16.38507 0 13.89584 0 17.61425 16.5313 16.58563 15.41685 15.49233 0 14.9309 17.24831 0 0 0 18.26761 0 0 0 0 0 19.11959 0 17.25068 16.58608 0 0 16.07816 0 14.84611 16.13391 0 0 14.62252 0 Q9BWG6 SCNM1_HUMAN Sodium channel modifier 1 SCNM1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; alternative mRNA splicing, via spliceosome [GO:0000380]; RNA splicing [GO:0008380]" enzyme binding [GO:0019899]; metal ion binding [GO:0046872] GO:0000380; GO:0005634; GO:0008380; GO:0016607; GO:0019899; GO:0046872 YRPEAPGPSVSLSPMPPSEVKLQSGK 1.769999981 0.543985188 0.543985188 0.039716951 2754.50038 15.33524 0 9.580771 13.55344 14.86845 0 0 0 12.34459 14.31651 0 0 0 14.11451 12.94592 8.520136 0 0 0 0 0 0 0 0 0 0 16.58266 13.96585 14.89663 12.43425 0 15.10947 0 0 15.72189 0 0 0 0 0 0 0 13.60629 0 11.71275 0 0 8.588675 Q9BWH6 RPAP1_HUMAN RNA polymerase II-associated protein 1 RPAP1 KIAA1403 Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366] DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] GO:0003677; GO:0003899; GO:0005634; GO:0006366 DTSSVAVNLPVPSGVAFPAVFLRSR 7.210000038 1 1 0.625421165 2586.965545 16.17661 14.76517 13.21012 0 0 0 0 0 17.55706 0 0 0 0 0 0 0 0 0 0 0 0 18.2792 0 18.4039 0 0 0 0 0 0 0 0 0 0 0 17.88952 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWJ5 SF3B5_HUMAN "Splicing factor 3B subunit 5, SF3b5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit)" SF3B5 SF3B10 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]" RNA binding [GO:0003723]; splicing factor binding [GO:1990935] GO:0000124; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0005689; GO:0006282; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0071005; GO:0071011; GO:1990935 FNLMEKMLQPCGPPADKPEEN 1.129999995 1 1 0.135633461 2460.202887 16.47216 15.76302 0 16.41129 16.52323 0 0 17.91594 16.18949 0 0 0 0 13.98988 0 0 15.2744 0 15.40247 0 0 15.16574 0 0 14.89787 12.02803 0 0 0 0 16.22371 15.89887 17.53945 17.62724 0 0 14.99984 15.42505 0 0 13.69559 0 15.55074 0 13.55811 15.94865 0 0 Q9BWK5 CYREN_HUMAN "Cell cycle regulator of non-homologous end joining, Cell cycle regulator of NHEJ (Modulator of retrovirus infection homolog)" CYREN C7orf49 MRI Homo sapiens (Human) double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] GO:0005634; GO:0005737; GO:0006303; GO:0033152; GO:0035861; GO:2001033 MRMAAVPVAAAR 2.859999895 1 1 0.198762427 1259.360296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.05096 0 16.70901 0 0 0 0 17.11772 0 0 0 0 0 17.36441 0 0 0 0 0 0 0 0 16.85292 0 0 0 0 0 0 0 0 0 0 16.41797 Q9BWN1 PRR14_HUMAN Proline-rich protein 14 PRR14 Homo sapiens (Human) muscle organ development [GO:0007517] chromosome [GO:0005694]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; muscle organ development [GO:0007517] GO:0005652; GO:0005654; GO:0005694; GO:0007517 DQVLSEPETKTMGK 21.44000053 1 1 0.290465244 1574.443313 19.36572 18.13218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.14295 0 19.32637 0 0 0 0 0 0 0 0 0 Q9BWS9 CHID1_HUMAN "Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein, SI-CLP)" CHID1 GL008 PSEC0104 SB139 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016] chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492] GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0016020; GO:0043202; GO:0045087; GO:0070062; GO:0070492; GO:1900016 AESVVLEHR 1.100000024 1 1 0.063633407 1040.603379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.20886 0 0 0 15.16993 0 0 0 0 16.20686 0 0 0 0 16.01555 11.5322 0 17.06459 0 0 0 10.44867 0 0 0 0 0 0 0 0 0 0 Q9BWT3 PAPOG_HUMAN "Poly(A) polymerase gamma, PAP-gamma, EC 2.7.7.19 (Neo-poly(A) polymerase, Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme, SRP RNA-adenylating enzyme)" PAPOLG PAP2 PAPG Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723] GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872 AVKLWAK 1.690000057 1 1 0.140791024 815.6610582 0 0 15.12171 0 14.99669 0 0 0 0 0 0 0 0 0 16.67891 0 13.20363 15.38726 0 0 0 17.59438 0 14.9025 0 0 16.88198 0 0 0 0 0 0 0 0 0 0 0 14.15338 0 0 0 0 0 0 0 0 15.82943 Q9BWT7 CAR10_HUMAN "Caspase recruitment domain-containing protein 10 (CARD-containing MAGUK protein 3, Carma 3)" CARD10 CARMA3 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981] CBM complex [GO:0032449]; cytoplasm [GO:0005737] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; signaling receptor complex adaptor activity [GO:0030159]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981] CARD domain binding [GO:0050700]; signaling receptor complex adaptor activity [GO:0030159] GO:0005737; GO:0007250; GO:0030159; GO:0032449; GO:0042981; GO:0050700; GO:0065003; GO:0090051; GO:1900182 AQPATPGLGSR 5.519999981 1 1 0.158117555 1053.534199 13.62938 16.37392 14.71968 0 0 13.89439 12.98911 11.82836 0 13.89731 0 14.38962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.34398 0 0 0 0 0 0 0 0 0 Q9BWU0 NADAP_HUMAN "Kanadaptin (Human lung cancer oncogene 3 protein, HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)" SLC4A1AP HLC3 Homo sapiens (Human) cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729] mRNA binding [GO:0003729] GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231 GGSKFK 4.539999962 0.417971879 0.417971879 0.039053495 622.7991397 12.53911 15.37955 0 0 15.16046 16.49551 13.93111 16.63684 0 0 0 0 16.9635 15.32542 14.15299 16.65677 16.79187 15.95437 13.27757 14.00003 15.62502 13.48259 16.7035 13.8866 14.77941 11.57431 14.16443 15.18813 0 12.18092 14.47769 14.74238 14.83363 15.70522 14.52313 16.81939 16.67346 0 9.463867 15.65193 17.1942 14.73318 13.78962 16.76068 15.31737 12.34655 0 0 Q9BWU1 CDK19_HUMAN "Cyclin-dependent kinase 19, EC 2.7.11.22 (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase)" CDK19 CDC2L6 CDK11 KIAA1028 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cellular response to lipopolysaccharide [GO:0071222]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0008353; GO:0016592; GO:0043065; GO:0048471; GO:0050729; GO:0071222; GO:0106310 TTYANSSLIK 4.019999981 0.470173568 0.470173568 0.226691617 1098.998206 0 0 0 15.56928 14.69427 11.25416 13.6507 14.94181 12.69144 0 14.76307 0 0 0 0 14.30086 15.43446 9.020459 15.37887 13.92405 15.0637 0 13.75073 0 0 0 14.56775 0 14.07139 0 0 14.97557 14.15389 0 0 0 0 0 0 0 0 14.60249 0 0 0 14.27751 0 0 Q9BWV3 CDAC1_HUMAN "Cytidine and dCMP deaminase domain-containing protein 1, EC 3.5.4.5 (Cytidine deaminase) (Testis development protein NYD-SP15)" CDADC1 Homo sapiens (Human) cytidine deamination [GO:0009972]; DNA cytosine deamination [GO:0070383] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; importin-alpha family protein binding [GO:0061676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; DNA cytosine deamination [GO:0070383] cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; importin-alpha family protein binding [GO:0061676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0004126; GO:0005634; GO:0005737; GO:0008270; GO:0009972; GO:0042803; GO:0047844; GO:0061676; GO:0070383 EAGQMQNLESAR 7.889999866 1 1 0.095781081 1331.508815 15.53522 0 13.66241 0 0 0 0 0 0 0 0 0 0 0 0 0 17.18875 0 0 0 0 0 0 0 0 0 16.24648 0 14.49933 13.82254 0 14.93219 14.24644 14.81036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWV7 TTLL2_HUMAN "Probable tubulin polyglutamylase TTLL2, EC 6.-.-.- (Testis-specific protein NYD-TSPG) (Tubulin--tyrosine ligase-like protein 2)" TTLL2 C6orf104 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] cilium [GO:0005929] cilium [GO:0005929]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GO:0000226; GO:0005524; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740 LQEAGVSIPPRR 13.26000023 1 1 0.299109588 1322.070523 0 13.70858 14.11052 0 0 0 0 0 16.65307 15.16306 0 0 16.20357 0 16.65151 0 0 0 0 17.01369 0 0 0 0 16.99254 0 0 13.34377 15.40455 14.73045 16.21107 0 0 0 0 15.67922 17.87981 0 17.36695 0 15.43723 0 18.34477 15.5134 16.53123 17.72618 17.6897 15.05036 Q9BWW9 APOL5_HUMAN "Apolipoprotein L5 (Apolipoprotein L-V, ApoL-V)" APOL5 Homo sapiens (Human) lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289] GO:0005576; GO:0005737; GO:0006629; GO:0006869; GO:0008035; GO:0008289; GO:0042157 DSMPDGNLSEEEK 11.19999981 1 1 0.330970784 1452.519635 13.72641 0 0 0 0 0 15.94361 12.7732 14.46761 15.07851 11.62716 12.43816 8.773106 12.56102 0 0 0 0 0 0 0 16.45422 0 0 0 0 14.3777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3996 15.37723 Q9BWX1 PHF7_HUMAN PHD finger protein 7 (Testis development protein NYD-SP6) PHF7 Homo sapiens (Human) cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872 LPQRGQSNR 6.539999962 1 1 0.137658803 1056.141328 13.46953 15.66616 15.78892 14.23108 0 0 15.35408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.77708 13.69219 0 0 0 0 16.01182 0 15.88808 0 0 0 0 0 13.85413 0 0 14.38429 14.42558 0 0 0 0 17.59045 0 0 15.28167 Q9BX10 GTPB2_HUMAN GTP-binding protein 2 GTPBP2 Homo sapiens (Human) translational elongation [GO:0006414] extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746] GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802 MAEKVGADITVLR 4.909999847 1 1 0.21267601 1419.178172 0 0 14.89681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.15982 0 0 0 0 0 0 0 0 0 0 0 14.17 0 0 15.11483 0 16.47842 14.63033 0 0 16.68509 0 0 0 15.0581 0 0 Q9BX26 SYCP2_HUMAN "Synaptonemal complex protein 2, SCP-2 (Synaptonemal complex lateral element protein, hsSCP2)" SYCP2 SCP2 Homo sapiens (Human) cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; meiotic nuclear division [GO:0140013]; negative regulation of apoptotic process [GO:0043066]; synaptonemal complex assembly [GO:0007130] lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; meiotic nuclear division [GO:0140013]; negative regulation of apoptotic process [GO:0043066]; synaptonemal complex assembly [GO:0007130] DNA binding [GO:0003677] GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007130; GO:0007140; GO:0007143; GO:0009566; GO:0043066; GO:0048808; GO:0051301; GO:0140013 HIKTAK 10.47000027 0.128373727 0.128373727 0.156788032 696.6472338 0 12.9747 14.84735 0 16.17339 0 0 15.52821 0 0 0 0 15.07773 0 0 15.62804 0 0 0 0 0 17.19476 0 0 16.15658 0 0 0 0 0 17.12215 0 17.57692 16.51396 0 0 0 0 0 0 0 0 17.18603 0 14.06901 13.21847 0 0 Q9BX40 LS14B_HUMAN "Protein LSM14 homolog B (RNA-associated protein 55B, hRAP55B)" LSM14B C20orf40 FAM61B RAP55B Homo sapiens (Human) regulation of translation [GO:0006417] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of translation [GO:0006417] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0006417 AEKGEEK 6.880000114 0.402568102 0.402568102 0.290111456 791.1320612 0 17.23 16.84339 0 0 0 18.33433 17.99806 0 20.47346 19.43274 0 0 0 0 0 19.90332 0 0 0 18.28628 0 0 17.49567 0 0 18.54251 0 18.03713 0 18.97047 0 19.74859 0 0 0 0 19.423 0 0 0 0 18.87147 17.90494 17.97875 0 19.71593 20.07227 Q9BX63 FANCJ_HUMAN "Fanconi anemia group J protein, Protein FACJ, EC 3.6.4.13 (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1, BRCA1-interacting protein 1)" BRIP1 BACH1 FANCJ Homo sapiens (Human) cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284] BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]" "4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]" GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0016887; GO:0031965; GO:0035825; GO:0043139; GO:0046872; GO:0051026; GO:0051539; GO:0070532; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918 NGLLVLPK 7.21999979 1 1 0.194984213 853.2254351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29344 0 16.25066 0 0 0 0 0 0 0 0 18.35018 0 0 0 0 0 0 0 0 0 0 19.58806 0 0 0 0 0 19.03654 17.25943 0 0 0 0 Q9BX66 SRBS1_HUMAN "Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein, CAP)" SORBS1 KIAA0894 KIAA1296 SH3D5 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149] adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915] adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149] actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159] GO:0001725; GO:0003779; GO:0005158; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0005915; GO:0005925; GO:0007160; GO:0008092; GO:0008286; GO:0016363; GO:0016600; GO:0030055; GO:0030159; GO:0031589; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046628; GO:0046889; GO:0048041; GO:1903078 HRGGEQAGR 2.930000067 1 1 0.175593567 966.459897 15.80968 16.69163 0 0 0 13.98508 0 15.00618 15.81644 0 15.74656 0 13.60203 15.05551 15.16681 14.78431 12.79381 13.73482 0 16.22493 14.61151 15.66975 0 14.97469 0 14.3523 0 0 15.71603 14.1836 14.38057 0 16.48367 14.64681 13.53925 16.04703 0 0 0 0 0 15.90912 0 0 0 0 0 0 Q9BX79 STRA6_HUMAN Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog) STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Homo sapiens (Human) adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; response to retinoic acid [GO:0032526]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import [GO:0071939]; vocal learning [GO:0042297] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; response to retinoic acid [GO:0032526]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import [GO:0071939]; vocal learning [GO:0042297] retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023] GO:0001568; GO:0001822; GO:0003184; GO:0003281; GO:0005886; GO:0005887; GO:0007507; GO:0007612; GO:0007631; GO:0016918; GO:0019841; GO:0030324; GO:0030325; GO:0030540; GO:0032526; GO:0032991; GO:0034632; GO:0034633; GO:0038023; GO:0042297; GO:0043010; GO:0043583; GO:0043585; GO:0048286; GO:0048520; GO:0048546; GO:0048566; GO:0048589; GO:0048745; GO:0048844; GO:0050890; GO:0050905; GO:0060322; GO:0060323; GO:0060325; GO:0060426; GO:0060539; GO:0060900; GO:0061029; GO:0061038; GO:0061143; GO:0061156; GO:0061205; GO:0071939; GO:0097070 NLLLFR 36.66999817 0.335997224 0.335997224 0.184276711 774.7708223 0 16.84487 0 18.82724 0 0 0 0 0 17.408 13.52402 0 0 0 0 10.69656 0 0 15.90951 19.43177 0 18.72158 16.50455 15.30824 0 0 17.23206 0 17.64882 0 12.46559 13.57422 17.44364 0 0 13.21964 17.06332 0 0 19.38956 0 16.99864 16.70317 0 19.14885 17.36874 0 16.13673 Q9BX82 ZN471_HUMAN Zinc finger protein 471 (EZFIT-related protein 1) ZNF471 ERP1 KIAA1396 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 VYVGKK 4.630000114 0.327991486 0.327991486 0.196786737 693.7150806 0 15.21955 13.69812 0 14.83544 0 13.77508 0 15.21174 15.90962 13.18424 0 0 16.87461 15.54319 14.86461 0 0 15.56629 13.28014 15.12678 0 15.75869 0 0 0 0 15.55399 0 16.65409 15.6722 0 0 13.0718 15.064 16.10102 0 0 16.89407 0 0 16.72256 0 0 0 0 0 0 Q9BX84 TRPM6_HUMAN "Transient receptor potential cation channel subfamily M member 6, EC 2.7.11.1 (Channel kinase 2) (Melastatin-related TRP cation channel 6)" TRPM6 CHAK2 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636] ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005261; GO:0005262; GO:0005524; GO:0005886; GO:0005887; GO:0009636; GO:0016324; GO:0031526; GO:0046872; GO:0051262; GO:0070588; GO:0098655; GO:0106310 AVIACILYR 5.75 1 1 0.197199191 1077.25511 0 0 15.48457 0 0 14.50089 16.46525 12.42881 10.71104 0 0 14.23921 0 15.84399 0 0 0 0 0 15.96914 0 17.56857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXA9 SALL3_HUMAN "Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3, hSALL3)" SALL3 ZNF796 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KMTDPNQCVICHR 12.03999996 0.410939097 0.410939097 0.434447979 1675.373348 0 0 17.24085 0 0 0 0 0 0 0 0 0 0 0 0 18.31675 0 0 0 0 0 0 0 0 0 19.38066 0 18.45194 0 0 0 18.39175 0 0 0 18.95556 0 0 0 17.82739 0 0 17.85746 0 0 17.39769 0 0 Q9BXB1 LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48) LGR4 GPR48 Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888] GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0004930; GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0007283; GO:0008528; GO:0009755; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0036335; GO:0045087; GO:0045892; GO:0045893; GO:0046849; GO:0048565; GO:0061290; GO:0072202; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013 ALSGLK 3.339999914 0.975753903 0.975753903 0.229455062 587.9268659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.55032 0 0 0 0 0 0 0 0 0 0 17.31768 0 19.2905 0 0 0 17.60527 0 0 0 0 0 0 0 0 0 0 0 16.51912 Q9BXB4 OSB11_HUMAN "Oxysterol-binding protein-related protein 11, ORP-11, OSBP-related protein 11" OSBPL11 ORP11 OSBP12 Homo sapiens (Human) fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890] sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] GO:0005654; GO:0005794; GO:0005829; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444 QGGEPVSTMK 16.20000076 0.781404674 0.781404674 0.406312549 1031.942295 0 15.77646 18.51226 16.43176 13.67535 16.12926 15.2695 0 13.60959 17.1774 15.05013 15.86978 0 15.87016 18.29992 9.776059 15.74343 0 12.65869 15.18309 15.68739 17.46939 18.69785 18.16427 18.59927 0 0 0 16.6216 0 18.45356 14.8276 0 0 15.5952 0 0 18.22023 0 0 19.0939 13.69856 0 17.51967 16.60231 16.82099 15.0141 15.19614 Q9BXB5 OSB10_HUMAN "Oxysterol-binding protein-related protein 10, ORP-10, OSBP-related protein 10" OSBPL10 ORP10 OSBP9 Homo sapiens (Human) phosphatidylserine acyl-chain remodeling [GO:0036150] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; phosphatidylserine acyl-chain remodeling [GO:0036150] cholesterol binding [GO:0015485]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] GO:0001786; GO:0005548; GO:0005829; GO:0005856; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0036150; GO:0043231 QGPMESR 8.899999619 1 1 0.25654222 819.4877713 0 0 15.02535 0 0 0 0 0 16.60437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.72728 0 0 0 0 0 0 0 0 0 0 0 0 18.70657 18.52605 18.49661 17.619 17.92956 17.38477 0 0 0 0 0 0 Q9BXC0 HCAR1_HUMAN Hydroxycarboxylic acid receptor 1 (G-protein coupled receptor 104) (G-protein coupled receptor 81) HCAR1 GPR104 GPR81 HCA1 FKSG80 Homo sapiens (Human) negative regulation of lipid catabolic process [GO:0050995] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; negative regulation of lipid catabolic process [GO:0050995] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021; GO:0050995 QPGHSK 2.200000048 1 1 0.170577679 653.7196855 0 0 0 0 0 0 17.92757 0 0 11.09299 0 0 0 17.80638 15.25853 0 0 17.28388 18.32321 0 16.70611 0 0 0 18.20705 17.12843 18.5077 15.07338 0 0 18.61438 17.11572 18.84303 0 16.69643 19.04168 18.67768 18.8875 18.76978 19.10577 18.71285 19.3466 0 17.38817 18.81559 19.52898 0 0 Q9BXC9 BBS2_HUMAN Bardet-Biedl syndrome 2 protein BBS2 Homo sapiens (Human) adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; visual perception [GO:0007601] BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005] BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; visual perception [GO:0007601] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0005829; GO:0007288; GO:0007601; GO:0008104; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032402; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0043001; GO:0043005; GO:0045444; GO:0045494; GO:0048854; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515 VGTASS 4.960000038 0.804889202 0.804889202 0.206941837 520.2348492 0 15.58462 16.98973 15.63608 16.41982 0 0 15.85561 15.22788 0 0 16.43863 16.50207 15.63896 0 15.70137 15.91797 17.17443 16.06191 16.85013 16.5564 15.26731 17.03514 16.54557 15.67472 15.4574 15.33256 16.40523 14.13936 15.64983 16.91833 16.41322 14.99704 14.40132 15.91928 15.84655 15.9913 16.08229 16.65614 0 14.72649 0 15.72979 0 17.93984 16.86525 16.26448 16.27256 Q9BXF3 CECR2_HUMAN Cat eye syndrome critical region protein 2 CECR2 KIAA1740 Homo sapiens (Human) apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192] CERF complex [GO:0090537]; nucleus [GO:0005634] CERF complex [GO:0090537]; nucleus [GO:0005634]; ATP-dependent chromatin remodeler activity [GO:0140658]; apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192] ATP-dependent chromatin remodeler activity [GO:0140658] GO:0005634; GO:0006309; GO:0006338; GO:0007010; GO:0007338; GO:0016192; GO:0061640; GO:0090537; GO:0097194; GO:0140658 QPFTMQPPVGINSLR 4.659999847 1 1 2.29E-13 1685.635339 14.90706 0 0 14.0598 15.39488 14.22574 14.56885 0 0 13.81529 0 14.13049 17.76033 0 0 14.20004 0 14.03893 13.56764 13.81395 16.21358 16.66846 16.06498 0 16.60079 14.86147 13.02486 0 0 0 0 0 0 0 0 0 0 0 0 14.75996 14.87534 0 0 0 0 0 0 0 Q9BXF6 RFIP5_HUMAN "Rab11 family-interacting protein 5, Rab11-FIP5 (Gamma-SNAP-associated factor 1, Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11)" RAB11FIP5 GAF1 KIAA0857 RIP11 Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008] centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658] centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]; gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267]; cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008] gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267] GO:0000139; GO:0005739; GO:0005741; GO:0005769; GO:0005794; GO:0030141; GO:0030658; GO:0031267; GO:0031901; GO:0034451; GO:0035773; GO:0043015; GO:0043231; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0070164; GO:0071468; GO:2000008 FLGQATVALDEVFGAGRAQHTQWYK 5.349999905 0.551383913 0.551383913 0.041399976 2792.704604 16.5262 16.05247 0 16.29716 16.60154 16.96204 13.31556 16.37855 12.27845 0 0 0 16.57427 0 15.47638 14.95142 15.85481 12.43683 0 0 16.31314 0 14.90074 0 0 14.78152 14.57117 15.83751 12.86134 0 15.24259 0 15.22898 0 15.88304 15.10808 15.1303 14.63364 17.16667 15.47917 11.86665 0 16.68157 0 0 0 0 15.57191 Q9BXG8 SPZ1_HUMAN Spermatogenic leucine zipper protein 1 (Testis-specific protein 1) (Testis-specific protein NYD-TSP1) SPZ1 TSP1 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] GO:0003677; GO:0003700; GO:0005634; GO:0005737 SAEMPTISK 7.409999847 0.737800479 0.737800479 0.168749598 982.1231682 0 17.49044 14.7149 15.05391 14.76308 0 0 0 0 0 13.97079 14.35006 0 0 15.39912 0 0 0 0 0 0 0 13.57946 0 0 0 0 0 0 17.22164 16.00252 0 0 0 0 0 0 0 0 0 0 0 0 14.60494 0 0 16.77201 0 Q9BXH1 BBC3_HUMAN "Bcl-2-binding component 3, isoforms 1/2 (JFY-1) (p53 up-regulated modulator of apoptosis)" BBC3 PUMA Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; toxin transport [GO:1901998] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; PUMA-BCL-xl complex [GO:0097143] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; PUMA-BCL-xl complex [GO:0097143]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; toxin transport [GO:1901998] GO:0001836; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006919; GO:0006974; GO:0008340; GO:0031334; GO:0032464; GO:0032471; GO:0034976; GO:0042771; GO:0043525; GO:0045926; GO:0051209; GO:0070059; GO:0070245; GO:0071456; GO:0071479; GO:0090200; GO:0097143; GO:0097190; GO:0097194; GO:1900740; GO:1901998; GO:1902237; GO:1903896; GO:2001056; GO:2001244 WPGGPR 5 1 1 0.27420355 668.1742502 0 0 0 16.08065 0 14.74775 14.66884 15.74339 0 0 0 16.4493 0 16.51481 0 0 15.86907 15.97568 16.16258 0 16.71328 0 0 0 0 15.67984 14.84674 0 0 15.46771 16.05245 15.2607 16.08084 16.0146 17.169 16.90183 0 15.67188 16.73801 16.14228 16.3424 15.93199 0 18.11501 16.39264 15.87504 16.64718 16.33742 Q9BXI2 ORNT2_HUMAN Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2) SLC25A2 ORNT2 Homo sapiens (Human) mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; L-ornithine transmembrane transporter activity [GO:0000064]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] L-ornithine transmembrane transporter activity [GO:0000064] GO:0000050; GO:0000064; GO:0005743; GO:0016021; GO:1990575 MMMKQLEAY 4.690000057 1 1 1.15E-12 1189.539008 13.72033 0 13.86897 13.60618 0 0 11.06016 15.30439 0 0 0 0 0 0 0 0 13.55563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXJ0 C1QT5_HUMAN Complement C1q tumor necrosis factor-related protein 5 C1QTNF5 CTRP5 UNQ303/PRO344 Homo sapiens (Human) inner ear development [GO:0048839]; protein secretion [GO:0009306] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; inner ear development [GO:0048839]; protein secretion [GO:0009306] identical protein binding [GO:0042802] GO:0005581; GO:0005615; GO:0005886; GO:0005923; GO:0009306; GO:0016324; GO:0016328; GO:0030133; GO:0042802; GO:0042995; GO:0048839 DGAPGAPGEK 1.970000029 0.979932129 0.979932129 0.264824353 899.2618565 15.69002 15.10378 14.7633 16.96807 0 17.08171 0 0 0 0 0 0 0 0 18.15997 19.19427 0 0 17.48382 15.44236 0 0 0 18.90977 0 18.59711 19.13531 18.08005 17.09775 16.99703 0 19.40046 0 0 17.54828 0 18.54517 18.6648 20.4204 0 0 0 19.06177 0 17.40946 0 0 17.24408 Q9BXJ1 C1QT1_HUMAN "Complement C1q tumor necrosis factor-related protein 1 (G protein-coupled receptor-interacting protein, GIP)" C1QTNF1 CTRP1 UNQ310/PRO353 Homo sapiens (Human) negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906] collagen binding [GO:0005518]; identical protein binding [GO:0042802] GO:0005518; GO:0005581; GO:0005615; GO:0005887; GO:0007204; GO:0010544; GO:0010628; GO:0010906; GO:0042802; GO:0043410; GO:0051897; GO:0090331; GO:2000860 GDRGLQGK 5.710000038 1 1 0.221523255 830.9006962 0 15.86352 0 0 0 0 0 0 15.36963 0 0 12.67798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.79497 11.10371 0 0 0 0 16.27923 0 0 0 0 0 0 0 15.83135 0 18.13704 15.77172 0 Q9BXJ9 NAA15_HUMAN "N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)" NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]" ribosome binding [GO:0043022]; RNA binding [GO:0003723] GO:0001525; GO:0003723; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0016020; GO:0016604; GO:0017196; GO:0030154; GO:0031415; GO:0043022; GO:0043066; GO:0043231; GO:0045893; GO:0050821 GCPPVFNTLR 3.99000001 0.843101978 0.843101978 0.198480332 1157.131838 11.64155 12.83406 15.31389 11.65289 15.46939 13.7297 0 0 0 16.54897 0 0 14.38319 0 0 0 13.94343 0 15.92973 0 0 12.6273 0 0 0 0 14.18646 13.76162 0 0 0 0 0 0 0 0 0 0 0 0 15.80643 0 0 0 0 0 0 0 Q9BXK1 KLF16_HUMAN "Krueppel-like factor 16 (Basic transcription element-binding protein 4, BTE-binding protein 4) (Novel Sp1-like zinc finger transcription factor 2) (Transcription factor BTEB4) (Transcription factor NSLP2)" KLF16 BTEB4 NSLP2 Homo sapiens (Human) dopamine receptor signaling pathway [GO:0007212]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dopamine receptor signaling pathway [GO:0007212]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007212; GO:0046872; GO:1990837 SDHLAKHAR 4.809999943 1 1 0.181081649 1034.8624 0 15.98646 16.27981 0 0 0 0 0 14.66757 0 0 0 17.06215 15.03527 0 16.00419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.51259 0 0 0 0 0 16.82802 18.22858 0 0 Q9BXL5 HEMGN_HUMAN "Hemogen (Erythroid differentiation-associated gene protein, EDAG-1) (Hemopoietic gene protein) (Negative differentiation regulator protein)" HEMGN EDAG NDR PRO1037 PRO1620 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of osteoblast differentiation [GO:0045667] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; cell differentiation [GO:0030154]; regulation of osteoblast differentiation [GO:0045667] GO:0005654; GO:0030154; GO:0045667 EIVEKALAPIEK 8.069999695 1 1 0.183280692 1340.755078 15.19984 0 15.20166 15.72282 16.50081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.47026 0 0 15.42814 0 0 14.79813 0 0 16.32045 0 0 11.4853 0 0 0 0 0 0 0 16.7469 Q9BXL6 CAR14_HUMAN "Caspase recruitment domain-containing protein 14 (CARD-containing MAGUK protein 2, Carma 2)" CARD14 CARMA2 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; CARD domain binding [GO:0050700]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CARD domain binding [GO:0050700] GO:0001934; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007250; GO:0016235; GO:0033209; GO:0043066; GO:0050700; GO:0051092 ASPLRLSFDR 3.269999981 1 1 0.126820786 1161.088178 12.53922 0 13.65997 12.99308 14.92843 0 0 0 0 0 0 10.6967 0 0 13.88593 0 0 0 13.06083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXM0 PRAX_HUMAN Periaxin PRX KIAA1620 Homo sapiens (Human) axon ensheathment [GO:0008366]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of RNA splicing [GO:0043484] cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; axon ensheathment [GO:0008366]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of RNA splicing [GO:0043484] GO:0005634; GO:0005737; GO:0005886; GO:0008366; GO:0030054; GO:0032287; GO:0043484 LPKVPEAALPEVR 7.119999886 1 1 0.283026896 1423.012096 15.13859 0 13.01939 0 0 14.59418 0 14.02712 14.14295 15.0474 0 0 0 0 0 0 0 0 0 16.44568 18.29739 0 0 0 0 0 0 16.83318 14.37179 0 14.37832 13.81313 0 0 11.727 0 16.58169 17.40457 0 0 0 0 0 0 15.82677 0 0 18.9561 Q9BXM7 PINK1_HUMAN "Serine/threonine-protein kinase PINK1, mitochondrial, EC 2.7.11.1 (BRPK) (PTEN-induced putative kinase protein 1)" PINK1 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]" astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]" ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625] GO:0000287; GO:0000422; GO:0000423; GO:0000785; GO:0001934; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0016020; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030097; GO:0030424; GO:0030426; GO:0031307; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0042981; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051091; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:0106310; GO:1900407; GO:1901525; GO:1901727; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903202; GO:1903204; GO:1903214; GO:1903298; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904783; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243 GGNGCLMAPEVSTARPGPR 8.5 1 1 0.586947924 1942.979329 17.67823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.43106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXP5 SRRT_HUMAN Serrate RNA effector molecule homolog (Arsenite-resistance protein 2) SRRT ARS2 ASR2 Homo sapiens (Human) "mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]" DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0016604; GO:0030674; GO:0031053; GO:0032991; GO:0046685; GO:0050769; GO:0097150; GO:0140262; GO:1990904 AGAGLGDGER 9.789999962 1 1 0.077681454 902.8315887 0 12.42253 15.01292 17.44996 0 0 15.91584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.16677 0 0 0 16.13721 0 0 0 11.58275 0 16.52926 0 0 0 0 0 0 0 16.09389 0 0 Q9BXP8 PAPP2_HUMAN "Pappalysin-2, EC 3.4.24.- (Pregnancy-associated plasma protein A2, PAPP-A2) (Pregnancy-associated plasma protein E1, PAPP-E)" PAPPA2 PLAC3 Homo sapiens (Human) bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; proteolysis [GO:0006508]; regulation of cell growth [GO:0001558]; response to salt stress [GO:0009651] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; proteolysis [GO:0006508]; regulation of cell growth [GO:0001558]; response to salt stress [GO:0009651] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0001558; GO:0004222; GO:0005576; GO:0005829; GO:0006508; GO:0008237; GO:0008270; GO:0009651; GO:0016324; GO:0044267; GO:0060349; GO:0070062 AYSSHEDK 2.99000001 1 1 0.240444654 934.9922149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.44543 0 0 0 0 0 0 Q9BXR0 TGT_HUMAN "Queuine tRNA-ribosyltransferase catalytic subunit 1, EC 2.4.2.64 (Guanine insertion enzyme) (tRNA-guanine transglycosylase)" QTRT1 TGT TGUT Homo sapiens (Human) tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234] mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479] GO:0005634; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030; GO:1990234 MAGAATQASLESAPR 2.940000057 0.380175799 0.380175799 0.124052621 1476.688273 15.5165 13.05399 18.72025 16.36752 16.68084 15.52564 0 16.52074 15.12618 16.60163 0 0 15.31681 0 15.9835 16.05989 0 0 13.54702 0 14.76441 15.67012 14.83229 13.25999 15.47635 0 13.77353 14.98914 14.84988 14.37347 14.54629 16.04935 18.14248 13.51853 14.55822 18.37867 14.27507 0 0 15.1659 15.30274 11.92833 11.60068 0 13.2069 15.65336 0 14.36155 Q9BXS0 COPA1_HUMAN "Collagen alpha-1(XXV) chain (Alzheimer disease amyloid-associated protein, AMY) (CLAC-P) [Cleaved into: Collagen-like Alzheimer amyloid plaque component, CLAC ]" COL25A1 Homo sapiens (Human) collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] GO:0001540; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0005886; GO:0005887; GO:0008201; GO:0016021; GO:0042802; GO:0062023 GDKGEQGDQGPR 4.539999962 0.003347597 0.003347597 0.149723863 1244.074697 0 0 0 0 0 0 0 0 15.14117 0 0 0 11.73304 13.07349 13.19251 10.42919 0 13.40026 0 14.08036 0 14.41639 10.9958 0 0 0 0 14.16257 16.81997 14.16877 9.400979 14.90274 14.49104 15.09594 0 0 0 0 0 0 0 14.38538 0 0 0 0 0 0 Q9BXS9 S26A6_HUMAN "Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1, Pendrin-L1)" SLC26A6 Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633] anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] GO:0005254; GO:0005452; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0008271; GO:0008272; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015499; GO:0015562; GO:0015660; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0042802; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:2001150 APDGSTLK 9.920000076 0.303871393 0.303871393 0.307143765 787.8779793 15.72134 16.88719 17.96645 0 16.64029 16.20493 0 17.37644 0 0 0 0 0 15.61229 0 17.93767 17.01743 0 0 16.45831 0 16.99144 0 0 17.28377 18.14651 0 0 0 18.56018 0 0 19.21177 0 17.92211 18.78252 0 0 0 0 18.86889 16.31445 0 0 0 0 0 0 Q9BXT2 CCG6_HUMAN Voltage-dependent calcium channel gamma-6 subunit (Neuronal voltage-gated calcium channel gamma-6 subunit) CACNG6 Homo sapiens (Human) calcium ion transport [GO:0006816]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514] calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:1902514; GO:1990454 GAAGRR 6.690000057 1 1 0.158262496 586.2958619 13.39154 15.42359 14.50283 15.64246 14.58479 15.0694 14.6701 14.85545 0 13.42266 15.27629 0 16.34135 0 0 15.45847 0 17.13958 16.50169 0 16.17693 16.68946 0 16.24202 16.06773 15.02946 16.30474 16.57437 15.92577 15.10561 15.472 15.56728 0 16.21525 16.0049 15.17901 17.41458 0 16.3772 0 0 17.7755 16.47541 17.42097 15.78963 17.64817 0 0 Q9BXT5 TEX15_HUMAN "Testis-expressed protein 15 (Cancer/testis antigen 42, CT42)" TEX15 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0005634; GO:0005737; GO:0006281; GO:0006306; GO:0007130; GO:0007140; GO:0007283; GO:0010529; GO:0010569; GO:0030154; GO:0031047 GPLPK 7.949999809 0.000121112 0.000121112 0.301369614 510.2834942 0 17.71961 0 0 16.72469 0 0 0 18.20465 20.35292 0 0 0 0 17.67567 0 19.74805 0 0 0 0 0 0 17.93805 0 0 0 0 16.60745 0 0 0 17.73363 0 0 0 0 0 0 0 0 0 16.68328 0 0 0 18.78736 0 Q9BXT6 M10L1_HUMAN "RNA helicase Mov10l1, EC 3.6.4.13 (Moloney leukemia virus 10-like protein 1, MOV10-like protein 1)" MOV10L1 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043046; GO:0043186; GO:0071546 SSGQSTSKK 2.089999914 1 1 0.154588444 909.8055811 14.96751 13.54066 15.63679 14.25008 16.86308 0 13.66048 14.72981 0 15.82407 0 13.96494 0 0 15.34411 0 14.76548 0 15.1684 13.27079 0 16.12699 0 0 16.74175 0 0 0 0 14.26379 15.83425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXU1 STK31_HUMAN "Serine/threonine-protein kinase 31, EC 2.7.11.1 (Serine/threonine-protein kinase NYD-SPK) (Sugen kinase 396, SgK396)" STK31 SGK396 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0106310 EEFTSVR 12.82999992 0.069794543 0.069794543 0.176155487 866.5863866 15.45717 14.95181 15.70778 0 0 14.91193 14.96669 15.34721 0 0 0 0 12.99119 14.51352 0 0 14.12848 0 14.40059 0 16.2 0 16.11954 16.07867 0 15.74343 15.25685 14.7957 16.16725 15.83065 15.13618 15.55367 15.40782 0 14.86694 13.21027 14.62147 15.64756 14.08586 16.39679 16.92352 16.77977 0 16.98057 17.54866 0 0 15.5255 Q9BXU7 UBP26_HUMAN "Ubiquitin carboxyl-terminal hydrolase 26, EC 3.4.19.12 (Deubiquitinating enzyme 26) (Ubiquitin thioesterase 26) (Ubiquitin-specific-processing protease 26)" USP26 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579 QQQKYLGK 3.970000029 1 1 0.267247442 993.9416016 0 14.92614 0 11.87368 0 15.3677 16.31168 16.64966 0 18.80459 0 14.79764 0 0 0 14.72212 15.79613 0 0 0 0 16.86954 16.50043 0 16.56657 15.3863 16.84381 15.455 10.9083 12.13286 17.75139 17.00553 17.29028 17.17672 15.7605 12.67117 16.8799 15.68698 14.77844 15.4512 0 17.95066 15.66161 0 14.37296 15.23795 14.19011 14.84278 Q9BXU9 CABP8_HUMAN "Calcium-binding protein 8, CaBP8 (Calneuron I) (Calneuron-1)" CALN1 CABP8 Homo sapiens (Human) integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509; GO:0005886; GO:0016021; GO:0032588; GO:0048471 EAFRVLDR 9.600000381 1 1 0.264467828 1006.369874 0 0 0 0 18.39058 0 0 0 0 0 0 0 15.32987 0 15.87296 16.77596 0 18.62919 16.67147 0 0 0 0 0 0 0 0 0 0 16.05303 18.13142 20.42278 17.65901 17.53839 18.69956 16.9319 0 0 0 0 17.29216 0 0 0 0 17.05705 16.68713 0 Q9BXW6 OSBL1_HUMAN "Oxysterol-binding protein-related protein 1, ORP-1, OSBP-related protein 1" OSBPL1A ORP1 OSBP8 OSBPL1 OSBPL1B Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; cholesterol metabolic process [GO:0008203]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; phospholipid binding [GO:0005543]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cholesterol metabolic process [GO:0008203]; vesicle-mediated transport [GO:0016192] cholesterol binding [GO:0015485]; phospholipid binding [GO:0005543]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] GO:0005543; GO:0005768; GO:0005770; GO:0005829; GO:0006699; GO:0008203; GO:0015248; GO:0015485; GO:0016020; GO:0016192; GO:0032934; GO:0043231; GO:0044232; GO:0070062 CVLNFKPCGLFGK 3.420000076 1 1 0.258245802 1534.01229 0 15.95724 0 13.54999 13.14323 15.89687 14.4965 14.84699 0 15.3176 16.11862 13.43495 13.59364 0 12.49369 15.09914 16.61307 0 0 16.42333 13.50452 15.65516 0 0 13.55413 15.35759 0 15.38197 0 0 0 16.96269 18.62028 0 0 0 10.51902 13.18945 0 15.11687 0 0 0 0 12.96739 0 15.37107 0 Q9BXW9 FACD2_HUMAN "Fanconi anemia group D2 protein, Protein FACD2" FANCD2 FACD Homo sapiens (Human) brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332] DNA polymerase binding [GO:0070182] GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348 YKLIGIIGAVTMAGIMAADR 8.06000042 0.157224372 0.157224372 4.58E-13 2095.950968 14.60982 12.72333 9.401235 15.19753 0 15.80929 0 14.85635 0 0 16.35323 0 14.81094 0 0 17.1534 14.0467 0 0 0 0 0 14.97401 0 0 16.87415 15.97261 16.8678 0 0 0 0 15.21204 0 0 14.50418 0 16.70495 15.04564 0 0 0 0 0 0 0 15.39753 0 Q9BXX0 EMIL2_HUMAN "EMILIN-2 (Elastin microfibril interface-located protein 2, Elastin microfibril interfacer 2) (Protein FOAP-10)" EMILIN2 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood coagulation [GO:0030194]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of platelet aggregation [GO:1901731]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood coagulation [GO:0030194]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of platelet aggregation [GO:1901731]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] extracellular matrix constituent conferring elasticity [GO:0030023] GO:0005576; GO:0005581; GO:0008217; GO:0030023; GO:0030194; GO:0030336; GO:0033627; GO:0042127; GO:0043065; GO:0045766; GO:0062023; GO:1900426; GO:1901731 HVSSLWNCVRQMNGTLR 5.28000021 0.891814888 0.891814888 0.19552762 2073.898982 14.7136 12.93072 12.81412 17.06433 12.84691 11.94751 0 0 0 0 0 0 0 0 0 13.79323 15.09551 0 0 0 0 0 0 13.63396 0 0 12.80169 0 0 0 0 0 0 13.78538 0 0 0 0 0 0 0 0 0 0 0 15.01686 0 0 Q9BXX3 AN30A_HUMAN Ankyrin repeat domain-containing protein 30A (Serologically defined breast cancer antigen NY-BR-1) ANKRD30A Homo sapiens (Human) ETVSQK 6.519999981 1 1 0.090727142 689.6012475 0 0 17.11778 0 0 0 17.03144 0 0 0 18.19219 0 0 0 0 0 0 0 0 0 0 17.79892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXY4 RSPO3_HUMAN "R-spondin-3 (Protein with TSP type-1 repeat, hPWTSR) (Roof plate-specific spondin-3, hRspo3) (Thrombospondin type-1 domain-containing protein 2)" RSPO3 PWTSR THSD2 Homo sapiens (Human) "blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]" extracellular region [GO:0005576] "extracellular region [GO:0005576]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]" frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] GO:0001974; GO:0002040; GO:0005102; GO:0005109; GO:0005576; GO:0008201; GO:0016055; GO:0030177; GO:0060670; GO:0090263; GO:2000052; GO:2000096 GKTCGFK 3.829999924 1 1 0.081564536 798.0075088 15.90248 0 10.62508 13.15671 0 14.64544 0 14.17429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.35534 0 0 0 0 15.28725 0 Q9BY12 SCAPE_HUMAN "S phase cyclin A-associated protein in the endoplasmic reticulum, S phase cyclin A-associated protein in the ER (Zinc finger protein 291)" SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0072520; GO:1990917 FPQQAWEEARQFFLK 5.480000019 0.364623427 0.364623427 0.109987908 1925.102343 17.02888 0 0 0 16.12192 0 0 0 17.10621 0 0 16.89998 0 0 0 0 0 16.68907 0 13.98087 0 16.49165 0 17.09365 0 0 14.30316 0 14.41713 0 17.20154 17.3278 14.81014 0 17.61214 0 0 0 17.2098 15.41426 13.43764 14.70139 0 0 11.49717 0 13.54716 15.97256 Q9BY15 AGRE3_HUMAN Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3) ADGRE3 EMR3 UNQ683/PRO1562 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0030667; GO:0101003 STGQGSQWSR 8.649999619 0.079187259 0.079187259 0.102482614 1093.964617 18.8547 16.4222 18.08272 16.439 0 12.45052 15.35668 0 0 0 0 0 0 18.15518 0 0 0 16.66735 15.72889 15.58531 16.05626 0 0 15.6431 10.91409 13.01008 14.00549 0 14.37008 0 17.57267 17.04204 0 12.74605 0 0 0 16.73592 17.49146 0 0 9.892998 10.61809 0 0 0 17.43609 0 Q9BY21 GPR87_HUMAN G-protein coupled receptor 87 (G-protein coupled receptor 95) GPR87 GPR95 FKSG78 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194] G protein-coupled purinergic nucleotide receptor activity [GO:0045028] GO:0005886; GO:0007186; GO:0007194; GO:0016021; GO:0045028 VVKPFGDSRMYSITFTK 14.76000023 1 1 0.535463122 1991.467495 21.0956 18.7754 0 19.31037 0 19.51314 19.91716 0 0 0 0 15.84121 0 0 17.80154 0 17.60723 0 0 0 18.97794 16.69857 18.61105 0 19.38062 18.2018 19.01996 19.17196 0 19.15978 19.35414 19.79065 19.14865 22.04194 0 20.52259 20.58831 20.33236 18.36544 20.81603 19.94443 17.62084 19.40672 18.22218 20.43156 18.60205 19.02787 0 Q9BY31 ZN717_HUMAN Zinc finger protein 717 (Krueppel-like factor X17) ZNF717 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 LFSYKSSLIIHQR 4.179999828 1 1 0.331332334 1590.660483 0 13.99185 14.91448 0 0 0 0 0 0 14.78439 0 0 16.24925 0 0 0 0 0 0 0 0 0 0 0 0 0 16.97926 15.1648 16.4996 0 16.69979 0 15.21404 0 13.87417 14.86319 0 0 15.98616 0 0 0 0 16.26103 17.11922 14.14233 0 0 Q9BY32 ITPA_HUMAN "Inosine triphosphate pyrophosphatase, ITPase, Inosine triphosphatase, EC 3.6.1.9 (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase, NTPase) (Putative oncogene protein hlc14-06-p)" ITPA C20orf37 My049 OK/SW-cl.9 Homo sapiens (Human) chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143] dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166] GO:0000166; GO:0005654; GO:0005737; GO:0005829; GO:0006193; GO:0009143; GO:0009204; GO:0035529; GO:0035870; GO:0036218; GO:0042802; GO:0043231; GO:0046872; GO:0047429; GO:0051276 MAASLVGKK 1.159999967 1 1 0 921.5008482 0 0 0 0 0 0 0 0 0 0 16.52721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5491 0 17.65562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY41 HDAC8_HUMAN "Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)" HDAC8 HDACL1 CDA07 Homo sapiens (Human) chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; sister chromatid cohesion [GO:0007062] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; sister chromatid cohesion [GO:0007062] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872] GO:0000118; GO:0000122; GO:0000228; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006333; GO:0006357; GO:0007062; GO:0030544; GO:0031397; GO:0031647; GO:0032204; GO:0046872; GO:0051879; GO:0071922; GO:0140297; GO:0160009 ASMVHSLIEAYALHK 3.5 1 1 0.051730003 1686.531976 16.25077 16.05534 17.28029 15.26766 16.71099 15.5464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.70438 0 0 0 0 0 Q9BY42 RTF2_HUMAN "Replication termination factor 2, RTF2 (Replication termination factor 2 domain-containing protein 1)" RTF2 C20orf43 RTFDC1 AD-007 CDA05 HSPC164 HSPC169 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752] nucleus [GO:0005634]; replication fork [GO:0005657] nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752] DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0005657; GO:0072711; GO:0097752; GO:1902979 TRMEER 7.960000038 1 1 0.151903321 821.4808596 16.0734 0 16.07925 15.55166 16.79008 15.43777 0 16.09545 15.43027 15.98864 0 0 0 0 15.42422 14.84622 0 16.24289 15.89605 0 17.38453 0 17.0005 0 0 16.08358 16.40773 16.1475 16.23097 15.41044 0 0 15.65488 0 14.62241 16.20721 0 17.89533 16.07599 16.36656 15.13365 16.44914 16.62994 15.80532 0 15.23421 14.97925 16.22626 Q9BY50 SC11C_HUMAN "Signal peptidase complex catalytic subunit SEC11C, EC 3.4.21.89 (Microsomal signal peptidase 21 kDa subunit, SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)" SEC11C SEC11L3 SPC21 SPCS4C Homo sapiens (Human) signal peptide processing [GO:0006465] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021 QLYYQVLNFAMIVSSALMIWK 8.729999542 1 1 0.232301129 2533.761464 0 16.488 0 0 0 16.31305 15.6431 16.74882 0 0 15.11819 16.18052 0 17.15458 0 0 0 16.10738 0 15.72795 0 14.67858 0 18.63164 0 0 0 14.68153 0 16.80957 0 19.97322 0 0 0 17.8273 0 17.953 0 0 0 0 17.42277 17.401 0 19.02849 17.54087 0 Q9BY66 KDM5D_HUMAN "Lysine-specific demethylase 5D, EC 1.14.11.67 (Histocompatibility Y antigen, H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)" KDM5D HY HYA JARID1D KIAA0234 SMCY Homo sapiens (Human) chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457] androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; metal ion binding [GO:0046872] GO:0001650; GO:0002457; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0046872; GO:0050681; GO:0060765 CILAECK 4.769999981 1 1 0.160783018 893.1242609 13.16806 0 0 0 0 0 0 0 0 16.7359 0 0 0 0 17.13934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY77 PDIP3_HUMAN "Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein, p46) (S6K1 Aly/REF-like target, SKAR)" POLDIP3 KIAA1649 PDIP46 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727] mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727 VTEEDIVELFCVCGALKR 2.400000095 0.924656451 0.924656451 4.58E-13 2142.087205 13.73733 13.25993 0 16.86187 12.81848 0 15.20623 13.62161 11.91396 0 13.19285 9.234415 0 0 15.20044 0 0 0 0 0 0 0 0 0 12.65609 14.7109 11.91481 12.68787 13.62743 0 0 0 0 0 14.10418 0 0 15.52816 0 15.43783 0 0 0 13.44529 0 0 10.98347 0 Q9BY78 RNF26_HUMAN "E3 ubiquitin-protein ligase RNF26, EC 2.3.2.27 (RING finger protein 26)" RNF26 Homo sapiens (Human) endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005789; GO:0006511; GO:0007032; GO:0008270; GO:0016021; GO:0016567; GO:0032479; GO:0050687; GO:0061630; GO:0070979; GO:1905719 TVLLLPCR 10.68999958 0.561867774 0.561867774 0.134097606 972.1711957 17.46401 13.73786 16.55041 16.24666 15.68079 14.65127 17.73337 12.65325 0 14.66683 15.24456 12.14526 10.66208 0 10.97638 16.79346 15.317 0 13.69754 17.4472 16.19842 17.46714 12.67989 16.67611 15.28553 17.17827 16.26275 15.70772 18.02719 0 18.97034 18.42539 16.75219 0 17.57681 16.52105 17.5003 17.38216 14.0602 0 16.0545 16.93393 14.72739 18.29607 14.34231 15.4184 0 16.0926 Q9BY89 K1671_HUMAN Uncharacterized protein KIAA1671 KIAA1671 Homo sapiens (Human) KCISLFR 12.28999996 1 1 0.226021863 924.1271986 15.58953 16.22368 13.5932 0 0 14.60787 14.79671 0 0 13.0191 0 15.33728 15.11391 15.75058 0 16.27351 0 15.59886 0 16.84945 0 0 0 0 0 14.46101 15.57925 14.37276 15.71777 14.19318 12.82024 13.54566 0 15.50067 15.71685 13.40446 14.78483 0 16.92856 15.50305 15.93794 14.78411 0 0 15.73412 0 13.40169 0 Q9BYB0 SHAN3_HUMAN "SH3 and multiple ankyrin repeat domains protein 3, Shank3 (Proline-rich synapse-associated protein 2, ProSAP2)" SHANK3 KIAA1650 PROSAP2 PSAP2 Homo sapiens (Human) "adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069] "ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" actin binding [GO:0003779]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160]; zinc ion binding [GO:0008270] GO:0000165; GO:0003779; GO:0005829; GO:0007416; GO:0007612; GO:0007613; GO:0008022; GO:0008270; GO:0014069; GO:0017124; GO:0021773; GO:0030160; GO:0030534; GO:0031234; GO:0032232; GO:0035176; GO:0035255; GO:0042297; GO:0043005; GO:0043197; GO:0043621; GO:0044309; GO:0045794; GO:0048170; GO:0048854; GO:0051835; GO:0051968; GO:0060170; GO:0060997; GO:0060999; GO:0061001; GO:0071625; GO:0097107; GO:0097110; GO:0097113; GO:0097114; GO:0097117; GO:1900271; GO:1900273; GO:1900451; GO:1900452; GO:2000463; GO:2000969 ETPSYAKR 9.380000114 1 1 0.241706771 952.0149727 14.64713 15.48471 16.97895 0 0 13.65028 17.05241 0 0 16.81163 15.8784 0 0 0 0 0 15.82293 0 14.78014 0 0 16.77967 0 17.10953 0 17.5304 0 18.09543 0 15.94731 0 0 0 0 18.16512 0 0 14.33852 0 0 0 14.51597 14.0358 0 0 0 0 16.83241 Q9BYC2 SCOT2_HUMAN "Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial, EC 2.8.3.5 (3-oxoacid CoA-transferase 2A) (Testis-specific succinyl-CoA:3-oxoacid CoA-transferase, SCOT-t)" OXCT2 FKSG25 Homo sapiens (Human) cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952] 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410] GO:0005739; GO:0005759; GO:0008260; GO:0008410; GO:0031514; GO:0046950; GO:0046952 AALRLLASVLGR 5.21999979 0.201072454 0.201072454 0.084136673 1240.028034 0 0 16.43688 15.20451 0 0 0 0 0 0 0 16.78758 15.90032 0 0 0 12.14643 0 0 0 13.57295 12.05558 0 0 17.01484 0 0 0 0 0 0 0 17.75404 15.47308 8.803907 0 0 0 0 12.93454 16.12579 0 13.93597 14.32136 15.6699 0 0 11.54191 Q9BYC5 FUT8_HUMAN "Alpha-(1,6)-fucosyltransferase, Alpha1-6FucT, EC 2.4.1.68 (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)" FUT8 Homo sapiens (Human) cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082] alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124] GO:0000139; GO:0001701; GO:0005794; GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0009312; GO:0010468; GO:0016020; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0019082; GO:0032580; GO:0033578; GO:0036071; GO:0042355; GO:0043112; GO:0046368; GO:0046921; GO:0070062; GO:1900407 EIEEATKK 3.039999962 1 1 0.21907328 945.9060087 0 13.27476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.76335 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYC9 RM20_HUMAN "39S ribosomal protein L20, mitochondrial, L20mt, MRP-L20 (Mitochondrial large ribosomal subunit protein bL20m)" MRPL20 Homo sapiens (Human) mitochondrial translation [GO:0032543]; ribosomal large subunit assembly [GO:0000027] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal large subunit assembly [GO:0000027] RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] GO:0000027; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0019843; GO:0032543 CTKAR 1.580000043 1 1 0.171108666 631.9035094 15.25219 0 16.14757 0 14.393 0 16.11528 14.87277 15.39152 12.79361 17.299 14.41363 0 0 0 0 0 0 0 0 0 0 16.93641 0 0 16.97076 0 0 0 0 0 16.90157 0 17.33986 0 0 0 0 0 0 0 0 16.56642 0 0 13.69381 0 0 Q9BYD1 RM13_HUMAN "39S ribosomal protein L13, mitochondrial, L13mt, MRP-L13 (Mitochondrial large ribosomal subunit protein uL13m)" MRPL13 Homo sapiens (Human) mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003729; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005840; GO:0006412; GO:0017148; GO:0032543 RTMMER 8.489999771 0.152769521 0.152769521 0.232369915 840.0406364 13.13656 0 12.54161 0 0 0 0 0 0 16.38582 0 13.87893 0 0 15.34733 0 16.09937 0 18.69893 0 16.11115 0 16.32031 17.10491 15.48106 14.02568 14.3788 14.91451 0 15.1682 18.02052 0 0 0 0 0 0 17.76611 0 0 0 16.62391 18.30806 0 0 16.97715 0 0 Q9BYD6 RM01_HUMAN "39S ribosomal protein L1, mitochondrial, L1mt, MRP-L1 (Mitochondrial large ribosomal subunit protein uL1m)" MRPL1 BM-022 Homo sapiens (Human) maturation of LSU-rRNA [GO:0000470]; mitochondrial translation [GO:0032543] cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762] cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0000470; GO:0003723; GO:0003735; GO:0005743; GO:0005762; GO:0022625; GO:0032543 IDPLLPK 1.450000048 0.296695113 0.296695113 0.047376741 796.6577718 18.39324 0 17.88527 15.52991 0 16.72301 16.60483 17.5373 0 0 16.75445 0 17.22685 14.53558 13.92186 0 11.55883 17.64527 17.07475 0 0 0 0 15.20477 18.44626 17.44545 16.64286 0 0 0 0 19.55168 0 18.73139 19.87556 0 0 0 0 17.161 0 0 0 16.04556 15.16388 0 14.72686 12.12866 Q9BYE2 TMPSD_HUMAN "Transmembrane protease serine 13, EC 3.4.21.- (Membrane-type mosaic serine protease, Mosaic serine protease)" TMPRSS13 MSP TMPRSS11 Homo sapiens (Human) blood microparticle [GO:0072562]; integral component of membrane [GO:0016021] blood microparticle [GO:0072562]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005044; GO:0016021; GO:0072562 SAPATRATR 11.27000046 0.471103489 0.471103489 0.154016059 931.8106107 14.65738 15.37023 14.37801 0 0 0 13.89089 15.40556 0 0 0 0 12.57606 16.97413 0 10.17004 15.51676 0 0 16.79717 0 13.39798 16.86447 16.02783 14.61516 16.09435 14.84503 12.66351 12.61782 14.47004 14.96447 16.28139 0 15.686 13.22619 14.39681 15.02425 16.03024 15.07598 13.21822 16.22669 14.21445 16.48875 16.06283 14.56347 14.97155 0 13.93148 Q9BYG0 B3GN5_HUMAN "Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase, EC 2.4.1.206 (Lactotriaosylceramide synthase, Lc(3)Cer synthase, Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5, BGnT-5, Beta-1,3-Gn-T5, Beta-1,3-N-acetylglucosaminyltransferase 5, Beta3Gn-T5)" B3GNT5 Homo sapiens (Human) brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]" "beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]" GO:0000139; GO:0006486; GO:0007417; GO:0007420; GO:0008457; GO:0008499; GO:0009247; GO:0016021; GO:0016266; GO:0016757; GO:0047256 NATDPK 10.52000046 1 1 0.125415498 645.9141339 0 19.84267 15.77469 0 0 15.19518 0 0 0 15.49536 15.48554 0 13.87067 12.35043 15.71858 0 11.70802 0 0 16.64533 17.6197 16.84713 15.83835 0 0 19.59645 15.06631 0 14.74223 0 0 0 0 0 0 16.15093 16.85267 15.88312 0 16.22873 0 0 0 17.95366 0 0 13.45101 16.29408 Q9BYG5 PAR6B_HUMAN "Partitioning defective 6 homolog beta, PAR-6 beta, PAR-6B" PARD6B PAR6B Homo sapiens (Human) axonogenesis [GO:0007409]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341] protein kinase C binding [GO:0005080] GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007043; GO:0007098; GO:0007163; GO:0007409; GO:0016324; GO:0030334; GO:0032991; GO:0051301; GO:0060341; GO:0065003; GO:0070062; GO:0070160 IFIQKK 5.769999981 0.08803267 0.08803267 0.249120514 775.9896535 17.99671 18.04521 0 0 0 0 0 18.40521 18.17091 17.06947 0 0 0 0 18.20161 18.14891 18.05744 0 0 0 0 17.95311 0 17.21456 18.39204 0 0 0 0 0 0 0 0 18.04948 0 0 0 0 0 0 0 17.45012 0 0 0 17.67769 0 0 Q9BYG7 MSTRO_HUMAN Protein maestro (Male-specific transcription in the developing reproductive organs) (Protein B29) MRO B29 C18orf3 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730] GO:0005730 GLGSFFIDITLQTRTLLDDENDSLR 7.78000021 1 1 0.211550996 2839.963931 15.6571 12.47379 0 15.32067 13.10645 14.53377 0 11.69085 0 13.80048 0 0 15.07672 0 0 0 13.96739 0 0 0 0 0 0 14.44996 0 0 0 0 0 0 0 0 0 0 0 13.70347 0 0 0 0 0 0 0 0 0 13.96838 15.4224 0 Q9BYG8 GSDMC_HUMAN "Gasdermin-C (Melanoma-derived leucine zipper-containing extranuclear factor) [Cleaved into: Gasdermin-C, N-terminal, GSDMC-NT; Gasdermin-C, C-terminal, GSDMC-CT ]" GSDMC MLZE Homo sapiens (Human) defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]" "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]" GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0016021; GO:0042742; GO:0070269; GO:0070273 MPSMLERISK 8.550000191 0.165579632 0.165579632 0.126467769 1190.770468 11.4787 15.14026 0 14.14173 15.93246 12.44952 0 0 0 15.41625 0 0 0 0 0 11.92121 0 17.02592 15.02334 13.96224 17.5401 11.52266 0 0 12.92964 17.397 10.47651 0 0 16.5161 0 0 0 0 0 0 11.84335 17.515 0 18.48139 16.34167 17.62786 13.73123 0 0 18.63242 18.14025 13.91118 Q9BYH8 IKBZ_HUMAN "NF-kappa-B inhibitor zeta (I-kappa-B-zeta, IkB-zeta, IkappaBzeta) (IL-1 inducible nuclear ankyrin-repeat protein, INAP) (Molecule possessing ankyrin repeats induced by lipopolysaccharide, MAIL)" NFKBIZ IKBZ INAP MAIL Homo sapiens (Human) inflammatory response [GO:0006954]; positive regulation of inflammatory response [GO:0050729]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; inflammatory response [GO:0006954]; positive regulation of inflammatory response [GO:0050729]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852] GO:0005634; GO:0006954; GO:0010468; GO:0016607; GO:0036464; GO:0050729; GO:0050852; GO:2000321 CLIQMGAAVEAK 8.430000305 0.635154545 0.635154545 0.308943775 1288.402768 15.40938 15.0025 14.78221 0 0 0 0 0 0 0 15.07651 0 0 0 12.05501 15.17224 15.48207 0 0 0 0 0 0 0 0 15.15905 0 14.93391 12.39917 13.74913 12.46514 0 15.48321 16.94533 15.61178 15.83782 15.677 15.58778 0 0 16.0772 16.66718 0 15.05515 0 17.5754 0 0 Q9BYJ0 FGFP2_HUMAN "Fibroblast growth factor-binding protein 2, FGF-BP2, FGF-binding protein 2, FGFBP-2 (37 kDa killer-specific secretory protein, Ksp37) (HBp17-related protein, HBp17-RP)" FGFBP2 KSP37 UNQ425/PRO1065 Homo sapiens (Human) cell-cell signaling [GO:0007267] extracellular space [GO:0005615] extracellular space [GO:0005615]; growth factor binding [GO:0019838]; cell-cell signaling [GO:0007267] growth factor binding [GO:0019838] GO:0005615; GO:0007267; GO:0019838 GSPEPNQQPEAGTPSLRPK 3.75999999 1 1 0.19532372 1989.510049 0 12.91994 15.57769 0 0 15.47359 0 0 0 0 0 0 0 0 0 0 14.10053 0 0 0 0 0 16.45749 15.69648 14.66751 0 15.8754 17.96504 0 0 0 0 16.57434 0 0 0 0 0 0 0 0 0 0 0 17.19906 0 0 0 Q9BYJ4 TRI34_HUMAN Tripartite motif-containing protein 34 (Interferon-responsive finger protein 1) (RING finger protein 21) TRIM34 IFP1 RNF21 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051091; GO:0051092; GO:0051607; GO:0061630 FAEAEDELVQQKQLVR 5.46999979 0.686119378 0.686119378 0.098853292 1904.259237 0 15.36695 15.77985 12.93776 14.38843 0 0 15.88463 0 0 0 0 0 14.85896 14.44178 15.88176 0 0 0 0 16.73299 0 15.27819 0 17.23951 17.0874 0 0 14.37983 15.57683 0 15.77313 0 0 16.92814 0 0 0 0 0 18.779 0 0 0 16.79818 0 18.36033 18.76764 Q9BYJ9 YTHD1_HUMAN "YTH domain-containing family protein 1, DF1 (Dermatomyositis associated with cancer putative autoantigen 1, DACA-1)" YTHDF1 C20orf21 Homo sapiens (Human) immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063] mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] GO:0000932; GO:0002376; GO:0002577; GO:0003723; GO:0003729; GO:0005737; GO:0007612; GO:0007613; GO:0010494; GO:0034063; GO:0043022; GO:0043488; GO:0045727; GO:0045948; GO:0061157; GO:0070925; GO:1900271; GO:1902667; GO:1990247 QVLKIISSYK 7.849999905 1 1 0.346703677 1177.755675 0 14.85324 0 0 0 0 0 0 0 0 0 0 16.57034 15.71668 15.6415 0 0 16.38021 0 16.50726 0 0 0 0 0 0 13.48159 0 15.09355 0 16.84681 0 0 16.46418 14.60581 0 15.82128 15.68697 17.61826 14.52513 0 17.23559 14.98876 15.68516 15.34294 0 0 16.43312 Q9BYK8 HELZ2_HUMAN "Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1, PDIP1, PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein, EC 3.6.4.-)" HELZ2 KIAA1769 PRIC285 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]" cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]" ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0030374; GO:0045944; GO:0046872 LHLLASLWK 6 1 1 0.41941486 1081.796062 0 0 0 19.14285 0 0 0 0 16.57394 18.04188 18.46034 0 0 0 0 0 0 0 0 0 0 0 0 16.77711 18.88531 19.1414 0 0 17.84752 0 18.14883 0 0 0 0 18.88495 0 19.51172 0 0 0 0 0 0 17.55738 0 0 0 Q9BYN7 ZN341_HUMAN Zinc finger protein 341 ZNF341 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872 RAHLAEHQR 1.429999948 1 1 0.13236683 1118.785109 0 0 0 15.40281 0 12.63913 0 14.91808 14.37929 0 0 0 0 15.41781 0 11.89339 0 13.6121 0 0 0 0 0 0 0 0 0 12.00563 15.22009 0 0 15.77684 14.59691 0 0 14.31053 0 0 13.63362 0 0 0 0 0 0 0 0 14.1388 Q9BYN8 RT26_HUMAN "28S ribosomal protein S26, mitochondrial, MRP-S26, S26mt (28S ribosomal protein S13, mitochondrial, MRP-S13, S13mt) (Mitochondrial small ribosomal subunit protein mS26)" MRPS26 C20orf193 RPMS13 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543 VNMPPAVDPAEFFVLMER 4.010000229 0.341480553 0.341480553 0.243626514 2078.597853 0 0 12.07629 0 0 14.38776 0 0 14.56423 0 0 14.55378 15.46033 14.44391 15.92816 15.06716 14.97388 14.23832 16.43282 17.03893 0 15.47374 14.29586 0 0 0 0 0 0 0 13.72587 10.70544 14.40589 0 13.2184 15.55537 18.11551 0 0 0 0 0 0 0 0 0 0 18.31601 Q9BYP7 WNK3_HUMAN "Serine/threonine-protein kinase WNK3, EC 2.7.11.1 (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3)" WNK3 KIAA1566 PRKWNK3 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062] ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0006884; GO:0007231; GO:0010765; GO:0010766; GO:0010800; GO:0018107; GO:0019869; GO:0019870; GO:0032414; GO:0035556; GO:0035633; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090279; GO:0106310; GO:1903078; GO:1903288; GO:1904062; GO:2000651 FCINQTIR 3.720000029 1 1 0.071127638 1051.369899 0 13.90896 15.38979 0 16.87597 0 0 12.84058 15.49918 0 0 0 0 16.1342 14.07029 0 0 0 0 0 13.92645 0 0 0 0 16.33768 0 0 13.5826 14.94504 0 0 16.11915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYR6 KRA33_HUMAN Keratin-associated protein 3-3 (High sulfur keratin-associated protein 3.3) (Keratin-associated protein 3.3) KRTAP3-3 KAP3.3 KRTAP3.3 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0045095 MDCCASRGCSVPTGPATTICSSDK 2.900000095 1 1 0.184461244 2634.10437 0 13.85688 11.34901 0 0 0 0 16.44075 0 13.97296 0 0 10.61118 0 0 0 0 0 15.54723 0 0 0 0 0 15.45784 0 15.87374 0 0 0 0 18.23234 0 0 0 0 16.18275 0 0 0 0 12.42952 15.73736 0 0 0 0 0 Q9BYR7 KRA32_HUMAN Keratin-associated protein 3-2 (High sulfur keratin-associated protein 3.2) (Keratin-associated protein 3.2) KRTAP3-2 KAP3.2 KRTAP3.2 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0045095 DCCASR 3 0.511363804 0.511363804 0.239161131 768.3244212 15.68533 15.63985 0 0 15.26413 14.89088 15.37126 0 15.40976 16.33777 16.29554 0 15.30512 0 15.75502 0 15.91347 15.92068 16.31578 16.79314 16.56619 15.95143 16.04906 15.86592 0 16.33894 17.29892 14.98931 15.03357 16.0313 0 16.75281 16.11029 16.80022 0 16.4199 16.85515 0 16.4737 15.19102 16.68367 17.23711 15.48054 15.11664 17.5269 16.7758 15.63382 16.38385 Q9BYS8 LRRC2_HUMAN Leucine-rich repeat-containing protein 2 LRRC2 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005737; GO:0007165; GO:0043231 FVSLMDNPIDNAQCEDGNEIMESERDR 3.849999905 0.288506359 0.288506359 4.11E-12 3201.221698 14.79764 10.82165 0 13.66082 14.54744 13.95566 14.61766 16.28405 15.11657 0 9.794621 13.64139 0 0 12.81996 0 14.85469 14.87114 0 0 14.7872 0 0 11.76768 0 15.08987 14.88822 0 13.8757 0 0 13.94958 14.28734 0 13.70278 0 0 0 0 0 0 0 0 0 0 0 0 14.56272 Q9BYT1 S17A9_HUMAN Solute carrier family 17 member 9 SLC17A9 C20orf59 Homo sapiens (Human) ADP transport [GO:0015866]; ATP export [GO:1904669]; ATP transport [GO:0015867]; exocytosis [GO:0006887]; guanine nucleotide transmembrane transport [GO:1903790] chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021] chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; guanine nucleotide transmembrane transporter activity [GO:0001409]; ADP transport [GO:0015866]; ATP export [GO:1904669]; ATP transport [GO:0015867]; exocytosis [GO:0006887]; guanine nucleotide transmembrane transport [GO:1903790] ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; guanine nucleotide transmembrane transporter activity [GO:0001409] GO:0001409; GO:0005347; GO:0006887; GO:0015217; GO:0015866; GO:0015867; GO:0016021; GO:0042584; GO:1903790; GO:1904669 SSMPICTVSMSQDFGWNKK 9.210000038 0.801959813 0.801959813 0.045333211 2218.313073 0 0 0 0 11.60526 0 0 0 0 0 0 16.51048 0 0 0 13.51375 14.3936 0 0 0 0 0 0 0 0 15.68976 13.70205 15.46499 0 0 0 0 0 0 0 0 0 13.42558 0 0 0 0 0 14.8515 0 0 0 0 Q9BYT3 STK33_HUMAN "Serine/threonine-protein kinase 33, EC 2.7.11.1" STK33 Homo sapiens (Human) mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0044773; GO:0046777; GO:0048471; GO:0106310 YPAKSGALSR 2.660000086 1 1 0.230733542 1050.89214 0 0 0 0 0 0 18.77273 0 0 0 0 0 18.82064 0 0 0 17.79017 0 0 0 16.75844 0 0 0 17.14222 0 0 0 0 0 18.42912 0 0 0 0 0 0 0 0 16.55214 0 0 16.55899 0 16.61317 0 0 0 Q9BYT8 NEUL_HUMAN "Neurolysin, mitochondrial, EC 3.4.24.16 (Angiotensin-binding protein) (Microsomal endopeptidase, MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)" NLN AGTBP KIAA1226 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; regulation of gluconeogenesis [GO:0006111]; regulation of skeletal muscle fiber differentiation [GO:1902809] extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; regulation of gluconeogenesis [GO:0006111]; regulation of skeletal muscle fiber differentiation [GO:1902809] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277] GO:0004222; GO:0005576; GO:0005758; GO:0005886; GO:0006111; GO:0006508; GO:0006518; GO:0007186; GO:0042277; GO:0046872; GO:1902809 EGIMNPEVGMK 5.010000229 1 1 0.198107613 1219.908974 14.84043 12.16696 14.16129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.54825 0 0 0 14.72659 15.14354 0 0 15.0584 16.7508 15.198 0 17.37044 0 0 15.81684 0 0 0 0 0 0 0 0 Q9BYT9 ANO3_HUMAN Anoctamin-3 (Transmembrane protein 16C) ANO3 C11orf25 TMEM16C GENX-3947 Homo sapiens (Human) calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] GO:0005229; GO:0005254; GO:0005886; GO:0016021; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0055085; GO:0061590; GO:0061591; GO:1902476 GLHDR 10.10999966 1 1 0.28028734 597.2806228 0 0 16.79433 0 0 17.18293 0 0 16.97709 0 0 17.92311 17.6489 0 17.069 0 17.73268 0 0 0 16.86249 18.30298 18.52481 0 0 18.20247 0 0 0 0 0 0 0 17.96444 0 0 0 0 18.76934 0 17.14989 0 0 0 17.86332 0 0 18.03116 Q9BYU1 PBX4_HUMAN Pre-B-cell leukemia transcription factor 4 (Homeobox protein PBX4) PBX4 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741] "chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0001741; GO:0005634; GO:0006357; GO:0007420; GO:0009887; GO:0043565; GO:0045893; GO:0048568; GO:0048666 AAPPRPAPSPPAPRR 2.720000029 1 1 0.103256059 1536.694454 0 0 0 0 0 0 14.37024 0 11.7974 13.95896 0 0 13.80139 0 0 0 0 0 0 0 0 0 0 0 16.33695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYV2 TRI54_HUMAN "Tripartite motif-containing protein 54 (Muscle-specific RING finger protein, MuRF) (Muscle-specific RING finger protein 3, MuRF-3, MuRF3) (RING finger protein 30)" TRIM54 MURF MURF3 RNF30 Homo sapiens (Human) cell differentiation [GO:0030154]; microtubule-based process [GO:0007017]; negative regulation of microtubule depolymerization [GO:0007026]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; Z disc [GO:0030018] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; Z disc [GO:0030018]; microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; microtubule-based process [GO:0007017]; negative regulation of microtubule depolymerization [GO:0007026]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005737; GO:0005874; GO:0005875; GO:0007017; GO:0007026; GO:0007165; GO:0008017; GO:0008270; GO:0016567; GO:0030018; GO:0030154; GO:0061630 GELLQALAR 8.069999695 0.129575863 0.129575863 0.267929761 968.9859649 15.57684 16.7139 15.49539 15.3572 14.61015 16.29078 14.98855 0 17.05927 16.17315 13.91817 13.92471 16.17804 13.66506 0 15.68063 12.21837 0 15.24944 14.88066 14.75855 0 0 16.56941 0 0 16.37157 0 0 15.08473 0 0 17.21306 0 14.14936 15.41968 16.13081 0 0 17.79446 0 0 14.46406 16.05954 0 0 0 17.00395 Q9BYV6 TRI55_HUMAN "Tripartite motif-containing protein 55 (Muscle-specific RING finger protein 2, MuRF-2, MuRF2) (RING finger protein 29)" TRIM55 MURF2 RNF29 Homo sapiens (Human) diapedesis [GO:0050904]; leukocyte migration involved in inflammatory response [GO:0002523]; macrophage migration [GO:1905517]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; diapedesis [GO:0050904]; leukocyte migration involved in inflammatory response [GO:0002523]; macrophage migration [GO:1905517]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0002523; GO:0005634; GO:0005737; GO:0005874; GO:0007165; GO:0008270; GO:0016567; GO:0042802; GO:0050904; GO:0061630; GO:1905517 SDQPMCEEHEEER 7.300000191 1 1 0.362754211 1691.92626 0 17.11849 13.11431 0 0 14.1285 16.64462 14.33119 0 0 0 12.88201 0 0 0 0 0 0 0 0 0 0 0 17.21244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22202 0 0 0 0 0 0 0 0 0 Q9BYV9 BACH2_HUMAN Transcription regulator protein BACH2 (BTB and CNC homolog 2) BACH2 Homo sapiens (Human) import into nucleus [GO:0051170]; primary adaptive immune response involving T cells and B cells [GO:0090721]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; import into nucleus [GO:0051170]; primary adaptive immune response involving T cells and B cells [GO:0090721]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0051170; GO:0090575; GO:0090721; GO:1990837 NDFQMMIK 12.14999962 1 1 0.395420125 1041.370543 0 15.91742 16.06199 16.58322 14.90219 15.73133 0 0 15.62025 16.82557 16.4771 16.59506 15.34403 0 0 16.55318 0 0 0 0 0 0 0 0 0 16.65519 14.40952 16.55223 0 15.36263 16.0415 16.76512 0 0 0 0 0 0 17.34324 0 16.07707 0 0 0 15.46362 17.01446 0 0 Q9BYW2 SETD2_HUMAN "Histone-lysine N-methyltransferase SETD2, EC 2.1.1.359 (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1, HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2, EC 2.1.1.-) (SET domain-containing protein 2, hSET2) (p231HBP)" SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]" alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279] GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634 LQSVVVVPK 4.309999943 1 1 0.203442128 968.8596182 15.71224 14.81136 0 0 0 0 12.65628 11.95984 14.67225 15.67411 0 0 0 15.91885 14.67736 0 0 15.85318 0 0 0 16.85157 0 17.98215 0 0 16.69241 0 0 0 0 0 17.35312 0 15.94913 0 17.16036 0 16.06934 17.81912 0 0 0 0 0 0 0 0 Q9BYX2 TBD2A_HUMAN "TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1, PARIS-1)" TBC1D2 PARIS1 PP8997 TBC1D2A Homo sapiens (Human) activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547] cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547] cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096] GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0030054; GO:0031410; GO:0043547; GO:0045296; GO:0090630 MEGAGENAPESSSSAPGSEESAR 3.960000038 1 1 0.108184567 2253.364559 14.16439 13.28568 14.89367 14.78663 12.10472 14.39267 15.47047 0 0 0 0 0 13.65513 0 0 12.91601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.77771 15.1764 12.04876 0 0 12.85244 0 0 0 Q9BYX4 IFIH1_HUMAN "Interferon-induced helicase C domain-containing protein 1, EC 3.6.4.13 (Clinically amyopathic dermatomyositis autoantigen 140 kDa, CADM-140 autoantigen) (Helicase with 2 CARD domains, Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5, MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2, RLR-2) (RNA helicase-DEAD box protein 116)" IFIH1 MDA5 RH116 Homo sapiens (Human) cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0039528; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051607; GO:0060760; GO:0071360; GO:0098586 IAAAENNGNESGVR 7.579999924 0.398094296 0.398094296 0.141830504 1401.329652 17.59407 16.92676 15.96128 0 0 0 16.40933 17.43552 17.70935 0 17.41675 17.23427 16.36767 17.2873 14.40793 12.96603 0 0 15.53313 0 0 0 0 0 17.06517 15.99897 16.73993 12.92045 0 0 0 19.32111 11.70379 17.60519 16.93551 0 14.52672 11.82465 0 16.38371 15.97501 0 10.95133 18.6476 16.34325 15.03675 0 15.73096 Q9BZ19 ANR60_HUMAN Ankyrin repeat domain-containing protein 60 ANKRD60 C20orf86 Homo sapiens (Human) MTMTPH 11.27000046 0.360418677 0.360418677 0.119564224 733.2636525 17.43927 0 0 0 0 0 0 0 15.31668 0 13.94001 0 0 17.9484 0 14.88451 0 0 17.57132 16.50616 0 0 16.45096 16.7186 18.12055 17.75834 16.40307 0 0 0 12.72778 16.56039 0 0 0 17.03846 0 14.95022 0 15.88546 0 14.0711 0 13.69441 0 0 11.87116 0 Q9BZ29 DOCK9_HUMAN "Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1, Zizimin-1)" DOCK9 KIAA1058 ZIZ1 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0043547; GO:0045296 QGCTAFR 6.909999847 0.262567699 0.262567699 0.214328934 838.6076853 14.89222 15.86594 10.54986 15.92227 12.49074 15.10404 13.82128 0 0 16.03801 16.88563 15.81754 15.03654 0 15.27105 15.01694 15.39815 13.26712 17.25804 13.08716 15.05233 15.78323 15.41286 16.74427 14.88979 16.41138 14.75611 12.82903 0 0 0 0 0 15.12639 0 0 0 0 15.56597 15.82307 0 15.37236 15.37825 14.97546 0 15.52708 0 15.04029 Q9BZ68 FR8P1_HUMAN Putative FERM domain-containing protein FRMD8P1 (FERM domain-containing 8 pseudogene 1) FRMD8P1 FKSG43 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090] cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090] GO:0005856; GO:0005886; GO:0090090 DSGVTPVNKLLK 11.01000023 1 1 0.494790956 1270.934663 0 0 0 14.25621 13.99058 15.20604 0 0 0 15.81064 0 0 0 14.84437 15.90059 15.06259 15.17097 0 0 0 0 0 15.99424 0 0 0 0 16.62416 16.34208 0 0 0 0 0 16.33458 0 0 17.31267 0 16.54126 0 16.4915 17.21999 0 0 0 0 0 Q9BZ71 PITM3_HUMAN "Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3, PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1, NIR-1)" PITPNM3 NIR1 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661] cell body [GO:0044297]; cell projection [GO:0042995]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cell body [GO:0044297]; cell projection [GO:0042995]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol biosynthetic process [GO:0006661] calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971] GO:0004620; GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008289; GO:0008526; GO:0012505; GO:0016020; GO:0030134; GO:0030971; GO:0042995; GO:0044297 DSPPLLDAPASPPQASR 1.909999967 1 1 0.207138165 1718.138094 0 0 0 0 0 0 16.57747 0 16.92117 17.89757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.74617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ72 PITM2_HUMAN "Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2, PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3, NIR-3)" PITPNM2 KIAA1457 NIR3 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015] calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091; GO:0048015 TQSQADGEQR 4.760000229 1 1 0.317797409 1120.681347 13.82766 0 0 0 0 0 0 0 0 0 15.89881 0 15.34626 0 11.8201 0 0 16.49106 16.06743 0 15.82087 0 15.58615 15.1487 0 0 0 0 0 0 0 0 0 0 0 0 14.9634 0 0 0 0 0 0 0 0 0 14.0441 0 Q9BZ76 CNTP3_HUMAN Contactin-associated protein-like 3 (Cell recognition molecule Caspr3) CNTNAP3 CASPR3 KIAA1714 Homo sapiens (Human) cell adhesion [GO:0007155]; cell recognition [GO:0008037] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell recognition [GO:0008037] GO:0005576; GO:0005886; GO:0007155; GO:0008037; GO:0016021 INREEAVVMVEVNQSTK 17.44000053 0.299618125 0.299618125 0.027685768 1945.962973 0 0 15.30133 0 14.60544 0 13.17537 12.17005 14.47115 12.7309 14.04089 15.39255 15.5125 13.00795 12.88662 19.79235 10.74278 14.74725 17.7369 12.58523 15.57922 15.67207 12.41834 0 16.22997 0 0 14.36584 0 16.20968 14.50061 14.03587 15.06048 14.17141 16.19846 14.47964 16.59644 17.15589 17.84064 0 10.81031 0 16.01662 0 0 0 0 0 Q9BZ81 MAGB5_HUMAN "Melanoma-associated antigen B5 (Cancer/testis antigen 3.3, CT3.3) (MAGE-B5 antigen)" MAGEB5 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 FSSFSQPY 4.889999866 0.659533203 0.659533203 0.217336586 961.7384038 0 0 15.55457 0 0 0 0 0 0 0 15.54107 9.458288 0 0 12.10882 0 0 0 0 0 11.11651 15.57649 0 0 0 0 0 0 15.63955 18.10306 0 0 17.01753 0 0 0 15.22427 0 0 0 0 0 0 0 16.31056 0 0 0 Q9BZ95 NSD3_HUMAN "Histone-lysine N-methyltransferase NSD3, EC 2.1.1.370, EC 2.1.1.371 (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1, WHSC1-like protein 1)" NSD3 WHSC1L1 DC28 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone methylation [GO:0016571]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537]; chromatin organization [GO:0006325]; histone methylation [GO:0016571]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537] GO:0000785; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016571; GO:0018024; GO:0045893; GO:0046872; GO:0046975; GO:0140537; GO:2001255 QIVWVKLGNYR 6.119999886 0.746450663 0.746450663 0.262450945 1376.089039 14.3947 0 0 0 14.70059 0 0 0 14.01101 0 0 0 13.57687 0 15.29863 14.16454 16.02346 14.45849 0 15.70531 0 0 0 0 0 14.73975 0 0 0 0 14.94177 0 0 0 16.35973 0 15.17259 14.21463 15.89981 15.84414 0 0 16.25662 16.01081 14.83993 12.69299 15.09018 15.59484 Q9BZA8 PC11Y_HUMAN "Protocadherin-11 Y-linked, Protocadherin-11 (Protocadherin on the Y chromosome, PCDH-Y) (Protocadherin prostate cancer, Protocadherin-PC) (Protocadherin-22)" PCDH11Y PCDH11 PCDH22 PCDHY Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283] integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225] integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007283; GO:0030177; GO:0061827; GO:0097225 NMQNSEWATPNPENR 2.779999971 1 1 0.376479024 1804.375528 15.21413 0 0 0 15.42855 0 0 15.73403 0 0 0 0 0 16.62266 0 15.98871 0 15.22176 0 16.97508 0 0 0 0 0 0 14.67782 15.87217 0 13.08946 0 0 15.24845 11.93555 13.36058 0 16.28959 0 0 10.55647 11.51993 15.04088 0 0 0 0 16.73765 0 Q9BZD4 NUF2_HUMAN "Kinetochore protein Nuf2, hNuf2, hNuf2R, hsNuf2 (Cell division cycle-associated protein 1)" NUF2 CDCA1 NUF2R Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052] "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]" protein-containing complex binding [GO:0044877] GO:0000775; GO:0000776; GO:0005654; GO:0005829; GO:0007052; GO:0007059; GO:0007094; GO:0008608; GO:0016020; GO:0031262; GO:0031617; GO:0044877; GO:0045132; GO:0051301; GO:0051315; GO:0051383 IVDSPEKLK 6.739999771 0.871160686 0.871160686 0.237257151 1027.55078 0 16.76309 17.2783 13.45935 14.44261 15.98661 0 0 16.33796 17.59117 0 0 13.79362 0 16.25751 17.00631 0 0 14.61168 14.6127 0 0 14.94994 15.51172 0 16.91451 0 15.01469 0 0 0 15.35211 15.31027 14.28989 0 0 16.53332 0 17.04679 0 0 0 0 16.51923 16.84043 0 17.73716 15.14733 Q9BZE0 GLIS2_HUMAN Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) GLIS2 NKL Homo sapiens (Human) "cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in kidney development [GO:0060994]" cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in kidney development [GO:0060994]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007417; GO:0016607; GO:0043433; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0060994; GO:0061005; GO:0061484; GO:0097730; GO:1900182; GO:1990837 YSNSSDR 10.39000034 4.92E-06 4.92E-06 0.227969596 829.1059188 18.565 19.15961 17.68074 16.14001 0 16.32834 18.75474 17.29023 0 16.97449 17.6968 16.85105 0 0 0 18.53204 0 17.7306 0 17.54643 0 0 18.48916 0 17.1207 0 0 0 0 17.29824 18.31715 17.3391 0 0 18.593 16.33351 17.86321 0 0 16.55527 0 0 18.28273 16.89499 16.95247 16.86691 0 17.38506 Q9BZE1 RM37_HUMAN "39S ribosomal protein L37, mitochondrial, L37mt, MRP-L37 (39S ribosomal protein L2, mitochondrial, L2mt, MRP-L2) (Mitochondrial large ribosomal subunit protein mL37)" MRPL37 MRPL2 RPML2 HSPC235 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 LIEGLPEK 31.30999947 0.012489175 0.012489175 0.13385921 898.5100558 17.89804 17.5968 20.45692 13.69515 18.62366 17.85242 17.25886 19.49377 18.16353 19.52041 19.53728 18.7021 18.86353 17.38105 19.3656 0 0 17.70651 19.5757 20.48758 17.33955 0 17.76438 19.04164 0 18.16412 17.96286 19.83149 16.6 18.51022 0 18.25235 18.21078 18.54188 17.77496 18.24788 19.04797 17.03989 0 19.089 18.05242 19.30525 20.07911 19.28094 17.61366 18.68851 19.10295 0 Q9BZE4 GTPB4_HUMAN GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1) GTPBP4 CRFG NOG1 Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723] GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821 GEADR 16.10000038 0.445928246 0.445928246 0.238450837 547.5096041 17.44601 16.42754 16.6904 0 0 16.67052 16.72844 17.06077 16.18236 0 16.51825 16.0696 15.85257 0 17.53949 16.09987 17.04557 16.53094 16.54132 16.29815 17.00121 0 16.57098 16.58653 17.48125 0 16.81026 17.04648 16.24238 16.55807 17.21529 16.86085 16.19155 16.76685 0 0 16.84234 17.54891 0 0 15.98048 17.1199 0 16.42101 17.64205 16.88948 0 17.79983 Q9BZE7 EVG1_HUMAN UPF0193 protein EVG1 C22orf23 Homo sapiens (Human) HIMDIMKR 3 1 1 2.32E-13 1061.109997 0 16.24747 0 12.38917 0 0 12.43222 12.80156 13.77384 0 14.30109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZF1 OSBL8_HUMAN "Oxysterol-binding protein-related protein 8, ORP-8, OSBP-related protein 8" OSBPL8 KIAA1451 ORP8 OSBP10 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204] cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965] cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204] cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343 WYLSGFYK 6.449999809 1 1 0.214044296 1066.775365 0 0 0 13.42615 14.79004 15.34206 10.46135 0 0 0 0 13.71365 0 0 0 14.36029 0 0 0 0 14.63022 0 0 0 13.24727 13.86578 15.73783 15.27798 16.28914 14.52461 14.79377 16.10312 15.1194 13.42516 14.1337 14.07741 0 16.0633 14.84373 16.48408 0 0 14.89942 0 16.71206 0 0 16.14254 Q9BZF9 UACA_HUMAN Uveal autoantigen with coiled-coil domains and ankyrin repeats UACA KIAA1561 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic signaling pathway [GO:0097190]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0043280; GO:0070062; GO:0097190; GO:1901223 IQESAK 14.48999977 0.030028956 0.030028956 0.260848985 674.1764753 0 0 17.27713 15.4346 0 0 0 0 0 0 0 16.39555 0 16.07861 0 0 0 0 0 0 17.53287 0 0 0 0 0 0 17.21726 15.94519 15.20468 17.28943 0 16.90639 16.64377 0 0 17.60902 0 0 18.22698 16.02289 16.22091 17.19464 16.9836 17.53427 17.17548 17.58638 16.27063 Q9BZH6 WDR11_HUMAN WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15) WDR11 BRWD2 KIAA1351 WDR15 Homo sapiens (Human) cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005829; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 ACLVTTVTSSGPSQSTIK 6.519999981 1 1 0.033678909 1836.263122 15.07296 13.29732 0 0 14.92672 0 0 12.52514 0 14.38652 0 14.76401 0 0 0 0 0 0 0 13.0075 0 0 13.45602 0 0 0 14.68563 14.78394 0 0 0 0 0 0 16.7171 0 0 0 0 0 15.0838 0 13.34426 0 0 0 0 0 Q9BZJ0 CRNL1_HUMAN "Crooked neck-like protein 1 (Crooked neck homolog, hCrn)" CRNKL1 CRN CGI-201 MSTP021 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]" RNA binding [GO:0003723] GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014 AITTLPR 4.590000153 0.370510697 0.370510697 0.249831431 771.2295934 0 15.64103 15.25566 14.43481 13.87263 14.56427 12.37451 15.2938 16.16392 15.65602 15.07154 14.75009 15.61189 14.26183 13.78571 16.02108 15.45929 15.67371 16.1816 14.54411 15.27874 16.79194 0 0 0 13.80683 15.57911 0 14.58368 16.65832 15.03512 0 0 0 0 16.16814 15.64943 16.98987 15.87073 15.88254 16.7095 15.08548 15.90118 0 15.89058 0 16.83551 0 Q9BZJ4 S2539_HUMAN Probable mitochondrial glutathione transporter SLC25A39 (Solute carrier family 25 member 39) SLC25A39 CGI-69 PRO2163 Homo sapiens (Human) heme biosynthetic process [GO:0006783]; mitochondrial transmembrane transport [GO:1990542] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; heme biosynthetic process [GO:0006783]; mitochondrial transmembrane transport [GO:1990542] GO:0005743; GO:0006783; GO:0016021; GO:1990542 LQSQRPSMASELMPSSR 1.320000052 1 1 6.93E-13 1922.822938 11.7796 0 0 14.95051 0 0 0 13.45876 0 0 15.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.96478 15.51614 0 0 0 0 0 0 Q9BZJ6 GPR63_HUMAN Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta) GPR63 PSP24B Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0016021; GO:0043235 LGLMSLQRPFQMSIDMGFK 1.460000038 1 1 0.208023314 2215.226372 0 14.55236 11.78604 12.83725 0 7.750369 0 14.2973 0 13.34631 0 12.28679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.43916 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZL6 KPCD2_HUMAN "Serine/threonine-protein kinase D2, EC 2.7.11.13 (nPKC-D2)" PRKD2 PKD2 HSPC187 Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:0106310; GO:1901727; GO:1902533; GO:2000573; GO:2001028 GRLPER 4.690000057 1 1 0.182258799 727.7253542 0 13.66067 15.44444 0 0 15.09565 14.24901 15.97587 0 14.97423 12.6473 0 15.7578 14.132 0 14.1195 14.01149 14.85736 0 15.28389 0 14.72261 0 14.55238 0 0 0 0 0 16.12156 0 0 0 0 0 0 16.53109 0 0 16.06034 0 0 0 0 17.12674 0 0 0 Q9BZM2 PA2GF_HUMAN "Group IIF secretory phospholipase A2, GIIF sPLA2, sPLA2-IIF, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase 2F)" PLA2G2F Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; innate immune response [GO:0045087]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644] cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; innate immune response [GO:0045087]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005829; GO:0005886; GO:0006644; GO:0016042; GO:0019369; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0042130; GO:0045087; GO:0047498; GO:0050482 NMVLCLMNQTYREEYR 2.829999924 1 1 0.258544005 2135.67743 14.47473 11.22534 9.039421 0 0 14.09081 0 12.32425 0 0 10.17719 14.39961 13.67426 13.06117 14.27618 14.83126 0 0 0 0 0 0 0 0 0 0 0 14.83389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZM3 GSX2_HUMAN GS homeobox 2 (Genetic-screened homeobox 2) (Homeobox protein GSH-2) GSX2 GSH2 Homo sapiens (Human) forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; hindbrain morphogenesis [GO:0021575]; neuron fate specification [GO:0048665]; olfactory bulb interneuron differentiation [GO:0021889]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of cell migration [GO:0030334]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; spinal cord association neuron differentiation [GO:0021527]; subpallium neuron fate commitment [GO:0060163]; telencephalon regionalization [GO:0021978] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; hindbrain morphogenesis [GO:0021575]; neuron fate specification [GO:0048665]; olfactory bulb interneuron differentiation [GO:0021889]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of cell migration [GO:0030334]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; spinal cord association neuron differentiation [GO:0021527]; subpallium neuron fate commitment [GO:0060163]; telencephalon regionalization [GO:0021978]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0002087; GO:0005634; GO:0005737; GO:0021527; GO:0021575; GO:0021798; GO:0021889; GO:0021978; GO:0030334; GO:0045747; GO:0048665; GO:0048714; GO:0048853; GO:0060163; GO:1990837 NSHAGCK 3.430000067 1 1 0.216395264 773.0171034 13.95419 0 0 0 0 0 16.40251 0 15.15777 0 0 0 0 16.26326 0 0 0 0 0 0 0 16.19688 14.39695 0 0 16.03692 0 0 14.75677 0 15.40942 16.12417 17.38546 16.19713 0 16.67658 17.33554 15.98321 0 17.1386 16.59937 16.63083 15.23186 15.64271 15.38239 17.04665 16.69192 0 Q9BZQ2 SHP1L_HUMAN Testicular spindle-associated protein SHCBP1L (SHC SH2 domain-binding protein 1-like protein) SHCBP1L C1orf14 Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis cytokinesis [GO:0007112]; positive regulation of chromosome organization [GO:2001252]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; meiotic spindle [GO:0072687] cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; cell differentiation [GO:0030154]; male meiosis cytokinesis [GO:0007112]; positive regulation of chromosome organization [GO:2001252]; spermatogenesis [GO:0007283] GO:0005737; GO:0007112; GO:0007283; GO:0030154; GO:0072687; GO:2001252 GEKSASAVSGDTAAATTLK 10.73999977 1 1 0.235787043 1765.722788 0 12.46538 0 0 15.86329 0 0 13.57498 0 15.25577 13.63043 0 16.36297 0 0 0 14.98426 14.96995 14.45314 0 0 0 15.0031 0 0 0 15.53799 0 0 0 0 0 0 15.96139 16.10546 0 0 0 0 18.20764 0 0 15.08663 0 0 0 0 0 Q9BZR6 RTN4R_HUMAN "Reticulon-4 receptor (Nogo receptor, NgR) (Nogo-66 receptor)" RTN4R NOGOR UNQ330/PRO526 Homo sapiens (Human) axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025] anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793] anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025] chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] GO:0005783; GO:0005886; GO:0005887; GO:0007166; GO:0007409; GO:0008201; GO:0009986; GO:0010977; GO:0022038; GO:0023041; GO:0030517; GO:0031362; GO:0035025; GO:0035374; GO:0038023; GO:0038131; GO:0043005; GO:0043025; GO:0043198; GO:0043204; GO:0043547; GO:0044295; GO:0044877; GO:0045121; GO:0048681; GO:0070062; GO:0098793; GO:0098978; GO:1905573; GO:1905576 LAGRDLK 9.659999847 1 1 0.124433602 772.8287363 14.03727 14.93633 15.7057 13.93226 0 0 6.417267 14.20998 0 0 0 0 15.63989 0 14.79655 15.85608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZR9 TRIM8_HUMAN "E3 ubiquitin-protein ligase TRIM8, EC 2.3.2.27 (Glioblastoma-expressed RING finger protein) (RING finger protein 27) (RING-type E3 ubiquitin transferase TRIM8) (Tripartite motif-containing protein 8)" TRIM8 GERP RNF27 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790] cytosol [GO:0005829]; PML body [GO:0016605] cytosol [GO:0005829]; PML body [GO:0016605]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] GO:0003713; GO:0005829; GO:0008270; GO:0010508; GO:0016567; GO:0016605; GO:0016740; GO:0019827; GO:0032897; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0046597; GO:0051091; GO:0051092; GO:1900182 AQAKFCSENAAQALHLGER 2.299999952 1 1 0.108326993 2101.314583 15.49459 0 0 0 0 14.01301 0 14.01486 0 14.2936 0 0 0 13.95368 11.81306 12.23812 0 0 0 0 14.21092 0 14.82918 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97424 0 0 0 0 0 0 0 0 0 0 0 Q9BZV1 UBXN6_HUMAN UBX domain-containing protein 6 (UBX domain-containing protein 1) UBXN6 UBXD1 UBXDC2 Homo sapiens (Human) endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236] GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503; GO:0070062 ESVGEK 4.400000095 1 1 0.226141095 648.4821867 17.33686 16.85783 14.48145 17.66205 0 16.52183 0 17.99044 18.22489 16.2833 15.07633 16.84138 16.72785 0 0 0 16.74978 16.00455 15.58707 13.92033 16.34933 14.98978 0 0 17.52515 17.16473 18.24794 0 16.27739 16.57608 18.11571 0 18.25139 16.7317 17.37215 17.28064 0 0 17.02309 0 0 0 0 15.94851 0 0 15.68576 0 Q9BZW7 TSG10_HUMAN Testis-specific gene 10 protein (Testis development protein NYD-SP7) TSGA10 CEP4L Homo sapiens (Human) spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; spermatogenesis [GO:0007283] GO:0005737; GO:0005814; GO:0007283; GO:0031514 MAIQSRDVAQFR 17.90999985 0.902242959 0.902242959 0.45068124 1438.927274 0 0 18.41865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.72435 0 0 19.52428 0 0 0 19.7023 0 18.59582 18.85273 0 0 0 19.49637 0 17.72602 0 0 0 0 0 0 16.67463 0 Q9BZX2 UCK2_HUMAN "Uridine-cytidine kinase 2, UCK 2, EC 2.7.1.48 (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2)" UCK2 UMPK Homo sapiens (Human) CTP salvage [GO:0044211]; UMP salvage [GO:0044206] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206] ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849] GO:0004849; GO:0005524; GO:0005737; GO:0005829; GO:0042802; GO:0043771; GO:0044206; GO:0044211 DLFQMK 3.25999999 1 1 0.247990776 796.7721084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8354 0 0 0 18.75062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.10663 Q9BZZ5 API5_HUMAN "Apoptosis inhibitor 5, API-5 (Antiapoptosis clone 11 protein, AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor, FIF) (Protein XAGL)" API5 MIG8 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270] fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006915; GO:0016020; GO:0016607; GO:0017134; GO:0043066; GO:2000270 ITNNINVLIK 16.18000031 0.229130402 0.229130402 0.009013897 1140.812257 17.75655 0 18.69499 14.15435 17.14853 12.80938 0 17.09161 14.63013 0 0 0 11.69083 0 11.21437 0 0 0 15.71681 14.74342 0 16.56327 0 12.62021 0 10.45975 10.39637 14.605 0 18.26002 15.69859 16.67763 0 0 15.51559 0 16.56921 16.06668 0 0 0 17.61076 0 0 0 0 15.81307 14.47457 Q9C019 TRI15_HUMAN Tripartite motif-containing protein 15 (RING finger protein 93) (Zinc finger protein 178) (Zinc finger protein B7) TRIM15 RNF93 ZNF178 ZNFB7 Homo sapiens (Human) innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790] transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0003713; GO:0005737; GO:0007500; GO:0008270; GO:0010468; GO:0016567; GO:0032481; GO:0044790; GO:0045087; GO:0051091; GO:0051092; GO:0061630; GO:1900246; GO:1901253 SVRYTR 3.609999895 0.377132744 0.377132744 0.217273638 783.3565411 0 17.72385 0 15.81457 16.14315 0 0 0 16.61575 13.56035 16.68293 0 17.11497 14.51371 14.6967 15.28694 15.67547 16.99384 0 17.1468 0 16.92258 16.24571 14.80699 0 15.78778 16.38362 0 0 16.45004 17.60398 0 0 16.94477 16.67878 16.76208 17.62391 16.60634 0 17.53479 16.19135 0 0 16.73307 0 17.33283 14.8335 0 Q9C035 TRIM5_HUMAN "Tripartite motif-containing protein 5, EC 2.3.2.27 (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5)" TRIM5 RNF88 Homo sapiens (Human) activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; suppression of viral release by host [GO:0044790] identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000209; GO:0000932; GO:0002218; GO:0003713; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0030674; GO:0031664; GO:0032880; GO:0038187; GO:0042802; GO:0042803; GO:0043123; GO:0043410; GO:0044790; GO:0045087; GO:0046596; GO:0046597; GO:0051091; GO:0051092; GO:0051607; GO:0061630; GO:0070534 EEKASWK 7.039999962 0.418731928 0.418731928 0.145194229 878.2252813 17.09639 0 16.17545 14.44913 15.87901 14.05318 16.24809 0 13.82602 14.48615 14.87808 17.73209 17.2763 11.48836 0 0 14.95008 17.87341 12.22308 0 0 18.60209 0 16.03572 12.31129 15.01856 16.89332 14.76313 0 0 11.39758 14.43475 0 0 18.22876 13.89556 16.98241 15.66499 15.37374 0 0 13.41812 13.62849 15.22137 16.74794 16.55303 0 0 Q9C037 TRIM4_HUMAN "E3 ubiquitin-protein ligase TRIM4, EC 2.3.2.27 (RING finger protein 87) (RING-type E3 ubiquitin transferase TRIM4) (Tripartite motif-containing protein 4)" TRIM4 RNF87 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0004842; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0010468; GO:0016567; GO:0042802; GO:0045087; GO:0061630 EDVMGITDRSK 8.649999619 1 1 4.61E-13 1251.619921 14.72455 0 0 11.97507 0 15.63735 0 0 15.85465 0 15.39485 14.36159 13.26976 15.13607 0 0 0 0 0 16.6908 15.01565 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1779 0 0 0 0 0 0 0 0 0 17.15427 0 0 0 Q9C040 TRIM2_HUMAN "Tripartite motif-containing protein 2, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2)" TRIM2 KIAA0517 RNF86 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 ENPIEDDLIFR 21.37999916 1 1 2.29E-13 1360.168484 19.7559 19.3224 16.25511 0 16.5525 18.31836 18.4603 0 0 10.16259 16.62531 22.16212 0 0 0 0 19.56161 0 16.94574 15.49798 0 0 17.21304 0 22.0292 0 21.4037 0 0 0 0 0 0 0 0 0 0 20.06813 20.4963 0 18.98875 0 0 0 0 0 22.06654 22.21267 Q9C075 K1C23_HUMAN "Keratin, type I cytoskeletal 23 (Cytokeratin-23, CK-23) (Keratin-23, K23)" KRT23 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109 SSMKVSATPK 8.869999886 1 1 0.181092617 1052.634325 13.23338 0 15.91272 0 0 0 0 0 0 0 15.60595 16.62343 0 0 0 0 0 0 0 14.64711 14.97921 0 16.11452 0 0 0 0 0 0 0 0 15.71037 0 14.74013 15.86494 14.7795 16.49388 15.02237 14.50845 15.60423 16.15374 0 16.05084 17.1216 15.41838 15.75533 15.64674 0 Q9C086 IN80B_HUMAN "INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog, hIes2) (PAP-1-associated protein 1, PAPA-1) (Zinc finger HIT domain-containing protein 4)" INO80B HMGA1L4 PAPA1 ZNHIT4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" metal ion binding [GO:0046872] GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0016604; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0046872; GO:0051726; GO:0060382 IKLGGQVLGTK 4.139999866 1 1 0.104801439 1114.391957 0 0 0 17.6523 0 9.558174 0 0 0 0 0 14.11026 0 0 15.40574 11.61119 0 0 10.65875 0 0 0 0 0 0 0 0 0 0 0 16.42303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C091 GRB1L_HUMAN GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein) GREB1L C18orf6 KIAA1772 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065] GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0061205; GO:0072177 TLSEMR 8.529999733 1 1 0.145972255 751.1871012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.32753 17.814 0 0 0 0 0 13.69235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C098 DCLK3_HUMAN "Serine/threonine-protein kinase DCLK3, EC 2.7.11.1 (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)" DCLK3 DCAMKL3 DCDC3C KIAA1765 Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0106310 DLKPENLLVQRNEDK 13.72000027 1 1 0.391778663 1810.13374 0 0 16.60531 16.44356 16.05413 0 15.59756 14.72573 15.82355 12.97175 16.42405 14.13365 17.31632 0 0 15.67922 0 0 0 0 0 0 17.08731 15.37673 0 0 16.40998 0 16.83217 0 15.98493 0 16.32554 16.38304 16.30247 0 0 0 0 0 0 16.14145 0 0 0 0 0 15.64757 Q9C099 LRCC1_HUMAN Leucine-rich repeat and coiled-coil domain-containing protein 1 (Centrosomal leucine-rich repeat and coiled-coil domain-containing protein) LRRCC1 CLERC KIAA1764 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005737; GO:0005813; GO:0005814; GO:0007049; GO:0051301 HALIWAQRK 14.64999962 0.075615376 0.075615376 1.60E-12 1122.740369 0 0 0 0 14.3165 0 0 0 0 0 15.97195 0 0 13.39883 15.62904 15.86768 17.41054 0 0 0 0 0 14.50926 12.9006 15.1911 13.05643 0 0 14.48951 0 0 0 0 0 0 0 16.33013 0 0 18.60043 0 15.85291 0 0 16.92892 0 0 0 Q9C0A0 CNTP4_HUMAN Contactin-associated protein-like 4 (Cell recognition molecule Caspr4) CNTNAP4 CASPR4 KIAA1763 Homo sapiens (Human) "cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]" cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734] "cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]" GO:0007155; GO:0016021; GO:0032225; GO:0032228; GO:0042734; GO:0042995; GO:2000821 GEFNLMNLDYEISFGGIPAPGK 1.120000005 1 1 0.057188044 2370.886552 15.88349 0 12.44078 0 0 0 0 0 11.11044 0 0 16.88576 12.66844 0 0 0 0 0 0 0 0 0 14.43528 0 0 0 0 0 0 0 0 0 0 0 15.2599 0 16.09921 0 0 12.44389 0 0 0 0 0 0 13.81396 0 Q9C0A1 ZFHX2_HUMAN "Zinc finger homeobox protein 2 (Zinc finger homeodomain protein 2, ZFH-2)" ZFHX2 KIAA1056 KIAA1762 ZNF409 Homo sapiens (Human) adult behavior [GO:0030534]; brain development [GO:0007420]; regulation of neuron differentiation [GO:0045664]; regulation of sensory perception of pain [GO:0051930]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; brain development [GO:0007420]; regulation of neuron differentiation [GO:0045664]; regulation of sensory perception of pain [GO:0051930]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0008270; GO:0030534; GO:0045664; GO:0051930 TQMSSLQLKIMK 9.220000267 0.231500417 0.231500417 0.139790996 1424.813911 18.13661 0 0 0 0 13.21178 13.76075 16.38008 15.74613 0 12.83095 13.46546 0 0 0 15.89985 0 15.66256 9.758357 0 0 0 0 17.48887 13.46579 16.93847 13.95595 0 16.57741 16.62614 0 16.12979 11.41437 17.32064 17.42836 12.49795 16.39375 16.12234 17.35871 16.23215 0 14.93653 0 16.16888 12.63573 0 0 16.6248 Q9C0B2 CFA74_HUMAN Cilia- and flagella-associated protein 74 CFAP74 C1orf222 KIAA1751 Homo sapiens (Human) axoneme assembly [GO:0035082] axoneme [GO:0005930] axoneme [GO:0005930]; axoneme assembly [GO:0035082] GO:0005930; GO:0035082 KPVGGTK 17.60000038 1.57E-08 1.57E-08 0.240093737 684.6975483 18.70909 17.9688 17.77129 0 0 15.69644 18.06475 0 17.62543 0 0 0 16.81203 0 18.72656 18.99304 18.2745 0 16.64099 16.96196 0 16.55844 0 0 0 17.69769 0 18.6957 18.24798 0 0 0 0 0 0 0 18.03658 0 17.83932 17.41547 17.69209 0 0 19.0411 0 18.87523 18.32398 16.6978 Q9C0B5 ZDHC5_HUMAN "Palmitoyltransferase ZDHHC5, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 5, DHHC-5) (Zinc finger protein 375)" ZDHHC5 KIAA1748 ZNF375 Homo sapiens (Human) positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] GO:0005886; GO:0016020; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030425; GO:0045335; GO:0062208; GO:1903078; GO:1905171 DEVQLKTTYSK 1.49000001 0.208910525 0.208910525 0.07394009 1310.734929 0 0 0 0 0 0 0 0 0 0 0 0 0 14.06237 0 0 0 0 0 14.94425 0 0 0 0 13.2611 0 0 0 0 0 0 0 14.23304 0 0 14.04888 0 0 11.87983 12.96325 13.81174 0 0 0 13.37654 0 0 0 Q9C0B7 TNG6_HUMAN Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7) TANGO6 KIAA1746 TMCO7 Homo sapiens (Human) protein secretion [GO:0009306] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein secretion [GO:0009306] GO:0009306; GO:0016021 DLYHLLK 7.070000172 0.281803548 0.281803548 0.278676045 902.0703912 16.052 0 15.00625 0 0 0 0 17.2172 0 0 0 0 0 0 18.03366 0 17.53401 0 0 16.13785 0 0 0 0 0 0 0 0 0 0 17.1009 17.94848 17.81982 0 16.76258 0 20.496 0 0 18.92749 0 0 0 0 0 0 0 0 Q9C0C2 TB182_HUMAN 182 kDa tankyrase-1-binding protein TNKS1BP1 KIAA1741 TAB182 Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004] adherens junction [GO:0005912]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004] ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877] GO:0000289; GO:0000792; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006302; GO:0007004; GO:0010800; GO:0019899; GO:0030014; GO:0031954; GO:0033138; GO:0044877; GO:0045296; GO:0071479; GO:0071532 ASPEPPGPESSSR 4.75 1 1 0.171345649 1295.231602 14.70724 0 0 0 0 0 0 16.1621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95553 0 0 0 16.82346 0 0 15.31448 13.49716 0 16.39243 0 0 0 0 0 0 0 Q9C0C7 AMRA1_HUMAN Activating molecule in BECN1-regulated autophagy protein 1 (DDB1- and CUL4-associated factor 3) AMBRA1 DCAF3 KIAA1736 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; mitophagy [GO:0000423]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to mitochondrial depolarisation [GO:0098780] autophagosome [GO:0005776]; axoneme [GO:0005930]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] autophagosome [GO:0005776]; axoneme [GO:0005930]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTPase binding [GO:0051020]; protein phosphatase binding [GO:0019903]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; mitophagy [GO:0000423]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to mitochondrial depolarisation [GO:0098780] GTPase binding [GO:0051020]; protein phosphatase binding [GO:0019903]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] GO:0000045; GO:0000209; GO:0000422; GO:0000423; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0005930; GO:0006914; GO:0007049; GO:0007399; GO:0010508; GO:0019903; GO:0030154; GO:0031410; GO:0031625; GO:0035307; GO:0043231; GO:0043552; GO:0045591; GO:0048471; GO:0051020; GO:0080008; GO:0098780; GO:1901526; GO:1904544; GO:1990756; GO:2000045 GLLPEAGQLAERGLSPR 10.32999992 1 1 0.328349411 1764.857055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.19222 0 Q9C0D0 PHAR1_HUMAN Phosphatase and actin regulator 1 PHACTR1 KIAA1733 RPEL1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149] cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202] cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149] actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864] GO:0003779; GO:0004864; GO:0005634; GO:0005829; GO:0008157; GO:0021987; GO:0030036; GO:0031032; GO:0031532; GO:0043149; GO:0045202; GO:0048870; GO:0140059; GO:2001222 RATLLLPPTLMAASSEDDIDR 5.829999924 0.044106487 0.044106487 0.471504889 2300.733299 0 0 0 0 0 0 0 17.48361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.37492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0D2 CE295_HUMAN Centrosomal protein of 295 kDa CEP295 KIAA1731 Homo sapiens (Human) centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599] microtubule binding [GO:0008017] GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0007099; GO:0008017; GO:0010825; GO:0046599; GO:1901985; GO:1903724; GO:1904951; GO:1990498 EALLVEK 6.039999962 0.734583616 0.734583616 0.159515621 802.6354355 16.64119 0 18.19316 15.31392 15.77447 0 19.92321 0 14.41194 17.05688 16.74561 18.7886 15.5733 16.96721 18.0001 17.55529 0 0 17.44347 0 15.29024 17.81496 13.44469 13.79197 0 18.58144 0 0 16.55721 0 0 19.1461 15.76864 18.98641 0 0 0 16.30732 14.2675 0 18.41679 18.50344 16.89055 0 15.08511 0 16.96044 16.54255 Q9C0D4 Z518B_HUMAN Zinc finger protein 518B ZNF518B KIAA1729 Homo sapiens (Human) chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006325; GO:0006357; GO:0046872 SERGPIDMSPNIETPLRPK 5.699999809 1 1 0.126788921 2152.390338 0 13.73948 14.63363 16.50296 0 0 14.80681 0 0 15.13818 14.29314 14.4255 0 14.96763 14.5082 0 0 0 0 0 0 0 0 14.73252 0 0 0 0 0 0 0 15.57419 0 0 0 0 0 0 0 0 0 11.64413 0 0 0 0 0 0 Q9C0D5 TANC1_HUMAN "Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)" TANC1 KIAA1728 Homo sapiens (Human) dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542] axon terminus [GO:0043679]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069] axon terminus [GO:0043679]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542] GO:0007520; GO:0008542; GO:0014069; GO:0030425; GO:0043025; GO:0043679; GO:0097062 AGIGKSLR 5.099999905 0.247464523 0.247464523 0.028154948 801.8326323 15.30611 15.68957 0 0 10.08007 14.53306 15.04623 0 15.6375 0 15.52345 14.04237 14.79032 16.25141 0 0 18.17619 16.47269 15.09874 17.29403 14.5513 17.88502 15.89857 15.44565 15.55243 15.54704 15.01115 15.69203 17.03287 15.57335 13.04678 16.9854 15.88459 18.03918 17.6247 17.12613 16.08662 13.30306 17.19588 15.30274 14.4217 0 0 17.09095 16.35091 16.13389 14.53693 15.25451 Q9C0D6 FHDC1_HUMAN FH2 domain-containing protein 1 (Inverted formin-1) FHDC1 INF1 KIAA1727 Homo sapiens (Human) cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] actin binding [GO:0003779]; microtubule binding [GO:0008017] GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005929; GO:0008017; GO:0043149; GO:0060271; GO:0090161 IEAMVLK 25.43000031 0.609657586 0.609657586 0.272219231 819.3422031 19.3265 0 18.70525 0 20.29032 19.93098 21.9325 19.08885 17.63119 19.11049 19.16088 22.24 19.06745 0 17.75036 0 0 18.14081 22.70841 17.97645 0 19.4964 18.45012 18.59559 0 19.93748 17.83159 0 17.78312 0 18.04712 19.04624 20.64791 21.44698 0 18.72319 0 19.19645 0 19.36288 0 0 19.73941 0 18.34152 19.41393 0 0 Q9C0D7 ZC12C_HUMAN "Probable ribonuclease ZC3H12C, EC 3.1.-.- (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C)" ZC3H12C KIAA1726 MCPIP3 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729] GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0046872; GO:0090502 NNFMGLK 1.970000029 0.911140561 0.911140561 0.207336281 840.4422004 0 15.90184 0 0 0 0 18.17213 0 0 0 0 17.25492 0 0 0 0 0 17.22477 0 0 0 0 0 0 18.01126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.50693 0 0 0 0 0 0 Q9C0D9 EPT1_HUMAN "Ethanolaminephosphotransferase 1, hEPT1, EC 2.7.8.1 (Selenoprotein I, SelI)" SELENOI EPT1 KIAA1724 SELI Homo sapiens (Human) phosphatidylethanolamine biosynthetic process [GO:0006646] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646] ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872] GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0016021; GO:0046872 AGYEYVSPEQLAGFDK 7.139999866 1 1 0.237372405 1774.581175 0 13.61758 14.01826 0 0 0 0 0 0 15.66051 0 12.82695 0 0 0 0 0 0 0 0 0 0 0 0 14.05103 0 15.54411 0 0 0 0 0 0 0 0 14.22635 0 13.83432 0 0 14.41706 0 13.92248 0 14.95515 0 0 16.3007 Q9C0E2 XPO4_HUMAN "Exportin-4, Exp4" XPO4 KIAA1721 Homo sapiens (Human) positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611] nuclear export signal receptor activity [GO:0005049] GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827 DQFSDQLASVGMLGR 8.5 1 1 0.30084041 1639.499558 0 15.18335 12.22327 0 16.17786 15.19342 15.64843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81694 16.6141 0 16.57812 16.34561 15.05883 0 0 0 0 0 0 15.07245 17.31585 0 0 17.3457 15.42323 0 0 0 0 0 0 Q9C0F0 ASXL3_HUMAN Putative Polycomb group protein ASXL3 (Additional sex combs-like protein 3) ASXL3 KIAA1713 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of transcription by RNA polymerase II [GO:0045944] PR-DUB complex [GO:0035517] PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; animal organ morphogenesis [GO:0009887]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975] GO:0003677; GO:0003682; GO:0009887; GO:0035517; GO:0042975; GO:0045944; GO:0046872; GO:0051055 AMIVCK 6.880000114 1 1 5.75E-13 718.4221402 0 14.04271 16.01217 11.25795 14.29516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.90062 0 0 0 0 0 16.56107 16.14251 0 0 0 16.64678 0 0 0 0 0 0 0 0 0 0 0 0 0 15.76496 Q9C0F1 CEP44_HUMAN "Centrosomal protein of 44 kDa, Cep44 (HBV PreS1-transactivated protein 3, PS1TP3)" CEP44 KIAA1712 Homo sapiens (Human) centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098] microtubule binding [GO:0008017] GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0007099; GO:0008017; GO:0010457; GO:0030496 MERMK 5.889999866 1 1 0.077868677 711.0684918 0 0 14.95916 0 0 0 0 0 0 0 0 12.49214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.06882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0G0 ZN407_HUMAN Zinc finger protein 407 ZNF407 KIAA1703 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0008270; GO:0010468; GO:0045944 DCAQGVK 11.26000023 1 1 0.143702141 774.7363307 0 11.87251 12.03169 15.73003 0 15.83899 0 0 12.93891 0 0 14.94579 0 0 0 0 0 0 0 0 0 0 12.37038 0 11.881 0 0 0 13.34023 14.78665 0 0 0 0 0 0 0 0 14.1299 16.15937 0 0 0 18.09201 13.88857 0 0 0 Q9C0G6 DYH6_HUMAN Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6) DNAH6 DNAHC6 DNHL1 HL2 KIAA1697 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285 FGADK 6.349999905 0.64611578 0.64611578 0.264244243 536.6756857 15.95953 14.06797 14.86317 0 13.8451 0 15.19144 15.31834 0 14.39789 0 0 16.19678 0 13.95391 0 0 17.30665 15.38676 12.83193 0 0 17.20067 14.2951 0 0 0 0 15.4527 0 15.6668 0 15.72864 14.04772 15.06049 0 0 16.31747 0 15.2237 14.50312 0 14.20892 0 0 0 17.23709 0 Q9C0H5 RHG39_HUMAN Rho GTPase-activating protein 39 ARHGAP39 KIAA1688 Homo sapiens (Human) postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173 HTQGLFRR 5.679999828 0.81179148 0.81179148 0.18270181 1014.452755 0 0 15.42205 0 0 0 0 17.04145 0 0 16.09892 0 15.04636 15.88141 14.40645 0 0 0 15.13773 16.31025 0 15.43477 0 0 0 15.40972 0 14.35052 0 13.8718 14.3866 15.44306 15.63249 15.06798 12.66156 14.29569 13.85588 15.69404 14.12961 0 14.65547 13.40753 15.88036 10.39617 16.38126 17.09949 15.00801 14.65198 Q9C0H9 SRCN1_HUMAN "SRC kinase signaling inhibitor 1 (SNAP-25-interacting protein, SNIP) (p130Cas-associated protein) (p140Cap)" SRCIN1 KIAA1684 P140 SNIP Homo sapiens (Human) exocytosis [GO:0006887]; negative regulation of protein secretion [GO:0050709]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; exocytosis [GO:0006887]; negative regulation of protein secretion [GO:0050709]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; substrate adhesion-dependent cell spreading [GO:0034446] protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] GO:0005737; GO:0006887; GO:0014069; GO:0015629; GO:0019901; GO:0019904; GO:0030027; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0034446; GO:0043025; GO:0045202; GO:0050709; GO:0061001; GO:0061098; GO:0061099; GO:0098793 QSLPLSR 12.17000008 0.199365705 0.199365705 0.267794976 800.0274383 15.11761 14.38572 0 0 0 16.59556 17.75237 14.50678 0 0 0 15.89116 14.20014 0 0 0 16.2514 0 17.70541 15.48578 16.7605 16.22137 16.7791 0 17.84048 18.59284 0 14.68911 15.95354 14.8725 15.98612 18.75872 0 17.68551 0 0 16.4581 0 0 15.55505 15.74073 0 15.36245 14.86522 0 17.03998 15.98017 16.29005 Q9C0I3 CCSE1_HUMAN Serine-rich coiled-coil domain-containing protein 1 (Coiled-coil serine-rich protein 1) CCSER1 FAM190A KIAA1680 Homo sapiens (Human) HSVGFSSSR 3.059999943 1 1 0 963.5960938 14.81801 15.79909 0 14.9202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0J8 WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa) WDR33 WDC146 Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283] collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283] RNA binding [GO:0003723] GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006378; GO:0007283 GPPDR 9.989999771 0.002808307 0.002808307 0.23401731 539.2164216 12.77304 0 16.44562 15.53282 15.58455 15.50452 15.82076 16.27178 0 0 15.5137 14.62811 16.63005 16.29108 15.33562 0 14.4173 15.81221 15.636 15.26269 16.19482 16.11746 15.61611 17.29475 15.74674 16.16997 0 0 13.92714 16.55085 14.70019 0 0 15.81001 15.81802 16.14365 16.89777 0 0 0 0 15.15567 15.63109 15.75603 16.0709 15.72522 16.44755 0 Q9GZK7 O11A1_HUMAN Olfactory receptor 11A1 (Hs6M1-18) (Olfactory receptor 11A2) (Olfactory receptor OR6-30) OR11A1 OR11A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 ILCIKQTETLD 6.869999886 1 1 0.106091307 1333.254211 13.25091 0 14.80776 0 0 13.04311 0 15.55317 13.60429 0 0 13.47674 14.55241 0 13.31506 0 11.91435 0 0 0 0 13.76514 14.55285 15.86341 0 0 0 0 10.69781 12.23936 0 0 0 0 0 0 13.44839 0 0 15.76611 15.50734 15.08451 0 0 16.36927 0 0 0 Q9GZL7 WDR12_HUMAN Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12) WDR12 Homo sapiens (Human) "maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]" "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]" ribonucleoprotein complex binding [GO:0043021] GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0007219; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545 ALHCCRGHAGSVDSIAVDGSGTK 1.710000038 1 1 0.159885422 2354.510021 12.67568 0 12.24294 0 0 0 0 13.95785 13.02441 0 0 9.525046 0 12.49566 12.49176 11.44444 14.4727 0 0 13.88467 0 0 0 0 11.50228 14.09212 11.32822 0 0 12.75259 0 0 13.51062 0 0 15.00695 0 14.16756 13.07899 15.28078 0 15.02146 0 13.23131 0 0 0 0 Q9GZM3 RPB1B_HUMAN "DNA-directed RNA polymerase II subunit RPB11-b1, RNA polymerase II subunit B11-b1, RPB11b1 (DNA-directed RNA polymerase II subunit J2)" POLR2J2 Homo sapiens (Human) "RNA polymerase II, core complex [GO:0005665]" "RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]" DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055] GO:0001055; GO:0003677; GO:0005665; GO:0046983 DTKVPK 12.85000038 1 1 0.26258823 687.2700067 0 0 0 0 0 17.92403 0 0 0 0 0 17.12362 17.17497 0 0 0 0 0 0 0 15.80573 0 0 0 0 0 0 0 15.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZN1 ARP6_HUMAN "Actin-related protein 6, hArp6 (hARPX)" ACTR6 CDA12 Homo sapiens (Human) "histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]" nucleosome binding [GO:0031491] GO:0000786; GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0006355; GO:0031491; GO:0043486 DMDIAKLK 11.56000042 0.697051406 0.697051406 0.286675832 953.1458424 15.35748 12.5783 15.68298 15.81355 14.64834 16.27061 0 0 13.46408 0 0 15.69637 14.99199 0 16.65912 15.65604 0 0 0 14.36962 0 0 0 0 0 0 0 0 0 0 0 15.12618 0 15.83509 16.1043 0 0 16.50933 0 15.92584 16.42496 15.55854 15.79387 15.39184 14.43083 15.1661 15.69783 0 Q9GZN2 TGIF2_HUMAN "Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2, TGFB-induced factor 2)" TGIF2 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]" centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0010470; GO:0038092; GO:0045666; GO:0060041; GO:1990837 MSDSDLGEDEGLLSLAGK 9.850000381 0.759569824 0.759569824 0.278902935 1848.447236 15.44741 14.58483 13.38413 15.28797 0 0 12.02183 14.60381 0 11.61806 14.92191 14.22008 14.30164 13.8221 0 0 0 0 15.40179 0 0 0 15.53305 15.44516 0 11.21565 0 15.32513 0 0 15.29748 0 0 0 0 16.3269 15.30952 0 0 15.63168 0 0 0 13.76062 14.56781 0 0 0 Q9GZN6 S6A16_HUMAN Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 (Solute carrier family 6 member 16) SLC6A16 NTT5 Homo sapiens (Human) neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725] neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293] GO:0005326; GO:0005887; GO:0006836; GO:0015293; GO:0035725 FGLQQLVVAK 5.869999886 0.78649056 0.78649056 0.162405178 1103.603115 18.41 0 15.44053 0 15.18398 0 0 0 0 0 0 0 0 0 0 0 0 17.38836 18.30041 15.12958 14.73948 0 0 0 18.03741 0 0 15.73021 0 0 0 0 0 0 0 0 0 0 0 0 16.63087 0 18.13249 15.7875 15.66491 0 16.76493 0 Q9GZP1 NRSN2_HUMAN Neurensin-2 NRSN2 C20orf98 Homo sapiens (Human) nervous system development [GO:0007399] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; nervous system development [GO:0007399] GO:0005886; GO:0007399; GO:0016021; GO:0030133; GO:0043005; GO:0043025 MMPSCNR 3.49000001 1 1 0.220221798 896.1065635 16.10111 15.87516 0 15.38239 0 15.67584 15.25374 16.2639 14.64504 15.52384 15.07372 0 0 12.09712 0 15.09686 0 15.10304 0 14.11351 0 0 0 0 0 14.08057 16.06526 13.22939 13.62303 0 0 0 16.86452 11.48464 11.96352 11.56399 0 0 15.86372 0 0 0 0 0 16.08867 0 0 0 Q9GZP9 DERL2_HUMAN "Derlin-2 (Degradation in endoplasmic reticulum protein 2, DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)" DERL2 DER2 FLANA CGI-101 SBBI53 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]" early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020] "early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]" misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; ubiquitin-specific protease binding [GO:1990381] GO:0000839; GO:0001967; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044877; GO:0051787; GO:1904153; GO:1990381 MAYQSLR 4.96999979 0.8180058 0.8180058 0.242582782 868.3435885 15.41088 15.34183 15.83812 14.44714 14.99385 14.87022 14.36782 12.52746 14.37113 15.25347 12.71079 13.69865 0 15.68771 13.69385 14.63905 13.7977 0 15.82235 14.29329 0 0 16.93841 14.45871 0 14.64118 15.44652 15.66133 0 0 0 16.24438 15.40192 0 0 0 0 0 16.45335 0 14.93676 15.84347 16.00015 0 15.47258 15.65948 15.96923 0 Q9GZQ3 COMD5_HUMAN "COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein, HCaRG)" COMMD5 HT002 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005829 VDVAISTSALAR 14.03999996 0.760036707 0.760036707 0.359921759 1203.65988 0 0 17.0097 0 0 0 16.75196 0 0 0 0 16.64928 0 0 16.51181 15.87314 0 0 0 0 0 0 0 0 0 16.70504 16.96141 15.14923 0 0 15.56703 16.18923 0 0 16.93937 16.73826 0 16.33306 0 0 0 14.74699 15.15032 14.72293 0 0 15.73891 18.43184 Q9GZQ4 NMUR2_HUMAN "Neuromedin-U receptor 2, NMU-R2 (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1)" NMUR2 NMU2R TGR1 Homo sapiens (Human) activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265] G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005886; GO:0006816; GO:0006940; GO:0007186; GO:0007200; GO:0007204; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0008188; GO:0016021; GO:0019722; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930 DKSLEADEGNANIQRPCR 3.150000095 0.539970398 0.539970398 0.201177785 2071.289178 0 0 0 0 0 0 0 0 0 0 15.03368 0 12.27421 0 0 0 0 0 0 0 0 0 0 0 0 14.63728 0 0 0 0 0 14.3544 0 0 13.70112 0 0 15.43765 0 0 0 0 0 0 15.07919 0 14.88989 0 Q9GZQ6 NPFF1_HUMAN Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022) NPFFR1 GPR147 NPFF1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277] GO:0004930; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0008188; GO:0042277 EEHHFMVDAR 12.89999962 0.677590728 0.677590728 0.202355845 1287.363356 17.76531 17.36333 0 0 16.04494 0 15.4788 10.59948 14.82053 0 0 14.83165 13.28907 0 12.84544 13.57014 14.14677 14.73877 0 0 14.16197 0 0 0 14.69068 11.93333 16.33197 0 14.74344 0 0 13.85342 0 11.79415 15.83321 0 0 13.94691 13.84406 16.04096 0 13.84306 12.99664 14.51249 9.684146 0 15.59922 0 Q9GZR1 SENP6_HUMAN "Sentrin-specific protease 6, EC 3.4.22.- (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6)" SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169] SUMO-specific endopeptidase activity [GO:0070139] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234 DVMKGSNPK 12.56000042 0.401776969 0.401776969 0.087709998 975.6396759 0 0 15.52787 0 0 0 0 17.24434 15.19264 16.8329 0 0 13.89882 0 0 0 0 0 15.53451 0 15.76775 0 0 0 0 0 0 15.67493 0 14.18892 0 14.70982 0 0 0 0 16.0642 16.8654 14.16719 14.76115 0 15.06222 13.0849 0 16.11714 16.91818 17.27047 17.04493 Q9GZR2 REXO4_HUMAN "RNA exonuclease 4, EC 3.1.-.- (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog, hPMC2)" REXO4 PMC2 XPMC2H Homo sapiens (Human) "DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]" nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]" 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0000737; GO:0000738; GO:0003690; GO:0003697; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0006364; GO:0008408; GO:0016607 EVAEMLK 4.710000038 1 1 0.193641914 832.8056231 0 15.92908 15.22622 0 0 15.36425 15.0902 0 14.94303 0 0 16.32403 14.53963 12.95926 0 0 14.91206 16.87276 15.10693 12.71432 18.19032 15.14252 15.79872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1578 15.576 14.03452 0 0 0 0 12.56759 0 Q9GZR5 ELOV4_HUMAN "Elongation of very long chain fatty acids protein 4, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4, ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)" ELOVL4 Homo sapiens (Human) "fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176] "endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] GO:0005783; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102337; GO:0102756 SEKQLMIENGK 3.420000076 1 1 0.15433079 1293.675445 0 0 11.20054 9.734181 0 0 0 0 8.868941 0 11.27504 0 0 14.02817 0 0 0 0 12.94003 0 0 0 0 13.916 13.60743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.27632 0 0 0 0 Q9GZR7 DDX24_HUMAN "ATP-dependent RNA helicase DDX24, EC 3.6.4.13 (DEAD box protein 24)" DDX24 Homo sapiens (Human) RNA metabolic process [GO:0016070] membrane [GO:0016020]; nucleolus [GO:0005730] membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887 YMDVVK 2.819999933 1 1 3.47E-13 752.7228348 16.72612 14.12609 0 0 0 14.13128 0 0 0 0 16.10697 15.87158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.65184 0 13.52023 0 0 14.3462 Q9GZS0 DNAI2_HUMAN Dynein axonemal intermediate chain 2 (Axonemal dynein intermediate chain 2) DNAI2 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777] GO:0003341; GO:0003777; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0009897; GO:0036126; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0060271; GO:0120293 EADAIK 12.75 0.02438182 0.02438182 0.345078336 647.0417998 14.0672 0 0 0 0 0 0 0 0 14.85263 15.55427 14.72702 15.22716 16.71901 16.75338 14.90399 14.27439 16.21499 0 0 0 0 16.05185 0 0 0 0 15.70122 0 16.56195 16.12854 15.88889 0 0 0 15.53056 0 0 17.17404 0 16.03656 0 0 0 0 16.83115 0 17.35879 Q9GZS1 RPA49_HUMAN "DNA-directed RNA polymerase I subunit RPA49, RNA polymerase I subunit A49 (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53)" POLR1E PAF53 PRAF1 Homo sapiens (Human) nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362] DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179] GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005730; GO:0005736; GO:0006362; GO:0042790 SALGPGVPHIINTK 15.75 1 1 0.219415226 1403.981867 0 0 16.16232 0 0 0 0 0 0 0 0 0 14.99322 0 14.69243 0 0 0 0 14.15407 16.10802 0 0 0 0 16.10032 0 15.73595 16.7271 15.38173 16.19217 14.69987 15.51842 15.77315 13.31266 15.28992 0 17.00495 0 15.84159 0 0 0 0 0 16.8004 0 0 Q9GZS9 CHST5_HUMAN "Carbohydrate sulfotransferase 5, EC 2.8.2.- (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha, GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase, I-GlcNAc6ST, Intestinal GlcNAc-6-sulfotransferase, hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3, GlcNAc6ST-3, Gn6st-3)" CHST5 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790] N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0008146; GO:0016021; GO:0018146; GO:0031228 GTISKQDVCK 9.25 0.457912415 0.457912415 0.153954378 1136.697098 0 0 0 0 16.17536 0 13.36668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.63175 0 0 0 0 0 0 0 0 0 0 16.54522 0 0 0 0 0 0 0 0 15.58071 0 0 0 Q9GZT4 SRR_HUMAN "Serine racemase, EC 5.1.1.18 (D-serine ammonia-lyase) (D-serine dehydratase, EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase, EC 4.3.1.17)" SRR Homo sapiens (Human) aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006563; GO:0007420; GO:0007568; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0043278; GO:0045177; GO:0070178; GO:0070179 SLVPDALER 5.400000095 0.414609611 0.414609611 0.229216448 1000.23391 17.02715 19.5539 17.63839 17.27312 16.58006 0 18.62808 16.70123 0 16.39377 15.6747 16.77535 15.41616 15.19502 13.18874 16.84114 14.99386 14.05241 15.37618 0 0 16.4398 16.50283 13.45073 15.83519 0 16.31606 14.35936 0 16.7194 17.59894 0 0 16.49863 16.98695 17.57931 0 0 0 13.48461 0 0 0 0 16.47216 0 14.98193 0 Q9GZT8 NIF3L_HUMAN NIF3-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein) NIF3L1 ALS2CR1 MDS015 My018 Homo sapiens (Human) "negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]" cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]" identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629; GO:1903507 VMSAVK 9.460000038 0.15968217 0.15968217 0.292082303 635.1859529 15.48221 15.81797 15.98189 16.34119 16.6738 0 16.31817 16.22382 14.80838 16.8459 15.69467 15.21108 16.2031 0 16.40471 16.96368 15.84446 17.10665 0 17.82496 16.7738 0 0 16.43944 0 15.65661 15.60093 15.5273 16.89137 16.08741 16.84342 0 0 16.56382 16.79835 16.59256 16.97264 17.5272 18.18423 17.397 16.93438 16.93053 16.77308 0 17.0791 16.19825 16.40549 17.38498 Q9GZU1 MCLN1_HUMAN "Mucolipin-1, ML1 (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1, TRPML1)" MCOLN1 ML4 TRPML1 MSTP080 Homo sapiens (Human) adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; phagosome maturation [GO:0090382]; protein homotetramerization [GO:0051289]; transferrin transport [GO:0033572] cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; iron ion transmembrane transporter activity [GO:0005381]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; phagosome maturation [GO:0090382]; protein homotetramerization [GO:0051289]; transferrin transport [GO:0033572]" "calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; iron ion transmembrane transporter activity [GO:0005381]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]" GO:0001891; GO:0002250; GO:0005261; GO:0005262; GO:0005381; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006812; GO:0008289; GO:0010008; GO:0016020; GO:0016021; GO:0030670; GO:0031902; GO:0033572; GO:0042802; GO:0042995; GO:0043231; GO:0043235; GO:0051289; GO:0070588; GO:0071277; GO:0071467; GO:0072345; GO:0090382; GO:0097352; GO:0097682; GO:0099604 NLTLKFHK 8.710000038 0.975512922 0.975512922 0.173924595 997.8741097 14.93236 13.45307 11.8991 0 15.72537 13.44088 0 15.90743 0 0 0 0 0 0 0 15.10818 0 0 0 0 0 0 0 0 14.94437 11.03064 13.06718 13.59017 14.69532 13.95165 14.41334 14.38493 0 16.4114 0 9.195875 0 0 0 15.66239 15.01678 15.38142 15.05174 0 0 15.20771 14.59855 15.48967 Q9GZU7 CTDS1_HUMAN "Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 3, NLI-IF, NLI-interacting factor 3) (Small C-terminal domain phosphatase 1, SCP1, Small CTD phosphatase 1)" CTDSP1 NIF3 NLIIF SCP1 Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] GO:0001933; GO:0004721; GO:0005634; GO:0005654; GO:0006357; GO:0006470; GO:0008420; GO:0045665; GO:0046872; GO:0050768; GO:0070062; GO:2000134 QPRPGS 1.929999948 0.408535033 0.408535033 0.300323414 641.803403 0 15.74841 0 13.04684 0 15.42739 14.57754 16.73081 15.02726 15.60631 15.94076 16.65716 0 16.3297 15.70159 0 11.88675 15.73143 0 16.83357 0 16.41407 0 16.56926 16.96518 16.00569 17.32729 0 0 0 16.04309 16.72178 15.48748 0 16.13828 17.78235 0 0 15.59516 0 17.06318 0 0 0 17.02736 0 0 0 Q9GZU8 PIP30_HUMAN PSME3-interacting protein (NEFA-interacting nuclear protein NIP30) (PA28G-interacting protein) PSME3IP1 C16orf94 FAM192A NIP30 PIP30 CDA018 CDA10 Homo sapiens (Human) negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091] GO:0005634; GO:0032091; GO:1901799 LTVKPIETK 11.06000042 0.372963488 0.372963488 0.224518002 1026.359127 16.2508 16.77092 0 0 0 14.81361 13.96666 15.68099 17.5373 17.78691 9.501714 0 14.20851 0 14.26964 0 0 16.04279 17.7688 0 12.55776 0 0 0 13.96031 17.38556 0 18.71832 0 17.64887 17.59422 17.90093 18.27032 0 15.77513 0 16.47782 17.46672 0 14.33614 0 15.04338 14.31169 14.39925 16.08058 15.09833 15.88127 11.19072 Q9GZV8 PRD14_HUMAN "PR domain zinc finger protein 14, EC 2.1.1.- (PR domain-containing protein 14)" PRDM14 Homo sapiens (Human) cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459 MAPPLLSPGLGLQR 2.349999905 1 1 1.60E-12 1465.355835 0 0 13.49898 0 0 14.12915 0 12.40059 0 0 13.44726 13.68064 15.07781 11.75274 14.95439 0 11.44482 14.35694 0 0 15.31258 0 0 14.0261 0 0 0 0 15.88282 12.10318 14.70578 14.46741 14.31597 0 0 0 16.45559 0 0 15.85029 0 0 0 15.91155 0 0 0 0 Q9GZW5 SCND2_HUMAN Putative SCAN domain-containing protein SCAND2P (SCAN domain-containing protein 2 pseudogene) SCAND2P SCAND2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357 EPGRQR 5.53000021 1 1 0.171738078 743.4832608 0 0 0 15.58657 15.51769 14.39421 0 0 15.02742 14.69444 0 0 15.09779 0 15.46198 0 14.02258 15.41823 16.57159 15.05729 15.5425 0 0 0 0 0 0 14.40153 17.02137 14.43271 16.01791 16.37692 0 0 13.00288 0 16.50364 15.92296 0 15.10456 16.6718 16.42514 14.99292 14.77845 16.41351 16.25993 15.74097 16.03503 Q9GZX5 ZN350_HUMAN Zinc finger protein 350 (KRAB zinc finger protein ZFQR) (Zinc finger and BRCA1-interacting protein with a KRAB domain 1) (Zinc finger protein ZBRK1) ZNF350 ZBRK1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]" GO:0000122; GO:0000978; GO:0001162; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016363; GO:0016604; GO:0017053; GO:0045892; GO:0046872 NVVLVGQPVVRCAASGDNR 2.059999943 1 1 0.331506737 2010.643604 14.41382 13.37753 6.699728 0 14.67505 11.6804 13.01462 14.13629 0 0 14.94358 13.24947 11.55399 0 0 0 0 14.43338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4681 0 0 0 0 0 0 0 0 0 0 15.98665 Q9GZX6 IL22_HUMAN "Interleukin-22, IL-22 (Cytokine Zcyto18) (IL-10-related T-cell-derived-inducible factor, IL-TIF)" IL22 ILTIF ZCYTO18 UNQ3099/PRO10096 Homo sapiens (Human) acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; response to glucocorticoid [GO:0051384] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-22 receptor binding [GO:0045518]; acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; response to glucocorticoid [GO:0051384] cytokine activity [GO:0005125]; interleukin-22 receptor binding [GO:0045518] GO:0005125; GO:0005576; GO:0005615; GO:0006953; GO:0006954; GO:0045518; GO:0051384 LFHGVSMSERCYLMK 5.28000021 1 1 2.06E-12 1873.697337 0 13.20728 12.08588 0 15.41809 14.5286 0 10.52957 0 0 0 0 0 11.51999 14.22467 0 13.87431 14.11619 0 14.55207 12.86017 13.21731 0 12.87737 12.54325 15.50459 14.67742 14.82208 14.10967 14.10408 0 0 14.7717 13.48483 13.66912 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZX7 AICDA_HUMAN "Single-stranded DNA cytosine deaminase, EC 3.5.4.38 (Activation-induced cytidine deaminase, AID) (Cytidine aminohydrolase)" AICDA AID Homo sapiens (Human) B cell differentiation [GO:0030183]; cellular response to lipopolysaccharide [GO:0071222]; cytidine to uridine editing [GO:0016554]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; isotype switching [GO:0045190]; mRNA processing [GO:0006397]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; regulation of nuclear cell cycle DNA replication [GO:0033262]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; B cell differentiation [GO:0030183]; cellular response to lipopolysaccharide [GO:0071222]; cytidine to uridine editing [GO:0016554]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; isotype switching [GO:0045190]; mRNA processing [GO:0006397]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; regulation of nuclear cell cycle DNA replication [GO:0033262]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0006397; GO:0008270; GO:0010529; GO:0016445; GO:0016446; GO:0016554; GO:0030183; GO:0031625; GO:0032991; GO:0033262; GO:0042742; GO:0042802; GO:0045190; GO:0045869; GO:0047844; GO:0051607; GO:0070383; GO:0071222; GO:0080111; GO:0090310 AGVQIAIMTFK 9.010000229 0.150648668 0.150648668 0.269862353 1178.014154 13.06302 0 13.34073 0 13.63089 0 12.81255 0 0 0 0 11.90673 0 13.95552 9.150756 0 0 0 0 0 0 0 0 0 14.16207 0 14.09708 0 0 0 15.1392 0 15.45798 0 0 0 0 0 0 0 14.09998 14.84602 0 0 0 0 13.90312 0 Q9GZZ1 NAA50_HUMAN "N-alpha-acetyltransferase 50, hNaa50p, EC 2.3.1.258 (N-acetyltransferase 13) (N-acetyltransferase 5, hNAT5) (N-acetyltransferase san homolog, hSAN) (N-epsilon-acetyltransferase 50, EC 2.3.1.-) (NatE catalytic subunit)" NAA50 MAK3 NAT13 NAT5 Homo sapiens (Human) "establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]" H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858] GO:0004596; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0010485; GO:0016573; GO:0031415; GO:0034087; GO:0052858; GO:0070062; GO:0071962 LGIGTKMLNHVLNICEK 1.870000005 1 1 0.41142013 1938.887964 16.56183 17.19668 0 0 0 14.45637 15.64454 0 0 0 0 16.68034 17.39896 0 0 0 0 0 0 13.06263 0 0 0 0 0 0 0 16.11626 0 0 0 15.86653 15.88578 14.35519 15.83328 0 14.97033 0 0 15.66564 12.62271 0 0 13.46561 0 0 0 0 Q9GZZ6 ACH10_HUMAN "Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10, NACHR alpha-10)" CHRNA10 NACHRA10 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; neurotransmitter receptor activity [GO:0030594]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; neurotransmitter receptor activity [GO:0030594]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005102; GO:0005262; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0007271; GO:0010996; GO:0016020; GO:0022848; GO:0030424; GO:0030594; GO:0034220; GO:0042127; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050877; GO:0050910; GO:0051899; GO:0070373; GO:0098981; GO:0099060 HDGAVR 4.889999866 0.624562085 0.624562085 0.194579868 655.482812 15.82483 17.02465 16.25749 16.49524 14.51961 16.37824 16.8194 0 0 16.58235 16.57196 15.87043 0 15.29807 0 17.12958 0 15.66803 17.82379 0 17.89018 0 0 0 17.20718 15.82733 0 15.13963 16.73313 15.9116 16.07405 16.89565 15.48178 16.85497 16.10456 17.30272 17.23947 0 17.32495 17.332 16.35985 17.43142 19.17821 0 0 17.24043 17.15958 16.35129 Q9GZZ9 UBA5_HUMAN "Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)" UBA5 UBE1DC1 Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270] GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008270; GO:0030218; GO:0030219; GO:0032446; GO:0033146; GO:0034976; GO:0042803; GO:0043231; GO:0050905; GO:0061709; GO:0071566; GO:0071569; GO:1990592 SGDGGGGRVR 8.199999809 1 1 0.153473361 918.1015036 15.33524 0 0 0 0 0 15.75657 0 9.172726 14.91339 14.51215 16.8825 0 14.36978 0 0 16.71535 0 0 0 0 0 17.03204 0 0 14.32848 0 0 0 0 15.6523 0 0 0 0 0 0 16.01858 0 0 0 0 0 0 0 0 0 0 Q9H000 MKRN2_HUMAN "E3 ubiquitin-protein ligase makorin-2, EC 2.3.2.27 (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2)" MKRN2 RNF62 HSPC070 Homo sapiens (Human) "negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription factor catabolic process [GO:1901485]; protein kinase B signaling [GO:0043491]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription factor catabolic process [GO:1901485]; protein kinase B signaling [GO:0043491]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]" LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0002862; GO:0003723; GO:0005634; GO:0006351; GO:0016567; GO:0030274; GO:0043491; GO:0045944; GO:0046872; GO:0061630; GO:1901223; GO:1901485 ASASER 7.480000019 0.80494231 0.80494231 0.290019253 619.0486496 0 15.74781 14.70691 0 14.47948 15.67846 13.7065 15.25413 14.84827 15.10576 0 15.95052 14.0201 17.01181 15.53121 13.66036 15.7089 14.67598 0 13.99132 16.22932 15.90058 17.25053 16.21004 16.95031 16.29646 16.08285 16.99816 13.61549 15.64916 0 0 15.69801 0 0 0 15.97723 0 0 14.22325 0 0 0 0 0 0 17.38913 0 Q9H013 ADA19_HUMAN "Disintegrin and metalloproteinase domain-containing protein 19, ADAM 19, EC 3.4.24.- (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker, MADDAM)" ADAM19 MLTNB FKSG34 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; protein processing [GO:0016485] collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; protein processing [GO:0016485] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; SH3 domain binding [GO:0017124] GO:0001890; GO:0004222; GO:0005634; GO:0005794; GO:0005886; GO:0006509; GO:0010628; GO:0016021; GO:0016485; GO:0017124; GO:0042987; GO:0046872; GO:0062023; GO:1902945; GO:2000049 FYRSLNIR 8.229999542 1 1 0.177388314 1067.876648 0 16.16299 8.484024 0 0 0 12.9901 13.91917 13.27524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.36576 0 0 0 0 14.09508 13.9339 0 0 0 0 12.34955 0 0 0 0 0 0 0 0 0 Q9H019 MFR1L_HUMAN Mitochondrial fission regulator 1-like MTFR1L FAM54B HYST1888 MSTP116 Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266] GO:0000266; GO:0005739; GO:0009060 DFHRMK 8.449999809 0.810491204 0.810491204 0.250122283 849.8129233 0 16.16842 14.9325 15.30795 14.01789 14.79143 11.90189 0 0 14.84684 0 16.10771 15.24498 13.57737 0 14.86863 0 13.11279 14.15309 0 0 0 0 0 15.68937 13.89779 0 0 10.26445 14.36943 15.84932 15.19975 12.44207 17.13771 0 16.65826 14.33632 14.72624 8.81749 11.09503 11.2493 13.15464 14.18037 15.03547 13.62389 13.03656 16.81364 0 Q9H061 T126A_HUMAN Transmembrane protein 126A TMEM126A Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981]; optic nerve development [GO:0021554] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]; optic nerve development [GO:0021554] GO:0005739; GO:0005743; GO:0016021; GO:0021554; GO:0032981 ALQLSEPGKEIH 9.779999733 1 1 0.095129511 1322.525174 14.91821 13.62521 13.86376 14.80894 0 0 0 0 15.10635 0 0 0 0 0 16.56619 0 0 14.90963 0 16.88941 16.06863 0 18.94054 19.09512 0 0 0 0 0 0 15.68973 0 0 0 0 0 0 16.52809 0 0 0 0 0 0 0 0 0 0 Q9H063 MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog MAF1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480] RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006] GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016479; GO:0016480; GO:0043231 EPSLSWVVNAVNCSLFSAVREDFK 3.569999933 0.859968662 0.859968662 2.29E-12 2754.029989 0 16.95201 12.51505 16.59333 14.1618 0 0 14.00508 0 0 0 0 14.15344 0 0 0 14.24282 0 0 0 11.76169 0 16.17472 0 0 0 0 13.554 0 0 0 0 16.09551 0 13.95113 0 0 12.70881 14.4845 0 0 0 0 0 0 0 11.34368 0 Q9H074 PAIP1_HUMAN "Polyadenylate-binding protein-interacting protein 1, PABP-interacting protein 1, PAIP-1, Poly(A)-binding protein-interacting protein 1" PAIP1 Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" RNA binding [GO:0003723]; translation activator activity [GO:0008494] GO:0003723; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008494; GO:0048255; GO:0070934; GO:0106002; GO:1900152; GO:2000767 APPSSQDK 15.67000008 1 1 0.192947182 829.0639436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32447 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4775 0 0 15.57088 15.36306 17.17182 0 15.89367 0 0 16.00074 0 0 0 0 0 0 0 Q9H089 LSG1_HUMAN "Large subunit GTPase 1 homolog, hLsg1, EC 3.6.1.-" LSG1 Homo sapiens (Human) nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000054; GO:0003924; GO:0005525; GO:0005654; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0016020; GO:0016604; GO:0051168 APAGGSLGR 10.93999958 0.599353969 0.599353969 0.101360379 784.9228261 0 15.73595 15.61285 14.77239 0 0 14.4603 15.88264 14.95865 0 0 15.13461 0 15.45524 14.37639 16.14413 13.91372 0 15.06304 0 0 0 0 15.24734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H091 ZMY15_HUMAN Zinc finger MYND domain-containing protein 15 ZMYND15 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]" histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872] GO:0005634; GO:0005737; GO:0007286; GO:0042826; GO:0045892; GO:0046872 ELESLVPR 5.28000021 1 1 0.185261547 944.4529152 14.56995 13.01451 14.14954 12.18694 12.86602 0 0 13.02511 15.35671 15.37371 0 12.81818 13.61467 12.90064 13.83961 15.4047 14.13967 15.71221 0 14.87051 14.35636 16.72796 14.28536 0 0 0 0 0 0 0 0 0 0 15.20816 0 0 15.84614 0 0 0 0 0 0 0 14.65531 0 0 0 Q9H095 DRC9_HUMAN Dynein regulatory complex protein 9 (IQ domain-containing protein G) IQCG DRC9 Homo sapiens (Human) cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544] GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0030544; GO:0031514; GO:0036126; GO:0044782; GO:0070062 DQLQEMKAK 8.539999962 0.743875027 0.743875027 0.178921813 1090.126009 0 16.52489 14.28607 14.04548 0 0 0 15.9247 16.5704 0 15.44558 14.64957 16.84737 15.60555 12.95718 15.59685 0 0 0 0 16.92753 16.16443 0 14.61573 15.21715 15.35202 15.49622 0 0 15.52481 0 0 16.29128 0 0 16.15243 0 17.55665 0 0 15.89897 15.68368 0 16.89121 17.43942 18.37205 0 0 Q9H0A0 NAT10_HUMAN "RNA cytidine acetyltransferase, EC 2.3.1.- (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein, hALP)" NAT10 ALP KIAA1709 Homo sapiens (Human) negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391] "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]" ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049] GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883 NMGKPAQPALSR 8.510000229 1 1 0.587854016 1269.233061 14.00113 0 0 0 0 18.39783 17.22464 0 0 18.25316 0 0 16.57709 17.76476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.61659 0 19.44019 18.50736 0 0 0 0 18.90069 0 17.71495 0 0 0 17.00126 0 17.11424 16.70055 Q9H0B3 IQCN_HUMAN IQ domain-containing protein N IQCN KIAA1683 Homo sapiens (Human) mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nucleus [GO:0005634] GO:0005634; GO:0005739 NKAVVPPR 8.159999847 0.918161273 0.918161273 0.250945118 880.8853012 17.43479 0 16.49165 16.48267 0 16.95868 0 16.71081 16.21853 17.09992 15.987 0 15.28324 0 0 11.80537 14.10051 13.99651 15.85702 0 11.87164 16.01441 14.00829 12.42791 0 0 0 0 16.37608 0 0 17.15623 16.69764 17.45241 0 14.70534 0 0 16.93371 15.45643 0 16.16653 0 14.87426 15.53392 14.4755 0 16.62177 Q9H0B6 KLC2_HUMAN "Kinesin light chain 2, KLC 2" KLC2 Homo sapiens (Human) lysosome localization [GO:0032418] cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; lysosome localization [GO:0032418] cadherin binding [GO:0045296]; kinesin binding [GO:0019894] GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0016020; GO:0016938; GO:0019894; GO:0032418; GO:0032991; GO:0045296 DMAGGAGPR 4.309999943 1 1 0.125625106 848.5525278 0 0 15.3596 0 14.9575 15.58085 15.82278 15.37716 0 14.76672 14.93216 16.57422 16.58003 16.11826 0 14.45607 15.32422 15.95961 0 14.71896 0 0 0 15.87165 0 0 0 0 0 0 0 0 0 0 0 0 13.2243 0 0 0 0 14.39032 0 0 0 0 0 0 Q9H0B8 CRLD2_HUMAN "Cysteine-rich secretory protein LCCL domain-containing 2 (Cysteine-rich secretory protein 11, CRISP-11) (LCCL domain-containing cysteine-rich secretory protein 2)" CRISPLD2 CRISP11 LCRISP2 UNQ2914/PRO1156/PRO9783 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; lung development [GO:0030324] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; lung development [GO:0030324] glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201] GO:0005539; GO:0005576; GO:0005615; GO:0008201; GO:0030133; GO:0030198; GO:0030324; GO:0031012; GO:0034774; GO:0060325; GO:0070062; GO:1904813 HGVQSLSK 8.770000458 1 1 0.045084743 855.4008843 14.04383 14.90515 0 0 0 13.96356 16.61639 17.18854 15.15597 0 0 0 17.07934 0 0 13.43235 0 13.32291 0 0 0 15.397 0 0 14.98059 0 0 0 0 0 0 14.57778 0 0 0 0 0 0 0 14.62154 0 0 0 0 13.17863 0 0 14.24863 Q9H0C1 ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 ZMYND12 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 APQKTIFVLK 4.300000191 0.210415304 0.210415304 0.159620199 1146.715991 15.71357 16.10484 0 10.14774 9.332247 0 0 0 10.48302 16.13523 15.27858 0 0 0 13.95368 13.40371 10.50391 12.5724 0 0 0 0 0 0 0 0 13.57678 0 14.20843 13.71109 0 0 0 15.89622 0 0 0 0 0 0 16.84602 9.163834 14.28783 0 12.81666 0 14.76704 16.00097 Q9H0C2 ADT4_HUMAN "ADP/ATP translocase 4 (ADP,ATP carrier protein 4) (Adenine nucleotide translocator 4, ANT 4) (Solute carrier family 25 member 31) (Sperm flagellar energy carrier protein)" SLC25A31 AAC4 ANT4 SFEC Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; regulation of mitochondrial membrane permeability [GO:0046902]; spermatogenesis [GO:0007283] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP:ADP antiporter activity [GO:0005471]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; regulation of mitochondrial membrane permeability [GO:0046902]; spermatogenesis [GO:0007283] ATP:ADP antiporter activity [GO:0005471] GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005757; GO:0005886; GO:0007141; GO:0007283; GO:0016020; GO:0030154; GO:0031514; GO:0046902; GO:0140021; GO:1990544 EFFHIDIGGR 5.079999924 0.345462024 0.345462024 4.58E-13 1191.17696 0 14.04699 0 12.29107 0 0 14.93056 0 13.20125 0 0 0 0 0 0 16.31544 0 0 16.41812 0 0 15.98477 17.59159 0 14.05019 12.0799 15.83672 0 0 0 0 0 0 0 13.815 0 16.57137 0 0 0 17.19092 0 17.06402 0 12.44706 0 11.23437 0 Q9H0C5 BTBD1_HUMAN "BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8, HCV NS5A-transactivated protein 8)" BTBD1 C15orf1 NS5ATP8 Homo sapiens (Human) muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393] cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0043393; GO:0097602 VLGKALSLIR 4.380000114 1 1 0.165106856 1069.174617 0 13.73594 14.18475 14.52371 15.18002 0 15.63004 14.92328 13.87856 0 14.00108 0 0 14.16835 0 12.83358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.21882 0 0 0 12.14186 0 0 0 0 0 0 0 Q9H0C8 ILKAP_HUMAN "Integrin-linked kinase-associated serine/threonine phosphatase 2C, ILKAP, EC 3.1.3.16" ILKAP Homo sapiens (Human) protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0046872 CLLDTFK 9.970000267 1 1 0.22541029 897.4321432 0 0 0 0 0 16.75519 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64096 0 17.83824 0 0 0 18.49714 17.45676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.50896 0 0 0 0 0 0 Q9H0D2 ZN541_HUMAN Zinc finger protein 541 ZNF541 Homo sapiens (Human) "cell differentiation [GO:0030154]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0003714; GO:0005634; GO:0005667; GO:0006357; GO:0007283; GO:0016575; GO:0030154; GO:0045892; GO:0046872 APGLEKR 4.820000172 0.851288795 0.851288795 0.301375201 770.8145597 15.36015 15.7352 14.764 14.73682 14.37032 13.26031 0 15.69923 15.67436 16.09703 0 16.1698 16.27548 16.40188 18.35439 17.16978 16.08699 16.72314 0 17.56962 17.58369 15.99478 17.23993 0 0 15.8219 17.09958 16.90599 15.67656 16.35263 16.91667 16.5294 17.63465 17.46931 16.41787 16.4633 17.25026 16.52509 18.24319 0 18.49311 18.32402 15.44533 18.36598 17.5959 16.86685 17.97766 17.06997 Q9H0D6 XRN2_HUMAN "5'-3' exoribonuclease 2, EC 3.1.13.- (DHM1-like protein, DHP protein)" XRN2 Homo sapiens (Human) "DNA catabolic process, exonucleolytic [GO:0000738]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]" aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process, exonucleolytic [GO:0000738]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]" 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147] GO:0000175; GO:0000738; GO:0000956; GO:0001147; GO:0003723; GO:0004518; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006396; GO:0006397; GO:0006401; GO:0007283; GO:0008409; GO:0016020; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0046872; GO:0060041 ASKEGMEAAVEK 10.68000031 0.013812316 0.013812316 0 1265.100791 0 0 0 0 0 0 0 0 0 0 0 0 15.23914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0E2 TOLIP_HUMAN Toll-interacting protein TOLLIP Homo sapiens (Human) autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" "interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]" GO:0005150; GO:0005576; GO:0005737; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0070062; GO:0070498 CSEEDLK 13.09000015 1 1 0.287164534 880.9600942 17.66363 0 0 0 0 0 17.31713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.71321 0 0 0 Q9H0E9 BRD8_HUMAN "Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa, TrCP120) (p120)" BRD8 SMAP SMAP2 Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812] "mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966] GO:0000786; GO:0000812; GO:0005654; GO:0005739; GO:0006325; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779 IRTMAQFLR 12.22000027 1 1 0.27931616 1151.30857 0 18.82732 16.52691 18.80519 18.25732 0 0 17.08381 0 0 17.9883 0 18.81336 0 0 16.79996 0 0 16.26997 0 16.69205 17.28313 0 0 17.66389 0 0 0 18.33439 20.16133 0 0 19.14732 0 18.88932 0 17.26824 0 0 20.51041 18.61263 18.71498 15.62194 0 0 16.85269 0 0 Q9H0F6 SHRPN_HUMAN "Sharpin (Shank-associated RH domain-interacting protein) (Shank-interacting protein-like 1, hSIPL1)" SHARPIN SIPL1 PSEC0216 Homo sapiens (Human) apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; defense response to bacterium [GO:0042742]; keratinization [GO:0031424]; mitochondrion organization [GO:0007005]; negative regulation of inflammatory response [GO:0050728]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; regulation of CD40 signaling pathway [GO:2000348]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] cytosol [GO:0005829]; dendrite [GO:0030425]; LUBAC complex [GO:0071797]; postsynaptic density [GO:0014069]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; dendrite [GO:0030425]; LUBAC complex [GO:0071797]; postsynaptic density [GO:0014069]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; defense response to bacterium [GO:0042742]; keratinization [GO:0031424]; mitochondrion organization [GO:0007005]; negative regulation of inflammatory response [GO:0050728]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; regulation of CD40 signaling pathway [GO:2000348]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0004842; GO:0005829; GO:0007005; GO:0007420; GO:0010803; GO:0014069; GO:0030262; GO:0030425; GO:0031424; GO:0031593; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0050728; GO:0071797; GO:0097039; GO:2000348 AIAGGDEK 14.21000004 0.233004838 0.233004838 0.245983904 759.5869559 19.01592 19.21 18.77011 18.67752 20.05325 19.31039 18.80353 18.68625 18.31357 20.14748 18.69583 18.57305 16.89666 10.30636 19.37906 18.93717 17.92997 18.76429 18.80968 15.97965 19.07611 18.71085 18.98738 20.85943 19.32279 19.35939 19.07925 20.14248 17.7483 0 19.39909 20.7866 19.56663 17.86197 20.00443 19.95266 16.88657 21.63467 18.49464 0 18.96799 17.79499 17.8399 0 19.69236 0 18.49721 17.8776 Q9H0G5 NSRP1_HUMAN "Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70, NSrp70)" NSRP1 CCDC55 NSRP70 Homo sapiens (Human) "developmental process [GO:0032502]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; developmental process [GO:0032502]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032502; GO:1990904 LLLGKDR 30.29999924 0.485611171 0.485611171 0.281968989 814.8470264 0 0 18.20695 0 18.11944 17.94889 18.46047 18.92677 18.3996 17.62738 19.166 18.96109 15.45549 0 0 18.21522 18.03672 19.34581 20.48925 0 19.22278 19.14331 17.88166 18.47176 18.73318 0 0 0 17.95053 18.33802 0 19.74084 18.40956 19.24829 16.86963 0 18.45974 18.73609 20.58807 18.40497 18.44481 0 18.9876 17.66986 0 16.44547 0 0 Q9H0H0 INT2_HUMAN "Integrator complex subunit 2, Int2" INTS2 KIAA1287 Homo sapiens (Human) snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472 ETSSSVLWQMR 2.920000076 1 1 0.375506646 1337.673673 0 0 0 0 0 0 0 0 15.67332 0 0 0 0 0 15.345 15.33948 16.08643 16.01019 0 0 0 0 0 14.12747 0 16.4695 15.58875 0 0 13.62244 0 0 0 0 15.47428 16.25363 15.83798 15.22534 16.29635 0 14.59057 16.68668 0 17.48228 16.21315 0 15.33006 0 Q9H0H5 RGAP1_HUMAN "Rac GTPase-activating protein 1 (Male germ cell RacGap, MgcRacGAP) (Protein CYK4 homolog, CYK4, HsCYK-4)" RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] "acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]" "alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]" GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007165; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149 SALDVK 9.979999542 1 1 0.11961192 632.4493567 15.40092 16.91081 14.21474 15.54627 15.31279 0 16.08129 16.64241 0 0 0 16.0438 14.85217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0I3 CC113_HUMAN Coiled-coil domain-containing protein 113 CCDC113 HSPC065 Homo sapiens (Human) cilium assembly [GO:0060271] axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; protein-containing complex [GO:0032991] axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271] GO:0005930; GO:0032991; GO:0034451; GO:0036064; GO:0060271 KGSILATQK 1.799999952 1 1 0.188341372 945.3762128 0 0 13.88961 0 14.61267 16.33751 0 0 0 0 0 15.98518 0 0 0 12.77352 15.38067 0 14.99087 0 0 0 0 0 14.53689 0 0 0 0 0 0 15.36318 0 0 17.96705 0 15.244 0 0 15.82716 0 0 15.41649 14.55069 14.93861 0 0 0 Q9H0I9 TKTL2_HUMAN "Transketolase-like protein 2, EC 2.2.1.1" TKTL2 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802] metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802] GO:0004802; GO:0005737; GO:0030976; GO:0046872 MMANDAKPDVK 6.320000172 0.961455762 0.961455762 0.408517548 1236.522213 0 0 0 11.40362 0 15.65348 0 0 0 0 0 15.76705 0 16.01462 0 0 0 0 0 15.86097 16.90672 0 0 0 0 0 0 14.86673 0 0 16.61358 14.97382 0 17.25429 0 16.54608 17.59055 16.82141 17.41079 0 0 16.28582 0 15.63766 0 17.85209 17.13502 0 Q9H0K1 SIK2_HUMAN "Serine/threonine-protein kinase SIK2, EC 2.7.11.1 (Qin-induced kinase) (Salt-inducible kinase 2, SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2)" SIK2 KIAA0781 QIK SNF1LK2 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0042149; GO:0046626; GO:0046777; GO:0106310 ITKTEVAIK 9.619999886 0.392222553 0.392222553 0.062349437 1003.716447 14.80489 14.98094 12.7535 16.33522 14.65419 0 14.25814 15.15406 13.46065 0 15.00536 0 14.89146 16.59633 15.62088 14.48135 0 14.80781 13.61963 13.75767 14.8551 13.37949 9.178871 13.64829 11.72674 15.84023 16.39966 16.34008 13.22918 13.69073 13.28065 16.35639 18.96231 15.34585 15.46908 9.71436 15.75462 16.82297 12.67268 14.82825 0 12.84651 12.6837 0 15.92213 15.66918 17.16326 0 Q9H0K6 PUS7L_HUMAN "Pseudouridylate synthase PUS7L, EC 5.4.99.- (Pseudouridylate synthase 7 homolog-like protein)" PUS7L Homo sapiens (Human) pseudouridine synthesis [GO:0001522] nucleus [GO:0005634] nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GO:0001522; GO:0003723; GO:0005634; GO:0009982 ERALLEALHR 5.619999886 1 1 0.131371523 1209.362044 8.856058 0 9.175364 0 0 0 0 0 0 14.62208 0 0 0 13.75602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.27389 17.80389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0L4 CSTFT_HUMAN "Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant, CSTF 64 kDa subunit tau variant) (TauCstF-64)" CSTF2T KIAA0689 Homo sapiens (Human) pre-mRNA cleavage required for polyadenylation [GO:0098789] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; pre-mRNA cleavage required for polyadenylation [GO:0098789] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0043231; GO:0098789 STGAS 9.840000153 1 1 5.74E-14 422.6194663 18.03576 0 17.66824 0 0 0 0 12.69505 0 0 0 0 0 0 0 0 0 13.2154 0 0 0 15.51478 0 0 0 0 15.24244 0 0 0 0 0 14.91746 0 13.59791 0 0 0 0 15.27276 0 0 0 0 0 0 0 0 Q9H0M0 WWP1_HUMAN "NEDD4-like E3 ubiquitin-protein ligase WWP1, EC 2.3.2.26 (Atrophin-1-interacting protein 5, AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1, Tiul1) (WW domain-containing protein 1)" WWP1 Homo sapiens (Human) "central nervous system development [GO:0007417]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; central nervous system development [GO:0007417]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]" ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007417; GO:0016567; GO:0034220; GO:0043161; GO:0045732; GO:0045892; GO:0046718; GO:0061630; GO:0070062 LYVIFR 17.05999947 0.017740052 0.017740052 0.209467 809.5188359 16.62877 15.42319 0 0 15.29463 0 15.22123 16.10831 15.52451 16.47909 15.29063 0 15.83754 16.18199 15.12598 15.80373 15.84733 15.88391 16.3589 15.34421 0 15.63223 0 16.31364 16.77408 15.56309 15.3991 0 16.39047 15.96503 16.95887 16.5291 15.79342 16.55532 16.30462 16.16704 17.26458 14.39145 16.63798 14.76554 0 15.77979 15.48281 16.63386 16.05791 15.87764 0 15.09424 Q9H0M5 ZN700_HUMAN Zinc finger protein 700 ZNF700 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KWSDQNIEYEYQNPR 6.449999809 1 1 6.89E-13 1969.490382 0 0 0 0 0 0 0 0 12.89575 0 0 0 0 0 0 0 14.3154 14.84554 0 14.60872 13.31919 12.4682 0 0 0 0 0 13.63056 13.59171 15.10468 13.99922 0 15.97711 0 14.88264 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0N5 PHS2_HUMAN "Pterin-4-alpha-carbinolamine dehydratase 2, PHS 2, EC 4.2.1.96 (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor)" PCBD2 DCOH2 DCOHM Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]" nucleus [GO:0005634] "nucleus [GO:0005634]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; positive regulation of transcription, DNA-templated [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]" 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505] GO:0004505; GO:0005634; GO:0006729; GO:0008124; GO:0042802; GO:0045893 LTAEERNQAILDLK 6.130000114 1 1 0.353222036 1614.240321 15.41329 15.82991 14.28023 10.25757 0 0 0 14.305 14.99687 13.88312 0 14.01046 15.05261 0 0 15.39126 15.05638 15.64506 13.81673 0 0 0 0 0 0 16.29208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0R6 GATA_HUMAN "Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial, Glu-AdT subunit A, EC 6.3.5.7 (Glutaminyl-tRNA synthase-like protein 1)" QRSL1 Homo sapiens (Human) glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of protein stability [GO:0031647] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of protein stability [GO:0031647] ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567] GO:0005524; GO:0005739; GO:0030956; GO:0031647; GO:0032543; GO:0050567; GO:0070681 EGFNDVVRGR 2.299999952 1 1 0.265315615 1149.171248 0 0 17.48808 0 0 0 16.58263 0 0 0 0 0 0 0 0 0 16.29986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27371 0 0 0 18.74582 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0T7 RAB17_HUMAN Ras-related protein Rab-17 RAB17 Homo sapiens (Human) cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of melanosome localization [GO:0032401]; filopodium assembly [GO:0046847]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; regulation of dendrite development [GO:0050773]; regulation of endocytosis [GO:0030100]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; transcytosis [GO:0045056] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of melanosome localization [GO:0032401]; filopodium assembly [GO:0046847]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; regulation of dendrite development [GO:0050773]; regulation of endocytosis [GO:0030100]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; transcytosis [GO:0045056] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0002415; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0016323; GO:0016324; GO:0019003; GO:0030100; GO:0030139; GO:0030425; GO:0032401; GO:0032402; GO:0032456; GO:0042470; GO:0043025; GO:0045056; GO:0046847; GO:0050773; GO:0051489; GO:0051963; GO:0055037; GO:0055038; GO:0060271; GO:0070062 MAQAHR 8.489999771 1 1 0.238780747 729.9781277 0 17.97478 16.80386 17.56268 0 0 17.70718 0 16.58943 20.20324 14.27884 18.62162 18.13648 0 17.69527 0 0 0 0 0 0 0 0 18.07945 19.29135 22.31088 0 17.71157 17.99837 0 0 0 20.40703 0 19.64631 0 0 0 0 0 0 17.837 0 17.87498 0 0 0 0 Q9H0U9 TSYL1_HUMAN "Testis-specific Y-encoded-like protein 1, TSPY-like protein 1" TSPYL1 TSPYL Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone binding [GO:0042393] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006334; GO:0019899; GO:0042393 MSGLDGVKR 6.340000153 0.236970708 0.236970708 0.156993333 962.721934 13.66215 16.21885 17.44893 14.7994 17.99494 17.04575 18.27511 14.98822 0 17.76183 0 10.64735 15.78389 16.33676 15.92894 13.34032 16.51995 16.03131 15.46127 15.56272 13.9515 16.12687 14.57019 16.36396 17.90945 11.33124 0 16.90522 17.66233 0 18.22022 0 17.58448 0 16.11114 16.94553 18.75885 17.3063 16.574 16.95988 16.61703 16.08987 14.44509 13.93531 8.149832 14.29411 18.15115 0 Q9H0V9 LMA2L_HUMAN "VIP36-like protein (Lectin mannose-binding 2-like, LMAN2-like protein)" LMAN2L VIPL PSEC0028 UNQ368/PRO704 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031] mannose binding [GO:0005537]; metal ion binding [GO:0046872] GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0005794; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0015031; GO:0016021; GO:0030134; GO:0046872 HLTIMMDIDGK 4.190000057 1 1 2.37E-13 1306.754131 14.84793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0W5 CCDC8_HUMAN Coiled-coil domain-containing protein 8 CCDC8 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; regulation of mitotic nuclear division [GO:0007088] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; microtubule cytoskeleton organization [GO:0000226]; regulation of mitotic nuclear division [GO:0007088] GO:0000226; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:1990393 VISKPATK 6.610000134 0.550064743 0.550064743 0.273061623 844.3194163 15.96797 0 0 15.94363 14.72144 14.41477 13.49865 0 16.10612 0 0 15.54805 0 17.14102 18.53679 0 0 17.31922 17.75682 15.66145 18.80821 17.62112 0 17.28378 17.95523 17.77566 18.44279 16.77245 11.34125 16.35007 16.47978 16.7847 15.0383 16.38298 17.38696 15.88088 18.93357 18.62912 14.38015 17.97475 16.41158 17.9872 16.99012 15.89064 18.29953 19.0224 18.99348 18.41108 Q9H0W8 SMG9_HUMAN Nonsense-mediated mRNA decay factor SMG9 SMG9 C19orf61 Homo sapiens (Human) "brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" cytosol [GO:0005829] "cytosol [GO:0005829]; identical protein binding [GO:0042802]; brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" identical protein binding [GO:0042802] GO:0000184; GO:0001654; GO:0001701; GO:0005829; GO:0007420; GO:0007507; GO:0042802 ERGGNQTSGIDFFITQER 6.28000021 0.160778835 0.160778835 0.330115923 2055.090679 0 13.59133 13.71155 15.75921 0 13.03393 16.46328 15.7805 0 14.79237 0 0 13.07457 0 0 6.732439 0 0 0 14.9147 0 0 0 0 15.89665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0X4 F234A_HUMAN Protein FAM234A (Protein ITFG3) FAM234A C16orf9 ITFG3 Homo sapiens (Human) cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] GO:0009986; GO:0016021; GO:0070062 VVRLGEGGPDSDQAIR 4.650000095 1 1 0.167319846 1668.362731 0 13.62334 0 0 0 13.892 0 0 14.78958 14.88315 14.45317 0 0 0 0 0 10.48284 12.08729 16.45253 0 14.55749 0 14.76772 0 0 0 0 0 15.47902 0 0 0 0 0 0 0 14.32767 15.11425 0 15.53777 14.21812 0 0 0 0 0 0 0 Q9H0Y0 ATG10_HUMAN "Ubiquitin-like-conjugating enzyme ATG10, EC 2.3.2.- (Autophagy-related protein 10, APG10-like)" ATG10 APG10L PP12616 Homo sapiens (Human) autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031] cytosol [GO:0005829] cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031] Atg12 transferase activity [GO:0019777] GO:0005829; GO:0006497; GO:0006914; GO:0006983; GO:0015031; GO:0016236; GO:0019777; GO:0031401; GO:0032446 MEEDEFIGEKTFQR 7.480000019 1 1 0.329121194 1756.98659 15.4482 16.08127 16.59998 15.77356 0 14.86251 0 0 16.39693 0 0 14.26653 0 0 14.72296 0 0 0 0 14.26124 0 15.5056 16.13799 0 15.4295 15.59994 14.07611 0 0 13.69849 16.63158 0 13.45254 15.19838 14.99626 14.56317 16.34148 13.77204 0 14.89954 13.71427 6.690953 0 0 0 16.1577 15.49662 15.29762 Q9H114 CSTL1_HUMAN Cystatin-like 1 (RCET11) CSTL1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869] cysteine-type endopeptidase inhibitor activity [GO:0004869] GO:0004869; GO:0005576 SQMQLTTGVEYIVTVKIGWTK 2.700000048 1 1 1.84E-12 2399.007927 0 17.47472 14.69602 0 14.81452 0 0 0 0 0 0 16.36393 0 0 0 0 0 0 0 0 15.31632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3891 0 0 0 0 0 15.18566 0 Q9H116 GZF1_HUMAN GDNF-inducible zinc finger protein 1 (Zinc finger and BTB domain-containing protein 23) (Zinc finger protein 336) GZF1 ZBTB23 ZNF336 Homo sapiens (Human) "branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001658; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0043565; GO:0045892; GO:0046872 ASNGMSSDLPPKK 6.480000019 1 1 0.454404845 1348.305455 0 0 0 0 17.29205 0 0 0 19.69785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.78655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H160 ING2_HUMAN "Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein, ING1Lp) (p32) (p33ING2)" ING2 ING1L Homo sapiens (Human) "chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]" CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580] "CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877] GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0007141; GO:0007165; GO:0007283; GO:0007286; GO:0008285; GO:0016580; GO:0016602; GO:0030317; GO:0030336; GO:0030511; GO:0030512; GO:0031065; GO:0035064; GO:0035091; GO:0040008; GO:0044877; GO:0045893; GO:0046872; GO:0048133; GO:0072520; GO:1902166; GO:1902455; GO:1902459; GO:2000772; GO:2001020 AKMDSSQPER 2.480000019 1 1 0.121430816 1163.849215 0 0 0 0 12.26956 0 0 15.7031 14.0023 0 0 9.67966 15.37477 0 0 0 0 0 0 0 8.377573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.50055 0 0 0 0 0 0 0 13.43899 0 9.840538 Q9H165 BC11A_HUMAN "B-cell lymphoma/leukemia 11A, BCL-11A (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog, EVI-9) (Zinc finger protein 856)" BCL11A CTIP1 EVI9 KIAA1809 ZNF856 Homo sapiens (Human) cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynaptic density [GO:0014069]; SWI/SNF complex [GO:0016514] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynaptic density [GO:0014069]; SWI/SNF complex [GO:0016514]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]" GO:0000122; GO:0000978; GO:0001067; GO:0001227; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016363; GO:0016514; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042382; GO:0042803; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:0140297; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173 VFKNCSNLTVHR 10.67000008 1 1 2.46E-13 1475.031423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H172 ABCG4_HUMAN "ATP-binding cassette sub-family G member 4, EC 7.6.2.-" ABCG4 WHITE2 Homo sapiens (Human) "cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of transcription, DNA-templated [GO:0006355]" ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016021; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0071403; GO:1990830 ALDVEDAK 1.090000033 1 1 0.199609689 860.9416962 0 15.68062 0 14.71664 0 14.65502 14.8651 14.7251 0 0 0 0 0 17.27331 13.45088 0 0 16.2414 0 13.75232 17.3351 0 0 0 0 0 15.88886 0 0 0 12.42949 0 0 16.47287 0 0 16.0475 17.88317 15.78138 0 16.7379 15.86762 0 0 17.63781 0 0 0 Q9H173 SIL1_HUMAN "Nucleotide exchange factor SIL1 (BiP-associated protein, BAP)" SIL1 UNQ545/PRO836 Homo sapiens (Human) cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457] adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082] GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082 LDINTNTYTSQDLKSALAK 7.21999979 0.971170723 0.971170723 0.101346554 2095.89743 0 0 0 15.66901 12.42557 0 0 0 0 0 0 0 14.50679 0 0 11.92928 12.79585 11.53314 0 0 0 0 0 0 0 11.88563 0 0 0 0 0 12.92172 17.10417 0 12.46179 15.2419 0 0 0 0 0 0 0 0 14.12481 0 0 0 Q9H175 CSRN2_HUMAN "Cysteine/serine-rich nuclear protein 2, CSRNP-2 (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12, TAIP-12)" CSRNP2 C12orf22 FAM130A1 TAIP12 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0019902; GO:0043565; GO:0045944 THYLHTIMKLELESK 8.199999809 1 1 3.20E-12 1859.305165 13.63206 10.70197 12.24531 13.01493 13.53862 11.34267 14.31274 14.21389 0 14.5528 12.02812 13.47748 16.23491 13.3421 16.38209 13.6079 0 15.35506 14.89346 0 0 16.46389 17.08965 0 0 14.33901 0 13.38195 13.93397 0 13.60275 0 0 0 0 0 0 13.14595 0 13.80426 14.65219 15.608 11.705 0 15.79069 0 0 14.24117 Q9H190 SDCB2_HUMAN "Syntenin-2 (Similar to TACIP18, SITAC) (Syndecan-binding protein 2)" SDCBP2 SITAC18 Homo sapiens (Human) cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399]" "identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]" GO:0005546; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007399; GO:0008022; GO:0008283; GO:0016607; GO:0035556; GO:0042802; GO:0042803; GO:0046907; GO:0046982; GO:0070062 TVTMHK 6.980000019 0.284868926 0.284868926 0.225080622 715.726943 0 0 0 15.34362 0 14.75735 15.12701 14.10261 13.89902 16.05704 15.27638 15.08898 0 0 0 0 16.12565 17.17656 0 0 0 0 16.01222 16.47324 0 0 15.91219 0 0 0 0 0 0 0 17.72182 0 15.22621 17.79735 0 0 15.14899 14.04849 15.81628 15.04561 0 0 0 14.1454 Q9H1A4 APC1_HUMAN "Anaphase-promoting complex subunit 1, APC1 (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)" ANAPC1 TSG24 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] molecular adaptor activity [GO:0060090] GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070979 LAPLLLGNPQPMVM 2.359999895 1 1 1.38E-12 1510.627092 0 0 0 0 14.40184 14.33894 14.65515 0 13.82803 14.30873 15.53511 12.92595 0 14.0503 0 0 0 15.65237 0 0 0 0 0 0 14.08651 15.26843 0 0 0 0 0 0 0 0 0 0 0 0 0 16.46193 0 0 0 0 0 0 15.56831 0 Q9H1A7 RPB1C_HUMAN "DNA-directed RNA polymerase II subunit RPB11-b2, RNA polymerase II subunit B11-b2, RPB11b2 (DNA-directed RNA polymerase II subunit J3)" POLR2J3 Homo sapiens (Human) "RNA polymerase II, core complex [GO:0005665]" "RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]" DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055] GO:0001055; GO:0003677; GO:0005665; GO:0046983 VPNACLFTMNKEDHTLGNIIK 5.650000095 1 1 0.339464522 2431.970503 0 12.92719 0 14.43237 0 13.73551 14.07667 0 0 15.19523 0 15.12169 11.61789 0 12.79751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.99532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1B5 XYLT2_HUMAN "Xylosyltransferase 2, EC 2.4.2.26 (Peptide O-xylosyltransferase 1) (Xylosyltransferase II, XT-II, XylT-II)" XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210] extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210] magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158] GO:0000139; GO:0000287; GO:0005615; GO:0006024; GO:0015012; GO:0016021; GO:0030145; GO:0030158; GO:0030203; GO:0030206; GO:0030210; GO:0050650 LSLHHAATAAPPMGTPLCRFEPR 3.119999886 1 1 0 2530.62354 11.57957 15.98624 14.61905 15.60595 0 0 0 0 15.56412 0 0 0 0 0 0 16.06866 0 0 0 0 16.90112 0 0 0 0 0 0 0 0 0 15.90755 0 0 0 0 15.3967 0 0 0 0 0 17.31955 0 0 0 0 0 0 Q9H1B7 I2BPL_HUMAN "Probable E3 ubiquitin-protein ligase IRF2BPL, EC 2.3.2.27 (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like)" IRF2BPL C14orf4 EAP1 KIAA1865 My039 Homo sapiens (Human) development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] GO:0000122; GO:0003714; GO:0005615; GO:0005634; GO:0005654; GO:0006357; GO:0007399; GO:0045944; GO:0046543; GO:0046872; GO:0061630 ASPEPPDSAEGALK 8.729999542 1 1 0.200704982 1369.794802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1C0 LPAR5_HUMAN "Lysophosphatidic acid receptor 5, LPA receptor 5, LPA-5 (G-protein coupled receptor 92) (G-protein coupled receptor 93)" LPAR5 GPR92 GPR93 Homo sapiens (Human) behavioral response to pain [GO:0048266]; positive regulation of CREB transcription factor activity [GO:0032793] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; behavioral response to pain [GO:0048266]; positive regulation of CREB transcription factor activity [GO:0032793] G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021; GO:0032793; GO:0048266 GLGTPHRAR 4.710000038 0.914154291 0.914154291 0.051748514 963.8730028 15.39855 0 0 14.70123 13.28864 14.51457 10.97896 0 14.61768 13.4326 14.70831 16.1291 0 15.52787 0 15.82345 13.08101 0 13.38784 16.07475 0 15.99156 13.25349 19.17022 0 15.38943 15.02195 14.35871 15.59797 13.51397 16.56946 16.41857 0 17.35141 14.01852 0 13.1052 17.01584 13.22694 16.11177 15.47782 14.34476 13.36382 0 17.51224 0 17.20313 14.90356 Q9H1C3 GL8D2_HUMAN "Glycosyltransferase 8 domain-containing protein 2, EC 2.4.1.-" GLT8D2 GALA4A UNQ1901/PRO4347 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757] glycosyltransferase activity [GO:0016757] GO:0005794; GO:0016021; GO:0016757 WIEHSK 5.820000172 0.028309584 0.028309584 0.219544859 799.1207729 16.49601 16.58575 0 15.52088 12.01095 14.56944 15.07868 0 15.58684 16.62771 0 0 16.17398 0 10.58976 15.27841 15.83722 13.79241 13.69703 13.06125 0 14.7612 16.0687 14.02287 0 0 15.03516 15.07495 15.5547 14.61045 0 0 0 0 0 0 0 0 16.03132 15.88748 15.42439 0 0 0 14.78457 0 0 0 Q9H1D0 TRPV6_HUMAN "Transient receptor potential cation channel subfamily V member 6, TrpV6 (CaT-like, CaT-L) (Calcium transport protein 1, CaT1) (Epithelial calcium channel 2, ECaC2)" TRPV6 ECAC2 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592] calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872] GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703 AQIVATTVMLERK 11.21000004 1 1 0.176194717 1473.145819 0 18.06448 14.98497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1D9 RPC6_HUMAN "DNA-directed RNA polymerase III subunit RPC6, RNA polymerase III subunit C6 (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit, RPC39)" POLR3F Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690] GO:0003690; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607 LLSMGQLDLLRSNTGLLYR 5.03000021 1 1 0.12556679 2180.317984 14.3709 14.10376 0 13.99103 10.99112 0 10.44418 0 12.8084 17.303 0 0 0 0 12.61873 14.81814 16.38981 0 14.39312 12.43923 0 0 0 0 0 0 0 12.22919 0 0 0 0 0 0 0 0 15.22897 0 0 0 0 0 0 0 0 0 13.0726 0 Q9H1H9 KI13A_HUMAN Kinesin-like protein KIF13A (Kinesin-like protein RBKIN) KIF13A RBKIN Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588] centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383 QPQSSGPDR 9.989999771 1 1 0.033757598 970.7811901 14.85335 13.86041 16.00016 15.35284 13.82914 13.79251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1I8 ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100) ASCC2 ASC1P100 RQT3 Homo sapiens (Human) "DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]" activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]" ubiquitin binding [GO:0043130] GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0016607; GO:0043130; GO:0072344; GO:0099053; GO:1990116 TMADRK 6.010000229 1 1 0.124011235 737.6094845 0 15.12164 0 0 0 15.07835 12.64023 14.26988 0 16.49403 15.07565 14.67565 0 14.7444 0 15.62828 0 0 16.14955 0 0 0 0 0 0 0 0 0 0 0 16.3457 16.73162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.50712 0 Q9H1J1 REN3A_HUMAN "Regulator of nonsense transcripts 3A (Nonsense mRNA reducing factor 3A) (Up-frameshift suppressor 3 homolog A, hUpf3)" UPF3A RENT3A UPF3 Homo sapiens (Human) "mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162] GO:0000184; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0017056; GO:0035145; GO:0042162; GO:0043231; GO:0045727; GO:0051028 AYINFRNPDDILLFR 15.51000023 0.690544188 0.690544188 0.079651708 1866.815202 0 15.34391 0 0 0 0 0 17.85833 14.73273 14.18251 15.86353 14.50844 0 0 13.96125 15.07193 0 0 15.40118 0 14.60758 0 15.63945 0 0 17.3193 0 14.94723 0 0 15.67571 13.77767 0 0 0 0 0 0 0 15.08359 16.35606 0 0 14.79403 0 0 15.7961 14.92414 Q9H1J7 WNT5B_HUMAN Protein Wnt-5b WNT5B Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fat cell differentiation [GO:0045444]; lens fiber cell development [GO:0070307]; muscle cell differentiation [GO:0042692]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; wound healing [GO:0042060] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fat cell differentiation [GO:0045444]; lens fiber cell development [GO:0070307]; muscle cell differentiation [GO:0042692]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; wound healing [GO:0042060] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102] GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0030182; GO:0030335; GO:0030666; GO:0042060; GO:0042692; GO:0045165; GO:0045444; GO:0060070; GO:0070062; GO:0070307; GO:0071300; GO:1904105; GO:2000052 TSEGMDGCELMCCGR 6.630000114 0.874397159 0.874397159 0.653382028 1758.687171 0 0 0 0 0 0 0 0 17.82404 0 19.76508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1K4 GHC2_HUMAN "Mitochondrial glutamate carrier 2, GC-2 (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18)" SLC25A18 GC2 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490] amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857] GO:0005280; GO:0005313; GO:0005743; GO:0006811; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0043490 ASFAHSFVSGCVAGSIAAVAVTPLDVLK 3.75999999 1 1 3.66E-12 2775.031356 0 0 13.06017 0 0 0 0 13.10537 0 0 0 14.33302 14.51704 0 0 0 14.9578 0 14.77143 0 14.1938 14.99013 15.27362 16.12513 0 11.03689 0 0 13.80082 15.39141 15.53239 0 16.22072 13.76073 0 0 0 0 0 14.51922 0 15.9146 14.05031 0 14.84367 0 0 0 Q9H1R2 DUS15_HUMAN "Dual specificity protein phosphatase 15, EC 3.1.3.16, EC 3.1.3.48 (VH1-related member Y) (Vaccinia virus VH1-related dual-specific protein phosphatase Y)" DUSP15 C20orf57 VHY Homo sapiens (Human) dephosphorylation [GO:0016311]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; regulation of oligodendrocyte differentiation [GO:0048713]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; regulation of oligodendrocyte differentiation [GO:0048713]; transforming growth factor beta receptor signaling pathway [GO:0007179] phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0004722; GO:0004725; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0016311; GO:0016791; GO:0042127; GO:0046330; GO:0048713 EATGRTAQR 8.239999771 1 1 0.144869505 991.4871156 0 12.26747 15.42136 0 14.22795 0 13.8368 15.05502 0 15.69982 0 0 0 14.17779 12.85559 0 14.51492 0 15.0463 15.88781 15.07254 0 0 0 14.99767 14.81508 0 14.20464 16.17645 15.42445 12.95922 14.31463 0 0 8.467731 0 13.84549 16.13758 0 13.71456 12.14535 13.60447 0 0 0 0 0 13.4807 Q9H1R3 MYLK2_HUMAN "Myosin light chain kinase 2, skeletal/cardiac muscle, MLCK2, EC 2.7.11.18" MYLK2 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; synapse [GO:0045202] cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; synapse [GO:0045202]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687] GO:0004683; GO:0004687; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006941; GO:0007274; GO:0010628; GO:0014816; GO:0018107; GO:0030017; GO:0032027; GO:0032971; GO:0035914; GO:0045202; GO:0046777; GO:0055008; GO:0060048 KISSSGALMALGV 10.21000004 1 1 0.041418521 1249.014861 0 0 0 0 0 15.15887 12.93111 15.83158 15.20975 15.92642 16.64548 17.62223 14.95251 0 18.90784 16.78766 16.19293 15.70187 0 12.76342 17.39785 0 0 15.1684 14.72714 0 0 0 0 0 0 17.91963 0 0 12.28081 16.4364 0 16.89609 16.18886 0 0 0 17.08979 0 14.10012 0 16.54632 0 Q9H1U9 S2551_HUMAN Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51) SLC25A51 MCART1 Homo sapiens (Human) aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD transmembrane transporter activity [GO:0051724]; aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549] NAD transmembrane transporter activity [GO:0051724] GO:0005739; GO:0005743; GO:0016021; GO:0019646; GO:0051724; GO:1990549 KLINLFR 27.20999908 0.44640258 0.44640258 0.121819576 902.9543308 16.88802 17.99907 17.48167 17.45041 17.53748 18.7892 17.67192 18.95832 17.33355 16.20312 18.0891 19.12809 17.11414 15.553 0 18.76184 0 22.25785 16.56961 16.40319 0 14.95687 18.15185 17.72357 18.20272 14.24952 20.2333 17.35037 23.72417 18.10652 19.70723 19.66617 16.80838 19.78578 17.37875 20.48249 17.89869 17.80889 17.87788 16.02909 18.16017 19.67735 17.70824 15.87437 18.64359 0 14.27794 22.72392 Q9H1X1 RSPH9_HUMAN Radial spoke head protein 9 homolog RSPH9 C6orf206 MRPS18AL1 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177] GO:0003341; GO:0005930; GO:0031514; GO:0035082; GO:0044458; GO:0060091; GO:0060294; GO:0062177; GO:0097729; GO:1904158 VNEGEK 14.57999992 3.32E-06 3.32E-06 0.25195628 674.1039996 20.65605 20.52758 18.1935 16.15888 0 20.34824 19.34332 18.70576 17.29583 19.96032 20.59048 0 0 0 18.45887 21.80714 17.28886 20.99034 20.21926 0 20.07142 20.87279 21.32685 19.28791 21.54696 20.17049 20.41895 20.98436 0 20.76389 18.85024 0 0 21.57589 21.19347 21.39755 20.58323 20.24975 20.0321 19.82789 18.85635 18.78556 20.16923 19.17173 21.16659 0 17.71118 0 Q9H1Y0 ATG5_HUMAN Autophagy protein 5 (APG5-like) (Apoptosis-specific protein) ATG5 APG5L ASP Homo sapiens (Human) aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015] GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009410; GO:0009620; GO:0010040; GO:0016020; GO:0016236; GO:0019883; GO:0030424; GO:0030670; GO:0031397; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061684; GO:0061739; GO:0070257; GO:0071500; GO:1901096; GO:1902017; GO:1902617; GO:1904973; GO:2000378; GO:2000619 SFPEKDLLHCPSK 12.13000011 1 1 0.292589365 1557.366696 0 0 16.80527 0 17.16171 0 16.95651 0 18.33031 0 0 16.23516 15.29762 0 0 0 0 0 0 0 0 0 0 0 0 15.62737 0 0 0 0 16.47423 0 0 0 20.04713 0 0 0 0 0 0 0 0 16.53875 0 0 16.51071 0 Q9H201 EPN3_HUMAN Epsin-3 (EPS-15-interacting protein 3) EPN3 Homo sapiens (Human) endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; EH domain binding [GO:1990175]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897] clathrin binding [GO:0030276]; EH domain binding [GO:1990175]; phospholipid binding [GO:0005543] GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005905; GO:0006897; GO:0019897; GO:0030125; GO:0030136; GO:0030276; GO:0043231; GO:0048471; GO:0070062; GO:1990175 SWQGDGSPMANGAGAVVHHQRDR 2.720000029 1 1 0.126862591 2448.461627 15.68393 15.01586 14.72465 0 0 14.88717 14.28961 0 15.25872 15.48773 0 13.6718 14.86213 0 0 14.11593 0 0 14.59422 0 0 0 15.68574 0 12.41987 0 0 0 0 0 0 17.02674 0 0 15.46782 0 15.81285 0 0 0 0 14.5258 16.06592 0 14.29202 0 0 0 Q9H221 ABCG8_HUMAN "ATP-binding cassette sub-family G member 8, EC 7.6.2.- (Sterolin-2)" ABCG8 Homo sapiens (Human) bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982] GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0009410; GO:0010949; GO:0014850; GO:0015914; GO:0015918; GO:0016324; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0070328; GO:0120020; GO:0140359 VRSGQMLAIIGSSGCGR 4.670000076 1 1 2.31E-13 1765.80903 15.12493 9.634257 14.67983 13.377 11.19189 14.44883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H222 ABCG5_HUMAN "ATP-binding cassette sub-family G member 5, EC 7.6.2.- (Sterolin-1)" ABCG5 Homo sapiens (Human) bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982] GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0009410; GO:0010212; GO:0010949; GO:0014850; GO:0015918; GO:0016324; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0070328; GO:0120020; GO:0140359 RGNPGSFQK 5.079999924 1 1 0.20006019 990.4394643 0 0 18.08224 0 18.39827 0 19.45244 0 0 18.5954 0 0 0 0 0 0 18.4125 0 0 0 0 0 0 18.74948 0 0 0 16.13296 0 0 0 20.65349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H237 PORCN_HUMAN "Protein-serine O-palmitoleoyltransferase porcupine, EC 2.3.1.250 (Protein MG61)" PORCN MG61 PORC PPN Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; acyltransferase activity [GO:0016746]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] acyltransferase activity [GO:0016746]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147] GO:0005783; GO:0005789; GO:0006497; GO:0009100; GO:0016020; GO:0016055; GO:0016746; GO:0017147; GO:0018345; GO:0030176; GO:0030258; GO:0032281; GO:0045234; GO:0060070; GO:0061355; GO:0098978; GO:0099072; GO:1990698 ARGTMVR 9.029999733 1 1 0.068893906 807.6178298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.16149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H239 MMP28_HUMAN "Matrix metalloproteinase-28, MMP-28, EC 3.4.24.- (Epilysin)" MMP28 MMP25 UNQ1893/PRO4339 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of macrophage chemotaxis [GO:0010760] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of macrophage chemotaxis [GO:0010760] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0004222; GO:0005615; GO:0005737; GO:0008270; GO:0010760; GO:0030198; GO:0030574; GO:0031012; GO:0062023 LQATTSGR 2.059999943 1 1 0.197612804 834.4540412 0 15.93919 15.94127 0 0 14.63639 16.34668 0 0 0 15.79431 16.1297 0 15.98402 0 15.0316 13.34277 14.79221 14.37712 0 15.99968 0 0 16.90726 16.99317 0 0 0 16.93073 16.46603 15.16207 16.47032 17.16808 0 16.44202 15.16237 15.59248 16.2537 14.48672 14.56152 16.03119 14.21036 14.92857 14.72452 14.60457 14.02959 15.95197 15.62975 Q9H251 CAD23_HUMAN Cadherin-23 (Otocadherin) CDH23 KIAA1774 KIAA1812 UNQ1894/PRO4340 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426] catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742 DAYVGALR 9.890000343 0.352170259 0.352170259 0.198622158 864.0825178 13.88221 13.92824 14.45699 16.60576 14.87474 14.33047 14.92056 14.95006 0 15.14051 14.99735 16.26744 0 0 0 0 14.58307 0 0 0 0 0 0 0 0 17.14864 0 13.56604 13.41364 0 0 17.04358 0 0 0 15.69692 0 16.26485 0 11.08083 0 14.49283 14.60047 0 16.46012 15.47107 0 0 Q9H254 SPTN4_HUMAN "Spectrin beta chain, non-erythrocytic 4 (Beta-IV spectrin) (Spectrin, non-erythroid beta chain 3)" SPTBN4 KIAA1642 SPTBN3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; fertilization [GO:0009566]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192] actin filament [GO:0005884]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091] actin filament [GO:0005884]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein-membrane anchor activity [GO:0106006]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; fertilization [GO:0009566]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein-membrane anchor activity [GO:0106006]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200] GO:0002028; GO:0003779; GO:0005200; GO:0005543; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0007409; GO:0007605; GO:0007628; GO:0008091; GO:0009566; GO:0010459; GO:0014704; GO:0016020; GO:0016192; GO:0016363; GO:0016605; GO:0019226; GO:0019902; GO:0021952; GO:0030036; GO:0030054; GO:0030506; GO:0030507; GO:0030864; GO:0033135; GO:0033268; GO:0033270; GO:0040018; GO:0042995; GO:0043025; GO:0043194; GO:0043203; GO:0045162; GO:0051015; GO:0051693; GO:0061337; GO:0070062; GO:0070852; GO:0072659; GO:0106006 AEELPR 13.81000042 1 1 0.25565547 713.7066182 17.72709 16.34432 13.70852 0 16.30834 15.70607 0 0 0 0 0 0 17.70743 16.65168 0 0 16.94424 16.40064 16.97254 0 16.24788 0 17.81187 0 18.38654 18.15493 17.65232 17.6123 16.18961 0 19.003 0 20.77873 17.88274 17.31119 18.35926 0 17.67775 0 0 0 0 16.03751 18.05418 18.27921 0 17.16416 0 Q9H267 VP33B_HUMAN "Vacuolar protein sorting-associated protein 33B, hVPS33B" VPS33B Homo sapiens (Human) collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vacuole [GO:0005773]; vesicle tethering complex [GO:0099023] clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vacuole [GO:0005773]; vesicle tethering complex [GO:0099023]; protein-containing complex binding [GO:0044877]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] protein-containing complex binding [GO:0044877] GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005773; GO:0005794; GO:0005829; GO:0006886; GO:0007032; GO:0015031; GO:0016192; GO:0017185; GO:0030136; GO:0030897; GO:0031091; GO:0031901; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0033263; GO:0044877; GO:0046907; GO:0048471; GO:0055037; GO:0061025; GO:0070889; GO:0090385; GO:0099023 VLLNAEDK 8.449999809 0.305293947 0.305293947 0.300171532 902.8834807 15.28268 14.46657 0 0 14.78974 0 15.06365 16.72574 14.9505 0 0 0 15.27087 0 14.31025 15.1299 15.73178 15.13321 0 15.88883 0 0 15.99484 16.59138 0 0 0 16.02419 0 0 15.48137 0 16.42686 0 0 0 0 0 0 15.4833 15.27461 0 0 0 0 0 15.65736 15.78737 Q9H269 VPS16_HUMAN "Vacuolar protein sorting-associated protein 16 homolog, hVPS16" VPS16 Homo sapiens (Human) "autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]" autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037] "autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]" actin binding [GO:0003779]; actin filament binding [GO:0051015] GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352 ASYAAEER 16.61000061 1 1 5.74E-13 895.8318718 0 0 0 0 0 0 0 13.95673 0 0 0 0 0 0 0 0 0 0 18.19853 0 0 0 13.88566 0 0 0 0 13.73385 6.030576 0 13.50536 18.12924 0 0 0 0 0 0 0 12.95613 0 0 13.42368 0 12.03305 0 0 10.44634 Q9H270 VPS11_HUMAN "Vacuolar protein sorting-associated protein 11 homolog, hVPS11 (RING finger protein 108)" VPS11 RNF108 PP3476 Homo sapiens (Human) autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630] GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0046872; GO:0048284; GO:0061630; GO:1902115; GO:1903364; GO:1903955; GO:2000643 HSKTQILHK 8.710000038 1 1 0.123447237 1092.210794 15.80563 13.71788 11.23163 12.63871 13.95448 12.79784 15.63452 15.43095 12.70741 11.58682 8.531808 14.11465 0 14.20412 11.09117 11.67978 14.17742 14.60481 11.751 13.73637 12.04197 14.97043 0 11.85701 0 0 0 15.59152 0 14.31869 14.33886 13.8619 0 0 0 12.91393 0 0 0 0 0 0 0 0 0 0 0 0 Q9H295 DCSTP_HUMAN "Dendritic cell-specific transmembrane protein, DC-STAMP, hDC-STAMP (Dendrocyte-expressed seven transmembrane protein) (IL-four-induced protein, FIND) (Transmembrane 7 superfamily member 4)" DCSTAMP TM7SF4 Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to tumor necrosis factor [GO:0071356]; membrane fusion [GO:0061025]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell growth [GO:0030308]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of bone resorption [GO:0045780]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of monocyte differentiation [GO:0045657] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular response to interleukin-4 [GO:0071353]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to tumor necrosis factor [GO:0071356]; membrane fusion [GO:0061025]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell growth [GO:0030308]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of bone resorption [GO:0045780]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of monocyte differentiation [GO:0045657] GO:0005789; GO:0005886; GO:0009986; GO:0010008; GO:0016021; GO:0030176; GO:0030308; GO:0030316; GO:0033116; GO:0034241; GO:0036006; GO:0043011; GO:0045657; GO:0045780; GO:0061025; GO:0071353; GO:0071356; GO:0072675 QMDMASADKS 6.829999924 1 1 4.60E-13 1102.75075 13.91443 13.60156 13.06237 11.74653 0 14.32401 12.36652 15.22499 0 0 15.9511 0 15.77792 16.17729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H299 SH3L3_HUMAN "SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1, SH3BP-1)" SH3BGRL3 P1725 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604] GO:0005737; GO:0016604; GO:0070062 ALAGNPK 18.45999908 1 1 0.269429255 670.7981104 0 0 0 0 15.98716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.11476 0 0 0 0 0 0 0 0 0 0 18.91438 0 0 0 0 0 18.22527 16.82181 0 15.78841 0 0 Q9H2A9 CHST8_HUMAN "Carbohydrate sulfotransferase 8, EC 2.8.2.- (GalNAc-4-O-sulfotransferase 1, GalNAc-4-ST1, GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)" CHST8 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001537; GO:0006790; GO:0007417; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0042446 FESMEDDANFFLSLIRAPR 8.18999958 1 1 0 2258.446069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.69754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2C0 GAN_HUMAN Gigaxonin (Kelch-like protein 16) GAN GAN1 KLHL16 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567] GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463 AEGSAVSDPQHAAR 6.050000191 1 1 0.314545312 1396.17439 15.78933 15.41755 13.3872 0 0 0 0 0 15.68233 0 15.71229 0 14.5027 0 0 16.38633 0 14.13703 0 16.35497 0 0 0 14.61188 13.66355 16.69263 15.87398 16.55815 15.90226 0 15.08344 15.74908 15.69104 16.21213 0 16.60589 0 0 18.10577 16.82323 17.32988 0 14.99699 0 17.47548 0 0 0 Q9H2C2 ARV1_HUMAN "Protein ARV1, hARV1" ARV1 HT035 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; sterol transporter activity [GO:0015248]; bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125] sterol transporter activity [GO:0015248] GO:0005789; GO:0005794; GO:0006665; GO:0006695; GO:0008206; GO:0015248; GO:0016021; GO:0016125; GO:0030301; GO:0032366; GO:0032383; GO:0032541; GO:0090181; GO:0097036 MGNGGRSGLQQGK 8.350000381 1 1 0.145467374 1290.392852 13.65358 0 0 0 0 13.48789 0 13.83049 14.55707 0 0 0 0 16.8551 0 0 0 0 0 0 16.67032 0 0 0 15.27012 0 0 0 0 0 13.86097 0 0 16.56762 0 14.3996 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2D6 TARA_HUMAN TRIO and F-actin-binding protein (Protein Tara) (Trio-associated repeat on actin) TRIOBP KIAA1662 TARA HRIHFB2122 Homo sapiens (Human) actin filament organization [GO:0007015]; actin modification [GO:0030047]; auditory receptor cell stereocilium organization [GO:0060088]; barbed-end actin filament capping [GO:0051016]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; stereocilium base [GO:0120044] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; stereocilium base [GO:0120044]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; auditory receptor cell stereocilium organization [GO:0060088]; barbed-end actin filament capping [GO:0051016]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of sound [GO:0007605] actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] GO:0005634; GO:0005737; GO:0005815; GO:0005925; GO:0007015; GO:0007049; GO:0007605; GO:0015629; GO:0030047; GO:0030496; GO:0031267; GO:0031625; GO:0045159; GO:0051015; GO:0051016; GO:0051301; GO:0060088; GO:0120044; GO:1900026 DDPRASSPNR 6.739999771 0.433170378 0.433170378 0.197304948 1115.285787 0 6.231592 15.77168 16.20981 0 16.35091 15.07489 13.84396 13.29191 14.91353 0 0 0 0 15.08128 0 0 14.7327 0 0 0 0 0 0 0 0 15.44455 0 0 0 0 0 0 13.83247 0 0 0 0 0 0 0 0 0 0 13.92594 0 0 0 Q9H2E6 SEM6A_HUMAN "Semaphorin-6A (Semaphorin VIA, Sema VIA) (Semaphorin-6A-1, SEMA6A-1)" SEMA6A KIAA1368 SEMAQ Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526] axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0005615; GO:0005887; GO:0006915; GO:0007010; GO:0007166; GO:0007399; GO:0007411; GO:0009887; GO:0016021; GO:0016525; GO:0030215; GO:0030335; GO:0030424; GO:0035924; GO:0045499; GO:0048843; GO:0050919; GO:0070373; GO:0071526; GO:0106089; GO:1900747; GO:1903671; GO:2001224 HLLDSPDSTDPLGAVSSHNHQDKK 3.809999943 0.267268091 0.267268091 0.040397846 2597.89282 16.98957 14.21322 15.04018 16.16522 0 0 10.9209 15.54324 0 0 15.83959 16.40068 14.94078 15.57723 13.23699 0 0 14.14249 0 0 11.0257 16.43146 0 14.54462 17.12484 0 0 0 17.6533 0 16.88713 18.56283 16.20156 17.15267 16.88341 15.59833 16.03635 0 16.1681 14.61509 14.64191 17.10015 17.08924 0 14.45416 17.20997 15.9249 14.86996 Q9H2F9 CCD68_HUMAN "Coiled-coil domain-containing protein 68 (Cutaneous T-cell lymphoma-associated antigen se57-1, CTCL-associated antigen se57-1)" CCDC68 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104] GO:0005737; GO:0005814; GO:0008104; GO:0034454; GO:0035556; GO:0120103 TEGVSPYLMLIR 26.72999954 0.440874696 0.440874696 0.131402718 1394.571363 0 0 18.33469 0 18.55191 0 0 0 15.79752 0 0 18.56637 0 0 16.25778 0 16.91885 0 0 17.25892 19.72427 19.3913 0 15.62916 15.01206 15.94761 16.97066 0 14.61721 12.71055 0 18.89117 19.09364 14.69553 14.15099 17.87745 16.96517 0 0 17.12785 14.97499 15.21805 11.55114 15.11336 0 0 12.97904 16.40754 Q9H2G2 SLK_HUMAN "STE20-like serine/threonine-protein kinase, STE20-like kinase, hSLK, EC 2.7.11.1 (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase, STE20-related kinase) (Serine/threonine-protein kinase 2)" SLK KIAA0204 STK2 Homo sapiens (Human) apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0042802; GO:0042803; GO:0042981; GO:0045296; GO:0046777; GO:0048471; GO:0051893; GO:0070062; GO:0106310 TAVIKENER 6.869999886 1 1 0.004195125 1055.851388 0 15.86507 14.75857 0 12.97826 0 0 15.17554 13.83683 0 0 15.19284 0 0 14.27202 15.0004 0 0 13.82349 0 0 15.53509 0 10.6059 14.37212 12.1517 0 0 14.80717 0 14.86895 13.81091 13.21362 0 0 0 16.95764 0 0 0 0 15.79288 0 15.8726 0 0 0 14.36182 Q9H2G4 TSYL2_HUMAN "Testis-specific Y-encoded-like protein 2, TSPY-like protein 2 (Cell division autoantigen 1) (Cutaneous T-cell lymphoma-associated antigen se20-4, CTCL-associated antigen se20-4) (Differentially-expressed nucleolar TGF-beta1 target protein) (Nuclear protein of 79 kDa, NP79)" TSPYL2 CDA1 DENTT TSPX HRIHFB2216 Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966] chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182] GO:0000182; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006334; GO:0007049; GO:0008156; GO:0009966; GO:0030308; GO:0042393; GO:0045786; GO:0045859 DEDIFR 10.22000027 1 1 0.209960934 795.1532206 11.82901 14.71 12.25107 16.21786 13.30218 14.95388 0 15.52321 0 7.76032 0 0 0 0 16.83461 15.08482 16.02701 15.98574 16.26155 0 0 14.09504 17.77158 0 0 16.12163 0 16.34091 0 17.08847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6518 0 Q9H2G9 GO45_HUMAN Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor) BLZF1 JEM1 Homo sapiens (Human) Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001] enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625] GO:0000139; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005801; GO:0007030; GO:0019899; GO:0031625; GO:0043001 AAITHDIPNK 1.669999957 0.985527337 0.985527337 0.248616618 1079.809652 0 11.77992 16.24847 0 0 15.57358 0 0 0 0 0 15.05353 15.30875 0 0 0 15.48563 0 0 0 0 0 14.88043 0 0 0 0 0 0 0 0 15.04763 0 0 16.42612 0 0 0 0 0 14.20949 0 0 0 0 16.84679 14.54075 13.95211 Q9H2H8 PPIL3_HUMAN "Peptidyl-prolyl cis-trans isomerase-like 3, PPIase, EC 5.2.1.8 (Cyclophilin J, CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3)" PPIL3 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" catalytic step 2 spliceosome [GO:0071013] "catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0000398; GO:0000413; GO:0003755; GO:0006457; GO:0071013 GGNSIWGK 6.03000021 0.396184176 0.396184176 0.057425758 819.1908141 17.86988 0 14.45874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.33507 17.3197 0 0 0 0 0 0 15.0556 0 0 0 0 0 0 12.39747 0 0 Q9H2I8 LRMDA_HUMAN Leucine-rich melanocyte differentiation-associated protein LRMDA C10orf11 CDA017 Homo sapiens (Human) melanocyte differentiation [GO:0030318] melanocyte differentiation [GO:0030318] GO:0030318 EKYLSLSGNHSSNK 6.96999979 1 1 0.463543368 1564.026457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.73804 16.97883 0 0 18.06113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2J4 PDCL3_HUMAN "Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1, VIAF-1)" PDCL3 PhLP2A VIAF1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]; protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184] GO:0001525; GO:0001938; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0010628; GO:0030036; GO:0032991; GO:0043184; GO:0044183; GO:0045766; GO:0048471; GO:0050730; GO:0050821; GO:0061077; GO:0097356; GO:1903645; GO:2000059 GILPPK 6.510000229 1 1 0.093612629 623.8054376 0 16.12813 15.75522 11.94875 15.3989 15.10789 14.73857 14.1704 0 11.55506 13.28779 14.45503 0 14.64529 0 0 0 0 0 0 15.66651 0 0 0 0 15.98272 0 14.81414 15.56163 0 0 0 0 0 0 0 0 0 0 0 0 0 16.09698 0 0 0 0 0 Q9H2K0 IF3M_HUMAN "Translation initiation factor IF-3, mitochondrial, IF-3(Mt), IF-3Mt, IF3(mt), IF3mt" MTIF3 DC38 Homo sapiens (Human) mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790] mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]" "ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" GO:0003743; GO:0005739; GO:0008135; GO:0032790; GO:0043022; GO:0043024; GO:0070124 DHGNDK 8.720000267 1 1 0.296537229 685.8449869 0 14.38284 15.71268 14.14389 0 14.66106 15.06956 15.18949 13.96458 15.43588 15.82119 15.67616 0 14.90864 0 16.27696 15.29981 16.08136 15.20921 16.20754 16.83458 15.89344 12.92636 16.99006 0 15.01788 15.46716 18.14396 16.46139 15.89618 15.71295 16.1078 14.28862 0 14.81192 16.259 16.1629 0 15.27345 0 16.44631 0 15.31596 15.12485 16.99866 15.74153 16.91328 17.02626 Q9H2K2 TNKS2_HUMAN "Poly [ADP-ribose] polymerase tankyrase-2, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 6, ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2, EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2, TANK2) (Tankyrase-like protein) (Tankyrase-related protein)" TNKS2 PARP5B TANK2 TNKL Homo sapiens (Human) "multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]" enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485] GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404 TQLCALLLAHGADPTLK 2.170000076 1 1 0.322666017 1822.15437 12.46302 0 0 13.52923 15.1392 0 11.89861 15.14809 0 0 15.54774 0 0 11.91373 0 12.91203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2K8 TAOK3_HUMAN "Serine/threonine-protein kinase TAO3, EC 2.7.11.1 (Cutaneous T-cell lymphoma-associated antigen HD-CL-09, CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A, hKFC-A) (Thousand and one amino acid protein 3)" TAOK3 DPK JIK KDS MAP3K18 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transferase activity [GO:0016740]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transferase activity [GO:0016740] GO:0000165; GO:0004674; GO:0004712; GO:0004860; GO:0005524; GO:0005737; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0035556; GO:0043408; GO:0043507; GO:0046329; GO:0046330; GO:0046777; GO:0048812; GO:0106310 EAKVAAADEK 6.900000095 1 1 0.217189863 1030.281081 13.41381 0 15.91952 14.82554 15.19307 14.63597 16.26683 0 11.3605 14.39085 0 16.10136 0 15.15119 0 0 15.4984 13.83261 0 0 14.67436 0 16.14825 15.34282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.36696 0 0 0 0 0 0 0 0 Q9H2M3 BHMT2_HUMAN "S-methylmethionine--homocysteine S-methyltransferase BHMT2, SMM-hcy methyltransferase, EC 2.1.1.10 (Betaine--homocysteine S-methyltransferase 2)" BHMT2 Homo sapiens (Human) L-methionine salvage [GO:0071267]; methylation [GO:0032259]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; methylation [GO:0032259]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477] S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270] GO:0005829; GO:0008270; GO:0032259; GO:0033477; GO:0046500; GO:0061627; GO:0070062; GO:0071267 HGSWGSGLDMHTKPWIRAR 4.949999809 1 1 0.332895875 2208.455743 14.60366 0 0 14.83189 15.35917 14.18498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2S1 KCNN2_HUMAN "Small conductance calcium-activated potassium channel protein 2, SK2, SKCa 2, SKCa2 (KCa2.2)" KCNN2 Homo sapiens (Human) ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018] cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286] GO:0005242; GO:0005516; GO:0005886; GO:0006811; GO:0006813; GO:0009986; GO:0015269; GO:0016021; GO:0016286; GO:0019904; GO:0030018; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0051393; GO:0071805; GO:0098914; GO:1901379 IDHAKVR 9.479999542 1 1 0.262722417 837.4590686 16.28125 13.76572 15.9908 13.43369 0 13.99343 11.64649 14.43041 14.88491 15.45622 0 15.76822 14.25831 15.69907 14.34339 13.91348 14.05911 14.56357 0 0 14.93071 0 0 0 0 13.17205 0 14.75012 0 0 14.32449 12.50231 0 0 16.26458 15.49068 0 15.20388 0 15.36349 14.81773 14.78279 14.26535 15.77619 14.41472 0 14.98599 0 Q9H2S9 IKZF4_HUMAN Zinc finger protein Eos (Ikaros family zinc finger protein 4) IKZF4 KIAA1782 ZNFN1A4 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]" bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0016604; GO:0019904; GO:0032991; GO:0043425; GO:0045892; GO:0045944; GO:0051260 GEHKVG 1.610000014 0.877934515 0.877934515 0.086294074 627.0507993 14.20602 0 14.40668 0 16.74318 15.52112 15.28604 17.40584 15.86332 17.03486 0 0 15.89011 0 0 0 13.58484 14.41717 14.04612 0 14.88354 15.87783 0 16.55241 16.48925 17.23085 0 13.72345 0 15.97336 14.25468 15.86608 18.41133 0 17.80006 15.3986 14.4512 15.00548 16.56542 15.70205 14.98361 15.17453 0 11.13898 0 12.72796 14.91946 14.53803 Q9H2T7 RBP17_HUMAN Ran-binding protein 17 RANBP17 Homo sapiens (Human) mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] GO:0005049; GO:0005525; GO:0005643; GO:0005737; GO:0006606; GO:0006611; GO:0031267; GO:0051028 LNFDVSSPNGILLFR 12.59000015 1 1 0.374464298 1691.921843 15.07368 14.91703 15.81195 14.26854 14.46838 14.83196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.92152 0 0 0 0 0 0 0 0 0 Q9H2U1 DHX36_HUMAN "ATP-dependent DNA/RNA helicase DHX36, EC 3.6.4.12, EC 3.6.4.13 (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1, G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)" DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]" GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070062; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767 GRHPGHLK 1.919999957 0.228513256 0.228513256 0.161822432 901.630965 16.49635 16.46186 18.48067 14.53262 15.56972 0 13.97766 13.5904 13.90928 16.81618 0 16.84681 16.23219 14.82102 0 0 11.99407 18.13228 0 16.96675 0 18.83749 0 15.08142 15.82012 17.61789 17.24996 14.90805 0 0 0 0 15.96182 18.64591 0 14.937 0 15.98469 0 0 0 0 15.28125 0 15.73869 14.50149 17.29077 15.91286 Q9H2U2 IPYR2_HUMAN "Inorganic pyrophosphatase 2, mitochondrial, EC 3.6.1.1 (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2, PPase 2)" PPA2 HSPC124 Homo sapiens (Human) diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881] inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722] GO:0000287; GO:0004427; GO:0004722; GO:0005739; GO:0005759; GO:0005829; GO:0006796; GO:0051881; GO:0071344 CNGGAINCTNVQISDSPFR 1.460000038 1 1 0.202643343 2110.592416 0 14.26525 14.72158 13.67551 0 0 12.27725 0 0 14.56783 0 0 14.88633 13.64609 0 0 11.6863 0 0 0 0 0 16.11394 11.71255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.74729 0 0 Q9H2U6 CO005_HUMAN Putative uncharacterized protein encoded by LINC00597 LINC00597 C15orf5 Homo sapiens (Human) CSCGNGK 4.090000153 1 1 0.222957914 782.2051873 17.52362 11.85556 16.90177 12.11874 15.21264 16.18511 15.89456 13.15269 16.3996 0 15.93785 17.43583 15.26696 13.93381 14.67832 0 0 15.29607 0 0 16.58786 0 0 0 17.00103 17.39947 0 0 0 16.22769 0 0 17.08538 0 0 17.19204 0 0 15.22593 0 0 0 14.92003 0 0 17.49107 15.2192 16.30792 Q9H2U9 ADAM7_HUMAN "Disintegrin and metalloproteinase domain-containing protein 7, ADAM 7 (Sperm maturation-related glycoprotein GP-83)" ADAM7 GP83 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004175; GO:0004222; GO:0005886; GO:0008237; GO:0016021 TVPGDNESEEDSKIK 4.710000038 1 1 0.37243479 1646.659791 14.95969 19.00648 0 15.68687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.10867 0 0 0 0 0 0 0 0 0 0 0 0 0 21.39651 0 0 18.96378 0 0 0 0 0 0 0 0 0 0 0 17.39708 Q9H2W6 RM46_HUMAN "39S ribosomal protein L46, mitochondrial, L46mt, MRP-L46 (Mitochondrial large ribosomal subunit protein mL46) (P2ECSL)" MRPL46 C15orf4 LIECG2 Homo sapiens (Human) mitochondrial translation [GO:0032543] cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0030054; GO:0032543 ALLLTGDFSQAGNKGHHVWVTK 3.079999924 1 1 0.169828381 2379.664799 15.42555 10.34069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.27275 0 0 0 20.82559 0 0 0 0 0 0 0 18.85472 0 0 Q9H2X0 CHRD_HUMAN Chordin CHRD UNQ217/PRO243 Homo sapiens (Human) BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine binding [GO:0019955]; BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501] cytokine binding [GO:0019955] GO:0001501; GO:0002053; GO:0005615; GO:0019955; GO:0021919; GO:0030336; GO:0030514; GO:0033504; GO:0045668; GO:0045785 DLEPELLR 6.260000229 1 1 1.94E-12 983.6128194 17.51693 0 14.39876 16.97287 0 0 16.21837 0 0 0 0 0 14.66202 0 0 0 12.98419 12.95798 0 12.28765 10.73667 0 0 0 11.66725 15.71167 17.02857 0 15.86998 0 17.65733 17.51865 17.58543 14.91672 16.17823 15.45102 0 11.69871 0 0 0 0 0 17.36982 0 16.75196 0 14.44499 Q9H2X6 HIPK2_HUMAN "Homeodomain-interacting protein kinase 2, hHIPk2, EC 2.7.11.1" HIPK2 Homo sapiens (Human) "adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]; adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]" ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790] GO:0000122; GO:0001654; GO:0001934; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006978; GO:0007179; GO:0007224; GO:0007628; GO:0008284; GO:0009952; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0030182; GO:0030218; GO:0030511; GO:0030514; GO:0030578; GO:0032092; GO:0042771; GO:0043388; GO:0043524; GO:0045766; GO:0045893; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051091; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059 YIRPVLQQVATALMK 3.480000019 1 1 0.335104935 1744.074877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2X9 S12A5_HUMAN "Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2, hKCC2) (Neuronal K-Cl cotransporter)" SLC12A5 KCC2 KIAA1176 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040] cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040] ammonium transmembrane transporter activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901] GO:0005886; GO:0005887; GO:0006811; GO:0006873; GO:0006884; GO:0006971; GO:0007268; GO:0007612; GO:0008519; GO:0009410; GO:0015108; GO:0015379; GO:0016021; GO:0019901; GO:0030644; GO:0032590; GO:0035264; GO:0040040; GO:0043005; GO:0043025; GO:0043204; GO:0045202; GO:0051452; GO:0055064; GO:0055075; GO:0060996; GO:0071944; GO:1902476; GO:1990573 NGDENYMEFLEVLTEHLDR 2.470000029 1 1 0.015864635 2323.885079 0 11.89264 12.88249 13.01646 16.01804 10.16333 12.85741 12.44267 8.713937 10.26113 13.27285 0 0 0 12.81411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2Y7 ZN106_HUMAN "Zinc finger protein 106, Zfp-106 (Zinc finger protein 474)" ZNF106 SH3BP3 ZFP106 ZNF474 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124] GO:0003723; GO:0005730; GO:0005829; GO:0008286; GO:0016020; GO:0016607; GO:0017124; GO:0046872 ASRNVEESEK 7.460000038 0.354126483 0.354126483 0.149220225 1149.489747 15.037 13.83938 16.12175 10.46533 11.11469 15.02277 15.21759 0 0 18.04118 0 15.47158 0 0 0 0 0 0 0 0 0 0 0 15.43828 15.59295 0 0 13.99003 13.71999 0 0 0 0 0 13.59837 0 0 0 14.1503 0 0 0 14.81366 0 13.17889 0 0 0 Q9H2Y9 SO5A1_HUMAN "Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4, OATP-RP4, OATPRP4) (Solute carrier family 21 member 15)" SLCO5A1 OATP5A1 SLC21A15 Homo sapiens (Human) sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252] sodium-independent organic anion transmembrane transporter activity [GO:0015347] GO:0005886; GO:0005887; GO:0015347; GO:0043231; GO:0043252 VDLSKTFSVSSALAMLQER 5.789999962 0.268917382 0.268917382 0.184045873 2098.613049 13.19501 0 0 13.61881 0 16.08351 0 0 0 0 0 13.63808 0 0 15.88678 0 0 0 0 16.21712 15.65556 15.30627 11.84095 0 14.54588 14.04403 0 0 0 0 0 0 13.49117 0 0 0 15.02271 13.61796 13.34767 14.15897 0 0 0 14.77937 0 15.29875 0 0 Q9H307 PININ_HUMAN "Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein, DRS protein, DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein)" PNN DRS MEMA Homo sapiens (Human) "cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] "catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]" DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] GO:0000398; GO:0003677; GO:0003723; GO:0005198; GO:0005882; GO:0005886; GO:0005911; GO:0007155; GO:0016020; GO:0016607; GO:0030057; GO:0071013 AVAVR 11.03999996 0.166458294 0.166458294 0.269286364 514.9300514 0 14.75514 14.17631 15.74251 0 0 15.60505 0 16.60331 0 0 16.12495 0 0 14.39802 0 14.80238 0 16.76285 15.76318 0 0 0 15.02278 14.75532 14.40707 15.67727 0 13.96036 0 0 0 15.75289 0 0 0 0 16.47415 0 0 16.49856 15.95713 0 15.71887 0 18.13325 14.59339 17.48757 Q9H313 TTYH1_HUMAN "Protein tweety homolog 1, hTTY1" TTYH1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chloride transport [GO:0006821]; filopodium assembly [GO:0046847]; ion transmembrane transport [GO:0034220]; iron ion transport [GO:0006826]; mitotic cell cycle [GO:0000278] chloride channel complex [GO:0034707]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202] chloride channel complex [GO:0034707]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iron ion transmembrane transporter activity [GO:0005381]; volume-sensitive chloride channel activity [GO:0072320]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chloride transport [GO:0006821]; filopodium assembly [GO:0046847]; ion transmembrane transport [GO:0034220]; iron ion transport [GO:0006826]; mitotic cell cycle [GO:0000278] calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iron ion transmembrane transporter activity [GO:0005381]; volume-sensitive chloride channel activity [GO:0072320] GO:0000278; GO:0005229; GO:0005254; GO:0005381; GO:0005509; GO:0005886; GO:0006821; GO:0006826; GO:0016021; GO:0030868; GO:0031527; GO:0031589; GO:0032433; GO:0034220; GO:0034707; GO:0045202; GO:0046847; GO:0072320; GO:0098609 FVQWQSSI 4.690000057 1 1 0.285018894 994.8213045 13.84519 14.60967 14.80002 0 14.54452 0 14.92447 0 15.15259 15.92591 15.15557 14.29883 14.68128 14.75832 0 0 13.72679 0 0 0 0 0 0 0 0 0 0 0 15.02114 14.94263 0 11.69176 0 0 15.18875 0 0 0 0 0 15.54176 0 0 0 0 0 0 0 Q9H324 ATS10_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 10, ADAM-TS 10, ADAM-TS10, ADAMTS-10, EC 3.4.24.-" ADAMTS10 Homo sapiens (Human) extracellular matrix organization [GO:0030198] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0001527; GO:0004222; GO:0005576; GO:0030198; GO:0031012; GO:0046872; GO:0062023 TELPALR 15.84000015 0.517626405 0.517626405 0.291596124 800.0055193 14.83519 15.16082 0 0 0 0 14.50661 13.42146 14.22093 14.94918 15.10785 13.95332 16.02132 0 10.83899 16.25899 13.72262 14.40102 0 0 16.67321 0 0 0 16.02774 0 15.68685 15.83104 16.46062 0 16.71226 0 16.37837 0 0 0 0 0 15.72663 0 14.83447 0 0 15.2143 16.66911 0 16.50483 15.19227 Q9H329 E41LB_HUMAN Band 4.1-like protein 4B (Erythrocyte membrane protein band 4.1-like 4B) (FERM-containing protein CG1) (Protein EHM2) EPB41L4B EHM2 LULU2 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; wound healing [GO:0042060] apical part of cell [GO:0045177]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; wound healing [GO:0042060] cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0008092; GO:0010628; GO:0031032; GO:0042060; GO:0045177; GO:0045785; GO:0051549 RHSTFK 5 1 1 0.074989926 775.0753459 0 14.22458 0 0 14.81319 0 0 0 0 0 0 0 0 0 0 0 0 16.21487 0 0 0 0 0 0 17.2736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.82173 0 0 0 19.8773 0 0 0 Q9H330 TM245_HUMAN Transmembrane protein 245 (Protein CG-2) TMEM245 C9orf5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ADGGGPK 12.23999977 1 1 0.145076828 601.271323 0 0 15.18013 15.15645 0 0 0 14.30425 0 0 0 0 13.56203 0 0 0 0 0 0 0 0 0 0 16.71167 0 0 0 0 0 0 0 0 0 0 0 0 17.38802 0 0 0 0 0 0 0 0 0 0 0 Q9H334 FOXP1_HUMAN "Forkhead box protein P1 (Mac-1-regulated forkhead, MFH)" FOXP1 HSPC215 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; endothelial cell activation [GO:0042118]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta production [GO:0032651]; regulation of interleukin-12 production [GO:0032655]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; T follicular helper cell differentiation [GO:0061470]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; endothelial cell activation [GO:0042118]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta production [GO:0032651]; regulation of interleukin-12 production [GO:0032655]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; T follicular helper cell differentiation [GO:0061470]" "androgen receptor binding [GO:0050681]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001227; GO:0002903; GO:0005634; GO:0005654; GO:0006357; GO:0006974; GO:0010468; GO:0010595; GO:0010629; GO:0030316; GO:0032496; GO:0032651; GO:0032655; GO:0032680; GO:0032745; GO:0036035; GO:0042116; GO:0042117; GO:0042118; GO:0042802; GO:0043621; GO:0045655; GO:0045892; GO:0046872; GO:0048661; GO:0050681; GO:0050727; GO:0050861; GO:0060766; GO:0061470; GO:1900424; GO:1901256; GO:1901509; GO:1990837; GO:2000341 EELNGAMEHTNSNESDSSPGR 4.099999905 1 1 1.83E-12 2276.811117 14.84718 11.38744 0 0 0 0 0 0 14.83901 0 0 0 0 14.24786 15.26062 0 0 15.4417 0 13.92728 14.77086 0 0 0 0 0 15.2247 0 16.56265 14.699 16.95451 13.88083 0 15.1397 15.1061 0 15.4184 0 12.67188 0 0 0 0 0 0 0 0 0 Q9H336 CRLD1_HUMAN "Cysteine-rich secretory protein LCCL domain-containing 1 (CocoaCrisp) (Cysteine-rich secretory protein 10, CRISP-10) (LCCL domain-containing cysteine-rich secretory protein 1) (Trypsin inhibitor Hl)" CRISPLD1 CRISP10 LCRISP1 UNQ342/PRO541 Homo sapiens (Human) face morphogenesis [GO:0060325]; hematopoietic stem cell homeostasis [GO:0061484] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; face morphogenesis [GO:0060325]; hematopoietic stem cell homeostasis [GO:0061484] GO:0005615; GO:0060325; GO:0061484; GO:0070062 GTTCNR 6.730000019 1 1 0.240143721 709.002545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.76291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H341 O51M1_HUMAN Olfactory receptor 51M1 (Odorant receptor HOR5'beta7) (Olfactory receptor OR11-40) OR51M1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 TKEIHR 12.34000015 0.412292182 0.412292182 0.086349518 784.5946136 21.39632 22.06487 19.25154 19.85561 20.72772 21.2096 16.7409 0 18.66049 20.327 21.01058 18.43309 18.036 17.93294 18.47264 0 18.50282 0 19.43127 18.11132 16.32931 19.79995 0 20.31249 0 19.10709 18.3955 19.85319 18.29154 18.54111 0 20.10567 21.37706 0 19.49439 19.92867 19.96715 19.8834 18.6674 0 18.48568 0 0 18.30158 19.49486 18.48118 17.16508 15.18705 Q9H344 O51I2_HUMAN Olfactory receptor 51I2 (Odorant receptor HOR5'beta12) (Olfactory receptor OR11-38) OR51I2 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 SVMATASR 9.180000305 1 1 0.22802509 838.815155 0 0 15.65112 15.94395 0 0 17.07691 0 0 14.46543 0 17.4347 0 0 14.55174 13.96443 13.27603 17.03194 0 0 0 0 14.43175 15.89287 17.21595 0 0 0 17.16403 0 0 16.55293 0 17.78285 18.79251 18.54529 15.62856 0 18.07551 0 15.94574 0 0 0 16.10081 16.36277 0 16.45939 Q9H347 UBQL3_HUMAN Ubiquilin-3 UBQLN3 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829] cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-dependent protein catabolic process [GO:0006511] polyubiquitin modification-dependent protein binding [GO:0031593] GO:0005829; GO:0006511; GO:0031593 LGLAYR 6.389999866 0.516999424 0.516999424 0.367300815 690.9450657 16.06162 0 15.01692 16.89728 17.60946 16.35135 15.49702 15.91774 16.19794 18.11746 16.04614 18.53292 0 16.73161 16.30558 0 0 0 0 0 0 0 0 17.80221 16.4662 0 0 16.21311 18.31811 16.04276 17.11437 14.10713 14.22476 19.15248 0 17.32433 17.74026 16.58595 16.40045 16.33639 17.17499 17.28291 17.03929 17.04727 16.68095 16.92192 16.50274 18.69573 Q9H3C7 GGNB2_HUMAN Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0033140; GO:0042532; GO:0060716; GO:0061099 CVCDIPTPLQTADEK 2.930000067 1 1 0.283330805 1747.348037 15.47118 15.14988 0 14.70062 14.62629 12.99811 15.28285 13.51072 13.98843 15.09192 0 14.67599 0 0 15.84818 14.48353 14.14876 0 0 0 0 0 16.50496 0 0 13.88463 0 0 15.07703 12.79993 0 13.35064 17.25262 15.00455 14.91422 0 0 0 0 0 0 15.20224 0 0 0 0 12.20485 0 Q9H3D4 P63_HUMAN "Tumor protein 63, p63 (Chronic ulcerative stomatitis protein, CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63, TP63) (Tumor protein p73-like, p73L) (p40) (p51)" TP63 KET P63 P73H P73L TP73L Homo sapiens (Human) "apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]" "chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WW domain binding [GO:0050699]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0006338; GO:0006357; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0007569; GO:0008283; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0043281; GO:0043589; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051262; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773; GO:2001235 VIDAVR 5.130000114 0.11980404 0.11980404 0.120412855 671.6446188 0 0 0 15.71023 14.71288 14.46267 0 0 0 0 14.97656 0 0 15.54393 17.53506 16.99471 0 17.10367 0 16.4179 0 13.44409 12.53132 12.0188 0 18.43249 17.04508 20.13105 13.54468 17.1121 14.68426 18.66404 0 16.94688 16.19455 18.2387 15.57975 15.55146 17.78069 17.93919 0 17.21294 15.40903 15.46171 16.14498 0 16.65505 0 Q9H3E2 SNX25_HUMAN Sorting nexin-25 SNX25 MSTP043 Homo sapiens (Human) negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801] endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231] endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801] phosphatidylinositol binding [GO:0035091] GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0035091; GO:0043231; GO:0060394 MDKALK 9.06000042 1 1 0.257834707 706.0068642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.45782 0 15.90747 0 0 0 0 0 18.70016 0 16.1475 0 0 16.20031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3F6 BACD3_HUMAN "BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3, hBACURD3 (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)" KCTD10 ULR061 MSTP028 Homo sapiens (Human) negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] identical protein binding [GO:0042802]; Notch binding [GO:0005112] GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260 EEMSGESVVSSAVPAAATR 5.630000114 0.275879979 0.275879979 0.164493887 1893.02994 18.70745 17.02778 0 15.30532 14.12353 0 0 12.66405 0 0 0 0 11.42122 0 16.4772 0 0 0 0 0 12.87055 17.07859 18.08763 0 11.95208 0 12.8819 0 14.67448 16.21519 15.42194 17.61394 16.65401 17.04898 0 14.54473 0 0 16.83106 17.99479 0 12.07416 0 15.11949 17.50914 0 0 15.57087 Q9H3G5 CPVL_HUMAN "Probable serine carboxypeptidase CPVL, EC 3.4.16.- (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein, VCP-like protein, hVLP)" CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185] serine-type carboxypeptidase activity [GO:0004185] GO:0004185; GO:0070062 VIVSLVLLMPGPCDGLFRSLYR 7.369999886 0.232752681 0.232752681 0.031601169 2506.565107 12.46656 0 8.784221 0 13.99129 0 0 0 0 0 0 0 12.76789 0 0 13.28589 0 0 0 0 0 0 0 0 0 0 0 12.08591 0 0 0 13.64083 15.02228 10.52616 0 16.46956 0 0 0 0 0 0 0 0 10.5024 10.69725 0 0 Q9H3H9 TCAL2_HUMAN "Transcription elongation factor A protein-like 2, TCEA-like protein 2 (Transcription elongation factor S-II protein-like 2)" TCEAL2 My048 MY0876G0 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] WW domain binding [GO:0050699] GO:0005634; GO:0050699 EKPESAGKAK 10.56999969 1 1 0.47031885 1045.246138 15.64239 0 15.78776 13.2431 15.30508 16.88868 16.2612 0 16.73469 0 11.87807 16.25274 16.27502 15.90984 0 16.13155 0 0 18.03618 0 0 0 15.73224 17.40932 15.42417 0 15.86147 0 0 0 0 15.8928 15.70382 0 17.0414 16.63769 17.22733 17.78366 0 17.23505 16.22276 16.30786 16.64241 16.11606 0 0 0 17.05985 Q9H3N8 HRH4_HUMAN "Histamine H4 receptor, H4R, HH4R (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144)" HRH4 GPCR105 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]" G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] GO:0004969; GO:0004993; GO:0005886; GO:0005887; GO:0006954; GO:0007187; GO:0007197; GO:0007204; GO:0007268; GO:0016907; GO:0030425; GO:0030594; GO:0043408; GO:0045202 EHVELLRAR 6.090000153 1 1 0.179317309 1119.821876 0 0 7.925398 0 9.07116 12.31292 13.88659 0 12.80916 16.08918 14.65307 15.61216 0 0 0 0 0 0 0 0 0 0 0 0 0 14.75422 0 0 16.30553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.21683 0 0 Q9H3Q1 BORG4_HUMAN Cdc42 effector protein 4 (Binder of Rho GTPases 4) CDC42EP4 BORG4 CEP4 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0003723; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007266; GO:0008360; GO:0012505; GO:0015629; GO:0015630; GO:0030838; GO:0031267; GO:0031274; GO:0045335; GO:0071346 SLSSSPVK 8.789999962 1 1 0.253163485 804.8741355 15.4714 0 14.35839 15.68378 15.96354 15.02731 15.29968 0 0 0 0 0 16.31851 0 15.1029 0 0 0 0 0 0 0 13.90048 15.8773 0 14.61725 15.67663 13.13413 0 16.36621 0 0 18.08878 18.19874 15.84658 0 0 0 0 0 0 0 0 0 15.23968 15.14205 0 15.91694 Q9H3R0 KDM4C_HUMAN "Lysine-specific demethylase 4C, EC 1.14.11.66 (Gene amplified in squamous cell carcinoma 1 protein, GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C)" KDM4C GASC1 JHDM3C JMJD2C KIAA0780 Homo sapiens (Human) blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; zinc ion binding [GO:0008270] GO:0000785; GO:0001825; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0006357; GO:0008270; GO:0008284; GO:0019827; GO:0019899; GO:0032452; GO:0032454; GO:0033169; GO:0050681; GO:0051864; GO:0060765; GO:0070544; GO:0140684; GO:1900113; GO:2000736 TSKSWR 6.130000114 1 1 0.180544274 763.6374254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3R5 CENPH_HUMAN "Centromere protein H, CENP-H (Interphase centromere complex protein 35)" CENPH ICEN35 Homo sapiens (Human) chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; kinetochore organization [GO:0051383]; mitotic spindle organization [GO:0007052] chromosome [GO:0005694]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinetochore binding [GO:0043515]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; kinetochore organization [GO:0051383]; mitotic spindle organization [GO:0007052] kinetochore binding [GO:0043515] GO:0000776; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0007052; GO:0007059; GO:0043515; GO:0051382; GO:0051383 EIVLQLEKNVDMM 11.27000046 1 1 7.02E-13 1576.764221 0 0 0 0 0 0 21.13024 0 20.90868 0 0 0 0 0 0 0 0 0 0 0 21.21204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3S1 SEM4A_HUMAN "Semaphorin-4A (Semaphorin-B, Sema B)" SEMA4A SEMAB SEMB UNQ783/PRO1317 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of inhibitory synapse assembly [GO:1905704]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; semaphorin-plexin signaling pathway [GO:0071526]; T-helper 1 cell differentiation [GO:0045063] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of inhibitory synapse assembly [GO:1905704]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; semaphorin-plexin signaling pathway [GO:0071526]; T-helper 1 cell differentiation [GO:0045063] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001525; GO:0001755; GO:0005615; GO:0005886; GO:0005887; GO:0007411; GO:0008360; GO:0010594; GO:0016525; GO:0030215; GO:0030335; GO:0045063; GO:0045499; GO:0048843; GO:0050919; GO:0071526; GO:1904891; GO:1905704 KSECAFK 2.309999943 0.927918375 0.927918375 0.215243014 871.2585807 0 0 15.34287 0 14.30866 0 0 0 15.37656 0 16.80352 0 0 15.15918 0 17.34294 0 14.41748 15.37274 0 16.68831 0 15.83236 16.08956 15.81175 0 0 17.26471 15.36027 0 15.99571 14.65304 0 13.96043 16.11215 15.92342 15.40461 14.36607 13.32282 15.59758 14.94333 17.06092 16.9226 13.67609 16.45116 14.47325 0 15.26859 Q9H3S7 PTN23_HUMAN "Tyrosine-protein phosphatase non-receptor type 23, EC 3.1.3.48 (His domain-containing protein tyrosine phosphatase, HD-PTP) (Protein tyrosine phosphatase TD14, PTP-TD14)" PTPN23 KIAA1471 Homo sapiens (Human) cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0043231; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:1903387; GO:1903393; GO:2000643 QQLLDRELK 8.18999958 1 1 0.345176749 1137.674477 0 0 0 0 0 0 0 0 17.67004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3U1 UN45A_HUMAN "Protein unc-45 homolog A, Unc-45A (GCUNC-45) (Smooth muscle cell-associated protein 1, SMAP-1)" UNC45A SMAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517] cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879] GO:0005794; GO:0005829; GO:0007517; GO:0016607; GO:0030154; GO:0045296; GO:0048471; GO:0051879; GO:0061077 EDAGAEKIFR 15.59000015 1 1 0.256142186 1135.835853 13.86963 14.68372 0 0 13.81808 0 0 0 0 0 16.31331 0 13.83475 0 0 14.96324 0 0 0 15.75355 0 0 15.97406 0 0 0 0 0 0 0 0 15.72588 0 0 0 0 0 0 0 16.37414 15.77532 0 0 0 0 0 0 0 Q9H3W5 LRRN3_HUMAN "Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3, NLRR-3)" LRRN3 Nbla10363 UNQ194/PRO220 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965] GO:0005615; GO:0016021; GO:0031012; GO:0051965 EGGLYTCIATNLVGADLK 7.519999981 0.435075581 0.435075581 0.163262036 1895.381265 16.68376 15.76385 15.47011 14.55931 0 14.75296 13.98907 15.78485 14.13833 10.47609 13.49776 15.39667 0 12.4134 14.74285 14.33177 0 0 0 0 0 0 15.92499 0 14.15648 17.13926 0 0 0 15.55276 0 0 0 0 15.26894 0 0 0 0 15.96743 14.10919 0 0 15.14916 0 0 16.18264 15.20105 Q9H3Z7 ABHGB_HUMAN "Protein ABHD16B, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 16B, Abhydrolase domain-containing protein 16B)" ABHD16B C20orf135 Homo sapiens (Human) monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] membrane [GO:0016020]; nucleoplasm [GO:0005654] membrane [GO:0016020]; nucleoplasm [GO:0005654]; acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] GO:0004620; GO:0005654; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651 MCVICFVK 5.28000021 1 1 0.179457473 1054.742617 0 17.35353 15.48442 11.87383 12.43156 14.62069 13.18309 14.45593 14.44845 14.94487 16.04367 14.21119 17.91098 0 0 13.77293 0 13.51437 15.03367 11.97909 0 0 0 0 15.7774 0 16.38822 0 0 0 0 15.85968 15.48747 0 0 0 0 15.33535 0 0 0 0 0 0 18.22155 0 0 0 Q9H410 DSN1_HUMAN Kinetochore-associated protein DSN1 homolog DSN1 C20orf172 MIS13 Homo sapiens (Human) cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] GO:0000070; GO:0000444; GO:0000776; GO:0000818; GO:0001650; GO:0005576; GO:0005654; GO:0005730; GO:0005829; GO:0016604; GO:0031617; GO:0035578; GO:0051301 ASDFSLEASVAEMK 9.729999542 1 1 2.32E-13 1485.830097 0 0 14.50485 0 0 0 0 0 10.26083 0 16.92467 0 0 0 13.33696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H422 HIPK3_HUMAN "Homeodomain-interacting protein kinase 3, EC 2.7.11.1 (Androgen receptor-interacting nuclear protein kinase, ANPK) (Fas-interacting serine/threonine-protein kinase, FIST) (Homolog of protein kinase YAK1)" HIPK3 DYRK6 FIST3 PKY Homo sapiens (Human) apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0009299; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0043066; GO:0043508; GO:0106310 EFVSLLKK 4.28000021 1 1 0.089126854 962.563861 11.34038 14.72844 12.99856 13.12079 14.51866 0 15.52193 16.29679 14.69544 0 0 15.40535 0 13.97078 0 15.29383 16.01347 0 0 0 14.96976 13.66704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H425 CA198_HUMAN Uncharacterized protein C1orf198 C1orf198 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 SMEKGEK 10.10000038 1 1 0.289334585 823.1232041 0 0 0 0 17.68565 0 0 0 0 0 0 0 0 17.7689 18.1728 0 0 0 0 0 0 0 0 0 0 18.08344 17.74681 0 0 0 0 0 0 0 0 17.78588 0 0 0 0 0 0 0 0 0 0 0 0 Q9H469 FXL15_HUMAN F-box/LRR-repeat protein 15 (F-box only protein 37) FBXL15 FBXO37 Homo sapiens (Human) bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0005737; GO:0005829; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146 VGSDGVR 8.029999733 0.019345468 0.019345468 0.160705957 689.861758 0 17.92522 15.57807 0 0 19.71316 18.66567 17.6695 0 0 14.90717 0 0 15.87202 0 16.39057 15.31503 17.4498 12.01269 16.91123 0 14.90893 15.07736 0 0 16.90153 0 16.23815 16.50035 0 12.61431 0 16.65551 13.78336 0 12.72754 0 0 18.38991 0 0 16.37063 0 15.81924 18.24344 16.36209 0 11.05566 Q9H477 RBSK_HUMAN "Ribokinase, RK, EC 2.7.1.15" RBKS RBSK Homo sapiens (Human) D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747] GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872 GANQCVQAARLGAMTSMVCK 1.720000029 1 1 2.29E-12 2168.299521 9.359298 14.36509 0 10.84116 13.08483 14.39449 0 13.86315 12.1328 0 13.33852 14.28184 0 14.10656 0 0 0 0 12.46247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H479 FN3K_HUMAN "Fructosamine-3-kinase, EC 2.7.1.171 (Protein-psicosamine 3-kinase FN3K) (Protein-ribulosamine 3-kinase FN3K, EC 2.7.1.172)" FN3K Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193]; epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525] ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193] GO:0005524; GO:0005829; GO:0016301; GO:0030389; GO:0030393; GO:0030855; GO:0036525; GO:0043687; GO:0102193; GO:0102194 EQLLRAELR 14.77999973 1 1 0.405226734 1128.325712 0 16.89314 0 16.86423 16.51686 16.9182 16.23746 0 16.51834 0 0 0 0 0 0 0 0 0 15.69771 0 0 0 15.35132 0 0 17.33722 0 15.52449 16.30719 0 0 16.03976 0 15.99716 0 0 0 0 16.36517 0 16.32978 0 0 16.38404 0 0 16.9004 0 Q9H490 PIGU_HUMAN "Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1, Protein CDC91-like 1) (GPI transamidase component PIG-U)" PIGU CDC91L1 PSEC0205 UNQ3055/PRO9875 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] GO:0005789; GO:0005886; GO:0006506; GO:0016020; GO:0016255; GO:0034394; GO:0042765; GO:0046425 TPMEMR 13.38000011 1 1 0.276847217 780.6913223 0 19.0808 17.38691 0 12.65408 18.35917 19.39451 17.26169 0 18.04408 18.12267 0 0 17.82247 16.65603 0 0 18.96021 16.72498 0 17.10234 0 0 0 20.60639 18.44724 0 0 19.01163 19.324 18.6787 18.03009 18.28275 0 21.05822 18.73175 19.2377 20.36476 18.87264 19.46641 17.40399 19.04528 17.02069 0 0 18.51066 0 18.06472 Q9H497 TOR3A_HUMAN Torsin-3A (ATP-dependent interferon-responsive protein) (Torsin family 3 member A) TOR3A ADIR Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0016887; GO:0070062 EETLDEIAQMMVYVPK 22.30999947 0.61425066 0.61425066 0.333642749 1895.035099 20.17109 21.78054 22.05582 20.94556 21.20896 20.39619 21.34869 21.30685 21.97995 22.09493 21.33643 21.41161 19.95449 19.5571 18.19385 0 19.9016 21.51257 19.75284 20.52353 20.5665 18.02371 0 19.27639 22.70827 22.1251 22.44854 22.50403 16.97305 18.02596 20.90309 21.50281 19.48501 22.15483 20.90888 21.97758 21.79246 22.65195 20.03365 20.58035 21.24133 21.43222 20.94801 0 20.72797 20.71255 21.80026 0 Q9H4A3 WNK1_HUMAN "Serine/threonine-protein kinase WNK1, EC 2.7.11.1 (Erythrocyte 65 kDa protein, p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1, hWNK1)" WNK1 HSN2 KDP KIAA0344 PRKWNK1 Homo sapiens (Human) cation homeostasis [GO:0055080]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cation homeostasis [GO:0055080]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0004712; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0007165; GO:0010766; GO:0010820; GO:0016020; GO:0018105; GO:0018107; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0030295; GO:0033633; GO:0034115; GO:0034260; GO:0035556; GO:0038116; GO:0048666; GO:0050801; GO:0050852; GO:0055080; GO:0090188; GO:0090263; GO:0097022; GO:0106310; GO:1903038; GO:1903288; GO:1904062; GO:1990869; GO:2000651 LGAAAADAVTGR 19.98999977 1 1 0.381532123 1072.910288 0 20.4363 19.90175 0 0 0 0 20.03327 0 19.50154 19.16954 18.27576 0 19.19938 17.69023 19.85655 19.72426 0 18.32472 0 0 19.46929 0 19.49175 0 0 0 0 18.24565 18.54362 0 0 0 0 19.1496 0 18.1807 20.93955 19.94752 0 0 0 17.44002 0 18.56843 0 0 19.12009 Q9H4B4 PLK3_HUMAN "Serine/threonine-protein kinase PLK3, EC 2.7.11.21 (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3, PLK-3) (Proliferation-related kinase)" PLK3 CNK FNK PRK Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]" ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000082; GO:0000086; GO:0000122; GO:0000278; GO:0000302; GO:0000922; GO:0002039; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005813; GO:0006468; GO:0006915; GO:0006970; GO:0006974; GO:0006977; GO:0007113; GO:0009314; GO:0030425; GO:0031122; GO:0032465; GO:0043025; GO:0043066; GO:0043491; GO:0044819; GO:0051302; GO:0090166; GO:0090316; GO:0106310; GO:1901796; GO:1904716; GO:2000777 CYEATDTETGSAYAVK 7.150000095 1 1 0.066593543 1766.292651 14.49333 0 13.77016 0 0 0 0 0 0 0 0 0 16.11118 0 0 0 0 0 0 0 0 0 0 0 0 0 14.10905 0 13.31913 0 0 15.44438 14.7098 0 0 0 13.61609 0 0 0 0 0 16.49545 0 0 0 0 0 Q9H4B7 TBB1_HUMAN Tubulin beta-1 chain TUBB1 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200] GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0051225; GO:0070062; GO:0072686 ALSVAELTQQMFDAR 1.480000019 1 1 0.428713136 1679.415662 0 0 0 0 18.62285 0 0 0 18.31335 17.29518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.68164 0 0 0 0 0 0 0 17.78899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4B8 DPEP3_HUMAN "Dipeptidase 3, EC 3.4.13.19" DPEP3 UNQ834/PRO1772 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] GO:0001669; GO:0005886; GO:0016805; GO:0031225; GO:0046872; GO:0070573 GRAQALMR 4.630000114 1 1 0.1988532 918.5098782 13.69383 16.10511 13.0112 13.39472 12.14594 0 0 14.85269 0 14.1749 15.66516 15.0381 13.88784 14.30469 14.52074 13.48752 0 0 0 0 0 16.56081 16.44334 16.57375 15.41601 0 0 0 15.34901 0 0 0 0 0 16.56384 0 0 0 15.25356 15.59775 0 14.95674 0 0 15.9157 15.62069 15.96453 16.02273 Q9H4D0 CSTN2_HUMAN "Calsyntenin-2 (Alcadein-gamma, Alc-gamma)" CLSTN2 CS2 Homo sapiens (Human) homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806] cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211] cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988] GO:0000139; GO:0001540; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0019894; GO:0030425; GO:0042988; GO:0045211; GO:0050806; GO:0051965; GO:0098978; GO:0099061 TSGEGRLR 8.399999619 1 1 0.21801132 874.6989461 0 0 17.09921 17.47961 0 16.5269 0 16.01961 13.34234 15.73585 17.8347 16.71558 14.31882 0 0 0 0 15.4782 0 0 16.54148 0 0 0 0 0 0 0 0 0 0 16.82293 0 0 0 0 0 0 17.23562 15.53194 0 16.46408 0 0 13.30501 0 16.49611 15.33485 Q9H4D5 NXF3_HUMAN "Nuclear RNA export factor 3 (TAP-like protein 3, TAPL-3)" NXF3 TAPL3 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasm [GO:0005737]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006406; GO:0016973; GO:0042272 LDIVDSLSALPK 3.630000114 1 1 0.293098986 1270.358222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4E7 DEFI6_HUMAN "Differentially expressed in FDCP 6 homolog, DEF-6 (IRF4-binding protein)" DEF6 IBP Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0016020; GO:0030175; GO:0048471; GO:0051056 QEWTAAIQMAIR 6.329999924 1 1 0.309591041 1434.499326 0 11.20873 13.40522 12.49759 0 13.98635 0 13.68509 15.62233 15.07949 0 14.54119 0 0 13.82857 15.25477 0 0 0 0 0 0 0 0 0 0 0 15.77953 0 0 15.04593 0 0 0 0 0 15.11383 0 0 0 0 0 0 0 0 0 0 0 Q9H4F8 SMOC1_HUMAN "SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1, SMOC-1)" SMOC1 Homo sapiens (Human) cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 DPTLGVVHR 3.730000019 1 1 0.084944905 995.1144247 0 14.05689 17.67168 15.72774 15.45485 13.67776 0 0 14.82943 15.37811 0 0 0 14.7899 0 0 0 0 0 0 0 0 0 13.77477 0 0 15.34118 0 0 0 0 0 0 0 0 0 15.9361 0 0 0 0 0 0 15.12522 0 0 0 0 Q9H4G0 E41L1_HUMAN "Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1, 4.1N)" EPB41L1 KIAA0338 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866] actin binding [GO:0003779]; structural molecule activity [GO:0005198] GO:0003779; GO:0005198; GO:0005829; GO:0005856; GO:0005886; GO:0030866; GO:0031032 QEFLDKPEDVLLKHQASINELK 2.910000086 1 1 0.586865637 2594.338236 0 19.72787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4G4 GAPR1_HUMAN "Golgi-associated plant pathogenesis-related protein 1, GAPR-1, Golgi-associated PR-1 protein (Glioma pathogenesis-related protein 2, GliPR 2)" GLIPR2 C9orf19 GAPR1 Homo sapiens (Human) positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] protein homodimerization activity [GO:0042803] GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 KMGVGK 1.529999971 1 1 2.32E-13 632.1352093 0 0 0 0 0 15.61892 0 0 0 0 0 16.97534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0746 0 0 0 0 0 0 0 16.7639 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4H8 FA83D_HUMAN Protein FAM83D (Spindle protein CHICA) FAM83D C20orf129 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; epithelial to mesenchymal transition [GO:0001837]; metaphase plate congression [GO:0051310]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; protein localization to mitotic spindle [GO:1902480]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; epithelial to mesenchymal transition [GO:0001837]; metaphase plate congression [GO:0051310]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; protein localization to mitotic spindle [GO:1902480]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165] kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] GO:0001837; GO:0005737; GO:0005819; GO:0005829; GO:0007165; GO:0008017; GO:0008283; GO:0015630; GO:0016477; GO:0019894; GO:0019901; GO:0032006; GO:0042176; GO:0045171; GO:0051301; GO:0051310; GO:0070372; GO:0072686; GO:0097431; GO:1902480; GO:1902808 FTLIDGIRVATGSYSFTWTDGK 6.010000229 0.747836888 0.747836888 0.145911139 2434.37154 16.74028 16.05157 0 16.988 0 0 14.83067 0 13.48424 14.16838 15.92225 12.83404 13.43019 0 13.83635 0 0 15.97044 0 12.445 14.40349 0 0 0 13.66805 14.74155 14.24647 15.78386 0 0 0 0 0 0 0 0 0 16.95549 0 15.41118 14.81869 0 13.07686 11.92292 14.59229 0 13.10753 12.07825 Q9H4I0 RD21L_HUMAN Double-strand-break repair protein rad21-like protein 1 RAD21L1 RAD21L Homo sapiens (Human) mitotic sister chromatid cohesion [GO:0007064]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130] chromosome [GO:0005694]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] chromosome [GO:0005694]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; mitotic sister chromatid cohesion [GO:0007064]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130] chromatin binding [GO:0003682] GO:0000795; GO:0003682; GO:0005634; GO:0005694; GO:0007064; GO:0007130; GO:0030893; GO:0034990; GO:0034991; GO:1990414 MGMQSFSLMK 7.809999943 1 1 0.121581991 1190.857097 0 16.04078 0 0 0 13.25056 0 0 13.81313 0 0 13.54053 0 14.73034 0 0 13.9346 0 0 0 0 0 0 0 0 0 0 0 0 14.65954 0 0 0 15.31873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4I8 SEHL2_HUMAN "Serine hydrolase-like protein 2, EC 3.1.-.-" SERHL2 SERHL Homo sapiens (Human) perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777] perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787] hydrolase activity [GO:0016787] GO:0005777; GO:0016787; GO:0048471 FSILGHSFGGVVGGMFFCTFPEMVDK 5.28000021 1 1 0.099732571 2870.205569 16.5276 0 14.4128 0 15.4779 14.55616 11.41978 7.894661 0 0 12.83607 13.48198 0 16.78042 0 15.32727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18458 0 0 0 0 0 0 13.93331 0 Q9H4I9 EMRE_HUMAN "Essential MCU regulator, mitochondrial (Single-pass membrane protein with aspartate-rich tail 1, mitochondrial)" SMDT1 C22orf32 EMRE Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851] GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006851; GO:0031305; GO:0036444; GO:0051560; GO:1990246 SLVPSRSVIVTR 13.55000019 1 1 0.357591854 1313.6961 16.17459 0 13.45165 11.58105 14.88111 0 0 0 0 0 0 0 15.72637 13.19759 0 13.12656 15.14592 15.60325 16.2532 18.40305 18.0248 15.34448 15.76459 15.07628 0 0 0 0 0 0 0 16.66582 16.15362 18.32694 17.10614 17.55692 19.07162 18.08535 0 18.37721 18.13766 19.05258 17.29011 14.68295 19.13718 19.31045 18.62255 17.97448 Q9H4L5 OSBL3_HUMAN "Oxysterol-binding protein-related protein 3, ORP-3, OSBP-related protein 3" OSBPL3 KIAA0704 ORP3 OSBP3 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699] cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038 GEMNYTQEPPVQKGFLLK 1.700000048 0.040903848 0.040903848 0.154799462 2079.359243 18.56369 16.99385 0 0 0 17.51235 17.25498 0 0 0 0 16.71611 0 0 0 0 0 0 0 0 0 0 11.45318 14.96671 15.1276 0 0 0 0 0 0 17.65548 14.98172 0 9.90793 0 0 0 0 0 0 0 0 0 0 0 13.80657 14.89062 Q9H4L7 SMRCD_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1, EC 3.6.4.12 (ATP-dependent helicase 1, hHEL1)" SMARCAD1 KIAA1122 Homo sapiens (Human) chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018] heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; ubiquitin binding [GO:0043130]; chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]" "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; ubiquitin binding [GO:0043130]" GO:0000018; GO:0000729; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0008094; GO:0016887; GO:0035861; GO:0043130; GO:0043596; GO:0051304; GO:0070932; GO:0070933; GO:0140658 LNYAIFDEGHMLK 3.680000067 7.65E-05 7.65E-05 3.20E-12 1567.086036 16.12385 14.68634 12.93091 16.49419 17.61588 16.10448 14.25589 15.9878 15.50595 15.58329 0 0 14.79475 0 0 0 0 0 0 0 0 0 0 15.28343 0 0 0 16.2872 0 0 16.9654 16.82261 18.49947 0 0 0 0 0 16.30728 0 0 0 0 0 12.5503 15.92437 0 0 Q9H4M7 PKHA4_HUMAN "Pleckstrin homology domain-containing family A member 4, PH domain-containing family A member 4 (Phosphoinositol 3-phosphate-binding protein 1, PEPP-1)" PLEKHA4 PEPP1 Homo sapiens (Human) "positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" "identical protein binding [GO:0042802]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0005546; GO:0005737; GO:0005886; GO:0031234; GO:0032266; GO:0042802; GO:0043325; GO:0080025; GO:0090263; GO:2000096 GEEGR 8.880000114 1 1 0.012339315 547.2977616 0 16.11923 0 0 0 0 0 17.22471 16.87264 0 0 0 0 0 0 15.2799 0 0 0 17.01837 16.29615 0 18.00733 17.52089 0 0 0 0 15.63127 16.88554 17.45574 17.22462 0 15.74875 0 0 0 0 0 0 0 0 0 0 0 0 15.71201 0 Q9H4R4 CT191_HUMAN Putative nuclear receptor corepressor 1-like protein NCOR1P1 (Nuclear receptor corepressor 1 pseudogene 1) NCOR1P1 C20orf191 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0006357; GO:0046966 EELIECMDRVDR 15.02999973 1 1 0.381608355 1579.455744 16.71484 13.56231 14.99026 15.75268 14.24262 10.36832 14.31486 16.85294 0 16.61496 14.51737 0 0 0 17.8917 0 0 0 14.00784 0 0 17.68928 15.51009 16.04986 0 17.08349 0 0 17.76966 14.75394 0 0 16.66491 0 0 0 0 0 0 0 15.08802 0 0 0 0 16.54555 0 18.54732 Q9H4W6 COE3_HUMAN "Transcription factor COE3 (Early B-cell factor 3, EBF-3) (Olf-1/EBF-like 2, O/E-2, OE-2)" EBF3 COE3 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045893; GO:0046872 FGIQENIPRGGTTMK 6.150000095 1 1 0.281144831 1665.841647 16.02696 13.42417 14.81275 14.19469 0 14.01659 11.9159 15.022 14.13921 0 17.90326 15.30903 14.1518 13.54216 0 12.80573 0 0 15.68074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54139 0 0 0 0 0 0 15.67587 0 0 0 0 Q9H4Y5 GSTO2_HUMAN "Glutathione S-transferase omega-2, GSTO-2, EC 2.5.1.18 (Glutathione S-transferase omega 2-2, GSTO 2-2) (Glutathione-dependent dehydroascorbate reductase, EC 1.8.5.1) (Monomethylarsonic acid reductase, MMA(V) reductase, EC 1.20.4.2)" GSTO2 Homo sapiens (Human) cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic metabolic process [GO:0006805] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491] GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0006805; GO:0016491; GO:0019852; GO:0042802; GO:0045174; GO:0050610; GO:0070062; GO:0071243 LWISAMK 2.569999933 1 1 0.296079462 863.6653104 0 0 15.6706 12.51354 15.69538 0 14.91467 14.41669 14.05292 14.28679 0 15.12248 0 0 16.5309 0 0 0 15.63689 15.946 0 0 0 0 0 15.77136 14.18458 12.3925 0 14.84305 0 0 0 0 0 0 12.61943 16.39016 0 0 0 0 16.4462 0 0 15.10951 0 14.87854 Q9H4Z2 ZN335_HUMAN "Zinc finger protein 335 (NRC-interacting factor 1, NIF-1)" ZNF335 Homo sapiens (Human) "brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]" histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]" metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976] GO:0000976; GO:0000978; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0045944; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182 ATLLRHMR 1.379999995 1 1 0.226036315 1012.691274 0 15.06131 0 0 0 16.05976 0 18.5037 0 0 17.98173 0 0 16.68854 0 0 0 0 0 0 16.48901 0 0 0 0 0 0 0 0 0 0 17.93093 0 0 0 0 0 0 0 17.38973 0 0 0 0 0 0 0 0 Q9H4Z3 CAPAM_HUMAN "mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, EC 2.1.1.62 (Cap-specific adenosine methyltransferase, CAPAM, hCAPAM) (Phosphorylated CTD-interacting factor 1, hPCIF1) (Protein phosphatase 1 regulatory subunit 121)" PCIF1 C20orf67 CAPAM PPP1R121 Homo sapiens (Human) mRNA methylation [GO:0080009]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727] intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727] mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047] GO:0005634; GO:0005654; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047; GO:1990269 DHSASK 8.109999657 1 1 0.26973358 643.7369946 0 0 18.54098 18.04371 19.46184 0 0 0 19.55257 18.6806 0 18.52489 0 18.04981 17.94742 0 0 18.9022 0 0 0 0 0 0 0 17.97707 20.76636 0 18.96229 0 18.74532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.41339 Q9H501 ESF1_HUMAN ESF1 homolog (ABT1-associated protein) ESF1 ABTAP C20orf6 HDCMC28P Homo sapiens (Human) rRNA processing [GO:0006364] extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0006364 DVASEVNLTAYKPK 15.69999981 1 1 0.029220762 1535.353991 16.10872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.629 14.19754 15.30622 0 0 19.42545 0 15.25276 0 0 19.77051 19.1228 0 0 0 0 0 0 20.14061 15.65512 18.37671 0 0 0 0 0 0 0 0 0 0 20.15428 0 Q9H521 YM006_HUMAN Putative uncharacterized protein LOC645739 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107] actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein serine/threonine kinase activity [GO:0004674]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107] protein serine/threonine kinase activity [GO:0004674] GO:0004674; GO:0005737; GO:0005856; GO:0016477; GO:0018107; GO:0031032; GO:0042641 VNTMWQES 8.449999809 1 1 0.072877129 1010.84321 13.8263 14.57785 16.49897 13.92786 14.37269 13.70644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H553 ALG2_HUMAN "Alpha-1,3/1,6-mannosyltransferase ALG2, EC 2.4.1.132, EC 2.4.1.257 (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)" ALG2 UNQ666/PRO1298 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]" "alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]" GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704 GAAVCAYVR 2.519999981 1 1 0.072368531 967.5689464 15.30193 0 14.14933 0 0 0 0 0 0 0 0 0 0 0 10.27792 0 8.058535 0 0 0 0 0 13.61548 0 13.97206 0 0 0 0 0 15.15775 0 0 0 0 0 14.71102 0 0 14.31267 14.07046 0 16.75994 0 14.6784 0 0 0 Q9H582 ZN644_HUMAN "Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2, Zep-2)" ZNF644 KIAA1221 ZEP2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]" GO:0000978; GO:0000981; GO:0001222; GO:0005634; GO:0006357; GO:0046872 DSVVGSSK 7.230000019 1 1 0.121266028 779.4149239 0 0 15.40776 0 0 15.44125 0 14.59904 14.66781 0 0 0 0 0 17.28818 0 16.67066 0 0 0 18.05517 0 0 15.71738 0 15.63651 0 16.78716 15.08841 13.60419 16.41233 15.27697 13.46942 15.44915 15.12275 12.49705 0 14.12149 0 0 0 0 0 17.01114 0 15.97144 15.5354 0 Q9H583 HEAT1_HUMAN "HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed ]" HEATR1 BAP28 UTP10 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]" 90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] "90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]" RNA binding [GO:0003723]; snoRNA binding [GO:0030515] GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0045943; GO:2000234 INNSK 11.72000027 1 1 0.283854362 574.1127941 0 0 0 17.75894 15.30651 0 0 18.29952 15.55476 0 0 0 0 0 14.46251 16.83956 16.44271 0 16.46716 14.84141 0 14.95199 16.29395 15.90683 0 0 16.32164 0 0 15.81206 0 0 0 0 16.68108 0 0 15.95361 0 0 0 0 16.17768 0 0 16.41951 15.80326 16.37821 Q9H598 VIAAT_HUMAN "Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter, hVIAAT)" SLC32A1 VGAT VIAAT Homo sapiens (Human) aging [GO:0007568]; hippocampus development [GO:0021766]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269] cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672] cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187]; aging [GO:0007568]; hippocampus development [GO:0021766]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269] amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187] GO:0005886; GO:0006811; GO:0007269; GO:0007568; GO:0009986; GO:0015171; GO:0015187; GO:0015495; GO:0021766; GO:0030285; GO:0030425; GO:0030672; GO:0043005; GO:0044292; GO:0044306; GO:0044316; GO:0048786; GO:0051286; GO:0060077; GO:0061202; GO:0098700; GO:0098982 FYIDVK 5.849999905 6.15E-05 6.15E-05 0.222441483 783.3278619 0 11.68988 0 0 0 0 18.37198 17.10666 0 0 18.1232 15.63485 0 16.06419 0 16.85016 0 0 0 17.798 0 17.48899 0 15.37544 16.55437 17.04969 10.56857 15.48109 16.94757 16.43483 16.12358 0 17.2954 15.17681 0 0 18.99587 0 16.69141 0 0 14.55171 18.06279 17.03963 0 0 0 0 Q9H5I1 SUV92_HUMAN "Histone-lysine N-methyltransferase SUV39H2, EC 2.1.1.355 (Histone H3-K9 methyltransferase 2, H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2, Su(var)3-9 homolog 2)" SUV39H2 KMT1B Homo sapiens (Human) "cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] GO:0000122; GO:0000775; GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006333; GO:0006338; GO:0007049; GO:0008270; GO:0018024; GO:0030154; GO:0034968; GO:0036123; GO:0036124; GO:0042754; GO:0045892; GO:0046974; GO:0048511; GO:0071456; GO:1904047 DMEYYLVK 6.110000134 1 1 0.173118249 1075.867846 12.80594 14.23241 14.54008 12.91159 15.09947 0 0 0 0 0 0 0 0 0 0 13.90863 13.76299 0 0 0 0 0 0 0 0 0 0 14.11595 15.52629 0 0 0 0 10.85708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5I5 PIEZ2_HUMAN Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B) PIEZO2 C18orf30 C18orf58 FAM38B Homo sapiens (Human) cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381] GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016020; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260 IERCMLTR 9.220000267 1 1 0.362738007 1079.094891 0 17.07489 17.72076 17.9663 0 0 17.92564 17.92698 16.75576 0 0 0 0 0 0 0 16.18483 0 0 0 0 17.50892 0 0 0 0 0 0 0 0 18.33682 0 19.86847 18.92545 0 17.99074 0 0 0 0 0 0 18.48633 0 0 0 18.92369 0 Q9H5P4 PDZD7_HUMAN PDZ domain-containing protein 7 PDZD7 PDZK7 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; sensory perception of sound [GO:0007605] cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696] cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; sensory perception of sound [GO:0007605] identical protein binding [GO:0042802] GO:0002141; GO:0002142; GO:0005615; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0007605; GO:0032420; GO:0032426; GO:0042802; GO:0045184; GO:0050910; GO:0060088; GO:0060117; GO:1990696 CGSTPSDTSSEDGVRR 5.28000021 0.001228028 0.001228028 0.252180962 1711.885442 15.47649 11.76058 0 0 0 13.35602 15.10076 16.32167 0 0 0 0 0 0 16.49415 0 15.63226 0 0 0 0 0 0 16.35954 16.90187 0 15.43532 15.78429 15.41191 14.75382 0 14.39491 0 10.97501 14.09743 12.78461 0 15.46452 0 13.15363 0 15.02937 15.88367 15.70118 0 14.77829 15.64139 0 Q9H5Q4 TFB2M_HUMAN "Dimethyladenosine transferase 2, mitochondrial, EC 2.1.1.- (Hepatitis C virus NS5A-transactivated protein 5, HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2, h-mtTFB, h-mtTFB2, hTFB2M, mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2)" TFB2M NS5ATP5 Homo sapiens (Human) mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation from mitochondrial promoter [GO:0006391] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; transcription coregulator activity [GO:0003712]; mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation from mitochondrial promoter [GO:0006391]" "mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; transcription coregulator activity [GO:0003712]" GO:0000179; GO:0003712; GO:0003723; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0031167; GO:0034246; GO:0042645 VLHMEPWSSFDIYTR 2.559999943 0.403865755 0.403865755 5.48E-12 1900.278778 12.98785 0 12.24869 0 0 0 0 15.88013 0 0 0 18.6664 0 16.16756 0 0 0 0 0 15.50222 0 0 18.0487 0 0 0 0 0 14.13319 0 0 0 16.27329 0 0 12.78167 17.62506 0 0 0 0 14.96563 15.47973 0 12.62936 16.90173 0 0 Q9H5V8 CDCP1_HUMAN "CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein, SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318)" CDCP1 TRASK UNQ2486/PRO5773 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005576; GO:0005886; GO:0016021 HITMLSIKSGER 1.769999981 1 1 0.086329914 1370.943484 0 11.99851 9.840518 0 13.9268 0 0 0 0 0 0 0 0 10.82134 0 0 13.27648 0 0 2.48369 0 0 0 13.02607 0 0 0 0 0 0 0 0 0 10.21845 13.53663 12.04708 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5Y7 SLIK6_HUMAN SLIT and NTRK-like protein 6 SLITRK6 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601] GO:0001964; GO:0002088; GO:0002093; GO:0005886; GO:0005887; GO:0007409; GO:0007416; GO:0007601; GO:0007605; GO:0008344; GO:0009986; GO:0021562; GO:0031223; GO:0035264; GO:0051965; GO:0060007; GO:0060384; GO:0090102; GO:1905606 LYLNGNHLTKLSK 4.329999924 1 1 0.259301063 1502.582974 0 13.36853 14.95175 13.3695 0 0 0 14.59372 15.39236 16.44827 0 0 0 0 0 0 0 0 16.60461 0 0 0 19.52437 0 0 0 14.42877 0 0 14.91521 15.60878 16.23081 0 16.53091 16.29613 0 0 16.43362 16.91253 15.79066 15.45983 0 0 17.57649 0 0 0 17.49454 Q9H5Z1 DHX35_HUMAN "Probable ATP-dependent RNA helicase DHX35, EC 3.6.4.13 (DEAH box protein 35)" DHX35 C20orf15 DDX35 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013] "catalytic step 2 spliceosome [GO:0071013]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0071013 LTEPLGMR 6.039999962 0.805123508 0.805123508 0.172884175 934.5975005 10.99969 15.57823 13.36007 15.86965 0 14.68068 13.96334 15.80253 0 14.095 14.56203 16.2418 0 0 14.10655 15.06006 15.32989 14.84536 0 0 0 17.29772 0 0 16.26339 14.75114 0 0 0 0 0 0 0 0 0 16.99115 0 0 0 13.10316 0 14.77707 0 0 0 0 0 0 Q9H609 ZN576_HUMAN Zinc finger protein 576 ZNF576 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872 QMHEVR 5.960000038 1 1 0.171954267 798.278736 14.88243 0 13.80152 13.86766 15.85867 17.18128 0 0 0 0 0 0 17.78705 12.50425 0 16.95438 15.63756 0 0 15.54594 0 0 0 0 14.99478 15.89434 15.91437 14.3235 0 15.24378 16.95971 0 0 0 0 0 0 16.54702 15.78567 0 15.4971 16.28902 16.81159 0 15.70676 0 0 13.03089 Q9H611 PIF1_HUMAN "ATP-dependent DNA helicase PIF1, EC 3.6.4.12 (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein)" PIF1 C15orf20 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004] "chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]" "chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]" 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162] GO:0000002; GO:0000287; GO:0000781; GO:0005524; GO:0005654; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0007004; GO:0010521; GO:0016887; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974 LGAQVMLVK 3.75999999 1 1 8.01E-13 957.5128661 15.92958 11.76999 0 15.25107 14.6827 14.09417 14.50596 14.67925 12.52052 12.58615 0 17.87563 13.7196 15.21426 15.2684 0 0 0 16.30334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H649 NSUN3_HUMAN "tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 3)" NSUN3 MSTP077 UG0651E06 Homo sapiens (Human) regulation of mitochondrial translation [GO:0070129]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; regulation of mitochondrial translation [GO:0070129]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127] methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] GO:0000049; GO:0001510; GO:0002127; GO:0005739; GO:0005759; GO:0005762; GO:0008168; GO:0016428; GO:0031167; GO:0070129 SWSTGK 13.73999977 0.260558605 0.260558605 0.286503949 665.9943861 17.91701 18.27963 17.09849 0 0 17.87397 0 18.44428 17.65686 0 19.12801 17.4498 17.17944 0 0 17.16339 17.26489 18.00768 0 0 0 0 0 19.10587 0 18.41298 0 19.61056 0 18.54988 19.2394 18.69491 17.86634 0 19.45426 19.70638 18.04733 19.33802 19.86284 19.1188 19.03298 0 19.57397 18.57035 18.34343 0 17.15951 20.01159 Q9H668 STN1_HUMAN CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog) STN1 OBFC1 Homo sapiens (Human) negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833] "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]" single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162] GO:0000723; GO:0000781; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0043231; GO:0045111; GO:0045740; GO:1990879 MQPGSSR 5.78000021 1 1 3.47E-13 763.5097121 0 0 15.02764 0 0 0 0 0 0 15.34084 0 0 15.61756 0 0 0 0 0 0 0 0 0 0 0 0 15.9286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.28536 0 0 0 0 0 0 0 Q9H672 ASB7_HUMAN "Ankyrin repeat and SOCS box protein 7, ASB-7" ASB7 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 IARLMLESEYR 5.289999962 1 1 4.59E-13 1396.816846 13.4615 13.89453 11.52763 14.28815 13.08293 0 14.52335 16.25277 0 15.18186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.71787 0 0 0 0 0 14.29308 0 0 0 0 0 0 0 15.03574 15.98924 0 0 0 0 0 12.87533 0 Q9H694 BICC1_HUMAN "Protein bicaudal C homolog 1, Bic-C" BICC1 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090] RNA binding [GO:0003723] GO:0001822; GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090 EMIMSVLDTK 7.989999771 1 1 0.108785829 1166.96926 13.72744 14.01213 10.39277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.44359 0 7.653265 0 0 15.72935 15.13342 0 0 13.79315 14.78446 14.12075 14.03406 0 15.13702 0 0 0 15.09895 0 0 0 8.10481 0 13.73942 0 0 0 0 0 Q9H6A9 PCX3_HUMAN Pecanex-like protein 3 (Pecanex homolog protein 3) PCNX3 PCNXL3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 VVAPGVR 4.230000019 0.000386235 0.000386235 0.279622965 697.6621313 18.07656 17.54519 17.60489 0 0 0 18.92118 18.83189 19.0599 0 18.01291 0 0 0 16.59164 0 18.08739 0 17.94202 0 0 20.01161 18.76938 16.41343 0 0 16.37255 0 16.27536 17.93844 0 19.17038 18.23833 0 0 0 18.5941 0 0 18.20962 0 0 0 19.00153 0 17.86069 0 0 Q9H6B4 CLMP_HUMAN "CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein, CAR-like membrane protein)" CLMP ACAM ASAM UNQ318/PRO363 Homo sapiens (Human) digestive tract development [GO:0048565] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; digestive tract development [GO:0048565] GO:0005881; GO:0005886; GO:0005923; GO:0009986; GO:0016021; GO:0048565 MSLLLLLLLVSYYVGTLGTHTEIKR 3.380000114 1 1 0.615473936 2850.494452 0 0 0 18.11317 0 0 0 0 0 0 0 0 0 0 0 0 0 17.74365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6D7 HAUS4_HUMAN HAUS augmin-like complex subunit 4 HAUS4 C14orf94 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] microtubule minus-end binding [GO:0051011] GO:0005813; GO:0005829; GO:0007098; GO:0051011; GO:0051225; GO:0051301; GO:0070652; GO:1990498 EQMLLLEKK 5.800000191 1 1 0.152310854 1146.758826 0 4.706577 0 12.60439 11.65837 0 16.06651 14.57754 0 0 0 0 0 0 14.02111 13.09169 0 14.56327 0 0 0 0 0 0 15.05573 0 0 16.18443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.00239 0 0 0 Q9H6F5 CCD86_HUMAN Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain) CCDC86 CYCLON Homo sapiens (Human) chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730 DTPLRR 5.360000134 0.164699838 0.164699838 0.114784727 758.1918432 0 18.5085 0 0 19.78575 11.04931 0 17.83964 0 0 0 0 0 18.53643 16.28621 18.83105 17.55805 0 14.79546 13.26887 0 0 15.01162 0 0 0 16.05201 0 17.84825 17.79841 0 12.67286 18.40639 17.78438 15.40538 0 0 0 16.67978 0 14.4777 14.00229 0 0 18.89863 16.41175 0 0 Q9H6K5 PRR36_HUMAN Proline-rich protein 36 PRR36 Homo sapiens (Human) AGAAARTPAAR 12.82999992 1 1 0.234589645 1013.151104 0 15.46862 9.229641 0 14.35503 13.38113 0 0 0 14.80414 0 0 13.95008 13.24724 14.55712 14.50201 0 0 14.20525 0 0 14.21789 16.65519 11.76278 0 0 0 0 0 0 0 14.81215 0 0 0 14.82777 14.65769 14.62823 0 15.80634 0 11.66916 12.71184 0 0 0 0 13.50929 Q9H6N6 MYH16_HUMAN Putative uncharacterized protein MYH16 (Myosin heavy chain 16 pseudogene) (myosin heavy polypeptide 5) MYH16 MYH5 Homo sapiens (Human) centriole [GO:0005814]; centrosome [GO:0005813]; myosin complex [GO:0016459] centriole [GO:0005814]; centrosome [GO:0005813]; myosin complex [GO:0016459] GO:0005813; GO:0005814; GO:0016459 AMMDAARMAEELR 9.369999886 1 1 0.279275198 1525.699825 0 0 0 0 0 0 18.91475 0 0 0 18.48054 0 0 0 0 0 0 0 0 0 16.76786 0 0 0 0 0 0 0 0 0 0 0 0 19.4562 19.54482 0 19.23449 0 16.87092 0 0 0 0 0 0 0 0 0 Q9H6P5 TASP1_HUMAN "Threonine aspartase 1, Taspase-1, EC 3.4.25.- [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta ]" TASP1 C20orf13 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]" identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298] GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604 RQSSEK 1.460000038 1 1 0.234153141 731.1152454 18.27129 17.98479 16.66241 0 17.56911 18.84625 17.5017 15.24566 16.82481 18.18696 17.27002 16.95751 16.82242 16.7847 17.10709 17.65895 17.57764 0 17.14547 17.00586 15.36717 17.38815 17.71003 0 17.40038 18.75652 17.2412 18.6794 0 18.21278 18.0621 18.77598 0 0 17.32507 17.33655 17.36022 16.91454 16.70972 16.50953 17.33961 16.76357 16.06945 17.1728 16.96258 18.18329 16.93475 17.07162 Q9H6R0 DHX33_HUMAN "ATP-dependent RNA helicase DHX33, EC 3.6.4.13 (DEAH box protein 33)" DHX33 DDX33 Homo sapiens (Human) positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227 ENFVNSK 2.930000067 0.714855433 0.714855433 0.068191779 838.5658061 0 0 14.81327 16.57809 0 0 0 0 0 0 0 0 16.81609 12.88585 0 0 0 0 0 0 0 0 0 0 0 14.46255 15.23122 15.84773 0 16.4832 15.69969 17.00385 0 0 0 0 0 0 15.98074 16.79303 16.12439 15.48097 16.64421 15.66982 15.1556 16.03434 0 0 Q9H6R3 ACSS3_HUMAN "Acyl-CoA synthetase short-chain family member 3, mitochondrial, EC 6.2.1.1 (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase, EC 6.2.1.17)" ACSS3 Homo sapiens (Human) ketone body biosynthetic process [GO:0046951]; lipid metabolic process [GO:0006629] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]; ketone body biosynthetic process [GO:0046951]; lipid metabolic process [GO:0006629] acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218] GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006629; GO:0043231; GO:0046951; GO:0047760; GO:0050218 QQDPGAALGKQYSLTR 15.43000031 1 1 0.13864816 1731.876129 0 0 0 0 0 0 15.45758 0 0 0 0 0 0 0 0 20.5538 0 14.45225 0 0 0 0 0 0 0 21.66145 0 0 0 0 21.87094 0 0 21.72673 0 0 0 19.59542 0 0 0 0 0 0 19.31836 0 0 0 Q9H6R4 NOL6_HUMAN "Nucleolar protein 6 (Nucleolar RNA-associated protein, Nrap)" NOL6 Homo sapiens (Human) rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409] condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456] condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409] RNA binding [GO:0003723] GO:0000794; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456 NSVWTQDGPSAQILQQLVVLAAEALPMLEK 2.799999952 1 1 2.30E-12 3264.538335 15.91819 0 12.83244 0 0 0 0 0 9.847389 0 0 13.60836 0 0 8.996478 0 0 11.48394 0 12.55727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.39448 0 0 0 0 0 0 0 0 Q9H6R7 WDCP_HUMAN WD repeat and coiled-coil-containing protein WDCP C2orf44 PP384 Homo sapiens (Human) protein complex oligomerization [GO:0051259] kinase binding [GO:0019900]; protein complex oligomerization [GO:0051259] kinase binding [GO:0019900] GO:0019900; GO:0051259 KAVTMTR 9.539999962 0.533571839 0.533571839 0.193355199 807.5362005 15.68262 14.80676 15.56028 13.9927 14.81115 15.66812 14.03169 15.36064 15.27919 15.18729 13.21459 0 15.5307 16.02425 15.13801 13.6392 15.37145 14.78463 16.10304 14.5526 15.99563 16.17488 0 0 15.20414 15.13694 16.1338 0 14.33707 13.76919 14.59392 14.67417 0 15.4038 15.88864 16.59892 15.89276 0 15.54947 13.90289 15.40485 15.34668 15.06734 15.65048 15.47015 16.83919 16.16206 16.2032 Q9H6S0 YTDC2_HUMAN "3'-5' RNA helicase YTHDC2, EC 3.6.4.13 (YTH domain-containing protein 2, hYTHDC2)" YTHDC2 Homo sapiens (Human) "germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]" endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770] "endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]" "3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]" GO:0003723; GO:0005524; GO:0005634; GO:0005783; GO:0007286; GO:0008186; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247 QPAPGGGGGGGPSPCGPGGGGRAK 2.49000001 0.556190372 0.556190372 0.126065012 1988.909693 14.08637 0 16.24112 0 17.05523 16.54009 16.62923 0 15.97959 0 0 12.39999 14.94344 14.4281 0 16.6322 14.92557 16.17204 10.48545 0 0 17.24325 15.02749 16.36881 17.93683 14.96572 0 10.40857 0 0 0 0 14.94077 0 14.74524 0 15.52772 0 16.38364 16.45979 14.94123 15.09731 15.52059 14.80394 17.14485 9.416117 15.32158 16.43636 Q9H6S3 ES8L2_HUMAN "Epidermal growth factor receptor kinase substrate 8-like protein 2, EPS8-like protein 2 (Epidermal growth factor receptor pathway substrate 8-related protein 2, EPS8-related protein 2)" EPS8L2 EPS8R2 PP13181 Homo sapiens (Human) positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605] actin binding [GO:0003779]; cadherin binding [GO:0045296] GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0007605; GO:0031982; GO:0032421; GO:0032426; GO:0032587; GO:0032991; GO:0035023; GO:0045296; GO:0050790; GO:0070062; GO:1900029 NANELSVLKDEVLEVLEDGR 2.480000019 1 1 1.38E-12 2243.268455 0 12.85566 0 0 15.98497 0 10.93372 0 0 13.67537 13.42707 14.42934 0 0 0 17.52362 0 15.14034 0 0 0 14.12833 0 13.76447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6T0 ESRP2_HUMAN Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) ESRP2 RBM35B PP7059 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of RNA splicing [GO:0043484]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of RNA splicing [GO:0043484]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000380; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0043484; GO:0050679; GO:0060441; GO:0060445; GO:1990904 GLPWQSSDQDVARFFK 11.31000042 1 1 0.376685468 1880.372752 0 15.63493 15.44321 0 0 0 0 12.98677 0 0 0 0 14.96709 0 11.53274 0 10.70499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.82536 0 0 0 16.97512 0 0 0 15.0178 0 0 0 0 15.55717 0 0 0 Q9H6T3 RPAP3_HUMAN RNA polymerase II-associated protein 3 RPAP3 Homo sapiens (Human) protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytosol [GO:0005829]; R2TP complex [GO:0097255]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytosol [GO:0005829]; R2TP complex [GO:0097255]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; protein stabilization [GO:0050821] GO:0005829; GO:0050821; GO:0097255; GO:0101031; GO:1990062 MTSANKAIELQLQVK 8.029999733 1 1 0 1690.411959 0 0 0 0 0 0 0 0 0 0 0 14.77829 0 0 0 0 0 0 0 0 0 0 0 0 0 16.28309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53092 0 0 0 Q9H6Z4 RANB3_HUMAN "Ran-binding protein 3, RanBP3" RANBP3 Homo sapiens (Human) protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267] GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006611; GO:0031267; GO:0050790; GO:0070412 LILNTK 38.97999954 0.903175652 0.903175652 0.045362113 701.2092435 16.3986 16.32601 15.54001 14.72117 16.588 17.65167 20.13555 16.87239 0 17.44653 16.91319 16.95399 16.33298 0 16.87844 15.68596 16.38055 16.66314 16.76318 16.22383 17.27516 16.93008 18.06012 18.57388 0 15.16741 17.29464 16.46815 16.00808 0 16.83453 18.68752 16.7377 16.18598 17.01129 17.76441 0 0 17.96532 14.78851 17.757 16.32266 0 16.33677 17.1874 17.27326 16.05466 15.20973 Q9H706 GARE1_HUMAN GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1) GAREM1 C18orf11 FAM59A GAREM Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] proline-rich region binding [GO:0070064] GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364 LNSISK 5.940000057 1 1 0.181056865 662.4799401 13.65479 0 13.73434 14.64943 0 0 0 0 14.39065 12.23778 0 0 0 0 0 0 0 15.11869 0 0 0 0 17.03797 0 0 0 0 0 0 0 15.10312 16.15504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H714 PACER_HUMAN "Protein associated with UVRAG as autophagy enhancer, Pacer (Protein Rubicon-like)" RUBCNL C13orf18 KIAA0226L Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagosome-endosome fusion [GO:0061910]; autophagosome-lysosome fusion [GO:0061909]; lipid metabolic process [GO:0006629]; regulation of glycogen metabolic process [GO:0070873]; regulation of lipid metabolic process [GO:0019216] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome maturation [GO:0097352]; autophagosome-endosome fusion [GO:0061910]; autophagosome-lysosome fusion [GO:0061909]; lipid metabolic process [GO:0006629]; regulation of glycogen metabolic process [GO:0070873]; regulation of lipid metabolic process [GO:0019216] phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] GO:0000421; GO:0006629; GO:0010314; GO:0019216; GO:0031410; GO:0032266; GO:0043231; GO:0061909; GO:0061910; GO:0070273; GO:0070873; GO:0097352; GO:1901981 KGLLAPLLK 3.589999914 1 1 0.134370837 953.8132933 15.12805 0 0 15.80381 0 15.48747 0 0 0 0 14.45874 14.63914 0 0 0 0 15.35944 0 0 0 0 0 16.63829 0 16.8238 0 0 0 14.99903 0 15.06816 16.50032 14.60943 14.564 14.0949 0 16.6348 15.23783 14.85314 15.48759 0 14.13639 14.0472 16.73116 14.82571 0 0 0 Q9H720 PG2IP_HUMAN PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog) CWH43 PGAP2IP Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506] GO:0005783; GO:0006506; GO:0016021 LFLWLLVGVGLLGLGLRHK 1 1 1 0.226870976 2104.987701 14.24782 0 14.07844 14.49365 3.930021 0 14.35315 12.64948 13.98898 0 0 0 12.13684 12.5155 13.09734 11.60543 0 0 0 0 0 0 0 0 0 10.73498 17.7004 0 0 0 0 10.89951 0 0 14.79305 0 0 15.59329 0 0 17.71298 14.77588 0 0 13.63954 0 0 0 Q9H765 ASB8_HUMAN "Ankyrin repeat and SOCS box protein 8, ASB-8" ASB8 PP14212 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 GLGTEK 11.05000019 1 1 0.141226533 604.4253331 16.15488 15.89162 0 15.08088 15.5842 13.29475 14.67075 15.71466 15.66904 0 14.50394 16.1568 0 15.62418 0 15.7313 15.32536 0 15.329 0 0 13.53254 14.27177 0 16.36436 14.31517 16.66716 0 0 0 0 0 0 0 16.65421 0 16.21367 0 0 0 16.57327 0 0 15.73698 16.93492 0 0 17.0117 Q9H773 DCTP1_HUMAN "dCTP pyrophosphatase 1, EC 3.6.1.12 (Deoxycytidine-triphosphatase 1, dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein)" DCTPP1 XTP3TPA CDA03 Homo sapiens (Human) dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143] dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556] GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840 MDINRR 3.650000095 1 1 0.088719013 820.3066919 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5297 0 15.13323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01904 14.08625 16.37168 0 17.94087 0 0 16.25312 0 0 0 0 0 0 0 Q9H788 SH24A_HUMAN SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38) SH2D4A PPP1R38 SH2A Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatase binding [GO:0019902] phosphatase binding [GO:0019902] GO:0005737; GO:0005829; GO:0019902 ANELLLSTGMPGSFLIRVSER 3.25 1 1 4.58E-13 2305.593357 0 0 14.77555 0 0 0 0 0 0 0 0 0 0 0 13.27358 0 13.51929 10.84162 0 0 13.46166 0 0 14.08434 0 0 0 9.890716 0 0 14.82656 0 0 15.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H792 PEAK1_HUMAN Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269) PEAK1 KIAA2002 Homo sapiens (Human) cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446] identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] GO:0004672; GO:0004715; GO:0005737; GO:0005925; GO:0006468; GO:0015629; GO:0016477; GO:0034446; GO:0042802; GO:0046777; GO:0048041; GO:0051893 EIAGLDTAPQIR 5.869999886 1 1 0.240246656 1282.672916 0 0 0 0 0 0 0 13.21917 0 0 0 0 0 0 0 0 15.79161 0 0 0 0 0 0 16.20251 0 0 16.25899 0 0 0 0 0 0 0 0 0 16.7873 15.20545 0 15.90509 0 15.88369 0 0 0 0 0 0 Q9H799 CPLN1_HUMAN Ciliogenesis and planar polarity effector 1 (Protein JBTS17) CPLANE1 C5orf42 JBTS17 Homo sapiens (Human) cilium assembly [GO:0060271] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271] GO:0016021; GO:0035869; GO:0060271 AGGAK 3.400000095 0.287054479 0.287054479 0.057283855 403.9450421 0 0 15.91118 0 17.94157 0 17.04572 15.27987 0 17.88704 0 18.37921 0 16.20331 10.03321 0 0 17.54913 16.88674 18.42428 18.86169 19.93621 0 0 14.94728 16.54036 19.54287 18.57518 17.44689 0 19.54482 0 0 0 0 0 17.16436 17.65787 17.32055 16.50215 0 18.21164 14.60828 0 17.4365 16.00852 0 0 Q9H7B2 RPF2_HUMAN Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog) RPF2 BXDC1 Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]" 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0000027; GO:0000463; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008097; GO:0019843; GO:0042273; GO:1901796; GO:1902570 CPEGTKPMLIFAGDDFDVTEDYR 2.630000114 1 1 2.29E-12 2675.211022 12.50914 14.14194 0 0 0 0 0 0 15.53635 0 0 15.16588 14.10288 0 0 0 14.2879 13.89338 0 14.87386 0 12.79616 0 14.00695 0 14.04367 0 15.8262 13.10626 13.1794 0 0 0 15.07038 10.99247 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7B4 SMYD3_HUMAN "Histone-lysine N-methyltransferase SMYD3, EC 2.1.1.354 (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)" SMYD3 ZMYND1 ZNFN3A1 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944] histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162] GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0034968; GO:0045184; GO:0045944; GO:0046872; GO:0071549 FATAKR 8.729999542 1 1 0.141927884 693.6498768 15.69126 0 13.9358 0 0 0 0 14.97925 15.03598 0 16.63661 0 0 0 0 17.36333 0 0 0 16.63133 16.57299 0 0 16.22807 0 16.33691 14.87357 0 0 0 0 0 0 0 0 0 0 17.23743 0 16.37568 0 17.31903 17.2889 0 0 0 16.30437 0 Q9H7C4 SYNCI_HUMAN Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1) SYNC SYNC1 Homo sapiens (Human) intermediate filament-based process [GO:0045103] cytosol [GO:0005829]; intermediate filament [GO:0005882]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; Z disc [GO:0030018] cytosol [GO:0005829]; intermediate filament [GO:0005882]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; intermediate filament-based process [GO:0045103] GO:0005829; GO:0005882; GO:0030018; GO:0031594; GO:0042383; GO:0045103; GO:0048471 LHAQAELER 5.949999809 1 1 0.217533973 1066.958002 0 0 12.82422 0 0 12.91453 15.11637 0 14.38995 13.51276 0 0 13.85506 14.16784 0 0 0 0 15.57761 0 17.61953 0 0 0 0 0 0 14.27876 0 0 0 16.08509 0 15.79052 0 0 16.39635 0 0 0 0 0 0 0 0 0 16.20481 0 Q9H7C9 AAMDC_HUMAN Mth938 domain-containing protein (Adipogenesis associated Mth938 domain-containing protein) AAMDC C11orf67 PTD015 Homo sapiens (Human) positive regulation of fat cell differentiation [GO:0045600] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; positive regulation of fat cell differentiation [GO:0045600] GO:0005737; GO:0045600 GMSEALK 5.860000134 1 1 0.013367961 734.3842659 0 0 0 0 0 0 0 0 0 0 0 0 16.77114 16.30562 0 15.67465 0 0 16.93685 0 0 0 0 0 14.52629 0 0 16.3395 0 15.43692 14.7457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7D0 DOCK5_HUMAN Dedicator of cytokinesis protein 5 DOCK5 Homo sapiens (Human) cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0010634; GO:0016477; GO:1900026; GO:1904694; GO:1904754 EAKAPPPPPPK 1.830000043 1 1 0.152796635 1129.243054 0 0 0 0 14.6776 0 0 0 15.80458 0 0 0 0 14.8606 0 0 0 13.31629 0 0 15.58723 0 0 0 0 0 0 13.24538 12.33939 11.97991 0 0 0 0 0 12.3381 0 0 0 7.502865 0 0 0 0 11.62097 0 0 0 Q9H7E2 TDRD3_HUMAN Tudor domain-containing protein 3 TDRD3 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA topological change [GO:0006265] cytosol [GO:0005829]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; DNA topological change [GO:0006265] chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006265; GO:0006325; GO:0035064; GO:0140225 RGGDGQPR 5.579999924 1 1 0.090130934 842.8327506 11.96844 15.44235 15.9945 13.5118 12.79133 0 0 0 14.49483 13.43969 13.84966 13.9843 17.55827 16.25724 17.80406 0 14.48532 15.12906 17.11116 0 0 17.56454 18.11662 0 0 12.95387 14.53726 14.86209 15.35379 15.28976 0 0 0 0 0 0 0 0 0 0 0 16.28109 0 0 0 0 0 0 Q9H7F0 AT133_HUMAN "Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase, EC 7.6.2.16)" ATP13A3 AFURS1 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872] GO:0005524; GO:0006874; GO:0015594; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038 HSAGLTKGMHAYR 6.809999943 1 1 6.95E-13 1428.640991 16.48697 0 0 0 0 0 0 0 0 0 0 12.01494 0 0 0 0 0 15.51407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.06157 0 0 0 0 0 0 0 0 0 0 0 Q9H7L2 KI3X1_HUMAN Putative killer cell immunoglobulin-like receptor-like protein KIR3DX1 (Leukocyte receptor cluster member 12) KIR3DX1 KIR3DL0 LENG12 Homo sapiens (Human) extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886] GO:0005576; GO:0005886 KPSLSTQVDPMMR 3.720000029 0.855736315 0.855736315 0.287594725 1489.036356 16.10322 0 15.15513 15.32638 0 0 12.76134 0 13.00913 0 0 16.94789 0 13.84077 0 0 14.93381 0 0 0 0 0 0 15.62726 0 15.06201 0 0 0 0 0 14.2326 0 16.62006 0 0 16.12017 0 16.82973 0 0 0 0 0 0 16.21458 0 0 Q9H7N4 SFR19_HUMAN "Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1, SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor, SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1, SR-A1)" SCAF1 SFRS19 SRA1 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122] GO:0003723; GO:0005634; GO:0006366; GO:0006397; GO:0008380; GO:0019904; GO:0099122 EGSSSSEGR 7.119999886 0.421275288 0.421275288 0.228040888 893.5081312 16.45223 16.82807 0 15.54375 15.74567 15.12847 18.28673 0 15.20164 0 17.02715 12.911 16.44799 14.71212 15.05337 16.24517 0 0 15.63484 15.1314 0 0 16.30944 16.51939 0 0 17.2741 15.25509 0 15.47352 17.40794 17.46001 14.62641 15.4815 0 0 0 17.12894 17.4798 0 15.77762 14.30667 15.75407 17.4715 10.19237 0 0 0 Q9H7T0 CTSRB_HUMAN "Cation channel sperm-associated auxiliary subunit beta, CatSper-beta" CATSPERB C14orf161 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; cilium [GO:0005929]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; cilium [GO:0005929]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005886; GO:0005929; GO:0007283; GO:0030154; GO:0036128; GO:0097228 ESPLIYVSVLLLNIFEFSSGIVYNK 3.460000038 1 1 4.72E-13 2844.681568 15.80184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7T3 CJ095_HUMAN Uncharacterized protein C10orf95 C10orf95 Homo sapiens (Human) LPKAEGDK 11.26000023 1 1 0.170251275 857.6961903 0 0 0 0 0 0 0 0 14.63914 0 0 0 16.01236 0 17.39582 0 16.20076 0 0 16.88452 17.02991 0 0 0 0 0 0 15.28729 15.49905 13.49476 15.85235 0 0 14.04362 17.12713 14.16137 0 17.29896 16.81037 0 15.6054 15.02162 0 0 0 0 0 0 Q9H7T9 AUNIP_HUMAN "Aurora kinase A and ninein-interacting protein, AIBp" AUNIP C1orf135 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; spindle organization [GO:0007051] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle pole [GO:0000922]; damaged DNA binding [GO:0003684]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; spindle organization [GO:0007051] damaged DNA binding [GO:0003684] GO:0000724; GO:0000922; GO:0003684; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0090734; GO:2001033 VQTHLIKPGTK 2.880000114 1 1 0.194591211 1221.552282 0 18.13774 0 0 0 0 0 0 16.09144 0 0 0 15.76514 0 0 0 0 0 0 0 0 0 0 16.74114 0 0 18.1846 0 0 0 0 17.91101 0 0 0 0 17.97998 17.36376 0 0 15.57917 16.106 0 0 0 0 0 0 Q9H7V2 SYNG1_HUMAN "Synapse differentiation-inducing gene protein 1, SynDIG1 (Dispanin subfamily C member 2, DSPC2) (Transmembrane protein 90B)" SYNDIG1 C20orf39 TMEM90B Homo sapiens (Human) intracellular protein transport [GO:0006886]; positive regulation of synapse assembly [GO:0051965]; synaptic vesicle clustering [GO:0097091] cell body [GO:0044297]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672] cell body [GO:0044297]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672]; glutamate receptor binding [GO:0035254]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; positive regulation of synapse assembly [GO:0051965]; synaptic vesicle clustering [GO:0097091] glutamate receptor binding [GO:0035254]; protein homodimerization activity [GO:0042803] GO:0005887; GO:0006886; GO:0014069; GO:0016020; GO:0030672; GO:0031901; GO:0035254; GO:0042803; GO:0043197; GO:0043198; GO:0043231; GO:0044297; GO:0051965; GO:0060076; GO:0097091; GO:0098839 YRPNIILYSEGVLR 18.35000038 0.524778605 0.524778605 0.000893391 1693.278671 19.42218 18.42159 18.64211 18.8041 18.92686 20.09193 18.97157 18.0756 0 19.57173 19.66307 18.00222 16.79535 18.75529 0 18.28793 18.9001 0 17.98146 17.47167 17.31401 18.32315 17.99277 19.00757 18.78104 18.65356 18.51383 17.54999 17.71841 18.38372 18.30381 18.08564 18.05624 18.56452 18.4044 0 19.57617 18.7071 18.88569 18.88665 19.23603 19.116 17.45988 18.7012 19.00367 16.65345 16.39655 18.63293 Q9H7X3 ZN696_HUMAN Zinc finger protein 696 ZNF696 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 CSSDAAK 6.329999924 1 1 0.251949183 738.3517542 0 15.59436 0 0 17.88303 0 0 17.96618 18.42308 0 0 18.02029 0 0 0 0 16.9528 0 0 0 0 19.11738 0 0 0 0 0 17.48608 0 0 17.02022 0 0 0 0 0 0 0 0 0 0 0 15.92684 0 0 0 0 17.62218 Q9H7Y0 DIK2B_HUMAN Divergent protein kinase domain 2B (Deleted in autism-related protein 1) DIPK2B CXorf36 DIA1R UNQ1862/PRO3743 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 DASAVGVIDK 6.829999924 1 1 0.07247895 975.4659826 0 0 13.41479 0 0 15.38934 14.3081 15.30454 0 0 0 0 16.75433 0 0 0 17.21755 15.70519 0 0 0 0 0 0 0 0 0 0 0 0 14.05863 0 0 14.07437 18.65355 0 0 0 0 0 0 0 0 0 0 0 13.41095 0 Q9H7Z3 NRDE2_HUMAN Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog) NRDE2 C14orf102 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin assembly by small RNA [GO:0031048]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin assembly by small RNA [GO:0031048]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]; RNA splicing [GO:0008380] GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006974; GO:0008380; GO:0016246; GO:0016607; GO:0031048; GO:0046833; GO:0051301; GO:1902369 MYLNFLVSLGNKER 4.460000038 1 1 0.242403492 1701.466896 11.90407 0 0 0 15.60896 14.83443 12.11904 14.19106 0 0 0 0 0 0 0 15.95884 0 0 0 0 0 0 0 0 0 0 0 14.55055 0 0 0 0 0 0 15.10789 0 0 0 0 0 0 15.25744 0 0 15.60648 0 0 0 Q9H7Z6 KAT8_HUMAN "Histone acetyltransferase KAT8, EC 2.3.1.48 (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1, MYST-1, hMOF)" KAT8 MOF MYST1 PP7073 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" enzyme binding [GO:0019899]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0000123; GO:0000776; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006325; GO:0010484; GO:0010485; GO:0010506; GO:0016363; GO:0016573; GO:0019899; GO:0030099; GO:0035064; GO:0042393; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046972; GO:0051571; GO:0061629; GO:0071339; GO:0072487; GO:1900095 VSPPTPAR 5.21999979 0.697320402 0.697320402 0.056376679 827.2759204 16.16904 14.86471 16.30816 17.19914 15.01991 15.16834 0 15.98683 14.56052 14.30194 17.50209 16.0368 13.23165 14.97429 14.1297 16.77423 14.15326 17.11227 17.433 13.39808 14.43854 17.18665 15.60965 15.95492 18.07452 14.80961 0 16.16809 0 0 16.42105 13.45753 18.13285 17.74909 16.2688 14.69787 17.09723 15.43093 13.93123 16.42494 12.93862 0 13.22579 0 16.13612 0 16.03935 14.25541 Q9H7Z7 PGES2_HUMAN "Prostaglandin E synthase 2, EC 5.3.99.3 (Membrane-associated prostaglandin E synthase-2, mPGE synthase-2) (Microsomal prostaglandin E synthase 2, mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form ]" PTGES2 C9orf15 PGES2 Homo sapiens (Human) "cyclooxygenase pathway [GO:0019371]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; secretion [GO:0046903]" azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; cyclooxygenase pathway [GO:0019371]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; secretion [GO:0046903]" 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220] GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0006629; GO:0006749; GO:0016021; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0036134; GO:0043295; GO:0045893; GO:0046903; GO:0048471; GO:0050220 KGSPR 5.079999924 4.38E-05 4.38E-05 0.052056325 544.867154 14.42227 0 15.06565 13.76974 11.94768 16.06372 17.06022 14.32705 0 14.6446 16.16505 16.91129 17.14383 15.23822 0 16.50619 17.4052 17.48638 14.17299 18.22219 0 17.64645 16.49713 17.06497 16.00172 16.977 0 16.00683 14.10547 0 16.97638 16.65165 16.69525 0 14.88904 17.33557 16.03323 17.85939 17.04492 0 15.99082 18.11448 17.41123 0 16.32496 16.7755 17.45281 15.44858 Q9H840 GEMI7_HUMAN "Gem-associated protein 7, Gemin-7 (SIP3)" GEMIN7 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Sm-like protein family complex [GO:0120114]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Sm-like protein family complex [GO:0120114]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504; GO:0120114 GFAPDGRR 4.179999828 1 1 8.01E-13 873.4066542 15.12509 0 15.35356 0 0 0 13.86819 15.26793 0 0 0 0 0 14.21813 14.55205 14.30388 15.41457 0 15.23104 10.19461 0 12.63655 16.52182 0 16.42289 12.25064 0 14.21932 15.8456 12.04211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H845 ACAD9_HUMAN "Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9, ACAD-9, EC 1.3.8.-)" ACAD9 Homo sapiens (Human) long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981] acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099] GO:0000062; GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991 ATLSEDK 12.69999981 0.149284229 0.149284229 0.25485628 764.4122898 18.94989 16.6758 19.42533 18.34616 17.8801 17.92339 20.01509 18.12701 0 19.0639 17.71775 20.91054 19.39204 19.46727 19.40896 18.30364 0 0 18.32334 0 0 0 0 0 19.30611 18.55007 19.63647 17.92627 18.93704 18.27213 0 18.57184 19.35036 0 19.26243 19.07183 0 18.94376 0 19.25706 18.75755 18.1086 17.92546 17.78433 18.43575 19.92559 20.1897 19.16897 Q9H857 NT5D2_HUMAN "5'-nucleotidase domain-containing protein 2, EC 3.1.3.-" NT5DC2 Homo sapiens (Human) 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] GO:0008253; GO:0046872 GLHYDIQK 4.659999847 1 1 0.152154626 972.9379267 15.20864 0 11.69959 0 0 0 0 0 14.00485 15.15567 13.69622 15.54589 15.95257 0 0 14.10351 0 0 0 0 0 0 0 0 0 15.21438 0 0 0 0 0 16.41896 0 0 0 0 0 14.97402 0 0 0 0 0 0 0 0 0 0 Q9H869 YYAP1_HUMAN YY1-associated protein 1 (Hepatocellular carcinoma susceptibility protein) (Hepatocellular carcinoma-associated protein 2) YY1AP1 HCCA2 YY1AP Homo sapiens (Human) "cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]" transcription coregulator activity [GO:0003712] GO:0001650; GO:0003712; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0008283; GO:0030154; GO:0051726 QLTVRIK 3.720000029 1 1 0.225124724 857.9426559 0 20.77207 0 19.47917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H871 RMD5A_HUMAN "E3 ubiquitin-protein transferase RMND5A, EC 2.3.2.27 (P44CTLH) (Protein RMD5 homolog A)" RMND5A Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0034657; GO:0043161; GO:0046872; GO:0061630 AVIEQR 14.36999989 1 1 0.255063356 715.7704144 0 19.77241 0 0 18.52267 18.14802 0 0 0 19.08914 0 19.08254 18.11536 17.87037 19.42748 0 19.29537 0 0 0 0 17.17852 0 0 20.66968 16.57463 18.16127 18.74655 0 0 19.00443 19.01432 0 0 0 19.21029 19.0733 0 0 0 0 0 17.90251 0 18.53997 16.39599 0 0 Q9H892 TTC12_HUMAN "Tetratricopeptide repeat protein 12, TPR repeat protein 12" TTC12 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288] centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288] GO:0005737; GO:0005813; GO:0007288; GO:0070286 MHNGFSIISDNEVIRR 2.369999886 1 1 0.026715253 1900.787429 0 14.8628 15.71629 10.58293 0 0 15.31369 0 0 0 0 13.96156 0 15.0601 13.79145 16.12169 0 0 0 0 0 0 0 0 17.06946 16.83353 0 16.08854 0 15.57631 0 0 0 0 0 0 0 0 0 0 18.51365 0 0 0 0 0 16.86377 0 Q9H898 ZMAT4_HUMAN Zinc finger matrin-type protein 4 ZMAT4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0008270; GO:0042802 GSKHQTNLK 3.410000086 1 1 0.164796986 1012.83331 0 14.44899 0 0 13.50906 13.44677 0 0 0 0 0 0 14.78732 12.94998 14.59289 0 0 0 17.83329 0 0 0 0 0 0 0 0 0 13.11901 0 0 0 0 0 0 0 15.84665 0 0 0 0 0 0 13.67479 0 0 0 0 Q9H8H0 NOL11_HUMAN Nucleolar protein 11 NOL11 L14 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0034455; GO:1901838 CKAEPSFYPR 8.56000042 1 1 0.29702672 1254.544059 13.74039 0 15.42676 12.13547 0 0 15.06381 0 14.80148 0 12.73826 0 0 0 0 14.15709 0 15.88896 15.3339 0 0 15.15107 14.44608 0 0 14.21805 0 0 0 0 15.25237 0 0 0 0 0 0 0 0 17.15409 0 0 0 17.20957 0 0 0 0 Q9H8H2 DDX31_HUMAN "Probable ATP-dependent RNA helicase DDX31, EC 3.6.4.13 (DEAD box protein 31) (Helicain)" DDX31 Homo sapiens (Human) ribosome biogenesis [GO:0042254] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0016887; GO:0042254; GO:0043231 GGGAGSSRVPR 8.460000038 1 1 0.117033814 1000.423991 15.01757 14.26302 14.56102 0 12.52282 15.30655 16.0562 13.37257 0 14.31007 0 7.985358 13.14325 0 0 15.37292 14.61797 0 14.06498 13.32102 14.15885 14.62009 0 0 0 13.94436 12.97373 15.78247 14.18729 14.86695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8J5 MANS1_HUMAN MANSC domain-containing protein 1 (Loss of heterozygosity 12 chromosomal region 3 protein) MANSC1 LOH12CR3 UNQ316/PRO361 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DTLSQK 17.12000084 1 1 0.237231903 691.549515 18.57897 19.32808 19.62235 19.43311 0 17.97603 19.00928 18.85867 18.01414 18.74371 17.96967 17.98002 17.40229 0 18.06643 18.03958 17.58987 0 19.44788 18.97647 0 0 0 0 0 19.16408 20.00217 16.89788 0 17.85473 0 19.45877 18.58955 0 19.54566 19.56705 0 0 17.93711 0 0 0 17.31153 0 0 17.17749 0 0 Q9H8K7 PAAT_HUMAN "ATPase PAAT, EC 3.6.1.- (Protein associated with ABC transporters, PAAT)" PAAT C10orf88 Homo sapiens (Human) cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] GO:0005737; GO:0005739; GO:0016887; GO:0042802 HMIGLQSSSTLGTLNK 1.75 1 1 0.058914704 1703.031714 14.74193 0 14.48364 0 0 0 0 15.17165 0 0 0 0 0 0 13.72365 0 0 0 0 0 0 0 14.41552 15.81359 0 0 0 0 13.13187 0 0 0 15.10889 15.01999 0 15.21994 14.89786 0 0 0 12.67111 15.61055 0 0 15.79218 14.8931 12.22577 0 Q9H8M2 BRD9_HUMAN Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8) BRD9 UNQ3040/PRO9856 Homo sapiens (Human) chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676] GO:0000785; GO:0003676; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0070577; GO:0140288; GO:1902459 LLPGFTTLGFK 5.010000229 1 1 0.056391764 1193.436516 0 13.51318 14.29739 10.40721 0 13.68811 14.74214 12.27973 12.36004 16.23491 13.66428 0 11.1937 12.59192 14.06176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8M7 MINY3_HUMAN "Ubiquitin carboxyl-terminal hydrolase MINDY-3, EC 3.4.19.12 (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP)" MINDY3 C10orf97 CARP DERP5 FAM188A MSTP126 My042 Homo sapiens (Human) apoptotic process [GO:0006915] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]; apoptotic process [GO:0006915] Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:0005654; GO:0006915; GO:0031965; GO:1990380 VGSYLKSPK 7.119999886 1 1 0.209662535 977.1043789 18.56354 0 0 0 0 0 0 0 0 0 0 16.40025 0 0 0 0 16.47451 0 0 0 0 0 0 0 18.74179 0 0 0 0 0 0 0 0 18.36852 0 19.93129 0 0 0 17.22221 0 0 0 16.85583 0 0 0 0 Q9H8N7 ZN395_HUMAN "Zinc finger protein 395 (HD-regulating factor 2, HDRF-2) (Huntington disease gene regulatory region-binding protein 2, HD gene regulatory region-binding protein 2, HDBP-2) (Papillomavirus regulatory factor 1, PRF-1) (Papillomavirus-binding factor)" ZNF395 HDBP2 PBF Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0016607; GO:0045944; GO:0046872 MASVLSRR 2.079999924 1 1 0.232966194 933.8266135 0 15.72266 10.2841 0 0 14.87118 0 0 0 16.65879 0 15.47838 0 0 0 15.31266 0 0 0 0 16.67256 0 0 0 0 0 0 0 0 0 0 15.21142 13.22588 14.99546 0 13.70452 0 15.58477 16.86581 0 14.48315 0 0 0 16.88882 16.15834 15.79509 0 Q9H8T0 AKTIP_HUMAN AKT-interacting protein (Ft1) (Fused toes protein homolog) AKTIP FTS Homo sapiens (Human) apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] ubiquitin conjugating enzyme activity [GO:0061631] GO:0000209; GO:0001934; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0032092; GO:0045022; GO:0061631; GO:0070695; GO:1905719 LPGVYVQPSYRSALMWFGVIFIR 5.21999979 1 1 0.21862563 2714.395277 14.84756 15.53115 0 0 0 14.98022 0 13.57371 0 0 15.51215 13.84474 0 16.31159 0 0 16.18624 0 0 0 0 0 0 0 0 0 0 16.61343 0 0 15.69435 16.41271 14.49565 0 14.21504 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8V3 ECT2_HUMAN Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) ECT2 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]" bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]" GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] GO:0000281; GO:0000902; GO:0005085; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0030154; GO:0030496; GO:0031267; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431 IMEVPVIK 14.64999962 1 1 0.156335822 927.6116237 16.48096 15.7915 16.89288 15.49634 15.65237 15.57193 16.33387 14.79779 15.39814 14.80558 0 16.33915 14.02459 15.76937 16.33115 15.66272 16.38953 15.53967 16.19707 16.33474 16.20693 17.38992 15.42776 17.05075 16.38669 15.65571 16.26174 15.54766 15.91303 0 16.76003 0 0 14.8808 16.05929 0 0 16.40731 17.01785 0 14.61833 16.44237 15.74018 15.71299 0 15.86657 16.39665 0 Q9H8W2 CF155_HUMAN Putative uncharacterized protein encoded by LINC00472 LINC00472 C6orf155 Homo sapiens (Human) QPGPQR 4.769999981 0.602841794 0.602841794 0.184509382 684.4166377 15.94207 12.3526 15.56341 16.67393 16.04194 14.12349 0 15.8418 0 0 0 14.15403 0 13.59365 14.77518 0 16.01588 15.48633 15.44689 0 0 0 0 0 0 0 0 0 0 15.61214 0 0 0 16.7826 16.03312 0 15.4921 0 0 16.08576 0 0 15.62114 15.21061 16.21466 0 0 0 Q9H8X9 ZDH11_HUMAN "Palmitoyltransferase ZDHHC11, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 11, DHHC-11) (Zinc finger protein 399)" ZDHHC11 ZNF399 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling adaptor activity [GO:0035591]; antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein targeting to membrane [GO:0006612] protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling adaptor activity [GO:0035591] GO:0002230; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010008; GO:0016021; GO:0018230; GO:0019706; GO:0035591; GO:0140374 LCQFSTR 6.289999962 1 1 0.109354273 910.4516596 0 0 17.19094 16.64613 0 0 0 15.23412 13.85917 0 17.39762 15.55385 0 0 0 0 0 0 0 0 0 0 14.91347 0 0 0 15.63296 17.08309 17.19541 0 0 0 0 0 0 0 0 17.59893 0 0 0 0 0 0 17.04525 0 13.20408 15.45892 Q9H8Y1 VRTN_HUMAN Vertnin VRTN C14orf115 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785] chromatin [GO:0000785]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357] sequence-specific DNA binding [GO:0043565] GO:0000785; GO:0006357; GO:0043565 DVTAVMAPPVGASSEDVEGGPSR 4.670000076 1 1 0.195678497 2227.901002 0 0 11.31253 14.70847 12.37808 0 6.936442 12.87696 10.26083 0 0 11.44096 14.94618 12.68735 13.33696 0 0 12.93297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8Y5 ANKZ1_HUMAN Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744) ANKZF1 ZNF744 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; ubiquitin-dependent ERAD pathway [GO:0030433] metal ion binding [GO:0046872] GO:0005737; GO:0016020; GO:0030433; GO:0046872; GO:0070301 ARPPYTVAADKSTR 2.569999933 1 1 0.049827414 1533.41732 0 0 12.61088 0 0 0 15.60087 0 0 12.6493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H900 ZWILC_HUMAN "Protein zwilch homolog, hZwilch" ZWILCH Homo sapiens (Human) cell division [GO:0051301]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; RZZ complex [GO:1990423] cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; RZZ complex [GO:1990423]; cell division [GO:0051301]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] GO:0000776; GO:0005828; GO:0005829; GO:0007094; GO:0034501; GO:0051301; GO:1990423 GDIQPWLHSGSNSLLSK 8.43999958 1 1 0.133124407 1839.622089 0 0 15.66328 16.23098 0 0 0 16.49621 11.57911 0 0 0 14.25974 0 0 0 0 12.96135 0 0 0 0 0 0 0 0 16.11965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H903 MTD2L_HUMAN "Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2, mitochondrial (NADP-dependent methylenetetrahydrofolate dehydrogenase 2-like protein, MTHFD2-like) [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase, EC 1.5.1.15, EC 1.5.1.5; Methenyltetrahydrofolate cyclohydrolase, EC 3.5.4.9 ]" MTHFD2L Homo sapiens (Human) 10-formyltetrahydrofolate metabolic process [GO:0009256]; folic acid metabolic process [GO:0046655]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; 10-formyltetrahydrofolate metabolic process [GO:0009256]; folic acid metabolic process [GO:0046655]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999] methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488] GO:0000105; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0005743; GO:0005759; GO:0006164; GO:0009086; GO:0009256; GO:0035999; GO:0046655 APGEPGSAFR 2.599999905 1 1 0.09708832 988.7245122 15.93436 0 16.88289 15.00018 0 15.28534 15.75255 0 0 0 15.08427 0 0 15.23699 15.14783 0 0 14.33579 0 0 0 0 0 0 0 15.53228 0 0 0 15.26454 0 0 14.57204 16.03578 15.39705 0 0 15.51322 13.75901 14.23423 12.06732 12.1918 14.33362 15.32182 13.72815 16.07402 0 0 Q9H930 SP14L_HUMAN Nuclear body protein SP140-like protein SP140L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0016604; GO:0046872 ESDQACGK 4.920000076 0.74590838 0.74590838 0.162353614 893.8819316 14.01201 0 0 0 0 0 18.33196 0 13.7524 0 0 12.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21776 15.79044 15.15849 0 15.55646 15.57033 0 0 0 0 0 0 0 0 0 0 16.03677 0 0 0 14.30091 0 Q9H936 GHC1_HUMAN "Mitochondrial glutamate carrier 1, GC-1 (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)" SLC25A22 GC1 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490] amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857] GO:0005280; GO:0005313; GO:0005743; GO:0006811; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0043490 LQSLQR 10.07999992 1 1 0.083230803 741.5762241 14.37191 13.72643 13.93133 13.2404 14.10389 13.78344 15.15247 0 0 0 0 0 0 0 0 0 0 0 15.47495 0 15.23613 15.43653 0 0 0 0 0 14.17668 13.72853 0 16.66794 0 0 0 0 16.37503 0 0 0 0 16.16997 0 0 0 15.24129 15.68564 12.60892 0 Q9H977 WDR54_HUMAN WD repeat-containing protein 54 WDR54 Homo sapiens (Human) negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408] vesicle [GO:0031982] vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408] protein homodimerization activity [GO:0042803] GO:0002091; GO:0031982; GO:0042058; GO:0042803; GO:0043408 LLSAGEDTFVHIWK 3.970000029 1 1 4.57E-13 1616.765873 0 13.83891 13.99238 14.39279 12.81586 0 14.66794 13.83363 12.49979 0 0 0 15.13514 14.52243 13.09171 14.12945 14.50644 14.74153 14.83181 15.28682 0 0 15.35903 14.71338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0351 0 0 0 0 0 0 0 Q9H987 SYP2L_HUMAN Synaptopodin 2-like protein SYNPO2L Homo sapiens (Human) heart morphogenesis [GO:0003007]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; heart morphogenesis [GO:0003007]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] actin binding [GO:0003779] GO:0003007; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0015629; GO:0016607; GO:0030018; GO:0030054; GO:0032233; GO:0035025; GO:0045214; GO:0051496 TLPHVTPK 3.269999981 1 1 0.107588762 895.3539782 0 0 0 0 0 0 0 0 0 0 0 13.08025 0 0 0 15.74826 0 0 0 16.69922 12.07093 13.72939 13.11861 0 0 10.8137 13.95248 0 14.42672 0 0 0 0 0 0 0 0 17.15638 0 0 0 0 15.09529 0 11.65278 15.0295 16.29522 0 Q9H992 MARH7_HUMAN "E3 ubiquitin-protein ligase MARCHF7, EC 2.3.2.27 (Axotrophin) (Membrane-associated RING finger protein 7) (Membrane-associated RING-CH protein VII, MARCH-VII) (RING finger protein 177) (RING-type E3 ubiquitin transferase MARCHF7)" MARCHF7 AXOT MARCH7 RNF177 Homo sapiens (Human) "negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]" cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]" MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] GO:0002643; GO:0005634; GO:0005829; GO:0005886; GO:0006513; GO:0008270; GO:0008284; GO:0016740; GO:0031624; GO:0042130; GO:0043130; GO:0043518; GO:0050821; GO:0051865; GO:0097371; GO:1901799; GO:1902166; GO:1902916; GO:1905524 GSSLNDTYHSR 5.28000021 1 1 0.201541379 1236.786449 15.00394 17.95648 16.60257 0 0 0 0 0 0 16.25652 0 18.72492 0 0 15.53904 0 0 0 0 15.87532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.96252 0 18.88348 0 0 16.31351 0 Q9H9A5 CNO10_HUMAN CCR4-NOT transcription complex subunit 10 CNOT10 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] GO:0000289; GO:0005634; GO:0005829; GO:0006402; GO:0016020; GO:0017148; GO:0030014; GO:0031047 NQLLPAVK 8.640000343 1.17E-05 1.17E-05 0.20558428 883.4754669 19.3448 18.28142 17.11147 0 0 18.71343 0 0 18.50084 16.92363 19.3124 0 19.08669 18.64178 15.73855 0 0 18.54825 0 17.64371 0 19.89175 0 16.97973 0 19.33512 16.66402 0 16.61853 0 17.79884 0 0 20.12997 20.20342 0 0 0 20.04592 17.60268 0 0 17.57277 18.77718 0 18.10438 0 18.97659 Q9H9A6 LRC40_HUMAN Leucine-rich repeat-containing protein 40 LRRC40 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] protein serine/threonine phosphatase activity [GO:0004722] GO:0004722; GO:0005737; GO:0007165; GO:0016020; GO:0043231 KSGQLNLSGR 5.510000229 1 1 0.283729569 1059.161133 0 0 0 0 0 0 0 17.72489 0 0 0 17.68928 0 18.22708 0 0 17.78973 20.6979 0 0 17.03255 0 17.28593 0 0 0 17.64473 0 18.15305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.99367 0 0 0 Q9H9B1 EHMT1_HUMAN "Histone-lysine N-methyltransferase EHMT1, EC 2.1.1.-, EC 2.1.1.367 (Euchromatic histone-lysine N-methyltransferase 1, Eu-HMTase1) (G9a-like protein 1, GLP, GLP1) (Histone H3-K9 methyltransferase 5, H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)" EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]" chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]" C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] GO:0000122; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0070742; GO:0120162 EVTIAKADTTSTVTPVPGQEK 7.400000095 1 1 3.67E-12 2171.384294 14.11466 13.21424 11.9494 12.81309 0 0 0 12.83384 12.93853 0 13.18155 0 0 0 0 0 10.67808 0 14.23825 0 12.33706 0 15.11548 14.98619 0 0 0 0 0 12.12257 14.28658 15.59618 0 0 0 0 0 14.06187 0 0 0 0 0 0 0 0 0 0 Q9H9B4 SFXN1_HUMAN Sideroflexin-1 SFXN1 Homo sapiens (Human) D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300] D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857] GO:0005739; GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542 MILIGRMSAQVPMNMTITGCMMTFYR 5.159999847 1 1 4.12E-12 3101.118418 15.34936 11.73178 18.1756 12.2245 14.0463 0 0 13.46133 0 0 0 0 12.69674 0 0 12.89351 11.59576 0 13.05021 14.96412 0 11.16328 0 0 0 0 0 14.68027 0 14.85055 15.2455 13.34251 11.00147 13.85488 0 12.75764 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9C1 SPE39_HUMAN "Spermatogenesis-defective protein 39 homolog, hSPE-39 (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)" VIPAS39 C14orf133 SPE39 VIPAR Homo sapiens (Human) cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023]; protein-containing complex binding [GO:0044877]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034] protein-containing complex binding [GO:0044877] GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007034; GO:0007283; GO:0008333; GO:0017185; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0046907; GO:0055037; GO:0090385; GO:0099023 IDALLSSSQIRWK 1.100000024 1 1 0.267942717 1517.104794 13.88244 0 0 0 0 13.96539 0 0 13.76322 0 0 0 0 0 0 15.42903 14.57248 0 0 16.335 0 0 0 15.37406 0 0 0 0 0 0 0 0 0 16.89739 0 16.7963 15.33074 0 14.85352 0 12.82508 0 0 0 0 0 0 0 Q9H9E3 COG4_HUMAN "Conserved oligomeric Golgi complex subunit 4, COG complex subunit 4 (Component of oligomeric Golgi complex 4)" COG4 Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" identical protein binding [GO:0042802] GO:0000139; GO:0000301; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0042802; GO:0048213; GO:0070085 ADDILDLK 2.039999962 0.236183271 0.236183271 0.041508404 901.8525822 18.52827 15.22949 0 13.42663 0 0 0 14.80478 0 16.40569 0 15.84831 12.95669 0 15.48785 0 15.7739 17.17648 13.19026 12.82112 0 18.19271 15.28663 15.86194 17.16768 0 16.56633 0 15.98077 0 15.06837 19.67918 18.08601 14.33585 16.48078 0 18.69977 15.48816 13.04088 15.65152 16.37302 15.09674 0 13.45857 14.70336 15.3676 0 15.29036 Q9H9F9 ARP5_HUMAN "Actin-related protein 5, hARP5 (Sarcoma antigen NY-SAR-16)" ACTR5 ARP5 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of transcription, DNA-templated [GO:0006355]; UV-damage excision repair [GO:0070914]" cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of transcription, DNA-templated [GO:0006355]; UV-damage excision repair [GO:0070914]" GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0006302; GO:0006310; GO:0006338; GO:0006355; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0051726; GO:0060382; GO:0070914 ELLEMRPFRSSFQVQLASNPVLDAWYGAR 1.710000038 1 1 4.57E-13 3380.386369 0 12.85339 13.3534 12.85172 0 0 0 0 7.357741 14.28146 15.2009 12.24947 0 0 13.96332 0 0 0 0 0 0 0 0 0 12.67214 0 14.13744 11.15446 14.97989 13.28976 0 0 0 0 0 0 0 10.34199 0 0 0 0 0 16.66947 14.58545 0 8.96288 12.12643 Q9H9G7 AGO3_HUMAN "Protein argonaute-3, Argonaute3, hAgo3, EC 3.1.26.n2 (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3, eIF-2C 3, eIF2C 3)" AGO3 EIF2C3 Homo sapiens (Human) miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of stem cell proliferation [GO:0072091]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501] condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of stem cell proliferation [GO:0072091]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]" "double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]" GO:0000794; GO:0000932; GO:0003723; GO:0003725; GO:0003727; GO:0004521; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0010501; GO:0010628; GO:0016020; GO:0016246; GO:0016442; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0036464; GO:0046872; GO:0070578; GO:0072091; GO:0090624; GO:1901224 KPSIAAVVGSMDAHPSR 2.25999999 1 1 0.175455151 1734.49237 0 0 13.50602 0 0 13.86697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.90582 0 14.28436 16.03102 0 16.1178 14.11804 15.21677 0 15.96283 0 0 0 0 16.82473 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9H4 VP37B_HUMAN "Vacuolar protein sorting-associated protein 37B, hVps37B (ESCRT-I complex subunit VPS37B)" VPS37B Homo sapiens (Human) macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] calcium-dependent protein binding [GO:0048306] GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0048306; GO:0070062; GO:1903774 MAGAGSEAR 4.800000191 0.733062923 0.733062923 0.161783556 849.2105385 0 0 0 14.81326 0 16.596 0 14.59936 0 15.1571 15.78089 0 0 0 15.79132 15.42297 0 0 0 0 0 15.06104 15.35424 12.12652 16.8075 0 16.53666 0 14.55345 0 0 13.66854 15.04426 15.82149 0 15.13209 0 0 15.90379 0 13.96475 0 15.16121 16.87068 0 0 14.91805 0 Q9H9J4 UBP42_HUMAN "Ubiquitin carboxyl-terminal hydrolase 42, EC 3.4.19.12 (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42)" USP42 Homo sapiens (Human) cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0007283; GO:0016579; GO:0030154; GO:0042981 DPLEEPKAK 11.60000038 0.556329608 0.556329608 0.128315248 1027.261806 12.29778 13.09083 19.3182 16.58782 0 16.44619 8.558544 16.35598 19.44168 16.63768 0 0 15.62842 15.07829 16.69941 16.76309 0 14.37517 17.22058 10.35178 15.19705 0 16.85238 18.5817 12.46428 18.70373 0 0 0 0 17.08915 11.63446 16.55799 0 17.97234 17.04173 16.72427 17.22837 13.49747 13.66669 17.67441 12.66335 14.45556 14.6896 15.32451 0 16.2965 15.75438 Q9H9L7 AKIR1_HUMAN Akirin-1 AKIRIN1 C1orf108 Homo sapiens (Human) myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944] transcription coregulator activity [GO:0003712] GO:0000785; GO:0003712; GO:0005634; GO:0005654; GO:0010592; GO:0010759; GO:0014839; GO:0031965; GO:0045663; GO:0045944; GO:1902723; GO:1902725 DQPTFTLR 2.359999895 1 1 0.194217585 976.4773449 15.6586 14.87929 15.12824 0 0 0 0 0 14.98797 0 0 0 0 15.19717 0 14.22867 0 0 0 0 0 0 0 14.15216 16.13095 14.80469 14.35977 12.62071 15.54443 15.2497 14.45611 16.71001 15.57116 16.22157 0 15.85333 15.7549 14.90411 15.81726 15.26946 0 12.60946 12.20422 15.65879 12.89396 14.99662 16.12678 13.90259 Q9H9P5 UNKL_HUMAN "Putative E3 ubiquitin-protein ligase UNKL, EC 2.3.2.- (RING finger protein unkempt-like) (Zinc finger CCCH domain-containing protein 5-like)" UNKL C16orf28 ZC3H5L ZC3HDC5L Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; transferase activity [GO:0016740] GO:0005634; GO:0005829; GO:0016567; GO:0016740; GO:0046872 QLDEAKR 9.659999847 0.53864491 0.53864491 0.249123215 858.76351 0 20.88148 0 0 0 16.07721 0 0 19.95879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.13434 0 0 0 0 15.90901 0 0 0 0 0 0 0 17.91739 0 Q9H9P8 L2HDH_HUMAN "L-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.2 (Duranin)" L2HGDH C14orf160 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281] integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]; 2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545] GO:0003973; GO:0005739; GO:0005743; GO:0006103; GO:0016021; GO:0031305; GO:0044281; GO:0047545 GIEMAK 13.18000031 1 1 0.184107004 661.5621071 0 0 16.45625 0 0 0 0 15.09335 0 0 0 0 17.02078 0 16.18836 0 0 0 0 0 0 0 0 0 0 0 0 0 16.56527 0 0 16.18542 0 16.0421 0 16.18794 16.6897 16.86881 16.35044 17.37074 17.06448 0 0 17.06059 16.15809 16.66294 16.88208 18.2191 Q9H9Q2 CSN7B_HUMAN "COP9 signalosome complex subunit 7b, SGN7b, Signalosome subunit 7b (JAB1-containing signalosome subunit 7b)" COPS7B CSN7B Homo sapiens (Human) COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] GO:0000338; GO:0005654; GO:0005829; GO:0008180; GO:0010387; GO:0045116; GO:2000434 KDINNIVK 7.050000191 1 1 0.09518685 944.0245387 0 15.95597 15.80136 15.53045 0 10.00917 0 15.19816 14.32389 14.14516 14.1482 14.58479 0 0 14.84439 0 0 0 0 0 0 0 0 0 0 0 0 15.02017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9S3 S61A2_HUMAN "Protein transport protein Sec61 subunit alpha isoform 2, Sec61 alpha-2" SEC61A2 Homo sapiens (Human) "posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784] "integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048] GO:0005048; GO:0005784; GO:0006616; GO:0008320; GO:0016021; GO:0031204; GO:0043022 EQQMVMR 7.059999943 0.985486746 0.985486746 0.195892966 953.3911096 0 0 0 0 0 12.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.34087 0 0 0 0 0 12.89447 14.73621 0 0 0 0 0 0 0 0 0 0 18.12434 0 0 0 0 0 0 0 0 0 Q9H9S4 CB39L_HUMAN Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein) CAB39L Homo sapiens (Human) intracellular signal transduction [GO:0035556] cytosol [GO:0005829] cytosol [GO:0005829]; protein serine/threonine kinase activator activity [GO:0043539]; intracellular signal transduction [GO:0035556] protein serine/threonine kinase activator activity [GO:0043539] GO:0005829; GO:0035556; GO:0043539 ASEEVSKSLQAMK 8.449999809 0.346239418 0.346239418 0.028449604 1423.442692 16.0937 0 12.05193 0 14.7972 16.29809 0 0 0 15.77628 13.82303 0 17.35653 0 0 0 13.49884 0 0 15.97857 0 12.03729 0 16.04202 16.98137 11.67822 0 0 15.43496 15.53906 0 0 0 15.86666 15.19156 17.46289 0 19.53508 17.63687 13.81305 0 0 0 0 0 0 12.41533 0 Q9H9T3 ELP3_HUMAN "Elongator complex protein 3, hELP3, EC 2.3.1.- (tRNA uridine(34) acetyltransferase)" ELP3 Homo sapiens (Human) central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]; central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]" "4 iron, 4 sulfur cluster binding [GO:0051539]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]" GO:0000049; GO:0001764; GO:0002098; GO:0002926; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006417; GO:0007417; GO:0008080; GO:0008607; GO:0016407; GO:0030335; GO:0033588; GO:0046872; GO:0051539; GO:0106261 CIGITIETRPDYCMK 6.639999866 0.002566614 0.002566614 3.42E-12 1870.632764 0 15.42937 0 0 0 15.0986 0 0 15.12399 0 16.79758 0 0 0 0 15.49412 12.48526 0 0 0 0 14.26517 16.82073 0 0 16.91494 16.02536 14.42529 0 17.47988 18.56891 0 0 19.67618 17.68915 17.95056 0 16.66895 15.81433 0 12.71974 0 0 17.17555 0 0 0 0 Q9H9Y6 RPA2_HUMAN "DNA-directed RNA polymerase I subunit RPA2, RNA polymerase I subunit 2, EC 2.7.7.6 (DNA-directed RNA polymerase I 135 kDa polypeptide, RPA135)" POLR1B Homo sapiens (Human) embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549] GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005829; GO:0007566; GO:0009303; GO:0014029; GO:0017126; GO:0032549; GO:0046872 HMVSDK 16.46999931 0.11784777 0.11784777 0.270775175 716.0185486 0 14.46567 0 0 0 0 0 0 15.05152 0 15.57456 0 14.92103 0 16.16247 16.20868 0 14.64632 17.36114 16.28279 17.2714 0 16.69663 16.50344 15.82564 14.90888 16.60544 14.85749 16.13439 16.44261 17.79018 15.71542 15.67642 17.14515 16.30476 0 17.68526 18.11893 18.65047 0 18.51634 17.42376 17.94207 17.38087 17.38925 19.25105 16.09722 16.83231 Q9HA38 ZMAT3_HUMAN Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein) ZMAT3 PAG608 WIG1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0006915; GO:0006974; GO:0008270; GO:0015031; GO:0040008 NYYAANSCPPPAR 5.230000019 1 1 0.415716636 1479.558298 0 0 13.48854 0 15.03398 0 16.40701 14.18843 14.06413 14.14102 13.206 13.55803 14.28982 13.89757 0 15.82109 0 0 0 0 0 0 0 0 0 16.52586 0 0 0 0 0 16.31623 0 0 15.92464 0 0 16.59314 0 0 0 0 14.34596 0 0 0 0 0 Q9HA64 KT3K_HUMAN "Ketosamine-3-kinase, EC 2.7.1.172 (Fructosamine-3-kinase-related protein, FN3K-RP, FN3K-related protein) (Protein-psicosamine 3-kinase FN3KRP, EC 2.7.1.-)" FN3KRP Homo sapiens (Human) post-translational protein modification [GO:0043687] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193]; post-translational protein modification [GO:0043687] ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193] GO:0005524; GO:0005829; GO:0016301; GO:0043687; GO:0102193 APGFEK 6.170000076 1 1 0.152027625 647.6193424 0 0 0 0 0 0 0 0 0 0 19.20673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.35859 0 0 0 0 0 18.38651 0 0 0 0 0 0 0 0 0 Q9HA72 CAHM2_HUMAN Calcium homeostasis modulator protein 2 (Protein FAM26B) CALHM2 FAM26B Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; positive regulation of apoptotic process [GO:0043065] cation channel activity [GO:0005261] GO:0005261; GO:0005887; GO:0043065 FLSLFFKSK 13.96000004 9.54E-10 9.54E-10 0.110304363 1116.556315 19.15956 20.95244 19.47972 21.19605 21.01677 21.32148 19.69502 20.32273 19.06646 18.83146 20.16353 20.51641 20.13275 20.37956 19.94851 20.19506 19.41908 19.33073 20.03703 20.17378 18.54484 19.68169 20.07229 20.5869 17.73978 19.60809 19.6283 18.94362 20.08143 18.01649 20.16943 20.27654 20.72289 20.69472 19.4788 20.27487 20.39979 20.519 19.155 20.78543 20.79544 21.48625 20.62105 20.30837 19.17352 19.8466 20.40877 20.10591 Q9HA82 CERS4_HUMAN "Ceramide synthase 4, CerS4, EC 2.3.1.- (LAG1 longevity assurance homolog 4) (Sphingosine N-acyltransferase CERS4, EC 2.3.1.24)" CERS4 LASS4 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148] DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291 FIGLPLSR 5.5 0.332702249 0.332702249 0.205289332 903.4864691 15.14812 14.12574 15.80018 17.22305 16.1289 0 0 0 0 17.80281 0 16.61702 0 0 15.93876 0 15.997 14.59939 0 16.80692 0 0 0 0 15.96126 0 0 15.87426 0 0 0 0 0 0 0 16.26152 17.82645 15.77858 0 0 0 0 0 0 0 0 0 0 Q9HA92 RSAD1_HUMAN "Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone)" RSAD1 Homo sapiens (Human) porphyrin-containing compound biosynthetic process [GO:0006779] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]" "4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; heme binding [GO:0020037]; metal ion binding [GO:0046872]" GO:0004109; GO:0005737; GO:0005739; GO:0006779; GO:0020037; GO:0046872; GO:0051539 GALPAPDPELAAEMYQRGR 9.140000343 1 1 1.83E-12 2054.205963 0 13.70165 0 0 13.87814 13.91252 13.98728 14.41436 12.79877 0 0 14.01116 14.22921 14.53418 0 0 0 0 0 0 14.9905 0 0 0 0 0 0 0 0 0 0 0 16.28074 16.42333 14.55113 0 13.63598 17.44916 0 0 12.84341 0 0 14.58964 0 0 0 13.01342 Q9HAD4 WDR41_HUMAN WD repeat-containing protein 41 WDR41 MSTP048 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; positive regulation of GTPase activity [GO:0043547]; regulation of autophagy [GO:0010506] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosomal membrane [GO:0005765] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; positive regulation of GTPase activity [GO:0043547]; regulation of autophagy [GO:0010506] GO:0005737; GO:0005765; GO:0006914; GO:0010506; GO:0032045; GO:0043547; GO:0045920; GO:0050777 ELIIFR 33.25 1 1 0.089060733 788.6640912 16.28412 14.25307 0 0 11.00478 14.99345 15.9697 15.47145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAH7 FBRS_HUMAN Probable fibrosin-1 FBRS FBS FBS1 Homo sapiens (Human) DRDLPFSRPQLR 12.46000004 1.95E-08 1.95E-08 0.428397272 1499.507634 21.60734 22.03547 20.67441 19.05849 22.22679 0 22.03728 21.25092 21.75005 21.67047 0 20.88567 0 0 0 0 21.98759 20.67343 0 20.51499 21.04568 0 0 0 0 19.82261 0 0 18.85999 0 0 19.17241 21.16174 21.1351 19.98255 21.04573 0 0 0 18.89474 21.81831 22.70914 19.73447 0 0 21.94159 22.97048 0 Q9HAK2 COE2_HUMAN "Transcription factor COE2 (Early B-cell factor 2, EBF-2)" EBF2 COE2 Homo sapiens (Human) adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cell fate determination [GO:0001709]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cell fate determination [GO:0001709]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001709; GO:0003682; GO:0005634; GO:0006357; GO:0035563; GO:0046872; GO:0050873; GO:0060612; GO:0120162 TAGNPRDMR 8.609999657 1 1 0.215687388 1017.631355 0 0 0 0 0 18.14055 0 16.95052 19.85096 19.85658 0 0 18.01362 18.44232 19.32156 21.07973 0 20.45395 0 18.35385 18.77745 19.35932 0 16.56062 17.86653 20.17765 20.66545 0 0 18.40471 0 0 0 20.70062 0 0 18.20591 0 20.19434 18.88657 17.87298 19.1218 19.59911 18.56099 20.09207 0 17.79122 15.96031 Q9HAN9 NMNA1_HUMAN "Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)" NMNAT1 NMNAT Homo sapiens (Human) ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of neuron death [GO:1901215]; nucleotide biosynthetic process [GO:0009165]; response to wounding [GO:0009611] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of neuron death [GO:1901215]; nucleotide biosynthetic process [GO:0009165]; response to wounding [GO:0009611] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515] GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:1901215; GO:1990966 VIMAELATK 4.820000172 1 1 0.14322712 977.9979579 16.74721 0 0 15.80642 14.89533 14.6347 0 0 0 16.94511 0 0 0 0 16.61961 0 0 0 0 0 0 0 0 18.70044 0 0 14.72492 16.73823 13.62484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.19819 16.49447 15.20115 Q9HAP2 MLXIP_HUMAN "MLX-interacting protein (Class E basic helix-loop-helix protein 36, bHLHe36) (Transcriptional activator MondoA)" MLXIP BHLHE36 KIAA0867 MIR MONDOA Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634] "chromatin [GO:0000785]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005741; GO:0006357; GO:0045944; GO:0046983 LQQERGQMQEEAR 5.190000057 1 1 0.347875746 1618.283034 0 0 14.41829 12.52811 15.46477 14.65399 0 0 0 0 0 0 0 0 0 0 0 14.69149 16.29036 0 0 0 0 16.86177 14.32232 0 0 0 13.5528 15.14508 0 16.57226 15.26967 16.69917 0 17.19649 0 14.85061 16.54549 0 15.70306 16.72214 16.2635 17.42921 14.98367 0 15.16536 0 Q9HAP6 LIN7B_HUMAN "Protein lin-7 homolog B, Lin-7B, hLin7B (Mammalian lin-seven protein 2, MALS-2) (Vertebrate lin-7 homolog 2, Veli-2, hVeli2)" LIN7B MALS2 VELI2 UNQ3116/PRO10200 Homo sapiens (Human) exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031] L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904] GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0019904; GO:0030165; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361 TDEGLGFNIMGGK 3.529999971 1 1 0.56564154 1355.33351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.54171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAS0 NJMU_HUMAN Protein Njmu-R1 C17orf75 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] GO:0005802; GO:0006886; GO:0031410; GO:0099041 GLELFR 9.920000076 0.927943826 0.927943826 0.221433676 734.3055506 14.95696 16.31179 15.31253 0 15.67131 15.61448 16.11216 15.66854 16.45522 0 0 16.01474 17.05628 15.33183 15.02359 16.71826 15.45634 0 15.92974 0 17.99308 0 16.69427 16.26029 15.12192 16.45366 17.58443 16.3954 14.74011 0 17.33265 17.36396 16.40084 16.2145 0 17.27196 17.26332 16.7125 0 15.74129 15.77404 16.97388 15.67011 17.22487 16.61089 18.26549 16.69455 16.51157 Q9HAS3 S28A3_HUMAN "Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3, CNT 3, hCNT3)" SLC28A3 CNT3 Homo sapiens (Human) nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862] brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862] nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213] GO:0005337; GO:0005345; GO:0005415; GO:0005789; GO:0005886; GO:0005887; GO:0015213; GO:0015293; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642; GO:1904823 YEHRIDEMLSPGR 5.929999828 1 1 0.558708284 1618.362696 18.15569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.12987 0 19.77307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAT2 SIAE_HUMAN "Sialate O-acetylesterase, EC 3.1.1.53 (H-Lse) (Sialic acid-specific 9-O-acetylesterase)" SIAE YSG2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; sialate 4-O-acetylesterase activity [GO:0106331]; sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682] sialate 4-O-acetylesterase activity [GO:0106331]; sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681] GO:0001681; GO:0002682; GO:0005615; GO:0005764; GO:0005975; GO:0070062; GO:0106330; GO:0106331 SAGIGFR 5.519999981 1 1 0.25709797 705.7739315 15.19787 0 17.71755 13.31058 15.05361 0 15.96595 0 0 13.66 15.0869 0 15.34649 0 0 0 0 16.28084 16.16427 0 0 0 15.75593 17.72915 18.31235 16.47676 17.58319 18.01882 0 16.07367 0 0 0 16.79724 17.50106 0 0 18.24928 0 16.34468 0 17.98372 0 0 0 17.80808 0 0 Q9HAT8 PELI2_HUMAN "E3 ubiquitin-protein ligase pellino homolog 2, Pellino-2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase pellino homolog 2)" PELI2 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630 NPDGHMDGLTTNGVLVMHPR 3.069999933 0.705100358 0.705100358 0.123634781 2177.222325 17.57383 9.769759 0 0 15.45622 0 11.92152 0 14.88236 13.39199 0 0 0 0 0 0 12.52528 11.51551 0 0 0 0 0 0 14.94572 0 0 0 0 0 0 0 0 0 0 16.31302 0 0 0 0 0 0 0 0 0 14.49334 0 0 Q9HAU0 PKHA5_HUMAN "Pleckstrin homology domain-containing family A member 5, PH domain-containing family A member 5 (Phosphoinositol 3-phosphate-binding protein 2, PEPP-2)" PLEKHA5 KIAA1686 PEPP2 Homo sapiens (Human) reproductive system development [GO:0061458] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] "cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; reproductive system development [GO:0061458]" "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]" GO:0005654; GO:0005829; GO:0010314; GO:0014069; GO:0016020; GO:0032266; GO:0061458; GO:0070273; GO:0080025; GO:0098978 VVHALEEK 5.880000114 0.892549753 0.892549753 0.068372114 924.9878165 0 0 14.75333 15.39778 0 0 0 16.02999 0 0 0 0 0 0 0 0 0 0 0 0 0 18.59494 0 17.43872 0 0 0 0 0 0 0 0 0 0 0 0 0 16.13781 0 0 0 0 0 0 0 14.79813 0 0 Q9HAU5 RENT2_HUMAN "Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog, hUpf2)" UPF2 KIAA1408 RENT2 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471 AAMDFCMNMNTKANR 8.869999886 1 1 0.257444851 1806.91451 0 0 0 16.81877 0 12.42867 15.58583 0 0 0 16.83803 15.14426 0 0 0 0 18.07311 0 0 0 0 0 0 13.72202 0 0 13.25005 0 0 0 14.84538 0 13.16009 0 15.96683 0 15.5199 0 17.25575 0 0 0 0 0 14.16269 0 0 0 Q9HAU8 RNPL1_HUMAN "Aminopeptidase RNPEPL1, EC 3.4.11.- (Arginyl aminopeptidase-like 1) (Methionyl aminopeptidase, EC 3.4.11.18)" RNPEPL1 Homo sapiens (Human) proteolysis [GO:0006508] metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] GO:0006508; GO:0008270; GO:0070006 FLESQMSR 2.25999999 0.593658447 0.593658447 0.118568031 1013.47364 15.9484 0 0 0 0 0 0 0 14.35452 0 0 0 0 0 12.97217 14.92246 0 0 14.34216 13.86896 13.10946 13.84389 15.93693 16.49075 14.95096 14.25924 0 14.51859 0 0 0 13.04867 13.93454 12.71993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAV4 XPO5_HUMAN "Exportin-5, Exp5 (Ran-binding protein 21)" XPO5 KIAA1291 RANBP21 Homo sapiens (Human) miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405] mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1900370; GO:1905172 TQVAIVR 7.099999905 0.387168467 0.387168467 0.209602509 786.5271112 0 13.20181 11.25945 14.8942 14.3335 15.10042 14.52028 14.49462 15.48462 15.90166 15.44701 16.35303 16.5627 15.66342 13.50657 15.75746 0 15.96641 0 15.32292 15.56008 0 14.29919 16.17551 16.23851 14.20997 0 14.72803 0 15.26468 0 0 15.75921 16.8714 14.77742 16.31807 16.54849 16.08145 15.88637 0 0 0 16.85941 15.45839 0 0 16.40928 0 Q9HAV5 TNR27_HUMAN "Tumor necrosis factor receptor superfamily member 27 (X-linked ectodysplasin-A2 receptor, EDA-A2 receptor)" EDA2R TNFRSF27 XEDAR UNQ2448/PRO5727/PRO34080 Homo sapiens (Human) ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]; ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031] GO:0005031; GO:0005886; GO:0005887; GO:0008544; GO:0010668; GO:0016021; GO:0038023; GO:0043123; GO:0046330; GO:0051092; GO:0072332 IGGLQDQECIPCTK 16.45000076 0.276583046 0.276583046 0.429995179 1618.013888 17.68334 0 0 18.11785 0 0 19.99737 0 0 0 18.47927 19.5739 0 0 0 0 0 0 0 0 0 0 17.93197 0 0 0 0 0 18.52208 0 0 19.47444 0 19.74286 0 0 0 0 0 18.20162 0 0 0 0 19.25615 0 18.20214 17.91227 Q9HAW0 BRF2_HUMAN "Transcription factor IIIB 50 kDa subunit, TFIIIB50, hTFIIIB50 (B-related factor 2, BRF-2) (hBRFU)" BRF2 BRFU PRO1470 Homo sapiens (Human) "cellular response to oxidative stress [GO:0034599]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription preinitiation complex assembly [GO:0070897]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; cellular response to oxidative stress [GO:0034599]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription preinitiation complex assembly [GO:0070897]" metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025] GO:0000126; GO:0001006; GO:0005634; GO:0005654; GO:0006352; GO:0006359; GO:0017025; GO:0034599; GO:0046872; GO:0070897; GO:0097550 EVTYSR 2.549999952 1 1 0.232151161 755.4076254 16.72552 0 0 0 0 0 0 0 17.90505 0 0 0 0 0 0 0 0 18.63731 0 0 0 0 0 17.59727 0 19.34078 0 19.97654 0 0 0 0 0 0 0 0 0 18.44866 0 0 0 0 0 0 0 0 0 0 Q9HAW4 CLSPN_HUMAN "Claspin, hClaspin" CLSPN Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]; activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105] anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217] GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0018105; GO:0032147; GO:0033314 SLLRNPFEAIRPGSAQQVK 5.989999771 1 1 1.38E-12 2112.373091 0 14.15255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.68514 0 0 0 0 0 0 9.753909 0 0 0 0 0 0 0 13.97567 0 0 0 15.11233 13.85818 11.98917 0 14.34183 0 5.689589 0 0 0 0 0 0 Q9HAY2 MAGF1_HUMAN "Melanoma-associated antigen F1, MAGE-F1 (MAGE-F1 antigen)" MAGEF1 Homo sapiens (Human) negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; protein ubiquitination [GO:0016567] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; protein ubiquitination [GO:0016567] GO:0000122; GO:0005634; GO:0016567; GO:0097428; GO:2000042; GO:2000060 AEASMR 7.300000191 0.287415445 0.287415445 0.276737461 679.3650318 18.14857 17.83247 17.23879 0 17.63013 18.63665 0 0 0 0 0 18.58604 18.21686 0 0 17.11947 0 17.56778 17.61307 0 17.80424 17.56013 0 0 17.4024 0 17.38816 0 0 0 0 0 0 17.67312 0 20.37062 0 0 0 0 19.08698 0 0 16.14594 0 0 0 0 Q9HAZ1 CLK4_HUMAN "Dual specificity protein kinase CLK4, EC 2.7.12.1 (CDC-like kinase 4)" CLK4 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0043484; GO:0046777; GO:0106310 ENSFLPFQIDHIR 6.340000153 1 1 0.364214763 1615.933662 0 0 17.43628 0 0 0 0 0 0 0 18.19326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.03203 0 0 0 17.71042 0 19.22475 0 18.28125 0 0 0 17.87352 0 0 0 0 0 Q9HAZ2 PRD16_HUMAN "Histone-lysine N-methyltransferase PRDM16, EC 2.1.1.367 (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1, MDS1/EVI1-like gene 1)" PRDM16 KIAA1675 MEL1 PFM13 Homo sapiens (Human) "brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; regulation of transcription by RNA polymerase II [GO:0006357]" aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]" GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016235; GO:0017053; GO:0018024; GO:0030512; GO:0030853; GO:0043457; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0046974; GO:0050873; GO:0070828; GO:0120162; GO:0140297 RADMQIVDGSAQCPGLASEK 10.60999966 1 1 0.048733115 2149.537869 13.1719 15.2795 13.94443 0 16.677 14.31371 14.27423 15.81074 15.76458 12.54355 11.50131 14.78783 12.81342 0 14.82837 14.07683 14.67575 13.35548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB07 MYG1_HUMAN "MYG1 exonuclease, EC 3.1.-.-" MYG1 C12orf10 Homo sapiens (Human) locomotory exploration behavior [GO:0035641] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclease activity [GO:0004518]; locomotory exploration behavior [GO:0035641] nuclease activity [GO:0004518] GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0035641 TRDPEK 5.46999979 0.669429064 0.669429064 0.287323462 746.0641671 18.81082 19.6992 18.07685 17.2546 17.82597 0 0 18.62125 19.41379 0 17.91409 17.39098 0 17.76619 0 0 16.99152 0 17.95949 17.35998 15.85951 0 0 0 19.09852 17.4368 0 17.08812 0 0 19.80722 18.70943 19.28771 18.65526 0 19.44443 0 0 19.1519 19.21922 17.79466 18.65203 0 0 17.06153 17.28986 18.276 17.94646 Q9HB15 KCNKC_HUMAN "Potassium channel subfamily K member 12 (Tandem pore domain halothane-inhibited potassium channel 2, THIK-2)" KCNK12 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244] GO:0005244; GO:0005887; GO:0022841; GO:0030322; GO:0034765; GO:0071805 DLTASNK 14.75 0.138109237 0.138109237 0.185823752 747.4261709 18.11066 15.67366 0 0 0 0 0 0 16.60002 0 18.63546 14.08249 17.28085 0 0 0 0 0 0 0 0 0 14.62103 9.799132 0 0 0 0 0 0 0 15.66088 16.53279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB19 PKHA2_HUMAN "Pleckstrin homology domain-containing family A member 2, PH domain-containing family A member 2 (Tandem PH domain-containing protein 2, TAPP-2)" PLEKHA2 TAPP2 Homo sapiens (Human) positive regulation of cell-matrix adhesion [GO:0001954] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; positive regulation of cell-matrix adhesion [GO:0001954]" "fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]" GO:0001954; GO:0001968; GO:0005634; GO:0005737; GO:0005886; GO:0008289; GO:0016020; GO:0030165; GO:0032991; GO:0043236; GO:0043325 SGDLLMR 12.42000008 0.932555795 0.932555795 0.297891926 806.7918714 15.55916 15.84479 14.29217 15.53443 15.86424 17.60214 0 14.97531 13.90914 17.62542 16.54501 15.06787 0 13.60594 14.4099 0 17.20479 15.15116 15.99972 0 0 16.06834 0 0 0 15.65886 0 15.51627 0 15.93102 17.69145 0 18.155 0 15.89034 0 15.9917 0 16.72243 17.26667 16.78912 15.0863 16.14323 0 15.01733 0 16.2685 15.77227 Q9HB20 PKHA3_HUMAN "Pleckstrin homology domain-containing family A member 3, PH domain-containing family A member 3 (Phosphatidylinositol-four-phosphate adapter protein 1, FAPP-1, Phosphoinositol 4-phosphate adapter protein 1)" PLEKHA3 FAPP1 Homo sapiens (Human) ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009] ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273] GO:0000139; GO:0005794; GO:0005829; GO:0035627; GO:0042802; GO:0070273; GO:0120009; GO:1902387; GO:1902388 ACLTDTR 4.300000191 0.25904119 0.25904119 0.046904284 836.8592163 0 16.4974 0 0 0 16.77162 15.95226 13.56551 13.36774 0 16.1133 0 0 0 0 13.72001 16.19257 16.10997 14.92718 16.81314 0 0 18.20277 0 17.77132 0 0 0 16.65988 0 0 13.51568 19.33794 12.78097 12.08562 16.66051 12.65802 9.132615 0 13.11232 0 0 18.96593 16.67439 0 11.76544 0 14.26175 Q9HB40 RISC_HUMAN "Retinoid-inducible serine carboxypeptidase, EC 3.4.16.- (Serine carboxypeptidase 1)" SCPEP1 RISC SCP1 MSTP034 UNQ265/PRO302 Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; retinoic acid metabolic process [GO:0042573] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; retinoic acid metabolic process [GO:0042573] serine-type carboxypeptidase activity [GO:0004185] GO:0004185; GO:0005829; GO:0042573; GO:0045776; GO:0070062; GO:0097746 AGHMVPSDQGDMALKMMR 1.100000024 0.251871586 0.251871586 0.147107177 1991.726692 0 0 0 16.09545 13.69962 0 16.19305 12.64662 12.60468 15.55463 15.46396 15.38054 0 18.53627 14.97963 12.76781 15.91915 11.36117 16.23152 13.14743 15.11414 15.62705 17.17261 15.67284 12.77197 0 0 17.28837 15.46214 14.87735 0 15.45575 16.36418 0 15.29168 13.95999 15.384 15.27592 0 14.67863 0 15.62554 14.28234 16.67185 17.45887 16.12178 15.68748 13.95842 Q9HB58 SP110_HUMAN Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110) SP110 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872 LITEMYTVAWFVR 4.289999962 1 1 0.126805729 1628.418308 16.1394 0 14.44446 0 0 0 0 15.55881 15.8082 0 0 0 0 0 0 0 0 16.35677 0 0 0 17.08217 0 0 0 0 0 16.67873 0 0 0 0 0 0 0 0 0 0 17.81414 0 0 0 0 0 0 0 0 0 Q9HBA0 TRPV4_HUMAN "Transient receptor potential cation channel subfamily V member 4, TrpV4 (Osm-9-like TRP channel 4, OTRPC4) (Transient receptor potential protein 12, TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2, VRL-2) (Vanilloid receptor-related osmotically-activated channel, VR-OAC)" TRPV4 VRL2 VROAC Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; vasopressin secretion [GO:0030103] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; vasopressin secretion [GO:0030103]" "actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]" GO:0000122; GO:0002024; GO:0003779; GO:0005034; GO:0005080; GO:0005216; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005783; GO:0005881; GO:0005886; GO:0005887; GO:0005912; GO:0005925; GO:0005929; GO:0006816; GO:0006874; GO:0006884; GO:0007015; GO:0007043; GO:0007204; GO:0007231; GO:0008017; GO:0008289; GO:0009612; GO:0009986; GO:0010759; GO:0010977; GO:0015275; GO:0016021; GO:0016324; GO:0019901; GO:0030027; GO:0030103; GO:0030175; GO:0030426; GO:0030864; GO:0031117; GO:0031410; GO:0031532; GO:0032587; GO:0032755; GO:0032868; GO:0034605; GO:0042169; GO:0042538; GO:0042593; GO:0042802; GO:0043014; GO:0043117; GO:0043622; GO:0045989; GO:0046330; GO:0046785; GO:0046872; GO:0047484; GO:0048487; GO:0050729; GO:0050891; GO:0051015; GO:0060351; GO:0070374; GO:0070509; GO:0070588; GO:0071470; GO:0071476; GO:0071477; GO:0071639; GO:0071642; GO:0071651; GO:0097009; GO:0097497; GO:0098703; GO:1902656; GO:1903444; GO:1903715; GO:2000340 NDTIPVLLDIAERTGNMR 11.85000038 1 1 0.107501859 2044.153346 0 14.77554 13.87087 0 0 0 0 15.49608 0 0 0 14.0801 0 0 15.78905 15.9944 16.10652 14.77398 16.31585 16.2538 0 0 0 0 15.68652 14.4201 15.90202 15.3608 12.14103 13.33515 14.26156 15.62283 14.75803 15.12946 14.84822 14.81968 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBD1 RC3H2_HUMAN "Roquin-2, EC 2.3.2.27 (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2)" RC3H2 MNAB RNF164 Homo sapiens (Human) "B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]" cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932] "cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]" DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003723; GO:0003725; GO:0003729; GO:0006511; GO:0009791; GO:0009986; GO:0010494; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0043231; GO:0046872; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628 EHDAQIVHIAMEAGLR 3.079999924 0.767127573 0.767127573 2.30E-13 1790.9823 0 14.56706 0 15.03655 0 0 13.1504 14.63126 0 0 0 0 0 0 0 17.99506 0 0 0 0 0 0 15.39223 0 17.71889 0 0 0 0 0 0 0 0 0 0 0 0 17.90981 0 0 0 0 0 0 0 17.37728 0 0 Q9HBE1 PATZ1_HUMAN "POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)" PATZ1 PATZ RIAZ ZBTB19 ZNF278 ZSG Homo sapiens (Human) "male gonad development [GO:0008584]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; male gonad development [GO:0008584]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]" GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0008584; GO:0010596; GO:0030217; GO:0031625; GO:0045892; GO:0045893; GO:0046872 FLLMRSVIEICQEVIK 12.81000042 1 1 0.589450321 1992.404499 0 0 0 0 0 19.01986 0 19.38531 0 0 0 19.06583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0271 0 19.96612 0 0 0 0 0 0 0 0 0 20.7338 0 0 0 0 0 0 19.52098 0 0 Q9HBG4 VPP4_HUMAN "V-type proton ATPase 116 kDa subunit a 4, V-ATPase 116 kDa isoform a 4 (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform)" ATP6V0A4 ATP6N1B ATP6N2 Homo sapiens (Human) intracellular pH reduction [GO:0051452]; ossification [GO:0001503]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; renal tubular secretion [GO:0097254]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035] "apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; intracellular pH reduction [GO:0051452]; ossification [GO:0001503]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; renal tubular secretion [GO:0097254]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035]" "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0000220; GO:0001503; GO:0005765; GO:0005768; GO:0005886; GO:0006885; GO:0007035; GO:0007605; GO:0010008; GO:0016021; GO:0016324; GO:0016471; GO:0030670; GO:0031526; GO:0033176; GO:0045177; GO:0046961; GO:0051117; GO:0051452; GO:0070062; GO:0097254; GO:1902600 ICDGFR 5.639999866 1 1 0.216229447 768.2106921 0 0 0 0 0 0 15.75517 19.78875 0 0 0 0 0 0 0 0 15.9684 15.89748 0 17.8337 0 17.29676 0 0 14.78933 0 0 0 17.52066 0 0 14.53046 0 0 0 0 0 0 17.06886 0 13.98242 15.56913 0 0 0 0 20.16063 0 Q9HBG6 IF122_HUMAN Intraflagellar transport protein 122 homolog (WD repeat-containing protein 10) (WD repeat-containing protein 140) IFT122 SPG WDR10 WDR140 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic heart tube development [GO:0035050]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic heart tube development [GO:0035050]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512] GO:0001843; GO:0005737; GO:0005929; GO:0010172; GO:0016020; GO:0030991; GO:0032391; GO:0035050; GO:0035721; GO:0036064; GO:0042073; GO:0045879; GO:0048593; GO:0060173; GO:0060271; GO:0061512; GO:0097542; GO:0097730; GO:1905515 CLDMSASR 5.840000153 0.880013585 0.880013585 0.26242552 938.2129822 16.33276 0 16.7709 0 15.857 0 14.16068 12.75553 14.06767 16.97387 16.36474 14.14372 13.48297 14.94843 14.24686 15.57508 15.89851 0 15.47636 0 0 15.59045 0 0 0 0 17.35074 17.01473 17.27951 16.50244 16.69285 0 0 0 16.29007 17.7161 17.4193 0 16.55877 15.35346 0 0 0 16.25615 14.86443 0 16.81905 0 Q9HBH5 RDH14_HUMAN "Retinol dehydrogenase 14, EC 1.1.1.300 (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)" RDH14 PAN2 SDR7C4 UNQ529/PRO1072 Homo sapiens (Human) osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649] 11-cis-retinol dehydrogenase activity [GO:0102354]; NADP-retinol dehydrogenase activity [GO:0052650] GO:0001649; GO:0005634; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0052650; GO:0102354 IVVVSSK 5.5 0.723040342 0.723040342 0.229515858 732.1897546 15.8871 12.99157 0 11.11074 0 16.45389 0 0 13.14072 0 15.54443 0 16.50639 14.12903 15.10973 0 0 0 17.93361 16.02999 16.27675 0 0 0 16.99677 16.03051 16.09867 14.41393 0 15.47531 16.7207 19.13203 14.67874 17.32623 14.51404 14.93407 16.68965 14.65793 15.44079 0 14.70764 0 16.32332 15.67036 15.56593 14.58399 16.48239 11.58698 Q9HBI0 PARVG_HUMAN Gamma-parvin PARVG Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of cell polarity [GO:0007163]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of cell polarity [GO:0007163]; substrate adhesion-dependent cell spreading [GO:0034446] actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0007160; GO:0007163; GO:0015629; GO:0030031; GO:0031532; GO:0034446 VNAVKEAIVNFVNQK 5.210000038 1 1 0.240683603 1671.884767 0 8.805068 0 15.12153 15.26052 14.29742 15.99011 0 0 0 14.80862 13.37193 13.42043 0 0 13.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBI1 PARVB_HUMAN Beta-parvin (Affixin) PARVB CGI-56 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446] actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0031532; GO:0034446; GO:0071963 TMIDPTSKEDPK 4.099999905 1 1 0.376678308 1377.547816 0 14.03934 0 11.04598 0 11.31892 0 0 14.30045 11.85946 0 0 0 0 0 0 0 0 15.42213 0 0 0 0 0 0 0 0 0 0 0 0 16.61966 0 14.49454 0 0 16.22765 0 0 0 0 0 16.18207 0 15.95996 0 0 0 Q9HBJ0 PLAC1_HUMAN Placenta-specific protein 1 PLAC1 Homo sapiens (Human) placenta development [GO:0001890] extracellular region [GO:0005576] extracellular region [GO:0005576]; placenta development [GO:0001890] GO:0001890; GO:0005576 GTPSKFVIPVSCAAPQK 2.279999971 1 1 0.305128596 1786.226464 0 12.96636 0 0 15.69165 0 0 0 0 0 0 14.63997 0 15.90158 15.08798 0 14.42853 0 0 0 0 13.58136 14.6269 0 15.85381 13.28402 0 14.61957 0 0 0 0 0 11.48464 10.63811 13.62082 0 0 0 0 0 0 0 0 0 15.08891 16.12683 0 Q9HBL0 TENS1_HUMAN Tensin-1 TNS1 TNS Homo sapiens (Human) cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723] actin binding [GO:0003779]; RNA binding [GO:0003723] GO:0003723; GO:0003779; GO:0005737; GO:0005856; GO:0005925; GO:0009986 EDLDDAFK 14.61999989 0.721630156 0.721630156 0.249422866 951.6421602 16.29873 18.29317 14.59711 0 0 0 0 17.5755 17.99557 17.82422 0 18.31271 17.5928 0 17.78108 18.38612 17.31069 0 0 0 0 18.97659 0 17.08348 17.24954 18.44859 17.55999 0 17.28609 0 0 0 0 0 19.58969 19.30357 19.07093 0 19.2432 17.98669 18.19649 18.08246 16.6235 0 17.92054 0 16.1313 17.5579 Q9HBL6 LRTM1_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 1 LRTM1 HT017 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919] heparin binding [GO:0008201]; Roundabout binding [GO:0048495] GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919 ERFDSSPA 2.390000105 1 1 0.096955334 908.585678 0 14.30727 14.08942 14.12926 16.35608 0 14.63024 12.49057 0 15.657 0 0 0 0 0 0 0 13.47275 0 0 0 0 0 0 0 15.5316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBM6 TAF9B_HUMAN "Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7, DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L)" TAF9B TAF9L Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein stabilization [GO:0050821]" nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein stabilization [GO:0050821]" protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003714; GO:0005654; GO:0005669; GO:0006352; GO:0016251; GO:0030307; GO:0033276; GO:0043066; GO:0046982; GO:0050821; GO:1902166 VINQMLEFAFR 10.14000034 0.47669071 0.47669071 0.489893607 1383.313565 0 16.62187 0 0 0 15.86306 0 0 0 0 0 0 0 0 0 0 0 17.27204 0 17.34181 0 0 0 17.35039 0 0 17.30481 0 0 0 0 0 0 0 0 0 0 0 0 18.45 0 0 0 0 18.09652 0 18.71346 0 Q9HBT6 CAD20_HUMAN Cadherin-20 CDH20 CDH7L3 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 EAQAGAAPK 4.389999866 1 1 0.137808791 842.2682049 0 15.52736 0 0 0 0 0 15.61256 16.06059 0 0 15.232 0 18.61396 0 0 0 0 0 19.44723 0 17.5162 0 17.47312 0 16.07449 0 15.66992 0 0 0 0 0 0 0 0 0 13.29788 0 14.24007 0 0 13.57944 0 0 0 0 0 Q9HBT7 ZN287_HUMAN Zinc finger protein 287 (Zinc finger protein with KRAB and SCAN domains 13) ZNF287 ZKSCAN13 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0001817; GO:0005634; GO:0006357; GO:0045893; GO:0046872 AQACTPVEDMSK 5.010000229 1 1 0.233448879 1337.038136 0 15.73366 14.81827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.86069 0 16.06615 0 0 0 0 15.62831 18.22406 15.71086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBU6 EKI1_HUMAN "Ethanolamine kinase 1, EKI 1, EC 2.7.1.82" ETNK1 EKI1 Homo sapiens (Human) phosphatidylethanolamine biosynthetic process [GO:0006646] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646] ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305] GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0016020 IGNSAASR 2.410000086 1 1 0.136754546 774.5240984 10.91107 0 0 0 0 0 15.96168 0 0 0 14.93356 0 0 0 0 0 0 0 11.20431 0 14.86876 0 17.20315 15.68791 0 15.7867 15.8354 0 14.84328 15.71725 0 0 0 0 0 0 13.24466 0 0 15.22927 0 0 0 13.91122 0 15.15554 14.77636 0 Q9HBW1 LRRC4_HUMAN "Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand, NGL-2)" LRRC4 BAG NAG14 UNQ554/PRO1111 Homo sapiens (Human) excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560] dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560] GO:0005886; GO:0043197; GO:0050804; GO:0060076; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861 CRTPPMSSVK 5.820000172 1 1 0.273946731 1178.34992 0 0 0 0 0 0 0 0 14.98247 0 0 0 14.85546 0 16.3951 0 13.71595 0 15.49766 14.99638 0 0 0 13.8658 15.69763 16.7082 0 0 0 0 0 14.1126 17.30456 0 0 0 0 0 0 0 17.44825 15.64824 0 0 0 0 0 0 Q9HBZ2 ARNT2_HUMAN "Aryl hydrocarbon receptor nuclear translocator 2, ARNT protein 2 (Class E basic helix-loop-helix protein 1, bHLHe1)" ARNT2 BHLHE1 KIAA0307 Homo sapiens (Human) "brain development [GO:0007420]; central nervous system development [GO:0007417]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; central nervous system development [GO:0007417]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" "aryl hydrocarbon receptor binding [GO:0017162]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0017162; GO:0034751; GO:0045893; GO:0045944; GO:0046982; GO:1990837 GQVLSVMYR 9.550000191 0.371653765 0.371653765 0.06323044 1067.616961 0 15.85092 15.84835 15.98175 15.97551 0 15.32287 15.35726 15.28707 16.81175 0 13.72272 0 15.49762 0 0 0 14.74287 16.6653 0 15.82955 0 17.48947 16.16944 15.1898 16.91082 16.40548 0 15.69075 17.39028 15.61084 17.0874 17.24863 0 16.9011 14.14373 13.70927 0 14.75202 14.96455 17.02844 14.07342 0 15.18214 17.29846 13.57967 16.37756 15.47173 Q9HC10 OTOF_HUMAN Otoferlin (Fer-1-like protein 2) OTOF FER1L2 Homo sapiens (Human) membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082] AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509] GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025 AGRSVFSAMK 3.220000029 1 1 0.106673119 1070.153521 0 0 15.96146 16.82458 13.59031 0 15.94202 0 12.42276 0 0 0 0 0 15.49961 0 0 0 0 0 0 15.87532 0 0 14.61473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC24 LFG4_HUMAN Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein) TMBIM4 GAAP LFG4 CGI-119 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848] GO:0000139; GO:0005795; GO:0006915; GO:0016020; GO:0016021; GO:0043066; GO:0050848 ADPDPR 6.349999905 1 1 0.203372642 670.3420932 16.35696 15.8692 0 15.72321 16.84867 14.30055 15.18969 13.50804 13.09859 14.65544 15.12218 15.2601 16.32233 14.50255 13.84117 15.302 0 15.06422 16.3795 15.01545 15.81979 15.0355 15.98185 0 15.77213 15.97671 16.71901 16.00445 15.80772 15.49522 16.03878 0 16.05908 0 0 0 16.6201 0 16.84923 0 0 0 0 15.40322 16.01851 0 0 15.80435 Q9HC29 NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1) NOD2 CARD15 IBD1 Homo sapiens (Human) activation of immune response [GO:0002253]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gamma-delta T cell activation [GO:0046645]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584] anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982] anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; activation of immune response [GO:0002253]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gamma-delta T cell activation [GO:0046645]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584] actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] GO:0002221; GO:0002227; GO:0002253; GO:0002606; GO:0002710; GO:0002720; GO:0002732; GO:0002830; GO:0002862; GO:0002925; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006952; GO:0006965; GO:0007584; GO:0009595; GO:0009986; GO:0016045; GO:0016323; GO:0019899; GO:0019901; GO:0030277; GO:0030544; GO:0031982; GO:0032088; GO:0032495; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0032991; GO:0034136; GO:0035556; GO:0038187; GO:0042742; GO:0042834; GO:0043123; GO:0043330; GO:0043406; GO:0043552; GO:0044877; GO:0045087; GO:0045089; GO:0045335; GO:0045747; GO:0045944; GO:0046330; GO:0046645; GO:0046658; GO:0050679; GO:0050700; GO:0050727; GO:0050731; GO:0050766; GO:0050830; GO:0050871; GO:0051092; GO:0051353; GO:0051770; GO:0051879; GO:0060585; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071407; GO:0071639; GO:0090022; GO:1900017; GO:1901224; GO:1902523; GO:1904417; GO:2000110; GO:2000363 SLYEMQEERLAR 6.070000172 0.93572396 0.93572396 0.046421286 1525.695623 11.82939 0 0 12.07856 17.80255 12.0344 12.50853 0 16.3818 0 0 0 0 16.63174 0 13.83131 14.33613 0 0 0 0 0 16.36771 12.10202 0 0 0 0 0 0 14.05151 0 14.17918 0 0 13.84762 0 0 15.46209 0 0 0 0 0 15.14841 0 0 0 Q9HC35 EMAL4_HUMAN "Echinoderm microtubule-associated protein-like 4, EMAP-4 (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)" EML4 C2orf2 EMAPL4 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017] GO:0000226; GO:0000278; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0007017; GO:0007080; GO:0008017; GO:0008608; GO:0015630; GO:0016020; GO:0030496; GO:0043014; GO:0048487; GO:0051301; GO:0072686 GPKGVYQISK 8.350000381 1 1 0.302533607 1076.753255 17.04919 0 0 0 0 0 0 17.93051 0 0 0 0 0 0 0 0 0 17.0049 0 0 16.37169 0 0 18.25006 18.30094 0 0 0 0 0 0 19.01645 19.36185 0 0 17.95204 0 0 19.99346 0 0 17.23759 0 0 0 17.56951 0 0 Q9HC36 MRM3_HUMAN "rRNA methyltransferase 3, mitochondrial, EC 2.1.1.- (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)" MRM3 RNMTL1 HC90 Homo sapiens (Human) rRNA 2'-O-methylation [GO:0000451] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0042802; GO:0070039 MFFFSR 2.890000105 0.970501184 0.970501184 0.199675204 851.3093708 16.56449 0 0 0 14.0987 15.71915 0 14.92312 0 0 0 15.22576 12.43954 14.8442 15.33834 0 14.87689 0 0 14.88331 14.63105 14.27794 0 15.01167 16.07441 0 15.16455 13.66856 14.76573 14.78613 15.43116 15.17291 0 0 14.22613 14.25204 0 15.95802 17.47901 14.83336 13.83465 0 0 13.08669 0 14.95339 16.0626 14.97203 Q9HC38 GLOD4_HUMAN Glyoxalase domain-containing protein 4 GLOD4 C17orf25 CGI-150 My027 Homo sapiens (Human) extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; cadherin binding [GO:0045296] cadherin binding [GO:0045296] GO:0005739; GO:0045296; GO:0070062 IAFSCPQK 5.880000114 0.788896203 0.788896203 0.210449677 951.3145302 0 16.30514 0 0 0 0 0 14.41152 0 17.96562 13.22182 17.74264 14.2542 15.35791 17.06988 0 0 0 0 0 15.34087 0 0 15.327 16.04954 0 12.78503 0 14.91439 0 0 0 0 18.91904 0 0 0 0 13.82803 17.16458 0 0 0 0 16.19925 14.46867 0 0 Q9HC52 CBX8_HUMAN "Chromobox protein homolog 8 (Polycomb 3 homolog, Pc3, hPc3) (Rectachrome 1)" CBX8 PC3 RC1 Homo sapiens (Human) chromatin organization [GO:0006325]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027]; chromatin organization [GO:0006325]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122] methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027] GO:0000122; GO:0000785; GO:0000792; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0016574; GO:0031519; GO:0035064; GO:0035102; GO:0097027 QDSDLVQCGVTSPSSAEATGKLAVDTFPAR 6.289999962 1 1 2.75E-12 3106.849406 0 0 0 0 0 0 0 14.72683 0 0 0 0 13.79237 11.97156 14.46996 12.99461 13.76654 0 13.00655 11.13503 13.17955 0 0 11.43779 0 0 0 14.94129 10.12155 15.06233 14.5749 12.22038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC56 PCDH9_HUMAN Protocadherin-9 PCDH9 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887] cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291 EQKDTYVMK 8.739999771 1 1 0.237804325 1158.09324 12.44249 0 14.18743 13.0384 15.29374 11.9466 0 15.012 13.5609 0 15.00904 17.60363 14.88863 13.69907 13.92915 0 11.89015 14.7091 15.18206 15.05935 12.97926 13.88478 0 15.59627 0 0 0 0 14.48415 13.80502 0 0 0 0 0 0 0 15.21315 0 0 0 15.1113 15.63212 0 0 14.4653 0 16.09228 Q9HC62 SENP2_HUMAN "Sentrin-specific protease 2, EC 3.4.22.- (Axam2) (SMT3-specific isopeptidase 2, Smt3ip2) (Sentrin/SUMO-specific protease SENP2)" SENP2 KIAA1331 Homo sapiens (Human) fat cell differentiation [GO:0045444]; heart development [GO:0007507]; labyrinthine layer development [GO:0060711]; mRNA transport [GO:0051028]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein desumoylation [GO:0016926]; protein transport [GO:0015031]; regulation of DNA endoreduplication [GO:0032875]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of Wnt signaling pathway [GO:0030111]; spongiotrophoblast layer development [GO:0060712]; trophoblast giant cell differentiation [GO:0060707]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; labyrinthine layer development [GO:0060711]; mRNA transport [GO:0051028]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein desumoylation [GO:0016926]; protein transport [GO:0015031]; regulation of DNA endoreduplication [GO:0032875]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of Wnt signaling pathway [GO:0030111]; spongiotrophoblast layer development [GO:0060712]; trophoblast giant cell differentiation [GO:0060707]; Wnt signaling pathway [GO:0016055] SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140] GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0007507; GO:0015031; GO:0016055; GO:0016605; GO:0016926; GO:0030111; GO:0031397; GO:0031398; GO:0031648; GO:0031965; GO:0032875; GO:0035562; GO:0045444; GO:0045944; GO:0051028; GO:0060707; GO:0060711; GO:0060712; GO:0070139; GO:0070140; GO:2000045 MYRWLVR 2.470000029 1 1 4.59E-13 1024.634149 13.90001 0 14.0975 0 15.063 14.68431 0 0 15.42956 0 0 0 0 0 0 0 0 12.17607 0 13.73768 0 0 0 0 0 13.67153 0 0 0 0 15.76592 13.93985 0 0 0 0 11.85764 15.50935 0 15.75871 0 0 12.56887 0 14.59161 0 0 16.15606 Q9HC77 CENPJ_HUMAN "Centromere protein J, CENP-J (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1)" CENPJ CPAP LAP LIP1 Homo sapiens (Human) astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleus [GO:0005634]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleus [GO:0005634]; procentriole replication complex [GO:0120099]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631] GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007099; GO:0007224; GO:0008275; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0042802; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046601; GO:0046785; GO:0051301; GO:0060236; GO:0060271; GO:0061511; GO:0120099; GO:1900087; GO:1902857; GO:1903724; GO:1904951; GO:1905515; GO:1905832 DSKAR 2.849999905 1 1 0.132687088 577.3759766 15.90277 0 15.37635 13.43676 13.96901 0 15.10075 0 15.4276 16.76683 0 0 0 15.09435 15.526 0 15.89276 0 0 16.28034 0 0 16.29168 0 0 15.43815 15.37356 16.9906 15.19557 14.45296 0 0 0 0 0 17.133 0 0 0 0 0 0 0 0 0 0 14.59196 0 Q9HC78 ZBT20_HUMAN Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288) ZBTB20 DPZF ZNF288 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000976; GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010629; GO:0016604; GO:0032728; GO:0032755; GO:0032760; GO:0045821; GO:0046872; GO:0046889; GO:0055088; GO:0071333; GO:1990837 VSQSEALQILTAASILQIK 9.529999733 1 1 0.101092162 2013.938232 15.24933 0 15.66054 0 0 14.30222 0 0 16.06086 0 0 13.18373 13.11752 0 13.99637 14.41883 14.84425 0 15.09513 16.61755 15.80637 13.85023 16.65868 13.73829 16.44474 0 0 0 13.47709 13.95526 14.07894 15.74937 13.53323 13.89103 0 17.91523 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC84 MUC5B_HUMAN "Mucin-5B, MUC-5B (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)" MUC5B MUC5 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0043231; GO:0070062 TGLLVEQSGDYIKVSIR 11.25 1 1 6.92E-13 1879.225555 0 14.23935 14.50869 15.30445 0 15.661 14.1419 0 0 7.856009 13.61345 0 0 0 14.92029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC96 CAN10_HUMAN "Calpain-10, EC 3.4.22.- (Calcium-activated neutral proteinase 10, CANP 10)" CAPN10 KIAA1845 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]; actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149] GO:0000149; GO:0004198; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006921; GO:0008092; GO:0031532; GO:0032024; GO:0032388; GO:0032869; GO:0046326; GO:0097050; GO:2000676 ALPGAWVKGQSAGGCR 9.350000381 1 1 0.337708776 1613.990809 16.32637 0 14.78772 0 0 0 14.90771 15.70375 0 0 15.11696 0 15.75417 11.27476 14.09526 0 0 0 16.60408 15.91105 0 0 0 0 14.14877 0 0 16.25576 0 0 0 0 16.79082 0 13.0165 0 0 0 15.89105 0 0 17.11814 0 0 16.27168 0 0 0 Q9HCC8 GDPD2_HUMAN "Glycerophosphoinositol inositolphosphodiesterase GDPD2, EC 3.1.4.43 (Glycerophosphodiester phosphodiesterase 3) (Glycerophosphodiester phosphodiesterase domain-containing protein 2) (Osteoblast differentiation promoting factor)" GDPD2 GDE3 OBDPF UNQ1935/PRO4418 Homo sapiens (Human) actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669] actin filament [GO:0005884]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872]; actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669] glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872] GO:0005737; GO:0005884; GO:0005886; GO:0006629; GO:0008889; GO:0016020; GO:0016021; GO:0030027; GO:0045669; GO:0046872; GO:0047394; GO:0090527 GAPMLAPENTLMSLRK 4.289999962 1 1 0.180519331 1729.056152 10.36305 15.33054 11.36999 0 15.2472 0 0 0 0 0 0 0 0 0 13.49414 0 0 0 15.39229 0 0 0 16.22086 0 0 0 0 12.60934 0 17.17358 0 16.17663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCC9 LST2_HUMAN "Lateral signaling target protein 2 homolog, hLst2 (Zinc finger FYVE domain-containing protein 28)" ZFYVE28 KIAA1643 LST2 Homo sapiens (Human) negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175] cytosol [GO:0005829]; early endosome membrane [GO:0031901] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175] metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266] GO:0005829; GO:0007175; GO:0031901; GO:0032266; GO:0042059; GO:0046872 SPTSLDSAVATQEAASEPVAEGMDGGPHK 3.529999971 1 1 1.83E-12 2855.534423 0 12.26644 0 13.03277 0 0 0 14.79824 12.97672 0 14.41515 0 0 0 12.30064 0 0 0 0 0 0 0 11.31002 0 15.4628 0 15.98178 14.16897 0 0 0 0 0 0 15.34876 0 0 16.50093 0 0 0 0 0 15.0793 14.17284 0 15.33165 15.06067 Q9HCD5 NCOA5_HUMAN "Nuclear receptor coactivator 5, NCoA-5 (Coactivator independent of AF-2, CIA)" NCOA5 KIAA1637 Homo sapiens (Human) glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966] actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966] chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0003682; GO:0003714; GO:0003723; GO:0005615; GO:0005654; GO:0009966; GO:0015629; GO:0042593; GO:0046627 DPMYDR 3.380000114 1 1 0.137223134 810.3173142 0 12.03435 16.29767 0 0 0 18.34455 0 0 19.63466 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCD6 TANC2_HUMAN "Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)" TANC2 KIAA1148 KIAA1636 Homo sapiens (Human) dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001] axon [GO:0030424]; dendritic spine [GO:0043197] axon [GO:0030424]; dendritic spine [GO:0043197]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001] GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0099519 EEGEK 10.10999966 0.005362686 0.005362686 0.278159499 591.8606531 18.21108 18.54019 18.47444 18.38247 17.10978 18.39135 0 0 0 0 17.60439 0 0 0 0 0 0 17.86594 0 17.6019 16.29455 0 19.75377 0 0 0 19.47169 0 0 0 18.37872 19.05639 18.28831 17.05825 0 0 0 0 19.25949 17.6957 17.10412 16.22957 16.78975 19.59048 16.16024 17.89926 0 0 Q9HCE0 EPG5_HUMAN Ectopic P granules protein 5 homolog EPG5 KIAA1632 Homo sapiens (Human) autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162] GO:0005737; GO:0005764; GO:0006862; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786 FLSEDNSDMIFMLLTKFDLK 10.02000046 1 1 0.646887487 2408.091042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCE1 MOV10_HUMAN "Helicase MOV-10, EC 3.6.4.13 (Armitage homolog) (Moloney leukemia virus 10 protein)" MOV10 KIAA1631 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]" cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] "cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]" 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005524; GO:0005615; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0150011 EVLTLR 12.60999966 0.135766566 0.135766566 0.291601594 731.0569404 18.97608 20.23087 24.22513 0 19.97938 21.54411 23.77997 19.10321 18.90989 0 24.13568 0 24.22714 18.45254 19.75191 23.55948 18.92104 17.90009 0 0 0 22.68004 17.87761 0 24.00819 24.19469 21.073 19.68977 17.82956 0 24.42336 0 0 21.59782 0 20.94254 18.30861 0 21.34914 0 24.22708 0 18.78632 0 17.29408 21.96404 24.10591 0 Q9HCE3 ZN532_HUMAN Zinc finger protein 532 ZNF532 KIAA1629 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 ATVISAASVQSASSAIIK 7.460000038 1 1 0.293730337 1703.485734 0 13.95646 0 14.09728 0 0 0 0 14.89229 0 14.17112 0 14.27428 0 0 16.39539 0 0 0 14.59964 0 0 0 15.61916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCE5 MET14_HUMAN "N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14, hMETTL14)" METTL14 KIAA1627 Homo sapiens (Human) "forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]" mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729] GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0006402; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0045727; GO:0061157; GO:0080009; GO:1901533 SPPPK 7.409999847 1 1 0.122312051 526.1718978 17.50546 16.73073 16.65143 12.31841 0 17.83208 0 0 0 14.12109 16.93374 0 13.59597 17.8853 0 0 15.94441 0 15.09998 0 18.60912 19.37087 15.34126 15.74681 17.4051 16.6243 0 12.35299 14.36838 15.39076 15.59597 16.22105 0 0 18.19038 0 13.80577 17.81068 14.51811 14.06308 16.5962 16.6155 16.01301 0 0 14.69283 15.45577 15.17761 Q9HCE6 ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF) ARHGEF10L GRINCHGEF KIAA1626 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005096; GO:0005829; GO:0030036; GO:0032933; GO:0051056; GO:0051496 DILALRVGGR 5.760000229 1 1 0.02940649 1069.528425 12.31742 0 13.60992 14.89379 0 13.44497 15.91833 0 12.65197 0 0 12.65876 11.45477 0 0 0 0 0 0 0 0 0 0 15.09826 0 14.27234 0 0 16.93959 0 0 0 0 0 0 0 0 0 0 0 12.9875 12.02197 0 0 0 14.21071 13.7535 0 Q9HCE7 SMUF1_HUMAN "E3 ubiquitin-protein ligase SMURF1, hSMURF1, EC 2.3.2.26 (HECT-type E3 ubiquitin transferase SMURF1) (SMAD ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-protein ligase 1)" SMURF1 KIAA1625 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000209; GO:0004842; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006611; GO:0007398; GO:0016567; GO:0030154; GO:0030424; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0032801; GO:0034394; GO:0043025; GO:0043161; GO:0045732; GO:0048185; GO:0060071; GO:0061630; GO:0061736; GO:0061753; GO:0070062; GO:0070411; GO:0070412; GO:0071211; GO:0072659; GO:1903861; GO:2000060 MRPKDLK 2.539999962 0.523201883 0.523201883 0.240093026 901.6589981 13.81978 0 17.7548 0 0 0 0 15.44093 0 0 0 0 0 0 0 0 0 13.01577 0 0 15.80609 14.57259 0 0 0 14.32781 15.65089 14.94081 0 15.60939 0 15.84864 0 16.68887 0 18.91502 0 0 15.78958 0 16.22278 15.56781 0 0 0 0 0 14.04813 Q9HCF6 TRPM3_HUMAN "Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3, LTrpC-3, LTrpC3) (Melastatin-2, MLSN2)" TRPM3 KIAA1616 LTRPC3 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951] calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261] GO:0005227; GO:0005261; GO:0005262; GO:0005886; GO:0005887; GO:0006812; GO:0016048; GO:0050951; GO:0051262; GO:0070588; GO:0098655 LQESIDPAGEETMSPTSPTLMPR 6.599999905 1 1 2.29E-12 2502.694407 15.95333 11.34188 0 0 0 14.66265 0 0 0 13.68827 13.03137 0 16.13947 0 0 0 14.45137 0 0 0 0 0 0 11.60629 0 14.82946 13.73841 0 0 0 16.10266 14.14501 16.58081 0 0 0 0 13.79434 15.34302 0 0 0 0 0 14.87672 13.90681 0 0 Q9HCG7 GBA2_HUMAN "Non-lysosomal glucosylceramidase, NLGase, EC 3.2.1.45 (Beta-glucocerebrosidase 2, Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2, EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2, EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase, EC 3.2.1.46) (Non-lysosomal glycosylceramidase)" GBA2 KIAA1605 SPG46 AD035 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295] GO:0004348; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0006687; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035 EAMANLSPE 6.96999979 0.652079165 0.652079165 0.248430805 962.0880911 16.88822 17.11466 17.41158 0 0 0 0 0 0 14.94231 16.408 15.65084 0 0 15.95234 0 14.87338 10.26465 0 0 0 15.98533 0 0 15.02905 0 0 0 0 16.60504 18.00795 0 17.38677 0 15.78143 15.63124 16.25443 16.04439 0 16.74965 15.61427 0 0 12.63534 0 16.41138 0 0 Q9HCG8 CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb) CWC22 KIAA1604 NCM Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0016607; GO:0048024; GO:0071005; GO:0071006; GO:0071007; GO:0071013 SDYEHSR 16.20999908 0.015526625 0.015526625 0.175832643 893.524452 17.54979 19.26308 17.48122 16.76301 0 15.98354 19.25827 0 17.6764 17.26908 19.01527 17.71096 18.08585 17.46196 16.89017 18.3805 15.4613 19.44527 18.85551 16.47137 0 18.85035 0 18.6496 19.67915 17.25716 19.33044 17.36745 19.43208 16.08139 20.78057 18.25714 19.14595 20.95386 18.27198 17.7398 18.08941 19.88253 17.85068 18.8598 0 19.32687 20.03942 18.32696 19.1705 18.75076 17.06088 18.50383 Q9HCH0 NCK5L_HUMAN "Nck-associated protein 5-like, NCKAP5-like (Centrosomal protein of 169 kDa, Cep169)" NCKAP5L CEP169 KIAA1602 FP1193 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] GO:0001578; GO:0005737; GO:0005813; GO:0007019; GO:0035371 TPGNSSK 11.56999969 0.896979272 0.896979272 0.237197649 692.7478605 0 13.09266 11.55672 16.01811 0 15.04422 0 16.01775 15.72374 0 0 0 16.0569 16.36457 17.36444 0 17.14523 15.79467 17.72096 0 15.83546 0 17.06634 0 15.24161 16.54411 0 17.18087 14.8903 14.55125 15.16774 0 15.33973 15.50622 17.41452 15.75296 16.47393 16.25626 16.33228 17.19751 0 0 18.19541 14.93019 16.49305 18.89459 16.06639 0 Q9HCI6 K1586_HUMAN "E3 SUMO-protein ligase KIAA1586, EC 2.3.2.- (E3 SUMO-protein transferase KIAA1586)" KIAA1586 Homo sapiens (Human) protein sumoylation [GO:0016925] SUMO ligase activity [GO:0061665]; protein sumoylation [GO:0016925] SUMO ligase activity [GO:0061665] GO:0016925; GO:0061665 AHGKIQDLLK 5.139999866 0.341448367 0.341448367 0.091970812 1122.574001 16.37692 13.03753 18.01788 15.26805 16.32011 0 13.36716 14.20322 15.95899 0 12.55085 0 0 0 15.07964 10.64408 14.45703 0 15.03871 16.5084 12.94324 17.03427 13.2005 0 0 0 19.02699 18.4039 0 0 0 16.98318 0 0 10.49804 0 15.92352 16.91223 15.51383 14.35344 13.45804 0 0 0 15.09314 0 0 17.56095 Q9HCJ0 TNR6C_HUMAN Trinucleotide repeat-containing gene 6C protein TNRC6C KIAA1582 Homo sapiens (Human) "gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0035195; GO:0035278; GO:0060213; GO:1900153 SPLLGPGR 6.460000038 0.206920952 0.206920952 0.226520655 797.9124712 16.15983 13.83024 0 0 0 15.08448 0 0 0 0 0 0 15.827 0 0 0 0 16.95912 0 16.44284 17.28156 0 0 0 0 16.472 0 16.77816 16.20047 15.89233 0 15.63058 14.71036 16.75554 17.02507 12.95867 17.09494 16.50008 17.323 0 16.96328 0 16.07733 0 16.3151 16.47204 0 0 Q9HCJ1 ANKH_HUMAN "Progressive ankylosis protein homolog, ANK" ANKH KIAA1581 UNQ241/PRO274 Homo sapiens (Human) bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; phosphate ion homeostasis [GO:0055062]; regulation of bone mineralization [GO:0030500]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886]; inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; phosphate ion homeostasis [GO:0055062]; regulation of bone mineralization [GO:0030500]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085] inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114] GO:0001501; GO:0005315; GO:0005576; GO:0005886; GO:0005887; GO:0007626; GO:0010467; GO:0015114; GO:0016021; GO:0019867; GO:0030282; GO:0030500; GO:0030504; GO:0055062; GO:0055074; GO:0055085; GO:0071344; GO:0071529; GO:1904383 EDAVEMLASYGLAYSLMK 4.059999943 0.007324615 0.007324615 0.095855853 2020.28356 14.61152 0 17.34421 0 15.66042 0 0 0 11.45284 0 13.95112 13.30718 0 0 0 0 0 10.38286 0 14.84259 14.51399 10.06178 13.75022 0 0 14.613 0 0 0 0 0 0 0 0 0 0 16.32635 16.95792 0 0 0 0 0 0 14.24097 11.76797 0 0 Q9HCJ2 LRC4C_HUMAN "Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand, NGL-1)" LRRC4C KIAA1580 NGL1 UNQ292/PRO331 Homo sapiens (Human) modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560] cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632] GO:0005615; GO:0005886; GO:0016020; GO:0016021; GO:0050770; GO:0050804; GO:0050839; GO:0098632; GO:0098685; GO:0098978; GO:0099061; GO:0099560 CNTPPNLK 7.78000021 0.47664699 0.47664699 0.06794187 942.3554069 15.44907 17.22239 17.27362 15.08209 15.69831 14.5019 18.90392 14.23111 15.35724 15.76329 17.04107 17.7832 11.39238 15.55258 9.739937 13.41772 19.42465 11.90159 16.70374 17.23955 14.45072 0 17.59166 18.01993 16.8406 12.56747 15.11426 15.72428 14.86037 14.89888 16.17306 17.90876 15.44685 16.66854 16.9796 16.814 14.63262 17.12557 15.64984 16.98084 17.06549 15.6359 16.36725 16.2505 13.85918 17.04628 16.28509 17.32623 Q9HCJ3 RAVR2_HUMAN Ribonucleoprotein PTB-binding 2 (Protein raver-2) RAVER2 KIAA1579 Homo sapiens (Human) "regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737 DFAAKAR 2.200000048 1 1 0.104927513 778.0355445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCJ6 VAT1L_HUMAN "Synaptic vesicle membrane protein VAT-1 homolog-like, EC 1.-.-.-" VAT1L KIAA1576 Homo sapiens (Human) oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] GO:0008270; GO:0016491 AEETEQMIEK 4.699999809 1 1 0.253462973 1224.345632 0 17.22311 0 12.22517 16.19324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12329 0 0 0 0 0 17.73471 0 16.65168 16.14496 0 0 0 0 0 17.6047 18.06954 0 0 0 0 18.23371 0 0 0 0 0 0 Q9HCK1 ZDBF2_HUMAN DBF4-type zinc finger-containing protein 2 ZDBF2 KIAA1571 Homo sapiens (Human) DNA methylation involved in embryo development [GO:0043045]; genomic imprinting [GO:0071514] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA methylation involved in embryo development [GO:0043045]; genomic imprinting [GO:0071514] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0008270; GO:0043045; GO:0071514 KLNPQK 5.289999962 1 1 0.193569376 726.5774303 15.38274 17.19972 17.40808 14.4297 16.5673 0 16.08364 15.77362 0 16.26033 14.83493 14.5561 13.79371 12.84581 13.1995 13.14917 15.31297 13.79841 12.57888 13.03927 0 16.25617 16.96238 14.93047 0 16.97553 0 0 0 0 16.5971 15.35023 16.29039 15.44787 0 13.71947 18.09945 15.11554 16.72916 0 16.77273 0 0 0 15.41208 15.42578 17.10885 0 Q9HCK8 CHD8_HUMAN "Chromodomain-helicase-DNA-binding protein 8, CHD-8, EC 3.6.4.12 (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1)" CHD8 HELSNF1 KIAA1564 Homo sapiens (Human) "brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]" MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]" armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039] GO:0000122; GO:0001701; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0007420; GO:0008013; GO:0016055; GO:0016887; GO:0032991; GO:0035064; GO:0035176; GO:0042393; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:0140658; GO:2000270 FLAYMEDR 4.489999771 1 1 0.128850194 1060.176541 13.78746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.44102 0 0 0 0 0 0 14.00638 0 0 0 0 0 14.99588 0 0 0 15.70316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCL0 PCD18_HUMAN Protocadherin-18 PCDH18 KIAA1562 Homo sapiens (Human) brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007420 SSYELQLTASDMGVPQR 8.43999958 1 1 0.260031081 1897.259524 14.11432 13.05221 0 14.0514 0 0 0 0 0 0 0 0 0 14.67057 15.31266 0 15.93885 12.90577 0 0 0 0 13.79329 0 17.22178 0 0 0 0 0 0 0 0 0 17.69594 0 0 0 0 0 0 0 0 0 0 0 0 16.87479 Q9HCM1 RESF1_HUMAN Retroelement silencing factor 1 RESF1 C12orf35 KIAA1551 Homo sapiens (Human) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309] nucleus [GO:0005634] nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase binding [GO:1990226]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309] histone binding [GO:0042393]; histone methyltransferase binding [GO:1990226] GO:0005634; GO:0042393; GO:0045869; GO:0090309; GO:1990226 DLLMAAGCIK 7.159999847 0.868101001 0.868101001 0.116789705 1106.550998 0 0 0 12.98303 0 0 0 0 15.29979 0 0 15.59199 17.24615 17.06855 19.04886 16.72983 17.45806 17.83495 18.22568 17.76434 18.16372 15.88852 15.92122 14.64795 0 16.74509 15.67739 15.9833 18.66919 0 16.03328 0 18.6104 17.92797 16.21311 16.80769 16.49301 0 18.36201 16.26802 18.24898 15.46759 0 0 0 16.6966 16.27168 0 Q9HCM2 PLXA4_HUMAN Plexin-A4 PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] semaphorin receptor activity [GO:0017154] GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0043087; GO:0048485; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:0097492; GO:1902287 GNVASLIMTVLQSK 5.639999866 1 1 0.394192762 1475.384561 0 0 0 15.67978 0 14.66928 0 0 0 0 0 16.16951 0 0 0 0 0 0 0 0 0 0 0 0 16.16658 16.56975 0 13.97308 15.92635 15.73464 15.57903 17.53498 13.24802 0 0 0 17.87173 17.91629 17.63849 17.08388 0 16.34088 17.20288 0 16.65752 15.65532 17.16419 0 Q9HCM3 K1549_HUMAN UPF0606 protein KIAA1549 KIAA1549 Homo sapiens (Human) integral component of membrane [GO:0016021]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] GO:0005886; GO:0016021; GO:0032391 TPGAVNDGR 8.090000153 1 1 0.171349628 887.4064505 0 14.28331 0 0 13.25035 0 14.11469 0 15.34372 14.21414 15.77394 15.35601 15.01851 13.59331 15.13599 0 0 0 0 0 0 0 16.35502 0 0 0 0 0 0 16.0449 0 15.17512 0 0 15.64493 0 0 16.08286 0 0 0 0 0 14.55188 0 0 15.19871 0 Q9HCM4 E41L5_HUMAN Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5) EPB41L5 KIAA1548 Homo sapiens (Human) "actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]" adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]" cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904] GO:0001701; GO:0001837; GO:0001839; GO:0001917; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0031032; GO:0032091; GO:0032092; GO:0032525; GO:0032587; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560 YSGKTEYQTTK 6.929999828 0.006691102 0.006691102 0.348990537 1301.905036 15.64984 14.00056 0 15.9359 14.50573 11.46791 16.20638 0 16.25579 14.45522 15.12912 0 0 15.32706 11.66643 14.56382 0 0 0 0 0 0 16.42478 0 0 0 0 0 0 14.83634 0 14.8561 16.14772 0 14.6011 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCM7 FBSL_HUMAN Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9) FBRSL1 AUTS2L KIAA1545 XTP9 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 GLELPRR 13.61999989 1 1 0.221566827 840.7867861 15.26458 0 0 0 0 15.85315 16.26965 0 0 0 0 0 0 14.32476 14.83693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCN3 PGAP6_HUMAN "Post-GPI attachment to proteins factor 6, EC 3.1.1.4 (GPI processing phospholipase A2, GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A)" PGAP6 TMEM6 TMEM8 TMEM8A Homo sapiens (Human) lipid metabolic process [GO:0006629] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; phospholipase A2 activity [GO:0004623]; lipid metabolic process [GO:0006629] phospholipase A2 activity [GO:0004623] GO:0004623; GO:0005765; GO:0005886; GO:0005887; GO:0006629; GO:0070062 AATLLLTLSNLMFLAPIAVSVR 1.860000014 0.977027535 0.977027535 0.228377178 2331.319266 0 0 12.97504 0 14.84011 0 0 0 13.73157 0 14.34171 0 16.65872 0 0 14.20956 15.1382 13.877 0 0 0 0 0 14.97329 13.06661 17.20042 13.28403 0 0 0 0 0 0 0 14.52459 0 0 0 0 0 0 0 0 0 0 10.86203 14.94747 0 Q9HCN4 GPN1_HUMAN "GPN-loop GTPase 1, EC 3.6.5.- (MBD2-interacting protein, MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1)" GPN1 MBDIN RPAP4 XAB1 HUSSY-23 Homo sapiens (Human) cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829 YKEVMK 1.200000048 0.268025815 0.268025815 0.319390683 797.774103 0 0 0 0 0 0 0 0 0 0 0 0 0 16.51995 0 0 0 0 0 0 0 0 0 16.59703 0 0 0 16.17719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.80605 17.54312 0 0 Q9HCN6 GPVI_HUMAN "Platelet glycoprotein VI, GPVI (Glycoprotein 6)" GP6 Homo sapiens (Human) collagen-activated signaling pathway [GO:0038065]; enzyme linked receptor protein signaling pathway [GO:0007167]; platelet activation [GO:0030168]; positive regulation of platelet aggregation [GO:1901731] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; collagen binding [GO:0005518]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; collagen-activated signaling pathway [GO:0038065]; enzyme linked receptor protein signaling pathway [GO:0007167]; platelet activation [GO:0030168]; positive regulation of platelet aggregation [GO:1901731] collagen binding [GO:0005518]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005518; GO:0005886; GO:0005887; GO:0007167; GO:0009986; GO:0030168; GO:0038023; GO:0038065; GO:0045121; GO:0070062; GO:0097197; GO:1901731; GO:1990782 MSPSPTALFCLGLCLGR 7.489999771 0.000725279 0.000725279 4.56E-12 1874.072955 0 11.80736 13.32636 13.97445 13.92577 11.12283 0 15.42705 13.26603 0 16.11497 14.91178 14.07889 0 0 13.43761 14.21016 14.97508 15.2735 0 14.66684 11.15746 13.89946 14.54127 15.68917 15.11931 15.30999 13.74903 13.11238 14.88028 15.76347 15.23397 0 15.1692 13.46511 14.12881 16.15346 16.1087 0 15.83734 0 15.27439 0 13.56338 0 0 0 0 Q9HCP0 KC1G1_HUMAN "Casein kinase I isoform gamma-1, CKI-gamma 1, EC 2.7.11.1" CSNK1G1 Homo sapiens (Human) endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0016055; GO:0018105; GO:0090263; GO:0106310 SAHCSRPSGSSSSSGVLMVGPNFR 4.679999828 0.089671962 0.089671962 0.032865049 2480.811419 0 14.2362 11.17453 0 0 14.18776 12.59979 14.0896 12.49967 6.227137 0 12.55682 0 0 0 0 0 0 15.30677 0 0 0 13.00583 0 0 8.97848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.975563 0 13.06011 0 Q9HCQ5 GALT9_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 9, EC 2.4.1.41 (Polypeptide GalNAc transferase 9, GalNAc-T9, pp-GaNTase 9) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9)" GALNT9 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 AILYPCHGMSSQLVR 14.27000046 1 1 0.516749481 1731.072245 18.98191 0 0 0 19.83578 0 17.49744 0 0 18.68894 0 17.64595 16.40215 0 0 0 0 16.94142 0 17.46651 18.50244 19.71171 19.64326 0 0 0 0 0 0 0 19.76425 18.65922 19.16877 0 0 20.9076 0 0 19.26871 0 0 0 0 19.00045 0 18.12764 19.07305 0 Q9HCQ7 NPVF_HUMAN Pro-FMRFamide-related neuropeptide VF [Cleaved into: Neuropeptide NPSF; Neuropeptide RFRP-1; Neuropeptide RFRP-2; Neuropeptide NPVF (Neuropeptide RFRP-3) ] NPVF C7orf9 RFRP Homo sapiens (Human) negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218] signaling receptor binding [GO:0005102] GO:0005102; GO:0005576; GO:0007218; GO:0032277 MEIISSK 12.05000019 0.691195726 0.691195726 0.374728817 823.0652415 15.57841 14.4275 15.15731 14.98947 12.75375 0 15.11557 14.68932 15.38642 0 15.75808 13.54106 0 0 0 15.47132 16.72042 0 16.39773 15.79169 17.31858 15.79211 13.20697 0 12.1523 16.81034 15.54591 14.28009 15.1072 0 0 0 15.23427 15.19086 0 17.78898 16.67772 12.64056 16.15055 15.48459 17.16453 14.9531 0 15.54808 13.5082 0 15.55993 15.90293 Q9HCR9 PDE11_HUMAN "Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, EC 3.1.4.35, EC 3.1.4.53 (cAMP and cGMP phosphodiesterase 11A)" PDE11A Homo sapiens (Human) metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829]; perikaryon [GO:0043204] "cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]" GO:0004112; GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0008152; GO:0010754; GO:0030553; GO:0043204; GO:0043951; GO:0046872; GO:0047555 CSADAENSFKESMEK 2.950000048 1 1 0.137897022 1747.77737 0 0 0 0 13.38518 0 10.49525 12.81575 0 11.97078 0 0 0 0 0 0 0 0 0 0 13.67614 0 0 0 0 0 0 0 0 0 16.94146 0 14.40197 0 14.70071 17.14439 0 15.6636 0 18.19546 14.1989 17.20065 0 0 17.24163 0 0 0 Q9HCS5 E41LA_HUMAN Band 4.1-like protein 4A (Erythrocyte membrane protein band 4.1-like 4A) (Protein NBL4) EPB41L4A EPB41L4 Homo sapiens (Human) actomyosin structure organization [GO:0031032] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032] cytoskeletal protein binding [GO:0008092] GO:0005737; GO:0005856; GO:0008092; GO:0031032 QENDMVDSAPQWEAVLRR 4.28000021 1 1 2.29E-12 2144.762174 9.115899 15.67089 14.65573 14.34304 0 14.75574 0 13.94187 13.64452 0 13.49179 0 11.46222 11.15653 15.0615 0 0 15.13093 13.90934 11.31452 0 0 14.32276 0 13.84709 14.71502 0 0 0 0 0 0 0 0 0 0 0 0 0 14.88413 12.83489 11.89838 0 0 13.07033 0 12.8086 0 Q9HCS7 SYF1_HUMAN Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2) XAB2 HCNP KIAA1177 SYF1 PP3898 Homo sapiens (Human) "blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]" catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]" GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014 ATKVNFK 8.340000153 1 1 0.231835645 805.8676189 0 0 14.32816 15.09734 0 13.6173 0 0 15.44978 0 0 0 0 16.08503 0 15.13705 16.82476 0 0 17.13329 16.43159 15.20271 0 0 17.03667 15.73178 16.80107 16.70265 15.49938 15.95577 16.90127 16.59999 15.47444 16.12964 0 15.66818 17.00561 16.70906 17.08106 16.38186 0 15.82305 16.49709 16.90854 16.76259 0 15.39945 16.17546 Q9HCU4 CELR2_HUMAN "Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2, EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3, Multiple EGF-like domains protein 3)" CELSR2 CDHF10 EGFL2 KIAA0279 MEGF3 Homo sapiens (Human) "cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] GO:0001764; GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007186; GO:0016021; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060071; GO:0060271; GO:0098609 NATQHTAGYFGSDVK 4.679999828 0.010642715 0.010642715 0.443153744 1596.013864 18.08444 0 0 0 0 0 0 0 0 0 0 0 0 16.65653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.32157 0 0 0 0 0 0 17.30557 0 0 0 0 17.9 0 0 0 0 0 0 Q9HCU5 PREB_HUMAN Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12) PREB SEC12 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400] DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0003400; GO:0003677; GO:0005085; GO:0005096; GO:0005634; GO:0005789; GO:0006888; GO:0009306; GO:0016020; GO:0030176; GO:0032527; GO:0048208; GO:0051020; GO:0070971 AGSKEQGPR 9.029999733 1 1 0.245329995 929.9380485 15.45462 0 16.00138 13.95542 16.20441 0 0 0 15.01203 0 16.10889 12.57362 14.486 14.91279 0 0 0 0 0 0 0 16.10435 0 0 0 16.37235 0 0 16.55455 0 0 15.70191 0 0 0 0 0 0 0 0 0 0 0 0 15.29382 0 0 15.85811 Q9HCX4 TRPC7_HUMAN "Short transient receptor potential channel 7, TrpC7 (Transient receptor protein 7, TRP-7, hTRP7)" TRPC7 TRP7 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338] cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]" "calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" GO:0005262; GO:0005635; GO:0005801; GO:0005886; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679 TLRSPFMK 12.03999996 1 1 0.239511437 995.9606163 0 15.91168 16.34317 0 0 13.41718 0 0 0 0 0 0 0 0 16.00308 0 17.72115 11.924 0 16.57685 18.19607 0 0 0 16.53343 0 0 0 16.09476 0 0 0 17.33624 0 0 16.95056 17.0786 18.49927 18.09268 0 16.97131 0 16.59558 16.09238 17.12695 17.27654 0 16.4031 Q9HCZ1 ZN334_HUMAN Zinc finger protein 334 ZNF334 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 TLNLGMNSVPSR 1.629999995 1 1 0.392558278 1304.158855 16.12507 0 15.8274 0 0 14.9121 0 0 15.01403 15.89148 16.50041 0 0 0 14.26624 0 0 15.93379 13.92154 14.64592 0 0 0 0 15.63323 0 0 14.4734 15.22832 0 0 0 0 0 0 0 0 16.9826 0 0 0 0 0 0 16.5041 0 0 0 Q9HD15 SRA1_HUMAN "Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein, SRAP)" SRA1 PP7684 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; SCAR complex [GO:0031209]; transcription regulator complex [GO:0005667] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; SCAR complex [GO:0031209]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346] DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713] GO:0002153; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007346; GO:0015630; GO:0030154; GO:0030374; GO:0031209; GO:0031252; GO:0042981; GO:0045171; GO:0045662; GO:0071391; GO:1990904 RSLFSEEAANEEK 2.579999924 1 1 0.486504469 1505.703428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7295 0 0 0 0 0 0 0 0 0 0 0 0 19.58295 0 0 0 0 0 0 0 0 0 Q9HD20 AT131_HUMAN "Endoplasmic reticulum transmembrane helix translocase, EC 7.4.2.- (Endoplasmic reticulum P5A-ATPase)" ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; transmembrane protein dislocase activity [GO:0140567]; cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031] ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; transmembrane protein dislocase activity [GO:0140567] GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569 EIQNASHR 7.25 1 1 0.187955229 952.4176993 0 0 0 0 0 0 0 0 0 0 0 0 16.23664 16.93147 16.19612 15.12139 15.0953 0 15.54765 0 16.2187 0 0 15.70797 0 0 14.33601 16.26487 14.13796 0 0 0 0 15.02703 0 0 0 0 13.086 0 13.67289 0 0 0 14.98724 14.83299 15.06089 0 Q9HD34 LYRM4_HUMAN LYR motif-containing protein 4 LYRM4 C6orf149 ISD11 CGI-203 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226] iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; iron-sulfur cluster assembly [GO:0016226] GO:0005739; GO:0005759; GO:0016226; GO:0016604; GO:1990221; GO:1990229 DLGVIR 7.300000191 0.003571365 0.003571365 0.232521576 671.549017 0 0 0 15.48757 0 0 16.50043 0 0 14.9883 0 0 16.06187 0 0 0 0 17.16126 0 0 0 0 0 13.49232 17.30794 0 0 16.84597 16.66764 17.29445 0 19.13276 0 0 0 0 19.37413 0 0 0 14.66741 0 0 0 0 16.62401 14.71348 0 Q9HD43 PTPRH_HUMAN "Receptor-type tyrosine-protein phosphatase H, R-PTP-H, EC 3.1.3.48 (Stomach cancer-associated protein tyrosine phosphatase 1, SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H)" PTPRH SAP1 Homo sapiens (Human) apoptotic process [GO:0006915]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; apoptotic process [GO:0006915]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470] cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] GO:0004725; GO:0005001; GO:0005737; GO:0005887; GO:0006470; GO:0006915; GO:0016324; GO:0031528; GO:0045296; GO:1990264 APAPNPGR 4.920000076 0.694019496 0.694019496 0.157196238 780.5419185 15.83206 15.63045 15.69007 15.88264 0 0 0 14.99632 14.43179 16.65489 15.51984 13.96877 15.25902 14.90344 16.33206 15.39851 14.08571 16.28207 13.29995 15.84532 16.12076 16.2154 14.47918 14.51742 17.54664 14.20051 14.36395 15.14132 15.47561 0 16.48995 0 0 16.7816 15.76107 0 16.08665 0 15.82078 0 0 0 0 16.03239 0 14.79865 0 0 Q9HD67 MYO10_HUMAN Unconventional myosin-X (Unconventional myosin-10) MYO10 KIAA0799 Homo sapiens (Human) cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]; cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]" "actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]" GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002 AYISMIVKK 24.40999985 1 1 0.292728026 1052.616235 0 10.84739 10.68881 0 13.3984 16.86818 16.95095 0 13.81279 16.77359 15.53782 15.88461 0 15.62601 16.00942 0 15.91666 0 0 0 16.97566 14.15452 17.15564 0 15.74765 0 16.36405 0 15.59489 0 16.02111 15.36117 0 0 0 16.22462 0 0 0 14.07795 15.61101 16.81204 12.6349 15.86661 0 0 16.88895 0 Q9HDB9 GAK5_HUMAN "Endogenous retrovirus group K member 5 Gag polyprotein (HERV-K(II) Gag protein) (HERV-K_3q12.3 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-5 ERVK5 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 FLVILQLVQAGEETQVGAPARAETR 5.75 1 1 0.171858585 2697.672785 0 14.37853 0 0 13.15143 14.20794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HDC5 JPH1_HUMAN "Junctophilin-1, JP-1 (Junctophilin type 1)" JPH1 JP1 Homo sapiens (Human) calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; structural constituent of muscle [GO:0008307]; calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314] structural constituent of muscle [GO:0008307] GO:0005654; GO:0005789; GO:0005886; GO:0007517; GO:0008307; GO:0014701; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0060314; GO:0060402 GGLFR 7.949999809 0.411065221 0.411065221 0.133326651 550.6882398 9.55911 13.98208 14.97091 15.5748 0 0 13.786 14.55972 0 0 15.18721 16.11012 14.22552 16.2174 0 18.65728 0 17.68673 16.18381 17.39722 13.86783 15.76354 17.59203 13.41755 13.00098 18.78565 0 16.8794 15.65746 0 14.27189 0 13.20172 16.49245 12.89243 15.68739 13.7689 16.58895 16.82285 16.45776 11.76138 15.30385 15.83932 0 0 0 13.7341 16.28213 Q9N2K0 ENH1_HUMAN "HERV-H_2q24.3 provirus ancestral Env polyprotein (Env protein HERV-H/p62) (Env protein HERV-H19) (Env protein HERV-Hcl.3) (Envelope polyprotein) (HERV-H/env62) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 MIFAGK 12.43999958 0.146804705 0.146804705 0.237276295 666.3006102 15.07537 0 15.53452 11.87408 14.42655 13.5518 14.09517 13.72133 14.30081 15.07959 14.59008 15.36246 16.02334 14.72617 16.28716 17.90165 14.72341 16.78163 18.37953 18.00747 15.69585 17.26544 16.00011 16.46447 16.04318 16.15139 0 14.77545 15.72323 15.05714 16.70647 15.67315 17.48829 17.07567 16.89005 16.84306 16.97169 17.02616 15.72297 16.1458 16.22637 16.50685 16.81641 0 16.32119 17.41785 17.44049 15.73142 Q9NNW5 WDR6_HUMAN WD repeat-containing protein 6 WDR6 Homo sapiens (Human) G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488] RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0010507; GO:0030488; GO:0070314 DGQLQPVLR 10.34000015 1 1 0.13715284 1026.377946 0 0 0 0 0 13.36322 0 0 14.90495 16.70044 16.6523 14.95612 14.96863 14.94884 0 0 0 14.13673 14.90602 12.93239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2033 15.94135 0 0 0 0 0 14.5351 0 Q9NNW7 TRXR2_HUMAN "Thioredoxin reductase 2, mitochondrial, EC 1.8.1.9 (Selenoprotein Z, SelZ) (TR-beta) (Thioredoxin reductase TR3)" TXNRD2 KIAA1652 TRXR2 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; response to hyperoxia [GO:0055093]; response to oxygen radical [GO:0000305]; response to selenium ion [GO:0010269]; response to xenobiotic stimulus [GO:0009410] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; response to hyperoxia [GO:0055093]; response to oxygen radical [GO:0000305]; response to selenium ion [GO:0010269]; response to xenobiotic stimulus [GO:0009410] flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; thioredoxin-disulfide reductase activity [GO:0004791] GO:0000305; GO:0004791; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009410; GO:0010269; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0044877; GO:0045454; GO:0050660; GO:0055093 SLNWGHR 7.460000038 1 1 0.108589177 870.4723057 12.48184 15.65693 15.9793 16.9346 0 0 17.37726 0 0 0 0 0 0 17.29701 14.30918 15.1633 14.79308 14.66772 0 0 14.47582 0 0 16.5525 0 0 0 0 0 17.86313 14.83997 16.09327 15.68343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NNX1 TUFT1_HUMAN Tuftelin TUFT1 Homo sapiens (Human) bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476] structural constituent of tooth enamel [GO:0030345] GO:0005576; GO:0005737; GO:0030282; GO:0030345; GO:0035556; GO:0042476 AATLEK 3.150000095 1 1 0.24982183 633.6698092 0 0 12.21315 0 0 0 0 0 0 0 0 14.97456 15.90947 15.67072 0 17.74047 0 0 0 0 16.95849 13.055 0 0 0 16.71691 18.89957 0 0 16.39942 17.09472 0 0 0 0 0 0 0 17.63297 0 0 17.21994 0 0 0 0 0 0 Q9NNZ6 PRM3_HUMAN Protamine-3 (Sperm protamine P3) PRM3 Homo sapiens (Human) cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] DNA binding [GO:0003677] GO:0000786; GO:0003677; GO:0005634; GO:0005737; GO:0007283; GO:0030154; GO:0030261; GO:0030317 LLLLEPER 9.869999886 0.811716676 0.811716676 0.246595971 983.9808608 12.15414 0 0 14.1247 12.5367 0 0 0 0 0 0 14.30235 12.75495 0 0 0 0 0 0 0 0 0 0 16.17041 14.86094 16.44396 0 14.71429 11.8435 0 0 0 0 0 13.42273 0 0 15.59792 0 15.71364 0 0 0 15.15754 0 0 0 0 Q9NP50 SHCAF_HUMAN SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog) SINHCAF C12orf14 FAM60A L4 Homo sapiens (Human) negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459] nucleus [GO:0005634]; Sin3 complex [GO:0016580] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459] GO:0000122; GO:0005634; GO:0008284; GO:0016580; GO:0030336; GO:0030512; GO:0045596; GO:1902455; GO:1902459 MFGFHKPK 5.840000153 1 1 0.331820184 1008.67777 12.72942 13.53543 15.68029 0 16.19603 0 0 15.12253 14.69122 16.13231 15.97884 14.34547 0 0 14.5526 11.61408 0 0 0 0 0 0 0 0 0 0 0 15.51926 11.00797 0 11.72567 0 0 0 15.7592 0 0 0 0 0 0 0 0 16.08592 0 0 0 0 Q9NP60 IRPL2_HUMAN "X-linked interleukin-1 receptor accessory protein-like 2, IL-1 receptor accessory protein-like 2, IL-1-RAPL-2, IL-1RAPL-2, IL1RAPL-2, EC 3.2.2.6 (IL1RAPL-2-related protein) (Interleukin-1 receptor 9, IL-1R-9, IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1, TIGIRR-1)" IL1RAPL2 IL1R9 Homo sapiens (Human) central nervous system development [GO:0007417]; regulation of presynapse assembly [GO:1905606] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; central nervous system development [GO:0007417]; regulation of presynapse assembly [GO:1905606]" "interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" GO:0004908; GO:0004910; GO:0005886; GO:0007417; GO:0016021; GO:0050135; GO:0061809; GO:0098978; GO:1905606 GWSIFELESRLHNMLVSGEIK 3.700000048 1 1 0.273821006 2460.099723 11.23326 0 14.55341 15.53569 0 13.05218 0 0 14.32425 0 16.59412 0 0 0 0 0 0 0 0 14.25395 0 0 15.72413 15.90424 0 14.15848 0 15.70485 15.81143 0 16.83526 0 14.11737 16.20336 0 0 12.80759 0 0 15.4806 0 15.59023 0 0 0 15.43248 0 0 Q9NP70 AMBN_HUMAN Ameloblastin AMBN Homo sapiens (Human) biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127] growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345] GO:0005576; GO:0005788; GO:0007155; GO:0008083; GO:0030345; GO:0031214; GO:0042127; GO:0042475 QLGSLQR 6.400000095 0.070661649 0.070661649 0.173546804 801.5484761 16.45468 16.13811 13.7189 0 16.31086 0 15.47163 0 15.85458 15.60751 10.36777 15.00781 16.62736 16.968 16.72893 16.48075 17.32023 16.36882 16.7212 17.57993 17.872 16.04599 16.93385 16.85315 17.78614 15.68118 16.53984 17.78114 17.05787 16.32524 16.62643 0 17.09746 17.10126 17.01377 15.80411 18.26978 17.32799 17.51581 17.49804 16.70052 17.53758 15.66761 17.21301 16.40864 17.57667 17.8781 16.54521 Q9NP71 MLXPL_HUMAN "Carbohydrate-responsive element-binding protein, ChREBP (Class D basic helix-loop-helix protein 14, bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein, WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein)" MLXIPL BHLHD14 MIO WBSCR14 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]" "carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0009653; GO:0010255; GO:0033137; GO:0035538; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009 SQVIHSGHFMVSSPHSDSLPR 3.150000095 1 1 0.013744853 2320.158899 16.04006 13.29443 0 0 11.46944 15.21482 0 14.25639 0 13.75465 16.53909 0 0 0 0 0 0 15.79842 10.99516 14.8398 15.96363 0 16.41743 15.40547 14.81839 12.80536 12.83714 0 10.73697 13.17371 17.00202 14.41132 17.34639 15.48202 13.67594 17.11172 16.06752 16.38635 14.45552 15.66178 16.04591 14.74112 15.60223 0 0 16.25783 0 15.22099 Q9NP73 ALG13_HUMAN "Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13, EC 2.4.1.141, EC 3.4.19.12 (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) (UDP-N-acetylglucosamine transferase subunit ALG13 homolog)" ALG13 CXorf45 GLT28D1 MDS031 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843] N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843] GO:0003723; GO:0004577; GO:0004843; GO:0005789 VDFYPGPGK 4.199999809 1 1 0.031156632 979.8336035 0 12.08215 0 12.49469 15.80042 0 12.8214 15.0385 14.74388 13.27672 11.81154 6.49179 11.06394 15.26502 13.59658 13.38176 13.63026 0 14.65388 13.93473 0 0 14.54496 12.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP74 PALMD_HUMAN Palmdelphin (Paralemmin-like protein) PALMD C1orf11 PALML Homo sapiens (Human) regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020]; regulation of cell shape [GO:0008360] GO:0005737; GO:0008360; GO:0016020; GO:0043197 VYDDGQK 7.840000153 1 1 0.108107978 823.5446152 15.23382 0 14.78196 14.52782 14.0719 0 0 15.26324 0 0 0 0 0 0 0 15.63945 0 0 16.33146 0 15.44117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.58497 0 0 0 0 15.87569 0 0 0 Q9NP81 SYSM_HUMAN "Serine--tRNA ligase, mitochondrial, EC 6.1.1.11 (SerRSmt) (Seryl-tRNA synthetase, SerRS) (Seryl-tRNA(Ser/Sec) synthetase)" SARS2 SARSM Homo sapiens (Human) mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434] ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049] GO:0000049; GO:0003723; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158; GO:0097056 MAASMARR 12.55000019 1 1 0.006497408 893.4567915 14.77652 15.02009 0 14.14081 0 0 14.82228 0 10.97321 16.04249 14.96973 14.51565 14.40417 0 14.37243 13.36119 0 0 0 0 14.93701 10.9935 10.51021 0 13.12652 10.02056 15.15603 14.90392 15.34006 13.92964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP87 DPOLM_HUMAN "DNA-directed DNA/RNA polymerase mu, Pol Mu, EC 2.7.7.7 (Terminal transferase)" POLM polmu Homo sapiens (Human) DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303] DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006303; GO:0006310; GO:0046872 EGLRTLDDLR 1.460000038 1 1 0.534277818 1188.863123 0 0 0 0 0 0 0 0 17.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.85484 0 18.68031 0 0 0 0 18.36498 0 17.41817 0 0 0 16.87881 Q9NP92 RT30_HUMAN "39S ribosomal protein S30, mitochondrial, MRP-S30, S30mt (Mitochondrial large ribosomal subunit protein mL65) (Mitochondrial large ribosomal subunit protein mS30) (Programmed cell death protein 9)" MRPS30 PDCD9 BM-047 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006915; GO:0032543 MQFMKYMVYPQTFALNADR 1.659999967 1 1 0.086506906 2370.536396 0 0 11.91028 14.45338 0 0 0 0 13.75942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.65833 13.87742 0 0 9.567358 0 0 0 0 0 0 11.26872 0 0 0 0 0 0 0 Q9NP97 DLRB1_HUMAN "Dynein light chain roadblock-type 1 (Bithoraxoid-like protein, BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)" DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162 Homo sapiens (Human) microtubule-based movement [GO:0007018]; visual behavior [GO:0007632] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632] dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0007632; GO:0016020; GO:0030286; GO:0045505; GO:0097542 DYFLIVIQNPTE 13.52000046 1 1 0.114705884 1450.596989 13.69148 13.46154 14.29657 13.16329 13.25924 12.39599 12.40692 10.57656 0 0 12.76055 13.53956 0 15.90018 14.45222 15.83886 0 0 0 0 0 16.19089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP99 TREM1_HUMAN "Triggering receptor expressed on myeloid cells 1, TREM-1 (Triggering receptor expressed on monocytes 1) (CD antigen CD354)" TREM1 Homo sapiens (Human) acute inflammatory response [GO:0002526]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil chemotaxis [GO:0030593]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; acute inflammatory response [GO:0002526]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil chemotaxis [GO:0030593]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945] scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] GO:0002250; GO:0002526; GO:0005576; GO:0005886; GO:0006959; GO:0016021; GO:0030593; GO:0035556; GO:0038023; GO:0045087; GO:0070945; GO:0097110 IRLVVTK 7.880000114 1 1 0.16057052 827.0654524 0 0 15.73434 11.69328 0 0 0 0 14.76189 0 0 0 0 13.69092 0 14.19399 0 0 0 0 0 0 0 0 0 0 0 13.73042 15.44407 0 0 17.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPA0 EMC7_HUMAN ER membrane protein complex subunit 7 EMC7 C11orf3 C15orf24 HT022 UNQ905/PRO1926 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] carbohydrate binding [GO:0030246] GO:0005789; GO:0016021; GO:0030176; GO:0030246; GO:0045050; GO:0071816; GO:0072546 EMEQSMNMLNSNHELPDVSEFMTR 4.480000019 1 1 4.59E-13 2916.796896 8.764138 15.0026 12.32176 11.63458 13.40022 13.40834 13.5933 14.29926 0 12.50561 0 14.46771 7.839444 9.266583 0 0 0 10.82804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPA2 MMP25_HUMAN "Matrix metalloproteinase-25, MMP-25, EC 3.4.24.- (Leukolysin) (Membrane-type matrix metalloproteinase 6, MT-MMP 6, MTMMP6) (Membrane-type-6 matrix metalloproteinase, MT6-MMP, MT6MMP)" MMP25 MMP20 MMPL1 MT6MMP Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GO:0004222; GO:0005576; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0035579; GO:0060022 MDPGTVATMR 7.78000021 1 1 0.266349317 1096.068642 15.38795 0 0 11.70549 0 0 0 0 0 14.984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPB1 NT5M_HUMAN "5'(3')-deoxyribonucleotidase, mitochondrial, 5',3'-nucleotidase, mitochondrial, EC 3.1.3.- (Deoxy-5'-nucleotidase 2, dNT-2)" NT5M DNT2 Homo sapiens (Human) DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223] 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166] GO:0000166; GO:0005739; GO:0005759; GO:0006260; GO:0008252; GO:0008253; GO:0009223; GO:0046079; GO:0046872 RGAAGGLGLAGGR 8.539999962 1 1 0.22538825 1112.116562 0 14.6765 16.07055 16.36132 0 0 13.7032 0 16.15446 0 0 0 14.01003 0 14.10812 13.98855 0 14.89063 15.56287 16.72707 0 0 0 0 15.01715 0 14.97171 0 0 15.65062 0 12.11738 0 12.55566 0 15.0318 0 16.39518 15.77531 15.5711 16.99313 13.26545 14.7061 15.00759 0 0 0 0 Q9NPB3 CABP2_HUMAN "Calcium-binding protein 2, CaBP2" CABP2 Homo sapiens (Human) sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; visual perception [GO:0007601] Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; visual perception [GO:0007601] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509] GO:0005246; GO:0005509; GO:0005794; GO:0005886; GO:0007165; GO:0007601; GO:0007605; GO:0048471 DGYIGCR 6.789999962 0.010463141 0.010463141 0.219586089 840.370121 0 0 15.39335 17.26793 18.01663 0 16.14648 16.33539 15.75531 0 0 0 0 0 0 18.06556 16.91159 13.02465 16.49379 17.00489 0 0 0 0 15.10534 0 0 0 19.00235 0 0 19.30331 17.47785 0 0 0 19.86249 16.43583 0 0 18.18645 16.02047 0 0 0 0 16.55824 17.51421 Q9NPB6 PAR6A_HUMAN "Partitioning defective 6 homolog alpha, PAR-6, PAR-6 alpha, PAR-6A (PAR6C) (Tax interaction protein 40, TIP-40)" PARD6A PAR6A Homo sapiens (Human) cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; viral process [GO:0016032] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; tight junction [GO:0070160]; GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; viral process [GO:0016032] GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134] GO:0001726; GO:0001933; GO:0005080; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0008134; GO:0016032; GO:0016324; GO:0030742; GO:0031267; GO:0034451; GO:0045197; GO:0045217; GO:0050714; GO:0051301; GO:0060341; GO:0070160; GO:0120157; GO:1904781 FDAEFR 14.68999958 1 1 0.095345429 783.6151947 15.6022 0 0 15.20351 0 0 0 0 0 0 0 16.44696 0 0 0 0 0 0 16.80886 0 0 15.31798 0 0 0 0 14.76301 0 0 0 0 0 16.47584 0 0 0 0 17.19251 0 0 15.56651 16.14142 15.04568 16.89938 14.32048 0 0 0 Q9NPB9 ACKR4_HUMAN "Atypical chemokine receptor 4 (C-C chemokine receptor type 11, C-C CKR-11, CC-CKR-11, CCR-11) (CC chemokine receptor-like 1, CCRL1) (CCX CKR)" ACKR4 CCBP2 CCR11 CCRL1 VSHK1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044] GO:0004950; GO:0005044; GO:0005769; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0055037; GO:0060326 ITSALYTLNFVSGMQFLACISIDR 1.00999999 1 1 1.83E-12 2736.758757 12.52391 16.38619 0 0 14.66014 0 0 0 0 0 16.58447 0 13.89495 14.19219 0 13.61558 14.44147 15.34562 0 14.35037 16.45396 0 0 0 0 0 0 15.2397 0 0 15.18265 15.36726 0 15.89525 14.6285 0 16.66737 0 0 15.37258 0 0 0 13.30093 0 0 0 13.0975 Q9NPC1 LT4R2_HUMAN "Leukotriene B4 receptor 2, LTB4-R 2, LTB4-R2 (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2)" LTB4R2 BLT2R BLTR2 Homo sapiens (Human) chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; keratinocyte migration [GO:0051546]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; keratinocyte migration [GO:0051546]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218] G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974] GO:0001632; GO:0004974; GO:0005654; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0007194; GO:0007218; GO:0008528; GO:0016020; GO:0051546 TTPQLKVVGQGR 4.059999943 1 1 0.068421086 1284.577391 12.76273 11.55663 0 0 13.14988 0 11.89363 7.992255 0 17.73384 0 10.67282 12.82916 0 0 12.14086 0 0 0 0 0 0 14.73425 0 0 0 0 0 13.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.74214 12.97792 0 0 0 Q9NPE2 NGRN_HUMAN Neugrin (Mesenchymal stem cell protein DSC92) (Neurite outgrowth-associated protein) (Spinal cord-derived protein FI58G) NGRN FI58G HT020 Homo sapiens (Human) mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131] intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131] RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016604; GO:0019843; GO:0030182; GO:0031966; GO:0045171; GO:0061668; GO:0070131; GO:0072686 GTGSGALPSGQK 7.5 1 1 0.208552883 1060.638236 15.59443 14.21823 13.92678 15.4669 0 0 0 13.37622 15.15648 0 0 0 0 0 0 0 0 14.20964 0 0 15.01587 16.54109 0 0 15.68497 14.34156 0 0 0 15.34943 16.4672 14.81128 0 15.45743 15.09507 0 0 15.54527 12.02685 13.62341 10.66137 0 14.40005 0 14.38238 0 0 14.70537 Q9NPF0 CD320_HUMAN "CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6, FDC-SM-8D6) (Transcobalamin receptor, TCblR) (CD antigen CD320)" CD320 8D6A UNQ198/PRO224 Homo sapiens (Human) B cell costimulation [GO:0031296]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; positive regulation of B cell proliferation [GO:0030890]; regulation of vitamin metabolic process [GO:0030656] endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; growth factor activity [GO:0008083]; B cell costimulation [GO:0031296]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; positive regulation of B cell proliferation [GO:0030890]; regulation of vitamin metabolic process [GO:0030656] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; growth factor activity [GO:0008083] GO:0005509; GO:0005783; GO:0005886; GO:0005887; GO:0008083; GO:0009235; GO:0010008; GO:0015889; GO:0016020; GO:0030656; GO:0030890; GO:0031296; GO:0031419; GO:0038024 ESLLLSEQK 16.62000084 0.831818342 0.831818342 0.226095046 1045.643842 15.60067 15.75389 16.4979 15.8475 15.24739 13.93528 15.19004 16.08347 13.96937 16.58089 13.63192 12.38434 14.30182 0 14.72046 15.96495 0 0 0 0 15.83711 18.68246 0 12.73752 0 0 14.99926 0 0 0 0 17.1574 16.46496 15.88246 0 0 0 17.27776 17.45476 16.52354 0 16.67134 15.38393 16.71588 15.94802 16.56219 15.21079 15.74589 Q9NPF2 CHSTB_HUMAN "Carbohydrate sulfotransferase 11, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1, C4S-1, C4ST-1, C4ST1)" CHST11 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659 NKFTQK 6.5 0.998829722 0.998829722 0.216919241 765.5945963 0 14.41996 0 13.32349 15.39526 0 15.30614 0 0 15.17437 14.95194 8.35033 16.48791 0 0 0 16.94266 13.71977 0 16.13444 0 16.81518 16.56122 16.43425 0 0 0 15.56912 15.97186 14.08969 16.27553 0 0 0 0 0 0 16.73798 0 15.78274 18.91579 14.13038 0 15.69861 0 16.1313 14.47239 14.82923 Q9NPF4 OSGEP_HUMAN "tRNA N6-adenosine threonylcarbamoyltransferase, EC 2.3.1.234 (N6-L-threonylcarbamoyladenine synthase, t(6)A synthase) (O-sialoglycoprotein endopeptidase, hOSGEP) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP) (tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP)" OSGEP GCPL1 Homo sapiens (Human) tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949] metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711] GO:0000408; GO:0002949; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0016607; GO:0046872; GO:0061711 LVELPYTVK 10.67000008 0.478656411 0.478656411 0.238866083 1060.75967 0 16.6865 0 0 0 0 0 0 0 15.21087 0 0 0 14.36358 14.41753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47383 16.17056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.54052 15.70251 Q9NPG3 UBN1_HUMAN Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein) UBN1 Homo sapiens (Human) DNA replication-independent chromatin assembly [GO:0006336] bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA replication-independent chromatin assembly [GO:0006336] DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0005654; GO:0005923; GO:0006336; GO:0016604; GO:0016605; GO:0034451 VGGVLCTEEK 4.289999962 1 1 0.036410391 1092.515701 0 0 0 0 14.0469 0 0 0 0 0 0 12.06607 9.824705 0 0 0 15.02988 0 13.84159 0 0 15.41368 0 14.73929 0 0 0 15.5778 11.37683 0 0 0 0 0 13.24242 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPG4 PCD12_HUMAN "Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2, VE-cad-2, VE-cadherin-2) [Cleaved into: Protocadherin-12, secreted form ]" PCDH12 UNQ395/PRO731 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; glycogen metabolic process [GO:0005977]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; labyrinthine layer development [GO:0060711]; neuron recognition [GO:0008038] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; glycogen metabolic process [GO:0005977]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; labyrinthine layer development [GO:0060711]; neuron recognition [GO:0008038] calcium ion binding [GO:0005509] GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0005977; GO:0007155; GO:0007156; GO:0008038; GO:0016339; GO:0060711; GO:0070062 TLRNQGNQGAPAESR 4.059999943 1 1 0.111108363 1597.002431 13.63233 13.56129 15.37464 0 0 14.70697 15.58641 0 13.56142 13.61615 13.72812 13.7416 0 0 0 13.87422 0 0 0 0 0 0 15.47628 0 0 0 16.10589 0 0 0 0 0 0 0 0 0 14.18564 0 0 0 0 0 0 0 0 0 0 0 Q9NPH0 PPA6_HUMAN "Lysophosphatidic acid phosphatase type 6, EC 3.1.3.2 (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1)" ACP6 ACPL1 LPAP UNQ205/PRO231 Homo sapiens (Human) dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644] acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791] GO:0002244; GO:0003993; GO:0005737; GO:0005739; GO:0005759; GO:0006644; GO:0006654; GO:0016311; GO:0016791; GO:0052642; GO:2001311 LWTPVGVLTSLAYCLHQR 1.330000043 1 1 0.041721072 2112.834883 0 9.407831 12.26564 0 13.42836 13.3625 0 0 13.06061 16.05612 0 0 14.79723 13.62742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.69535 0 0 14.65866 14.07773 0 0 0 0 0 0 0 Q9NPH3 IL1AP_HUMAN "Interleukin-1 receptor accessory protein, IL-1 receptor accessory protein, IL-1RAcP, EC 3.2.2.6 (Interleukin-1 receptor 3, IL-1R-3, IL-1R3)" IL1RAP C3orf13 IL1R3 Homo sapiens (Human) immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]" "interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" GO:0002114; GO:0004908; GO:0005149; GO:0005576; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0016020; GO:0032736; GO:0032753; GO:0032754; GO:0032755; GO:0045087; GO:0050135; GO:0051092; GO:0051965; GO:0061809; GO:0065003; GO:0098978; GO:0099151; GO:0099545; GO:0099560; GO:1905606 DLEEPINFR 18.95999908 1 1 0.447352373 1132.110318 0 0 18.19364 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPH5 NOX4_HUMAN "NADPH oxidase 4, EC 1.6.3.- (Kidney oxidase-1, KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase)" NOX4 RENOX Homo sapiens (Human) bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell aging [GO:0007569]; cell morphogenesis [GO:0000902]; cellular response to glucose stimulus [GO:0071333]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; reactive oxygen species biosynthetic process [GO:1903409]; reactive oxygen species metabolic process [GO:0072593]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell aging [GO:0007569]; cell morphogenesis [GO:0000902]; cellular response to glucose stimulus [GO:0071333]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; reactive oxygen species biosynthetic process [GO:1903409]; reactive oxygen species metabolic process [GO:0072593]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] GO:0000166; GO:0000902; GO:0003015; GO:0005634; GO:0005730; GO:0005739; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0006954; GO:0007569; GO:0008285; GO:0009055; GO:0010467; GO:0016021; GO:0016174; GO:0016175; GO:0019826; GO:0020037; GO:0042554; GO:0043020; GO:0043406; GO:0045453; GO:0048471; GO:0050660; GO:0050667; GO:0051897; GO:0055007; GO:0061098; GO:0070374; GO:0071333; GO:0072341; GO:0072593; GO:0097038; GO:1903409; GO:1990782; GO:2000573 LFIGRPR 5.75 1 1 0.052929003 858.0399611 14.81106 15.08927 17.56341 0 14.89842 0 0 0 0 0 15.58791 0 0 12.82921 0 0 0 0 0 0 0 0 11.69494 0 15.54576 0 0 0 0 0 0 15.21601 0 0 14.76698 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPH6 OBP2B_HUMAN "Odorant-binding protein 2b (Odorant-binding protein IIb, OBPIIb)" OBP2B UNQ653/PRO1283 Homo sapiens (Human) chemosensory behavior [GO:0007635]; sensory perception of smell [GO:0007608] extracellular space [GO:0005615] extracellular space [GO:0005615]; odorant binding [GO:0005549]; small molecule binding [GO:0036094]; chemosensory behavior [GO:0007635]; sensory perception of smell [GO:0007608] odorant binding [GO:0005549]; small molecule binding [GO:0036094] GO:0005549; GO:0005615; GO:0007608; GO:0007635; GO:0036094 VTALGGGKLEATFTFMR 14.46000004 1 1 0 1812.210287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.30644 0 0 0 Q9NPI1 BRD7_HUMAN Bromodomain-containing protein 7 (75 kDa bromodomain protein) (Protein CELTIX-1) BRD7 BP75 CELTIX1 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of histone acetylation [GO:0035066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of histone acetylation [GO:0035066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0007049; GO:0008285; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0035066; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0070577; GO:2000045; GO:2000134; GO:2000781; GO:2000819 GGHSR 5.730000019 1 1 0.29036964 513.5491532 0 0 18.42736 17.90824 0 0 17.44805 0 17.85545 0 0 16.1994 0 0 0 0 0 17.68102 21.19622 0 0 0 0 17.25833 0 0 0 17.61188 16.89519 0 0 0 0 0 17.82149 0 0 0 0 16.5547 0 17.9799 0 17.74039 0 0 17.56009 15.99235 Q9NPI6 DCP1A_HUMAN "mRNA-decapping enzyme 1A, EC 3.6.1.62 (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF)" DCP1A SMIF Homo sapiens (Human) "deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]; protein localization to cytoplasmic stress granule [GO:1903608]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]; protein localization to cytoplasmic stress granule [GO:1903608]" enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729] GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0019894; GO:0031087; GO:0036464; GO:0042802; GO:0043085; GO:0110156; GO:1903608 GAMVASFSPAAGQLATPESFIEPPSK 5.989999771 0.835116506 0.835116506 0.084312194 2589.565446 13.15949 12.33273 0 13.21322 11.99691 12.2863 0 0 0 11.54962 11.03277 10.78628 0 0 0 0 0 0 0 11.21247 0 0 11.54804 0 0 0 0 14.95596 0 13.08457 0 0 13.26156 10.85542 0 12.84297 11.20452 0 0 11.29985 11.89662 0 0 0 13.44719 0 0 14.29415 Q9NPI8 FANCF_HUMAN "Fanconi anemia group F protein, Protein FACF" FANCF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] GO:0000785; GO:0005654; GO:0006513; GO:0006974; GO:0036297; GO:0043240 LQEVGK 7.269999981 0.01428822 0.01428822 0.053244363 673.3635559 15.14448 0 0 0 0 0 0 0 15.60194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.25467 0 0 0 0 0 0 17.78853 16.52022 0 0 0 0 0 0 0 0 0 0 17.31232 Q9NPJ6 MED4_HUMAN "Mediator of RNA polymerase II transcription subunit 4 (Activator-recruited cofactor 36 kDa component, ARC36) (Mediator complex subunit 4) (TRAP/SMCC/PC2 subunit p36 subunit) (Vitamin D3 receptor-interacting protein complex 36 kDa component, DRIP36)" MED4 ARC36 DRIP36 VDRIP HSPC126 Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]" nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809] GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0070847 LGGGLGVAGGNSTR 2.200000048 1 1 0.069933087 1215.599947 14.13274 0 14.57837 0 15.94186 0 0 0 14.08851 0 0 0 0 0 0 14.66125 0 0 13.80005 0 0 0 0 0 15.09025 0 15.32487 16.15051 0 0 0 15.37734 14.94942 0 0 0 0 0 0 0 0 16.19501 16.14733 0 0 0 0 0 Q9NPR2 SEM4B_HUMAN Semaphorin-4B (Semaphorin-C) SEMA4B KIAA1745 SEMAC UNQ749/PRO1480 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0045202; GO:0045499; GO:0048843; GO:0050919; GO:0071526 GLLYAASHSGVVQVPMANCSLYR 3.119999886 1 1 0.255027667 2493.634601 0 0 11.4669 13.97992 0 0 0 0 13.07073 0 0 0 0 0 0 0 12.9277 0 0 0 0 15.27493 0 0 0 12.59586 14.83447 0 13.70571 0 14.1844 12.84238 15.96208 15.45578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ11 AT132_HUMAN "Polyamine-transporting ATPase 13A2, EC 7.6.2.-" ATP13A2 PARK9 Homo sapiens (Human) autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982] "autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]" "ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]" GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0015417; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031902; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152 FYKHSMK 7.710000038 0.741566062 0.741566062 0.204232663 957.1804736 16.7819 9.741111 13.90876 15.48275 0 0 13.08788 15.59683 0 0 0 0 0 0 0 0 0 14.31573 16.00667 0 0 0 0 14.50028 0 0 0 16.53107 14.43258 0 0 0 0 0 0 0 17.87709 0 0 0 0 14.04114 15.25831 15.08385 14.93472 0 0 14.56101 Q9NQ30 ESM1_HUMAN "Endothelial cell-specific molecule 1, ESM-1" ESM1 Homo sapiens (Human) angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040] extracellular region [GO:0005576] extracellular region [GO:0005576]; hepatocyte growth factor receptor binding [GO:0005171]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040] hepatocyte growth factor receptor binding [GO:0005171]; integrin binding [GO:0005178] GO:0001525; GO:0002040; GO:0005171; GO:0005178; GO:0005576; GO:0008284; GO:1902204 ENAAGSPVMR 8.529999733 1 1 0.060903171 1032.483731 14.28537 0 0 0 0 0 0 0 0 0 0 0 14.41346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.11474 0 0 0 0 0 0 0 0 0 0 0 Q9NQ32 CK016_HUMAN Uncharacterized protein C11orf16 C11orf16 Homo sapiens (Human) MESSTGPR 5.96999979 1 1 0.103314421 864.9337387 15.17197 0 15.31242 0 0 0 0 0 0 0 0 0 0 0 0 14.8721 0 15.73883 0 0 0 0 0 0 15.5698 0 0 0 0 0 0 0 0 0 0 14.85026 0 0 0 0 0 0 0 0 0 0 0 14.23999 Q9NQ38 ISK5_HUMAN "Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor, LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665 ]" SPINK5 Homo sapiens (Human) cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of immune response [GO:0050777]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572]; regulation of cell adhesion [GO:0030155]; regulation of T cell differentiation [GO:0045580]; regulation of timing of anagen [GO:0051884] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of immune response [GO:0050777]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572]; regulation of cell adhesion [GO:0030155]; regulation of T cell differentiation [GO:0045580]; regulation of timing of anagen [GO:0051884] serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002787; GO:0004867; GO:0005576; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005938; GO:0007417; GO:0009913; GO:0016525; GO:0030154; GO:0030155; GO:0030198; GO:0030855; GO:0035315; GO:0043231; GO:0045580; GO:0048471; GO:0050777; GO:0051884; GO:0097209; GO:1900004; GO:1902572 ENDPIRGPDGK 3.440000057 1 1 0.38460608 1196.808356 15.51864 16.21703 15.07778 14.99261 0 14.26977 13.14615 13.11254 0 9.85105 0 0 0 0 0 15.30165 15.25565 0 14.92089 0 12.85254 0 14.14378 0 0 0 16.12572 0 0 0 0 0 0 13.86004 0 0 0 16.91551 0 16.33635 17.2095 0 0 0 0 0 16.49385 0 Q9NQ55 SSF1_HUMAN "Suppressor of SWI4 1 homolog, Ssf-1 (Brix domain-containing protein 3) (Peter Pan homolog)" PPAN BXDC3 SSF1 Homo sapiens (Human) ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] "nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]" RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0000027; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0019843; GO:0030687 DVVSSLRR 14.67000008 1 1 0.29291221 930.0609642 0 17.13071 17.98077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.04993 0 0 18.20554 0 0 0 0 0 0 0 0 0 0 0 20.01047 0 0 19.26641 0 17.87922 0 0 18.74614 0 0 0 0 Q9NQ66 PLCB1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1, EC 3.1.4.11 (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I, PLC-I) (Phospholipase C-beta-1, PLC-beta-1)" PLCB1 KIAA0581 Homo sapiens (Human) "activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]; activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]" "calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]" GO:0000086; GO:0000785; GO:0004435; GO:0004629; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007186; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032735; GO:0032957; GO:0032991; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0060466; GO:0070062; GO:0070498; GO:0080154; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:2000344; GO:2000438; GO:2000560 SHKSSEGSGK 13.81000042 1 1 0.261976022 1002.285005 0 17.28012 0 0 0 16.09232 0 0 0 0 0 0 0 0 0 0 16.86077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ75 CASS4_HUMAN "Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein, HEPL)" CASS4 C20orf32 HEFL Homo sapiens (Human) actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; protein tyrosine kinase binding [GO:1990782]; actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] protein tyrosine kinase binding [GO:1990782] GO:0005737; GO:0005856; GO:0005925; GO:0007155; GO:0007169; GO:0016477; GO:0030335; GO:0051897; GO:0061098; GO:0090527; GO:1900026; GO:1990782 TTSPSPEPDR 7.769999981 0.613464415 0.613464415 0.235600046 1086.761374 13.12162 15.57501 16.22138 6.556757 0 0 0 0 15.2993 14.66619 14.402 0 0 13.17305 15.32367 0 0 0 0 14.30888 0 0 15.55918 16.24484 16.30618 0 16.43296 0 16.92545 0 14.65612 14.90204 16.81063 0 0 15.77104 0 17.31779 16.45885 0 16.28433 0 16.23536 15.49731 0 0 16.04942 0 Q9NQ76 MEPE_HUMAN "Matrix extracellular phosphoglycoprotein (Osteoblast/osteocyte factor 45, OF45) (Osteoregulin)" MEPE Homo sapiens (Human) biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501] extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201] GO:0001501; GO:0005201; GO:0005576; GO:0005788; GO:0031012; GO:0031214; GO:1990430 NKGMPQGK 6.840000153 0.900920093 0.900920093 0.232789859 875.2961488 14.07673 15.36639 0 14.03557 15.93688 17.14006 16.1858 16.57567 15.42398 15.50555 15.83513 0 16.22455 0 16.54502 0 15.67154 15.36868 16.09757 0 14.17663 14.75306 15.84036 15.95689 15.03557 0 0 15.04191 0 14.18409 0 0 17.27431 0 16.83775 0 15.37467 16.46173 0 0 13.77004 15.27983 13.82369 0 15.50083 0 16.79506 0 Q9NQ79 CRAC1_HUMAN "Cartilage acidic protein 1 (68 kDa chondrocyte-expressed protein, CEP-68) (ASPIC)" CRTAC1 ASPIC1 CEP68 Homo sapiens (Human) axonal fasciculation [GO:0007413] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; axonal fasciculation [GO:0007413] calcium ion binding [GO:0005509] GO:0005509; GO:0007413; GO:0070062 KSGAHLR 5.699999809 1 1 0.265262322 768.0979849 16.59992 0 16.36535 18.51672 0 15.76289 0 16.5033 16.47353 0 0 15.14819 13.39462 15.58821 15.77426 14.55508 0 14.63726 17.07017 16.27631 14.25471 18.25881 15.46366 16.43137 16.78538 14.95667 0 16.7886 0 14.49715 16.55934 0 18.64295 0 16.66472 0 0 16.85637 0 0 15.48933 0 14.61817 0 16.96072 14.45275 16.79985 12.53999 Q9NQ86 TRI36_HUMAN "E3 ubiquitin-protein ligase TRIM36, EC 2.3.2.27 (RING finger protein 98) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) (Zinc-binding protein Rbcc728)" TRIM36 RBCC728 RNF98 Homo sapiens (Human) acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051] alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000281; GO:0001669; GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0007051; GO:0007340; GO:0008270; GO:0043014; GO:0051726; GO:0070507 AIDSSK 5.989999771 1 1 0.023567994 620.9084133 0 0 14.16895 0 0 0 12.7486 16.11957 15.35063 14.75574 15.50684 15.21319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.00044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ87 HEYL_HUMAN "Hairy/enhancer-of-split related with YRPW motif-like protein, hHeyL (Class B basic helix-loop-helix protein 33, bHLHb33) (Hairy-related transcription factor 3, HRT-3, hHRT3)" HEYL BHLHB33 HRT3 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AF-1 domain binding [GO:0050683]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]" "AF-1 domain binding [GO:0050683]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003151; GO:0003180; GO:0003181; GO:0003184; GO:0003198; GO:0003203; GO:0003208; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007219; GO:0009952; GO:0010629; GO:0014031; GO:0032835; GO:0035914; GO:0042803; GO:0043433; GO:0045666; GO:0045892; GO:0045944; GO:0050683; GO:0050767; GO:0060317; GO:0060412; GO:0060766; GO:0061314; GO:0071773; GO:0072014 ATGIILPARR 1.610000014 1 1 0.137456341 1068.293198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.78911 0 0 0 0 15.47004 0 0 0 0 0 0 0 0 0 0 0 0 17.43296 0 0 0 0 0 0 0 0 0 Q9NQ89 CL004_HUMAN Protein C12orf4 C12orf4 Homo sapiens (Human) regulation of mast cell degranulation [GO:0043304] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304] GO:0005737; GO:0043304 ERFCNR 1.169999957 1 1 0.103183547 882.6312388 0 16.34398 16.918 13.88848 14.66531 0 13.05874 0 16.66764 0 14.96344 0 0 0 0 0 0 0 0 0 0 16.07652 14.64921 0 0 0 0 16.26255 12.4531 0 0 15.91115 0 0 0 0 0 18.874 0 0 0 0 0 0 15.01184 0 0 0 Q9NQ90 ANO2_HUMAN Anoctamin-2 (Transmembrane protein 16B) ANO2 C12orf3 TMEM16B Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel complex [GO:0034707]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0034220; GO:0034707; GO:0046983; GO:0055085; GO:1902476 MATPGPR 2.089999914 1 1 0.044007837 728.5799341 0 14.65241 0 0 0 0 0 13.35465 0 16.27928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.78462 0 17.71702 0 0 0 0 0 0 0 0 0 0 Q9NQA5 TRPV5_HUMAN "Transient receptor potential cation channel subfamily V member 5, TrpV5 (Calcium transport protein 2, CaT2) (Epithelial calcium channel 1, ECaC, ECaC1) (Osm-9-like TRP channel 3, OTRPC3)" TRPV5 ECAC1 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872] GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016324; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0070588; GO:0098703 AQVVATTVMLERK 4.659999847 0.434091568 0.434091568 0.336441368 1461.371657 16.40131 15.99877 0 16.59711 15.55785 15.05267 15.2805 16.00329 15.29228 14.00258 16.54997 0 14.65145 0 0 14.09465 14.68907 14.52737 13.76738 16.92428 13.54106 0 16.85227 0 0 16.10096 0 0 0 0 0 0 16.71865 0 17.1707 0 0 0 0 0 0 0 0 0 17.45421 16.6147 15.1452 13.03899 Q9NQC3 RTN4_HUMAN "Reticulon-4 (Foocen) (Neurite outgrowth inhibitor, Nogo protein) (Neuroendocrine-specific protein, NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)" RTN4 KIAA0886 NOGO My043 SP1507 Homo sapiens (Human) apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334] cell junction [GO:0030054]; cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell junction [GO:0030054]; cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334] cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625] GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030176; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0042995; GO:0045296; GO:0045766; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0120078; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213 DSKEDSDMLAAGGK 2.930000067 1 1 1.38E-12 1439.633999 14.71961 15.13342 11.72665 11.43198 0 0 0 0 13.95151 0 0 15.57677 0 15.29298 0 0 13.57623 0 0 14.19153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQC7 CYLD_HUMAN "Ubiquitin carboxyl-terminal hydrolase CYLD, EC 3.4.19.12 (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)" CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) cell cycle [GO:0007049]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270] GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006511; GO:0007049; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0031234; GO:0032088; GO:0032480; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070423; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242 SKNTWYIDEVAEDPAK 5.570000172 1 1 0.29682004 1866.418753 0 0 0 0 0 0 0 14.00179 0 0 15.74555 0 15.15852 15.05138 0 0 0 12.31982 0 0 0 14.70877 0 0 0 0 0 0 14.15523 0 0 0 0 0 15.44936 15.53462 0 0 0 14.07341 13.95114 15.63331 13.03775 15.34899 16.99012 15.56172 0 16.43043 Q9NQF3 SERHL_HUMAN "Serine hydrolase-like protein, SHL, EC 3.1.-.-" SERHL SERHL2 Homo sapiens (Human) hydrolase activity [GO:0016787] hydrolase activity [GO:0016787] GO:0016787 QRTALTSSAGSCVR 3.460000038 1 1 0.379625192 1491.929957 0 12.9004 0 0 14.99125 14.15625 0 0 0 13.63275 0 0 0 16.43723 0 0 0 13.32393 0 0 0 0 0 15.98669 0 14.83415 0 16.01505 0 0 0 15.48192 0 0 13.39326 0 17.11355 0 0 0 0 0 0 0 0 16.23643 0 0 Q9NQG7 HPS4_HUMAN Hermansky-Pudlak syndrome 4 protein (Light-ear protein homolog) HPS4 KIAA1667 Homo sapiens (Human) blood coagulation [GO:0007596]; hemostasis [GO:0007599]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] GO:0005085; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0016192; GO:0030318; GO:0031085; GO:0031267; GO:0031410; GO:0042470; GO:0042803; GO:0042827; GO:0046907; GO:0046983; GO:0048075; GO:0050821; GO:0060155; GO:1903232; GO:1903955 GEVLGLSSSLGK 5.909999847 1 1 0.260142425 1145.881057 15.84484 11.00163 14.42831 9.531819 14.98245 9.663874 0 14.63686 0 14.59882 0 13.55984 0 0 14.81557 0 0 0 0 14.92316 16.62781 0 0 0 0 8.829999 0 0 0 0 0 15.70812 0 0 14.91125 0 0 0 0 0 0 0 15.03497 14.24578 15.51778 15.22819 0 14.0098 Q9NQH7 XPP3_HUMAN "Xaa-Pro aminopeptidase 3, X-Pro aminopeptidase 3, EC 3.4.11.9 (Aminopeptidase P3, APP3)" XPNPEP3 Homo sapiens (Human) glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803] GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006 DAPEKFR 12.07999992 0.557783961 0.557783961 0.290229335 863.9306704 0 15.606 0 0 0 15.29275 0 14.88804 0 0 0 0 0 16.15985 0 15.8339 0 0 0 0 0 0 0 0 0 0 13.90412 13.29663 15.06272 15.84703 15.8524 14.1626 13.51543 15.03971 15.3289 14.74942 14.95657 0 14.07292 15.34033 15.77424 15.25377 14.63247 0 0 17.17767 0 0 Q9NQI0 DDX4_HUMAN "Probable ATP-dependent RNA helicase DDX4, EC 3.6.4.13 (DEAD box protein 4) (Vasa homolog)" DDX4 VASA Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0030317; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511 GGRGSFR 7.809999943 0.183660939 0.183660939 0.245502776 736.1524738 16.75053 12.71278 16.17458 16.10722 0 0 0 0 0 0 0 0 17.50576 13.80002 17.78926 0 0 16.19328 17.28356 0 16.19485 16.24807 0 15.56224 0 16.89478 0 15.26341 16.64568 16.20294 0 0 17.18354 0 16.71734 15.75303 18.45914 17.84912 16.88299 0 17.30081 15.9315 17.87038 0 17.46664 0 18.15886 0 Q9NQL9 DMRT3_HUMAN Doublesex- and mab-3-related transcription factor 3 DMRT3 DMRTA3 Homo sapiens (Human) adult walking behavior [GO:0007628]; male sex differentiation [GO:0046661]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; transmission of nerve impulse [GO:0019226]; ventral spinal cord interneuron specification [GO:0021521] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult walking behavior [GO:0007628]; male sex differentiation [GO:0046661]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; transmission of nerve impulse [GO:0019226]; ventral spinal cord interneuron specification [GO:0021521]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0007628; GO:0019226; GO:0021521; GO:0042487; GO:0046661; GO:0046872; GO:1990837 YPLMLRNTLAR 7.599999905 1 1 0.340304372 1362.916036 0 0 0 14.53035 0 0 0 14.87335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0895 17.89688 14.31118 14.02928 0 12.91465 15.28959 0 15.09803 15.47026 0 0 0 0 16.83417 16.77266 15.86357 0 0 16.44658 17.59327 17.34377 0 0 0 15.50328 Q9NQP4 PFD4_HUMAN Prefoldin subunit 4 (Protein C-1) PFDN4 PFD4 Homo sapiens (Human) negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907 MAATMK 1.559999943 1 1 0.207981019 667.4148702 16.31685 0 15.72966 16.16828 0 16.25573 15.59526 14.81729 17.20662 0 16.65789 0 15.81254 14.9794 13.38973 15.32001 15.58681 17.05327 0 16.28873 0 16.3781 16.32565 15.6076 16.42168 16.07225 0 15.68913 0 15.48061 16.27659 15.48468 16.03412 16.59319 0 16.21509 16.89044 17.17041 15.58315 16.42134 15.42522 15.84306 16.59333 16.71532 16.43589 0 16.1458 16.91979 Q9NQQ7 S35C2_HUMAN Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein) SLC35C2 C20orf5 OVCOV1 CGI-15 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786] antiporter activity [GO:0015297] GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0033116; GO:0036066; GO:0045747 ALHSRGDGGPK 6.840000153 0.267462254 0.267462254 0.037893628 1095.75439 12.99547 0 0 0 15.4922 12.56493 15.37749 0 0 13.09076 10.16658 14.65866 10.89474 0 12.39602 14.55289 8.401666 8.102065 0 0 0 13.8704 0 14.04302 0 13.49577 0 12.71545 14.68924 14.88165 0 0 0 0 0 0 0 0 0 0 14.68159 13.44807 16.05012 0 0 13.82432 0 0 Q9NQR1 KMT5A_HUMAN "N-lysine methyltransferase KMT5A, EC 2.1.1.- (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A, EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07, PR-Set7, PR/SET07) (SET domain-containing protein 8)" KMT5A PRSET7 SET07 SET8 SETD8 Homo sapiens (Human) "cell division [GO:0051301]; chromatin organization [GO:0006325]; mitotic chromosome condensation [GO:0007076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]" chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell division [GO:0051301]; chromatin organization [GO:0006325]; mitotic chromosome condensation [GO:0007076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]" histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0007076; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0042799; GO:0043516; GO:0045892; GO:0051301; GO:1901796 GPGRPRTDGENVFTGQSK 8.960000038 1 1 0.184564362 1903.93746 0 0 0 15.28642 0 0 0 0 12.30334 15.86602 0 0 0 0 0 14.71508 0 0 0 0 0 0 15.51829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.18017 12.83771 0 Q9NQR7 CC177_HUMAN Coiled-coil domain-containing protein 177 (Myelin proteolipid protein-like protein) CCDC177 C14orf162 PLPL Homo sapiens (Human) ALADLVR 3.339999914 1 1 0.304711405 757.9771102 0 0 0 0 17.14744 19.06326 16.7434 0 0 17.35831 0 18.26205 15.34914 17.18787 16.77406 0 18.35323 0 16.41357 0 0 17.45442 0 0 0 0 0 0 17.24892 0 19.05997 0 0 17.29662 0 18.54063 0 0 0 0 17.54122 0 0 17.60092 0 0 0 15.1239 Q9NQR9 G6PC2_HUMAN "Glucose-6-phosphatase 2, G-6-Pase 2, G6Pase 2, EC 3.1.3.9 (Islet-specific glucose-6-phosphatase catalytic subunit-related protein)" G6PC2 IGRP Homo sapiens (Human) gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796] glucose-6-phosphatase activity [GO:0004346] GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0016021; GO:0042593; GO:0050796; GO:0051156 MDFLHR 1.25 1 1 8.03E-13 835.5289336 14.61529 13.55019 15.21502 0 15.4507 0 14.60455 10.93129 14.38291 0 15.12222 14.81362 0 14.54231 14.83944 0 16.25486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.38099 0 0 0 0 0 0 Q9NQS1 AVEN_HUMAN Cell death regulator Aven AVEN Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] GO:0005829; GO:0006915; GO:0010972; GO:0012505; GO:0016020; GO:0043066 GRPGGDR 1.220000029 1 1 0.257335457 715.4638764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.64219 0 0 0 0 0 0 0 0 0 0 0 Q9NQS5 GPR84_HUMAN G-protein coupled receptor 84 (Inflammation-related G-protein coupled receptor EX33) GPR84 EX33 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604]; neuropeptide signaling pathway [GO:0007218] G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604] GO:0001604; GO:0005886; GO:0005887; GO:0007218; GO:0008528; GO:0035579; GO:0043235; GO:0070821 QFRQAYGSILK 2.329999924 1 1 0.248381459 1312.213981 0 0 12.97163 0 0 0 0 14.90015 0 0 0 0 0 0 0 0 0 0 0 18.35571 0 0 0 0 0 0 0 0 0 14.33572 17.08554 0 0 15.06783 15.41387 16.58269 0 0 15.33775 0 0 0 0 15.63183 0 0 0 0 Q9NQS7 INCE_HUMAN Inner centromere protein INCENP Homo sapiens (Human) chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein phosphorylation [GO:0006468] "central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]" "central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; protein serine/threonine kinase activator activity [GO:0043539]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein phosphorylation [GO:0006468]" protein serine/threonine kinase activator activity [GO:0043539] GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0000800; GO:0000801; GO:0001934; GO:0005634; GO:0005654; GO:0005721; GO:0005819; GO:0005829; GO:0005874; GO:0006468; GO:0007052; GO:0007059; GO:0010369; GO:0015630; GO:0016572; GO:0016604; GO:0030496; GO:0032133; GO:0032991; GO:0043539; GO:0051256; GO:0051257; GO:0051310; GO:0071902; GO:0090267; GO:1901970; GO:1902425; GO:1903490; GO:1990385 TPSSPCPASK 4.199999809 1 1 0.182322813 1031.182408 0 0 0 0 0 0 15.50736 0 0 0 0 0 16.683 0 0 0 0 15.24361 15.22108 0 15.93412 0 0 0 0 0 0 0 0 15.34659 0 0 0 15.49659 15.52247 15.74436 15.58961 15.01055 16.4778 10.71759 15.77694 0 0 0 0 14.82376 0 0 Q9NQT4 EXOS5_HUMAN Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B) EXOSC5 CML28 RRP46 Homo sapiens (Human) "defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723] GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019 ATLEVILRPK 4.46999979 0.294729412 0.294729412 0.248201804 1138.300693 13.62474 16.12934 0 0 18.64736 15.58811 18.17363 0 16.1542 14.7824 0 0 18.90102 18.2358 16.57124 0 0 18.65028 0 0 0 19.42011 18.93103 16.90025 0 17.07631 0 0 17.37623 0 0 18.61834 0 0 0 17.01474 0 0 0 0 18.86687 16.51994 0 0 16.07211 18.56667 0 18.28688 Q9NQT8 KI13B_HUMAN Kinesin-like protein KIF13B (Kinesin-like protein GAKIN) KIF13B GAKIN KIAA0639 Homo sapiens (Human) microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110] axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0042110; GO:0050770; GO:0071889 ATGPVR 13.52000046 0.495361269 0.495361269 0.315521926 600.7697199 0 0 14.52957 15.45135 14.47112 14.66125 15.45707 14.9955 15.89707 16.20624 15.50954 14.498 15.52596 15.89553 15.28715 15.26107 16.5991 15.50157 16.71281 16.33125 0 15.98272 16.79887 16.69148 14.65692 0 0 15.76437 0 15.55765 15.78117 15.20074 0 15.9396 15.37027 14.9459 16.0619 0 17.07576 16.59286 0 0 0 15.71474 0 0 16.08109 15.88779 Q9NQV8 PRDM8_HUMAN "PR domain zinc finger protein 8, EC 2.1.1.- (PR domain-containing protein 8)" PRDM8 PFM5 Homo sapiens (Human) "methylation [GO:0032259]; oligodendrocyte development [GO:0014003]; regulation of transcription, DNA-templated [GO:0006355]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; oligodendrocyte development [GO:0014003]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168] GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0008168; GO:0014003; GO:0016604; GO:0032259; GO:0046872 MEDTGIQR 4.329999924 1 1 0.104154093 965.7347335 15.55154 0 0 0 15.89499 0 13.03908 16.57209 17.04512 17.73634 16.14856 0 16.04125 0 0 16.97896 0 15.73661 0 0 0 0 0 11.61165 0 12.85829 0 16.14654 16.58223 0 0 0 16.08936 0 0 0 0 14.20166 14.94446 0 0 0 0 0 0 0 0 0 Q9NQW5 PRDM7_HUMAN "Histone-lysine N-methyltransferase PRDM7, EC 2.1.1.- (PR domain zinc finger protein 7) (PR domain-containing protein 7) ([histone H3]-lysine4 N-methyltransferase PRDM7)" PRDM7 PFM4 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; recombination hotspot binding [GO:0010844]; chromatin organization [GO:0006325]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; recombination hotspot binding [GO:0010844] GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0010468; GO:0010844; GO:0010845; GO:0042800; GO:0046975; GO:0080182 MNYNALITVGLR 1.330000043 1 1 0.422776031 1365.184159 0 0 0 0 0 0 0 0 0 0 16.18746 0 0 15.8771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQW6 ANLN_HUMAN Anillin ANLN Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106] actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654] actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; actomyosin contractile ring assembly [GO:0000915]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106] actin binding [GO:0003779]; cadherin binding [GO:0045296] GO:0000281; GO:0000915; GO:0000921; GO:0002244; GO:0003779; GO:0005654; GO:0005826; GO:0005829; GO:0005938; GO:0007096; GO:0015629; GO:0030496; GO:0031106; GO:0032059; GO:0045296; GO:0090521; GO:1904172 EFCAR 5.690000057 1 1 0.16536517 684.6151682 16.14546 15.65456 14.66477 0 13.50955 0 0 0 0 0 0 16.1235 0 11.41951 0 0 16.24719 16.40457 14.6599 0 0 0 0 0 0 15.17733 0 0 0 15.73769 16.82118 14.78823 15.93663 0 0 15.8216 0 0 15.62787 0 16.53643 17.33076 0 0 17.0239 0 16.83006 0 Q9NQW7 XPP1_HUMAN "Xaa-Pro aminopeptidase 1, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P, sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)" XPNPEP1 XPNPEPL XPNPEPL1 Homo sapiens (Human) bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062 NSAESEGMRR 2.019999981 1 1 0.017597401 1153.595863 13.18818 13.9789 13.25166 0 0 0 0 0 0 0 0 0 14.54922 9.553975 0 0 14.25904 0 0 0 0 0 16.49679 0 0 0 13.52507 0 0 15.27885 14.86127 0 0 16.40248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQW8 CNGB3_HUMAN "Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3, CNG channel beta-3)" CNGB3 Homo sapiens (Human) cation transport [GO:0006812]; signal transduction [GO:0007165]; visual perception [GO:0007601] photoreceptor outer segment [GO:0001750]; transmembrane transporter complex [GO:1902495] photoreceptor outer segment [GO:0001750]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; cation transport [GO:0006812]; signal transduction [GO:0007165]; visual perception [GO:0007601] cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223] GO:0001750; GO:0005222; GO:0005223; GO:0006812; GO:0007165; GO:0007601; GO:0030553; GO:1902495 DLALLFPPK 27.19000053 1 1 0.202534168 1014.773535 0 22.4609 22.62801 21.6277 22.28582 22.47704 22.50192 22.15231 23.27731 23.08463 19.14362 23.55483 22.65381 22.75433 17.27813 0 21.4515 22.51136 0 21.285 22.03333 0 23.33424 21.80259 18.93256 23.17702 0 21.12999 22.25919 21.41351 22.98337 23.30571 0 22.56099 0 0 23.1891 23.17618 23.51935 0 20.96551 0 22.7763 22.19903 0 20.98258 20.73926 21.45281 Q9NQX0 PRDM6_HUMAN "Putative histone-lysine N-methyltransferase PRDM6, EC 2.1.1.361 (PR domain zinc finger protein 6) (PR domain-containing protein 6)" PRDM6 PFM3 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468] histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0000122; GO:0005634; GO:0006325; GO:0010468; GO:0022008; GO:0042054; GO:0042802; GO:0046872; GO:0051151 CDMCADNR 5.400000095 1 1 0.081909437 1054.628475 14.82093 17.26646 8.825614 0 16.15304 0 0 0 0 13.85662 0 0 13.8765 8.216123 0 0 0 0 0 0 0 0 0 0 0 0 0 14.26018 0 0 0 0 15.91553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQX1 PRDM5_HUMAN "PR domain zinc finger protein 5, EC 2.1.1.- (PR domain-containing protein 5)" PRDM5 PFM2 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]" nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000278; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0010468; GO:0016575; GO:0016604; GO:0043565; GO:0045892; GO:0045944; GO:0046872; GO:0051567; GO:0140297; GO:1903053; GO:1990830 QSTAGRK 16.56999969 1 1 0.247729762 746.7836053 15.25754 13.49373 15.96051 16.04418 15.15185 15.51435 15.49524 14.87777 0 14.33538 13.16404 15.36234 0 0 14.02817 0 13.2857 15.67514 16.74325 16.74506 15.37671 15.53262 14.64493 13.94906 0 0 0 0 14.58158 14.42128 0 16.00182 15.41379 16.72137 15.3055 0 15.98863 0 0 0 0 14.91156 14.80289 15.35521 16.0363 0 0 14.8012 Q9NQX5 NPDC1_HUMAN "Neural proliferation differentiation and control protein 1, NPDC-1" NPDC1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 KESGHSTPPLPK 14.80000019 1 1 0.452431241 1278.440422 18.9003 19.81351 19.9198 0 0 18.34627 20.89721 20.11361 17.00998 21.27714 18.24357 15.18317 20.70818 0 0 19.87544 0 0 0 0 19.84437 0 19.58823 0 20.23191 0 0 17.90372 19.90029 19.13635 0 21.03735 20.83405 0 20.08969 0 0 21.01581 17.299 19.83541 0 19.3287 20.22477 17.29771 20.29394 0 0 0 Q9NQX6 ZN331_HUMAN Zinc finger protein 331 (C2H2-like zinc finger protein rearranged in thyroid adenomas) (Zinc finger protein 361) (Zinc finger protein 463) ZNF331 RITA ZNF361 ZNF463 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270 AFICGSSLIQHKR 8.170000076 1 1 0.335813535 1517.728206 0 0 18.06062 0 0 0 0 0 16.77564 0 17.30692 0 18.07383 0 0 0 0 0 0 0 0 0 17.5815 0 0 17.39976 0 0 0 20.49235 17.27921 0 0 0 0 0 19.51045 0 19.67813 0 0 0 0 0 0 0 0 0 Q9NQZ5 STAR7_HUMAN "StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7, StARD7)" STARD7 GTT1 Homo sapiens (Human) mitochondrial outer membrane [GO:0005741] mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289] lipid binding [GO:0008289] GO:0005741; GO:0008289 FVTGLRVR 6.289999962 0.576822221 0.576822221 0.107062713 950.205914 13.7347 15.07426 14.6441 13.32911 14.50458 0 0 0 0 0 0 14.91562 0 14.18942 13.44688 0 16.0137 15.80301 0 14.84082 16.61076 13.13819 13.83425 0 0 0 17.04622 0 0 0 0 0 0 0 0 16.14625 15.98296 0 0 0 15.59086 14.58578 0 0 0 0 0 0 Q9NQZ6 ZC4H2_HUMAN Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127) ZC4H2 HCA127 KIAA1166 Homo sapiens (Human) nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; regulation of transcription regulatory region DNA binding [GO:2000677]; spinal cord motor neuron differentiation [GO:0021522] cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; regulation of transcription regulatory region DNA binding [GO:2000677]; spinal cord motor neuron differentiation [GO:0021522] metal ion binding [GO:0046872] GO:0003358; GO:0005634; GO:0005737; GO:0006513; GO:0007399; GO:0007528; GO:0021522; GO:0032991; GO:0043025; GO:0045211; GO:0045666; GO:0046872; GO:0051091; GO:2000677 ADEQEIMCK 3.950000048 1 1 0.123404215 1123.845708 0 14.57976 0 0 0 0 0 0 0 0 0 12.1683 0 15.23296 0 11.46058 0 0 0 14.42732 0 0 0 13.14285 0 0 0 13.25409 15.69622 0 14.67027 0 0 14.20266 0 0 0 0 0 15.15472 14.93099 0 0 0 0 0 0 0 Q9NQZ8 ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) ZNF71 EZFIT Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 GACPPVR 5 1 1 0.240283031 755.2349533 13.83944 0 0 14.51143 0 0 15.03904 0 14.05842 14.70928 16.24142 15.63062 0 15.26178 0 15.80234 0 0 16.83771 0 0 0 0 0 15.37509 15.8381 0 0 0 15.96704 0 0 17.37503 16.33313 15.96119 0 16.75309 0 0 0 15.89814 0 0 0 0 0 15.70797 0 Q9NR09 BIRC6_HUMAN "Baculoviral IAP repeat-containing protein 6, EC 2.3.2.27 (BIR repeat-containing ubiquitin-conjugating enzyme, BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon, APOLLON)" BIRC6 KIAA1289 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712] cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712] cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237 INQNVAALPVASSVMDR 4.28000021 1 1 0.220074896 1800.432861 0 13.67557 14.93871 15.27043 15.7457 11.96101 14.53093 0 10.46688 15.52278 0 0 0 0 0 0 0 13.11662 0 0 0 0 0 0 0 15.57155 14.27568 0 11.38619 14.31685 0 0 0 0 13.36967 0 14.51616 16.92194 0 17.59248 0 0 11.37968 0 0 0 0 0 Q9NR11 ZN302_HUMAN Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327) ZNF302 ZNF135L ZNF140L ZNF327 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 IHSMKK 12.72000027 0.530981421 0.530981421 0.199402423 759.0433071 0 17.75826 15.23872 0 16.70434 0 0 0 18.14154 13.66654 18.79534 0 11.85741 0 18.04284 14.32533 0 0 0 0 15.99894 0 19.07263 0 17.65413 16.43255 16.71067 15.904 16.76882 15.09262 18.52507 19.48767 16.97583 0 17.17862 16.6556 0 17.65526 18.74509 0 10.4441 0 0 14.57473 14.64123 0 0 15.16759 Q9NR16 C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b) CD163L1 CD163B M160 UNQ6434/PRO23202 Homo sapiens (Human) external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044] scavenger receptor activity [GO:0005044] GO:0005044; GO:0005576; GO:0009897; GO:0016021 HKEDAGVICSEFTALR 3.369999886 1 1 0.309324826 1831.72082 14.60703 16.25198 11.67111 0 0 0 0 12.7879 0 0 0 17.24914 0 0 0 12.1962 0 0 0 0 0 0 15.87686 15.05964 0 12.50523 0 0 0 0 0 0 0 0 0 15.75824 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR22 ANM8_HUMAN "Protein arginine N-methyltransferase 8, EC 2.1.1.319 (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4)" PRMT8 HRMT1L3 HRMT1L4 Homo sapiens (Human) "histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]" anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; plasma membrane [GO:0005886] "anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]" enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] GO:0005886; GO:0006479; GO:0008469; GO:0008757; GO:0016571; GO:0018216; GO:0019899; GO:0019919; GO:0035241; GO:0035242; GO:0042802; GO:0042803; GO:0043393; GO:0051260; GO:0098753; GO:1904047 DVAMK 4.440000057 0.133739054 0.133739054 0.139775545 579.9864385 13.15328 15.78306 15.42939 13.8569 7.80643 13.67501 14.91068 18.35588 13.14681 17.14673 14.43096 14.34213 16.00083 13.80368 0 0 16.93651 0 15.68548 15.1996 14.05387 14.67063 15.53573 15.91385 15.86557 15.2488 17.22389 15.39533 0 15.62979 15.89953 0 13.49382 16.04493 18.41979 17.64212 14.33176 17.20953 16.68211 0 16.72772 0 14.92113 13.92254 14.74858 16.51194 16.57809 13.36341 Q9NR28 DBLOH_HUMAN "Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase, Smac)" DIABLO SMAC Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065] GO:0005739; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0008625; GO:0008631; GO:0008635; GO:0009898; GO:0035631; GO:0043065; GO:0051402; GO:0097193 AESEQEAYLR 13.77000046 1 1 0.518541411 1195.432844 20.6857 0 19.59064 17.41657 18.55227 0 0 0 0 20.31073 18.2364 19.64183 0 18.01053 16.23734 0 0 0 0 0 0 0 0 0 0 0 0 0 19.15308 0 0 0 0 0 18.16822 0 0 0 0 0 0 0 0 18.22461 0 0 0 19.19939 Q9NR30 DDX21_HUMAN "Nucleolar RNA helicase 2, EC 3.6.4.13 (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)" DDX21 Homo sapiens (Human) chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366] B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366] 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515] GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005694; GO:0005730; GO:0005739; GO:0005829; GO:0006338; GO:0006364; GO:0006366; GO:0016020; GO:0016887; GO:0019843; GO:0030515; GO:0035066; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045943; GO:0045944; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016 ELANQVSK 6.429999828 1 1 2.29E-13 888.7060546 0 0 0 14.13008 12.29998 16.19085 14.09953 11.23197 0 0 15.63252 0 12.70632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.57403 0 0 0 0 0 0 0 0 0 0 0 12.66614 0 0 0 0 0 Q9NR45 SIAS_HUMAN "Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)" NANS SAS Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085] N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444] GO:0005737; GO:0005829; GO:0006055; GO:0008781; GO:0016051; GO:0047444; GO:0050462; GO:0070062; GO:0070085 GRPMVISSGMQSMDTMK 6.739999771 1 1 0.149409415 1903.806786 13.62383 14.43199 17.08955 16.44053 15.60347 0 15.42745 13.97914 14.67523 0 15.79328 0 16.07731 15.23462 0 15.84904 15.78728 0 15.60381 0 0 0 0 0 0 15.72138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.07877 17.39932 0 0 16.38538 0 16.29801 0 Q9NR46 SHLB2_HUMAN Endophilin-B2 (SH3 domain-containing GRB2-like protein B2) SH3GLB2 KIAA1848 PP578 Homo sapiens (Human) membrane organization [GO:0061024] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; membrane organization [GO:0061024] cadherin binding [GO:0045296]; identical protein binding [GO:0042802] GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0042802; GO:0045296; GO:0061024 MDFNMKK 3.710000038 1 1 0.259575806 946.2927755 0 0 14.51669 13.37478 0 14.21117 12.42112 12.80811 16.71625 15.89688 15.96675 0 0 0 14.79579 15.58835 15.51932 15.46251 0 15.03253 15.08254 16.47268 0 0 15.33149 0 0 15.09801 0 15.81371 16.527 0 15.41725 0 0 16.414 15.50896 0 0 0 0 0 0 16.64319 0 0 0 0 Q9NR48 ASH1L_HUMAN "Histone-lysine N-methyltransferase ASH1L, EC 2.1.1.359, EC 2.1.1.367 (ASH1-like protein, huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H)" ASH1L KIAA1420 KMT2H Homo sapiens (Human) chromatin organization [GO:0006325]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038] bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872] GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006325; GO:0007338; GO:0009791; GO:0018024; GO:0030317; GO:0042800; GO:0043124; GO:0043409; GO:0045944; GO:0046697; GO:0046872; GO:0046974; GO:0046975; GO:0061038; GO:0097676; GO:1903699; GO:1903709 LLNQILSSSVESSNKGK 1.039999962 0.168679968 0.168679968 0.125458194 1802.916917 17.2781 13.28095 18.20789 0 12.61064 0 16.22657 17.18891 0 0 17.26589 15.36414 15.40952 12.94678 17.41343 16.92507 0 0 14.39157 0 0 18.19928 0 0 13.84335 0 15.25938 17.17278 0 0 16.67421 17.57416 16.17207 0 0 0 0 14.21076 13.0929 16.70003 15.48001 0 0 0 16.81886 0 0 15.47144 Q9NR55 BATF3_HUMAN "Basic leucine zipper transcriptional factor ATF-like 3, B-ATF-3 (21 kDa small nuclear factor isolated from T-cells) (Jun dimerization protein p21SNFT)" BATF3 SNFT Homo sapiens (Human) dendritic cell differentiation [GO:0097028]; integrated stress response signaling [GO:0140467]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dendritic cell differentiation [GO:0097028]; integrated stress response signaling [GO:0140467]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0009615; GO:0043011; GO:0090575; GO:0097028; GO:0140467; GO:1990837 SQGLPAAGSVLQR 6.300000191 1 1 0.388085026 1283.000318 14.53671 0 14.97906 13.98086 0 0 0 0 15.47198 0 0 14.11272 13.65978 0 0 0 0 15.69241 0 0 13.88528 0 0 0 0 0 0 0 16.87023 0 0 0 13.92269 0 14.50259 0 13.59388 0 0 15.49179 16.35259 0 0 15.32582 0 0 0 0 Q9NR61 DLL4_HUMAN "Delta-like protein 4 (Drosophila Delta homolog 4, Delta4)" DLL4 UNQ1895/PRO4341 Homo sapiens (Human) angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] GO:0000122; GO:0001525; GO:0001569; GO:0001974; GO:0003180; GO:0003208; GO:0003209; GO:0003222; GO:0003344; GO:0005112; GO:0005509; GO:0005886; GO:0007165; GO:0007219; GO:0007601; GO:0008015; GO:0008285; GO:0010596; GO:0010628; GO:0010629; GO:0016021; GO:0030217; GO:0035912; GO:0035924; GO:0044344; GO:0045746; GO:0045747; GO:0050767; GO:0060579; GO:0061074; GO:0061314; GO:0072554; GO:0090051; GO:1903588; GO:2000179 GTMPGK 6.619999886 1 1 0.255475463 603.3291845 16.84241 16.76657 16.28549 0 17.4766 17.23699 15.77298 18.90738 16.93597 0 0 0 17.8413 0 0 0 18.43258 0 18.55191 0 0 0 0 0 0 0 0 0 0 0 0 0 19.07574 17.01092 0 0 0 0 19.52554 0 0 0 0 0 16.42081 17.27017 18.05068 0 Q9NR63 CP26B_HUMAN "Cytochrome P450 26B1, EC 1.14.13.- (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2, Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome)" CYP26B1 CYP26A2 P450RAI2 Homo sapiens (Human) bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]" "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]" GO:0001709; GO:0001768; GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006766; GO:0006805; GO:0006954; GO:0007140; GO:0007283; GO:0008401; GO:0009954; GO:0010628; GO:0016125; GO:0016491; GO:0016709; GO:0020037; GO:0030326; GO:0033189; GO:0034653; GO:0042573; GO:0043587; GO:0045580; GO:0048384; GO:0048387; GO:0060349; GO:0061436; GO:0070268; GO:0071300; GO:2001037 SEDKDGR 10.17000008 1 1 0.199263578 805.2250407 18.4804 17.1377 16.53117 17.41583 17.06182 13.26655 16.38872 0 0 14.82924 0 16.88329 13.32778 15.24849 0 0 18.17789 0 16.38225 0 17.05792 17.42579 14.87316 17.77384 0 16.60373 0 0 13.81086 16.19932 17.77841 18.91982 16.86329 14.8718 0 15.04998 17.82037 15.69729 15.69259 16.15889 16.99388 12.18386 13.88262 0 17.24479 15.40166 16.44403 0 Q9NR77 PXMP2_HUMAN Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein) PXMP2 PMP22 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991] GO:0005737; GO:0005739; GO:0005778; GO:0005829; GO:0016020; GO:0016021; GO:0032991 RALAQYLLFLR 11.06000042 1 1 0.19342963 1362.656379 15.2766 15.27747 13.39799 0 0 0 14.67893 15.35241 15.17164 12.51205 15.77302 11.40397 15.55901 15.91576 0 0 0 0 0 16.55634 0 16.69292 0 0 14.92115 14.19076 15.91075 14.22647 15.6561 0 0 17.45015 0 16.72835 0 0 0 0 0 0 0 0 16.11651 0 0 0 0 0 Q9NR81 ARHG3_HUMAN "Rho guanine nucleotide exchange factor 3 (Exchange factor found in platelets and leukemic and neuronal tissues, XPLN)" ARHGEF3 Homo sapiens (Human) positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0007266; GO:0035025; GO:0051056 VKPLSR 5.46999979 1 1 0.283097025 700.2078263 0 16.91213 0 0 15.44234 0 17.81369 0 16.75667 0 0 17.10495 17.81655 0 0 0 15.83359 17.60886 17.00427 16.15859 17.03793 18.76879 17.00546 0 0 0 0 15.65105 16.56387 0 18.96392 0 0 17.7579 0 0 18.46852 17.77197 17.09279 0 0 0 0 16.99943 0 0 0 0 Q9NR82 KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5) KCNQ5 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805 EQGEASSSQK 7 1 1 0.203380919 1049.722753 14.88349 15.50919 16.17603 0 0 0 16.05752 0 0 16.18303 0 0 15.86814 0 16.17169 15.41764 14.38536 0 14.72668 15.24765 0 16.00494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92828 0 0 0 0 0 0 0 0 0 Q9NR83 S2A4R_HUMAN "SLC2A4 regulator (GLUT4 enhancer factor, GEF) (Huntington disease gene regulatory region-binding protein 1, HDBP-1)" SLC2A4RG HDBP1 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0016607; GO:0046872 AAGRDPSALR 2.519999981 1 1 0.292333699 1013.729154 0 0 0 15.69624 0 0 17.79881 18.49667 0 17.60239 16.86801 18.02247 0 0 0 0 0 0 0 0 16.38787 0 0 17.70787 0 17.72173 0 17.6166 17.87629 0 17.74506 0 0 0 0 17.96098 18.8913 0 0 0 0 0 0 0 18.11038 0 0 0 Q9NR96 TLR9_HUMAN Toll-like receptor 9 (CD antigen CD289) TLR9 UNQ5798/PRO19605 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of gastrointestinal epithelium [GO:0030277]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of B cell differentiation [GO:0045577]; regulation of toll-like receptor 9 signaling pathway [GO:0034163]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome [GO:0036019]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome [GO:0036019]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; interleukin-1 receptor binding [GO:0005149]; NAD+ nucleosidase activity [GO:0003953]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; unmethylated CpG binding [GO:0045322]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of gastrointestinal epithelium [GO:0030277]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of B cell differentiation [GO:0045577]; regulation of toll-like receptor 9 signaling pathway [GO:0034163]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224] interleukin-1 receptor binding [GO:0005149]; NAD+ nucleosidase activity [GO:0003953]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; unmethylated CpG binding [GO:0045322] GO:0000139; GO:0002224; GO:0002237; GO:0002639; GO:0002755; GO:0003953; GO:0004888; GO:0005149; GO:0005576; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005886; GO:0006954; GO:0007249; GO:0007252; GO:0010008; GO:0010628; GO:0016021; GO:0016323; GO:0016324; GO:0030277; GO:0030890; GO:0032009; GO:0032088; GO:0032715; GO:0032717; GO:0032722; GO:0032725; GO:0032727; GO:0032728; GO:0032729; GO:0032733; GO:0032735; GO:0032741; GO:0032755; GO:0032757; GO:0032760; GO:0034122; GO:0034123; GO:0034162; GO:0034163; GO:0035197; GO:0036019; GO:0036020; GO:0038187; GO:0042742; GO:0042803; GO:0043123; GO:0043410; GO:0043507; GO:0045087; GO:0045322; GO:0045577; GO:0045944; GO:0046330; GO:0050729; GO:0050829; GO:0050871; GO:0051092; GO:0051607; GO:0051770; GO:1901224; GO:1901895 DNHHFYNR 9.569999695 0.010842936 0.010842936 0.24049032 1102.165445 14.03849 15.60333 16.10532 0 0 0 15.30912 0 0 0 14.72238 0 0 0 0 0 0 0 14.25125 15.78146 0 0 15.97694 0 16.21856 0 15.27616 0 15.33403 0 0 13.84221 15.90153 14.44041 14.10188 0 11.91216 0 16.97441 0 14.29464 11.73781 15.21619 15.07233 13.52764 14.97 0 0 Q9NR99 MXRA5_HUMAN "Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan, Adlican)" MXRA5 Homo sapiens (Human) response to transforming growth factor beta [GO:0071559] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; response to transforming growth factor beta [GO:0071559] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559 ITGTSPRR 8.770000458 0.650428653 0.650428653 0.310850021 886.9924596 19.60335 18.23953 19.0401 18.19287 0 0 0 18.8247 0 18.48898 0 18.88633 0 0 17.92093 0 0 17.89017 18.69013 16.87978 0 0 19.32279 0 19.68728 0 18.24936 19.6667 17.20325 15.56768 21.01644 20.0228 18.62617 19.27841 19.57656 19.98248 19.38321 0 0 0 0 0 18.43853 18.80312 19.00356 18.38569 18.40837 18.96317 Q9NRA2 S17A5_HUMAN "Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter, AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)" SLC17A5 Homo sapiens (Human) amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739] carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857] GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672 ISHYEK 2.470000029 1 1 0.121542702 775.9009271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.12076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRC1 ST7_HUMAN Suppressor of tumorigenicity 7 protein (Protein FAM4A1) (Protein HELG) ST7 FAM4A1 HELG RAY1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; regulation of cell differentiation [GO:0045595] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; extracellular matrix organization [GO:0030198]; regulation of cell differentiation [GO:0045595] GO:0016021; GO:0030198; GO:0045595 AVSDK 3.950000048 1.63E-08 1.63E-08 0.299805382 516.0560155 0 0 0 18.71424 0 0 0 19.21645 0 17.25684 17.63291 0 17.76118 18.33571 0 16.823 18.58614 0 0 0 17.91076 17.58686 17.49287 0 0 0 18.34958 0 0 0 0 0 0 0 0 0 0 0 18.8181 0 17.6482 18.31073 0 0 0 19.32662 0 0 Q9NRC6 SPTN5_HUMAN "Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)" SPTBN5 BSPECV HUBSPECV HUSPECV Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041] apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091] apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041] actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; spectrin binding [GO:0030507] GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0007030; GO:0007041; GO:0008022; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030507; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0043621; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381 AGQPHSPR 6.639999866 1 1 0.142771123 849.9823282 0 0 0 0 0 0 0 0 0 0 0 17.16658 0 0 0 0 0 0 0 0 0 18.5068 0 0 0 0 0 0 0 0 0 0 0 0 19.14677 0 0 0 0 18.05399 0 0 0 0 0 0 0 0 Q9NRD5 PICK1_HUMAN PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) PICK1 PRKCABP Homo sapiens (Human) "cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102] GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090 TIKPMLTDLNTYLNKAIPDTR 13.14999962 1 1 0.441517097 2434.597596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRD9 DUOX1_HUMAN "Dual oxidase 1, EC 1.11.1.-, EC 1.6.3.1 (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1)" DUOX1 DUOX LNOX1 THOX1 Homo sapiens (Human) cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] GO:0004601; GO:0005509; GO:0005783; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0009986; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0031252; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0050661; GO:0050665; GO:0051591; GO:0090303; GO:0106293; GO:0106294; GO:2000147 DGNGYLSFR 1 1 1 0.235444364 1028.217837 0 0 0 0 0 17.10522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.83819 0 0 0 0 0 0 0 0 0 0 0 0 0 16.95232 0 0 0 0 0 0 Q9NRG1 PRDC1_HUMAN Phosphoribosyltransferase domain-containing protein 1 PRTFDC1 HHGP Homo sapiens (Human) purine ribonucleoside salvage [GO:0006166] magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine ribonucleoside salvage [GO:0006166] magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] GO:0000166; GO:0000287; GO:0006166; GO:0042803 MAGSSEEAPDYGR 2.829999924 1 1 0.270324084 1370.526134 13.25 15.66897 13.7447 13.85279 0 14.14901 14.28966 13.36178 13.97996 0 0 0 0 0 15.06576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.67646 0 0 0 0 0 16.74593 0 0 0 0 0 0 0 0 0 0 Q9NRG4 SMYD2_HUMAN "N-lysine methyltransferase SMYD2, EC 2.1.1.- (HSKM-B) (Histone methyltransferase SMYD2, EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2)" SMYD2 KMT3C Homo sapiens (Human) "chromatin organization [GO:0006325]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]" histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993] GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0007507; GO:0008285; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975; GO:1901796 QKIHPER 1.320000052 1 1 0.248421394 908.3028201 0 0 0 0 0 0 0 0 0 0 0 17.57229 0 0 0 0 0 0 0 0 0 19.53959 0 0 0 0 16.81353 0 0 16.67715 0 0 0 0 0 0 0 17.23302 0 0 0 0 0 0 0 0 0 0 Q9NRG9 AAAS_HUMAN Aladin (Adracalin) AAAS ADRACALA GL003 Homo sapiens (Human) fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822] GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0046822; GO:0051028; GO:0072686; GO:0090307 WPTLSGRCQTGCWSPDGSR 6.139999866 1 1 2.29E-12 2208.008829 0 15.22529 0 0 0 16.02279 11.95866 15.14841 15.30598 0 0 0 0 0 16.30335 14.86647 0 0 0 0 0 0 0 0 0 0 16.15398 15.4017 17.0482 0 16.46132 16.23477 16.93529 0 0 0 15.84185 0 0 0 0 0 0 0 0 17.30891 0 0 Q9NRI5 DISC1_HUMAN Disrupted in schizophrenia 1 protein DISC1 KIAA0457 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]" cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; endoplasmic reticulum [GO:0005783]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] "cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; endoplasmic reticulum [GO:0005783]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]" identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877] GO:0000226; GO:0001764; GO:0001954; GO:0002052; GO:0005634; GO:0005739; GO:0005783; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0008021; GO:0010976; GO:0014069; GO:0019894; GO:0021846; GO:0021852; GO:0030177; GO:0030286; GO:0031929; GO:0032091; GO:0036064; GO:0042802; GO:0044297; GO:0044877; GO:0045111; GO:0045773; GO:0048471; GO:0051560; GO:0051602; GO:0051966; GO:0060070; GO:0060090; GO:0060271; GO:0060998; GO:0071539; GO:0090128; GO:0090724; GO:0097546; GO:1905515; GO:2000060 EDYNRLR 4.510000229 1 1 0.119399093 967.9665011 14.31148 0 15.19766 0 15.89425 13.47726 14.20644 0 13.29495 16.29629 14.1221 0 16.08543 0 0 0 0 0 0 0 0 0 0 15.68335 0 16.71163 0 0 0 0 0 0 0 0 0 0 0 0 0 14.46516 0 0 0 0 0 0 12.56499 0 Q9NRJ1 MOST1_HUMAN Protein MOST-1 C8orf17 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] GO:0005634; GO:0005737; GO:0005789; GO:0008284; GO:0043066 MLADLTPGVEMSCR 2.069999933 1 1 2.06E-12 1612.841336 14.59589 15.4007 0 13.85063 15.3291 0 0 0 15.39493 0 14.69954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.81063 0 16.15141 0 16.08487 16.62812 0 0 0 16.23505 0 0 15.7923 14.70126 0 0 0 0 0 0 Q9NRJ2 GSAS1_HUMAN Putative uncharacterized protein GSN-AS1 (GSN antisense RNA 1) (GSN antisense gene protein 1) (Protein MOST-2) GSN-AS1 C9orf31 MOST2 Homo sapiens (Human) APSPVPASSLQDHSR 7.139999866 0.560663521 0.560663521 0.330907646 1547.657725 0 0 0 0 14.10162 0 14.83744 12.90273 0 0 0 14.83597 15.82327 0 0 0 19.79775 0 12.29665 0 0 0 0 13.36447 0 0 0 0 0 0 0 0 0 0 0 16.75996 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRJ5 PAPOB_HUMAN "Poly(A) polymerase beta, PAP-beta, EC 2.7.7.19 (Polynucleotide adenylyltransferase beta) (Testis-specific poly(A) polymerase)" PAPOLB PAPT Homo sapiens (Human) mRNA polyadenylation [GO:0006378] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723] GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006378; GO:0046872 GADIDALCVAPSHVDR 5.53000021 1 1 0.367411419 1694.999081 0 0 18.49561 0 18.79643 19.12795 0 0 0 21.78545 0 0 0 19.37993 18.14877 20.33665 0 20.37424 19.03297 0 20.02048 0 0 0 0 19.85605 20.69786 18.92093 0 0 0 0 0 0 0 0 19.25236 22.43432 0 0 0 18.58993 0 19.97611 0 0 20.3594 0 Q9NRK6 ABCBA_HUMAN "ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein, ABC-me protein) (ATP-binding cassette transporter 10, ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2, M-ABC2)" ABCB10 Homo sapiens (Human) erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985] integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803] GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0032592; GO:0034514; GO:0042803; GO:0045648; GO:0046985; GO:0048821; GO:0070455; GO:0140359 ALLKNPK 12.42000008 0.009131705 0.009131705 0.309499691 782.910276 19.24011 0 0 0 16.56806 17.30601 18.10563 0 17.48677 0 16.78517 16.81962 0 18.56287 17.39517 0 0 0 16.03865 0 0 17.20948 0 0 0 0 19.24403 17.52224 17.75882 0 0 0 0 0 19.42931 0 0 18.90796 0 0 17.68858 0 0 0 0 19.16308 0 0 Q9NRL2 BAZ1A_HUMAN "Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1, hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180, WCRF180) (hWALp1)" BAZ1A ACF1 WCRF180 HSPC317 Homo sapiens (Human) chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872] GO:0000228; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006357; GO:0008623; GO:0016584; GO:0016590; GO:0042766; GO:0045740; GO:0046872 ELPEPTPVK 2.470000029 1 1 0.159626918 1010.585186 15.70509 0 13.81315 0 0 14.26338 15.54934 0 14.18068 16.2548 0 0 15.45046 14.13411 12.68473 0 14.59804 14.53402 14.0133 15.8075 0 0 15.6745 16.31937 14.53495 15.05413 0 0 14.50793 9.825973 16.51927 14.01193 14.79205 16.49784 0 14.66438 0 15.17034 0 15.47298 0 0 14.41577 15.93351 0 14.17406 13.33756 14.76493 Q9NRM1 ENAM_HUMAN Enamelin ENAM Homo sapiens (Human) ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175] structural constituent of tooth enamel [GO:0030345] GO:0005576; GO:0005788; GO:0030345; GO:0031012; GO:0031214; GO:0036305; GO:0070175; GO:0097186 DIISPTSILPGQR 9.899999619 0.704887867 0.704887867 0.165084845 1398.02126 0 12.41258 9.221328 16.29003 16.01045 16.09251 15.16721 15.90716 17.26097 16.03797 16.79651 0 0 17.17428 15.38485 0 15.40171 15.4941 0 0 16.18633 14.997 0 0 12.69859 0 12.2265 0 16.80961 0 16.43537 0 13.37112 14.50912 13.50546 13.4905 15.13542 16.57164 0 0 18.73409 15.29671 14.21469 0 17.49997 17.3317 17.07283 18.2425 Q9NRM7 LATS2_HUMAN "Serine/threonine-protein kinase LATS2, EC 2.7.11.1 (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)" LATS2 KPM Homo sapiens (Human) cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000082; GO:0000922; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0009755; GO:0017015; GO:0018105; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0090090; GO:0106310; GO:1900181 SKSEQYDLDSLCAGMEQSLR 11.86999989 1 1 0.31366029 2316.097534 18.93689 0 0 0 18.24768 19.0868 0 0 0 0 0 19.91076 0 0 17.36555 16.75728 0 0 0 0 16.80738 0 0 0 19.56558 0 0 0 17.28548 18.86176 0 0 0 0 0 0 0 0 0 0 0 0 17.71331 0 0 18.86509 0 0 Q9NRN5 OLFL3_HUMAN Olfactomedin-like protein 3 (HNOEL-iso) (hOLF44) OLFML3 PSEC0035 PSEC0173 PSEC0244 UNQ663/PRO1294 Homo sapiens (Human) signal transduction [GO:0007165] extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; signal transduction [GO:0007165] GO:0005615; GO:0007165; GO:1903561 ARIQCSFDASGTLTPER 6.619999886 1 1 0.232338664 1907.803226 14.54951 0 12.84432 14.2505 10.17467 0 0 14.52056 0 0 0 14.19121 0 14.53613 0 13.59407 14.07128 0 0 11.85206 0 0 0 0 0 16.2787 0 0 0 0 0 0 0 0 0 0 0 0 0 14.99372 15.97719 0 0 0 0 0 0 0 Q9NRN9 METL5_HUMAN "rRNA N6-adenosine-methyltransferase METTL5, EC 2.1.1.- (Methyltransferase-like protein 5)" METTL5 DC3 HSPC133 Homo sapiens (Human) positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863] cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863] nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740] GO:0003676; GO:0005634; GO:0008988; GO:0016740; GO:0031167; GO:0042995; GO:0045727; GO:0048863; GO:0098793; GO:0098794; GO:1904047 TALEMARTAVYSLHK 3.329999924 0.997359931 0.997359931 0 1703.26155 0 14.64609 0 15.75027 0 16.04395 0 15.15939 16.39779 14.98254 0 15.38107 0 0 0 13.91426 0 0 15.02939 0 0 0 0 0 14.56277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRP2 COXM2_HUMAN COX assembly mitochondrial protein 2 homolog CMC2 C16orf61 DC13 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 SREHGIAMR 5.820000172 0.226784438 0.226784438 0.156603805 1073.247606 15.86842 17.5616 19.47607 0 0 17.43257 9.926258 13.36495 0 0 16.7458 0 0 0 14.38995 12.66384 13.46228 0 15.09745 9.869217 15.22925 0 14.11829 12.93856 16.32615 0 0 0 0 0 16.42745 15.69105 0 14.70596 13.96608 0 15.55122 16.2673 14.33506 15.85035 0 15.84001 12.17752 12.69598 13.55139 0 0 0 Q9NRP4 SDHF3_HUMAN "Succinate dehydrogenase assembly factor 3, mitochondrial, SDH assembly factor 3, SDHAF3" SDHAF3 ACN9 DC11 Homo sapiens (Human) mitochondrial respiratory chain complex II assembly [GO:0034553]; regulation of gluconeogenesis [GO:0006111]; succinate metabolic process [GO:0006105] mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759] mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II assembly [GO:0034553]; regulation of gluconeogenesis [GO:0006111]; succinate metabolic process [GO:0006105] GO:0005758; GO:0005759; GO:0006105; GO:0006111; GO:0034553 HVSRVR 5.119999886 1 1 0.090959125 754.7481059 14.01426 15.29007 13.35516 13.50108 15.94011 0 15.66919 13.83476 14.14725 12.13481 0 16.37897 14.83706 13.84728 13.67796 0 15.2466 14.34475 0 14.89327 14.04352 15.76384 16.19896 0 0 0 17.12803 0 0 0 0 0 0 0 0 0 0 0 0 15.96483 0 0 0 0 0 0 0 0 Q9NRP7 STK36_HUMAN "Serine/threonine-protein kinase 36, EC 2.7.11.1 (Fused homolog)" STK36 KIAA1278 Homo sapiens (Human) brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor binding [GO:0001222]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor binding [GO:0001222] GO:0001222; GO:0003351; GO:0004674; GO:0004712; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007224; GO:0007228; GO:0007420; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310 KYSAQVVALK 14.40999985 1 1 0.14965567 1107.467836 17.68151 15.07378 15.75307 0 17.64245 16.0936 18.25276 0 0 18.3391 0 17.01341 18.9699 0 18.13184 17.06233 0 0 16.99337 0 17.98024 17.58966 0 0 15.66691 18.12609 18.09975 17.49084 18.29219 0 0 18.14621 0 0 0 17.28257 0 18.45652 18.3117 0 15.43305 0 15.53662 17.95122 18.50514 0 15.48076 17.48971 Q9NRR4 RNC_HUMAN "Ribonuclease 3, EC 3.1.26.3 (Protein Drosha) (Ribonuclease III, RNase III) (p241)" DROSHA RN3 RNASE3L RNASEN Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332] GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628 GPSIQQAEMGAAMDALEK 11.60999966 1 1 0.317191693 1845.831165 0 0 0 0 0 0 0 15.31164 0 0 0 0 0 17.16709 0 16.61399 0 0 0 20.00867 0 0 0 0 19.22111 0 0 0 0 0 0 0 19.5078 0 0 14.80641 19.03179 0 0 0 0 18.12073 0 0 18.20026 0 0 0 Q9NRR5 UBQL4_HUMAN "Ubiquilin-4 (Ataxin-1 interacting ubiquitin-like protein, A1Up) (Ataxin-1 ubiquitin-like-interacting protein A1U) (Connexin43-interacting protein of 75 kDa, CIP75)" UBQLN4 C1orf6 CIP75 UBIN Homo sapiens (Human) autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593] GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005789; GO:0005829; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0031410; GO:0031593; GO:0032434; GO:0032991; GO:0036435; GO:0042802; GO:0048471; GO:0090734; GO:1901097; GO:2000042 NPEISHMLNNPELMR 28.03000069 0.483942926 0.483942926 0.108496721 1811.498868 16.37721 14.34163 0 0 13.65406 0 16.87291 0 0 13.35843 0 0 13.98772 12.60545 11.3564 0 0 0 17.78945 0 13.76747 0 0 0 16.3143 17.74454 14.47928 0 0 0 0 0 0 0 0 0 15.3532 0 0 0 0 0 0 0 0 0 0 0 Q9NRR6 INP5E_HUMAN "Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase, EC 3.1.3.86)" INPP5E Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]" "inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]" GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0005930; GO:0006661; GO:0014067; GO:0016314; GO:0017148; GO:0032580; GO:0034485; GO:0046855; GO:0046856; GO:1903565 SSAADVTTR 7.46999979 1 1 0.215409113 908.3203596 12.16585 0 0 0 0 15.01511 0 0 12.44804 0 15.01194 12.77996 0 14.54062 0 16.75435 0 0 16.39613 0 15.91891 0 14.16262 0 0 0 0 0 0 16.0437 13.8752 0 15.14285 0 15.43106 0 16.57832 0 0 0 15.1966 0 0 0 0 0 0 0 Q9NRS6 SNX15_HUMAN Sorting nexin-15 SNX15 Homo sapiens (Human) intracellular protein transport [GO:0006886] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886] phosphatidylinositol binding [GO:0035091] GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0030659; GO:0035091; GO:0043231 HYTVSDPR 4.570000172 0.931629419 0.931629419 0.018283473 975.5699768 15.03562 14.68188 9.929601 0 14.47651 14.18641 15.47379 15.85955 0 16.22256 0 0 14.42362 0 0 0 0 0 0 0 0 0 13.96852 13.05191 0 0 0 0 0 0 0 15.28469 16.3442 0 0 0 0 16.83737 15.96749 0 0 0 0 15.17682 0 0 0 0 Q9NRW1 RAB6B_HUMAN "Ras-related protein Rab-6B, EC 3.6.5.2" RAB6B Homo sapiens (Human) "Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynapse [GO:0098793] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] GO:0000139; GO:0003924; GO:0005525; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0007030; GO:0012505; GO:0031410; GO:0031489; GO:0042147; GO:0098793 AKELSVMFIETSAK 8.590000153 1 1 0.111986259 1568.420362 17.46401 0 16.85425 0 18.71844 0 14.57591 16.76671 0 0 17.49877 0 16.37867 17.00343 16.74556 0 17.22378 14.75904 0 0 0 0 20.0206 16.67074 0 16.82937 16.91614 0 14.84741 0 13.73768 0 17.44276 0 0 0 16.67695 0 0 0 17.92873 0 15.38975 13.3729 0 17.20093 16.21815 14.73477 Q9NRW4 DUS22_HUMAN "Dual specificity protein phosphatase 22, EC 3.1.3.16, EC 3.1.3.48 (JNK-stimulatory phosphatase-1, JSP-1) (Low molecular weight dual specificity phosphatase 2, LMW-DSP2) (Mitogen-activated protein kinase phosphatase x, MAP kinase phosphatase x, MKP-x)" DUSP22 JSP1 LMWDSP2 MKPX Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GO:0000122; GO:0002710; GO:0004722; GO:0004725; GO:0004726; GO:0005737; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0030336; GO:0031941; GO:0035335; GO:0042127; GO:0046330; GO:0050860; GO:0050868; GO:0051895; GO:0061851; GO:0071364; GO:1903996; GO:1990782 DAEQLSKNK 6.110000134 1 1 1.15E-12 1028.836554 0 0 0 0 0 0 12.14701 0 0 0 16.20848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.50341 0 0 0 0 14.30814 0 0 0 0 0 0 14.93215 0 0 0 0 0 0 0 0 0 Q9NRX1 PNO1_HUMAN RNA-binding protein PNO1 (Partner of NOB1) PNO1 Homo sapiens (Human) cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0005829 GDHLSRAIGR 1.809999943 0.982273936 0.982273936 0.188238581 1078.367649 15.25206 14.61493 15.91367 13.66072 0 0 0 14.69368 0 11.10282 15.81782 0 15.67747 16.74971 13.28482 16.13453 15.51374 15.26567 0 0 0 17.29071 0 0 0 17.2294 0 17.20271 15.75837 0 15.44665 16.04837 0 0 16.84145 15.38423 0 0 0 0 0 0 15.14105 15.4902 0 14.55127 0 0 Q9NRX2 RM17_HUMAN "39S ribosomal protein L17, mitochondrial, L17mt, MRP-L17 (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m)" MRPL17 LIP2 Homo sapiens (Human) mitochondrial translation [GO:0032543] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0015934; GO:0019904; GO:0032543 AKMAVIEYK 2.809999943 1 1 0.646370738 1069.41604 0 0 0 0 0 0 0 0 0 0 18.30019 17.57544 0 0 0 0 0 0 17.52148 17.30674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRX3 NUA4L_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 (NADH-ubiquinone oxidoreductase MLRQ subunit homolog, NUOMS)" NDUFA4L2 Homo sapiens (Human) mitochondrial respiratory chain complex IV [GO:0005751] mitochondrial respiratory chain complex IV [GO:0005751] GO:0005751 AGASLGARFYR 4.380000114 1 1 0.076113264 1168.274223 15.0115 14.8747 15.68844 0 0 0 14.25105 0 15.67875 17.60916 15.75074 15.44155 12.41102 15.48069 14.12117 16.27623 0 16.66022 15.46802 15.81726 0 0 0 0 16.39528 0 0 0 15.53561 0 15.80035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3194 0 Q9NRY4 RHG35_HUMAN "Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1, GRF-1) (Rho GAP p190A, p190-A)" ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP Homo sapiens (Human) "axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]" actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]" DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007165; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0031668; GO:0032794; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0044877; GO:0045724; GO:0050770; GO:0051056; GO:0097485 AQSNGSGNGSDSEMDTSSLER 4.960000038 1 1 1.83E-12 2128.118723 0 0 14.75396 0 17.07479 16.15744 12.96723 12.68856 0 13.30935 16.90168 14.92964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRY5 F1142_HUMAN Protein FAM114A2 FAM114A2 C5orf3 Homo sapiens (Human) purine nucleotide binding [GO:0017076] purine nucleotide binding [GO:0017076] GO:0017076 GLMNR 1.070000052 1 1 0.250538943 606.1756144 15.78794 14.73436 0 0 0 0 0 16.45798 0 0 0 0 15.67093 16.00715 0 15.07814 0 13.88198 17.2245 16.88599 0 15.67833 0 0 0 0 15.87074 0 0 0 15.64051 15.91645 15.13533 0 14.71874 15.53414 17.07496 16.833 0 15.02934 16.75615 14.9867 16.3647 17.58776 16.83076 17.52925 15.50254 17.1239 Q9NRZ5 PLCD_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase delta, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 4, 1-AGP acyltransferase 4, 1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta, LPAAT-delta)" AGPAT4 UNQ499/PRO1016 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746 MDLAGLLK 7.510000229 0.305666536 0.305666536 0.108562506 875.1021611 0 0 0 15.79236 0 0 16.16292 0 16.67213 0 14.43673 0 16.05675 0 13.71129 17.54548 0 14.45241 0 15.93541 13.48169 16.24617 12.93023 0 0 16.84634 13.07055 16.00943 12.11172 0 16.39678 0 0 15.08702 0 13.4318 16.96484 15.05642 16.54363 16.58331 0 0 0 0 0 15.37724 15.70901 15.83962 Q9NRZ9 HELLS_HUMAN "Lymphoid-specific helicase, EC 3.6.4.- (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6)" HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508] "chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]" ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787] GO:0000775; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006346; GO:0007049; GO:0010216; GO:0016787; GO:0031508; GO:0046651; GO:0051301; GO:0140658; GO:1990830; GO:2001243 FLLTKMEQQQLEEQK 1.769999981 1 1 9.20E-13 1893.322877 0 14.8056 13.89563 0 0 15.14548 15.31983 0 16.02099 15.77094 0 0 14.64569 0 14.176 12.12633 15.30569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS00 C1GLT_HUMAN "Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, EC 2.4.1.122 (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1, Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1, C1GalT1, Core 1 beta3-Gal-T1)" C1GALT1 Homo sapiens (Human) "angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]" glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872] GO:0000139; GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872; GO:0060576 CNKVLFMSSEENK 8.649999619 1 1 0.058256071 1601.14782 0 0 16.1368 15.62936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS15 LTBP3_HUMAN "Latent-transforming growth factor beta-binding protein 3, LTBP-3" LTBP3 Homo sapiens (Human) bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179] calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431] GO:0005509; GO:0005576; GO:0007179; GO:0030502; GO:0032331; GO:0036363; GO:0045780; GO:0046849; GO:0048251; GO:0050431; GO:0060349; GO:0060430; GO:0062023; GO:0070062; GO:1902462; GO:2000741 CVNLPGSYR 2.640000105 1 1 0.279616427 1066.561731 0 0 17.19191 0 16.88273 0 0 0 0 16.35667 17.49731 0 16.88595 17.10816 0 0 14.46504 0 0 15.98596 0 0 0 0 0 16.80244 0 0 0 0 18.81183 0 18.89325 17.64126 0 0 0 18.27299 17.00825 0 0 0 0 0 0 0 0 0 Q9NS37 ZHANG_HUMAN "CREB/ATF bZIP transcription factor (Host cell factor-binding transcription factor Zhangfei, HCF-binding transcription factor Zhangfei)" CREBZF ZF Homo sapiens (Human) "ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]; ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0009615; GO:0036500; GO:0042802; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0090575; GO:0140467 AVLANETGLARLLSR 12.47000027 1 1 0.299638226 1581.227941 0 16.51334 15.62675 16.12809 0 0 0 17.06399 0 0 0 0 0 16.71142 0 15.63313 0 0 0 0 0 0 0 15.65898 0 0 0 16.05863 0 0 0 15.12078 16.76438 15.57583 0 0 16.29151 0 0 0 0 0 0 0 0 0 0 0 Q9NS40 KCNH7_HUMAN "Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3, ERG-3, Eag-related protein 3, Ether-a-go-go-related protein 3, hERG-3) (Voltage-gated potassium channel subunit Kv11.3)" KCNH7 ERG3 Homo sapiens (Human) circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249] GO:0005242; GO:0005249; GO:0005886; GO:0005887; GO:0007623; GO:0034765; GO:0042391; GO:0044877; GO:0071805; GO:0086011 ESCSPSEADDTK 11.96000004 1 1 0.021824413 1326.336504 11.00633 14.43952 0 0 0 0 0 0 13.77656 0 0 0 0 0 0 0 12.32027 0 14.22335 15.01425 14.27682 15.59473 0 11.77014 15.34256 0 12.87546 0 0 0 0 0 0 0 0 16.19397 0 12.81655 0 0 0 0 0 0 0 0 0 0 Q9NS56 TOPRS_HUMAN "E3 ubiquitin-protein ligase Topors, EC 2.3.2.27 (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3, p53-binding protein 3, p53BP3)" TOPORS LUN TP53BPL Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]" centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151] "centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]" antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006351; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0010842; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0030496; GO:0032391; GO:0034504; GO:0035845; GO:0036064; GO:0042127; GO:0042771; GO:0043066; GO:0043161; GO:0044547; GO:0045893; GO:0046548; GO:0046549; GO:0046872; GO:0051443; GO:0051457; GO:0061630; GO:0070936 DCDMS 22.14999962 0.557988763 0.557988763 0.116842493 627.6446642 14.69895 11.28121 17.43236 0 0 0 0 0 14.80879 8.375754 16.68566 14.58976 10.66175 0 15.00035 15.71733 17.62658 15.50859 0 0 0 14.18324 11.87898 17.53711 15.70381 17.57048 15.50489 0 0 14.57525 16.88239 16.45466 15.94924 15.64426 17.78364 0 16.53686 15.80532 15.80937 15.22637 0 12.42532 14.06241 0 14.66694 16.86999 14.36171 17.0369 Q9NS62 THSD1_HUMAN Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module) THSD1 TMTSP UNQ3010/PRO9769 Homo sapiens (Human) focal adhesion assembly [GO:0048041] cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021] cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; extracellular matrix binding [GO:0050840]; focal adhesion assembly [GO:0048041] extracellular matrix binding [GO:0050840] GO:0005576; GO:0005768; GO:0005829; GO:0005925; GO:0010008; GO:0016021; GO:0048041; GO:0050840; GO:0071944 GPSPSHKSVSR 5.489999771 0.606721163 0.606721163 0.257097671 1138.126865 14.79092 0 13.39311 15.09752 14.4206 14.41164 0 0 0 0 0 13.58374 14.71757 0 0 0 0 16.47614 12.74061 15.95464 14.36011 15.41649 0 0 0 0 15.45388 14.83885 15.23916 13.69553 0 15.96241 13.52106 16.07865 14.96688 0 13.68524 15.79474 15.27856 15.45819 14.7209 0.2015113 15.78156 14.85793 15.73481 14.85742 15.62244 14.3207 Q9NS64 RPRM_HUMAN Protein reprimo RPRM Homo sapiens (Human) regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346] GO:0005737; GO:0007346; GO:0016021; GO:0051726 SEGMINFLVK 5.460000038 1 1 0.008369389 1152.148689 0 0 14.15397 15.3913 11.11469 13.7604 12.17995 0 0 0 16.28027 15.45365 0 14.29233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3152 0 0 0 0 13.43453 0 0 0 0 0 0 0 12.49788 12.40757 13.81499 0 0 0 Q9NS66 GP173_HUMAN Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3) GPR173 SREB3 Homo sapiens (Human) negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165] G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968] GO:0004930; GO:0004968; GO:0005886; GO:0007165; GO:0016021; GO:2001223 YMAIAHHRFYAK 2.140000105 1 1 0.473292852 1522.746674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.58931 16.86068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.96166 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS75 CLTR2_HUMAN "Cysteinyl leukotriene receptor 2, CysLTR2 (G-protein coupled receptor GPCR21, hGPCR21) (G-protein coupled receptor HG57) (HPN321)" CYSLTR2 CYSLT2 CYSLT2R PSEC0146 Homo sapiens (Human) cellular response to glucagon stimulus [GO:0071377]; immune response [GO:0006955]; neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; guanyl-nucleotide exchange factor activity [GO:0005085]; leukotriene receptor activity [GO:0004974]; cellular response to glucagon stimulus [GO:0071377]; immune response [GO:0006955]; neuropeptide signaling pathway [GO:0007218] cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; guanyl-nucleotide exchange factor activity [GO:0005085]; leukotriene receptor activity [GO:0004974] GO:0001631; GO:0004974; GO:0005085; GO:0005886; GO:0005887; GO:0006955; GO:0007218; GO:0008528; GO:0071377 GHPQKAK 1.24000001 0.477744579 0.477744579 0.075901278 764.4578404 17.67916 0 11.33954 0 0 0 0 0 0 14.73757 16.44211 16.1898 0 15.21792 13.58456 0 15.86098 0 0 15.54336 0 15.93566 15.22009 17.75864 14.32995 13.79888 0 0 0 15.21897 16.72915 16.72078 15.69523 0 16.2271 0 0 16.47584 17.22851 0 13.56361 0 0 0 0 0 0 15.67375 Q9NS87 KIF15_HUMAN "Kinesin-like protein KIF15 (Kinesin-like protein 2, hKLP2) (Kinesin-like protein 7) (Serologically defined breast cancer antigen NY-BR-62)" KIF15 KLP2 KNSL7 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; regulation of mitotic spindle assembly [GO:1901673] centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; regulation of mitotic spindle assembly [GO:1901673] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0007018; GO:0008017; GO:0016020; GO:0016887; GO:1901673 NAEILRMK 6.010000229 0.448309243 0.448309243 0.29891453 991.3746312 17.87475 0 0 0 0 0 0 0 0 0 0 0 16.12763 0 17.25407 0 16.15104 0 16.95474 0 0 0 0 0 0 17.53124 0 0 0 0 17.8958 0 0 0 0 0 19.94599 0 0 18.11076 0 0 17.38287 0 0 0 16.9574 19.60031 Q9NS91 RAD18_HUMAN "E3 ubiquitin-protein ligase RAD18, EC 2.3.2.27 (Postreplication repair protein RAD18, hHR18, hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18)" RAD18 RNF73 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513] damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403] GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0044877; GO:0046872; GO:0051865; GO:0051984; GO:0060548; GO:0061630; GO:0097505 AAESAEIEPR 4.550000191 1 1 9.19E-13 1069.600854 13.17956 0 0 12.56937 14.8916 0 0 0 0 0 9.763923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.57718 0 0 0 0 17.0628 0 11.60222 0 0 0 Q9NSA0 S22AB_HUMAN Solute carrier family 22 member 11 (Organic anion transporter 4) SLC22A11 OAT4 Homo sapiens (Human) organic anion transport [GO:0015711]; urate metabolic process [GO:0046415] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; organic anion transport [GO:0015711]; urate metabolic process [GO:0046415] inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] GO:0005452; GO:0005886; GO:0005887; GO:0008514; GO:0009897; GO:0015347; GO:0015711; GO:0016324; GO:0046415; GO:0070062 NLTIEVLMSSVK 3.710000038 1 1 0 1348.134905 0 15.31756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSA2 KCND1_HUMAN Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1) KCND1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076] dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005250; GO:0005886; GO:0008076; GO:0014069; GO:0016021; GO:0034765; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805 DPDMFR 7.659999847 0.311023623 0.311023623 0.245142219 781.0398867 0 0 0 0 0 0 0 0 15.15547 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8012 0 15.17771 13.92748 14.61683 15.49244 13.97453 0 0 0 14.33344 16.08269 15.75151 15.66942 15.50521 0 15.96823 0 0 16.5122 16.08168 15.80682 16.63046 15.83486 16.72988 16.83565 Q9NSB4 KRT82_HUMAN "Keratin, type II cuticular Hb2 (Keratin-82, K82) (Type II hair keratin Hb2) (Type-II keratin Kb22)" KRT82 KRTHB2 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280] structural constituent of skin epidermis [GO:0030280] GO:0005829; GO:0030280; GO:0045095 CGGTLPGFGYR 3.99000001 0.908463418 0.908463418 0.349148476 1185.026011 13.17828 0 0 0 0 0 0 0 0 0 0 0 7.756369 0 14.8874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9474 0 0 0 0 0 0 0 0 0 0 Q9NSB8 HOME2_HUMAN "Homer protein homolog 2, Homer-2 (Cupidin)" HOMER2 Homo sapiens (Human) behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; synaptic receptor adaptor activity [GO:0030160]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605] actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; synaptic receptor adaptor activity [GO:0030160] GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035256; GO:0035584; GO:0043229; GO:0045177; GO:0048148; GO:0048875; GO:0070885; GO:0098978; GO:2001256 IISVDGAK 8.619999886 1 1 0.316864005 801.7803626 13.91539 13.66681 0 14.83423 0 0 0 0 11.73112 0 0 0 12.84963 0 0 0 0 0 0 15.86885 0 0 0 11.94425 17.08817 13.45405 14.59631 0 0 14.26821 0 0 15.23199 15.75792 0 0 0 15.74161 0 0 0 13.68443 15.80545 0 15.01394 0 13.37168 0 Q9NSC2 SALL1_HUMAN "Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1, HSal1, Sal-1)" SALL1 SAL1 ZNF794 Homo sapiens (Human) "adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]" chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]" "beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000792; GO:0000978; GO:0000981; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092 AFTTKGNLK 13 0.831935763 0.831935763 0.135128366 977.6086172 15.46339 15.18764 13.42605 0 0 0 15.58001 0 0 14.54189 15.41138 15.32644 14.92802 14.20282 15.06177 0 0 0 0 0 0 14.7905 0 15.33816 15.24063 16.79006 15.2622 15.34445 16.08706 13.49014 14.59262 0 14.46757 0 15.56109 16.1647 13.94586 16.22472 15.47421 0 13.58371 15.78586 15.04189 15.70044 0 11.18183 0 0 Q9NSC7 SIA7A_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, EC 2.4.99.3 (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I, ST6GalNAcI) (Sialyltransferase 7A, SIAT7-A)" ST6GALNAC1 SIAT7A UNQ543/PRO848 Homo sapiens (Human) oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" "alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]" GO:0000139; GO:0001665; GO:0006486; GO:0008373; GO:0009312; GO:0016021 MLAPTGAVSTR 4.989999771 1 1 0.329288186 1103.020969 16.84158 15.7308 13.90679 0 0 14.6359 15.53208 0 15.05094 0 0 15.26178 0 0 0 0 0 0 0 16.33115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.68699 16.14816 16.81404 0 0 0 0 0 0 Q9NSD7 RL3R1_HUMAN "Relaxin-3 receptor 1, RLN3 receptor 1 (G protein-coupled receptor SALPR) (G-protein coupled receptor GPCR135) (Relaxin family peptide receptor 3) (Somatostatin- and angiotensin-like peptide receptor)" RXFP3 GPCR135 RLN3R1 SALPR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467] G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0008528; GO:0032467 AMCKIVSMVTSMNMYASVFFLTAMSVTR 2.809999943 0.946467996 0.946467996 0.196784047 3239.617295 0 16.78696 0 0 0 15.45532 14.89849 15.00292 0 0 0 13.41299 15.21089 9.545285 0 0 0 0 0 13.60156 14.00185 0 0 0 0 0 0 16.10488 0 0 0 0 0 0 0 0 0 14.93767 0 0 0 0 0 12.94443 12.48631 0 0 0 Q9NSD9 SYFB_HUMAN "Phenylalanine--tRNA ligase beta subunit, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase beta subunit, PheRS)" FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723] GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006432; GO:0009328; GO:0016020; GO:0051290 NPGFEIIHGLLDRIMQLLDVPPGEDK 12.22999954 1 1 1.84E-12 2932.306464 14.1434 0 0 13.31883 0 0 12.43422 11.35337 0 15.26379 13.47365 12.6012 0 13.80598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSE4 SYIM_HUMAN "Isoleucine--tRNA ligase, mitochondrial, EC 6.1.1.5 (Isoleucyl-tRNA synthetase, IleRS)" IARS2 Homo sapiens (Human) isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006428; GO:0032543 ARSFAK 9.909999847 0.469910502 0.469910502 0.198076403 677.2445617 0 0 13.58954 0 0 14.07882 0 16.49541 0 0 0 0 0 16.01089 0 0 0 0 0 0 0 0 16.35921 0 0 0 17.58522 16.61685 0 0 18.00388 11.85546 13.95448 16.44178 18.46707 16.67911 0 0 18.68512 15.15845 0 17.55589 16.4609 0 15.8815 0 0 15.15063 Q9NSI6 BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007010; GO:0008360 ELSSGNESSSSVR 2.819999933 1 1 0.020063244 1338.544813 0 0 0 0 0 0 10.48819 0 0 14.72497 0 0 14.94863 0 0 0 0 0 0 0 0 0 0 0 15.6413 15.42839 0 0 0 0 0 15.03906 0 0 0 0 0 10.54373 0 0 0 0 0 0 0 16.12624 0 0 Q9NSI8 SAMN1_HUMAN "SAM domain-containing protein SAMSN-1 (Hematopoietic adaptor containing SH3 and SAM domains 1) (Nash1) (SAM domain, SH3 domain and nuclear localization signals protein 1) (SH3-SAM adaptor protein)" SAMSN1 HACS1 Homo sapiens (Human) negative regulation of adaptive immune response [GO:0002820]; negative regulation of B cell activation [GO:0050869]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ruffle [GO:0001726]; phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of B cell activation [GO:0050869]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732] phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723] GO:0001726; GO:0001784; GO:0002820; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0050732; GO:0050869 GDIIDIICKTPMGMWTGMLNNK 5.21999979 0.895820737 0.895820737 0.092560268 2559.281319 0 13.02889 14.35634 14.41385 0 0 0 0 16.043 0 0 13.37792 0 0 15.82764 0 0 0 15.17493 0 0 0 0 0 0 0 0 0 0 12.70837 13.89128 0 0 15.44123 0 15.62537 15.5179 0 0 13.65575 0 0 0 16.04478 0 15.77641 0 0 Q9NSJ1 Z355P_HUMAN Putative zinc finger protein 355P (Zinc finger protein ZnFP01) ZNF355P ZNF834 PRED65 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 DCGKIFK 7.329999924 1 1 0.161261317 866.4045356 18.88686 14.23134 0 17.76211 0 15.64667 0 17.08147 15.86269 0 17.73649 16.59731 17.16186 0 15.88096 0 16.89148 0 17.38538 16.56761 13.84449 0 16.97186 0 0 0 16.66004 0 14.04128 0 12.66541 17.66936 14.63466 17.64877 17.30572 18.16193 18.38706 0 14.49565 13.60069 0 15.48792 16.44689 17.02921 12.65096 16.7413 0 17.54783 Q9NSK0 KLC4_HUMAN "Kinesin light chain 4, KLC 4 (Kinesin-like protein 8)" KLC4 KNSL8 Homo sapiens (Human) cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] GO:0005737; GO:0005871; GO:0005874 RSSELLVR 2.849999905 1 1 0.250596728 958.9177755 15.97937 15.54892 15.32644 11.13847 0 14.17516 13.02507 13.64291 9.95682 15.82761 13.9024 15.51395 0 13.97844 15.6478 14.07439 12.89888 14.28142 0 13.60144 6.897024 0 10.98684 13.60278 0 0 14.33337 15.26249 15.39569 16.57829 16.04835 13.27426 0 12.30712 13.96523 13.6223 14.94838 0 16.40445 15.34017 0 0 7.87948 12.9666 14.97948 0 0 0 Q9NSN8 SNTG1_HUMAN "Gamma-1-syntrophin, G1SYN (Syntrophin-4, SYN4)" SNTG1 Homo sapiens (Human) cell communication [GO:0007154] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]; cell communication [GO:0007154] actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198] GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0007154; GO:0008022; GO:0016010; GO:0016013; GO:0032587 NAGEEVTLTVSFLKR 6.179999828 1 1 0.040504595 1663.256605 0 0 15.13662 0 0 0 0 0 0 0 0 13.45108 0 15.02938 0 13.30036 0 0 14.87888 0 0 0 0 0 15.76614 0 13.68989 0 0 0 17.61677 0 0 0 0 0 0 16.33672 0 0 0 0 15.32924 0 0 0 0 0 Q9NSU2 TREX1_HUMAN "Three-prime repair exonuclease 1, EC 3.1.11.2 (3'-5' exonuclease TREX1) (Deoxyribonuclease III, DNase III)" TREX1 Homo sapiens (Human) "activation of immune response [GO:0002253]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to reactive oxygen species [GO:0034614]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response in brain or nervous system [GO:0002383]; inflammatory response to antigenic stimulus [GO:0002437]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; metal ion binding [GO:0046872]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]; activation of immune response [GO:0002253]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to reactive oxygen species [GO:0034614]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response in brain or nervous system [GO:0002383]; inflammatory response to antigenic stimulus [GO:0002437]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]" "3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; metal ion binding [GO:0046872]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]" GO:0000287; GO:0000738; GO:0001568; GO:0001822; GO:0002253; GO:0002281; GO:0002320; GO:0002383; GO:0002437; GO:0002457; GO:0002637; GO:0003007; GO:0003015; GO:0003228; GO:0003690; GO:0003697; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0006091; GO:0006110; GO:0006259; GO:0006260; GO:0006281; GO:0006298; GO:0006304; GO:0006310; GO:0008250; GO:0008296; GO:0008301; GO:0008340; GO:0008408; GO:0008853; GO:0019217; GO:0031571; GO:0032197; GO:0032405; GO:0032407; GO:0032479; GO:0032508; GO:0032558; GO:0032680; GO:0032993; GO:0034614; GO:0035458; GO:0035781; GO:0042803; GO:0043277; GO:0043457; GO:0043596; GO:0045184; GO:0045824; GO:0046872; GO:0046890; GO:0050699; GO:0050727; GO:0050790; GO:0050821; GO:0050863; GO:0051607; GO:0060337; GO:0060339; GO:0061635; GO:0071480; GO:0072711; GO:0097281; GO:1904161; GO:1905671 NTSPSLGESR 1.24000001 1 1 0.243349187 1048.253794 0 0 14.94815 14.94575 14.94474 14.05409 15.04137 15.02798 0 0 15.9247 0 14.36222 0 0 0 14.44682 16.60538 0 14.5243 15.03393 14.22336 16.64681 0 0 16.27207 0 0 14.07587 14.00369 16.73361 0 0 0 0 0 15.45175 0 15.96432 0 15.21127 0 14.60697 14.90901 0 0 0 15.07661 Q9NT62 ATG3_HUMAN "Ubiquitin-like-conjugating enzyme ATG3, EC 2.3.2.- (Autophagy-related protein 3, APG3-like, hApg3) (Protein PC3-96)" ATG3 APG3 APG3L Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017] cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829] cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017] Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787] GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0006464; GO:0006612; GO:0016567; GO:0019776; GO:0019777; GO:0019787; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017 IVEACK 6.03000021 0.563812077 0.563812077 0.229932894 721.0937904 0 14.76621 16.16847 0 0 0 17.02917 0 0 0 0 0 0 0 0 0 16.65565 15.03667 16.73297 0 0 0 0 0 0 14.42651 0 0 17.4027 0 0 0 17.12348 16.19753 17.02244 0 17.99268 16.51388 0 0 0 16.83453 0 16.93349 16.32789 15.40772 0 16.78824 Q9NT99 LRC4B_HUMAN "Leucine-rich repeat-containing protein 4B (Netrin-G3 ligand, NGL-3)" LRRC4B LRIG4 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; signaling receptor binding [GO:0005102]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] signaling receptor binding [GO:0005102] GO:0005102; GO:0005886; GO:0042734; GO:0044300; GO:0051965; GO:0098978; GO:0099061; GO:0099151; GO:0099560; GO:1905606 CRTGTSMTSVNWLTPNGTLMTHGSYR 9.670000076 1 1 2.75E-12 2944.386287 16.17621 0 15.24603 15.51092 16.2732 0 15.05949 14.52906 0 0 0 0 0 15.31817 0 0 0 0 0 0 0 14.51183 0 0 0 0 0 0 0 14.99362 0 12.64116 0 0 14.38252 0 0 10.62949 0 13.35117 10.06491 0 0 0 0 0 0 0 Q9NTG1 PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein (PKD and REJ homolog) PKDREJ Homo sapiens (Human) acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509] GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0016021; GO:0050982 MRPGPALLLLGVGLSLSVGR 6.929999828 1 1 0.161320173 2023.056954 14.6311 17.07281 0 0 10.95965 14.19184 13.81717 0 14.19749 0 0 0 0 0 0 15.6138 0 9.942275 0 0 0 0 15.50992 0 0 15.11238 15.03093 13.74378 0 0 0 0 0 0 0 16.13745 0 0 14.74377 0 0 0 0 0 15.44484 0 0 0 Q9NTG7 SIR3_HUMAN "NAD-dependent protein deacetylase sirtuin-3, mitochondrial, hSIRT3, EC 2.3.1.286 (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)" SIRT3 SIR2L3 Homo sapiens (Human) aerobic respiration [GO:0009060]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476] NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] GO:0003950; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0008270; GO:0009060; GO:0017136; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070403; GO:1901671; GO:1902553; GO:2000304 VSGIPASK 10.72000027 0.315258443 0.315258443 0.265123623 759.0925478 16.03393 15.77368 0 10.00897 15.30466 15.80278 16.62234 0 16.1721 15.72205 0 14.11841 16.88664 15.64587 0 0 17.18892 16.36377 15.74357 16.71419 0 0 0 17.29881 16.21416 17.95823 16.06381 16.3192 15.63978 0 0 0 0 16.74776 0 17.37332 0 16.9988 16.65487 15.92919 17.36591 0 16.33383 0 0 0 0 0 Q9NTI5 PDS5B_HUMAN Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3) PDS5B APRIN AS3 KIAA0979 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]" DNA binding [GO:0003677] GO:0000775; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0007064; GO:0008283; GO:0008285; GO:0042127; GO:0051301 EAMMGLAQIYK 6.300000191 1 1 0.199914672 1253.498168 15.85244 0 13.48312 13.8115 0 14.8408 13.20621 14.8141 13.11551 15.22171 0 16.23467 0 15.84487 0 0 14.76656 0 0 0 0 14.74265 0 0 0 0 15.0645 16.61365 0 0 16.23683 0 15.6958 0 13.86584 0 0 0 12.03617 16.13916 16.01431 0 0 0 0 0 0 0 Q9NTJ5 SAC1_HUMAN "Phosphatidylinositol-3-phosphatase SAC1, EC 3.1.3.64 (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)" SACM1L KIAA0851 SAC1 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812] GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0006661; GO:0016021; GO:0016791; GO:0034596; GO:0043812; GO:0046856; GO:0140268 THLGLIMDGWNSMIR 6.869999886 1 1 1.60E-12 1759.516415 0 0 0 0 10.90954 0 0 0 0 0 0 0 0 15.7075 0 15.37643 15.84529 0 16.48946 16.0353 16.22424 16.89964 15.75931 16.06632 0 14.8405 0 0 15.70324 16.4467 0 0 12.3578 17.04918 14.17922 12.15471 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTN3 S35D1_HUMAN "UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, UDP-GlcA/UDP-GalNAc transporter (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7, UGTrel7)" SLC35D1 KIAA0260 UGTREL7 Homo sapiens (Human) carbohydrate transport [GO:0008643] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643] antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] GO:0005461; GO:0005462; GO:0005463; GO:0005789; GO:0005794; GO:0008643; GO:0015297; GO:0016021 LLAAGFYGVSSFLIVVVNK 3.119999886 1 1 0.726705642 1995.581583 0 0 0 0 0 0 0 17.60942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTZ6 RBM12_HUMAN "RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus, SWAN)" RBM12 KIAA0765 HRIHFB2091 Homo sapiens (Human) regulation of RNA splicing [GO:0043484] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0043484; GO:1990904 NNGNGLVK 16.17000008 1 1 0.277854749 812.0314617 17.16244 16.37928 14.87354 15.53079 0 13.89567 15.50007 0 14.80711 0 15.42966 0 16.65693 15.82967 15.61457 0 0 16.57343 0 15.45323 0 0 0 0 0 0 16.3185 14.89054 15.99128 16.62282 17.81029 16.76402 16.72161 16.08823 14.54039 15.5231 15.63206 13.33401 15.39321 16.22991 16.76261 16.4925 17.3943 0 17.31231 16.18081 12.38263 15.5048 Q9NU02 ANKE1_HUMAN Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5) ANKEF1 ANKRD5 Homo sapiens (Human) calcium ion binding [GO:0005509] calcium ion binding [GO:0005509] GO:0005509 GKTPPILK 9.300000191 0.036701348 0.036701348 0.239938011 853.5010655 17.57523 12.76454 13.29642 14.91733 14.68626 15.83161 0 0 0 0 0 15.97503 0 0 0 16.76964 15.98735 0 15.06202 0 0 15.4541 16.2517 0 0 0 0 0 15.60868 0 0 15.16453 17.33807 0 0 0 0 0 0 0 0 0 19.17965 0 0 0 0 0 Q9NU22 MDN1_HUMAN Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) MDN1 KIAA0301 Homo sapiens (Human) ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] "cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016020; GO:0016887; GO:0030687; GO:0045111 AEFAK 9.260000229 1 1 0.2398098 562.0692249 16.79114 18.83076 0 0 16.9409 0 0 17.75825 17.58134 0 16.31112 0 0 0 0 0 16.7977 0 0 16.84436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.13116 0 0 0 17.61972 0 0 0 0 0 0 Q9NU53 GINM1_HUMAN Glycoprotein integral membrane protein 1 GINM1 C6orf72 UNQ710/PRO1361 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MEGAPPGSLALR 3.349999905 1 1 0.270710686 1213.787764 7.897054 12.07675 15.75149 14.45565 14.37351 13.88018 0 9.328765 0 0 16.46012 0 15.37294 12.33416 0 0 0 0 0 0 16.27834 0 0 0 15.66545 14.96767 15.61984 14.14736 0 0 16.24042 0 0 0 0 0 15.90812 0 0 0 0 0 16.5075 16.70987 0 17.12642 0 0 Q9NUB1 ACS2L_HUMAN "Acetyl-coenzyme A synthetase 2-like, mitochondrial, EC 6.2.1.1 (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2, AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase, EC 6.2.1.17)" ACSS1 ACAS2L KIAA1846 Homo sapiens (Human) acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542] acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218] GO:0003987; GO:0005524; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218 YDRSSLR 1.049999952 1 1 0.157802989 898.1322965 0 0 0 0 0 14.21585 0 0 0 0 0 11.15787 15.32216 0 0 0 0 0 0 16.00613 0 0 0 0 0 14.51645 16.21016 15.19414 14.25306 14.46764 0 15.05974 16.42565 0 0 12.83489 0 0 0 0 16.15031 14.72402 15.7534 0 15.93892 0 0 13.59573 Q9NUB4 CT141_HUMAN Uncharacterized protein C20orf141 C20orf141 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EDPIPVPPR 20.31999969 1 1 1.03E-12 1015.433307 0 0 14.35519 0 15.6599 14.73361 0 0 15.31648 0 0 0 0 0 0 14.79191 0 13.71023 15.32275 0 0 15.27095 0 0 0 0 0 14.24337 0 0 0 0 15.28739 13.96228 12.21009 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUD5 ZCHC3_HUMAN Zinc finger CCHC domain-containing protein 3 ZCCHC3 C20orf99 Homo sapiens (Human) activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0002218; GO:0003690; GO:0003723; GO:0005737; GO:0008270; GO:0009597; GO:0032481; GO:0045087; GO:0051607; GO:0071360; GO:1900246 TCFKCGSR 5.130000114 0.88512063 0.88512063 0.146822563 1014.875234 15.46722 0 0 0 0 0 13.78287 13.20283 0 0 0 0 0 0 0 0 14.72012 15.66455 0 0 13.26049 0 0 18.02279 0 0 14.22869 16.2571 13.52845 16.3304 16.46308 13.76398 0 14.73331 10.34484 15.7589 0 0 0 0 0 0 0 0 0 0 14.34192 0 Q9NUD7 CT096_HUMAN Uncharacterized protein C20orf96 C20orf96 Homo sapiens (Human) KVLESLSDK 11.61999989 0.462036759 0.462036759 0.293103909 1023.52966 15.76827 15.92924 0 0 0 0 0 0 15.39528 0 0 0 14.58074 12.65809 11.59764 15.76548 12.23518 15.9325 0 0 14.68658 0 14.39486 16.4555 13.77922 14.10658 15.56765 0 14.32616 14.77691 15.92439 15.40806 0 14.81972 15.88076 14.8611 0 10.85561 0 15.63238 14.65218 15.22011 0 0 0 10.89303 11.14974 0 Q9NUE0 ZDH18_HUMAN "Palmitoyltransferase ZDHHC18, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 18, DHHC-18) (Zinc finger DHHC domain-containing protein 18)" ZDHHC18 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706 AKPDASMVGGHP 6.820000172 1 1 0.015501987 1165.727842 0 15.86527 0 0 0 15.81116 0 0 0 0 0 0 16.35606 0 0 14.0072 0 0 16.18892 17.40402 0 0 0 0 0 16.47444 16.74209 14.98289 15.62132 15.90235 15.72946 0 14.89759 0 15.57809 16.60421 16.87073 0 0 15.17198 15.14229 15.60155 0 0 0 0 0 14.7666 Q9NUG4 CCM2L_HUMAN "Cerebral cavernous malformations 2 protein-like, CCM2-like" CCM2L C20orf160 Homo sapiens (Human) heart morphogenesis [GO:0003007] heart morphogenesis [GO:0003007] GO:0003007 DNEELILR 4.400000095 1 1 9.14E-13 1001.50434 13.86243 14.89229 0 0 13.69777 14.66937 12.48925 0 0 0 12.59823 11.73012 12.42146 0 0 13.58893 14.41792 13.55682 13.00185 0 0 13.08772 16.24797 0 13.80514 12.55434 0 15.09111 13.92063 12.71724 16.38156 0 0 0 0 0 16.43887 0 0 15.953 15.11154 13.52788 0 0 0 0 0 0 Q9NUG6 PDRG1_HUMAN p53 and DNA damage-regulated protein 1 PDRG1 C20orf126 PDRG Homo sapiens (Human) protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821] unfolded protein binding [GO:0051082] GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0101031; GO:1990062 QIVDLDTK 6.980000019 1 1 0.133812781 932.451466 0 0 0 14.6744 0 13.62971 0 0 0 14.76549 15.6679 10.15134 0 15.23159 0 15.63176 0 0 0 17.3742 0 17.78354 0 17.08467 14.6433 0 0 16.8905 0 0 0 0 16.86391 0 16.65001 17.74693 0 19.63428 0 0 13.21658 17.28112 0 0 0 16.81204 16.31523 0 Q9NUL3 STAU2_HUMAN Double-stranded RNA-binding protein Staufen homolog 2 STAU2 Homo sapiens (Human) anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468] double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] GO:0003723; GO:0003725; GO:0005730; GO:0005783; GO:0005874; GO:0010468; GO:0010494; GO:0016020; GO:0019894; GO:0030424; GO:0030544; GO:0031965; GO:0032839; GO:0032956; GO:0034599; GO:0043022; GO:0043025; GO:0043198; GO:0048592; GO:0051019; GO:0051489; GO:0051965; GO:0061003; GO:0098964; GO:1900454; GO:1990124 EFVMQVKVGNEVATGTGPNK 4.539999962 0.114951849 0.114951849 0.179080198 2120.667365 14.52524 15.17732 10.6627 0 0 15.22077 0 15.55824 0 15.0928 15.17034 0 0 0 10.70747 0 0 0 0 0 13.10772 0 14.73144 0 0 0 15.39453 14.96943 0 0 0 0 0 14.83683 0 0 0 0 13.03754 10.48336 13.35794 0 13.72324 0 0 0 0 0 Q9NUN5 LMBD1_HUMAN "Lysosomal cobalamin transport escort protein LMBD1, LMBD1 (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein)" LMBRD1 C6orf209 NESI BM-021 CD001 MSTP044 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; cobalamin metabolic process [GO:0009235]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462]; protein localization to vacuole [GO:0072665] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein-membrane adaptor activity [GO:0043495]; clathrin-dependent endocytosis [GO:0072583]; cobalamin metabolic process [GO:0009235]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462]; protein localization to vacuole [GO:0072665] AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein-membrane adaptor activity [GO:0043495] GO:0005158; GO:0005765; GO:0005774; GO:0005789; GO:0005886; GO:0007369; GO:0009235; GO:0016020; GO:0016021; GO:0030136; GO:0031419; GO:0032050; GO:0035612; GO:0038016; GO:0043231; GO:0043495; GO:0045334; GO:0061462; GO:0072583; GO:0072665 NQNGTFK 15.23999977 0.731820345 0.731820345 0.169167741 804.2816006 16.72368 16.25911 15.75406 0 17.39984 16.15347 0 0 17.08658 0 15.85551 17.55714 17.1197 0 16.38692 0 15.10338 0 17.32458 0 0 0 16.95963 15.54079 0 15.29765 0 16.15845 0 16.17643 15.13293 0 15.72112 0 0 0 16.23605 13.56617 0 17.56019 16.24822 0 17.89394 16.82689 17.47259 16.14234 16.54551 0 Q9NUN7 ACER3_HUMAN "Alkaline ceramidase 3, AlkCDase 3, Alkaline CDase 3, EC 3.5.1.-, EC 3.5.1.23 (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase, aPHC)" ACER3 APHC PHCA Homo sapiens (Human) ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270] GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030148; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121 APAADR 4.809999943 0.940635681 0.940635681 0.267448734 601.1163177 16.56249 13.43941 15.34813 14.68367 15.58474 14.87704 15.89092 15.30434 0 0 14.10845 15.40761 0 15.99015 14.20356 0 15.6362 15.30355 15.68528 15.93964 0 0 16.46877 0 0 0 16.22753 15.48507 16.16011 0 15.01083 0 0 16.15393 0 0 16.4063 16.31972 0 15.68623 16.21399 16.27474 16.67387 0 0 0 0 0 Q9NUP7 TRM13_HUMAN "tRNA:m(4)X modification enzyme TRM13 homolog, EC 2.1.1.225 (Coiled-coil domain-containing protein 76)" TRMT13 CCDC76 Homo sapiens (Human) tRNA methylation [GO:0030488] metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488] metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175] GO:0008175; GO:0030488; GO:0046872; GO:0106050 LLIDQGR 30.87000084 0.675828636 0.675828636 0.220831647 811.7637729 18.7398 18.64668 19.31339 16.75531 17.33627 16.84311 14.70703 16.10649 17.84859 16.6632 16.8067 17.02741 18.61564 20.01256 16.42922 18.33451 16.62983 18.07187 17.58214 17.86728 16.83198 17.19997 16.90356 18.46071 18.82142 17.4726 18.1591 16.38995 17.28246 19.83092 19.79274 19.15107 18.49613 0 18.45069 17.29567 19.33461 0 16.76053 17.52941 19.74576 17.29418 17.72237 16.95134 19.13001 16.6131 17.95639 16.83214 Q9NUQ2 PLCE_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 5, 1-AGP acyltransferase 5, 1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon, LPAAT-epsilon)" AGPAT5 Homo sapiens (Human) acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746 KTLPSMLILSGLTAGMLMTDAGR 13.22999954 1 1 3.20E-12 2392.722037 13.94273 13.89263 0 12.81435 14.43327 0 0 13.5833 0 0 0 15.0239 16.68035 0 12.88763 0 0 0 0 16.18805 0 16.47693 0 15.41788 16.09799 0 0 14.73682 0 0 15.36425 13.52065 14.51469 13.88691 13.64068 8.224022 0 0 0 0 0 14.98771 0 0 15.69644 0 0 15.87004 Q9NUQ6 SPS2L_HUMAN "SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein, SGNP)" SPATS2L DNAPTP6 SP1224 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0032991 AANPKMVSSLPSTADPSHQTMPANK 3.160000086 1 1 1.83E-12 2612.97705 0 0 0 0 0 0 0 0 12.46673 15.01111 0 13.22742 0 0 0 0 0 0 14.70408 0 0 0 16.95004 13.83513 0 0 15.45307 0 0 0 0 15.30771 0 0 15.1597 0 0 0 0 15.58149 13.58862 14.31496 14.9288 0 0 0 0 0 Q9NUQ7 UFSP2_HUMAN "Ufm1-specific protease 2, UfSP2, EC 3.4.22.-" UFSP2 C4orf20 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146] thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567] GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0016790; GO:0033146; GO:0071567 SIPTHR 5.829999924 1 1 0.101183471 709.8308751 0 14.30193 14.48214 0 15.7691 0 0 15.28415 16.42993 13.42864 0 14.13938 13.69787 0 0 15.66197 0 15.07653 0 0 0 0 0 0 0 0 0 0 0 16.10608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUQ8 ABCF3_HUMAN ATP-binding cassette sub-family F member 3 ABCF3 Homo sapiens (Human) defense response to virus [GO:0051607] membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607] ATP binding [GO:0005524]; cadherin binding [GO:0045296] GO:0005524; GO:0016020; GO:0045296; GO:0051607 MLEKLPELKPVDK 10.53999996 1 1 0.27478143 1556.480714 15.12784 0 0 0 14.03721 14.38675 0 0 13.97386 16.1431 16.65199 15.0585 14.89208 13.71607 13.91202 0 0 0 0 0 0 0 0 0 0 15.29327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUT2 MITOS_HUMAN "Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial, ABCB8) (Mitochondrial ATP-binding cassette 1, M-ABC1) (Mitochondrial sulfonylurea-receptor, MITOSUR)" ABCB8 MABC1 MITOSUR Homo sapiens (Human) cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085] ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626] GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0006884; GO:0016021; GO:0031966; GO:0042626; GO:0043190; GO:0055085; GO:0062157; GO:0071805; GO:0140141; GO:0140359 LTLLLMVATPALMGVGTLMGSGLRK 2.75999999 1 1 0.254609929 2574.524555 0 0 0 0 0 0 16.57747 0 0 0 0 15.62087 15.24482 0 0 0 0 0 19.54025 0 0 0 0 0 0 15.70007 0 0 0 0 17.76977 0 0 0 18.10238 0 17.47549 0 15.39663 0 0 0 0 15.99463 0 0 17.88616 0 Q9NUU7 DD19A_HUMAN "ATP-dependent RNA helicase DDX19A, EC 3.6.4.13 (DDX19-like protein) (DEAD box protein 19A)" DDX19A DDX19L Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016020; GO:0016887; GO:0016973 VEPSDR 8.229999542 1 1 0.212969734 701.6336624 18.95575 15.27395 16.32454 15.7347 13.65798 13.77999 14.74835 12.5639 0 0 0 0 0 12.84623 0 14.63963 13.97335 16.17286 0 0 14.39113 0 0 0 16.43317 17.96107 16.54098 0 0 0 16.46913 14.33565 14.2605 15.47897 17.49848 15.15364 16.53253 15.89696 0 16.48771 15.35183 17.12064 0 0 0 0 0 16.00748 Q9NUV7 SPTC3_HUMAN "Serine palmitoyltransferase 3, EC 2.3.1.50 (Long chain base biosynthesis protein 2b, LCB2b) (Long chain base biosynthesis protein 3, LCB 3) (Serine-palmitoyl-CoA transferase 3, SPT 3)" SPTLC3 C20orf38 SPTLC2L Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphingoid biosynthetic process [GO:0046520]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; sphingoid biosynthetic process [GO:0046520]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] GO:0004758; GO:0005789; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046512; GO:0046513; GO:0046520 SLKLIMGLDGTTQGLQR 2.150000095 1 1 0.285659596 1830.446937 0 15.21893 16.75802 15.41412 0 12.68102 14.76243 12.0063 0 12.99347 0 0 0 0 14.83867 13.55753 0 0 17.3054 0 0 15.85713 15.55738 0 0 0 0 15.26257 17.50151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.269 Q9NUZ1 ACOXL_HUMAN "Acyl-coenzyme A oxidase-like protein, Acyl-CoA oxidase-like protein, EC 1.3.3.-" ACOXL Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660] GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0033540; GO:0050660; GO:0055088; GO:0071949 FAMDLPLLK 12.44999981 1 1 0.129813661 1062.572153 16.86642 12.69742 0 0 0 13.29276 16.19119 0 18.31448 14.83242 13.65969 0 15.96574 15.86722 16.85482 16.81483 16.37685 17.95691 17.57129 18.13551 18.35934 16.71058 16.70585 17.10045 0 15.34757 17.87846 17.87738 17.02694 17.26385 14.51007 16.76463 16.48231 18.16328 18.2747 17.24999 18.39426 18.76833 17.60115 18.10086 17.44013 17.40872 17.58771 18.23429 17.15783 17.82804 18.16626 18.71997 Q9NV06 DCA13_HUMAN DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1) DCAF13 WDSOF1 HSPC064 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]" cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]" estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723] GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0080008 ANASEK 3.5 1 1 0.007475627 621.178265 0 0 15.87836 0 0 0 0 0 0 0 0 0 0 0 16.55758 0 0 0 0 0 0 15.84764 0 0 0 0 15.81408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV29 TM100_HUMAN Transmembrane protein 100 TMEM100 Homo sapiens (Human) angiogenesis [GO:0001525]; arterial endothelial cell differentiation [GO:0060842]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of vasculogenesis [GO:2001214]; protein kinase B signaling [GO:0043491]; regulation of calcium-mediated signaling [GO:0050848]; regulation of sensory perception of pain [GO:0051930]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; arterial endothelial cell differentiation [GO:0060842]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of vasculogenesis [GO:2001214]; protein kinase B signaling [GO:0043491]; regulation of calcium-mediated signaling [GO:0050848]; regulation of sensory perception of pain [GO:0051930]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0001701; GO:0003198; GO:0005783; GO:0005886; GO:0007219; GO:0016021; GO:0030509; GO:0043204; GO:0043491; GO:0045603; GO:0048471; GO:0050848; GO:0051930; GO:0060842; GO:0071773; GO:2001214 AHMAATMEK 5.75 1 1 0.228015776 987.2238578 16.7245 0 0 0 15.13739 0 0 0 0 15.06055 0 14.22153 0 0 0 0 0 0 0 15.46937 12.37713 15.93024 0 0 0 0 17.1771 0 15.60163 0 0 18.0963 16.55045 15.70242 0 0 16.55089 0 0 0 0 0 0 13.7175 0 0 0 0 Q9NV56 MRGBP_HUMAN "MRG/MORF4L-binding protein (MRG-binding protein) (Up-regulated in colon cancer 4, Urcc4)" MRGBP C20orf20 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]" NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786] "NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000786; GO:0005654; GO:0006325; GO:0006357; GO:0016573; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779 ASEKSSK 7.480000019 0.254285157 0.254285157 0.253689599 736.3625042 16.08113 16.14728 16.17389 17.70079 18.80181 0 14.60946 0 16.56509 0 0 0 16.7584 0 15.45467 0 15.58447 0 16.68567 0 18.03817 15.11021 0 15.63482 17.84748 16.85586 16.46161 16.15097 15.59789 17.0171 0 17.47695 16.96235 16.74706 0 16.34618 17.28713 16.68389 17.68324 17.42703 17.77152 16.27317 17.47289 17.68926 17.07955 17.24495 16.65736 17.43117 Q9NV66 TYW1_HUMAN "S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1, EC 4.1.3.44 (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein)" TYW1 RSAFD1 Homo sapiens (Human) wybutosine biosynthetic process [GO:0031591] "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]; wybutosine biosynthetic process [GO:0031591]" "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]" GO:0010181; GO:0031591; GO:0046872; GO:0051539; GO:0102521 EAIENHQNMIK 10.82999992 1 1 0.462113409 1342.094624 0 0 0 17.3494 17.59858 0 0 0 0 0 0 0 0 0 16.77743 0 0 18.27128 17.22836 0 0 0 0 0 0 0 0 18.57099 17.77218 18.04481 0 0 0 0 18.92601 20.17785 0 19.08662 0 17.5262 0 0 17.80783 0 0 0 0 0 Q9NV70 EXOC1_HUMAN Exocyst complex component 1 (Exocyst complex component Sec3) EXOC1 SEC3 SEC3L1 BM-012 Homo sapiens (Human) defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]" "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048015; GO:0048471; GO:0050714; GO:0051607; GO:0090148; GO:0090522; GO:0090543; GO:0098592 DFFEVAKIK 3.109999895 1 1 0.054937504 1096.725781 16.00388 15.64431 0 0 0 14.40632 12.10709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.39521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV72 ZN701_HUMAN Zinc finger protein 701 ZNF701 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 KLMSSTER 9.170000076 1 1 4.60E-13 950.4307405 0 16.47157 15.36417 0 0 0 0 0 0 0 0 0 15.7336 0 0 0 0 0 0 0 0 0 14.27445 0 0 0 15.18366 0 0 0 0 0 0 0 0 0 0 14.44827 0 0 0 0 0 0 0 0 0 0 Q9NV79 PCMD2_HUMAN Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 PCMTD2 C20orf36 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] GO:0004719; GO:0005737 ITRTGPSAWETK 9.979999542 1 1 0.045453867 1345.298629 0 0 0 15.6728 0 16.15942 0 0 0 0 0 15.06001 0 10.69294 0 0 0 15.44827 0 0 0 0 0 0 16.50218 0 14.52219 0 0 0 0 14.40815 0 14.64385 14.10327 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVA2 SEP11_HUMAN Septin-11 SEPTIN11 SEPT11 Homo sapiens (Human) cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640] axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725] axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] GO:0001725; GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0030424; GO:0031105; GO:0032153; GO:0034613; GO:0043197; GO:0060090; GO:0061640 NASFT 3.549999952 0.34733209 0.34733209 0.165430057 539.3084433 15.50145 13.99233 15.18827 0 15.06639 15.20266 0 15.78304 0 0 0 15.20086 15.09047 14.90856 16.50657 15.68993 15.30522 16.46179 14.67029 15.34954 15.26589 16.79847 16.69428 15.84893 12.10161 14.47713 13.46886 13.01886 15.31385 14.92569 15.13808 15.32817 15.15169 15.83296 12.79391 16.06507 15.72287 16.23207 16.44972 14.94463 0 15.79304 16.10254 14.61498 13.8567 16.24103 17.26092 14.82763 Q9NVC6 MED17_HUMAN "Mediator of RNA polymerase II transcription subunit 17 (Activator-recruited cofactor 77 kDa component, ARC77) (Cofactor required for Sp1 transcriptional activation subunit 6, CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component, Trap80) (Transcriptional coactivator CRSP77) (Vitamin D3 receptor-interacting protein complex 80 kDa component, DRIP80)" MED17 ARC77 CRSP6 DRIP77 DRIP80 TRAP80 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809] GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006367; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0051123; GO:0060261; GO:0070847 NGPESGSKIMVQFPR 7.039999962 0.502545714 0.502545714 0.085406837 1646.638942 15.97995 0 15.10607 0 0 14.70065 14.85151 0 14.55535 15.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.05355 13.99721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22665 16.18073 0 0 0 0 0 0 Q9NVD3 SETD4_HUMAN "SET domain-containing protein 4, EC 2.1.1.-, EC 2.1.1.364" SETD4 C21orf18 C21orf27 Homo sapiens (Human) histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 monomethylation [GO:0097692]; histone H4-K20 trimethylation [GO:0034773]; inflammatory response [GO:0006954]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; protein-lysine N-methyltransferase activity [GO:0016279]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 monomethylation [GO:0097692]; histone H4-K20 trimethylation [GO:0034773]; inflammatory response [GO:0006954]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863] histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; protein-lysine N-methyltransferase activity [GO:0016279] GO:0005634; GO:0005829; GO:0006954; GO:0016279; GO:0018023; GO:0018026; GO:0032755; GO:0032760; GO:0034773; GO:0042799; GO:0042800; GO:0044648; GO:0050729; GO:0071863; GO:0097692 VSHMKDEK 10.23999977 0.605279982 0.605279982 0.016768642 989.5899829 0 0 0 17.22836 0 14.32592 11.05965 8.843022 12.14116 0 15.73499 16.57029 12.89899 0 0 13.28253 14.84568 15.53952 16.94181 0 0 16.09831 13.03466 0 0 13.68645 13.84465 0 13.6732 0 12.96102 14.44277 0 0 15.37845 14.02253 0 14.1196 0 14.56112 15.45686 15.93019 10.74009 13.90699 16.24611 16.17251 0 13.56178 Q9NVD7 PARVA_HUMAN Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2) PARVA MXRA2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446] actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860] GO:0002040; GO:0003148; GO:0003779; GO:0004860; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0031532; GO:0034113; GO:0034446; GO:0045296; GO:0050821; GO:0060271; GO:0070252; GO:0071670 SPTPKSPPSR 17.84000015 1 1 0.318648607 1053.053719 13.67803 15.0634 13.18401 0 0 0 0 0 0 0 0 0 0 14.47284 0 15.85017 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6584 0 15.30719 13.49851 0 0 15.67109 0 0 0 0 16.05595 0 0 0 0 0 0 0 Q9NVE4 CCD87_HUMAN Coiled-coil domain-containing protein 87 CCDC87 Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344 NEVVVQAAAVRVSDR 3.730000019 1 1 0.258902547 1613.775803 0 15.76997 0 0 11.064 0 14.10942 0 0 12.0993 13.61186 14.12423 0 0 0 0 0 0 0 0 14.16971 0 15.33516 0 14.20962 14.07462 13.67603 0 0 13.25957 0 14.17755 0 0 0 0 0 14.12861 0 13.42098 0 18.44935 14.36297 0 13.18183 0 0 12.48917 Q9NVE5 UBP40_HUMAN "Ubiquitin carboxyl-terminal hydrolase 40, EC 3.4.19.12 (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40)" USP40 Homo sapiens (Human) protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0031647 DGDTIGVK 6.909999847 1 1 0.304271866 801.6082259 0 0 0 17.89689 18.38777 0 17.63207 0 0 17.82825 0 0 16.87981 0 0 18.5498 0 0 16.57242 0 18.46521 17.14602 0 0 0 0 0 0 17.0689 0 0 0 18.71866 18.5924 0 19.80862 0 0 14.4233 17.25419 0 0 18.00927 0 0 0 0 18.5088 Q9NVE7 PANK4_HUMAN "4'-phosphopantetheine phosphatase, EC 3.1.3.- (Inactive pantothenic acid kinase 4, hPanK4)" PANK4 Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872 EDMAKSLLHMISNDIGQLACLHAR 5.409999847 1 1 0.055394273 2723.231409 15.63235 15.05834 0 14.04003 0 0 0 0 11.85226 14.37119 18.05038 13.71907 16.99267 8.318459 0 11.45608 0 0 0 14.54459 0 16.74954 0 0 0 16.23413 0 16.88341 15.09759 0 20.06427 14.45842 0 0 0 0 0 15.79309 0 15.36704 13.52428 0 0 13.82146 0 0 0 0 Q9NVF7 FBX28_HUMAN F-box only protein 28 FBXO28 CENP-30 KIAA0483 Homo sapiens (Human) protein polyubiquitination [GO:0000209] kinetochore [GO:0000776] kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209] identical protein binding [GO:0042802] GO:0000209; GO:0000776; GO:0042802 LMGSPPVPGPSAALTTMQLFSK 1.539999962 1 1 0.250525619 2229.221025 9.264452 0 12.09011 0 11.19163 11.50326 0 14.68841 0 11.58895 13.82404 0 13.96504 12.34898 7.798967 0 0 0 0 0 0 0 16.14972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVH0 EXD2_HUMAN "Exonuclease 3'-5' domain-containing protein 2, EC 3.1.11.1 (3'-5' exoribonuclease EXD2, EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)" EXD2 C14orf114 EXDL2 Homo sapiens (Human) DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310] GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090305; GO:0090734 RDSYIR 22 0.041855346 0.041855346 0.159506183 809.5952063 20.15615 17.43822 21.35003 16.63366 17.08957 17.75299 16.98936 19.62628 18.3732 18.69303 18.03571 17.36334 18.95545 18.49587 18.3328 16.81831 16.87951 17.52536 17.93804 17.22083 17.87997 18.30485 17.59962 17.7483 19.36512 16.55828 17.77747 16.9124 16.7479 17.78806 16.69891 19.3562 19.63089 18.36249 18.2432 20.74088 20.27849 18.98459 20.02568 17.96132 16.99349 19.57515 19.48256 16.38964 16.11478 17.89557 15.92681 18.10271 Q9NVH2 INT7_HUMAN "Integrator complex subunit 7, Int7" INTS7 C1orf73 Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034472; GO:0071479 LGMLSVLSTLSGTIAIK 9.260000229 1 1 2.06E-12 1716.74783 14.25696 14.63413 0 0 0 0 0 14.13872 13.53022 0 0 14.49522 15.48972 0 0 10.55533 15.11593 15.10483 11.15732 0 0 0 0 0 0 15.01607 0 16.02484 0 14.59953 0 0 15.56681 14.51159 14.4121 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVI1 FANCI_HUMAN "Fanconi anemia group I protein, Protein FACI" FANCI KIAA1794 Homo sapiens (Human) cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398] DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182] GO:0000785; GO:0003677; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0016020; GO:0031398; GO:0036297; GO:0070182; GO:1990391 EGSLVNGK 7.460000038 1 1 0.21985592 803.6176925 15.20528 0 14.61825 17.6234 13.51632 0 15.03643 0 0 0 0 0 0 16.46444 15.82419 0 14.87036 15.81728 0 0 0 16.69874 0 0 15.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.37406 0 0 0 0 Q9NVI7 ATD3A_HUMAN ATPase family AAA domain-containing protein 3A ATAD3A Homo sapiens (Human) antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] GO:0001558; GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0016021; GO:0016887; GO:0042645; GO:0042802; GO:0043066; GO:0140374 ATLNAFLYRTGQHSNK 1.629999995 1 1 0.277412036 1821.163411 14.74377 11.17445 11.30814 14.53292 13.90557 0 12.15081 0 0 16.74393 0 15.6486 13.12817 12.72195 0 0 14.23095 13.31882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.55663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVL8 CC198_HUMAN Uncharacterized protein CCDC198 CCDC198 C14orf105 Homo sapiens (Human) EVETPSAGR 9.479999542 0.375987202 0.375987202 0.197909059 943.3732294 0 17.51089 0 14.30406 0 17.18246 17.23163 15.38542 15.27466 15.96867 17.50003 17.43292 14.86708 12.45788 14.29495 13.39579 16.09243 16.25035 15.04727 15.8013 13.04168 16.36083 16.78549 0 17.02524 15.44302 14.95886 16.813 17.8369 16.58327 18.17937 18.99738 17.81138 15.97573 16.08892 14.742 16.08978 12.23776 15.06164 16.2885 18.47708 12.44288 13.50623 17.77008 17.51821 16.03079 17.42141 16.30478 Q9NVM9 INT13_HUMAN Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95) INTS13 ASUN C12orf11 GCT1 Homo sapiens (Human) cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346] GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016604; GO:0030317; GO:0032039; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435 EELAEAEIIK 16.05999947 1 1 0.306367572 1145.535268 13.4709 18.30645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVN8 GNL3L_HUMAN Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) "negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]" GTP binding [GO:0005525]; RNA binding [GO:0003723] GO:0003723; GO:0005525; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0016020; GO:0031334; GO:0031397; GO:0031647; GO:0032091; GO:0032211; GO:0033234; GO:0042254; GO:1904816 IMETDPLQQGQALASALK 10.81999969 1 1 2.07E-12 1930.247513 0 15.85167 14.41286 0 14.30522 0 0 14.60843 14.56803 0 14.25696 0 13.97872 0 0 0 0 14.2283 0 0 0 0 0 0 0 0 0 0 0 15.43886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVP1 DDX18_HUMAN "ATP-dependent RNA helicase DDX18, EC 3.6.4.13 (DEAD box protein 18) (Myc-regulated DEAD box protein, MrDb)" DDX18 cPERP-D Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730] "chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0016887 STVLTNGEAAMQSSNSESKK 3.869999886 1 1 4.91E-13 2085.997791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVP4 DZAN1_HUMAN Double zinc ribbon and ankyrin repeat-containing protein 1 DZANK1 C20orf12 C20orf84 Homo sapiens (Human) eye photoreceptor cell development [GO:0042462] metal ion binding [GO:0046872]; eye photoreceptor cell development [GO:0042462] metal ion binding [GO:0046872] GO:0042462; GO:0046872 ACGTGNPAHLR 1.840000033 1 1 0.253079184 1154.866934 0 0 0 0 0 0 0 19.73236 0 0 0 0 18.09765 0 0 0 0 0 0 0 0 19.19272 0 18.59751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.48612 0 0 0 0 0 0 0 Q9NVR0 KLH11_HUMAN Kelch-like protein 11 KLHL11 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 DTEDGLK 10.64000034 0.612073481 0.612073481 0.249378273 777.5188591 16.06075 15.61727 0 0 14.92171 15.63777 14.69435 16.23602 0 17.37817 0 0 15.44762 13.62971 0 0 14.02019 15.09027 0 0 0 17.22514 15.03403 16.70017 14.33908 13.51056 17.05914 16.07536 0 12.39882 0 0 16.89101 0 0 0 0 0 0 14.89515 0 16.32099 0 0 0 0 0 16.36682 Q9NVR2 INT10_HUMAN "Integrator complex subunit 10, Int10" INTS10 C8orf35 Homo sapiens (Human) snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0016180; GO:0032039 HHTVTR 6.880000114 0.503160536 0.503160536 0.189524818 751.7744486 14.59635 0 15.45879 13.09186 14.45108 14.85932 15.28045 0 9.612368 15.65955 0 0 0 15.79292 0 0 0 0 0 0 0 0 0 16.98633 0 0 0 0 0 0 0 0 0 0 0 0 0 15.09303 0 0 0 0 0 0 16.27122 0 0 0 Q9NVR7 TBCC1_HUMAN TBCC domain-containing protein 1 TBCCD1 Homo sapiens (Human) maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616] cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616]; maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360] GO:0005737; GO:0008360; GO:0030334; GO:0031616; GO:0051661; GO:0051684 SVTIEK 3.00999999 1 1 0.287726002 676.6573454 0 0 0 0 0 0 0 19.39335 0 17.61385 0 0 0 0 0 0 0 0 0 0 18.96116 0 0 0 0 19.40056 18.1744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.88274 0 0 0 Q9NVS9 PNPO_HUMAN "Pyridoxine-5'-phosphate oxidase, EC 1.4.3.5 (Pyridoxamine-phosphate oxidase)" PNPO Homo sapiens (Human) pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615] cytosol [GO:0005829] cytosol [GO:0005829]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615] FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733] GO:0004733; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823 SAAMDLGPMRK 3.180000067 1 1 0.134526577 1204.9921 12.02774 13.18455 0 0 14.13213 14.70443 13.99037 13.5764 13.62469 0 0 0 12.72542 13.76793 13.3539 13.85755 0 0 0 0 0 0 13.96576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.92746 0 0 0 0 0 0 0 0 0 0 Q9NVU7 SDA1_HUMAN "Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1, hSDA)" SDAD1 NUC130 Homo sapiens (Human) protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055] GO:0000055; GO:0005654; GO:0005730; GO:0015031; GO:0042273 NVMMSAR 7.730000019 0.478520751 0.478520751 0.279113926 841.8082551 15.29679 15.43211 14.5169 14.74504 15.97207 16.0001 16.16247 15.30433 0 15.32852 15.21346 15.21366 14.59773 0 16.51511 0 16.68095 15.2531 15.30158 17.44127 0 0 0 0 0 0 16.50514 0 0 16.47895 16.69769 15.72549 16.40787 16.8483 0 16.63822 17.54072 16.67501 17.01259 17.23338 15.64784 15.29451 16.86376 17.49943 17.00238 16.43867 0 16.29628 Q9NVV0 TM38B_HUMAN "Trimeric intracellular cation channel type B, TRIC-B, TRICB (Transmembrane protein 38B)" TMEM38B C9orf87 Homo sapiens (Human) bone development [GO:0060348]; bone mineralization [GO:0030282]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extracellular matrix constituent secretion [GO:0070278]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; phospholipid biosynthetic process [GO:0008654]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; secretion by lung epithelial cell involved in lung growth [GO:0061033] integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sarcoplasmic reticulum membrane [GO:0033017] integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sarcoplasmic reticulum membrane [GO:0033017]; identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extracellular matrix constituent secretion [GO:0070278]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; phospholipid biosynthetic process [GO:0008654]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; secretion by lung epithelial cell involved in lung growth [GO:0061033] identical protein binding [GO:0042802]; potassium channel activity [GO:0005267] GO:0005267; GO:0005634; GO:0007029; GO:0008654; GO:0010881; GO:0014808; GO:0016021; GO:0030282; GO:0031965; GO:0033017; GO:0042802; GO:0048286; GO:0060348; GO:0060487; GO:0061033; GO:0070278; GO:0071313 MSYPAK 5.829999924 1 1 6.87E-13 711.5059676 14.48459 13.73576 14.60381 14.40362 16.6313 0 0 0 0 0 0 0 0 0 0 15.38246 0 0 0 0 0 0 0 0 0 0 16.57456 0 0 0 15.92175 0 16.07604 16.18564 16.90816 16.94382 17.68995 0 0 0 0 0 0 0 0 0 0 0 Q9NVV4 PAPD1_HUMAN "Poly(A) RNA polymerase, mitochondrial, PAP, EC 2.7.7.19 (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1, TUTase 1) (mtPAP)" MTPAP PAPD1 Homo sapiens (Human) histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; UTP binding [GO:0002134] GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005739; GO:0006378; GO:0016779; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817 VQRPIVR 11.93000031 0.604428828 0.604428828 0.243031322 868.0049929 18.33574 20.04394 14.25892 0 17.52687 20.05507 18.20588 11.92317 0 17.24517 19.34855 14.41083 16.25227 17.60398 18.3067 18.15802 16.90104 18.19427 0 17.27688 0 0 0 0 0 0 20.33858 0 0 15.48135 18.87329 20.30923 20.50332 0 18.5937 17.57533 19.16389 19.1653 0 17.98812 18.59069 0 0 0 18.52135 0 0 21.36174 Q9NW08 RPC2_HUMAN "DNA-directed RNA polymerase III subunit RPC2, RNA polymerase III subunit C2, EC 2.7.7.6 (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)" POLR3B Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549] GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607 GATDSYIEK 5 1 1 0.135791216 982.3780179 16.21978 15.55576 15.35699 12.83462 15.1959 15.24449 0 0 16.34824 14.57377 0 14.26529 0 0 0 0 0 0 0 0 0 15.00138 0 0 0 0 0 0 0 14.99362 0 0 0 0 0 15.94973 0 0 0 14.26273 0 16.65708 0 0 0 0 0 0 Q9NW13 RBM28_HUMAN RNA-binding protein 28 (RNA-binding motif protein 28) RBM28 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleolus [GO:0005730]; spliceosomal complex [GO:0005681] nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] RNA binding [GO:0003723] GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380 MRSKPATGEPQK 3.109999895 1 1 0.244493482 1328.605585 0 15.44331 14.14099 0 14.07139 15.68847 0 0 15.82283 0 15.0382 0 0 15.38639 0 0 0 13.95751 0 0 15.40356 0 0 0 14.59554 0 0 16.72749 13.78753 0 0 0 0 0 13.83632 17.45421 0 0 0 16.85062 16.22474 0 0 13.97434 0 0 0 0 Q9NW15 ANO10_HUMAN Anoctamin-10 (Transmembrane protein 16K) ANO10 TMEM16K Homo sapiens (Human) cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]; cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229] GO:0005227; GO:0005229; GO:0005886; GO:0006812; GO:0006821; GO:0016020; GO:0016021; GO:0034220; GO:0043231; GO:0055085 IRMLLGAEAVGLVK 4.949999809 1 1 0.424204179 1485.794988 0 0 0 0 0 0 0 17.4241 0 0 16.42027 17.4621 18.25677 0 0 0 0 0 18.50271 0 18.65302 0 0 0 0 0 0 0 18.56253 0 0 0 0 19.88247 0 0 0 19.15186 19.02181 0 0 0 0 0 0 0 0 18.78025 Q9NW64 RBM22_HUMAN Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) (Zinc finger CCCH domain-containing protein 16) RBM22 ZC3H16 199G4 Homo sapiens (Human) "cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]" calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0017070; GO:0033120; GO:0036002; GO:0042307; GO:0045292; GO:0046827; GO:0046872; GO:0048306; GO:0071006; GO:0071007; GO:0071013; GO:0071466 TITVVQRQQCAFIQFATR 10.89999962 1 1 0.234459857 2171.788898 0 15.09419 15.15952 0 11.27398 0 0 0 0 15.08806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW68 BSDC1_HUMAN BSD domain-containing protein 1 BSDC1 UNQ2494/PRO5781 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 VLPKDLSQK 4.239999771 1 1 0.016909224 1027.325724 15.48402 0 0 15.69184 0 0 15.58258 15.22255 0 0 15.15815 13.95424 0 0 0 15.35906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW75 GPTC2_HUMAN G patch domain-containing protein 2 GPATCH2 GPATC2 Homo sapiens (Human) nuclear speck [GO:0016607]; nucleolus [GO:0005730] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676] nucleic acid binding [GO:0003676] GO:0003676; GO:0005730; GO:0016607 GLGLGFPLPK 7.510000229 0.348840296 0.348840296 0.229098742 999.3185175 17.46018 17.19318 15.8709 16.33269 0 16.70928 18.32213 16.41389 14.35322 15.83595 17.98985 14.57158 17.49087 12.7032 13.77508 14.90382 15.58814 14.97223 15.68788 16.20315 17.66651 17.15829 17.13423 17.05144 0 14.17395 0 16.09319 0 15.28008 0 16.8872 0 0 15.95131 15.87861 14.62866 16.33066 18.39538 0 13.68261 0 17.99056 15.75191 14.91064 18.39189 15.61938 17.60929 Q9NW97 TMM51_HUMAN Transmembrane protein 51 TMEM51 C1orf72 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TEVGGGILK 8.100000381 0.459951639 0.459951639 0.266673014 872.3247571 18.83766 17.60501 18.33649 13.59071 17.96806 17.13865 0 0 0 17.4721 0 18.57297 0 0 0 0 0 0 0 0 16.57128 16.53346 0 0 0 0 0 0 17.40596 0 18.75187 0 18.86792 0 18.87438 0 17.10916 0 17.94691 17.17915 17.8203 16.90401 0 0 0 17.80351 0 17.32847 Q9NWD8 TM248_HUMAN Transmembrane protein 248 TMEM248 C7orf42 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LTVIVPDDDR 3.309999943 1 1 0.085404792 1144.68787 15.20556 0 17.13755 0 16.31148 15.06536 13.53184 0 0 8.837421 14.82917 0 0 18.62855 13.45664 0 0 12.28088 0 15.22482 0 0 0 0 0 0 0 0 0 0 16.47716 0 16.16049 0 13.84513 14.9902 15.45785 18.0482 0 0 16.95693 13.14302 15.86635 0 0 0 0 14.24518 Q9NWH9 SLTM_HUMAN SAFB-like transcription modulator (Modulator of estrogen-induced transcription) SLTM MET Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684 IEGKDEK 14.81000042 1 1 0.254231833 818.0168549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.24708 0 0 0 16.00192 0 0 0 0 0 0 15.92214 0 0 0 0 0 0 0 15.26885 13.03218 0 15.00467 11.8136 0 0 0 0 16.10665 0 0 0 0 Q9NWL6 ASND1_HUMAN Asparagine synthetase domain-containing protein 1 (HCV NS3-transactivated protein 1) ASNSD1 NS3TP1 Nbla00058 Homo sapiens (Human) asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541] asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541] asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066] GO:0004066; GO:0006529; GO:0006541 DENLTANEVLK 10.26000023 1 1 0.333687178 1246.192333 10.40313 0 0 14.72028 11.95935 0 0 0 0 0 11.89276 0 0 14.04791 15.80889 0 0 0 0 0 0 0 15.62144 0 0 0 0 0 15.93803 0 0 0 0 15.62106 0 0 0 0 0 0 0 0 0 16.26882 0 0 0 0 Q9NWM3 CUED1_HUMAN CUE domain-containing protein 1 CUEDC1 Homo sapiens (Human) ubiquitin binding [GO:0043130] ubiquitin binding [GO:0043130] GO:0043130 RSSSGSGGGGTAGAR 13.78999996 1 1 0.459150803 1263.627135 0 18.22931 19.08217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.35755 0 0 0 0 0 0 0 0 Q9NWM8 FKB14_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP14, PPIase FKBP14, EC 5.2.1.8 (22 kDa FK506-binding protein, 22 kDa FKBP, FKBP-22) (FK506-binding protein 14, FKBP-14) (Rotamase)" FKBP14 FKBP22 UNQ322/PRO381 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0003755; GO:0005509; GO:0005788 IPPESTLIFNIDLLEIRNGPR 1.25999999 1 1 4.58E-12 2408.272499 13.87276 0 12.41849 0 14.81778 11.74617 9.712662 16.69837 13.64477 14.90232 0 14.60371 12.97784 13.61218 0 15.26049 0 15.03494 0 11.7551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.43551 0 0 0 0 0 14.84717 0 Q9NWQ4 GPT2L_HUMAN G patch domain-containing protein 2-like GPATCH2L C14orf118 KIAA1152 Homo sapiens (Human) EVAPVTNFSDSDDTMVAK 1.450000048 1 1 0.458623017 1941.430733 14.47031 15.4519 0 0 0 0 0 0 0 0 14.46027 13.21943 11.7601 0 15.59254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.81383 0 0 0 15.70401 0 0 0 0 0 0 Q9NWQ8 PHAG1_HUMAN Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp) PAG1 CBP PAG Homo sapiens (Human) adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165] SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591] GO:0002250; GO:0005886; GO:0007165; GO:0016021; GO:0035556; GO:0035591; GO:0042169; GO:0045121; GO:0050863; GO:0050868 GHSGKAK 8.75 1 1 0.142627924 684.4188046 0 15.17554 0 14.12455 0 0 15.04877 0 16.65598 0 0 0 0 0 0 14.94801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.37996 16.7901 0 0 0 0 0 0 0 16.6304 0 0 0 0 17.46807 0 0 Q9NWV8 BABA1_HUMAN BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex) BABAM1 C19orf62 MERIT40 NBA1 HSPC142 Homo sapiens (Human) cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0010212; GO:0016604; GO:0044818; GO:0045739; GO:0051301; GO:0070531; GO:0070536; GO:0070537; GO:0070552 SWQVPPPAPEVQIR 9.170000076 0.606396317 0.606396317 0.069618403 1604.630984 0 0 16.85136 15.39857 15.77447 0 0 0 16.62145 13.33378 15.0943 0 15.05713 16.96803 0 13.21628 14.84158 12.10829 17.44347 0 15.47111 0 11.07167 13.80929 18.78177 0 0 14.9514 0 0 0 0 15.22361 0 10.98324 7.622881 17.18914 12.1422 15.93744 17.92135 12.64455 0 14.21141 0 13.11714 0 0 0 Q9NWW5 CLN6_HUMAN "Ceroid-lipofuscinosis neuronal protein 6, Protein CLN6" CLN6 Homo sapiens (Human) cellular macromolecule catabolic process [GO:0044265]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; locomotion involved in locomotory behavior [GO:0031987]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]; protein catabolic process [GO:0030163]; visual perception [GO:0007601] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; lysophosphatidic acid binding [GO:0035727]; protein homodimerization activity [GO:0042803]; sulfatide binding [GO:0120146]; cellular macromolecule catabolic process [GO:0044265]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; locomotion involved in locomotory behavior [GO:0031987]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]; protein catabolic process [GO:0030163]; visual perception [GO:0007601] lysophosphatidic acid binding [GO:0035727]; protein homodimerization activity [GO:0042803]; sulfatide binding [GO:0120146] GO:0001573; GO:0005730; GO:0005769; GO:0005783; GO:0005788; GO:0005789; GO:0007040; GO:0007042; GO:0007601; GO:0008203; GO:0016020; GO:0016021; GO:0030163; GO:0030203; GO:0031987; GO:0035727; GO:0042803; GO:0043231; GO:0044265; GO:0045121; GO:0045862; GO:0120146 ENPIIK 1.99000001 2.34E-09 2.34E-09 0.251125143 712.544922 0 0 18.48182 17.91897 0 17.44437 16.46864 0 17.83965 0 0 0 17.83067 17.74791 0 0 0 17.70146 0 0 0 0 16.41697 0 0 0 19.00969 0 0 19.00724 0 0 0 0 20.13637 0 0 0 19.45101 0 0 0 0 16.80709 17.28966 18.2079 16.80436 18.03203 Q9NWW7 CB042_HUMAN Uncharacterized protein C2orf42 C2orf42 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654 ISIGSAK 13.88000011 1 1 0.203971452 675.6467601 15.8206 15.81838 14.8976 14.70695 0 15.60249 15.83321 15.18965 0 0 0 0 15.0148 16.21214 17.12955 15.96021 0 16.45934 0 17.61509 0 0 0 0 17.62166 15.62685 16.31936 16.00474 17.34006 16.55 16.013 16.55507 16.05771 16.8878 17.74475 0 17.79833 18.79977 16.90393 17.17888 17.56411 17.43351 17.70635 0 17.30149 17.11676 0 0 Q9NWX5 ASB6_HUMAN "Ankyrin repeat and SOCS box protein 6, ASB-6" ASB6 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 KAETVLDLMVTNSQK 15.80000019 1 1 0.519208008 1693.601872 17.15334 12.88262 0 0 0 0 19.89173 0 18.02927 0 0 0 17.68676 0 0 0 0 0 0 0 17.83519 0 0 0 0 0 0 18.82624 0 0 21.32813 0 20.72377 0 0 0 0 0 18.59461 0 0 0 0 18.70069 0 18.45922 16.7818 0 Q9NWX6 THG1_HUMAN "Probable tRNA(His) guanylyltransferase, EC 2.7.7.79 (Induced in high glucose-1, IHG-1) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase)" THG1L ICF45 Homo sapiens (Human) mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193]; mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193] GO:0000049; GO:0000287; GO:0005085; GO:0005524; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006400; GO:0006979; GO:0008033; GO:0008053; GO:0008193; GO:0016779; GO:0042802; GO:0051289; GO:1990046; GO:1990234 SKFEYVR 6.570000172 1 1 1.26E-12 928.610624 13.52283 15.15142 0 0 0 16.38173 0 0 0 0 0 0 0 0 0 0 15.40775 14.44038 0 0 0 0 0 0 0 0 0 0 0 13.99179 0 0 0 0 0 0 16.03147 15.52057 0 0 0 0 0 0 0 0 0 16.53022 Q9NWY4 HPF1_HUMAN Histone PARylation factor 1 HPF1 C4orf27 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835] chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572] GO:0000785; GO:0003682; GO:0005634; GO:0006302; GO:0006974; GO:0010835; GO:0018312; GO:0031056; GO:0042393; GO:0072572; GO:0090734 VGGGGKR 3.130000114 1 1 0.152923565 626.2270203 0 0 0 13.20915 0 0 0 14.49596 14.09282 0 0 0 0 0 14.51069 0 0 0 0 15.62236 0 0 0 0 16.86246 16.28915 14.69949 16.73738 15.21166 0 15.56729 0 0 0 0 0 0 16.19346 16.41413 17.06366 0 0 14.24618 0 0 0 0 0 Q9NX02 NALP2_HUMAN "NACHT, LRR and PYD domains-containing protein 2 (Nucleotide-binding site protein 1) (PYRIN domain and NACHT domain-containing protein 1) (PYRIN-containing APAF1-like protein 2)" NLRP2 NALP2 NBS1 PAN1 PYPAF2 Homo sapiens (Human) apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; Pyrin domain binding [GO:0032090]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731] ATP binding [GO:0005524]; Pyrin domain binding [GO:0032090] GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006954; GO:0032088; GO:0032090; GO:0032731; GO:0043231; GO:0043280; GO:0045087 KERPPLDVDEMLER 5.059999943 1 1 0.286970597 1746.078337 0 16.85693 12.4768 0 0 0 16.40086 15.70064 0 0 0 15.01688 14.39544 0 15.19704 0 15.22759 0 13.23492 0 0 14.78432 0 15.85409 0 0 12.73285 0 0 13.94008 0 0 0 0 0 16.29612 0 12.001 17.01538 16.0626 14.05129 15.84138 14.35861 0 0 15.81356 0 0 Q9NX04 CA109_HUMAN Uncharacterized protein C1orf109 C1orf109 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829 QLVAGDIVLDK 1.220000029 0.023968497 0.023968497 0.166955859 1171.540847 14.67176 10.84642 0 0 0 0 14.43288 0 15.12782 0 0 15.78486 14.42995 12.61673 15.33664 14.41139 14.07696 0 15.62279 0 0 14.37101 0 14.0586 15.03118 0 0 13.20793 14.32156 14.87806 14.8415 15.16186 15.0222 12.64358 0 15.55389 12.24017 15.58848 15.88688 14.36452 12.40044 13.05169 15.79637 12.73996 15.0514 15.30998 13.45906 13.81889 Q9NX09 DDIT4_HUMAN "DNA damage-inducible transcript 4 protein (HIF-1 responsive protein RTP801) (Protein regulated in development and DNA damage response 1, REDD-1)" DDIT4 REDD1 RTP801 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of glycolytic process [GO:0045820]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of TOR signaling [GO:0032007]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron death [GO:1901216]; protein-containing complex disassembly [GO:0032984]; reactive oxygen species metabolic process [GO:0072593]; regulation of TOR signaling [GO:0032006]; response to hypoxia [GO:0001666] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 14-3-3 protein binding [GO:0071889]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of glycolytic process [GO:0045820]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of TOR signaling [GO:0032007]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron death [GO:1901216]; protein-containing complex disassembly [GO:0032984]; reactive oxygen species metabolic process [GO:0072593]; regulation of TOR signaling [GO:0032006]; response to hypoxia [GO:0001666] 14-3-3 protein binding [GO:0071889] GO:0001666; GO:0001764; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007420; GO:0010801; GO:0030182; GO:0032006; GO:0032007; GO:0032984; GO:0033137; GO:0042771; GO:0045820; GO:0048011; GO:0051607; GO:0071549; GO:0071889; GO:0072593; GO:1901216; GO:1902532 LLMPSQLVSQVGKELLR 1.50999999 1 1 0.536070018 1927.432284 0 15.42661 16.15559 0 0 0 17.57508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.99177 0 0 0 0 0 0 0 16.86217 0 0 0 0 0 0 0 0 Q9NX31 OSER1_HUMAN Oxidative stress-responsive serine-rich protein 1 (Oxidative stress-responsive protein 1) (Peroxide-inducible transcript 1 protein) OSER1 C20orf111 BM-038 HSPC168 HSPC207 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301] cellular response to hydrogen peroxide [GO:0070301] GO:0070301 VDASGSVASLSVGEGTGVR 5.039999962 1 1 0.170368884 1747.447489 0 0 0 16.18467 0 0 0 0 0 16.54868 0 15.46722 0 14.266 13.55658 0 0 0 0 0 13.47658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.96613 0 0 0 Q9NX40 OCAD1_HUMAN OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen) OCIAD1 ASRIJ OCIA Homo sapiens (Human) endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736] GO:0005764; GO:0005768; GO:0005794; GO:0006897; GO:0016020; GO:0046427; GO:0061484; GO:2000736 YGSIPK 3.24000001 1 1 0.199369745 665.5600775 19.17444 17.13071 15.09179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX45 SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 SOHLH2 TEB1 Homo sapiens (Human) cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007283; GO:0009994; GO:0030154; GO:0042803; GO:0046982; GO:1990837 NGNGLELNASLSEFEKNK 4.699999809 1 1 0.493019283 1963.26 0 0 0 16.78646 0 0 0 0 0 0 0 0 18.01881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.58231 0 19.08706 0 0 0 17.22614 0 0 0 0 16.86346 0 0 18.34709 0 0 0 17.62198 Q9NX58 LYAR_HUMAN Cell growth-regulating nucleolar protein LYAR PNAS-5 Homo sapiens (Human) erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416]; erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416] GO:0000122; GO:0001750; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0046872; GO:0048821; GO:0050766; GO:0140297; GO:0140416 GYEGK 3.059999943 1 1 0.103525944 554.2557145 14.80368 14.8535 13.48411 13.6757 15.9499 13.63698 15.23293 0 15.20004 13.2141 16.2143 15.84348 14.28095 0 15.23035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX62 IMPA3_HUMAN "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase, Golgi-resident PAP phosphatase, gPAPP, EC 3.1.3.7 (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Myo-inositol monophosphatase A3) (Phosphoadenosine phosphate 3'-nucleotidase)" BPNT2 IMPA3 IMPAD1 Homo sapiens (Human) chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501] cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]; chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501]" "3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]" GO:0001501; GO:0001958; GO:0002063; GO:0005654; GO:0005794; GO:0005796; GO:0005829; GO:0008254; GO:0008441; GO:0009791; GO:0012505; GO:0016020; GO:0016021; GO:0016604; GO:0030204; GO:0032588; GO:0042733; GO:0046854; GO:0046855; GO:0046872; GO:0097657 SSYNEK 2.329999924 1 1 0.067681924 726.6978534 0 15.57905 12.60982 15.5182 11.95159 14.69297 0 0 0 0 14.77613 0 16.49946 0 0 0 0 0 17.04401 17.17896 0 17.06504 0 0 16.64322 15.31294 0 14.3246 15.79255 0 0 0 0 0 0 0 0 16.74835 0 0 0 0 0 0 0 0 0 0 Q9NX63 MIC19_HUMAN MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3) CHCHD3 MIC19 MINOS3 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053] extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401] extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053] molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902] GO:0001401; GO:0005634; GO:0005739; GO:0005743; GO:0007007; GO:0008053; GO:0019902; GO:0042407; GO:0044284; GO:0060090; GO:0061617; GO:0070062; GO:0140275 AAEEVEAK 7.369999886 1 1 0.209804099 844.7909109 14.18704 15.79249 0 0 16.44113 17.06767 0 16.34192 0 0 0 0 0 14.59651 0 15.34871 0 0 0 0 0 0 15.783 0 15.77312 0 0 0 0 16.68543 15.28543 16.73063 0 0 16.737 0 0 16.76808 0 0 0 0 0 0 0 0 0 0 Q9NX74 DUS2L_HUMAN "tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, EC 1.3.1.91 (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8, URLC8) (tRNA-dihydrouridine synthase 2-like, hDUS2)" DUS2 DUS2L Homo sapiens (Human) negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943] double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264] GO:0000049; GO:0002943; GO:0003725; GO:0004860; GO:0005737; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0060548; GO:0070402; GO:0102264 EQLESPQGR 10.85000038 0.647840321 0.647840321 0.077599226 1041.843948 0 0 15.07302 15.63429 0 16.12543 15.86093 13.88706 15.03816 16.97621 16.55026 13.65263 17.79779 18.59445 18.48204 0 18.4351 17.67927 0 16.79782 18.85269 18.43199 17.77526 18.3947 14.50151 16.13799 15.35035 0 17.09277 17.06973 0 15.74677 15.86578 17.15586 16.35178 0 16.78819 17.80168 0 19.23503 17.9103 18.31412 13.82412 0 15.54366 0 16.05273 17.22118 Q9NX76 CKLF6_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 6 (Chemokine-like factor superfamily member 6) CMTM6 CKLFSF6 Homo sapiens (Human) endocytic recycling [GO:0032456]; protein transport [GO:0015031]; regulation of protein stability [GO:0031647] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; regulation of protein stability [GO:0031647] GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0031647; GO:0031901; GO:0032456; GO:0035577; GO:0035579; GO:0055038 MENGAVYSPTTEEDPGPAR 1.99000001 0.19955571 0.19955571 0.157896248 2036.877331 15.03837 0 11.57094 0 0 0 0 14.13932 0 0 0 0 0 0 0 0 0 11.81935 12.94335 0 0 15.45813 15.61151 0 0 13.93641 0 0 0 12.7862 0 0 0 0 0 0 11.99095 13.93595 0 0 0 0 13.002 0 0 0 0 0 Q9NX77 ENK13_HUMAN "Endogenous retrovirus group K member 13-1 Env polyprotein (Envelope polyprotein) (HERV-K_16p13.3 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVK13-1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198] structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0016021 VPLTTKTNK 6.239999771 0.932772577 0.932772577 0.26836442 1001.307412 15.14525 15.8781 15.78071 0 0 15.8825 15.2221 15.73474 15.28445 0 15.80096 16.02596 14.83177 15.95086 0 0 0 0 16.09787 14.82773 0 16.21471 0 0 0 16.27758 16.54382 0 0 15.64094 0 0 0 15.28166 14.92368 14.82734 0 0 0 15.25264 14.80437 16.19088 15.04392 0 0 17.21207 16.46248 15.05617 Q9NX78 TM260_HUMAN Transmembrane protein 260 TMEM260 C14orf101 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MSPHGDGR 4.119999886 1 1 0.245194281 872.6301274 13.84022 15.50635 0 14.58759 15.57219 15.69555 15.65117 0 15.02806 0 16.33161 13.67805 15.5074 16.2508 14.97641 14.96647 14.9696 0 0 15.82899 0 0 15.38771 0 0 0 0 0 0 14.67578 0 0 15.33074 16.19786 0 0 0 0 16.36218 0 0 0 0 0 0 0 0 14.81833 Q9NX95 SYBU_HUMAN Syntabulin (Golgi-localized syntaphilin-related protein) (Syntaxin-1-binding protein) SYBU GOLSYN KIAA1472 Homo sapiens (Human) axonal transport of mitochondrion [GO:0019896]; synapse maturation [GO:0060074] axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; kinesin binding [GO:0019894]; syntaxin-1 binding [GO:0017075]; axonal transport of mitochondrion [GO:0019896]; synapse maturation [GO:0060074] kinesin binding [GO:0019894]; syntaxin-1 binding [GO:0017075] GO:0000139; GO:0005881; GO:0016021; GO:0017075; GO:0019894; GO:0019896; GO:0031410; GO:0043231; GO:0060074; GO:1904115 GSDCSPIMR 4.940000057 0.618527114 0.618527114 0.246481087 1039.390739 16.08941 17.4526 16.24682 15.6086 0 0 15.82293 13.90302 0 15.92216 0 17.48862 0 14.3814 13.51794 13.92078 16.16528 0 0 0 14.611 0 16.50502 0 16.83185 0 16.29395 16.58517 16.43089 0 15.43274 0 16.40932 0 0 0 0 0 0 16.43578 16.30537 15.79298 16.03688 0 16.19795 17.49953 15.61083 16.02331 Q9NXA8 SIR5_HUMAN "NAD-dependent protein deacylase sirtuin-5, mitochondrial, EC 2.3.1.- (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)" SIRT5 SIR2L5 Homo sapiens (Human) mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667] NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270] GO:0003950; GO:0005634; GO:0005739; GO:0005758; GO:0005759; GO:0005829; GO:0006471; GO:0006476; GO:0007005; GO:0008270; GO:0010566; GO:0010667; GO:0031667; GO:0034979; GO:0036046; GO:0036047; GO:0036048; GO:0036049; GO:0036054; GO:0036055; GO:0061697; GO:0061698; GO:0070403; GO:2000378 NQICLKMARPSSSMADFR 2.779999971 1 1 0.140065896 2111.969433 12.08937 10.64773 14.71656 0 11.19798 0 15.28156 0 0 0 0 0 0 16.3839 0 0 0 0 0 0 13.87556 0 15.92317 0 0 11.23801 13.18404 0 0 12.47166 0 16.06024 0 0 17.26121 0 0 0 0 14.64532 0 0 12.03952 0 0 0 14.33633 0 Q9NXB0 MKS1_HUMAN Meckel syndrome type 1 protein MKS1 Homo sapiens (Human) "branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]" centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038] "centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]" GO:0001843; GO:0003271; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1901620; GO:1905515; GO:1990403; GO:2000095 IPGSFK 9.510000229 1 1 0.161745554 647.4624082 0 0 0 0 0 0 0 0 0 0 15.01131 14.59423 0 0 12.24119 0 13.0609 0 0 0 0 14.62223 0 0 17.97349 15.48761 0 14.88777 15.17113 14.04144 18.93942 13.75157 17.30643 17.12789 16.86559 0 0 0 19.23569 0 0 0 14.06087 0 0 19.02506 0 0 Q9NXD2 MTMRA_HUMAN Myotubularin-related protein 10 (Inactive phosphatidylinositol 3-phosphatase 10) MTMR10 Homo sapiens (Human) phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol dephosphorylation [GO:0046856] phosphatidylinositol-3-phosphatase activity [GO:0004438] GO:0004438; GO:0005737; GO:0005829; GO:0046856 LICSNFK 4.559999943 1 1 0.143162123 881.5610162 13.81385 16.13102 0 14.85888 14.71152 11.89809 15.94835 0 0 16.23755 0 0 0 0 0 0 15.70867 0 0 0 16.33666 16.48817 15.88176 16.0296 0 0 0 0 14.6386 14.68169 0 0 0 0 15.92066 0 16.58379 17.32749 18.11557 0 13.91764 16.60397 18.28389 0 16.70976 0 15.70434 0 Q9NXE4 NSMA3_HUMAN "Sphingomyelin phosphodiesterase 4, EC 3.1.4.12 (Neutral sphingomyelinase 3, nSMase-3, nSMase3) (Neutral sphingomyelinase III)" SMPD4 KIAA1418 SKNY Homo sapiens (Human) cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685] metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290] GO:0000139; GO:0004767; GO:0005635; GO:0005640; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0006685; GO:0007029; GO:0016021; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356 GPRLSLR 2.039999962 0.324166417 0.324166417 0.072777299 799.4293601 0 17.38351 15.30179 15.88254 13.51146 0 0 0 0 17.12482 0 0 16.26608 0 0 0 0 16.5053 0 16.05627 13.29931 0 17.62842 0 0 0 0 0 0 17.37962 14.59416 18.2659 16.18862 0 18.02624 13.98012 17.17515 17.63962 16.70226 0 15.66334 15.46173 0 0 16.85583 0 0 0 Q9NXE8 CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25) CWC25 CCDC49 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006 SRSPRPSK 6.389999866 0.517953873 0.517953873 0.082420799 914.6104283 16.91208 14.86553 15.86583 15.67567 0 13.89911 0 15.42895 16.3209 15.60213 16.51601 0 14.53026 0 0 0 0 0 0 0 0 0 15.72568 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7358 0 0 15.15589 0 16.47188 0 0 0 0 0 0 Q9NXF1 TEX10_HUMAN Testis-expressed protein 10 TEX10 L18 Nbla10363 Homo sapiens (Human) mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0071339 QHDFQK 7.170000076 0.408816963 0.408816963 0.163317458 803.0086597 0 13.74247 0 13.95011 14.2477 14.65408 0 15.07417 11.21175 0 0 0 14.44049 15.69224 0 14.44412 12.41455 14.97628 14.10054 0 0 0 0 0 0 0 0 14.40899 0 15.2492 0 0 0 0 14.46545 0 0 0 0 15.26068 0 0 0 0 0 0 13.12671 0 Q9NXG0 CNTLN_HUMAN Centlein (Centrosomal protein) CNTLN C9orf101 C9orf39 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365] protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0033365; GO:0070062 AKSEMATMK 14.82999992 1 1 1.03E-12 1013.674203 16.2403 14.27923 14.61215 13.95644 0 15.35685 0 0 0 15.32508 0 13.17665 15.29781 15.89009 0 0 0 0 0 0 0 0 13.14272 15.82833 15.66198 17.03646 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22861 14.99667 0 0 0 0 0 18.42261 0 Q9NXH8 TOR4A_HUMAN Torsin-4A (Torsin family 4 member A) TOR4A C9orf167 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; platelet alpha granule lumen [GO:0031093] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005576; GO:0005635; GO:0005788; GO:0016021; GO:0016887; GO:0031093 ASLLAVLSR 13.23999977 1 1 0.396577981 927.8440023 15.07183 16.30099 14.96314 16.02915 0 15.19911 15.88926 0 15.01615 16.03515 14.26156 16.28412 14.64882 15.5867 15.56849 16.1749 15.91105 16.06482 14.59844 14.94557 16.66828 0 0 14.94395 15.81378 15.8014 15.89579 15.18856 16.30434 15.19166 16.43222 0 0 15.10279 16.23222 16.70536 15.78522 17.01784 0 0 0 0 15.60797 16.21966 15.64527 0 16.34939 0 Q9NXL2 ARH38_HUMAN Rho guanine nucleotide exchange factor 38 ARHGEF38 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737 LNIHSISK 8.140000343 0.606539845 0.606539845 0.093147133 911.6506894 15.74773 13.32027 13.08369 13.82948 0 0 16.42358 0 0 0 14.16052 0 16.29173 15.19412 17.38147 12.44972 16.33239 13.98794 16.19055 13.63876 16.6248 15.70928 16.25016 15.33851 16.54576 13.06894 0 11.4473 16.18885 15.5124 0 15.31421 16.17358 0 0 15.03263 14.24221 17.93317 15.50172 12.86695 13.39517 17.18613 15.96514 0 0 16.18797 0 0 Q9NXL9 MCM9_HUMAN "DNA helicase MCM9, hMCM9, EC 3.6.4.12 (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9)" MCM9 C6orf61 MCMDC1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697] GO:0000724; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0032508; GO:0036298; GO:0042555; GO:0044877; GO:0070716; GO:0071168; GO:0097362 IISSFILENKGYPSK 17.45999908 1 1 0.266183798 1693.28001 0 14.03451 14.86384 14.43579 0 14.9307 15.23821 0 0 14.35422 0 0 0 0 0 15.21237 0 13.92433 0 0 14.75036 0 0 0 0 0 0 13.90534 16.5094 0 15.6652 16.65898 0 0 0 0 0 0 0 0 0 0 0 0 15.46642 0 16.54327 0 Q9NXN4 GDAP2_HUMAN Ganglioside-induced differentiation-associated protein 2 GDAP2 Homo sapiens (Human) response to retinoic acid [GO:0032526] lysosomal membrane [GO:0005765] lysosomal membrane [GO:0005765]; response to retinoic acid [GO:0032526] GO:0005765; GO:0032526 LLPLYFPRSLK 6.570000172 7.93E-05 7.93E-05 0.187520917 1345.848371 0 17.89472 0 0 0 0 15.77741 16.49878 0 0 0 0 0 0 0 0 17.3468 0 0 0 0 0 0 0 0 0 17.20675 0 0 0 0 0 19.37599 0 17.46054 0 0 18.1093 0 0 17.21761 17.52372 0 0 0 15.7099 0 0 Q9NXP7 GIN1_HUMAN "Gypsy retrotransposon integrase-like protein 1, GIN-1 (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)" GIN1 TGIN1 ZH2C2 Homo sapiens (Human) DNA integration [GO:0015074] nucleic acid binding [GO:0003676]; DNA integration [GO:0015074] nucleic acid binding [GO:0003676] GO:0003676; GO:0015074 NTPYFQMFSR 11.82999992 1 1 0.188413785 1307.321872 15.81302 0 18.11976 0 0 0 15.96812 0 0 0 0 0 0 0 0 0 0 0 0 0 13.57701 0 0 13.71484 0 0 0 17.31659 13.20658 0 0 0 0 0 0 18.08126 0 0 0 0 0 0 16.99799 0 0 0 16.51501 0 Q9NXR8 ING3_HUMAN Inhibitor of growth protein 3 (p47ING3) ING3 HSPC301 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]" NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812] "NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]" metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] GO:0000786; GO:0000812; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016573; GO:0032777; GO:0035064; GO:0035267; GO:0040008; GO:0042981; GO:0043065; GO:0043967; GO:0043968; GO:0045893; GO:0046872; GO:0051726; GO:1905168; GO:2000779 WYCPQCTAAMKR 5.760000229 1 1 1.14E-12 1586.539237 15.22044 0 13.81929 13.28836 12.97826 14.8972 0 12.9365 12.88011 0 12.33294 15.08669 0 0 13.51872 14.53991 0 16.12271 12.9592 13.62598 10.20932 0 15.33138 0 0 0 0 0 15.22433 14.69987 15.23897 14.62536 12.68931 13.83193 0 0 16.14409 15.1228 0 0 14.51192 14.88762 0 0 0 0 0 14.38746 Q9NXS2 QPCTL_HUMAN "Glutaminyl-peptide cyclotransferase-like protein, EC 2.3.2.5 (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC, gQC)" QPCTL Homo sapiens (Human) "peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]" glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270] GO:0000139; GO:0005794; GO:0008270; GO:0016020; GO:0016021; GO:0016603; GO:0017186 TPGSPGNLQVRK 6.840000153 1 1 0.455716551 1254.88418 0 10.0461 11.39701 14.13552 14.32598 0 0 14.20047 14.89459 0 14.36716 11.66185 13.67633 0 0 15.48448 0 0 0 14.73228 15.09146 0 0 0 0 16.54766 0 0 15.49631 0 0 16.60458 0 0 16.31689 0 15.53489 17.37549 0 16.03284 0 16.60228 0 0 0 15.72268 16.08059 15.57767 Q9NXS3 KLH28_HUMAN Kelch-like protein 28 (BTB/POZ domain-containing protein 5) KLHL28 BTBD5 Homo sapiens (Human) YDPSKDSWEMVASMADK 5.690000057 1 1 0.397338899 1990.79536 0 0 12.57307 0 0 0 15.52653 0 15.85841 17.70225 0 13.02873 17.99544 9.699737 0 0 0 0 0 0 0 0 16.21224 16.51128 0 16.56298 0 0 0 0 0 0 0 16.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXV6 CARF_HUMAN CDKN2A-interacting protein (Collaborator of ARF) CDKN2AIP CARF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell growth [GO:0030308]; positive regulation of cell growth [GO:0030307]; positive regulation of signal transduction [GO:0009967]; regulation of protein stability [GO:0031647] granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell growth [GO:0030308]; positive regulation of cell growth [GO:0030307]; positive regulation of signal transduction [GO:0009967]; regulation of protein stability [GO:0031647] p53 binding [GO:0002039]; RNA binding [GO:0003723] GO:0001652; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0006974; GO:0009967; GO:0030307; GO:0030308; GO:0031647 VIEGKNSSAVEQDHAK 5.329999924 1 1 0.455053807 1713.690098 0 0 0 0 0 0 0 0 17.59142 0 0 0 0 0 0 0 0 0 16.28602 0 14.18504 0 0 0 0 18.63862 0 18.86987 0 0 0 0 0 17.84001 19.41148 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXW2 DJB12_HUMAN DnaJ homolog subfamily B member 12 DNAJB12 Homo sapiens (Human) cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] Hsp70 protein binding [GO:0030544] GO:0005783; GO:0005789; GO:0016020; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0036503; GO:0051085; GO:0065003; GO:0071218 AIQSNQPDR 4.599999905 1 1 0.305787773 1027.847343 15.31954 16.65256 16.7157 17.45029 17.88308 17.57013 0 0 17.78685 0 17.43764 0 0 0 16.59119 17.70995 0 0 0 0 0 0 17.9179 0 0 0 0 17.1551 0 0 0 18.3705 0 0 0 19.66573 17.52249 0 0 17.13519 0 18.02545 0 0 0 0 0 0 Q9NXX6 NSE4A_HUMAN "Non-structural maintenance of chromosomes element 4 homolog A, NS4EA, Non-SMC element 4 homolog A" NSMCE4A C10orf86 PP4762 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0006281; GO:0016604; GO:0016925; GO:0030915; GO:0032204; GO:2001022 GPEGR 7.230000019 0.358177215 0.358177215 0.158703041 514.3857853 16.71128 17.6913 0 18.79735 18.23502 17.48314 16.83049 18.25834 16.93355 18.67566 16.42819 16.79083 16.47445 16.57874 16.6436 17.44807 18.21246 16.31924 17.35098 18.24187 17.12984 18.15688 16.60739 17.51784 16.6812 18.17673 17.71077 18.18958 16.36312 16.52656 17.54829 17.09468 17.37688 18.4024 17.62892 16.86392 16.7594 15.5185 17.06115 18.06487 17.06435 17.39232 18.10999 15.57068 15.46781 17.48377 16.78801 16.97256 Q9NXZ1 SAGE1_HUMAN "Sarcoma antigen 1 (Cancer/testis antigen 14, CT14)" SAGE1 SAGE Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; snRNA 3'-end processing [GO:0034472] GO:0005654; GO:0016604; GO:0032039; GO:0034472 EEKMESGKPQTDK 9.329999924 0.452168047 0.452168047 0.395940879 1523.427914 0 14.61101 12.4582 0 14.74887 15.73119 10.55422 0 13.89572 12.84534 16.11352 16.03987 0 14.66656 0 0 0 0 15.86326 0 16.20395 0 0 0 0 0 0 11.10822 0 15.89581 0 16.4232 0 16.86728 15.98278 17.1468 0 0 0 14.91316 18.28745 0 0 0 0 0 0 0 Q9NXZ2 DDX43_HUMAN "Probable ATP-dependent RNA helicase DDX43, EC 3.6.4.13 (Cancer/testis antigen 13, CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen)" DDX43 HAGE Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0016887 TGPEGYSVGR 10.82999992 1 1 0.07327418 1022.732006 13.03835 0 0 0 10.59397 0 18.29207 0 0 12.07245 15.9362 15.06842 0 0 16.75615 13.01398 0 14.39959 15.88348 17.08641 13.24697 17.21514 15.45837 9.437531 13.13857 13.14919 17.43315 15.53347 16.03617 0 0 15.84312 15.90085 0 16.80922 0 16.50128 17.46296 0 16.98151 13.16323 16.15724 0 15.7906 0 14.3963 16.61897 15.1303 Q9NY26 S39A1_HUMAN "Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1, ZIP-1, hZIP1)" SLC39A1 IRT1 ZIP1 ZIRTL CGI-08 CGI-71 Homo sapiens (Human) cation transport [GO:0006812]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]; cation transport [GO:0006812]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577] inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385] GO:0001701; GO:0005102; GO:0005385; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0016021; GO:0022890; GO:0048701; GO:0060173; GO:0071577 GILAVSLSLR 5.539999962 0.176186323 0.176186323 0.274700978 1028.441629 17.4429 18.0705 0 0 0 0 0 17.58641 19.5879 16.39036 0 0 16.27297 0 0 0 17.16404 0 0 0 0 0 0 16.23406 17.8175 17.84955 17.00512 16.67721 16.73056 0 19.00777 17.70643 0 17.81708 0 0 17.21563 0 0 17.37041 0 18.21792 0 0 0 0 0 0 Q9NY27 PP4R2_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 2 PPP4R2 SBBI57 Homo sapiens (Human) cellular protein modification process [GO:0006464]; histone dephosphorylation [GO:0016576]; mRNA processing [GO:0006397]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569]; RNA splicing [GO:0008380] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; cellular protein modification process [GO:0006464]; histone dephosphorylation [GO:0016576]; mRNA processing [GO:0006397]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569]; RNA splicing [GO:0008380] protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006397; GO:0006464; GO:0006470; GO:0008380; GO:0010569; GO:0016576; GO:0019888; GO:0030289; GO:0030674; GO:0033128; GO:2000779 ETEELVGSNSSK 5.650000095 1 1 0.438458865 1279.34451 19.66337 0 0 17.67187 0 0 0 0 0 0 15.19005 0 0 18.22734 17.55368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.70162 19.60181 0 0 0 20.01186 0 17.28199 17.71849 0 0 0 0 0 0 0 Q9NY46 SCN3A_HUMAN Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3) SCN3A KIAA1356 NAC3 Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; cytoplasm [GO:0005737]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; cytoplasm [GO:0005737]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005737; GO:0006814; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010 GRIDLPIK 2.519999981 1 1 0.276952388 912.7723342 18.71524 16.85333 18.11177 0 19.27377 18.20681 17.49203 0 0 0 0 0 16.62707 0 16.8003 0 18.51303 0 0 0 0 0 16.73955 16.66108 18.72208 0 0 0 0 16.79103 19.48291 18.4712 0 0 16.85072 0 0 17.59453 18.3264 0 17.59305 0 0 0 16.76846 18.59675 17.63865 18.09837 Q9NY47 CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2 ] CACNA2D2 KIAA0558 Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765] plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005886; GO:0005891; GO:0034765; GO:0046872 INTQEYLDVLGRPMVLAGK 5.320000172 1 1 3.65E-12 2132.842947 0 0 0 17.76766 0 0 0 12.09969 15.74613 12.52888 17.45528 17.0382 0 16.33853 12.81054 10.18856 16.07966 0 0 15.9672 10.97079 0 16.67394 10.53285 14.72213 18.06584 0 0 0 14.41492 0 0 16.67075 12.54577 12.02564 12.4 16.04597 15.78426 0 15.1497 16.09176 12.98086 17.34019 0 14.0771 14.7886 0 17.60296 Q9NY61 AATF_HUMAN Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1) AATF CHE1 DED HSPC277 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254] leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156] GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005794; GO:0006357; GO:0006974; GO:0007155; GO:0007346; GO:0019901; GO:0032929; GO:0040016; GO:0042254; GO:0042985; GO:0043066; GO:0043522; GO:0045944; GO:0048156; GO:2000378; GO:2001234 LEMEDYPSFMAKR 7.599999905 1 1 0.450903688 1633.125459 0 0 0 0 0 0 0 16.56252 0 17.46631 0 0 0 17.43472 0 0 0 17.82034 0 0 0 0 19.9232 0 0 0 0 0 0 0 19.61731 0 18.56644 0 0 19.35596 0 0 0 0 0 0 18.27904 17.39997 0 0 0 0 Q9NY64 GTR8_HUMAN "Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8, GLUT-8) (Glucose transporter type X1)" SLC2A8 GLUT8 GLUTX1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666] clathrin-coated endocytic vesicle membrane [GO:0030669]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] clathrin-coated endocytic vesicle membrane [GO:0030669]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666] D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355] GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030669; GO:0033300; GO:0055056; GO:0070837; GO:1904659 GKTLEQITAHFEGR 3.25999999 1 1 0.042312814 1586.844315 0 0 0 0 0 0 0 0 0 0 0 14.09055 0 0 0 13.88032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.33926 16.83465 14.69266 0 0 0 14.69751 0 0 0 0 0 0 0 0 0 0 Q9NY74 ETAA1_HUMAN Ewing's tumor-associated antigen 1 (Ewing's tumor-associated antigen 16) ETAA1 ETAA16 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297] protein serine/threonine kinase activator activity [GO:0043539] GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0031297; GO:0043539; GO:0043596; GO:0071902; GO:2000001 KPIKGNTK 4.170000076 1 1 0.180298193 881.6060336 12.81017 0 16.39709 13.99045 15.9981 15.40448 0 15.93073 0 0 15.80572 0 15.52728 0 15.14709 0 14.45747 0 15.76723 15.71905 16.23949 0 0 0 15.22236 0 15.20013 15.88404 16.59428 0 0 0 15.87812 13.88062 14.51222 14.61001 16.47799 15.24349 15.67145 15.20537 14.67944 15.63071 15.15317 16.59743 16.18965 14.08499 15.63097 15.5551 Q9NY87 SPNXC_HUMAN "Sperm protein associated with the nucleus on the X chromosome C (Cancer/testis antigen 11.3, CT11.3) (Cancer/testis-associated protein CTp11) (Nuclear-associated protein SPAN-Xc, SPANX-C) (SPANX family member C)" SPANXC Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 LKTSESSTILVVR 5.340000153 1 1 0.282859255 1433.266244 0 14.71031 15.5715 13.15042 0 15.17902 0 0 13.28089 15.13754 15.50202 13.35077 0 10.75236 15.91046 14.91619 0 11.95492 14.56781 13.93049 0 13.77114 15.82199 0 0 0 14.98565 0 0 0 0 14.34137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY91 SC5A4_HUMAN Solute carrier family 5 member 4 SLC5A4 SAAT1 SGLT3 Homo sapiens (Human) sodium ion transport [GO:0006814] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814] glucose:sodium symporter activity [GO:0005412] GO:0005412; GO:0005886; GO:0006814; GO:0016021 RFGGER 10.52999973 1 1 0.271740577 720.8061726 14.12651 0 15.2001 14.92449 14.98042 12.68231 14.39845 15.39813 14.22011 0 15.04002 15.37087 16.39467 15.47742 14.30905 16.46466 11.67692 12.94479 14.82118 0 15.26519 0 0 0 16.54659 0 0 15.28865 15.73839 14.14118 14.53676 16.49527 0 15.35588 14.65622 0 0 15.77867 17.38567 16.66633 0 0 16.07337 0 16.01691 0 15.33352 0 Q9NY93 DDX56_HUMAN "Probable ATP-dependent RNA helicase DDX56, EC 3.6.4.13 (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)" DDX56 DDX21 NOH61 Homo sapiens (Human) positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364] membrane [GO:0016020]; nucleolus [GO:0005730] membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020; GO:0016887 ASDPEAGVAR 6.880000114 1 1 1.37E-12 973.2310049 16.50959 14.103 0 12.31629 15.63697 14.75873 15.76616 13.29603 14.89535 15.12329 13.22397 0 14.89518 0 0 0 0 0 15.10005 0 0 0 0 0 16.20956 13.86176 15.01799 12.89849 15.11347 13.5392 0 0 0 0 0 0 0 0 0 0 0 0 11.96052 0 0 0 0 0 Q9NY99 SNTG2_HUMAN "Gamma-2-syntrophin, G2SYN (Syntrophin-5, SYN5)" SNTG2 Homo sapiens (Human) central nervous system development [GO:0007417] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; central nervous system development [GO:0007417] actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] GO:0003779; GO:0005198; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109 ATFMEVQRTGSR 2.819999933 1 1 0.306380552 1382.768876 0 0 14.3264 0 0 0 12.8084 15.33614 14.18078 0 13.57394 13.82849 0 13.74766 0 0 0 0 0 14.16788 0 0 0 0 0 14.05016 0 0 14.98094 0 0 14.10374 0 0 0 0 0 0 0 14.42183 0 0 0 0 13.14575 0 16.76456 0 Q9NYA1 SPHK1_HUMAN "Sphingosine kinase 1, SK 1, SPK 1, EC 2.7.1.91 (Acetyltransferase SPHK1, EC 2.3.1.-)" SPHK1 SK1 SPHK SPK Homo sapiens (Human) blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036] GO:0000287; GO:0001568; GO:0001727; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006665; GO:0006670; GO:0006954; GO:0007420; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0016020; GO:0016310; GO:0016407; GO:0017050; GO:0019722; GO:0030100; GO:0030139; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035556; GO:0035924; GO:0038036; GO:0043066; GO:0043231; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071363; GO:0071897; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364 DPAGGPR 1.389999986 0.515886366 0.515886366 0.107625718 670.4773787 0 14.37432 12.97492 0 0 0 0 0 0 0 16.19265 0 0 0 0 0 0 0 0 0 0 0 15.02839 0 0 0 0 15.5177 0 15.94778 0 0 0 0 0 0 0 0 0 15.40006 0 17.41969 0 0 0 16.37382 16.66763 17.59501 Q9NYA3 GOG6A_HUMAN Golgin subfamily A member 6A (Golgin linked to PML) (Golgin-like protein) GOLGA6A GLP GOLGA6 Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 SLSELKNQMAEPPSLAPPAVTSVVEQLQDEAK 2.420000076 1 1 0.181055989 3406.460145 0 0 0 0 11.59542 7.372975 0 7.718947 0 14.3164 13.32394 12.69819 10.78539 13.42327 12.03982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYA4 MTMR4_HUMAN "Myotubularin-related protein 4, EC 3.1.3.48 (FYVE domain-containing dual specificity protein phosphatase 2, FYVE-DSP2) (Zinc finger FYVE domain-containing protein 11)" MTMR4 KIAA0647 ZFYVE11 Homo sapiens (Human) negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615] "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]" GO:0004438; GO:0004722; GO:0004725; GO:0005615; GO:0005768; GO:0005829; GO:0006470; GO:0006661; GO:0007179; GO:0010506; GO:0019903; GO:0030512; GO:0031901; GO:0046856; GO:0046872; GO:0052629; GO:0060304 IPVVVYR 6.420000076 1 1 0.302450468 845.9043881 15.18071 16.80835 0 0 0 0 14.883 16.14701 0 0 0 13.33806 0 0 16.93423 0 14.19666 0 16.23693 15.29899 0 0 16.67743 0 0 0 17.27858 17.54295 0 15.76499 0 0 16.7754 16.14798 17.2247 17.30234 15.62371 18.19845 0 16.95092 17.55087 16.86134 17.16893 16.89205 17.38086 17.39924 15.31947 15.98064 Q9NYB5 SO1C1_HUMAN "Solute carrier organic anion transporter family member 1C1 (Organic anion transporter F, OATP-F) (Organic anion transporter polypeptide-related protein 5, OAT-RP-5, OATPRP5) (Organic anion-transporting polypeptide 14, OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter)" SLCO1C1 OATP14 OATP1C1 OATPF SLC21A14 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; bile acid and bile salt transport [GO:0015721]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015349; GO:0015721; GO:0016323; GO:0043252; GO:0055085; GO:0070327; GO:0150104; GO:2000611 ERTMVSTR 3.890000105 1 1 0.17953601 980.3979273 0 0 0 15.12797 0 0 14.11955 11.59701 15.65919 12.83429 15.91518 16.71349 15.43946 0 14.12417 0 0 14.16242 0 0 0 0 0 0 0 0 0 0 0 15.91766 0 0 16.03123 0 0 0 0 0 0 0 0 0 13.99166 0 0 13.96724 0 0 Q9NYC9 DYH9_HUMAN Dynein axonemal heavy chain 9 (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9) DNAH9 DNAH17L DNEL1 KIAA0357 Homo sapiens (Human) cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; mucociliary clearance [GO:0120197] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; mucociliary clearance [GO:0120197] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0036157; GO:0045505; GO:0051959; GO:0090660; GO:0097729; GO:0120135; GO:0120197 AALAAENADGEPGADR 30.92000008 1 1 0.203814052 1527.97624 24.01407 0 0 0 0 24.04543 0 0 0 0 0 0 23.58134 0 0 23.17624 0 0 0 0 0 23.44995 0 0 0 0 0 0 21.72569 0 0 0 0 23.75042 22.31023 22.71845 0 0 0 0 0 23.54472 0 23.5835 0 0 0 22.23974 Q9NYD6 HXC10_HUMAN Homeobox protein Hox-C10 (Homeobox protein Hox-3I) HOXC10 HOX3I Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0009952; GO:0009954; GO:0016604; GO:0021520; GO:0030326; GO:0045944; GO:0050905; GO:0120163; GO:1990837 SAGMYMQSGSDFNCGVMRGCGLAPSLSK 5.159999847 1 1 0.219138284 2983.83204 0 0 0 0 0 0 0 0 0 14.61839 0 0 0 0 0 10.80321 0 0 0 0 0 0 0 0 14.66751 0 15.83335 0 0 0 0 0 16.57434 0 18.03187 0 0 0 14.38891 0 0 0 0 0 14.71345 0 0 0 Q9NYF0 DACT1_HUMAN "Dapper homolog 1, hDPR1 (Dapper antagonist of catenin 1) (Hepatocellular carcinoma novel gene 3 protein)" DACT1 DPR1 HNG3 Homo sapiens (Human) "embryonic hindgut morphogenesis [GO:0048619]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube development [GO:0021915]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein stability [GO:0031647]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; histone deacetylase binding [GO:0042826]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; embryonic hindgut morphogenesis [GO:0048619]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube development [GO:0021915]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein stability [GO:0031647]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]" beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; histone deacetylase binding [GO:0042826]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GO:0000122; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008013; GO:0016055; GO:0021915; GO:0030177; GO:0030178; GO:0031647; GO:0032091; GO:0032092; GO:0042826; GO:0045202; GO:0045732; GO:0046329; GO:0048619; GO:0051018; GO:0060828; GO:0061629; GO:0070097; GO:0090090; GO:0090263; GO:1903364; GO:1904864; GO:2000095; GO:2000134 GAGGAGAAAPR 5.639999866 1 1 5.48E-05 855.1183712 0 0 0 0 0 0 0 0 0 0 0 0 0 15.55447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.01735 0 0 14.53571 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYF3 FA53C_HUMAN Protein FAM53C FAM53C C5orf6 Homo sapiens (Human) protein import into nucleus [GO:0006606] nucleus [GO:0005634] nucleus [GO:0005634]; protein import into nucleus [GO:0006606] GO:0005634; GO:0006606 RLRPSLDFDK 7.989999771 0.752840936 0.752840936 0.196385757 1244.082724 0 0 0 15.45686 0 0 13.27804 15.37746 0 0 0 0 0 0 0 0 0 15.37607 0 0 0 0 16.57456 14.97532 0 0 16.15517 0 0 0 0 0 13.25274 0 0 9.441109 0 0 0 9.521435 0 15.74568 0 0 0 0 0 0 Q9NYF5 FA13B_HUMAN Protein FAM13B (GAP-like protein N61) FAM13B C5orf5 FAM13B1 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0007165; GO:0051056 NAQKEDR 2.960000038 1 1 0.213658174 861.5099518 0 0 0 12.33483 16.02322 15.76246 0 15.51093 0 14.2672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.51818 0 17.16806 0 0 15.55267 16.88183 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYF8 BCLF1_HUMAN "Bcl-2-associated transcription factor 1, Btf (BCLAF1 and THRAP3 family member 1)" BCLAF1 BTF KIAA0164 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]" cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]" DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GO:0003677; GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0016592; GO:0016607; GO:0043065; GO:0043620; GO:0045892; GO:0045944; GO:1990830; GO:2000144; GO:2001022; GO:2001244 EEDKNSER 8.779999733 0.546656966 0.546656966 0.149666127 1007.665782 14.8294 14.4064 0 14.70451 0 0 11.92997 16.37107 0 13.09965 15.23432 14.49076 0 13.65471 0 0 0 0 0 0 14.13493 0 0 0 0 0 0 0 0 0 0 0 0 14.2912 0 15.25577 13.769 0 15.42486 0 15.53542 0 0 0 0 0 0 0 Q9NYG2 ZDHC3_HUMAN "Palmitoyltransferase ZDHHC3, EC 2.3.1.225 (Acyltransferase ZDHHC3, EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3, DHHC-3)" ZDHHC3 HSD49 Homo sapiens (Human) "lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]" endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]" palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:0140439; GO:1902685; GO:1903546 AMLTDPGAVPKGNATK 9.539999962 1 1 0.513862602 1587.005233 16.95743 17.22629 16.17692 16.31001 0 0 0 19.42845 0 0 0 0 0 0 17.56745 16.64015 0 0 0 0 17.26172 0 0 0 16.88626 18.17931 0 0 17.7977 0 15.19999 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32318 0 0 0 Q9NYH9 UTP6_HUMAN U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein) UTP6 C17orf40 HCA66 MHAT Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" snoRNA binding [GO:0030515] GO:0000462; GO:0005654; GO:0005694; GO:0005730; GO:0030515; GO:0032040; GO:0034388 MELMHAEK 7.650000095 0.9030689 0.9030689 0.024486727 1003.025568 0 0 0 0 0 0 0 0 13.73898 0 0 0 0 0 11.51977 0 0 0 0 0 0 0 0 0 0 0 0 16.24972 0 0 0 0 0 0 0 0 0 0 0 0 15.07406 0 0 0 0 0 0 0 Q9NYI0 PSD3_HUMAN "PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D, Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3)" PSD3 EFA6D EFA6R HCA67 KIAA0942 Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012] postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of ARF protein signal transduction [GO:0032012] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0014069; GO:0032012; GO:0032587 ELLSNDESEAAGLK 2.809999943 1 1 0.372678885 1474.26516 14.7787 13.1108 0 0 0 0 0 14.18996 0 0 0 0 16.12983 0 0 16.4581 0 15.32723 17.01019 0 0 0 15.68651 16.91384 0 15.9102 0 14.9348 17.05712 17.2685 15.81759 16.804 17.13326 17.10044 0 0 0 0 17.934 16.60381 17.03513 17.4213 0 17.07411 17.05399 17.86806 17.52945 0 Q9NYJ8 TAB2_HUMAN "TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2, TAB-2) (TGF-beta-activated kinase 1-binding protein 2)" TAB2 KIAA0733 MAP3K7IP2 Homo sapiens (Human) heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496] cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] GO:0005654; GO:0005829; GO:0005886; GO:0007507; GO:0008270; GO:0010008; GO:0010507; GO:0032496; GO:0043123; GO:0043130; GO:0045860; GO:0070530 FNPIMVTLAPNIQTGR 4.619999886 1 1 0.491300909 1771.284201 0 0 14.5046 0 0 0 17.33259 0 17.26667 0 17.5476 0 0 0 0 0 0 0 0 0 16.45412 0 0 0 0 16.32533 0 0 0 0 0 0 0 0 17.34508 0 0 0 17.46226 0 0 0 0 0 0 0 0 0 Q9NYL2 M3K20_HUMAN "Mitogen-activated protein kinase kinase kinase 20, EC 2.7.11.25 (Human cervical cancer suppressor gene 4 protein, HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase, MLK-related kinase, MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)" MAP3K20 MLTK ZAK HCCS4 Homo sapiens (Human) cell cycle [GO:0007049]; cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; JNK cascade [GO:0007254]; limb development [GO:0060173]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; JNK cascade [GO:0007254]; limb development [GO:0060173]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723] GO:0000077; GO:0000287; GO:0003723; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007010; GO:0007049; GO:0007254; GO:0008219; GO:0030154; GO:0038066; GO:0042733; GO:0043065; GO:0051403; GO:0060173; GO:0071480; GO:0106310; GO:1904291 GDSSAEMSVYASLFKENNITGK 4.75 1 1 0.194199872 2364.374358 10.58971 14.79287 8.89582 10.91276 16.61095 12.21367 0 0 0 0 0 0 0 0 0 0 14.4309 11.65063 13.09192 0 0 0 0 0 0 15.01666 0 0 0 15.26205 14.17086 0 0 12.87283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYN1 RASLC_HUMAN "Ras-like protein family member 12, EC 3.6.5.2 (Ras-like protein Ris)" RASL12 RIS Homo sapiens (Human) signal transduction [GO:0007165] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007165; GO:0019003 SIPALLLGNK 5.880000114 1 1 0.180525725 1025.876512 0 12.37329 14.1942 14.05332 14.66432 13.21139 15.43094 14.96558 15.10446 0 13.9318 15.71967 0 0 0 14.13396 0 14.90747 15.29602 14.60993 0 0 0 0 0 0 0 17.34722 0 0 15.88006 17.03746 0 0 15.9697 15.75362 0 0 0 0 15.351 0 0 15.56435 0 0 0 0 Q9NYP3 DONS_HUMAN Protein downstream neighbor of Son (B17) DONSON C21orf60 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478] nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894] nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]; DNA damage checkpoint signaling [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478] GO:0000077; GO:0005634; GO:0005657; GO:0006260; GO:0007095; GO:0030894; GO:0033260; GO:0048478 HEVQMDHRPESVVLVK 7.510000229 2.68E-06 2.68E-06 0.073812607 1903.592919 17.83424 0 0 15.60691 16.38527 15.92617 14.85981 0 0 15.49933 17.19655 17.23438 16.60946 15.74081 0 0 16.01027 14.69024 14.59079 0 14.35936 15.82056 17.29564 18.06737 17.46412 14.94913 15.69071 16.12415 16.12834 17.1029 16.17574 0 16.26933 16.0572 17.03871 16.86864 16.80422 17.04709 15.49137 16.75707 17.53489 16.01216 16.80476 16.66351 16.74474 15.89248 17.12415 17.03436 Q9NYQ6 CELR1_HUMAN "Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2, hFmi2)" CELSR1 CDHF9 FMI2 Homo sapiens (Human) "apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016021; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609 ETKETHVLR 2.549999952 1 1 0.102283631 1111.327234 0 0 0 15.47287 0 14.11032 15.02981 11.84278 14.92317 14.92321 0 14.89302 14.81132 11.6695 13.19915 14.92689 14.54437 14.79336 15.05973 13.94736 11.56569 12.62792 14.56605 17.3703 0 0 15.17946 0 0 0 0 13.74011 0 0 15.38211 0 15.19995 0 0 0 0 0 0 0 14.84749 0 0 0 Q9NYQ8 FAT2_HUMAN "Protocadherin Fat 2, hFat2 (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1, Multiple EGF-like domains protein 1)" FAT2 CDHF8 KIAA0811 MEGF1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005794; GO:0005886; GO:0005912; GO:0007156; GO:0010631; GO:0016021; GO:0031589; GO:0070062; GO:0098609 DVFNLVAKATDGGGR 3.730000019 1 1 0.16899035 1519.419096 17.46609 17.75826 17.6669 0 0 0 0 12.34297 0 13.66654 14.76153 0 0 16.71544 15.63649 12.93671 17.49389 0 13.33086 10.65874 0 0 0 15.48703 17.91812 13.78864 13.48603 16.4718 0 16.89628 13.96855 15.52423 0 15.12758 11.59059 17.31203 0 14.15481 0 11.80393 15.17625 0 13.08491 14.80429 0 11.42095 0 14.88888 Q9NYS0 KBRS1_HUMAN "NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1, Kappa B-Ras protein 1, KappaB-Ras1)" NKIRAS1 KBRAS1 Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129] GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0007249; GO:0010803; GO:0032484; GO:0032794; GO:0043129; GO:0048286 SSFPLPGRK 2.420000076 0.026292294 0.026292294 0.258228674 987.3444056 0 0 0 0 0 0 16.71676 0 15.59363 0 0 17.8597 17.63806 0 0 0 0 0 0 0 0 18.13902 0 0 0 0 18.05052 16.55798 17.11621 0 15.44712 0 0 0 0 0 0 0 0 0 0 0 17.50255 0 16.56483 15.58114 0 0 Q9NYU1 UGGG2_HUMAN "UDP-glucose:glycoprotein glucosyltransferase 2, UGT2, hUGT2, EC 2.4.1.- (UDP--Glc:glycoprotein glucosyltransferase 2) (UDP-glucose ceramide glucosyltransferase-like 1)" UGGT2 UGCGL2 UGT2 Homo sapiens (Human) endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0071712; GO:1904380 IAVNQHMR 7.119999886 0.309260875 0.309260875 0.203089848 967.5180802 15.44357 16.70886 16.96078 0 0 13.6767 16.69916 15.75046 15.36103 15.61829 14.86828 15.85078 16.37534 16.0615 0 16.54721 16.71692 15.59208 0 17.38947 16.76982 0 0 14.95921 16.70706 15.93986 15.79489 16.22209 0 14.19475 16.30961 16.31173 14.8742 0 15.11317 16.90611 16.3723 12.81009 16.22705 16.86235 15.65385 15.23743 15.12761 13.9043 14.95898 14.25759 0 15.55271 Q9NYU2 UGGG1_HUMAN "UDP-glucose:glycoprotein glucosyltransferase 1, UGT1, hUGT1, EC 2.4.1.- (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)" UGGT1 GT UGCGL1 UGGT UGT1 UGTR Homo sapiens (Human) 'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0051084; GO:0070062; GO:0071712; GO:1904380 GMSSK 2.309999943 1 1 0 507.5161022 16.68126 0 15.87005 0 0 0 0 0 17.17884 16.48905 16.69892 16.9096 16.07887 16.19563 16.99501 0 16.83582 16.07275 17.92881 18.0493 0 0 0 0 0 0 0 0 0 0 0 17.64407 0 0 0 0 0 0 0 0 0 0 0 0 17.09933 0 0 0 Q9NYV4 CDK12_HUMAN "Cyclin-dependent kinase 12, EC 2.7.11.22, EC 2.7.11.23 (Cdc2-related kinase, arginine/serine-rich, CrkRS) (Cell division cycle 2-related protein kinase 7, CDC2-related protein kinase 7) (Cell division protein kinase 12, hCDK12)" CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] GO:0000307; GO:0002944; GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0046777; GO:0070816; GO:0106310; GO:2000737 LVSKHK 4.699999809 1 1 0.248500766 712.8158369 0 0 0 0 0 0 0 0 0 0 0 0 16.6387 0 16.68585 16.79485 16.41711 0 0 17.39712 0 0 0 0 0 15.61441 0 0 0 14.16973 14.53121 14.62561 0 0 16.20506 0 17.65359 0 0 0 0 0 17.44293 0 0 0 0 0 Q9NYV6 RRN3_HUMAN "RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA, TIF-IA)" RRN3 TIFIA Homo sapiens (Human) "cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]" RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0008283; GO:0042254; GO:0045893; GO:0048872; GO:1902254; GO:2000142 LPGDAAASSSAVK 3.710000038 0.502729177 0.502729177 0.211472788 1173.751972 16.48701 14.24901 0 0 0 14.86049 12.35151 0 14.24563 15.82946 0 0 0 0 13.17496 0 0 0 0 0 15.93358 0 0 0 0 16.51626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81666 0 0 0 0 Q9NYW0 T2R10_HUMAN "Taste receptor type 2 member 10, T2R10 (Taste receptor family B member 2, TRB2)" TAS2R10 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 HNRQMQSNVTGLR 3.900000095 0.191283569 0.191283569 0.31462119 1557.37912 0 0 0 0 0 0 0 13.782 13.39635 0 0 0 0 0 0 0 16.38348 0 0 0 0 0 0 0 15.22233 0 0 15.72419 16.53782 13.95812 13.9491 13.84105 0 15.54235 15.35947 14.25173 0 13.94435 0 14.07905 14.07556 12.1927 13.55627 14.87444 17.30183 17.47864 0 17.07265 Q9NYW5 TA2R4_HUMAN "Taste receptor type 2 member 4, T2R4" TAS2R4 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; respiratory gaseous exchange by respiratory system [GO:0007585] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; respiratory gaseous exchange by respiratory system [GO:0007585] bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] GO:0001580; GO:0004930; GO:0005886; GO:0007585; GO:0008527; GO:0016021; GO:0033038; GO:0060170 SHRISSSDR 15.60999966 1 1 0.155313451 1045.175979 0 0 14.79148 0 14.56518 14.08659 8.701708 14.53932 0 15.66593 15.0159 0 0 0 0 14.16883 0 14.43617 0 0 0 0 14.49444 0 0 14.39754 0 0 0 14.01753 14.86163 0 15.74695 0 0 0 0 16.08673 0 0 0 15.63219 0 0 0 0 0 15.3137 Q9NYY8 FAKD2_HUMAN "FAST kinase domain-containing protein 2, mitochondrial" FASTKD2 KIAA0971 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396] RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0006396; GO:0006915; GO:0019843; GO:0032543; GO:0035770; GO:0042645; GO:0044528; GO:0070131; GO:1902775 GFLAMKMR 4.130000114 0.846710742 0.846710742 0.174586289 985.7605054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYZ2 MFRN1_HUMAN Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37) SLC25A37 MFRN MSCP HT015 Homo sapiens (Human) iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]; positive regulation of hemoglobin biosynthetic process [GO:0046985] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]; positive regulation of hemoglobin biosynthetic process [GO:0046985] iron ion transmembrane transporter activity [GO:0005381] GO:0005381; GO:0005739; GO:0005743; GO:0016021; GO:0046985; GO:0048250; GO:0055072 MDGDSRDGGGGK 4.630000114 1 1 0.403034849 1168.262213 15.84788 14.12554 16.06978 14.74909 16.28392 16.33471 15.40801 0 15.75649 0 14.33333 0 16.01056 0 0 0 0 16.23388 0 14.90233 15.00768 0 15.63869 0 0 0 0 0 16.5625 16.36101 0 0 0 16.23776 0 0 0 16.42491 0 0 0 16.39551 0 16.67443 15.38788 16.92108 16.13746 0 Q9NYZ3 GTSE1_HUMAN "G2 and S phase-expressed protein 1, GTSE-1 (Protein B99 homolog)" GTSE1 Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]" cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654] "cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; microtubule binding [GO:0008017]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]" microtubule binding [GO:0008017] GO:0005654; GO:0005829; GO:0005881; GO:0006977; GO:0007017; GO:0008017; GO:0015630; GO:0016020 KNSAMR 8.680000305 1 1 0.066953606 721.7904769 14.25529 0 12.33328 0 0 0 0 0 0 13.53499 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3657 13.90216 0 14.34234 0 0 0 0 0 0 17.85829 0 0 0 0 0 0 0 0 0 0 0 0 0 14.50089 Q9NZ08 ERAP1_HUMAN "Endoplasmic reticulum aminopeptidase 1, EC 3.4.11.- (ARTS-1) (Adipocyte-derived leucine aminopeptidase, A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)" ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154 Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]" "aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]" GO:0001525; GO:0002250; GO:0002474; GO:0004175; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062 NVHMKQEHYMK 2.109999895 0.341058552 0.341058552 0.295917238 1461.16328 0 16.15488 14.73721 0 0 17.46703 0 0 14.37207 15.10648 13.89705 16.04917 0 0 0 15.62791 0 0 0 0 13.35274 0 0 0 0 16.15602 0 0 0 0 0 0 0 0 15.09376 0 0 0 0 0 0 0 0 0 14.20958 0 0 0 Q9NZ20 PA2G3_HUMAN "Group 3 secretory phospholipase A2, EC 3.1.1.4 (Group III secretory phospholipase A2, GIII sPLA2, sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)" PLA2G3 Homo sapiens (Human) acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288] centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288] calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872] GO:0001675; GO:0002532; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0006658; GO:0007288; GO:0010629; GO:0010744; GO:0010976; GO:0019372; GO:0031394; GO:0032308; GO:0034374; GO:0034375; GO:0042116; GO:0043303; GO:0043524; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0046488; GO:0046872; GO:0047498; GO:0048469; GO:0050482; GO:0055037; GO:0060271; GO:0060376; GO:1900017; GO:1900222; GO:1903595; GO:2001135 GPMSFYNQCLQLTQAARRPDR 6.809999943 1 1 0.206125754 2525.987869 0 14.95388 12.78897 0 0 13.45914 0 0 14.89838 0 0 13.79611 18.19402 0 17.63579 0 14.25816 0 16.8584 19.24776 0 17.2463 17.74694 0 15.39443 0 15.96907 0 0 0 16.32818 12.38809 0 15.07132 0 12.11614 15.13782 13.29788 0 14.75996 0 0 0 0 0 0 0 0 Q9NZ38 IDAS1_HUMAN Uncharacterized protein IDI2-AS1 (IDI2 antisense RNA 1) (IDI2 antisense gene protein 1) IDI2-AS1 C10orf110 HT009 Homo sapiens (Human) KSSALGK 8.25 0.89245677 0.89245677 0.247009388 691.1441478 15.99534 17.40773 14.16052 0 12.27563 14.62462 14.10957 15.33883 16.11559 17.1788 16.35 0 14.90406 16.01521 0 16.58494 14.9488 13.7076 16.41883 0 0 16.97729 14.91327 15.24478 14.77358 0 0 0 0 16.35899 12.87911 15.82972 15.24066 0 15.4253 17.31914 0 15.21946 0 15.67879 0 16.08867 16.63004 15.1465 16.07005 16.80394 0 16.49608 Q9NZ43 USE1_HUMAN Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31) USE1 USE1L MDS032 Homo sapiens (Human) "lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]" SNAP receptor activity [GO:0005484] GO:0005484; GO:0005783; GO:0005789; GO:0006890; GO:0007041; GO:0015031; GO:0016021; GO:0030163; GO:0031201; GO:0032940 MADQNLEK 6.480000019 1 1 2.17E-12 964.9044803 18.0626 13.7711 0 16.09514 16.22087 0 12.05758 13.55222 0 10.31925 0 10.55308 0 12.68562 14.14823 14.34347 0 11.36199 12.62049 14.97683 13.75992 16.70687 17.41286 17.44069 17.75758 14.5946 13.91146 13.73244 14.41195 14.66427 14.82093 18.22331 14.81014 0 15.026 0 15.64756 0 16.5732 16.22154 0 12.83227 17.20477 13.16339 15.17521 15.88169 14.59081 16.46272 Q9NZ45 CISD1_HUMAN CDGSH iron-sulfur domain-containing protein 1 (MitoNEET) CISD1 C10orf70 ZCD1 MDS029 Homo sapiens (Human) regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457]" "2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" GO:0005739; GO:0005741; GO:0010506; GO:0016021; GO:0042802; GO:0043457; GO:0046872; GO:0051537 SLTSSSSVR 1.590000033 0.918919504 0.918919504 0.215032829 920.8669604 0 0 12.46421 0 0 0 0 0 14.52771 14.37071 0 12.77609 15.00915 0 0 0 0 16.45287 0 0 0 16.67118 0 16.26406 0 0 0 0 0 0 16.56057 0 15.70013 0 0 0 0 15.34515 0 0 15.72395 15.11332 0 0 0 0 0 16.90623 Q9NZ52 GGA3_HUMAN "ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)" GGA3 KIAA0154 Homo sapiens (Human) endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647] phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130] GO:0005764; GO:0005794; GO:0005802; GO:0006622; GO:0006886; GO:0010008; GO:0031267; GO:0031647; GO:0031648; GO:0031901; GO:0032456; GO:0032991; GO:0034394; GO:0035091; GO:0043001; GO:0043130; GO:0044877; GO:0045732; GO:0055038; GO:1902430 VIELLYSWTMALPEEAK 5.139999866 1 1 0.110265329 2008.345423 12.92319 0 15.03199 14.10128 0 13.63151 0 15.18003 13.57753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.52577 13.85503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ71 RTEL1_HUMAN "Regulator of telomere elongation helicase 1, EC 3.6.4.12 (Novel helicase-like)" RTEL1 C20orf41 KIAA1088 NHL Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657] "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657]" "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]" GO:0000723; GO:0000732; GO:0000781; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0010569; GO:0016887; GO:0031297; GO:0032206; GO:0032508; GO:0043247; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1902990; GO:1904355; GO:1904358; GO:1904430; GO:1904506; GO:1904535 GVIVTGLPYPPRMDPR 3.140000105 1 1 0.276166815 1767.553339 0 0 14.53768 0 0 0 0 0 0 15.11573 0 0 0 0 0 16.39679 0 0 0 0 0 0 0 14.34245 0 0 14.70451 0 0 0 15.76107 0 13.92057 8.987556 0 17.19099 0 14.12541 0 0 0 0 0 17.75968 18.58546 0 0 0 Q9NZ72 STMN3_HUMAN Stathmin-3 (SCG10-like protein) STMN3 SCLIP Homo sapiens (Human) blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110] protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631] GO:0001835; GO:0005737; GO:0005794; GO:0005829; GO:0007019; GO:0007399; GO:0015631; GO:0019904; GO:0030426; GO:0031110; GO:0031122; GO:0031175; GO:0035021; GO:0043005; GO:0043087; GO:0051493 ELHAAEVRR 2.529999971 1 1 0.286236469 1080.425001 0 16.24821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.62527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ94 NLGN3_HUMAN Neuroligin-3 (Gliotactin homolog) NLGN3 KIAA1480 NL3 Homo sapiens (Human) "adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" "asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] GO:0002087; GO:0005886; GO:0005887; GO:0006898; GO:0007158; GO:0007268; GO:0007416; GO:0007612; GO:0009986; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0048675; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051968; GO:0060024; GO:0060076; GO:0060080; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054; GO:0099055; GO:0099060; GO:2000463; GO:2000969 WLRLGPPSLSLSPKPTVGR 8.06000042 0.130363926 0.130363926 0.153921112 2056.216986 0 0 19.06583 0 0 18.26541 16.70046 16.33489 19.77423 17.70412 14.627 0 0 13.43707 0 0 0 0 0 0 9.67522 18.11246 16.9531 0 12.65126 0 14.14602 0 0 0 14.9514 17.7162 0 13.23003 16.55253 17.09594 16.38285 17.13453 17.04511 18.52524 17.67441 16.89684 0 11.12316 13.56061 15.35069 15.26912 16.37322 Q9NZB2 F120A_HUMAN Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A) FAM120A C9orf10 KIAA0183 OSSA Homo sapiens (Human) cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020 SSAMSSDGSLAENGVMAEEKPAPQMNGSTGDAR 5.28000021 0.885971487 0.885971487 0.183673405 3297.799258 17.97511 14.16435 9.604689 0 0 13.48349 0 14.97966 0 0 12.53002 0 0 11.99256 12.05746 0 0 0 0 0 0 0 0 0 13.87926 14.63396 11.58356 9.259307 0 11.27233 0 0 0 0 14.02331 0 12.98256 12.8237 0 13.11364 0 0 0 0 0 0 0 0 Q9NZB8 MOCS1_HUMAN "Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase, EC 4.1.99.22 (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase, EC 4.6.1.17 (Molybdenum cofactor biosynthesis protein C) ]" MOCS1 MIG11 Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634] "cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]" "4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]" GO:0005525; GO:0005634; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799 ADSDANSK 5.75 0.327375323 0.327375323 0.105395515 806.5477305 0 11.70552 0 13.80173 0 14.80843 0 15.28325 0 15.62005 13.50786 13.68937 14.9907 0 0 0 0 0 0 0 12.93847 0 0 0 0 0 0 0 0 0 0 14.52261 0 0 0 0 0 0 15.77705 0 0 0 0 0 15.98637 0 0 0 Q9NZC2 TREM2_HUMAN "Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)" TREM2 Homo sapiens (Human) "amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; astrocyte activation [GO:0048143]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptidoglycan [GO:0071224]; complement-mediated synapse pruning [GO:0150062]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; defense response to Gram-negative bacterium [GO:0050829]; dendritic cell differentiation [GO:0097028]; dendritic spine maintenance [GO:0097062]; detection of lipopolysaccharide [GO:0032497]; detection of lipoteichoic acid [GO:0070392]; detection of peptidoglycan [GO:0032499]; excitatory synapse pruning [GO:1905805]; humoral immune response [GO:0006959]; import into cell [GO:0098657]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of autophagy [GO:0010507]; negative regulation of cell activation [GO:0050866]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of tumor necrosis factor production [GO:0032720]; osteoclast differentiation [GO:0030316]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of C-C chemokine receptor CCR7 signaling pathway [GO:1903082]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of CD40 signaling pathway [GO:2000350]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of complement activation, classical pathway [GO:0045960]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of kinase activity [GO:0033674]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of synapse pruning [GO:1905808]; positive regulation of TOR signaling [GO:0032008]; pyroptosis [GO:0070269]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of gene expression [GO:0010468]; regulation of hippocampal neuron apoptotic process [GO:0110089]; regulation of innate immune response [GO:0045088]; regulation of interleukin-6 production [GO:0032675]; regulation of intracellular signal transduction [GO:1902531]; regulation of lipid metabolic process [GO:0019216]; regulation of macrophage inflammatory protein 1 alpha production [GO:0071640]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; regulation of resting membrane potential [GO:0060075]; regulation of toll-like receptor 6 signaling pathway [GO:0034151]; regulation of TOR signaling [GO:0032006]; respiratory burst after phagocytosis [GO:0045728]; response to axon injury [GO:0048678]; response to ischemia [GO:0002931]; social behavior [GO:0035176]" extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] "extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; kinase activator activity [GO:0019209]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid binding [GO:0070891]; low-density lipoprotein particle binding [GO:0030169]; peptidoglycan binding [GO:0042834]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; sulfatide binding [GO:0120146]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle binding [GO:0034189]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; astrocyte activation [GO:0048143]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptidoglycan [GO:0071224]; complement-mediated synapse pruning [GO:0150062]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; defense response to Gram-negative bacterium [GO:0050829]; dendritic cell differentiation [GO:0097028]; dendritic spine maintenance [GO:0097062]; detection of lipopolysaccharide [GO:0032497]; detection of lipoteichoic acid [GO:0070392]; detection of peptidoglycan [GO:0032499]; excitatory synapse pruning [GO:1905805]; humoral immune response [GO:0006959]; import into cell [GO:0098657]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of autophagy [GO:0010507]; negative regulation of cell activation [GO:0050866]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of tumor necrosis factor production [GO:0032720]; osteoclast differentiation [GO:0030316]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of C-C chemokine receptor CCR7 signaling pathway [GO:1903082]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of CD40 signaling pathway [GO:2000350]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of complement activation, classical pathway [GO:0045960]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of kinase activity [GO:0033674]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of synapse pruning [GO:1905808]; positive regulation of TOR signaling [GO:0032008]; pyroptosis [GO:0070269]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of gene expression [GO:0010468]; regulation of hippocampal neuron apoptotic process [GO:0110089]; regulation of innate immune response [GO:0045088]; regulation of interleukin-6 production [GO:0032675]; regulation of intracellular signal transduction [GO:1902531]; regulation of lipid metabolic process [GO:0019216]; regulation of macrophage inflammatory protein 1 alpha production [GO:0071640]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; regulation of resting membrane potential [GO:0060075]; regulation of toll-like receptor 6 signaling pathway [GO:0034151]; regulation of TOR signaling [GO:0032006]; respiratory burst after phagocytosis [GO:0045728]; response to axon injury [GO:0048678]; response to ischemia [GO:0002931]; social behavior [GO:0035176]" amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; kinase activator activity [GO:0019209]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid binding [GO:0070891]; low-density lipoprotein particle binding [GO:0030169]; peptidoglycan binding [GO:0042834]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; sulfatide binding [GO:0120146]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle binding [GO:0034189] GO:0001530; GO:0001540; GO:0001774; GO:0001786; GO:0001934; GO:0002282; GO:0002588; GO:0002862; GO:0002931; GO:0004888; GO:0005543; GO:0005576; GO:0005886; GO:0005887; GO:0006910; GO:0006911; GO:0006959; GO:0007613; GO:0008035; GO:0008289; GO:0008429; GO:0010468; GO:0010507; GO:0010628; GO:0010822; GO:0010875; GO:0010887; GO:0010891; GO:0010983; GO:0014067; GO:0014068; GO:0016021; GO:0019209; GO:0019216; GO:0030169; GO:0030316; GO:0031226; GO:0032006; GO:0032008; GO:0032497; GO:0032499; GO:0032675; GO:0032691; GO:0032720; GO:0032733; GO:0033674; GO:0034136; GO:0034144; GO:0034151; GO:0034185; GO:0034186; GO:0034189; GO:0034241; GO:0034351; GO:0035176; GO:0038023; GO:0038160; GO:0042834; GO:0043124; GO:0043277; GO:0044853; GO:0044877; GO:0045088; GO:0045672; GO:0045728; GO:0045960; GO:0048143; GO:0048678; GO:0050714; GO:0050730; GO:0050731; GO:0050766; GO:0050829; GO:0050850; GO:0050866; GO:0050921; GO:0055088; GO:0060075; GO:0060100; GO:0061518; GO:0061889; GO:0070269; GO:0070345; GO:0070374; GO:0070392; GO:0070891; GO:0071223; GO:0071224; GO:0071333; GO:0071396; GO:0071456; GO:0071640; GO:0071813; GO:0097028; GO:0097062; GO:0097110; GO:0098657; GO:0110089; GO:0120035; GO:0120146; GO:0140052; GO:0150062; GO:0150079; GO:0150094; GO:1900015; GO:1900016; GO:1900223; GO:1900226; GO:1901076; GO:1901224; GO:1901800; GO:1901980; GO:1902227; GO:1902531; GO:1903078; GO:1903082; GO:1903376; GO:1903753; GO:1903980; GO:1904093; GO:1904141; GO:1904646; GO:1904951; GO:1905291; GO:1905581; GO:1905805; GO:1905808; GO:1905907; GO:1990782; GO:2000350; GO:2001171 VLVEVLADPLDHR 3.480000019 0.995923638 0.995923638 0.451855244 1475.266614 15.39393 14.4509 0 14.95062 14.74819 14.85292 14.0765 13.1398 14.05753 0 0 0 0 0 0 0 0 16.86267 0 0 0 0 0 0 15.54103 15.43426 0 0 0 0 0 0 16.48221 14.76678 16.45054 0 0 16.71348 0 0 0 0 0 16.56439 15.97706 0 0 0 Q9NZD4 AHSP_HUMAN Alpha-hemoglobin-stabilizing protein (Erythroid differentiation-related factor) (Erythroid-associated factor) AHSP EDRF ERAF Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; hemoglobin complex [GO:0005833] cytoplasm [GO:0005737]; hemoglobin complex [GO:0005833]; hemoglobin binding [GO:0030492]; unfolded protein binding [GO:0051082]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; protein folding [GO:0006457]; protein stabilization [GO:0050821] hemoglobin binding [GO:0030492]; unfolded protein binding [GO:0051082] GO:0005737; GO:0005833; GO:0006457; GO:0020027; GO:0030097; GO:0030218; GO:0030492; GO:0050821; GO:0051082 DLISAGLK 22.82999992 0.902237296 0.902237296 0.230008317 813.0732119 17.55968 17.99547 0 0 0 17.28378 0 0 0 0 18.13705 0 17.62562 0 0 0 0 0 0 0 0 0 18.14349 0 0 0 0 0 0 0 0 18.14896 17.15468 0 17.73574 0 18.80447 0 0 17.9758 18.01772 19.77028 0 0 18.26178 17.60565 0 0 Q9NZH7 IL36B_HUMAN "Interleukin-36 beta (FIL1 eta) (Interleukin-1 eta, IL-1 eta) (Interleukin-1 family member 8, IL-1F8) (Interleukin-1 homolog 2, IL-1H2)" IL36B IL1F8 IL1H2 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of T cell differentiation [GO:0045582] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of T cell differentiation [GO:0045582] cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0006955; GO:0010628; GO:0019221; GO:0045087; GO:0045582; GO:0071222 TNIGMPGRM 8.75 0.754950523 0.754950523 0.242924115 992.8177565 16.42639 14.47585 15.52794 15.53104 14.75961 15.05104 14.45329 14.5497 14.02635 0 15.61167 16.25306 15.84504 14.76899 0 0 0 14.87827 16.16266 14.60631 16.76767 15.50185 0 16.09296 0 0 0 16.33893 0 0 0 0 16.63547 0 14.66933 15.16832 0 16.30169 16.20464 16.67549 14.20233 17.8362 15.95429 15.81316 0 0 0 0 Q9NZI8 IF2B1_HUMAN "Insulin-like growth factor 2 mRNA-binding protein 1, IGF2 mRNA-binding protein 1, IMP-1, IMP1 (Coding region determinant-binding protein, CRD-BP) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zipcode-binding protein 1, ZBP-1)" IGF2BP1 CRDBP VICKZ1 ZBP1 Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]" CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904] "CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]" mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007399; GO:0010468; GO:0010494; GO:0010610; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0043025; GO:0043197; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0051252; GO:0070934; GO:0070937; GO:0097150; GO:0140059; GO:1900152; GO:1990247; GO:1990904; GO:2000767 MILEIMHK 11.68999958 0.413794279 0.413794279 0.140433991 1014.642195 17.59263 15.92904 15.09265 14.68942 15.89384 16.83624 15.47521 17.02441 13.99655 16.045 17.21558 17.18142 14.24999 16.7414 15.97308 16.82043 18.16635 0 14.06361 16.8764 17.53153 12.91318 17.40097 16.44302 17.66281 16.68116 15.37896 16.15651 16.30199 12.72927 17.04257 16.13079 17.74074 17.11799 17.1531 15.003 0 16.70909 14.82734 15.33149 13.51071 16.66533 16.35268 16.17162 19.10024 14.87483 0 13.17244 Q9NZJ0 DTL_HUMAN Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein) DTL CDT2 CDW1 DCAF2 L2DTL RAMP Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] protein-macromolecule adaptor activity [GO:0030674] GO:0000209; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0007095; GO:0009411; GO:0010971; GO:0019985; GO:0030674; GO:0031464; GO:0031465; GO:0031965; GO:0043161; GO:0045732; GO:0048511; GO:0051726; GO:0080008 IMSPR 3.789999962 0.724496961 0.724496961 0.281911536 619.0016117 17.37346 15.19946 0 16.09346 0 0 18.47053 15.99606 0 0 0 18.37396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.75493 0 0 17.03086 0 0 0 18.38065 0 0 18.70114 16.81787 0 0 0 0 0 17.62094 0 0 Q9NZJ4 SACS_HUMAN "Sacsin (DnaJ homolog subfamily C member 29, DNAJC29)" SACS KIAA0730 Homo sapiens (Human) negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457] axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634] axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457] chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628] GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084 FSLSESGR 3.339999914 1 1 0.159185035 880.1272968 16.08331 0 14.62752 0 0 13.83341 14.18912 0 16.78953 0 15.66061 0 0 0 0 0 15.90269 11.65007 0 17.2931 16.2844 17.05966 0 0 17.07656 17.06223 17.46513 17.65657 17.4208 16.70541 17.79974 17.41668 18.31852 17.10789 0 0 17.67703 18.23439 16.79192 0 13.26652 13.94122 0 0 0 17.69564 16.18688 16.66525 Q9NZJ5 E2AK3_HUMAN "Eukaryotic translation initiation factor 2-alpha kinase 3, EC 2.7.11.1 (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase, HsPEK)" EIF2AK3 PEK PERK Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004712; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0010998; GO:0016020; GO:0017148; GO:0018105; GO:0019722; GO:0019899; GO:0019903; GO:0030176; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032055; GO:0032057; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070417; GO:0106310; GO:1900182; GO:1902235; GO:1990737 IISDVEEQEAAIMDIVIK 9.229999542 1 1 0.2544046 2015.750255 0 0 0 0 0 15.87337 0 0 13.56439 0 0 0 13.43668 0 0 0 0 14.25296 0 0 10.55016 0 0 16.20031 0 12.8358 13.31979 0 13.80661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.60442 Q9NZL3 ZN224_HUMAN "Zinc finger protein 224 (Bone marrow zinc finger 2, BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)" ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872 APCLLK 4.789999962 0.12171641 0.12171641 0.226144468 698.5544012 0 0 0 0 15.18019 16.44144 0 0 0 0 0 0 15.41855 9.661558 17.5181 0 0 15.57852 0 13.87272 0 0 0 12.13958 0 0 0 16.52883 16.40701 14.47913 17.07961 0 0 0 16.81629 14.65988 0 0 0 0 0 14.42982 17.11535 0 16.88368 15.01708 0 0 Q9NZM1 MYOF_HUMAN Myoferlin (Fer-1-like protein 3) MYOF FER1L3 KIAA1207 Homo sapiens (Human) blood circulation [GO:0008015]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292] caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; blood circulation [GO:0008015]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292] metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] GO:0001778; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0007009; GO:0007520; GO:0008015; GO:0016021; GO:0030659; GO:0031410; GO:0031965; GO:0033292; GO:0043231; GO:0046872; GO:0061025; GO:0070062 KDLTQTASSTAR 1.460000038 1 1 0.236372222 1279.880064 0 0 16.05921 0 0 0 0 0 0 20.25412 16.46227 0 14.4929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32505 0 0 0 0 16.96557 0 0 0 0 Q9NZM3 ITSN2_HUMAN Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein) ITSN2 KIAA1256 SH3D1B SWAP Homo sapiens (Human) cell differentiation [GO:0030154]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; positive regulation of dendrite extension [GO:1903861] centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; presynapse [GO:0098793] centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; positive regulation of dendrite extension [GO:1903861] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090] GO:0005085; GO:0005509; GO:0005813; GO:0005829; GO:0005905; GO:0006897; GO:0016197; GO:0030154; GO:0060090; GO:0070062; GO:0098793; GO:0150007; GO:1903861 NREQEEIVR 11.68000031 0.657192171 0.657192171 0.438679995 1173.412805 13.57393 13.41313 0 0 0 0 0 0 0 0 0 0 0 15.7075 0 16.1806 0 0 0 16.974 15.81126 0 15.35993 0 16.97133 14.88626 16.43463 15.96959 0 0 0 14.82848 0 17.24353 15.52475 15.05599 18.07329 17.36467 17.07821 16.55744 0 17.35715 0 0 16.942 0 17.29878 16.89487 Q9NZN1 IRPL1_HUMAN "Interleukin-1 receptor accessory protein-like 1, IL-1-RAPL-1, IL-1RAPL-1, IL1RAPL-1, EC 3.2.2.6 (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2, TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)" IL1RAPL1 OPHN4 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545] axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]" "NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]" GO:0005102; GO:0005737; GO:0005886; GO:0007157; GO:0007165; GO:0009986; GO:0010975; GO:0016021; GO:0030182; GO:0030424; GO:0030425; GO:0045211; GO:0045920; GO:0050135; GO:0050775; GO:0051965; GO:0061809; GO:0097105; GO:0098978; GO:0099175; GO:0099545; GO:1905606 IEIMLFYR 6.699999809 1 1 0.245958899 1100.065234 0 0 0 0 0 0 0 17.68845 18.06895 0 0 15.99068 0 0 0 16.86026 15.46678 0 0 0 0 0 0 0 0 17.20116 0 0 0 16.0042 0 0 0 0 0 0 0 0 0 0 0 16.83853 0 0 0 0 0 0 Q9NZN4 EHD2_HUMAN EH domain-containing protein 2 (PAST homolog 2) EHD2 PAST2 Homo sapiens (Human) cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659] caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904] GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0010008; GO:0015630; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0070062; GO:0072659; GO:0097320; GO:1901741; GO:2001137 YDEIFYNLAPADGKLSGSK 6.139999866 1 1 0.172465202 2089.141292 14.23522 14.13874 15.47504 0 15.34093 14.00092 16.85883 0 11.29797 14.41024 15.57142 12.79226 0 0 13.59521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZP6 NPAP1_HUMAN Nuclear pore-associated protein 1 NPAP1 C15orf2 Homo sapiens (Human) cell differentiation [GO:0030154]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283] intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; cell differentiation [GO:0030154]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283] nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] GO:0005637; GO:0005643; GO:0005654; GO:0005886; GO:0006405; GO:0006606; GO:0007283; GO:0008139; GO:0017056; GO:0030154; GO:0043231 HVCFQLP 3.930000067 1 1 0.265975707 900.2594575 13.96253 0 11.59075 0 0 0 0 15.07681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.56475 0 11.77833 15.73007 0 0 0 0 16.33391 15.5681 14.80875 16.88189 0 0 13.68086 16.23372 15.25371 10.13313 0 0 0 0 Q9NZQ0 DJC27_HUMAN DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein) DNAJC27 RABJS RBJ Homo sapiens (Human) intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701] nucleus [GO:0005634] nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0070374; GO:0071701 DSWDMLGVKPGASR 2.769999981 1 1 0.341416628 1534.976056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.26472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZQ3 SPN90_HUMAN "NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein, VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1, DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein, WISH) (Wiskott-Aldrich syndrome protein-interacting protein)" NCKIPSD AF3P21 SPIN90 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976] cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634] cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976] Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124] GO:0005634; GO:0005829; GO:0005882; GO:0006897; GO:0007010; GO:0008092; GO:0010976; GO:0017124; GO:0071933 LLLLLNR 23.27000046 1 1 0.289359191 854.6514096 14.38436 18.11053 0 17.38409 16.68907 16.54684 0 18.77916 0 0 0 16.89842 16.72647 0 18.35722 0 17.70847 16.82105 0 16.75424 0 0 0 0 0 17.84099 0 0 0 0 20.06638 17.38056 18.4602 17.0577 0 18.25805 16.59568 19.20707 0 0 0 16.74689 17.90757 0 0 0 17.49817 0 Q9NZQ8 TRPM5_HUMAN "Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5, LTrpC-5, LTrpC5) (MLSN1- and TRP-related gene 1 protein)" TRPM5 LTRPC5 MTR1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of taste [GO:0050909] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ligand-gated calcium channel activity [GO:0099604]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of taste [GO:0050909] calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ligand-gated calcium channel activity [GO:0099604]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244] GO:0005216; GO:0005227; GO:0005244; GO:0005261; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0016021; GO:0030425; GO:0034765; GO:0043025; GO:0050909; GO:0070588; GO:0098655; GO:0099604 DSEGEVLRK 4.059999943 1 1 0.273394083 1032.308848 15.62786 14.64108 0 0 0 16.09164 0 0 13.4809 0 13.59519 0 0 15.80094 0 14.85112 0 0 0 0 0 0 14.68534 0 0 0 0 0 14.15456 0 0 16.39198 0 15.51686 0 15.5736 14.54433 14.78113 0 14.93295 16.13419 15.38645 0 0 13.40529 0 0 0 Q9NZQ9 TMOD4_HUMAN "Tropomodulin-4 (Skeletal muscle tropomodulin, Sk-Tmod)" TMOD4 Homo sapiens (Human) actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694] cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865] cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694] actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523] GO:0005523; GO:0005856; GO:0005865; GO:0006936; GO:0007015; GO:0030016; GO:0030239; GO:0051015; GO:0051694 QWPGDAVEMEMATVLEQCPSIVR 2.130000114 0.064885892 0.064885892 1.38E-12 2662.878072 0 0 0 0 13.90329 14.49693 0 0 0 0 0 0 15.60352 15.37406 0 0 0 14.27025 14.77858 14.50324 0 0 15.41609 0 15.25237 0 0 13.83375 0 15.46193 0 0 14.51528 0 14.9855 0 0 0 0 0 14.92679 12.36987 0 0 0 18.28021 0 0 Q9NZR2 LRP1B_HUMAN "Low-density lipoprotein receptor-related protein 1B, LRP-1B (Low-density lipoprotein receptor-related protein-deleted in tumor, LRP-DIT)" LRP1B LRPDIT Homo sapiens (Human) protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0016021; GO:0043235 AIAVDPIAGK 8.659999847 1 1 0.169167348 954.3816998 18.79213 14.20839 12.96045 0 15.64927 14.0829 14.00486 14.89961 16.41312 14.51462 15.18097 16.23955 0 13.46367 15.23037 0 0 0 14.30355 13.96221 0 0 0 0 0 0 0 0 16.26729 0 0 0 15.68784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.86419 Q9NZR4 VSX1_HUMAN Visual system homeobox 1 (Homeodomain protein RINX) (Retinal inner nuclear layer homeobox protein) (Transcription factor VSX1) VSX1 RINX Homo sapiens (Human) "neuron development [GO:0048666]; neuron maturation [GO:0042551]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; neuron development [GO:0048666]; neuron maturation [GO:0042551]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0007601; GO:0042551; GO:0048666; GO:0050896; GO:0060040; GO:1990837 GPEPAAPLAPSRPPPALGRQK 2.019999981 0.102519803 0.102519803 0.141868339 2104.412095 0 15.48969 13.56905 13.78805 0 0 0 0 11.01711 13.08064 11.28725 14.18843 0 15.79114 0 0 16.14196 14.66981 12.4945 0 16.06329 0 0 0 0 0 17.57747 0 13.34206 17.53532 12.97674 13.31001 0 0 0 0 0 17.35735 0 13.97252 17.28445 15.50807 14.82196 0 0 17.45482 0 0 Q9NZS9 BFAR_HUMAN Bifunctional apoptosis regulator (RING finger protein 47) BFAR BAR RNF47 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0005783; GO:0005887; GO:0006511; GO:0006915; GO:0016020; GO:0030176; GO:0030674; GO:0043066; GO:0043161; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1903895 AILMELER 6.639999866 1 1 0.038843217 975.9468661 16.01867 0 16.65746 13.47842 16.08923 16.14337 0 15.73654 11.50605 0 0 14.84565 0 17.90329 12.92671 0 0 16.06163 0 14.40935 0 14.66064 16.29262 16.069 0 13.52962 0 17.92421 0 0 0 18.08917 12.44672 16.98462 13.1903 15.40817 16.60712 13.67706 0 15.27264 16.86787 16.81021 15.02809 14.12758 0 0 13.4756 15.25106 Q9NZT2 OGFR_HUMAN "Opioid growth factor receptor, OGFr (Protein 7-60) (Zeta-type opioid receptor)" OGFR Homo sapiens (Human) regulation of cell growth [GO:0001558] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; opioid growth factor receptor activity [GO:0140625]; regulation of cell growth [GO:0001558] opioid growth factor receptor activity [GO:0140625] GO:0001558; GO:0005634; GO:0005737; GO:0016020; GO:0140625 ELPGVR 6.539999962 1 1 3.46E-13 669.6351368 0 0 0 0 13.97313 15.25152 0 12.03737 15.77252 13.79138 12.86331 14.66581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.85216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8898 0 0 0 0 0 Q9NZU0 FLRT3_HUMAN Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3) FLRT3 KIAA1469 UNQ856/PRO1865 Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560] axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560] chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674] GO:0003345; GO:0005104; GO:0005615; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0007416; GO:0007507; GO:0008543; GO:0014069; GO:0030054; GO:0030674; GO:0031012; GO:0031175; GO:0032584; GO:0042803; GO:0043679; GO:0044295; GO:0045499; GO:0048598; GO:0048678; GO:0051965; GO:0060322; GO:0097060; GO:0098742; GO:0098978; GO:0099055; GO:0099560; GO:1990138 LALPMTALR 6.170000076 0.381557167 0.381557167 0.130672759 1000.546933 17.42138 17.49085 0 14.93841 15.47614 15.93402 16.83933 0 0 15.44961 0 17.13471 17.018 13.95984 15.80286 0 14.2233 16.43961 0 0 15.18376 0 16.59656 0 13.5449 0 0 15.60488 15.6344 14.81693 0 0 17.82386 15.15524 16.89288 0 16.4831 17.75438 0 17.59034 0 16.11149 0 15.72048 16.90675 14.25005 17.6136 12.6656 Q9NZU5 LMCD1_HUMAN LIM and cysteine-rich domains protein 1 (Dyxin) LMCD1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611] transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0010611; GO:0070886 GTCSGFEPHSWR 4.300000191 0.307219863 0.307219863 0.332423766 1421.702533 16.63616 3.239412 13.51261 14.87944 0 0 0 15.04046 14.88462 15.6741 14.01045 14.42035 0 14.89739 0 0 13.56841 0 15.53648 0 0 0 0 0 15.57179 16.11409 0 0 0 14.77964 0 16.08933 0 0 0 0 0 0 16.55615 0 0 0 0 0 0 0 0 15.59858 Q9NZU7 CABP1_HUMAN "Calcium-binding protein 1, CaBP1 (Calbrain) (Caldendrin)" CABP1 Homo sapiens (Human) negative regulation of protein import into nucleus [GO:0042308]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; enzyme inhibitor activity [GO:0004857]; nuclear localization sequence binding [GO:0008139]; negative regulation of protein import into nucleus [GO:0042308]; response to stimulus [GO:0050896]; visual perception [GO:0007601] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; enzyme inhibitor activity [GO:0004857]; nuclear localization sequence binding [GO:0008139] GO:0000139; GO:0004857; GO:0005509; GO:0005615; GO:0005856; GO:0005886; GO:0005938; GO:0007601; GO:0008139; GO:0014069; GO:0042308; GO:0048306; GO:0048471; GO:0050896 AAAAAASGGSR 1.74000001 1 1 0.291703276 890.3599542 0 18.88798 0 17.16893 0 0 0 19.15009 0 0 0 0 0 0 17.95876 16.87168 0 0 0 0 16.58135 18.3257 17.22978 17.01236 18.9515 0 18.54337 0 17.39021 0 0 0 0 18.36314 18.6331 19.27699 19.03122 0 19.0478 0 0 0 0 18.2966 0 17.60448 0 0 Q9NZW4 DSPP_HUMAN "Dentin sialophosphoprotein [Cleaved into: Dentin phosphoprotein (Dentin phosphophoryn, DPP); Dentin sialoprotein, DSP ]" DSPP Homo sapiens (Human) biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; multicellular organism development [GO:0007275]; odontoblast differentiation [GO:0071895]; ossification [GO:0001503]; regulation of odontoblast differentiation [GO:1901329]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; multicellular organism development [GO:0007275]; odontoblast differentiation [GO:0071895]; ossification [GO:0001503]; regulation of odontoblast differentiation [GO:1901329]; skeletal system development [GO:0001501] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201] GO:0001501; GO:0001503; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005634; GO:0005737; GO:0007275; GO:0031012; GO:0031214; GO:0071895; GO:0097187; GO:1901329 SNTNGNTDK 6.760000229 0.932032585 0.932032585 0.217358199 950.969411 0 16.77226 17.03225 18.20391 0 0 12.83571 16.5541 15.46572 18.65567 0 18.11685 14.55214 13.05596 0 0 0 0 0 15.40912 12.43475 16.40123 14.99709 0 17.77102 16.95811 16.58261 16.27191 17.46174 0 16.91188 17.52949 0 17.4226 15.90553 0 0 0 18.95889 18.12799 17.1671 16.43628 8.435129 0 16.6762 16.15602 16.55181 13.89689 Q9P016 THYN1_HUMAN Thymocyte nuclear protein 1 (Thymocyte protein Thy28) THYN1 THY28 HSPC144 MDS012 My0054 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 TENSGEALAK 7.139999866 0.65807426 0.65807426 0.232224137 1019.713817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.79327 0 0 0 0 0 0 0 0 0 18.59259 0 0 0 0 Q9P032 NDUF4_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa) NDUFAF4 C6orf66 HRPAP20 HSPC125 My013 Homo sapiens (Human) defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] calmodulin binding [GO:0005516] GO:0005516; GO:0005739; GO:0005743; GO:0008284; GO:0031966; GO:0032981; GO:0043066; GO:0051607 DPVSSLQVK 4.269999981 0.470404744 0.470404744 0.271304926 973.7052728 15.13079 14.93311 12.58799 14.89041 0 0 0 0 0 16.32153 0 16.04296 14.75959 0 0 0 13.10429 15.7073 16.55596 15.63211 13.2949 0 14.74998 13.83216 0 0 0 0 16.21628 0 15.48673 0 14.86714 15.89662 0 16.33413 0 15.45949 15.78326 16.4745 0 15.18156 16.22348 0 0 14.9562 15.15913 0 Q9P0J0 NDUAD_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6, CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein, GRIM-19, Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit)" NDUFA13 GRIM19 CDA016 CGI-39 Homo sapiens (Human) "aerobic respiration [GO:0009060]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; electron transport chain [GO:0022900]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]" cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; aerobic respiration [GO:0009060]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; electron transport chain [GO:0022900]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]" ATP binding [GO:0005524] GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005746; GO:0005747; GO:0009060; GO:0010952; GO:0022900; GO:0030308; GO:0031966; GO:0032981; GO:0035458; GO:0042776; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243 ENLEEEAIIMK 6.190000057 1 1 0.478465006 1335.710244 0 14.57487 0 21.43639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.16487 0 0 0 0 19.58813 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8813 0 0 0 0 0 0 0 0 0 0 Q9P0L1 ZKSC7_HUMAN Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64) ZKSCAN7 ZNF167 ZNF448 ZNF64 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 GSELTPKQEFFK 1 1 1 0.527726326 1410.616631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.419 0 0 0 0 0 0 0 0 0 0 0 Q9P0L2 MARK1_HUMAN "Serine/threonine-protein kinase MARK1, EC 2.7.11.1, EC 2.7.11.26 (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c, Par-1c, Par1c)" MARK1 KIAA1477 MARK Homo sapiens (Human) cytoskeleton organization [GO:0007010]; establishment of mitochondrion localization [GO:0051654]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of neuron projection development [GO:0010975]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; cytoskeleton organization [GO:0007010]; establishment of mitochondrion localization [GO:0051654]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of neuron projection development [GO:0010975]; Wnt signaling pathway [GO:0016055]" "ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]" GO:0000226; GO:0000287; GO:0001764; GO:0001786; GO:0004674; GO:0004712; GO:0005524; GO:0005546; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0015630; GO:0016055; GO:0018105; GO:0030425; GO:0035556; GO:0048156; GO:0050321; GO:0050773; GO:0051654; GO:0070300; GO:0106310 EEGKDSKPR 9.359999657 1 1 0.235968507 1045.481989 16.71862 15.09706 15.15933 0 0 0 0 0 14.7829 0 0 0 0 0 0 0 15.27442 0 0 16.72669 0 0 0 0 0 14.80854 0 15.60755 0 15.16698 16.27095 16.74402 0 15.88445 12.95078 0 15.22454 17.0276 16.45078 0 0 15.49186 14.67826 0 0 0 16.1906 16.35943 Q9P0L9 PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1) PKD2L1 PKD2L PKDL TRPP3 Homo sapiens (Human) cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725] actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; sour taste receptor activity [GO:0033040]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725] alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; sour taste receptor activity [GO:0033040] GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0009986; GO:0015269; GO:0015629; GO:0016020; GO:0016021; GO:0031410; GO:0033040; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071468; GO:0071805; GO:0097730; GO:0098662 SGPEAARAGGWVSGEEFYMLTR 3.019999981 1 1 0.063544054 2375.806217 12.85408 11.66457 0 0 13.55104 11.17449 14.16138 10.75669 0 13.25476 0 0 12.36496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0M2 AKA7G_HUMAN "A-kinase anchor protein 7 isoform gamma, AKAP-7 isoform gamma (A-kinase anchor protein 18 kDa, AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma, PRKA7 isoform gamma)" AKAP7 AKAP18 Homo sapiens (Human) modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738] nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901] GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686 IDPDLYEK 3.470000029 1 1 1.18E-13 992.8151894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0M4 IL17C_HUMAN "Interleukin-17C, IL-17C (Cytokine CX2)" IL17C UNQ561/PRO1122 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954] cytokine activity [GO:0005125] GO:0005125; GO:0005576; GO:0005615; GO:0006954; GO:0007166; GO:0007267 GCIDARTGR 8.640000343 1 1 0.178148586 1006.227911 15.00167 17.21359 15.34625 9.172527 13.48187 13.01779 0 0 0 15.56662 15.17134 15.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17078 0 0 0 0 15.32518 17.00219 0 0 0 0 0 0 0 0 0 0 0 10.41374 0 0 0 0 Q9P0M6 H2AW_HUMAN "Core histone macro-H2A.2, Histone macroH2A2, mH2A2" MACROH2A2 H2AFY2 Homo sapiens (Human) "brain development [GO:0007420]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]" chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976] GO:0000122; GO:0000781; GO:0000785; GO:0000786; GO:0000976; GO:0000977; GO:0001740; GO:0003677; GO:0005654; GO:0006334; GO:0007420; GO:0007549; GO:0031490; GO:0045618; GO:0045814; GO:0046982; GO:0070062; GO:0071169; GO:1901837 EGTSNSTSEDGPGDGFTILSSK 4.730000019 1 1 0.457095447 2186.457678 19.61138 19.30319 0 0 0 0 0 19.88379 14.81036 13.65521 12.18744 18.90231 0 0 18.16603 0 0 0 18.191 0 0 19.36431 0 0 0 0 19.78177 0 0 0 0 20.59369 0 0 0 0 0 19.5171 0 0 0 0 17.68525 0 0 0 18.44303 0 Q9P0T4 ZN581_HUMAN Zinc finger protein 581 ZNF581 HSPC189 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 RASHLAR 14.93999958 1 1 0.235189783 811.2358516 15.07543 15.78587 15.63928 11.49496 12.31802 0 0 0 0 13.3389 15.48635 14.99494 13.52202 0 14.80941 0 0 0 0 14.93081 0 15.41306 0 0 14.443 0 0 0 0 13.11204 0 16.12954 0 0 13.70971 0 0 0 0 0 15.23737 0 0 16.34177 12.36357 0 0 0 Q9P0T7 TMEM9_HUMAN "Proton-transporting V-type ATPase complex assembly regulator TMEM9, v-ATPase assembly regulator TMEM9 (Dermal papilla-derived protein 4) (Transmembrane protein 9, Protein TMEM9)" TMEM9 DERP4 TMEM9A HSPC186 PSEC0012 UNQ631/PRO1248 Homo sapiens (Human) endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176] integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585] integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585]; endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176] GO:0005764; GO:0005765; GO:0005770; GO:0007042; GO:0015031; GO:0015630; GO:0016021; GO:0032585; GO:0042176; GO:0043231; GO:0045171; GO:0048388; GO:0070070; GO:0072686; GO:0090263 SMAAAAASLGGPRANTVLER 3.390000105 1 1 0.199416704 1942.90919 14.98397 14.34044 0 0 0 0 0 14.69718 0 0 0 12.81299 12.12887 0 0 14.75882 0 0 13.87702 0 15.2689 14.85652 0 0 0 0 13.05903 14.4816 13.36522 0 17.30718 14.90244 12.69534 11.59643 13.16531 13.67556 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0U3 SENP1_HUMAN "Sentrin-specific protease 1, EC 3.4.22.- (Sentrin/SUMO-specific protease SENP1)" SENP1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508] endopeptidase activity [GO:0004175]; SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140] GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006508; GO:0006919; GO:0016926; GO:0031965; GO:0045944; GO:0070139; GO:0070140; GO:0097190 CLSSSKNTLK 4.730000019 1 1 0.290625331 1137.8709 17.18373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.43863 0 17.70703 0 0 0 19.02468 0 0 0 0 0 Q9P0V3 SH3B4_HUMAN SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein) SH3BP4 BOG25 EHB10 TTP Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790] GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] GO:0005092; GO:0005634; GO:0005737; GO:0005905; GO:0006897; GO:0008285; GO:0010508; GO:0030136; GO:0030308; GO:0031267; GO:0032007; GO:0034260; GO:0042802; GO:0050790; GO:0061462; GO:0070062; GO:0071230 AANSNGLPR 1.809999943 0.322331935 0.322331935 0.251554261 899.9130864 0 0 0 14.98423 0 0 15.96983 0 0 0 0 0 0 0 15.72867 18.81943 14.36987 13.85146 0 0 0 0 0 14.87415 0 0 16.83394 0 0 12.98502 0 0 15.70666 0 0 0 0 16.85399 0 0 0 0 0 0 0 0 0 0 Q9P0W8 SPAT7_HUMAN Spermatogenesis-associated protein 7 (HSD-3.1) (Spermatogenesis-associated protein HSD3) SPATA7 HSD3 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200]; microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0000226; GO:0005654; GO:0005739; GO:0005829; GO:0005930; GO:0007601; GO:0015630; GO:0032391; GO:0036064; GO:0045494; GO:0050896; GO:0120200; GO:0120206; GO:1903546; GO:1903621 ALDMLLSAPK 5.130000114 1 1 0.152311963 1075.746299 15.89166 16.05599 14.98165 7.333758 0 0 16.50718 0 14.55158 15.26457 18.41745 0 0 15.12002 14.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.32578 0 0 0 15.19571 0 0 0 0 16.64024 0 0 0 0 Q9P0X4 CAC1I_HUMAN "Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3, Ca(v)3.3)" CACNA1I KIAA1120 Homo sapiens (Human) calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431] neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431] low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0007165; GO:0008332; GO:0019228; GO:0030317; GO:0030431; GO:0034765; GO:0043005; GO:0045956; GO:0070509; GO:0086010 APLPMGLGPLAPPPQPLPGELEPGDAASKR 3.710000038 1 1 1.83E-12 2970.472778 11.72126 12.19 12.02557 14.42391 12.96986 12.20289 0 0 0 13.4923 0 15.22966 12.1585 11.23272 13.62095 11.28046 0 13.21867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P107 GMIP_HUMAN "GEM-interacting protein, GMIP" GMIP Homo sapiens (Human) activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046872; GO:0051056; GO:0090630 RMNEAVQALR 7.130000114 0.056887396 0.056887396 0.079410592 1188.429367 14.89983 0 5.148437 12.61457 14.26901 13.1064 0 11.35622 0 14.42889 0 0 0 12.38131 0 10.63806 10.72329 9.987067 15.91536 0 13.38119 0 0 11.61727 0 0 0 0 0 0 0 0 0 0 14.16396 0 0 0 0 0 0 0 0 0 13.0914 0 0 0 Q9P109 GCNT4_HUMAN "Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4, EC 2.4.1.102 (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3, C2GnT3)" GCNT4 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]" "acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]" GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0008375; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993 DTYSPDEHFWATLIR 5.429999828 0.170069456 0.170069456 0.168768644 1852.265151 0 17.50234 0 0 0 0 15.55632 15.96271 0 0 14.91814 17.26577 0 13.39903 0 0 0 15.1756 0 0 16.93444 16.13033 16.239 15.03123 16.63699 0 19.41812 0 16.95387 19.11968 0 19.72134 0 0 0 13.70318 0 0 16.98055 18.32005 0 16.48772 14.48244 0 14.32934 14.63383 0 17.92542 Q9P127 LUZP4_HUMAN "Leucine zipper protein 4 (Cancer/testis antigen 28, CT-28, CT28) (Tumor antigen HOM-TES-85)" LUZP4 Homo sapiens (Human) mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA transport [GO:0051028] RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005737; GO:0051028 DLIATQR 22.29999924 1 1 0.069696885 815.7094272 14.86754 0 0 0 0 0 0 0 0 0 17.75326 0 16.97039 0 0 0 0 0 0 0 0 0 0 0 0 18.05687 0 0 16.57398 0 0 15.92206 0 0 0 0 0 0 0 0 0 0 0 0 0 16.13433 0 16.18794 Q9P1A2 PP4RL_HUMAN Putative serine/threonine-protein phosphatase 4 regulatory subunit 1-like PPP4R1L C20orf192 PRO1085 Homo sapiens (Human) protein dephosphorylation [GO:0006470] protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470] protein phosphatase regulator activity [GO:0019888] GO:0006470; GO:0019888 LVSDPCR 8.949999809 1 1 0.193386924 845.323878 0 16.12908 14.1508 14.22075 13.79833 13.81243 18.14921 14.09424 14.44753 13.01959 13.98317 14.5363 0 15.89023 15.44281 15.59365 16.25694 14.86222 0 17.81352 0 0 0 0 15.08504 14.90353 14.6477 13.01673 13.28535 14.212 16.62653 13.87138 15.48714 0 18.74646 15.21178 15.24157 14.87536 14.75879 0 15.16928 15.11951 16.30161 14.86023 0 16.30489 0 15.04822 Q9P1Q0 VPS54_HUMAN Vacuolar protein sorting-associated protein 54 (Hepatocellular carcinoma protein 8) (Tumor antigen HOM-HCC-8) (Tumor antigen SLP-8p) VPS54 HCC8 Homo sapiens (Human) "Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells within a tissue [GO:0048873]; lysosomal transport [GO:0007041]; musculoskeletal movement [GO:0050881]; neurofilament cytoskeleton organization [GO:0060052]; protein transport [GO:0015031]; regulation of growth [GO:0040008]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; syntaxin binding [GO:0019905]; Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells within a tissue [GO:0048873]; lysosomal transport [GO:0007041]; musculoskeletal movement [GO:0050881]; neurofilament cytoskeleton organization [GO:0060052]; protein transport [GO:0015031]; regulation of growth [GO:0040008]; retrograde transport, endosome to Golgi [GO:0042147]" syntaxin binding [GO:0019905] GO:0000938; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006896; GO:0007041; GO:0015031; GO:0016020; GO:0019905; GO:0032588; GO:0040008; GO:0042147; GO:0048471; GO:0048873; GO:0050881; GO:0060052 ASSHSSSPVPQGSSSDVFFK 7.820000172 1 1 0.754186218 2038.668562 0 0 0 0 0 0 0 16.73642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1U1 ARP3B_HUMAN Actin-related protein 3B (ARP3-beta) (Actin-like protein 3B) (Actin-related protein ARP4) ACTR3B ARP11 ARP4 Homo sapiens (Human) cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; actin binding [GO:0003779]; ATP binding [GO:0005524] actin binding [GO:0003779]; ATP binding [GO:0005524] GO:0003779; GO:0005524; GO:0005737; GO:0005856; GO:0042995; GO:0070062 RPLYKNVVLSGGSTMFR 9.470000267 1 1 0.130853874 1939.995267 15.75152 16.138 15.40132 18.2433 15.2155 16.27804 13.21597 0 14.70755 0 0 15.45736 17.0341 17.79568 17.06066 16.42676 16.10478 0 0 0 17.17146 0 0 17.03353 0 18.28627 0 13.54524 16.64614 0 17.42063 0 16.88341 16.13203 0 15.34423 16.7993 17.20244 0 15.41744 15.31466 0 0 17.61977 0 17.5552 0 0 Q9P1V8 SAM15_HUMAN "Sterile alpha motif domain-containing protein 15, SAM domain-containing protein 15" SAMD15 C14orf174 FAM15A Homo sapiens (Human) EGEPDSAK 3.369999886 1 1 0.097898127 831.9874346 0 16.83431 0 14.59012 15.93906 13.73367 16.22379 0 13.29194 14.86912 16.93808 15.74921 0 16.48626 14.14381 0 0 16.1061 0 0 0 0 0 0 15.76614 0 15.34774 0 0 0 0 0 0 0 0 15.56661 0 0 0 0 15.79068 0 0 16.10185 0 0 14.63334 0 Q9P1Y5 CAMP3_HUMAN Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha) CAMSAP3 KIAA1543 Homo sapiens (Human) cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell-cell adhesion [GO:0090136]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; in utero embryonic development [GO:0001701]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; protein transport along microtubule [GO:0098840]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of Golgi organization [GO:1903358]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]; zonula adherens maintenance [GO:0045218] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule minus-end [GO:0036449]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; zonula adherens [GO:0005915] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule minus-end [GO:0036449]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell-cell adhesion [GO:0090136]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; in utero embryonic development [GO:0001701]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; protein transport along microtubule [GO:0098840]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of Golgi organization [GO:1903358]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]; zonula adherens maintenance [GO:0045218] actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507] GO:0000226; GO:0001701; GO:0003341; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0005915; GO:0005930; GO:0007026; GO:0009792; GO:0030334; GO:0030507; GO:0030951; GO:0031113; GO:0031122; GO:0031175; GO:0031514; GO:0033043; GO:0034453; GO:0036064; GO:0036449; GO:0045198; GO:0045218; GO:0051011; GO:0051015; GO:0051893; GO:0070507; GO:0090136; GO:0098840; GO:1903358 ANHFLILFR 25.10000038 0.323707312 0.323707312 0.303829434 1131.794321 17.51903 0 17.12425 0 0 0 18.58097 18.61863 18.98189 19.18149 0 0 0 0 0 17.50562 0 18.40018 0 18.30047 16.5747 18.87842 17.77568 18.86465 0 0 0 0 17.70471 0 18.40779 0 18.48519 0 18.3973 0 0 17.7474 0 18.27205 19.03451 18.59302 0 0 18.41178 18.73889 0 18.47058 Q9P1Y6 PHRF1_HUMAN PHD and RING finger domain-containing protein 1 PHRF1 KIAA1542 Homo sapiens (Human) mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366] membrane [GO:0016020] membrane [GO:0016020]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366] metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063] GO:0006366; GO:0006397; GO:0016020; GO:0019904; GO:0046872; GO:0070063 TPAPR 4.179999828 1 1 0.122705548 541.6738324 13.91273 0 16.06309 0 15.2164 15.70404 0 0 16.13745 0 15.29667 0 15.49989 0 0 0 0 0 0 0 0 0 0 0 15.97395 0 0 0 14.46957 0 16.10623 15.32155 0 16.32241 0 13.67377 15.60506 0 0 0 16.88007 0 0 0 17.99624 0 0 0 Q9P1Z0 ZBTB4_HUMAN "Zinc finger and BTB domain-containing protein 4 (KAISO-like zinc finger protein 1, KAISO-L1)" ZBTB4 KIAA1538 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0006974; GO:0008327; GO:0010428; GO:0016604; GO:0019901; GO:0042803; GO:0043565; GO:0045892; GO:0046872 SVLAASSPFFR 10.90999985 1 1 0.483520875 1181.526338 17.66814 18.41112 0 0 0 0 16.87021 0 17.66545 0 0 17.35401 0 19.06581 0 0 0 20.2012 0 17.75188 0 0 0 0 0 18.03907 0 0 0 0 0 0 0 19.77704 0 0 18.37091 0 0 0 0 0 0 0 0 0 20.2205 18.03683 Q9P1Z2 CACO1_HUMAN Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3) CALCOCO1 KIAA1536 PP13275 UNQ2436/PRO4996 Homo sapiens (Human) "intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] GO:0000785; GO:0000976; GO:0000978; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005829; GO:0007165; GO:0008013; GO:0008022; GO:0010628; GO:0016055; GO:0030374; GO:0030518; GO:0043231; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0070016 EQLRGAQELAASSQQK 10.98999977 1 1 0.038991296 1744.308912 0 15.35487 16.78705 17.26218 15.4677 0 0 0 0 14.38486 15.82062 0 16.06265 16.95713 16.73611 17.37833 0 14.55809 0 16.59835 17.09655 11.97316 0 0 15.25353 14.89704 14.6226 13.05893 12.1514 13.06914 16.98486 14.41115 15.21907 17.95544 0 15.60848 0 13.86189 11.47836 13.61302 14.76804 16.50953 17.14419 0 0 0 8.896737 16.8273 Q9P1Z3 HCN3_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 HCN3 KIAA1535 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to dopamine [GO:1903351]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; response to cisplatin [GO:0072718]; sodium ion transmembrane transport [GO:0035725] cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cellular response to cAMP [GO:0071320]; cellular response to dopamine [GO:1903351]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; response to cisplatin [GO:0072718]; sodium ion transmembrane transport [GO:0035725] cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] GO:0003254; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0043025; GO:0044316; GO:0071320; GO:0071805; GO:0072718; GO:0086091; GO:0098907; GO:1903351; GO:2001257 LPADTR 15.32999992 1 1 0.247799248 673.5148137 20.7634 17.62991 0 0 0 18.02054 0 0 0 0 0 0 0 0 0 18.84798 16.44906 0 0 0 18.89314 16.63132 17.01715 16.98351 0 0 0 16.86452 17.32081 0 17.23999 19.21501 18.77029 18.55613 0 17.10773 0 0 0 0 0 0 19.0796 17.7258 0 0 0 0 Q9P1Z9 CC180_HUMAN Coiled-coil domain-containing protein 180 CCDC180 C9orf174 KIAA1529 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 MDESKEGSIQGLEEMQVER 10.97999954 1 1 0.44361305 2212.000996 0 0 15.762 21.63359 0 21.17939 20.45022 0 0 0 0 0 18.79833 0 20.91103 0 0 0 19.51412 0 0 0 0 0 0 0 0 0 0 0 0 0 21.75658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P202 WHRN_HUMAN Whirlin (Autosomal recessive deafness type 31 protein) WHRN DFNB31 KIAA1526 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696] actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] identical protein binding [GO:0042802] GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0060088; GO:0060122; GO:1990075; GO:1990227; GO:1990696 FDHLVLRR 2.890000105 1 1 0.167292486 1055.648109 0 13.0283 0 0 15.82246 0 0 0 0 15.46375 14.95139 0 0 0 13.39493 0 0 0 0 0 0 13.80381 16.27049 0 15.03923 0 0 0 0 0 0 17.01517 16.68446 0 0 0 0 0 0 0 15.83759 0 0 0 13.66454 0 15.1114 0 Q9P203 BTBD7_HUMAN BTB/POZ domain-containing protein 7 BTBD7 KIAA1525 Homo sapiens (Human) morphogenesis of a branching epithelium [GO:0061138]; regulation of branching involved in salivary gland morphogenesis [GO:0060693] nucleus [GO:0005634] nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; regulation of branching involved in salivary gland morphogenesis [GO:0060693] GO:0005634; GO:0060693; GO:0061138 AVISAR 3.019999981 1 1 0.305793138 617.0647061 17.26528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.38954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P206 K1522_HUMAN Uncharacterized protein KIAA1522 KIAA1522 Homo sapiens (Human) cell differentiation [GO:0030154] cell differentiation [GO:0030154] GO:0030154 APPPVAR 5.860000134 1 1 0.303633445 706.8655255 15.07693 13.71575 14.74448 17.23053 17.11832 0 17.28497 16.13188 15.33431 15.86016 16.59429 0 0 15.63275 17.03916 16.65781 17.11855 0 0 0 16.94213 18.59289 18.77963 18.82504 0 0 16.75242 17.56623 13.73176 0 15.79653 17.01917 16.61134 16.98347 17.15853 16.92871 0 16.74344 0 16.36381 17.25949 15.137 0 17.92217 16.62756 17.0166 17.34715 0 Q9P209 CEP72_HUMAN "Centrosomal protein of 72 kDa, Cep72" CEP72 KIAA1519 Homo sapiens (Human) centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051] GO:0005654; GO:0005739; GO:0005813; GO:0005829; GO:0007051; GO:0007099; GO:0033566; GO:0034451; GO:1904779 GCCLEK 10.85000038 1.56E-08 1.56E-08 0.242833951 767.0925943 21.16385 18.22186 21.53113 17.83482 18.83032 21.34146 0 0 21.87488 20.3248 0 0 18.69023 18.72839 21.51521 0 20.2068 20.95661 0 22.50291 0 21.01693 0 21.2215 0 0 18.49804 19.8016 0 19.25577 0 18.71059 17.96253 0 0 0 0 19.50183 20.63803 21.6231 20.82076 0 0 21.21839 0 20.53646 21.55582 0 Q9P212 PLCE1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, EC 3.1.4.11 (Pancreas-enriched phospholipase C) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1, PLC-epsilon-1)" PLCE1 KIAA1516 PLCE PPLC Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate-mediated signaling [GO:0048016]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267]; calcium-mediated signaling [GO:0019722]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate-mediated signaling [GO:0048016]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940] enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267] GO:0000139; GO:0001558; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0006940; GO:0007010; GO:0007173; GO:0007200; GO:0007204; GO:0007265; GO:0007507; GO:0008277; GO:0010592; GO:0016042; GO:0019722; GO:0019899; GO:0030027; GO:0031267; GO:0032835; GO:0043410; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0048016 AHQTPVDILK 7.829999924 0.165747449 0.165747449 0.229134035 1121.435246 16.50461 14.16529 0 15.87969 14.83957 13.45167 0 11.5605 0 0 0 15.20795 0 0 0 13.3024 13.12097 13.98758 0 0 11.71726 0 15.6251 0 0 14.76473 14.9051 0 0 0 15.13591 0 0 0 0 15.36976 0 0 15.69338 14.00541 0 0 0 15.47295 13.6943 0 0 15.36062 Q9P215 POGK_HUMAN Pogo transposable element with KRAB domain POGK KIAA1513 LST003 SLTP003 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]" DNA binding [GO:0003677] GO:0003677; GO:0005634; GO:0005654; GO:0006355 SVLALR 1.019999981 1 1 0.061365074 657.2883573 0 0 20.75601 0 0 0 0 0 18.66389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.46314 0 0 0 0 0 0 0 0 0 0 0 0 17.60245 0 0 0 0 0 0 0 18.43502 0 Q9P218 COKA1_HUMAN Collagen alpha-1(XX) chain COL20A1 KIAA1510 Homo sapiens (Human) collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0062023 GEKGDHGLPGLQGHPGHQGIPGR 1.50999999 1 1 0.288360857 2301.439793 0 11.49543 13.11857 12.64398 14.52508 11.50737 14.93774 16.01943 13.12213 9.764253 14.09113 0 0 0 0 13.96761 13.29683 0 0 0 0 14.89124 0 16.22883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P219 DAPLE_HUMAN "Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues, hDaple) (Hook-related protein 2, HkRP2)" CCDC88C DAPLE KIAA1509 Homo sapiens (Human) apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098] cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737] cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098] dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621] GO:0001932; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005737; GO:0005813; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031098; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043621; GO:0051959; GO:0090090 EAWGPGHK 8.56000042 0.457227826 0.457227826 0.185750835 881.4246296 0 14.5471 14.7731 14.84333 15.97135 15.41182 15.89773 15.89441 16.41201 16.39585 13.0201 11.3174 0 16.94559 16.99789 17.12219 17.29014 15.31154 16.79228 17.73354 13.30855 14.12219 16.02022 13.33768 17.11855 13.56252 17.36599 0 16.07561 0 0 17.17579 0 16.02905 14.93989 0 17.45318 17.20273 18.04231 0 18.39957 17.04008 18.27154 17.14968 17.40955 0 17.32172 0 Q9P225 DYH2_HUMAN Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3) DNAH2 DNAHC2 DNHD3 KIAA1503 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 AGSSDR 1.940000057 0.903162897 0.903162897 0.138077525 591.3533397 16.19281 18.32224 17.11423 0 16.53834 16.20697 16.12196 17.24388 17.98284 17.20356 16.41527 16.14841 17.60914 17.84723 18.30987 16.15596 17.05181 17.53951 18.27914 17.03556 16.2637 17.00157 17.74422 17.60432 0 17.35995 0 17.72702 13.71899 17.69624 17.99634 17.41712 16.45543 15.7623 16.69169 18.52774 18.09915 17.48423 16.4926 16.96261 18.13123 17.52093 16.31672 17.15124 18.85561 0 17.45143 17.17333 Q9P227 RHG23_HUMAN Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23) ARHGAP23 KIAA1501 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0007165; GO:0051056; GO:0070062 DDSAAAPK 5.420000076 0.463811606 0.463811606 0.244346701 774.1580386 15.81987 0 14.64129 13.80179 15.22157 15.29406 11.99105 14.43188 15.38686 15.36807 12.95518 15.42076 17.03459 14.17888 0 0 14.60034 0 15.70744 13.97093 14.45121 13.22048 14.17371 15.27306 0 15.04626 13.91971 0 15.58238 0 0 14.58345 0 0 14.70289 0 16.77497 15.7824 0 16.14615 0 11.69545 0 0 16.51372 15.28417 14.6261 15.98269 Q9P232 CNTN3_HUMAN "Contactin-3 (Brain-derived immunoglobulin superfamily protein 1, BIG-1) (Plasmacytoma-associated neuronal glycoprotein)" CNTN3 KIAA1496 PANG Homo sapiens (Human) cell adhesion [GO:0007155] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0005576; GO:0005886; GO:0007155; GO:0031225; GO:0043005 MKVAGNETSAR 7.110000134 1 1 0.383975728 1181.430132 15.77299 12.99592 0 0 15.83799 0 0 14.93266 14.29788 0 0 13.33802 16.66195 14.75836 15.55375 0 0 0 16.97179 0 17.70753 0 0 0 15.17628 17.33075 0 16.59712 0 15.66493 16.84933 0 15.092 0 0 15.46797 16.30701 18.17677 16.60247 0 0 16.45044 0 13.03387 0 15.92981 0 0 Q9P241 AT10D_HUMAN "Phospholipid-transporting ATPase VD, EC 7.6.2.1 (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D)" ATP10D ATPVD KIAA1487 Homo sapiens (Human) cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287] GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006812; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0140326; GO:0140351; GO:1990531 DACGMLMSTILKELQK 2.450000048 1 1 1.37E-12 1832.606472 14.51119 0 14.23036 0 0 13.52541 0 0 0 0 0 10.97461 14.87352 12.86157 0 0 0 0 0 0 14.59622 0 0 12.014 0 0 13.5904 0 14.21942 0 15.22134 12.06753 0 15.24566 0 14.53786 11.00541 0 13.89828 0 0 15.98099 0 0 16.72021 0 0 16.15002 Q9P246 STIM2_HUMAN Stromal interaction molecule 2 STIM2 KIAA1482 Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279] GO:0002115; GO:0005246; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0015279; GO:0016021; GO:0032237; GO:0051928 HITIEDLWK 31.37000084 1 1 0.207551147 1154.645195 21.06433 18.79942 20.85317 0 0 20.70226 21.02459 0 0 19.38702 22.07417 15.94068 21.46085 0 0 16.12523 19.42249 0 0 0 20.68782 21.64473 0 0 20.63708 21.66145 20.1446 20.97699 20.43883 21.30239 0 21.00567 22.40594 0 20.64938 20.682 21.01907 0 0 21.17075 21.02402 0 0 20.84885 20.62004 0 21.2921 19.97724 Q9P253 VPS18_HUMAN "Vacuolar protein sorting-associated protein 18 homolog, hVPS18" VPS18 KIAA1475 Homo sapiens (Human) autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718] actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynapse [GO:0098793] actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynapse [GO:0098793]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718] actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630] GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0007040; GO:0008333; GO:0016567; GO:0019905; GO:0030123; GO:0030136; GO:0030674; GO:0030897; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0046718; GO:0046872; GO:0048284; GO:0061630; GO:0098793; GO:0098978; GO:2000300 SAPRAFAWMMGDGVLYGALDCGRPDSLLSEER 3.039999962 1 1 1.84E-12 3542.464528 0 0 14.1478 13.90955 11.14579 0 13.21523 13.61084 14.82044 11.51788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P258 RCC2_HUMAN Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa) RCC2 KIAA1470 TD60 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027] "chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]" "chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]" guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0003723; GO:0005085; GO:0005730; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023 DEMVPR 15.61999989 1 1 1.16E-13 743.4838745 14.571 0 15.54066 0 14.40553 0 0 13.76061 0 0 0 0 0 0 0 0 0 13.82206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P260 RELCH_HUMAN "RAB11-binding protein RELCH (LisH domain and HEAT repeat-containing protein KIAA1468) (RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing) (RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats)" RELCH KIAA1468 Homo sapiens (Human) intracellular cholesterol transport [GO:0032367] recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367] GO:0005802; GO:0032367; GO:0055037 ECEQK 6.860000134 1 1 0.289082086 692.3147984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.44064 0 0 0 19.29208 0 0 0 19.68456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P265 DIP2B_HUMAN "Disco-interacting protein 2 homolog B, DIP2 homolog B" DIP2B KIAA1463 Homo sapiens (Human) negative regulation of axon extension [GO:0030517]; positive regulation of peptidyl-lysine acetylation [GO:2000758] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]; alpha-tubulin binding [GO:0043014]; negative regulation of axon extension [GO:0030517]; positive regulation of peptidyl-lysine acetylation [GO:2000758] alpha-tubulin binding [GO:0043014] GO:0005634; GO:0005737; GO:0016020; GO:0030424; GO:0030425; GO:0030517; GO:0043014; GO:0043204; GO:0070062; GO:2000758 DSFLADQLDPIYVAYNM 10.56999969 1 1 2.06E-12 1991.213459 14.9494 0 0 14.59076 0 14.89775 14.38787 13.1309 13.56379 0 0 0 16.87338 16.06144 0 15.21845 14.35585 0 0 13.78885 0 0 0 17.81947 17.3971 17.50582 16.36903 0 14.44248 0 0 0 16.76498 15.65102 0 16.15351 16.4196 0 0 0 13.75335 0 0 0 0 0 0 0 Q9P266 JCAD_HUMAN "Junctional protein associated with coronary artery disease, JCAD" JCAD KIAA1462 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748] adherens junction [GO:0005912]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587] adherens junction [GO:0005912]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; cell adhesion [GO:0007155]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748] GO:0005912; GO:0007155; GO:0032587; GO:0043410; GO:0048471; GO:0090050; GO:1900748; GO:1903589; GO:1903672 GNSPEMR 3.49000001 7.23E-06 7.23E-06 0.285140635 790.335264 0 17.07441 18.97816 0 0 0 17.89797 0 0 0 19.62129 0 0 0 0 0 0 0 0 0 0 18.12784 0 0 0 0 0 0 17.35668 0 0 0 0 18.88486 19.30939 0 0 0 0 0 0 0 0 0 0 17.71786 16.32634 0 Q9P267 MBD5_HUMAN Methyl-CpG-binding domain protein 5 (Methyl-CpG-binding protein MBD5) MBD5 KIAA1461 Homo sapiens (Human) glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014] chromocenter [GO:0010369]; chromosome [GO:0005694]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromocenter [GO:0010369]; chromosome [GO:0005694]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014] chromatin binding [GO:0003682] GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0007399; GO:0010369; GO:0030496; GO:0040014; GO:0042593; GO:0050795; GO:0060399; GO:0070062 LMIGSSNAMGR 1.190000057 0.640215576 0.640215576 0.186250602 1152.957165 0 0 14.60752 11.6736 0 0 0 0 0 0 0 12.4539 0 16.25303 12.14776 15.9667 0 0 16.9906 15.50833 0 16.33264 0 15.09201 0 0 0 14.89359 0 11.41492 15.21645 0 11.80737 17.11187 15.41075 14.24881 15.197 0 0 15.9851 0 14.72032 15.53299 0 15.21223 16.79563 14.00756 16.43566 Q9P273 TEN3_HUMAN "Teneurin-3, Ten-3 (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3, Ten-m3) (Teneurin transmembrane protein 3)" TENM3 KIAA1455 ODZ3 TNM3 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; camera-type eye morphogenesis [GO:0048593]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165] cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0005887; GO:0007156; GO:0007157; GO:0007165; GO:0010976; GO:0016020; GO:0030424; GO:0042803; GO:0043005; GO:0046982; GO:0048593; GO:0048666; GO:0050839; GO:1903385 DYITDVNSWLVTFGFHLHNAIPGFPVPK 1.149999976 0.402275771 0.402275771 5.02E-12 3185.030603 16.93383 12.69742 0 0 15.20443 0 0 0 16.16714 9.434449 16.31094 16.28925 17.53751 16.47065 0 17.36691 0 17.90933 17.24439 17.56701 17.07507 16.51586 14.23431 16.44805 13.45943 16.32815 16.73279 0 17.35942 0 15.83429 0 17.08635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.79814 Q9P275 UBP36_HUMAN "Ubiquitin carboxyl-terminal hydrolase 36, EC 3.4.19.12 (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36)" USP36 KIAA1453 Homo sapiens (Human) histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843] GO:0003723; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007000; GO:0016242; GO:0016578; GO:0016579; GO:0016607; GO:0031647; GO:0042981; GO:0050821; GO:1903146; GO:1903955; GO:2000232 AVEEDGHLK 19.5 1 1 0.086304433 993.6977149 0 17.68084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.91328 0 0 0 0 0 0 0 0 0 0 0 0 Q9P278 FNIP2_HUMAN Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932] ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087] GO:0000122; GO:0001932; GO:0005737; GO:0005765; GO:0005829; GO:0006468; GO:0008630; GO:0031334; GO:0033138; GO:0034451; GO:0042030; GO:0051087 APTLLQK 16.32999992 1 1 0.189071555 769.4582774 18.22674 15.8407 20.72528 21.04155 21.193 16.78569 17.8644 19.04345 17.50607 0 17.49303 0 0 0 0 0 0 0 0 0 0 18.13934 18.23573 0 0 0 0 17.04119 0 0 19.73692 0 0 0 18.04437 17.3475 18.35573 0 0 0 0 0 0 0 0 0 17.7979 0 Q9P281 BAHC1_HUMAN "BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2, BAH domain-containing protein 2)" BAHCC1 BAHD2 KIAA1447 Homo sapiens (Human) chromatin binding [GO:0003682] chromatin binding [GO:0003682] GO:0003682 AREALFPVHSVATPIFGNGFR 2.930000067 1 1 0.126552273 2286.811581 0 14.06011 14.74664 0 0 12.3952 0 0 0 0 0 0 12.43707 0 0 13.63568 0 15.53661 15.65214 0 0 14.14842 12.39714 14.42275 14.05841 13.39669 0 0 13.06825 15.93452 0 0 0 14.94851 9.35814 11.26103 15.46813 12.38829 0 0 0 0 0 0 0 0 0 0 Q9P283 SEM5B_HUMAN Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] GO:0001755; GO:0007411; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526 TCNPEGCPEVR 15.05000019 0.741288066 0.741288066 0.070994073 1318.441845 14.69956 13.39237 15.56764 11.26797 0 13.4257 14.71744 14.5501 0 0 0 14.82808 12.59592 0 14.00716 15.8052 13.05365 15.76549 0 12.5286 0 0 14.36273 15.05532 0 0 11.14751 0 0 11.94693 15.43961 14.15051 0 0 14.7459 12.52629 0 0 0 0 14.99273 14.53067 11.91544 0 16.4777 14.39233 15.45564 0 Q9P286 PAK5_HUMAN "Serine/threonine-protein kinase PAK 5, EC 2.7.11.1 (p21-activated kinase 5, PAK-5) (p21-activated kinase 7, PAK-7)" PAK5 KIAA1264 PAK7 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001558; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007010; GO:0007165; GO:0007612; GO:0007613; GO:0007626; GO:0008283; GO:0016477; GO:0035556; GO:0043408; GO:0045202; GO:0106310; GO:2001237 HTGKQVAVK 22.71999931 0.138413578 0.138413578 0.274061003 967.6015244 15.4405 14.83614 17.07935 17.27017 15.25723 15.16895 13.94589 16.99176 16.01027 0 14.88344 0 16.26516 14.94925 17.54954 0 17.12946 15.76102 0 17.31301 14.3912 0 0 0 15.19318 0 14.44467 16.04595 16.96165 16.39789 0 14.87632 18.61932 14.66263 0 0 16.51668 0 0 0 13.96661 0 16.82301 0 0 0 0 0 Q9P287 BCCIP_HUMAN BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1) BCCIP TOK1 Homo sapiens (Human) DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631] GO:0000079; GO:0000132; GO:0000226; GO:0003723; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007052; GO:0015631; GO:0019207; GO:0019908; GO:0034453; GO:0061101; GO:0090307; GO:0097431 AALMFANAEEEFFYEK 13.05000019 1 1 0.357355158 1905.926035 0 0 0 0 0 0 0 0 0 15.63277 14.37691 12.71497 15.48264 0 0 0 15.14718 0 0 0 17.02246 0 0 14.90418 0 15.14066 0 0 15.44546 15.16219 0 0 0 0 13.9698 0 0 0 0 15.16056 0 0 0 0 0 0 0 0 Q9P2B7 CFA97_HUMAN Cilia- and flagella-associated protein 97 CFAP97 KIAA1430 Homo sapiens (Human) spermatogenesis [GO:0007283] spermatogenesis [GO:0007283] GO:0007283 QNDDPK 9.319999695 0.706597447 0.706597447 0.189639184 718.1604365 13.52205 14.69211 15.72441 0 13.01019 0 14.45471 15.82894 0 0 15.22327 0 0 15.59209 0 14.52475 14.03942 0 13.622 15.40255 15.65444 0 0 15.89138 16.97081 0 0 0 0 0 0 16.09352 0 16.3278 17.09074 15.89513 0 0 0 15.64437 0 15.07676 0 15.63939 0 0 0 0 Q9P2D0 IBTK_HUMAN "Inhibitor of Bruton tyrosine kinase, IBtk" IBTK BTKI KIAA1417 Homo sapiens (Human) negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209] protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292] GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209 EAVYTMGLNGGQLGCLLDPNGEKCVTAPR 2.930000067 1 1 0.225202778 3135.975961 16.02003 17.84254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2D1 CHD7_HUMAN "Chromodomain-helicase-DNA-binding protein 7, CHD-7, EC 3.6.4.12 (ATP-dependent helicase CHD7)" CHD7 KIAA1416 Homo sapiens (Human) "adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GO:0000978; GO:0001501; GO:0001701; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006364; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042472; GO:0043584; GO:0045944; GO:0048752; GO:0048806; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060173; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841 KMGGAMAPPMK 15.01000023 1 1 0.28941578 1149.569061 13.23615 0 12.75184 0 15.79199 0 0 15.64209 15.66287 14.29382 14.47738 0 0 15.59269 0 15.69791 0 0 0 16.85966 15.489 0 17.67341 0 14.79678 0 0 16.26581 0 0 0 0 0 15.92259 14.58281 15.70333 15.72354 16.22962 0 0 0 0 0 0 0 0 0 0 Q9P2D3 HTR5B_HUMAN HEAT repeat-containing protein 5B HEATR5B KIAA1414 p200 p200a Homo sapiens (Human) "endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0016607; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471 KEAESKPK 10.64999962 0.365611881 0.365611881 0.219076234 914.9931375 14.28581 11.77464 18.72571 15.32215 13.3327 17.16339 15.40022 0 0 0 0 0 15.92108 0 13.1684 16.46183 16.85021 0 16.56823 16.74628 0 17.47521 15.78655 15.82888 15.84686 0 0 19.47881 18.09696 16.13809 15.61567 17.58283 15.53836 18.35591 17.8524 17.16716 16.84228 17.63551 15.76382 18.56504 14.12396 0 15.4198 15.40217 13.90089 16.53278 17.299 17.58302 Q9P2D6 F135A_HUMAN Protein FAM135A FAM135A KIAA1411 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255] cellular lipid metabolic process [GO:0044255] GO:0044255 TIEIKPSNK 3.859999895 0.351102591 0.351102591 0.279437252 1027.09195 14.88893 0 0 15.81036 13.8335 0 0 16.44337 0 15.13543 14.26018 0 0 13.40259 13.66369 17.31363 13.98929 0 12.88222 16.13384 14.4915 15.50763 0 15.79668 0 15.91432 0 15.53571 0 0 17.20702 0 0 0 14.26114 0 0 0 0 15.25563 15.82307 0 0 0 0 0 0 17.24438 Q9P2D7 DYH1_HUMAN "Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1, HSRF-1) (hDHC7)" DNAH1 DHC7 DNAHC1 KIAA1410 Homo sapiens (Human) cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 FGGAPAGPAGTGK 4.21999979 1 1 0.264211315 1087.635902 0 0 0 14.93556 0 0 0 15.08163 0 0 0 0 13.35678 0 16.1159 0 0 0 0 15.87143 0 0 15.65014 15.5049 0 0 14.70614 0 0 0 15.79529 15.24368 12.24998 16.32472 0 0 0 0 0 0 0 0 15.29018 15.56637 0 0 0 0 Q9P2D8 UNC79_HUMAN Protein unc-79 homolog UNC79 KIAA1409 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 KNLPAGGAMIR 4.909999847 0.938742042 0.938742042 0.188661474 1127.468752 15.34385 17.7979 0 15.96737 0 18.58219 0 17.81708 0 0 14.2009 12.73959 0 0 0 9.317339 16.31818 0 0 0 15.59994 14.43983 0 0 13.40911 0 14.04018 14.23594 16.88274 13.70569 15.71286 15.73588 0 14.59978 17.25007 13.84644 0 0 17.63987 0 0 0 16.3124 0 13.50663 12.3695 0 16.45909 Q9P2E2 KIF17_HUMAN Kinesin-like protein KIF17 (KIF3-related motor protein) KIF17 KIAA1405 KIF3X Homo sapiens (Human) anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0015031; GO:0016192; GO:0016887; GO:0030030; GO:0032391; GO:0032839; GO:0036064; GO:0043005; GO:0098971; GO:1990075 LARLSSTVAR 5.230000019 1 1 0.077918273 1073.411114 17.11192 14.10004 9.497762 16.06072 0 0 0 14.92867 0 0 0 14.59465 0 8.26724 15.17984 0 0 0 0 0 0 0 0 0 10.87493 0 16.06784 14.31507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2E3 ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 ZNFX1 KIAA1404 Homo sapiens (Human) activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of viral genome replication [GO:0045071] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of viral genome replication [GO:0045071] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0051607 KMHVLEEK 11.56999969 0.808172405 0.808172405 0.190067591 1015.639702 16.87572 15.22338 0 0 0 17.02027 17.98281 0 16.59423 16.03368 17.17748 0 15.84281 0 0 0 0 0 17.13864 16.08385 17.10669 17.14367 18.87481 18.45676 0 16.49733 16.56002 0 0 18.39025 0 0 17.84237 0 16.85074 0 17.07896 18.34838 17.32082 17.32215 16.60851 17.56194 0 15.74065 17.44184 17.4823 14.73715 0 Q9P2E7 PCD10_HUMAN Protocadherin-10 PCDH10 KIAA1400 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156 GNEMNLFR 16.31999969 0.314522445 0.314522445 0.255651808 977.0564115 15.54342 0 13.43264 12.34029 13.56824 14.11751 0 14.84197 15.53882 0 0 0 0 0 0 0 0 0 0 0 0 12.67776 0 15.57446 0 8.479778 13.42916 0 16.16022 15.31959 0 15.6453 16.23212 0 0 0 0 0 0 13.41552 14.03887 0 0 14.29337 10.97624 0 0 15.60407 Q9P2E9 RRBP1_HUMAN "Ribosome-binding protein 1 (180 kDa ribosome receptor homolog, RRp) (ES/130-related protein) (Ribosome receptor protein)" RRBP1 KIAA1398 Homo sapiens (Human) osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ribosome [GO:0005840] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ribosome [GO:0005840]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412] RNA binding [GO:0003723]; signaling receptor activity [GO:0038023] GO:0001649; GO:0003723; GO:0005783; GO:0005840; GO:0006412; GO:0015031; GO:0016020; GO:0030176; GO:0038023 AATRLQELLK 24.25 0.658984601 0.658984601 0.201611757 1142.585487 18.76184 19.82567 19.15925 18.74982 16.14837 20.35284 20.07587 19.59157 19.83972 16.60543 21.48353 19.02544 0 16.78077 19.79586 20.97016 17.50271 18.98135 17.12575 16.62362 19.17536 19.98142 18.81076 19.49775 20.91105 20.2406 21.17635 0 18.34849 17.81789 18.00809 17.19913 17.44009 20.47653 17.95038 17.18399 21.57357 20.744 21.343 20.45588 19.2583 20.181 19.75714 15.83385 19.5418 20.40047 19.49288 17.19522 Q9P2F5 STOX2_HUMAN Storkhead-box protein 2 STOX2 KIAA1392 Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; embryo development ending in birth or egg hatching [GO:0009792]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0001228; GO:0001893; GO:0005634; GO:0005737; GO:0009792; GO:0045944 STVNFSYK 12.60000038 0.701344371 0.701344371 0.145399674 947.6404895 16.26406 15.07064 0 0 0 13.83877 0 15.17116 15.72076 0 15.26758 0 0 0 0 0 14.08297 15.40154 0 15.65264 0 16.3258 0 15.90163 16.05458 0 16.33101 14.40068 11.70899 14.72867 16.21154 16.65887 14.55933 6.36316 16.27146 12.8663 16.54222 0 0 16.87527 0 13.85486 0 0 0 0 0 15.25173 Q9P2F6 RHG20_HUMAN Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20) ARHGAP20 KIAA1391 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005829; GO:0007165; GO:0051056 CSEPNIEDQNR 15.71000004 1 1 6.93E-13 1361.061937 0 16.1456 17.54148 0 0 16.85996 16.01659 0 0 0 0 0 16.40416 0 15.9262 0 16.3202 0 0 0 0 0 0 0 0 0 0 0 17.22733 0 0 0 0 0 0 0 0 0 0 0 16.40524 0 0 0 0 0 0 16.46831 Q9P2F8 SI1L2_HUMAN "Signal-induced proliferation-associated 1-like protein 2, SIPA1-like protein 2" SIPA1L2 KIAA1389 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0051056; GO:0090630 TSVTVKVVIIQPHDDGSPR 3.059999943 1 1 0.653599958 2047.769208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.70627 0 0 0 0 0 Q9P2G1 AKIB1_HUMAN "Ankyrin repeat and IBR domain-containing protein 1, EC 2.3.2.31" ANKIB1 KIAA1386 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630 APAVDCGK 6.239999771 0.577537477 0.577537477 0.18030385 814.4966606 0 0 16.9305 0 0 14.16404 14.43658 0 0 0 0 17.68432 16.80381 15.62501 0 0 0 0 0 0 16.00282 15.64255 0 0 0 16.07511 0 0 0 0 0 18.37982 0 17.39741 0 0 18.55029 0 0 0 0 0 0 0 0 16.33064 0 0 Q9P2G4 MAP10_HUMAN Microtubule-associated protein 10 (Microtubule regulator of 120 KDa) MAP10 KIAA1383 MTR120 Homo sapiens (Human) cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886] microtubule binding [GO:0008017] GO:0005813; GO:0005881; GO:0008017; GO:0030496; GO:0031122; GO:0032467; GO:0032886; GO:0051256; GO:0051301; GO:0097431; GO:1990023 LQPATLHCRLLR 3.579999924 1 1 0.204871907 1477.387735 0 14.38193 0 0 0 13.27792 0 0 0 0 0 14.7823 0 0 0 14.69005 0 11.8623 0 0 0 0 9.777668 0 16.08673 0 13.53998 15.212 14.7818 0 16.46118 14.71859 13.71949 0 0 0 0 0 0 0 0 0 17.01212 0 0 0 0 0 Q9P2H0 CE126_HUMAN Centrosomal protein of 126 kDa CEP126 KIAA1377 Homo sapiens (Human) cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515] centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496] centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515] GO:0005737; GO:0005813; GO:0007052; GO:0030496; GO:0031122; GO:0060271; GO:0097546; GO:1905515 INCEKEMNENMR 27.79999924 0.989090204 0.989090204 0.207191476 1587.939686 0 0 0 0 0 0 0 0 12.9789 0 16.3075 15.06484 0 0 15.09545 0 0 0 0 0 0 0 14.60967 0 13.42728 0 15.79052 15.67257 0 0 16.03338 11.90852 0 0 0 15.86559 0 0 0 14.65255 0 0 0 0 0 0 0 15.73954 Q9P2H5 UBP35_HUMAN "Ubiquitin carboxyl-terminal hydrolase 35, EC 3.4.19.12 (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35)" USP35 KIAA1372 USP34 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579 KHCITEDTPPTSLYIEGLDSK 3.140000105 1 1 0.113851826 2404.660656 0 0 0 0 13.93177 14.84624 14.85293 13.45456 14.23616 14.65721 14.07402 0 13.60514 0 13.5882 0 12.97412 0 0 0 0 0 0 0 0 0 15.12694 0 0 0 0 16.44869 0 0 0 0 0 0 0 0 16.47449 13.88582 0 0 0 0 14.64485 0 Q9P2I0 CPSF2_HUMAN "Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit, CPSF 100 kDa subunit)" CPSF2 CPSF100 KIAA1367 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005847; GO:0006378; GO:0006398; GO:0016020; GO:0098789 SDGDSIK 12.18999958 1 1 0.31167794 721.3581214 0 18.9585 0 0 0 17.4363 0 18.53226 0 0 0 19.02321 0 16.50528 0 0 16.95757 0 0 0 18.85353 17.3074 18.79977 17.93418 0 19.35153 22.70845 16.69209 0 16.12451 18.86603 0 0 21.48662 18.39464 0 18.10499 0 0 20.28368 20.48831 0 17.03853 18.97481 18.53806 0 19.53173 18.01009 Q9P2J2 TUTLA_HUMAN "Protein turtle homolog A (Immunoglobulin superfamily member 9A, IgSF9A)" IGSF9 IGSF9A KIAA1355 NRT1 Homo sapiens (Human) axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807] axon [GO:0030424]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807] cell-cell adhesion mediator activity [GO:0098632] GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016358; GO:0030424; GO:0030425; GO:0050807; GO:0060077; GO:0070593; GO:0098632 RLDGYVLEGR 9.569999695 0.81708467 0.81708467 0.372876967 1178.378204 0 15.74401 0 14.81937 0 0 0 0 0 0 0 0 15.17858 0 0 16.06635 0 15.8203 0 16.16329 14.94491 13.53694 16.03219 0 15.39593 0 14.82148 0 15.12335 15.06167 15.10393 15.76668 0 13.38997 16.3528 0 0 0 0 0 16.29804 15.82389 0 0 16.23247 0 0 0 Q9P2J5 SYLC_HUMAN "Leucine--tRNA ligase, cytoplasmic, EC 6.1.1.4 (Leucyl-tRNA synthetase, LeuRS)" LARS1 KIAA1352 LARS Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823] GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253 KMIDAGDALIYMEPEK 1.139999986 0.294296801 0.294296801 4.79E-12 1856.0592 0 8.282296 0 0 14.02256 16.06459 0 9.020055 13.43408 12.67265 17.39786 0 14.00239 0 15.03943 13.63464 15.53998 0 13.37664 16.51398 15.66781 12.84997 15.81489 14.14678 13.22262 13.44511 0 14.90235 14.76286 16.26229 11.62786 0 16.84653 0 16.7177 11.68442 15.21868 15.26031 15.13676 0 16.25149 0 15.45214 15.93394 0 15.66271 0 0 Q9P2K1 C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A CC2D2A KIAA1345 Homo sapiens (Human) axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038] ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038]; axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] GO:0001822; GO:0001843; GO:0005829; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403 RWFGDDGR 5.119999886 0.400857836 0.400857836 0.081537787 1009.657182 13.9967 0 0 0 15.61464 15.45845 0 0 14.25548 0 0 0 0 0 0 0 16.40714 0 0 0 0 0 0 0 0 0 0 0 0 16.06004 0 0 0 14.52876 0 7.419394 0 0 0 14.35545 8.802118 14.25729 0 0 0 0 0 14.70449 Q9P2K5 MYEF2_HUMAN "Myelin expression factor 2, MEF-2, MyEF-2 (MST156)" MYEF2 KIAA1341 Homo sapiens (Human) myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; regulation of transcription by RNA polymerase II [GO:0006357] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006357; GO:0014902; GO:0030182; GO:0071014; GO:1990904; GO:2000815 EKVGEVTYVELFK 2.519999981 1 1 0.37534747 1539.743022 0 15.30756 0 0 0 0 0 0 0 16.01603 0 16.041 0 0 0 14.56938 0 0 16.47288 0 0 16.74349 16.32189 17.78987 0 0 0 0 0 0 0 0 0 14.34547 0 0 15.20796 14.95079 0 0 0 0 0 0 0 14.98852 0 15.66753 Q9P2K8 E2AK4_HUMAN "eIF-2-alpha kinase GCN2, EC 2.7.11.1 (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein)" EIF2AK4 GCN2 KIAA1338 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; polysome [GO:0005844] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tRNA binding [GO:0000049]; adaptive immune response [GO:0002250]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tRNA binding [GO:0000049] GO:0000049; GO:0000077; GO:0001934; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0004712; GO:0005524; GO:0005829; GO:0005844; GO:0006446; GO:0006468; GO:0007049; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0036492; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138; GO:1990253 GDVWR 17.22999954 0.394675702 0.394675702 0.224571009 632.5989945 20.89536 21.41753 21.64488 21.1642 19.93744 13.78859 21.40595 21.42632 22.40633 21.9771 21.10671 20.8324 19.42492 18.04752 21.07396 17.44539 20.7261 20.89015 19.36364 20.57139 20.93245 0 20.99688 18.95401 21.87979 20.20144 19.72116 22.02396 21.48716 0 21.16594 20.04117 22.79646 21.65737 21.40291 22.31737 18.13044 21.42056 22.23656 0 17.77031 17.71255 21.31391 19.70123 20.2858 21.07728 21.85706 21.97009 Q9P2L0 WDR35_HUMAN WD repeat-containing protein 35 (Intraflagellar transport protein 121 homolog) WDR35 IFT121 KIAA1336 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512] GO:0005813; GO:0005929; GO:0005930; GO:0030991; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:1990830 THVIAASK 7.019999981 1 1 0.098317036 826.175378 14.00789 12.43251 13.21433 11.52889 14.22439 15.34552 0 0 0 0 15.9626 0 13.95447 13.96414 0 0 0 0 0 15.05773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2M1 LR2BP_HUMAN "LRP2-binding protein (Megalin-binding protein, MegBP)" LRP2BP KIAA1325 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 LWLIAADNGNPKASVK 2.480000019 1 1 0.185240634 1696.795784 0 0 11.93378 0 0 15.83143 0 0 0 0 15.42205 0 0 0 0 14.02476 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12494 14.92278 0 0 0 0 0 0 15.08098 0 0 14.61005 0 0 0 0 0 0 0 Q9P2M7 CING_HUMAN Cingulin CGN KIAA1319 Homo sapiens (Human) bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296] actin binding [GO:0003779]; cadherin binding [GO:0045296] GO:0003779; GO:0005886; GO:0005923; GO:0016459; GO:0030054; GO:0045296 HGLETQVMELQNKLK 4.369999886 1 1 0.335901837 1783.635261 14.68121 0 14.04688 13.51033 13.46683 14.6509 14.29812 13.68485 0 13.48896 0 16.08249 0 0 0 0 0 0 0 0 0 0 0 0 15.86626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0013 0 0 0 0 0 16.21794 0 Q9P2N2 RHG28_HUMAN Rho GTPase-activating protein 28 (Rho-type GTPase-activating protein 28) ARHGAP28 KIAA1314 Homo sapiens (Human) negative regulation of GTP binding [GO:1904425]; negative regulation of stress fiber assembly [GO:0051497]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of GTP binding [GO:1904425]; negative regulation of stress fiber assembly [GO:0051497]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030833; GO:0051056; GO:0051497; GO:1904425 LMLKYQK 7.269999981 0.578870773 0.578870773 0.216510379 922.5685101 15.47201 14.84501 15.02748 0 14.6783 14.44201 13.87245 15.91587 17.66872 16.29536 14.98619 15.55352 14.75202 0 0 0 15.14158 14.29024 13.07414 15.63561 14.77396 0 15.87341 14.88666 15.96899 16.62689 16.57641 0 0 0 0 0 15.78642 0 15.88192 0 15.04384 14.83192 0 16.52396 0 16.308 0 15.48806 16.28448 16.04783 0 0 Q9P2N4 ATS9_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 9, ADAM-TS 9, ADAM-TS9, ADAMTS-9, EC 3.4.24.-" ADAMTS9 KIAA1312 Homo sapiens (Human) aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671 FYSEEEAELK 9.949999809 1 1 0.447921901 1243.93412 18.76909 0 0 0 0 0 0 0 0 0 0 16.553 0 0 0 0 0 0 0 0 17.80912 0 18.08019 0 0 0 18.30556 16.92705 0 17.82724 0 0 0 19.91138 0 0 19.01867 0 17.32993 0 0 0 0 0 0 0 0 18.51716 Q9P2N6 KANL3_HUMAN KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD) KANSL3 KIAA1310 NSL3 PRTD SI1 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654] "histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" GO:0000123; GO:0005654; GO:0006325; GO:0043231; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0045944; GO:0051571; GO:1900095 QNMLVR 3.769999981 0.980712712 0.980712712 0.062344134 775.4713129 16.22353 16.93986 15.51371 15.79316 0 15.97366 15.2522 17.96847 11.2192 13.70456 16.39417 16.05537 0 17.64204 0 17.59371 0 0 0 15.50536 0 0 16.35957 14.75272 17.38475 16.51008 0 0 16.92912 15.65217 0 19.11562 15.83171 12.54136 18.35646 16.93953 16.66998 0 13.93573 18.41659 17.22469 0 0 13.23712 0 14.98757 0 12.91481 Q9P2P1 NYNRI_HUMAN Protein NYNRIN (NYN domain and retroviral integrase catalytic domain-containing protein) (Protein cousin of GIN1) NYNRIN CGIN1 KIAA1305 Homo sapiens (Human) "DNA integration [GO:0015074]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]; DNA integration [GO:0015074]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729] GO:0003729; GO:0004521; GO:0005634; GO:0015074; GO:0016021; GO:0036464; GO:0090502 AAEEDDLDSSLASVFR 10.22999954 1 1 0.180332411 1723.908563 15.19091 15.33717 15.74979 15.89899 14.25686 17.49384 15.42745 14.59238 0 11.59141 15.81706 14.41975 14.05599 15.12089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2P6 STAR9_HUMAN "StAR-related lipid transfer protein 9 (START domain-containing protein 9, StARD9)" STARD9 KIAA1300 Homo sapiens (Human) microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225] centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634] centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225] ATP binding [GO:0005524]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0007018; GO:0008017; GO:0008289; GO:0051225 DEHTASAADTSR 3.519999981 1 1 4.58E-13 1257.818266 16.07404 0 12.80597 17.53685 0 0 0 11.73661 11.97575 13.02985 16.26411 13.34616 0 11.45126 0 0 0 12.99146 0 0 0 0 0 0 0 0 0 0 0 13.28785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.10875 0 0 0 Q9P2Q2 FRM4A_HUMAN FERM domain-containing protein 4A FRMD4A FRMD4 KIAA1294 Homo sapiens (Human) establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-macromolecule adaptor activity [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714] protein-macromolecule adaptor activity [GO:0030674] GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162 DMLAALK 4.670000076 1 1 0.059917364 777.5750885 13.0796 0 0 0 0 0 0 0 14.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.04442 0 0 0 15.69584 0 0 16.61246 0 15.85954 16.21756 16.08996 0 15.77893 12.63239 0 0 0 15.98447 0 0 0 0 0 0 Q9P2R3 ANFY1_HUMAN "Rabankyrin-5, Rank-5 (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)" ANKFY1 ANKHZN KIAA1255 Homo sapiens (Human) "endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020] "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]" metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267] GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0031267; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981 AIVRSGAR 11.88000011 1 1 0.255252073 829.7639347 15.94633 17.61292 17.02612 0 0 0 19.09632 0 0 17.42626 0 0 16.71292 0 0 0 18.55239 0 0 0 16.95407 0 0 0 0 0 0 0 17.27318 0 18.91956 0 0 0 0 18.23372 0 0 19.279 16.50031 0 0 16.54886 0 0 18.35957 0 16.61698 Q9P2R6 RERE_HUMAN Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0046872; GO:0048755; GO:0048813 DHLLMNVK 5.400000095 1 1 0.2396388 985.403008 0 0 0 0 0 0 0 0 19.2857 0 0 17.27811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.22303 0 0 0 16.5531 0 0 0 0 0 0 0 0 0 17.64478 0 16.26044 Q9P2S2 NRX2A_HUMAN Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha) NRXN2 KIAA0921 Homo sapiens (Human) adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005246; GO:0005886; GO:0007158; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0032991; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793 DVVYK 10.59000015 0.465156078 0.465156078 0.166265868 623.479724 15.87369 16.43679 15.7638 16.17604 15.92821 14.73884 15.39155 15.55417 16.2066 15.3709 16.793 14.28353 0 15.71739 16.20883 16.53049 15.96719 16.06635 0 13.86656 0 16.67048 15.84316 0 16.02176 0 16.08111 15.66354 15.18933 14.31635 16.13442 15.64771 16.02266 15.98127 0 15.51365 0 16.47037 16.64107 15.28951 17.51581 16.94599 13.81441 14.29685 15.89232 16.60326 0 15.10547 Q9P2S6 ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 (Testis-specific ankyrin-like protein 1) (Zinc finger MYND domain-containing protein 13) ANKMY1 TSAL1 ZMYND13 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 SGFAPCGPKEQLSMEMILK 3 1 1 0.127954109 2123.485534 17.94551 9.016873 0 15.47414 13.51492 0 17.13899 0 13.67945 0 0 0 0 15.84205 0 0 0 0 0 15.47939 0 0 0 0 0 0 0 15.42923 0 17.47749 0 0 0 0 0 0 0 0 0 0 15.29837 0 0 0 0 0 0 0 Q9P2T0 THEG_HUMAN "Testicular haploid expressed gene protein (Cancer/testis antigen 56, CT56)" THEG Homo sapiens (Human) cell differentiation [GO:0030154]; chaperone-mediated protein complex assembly [GO:0051131]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; cell differentiation [GO:0030154]; chaperone-mediated protein complex assembly [GO:0051131]; spermatogenesis [GO:0007283] GO:0005634; GO:0007283; GO:0030154; GO:0051131 ELAAPK 5.25 0.241519898 0.241519898 0.274410273 627.8612121 16.01549 14.58188 14.71374 14.53457 15.67752 14.9019 0 0 14.77397 16.07535 15.05748 15.76597 16.2458 15.36721 14.85508 16.05382 15.9488 16.64654 16.67812 16.97216 16.68492 17.58868 15.35558 15.69969 17.81255 16.97493 15.05468 16.06064 17.00221 16.67002 15.24384 15.82019 15.83317 16.62951 17.66518 17.66696 0 17.56105 17.16598 15.68709 15.24457 17.63878 17.58059 17.59457 16.34969 18.19955 18.49858 15.90661 Q9P2T1 GMPR2_HUMAN "GMP reductase 2, GMPR 2, EC 1.7.1.7 (Guanosine 5'-monophosphate oxidoreductase 2, Guanosine monophosphate reductase 2)" GMPR2 Homo sapiens (Human) GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144] cytosol [GO:0005829]; GMP reductase complex [GO:1902560] cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144] GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872] GO:0003920; GO:0005829; GO:0006144; GO:0046037; GO:0046872; GO:1902560 QTYSGVPIIAANMDTVGTFEMAK 9.369999886 1 1 0.153625159 2459.018776 15.58505 0 14.74618 14.4892 14.18188 13.57005 17.42162 0 0 16.62893 18.29431 15.25739 11.61339 19.81779 0 0 14.39569 15.97121 0 15.49564 0 0 19.86051 15.29169 0 0 18.54099 0 17.0725 18.13498 0 0 0 0 0 0 17.87035 18.37265 14.73936 0 0 16.08459 0 15.91898 0 17.35105 0 0 Q9P2V4 LRIT1_HUMAN "Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 (Leucine-rich repeat-containing protein 21) (Photoreceptor-associated LRR superfamily protein) (Retina-specific protein PAL)" LRIT1 LRRC21 PAL Homo sapiens (Human) integral component of endoplasmic reticulum membrane [GO:0030176] integral component of endoplasmic reticulum membrane [GO:0030176] GO:0030176 SLLGGTALLR 7.610000134 1 1 0.292000614 1000.461932 0 14.46013 15.28277 11.44397 15.16839 15.77329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2641 0 14.54544 0 14.77625 0 16.05786 0 15.94718 15.42867 16.37964 14.91515 15.01144 9.226576 0 16.16828 0 14.48238 13.41197 0 0 0 0 0 15.5636 0 Q9P2W9 STX18_HUMAN Syntaxin-18 (Cell growth-inhibiting gene 9 protein) STX18 GIG9 Homo sapiens (Human) "endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484] GO:0000139; GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0016021; GO:0019904; GO:0031201; GO:0090158; GO:1902117; GO:1902953; GO:1903358 LEPEPNTK 12.80000019 1 1 0.181302802 925.384561 12.66101 16.55022 15.8934 15.12611 0 14.7595 16.08624 14.94743 16.08708 15.41105 12.47012 16.34184 14.7186 14.40531 15.74267 0 0 0 0 16.20682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.59823 0 0 0 0 0 0 0 0 0 0 0 Q9P2Y4 ZN219_HUMAN Zinc finger protein 219 ZNF219 Homo sapiens (Human) "limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]" integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001505; GO:0003677; GO:0003700; GO:0004969; GO:0005634; GO:0005654; GO:0006355; GO:0016021; GO:0032332; GO:0045892; GO:0045944; GO:0046872; GO:0060174 REPPSLLGYLSLR 1.179999948 0.962314904 0.962314904 0.273995489 1499.781077 13.80186 14.66741 13.79002 15.98014 0 14.36661 15.04799 0 14.58981 14.97182 14.36112 16.05825 15.4416 14.97077 16.12519 13.13371 14.33597 0 14.70907 0 0 0 0 0 0 0 0 14.03051 0 0 0 0 0 0 0 0 0 0 0 0 0 12.14412 0 16.56487 0 0 0 0 Q9UBB4 ATX10_HUMAN Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein) ATXN10 SCA10 Homo sapiens (Human) cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175] GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0016020; GO:0030425; GO:0031175; GO:0043025; GO:0048471; GO:0060271 ALTALFK 9.779999733 1 1 0.069032536 763.5523198 11.92911 13.30606 13.3614 14.70976 0 15.40587 0 0 0 16.17373 15.20919 13.67371 15.02193 0 13.11031 15.36558 0 0 15.55451 0 15.60386 0 0 0 0 0 0 0 15.1397 15.93805 0 0 0 16.31096 0 13.41095 0 0 0 15.32523 0 0 0 0 0 14.20571 14.47836 0 Q9UBB9 TFP11_HUMAN "Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1, STIP-1)" TFIP11 STIP HSPC006 Homo sapiens (Human) "biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]" "catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]" "catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]" nucleic acid binding [GO:0003676] GO:0000390; GO:0000398; GO:0000781; GO:0003676; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006396; GO:0016607; GO:0031012; GO:0031214; GO:0031333; GO:0031848; GO:0032091; GO:0071008; GO:0071013; GO:1904876; GO:2001033 LLQKMGYVPGR 5.239999771 1 1 4.60E-13 1278.85556 14.8651 13.29296 15.84017 0 0 14.98423 0 0 0 0 0 0 0 0 0 0 0 0 0 13.89806 0 0 0 0 0 14.78647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.78956 Q9UBC1 IKBL1_HUMAN "NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein, I-kappa-B-like protein, IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1)" NFKBIL1 IKBL Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720] GO:0005634; GO:0005654; GO:0005829; GO:0007249; GO:0031665; GO:0032088; GO:0032720; GO:0034122; GO:0071222 SSMASTSRR 6.019999981 1 1 0.086669995 999.6864383 0 0 0 0 0 0 0 0 0 0 0 0 13.39627 0 15.33024 0 11.62231 15.5839 13.52017 0 0 0 17.29571 0 14.58076 9.411975 0 0 0 0 14.46693 0 0 15.59864 0 15.3271 10.85892 16.8381 0 15.3597 0 0 15.05786 15.37066 14.82758 13.66423 12.38302 0 Q9UBC2 EP15R_HUMAN "Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein, Eps15R)" EPS15L1 EPS15R Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197] clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; endosomal transport [GO:0016197] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296 NDPFTSDPFTK 22.85000038 0.809022665 0.809022665 0.260947687 1269.833693 19.13441 21.34546 20.94831 15.98996 20.63829 19.56057 20.41659 20.68687 20.83147 17.46568 21.08999 21.04648 19.07603 20.85315 20.93981 18.88334 0 21.9446 21.18455 19.53051 20.88447 21.82935 0 20.68995 0 15.67854 20.6116 20.12805 20.30459 21.66421 21.63053 20.80388 22.57905 21.78128 21.79339 22.85641 22.02949 22.68282 22.08093 21.32229 20.5391 19.78544 0 21.79883 22.00427 19.22676 21.18769 20.8006 Q9UBC3 DNM3B_HUMAN "DNA (cytosine-5)-methyltransferase 3B, Dnmt3b, EC 2.1.1.37 (DNA methyltransferase HsaIIIB, DNA MTase HsaIIIB, M.HsaIIIB)" DNMT3B Homo sapiens (Human) C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571] catalytic complex [GO:1902494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "catalytic complex [GO:1902494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]" "DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]" GO:0000122; GO:0003677; GO:0003714; GO:0003886; GO:0005634; GO:0005654; GO:0006306; GO:0009008; GO:0010628; GO:0046872; GO:0051571; GO:0051573; GO:0051718; GO:0090116; GO:1902494 EDSILVNGACSDQSSDSPPILEAIRTPEIR 1.809999943 1 1 9.20E-13 3269.888712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.33967 13.64242 15.38336 0 0 0 0 14.90154 0 0 15.19002 0 0 0 0 0 9.21436 14.3273 0 14.81167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBC5 MYO1A_HUMAN "Unconventional myosin-Ia (Brush border myosin I, BBM-I, BBMI) (Myosin I heavy chain, MIHC)" MYO1A MYHL Homo sapiens (Human) actin filament organization [GO:0007015]; microvillus assembly [GO:0030033]; sensory perception of sound [GO:0007605]; vesicle localization [GO:0051648]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; microvillus assembly [GO:0030033]; sensory perception of sound [GO:0007605]; vesicle localization [GO:0051648]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016323; GO:0016324; GO:0016328; GO:0016459; GO:0030033; GO:0030050; GO:0030864; GO:0031941; GO:0031982; GO:0044853; GO:0051015; GO:0051648 AVQSAMAVIGFSEEEIR 8.5 1 1 0.280627323 1854.312393 14.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.53074 13.80806 0 0 0 0 0 0 0 16.25673 0 0 0 0 13.88465 14.63846 0 0 15.81892 16.11548 15.29875 15.10752 0 0 0 16.70139 0 0 0 0 0 0 0 Q9UBF2 COPG2_HUMAN "Coatomer subunit gamma-2 (Gamma-2-coat protein, Gamma-2-COP)" COPG2 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" structural molecule activity [GO:0005198] GO:0000139; GO:0005198; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0030426; GO:0072384 LALADGVTMQVTVRSK 4.789999962 0.241632253 0.241632253 0.467330528 1704.922667 20.3864 0 19.2176 19.5221 0 0 19.46774 19.13946 0 0 0 18.87235 0 19.84942 18.1594 0 0 0 0 0 0 0 0 19.46549 0 0 0 0 17.86534 18.90239 0 0 0 18.73435 0 20.83036 19.52258 0 0 0 0 0 19.13307 0 0 0 0 0 Q9UBG3 CRNN_HUMAN Cornulin (53 kDa putative calcium-binding protein) (53 kDa squamous epithelial-induced stress protein) (58 kDa heat shock protein) (Squamous epithelial heat shock protein 53) (Tumor-related protein) CRNN C1orf10 DRC1 PDRC1 SEP53 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914] GO:0005509; GO:0005737; GO:0009408; GO:0010468; GO:0010838; GO:0014066; GO:0016020; GO:0046914; GO:0048306; GO:0051092; GO:0070062; GO:0071345; GO:0098609; GO:1902808 VAQACFK 16.22999954 0.837097824 0.837097824 0.127628277 822.3967982 16.50371 0 0 17.30147 0 0 16.07876 0 11.07059 15.9325 16.14981 0 0 0 0 10.17637 0 0 0 0 0 0 0 0 15.35252 0 13.37812 15.7412 0 0 0 0 0 0 0 0 14.0031 0 0 0 0 0 0 14.8938 0 0 0 0 Q9UBH0 I36RA_HUMAN "Interleukin-36 receptor antagonist protein, IL-36Ra (FIL1 delta) (IL-1-related protein 3, IL-1RP3) (Interleukin-1 HY1, IL-1HY1) (Interleukin-1 delta, IL-1 delta) (Interleukin-1 family member 5, IL-1F5) (Interleukin-1 receptor antagonist homolog 1, IL-1ra homolog 1) (Interleukin-1-like protein 1, IL-1L1)" IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342 Homo sapiens (Human) antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]; antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715] cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149] GO:0001960; GO:0002437; GO:0005125; GO:0005149; GO:0005152; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0019732; GO:0032689; GO:0032700; GO:0032715; GO:0045087; GO:0071222 GEEISVVPNR 8.350000381 0.506805658 0.506805658 0.236195015 1100.260924 12.36745 13.70313 13.58658 13.93083 14.37646 14.26527 0 0 0 0 14.73716 0 14.22084 17.30987 0 0 0 14.80581 9.630497 0 0 14.87506 14.97294 14.03983 15.80421 0 0 0 15.25006 0 0 0 0 0 0 0 14.96529 0 0 0 0 0 0 0 0 0 15.40204 0 Q9UBH6 XPR1_HUMAN "Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3, X-receptor)" XPR1 SYG1 XR Homo sapiens (Human) cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615] efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023 MKFAEHLSAHITPEWR 8.399999619 1 1 0.249107355 1968.880683 16.27153 14.57737 14.95917 0 0 0 15.09374 0 0 0 0 0 0 15.48857 12.22467 0 13.77774 0 0 0 0 0 15.17447 16.57404 14.17451 0 0 0 0 0 0 0 0 0 0 0 0 0 17.09891 0 0 0 0 0 0 0 0 0 Q9UBJ2 ABCD2_HUMAN "ATP-binding cassette sub-family D member 2, EC 3.1.2.-, EC 7.6.2.- (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein, hALDR)" ABCD2 ALD1 ALDL1 ALDR ALDRP Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0007031; GO:0015910; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1903427; GO:1990535; GO:2001280 THMLNAAADRVK 6.139999866 1 1 0.226129622 1343.437697 15.23245 0 12.97848 0 0 0 0 0 0 0 0 13.18373 0 0 0 14.44963 0 0 0 0 15.54801 14.31226 0 0 16.44754 0 0 0 13.47709 0 14.42863 0 0 0 16.07218 0 0 15.05035 0 0 15.68085 0 0 0 15.27657 0 18.48042 0 Q9UBK7 RBL2A_HUMAN Rab-like protein 2A RABL2A Homo sapiens (Human) intracellular protein transport [GO:0006886] endomembrane system [GO:0012505] endomembrane system [GO:0012505]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0006886; GO:0012505 TKPSELDQGK 4.050000191 0.043489832 0.043489832 0.214255699 1101.590223 0 0 0 0 0 0 18.69328 18.51616 0 0 0 0 0 16.99498 0 0 0 0 0 0 0 0 0 0 17.29566 0 17.54988 17.67687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.55404 0 0 16.28398 0 0 Q9UBK8 MTRR_HUMAN "Methionine synthase reductase, MSR, EC 1.16.1.8 (Aquacobalamin reductase, AqCbl reductase)" MTRR Homo sapiens (Human) DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; [methionine synthase] reductase activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; S-adenosylmethionine cycle [GO:0033353]" "[methionine synthase] reductase activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]" GO:0003958; GO:0005654; GO:0005829; GO:0006306; GO:0009086; GO:0010181; GO:0016491; GO:0016723; GO:0030586; GO:0033353; GO:0043418; GO:0045111; GO:0046655; GO:0050660; GO:0050667; GO:0070402; GO:0071949; GO:1904042 ALAPKISISPR 7.619999886 1 1 0.173824509 1149.183934 15.29271 16.14334 11.09637 0 0 0 0 15.08116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.75039 0 15.16799 0 0 0 0 0 15.20899 0 0 0 0 0 16.21671 0 15.75239 0 0 13.69102 0 0 0 0 0 0 Q9UBK9 UXT_HUMAN "Protein UXT (Androgen receptor trapped clone 27 protein, ART-27) (Ubiquitously expressed transcript protein)" UXT HSPC024 Homo sapiens (Human) apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; spindle pole [GO:0000922] centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; spindle pole [GO:0000922]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357] beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000226; GO:0000785; GO:0000922; GO:0003682; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005856; GO:0006357; GO:0006915; GO:0007098; GO:0008017; GO:0047497; GO:0048487; GO:0050821; GO:0101031; GO:1990062 ELQGLQNFPEKPHH 1.460000038 1 1 0.304124221 1673.473022 0 0 14.93381 14.97797 0 0 0 0 0 0 14.43526 0 0 16.11915 14.19712 0 0 16.50887 0 0 0 16.10076 0 0 0 0 0 0 0 15.04171 0 0 0 0 17.09118 0 0 0 0 0 0 0 4.459944 0 0 0 0 0 Q9UBL0 ARP21_HUMAN "cAMP-regulated phosphoprotein 21, ARPP-21 (Thymocyte cAMP-regulated phosphoprotein)" ARPP21 TARPP Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676] calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676] GO:0003676; GO:0005516; GO:0005737 SKSGAGK 8.050000191 1 1 0.118284489 633.2691942 0 16.21292 0 0 14.77635 0 0 17.05282 0 0 0 13.26355 0 0 15.69901 15.7757 0 0 0 16.38266 0 15.74413 15.79529 0 0 0 17.56479 0 0 0 0 0 0 15.68629 0 0 0 0 0 0 0 0 16.56134 15.98892 16.97666 0 18.37066 0 Q9UBL3 ASH2L_HUMAN Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein) ASH2L ASH2L1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627] euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627] beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976] GO:0000791; GO:0000976; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0008013; GO:0008284; GO:0030097; GO:0035097; GO:0043627; GO:0044665; GO:0044666; GO:0045944; GO:0046872; GO:0048188; GO:0051568; GO:0071339 ASHGVRK 8.5 1 1 4.60E-13 756.4193508 0 0 15.75746 0 0 0 0 0 0 0 0 0 0 0 0 0 15.97453 0 16.42636 0 0 16.31643 0 0 0 0 0 0 0 16.38398 0 0 16.36396 0 0 17.19092 18.45847 17.36669 0 0 0 17.54426 0 0 0 0 0 18.16014 Q9UBL6 CPNE7_HUMAN Copine-7 (Copine VII) CPNE7 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; transporter activity [GO:0005215] GO:0005215; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006629; GO:0046872; GO:0070062; GO:0071277 KVTRPLLLK 6.019999981 1 1 0.196543061 1068.646688 0 20.22525 12.85515 0 0 0 18.17085 0 17.72808 0 0 0 16.97559 0 0 18.25965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.02572 0 18.5888 0 0 0 0 0 Q9UBM1 PEMT_HUMAN "Phosphatidylethanolamine N-methyltransferase, PEAMT, PEMT, EC 2.1.1.17, EC 2.1.1.71 (PEMT2) (Phospholipid methyltransferase, PLMT)" PEMT PEMPT PNMT Homo sapiens (Human) blastocyst hatching [GO:0001835]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingomyelin biosynthetic process [GO:0006686] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]; blastocyst hatching [GO:0001835]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingomyelin biosynthetic process [GO:0006686] phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608] GO:0000773; GO:0001835; GO:0004608; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006686; GO:0016021; GO:0031966; GO:0032259; GO:0043231; GO:0080101; GO:0120162 ASGSHK 2.339999914 0.166615188 0.166615188 0.149459079 585.5601903 0 16.34095 15.97219 0 14.96853 16.93207 11.00055 14.27707 13.58334 0 12.76632 13.98758 14.80084 16.76293 0 0 0 0 0 0 0 0 0 0 0 0 15.54897 0 0 15.10994 0 0 0 0 0 0 16.17122 17.11329 14.40244 0 0 0 0 0 0 0 0 0 Q9UBM4 OPT_HUMAN Opticin (Oculoglycan) OPTC OPT Homo sapiens (Human) collagen fibril organization [GO:0030199] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; collagen fibril organization [GO:0030199] extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0030199; GO:0031012 SVHLQNNLIETMQR 6.829999924 1 1 4.60E-13 1692.797653 0 0 15.41932 14.20092 0 0 0 0 13.03303 14.1229 0 0 12.11878 0 0 15.70045 0 0 15.82766 0 0 0 0 0 0 0 0 0 13.38542 0 0 0 0 0 0 0 0 0 0 0 16.06642 0 0 0 0 0 0 0 Q9UBN4 TRPC4_HUMAN "Short transient receptor potential channel 4, TrpC4 (Trp-related protein 4, hTrp-4, hTrp4)" TRPC4 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]" "beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" GO:0005262; GO:0005886; GO:0005887; GO:0005901; GO:0006816; GO:0006828; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0034703; GO:0034704; GO:0045296; GO:0048709; GO:0051480; GO:0070509; GO:0070588; GO:0070679 ESWDMWHPTLVAEALFAIANIFSSLR 5.900000095 0.627986193 0.627986193 4.12E-12 3004.891477 0 16.80868 0 12.65003 0 15.21079 0 8.593329 0 0 16.32782 0 0 0 0 14.14195 16.03122 14.29985 0 0 0 0 0 15.57224 15.49815 0 12.25381 0 0 0 0 0 16.21822 0 0 0 0 12.47761 0 0 0 0 0 0 0 0 15.61078 0 Q9UBN6 TR10D_HUMAN "Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2, DcR2) (TNF-related apoptosis-inducing ligand receptor 4, TRAIL receptor 4, TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264)" TNFRSF10D DCR2 TRAILR4 TRUNDD UNQ251/PRO288 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165] TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0005886; GO:0006915; GO:0007165; GO:0009986; GO:0016021; GO:0043066; GO:0045569 EEECPAGSHR 7.539999962 1 1 0.062989939 1170.13992 16.20007 12.00126 16.21554 14.92276 13.44749 0 0 14.46199 15.44995 0 15.02002 0 0 15.34147 0 0 15.27035 0 15.73746 14.10872 0 15.43458 13.60614 0 0 0 0 0 16.13116 0 0 0 0 16.65056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBN7 HDAC6_HUMAN "Histone deacetylase 6, HD6, EC 3.5.1.98 (Tubulin-lysine deacetylase HDAC6, EC 3.5.1.-)" HDAC6 KIAA0901 JM21 Homo sapiens (Human) "aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]" aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] "aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]" actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] GO:0000118; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090042; GO:1901300; GO:1903146; GO:1904115; GO:2000273 LVDAVLGAEIR 4.360000134 1 1 2.32E-13 1156.52822 0 16.17609 14.86602 0 0 0 0 0 14.53339 0 0 13.10697 0 0 0 0 0 0 0 0 0 0 0 0 14.17509 0 0 0 0 0 0 0 0 0 0 0 15.70795 0 0 0 0 0 0 0 0 0 0 0 Q9UBP0 SPAST_HUMAN "Spastin, EC 5.6.1.1 (Spastic paraplegia 4 protein)" SPAST ADPSP FSP2 KIAA1083 SPG4 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877] GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005811; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007084; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0044877; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0061640; GO:0070062; GO:0071782; GO:0090148; GO:1904115 EQAVEWYKK 2.579999924 0.544339597 0.544339597 0.217933833 1180.408051 0 0 0 0 0 8.074463 14.84447 0 12.78813 9.952555 0 0 0 15.79981 3.226864 14.89415 0 0 15.99822 0 0 0 0 0 0 0 13.81809 0 0 0 0 0 15.2093 0 0 14.78448 0 0 0 0 0 0 15.67047 0 0 0 0 15.11528 Q9UBP8 KAAG1_HUMAN Kidney-associated antigen 1 (RU2 antisense gene protein) KAAG1 RU2AS Homo sapiens (Human) immune response [GO:0006955] immune response [GO:0006955] GO:0006955 LTNPQVK 10.68999958 1 1 0.316552037 798.8143487 0 0 0 17.86409 0 0 0 16.66565 0 17.86485 0 16.79863 0 0 0 17.48943 0 17.62218 18.61629 17.96586 17.56098 17.77304 0 0 0 18.33268 18.57547 16.94868 0 17.65376 0 0 17.70096 18.37072 15.89291 19.07184 0 0 0 0 0 18.2973 18.467 0 0 17.73886 18.15561 18.49896 Q9UBQ5 EIF3K_HUMAN "Eukaryotic translation initiation factor 3 subunit K, eIF3k (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)" EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743] GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022 VWMSKYGWSADESGQIFICSQEESIKPK 1.769999981 1 1 4.59E-12 3306.159188 12.06127 0 14.95959 0 0 14.076 14.53191 13.65659 11.45138 13.77843 15.16943 15.30158 11.83811 13.22509 13.74895 12.35791 0 0 0 0 0 0 0 0 0 15.16743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBQ6 EXTL2_HUMAN "Exostosin-like 2, EC 2.4.1.223 (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2 ]" EXTL2 EXTR2 Homo sapiens (Human) heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; UDP-N-acetylgalactosamine metabolic process [GO:0019276] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]" "alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]" GO:0001888; GO:0005539; GO:0005576; GO:0005654; GO:0005783; GO:0005789; GO:0005829; GO:0006044; GO:0006486; GO:0015012; GO:0016021; GO:0019276; GO:0030145; GO:0035248; GO:0047237 LPGRVMGIR 3.329999924 0.347253948 0.347253948 0.258980973 1014.116024 16.46961 0 13.53891 14.90554 13.81474 14.69084 10.24454 14.25329 15.12364 12.35047 15.26785 0 13.00393 0 0 15.12643 8.115193 14.95231 0 0 0 15.32182 0 0 0 0 0 15.75542 0 0 0 0 15.62852 0 16.97626 15.16875 14.42535 0 0 0 14.88415 0 13.91823 15.49872 0 14.74758 0 0 Q9UBR4 LHX3_HUMAN "LIM/homeobox protein Lhx3, LIM homeobox protein 3" LHX3 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; pituitary gland development [GO:0021983]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; ventral spinal cord interneuron specification [GO:0021521]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; pituitary gland development [GO:0021983]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; ventral spinal cord interneuron specification [GO:0021521]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0005667; GO:0006357; GO:0008045; GO:0009887; GO:0021520; GO:0021521; GO:0021526; GO:0021527; GO:0021983; GO:0030182; GO:0030324; GO:0043066; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048839; GO:0061629 SRGGSK 2.190000057 1 1 0.096943565 591.5532473 14.26223 15.05883 0 0 16.18086 14.71671 0 0 0 11.68523 16.30626 0 15.57391 15.30183 12.6544 16.12413 0 0 15.64538 17.44394 0 0 0 0 0 15.69971 0 0 0 0 0 0 0 18.61245 16.19641 0 0 0 0 16.54784 0 0 0 0 0 0 0 0 Q9UBS0 KS6B2_HUMAN "Ribosomal protein S6 kinase beta-2, S6K-beta-2, S6K2, EC 2.7.11.1 (70 kDa ribosomal protein S6 kinase 2, P70S6K2, p70-S6K 2) (S6 kinase-related kinase, SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta, S6K-beta, p70 S6 kinase beta, p70 S6K-beta, p70 S6KB, p70-beta)" RPS6KB2 STK14B Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412] ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0007165; GO:0018105; GO:0031929; GO:0042277; GO:0043491; GO:0045948; GO:0106310 DLKPENIMLSSQGHIK 17.13999939 0.48070544 0.48070544 0.182398636 1806.498056 0 13.07453 0 13.7522 0 12.92786 13.15435 8.562015 13.60342 13.35116 0 15.64253 0 0 12.64015 0 16.5739 0 0 0 0 0 17.09953 0 13.98014 17.38258 15.80019 15.39574 0 13.09884 0 0 0 0 0 0 14.69166 0 0 14.41668 16.85497 0 0 15.55549 0 0 0 0 Q9UBS8 RNF14_HUMAN "E3 ubiquitin-protein ligase RNF14, EC 2.3.2.31 (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)" RNF14 ARA54 HRIHFB2038 Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787] GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630 LFLCSICFCEKLGSECMYFLECR 1.690000057 1 1 1.40E-12 3038.620051 8.726695 9.95084 0 0 12.74572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.58503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBS9 SUCO_HUMAN SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1) SUCO C1orf9 CH1 OPT SLP1 Homo sapiens (Human) ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0016021; GO:0030867; GO:0032967; GO:0045669; GO:0046850 LGTFHGRDER 6.380000114 1 1 0.192078629 1188.629767 12.85408 11.66457 0 0 13.55104 0 14.16138 10.75669 15.59687 12.90298 0 0 15.36458 0 14.05481 13.93834 0 0 15.92242 0 0 0 0 0 17.01764 0 0 0 0 0 0 0 0 0 14.44452 0 0 0 0 0 15.38413 0 14.47855 0 0 14.44906 0 0 Q9UBT6 POLK_HUMAN "DNA polymerase kappa, EC 2.7.7.7 (DINB protein, DINP)" POLK DINB1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]" damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0034644; GO:0042276; GO:0046872 DKPIAVGSMSMLSTSNYHAR 2.369999886 1 1 0.031423981 2181.762926 16.61298 0 0 0 0 11.29172 0 0 14.6979 15.61714 15.70566 0 0 17.95255 14.66545 0 0 13.0424 0 0 15.19035 0 0 0 18.11998 0 14.33857 0 0 13.71346 18.13495 0 0 0 13.32825 0 15.36787 16.73644 13.44505 13.67017 0 0 13.74279 0 13.72444 13.77452 11.04454 0 Q9UBT7 CTNL1_HUMAN "Alpha-catulin (Alpha-catenin-related protein, ACRP) (Catenin alpha-like protein 1)" CTNNAL1 Homo sapiens (Human) cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015 LIPLCHQLQTVTK 1.330000043 1 1 0.496516483 1550.224228 0 15.91752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.47865 11.67195 0 17.34336 19.3092 0 0 0 0 0 0 18.59357 0 0 0 0 0 0 0 0 0 0 0 17.50553 0 0 0 0 0 Q9UBU2 DKK2_HUMAN "Dickkopf-related protein 2, Dickkopf-2, Dkk-2, hDkk-2" DKK2 UNQ682/PRO1316 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019] GO:0005615; GO:0016055; GO:0039706; GO:0048019; GO:0090090; GO:0090263 MAALMR 2.940000057 1 1 1.14E-13 707.511146 14.00464 15.21648 14.50652 13.90157 14.36969 13.86443 16.28864 15.8433 15.8503 14.04415 14.93043 14.57751 0 16.74233 17.48617 16.52338 15.3386 16.44675 0 17.3382 0 0 0 0 17.14536 14.78405 15.12912 0 15.7775 0 0 0 0 0 0 0 0 0 0 15.45486 15.85801 0 0 0 0 0 0 0 Q9UBU8 MO4L1_HUMAN Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Protein MSL3-1) (Transcription factor-like protein MRG15) MORF4L1 MRG15 FWP006 HSPC008 HSPC061 PP368 Homo sapiens (Human) "cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3 complex [GO:0016580] "histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485] GO:0000123; GO:0000724; GO:0000786; GO:0003682; GO:0005654; GO:0006325; GO:0008283; GO:0016573; GO:0016575; GO:0016580; GO:0016607; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0047485; GO:0051726; GO:1905168; GO:2000779 SAVRPRR 11.64999962 0.044679906 0.044679906 0.21749708 843.315478 0 0 0 0 0 0 0 15.73847 0 0 0 0 16.82702 18.15516 0 16.97782 15.13947 15.6092 0 0 0 0 0 0 15.73563 0 0 15.44578 0 0 0 0 0 16.61973 0 14.3062 0 0 0 0 0 0 18.35333 0 0 0 0 0 Q9UBU9 NXF1_HUMAN Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 TAP Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405 LKDPTLR 9.279999733 1 1 0.22318514 841.5116643 15.60824 15.57604 16.88325 14.24564 14.26257 15.20044 14.74585 15.93383 15.59235 14.20599 14.47947 17.67536 15.06628 16.80332 0 0 14.38962 15.47213 0 15.50394 0 13.88199 14.60301 16.23329 16.08668 16.08024 15.8507 15.12301 0 0 0 0 0 0 0 16.6922 15.81898 14.95023 16.53979 15.82342 14.78263 0 0 0 0 0 0 15.54982 Q9UBV2 SE1L1_HUMAN "Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1, Sel-1L)" SEL1L TSA305 UNQ128/PRO1063 Homo sapiens (Human) "ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]" Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021] "Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0016021; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0050821 DHTTAGR 5.21999979 0.674760759 0.674760759 0.30250015 756.8031338 15.83849 14.68757 0 14.55443 15.72827 16.4627 0 0 17.09268 16.64077 12.93368 15.70156 17.39451 15.24513 0 0 17.61445 16.585 0 16.67068 16.83401 0 0 16.33694 14.81645 16.73341 15.89469 0 0 0 16.00089 0 17.37526 15.98756 16.47264 0 15.92182 17.67979 15.87238 16.58663 0 16.78355 0 14.63229 16.22841 15.42897 13.92553 15.87868 Q9UBV4 WNT16_HUMAN Protein Wnt-16 WNT16 Homo sapiens (Human) bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399] cytokine activity [GO:0005125]; frizzled binding [GO:0005109] GO:0003408; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0010628; GO:0014068; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0060070; GO:0060317; GO:0060548; GO:0090399; GO:0090403 QKELCK 6.28000021 0.693529427 0.693529427 0.207672145 805.4628367 0 0 0 15.88432 0 15.95807 0 14.54734 14.84448 0 15.64581 0 16.59522 15.21264 0 15.87609 16.08031 0 17.44318 15.91326 16.9908 15.97259 0 0 15.8916 15.33873 15.97559 16.10252 13.28286 15.84596 15.909 15.99822 15.58233 16.42882 15.8457 16.25222 16.89186 17.28926 17.29863 15.40001 0 16.1305 16.61179 16.49387 0 17.36641 16.72834 0 Q9UBV7 B4GT7_HUMAN "Beta-1,4-galactosyltransferase 7, Beta-1,4-GalTase 7, Beta4Gal-T7, b4Gal-T7, EC 2.4.1.- (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase, EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)" B4GALT7 XGALT1 UNQ748/PRO1478 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; glycosylation [GO:0070085]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; glycosylation [GO:0070085]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]" "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]" GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030166; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0070085; GO:0097435 EGGLNTVK 6.519999981 0.25079903 0.25079903 0.012754608 817.5387027 16.37927 0 0 15.60536 14.2266 0 0 18.60178 0 0 0 0 15.37722 14.89542 0 0 0 0 16.4061 12.59282 0 16.09179 0 12.92003 18.15022 0 0 0 0 0 0 15.4163 17.11052 0 0 16.25739 14.49226 16.24443 14.44111 12.85552 0 0 0 0 0 0 17.21927 0 Q9UBW5 BIN2_HUMAN Bridging integrator 2 (Breast cancer-associated protein 1) BIN2 BRAP1 Homo sapiens (Human) "cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]" cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; secretory granule lumen [GO:0034774] "cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; secretory granule lumen [GO:0034774]; phospholipid binding [GO:0005543]; cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]" phospholipid binding [GO:0005543] GO:0001891; GO:0002102; GO:0005543; GO:0005576; GO:0005886; GO:0005938; GO:0006911; GO:0030054; GO:0034774; GO:0042995; GO:0060326; GO:0071800; GO:0097320; GO:1904813 AEEEFNK 12.14000034 1 1 0.241483016 866.5179148 0 15.25393 17.79956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.35412 0 0 0 0 0 18.49233 0 0 0 19.68995 0 0 0 0 0 0 0 0 0 0 0 19.01393 0 0 17.42639 0 0 0 0 Q9UBW7 ZMYM2_HUMAN Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198) ZMYM2 FIM RAMP ZNF198 Homo sapiens (Human) cytosol [GO:0005829]; PML body [GO:0016605] cytosol [GO:0005829]; PML body [GO:0016605]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] GO:0005829; GO:0008270; GO:0016605; GO:0031624 MFECYLSKSPQNLNQR 16.76000023 1 1 2.29E-12 2031.669956 0 16.23127 16.05548 0 15.6303 0 15.26129 16.8893 16.30178 0 15.96101 16.4207 17.03511 16.1692 16.80974 16.42001 16.23965 0 15.50161 17.30082 0 15.43891 0 0 0 16.68274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBX0 HESX1_HUMAN "Homeobox expressed in ES cells 1 (Homeobox protein ANF, hAnf)" HESX1 HANF Homo sapiens (Human) brain development [GO:0007420]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cadmium ion [GO:0071276]; ERK1 and ERK2 cascade [GO:0070371]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; gonad development [GO:0008406]; leukemia inhibitory factor signaling pathway [GO:0048861]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; otic vesicle formation [GO:0030916]; pituitary gland development [GO:0021983]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; thyroid gland development [GO:0030878] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cadmium ion [GO:0071276]; ERK1 and ERK2 cascade [GO:0070371]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; gonad development [GO:0008406]; leukemia inhibitory factor signaling pathway [GO:0048861]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; otic vesicle formation [GO:0030916]; pituitary gland development [GO:0021983]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; thyroid gland development [GO:0030878]" "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007420; GO:0008022; GO:0008406; GO:0010467; GO:0019827; GO:0021983; GO:0030878; GO:0030916; GO:0035264; GO:0042803; GO:0043010; GO:0043584; GO:0045995; GO:0047485; GO:0048853; GO:0048861; GO:0048863; GO:0060070; GO:0070371; GO:0071276; GO:1990837 ESQFLMAK 7.519999981 0.595692933 0.595692933 0.206621066 968.38081 14.06353 16.18692 8.437937 18.822 12.29 0 18.56495 14.21705 14.84613 15.8892 0 15.49363 0 15.57345 0 0 14.54929 13.54564 15.47465 0 0 15.05739 16.82813 15.04489 0 0 0 16.47806 14.45693 16.07743 0 0 0 15.00392 0 17.41449 11.40851 14.82691 0 0 15.03821 0 15.27318 0 0 0 0 0 Q9UBX1 CATF_HUMAN "Cathepsin F, CATSF, EC 3.4.22.41" CTSF Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603] cysteine-type endopeptidase activity [GO:0004197] GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0005886; GO:0006508; GO:0019886; GO:0043202; GO:0043231; GO:0051603; GO:0062023; GO:0070062; GO:1903561 AVLGLVRGR 7.010000229 1 1 0.045527551 939.7355424 15.83428 0 13.53564 0 0 0 15.39819 0 0 0 0 15.47563 15.37452 0 0 0 0 0 0 0 0 0 17.14414 0 16.15659 0 0 0 0 0 14.40157 0 0 15.64102 15.32094 0 16.60678 0 0 0 0 0 0 0 0 0 0 0 Q9UBY0 SL9A2_HUMAN "Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2, NHE-2) (Solute carrier family 9 member 2)" SLC9A2 NHE2 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] GO:0005886; GO:0006811; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719 DMPSTPPTPHSREK 1.059999943 1 1 0.373772372 1596.158557 15.15109 0 15.23557 15.08074 0 13.67397 14.53363 10.75811 13.3922 15.60622 0 0 0 13.83484 0 0 15.40018 0 0 12.80369 0 15.34227 14.67046 0 15.4528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBZ4 APEX2_HUMAN "DNA-(apurinic or apyrimidinic site) endonuclease 2, EC 3.1.11.2 (AP endonuclease XTH2) (APEX nuclease 2) (APEX nuclease-like 2) (Apurinic-apyrimidinic endonuclease 2, AP endonuclease 2)" APEX2 APE2 APEXL2 XTH2 Homo sapiens (Human) base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310] fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310] DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270] GO:0001650; GO:0003677; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006284; GO:0006310; GO:0007049; GO:0008081; GO:0008270; GO:0008311; GO:0043231 SGYSGVATFCK 13.77999973 1 1 0.045506856 1175.904086 0 14.78088 0 0 0 0 0 0 15.75817 0 13.96198 0 0 13.50061 0 0 16.68991 0 0 0 0 0 0 0 0 0 0 0 16.55813 16.28399 15.28455 0 16.19471 16.44392 0 14.55866 17.43724 0 0 0 0 16.41658 0 16.72972 0 0 18.09379 0 Q9UBZ9 REV1_HUMAN "DNA repair protein REV1, EC 2.7.7.- (Alpha integrin-binding protein 80, AIBP80) (Rev1-like terminal deoxycytidyl transferase)" REV1 REV1L Homo sapiens (Human) DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] GO:0003684; GO:0003887; GO:0005654; GO:0006260; GO:0009411; GO:0017125; GO:0042276; GO:0046872; GO:0070987 AADIPDSSLWENPDSAQANGIDSVLSR 2.519999981 1 1 0.080623203 2828.008427 0 0 9.026469 0 0 10.08491 0 0 16.55214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.33946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UC06 ZNF70_HUMAN Zinc finger protein 70 (Zinc finger protein N27C7-1) ZNF70 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076] "cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005737; GO:0006357; GO:0043076; GO:0046872 IHSGEKL 3.900000095 1 1 0.195176607 785.8094675 14.50952 13.67721 14.45105 15.49293 0 0 0 0 0 0 14.71333 0 0 0 0 0 14.85548 15.63412 0 15.05819 0 15.56628 0 0 0 13.4218 15.46494 15.14131 0 0 14.72091 15.57154 0 12.85358 16.09339 14.56292 0 0 0 14.63248 16.44191 0 0 0 0 9.502491 13.37977 16.40596 Q9UDR5 AASS_HUMAN "Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase, LKR, LOR, EC 1.5.1.8; Saccharopine dehydrogenase, SDH, EC 1.5.1.9 ]" AASS Homo sapiens (Human) L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]" "histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714]" GO:0000122; GO:0003714; GO:0004753; GO:0004754; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006554; GO:0019878; GO:0031061; GO:0033512; GO:0042393; GO:0043231; GO:0047130; GO:0047131 AQEANMGLLDEILKQEIR 3.640000105 1 1 1.38E-12 2087.224383 15.17945 14.87003 15.3873 11.94326 0 15.97311 16.06347 14.77516 15.74926 14.5107 12.20179 0 0 0 0 0 0 0 0 0 0 0 0 0 15.16728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDT6 CLIP2_HUMAN "CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115, CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein)" CLIP2 CYLN2 KIAA0291 WBSCR3 WBSCR4 WSCR4 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122] cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122] microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010] GO:0005634; GO:0005737; GO:0005875; GO:0008017; GO:0031122; GO:0035371; GO:0051010 ESVLNSSVK 11.17000008 0.525052309 0.525052309 0.170605715 963.8767998 15.8725 18.21701 15.70199 14.20096 17.50051 17.31524 17.31914 19.1596 0 17.41453 14.9269 17.26543 13.37739 0 0 11.04795 17.45233 15.62607 15.19235 14.97595 12.84716 17.26837 16.37676 0 16.00652 13.94039 15.22389 16.10172 14.46047 13.80675 0 15.86781 14.77567 0 15.40531 15.87374 17.21539 16.73281 0 14.06152 0 15.49539 16.27216 12.1862 13.58887 16.05607 0 14.97717 Q9UDW1 QCR9_HUMAN Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein) UQCR10 UCRC HSPC119 Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" ubiquinol-cytochrome-c reductase activity [GO:0008121] GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0045333 MAAATLTSKLYSLLFR 9.93999958 0.438507199 0.438507199 1.60E-12 1802.574011 15.7923 0 15.64271 16.90008 14.10318 0 0 14.89223 15.6529 13.0147 15.35671 0 0 0 14.93295 12.88003 0 12.68212 14.81155 0 16.87978 16.07837 0 0 0 0 16.28839 0 12.73286 0 13.77964 0 15.31928 0 15.08885 0 17.46982 16.50494 0 14.21727 0 16.64987 0 13.8505 14.80507 13.49047 0 0 Q9UDX4 S14L3_HUMAN SEC14-like protein 3 (Tocopherol-associated protein 2) SEC14L3 TAP2 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; lipid binding [GO:0008289] lipid binding [GO:0008289] GO:0005737; GO:0008289; GO:0016607; GO:0070062 LFPVGYNLMKPFLSEDTR 9.590000153 1 1 0.110283107 2141.902773 0 0 0 14.18887 0 0 0 0 15.81889 13.81576 15.57583 17.68718 14.85612 14.91873 17.13572 0 0 0 0 14.55797 0 0 0 12.76239 16.5111 16.56069 0 0 0 0 0 0 0 17.78632 0 0 0 0 20.71998 0 0 0 0 0 0 0 15.01247 0 Q9UDX5 MTFP1_HUMAN "Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein, MTP18)" MTFP1 MTP18 HSPC242 My022 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850] GO:0000266; GO:0005739; GO:0005743; GO:0006915; GO:0014850; GO:0016021 SVDFLLDSSLRK 8.899999619 0.412609637 0.412609637 0.057209591 1379.111745 16.59773 0 0 14.34729 16.95317 14.19271 15.86405 0 14.56493 0 15.13636 16.44708 16.32729 0 13.23555 0 14.59105 17.06603 10.60328 0 0 0 12.47306 0 0 9.547702 15.51984 0 14.0217 0 16.87466 14.46669 0 10.36987 14.52141 16.58525 0 15.22244 0 14.16288 0 11.74381 0 0 0 14.39893 17.51343 0 Q9UDY2 ZO2_HUMAN Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2) TJP2 X104 ZO2 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; homotypic cell-cell adhesion [GO:0034109]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]; regulation of membrane permeability [GO:0090559] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; homotypic cell-cell adhesion [GO:0034109]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]; regulation of membrane permeability [GO:0090559] cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674] GO:0004385; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0019904; GO:0030674; GO:0034109; GO:0035633; GO:0044291; GO:0045216; GO:0045296; GO:0050839; GO:0050892; GO:0090557; GO:0090559; GO:0098609; GO:0150105; GO:1905605; GO:1990782 DAGSEK 6.389999866 1 1 0.046721385 606.8709383 14.63149 0 14.88029 0 0 0 15.71827 13.10238 0 0 15.28723 0 0 18.41956 0 17.79053 0 0 16.94692 15.81634 0 0 0 15.95854 17.06616 0 16.80274 15.78286 0 0 11.54255 0 0 14.64428 0 17.75427 0 17.81613 0 0 18.16835 15.93679 16.39103 0 17.87853 15.07125 0 15.94644 Q9UDY4 DNJB4_HUMAN "DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog, HSP40 homolog, Heat shock protein 40 homolog) (Human liver DnaJ-like protein)" DNAJB4 DNAJW HLJ1 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986] ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0051082; GO:0051085; GO:0051087 MGGGR 1.789999962 1 1 0.224189687 477.4533241 16.51891 15.41658 15.00052 15.6907 0 14.42252 0 15.2911 0 0 0 0 0 0 16.00674 0 14.93251 16.17798 16.48795 0 14.60319 0 17.34128 0 16.34684 18.78725 0 14.71786 0 0 0 0 18.28657 17.30778 0 13.0103 17.93621 0 0 15.83424 0 0 14.96714 0 0 0 0 0 Q9UDY8 MALT1_HUMAN "Mucosa-associated lymphoid tissue lymphoma translocation protein 1, EC 3.4.22.- (MALT lymphoma-associated translocation) (Paracaspase)" MALT1 MLT Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852] cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842] GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0007250; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321 EIPNGNTSELIFNAVHVK 3.880000114 0.41173473 0.41173473 0.069988227 1982.514912 14.31647 0 0 11.69514 0 0 0 0 14.65752 14.69063 15.6275 0 0 0 0 13.84854 15.25691 0 0 0 0 0 0 0 0 19.2352 12.89265 0 0 0 0 13.56109 13.64638 0 0 0 0 0 14.02609 0 0 0 0 0 0 0 14.03831 0 Q9UEF7 KLOT_HUMAN "Klotho, EC 3.2.1.31 [Cleaved into: Klotho peptide ]" KL Homo sapiens (Human) acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280] beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499] GO:0002526; GO:0003085; GO:0004566; GO:0005104; GO:0005179; GO:0005499; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0005975; GO:0006112; GO:0007568; GO:0008286; GO:0008422; GO:0008543; GO:0014823; GO:0016021; GO:0016324; GO:0017134; GO:0030501; GO:0033280; GO:0042421; GO:0055074; GO:0070062; GO:0090080; GO:1990776 VLEFDIGWLAEPIFGSGDYPWVMR 2.069999933 1 1 9.18E-13 2797.831798 0 0 0 0 0 15.03991 0 0 0 0 0 0 0 0 0 0 0 0 0 15.30348 0 0 0 0 0 0 13.36631 0 0 15.03418 0 15.64946 10.7809 13.38032 14.13141 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UEG4 ZN629_HUMAN Zinc finger protein 629 (Zinc finger protein 65) ZNF629 KIAA0326 ZNF65 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 GNSYPGAAEGR 1.25 0.000647227 0.000647227 0.120535682 1078.804293 15.34923 16.37795 6.518115 14.80174 17.81077 15.37464 12.3036 9.503556 13.6889 16.65474 11.40253 16.66787 0 15.98829 16.59827 14.18937 17.05389 0 10.4466 0 16.11159 15.03784 18.28152 16.56656 0 16.73657 0 16.64174 11.3222 13.67564 18.51459 14.0601 16.17831 15.2409 9.54968 15.813 16.98575 16.32144 15.48996 17.26843 13.9521 0 16.08815 9.198061 16.37839 0 15.4889 0 Q9UET6 TRM7_HUMAN "Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase, EC 2.1.1.205 (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1)" FTSJ1 JM23 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128] RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175] GO:0001510; GO:0002128; GO:0002181; GO:0005737; GO:0005829; GO:0006400; GO:0008173; GO:0008175; GO:0009020; GO:0030488; GO:0052666 EFQLFQGVTR 7.96999979 1 1 1.15E-12 1223.462361 13.27424 0 0 0 0 0 0 0 0 0 0 14.66301 0 0 15.40553 12.84334 0 0 0 14.89515 17.04218 0 0 0 16.59803 0 0 13.19427 0 0 0 0 0 0 0 0 14.55018 0 0 15.60104 0 0 0 0 0 0 0 0 Q9UEY8 ADDG_HUMAN Gamma-adducin (Adducin-like protein 70) ADD3 ADDL Homo sapiens (Human) barbed-end actin filament capping [GO:0051016] brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; barbed-end actin filament capping [GO:0051016] actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200] GO:0000794; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0014069; GO:0016020; GO:0051015; GO:0051016 TPSFLK 5.420000076 0.16387251 0.16387251 0.243067346 694.7684606 0 15.62221 15.39753 0 0 0 0 0 0 0 0 15.1085 16.0095 15.80249 16.6279 0 15.83785 11.71098 15.61012 15.53908 16.82417 0 0 0 15.67916 15.40607 15.3341 0 17.11298 16.65041 16.40035 16.76597 0 17.12756 15.98563 15.78573 17.3176 18.28145 16.22975 18.06994 16.1882 17.10609 15.39272 0 0 15.69583 19.37584 14.64463 Q9UF56 FXL17_HUMAN F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13) FBXL17 FBL17 FBX13 FBXO13 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043153; GO:0043161; GO:0051726 ISDEGMIVIAK 6.789999962 0.645940542 0.645940542 0.167005834 1188.372476 16.39212 0 0 0 0 10.08342 12.841 13.24263 0 0 0 0 0 12.70688 0 0 0 0 0 0 0 15.69598 0 0 0 14.16749 0 13.96932 6.547565 0 0 0 0 0 0 0 15.71445 0 0 0 0 14.66981 13.79913 15.50228 13.01107 15.50094 0 14.59557 Q9UF83 YM012_HUMAN Uncharacterized protein DKFZp434B061 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ASLTMTPSR 5.360000134 1 1 0.116241395 976.5389688 11.71828 14.8815 16.33085 0 14.73157 13.87944 0 15.18998 13.19649 14.0408 0 0 0 0 0 15.40093 0 0 0 0 0 0 0 13.14278 0 0 0 0 15.68184 14.66172 0 0 0 0 0 0 0 16.10134 16.11456 0 0 0 0 0 0 0 0 0 Q9UFC0 LRWD1_HUMAN "Leucine-rich repeat and WD repeat-containing protein 1 (Centromere protein 33, CENP-33) (Origin recognition complex-associated protein, ORC-associated protein, ORCA)" LRWD1 CENP-33 ORCA Homo sapiens (Human) chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169]" chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064] GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005654; GO:0005664; GO:0005721; GO:0005730; GO:0005737; GO:0005815; GO:0006270; GO:0006325; GO:0008327; GO:0035064; GO:0043231; GO:0071169 QPPLLPAALQAPTQILK 8.680000305 0.647526085 0.647526085 5.02E-12 1799.405916 0 0 11.24265 12.73318 0 15.38708 13.67062 0 0 0 12.22955 14.76812 0 0 16.99943 0 15.36755 0 10.60245 0 15.72736 0 0 0 0 14.6117 0 16.09753 0 13.64099 0 15.64254 16.47399 15.67107 15.92292 0 10.84369 0 17.56317 0 15.84204 16.1824 19.02083 0 0 0 13.03053 17.78287 Q9UFH2 DYH17_HUMAN Dynein axonemal heavy chain 17 (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein axonemal light chain 2) DNAH17 DNAHL1 DNEL2 Homo sapiens (Human) cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285 EHIPEACLK 1.889999986 1 1 0.166431703 1095.805978 15.41064 13.67126 0 0 14.94602 12.25021 0 14.93567 9.451061 6.06231 0 0 15.07441 0 0 0 0 11.49991 0 0 0 0 0 0 0 0 16.77459 16.09609 0 0 0 0 0 0 0 0 0 0 0 0 0 15.18441 16.17913 0 0 0 0 0 Q9UFP1 GAK1A_HUMAN Golgi-associated kinase 1A (Protein FAM198A) GASK1A C3orf41 FAM198A Homo sapiens (Human) caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] GO:0005576; GO:0005783; GO:0005794; GO:0005901; GO:0043231 ESPGGDLR 9 1 1 0.034884198 831.6870304 13.77112 0 15.84404 0 14.38432 0 16.61543 0 0 0 0 14.89098 0 0 15.29678 0 14.14248 0 0 12.97101 14.62189 0 0 0 0 0 0 0 0 0 0 0 0 0 14.32794 0 14.42046 0 0 15.97404 0 0 0 0 0 0 0 0 Q9UFV1 TBC29_HUMAN Putative TBC1 domain family member 29 TBC1D29P TBC1D29 Homo sapiens (Human) GPSLLQTPPRVPGQQALSR 3.50999999 1 1 0.645733675 2002.718298 0 18.38125 18.57294 18.63804 0 0 0 0 0 0 0 0 17.7564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UFW8 CGBP1_HUMAN "CGG triplet repeat-binding protein 1, CGG-binding protein 1 (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein)" CGGBP1 CGGBP Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]" DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802] GO:0000122; GO:0003690; GO:0005634; GO:0005654; GO:0010468; GO:0040029; GO:0042802; GO:0140297 HVKNGGSIPK 3.480000019 1 1 0.071884688 1037.149954 13.74299 0 0 16.1484 17.47446 11.63688 0 0 14.65474 0 0 14.41504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UG01 IF172_HUMAN Intraflagellar transport protein 172 homolog IFT172 KIAA1179 Homo sapiens (Human) bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522] GO:0001843; GO:0001947; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007420; GO:0008544; GO:0009953; GO:0016485; GO:0021522; GO:0030992; GO:0031122; GO:0035720; GO:0036064; GO:0042073; GO:0045879; GO:0045880; GO:0048596; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097542; GO:0097598; GO:1903561; GO:1905515 AGDLFEK 4.929999828 1 1 0.265212754 778.0985474 0 16.9885 0 0 0 16.53642 18.90646 0 0 17.96591 0 0 0 0 0 0 0 0 0 0 16.47972 0 0 0 0 18.11991 0 0 18.90187 0 17.61778 0 22.4734 19.09624 0 0 18.88059 0 19.60472 0 0 0 0 0 16.26812 0 0 0 Q9UG22 GIMA2_HUMAN "GTPase IMAP family member 2 (Immunity-associated protein 2, hIMAP2)" GIMAP2 IMAP2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; identical protein binding [GO:0042802] GTP binding [GO:0005525]; identical protein binding [GO:0042802] GO:0005525; GO:0005654; GO:0005783; GO:0005811; GO:0042802 KQAFESK 13.14999962 1 1 0.590670441 839.0374826 0 0 0 0 0 0 0 0 0 19.87562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.21151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UG56 PISD_HUMAN "Phosphatidylserine decarboxylase proenzyme, mitochondrial, EC 4.1.1.65 [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain ]" PISD Homo sapiens (Human) mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] phosphatidylserine decarboxylase activity [GO:0004609] GO:0004609; GO:0005634; GO:0005739; GO:0006646; GO:0010821; GO:0016540; GO:0031305; GO:0035694 DLHTNSPRHSK 11.48999977 1 1 1.37E-12 1291.129979 0 0 14.93514 0 0 15.31627 0 0 0 0 0 16.75612 0 0 16.94457 0 0 0 15.54917 14.56717 16.27188 15.00707 0 0 0 15.49709 0 14.56646 15.55998 0 15.18722 0 0 0 0 0 14.13616 0 0 0 14.99169 0 15.45639 0 14.61111 0 0 0 Q9UG63 ABCF2_HUMAN ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2) ABCF2 HUSSY-18 Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524] ATP binding [GO:0005524] GO:0005524; GO:0016020 HSHVKIGR 9.109999657 1 1 0.13640048 933.0717836 0 0 0 16.43548 0 0 0 0 16.44249 0 16.71522 14.94954 0 0 15.01382 0 14.21789 0 0 0 0 0 0 0 0 0 0 13.80464 0 0 0 15.21057 15.52132 0 13.55302 0 0 0 0 0 15.10144 18.23189 0 0 0 14.88129 0 0 Q9UGF5 O14J1_HUMAN Olfactory receptor 14J1 (Hs6M1-28) (Olfactory receptor 5U1) (Olfactory receptor OR6-25) OR14J1 OR5U1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 MVNLTSMSGFLLMGFSDER 10.02999973 0.286529928 0.286529928 0.038787262 2167.592707 21.0173 20.1326 21.07408 19.14323 19.69103 19.68236 20.29627 0 0 19.58584 19.5741 0 19.53855 20.24933 18.17401 19.50311 19.69933 0 20.47915 20.25838 17.30772 18.80404 0 0 16.72218 19.04566 0 18.04183 17.53423 16.86197 12.97011 19.30577 18.41567 18.83961 17.24483 18.23355 0 18.15859 0 18.70108 19.47347 17.89269 18.98346 17.11935 0 18.27777 17.56722 0 Q9UGH3 S23A2_HUMAN "Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2, hSVCT2) (Yolk sac permease-like molecule 2)" SLC23A2 KIAA0238 NBTL1 SLC23A1 SVCT2 YSPL2 Homo sapiens (Human) cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904] L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229] GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0015229; GO:0015882; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0070904; GO:0071361; GO:1901215; GO:1903861 NVKFPLPIYK 9.800000191 0.387836307 0.387836307 0.106530658 1221.679216 0 0 13.22952 0 0 0 0 0 6.989971 16.96663 0 12.5926 12.93472 9.599805 0 0 0 14.58239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.98237 0 0 14.96786 0 16.44444 15.75071 13.50839 0 0 0 15.38997 15.48581 Q9UGI0 ZRAN1_HUMAN "Ubiquitin thioesterase ZRANB1, EC 3.4.19.12 (TRAF-binding domain-containing protein, hTrabid) (Zinc finger Ran-binding domain-containing protein 1)" ZRANB1 TRABID Homo sapiens (Human) cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055] deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843] GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0031593; GO:0035523; GO:0043231; GO:0046872; GO:0070530; GO:0070536; GO:0071947; GO:0101005; GO:1990168 CTMCRAQRPSGTIITEDPFK 9.710000038 1 1 1.83E-12 2385.02106 14.19776 14.30905 14.2874 0 0 0 0 0 0 0 0 0 0 13.30254 0 14.0431 12.92569 0 0 0 0 0 0 0 8.813399 0 12.89187 0 12.34105 0 0 0 0 0 0 0 0 13.30451 13.45068 0 0 0 14.41264 0 0 0 0 11.6953 Q9UGI6 KCNN3_HUMAN "Small conductance calcium-activated potassium channel protein 3, SK3, SKCa 3, SKCa3 (KCa2.3)" KCNN3 K3 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805] calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286] GO:0005242; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0016021; GO:0016286; GO:0043005; GO:0043025; GO:0071805 SEDLEK 4.53000021 1 1 0.150576802 719.4826149 15.97857 16.45473 16.59027 14.97022 0 15.01418 14.81071 0 13.49618 0 0 0 0 17.15732 0 15.72198 15.60248 16.25713 0 15.51492 14.83637 0 13.8794 16.32902 0 16.00312 17.09272 15.23386 15.06233 0 0 16.18725 0 0 0 0 0 15.9266 16.14998 16.70565 15.39169 0 15.25256 14.94871 16.65484 15.04798 15.46864 15.04711 Q9UGI9 AAKG3_HUMAN "5'-AMP-activated protein kinase subunit gamma-3, AMPK gamma3, AMPK subunit gamma-3" PRKAG3 AMPKG3 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873] AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] GO:0004679; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005978; GO:0006096; GO:0006468; GO:0006633; GO:0014873; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0050790; GO:0071900 EPGLEHALR 2.910000086 1 1 0.004231975 1021.813436 0 15.22287 14.5131 0 0 0 13.48875 13.52852 0 14.17809 14.88312 0 0 15.07703 0 13.71704 0 0 16.62915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGJ0 AAKG2_HUMAN "5'-AMP-activated protein kinase subunit gamma-2, AMPK gamma2, AMPK subunit gamma-2 (H91620p)" PRKAG2 Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006468; GO:0006469; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0010800; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0042149; GO:0043531; GO:0045860; GO:0046320; GO:0046324; GO:0050790 AAPLWESK 5.260000229 1 1 0.294341317 900.8494549 0 0 14.86886 17.13531 13.63623 0 15.55969 16.50919 0 16.36519 0 16.08891 0 14.91233 0 0 0 15.00524 16.1335 13.13029 15.26104 0 15.53192 16.54704 14.76606 14.80278 16.0708 15.7986 0 15.01757 16.23665 0 16.10028 0 0 0 0 0 16.28727 0 0 0 14.61163 0 0 0 14.59632 14.11029 Q9UGJ1 GCP4_HUMAN "Gamma-tubulin complex component 4, GCP-4, hGCP4 (Gamma-ring complex protein 76 kDa, h76p, hGrip76)" TUBGCP4 76P GCP4 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003 IHGCQILETVYK 5.699999809 1 1 0.29654991 1460.972329 0 0 0 0 0 0 14.74936 0 17.44502 0 16.04483 0 0 0 0 0 0 0 0 0 17.65874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.89346 0 0 0 0 0 0 0 0 0 0 0 Q9UGL1 KDM5B_HUMAN "Lysine-specific demethylase 5B, EC 1.14.11.67 (Cancer/testis antigen 31, CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1, RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)" KDM5B JARID1B PLU1 RBBP2H1 Homo sapiens (Human) "branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]" DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034720; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864 AVGSHIR 3.279999971 0.351588517 0.351588517 0.026543663 738.2951282 17.15878 16.15951 0 16.85832 15.24807 0 13.85783 17.54895 14.04485 15.06441 17.13874 17.05388 16.36945 14.57944 15.1648 16.02594 18.76851 16.55921 13.42098 14.73932 15.94041 14.46066 15.08524 14.99787 18.55475 14.68994 17.38886 12.83342 12.05591 12.71033 0 15.60433 14.40129 18.13758 0 15.75803 17.00681 0 16.96351 16.93295 13.55538 17.06117 10.97418 18.28365 0 12.10905 0 16.86253 Q9UGM5 FETUB_HUMAN Fetuin-B (16G2) (Fetuin-like protein IRL685) (Gugu) FETUB Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; negative regulation of endopeptidase activity [GO:0010951]; single fertilization [GO:0007338] extracellular exosome [GO:0070062]; extracellular region [GO:0005576] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of endopeptidase activity [GO:0010951]; single fertilization [GO:0007338] cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191] GO:0004866; GO:0004869; GO:0005576; GO:0007338; GO:0007339; GO:0008191; GO:0010951; GO:0070062 VNDAQEYRR 3.680000067 1 1 0.101870666 1151.437525 12.4201 15.61404 15.87224 14.76285 0 0 0 14.78619 0 12.98979 0 12.75722 12.38586 0 13.62935 0 0 0 0 0 0 0 0 0 0 15.76539 0 13.78127 0 0 0 0 0 14.70166 0 0 14.5623 0 15.55071 0 0 0 0 0 0 0 0 0 Q9UGN5 PARP2_HUMAN "Poly [ADP-ribose] polymerase 2, PARP-2, hPARP-2, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 2, ARTD2) (DNA ADP-ribosyltransferase PARP2, EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2, ADPRT-2) (Poly[ADP-ribose] synthase 2, pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2, EC 2.4.2.-)" PARP2 ADPRT2 ADPRTL2 Homo sapiens (Human) base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; nucleosome binding [GO:0031491]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; nucleosome binding [GO:0031491]; protein ADP-ribosylase activity [GO:1990404] GO:0003677; GO:0003682; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0016570; GO:0018312; GO:0030592; GO:0031491; GO:0061051; GO:0070212; GO:0070213; GO:0090734; GO:0097191; GO:0140294; GO:1901215; GO:1990404 KMPVAGGK 1.190000057 1 1 1.19E-13 798.6699265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.97895 0 0 0 0 0 Q9UGR2 Z3H7B_HUMAN "Zinc finger CCCH domain-containing protein 7B (Rotavirus 'X'-associated non-structural protein, RoXaN)" ZC3H7B KIAA1031 Homo sapiens (Human) posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196] metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0010608; GO:0035196; GO:0035198; GO:0046872 ASSSMGAPRTHGPSTFDLQMK 5.25 1 1 1.83E-12 2234.235909 0 0 17.00191 0 15.29455 12.0452 0 0 0 0 0 0 0 13.20283 0 0 0 0 0 0 0 14.76416 0 13.28351 0 0 0 0 0 9.390087 13.99098 13.21881 0 13.06384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGU0 TCF20_HUMAN "Transcription factor 20, TCF-20 (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein, SPRE-binding protein)" TCF20 KIAA0292 SPBP Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0045944; GO:0046872 GMELK 2.25999999 0.467600822 0.467600822 0.146974435 576.5946655 0 0 10.79009 15.2567 15.20979 10.40394 14.70073 15.92674 0 15.53889 0 13.51349 16.16748 0 16.21334 16.17859 17.3772 14.1594 0 0 13.9481 14.54974 15.89297 15.1119 0 17.17833 0 0 15.97464 14.08304 13.67049 16.57202 13.12992 14.03388 17.36705 16.91268 0 18.31259 0 19.06048 18.0844 16.75761 0 16.27137 0 16.76797 17.02983 0 Q9UH03 SEPT3_HUMAN Neuronal-specific septin-3 SEPTIN3 SEP3 SEPT3 Homo sapiens (Human) cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042802; GO:0043005; GO:0060090; GO:0061640; GO:0098793; GO:0099569 QESMPFAVVGSDK 3.609999895 1 1 0.351038717 1410.986995 0 15.93773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.60261 0 0 0 0 0 0 15.45399 0 15.05443 0 0 0 0 16.10053 0 0 17.68217 16.63894 15.93813 0 16.2438 0 15.87817 15.46714 14.5288 0 0 0 Q9UH36 SRR1L_HUMAN SRR1-like protein (SRR1 domain-containing protein) SRRD SRR1L Homo sapiens (Human) heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]; rhythmic process [GO:0048511] GO:0005634; GO:0005737; GO:0006783; GO:0007017; GO:0042752; GO:0048511; GO:0070453 GREAAPR 10.89999962 0.190619454 0.190619454 0.280978423 756.0240511 18.20885 0 15.11606 13.81536 0 16.88336 0 16.5404 0 15.49546 13.59563 9.405877 16.85924 14.20101 0 17.02543 15.51858 15.69505 0 0 0 17.47658 0 0 15.67908 16.9742 0 17.29414 16.9997 15.79833 16.96287 16.20247 16.01554 14.96668 0 0 17.53658 18.14402 0 0 14.32928 16.2951 16.46445 0 0 17.50254 0 15.91315 Q9UH64 NSGX_HUMAN Putative protein CDKN2A-DT (CDKN2A antisense RNA 1) (CDKN2A antisense gene protein 1) (Protein CDKN2A-AS1) (Susceptibility protein NSG-x) CDKN2A-DT C9orf53 CDKN2A-AS1 Homo sapiens (Human) SEPRACNNPTVAENR 14.68000031 0.947462797 0.947462797 0.108269057 1715.433109 17.41705 17.45913 0 0 0 0 15.04171 13.022 14.65597 14.68382 0 16.14658 14.47086 16.13354 16.16876 11.16883 14.06705 13.62876 0 0 14.70617 13.92446 14.39941 0 17.20349 17.08807 15.2877 14.73892 15.23187 16.50766 14.80845 13.79151 0 15.72723 16.49399 13.44623 15.49961 15.78282 15.73203 0 0 0 0 0 0 0 0 15.58189 Q9UH99 SUN2_HUMAN "SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein, Rab5IP) (Sad1/unc-84 protein-like 2)" SUN2 FRIGG KIAA0668 RAB5IP UNC84B Homo sapiens (Human) centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; positive regulation of cell migration [GO:0030335] endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; positive regulation of cell migration [GO:0030335] cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495] GO:0005521; GO:0005635; GO:0005639; GO:0006998; GO:0007052; GO:0007097; GO:0008017; GO:0010008; GO:0030335; GO:0031022; GO:0031965; GO:0034993; GO:0042802; GO:0043495; GO:0051321; GO:0051642; GO:0090292; GO:0140444 RGTGGSESSR 2.640000105 1 1 8.09E-13 993.6755748 0 0 15.87374 16.74435 0 16.51167 0 0 0 16.55555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHA3 RLP24_HUMAN Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like) RSL24D1 C15orf15 RPL24L My024 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005654; GO:0005730; GO:0005840; GO:0006412; GO:0042273 APLAGK 7.21999979 1 1 0.198507866 553.4844695 0 0 0 0 0 0 18.81683 0 0 0 0 18.52665 0 0 0 0 0 0 0 0 19.20697 0 0 0 19.21968 0 0 0 0 18.57482 0 0 0 0 0 0 0 0 0 18.38431 0 0 0 0 0 0 0 0 Q9UHB6 LIMA1_HUMAN LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm) LIMA1 EPLIN SREBP3 PP624 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529] actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529] actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872] GO:0001725; GO:0001726; GO:0003785; GO:0005829; GO:0005886; GO:0005925; GO:0008203; GO:0015629; GO:0016477; GO:0030299; GO:0030835; GO:0031526; GO:0031529; GO:0032154; GO:0042632; GO:0045296; GO:0046872; GO:0051015; GO:0051017 KNGNVGK 10.09000015 1 1 0.293423704 717.1188824 17.59724 0 0 17.85416 0 0 0 21.25078 18.07726 0 18.09894 18.18689 18.26114 21.03997 0 0 0 0 17.32454 0 0 18.18744 18.77326 0 0 17.36433 20.45163 0 0 0 0 0 18.95748 22.22595 22.89789 18.66183 0 0 0 0 0 0 0 16.61742 0 0 0 0 Q9UHB7 AFF4_HUMAN "AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein, Protein AF-5q31) (Major CDK9 elongation factor-associated protein)" AFF4 AF5Q31 MCEF HSPC092 Homo sapiens (Human) regulation of gene expression [GO:0010468]; spermatid development [GO:0007286] euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468]; spermatid development [GO:0007286] GO:0000791; GO:0001650; GO:0005654; GO:0007286; GO:0008023; GO:0010468; GO:0032783 AHLTK 4.349999905 0.361173481 0.361173481 0.191055287 569.3542419 15.70402 13.78516 16.08591 14.10088 15.90737 15.04707 15.65914 15.63867 0 0 15.85744 15.58547 15.1269 16.22494 15.53139 15.14929 14.51131 16.00816 14.8665 0 0 14.86437 0 15.87412 9.864925 15.05605 15.26448 0 16.05105 13.78872 16.24084 15.40598 15.49658 15.43894 16.53278 16.23598 0 15.39969 14.49143 0 14.51258 15.58886 16.15931 15.96979 0 16.8546 14.12372 13.71135 Q9UHB9 SRP68_HUMAN "Signal recognition particle subunit SRP68, SRP68 (Signal recognition particle 68 kDa protein)" SRP68 Homo sapiens (Human) response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047] GO:0003723; GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0005840; GO:0005925; GO:0006614; GO:0008312; GO:0009410; GO:0019904; GO:0030942; GO:0048500 YLLLVLMDAERAWSYAMQLK 1.769999981 1 1 4.12E-12 2430.204703 0 0 0 14.84536 14.32855 0 0 10.83435 0 16.90722 0 14.71969 0 12.89111 15.49438 0 0 14.2151 0 0 0 14.89464 0 0 0 14.91054 14.31894 16.43681 14.35278 15.01498 14.98839 14.74017 0 0 0 0 0 15.54565 0 15.31821 0 16.32782 15.93376 0 0 0 0 0 Q9UHC1 MLH3_HUMAN DNA mismatch repair protein Mlh3 (MutL protein homolog 3) MLH3 Homo sapiens (Human) female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696]; female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696] GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300 STVTKSIVEEFIR 4.590000153 1 1 0.436318771 1508.730436 13.91868 0 14.42827 0 15.23247 0 0 0 0 0 13.35604 0 14.88589 14.22736 0 0 15.19592 0 9.748099 0 0 0 0 0 15.73737 0 0 0 0 0 0 0 0 0 0 16.88342 15.39886 0 16.82044 0 15.96527 0 0 0 0 0 0 0 Q9UHC6 CNTP2_HUMAN Contactin-associated protein-like 2 (Cell recognition molecule Caspr2) CNTNAP2 CASPR2 KIAA0868 Homo sapiens (Human) adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] enzyme binding [GO:0019899] GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0008283; GO:0009986; GO:0016020; GO:0016021; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625; GO:1903598 CVPNHCEHGGK 5.110000134 1 1 0.428137396 1295.033777 0 0 0 0 0 15.10133 0 15.0828 0 0 0 0 0 0 0 0 0 0 16.58261 0 0 0 0 0 0 0 0 14.56025 15.80778 0 15.77425 0 17.62868 16.89591 16.10401 0 0 16.99977 18.07886 17.21095 0 17.08669 14.44745 16.59555 14.7168 17.17143 0 0 Q9UHD2 TBK1_HUMAN "Serine/threonine-protein kinase TBK1, EC 2.7.11.1 (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)" TBK1 NAK Homo sapiens (Human) activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0002218; GO:0003676; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0033138; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0106310; GO:1901214; GO:1902554; GO:1904417 HTMTPIYPSSNTLVEMTLGMKK 1.340000033 0.084004477 0.084004477 0.035433693 2511.929752 14.56577 0 13.82101 0 13.72668 0 0 0 10.9709 0 0 0 0 0 13.05206 0 0 8.713421 14.80138 13.55746 0 15.77578 0 13.02287 0 0 0 0 0 0 0 12.55659 0 0 0 0 11.71149 0 0 12.65167 0 0 0 15.09848 14.40636 0 0 0 Q9UHD8 SEPT9_HUMAN "Septin-9 (MLL septin-like fusion protein MSF-A, MLL septin-like fusion protein) (Ovarian/Breast septin, Ov/Br septin) (Septin D1)" SEPTIN9 KIAA0991 MSF SEPT9 Homo sapiens (Human) cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857] cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] GO:0001725; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005930; GO:0005940; GO:0015629; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0045296; GO:0048471; GO:0060090; GO:0061640; GO:0097730; GO:1902857 TSSGRLR 7.630000114 1 1 0.105902912 775.9351974 0 0 0 0 15.24828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93353 0 16.05951 0 0 17.09468 15.44507 0 0 0 0 0 16.60197 0 0 0 0 0 0 0 0 0 17.9065 0 0 0 0 0 Q9UHE8 STEA1_HUMAN "Metalloreductase STEAP1, EC 1.16.1.- (Six-transmembrane epithelial antigen of prostate 1)" STEAP1 PRSS24 STEAP Homo sapiens (Human) ion transport [GO:0006811]; iron ion homeostasis [GO:0055072] cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; channel activity [GO:0015267]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transporter activity [GO:0005215]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072] channel activity [GO:0015267]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transporter activity [GO:0005215] GO:0005215; GO:0005768; GO:0005886; GO:0005887; GO:0005911; GO:0006811; GO:0010008; GO:0015267; GO:0016020; GO:0016491; GO:0046872; GO:0055072 IPILVINK 9.630000114 0.366091937 0.366091937 0.188214651 909.8176029 0 15.57281 15.7889 0 0 0 0 0 0 0 0 15.27855 0 14.0063 17.10433 0 14.90954 16.69245 0 0 0 0 0 0 0 0 0 0 15.63266 0 0 17.57026 17.41411 16.32775 0 0 0 0 0 15.44251 0 0 0 0 0 0 0 0 Q9UHF1 EGFL7_HUMAN "Epidermal growth factor-like protein 7, EGF-like protein 7 (Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7) (NOTCH4-like protein) (Vascular endothelial statin, VE-statin) (Zneu1)" EGFL7 MEGF7 UNQ187/PRO1449 Homo sapiens (Human) anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102] GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0009986; GO:0045746; GO:0048856; GO:0062023 GGPPR 2.480000019 1 1 0.238360418 484.30083 0 0 17.06537 17.03712 17.76148 0 17.54808 17.32333 0 0 0 0 0 16.21158 0 0 0 0 0 0 0 0 0 16.74813 0 16.25211 0 0 15.73982 0 0 0 17.63939 18.45249 16.95814 16.95655 0 0 0 17.76578 0 0 17.17487 0 18.37525 16.6665 17.17013 15.8128 Q9UHF3 NAT8B_HUMAN "Putative N-acetyltransferase 8B, EC 2.3.1.- (Acetyltransferase 1, ATase1) (Camello-like protein 2)" NAT8B CML2 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]; amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]" "lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]" GO:0001702; GO:0004468; GO:0005789; GO:0005793; GO:0008080; GO:0010628; GO:0016021; GO:0018003; GO:0033116; GO:0043066; GO:0050435; GO:1990000 YVDIALR 6.900000095 1 1 0.103925709 849.7100236 16.97168 0 0 0 0 14.34157 0 0 16.51917 0 0 17.53027 14.51309 0 0 0 15.36276 18.00589 0 0 12.82944 0 0 0 13.48687 0 16.84587 14.83056 0 0 0 0 0 0 16.41555 0 0 16.40297 0 0 0 0 0 0 0 0 14.19518 0 Q9UHF7 TRPS1_HUMAN Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79) TRPS1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000785; GO:0000977; GO:0001227; GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0019904; GO:0032330; GO:0032991 SHSAQQPVLVSQTLDIHK 3.400000095 0.516007423 0.516007423 0.059216793 1987.265461 0 0 0 17.68509 12.98058 0 16.22322 14.79282 16.27296 19.06722 17.22526 16.47722 0 0 15.88793 10.06796 16.22021 13.03829 14.89767 0 0 18.29169 18.99592 0 0 0 17.17463 0 15.92398 17.02846 17.43855 17.3152 14.35329 0 16.08157 14.20289 0 15.32941 18.15522 0 9.216983 14.12807 0 0 15.03188 16.07019 15.90792 11.05721 Q9UHG3 PCYOX_HUMAN "Prenylcysteine oxidase 1, EC 1.8.3.5 (Prenylcysteine lyase)" PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183 Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; prenylcysteine oxidase activity [GO:0001735]; chloride transmembrane transport [GO:1902476]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] prenylcysteine oxidase activity [GO:0001735] GO:0001735; GO:0005764; GO:0005886; GO:0030327; GO:0030328; GO:0034361; GO:0070062; GO:1902476 YTGNPTK 6.449999809 1 1 0.268701772 781.054169 15.58087 0 0 0 0 15.5844 15.35815 0 16.23135 0 14.93802 0 0 0 0 0 0 0 17.20962 0 0 0 16.15093 0 0 0 0 0 0 0 0 16.60315 0 0 16.82108 0 0 0 17.99809 16.83048 0 0 0 0 0 0 0 0 Q9UHI7 S23A1_HUMAN "Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1, hSVCT1) (Yolk sac permease-like molecule 3)" SLC23A1 SVCT1 YSPL3 Homo sapiens (Human) brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904] dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081] GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070904 RVVQYGAAIMLVLGTIGK 3.319999933 0.421392739 0.421392739 0.164062954 1905.559088 15.58518 17.22893 12.64639 17.77681 0 15.74224 0 17.77432 15.00731 13.41651 15.21815 15.98719 15.25583 14.86328 12.57951 17.19013 16.68171 13.99027 17.61512 0 0 0 15.91231 16.73888 17.39884 0 13.29366 0 14.72824 15.33648 16.34213 0 16.2315 13.49745 14.34334 15.77396 15.60899 0 17.52948 15.82353 15.42007 0 0 9.188748 16.16082 0 15.44854 14.08785 Q9UHJ3 SMBT1_HUMAN "Scm-like with four MBT domains protein 1, hSFMBT (Renal ubiquitous protein 1)" SFMBT1 RU1 Homo sapiens (Human) "cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635 QTLIGACSPPVPLLEGLRNGR 3.869999886 0.008601096 0.008601096 0.12419547 2247.981301 15.3368 15.06086 15.35657 14.27332 0 12.83067 14.66521 14.44619 10.5623 15.13326 16.57916 16.36837 14.10097 0 15.08203 0 0 14.14005 14.90628 15.53067 13.14452 15.68382 13.40171 14.23319 15.9175 0 16.27246 13.58392 16.55193 14.20298 0 13.53482 16.59613 16.20763 0 14.82089 14.67447 12.01124 0 13.68492 0 15.95915 12.04381 14.80066 15.34063 0 0 15.57278 Q9UHL0 DDX25_HUMAN "ATP-dependent RNA helicase DDX25, EC 3.6.4.13 (DEAD box protein 25) (Gonadotropin-regulated testicular RNA helicase)" DDX25 GRTH Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0006417; GO:0007286; GO:0010494; GO:0016887; GO:0016973; GO:0033391 QVTIVVNFDLPVK 4.269999981 0.978647232 0.978647232 0.049546627 1471.528708 17.62369 0 0 14.81444 17.35451 16.9801 16.36717 14.37201 0 0 0 0 0 0 15.85426 0 16.23904 0 13.7366 17.74342 16.88974 0 10.64298 14.34109 0 0 0 15.99969 4.804131 13.73575 15.9929 0 17.82184 0 16.67696 13.31798 0 0 16.12758 0 0 0 0 0 15.78189 0 0 14.69374 Q9UHL4 DPP2_HUMAN "Dipeptidyl peptidase 2, EC 3.4.14.2 (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II, DPP II) (Quiescent cell proline dipeptidase)" DPP7 DPP2 QPP Homo sapiens (Human) lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] GO:0004177; GO:0005576; GO:0005794; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0070062; GO:1905146 CTQGVREAFR 10.21000004 1 1 0.049611427 1224.316033 9.446607 9.359151 12.82536 12.16312 12.88075 11.58878 13.07702 10.72485 0 14.95174 13.17909 10.64276 16.35632 14.32438 13.49205 14.52626 0 12.51772 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95893 0 0 0 0 0 0 0 0 14.90171 0 14.62161 0 0 15.29222 0 0 Q9UHM6 OPN4_HUMAN Melanopsin (Opsin-4) OPN4 MOP Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; thermotaxis [GO:0043052]; visual perception [GO:0007601] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; thermotaxis [GO:0043052]; visual perception [GO:0007601] 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020] GO:0005502; GO:0005886; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016021; GO:0018298; GO:0030424; GO:0030425; GO:0042752; GO:0043052; GO:0043204; GO:0048511; GO:0050960; GO:0071482; GO:0097381; GO:1990384; GO:1990913 ALQTFGACK 8.680000305 1 1 0.234030565 995.6883253 17.33678 15.23599 14.69928 12.7857 16.63304 14.22651 17.99811 20.13375 17.49311 16.2497 12.84766 11.23279 0 12.88518 0 16.38276 0 0 0 16.51833 16.98031 0 14.99276 19.50511 0 16.70782 16.47697 17.21336 17.68213 0 16.88214 16.59961 18.9858 0 18.12222 0 0 0 0 0 15.65432 0 14.28998 16.43736 17.59782 18.74103 0 15.88469 Q9UHP6 RSP14_HUMAN Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1) RSPH14 RTDR1 Homo sapiens (Human) DSNSMVR 2.869999886 1 1 0.244714933 823.6315425 0 0 18.73314 0 0 0 0 17.94858 0 0 17.17193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHQ1 NARF_HUMAN "Nuclear prelamin A recognition factor (Iron-only hydrogenase-like protein 2, IOP2)" NARF Homo sapiens (Human) lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; lamin binding [GO:0005521] lamin binding [GO:0005521] GO:0005521; GO:0005638; GO:0005652; GO:0005654; GO:0005730; GO:0031981 GADCVLTSGEIAQIMEQGDLSVR 6.920000076 1 1 0.238462585 2448.329757 13.97184 0 14.32874 0 0 14.21975 0 15.89107 14.62689 0 0 14.36924 17.39417 0 0 15.83931 0 16.70423 18.06276 18.89777 0 15.63056 17.65884 16.96302 14.72301 0 0 16.24346 0 0 15.65188 14.66562 14.79283 14.03595 15.22029 0 0 16.58438 0 15.80727 14.89822 16.03962 14.74079 0 15.70056 0 0 13.34391 Q9UHQ7 TCAL9_HUMAN "Transcription elongation factor A protein-like 9, TCEA-like protein 9 (Transcription elongation factor S-II protein-like 9) (WW domain-binding protein 5, WBP-5)" TCEAL9 WBP5 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] WW domain binding [GO:0050699] GO:0005634; GO:0050699 LIQSLQEFK 13.72999954 1 1 0.258002098 1106.235073 19.85511 20.06164 18.02051 0 20.00524 19.92499 19.80005 0 19.92218 0 17.47848 0 0 19.84597 0 18.79727 21.39086 20.90671 16.44168 0 19.21045 0 0 15.87428 0 20.36475 0 18.35965 20.54827 0 21.83213 18.40773 0 0 19.54866 22.25268 21.23687 21.0838 21.61971 20.77051 0 0 16.38667 18.17681 18.29058 17.12475 0 0 Q9UHQ9 NB5R1_HUMAN "NADH-cytochrome b5 reductase 1, b5R.1, EC 1.6.2.2 (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)" CYB5R1 NQO3A2 UNQ3049/PRO9865 Homo sapiens (Human) bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] "endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]" "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]" GO:0004128; GO:0005739; GO:0005789; GO:0005886; GO:0015701; GO:0016020; GO:0016021; GO:0016126; GO:0031092; GO:0070062; GO:0071949 FKLWFTLDHPPK 7.420000076 1 1 0.537292807 1529.702269 0 17.80631 0 18.21586 0 0 0 0 0 17.88043 0 0 0 0 0 0 0 0 0 0 0 0 19.61935 17.86012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.77291 0 0 0 0 0 Q9UHR4 BI2L1_HUMAN "Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1, BAI1-associated protein 2-like protein 1 (Insulin receptor tyrosine kinase substrate)" BAIAP2L1 IRTKS Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of insulin receptor signaling pathway [GO:0046626]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; proline-rich region binding [GO:0070064]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of insulin receptor signaling pathway [GO:0046626]; response to bacterium [GO:0009617] actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; proline-rich region binding [GO:0070064] GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007009; GO:0009617; GO:0030838; GO:0046626; GO:0051017; GO:0051764; GO:0070062; GO:0070064; GO:0098641; GO:2000251 MPPAPSGRAYTSPLIDMFNNPATAAPNSQR 3.809999943 1 1 0.177759127 3205.545605 14.03797 14.05983 0 15.58519 14.33309 0 14.61338 14.71648 14.03672 0 8.506832 14.70494 13.27322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHR6 ZNHI2_HUMAN Zinc finger HIT domain-containing protein 2 (Protein FON) ZNHIT2 C11orf5 Homo sapiens (Human) metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0046872 GAMHEVAR 4.199999809 1 1 0.180727847 886.2172492 13.99763 14.37762 0 13.13377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHV7 MED13_HUMAN "Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component, ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component, Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250, DRIP250)" MED13 ARC250 KIAA0593 THRAP1 TRAP240 Homo sapiens (Human) "cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]" mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]" nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809] GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0030374; GO:0042632; GO:0042809; GO:0043433; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328 QFYPISCCLKEMSEEK 7.809999943 0.121636152 0.121636152 0.13541634 2049.375481 17.4518 0 16.19847 9.126029 9.692772 14.53723 0 0 14.71706 0 0 0 0 0 0 0 0 0 11.48264 0 0 16.42847 19.37605 15.05148 0 16.63886 0 0 0 0 17.39043 8.99017 14.66429 15.25436 0 0 0 15.60982 0 14.34734 0 14.63923 16.75759 0 15.00827 0 16.70252 0 Q9UHW9 S12A6_HUMAN Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3) SLC12A6 KCC3 Homo sapiens (Human) ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901] GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:0071476; GO:0071477; GO:0140157; GO:1902476; GO:1990573 LNEVIVNK 2.349999905 0.898612142 0.898612142 0.262967234 929.755191 17.30614 17.8905 17.86655 20.47727 20.09312 18.5407 18.43633 0 18.08238 0 0 16.07279 0 0 0 16.19717 0 16.66291 0 0 15.9484 0 0 0 0 0 19.11026 0 0 0 0 0 0 19.12996 0 19.09601 18.04049 19.54397 17.46308 18.13679 0 18.0557 0 0 0 0 0 0 Q9UHY7 ENOPH_HUMAN "Enolase-phosphatase E1, EC 3.1.3.77 (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)" ENOPH1 MASA MSTP145 Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284] cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]" "2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]" GO:0000287; GO:0005634; GO:0005829; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874 AAFTAGR 6.039999962 7.47E-05 7.47E-05 0.288659271 692.7042602 18.60652 0 19.67343 15.72041 0 17.20459 0 0 0 0 0 16.68844 0 0 17.78958 0 17.71221 18.84362 0 0 0 0 19.752 0 0 0 0 0 0 18.14482 0 0 0 0 0 18.65472 0 0 18.1626 18.28696 0 19.23873 0 11.41317 0 0 0 0 Q9UI12 VATH_HUMAN "V-type proton ATPase subunit H, V-ATPase subunit H (Nef-binding protein 1, NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)" ATP6V1H CGI-11 Homo sapiens (Human) endocytosis [GO:0006897]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; endocytosis [GO:0006897]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" "enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0000139; GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006897; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0030234; GO:0033176; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:1902600 RVIEQLGGK 3 1 1 0.280286624 1000.334893 0 0 0 14.57539 21.13284 19.73909 0 0 0 0 16.16692 0 0 0 0 0 0 0 0 0 16.86408 0 17.69623 0 17.61707 0 17.82113 0 0 0 0 18.57279 0 0 0 17.96645 0 0 18.29585 0 0 0 0 16.85541 0 0 0 0 Q9UI17 M2GD_HUMAN "Dimethylglycine dehydrogenase, mitochondrial, EC 1.5.8.4 (ME2GLYDH)" DMGDH Homo sapiens (Human) amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695] dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865 GLLLRSCPLQGSPGRPR 2.74000001 1 1 0.267280334 1863.515406 0 11.21328 14.49696 13.82059 12.34058 15.39316 14.80235 14.9835 13.05963 0 0 0 14.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.08412 0 0 Q9UI30 TR112_HUMAN Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog) TRMT112 AD-001 HSPC152 HSPC170 Homo sapiens (Human) histone lysine methylation [GO:0034968]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; histone lysine methylation [GO:0034968]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488] protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276] GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0031167; GO:0032991; GO:0034968; GO:0046982; GO:0048471; GO:0070476; GO:2000234 GVGSRGFPLR 5.309999943 0.175178379 0.175178379 0.247794166 1045.732281 0 17.76738 12.96679 0 0 0 0 0 15.5109 0 0 0 0 15.44386 0 0 0 16.60828 0 0 0 16.77846 0 0 0 0 0 0 0 0 0 18.94695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.90124 0 Q9UI32 GLSL_HUMAN "Glutaminase liver isoform, mitochondrial, GLS, EC 3.5.1.2 (L-glutaminase) (L-glutamine amidohydrolase)" GLS2 GA Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981] glutaminase activity [GO:0004359] GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0042981; GO:0072593 AEKFDFVLQYLNK 24.44000053 0.164127469 0.164127469 0.447206058 1614.207493 0 16.27761 0 0 0 0 19.40616 0 0 18.81307 18.21858 0 17.77043 0 0 0 19.95437 0 0 0 17.86095 0 18.94032 0 0 0 0 18.3653 17.08895 0 19.15135 0 18.49601 20.32463 0 19.78615 0 0 19.24129 0 0 17.85993 17.10854 17.6851 18.58368 18.67362 0 0 Q9UI33 SCNBA_HUMAN "Sodium channel protein type 11 subunit alpha (Peripheral nerve sodium channel 5, PN5) (Sensory neuron sodium channel 2) (Sodium channel protein type XI subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.9) (hNaN)" SCN11A SCN12A SNS2 Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; C-fiber [GO:0044299]; extracellular exosome [GO:0070062]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; C-fiber [GO:0044299]; extracellular exosome [GO:0070062]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0009410; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0044299; GO:0051930; GO:0070062; GO:0086010 GAAIIQKAFR 8.590000153 1 1 0.189000746 1078.283667 15.64454 0 0 12.32952 0 0 15.70017 0 0 0 0 14.8898 0 14.85092 0 12.79681 0 0 0 0 0 0 0 0 0 15.81816 0 0 17.31376 0 0 0 0 0 0 0 0 0 0 15.60495 0 0 0 0 0 0 0 0 Q9UI42 CBPA4_HUMAN "Carboxypeptidase A4, EC 3.4.17.- (Carboxypeptidase A3)" CPA4 CPA3 UNQ694/PRO1339 Homo sapiens (Human) histone acetylation [GO:0016573]; proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; histone acetylation [GO:0016573]; proteolysis [GO:0006508] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0016573 EWISQATAIWTARK 2.769999981 1 1 0.040938476 1660.843381 0 0 16.80632 0 0 0 0 0 17.91225 0 16.81729 19.14511 18.92604 17.12767 17.75467 0 0 0 0 0 0 0 18.17284 15.70244 0 17.72775 0 0 0 0 0 0 0 17.70234 0 17.50077 0 0 17.98563 0 17.14109 17.88293 0 0 0 0 18.8425 0 Q9UI46 DNAI1_HUMAN Dynein axonemal intermediate chain 1 (Axonemal dynein intermediate chain 1) DNAI1 Homo sapiens (Human) cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] 9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157] 9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005856; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729; GO:0120293 DELVAGSQESVK 13.10000038 1 1 0.255322875 1262.720231 14.40216 0 0 14.90408 14.79463 0 0 0 0 15.4573 0 14.79363 12.64089 0 0 0 0 16.93712 0 0 0 0 0 0 0 16.74913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI47 CTNA3_HUMAN Catenin alpha-3 (Alpha T-catenin) (Cadherin-associated protein) CTNNA3 Homo sapiens (Human) actin filament organization [GO:0007015]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; lamellipodium [GO:0030027] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; lamellipodium [GO:0030027]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; actin filament organization [GO:0007015]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] GO:0005829; GO:0005856; GO:0005912; GO:0005916; GO:0007015; GO:0008013; GO:0016477; GO:0030027; GO:0045296; GO:0051015; GO:0086073; GO:0086091; GO:0090136; GO:0098609; GO:0098911 NTMEMYK 13.73999977 0.487602025 0.487602025 0.197973835 933.7306806 0 0 0 0 0 15.10378 0 0 14.24201 0 0 0 0 0 0 0 0 0 0 0 0 15.60924 0 16.05333 0 0 0 13.93019 0 0 15.73492 0 0 0 0 0 0 0 17.05202 0 0 0 0 0 0 0 0 0 Q9UIA9 XPO7_HUMAN "Exportin-7, Exp7 (Ran-binding protein 16)" XPO7 KIAA0745 RANBP16 Homo sapiens (Human) protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611] nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0031267 TSFMMLFEWIYPSYMPILQR 2.24000001 1 1 0.331462829 2601.423974 14.0714 0 18.36036 0 0 0 0 0 0 0 0 0 0 0 0 18.10822 0 18.27596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIB8 SLAF5_HUMAN SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84) CD84 SLAMF5 Homo sapiens (Human) adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response [GO:0006952]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innate immune response [GO:0045087]; negative regulation of granulocyte macrophage colony-stimulating factor production [GO:0032685]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of macrophage activation [GO:0043030]; regulation of store-operated calcium entry [GO:2001256]; T cell activation [GO:0042110] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response [GO:0006952]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innate immune response [GO:0045087]; negative regulation of granulocyte macrophage colony-stimulating factor production [GO:0032685]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of macrophage activation [GO:0043030]; regulation of store-operated calcium entry [GO:2001256]; T cell activation [GO:0042110] identical protein binding [GO:0042802] GO:0002250; GO:0005886; GO:0005887; GO:0006914; GO:0006952; GO:0007156; GO:0009897; GO:0032685; GO:0032701; GO:0032715; GO:0032760; GO:0033004; GO:0042110; GO:0042802; GO:0043030; GO:0043231; GO:0043305; GO:0045087; GO:0071639; GO:2001256 YNLQIYR 3.779999971 1 1 0.031292206 971.2983749 0 0 14.58662 11.06332 0 13.16426 0 0 0 13.8004 0 14.28752 0 0 0 14.31287 0 12.51001 0 0 0 0 0 0 15.74436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIF3 TEKT2_HUMAN "Tektin-2 (Tektin-t) (Testicular tektin) (Testicular tektin B1-like protein, TEKTB1, Tektin-B1)" TEKT2 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159] GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0015630; GO:0030317; GO:0031514; GO:0036159; GO:0060271; GO:0060294 VATEFAFR 6.849999905 0.732038677 0.732038677 0.117809651 941.3657342 0 16.73526 16.47447 17.89676 0 14.04694 15.73396 0 16.06369 16.77367 17.43318 13.81032 13.71504 13.68572 16.17175 0 12.00107 17.25269 0 10.11147 14.21764 15.07669 16.53116 14.77714 20.13232 18.5931 17.94861 14.77256 16.06791 16.08133 18.27264 18.31999 0 16.28922 15.7109 0 16.44674 13.55173 16.34256 9.759974 15.67889 17.40185 11.33469 0 14.03361 16.09268 16.26875 0 Q9UIF7 MUTYH_HUMAN "Adenine DNA glycosylase, EC 3.2.2.31 (MutY homolog, hMYH)" MUTYH MYH Homo sapiens (Human) base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]" "4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]" GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539 AEDEMDLDR 8.149999619 1 1 0.306263706 1093.964571 15.36044 0 16.59883 0 0 0 14.34303 15.42917 0 0 16.36791 0 0 0 0 16.0587 16.49755 15.57736 0 14.18588 0 0 0 0 0 16.70206 0 0 0 16.15094 0 17.3527 16.37427 0 0 0 15.66136 0 0 0 16.6035 15.43212 17.4149 0 18.84966 0 0 0 Q9UIF8 BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) BAZ2B KIAA1476 Homo sapiens (Human) chromatin remodeling [GO:0006338]; modulation of age-related behavioral decline [GO:0090647]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; modulation of age-related behavioral decline [GO:0090647]; regulation of transcription by RNA polymerase II [GO:0006357] DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872; GO:0090647 LIVPSPDVLKAGNK 3.730000019 1 1 1.15E-12 1450.201053 13.86876 0 0 0 0 11.73424 0 0 13.95677 0 0 0 0 0 0 0 0 0 0 0 15.45958 18.3205 0 0 0 0 0 0 0 0 0 0 0 0 14.47725 15.5759 0 0 0 16.01943 0 0 16.79376 0 0 0 0 0 Q9UIF9 BAZ2A_HUMAN "Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5, TTF-I-interacting protein 5, Tip5) (hWALp3)" BAZ2A KIAA0314 TIP5 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553] "chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553]; DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723] GO:0000183; GO:0001188; GO:0003677; GO:0003723; GO:0005677; GO:0005730; GO:0005829; GO:0006306; GO:0006338; GO:0006351; GO:0006355; GO:0016575; GO:0016607; GO:0016922; GO:0033553; GO:0042393; GO:0046872; GO:0070577 ITELLNKTDNRPLK 4.570000172 0.121650994 0.121650994 0.518935098 1654.989607 0 0 0 20.36927 0 0 19.5931 0 0 19.95505 0 19.46121 18.46165 0 19.84546 0 18.05586 0 16.89819 18.28627 0 0 20.07885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7249 17.66628 19.04213 0 0 19.19751 0 0 0 19.33497 Q9UIG0 BAZ1B_HUMAN "Tyrosine-protein kinase BAZ1B, EC 2.7.10.2 (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2)" BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; histone H2A phosphorylation [GO:1990164]; histone phosphorylation [GO:0016572]; negative regulation of mitotic chromosome condensation [GO:1905213]; nucleosome positioning [GO:0016584]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357] B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535] B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; histone H2A phosphorylation [GO:1990164]; histone phosphorylation [GO:0016572]; negative regulation of mitotic chromosome condensation [GO:1905213]; nucleosome positioning [GO:0016584]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357] ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270] GO:0000793; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005654; GO:0005721; GO:0005730; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0016572; GO:0016584; GO:0035066; GO:0035173; GO:0042393; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0110016; GO:1905213; GO:1990164; GO:2001020 KPNLGLK 5.320000172 0.303094774 0.303094774 0.221925991 770.2618468 0 0 14.62666 14.67233 13.66676 15.39074 13.89127 14.31985 14.23763 0 15.16144 0 14.42269 0 13.71536 0 15.88707 16.16025 0 15.10643 15.62235 15.22796 14.57897 16.7623 0 0 0 17.17114 14.74391 0 0 0 0 0 0 16.56493 0 0 16.83193 14.82381 15.32861 13.43732 0 15.13482 15.88517 15.92569 15.43771 0 Q9UIG5 PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein (Protein SEEK1) PSORS1C1 C6orf16 SEEK1 Homo sapiens (Human) MTCTDQK 2.720000029 0.335555673 0.335555673 0.23182599 900.3169795 0 0 0 12.82332 0 14.28335 15.98365 0 15.03792 16.05884 12.64089 15.92615 11.42414 0 14.29559 15.28682 16.04589 13.67528 13.29943 15.54792 17.13753 0 0 0 15.01997 16.32772 0 15.14211 16.16979 0 15.64162 16.99016 16.60565 0 17.1446 15.51033 15.33927 16.38513 16.38857 0 15.96018 9.086922 0 14.95312 12.87383 15.69019 16.65651 0 Q9UII2 ATIF1_HUMAN "ATPase inhibitor, mitochondrial (ATP synthase F1 subunit epsilon) (Inhibitor of F(1)F(o)-ATPase, IF(1), IF1)" ATP5IF1 ATPI ATPIF1 Homo sapiens (Human) angiogenesis [GO:0001525]; erythrocyte differentiation [GO:0030218]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; mitochondrial depolarization [GO:0051882]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of hydrolase activity [GO:0051346]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; reactive oxygen species metabolic process [GO:0072593]; regulation of ATP metabolic process [GO:1903578]; regulation of protein targeting to mitochondrion [GO:1903214] cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; angiostatin binding [GO:0043532]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mitochondrial proton-transporting ATP synthase complex binding [GO:0140260]; protein homodimerization activity [GO:0042803]; angiogenesis [GO:0001525]; erythrocyte differentiation [GO:0030218]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; mitochondrial depolarization [GO:0051882]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of hydrolase activity [GO:0051346]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; reactive oxygen species metabolic process [GO:0072593]; regulation of ATP metabolic process [GO:1903578]; regulation of protein targeting to mitochondrion [GO:1903214] angiostatin binding [GO:0043532]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mitochondrial proton-transporting ATP synthase complex binding [GO:0140260]; protein homodimerization activity [GO:0042803] GO:0001525; GO:0001937; GO:0004857; GO:0005516; GO:0005739; GO:0006091; GO:0006783; GO:0009986; GO:0019899; GO:0030218; GO:0032780; GO:0032991; GO:0042030; GO:0042802; GO:0042803; GO:0043532; GO:0051117; GO:0051346; GO:0051882; GO:0072593; GO:0140260; GO:1901030; GO:1903052; GO:1903214; GO:1903578; GO:1904925 EAGGAFGKR 2.809999943 1 1 0.310778169 893.234855 0 0 0 18.97997 0 17.86403 18.5771 0 16.43832 16.78789 17.99207 17.10795 0 18.07551 0 18.04263 18.35835 0 18.01473 16.81882 0 0 0 0 0 19.33578 0 0 0 17.55768 17.65882 18.86255 0 0 0 19.35588 0 17.80717 0 19.0095 17.00448 17.60289 0 0 0 17.73299 18.70285 17.5467 Q9UII4 HERC5_HUMAN "E3 ISG15--protein ligase HERC5, EC 2.3.2.- (Cyclin-E-binding protein 1) (HECT domain and RCC1-like domain-containing protein 5)" HERC5 CEB1 CEBP1 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cyclin binding [GO:0030332]; ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688] cyclin binding [GO:0030332]; ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000079; GO:0003723; GO:0004842; GO:0005737; GO:0005829; GO:0016567; GO:0030332; GO:0032020; GO:0042296; GO:0045087; GO:0048471; GO:0050688; GO:0051607; GO:0061630 FESILQEK 9.390000343 1 1 0.104348069 989.653836 14.84389 0 14.21314 15.76352 0 0 0 14.19499 13.83001 0 0 15.55389 0 13.77644 0 14.18598 0 0 0 0 0 0 15.61569 0 13.1823 0 0 0 0 0 0 0 0 0 0 0 12.79074 0 0 0 0 14.4357 0 0 0 0 0 0 Q9UII5 ZN107_HUMAN Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25) ZNF107 ZFD25 ZNF588 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 LTAHKK 9.270000458 0.969270051 0.969270051 0.168517503 696.5443745 16.42463 13.3018 16.17145 16.38054 15.4183 16.22738 0 15.02206 16.30968 15.60043 16.72847 13.55791 16.66373 15.68566 14.85092 15.99515 15.44797 16.33324 16.92815 0 14.89347 0 0 0 17.05823 0 16.56502 0 16.25466 16.995 0 0 0 16.89219 16.4052 0 0 17.39114 0 16.4426 15.90898 0 0 16.2988 0 0 0 0 Q9UIJ7 KAD3_HUMAN "GTP:AMP phosphotransferase AK3, mitochondrial, EC 2.7.4.10 (Adenylate kinase 3, AK 3) (Adenylate kinase 3 alpha-like 1)" AK3 AK3L1 AK6 AKL3L Homo sapiens (Human) ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051] ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899] GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899 LIPDDVMTR 4.489999771 1 1 0.184620094 1062.360279 14.32327 16.51337 0 15.57015 15.51178 13.00172 14.71025 17.02784 15.79014 0 14.46854 14.28612 15.09835 14.15719 16.10342 14.71736 11.35842 0 14.35281 0 0 0 0 0 16.16436 0 0 0 0 0 0 0 0 14.66384 0 14.73278 0 0 15.11073 16.32878 15.68812 0 0 15.50406 0 15.44185 0 0 Q9UIL4 KIF25_HUMAN Kinesin-like protein KIF25 (Kinesin-like protein 3) KIF25 KNSL3 Homo sapiens (Human) establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of autophagy [GO:0010507]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; organelle organization [GO:0006996]; protein homotetramerization [GO:0051289] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of autophagy [GO:0010507]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; organelle organization [GO:0006996]; protein homotetramerization [GO:0051289] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] GO:0000070; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0006996; GO:0007018; GO:0008017; GO:0008569; GO:0010507; GO:0016887; GO:0046603; GO:0051289; GO:0051294; GO:0051647 ARQVQR 2.99000001 1 1 0.140926726 756.8802217 0 0 16.18827 0 16.36752 15.7449 14.37416 0 0 13.84348 0 0 0 0 0 11.26943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5769 16.45222 20.14758 0 0 17.31297 0 0 0 0 0 0 0 16.31048 0 0 Q9UIL8 PHF11_HUMAN PHD finger protein 11 (BRCA1 C-terminus-associated protein) (Renal carcinoma antigen NY-REN-34) PHF11 BCAP Homo sapiens (Human) nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872] metal ion binding [GO:0046872] GO:0005634; GO:0005654; GO:0031965; GO:0046872 LLCQQHAQFPIIAQSAK 4.5 1 1 1.60E-12 1951.951775 0 0 13.36781 0 0 14.03084 14.22514 0 0 0 0 11.84997 17.31369 0 0 13.61704 0 0 0 0 16.01536 0 14.42426 14.04601 0 0 14.50024 0 0 0 0 0 0 16.8975 14.85786 0 13.22985 0 0 14.74942 0 12.76612 0 0 0 0 0 15.88218 Q9UIQ6 LCAP_HUMAN "Leucyl-cystinyl aminopeptidase, Cystinyl aminopeptidase, EC 3.4.11.3 (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase, IRAP) (Oxytocinase, OTase) (Placental leucine aminopeptidase, P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form ]" LNPEP OTASE Homo sapiens (Human) "antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]" cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]" aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] GO:0000209; GO:0002480; GO:0004177; GO:0005576; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0007565; GO:0008217; GO:0008237; GO:0008270; GO:0016020; GO:0030163; GO:0030659; GO:0031905; GO:0042277; GO:0043171; GO:0048471; GO:0060395; GO:0070006; GO:0120163 YQSVSLLDK 1.860000014 1 1 0.153201137 1053.553248 0 10.47053 12.38531 14.72265 17.52338 15.54248 15.63458 0 0 17.01611 16.04914 14.53093 0 0 12.69425 0 0 0 0 0 0 15.61582 0 0 0 0 0 0 0 15.56082 0 0 0 0 0 0 0 16.65881 15.99251 0 0 0 0 14.80528 0 16.15396 0 0 Q9UIS9 MBD1_HUMAN Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1) MBD1 CXXC3 PCM1 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]" chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]" DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006366; GO:0008270; GO:0008327; GO:0010385; GO:0016363; GO:0016607; GO:0045322; GO:0045892 DLKKPGAR 13.02999973 1 1 0.567373551 883.018078 0 0 0 0 0 16.87712 0 0 0 0 0 0 0 0 0 0 0 0 17.13616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.26981 0 0 0 0 Q9UIV8 SPB13_HUMAN "Serpin B13 (HaCaT UV-repressible serpin, Hurpin) (Headpin) (Peptidase inhibitor 13, PI-13) (Proteinase inhibitor 13)" SERPINB13 PI13 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of keratinocyte apoptotic process [GO:1902173]; regulation of proteolysis [GO:0030162]; response to UV [GO:0009411] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of keratinocyte apoptotic process [GO:1902173]; regulation of proteolysis [GO:0030162]; response to UV [GO:0009411] cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0002020; GO:0004867; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0009411; GO:0010951; GO:0016607; GO:0030162; GO:0043202; GO:0070062; GO:1902173 YYHASLEPVDFVNAADESRK 7.480000019 1 1 2.75E-12 2311.100354 14.54078 14.67033 14.31453 0 0 9.724477 0 0 0 0 0 0 17.71164 0 0 0 0 0 0 0 16.17358 0 17.62011 13.59723 7.064343 0 16.10019 0 0 0 14.68326 0 12.32867 16.18089 0 0 0 16.40814 0 0 0 0 0 0 11.14879 0 14.28813 0 Q9UIW0 VAX2_HUMAN Ventral anterior homeobox 2 VAX2 Homo sapiens (Human) axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic eye morphogenesis [GO:0048048]; forebrain development [GO:0030900]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic eye morphogenesis [GO:0048048]; forebrain development [GO:0030900]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]" "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007398; GO:0007409; GO:0007417; GO:0007601; GO:0009950; GO:0016055; GO:0030182; GO:0030900; GO:0031490; GO:0048048; GO:0060041; GO:1990837 MGDGGAER 5.630000114 1 1 0.266653685 808.1925994 15.35484 15.52076 16.07071 15.81264 15.67008 15.83384 15.04728 16.00706 14.98369 0 15.96399 15.98192 17.29746 16.02864 15.90562 0 15.06454 15.74524 0 15.81491 13.47866 0 0 15.93117 16.42658 12.90529 15.63443 15.80138 16.25636 16.06401 16.55848 15.94914 16.63452 16.41016 14.39105 17.05154 0 16.55029 16.89561 0 16.40891 0 15.1274 16.6557 0 0 15.05818 0 Q9UIW2 PLXA1_HUMAN Plexin-A1 (Semaphorin receptor NOV) PLXNA1 NOV PLXN1 Homo sapiens (Human) dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] semaphorin receptor activity [GO:0017154] GO:0002116; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014910; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:0060666; GO:0070062; GO:1902287; GO:1990138 LSPETGPR 6.53000021 1 1 5.71E-13 857.4451762 14.02896 0 15.12558 16.07814 16.30007 0 0 15.09894 13.20086 0 15.3392 0 0 0 13.20694 0 0 0 15.05054 0 0 0 0 0 15.72205 0 14.1049 11.96858 15.34766 0 15.25362 14.5724 9.120336 0 14.40287 13.71443 0 10.5047 0 13.07985 0 12.24688 0 14.05224 0 0 0 16.22971 Q9UIY3 RWD2A_HUMAN RWD domain-containing protein 2A RWDD2A RWDD2 Homo sapiens (Human) HISCKHAESVETEGNGEDLR 2.440000057 1 1 0.249835587 2268.551935 15.90061 0 0 13.10626 15.02766 14.41724 0 12.35549 13.46012 0 0 0 0 0 0 0 0 0 0 14.02958 0 0 0 0 0 16.37526 10.99605 15.2722 0 0 0 0 0 0 0 0 0 0 0 15.97396 0 0 0 17.01742 11.40629 14.15525 0 12.61695 Q9UJ14 GGT7_HUMAN "Glutathione hydrolase 7, EC 3.4.19.13 (Gamma-glutamyltransferase 7, GGT 7, EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) [Cleaved into: Glutathione hydrolase 7 heavy chain; Glutathione hydrolase 7 light chain ]" GGT7 GGTL3 GGTL5 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883] glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0036374; GO:0102953; GO:0103068; GO:1901750; GO:1902883 ALAEQLPPNMSER 3.779999971 1 1 0 1454.81746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ68 MSRA_HUMAN "Mitochondrial peptide methionine sulfoxide reductase, EC 1.8.4.11 (Peptide-methionine (S)-S-oxide reductase, Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase, PMSR)" MSRA Homo sapiens (Human) cellular protein modification process [GO:0006464]; cellular response to oxidative stress [GO:0034599]; methionine metabolic process [GO:0006555]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464]; cellular response to oxidative stress [GO:0034599]; methionine metabolic process [GO:0006555]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113] GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006464; GO:0006555; GO:0006979; GO:0008113; GO:0015629; GO:0030091; GO:0034599; GO:0036456; GO:0070062 TGHAEVVRVVYQPEHMSFEELLK 6.300000191 1 1 3.20E-12 2689.772348 11.96932 14.51812 0 12.80327 0 0 11.27422 12.35155 13.26917 0 0 0 0 0 12.98058 13.43532 0 10.73766 0 13.54381 0 0 0 0 0 0 0 14.5381 11.41813 13.64938 0 0 0 0 0 0 0 0 0 0 0 0 13.55231 0 0 0 0 0 Q9UJ71 CLC4K_HUMAN C-type lectin domain family 4 member K (Langerin) (CD antigen CD207) CD207 CLEC4K Homo sapiens (Human) defense response to virus [GO:0051607] clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; defense response to virus [GO:0051607] carbohydrate binding [GO:0030246]; mannose binding [GO:0005537] GO:0005537; GO:0005886; GO:0009897; GO:0016021; GO:0030139; GO:0030246; GO:0030669; GO:0031901; GO:0051607 RPYVPSEP 12.44999981 1 1 0.239182592 945.7458204 0 0 16.46585 16.59921 0 13.01335 15.4263 13.10778 16.52369 15.94209 16.99111 15.37173 13.95395 14.66965 14.77284 14.95251 13.41417 15.34293 15.95994 12.78766 16.35482 14.39455 16.41825 16.83595 0 15.02628 17.188 0 0 15.60239 0 0 0 15.87519 16.4621 15.8823 15.30498 0 0 0 0 15.54101 0 0 0 13.75995 15.55336 15.57888 Q9UJ96 KCNG2_HUMAN Potassium voltage-gated channel subfamily G member 2 (Cardiac potassium channel subunit) (Voltage-gated potassium channel subunit Kv6.2) KCNG2 KCNF2 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008016; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0070062; GO:0071805 SPCAFRAIVALLR 9.520000458 0.798262894 0.798262894 0.249087903 1473.02821 17.00921 16.88195 11.16575 0 17.03447 12.637 16.02536 0 15.57944 17.75055 0 13.58562 0 16.74429 0 0 0 18.36816 17.04597 16.48695 15.95187 0 0 16.91451 16.6723 18.62103 17.76755 16.82203 9.083152 0 0 0 18.7036 16.20502 0 16.96409 0 17.885 14.195 0 0 18.32666 16.23187 14.69151 0 0 15.20188 0 Q9UJ98 STAG3_HUMAN Cohesin subunit SA-3 (SCC3 homolog 3) (Stromal antigen 3) (Stromalin-3) STAG3 Homo sapiens (Human) establishment of meiotic sister chromatid cohesion [GO:0034089]; sister chromatid cohesion [GO:0007062]; synaptonemal complex assembly [GO:0007130] "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; extracellular space [GO:0005615]; meiotic cohesin complex [GO:0030893]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; extracellular space [GO:0005615]; meiotic cohesin complex [GO:0030893]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; establishment of meiotic sister chromatid cohesion [GO:0034089]; sister chromatid cohesion [GO:0007062]; synaptonemal complex assembly [GO:0007130]" chromatin binding [GO:0003682] GO:0000775; GO:0000785; GO:0000795; GO:0003682; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0007062; GO:0007130; GO:0008278; GO:0030893; GO:0034089 EMEEEDGSELDFAQGQPVAGTER 1.049999952 1 1 1.83E-12 2541.080035 14.13772 0 16.11185 0 0 14.51822 13.37711 15.55038 13.18145 15.03818 14.30181 0 0 0 0 0 0 0 0 0 0 0 15.54246 14.63259 0 0 16.05866 0 0 0 0 0 0 0 0 0 0 0 0 0 16.02414 0 0 0 0 0 0 0 Q9UJA3 MCM8_HUMAN "DNA helicase MCM8, EC 3.6.4.12 (Minichromosome maintenance 8)" MCM8 C20orf154 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697] GO:0000724; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006974; GO:0007049; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0071168; GO:0097362 CMFLLYIEANSISNSKGQK 5.360000134 1 1 0.179720662 2202.06322 14.96599 0 14.69318 0 0 0 0 14.23595 13.81932 0 15.84035 0 0 0 0 0 0 0 0 15.53229 0 0 0 16.08629 0 0 16.16286 14.54031 15.61718 0 15.59884 16.28308 0 0 0 0 17.7669 0 0 0 0 0 0 0 0 0 0 0 Q9UJC3 HOOK1_HUMAN "Protein Hook homolog 1, h-hook1, hHK1" HOOK1 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] GO:0003779; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007030; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0042802; GO:0042803; GO:0045022; GO:0051959; GO:0070695; GO:1905198; GO:1905719 SEGESSSKLK 3.25999999 1 1 0.212641874 1050.752301 5.77644 15.68179 13.91964 0 13.87957 12.99375 12.02102 14.02566 14.34909 14.60723 13.56393 0 14.86396 0 14.34232 0 0 0 15.77533 15.86118 0 14.70744 0 15.81771 15.42111 0 0 0 16.40965 0 0 0 0 0 0 0 0 16.06793 16.15477 0 0 0 0 0 0 0 0 0 Q9UJF2 NGAP_HUMAN Ras GTPase-activating protein nGAP (RAS protein activator-like 2) RASAL2 NGAP Homo sapiens (Human) adipose tissue development [GO:0060612]; gene expression [GO:0010467]; multicellular organism growth [GO:0035264]; regulation of GTPase activity [GO:0043087]; regulation of protein activation cascade [GO:2000257]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; adipose tissue development [GO:0060612]; gene expression [GO:0010467]; multicellular organism growth [GO:0035264]; regulation of GTPase activity [GO:0043087]; regulation of protein activation cascade [GO:2000257]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096] GO:0002021; GO:0005096; GO:0005829; GO:0007165; GO:0009749; GO:0010467; GO:0035264; GO:0043087; GO:0060612; GO:2000257 DLAPKK 6.400000095 0.837437212 0.837437212 0.189493177 669.5690146 0 19.33661 18.73635 0 18.70529 0 0 0 0 0 0 0 0 0 0 18.40149 18.99382 0 0 16.02011 0 0 0 19.31005 0 18.81141 0 0 0 0 0 0 0 0 0 0 0 0 18.82658 0 0 0 0 0 0 0 17.24079 0 Q9UJL9 ZF69B_HUMAN Zinc finger protein 69 homolog B (Zinc finger protein 643) ZFP69B ZNF643 Homo sapiens (Human) Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0046872 NTFSNVV 3.140000105 0.240074143 0.240074143 0.233606239 780.7564615 13.86182 14.64548 0 16.25032 0 0 15.79068 0 15.75717 14.58772 0 15.31278 13.62691 14.72482 16.68619 14.61424 15.24822 14.15338 0 15.59075 15.14668 16.37195 16.10504 0 0 0 15.38615 0 0 0 16.03376 0 16.2991 0 17.4153 0 16.35551 15.39726 15.47178 0 0 14.64616 15.00911 15.6807 0 0 0 0 Q9UJM8 HAOX1_HUMAN "2-Hydroxyacid oxidase 1, HAOX1, EC 1.1.3.15 (Glycolate oxidase, GO, GOX) (Glyoxylate oxidase, EC 1.2.3.5)" HAO1 GOX1 Homo sapiens (Human) fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969]; fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0010181; GO:0046296; GO:0047969 GTDVLK 6.659999847 0.405790895 0.405790895 0.114650731 632.281268 16.67904 15.63173 18.19731 18.51095 16.5761 13.69027 15.08925 0 15.92469 16.74726 17.71738 16.21161 0 14.01541 14.64317 18.26115 17.06251 14.66809 14.40988 15.27683 15.48111 0 17.02821 15.64911 16.29835 14.99741 13.56982 15.87365 15.78192 16.20108 15.27977 15.47409 16.2503 0 16.4946 15.21946 15.0436 16.26207 16.92183 12.27983 16.60201 14.26716 16.70194 15.7841 19.49898 15.40358 14.84096 0 Q9UJQ1 LAMP5_HUMAN "Lysosome-associated membrane glycoprotein 5 (Brain and dendritic cell-associated LAMP) (Brain-associated LAMP-like protein, BAD-LAMP) (Lysosome-associated membrane protein 5, LAMP-5)" LAMP5 C20orf103 Homo sapiens (Human) establishment of protein localization to organelle [GO:0072594] cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; growth cone membrane [GO:0032584]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672] cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; growth cone membrane [GO:0032584]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; establishment of protein localization to organelle [GO:0072594] GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0030659; GO:0030672; GO:0031901; GO:0031902; GO:0032584; GO:0032590; GO:0033116; GO:0055038; GO:0072594 SQYKHMG 17.36000061 1 1 0.250235774 866.3056946 0 14.96616 0 16.75066 14.18901 16.40155 0 16.38365 14.79455 0 0 0 0 15.47571 0 0 15.75934 16.60342 0 14.28197 0 18.083 15.55396 0 0 0 18.06045 13.23641 0 0 17.08096 0 15.40303 0 0 0 17.62469 0 0 0 15.10553 0 0 16.00907 0 0 0 0 Q9UJT0 TBE_HUMAN Tubulin epsilon chain (Epsilon-tubulin) TUBE1 TUBE Homo sapiens (Human) centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; microtubule [GO:0005874]; pericentriolar material [GO:0000242] cytoplasm [GO:0005737]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200] GO:0000226; GO:0000242; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007098 ARAVLIDMEEGVVNEILQGPLR 10.31000042 1 1 0.104933828 2437.819675 0 0 14.8931 0 0 12.75237 13.16634 14.70653 0 0 0 0 14.90119 15.42723 0 0 0 15.28887 0 14.75154 0 15.76213 0 15.40758 16.69955 0 15.81745 14.5977 0 0 0 0 14.60041 0 0 0 0 0 0 17.78174 0 0 0 0 0 0 0 17.58561 Q9UJU2 LEF1_HUMAN "Lymphoid enhancer-binding factor 1, LEF-1 (T cell-specific transcription factor 1-alpha, TCF1-alpha)" LEF1 Homo sapiens (Human) "anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-4 [GO:0071353]; chorio-allantoic fusion [GO:0060710]; dentate gyrus development [GO:0021542]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; forebrain neuroblast division [GO:0021873]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; histone H3 acetylation [GO:0043966]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; mammary gland development [GO:0030879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; paraxial mesoderm formation [GO:0048341]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary palate development [GO:0062009]; sensory perception of taste [GO:0050909]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; T cell receptor V(D)J recombination [GO:0033153]; T-helper 1 cell differentiation [GO:0045063]; tongue development [GO:0043586]; trachea gland development [GO:0061153]" beta-catenin-TCF complex [GO:1990907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] "beta-catenin-TCF complex [GO:1990907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; estrogen receptor binding [GO:0030331]; gamma-catenin binding [GO:0045295]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416]; anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-4 [GO:0071353]; chorio-allantoic fusion [GO:0060710]; dentate gyrus development [GO:0021542]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; forebrain neuroblast division [GO:0021873]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; histone H3 acetylation [GO:0043966]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; mammary gland development [GO:0030879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; paraxial mesoderm formation [GO:0048341]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary palate development [GO:0062009]; sensory perception of taste [GO:0050909]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; T cell receptor V(D)J recombination [GO:0033153]; T-helper 1 cell differentiation [GO:0045063]; tongue development [GO:0043586]; trachea gland development [GO:0061153]" "armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; estrogen receptor binding [GO:0030331]; gamma-catenin binding [GO:0045295]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416]" GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001228; GO:0001569; GO:0001649; GO:0001756; GO:0001837; GO:0002040; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0008013; GO:0008284; GO:0008301; GO:0010628; GO:0010718; GO:0021542; GO:0021861; GO:0021873; GO:0021943; GO:0022408; GO:0022409; GO:0030177; GO:0030223; GO:0030326; GO:0030331; GO:0030335; GO:0030509; GO:0030854; GO:0030879; GO:0032696; GO:0032713; GO:0032714; GO:0032993; GO:0033153; GO:0042100; GO:0042393; GO:0042475; GO:0042826; GO:0043066; GO:0043392; GO:0043565; GO:0043586; GO:0043923; GO:0043966; GO:0043967; GO:0045063; GO:0045295; GO:0045588; GO:0045597; GO:0045843; GO:0045892; GO:0045893; GO:0045944; GO:0048341; GO:0050767; GO:0050909; GO:0060033; GO:0060070; GO:0060325; GO:0060326; GO:0060710; GO:0061153; GO:0062009; GO:0070016; GO:0070742; GO:0071345; GO:0071353; GO:0071864; GO:0071866; GO:0090068; GO:0097043; GO:0140416; GO:1902262; GO:1902732; GO:1990837; GO:1990907 DNYGK 8.109999657 1 1 0.123169415 597.446982 14.27937 10.4502 13.28453 0 11.58358 0 0 15.54442 15.60734 14.00752 0 0 0 0 16.62248 15.96426 0 15.51997 14.61793 15.44395 0 0 0 14.79673 0 0 0 0 0 0 0 0 0 16.1273 15.99132 0 0 0 0 0 0 16.22018 0 0 0 0 0 0 Q9UJU6 DBNL_HUMAN "Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa, HIP-55) (SH3 domain-containing protein 7)" DBNL CMAP SH3P7 PP5423 Homo sapiens (Human) adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416] cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; site of polarized growth [GO:0030427]; tertiary granule lumen [GO:1904724] cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; site of polarized growth [GO:0030427]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904] GO:0000139; GO:0001726; GO:0002102; GO:0002250; GO:0003779; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006898; GO:0007416; GO:0008022; GO:0008047; GO:0014069; GO:0016601; GO:0019904; GO:0030027; GO:0030425; GO:0030427; GO:0030665; GO:0030833; GO:0030864; GO:0034774; GO:0043204; GO:0043231; GO:0045211; GO:0045296; GO:0045773; GO:0048812; GO:0051015; GO:0061003; GO:0070062; GO:0071800; GO:0097178; GO:0098974; GO:1904724; GO:1904813 EEENRR 9.170000076 1 1 0.150535826 831.3578377 16.92823 14.24474 14.77518 14.78565 0 0 0 0 14.88411 0 15.51564 14.70042 15.9705 14.39807 13.62125 15.17336 12.96982 14.60209 0 13.59476 0 0 0 0 15.74397 0 0 0 16.90642 0 0 0 0 0 13.83638 15.51765 0 0 17.19445 0 0 17.1882 0 0 0 0 0 0 Q9UJV3 TRIM1_HUMAN "Probable E3 ubiquitin-protein ligase MID2, EC 2.3.2.27 (Midin-2) (Midline defect 2) (Midline-2) (RING finger protein 60) (RING-type E3 ubiquitin transferase MID2) (Tripartite motif-containing protein 1)" MID2 FXY2 RNF60 TRIM1 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] GO:0003713; GO:0005737; GO:0005874; GO:0008017; GO:0008270; GO:0010508; GO:0016567; GO:0016740; GO:0019899; GO:0032897; GO:0035372; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0046597; GO:0051091; GO:0051092; GO:0051219; GO:0070062 ISNDGLQMEK 7.590000153 0.235700622 0.235700622 2.28E-13 1147.518669 0 16.68944 13.98419 0 0 17.02615 14.54993 0 15.5905 16.58579 14.26765 12.02481 14.29538 13.93429 0 16.64262 17.99939 0 0 0 14.77172 0 0 16.23193 14.03531 16.04566 14.53317 0 0 15.69237 0 0 16.4893 16.39337 16.47391 8.324779 13.81875 13.44298 12.04522 15.86179 14.61005 15.02562 0 12.46172 0 15.21475 15.99947 13.44127 Q9UJV9 DDX41_HUMAN "Probable ATP-dependent RNA helicase DDX41, EC 3.6.4.13 (DEAD box protein 41) (DEAD box protein abstrakt homolog)" DDX41 ABS Homo sapiens (Human) "apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006915; GO:0008283; GO:0016020; GO:0016887; GO:0030154; GO:0046872; GO:0071013 EEAKMVYLLECLQK 8.760000229 1.57E-08 1.57E-08 0.272357861 1769.970764 15.40167 0 0 11.24013 14.89383 15.48495 0 0 14.33024 15.95626 16.74834 0 0 15.47913 0 15.81496 0 17.05744 0 11.87596 17.09796 16.74537 16.29847 0 0 0 16.4674 16.486 15.89449 13.13236 16.15384 0 15.79708 15.85631 15.7184 15.05129 18.04801 13.3968 15.46998 0 0 14.76803 0 15.03681 14.56902 15.38325 13.65951 0 Q9UJW0 DCTN4_HUMAN "Dynactin subunit 4, Dyn4 (Dynactin subunit p62)" DCTN4 Homo sapiens (Human) cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485] protein N-terminus binding [GO:0047485] GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0030017; GO:0047485 ELVLAGK 4.980000019 1 1 3.46E-13 729.5762458 15.26465 0 0 0 0 0 0 0 0 0 0 0 0 0 16.84595 16.49339 0 0 0 0 0 0 0 0 0 17.04083 0 15.59445 0 0 0 0 16.96016 17.09754 15.13003 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJW3 DNM3L_HUMAN DNA (cytosine-5)-methyltransferase 3-like DNMT3L Homo sapiens (Human) "C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; male meiosis I [GO:0007141]; negative regulation of DNA methylation [GO:1905642]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation [GO:1905643]; regulation of gene expression by genomic imprinting [GO:0006349]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]" catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; male meiosis I [GO:0007141]; negative regulation of DNA methylation [GO:1905642]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation [GO:1905643]; regulation of gene expression by genomic imprinting [GO:0006349]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]" enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] GO:0005634; GO:0005737; GO:0005829; GO:0006306; GO:0006349; GO:0007141; GO:0007283; GO:0008047; GO:0019899; GO:0032776; GO:0043046; GO:0045892; GO:0046872; GO:0048863; GO:0090116; GO:1902494; GO:1905642; GO:1905643 VWSNIPAIR 6.53000021 1 1 4.63E-13 1056.264946 0 17.3221 14.75183 0 0 0 15.90897 15.11176 13.71813 0 0 14.85388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJW7 ZN229_HUMAN Zinc finger protein 229 ZNF229 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 YGSGLLSHK 7.059999943 1 1 0.168517314 963.83955 0 15.90403 0 0 14.95658 0 0 0 15.40372 0 0 15.93287 16.57203 15.93464 0 0 13.9483 14.93678 0 13.84949 0 14.03248 14.28206 16.27305 0 0 0 14.70838 14.39663 11.151 15.46896 12.96337 15.4487 0 0 0 0 0 0 0 0 0 0 0 0 14.99905 0 0 Q9UJW8 ZN180_HUMAN Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 THTGEKPYRCNQCGK 5.630000114 0.495086253 0.495086253 0.314217297 1836.651135 0 14.4348 14.09049 0 17.4802 0 0 0 14.12948 0 0 15.3997 0 0 0 13.56947 16.07005 0 0 0 0 0 0 0 0 16.52633 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27905 0 0 0 0 0 0 0 0 Q9UJX0 OSGI1_HUMAN "Oxidative stress-induced growth inhibitor 1 (Bone marrow stromal cell-derived growth inhibitor, BMSC-derived growth inhibitor) (Ovary, kidney and liver protein 38, huOKL38) (Pregnancy-induced growth inhibitor OKL38)" OSGIN1 BDGI OKL38 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127] growth factor activity [GO:0008083]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127] growth factor activity [GO:0008083] GO:0008083; GO:0030154; GO:0030308; GO:0030334; GO:0042127; GO:0042981; GO:0043065 ETRKPP 4.349999905 0.507549584 0.507549584 3.44E-13 727.2409561 0 15.44349 0 13.98406 0 0 12.93885 0 0 0 15.50895 0 0 0 0 0 0 0 14.89565 0 0 0 15.32247 0 14.35531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1216 12.24398 0 15.40691 0 15.86252 0 0 0 Q9UJX2 CDC23_HUMAN "Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8, APC8) (Cyclosome subunit 8)" CDC23 ANAPC8 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin-protein transferase activity [GO:0004842] GO:0000278; GO:0004842; GO:0005654; GO:0005680; GO:0005737; GO:0005829; GO:0006511; GO:0007080; GO:0007091; GO:0007096; GO:0007346; GO:0016567; GO:0030071; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979 IENMDTFSNLLYVRSMK 3.859999895 1 1 0.114686311 2077.555539 0 0 0 0 0 0 0 0 13.9536 0 0 0 0 0 0 15.54125 14.45571 0 0 0 0 0 17.60258 0 14.38695 0 14.60906 0 0 0 0 0 0 17.06459 16.50614 0 0 0 0 0 0 0 0 0 15.88517 0 0 0 Q9UJX4 APC5_HUMAN "Anaphase-promoting complex subunit 5, APC5 (Cyclosome subunit 5)" ANAPC5 APC5 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] protein phosphatase binding [GO:0019903] GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007049; GO:0007346; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979 SDSYVLLEHSVKK 5.170000076 1 1 0.189389746 1508.303774 0 12.3049 16.40583 11.34122 0 14.66531 0 0 13.99972 6.828477 0 0 16.38535 0 0 0 0 0 0 14.13957 0 0 16.21557 0 16.31111 12.89114 0 0 16.2768 15.21727 0 16.34686 0 0 13.77069 0 0 0 0 0 0 0 0 0 12.92782 0 0 0 Q9UJX5 APC4_HUMAN "Anaphase-promoting complex subunit 4, APC4 (Cyclosome subunit 4)" ANAPC4 APC4 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0051445; GO:0070979 NTTTSVQDEFMHLLLWGK 6.389999866 1 1 2.30E-12 2116.525198 13.87954 12.2747 16.13731 0 14.07547 0 14.98967 0 0 14.02102 0 15.10081 15.01017 15.69325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJX6 ANC2_HUMAN "Anaphase-promoting complex subunit 2, APC2 (Cyclosome subunit 2)" ANAPC2 APC2 KIAA1406 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of gene expression [GO:0010629]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of gene expression [GO:0010629]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] ubiquitin protein ligase binding [GO:0031625] GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0010629; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0051445; GO:0070979; GO:0090129 SLLADR 9.720000267 1 1 0.100286572 673.3940374 0 0 0 0 15.0846 13.62692 0 0 15.63351 12.55366 0 14.70202 0 0 0 16.71726 0 0 0 0 0 0 0 0 13.45505 14.02285 0 0 14.17212 16.3582 16.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJY4 GGA2_HUMAN "ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2) (VHS domain and ear domain of gamma-adaptin, Vear)" GGA2 KIAA1080 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394] phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130] GO:0005794; GO:0005802; GO:0006886; GO:0010008; GO:0030136; GO:0031267; GO:0031901; GO:0034394; GO:0035091; GO:0043001; GO:0043130 IRDAYQMLK 6.179999828 0.845697284 0.845697284 0.221092047 1154.768859 15.18919 15.18473 15.5699 14.21607 15.08578 14.99435 14.76458 12.75829 15.2796 15.96954 16.59222 13.54549 0 14.84975 14.67975 13.45418 13.49273 14.26358 0 0 0 0 0 0 14.43334 15.44401 0 16.26987 14.97891 0 16.27602 15.73361 15.11658 0 15.30504 14.25965 0 15.97068 0 14.71106 0 0 14.01955 0 0 0 0 14.69768 Q9UJZ1 STML2_HUMAN "Stomatin-like protein 2, mitochondrial, SLP-2 (EPB72-like protein 2) (Paraprotein target 7, Paratarg-7)" STOML2 SLP2 HSPC108 Homo sapiens (Human) "CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]" cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758] "cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]" cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032743; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046 GTGALLLRGSLLASGR 2.589999914 1 1 0.125316841 1541.393956 0 0 0 0 0 0 0 0 17.64465 0 14.62554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.81559 0 0 0 0 0 0 0 0 0 19.3679 0 0 17.92627 0 0 0 0 0 0 0 0 0 Q9UK11 ZN223_HUMAN Zinc finger protein 223 ZNF223 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872 SGLDLHHR 12.56999969 1 1 0.262727456 933.9724701 16.52193 0 16.49776 0 13.87633 0 0 0 0 0 0 0 15.86576 15.75682 0 0 16.97037 0 0 0 0 17.79926 11.67541 16.49474 0 17.65058 0 15.02665 18.55483 17.38592 17.02054 0 18.92648 16.75115 15.90162 14.08691 0 0 13.32747 0 0 17.09236 0 0 16.66685 0 15.32139 0 Q9UK12 ZN222_HUMAN Zinc finger protein 222 ZNF222 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 DHSGENPSKCEDCGK 21.30999947 1 1 0.00969368 1720.166294 0 14.73535 11.96882 14.57569 16.07217 11.30967 0 11.55167 0 14.74168 0 14.55859 0 0 0 0 0 0 0 0 0 0 0 18.10881 0 13.76166 16.6621 0 0 15.07583 0 17.01698 15.56681 15.11699 14.92858 0 0 0 0 0 0 0 0 0 16.24631 0 0 0 Q9UK13 ZN221_HUMAN Zinc finger protein 221 ZNF221 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 SALNSHSMVHIEEKPYK 7.690000057 1 1 0.319374789 1969.483299 12.96556 13.58187 13.5187 0 0 0 0 0 12.96142 0 0 0 13.14182 0 0 0 14.32938 0 0 0 0 0 0 0 0 0 0 0 0 13.77542 0 14.15239 0 0 0 0 0 0 0 14.51554 12.94897 16.10548 0 0 0 0 0 0 Q9UK22 FBX2_HUMAN F-box only protein 2 FBXO2 FBX2 Homo sapiens (Human) cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842] GO:0001540; GO:0004842; GO:0005737; GO:0005783; GO:0005829; GO:0006464; GO:0006508; GO:0006516; GO:0016020; GO:0016567; GO:0019005; GO:0030246; GO:0030433; GO:0031146; GO:0031396; GO:0043197 FVRFEHGGQDSVYWK 4.670000076 0.2996521 0.2996521 0.122881826 1855.332207 14.63629 0 17.52595 0 10.53201 0 15.7952 0 0 0 10.23838 16.45298 12.40469 11.35018 15.69993 0 0 0 0 18.11226 16.97259 12.74267 0 17.18184 17.0238 0 0 17.54145 16.12533 0 16.93708 0 17.19599 0 7.48557 11.57713 17.1287 0 16.15527 14.34066 13.25919 17.71629 15.40577 0 0 18.55408 0 17.92542 Q9UK32 KS6A6_HUMAN "Ribosomal protein S6 kinase alpha-6, S6K-alpha-6, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 6, p90-RSK 6, p90RSK6) (Ribosomal S6 kinase 4, RSK-4) (pp90RSK4)" RPS6KA6 RSK4 Homo sapiens (Human) "central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]" ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GO:0000287; GO:0001650; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006978; GO:0007165; GO:0007417; GO:0018105; GO:0045992; GO:0070373; GO:0106310; GO:2000381 DLKPENILLDEIGHIK 5.550000191 0.273547083 0.273547083 0.442302247 1846.591084 15.66183 15.60916 0 0 13.22607 0 15.73279 0 15.40479 0 0 18.01614 0 0 0 0 0 16.25897 0 15.43698 0 0 15.22793 16.95739 0 0 0 0 0 0 0 0 0 0 0 0 0 16.69955 0 17.60195 0 0 0 0 0 0 0 0 Q9UK39 NOCT_HUMAN "Nocturnin, EC 3.1.3.108 (Carbon catabolite repression 4-like protein)" NOCT CCR4 CCRN4L NOC Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; P-body assembly [GO:0033962]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; P-body assembly [GO:0033962]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366] 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535] GO:0000175; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006366; GO:0006739; GO:0009991; GO:0010629; GO:0019178; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757 RLPAPGLR 10.06999969 1 1 0.190257257 879.8958806 0 0 13.86803 13.71463 12.32862 0 14.64156 13.7885 12.16701 14.62095 14.68299 11.2909 0 10.35114 0 13.96424 0 0 0 0 0 15.93927 0 0 0 0 0 0 0 0 0 0 0 0 0 16.50508 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK41 VPS28_HUMAN "Vacuolar protein sorting-associated protein 28 homolog, H-Vps28 (ESCRT-I complex subunit VPS28)" VPS28 Homo sapiens (Human) macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130] GO:0000813; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010008; GO:0016236; GO:0031397; GO:0031902; GO:0036258; GO:0039702; GO:0043130; GO:0043162; GO:0043328; GO:0044877; GO:0045732; GO:0070062; GO:2000397 QVQGSEISSIDEFCR 3.269999981 1 1 0.021835594 1753.902818 15.45051 11.82065 13.05239 13.37026 11.99551 14.29522 14.18693 0 13.60972 0 0 0 13.92944 13.65864 0 0 0 0 0 14.60154 0 14.07648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK59 DBR1_HUMAN "Lariat debranching enzyme, EC 3.1.-.-" DBR1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]" metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419] GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872 YRHMQTFYR 7.179999828 0.467022717 0.467022717 0.115459904 1319.683632 12.13266 10.76947 10.51485 0 13.39882 0 0 0 14.01101 0 0 0 0 12.11118 0 0 0 0 14.48171 0 11.21594 12.54911 0 0 10.93938 14.15805 0 9.793364 12.43638 0 0 13.44837 0 0 0 15.07257 0 0 0 0 14.90859 0 13.44452 12.6749 15.6086 0 0 11.58832 Q9UK61 TASOR_HUMAN Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein) TASOR C3orf63 FAM208A KIAA1105 Homo sapiens (Human) "anterior/posterior axis specification, embryo [GO:0008595]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" heterochromatin [GO:0000792]; nucleoplasm [GO:0005654] "heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; anterior/posterior axis specification, embryo [GO:0008595]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" chromatin binding [GO:0003682]; RNA binding [GO:0003723] GO:0000792; GO:0003682; GO:0003723; GO:0005654; GO:0008595; GO:0045814; GO:0045869; GO:0060809; GO:0090309; GO:0097355 GFGSGK 5.389999866 0.6695261 0.6695261 0.268614855 554.866946 13.69595 16.06636 0 15.75019 15.19679 14.95752 15.45547 0 15.09513 0 13.31763 15.20425 0 0 0 0 0 0 0 0 15.60091 16.37165 16.15304 0 0 9.768986 15.46844 15.16841 15.33023 0 13.74773 0 0 15.56656 15.26638 0 0 15.67889 0 16.03175 0 0 0 0 15.60764 0 0 15.80609 Q9UK73 FEM1B_HUMAN "Protein fem-1 homolog B, FEM1b (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha, F1A-alpha)" FEM1B F1AA KIAA0396 Homo sapiens (Human) apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] death receptor binding [GO:0005123]; ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0031462; GO:0043161; GO:0051438; GO:0060442; GO:0060743; GO:0140627; GO:1902041; GO:1990756; GO:2000001 EGLAGYVYKAASEGK 4.949999809 1 1 0.567415386 1542.98863 0 0 0 0 0 0 18.18842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.03773 0 0 0 0 0 0 0 0 0 0 0 0 0 19.28855 0 0 0 0 0 0 0 16.7789 0 0 0 0 Q9UK76 JUPI1_HUMAN "Jupiter microtubule associated homolog 1 (Androgen-regulated protein 2) (Hematological and neurological expressed 1 protein) [Cleaved into: Jupiter microtubule associated homolog 1, N-terminally processed ]" JPT1 ARM2 HN1 Homo sapiens (Human) cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0031965 EDLESSGLQR 9.760000229 0.699034572 0.699034572 0.266875386 1135.148209 0 0 11.75241 14.55527 14.3098 0 15.58446 0 14.89438 0 0 0 15.14659 0 0 0 0 0 0 0 15.49397 14.62839 0 0 0 0 16.57287 0 0 16.55862 0 15.21543 0 16.19283 0 0 14.62424 0 0 0 14.60477 16.21892 15.8089 0 0 0 0 0 Q9UK96 FBX10_HUMAN F-box only protein 10 FBXO10 FBX10 PRMT11 Homo sapiens (Human) apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0042981 AKMEGNIFR 2.380000114 1 1 0.22699159 1079.589795 0 15.88712 14.67086 15.66832 14.21262 14.23475 15.0864 12.88117 15.49873 0 0 15.17422 0 0 19.38799 0 0 14.43326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.88154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK99 FBX3_HUMAN F-box only protein 3 FBXO3 FBX3 Homo sapiens (Human) proteolysis [GO:0006508] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis [GO:0006508] ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005654; GO:0005829; GO:0006508 IEMSKDALPEK 6.28000021 1 1 0.12224278 1276.940287 0 12.12297 0 14.69928 0 12.84098 0 0 12.68983 14.58952 0 14.98019 16.61901 0 0 0 12.05119 0 11.47175 12.69609 12.52374 15.53566 15.34567 12.78148 0 17.40544 18.38266 11.49598 0 0 0 14.81953 0 0 13.03067 14.27266 14.42126 0 15.18423 15.24913 17.48879 0 0 14.19965 17.23833 17.26544 0 0 Q9UKA1 FBXL5_HUMAN F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5) (F-box protein FBL4/FBL5) (p45SKP2-like protein) FBXL5 FBL4 FBL5 FLR1 Homo sapiens (Human) iron ion homeostasis [GO:0055072]; positive regulation of cellular protein catabolic process [GO:1903364]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; iron ion binding [GO:0005506]; ubiquitin-protein transferase activity [GO:0004842]; iron ion homeostasis [GO:0055072]; positive regulation of cellular protein catabolic process [GO:1903364]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] iron ion binding [GO:0005506]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0004842; GO:0005506; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072; GO:1903364 GLSLWNHAEER 4.130000114 1 1 0.289021882 1312.687396 0 15.38973 0 14.91576 13.9692 0 0 0 0 0 13.22566 12.57761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.75251 0 0 0 0 0 0 0 0 15.76174 0 0 Q9UKA4 AKA11_HUMAN "A-kinase anchor protein 11, AKAP-11 (A-kinase anchor protein 220 kDa, AKAP 220, hAKAP220) (Protein kinase A-anchoring protein 11, PRKA11)" AKAP11 AKAP220 KIAA0629 Homo sapiens (Human) cortical actin cytoskeleton organization [GO:0030866]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; renal water homeostasis [GO:0003091] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; cortical actin cytoskeleton organization [GO:0030866]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; renal water homeostasis [GO:0003091] protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157] GO:0003091; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0008104; GO:0008157; GO:0030866; GO:0034237; GO:0035556; GO:0036010; GO:0051018 EDSGLFSPIR 6.320000172 1 1 0.065723078 1121.72353 14.2293 11.12663 0 14.15182 15.27643 0 0 0 12.27528 0 0 13.09317 14.28125 0 0 0 0 0 0 0 0 15.00189 0 0 8.97318 12.7341 0 10.74524 15.06053 13.68527 0 0 0 0 0 0 0 15.77184 0 14.05267 13.56696 14.84193 0 0 0 0 0 0 Q9UKC9 FBXL2_HUMAN F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2) (F-box protein FBL2/FBL3) FBXL2 FBL2 FBL3 Homo sapiens (Human) cellular protein modification process [GO:0006464]; modulation by host of viral RNA genome replication [GO:0044830]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; cellular protein modification process [GO:0006464]; modulation by host of viral RNA genome replication [GO:0044830]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903] GO:0005516; GO:0005737; GO:0006464; GO:0006508; GO:0006513; GO:0010506; GO:0014066; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830 GCIGVGDSSLK 5.550000191 1 1 0.198105643 1093.858062 8.643178 0 14.17504 13.8999 0 11.44458 12.7527 14.75414 0 0 0 0 13.29625 0 15.28588 0 0 0 0 0 0 0 0 0 0 14.51508 0 15.33008 0 0 0 0 0 0 0 0 14.79374 0 0 0 0 0 0 0 0 0 0 0 Q9UKD2 MRT4_HUMAN mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4) MRTO4 C1orf33 MRT4 Homo sapiens (Human) nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]" RNA binding [GO:0003723] GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273 HSRMFFGK 7.730000019 1 1 0.505770076 1010.69827 0 0 0 19.29384 0 0 18.03397 0 0 0 0 0 0 0 0 0 18.06674 0 0 17.4096 0 0 0 0 18.14914 0 0 0 0 0 0 18.21606 0 19.33069 20.97243 0 18.45213 0 0 0 0 17.34097 0 19.6789 0 0 0 0 Q9UKE5 TNIK_HUMAN "TRAF2 and NCK-interacting protein kinase, EC 2.7.11.1" TNIK KIAA0551 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; Wnt signaling pathway [GO:0016055] "apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]" "apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; Wnt signaling pathway [GO:0016055]" ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0001934; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030033; GO:0031532; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048812; GO:0048814; GO:0055037; GO:0070062; GO:0072659; GO:0098793; GO:0098978; GO:0099092; GO:0106310 NHSQRPATEQLMK 3.890000105 1 1 1.38E-12 1540.634917 0 0 0 0 0 9.724477 0 0 0 0 0 0 17.71164 0 0 0 0 0 0 0 0 0 0 0 0 0 16.10019 0 0 0 0 0 0 16.18089 0 0 0 0 0 0 0 0 0 0 11.14879 16.55516 0 0 Q9UKF2 ADA30_HUMAN "Disintegrin and metalloproteinase domain-containing protein 30, ADAM 30, EC 3.4.24.-" ADAM30 UNQ2509/PRO5997 Homo sapiens (Human) external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] GO:0004222; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0031902; GO:1990913 ATISTCMGGLRGVFNIDAK 1.220000029 1 1 0.286501057 2010.820466 0 0 14.94705 15.68753 0 13.73673 15.83019 13.94615 12.85394 15.87465 10.47686 13.7998 0 12.23782 13.89994 0 14.84904 0 14.87731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.70156 0 13.52033 12.97295 0 0 0 0 0 0 0 Q9UKF5 ADA29_HUMAN "Disintegrin and metalloproteinase domain-containing protein 29, ADAM 29 (Cancer/testis antigen 73, CT73)" ADAM29 Homo sapiens (Human) male gonad development [GO:0008584]; spermatogenesis [GO:0007283] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; spermatogenesis [GO:0007283] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004222; GO:0005886; GO:0005887; GO:0007283; GO:0008237; GO:0008584; GO:0009897; GO:1990913 IQCENVTEIPNMSDHTTVHWAR 17.04999924 1 1 0.687568989 2655.0549 0 19.01543 17.89908 15.11964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.53213 0 0 0 0 0 0 0 0 0 0 Q9UKG4 S13A4_HUMAN Solute carrier family 13 member 4 (Na(+)/sulfate cotransporter SUT-1) (NaS2) SLC13A4 SUT1 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium:sulfate symporter activity [GO:0015382]; anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272] sodium:sulfate symporter activity [GO:0015382] GO:0005886; GO:0005887; GO:0008272; GO:0015382; GO:0016021; GO:0098656 LGDISYPEMVTGFFFILMTVLWFTR 3.710000038 1 1 1.38E-12 2999.832152 0 11.81043 14.95164 13.71478 0 11.83372 16.87991 12.35384 12.88889 11.59587 0 13.64647 0 0 0 13.04975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKG9 OCTC_HUMAN "Peroxisomal carnitine O-octanoyltransferase, COT, EC 2.3.1.137" CROT COT Homo sapiens (Human) carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791] carnitine O-octanoyltransferase activity [GO:0008458] GO:0005777; GO:0005782; GO:0005829; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015908; GO:0015936; GO:0033540; GO:0043231; GO:0051791 GFDRHLLGLLLIAK 5.010000229 0.484945446 0.484945446 4.58E-13 1566.916339 14.59521 0 13.693 0 0 15.16269 0 14.03444 14.98391 14.4202 11.87807 16.13124 0 0 0 15.66874 0 0 18.02761 0 0 0 0 16.47147 15.42417 15.69052 16.88516 0 0 0 0 0 0 0 0 0 17.2146 0 0 0 0 0 0 0 0 0 0 0 Q9UKI8 TLK1_HUMAN "Serine/threonine-protein kinase tousled-like 1, EC 2.7.11.1 (PKU-beta) (Tousled-like kinase 1)" TLK1 KIAA0137 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0001672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006468; GO:0006886; GO:0006974; GO:0007049; GO:0007059; GO:0018105; GO:0035556; GO:0106310 FDVHQLANDPYLLPHMR 3.269999981 1 1 0.141384894 2082.90258 13.69896 13.98341 12.67499 0 0 0 13.39632 0 12.3652 0 0 14.07631 0 0 0 0 13.35641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.63427 13.08893 13.70316 0 0 0 0 0 0 0 0 14.9098 Q9UKI9 PO2F3_HUMAN "POU domain, class 2, transcription factor 3 (Octamer-binding protein 11, Oct-11) (Octamer-binding transcription factor 11, OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1)" POU2F3 OTF11 PLA1 Homo sapiens (Human) epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008544; GO:0016604; GO:0043565; GO:0043922; GO:0045944; GO:1990837 WNHSTYLH 10.81999969 0.653751493 0.653751493 0.376067422 1057.080002 14.0912 12.64927 12.48893 0 0 14.8972 15.17298 0 16.60922 0 0 0 0 0 15.76508 0 0 0 15.18443 0 0 15.5558 0 0 0 0 0 15.19208 0 0 0 14.47221 0 13.83193 15.16993 0 0 14.47059 0 0 14.93227 0 12.88417 0 14.69586 0 0 0 Q9UKJ3 GPTC8_HUMAN G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0046872 DDGRGDDSK 12.88000011 1 1 0.372403383 965.0377678 0 0 15.59715 0 0 0 13.68457 14.41451 0 14.38503 0 14.55287 15.28403 14.85789 15.44747 16.3564 0 16.74018 0 0 0 0 0 0 0 16.54719 0 0 0 0 0 0 0 0 0 16.32795 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKK3 PARP4_HUMAN "Protein mono-ADP-ribosyltransferase PARP4, EC 2.4.2.- (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4, ARTD4) (PARP-related/IalphaI-related H5/proline-rich, PH5P) (Poly [ADP-ribose] polymerase 4, PARP-4) (Vault poly(ADP-ribose) polymerase, VPARP)" PARP4 ADPRTL1 KIAA0177 PARPL Homo sapiens (Human) cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404] GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006281; GO:0006464; GO:0006471; GO:0006954; GO:0006974; GO:0008219; GO:0009410; GO:0016020; GO:0019899; GO:0051972; GO:0070062; GO:0140289; GO:1990404; GO:1990904 KIPFSK 2.650000095 0.421497077 0.421497077 0.126000951 718.4725501 10.74152 0 16.6656 10.08419 0 12.28421 16.85325 17.38608 15.85667 0 15.9805 15.55349 15.9055 14.84105 0 17.67179 15.28726 0 15.97676 15.79471 14.11494 18.50397 15.07757 14.36991 16.44021 17.74354 0 16.91156 13.53208 0 0 0 17.51515 14.08729 18.33347 14.11872 0 0 16.27427 0 15.78783 0 17.64172 17.41779 0 0 0 14.90162 Q9UKL0 RCOR1_HUMAN REST corepressor 1 (Protein CoREST) RCOR1 KIAA0071 RCOR Homo sapiens (Human) "chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714] GO:0000118; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0006357; GO:0010629; GO:0016575; GO:0017053; GO:0019899; GO:0030218; GO:0045654; GO:0045892; GO:0070933; GO:1990391 LDGGIEPYR 19.31999969 1 1 0.432183315 1014.200589 13.88925 15.58681 14.14549 13.92526 14.65503 14.96489 15.50424 14.62765 15.03287 14.90332 13.12983 15.91557 0 12.74731 15.90242 0 0 15.68568 0 0 0 0 0 0 0 0 0 0 0 0 0 16.42419 15.35408 16.27925 0 0 0 0 16.49301 0 0 16.04041 0 15.66844 0 0 15.63664 0 Q9UKL2 O52A1_HUMAN Olfactory receptor 52A1 (HPFH1OR) (Odorant receptor HOR3'beta4) (Olfactory receptor OR11-319) OR52A1 Homo sapiens (Human) sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; transmembrane signaling receptor activity [GO:0004888]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0004930; GO:0004984; GO:0005887; GO:0007165; GO:0007608 SLHEPLYIFLGMLGATDIALASSIMPK 3.569999933 0.950863063 0.950863063 4.12E-12 2903.577492 0 15.48519 14.57465 0 11.62606 0 0 13.46894 15.11174 0 13.92532 0 0 0 10.92708 11.50838 0 0 18.89414 0 0 0 16.11883 0 0 0 0 0 0 0 0 0 0 12.63367 9.233723 0 15.71186 0 0 0 14.87573 0 0 0 0 0 0 0 Q9UKL3 C8AP2_HUMAN CASP8-associated protein 2 (FLICE-associated huge protein) CASP8AP2 FLASH KIAA1315 RIP25 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cell cycle [GO:0007049]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor binding [GO:0005123]; peptidase activator activity involved in apoptotic process [GO:0016505]; SUMO polymer binding [GO:0032184]; transcription corepressor activity [GO:0003714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cell cycle [GO:0007049]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; signal transduction [GO:0007165] cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor binding [GO:0005123]; peptidase activator activity involved in apoptotic process [GO:0016505]; SUMO polymer binding [GO:0032184]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006919; GO:0007049; GO:0007165; GO:0008625; GO:0008656; GO:0016505; GO:0016605; GO:0032184; GO:0036337; GO:0071260; GO:0097190 KNGIVDR 6.96999979 0.052647244 0.052647244 0.215311392 802.5007891 0 0 15.78245 0 0 15.75461 0 15.5877 0 0 16.98692 14.71513 15.72396 0 16.06498 0 15.01503 16.39256 0 16.92294 16.51464 15.19096 14.70486 11.67267 16.66872 17.65709 17.68086 0 0 16.46663 0 0 17.57569 0 16.48226 0 17.66978 0 0 0 16.49925 16.52337 16.30338 15.37552 0 0 0 15.90216 Q9UKM7 MA1B1_HUMAN "Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase, EC 3.2.1.113 (ER alpha-1,2-mannosidase) (ER mannosidase 1, ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)" MAN1B1 UNQ747/PRO1477 Homo sapiens (Human) "endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082]" cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082]" "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0019082; GO:0030433; GO:0031410; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382 EFEEAR 7.440000057 1 1 0.18326565 779.758726 18.02403 0 17.84603 0 17.63232 16.44683 0 15.90435 0 16.56172 16.58888 16.28694 0 16.72077 16.76921 0 15.8588 0 0 16.16451 0 0 16.92451 17.61524 0 0 0 16.89549 15.26408 0 0 0 17.07417 17.2173 0 0 17.38288 18.62484 16.59157 14.8233 16.45399 0 16.26297 17.16226 0 0 0 16.66433 Q9UKN1 MUC12_HUMAN "Mucin-12, MUC-12 (Mucin-11, MUC-11)" MUC12 MUC11 Homo sapiens (Human) regulation of cell growth [GO:0001558] Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005796; GO:0005886; GO:0005887 LACVNKCTK 2.49000001 0.750507891 0.750507891 0.216247352 1092.975143 0 14.93484 16.20674 18.00392 13.30098 0 0 11.87411 0 0 0 0 0 0 0 13.39872 14.0918 0 0 0 0 15.14871 0 15.49518 0 0 0 0 0 0 0 14.43893 16.1293 0 0 15.41676 0 0 0 15.56108 0 15.48171 15.74956 12.77581 15.0814 13.34793 12.21651 13.89991 Q9UKN7 MYO15_HUMAN Unconventional myosin-XV (Unconventional myosin-15) MYO15A MYO15 Homo sapiens (Human) actin filament organization [GO:0007015]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 AMLAGRSSK 2.039999962 1 1 0.128587864 936.0972771 16.16564 0 12.96403 13.60923 0 14.52224 16.18849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.77826 0 0 13.9123 0 0 0 0 0 0 0 0 0 0 0 13.81642 0 0 0 0 0 0 0 0 Q9UKN8 TF3C4_HUMAN "General transcription factor 3C polypeptide 4, EC 2.3.1.48 (TF3C-delta) (Transcription factor IIIC 90 kDa subunit, TFIIIC 90 kDa subunit, TFIIIC90) (Transcription factor IIIC subunit delta)" GTF3C4 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; RNA polymerase III general transcription initiation factor activity [GO:0000995] GO:0000127; GO:0000995; GO:0003677; GO:0004402; GO:0005654; GO:0005739; GO:0006383; GO:0006384; GO:0008047; GO:0042791; GO:0042797 MSGLIVGSAFGPIK 6.619999886 1 1 0.333672516 1394.298825 16.30989 0 0 15.63601 14.28059 14.29561 0 0 14.65754 14.71236 14.69659 15.12306 0 16.31775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68784 0 14.93641 0 16.88898 0 0 0 15.70267 0 0 0 0 0 0 0 Q9UKP4 ATS7_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 7, ADAM-TS 7, ADAM-TS7, ADAMTS-7, EC 3.4.24.- (COMPase)" ADAMTS7 Homo sapiens (Human) cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in cellular protein catabolic process [GO:0051603] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in cellular protein catabolic process [GO:0051603] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773 EIRIQEVAEAANFLALR 4.050000191 1 1 0.48806044 1942.319004 0 0 0 0 0 0 0 17.50187 0 17.88247 0 0 15.94154 0 0 0 0 17.57845 0 0 0 0 0 0 0 0 16.90313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.90754 0 0 0 0 0 0 Q9UKP5 ATS6_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 6, ADAM-TS 6, ADAM-TS6, ADAMTS-6, EC 3.4.24.-" ADAMTS6 Homo sapiens (Human) aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 NKPCGTLGLASVAGMCEPER 6.090000153 1 1 0.136733696 2147.41822 9.095655 10.6897 0 0 0 0 0 0 12.88789 0 0 14.02411 0 0 0 0 0 12.58277 15.03854 0 0 0 0 0 0 17.72665 0 15.78583 12.75618 12.50337 12.53535 0 0 14.87701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKQ2 ADA28_HUMAN "Disintegrin and metalloproteinase domain-containing protein 28, ADAM 28, EC 3.4.24.- (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II, eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L, MDC-L)" ADAM28 ADAM23 MDCL Homo sapiens (Human) spermatogenesis [GO:0007283] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; spermatogenesis [GO:0007283] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004175; GO:0004222; GO:0005576; GO:0005739; GO:0005886; GO:0007283; GO:0008237; GO:0016021; GO:0046872 EPEQQEQFETELKYK 1.929999948 0.300735295 0.300735295 0.108471694 1922.533152 0 16.70222 0 0 0 0 15.19305 13.02215 0 0 0 17.31041 0 14.51268 13.98379 0 0 16.68907 0 0 16.17063 0 0 13.18561 0 0 0 15.12982 15.37952 9.165317 16.20379 16.60653 0 15.45463 17.16637 0 0 17.07099 15.99139 0 15.35633 13.33206 0 14.68556 0 17.79627 0 16.85637 Q9UKR3 KLK13_HUMAN "Kallikrein-13, EC 3.4.21.- (Kallikrein-like protein 4, KLK-L4)" KLK13 KLKL4 Homo sapiens (Human) protein processing [GO:0016485]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hydrolase activity [GO:0016787]; serine-type endopeptidase activity [GO:0004252]; protein processing [GO:0016485]; proteolysis [GO:0006508] hydrolase activity [GO:0016787]; serine-type endopeptidase activity [GO:0004252] GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0006508; GO:0016485; GO:0016787; GO:0030141 MWPLALVIASLTLALSGGVSQESSK 17.02000046 1 1 1.38E-12 2558.368204 14.88152 11.93754 10.03126 13.44717 13.50778 0 15.87314 0 10.90031 13.41704 0 0 0 10.21048 0 14.81719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKS6 PACN3_HUMAN Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511) PACSIN3 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100] calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543] GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0008092; GO:0008289; GO:0019855; GO:0030100; GO:0042802; GO:0045806; GO:0051044; GO:0051926; GO:0070062; GO:0097320 GAFHRPVLGGFRESR 2.700000048 1 1 7.03E-13 1683.853009 0 0 13.57196 0 14.64066 0 0 0 0 0 0 0 0 0 0 0 0 0 17.44695 0 0 17.62121 0 0 0 0 0 0 0 0 0 0 14.90091 14.03102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKT4 FBX5_HUMAN F-box only protein 5 (Early mitotic inhibitor 1) FBXO5 EMI1 FBX5 Homo sapiens (Human) cell division [GO:0051301]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of response to DNA damage stimulus [GO:2001021]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; anaphase-promoting complex binding [GO:0010997]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948]; cell division [GO:0051301]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of response to DNA damage stimulus [GO:2001021]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050] anaphase-promoting complex binding [GO:0010997]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948] GO:0001556; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006275; GO:0007057; GO:0007088; GO:0007346; GO:0008284; GO:0010971; GO:0010997; GO:0016050; GO:0016567; GO:0019901; GO:0032876; GO:0045669; GO:0045835; GO:0045841; GO:0046785; GO:0046872; GO:0051301; GO:0051444; GO:0070169; GO:0072687; GO:1904667; GO:1905322; GO:1990948; GO:2000773; GO:2001021 GAFQLYSKAIQR 2.349999905 1 1 0.490105723 1381.520921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.22641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKT5 FBX4_HUMAN F-box only protein 4 FBXO4 FBX4 Homo sapiens (Human) aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511] protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0000151; GO:0000209; GO:0000723; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007568; GO:0010608; GO:0016567; GO:0019005; GO:0019725; GO:0031146; GO:0031398; GO:0031647; GO:0031648; GO:0032212; GO:0035726; GO:0042803; GO:0048147; GO:0061630; GO:0071479; GO:1900181; GO:1902916; GO:2000001 MAGSEPR 10.89000034 0.109048657 0.109048657 0.232980873 745.0322332 0 15.0323 0 0 14.37282 0 13.90952 17.58898 15.76066 0 16.28426 16.94789 16.63337 0 0 14.37906 14.93381 14.12404 14.39623 16.40178 16.11432 0 0 0 0 15.37993 0 0 15.12056 15.32177 17.85377 15.79951 0 14.95951 12.98186 0 0 0 0 0 17.77933 14.55079 16.89729 0 15.31025 0 0 15.97109 Q9UKU9 ANGL2_HUMAN Angiopoietin-related protein 2 (Angiopoietin-like protein 2) ANGPTL2 ARP2 UNQ170/PRO196 Homo sapiens (Human) multicellular organism development [GO:0007275] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275] signaling receptor binding [GO:0005102] GO:0005102; GO:0005615; GO:0007275; GO:0062023; GO:0070062 SRYQDGVYWAEFR 1.940000057 0.056773111 0.056773111 0.04316247 1675.940687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKV3 ACINU_HUMAN "Apoptotic chromatin condensation inducer in the nucleus, Acinus" ACIN1 ACINUS KIAA0670 Homo sapiens (Human) "apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]" ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]" ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723] GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0019899; GO:0030218; GO:0030263; GO:0043065; GO:0045657; GO:0048025; GO:0061574 LQPERGSPK 3.279999971 1 1 0.007047341 1012.069274 16.31249 16.30051 14.96397 0 0 0 9.914357 0 13.87129 0 12.83496 0 11.9866 0 13.4542 13.34525 14.56094 13.57968 15.24419 0 0 12.95249 13.9937 12.07785 14.20106 13.48682 14.18548 0 15.52459 0 15.41113 0 13.51027 16.7694 0 13.67126 13.48243 14.83842 17.01795 15.36726 12.8506 15.52312 0 14.88492 0 0 0 13.48045 Q9UKV8 AGO2_HUMAN "Protein argonaute-2, Argonaute2, hAgo2, EC 3.1.26.n2 (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2, eIF-2C 2, eIF2C 2) (PAZ Piwi domain protein, PPD) (Protein slicer)" AGO2 EIF2C2 Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; mRNA destabilization-mediated gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; mRNA destabilization-mediated gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]" "core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]" GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0016020; GO:0016246; GO:0016442; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0036464; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904 EIVEHMVQHFK 2.230000019 1 1 0.478322602 1413.15015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKW4 VAV3_HUMAN "Guanine nucleotide exchange factor VAV3, VAV-3" VAV3 Homo sapiens (Human) angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cellular response to DNA damage stimulus [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; immunological synapse [GO:0001772] cytosol [GO:0005829]; immunological synapse [GO:0001772]; epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cellular response to DNA damage stimulus [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906] epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872] GO:0001525; GO:0001772; GO:0005085; GO:0005096; GO:0005154; GO:0005829; GO:0006906; GO:0006974; GO:0007229; GO:0007264; GO:0008361; GO:0009410; GO:0030032; GO:0030168; GO:0030593; GO:0030890; GO:0038095; GO:0038096; GO:0043087; GO:0043552; GO:0045785; GO:0046872; GO:0050853; GO:0051056 QVDPGLPK 8.710000038 1 1 0.271921947 852.9619273 0 0 0 16.4526 0 0 0 0 17.51083 0 11.81909 0 0 0 17.73709 0 0 0 0 0 0 0 0 17.31616 18.28449 17.36655 17.27311 0 0 0 0 0 0 0 18.33582 17.83706 18.73964 17.38239 21.18607 0 0 0 0 0 0 0 16.07163 0 Q9UKW6 ELF5_HUMAN "ETS-related transcription factor Elf-5 (E74-like factor 5) (Epithelium-restricted ESE-1-related Ets factor) (Epithelium-specific Ets transcription factor 2, ESE-2)" ELF5 ESE2 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:1990837 ALRYYYK 10.71000004 1 1 0.139482929 977.6852161 0 0 14.16153 0 0 14.12915 11.99282 0 14.962 0 0 13.68064 15.07781 0 14.95439 0 0 14.35694 0 0 0 14.0956 13.70434 0 0 14.44828 0 0 15.88282 0 14.75449 0 0 0 0 0 15.66084 0 0 13.66518 0 15.7016 0 0 0 0 16.04677 0 Q9UKX3 MYH13_HUMAN "Myosin-13 (Myosin heavy chain 13) (Myosin heavy chain, skeletal muscle, extraocular, MyHC-EO) (Myosin heavy chain, skeletal muscle, laryngeal, MyHC-IIL) (Superfast myosin)" MYH13 Homo sapiens (Human) cellular response to starvation [GO:0009267]; muscle contraction [GO:0006936] extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982] extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular response to starvation [GO:0009267]; muscle contraction [GO:0006936] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0009267; GO:0030016; GO:0032982; GO:0051015; GO:0070062 SELKMEIDDMASNIEALSK 12.38000011 1 1 0.139374972 2156.33963 12.97423 0 0 0 0 0 0 15.07695 0 0 0 0 15.41879 0 0 9.974621 14.63327 13.52419 15.14081 0 0 15.28454 0 15.07952 15.86465 0 14.64432 14.15543 15.69098 0 16.00294 0 0 16.61845 0 0 13.5354 0 0 0 14.78457 12.91354 0 0 0 0 0 0 Q9UKY0 PRND_HUMAN Prion-like protein doppel (PrPLP) (Prion protein 2) PRND DPL UNQ1830/PRO3443 Homo sapiens (Human) acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260] copper ion binding [GO:0005507] GO:0005507; GO:0005576; GO:0005886; GO:0006878; GO:0007340; GO:0031362; GO:0051260 KLDIDFGAEGNR 5.710000038 1 1 0.073788204 1334.366168 0 0 0 0 15.25883 0 0 0 15.2608 0 14.95979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.84057 0 0 0 16.15722 14.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKZ1 CNO11_HUMAN CCR4-NOT transcription complex subunit 11 CNOT11 C2orf29 C40 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] GO:0000289; GO:0005634; GO:0005829; GO:0006402; GO:0017148; GO:0030014; GO:0031047 FFLSQLMLAPPR 4.110000134 0.356406838 0.356406838 0.102207663 1435.431642 0 13.2291 15.52903 0 0 11.86627 0 0 13.58266 13.76882 0 11.49736 0 14.60138 0 15.99195 13.94643 16.29243 0 15.75063 13.05304 15.31001 7.106359 15.79074 0 16.68624 0 14.9154 12.13084 15.30187 0 15.84079 13.63299 0 15.62285 0 17.24621 0 16.39753 14.50506 16.17955 17.48713 0 10.26449 15.17769 14.21962 12.90194 0 Q9UKZ4 TEN1_HUMAN "Teneurin-1, Ten-1 (Protein Odd Oz/ten-m homolog 1) (Tenascin-M1, Ten-m1) (Teneurin transmembrane protein 1) [Cleaved into: Ten-1 intracellular domain, IDten-1, Ten-1 ICD; Teneurin C-terminal-associated peptide, TCPA-1 (Ten-1 extracellular domain, Ten-1 ECD) ]" TENM1 ODZ1 TNM1 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359] cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0006359; GO:0006955; GO:0007157; GO:0007218; GO:0007399; GO:0008201; GO:0008285; GO:0016363; GO:0016607; GO:0030838; GO:0033138; GO:0042803; GO:0043005; GO:0043406; GO:0046982; GO:0048471; GO:0048666; GO:0050839; GO:0051491; GO:0090316 HGYQLEMGSDVDTETEGAASPDHALR 7.539999962 1 1 2.75E-12 2785.675175 0 0 0 0 12.74846 0 0 0 11.13788 11.64975 15.01401 0 12.36956 0 0 0 13.69823 16.69257 0 14.68292 0 0 0 0 0 0 0 0 0 0 13.57999 13.8832 0 0 0 0 0 15.57542 13.82383 0 0 0 0 0 13.27944 0 14.12547 0 Q9UKZ9 PCOC2_HUMAN "Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2, PCPE-2, Procollagen C-proteinase enhancer 2)" PCOLCE2 PCPE2 UNQ250/PRO287 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830] extracellular region [GO:0005576] extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830] collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504] GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830 ITVPEGK 2.880000114 1 1 0.091616438 743.7107943 0 0 0 0 0 0 0 0 0 16.37306 0 0 0 14.74896 0 0 0 0 0 15.44209 0 0 0 0 0 0 0 0 16.40964 0 0 0 14.76595 0 0 0 16.12138 0 0 13.87792 15.49384 15.57508 0 14.99012 15.47222 0 0 0 Q9UL12 SARDH_HUMAN "Sarcosine dehydrogenase, mitochondrial, SarDH, EC 1.5.8.3 (BPR-2)" SARDH DMGDHL1 Homo sapiens (Human) sarcosine catabolic process [GO:1901053] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053] oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480] GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:1901053 NGQVVGHVR 6.210000038 1 1 0.258162614 964.448926 0 0 0 16.41517 0 16.46025 17.60332 0 18.37118 0 17.46407 0 0 0 16.70905 16.34103 0 0 0 15.88259 15.99925 0 16.13585 0 0 0 18.13865 0 0 17.45134 0 0 0 17.9791 0 0 17.0559 0 0 0 0 0 16.29382 17.27546 0 15.70856 0 17.45053 Q9UL15 BAG5_HUMAN "BAG family molecular chaperone regulator 5, BAG-5 (Bcl-2-associated athanogene 5)" BAG5 KIAA0873 Homo sapiens (Human) Golgi organization [GO:0007030]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein refolding [GO:0061084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neuron death [GO:0070997]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of inclusion body assembly [GO:0090083]; regulation of ubiquitin-protein transferase activity [GO:0051438] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein refolding [GO:0061084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neuron death [GO:0070997]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of inclusion body assembly [GO:0090083]; regulation of ubiquitin-protein transferase activity [GO:0051438] adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] GO:0000774; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0007030; GO:0010977; GO:0016020; GO:0016234; GO:0019901; GO:0031397; GO:0031625; GO:0032435; GO:0048471; GO:0050821; GO:0051087; GO:0051438; GO:0051444; GO:0061084; GO:0070997; GO:0090083; GO:1902176 TEIRNYR 11.42000008 1 1 0.215679805 952.499804 12.78805 15.49785 0 15.45061 0 15.15085 17.99137 0 0 15.34365 16.3736 0 0 0 0 0 0 0 13.55026 13.95898 0 0 0 15.61496 0 0 0 0 0 16.21665 15.36173 16.3569 0 0 0 0 0 0 0 0 16.61387 0 0 0 0 16.00713 0 17.12272 Q9UL16 CFA45_HUMAN Cilia- and flagella-associated protein 45 (Coiled-coil domain-containing protein 19) (Nasopharyngeal epithelium-specific protein 1) CFAP45 CCDC19 NESG1 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AMP binding [GO:0016208]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] AMP binding [GO:0016208] GO:0005576; GO:0005634; GO:0005654; GO:0005930; GO:0016208; GO:0030317; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0097729 EATMDAVMTR 4.78000021 1 1 0.095189607 1139.993144 15.03216 12.7237 15.01679 14.54391 13.17153 15.21207 0 0 15.94703 16.0081 13.41852 0 16.58278 0 0 13.50714 15.7447 15.18647 15.10121 16.12577 13.62296 0 13.86685 0 0 15.49942 0 0 0 0 0 0 15.25633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL17 TBX21_HUMAN "T-box transcription factor TBX21, T-box protein 21 (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM)" TBX21 TBET TBLYM Homo sapiens (Human) "cell fate specification [GO:0001708]; cellular response to organic substance [GO:0071310]; lymphocyte migration [GO:0072676]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of T cell differentiation [GO:0045580]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]; T-helper 1 cell lineage commitment [GO:0002296]" neuronal cell body [GO:0043025]; nucleus [GO:0005634] "neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell fate specification [GO:0001708]; cellular response to organic substance [GO:0071310]; lymphocyte migration [GO:0072676]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of T cell differentiation [GO:0045580]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]; T-helper 1 cell lineage commitment [GO:0002296]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001708; GO:0002296; GO:0005634; GO:0006357; GO:0009615; GO:0032703; GO:0043025; GO:0043161; GO:0043565; GO:0045580; GO:0045892; GO:0045893; GO:0045944; GO:0048304; GO:0071310; GO:0072676; GO:1990837; GO:2000320; GO:2000329; GO:2000552; GO:2000556 AGLYPGPR 3.269999981 1 1 6.88E-13 831.7198483 0 0 0 0 15.17347 0 0 0 16.48082 0 0 0 0 14.81582 0 0 0 0 0 12.4768 0 15.57133 0 0 0 0 0 0 0 15.45125 0 0 16.07857 15.67459 0 0 0 0 12.96153 0 13.16363 0 0 0 0 0 0 0 Q9UL18 AGO1_HUMAN "Protein argonaute-1, Argonaute1, hAgo1 (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1, eIF-2C 1, eIF2C 1) (Putative RNA-binding protein Q99)" AGO1 EIF2C1 Homo sapiens (Human) miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of angiogenesis [GO:0016525]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of angiogenesis [GO:0016525]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501] core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727] GO:0000932; GO:0000956; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0010501; GO:0016246; GO:0016442; GO:0016525; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0036464; GO:0045944; GO:0070578; GO:1990904 NIDEQPKPLTDSQR 8.710000038 1 1 0.32421771 1642.557963 17.97672 0 0 17.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL25 RAB21_HUMAN Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157] axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506] axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005789; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0008089; GO:0009898; GO:0012505; GO:0012506; GO:0017157; GO:0019003; GO:0030516; GO:0031901; GO:0032154; GO:0032482; GO:0032580; GO:0045202; GO:0048260; GO:0050775; GO:0050821; GO:0070062; GO:0098559; GO:1904115; GO:2000643 RGVQIIDDEPQAQTSGGGCCSSG 3.660000086 0.185496807 0.185496807 0.278187545 2378.387952 14.74213 12.67223 11.9809 0 14.69479 0 13.50354 0 0 11.04643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.39695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL26 RB22A_HUMAN "Ras-related protein Rab-22A, Rab-22" RAB22A RAB22 Homo sapiens (Human) endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0012505; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0070062; GO:0097494 ALAPMYYR 10.22000027 1 1 0.230413247 1000.325971 15.46398 12.37964 0 13.8616 15.9081 16.84504 16.01273 14.28954 0 16.48204 0 13.64647 11.62544 15.07336 14.25124 0 12.92251 14.51659 10.55626 16.76886 0 16.47311 15.82802 16.06013 0 16.19197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.87965 15.43477 13.52622 0 15.89682 15.19675 Q9UL36 ZN236_HUMAN Zinc finger protein 236 ZNF236 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0071333 AHIMLHEK 18.30999947 0.51157397 0.51157397 0.095101268 982.3660587 15.98752 0 0 0 0 0 15.11626 0 12.96333 0 18.34697 0 15.91533 0 15.64984 14.03134 0 0 0 0 0 0 0 0 0 15.93656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.57627 0 0 0 Q9UL41 PNMA3_HUMAN Paraneoplastic antigen Ma3 PNMA3 MA3 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] nucleolus [GO:0005730] nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; positive regulation of apoptotic process [GO:0043065] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0005730; GO:0008270; GO:0043065 RTVSDMNR 1.200000048 1 1 5.75E-13 994.5284219 0 0 0 0 13.2376 0 0 0 12.30665 0 0 17.91133 0 0 13.50276 0 0 0 0 14.39903 0 0 0 0 15.14645 15.9648 0 0 0 0 0 0 0 0 0 0 0 17.35662 0 15.79121 0 0 0 0 0 0 0 0 Q9UL51 HCN2_HUMAN "Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2, BCNG-2)" HCN2 BCNG2 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0007267; GO:0008076; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:1990573; GO:2001257 APRTSPYGGLPAAPLAGPALPAR 5.289999962 1 1 4.61E-13 2203.379982 0 0 0 0 15.29463 12.38059 14.51957 0 0 0 0 13.83037 12.32827 0 9.446576 0 0 0 12.9143 0 0 0 0 0 0 0 0 0 12.98214 0 0 10.35172 0 0 0 0 0 0 0 14.3189 14.16209 0 0 0 0 0 0 0 Q9UL52 TM11E_HUMAN "Transmembrane protease serine 11E, EC 3.4.21.- (Serine protease DESC1) (Transmembrane protease serine 11E2) [Cleaved into: Transmembrane protease serine 11E non-catalytic chain; Transmembrane protease serine 11E catalytic chain ]" TMPRSS11E DESC1 TMPRSS11E2 UNQ742/PRO1461 Homo sapiens (Human) cognition [GO:0050890]; proteolysis [GO:0006508] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cognition [GO:0050890]; proteolysis [GO:0006508] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0050890 VDPHSVK 9.729999542 1 1 0.265374381 781.8438987 12.72399 13.82933 0 15.54492 14.24539 15.63466 14.99071 14.40833 16.81142 16.22436 13.72174 0 12.99187 16.18845 17.19869 0 0 15.34333 0 0 0 0 0 15.79624 0 0 0 14.71245 0 15.06968 0 15.2556 16.13505 0 0 0 0 0 0 16.85934 0 16.34448 0 0 0 16.58368 0 0 Q9UL54 TAOK2_HUMAN "Serine/threonine-protein kinase TAO2, EC 2.7.11.1 (Kinase from chicken homolog C, hKFC-C) (Prostate-derived sterile 20-like kinase 1, PSK-1, PSK1, Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2)" TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; basal dendrite arborization [GO:0150020]; basal dendrite morphogenesis [GO:0150019]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; regulation of MAPK cascade [GO:0043408]; stress-activated MAPK cascade [GO:0051403] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; neuropilin binding [GO:0038191]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; basal dendrite arborization [GO:0150020]; basal dendrite morphogenesis [GO:0150019]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; regulation of MAPK cascade [GO:0043408]; stress-activated MAPK cascade [GO:0051403] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; neuropilin binding [GO:0038191]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] GO:0000165; GO:0001558; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0006612; GO:0006915; GO:0006974; GO:0007095; GO:0007409; GO:0008360; GO:0015629; GO:0016021; GO:0016477; GO:0030036; GO:0030424; GO:0030659; GO:0031410; GO:0031434; GO:0031954; GO:0032147; GO:0032874; GO:0032956; GO:0035556; GO:0038191; GO:0043005; GO:0043235; GO:0043408; GO:0043410; GO:0043539; GO:0044294; GO:0044295; GO:0046330; GO:0046777; GO:0048041; GO:0048156; GO:0048812; GO:0050321; GO:0051403; GO:0106310; GO:0150019; GO:0150020 ALQGCGAVGDR 1.929999948 0.993469417 0.993469417 0.305540554 1102.951285 16.56859 17.99652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2552 0 0 0 0 0 0 17.06755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL62 TRPC5_HUMAN "Short transient receptor potential channel 5, TrpC5 (Transient receptor protein 5, TRP-5, hTRP-5, hTRP5)" TRPC5 TRP5 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630] calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] "calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]" "actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" GO:0003779; GO:0005262; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007204; GO:0007399; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045121; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:1902630 RPSGEK 6.139999866 0.351259351 0.351259351 0.169622771 674.3204543 0 18.25373 0 0 0 0 0 0 0 18.43267 18.81771 15.72219 0 0 0 18.9135 16.21086 16.51235 0 0 14.05325 17.53454 0 0 17.66441 18.41225 0 0 14.29092 16.13535 16.05303 16.47942 0 17.18909 0 15.56736 17.83713 18.46383 0 17.14921 17.86983 0 17.59291 13.80182 0 15.59019 16.70006 14.56465 Q9UL63 MKLN1_HUMAN Muskelin MKLN1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; signal transduction [GO:0007165] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005737; GO:0005829; GO:0005938; GO:0007160; GO:0007165; GO:0008360; GO:0031532; GO:0042802; GO:0042803; GO:0098794 DSGMVPMTGFTQR 2.089999914 1 1 0.466229982 1460.081214 0 0 16.07223 16.09563 14.73044 16.2774 0 0 0 0 0 0 0 0 0 0 0 0 0 15.54915 0 16.50506 0 0 0 0 0 0 0 15.96042 0 16.30383 0 0 0 0 0 0 17.5994 0 16.71222 0 0 0 0 0 0 0 Q9ULB1 NRX1A_HUMAN Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha) NRXN1 KIAA0578 Homo sapiens (Human) "adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982] "cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023] GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463 DCSQEDNNVEGLAHLMMGDQGKSK 6.849999905 0.463015258 0.463015258 0.174702456 2678.187711 13.0683 14.50428 14.04892 14.96008 0 0 15.96146 13.20844 14.47611 15.30001 15.14274 0 13.30154 15.35004 0 11.83052 0 0 13.06166 0 0 0 0 0 0 10.51671 0 0 0 0 0 0 0 14.70665 14.47498 0 16.11308 0 0 0 18.35183 14.09567 0 0 0 0 14.13153 0 Q9ULC3 RAB23_HUMAN Ras-related protein Rab-23 RAB23 HSPC137 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308] autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094 NEEAEALAK 10.90999985 1 1 0.313749557 976.0554034 16.58551 17.20665 0 0 17.38153 0 0 0 0 0 16.50784 0 17.84183 17.45932 15.83138 0 0 0 0 0 16.26685 0 0 0 0 0 17.0528 19.42169 0 0 0 16.97673 0 0 0 0 17.05934 0 17.95468 17.796 0 0 0 0 0 16.63363 0 0 Q9ULC5 ACSL5_HUMAN "Long-chain-fatty-acid--CoA ligase 5, EC 6.2.1.3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5, LACS 5)" ACSL5 ACS5 FACL5 UNQ633/PRO1250 Homo sapiens (Human) lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467] GO:0001676; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0010747; GO:0016020; GO:0016021; GO:0035338; GO:0047676; GO:2001236 LAVSSK 13.47999954 0.979076803 0.979076803 0.260105394 603.8234241 16.23196 13.17335 0 15.68329 16.95616 17.77324 17.30854 17.92989 0 0 0 15.26011 17.4364 17.83859 0 16.8215 0 0 0 17.29968 16.33365 16.04569 15.85956 0 18.91427 16.15154 18.43773 16.34241 17.1534 0 0 18.94058 0 16.68714 16.30046 15.78176 16.42495 14.72862 15.29003 18.6881 16.94594 19.32362 16.97869 15.88581 14.30472 0 15.67814 16.31351 Q9ULD2 MTUS1_HUMAN Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1) MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 Homo sapiens (Human) regulation of macrophage chemotaxis [GO:0010758] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; microtubule binding [GO:0008017]; regulation of macrophage chemotaxis [GO:0010758] microtubule binding [GO:0008017] GO:0005615; GO:0005634; GO:0005730; GO:0005739; GO:0005794; GO:0005815; GO:0005819; GO:0005874; GO:0005886; GO:0008017; GO:0010758; GO:0015630 GKDLGTQNHTSELILSSPPGQK 1.75999999 1 1 0.192818523 2307.266444 16.05795 0 8.964159 0 0 13.60439 0 14.23037 0 0 0 13.62704 0 14.78827 0 0 0 0 0 0 0 0 0 0 14.18945 12.3463 0 0 0 10.47937 0 10.95296 15.27484 15.06084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULD4 BRPF3_HUMAN Bromodomain and PHD finger-containing protein 3 BRPF3 KIAA1286 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776] cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872] GO:0000123; GO:0005576; GO:0005829; GO:0006325; GO:0006357; GO:0043966; GO:0044154; GO:0045740; GO:0046872; GO:0050793; GO:0070776; GO:1903706 SRGKPALSR 2.369999886 0.476395905 0.476395905 0.102002946 971.8592546 17.30563 16.01906 15.20299 0 0 0 16.38251 20.01913 13.85302 17.53209 12.22841 0 12.79707 14.84614 10.60958 0 17.06859 16.85657 16.54701 0 15.78293 16.8693 18.96759 17.80312 7.04091 15.32882 15.84188 13.82252 17.18513 17.65554 13.1825 18.32911 17.30181 0 15.54864 0 13.91742 0 16.74382 17.75964 15.1231 15.8862 14.39506 13.8049 0 0 16.27998 14.725 Q9ULD6 INTU_HUMAN Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6) INTU KIAA1284 PDZD6 PDZK6 Homo sapiens (Human) cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; intraciliary transport [GO:0042073]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; intraciliary transport [GO:0042073]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192] GO:0001736; GO:0005737; GO:0005929; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0016192; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0036064; GO:0042073; GO:0042733; GO:0043587; GO:0044458; GO:0045880; GO:0051782; GO:0060021; GO:0060173; GO:0060271; GO:1902017; GO:1905515 APPVMAYWVVGR 12.47000027 0.499385208 0.499385208 0.46998609 1362.950299 0 20.07532 0 0 0 18.46515 0 0 19.35123 0 0 0 18.40263 0 0 0 0 0 18.01302 0 0 0 0 0 0 19.10335 0 19.71635 18.7836 19.30291 0 0 0 19.35296 21.50333 0 0 19.59108 0 18.78293 17.13795 18.74614 18.66002 0 0 0 0 0 Q9ULD8 KCNH3_HUMAN "Potassium voltage-gated channel subfamily H member 3 (Brain-specific eag-like channel 1, BEC1) (Ether-a-go-go-like potassium channel 2, ELK channel 2, ELK2) (Voltage-gated potassium channel subunit Kv12.2)" KCNH3 KIAA1282 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] voltage-gated potassium channel activity [GO:0005249] GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0016021; GO:0034765; GO:0042391; GO:0071805 GEVALFLVSHK 5.460000038 1 1 0.275760916 1200.020101 0 0 13.97544 11.96832 0 15.47359 0 15.25397 13.7965 0 0 0 0 0 0 15.05559 0 0 15.26562 0 0 16.58631 14.52104 14.3099 0 0 15.08839 0 0 0 16.46219 16.89554 0 0 16.91426 0 0 0 13.00031 14.7709 16.91034 0 0 0 0 0 0 15.94132 Q9ULD9 ZN608_HUMAN Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36) ZNF608 KIAA1281 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] metal ion binding [GO:0046872] GO:0000122; GO:0005634; GO:0006357; GO:0046872 SAPDSGLMGNSMLVK 5.539999962 1 1 0.443963781 1505.592527 0 0 0 0 15.786 0 0 0 0 0 0 0 0 0 0 0 0 16.59185 0 18.03529 0 0 0 17.86363 0 0 0 16.33963 16.77504 15.7717 0 0 16.71491 0 0 16.26833 15.59406 16.75561 17.13511 16.76373 0 0 17.4987 16.72007 0 0 0 0 Q9ULE0 WWC3_HUMAN Protein WWC3 WWC3 KIAA1280 Homo sapiens (Human) "cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]" kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090] GO:0000122; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0035330; GO:0035331; GO:0046621; GO:0060090 DRLQLIK 3.029999971 1 1 0.097050628 883.886348 17.06943 14.45523 14.72611 0 0 15.2358 0 0 0 14.69033 0 13.135 14.29002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.82326 16.03219 0 0 0 0 Q9ULE4 F184B_HUMAN Protein FAM184B FAM184B KIAA1276 Homo sapiens (Human) HTVEIK 1.620000005 1 1 0.025602826 725.3008828 15.16405 16.26793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.93539 0 0 0 0 0 Q9ULE6 PALD_HUMAN Paladin PALD1 KIAA1274 PALD Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725] protein tyrosine phosphatase activity [GO:0004725] GO:0004725; GO:0005737; GO:0005829 AHLSEPPPGK 6.059999943 1 1 4.63E-13 1032.329741 15.16173 14.63213 0 0 15.02886 0 15.23068 0 0 0 13.32028 13.21588 0 0 0 0 0 0 0 0 0 16.47767 17.06875 0 0 0 0 0 0 14.83516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULF5 S39AA_HUMAN "Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10, ZIP-10)" SLC39A10 KIAA1265 ZIP10 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578] zinc ion transmembrane transporter activity [GO:0005385] GO:0002903; GO:0005385; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615 GEPSNEPSTETNK 7.570000172 1 1 0.546197922 1389.708126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.98174 0 0 17.47598 0 0 0 0 0 0 0 0 18.9395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULG1 INO80_HUMAN "Chromatin-remodeling ATPase INO80, hINO80, EC 3.6.4.- (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A)" INO80 INO80A INOC1 KIAA1259 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]" cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]" "actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]" GO:0000070; GO:0000723; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0006275; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0033044; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043618; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051225; GO:0051301; GO:0051726; GO:0060382; GO:0070914; GO:0071479; GO:0140658; GO:1904507; GO:2000045 GRPKGSGSTAK 5.179999828 1 1 0.063956355 1044.753116 14.88851 15.88535 16.20744 0 15.56861 0 0 14.9577 15.98861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.04209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULH0 KDIS_HUMAN Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein) KIDINS220 ARMS KIAA1250 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976] PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887] GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090 DGNTALMIASK 7.53000021 1 1 0.29489214 1118.889112 15.90491 13.59746 15.51414 12.30526 15.92733 0 0 0 0 0 0 0 15.18566 0 0 0 0 13.26295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULH4 LRFN2_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1) LRFN2 KIAA1246 SALM1 Homo sapiens (Human) modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175] cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175] GO:0005886; GO:0009986; GO:0050804; GO:0098685; GO:0099061; GO:0099175 VKMYQLQYNCSDDEVLIYR 2.119999886 0.079582669 0.079582669 0.038364302 2454.336337 0 0 17.21491 9.297158 15.32314 12.20938 15.85744 15.27272 0 15.55414 14.80494 14.00546 0 0 14.78388 0 15.81574 0 0 0 14.82717 0 17.49721 17.13482 14.04325 0 13.06751 0 0 0 15.18948 0 15.42809 15.64277 0 0 0 0 16.77007 0 16.38689 15.5294 16.35964 14.19508 0 0 15.69901 16.12451 Q9ULH7 MRTFB_HUMAN "Myocardin-related transcription factor B, MRTF-B (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2)" MRTFB KIAA1243 MKL2 Homo sapiens (Human) muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145] nucleus [GO:0005634] nucleus [GO:0005634]; cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]; muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145] cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:1902895 MIDSSK 14.60999966 0.138525173 0.138525173 0.30000099 682.9404535 14.03725 15.43635 13.97882 0 0 0 0 0 0 0 0 14.67139 16.45059 0 14.66235 15.75044 16.36357 16.2236 17.30522 0 16.54754 16.9199 16.43215 0 17.2521 16.04623 0 15.1651 0 0 16.84887 16.66539 15.82897 16.3813 14.78005 16.90023 16.95096 0 19.00624 16.16743 16.35466 16.9273 17.5572 0 16.9263 0 18.51911 17.90126 Q9ULI0 ATD2B_HUMAN ATPase family AAA domain-containing protein 2B ATAD2B KIAA1240 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; positive regulation of transcription by RNA polymerase II [GO:0045944] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577] GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0042393; GO:0045944; GO:0070577 LILEQAK 29.84000015 0.920502365 0.920502365 0.232147443 814.4905355 0 17.42806 17.76413 17.31739 17.43134 17.52003 17.75045 17.88669 17.84785 0 17.61919 17.5297 17.04638 16.74983 17.10517 17.97495 17.73448 17.81405 17.20044 17.83284 17.34978 17.41899 17.48246 18.1158 17.91311 16.9919 17.41122 16.92229 17.74717 17.4949 15.14285 17.85828 16.73168 16.91139 16.88221 17.8601 0 17.49261 0 16.74065 16.95507 17.71784 16.74781 17.82068 16.19625 17.4076 16.95108 16.79239 Q9ULI1 NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239) NWD2 KIAA1239 Homo sapiens (Human) ESTEVFAR 7.210000038 0.222358584 0.222358584 0.187776838 938.7950292 16.67596 0 14.55981 15.97169 17.03849 14.90631 16.11149 15.51171 11.71904 15.85596 14.82305 11.37407 14.94832 14.66394 13.4645 13.51562 15.24267 0 0 13.71114 14.73394 0 0 0 17.59048 16.31247 0 0 14.98017 0 14.62589 17.69328 0 0 0 16.31018 15.90328 16.63289 0 0 15.08365 0 13.45359 0 0 16.27719 15.326 0 Q9ULI3 HEG1_HUMAN Protein HEG homolog 1 HEG1 KIAA1237 Homo sapiens (Human) cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222] cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222] calcium ion binding [GO:0005509] GO:0001570; GO:0001701; GO:0001886; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005576; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299 GICNLVR 13.75 0.623617113 0.623617113 0.18865461 831.9169701 11.74208 0 0 0 0 14.74113 13.89466 14.46032 14.5548 14.55606 0 14.14642 0 16.60514 14.63975 0 0 0 0 0 0 0 0 0 0 11.3321 0 0 15.21097 0 0 15.86296 0 0 14.46215 0 0 0 0 15.37885 0 0 11.60262 12.49854 0 15.83148 16.75408 0 Q9ULI4 KI26A_HUMAN Kinesin-like protein KIF26A KIF26A KIAA1236 Homo sapiens (Human) enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560] cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] GO:0001560; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0008017; GO:0009968; GO:0048484 AASKTK 2.440000057 1 1 0.146129652 603.5437373 0 0 0 0 0 0 0 0 15.91395 0 0 0 15.44112 0 0 0 0 0 0 0 0 16.21368 0 0 16.71262 0 0 0 0 15.73612 14.42163 0 16.34484 16.71675 16.2944 16.23353 0 15.1811 15.39649 0 0 17.34012 0 0 0 0 0 0 Q9ULJ1 ODF2L_HUMAN Protein BCAP (Basal body centriole-associated protein) (Outer dense fiber protein 2-like) ODF2L BCAP KIAA1229 Homo sapiens (Human) cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of cilium assembly [GO:1902017] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of cilium assembly [GO:1902017] GO:0005737; GO:0005813; GO:0005814; GO:0030030; GO:0034451; GO:0036064; GO:1902017; GO:1902018 QLEAALEEGRQK 8.079999924 1 1 6.91E-13 1378.337454 13.57009 0 0 0 16.03209 14.8282 15.12938 0 14.22659 0 11.07645 0 0 0 0 0 0 0 15.5783 16.09601 0 0 16.83314 0 0 0 0 0 14.52562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.41646 0 0 0 Q9ULJ3 ZBT21_HUMAN Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295) ZBTB21 KIAA1227 ZNF295 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]; sequence-specific DNA binding [GO:0043565]" GO:0000122; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008327; GO:0031208; GO:0042802; GO:0043565; GO:0045892; GO:0046872 EVYQCR 2.680000067 1 1 0.055208511 855.3922025 14.78194 15.22561 8.625778 0 16.44314 0 14.18429 16.84867 14.46196 0 15.28539 14.89678 0 14.64093 0 0 0 0 0 12.59215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULJ7 ANR50_HUMAN Ankyrin repeat domain-containing protein 50 ANKRD50 KIAA1223 Homo sapiens (Human) endocytic recycling [GO:0032456]; protein transport [GO:0015031] endosome [GO:0005768] endosome [GO:0005768]; endocytic recycling [GO:0032456]; protein transport [GO:0015031] GO:0005768; GO:0015031; GO:0032456 VAALEGHR 9.970000267 1 1 0.032360753 852.4793409 14.573 14.53737 12.65205 0 0 0 16.54532 0 0 0 0 13.42724 0 14.09442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.22636 15.98836 0 14.54857 0 0 15.50911 16.37382 0 12.12454 15.95292 0 0 15.78512 0 15.53448 0 0 Q9ULK0 GRID1_HUMAN "Glutamate receptor ionotropic, delta-1, GluD1, GluR delta-1 subunit" GRID1 KIAA1220 Homo sapiens (Human) "modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]" extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]" glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GO:0004970; GO:0005886; GO:0008066; GO:0015276; GO:0035176; GO:0035249; GO:0038023; GO:0042802; GO:0045211; GO:0050804; GO:0070062; GO:0098978; GO:0099061; GO:1904315 WHSMASLNCIR 1.769999981 1 1 0.207802996 1373.51464 0 0 0 0 0 0 16.84718 0 0 0 0 0 0 0 0 0 15.57886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULK2 AT7L1_HUMAN Ataxin-7-like protein 1 (Ataxin-7-like protein 4) ATXN7L1 ATXN7L4 KIAA1218 Homo sapiens (Human) VASPAK 2.880000114 1 1 0.112636344 570.1258857 15.14079 14.79283 14.92011 16.06572 15.6547 0 0 0 0 0 0 0 0 0 13.74926 0 0 0 0 15.70402 15.70598 0 0 16.07481 15.40738 0 0 0 0 15.28865 13.22452 15.80943 13.24006 14.01571 15.62094 0 16.88456 0 0 0 0 13.8668 13.10648 0 17.35411 0 0 0 Q9ULK4 MED23_HUMAN "Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component, ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3, CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog, hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component, DRIP130)" MED23 ARC130 CRSP3 DRIP130 KIAA1216 SUR2 Homo sapiens (Human) "positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" transcription coactivator activity [GO:0003713] GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 LISCLGAFR 7.449999809 1 1 0.160299919 1036.787458 0 0 0 0 15.26013 0 17.00097 0 0 16.98211 15.01523 0 11.26227 0 0 15.30644 0 18.31848 0 0 0 0 0 0 0 0 15.66593 0 10.9352 0 0 0 17.62738 0 0 0 0 17.522 0 0 0 0 0 0 15.83612 0 0 0 Q9ULK5 VANG2_HUMAN Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2) VANGL2 KIAA1215 STB1 Homo sapiens (Human) "apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001736; GO:0001843; GO:0001947; GO:0005886; GO:0005911; GO:0016021; GO:0016324; GO:0016328; GO:0035787; GO:0045176; GO:0060071; GO:1905515 KVSGFK 10.47000027 0.264648527 0.264648527 0.206175507 667.3142998 0 15.3617 15.93352 0 0 0 0 0 0 0 12.76138 16.21831 0 0 15.89701 15.67574 17.50039 15.69684 0 17.25106 17.33404 0 16.80212 0 0 0 16.79695 15.58532 16.12635 15.60029 16.97656 16.5511 15.95657 0 15.39897 0 17.09493 15.38313 17.27054 17.12578 15.41134 14.65984 16.16651 15.11647 17.13126 0 0 16.02633 Q9ULL0 K1210_HUMAN Acrosomal protein KIAA1210 KIAA1210 Homo sapiens (Human) acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669] GO:0001669 APPSQKYK 4.539999962 1 1 0.025240217 917.4843535 0 15.07359 14.50037 13.01789 13.68373 14.42036 13.65611 14.08495 14.7102 0 14.57734 0 0 0 14.46952 13.2389 0 15.12696 16.15462 14.16597 0 14.96147 13.11588 0 11.00087 0 0 0 0 15.03547 14.09716 14.90462 0 12.27142 0 0 0 15.2821 0 15.48148 0 0 0 0 14.53194 14.9052 0 0 Q9ULL4 PLXB3_HUMAN Plexin-B3 PLXNB3 KIAA1206 PLXN6 Homo sapiens (Human) cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154]; cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] GO:0001938; GO:0002116; GO:0005886; GO:0005887; GO:0007156; GO:0007162; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030334; GO:0030336; GO:0034260; GO:0043087; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632; GO:1902287 QMVERYYADIR 8.729999542 0.396867156 0.396867156 0.058685581 1444.444048 0 0 0 0 0 0 0 0 10.82415 12.02578 15.70099 17.71244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.799703 0 11.63472 15.24027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.00653 Q9ULL8 SHRM4_HUMAN Protein Shroom4 (Second homolog of apical protein) SHROOM4 KIAA1202 SHAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890] actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725] actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890] actin filament binding [GO:0051015]; myosin II binding [GO:0045159] GO:0001725; GO:0005654; GO:0005737; GO:0005884; GO:0005912; GO:0005925; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043231; GO:0043296; GO:0045159; GO:0050890; GO:0051015 AVCKSNEFEK 3.420000076 1 1 0.047311131 1213.241536 14.26125 11.44872 11.60855 15.16106 17.98345 11.81343 13.55571 0 0 0 0 12.61277 10.98253 14.85921 13.54804 0 0 0 0 0 0 13.48445 14.55748 0 14.23896 0 0 0 11.23538 9.795198 0 0 0 0 13.72928 0 0 0 0 0 15.82652 0 0 0 0 0 0 0 Q9ULM0 PKHH1_HUMAN "Pleckstrin homology domain-containing family H member 1, PH domain-containing family H member 1" PLEKHH1 KIAA1200 Homo sapiens (Human) cytoskeleton [GO:0005856] cytoskeleton [GO:0005856] GO:0005856 EIVAGR 1.320000052 1 1 0.19308048 643.6681643 15.043 16.31499 16.67525 0 15.64161 15.88722 14.6914 14.8517 16.50579 0 0 0 16.39023 16.31333 0 0 15.31827 16.10019 16.09319 13.45018 0 16.60591 13.876 14.51227 15.42311 15.07758 16.32282 16.75834 0 17.0175 15.72343 0 0 0 13.59704 0 16.60365 15.38488 14.5299 16.75431 15.6648 16.37607 15.12338 14.98809 14.33811 16.54694 14.55265 0 Q9ULM6 CNOT6_HUMAN "CCR4-NOT transcription complex subunit 6, EC 3.1.13.4 (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase)" CNOT6 CCR4 CCR4a KIAA1194 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]" CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] "CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]" 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723] GO:0000175; GO:0000289; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0008284; GO:0010606; GO:0016020; GO:0030014; GO:0030374; GO:0035195; GO:0043928; GO:0046872; GO:0070966 NIIDKASR 5.760000229 1 1 0.238851398 915.8880814 15.62935 0 0 16.39994 0 0 15.33822 16.41613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULN7 PNM8B_HUMAN Paraneoplastic antigen-like protein 8B (PNMA-like protein 2) PNMA8B KIAA1183 PNMAL2 Homo sapiens (Human) GVTPEK 14.44999981 0.841153145 0.841153145 0.232638711 632.6822108 15.25254 15.23229 16.37789 15.08342 14.20313 15.97475 15.0001 13.50865 16.22835 16.33792 15.30525 16.52108 15.06629 15.65042 15.64831 15.89013 16.61872 0 15.59954 16.4737 16.87661 16.48923 0 16.08013 16.14857 0 15.49526 9.701278 15.11802 15.62793 15.71664 16.21354 16.21585 17.76789 0 17.54374 16.18127 0 15.87296 15.5823 16.75279 17.06433 16.48473 17.13552 0 15.90594 0 17.42004 Q9ULP9 TBC24_HUMAN TBC1 domain family member 24 TBC1D24 KIAA1171 Homo sapiens (Human) neuron death in response to oxidative stress [GO:0036475]; neuron projection development [GO:0031175] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; neuron death in response to oxidative stress [GO:0036475]; neuron projection development [GO:0031175] GTPase activator activity [GO:0005096] GO:0005096; GO:0005737; GO:0005886; GO:0030054; GO:0030659; GO:0031175; GO:0031594; GO:0036475; GO:0043195 ILACNDPGR 3.660000086 1 1 0.156845687 1015.560516 12.79702 0 14.15742 0 0 0 11.80882 0 14.64662 0 14.78877 0 12.5866 14.93345 0 15.51207 0 15.07159 13.59779 0 13.82399 0 13.93304 0 0 0 13.51024 0 14.49197 0 0 0 17.13005 0 0 15.72123 0 0 0 15.19404 0 17.6459 14.58514 0 0 0 15.35956 0 Q9ULR5 PAI2B_HUMAN "Polyadenylate-binding protein-interacting protein 2B, PABP-interacting protein 2B, PAIP-2B, Poly(A)-binding protein-interacting protein 2B" PAIP2B KIAA1155 Homo sapiens (Human) negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947] cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; translation repressor activity [GO:0030371]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]" "translation repressor activity [GO:0030371]; translation repressor activity, mRNA regulatory element binding [GO:0000900]" GO:0000900; GO:0005737; GO:0017148; GO:0030371; GO:0045947 NGSNMANTSPSVK 7.170000076 1 1 0.513950343 1321.98831 0 0 0 0 0 0 0 0 0 0 0 0 17.30185 0 0 0 19.30913 0 0 0 0 0 0 18.93746 18.18368 0 0 17.85746 0 0 0 18.36627 0 0 0 0 0 0 0 15.93019 0 19.20589 0 0 0 0 0 0 Q9ULT0 TTC7A_HUMAN "Tetratricopeptide repeat protein 7A, TPR repeat protein 7A" TTC7A KIAA1140 TTC7 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; hemopoiesis [GO:0030097]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cellular iron ion homeostasis [GO:0006879]; hemopoiesis [GO:0030097]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005737; GO:0005886; GO:0006879; GO:0030097; GO:0046854; GO:0072659 GRLAEVK 12.85999966 0.225180238 0.225180238 0.135489435 773.4359812 18.06501 17.26319 17.31932 16.00789 16.17401 16.87964 17.20554 13.95847 16.17934 17.3713 15.93494 17.09696 0 17.24188 0 16.65425 15.50972 17.24032 17.08585 16.61559 16.01607 0 17.12024 17.11605 16.48902 17.14937 17.03003 17.29907 16.89902 16.64697 17.47785 0 14.8589 16.78165 17.06575 15.83314 17.21147 16.75825 18.936 17.0401 14.716 16.60265 16.58802 16.11267 16.56432 17.10862 17.62435 16.04285 Q9ULT6 ZNRF3_HUMAN "E3 ubiquitin-protein ligase ZNRF3, EC 2.3.2.27 (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3)" ZNRF3 KIAA1133 RNF203 Homo sapiens (Human) "limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]" frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0005109; GO:0005886; GO:0005887; GO:0006511; GO:0016055; GO:0016567; GO:0038018; GO:0046872; GO:0060173; GO:0061630; GO:0072089; GO:0090090; GO:2000051; GO:2000095 GLRCSR 4.360000134 1 1 0.021111481 748.8613216 0 0 0 0 0 0 0 16.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29908 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULT8 HECD1_HUMAN "E3 ubiquitin-protein ligase HECTD1, EC 2.3.2.26 (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)" HECTD1 KIAA1131 Homo sapiens (Human) anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0001779; GO:0001843; GO:0003170; GO:0003281; GO:0006511; GO:0032436; GO:0035904; GO:0046872; GO:0048856; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077 DGFNK 2.24000001 1 1 0.139073727 580.3649838 0 0 0 13.37488 14.16617 15.65225 13.44389 16.11563 14.26011 15.74556 15.17667 15.95639 16.89532 16.53607 16.04355 16.6371 0 14.24147 0 16.11665 0 0 0 0 15.11939 16.31994 15.67017 15.06607 0 0 0 0 0 0 15.35723 0 0 0 0 0 15.70256 0 15.40227 0 17.41886 0 16.62744 0 Q9ULU4 PKCB1_HUMAN "Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3, CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)" ZMYND8 KIAA1125 PRKCBP1 RACK7 Homo sapiens (Human) negative regulation of cell migration [GO:0030336] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of cell migration [GO:0030336] DNA-binding transcription factor binding [GO:0140297]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0070577; GO:0140297 DPGSAERTAQK 3.700000048 0.714742184 0.714742184 0.215619238 1160.524089 0 14.72981 0 0 13.76551 0 18.3433 0 13.29878 14.79391 13.71248 0 0 14.2769 15.06554 0 15.02178 15.11119 14.57733 11.69646 0 0 0 14.64723 0 0 0 0 0 0 0 14.87658 0 15.60746 14.37027 0 0 14.67378 0 0 0 0 14.79908 0 0 0 14.77257 0 Q9ULU8 CAPS1_HUMAN "Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1, CAPS-1)" CADPS CAPS CAPS1 KIAA1121 Homo sapiens (Human) dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle membrane [GO:0099012]; presynapse [GO:0098793] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle membrane [GO:0099012]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] GO:0005829; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0019901; GO:0045921; GO:0046872; GO:0098793; GO:0098978; GO:0099012; GO:1990504 VARMVQSGGCSANDSR 8.460000038 1 1 0.57186615 1694.420318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.44114 0 0 18.20063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULV3 CIZ1_HUMAN Cip1-interacting zinc finger protein (CDKN1A-interacting zinc finger protein 1) (Nuclear protein NP94) (Zinc finger protein 356) CIZ1 LSFR1 NP94 ZNF356 Homo sapiens (Human) maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin binding [GO:0030332]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298] cyclin binding [GO:0030332]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0005634; GO:0005654; GO:0005886; GO:0008270; GO:0030332; GO:0032298; GO:0051457 EPPGQLQVK 4.900000095 1 1 0.21534726 995.9946728 15.96442 13.13546 14.07124 16.05149 0 12.01292 0 0 13.87418 16.35093 0 13.9412 0 0 0 0 13.73096 0 18.47793 0 0 15.98808 15.02123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.81171 0 14.36383 0 15.01627 0 0 Q9ULV4 COR1C_HUMAN Coronin-1C (Coronin-3) (hCRNN4) CORO1C CRN2 CRNN4 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]; actin filament binding [GO:0051015]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165] actin filament binding [GO:0051015]; small GTPase binding [GO:0031267] GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016477; GO:0016600; GO:0030017; GO:0030027; GO:0031267; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394 KQEIVAEK 3.650000095 0.265378177 0.265378177 0.18520546 945.5378299 0 15.38626 15.27173 0 0 14.22169 0 14.2989 15.70175 0 0 15.47743 15.74772 0 17.14257 14.47645 15.05153 16.42356 16.10483 15.63782 15.35755 15.41242 15.56674 16.51605 16.96124 15.32051 0 14.5018 15.70747 15.62407 16.23472 0 15.40815 0 14.27689 14.08133 15.40025 16.65516 16.00644 16.012 15.52872 16.57665 12.29273 11.21851 16.44376 16.19862 15.56308 14.12624 Q9ULV5 HSF4_HUMAN "Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)" HSF4 Homo sapiens (Human) cell development [GO:0048468]; histone H3-K9 demethylation [GO:0033169]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; histone H3-K9 demethylation [GO:0033169]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007601; GO:0008284; GO:0016607; GO:0019903; GO:0033169; GO:0042802; GO:0045597; GO:0045944; GO:0048468; GO:0070306; GO:1990837 LLGEVQALR 5.010000229 1 1 0.22810244 998.5892124 0 0 0 0 0 0 0 0 0 16.04211 14.91485 0 0 0 16.46128 0 0 0 0 0 0 0 0 14.29051 0 11.79568 0 16.31879 0 0 0 0 15.57459 14.31545 0 0 0 0 17.41904 0 0 0 0 0 0 0 0 0 Q9ULW0 TPX2_HUMAN "Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2, DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100, p100)" TPX2 C20orf1 C20orf2 DIL2 HCA519 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of mitotic spindle organization [GO:0060236] axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of mitotic spindle organization [GO:0060236] importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] GO:0000278; GO:0000922; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005880; GO:0006915; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0019901; GO:0030295; GO:0032147; GO:0043203; GO:0045171; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307 ARAVTCK 4.659999847 1 1 0.297471876 805.8492966 0 0 0 0 0 0 0 0 18.18628 17.13767 0 0 16.98481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54923 17.72445 0 0 0 0 0 0 0 Q9ULW2 FZD10_HUMAN "Frizzled-10, Fz-10, hFz10 (FzE7) (CD antigen CD350)" FZD10 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956] cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956] G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0009986; GO:0016021; GO:0017147; GO:0030182; GO:0032956; GO:0034260; GO:0038031; GO:0042813; GO:0043507; GO:0043547; GO:0060070; GO:0071300 KAQHPQK 9.569999695 1 1 0.161985974 837.1386073 0 14.53441 0 0 11.7601 8.675522 14.45628 0 13.78759 12.66693 0 0 0 14.80836 0 10.92421 0 15.07313 15.71058 12.21284 0 0 13.68897 12.55996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULW8 PADI3_HUMAN "Protein-arginine deiminase type-3, EC 3.5.3.15 (Peptidylarginine deiminase III) (Protein-arginine deiminase type III)" PADI3 PAD3 PDI3 Homo sapiens (Human) histone citrullination [GO:0036414]; protein citrullination [GO:0018101] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668]; histone citrullination [GO:0036414]; protein citrullination [GO:0018101] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668] GO:0004668; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0018101; GO:0036414; GO:0042802 EYPLGRILIGGNLPGSSGR 11.68999958 1 1 0.656296679 1956.67059 14.56779 17.00159 0 0 0 0 0 0 0 20.94262 0 0 0 0 19.71107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULX5 RN112_HUMAN "RING finger protein 112, EC 2.3.2.27 (Brain finger protein) (Zinc finger protein 179)" RNF112 BFP ZNF179 Homo sapiens (Human) cell death in response to hydrogen peroxide [GO:0036474]; cell death in response to oxidative stress [GO:0036473]; embryonic brain development [GO:1990403]; endoplasmic reticulum organization [GO:0007029]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neuron differentiation [GO:0030182]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of neuron differentiation [GO:0045666]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; regulation of cell cycle [GO:0051726]; response to hydroperoxide [GO:0033194] cell body [GO:0044297]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] cell body [GO:0044297]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell death in response to hydrogen peroxide [GO:0036474]; cell death in response to oxidative stress [GO:0036473]; embryonic brain development [GO:1990403]; endoplasmic reticulum organization [GO:0007029]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neuron differentiation [GO:0030182]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of neuron differentiation [GO:0045666]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; regulation of cell cycle [GO:0051726]; response to hydroperoxide [GO:0033194] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0007029; GO:0008021; GO:0008270; GO:0014069; GO:0016021; GO:0016604; GO:0019898; GO:0030182; GO:0033194; GO:0036473; GO:0036474; GO:0043005; GO:0043204; GO:0043621; GO:0044297; GO:0045666; GO:0045687; GO:0051260; GO:0051726; GO:0051865; GO:0061630; GO:0070315; GO:1990403 VLPDTMR 3.700000048 1 1 0.165298988 847.6827336 0 0 16.90958 0 0 0 0 0 0 0 0 0 0 0 0 15.69553 0 0 0 0 0 0 15.9591 0 0 16.36848 0 0 0 0 0 0 15.40357 16.23564 0 0 16.13811 0 0 0 0 0 0 0 16.11316 0 0 0 Q9ULX6 AKP8L_HUMAN "A-kinase anchor protein 8-like, AKAP8-like protein (Helicase A-binding protein 95, HAP95) (Homologous to AKAP95 protein, HA95) (Neighbor of A-kinase-anchoring protein 95, Neighbor of AKAP95)" AKAP8L NAKAP NAKAP95 HRIHFB2018 Homo sapiens (Human) cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone phosphorylation [GO:0033127]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone phosphorylation [GO:0033127]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380] DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723] GO:0000785; GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005737; GO:0006397; GO:0007076; GO:0008380; GO:0010793; GO:0016363; GO:0016605; GO:0016607; GO:0017151; GO:0031065; GO:0033127; GO:0034237; GO:0042826; GO:0044839; GO:0045944; GO:0046872; GO:0051081; GO:1990904 TMDHNRNR 6.269999981 1 1 0.157588747 1061.721887 0 13.40572 0 0 0 0 12.3206 15.37147 0 0 0 0 15.96205 0 0 14.3759 15.36094 15.74517 14.09939 12.26084 15.00177 0 17.37865 0 0 0 0 0 0 0 0 0 0 14.3957 0 0 0 0 0 0 0 15.6453 0 0 15.07027 17.18377 0 0 Q9UM00 TMCO1_HUMAN "Calcium load-activated calcium channel, CLAC channel (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3)" TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; ribosome binding [GO:0043022]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983] calcium channel activity [GO:0005262]; ribosome binding [GO:0043022] GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0006874; GO:0006983; GO:0030176; GO:0032469; GO:0043022; GO:0070588 ILGLAPSR 10.85000038 1 1 0.58615938 830.0607688 16.20416 0 0 0 0 16.42243 0 0 0 0 0 17.4003 0 16.63286 0 0 0 0 0 0 0 0 0 0 15.95739 0 0 0 0 0 17.53714 0 0 0 0 0 0 0 16.97236 0 0 0 0 16.62177 0 0 17.31281 0 Q9UM11 FZR1_HUMAN "Fizzy-related protein homolog, Fzr (CDC20-like protein 1) (Cdh1/Hct1 homolog, hCDH1)" FZR1 CDH1 FYR FZR KIAA1242 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757] GO:0005654; GO:0005680; GO:0005829; GO:0006281; GO:0007095; GO:0007346; GO:0008284; GO:0010997; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0051445; GO:0070306; GO:0070979; GO:0090344; GO:1904668; GO:1905786; GO:1990757 QIVIQNENTMPRVTEMR 1.090000033 0.498589605 0.498589605 0.383746688 2073.891978 0 0 0 0 0 0 15.19933 0 13.95627 0 14.43405 0 15.02108 0 0 0 0 12.06794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.80406 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM19 HPCL4_HUMAN "Hippocalcin-like protein 4, HLP4" HPCAL4 Homo sapiens (Human) central nervous system development [GO:0007417]; signal transduction [GO:0007165] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; central nervous system development [GO:0007417]; signal transduction [GO:0007165] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904] GO:0005246; GO:0005509; GO:0007165; GO:0007417; GO:0008022; GO:0019904 MVGTVIMMR 2.720000029 1 1 0.354232688 1070.161604 0 0 14.04988 0 0 0 0 0 0 0 17.22005 0 0 0 0 15.399 0 0 0 0 16.65785 0 16.37515 0 0 0 16.19821 17.33627 15.9098 0 0 15.53638 0 0 14.65109 0 0 0 14.08004 0 0 18.38103 0 0 0 0 0 0 Q9UM21 MGT4A_HUMAN "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A, EC 2.4.1.145 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa, GlcNAc-T IVa, GnT-IVa, N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form ]" MGAT4A Homo sapiens (Human) glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491]; positive regulation of protein glycosylation in Golgi [GO:0090284]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; peroxisome [GO:0005777] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; peroxisome [GO:0005777]; acetylglucosaminyltransferase activity [GO:0008375]; alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491]; positive regulation of protein glycosylation in Golgi [GO:0090284]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]" "acetylglucosaminyltransferase activity [GO:0008375]; alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" GO:0000139; GO:0005777; GO:0005783; GO:0005788; GO:0005793; GO:0005795; GO:0006487; GO:0006491; GO:0008375; GO:0008453; GO:0008454; GO:0016021; GO:0019082; GO:0042803; GO:0046487; GO:0046872; GO:0070062; GO:0090284 EFLALK 10.57999992 0.657352448 0.657352448 0.252960408 720.708459 15.58858 14.7796 0 0 0 17.08125 0 0 20.10227 0 0 17.09632 0 0 18.56894 18.88775 0 0 0 0 16.80951 17.42189 0 0 0 0 0 0 0 0 0 0 0 0 18.87454 0 18.18356 0 0 17.42361 0 0 0 0 18.15352 0 0 0 Q9UM47 NOTC3_HUMAN "Neurogenic locus notch homolog protein 3, Notch 3 [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain ]" NOTCH3 Homo sapiens (Human) artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] GO:0000122; GO:0000139; GO:0005509; GO:0005576; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0015629; GO:0016021; GO:0019899; GO:0030900; GO:0038023; GO:0042802; GO:0043235; GO:0045296; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104 DGINR 10.68999958 0.008318659 0.008318659 0.314008915 574.9325893 17.31965 17.87689 19.25293 0 0 18.99943 0 0 0 0 16.72515 0 0 0 0 18.00766 16.55321 0 0 0 0 0 0 18.08732 0 0 0 0 18.81839 17.59195 0 18.17834 0 18.01764 18.43066 0 0 0 0 0 0 0 17.51582 0 0 0 0 0 Q9UM54 MYO6_HUMAN Unconventional myosin-VI (Unconventional myosin-6) MYO6 KIAA0389 Homo sapiens (Human) "actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]" "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]" "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]" actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001] GO:0000146; GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016461; GO:0016591; GO:0030048; GO:0030050; GO:0030139; GO:0030175; GO:0030330; GO:0030665; GO:0031410; GO:0031941; GO:0031965; GO:0031982; GO:0032587; GO:0042472; GO:0042491; GO:0042802; GO:0043531; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060001; GO:0070062 AEACIKMQK 13.38000011 1 1 0.089597163 1095.448411 15.23687 14.76662 0 11.17212 0 12.67384 11.91678 12.40031 13.51467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.79756 0 0 0 0 0 0 0 Q9UM73 ALK_HUMAN "ALK tyrosine kinase receptor, EC 2.7.10.1 (Anaplastic lymphoma kinase) (CD antigen CD246)" ALK Homo sapiens (Human) adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GO:0004704; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0016310; GO:0021766; GO:0030534; GO:0032991; GO:0033674; GO:0036269; GO:0042127; GO:0042802; GO:0042981; GO:0043235; GO:0043410; GO:0045664; GO:0046777; GO:0048666; GO:0050995; GO:0051092; GO:0060159; GO:0070062; GO:0090648; GO:0097009; GO:1900006 EPHDR 5.909999847 0.318987072 0.318987072 4.59E-13 654.3249877 12.63827 14.60029 14.72887 0 0 15.15186 16.83628 0 15.22341 16.27595 15.77509 15.32827 0 16.42078 15.24589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.14945 Q9UM82 SPAT2_HUMAN Spermatogenesis-associated protein 2 SPATA2 KIAA0757 PD1 Homo sapiens (Human) necroptotic process [GO:0070266]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of inflammatory response [GO:0050727]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin-specific protease binding [GO:1990381]; necroptotic process [GO:0070266]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of inflammatory response [GO:0050727]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin-specific protease binding [GO:1990381] GO:0001650; GO:0005654; GO:0005737; GO:0007283; GO:0010803; GO:0030159; GO:0044877; GO:0050727; GO:0060544; GO:0070266; GO:0070536; GO:0072520; GO:1990108; GO:1990381 FMPNNQLNYKSTQLSHLVYR 3.609999895 1 1 1.38E-12 2469.080058 0 0 0 0 15.9585 0 16.6842 0 0 0 0 0 0 16.24333 0 0 0 0 0 0 16.90914 0 0 15.01346 0 0 0 0 0 0 17.12795 0 16.73795 14.19952 0 16.38283 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMD9 COHA1_HUMAN "Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1, LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen, 97 kDa LAD antigen, 97-LAD) (Linear IgA bullous disease antigen of 97 kDa, LABD97) ]" COL17A1 BP180 BPAG2 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0005886; GO:0005887; GO:0005911; GO:0007160; GO:0008544; GO:0030020; GO:0030056; GO:0030198; GO:0031012; GO:0031581; GO:0062023 GDMGSPGPKGDR 6.449999809 1 1 0.116400238 1175.591697 0 0 6.120511 18.06898 12.20104 12.81892 0 0 7.758375 0 0 0 13.76633 0 0 0 0 0 13.78997 0 0 16.57612 0 0 13.83371 0 15.4173 0 0 0 0 0 0 0 0 0 0 15.71585 0 0 0 0 0 0 0 0 0 14.40189 Q9UMF0 ICAM5_HUMAN "Intercellular adhesion molecule 5, ICAM-5 (Telencephalin)" ICAM5 TLCN TLN Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] integrin binding [GO:0005178] GO:0005178; GO:0005886; GO:0005887; GO:0006909; GO:0007155; GO:0098609 GAVLTATVLAR 9.350000381 0.131069973 0.131069973 0.100599232 1070.978391 16.33588 0 14.43421 0 16.00104 0 18.25511 0 0 17.21786 0 13.32529 0 11.56335 0 0 16.03113 10.67189 16.24325 13.46088 14.68766 0 0 16.76598 0 9.199366 15.34602 17.09539 17.57855 14.61391 0 0 17.00903 17.01366 16.76279 16.85986 14.57083 0 8.789617 0 0 0 0 0 13.66492 15.6046 14.62299 17.0899 Q9UMN6 KMT2B_HUMAN "Histone-lysine N-methyltransferase 2B, Lysine N-methyltransferase 2B, EC 2.1.1.364 (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7, WBP-7)" KMT2B HRX2 KIAA0304 MLL2 MLL4 TRX2 WBP7 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]" histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]" histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0006325; GO:0008270; GO:0035097; GO:0042800; GO:0044648; GO:0044665; GO:0045322; GO:0045893; GO:0051568; GO:0097692 FPGRPRGAGGGGGR 5.019999981 1 1 0.089563404 1298.124343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.97136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.54009 0 0 0 0 0 0 0 0 0 0 0 Q9UMQ6 CAN11_HUMAN "Calpain-11, EC 3.4.22.- (Calcium-activated neutral proteinase 11, CANP 11)" CAPN11 Homo sapiens (Human) proteolysis [GO:0006508] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]; proteolysis [GO:0006508] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233] GO:0001669; GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0008233 GFGLDACR 10.52000046 1 1 0.054394062 894.5973911 0 14.66158 17.56929 0 16.47595 15.4291 0 15.85303 0 14.24752 14.38932 0 0 0 0 0 0 0 0 15.62927 14.03755 16.21083 0 16.73777 15.71689 13.54037 0 0 16.04706 0 0 15.08341 15.49656 15.31368 13.18022 0 17.03367 0 16.78419 15.3473 14.81617 0 17.46019 0 16.10776 16.6385 0 0 Q9UMR2 DD19B_HUMAN "ATP-dependent RNA helicase DDX19B, EC 3.6.4.13 (DEAD box RNA helicase DEAD5) (DEAD box protein 19B)" DDX19B DBP5 DDX19 TDBP Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0010494; GO:0016020; GO:0016887; GO:0016973; GO:0070062 HSMNILNRIQEHFNK 6.449999809 1 1 0.157092565 1896.133516 0 18.40107 0 15.13495 0 0 0 9.765998 16.06142 0 0 0 14.13542 15.0844 0 0 13.91686 0 0 0 0 0 0 15.48409 14.0879 0 0 0 0 0 0 0 0 0 16.4977 0 0 0 16.91085 0 0 0 0 0 12.57634 0 0 0 Q9UMR7 CLC4A_HUMAN C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor) (CD antigen CD367) CLEC4A CLECSF6 DCIR LLIR HDCGC13P Homo sapiens (Human) "adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]" external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]" calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888] GO:0001818; GO:0002250; GO:0002470; GO:0004888; GO:0005509; GO:0005537; GO:0005886; GO:0005887; GO:0006955; GO:0007155; GO:0007166; GO:0009897; GO:0030246; GO:0032720; GO:0036037; GO:0042590; GO:0061760 SVCEMMK 5.920000076 1 1 0.478271222 915.5299039 0 0 0 0 15.16972 0 0 0 0 16.91997 0 0 15.63249 0 0 0 0 0 0 0 0 16.62449 0 15.96082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMS0 NFU1_HUMAN "NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)" NFU1 HIRIP5 CGI-33 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]" "4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]" GO:0005506; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016226; GO:0051539; GO:0097428 AATARR 8.329999924 1 1 0.273333273 646.9458998 15.51486 0 0 15.92189 0 14.9943 14.98334 0 14.45648 16.19587 15.21488 0 0 0 0 0 14.62108 0 0 0 0 0 0 0 0 0 0 15.69467 0 0 0 0 0 0 0 15.54945 0 0 16.72155 0 0 0 0 0 0 0 0 0 Q9UMS5 PHTF1_HUMAN Protein PHTF1 PHTF1 PHTF Homo sapiens (Human) cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0005801; GO:0016021 DSDSLAESEFESAAFSQGSR 2.5 1 1 4.71E-13 2119.428405 20.34206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMS6 SYNP2_HUMAN Synaptopodin-2 (Genethonin-2) (Myopodin) SYNPO2 Homo sapiens (Human) autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein-macromolecule adaptor activity [GO:0030674]; autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298] 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein-macromolecule adaptor activity [GO:0030674] GO:0000045; GO:0001725; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0015629; GO:0030018; GO:0030335; GO:0030674; GO:0031005; GO:0032233; GO:0043231; GO:0051371; GO:0051393; GO:0061684; GO:0071889; GO:0099023; GO:2000298 EQDAAQTDGLRTTTSYQR 4.769999981 0.994272649 0.994272649 1.38E-12 2040.90062 10.79352 0 0 0 0 14.05468 13.55423 12.32776 0 14.64541 15.95591 0 0 0 0 0 15.3664 0 0 0 0 0 0 0 0 0 0 0 0 0 15.51244 14.73705 0 0 0 16.26236 0 0 0 0 0 0 17.55522 0 0 15.9004 0 0 Q9UMX0 UBQL1_HUMAN "Ubiquilin-1 (Protein linking IAP with cytoskeleton 1, PLIC-1, hPLIC-1)" UBQLN1 DA41 PLIC1 Homo sapiens (Human) aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991] aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593] GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071 QQLPTFLQQMQNPDTLSAMSNPR 5.809999943 1 1 0.411301974 2676.828374 16.26704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMX2 OAZ3_HUMAN "Ornithine decarboxylase antizyme 3, AZ3, ODC-Az 3" OAZ3 Homo sapiens (Human) negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ornithine decarboxylase inhibitor activity [GO:0008073]; negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283] ornithine decarboxylase inhibitor activity [GO:0008073] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0007283; GO:0008073; GO:0045732; GO:0072562; GO:0090316; GO:1902268 EKMLPR 28.5 2.48E-06 2.48E-06 0.236789712 773.9894025 17.30484 18.51523 19.11555 16.2455 0 17.02968 0 17.61076 18.21541 18.83773 16.74737 0 0 18.11073 0 17.50396 0 0 16.66448 0 19.14628 20.3455 0 20.75012 0 0 19.65654 18.06323 19.02803 16.37726 0 20.85932 21.46069 0 0 0 0 19.21748 18.92096 0 18.29049 18.4529 17.85476 0 20.92485 0 0 17.55114 Q9UMX3 BOK_HUMAN "Bcl-2-related ovarian killer protein, hBOK (Bcl-2-like protein 9, Bcl2-L-9)" BOK BCL2L9 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836] cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836] BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625] GO:0001836; GO:0005102; GO:0005634; GO:0005640; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0006915; GO:0006919; GO:0006921; GO:0007420; GO:0008584; GO:0008630; GO:0008635; GO:0010506; GO:0016020; GO:0016021; GO:0031625; GO:0031901; GO:0031966; GO:0032588; GO:0033106; GO:0042803; GO:0043065; GO:0043524; GO:0044877; GO:0046982; GO:0048709; GO:0051259; GO:0051400; GO:0051402; GO:0051480; GO:0051902; GO:0055038; GO:0060546; GO:0072332; GO:0097192; GO:1900119; GO:1901029; GO:1901030; GO:1901382; GO:1902237; GO:1903899; GO:1904708; GO:2001244 KTLATWLR 3.410000086 0.52885884 0.52885884 0.245278582 989.0486769 0 16.9276 0 0 0 0 17.23323 17.03434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.14874 16.37233 0 0 0 18.36079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMY4 SNX12_HUMAN Sorting nexin-12 SNX12 Homo sapiens (Human) endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; retromer complex [GO:0030904] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; retromer complex [GO:0030904]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100] enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] GO:0005769; GO:0010629; GO:0010955; GO:0015031; GO:0019899; GO:0030100; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0034499; GO:0035091; GO:0042177; GO:0051224; GO:2000642 IVVPPLPGKALK 17.63999939 0.270763099 0.270763099 0.161639718 1231.816469 14.36817 13.2467 13.29797 0 13.39685 13.14419 13.66017 12.8486 0 13.42351 12.35251 15.0257 15.55193 0 0 0 0 0 0 0 14.51151 0 15.74144 15.21512 0 0 0 0 0 0 0 16.58966 16.30702 0 12.80665 0 0 14.70863 16.35233 0 0 0 0 0 0 0 0 14.09696 Q9UMZ2 SYNRG_HUMAN Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) SYNRG AP1GBP1 SYNG Homo sapiens (Human) endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 SVSTPQSTGSAATMTALAATK 4.139999866 0.273711741 0.273711741 0.004617132 1994.201346 0 0 0 0 17.16629 0 0 0 13.97524 0 0 0 0 0 0 16.17919 0 0 14.4824 0 0 17.05331 14.87331 0 15.0244 15.1969 0 0 0 0 0 0 17.49672 0 14.85076 0 17.32635 0 0 0 16.16516 0 13.72115 0 13.34874 0 15.33207 0 Q9UN30 SCML1_HUMAN Sex comb on midleg-like protein 1 SCML1 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin binding [GO:0003682]; histone binding [GO:0042393] GO:0003682; GO:0005634; GO:0042393; GO:0045892 IQRFHAR 1.00999999 1 1 0.153108775 927.8811818 13.6828 0 0 0 0 0 0 13.82506 15.98586 0 0 0 0 0 15.32456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.26053 0 0 16.23255 15.48367 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN36 NDRG2_HUMAN Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613) NDRG2 KIAA1248 SYLD Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; regulation of platelet-derived growth factor production [GO:0090361]; regulation of vascular endothelial growth factor production [GO:0010574]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; regulation of platelet-derived growth factor production [GO:0090361]; regulation of vascular endothelial growth factor production [GO:0010574]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]; Wnt signaling pathway [GO:0016055] GO:0001818; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0010574; GO:0016055; GO:0021762; GO:0030154; GO:0030426; GO:0048471; GO:0048662; GO:0070062; GO:0070373; GO:0090361 GGDITLR 7.679999828 1 1 0.252527109 732.5837234 17.10542 0 16.9087 0 17.50864 0 0 0 0 0 0 0 17.8001 18.83426 0 19.67763 0 18.68984 18.49979 0 17.69657 0 19.5856 17.71226 20.26391 0 0 19.83634 0 0 0 20.01296 0 19.93129 0 18.3205 17.69033 0 0 0 17.55062 0 0 17.65858 0 20.23737 0 0 Q9UN37 VPS4A_HUMAN "Vacuolar protein sorting-associated protein 4A, EC 3.6.4.6 (Protein SKD2) (VPS4-1, hVPS4)" VPS4A VPS4 Homo sapiens (Human) abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein disaggregase activity [GO:0140545]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein disaggregase activity [GO:0140545]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] GO:0000916; GO:0000922; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006914; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0007084; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0046761; GO:0048471; GO:0051301; GO:0060548; GO:0061640; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0072319; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:0140545; GO:1903076; GO:1903543; GO:1903774; GO:1904896; GO:1904903; GO:1904949 TEGYSGADISIIVR 8.850000381 1 1 0.576798015 1479.896959 0 0 0 17.83323 0 0 0 18.31561 0 0 0 0 0 0 0 0 0 18.20216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.32345 0 0 0 0 0 Q9UN67 PCDBA_HUMAN "Protocadherin beta-10, PCDH-beta-10" PCDHB10 UNQ1906/PRO4352 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202 SGTSTVR 2.74000001 1 1 0.142519061 706.1626 15.62279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.95536 0 0 0 0 19.62089 0 0 0 0 16.16381 0 0 0 0 17.16849 16.5078 0 0 0 0 0 16.66065 0 0 16.45975 0 0 0 0 Q9UN70 PCDGK_HUMAN "Protocadherin gamma-C3, PCDH-gamma-C3 (Protocadherin-2) (Protocadherin-43, PC-43)" PCDHGC3 PCDH2 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016020; GO:0016339; GO:0043524; GO:0050808 DAGTPSLSALTIVR 2.140000105 1 1 0.207796636 1400.551057 0 0 0 0 0 0 0 0 15.71675 0 14.64766 16.15551 0 0 0 0 0 15.55478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN71 PCDGG_HUMAN "Protocadherin gamma-B4, PCDH-gamma-B4 (Cadherin-20) (Fibroblast cadherin-2)" PCDHGB4 CDH20 FIB2 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016020; GO:0016339 SDGSK 3.329999924 1 1 0.206617124 494.1884193 12.75469 18.5861 19.45498 0 0 16.52596 0 0 17.6535 0 0 17.46032 0 16.18927 17.40602 0 0 15.45501 0 16.40503 0 0 0 18.78952 18.99834 18.93324 18.4885 0 0 17.19111 0 17.34132 0 0 18.8677 19.04335 18.93266 0 0 16.46783 0 0 16.53729 0 0 15.7581 0 0 Q9UN74 PCDA4_HUMAN "Protocadherin alpha-4, PCDH-alpha-4" PCDHA4 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0042802 SKFHIDPITGQIIVK 3.200000048 1 1 0.267160323 1692.83256 14.96477 0 13.83203 0 0 0 0 0 15.13642 0 0 0 0 0 0 0 0 0 0 16.14691 14.01503 0 0 0 0 14.665 0 0 0 0 0 0 0 16.78336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN79 SOX13_HUMAN Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12) SOX13 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; gamma-delta T cell differentiation [GO:0042492]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; gamma-delta T cell differentiation [GO:0042492]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001217; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0009653; GO:0021529; GO:0042492; GO:0042802; GO:0043565; GO:0045165; GO:0045588; GO:0045892; GO:0090090; GO:0090336 AIQDAR 1.110000014 0.896874666 0.896874666 0.211037531 671.7420387 15.24234 9.059141 14.70912 14.14083 0 14.81212 16.19732 0 0 15.17727 13.82187 15.09904 0 14.85945 14.34008 16.0422 0 15.20936 15.84093 14.52101 16.07605 15.84115 15.0507 0 16.62005 0 0 0 16.00221 0 0 0 0 16.47647 0 16.22013 15.47448 0 0 14.78477 0 0 0 13.29486 16.00571 0 15.69588 0 Q9UN81 LORF1_HUMAN "LINE-1 retrotransposable element ORF1 protein, L1ORF1p (LINE retrotransposable element 1) (LINE1 retrotransposable element 1)" L1RE1 LRE1 Homo sapiens (Human) "transposition, RNA-mediated [GO:0032197]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transposition, RNA-mediated [GO:0032197]" identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727] GO:0000166; GO:0003697; GO:0003727; GO:0005730; GO:0005737; GO:0010494; GO:0032197; GO:0036464; GO:0042802; GO:1990904 QANVQIQEIQR 3.230000019 0.820357144 0.820357144 4.58E-13 1329.825959 14.68614 0 0 14.37305 14.32489 16.05149 14.09545 0 14.68512 13.70883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.68762 0 0 0 13.86092 0 0 0 0 0 0 0 0 0 0 0 14.65794 0 14.53468 0 11.80919 0 0 0 Q9UNA0 ATS5_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 5, ADAM-TS 5, ADAM-TS5, ADAMTS-5, EC 3.4.24.- (A disintegrin and metalloproteinase with thrombospondin motifs 11, ADAM-TS 11, ADAMTS-11) (ADMP-2) (Aggrecanase-2)" ADAMTS5 ADAMTS11 ADMP2 Homo sapiens (Human) defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; negative regulation of cold-induced thermogenesis [GO:0120163]; proteolysis [GO:0006508]; tooth eruption [GO:0044691] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; negative regulation of cold-induced thermogenesis [GO:0120163]; proteolysis [GO:0006508]; tooth eruption [GO:0044691] endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270] GO:0004175; GO:0004222; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0006508; GO:0007520; GO:0008201; GO:0008233; GO:0008237; GO:0008270; GO:0022617; GO:0030198; GO:0031012; GO:0042742; GO:0044691; GO:0050840; GO:0062023; GO:0120163 VGYLVYAGGR 6.429999828 1 1 0.151617216 1053.319386 14.36308 0 16.23313 15.36561 0 0 0 0 0 0 13.84579 0 0 0 0 0 0 0 15.79206 0 0 16.60947 14.82424 0 0 0 0 0 0 15.32271 0 0 0 0 0 0 0 0 18.68643 0 0 0 0 13.31188 0 0 0 15.69361 Q9UNA1 RHG26_HUMAN Rho GTPase-activating protein 26 (GTPase regulator associated with focal adhesion kinase) (Oligophrenin-1-like protein) (Rho-type GTPase-activating protein 26) ARHGAP26 GRAF KIAA0621 OPHN1L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543] GO:0005096; GO:0005543; GO:0005829; GO:0005856; GO:0005925; GO:0007165; GO:0007399; GO:0030036; GO:0051056 NLSSAK 4.429999828 0.01598496 0.01598496 0.186621881 621.4921668 15.84844 14.10981 15.93735 14.89983 0 14.69613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.89216 14.72929 15.16972 0 15.72559 0 15.44386 11.79483 0 0 15.05 16.07615 16.90615 0 14.86685 0 0 16.97209 15.4361 0 0 15.60871 15.39735 15.35789 Q9UND3 NPIA1_HUMAN "Nuclear pore complex-interacting protein family member A1 (Nuclear pore complex-interacting protein, NPIP)" NPIPA1 NPIP Homo sapiens (Human) mRNA transport [GO:0051028]; protein transport [GO:0015031] nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; mRNA transport [GO:0051028]; protein transport [GO:0015031] GO:0005643; GO:0005654; GO:0015031; GO:0031965; GO:0051028 KPLCNR 3.839999914 1 1 0.245915215 786.9774927 0 15.46379 11.74628 0 0 0 15.8984 0 15.63066 0 0 0 0 0 0 0 0 0 0 0 0 16.92183 14.96297 0 15.70024 0 10.70661 15.75836 16.41941 14.77287 15.94284 0 15.80927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNE7 CHIP_HUMAN "E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)" STUB1 CHIP PP1131 Homo sapiens (Human) cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579] chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031 SPSAQELK 15.40999985 1 1 0.186221744 859.3154386 18.15282 15.33979 12.41994 0 0 0 0 0 15.06563 17.94689 0 0 15.74254 0 0 0 0 0 0 0 0 0 0 16.01669 14.57653 16.10469 0 0 0 15.38157 0 0 0 0 16.54338 0 0 13.75421 0 0 14.7512 0 0 0 16.36068 0 0 0 Q9UNF1 MAGD2_HUMAN "Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein, BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen)" MAGED2 BCG1 Homo sapiens (Human) female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294] GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294 AQETEAAPSQAPADEPEPESAAAQSQENQDTRPKVK 8.659999847 1 1 0.106747106 3805.697862 0 0 14.51179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNH6 SNX7_HUMAN Sorting nexin-7 SNX7 Homo sapiens (Human) positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031] early endosome [GO:0005769]; early endosome membrane [GO:0031901] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phosphatidylinositol binding [GO:0035091]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031] phosphatidylinositol binding [GO:0035091] GO:0005769; GO:0015031; GO:0031901; GO:0035091; GO:2000786 QGPGLLSR 10.38000011 1 1 4.59E-13 827.4826892 15.72009 14.89869 0 15.59734 0 16.00737 15.6681 0 15.40972 14.47466 0 15.93905 0 0 0 16.85977 16.40123 0 15.43025 16.13941 16.06376 0 0 0 0 0 14.35206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNI1 CELA1_HUMAN "Chymotrypsin-like elastase family member 1, EC 3.4.21.36 (Elastase-1) (Pancreatic elastase 1)" CELA1 ELA1 Homo sapiens (Human) elastin catabolic process [GO:0060309]; exocrine pancreas development [GO:0031017]; inflammatory response [GO:0006954]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas morphogenesis [GO:0061113]; positive regulation of angiogenesis [GO:0045766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proteolysis [GO:0006508]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; tissue remodeling [GO:0048771]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; elastin catabolic process [GO:0060309]; exocrine pancreas development [GO:0031017]; inflammatory response [GO:0006954]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas morphogenesis [GO:0061113]; positive regulation of angiogenesis [GO:0045766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proteolysis [GO:0006508]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; tissue remodeling [GO:0048771]; Wnt signaling pathway [GO:0016055] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] GO:0000122; GO:0004252; GO:0005615; GO:0006508; GO:0006954; GO:0009791; GO:0016055; GO:0031017; GO:0035264; GO:0042127; GO:0045595; GO:0045766; GO:0045944; GO:0046872; GO:0048771; GO:0060309; GO:0061113 NTMVCAGGDGVR 9.609999657 1 1 0.53140024 1234.890637 0 0 0 0 0 0 0 0 14.27678 0 0 0 0 0 18.90015 0 0 0 0 0 15.27528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNI6 DUS12_HUMAN "Dual specificity protein phosphatase 12, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity tyrosine phosphatase YVH1)" DUSP12 Homo sapiens (Human) cellular protein modification process [GO:0006464]; dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470] kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006470; GO:0008138; GO:0008270; GO:0016311; GO:0016791; GO:0019900; GO:0033133 DEVLYKCR 9.210000038 0.351579577 0.351579577 0.188996152 1081.538737 15.10195 0 13.98946 0 0 0 0 13.38097 0 0 0 0 0 0 0 0 0 15.31151 13.20756 13.10423 13.75909 15.95036 15.95194 15.70996 15.06975 0 14.7072 15.17155 0 0 15.08319 14.28803 14.76666 14.21741 15.2893 0 16.05626 0 0 15.94734 0 15.35901 0 15.38445 0 0 13.21477 0 Q9UNK0 STX8_HUMAN Syntaxin-8 STX8 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625] GO:0000149; GO:0005484; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005829; GO:0005887; GO:0006886; GO:0006906; GO:0008333; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031902; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076 RVNMVDR 1 1 1 0.019867079 889.7234266 0 14.68831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.91005 0 0 15.80582 0 0 0 0 0 0 15.71612 0 0 0 0 15.07524 12.88616 16.30077 0 0 0 13.73723 0 0 0 0 0 0 0 0 Q9UNQ0 ABCG2_HUMAN "Broad substrate specificity ATP-binding cassette transporter ABCG2, EC 7.6.2.2 (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)" ABCG2 ABCP BCRP BCRP1 MXR Homo sapiens (Human) biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] GO:0005524; GO:0005654; GO:0005886; GO:0006869; GO:0008514; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015711; GO:0015878; GO:0016021; GO:0016324; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0042802; GO:0042803; GO:0042910; GO:0045121; GO:0046415; GO:0055085; GO:0070633; GO:0097744; GO:0098591; GO:0140115; GO:0150104; GO:1990748; GO:1990962 ATEIIEPSK 1.480000019 0.102700256 0.102700256 0.009223706 988.3656174 14.22317 16.07393 0 0 0 0 0 0 13.8287 13.19478 0 0 15.44454 13.43962 13.55898 0 0 0 0 0 14.70276 0 0 0 16.35199 0 0 0 0 0 0 15.03824 0 0 0 0 0 0 0 15.49513 0 0 0 0 0 0 14.85425 14.3278 Q9UNQ2 DIM1_HUMAN "Probable dimethyladenosine transferase, EC 2.1.1.183 (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)" DIMT1 DIMT1L HUSSY-05 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]" "18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234 SGAIGR 1.75 1 1 0.244125804 560.2422575 16.13793 15.82531 17.62769 0 0 0 0 0 0 0 0 0 0 17.09431 0 0 0 0 15.81524 16.84324 0 16.48767 16.50143 0 17.72219 17.51619 16.66426 0 0 16.38468 0 0 0 17.62575 0 0 0 18.2874 0 0 0 0 0 0 0 18.46337 16.11657 0 Q9UNS1 TIM_HUMAN "Protein timeless homolog, hTIM" TIMELESS TIM TIM1 TIMELESS1 Homo sapiens (Human) "branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]" DNA binding [GO:0003677]; identical protein binding [GO:0042802] GO:0000076; GO:0000122; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0009582; GO:0030324; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048478; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781 ALLLAHKK 1.840000033 1 1 0.173442794 893.6910847 16.40143 15.00181 0 0 0 0 15.88997 0 13.42448 15.43954 15.12482 15.95509 16.12831 15.34789 0 0 0 14.44134 0 16.21878 15.63006 0 15.51544 15.22126 16.55914 0 14.84137 0 15.28475 14.43657 14.99929 0 15.51826 12.92204 0 14.35697 16.71393 15.61155 16.92904 15.2658 16.25413 16.29105 15.18362 14.98728 15.14653 16.1859 16.20606 15.30374 Q9UNW1 MINP1_HUMAN "Multiple inositol polyphosphate phosphatase 1, EC 3.1.3.62 (2,3-bisphosphoglycerate 3-phosphatase, 2,3-BPG phosphatase, EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase, Ins(1,3,4,5)P(4) 3-phosphatase)" MINPP1 MIPP UNQ900/PRO1917 Homo sapiens (Human) bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]; bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]" "acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]" GO:0001503; GO:0003993; GO:0005783; GO:0005788; GO:0006797; GO:0030282; GO:0030351; GO:0034417; GO:0043647; GO:0051717; GO:0052745; GO:0052826; GO:0070062; GO:0101006 LITSSK 7.059999943 1 1 0.126526489 645.4386984 16.48859 0 0 0 0 0 0 15.0622 15.45089 0 0 14.92737 0 0 0 16.00422 0 0 0 13.91713 0 0 0 0 0 16.37332 0 0 0 0 16.91532 0 15.16583 16.37461 14.85209 0 0 16.97678 15.28037 17.24973 16.62948 16.33892 15.2702 16.04868 15.47759 16.22997 16.94166 16.22773 Q9UNW8 GP132_HUMAN Probable G-protein coupled receptor 132 (G2 accumulation protein) GPR132 G2A Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] G protein-coupled receptor activity [GO:0004930] GO:0000082; GO:0004930; GO:0005886; GO:0010972; GO:0016021 CPMLLK 20.25 0.338056982 0.338056982 0.244113432 762.0386162 18.2135 19.09359 18.61115 0 15.28102 0 21.54016 0 21.31044 17.09639 0 16.98907 18.74444 18.24773 18.66063 19.89181 0 18.12315 20.05333 17.44826 0 0 18.06194 18.04852 22.5887 0 21.07516 0 18.1079 19.72703 0 19.78669 19.99442 20.72843 20.72176 21.14278 19.98779 18.65938 19.26265 0 0 0 0 17.2822 18.22805 18.72527 17.78858 18.49927 Q9UNX4 WDR3_HUMAN WD repeat-containing protein 3 WDR3 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388 GEKILILQGLK 10.14000034 1 1 0.123921859 1216.053501 0 15.73733 12.13934 0 0 0 0 14.05741 0 0 0 0 13.37043 14.48189 0 0 0 0 0 11.86117 0 0 0 0 0 0 0 0 0 0 0 0 15.91052 0 0 0 0 0 0 10.7468 0 0 0 0 0 0 0 0 Q9UNX9 KCJ14_HUMAN "ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4, IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14)" KCNJ14 IRK4 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] inward rectifier potassium channel activity [GO:0005242] GO:0005242; GO:0005886; GO:0008076; GO:0030425; GO:0034765; GO:0043025; GO:1990573 AEQASHSLK 13.10000038 0.681856096 0.681856096 0.225394651 970.588703 18.7738 15.28839 17.42377 17.08224 0 17.83538 16.1139 15.51214 15.70944 15.28969 16.5275 15.49642 15.21794 14.60408 13.4348 17.00832 16.10935 15.41761 14.01034 13.5376 12.87611 16.68735 15.49108 17.28436 16.09687 10.57179 17.57006 16.43133 16.10639 13.52069 0 17.44712 20.25152 18.25234 15.58538 0 19.1074 0 0 0 16.06866 0 15.83478 14.14821 16.00658 16.28281 16.21722 0 Q9UNY5 ZN232_HUMAN Zinc finger protein 232 (Zinc finger and SCAN domain-containing protein 11) ZNF232 ZSCAN11 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0043231; GO:0046872 DHECSECGK 1.580000043 1 1 6.88E-13 1122.233534 14.71566 14.83216 14.06168 0 14.94664 0 13.95397 0 0 0 0 0 0 0 15.52421 0 0 0 17.65455 0 0 0 12.69842 16.34957 0 15.55309 0 0 0 0 15.74057 0 14.89653 0 0 0 0 0 16.95128 15.76791 13.8671 0 0 15.88454 0 0 0 0 Q9UNZ5 L10K_HUMAN Leydig cell tumor 10 kDa protein homolog C19orf53 HSPC023 Homo sapiens (Human) KGAAAATSSK 9.520000458 0.255715698 0.255715698 0.252142104 891.119566 0 0 0 0 0 0 17.42495 0 16.10272 0 0 16.56948 0 0 0 18.07436 0 0 0 0 0 0 0 0 0 0 0 17.09319 17.65432 0 17.42862 0 0 0 0 18.73232 0 18.32891 0 0 0 18.06236 0 17.41539 0 0 0 0 Q9UP52 TFR2_HUMAN "Transferrin receptor protein 2, TfR2" TFR2 Homo sapiens (Human) acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572] cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; transferrin receptor activity [GO:0004998]; acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572] co-receptor binding [GO:0039706]; transferrin receptor activity [GO:0004998] GO:0004998; GO:0005886; GO:0005887; GO:0006826; GO:0006879; GO:0006898; GO:0006953; GO:0009897; GO:0010039; GO:0031410; GO:0033572; GO:0039706; GO:0045807; GO:0045944; GO:0055072; GO:0071281; GO:0090277; GO:0140298; GO:1903319; GO:1990712 AVVYVSLDNAVLGDDKFHAK 1.899999976 1 1 0.166476985 2163.960914 0 0 11.25035 0 0 12.31431 14.38055 0 0 13.6413 14.28311 13.24324 13.65509 13.07746 0 0 0 0 15.99821 0 0 0 0 0 0 13.11479 15.24049 0 0 0 0 16.12446 0 0 0 0 16.18086 0 0 0 0 13.84779 0 0 16.27786 0 0 0 Q9UPA5 BSN_HUMAN Protein bassoon (Zinc finger protein 231) BSN KIAA0434 ZNF231 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of synaptic vesicle cycle [GO:0098693] axon [GO:0030424]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] axon [GO:0030424]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; structural constituent of presynaptic active zone [GO:0098882]; chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of synaptic vesicle cycle [GO:0098693] metal ion binding [GO:0046872]; structural constituent of presynaptic active zone [GO:0098882] GO:0005634; GO:0007268; GO:0008021; GO:0009986; GO:0014069; GO:0030424; GO:0030425; GO:0030672; GO:0035418; GO:0044306; GO:0046872; GO:0048786; GO:0048788; GO:0060076; GO:0098685; GO:0098693; GO:0098882; GO:0098978; GO:0098982; GO:0099526; GO:1904071 AAAKPKTMPK 2.559999943 1 1 0.036744763 1041.423982 0 0 16.68959 0 0 0 0 0 0 0 0 14.19448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21116 15.44709 0 0 0 0 0 0 0 15.02214 0 14.50072 0 15.04774 0 0 0 0 0 0 Q9UPC5 GPR34_HUMAN Probable G-protein coupled receptor 34 GPR34 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005887; GO:0007186; GO:0045028 IQSSSK 5.659999847 1 1 0.20591168 648.7613196 15.67313 15.35941 0 17.45577 15.77062 0 15.75086 14.50424 15.13085 0 0 14.14102 0 0 0 0 0 18.1931 0 16.28468 0 0 12.96534 0 0 16.10661 0 0 0 0 0 16.46159 0 0 0 16.61611 0 0 0 0 16.0796 0 0 0 0 0 0 0 Q9UPE1 SRPK3_HUMAN "SRSF protein kinase 3, EC 2.7.11.1 (Muscle-specific serine kinase 1, MSSK-1) (Serine/arginine-rich protein-specific kinase 3, SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23)" SRPK3 MSSK1 STK23 Homo sapiens (Human) cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000245; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0007519; GO:0030154; GO:0035556; GO:0050684; GO:0060537; GO:0106310 GGYHPVK 9.68999958 1 1 0.085552848 756.3696262 0 9.597686 13.7156 0 0 0 0 0 0 0 0 0 0 19.33494 0 18.5276 0 0 19.40611 0 0 0 0 0 14.92064 18.11976 15.99353 16.11229 0 0 0 16.89876 15.0071 14.77176 15.74834 13.3473 14.90608 15.03839 0 0 15.47024 0 0 0 0 0 0 0 Q9UPG8 PLAL2_HUMAN Zinc finger protein PLAGL2 (Pleiomorphic adenoma-like protein 2) PLAGL2 KIAA0198 Homo sapiens (Human) "chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006351; GO:0006357; GO:0006629; GO:0009791; GO:0034378; GO:0043565; GO:0046872; GO:2001244 DVMGTK 5.409999847 1 1 0.142920001 665.633675 0 0 0 0 0 0 0 0 15.72933 0 0 0 17.05923 0 0 0 15.83592 0 0 0 0 0 16.57907 0 0 16.35096 16.38759 0 0 0 16.11156 16.82872 0 0 15.86542 0 0 16.02576 16.73602 12.812 16.66198 14.13079 16.32155 15.57782 0 0 0 15.69324 Q9UPI3 FLVC2_HUMAN "Feline leukemia virus subgroup C receptor-related protein 2 (Calcium-chelate transporter, CCT)" FLVCR2 C14orf58 Homo sapiens (Human) heme export [GO:0097037] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; heme export [GO:0097037] heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232] GO:0005886; GO:0015232; GO:0016021; GO:0020037; GO:0097037 ANKETLENK 8.720000267 1 1 0 1046.700924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPM6 LHX6_HUMAN "LIM/homeobox protein Lhx6, LIM homeobox protein 6 (LIM/homeobox protein Lhx6.1)" LHX6 LHX6.1 Homo sapiens (Human) cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0021799; GO:0021800; GO:0021853; GO:0021884; GO:0030182; GO:0046872; GO:0048469; GO:1990837 MAQPGSGCK 4.920000076 1 1 0.233238603 934.8682449 15.8654 0 0 16.37767 15.52898 14.80655 15.15346 16.67403 14.97558 14.206 16.36789 0 0 15.32063 0 0 0 0 0 0 0 16.18985 0 15.67757 15.55462 14.86792 16.00392 14.96014 15.23884 15.42821 0 16.26935 14.60171 15.15178 15.13055 15.41997 14.50206 15.27664 13.32014 15.8417 14.75973 16.15025 14.33624 15.13959 0 16.29271 16.60155 15.1809 Q9UPM8 AP4E1_HUMAN AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin) AP4E1 Homo sapiens (Human) protein localization [GO:0008104]; protein targeting [GO:0006605]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; cargo adaptor activity [GO:0140312]; protein localization [GO:0008104]; protein targeting [GO:0006605]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] cargo adaptor activity [GO:0140312] GO:0005802; GO:0006605; GO:0006898; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0140312 LGSLVRGITALTSK 6.639999866 1 1 0.183992408 1416.730214 0 0 15.69919 13.51847 0 14.89215 0 15.70428 0 13.45239 14.10502 14.86993 0 0 16.55989 0 14.47972 16.15795 0 0 0 16.92056 0 0 14.69958 0 0 0 0 0 0 0 0 0 15.52172 15.52668 14.28247 0 0 15.79475 16.80379 15.71003 15.1543 0 16.49022 0 0 16.13334 Q9UPN3 MACF1_HUMAN "Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein, ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)" MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 DATER 4.190000057 1 1 0.191398668 590.8592242 0 15.80226 0 0 0 17.14808 16.95716 0 0 0 0 0 0 0 17.33108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.74647 0 0 0 0 Q9UPN4 CP131_HUMAN Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1) CEP131 AZI1 KIAA1118 Homo sapiens (Human) cell cycle [GO:0007049]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288] protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0005829; GO:0007049; GO:0007288; GO:0008284; GO:0010824; GO:0015630; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042803; GO:0043231; GO:0044877; GO:0045171; GO:0060271; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953 AAIQELQQK 12.61999989 0.651562452 0.651562452 0.227673855 1027.60643 0 14.99496 0 0 16.04703 0 0 13.65947 17.32771 0 13.20709 0 15.0084 0 16.9949 0 13.98163 0 0 15.63202 16.39856 15.20571 0 12.91585 14.42016 16.84178 0 0 0 0 15.5163 13.13818 12.68306 0 0 0 0 0 15.77398 13.89977 14.47709 0 18.91684 0 19.01634 0 15.28321 0 Q9UPN6 SCAF8_HUMAN SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) SCAF8 CCAP7 KIAA1116 RBM16 Homo sapiens (Human) "mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]" cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]" mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993] GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805 GLPPIRSK 4.21999979 1 1 0.250939258 869.2531752 15.25778 15.47376 16.96654 14.51502 15.22996 14.86006 0 0 0 15.0221 13.46671 16.63828 15.25592 0 14.37343 16.80894 15.93513 0 15.23785 15.21762 0 16.30502 17.12827 15.17438 0 0 17.3588 0 0 0 0 15.64085 15.46209 0 16.62885 0 17.18039 16.36802 15.47773 12.82344 0 0 15.69887 14.97398 0 16.49182 16.63057 15.73243 Q9UPP1 PHF8_HUMAN "Histone lysine demethylase PHF8, EC 1.14.11.27, EC 1.14.11.65 (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8)" PHF8 KIAA1111 ZNF422 Homo sapiens (Human) "brain development [GO:0007420]; chromatin organization [GO:0006325]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin organization [GO:0006325]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] GO:0000082; GO:0003682; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558; GO:0140680; GO:0140683 KDGLGMTLPSPSFTVR 7.320000172 1 1 0.071800468 1721.617471 0 0 0 0 17.64304 0 0 0 17.36052 14.30794 14.48914 0 13.68916 0 14.63738 13.72708 14.71894 14.4952 16.02324 0 0 0 0 0 14.88286 0 0 0 0 0 0 0 0 0 0 0 13.44153 0 0 0 0 13.53838 0 0 13.47581 0 0 0 Q9UPP2 IQEC3_HUMAN IQ motif and SEC7 domain-containing protein 3 IQSEC3 KIAA1110 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629] cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005654; GO:0005829; GO:0014069; GO:0030036; GO:0032012; GO:0045211; GO:0060077; GO:0098690; GO:0098982; GO:0099629 AACTIQTAFRQYQLSK 3.5 1 1 2.28E-12 1885.265526 0 14.84967 13.05665 8.86089 14.24058 14.3331 0 14.77984 14.6495 0 0 16.30043 0 14.77941 12.42053 14.54917 0 0 0 13.16782 15.28856 0 0 0 12.95281 15.76359 14.21318 0 12.76401 0 0 14.63848 0 0 13.74044 0 0 17.00599 0 13.61454 13.62648 0 11.47917 14.68912 13.41894 0 14.65673 15.37667 Q9UPP5 K1107_HUMAN "AP2-interacting clathrin-endocytosis protein, APache" KIAA1107 Homo sapiens (Human) clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; neuron projection development [GO:0031175]; synaptic vesicle recycling via endosome [GO:0036466] axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle [GO:0030136]; neuron projection terminus [GO:0044306]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021] axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle [GO:0030136]; neuron projection terminus [GO:0044306]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; neuron projection development [GO:0031175]; synaptic vesicle recycling via endosome [GO:0036466] GO:0008021; GO:0030136; GO:0030424; GO:0031175; GO:0036466; GO:0044297; GO:0044306; GO:0098793; GO:0150007 VTNGTSNK 3.74000001 0.709868729 0.709868729 1.14E-12 817.4703859 15.57987 16.22122 12.43394 15.28848 15.62984 16.0101 16.47894 17.38835 15.81856 17.88201 0 15.67276 0 0 18.21389 17.70477 15.02728 0 16.44934 0 13.51707 16.80737 16.36838 14.92463 0 0 0 0 0 0 0 19.3985 17.15767 16.77446 0 0 16.85903 12.16116 0 15.85232 0 14.57907 0 0 0 0 17.2032 15.80488 Q9UPQ0 LIMC1_HUMAN LIM and calponin homology domains-containing protein 1 LIMCH1 KIAA1102 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893] cytoplasm [GO:0005737]; stress fiber [GO:0001725] cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893] actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034] GO:0001725; GO:0001934; GO:0003779; GO:0005737; GO:0030336; GO:0031032; GO:0032034; GO:0046872; GO:0051496; GO:0051893; GO:0060327 EFEGLLAQMR 1.629999995 0.278757811 0.278757811 0.196269282 1210.234613 14.82268 12.50735 13.81033 0 0 0 0 0 0 0 13.8335 15.21284 14.44762 14.19134 0 0 0 12.0879 10.31666 15.78337 0 14.6263 0 0 14.14229 12.81069 13.21172 0 0 14.0241 12.63251 13.50848 0 14.25297 0 0 0 0 0 15.068 14.1428 0 0 0 0 0 0 0 Q9UPQ7 PZRN3_HUMAN "E3 ubiquitin-protein ligase PDZRN3, EC 2.3.2.27 (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3, Protein SEMACAP3)" PDZRN3 KIAA1095 LNX3 SEMCAP3 Homo sapiens (Human) neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594] cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0004842; GO:0005737; GO:0007528; GO:0008270; GO:0016567; GO:0031594; GO:0061630 AHNGALQAR 12.81000042 0.160425663 0.160425663 0.057476001 937.9522723 16.93774 16.53273 0 0 0 0 0 0 16.87691 0 15.94326 0 0 18.08065 15.86958 0 0 17.62692 15.74512 17.63609 0 0 10.8294 11.21413 16.08828 19.15668 16.11801 16.81041 17.20735 14.86294 0 16.72259 15.50678 0 0 16.39321 17.83779 16.89027 19.00737 17.09343 12.98522 0 17.53265 0 17.38034 17.35149 0 16.36048 Q9UPQ9 TNR6B_HUMAN Trinucleotide repeat-containing gene 6B protein TNRC6B KIAA1093 Homo sapiens (Human) "gene silencing by miRNA [GO:0035195]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0031047; GO:0035195; GO:0035278; GO:0060213; GO:1900153; GO:1905618 NGAIVAPGKTR 2.539999962 1 1 0.097110699 1082.980001 12.93057 15.10812 12.58267 11.35616 15.43726 11.27609 14.45525 14.14696 12.41326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.88655 0 0 0 0 0 0 0 0 0 0 0 0 17.10904 0 0 0 0 0 0 0 0 13.45477 0 Q9UPR3 SMG5_HUMAN "Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog, hSMG-5)" SMG5 EST1B KIAA1089 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625] GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0042826; GO:0051721; GO:0070034 KPVSASGK 1.830000043 1 1 6.91E-13 771.4270869 0 0 0 0 0 0 0 0 0 0 0 0 17.15638 0 0 16.32643 0 0 0 0 0 17.33141 0 0 0 0 0 0 15.11995 0 17.2004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPR5 NAC2_HUMAN Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2) SLC8A2 KIAA1087 NCX2 Homo sapiens (Human) calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202] axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081] GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:0150104; GO:1903779; GO:1905060; GO:1990034 RIAEMGKPVLGENCR 2.539999962 0.605351567 0.605351567 0.388844644 1744.940659 13.42933 10.32195 13.73672 16.35418 14.50244 0 14.87558 0 15.03702 0 16.22916 14.63752 0 16.4138 14.86269 13.88145 0 0 0 0 0 0 0 0 0 0 0 16.26452 0 0 0 0 0 15.36996 0 0 0 0 0 0 0 0 0 0 0 0 14.54972 0 Q9UPR6 ZFR2_HUMAN Zinc finger RNA-binding protein 2 ZFR2 KIAA1086 Homo sapiens (Human) double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] GO:0003725; GO:0003727; GO:0008270 GGEGLV 25.55999947 0.560828209 0.560828209 0.23396096 531.1346311 0 15.48586 15.25321 0 13.48044 11.45957 15.7011 15.80775 15.48414 17.02103 16.35055 14.1693 15.09814 15.93653 15.30451 16.25779 15.0769 15.54918 15.16781 16.33357 15.18473 16.28672 17.2765 17.21955 15.93 16.35351 14.17916 0 16.24456 0 16.25502 15.98119 16.57516 15.76825 14.70621 16.76543 16.21556 16.89916 16.71739 15.55389 15.54406 14.17797 16.99084 0 15.50443 0 15.51212 14.99945 Q9UPS8 ANR26_HUMAN Ankyrin repeat domain-containing protein 26 ANKRD26 KIAA1074 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] centrosome [GO:0005813]; negative regulation of fat cell differentiation [GO:0045599] GO:0005813; GO:0045599 EYVQVLK 2.309999943 1 1 0.192237394 876.41282 0 14.10347 14.57037 14.50426 0 0 0 0 0 0 0 0 0 0 0 0 15.80294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.69436 0 0 Q9UPT5 EXOC7_HUMAN Exocyst complex component 7 (Exocyst complex component Exo70) EXOC7 EXO70 KIAA1067 Homo sapiens (Human) exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0032584; GO:0034451; GO:0090148; GO:0090522; GO:0090543; GO:2000535 LFDTSA 7.460000038 1 1 0.235875349 653.1420592 0 15.57815 15.65613 15.66663 0 15.67388 16.13793 0 15.75561 0 15.38295 16.49185 0 15.4513 15.56809 0 0 0 0 16.72391 15.88838 15.53798 16.27483 16.08044 0 0 0 17.18528 15.5582 0 0 0 0 0 0 0 0 0 0 0 14.97012 0 15.75444 0 0 0 0 0 Q9UPT6 JIP3_HUMAN "C-Jun-amino-terminal kinase-interacting protein 3, JIP-3, JNK-interacting protein 3 (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)" MAPK8IP3 JIP3 KIAA1066 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192] JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] GO:0000139; GO:0005078; GO:0005737; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0043066; GO:0044297; GO:0046328; GO:0046330; GO:0048471; GO:0050821; GO:0061564; GO:0099641; GO:1904115 IPMAQRR 7.429999828 0.44592315 0.44592315 0.211417457 888.325397 14.02462 14.09602 0 0 0 0 0 0 0 16.12108 0 0 17.72779 15.67683 17.01066 14.97945 0 15.10966 0 17.96339 16.1258 0 0 15.58915 10.66422 14.5227 16.92628 17.56926 14.97068 17.22601 16.53634 16.5034 14.73204 16.2356 14.42058 14.58358 17.39697 16.34378 18.63066 16.6448 13.55527 15.21765 6.793787 17.37643 16.77799 15.73786 0 17.87576 Q9UPT8 ZC3H4_HUMAN Zinc finger CCCH domain-containing protein 4 ZC3H4 C19orf7 KIAA1064 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]" metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0045892; GO:0046872 APTDPR 4.809999943 0.717248261 0.717248261 0.25025356 655.786754 13.901 15.4624 0 0 0 14.68314 15.43774 14.51917 14.98082 15.17982 16.45824 0 0 0 0 15.32948 0 0 16.97718 15.68183 16.20766 0 0 15.53429 16.17291 0 0 0 0 0 0 0 15.96071 16.19155 0 0 0 16.40972 0 14.90014 15.07588 0 0 0 0 0 0 0 Q9UPU5 UBP24_HUMAN "Ubiquitin carboxyl-terminal hydrolase 24, EC 3.4.19.12 (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)" USP24 KIAA1057 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579 GLFVEKMPAR 5.010000229 1 1 0.026309858 1147.858065 8.826991 0 11.68048 13.57148 11.88104 14.48817 12.78766 0 13.74399 13.93684 0 0 0 0 14.46083 9.714729 11.72407 0 0 0 0 0 0 0 0 8.838489 0 0 0 12.41296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPU7 TBD2B_HUMAN TBC1 domain family member 2B TBC1D2B KIAA1055 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897] cytosol [GO:0005829]; early endosome [GO:0005769] cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897] GTPase activator activity [GO:0005096] GO:0005096; GO:0005769; GO:0005829; GO:0006897; GO:0090630 DIIGSYK 10.32999992 0.338932574 0.338932574 0.286293428 798.0291696 16.30049 15.4585 14.997 14.41942 12.79803 13.27527 0 12.95198 14.95323 14.453 15.012 14.83047 16.3509 13.48975 0 15.46647 14.86953 15.1626 15.14233 0 15.84518 0 14.69576 16.84399 14.86745 0 15.67199 0 15.99899 14.46969 0 0 0 14.33886 16.32076 14.26893 15.71513 15.84413 0 0 15.58009 15.34425 0 16.03195 0 15.97868 15.34548 0 Q9UPV0 CE164_HUMAN "Centrosomal protein of 164 kDa, Cep164" CEP164 KIAA1052 NPHP15 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007049; GO:0051301; GO:0060271; GO:0097539 EHSAELERLCSSLEAK 10.56000042 0.951785147 0.951785147 0.235251324 1859.335735 0 0 15.94611 0 0 0 0 15.46255 0 16.10321 0 0 17.74468 0 0 0 17.48484 0 0 16.43776 0 0 0 14.50862 0 0 0 0 0 0 0 0 0 19.25107 0 0 16.01656 0 0 0 0 0 0 0 17.57971 15.46303 16.65441 0 Q9UPV9 TRAK1_HUMAN Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein) (Protein Milton) TRAK1 KIAA1042 OIP106 Homo sapiens (Human) anterograde axonal transport of mitochondrion [GO:0098957]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; anterograde axonal transport of mitochondrion [GO:0098957]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496] GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005829; GO:0005938; GO:0006357; GO:0006493; GO:0006605; GO:0008333; GO:0017022; GO:0022008; GO:0030425; GO:0031410; GO:0031966; GO:0047496; GO:0048311; GO:0050811; GO:0098957; GO:1904115 HELSMK 6.019999981 1 1 0.056245088 744.2644138 16.49361 13.45106 15.93364 0 0 15.52338 0 15.75641 13.00913 15.5595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64713 0 0 0 0 0 0 0 0 0 0 17.08893 0 15.22985 0 Q9UPW5 CBPC1_HUMAN "Cytosolic carboxypeptidase 1, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1)" AGTPBP1 CCP1 KIAA1035 NNA1 Homo sapiens (Human) adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] GO:0001754; GO:0004181; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0042133; GO:0043231; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060 IVGLLAQLEK 10.53999996 1 1 0.100981779 1083.095581 0 13.54122 15.08278 14.33298 15.18867 9.869556 0 8.550252 0 0 14.65006 16.18527 12.37927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPW6 SATB2_HUMAN DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2) SATB2 KIAA1034 Homo sapiens (Human) cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000118; GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002076; GO:0003682; GO:0005654; GO:0005667; GO:0006338; GO:0006357; GO:0009880; GO:0016363; GO:0021902; GO:0042826; GO:0045944; GO:0048704; GO:0051216; GO:0060021; GO:0071310 KEEDPR 16.57999992 1 1 0.208373244 772.9653235 14.17957 15.1912 0 0 0 0 0 14.01079 0 0 0 13.16519 0 0 0 0 17.24223 17.32805 0 0 0 0 0 21.07186 0 16.03705 0 0 0 0 0 16.26455 21.89251 0 22.33602 0 17.31447 0 0 0 16.33936 0 0 0 0 0 0 0 Q9UPW8 UN13A_HUMAN Protein unc-13 homolog A (Munc13-1) UNC13A KIAA1032 Homo sapiens (Human) "cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] "neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075] GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007269; GO:0007528; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030154; GO:0030672; GO:0031594; GO:0035249; GO:0042734; GO:0043005; GO:0043195; GO:0048786; GO:0051966; GO:0061789; GO:0098831; GO:0099011; GO:0099525; GO:1903861 APVAPTEAPDMAKVAPKPATPDK 10.01000023 1 1 1.84E-12 2318.903334 13.14368 0 13.98195 9.121446 0 11.54666 6.417267 13.45481 13.96936 0 15.95477 13.98696 0 0 13.66795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPX6 MNAR1_HUMAN Major intrinsically disordered Notch2-binding receptor 1 (Membrane integral NOTCH2-associated receptor 1) (Ubiquitination and mTOR signaling protein) MINAR1 KIAA1024 UBTOR Homo sapiens (Human) angiogenesis [GO:0001525]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TOR signaling [GO:0032007] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TOR signaling [GO:0032007] GO:0001525; GO:0005886; GO:0008285; GO:0010977; GO:0016021; GO:0016525; GO:0030308; GO:0031397; GO:0032007 KIMVAADIVTIFNLIQMNGGAAK 6.480000019 1 1 4.57E-12 2434.14692 16.8261 0 0 0 16.47084 0 0 0 0 0 16.6767 0 0 15.57653 14.67526 16.14067 0 0 0 15.90482 0 15.92346 15.58719 0 0 0 0 0 0 15.91589 0 0 17.13287 15.49118 12.20693 17.73036 17.07442 15.87409 18.95087 0 0 0 16.6909 15.68929 12.38685 0 0 0 Q9UPX8 SHAN2_HUMAN "SH3 and multiple ankyrin repeat domains protein 2, Shank2 (Cortactin-binding protein 1, CortBP1) (Proline-rich synapse-associated protein 1)" SHANK2 CORTBP1 KIAA1022 PROSAP1 Homo sapiens (Human) adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; regulation of synapse organization [GO:0050807]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of postsynaptic density [GO:0098919]; synaptic receptor adaptor activity [GO:0030160]; adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; regulation of synapse organization [GO:0050807]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625] ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of postsynaptic density [GO:0098919]; synaptic receptor adaptor activity [GO:0030160] GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007420; GO:0007584; GO:0007612; GO:0008022; GO:0008284; GO:0008306; GO:0008344; GO:0009410; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0048786; GO:0050807; GO:0060170; GO:0060291; GO:0060292; GO:0071625; GO:0098686; GO:0098919; GO:0098978 MNIERALK 7.460000038 0.665849626 0.665849626 0.13874797 975.5480951 11.83927 14.35166 15.28221 12.10516 12.23018 8.872895 0 0 0 0 14.55995 14.13236 0 0 0 15.27394 0 0 16.0449 14.13613 0 15.42231 14.39054 16.66542 13.00217 13.86368 14.27112 17.46902 15.27067 14.47906 0 0 0 0 0 0 0 14.81879 0 0 12.71822 0 12.74334 17.95752 16.4329 0 12.38101 14.54332 Q9UPY3 DICER_HUMAN "Endoribonuclease Dicer, EC 3.1.26.3 (Helicase with RNase motif, Helicase MOI)" DICER1 DICER HERNA KIAA0928 Homo sapiens (Human) "apoptotic DNA fragmentation [GO:0006309]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA catabolic process [GO:0016078]" ARC complex [GO:0033167]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "ARC complex [GO:0033167]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; apoptotic DNA fragmentation [GO:0006309]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA catabolic process [GO:0016078]" ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; siRNA binding [GO:0035197] GO:0000122; GO:0003677; GO:0003723; GO:0003725; GO:0004386; GO:0004521; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006309; GO:0010586; GO:0010626; GO:0010629; GO:0014040; GO:0016078; GO:0016442; GO:0019904; GO:0021675; GO:0030422; GO:0030423; GO:0031054; GO:0031643; GO:0032290; GO:0032720; GO:0033167; GO:0035087; GO:0035196; GO:0035197; GO:0035280; GO:0038061; GO:0046872; GO:0048471; GO:0048812; GO:0070062; GO:0070578; GO:0070883; GO:0090501; GO:0090502 IPPRCMFDHPDADK 3.619999886 1 1 0.087814982 1699.505694 14.72032 0 13.48601 16.00012 0 0 14.92873 0 0 0 0 0 0 0 13.45332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.44265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPY5 XCT_HUMAN Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT) SLC7A11 Homo sapiens (Human) adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179] GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0015327; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211 CPDMHRPFK 10.5 1 1 0.792555241 1202.588919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.64144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPY8 MARE3_HUMAN "Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3, EBF3) (End-binding protein 3, EB3) (RP3)" MAPRE3 Homo sapiens (Human) "cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]" cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233] "cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]" identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901] GO:0005737; GO:0005815; GO:0008017; GO:0008022; GO:0008104; GO:0015630; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0042802; GO:0045737; GO:0045860; GO:0045893; GO:0048471; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721 IEQLCSGAAYCQFMDMLFPGCVHLRK 1.49000001 1 1 9.14E-13 3146.246591 13.83479 14.16349 0 14.79567 14.9447 12.23922 0 13.66503 0 0 13.22745 11.36714 10.70705 14.49079 0 12.41309 11.97009 0 10.62625 0 0 0 14.69323 0 14.88239 16.63922 13.05781 0 0 0 0 0 0 0 0 0 0 0 0 12.76239 0 0 0 0 0 0 0 0 Q9UPZ3 HPS5_HUMAN "Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog, Ru2)" HPS5 AIBP63 KIAA1017 Homo sapiens (Human) blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155] GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232 ESVSSFVRK 14.72000027 1 1 0.041159984 1038.554281 12.0778 12.76331 15.47089 14.46851 13.88684 14.8153 0 14.52793 0 0 11.99011 14.46635 0 0 0 0 0 0 0 0 0 14.39331 0 15.71445 0 12.85801 14.7976 15.0128 14.12931 0 13.34425 0 0 0 0 0 0 14.85736 0 0 0 0 0 0 0 0 0 0 Q9UPZ9 CILK1_HUMAN "Serine/threonine-protein kinase ICK, EC 2.7.11.1 (Ciliogenesis associated kinase 1) (Intestinal cell kinase, hICK) (Laryngeal cancer kinase 2, LCK2) (MAK-related kinase, MRK)" CILK1 ICK KIAA0936 Homo sapiens (Human) cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0001650; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0035720; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0097542; GO:0097546; GO:0106310 ISSRQHQASQPPLHLTYPYK 5.440000057 1 1 1.38E-12 2355.116393 0 0 0 0 12.17714 0 15.65793 0 0 13.54636 10.79052 15.44555 14.15374 0 13.62328 0 0 0 0 0 0 0 0 0 0 0 15.60136 0 14.2318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5137 0 0 0 0 Q9UQ10 DHDH_HUMAN "Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase, EC 1.3.1.20 (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase, EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) (Hum2DD)" DHDH 2DD Homo sapiens (Human) D-xylose catabolic process [GO:0042843] "D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]" "D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]" GO:0000166; GO:0042843; GO:0047115; GO:0047837 AEFGK 4.480000019 0.871593058 0.871593058 0.200986064 554.0979432 0 0 0 0 0 0 15.16445 0 0 0 0 0 0 0 0 16.90679 0 0 0 0 0 0 0 0 15.43662 13.22678 0 0 0 0 0 0 0 15.51164 0 13.24081 17.27273 16.11893 0 0 0 0 14.45178 0 0 0 0 0 Q9UQ13 SHOC2_HUMAN Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog) SHOC2 KIAA0862 Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] GO:0000164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007265; GO:0008157; GO:0008543; GO:0019888; GO:0019903; GO:0046579 DPKVPSAK 9.300000191 1 1 0.382189308 842.1426698 16.04641 16.0865 0 0 16.05729 16.54267 16.49571 16.98161 16.22342 0 15.29213 0 13.81994 16.35318 0 0 16.34861 0 13.92069 16.26351 14.85395 0 15.69436 15.52713 16.82916 15.65774 15.78281 17.07265 11.35056 0 0 0 0 0 16.24568 0 0 0 0 14.73203 15.70367 0 0 13.50111 15.76211 0 0 0 Q9UQ16 DYN3_HUMAN "Dynamin-3, EC 3.6.5.5 (Dynamin, testicular) (T-dynamin)" DNM3 KIAA0820 Homo sapiens (Human) endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; synapse assembly [GO:0007416]; synaptic vesicle endocytosis [GO:0048488] apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083] apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; synapse assembly [GO:0007416]; synaptic vesicle endocytosis [GO:0048488] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802] GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0007416; GO:0008017; GO:0014069; GO:0016020; GO:0030424; GO:0031623; GO:0031798; GO:0031802; GO:0042802; GO:0043083; GO:0043197; GO:0044327; GO:0045202; GO:0046847; GO:0048471; GO:0048488; GO:0050998; GO:0051491; GO:0061002; GO:0061828; GO:0061829; GO:0070062; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099186; GO:1903423 ASLLRAGVYPDK 5.96999979 1 1 0.027907158 1287.672227 0 10.19253 0 17.71014 15.0024 12.56619 0 0 0 0 0 14.4701 0 0 0 0 0 0 0 0 0 0 13.1214 15.20856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ35 SRRM2_HUMAN "Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa, SR-related nuclear matrix protein of 300 kDa, Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803, TaxREB803)" SRRM2 KIAA0324 SRL300 SRM300 HSPC075 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0047485; GO:0070742; GO:0071005; GO:0071007; GO:0071013 IPAASAAAMNLASAR 1.330000043 1 1 0.204690616 1410.310975 0 14.58249 0 0 0 0 15.8448 0 0 13.66 0 0 0 0 0 0 0 16.17245 0 0 0 0 0 10.45315 0 15.02236 0 0 0 0 0 14.08579 0 16.14003 0 15.25787 0 15.22474 0 0 0 0 0 0 0 13.87283 0 0 Q9UQ80 PA2G4_HUMAN "Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog, hG4-1) (ErbB3-binding protein 1)" PA2G4 EBP1 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]" azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]" nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] GO:0003676; GO:0003714; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0045597; GO:0045892; GO:0070062 SLVEASSSGVSVLSLCEKGDAMIMEETGK 4.75 0.477001727 0.477001727 1.83E-12 3045.771372 6.58212 12.2123 0 15.19172 13.45774 0 15.59599 10.5659 0 15.22033 0 11.61389 14.81594 0 15.57751 0 0 0 14.3286 0 0 0 14.98658 0 15.14361 0 13.51024 0 0 0 0 0 0 0 0 0 17.37204 0 0 11.9274 14.79474 0 0 0 0 0 15.23608 0 Q9UQ84 EXO1_HUMAN "Exonuclease 1, hExo1, EC 3.1.-.- (Exonuclease I, hExoI)" EXO1 EXOI HEX1 Homo sapiens (Human) DNA recombination [GO:0006310]; DNA repair [GO:0006281]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656] 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145] GO:0002455; GO:0003677; GO:0003682; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006298; GO:0006310; GO:0008409; GO:0016446; GO:0016604; GO:0017108; GO:0035312; GO:0045145; GO:0045190; GO:0046872; GO:0048256; GO:0051321; GO:0051908; GO:0090656 KNSSEGNK 3.380000114 0.67318815 0.67318815 0.260303842 864.2353103 16.31292 19.02524 16.29912 0 0 0 0 0 0 18.98547 0 0 16.68718 0 0 0 0 16.76101 15.92561 0 0 0 0 0 0 0 0 0 16.84529 19.16343 0 0 18.60309 16.80683 0 0 18.87158 0 19.70183 0 0 18.32724 17.84488 19.75434 0 0 0 0 Q9UQB3 CTND2_HUMAN "Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein, NPRAP) (Neurojungin)" CTNND2 NPRAP Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 GSSPKQSPSR 7.380000114 0.307271808 0.307271808 0.088534438 1031.817144 0 14.37353 16.95091 16.24373 15.58518 9.243081 15.21653 0 0 14.46178 13.77171 0 14.9374 15.95657 15.00866 13.15155 14.06476 16.87419 8.929984 14.12906 0 16.29297 17.65886 16.42425 17.14421 11.31458 12.96943 0 17.07085 17.76132 15.83991 0 14.25003 11.63552 16.96316 15.74574 15.05635 16.84405 12.99584 0 16.54301 0 16.45594 13.53083 14.24618 13.98077 14.70476 14.64418 Q9UQB8 BAIP2_HUMAN "Brain-specific angiogenesis inhibitor 1-associated protein 2, BAI-associated protein 2, BAI1-associated protein 2, Protein BAP2 (Fas ligand-associated factor 3, FLAF3) (Insulin receptor substrate p53/p58, IRS-58, IRSp53/58) (Insulin receptor substrate protein of 53 kDa, IRSp53, Insulin receptor substrate p53)" BAIAP2 Homo sapiens (Human) "actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; insulin receptor signaling pathway [GO:0008286]; modification of synaptic structure, modulating synaptic transmission [GO:0099564]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synaptic plasticity [GO:0048167]; response to bacterium [GO:0009617]" "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; rough endoplasmic reticulum [GO:0005791]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060]" "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; rough endoplasmic reticulum [GO:0005791]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; insulin receptor signaling pathway [GO:0008286]; modification of synaptic structure, modulating synaptic transmission [GO:0099564]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synaptic plasticity [GO:0048167]; response to bacterium [GO:0009617]" cadherin binding involved in cell-cell adhesion [GO:0098641]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221] GO:0001221; GO:0001726; GO:0005654; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0007009; GO:0007409; GO:0007420; GO:0008022; GO:0008093; GO:0008286; GO:0008360; GO:0009617; GO:0016358; GO:0030027; GO:0030141; GO:0030165; GO:0030175; GO:0030838; GO:0032956; GO:0035418; GO:0042802; GO:0043025; GO:0043198; GO:0044306; GO:0048167; GO:0051017; GO:0051764; GO:0060076; GO:0061003; GO:0061845; GO:0061846; GO:0070062; GO:0070064; GO:0071364; GO:0097060; GO:0097110; GO:0098641; GO:0098685; GO:0098978; GO:0099092; GO:0099523; GO:0099524; GO:0099564; GO:1905232; GO:1905274; GO:2000251; GO:2000463 QGELENYVSDGYKTALTEER 6.539999962 1 1 0.241813654 2302.432747 0 15.36708 16.85779 15.98249 15.296 0 14.63113 14.81511 1.099677 0 0 17.15529 0 0 0 15.85373 12.83072 0 15.37442 10.73209 0 15.70461 0 9.100988 0 16.75887 0 0 0 19.13865 0 18.4714 0 18.13459 17.78827 0 18.65758 0 18.28657 0 0 0 0 0 0 0 18.43083 0 Q9UQC2 GAB2_HUMAN GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100) GAB2 KIAA0571 Homo sapiens (Human) osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306]" "phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]" GO:0005068; GO:0005547; GO:0005737; GO:0005829; GO:0005886; GO:0008284; GO:0030316; GO:0043306; GO:0043325; GO:0048015 MSGGGDVVCTGWLR 6.619999886 1 1 0.466780045 1511.512915 0 0 0 14.58131 0 0 0 0 0 0 14.8277 0 0 15.75447 0 16.13647 0 15.32529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQD0 SCN8A_HUMAN Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6) SCN8A MED Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; peripheral nervous system development [GO:0007422]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] axon [GO:0030424]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ATP binding [GO:0005524]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; peripheral nervous system development [GO:0007422]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] ATP binding [GO:0005524]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] GO:0001518; GO:0005244; GO:0005248; GO:0005524; GO:0005886; GO:0006814; GO:0007399; GO:0007422; GO:0016021; GO:0019228; GO:0030018; GO:0030054; GO:0030424; GO:0031410; GO:0033268; GO:0034765; GO:0035725; GO:0042552; GO:0043194; GO:0086010 NGDFQKNGNGTTSGIGSSVEK 13.57999992 1 1 2.75E-12 2097.191022 13.57893 15.65755 0 13.61236 0 0 0 13.13814 0 0 0 0 14.74825 0 0 0 0 0 0 0 0 0 0 0 12.52954 0 0 0 14.97461 0 16.27444 0 0 0 0 15.43007 0 0 14.3268 0 0 0 0 0 0 0 0 0 Q9UQE7 SMC3_HUMAN "Structural maintenance of chromosomes protein 3, SMC protein 3, SMC-3 (Basement membrane-associated chondroitin proteoglycan, Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide, hCAP)" SMC3 BAM BMH CSPG6 SMC3L1 Homo sapiens (Human) cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cohesin loading activity [GO:0061775]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]" ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cohesin loading activity [GO:0061775]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982] GO:0000278; GO:0000775; GO:0000785; GO:0000800; GO:0003682; GO:0003690; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006275; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0016363; GO:0016887; GO:0019827; GO:0030893; GO:0034089; GO:0034990; GO:0034991; GO:0036033; GO:0046982; GO:0048487; GO:0051301; GO:0051321; GO:0061775; GO:0070840; GO:0090307; GO:0097431 GYKSIMELMNVLELR 7.760000229 1 1 0.116064571 1812.960933 0 0 0 14.45759 13.19679 0 14.92595 0 12.54401 14.4972 15.56328 0 0 0 14.37152 0 14.58884 0 0 0 0 0 0 0 0 15.07413 0 0 0 0 0 0 0 0 0 0 0 0 0 17.49248 15.93817 13.5776 0 0 0 0 0 0 Q9UQF0 SYCY1_HUMAN "Syncytin-1 (Endogenous retrovirus group W member 1) (Env-W) (Envelope polyprotein gPr73) (Enverin) (HERV-7q Envelope protein) (HERV-W envelope protein) (HERV-W_7q21.2 provirus ancestral Env polyprotein) (Syncytin) [Cleaved into: Surface protein, SU (gp50); Transmembrane protein, TM (gp24) ]" ERVW-1 ERVWE1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anatomical structure morphogenesis [GO:0009653]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768] GO:0000768; GO:0005886; GO:0006949; GO:0007520; GO:0009653; GO:0016021 LQMEPK 3.470000029 0.021800254 0.021800254 0.139003697 761.352651 16.5816 0 0 0 0 0 0 0 0 0 16.00552 0 0 0 0 16.11308 0 0 0 0 19.32015 0 0 0 0 0 0 0 0 0 15.25627 17.17527 0 0 0 0 16.53371 0 0 0 0 0 0 0 0 0 0 0 Q9UQF2 JIP1_HUMAN "C-Jun-amino-terminal kinase-interacting protein 1, JIP-1, JNK-interacting protein 1 (Islet-brain 1, IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1)" MAPK8IP1 IB1 JIP1 PRKM8IP Homo sapiens (Human) "JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]" cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]" kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007258; GO:0016192; GO:0019894; GO:0019901; GO:0030425; GO:0031966; GO:0043508; GO:0044297; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243 VSRSSSPLK 4.730000019 0.039545093 0.039545093 0.266556469 961.3734442 0 0 0 0 0 0 0 0 18.02725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.40167 17.65574 0 0 17.82102 0 0 16.96702 0 0 0 18.07881 0 0 19.02591 0 17.34149 0 17.28272 17.10546 0 0 0 Q9UQL6 HDAC5_HUMAN "Histone deacetylase 5, HD5, EC 3.5.1.98 (Antigen NY-CO-9)" HDAC5 KIAA0600 Homo sapiens (Human) "B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein deacetylase activity [GO:0033558]; protein kinase C binding [GO:0005080]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor binding [GO:0001222]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]" DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein deacetylase activity [GO:0033558]; protein kinase C binding [GO:0005080]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor binding [GO:0001222] GO:0000118; GO:0000122; GO:0000978; GO:0001222; GO:0004407; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006338; GO:0006476; GO:0006954; GO:0010830; GO:0010832; GO:0016575; GO:0016607; GO:0030183; GO:0031507; GO:0032869; GO:0033558; GO:0040029; GO:0042113; GO:0042802; GO:0042826; GO:0043393; GO:0045892; GO:0045944; GO:0046872; GO:0051091; GO:0061629; GO:0090051; GO:0140297 QQQLQLGK 6.849999905 0.116762862 0.116762862 0.201417806 943.7788842 14.48042 14.93033 16.03471 0 0 15.66116 14.43364 12.32373 15.00405 0 14.04778 15.71707 0 0 13.52746 16.19203 0 16.14587 0 0 0 0 15.2872 0 0 0 17.57251 16.45427 0 15.44739 15.49658 17.89337 0 0 0 0 16.58626 0 0 0 0 0 0 0 0 0 0 0 Q9UQM7 KCC2A_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit alpha, CaM kinase II subunit alpha, CaMK-II subunit alpha, EC 2.7.11.17" CAMK2A CAMKA KIAA0968 Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; response to ischemia [GO:0002931] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; response to ischemia [GO:0002931] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000082; GO:0002931; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005954; GO:0006468; GO:0006816; GO:0010666; GO:0014069; GO:0016301; GO:0018105; GO:0030666; GO:0035254; GO:0038166; GO:0042802; GO:0042803; GO:0043005; GO:0043197; GO:0046777; GO:0046872; GO:0046928; GO:0048168; GO:0051092; GO:0051346; GO:0051928; GO:0060996; GO:0106310; GO:1902108; GO:1990443; GO:2000124; GO:2001222 KSDGVK 14.53999996 0.816178977 0.816178977 0.304915993 633.130085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.00822 0 0 0 0 18.27126 0 18.61609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQN3 CHM2B_HUMAN "Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)" CHMP2B CGI-84 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cognition [GO:0050890]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; neuron cellular homeostasis [GO:0070050]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cognition [GO:0050890]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; neuron cellular homeostasis [GO:0070050]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005737; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007032; GO:0007080; GO:0010824; GO:0015031; GO:0016236; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045296; GO:0045324; GO:0046761; GO:0050890; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070050; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930 MAGAMSTTAK 7.159999847 0.604642332 0.604642332 0.282974487 1003.923744 0 0 15.40511 16.63403 15.09093 16.06322 13.56884 13.46622 0 0 0 0 17.1159 0 15.47462 0 0 17.03814 14.50911 15.86649 12.0924 15.39136 15.08586 15.88526 15.66423 17.44038 16.45533 15.34853 17.06587 17.42054 0 17.04489 0 16.30015 16.43514 15.60813 0 0 0 15.34009 16.02152 15.28121 16.31904 16.53332 17.61652 0 0 15.90371 Q9UQP3 TENN_HUMAN "Tenascin-N, TN-N (Tenascin-W, TN-W)" TNN TNW Homo sapiens (Human) axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] identical protein binding [GO:0042802]; integrin binding [GO:0005178] GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0033689; GO:0042802; GO:0043025; GO:0045668; GO:0062023; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905240; GO:1905899; GO:1990026; GO:1990138; GO:2001223 AQTEIDGPK 7.010000229 1 1 0.131258591 959.1899843 14.86892 0 0 0 0 0 0 13.06015 0 16.0402 0 0 0 0 0 0 0 12.65913 0 0 0 0 0 16.49379 0 0 0 15.63902 14.54067 0 14.51767 0 0 14.81635 0 0 14.74973 0 0 0 0 0 0 0 0 0 0 0 Q9UQQ1 NALDL_HUMAN "Aminopeptidase NAALADL1, EC 3.4.11.- (100 kDa ileum brush border membrane protein, I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein, NAALADase L)" NAALADL1 NAALADASEL NAALADL Homo sapiens (Human) peptide catabolic process [GO:0043171] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171] aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0004177; GO:0004180; GO:0005509; GO:0008233; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171 VLGTLLK 4.440000057 1 1 0.139979011 742.7448495 18.58143 0 0 0 0 0 0 0 0 0 17.82059 16.29396 0 18.61985 0 17.74918 15.8605 0 0 0 15.09767 15.61943 0 18.14429 0 15.12961 0 0 16.37723 13.50892 13.3218 11.02233 0 18.76162 16.92547 12.34073 16.22966 17.83872 13.96672 18.62449 0 16.27384 0 16.08985 16.60083 17.18987 17.0486 14.00297 Q9UQQ2 SH2B3_HUMAN SH2B adapter protein 3 (Lymphocyte adapter protein) (Lymphocyte-specific adapter protein Lnk) (Signal transduction protein Lnk) SH2B3 LNK Homo sapiens (Human) cellular response to chemokine [GO:1990869]; cellular response to interleukin-3 [GO:0036016]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; monocyte homeostasis [GO:0035702]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; neutrophil homeostasis [GO:0001780]; thrombopoietin-mediated signaling pathway [GO:0038163] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; signaling receptor complex adaptor activity [GO:0030159]; stem cell factor receptor binding [GO:0005173]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to chemokine [GO:1990869]; cellular response to interleukin-3 [GO:0036016]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; monocyte homeostasis [GO:0035702]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; neutrophil homeostasis [GO:0001780]; thrombopoietin-mediated signaling pathway [GO:0038163] protein tyrosine kinase binding [GO:1990782]; signaling receptor complex adaptor activity [GO:0030159]; stem cell factor receptor binding [GO:0005173]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] GO:0001780; GO:0005068; GO:0005173; GO:0005829; GO:0005886; GO:0008285; GO:0030159; GO:0035162; GO:0035556; GO:0035702; GO:0035855; GO:0036016; GO:0038163; GO:0042532; GO:0043407; GO:0046426; GO:0048821; GO:0051898; GO:0060761; GO:0070100; GO:0090331; GO:1900235; GO:1990782; GO:1990869 APGPDGPDR 6.420000076 0.453659087 0.453659087 0.263757693 881.9295041 16.35991 15.38278 15.67826 14.94717 13.83812 15.0436 0 0 0 15.14471 0 16.24554 0 14.24766 0 0 0 14.86963 15.58076 0 0 0 16.31974 0 16.16779 0 16.50498 0 15.23036 0 0 15.86212 0 0 14.53399 0 0 0 0 0 0 14.93677 0 0 15.3756 15.06354 0 0 Q9Y217 MTMR6_HUMAN "Myotubularin-related protein 6 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR6 Homo sapiens (Human) endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]" "phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]" GO:0004438; GO:0004722; GO:0004725; GO:0005635; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0006470; GO:0006661; GO:0006897; GO:0032587; GO:0046856; GO:0048471; GO:0052629; GO:0106018 LNAMANR 18.14999962 0.204302877 0.204302877 0.154482933 801.8288024 13.85283 14.64851 9.699535 11.2973 15.41816 18.135 0 15.29327 0 0 16.68453 16.63647 0 16.76997 15.31125 16.5441 12.99532 0 15.16959 17.77532 16.58711 0 16.85894 15.81656 16.5832 19.68413 17.14353 0 0 0 15.64056 0 0 0 15.04732 15.19562 0 15.49046 12.01017 16.84441 16.02745 0 0 17.27422 0 16.05724 0 0 Q9Y222 DMTF1_HUMAN "Cyclin-D-binding Myb-like transcription factor 1, hDMTF1 (Cyclin-D-interacting Myb-like protein 1, hDMP1)" DMTF1 DMP1 Homo sapiens (Human) "cell cycle [GO:0007049]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cell cycle [GO:0007049]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007049 SASSVK 10.85999966 0.478698224 0.478698224 0.140156972 578.3271684 0 0 0 0 0 0 14.92179 0 0 0 0 0 14.90294 0 0 20.32049 0 15.48443 0 0 20.28298 0 0 0 0 0 0 0 0 0 17.16752 0 18.80055 0 0 20.21056 0 0 0 0 0 21.16998 0 0 0 21.08749 16.01303 0 Q9Y223 GLCNE_HUMAN "Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing), EC 3.2.1.183 (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase, EC 2.7.1.60 (ManAc kinase) ]" GNE GLCNE Homo sapiens (Human) cell adhesion [GO:0007155]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate metabolic process [GO:0006054]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761]; cell adhesion [GO:0007155]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate metabolic process [GO:0006054]; UDP-N-acetylglucosamine metabolic process [GO:0006047]" "ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761]" GO:0004553; GO:0005524; GO:0005737; GO:0005829; GO:0006045; GO:0006047; GO:0006054; GO:0007155; GO:0008761; GO:0009384; GO:0046872 EMVRVMR 16.42000008 0.966063976 0.966063976 0.090556926 953.4743576 13.16931 13.41614 12.00164 0 0 0 15.06604 12.68085 14.02887 0 0 0 0 0 15.93708 0 0 14.78089 11.9255 13.99021 15.53588 0 0 0 15.72757 14.70149 13.72448 15.07639 0 13.76884 13.84025 13.44971 0 15.11445 15.96016 15.53295 15.48374 16.36048 17.99529 13.10822 0 17.32655 0 0 0 16.19122 0 16.57021 Q9Y227 ENTP4_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 4, NTPDase 4, EC 3.6.1.15, EC 3.6.1.6 (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase, UDPase, EC 3.6.1.42)" ENTPD4 KIAA0392 LALP70 LYSAL1 Homo sapiens (Human) CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; UDP catabolic process [GO:0006256] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; CTPase activity [GO:0043273]; cytidine-diphosphatase activity [GO:0036384]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; UDP catabolic process [GO:0006256] CTPase activity [GO:0043273]; cytidine-diphosphatase activity [GO:0036384]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134] GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0009134; GO:0016020; GO:0017110; GO:0017111; GO:0030173; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712; GO:0097637 ETIQPFMNK 2.809999943 0.589747131 0.589747131 0.168144511 1122.469068 14.90972 0 13.11306 0 0 11.51118 0 0 0 0 0 0 0 0 0 17.64886 13.50844 15.07474 0 15.07202 0 0 15.59157 0 14.59029 14.81976 14.1332 5.52055 12.38209 14.31738 15.24104 14.49466 14.46256 0 14.38965 13.42927 12.98866 15.49122 14.6638 12.67221 14.98187 15.48677 0 14.94708 15.081 0 13.36588 13.90905 Q9Y233 PDE10_HUMAN "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, EC 3.1.4.17" PDE10A Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]" "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]" GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0010754; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555 FSIEKGIAGQVAR 15.77000046 1 1 0.069421308 1375.400923 0 16.16539 0 16.87621 0 0 0 0 0 16.51861 16.69096 16.02392 0 0 0 16.51542 0 0 0 0 0 0 0 0 0 16.36061 0 0 0 0 0 0 0 0 0 0 17.33272 0 0 16.07067 17.74132 17.25763 16.42777 0 16.10307 0 0 0 Q9Y235 ABEC2_HUMAN "C->U-editing enzyme APOBEC-2, EC 3.5.4.36 (mRNA(cytosine(6666)) deaminase 2)" APOBEC2 Homo sapiens (Human) cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397] cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0006397; GO:0016554; GO:0016556; GO:0042802; GO:0046872; GO:0080111 GGQVQASR 14.02000046 1.04E-05 1.04E-05 0.282348915 803.0853318 0 19.98106 0 0 0 0 0 16.6156 17.61758 19.05004 0 18.41673 17.80879 0 17.61479 16.85466 0 0 0 0 16.39167 0 0 0 0 0 0 18.10376 17.63376 18.63506 0 0 18.4985 0 0 0 18.96516 0 16.36131 0 17.47888 0 0 17.8974 0 0 0 18.93134 Q9Y238 DLEC1_HUMAN "Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1, DLC-1)" DLEC1 DLC1 Homo sapiens (Human) cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487] GO:0002357; GO:0005737; GO:0005829; GO:0007283; GO:0008285; GO:0030154; GO:0043014; GO:0048487 AIAENER 6.139999866 0.464946538 0.464946538 0.192688081 801.7402535 0 14.9446 0 0 0 0 0 0 0 0 0 15.70201 16.32409 0 16.00406 0 0 15.01474 0 17.27712 0 16.84244 17.01294 0 17.21566 0 16.54241 0 15.80349 16.80297 16.47244 16.72375 16.98619 0 0 17.38989 0 17.52885 17.24176 17.37458 16.92657 17.32447 15.98237 17.1831 17.08541 17.92178 16.51447 18.01468 Q9Y240 CLC11_HUMAN C-type lectin domain family 11 member A (C-type lectin superfamily member 3) (Lymphocyte secreted C-type lectin) (Osteolectin) (Stem cell growth factor) (p47) CLEC11A CLECSF3 LSLCL SCGF Homo sapiens (Human) ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]; ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284] carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083] GO:0001503; GO:0005576; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0030246 DAVQALQEAQGR 4.679999828 1 1 0.011031445 1284.801303 0 0 0 0 0 0 0 0 0 0 0 0 0 12.63976 0 0 0 12.07469 0 0 0 13.56837 0 0 14.58661 0 18.07483 0 0 0 0 11.66109 0 16.59517 0 12.81392 14.12933 0 10.11548 0 14.15573 0 0 0 0 0 0 0 Q9Y248 PSF2_HUMAN DNA replication complex GINS protein PSF2 (GINS complex subunit 2) GINS2 PSF2 CGI-122 DC5 HSPC037 Homo sapiens (Human) DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0000727; GO:0000811; GO:0005634; GO:0005654; GO:0006268; GO:0071162; GO:1900264; GO:1903934 LLLNHASDNIPK 6.079999924 1 1 3.42E-12 1332.212781 16.79639 13.65175 0 0 12.77453 16.06224 0 14.16393 0 0 15.33797 16.61985 14.97379 15.02174 15.89272 15.76845 11.81664 14.44455 12.65022 0 13.37591 0 0 15.753 0 0 0 18.10814 17.45044 16.95646 16.17118 18.29792 15.60551 0 15.62975 0 0 15.25168 15.49006 0 0 0 16.75169 0 14.78122 15.26906 15.04894 0 Q9Y250 LZTS1_HUMAN Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1) LZTS1 FEZ1 Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synaptic plasticity [GO:0048167] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synaptic plasticity [GO:0048167] microtubule binding [GO:0008017] GO:0005737; GO:0005886; GO:0008017; GO:0014069; GO:0016242; GO:0043197; GO:0044772; GO:0048167; GO:0048814 SSSKMGK 6.869999886 0.279031485 0.279031485 0.236933346 740.6336449 15.62994 15.82296 16.03374 0 15.73533 0 0 0 15.17414 16.49238 16.00895 15.69976 15.8744 16.55822 15.43396 18.49052 17.90672 18.28922 15.48893 19.10521 16.95395 16.2699 17.20959 16.76567 18.30661 17.69152 18.16551 18.40401 19.24514 17.56399 18.68411 18.31989 18.32884 18.54501 18.8152 18.51739 19.5331 19.83891 17.14918 16.18796 19.23487 17.31645 16.66424 19.83102 18.26015 17.01081 19.59056 19.89601 Q9Y252 RNF6_HUMAN "E3 ubiquitin-protein ligase RNF6, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RNF6)" RNF6 SPG2 Homo sapiens (Human) "negative regulation of axon extension [GO:0030517]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of axon extension [GO:0030517]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006511; GO:0016567; GO:0016605; GO:0030424; GO:0030517; GO:0031965; GO:0043231; GO:0044314; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630; GO:0070936; GO:0085020 LERSGIR 8.229999542 1 1 0.015866517 829.3665933 0 15.77017 17.04413 0 0 0 0 0 16.40311 0 0 0 0 0 16.19872 0 0 16.86099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y253 POLH_HUMAN "DNA polymerase eta, EC 2.7.7.7 (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)" POLH RAD30 RAD30A XPV Homo sapiens (Human) cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494 LEESSK 2.339999914 1 1 0.213124998 694.2070024 14.96301 16.19202 0 0 0 0 0 0 0 0 16.41505 0 16.80865 15.04899 0 15.8261 16.3732 15.74832 0 16.98639 16.40915 0 0 0 16.7683 0 0 0 0 0 0 17.71907 0 17.12252 17.29086 18.30908 17.24232 17.63576 0 16.72779 17.57724 0 0 16.13201 15.74362 0 0 0 Q9Y255 PRLD1_HUMAN "PRELI domain-containing protein 1, mitochondrial (25 kDa protein of relevant evolutionary and lymphoid interest) (Px19-like protein)" PRELID1 PRELI CGI-106 SBBI12 Homo sapiens (Human) apoptotic process [GO:0006915]; immune response [GO:0006955]; intermembrane lipid transfer [GO:0120009]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; immune response [GO:0006955]; intermembrane lipid transfer [GO:0120009]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580] GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0006955; GO:0007275; GO:0010917; GO:0010950; GO:0015914; GO:0032991; GO:0043066; GO:0045580; GO:0051881; GO:0070234; GO:0090201; GO:0097035; GO:0120009; GO:1901857; GO:2001140 LQGEAPSK 6.519999981 1 1 0.301244901 829.3824052 0 0 17.64277 18.59721 0 0 0 0 0 0 0 0 0 0 0 0 18.58764 16.50149 0 15.52308 17.34003 0 16.40268 0 16.29642 0 17.34547 0 18.05156 0 0 0 0 0 0 18.66174 0 0 0 0 0 0 17.3189 0 0 16.96706 0 0 Q9Y256 FACE2_HUMAN "CAAX prenyl protease 2, EC 3.4.-.- (Farnesylated proteins-converting enzyme 2, FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog, hRCE1)" RCE1 FACE2 RCE1A RCE1B Homo sapiens (Human) CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342] cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222] GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005887; GO:0008238; GO:0016020; GO:0018342; GO:0030176; GO:0071586 AGDSEAPLCS 4.460000038 1 1 0.2127792 1005.54718 14.6677 0 0 0 0 0 0 0 0 0 14.9612 15.84843 16.22495 0 0 15.17452 0 15.46785 0 14.28907 16.50978 13.87136 16.16821 17.56683 0 0 0 0 0 0 0 0 17.48026 13.17041 18.24452 0 0 0 0 0 15.24502 0 0 13.65942 0 16.97947 0 0 Q9Y259 CHKB_HUMAN "Choline/ethanolamine kinase (Choline kinase beta, CK, CKB, EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase, EK, EC 2.7.1.82) (Ethanolamine kinase beta, EKB) (choline/ethanolamine kinase beta, CKEKB)" CHKB CHETK CHKL Homo sapiens (Human) CDP-choline pathway [GO:0006657]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; CDP-choline pathway [GO:0006657]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646] ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305] GO:0004103; GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0006656; GO:0006657; GO:0007517 VYPVSGGLSNLLFR 9.529999733 1 1 1.37E-12 1520.136163 12.86286 15.46862 9.229641 14.46382 13.18043 0 0 0 0 0 0 13.93226 13.25233 15.17275 0 0 0 14.06308 0 0 13.69693 14.35332 16.96453 0 0 16.33735 0 0 13.59542 14.49953 0 13.56322 0 13.36493 0 0 0 0 0 15.37019 0 11.66916 12.71184 0 0 0 0 0 Q9Y261 FOXA2_HUMAN "Hepatocyte nuclear factor 3-beta, HNF-3-beta, HNF-3B (Forkhead box protein A2) (Transcription factor 3B, TCF-3B)" FOXA2 HNF3B TCF3B Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chromatin organization [GO:0006325]; dopaminergic neuron differentiation [GO:0071542]; endocrine pancreas development [GO:0031018]; negative regulation of detection of glucose [GO:2000971]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of blood coagulation [GO:0030193]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-6 [GO:0070741]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chromatin organization [GO:0006325]; dopaminergic neuron differentiation [GO:0071542]; endocrine pancreas development [GO:0031018]; negative regulation of detection of glucose [GO:2000971]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of blood coagulation [GO:0030193]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-6 [GO:0070741]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GO:0000432; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001708; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0008344; GO:0009653; GO:0010719; GO:0019904; GO:0030054; GO:0030154; GO:0030193; GO:0031018; GO:0033132; GO:0040019; GO:0043433; GO:0045893; GO:0045944; GO:0061178; GO:0061987; GO:0070741; GO:0071542; GO:0090009; GO:1990837; GO:2000049; GO:2000543; GO:2000971 AYEQVMHYPGYGSPMPGSLAMGPVTNK 1.379999995 1 1 4.57E-12 2899.07105 13.87145 12.95792 15.40725 0 13.56684 13.48268 14.53639 9.934956 0 14.32734 14.7874 0 0 0 9.685966 0 0 0 14.83663 0 0 0 0 12.9432 14.75509 0 16.06993 0 0 0 0 0 0 0 0 0 14.43783 0 0 0 0 13.43995 0 0 11.5309 0 0 0 Q9Y264 ANGP4_HUMAN "Angiopoietin-4, ANG-4 (Angiopoietin-3, ANG-3)" ANGPT4 ANG3 ANG4 Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] GO:0001525; GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007219; GO:0010595; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0050731; GO:0062023; GO:0071456 YKMDGIR 2.799999952 1 1 0.116390566 879.4937295 0 0 0 0 0 0 0 0 0 0 14.90017 16.66872 0 11.66388 0 0 0 0 0 0 0 0 0 0 0 0 17.54995 0 15.81189 0 0 15.32256 0 0 0 0 16.02225 0 16.20788 0 0 0 10.10845 0 0 0 0 0 Q9Y265 RUVB1_HUMAN "RuvB-like 1, EC 3.6.4.12 (49 kDa TATA box-binding protein-interacting protein, 49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein, ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238, NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha, TAP54-alpha)" RUVBL1 INO80H NMP238 TIP49 TIP49A Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nucleosome mobilization [GO:0042766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]" chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812] "chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nucleosome mobilization [GO:0042766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]" ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713] GO:0000492; GO:0000723; GO:0000786; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016887; GO:0017025; GO:0031011; GO:0033044; GO:0035267; GO:0040008; GO:0042766; GO:0042981; GO:0043486; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0045893; GO:0045995; GO:0050821; GO:0051117; GO:0051301; GO:0051726; GO:0060382; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:0101031; GO:0120293; GO:1904507; GO:1904874; GO:1905168; GO:1990062; GO:1990904; GO:2000779 QAASGLVGQENAR 6.769999981 0.214883953 0.214883953 0.00209374 1300.503734 11.32402 11.79013 14.68325 10.39366 0 0 13.92233 0 0 0 0 10.6351 0 0 0 0 0 0 14.5778 0 0 0 12.10505 0 14.07705 0 0 0 0 0 15.05512 0 0 0 10.83157 0 0 12.84952 0 11.70355 0 0 0 0 0 12.88466 0 12.59906 Q9Y272 RASD1_HUMAN Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1) RASD1 AGS1 DEXRAS1 Homo sapiens (Human) "G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]" nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] "nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]" GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0045892; GO:0048471 CAYFEISAKK 2.359999895 0.798124194 0.798124194 0.132039989 1216.617107 13.94944 15.41176 0 0 0 0 0 15.17 0 14.28316 0 0 0 0 0 12.33535 0 0 10.43034 0 0 0 0 15.69071 14.38751 0 0 0 0 15.82194 15.71612 12.07137 13.52612 10.89891 0 0 15.50603 0 14.14261 11.69235 14.52537 14.5849 15.10239 0 0 0 0 0 Q9Y275 TN13B_HUMAN "Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator, BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1, TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form ]" TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738 Homo sapiens (Human) B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; immune response [GO:0006955]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; immune response [GO:0006955]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] GO:0001782; GO:0002636; GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005925; GO:0006955; GO:0007165; GO:0016021; GO:0030183; GO:0030890; GO:0031295; GO:0031296; GO:0033209; GO:0042102; GO:0043231; GO:0048018; GO:0048471 LKECVSILPR 6.949999809 1 1 0.358115655 1214.070131 0 0 0 14.03781 14.00162 0 0 14.51077 14.44971 13.82295 14.3766 14.66968 15.16288 14.87787 0 15.52536 0 0 13.41025 0 0 12.83928 12.23069 0 0 0 0 0 0 0 14.88341 0 0 0 16.349 0 0 0 0 0 0 16.28777 0 0 15.51872 0 0 0 Q9Y283 INVS_HUMAN Inversin (Inversion of embryo turning homolog) (Nephrocystin-2) INVS INV NPHP2 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055] cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819] cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055] calmodulin binding [GO:0005516] GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0005929; GO:0016020; GO:0016055; GO:0090090 RPNETAR 11.36999989 0.781433046 0.781433046 0.17905129 841.6234159 15.47292 15.48412 0 15.15419 0 0 14.21069 15.37646 0 14.82987 15.04537 0 16.07235 16.92814 0 0 16.61039 0 0 0 15.99448 16.89921 0 15.27973 16.73663 16.09592 0 14.88434 0 15.7233 17.56488 15.87998 16.15726 15.66206 14.91741 15.99734 17.53574 17.67699 17.17934 15.48345 16.56946 16.99882 14.74285 17.47403 14.24613 13.38389 14.61419 16.99852 Q9Y297 FBW1A_HUMAN F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit) BTRC BTRCP FBW1A FBXW1A Homo sapiens (Human) "branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]" beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase activity [GO:0061630] GO:0000209; GO:0005654; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0033598; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0043433; GO:0045309; GO:0045862; GO:0045879; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1904668; GO:1990756; GO:1990757 FMCSMPR 6.75 0.006964582 0.006964582 0.308577076 944.8517638 0 0 15.13143 0 0 0 0 0 0 16.8644 13.12337 0 0 0 16.9836 17.46922 0 0 0 0 0 17.99789 0 0 0 0 16.70745 15.84883 16.14182 0 0 0 0 0 20.90909 0 16.03921 18.37315 0 0 0 16.24125 0 0 0 16.22275 17.97062 0 Q9Y2A9 B3GN3_HUMAN "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3, EC 2.4.1.149 (Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase, EC 2.4.1.146) (Beta-1,3-galactosyltransferase 8, Beta-1,3-GalTase 8, Beta3Gal-T8, Beta3GalT8, b3Gal-T8) (Beta-3-Gx-T8) (Core 1 extending beta-1,3-N-acetylglucosaminyltransferase) (Core1-beta3GlcNAcT) (Transmembrane protein 3) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, BGnT-3, Beta-1,3-Gn-T3, Beta-1,3-N-acetylglucosaminyltransferase 3, Beta3Gn-T3) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8)" B3GNT3 B3GALT8 TMEM3 UNQ637/PRO1266 Homo sapiens (Human) keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311] Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] "Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" "beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" GO:0000139; GO:0005887; GO:0008194; GO:0008457; GO:0008499; GO:0008532; GO:0016266; GO:0016757; GO:0018146; GO:0030311; GO:0047223 DLLLVHR 8.81000042 1 1 0.246674604 865.1220588 15.43026 16.3111 16.04233 16.1894 0 16.63203 0 0 0 0 0 0 0 0 0 14.64153 15.71926 16.05658 0 16.24231 15.86512 0 17.21808 0 15.63564 0 16.45923 15.81061 16.04022 16.58582 15.32025 12.07778 15.07932 15.52593 0 15.06531 16.45881 14.51178 0 15.82544 0 15.60363 16.77472 14.78742 15.73733 15.73156 17.17507 15.29499 Q9Y2B0 CNPY2_HUMAN Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4) CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; regulation of low-density lipoprotein particle clearance [GO:0010988] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; regulation of low-density lipoprotein particle clearance [GO:0010988] GO:0005783; GO:0010629; GO:0010988; GO:1905599 TIQMGSFR 3.319999933 0.397486001 0.397486001 0.174283964 941.9276771 13.64237 16.64143 15.05286 14.27117 0 0 15.07237 0 15.59831 16.06214 0 16.10894 14.84638 12.47808 12.96142 0 13.92453 14.34788 15.77066 0 15.26457 0 0 0 15.41012 0 0 0 0 0 0 15.5841 15.71326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.23495 Q9Y2B4 T53G5_HUMAN TP53-target gene 5 protein (TP53-inducible gene 5 protein) TP53TG5 C20orf10 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308] GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0030308; GO:0035556 RPKNSR 7.550000191 1 1 0.228814573 756.4256322 0 0 0 0 0 0 0 18.12603 0 18.46904 0 0 0 0 0 17.10382 0 0 16.67334 17.13419 0 0 0 0 0 17.99424 0 0 0 0 0 18.86753 0 0 0 0 0 0 18.10207 0 16.81048 0 0 0 0 0 0 0 Q9Y2B5 VP9D1_HUMAN VPS9 domain-containing protein 1 (Protein ATP-BL) VPS9D1 ATPBL C16orf7 Homo sapiens (Human) ATP synthesis coupled proton transport [GO:0015986]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; endocytic vesicle [GO:0030139] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; transporter activity [GO:0005215]; ATP synthesis coupled proton transport [GO:0015986]; vesicle-mediated transport [GO:0016192] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; transporter activity [GO:0005215] GO:0005085; GO:0005096; GO:0005215; GO:0005829; GO:0015986; GO:0016192; GO:0030139; GO:0031267; GO:0042802 MAAAAGDGTVKPLQSAMK 12.63000011 0.96966666 0.96966666 0.128582657 1763.911874 12.55597 0 0 0 14.08782 0 14.70485 0 14.75292 0 0 0 0 0 16.48612 14.06634 0 15.415 0 0 17.19179 0 16.08955 0 14.17705 13.4092 0 0 0 0 0 0 0 14.3299 0 15.09311 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2C3 B3GT5_HUMAN "Beta-1,3-galactosyltransferase 5, Beta-1,3-GalTase 5, Beta3Gal-T5, Beta3GalT5, b3Gal-T5, EC 2.4.1.- (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)" B3GALT5 Homo sapiens (Human) lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" "glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016021; GO:0016757 TLLDYWQALENSR 9.229999542 1 1 0.440302638 1608.80916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.03399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2C5 S17A4_HUMAN Probable small intestine urate exporter (Solute carrier family 17 member 4) SLC17A4 Homo sapiens (Human) anion transport [GO:0006820]; phosphate-containing compound metabolic process [GO:0006796]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; phosphate-containing compound metabolic process [GO:0006796]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814] sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857] GO:0005436; GO:0005764; GO:0005887; GO:0006796; GO:0006814; GO:0006820; GO:0015136; GO:0015739; GO:0016020; GO:0016021; GO:0016324; GO:0022857 MSTGPDVK 7.099999905 1 1 0.288996376 833.5841882 0 0 0 0 16.77664 17.76996 18.24331 0 0 0 0 17.96738 0 15.88212 0 0 0 0 0 0 17.47466 16.89587 17.67489 16.31942 20.09294 19.81318 0 0 18.48982 19.58487 0 0 19.15168 19.49291 0 0 0 0 0 18.41772 0 18.0109 0 0 0 0 0 17.40134 Q9Y2D1 ATF5_HUMAN "Cyclic AMP-dependent transcription factor ATF-5, cAMP-dependent transcription factor ATF-5 (Activating transcription factor 5) (Transcription factor ATFx)" ATF5 ATFX Homo sapiens (Human) "cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]; cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]" GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006355; GO:0006357; GO:0007623; GO:0008285; GO:0009791; GO:0015631; GO:0019900; GO:0021891; GO:0021930; GO:0035264; GO:0043066; GO:0043565; GO:0045444; GO:0045892; GO:0045893; GO:0045944; GO:0046605; GO:0090575; GO:1902750 SAALR 12.19999981 0.710302234 0.710302234 0.250833971 518.5201002 18.51149 19.99751 0 0 0 15.69454 0 0 0 17.44268 0 17.10763 0 0 0 17.98351 0 0 0 15.85122 0 0 19.04601 0 0 0 0 0 0 0 0 0 18.07622 17.7809 0 0 18.82071 0 19.32514 0 17.36105 16.37368 16.61396 17.77938 0 0 0 0 Q9Y2D4 EXC6B_HUMAN Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) EXOC6B KIAA0919 SEC15B SEC15L2 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145] exocyst [GO:0000145]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522 NQVTDTNR 14.17000008 0.682269096 0.682269096 0.281717882 948.0320411 20.17649 0 16.05516 15.5482 21.20896 0 21.34869 18.12544 18.22498 15.79095 21.33643 16.83302 17.79489 19.5571 0 17.74449 0 16.65606 17.23376 0 16.77104 19.40074 18.35676 17.40618 17.02521 18.41191 22.44854 0 18.03811 0 0 0 19.69589 0 17.55918 18.56959 18.83976 0 20.03365 20.07396 21.23415 18.23789 17.38971 20.17247 0 20.71255 16.28773 21.72749 Q9Y2D8 ADIP_HUMAN "Afadin- and alpha-actinin-binding protein, ADIP (Afadin DIL domain-interacting protein) (SSX2-interacting protein)" SSX2IP KIAA0923 Homo sapiens (Human) cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein domain specific binding [GO:0019904]; cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020] protein domain specific binding [GO:0019904] GO:0005634; GO:0005737; GO:0005912; GO:0007098; GO:0007155; GO:0019904; GO:0031252; GO:0032991; GO:0034451; GO:0035020; GO:0035735; GO:0036064; GO:0060271; GO:2000145 NEDEMYK 13.46000004 1 1 0.230439367 930.157504 16.05589 0 0 13.35166 0 0 0 0 0 0 14.60662 16.58383 14.78081 0 0 14.61307 15.1966 0 0 16.28785 16.4205 0 0 0 0 0 15.78724 0 15.4668 0 0 17.81054 0 0 0 0 0 0 0 16.45291 0 0 16.21032 0 15.37573 0 14.23874 15.95261 Q9Y2E4 DIP2C_HUMAN "Disco-interacting protein 2 homolog C, DIP2 homolog C" DIP2C KIAA0934 Homo sapiens (Human) DGSVLGVTVTR 6.570000172 0.012178234 0.012178234 0.053588992 1103.73541 14.56636 14.42918 13.80436 0 0 14.16658 14.54029 13.77831 15.34858 13.57347 0 0 16.14209 15.38878 0 15.55772 14.81358 0 14.55647 15.88648 14.99281 13.08002 16.39601 15.10568 0 16.84228 14.28392 6.275543 12.39358 0 0 0 0 0 0 7.609893 16.17619 14.77703 16.91817 0 12.95911 0 0 8.118203 14.91179 16.95578 0 16.432 Q9Y2E5 MA2B2_HUMAN "Epididymis-specific alpha-mannosidase, EC 3.2.1.24 (Alpha-1,6-mannosidase) (Mannosidase alpha class 2B member 2)" MAN2B2 KIAA0935 Homo sapiens (Human) mannose metabolic process [GO:0006013] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013] alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0043202; GO:0046872; GO:0070062 QSNRTVR 8.840000153 1 1 0.219228128 859.8914232 16.31276 7.785418 11.17545 14.78358 15.32555 15.36242 0 14.56528 14.57309 14.27924 13.52142 0 14.19369 16.19122 14.03951 13.33627 14.37768 0 0 14.17062 0 0 16.25626 0 16.13661 14.96327 0 14.09619 16.29836 16.72563 16.86159 15.81001 0 13.84177 15.2459 16.58214 0 0 16.3229 16.28895 16.09957 14.66532 0 15.53155 0 15.5346 15.28616 0 Q9Y2E6 DTX4_HUMAN "E3 ubiquitin-protein ligase DTX4, EC 2.3.2.27 (Protein deltex-4, Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4)" DTX4 KIAA0937 RNF155 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0004842; GO:0005654; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0032479; GO:0061630 NMPPPGVVK 1.5 1 1 0.092431117 950.7435315 0 0 0 16.83365 0 16.06181 0 0 0 0 0 17.59857 0 0 0 0 0 0 15.22121 0 12.43475 16.3548 0 0 0 0 0 0 12.77649 16.82535 13.51463 17.52949 0 0 0 0 16.49092 0 16.84793 0 0 0 0 0 0 14.69966 16.24531 0 Q9Y2E8 SL9A8_HUMAN "Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8, NHE-8) (Solute carrier family 9 member 8)" SLC9A8 KIAA0939 NHE8 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] GO:0000139; GO:0005794; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805 KNMSDVSGWQTFLQALDYFLK 2.630000114 0.737768829 0.737768829 0.099435731 2490.621152 15.63083 15.63491 14.68877 13.78977 13.77456 0 0 0 11.07383 15.51503 0 14.26324 0 15.55049 0 13.09212 0 15.49895 0 15.33362 14.23235 0 0 0 0 14.64507 0 15.24359 13.63256 13.49218 15.21599 0 0 0 0 0 0 0 0 15.59223 0 0 14.37103 0 0 0 14.65339 0 Q9Y2F5 ICE1_HUMAN Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) ICE1 KIAA0947 Homo sapiens (Human) positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] Cajal body [GO:0015030]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] Cajal body [GO:0015030]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein-macromolecule adaptor activity [GO:0030674]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] protein-macromolecule adaptor activity [GO:0030674] GO:0000791; GO:0005654; GO:0008023; GO:0015030; GO:0016604; GO:0030674; GO:0031334; GO:0035363; GO:0042795; GO:0042796; GO:0045945; GO:0090316 HWTTASRSMSDR 6.610000134 1 1 0.031808281 1446.562774 15.77086 0 15.20435 0 14.42319 14.07079 0 0 14.28028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.23545 0 0 0 0 15.12716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2F9 BTBD3_HUMAN BTB/POZ domain-containing protein 3 BTBD3 KIAA0952 Homo sapiens (Human) cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008] identical protein binding [GO:0042802] GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0042802; GO:0048813 YIVPHLAR 14.28999996 1 1 0.249635648 969.5565719 14.9111 13.25206 0 14.51252 14.69262 14.68438 14.92519 14.05111 13.25851 12.32392 0 10.15303 0 14.73132 0 14.56547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2G1 MYRF_HUMAN "Myelin regulatory factor, EC 3.4.-.- (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal ]" MYRF C11orf9 KIAA0954 MRF Homo sapiens (Human) "central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]" cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]; central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]" GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016021; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0042802; GO:0043565; GO:0045893; GO:0048709 AQVPDTVFHHGRVGINTDRPDEALVVHGNVK 10.98999977 1 1 0.039160701 3376.642551 13.77287 15.79289 0 7.602714 11.47516 0 9.136415 13.82305 12.98897 0 0 13.09384 11.43698 9.390469 10.07404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2G2 CARD8_HUMAN "Caspase recruitment domain-containing protein 8, EC 3.4.-.- (CARD-inhibitor of NF-kappa-B-activating ligand, CARDINAL) (Tumor up-regulated CARD-containing antagonist of CASP9, TUCAN) [Cleaved into: Caspase recruitment domain-containing protein 8, C-terminus, CARD8-CT; Caspase recruitment domain-containing protein 8, N-terminus, CARD8-NT ]" CARD8 DACAR KIAA0955 NDPP1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; CARD8 inflammasome complex assembly [GO:0140633]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; self proteolysis [GO:0097264] CARD8 inflammasome complex [GO:0140634]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] CARD8 inflammasome complex [GO:0140634]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; endopeptidase activity [GO:0004175]; NACHT domain binding [GO:0032089]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; CARD8 inflammasome complex assembly [GO:0140633]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; self proteolysis [GO:0097264] CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; endopeptidase activity [GO:0004175]; NACHT domain binding [GO:0032089]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621] GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006919; GO:0006954; GO:0008233; GO:0008656; GO:0010804; GO:0031665; GO:0032088; GO:0032089; GO:0032691; GO:0032731; GO:0032991; GO:0038187; GO:0042803; GO:0042981; GO:0043122; GO:0043124; GO:0043280; GO:0043621; GO:0050700; GO:0051260; GO:0051607; GO:0061702; GO:0070269; GO:0072559; GO:0097264; GO:0097340; GO:0140374; GO:0140608; GO:0140633; GO:0140634; GO:1900226 EPIQLEITEKR 16.5 1 1 0.601347332 1356.514978 0 0 0 0 0 18.97318 0 0 0 0 0 0 18.58436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2G3 AT11B_HUMAN "Phospholipid-transporting ATPase IF, EC 7.6.2.1 (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)" ATP11B ATPIF ATPIR KIAA0956 Homo sapiens (Human) aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556] GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531 DEIFPADLVLLSSDR 3.799999952 1 1 0.613316861 1690.378474 12.7822 0 17.94111 0 0 0 0 0 17.60929 0 0 0 0 0 0 0 0 0 0 18.32578 0 0 0 0 0 0 0 0 0 0 0 0 19.00997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6777 Q9Y2G4 ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 (Diversin) ANKRD6 KIAA0957 Homo sapiens (Human) "negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096 AGANVLAKNK 7.5 1 1 2.29E-13 988.0105901 15.34579 12.30548 13.42021 13.44389 15.10933 14.88206 13.74958 12.93134 15.10131 0 12.28588 0 13.56157 14.94008 15.4626 0 14.1814 11.84232 12.89246 0 14.84632 14.29609 0 0 0 0 0 0 0 11.2121 0 0 0 0 0 0 0 0 0 14.80414 0 14.83332 0 0 0 0 0 0 Q9Y2G9 SBNO2_HUMAN Protein strawberry notch homolog 2 SBNO2 KIAA0963 Homo sapiens (Human) "bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]" chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] GO:0002281; GO:0005634; GO:0006355; GO:0030282; GO:0030316; GO:0031490; GO:0042393; GO:0045892; GO:0045944; GO:0050727; GO:0061430; GO:0071222; GO:0071348; GO:0071354; GO:0072675; GO:1990830 GVGAMEIVAMDMKVSGMYIAR 3.299999952 0.78609097 0.78609097 0.16739307 2239.41429 0 0 0 12.3138 0 0 12.55447 14.23997 0 0 13.87024 0 0 0 0 8.083526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.24793 14.24471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H0 DLGP4_HUMAN "Disks large-associated protein 4, DAP-4 (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4, SAPAP-4)" DLGAP4 DAP4 KIAA0964 SAPAP4 Homo sapiens (Human) regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572] cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] molecular adaptor activity [GO:0060090] GO:0005886; GO:0023052; GO:0031594; GO:0060090; GO:0098962; GO:0098978; GO:0098981; GO:0099572 SSVPSHSMSSR 5.46999979 0.671241462 0.671241462 0.063679767 1177.011094 13.88868 15.74668 17.2245 0 0 14.12223 0 12.51379 5.912094 0 14.03773 0 13.0741 13.79912 13.86238 0 0 0 0 0 0 0 14.54234 0 15.20555 0 16.56332 0 0 14.63533 17.00485 15.26515 16.43872 0 0 15.46333 0 16.44522 14.91933 0 0 0 14.13488 0 13.68861 0 15.81285 0 Q9Y2H1 ST38L_HUMAN "Serine/threonine-protein kinase 38-like, EC 2.7.11.1 (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2)" STK38L KIAA0965 NDR2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128] actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0003779; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0015629; GO:0016020; GO:0018105; GO:0035556; GO:0051128; GO:0106310 GSIPTYMKAGK 4.130000114 1 1 0.087773287 1172.401033 0 0 0 0 8.026401 0 0 0 13.20304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.46447 16.11903 12.71963 14.05857 14.55936 0 0 14.46687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H2 SAC2_HUMAN "Phosphatidylinositide phosphatase SAC2, EC 3.1.3.25 (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2, hSAC2)" INPP5F KIAA0966 SAC2 MSTP007 MSTP047 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896] inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803] GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135 GQESPLK 7.590000153 1 1 0.035977508 757.0249779 16.70356 15.44586 17.35088 16.78509 12.51892 16.50403 13.96509 0 0 12.89001 16.95177 17.09618 15.06184 13.72722 16.07185 0 0 14.88846 16.17044 16.84572 14.88939 12.41656 12.18998 15.55822 14.57424 13.09781 16.01915 12.38962 14.88094 0 0 0 17.39658 18.20034 0 17.25421 16.71502 11.09944 16.35286 15.96802 0 15.19979 13.3498 16.3572 14.44524 11.82634 14.10608 13.17897 Q9Y2H5 PKHA6_HUMAN "Pleckstrin homology domain-containing family A member 6, PH domain-containing family A member 6 (Phosphoinositol 3-phosphate-binding protein 3, PEPP-3)" PLEKHA6 KIAA0969 PEPP3 Homo sapiens (Human) NPNAPVTK 2.24000001 1 1 6.89E-13 838.2074004 0 12.45944 13.05396 17.95653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.37081 0 0 14.88266 0 16.84805 0 17.33189 19.11472 0 0 0 0 0 0 0 13.91561 0 Q9Y2H8 ZN510_HUMAN Zinc finger protein 510 ZNF510 KIAA0972 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 STLRDHHR 3.309999943 0.987318039 0.987318039 0.151913398 1021.710421 0 15.59993 0 0 0 14.31815 0 0 0 0 0 14.90991 0 0 0 0 0 0 0 15.28509 16.10094 0 0 0 16.10242 15.64846 0 14.52783 14.95191 10.81198 13.79168 14.21467 0 14.19773 17.68265 0 0 0 15.84049 16.48834 0 0 14.71283 10.73879 14.4715 0 0 13.15618 Q9Y2H9 MAST1_HUMAN "Microtubule-associated serine/threonine-protein kinase 1, EC 2.7.11.1 (Syntrophin-associated serine/threonine-protein kinase)" MAST1 KIAA0973 SAST Homo sapiens (Human) brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310 ATTPGGRTLER 11.94999981 1 1 0.307739626 1155.850185 0 0 0 17.65401 0 0 0 0 0 0 0 0 0 0 0 0 16.68361 0 0 0 0 16.44709 0 0 0 0 0 0 19.16787 0 20.01886 0 19.83714 0 0 0 0 18.40836 0 0 16.84986 0 0 0 0 0 16.15294 0 Q9Y2I1 NISCH_HUMAN "Nischarin (Imidazoline receptor 1, I-1, IR1) (Imidazoline receptor antisera-selected protein, hIRAS) (Imidazoline-1 receptor, I1R) (Imidazoline-1 receptor candidate protein, I-1 receptor candidate protein, I1R candidate protein)" NISCH IRAS KIAA0975 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601] identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901] GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0043231; GO:0045171; GO:0055037 IDKNLLPPK 28.25 1 1 0.501744995 1036.531993 16.92385 0 20.02929 16.43579 0 17.71218 0 17.38037 0 0 0 0 0 0 17.94275 17.27498 17.33961 0 0 0 0 0 0 0 0 0 0 0 17.36357 0 0 0 0 0 0 20.3242 0 0 0 0 0 0 0 19.7403 0 0 0 0 Q9Y2I6 NINL_HUMAN Ninein-like protein NINL KIAA0980 NLP Homo sapiens (Human) microtubule anchoring at centrosome [GO:0034454] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; calcium ion binding [GO:0005509]; microtubule anchoring at centrosome [GO:0034454] calcium ion binding [GO:0005509] GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0015630; GO:0034454; GO:0045171 YVNGSKWYGR 2.829999924 1 1 0.013776562 1230.538784 0 0 0 0 17.78853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2I7 FYV1_HUMAN "1-phosphatidylinositol 3-phosphate 5-kinase, Phosphatidylinositol 3-phosphate 5-kinase, EC 2.7.1.150 (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III, PIPkin-III, Type III PIP kinase) (Serine-protein kinase PIKFYVE, EC 2.7.11.1)" PIKFYVE KIAA0981 PIP5K3 Homo sapiens (Human) "1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]" cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670] "cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]" "1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]" GO:0000139; GO:0000285; GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0016887; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 ISAMDASPR 4.789999962 0.010998036 0.010998036 0.28854555 963.2755689 18.28327 18.64818 0 17.39513 0 0 0 0 0 0 16.83376 0 0 17.43032 0 0 0 0 0 0 0 0 0 0 17.71485 18.68358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2I8 WDR37_HUMAN WD repeat-containing protein 37 WDR37 KIAA0982 Homo sapiens (Human) "cytoplasm [GO:0005737]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "cytoplasm [GO:0005737]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" GO:0005634; GO:0005737; GO:0030687 TKASHSTSQLSQK 4.800000191 1 1 0.011572846 1402.148325 0 0 0 0 16.13026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.99487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.22039 0 0 0 0 0 0 Q9Y2I9 TBC30_HUMAN TBC1 domain family member 30 TBC1D30 KIAA0984 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0031267; GO:0036064; GO:0043547; GO:0090630; GO:1902018 DRLLHK 9.770000458 0.527321279 0.527321279 0.231013344 780.6266484 14.42197 0 0 0 0 0 15.61973 0 0 0 0 0 0 0 0 0 17.4342 0 16.91495 0 17.80177 0 17.39224 0 16.85903 16.73908 16.94731 16.60826 17.46176 0 16.09521 15.81936 15.61821 16.77975 17.57362 16.30733 0 17.73474 18.59325 16.86407 16.12106 17.43935 17.35747 17.82826 17.81845 0 17.84795 17.96519 Q9Y2J4 AMOL2_HUMAN "Angiomotin-like protein 2 (Leman coiled-coil protein, LCCP)" AMOTL2 KIAA0989 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; hippo signaling [GO:0035329]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055] bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; hippo signaling [GO:0035329]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055] GO:0001525; GO:0003365; GO:0005829; GO:0005886; GO:0005923; GO:0016055; GO:0030036; GO:0030334; GO:0031410; GO:0035329; GO:0055037 LKVLHAQILEK 16.01000023 1 1 0.264935972 1288.328947 0 15.92379 8.961805 0 18.00646 16.4265 0 18.44471 0 18.11326 0 0 15.63725 0 0 16.68627 0 14.9406 0 19.1803 16.48282 0 17.60592 0 0 0 15.09482 0 0 0 16.33482 0 0 15.67662 0 0 0 15.65262 0 17.34951 0 0 0 0 0 0 0 0 Q9Y2J8 PADI2_HUMAN "Protein-arginine deiminase type-2, EC 3.5.3.15 (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II)" PADI2 KIAA0994 PAD2 PDI2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of lymphocyte chemotaxis [GO:1901624]; protein citrullination [GO:0018101]; regulation of chromatin disassembly [GO:0010848]; substantia nigra development [GO:0021762] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; estrogen receptor binding [GO:0030331]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668]; cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of lymphocyte chemotaxis [GO:1901624]; protein citrullination [GO:0018101]; regulation of chromatin disassembly [GO:0010848]; substantia nigra development [GO:0021762] calcium ion binding [GO:0005509]; estrogen receptor binding [GO:0030331]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668] GO:0000791; GO:0004668; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0010848; GO:0018101; GO:0021762; GO:0030331; GO:0030520; GO:0035578; GO:0036413; GO:0036414; GO:0042803; GO:0045815; GO:0070062; GO:0070100; GO:1901624; GO:1990830 QKDGHGEAIMFK 6.039999962 1 1 0.108586124 1376.123935 13.37583 16.07491 15.16219 7.522533 0 12.28604 13.71777 0 13.45173 0 0 13.07724 13.27923 14.53987 0 14.5287 11.51891 0 16.17419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6744 0 0 0 0 0 0 Q9Y2K2 SIK3_HUMAN "Serine/threonine-protein kinase SIK3, EC 2.7.11.1 (Salt-inducible kinase 3, SIK-3) (Serine/threonine-protein kinase QSK)" SIK3 KIAA0999 QSK L19 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321] GO:0000226; GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0006468; GO:0035556; GO:0050321; GO:0106310; GO:1904263; GO:1904515 GISISPSAGQMQMQHR 2.710000038 0.116214328 0.116214328 0.156378072 1728.862284 11.20006 0 13.68522 15.48544 12.79468 0 0 0 0 18.67453 0 0 0 0 17.82391 0 17.22365 16.56576 0 16.14488 18.10756 16.99611 13.72579 0 17.17247 18.33138 17.17494 0 12.60345 0 0 0 17.54799 0 0 16.86019 18.11108 0 0 0 0 0 16.47308 10.76013 0 0 0 13.28929 Q9Y2K3 MYH15_HUMAN Myosin-15 (Myosin heavy chain 15) MYH15 KIAA1000 Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774] GO:0003774; GO:0005516; GO:0005524; GO:0005829; GO:0016459; GO:0030016; GO:0032982; GO:0043231; GO:0051015 EALINQLSR 8.869999886 1 1 0.494342057 1044.565407 16.41333 16.15016 14.51202 0 0 0 0 14.76678 0 0 0 13.903 16.01078 0 0 0 0 0 0 0 0 0 0 15.52115 0 16.41471 0 0 0 0 0 16.10159 15.40165 0 11.73482 16.98139 13.29814 0 16.30038 15.09591 0 16.30771 16.93216 0 16.25477 0 0 16.60377 Q9Y2K5 R3HD2_HUMAN R3H domain-containing protein 2 R3HDM2 KIAA1002 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723; GO:0005634 TEADKLFTQLAMSGAK 3.359999895 1 1 0.082202744 1725.980352 0 0 0 0 15.72134 15.47745 15.26653 0 15.46025 0 0 14.05342 0 0 14.98654 0 0 0 0 0 0 16.55797 0 0 0 15.25116 0 0 0 0 15.9717 0 15.49912 0 0 14.90471 0 15.69869 17.04637 15.94636 16.25146 0 0 15.82112 0 0 0 14.38612 Q9Y2K7 KDM2A_HUMAN "Lysine-specific demethylase 2A, EC 1.14.11.27 (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)" KDM2A CXXC8 FBL11 FBL7 FBXL11 JHDM1A KIAA1004 Homo sapiens (Human) chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357] histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] GO:0003712; GO:0005654; GO:0006303; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0010944; GO:0032452; GO:0032922; GO:0042752; GO:0045322; GO:0051864; GO:0070544; GO:0140680 GIEMTMAQWTR 6.849999905 1 1 0.51151735 1354.115279 0 0 0 0 0 0 0 0 19.5288 0 0 0 0 0 0 0 0 16.41331 0 0 0 0 0 0 0 0 0 0 18.07176 0 18.22215 0 0 0 0 0 0 19.16277 0 0 0 18.69802 0 16.2624 0 0 18.25159 0 Q9Y2L1 RRP44_HUMAN "Exosome complex exonuclease RRP44, EC 3.1.13.-, EC 3.1.26.- (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)" DIS3 KIAA1008 RRP44 Homo sapiens (Human) CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0043928; GO:0071034 TRAGGVMK 6.800000191 1 1 0.020896155 836.4717064 0 0 0 14.18926 0 0 15.6128 0 0 15.00629 16.20719 14.36656 0 0 14.6263 0 0 0 0 0 0 0 0 0 12.19461 12.93476 0 0 0 0 0 0 0 13.60665 0 0 0 0 0 15.52736 0 15.88717 0 0 0 0 15.06737 0 Q9Y2L5 TPPC8_HUMAN Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022] GO:0000407; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0031410; GO:0034497; GO:0048208; GO:0099022; GO:1990072 EFHIVQVSSSSKHWK 4.889999866 1 1 0.253030737 1799.109594 0 0 0 14.79597 0 0 0 0 0 0 0 0 16.78169 0 0 17.63091 0 13.05823 0 0 0 0 0 0 0 0 15.49675 0 0 0 0 0 0 0 13.908 0 17.1861 16.25543 0 0 0 0 0 0 0 0 0 0 Q9Y2L6 FRM4B_HUMAN FERM domain-containing protein 4B (GRP1-binding protein GRSP1) FRMD4B GRSP1 KIAA1013 Homo sapiens (Human) establishment of epithelial cell polarity [GO:0090162] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726]; establishment of epithelial cell polarity [GO:0090162] GO:0001726; GO:0005615; GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0090162 VGTAFK 6.03000021 0.598541915 0.598541915 0.259128478 622.716641 0 15.09616 13.31661 14.31911 14.85958 14.45596 0 0 14.88131 0 14.77505 15.55136 0 15.61152 0 15.76838 15.02512 17.04223 17.38297 0 0 15.08 0 15.83253 15.33201 15.53147 15.96261 16.54947 15.7559 15.64797 15.49032 14.67772 0 15.6194 15.11698 13.96125 17.00376 16.77983 16.19297 13.30502 16.31144 15.34535 0 16.05767 15.89531 17.09203 0 15.54744 Q9Y2M0 FAN1_HUMAN "Fanconi-associated nuclease 1, EC 3.1.21.-, EC 3.1.4.1 (FANCD2/FANCI-associated nuclease 1, hFAN1) (Myotubularin-related protein 15)" FAN1 KIAA1018 MTMR15 Homo sapiens (Human) "DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]" cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; magnesium ion binding [GO:0000287]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]" 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; magnesium ion binding [GO:0000287]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036] GO:0000287; GO:0000724; GO:0004528; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006289; GO:0008409; GO:0017108; GO:0033683; GO:0036297; GO:0045171; GO:0070336; GO:0140036 SQSLS 5.360000134 0.958550394 0.958550394 0.264934684 520.2041581 0 16.721 0 19.38605 17.25166 0 0 0 18.44273 0 17.18145 0 17.16455 19.58754 0 20.17541 0 0 0 0 18.05071 0 0 0 0 19.68171 17.24795 0 0 16.99309 0 0 0 18.00298 0 0 0 16.53681 18.46391 20.04513 0 0 17.16366 16.82647 0 17.67023 0 0 Q9Y2P8 RCL1_HUMAN RNA 3'-terminal phosphate cyclase-like protein RCL1 RNAC RPC2 RPCL1 RTC2 HSPC338 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]" endoribonuclease activity [GO:0004521] GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730 ITNGSR 8.899999619 1 1 0.195733622 647.641135 0 0 0 0 0 0 0 0 0 16.54755 0 11.70396 0 0 0 16.61087 16.85531 16.30107 0 17.49408 17.39851 0 17.85545 0 0 15.64309 0 16.07698 17.78425 16.01933 17.79968 17.44997 0 16.50056 0 15.83734 17.69904 18.34899 0 16.43567 16.9049 16.46496 17.23171 15.55899 16.96506 16.95323 17.59855 17.23984 Q9Y2Q0 AT8A1_HUMAN "Phospholipid-transporting ATPase IA, EC 7.6.2.1 (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)" ATP8A1 ATPIA Homo sapiens (Human) aminophospholipid translocation [GO:0140331]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transport across blood-brain barrier [GO:0150104] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; aminophospholipid translocation [GO:0140331]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transport across blood-brain barrier [GO:0150104] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0030335; GO:0031090; GO:0031410; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0045332; GO:0061092; GO:0070062; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:0150104; GO:1990531 TPSGK 9.569999695 0.00231286 0.00231286 0.072705621 489.1721272 13.10702 8.546457 14.92136 0 18.11101 0 0 16.77444 16.06807 15.90122 14.46202 15.74714 15.58847 14.18448 14.54647 15.00802 0 0 16.52414 14.8123 15.7118 15.73209 15.14794 0 14.88584 13.71081 11.18283 12.39909 0 18.06446 14.36764 16.08944 15.65703 0 15.39007 0 15.55188 0 0 14.92528 16.46691 14.07111 14.19884 12.72039 14.81795 15.55918 15.83016 14.47619 Q9Y2Q3 GSTK1_HUMAN "Glutathione S-transferase kappa 1, EC 2.5.1.18 (GST 13-13) (GST class-kappa) (GSTK1-1, hGSTK1) (Glutathione S-transferase subunit 13)" GSTK1 HDCMD47P Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749] glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006749; GO:0016020; GO:0030855; GO:0070062 IATPKVK 12.05000019 1 1 0.259435965 754.1703037 16.13858 13.82595 13.9665 0 15.93192 15.98195 0 0 0 14.51777 0 16.20366 0 15.16371 15.96204 13.94008 0 16.00782 0 15.38014 15.29768 0 0 0 0 15.30328 16.80927 14.33872 15.50126 0 0 16.00227 15.43292 16.72216 16.49163 0 16.75215 0 18.37283 0 0 0 15.30643 16.26653 0 14.41487 14.91366 0 Q9Y2Q9 RT28_HUMAN "28S ribosomal protein S28, mitochondrial, MRP-S28, S28mt (28S ribosomal protein S35, mitochondrial, MRP-S35, S35mt) (Mitochondrial small ribosomal subunit protein bS1m)" MRPS28 MRPS35 HSPC007 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] RNA binding [GO:0003723] GO:0003723; GO:0005739; GO:0005743; GO:0005763; GO:0032543 MAALCR 2.5 1 1 0.290341845 738.1053224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2068 0 0 0 0 0 0 0 0 0 18.13764 0 0 0 0 0 0 0 0 0 0 0 0 18.08978 0 0 0 20.16054 Q9Y2R4 DDX52_HUMAN "Probable ATP-dependent RNA helicase DDX52, EC 3.6.4.13 (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)" DDX52 ROK1 HUSSY-19 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0016020; GO:0016887; GO:0030490 IHMIHKAAVAAK 9.319999695 1 1 0.125605606 1299.379447 14.45726 0 0 0 0 0 0 0 0 0 14.48698 0 0 14.21192 0 0 0 0 0 0 0 15.23664 0 12.70427 0 0 0 0 0 0 16.13068 0 0 16.6196 14.94659 0 0 16.93988 0 0 0 0 0 0 0 0 0 0 Q9Y2R5 RT17_HUMAN "28S ribosomal protein S17, mitochondrial, MRP-S17, S17mt (Mitochondrial small ribosomal subunit protein uS17m)" MRPS17 RPMS17 HSPC011 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0019843; GO:0032543 ALPVPR 10.32999992 1 1 0.252918504 653.5446005 0 16.28424 0 0 0 0 17.84544 0 0 0 0 0 0 16.81227 18.1097 18.49446 18.29383 17.28654 0 0 16.83725 0 0 0 16.80082 0 0 17.20293 0 17.91895 20.17747 0 0 0 18.60055 0 18.09048 20.0899 18.91727 16.90323 18.63015 0 19.43924 0 0 0 0 0 Q9Y2R9 RT07_HUMAN "28S ribosomal protein S7, mitochondrial, MRP-S7, S7mt (Mitochondrial small ribosomal subunit protein uS7m) (bMRP-27a, bMRP27a)" MRPS7 Homo sapiens (Human) mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] GO:0000028; GO:0003723; GO:0003729; GO:0003735; GO:0005743; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543 FYQVPVPLPDRR 5.570000172 1 1 0.397730711 1485.280399 0 0 14.98171 13.67519 0 0 6.936442 0 0 0 15.1386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2S6 TMA7_HUMAN Translation machinery-associated protein 7 (Coiled-coil domain-containing protein 72) TMA7 CCDC72 HSPC016 HSPC330 Homo sapiens (Human) GPLATGGIKK 6.010000229 0.454527736 0.454527736 0.258934117 941.734051 12.82753 16.24065 15.06506 16.34649 12.97782 16.14915 15.15735 13.95833 15.65813 0 15.94832 15.19717 15.58263 0 0 0 12.84962 0 15.75332 0 0 0 0 0 15.37264 0 15.16034 15.1106 16.45983 0 0 15.55227 15.70217 15.36982 15.60756 0 0 0 0 0 0 0 0 0 14.9259 15.14664 0 14.345 Q9Y2T1 AXIN2_HUMAN "Axin-2 (Axin-like protein, Axil) (Axis inhibition protein 2) (Conductin)" AXIN2 Homo sapiens (Human) bone mineralization [GO:0030282]; cell death [GO:0008219]; cell population proliferation [GO:0008283]; cellular protein localization [GO:0034613]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; intramembranous ossification [GO:0001957]; maintenance of DNA repeat elements [GO:0043570]; mRNA stabilization [GO:0048255]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; odontogenesis [GO:0042476]; positive regulation of cell death [GO:0010942]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chondrocyte development [GO:0061181]; regulation of mismatch repair [GO:0032423]; secondary heart field specification [GO:0003139]; somitogenesis [GO:0001756]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; bone mineralization [GO:0030282]; cell death [GO:0008219]; cell population proliferation [GO:0008283]; cellular protein localization [GO:0034613]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; intramembranous ossification [GO:0001957]; maintenance of DNA repeat elements [GO:0043570]; mRNA stabilization [GO:0048255]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; odontogenesis [GO:0042476]; positive regulation of cell death [GO:0010942]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chondrocyte development [GO:0061181]; regulation of mismatch repair [GO:0032423]; secondary heart field specification [GO:0003139]; somitogenesis [GO:0001756]; Wnt signaling pathway [GO:0016055] beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] GO:0001756; GO:0001934; GO:0001957; GO:0003139; GO:0003413; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0008013; GO:0008219; GO:0008283; GO:0008285; GO:0010718; GO:0010942; GO:0016055; GO:0019899; GO:0019901; GO:0030282; GO:0030877; GO:0031625; GO:0032423; GO:0034613; GO:0042476; GO:0043161; GO:0043570; GO:0045668; GO:0045860; GO:0048255; GO:0061181; GO:0070411; GO:0070602; GO:0071407; GO:0090090; GO:2000054 QMNLKDTK 5.559999943 1 1 0.049347989 995.9053531 0 15.6883 16.22296 17.36481 16.61384 0 0 0 16.37674 0 16.18827 0 15.49596 15.22559 0 14.6984 14.92557 0 16.56993 0 0 15.22982 2.274087 0 18.02443 0 0 12.09509 0 15.66638 17.38234 15.23585 14.02565 17.67121 14.80935 0 13.36651 18.00447 17.54805 0 13.42878 0 13.32681 0 13.48911 17.44037 15.03712 0 Q9Y2T2 AP3M1_HUMAN AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Mu-adaptin 3A) (Mu3A-adaptin) AP3M1 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; small GTPase binding [GO:0031267]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192]" small GTPase binding [GO:0031267] GO:0005764; GO:0005765; GO:0005769; GO:0005794; GO:0006622; GO:0006897; GO:0008089; GO:0016192; GO:0030123; GO:0030131; GO:0030659; GO:0031267; GO:0031410; GO:0035654; GO:0046907; GO:0048490; GO:0060155; GO:1903232; GO:1904115 YTNNEAYFDVVEEIDAIIDK 3.809999943 1 1 0.034007992 2362.394089 0 14.95634 0 14.17949 14.81227 12.7269 0 12.97096 10.63282 11.76599 12.36366 14.5833 11.8562 0 0 0 0 11.04958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.39508 Q9Y2T4 2ABG_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (IMYPNO1) (PP2A subunit B isoform B55-gamma) (PP2A subunit B isoform PR55-gamma) (PP2A subunit B isoform R2-gamma) (PP2A subunit B isoform gamma) PPP2R2C Homo sapiens (Human) peptidyl-serine dephosphorylation [GO:0070262] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; peptidyl-serine dephosphorylation [GO:0070262] protein phosphatase regulator activity [GO:0019888] GO:0000159; GO:0005829; GO:0019888; GO:0070262 GEDTDTR 3.5 1 1 0.256812884 795.0016856 0 17.34315 0 16.74038 17.00693 15.51676 0 0 0 0 0 15.70491 0 0 0 14.91381 0 15.30384 0 0 13.95851 0 14.8699 15.06188 14.44411 0 0 0 16.48022 14.39808 0 0 17.72783 18.38147 0 0 0 0 16.75111 16.73615 0 17.79879 0 0 16.20096 0 0 0 Q9Y2U5 M3K2_HUMAN "Mitogen-activated protein kinase kinase kinase 2, EC 2.7.11.25 (MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2)" MAP3K2 MAPKKK2 MEKK2 Homo sapiens (Human) "cellular response to mechanical stimulus [GO:0071260]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to mechanical stimulus [GO:0071260]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]" ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0019901; GO:0045893; GO:0046872; GO:0071260; GO:0106310 SRMPR 7.309999943 0.399983108 0.399983108 0.181731966 645.3029143 0 15.27942 16.85736 0 15.47969 0 0 14.8772 0 0 0 15.62784 0 15.63282 0 0 0 0 0 16.07265 0 0 0 0 15.7249 0 0 14.29129 0 15.28078 16.77027 0 0 16.56419 15.03927 0 17.51797 17.18714 16.181 0 16.0568 16.10013 16.22072 15.57183 17.32687 0 0 17.60016 Q9Y2W1 TR150_HUMAN "Thyroid hormone receptor-associated protein 3 (BCLAF1 and THRAP3 family member 2) (Thyroid hormone receptor-associated protein complex 150 kDa component, Trap150)" THRAP3 BCLAF2 TRAP150 Homo sapiens (Human) "circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" extracellular exosome [GO:0070062]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; phosphoprotein binding [GO:0051219]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; phosphoprotein binding [GO:0051219]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809] GO:0000381; GO:0000956; GO:0000978; GO:0003677; GO:0003712; GO:0003713; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0006397; GO:0007623; GO:0008380; GO:0016592; GO:0016607; GO:0030374; GO:0042753; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0048026; GO:0048255; GO:0051219; GO:0070062 DLVHSNK 4.039999962 1 1 0.262177173 811.0448247 0 0 0 20.07172 0 0 0 17.30249 0 0 0 18.76218 0 0 0 0 0 0 0 0 0 0 0 18.87099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2W7 CSEN_HUMAN "Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator, DREAM) (Kv channel-interacting protein 3, KChIP3)" KCNIP3 CSEN DREAM KCHIP3 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; signal transduction [GO:0007165]" "calcium ion binding [GO:0005509]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated ion channel activity [GO:0005244]" GO:0000122; GO:0000978; GO:0001227; GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0008076; GO:0015459; GO:0072659; GO:1901379 GFKNECPTGLVDEDTFK 5.820000172 1 1 0.469691136 1955.534683 0 0 0 0 0 0 17.45559 0 0 0 0 0 0 0 0 0 18.89623 0 0 0 0 0 0 0 0 0 0 18.09542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2X3 NOP58_HUMAN Nucleolar protein 58 (Nucleolar protein 5) NOP58 NOL5 NOP5 HSPC120 Homo sapiens (Human) rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094] GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761 LGGVIKEK 8.569999695 1 1 0.433809617 842.0977868 16.44895 16.17461 16.49977 16.77912 16.51725 14.79047 0 15.95356 16.89673 0 0 15.41588 0 0 15.63708 15.53827 0 0 15.37737 0 0 15.52223 0 0 0 0 0 16.54387 0 15.332 0 0 0 15.48 0 0 0 17.33996 17.0225 14.98977 15.82333 0 0 0 15.48756 0 0 0 Q9Y2X7 GIT1_HUMAN "ARF GTPase-activating protein GIT1, ARF GAP GIT1 (Cool-associated and tyrosine-phosphorylated protein 1, CAT-1, CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1)" GIT1 Homo sapiens (Human) brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neuron development [GO:0048666]; positive regulation of microtubule nucleation [GO:0090063]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300] calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neuron development [GO:0048666]; positive regulation of microtubule nucleation [GO:0090063]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300] gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877] GO:0001957; GO:0005096; GO:0005739; GO:0005813; GO:0005829; GO:0005925; GO:0007420; GO:0007626; GO:0008277; GO:0014069; GO:0016020; GO:0030027; GO:0032465; GO:0032691; GO:0043015; GO:0044305; GO:0044877; GO:0045454; GO:0045820; GO:0046872; GO:0048013; GO:0048666; GO:0061743; GO:0071222; GO:0090063; GO:0097431; GO:0098794; GO:0099171; GO:0106015; GO:2000300 ALATSEAK 8.590000153 0.098288842 0.098288842 0.265435213 789.7879446 0 16.91143 0 0 16.63548 0 18.4415 0 18.68291 16.67593 16.47712 0 0 0 0 0 18.32814 0 0 16.58556 0 16.8922 0 0 0 17.19463 18.34765 18.64874 0 0 19.30519 17.43 0 0 18.27461 0 0 17.64235 0 0 0 0 0 0 0 18.68387 0 0 Q9Y2Y9 KLF13_HUMAN "Krueppel-like factor 13 (Basic transcription element-binding protein 3, BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1, RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1)" KLF13 BTEB3 NSLP1 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837 SDASSPTISPASSP 1.620000005 0.058652677 0.058652677 0.162391134 1299.283067 10.93128 13.34 15.22583 0 0 12.85836 0 0 0 0 0 0 12.67123 11.9655 0 0 0 14.57052 14.48432 0 0 0 0 12.93334 0 14.87847 0 0 0 15.19688 0 0 0 15.97166 13.9366 0 0 0 0 0 0 0 0 0 10.97332 15.06504 16.28674 0 Q9Y2Z0 SGT1_HUMAN Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog) SUGT1 Homo sapiens (Human) mitotic cell cycle [GO:0000278]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; chaperone binding [GO:0051087]; mitotic cell cycle [GO:0000278]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647] chaperone binding [GO:0051087] GO:0000151; GO:0000278; GO:0000776; GO:0005634; GO:0005829; GO:0031647; GO:0032991; GO:0050821; GO:0051087 LDIETGFHR 9.399999619 0.668629289 0.668629289 0.17247103 1087.80499 0 14.86265 0 0 0 14.21067 0 0 10.6858 0 0 0 0 0 15.76665 15.94928 0 0 15.54653 0 0 0 0 0 0 0 0 13.81153 0 0 0 0 16.24429 0 0 0 0 0 0 0 15.70205 0 0 0 10.58348 0 13.7664 0 Q9Y2Z4 SYYM_HUMAN "Tyrosine--tRNA ligase, mitochondrial, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS)" YARS2 CGI-04 Homo sapiens (Human) mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039] ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831] GO:0000049; GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006412; GO:0016604; GO:0042803; GO:0043039; GO:0070184; GO:0072545 AGHNVIALVGGATARLGDPSGR 2.670000076 1 1 0.259065153 2089.668792 0 13.73223 0 0 0 0 0 0 0 0 0 0 0 11.66813 0 0 0 14.43617 0 11.90882 0 0 0 0 0 0 0 13.56177 0 0 16.05172 0 0 15.08863 11.62809 0 15.60987 0 0 0 14.94955 15.06434 0 0 0 0 0 0 Q9Y305 ACOT9_HUMAN "Acyl-coenzyme A thioesterase 9, mitochondrial, Acyl-CoA thioesterase 9, EC 3.1.2.- (Acyl-CoA thioester hydrolase 9)" ACOT9 CGI-16 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637] acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-CoA hydrolase activity [GO:0016290] GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0016290; GO:0047617; GO:0052689 IDMCKK 22.26000023 1 1 0.245023037 809.446268 20.59136 18.68848 19.85 0 17.98817 18.46602 19.81842 18.62741 19.2213 20.70611 19.76137 19.18641 19.70765 20.41766 20.47234 19.02276 19.98958 18.99682 19.64848 19.69307 19.15107 19.24162 18.5787 17.63925 19.77985 20.18721 18.29279 19.45193 20.59063 19.95731 20.31741 18.68127 18.81521 20.24164 16.5806 19.03548 18.92842 19.43103 0 0 18.33195 20.7099 18.07929 17.26993 0 18.81558 0 0 Q9Y312 AAR2_HUMAN Protein AAR2 homolog (AAR2 splicing factor homolog) AAR2 C20orf4 CGI-23 PRO0225 Homo sapiens (Human) spliceosomal tri-snRNP complex assembly [GO:0000244] spliceosomal complex [GO:0005681]; U5 snRNP [GO:0005682] spliceosomal complex [GO:0005681]; U5 snRNP [GO:0005682]; spliceosomal tri-snRNP complex assembly [GO:0000244] GO:0000244; GO:0005681; GO:0005682 AAVQMDPELAKR 1.179999948 1 1 0.714504458 1345.345665 18.00291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.18994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y320 TMX2_HUMAN Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14) TMX2 TXNDC14 CGI-31 My009 PIG26 PSEC0045 UNQ237/PRO270 Homo sapiens (Human) brain development [GO:0007420] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; brain development [GO:0007420] disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802] GO:0005739; GO:0005789; GO:0007420; GO:0015036; GO:0016021; GO:0031966; GO:0042802; GO:0043227; GO:0044233 YTDVSTR 5.860000134 1 1 0.277124481 839.9671551 0 0 0 0 0 0 0 14.41465 0 0 0 14.47614 16.62345 0 16.21199 0 0 0 0 0 0 0 0 16.40549 0 0 17.18842 0 0 0 15.72704 0 0 17.17562 16.83007 0 17.64973 0 16.95302 0 0 16.73425 13.74752 16.27697 0 0 16.18117 0 Q9Y371 SHLB1_HUMAN "Endophilin-B1 (Bax-interacting factor 1, Bif-1) (SH3 domain-containing GRB2-like protein B1)" SH3GLB1 KIAA0491 CGI-61 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; membrane organization [GO:0061024]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; membrane organization [GO:0061024]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] GO:0000139; GO:0000421; GO:0005737; GO:0005741; GO:0005829; GO:0006914; GO:0006915; GO:0008289; GO:0010508; GO:0016020; GO:0016241; GO:0030496; GO:0031334; GO:0031410; GO:0031647; GO:0032465; GO:0032801; GO:0032991; GO:0034198; GO:0042149; GO:0042802; GO:0042803; GO:0045296; GO:0048102; GO:0061024; GO:0090148; GO:1903527; GO:1903778; GO:1903955; GO:2000786 IMKQTEVLLQPNPNAR 3.849999905 1 1 0.202801599 1851.392161 16.47469 0 0 14.87938 0 0 0 0 16.27335 16.94644 0 0 14.96906 0 15.43372 16.32742 0 0 0 16.14669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y375 CIA30_HUMAN "Complex I intermediate-associated protein 30, mitochondrial (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1)" NDUFAF1 CIA30 CGI-65 Homo sapiens (Human) "chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; NADH dehydrogenase complex assembly [GO:0010257]; protein-containing complex assembly [GO:0065003]" cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; NADH dehydrogenase complex assembly [GO:0010257]; protein-containing complex assembly [GO:0065003]" unfolded protein binding [GO:0051082] GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0005829; GO:0006120; GO:0010257; GO:0032981; GO:0051082; GO:0051131; GO:0065003 GAFER 10.81000042 0.090243913 0.090243913 0.183001169 578.4657806 0 14.82614 12.48569 11.20731 15.68431 0 14.86257 13.91129 0 15.59521 15.35345 14.87409 14.39978 13.32275 15.55527 0 0 16.54959 0 15.85932 15.59613 0 0 0 15.08494 15.46508 16.10976 16.23368 16.07534 14.24735 13.18232 14.6785 16.17056 15.32217 16.02741 15.20983 15.51659 0 16.57779 15.24396 17.05993 15.65429 16.26022 15.0372 15.60877 0 16.95061 0 Q9Y383 LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 LUC7L2 CGI-59 CGI-74 Homo sapiens (Human) mRNA splice site selection [GO:0006376] nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376] enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004 SRSMSR 8.340000153 1 1 0.13367591 738.5462437 16.5154 0 16.07612 14.933 0 0 0 16.59363 0 0 15.87631 0 16.18777 15.54882 15.9516 16.53895 0 15.54592 0 0 0 0 0 0 17.14897 16.06961 0 0 0 0 0 0 16.15123 0 0 16.99555 17.61974 0 17.60325 18.80464 17.86788 16.9688 17.52151 16.06705 16.18732 17.59459 16.92345 17.14441 Q9Y385 UB2J1_HUMAN "Ubiquitin-conjugating enzyme E2 J1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1, NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E, HsUBC6e)" UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205 Homo sapiens (Human) "negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]" ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625] GO:0000209; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0032680; GO:0061631; GO:1904153 NTSMSPRQR 11.80000019 0.208732545 0.208732545 0.291283534 1089.814185 14.75279 15.76251 15.64267 0 0 15.18764 0 13.71635 0 0 0 16.2077 0 0 0 15.82825 0 0 0 0 15.61441 0 16.86315 0 12.42691 14.37928 15.81286 14.81979 15.46025 0 0 16.77499 0 0 0 16.24109 0 16.85961 16.30491 15.52163 16.01376 15.74485 16.41396 15.68055 0 16.31144 16.51885 16.73016 Q9Y397 ZDHC9_HUMAN "Palmitoyltransferase ZDHHC9, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 9, DHHC-9, DHHC9) (Zinc finger protein 379) (Zinc finger protein 380)" ZDHHC9 CXorf11 ZDHHC10 ZNF379 ZNF380 CGI-89 UNQ261/PRO298 Homo sapiens (Human) MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849]; MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849] GO:0000139; GO:0000165; GO:0002178; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0031228; GO:0043849 MSVMVVR 9.930000305 0.581035852 0.581035852 0.173307728 853.9112564 0 0 15.80048 13.91649 14.67968 15.80542 14.73699 16.12508 0 16.19746 0 0 15.72089 0 0 0 0 15.86196 16.31502 10.46976 0 0 0 13.77804 17.05858 0 17.0026 0 0 15.69953 0 14.86971 15.37492 13.20915 0 15.10786 14.83372 14.82115 15.18139 0 15.80926 13.22367 17.51257 16.19128 16.05047 15.08052 0 0 Q9Y399 RT02_HUMAN "28S ribosomal protein S2, mitochondrial, MRP-S2, S2mt (Mitochondrial small ribosomal subunit protein uS2m)" MRPS2 CGI-91 Homo sapiens (Human) mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543] structural constituent of ribosome [GO:0003735] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0061668 MATSSAALPR 7.099999905 1 1 0.520255044 1021.923821 0 0 0 0 0 0 0 0 0 0 0 16.65551 0 0 0 0 0 0 20.05546 0 0 0 18.47408 0 0 0 0 0 0 18.91682 0 19.92627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3A2 UTP11_HUMAN "Probable U3 small nucleolar RNA-associated protein 11, U3 snoRNA-associated protein 11 (UTP11-like protein)" UTP11 UTP11L CGI-94 HDCMB12P Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0043065 QQNKHVFFFDTK 2.799999952 1 1 0.03060014 1538.820319 0 0 0 0 0 0 14.35781 0 0 0 0 0 15.3328 0 0 0 0 14.04517 0 0 0 0 16.72472 0 13.73098 0 16.36594 0 15.94913 15.73482 0 0 15.74368 0 15.19745 0 16.11332 0 14.45194 14.86081 0 15.86521 0 0 0 0 0 0 Q9Y3A4 RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14) RRP7A CGI-96 Homo sapiens (Human) blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364] CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456] CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364] RNA binding [GO:0003723] GO:0000028; GO:0001825; GO:0003723; GO:0005654; GO:0005737; GO:0006364; GO:0032545; GO:0034456 MEHLAQLR 1.659999967 1 1 0.097340624 999.4357779 13.82347 14.76841 14.14873 12.27171 11.78133 13.68694 15.66347 0 12.78987 13.44301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.09124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3785 0 0 0 0 0 0 0 Q9Y3A5 SBDS_HUMAN Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein) SBDS CGI-97 Homo sapiens (Human) bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364] microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] GO:0000922; GO:0001833; GO:0002244; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539 LTNVAVVRMK 3.799999952 0.082400851 0.082400851 0.069577738 1146.145476 16.53108 14.36296 0 0 0 15.61032 11.71959 15.40011 0 16.80748 13.90091 12.77476 15.79278 19.04483 13.61999 0 0 15.08662 14.29373 15.27429 18.07896 0 17.09022 14.65069 0 0 15.97733 0 15.3924 0 0 0 15.13963 0 15.47095 0 15.93983 0 16.48957 0 16.48947 0 10.7205 13.25119 17.87954 0 0 0 Q9Y3B6 EMC9_HUMAN ER membrane protein complex subunit 9 (Protein FAM158A) EMC9 C14orf122 FAM158A CGI-112 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005737; GO:0005789; GO:0045050; GO:0071816; GO:0072546 LVPQPR 4.809999943 0.452044517 0.452044517 0.128853937 708.9091422 15.29449 14.54113 0 12.23196 15.56555 14.28409 0 15.70563 0 13.87277 0 12.17073 0 13.21445 19.03243 0 0 0 0 16.07255 17.22525 16.12944 15.33728 0 0 14.47863 14.26473 0 17.08572 12.03296 0 14.3663 17.38779 0 0 0 0 14.77058 11.97079 15.88534 0 15.89811 0 0 14.19477 14.03339 12.89916 16.42606 Q9Y3B7 RM11_HUMAN "39S ribosomal protein L11, mitochondrial, L11mt, MRP-L11 (Mitochondrial large ribosomal subunit protein uL11m)" MRPL11 CGI-113 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:0070180 GVSINQFCK 2.769999981 1 1 0.115051999 1052.001417 0 0 15.31278 11.95428 15.39466 14.72273 14.21605 14.27509 14.73964 0 0 0 11.70055 15.5112 14.7923 15.50857 15.28061 0 12.60775 11.8384 0 14.23725 15.93905 0 0 0 0 0 0 15.50946 0 0 0 0 15.13694 0 0 0 0 15.5451 0 0 0 0 0 14.3219 14.03925 0 Q9Y3C0 WASC3_HUMAN WASH complex subunit 3 (Coiled-coil domain-containing protein 53) WASHC3 AD-016 CCDC53 CGI-116 x0009 Homo sapiens (Human) actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315] early endosome membrane [GO:0031901]; WASH complex [GO:0071203] early endosome membrane [GO:0031901]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315] GO:0006887; GO:0015031; GO:0016197; GO:0030041; GO:0031901; GO:0034315; GO:0071203 MDEDGLPLMGSGIDLTK 12.61999989 1 1 0.202775891 1807.11886 0 14.08897 0 0 16.53664 13.38808 0 0 0 0 0 13.67912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.05885 15.84367 0 0 0 14.97166 0 14.95716 0 0 12.35264 0 0 0 0 13.71628 0 0 0 15.74901 Q9Y3C6 PPIL1_HUMAN "Peptidyl-prolyl cis-trans isomerase-like 1, PPIase, EC 5.2.1.8 (Rotamase PPIL1)" PPIL1 CYPL1 CGI-124 UNQ2425/PRO4984 Homo sapiens (Human) "embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718; GO:1990403 VCQGIGMVNR 2.410000086 1 1 0.067692202 1150.339055 14.39215 14.35892 13.03857 14.0266 11.77891 13.92307 14.26251 13.23816 12.26614 17.50872 12.62027 10.40297 0 0 0 15.47505 0 0 0 13.79934 8.171681 0 17.10051 0 13.72868 0 0 0 0 13.27174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.16139 0 0 0 Q9Y3E7 CHMP3_HUMAN "Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24, hVps24)" CHMP3 CGI149 NEDF VPS24 CGI-149 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; ubiquitin-specific protease binding [GO:1990381] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005770; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006915; GO:0006997; GO:0007080; GO:0010824; GO:0015031; GO:0016236; GO:0019076; GO:0030496; GO:0031210; GO:0031410; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0042802; GO:0043162; GO:0044790; GO:0045324; GO:0046761; GO:0051258; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930; GO:1990381; GO:2000641 AHMNSVLMGMKNQLAVLR 4.599999905 1 1 1.38E-12 2014.73165 0 12.88435 13.24234 14.70451 0 14.69436 0 0 0 13.09965 0 0 0 0 0 0 0 0 0 0 0 0 11.98739 0 14.74723 0 16.40527 0 0 0 0 0 0 0 0 0 0 0 0 14.11482 15.53542 0 0 0 0 0 0 0 Q9Y3M8 STA13_HUMAN "StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein, DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13, StARD13)" STARD13 DLC2 GT650 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966] cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; lipid binding [GO:0008289] GO:0005096; GO:0005811; GO:0005829; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0051056; GO:0090051; GO:0097498 KVGDGNPLK 5.449999809 0.093320608 0.093320608 0.272797517 926.2540885 0 0 0 0 0 0 0 18.21742 0 0 0 16.08946 0 0 0 0 16.95183 0 0 16.74264 0 0 15.77812 0 0 19.97767 0 0 0 0 0 18.56634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3M9 ZN337_HUMAN Zinc finger protein 337 ZNF337 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 DKSSYNK 9.619999886 0.002333762 0.002333762 0.140607439 840.6188621 0 21.85295 0 0 0 0 0 0 0 0 0 0 17.23573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.59979 0 0 0 0 0 0 0 0 0 19.01332 0 0 0 0 0 0 0 0 Q9Y3P9 RBGP1_HUMAN Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA) RABGAP1 HSPC094 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; regulation of GTPase activity [GO:0043087] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; regulation of GTPase activity [GO:0043087] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631] GO:0005096; GO:0005813; GO:0005829; GO:0005875; GO:0007049; GO:0015631; GO:0031267; GO:0043087; GO:0090630 EYHTMR 11 1 1 0.252392756 836.3741555 0 0 0 0 14.40131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.85853 11.86642 14.30718 0 0 0 0 14.13767 0 0 0 0 0 13.4905 0 0 0 0 16.542 0 Q9Y3Q0 NALD2_HUMAN "N-acetylated-alpha-linked acidic dipeptidase 2, EC 3.4.17.21 (Glutamate carboxypeptidase III, GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II, NAALADase II)" NAALAD2 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; serine-type peptidase activity [GO:0008236] GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016021; GO:0016805; GO:0046872 QLSVAQLR 3.940000057 0.750268579 0.750268579 0.252585277 913.7806122 16.32943 15.69425 17.04421 14.90508 15.53456 14.69117 15.31483 0 13.53652 15.84796 15.46468 16.46919 15.72374 16.1468 15.90938 15.91561 14.45082 15.8188 16.54738 17.10127 0 16.42961 13.81975 16.11859 17.42379 0 16.6608 16.40158 16.49691 0 17.04066 15.3205 15.78487 16.13407 16.64948 15.51463 15.59369 16.44292 16.27642 16.17491 16.95267 0 16.32524 16.68469 16.27348 16.15992 15.44594 16.3181 Q9Y3Q7 ADA18_HUMAN "Disintegrin and metalloproteinase domain-containing protein 18, ADAM 18 (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III, tMDC III)" ADAM18 TMDC3 UNQ858/PRO1867 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] GO:0004222; GO:0007155; GO:0007283; GO:0007339; GO:0008237; GO:0016020; GO:0016021; GO:0030154 VPLNSQIK 6.739999771 0.199350864 0.199350864 0.163248564 898.2963459 14.44021 0 0 15.37661 16.78378 0 0 0 17.41113 0 0 0 0 16.63932 0 0 18.08282 0 16.197 18.09101 0 17.06388 14.50974 16.63344 0 0 0 0 0 16.83438 17.15046 0 0 0 16.90377 0 0 13.49807 17.94293 18.35236 18.93794 19.82535 0 0 0 0 18.56819 16.99531 Q9Y3R4 NEUR2_HUMAN "Sialidase-2, EC 3.2.1.18 (Cytosolic sialidase) (N-acetyl-alpha-neuraminidase 2)" NEU2 Homo sapiens (Human) cellular oligosaccharide catabolic process [GO:0051692]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; glycosphingolipid metabolic process [GO:0006687]; oligosaccharide catabolic process [GO:0009313] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; cellular oligosaccharide catabolic process [GO:0051692]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; glycosphingolipid metabolic process [GO:0006687]; oligosaccharide catabolic process [GO:0009313] exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308] GO:0004308; GO:0005737; GO:0005829; GO:0006516; GO:0006687; GO:0006689; GO:0009313; GO:0016020; GO:0043231; GO:0051692; GO:0052794; GO:0052795; GO:0052796; GO:1902494 DEHAELIVLRR 21.12000084 1 1 0.139936156 1351.315353 0 15.8861 0 0 0 14.93701 0 0 0 0 0 14.96341 12.19431 0 15.64594 16.08522 0 0 16.68333 0 15.56612 16.17104 17.8735 17.36567 14.95289 16.28784 0 0 14.34491 18.23181 0 17.88914 0 0 14.81472 0 0 15.27297 15.40905 0 17.08926 0 15.7864 0 16.46946 0 0 0 Q9Y3R5 DOP2_HUMAN Protein dopey-2 DOP1B C21orf5 DOPEY2 KIAA0933 Homo sapiens (Human) cognition [GO:0050890]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; cognition [GO:0050890]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0007029; GO:0009880; GO:0015031; GO:0031901; GO:0050890; GO:0070062 ERQEAVEALFK 24.73999977 0.771071017 0.771071017 9.17E-13 1319.668274 9.676688 12.35123 0 15.40638 0 0 0 16.04016 0 15.12881 0 0 0 0 0 0 0 13.59455 0 0 0 0 0 0 0 17.90289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.04765 17.28169 0 Q9Y3S1 WNK2_HUMAN "Serine/threonine-protein kinase WNK2, EC 2.7.11.1 (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43)" WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0008285; GO:0010766; GO:0019869; GO:0019870; GO:0035556; GO:0046777; GO:0050801; GO:0070373; GO:0090263; GO:0106310; GO:1903288; GO:2000651 AARPGPQR 10.47000027 1 1 0.382824992 853.8181909 0 15.39787 0 14.19152 18.21342 0 16.50798 15.77645 13.18957 13.99292 13.36003 14.51539 14.25711 12.74291 13.32634 14.42061 16.97772 0 0 0 0 14.60037 0 0 17.91841 0 0 0 0 17.62446 0 0 16.57555 0 0 16.87729 0 0 0 0 0 15.8917 0 15.86815 0 0 0 0 Q9Y3T6 R3HC1_HUMAN R3H and coiled-coil domain-containing protein 1 R3HCC1 Homo sapiens (Human) nucleic acid binding [GO:0003676] nucleic acid binding [GO:0003676] GO:0003676 ERPQTNATVAR 16.12000084 1 1 0.345484962 1241.707202 0 0 15.42592 0 14.03372 15.38002 0 14.89944 14.17439 0 0 0 17.17565 15.28967 13.6648 13.67516 15.24383 16.60005 0 15.15545 13.92526 0 16.33284 16.14551 0 16.40639 15.9779 15.59012 0 0 0 0 16.18126 0 15.22026 17.20901 0 0 0 15.16905 16.37793 0 0 14.05812 0 0 16.2983 0 Q9Y3U8 RL36_HUMAN 60S ribosomal protein L36 (Large ribosomal subunit protein eL36) RPL36 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788 EELSNVLAAMRK 13.27999973 1 1 0.108262282 1377.803745 15.60529 16.14397 13.47857 0 0 11.62959 0 15.72255 15.65378 0 0 0 0 0 0 0 0 10.84074 0 14.61086 0 0 0 0 14.90866 0 0 0 14.77996 0 16.77652 16.20089 15.25981 14.8265 0 0 13.42307 0 0 0 0 0 0 0 0 0 0 0 Q9Y3X0 CCDC9_HUMAN Coiled-coil domain-containing protein 9 CCDC9 Homo sapiens (Human) RNA binding [GO:0003723] RNA binding [GO:0003723] GO:0003723 AEASSRR 13.47999954 1 1 0.305701974 777.8658764 16.97478 0 14.93888 16.34007 15.71242 15.78423 0 0 16.69856 16.21685 0 15.99724 0 0 0 15.64367 15.08484 0 0 14.76206 0 16.96318 0 0 0 14.45151 0 15.27715 0 16.50219 0 15.30416 14.97188 16.49268 15.81801 0 16.58578 0 16.21988 16.96839 0 15.79148 0 0 0 16.11922 0 17.58139 Q9Y426 C2CD2_HUMAN C2 domain-containing protein 2 (Transmembrane protein 24-like) C2CD2 C21orf25 C21orf258 TMEM24L Homo sapiens (Human) cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0005829; GO:0016021 LLSRHR 7.289999962 1 1 0.205588003 780.416796 16.52566 15.44207 15.6425 16.12652 0 0 0 0 0 16.76925 15.97653 14.83136 15.79472 12.89487 15.85849 14.94497 13.06832 15.07333 0 16.55734 0 0 0 0 15.67275 14.88859 16.29209 0 0 0 0 17.50688 0 0 16.03817 16.40044 0 0 0 0 0 0 17.3679 16.01216 0 16.44275 15.05181 17.14435 Q9Y446 PKP3_HUMAN Plakophilin-3 PKP3 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; protein localization to plasma membrane [GO:0072659] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; protein localization to plasma membrane [GO:0072659] alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899] GO:0001533; GO:0002159; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0010628; GO:0019899; GO:0030054; GO:0030057; GO:0045294; GO:0045296; GO:0050839; GO:0072659; GO:0098609; GO:0098641; GO:1902373; GO:1990124 QASSSSSR 1.720000029 1 1 0.044275945 808.7332628 13.35116 13.83313 13.69518 0 15.72441 13.93542 14.95302 13.2263 0 0 14.30651 15.65297 16.50075 15.24419 15.58568 16.00324 13.64457 0 0 0 0 15.53258 0 0 0 0 0 0 0 0 15.93332 0 15.80071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y448 SKAP_HUMAN "Small kinetochore-associated protein, SKAP (Kinetochore-localized astrin-binding protein, Kinastrin) (Kinetochore-localized astrin/SPAG5-binding protein) (TRAF4-associated factor 1)" KNSTRN C15orf23 SKAP TRAF4AF1 HSD11 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; chromosome segregation [GO:0007059]; microtubule cytoskeleton organization [GO:0000226]; mitotic sister chromatid segregation [GO:0000070]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; spindle pole [GO:0000922]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; chromosome segregation [GO:0007059]; microtubule cytoskeleton organization [GO:0000226]; mitotic sister chromatid segregation [GO:0000070]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; spindle organization [GO:0007051] microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803] GO:0000070; GO:0000226; GO:0000776; GO:0000922; GO:0001726; GO:0005634; GO:0005737; GO:0005815; GO:0005886; GO:0007051; GO:0007059; GO:0016477; GO:0034451; GO:0035371; GO:0042803; GO:0051010; GO:0051301; GO:0051988; GO:0071364; GO:0072686 KFLFETQAADLAGGTTVAAGNLLNESEK 6.800000191 1 1 0.053075642 2895.826344 8.803637 0 13.57426 0 0 0 0 15.41345 0 0 0 14.86658 0 12.99569 0 15.33174 8.058535 0 0 0 0 0 0 0 11.89588 0 0 0 13.2288 15.00085 14.57506 0 0 0 13.32683 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y450 HBS1L_HUMAN HBS1-like protein (ERFS) HBS1L HBS1 KIAA1038 Homo sapiens (Human) signal transduction [GO:0007165]; translation [GO:0006412] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; signal transduction [GO:0007165]; translation [GO:0006412] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007165; GO:0016020; GO:0070062 GVTMDVGMTKFETTTK 3.410000086 1 1 0.317070236 1745.754747 15.71938 13.80799 16.73316 12.73042 0 15.7628 14.2737 0 0 0 17.52058 0 0 14.11724 0 0 13.94276 13.66361 15.28875 0 0 0 0 16.00628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.49372 0 0 0 0 Q9Y458 TBX22_HUMAN "T-box transcription factor TBX22, T-box protein 22" TBX22 TBOX22 Homo sapiens (Human) "cell fate specification [GO:0001708]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0006357; GO:0045892 LISGSNHLK 10.5 0.423208624 0.423208624 0.237651926 969.352834 0 16.42202 16.01077 11.95461 14.7195 15.53089 14.98572 0 15.07682 13.92902 0 17.54231 13.60169 14.20562 0 13.83798 0 0 0 16.02453 15.55302 0 16.31585 12.44725 0 15.86885 14.05673 0 0 0 15.5845 0 0 0 0 0 15.78101 0 0 14.85912 15.74627 0 0 16.07707 0 0 0 0 Q9Y462 ZN711_HUMAN Zinc finger protein 711 (Zinc finger protein 6) ZNF711 CMPX1 ZNF6 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010468; GO:0043565; GO:0045893; GO:0046872 HLDLFQGHK 6.429999828 1 1 0.204288159 1097.938945 13.49682 12.83615 14.29877 12.24319 15.36154 13.82085 15.63047 15.45081 14.32599 0 0 7.903785 14.18184 16.22728 14.99963 13.93162 14.63008 0 14.25632 14.38884 14.20779 15.8952 16.559 14.02837 0 14.02005 0 0 0 0 0 0 0 0 15.08764 0 0 0 0 0 0 0 0 0 0 14.84884 0 14.01467 Q9Y467 SALL2_HUMAN "Sal-like protein 2 (Zinc finger protein 795) (Zinc finger protein SALL2) (Zinc finger protein Spalt-2, Sal-2, hSal2)" SALL2 KIAA0360 SAL2 ZNF795 Homo sapiens (Human) eye development [GO:0001654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; eye development [GO:0001654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0005634; GO:0006357; GO:0045944; GO:0046872 AQNSCPICQK 4.829999924 1 1 4.56E-13 1206.032008 0 16.43204 16.21586 12.7817 13.78864 0 0 0 16.78294 18.31612 12.0412 0 14.78942 15.18707 14.60375 16.65086 16.17968 13.05832 16.20175 0 14.69619 14.79722 16.77931 0 18.36751 17.32168 18.38802 0 16.93764 0 16.50282 0 0 0 0 12.47413 15.14521 15.67705 16.48363 17.05545 14.21331 0 16.96514 15.21206 16.76943 0 16.69514 17.19136 Q9Y468 LMBL1_HUMAN "Lethal(3)malignant brain tumor-like protein 1, H-l(3)mbt, H-l(3)mbt protein, L(3)mbt-like (L(3)mbt protein homolog) (L3MBTL1)" L3MBTL1 KIAA0681 L3MBT L3MBTL Homo sapiens (Human) "chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitotic nuclear division [GO:0007088]" chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome [GO:0000793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome [GO:0000793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; nucleosome binding [GO:0031491]; SAM domain binding [GO:0032093]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitotic nuclear division [GO:0007088]" chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; nucleosome binding [GO:0031491]; SAM domain binding [GO:0032093]; zinc ion binding [GO:0008270] GO:0000785; GO:0000793; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0007088; GO:0008270; GO:0030097; GO:0031491; GO:0031507; GO:0032093; GO:0035064; GO:0042393; GO:0042802; GO:0045652; GO:0045892; GO:0051726; GO:0061793 NGFKLGMK 8.600000381 1 1 0.581057539 911.3200823 18.44619 0 0 0 0 0 0 0 17.19201 0 0 0 0 18.64938 17.41696 0 0 17.64207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.15382 0 0 0 0 0 0 0 0 0 19.26427 17.12749 16.77426 17.31586 0 18.6686 Q9Y473 ZN175_HUMAN Zinc finger protein 175 (Zinc finger protein OTK18) ZNF175 Homo sapiens (Human) defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0045944; GO:0046872; GO:0051607 CSYSVK 3.180000067 1 1 0.181783558 742.7240313 14.75545 15.28547 0 0 0 15.04157 0 0 0 0 0 15.31847 15.70318 0 0 0 0 0 0 13.47366 14.85306 0 15.62548 0 14.514 15.24421 0 15.44667 15.68097 13.3535 0 0 0 0 0 0 13.87286 0 0 16.09955 0 0 0 0 0 0 0 0 Q9Y478 AAKB1_HUMAN "5'-AMP-activated protein kinase subunit beta-1, AMPK subunit beta-1, AMPKb" PRKAB1 AMPK Homo sapiens (Human) cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165] protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901] GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0007165; GO:0010628; GO:0019901; GO:0031588; GO:0031669; GO:0035878; GO:0050790; GO:0120162 TDFEVFDALMVDSQK 5.679999828 1 1 0.121219663 1759.916024 13.42579 14.62144 0 15.50293 11.9075 0 15.59966 0 0 0 12.08019 15.06675 12.56621 0 14.18456 13.25399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.83627 0 0 14.60726 0 0 0 0 0 0 0 Q9Y483 MTF2_HUMAN "Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2, hPCl2)" MTF2 PCL2 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222] GO:0000122; GO:0000977; GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006325; GO:0006355; GO:0007379; GO:0019827; GO:0035064; GO:0035098; GO:0045944; GO:0046872; GO:0048863; GO:0061086; GO:0061087; GO:1990830 MRDSTGAGNSLVHK 6.139999866 0.684309185 0.684309185 0.417172739 1471.849631 0 15.22529 15.03178 0 15.27459 15.67155 0 0 0 17.71423 0 0 15.72099 16.56049 14.06345 0 0 0 0 16.11454 0 0 0 0 17.71321 0 17.06196 0 0 0 15.80591 0 0 16.83253 16.57233 0 18.47156 0 16.19587 17.90795 16.56337 18.64159 18.00224 17.05675 0 0 16.96788 0 Q9Y484 WIPI4_HUMAN "WD repeat domain phosphoinositide-interacting protein 4, WIPI-4 (WD repeat-containing protein 45)" WDR45 WDRX1 WDRXI4 WIPI4 JM5 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] "cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]" "phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]" GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981; GO:2000786 LVLEFTFTKPVLSVR 4.170000076 1 1 0.186165382 1748.310584 15.14435 15.88737 16.25858 13.7946 14.91908 0 0 0 16.45996 0 0 0 0 13.59274 14.53077 0 14.16435 0 0 14.00979 16.13746 15.84411 15.09305 16.60237 0 0 16.07975 0 0 0 16.22147 0 0 14.64773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y485 DMXL1_HUMAN "DmX-like protein 1, X-like 1 protein" DMXL1 XL1 Homo sapiens (Human) vacuolar acidification [GO:0007035] RAVE complex [GO:0043291] RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035] GO:0007035; GO:0043291 ERVQNALEVNLR 6.440000057 1 1 1 1439.997549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.51438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y487 VPP2_HUMAN "V-type proton ATPase 116 kDa subunit a 2, V-ATPase 116 kDa subunit a 2 (Lysosomal H(+)-transporting ATPase V0 subunit a 2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2)" ATP6V0A2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0000139; GO:0000220; GO:0001669; GO:0005765; GO:0005886; GO:0005925; GO:0006879; GO:0006955; GO:0007035; GO:0010008; GO:0016021; GO:0016241; GO:0016471; GO:0030670; GO:0033176; GO:0036295; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:0061795; GO:1902600 AAESVYSR 5.46999979 1 1 0.370035805 885.1774451 14.19158 0 0 15.35691 14.85897 15.03075 15.81023 14.52876 15.58513 14.87545 0 0 0 15.65571 0 14.95247 0 15.69509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.64125 0 0 0 0 0 0 0 0 0 0 15.3547 Q9Y490 TLN1_HUMAN Talin-1 TLN1 KIAA1027 TLN Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 ALGDLISATK 11.5 1 1 0.220866489 989.2423302 12.86609 13.85849 16.87616 13.68079 15.47182 14.52152 14.52264 0 14.0949 0 15.64925 0 14.62786 0 0 0 0 15.00683 0 0 14.36131 0 0 16.9057 0 15.83054 0 0 0 0 15.32397 15.18051 14.62601 0 17.51915 0 0 0 0 0 0 0 0 0 0 0 14.94468 14.61483 Q9Y493 ZAN_HUMAN Zonadhesin ZAN Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609] GO:0005615; GO:0005886; GO:0007339; GO:0016021; GO:0031012; GO:0098609 GSTAYLDIALDALSIRR 1.909999967 1 1 0.273444412 1835.817378 0 0 0 10.07506 12.14594 14.65806 7.602327 0 15.61292 15.6108 14.4359 0 0 0 15.77568 0 0 14.02695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.44076 0 0 0 Q9Y496 KIF3A_HUMAN Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A) KIF3A KIF3 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507]; anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507] GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006996; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0019903; GO:0030507; GO:0031267; GO:0034454; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115 KVWTMLMAAK 6.679999828 0.626959503 0.626959503 9.15E-13 1201.530728 10.49301 14.05247 15.38796 14.13146 13.9813 15.91091 16.15796 13.31637 0 14.07354 0 14.9533 12.56978 0 0 13.87062 0 13.82127 0 0 13.60891 0 0 0 0 0 14.83393 13.45386 0 0 0 0 0 0 0 0 0 14.60098 0 0 12.22601 0 0 0 13.6412 0 16.28073 11.06306 Q9Y4A5 TRRAP_HUMAN "Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor, PAF350/400) (STAF40) (Tra1 homolog)" TRRAP PAF400 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276] "Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" transcription coregulator activity [GO:0003712] GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0016578; GO:0033276; GO:0035267; GO:0035521; GO:0035522; GO:0042981; GO:0043484; GO:0043966; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779 ALNSTNSELQEAGEACMR 6.260000229 1 1 2.75E-12 1995.723803 13.13734 14.61466 0 0 0 12.43614 0 0 13.48128 0 0 0 15.42495 15.58324 15.65507 0 0 13.59046 16.25857 0 16.15798 14.71685 16.95298 0 0 13.80784 0 14.9079 14.36743 0 15.36485 14.44519 14.49421 16.36524 11.78436 0 0 0 0 0 14.86075 0 0 0 0 0 0 0 Q9Y4A8 NF2L3_HUMAN "Nuclear factor erythroid 2-related factor 3, NF-E2-related factor 3, NFE2-related factor 3 (Nuclear factor, erythroid derived 2, like 3)" NFE2L3 NRF3 Homo sapiens (Human) integrated stress response signaling [GO:0140467]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; integrated stress response signaling [GO:0140467]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0090575; GO:0140467 AINIMK 3.299999952 1 1 0.034838412 705.4726955 14.99299 14.09364 10.50944 14.05414 15.3433 14.10154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4B4 ARIP4_HUMAN "Helicase ARIP4, EC 3.6.4.12 (Androgen receptor-interacting protein 4) (RAD54-like protein 2)" RAD54L2 ARIP4 KIAA0809 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0016887; GO:0140658 GDEKPVASVRPVQSTPIPMMPR 1.580000043 1 1 0.279415303 2408.641583 15.10036 0 0 15.35347 12.73983 13.061 0 0 12.37009 0 0 0 0 0 14.6154 0 0 13.82596 0 0 14.04565 15.56414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4B5 MTCL1_HUMAN Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2) MTCL1 CCDC165 KIAA0802 SOGA2 Homo sapiens (Human) establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] GO:0000922; GO:0001578; GO:0003723; GO:0005615; GO:0005737; GO:0005856; GO:0008017; GO:0010506; GO:0016324; GO:0016327; GO:0016328; GO:0030496; GO:0042803; GO:0045197; GO:0090314; GO:0097427 AEMEDMR 6.039999962 0.358836979 0.358836979 0.123087215 913.3846243 0 0 16.08388 0 0 14.64279 14.43655 0 8.160881 0 0 0 13.20157 15.37017 15.56036 16.08928 15.15802 10.52655 15.23661 15.85348 15.59737 0 0 14.2674 0 0 16.20498 15.60844 14.67431 0 15.18757 14.99547 13.74776 11.34862 17.87825 15.62891 0 16.66032 17.28671 16.49986 16.14232 12.56724 15.32444 0 18.05375 14.71194 18.02796 14.91583 Q9Y4C0 NRX3A_HUMAN Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha) NRXN3 C14orf60 KIAA0743 Homo sapiens (Human) adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023] GO:0005886; GO:0005887; GO:0007158; GO:0007411; GO:0007612; GO:0030534; GO:0035176; GO:0038023; GO:0046872; GO:0050839; GO:0071625; GO:0097109 VKATQK 12.93000031 1 1 0.095679949 675.3144029 14.60235 14.45543 0 13.66861 14.40735 14.00212 11.97852 0 11.2052 14.0715 14.70498 14.43303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.31898 0 Q9Y4C1 KDM3A_HUMAN "Lysine-specific demethylase 3A, EC 1.14.11.65 (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)" KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]" androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712] GO:0000118; GO:0000785; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0007290; GO:0009755; GO:0016020; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051573; GO:0120162; GO:0140683; GO:1990830; GO:2000036; GO:2000736 AVKGVR 9.359999657 3.63E-07 3.63E-07 0.286186904 630.8900798 0 0 0 0 0 0 0 19.70481 18.37433 0 19.26241 0 0 17.21305 0 0 0 0 0 0 16.19104 0 0 0 0 16.87601 0 0 0 0 19.25202 0 0 17.53158 0 18.59212 21.01391 0 19.45166 0 0 0 0 0 0 0 0 0 Q9Y4C8 RBM19_HUMAN Probable RNA-binding protein 19 (RNA-binding motif protein 19) RBM19 KIAA0682 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]" RNA binding [GO:0003723] GO:0000398; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019 DGKFR 6.849999905 1 1 0.062132037 621.441397 14.79515 14.31675 0 12.66386 14.16146 0 15.69192 13.98319 15.21355 15.24184 0 10.51384 14.43566 0 0 0 15.24383 16.06408 14.61658 15.68544 0 0 0 15.07926 0 0 0 0 0 17.35757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.22229 0 15.51194 0 Q9Y4D1 DAAM1_HUMAN Disheveled-associated activator of morphogenesis 1 DAAM1 KIAA0666 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] "ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0030036; GO:0031267; GO:0031514; GO:0036064; GO:0042802; GO:0060071 GATSWPEFYIDQLNSMAARK 8.449999809 1 1 0.091120933 2284.203585 0 0 11.46131 14.31314 12.00692 13.79624 8.588158 13.50343 12.35963 13.62503 14.93202 9.180206 12.41034 11.88374 13.82031 13.42919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.08512 0 9.888877 0 0 0 Q9Y4D2 DGLA_HUMAN "Diacylglycerol lipase-alpha, DAGL-alpha, DGL-alpha, EC 3.1.1.116 (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)" DAGLA C11orf11 KIAA0659 NSDDR Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921] dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196] dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921] acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872] GO:0005886; GO:0007216; GO:0007405; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077 IIVGATK 5.690000057 1 1 0.100056685 698.4063961 14.13506 0 15.10652 11.97114 0 16.7108 13.31975 0 0 16.12101 0 13.8162 0 0 0 13.6648 0 0 0 0 0 14.89716 0 15.91284 0 13.99913 0 0 0 0 0 0 15.11673 16.48483 0 0 0 0 0 0 0 0 0 16.48969 17.96846 18.41909 16.05716 0 Q9Y4D7 PLXD1_HUMAN Plexin-D1 PLXND1 KIAA0620 Homo sapiens (Human) angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416] integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416] protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154] GO:0001525; GO:0001569; GO:0001822; GO:0002116; GO:0003151; GO:0003279; GO:0005886; GO:0005887; GO:0007162; GO:0007416; GO:0008360; GO:0017154; GO:0019904; GO:0030027; GO:0030334; GO:0031258; GO:0032092; GO:0035904; GO:0043087; GO:0043542; GO:0045765; GO:0050772; GO:0060666; GO:0060976; GO:0071526; GO:1902287 EQDSLGLQSHEYRVK 5.78000021 1 1 0.376382751 1789.880824 12.16237 15.61349 12.21662 0 12.81211 0 14.88474 0 0 16.40122 0 0 13.83624 0 15.02041 0 16.86055 12.99637 0 0 0 0 0 0 0 15.30831 0 0 0 0 0 0 0 0 15.68576 0 0 0 0 0 0 0 0 16.23616 0 0 0 14.80502 Q9Y4D8 HECD4_HUMAN "Probable E3 ubiquitin-protein ligase HECTD4, EC 2.3.2.26 (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)" HECTD4 C12orf51 KIAA0614 Homo sapiens (Human) glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0006006; GO:0016021; GO:0042593 LVPGAREVLTEIFK 4.880000114 0.9650442 0.9650442 0.229349421 1570.910757 0 0 0 0 15.41808 0 16.498 0 0 17.31366 0 0 14.94615 0 0 0 15.44297 0 0 0 0 0 0 0 15.13883 0 0 0 0 0 0 0 0 0 0 0 0 16.8985 13.28385 0 14.75407 0 0 0 13.3472 0 0 0 Q9Y4E1 WAC2C_HUMAN "WASH complex subunit 2C (Vaccinia virus penetration factor, VPEF)" WASHC2C FAM21C KIAA0592 VPEF Homo sapiens (Human) "endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]" "phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]" GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0016197; GO:0031901; GO:0032266; GO:0032456; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1900024; GO:1901981; GO:1905394; GO:2000813 MMNRTTPDQELVPASEPVWERPWSVEEIR 3.279999971 1 1 4.60E-13 3483.817664 14.92091 13.86008 0 13.88476 0 9.991055 13.97623 0 0 0 0 11.43934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4E5 ZN451_HUMAN "E3 SUMO-protein ligase ZNF451, EC 2.3.2.- (Coactivator for steroid receptors) (E3 SUMO-protein transferase ZNF451) (Zinc finger protein 451)" ZNF451 COASTER KIAA0576 KIAA1702 Homo sapiens (Human) negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468] nucleus [GO:0005634]; PML body [GO:0016605] nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714]; negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468] metal ion binding [GO:0046872]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0005634; GO:0010468; GO:0016605; GO:0016925; GO:0030512; GO:0045944; GO:0046872; GO:0060633; GO:0061665; GO:2000616 CVACHK 8.600000381 1 1 0.11464651 774.9404614 13.25414 17.60407 17.68714 0 15.0397 14.43481 16.89667 17.71633 0 0 13.44703 0 16.3251 13.53372 0 0 10.45808 14.33718 16.21906 17.98199 0 18.44757 13.29328 15.8071 11.46485 17.56472 15.79636 0 14.56523 0 15.88015 18.91381 14.28607 15.90339 0 17.11172 17.2526 0 17.44391 7.084331 0 0 0 17.98752 0 0 15.3953 15.99511 Q9Y4E6 WDR7_HUMAN WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG) WDR7 KIAA0541 TRAG Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244; GO:0005737 LARLIWTSNR 4.659999847 0.527776599 0.527776599 0.253147209 1229.72383 0 0 17.29507 18.19912 0 0 0 0 0 17.81952 18.61673 19.01793 0 16.45903 18.00332 0 20.00439 0 0 0 0 18.40102 18.96476 20.63281 0 0 0 17.33625 0 0 19.46079 0 0 19.46689 20.20044 20.62879 19.6877 0 0 0 0 15.67911 19.22627 0 0 0 19.78435 0 Q9Y4E8 UBP15_HUMAN "Ubiquitin carboxyl-terminal hydrolase 15, EC 3.4.19.12 (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4)" USP15 KIAA0529 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; thiol-dependent deubiquitinase [GO:0004843]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; thiol-dependent deubiquitinase [GO:0004843]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649] GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016579; GO:0016604; GO:0030509; GO:0035520; GO:0035616; GO:0042802; GO:0046332; GO:0060389; GO:0061649; GO:1900246; GO:1905035; GO:1990167; GO:1990380 SYAELIK 8.340000153 1 1 0.321041615 822.1474057 17.93997 0 0 0 0 0 0 0 0 0 18.0213 0 0 16.56932 0 16.73462 0 0 0 0 0 0 0 18.06127 0 0 17.72834 0 0 0 0 19.89663 18.34927 0 0 0 0 0 19.63173 0 18.40535 0 0 0 0 17.1278 0 0 Q9Y4F1 FARP1_HUMAN "FERM, ARHGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (FERM, RhoGEF and pleckstrin domain-containing protein 1) (Pleckstrin homology domain-containing family C member 2, PH domain-containing family C member 2)" FARP1 CDEP PLEKHC2 Homo sapiens (Human) dendrite morphogenesis [GO:0048813]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; dendrite morphogenesis [GO:0048813]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] GO:0005085; GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0030175; GO:0030425; GO:0031234; GO:0031267; GO:0043197; GO:0048813; GO:0098890; GO:0098942; GO:0098974; GO:0098978; GO:1905606 NIQGMKHLAAHLWK 7.71999979 1 1 0.19749403 1647.468929 0 15.03848 0 0 14.8996 13.40521 0 0 0 0 0 0 0 16.8491 0 0 0 16.32654 0 15.5857 0 0 0 0 0 0 0 0 0 0 15.78809 15.86129 0 0 0 0 0 0 0 0 0 14.86673 0 0 0 0 0 0 Q9Y4F3 MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1) MARF1 KIAA0430 LKAP Homo sapiens (Human) double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; ribonuclease activity [GO:0004540]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]; regulation of gene expression [GO:0010468] CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; ribonuclease activity [GO:0004540] GO:0004540; GO:0005737; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0016020; GO:0016441; GO:0043231; GO:0048477; GO:1903231; GO:1905762 ATPGK 3.420000076 0.672676027 0.672676027 0.33531657 473.5352428 19.69676 16.73134 18.76252 18.26468 16.05733 16.858 19.09678 18.67983 18.65825 19.3771 0 0 18.93333 19.09338 17.39275 18.54369 18.35388 20.51844 0 18.55226 0 17.21455 0 18.05233 20.93638 17.7252 20.93893 18.50109 17.88505 0 19.89604 17.93448 19.83286 20.74278 20.93571 19.20066 17.97674 18.82308 0 0 18.56149 19.09476 0 18.87137 19.13679 20.50505 18.96735 17.57374 Q9Y4F4 TGRM1_HUMAN TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) TOGARAM1 FAM179B KIAA0423 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] microtubule binding [GO:0008017] GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:0072686; GO:0090307; GO:1905515 ADLSTVGHKK 3.24000001 0.83876133 0.83876133 0.222226099 1050.492513 0 16.0304 9.268474 13.37138 0 13.68665 0 0 15.27072 15.56653 15.27225 11.67984 16.02995 0 0 16.02511 14.352 15.05541 14.79005 13.90362 0 0 14.76657 16.40777 0 0 0 0 0 0 15.46567 0 16.52384 0 15.42592 0 0 0 0 0 0 0 0 0 0 0 15.2771 0 Q9Y4F9 RIPR2_HUMAN Rho family-interacting cell polarization regulator 2 RIPOR2 C6orf32 DIFF48 FAM65B KIAA0386 PL48 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to chemokine [GO:1990869]; chemotaxis [GO:0006935]; negative regulation of cell adhesion [GO:0007162]; negative regulation of establishment of T cell polarity [GO:1903904]; negative regulation of protein localization to cell leading edge [GO:1905872]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T cell migration [GO:2000405]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic spindle assembly [GO:1901673]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; 14-3-3 protein binding [GO:0071889]; cell adhesion [GO:0007155]; cellular response to chemokine [GO:1990869]; chemotaxis [GO:0006935]; negative regulation of cell adhesion [GO:0007162]; negative regulation of establishment of T cell polarity [GO:1903904]; negative regulation of protein localization to cell leading edge [GO:1905872]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T cell migration [GO:2000405]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic spindle assembly [GO:1901673]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741] 14-3-3 protein binding [GO:0071889] GO:0005737; GO:0005856; GO:0006935; GO:0007155; GO:0007162; GO:0007605; GO:0016324; GO:0030175; GO:0032420; GO:0035024; GO:0042130; GO:0045663; GO:0048741; GO:0051491; GO:0051726; GO:0060171; GO:0071889; GO:0090023; GO:1901673; GO:1901741; GO:1903904; GO:1905872; GO:1990869; GO:2000114; GO:2000391; GO:2000405; GO:2001107 AACLALKILEATESIK 5.139999866 1 1 0.373909345 1730.762192 0 16.37183 13.37228 0 0 15.24024 0 0 12.65073 16.35823 0 0 0 0 0 0 0 0 0 0 16.01802 0 15.22875 0 0 0 14.14974 0 16.57567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9832 0 0 0 13.95053 Q9Y4G2 PKHM1_HUMAN "Pleckstrin homology domain-containing family M member 1, PH domain-containing family M member 1 (162 kDa adapter protein, AP162)" PLEKHM1 KIAA0356 Homo sapiens (Human) autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031] autolysosome [GO:0044754]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730] autolysosome [GO:0044754]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031] metal ion binding [GO:0046872] GO:0005730; GO:0005764; GO:0005765; GO:0015031; GO:0031902; GO:0032418; GO:0043231; GO:0044754; GO:0045780; GO:0046872; GO:0061909; GO:1900029; GO:1902774 KLVGSVK 12.38000011 0.01404978 0.01404978 0.175520498 727.2612889 0 14.72374 14.15012 14.71338 14.25453 12.06255 0 0 14.54739 16.4979 13.04665 13.33825 0 13.36504 0 16.55104 14.19991 0 15.73507 15.67055 15.98935 0 0 0 0 16.20966 15.67928 0 16.20769 0 0 0 0 0 0 0 16.2806 0 0 16.0751 0 15.5043 13.90655 0 16.47413 16.91077 14.4132 14.4273 Q9Y4G6 TLN2_HUMAN Talin-2 TLN2 KIAA0320 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043] actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] GO:0001726; GO:0003779; GO:0005178; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015; GO:0098609 AAVPTVSDQAAAMQLSQCAK 4.369999886 0.878194213 0.878194213 0.174808117 2063.96996 0 13.17144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.31028 0 0 15.18035 0 0 0 0 0 0 15.99325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4G8 RPGF2_HUMAN "Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF, CNrasGEF) (Neural RAP guanine nucleotide exchange protein, nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1, PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1)" RAPGEF2 KIAA0313 NRAPGEP PDZGEF1 Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591] beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; WW domain binding [GO:0050699] GO:0000165; GO:0001568; GO:0001764; GO:0005085; GO:0005096; GO:0005509; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007186; GO:0007218; GO:0007264; GO:0007265; GO:0008285; GO:0010976; GO:0016020; GO:0016324; GO:0019933; GO:0019992; GO:0021591; GO:0021884; GO:0030033; GO:0030139; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0035556; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048167; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070300; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:0072659; GO:0090557; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224 KPVKSETSPVAPR 3.789999962 0.570299149 0.570299149 0.280374427 1395.737508 12.25524 12.51386 14.7929 0 0 0 0 0 15.53957 0 16.03883 0 0 15.10418 0 0 13.97672 0 12.69063 10.33905 10.43095 15.30023 0 0 0 0 0 14.99286 0 0 0 0 16.28132 0 14.02469 0 15.04866 0 14.76379 15.59373 0 15.31279 15.26426 16.50047 17.35058 0 0 0 Q9Y4I1 MYO5A_HUMAN "Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)" MYO5A MYH12 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] GO:0000146; GO:0001726; GO:0003723; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006892; GO:0007015; GO:0015031; GO:0015629; GO:0016020; GO:0016192; GO:0016459; GO:0030048; GO:0030050; GO:0030426; GO:0031267; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0042470; GO:0043005; GO:0051015; GO:0070062; GO:0072659 DADSCTIPPK 7.960000038 0.138383225 0.138383225 0.129453731 1102.63693 15.65248 11.33684 15.88735 17.12353 0 0 13.94153 11.34755 10.72821 15.58489 0 0 16.45675 16.67406 14.80866 11.09709 17.01442 12.87152 17.20553 15.22105 10.64249 0 15.7344 15.47691 14.94183 15.31702 14.40111 16.15893 0 12.96788 14.9008 10.75681 17.03265 16.39603 15.18618 15.04897 16.03949 16.1108 13.67126 13.19852 15.41851 15.31969 15.88243 11.45685 15.98449 12.58579 16.36441 0 Q9Y4I5 MTL5_HUMAN "Tesmin (Metallothionein-like 5, testis-specific) (Testis-specific metallothionein-like protein)" TESMIN MTL5 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular metal ion homeostasis [GO:0006875]; male meiotic nuclear division [GO:0007140]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cellular metal ion homeostasis [GO:0006875]; male meiotic nuclear division [GO:0007140]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]" metal ion binding [GO:0046872] GO:0005634; GO:0005737; GO:0006355; GO:0006875; GO:0007140; GO:0007283; GO:0010038; GO:0030154; GO:0046872 EPVLHAFNPALGADCKGQVK 8.670000076 1 1 0.287611009 2152.869939 15.02137 0 10.80174 0 0 0 0 0 0 0 14.46667 0 14.26841 14.84273 0 0 0 0 0 0 0 0 0 0 0 0 16.37969 0 0 0 14.72822 13.6531 0 15.71088 0 0 0 0 0 15.46352 9.138938 0 0 0 0 0 0 13.99766 Q9Y4J8 DTNA_HUMAN "Dystrobrevin alpha, DTN-A (Alpha-dystrobrevin) (Dystrophin-related protein 3)" DTNA DRP3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neuromuscular synaptic transmission [GO:0007274]; signal transduction [GO:0007165]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536] cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; neuromuscular synaptic transmission [GO:0007274]; signal transduction [GO:0007165]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536] zinc ion binding [GO:0008270] GO:0005654; GO:0005737; GO:0005886; GO:0006941; GO:0007165; GO:0007268; GO:0007274; GO:0008270; GO:0030054; GO:0032991; GO:0045111; GO:0045202; GO:0099536 GNTMAER 3.74000001 1 1 0.227102201 797.125368 0 13.83526 0 0 11.92834 14.56711 14.97906 14.12618 0 12.07793 14.47915 16.08451 0 14.78819 15.13604 13.98689 16.49456 13.76284 14.78322 15.68233 12.85011 15.37446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.31222 0 0 0 0 15.40549 0 0 0 0 0 0 Q9Y4K0 LOXL2_HUMAN "Lysyl oxidase homolog 2, EC 1.4.3.13 (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14)" LOXL2 Homo sapiens (Human) "aging [GO:0007568]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]" basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; aging [GO:0007568]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]" calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044] GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005783; GO:0006464; GO:0007155; GO:0007568; GO:0009055; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0046688; GO:0062023; GO:0070492; GO:0070828; GO:1902455 AILSTYR 5.050000191 1 1 0.230397877 822.4024561 0 0 0 16.00356 15.47861 15.19294 0 0 0 0 0 17.81258 0 0 0 0 0 0 0 0 15.26198 0 16.61814 14.60192 0 15.74009 14.4712 0 16.42003 0 0 16.58568 0 0 0 17.237 18.78018 0 0 17.96503 0 0 0 0 0 0 0 14.65052 Q9Y4K1 CRBG1_HUMAN Beta/gamma crystallin domain-containing protein 1 (Absent in melanoma 1 protein) CRYBG1 AIM1 Homo sapiens (Human) carbohydrate binding [GO:0030246] carbohydrate binding [GO:0030246] GO:0030246 QPPPASSPTKR 2.49000001 1 1 0.170752737 1166.47541 0 14.50228 9.24807 0 15.54749 0 0 0 0 0 0 0 15.78252 14.77652 0 12.77287 0 13.82743 0 15.1494 14.49524 0 0 0 14.83136 11.72539 0 0 15.33323 14.64242 14.12835 14.42263 16.29356 0 0 13.17921 0 14.6632 15.52931 0 0 15.93264 13.42848 12.94298 13.69456 0 13.30395 16.41475 Q9Y4K3 TRAF6_HUMAN "TNF receptor-associated factor 6, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6)" TRAF6 RNF85 Homo sapiens (Human) "activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002223; GO:0002637; GO:0002726; GO:0002753; GO:0002755; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006974; GO:0007249; GO:0007250; GO:0008270; GO:0009898; GO:0010008; GO:0019886; GO:0019901; GO:0030316; GO:0031398; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0038095; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0047485; GO:0048468; GO:0048471; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679 FDMGSLR 9.569999695 0.024392799 0.024392799 0.232080104 842.5388156 17.98899 17.67682 15.95797 18.2634 0 0 18.92761 0 17.19401 0 0 17.37456 0 17.46622 0 0 18.85853 0 17.03944 17.4193 18.90724 17.47663 18.73467 0 0 19.5702 0 0 16.97107 0 0 0 0 0 20.07001 0 20.47706 18.61881 19.43097 0 0 18.3431 16.98931 17.78045 0 18.06123 0 18.32519 Q9Y4K4 M4K5_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 5, EC 2.7.11.1 (Kinase homologous to SPS1/STE20, KHS) (MAPK/ERK kinase kinase kinase 5, MEK kinase kinase 5, MEKKK 5)" MAP4K5 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0008349; GO:0035556; GO:0106310 ALFLMSK 13.53999996 0.398668647 0.398668647 0.080947752 824.7360205 17.34742 0 0 16.24558 15.44866 17.19619 15.88505 16.6711 0 0 16.48111 0 14.0885 16.15498 17.31969 0 0 15.42603 16.22383 0 0 15.0026 0 17.74282 17.14835 15.50017 0 0 15.53253 15.67771 16.06964 16.64457 15.89972 16.82147 16.84444 18.51074 16.55766 0 16.07751 16.25949 0 16.46608 15.65089 0 0 17.55878 17.24652 14.96193 Q9Y4L1 HYOU1_HUMAN "Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein, ORP-150) (170 kDa glucose-regulated protein, GRP-170)" HYOU1 GRP170 ORP150 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931] endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790] endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0016020; GO:0016887; GO:0034663; GO:0034976; GO:0051082; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382 EEISGK 11.18000031 1 1 0.192082549 661.4185406 13.83706 15.60246 14.12632 15.50493 0 13.08471 14.44586 16.27851 16.20733 15.96496 15.7117 14.80734 0 16.70006 14.53661 15.77822 14.68683 15.61774 15.65094 14.27022 14.80208 17.25701 16.07635 16.52839 0 0 0 0 16.35969 0 15.19196 0 0 16.18583 0 15.90931 16.53037 0 0 15.9681 0 0 0 0 15.64018 16.70772 0 0 Q9Y4M8 CH071_HUMAN Putative uncharacterized protein encoded by LINC00588 LINC00588 C8orf71 Homo sapiens (Human) AHATSSVKPRAR 5.96999979 1 1 0.211351034 1280.455585 0 10.53448 12.25797 0 15.43994 14.02297 0 0 0 0 0 0 14.75766 0 0 0 15.53806 0 0 15.05517 0 0 0 0 0 16.1811 16.91007 0 0 0 0 0 0 15.02165 15.44856 15.3856 0 15.93186 15.72525 15.45209 16.43418 0 0 15.39359 0 0 14.14831 0 Q9Y4P3 TBL2_HUMAN "Transducin beta-like protein 2 (WS beta-transducin repeats protein, WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein)" TBL2 WBSCR13 UNQ563/PRO1125 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968] phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369] GO:0003723; GO:0005783; GO:0019901; GO:0030176; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456 ANGFPPDKSSGSK 8.399999619 0.8368119 0.8368119 0.028789966 1291.070218 13.72396 0 0 0 15.27835 16.17524 0 14.28364 0 0 0 14.28387 13.83152 14.80937 0 11.97878 0 0 8.737085 13.67605 15.72805 16.09054 0 12.82514 0 0 15.1234 0 14.89087 14.94415 0 16.15002 18.87038 13.88316 0 0 0 15.0183 0 0 18.06972 11.6991 14.21906 0 14.48601 0 13.59657 13.86466 Q9Y4P8 WIPI2_HUMAN "WD repeat domain phosphoinositide-interacting protein 2, WIPI-2 (WIPI49-like protein 2)" WIPI2 CGI-50 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]" "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]" GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005829; GO:0006497; GO:0009267; GO:0010314; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0044804; GO:0061739; GO:0080025; GO:0098792 LATASEKGTVIR 5.570000172 1 1 0.107431124 1249.481979 0 0 0 0 0 12.497 15.13149 0 14.84882 15.6191 0 14.85057 15.24737 0 15.39563 0 0 0 0 0 0 0 13.5498 0 0 14.16286 14.80672 0 0 14.72503 0 15.14336 0 0 15.66595 0 0 0 0 0 0 0 0 0 0 0 14.32149 15.06166 Q9Y4P9 SPEF1_HUMAN Sperm flagellar protein 1 SPEF1 C20orf28 Homo sapiens (Human) "axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of cell death [GO:0060548]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]" 9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902] "9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of cell death [GO:0060548]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]" actin binding [GO:0003779]; microtubule binding [GO:0008017] GO:0001578; GO:0003341; GO:0003779; GO:0005737; GO:0005874; GO:0005902; GO:0005930; GO:0007026; GO:0008017; GO:0016323; GO:0016324; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0046847; GO:0051493; GO:0060548; GO:0097542; GO:0097729; GO:1904158; GO:1990716; GO:2000095 IEDLSRR 1.720000029 1 1 0.287450502 889.8973951 0 0 14.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.34101 0 0 0 17.0019 0 0 0 14.57803 0 0 0 0 0 0 0 0 0 0 0 0 0 15.01672 0 0 0 0 0 15.84957 0 Q9Y4R7 TTLL3_HUMAN "Tubulin monoglycylase TTLL3, EC 6.3.2.- (HOTTL) (Tubulin--tyrosine ligase-like protein 3)" TTLL3 PRO0207 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126] "axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]" "ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]" GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0035082; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736 QHSKLVGTK 8.270000458 0.210344881 0.210344881 0.315609633 996.1346117 0 12.89188 15.94053 11.32329 16.29495 0 0 0 0 0 0 13.04673 0 15.25747 0 0 0 0 0 0 12.98781 12.33844 0 0 14.59375 0 0 12.56617 0 13.83581 0 14.14043 14.76924 0 0 0 0 16.39539 0 0 14.82021 16.33322 14.04347 0 0 10.42647 11.64658 15.41399 Q9Y4R8 TELO2_HUMAN "Telomere length regulation protein TEL2 homolog (Protein clk-2 homolog, hCLK2)" TELO2 KIAA0683 Homo sapiens (Human) positive regulation of DNA damage checkpoint [GO:2000003]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004] "ASTRA complex [GO:0070209]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]" "ASTRA complex [GO:0070209]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]; Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]; positive regulation of DNA damage checkpoint [GO:2000003]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004]" Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162] GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0007004; GO:0016020; GO:0016604; GO:0019901; GO:0031931; GO:0031932; GO:0032006; GO:0034399; GO:0042162; GO:0044877; GO:0050821; GO:0051879; GO:0060090; GO:0070209; GO:0071902; GO:0110078; GO:1904263; GO:1904515; GO:2000003 RLGMIVAEVVSAR 10.39000034 1 1 0.0995216 1416.719305 0 15.41261 18.46648 0 0 15.18752 0 0 0 0 15.54626 16.35331 17.33651 0 0 0 0 0 0 0 16.48828 0 0 0 15.68118 0 0 0 0 0 16.36901 0 0 15.17404 14.92756 15.57186 0 0 16.65627 16.8291 9.741915 0 17.99954 17.72634 19.02589 13.41608 0 16.81875 Q9Y4W6 AFG32_HUMAN "AFG3-like protein 2, EC 3.4.24.- (Paraplegin-like protein)" AFG3L2 Homo sapiens (Human) axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0055001; GO:0060013; GO:0065003 DFVNNYLSK 10.60999966 0.438003004 0.438003004 0.164552366 1099.482066 14.45795 15.48475 0 0 13.24036 0 9.751763 14.09644 14.10247 0 15.47773 0 14.60094 0 12.10136 11.31504 0 0 0 0 0 0 0 0 0 14.60254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4Z0 LSM4_HUMAN "U6 snRNA-associated Sm-like protein LSm4 (Glycine-rich protein, GRP)" LSM4 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]" cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] "cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]" PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] GO:0000387; GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005829; GO:0008380; GO:0016020; GO:0017070; GO:0032991; GO:0033962; GO:0042731; GO:0046540; GO:0071005; GO:0097526; GO:0120115 GMGGAGRGVFGGR 5.889999866 0.19972685 0.19972685 0.362085296 1194.270503 15.32566 15.16125 14.85748 0 15.38874 0 13.58664 10.88061 0 0 11.56722 14.04123 14.71587 13.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.47826 0 0 0 0 Q9Y519 T184B_HUMAN Transmembrane protein 184B (Putative MAPK-activating protein FM08) TMEM184B C22orf5 PSEC0108 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DNEKTLLLSSDDEF 10.64999962 1 1 0.319488157 1626.095616 0 0 0 0 0 17.2126 0 0 17.09697 0 0 0 0 0 0 0 0 0 18.95908 0 0 0 18.23369 0 0 0 0 0 0 0 0 0 0 0 0 0 17.80233 0 0 0 0 0 0 0 0 0 0 0 Q9Y520 PRC2C_HUMAN Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) PRRC2C BAT2D1 BAT2L2 KIAA1096 XTP2 Homo sapiens (Human) cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063] protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723] GO:0002244; GO:0003723; GO:0005829; GO:0008022; GO:0010494; GO:0016020; GO:0030154; GO:0034063 ISAVESQPSR 6.449999809 0.229372635 0.229372635 0.252586061 1072.066605 14.43154 7.572981 0 15.16848 0 17.4439 0 16.95548 0 15.74354 0 0 0 0 0 11.74674 14.44788 0 13.91678 13.41945 15.47775 0 14.40387 0 13.23845 12.27609 14.14527 14.30887 15.43998 13.98415 0 0 0 0 0 0 11.04997 13.36703 0 15.87247 14.34305 0 15.08102 0 0 0 0 15.00632 Q9Y546 LRC42_HUMAN Leucine-rich repeat-containing protein 42 LRRC42 Homo sapiens (Human) ENGQLHMVNLALDGVR 3.299999952 0.576661646 0.576661646 0.20740345 1782.414318 14.84082 14.45747 12.88521 0 14.0002 12.54701 15.74228 0 10.71119 0 0 0 15.48375 15.24098 13.6005 0 0 0 0 0 15.05201 0 0 0 0 0 15.48826 0 13.61696 13.63597 0 0 0 0 11.50478 0 0 0 15.90771 9.042872 0 0 12.74949 0 0 0 0 15.01676 Q9Y548 YIPF1_HUMAN Protein YIPF1 (YIP1 family member 1) YIPF1 Homo sapiens (Human) vesicle-mediated transport [GO:0016192] Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; small GTPase binding [GO:0031267]; vesicle-mediated transport [GO:0016192] small GTPase binding [GO:0031267] GO:0000138; GO:0005654; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0016021; GO:0016192; GO:0030133; GO:0031267; GO:0031902 EEDDELLGNDDSDK 5.929999828 1 1 0.418617484 1592.7416 16.71265 16.16406 14.87461 0 13.69893 13.91358 0 15.41151 15.21336 0 15.96377 0 0 15.74511 0 0 16.89602 0 0 0 0 0 0 0 0 0 0 15.37739 15.09031 15.26265 16.74473 17.18018 0 0 17.2732 16.39122 17.49216 14.31235 14.28891 16.83653 16.0774 15.65331 0 15.70059 17.01224 0 0 0 Q9Y561 LRP12_HUMAN "Low-density lipoprotein receptor-related protein 12, LDLR-related protein 12, LRP-12 (Suppressor of tumorigenicity 7 protein)" LRP12 ST7 Homo sapiens (Human) endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle receptor activity [GO:0005041]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165] low-density lipoprotein particle receptor activity [GO:0005041] GO:0001764; GO:0005041; GO:0005887; GO:0005905; GO:0006897; GO:0007165; GO:0016021; GO:0031175; GO:0040008 DMAGASGGVAAPLPQK 1.919999957 1 1 0.129247336 1469.735849 14.25505 15.03069 15.27143 15.40463 0 0 0 17.26991 0 0 14.26435 0 15.93557 14.17419 12.15816 13.39529 0 15.14566 18.02059 0 16.11584 14.21879 0 0 0 16.05951 17.32053 12.8618 15.16254 16.6288 15.43664 8.284001 0 0 13.21928 14.61405 15.8399 0 0 15.8885 16.20214 16.20459 15.02241 17.85743 16.52902 0 0 11.58464 Q9Y572 RIPK3_HUMAN "Receptor-interacting serine/threonine-protein kinase 3, EC 2.7.11.1 (RIP-like protein kinase 3) (Receptor-interacting protein 3, RIP-3)" RIPK3 RIP3 Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; amyloid fibril formation [GO:1990000]; apoptotic signaling pathway [GO:0097190]; cellular protein modification process [GO:0006464]; cellular response to hydrogen peroxide [GO:0070301]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lymph node development [GO:0048535]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ligase activity [GO:0051351]; positive regulation of necroptotic process [GO:0060545]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; regulation of activated T cell proliferation [GO:0046006]; regulation of activation-induced cell death of T cells [GO:0070235]; regulation of adaptive immune response [GO:0002819]; regulation of apoptotic process [GO:0042981]; regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000452]; regulation of interferon-gamma production [GO:0032649]; regulation of T cell mediated cytotoxicity [GO:0001914]; signal transduction [GO:0007165]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; activation of protein kinase activity [GO:0032147]; amyloid fibril formation [GO:1990000]; apoptotic signaling pathway [GO:0097190]; cellular protein modification process [GO:0006464]; cellular response to hydrogen peroxide [GO:0070301]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lymph node development [GO:0048535]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ligase activity [GO:0051351]; positive regulation of necroptotic process [GO:0060545]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; regulation of activated T cell proliferation [GO:0046006]; regulation of activation-induced cell death of T cells [GO:0070235]; regulation of adaptive immune response [GO:0002819]; regulation of apoptotic process [GO:0042981]; regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000452]; regulation of interferon-gamma production [GO:0032649]; regulation of T cell mediated cytotoxicity [GO:0001914]; signal transduction [GO:0007165]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]" ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] GO:0001914; GO:0002819; GO:0003713; GO:0004672; GO:0004674; GO:0004704; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0007165; GO:0007249; GO:0010922; GO:0032147; GO:0032649; GO:0032991; GO:0033077; GO:0042802; GO:0042981; GO:0043029; GO:0044877; GO:0046006; GO:0046777; GO:0048535; GO:0048536; GO:0048538; GO:0051092; GO:0051351; GO:0051353; GO:0051607; GO:0060545; GO:0070235; GO:0070266; GO:0070301; GO:0097190; GO:0097300; GO:0097527; GO:0097528; GO:0106310; GO:1990000; GO:2000379; GO:2000452; GO:2001244 LLKEVVLGMFYLHDQNPVLLHR 1.610000014 1 1 1.38E-12 2651.388721 0 0 0 0 0 0 0 0 0 0 0 0 0 15.86338 0 15.69173 0 16.06168 13.31052 16.847 16.86995 14.07266 14.34605 15.44772 16.0203 0 0 0 0 13.81363 15.13218 0 0 14.49258 0 13.24601 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y573 IPP_HUMAN "Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide, IPP) (Kelch-like protein 27)" IPP KLHL27 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779] actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0015629 WEVVGNMAVSR 3.309999943 1 1 0.264882263 1248.475327 14.07671 13.45633 14.9823 13.31557 0 12.66248 15.52678 15.28887 0 0 13.30385 0 0 7.556188 0 14.48497 0 0 0 0 15.81642 0 0 0 0 0 0 0 0 0 0 15.91288 0 0 0 0 0 0 17.85448 0 0 0 0 0 16.2072 0 0 0 Q9Y586 MB212_HUMAN Protein mab-21-like 2 MAB21L2 Homo sapiens (Human) camera-type eye development [GO:0043010]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284] GO:0001654; GO:0005634; GO:0005737; GO:0007399; GO:0008284; GO:0010172; GO:0043010 FISSLSEIDAR 1.480000019 0.153317437 0.153317437 0.192102446 1240.282654 14.93513 15.27519 0 0 15.82437 0 15.4275 0 13.72568 16.08704 16.49717 0 15.70125 0 13.47029 14.16907 0 0 14.71082 0 16.03154 16.32188 14.96589 0 15.26465 0 11.61393 0 14.60779 0 15.06131 0 15.49252 14.92839 14.70313 0 0 15.5317 0 14.7319 0 14.97021 15.69379 14.65039 15.6215 15.26755 13.53817 12.44181 Q9Y5B0 CTDP1_HUMAN "RNA polymerase II subunit A C-terminal domain phosphatase, EC 3.1.3.16 (TFIIF-associating CTD phosphatase)" CTDP1 FCP1 Homo sapiens (Human) cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368] phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096] GO:0000922; GO:0001096; GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006368; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0051233; GO:0051301; GO:0061052; GO:0070940 DDHTKAQR 4.480000019 1 1 0.089146026 969.4747144 0 13.14618 10.75495 0 0 15.90886 0 0 0 15.92216 0 0 15.25679 0 0 0 14.44437 0 0 0 0 0 0 0 0 13.96041 0 15.17079 0 0 0 14.66055 0 0 11.98794 0 0 15.17122 0 0 0 0 0 0 0 0 0 0 Q9Y5B9 SP16H_HUMAN "FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16, hSPT16)" SUPT16H FACT140 FACTP140 Homo sapiens (Human) "DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent chromatin organization [GO:0034724]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent chromatin organization [GO:0034724]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" nucleosome binding [GO:0031491]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0006366; GO:0006368; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101 LAESVEK 1.399999976 1 1 0.126998431 776.3582068 0 11.68393 0 15.84475 0 0 0 15.28971 14.0767 0 15.96747 0 10.05115 15.38591 0 15.87269 13.50645 0 13.43551 0 12.65329 0 13.70005 0 0 0 0 0 0 0 0 15.50814 14.99629 0 14.9949 0 0 0 0 0 14.52361 0 0 0 0 0 0 0 Q9Y5E4 PCDB5_HUMAN "Protocadherin beta-5, PCDH-beta-5" PCDHB5 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202 TAEIRLK 6.070000172 1 1 0.266278369 829.9277952 13.81079 15.65218 14.61125 0 14.42079 16.12025 0 15.94995 0 16.78644 17.87324 0 14.93529 0 11.49308 0 0 14.44343 0 13.89959 0 0 0 15.96287 0 0 0 0 0 15.71177 0 0 0 0 16.49409 16.69557 0 0 0 0 0 16.34319 0 0 0 0 0 0 Q9Y5E6 PCDB3_HUMAN "Protocadherin beta-3, PCDH-beta-3" PCDHB3 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202 IIDVNDHSPVFFENEMHLK 4.860000134 1 1 0.245690098 2299.337133 0 13.8018 13.98626 11.79219 12.9467 12.89214 14.62318 13.57672 0 12.73148 14.67172 0 14.15061 14.74837 13.36755 0 14.17655 15.42553 11.43506 0 0 16.23565 15.93307 0 0 0 0 0 0 0 0 16.3493 0 10.61657 0 0 0 0 0 0 14.69603 14.38377 0 0 0 16.04823 14.97744 0 Q9Y5E8 PCDBF_HUMAN "Protocadherin beta-15, PCDH-beta-15" PCDHB15 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391] integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0032391 LVTEGALDR 2.900000095 1 1 0.117350278 975.7722096 12.61905 13.88844 13.35897 14.69794 13.1436 14.00902 15.67573 13.146 14.99034 16.33298 15.91231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.78017 16.61304 0 0 0 Q9Y5F0 PCDBD_HUMAN "Protocadherin beta-13, PCDH-beta-13" PCDHB13 UNQ332/PRO531 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; postsynaptic membrane [GO:0045211] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; postsynaptic membrane [GO:0045211]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0032391; GO:0045211; GO:0097381 LHLQLNQETADLLLNEKLDR 15.51000023 1 1 0.252384876 2375.600293 0 18.13452 0 0 0 0 18.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 18.61992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.91931 0 0 0 0 0 0 0 0 0 17.40653 0 Q9Y5F2 PCDBB_HUMAN "Protocadherin beta-11, PCDH-beta-11" PCDHB11 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202 VVSNDK 17.21999931 1 1 0.231380617 661.706237 6.902163 16.75032 18.31812 0 0 17.89588 17.744 16.90374 0 0 0 0 17.39177 16.63167 0 0 18.93924 17.31768 0 17.37088 0 0 0 0 0 0 17.13724 0 0 0 18.00818 17.62569 0 17.95085 17.41365 17.33529 18.69148 0 0 0 0 0 0 16.65811 17.16433 0 0 0 Q9Y5F6 PCDGM_HUMAN "Protocadherin gamma-C5, PCDH-gamma-C5" PCDHGC5 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0043524; GO:0050808 NLFGLDPSSGAIHVLGPIDFEESR 2.920000076 1 1 0.262840625 2570.922111 13.75278 13.16613 14.00223 0 0 0 0 0 0 0 0 15.15502 0 14.48234 0 15.47508 0 0 16.02502 0 0 0 16.39406 16.6513 0 0 0 0 14.88164 0 13.51566 0 0 0 13.44697 0 8.577464 0 0 0 15.6054 0 13.04152 0 0 0 0 0 Q9Y5F9 PCDGI_HUMAN "Protocadherin gamma-B6, PCDH-gamma-B6" PCDHGB6 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156 CNIETDIPFK 3.579999924 1 1 0.079965452 1236.336778 0 0 11.1064 0 14.68189 0 8.081136 0 0 17.55612 0 0 0 14.17679 0 0 0 0 0 0 0 0 12.58062 0 0 0 0 14.23724 0 10.71564 0 0 0 0 15.25116 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5G1 PCDGF_HUMAN "Protocadherin gamma-B3, PCDH-gamma-B3" PCDHGB3 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156 IVQDTK 3.559999943 1 1 2.30E-13 703.516161 14.83781 0 15.06946 16.53628 0 14.72491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.55458 0 0 15.93127 16.12674 0 13.66154 0 0 14.67752 14.64341 0 16.14049 15.69086 0 0 15.45282 0 0 0 0 0 0 0 0 0 0 Q9Y5G3 PCDGD_HUMAN "Protocadherin gamma-B1, PCDH-gamma-B1" PCDHGB1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887] growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426 DLGLSVR 1.950000048 1 1 0.023710388 758.5111544 0 0 0 0 0 0 18.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 16.35974 0 0 0 0 0 0 0 0 0 16.91845 0 0 0 0 0 0 18.10953 0 0 0 0 0 16.83693 0 0 0 0 Q9Y5G4 PCDG9_HUMAN "Protocadherin gamma-A9, PCDH-gamma-A9" PCDHGA9 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509]; RNA binding [GO:0003723] GO:0003723; GO:0005509; GO:0005887; GO:0007155; GO:0007156 DLQMQVTASDSGSPPLSSNVSLR 5.079999924 1 1 4.56E-12 2405.125465 12.62187 0 0 16.51516 0 13.19118 17.06355 14.31334 13.89086 0 0 14.41496 14.58674 14.52158 11.25084 0 14.97508 0 0 14.36687 0 0 0 16.6517 0 15.15963 14.7725 14.52652 0 12.08406 0 15.51798 0 0 13.29203 0 17.37303 14.71772 0 0 12.92675 14.38094 14.71367 10.67182 0 11.0759 15.14379 0 Q9Y5H3 PCDGA_HUMAN "Protocadherin gamma-A10, PCDH-gamma-A10" PCDHGA10 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156 YTGEIK 5.309999943 0.412464499 0.412464499 0.263502114 709.2185185 0 0 0 0 0 0 0 0 0 0 17.05912 0 0 0 17.85553 0 0 0 16.1886 0 0 0 0 0 0 0 0 0 16.264 0 0 18.50991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H6 PCDA8_HUMAN "Protocadherin alpha-8, PCDH-alpha-8" PCDHA8 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 VGGTGGAASK 4.53000021 1 1 0.227056026 803.8873235 15.70753 15.50099 0 13.78272 14.7021 14.48327 0 14.48993 0 0 15.95474 15.15317 0 0 0 14.98218 15.47304 0 0 0 15.5143 16.15971 0 0 16.73483 14.7456 14.71329 15.23878 15.29838 13.59669 13.98363 16.2669 15.76838 13.12605 15.54479 15.18167 14.78074 16.01621 0 13.83523 15.79063 15.31756 16.0092 0 0 14.98799 12.24595 0 Q9Y5H9 PCDA2_HUMAN "Protocadherin alpha-2, PCDH-alpha-2" PCDHA2 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] GO:0005509; GO:0005634; GO:0005783; GO:0005887; GO:0007155; GO:0007156; GO:0007399 GTPSMSGHCKISLK 9.029999733 1 1 0.588802244 1517.343161 15.24504 0 18.32144 18.56199 19.73227 18.50631 19.67819 0 17.55227 18.74681 18.71629 18.173 17.39467 14.92504 19.12222 19.31905 0 0 18.34953 0 18.77129 20.53798 19.92955 19.75221 0 19.29046 0 20.79044 17.82868 19.28905 20.8856 0 21.66391 20.13654 0 0 20.83261 20.06323 20.92208 19.67869 18.20832 18.20761 0 18.30183 18.87473 0 18.47566 18.8412 Q9Y5I1 PCDAB_HUMAN "Protocadherin alpha-11, PCDH-alpha-11" PCDHA11 CNRS7 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 TDLMAFSPSLPLGLNK 2.890000105 1 1 0.3433469 1719.627746 0 0 0 14.35095 0 0 0 14.06569 0 0 13.50413 0 0 0 0 15.61636 0 0 0 0 0 0 0 0 16.48168 0 15.89304 0 0 0 0 0 0 0 0 0 15.78546 0 16.96428 0 0 15.82437 0 15.91263 0 0 0 16.79167 Q9Y5I3 PCDA1_HUMAN "Protocadherin alpha-1, PCDH-alpha-1" PCDHA1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005783; GO:0005887; GO:0007155; GO:0007156; GO:0007399 VASKTHR 5 1 1 0.09963962 799.5824117 15.01624 12.39491 14.20236 13.87108 0 14.41826 0 0 0 0 0 14.58418 0 0 0 0 0 0 0 0 19.10374 17.17796 0 0 16.83056 0 15.41513 16.25986 17.2387 16.00316 16.64731 0 0 0 15.09141 0 17.6306 17.46302 0 0 0 0 0 0 0 0 0 0 Q9Y5I7 CLD16_HUMAN "Claudin-16 (Paracellin-1, PCLN-1)" CLDN16 PCLN1 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular metal ion homeostasis [GO:0006875]; intercellular transport [GO:0010496]; metal ion transport [GO:0030001] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular metal ion homeostasis [GO:0006875]; intercellular transport [GO:0010496]; metal ion transport [GO:0030001] identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0005923; GO:0006875; GO:0007155; GO:0010496; GO:0015095; GO:0016021; GO:0016338; GO:0030001; GO:0042802; GO:0070830 AYSAAGVSMAK 7.400000095 1 1 0.357698033 1072.135842 0 14.57844 9.763926 15.97151 15.50653 0 12.50485 15.82566 15.13129 14.24357 0 0 15.66096 15.78076 0 0 0 15.65671 0 0 16.39047 0 0 0 0 16.08622 0 0 15.69604 0 15.91165 0 0 0 0 0 0 16.29707 0 0 0 0 0 0 0 0 15.45757 0 Q9Y5J5 PHLA3_HUMAN Pleckstrin homology-like domain family A member 3 (TDAG51/Ipl homolog 1) PHLDA3 TIH1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of apoptotic process [GO:0043065] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]; anatomical structure morphogenesis [GO:0009653]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of apoptotic process [GO:0043065]" "phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]" GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0009653; GO:0010314; GO:0032266; GO:0042771; GO:0043065; GO:0043325; GO:0051898; GO:0080025 AVECVESTGR 5.860000134 1 1 0.137589999 1107.351166 14.43312 14.86782 10.58485 0 0 0 0 13.71595 0 0 0 14.20709 0 0 14.43989 0 0 0 0 12.53022 0 0 0 0 0 0 15.10603 14.59944 0 0 13.91314 10.89453 15.05559 14.84001 15.69617 0 14.05861 14.34677 13.36355 15.78178 13.96423 0 14.22157 13.39133 14.1891 12.67551 12.11566 15.61657 Q9Y5J7 TIM9_HUMAN Mitochondrial import inner membrane translocase subunit Tim9 TIMM9 TIM9 TIM9A TIMM9A Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087 AGLLGQPR 6.650000095 1 1 0 811.3341085 0 0 0 13.87727 14.47836 14.19426 13.24046 14.86982 14.99271 0 14.11791 13.04752 15.81025 0 0 16.0071 14.65889 0 16.83182 13.76199 0 14.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.27269 0 0 0 0 0 0 0 0 0 Q9Y5K3 PCY1B_HUMAN "Choline-phosphate cytidylyltransferase B, EC 2.7.7.15 (CCT-beta) (CTP:phosphocholine cytidylyltransferase B, CCT B, CT B) (Phosphorylcholine transferase B)" PCYT1B CCTB Homo sapiens (Human) CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283] choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210] GO:0001541; GO:0004105; GO:0005737; GO:0005783; GO:0005789; GO:0006656; GO:0006657; GO:0007283; GO:0031210; GO:0042802 EAGMFVPTQRTEGISTSDIITR 3.619999886 1 1 0.376751753 2423.198318 0 0 19.04167 0 0 0 0 0 20.32679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.45958 0 0 0 0 0 21.70243 0 19.76553 0 0 0 0 0 0 0 0 0 Q9Y5K6 CD2AP_HUMAN CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains) CD2AP Homo sapiens (Human) "actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; vesicle organization [GO:0016050]" actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle [GO:0031982] "actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle [GO:0031982]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; vesicle organization [GO:0016050]" beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172] GO:0001650; GO:0001726; GO:0005172; GO:0005200; GO:0005737; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007049; GO:0007165; GO:0008013; GO:0008022; GO:0015629; GO:0016050; GO:0016477; GO:0017124; GO:0030139; GO:0030424; GO:0030425; GO:0031252; GO:0031941; GO:0031982; GO:0032911; GO:0034451; GO:0042802; GO:0043161; GO:0044877; GO:0045296; GO:0048259; GO:0048471; GO:0050714; GO:0051058; GO:0051301; GO:0065003; GO:0070062; GO:0098609; GO:1900182; GO:2000249 ERHGNVASLVQR 3.130000114 1 1 0.218905422 1366.65538 16.20355 0 0 0 0 0 0 0 0 14.96374 0 0 0 16.55892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.80017 13.32662 0 14.90854 0 12.99593 0 0 15.29126 0 0 0 0 0 0 0 0 0 Q9Y5L0 TNPO3_HUMAN "Transportin-3 (Importin-12, Imp12) (Transportin-SR, TRN-SR)" TNPO3 IPO12 Homo sapiens (Human) protein import into nucleus [GO:0006606] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0031267; GO:0042802; GO:0043231; GO:0061608 IVERCCR 4.630000114 1 1 0.154289512 992.996246 14.52574 0 0 0 0 0 0 15.92783 0 0 0 0 0 0 0 15.04496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.33221 0 0 0 0 0 0 0 0 0 Q9Y5L4 TIM13_HUMAN Mitochondrial import inner membrane translocase subunit Tim13 TIMM13 TIM13B TIMM13A TIMM13B Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] zinc ion binding [GO:0008270] GO:0001650; GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0042719; GO:0045039 CIAMCMDR 4.650000095 1 1 0.237373147 1088.51321 14.9794 13.42696 14.06071 15.89081 14.07169 15.39181 14.02729 0 0 15.7555 0 0 0 15.56806 0 16.80455 0 0 15.91023 16.11341 0 0 16.99158 0 0 0 0 0 0 15.66738 0 14.38777 16.48185 15.26207 14.50604 0 0 15.44939 15.31069 0 0 15.47577 0 15.08131 0 0 0 0 Q9Y5M1 F215A_HUMAN "Uncharacterized protein FAM215A (Apoptosis-related protein 2, APR-2)" FAM215A APR2 C17orf88 Homo sapiens (Human) GSEPPGRSAGLQGATER 5.46999979 1 1 0.457892346 1670.541954 0 0 0 0 0 0 0 0 0 0 0 17.64535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5M8 SRPRB_HUMAN "Signal recognition particle receptor subunit beta, SR-beta (Protein APMCF1)" SRPRB PSEC0230 Homo sapiens (Human) "protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785] "cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" GTP binding [GO:0005525] GO:0005525; GO:0005737; GO:0005785; GO:0005789; GO:0005881; GO:0006617; GO:0016020; GO:0016021; GO:0045047 LLTGLYR 1.820000052 1 1 0.192115999 836.612744 14.99999 11.89345 12.73643 15.94813 0 17.07767 0 0 14.66325 16.38624 14.28531 0 0 0 0 14.6804 0 0 0 0 14.80449 0 0 0 0 0 0 0 14.3381 0 0 0 0 0 0 0 0 0 0 16.03226 15.43504 0 0 0 0 0 0 0 Q9Y5Q6 INSL5_HUMAN "Insulin-like peptide INSL5, Insulin-like peptide 5 [Cleaved into: Insulin-like peptide INSL5 B chain; Insulin-like peptide INSL5 A chain ]" INSL5 UNQ156/PRO182 Homo sapiens (Human) positive regulation of feeding behavior [GO:2000253] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; positive regulation of feeding behavior [GO:2000253] G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179] GO:0001664; GO:0005179; GO:0005576; GO:2000253 KHSVMSR 8.880000114 1 1 0.094471549 859.4407718 0 14.093 13.50544 16.18599 13.95494 0 12.01252 14.2679 0 16.0251 0 14.01623 0 14.07578 13.77726 14.66205 0 0 0 14.98556 15.07396 0 14.58227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5Q9 TF3C3_HUMAN "General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit, TFIIIC 102 kDa subunit, TFIIIC102) (Transcription factor IIIC subunit gamma, TF3C-gamma)" GTF3C3 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0031965; GO:0042791; GO:0042797 ELEYFGLSAAILDK 9.710000038 0.865794361 0.865794361 0.320535119 1568.179926 15.67723 17.21292 14.98245 0 0 13.31145 16.96731 14.9803 15.78616 11.97542 16.55356 19.38248 0 0 0 0 13.07506 15.01334 0 14.38033 14.56734 0 0 0 16.26086 16.67874 16.47349 15.6468 0 0 15.46587 0 16.71311 0 17.82483 0 0 0 0 0 16.39621 12.12605 0 0 0 16.81992 13.86876 15.28204 Q9Y5R6 DMRT1_HUMAN Doublesex- and mab-3-related transcription factor 1 (DM domain expressed in testis protein 1) DMRT1 DMT1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of male gonad development [GO:2000020]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nodal signaling pathway [GO:1900107]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of male gonad development [GO:2000020]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nodal signaling pathway [GO:1900107]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]" "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0002176; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0007281; GO:0007283; GO:0007548; GO:0008354; GO:0030238; GO:0035556; GO:0042802; GO:0045835; GO:0045840; GO:0045944; GO:0046661; GO:0046872; GO:0048599; GO:0060008; GO:0060009; GO:0060903; GO:1900107; GO:1990837; GO:2000020 GGGSGSGASDLGAGSK 17.07999992 1 1 0.354579201 1264.062213 0 21.41183 20.17827 15.08751 0 0 0 20.77694 22.84247 0 0 0 19.4116 0 0 0 19.94022 0 0 20.54494 20.91575 20.12742 0 18.06337 19.84177 21.02511 0 20.04446 0 21.41353 0 21.40062 0 22.04121 21.40291 21.64545 0 0 22.04796 19.48297 0 20.42245 0 0 0 0 21.87025 21.94479 Q9Y5S2 MRCKB_HUMAN "Serine/threonine-protein kinase MRCK beta, EC 2.7.11.1 (CDC42-binding protein kinase beta, CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta, MRCK beta, Myotonic dystrophy protein kinase-like beta)" CDC42BPB KIAA1124 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] GO:0000287; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006468; GO:0007010; GO:0007163; GO:0007165; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031267; GO:0031532; GO:0042641; GO:0044877; GO:0070062; GO:0106310 EELHKQLVEASER 4.53000021 1 1 0.300977802 1568.298515 0 14.04558 14.9604 15.01475 0 0 0 0 0 0 0 0 0 13.62338 0 13.64867 15.39152 14.30122 0 15.30716 0 0 0 15.51686 0 14.07831 0 0 14.59763 0 0 13.97016 16.26755 12.84546 0 0 15.25707 0 0 0 16.14159 15.99684 0 0 15.22659 0 0 0 Q9Y5W5 WIF1_HUMAN "Wnt inhibitory factor 1, WIF-1" WIF1 UNQ191/PRO217 Homo sapiens (Human) anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147] GO:0005102; GO:0005576; GO:0007165; GO:0009986; GO:0016055; GO:0017147; GO:0030178; GO:0045600; GO:0048856 NGGFCNER 6.239999771 1 1 0.221104295 952.7734321 16.27505 0 0 16.91325 10.17467 0 0 16.22644 0 0 16.44457 13.74627 0 14.73213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.68773 0 0 16.38362 0 0 0 0 0 0 0 0 0 0 0 15.5924 15.99268 16.09759 0 Q9Y5W7 SNX14_HUMAN Sorting nexin-14 SNX14 Homo sapiens (Human) autophagosome maturation [GO:0097352]; protein transport [GO:0015031] cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] "cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome maturation [GO:0097352]; protein transport [GO:0015031]" "phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]" GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016021; GO:0030425; GO:0031902; GO:0035091; GO:0043231; GO:0080025; GO:0097352 TMGQKLK 14.06000042 1 1 0.22334558 820.4666284 16.22885 0 14.85766 0 15.34319 15.7536 15.32638 14.19366 16.04902 16.27895 15.52899 15.40901 15.24648 16.30006 14.88773 15.83888 16.03429 15.05944 0 15.00325 0 16.18231 16.89731 15.22012 16.03644 16.75473 15.66724 15.4963 16.45128 0 0 15.4989 0 15.3552 16.03946 17.41939 0 16.52686 16.6238 17.251 16.22816 15.45534 0 15.66154 14.60357 15.50229 16.71772 16.35306 Q9Y5W8 SNX13_HUMAN Sorting nexin-13 (RGS domain- and PHOX domain-containing protein) (RGS-PX1) SNX13 KIAA0713 Homo sapiens (Human) intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547] phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] GO:0005769; GO:0006886; GO:0009968; GO:0031901; GO:0032266; GO:0035091; GO:0043231; GO:0043547 AYSKGK 10.52999973 1 1 0.221586105 653.5347927 15.4862 16.35217 15.70465 16.01523 14.86658 14.89726 15.69779 16.81537 16.338 14.29608 0 15.64591 0 14.77753 15.63565 15.42302 14.96297 16.70078 0 0 15.19794 17.16508 0 15.84582 0 0 0 0 16.60687 0 0 0 16.63661 16.03689 13.97101 16.50255 16.21433 0 17.80231 16.37765 0 0 14.46775 0 0 15.68706 0 0 Q9Y5W9 SNX11_HUMAN Sorting nexin-11 SNX11 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050] endosome [GO:0005768]; membrane [GO:0016020] endosome [GO:0005768]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050] phosphatidylinositol phosphate binding [GO:1901981] GO:0005768; GO:0006886; GO:0016020; GO:0016050; GO:1901981 SCCFLPR 1.809999943 0.99297899 0.99297899 0.285095536 938.2102751 0 0 0 0 15.70401 13.86932 16.73024 0 0 0 0 15.21351 0 0 15.0585 15.64517 0 0 0 16.29812 16.95504 0 0 0 0 0 0 16.18948 0 0 0 16.12861 0 0 0 16.03396 14.20002 14.92485 16.91126 0 0 0 0 11.05843 17.17427 15.39424 13.73267 12.50935 Q9Y5X1 SNX9_HUMAN "Sorting nexin-9 (SH3 and PX domain-containing protein 1, Protein SDP1) (SH3 and PX domain-containing protein 3A)" SNX9 SH3PX1 SH3PXD3A Homo sapiens (Human) cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898] clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802] clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898] 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625] GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0030838; GO:0031234; GO:0031410; GO:0031625; GO:0032437; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045296; GO:0045860; GO:0051044; GO:0060988; GO:0065003; GO:0070062; GO:0071933; GO:0097320 DEKEWK 4.210000038 1 1 0.023572853 833.8002402 0 0 0 17.91569 14.72968 14.28775 0 13.06287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.63434 18.00243 0 0 15.57011 0 0 17.08464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5X2 SNX8_HUMAN Sorting nexin-8 SNX8 Homo sapiens (Human) early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231 HVEYEVSSQR 4.210000038 1 1 0.19562145 1234.888027 14.00299 15.22866 15.13173 12.63625 0 17.81948 14.14748 12.45371 12.7174 0 10.27737 13.75017 16.33412 12.47483 12.73346 0 14.28187 0 0 0 0 9.948502 0 15.05311 17.76686 16.39025 15.67363 0 0 0 17.73335 0 0 0 0 0 0 0 15.66725 0 0 0 0 0 0 0 0 0 Q9Y5X4 NR2E3_HUMAN Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor) NR2E3 PNR RNR Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000978; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007165; GO:0007601; GO:0007602; GO:0008270; GO:0008285; GO:0010628; GO:0030154; GO:0042462; GO:0043565; GO:0045944; GO:0048856; GO:0060041 METRPTALMSSTVAAAAPAAGAASRK 3.619999886 1 1 9.21E-13 2532.470976 0 0 13.50672 0 0 0 0 0 0 0 0 0 14.74032 0 0 13.85251 0 0 0 0 0 0 0 0 16.75947 0 15.65386 0 0 0 16.47837 18.54446 0 17.00792 0 0 0 15.23908 0 0 0 0 0 0 0 0 0 0 Q9Y5Y6 ST14_HUMAN "Suppressor of tumorigenicity 14 protein, EC 3.4.21.109 (Matriptase) (Membrane-type serine protease 1, MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)" ST14 PRSS14 SNC19 TADG15 Homo sapiens (Human) epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508] basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016323; GO:0019897; GO:0030216; GO:0060672 GGGGPK 2.910000086 1 1 0.23016423 471.3419811 0 13.25524 0 0 0 0 15.90334 0 17.00658 0 0 0 0 0 18.27311 0 0 0 0 0 0 0 0 17.71673 0 0 0 0 0 0 18.31598 0 0 0 0 0 0 0 0 0 0 0 0 17.73655 0 0 0 0 Q9Y5Y7 LYVE1_HUMAN "Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1 (Cell surface retention sequence-binding protein 1, CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor)" LYVE1 CRSBP1 HAR XLKD1 UNQ230/PRO263 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cellular extravasation [GO:0002693]; response to wounding [GO:0009611] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; hyaluronic acid binding [GO:0005540]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; anatomical structure morphogenesis [GO:0009653]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cellular extravasation [GO:0002693]; response to wounding [GO:0009611] hyaluronic acid binding [GO:0005540]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] GO:0002693; GO:0004888; GO:0005540; GO:0005886; GO:0005887; GO:0006027; GO:0007160; GO:0009611; GO:0009653; GO:0016020; GO:0038023; GO:0070062 AEELSIQVSCR 6.329999924 1 1 0.152517343 1291.305603 0 14.38543 0 12.95989 14.73296 0 15.47124 11.66515 15.29466 14.40664 16.09186 0 0 0 12.81683 0 0 0 0 0 0 0 0 0 0 14.20463 0 0 9.886811 0 0 11.45298 0 0 0 0 10.63596 0 0 0 0 0 0 0 0 13.76654 14.9756 0 Q9Y5Z7 HCFC2_HUMAN "Host cell factor 2, HCF-2 (C2 factor)" HCFC2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Set1C/COMPASS complex [GO:0048188] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Set1C/COMPASS complex [GO:0048188]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]" transcription coactivator activity [GO:0003713] GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0016032; GO:0016604; GO:0035097; GO:0044665; GO:0048188; GO:0051568; GO:0071339 DSGSPKMYVFGGMCGAR 6.039999962 1 1 0.078731045 1836.487203 11.63811 0 10.30529 14.10473 0 0 0 0 0 0 0 12.8667 0 0 0 10.66712 0 0 0 0 0 0 0 14.86492 0 13.65787 0 15.15026 0 13.55413 0 0 0 0 0 14.04021 0 0 0 14.35242 15.79863 0 0 0 0 0 0 0 Q9Y608 LRRF2_HUMAN "Leucine-rich repeat flightless-interacting protein 2, LRR FLII-interacting protein 2" LRRFIP2 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" "LRR domain binding [GO:0030275]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" LRR domain binding [GO:0030275] GO:0006355; GO:0016055; GO:0030275 QISEYK 6.690000057 5.65E-05 5.65E-05 0.175464643 766.4433834 15.72238 0 14.90764 15.22559 14.91917 15.01991 0 15.38569 0 15.56313 0 0 0 0 0 16.35815 0 16.09034 0 14.62243 15.84478 16.03113 17.03236 16.43213 0 0 16.74714 16.3524 16.96585 14.47712 15.21787 15.79198 14.81607 0 15.69167 0 17.36533 16.50055 16.23313 14.81055 15.04043 16.30339 16.784 13.82958 13.74926 16.32285 16.27984 14.8347 Q9Y615 ACL7A_HUMAN Actin-like protein 7A (Actin-like-7-alpha) ACTL7A Homo sapiens (Human) acrosome assembly [GO:0001675]; fertilization [GO:0009566] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dynactin complex [GO:0005869]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dynactin complex [GO:0005869]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; structural constituent of cytoskeleton [GO:0005200]; acrosome assembly [GO:0001675]; fertilization [GO:0009566] structural constituent of cytoskeleton [GO:0005200] GO:0001669; GO:0001673; GO:0001675; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005856; GO:0005869; GO:0009566; GO:0031514; GO:0032991 SMQLGLHTQTVSCLNKCDIALK 3.049999952 0.266589105 0.266589105 0.124281506 2517.582987 0 14.57768 0 0 14.92993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6.791719 0 0 0 0 0 0 0 0 0 0 0 12.83992 0 16.09186 11.98814 0 0 0 0 0 0 0 0 Q9Y617 SERC_HUMAN "Phosphoserine aminotransferase, EC 2.6.1.52 (Phosphohydroxythreonine aminotransferase, PSAT)" PSAT1 PSA Homo sapiens (Human) L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615] identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170] GO:0004648; GO:0005737; GO:0005829; GO:0006564; GO:0008615; GO:0030170; GO:0042802; GO:0070062 AAEEAKK 11.39999962 0.374941915 0.374941915 0.007128286 747.4322578 16.22683 16.00088 0 0 14.724 11.97881 0 15.6445 15.87561 15.96721 17.41046 17.60114 14.09682 16.73914 13.18399 14.7292 17.43863 12.49564 14.51732 0 14.2612 16.4989 16.41363 0 0 0 15.72307 18.95764 14.65042 18.6553 0 12.43915 14.38231 0 0 0 16.20042 0 12.96661 13.89828 12.31501 13.67173 17.93736 17.73848 0 16.20291 0 0 Q9Y618 NCOR2_HUMAN "Nuclear receptor corepressor 2, N-CoR2 (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor, SMRT) (T3 receptor-associating factor, TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)" NCOR2 CTG26 Homo sapiens (Human) "estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243]" chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; transcription corepressor activity [GO:0003714]; estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243]" chromatin binding [GO:0003682]; DNA binding [GO:0003677]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; transcription corepressor activity [GO:0003714] GO:0000122; GO:0000785; GO:0003677; GO:0003682; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0010243; GO:0010565; GO:0016020; GO:0016363; GO:0016604; GO:0017053; GO:0032355; GO:0035259; GO:0042826; GO:0044849; GO:0044877; GO:0045892; GO:0046965; GO:0047485; GO:0060766; GO:1903799 KLILYFK 20.54999924 0.457605153 0.457605153 0.224365133 925.1514715 16.58876 18.09017 16.79501 18.91235 15.83679 17.58625 16.41271 16.81896 18.04949 18.26093 16.7513 15.69362 15.93201 15.68273 15.73721 15.28724 17.42571 16.76704 16.92854 18.82103 15.09943 16.95864 15.97893 16.8774 16.24414 18.20292 16.18748 0 0 14.93856 17.73131 17.93327 17.38583 0 16.96859 16.5758 17.2985 18.82055 16.00034 17.031 16.74421 0 16.76361 0 16.28578 16.28737 14.42316 15.54475 Q9Y620 RA54B_HUMAN "DNA repair and recombination protein RAD54B, EC 3.6.4.- (RAD54 homolog B)" RAD54B Homo sapiens (Human) determination of adult lifespan [GO:0008340]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724]; determination of adult lifespan [GO:0008340]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410] ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724] GO:0000724; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0006312; GO:0007131; GO:0008340; GO:0009410; GO:0010212; GO:0015616; GO:0016787; GO:0140658 EGIIFLYECVMGMRMNGR 5.369999886 0.039296336 0.039296336 0.069414616 2191.328716 0 0 0 0 0 0 0 0 0 0 0 15.7914 0 0 0 12.80162 16.94778 0 0 22.08512 0 16.82091 0 0 16.35947 0 0 17.40129 0 0 16.87166 0 0 0 0 0 0 17.81372 0 7.952849 0 0 0 0 18.5981 0 0 0 Q9Y623 MYH4_HUMAN "Myosin-4 (Myosin heavy chain 2b, MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb, MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal)" MYH4 Homo sapiens (Human) actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146] GO:0000146; GO:0003725; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0016887; GO:0030016; GO:0030017; GO:0030048; GO:0030049; GO:0032982; GO:0046034; GO:0051015 DAMVSQLSR 3.980000019 0.012830636 0.012830636 2.17E-12 1006.837327 13.7944 0 10.9374 15.26155 17.72317 0 0 0 0 10.94978 16.35245 14.56955 14.25592 15.44178 16.60944 0 0 14.51563 0 10.98094 0 17.66715 16.461 13.28537 16.80399 15.32341 12.07157 15.53643 16.31738 12.79715 14.92628 17.31333 14.87002 12.56522 16.19589 0 15.79294 0 17.03449 13.42126 0 14.45057 8.392653 9.146929 0 0 15.44099 16.9942 Q9Y657 SPIN1_HUMAN Spindlin-1 (Ovarian cancer-related protein) (Spindlin1) SPIN1 OCR SPIN Homo sapiens (Human) "chromatin organization [GO:0006325]; gamete generation [GO:0007276]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]; Wnt signaling pathway [GO:0016055]" cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; gamete generation [GO:0007276]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]; Wnt signaling pathway [GO:0016055]" methylated histone binding [GO:0035064] GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0005829; GO:0006325; GO:0006355; GO:0007276; GO:0009303; GO:0016055; GO:0030177; GO:0031965; GO:0035064; GO:0045893; GO:0051321 TPGQRSR 2.420000076 1 1 0.220703664 802.328558 15.08268 15.54709 0 0 0 0 0 0 0 0 0 14.59717 0 0 0 16.82557 0 16.50126 0 0 0 0 0 0 0 0 0 0 0 0 16.20472 0 16.21757 16.05812 15.54873 0 0 0 16.10475 0 16.57656 0 0 0 0 0 0 0 Q9Y662 HS3SB_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 3B1, EC 2.8.2.30 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1, 3-OST-3B, Heparan sulfate 3-O-sulfotransferase 3B1, h3-OST-3B)" HS3ST3B1 3OST3B1 HS3ST3B Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; protein sulfation [GO:0006477]" Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] "Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; protein sulfation [GO:0006477]" [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872] GO:0000139; GO:0005887; GO:0006024; GO:0006477; GO:0008467; GO:0015012; GO:0015015; GO:0033872 EAPARISAMSK 3.569999933 0.569760561 0.569760561 0.364549941 1176.04691 15.59787 0 13.06786 15.96705 0 12.29115 0 13.39845 14.82643 0 0 0 16.2923 0 0 0 16.39175 0 0 0 0 0 0 0 0 0 16.01748 0 0 0 0 0 0 0 0 0 0 0 0 0 15.99091 0 0 0 0 0 0 0 Q9Y664 KPTN_HUMAN KICSTOR complex protein kaptin (Actin-associated protein 2E4) KPTN Homo sapiens (Human) actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462] KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420] KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462] actin filament binding [GO:0051015] GO:0005765; GO:0007015; GO:0030027; GO:0032420; GO:0034198; GO:0042149; GO:0051015; GO:0061462; GO:0098871; GO:0140007; GO:1904262 MMGEAAVAAGPCPLR 5.409999847 1 1 0.405412904 1562.78067 15.0784 0 14.74888 0 11.87419 0 0 14.51196 0 0 0 13.43396 12.99187 15.97345 14.0407 0 13.29148 13.42957 14.85353 0 0 16.45712 0 0 0 0 0 0 13.82967 0 13.00699 0 13.45274 14.64961 12.45876 15.21241 0 16.3485 0 12.90349 14.16992 16.3007 0 0 0 0 17.57255 16.18361 Q9Y672 ALG6_HUMAN "Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase, EC 2.4.1.267 (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)" ALG6 My046 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]" "dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]" GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0042281; GO:0046527 GYESQAHK 8.159999847 1 1 0.142214943 919.4272325 0 0 0 0 0 0 0 15.91881 0 0 15.08578 13.24004 15.64382 0 0 0 14.21227 0 15.35127 0 16.50675 0 15.05755 13.84364 0 0 14.24041 14.98613 0 0 14.57189 14.96311 0 14.67459 15.01452 0 12.90869 0 0 0 0 0 0 0 0 14.38483 0 0 Q9Y673 ALG5_HUMAN "Dolichyl-phosphate beta-glucosyltransferase, DolP-glucosyltransferase, EC 2.4.1.117 (Asparagine-linked glycosylation protein 5 homolog)" ALG5 HSPC149 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]; determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576] GO:0004576; GO:0004581; GO:0005789; GO:0006486; GO:0006487; GO:0007368; GO:0016020; GO:0016021; GO:0018279 VRVITLVK 5.449999809 0.636579394 0.636579394 0.28993948 929.1400825 15.76882 17.29984 18.60499 18.40427 0 0 17.98145 0 18.35633 17.80478 0 0 0 0 0 0 0 18.87704 18.27943 16.0943 0 0 0 0 0 18.80969 0 17.51279 0 0 0 0 0 19.22286 0 0 18.17503 0 17.55892 0 0 17.6388 0 17.11061 16.03517 17.02166 0 0 Q9Y675 SNURF_HUMAN SNRPN upstream reading frame protein SNURF Homo sapiens (Human) nuclear speck [GO:0016607]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleus [GO:0005634] GO:0005634; GO:0016607 QAFLAETPR 5.21999979 0.166018173 0.166018173 0.225240387 1030.106469 15.49221 15.38077 14.2798 11.09179 0 15.57979 15.10213 0 16.16228 14.60476 16.58054 15.01744 0 0 0 0 0 0 17.36106 16.2382 0 15.64018 0 0 14.61907 15.55814 13.43366 0 15.32999 0 14.72341 15.06751 14.24545 0 15.20237 0 0 0 0 14.65448 0 0 0 15.89199 15.15306 15.97635 16.5348 13.88325 Q9Y678 COPG1_HUMAN "Coatomer subunit gamma-1 (Gamma-1-coat protein, Gamma-1-COP)" COPG1 COPG Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306] structural molecule activity [GO:0005198] GO:0000139; GO:0005198; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0051683; GO:0072384 GGHDILVR 5.980000019 1 1 0.168800237 866.1639337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.89158 0 0 0 18.0191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y680 FKBP7_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP7, PPIase FKBP7, EC 5.2.1.8 (23 kDa FK506-binding protein, 23 kDa FKBP, FKBP-23) (FK506-binding protein 7, FKBP-7) (Rotamase)" FKBP7 FKBP23 UNQ670/PRO1304 Homo sapiens (Human) peptidyl-proline modification [GO:0018208] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; peptidyl-proline modification [GO:0018208] calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0003755; GO:0005509; GO:0005528; GO:0005783; GO:0005788; GO:0018208 VVIPPSFAYGK 4.449999809 0.161932334 0.161932334 0.051738381 1177.260838 13.10334 0 0 14.44156 13.84651 0 0 13.05406 0 0 0 12.80897 0 0 0 18.3156 0 0 14.0815 0 13.99082 0 0 15.06941 17.89391 0 0 15.22214 0 0 0 15.27595 0 0 0 0 12.36018 0 14.83545 0 0 12.49783 11.26146 0 0 0 12.72808 0 Q9Y689 ARL5A_HUMAN ADP-ribosylation factor-like protein 5A ARL5A ARFLP5 ARL5 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0016192; GO:1903292 VIIVGLDNAGK 6.300000191 1 1 0.119506436 1097.509701 15.35245 15.16299 0 15.6735 14.36415 13.25539 0 0 0 0 0 0 0 8.442018 0 0 0 0 15.29318 0 0 0 0 0 0 0 0 0 0 0 15.53675 15.71906 0 0 0 0 0 0 0 0 0 0 0 0 0 14.41183 0 0 Q9Y692 GMEB1_HUMAN "Glucocorticoid modulatory element-binding protein 1, GMEB-1 (DNA-binding protein p96PIF) (Parvovirus initiation factor p96, PIF p96)" GMEB1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp27 protein binding [GO:0051008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp27 protein binding [GO:0051008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0042802; GO:0046872; GO:0051008; GO:1990837 AILLWKK 5.889999866 1 1 0.199423288 869.6646452 0 0 15.09731 0 0 16.44444 14.76313 14.85374 12.37638 0 0 13.54873 0 0 0 6.11677 15.9473 16.94487 0 15.91004 17.31589 0 0 0 0 0 0 17.10068 16.11781 0 16.58667 16.07098 15.91293 0 0 0 0 0 0 0 0 15.75624 0 0 0 0 15.8339 0 Q9Y697 NFS1_HUMAN "Cysteine desulfurase, mitochondrial, EC 2.8.1.7" NFS1 NIFS HUSSY-08 Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777] cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0046872; GO:0051536; GO:1990229 LRVGDR 6.619999886 1 1 0.262397161 717.0025243 0 0 0 0 0 0 0 0 0 15.0812 0 0 0 0 0 15.99612 0 0 15.66518 0 0 16.85885 0 14.26494 0 0 16.80681 0 0 16.12399 0 16.13768 0 0 0 16.10881 15.99543 16.85487 16.45117 0 17.40355 17.14602 0 15.74906 17.16448 17.22457 15.6698 17.45543 Q9Y6A5 TACC3_HUMAN Transforming acidic coiled-coil-containing protein 3 (ERIC-1) TACC3 ERIC1 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236] GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850 KEQMR 6.610000134 1 1 0.270513539 708.0805136 0 0 15.04113 0 0 0 16.45328 0 0 0 0 0 0 16.82745 17.07659 0 0 15.95803 0 0 16.4521 18.52153 18.95917 0 16.19844 16.16252 16.94603 16.6858 15.7644 0 16.56245 16.68758 15.23177 0 16.65545 17.88428 17.45812 17.56767 15.82483 15.67095 16.52991 16.6526 15.84627 0 17.26385 0 0 16.81459 Q9Y6B7 AP4B1_HUMAN AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin) AP4B1 Homo sapiens (Human) protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] clathrin binding [GO:0030276] GO:0005802; GO:0005829; GO:0006605; GO:0008104; GO:0016192; GO:0019898; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588 SSSPGVVMGATK 14.14999962 1 1 0.214309371 1120.734245 13.10032 0 13.14201 12.9357 15.11973 13.86558 11.95413 14.45369 11.43566 0 13.21007 15.25935 0 0 0 0 0 0 12.58417 14.49715 0 15.18614 0 0 0 15.7385 0 0 14.88993 0 16.20266 0 0 0 0 0 0 0 13.99356 14.48524 0 0 0 0 0 16.66061 0 15.02393 Q9Y6C2 EMIL1_HUMAN "EMILIN-1 (Elastin microfibril interface-located protein 1, Elastin microfibril interfacer 1)" EMILIN1 EMI Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668]; extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640]; aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640] GO:0003180; GO:0005576; GO:0005581; GO:0005615; GO:0007155; GO:0007160; GO:0008217; GO:0010628; GO:0010629; GO:0010811; GO:0016477; GO:0016525; GO:0030023; GO:0030194; GO:0030512; GO:0030948; GO:0032966; GO:0033627; GO:0034668; GO:0042127; GO:0042802; GO:0045766; GO:0048251; GO:0050866; GO:0060394; GO:0062023; GO:0070062; GO:0070373; GO:0098640; GO:1900426; GO:1901203; GO:1904027; GO:1905522; GO:1990971 LLASVEER 8.039999962 1 1 0.270156726 915.3409282 16.00098 14.41328 15.5498 14.36411 14.8177 12.74031 13.84753 0 0 10.59768 15.65788 0 15.1196 0 0 15.05162 13.848 0 14.40471 14.37024 0 15.88974 0 0 15.61358 0 14.3866 0 0 0 0 15.70573 0 14.93208 17.38693 0 0 0 16.72566 16.40672 0 0 14.85689 13.8042 0 0 0 14.53137 Q9Y6C5 PTC2_HUMAN "Protein patched homolog 2, PTC2" PTCH2 UNQ560/PRO1121/PRO57079 Homo sapiens (Human) cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224] hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119] GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0045879; GO:0097108 GPGPATG 1.470000029 1 1 0.162161803 556.6913859 14.8303 16.51568 12.55479 15.51322 11.55332 14.62196 15.82978 0 0 0 0 0 0 15.65116 0 0 0 0 0 0 12.56826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.53122 0 16.89701 0 0 0 0 0 0 0 0 0 Q9Y6C9 MTCH2_HUMAN Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein) MTCH2 MIMP HSPC032 Homo sapiens (Human) lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635] GO:0005634; GO:0005739; GO:0005741; GO:0005743; GO:0010635; GO:0016020; GO:0016021; GO:0043065; GO:0055088; GO:0070585; GO:2000738 MADAASQVLLGSGLTILSQPLMYVK 11.55000019 1 1 0.434928613 2621.436871 0 0 0 0 0 0 0 22.77418 22.64373 0 0 20.56685 0 22.07593 0 22.02778 21.33089 0 0 0 0 0 0 0 0 22.47179 0 0 0 0 0 0 0 0 18.40067 0 0 0 0 22.77899 0 0 0 0 0 0 20.54648 0 Q9Y6D0 SELK_HUMAN "Selenoprotein K, SelK" SELENOK SELK HSPC030 HSPC297 Homo sapiens (Human) calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; protein palmitoylation [GO:0018345]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein transport [GO:0051223]; respiratory burst after phagocytosis [GO:0045728]; response to oxidative stress [GO:0006979] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; protein palmitoylation [GO:0018345]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein transport [GO:0051223]; respiratory burst after phagocytosis [GO:0045728]; response to oxidative stress [GO:0006979] identical protein binding [GO:0042802] GO:0002230; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006816; GO:0006979; GO:0010742; GO:0016021; GO:0018345; GO:0032469; GO:0032755; GO:0032760; GO:0042102; GO:0042802; GO:0045728; GO:0050848; GO:0051223; GO:0070059; GO:0071639; GO:2000406 MVYISNGQVLDSR 12.53999996 1 1 0.044233349 1481.914272 10.43584 15.71966 13.90554 0 0 0 14.77292 10.57928 14.92028 11.45274 0 6.695354 0 15.42519 13.33596 8.720258 9.756022 14.49141 0 14.60602 15.44071 14.11716 0 0 0 13.25437 0 0 0 13.08054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6D5 BIG2_HUMAN "Brefeldin A-inhibited guanine nucleotide-exchange protein 2, Brefeldin A-inhibited GEP 2 (ADP-ribosylation factor guanine nucleotide-exchange factor 2)" ARFGEF2 ARFGEP2 BIG2 Homo sapiens (Human) endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012] asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802] asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802]; GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012] GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] GO:0000139; GO:0001881; GO:0005085; GO:0005794; GO:0005802; GO:0005815; GO:0005829; GO:0005879; GO:0006887; GO:0006893; GO:0007032; GO:0010256; GO:0015031; GO:0016020; GO:0017022; GO:0031410; GO:0032012; GO:0032279; GO:0032280; GO:0032760; GO:0034237; GO:0035556; GO:0043197; GO:0043231; GO:0048471; GO:0050811; GO:0055037 DMAIR 4.829999924 1 1 0.38566885 620.6597452 0 0 0 0 0 0 0 0 0 0 0 0 16.54462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6D6 BIG1_HUMAN "Brefeldin A-inhibited guanine nucleotide-exchange protein 1, Brefeldin A-inhibited GEP 1 (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1)" ARFGEF1 ARFGEP1 BIG1 Homo sapiens (Human) endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0006887; GO:0007030; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0090284; GO:0090303; GO:2000114 FLTSQQLFK 3.220000029 1 1 0.157938465 1110.637611 0 0 0 0 0 14.53574 0 0 0 0 0 12.38327 0 0 0 12.60215 9.956769 0 0 13.65037 0 0 0 0 0 0 0 13.24408 13.44196 0 0 13.84563 10.73436 0 15.47278 14.60126 0 0 14.76247 0 0 0 14.59352 0 0 0 0 15.06771 Q9Y6D9 MD1L1_HUMAN "Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1, MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog, HsMAD1, hMAD1) (Tax-binding protein 181)" MAD1L1 MAD1 TXBP181 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538] identical protein binding [GO:0042802]; kinetochore binding [GO:0043515] GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728 MQEQLER 2.109999895 0.564864159 0.564864159 0.302150636 932.2598341 17.4455 0 0 0 17.15318 0 16.90809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.73724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6E0 STK24_HUMAN "Serine/threonine-protein kinase 24, EC 2.7.11.1 (Mammalian STE20-like protein kinase 3, MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal, MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal, MST3/C) ]" STK24 MST3 STK3 Homo sapiens (Human) cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165] ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000139; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0008631; GO:0009267; GO:0030336; GO:0042542; GO:0045296; GO:0046777; GO:0046872; GO:0048679; GO:0048680; GO:0070062; GO:0097194; GO:0106310 GEPPHSELHPMK 10.77999973 1 1 0.325699831 1373.710407 0 14.50915 15.37713 0 0 0 0 0 14.91689 0 16.43385 0 0 16.74128 0 15.45542 13.64646 8.388667 0 0 0 0 14.69585 0 17.35413 0 16.83181 14.48262 0 0 14.3776 16.07964 15.0499 0 0 0 16.67278 15.11759 0 15.3915 16.49954 15.35923 0 16.63468 16.17544 0 0 0 Q9Y6E2 5MP1_HUMAN eIF5-mimic protein 1 (Basic leucine zipper and W2 domain-containing protein 2) BZW2 5MP1 HSPC028 MSTP017 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of translational initiation [GO:0006446] cadherin binding [GO:0045296] GO:0005737; GO:0006446; GO:0007399; GO:0016020; GO:0030154; GO:0045296 AFSETEQTK 4.840000153 1 1 0.15805403 1039.766602 0 0 0 0 0 0 0 0 16.52044 0 11.85924 0 12.39255 0 0 0 0 0 0 0 0 0 13.99789 0 0 0 0 16.56343 0 0 0 14.36949 0 0 0 0 0 0 12.96446 0 0 0 0 0 15.88517 0 17.26078 0 Q9Y6F1 PARP3_HUMAN "Protein mono-ADP-ribosyltransferase PARP3, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 3, ARTD3) (DNA ADP-ribosyltransferase PARP3, EC 2.4.2.-) (IRT1) (NAD(+) ADP-ribosyltransferase 3, ADPRT-3) (Poly [ADP-ribose] polymerase 3, PARP-3, hPARP-3) (Poly[ADP-ribose] synthase 3, pADPRT-3)" PARP3 ADPRT3 ADPRTL3 Homo sapiens (Human) DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723] centriole [GO:0005814]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] centriole [GO:0005814]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723] catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404] GO:0000723; GO:0003824; GO:0003950; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006281; GO:0006302; GO:0006471; GO:0016604; GO:0030592; GO:0035861; GO:0045171; GO:0045829; GO:0051106; GO:0060236; GO:0070212; GO:0070213; GO:0140289; GO:0140294; GO:1905662; GO:1990166; GO:1990404; GO:2001034 TKNNWAER 14.77000046 1 1 0.202442687 1018.499474 0 15.33242 0 19.55828 0 0 16.0839 0 0 17.5614 0 0 18.45893 0 17.6791 17.72541 16.49643 18.70221 19.44079 16.00553 18.86689 0 17.72005 17.05693 0 16.75135 0 17.01131 18.35343 18.98184 17.79688 18.52329 17.97341 17.47662 0 20.39869 18.59522 19.3562 19.4548 19.33569 18.00168 19.61178 20.14456 17.36866 16.99903 18.05934 18.39668 19.24143 Q9Y6F6 IRAG1_HUMAN "Inositol 1,4,5-triphosphate receptor associated 1 (Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate) (JAW1-related protein MRVI1) (Protein MRVI1)" IRAG1 IRAG JAW1L MRVI1 Homo sapiens (Human) cGMP-mediated signaling [GO:0019934] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; cGMP-mediated signaling [GO:0019934] GO:0005789; GO:0016021; GO:0016529; GO:0019934; GO:0031095; GO:0048471 SMSLTLGKNMPR 6.849999905 1 1 0.094813595 1350.563446 0 0 0 0 0 0 0 0 0 0 0 0 0 16.54577 0 15.6587 0 0 0 16.89237 0 0 0 0 0 0 15.35151 16.1002 0 0 17.5879 15.05508 0 17.315 0 16.28232 16.47457 16.95515 0 15.91745 0 0 0 0 0 0 0 16.55584 Q9Y6F8 CDY1_HUMAN "Testis-specific chromodomain protein Y 1, EC 2.3.1.48" CDY1 CDY1A; CDY1B Homo sapiens (Human) spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; spermatogenesis [GO:0007283] histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0004402; GO:0005634; GO:0007283; GO:0035064 TQIHPLMSQMSGSVTASMATGSATRK 6.920000076 1 1 0.247241074 2695.690038 14.35753 0 8.698849 0 0 0 0 14.21272 0 0 14.38312 14.04805 0 14.76837 0 13.23912 0 0 13.27712 0 0 0 15.11647 0 0 0 15.83948 0 13.93643 0 0 0 15.61677 0 0 0 13.87025 0 15.54523 15.79539 0 0 0 16.2218 0 14.37155 0 0 Q9Y6F9 WNT6_HUMAN Protein Wnt-6 WNT6 Homo sapiens (Human) "axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]" cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]" cytokine activity [GO:0005125]; frizzled binding [GO:0005109] GO:0001658; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0009798; GO:0009986; GO:0010628; GO:0030182; GO:0030666; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060070; GO:0060684; GO:0061303; GO:0070062; GO:0070172; GO:0071300; GO:0072079 TGSPGTR 8.239999771 1 1 0.059384729 676.3644826 15.04497 17.22682 18.11264 16.91656 17.63119 17.4706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6G3 RM42_HUMAN "39S ribosomal protein L42, mitochondrial, L42mt, MRP-L42 (39S ribosomal protein L31, mitochondrial, L31mt, MRP-L31) (Mitochondrial large ribosomal subunit protein mL42)" MRPL42 MRPL31 MRPS32 RPML31 HSPC204 PTD007 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0005886; GO:0006412; GO:0032543 MAVAAVK 28.18000031 0.003396253 0.003396253 0.260129182 706.2236327 16.60982 15.64148 0 15.14011 15.56208 14.85198 16.23172 15.25775 13.51317 0 15.82447 15.16674 0 15.30305 17.23834 15.95302 15.4063 0 16.43427 0 15.65739 0 17.30369 0 16.58382 16.04794 0 15.77054 16.77167 0 15.15831 16.79444 16.27154 0 0 0 0 0 16.83574 15.64571 16.40177 16.04145 0 0 0 16.04285 15.70624 0 Q9Y6G9 DC1L1_HUMAN "Cytoplasmic dynein 1 light intermediate chain 1, LIC1 (Dynein light chain A, DLC-A) (Dynein light intermediate chain 1, cytosolic)" DYNC1LI1 DNCLI1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; RNA binding [GO:0003723] GO:0000226; GO:0000776; GO:0000922; GO:0003723; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005886; GO:0007018; GO:0007049; GO:0016020; GO:0019003; GO:0030667; GO:0045504; GO:0051301; GO:0090267; GO:0101003 AEDNFEDIITKPPVR 4.909999847 1 1 0.172073647 1740.926765 0 0 0 12.20435 15.84778 0 14.99889 0 0 0 0 14.80015 16.61951 0 0 0 0 0 0 0 0 16.2982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6H1 CHCH2_HUMAN "Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein, NS2TP)" CHCHD2 C7orf17 AAG10 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; sequence-specific DNA binding [GO:0043565]; cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037] DNA-binding transcription factor binding [GO:0140297]; sequence-specific DNA binding [GO:0043565] GO:0005634; GO:0005739; GO:0005758; GO:0007005; GO:0034599; GO:0043565; GO:0045944; GO:0140297; GO:1900037; GO:1905448 QCRLANGLA 7.420000076 1 1 0.34485967 1001.350725 15.43884 14.47834 16.39956 14.31274 15.30362 14.8232 0 11.85055 0 12.24584 15.20496 15.10545 15.05971 16.32326 16.08988 0 16.41539 0 0 15.84745 0 16.36655 14.92054 0 0 15.84605 13.88169 15.86944 16.43796 0 0 0 0 0 16.17498 16.25064 17.51308 17.27496 17.11123 15.83925 15.97092 0 15.45464 0 16.88765 0 0 16.00257 Q9Y6H3 ATP23_HUMAN "Mitochondrial inner membrane protease ATP23 homolog, EC 3.4.24.- (Ku70-binding protein 3) (XRCC6-binding protein 1)" ATP23 KUB3 XRCC6BP1 Homo sapiens (Human) double-strand break repair via nonhomologous end joining [GO:0006303]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] cell junction [GO:0030054]; cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extrinsic component of mitochondrial inner membrane [GO:0031314]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extrinsic component of mitochondrial inner membrane [GO:0031314]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; DNA-dependent protein kinase activity [GO:0004677]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; double-strand break repair via nonhomologous end joining [GO:0006303]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] DNA-dependent protein kinase activity [GO:0004677]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] GO:0004222; GO:0004677; GO:0005829; GO:0005886; GO:0005958; GO:0006303; GO:0030054; GO:0031314; GO:0033615; GO:0034982; GO:0043231; GO:0046872 AGAPDERR 4.760000229 1 1 0.12164378 871.6945443 10.40155 0 12.75204 0 14.28196 15.28755 0 13.02291 14.65259 15.66752 0 13.05138 0 0 0 16.03427 0 0 0 0 0 0 0 0 15.97969 13.43084 14.9565 15.01901 14.44439 0 15.14463 0 15.55699 0 0 0 14.63008 0 13.62048 13.81601 0 14.05698 0 0 0 0 0 0 Q9Y6H5 SNCAP_HUMAN "Synphilin-1, Sph1 (Alpha-synuclein-interacting protein)" SNCAIP Homo sapiens (Human) cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928] identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625] GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083 KIPLEK 7.260000229 8.18E-08 8.18E-08 0.278015588 727.3687949 16.7869 0 0 16.72756 0 0 18.99667 0 0 0 19.13342 0 18.17809 16.38092 0 0 18.05547 0 0 17.43677 0 0 0 17.03344 16.15457 18.06989 0 19.05345 17.61764 18.40074 0 0 19.28929 0 19.68308 0 0 0 0 0 18.74892 19.67353 0 0 0 0 18.49457 0 Q9Y6I3 EPN1_HUMAN Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1) EPN1 Homo sapiens (Human) embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219] clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] GO:0001701; GO:0005543; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0007219; GO:0007565; GO:0030125; GO:0030276; GO:0048568; GO:1903671 DFQYVDR 13.85000038 0.041990116 0.041990116 0.143659096 942.3207946 0 17.14421 16.44933 15.51157 15.96784 0 18.27243 18.89838 0 16.50344 16.53732 0 0 17.73572 15.68515 16.81247 12.78915 15.4144 0 0 13.84893 17.29442 17.07517 16.48528 17.58125 0 0 16.43205 19.24254 0 18.00874 19.5491 18.13261 10.50985 0 15.97677 15.13444 13.91968 14.58314 10.75593 0 18.14592 0 16.29221 17.0475 0 0 0 Q9Y6I7 WSB1_HUMAN "WD repeat and SOCS box-containing protein 1, WSB-1 (SOCS box-containing WD protein SWiP-1)" WSB1 SWIP1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314] ubiquitin protein ligase activity [GO:0061630] GO:0005829; GO:0035556; GO:0044314; GO:0061630; GO:0140454 LLEFLSYR 4.78000021 1 1 0.103887954 1040.658144 0 0 0 0 15.58231 13.23457 0 13.97699 13.89435 0 15.73593 14.77275 0 13.36651 13.88995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6I8 PXMP4_HUMAN Peroxisomal membrane protein 4 (24 kDa peroxisomal intrinsic membrane protein) PXMP4 PMP24 Homo sapiens (Human) cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] GO:0005777; GO:0005778; GO:0005829; GO:0016021 MAAPPQLR 11.78999996 0.297799945 0.297799945 0.280515698 899.9904193 14.00133 0 14.481 13.92586 15.27938 0 0 0 0 0 0 0 11.25672 13.5074 0 0 0 0 14.19973 0 13.67065 16.39481 0 0 10.45886 0 16.44501 13.65156 16.4233 15.76477 0 15.22874 0 0 0 0 0 0 0 0 16.59923 12.16131 15.52976 0 0 0 0 15.94871 Q9Y6J0 CABIN_HUMAN "Calcineurin-binding protein cabin-1 (Calcineurin inhibitor, CAIN)" CABIN1 KIAA0330 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent chromatin assembly [GO:0006336] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent chromatin assembly [GO:0006336] protein phosphatase inhibitor activity [GO:0004864] GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235 FDSWAGMALARASR 5.889999866 1 1 0 1552.161574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6K5 OAS3_HUMAN "2'-5'-oligoadenylate synthase 3, (2-5')oligo(A) synthase 3, 2-5A synthase 3, EC 2.7.7.84 (p100 OAS, p100OAS)" OAS3 P/OKcl.4 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] GO:0001730; GO:0003725; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006139; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0043231; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060339; GO:0060700; GO:0071639; GO:0071650; GO:0071659; GO:2000342 GPGLPR 1.820000052 1 1 0.194542987 596.4755106 0 0 14.72332 0 0 14.12123 15.33075 0 13.72598 15.54329 12.65919 13.82363 15.27038 13.62512 0 15.26601 15.50501 16.70014 16.51414 16.17306 15.64127 0 15.74185 0 0 15.44207 0 0 0 16.52108 0 0 0 0 0 0 0 0 0 0 16.04923 0 0 16.4453 0 0 0 0 Q9Y6L6 SO1B1_HUMAN "Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1, LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2, OATP-2) (Solute carrier family 21 member 6)" SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015349; GO:0015711; GO:0015721; GO:0016020; GO:0016323; GO:0042167; GO:0043252 YCNGLKMFLAALSLSFIAK 5.190000057 1 1 0 2146.360359 16.59423 0 15.65295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6M1 IF2B2_HUMAN "Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, IMP-2 (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)" IGF2BP2 IMP2 VICKZ2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247 AQGRIFGK 11.57999992 1 1 0.219540654 877.4439363 16.78926 14.43501 0 0 14.6995 14.59869 0 16.3638 0 17.3625 15.54069 14.47462 13.76675 15.22116 15.34435 8.835226 0 14.72966 16.45549 14.63432 15.40671 0 0 0 15.23046 16.24851 0 0 14.78361 0 0 15.40576 16.45945 0 15.91134 0 11.65647 16.80909 15.85197 15.58085 13.94451 0 0 0 0 0 16.4023 15.54721 Q9Y6M5 ZNT1_HUMAN "Zinc transporter 1, ZnT-1 (Solute carrier family 30 member 1)" SLC30A1 ZNT1 Homo sapiens (Human) cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385] GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010312; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0070509; GO:0070574; GO:0071577; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0099061 LLCMLALTFMFMVLEVVVSR 6.699999809 1 1 0.131504163 2417.642721 11.57107 0 0 0 0 13.82104 0 0 0 0 13.00318 0 13.88192 0 0 0 12.14384 13.13124 14.80997 0 0 15.53565 0 12.11275 0 0 0 12.63795 11.68816 0 11.8373 0 0 13.3038 12.313 10.52066 15.3779 0 15.17372 14.51189 14.71277 13.65715 0 0 0 0 0 0 Q9Y6M7 S4A7_HUMAN "Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b, Bicarbonate transporter) (Solute carrier family 4 member 7)" SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857] GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0032420; GO:0050801; GO:0051453; GO:0055085; GO:0060117 IEPPK 2.380000114 1 1 0.276795022 582.7145962 14.78164 14.0636 15.82243 0 15.49916 0 0 15.33781 14.50327 0 15.69086 16.10862 0 0 0 0 16.34007 0 16.33498 0 0 0 16.10909 0 0 0 0 0 0 0 0 15.98597 0 0 0 16.48355 0 0 0 16.23441 0 0 0 0 16.10207 0 16.24723 0 Q9Y6N1 COX11_HUMAN "Cytochrome c oxidase assembly protein COX11, mitochondrial" COX11 Homo sapiens (Human) metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132] integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132] copper ion binding [GO:0005507]; electron transfer activity [GO:0009055] GO:0005507; GO:0005739; GO:0009055; GO:0031304; GO:0031305; GO:0032991; GO:0033132; GO:0055065 IENMVPVK 7.329999924 0.7806229 0.7806229 0.284218474 945.6229066 0 16.95193 0 0 16.1885 18.20772 0 0 16.28074 16.9939 16.77389 16.57728 17.76997 0 0 0 0 0 0 0 0 0 0 0 17.90202 0 16.26814 0 0 0 18.94607 18.8646 0 0 0 0 0 0 17.06548 16.13335 0 0 18.11834 17.19925 0 0 0 0 Q9Y6N5 SQOR_HUMAN "Sulfide:quinone oxidoreductase, mitochondrial, SQOR, EC 1.8.5.8 (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)" SQOR SQRDL CGI-44 Homo sapiens (Human) "hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]" mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]" FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224] GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949 VTELNPDK 11.61999989 1 1 1.17E-13 915.4831939 0 0 15.30852 0 14.83873 0 0 0 0 0 0 0 0 0 0 15.99071 0 0 0 0 0 0 0 0 0 14.73948 0 0 0 0 0 0 0 15.70452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6N7 ROBO1_HUMAN Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) ROBO1 DUTT1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748 DQVVALGR 7.789999962 0.791894078 0.791894078 0.280361033 857.1825833 18.59361 17.65549 17.26996 19.03221 0 0 18.14356 18.74882 0 19.40751 19.49733 20.17259 0 17.60133 0 0 0 0 17.16797 0 0 18.73963 0 18.10185 19.266 0 19.64731 18.00589 16.97838 18.65589 19.24275 0 18.97182 0 0 0 0 18.24213 0 0 0 0 0 0 17.22891 0 19.4771 18.33467 Q9Y6N8 CAD10_HUMAN Cadherin-10 (T2-cadherin) CDH10 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098609; GO:0098742; GO:0098978; GO:0098982; GO:0099059; GO:0099060 FNKLAEMYGGGESDK 3.220000029 1 1 0.124900376 1645.013024 14.60015 17.74477 16.99985 11.0415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Q2 STON1_HUMAN Stonin-1 (Stoned B-like factor) STON1 SALF SBLF STN1 Homo sapiens (Human) regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; synaptic vesicle [GO:0008021] clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] clathrin adaptor activity [GO:0035615] GO:0008021; GO:0016020; GO:0016192; GO:0030100; GO:0030136; GO:0031410; GO:0035615; GO:0048488 CSTNPGK 6.099999905 1 1 0.212444394 759.8245221 15.21263 0 14.16777 0 0 15.94295 0 0 15.06793 0 0 0 15.55469 15.6743 14.58659 16.42109 15.68117 15.4417 0 0 0 0 16.03586 0 0 0 0 15.63463 0 15.4857 0 14.23677 16.36213 0 15.55202 0 16.60418 15.7792 15.44293 15.91021 0 15.75624 7.216362 15.23378 16.87177 14.74633 16.52521 16.3906 Q9Y6Q3 ZFP37_HUMAN "Zinc finger protein 37 homolog, Zfp-37" ZFP37 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270 GEAPWLGK 3.400000095 1 1 0.198963911 857.4064747 17.46112 13.70093 12.69333 15.67854 14.10584 17.85833 15.63637 0 14.35009 14.42903 0 14.40362 0 0 0 0 16.40456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.23474 0 0 0 0 0 0 0 16.35522 0 15.27454 0 0 Q9Y6Q9 NCOA3_HUMAN "Nuclear receptor coactivator 3, NCoA-3, EC 2.3.1.48 (ACTR) (Amplified in breast cancer 1 protein, AIB-1) (CBP-interacting protein, pCIP) (Class E basic helix-loop-helix protein 42, bHLHe42) (Receptor-associated coactivator 3, RAC-3) (Steroid receptor coactivator protein 3, SRC-3) (Thyroid hormone receptor activator molecule 1, TRAM-1)" NCOA3 AIB1 BHLHE42 RAC3 TRAM1 Homo sapiens (Human) cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035] disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] GO:0000785; GO:0000993; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016922; GO:0030374; GO:0032870; GO:0032991; GO:0035624; GO:0043697; GO:0045618; GO:0045944; GO:0046966; GO:0046983; GO:0047485; GO:0070062; GO:0071392; GO:0097718; GO:1902459; GO:2000035 TNTPKQLR 4.96999979 0.50530982 0.50530982 0.293859674 956.9266155 15.17408 13.32865 13.44331 0 0 0 0 0 13.00718 15.12515 0 13.54562 0 0 15.53278 0 13.90558 12.85343 0 15.72636 15.77021 0 0 0 0 0 0 0 13.20373 0 0 0 0 15.97927 0 0 11.9047 15.63284 0 13.08504 0 0 0 0 0 15.68697 0 14.91611 Q9Y6R1 S4A4_HUMAN "Electrogenic sodium bicarbonate cotransporter 1, Sodium bicarbonate cotransporter (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1)" SLC4A4 NBC NBC1 NBCE1 Homo sapiens (Human) bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; positive regulation of glycolytic process [GO:0045821]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; positive regulation of glycolytic process [GO:0045821]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] GO:0005452; GO:0005886; GO:0005887; GO:0006814; GO:0008510; GO:0009986; GO:0015293; GO:0015701; GO:0016020; GO:0016323; GO:0022857; GO:0035725; GO:0036376; GO:0042391; GO:0042802; GO:0045821; GO:0050801; GO:0051453; GO:0055085; GO:0070062; GO:0150104 WSKPHVATLSLHSLFELR 3.859999895 1 1 0.533836602 2121.38972 0 17.28586 15.06905 17.77293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6R4 M3K4_HUMAN "Mitogen-activated protein kinase kinase kinase 4, EC 2.7.11.25 (MAP three kinase 1) (MAPK/ERK kinase kinase 4, MEK kinase 4, MEKK 4)" MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] GO:0000165; GO:0001890; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:0106310; GO:1900745; GO:1904355 LSAPVR 7.099999905 0.224038363 0.224038363 0.304680319 641.1128942 0 16.11011 15.72745 15.98333 0 16.99634 0 15.35131 0 15.79152 16.13563 15.50105 0 16.13431 15.36891 0 0 0 0 0 0 15.80296 15.16677 16.57041 16.17844 0 0 0 15.98313 0 15.14317 0 15.92621 0 16.18162 17.73827 0 0 0 16.90778 0 16.01244 0 16.14689 0 0 0 16.71681 Q9Y6R7 FCGBP_HUMAN "IgGFc-binding protein (Fcgamma-binding protein antigen, FcgammaBP)" FCGBP Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] GO:0005615; GO:0031012; GO:0070062 SRLPVSLSEGR 10.10999966 1 1 0.616342782 1200.263105 0 19.73714 19.74038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.37688 0 0 0 0 0 18.23367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6W5 WASF2_HUMAN "Wiskott-Aldrich syndrome protein family member 2, WASP family protein member 2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2)" WASF2 WAVE2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601] actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124] GO:0001525; GO:0001667; GO:0001726; GO:0003779; GO:0005769; GO:0005829; GO:0005911; GO:0006897; GO:0007188; GO:0010592; GO:0015629; GO:0016323; GO:0016601; GO:0017124; GO:0030027; GO:0030032; GO:0030036; GO:0030048; GO:0031209; GO:0032991; GO:0034237; GO:0035855; GO:0045202; GO:0045296; GO:0051018; GO:0051497; GO:0070062; GO:0071933; GO:0072673; GO:0098974; GO:2000601 QTLPSVR 11.07999992 0.897524118 0.897524118 0.247281129 801.2630932 16.24491 12.87834 15.01839 14.99655 14.18489 14.86078 16.27247 15.85957 14.73585 16.54538 16.28767 14.01832 0 14.95214 0 0 0 0 15.91351 14.88862 0 15.85157 0 16.95613 17.14462 0 16.88041 15.66609 0 16.92807 0 17.88474 0 17.23767 13.14874 0 13.92564 0 16.96222 0 15.97945 0 0 0 14.17909 0 16.57499 16.62327 Q9Y6W6 DUS10_HUMAN "Dual specificity protein phosphatase 10, EC 3.1.3.16, EC 3.1.3.48 (Mitogen-activated protein kinase phosphatase 5, MAP kinase phosphatase 5, MKP-5)" DUSP10 MKP5 Homo sapiens (Human) dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496] JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] GO:0002819; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0008330; GO:0008432; GO:0010633; GO:0016311; GO:0016607; GO:0016791; GO:0017017; GO:0030336; GO:0032496; GO:0033549; GO:0035970; GO:0043409; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0048715; GO:0050680; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264 ILTPKLMGVETVV 10.14000034 1 1 6.87E-13 1415.684553 0 0 0 15.60251 11.77737 13.78741 0 0 13.76505 0 15.58673 0 16.18667 0 0 0 12.49318 14.54065 14.30507 0 0 0 0 15.27632 0 0 0 0 14.32829 0 13.69917 0 15.9889 14.51328 0 15.05814 15.52647 0 0 0 0 15.29758 0 0 0 0 0 0 Q9Y6X0 SETBP_HUMAN "SET-binding protein, SEB" SETBP1 KIAA0437 Homo sapiens (Human) cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677] DNA binding [GO:0003677] GO:0003677; GO:0005654; GO:0005829; GO:0016604 HGVHLQGPVSMGLGDMQPSLNPPK 3.910000086 1 1 0.017872799 2527.386466 14.4618 0 15.00071 0 15.57828 12.97269 0 0 0 0 0 13.18105 14.96125 0 0 0 0 14.91343 14.23128 14.05227 0 0 16.46529 0 0 14.22078 15.13651 0 14.68985 0 0 12.67822 16.35683 15.3679 13.94561 0 0 0 0 0 16.51814 0 0 0 0 0 0 0 Q9Y6X6 MYO16_HUMAN Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16) MYO16 KIAA0865 MYO16B NYAP3 Homo sapiens (Human) cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903]; cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903] GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0014065; GO:0016459; GO:0019903; GO:0021549; GO:0048471; GO:0048812; GO:0051015; GO:2000134 QMKLQRPMSMLTDVK 13.13000011 1 1 0.392382437 1836.749353 0 0 13.22301 0 0 0 0 0 0 0 15.78143 11.67853 14.15344 0 0 0 14.24282 0 0 0 0 0 16.17241 16.355 0 0 0 13.554 0 0 0 0 16.21925 0 0 0 0 12.70881 0 0 0 0 0 0 12.73151 0 0 0 Q9Y6X8 ZHX2_HUMAN "Zinc fingers and homeoboxes protein 2 (Alpha-fetoprotein regulator 1, AFP regulator 1) (Regulator of AFP) (Zinc finger and homeodomain protein 2)" ZHX2 AFR1 KIAA0854 RAF Homo sapiens (Human) "mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]" "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]" GO:0000122; GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006402; GO:0035019; GO:0042802; GO:0042803; GO:0045665; GO:0045892; GO:0046872; GO:0046982; GO:0060040 EKTQGQVK 2.880000114 1 1 0.197164136 916.4922423 14.75308 0 15.431 13.38839 14.73796 0 15.13919 15.61448 14.72531 16.03035 0 0 16.32733 14.85077 15.46874 14.5317 15.8731 13.59661 16.10385 8.06818 13.79021 14.29269 15.63629 17.04238 15.58662 17.23202 15.39764 0 0 14.48716 0 0 0 15.69116 15.52218 0 17.2674 0 0 16.06729 13.95353 15.42539 0 15.01591 15.30648 0 15.0431 0 Q9Y6Z5 AFDDT_HUMAN Putative uncharacterized protein AFDN-DT (AFDN divergent transcript) (Protein HGC6.4) AFDN-DT AFDN-AS1 C6orf124 Homo sapiens (Human) AVLGPNGR 2.170000076 0.419846237 0.419846237 0.23530919 783.8488718 12.96674 0 0 0 14.40217 15.18979 13.9373 14.44752 14.29906 15.66283 0 16.03388 15.22985 14.7472 0 0 15.77336 0 0 0 0 0 14.45593 0 0 0 0 15.28781 16.03501 0 15.91274 0 14.85584 14.36902 15.15897 15.47747 14.91598 0 0 15.69415 0 0 0 15.89856 0 13.46905 13.08889 0 Q9Y6Z7 COL10_HUMAN "Collectin-10 (Collectin liver protein 1, CL-L1) (Collectin-34, CL-34)" COLEC10 CLL1 UNQ366/PRO702 Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370] "collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370]; chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" chemoattractant activity [GO:0042056]; mannose binding [GO:0005537] GO:0001867; GO:0002752; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0005794; GO:0006508; GO:0009897; GO:0042056; GO:1903028; GO:1904888; GO:1905370 FYYIVQEEKNYR 5.239999771 1 1 0.341479824 1652.73675 15.55768 0 0 0 15.29869 0 0 18.94066 0 0 0 0 16.67377 0 0 17.19689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.29013 0 0 14.46075 0 0 13.02207 16.63237 0 0 0 0 0 15.43489 0 16.53028 0 U3KPV4 A3LT2_HUMAN "Alpha-1,3-galactosyltransferase 2, EC 2.4.1.87 (Isoglobotriaosylceramide synthase, iGb3 synthase, iGb3S)" A3GALT2 A3GALT2P IGBS3S Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular response to manganese ion [GO:0071287]; glycosphingolipid biosynthetic process [GO:0006688]; lipid glycosylation [GO:0030259] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; N-acetyllactosaminide 3-alpha-galactosyltransferase activity [GO:0047276]; carbohydrate metabolic process [GO:0005975]; cellular response to manganese ion [GO:0071287]; glycosphingolipid biosynthetic process [GO:0006688]; lipid glycosylation [GO:0030259] glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; N-acetyllactosaminide 3-alpha-galactosyltransferase activity [GO:0047276] GO:0005794; GO:0005975; GO:0006688; GO:0016021; GO:0016757; GO:0030259; GO:0031982; GO:0032580; GO:0046872; GO:0047276; GO:0071287 VALGPGRR 7.170000076 0.010038396 0.010038396 0.15590111 826.1869536 14.21528 15.36238 14.25871 0 0 15.01388 0 13.87601 13.90175 16.03965 0 0 14.3816 14.0879 14.55838 0 14.93272 0 0 16.08654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.60372 0 0 15.48722 0 0 0 13.54496 14.9611 0 0 0